[{"RECTYPE": "D", "MH": "Calcimycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "4-Benzoxazolecarboxylic acid, 5-(methylamino)-2-((3,9,11-trimethyl-8-(1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl)-1,7-dioxaspiro(5.5)undec-2-yl)methyl)-, (6S-(6alpha(2S*,3S*),8beta(R*),9beta,11alpha))-|T109|T195|NON|EQV|NLM (2024)|220922|abbcdef", "ENTRY": "A23187, Antibiotic", "MN": "D04.345.674.625.125", "PA": "Calcium Ionophores", "MH_TH": "NLM (1975)", "ST": "T195", "RN": "37H9VM9WZL", "RR": "52665-69-7 (Calcimycin)", "PI": "Carboxylic Acids (1973-1974)", "MS": "An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports CALCIUM and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems.", "OL": "use CALCIMYCIN to search A 23187 1975-90", "PM": "91; was A 23187 1975-90 (see under ANTIBIOTICS 1975-83)", "HN": "91(75); was A 23187 1975-90 (see under ANTIBIOTICS 1975-83)", "MR": "20230226", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D000001"}, {"RECTYPE": "D", "MH": "Temefos", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Temephos|T109|T131|TRD|EQV|NLM (1996)|941201|abbcdef", "MN": "D02.886.300.692.800", "PA": "Insecticides", "MH_TH": "USAN (1974)", "ST": "T131", "N1": "Phosphorothioic acid, O,O'-(thiodi-4,1-phenylene) O,O,O',O'-tetramethyl ester", "RN": "ONP3ME32DL", "RR": "3383-96-8 (Temefos)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING ", "PI": "Insecticides (1966-1971)", "MS": "An organothiophosphate insecticide.", "PM": "96; was ABATE 1972-95 (see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90)", "HN": "96; was ABATE 1972-95 (see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000002"}, {"RECTYPE": "D", "MH": "Abattoirs", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Slaughterhouses|T073|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Slaughterhouse", "MN": "J03.540.020", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Places where animals are slaughtered and dressed for market.", "MR": "20160608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000003"}, {"RECTYPE": "D", "MH": "Abbreviations as Topic", "ENTRY": "Acronyms as Topic|T170|NON|NRW|NLM (2008)|070629|abcdef", "MN": "L01.559.598.400.556.131", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "includes acronyms; do not confuse with Publication Type ABBREVIATIONS", "MS": "Works about shortened forms of written words or phrases used for brevity.", "PM": "2008; see ABBREVIATIONS 1963-2007", "HN": "2008(1963)", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D000004"}, {"RECTYPE": "D", "MH": "Abdomen", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "ENTRY": "Abdomens", "MN": "A01.923.047", "EC": "injuries:Abdominal Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "general or unspecified; prefer specifics; ABDOMINAL MUSCLES and specifics are available; abrupt disease requiring emergency surgery equals ABDOMEN, ACUTE", "MS": "That portion of the body that lies between the THORAX and the PELVIS.", "MR": "20160809", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000005"}, {"RECTYPE": "D", "MH": "Abdomen, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Acute Abdomens", "MN": "C23.888.821.030.249", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A clinical syndrome with acute abdominal pain that is severe, localized, and rapid in onset. Acute abdomen may be caused by a variety of disorders, injuries, or diseases.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000006"}, {"RECTYPE": "D", "MH": "Abdominal Injuries", "DE": "ABDOMINAL INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injury, Abdominal", "MN": "C26.017", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "general term for inj of organs in the abdom cavity; prefer specific organs /inj", "MS": "General or unspecified injuries involving organs in the abdominal cavity.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000007"}, {"RECTYPE": "D", "MH": "Abdominal Neoplasms", "DE": "ABDOMINAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasms, Abdominal", "MN": "C04.588.033", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "general term for neoplasms of organs in the abdominal cavity; prefer specific organ/neoplasm terms; coordinate IM with histological type of neoplasm if given (IM)", "MS": "New abnormal growth of tissue in the ABDOMEN.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000008"}, {"RECTYPE": "D", "MH": "Abdominal Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Transverse Abdominals", "MN": "A02.633.567.050", "FX": "Abdominal Wall", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "/growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent", "MS": "Muscles forming the ABDOMINAL WALL including RECTUS ABDOMINIS; ABDOMINAL OBLIQUE MUSCLES, transversus abdominis, pyramidalis muscles and quadratus abdominis.", "OL": "use ABDOMINAL MUSCLES to search ABDOMINAL WALL 1966-92", "PM": "93; was ABDOMINAL WALL 1963-92", "HN": "93; was ABDOMINAL WALL 1966-92", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D000009"}, {"RECTYPE": "D", "MH": "Abducens Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sixth Cranial Nerve|T023|NON|EQV|NLM (1998)|960731|abcdef", "ENTRY": "Sixth Cranial Nerves", "MN": "A08.800.800.120.030", "FX": "Abducens Nucleus", "EC": "injuries:Abducens Nerve Injury", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The 6th cranial nerve which originates in the ABDUCENS NUCLEUS of the PONS and sends motor fibers to the lateral rectus muscles of the EYE. Damage to the nerve or its nucleus disrupts horizontal eye movement control.", "OL": "use ABDUCENS NERVE to search ABDUCENT NERVE 1966-76", "PM": "77; was ABDUCENT NERVE 1963-76", "HN": "77; was ABDUCENT NERVE 1963-76", "MR": "20140620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000010"}, {"RECTYPE": "D", "MH": "Abelson murine leukemia virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Abelson Leukemia Virus|T005|EPO|EQV|NLM (1980)|990101|abcdef", "ENTRY": "Virus, Abelson Leukemia", "MN": "B04.820.650.375.525.020", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11788", "AN": "infection: coordinate with RETROVIRIDAE INFECTIONS + TUMOR VIRUS INFECTIONS + LEUKEMIA, EXPERIMENTAL", "PI": "Mouse Leukemia Viruses (1966-1979)", "MS": "A replication-defective strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) capable of transforming lymphoid cells and producing a rapidly progressing lymphoid leukemia after superinfection with FRIEND MURINE LEUKEMIA VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; or RAUSCHER VIRUS.", "PM": "2002; see ABELSON LEUKEMIA VIRUS 1991-2001, see MOUSE LEUKEMIA VIRUSES 1980-1990", "HN": "2002 (1980)", "MR": "20200813", "DA": "19790416", "DC": "1", "DX": "19910101", "UI": "D000011"}, {"RECTYPE": "D", "MH": "Abetalipoproteinemia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Microsomal Triglyceride Transfer Protein Deficiency|T047|NON|EQV|NLM (2007)|OMIM (2013)|050720|MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN DEFIC|abcdeefv", "ENTRY": "Diseases, Betalipoprotein Deficiency", "MN": "C18.452.648.398.500.440.500", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An autosomal recessive disorder of lipid metabolism. It is caused by mutation of the microsomal triglyceride transfer protein that catalyzes the transport of lipids (TRIGLYCERIDES; CHOLESTEROL ESTERS; PHOSPHOLIPIDS) and is required in the secretion of BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include defective intestinal lipid absorption, very low serum cholesterol level, and near absent LDL.", "PM": "1966", "HN": "1966(1964)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000012"}, {"RECTYPE": "D", "MH": "Congenital Abnormalities", "DE": "CONGEN ABNORM", "AQ": "BL CF CL DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fetal Malformations|T019|NON|REL|NLM (2021)|191122|abcdef", "ENTRY": "Malformation, Fetal", "MN": "C16.131", "EC": "chemically induced:Abnormalities, Drug-Induced", "MH_TH": "NLM (1980)", "ST": "T019", "AN": "general only; prefer specifics or /abnorm with specific anatomical term or specific animal", "MS": "Malformations of organs or body parts during development in utero.", "PM": "2008; see ABNORMALITIES 1963-2007", "HN": "2008 (1963)", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D000013"}, {"RECTYPE": "D", "MH": "Abnormalities, Drug-Induced", "DE": "ABNORM DRUG IND", "AQ": "BL CF CL DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Drug-Induced Abnormality", "MN": "C16.131.042", "FX": "Teratogens", "MH_TH": "NLM (1964)", "ST": "T019", "AN": "IM; do not use /chem ind /compl /congen & do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific chem /adv eff-pois-tox (IM) + specific organ /abnorm or specific abnorm /chem ind (IM); Manual 23.20.3", "MS": "Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D000014"}, {"RECTYPE": "D", "MH": "Abnormalities, Multiple", "DE": "ABNORM MULTIPLE", "AQ": "BL CF CI CL DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Multiple Abnormalities|T019|NON|EQV|UNK (19XX)|860101|MULTIPLE ABNORM|abcdefv", "MN": "C16.131.077", "FX": "Intellectual Disability", "MH_TH": "NLM (1968)", "ST": "T019", "AN": "coordinate with specific abnormalities", "PI": "Abnormalities (1966-1967)", "MS": "Congenital abnormalities that affect more than one organ or body structure.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20151201", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000015"}, {"RECTYPE": "D", "MH": "Abnormalities, Radiation-Induced", "DE": "ABNORM RAD IND", "AQ": "BL CF CL DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Radiation-Induced Abnormality", "MN": "N06.850.810.300.360.031", "FX": "Teratogenesis", "MH_TH": "NLM (1979)", "ST": "T019", "AN": "coordinate with specific abnormality  ", "PI": "Radiation Injuries (1966-1978)", "MS": "Congenital changes in the morphology of organs produced by exposure to ionizing or non-ionizing radiation.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19780320", "DC": "1", "DX": "19790101", "UI": "D000016"}, {"RECTYPE": "D", "MH": "ABO Blood-Group System", "AQ": "AD AE AN BI BL CF CH CL EC GE HI IM IP ME PD PH PO TO TU UL UR", "PRINT ENTRY": "ABO Factors|T129|NON|NRW|UNK (19XX)|750722|abcdef", "ENTRY": "System, ABO Blood-Group", "MN": "D23.050.705.230.031", "MH_TH": "NLM (1976)", "ST": "T022", "RN": "0", "AN": "IM; coord with disease /blood (IM), not /immunol nor /genet; TN 230", "MS": "The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane.", "OL": "use ABO BLOOD-GROUP SYSTEM to search ABO FACTORS 1966-75", "PM": "76; was ABO FACTORS 1963-75", "HN": "76; was ABO FACTORS 1963-75", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D000017"}, {"RECTYPE": "D", "MH": "Abomasum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Abomasums", "MN": "A13.869.106", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "a ruminant's 4th stomach; dis: coord IM with STOMACH DISEASES /vet (IM); neopl: coord IM with STOMACH NEOPLASMS /vet (IM) + histol type /vet (IM); ulcer: coord IM with STOMACH ULCER /vet (IM)", "PI": "Stomach (1966-1967)", "MS": "The fourth stomach of ruminating animals. It is also called the \"true\" stomach. It is an elongated pear-shaped sac lying on the floor of the abdomen, on the right-hand side, and roughly between the seventh and twelfth ribs. It leads to the beginning of the small intestine. (From Black's Veterinary Dictionary, 17th ed)", "PM": "68", "HN": "68", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000018"}, {"RECTYPE": "D", "MH": "Abortifacient Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Postconception Contraceptive Agents", "MN": "D27.505.954.705.131", "FX": "Oxytocics", "MH_TH": "POPLINE (1978)", "ST": "T121", "RN": "0", "AN": "use no qualifiers for abortifacients when used to interrupt pregnancy; note entry term ABORTIFACIENT EFFECT: use only for the abortifacient effect of a chemical substance", "PI": "Abortion, Induced (1970-1974)", "MS": "Chemical substances that interrupt pregnancy after implantation.", "PM": "75", "HN": "75", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D000019"}, {"RECTYPE": "D", "MH": "Abortifacient Agents, Nonsteroidal", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nonsteroidal Abortifacient Agents", "MN": "D27.505.954.705.131.100", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "do not use /ther use for use of the abortifacients as abortifacients", "PI": "specific chemical (1971-1974)", "MS": "Non-steroidal chemical compounds with abortifacient activity.", "PM": "91; was see under ABORTIFACIENT AGENTS 1975-90", "HN": "91(75); was see under ABORTIFACIENT AGENTS 1975-90", "MR": "20140625", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000020"}, {"RECTYPE": "D", "MH": "Abortifacient Agents, Steroidal", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Steroidal Abortifacient Agents", "MN": "D27.505.954.705.131.200", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "do not use /ther use for use of the abortifacients as abortifacients", "PI": "specific chemical (1970-1974)", "MS": "Steroidal compounds with abortifacient activity.", "PM": "91; was see under ABORTIFACIENT AGENTS 1975-90", "HN": "91(75); was see under ABORTIFACIENT AGENTS 1975-90", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000021"}, {"RECTYPE": "D", "MH": "Abortion, Spontaneous", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "ENTRY": "Tubal Abortions", "MN": "G08.686.784.769.496.125", "FX": "Abortifacient Agents", "EC": "veterinary:Abortion, Veterinary", "MH_TH": "NLM (1999)", "ST": "T047", "AN": "/chem ind permitted but do not confuse with ABORTION, INDUCED; check the tags HUMANS & FEMALE & PREGNANCY", "MS": "Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.", "PM": "99; see ABORTION 1966-98; for ABORTION, SPONTANEOUS see ABORTION 1992-98", "HN": "99(63)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D000022"}, {"RECTYPE": "D", "MH": "Abortion Applicants", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Abortion Seekers|T101|NON|EQV|POPLINE (1978)|741111|abcdef", "ENTRY": "Seekers, Repeated Abortion", "MN": "M01.050", "MH_TH": "NLM (1975)", "ST": "T101", "AN": "don't forget also check tags HUMANS & FEMALE & PREGNANCY", "PI": "Abortion, Therapeutic (1966-1974)", "MS": "Individuals requesting induced abortions.", "PM": "76; was see under ABORTION 1975", "HN": "76(75); was see under ABORTION 1975", "MR": "20150623", "DA": "19741119", "DC": "1", "DX": "19760101", "UI": "D000023"}, {"RECTYPE": "D", "MH": "Abortion, Criminal", "AQ": "AE CL EC EH ES HI LJ MO PC PX SN TD", "PRINT ENTRY": "Abortion, Illegal|T033|NON|EQV|POPLINE (1978)|770317|abcdef", "ENTRY": "Illegal Abortions", "MN": "I01.198.240.089", "MH_TH": "NLM (1966)", "ST": "T033", "AN": "don't forget also check tags HUMANS & FEMALE & PREGNANCY; for abortifacients in crim abort see note on ABORTION, INDUCED", "MS": "Illegal termination of pregnancy.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000024"}, {"RECTYPE": "D", "MH": "Abortion, Eugenic", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Eugenic Abortion|T061|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Selective Abortions", "MN": "E04.520.050.050", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "add HUMANS or ANIMALS & FEMALE & PREGNANCY", "MS": "Abortion performed because of possible fetal defects.", "PM": "91; was see under ABORTION, INDUCED 1975-90", "HN": "91(75); was see under ABORTION, INDUCED 1975-90", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000025"}, {"RECTYPE": "D", "MH": "Abortion, Habitual", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Miscarriage, Recurrent|T047|NON|EQV|NLM (1999)|971008|abcdef", "ENTRY": "Recurrent Miscarriages", "MN": "C12.050.703.039.089", "FX": "Fetal Death", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Three or more consecutive spontaneous abortions.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000026"}, {"RECTYPE": "D", "MH": "Abortion, Incomplete", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Miscarriage, Missed|T047|NON|EQV|NLM (2024)|230109|abcdef", "ENTRY": "Missed Miscarriages", "MN": "C12.050.703.039.093", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "restrict to spontaneous, not induced abortions; check the tags FEMALE & PREGNANCY", "PI": "Abortion, Spontaneous (1966-1974)", "MS": "Premature loss of PREGNANCY in which not all the products of CONCEPTION have been expelled.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20230615", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D000027"}, {"RECTYPE": "D", "MH": "Abortion, Induced", "DE": "ABORTION IND", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Embryotomy|T061|NON|NRW|UNK (19XX)|850606|abcdef", "ENTRY": "Techniques, Abortion", "MN": "E04.520.050", "FX": "Aborted Fetus", "MH_TH": "POPLINE (1978)", "ST": "T061", "AN": "for use of an abortifacient, coordinate with abortifacient agent with no qualifiers, not  \u200c/\u200cadv \u200ceff unless text specifically discusses adverse effects;  check the tags FEMALE & PREGNANCY ", "PI": "Abortion, Therapeutic (1966-1970)", "MS": "Intentional removal of a fetus from the uterus by any of a number of techniques. (POPLINE, 1978)", "OL": "use ABORTION, INDUCED to search EMBRYOTOMY 1966-85; search ABORTION, CRIMINAL & ABORTION, LEGAL & ABORTION, THERAPEUTIC 1966-70", "PM": "71; was see under ABORTION, CRIMINAL & ABORTION, THERAPEUTIC 1963-70, was see under ABORTION, LEGAL 1964-70; EMBRYOTOMY was heading 1963-85", "HN": "71; was see under ABORTION, CRIMINAL & ABORTION, THERAPEUTIC 1963-70, was see under ABORTION, LEGAL 1964-70; EMBRYOTOMY was heading 1963-85", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D000028"}, {"RECTYPE": "D", "MH": "Abortion, Legal", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Abortion on Demand|T061|NON|NRW|BIOETHICS (1989)|770317|abcdef", "ENTRY": "Legal Abortions", "MN": "E04.520.050.055", "MH_TH": "POPLINE (1978)", "ST": "T061", "AN": "add HUMANS & FEMALE & PREGNANCY", "MS": "Termination of pregnancy under conditions allowed under local laws. (POPLINE Thesaurus, 1991)", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D000029"}, {"RECTYPE": "D", "MH": "Abortion, Missed", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Missed Abortions", "MN": "C12.050.703.039.173", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY", "MS": "The retention in the UTERUS of a dead FETUS two months or more after its DEATH.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000030"}, {"RECTYPE": "D", "MH": "Abortion, Septic", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Septic Abortions", "MN": "C12.050.703.700.173", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "/vet permitted only if discussed as \"septic\" abortion: do not use automatically for animal abortion in brucellosis, vibriosis, trichomoniasis, etc; check the tags FEMALE & PREGNANCY", "MS": "Any type of abortion, induced or spontaneous, that is associated with infection of the UTERUS and its appendages. It is characterized by FEVER, uterine tenderness, and foul discharge.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000031"}, {"RECTYPE": "D", "MH": "Abortion, Therapeutic", "DE": "ABORTION THER", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Therapeutic Abortions", "MN": "E04.520.050.060", "MH_TH": "POPLINE (1978)", "ST": "T061", "AN": "check the tags FEMALE & PREGNANCY ", "MS": "Abortion induced to save the life or health of a pregnant woman. (From Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000032"}, {"RECTYPE": "D", "MH": "Abortion, Threatened", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Threatened Miscarriages", "MN": "C12.050.703.090", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY", "MS": "UTERINE BLEEDING from a GESTATION of less than 20 weeks without any CERVICAL DILATATION. It is characterized by vaginal bleeding, lower back discomfort, or midline pelvic cramping and a risk factor for MISCARRIAGE.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000033"}, {"RECTYPE": "D", "MH": "Abortion, Veterinary", "DE": "ABORTION VET", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "ENTRY": "Veterinary Abortions", "MN": "C22.021", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific type of abortion /vet (IM); check the tags ANIMALS & FEMALE & PREGNANCY", "MS": "Premature expulsion of the FETUS in animals.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000034"}, {"RECTYPE": "D", "MH": "Abreaction", "ENTRY": "Abreactions", "MN": "F04.754.720.107", "MH_TH": "NLM (1968)", "ST": "T041", "MS": "A process in psychotherapy in which the patient is \"desensitized\" to emotionally painful, often forgotten (repressed) memories by recalling and reacting to them in the \"safety\" of the treatment setting.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000035"}, {"RECTYPE": "D", "MH": "Abrin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Abrin C|T116|T123|NON|NRW|UNK (19XX)|810608|abbcdef", "MN": "D12.776.765.678.906.111", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Abrins", "RN": "1393-62-0", "PI": "Plant Proteins (1971-1975)", "MS": "A toxic lectin from the seeds of jequirity, Abrus precatorius L. Very active poison. Five different proteins have so far been isolated: Abrus agglutinin, the component responsible for: hemagglutinating activity, & abrins a-d, the toxic principals each consisting of two peptide chains are held together by disulfide bonds.", "PM": "91; was see under PLANT PROTEINS 1975-90", "HN": "91(75); was see under PLANT PROTEINS 1975-90", "MR": "20070709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000036"}, {"RECTYPE": "D", "MH": "Abruptio Placentae", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Placental Abruption|T047|NON|EQV|NLM (2006)|050303|abcdef", "ENTRY": "Placental Abruptions", "MN": "C12.050.703.590.132", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Premature separation of the normally implanted PLACENTA from the UTERUS. Signs of varying degree of severity include UTERINE BLEEDING, uterine MUSCLE HYPERTONIA, and FETAL DISTRESS or FETAL DEATH.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000037"}, {"RECTYPE": "D", "MH": "Abscess", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Abscesses", "MN": "C23.550.470.756.100", "FX": "Empyema", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "coordinate with site (organ/disease term)  + precoordinated organism/infection term; if unspecified bacterial abscess do not coordinate with BACTERIAL INFECTIONS (since most abscesses are bacterial) but coordinate with specific bacterial infection term if given (as ABSCESS + STAPHYLOCOCCAL INFECTIONS) ", "MS": "Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000038"}, {"RECTYPE": "D", "MH": "Peritonsillar Abscess", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Abscess, Peritonsillar|T047|NON|EQV|UNK (19XX)|880523|abcdef", "ENTRY": "Peritonsillar Abscesses", "MN": "C09.775.649.750.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with infection term (IM) but not BACTERIAL INFECTIONS (since most abscesses are bacterial)", "MS": "An accumulation of purulent material in the area between the PALATINE TONSIL and its capsule.", "OL": "use PERITONSILLAR ABSCESS to search ABSCESS, PERITONSILLAR 1966-88", "PM": "89; was ABSCESS, PERITONSILLAR 1963-88", "HN": "89; was ABSCESS, PERITONSILLAR 1963-88", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19890101", "UI": "D000039"}, {"RECTYPE": "D", "MH": "Abscisic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2,4-Pentadienoic acid, 5-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-, (S-(Z,E))-|T109|T123|NON|EQV|NLM (2020)|190626|abbcdef", "ENTRY": "Abscissins|T109|T123|NON|EQV|NLM (1993)|920415|abbcdef", "MN": "D02.455.849.765.521.500", "PA": "Plant Growth Regulators", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "72S9A8J5GW", "RR": "7773-56-0 (cpd w/o isomeric designation)", "PI": "Cyclohexanecarboxylic Acids (1974)", "MS": "Abscission-accelerating plant growth substance isolated from young cotton fruit, leaves of sycamore, birch, and other plants, and from potatoes, lemons, avocados, and other fruits.", "PM": "93; see ABSCISSINS 1991-92, see CYCLOHEXANECARBOXYLIC ACID 1975-90", "HN": "93(75)", "MR": "20190702", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000040"}, {"RECTYPE": "D", "MH": "Absenteeism", "MN": "F02.784.692.107", "MH_TH": "NLM (1966)", "ST": "T055", "MS": "Chronic absence from work or other duty.", "HN": "was in Cat F & J 1967-82, was in Cat F & I 1963-66", "CATSH": "CAT LIST", "MR": "19940527", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D000041"}, {"RECTYPE": "D", "MH": "Absorption", "AQ": "DE GE IM PH RE", "MN": "G07.690.725.015", "FX": "Skin Absorption", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "beginning in 2015: used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000042"}, {"RECTYPE": "D", "MH": "Abstracting and Indexing", "DE": "ABSTRACTING INDEXING", "AQ": "CL EC ES HI MT SN ST TD", "PRINT ENTRY": "Indexing as Topic|T057|NON|NRW|NLM (2008)|070621|abcdef", "ENTRY": "Indexing and Abstracting as Topic|T057|NON|EQV|NLM (2008)|071030|abcdef", "MN": "L01.462.750.245.100", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "medical abstracting & indexing: do not coordinate with MEDICINE; do not confuse with Publication Types ABSTRACTS or MEETING ABSTRACT", "MS": "Works about activities performed to identify concepts and aspects of published information and research reports.", "PM": "2008; see ABSTRACTING AND INDEXING 1963-2007; for INDEXES as topic see REFERENCE BOOKS 1996-98", "HN": "2008(1963); for INDEXES as topic use REFERENCE BOOKS 1996-1998", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D000043"}, {"RECTYPE": "D", "MH": "Dental Abutments", "DE": "DENT ABUTMENTS", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Abutments, Dental|T023|T074|NON|EQV|NLM (1991)|900409|ABUTMENTS DENT|abbcdefv", "ENTRY": "Dental Abutment|T023|T074|NON|EQV|NLM (1991)|900409|DENT ABUTMENT|abbcdefv", "MN": "E07.695.190.175", "MH_TH": "NLM (1970)", "ST": "T074", "PI": "Denture, Partial (1966-1969)", "MS": "Natural teeth or teeth roots used as anchorage for a fixed or removable denture or other prosthesis (such as an implant) serving the same purpose.", "OL": "use DENTAL ABUTMENTS to search ABUTMENTS, DENTAL 1970-90", "PM": "91; was ABUTMENTS, DENTAL 1970-90", "HN": "91; was ABUTMENTS, DENTAL 1970-90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D000044"}, {"RECTYPE": "D", "MH": "Acacia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Wattle Tree|T002|NON|EQV|UNK (19XX)|850514|abcdef", "ENTRY": "catechus, Acacia", "MN": "B01.875.800.575.912.250.401.025", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid3808", "RR": "txid138017", "AN": "acacia pharmaceut agents are probably GUM ARABIC", "MS": "A plant genus of the family FABACEAE. The gums and tanning agents obtained from Acacia are called GUM ARABIC. The common name catechu is more often used for Areca catechu (ARECA).", "PM": "91,63-85; was see under TREES 1986-90; was heading 1963-85", "HN": "91(86)63; was see under TREES 1986-90; was heading 1963-85", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000045"}, {"RECTYPE": "D", "MH": "Academic Medical Centers", "DE": "ACAD MED CENTERS", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "University Medical Centers|T073|T093|NON|EQV|UNK (19XX)|790601|UNIV MED CENTERS|abbcdefv", "ENTRY": "University Medical Center|T073|T093|NON|EQV|NLM (1991)|891129|UNIV MED CENTER|abbcdefv", "MN": "N02.278.020", "FX": "Tertiary Care Centers", "MH_TH": "NLM (1980)", "ST": "T093", "AN": "specify geog", "PI": "Hospitals, University (1975-1979)", "MS": "Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc.", "OL": "search HOSPITALS, UNIVERSITY 1979", "PM": "80; was see HOSPITALS, UNIVERSITY 1979", "HN": "80; was see HOSPITALS, UNIVERSITY 1979", "MR": "20190524", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D000046"}, {"RECTYPE": "D", "MH": "Academies and Institutes", "DE": "ACADEMIES INSTITUTES", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Research Institutes|T092|NON|NRW|BIOETHICS (1974)|770317|abcdef", "ENTRY": "Research Institute", "MN": "N03.540.052", "MH_TH": "NLM (1965)", "ST": "T092", "MS": "Organizations representing specialized fields which are accepted as authoritative; may be non-governmental, university or an independent research organization, e.g., National Academy of Sciences, Brookings Institution, etc.", "PM": "70", "HN": "70(65)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D000047"}, {"RECTYPE": "D", "MH": "Acanthamoeba", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Acanthamoebas", "MN": "B01.046.500.100.075.080", "MH_TH": "NLM (1988)", "ST": "T204", "RN": "txid5754", "AN": "infection: coordinate with AMEBIASIS; for encephalitis caused by this organism, coordinate also with CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS + INFECTIOUS ENCEPHALITIS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent ", "PI": "Amoeba (1966-1987)", "MS": "A genus of free-living soil amoebae that produces no flagellate stage. Its organisms are pathogens for several infections in humans and have been found in the eye, bone, brain, and respiratory tract.", "PM": "88", "HN": "88", "MR": "20200813", "DA": "19870430", "DC": "1", "DX": "19880101", "UI": "D000048"}, {"RECTYPE": "D", "MH": "Acanthocephala", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Thorny-Headed Worms|T204|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Worms, Thorny-Headed", "MN": "B01.050.500.500.132", "MH_TH": "NLM (1974)", "ST": "T204", "RN": "txid10232", "AN": "infection: coordinate with HELMINTHIASIS or HELMINTHIASIS, ANIMAL; coordinate with specific helminth terms (ANTIGENS, HELMINTH, etc.) if pertinent", "MS": "A phylum of parasitic worms, closely related to tapeworms and containing two genera: Moniliformis, which sometimes infects man, and Macracanthorhynchus, which infects swine.", "OL": "search HELMINTHS 1966-73", "PM": "74; was see under HELMINTHS 1963-73", "HN": "74; was see under HELMINTHS 1963-73", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000049"}, {"RECTYPE": "D", "MH": "Acanthocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Acanthocyte", "MN": "A15.145.229.334.330.100", "MH_TH": "NLM (1975)", "ST": "T025", "MS": "Erythrocytes with protoplasmic projections giving the cell a thorny appearance.", "PM": "91; was see under ERYTHROCYTES, ABNORMAL 1975-90", "HN": "91(75); was see under ERYTHROCYTES, ABNORMAL 1975-90", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000050"}, {"RECTYPE": "D", "MH": "Acantholysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Acantholyses", "MN": "C23.550.035", "MH_TH": "NLM (1969)", "ST": "T046", "AN": "ACANTHOLYSIS BULLOSA see EPIDERMOLYSIS BULLOSA is also available", "PI": "specific skin disease/pathology (1966-1968)", "MS": "Separation of the prickle cells of the stratum spinosum of the epidermis, resulting in atrophy of the prickle cell layer. It is seen in diseases such as pemphigus vulgaris (see PEMPHIGUS) and DARIER DISEASE.", "PM": "91; was see under SKIN DISEASES 1969-90", "HN": "91(69); was see under SKIN DISEASES 1969-90", "CATSH": "CAT LIST", "MR": "20080710", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000051"}, {"RECTYPE": "D", "MH": "Acanthosis Nigricans", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Nigricans, Acanthosis", "MN": "C17.800.621.430.530.100", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a type of melanosis", "MS": "A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder.", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000052"}, {"RECTYPE": "D", "MH": "Acari", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.166.132", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid6933", "PI": "Arachnida (1966-1974)", "MS": "A large, subclass of arachnids comprising the MITES and TICKS, including parasites of plants, animals, and humans, as well as several important disease vectors.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D000053"}, {"RECTYPE": "D", "MH": "Acceleration", "AQ": "AE", "ENTRY": "Accelerations", "MN": "G01.482.107", "MH_TH": "NLM (1966)", "ST": "T067", "AN": "IM", "MS": "An increase in the rate of speed.", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000054"}, {"RECTYPE": "D", "MH": "Accessory Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Spinal Accessory Nerve|T023|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Spinal Accessory Nerves", "MN": "A08.800.800.120.060", "EC": "injuries:Accessory Nerve Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The 11th cranial nerve which originates from NEURONS in the MEDULLA and in the CERVICAL SPINAL CORD. It has a cranial root, which joins the VAGUS NERVE (10th cranial) and sends motor fibers to the muscles of the LARYNX, and a spinal root, which sends motor fibers to the TRAPEZIUS and the sternocleidomastoid muscles.", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000055"}, {"RECTYPE": "D", "MH": "Accident Prevention", "DE": "ACCIDENT PREV", "AQ": "EC HI IS LJ MT SN ST TD", "ENTRY": "Preventions, Accident", "MN": "N06.850.135.060", "FX": "Protective Devices", "MH_TH": "NLM (1966)", "ST": "T078", "MS": "Efforts and designs to reduce the incidence of unexpected undesirable events in various environments and situations.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000056"}, {"RECTYPE": "D", "MH": "Accident Proneness", "ENTRY": "Pronenesses, Accident", "MN": "F01.145.015", "MH_TH": "NLM (1975)", "ST": "T055", "PI": "Accidents (1966-1974)", "MS": "Tendency toward involvement in accidents. Implies certain personality characteristics which predispose to accidents.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D000057"}, {"RECTYPE": "D", "MH": "Accidental Falls", "AQ": "EC HI MO PC SN", "PRINT ENTRY": "Falls, Accidental|T037|NON|EQV|UNK (19XX)|860624|abcdef", "ENTRY": "Fall, Accidental", "MN": "N06.850.135.122", "MH_TH": "NLM (1987)", "ST": "T037", "PI": "Accidents (1966-1986)", "MS": "Falls due to slipping or tripping which may result in injury.", "PM": "91; was see under ACCIDENTS 1987-90", "HN": "91(87); was see under ACCIDENTS 1987-90", "MR": "20150616", "DA": "19860624", "DC": "1", "DX": "19910101", "UI": "D000058"}, {"RECTYPE": "D", "MH": "Accidents", "AQ": "CL EC HI LJ MO PX SN TD", "ENTRY": "Accident", "MN": "N06.850.135", "EC": "prevention & control:Accident Prevention", "MH_TH": "POPLINE (1986)", "ST": "T037", "AN": "general or unspecified; prefer specifics", "MS": "Unexpected and unintentional events, typically resulting in ACCIDENTAL INJURIES.", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000059"}, {"RECTYPE": "D", "MH": "Accidents, Aviation", "AQ": "CL EC HI LJ MO PC PX SN TD", "ENTRY": "Aviation Accidents", "MN": "N06.850.135.185", "MH_TH": "NLM (1966)", "ST": "T068", "MS": "Unanticipated events associated with AIRCRAFT.", "MR": "20151130", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000060"}, {"RECTYPE": "D", "MH": "Accidents, Home", "AQ": "CL EC HI LJ MO PC PX SN TD", "PRINT ENTRY": "Home Accidents|T067|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Home Accident", "MN": "N06.850.135.217", "MH_TH": "NLM (1969)", "ST": "T067", "PI": "Accidents (1966-1968)", "MS": "ACCIDENTS which occur within the home.", "PM": "70", "HN": "70(69)", "MR": "20151130", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D000061"}, {"RECTYPE": "D", "MH": "Accidents, Occupational", "DE": "ACCIDENTS OCCUP", "AQ": "CL EC HI LJ MO PC PX SN TD", "PRINT ENTRY": "Accidents, Industrial|T067|NON|NRW|UNK (19XX)|780508|ACCIDENTS INDUST|abcdefv", "ENTRY": "Occupational Accident", "MN": "N06.850.135.240", "FX": "Occupational Injuries", "MH_TH": "NLM (1966)", "ST": "T067", "AN": "coordinate IM with specific occupation (IM)", "MS": "Unforeseen occurrences, especially injuries in the course of work-related activities.", "OL": "use ACCIDENTS, OCCUPATIONAL to search ACCIDENTS, INDUSTRIAL 1966-78", "PM": "79; was ACCIDENTS, INDUSTRIAL 1963-78", "HN": "79; was in Cat G & J 1979-82, was ACCIDENTS, INDUSTRIAL in Cat G & J 1967-78 & Cat G & I 1963-66", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D000062"}, {"RECTYPE": "D", "MH": "Accidents, Traffic", "AQ": "CL EC HI LJ MO PC PX SN TD", "PRINT ENTRY": "Traffic Crashes|T067|NON|NRW|NLM (2020)|190419|abcdef", "ENTRY": "Traffic Collision", "MN": "N06.850.135.392", "FX": "Seat Belts", "MH_TH": "NLM (1966)", "ST": "T067", "MS": "Accidents on streets, roads, and highways involving drivers, passengers, pedestrians, or vehicles. Traffic accidents refer to AUTOMOBILES (passenger cars, buses, and trucks), BICYCLING, and MOTORCYCLES but not OFF-ROAD MOTOR VEHICLES; RAILROADS nor snowmobiles.", "MR": "20190531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000063"}, {"RECTYPE": "D", "MH": "Acclimatization", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Acclimation|T040|NON|EQV|NLM (1996)|941031|abcdef", "MN": "G16.012.500.133", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "Adaptation to a new environment or to a change in the old.", "CATSH": "CAT LIST", "MR": "20160219", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000064"}, {"RECTYPE": "D", "MH": "Accommodation, Ocular", "AQ": "DE ES GE IM PH RE", "ENTRY": "Ocular Distance Accommodations", "MN": "G14.010", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "do not confuse with ADAPTATION, OCULAR, adjustment of eye to light", "MS": "The dioptric adjustment of the EYE (to attain maximal sharpness of retinal imagery for an object of regard) referring to the ability, to the mechanism, or to the process. Ocular accommodation is the effecting of refractive changes by changes in the shape of the CRYSTALLINE LENS. Loosely, it refers to ocular adjustments for VISION, OCULAR at various distances. (Cline et al., Dictionary of Visual Science, 4th ed)", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000065"}, {"RECTYPE": "D", "MH": "Accounting", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Accountings", "MN": "N03.219.463.030", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "coordinate with specialty or specific financial endeavor ", "MS": "System of recording financial transactions.", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000066"}, {"RECTYPE": "D", "MH": "Oil and Gas Industry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Oil Refinery|T057|NON|NRW|NLM (2021)|191129|abcdef", "ENTRY": "Refinery, Oil", "MN": "J01.576.655.875.750", "FX": "Petroleum", "MH_TH": "NLM (2015)", "ST": "T092", "MS": "INDUSTRY concerned with the extraction, processing, distribution, marketing and storage of PETROLEUM and NATURAL GAS.", "PM": "2015", "HN": "2015", "MR": "20200116", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066388"}, {"RECTYPE": "D", "MH": "Coal Industry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Industry, Coal", "MN": "J01.576.655.875.200", "FX": "Fossil Fuels", "MH_TH": "NLM (2015)", "ST": "T092", "PI": "Coal Mining (1965-2014)", "MS": "Enterprise associated with the mining, processing, marketing and distribution of COAL.", "PM": "2015", "HN": "2016", "MR": "20151005", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066428"}, {"RECTYPE": "D", "MH": "Driving Under the Influence", "AQ": "EH ES HI LJ PC PH PX SN TD", "ENTRY": "While Intoxicated, Driving", "MN": "I03.125.649", "MH_TH": "OBSSR (2016)", "ST": "T055", "PI": "Automobile Driving (1967-2015)", "MS": "Operating a motor vehicle while impaired by alcohol or other drugs including those prescribed by physicians.", "PM": "2016", "HN": "2016", "MR": "20190506", "DA": "20150702", "DC": "1", "DX": "20160101", "UI": "D000066448"}, {"RECTYPE": "D", "MH": "Human Embryonic Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "hESC|T025|NON|EQV|NLM (2021)|191230|abcdef", "ENTRY": "hESCs|T025|ABB|EQV|NLM (2016)|140707|abcdef", "MN": "A11.872.700.250.750", "MH_TH": "NLM (2016)", "ST": "T025", "PI": "Embryonic Stem Cells (2006-2015)", "MS": "A type of PLURIPOTENT STEM CELLS derived from early stage human embryos, up to and including the BLASTOCYST stage.", "PM": "2016", "HN": "2016", "MR": "20200527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066449"}, {"RECTYPE": "D", "MH": "Mouse Embryonic Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "mESC|T025|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "mESCs|T025|ABB|EQV|NLM (2016)|140707|abcdef", "MN": "A11.872.700.250.875", "MH_TH": "NLM (2016)", "ST": "T025", "PI": "Embryonic Stem Cells (2006-2015)", "MS": "PLURIPOTENT STEM CELLS derived from the BLASTOCYST INNER CELL MASS of day 3.5 mouse embryos.", "PM": "2016", "HN": "2016", "MR": "20200527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066450"}, {"RECTYPE": "D", "MH": "Embryonic Germ Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Germ Cell, Embryonic", "MN": "A11.872.700.250.625", "MH_TH": "NLM (2016)", "ST": "T025", "PI": "Germ Cells (1974-2015)", "MS": "PLURIPOTENT STEM CELLS that are derived from early GERM CELLS.", "PM": "2016", "HN": "2016", "MR": "20150710", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000066473"}, {"RECTYPE": "D", "MH": "Work Performance", "AQ": "CL EC ED ES HI LJ OG SD SN ST TD", "ENTRY": "Work Performances", "MN": "I03.946.675", "FX": "Workplace", "MH_TH": "OBSSR (2016)", "ST": "T080", "PI": "Employee Performance Appraisal (1963-2015)", "MS": "Measure of how well someone performs given tasks at their place of work.", "PM": "2016", "HN": "2016", "MR": "20150616", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066477"}, {"RECTYPE": "D", "MH": "Criminal Behavior", "AQ": "CL DE EH ES HI PH", "PRINT ENTRY": "Criminality|T055|NON|EQV|NLM (2022)|210122|abcdef", "ENTRY": "Unlawful Behaviors", "MN": "F01.145.250", "FX": "Criminals", "MH_TH": "OBSSR (2016)", "ST": "T055", "PI": "Criminal Psychology (1963-2015)", "MS": "Conduct leading to commission of unlawful acts.", "PM": "2016", "HN": "2016", "MR": "20210305", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066479"}, {"RECTYPE": "D", "MH": "Clinical Decision-Making", "AQ": "ES MT", "ENTRY": "Medical Decision Making", "MN": "E01.055", "FX": "Relational Autonomy", "MH_TH": "NLM (2016)", "ST": "T060", "AN": "use DECISION MAKING for decision making by the patient", "PI": "Decision Making (1972-2015)", "MS": "Process of formulating a diagnosis based on medical history and physical or mental examinations, and/or choosing an appropriate intervention.", "PM": "2016", "HN": "2016", "MR": "20190508", "DA": "20150702", "DC": "1", "DX": "20160101", "UI": "D000066491"}, {"RECTYPE": "D", "MH": "Cognitive Aging", "AQ": "PH PX", "ENTRY": "Aging, Cognitive", "MN": "G07.345.124.260", "FX": "Cognition Disorders", "MH_TH": "OBSSR (2016)", "ST": "T041", "PI": "Aging (1984-2015)", "MS": "Phenomenon that occurs when learning and memory abilities decrease naturally due to age.", "PM": "2016", "HN": "2016", "MR": "20160617", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000066492"}, {"RECTYPE": "D", "MH": "Cognitive Neuroscience", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Social Neuroscience|T090|NON|REL|NLM (2021)|200116|abcdef", "ENTRY": "Social Neurosciences", "MN": "H01.158.610.030", "MH_TH": "OBSSR (2016)", "ST": "T090", "AN": "use for the discipline only (education, history, etc)", "MS": "Field of study concerning MENTAL PROCESSES; LEARNING; and the brain regions associated with them.", "PM": "2016", "HN": "2016", "MR": "20200429", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000066494"}, {"RECTYPE": "D", "MH": "Emotional Adjustment", "AQ": "CL DE ES PH RE", "ENTRY": "Psychological Adjustments", "MN": "F01.752.543.500.250", "FX": "Social Adjustment", "MH_TH": "OBSSR (2016)", "ST": "T041", "MS": "Psychological process that occurs when an individual adapts to a significant emotional event or stimulus.", "PM": "2016; for PSYCHOLOGICAL ADJUSTMENT see ADAPTATION, PSYCHOLOGICAL 2000-2015", "HN": "2016; for PSYCHOLOGICAL ADJUSTMENT use ADAPTATION, PSYCHOLOGICAL 2000-2015", "MR": "20150709", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000066498"}, {"RECTYPE": "D", "MH": "Facial Recognition", "AQ": "DE ES PH RE", "PRINT ENTRY": "Facial Identity Recognition|T041|T054|NON|EQV|NLM (2021)|200528|abbcdef", "ENTRY": "Recognition, Facial Identity", "MN": "F02.463.593.932.622.500", "FX": "Prosopagnosia", "MH_TH": "OBSSR (2016)", "ST": "T054", "AN": "human and animal; AUTOMATED FACIAL RECOGNITION is also available", "PI": "Pattern Recognition, Visual (1977-2015)", "MS": "Ability to identify an individual from their facial features.", "PM": "2016", "HN": "2016", "MR": "20200622", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000066499"}, {"RECTYPE": "D", "MH": "Grandparents", "AQ": "ED PX", "ENTRY": "Grandmothers", "MN": "M01.264", "FX": "Family", "MH_TH": "NLM (2016)", "ST": "T099", "PI": "Intergenerational Relations (1963-2015)", "MS": "Member of a family who has children and grandchildren.", "PM": "2016", "HN": "2016", "MR": "20190322", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066502"}, {"RECTYPE": "D", "MH": "Help-Seeking Behavior", "ENTRY": "Help-Seeking Behaviors", "MN": "F01.145.813.217", "MH_TH": "OBSSR (2016)", "ST": "T054", "MS": "Form of social behavior in which assistance is sought from others.", "PM": "2016", "HN": "2016", "MR": "20141015", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066505"}, {"RECTYPE": "D", "MH": "Heuristics", "AQ": "CL DE ES PH RE", "ENTRY": "Heuristic", "MN": "F02.463.785.810.500", "FX": "Computer Heuristics", "MH_TH": "NLM (2016)", "ST": "T041", "MS": "Experience-based techniques for problem-solving, learning, and discovery that find a solution which is not guaranteed to be optimal, but sufficient for a given set of goals.", "PM": "2016", "HN": "2016", "MR": "20190705", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000066506"}, {"RECTYPE": "D", "MH": "Intimate Partner Violence", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Violence, Intimate Partner", "MN": "I01.880.735.900.688", "FX": "Sex Offenses", "MH_TH": "OBSSR (2016)", "ST": "T053", "PI": "Spouse Abuse (1997-2015)", "MS": "A pattern of assaultive and coercive behavior by an individual against their partner or spouse that may include physical injury, psychological abuse, sexual assault, progressive isolation, stalking, deprivation, intimidation, and reproductive coercion.", "PM": "2016", "HN": "2016", "MR": "20150409", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066511"}, {"RECTYPE": "D", "MH": "Neurological Rehabilitation", "AQ": "CL EC ED ES HI IS LJ MT OG PX SN ST TD", "ENTRY": "Rehabilitation, Neurological", "MN": "N02.421.784.511", "MH_TH": "NLM (2016)", "ST": "T061", "PI": "Rehabilitation (1963-2015)", "MS": "Physician-supervised programs designed to rehabilitate people with diseases, trauma, or disorders of the NERVOUS SYSTEM.", "PM": "2016", "HN": "2016", "MR": "20190705", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066530"}, {"RECTYPE": "D", "MH": "Physical Abuse", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Violence, Physical", "MN": "I01.880.735.900.744", "MH_TH": "OBSSR (2016)", "ST": "T055", "PI": "Child Abuse (1963-2016)", "MS": "Violence inflicted on an individual through physical contact.", "PM": "2016", "HN": "2016", "MR": "20150409", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066550"}, {"RECTYPE": "D", "MH": "Problem Behavior", "AQ": "PX", "ENTRY": "Psychology Dysfunctional Behaviors", "MN": "F01.145.179.750", "FX": "Attention Deficit and Disruptive Behavior Disorders", "MH_TH": "OBSSR (2016)", "ST": "T055", "PI": "Child Behavior Disorders (1963-2016)", "MS": "Troublesome or disruptive behavioral displays.", "PM": "2016", "HN": "2016", "MR": "20160705", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000066553"}, {"RECTYPE": "D", "MH": "Underage Drinking", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Adolescent Alcohol Intake|T055|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Minimum Drinking Ages", "MN": "I01.880.735.878", "FX": "Alcohol Drinking in College", "MH_TH": "OBSSR (2016)", "ST": "T055", "MS": "Consumption of ALCOHOLIC BEVERAGES by persons under the legal drinking age.", "PM": "2016", "HN": "2016", "MR": "20210512", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000066608"}, {"RECTYPE": "D", "MH": "Ectopic Gene Expression", "AQ": "DE GE IM PH RE", "ENTRY": "Gene Expressions, Ectopic", "MN": "G05.308.202", "MH_TH": "NLM (2016)", "ST": "T045", "PI": "Gene Expression Regulation (1981-2015)", "MS": "The expression of a gene in an abnormal place,  or at an abnormal  time in an organism. Ectopic Gene  Expression is often induced artificially by genetic techniques.", "PM": "2016", "HN": "2016", "MR": "20160617", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000066630"}, {"RECTYPE": "D", "MH": "Cell Plasticity", "AQ": "DE GE IM PH RE", "ENTRY": "Plasticity, Cellular", "MN": "G04.356.250", "FX": "Neuronal Plasticity", "MH_TH": "NLM (2016)", "ST": "T043", "PI": "Cell Differentiation (1966-2015)", "MS": "The ability of a cell to change its PHENOTYPE in response to changes in the environment.", "PM": "2016", "HN": "2016", "MR": "20160115", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000066670"}, {"RECTYPE": "D", "MH": "Cell Self Renewal", "AQ": "DE GE IM PH RE", "ENTRY": "Stem Cell Self-Renewals", "MN": "G07.345.249.410.750.500.625", "FX": "Stem Cells", "MH_TH": "NLM (2016)", "ST": "T043", "PI": "Cell Differentiation (1966-2015)", "MS": "The ability of certain cell types, such as progenitor cells or tumor cells,  to go through numerous cycles of CELL DIVISION while still maintaining an undifferentiated or partially differentiated state.", "PM": "2016", "HN": "2016", "MR": "20160115", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000066673"}, {"RECTYPE": "D", "MH": "Rehabilitation Research", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Research, Rehabilitation", "MN": "H01.770.644.145.472", "FX": "Disabled Persons", "MH_TH": "OBSSR (2016)", "ST": "T062", "PI": "Rehabilitation (2004-2015)", "MS": "Studies and research concerning the psychological, educational, social, vocational, industrial, and economic aspects of REHABILITATION.", "PM": "2016", "HN": "2016", "MR": "20141015", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066768"}, {"RECTYPE": "D", "MH": "Orthodontists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Orthopedists, Dentofacial", "MN": "N02.360.330.330.655", "MH_TH": "NLM (2016)", "ST": "T097", "MS": "Dentists who specialize in the treatment of misaligned TEETH and MALOCCLUSION.", "PM": "2016", "HN": "2016", "MR": "20230620", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066792"}, {"RECTYPE": "D", "MH": "Oral and Maxillofacial Surgeons", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Maxillofacial and Oral Surgeons|T097|NON|EQV|NLM (2022)|210625|abcdef", "ENTRY": "Surgeons, Oral", "MN": "N02.360.810.910.813", "MH_TH": "NLM (2016)", "ST": "T097", "MS": "Dentists who specialize in the surgical treatment of injuries, diseases, and abnormalities of the oral and maxillofacial regions.", "PM": "2016", "HN": "2016", "MR": "20230620", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066794"}, {"RECTYPE": "D", "MH": "Neuroprotection", "AQ": "DE GE IM PH RE", "ENTRY": "Protection, Neuronal", "MN": "G11.561.645", "MH_TH": "NLM (2016)", "ST": "T039", "MS": "The physiological processes and techniques used by the body to prevent neuronal injury and degeneration in the central nervous system following acute disorders or as a result of chronic neurodegenerative diseases.", "PM": "2016", "HN": "2016", "MR": "20190705", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000066829"}, {"RECTYPE": "D", "MH": "Diet, Food, and Nutrition", "MN": "G07.203", "MH_TH": "NLM (2016)", "ST": "T040", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Concepts involved with nutritional physiology, including categories of substances eaten for sustenance, nutritional phenomena and processes, eating patterns and habits, and measurable nutritional parameters.", "PM": "2016", "HN": "2016", "MR": "20150617", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066888"}, {"RECTYPE": "D", "MH": "Triticale", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Triticum x Secale|T168|NON|EQV|NLM (2016)|140812|abcdef", "MN": "B01.875.800.575.912.250.822.906", "MH_TH": "NLM (1998)", "ST": "T168", "RN": "txid49317", "PI": "Poaceae (1970-2015)", "MS": "A CEREAL GRAIN plant resulting from a cross between TRITICUM and SECALE CEREALE.", "PM": "2016; see CEREALS 1998-2015", "HN": "2016; use EDIBLE GRAIN 1998-2015", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066889"}, {"RECTYPE": "D", "MH": "Critical Care Outcomes", "ENTRY": "Outcomes, Critical Care", "MN": "N05.715.360.575.575.399.250", "MH_TH": "NLM (2016)", "ST": "T058", "MS": "A measure of the mortality and morbidity rates among patients who receive CRITICAL CARE and INTENSIVE CARE as determined from the date of hospital discharge or release.", "PM": "2016", "HN": "2016", "MR": "20190530", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066891"}, {"RECTYPE": "D", "MH": "Simulation Training", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Training, Simulation", "MN": "I02.903.847", "MH_TH": "NLM (2016)", "ST": "T065", "MS": "A highly customized interactive medium or program that allows individuals to learn and practice real world activities in an accurate, realistic, safe and secure environment.", "PM": "2016", "HN": "2016", "MR": "20141015", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066908"}, {"RECTYPE": "D", "MH": "Millets", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Millet", "MN": "B01.875.800.575.912.250.822.587", "MH_TH": "NLM (2016)", "ST": "T168", "AN": "general or unspecified; note several specific millet terms are available", "PI": "Panicum (1981-2015)", "MS": "An agronomic group especially of small-seeded grasses, mainly grown for human and animal consumption.", "PM": "2016", "HN": "2016", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066928"}, {"RECTYPE": "D", "MH": "Biobehavioral Sciences", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sciences, Biobehavioral", "MN": "H01.770.644.108.687", "FX": "Interdisciplinary Studies", "MH_TH": "NLM (2016)", "ST": "T062", "MS": "An interdisciplinary scientific approach to the study of complex interactions among biological, social, behavioral and environmental factors.", "PM": "2016", "HN": "2016", "MR": "20200221", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000066949"}, {"RECTYPE": "D", "MH": "Protein Corona", "AQ": "AN CH IM ME MT", "ENTRY": "Corona, Protein", "MN": "D12.776.791", "MH_TH": "NLM (2016)", "ST": "T116", "RN": "0", "MS": "A layer of protein coating adsorbed by NANOPARTICLES upon entry into PLASMA or other protein-containing biological fluids, which affects how nanoparticles are internalized by cells and cleared from the body.", "PM": "2016", "HN": "2016", "MR": "20220712", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000066970"}, {"RECTYPE": "D", "MH": "Vegetarians", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Vegetarians, Ovo-Lacto", "MN": "M01.928", "FX": "Diet, Vegetarian", "MH_TH": "NLM (2016)", "ST": "T098", "PI": "Diet, Vegetarian (1963-2015)", "MS": "Persons who do not eat MEAT.", "PM": "2016", "HN": "2016", "MR": "20221215", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000066988"}, {"RECTYPE": "D", "MH": "Vegans", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Vegan", "MN": "M01.928.500", "FX": "Diet, Vegan", "MH_TH": "NLM (2016)", "ST": "T098", "PI": "Diet, Vegetarian (1967-2015)", "MS": "Persons who avoid consuming animal products or animal-derived substances, such as MEAT; EGGS; or HONEY.  Some vegans also refrain from using animals or animal products in any form or for any purpose, such as in CLOTHING or household goods.", "PM": "2016", "HN": "2016", "MR": "20141015", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000066989"}, {"RECTYPE": "D", "MH": "Accounts Payable and Receivable", "DE": "ACCOUNTS PAYABLE RECEIVABLE", "ENTRY": "Accounts Payable|T081|NON|NRW|NLM (1991)|900308|abcdef", "MN": "N03.219.463.030.080", "MH_TH": "NLM (1978)", "ST": "T081", "PI": "Accounting (1966-1977)", "MS": "Short-term debt obligations and assets occurring in the regular course of operational transactions.", "PM": "91; was see under ACCOUNTING 1978-90", "HN": "91(78); was see under ACCOUNTING 1978-90", "MR": "19900530", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D000067"}, {"RECTYPE": "D", "MH": "Youth Sports", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Youth Sports, Organized", "MN": "I03.450.642.845.987", "MH_TH": "NLM (2016)", "ST": "T100", "PI": "Sports (1970-2014)", "MS": "SPORTS activities designed and/or organized for CHILDREN or YOUTH.", "PM": "2016", "HN": "2016", "MR": "20141015", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067009"}, {"RECTYPE": "D", "MH": "Literacy", "AQ": "EH HI PX SN ST TD", "PRINT ENTRY": "Illiteracy|T080|NON|REL|NLM (1988)|750101|abcdef", "MN": "N01.824.196.500", "FX": "Writing", "MH_TH": "OBSSR (2016)", "ST": "T041", "MS": "Ability to read and write.", "PM": "2016; for ILLITERACY see EDUCATIONAL STATUS", "HN": "2016; for ILLITERACY use EDUCATIONAL STATUS", "MR": "20170630", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000067010"}, {"RECTYPE": "D", "MH": "Severe Acute Malnutrition", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Malnutrition, Severe Acute", "MN": "C18.654.521.719", "MH_TH": "NLM (2016)", "ST": "T047", "PI": "Nutrition Disorders (1980-2014)", "MS": "Acute form of MALNUTRITION which usually affects children, characterized by a very low weight for height (below -3z scores of the median World Health Organization standards), visible severe wasting, or occurrence of nutritional EDEMA.  It can be a direct or indirect cause of fatality in children suffering from DIARRHEA and PNEUMONIA. Do not confuse with starvation, a condition in which the body is not getting enough food, usually for extended periods of time.", "PM": "2016", "HN": "2016", "MR": "20141015", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067011"}, {"RECTYPE": "D", "MH": "Banking, Personal", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Savings Account", "MN": "N03.219.463.030.100", "FX": "Medical Savings Accounts", "MH_TH": "NLM (2016)", "ST": "T057", "PI": "Economics (1975-2014)", "MS": "A financial account set up between a financial institution (such as a commercial bank) and a customer (individual, group, or business), whereby the latter may deposit and withdraw money, and where applicable, be paid interest.", "PM": "2016", "HN": "2016", "MR": "20141023", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067012"}, {"RECTYPE": "D", "MH": "Evidence-Based Facility Design", "AQ": "CL EC ES HI IS LJ MT SN ST TD", "ENTRY": "Facility Designs, Evidence-Based", "MN": "N02.278.200.252", "MH_TH": "NLM (2016)", "ST": "T057", "MS": "An approach, process, or methodology which emphasizes credible evidence and the best available scientific knowledge, judiciously integrated to achieve the best possible outcomes in structural design. For example, the design of a new OUTPATIENT CLINIC might incorporate a review of published research on outpatient clinic design, decisions on similar past projects, along with interviews with staff and consumers.", "PM": "2016", "HN": "2016", "MR": "20141015", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067013"}, {"RECTYPE": "D", "MH": "Physical Appearance, Body", "AQ": "DE EH GE IM PH RE", "ENTRY": "Body Physical Appearance", "MN": "G07.100.175", "FX": "Body Image", "MH_TH": "NLM (2016)", "ST": "T032", "MS": "Externally visible physical characteristics of a body.", "PM": "2016", "HN": "2016", "MR": "20220712", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067029"}, {"RECTYPE": "D", "MH": "Fruit and Vegetable Juices", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "ENTRY": "Vegetable Juice", "MN": "J02.200.606", "MH_TH": "NLM (2016)", "ST": "T168", "AN": "coordinate with specific fruit or vegetable", "PI": "Beverages (1963-2015)", "MS": "The liquids extracted from plants.", "PM": "2016", "HN": "2016", "MR": "20190709", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067030"}, {"RECTYPE": "D", "MH": "Ghee", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Oils, Butter", "MN": "J02.500.375.200.500", "MH_TH": "UNK (19XX)", "ST": "T168", "RN": "0", "PI": "Dietary Fats (1969-2015)", "MS": "The clarified portion of milk, cream, or butter obtained by the removal of the nonfat constituents. (from Dictionary of Food Ingredients, 4th ed., 2001)", "PM": "2016; see DIETARY FATS 1982-2015", "HN": "2016; use DIETARY FATS 1982-2015", "MR": "20150112", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067048"}, {"RECTYPE": "D", "MH": "Hydraulic Fracking", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Hydrofracturings", "MN": "J01.576.655.875.750.500", "MH_TH": "NLM (2016)", "ST": "T057", "MS": "A drilling technology in which NATURAL GAS is extracted from large deposits of impermeable rock formations known as shale, deep within the earth\u2019s crust. This drilling technique involves injecting large volumes of high-pressure fracturing fluid (a mixture of water, sand, and chemicals) several thousand feet underground, thereby creating cracks or fissures in the shale formation, and releasing trapped gas.", "PM": "2016", "HN": "2016", "MR": "20141015", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067071"}, {"RECTYPE": "D", "MH": "Psychological Trauma", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Trauma, Psychological", "MN": "F03.950.750.375", "FX": "Stress Disorders, Post-Traumatic", "MH_TH": "NLM (2016)", "ST": "T048", "PI": "Depression (1965-2014)", "MS": "An emotionally painful, shocking, stressful, and sometimes life-threatening experience. It can result from witnessing distressing events such as natural disasters, physical or sexual abuse, and terrorism or other acts of violence. (https://www.nimh.nih.gov/health/)", "PM": "2016", "HN": "2016", "MR": "20210630", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067073"}, {"RECTYPE": "D", "MH": "Peer Influence", "ENTRY": "Pressure, Peer", "MN": "F01.829.316.483.750", "MH_TH": "NLM (2016)", "ST": "T054", "PI": "Peer Group (1968-2015)", "MS": "The effect or sway that a PEER GROUP exerts on the beliefs, value systems and behavior of each member of a group. The social expectations for individuals to conform to peer group influence is known as peer pressure.", "PM": "2016", "HN": "2016", "MR": "20230226", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067074"}, {"RECTYPE": "D", "MH": "Vegetable Products", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Vegetable Product", "MN": "J02.500.850.800", "MH_TH": "NLM (2016)", "ST": "T168", "PI": "Vegetables (1966-2015)", "MS": "Food that is manufactured from various parts of vegetables.", "PM": "2016", "HN": "2016", "MR": "20210510", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067075"}, {"RECTYPE": "D", "MH": "Direct-to-Consumer Advertising", "AQ": "CL EC ES HI LJ MT SN ST TD", "ENTRY": "Marketing, Direct-to-Consumer", "MN": "J01.219.687.274.500", "MH_TH": "NLM (2016)", "ST": "T057", "PI": "Advertising as Topic (1983-2014)", "MS": "Advertising that directly targets consumers of certain products such as pharmaceuticals.", "PM": "2016", "HN": "2016", "MR": "20141015", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067088"}, {"RECTYPE": "D", "MH": "Direct-To-Consumer Screening and Testing", "AQ": "CL EC ES HI LJ MT OG PX SD SN ST TD", "ENTRY": "Testings, Direct-To-Consumer", "MN": "N02.421.726.233.166", "FX": "Diagnostic Self Evaluation", "MH_TH": "NLM (2016)", "ST": "T062", "MS": "Laboratory testing and diagnostic imaging services offered to consumers outside of the patient-physician relationship.", "PM": "2016", "HN": "2016", "MR": "20150626", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067108"}, {"RECTYPE": "D", "MH": "Extracellular Vesicles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Vesicles, Extracellular", "MN": "A11.284.295.588", "MH_TH": "NLM (2016)", "ST": "T026", "MS": "Membrane limited structures derived from cell membranes and cytoplasmic material, and released into EXTRACELLULAR SPACE. They circulate through the EXTRACELLULAR FLUID and through the peripheral blood in the MICROVASCULATURE where cells, much larger, cannot, thereby affecting a variety of intercellular communication processes.", "PM": "2016", "HN": "2016", "MR": "20150710", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000067128"}, {"RECTYPE": "D", "MH": "Fungal Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, Fungal", "MN": "B04.352", "MH_TH": "NLM (2016)", "ST": "T005", "AN": "coordinate with specific fungus/ virol", "PI": "Fungi or specific/virology (1994-2015)", "MS": "Viruses infecting species of FUNGI.", "PM": "2016", "HN": "2016", "MR": "20200902", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067148"}, {"RECTYPE": "D", "MH": "Telocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Telocyte|T025|NON|EQV|NLM (2022)|201019|abcdef", "ENTRY": "Interstitial Cell of Cajal Like Cells", "MN": "A11.329.830.750", "FX": "Interstitial Cells of Cajal", "MH_TH": "NLM (2016)", "ST": "T025", "MS": "A type of interstitial cells that have very long and thin CELL SURFACE EXTENSIONS called TELOPODES.", "PM": "2016; for INTERSTITIAL CELL OF CAJAL-LIKE CELLS see INTERSTITIAL CELLS OF CAJAL 2010-2015", "HN": "2016; for INTERSTITIAL CELL OF CAJAL-LIKE CELLS use INTERSTITIAL CELLS OF CAJAL 2010-2015", "MR": "20210630", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067170"}, {"RECTYPE": "D", "MH": "Exoskeleton Device", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Robotic Exoskeletons", "MN": "E07.341", "FX": "Robotics", "MH_TH": "NLM (2016)", "ST": "T074", "PI": "Robotics (1999-2015)", "MS": "Device designed to wear externally to support muscular skeletal system in various movements such as RANGE OF MOTIONS; WEIGHT-BEARING; GAIT; and LOCOMOTION.", "PM": "2016", "HN": "2016", "MR": "20150706", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000067190"}, {"RECTYPE": "D", "MH": "Shellfish Hypersensitivity", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Shellfish Hypersensitivities", "MN": "C20.543.480.370.763", "FX": "Shellfish Poisoning", "MH_TH": "NLM (2016)", "ST": "T047", "PI": "Shellfish (1964-2015)", "MS": "Allergic reaction to SHELLFISH or shellfish products.", "PM": "2016", "HN": "2016", "MR": "20141121", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067208"}, {"RECTYPE": "D", "MH": "Failure to Rescue, Health Care", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Rescues, Failure to (Health Care)", "MN": "N05.715.360.575.575.800.760.500", "MH_TH": "NLM (2016)", "ST": "T080", "PI": "Treatment Failure (2005-2015)", "MS": "Inability to prevent a clinical deterioration resulting from a complication of an underlying medical condition or a complication of medical care. It implies that common risk factors for such a complication were not recognized in a timely manner or treated appropriately.", "PM": "2016", "HN": "2016", "MR": "20190530", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000067248"}, {"RECTYPE": "D", "MH": "Psychiatric Rehabilitation", "AQ": "CL EC ED ES HI IS LJ MT OG PX SN ST TD", "PRINT ENTRY": "Psychosocial Care|T058|NON|NRW|NLM (2021)|200118|abcdef", "ENTRY": "Rehabilitation, Psychosocial", "MN": "N02.421.784.578", "MH_TH": "OBSSR (2016)", "ST": "T058", "MS": "Specialty field that promotes recovery, community functioning, and increased well-being of individuals diagnosed with mental disorders that impair their ability to live meaningful lives.", "PM": "2016", "HN": "2016", "MR": "20200429", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067250"}, {"RECTYPE": "D", "MH": "Symptom Flare Up", "ENTRY": "Worsening, Symptom", "MN": "C23.550.291.937.500", "MH_TH": "NLM (2016)", "ST": "T067", "PI": "Recurrence (1972-2015)", "MS": "A transient exacerbation of symptoms of an existing disease or condition.", "PM": "2016", "HN": "2016", "MR": "20181005", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067251"}, {"RECTYPE": "D", "MH": "Isolated Heart Preparation", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Working Heart Techniques", "MN": "E05.598.750", "FX": "Myocardial Reperfusion Injury", "MH_TH": "NLM (2016)", "ST": "T059", "PI": "Perfusion (1963-2015)", "MS": "Method of isolation and maintenance of a working heart for various cardiac measurements. The model allows for the separation of cardiac and systemic variables in the denervated heart.", "PM": "2016", "HN": "2016", "MR": "20181102", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067268"}, {"RECTYPE": "D", "MH": "Diet, Vegan", "AQ": "AE CL EC EH ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Vegan Diet|T061|NON|EQV|NLM (2003)|020417|abcdef", "ENTRY": "Vegan Diets", "MN": "G07.203.650.240.278.500.750", "FX": "Vegans", "MH_TH": "NLM (2003)", "ST": "T061", "PI": "Diet, Vegetarian (1967-2015)", "MS": "Dietary practice of avoiding animal products in any form.", "PM": "2016; see DIET, VEGETARIAN 2003-2015", "HN": "2016; use DIET, VEGETARIAN 2003-2015", "MR": "20221215", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000067269"}, {"RECTYPE": "D", "MH": "Behavior Observation Techniques", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Observations, Behavioral", "MN": "F04.669.112", "MH_TH": "OBSSR (2016)", "ST": "T062", "MS": "A wide range of formal and informal techniques used to document behavior.", "PM": "2016", "HN": "2016", "MR": "20150707", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000067289"}, {"RECTYPE": "D", "MH": "Behavior Rating Scale", "AQ": "HI SN ST", "ENTRY": "Tests, Behavioral", "MN": "F04.711.271", "MH_TH": "OBSSR (2016)", "ST": "T075", "MS": "Instrument designed to assess human or animal behavior, using a standardized format.", "PM": "2016", "HN": "2016", "MR": "20150707", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000067290"}, {"RECTYPE": "D", "MH": "Alcohol Drinking in College", "AQ": "EH PX", "ENTRY": "Student Drinking, University", "MN": "F01.145.317.269.625", "FX": "Underage Drinking", "MH_TH": "OBSSR (2016)", "ST": "T054", "PI": "Alcohol Drinking (1963-2015)", "MS": "Alcohol consumption among college students.", "PM": "2016", "HN": "2016", "MR": "20150707", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000067292"}, {"RECTYPE": "D", "MH": "Obesity, Metabolically Benign", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Obesity, Metabolically Healthy", "MN": "C23.888.144.699.500.250", "MH_TH": "NLM (2016)", "ST": "T184", "PI": "Obesity (2005-2015)", "MS": "A sub-PHENOTYPE of obese individuals who have a risk for CARDIOVASCULAR DISEASES between that of healthy individuals with normal weight and unhealthy individuals with obesity.", "PM": "2016", "HN": "2016", "MR": "20210707", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067329"}, {"RECTYPE": "D", "MH": "Whole Grains", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "ENTRY": "Whole Grain Cereal", "MN": "J02.500.775.500.500", "MH_TH": "NLM (2016)", "ST": "T168", "PI": "Cereals (1973-2015)", "MS": "Edible seeds which contain all components of the seed - germ, bran, and ENDOSPERM.", "PM": "2016", "HN": "2016", "MR": "20210510", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067348"}, {"RECTYPE": "D", "MH": "Transanal Endoscopic Surgery", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Transanal Endoscopic Surgeries", "MN": "E04.502.250.630.500", "MH_TH": "NLM (2016)", "ST": "T061", "MS": "Surgical procedures performed through the anus using a PROCTOSCOPE.", "PM": "2016", "HN": "2016", "MR": "20170620", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067368"}, {"RECTYPE": "D", "MH": "Transanal Endoscopic Microsurgery", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Transanal Endoscopic Microsurgeries", "MN": "E04.502.250.630.500.500", "MH_TH": "NLM (2016)", "ST": "T061", "PI": "microsurgery (1985-2015)", "MS": "A specialized form of transanal endoscopic surgery for microscopically controlled operations in the RECTUM.", "PM": "2016", "HN": "2016", "MR": "20150112", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067369"}, {"RECTYPE": "D", "MH": "Cold Injury", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injury, Cold", "MN": "C26.212", "MH_TH": "NLM (2016)", "ST": "T037", "MS": "A physical injury caused by exposure of the body to extremely low ambient temperatures that may lead to loss of body parts, or in extreme cases, death. Examples of cold injury are FROSTBITE and CHILBLAINS.", "PM": "2016", "HN": "2016", "MR": "20150706", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000067390"}, {"RECTYPE": "D", "MH": "Personal Protective Equipment", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "PPE Personal Protective Equipment|T073|ABX|EQV|NLM (2021)|200410|abcdef", "ENTRY": "Protective Equipment, Personal", "MN": "J01.637.708.560", "MH_TH": "NLM (2016)", "ST": "T073", "MS": "Specialized clothing or equipment worn for protection against health hazards. Personal Protective Equipment may include MASKS; RESPIRATORY PROTECTIVE DEVICES; HEAD PROTECTIVE DEVICES; EYE PROTECTIVE DEVICES; EAR PROTECTIVE DEVICES; PROTECTIVE CLOTHING; and protective footwear.", "PM": "2016", "HN": "2016", "MR": "20220714", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067393"}, {"RECTYPE": "D", "MH": "Nerve Agents", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO", "PRINT ENTRY": "Nerve Agent|T131|NON|EQV|NLM (2021)|191219|abcdef", "ENTRY": "Gas, Nerve", "MN": "D27.720.777.300.500", "MH_TH": "NLM (2016)", "ST": "T131", "RN": "0", "PI": "Organophosphorus Compounds (1982-2015)", "MS": "A class of compounds that adversely affect the transmission of impulses through the NERVOUS SYSTEM.", "PM": "2016", "HN": "2016", "MR": "20200527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067397"}, {"RECTYPE": "D", "MH": "War-Related Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "War-Related Injury", "MN": "I01.880.735.950.500.951.500", "FX": "Stress Disorders, Post-Traumatic", "MH_TH": "NLM (2016)", "ST": "T037", "MS": "WOUNDS and INJURIES and PSYCHOLOGICAL TRAUMA sustained during WAR.", "PM": "2016", "HN": "2016", "MR": "20230526", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067398"}, {"RECTYPE": "D", "MH": "Abnormal Involuntary Movement Scale", "MN": "E01.370.600.550.162", "MH_TH": "NLM (2016)", "ST": "T081", "MS": "A rating scale that measures INVOLUNTARY MOVEMENTS known as TARDIVE DYSKINESIA.", "PM": "2016", "HN": "2016", "MR": "20150707", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000067399"}, {"RECTYPE": "D", "MH": "Blood Alcohol Content", "ENTRY": "Level, Blood Alcohol", "MN": "D02.033.375.135", "FX": "Driving Under the Influence", "MH_TH": "NLM (2016)", "ST": "T081", "RN": "0", "MS": "Mass of alcohol per unit of BLOOD volume.", "PM": "2016", "HN": "2016", "MR": "20141202", "DA": "20150702", "DC": "1", "DX": "20160101", "UI": "D000067401"}, {"RECTYPE": "D", "MH": "Social Communication Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Social Communication Disorders", "MN": "F03.625.374.250", "MH_TH": "NLM (2016)", "ST": "T048", "MS": "Persistent difficulties in the social uses of verbal and nonverbal communications. (DSM-V)", "PM": "2016", "HN": "2016", "MR": "20150210", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067404"}, {"RECTYPE": "D", "MH": "Legal Services", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Services, Legal", "MN": "I01.880.604.583.482", "MH_TH": "NLM (2016)", "ST": "T064", "MS": "Services provided by ATTORNEYS and paralegal staff.", "PM": "2016", "HN": "2016", "MR": "20141202", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067408"}, {"RECTYPE": "D", "MH": "Defamation", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Vilifications", "MN": "I01.880.735.191.051", "FX": "Jurisprudence", "MH_TH": "NLM (2016)", "ST": "T080", "MS": "Public false statements that are illegal and damaging to the reputation of a person, group, business, organization, or institution.", "PM": "2016", "HN": "2016", "MR": "20190322", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067448"}, {"RECTYPE": "D", "MH": "Anger Management Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Training, Anger Management", "MN": "F04.754.137.087", "MH_TH": "OBSSR (2016)", "ST": "T061", "PI": "Anger (1977-2016)", "MS": "System of psychological and/or therapeutic techniques used to control and or reduce the triggers, degrees, and effects of ANGER.", "PM": "2016", "HN": "2016", "MR": "20150112", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067449"}, {"RECTYPE": "D", "MH": "Psychology, Sports", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychology, Sport", "MN": "F04.096.628.914", "FX": "Sports Medicine", "MH_TH": "OBSSR (2016)", "ST": "T090", "PI": "Sports (1970-2015)", "MS": "Field of research that studies mental factors influencing the attainment of athletic skills and athletic performance.", "PM": "2016", "HN": "2016", "MR": "20180629", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067450"}, {"RECTYPE": "D", "MH": "War Exposure", "AQ": "AE CL EC ES HI LJ PC SN", "ENTRY": "War Exposures", "MN": "N06.850.460.350.600.903", "FX": "Veterans Health", "MH_TH": "NLM (2016)", "ST": "T078", "PI": "Warfare (1996-2015)", "MS": "The health and other ramifications of military and civilian exposure to WAR .", "PM": "2016", "HN": "2016", "MR": "20180629", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000067453"}, {"RECTYPE": "D", "MH": "Childhood-Onset Fluency Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Fluency Disorders, Childhood-Onset", "MN": "F03.625.374.125", "MH_TH": "NLM (2016)", "ST": "T048", "PI": "Communication Disorders (1990-2015)", "MS": "Disturbances in the normal fluency and time patterning of speech that are inappropriate for the individual's age and language skills. (DSM-V)", "PM": "2016", "HN": "2016", "MR": "20150630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067454"}, {"RECTYPE": "D", "MH": "No-Show Patients", "AQ": "EC ES PX SN TD", "ENTRY": "Patients, No-Show", "MN": "N05.300.150.800.500.600.750", "FX": "Patient Dropouts", "MH_TH": "NLM (2016)", "ST": "T081", "MS": "PATIENTS who do not turn up for scheduled healthcare appointments. Do not confuse with PATIENT DROPOUTS.", "PM": "2016", "HN": "2016", "MR": "20170620", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067455"}, {"RECTYPE": "D", "MH": "Cellular Reprogramming Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Techniques, Directed Differentiation", "MN": "E05.393.085", "FX": "Cellular Reprogramming", "MH_TH": "NLM (2016)", "ST": "T062", "PI": "Cellular Reprogramming (2015)", "MS": "Procedures used for the induction of CELLULAR REPROGRAMMING to change the terminal phenotype of a cell, such as the generation of INDUCED PLURIPOTENT STEM CELLS from differentiated adult cells by the forced expression of specific genes.", "PM": "2016", "HN": "2016", "MR": "20170316", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067470"}, {"RECTYPE": "D", "MH": "Metacognition", "AQ": "CL DE ES PH RE", "ENTRY": "Monitoring, Metacognitive", "MN": "F02.463.188.756", "FX": "Self-Assessment", "MH_TH": "NLM (2016)", "ST": "T041", "PI": "Self-Concept (1985-2015)", "MS": "Awareness and understanding of one's own thought processes.", "PM": "2016", "HN": "2016", "MR": "20170620", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067489"}, {"RECTYPE": "D", "MH": "Prescription Drug Overuse", "AQ": "AE CL EC ES HI LJ MO NU PC PX SN TD", "ENTRY": "Prescription Drug Overutilizations", "MN": "F03.900.384.500.750", "MH_TH": "NLM (2016)", "ST": "T055", "MS": "The use of a medication in an amount more than as prescribed.", "PM": "2016", "HN": "2016", "MR": "20230531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067490"}, {"RECTYPE": "D", "MH": "Near Miss, Healthcare", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Near Misses, Healthcare", "MN": "N05.700.513", "MH_TH": "NLM (2016)", "ST": "T080", "MS": "Event that presented a risk but did not result in a patient harm.", "PM": "2016", "HN": "2016", "MR": "20150626", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067491"}, {"RECTYPE": "D", "MH": "RNAi Therapeutics", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "RNAi Therapeutic|T061|NON|EQV|NLM (2022)|201023|abcdef", "ENTRY": "Therapy, RNAi-Based", "MN": "E02.095.301.250", "FX": "Gene Expression Regulation", "MH_TH": "NLM (2016)", "ST": "T061", "PI": "RNA Interference (2004-2015)", "MS": "A form of disease treatment which involves the silencing of genes that are associated with a disease by the process of RNA INTERFERENCE.", "PM": "2016", "HN": "2016", "MR": "20210630", "DA": "20150702", "DC": "1", "DX": "20160101", "UI": "D000067492"}, {"RECTYPE": "D", "MH": "Dynamic Light Scattering", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Scatterings, Quasi-Elastic Light (QELS)", "MN": "E05.196.822.325", "MH_TH": "NLM (2016)", "ST": "T059", "PI": "Scattering, Radiation (1974-2015)", "MS": "An analytical technique for measuring particle size of molecules that are less than a micron in diameter dispersed or dissolved in a liquid.", "PM": "2016", "HN": "2016", "MR": "20150121", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067493"}, {"RECTYPE": "D", "MH": "Time Out, Healthcare", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Timeouts, Surgical", "MN": "N05.700.739", "MH_TH": "NLM (2016)", "ST": "T058", "MS": "A period of time away from normal workflow taken to ensure key procedural details have been reviewed for better PATIENT SAFETY and help prevent MEDICAL ERRORS.", "PM": "2016", "HN": "2016", "MR": "20150109", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067494"}, {"RECTYPE": "D", "MH": "Healthcare Failure Mode and Effect Analysis", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "HFMEA|T058|ABB|EQV|NLM (2016)|141119|abcdef", "MN": "N06.850.520.830.600.800.715.500", "MH_TH": "NLM (2016)", "ST": "T058", "PI": "Risk Assessment (2002-2015)", "MS": "Prospective risk assessment tool aimed at identifying potential risks and their impact in healthcare settings.", "PM": "2016", "HN": "2016", "MR": "20150109", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067495"}, {"RECTYPE": "D", "MH": "Spirit Possession", "AQ": "HI", "ENTRY": "Spirit Possessions", "MN": "K01.844.619.500", "FX": "Superstitions", "MH_TH": "NLM (2016)", "ST": "T078", "MS": "The idea that abnormal behavior or a medical condition is evidence that a person is under the control of a supernatural power or spirit. This belief was most commonly held in religion and medicine of the medieval period and is also held in many tribal cultures today.", "PM": "2016", "HN": "2016", "MR": "20190705", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067496"}, {"RECTYPE": "D", "MH": "Crew Resource Management, Healthcare", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Healthcare CRMs", "MN": "N04.590.254", "MH_TH": "NLM (2016)", "ST": "T058", "PI": "Patient Care Team (2000-2015)", "MS": "A range of healthcare related training designed to reduce MEDICAL ERRORS and improve PATIENT SAFETY by emphasizing TEAMWORK and human factors (see HUMAN ENGINEERING).", "PM": "2016", "HN": "2016", "MR": "20150109", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067498"}, {"RECTYPE": "D", "MH": "Computer Heuristics", "AQ": "PX", "ENTRY": "Heuristics, Computer", "MN": "L01.224.050.375.095", "FX": "Heuristics", "MH_TH": "NLM (2016)", "ST": "T066", "MS": "Trial-and-error methods of problem-solving used when an algorithmic approach is impractical", "MR": "20190322", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000067508"}, {"RECTYPE": "D", "MH": "Ataxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Spinocerebellar Ataxia Protein|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Proteins, Spinocerebellar Ataxia", "MN": "D12.776.660.075", "FX": "Spinocerebellar Ataxias", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "PI": "Nuclear Proteins (1995-2015)", "MS": "A family of predominantly nuclear proteins that regulate gene transcription and protein degradation. The expansion of CAG trinucleotide repeats in genes that encode Ataxins is associated with SPINOCEREBELLAR ATAXIAS (SCA). In SCA patients, the number of CAG repeats correlates with the severity of disease and inversely correlates with the age of disease onset.", "PM": "2016", "HN": "2016", "MR": "20200527", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067528"}, {"RECTYPE": "D", "MH": "Alarmins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Danger Associated Molecular Pattern Molecules", "MN": "D23.469.025", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "PI": "HMGB1 Protein (2004-2015)", "MS": "A structurally diverse group of endogenous molecules that are multifunctional, having physiological functions inside the cell, but when released from dying cells or from cells under stress or certain immune cells, they function to activate INNATE IMMUNITY. Uncontrolled and excessive release of alarmins may contribute to INFLAMMATION; CARCINOGENESIS, and NEOPLASM METASTASIS. Alarmins are also critical for heart and nerve tissue homeostasis.", "PM": "2016", "HN": "2016", "MR": "20210707", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067531"}, {"RECTYPE": "D", "MH": "Dermal Fillers", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Fillers, Skin", "MN": "D27.720.102.461", "FX": "Injections, Subcutaneous", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "MS": "Materials such as COLLAGEN or HYALURONIC ACID that are injected or deposited into the DERMIS for the purpose of skin augmentation.", "PM": "2016", "HN": "2016", "MR": "20150121", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067548"}, {"RECTYPE": "D", "MH": "Action Spectrum", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Spectrum, Action", "MN": "E05.196.867.826.150", "MH_TH": "NLM (2016)", "ST": "T059", "MS": "A technique used to measure the rate of physiological activity plotted against wavelength of light. An action spectrum depicts the most effective wavelength of light (also known as spectral sensitivity) that is required for each specific process.", "PM": "2016", "HN": "2016", "MR": "20150616", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067549"}, {"RECTYPE": "D", "MH": "Diplomacy", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "MN": "I01.738.305", "MH_TH": "NLM (2016)", "ST": "T054", "MS": "The art and practice of conducting negotiations between people, nations or other parties such as organizations.", "PM": "2016", "HN": "2016", "MR": "20170620", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067551"}, {"RECTYPE": "D", "MH": "Mutation Accumulation", "ENTRY": "Spontaneous Mutation Accumulations", "MN": "G05.365.590.594", "FX": "Mutagenesis", "MH_TH": "NLM (2016)", "ST": "T045", "PI": "Mutation (1977-2015)", "MS": "Concept which describes the incremental effects of MUTATION in living organisms.", "PM": "2016", "HN": "2016", "MR": "20150121", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067552"}, {"RECTYPE": "D", "MH": "Internal Ribosome Entry Sites", "AQ": "DE GE IM PH RE", "ENTRY": "Internal Ribosome Entry Site|T086|T114|NON|EQV|NLM (2016)|150112|abbcdef", "MN": "G05.360.080.689.687.093", "MH_TH": "NLM (2016)", "ST": "T114", "RN": "0", "MS": "Sequences within MESSENGER RNA that enable PROTEIN TRANSLATION INITIATION independent of 5' CAPPED RNA.", "PM": "2016", "HN": "2016", "MR": "20150112", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067556"}, {"RECTYPE": "D", "MH": "Biological Mimicry", "AQ": "DE GE IM PH RE", "ENTRY": "Mullerian Mimicries", "MN": "G16.012.750", "FX": "Biomimetics", "MH_TH": "NLM (2016)", "ST": "T070", "MS": "Resemblance in appearance, structure, function, sound, scent or behavior between related or unrelated species, occurring in the same geographic location.", "PM": "2016", "HN": "2016", "MR": "20160602", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067558"}, {"RECTYPE": "D", "MH": "Specific Learning Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Specific Learning Disorders", "MN": "F03.625.562.700", "MH_TH": "NLM (2016)", "ST": "T048", "MS": "Diagnosed when there are specific deficits in an individual\u2019s ability to perceive or process information efficiently and accurately. This  disorder first manifests during the years of formal schooling and is characterized by persistent and impairing difficulties with learning foundational academic skills in reading, writing, and/or math. The individual\u2019s performance of the affected academic skills is well below average for age, or acceptable performance levels are achieved only with extraordinary effort. Specific learning disorder may occur in individuals identified as intellectually gifted and manifest only when the learning demands or assessment procedures (e.g., timed tests) pose barriers that cannot be overcome by their innate intelligence and compensatory strategies. For all individuals, specific learning disorder can produce lifelong impairments in activities dependent on the skills, including occupational performance. (from DSM-V)", "PM": "2016", "HN": "2016", "MR": "20230531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067559"}, {"RECTYPE": "D", "MH": "Potentially Inappropriate Medication List", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "STOPPs (Screening Tool of Older Person's Potentially Inappropriate Prescriptions)", "MN": "N05.700.594", "FX": "Inappropriate Prescribing", "MH_TH": "NLM (2016)", "ST": "T080", "PI": "Medication Errors (2003-2015)", "MS": "A list, criteria, or screening tool designed to improve PATIENT SAFETY by determining an individual's exposure to potentially inappropriate drugs. They are designed to prevent MEDICATION ERRORS by INAPPROPRIATE PRESCRIBING. Analysis for a list includes factors such as DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; AGE FACTORS; GENDER; and existing medical conditions.", "PM": "2016", "HN": "2016", "MR": "20150709", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000067561"}, {"RECTYPE": "D", "MH": "Late Onset Disorders", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "ENTRY": "Onset Disorders, Later", "MN": "C23.550.291.883", "MH_TH": "NLM (2016)", "ST": "T047", "PI": "Age of Onset (1984-2015)", "MS": "Pathological conditions (Disorder, SYNDROME, or DISEASE) whose SIGNS AND SYMPTOMS manifest late in the life of an individual.", "PM": "2016; see AGE OF ONSET 1997-2015", "HN": "2016; use AGE OF ONSET 1997-2015", "MR": "20150708", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000067562"}, {"RECTYPE": "D", "MH": "Phakopsora pachyrhizi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Physopella pachyrhizi|T004|NON|EQV|NLM (2021)|200318|abcdef", "ENTRY": "Soybean Rusts, Asian", "MN": "B01.300.179.113", "MH_TH": "NLM (2016)", "ST": "T004", "RN": "txid170000", "PI": "Basidiomycota (1980-2015)", "MS": "Fungal pathogen which causes Soybean Rust disease in Soybeans (Glycine max).", "PM": "2016", "HN": "2016", "MR": "20200527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067563"}, {"RECTYPE": "D", "MH": "Farmers", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Workers, Farm", "MN": "M01.526.390", "MH_TH": "NLM (2016)", "ST": "T097", "PI": "Agriculture (1963-2015)", "MS": "Persons who cultivate land or crops, or raise LIVESTOCK.", "PM": "2016; for AGRICULTURAL WORKERS see AGRICULTURE 1981-2015", "HN": "2016; for AGRICULTURAL WORKERS use AGRICULTURE 1981-2015", "MR": "20150707", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000067565"}, {"RECTYPE": "D", "MH": "Culturally Appropriate Technology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Technology, Soft", "MN": "J01.897.052", "FX": "Diffusion of Innovation", "MH_TH": "NLM (2016)", "ST": "T170", "MS": "A SCIENCE or TECHNOLOGY that promotes self-sufficiency and is suitable to the cultural, environmental, economic and social conditions of the geographic area in which it is applied.", "PM": "2016", "HN": "2016", "MR": "20150121", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067568"}, {"RECTYPE": "D", "MH": "Social Learning", "AQ": "CL DE ES PH RE", "ENTRY": "Learning, Social", "MN": "F02.784.629.529.663", "FX": "Socialization", "MH_TH": "NLM (2016)", "ST": "T041", "PI": "Learning (1963-2015)", "MS": "The concept of new knowledge acquisition through observation and interaction with others.", "PM": "2016", "HN": "2016", "MR": "20150121", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067570"}, {"RECTYPE": "D", "MH": "Financial Statements", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Worth, Net", "MN": "N03.219.463.030.140", "FX": "Financial Management", "MH_TH": "NLM (2016)", "ST": "T081", "MS": "Formal and structured record of financial activities of a business, person, or other entity.", "PM": "2016", "HN": "2016", "MR": "20150702", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067571"}, {"RECTYPE": "D", "MH": "Miners", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Workers, Mine", "MN": "M01.526.693", "MH_TH": "NLM (2016)", "ST": "T097", "PI": "Mining (1963-2015)", "MS": "Persons who work in a mine to extract ore or MINERALS from the earth.", "PM": "2016", "HN": "2016", "MR": "20150112", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067572"}, {"RECTYPE": "D", "MH": "Chronopharmacokinetics", "ENTRY": "Chronopharmacokinetic", "MN": "G07.690.725.249", "FX": "Drug Chronotherapy", "MH_TH": "NLM (2016)", "ST": "T039", "MS": "Absorption, metabolism and elimination of drugs in relation to time of day at which they are administered, and the mechanisms responsible for time-dependent variations.", "PM": "2016", "HN": "2016", "MR": "20150121", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067573"}, {"RECTYPE": "D", "MH": "Administrative Claims, Healthcare", "AQ": "CL EC LJ SN", "ENTRY": "Healthcare Administrative Claims", "MN": "N04.452.859.564.137", "MH_TH": "NLM (2016)", "ST": "T170", "MS": "Information relating to itemized coding of procedures and costs associated with healthcare delivery, used as a means for tracking healthcare utilization, patterns of care, and treatment outcomes.", "PM": "2016", "HN": "2016", "MR": "20150121", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067575"}, {"RECTYPE": "D", "MH": "Child Health", "AQ": "CL EC EH ES HI LJ SN ST TD", "PRINT ENTRY": "Child Wellbeing|T039|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Wellbeing, Child", "MN": "N01.400.225", "FX": "Child Welfare", "MH_TH": "NLM (1978)", "ST": "T078", "PI": "Child Welfare (1978-2015)", "MS": "The concept covering the physical and mental conditions of CHILDREN.", "PM": "2016; for CHILD HEALTH see CHILD WELFARE 1978-2015; for ADOLESCENT WELL BEING and CHILD WELL BEING see CHILD WELFARE 2016-2020", "HN": "2016; for CHILD HEALTH use CHILD WELFARE 1978-2015; for ADOLESCENT WELL BEING and CHILD WELL BEING use CHILD WELFARE 2016-2020", "MR": "20210512", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000067576"}, {"RECTYPE": "D", "MH": "Interleukin-33", "DS": "INTERLEUKIN 033", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Interleukin 33", "MN": "D23.529.374.465.850", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "PI": "Interleukins (2005-2015)", "MS": "A member of the INTERLEUKIN-1 protein  family involved in the maturation of TH2 CELLS and the activation of MAST CELLS; BASOPHILS; EOSINOPHILS and NK CELLS. It is also produced by ENDOTHELIAL CELLS; EPITHELIAL CELLS and FIBROBLASTS; where it can function as an alarmin to modulate immune and inflammatory responses to tissue damage.", "PM": "2016; INTERLEUKIN-33 was indexed under INTERLEUKINS 2005-2015", "HN": "2016 (2005)", "MR": "20160630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067596"}, {"RECTYPE": "D", "MH": "S100A12 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, S100A12", "MN": "D12.776.157.125.750.875", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "PI": "S100 Proteins (2003-2015)", "MS": "A member of the S100 PROTEIN FAMILY that regulates INFLAMMATION and the immune response. It recruits LEUKOCYTES, promotes cytokine and chemokine production, and regulates leukocyte adhesion and migration. S100A12 can also function via binding to ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTORS, to stimulate innate immune cells.", "PM": "2016; S100A12 PROTEIN was indexed under S100 PROTEINS 2003-2015, and under CALCIUM-BINDING PROTEINS 1994-2002", "HN": "2016 (1994)", "MR": "20160701", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067616"}, {"RECTYPE": "D", "MH": "Telopodes", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Telopode", "MN": "A11.329.830.750.500", "MH_TH": "NLM (2016)", "ST": "T026", "MS": "The very long and thin extensions of telocytes' cell surface, that have alternating thick and thin sections called podoms and podomers.", "PM": "2016", "HN": "2016", "MR": "20150612", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067617"}, {"RECTYPE": "D", "MH": "Drosophila simulans", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "simulans, Drosophila", "MN": "B01.050.500.131.617.720.500.500.750.310.250.750", "MH_TH": "NLM (2016)", "ST": "T204", "RN": "txid7240", "PI": "Drosophila (1963-2015)", "MS": "A species of fruit fly.", "PM": "2016", "HN": "2016", "MR": "20200813", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000067636"}, {"RECTYPE": "D", "MH": "Optimism", "AQ": "PX", "PRINT ENTRY": "Positive Attitude|T055|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Attitude, Positive", "MN": "F01.100.787", "MH_TH": "OBSSR (2016)", "ST": "T055", "MS": "Mental attitude that interprets life events as generally being positive.", "PM": "2016", "HN": "2016", "MR": "20210512", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067656"}, {"RECTYPE": "D", "MH": "Pessimism", "AQ": "PX", "ENTRY": "Thinking, Negative", "MN": "F01.100.893", "MH_TH": "OBSSR (2016)", "ST": "T055", "MS": "Mental attitude that interprets life events as generally being negative.", "PM": "2016", "HN": "2016", "MR": "20160302", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067657"}, {"RECTYPE": "D", "MH": "Ataxin-1", "DS": "ATAXIN001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, SCA1", "MN": "D12.776.660.075.500", "FX": "Spinocerebellar Ataxias", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "PI": "Nuclear Proteins (1995-2015)", "MS": "A chromatin-binding factor that represses Notch signaling and associates with RNA. Expansion of the polyglutamine tract by expanded CAG repeats in the ATXN1 gene coding region is associated with SPINOCEREBELLAR ATAXIA 1.", "PM": "2016; ATAXIN-1 was indexed under NERVE TISSUE PROTEINS AND NUCLEAR PROTEINS 1995-2015", "HN": "2016 (1995)", "MR": "20151123", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067696"}, {"RECTYPE": "D", "MH": "Adolescent Health", "AQ": "CL EC EH ES HI LJ SN ST TD", "PRINT ENTRY": "Adolescent Wellbeing|T040|NON|REL|NLM (2021)|OBSSR (2021)|200526|abcdeef", "ENTRY": "Wellbeing, Adolescent", "MN": "N01.400.075", "FX": "Adolescent Medicine", "MH_TH": "NLM (2016)", "ST": "T078", "MS": "The concept covering the physical and mental conditions of ADOLESCENTS.", "PM": "2016", "HN": "2016", "MR": "20210512", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067697"}, {"RECTYPE": "D", "MH": "Ataxin-2", "DS": "ATAXIN002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, SCA2", "MN": "D12.776.664.962.452.125", "FX": "Spinocerebellar Ataxias", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "PI": "Proteins (1996-2005)", "MS": "A Poly(A) RNA-binding protein that negatively regulates EGFR ENDOCYTOSIS. An increased risk for developing AMYOTROPHIC LATERAL SCLEROSIS 13 is observed in patients who have more than 23 CAG repeats in the ATXN2 gene coding sequence. Larger CAG expansions in the ATXN2 gene occur in SPINOCEREBELLAR ATAXIA 2 patients.", "PM": "2016; ATAXIN-2 was indexed under PROTEINS 1996-2005, and under NERVE TISSUE PROTEINS 2005-2015", "HN": "2016; use SCA2 PROTEIN (NM) 1996-2015", "MR": "20151123", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067698"}, {"RECTYPE": "D", "MH": "Ataxin-3", "DS": "ATAXIN003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Machado Joseph Disease Protein", "MN": "D12.776.660.075.875", "FX": "Spinocerebellar Ataxias", "MH_TH": "NLM (2016)", "ST": "T126", "RN": "EC 3.4.19.12", "PI": "Proteins (1995-1997)", "MS": "A deubiquitinating enzyme of the ATAXINS family. It functions in protein homeostasis, GENETIC TRANSCRIPTION; CYTOSKELETON regulation, and MYOGENESIS. CAG TRINUCLEOTIDE REPEAT EXPANSION in the Ataxin-3 gene coding region is associated with spinocerebellar ataxia-3 (MACHADO-JOSEPH DISEASE).", "PM": "2016; ATAXIN-3 was indexed under NERVE TISSUE PROTEINS AND NUCLEAR PROTEINS 1998-2015, and under PROTEINS 1995-1997", "HN": "2016 (1995)", "MR": "20160527", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067699"}, {"RECTYPE": "D", "MH": "Point-of-Care Testing", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Point-Of-Care Tests|T060|NON|EQV|NLM (2021)|200115|abcdef", "ENTRY": "Tests, Point-Of-Care Diagnostic", "MN": "N04.590.874.500", "MH_TH": "NLM (2016)", "ST": "T060", "MS": "Allows patient diagnoses in the physician\u2019s office, in other ambulatory setting or at bedside. The results of care are timely, and allow rapid treatment to the patient. (from NIH Fact Sheet Point-of-Care Diagnostic Testing, 2010.)", "PM": "2016; for BEDSIDE TESTING see POINT-OF-CARE SYSTEMS 1995-2015", "HN": "2016; for BEDSIDE TESTING use POINT-OF-CARE SYSTEMS 1995-2015", "MR": "20200609", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000067716"}, {"RECTYPE": "D", "MH": "Ataxin-7", "DS": "ATAXIN007", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, SCA7", "MN": "D12.776.660.075.900", "FX": "Spinocerebellar Ataxias", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1997-2015)", "MS": "A component of the STAGA transcription coactivator-HAT complex that functions in Cone Rod Homeobox Protein (CRX)-dependent gene activation. It also stabilizes MICROTUBULES. CAG repeat expansion in the ATXN-7 coding region is associated with the development of SPINOCEREBELLAR ATAXIA 7.", "PM": "2016; ATAXIN-7 was indexed under NERVE TISSUE PROTEINS 1997-2015", "HN": "2016", "MR": "20151123", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000067719"}, {"RECTYPE": "D", "MH": "Ataxin-10", "DS": "ATAXIN010", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, SCA10", "MN": "D12.776.631.069.950", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (2006-2015)", "MS": "An ataxin that is associated with the survival of cerebellar neurons. Expansion of the ATTCT pentanucleotide in the ATXN10 coding region is associated with SPINOCEREBELLAR ATAXIA 10.", "PM": "2016; ATAXIN-10 was indexed under NERVE TISSUE PROTEINS 2006-2015", "HN": "2016", "MR": "20151123", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067736"}, {"RECTYPE": "D", "MH": "Glucagon-Like Peptide Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Glucagon-Like Receptor|T116|T192|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Receptors, Glucagon-Like Peptide", "MN": "D12.776.543.750.750.360.100", "MH_TH": "NLM (2016)", "ST": "T192", "RN": "0", "PI": "Receptors, Glucagon (1995-2015)", "MS": "G-PROTEIN COUPLED CELL SURFACE RECEPTORS that bind GLUCAGON-LIKE PEPTIDES and are expressed by cells in pancreatic, intestinal, and neural tissues. These receptors regulate cellular responses to BLOOD GLUCOSE, INSULIN, and INFLAMMATION signals.", "PM": "2016", "HN": "2016", "MR": "20200527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067756"}, {"RECTYPE": "D", "MH": "Glucagon-Like Peptide-1 Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Glucagon-Like Peptide-1", "MN": "D12.776.543.750.750.360.100.500", "MH_TH": "NLM (2016)", "ST": "T192", "RN": "0", "PI": "Receptors, Glucagon (1995-2015)", "MS": "A receptor for GLUCAGON-LIKE PEPTIDE 1 (GLP-1) expressed primarily on the surface of beta and ductal exocrine cells of the pancreas, as well as cells of other tissues. GLP-1 acts through GLP-1R to potentiate signaling in pancreatic cells in response to glucose-stimulated insulin secretion (GSIS).", "PM": "2016; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR was indexed under RECEPTORS, GLUCAGON 1995-2015, and under RECEPTORS, CELL SURFACE 1987-1995", "HN": "2016", "MR": "20160617", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067757"}, {"RECTYPE": "D", "MH": "Glucagon-Like Peptide-2 Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Glucagon-Like Peptide-2", "MN": "D12.776.543.750.750.360.100.600", "MH_TH": "NLM (2016)", "ST": "T192", "RN": "0", "PI": "Receptors, Glucagon (2000-2015)", "MS": "A receptor for GLUCAGON-LIKE PEPTIDE 2 (GLP-2) that is expressed on the surface of intestinal cells as well as neural cells. GLP-2 and other peptides act through GLP-2R to regulate cellular responses to BLOOD GLUCOSE, INFLAMMATION, and FOOD INTAKE.", "PM": "2016; GLUCAGON-LIKE PEPTIDE-2 RECEPTOR was indexed under RECEPTORS, GLUCAGON 2000-2015", "HN": "2016", "MR": "20160617", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067758"}, {"RECTYPE": "D", "MH": "Receptor for Advanced Glycation End Products", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptor for Advanced Glycation Endproduct|T116|T192|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Receptor, Amphoterin", "MN": "D23.469.850", "FX": "Advanced Oxidation Protein Products", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1993-2015)", "MS": "A single-pass transmembrane CELL SURFACE RECEPTOR that binds ADVANCED GLYCATION END PRODUCTS to mediate cellular responses to both acute and chronic vascular inflammation in conditions such as ATHEROSCLEROSIS and DIABETES MELLITUS, TYPE 2.", "PM": "2018; see ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR 2016-2017; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1993-2015, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1991-1993", "HN": "2018 (1991)", "MR": "20220407", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067759"}, {"RECTYPE": "D", "MH": "RNA Recognition Motif Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "RNA Binding Domain Proteins", "MN": "D12.776.664.962.813", "FX": "RNA Recognition Motif", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "RNA-Binding Proteins (1993-2015)", "MS": "A family of RNA-BINDING PROTEINS that contain an RNA RECOGNITION MOTIF and two ribonucleoprotein (RNP) domains which bind RNA, in addition to other domains that allow for high affinity binding, sequence specificity, and protein interactions. Examples of RNA recognition motif proteins include HETEROGENEOUS NUCLEAR RIBONUCLEARPROTEINS (hnRNP) and EMBRYONIC LETHAL ABNORMAL-VISION (ELAV) proteins.", "PM": "2016; RNA RECOGNITION MOTIF PROTEINS was indexed under RNA-BINDING PROTEINS (1993-2015)", "HN": "2016 (1993)", "MR": "20160415", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067776"}, {"RECTYPE": "D", "MH": "ELAV-Like Protein 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "protein, ELAVL2", "MN": "D12.776.664.962.813.500.500", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "ELAV Proteins  (2005-2015)", "MS": "A neural-specific RRM protein that binds to several 3'UTRs, including its own as well as that of PROTO-ONCOGENE PROTEINS C-FOS  and ID DNA BINDING PROTEIN INHIBITOR. It binds through the recognition of a GAAA motif in the RNAs.", "PM": "2016; see HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS 2012-2015", "HN": "2016; use ELAV PROTEINS 2012-2015", "MR": "20151123", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000067777"}, {"RECTYPE": "D", "MH": "ELAV-Like Protein 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, HuC", "MN": "D12.776.664.962.813.500.750", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "ELAV Proteins  (2005-2015)", "MS": "A neural-specific RRM protein which contains three RNP-type RNA recognition motifs (RRMs). Human ELAVL3 is recognized by the anti-Hu serum antibody from patients with paraneoplastic encephalomyelitis and sensory neuronopathy (PEM/PSN). It also functions in neurogenesis.", "PM": "2016; see HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS 2012-2015", "HN": "2016; use ELAV PROTEINS 2012-2015", "MR": "20151123", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000067778"}, {"RECTYPE": "D", "MH": "ELAV-Like Protein 4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, HuD", "MN": "D12.776.664.962.813.500.875", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "ELAV Proteins (2005-2015)", "MS": "An RRM protein which binds AU-rich sequences in the 3' UNTRANSLATED REGIONS of mRNAs for PROTO-ONCOGENE PROTEINS C-FOS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; and GAP-43 PROTEIN. It functions in neuron-specific RNA processing.", "PM": "2016; see HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS 2012-2015", "HN": "2016; use ELAV PROTEINS 2012-2015", "MR": "20151123", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000067779"}, {"RECTYPE": "D", "MH": "ELAV-Like Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "protein, ELAVL1", "MN": "D12.776.664.962.813.500.250", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "RNA-Binding Proteins (2000-2015)", "MS": "An RRM protein that binds to the 3'-UTR region of mRNAs and increases their stability. In EMBRYONIC STEM CELLS, it binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs and preferentially binds mRNAs that are not methylated by N6-methyladenosine (m6A), to stabilize them and promote differentiation.", "PM": "2016; see HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS 2012-2015", "HN": "2016; use ELAV PROTEINS 2012-2015", "MR": "20150710", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000067780"}, {"RECTYPE": "D", "MH": "Whey", "AQ": "AD AE CH CL CY DE DG EC EN HI IM LJ ME MI PH PO PS RE SD SN ST TO VI", "MN": "J02.500.350.525.760", "MH_TH": "NLM (2016)", "ST": "T168", "PI": "Dairy Products (1964-2015)", "MS": "The liquid components of milk that remain after the CASEIN, fat, and fat soluble components have been removed. It is also a byproduct of cheese production.", "PM": "2016", "HN": "2016", "MR": "20190709", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067796"}, {"RECTYPE": "D", "MH": "Whey Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Whey", "MN": "J02.500.428.159.750.500", "MH_TH": "NLM (2016)", "ST": "T116", "RN": "0", "MS": "The protein components of milk obtained from the whey.", "PM": "2016; WHEY PROTEIN (NM) was indexed as MILK PROTEINS (1984-2015)", "HN": "2016 (1984)", "MR": "20190708", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067816"}, {"RECTYPE": "D", "MH": "Hoarding Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Obsessive Hoarding|T048|NON|BRD|NLM (2012)|110404|abcdef", "ENTRY": "Hoarding, Obsessive", "MN": "F03.080.600.250", "MH_TH": "NLM (2016)", "ST": "T048", "AN": "differentiate from HOARDING", "MS": "Disordered behavior associated with clinically significant distress or impairment in social, occupational or other important areas of functioning and persistent difficulty parting with possessions due to a perceived need to save the items and distress associated with discarding them. (from DSM-V) The quantity of collected items sets the behavior apart from normal collecting behaviors.", "PM": "2016", "HN": "2016", "MR": "20170308", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067836"}, {"RECTYPE": "D", "MH": "Poly(ADP-ribose) Polymerase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Poly(ADP-ribosylation) Inhibitor|T121|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Inhibitors, PARP", "MN": "D27.505.954.248.692", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES.", "PM": "2016", "HN": "2016", "MR": "20200527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067856"}, {"RECTYPE": "D", "MH": "Autism Spectrum Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Autistic Spectrum Disorder|T048|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Disorder, Autistic Spectrum", "MN": "F03.625.164.113", "MH_TH": "NLM (2016)", "ST": "T048", "PI": "Child Development Disorders, Pervasive (2010-2015)", "MS": "Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)", "PM": "2016; see CHILD DEVELOPMENT DISORDERS, PERVASIVE 2010-2015", "HN": "2016; use CHILD DEVELOPMENT DISORDERS, PERVASIVE 2010-2015", "MR": "20210512", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000067877"}, {"RECTYPE": "D", "MH": "CELF Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, CUGBP", "MN": "D12.776.664.962.813.250", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1997-2004)", "MS": "A family of RRM proteins which contain two N-terminal RNA RECOGNITION MOTIF (RRM) domains, one C-terminal RRM domain, and a divergent segment of 160-230 amino acids between the second and third RRM domains. They regulate pre-mRNA ALTERNATIVE SPLICING and also function in RNA EDITING and PROTEIN BIOSYNTHESIS.", "PM": "2016", "HN": "2016", "MR": "20150226", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067878"}, {"RECTYPE": "D", "MH": "CELF1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, CUGBP1", "MN": "D12.776.664.962.813.250.500", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1997-2004)", "MS": "A member of the CELF PROTEINS family which binds GU rich elements (GREs) and CUG-triplet repeats in the 3'UTR of mammalian mRNA transcripts that undergo rapid turnover. It also binds AU-rich elements (AREs or EDEN-like) in the 3'UTR of JUN and FOS mRNAs. Mutations in the human CELF1 gene are associated with MYOTONIC DYSTROPHY type 1.", "PM": "2016", "HN": "2016", "MR": "20150226", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067879"}, {"RECTYPE": "D", "MH": "Industrial Development", "AQ": "ES HI LJ SN TD", "PRINT ENTRY": "Industrialization|T057|NON|BRD|NLM (1978)|961202|abcdef", "ENTRY": "Technology Developments", "MN": "J01.576.519", "MH_TH": "NLM (2016)", "ST": "T078", "MS": "Activity concerned with the planning and building of industries through manufacturing, provision of specialized services, and COMMERCE.", "PM": "2016; for INDUSTRIALIZATION see INDUSTRY 2000-2015", "HN": "2016; for INDUSTRIALIZATION use INDUSTRY 2000-2015", "MR": "20150710", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000067896"}, {"RECTYPE": "D", "MH": "Cloud Computing", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Fog Computing|T066|NON|REL|NLM (2024)|230419|abcdef", "ENTRY": "Storages, Cloud", "MN": "L01.224.097", "FX": "Technology", "MH_TH": "NLM (2016)", "ST": "T066", "MS": "Storing and processing data on multiple servers that can be accessed through the Internet.", "PM": "2016", "HN": "2016", "MR": "20230526", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067917"}, {"RECTYPE": "D", "MH": "Natural Resources", "AQ": "SD", "ENTRY": "Supply, Land", "MN": "N06.230.350", "FX": "Conservation of Natural Resources", "MH_TH": "NLM (1983)", "ST": "T081", "AN": "coordinate with  specific natural resource if pertinent", "MS": "Materials or substances such as land, timber, fresh water, fossil fuels, or mineral deposits that occur in a natural state and have economic value or usefulness to humans.", "PM": "2016; see CONSERVATION OF NATURAL RESOURCES 1991-2015; for LAND SUPPLY see AGRICULTURE 1978-2015", "HN": "2016;  use CONSERVATION OF NATURAL RESOURCES 1991-2015; for LAND SUPPLY use AGRICULTURE 1978-2015", "MR": "20150707", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000067936"}, {"RECTYPE": "D", "MH": "Glycemic Load", "AQ": "DE EH GE IM PH RE", "ENTRY": "Load, Glycemic", "MN": "N06.850.601.750.750", "MH_TH": "NLM (2016)", "ST": "T081", "AN": "GLYCEMIC INDEX is also available", "PI": "Glycemic Index (2003-2015)", "MS": "A quantitative value of a measured amount of a specific food that is equal to the GLYCEMIC INDEX of that food multiplied by the carbohydrate content of that food.", "PM": "2016", "HN": "2016", "MR": "20160427", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000067940"}, {"RECTYPE": "D", "MH": "Adenylyl Cyclase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inhibitors, Adenylyl Cyclase", "MN": "D27.505.519.389.108", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "PI": "Adenylyl Cyclase/antagonists & inhibitors (1968-2015)", "MS": "Compounds that bind to and inhibit the action of ADENYLYL CYCLASES.", "PM": "2016", "HN": "2016", "MR": "20150402", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000067956"}, {"RECTYPE": "D", "MH": "RAW 264.7 Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "RAW 264.7 Cell", "MN": "A11.733.397.815", "MH_TH": "NLM (2016)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMALS and MICE", "PI": "Macrophages (1983-2015)", "MS": "A transformed macrophage cell line isolated from ASCITES of mice infected with ABELSON MURINE LEUKEMIA VIRUS.", "PM": "2016", "HN": "2016", "MR": "20150706", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000067996"}, {"RECTYPE": "D", "MH": "Accreditation", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Accreditations", "MN": "N05.700.200.100", "FX": "Licensure", "MH_TH": "NLM (1964)", "ST": "T064", "AN": "by the profession; do not confuse with LICENSURE (by the state)", "MS": "Certification as complying with a standard set by non-governmental organizations, applied for by institutions, programs, and facilities on a voluntary basis.", "PM": "66", "HN": "66(64)", "MR": "19940603", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000068"}, {"RECTYPE": "D", "MH": "Clostridiales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.353.625", "MH_TH": "NLM (2016)", "ST": "T007", "RN": "txid186802", "PI": "Bacteria (2001-2015)", "MS": "An order of anaerobic bacteria that are predominantly GRAM POSITIVE within the phylum Firmicutes. It includes the Clostridium and Eubacterium genera.", "PM": "2016", "HN": "2016", "MR": "20200813", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000068016"}, {"RECTYPE": "D", "MH": "Graphic Novel", "ENTRY": "Graphic Novels|T170|NON|EQV|NLM (2016)|150116|abcdef", "MN": "V02.700.225.500", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "This heading is used as a Publication Type. Graphic novels as a subject are indexed under the main heading GRAPHIC NOVELS AS TOPIC.  INDEXER: Do not use ", "PI": "Cartoons (2014-2015)", "MS": "Book-length narratives told using a combination of words and sequential art, often presented in comic book style. from (Fletcher-Spear et al., ALA Review, Winter 2005)", "HN": "2016; use CARTOONS 2014-2015", "MR": "20230531", "DA": "20150701", "DC": "2", "DX": "20160101", "UI": "D000068036"}, {"RECTYPE": "D", "MH": "South Sudan", "AQ": "EH EP", "MN": "Z01.058.290.120.745", "MH_TH": "NLM (2016)", "ST": "T083", "PI": "Susan (1988-2015)", "MS": "A nation located in East-Central Africa; south of Sudan, north of Uganda and Kenya, west of Ethiopia. Independence from SUDAN was attained on 9 July 2011. The capital is Juba. (from CIA. World Factbook, 2014.)", "HN": "2016", "MR": "20210126", "DA": "20150701", "DC": "4", "DX": "20160101", "UI": "D000068037"}, {"RECTYPE": "D", "MH": "Motor Disorders", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "MN": "F03.608", "MH_TH": "NLM (2016)", "ST": "T048", "PI": "Motor Skills Disorders (1998-2015)", "MS": "Motor skills deficits that significantly and persistently interfere with ACTIVITIES OF DAILY LIVING appropriate to chronological age.  (from DSM-5)", "PM": "2016; see MOTOR SKILLS DISORDERS 1998-2015", "HN": "2016; use MOTOR SKILLS DISORDERS 1998-2015", "MR": "20190429", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068079"}, {"RECTYPE": "D", "MH": "Maternal Health", "AQ": "CL EC EH ES HI LJ SN ST TD", "ENTRY": "Health, Maternal", "MN": "N01.400.900.500", "FX": "Maternal Welfare", "MH_TH": "NLM (1992)", "ST": "T078", "PI": "Maternal Welfare (1974-2015)", "MS": "The health of women during PREGNANCY; childbirth and the POSTPARTUM PERIOD.", "PM": "2016; see MATERNAL WELFARE 1974-2015", "HN": "2016 (1974); use MATERNAL WELFARE 1974-2015", "MR": "20150706", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000068097"}, {"RECTYPE": "D", "MH": "Seed Bank", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Seedbanks", "MN": "N02.278.065.650", "MH_TH": "NLM (2016)", "ST": "T002", "PI": "Seeds (2000-2015)", "MS": "A repository of seeds maintained under optimal conditions that ensure long term storage, intended for use as a source of replenishment of seed stock or plant genetic material.", "PM": "2016", "HN": "2016", "MR": "20180629", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068098"}, {"RECTYPE": "D", "MH": "Trauma and Stressor Related Disorders", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Trauma and Stress Related Disorders|T048|NON|EQV|NLM (2022)|210517|abcdef", "MN": "F03.950", "MH_TH": "NLM (2016)", "ST": "T048", "MS": "Disorders in which exposure to a traumatic or stressful event is explicitly a diagnostic criterion.", "PM": "2016", "HN": "2016", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068099"}, {"RECTYPE": "D", "MH": "Maternal-Child Health Services", "DE": "MATERNAL CHILD HEALTH SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Services, Maternal-Child Health", "MN": "N02.421.143.620.275", "MH_TH": "NLM (1978)", "ST": "T058", "PI": "Maternal-Child Health Centers (1978-2015)", "MS": "Programs organized for the purpose of providing medical and social services for mothers and children.", "PM": "2016; see MATERNAL-CHILD HEALTH CENTERS 1978-2015", "HN": "2016 (1978); use MATERNAL-CHILD HEALTH CENTERS 1978-2015", "MR": "20190701", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000068101"}, {"RECTYPE": "D", "MH": "Serine-Arginine Splicing Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Splicing Proteins, Serine-Arginine-Rich", "MN": "D12.776.664.962.829.500", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "170974-22-8", "MS": "A family of regulatory factors essential for constitutive and alternative splicing in RNA metabolism.", "PM": "2016; SERINE-ARGININE-RICH SPLICING PROTEINS was indexed under PHOSPHOPROTEINS 1995-2006, under NUCLEAR PROTEINS 2007-2015, and under RNA-BINDING PROTEINS 2007-2015", "HN": "2016 (1995)", "MR": "20160701", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068103"}, {"RECTYPE": "D", "MH": "Infant Health", "AQ": "CL EC EH ES HI LJ SN ST TD", "ENTRY": "Infant Health, Newborn", "MN": "N01.400.388", "FX": "Infant Welfare", "MH_TH": "NLM (1994)", "ST": "T078", "PI": "Infant Welfare (1994-2015)", "MS": "The concept covering the physical and mental conditions of INFANTS.", "PM": "2016; see INFANT WELFARE 1994-2015", "HN": "2016; use INFANT WELFARE 1994-2015", "MR": "20150708", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000068104"}, {"RECTYPE": "D", "MH": "Bipolar and Related Disorders", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "MN": "F03.600.150", "MH_TH": "NLM (2016)", "ST": "T048", "MS": "These disorders are related to both SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS and DEPRESSIVE DISORDER in terms of symptomatology, family history, and genetics. (DSM-5).", "PM": "2016", "HN": "2016", "MR": "20220523", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068105"}, {"RECTYPE": "D", "MH": "Gender Dysphoria", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Gender Identity Disorder|T048|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Identity Disorder, Gender", "MN": "F03.835.550", "MH_TH": "NLM (2016)", "ST": "T048", "MS": "A marked difference between the individual\u2019s expressed/experienced gender and the gender others would assign to the individual, and it must continue for at least six months. (from DSM-5)", "PM": "2016", "HN": "2016", "MR": "20210512", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068116"}, {"RECTYPE": "D", "MH": "Formative Feedback", "ENTRY": "Feedback, Formative", "MN": "F02.784.629.529.223", "MH_TH": "NLM (2016)", "ST": "T057", "PI": "Learning (2010-2015)", "MS": "Information communicated to the learner that is intended to modify the learner\u2019s thinking or behavior for the purpose of improving learning.", "PM": "2016", "HN": "2016", "MR": "20170630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068156"}, {"RECTYPE": "D", "MH": "Aripiprazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "OPC-14597|T109|T121|NRW|NLM (1995)|abbde", "MN": "D03.633.100.810.835.122", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "82VFR53I78", "MS": "A piperazine and quinolone derivative that is used primarily as an antipsychotic agent. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. It is used for the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER, and as an adjunct therapy for the treatment of depression.", "PM": "2016; ARIPIPRAZOLE was indexed under QUINOLONES 1995-2015 and under PIPERAZINES 1995-2015", "HN": "2016 (1995)", "MR": "20180620", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068180"}, {"RECTYPE": "D", "MH": "Prunus dulcis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Trees, Almond", "MN": "B01.875.800.575.912.250.859.937.500.625.500", "MH_TH": "NLM (2016)", "ST": "T002", "RN": "txid3755", "PI": "Prunus (2001-2015)", "MS": "A plant species in the family ROSACEAE, genus Prunus which produces edible seeds called almonds.", "PM": "2016; for ALMONDS see PRUNUS 2002-2015", "HN": "2016; for ALMONDS use PRUNUS 2002-2015", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068181"}, {"RECTYPE": "D", "MH": "Albumin-Bound Paclitaxel", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Protein Bound Paclitaxel", "MN": "D12.776.034.073", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "An injectable formulation of albumin-bound paclitaxel NANOPARTICLES.", "PM": "2016; ALBUMIN-BOUND PACLITAXEL was indexed under ALBUMINS and PACLITAXEL 2005-2015, and under TAXOIDS 2002-2005", "HN": "2016 (2002)", "MR": "20150605", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068196"}, {"RECTYPE": "D", "MH": "Child Protective Services", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "ENTRY": "Welfare Agency, Child", "MN": "N03.540.400.500", "FX": "Social Work", "MH_TH": "NLM (2010)", "ST": "T057", "MS": "Local governmental offices which investigate reports of abuse and neglect of children, and act to assure a safe environment for minors.", "PM": "2016; see CHILD WELFARE 2010-2015", "HN": "2016 (2010); use CHILD WELFARE 2010-2015", "MR": "20150707", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000068216"}, {"RECTYPE": "D", "MH": "Social Workers", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Workers, Social", "MN": "M01.526.919", "MH_TH": "BIOETHICS (1976)", "ST": "T097", "PI": "Social Work (2010-2015)", "MS": "Professionals who work with persons affected by social disadvantages such as POVERTY; mental and physical illness or disability, and social injustice.  Their focus is on both the individual and his or her environment, including violations of their civil liberties and human rights.", "PM": "2016; see SOCIAL WORK 1976-2015", "HN": "2016 (1976); use SOCIAL WORK 1976-2015", "MR": "20150707", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000068217"}, {"RECTYPE": "D", "MH": "Prunus africana", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Prune, African|T002|NON|EQV|NLM (2003)|010924|abcdef", "ENTRY": "Prunes, African", "MN": "B01.875.800.575.912.250.859.937.500.625.250", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid379279", "MS": "A plant species in the family ROSACEAE. The bark extract known as pygeum is an ingredient in FOLK REMEDIES.", "PM": "2016; see PYGEUM 2002-2015; for PYGEUM AFRICANUM see PYGEUM 2002-2015; for AFRICAN PRUNE see PYGEUM 2002-2015", "HN": "2016 (2002)", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068218"}, {"RECTYPE": "D", "MH": "Prunus armeniaca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Apricot|T168|NON|NRW|NLM (1983)|970206|abcdef", "ENTRY": "Trees, Apricot", "MN": "B01.875.800.575.912.250.859.937.500.625.375", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid36596", "PI": "Prunus (2001-2015)", "MS": "A plant species in the family ROSACEAE. It is the source of apricot fruit.", "PM": "2016; see PRUNUS 2002-2015; for APRICOT see PRUNUS 2002-2015 and ROSALES 1998-2001", "HN": "2016; use PRUNUS 2002-2015; for APRICOT use PRUNUS 2002-2015 and ROSALES 1998-2001", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068219"}, {"RECTYPE": "D", "MH": "Prunus avium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Trees, Sweet Cherry", "MN": "B01.875.800.575.912.250.859.937.500.625.400", "MH_TH": "NLM (2016)", "ST": "T002", "RN": "txid42229", "RR": "txid23207", "PI": "Prunus (2001-2015)", "MS": "A plant species in the family ROSACEAE. It is the source of the sweet cherry fruit.", "PM": "2016; for PRUNUS SEROTINA see PRUNUS 2002-2015", "HN": "2016; for PRUNUS SEROTINA use PRUNUS 2002-2015", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068220"}, {"RECTYPE": "D", "MH": "Refugium", "ENTRY": "Refugia|T070|NON|EQV|NLM (2016)|150206|abcdef", "MN": "G16.500.819", "MH_TH": "NLM (2016)", "ST": "T070", "MS": "Area in an environment in which a population of organisms can survive through a period of unfavorable conditions.", "PM": "2016", "HN": "2016", "MR": "20150624", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068236"}, {"RECTYPE": "D", "MH": "Distance Counseling", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "E-Therapies", "MN": "N04.590.374.800.138", "FX": "Mental Health Teletherapy", "MH_TH": "NLM (2016)", "ST": "T057", "PI": "Counseling (2005-2015)", "MS": "Counseling conducted via electronic or other non-face-to-face interactions.", "PM": "2016", "HN": "2016", "MR": "20230602", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068237"}, {"RECTYPE": "D", "MH": "Lubiprostone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "0211, SPI", "MN": "D10.251.355.325.050.500", "MH_TH": "NLM (2016)", "ST": "T121", "N1": "7-((1R,4R,6R,9R)-4-(1,1-difluoropentyl)-4-hydroxy-8-oxo-5-oxabicyclo(4.3.0)non-9-yl)heptanoic acid", "RN": "7662KG2R6K", "MS": "Member of a bicyclic fatty acid class of compounds derived from PROSTAGLANDIN E1 involved in chloride channel gating.", "PM": "2016; LUBIPROSTONE was indexed under ALPROSTADIL 2005-2015", "HN": "2016 (2005)", "MR": "20150709", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068238"}, {"RECTYPE": "D", "MH": "Prunus persica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Peach|T002|T168|NON|REL|NLM (2002)|010315|abbcdef", "ENTRY": "Trees, Peach", "MN": "B01.875.800.575.912.250.859.937.500.625.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3760", "PI": "Prunus (2001-2015)", "MS": "A plant species in the family ROSACEAE. It is a tree that produces peach fruit.", "PM": "2016; see PRUNUS 2002-2015; for PEACH see PRUNUS 2002-2015", "HN": "2016; use PRUNUS 2002-2015; for PEACH use PRUNUS 2002-2015", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068239"}, {"RECTYPE": "D", "MH": "Data Anonymization", "AQ": "ES HI LJ PX ST", "ENTRY": "Masking, Data", "MN": "N04.452.910.200.500", "FX": "Personally Identifiable Information", "MH_TH": "NLM (2016)", "ST": "T170", "MS": "Removal of personally identifiable information via encryption or other methods.", "PM": "2016", "HN": "2016", "MR": "20170703", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000068240"}, {"RECTYPE": "D", "MH": "Personally Identifiable Information", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "MN": "I01.880.604.583.080.660", "FX": "Data Anonymization", "MH_TH": "NLM (2016)", "ST": "T169", "MS": "Information that can be used to distinguish or trace an individual\u2019s identity, either alone or when combined with other personal or identifying information that is linked or linkable to a specific individual.", "PM": "2016", "HN": "2016", "MR": "20150629", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000068241"}, {"RECTYPE": "D", "MH": "Prunus domestica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Plum|T002|T168|NON|REL|NLM (2002)|010315|abbcdef", "ENTRY": "salicinas, Prunus", "MN": "B01.875.800.575.912.250.859.937.500.625.450", "MH_TH": "NLM (2016)", "ST": "T002", "RN": "txid3758", "RR": "txid88123", "PI": "Prunus (2001-2015)", "MS": "A plant species in the family ROSACEAE. It is a tree that produces fruits called plums.", "PM": "2016; for PRUNUS CERASIFERA see PRUNUS 2002-2015; for PLUM see PRUNUS 2002-2015", "HN": "2016; for PRUNUS CERASIFERA use PRUNUS 2002-2015; for PLUM use PRUNUS 2002-2015", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068242"}, {"RECTYPE": "D", "MH": "Darbepoetin alfa", "AQ": "AD AE AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Novel Erythropoiesis Stimulating Protein|T116|T121|NON|EQV|NLM (2016)|150209|abbcdef", "MN": "D12.776.395.240.150.500", "MH_TH": "NLM (2016)", "ST": "T121", "N1": "30-l-Asparagine-32-l-threonine-87-l-valine-88-l-asparagine-90-l-threonineerythropoietin (human)", "RN": "15UQ94PT4P", "RR": "209810-58-2 (darbepoetin alfa)", "MS": "A recombinant protein which stimulates ERYTHROPOIESIS used to treat ANEMIA.", "PM": "2016; DARBEPOETIN ALFA was indexed under ERYTHROPOIETIN 2000-2015", "HN": "2016 (2000)", "MR": "20230316", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068256"}, {"RECTYPE": "D", "MH": "Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Atripla|T114|TRD|NRW|NLM (2010)|UK|US|100709|abcdeeef", "MN": "D26.310.375", "FX": "Antiretroviral Therapy, Highly Active", "MH_TH": "NLM (2016)", "ST": "T114", "RN": "0", "MS": "Inhibitor of reverse transcriptases or of RNA-directed DNA polymerases.", "PM": "2016; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination was indexed under ADENINE 2007-2015, under DEOXYCYTIDINE 2007-2015, under OXAZINES 2007-2015, under ORGANOPHOSPHATES 2007-2015, and under DRUG COMBINATIONS 2007-2015", "HN": "2016 (2007)", "MR": "20190429", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068257"}, {"RECTYPE": "D", "MH": "Bevacizumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Bevacizumab awwb", "MN": "D12.776.377.715.548.114.224.200.438", "FX": "Receptors, Vascular Endothelial Growth Factor", "MH_TH": "NLM (2016)", "ST": "T129", "RN": "2S9ZZM9Q9V", "MS": "An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.", "PM": "2016; BEVACIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2015, and under ANTIBODIES, MONOCLONAL 2002-2011", "HN": "2016 (2002)", "MR": "20181102", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068258"}, {"RECTYPE": "D", "MH": "Giraffes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Okapi", "MN": "B01.050.150.900.649.313.500.380.443", "MH_TH": "NLM (2016)", "ST": "T015", "RN": "txid9893", "RR": "txid86972", "PI": "Artiodactyla (1963-2015)", "MS": "Four-legged hoofed mammals with extremely long necks and legs belonging to the family Giraffidae.", "PM": "2016", "HN": "2016", "MR": "20200813", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068276"}, {"RECTYPE": "D", "MH": "Risedronic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bisphosphonate Risedronate Sodium|T109|T121|NON|NRW|NLM (2019)|190103|abbcdef", "ENTRY": "Sodium, Bisphosphonate Risedronate", "MN": "D03.383.725.836", "MH_TH": "NLM (1992)", "ST": "T121", "N1": "Phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis-", "RN": "KM2Z91756Z", "RR": "OFG5EXG60L", "MS": "A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.", "PM": "2019; see RISEDRONATE SODIUM 2014-2018; RISEDRONATE SODIUM was indexed under ETIDRONIC ACID 2014-2015", "HN": "2019 (2014)", "MR": "20190103", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068296"}, {"RECTYPE": "D", "MH": "Fluticasone-Salmeterol Drug Combination", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Fluticasone Salmeterol Drug Combination", "MN": "D26.310.438", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.", "PM": "2016; FLUTICASONE PROPRIONATE-SALMETEROL XINAFOATE DRUG COMBINATION was indexed under ALBUTEROL 2001-2015; and under ANDROSTADIENES 2001-2015.", "HN": "2016 (2001)", "MR": "20170117", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068297"}, {"RECTYPE": "D", "MH": "Fluticasone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Propionate, Fluticasone", "MN": "D04.210.500.054.079.129.114", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "CUT2W21N7U", "MS": "A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS.", "PM": "2016; FLUTICASONE was indexed under ANDROSTADIENES 1990-2015", "HN": "2016 (1990)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068298"}, {"RECTYPE": "D", "MH": "Salmeterol Xinafoate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Xinafoate, Salmeterol", "MN": "D02.092.471.683.061.750", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "6EW8Q962A5", "RR": "2I4BC502BT (Salmeterol)", "MS": "A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR when administered by inhalation. It is used to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.", "PM": "2016; SALMETEROL XINAFOATE was indexed under ALBUTEROL 1989-2015", "HN": "2016 (1989)", "MR": "20150605", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068299"}, {"RECTYPE": "D", "MH": "Parks, Recreational", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Green Space|T083|NON|REL|NLM (2021)|200203|abcdef", "ENTRY": "Urban Park", "MN": "J03.925.680", "MH_TH": "NLM (2016)", "ST": "T083", "PI": "Recreation (1989-2015)", "MS": "An area of land open to the public for enjoyment.", "PM": "2016", "HN": "2016", "MR": "20200618", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068316"}, {"RECTYPE": "D", "MH": "Warfare and Armed Conflicts", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Armed Conflicts and Warfare|T068|NON|EQV|NLM (2016)|150212|abcdef", "MN": "I01.880.735.950", "MH_TH": "NLM (2016)", "ST": "T068", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Engaging in any type of conflict including war or military conflict against another nation or organized group.", "PM": "2016", "HN": "2016", "MR": "20190429", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068336"}, {"RECTYPE": "D", "MH": "Armed Conflicts", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "War|T052|NON|REL|NLM (1973)|990101|abcdef", "ENTRY": "Conflicts, Armed", "MN": "I01.880.735.950.250", "MH_TH": "NLM (2016)", "ST": "T068", "MS": "Any differences arising between two nations or groups and leading to the intervention of armed forces.", "PM": "2016; for WAR see WARFARE 1973-2018", "HN": "2016; for WAR use WARFARE 1973-2018", "MR": "20171214", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068337"}, {"RECTYPE": "D", "MH": "Everolimus", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Zortress|T109|TRD|NRW|NLM (2023)|211101|abcdef", "ENTRY": "RAD, SDZ", "MN": "D02.540.505.760.500", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "9HW64Q8G6G", "MS": "A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and kidney transplant patients by blocking cell proliferation signals. It is also an ANTINEOPLASTIC AGENT.", "PM": "2016; EVEROLIMUS was indexed under SIROLIMUS 1998-2015; and under POLYENES 1997-1998", "HN": "2016 (1997)", "MR": "20220714", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068338"}, {"RECTYPE": "D", "MH": "Aspirin, Dipyridamole Drug Combination", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Retard, Asasantin", "MN": "D26.310.125", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "A drug combination of aspirin and dipyridamole that functions as a PLATELET AGGREGATION INHIBITOR, used to prevent THROMBOSIS and STROKE in TRANSIENT ISCHEMIC ATTACK patients.", "PM": "2016; ASPIRIN-DIPYRIDAMOLE DRUG COMBINATION was indexed under ASPIRIN and DIPYRIDAMOLE 1986-2015", "HN": "2016 (1986)", "MR": "20160527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068342"}, {"RECTYPE": "D", "MH": "Self-Control", "AQ": "PX", "ENTRY": "Regulation, Self", "MN": "F01.145.813.595", "FX": "Temperance", "MH_TH": "OBSSR (2016)", "ST": "T054", "MS": "An individual's ability to manage and monitor their emotions, behaviors, and desires in the face of external demands in order to function in society.", "PM": "2016; for SELF REGULATION see SOCIAL CONTROL, INFORMAL 1997-2015", "HN": "2016; for SELF REGULATION use SOCIAL CONTROL, INFORMAL 1997-2015", "MR": "20150709", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068356"}, {"RECTYPE": "D", "MH": "Saline Waters", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Waters, Saline", "MN": "G16.500.275.725", "FX": "Hypertonic Solutions", "MH_TH": "NLM (2016)", "ST": "T167", "MS": "Water from natural sources which contain significant concentrations of dissolved salts such as sodium chloride.", "PM": "2016", "HN": "2016", "MR": "20150706", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000068357"}, {"RECTYPE": "D", "MH": "Compassion Fatigue", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Vicarious Traumas", "MN": "F02.830.900.666.750", "FX": "Stress Disorders, Post-Traumatic", "MH_TH": "NLM (2016)", "ST": "T048", "MS": "Emotional distress caused by repeated or prolonged expression of compassion or empathy. It may occur in individuals working in care giving professions.", "PM": "2016", "HN": "2016", "MR": "20161014", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000068376"}, {"RECTYPE": "D", "MH": "Plantaginaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Stemodia|T002|NON|NRW|NLM (2003)|020328|abcdef", "ENTRY": "Speedwell Families", "MN": "B01.875.800.575.912.250.583.700", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid156152", "RR": "txid69062", "MS": "A plant family of order Lamiales. The Plantago genus is best known. Lesser known members include Hippuris, Littorella and Callitriche.", "PM": "2016; for GLOBULARIA and STEMODIA see SCROPHULARIACEAE 2003-2015", "HN": "2016; for GLOBULARIA and STEMODIA use SCROPHULARIACEAE 2003-2015", "MR": "20210630", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000068377"}, {"RECTYPE": "D", "MH": "Lamiales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Proboscidea Plant|T002|NON|NRW|NLM (2003)|010918|abcdef", "ENTRY": "Proboscidea Plants", "MN": "B01.875.800.575.912.250.583", "MH_TH": "NLM (2016)", "ST": "T002", "RN": "txid4143", "RR": "txid24234", "PI": "Angiosperms (2004-2015)", "MS": "An order of the Lamiidae clade. Lamiales is one of the largest orders of flowering plants and includes pot-herbs in the mint family (MINT; SAGE; OREGANO; BASIL); SESAME, foxgloves; SNAPDRAGONS; and the olive family.", "PM": "2016; for PROBOSCIDEA PLANT see PEDALIACEAE 2003-2015", "HN": "2016; for PROBOSCIDEA PLANT use PEDALIACEAE 2003-2015", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068378"}, {"RECTYPE": "D", "MH": "Clinical Study", "MN": "V03.175", "MH_TH": "NLM (2016)", "ST": "T170", "AN": "This heading is used as a Publication Type for original report  of  the conduct or results of a specific clinical study. A different heading CLINICAL STUDIES AS TOPIC is used for general design, methodology, economics, etc. of clinical studies. Prefer the specifics: CLINICAL TRIAL or OBSERVATIONAL STUDY.", "MS": "A work that reports on the results of a research study to evaluate interventions or exposures on biomedical or health-related outcomes.  The two main types of clinical studies are interventional studies (clinical trials) and observational studies. While most clinical studies concern humans, this publication type may be used for clinical veterinary articles meeting the requisites for humans.", "HN": "2016", "MR": "20150629", "DA": "20150701", "DC": "2", "DX": "20160101", "UI": "D000068397"}, {"RECTYPE": "D", "MH": "Surgical Clearance", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Surgical Clearances", "MN": "E01.370.505", "FX": "Physical Examination", "MH_TH": "NLM (2016)", "ST": "T060", "MS": "Process of evaluating the health of a patient and determining if they are healthy enough for surgery.", "PM": "2016", "HN": "2016", "MR": "20190705", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068436"}, {"RECTYPE": "D", "MH": "Pemetrexed", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Disodium, Pemetrexed", "MN": "D12.125.119.409.525", "MH_TH": "NLM (2001)", "ST": "T121", "N1": "L-Glutamic acid, N-(4-(2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-", "RN": "04Q9AIZ7NO", "RR": "2PKU919BA9", "MS": "A guanine-derived ANTINEOPLASTIC AGENT that functions as a NUCLEIC ACID SYNTHESIS INHIBITOR through its binding to, and inhibition of, THYMIDYLATE SYNTHASE.", "PM": "2016; PEMETREXED was indexed under GLUTAMATES 1994-2015, and under GUANINE 1994-2015", "HN": "2016 (1994)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068437"}, {"RECTYPE": "D", "MH": "Brimonidine Tartrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "UK14304", "MN": "D03.633.100.857.070", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "6-quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)", "RN": "4S9CL2DY2H", "RR": "E6GNX3HHTE", "MS": "A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.", "PM": "2016; BRIMONIDINE TARTRATE was indexed under QUINOXALINES 1980-2015, and under IMIDAZOLES 1978-1980", "HN": "2016 (1978)", "MR": "20180521", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068438"}, {"RECTYPE": "D", "MH": "Clinical Studies as Topic", "AQ": "CL EC ES HI IS LJ MT PX SN ST VE", "MN": "N06.850.520.450.250", "MH_TH": "NLM (2016)", "ST": "T170", "AN": "for general design, methodology, economics, etc. of clinical studies; a different heading CLINICAL STUDY is used for reports of a specific clinical study", "MS": "Works about research studies that evaluate interventions or exposures on biomedical or health-related outcomes.  The two main types of clinical studies are interventional studies (clinical trials) and observational studies.", "PM": "2016 (1963)", "HN": "2016", "MR": "20180629", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068456"}, {"RECTYPE": "D", "MH": "Beijing", "AQ": "EH EP", "ENTRY": "Peking|T083|NAM|EQV|NLM (2016)|150301|abcdef", "MN": "Z01.433.114", "MH_TH": "NLM (2016)", "ST": "T083", "PI": "China (1966-2015)", "MS": "Capital of CHINA.", "HN": "2016", "MR": "20150527", "DA": "20150701", "DC": "4", "DX": "20160101", "UI": "D000068476"}, {"RECTYPE": "D", "MH": "African Union", "AQ": "EC HI OG ST", "ENTRY": "Union, African", "MN": "N03.540.089", "MH_TH": "NLM (2016)", "ST": "T092", "AN": "Cataloger: Use NAF entry", "MS": "A geopolitical organization of African nations with a mission to integrate vital interests, promote international relations, political stability, and economic development among member states.", "PM": "2016", "HN": "2016", "MR": "20150629", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068516"}, {"RECTYPE": "D", "MH": "Firmicutes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.353", "MH_TH": "NLM (2016)", "ST": "T007", "RN": "txid1239", "PI": "Gram-Positive Bacteria (2004-2015)", "MS": "A phylum of predominantly GRAM-POSITIVE BACTERIA that includes the orders Bacillales and Clostridiales. Firmicutes and BACTEROIDETES are the two bacterial phyla that constitute the majority of the human gut MICROBIOTA.", "PM": "2016", "HN": "2016", "MR": "20200813", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000068536"}, {"RECTYPE": "D", "MH": "Dutasteride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "745, GG", "MN": "D04.210.500.925.100.125", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "O0J6XJN02I", "RR": "164656-23-9", "MS": "A 5-ALPHA-REDUCTASE INHIBITOR that is reported to inhibit both type-1 and type2 isoforms of the enzyme and is used to treat BENIGN PROSTATIC HYPERPLASIA.", "PM": "2016; DUTASTERIDE was indexed under AZASTEROIDS 1998-2015.", "HN": "2016 (1998)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068538"}, {"RECTYPE": "D", "MH": "Calceolariaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Calceolaria|T002|NON|NRW|NLM (2004)|030506|abcdef", "ENTRY": "Porodittia|T002|NON|NRW|NLM (2016)|150304|abcdef", "MN": "B01.875.800.575.912.250.583.190", "MH_TH": "NLM (2016)", "ST": "T002", "RN": "txid155890", "RR": "txid91331", "MS": "A family in the order Lamiales with several species that are used in TRADITIONAL MEDICINE.", "PM": "2016; for CALCEOLARIA see SCROPHULARIACEAE 2004-2015", "HN": "2016; for CALCEOLARIA use SCROPHULARIACEAE 2004-2015", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068543"}, {"RECTYPE": "D", "MH": "Interferon beta-1a", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta-1a, Interferon", "MN": "D23.529.374.440.890.275.500", "MH_TH": "NLM (2016)", "ST": "T129", "RN": "XRO4566Q4R", "RR": "74899-71-1", "MS": "An interferon beta-1 subtype that has a methionine at position 1, a cysteine at position 17, and is glycosylated at position 80. It functions as an ANTI-VIRAL AGENT and IMMUNOMODULATOR and is used to manage the symptoms of RELAPSING-REMITTING MULTIPLE SCLEROSIS.", "PM": "2016; INTERFERON BETA 1A was indexed under INTERFERON-BETA 1994-2015", "HN": "2016 (1994)", "MR": "20180301", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068556"}, {"RECTYPE": "D", "MH": "Olmesartan Medoxomil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Medoxomil, Olmesartan", "MN": "D03.383.129.617.584", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "6M97XTV3HD", "RR": "144689-24-7 (olmesartan medoxomil)", "MS": "An ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to manage HYPERTENSION.", "PM": "2016; OLMESARTAN MEDOXOMIL was  indexed under IMIDAZOLES 1996-2015, and under TETRAZOLES 1996-2015", "HN": "2016 (1996)", "MR": "20180301", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068557"}, {"RECTYPE": "D", "MH": "Amlodipine Besylate, Olmesartan Medoxomil Drug Combination", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Medoxomil, Amlodipine Besylate-Olmesartan", "MN": "D26.310.063", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "PI": "Antihypertensive Agents (2012-2015)", "MS": "A pharmaceutical preparation of amlodipine besylate and olmesartan medoxomil  that combines ANGIOTENSIN II TYPE I RECEPTOR ANTAGONIST and CALCIUM CHANNEL BLOCKER activities. It is used in the management of HYPERTENSION.", "PM": "2016", "HN": "2016", "MR": "20160527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068558"}, {"RECTYPE": "D", "MH": "Interferon beta-1b", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Beta Seron", "MN": "D23.529.374.440.890.275.750", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "145155-23-3", "MS": "A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS.", "PM": "2016; INTERFERON BETA-1B was previously indexed under INTERFERON BETA, 1991-2015; RECOMBINANT PROTEINS, 1988-1991; and under INTERFERON TYPE I, 1985-1988", "HN": "2016 (1985)", "MR": "20171214", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068576"}, {"RECTYPE": "D", "MH": "Nebivolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R67555", "MN": "D03.633.100.150.755", "MH_TH": "USAN (1987)", "ST": "T121", "RN": "030Y90569U", "RR": "JGS34J7L9I", "MS": "A cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.", "PM": "2016; NEBIVOLOL was indexed under BENZOPYRANS, 1987-2015; and under ETHANOLAMINES 1987-2015", "HN": "2016 (1987)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068577"}, {"RECTYPE": "D", "MH": "Celecoxib", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SC58635", "MN": "D03.383.129.539.160", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "JCX84Q7J1L", "RR": "169590-42-5", "MS": "A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.", "PM": "2016; CELECOXIB was indexed under PYRAZOLES 1997-2015, and under SULFONAMIDES 1997-2015", "HN": "2016 (1997)", "MR": "20230608", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068579"}, {"RECTYPE": "D", "MH": "Varenicline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Varenicline Tartrate|T109|T121|NON|NRW|FDA SRS (2015)|INN (19XX)|USAN (2009)|150306|abbcdeeef", "MN": "D03.633.100.857.942", "MH_TH": "USAN (2005)", "ST": "T121", "RN": "W6HS99O8ZO", "RR": "82269ASB48", "MS": "A benzazepine derivative that functions as an ALPHA4-BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.", "PM": "2016; VARENICLINE was indexed under BENZAZEPINES, 2005-2015 and under QUINOXALINES, 2005-2015", "HN": "2016 (2005)", "MR": "20180619", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000068580"}, {"RECTYPE": "D", "MH": "Tadalafil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3- benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-|T109|T121|NON|EQV|NLM (2020)|190201|abbcdef", "ENTRY": "IC351|T109|T121|LAB|NRW|NLM (2001)|010702|abbcdef", "MN": "D03.633.300.154.672", "FX": "Sildenafil Citrate", "MH_TH": "USAN (2001)", "ST": "T121", "RN": "742SXX0ICT", "RR": "171596-29-5", "MS": "A carboline derivative and PHOSPHODIESTERASE 5 INHIBITOR that is used primarily to treat ERECTILE DYSFUNCTION; BENIGN PROSTATIC HYPERPLASIA and PRIMARY PULMONARY HYPERTENSION.", "PM": "2016; TADALAFIL was indexed under CARBOLINES 2001-2015; and under PHOSPHODIESTERASE INHIBITORS 2001-2003", "HN": "2016 (2001)", "MR": "20210628", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000068581"}, {"RECTYPE": "D", "MH": "Certolizumab Pegol", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Cimzia|T116|T121|T129|TRD|NRW|NLM (2012)|110805|abbbcdef", "MN": "D12.776.377.715.548.680.650.250", "FX": "Tumor Necrosis Factor-alpha", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "UMD07X179E", "RR": "428863-50-7", "MS": "A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.", "PM": "2016; CERTILIZUMAB PEGOL was indexed under IMMUNOGLOBULIN FAB FRAGMENTS 2003-2015, POLYETHYLENE GLYCOLS 2003-2015, and under ANTIBODIES, MONOCLONAL, HUMANIZED 2003-2015", "HN": "2016 (2003)", "MR": "20210701", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068582"}, {"RECTYPE": "D", "MH": "Censorship, Research", "ENTRY": "Research Censorship", "MN": "N05.350.670.250", "FX": "Ethics", "MH_TH": "NLM (2016)", "ST": "T078", "MS": "The act or practice of scrutinizing the practice of scientific research for the purpose of preventing or suppressing the unethical applications as well knowledge derived from it.", "PM": "2016", "HN": "2016", "MR": "20150616", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000068597"}, {"RECTYPE": "D", "MH": "Data Accuracy", "ENTRY": "Quality, Data", "MN": "N05.715.360.325.685.250", "MH_TH": "NLM (2016)", "ST": "T170", "MS": "A measure of scientific precision, exactness, or correctness of quantitative or qualitative values, relative to the actual or true measurements.", "PM": "2016; for DATA QUALITY see RESEARCH DESIGN 1995-2015", "HN": "2016; for DATA QUALITY use RESEARCH DESIGN 1995-2015", "MR": "20180629", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068598"}, {"RECTYPE": "D", "MH": "Brimonidine Tartrate, Timolol Maleate Drug Combination", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tartrate-Timolol Maleate, Brimonidine", "MN": "D26.310.312", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.", "PM": "2016; BRIMONIDINE TARTRATE-TIMOLOL MALEATE DRUG COMBINATION was indexed under QUINOXALINES 2011-2015, under TIMOLOL 2011-2015, and under DRUG COMBINATIONS 2011-2015", "HN": "2016 (2011)", "MR": "20160527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068599"}, {"RECTYPE": "D", "MH": "Albuterol, Ipratropium Drug Combination", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Respimat, Combivent", "MN": "D26.310.344", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "A combined pharmaceutical preparation of Ipratropium Bromide and Albuterol Sulfate that is used to treat the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.", "PM": "2016; ALBUTEROL-IPRATROPIUM was indexed under ALBUTEROL 1999-2015, and under IPRATROPIUM 1999-2015", "HN": "2016 (1999)", "MR": "20160527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068600"}, {"RECTYPE": "D", "MH": "Dual Use Research", "AQ": "ES HI LJ SN", "ENTRY": "Use Research, Dual", "MN": "H01.770.644.217", "FX": "Censorship, Research", "MH_TH": "NLM (2016)", "ST": "T062", "MS": "Concept relating to technologies and/or information emanating from research that holds the potential for both benevolent and malevolent applications to humanity and the environment.", "PM": "2016", "HN": "2016", "MR": "20150616", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000068601"}, {"RECTYPE": "D", "MH": "Professionalism", "AQ": "EC ED ES HI LJ ST TD", "ENTRY": "Professionalism, Surgical", "MN": "N05.350.340.581", "FX": "Professional Competence", "MH_TH": "NLM (2016)", "ST": "T078", "MS": "The level of skill, good judgment, and polite behavior expected from people trained to do their jobs well.", "PM": "2016", "HN": "2016", "MR": "20150626", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000068616"}, {"RECTYPE": "D", "MH": "Genetic Background", "ENTRY": "Genetic Backgrounds", "MN": "G05.346", "FX": "Heredity", "MH_TH": "NLM (2016)", "ST": "T032", "PI": "Genetics (1963-2015)", "MS": "The entire genetic composition of a strain or individual that interacts with a gene of interest.", "PM": "2016", "HN": "2016", "MR": "20190322", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068617"}, {"RECTYPE": "D", "MH": "Selective Breeding", "AQ": "GE HI", "ENTRY": "Selective Breedings", "MN": "G05.090.701", "FX": "Reproductive Techniques", "MH_TH": "NLM (2016)", "ST": "T063", "MS": "A process in which offspring possessing desired genetic traits are produced.", "PM": "2016", "HN": "2016", "MR": "20190705", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068618"}, {"RECTYPE": "D", "MH": "Legendary Creatures", "AQ": "HI", "ENTRY": "Vampire", "MN": "I01.076.201.450.515.500", "MH_TH": "NLM (2016)", "ST": "T078", "MS": "An unverified animal or humanoid, sometimes supernatural, often believed to be real and described in MYTHOLOGY, FOLKLORE, or legends. Some legendary creatures, such as the unicorn, were documented in scholarly antiquarian accounts of natural history.", "PM": "2016", "HN": "2016", "MR": "20190705", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068636"}, {"RECTYPE": "D", "MH": "Mometasone Furoate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Twisthaler, Asmanex", "MN": "D04.210.500.745.432.719.526", "FX": "Formoterol Fumarate", "MH_TH": "USAN (1987)", "ST": "T121", "RN": "04201GDN4R", "RR": "MTW0WEG809", "MS": "A pregnadienediol derivative ANTI-ALLERGIC AGENT and ANTI-INFLAMMATORY AGENT that is used in the management of ASTHMA and ALLERGIC RHINITIS. It is also used as a topical treatment for skin disorders.", "PM": "2016; MOMETASONE FUROATE was indexed under PREGNADIENEDIOLS 1987-2015", "HN": "2016 (1987)", "MR": "20160425", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068656"}, {"RECTYPE": "D", "MH": "Fallopia multiflora", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Fo Ti", "MN": "B01.875.800.575.912.250.825.359.590", "MH_TH": "NLM (2016)", "ST": "T002", "RN": "txid76025", "PI": "Polygonaceae (2002-2015)", "MS": "A species of Fallopia in the buckwheat family (Polygonaceae). Its roots are used in TRADITIONAL CHINESE MEDICINE.", "PM": "2016", "HN": "2016", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068676"}, {"RECTYPE": "D", "MH": "Sildenafil Citrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "UK 9248010", "MN": "D03.633.100.759.824", "FX": "Tadalafil", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "BW9B0ZE037", "RR": "TP0E2BW57H", "MS": "A PHOSPHODIESTERASE TYPE-5 INHIBITOR; VASODILATOR AGENT and UROLOGICAL AGENT  that is used in the treatment of ERECTILE DYSFUNCTION and PRIMARY PULMONARY HYPERTENSION.", "PM": "2016; SILDENAFIL CITRATE was indexed under PIPERAZINES; PURINES; and under SULFONAMIDES 1997-2015", "HN": "2016 (1997)", "MR": "20160531", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068677"}, {"RECTYPE": "D", "MH": "Emtricitabine, Rilpivirine, Tenofovir Drug Combination", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Drug Combination, Emtricitabine-Rilpivirine-Tenofovir", "MN": "D26.310.407", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir disoproxil fumarate. It is used to treat HIV INFECTIONS.", "PM": "2016; EMTRICITABINE, RILPIVIRINE, TENOFOVIR DRUG COMBINATION was indexed under NITRILES; PYRIMIDINES; ORGANOPHOSPHONATES; ADENINE; and DEOXYCYTIDINE 2012-2015", "HN": "2016 (2012)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068678"}, {"RECTYPE": "D", "MH": "Emtricitabine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Beta L 2',3' dideoxy 5 fluoro 3' thiacytidine", "MN": "D13.570.685.245.500.600", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "G70B4ETF4S", "MS": "A deoxycytidine analog and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B viruses. It is used to treat HIV INFECTIONS.", "PM": "2016; EMTRICITABINE was indexed under DEOXYCYTIDINE 1999-2015", "HN": "2016 (1999)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068679"}, {"RECTYPE": "D", "MH": "Rilpivirine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Rilpivirine", "MN": "D03.383.742.755", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "FI96A8X663", "RR": "500287-72-9", "MS": "A diarylpyrimidine derivative and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 that is used in the treatment of HIV INFECTIONS. It is also used in combination with other ANTI-HIV AGENTS, since ANTIVIRAL DRUG RESISTANCE emerges rapidly when it is used alone.", "PM": "2016; RILPIVIRINE was indexed under NITRILES 2005-2015, and under PYRIMIDINES 2005-2015", "HN": "2016 (2005)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068696"}, {"RECTYPE": "D", "MH": "Tenofovir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Fumarate, Tenofovir Disoproxil", "MN": "D03.633.100.759.138.881", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "99YXE507IL", "RR": "OTT9J7900I", "MS": "An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.", "PM": "2016; TENOFOVIR DIDOPROXIL was indexed under ORGANOPHOSPHONATES 2004-2015, ADENINE 2004-2015, and under ORGANOPHOSPHOROUS COMPOUNDS 2001-2004", "HN": "2016 (2001)", "MR": "20160705", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000068698"}, {"RECTYPE": "D", "MH": "Glatiramer Acetate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Acetate, Glatiramer", "MN": "D12.644.219", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "5M691HL4BO", "RR": "U782C039QP", "MS": "A random polymer of L-ALANINE, L-GLUTAMIC ACID, L-LYSINE, and L-TYROSINE that structurally resembles MYELIN BASIC PROTEIN. It is used in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS.", "PM": "2016; GLATIRAMER ACETATE was indexed under PEPTIDES 1994-2015", "HN": "2016 (1994)", "MR": "20150605", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068717"}, {"RECTYPE": "D", "MH": "Rosuvastatin Calcium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Calcium, Rosuvastatin", "MN": "D03.383.742.775", "FX": "Simvastatin", "MH_TH": "USAN (2001)", "ST": "T121", "RN": "83MVU38M7Q", "RR": "413KH5ZJ73", "MS": "A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES.", "PM": "2016; ROSUVASTATIN CALCIUM was indexed under FLUOROBENZENES; PYRIMIDINES; and SULFONAMIDES 2001-2015", "HN": "2016 (2001)", "MR": "20160531", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000068718"}, {"RECTYPE": "D", "MH": "Duloxetine Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "LY248686", "MN": "D03.383.903.260", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "9044SC542W", "RR": "O5TNM5N07U", "MS": "A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.", "PM": "2016; DULOXETINE was indexed under THIOPHENES 1989-2015", "HN": "2016 (1989)", "MR": "20160531", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000068736"}, {"RECTYPE": "D", "MH": "Tolterodine Tartrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tartrate, Tolterodine", "MN": "D02.455.426.559.389.657.239.756", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "5T619TQR3R", "RR": "WHE7A56U7K", "MS": "An ANTIMUSCARINIC AGENT selective for the MUSCARINIC RECEPTORS of the BLADDER that is used in the treatment of URINARY INCONTINENCE and URINARY URGE INCONTINENCE.", "PM": "2016; TOLTERODINE TARTRATE was indexed under BENZHYDRYL COMPOUNDS, CRESOLS, and PHENYLPROPANOLAMINE 1996-2015", "HN": "2016 (1996)", "MR": "20160519", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000068737"}, {"RECTYPE": "D", "MH": "Valsartan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "48933, CGP", "MN": "D12.125.142.930.500", "FX": "Losartan", "MH_TH": "USAN (1993)", "ST": "T121", "N1": "L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-", "RN": "80M03YXJ7I", "RR": "137862-53-4", "MS": "A tetrazole derivative and ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to treat HYPERTENSION.", "PM": "2016; VALSARTAN was indexed under TETRAZOLES and VALINE 1993-2015", "HN": "2016 (1993)", "MR": "20160601", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000068756"}, {"RECTYPE": "D", "MH": "Ononis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Restharrows", "MN": "B01.875.800.575.912.250.401.604", "MH_TH": "NLM (2016)", "ST": "T002", "RN": "txid58889", "MS": "A genus of the pea family (Fabaceae), native from Europe to Central Asia and used in TRADITIONAL MEDICINE.", "PM": "2016", "HN": "2016", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068757"}, {"RECTYPE": "D", "MH": "Mometasone Furoate, Formoterol Fumarate Drug Combination", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Zenhale|T109|T121|TRD|NRW|NLM (2016)|150320|abbcdef", "MN": "D26.310.469", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "A pharmaceutical preparation of mometasone furoate and formoterol fumarate that is used as an inhaled dosage form for the treatment of ASTHMA.", "PM": "2016; MOMETASONE FUROATE, FORMOTEROL FUMARATE DRUG COMBINATION was indexed under ETHANOLAMINES and PREGNADIENEDIOLS 2011-2015", "HN": "2016 (2011)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068758"}, {"RECTYPE": "D", "MH": "Formoterol Fumarate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxis|T109|T121|TRD|NRW|AU|DE|ES|MX|NL|NLM (2003)|UK|030310|abbcdeeeeeeef", "MN": "D02.092.063.291.425", "FX": "Mometasone Furoate", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "W34SHF8J2K", "RR": "F91H02EBWT", "MS": "An ADRENERGIC BETA-2 RECEPTOR AGONIST with a prolonged duration of action. It is used to manage ASTHMA and in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.", "PM": "2016; FORMOTEROL FUMARATE was indexed under ETHANOLAMINES 1976-2015", "HN": "2016 (1976)", "MR": "20150707", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068759"}, {"RECTYPE": "D", "MH": "Serotonin and Noradrenaline Reuptake Inhibitors", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "SNRI|T109|T121|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "NRIs and SSRIs", "MN": "D27.505.696.577.600.693", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "PI": "Serotonin Uptake Inhibitors (1999-2015)", "MS": "Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS.", "PM": "2016", "HN": "2016", "MR": "20200527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068760"}, {"RECTYPE": "D", "MH": "Sleep Aids, Pharmaceutical", "AQ": "AA AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pills, Sleeping", "MN": "D27.505.954.427.210.350.500", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "PI": "Sleep Wake Disorders (1999-2015)", "MS": "Drugs used to induce SLEEP, prevent SLEEPLESSNESS, or treat SLEEP INITIATION AND MAINTENANCE DISORDERS.", "PM": "2016", "HN": "2016", "MR": "20171208", "DA": "20150702", "DC": "1", "DX": "20160101", "UI": "D000068776"}, {"RECTYPE": "D", "MH": "Orexin Receptor Antagonists", "AQ": "AA AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Orexin Receptor Antagonist|T121|NON|EQV|NLM (2021)|200309|abcdef", "ENTRY": "Receptor Antagonist, Orexin", "MN": "D27.505.954.427.210.350.500.500", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "PI": "Orexin Receptors (2014-2015)", "MS": "Substances that bind to and inhibit the action of OREXIN RECEPTORS. Drugs in this class have been used as SLEEP AIDS, PHARMACEUTICAL.", "PM": "2016", "HN": "2016", "MR": "20200527", "DA": "20150702", "DC": "1", "DX": "20160101", "UI": "D000068796"}, {"RECTYPE": "D", "MH": "Orexins", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Orexin|T123|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Orexin B", "MN": "D12.776.631.650.363", "FX": "Orexin Receptors", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "MS": "Neuropeptide hormones that play a role in regulating a variety of behavioral and physiological processes in response to motivational stimuli.", "PM": "2016; OREXINS was indexed under NEUROPEPTIDES & INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 2005-2015, and under CARRIER PROTEINS 1998-2004", "HN": "2016", "MR": "20200527", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068797"}, {"RECTYPE": "D", "MH": "Hoodia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Hoodia gordonii|T002|NON|NRW|NLM (2016)|150324|abcdef", "MN": "B01.875.800.575.912.250.456.500.389", "MH_TH": "NLM (2016)", "ST": "T002", "RN": "txid197265", "RR": "txid197266", "PI": "Apocynaceae  (2007-2015)", "MS": "A genus in the dogbane family (Apocynaceae) used in TRADITIONAL MEDICINE for appetite-suppressant properties.", "PM": "2016", "HN": "2016", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068798"}, {"RECTYPE": "D", "MH": "Prasugrel Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Prasugrel", "MN": "D03.383.903.600", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "G89JQ59I13", "RR": "389574-19-0 (prasugrel hydrochloride)", "MS": "A piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNSTABLE ANGINA and MYOCARDIAL INFARCTION, as well as in those undergoing PERCUTANEOUS CORONARY INTERVENTIONS.", "PM": "2016; PRASUGREL HYDROCHLORIDE was indexed under PIPERAZINES and THIOPHENES 2000-2015", "HN": "2016 (2000)", "MR": "20180705", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000068799"}, {"RECTYPE": "D", "MH": "Etanercept", "AQ": "AA AD AE BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TNR001", "MN": "D12.776.543.750.705.852.760.232", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "OP401G7OJC", "RR": "185243-69-0", "MS": "A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.", "PM": "2016; ETANERCEPT was indexed under IMMUNOGLOBULIN G and RECEPTORS, TUMOR NECROSIS FACTOR 1997-2015", "HN": "2016 (1997)", "MR": "20171214", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000068800"}, {"RECTYPE": "D", "MH": "Adapalene, Benzoyl Peroxide Drug Combination", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Epiduo|T109|T121|TRD|NRW|NLM (2016)|150324|abbcdef", "MN": "D26.310.032", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "PI": "Naphthalenes (2007-2015)", "MS": "A pharmaceutical preparation of adapalene and benzoyl peroxide that is used as a DERMATOLOGIC AGENT for the topical treatment of ACNE.", "PM": "2016", "HN": "2016", "MR": "20150616", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068801"}, {"RECTYPE": "D", "MH": "Adapalene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "271, CD", "MN": "D04.615.638.090", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "1L4806J2QF", "RR": "106685-40-9 (adapalene)", "MS": "A naphthalene derivative that has specificity for RETINOIC ACID RECEPTORS. It is used as a DERMATOLOGIC AGENT for the treatment of ACNE.", "PM": "2016; ADAPALENE was indexed under NAPHTHALENES 1990-2015", "HN": "2016 (1990)", "MR": "20150616", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068816"}, {"RECTYPE": "D", "MH": "Epoetin Alfa", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Recombinant 1 165 Erythropoietin, Glycoform Alpha", "MN": "D23.529.374.410.240.150.750", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1-165-Erythropoietin (human clone lambdaHEPOFL13 protein moiety), glycoform alpha", "RN": "64FS3BFH5W", "RR": "113427-24-0", "MS": "A recombinant glycosylated form of erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients.", "PM": "2016; EPOETIN ALFA was indexed under ERYTHROPOIETIN 2011-2015", "HN": "2016 (2011)", "MR": "20230316", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068817"}, {"RECTYPE": "D", "MH": "Cetuximab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "MAb C225|T116|T129|LAB|NRW|NLM (2000)|abbcde", "MN": "D12.776.377.715.548.114.224.200.750", "FX": "ErbB Receptors", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "PQX0D8J21J", "RR": "205923-56-4", "MS": "A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.", "PM": "2016; CETUXIMAB was indexed under ANTIBODIES, MONOCLONAL 2000-2013; and under ANTIBODIES, MONOCLONAL, HUMANIZED 2013-2015", "HN": "2016 (2000)", "MR": "20180702", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068818"}, {"RECTYPE": "D", "MH": "Hyssopus Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Hyssopus", "MN": "B01.875.800.575.912.250.583.520.330", "MH_TH": "NLM (2016)", "ST": "T002", "RN": "txid39168", "RR": "txid39324", "PI": "Lamiaceae (2002-2015)", "MS": "A genus in the mint family (Lamiaceae). Members contain thujone and PHENOL. Distinguished from AGASTACHE (giant hyssop) and BACOPA (water hyssop).  Also distinguished from the genus of WASPS with the same genus name Hyssopus.", "PM": "2016; for HYSSOP see LAMIACEAE 2003-2015", "HN": "2016; for HYSSOP use LAMIACEAE 2003-2015", "MR": "20210630", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000068819"}, {"RECTYPE": "D", "MH": "Rivastigmine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tartrate, Rivastigmine Hydrogen", "MN": "D02.241.081.251.583.899", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)", "RN": "PKI06M3IW0", "RR": "9IY2357JPE", "MS": "A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.", "PM": "2016; RIVASTIGMINE was indexed under PHENYLCARBAMATES 2004-2015; and under CARBAMATES 1992-2004", "HN": "2016 (1992)", "MR": "20160520", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000068836"}, {"RECTYPE": "D", "MH": "Parmeliaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Lichen islandicus|T004|NON|NRW|NLM (2022)|210211|abcdef", "ENTRY": "Moss, Iceland", "MN": "B01.300.340.458", "MH_TH": "NLM (2016)", "ST": "T004", "RN": "txid78060", "RR": "txid78064", "PI": "Ascomycota (2004-2015)", "MS": "The largest family of lichen-forming fungi.", "PM": "2016", "HN": "2016", "MR": "20210326", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068837"}, {"RECTYPE": "D", "MH": "Amlodipine, Valsartan Drug Combination", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Drug Combination, Amlodipine-Valsartan", "MN": "D26.310.094", "MH_TH": "NLM (2010)", "ST": "T121", "RN": "0", "MS": "A pharmaceutical preparation of amlodipine and valsartan that is used for the treatment of HYPERTENSION.", "PM": "2016; AMLODIPINE, VALSARTAN DRUG COMBINATION was indexed under DRUG COMBINATIONS, TETRAZOLES, and AMLODIPINE 2008-2015", "HN": "2016 (2008)", "MR": "20190222", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068838"}, {"RECTYPE": "D", "MH": "Eugenia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Trees, Surinam Cherry", "MN": "B01.875.800.575.912.250.773.374", "MH_TH": "NLM (2002)", "ST": "T001", "RN": "txid119950", "RR": "txid119951", "PI": "Syzygium (2002-2015)", "MS": "A genus in the family Myrtaceae sometimes known as \"stoppers\" in FOLK MEDICINE. Many species of the genus SYZYGIUM have synonymous names that begin with the Eugenia genus name.", "PM": "2016; see CLOVE 2002-2004", "HN": "2016; see SYZYGIUM 2005-2015; see CLOVE 2002-2004", "MR": "20210630", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000068856"}, {"RECTYPE": "D", "MH": "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18", "AQ": "AA AD AE AG AI BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Human Papillomavirus Vaccine L1, Types 6,11,16,18|T121|T129|NON|NRW|NLM (2022)|201009|abbcdef", "ENTRY": "Human Papillomavirus Vaccine L1, Type 6,11,16,18|T121|T129|NON|NRW|NLM (2006)|150327|abbcdef", "MN": "D20.215.894.899.498.500", "MH_TH": "NLM (2016)", "ST": "T129", "RN": "0", "MS": "A vaccine containing L1 capsid proteins from four types of HPV (ALPHAPAPILLOMAVIRUS), types 6, 11, 16 and 18 that is used to prevent infections from human papillomaviruses of these subtypes.", "PM": "2016; HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE QUADRIVALENT (TYPES 6, 11, 16, 18) was indexed under PAPILLOMAVIRUS VACCINES 2006-2015", "HN": "2016 (2006)", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068857"}, {"RECTYPE": "D", "MH": "Kombucha Tea", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "ENTRY": "Teas, Kombucha", "MN": "J02.350.594.906", "MH_TH": "NLM (2016)", "ST": "T168", "RN": "0", "PI": "Tea (1995-2015)", "MS": "A beverage made by FERMENTATION of black tea and/or green tea.", "PM": "2016", "HN": "2016", "MR": "20210707", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068858"}, {"RECTYPE": "D", "MH": "Fingolimod Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Gilenya|T109|T121|TRD|NRW|NLM (2014)|130830|abbcdef", "MN": "D02.092.063.700.350", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "G926EC510T", "RR": "3QN8BYN5QF", "MS": "A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS.", "PM": "2016; FINGOLIMOD HYDROCHLORIDE was indexed under PROPYLENE GLYCOLS and SPHINGOSINE 1996-2015", "HN": "2016 (1996)", "MR": "20190617", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000068876"}, {"RECTYPE": "D", "MH": "Imatinib Mesylate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Methanesulfonate, Imatinib", "MN": "D03.383.742.349", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "8A1O1M485B", "RR": "BKJ8M8G5HI", "MS": "A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.", "PM": "2016; IMATINIB MESYLATE was indexed under BENZAMIDES, PIPERAZINES, and PYRIMIDINES 1996-2015", "HN": "2016 (1996)", "MR": "20230804", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000068877"}, {"RECTYPE": "D", "MH": "Trastuzumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "PRINT ENTRY": "Trazimera|T116|TRD|NRW|NLM (2020)|190409|abcdef", "ENTRY": "beta, Trastuzumab", "MN": "D12.776.377.715.548.114.224.200.875", "FX": "Receptor, ErbB-2", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "P188ANX8CK", "RR": "180288-69-1", "MS": "A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.", "PM": "2016; TRASTUZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 1998-2015", "HN": "2016 (1998)", "MR": "20200206", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068878"}, {"RECTYPE": "D", "MH": "Adalimumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Antibody, D2E7", "MN": "D12.776.377.715.548.114.224.200.250", "FX": "Tumor Necrosis Factor-alpha", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "FYS6T7F842", "MS": "A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.", "PM": "2016; ADALIMUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2002-2015", "HN": "2016 (2002)", "MR": "20210701", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068879"}, {"RECTYPE": "D", "MH": "Isophane Insulin, Human", "AQ": "AA AD AE BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "N, Novolin", "MN": "D12.644.548.586.200.500.625.500.500", "MH_TH": "NLM (2012)", "ST": "T125", "RN": "0", "MS": "Human isophane insulin that is used to manage BLOOD GLUCOSE levels in patients with DIABETES.", "PM": "2016; ISOPHANE INSULIN, HUMAN was indexed under INSULIN, ISOPHANE and INSULIN, REGULAR, HUMAN 2011-2015", "HN": "2016 (2011)", "MR": "20150616", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068880"}, {"RECTYPE": "D", "MH": "Animals, Exotic", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Pets, Exotic", "MN": "B01.050.050.126", "MH_TH": "NLM (2016)", "ST": "T008", "AN": "use only when specified by author; coordinate with ANIMALS, WILD or ANIMALS, ZOO as needed", "MS": "Animals native to a foreign country or of foreign origin or character, that are not native to the United States.", "PM": "2016", "HN": "2016", "MR": "20200902", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068881"}, {"RECTYPE": "D", "MH": "Paliperidone Palmitate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sustenna, Invega", "MN": "D03.383.742.592", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "R8P8USM8FR", "RR": "838F01T721", "MS": "A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.", "PM": "2016; PALIPERIDONE was indexed under PYRIMIDINES and ISOXAZOLES, 1993-2015; PALIPERIDONE PALMITATE was indexed under ISOXAZOLES and PALMITATE 2010-2015.", "HN": "2016 (1993)", "MR": "20160531", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000068882"}, {"RECTYPE": "D", "MH": "Immunosenescence", "AQ": "DE GE IM PH RE", "MN": "G12.460.500", "MH_TH": "NLM (2016)", "ST": "T040", "PI": "Aging (2015)", "MS": "The decline in the function of the IMMUNE SYSTEM during aging.", "PM": "2016", "HN": "2016", "MR": "20160617", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068884"}, {"RECTYPE": "D", "MH": "Canagliflozin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Invokana|T109|T121|TRD|NRW|NLM (2014)|140813|abbcdef", "MN": "D09.408.348.113", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "0SAC974Z85", "RR": "928672-86-0 (Hemihydrate)", "MS": "A glucoside-derived SODIUM-GLUCOSE TRANSPORTER 2 inhibitor that stimulates urinary excretion of glucose by suppressing renal glucose reabsorption. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.", "PM": "2016; CANAGLIFLOZIN was indexed under GLUCOSIDES and THIOPHENES 2014-2015", "HN": "2016 (2014)", "MR": "20180228", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068896"}, {"RECTYPE": "D", "MH": "Iridescence", "AQ": "DE GE IM PH RE", "ENTRY": "Iridescent Colorings", "MN": "G01.590.310", "MH_TH": "NLM (2016)", "ST": "T070", "MS": "The changing of the color of an object due to variations in the angle of illumination or observation.", "PM": "2016; OPALESCENCE was indexed under PEROXIDES 1969-2015", "HN": "2016; for OPALESCENCE (NM) use CARBAMIDE PEROXIDE (NM) 1969-2015", "MR": "20150709", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068897"}, {"RECTYPE": "D", "MH": "Raltegravir Potassium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Potassium, Raltegravir", "MN": "D03.383.773.812.752", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "43Y000U234", "RR": "871038-72-1 (raltegravir potassium)", "MS": "A pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.", "PM": "2016; RALTEGRAVIR POTASSIUM was indexed under PYRROLIDINONES 2008-2015; and under ORGANIC CHEMICALS 2006-2008", "HN": "2016 (2006)", "MR": "20160531", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000068898"}, {"RECTYPE": "D", "MH": "Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sitagliptin Phosphate-Metformin Hydrochloride Drug Combination|T121|NON|EQV|NLM (2016)|150401|abcdef", "MN": "D26.310.750", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.", "PM": "2016; SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE DRUG COMBINATION was indexed under METFORMIN and PYRAZINES 2008-2015", "HN": "2016 (2008)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068899"}, {"RECTYPE": "D", "MH": "Sitagliptin Phosphate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phosphate, Sitagliptin", "MN": "D03.383.679.875", "FX": "Linagliptin", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "TS63EW8X6F", "RR": "QFP0P1DV7Z", "MS": "A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.", "PM": "2016; SITAGLIPTIN PHOSPHATE was indexed under PYRAZINES and TRIAZOLES 2005-2015", "HN": "2016 (2005)", "MR": "20160531", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000068900"}, {"RECTYPE": "D", "MH": "Spatial Regression", "ENTRY": "Weighted Regressions, Geographically", "MN": "N06.850.520.830.933.375", "MH_TH": "NLM (2016)", "ST": "T081", "PI": "Regression Analysis (1996-2015)", "MS": "Methods used to take into account and incorporate spatial autocorrelation and regional variation into regression analysis models of data that has spatial dependency, and also to provide information on the spatial relationships among the variables.", "PM": "2016", "HN": "2016", "MR": "20150616", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068916"}, {"RECTYPE": "D", "MH": "Theranostic Nanomedicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Photothermal Theranostics|T091|NON|REL|NLM (2021)|200115|abcdef", "ENTRY": "Theranostic Nanomedicines", "MN": "J01.897.520.600.600.500", "MH_TH": "NLM (2016)", "ST": "T091", "PI": "Nanomedicine (2013-2015)", "MS": "An integrated nano-scale approach to MEDICINE which involves concurrent diagnosis, drug delivery, therapy, and monitoring of therapeutic response.", "PM": "2016", "HN": "2016", "MR": "20200221", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000068936"}, {"RECTYPE": "D", "MH": "Cosmeceuticals", "AQ": "AD AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Cosmeceutical|T073|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D27.720.269.285", "MH_TH": "NLM (2016)", "ST": "T073", "RN": "0", "PI": "Cosmetics (2000-2015)", "MS": "COSMETICS that are associated with therapeutic effects.", "PM": "2016", "HN": "2016", "MR": "20200527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068937"}, {"RECTYPE": "D", "MH": "Prisoner Dilemma", "PRINT ENTRY": "Prisoner's Dilemma|T078|NON|EQV|UNK (19XX)|780310|abcdef", "ENTRY": "Dilemma, Prisoners", "MN": "E05.385.500", "MH_TH": "UNK (19XX)", "ST": "T078", "MS": "A scenario in decision analysis in which two individuals motivated entirely by self-preservation at the expense of the other, end up in a worse state than if they had cooperated with each other in the decision-making process.", "PM": "2016; see GAME THEORY 1985-2015", "HN": "2016; use GAME THEORY 1985-2015", "MR": "20150708", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000068956"}, {"RECTYPE": "D", "MH": "Games, Recreational", "AQ": "IN PX", "ENTRY": "Recreational Games", "MN": "I03.450.642.693.465", "FX": "Video Games", "MH_TH": "NLM (2016)", "ST": "T056", "MS": "Activity typically involving several individuals for the purpose of leisure, amusement, entertainment or pleasure.", "PM": "2016", "MR": "20150616", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068957"}, {"RECTYPE": "D", "MH": "Return to Sport", "AQ": "CL EC ED ES HI LJ PH PX SN ST TD", "ENTRY": "to Sports, Return", "MN": "I03.450.642.845.605", "MH_TH": "NLM (2016)", "ST": "T080", "MS": "Resumption of sporting activity following a hiatus or period of absence due to injury or other reasons.", "PM": "2016", "HN": "2016", "MR": "20151124", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068958"}, {"RECTYPE": "D", "MH": "Body Weight Maintenance", "AQ": "DE GE IM PH RE", "ENTRY": "Weight Maintenances, Body", "MN": "G07.345.249.314.120.250", "FX": "Weight Cycling", "MH_TH": "NLM (2016)", "ST": "T052", "MS": "Sustaining BODY WEIGHT after BODY WEIGHT CHANGES have been achieved.", "PM": "2016", "HN": "2016", "MR": "20210707", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068959"}, {"RECTYPE": "D", "MH": "Concierge Medicine", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Medicine, Retainer", "MN": "N04.452.758.708.450.500", "MH_TH": "NLM (2016)", "ST": "T091", "PI": "Health Services Accessibility (2000-2015)", "MS": "An arrangement in which a patient pays an annual fee to a physician in exchange for services over and beyond normal insurance-reimbursed services.", "PM": "2016", "HN": "2016", "MR": "20150616", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000068977"}, {"RECTYPE": "D", "MH": "Smartphone", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "ENTRY": "Smartphones", "MN": "L01.462.500.847.698.300.250", "FX": "Mobile Applications", "MH_TH": "NLM (2015)", "ST": "T073", "MS": "A cell phone with advanced computing and connectivity capability built on an operating system.", "PM": "2016; see CELL PHONES 2015", "HN": "2016; use CELL PHONES 2015", "MR": "20220712", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000068997"}, {"RECTYPE": "D", "MH": "Humidifiers", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Humidifier", "MN": "J01.494.650", "FX": "Respiration, Artificial", "MH_TH": "NLM (2016)", "ST": "T074", "MS": "Machines that add moisture to the air.", "PM": "2016", "HN": "2016", "MR": "20190705", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000068998"}, {"RECTYPE": "D", "MH": "Acculturation", "AQ": "HI", "ENTRY": "Cultural Assimilation", "MN": "I01.880.853.100.079", "MH_TH": "POPLINE (1986)", "ST": "T054", "MS": "Process of cultural change in which one group or members of a group assimilate various cultural patterns from another.", "HN": "1963", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000069"}, {"RECTYPE": "D", "MH": "Insulin Glargine", "AQ": "AA AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Semglee|T116|T121|TRD|REL|NLM (2023)|210813|abbcdef", "ENTRY": "Solostar, Lantus", "MN": "D12.644.548.586.200.300.100", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "2ZM8CX04RZ", "RR": "160337-95-1", "MS": "A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.", "PM": "2016; INSULIN GLARGINE was indexed under INSULIN, LONG ACTING 2011-2015; and under INSULIN 1997-2011", "HN": "2016 (1997)", "MR": "20220413", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069036"}, {"RECTYPE": "D", "MH": "Lurasidone Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SM13,496", "MN": "D03.633.100.513.437", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "O0P4I5851I", "RR": "367514-88-3 (lurasidone hydrochloride)", "MS": "A thiazole derivative and atypical ANTIPSYCHOTIC AGENT that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST; SEROTONIN 5-HT2 RECEPTOR ANTAGONIST, serotonin 5-HT7 receptor antagonist, and antagonist of the adrenergic \u03b12A and \u03b12C receptors, as well as a partial SEROTONIN 5-HT1A RECEPTOR AGONIST. It is used in the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER.", "PM": "2016; LURASIDONE HYDROCHLORIDE was indexed under ISOINDOLES and THIAZOLES 2008-2015", "HN": "2016 (2008)", "MR": "20160531", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069056"}, {"RECTYPE": "D", "MH": "Insulin Detemir", "AQ": "AA AD AE BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Insulin Detemir, Basal", "MN": "D12.644.548.586.200.300.050", "MH_TH": "USAN (19XX)", "ST": "T125", "RN": "4FT78T86XV", "RR": "169148-63-4", "MS": "A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.", "PM": "2016; INSULIN DETEMIR was indexed under INSULIN, LONG-ACTING 2011-2015; under INSULIN 1997-2011; and under CARRIER PROTEINS 1997-2004", "HN": "2016 (1997)", "MR": "20170117", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069057"}, {"RECTYPE": "D", "MH": "Vardenafil Dihydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trihydrate, Vardenafil Hydrochloride", "MN": "D03.383.606.960", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "5O8R96XMH7", "RR": "UCE6F4125H", "MS": "A piperazine derivative, PHOSPHODIESTERASE 5 INHIBITOR and VASODILATOR AGENT that is used as a UROLOGICAL AGENT in the treatment of ERECTILE DYSFUNCTION.", "PM": "2016; VARDENAFIL DIHYDROCHLORIDE was indexed under IMIDAZOLES and PIPERAZINES 2001-2015", "HN": "2016 (2001)", "MR": "20210510", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000069058"}, {"RECTYPE": "D", "MH": "Atorvastatin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CI981", "MN": "D10.251.450.200", "MH_TH": "USAN (1994)", "ST": "T121", "RN": "A0JWA85V8F", "RR": "C0GEJ5QCSO", "MS": "A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.", "PM": "2019; see ATORVASTATIN CALCIUM 2016-2018; ATORVASTATIN CALCIUM was indexed under HEPTANOIC ACIDS and PYRROLES 1990-2015", "HN": "2019 (1990)", "MR": "20180702", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000069059"}, {"RECTYPE": "D", "MH": "Fractures, Multiple", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Multiple Fractures", "MN": "C26.640.500", "MH_TH": "NLM (2016)", "ST": "T037", "MS": "Injuries involving the breaking of either several bones or one bone in two or more places.", "PM": "2016", "HN": "2016", "MR": "20150522", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069076"}, {"RECTYPE": "D", "MH": "Memory Consolidation", "AQ": "CL DE PH RE", "ENTRY": "Memory Consolidations", "MN": "F02.463.425.540.305.500", "FX": "Learning", "MH_TH": "NLM (2016)", "ST": "T041", "MS": "Neurological process involving the conversion of learned information into long-term memory.", "PM": "2016", "HN": "2016", "MR": "20150522", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069077"}, {"RECTYPE": "D", "MH": "Seroconversion", "AQ": "DE GE PH RE", "ENTRY": "Seroconversions", "MN": "G12.800", "FX": "Immune System Phenomena", "MH_TH": "NLM (2016)", "ST": "T070", "MS": "The appearance of antibodies against causative agents in the blood of individuals during the course of an infection or following immunization.", "PM": "2016", "HN": "2016", "MR": "20160623", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069078"}, {"RECTYPE": "D", "MH": "Radiation Exposure", "AQ": "AE AN CL EC ES HI LJ PC SN ST", "ENTRY": "Exposure, Radiation", "MN": "N06.850.460.350.850", "FX": "Environmental Pollutants", "MH_TH": "NLM (2016)", "ST": "T037", "MS": "Phenomenon in which organisms are subjected to radiation.", "PM": "2016", "HN": "2016", "MR": "20150522", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069079"}, {"RECTYPE": "D", "MH": "Health Smart Cards", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Smart Cards, Health", "MN": "N06.850.520.308.940.968.625.500", "MH_TH": "NLM (2016)", "ST": "T074", "MS": "Hand-sized cards with built-in computer chips used for accessing, storing, and protecting patients' medical information.", "PM": "2016", "HN": "2016", "MR": "20170630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069098"}, {"RECTYPE": "D", "MH": "Type I Secretion Systems", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "System, T1SS Secretion", "MN": "D05.500.890.500.500", "MH_TH": "NLM (2016)", "ST": "T116", "RN": "0", "PI": "Bacterial Secretion Systems (2010-2015)", "MS": "Gram-negative bacterial secretion systems which translocate effectors in a single step across the inner and outer membranes. The one-step secretion is carried out by a channel that passes from the CYTOPLASM, through the inner membrane, PERIPLASMIC SPACE, and outer membrane, to the EXTRACELLULAR SPACE. The specificity of type I secretions systems are determined by the specificity of the three subcomponents forming the channel - an ATP transporter (ATP-BINDING CASSETTE TRANSPORTERS); a membrane fusion protein (MEMBRANE FUSION PROTEINS); and an outer membrane protein (BACTERIAL OUTER MEMBRANE PROTEINS.)", "PM": "2016", "HN": "2016", "MR": "20150625", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069177"}, {"RECTYPE": "D", "MH": "Type II Secretion Systems", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "System, T2SS Secretion", "MN": "D05.500.890.500.750", "MH_TH": "NLM (2016)", "ST": "T116", "RN": "0", "PI": "Bacterial Secretion Systems (2010-2015)", "MS": "Gram-negative bacterial secretion systems which carry out the secretion of folded proteins.T2SSs secrete folded proteins from the PERIPLASMIC SPACE that have been exported there by SEC TRANSLOCASE or TAT SECRETION SYSTEMS, or they secrete folded proteins directly from the CYTOPLASM. The T2SSs have four substructures, an ATPase, an inner membrane platform, a pseudopilin, and secretin, an outer membrane complex which is a channel for secretion. (This bacterial secretin is not the same as the mammalian hormone also named SECRETIN.)", "PM": "2016", "HN": "2016", "MR": "20150625", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069178"}, {"RECTYPE": "D", "MH": "Gastrointestinal Microbiome", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Enteric Bacteria|T007|NON|NRW|NLM (1998)|960711|abcdef", "ENTRY": "Microflora, Intestinal", "MN": "N06.230.124.049.100.500.250", "FX": "Brain-Gut Axis", "MH_TH": "NLM (2016)", "ST": "T001", "MS": "All of the microbial organisms that naturally exist within the GASTROINTESTINAL TRACT.", "PM": "2018; for ENTERIC BACTERIA see ENTEROBACTERIACEAE 1998-2017", "HN": "2018; for ENTERIC BACTERIA use ENTEROBACTERIACEAE 1998-2017", "MR": "20210305", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069196"}, {"RECTYPE": "D", "MH": "Contraceptive Prevalence Surveys", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Surveys, Contraceptive Prevalence", "MN": "N06.850.520.308.980.313", "MH_TH": "POPLINE (1980)", "ST": "T062", "MS": "Collections of data, obtained from voluntary subjects, that measure the usage rate of methods of CONTRACEPTION; CONTRACEPTIVE DEVICES; or CONTRACEPTIVE AGENTS.", "PM": "2016; see DATA COLLECTION 1987-2015", "HN": "2016; use DATA COLLECTION 1987-2015", "MR": "20170630", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000069216"}, {"RECTYPE": "D", "MH": "Pericardial Fluid", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Pericardium Fluids", "MN": "A12.207.270.651", "MH_TH": "NLM (2016)", "ST": "T031", "PI": "Pericardium (1964-2015)", "MS": "Watery fluid produced in the serous and visceral pericardium surrounding the surface of the HEART.", "PM": "2016", "HN": "2016", "MR": "20150626", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069236"}, {"RECTYPE": "D", "MH": "Arthrocentesis", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Temporomandibular Joint Aspirations", "MN": "E05.200.998.329.465", "MH_TH": "NLM (2016)", "ST": "T058", "PI": "Paracentesis (1996-2015)", "MS": "Puncture and aspiration of fluid (e.g., SYNOVIAL FLUID) from a joint cavity. It is used sometimes to irrigate or administer drugs into a joint cavity.", "PM": "2016", "HN": "2016", "MR": "20150709", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069237"}, {"RECTYPE": "D", "MH": "Thoracentesis", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Thoracocenteses", "MN": "E05.200.998.329.810", "FX": "Pneumothorax", "MH_TH": "NLM (2016)", "ST": "T061", "PI": "Paracentesis (1966-2015)", "MS": "Aspiration of fluid or air from the THORACIC CAVITY. It is coupled sometimes  with the administration of drugs into the PLEURAL CAVITY.", "PM": "2016", "HN": "2016", "MR": "20150709", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069258"}, {"RECTYPE": "D", "MH": "Superficial Musculoaponeurotic System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Systems, Superficial Musculoaponeurotic", "MN": "A01.598.500", "FX": "Rhytidoplasty", "MH_TH": "NLM (2016)", "ST": "T029", "PI": "Neck (1976-2015)", "MS": "Layer between the superficial fat compartment and superficial facial muscles in the head and the neck.", "PM": "2016", "HN": "2016", "MR": "20150708", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069259"}, {"RECTYPE": "D", "MH": "Podosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Podosome", "MN": "A11.436.275.841", "FX": "Mechanotransduction, Cellular", "MH_TH": "NLM (2016)", "ST": "T026", "PI": "Extracellular Matrix (1996-2015)", "MS": "Actin-rich adhesive structures found at the ventral surface of metazoan ENDOTHELIAL CELLS. When found  in cultured cancer cells they are referred to as invadopodia. These are matrix-degrading structures composed of an ACTIN CYTOSKELETON core and an INTEGRINS-containing ring complex.", "PM": "2016", "HN": "2016", "MR": "20150709", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069261"}, {"RECTYPE": "D", "MH": "Plantar Plate", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Volar Plates, Toe", "MN": "A10.165.669.514.538", "MH_TH": "NLM (2016)", "ST": "T023", "PI": "Metatarsophalangeal Joint (1979-2015)", "MS": "Fibrocartilaginous ligament at the metatarsophalangeal and the interphalangeal joint of the toe.", "PM": "2016", "HN": "2016", "MR": "20170620", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069262"}, {"RECTYPE": "D", "MH": "Fallopia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.825.359", "MH_TH": "NLM (2016)", "ST": "T002", "RN": "txid76024", "MS": "Genus of flowering herbaceous perennial plants and vines in the family Polygonaceae.", "PM": "2016", "HN": "2016", "MR": "20210630", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000069263"}, {"RECTYPE": "D", "MH": "Arterial Switch Operation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Techniques, Double-Switch", "MN": "E04.928.220.055", "FX": "Transposition of Great Vessels", "MH_TH": "NLM (2016)", "ST": "T061", "PI": "Transposition of Great Vessels (1971-2015)", "MS": "Surgical procedure for anatomical correction of transposed great arteries (e.g., DOUBLE OUTLET RIGHT VENTRICLE).", "PM": "2016", "HN": "2016", "MR": "20150622", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069278"}, {"RECTYPE": "D", "MH": "Drug Resistant Epilepsy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Resistant Epilepsy, Medication", "MN": "C10.228.140.490.125", "MH_TH": "NLM (2016)", "ST": "T047", "PI": "Epilepsy (1968-2015)", "MS": "Epileptic condition in which adequate trials of two tolerated and appropriately chosen and used ANTIEPILEPTIC DRUGS schedules to achieve sustained seizure freedom failed.", "PM": "2016", "HN": "2016", "MR": "20170224", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069279"}, {"RECTYPE": "D", "MH": "Electrocorticography", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Intraoperative Electrocorticographies", "MN": "E01.370.405.243", "MH_TH": "NLM (2016)", "ST": "T060", "PI": "Electroencephalography (1965-2015)", "MS": "Recording of brain electrical activities in which the electrodes are placed directly on the CEREBRAL CORTEX.", "PM": "2016", "HN": "2016", "MR": "20220523", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069280"}, {"RECTYPE": "D", "MH": "Autoimmune Hypophysitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Anti-PIT-1 Antibody", "MN": "C20.111.273", "MH_TH": "NLM (2016)", "ST": "T047", "PI": "Pituitary Diseases (1967-2015)", "MS": "Immune-mediated inflammation of the PITUITARY GLAND often associated with other autoimmune diseases (e.g., HASHIMOTO DISEASE; GRAVES DISEASE; and ADDISON DISEASE).", "PM": "2016", "HN": "2016", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069281"}, {"RECTYPE": "D", "MH": "Canaliculitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lacrimal Canaliculitides", "MN": "C11.496.221.500", "FX": "Corneal Ulcer", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Lacrimal Apparatus Diseases (1973-2015)", "MS": "Inflammation and infection of the lacrimal canaliculus area in the LACRIMAL APPARATUS.", "PM": "2016; was indexed under CORNEAL ULCER 2010-2015 and DACRYOCYSTITIS 2010-2015", "HN": "2016 (2010)", "MR": "20150707", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069282"}, {"RECTYPE": "D", "MH": "Rituximab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Rituximab CD20 Antibody", "MN": "D12.776.377.715.548.114.224.284.785", "FX": "Antigens, CD20", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "4F4X42SYQ6", "RR": "174722-31-7", "MS": "A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.", "PM": "2016; RITUXIMAB was indexed under ANTIBODIES, MONOCLONAL, MURINE-DERIVED 1995-2016", "HN": "2016 (1995)", "MR": "20200527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069283"}, {"RECTYPE": "D", "MH": "Protein Translocation Systems", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Translocation Systems, Protein", "MN": "D05.500.890", "FX": "Membrane Transport Proteins", "MH_TH": "NLM (2016)", "ST": "T116", "RN": "0", "MS": "Multiprotein complexes that carry out PROTEIN TRANSPORT across CELL MEMBRANES.", "PM": "2016", "HN": "2016", "MR": "20150625", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069284"}, {"RECTYPE": "D", "MH": "Infliximab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "cA2, Monoclonal Antibody", "MN": "D12.776.377.715.548.114.224.642", "FX": "Tumor Necrosis Factor-alpha", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "B72HH48FLU", "RR": "170277-31-3", "MS": "A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE.", "PM": "2016; INFLIXIMAB was indexed under ANTIBODIES, MONOCLONAL 1997-2015", "HN": "2016 (1997)", "MR": "20210701", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069285"}, {"RECTYPE": "D", "MH": "Bortezomib", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "PS341", "MN": "D03.383.679.450", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "69G8BD63PP", "RR": "179324-69-7", "MS": "A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.", "PM": "2016; BORTEZOMIB was indexed under BORONIC ACIDS and PYRAZINES 2000-2015", "HN": "2016 (2000)", "MR": "20160527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069286"}, {"RECTYPE": "D", "MH": "Capecitabine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Xeloda|T114|T121|TRD|NRW|NLM (1999)|991126|abbcdef", "MN": "D13.570.685.245.500.425", "MH_TH": "USAN (1997)", "ST": "T121", "RN": "6804DJ8Z9U", "RR": "154361-50-9 (capecitabine)", "MS": "A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.", "PM": "2016; CAPECITABINE was indexed under DEOXYCYTIDINE and FLUOROURACIL 1998-2015", "HN": "2016 (1998)", "MR": "20160527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069287"}, {"RECTYPE": "D", "MH": "Parasite Encystment", "AQ": "DE GE IM PH RE", "ENTRY": "Protozoan Parasite Encystations", "MN": "G07.345.500.550.875", "FX": "Trophozoites", "MH_TH": "NLM (2016)", "ST": "T040", "MS": "Process by which certain parasites such as GIARDIA and ENTAMOEBA convert from the TROPHOZOITE to SCHIZONT when exposed to stress.", "PM": "2016", "HN": "2016", "MR": "20160617", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069289"}, {"RECTYPE": "D", "MH": "Incisional Hernia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Postoperative Hernias", "MN": "C23.550.767.500", "MH_TH": "NLM (2016)", "ST": "T190", "PI": "Hernia (1966-2015)", "MS": "Protrusion of tissue at or near the site of an incision from a previous surgery.", "PM": "2016", "HN": "2016", "MR": "20150626", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069290"}, {"RECTYPE": "D", "MH": "Pyroptosis", "AQ": "DE GE IM PH RE", "ENTRY": "Pyroptotic Cell Deaths", "MN": "G04.146.954.035.530", "FX": "Necrosis", "MH_TH": "NLM (2016)", "ST": "T043", "PI": "Apoptosis (2005-2015)", "MS": "Type of programmed cell death associated with infection by intracellular pathogens. It is characterized by INFLAMMASOME formation; activation of CASPASE 1; and CYTOKINES mediated inflammation.", "PM": "2016", "HN": "2016", "MR": "20190530", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069292"}, {"RECTYPE": "D", "MH": "Plasmablastic Lymphoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Plasmablasts Diffuse Large B cell Lymphoma", "MN": "C20.683.515.761.480.150.585.500", "MH_TH": "NLM (2016)", "ST": "T191", "PI": "Lymphoma, Large B-Cell, Diffuse (1998-2015)", "MS": "Malignant lymphoma composed of large B lymphoid cells which have the immunophenotype of plasma cells and a predilection for the ORAL CAVITY.", "PM": "2016", "HN": "2016", "MR": "20150709", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069293"}, {"RECTYPE": "D", "MH": "Twin-Arginine-Translocation System", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Twin Arginine Transport System", "MN": "D05.500.890.750", "MH_TH": "NLM (2016)", "ST": "T116", "RN": "0", "MS": "Protein translocase in BACTERIA or CHLOROPLASTS that exports or secretes folded proteins. In GRAM-NEGATIVE BACTERIA, twin-arginine translocase (TAT) is involved in the export of folded proteins to the PERIPLASM. In chloroplasts, TAT is involved in transporting folded proteins across the membranes of THYLAKOIDS.", "PM": "2016", "HN": "2016", "MR": "20150625", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069294"}, {"RECTYPE": "D", "MH": "Mammary Analogue Secretory Carcinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "MN": "C04.557.470.200.588", "MH_TH": "NLM (2016)", "ST": "T191", "PI": "Carcinoma (2010-2015)", "MS": "A malignant neoplasm of epithelial cells of the SALIVARY GLANDS, with microcystic architecture, low-grade nuclei, and granular vacuolated cytoplasm.", "PM": "2016", "HN": "2016", "MR": "20150622", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069295"}, {"RECTYPE": "D", "MH": "Type III Secretion Systems", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "System, T3SS Secretion", "MN": "D05.500.890.500.875", "MH_TH": "NLM (2016)", "ST": "T116", "RN": "0", "PI": "Bacterial Secretion Systems (2010-2015)", "MS": "Multiprotein transmembrane complexes in GRAM-NEGATIVE BACTERIA involved in either the secretion of effector proteins from the bacterial cytoplasm into host cells, or the secretion and assembly of flagellar components. The major component of the T3SSs is called the injectosome or needle complex.", "PM": "2016", "HN": "2016", "MR": "20150625", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069296"}, {"RECTYPE": "D", "MH": "Acne Conglobata", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Conglobatas, Acne", "MN": "C17.800.794.111.500", "MH_TH": "NLM (2016)", "ST": "T047", "PI": "Acne Vulgaris (1964-2015)", "MS": "Severe and chronic form of acne characterized by large, burrowing abscesses associated with disfigurement.", "PM": "2016", "HN": "2016", "MR": "20150622", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069316"}, {"RECTYPE": "D", "MH": "Type IV Secretion Systems", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "System, T4SS Secretion", "MN": "D05.500.890.500.937", "MH_TH": "NLM (2016)", "ST": "T116", "RN": "0", "PI": "Bacterial Secretion Systems (2010-2015)", "MS": "Multiprotein complexes that transport single proteins, multiprotein complexes, and nucleoprotein complexes from the CYTOPLASM into the EXTRACELLULAR SPACE or into recipient cells. T4SSs are found in GRAM-NEGATIVE BACTERIA, while homologous components to T4SSs are found in GRAM-POSTIVE BACTERIA.", "PM": "2016", "HN": "2016", "MR": "20150625", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069319"}, {"RECTYPE": "D", "MH": "Type V Secretion Systems", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Two-Partner Secretion System|T116|NON|NRW|NLM (2021)|191118|abcdef", "ENTRY": "Two Partner Secretion Systems", "MN": "D05.500.890.500.968", "MH_TH": "NLM (2016)", "ST": "T116", "RN": "0", "PI": "Bacterial Secretion Systems (2010-2015)", "MS": "Secretion systems of GRAM-NEGATIVE BACTERIA (single membrane proteins or multiprotein complexes) that carry out secretion of proteins from the PERIPLASMIC SPACE to the EXTRACELLULAR SPACE via a beta-barrel transmembrane pore. There are several T5SS subtypes: T5aSS monomeric autotransporters, T5bSS two-partner secretions systems (TPSS), T5cSS trimeric autotransporters, T5dSS fused two-partner secretion systems, and T5eSS autotransporters with inverted domains.", "PM": "2016", "HN": "2016", "MR": "20200527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069320"}, {"RECTYPE": "D", "MH": "Mitochondrial Replacement Therapy", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Transfer Techniques, Spindle", "MN": "E05.820.800.750.350", "MH_TH": "NLM (2016)", "ST": "T062", "PI": "Cellular Reprogramming (2014-2015)", "MS": "In vitro fertilization technique that uses mitochondrial DNA from a healthy donor in order to prevent the transmission of MITOCHONDRIAL DISEASE.", "PM": "2016", "HN": "2016", "MR": "20150626", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069321"}, {"RECTYPE": "D", "MH": "Self Expandable Metallic Stents", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Self Expandable Metallic Stent|T074|NON|EQV|NLM (2016)|150508|abcdef", "MN": "E07.695.750.750", "MH_TH": "NLM (2016)", "ST": "T074", "PI": "Stents (2014-2015)", "MS": "Cylindrical metallic tubes that are inserted to hold open a structure in order to treat vascular, bile duct, esophageal and other tubular organ constrictions.", "PM": "2016", "HN": "2016", "MR": "20150622", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069322"}, {"RECTYPE": "D", "MH": "Neurovascular Coupling", "AQ": "DE GE IM PH RE", "ENTRY": "Responses, Hemodynamic Brain", "MN": "G09.330.100.159.500", "FX": "Hemodynamics", "MH_TH": "NLM (2016)", "ST": "T042", "PI": "Cerebrovascular Circulation (1997-2015)", "MS": "Mechanism by which changes in neural activity are tightly associated with regional cortical HEMODYNAMICS and metabolism changes. The association is often inferred from NEUROIMAGING signals (e.g., fMRI; or NIR SPECTROSCOPY).", "PM": "2016", "HN": "2016", "MR": "20160617", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069336"}, {"RECTYPE": "D", "MH": "Fused Kidney", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Renal Fusions", "MN": "C16.131.939.445", "MH_TH": "NLM (2016)", "ST": "T019", "PI": "Kidney Diseases (1963-2015)", "MS": "Congenital fusion of two kidneys.", "PM": "2016", "HN": "2016", "MR": "20210630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069337"}, {"RECTYPE": "D", "MH": "Neuropathology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Neuropathologist", "MN": "H02.403.650.375", "MH_TH": "NLM (2016)", "ST": "T091", "AN": "use for the discipline only (education, history, etc.) only", "PI": "Nervous System Diseases (1965-2015)", "MS": "The branch of medicine and biomedical science concerned with diseases of the nervous system.", "PM": "2016", "HN": "2016", "MR": "20150701", "DA": "20150702", "DC": "1", "DX": "20160101", "UI": "D000069338"}, {"RECTYPE": "D", "MH": "Trachelectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Vaginal Trachelectomies", "MN": "E04.950.300.399.690", "MH_TH": "NLM (2016)", "ST": "T061", "PI": "Hysterectomy (1988-2015)", "MS": "Surgical removal or resection of the CERVIX UTERI.", "PM": "2016", "HN": "2016", "MR": "20150626", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069339"}, {"RECTYPE": "D", "MH": "Deprescriptions", "ENTRY": "Deprescription", "MN": "E02.319.243", "FX": "Potentially Inappropriate Medication List", "MH_TH": "NLM (2016)", "ST": "T170", "PI": "Drug Prescriptions (2007-2015)", "MS": "Directions written to discontinue use of PRESCRIPTION DRUGS in order to reduce unnecessary and/or excessive medications (see POLYPHARMACY), DRUG SIDE EFFECTS and ADVERSE DRUG REACTION.", "PM": "2016", "HN": "2016", "MR": "20200527", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069340"}, {"RECTYPE": "D", "MH": "Transitional Care", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Home Transition|T058|NON|NRW|NLM (2022)|210223|abcdef", "ENTRY": "Transitions, Home", "MN": "N04.590.233.727.210.812", "MH_TH": "NLM (2016)", "ST": "T058", "PI": "Continuity of Patient Care (1987-2015)", "MS": "Health care provided during a transition to a different mode of care (e.g., TRANSITION TO ADULT CARE).", "PM": "2016", "HN": "2016", "MR": "20210706", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069341"}, {"RECTYPE": "D", "MH": "Medical Overuse", "AQ": "EC LJ PC SN TD", "PRINT ENTRY": "Unnecessary Health Care|T055|T058|NON|EQV|NLM (2022)|210106|abbcdef", "ENTRY": "Preference Misdiagnoses", "MN": "N05.300.150.395.450", "FX": "Polypharmacy", "MH_TH": "NLM (2016)", "ST": "T058", "PI": "Unnecessary Procedures (2014-2015)", "MS": "Excessive or unnecessary utilization of health services by patients or physicians.", "PM": "2016; for HEALTH SERVICES OVERUTILIZATION see HEALTH SERVICES MISUSE 1978-2015", "HN": "2016; for HEALTH SERVICES OVERUTILIZATION use HEALTH SERVICES MISUSE 1978-2015", "MR": "20210305", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069342"}, {"RECTYPE": "D", "MH": "Bone-Implant Interface", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Interfaces, Bone-Prosthesis", "MN": "E07.695.125", "FX": "Osseointegration", "MH_TH": "NLM (2016)", "ST": "T030", "PI": "Osseointegration (1989-2015)", "MS": "Region of interaction between the bone and PROSTHESES AND IMPLANTS which becomes bonded through cellular and extracellular interactions similar to OSSEOINTEGRATION.", "PM": "2016", "HN": "2016", "MR": "20150626", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069343"}, {"RECTYPE": "D", "MH": "Erlotinib Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "OSI774", "MN": "D03.633.100.786.375", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "DA87705X9K", "RR": "J4T82NDH7E", "MS": "A quinazoline derivative and ANTINEOPLASTIC AGENT that functions as a PROTEIN KINASE INHIBITOR for EGFR associated tyrosine kinase. It is used in the treatment of NON-SMALL CELL LUNG CANCER.", "PM": "2016; ERLOTINIB HYDROCHLORIDE was indexed under QUINAZOLINES 1999-2015", "HN": "2016 (1999)", "MR": "20230804", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000069347"}, {"RECTYPE": "D", "MH": "Quetiapine Fumarate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ICI204636", "MN": "D03.633.300.276.500", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "2S3PL1B6UJ", "RR": "BGL0JSY5SI", "MS": "A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER.", "PM": "2016; QUETIAPINE FUMARATE was indexed under DIBENZOTHIAZEPINES 1991-2015", "HN": "2016 (1991)", "MR": "20180702", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069348"}, {"RECTYPE": "D", "MH": "Linezolid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "U100766", "MN": "D03.383.129.462.600.550", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "ISQ9I6J12J", "RR": "165800-03-3", "MS": "An oxazolidinone and acetamide derived ANTI-BACTERIAL AGENT and PROTEIN SYNTHESIS INHIBITOR that is used in the treatment of GRAM-POSITIVE BACTERIAL INFECTIONS of the skin and respiratory tract.", "PM": "2016; LINEZOLID was indexed under ACETAMIDES and OXAZOLIDINONES 2000-2015; and under OXAZOLES 1996-2000", "HN": "2016 (1996)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069349"}, {"RECTYPE": "D", "MH": "Telerehabilitation", "AQ": "CL EC ES HI IS LJ MT OG SN ST TD", "ENTRY": "Virtual Rehabilitations", "MN": "N04.590.374.800.850", "FX": "Exergaming", "MH_TH": "NLM (2016)", "ST": "T058", "PI": "Telemedicine (1996-2015)", "MS": "Delivery of therapeutic rehabilitation at a distance or offsite using telecommunication technologies.", "PM": "2016", "HN": "2016", "MR": "20220712", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069350"}, {"RECTYPE": "D", "MH": "Tympanocentesis", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Tympanocenteses", "MN": "E05.200.998.329.905", "FX": "Otitis Media", "MH_TH": "NLM (2016)", "ST": "T061", "PI": "Paracentesis (1997-2015)", "MS": "Needle aspiration of fluid from the MIDDLE EAR through a puncture in the TYMPANIC MEMBRANE.", "MR": "20150706", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000069356"}, {"RECTYPE": "D", "MH": "Type VI Secretion Systems", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Systems, T6SS Secretion", "MN": "D05.500.890.500.984", "MH_TH": "NLM (2016)", "ST": "T116", "RN": "0", "PI": "Bacterial Secretion Systems (2010-2015)", "MS": "Multiprotein complexes in GRAM NEGATIVE BACTERIA that deliver effector proteins into eukaryotic or prokaryotic cells by a mechanism similar to the contractile tail of bacteriophages. They are composed of a cell envelope-spanning tube which is surrounded by a contractile sheath and tipped by a cell puncturing complex; a base plate structure that anchors the assembly to the cell envelope; and an ATPase involved in the sheath contraction and disassembly of the complex.", "PM": "2016", "HN": "2016", "MR": "20150625", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069376"}, {"RECTYPE": "D", "MH": "Type VII Secretion Systems", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Type VII Secretion System|T116|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Systems, ESX Secretion", "MN": "D05.500.890.500.992", "MH_TH": "NLM (2016)", "ST": "T116", "RN": "0", "PI": "Bacterial Secretion Systems (2010-2015)", "MS": "Bacterial secretion systems found in bacteria that have a MYCOLIC ACID-containing outer membrane such as MYCOBACTERIACEAE; Corynebacteriaceae; and NOCARDIACEAE. These are also known as ESX secretion systems because the first to be discovered is involved in secreting major virulence factors EsxA and EsxB. There are several subtypes of T7SSs including ESX-1, ESX-2, ESX-3, ESX-4, and ESX-5 secretion systems. The subtypes share some core components including an inner membrane channel-forming ATPase complex, a membrane-anchored mycosin, and a second channel that spans the outer mycolic acid-containing membrane.", "PM": "2016", "HN": "2016", "MR": "20200527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069377"}, {"RECTYPE": "D", "MH": "Mitochondrial Ribosomes", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Ribosomes, Mitochondrial", "MN": "A11.284.430.214.190.875.811.370", "MH_TH": "NLM (2016)", "ST": "T026", "PI": "Ribosomes (1964-2015)", "MS": "Multicomponent ribonucleoprotein structures contained in MITOCHONDRIA that specialize in the PROTEIN BIOSYNTHESIS of a small number of proteins involved in energy production for the cell.", "PM": "2016", "HN": "2016", "MR": "20150625", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069396"}, {"RECTYPE": "D", "MH": "Intravital Microscopy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Microscopy, Intravital", "MN": "E05.595.185", "MH_TH": "NLM (2016)", "ST": "T062", "PI": "Microscopy (1963-2015)", "MS": "Type of microscopy used to study biological systems at high resolution.", "PM": "2016", "HN": "2016", "MR": "20151124", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069416"}, {"RECTYPE": "D", "MH": "Toxicological Phenomena", "AQ": "DE GE IM PH RE", "ENTRY": "Toxicological Concept", "MN": "G07.690.936", "MH_TH": "NLM (2016)", "ST": "T038", "AN": "general or unspecified; prefer specifics", "PI": "Pharmacological Phenomena (1998-2015)", "MS": "The nature and effects of chemical, physical or biological poisons on living organisms.", "PM": "2016", "HN": "2016", "MR": "20150706", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000069436"}, {"RECTYPE": "D", "MH": "Pharmacological Phenomena", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Pharmacological Processes|T070|NON|NRW|NLM (2009)|080516|abcdef", "ENTRY": "Processes, Pharmacological", "MN": "G07.690.773", "MH_TH": "NLM (2009)", "ST": "T038", "AN": "general or unspecified; prefer specifics", "MS": "Interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function.", "PM": "2016; for PHARMACOLOGICAL PROCESSES see PHARMACOLOGICAL PROCESSES 2009-2015; for PHARMACOLOGICAL PHENOMENA see PHARMACOLOGICAL PHENOMENA 2009-2015.", "HN": "2016 (2009); for PHARMACOLOGICAL PROCESSES use PHARMACOLOGICAL PROCESSES 2009-2015; for PHARMACOLOGICAL PHENOMENA use PHARMACOLOGICAL PHENOMENA 2009-2015.", "MR": "20190701", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000069437"}, {"RECTYPE": "D", "MH": "Ezetimibe", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "58235, SCH", "MN": "D03.383.082.301.550", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "EOR26LQQ24", "RR": "163222-33-1", "MS": "An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS B in the treatment of HYPERLIPIDEMIAS.", "PM": "2016; EZETIMIBE was indexed under AZETIDINES 1998-2015", "HN": "2016 (1998)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069438"}, {"RECTYPE": "D", "MH": "Dasatinib", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "354825, BMS", "MN": "D03.383.742.148", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "RBZ1571X5H", "RR": "302962-49-8 (dasatinib)", "MS": "A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB.", "PM": "2016; DASATINIB was indexed under PYRIMIDINES and THIAZOLES 2004-2015", "HN": "2016 (2004)", "MR": "20230804", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069439"}, {"RECTYPE": "D", "MH": "Natalizumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Tysabri|T116|T121|T129|TRD|NRW|NLM (2004)|041206|abbbcdef", "MN": "D12.776.377.715.548.114.224.200.813", "FX": "Integrin alpha4", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "0", "MS": "A humanized monoclonal immunoglobulin G4 antibody to human INTEGRIN ALPHA4 that binds to the alpha4 subunit of INTEGRIN ALPHA4BETA1 and integrin alpha4beta7. It is used as an IMMUNOLOGIC FACTOR in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS and CROHN'S DISEASE.", "PM": "2016; NATALIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015 and under  ANTIBODIES, MONOCLONAL 2002-2011", "HN": "2016 (2002)", "MR": "20150626", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069442"}, {"RECTYPE": "D", "MH": "Heptavalent Pneumococcal Conjugate Vaccine", "AQ": "AA AD AE AG AI BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Seven Valent Pneumococcal PS Meningococcal OMPC Conjugate Vaccine", "MN": "D20.215.894.815.410", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "MS": "A pneumococcal vaccine which contains 7 pneumococcal serotypes (6B, 14, 19F, 23F, 18C, 4, 9V), each conjugated individually to the outer membrane protein complex of NEISSERIA MENINGITIDIS.", "PM": "2016; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE was indexed under MENINGOCOCCAL VACCINES 1996-2009; under BACTERIAL VACCINES 1998-2000; under POLYSACCHARIDES BACTERIAL 1996-1997; and under BACTERIAL OUTER MEMBRANE PROTEINS 1996-1997", "HN": "2016 (1996)", "MR": "20200609", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069443"}, {"RECTYPE": "D", "MH": "Omalizumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Xolair|T121|T129|TRD|NRW|AU|US|030310|abbcdeef", "MN": "D12.776.377.715.548.114.224.200.844", "MH_TH": "USAN (19XX)", "ST": "T129", "N1": "Immunoglobulin G, anti-(human immunoglobulin E Fc region)(human-mouse monoclonal E25 clone pSVIE26 gamma-chain), disulfide with human-mouse monoclonal E25 clone pSVIE26 kappa-chain, dimer", "RN": "2P471X1Z11", "RR": "242138-07-4", "MS": "An anti-IgE, recombinant, humanized monoclonal antibody which specifically binds to the C epsilon3 domain of IMMUNOGLOBULIN E, the site of high-affinity IgE receptor binding. It inhibits the binding of IgE to MAST CELLS and BASOPHILS to reduce the severity of the allergic response and is used in the management of persistent allergic ASTHMA.", "PM": "2016; OMALIZUMAB was indexed under ANTIBODIES, ANTI-IDIOTYPIC and ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015; and under ANTIBODIES, MONOCLONAL 2001-2011", "HN": "2016 (2001)", "MR": "20170620", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069444"}, {"RECTYPE": "D", "MH": "Atomoxetine Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Atomoxetine", "MN": "D02.092.831.085", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "57WVB6I2W0", "RR": "ASW034S0B8", "MS": "A propylamine derivative and selective ADRENERGIC UPTAKE INHIBITOR that is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.", "PM": "2016; ATOMOXETINE HYDROCHLORIDE was indexed under PROPYLAMINES 1984-2015", "HN": "2016 (1984)", "MR": "20150708", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069445"}, {"RECTYPE": "D", "MH": "Atazanavir Sulfate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CGP73547", "MN": "D12.644.456.157", "MH_TH": "USAN (2002)", "ST": "T121", "RN": "4MT4VIE29P", "RR": "QZU4H47A3S", "MS": "An azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with other ANTI-HIV AGENTS.", "PM": "2016; ATAZANAVIR SULFATE was indexed under OLIGOPEPTIDES and PYRIDINES 2000-2015", "HN": "2016 (2000)", "MR": "20160711", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069446"}, {"RECTYPE": "D", "MH": "Tiotropium Bromide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Bromide, Tiotropium", "MN": "D03.605.869.822.887", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "XX112XZP0J", "RR": "186691-13-4 (tiotropium)", "MS": "A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.", "PM": "2016; TIOTROPIUM BROMIDE was indexed under SCOPOLAMINE DERIVATIVES 1993-2015", "HN": "2016 (1993)", "MR": "20160601", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069447"}, {"RECTYPE": "D", "MH": "Denosumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Xgeva|T116|T121|T129|TRD|NRW|NLM (2011)|110223|abbbcdef", "MN": "D12.776.377.715.548.114.224.200.782", "FX": "RANK Ligand", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "4EQZ6YO2HI", "RR": "615258-40-7 (denosumab)", "MS": "A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS.", "PM": "2016; DENOSUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2015; and under ANTIBODIES, MONOCLONAL 2004-2012", "HN": "2016 (2004)", "MR": "20170620", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069448"}, {"RECTYPE": "D", "MH": "Cinacalcet", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sensipar|T109|T121|TRD|NRW|NLM (2004)|040311|abbcdef", "MN": "D04.615.638.183", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "UAZ6V7728S", "PM": "2019; was CINACALCET HYDROCHLORIDE 2016-2018; CINACALCET HYDROCHLORIDE was indexed under NAPHTHALENES 2003-2015", "HN": "2019 (2003)", "MR": "20180522", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069449"}, {"RECTYPE": "D", "MH": "Liraglutide", "AQ": "AA AD AE BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Victoza|T116|T121|TRD|NRW|NLM (2010)|150520|abbcdef", "MN": "D06.472.317.680.500.500.500", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "839I73S42A", "RR": "204656-20-2", "MS": "An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.", "PM": "2016; LIRAGLUTIDE was indexed under GLUCAGON-LIKE PEPTIDE 1 2005-2015; and under GLUCAGON 2001-2005", "HN": "2016 (2001)", "MR": "20230531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069450"}, {"RECTYPE": "D", "MH": "Long Term Adverse Effects", "AQ": "BL CF CI CL CN DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Adverse Effects, Long Term|T046|NON|EQV|NLM (2016)|150611|abcdef", "MN": "C23.550.543", "MH_TH": "NLM (2016)", "ST": "T046", "MS": "Persistent detrimental effects from treatment for a condition. Included are effects from surgery such as POSTOPERATIVE COMPLICATIONS, and from DRUG THERAPY, such as CHEMICALLY INDUCED DISORDERS, or other THERAPEUTICS. Failure to attain a desired outcome from treatment for the condition is not considered an adverse effect.", "PM": "2016", "HN": "2016", "MR": "20150625", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069451"}, {"RECTYPE": "D", "MH": "Pathogen-Associated Molecular Pattern Molecules", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pathogen-Associated Molecular Pattern|T085|NON|REL|NLM (2021)|200129|abcdef", "ENTRY": "Pathogen Associated Molecular Patterns", "MN": "D23.585", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "MS": "Pathogens' molecules with specific sequence patterns that are recognized by PATTERN RECOGNITION RECEPTORS. They include microbial DNA, double-stranded RNA, surface glycoproteins, lipopolysaccharides, peptidoglycans, and lipoteichoic acid.", "PM": "2016", "HN": "2016", "MR": "20220523", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069452"}, {"RECTYPE": "D", "MH": "Ultrasonic Waves", "AQ": "AE", "ENTRY": "Waves, Ultrasound", "MN": "G01.750.770.776.891", "FX": "Ultrasonics", "EC": "therapy:Ultrasonic Therapy", "MH_TH": "NLM (2016)", "ST": "T070", "PI": "Ultrasonography (1963-2015)", "MS": "Oscillating sound wave with a frequency higher than the upper limit of the human hearing range.", "PM": "2016; for ULTRASOUND RADIATION see SOUND 2012-2015", "HN": "2016; for ULTRASOUND RADIATION use SOUND 2012-2015", "MR": "20150707", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069453"}, {"RECTYPE": "D", "MH": "Darunavir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "UIC 94017", "MN": "D03.383.312.303", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "(3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester", "RN": "YO603Y8113", "RR": "33O78XF0BW", "MS": "An HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS.", "PM": "2016; DARUNAVIR was indexed under SULFONAMIDES 2004-2015", "HN": "2016 (2004)", "MR": "20160528", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069454"}, {"RECTYPE": "D", "MH": "Palivizumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Monoclonal Antibody MEDI493", "MN": "D12.776.377.715.548.114.224.200.860", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "DQ448MW7KS", "RR": "188039-54-5", "MS": "A humanized monoclonal antibody and ANTIVIRAL AGENT  that is used to prevent RESPIRATORY SYNCYTIAL VIRUS INFECTIONS in high risk pediatric patients.", "PM": "2016; PALIVIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 1998-2015", "HN": "2016 (1998)", "MR": "20170410", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069455"}, {"RECTYPE": "D", "MH": "Silent Mutation", "AQ": "DE GE IM PH RE", "ENTRY": "Synonymous Mutation", "MN": "G05.365.590.803", "MH_TH": "NLM (2016)", "ST": "T045", "PI": "Mutation (1982-2015)", "MS": "A change to a DNA SEQUENCE that doesn't change the AMINO ACID SEQUENCE of the protein made.", "PM": "2016", "HN": "2016", "MR": "20150625", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069456"}, {"RECTYPE": "D", "MH": "Population Forecast", "AQ": "MT", "ENTRY": "Projection, Population", "MN": "N01.224.667", "FX": "Population Growth", "MH_TH": "NLM (1981)", "ST": "T170", "PI": "Forecasting (1977-2015)", "MS": "Estimates of projected population.", "PM": "2016; see FORECASTING 1981-2015; for POPULATION GROWTH ESTIMATE see POPULATION GROWTH 1980-2015", "HN": "2016; use FORECASTING 1981-2015; for POPULATION GROWTH ESTIMATE use POPULATION GROWTH 1980-2015", "MR": "20150706", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000069457"}, {"RECTYPE": "D", "MH": "Ranolazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RS43285", "MN": "D03.383.606.841", "MH_TH": "USAN (1988)", "ST": "T121", "RN": "A6IEZ5M406", "RR": "F71253DJUN", "MS": "An acetanilide and piperazine derivative that functions as a SODIUM CHANNEL BLOCKER and prevents the release of enzymes during MYOCARDIAL ISCHEMIA. It is used in the treatment of ANGINA PECTORIS.", "PM": "2016; RANOLAZINE was indexed under ACETANILIDES and PIPERAZINES 1988-2015", "HN": "2016 (1988)", "MR": "20160426", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069458"}, {"RECTYPE": "D", "MH": "Teas, Herbal", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Herbal Teas|T168|NON|EQV|UNK (19XX)|850430|abcdef", "ENTRY": "Tisane", "MN": "J02.200.950", "MH_TH": "NLM (1991)", "ST": "T168", "RN": "0", "MS": "Beverages prepared from an infusion of plant tissues.", "PM": "2016; see BEVERAGES 1986-2015", "HN": "2016; use BEVERAGES 1986-2015", "MR": "20190708", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069459"}, {"RECTYPE": "D", "MH": "Teas, Medicinal", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "ENTRY": "Tea, Medicinal", "MN": "J02.200.975", "MH_TH": "UNK (19XX)", "ST": "T168", "MS": "Beverages used in TRADITIONAL MEDICINE that are prepared from the infusion of plant tissue (HERBAL TEA), and/or animal tissue or other organisms such as FUNGI.", "PM": "2016; see BEVERAGES 1986-2015", "HN": "2016; use BEVERAGES 1986-2015", "MR": "20190708", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000069460"}, {"RECTYPE": "D", "MH": "Bendamustine Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Bendamustine", "MN": "D03.633.100.103.123", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "981Y8SX18M", "RR": "9266D9P3PQ", "MS": "A nitrogen mustard compound that functions as an ALKYLATING ANTINEOPLASTIC AGENT and is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA and NON-HODGKIN'S LYMPHOMA.", "PM": "2016; BENDAMUSTINE HYDROCHLORIDE was indexed under NITROGEN MUSTARD COMPOUNDS 1982-2015 and under BENZIMIDAZOLES 1972-1982", "HN": "2016 (1972)", "MR": "20160527", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069461"}, {"RECTYPE": "D", "MH": "Dimethyl Fumarate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "compound, BG12", "MN": "D02.241.081.337.302.500", "MH_TH": "USAN (19XX)", "ST": "T109", "RN": "FO2303MNI2", "RR": "624-49-7 (dimethyl fumarate)", "MS": "A fumarate derivative that is used as a DERMATOLOGIC AGENT in the treatment of PSORIASIS and SKIN DISEASES. It also may be used as an IMMUNOSUPPRESSIVE AGENT in the treatment of MULTIPLE SCLEROSIS.", "PM": "2016; DIMETHYL FUMARATE was indexed under FUMARATES 1988-2015", "HN": "2016 (1988)", "MR": "20150626", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069462"}, {"RECTYPE": "D", "MH": "Olive Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Oils, Olive", "MN": "J02.500.375.400.500", "MH_TH": "NLM (2016)", "ST": "T168", "RN": "0", "PI": "Plant Oils (1986-2015)", "MS": "Oil extracted from fruit of the OLIVE TREE (genus Olea).", "PM": "2016; OLIVE OIL was indexed under PLANT OILS 1986-2015, and under OILS 1984-1986", "HN": "2016 (1984)", "MR": "20171208", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000069463"}, {"RECTYPE": "D", "MH": "Solifenacin Succinate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Succinate, Solifenacin", "MN": "D03.633.100.531.820.594", "MH_TH": "USAN (2001)", "ST": "T121", "RN": "KKA5DLD701", "RR": "A8910SQJ1U", "MS": "A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.", "PM": "2016; SOLIFENACIN SUCCINATE was indexed under QUINUCLIDINES and TETRAHYDROISOQUINOLINES 2003-2015; and under ISOQUINOLINES 2001-2003", "HN": "2016 (2001)", "MR": "20160531", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069464"}, {"RECTYPE": "D", "MH": "Febuxostat", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TEI6720", "MN": "D03.383.129.708.274", "MH_TH": "USAN (2002)", "ST": "T109", "N1": "5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl-", "RN": "101V0R1N2E", "RR": "144060-53-7", "MS": "A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT.", "PM": "2016; FEBUXOSTAT was indexed under THIAZOLES 1994-2015", "HN": "2016 (1994)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069465"}, {"RECTYPE": "D", "MH": "Red Meat", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Veal|T168|NON|NRW|NLM (2020)|190506|abcdef", "ENTRY": "Red Meats", "MN": "J02.500.600.813", "MH_TH": "NLM (2016)", "ST": "T168", "PI": "Meat (1975-2015)", "MS": "Meat such as beef, goat, pork, or lamb which contains more MYOGLOBIN than POULTRY or SEAFOOD.", "PM": "2016", "HN": "2016", "MR": "20191106", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069466"}, {"RECTYPE": "D", "MH": "Fecal Microbiota Transplantation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Intestinal Microbiota Transplantation|T061|NON|EQV|NLM (2022)|210524|abcdef", "ENTRY": "Transplants, Intestinal Microbiota", "MN": "E02.095.231", "MH_TH": "NLM (2016)", "ST": "T061", "MS": "Transfer of GASTROINTESTINAL MICROBIOTA from one individual to another by infusion of donor FECES to the upper or lower GASTROINTESTINAL TRACT of the recipient.", "PM": "2016", "HN": "2016", "MR": "20210707", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069467"}, {"RECTYPE": "D", "MH": "Desvenlafaxine Succinate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "WY45233", "MN": "D10.289.510.500.303", "MH_TH": "USAN (2006)", "ST": "T121", "RN": "ZB22ENF0XR", "RR": "NG99554ANW", "MS": "A cyclohexanol and phenol derivative and metabolite of venlafaxine that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.", "PM": "2016; DESVENLAFAXINE SUCCINATE was indexed under CYCLOHEXANOLS 1994-2015", "HN": "2016 (1994)", "MR": "20150707", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069468"}, {"RECTYPE": "D", "MH": "Medical-Surgical Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Medical-Surgical|T058|T091|NON|EQV|NLM (2016)|150522|abbcdef", "MN": "N02.421.533.475", "FX": "Operating Room Nursing", "MH_TH": "NLM (2016)", "ST": "T091", "MS": "The area of nursing concerned with the needs and care of adult medical and surgical patients.", "PM": "2016", "HN": "2016", "MR": "20150630", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069469"}, {"RECTYPE": "D", "MH": "Venlafaxine Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Wy45030", "MN": "D10.289.510.500.901", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "7D7RX5A8MO", "RR": "GRZ5RCB1QG", "MS": "A cyclohexanol and phenylethylamine derivative that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.", "PM": "2016; VENLAFAXINE HYDROCHLORIDE was indexed under CYCLOHEXANOLS 1986-2015", "HN": "2016 (1986)", "MR": "20150707", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069470"}, {"RECTYPE": "D", "MH": "Neurosurgeons", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Surgeons, Neurological", "MN": "N02.360.810.910.750", "MH_TH": "NLM (2016)", "ST": "T097", "MS": "Qualified medical professionals who specialize in surgical treatment of diseases of the BRAIN and other parts of the NERVOUS SYSTEM.", "PM": "2016", "HN": "2016", "MR": "20180629", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069471"}, {"RECTYPE": "D", "MH": "Colesevelam Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Colesevelam", "MN": "D02.455.326.271.122.100.500", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "P4SG24WI5Q", "RR": "1XU104G55N", "MS": "An allylamine derivative that binds BILE ACIDS in the intestine and is used as an ANTICHOLESTEREMIC AGENT in the treatment of HYPERCHOLESTEROLEMIA and HYPERLIPIDEMIAS.", "PM": "2016; COLESEVELAM HYDROCHLORIDE was indexed under ALLYLAMINE 1997-2015", "HN": "2016 (1997)", "MR": "20150707", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069472"}, {"RECTYPE": "D", "MH": "Radiation Dose Hypofractionation", "AQ": "ST", "ENTRY": "Radiotherapy Minibeam", "MN": "E02.815.639.200.500", "FX": "Radiation", "MH_TH": "NLM (2019)", "ST": "T061", "MS": "A treatment schedule in which the total dose of radiation is divided into large doses but fewer exposure times.", "PM": "2019; see Dose Hypofractionation 2016-2018", "HN": "2019(2016)", "MR": "20181105", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069473"}, {"RECTYPE": "D", "MH": "Sofosbuvir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "GS7977", "MN": "D13.695.827.919.877.500", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "WJ6CA3ZU8B", "MS": "A uridine monophosphate analog inhibitor of HEPATITIS C VIRUS (HCV) polymerase NS5B that is used as an ANTIVIRAL AGENT in the treatment of CHRONIC HEPATITIS C.", "PM": "2016; SOFOSBUVIR was indexed under URIDINE MONOPHOSPHATE 2010-2015", "HN": "2016 (2010)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069474"}, {"RECTYPE": "D", "MH": "Re-Irradiation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Reirradiation|T061|NON|EQV|NLM (2016)|150522|abcdef", "MN": "E02.887.500", "MH_TH": "NLM (2016)", "ST": "T061", "PI": "Radiotherapy (1965-2015)", "MS": "Treatment in which a repeat course of RADIOTHERAPY is administered.", "PM": "2016", "HN": "2016", "MR": "20150626", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069475"}, {"RECTYPE": "D", "MH": "Linagliptin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "1356, BI", "MN": "D03.633.100.786.563", "FX": "Sitagliptin Phosphate", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "3X29ZEJ4R2", "RR": "668270-12-0", "MS": "A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.", "PM": "2016; LINAGLIPTIN was indexed under PURINES and QUINAZOLINES 2011-2015", "HN": "2016 (2011)", "MR": "20160531", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069476"}, {"RECTYPE": "D", "MH": "Lisdexamfetamine Dimesylate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NRP 104", "MN": "D02.092.471.683.152.110.200.500", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "SJT761GEGS", "RR": "H645GUL8KJ", "MS": "A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.", "PM": "2016; LISDEXAMFETAMINE DIMESYLATE was indexed under DEXTROAMPHETAMINE 2006-2015", "HN": "2016 (2006)", "MR": "20150626", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069478"}, {"RECTYPE": "D", "MH": "Buprenorphine, Naloxone Drug Combination", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Naloxone, Buprenorphine", "MN": "D26.310.352", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESICS with naloxone, a NARCOTIC ANTAGONISTS to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIOID SUBSTITUTION THERAPY.", "PM": "2016; BUPRENORPHINE, NALOXONE DRUG COMBINATION was indexed under BUPRENORPHINE and NALOXONE 2006-2015", "HN": "2016 (2006)", "MR": "20190327", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069479"}, {"RECTYPE": "D", "MH": "Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Truvada|T114|T121|TRD|NRW|NLM (2004)|041103|abbcdef", "MN": "D26.310.423", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "A pharmaceutical preparation of emtricitabine and tenofovir that is used as an ANTI-HIV AGENT in the treatment and prevention of HIV INFECTIONS.", "PM": "2016; EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE DRUG COMBINATION was indexed under DEOXYCYTIDINE and ORGANOPHOSPHORUS COMPOUNDS 2005-2015", "HN": "2016 (2005)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069480"}, {"RECTYPE": "D", "MH": "Origin of Life", "PRINT ENTRY": "Prebiotic Chemical Evolution|T077|NON|EQV|NLM (2023)|211013|abcdef", "ENTRY": "Prebiotic Chemical Evolutions", "MN": "I01.076.368.584.542", "MH_TH": "UNK (19XX)", "ST": "T077", "PI": "Organelle Biogenesis (1978-2015)", "MS": "The process by which life began.", "PM": "2016; see BIOGENESIS 1978-2015", "HN": "2016 (1966)", "MR": "20220413", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000069497"}, {"RECTYPE": "D", "MH": "Ezetimibe, Simvastatin Drug Combination", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ezetimibe Simvastatin Combination", "MN": "D26.310.431", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "A pharmaceutical preparation of ezetimibe and simvastatin that is used in the treatment of HYPERCHOLESTEROLEMIA and HYPERLIPIDEMIAS.", "PM": "2016; ETIMIBE SIMVASTATIN DRUG COMBINATION was indexed under AZETIDINES and SIMVASTATIN 2004-2015", "HN": "2016 (2004)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069499"}, {"RECTYPE": "D", "MH": "Abiraterone Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Zytiga|T109|T121|TRD|NRW|NLM (2014)|US|121220|abbcdeef", "MN": "D04.210.500.054.079.065", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "EM5OCB9YJ6", "RR": "154229-18-2", "MS": "An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER.", "PM": "2016; ABIRATERONE ACETATE was indexed under ANDROSTENES 1994-2015", "HN": "2016 (1994)", "MR": "20160527", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069501"}, {"RECTYPE": "D", "MH": "Budesonide, Formoterol Fumarate Drug Combination", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Drug Combination, Budesonide-Formoterol", "MN": "D26.310.348", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.", "PM": "2016; BUDESONIDE, FORMOTEROL FUMARATE DRUG COMBINATION was indexed under ETHANOLAMINES and ADRENAL CORTEX HORMONES 2002-2015", "HN": "2016 (2002)", "MR": "20160527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069502"}, {"RECTYPE": "D", "MH": "Vilazodone Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Vilazodone", "MN": "D03.633.100.473.957", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "U8HTX2GK8J", "RR": "S239O2OOV3", "MS": "A benzofuran, indole, and piperazine derivative that functions as a SEROTONIN UPTAKE INHIBITOR and partial SEROTONIN 5-HT1 RECEPTOR AGONIST. It is used as an ANTIDEPRESSIVE AGENT.", "PM": "2016; VILAZODONE HYDROCHLORIDE was indexed under INDOLES; PIPERAZINES; and BENZOFURANS 2004-2015", "HN": "2016 (2004)", "MR": "20220718", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069503"}, {"RECTYPE": "D", "MH": "International Law", "AQ": "ED ES HI", "ENTRY": "Laws, International", "MN": "N03.706.535.533", "FX": "Internationality", "MH_TH": "NLM (2016)", "ST": "T089", "MS": "The body of law that governs the legal relations between or among sovereign states or nations.", "PM": "2016", "HN": "2016", "MR": "20150630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069516"}, {"RECTYPE": "D", "MH": "Blog", "PRINT ENTRY": "Weblog|T170|NON|EQV|NLM (2022)|200716|abcdef", "ENTRY": "Weblogs|T170|NON|EQV|NLM (2016)|150528|abcdef", "MN": "V02.530.150.250", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Blogs as a subject are indexed under the main heading BLOGGING. INDEXER: Do not use", "PI": "Blogging  (2010-2015)", "MS": "A website that contains conversational personal reflections, comments and sometimes links to other sites; typically run by an individual or small group.", "HN": "2016", "MR": "20210630", "DA": "20150701", "DC": "2", "DX": "20160101", "UI": "D000069520"}, {"RECTYPE": "D", "MH": "Adult Day Care Centers", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Day Care Centers, Adult|T092|NON|EQV|NLM (2016)|150610|abcdef", "MN": "N02.421.143.065", "MH_TH": "NLM (2016)", "ST": "T092", "PI": "Day Care, Medical (1981-2015)", "MS": "Non-residential facilities that are designed to provide care and companionship for seniors who need assistance or supervision during the day.", "PM": "2016", "HN": "2016", "MR": "20191118", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069537"}, {"RECTYPE": "D", "MH": "Infectious Encephalitis", "DE": "INFECT ENCEPH", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Infections, Encephalitis", "MN": "C10.586.250.520", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coordinate with specific organism/infection term; note ENCEPHALITIS, VIRAL is available ", "PI": "Encephalitis (1964-2015)", "MS": "Brain inflammation caused by an infectious agent.", "PM": "2016; see ENCEPHALITIS 1964-2015", "HN": "2016; use ENCEPHALITIS 1964-2015", "MR": "20210630", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000069544"}, {"RECTYPE": "D", "MH": "Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Genvoya|T109|T121|TRD|NRW|NLM (2021)|200309|abbcdef", "ENTRY": "Pill, Quad", "MN": "D26.310.391", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "0", "MS": "A pharmaceutical preparation of the ANTI-HIV AGENTS elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate that is used in the treatment of HIV INFECTIONS.", "PM": "2016; ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE was indexed under CARBAMATES; DEOXYCITIDINE; THIAZOLES; QUINOLONES and ORGANOPHOSPHONATES 2012-2015", "HN": "2016 (2012)", "MR": "20200527", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069545"}, {"RECTYPE": "D", "MH": "Cobicistat", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "9350, GS", "MN": "D03.383.129.708.189", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "LW2E03M5PG", "MS": "A carbamate and thiazole derivative that functions as a CYTOCHROME P450 CYP3A INHIBITOR to enhance the concentration of ANTI-HIV AGENTS, with which it is used in combination, for the treatment of HIV INFECTIONS.", "PM": "2016; COBICISTAT was indexed under CARBAMATES and THIAZOLES 2011-2015", "HN": "2016 (2011)", "MR": "20160528", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069547"}, {"RECTYPE": "D", "MH": "Ustekinumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Stelara|T116|T121|T129|TRD|NRW|NLM (2016)|150604|abbbcdef", "MN": "D12.776.377.715.548.114.224.200.937", "FX": "Interleukin-23", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "FU77B4U5Z0", "MS": "A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.", "PM": "2016; USTEKINUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015; and under ANTIBODIES, MONOCLONAL 2005-2011", "HN": "2016 (2005)", "MR": "20170620", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069549"}, {"RECTYPE": "D", "MH": "Machine Learning", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Transfer Learning|T066|NON|NRW|NLM (2020)|190307|abcdef", "ENTRY": "Learning, Transfer", "MN": "L01.224.050.375.530", "MH_TH": "NLM (2016)", "ST": "T066", "MS": "A type of ARTIFICIAL INTELLIGENCE that enable COMPUTERS to independently initiate and execute LEARNING when exposed to new data.", "PM": "2016; see ARTIFICIAL INTELLIGENCE 1997-2015", "HN": "2016; use ARTIFICIAL INTELLIGENCE 1997-2015", "MR": "20190429", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000069550"}, {"RECTYPE": "D", "MH": "Environmental Psychology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychology, Environmental", "MN": "F04.096.628.033", "FX": "Environmental Medicine", "MH_TH": "NLM (2016)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "MS": "The field that studies interactions between individuals and the built and natural environment. It includes investigating behaviors that inhibit or foster sustainable, climate-healthy, and nature-enhancing choices.", "PM": "2016", "HN": "2016", "MR": "20150701", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069551"}, {"RECTYPE": "D", "MH": "Rivaroxaban", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "BAY 597939", "MN": "D03.383.903.727", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "9NDF7JZ4M3", "MS": "A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM.  It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.", "PM": "2016; RIVAROXABAN was indexed under MORPHOLINES and THIOPHENES 2005-2015", "HN": "2016 (2005)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069552"}, {"RECTYPE": "D", "MH": "Supervised Machine Learning", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Semi supervised Learning", "MN": "L01.224.050.375.530.500", "FX": "Unsupervised Machine Learning", "MH_TH": "NLM (2016)", "ST": "T066", "MS": "A MACHINE LEARNING paradigm used to make predictions about future instances based on a given set of labeled paired input-output training (sample) data.", "PM": "2016", "HN": "2016", "MR": "20170703", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069553"}, {"RECTYPE": "D", "MH": "Injection, Intratympanic", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Transtympanic Administrations", "MN": "E02.319.267.530.655", "MH_TH": "NLM (2016)", "ST": "T061", "PI": "Injections (1968-2015)", "MS": "The administration of  liquid substances into the TYMPANIC CAVITY with a hypodermic syringe.", "PM": "2016", "HN": "2016", "MR": "20150626", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069555"}, {"RECTYPE": "D", "MH": "Travoprost", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Z, Travatan", "MN": "D23.469.700.670.175.500", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "WJ68R08KX9", "RR": "157283-68-6", "MS": "A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.", "PM": "2016; TRAVOPROST was indexed under CLOPROSTENOL 2001-2015", "HN": "2016 (2001)", "MR": "20150626", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069557"}, {"RECTYPE": "D", "MH": "Unsupervised Machine Learning", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Machine Learning, Unsupervised", "MN": "L01.224.050.375.530.750", "FX": "Supervised Machine Learning", "MH_TH": "NLM (2016)", "ST": "T066", "MS": "A MACHINE LEARNING paradigm used to make predictions about future instances based on a given set of unlabeled paired input-output training (sample) data.", "PM": "2016", "HN": "2016", "MR": "20170703", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069558"}, {"RECTYPE": "D", "MH": "Loteprednol Etabonate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Etabonate, Loteprednol", "MN": "D04.210.500.054.079.129.284", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "YEH1EZ96K6", "RR": "82034-46-6", "MS": "An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions.", "PM": "2016; LOTEPREDNOL ETABONATE was indexed under ANDROSTADIENES 1990-2015", "HN": "2016 (1990)", "MR": "20160531", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069559"}, {"RECTYPE": "D", "MH": "Health Equity", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Equity, Health", "MN": "N05.300.430.383", "MH_TH": "NLM (2016)", "ST": "T080", "MS": "Opportunity to attain full health potential and no one is disadvantaged from achieving this potential because of their social position or other socially determined circumstance.", "PM": "2016", "HN": "2016", "MR": "20150629", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069576"}, {"RECTYPE": "D", "MH": "Morcellation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "MN": "E04.502.648", "MH_TH": "NLM (2016)", "ST": "T061", "PI": "Minimally Invasive Surgical Procedures (2000-2015)", "MS": "Use of a non-cautery\u2013dependent mechanical device that simultaneously cuts and aspirates polyp and/or myoma tissue.", "PM": "2016", "HN": "2016", "MR": "20150629", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069577"}, {"RECTYPE": "D", "MH": "Waterborne Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Waterborne Disease", "MN": "C01.936", "MH_TH": "NLM (2016)", "ST": "T047", "MS": "Illnesses due to micro-organisms and chemicals in drinking water, those caused by organisms having part of their lifecycle in water or those with water-related vectors, and others spread by aerosols containing pathogens.", "PM": "2016", "HN": "2016", "MR": "20190617", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069578"}, {"RECTYPE": "D", "MH": "Ranibizumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "V2, RhuFab", "MN": "D12.776.377.715.548.114.224.200.868", "FX": "Vascular Endothelial Growth Factor A", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "ZL1R02VT79", "RR": "347396-82-1", "MS": "A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION.", "PM": "2016; RANIBIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015; and under ANTIBODIES, MONOCLONAL 2005-2011", "HN": "2016 (2005)", "MR": "20170410", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069579"}, {"RECTYPE": "D", "MH": "Bimatoprost", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "192024, AGN", "MN": "D23.469.700.670.175.250", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-", "RN": "QXS94885MZ", "RR": "155206-00-1", "MS": "A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.", "PM": "2016; BIMATOPROST was indexed under AMIDES and CLOPROSTENOL 2001-2015", "HN": "2016 (2001)", "MR": "20150626", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069580"}, {"RECTYPE": "D", "MH": "Exposure to Violence", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Violence, Exposure to", "MN": "I01.880.735.900.869", "MH_TH": "NLM (2016)", "ST": "T054", "MS": "Experience of and exposure to VIOLENCE.", "PM": "2016", "HN": "2016", "MR": "20150629", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069581"}, {"RECTYPE": "D", "MH": "Eszopiclone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Lunesta|T109|T121|TRD|NRW|NLM (2005)|050501|abbcdef", "MN": "D03.383.725.322", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "(+)-(5S)-6(chloropyridine-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)-pyrazin-5-yl-4-methyl-piperazine-1-carboxylate", "RN": "UZX80K71OE", "RR": "138729-47-2", "MS": "A pyridine, pyrazine, and piperazine derivative that is used as a HYPNOTIC AND SEDATIVE in the treatment of INSOMNIA.", "PM": "2016; ESZOPICLONE was indexed under PIPERAZINES and AZABICYCLO COMPOUNDS 2007-2015", "HN": "2016 (2007)", "MR": "20160531", "DA": "20150706", "DC": "1", "DX": "20160101", "UI": "D000069582"}, {"RECTYPE": "D", "MH": "Pregabalin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "GABA, 3-isobutyl", "MN": "D12.125.190.350.450", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "55JG375S6M", "RR": "148553-50-8", "MS": "A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.", "PM": "2016; PREGABALIN was indexed under GAMMA-AMINOBUTYRIC ACID 1993-2015", "HN": "2016 (1993)", "MR": "20150626", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069583"}, {"RECTYPE": "D", "MH": "Unilateral Breast Neoplasms", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Unilateral Breast Cancers", "MN": "C17.800.090.500.682", "MH_TH": "NLM (2016)", "ST": "T191", "AN": "human only; coordinate IM with histological type of neoplasm (IM)", "PI": "Breast Neoplasms (1977-2015)", "MS": "Tumors or cancer found specifically in one human BREAST, but not in both.", "PM": "2016", "HN": "2016", "MR": "20180630", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069584"}, {"RECTYPE": "D", "MH": "Filgrastim", "AQ": "AA AD AE AN BI CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Tbo Filgrastim", "MN": "D23.529.374.410.240.350.500", "MH_TH": "USAN (1990)", "ST": "T129", "RN": "PVI5M0M1GW", "RR": "121181-53-1", "MS": "A recombinant granulocyte colony-stimulating factor (G-CSF) that is used in the treatment and prevention of NEUTROPENIA, preparation and collection of blood progenitor cells, and for use in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION.", "PM": "2016; FILGRASTIM was indexed under GRANULOCYTE COLONY-STIMULATING FACTOR 2011-2015", "HN": "2016 (2011)", "MR": "20230316", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069585"}, {"RECTYPE": "D", "MH": "Adult Survivors of Child Adverse Events", "AQ": "CL HI LJ PX SN", "ENTRY": "Adult Survivors of Childhood Trauma|T101|NON|EQV|NLM (2016)|150630|abcdef", "MN": "M01.860.300", "MH_TH": "NLM (2016)", "ST": "T101", "MS": "Persons who experienced traumatic events during childhood.", "PM": "2016", "HN": "2016", "MR": "20150630", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069586"}, {"RECTYPE": "D", "MH": "Round Ligaments", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Round Ligament|T023|NON|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Oblique Cords", "MN": "A10.165.669.901", "MH_TH": "NLM (2016)", "ST": "T023", "PI": "Ligaments (1966-2015)", "MS": "Cord-like fibrous tissue structure that connects two articular extremities of bones, ligaments and /or cartilages.", "PM": "2016; ROUND LIGAMENT now ROUND LIGAMENT OF UTERUS, was a heading 1991-2015", "HN": "2016", "MR": "20170620", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D000069590"}, {"RECTYPE": "D", "MH": "Round Ligament of Liver", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Round Ligaments, Hepatic", "MN": "A10.165.669.901.750", "MH_TH": "NLM (2016)", "ST": "T023", "PI": "Ligaments (1963-2015)", "MS": "A cord-like remnant structure formed from the closed left fetal UMBILICAL VEIN. It is located along the lower edge of the falciform ligament.", "MR": "20170620", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000069592"}, {"RECTYPE": "D", "MH": "Round Ligament of Femur", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ligamentum Teres Femori", "MN": "A10.165.669.901.500", "MH_TH": "NLM (2016)", "ST": "T023", "PI": "Ligaments (1963-2015)", "MS": "Ligament that connects the fovea of the FEMUR HEAD and the ACETABULUM notch in the HIP JOINT.", "MR": "20170620", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000069593"}, {"RECTYPE": "D", "MH": "Abatacept", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Immunoconjugate, CTLA4-Ig", "MN": "D12.776.377.715.548.114.580.225", "FX": "CTLA-4 Antigen", "MH_TH": "USAN (2004)", "ST": "T129", "RN": "7D0YB67S97", "RR": "332348-12-6", "MS": "A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS.", "PM": "2016; ABATACEPT was indexed under IMMUNOCONJUGATES 2002-2015", "HN": "2016 (2002)", "MR": "20200228", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069594"}, {"RECTYPE": "D", "MH": "Presenteeism", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Presence, Sickness", "MN": "F04.096.628.779.450", "MH_TH": "NLM (2016)", "ST": "T091", "MS": "Reporting for work despite feeling ill.", "PM": "2016", "HN": "2016", "MR": "20150629", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069597"}, {"RECTYPE": "D", "MH": "Crop Production", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Production, Crop", "MN": "J01.040.227", "MH_TH": "NLM (2016)", "ST": "T090", "PI": "Agriculture (1978-2015)", "MS": "The science and practice of cultivating PLANTS that have economic value to man. It includes plant breeding, seed production, weeding, use of fertilizers, harvesting, storage, transportation, and marketing.", "PM": "2016", "HN": "2016", "MR": "20150629", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069599"}, {"RECTYPE": "D", "MH": "Plant Breeding", "AQ": "EC HI LJ MT SN ST", "ENTRY": "Breeding, Plant", "MN": "J01.040.227.500", "MH_TH": "NLM (2016)", "ST": "T040", "MS": "The purposeful manipulation of plant species with the goal of creating desired genotypes and phenotypes, using techniques such as controlled pollination and or genetic engineering, followed by artificial selection of progeny.", "PM": "2016", "HN": "2016", "MR": "20150629", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069600"}, {"RECTYPE": "D", "MH": "Crop Protection", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Protection, Crop", "MN": "J01.040.237", "MH_TH": "NLM (2016)", "ST": "T068", "MS": "The science and practice of preventing, minimizing, or eliminating damage to AGRICULTURAL CROPS by pest organisms, weeds, and disease-causing agents.", "PM": "2016", "HN": "2016", "MR": "20150629", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069601"}, {"RECTYPE": "D", "MH": "Working Poor", "AQ": "CL EC ED EH ES HI LJ PC PX SN TD", "ENTRY": "Poor, Working", "MN": "M01.987", "FX": "Poverty Areas", "MH_TH": "NLM (2016)", "ST": "T102", "PI": "Poverty (1975-2015)", "MS": "People who are in the labor force either working or looking for work for 27 weeks or more in a year, but whose income fall below a given poverty line.", "PM": "2016", "HN": "2016", "MR": "20150629", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069602"}, {"RECTYPE": "D", "MH": "Sevelamer", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Sevelamer", "MN": "D02.092.782.634", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "poly(allylamine-co-N,N'-diallyl-1,3-diamino-2-hydroxypropane)", "RN": "9YCX42I8IU", "RR": "845273-93-0", "PI": "Polyethylene (2000-2015)", "MS": "A polymeric amine that binds phosphate and is used to treat HYPERPHOSPHATEMIA in patients with kidney disease.", "PM": "2016; SEVELAMER was indexed under POLYAMINES 2006-2015, and under EPOXY COMPOUNDS and POLYETHYLENES 2000-2005", "HN": "2016 (2000)", "MR": "20150709", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000069603"}, {"RECTYPE": "D", "MH": "Dabigatran", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Mesylate, Dabigatran Etexilate", "MN": "D03.633.100.103.280", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "I0VM4M70GC", "RR": "SC7NUW5IIT", "MS": "A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of  thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.", "PM": "2016; DABIGATRAN was indexed under BENZIMIDOAZOLES and BETA-ALANINE 2010-2015; DABIGATRAN ETEXILATE was indexed under BENZIMIDOAZOLES and PYRIDINES 2002-2015", "HN": "2016 (2002)", "MR": "20160528", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000069604"}, {"RECTYPE": "D", "MH": "Olopatadine Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "KW4943A", "MN": "D03.633.300.382.696", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "2XG66W44KF", "RR": "D27V6190PM", "MS": "An antihistamine with mast-cell stabilizing properties used as eye drops in the treatment of ALLERGIC CONJUNCTIVITIS.", "PM": "2016; OLOPATADINE HYDROCHLORIDE was indexed under DIBENZOXEPINS1992-2015", "HN": "2016 (1992)", "MR": "20160531", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000069605"}, {"RECTYPE": "D", "MH": "Simeprevir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "435350, TMC", "MN": "D03.633.300.819", "MH_TH": "NLM (2016)", "ST": "T121", "RN": "9WS5RD66HZ", "MS": "Oral HCV-PROTEASE INHIBITOR effective against hepatitis C virus (HCV) serine protease NS3/4A. It is used in the treatment of chronic hepatitis C (Antivirals) genotype 1 infection in adults with compensated liver disease, including CIRRHOSIS.", "PM": "2016; SIMEPREVIR was indexed under SULFONAMIDES and HETEROCYCLIC COMPOUNDS, 3-RING 2008-2015", "HN": "2016 (2008)", "MR": "20160531", "DA": "20150710", "DC": "1", "DX": "20160101", "UI": "D000069616"}, {"RECTYPE": "D", "MH": "Pedestrians", "AQ": "CL ED HI LJ PX SN", "MN": "M01.665", "MH_TH": "NLM (2016)", "ST": "T098", "MS": "Persons traveling on foot.", "PM": "2016", "HN": "2016", "MR": "20160705", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D000069636"}, {"RECTYPE": "D", "MH": "Undocumented Immigrants", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Workers, Undocumented", "MN": "M01.189.500", "MH_TH": "NLM (2016)", "ST": "T098", "PI": "Transients and Migrants (1981-2015)", "MS": "Foreign nationals residing in a country without legal immigration status, or in violation of the immigration laws of that country.", "PM": "2016", "HN": "2016", "MR": "20200618", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D000069756"}, {"RECTYPE": "D", "MH": "Adipose Tissue, Beige", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tissues, Brite Adipose", "MN": "A10.165.114.161", "MH_TH": "NLM (2017)", "ST": "T024", "PI": "Adipose Tissue, Brown (2013-2016)", "MS": "Brown fat-like adipose tissue that develops in WHITE ADIPOSE TISSUE from non-MYOGENIC REGULATORY FACTOR 5 expressing cell lineage.", "PM": "2017", "HN": "2017", "MR": "20160115", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000069796"}, {"RECTYPE": "D", "MH": "Adipocytes, Beige", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Fat Cells, Brite", "MN": "A11.329.114.125", "MH_TH": "NLM (2017)", "ST": "T025", "PI": "Adipose Tissue, Brown (2012-2016)", "MS": "Brown fat-like cells that develop in the WHITE FAT from non-MYOGENIC REGULATORY FACTOR 5 expressing CELL LINEAGE.", "PM": "2017", "HN": "2017", "MR": "20160616", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000069797"}, {"RECTYPE": "D", "MH": "SEC Translocation Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SecYEG Translocation Channel|T116|NON|NRW|NLM (2021)|191118|abcdef", "ENTRY": "Translocons, SEC", "MN": "D12.776.543.585.875", "MH_TH": "NLM (2017)", "ST": "T116", "RN": "0", "PI": "Membrane Transport Proteins (1999-2016)", "MS": "Universally conserved multiprotein complexes that form the protein transport channel of the general secretory (SEC) pathway. The SEC translocase is present in all bacteria, archaea, and eukaryotes. It is in the ENDOPLASMIC RETICULUM membrane of eukaryotic cells, in the THYLAKOID MEMBRANE in CHLOROPLASTS and in some protozoa in the INNER MITOCHONDRIAL MEMBRANE.", "PM": "2017; SEC61 PROTEIN was indexed under SEC TRANSLOCATION CHANNELS 2016-2017 and MEMBRANE PROTEINS 1992-2016", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069816"}, {"RECTYPE": "D", "MH": "Degloving Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Wounds, Degloving", "MN": "C26.808.500", "MH_TH": "NLM (2017)", "ST": "T037", "MS": "Avulsions of the superficial tissues of SKIN and SUBCUTANEOUS TISSUE from the underlying FASCIA.", "PM": "2017", "HN": "2017", "MR": "20160617", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069836"}, {"RECTYPE": "D", "MH": "Staghorn Calculi", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Staghorn Calculus", "MN": "C23.300.175.850.550.500", "FX": "Struvite", "MH_TH": "NLM (2017)", "ST": "T046", "PI": "Kidney Calculi (1963-2016)", "MS": "Renal calculi with a characteristic shape like antlers of a deer, formed as it extends into multiple calices of the RENAL PELVIS. A large number of staghorn calculi as well as other URINARY CALCULI are composed of STRUVITE.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069856"}, {"RECTYPE": "D", "MH": "Struvite", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Struvite Crystal|T197|NON|NRW|NLM (2021)|191122|abcdef", "ENTRY": "Crystals, Struvite", "MN": "D01.695.625.675.650.887", "FX": "Staghorn Calculi", "MH_TH": "NLM (2017)", "ST": "T197", "RN": "AW3EJL1462", "RR": "7785-21-9 (H3PO4-NH4-Mg[1:1:1])", "PI": "Phosphates (1963-2016)", "MS": "The mineral magnesium ammonium phosphate with the formula NH4MgPO4. It is associated with urea-splitting organisms in a high magnesium, high phosphate, alkaline environment. Accumulation of crystallized struvite is found in the urinary tract as struvite CALCULI and as scale on sewage system equipment and wastewater pipes.", "PM": "2017; STRUVITE was indexed under MAGNESIUM COMPOUNDS 1994-2016, AMMONIUM COMPOUNDS 1974-1981, MAGNESIUM 1974-1983, and under PHOSPHATES 1974-2016", "HN": "2017 (1974)", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069877"}, {"RECTYPE": "D", "MH": "Transcription Activator-Like Effector Nucleases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TALEN|T116|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Transcription Activator Like Effector Nucleases", "MN": "D12.776.828.300.850", "MH_TH": "NLM (2017)", "ST": "T116", "RN": "EC 3.1.-", "MS": "Artificial nucleases that cleave DNA at a defined distance from specific DNA sequences recognized by TRANSCRIPTION ACTIVATOR-LIKE EFFECTORS. They are composed of an endodeoxyribonuclease fused to DNA-binding domains of the transcription activator-like effectors.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069896"}, {"RECTYPE": "D", "MH": "Endoscopic Mucosal Resection", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Submucosal Tunneling Endoscopic Resection|T061|NON|REL|NLM (2022)|200902|abcdef", "ENTRY": "Submucosal Dissection, Endoscopic", "MN": "E04.502.250.250.250.230", "MH_TH": "NLM (2017)", "ST": "T061", "MS": "A method for removing lesions from gastrointestinal MUCOUS MEMBRANES. The mucosal  tissue with the lesion is elevated by injecting a solution into the submucosal layer underneath it. The elevated tissue with the lesion is then cut out.", "PM": "2017", "HN": "2017", "MR": "20210305", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069916"}, {"RECTYPE": "D", "MH": "Chocolate", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Powders, Cocoa", "MN": "J02.500.195", "MH_TH": "UNK (19XX)", "ST": "T168", "PI": "Cacao (1963-2016)", "MS": "Food product prepared from fermenting, roasting, and grinding seeds of the COCOA plant.", "PM": "2017;  see  CACAO 1963-2016", "HN": "2017; use CACAO 1963-2016", "MR": "20180619", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069956"}, {"RECTYPE": "D", "MH": "Bacillus licheniformis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.158.218.376", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1402", "PI": "Bacillus (1963-2016)", "MS": "A species of  Bacillus that occurs in soil and is frequently found on bird feathers. Some strains cause FOODBORNE DISEASE, whereas other strains produce ANTIFUNGAL AGENTS and ANTIBACTERIAL AGENTS and function as PROBIOTICS. This species can also produce enzymes for industrial applications.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069976"}, {"RECTYPE": "D", "MH": "Bacillus amyloliquefaciens", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.158.218.076", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1390", "PI": "Bacillus (1967-2016)", "MS": "A non-pathogenic species of Bacillus that occurs in soil as well as some fermented vegetables and FERMENTED DAIRY PRODUCTS. It produces BACTERIOCINS and ANTIFUNGAL AGENTS and is used in FOOD PRESERVATION as well as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069977"}, {"RECTYPE": "D", "MH": "Bifidobacterium longum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.100.500", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid216816", "PI": "Bifidobacterium (1983-2016)", "MS": "A species of Bifidobacterium that occurs in the human GASTROINTESTINAL TRACT and VAGINA. It inhibits the growth of pathogenic bacteria, may modulate the immune response, and is used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069978"}, {"RECTYPE": "D", "MH": "Bacillus pumilus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.158.218.613", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1408", "PI": "Bacillus (1963-2016)", "MS": "A species of Bacillus that occurs in soil, especially around the roots of some plants where it has anti-fungal and anti-nematode activities. It can also produce enzymes for industrial applications.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069979"}, {"RECTYPE": "D", "MH": "Lacticaseibacillus paracasei", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Lactobacillus paracasei|T007|NON|EQV|NLM (2017)|150813|abcdef", "MN": "B03.510.550.450.606.750", "MH_TH": "NLM (2023)", "ST": "T007", "RN": "txid1597", "PI": "Lactobacillus (1992-2016)", "MS": "A species of Lacticaseibacillus that occurs in the GUT MICROBIOTA of healthy humans as well as FERMENTED DAIRY PRODUCTS and fermented vegetables. It is used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20220712", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069980"}, {"RECTYPE": "D", "MH": "Escherichia coli O104", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Escherichia coli O104-H4|T007|NON|NRW|NLM (2017)|150814|abcdef", "MN": "B03.660.250.150.180.100.800.250.250", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid2072453", "RR": "txid1038927", "AN": "infection: coordinate IM with ESCHERICHIA COLI INFECTIONS (IM)", "PI": "Escherichia coli Infections (2001-2016)", "MS": "An enterohemorrhagic Escherichia coli of the O subfamily that can cause severe FOODBORNE DISEASE. The H4 serotype strain produces SHIGA TOXINS and has been linked to human disease outbreaks, including some cases of HEMOLYTIC-UREMIC SYNDROME, resulting from contamination of foods by feces containing E. coli O104.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069981"}, {"RECTYPE": "D", "MH": "Bifidobacterium animalis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Bifidobacterium lactis|T007|NON|EQV|NLM (2017)|150814|abcdef", "MN": "B03.510.460.400.400.049.100.250", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid28025", "RR": "txid552531", "PI": "Bifidobacterium (1992-2016)", "MS": "A species of Bifidobacterium that occurs in the LARGE INTESTINE of humans and other mammals and in FERMENTED DAIRY PRODUCTS. It is used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069982"}, {"RECTYPE": "D", "MH": "Saccharomyces boulardii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "boulardius, Saccharomyces", "MN": "B01.300.930.705.328", "MH_TH": "NLM (2017)", "ST": "T004", "RN": "txid252598", "PI": "Saccharomyces (1982-2016)", "MS": "A species of Saccharomyces that is used as a PROBIOTIC, such as in the treatment of DIARRHEA and PSEUDOMEMBRANOUS ENTEROCOLITIS associated with CLOSTRIDIUM INFECTIONS.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069983"}, {"RECTYPE": "D", "MH": "Bifidobacterium breve", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.100.375", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1685", "PI": "Bifidobacterium (1984-2016)", "MS": "A species of Bifidobacterium present in the human GUT MICROBIOTA. It is used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069984"}, {"RECTYPE": "D", "MH": "Bifidobacterium bifidum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.100.313", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1681", "PI": "Bifidobacterium (1984-2016)", "MS": "A species of Bifidobacterium that occurs in the human GASTROINTESTINAL TRACT, especially in infants, and in FERMENTED DAIRY PRODUCTS. It produces BACTERIOCINS and is used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069985"}, {"RECTYPE": "D", "MH": "Ligilactobacillus salivarius", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Lactobacillus salivarius|T007|NON|EQV|NLM (2017)|150817|abcdef", "MN": "B03.510.550.450.689", "MH_TH": "NLM (2023)", "ST": "T007", "RN": "txid1624", "PI": "Lactobacillus (1963-2016)", "MS": "A species of Lactobacillus that occurs in the human GASTROINTESTINAL TRACT and ORAL MUCOSA. It produces BACTERIOCINS and is used as a PROBIOTIC.", "PM": "2023; see LACTOBACILLUS SALIVARIUS 2017-2022", "HN": "2023(2017)", "MR": "20221031", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069996"}, {"RECTYPE": "D", "MH": "Mastic Resin", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Resin, Mastic", "MN": "D20.215.721.500.626", "FX": "Gum Arabic", "MH_TH": "NLM (2017)", "ST": "T121", "RN": "0", "PI": "Resins, Plant (2003-2016)", "MS": "Dried tree sap from the MASTIC TREE that is used in TRADITIONAL MEDICINE and chewed as gum.", "PM": "2017; GUM MASTIC was indexed under RESINS, PLANT 2003-2016, and under PLANT EXTRACTS 1985-2002", "HN": "2017 (1985)", "MR": "20160622", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069997"}, {"RECTYPE": "D", "MH": "Lactobacillus gasseri", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.450.475.363", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1596", "PI": "Lactobacillus (1984-2016)", "MS": "A species of Lactobacillus that occurs in the human ORAL MUCOSA; GASTROINTESTINAL TRACT; and VAGINA. It produces BACTERIOCINS, can modulate the immune response, and is used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069998"}, {"RECTYPE": "D", "MH": "Lactobacillus johnsonii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.450.475.453", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid33959", "PI": "Lactobacillus (1992-2016)", "MS": "A species of Lactobacillus that occurs in the human GASTROINTESTINAL TRACT and VAGINA. It produces BACTERIOCINS and HYDROGEN PEROXIDE and is used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000069999"}, {"RECTYPE": "D", "MH": "Acebutolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NovoAcebutolol", "MN": "D02.092.063.624.698.025", "PA": "Sympathomimetics", "MH_TH": "USAN (1973)", "ST": "T121", "N1": "Butanamide, N-(3-acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-, (+-)-", "RN": "67P356D8GH", "RR": "B025Y34C54", "PI": "Propylamines (1974)", "MS": "A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.", "PM": "75", "HN": "75", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D000070"}, {"RECTYPE": "D", "MH": "Bacillus coagulans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Lactobacillus sporogenes|T007|NON|EQV|NLM (2017)|150818|abcdef", "MN": "B03.510.460.410.158.218.314", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1398", "PI": "Bacillus (1963-2016)", "MS": "A microaerophilic, LACTIC ACID producing species of Bacillus that occurs in FERMENTED FOODS. It also produces ANTI-INFECTIVE AGENTS and is used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20210712", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070000"}, {"RECTYPE": "D", "MH": "Streptococcus salivarius", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872.663", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1304", "PI": "Streptococcus (1963-2016)", "MS": "A species of Streptococcus that occurs in the human oral cavity and upper respiratory tract. It is a constituent of DENTAL PLAQUE and some strains may be pathogenic if they enter the bloodstream. However, other strains such as Streptococcus salivarius K12 produce BACTERIOCINS and are used as PROBIOTICS.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070001"}, {"RECTYPE": "D", "MH": "Propionibacterium freudenreichii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.600.600.800", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1744", "PI": "Propionibacterium (1963-2016)", "MS": "A species of Propionibacterium that occurs in raw milk and cheese. It produces ANTI-INFECTIVE AGENTS and ANTI-INFLAMMATORY AGENTS and is used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070002"}, {"RECTYPE": "D", "MH": "Lactobacillus crispatus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.450.475.238", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid47770", "PI": "Lactobacillus (1995-2016)", "MS": "A species of Lactobacillus that occurs in the human GASTROINTESTINAL TRACT and the VAGINA of healthy women. It produces LACTIC ACID and HYDROGEN PEROXIDE, and is used as a PROBIOTIC. It is also used for the treatment and prevention of BACTERIAL VAGINOSIS.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070003"}, {"RECTYPE": "D", "MH": "Ocimum sanctum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Holy Basils", "MN": "B01.875.800.575.912.250.583.520.647.750", "MH_TH": "NLM (2017)", "ST": "T002", "RN": "txid204149", "PI": "Ocimum (1995-2016)", "MS": "A plant species of the genus OCIMUM, family LAMIACEAE that has been used in TRADITIONAL MEDICINE.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070004"}, {"RECTYPE": "D", "MH": "Bifidobacterium adolescentis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.100.125", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1680", "PI": "Bifidobacterium (1984-2016)", "MS": "A species of Bifidobacterium that occurs in the GASTROINTESTINAL TRACT of mammals and healthy humans from birth until late adulthood. It produces ANTI-VIRAL AGENTS and ANTI-INFLAMMATORY AGENTS and is used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070005"}, {"RECTYPE": "D", "MH": "Pediococcus pentosaceus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.450.737.750", "FX": "Probiotics", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1255", "PI": "Pediococcus (1963-2016)", "MS": "A species of Pediococcus that occurs in FERMENTED FOODS where its ability to produce LACTIC ACID and PEDIOCINS make it useful as a FOOD PRESERVATION agent. It is also used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20210712", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070006"}, {"RECTYPE": "D", "MH": "Leuconostoc mesenteroides", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.475.450.500", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1245", "PI": "Leuconostoc (1963-2016)", "MS": "A species of Leuconostoc that occurs on fruits and vegetables and in their fermented products, as well as FERMENTED DAIRY PRODUCTS. It produces LACTIC ACID and BACTERIOCINS and is used as a PROBIOTIC; however, it has also caused infections in immunocompromised patients.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070007"}, {"RECTYPE": "D", "MH": "Pediococcus acidilactici", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.450.737.500", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1254", "PI": "Pediococcus (1975-2016)", "MS": "A species of Pediococcus that occurs in FERMENTED FOODS where its ability to produce LACTIC ACID and PEDIOCINS makes it useful in FOOD PRESERVATION. It is also used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20210712", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070016"}, {"RECTYPE": "D", "MH": "Pediocins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pediocin|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "MN": "D12.776.543.695.110.850", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Bacteriocins (1990-2016)", "MS": "Bacteriocins produced by species of PEDIOCOCCUS. They range from 3.5-4.6 kDa in mass, contain a conserved YGNGVXCXK motif and beta sheet at their N-terminals, and a more diverse hydrophobic or amphiphilic C-terminal alpha helical domain. They function as antimicrobial peptides against several pathogenic species of GRAM-POSITIVE BACTERIA, including LISTERIA MONOCYTOGENES and are useful as FOOD PRESERVATIVES.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070017"}, {"RECTYPE": "D", "MH": "Lactobacillus pentosus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.450.475.586", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1589", "PI": "Lactobacillus (1963-2016)", "MS": "A species of Lactobacillus that occurs in FERMENTED FOODS where its ability to produce LACTIC ACID; ANTI-INFECTIVE AGENTS; and BACTERIOCINS make it useful as a FOOD PRESERVATION agent. It is also used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20210712", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070018"}, {"RECTYPE": "D", "MH": "Bacillus clausii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.158.218.283", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid79880", "PI": "Bacillus (2000-2016)", "MS": "An alkalophilic species of Bacillus that occurs in soil. It produces ANTI-BACTERIAL AGENTS and is used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070019"}, {"RECTYPE": "D", "MH": "Faecalibacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.413", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid216851", "PI": "Gram-Positive Bacteria (2002-2016)", "MS": "A genus of Gram-negative, non-spore forming, anaerobic, rod shaped bacteria in the Ruminococcaceae family, order Clostridiales that occur in the human gut.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070036"}, {"RECTYPE": "D", "MH": "Faecalibacterium prausnitzii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Fusobacterium prausnitzii|T007|NON|EQV|NLM (2017)|150820|abcdef", "MN": "B03.440.425.410.413.500", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid853", "PI": "Gram-Positive Bacteria (2002-2016)", "MS": "A species of FAECALIBACTERIUM, previously classified in the FUSOBACTERIUM genus, that is a major constituent of the GUT MICROBIOTA in healthy humans. It has anti-inflammatory activity and reduced numbers of this species occur in patients with INFLAMMATORY BOWEL DISEASES such as CROHN DISEASE.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070037"}, {"RECTYPE": "D", "MH": "Paenibacillus polymyxa", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Bacillus polymyxa|T007|NON|EQV|NLM (2017)|150824|abcdef", "MN": "B03.585.860", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1406", "PI": "Paenibacillus (2010-2016)", "MS": "A species of Paenibacillus formerly classified as Bacillus polymyxa that occurs in marine sediments and soil, especially around plant roots and RHIZOMES where it performs NITROGEN FIXATION. It has activity against several species of pathogenic bacteria and produces POLYMYXINS.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070057"}, {"RECTYPE": "D", "MH": "Streptococcus iniae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872.405", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1346", "AN": "infection: coordinate IM with STREPTOCOCCAL INFECTIONS (IM)", "PI": "Streptococcus (1996-2016)", "MS": "A species of Streptococcus that is pathogenic in fish and may also cause disease in humans who routinely handle infected fish. Those who are of Asian descent, elderly, or have chronic diseases such as DIABETES MELLITUS; RHEUMATIC HEART DISEASE; or LIVER CIRRHOSIS are more susceptible to Streptococcus iniae infections.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070058"}, {"RECTYPE": "D", "MH": "Paenibacillus larvae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.645.500", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1464", "PI": "Paenibacillus (2010-2016)", "MS": "A species of Paenibacillus that causes American Foulbrood, a fatal disease of honeybees (APIS) and honeybee colonies.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070059"}, {"RECTYPE": "D", "MH": "Bdellovibrio bacteriovorus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.125.050.500", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid959", "PI": "Bdellovibrio (1977-2016)", "MS": "A non-pathogenic, obligate aerobic, Gram-negative species of Bdellovibrio that occurs in water and soil, as well as the intestines of birds and mammals. It can infect and lyse pathogenic GRAM-NEGATIVE BACTERIA and can function as a PROBIOTIC and ANTI-BACTERIAL AGENT.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070060"}, {"RECTYPE": "D", "MH": "Enterococcus hirae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Streptococcus faecium ATCC 9790|T007|NON|EQV|NLM (2017)|150918|abcdef", "MN": "B03.510.550.250.250.475", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1354", "AN": "infection: coordinate IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM)", "PI": "Enterococcus (1967-2016)", "MS": "A species of Enterococcus that occurs in the GASTROINTESTINAL TRACT of birds and mammals, and to a lesser extent humans. Some strains cause diseases including DIARRHEA; BACTEREMIA; and ENDOCARDITIS  in humans and animals.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070076"}, {"RECTYPE": "D", "MH": "Bacteroides thetaiotaomicron", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.194.152.700", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid818", "AN": "infection: coordinate IM with BACTEROIDES INFECTIONS (IM)", "PI": "Bacteroides (1971-2016)", "MS": "A species of Bacteroides that is a major constituent of the human GUT MICROBIOTA. It normally produces enzymes important for the digestion of vegetable matter. However, it can also cause OPPORTUNISTIC INFECTIONS that result in intra-abdominal SEPSIS; BACTEREMIA; and PERITONITIS.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070077"}, {"RECTYPE": "D", "MH": "Aeromonas veronii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.450.019.025.845", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid654", "AN": "infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS", "PI": "Aeromonas (1987-2016)", "MS": "A species of Aeromonas that occurs mostly as single cells in soil and freshwater environments. It also inhabits the digestive tract of the leech HIRUDO MEDICINALIS, where it aids in the digestion of blood and prevents colonization by other bacteria. It is pathogenic in fish and potentially in humans who consume infected fish or immunocompromised patients receiving LEECH THERAPY.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000070079"}, {"RECTYPE": "D", "MH": "Pseudomonas chlororaphis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.580.590.140", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid587753", "PI": "Pseudomonas (1972-2016)", "MS": "A non-pathogenic species of Pseudomonas that occurs in soil, especially in the RHIZOSPHERE surrounding plant roots, as well as on the leaves of plants. It has anti-fungal and anti-nematode activities and is used in agriculture as a biocontrol agent.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070096"}, {"RECTYPE": "D", "MH": "Butyrivibrio fibrisolvens", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.353.625.250.500", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid831", "PI": "Butyrivibrio (2004-2016)", "MS": "A species of Butyrivibrio that occurs primarily in the RUMEN where it has important activities in LIPID METABOLISM and the production of BUTYRATES.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070097"}, {"RECTYPE": "D", "MH": "Bacillus firmus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.158.218.345", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1399", "PI": "Bacillus (1977-2016)", "MS": "A species of Bacillus that occurs in soil and marine sediments. Many strains are alkalophilic and able to metabolize HEAVY METALS; it may therefore be a useful species for ENVIRONMENTAL BIODEGRADATION.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070098"}, {"RECTYPE": "D", "MH": "Streptococcus gallolyticus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872.243", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid315405", "PI": "Streptococcus (1996-2016)", "MS": "A species of Streptococcus that occurs in the GASTROINTESTINAL TRACT of birds, mammals and healthy humans.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070099"}, {"RECTYPE": "D", "MH": "Informal Sector", "ENTRY": "Sector, Informal", "MN": "I01.791.500", "MH_TH": "NLM (1987)", "ST": "T078", "MS": "A component of the private sector characterized by ease of entry; reliance on indigenous resources; family ownership; small scale operations;  skills acquired outside of the formal sector; and unregulated markets.", "PM": "2017", "HN": "2017", "MR": "20170703", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070100"}, {"RECTYPE": "D", "MH": "Megasphaera elsdenii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.400.500.500", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid907", "PI": "Megasphaera (2004-2016)", "MS": "A species of Megasphaera that occurs primarily in the RUMEN and is able to metabolize LACTIC ACID.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070101"}, {"RECTYPE": "D", "MH": "Lotus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Trefoil|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "Trefoils", "MN": "B01.875.800.575.912.250.401.565", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid3867", "RR": "txid34305", "AN": "AMERICAN LOTUS, INDIAN LOTUS and SACRED LOTUS see NELUMBO are also available; lotus seeds and lotus nuts are from the genus NELUMBO, especially NELUMBO NUCIFERA ", "MS": "A genus of the PEA FAMILY. The genus Lotus, formerly known as Tetragonolobus, is unrelated to other plants with the common name of lotus (NELUMBO and NYMPHAEA).", "PM": "2017", "HN": "2017(2002)", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070116"}, {"RECTYPE": "D", "MH": "Lipid Droplet Associated Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Lipid Droplet", "MN": "D12.776.157.464", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1993-2016)", "MS": "Proteins, such as PERILIPINS, that localize to LIPID DROPLETS either transiently or constitutively.", "PM": "2017", "HN": "2017", "MR": "20160115", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070136"}, {"RECTYPE": "D", "MH": "Perilipins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Perilipin-Adipophilin-TIP47", "MN": "D12.776.157.464.500", "MH_TH": "NLM (2017)", "ST": "T116", "RN": "0", "PI": "Carrier Proteins (1991-2016)", "MS": "A family of vertebrate and insect lipid droplet associated proteins. They consist of a conserved N-terminal PAT domain (an alpha-helical region of about 110 amino acids), an 11-mer repeat region, and lipid-binding hydrophobic regions or 4-helix bundles near their C-termini. Perilipins transiently or constitutively localize to LIPID DROPLETS in ADIPOCYTES and FOAM CELLS, especially in regions adjacent to the PLASMA MEMBRANE and ENDOPLASMIC RECTICULUM. They are critical for lipid droplet synthesis and homeostasis as well as the regulation of lipid metabolism. Genetic variations in perilipins are associated with ATHEROSCLEROSIS; OBESITY; and DIABETES MELLITUS.", "PM": "2017", "HN": "2017", "MR": "20160119", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070137"}, {"RECTYPE": "D", "MH": "Nogo Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Nogo Receptor|T116|T192|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Receptors, Nogo", "MN": "D12.776.631.651", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (2001-2016)", "MS": "GPI-linked proteins consisting of eight elongated leucine-rich repeats at their N-temini that are connected to the GPI  by a \"stalk\" region rich in prolines, serines and threonines. They bind to NOGO PROTEIN; however, some Nogo receptors also bind MYELIN ASSOCIATED GLYCOPROTEIN and other cell surface glycoproteins. Interactions between Nogo receptors and their ligands modulate nerve growth and NEURONAL PLASTICITY.", "PM": "2017", "HN": "2017", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070156"}, {"RECTYPE": "D", "MH": "Pogostemon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Pogostemon cablin|T002|NON|NRW|NLM (2017)|150902|abcdef", "MN": "B01.875.800.575.912.250.583.520.754", "MH_TH": "NLM (2017)", "ST": "T002", "RN": "txid21861", "RR": "txid28511", "PI": "Lamiaceae (2000-2016)", "MS": "Genus in the Lamiaceae family. VOLATILE OILS from several species of Pogostemon are used in PERFUME; INSECT REPELLENTS; and ALTERNATIVE THERAPIES.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070177"}, {"RECTYPE": "D", "MH": "Streptococcus gallolyticus subspecies gallolyticus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Streptococcus gallolyticus subsp. gallolyticus|T007|NON|EQV|NLM (2017)|150902|abcdef", "MN": "B03.510.550.737.872.243.500", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid53354", "AN": "infection: coordinate IM with STREPTOCOCCAL INFECTIONS (IM)", "PI": "Streptococcus (2007-2016)", "MS": "A subspecies of Streptococcus gallolyticus. It and other subspecies have been reported to cause infections resulting in BACTEREMIA; ENDOCARDITIS; and neonatal MENINGITIS.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070197"}, {"RECTYPE": "D", "MH": "Psacalium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Matariques", "MN": "B01.875.800.575.912.250.100.605", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid98713", "RR": "txid98714", "PI": "Asteraceae (1999-2016)", "MS": "A genus of the Asteraceae family. Several of its species are used in TRADITIONAL MEDICINE.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070216"}, {"RECTYPE": "D", "MH": "Bifidobacterium longum subspecies infantis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Bifidobacterium longum ssp. infantis|T007|NON|EQV|NLM (2017)|150908|abcdef", "MN": "B03.510.460.400.400.049.100.500.500", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1682", "PI": "Bifidobacterium (1983-2016)", "MS": "A subspecies of Bifidobacterium longum that occurs in the GASTROINTESTINAL TRACT of human infants and is used as a PROBIOTIC. It may also be used in the treatment of IRRITABLE BOWEL SYNDROME.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070236"}, {"RECTYPE": "D", "MH": "Latilactobacillus sakei", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Lactobacillus bavaricus|T007|NON|EQV|NLM (2023)|220411|abcdef", "ENTRY": "Lactobacillus sakei|T007|NON|EQV|NLM (2017)|150909|abcdef", "MN": "B03.510.550.450.639", "MH_TH": "NLM (2023)", "ST": "T007", "RN": "txid1599", "PI": "Lactobacillus (1994-2016)", "MS": "A species of Lactobacillus that occurs in fermented meat and fish. It produces the BACTERIOCIN Sakacin P and is used for FOOD PRESERVATION and as a PROBIOTIC.", "PM": "2023; see LACTOBACILLUS SAKEI 2017-2022", "HN": "2023(2017)", "MR": "20221031", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070256"}, {"RECTYPE": "D", "MH": "Bifidobacterium pseudocatenulatum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.100.750", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid28026", "PI": "Bifidobacterium (2008-2016)", "MS": "A species of Bifidobacterium that occurs in the GASTROINTESTINAL TRACT of mammals and healthy humans. It has anti-inflammatory activity and is used as a PROBIOTIC.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070257"}, {"RECTYPE": "D", "MH": "Teacher Training", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Training, Teacher", "MN": "I02.358.984", "MH_TH": "NLM (2017)", "ST": "T065", "PI": "Teaching (1963-2016)", "MS": "A curriculum-centered process of equipping individuals with professional knowledge and skills required to become effective teachers.", "PM": "2017", "HN": "2017", "MR": "20160302", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070260"}, {"RECTYPE": "D", "MH": "Sleep Hygiene", "AQ": "CL DE ES PH RE", "ENTRY": "Sleep Habits, Good", "MN": "F02.830.855.734", "FX": "Sleep Wake Disorders", "MH_TH": "NLM (2017)", "ST": "T055", "MS": "Habits and practices conducive to getting the right amount and quality of sleep, and include  responding to environmental factors that may influence one's sleep.", "PM": "2017", "HN": "2017", "MR": "20160303", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070263"}, {"RECTYPE": "D", "MH": "Heart Rate Determination", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Heart Rate Monitoring|T060|T061|NON|EQV|NLM (2023)|210808|abbcdef", "ENTRY": "Rate Monitoring, Heart", "MN": "E01.370.600.315", "FX": "Pulse", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Heart Rate (1967-2016)", "MS": "Methods, techniques, and processes by which HEART RATE is measured.", "PM": "2017", "HN": "2017", "MR": "20220712", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070276"}, {"RECTYPE": "D", "MH": "Orthodontic Friction", "AQ": "DE PH RE", "ENTRY": "Friction, Orthodontic", "MN": "G01.154.090.625", "MH_TH": "NLM (2017)", "ST": "T067", "MS": "Physical resistance to motion between dental surfaces.", "PM": "2017", "HN": "2017", "MR": "20151124", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070297"}, {"RECTYPE": "D", "MH": "Pediatric Emergency Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Pediatric Emergency", "MN": "H02.403.670.450", "MH_TH": "NLM (2017)", "ST": "T090", "MS": "Branch of EMERGENCY MEDICINE dealing with the emergency care of children.", "PM": "2017", "HN": "2017", "MR": "20181012", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070316"}, {"RECTYPE": "D", "MH": "Strategic Planning", "AQ": "EC SN ST", "ENTRY": "Planning, Strategic", "MN": "N04.452.718.500", "MH_TH": "NLM (2017)", "ST": "T057", "MS": "A rigorous and systematic process which entails defining plans, decisions, and sequence of steps to be taken in the future.", "PM": "2017", "HN": "2017", "MR": "20151124", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070318"}, {"RECTYPE": "D", "MH": "Student Run Clinic", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Student-Run Free Clinics", "MN": "N02.278.912", "MH_TH": "NLM (2017)", "ST": "T093", "MS": "Healthcare setting managed by medical personnel in training.", "PM": "2017", "HN": "2017", "MR": "20170123", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070319"}, {"RECTYPE": "D", "MH": "Expropriation", "AQ": "EC HI", "ENTRY": "Expropriations", "MN": "I01.261.506", "MH_TH": "NLM (2017)", "ST": "T064", "MS": "Taking of goods, property, or right of use by GOVERNMENT or others.", "PM": "2017", "HN": "2017", "MR": "20151124", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070337"}, {"RECTYPE": "D", "MH": "Pilots", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Co-Pilots", "MN": "M01.526.727", "MH_TH": "NLM (2017)", "ST": "T057", "MS": "Persons skilled and/or qualified to operate an aircraft or ship.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070356"}, {"RECTYPE": "D", "MH": "Asparagaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Muscari|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Polianthes|T002|NON|NRW|NLM (2004)|030417|abcdef", "MN": "B01.875.800.575.912.250.618.100.060", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid40552", "RR": "txid39546", "MS": "A family of flowering subshrubs and shrubs in the class Magnoliopsida.", "PM": "2017; see LILIACEAE 2003-2016; for AGAVACEAE see AGAVACEAE 2002-2016;  for CONVALLARIACEAE and MUSCARI see LILIACEAE 2003-2016; for HESPERALOE and POLIANTHES see AGAVACEAE 2003-2016;", "HN": "2017; for AGAVACEAE use AGAVACEAE 2002-2016; for CONVALLARIACEAE and MUSCARI use LILIACEAE 2003-2016", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070357"}, {"RECTYPE": "D", "MH": "Value-Based Health Insurance", "AQ": "EC OG SN", "ENTRY": "Value-Based Health Insurances", "MN": "N04.761.744.750", "MH_TH": "NLM (2019)", "ST": "T058", "PI": "Insurance, Health (2010-2016)", "MS": "Approach to improve the quality of care by selectively encouraging or discouraging the use of specific health care services, based on their potential benefit to patients' health, relative to their cost. One element is lowering beneficiary cost sharing or out-of-pocket spending to increase medication adherence.", "PM": "2019; see Value-Based Insurance 2017-2018", "HN": "2019(2017)", "MR": "20190705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070376"}, {"RECTYPE": "D", "MH": "Anti-Vaccination Movement", "AQ": "CL EC ED ES HI LJ PX SN ST TD", "ENTRY": "Movements, Antivaccination", "MN": "I03.088", "FX": "Vaccination Refusal", "MH_TH": "NLM (2017)", "ST": "T054", "MS": "Group activities directed against VACCINATION.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070377"}, {"RECTYPE": "D", "MH": "Amaryllidaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Zephyranthes|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Zephyrlilies", "MN": "B01.875.800.575.912.250.618.100.050", "MH_TH": "NLM (2005)", "ST": "T002", "RN": "txid4668", "RR": "txid82256", "MS": "A family of herbaceous plants with bulbs or rhizomes in the order Asparagales.", "PM": "2017; for CLIVIA, HIPPEASTRUM, and ZEPHYRANTHES see LILIACEAE 2003-2016;  for CYRTANTHUS see LILIACEAE 2004-2016", "HN": "2017; for CLIVIA, HIPPEASTRUM, and ZEPHYRANTHES use LILIACEAE 2003-2016;  for CYRTANTHUS use LILIACEAE 2004-2016", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070378"}, {"RECTYPE": "D", "MH": "Attentional Bias", "AQ": "CL DE ES PH RE", "ENTRY": "Biases, Attentional", "MN": "F02.830.104.214.500", "MH_TH": "NLM (2017)", "ST": "T055", "PI": "Attention (1980-2016)", "MS": "An increased focus or awareness of certain stimuli over others, which influence behavior.", "PM": "2017", "HN": "2017", "MR": "20151124", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070379"}, {"RECTYPE": "D", "MH": "Asphodelaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Phormium|T002|NON|NRW|NLM (2003)|010823|abcdef", "ENTRY": "Zealand Flax, New", "MN": "B01.875.800.575.912.250.618.100.970", "MH_TH": "NLM (2008)", "ST": "T002", "RN": "txid51383", "RR": "txid703538", "PI": "Angiosperms (2010-2016)", "MS": "A family of flowering plants in the order Asparagales.", "PM": "2023; for PHORMIUM see ASPARAGACEAE 2003-2016; for ASPHODELACEAE see LLILIACEAE 2007-2016; for BULBINE see LILIACEAE 2003-2016", "HN": "2023; for PHORMIUM use ASPARAGACEAE 2003-2016; for ASPHODELACEAE use LLILIACEAE 2007-2016; for BULBINE use LILIACEAE 2003-2016", "MR": "20230226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070380"}, {"RECTYPE": "D", "MH": "Asparagales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Galtonia|T002|NON|NRW|NLM (2003)|020326|abcdef", "MN": "B01.875.800.575.912.250.618.100", "MH_TH": "NLM (2017)", "ST": "T002", "RN": "txid73496", "RR": "txid81750", "MS": "An order of monocotyledons plants in the superorder Lilianae of the class Magnoliopsida (Angiosperms).", "PM": "2016", "HN": "2016", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070381"}, {"RECTYPE": "D", "MH": "Liliales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Alstroemeriaceae|T002|NON|NRW|NLM (2017)|150930|abcdef", "MN": "B01.875.800.575.912.250.618.875", "MH_TH": "NLM (2017)", "ST": "T002", "RN": "txid4667", "RR": "txid56740", "PI": "Angiosperms (2002-2016)", "MS": "An order of monocots that grow from bulbs or corms to become herbs or vines.", "PM": "2016", "HN": "2016", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070396"}, {"RECTYPE": "D", "MH": "Antagomirs", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Anti-miR|T114|NON|EQV|NLM (2021)|200113|abcdef", "ENTRY": "Anti miRs", "MN": "D13.695.578.424.112", "FX": "RNA Interference", "MH_TH": "NLM (2017)", "ST": "T114", "RN": "0", "PI": "MicroRNAs (2005-2016)", "MS": "Chemically-engineered oligonucleotides used to selectively inhibit expression of target genes through sequence-specific binding of corresponding microRNA (miRNA) sites.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070416"}, {"RECTYPE": "D", "MH": "Tannerella forsythia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Tannerella forsythia ATCC 43037|T007|NON|EQV|NLM (2017)|151102|abcdef", "MN": "B03.440.080.850.500", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid28112", "AN": "infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS", "MS": "A periodontal pathogen which is a gram-negative member of BACTEROIDETES. It is implicated in PERIODONTITIS.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070436"}, {"RECTYPE": "D", "MH": "Colchicaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618.875.175", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41218", "PI": "Liliaceae (2003-2016)", "MS": "A family in the order Liliales.", "PM": "2017; see LILIACEAE 2003-2016", "HN": "2017; use LILIACEAE 2003-2016", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070437"}, {"RECTYPE": "D", "MH": "Call Centers", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Centers, Call", "MN": "N02.421.297.036", "MH_TH": "NLM (2017)", "ST": "T057", "MS": "A facility set up for the purpose of handling large volumes of telephone calls. Call Centers typically utilize some form of computer automation for receiving, dispatching, screening, logging and forwarding telephone calls.", "PM": "2017", "HN": "2017", "MR": "20170630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070456"}, {"RECTYPE": "D", "MH": "Hypoxidaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618.100.230", "MH_TH": "NLM (2017)", "ST": "T002", "RN": "txid4674", "PI": "Angiosperms (2000-2016)", "MS": "A family of perennial herbaceous plants, in the order Asparagales, with the underground storage organs, rhizomes or corms.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070476"}, {"RECTYPE": "D", "MH": "Kinanthropometry", "AQ": "HI IS MT", "ENTRY": "Kinanthropometries", "MN": "N06.850.505.200.100.700", "MH_TH": "NLM (2017)", "ST": "T081", "PI": "Anthropometry (1980-2016)", "MS": "A measure of human size, shape, proportion, composition, maturation, and gross function; in relation to body movement, physical exercise, fitness, and performance.", "PM": "2017", "HN": "2017", "MR": "20151124", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070496"}, {"RECTYPE": "D", "MH": "Healthy Lifestyle", "AQ": "CL DE ES PH RE", "ENTRY": "Lifestyles, Healthy", "MN": "F01.829.458.205", "FX": "Health Behavior", "MH_TH": "NLM (2017)", "ST": "T054", "PI": "Life Style (1984-2016)", "MS": "A pattern of behavior involving LIFE STYLE choices which ensure optimum health. Examples are eating right; maintaining physical, emotional, and spiritual wellness, and taking preemptive steps against communicable diseases.", "PM": "2017", "HN": "2017", "MR": "20170117", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070497"}, {"RECTYPE": "D", "MH": "Intersectoral Collaboration", "ENTRY": "Intersectoral Collaborations", "MN": "N04.226", "MH_TH": "NLM (2017)", "ST": "T058", "PI": "Cooperative Behavior (1986-2016)", "MS": "Cooperative actions and ventures among health and health-related groups and organizations intended to improve health outcomes.", "PM": "2017", "HN": "2017", "MR": "20210706", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070516"}, {"RECTYPE": "D", "MH": "Independent Medical Evaluation", "ENTRY": "Medical Examinations, Independent", "MN": "N05.715.360.425", "FX": "Physical Examination", "MH_TH": "NLM (2017)", "ST": "T062", "MS": "An assessment of HEALTH STATUS requested by third parties (e.g. insurers, adjudicating bodies, law enforcement, attorneys, etc) on a subject\u2019s functional ability. Such information may be used in optimizing treatment or making informed decisions on compensation.", "PM": "2017", "HN": "2017", "MR": "20151124", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070536"}, {"RECTYPE": "D", "MH": "C2 Domains", "AQ": "DE GE IM PH RE", "ENTRY": "Tensin-type Domains, C2", "MN": "G02.111.570.820.709.275.750.125", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Protein Binding (1990-2016)", "MS": "Protein modules that function in the targeting of proteins to CELL MEMBRANES. They consist of an eight-stranded anti-parallel beta-sandwich composed of a pair of four-stranded beta-sheets. This structural unit forms a pocket on the membrane-interacting face of the protein and co-ordinates the binding of 2 to 3 calcium ions; however, not all C2 domains bind calcium. Examples of C2 domain-containing proteins include PROTEIN KINASE C and PTEN PHOSPHOHYDROLASE.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070538"}, {"RECTYPE": "D", "MH": "Pleckstrin Homology Domains", "AQ": "DE GE IM PH RE", "ENTRY": "Homology Domains, Pleckstrin", "MN": "G02.111.570.820.709.275.750.469", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Protein Structure, Tertiary (1994-2016)", "MS": "Protein domains of approximately 120 amino acids that form two perpendicular anti-parallel beta sheets connected by a loop of variable length and a C-terminal amphipathic helix. PH domains occur in many INTRACELLULAR SIGNALING PROTEINS and CYTOSKELETAL PROTEINS where they bind PHOSPHATIDYLINOSITOLS within the CELL MEMBRANE and INTRACELLULAR MEMBRANES, as well as proteins that include the Betagamma-subunits of  HETEROTRIMERIC GTP-BINDING PROTEINS, and PROTEIN KINASE C. These interactions allow the targeting of proteins to different cellular compartments and SIGNAL TRANSDUCTION PATHWAYS.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070539"}, {"RECTYPE": "D", "MH": "Melanthiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618.875.625", "MH_TH": "NLM (2017)", "ST": "T002", "RN": "txid50362", "PI": "Angiosperms (2006-2016)", "MS": "A family in the order Liliales, of bulbous or rhizomatous woodland and alpine perennial herbs.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070556"}, {"RECTYPE": "D", "MH": "Immunoglobulin Domains", "AQ": "DE GE IM PH RE", "ENTRY": "V-set Domains, Immunoglobulin", "MN": "G02.111.570.820.709.275.750.250", "FX": "Immunoglobulin Variable Region", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Immunoglobulins (1976-2016)", "MS": "Compact globular protein domains of about 80 to 110 amino acids.They are characterized by two antiparallel beta sheets stabilized by HYDROPHOBIC INTERACTIONS and disulfide bonds between opposing strands. Three major subtypes of Ig domains are recognized: variable (V), intermediate (I), and constant (C1 or C2). Members of the immunoglobulin superfamily include ANTIGEN RECEPTORS; CYTOKINE RECEPTORS; and CELL ADHESION MOLECULES which possess immunoglobulin domains.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070557"}, {"RECTYPE": "D", "MH": "Talipes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Varus, Talipes", "MN": "C16.131.621.585.512.500.681", "MH_TH": "ORD (2010)", "ST": "T190", "PI": "Foot Deformities, Congenital (1964-2016)", "MS": "Deformity in which the foot is misaligned with respect to the TALUS in the ANKLE JOINT. While mostly congenital, as in CLUBFOOT, acquired deformities are included. Acquired talipedes are often associated with other foot deformities such as SYNDACTYLY and POLYDACTYLY.", "PM": "2017; for TALIPES see CLUBFOOT 2010-2016", "HN": "2017; for TALIPES use CLUBFOOT 2010-2016", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070558"}, {"RECTYPE": "D", "MH": "Gizzard, Non-avian", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Non-avian Gizzards", "MN": "A13.433", "FX": "Gizzard, Avian", "MH_TH": "NLM (2017)", "ST": "T023", "PI": "Gizzard, Non-avian (1968-2016)", "MS": "A component of the gastrointestinal tract of some reptiles (ALLIGATORS AND CROCODILES), as well as certain fish, mollusks, and insects. It functions to mechanically grind food.", "PM": "2017", "HN": "2017", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070559"}, {"RECTYPE": "D", "MH": "NLR Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleotide-Binding Domain Leucine-Rich Repeat Protein|T116|T123|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Receptors, NOD-like", "MN": "D12.644.360.539", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Nod Signaling Adaptor Proteins (2007-2016)", "MS": "Intracellular signaling proteins that are defined by the presence of a NUCLEOTIDE-binding region and LEUCINE-rich repeats. Their general structure consists of any of a variety of effector domains at their N-termini such as a caspase recruitment domain (CARD), a central nucleotide-binding domain, and a variable number of C-terminal leucine-rich repeats. They are important for pathogen recognition in the INNATE IMMUNE RESPONSE of animals and plants. Members of the NLR protein family include the NOD SIGNALING ADAPTOR PROTEINS.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070576"}, {"RECTYPE": "D", "MH": "Parkinson Disease Associated Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Parkinson Associated", "MN": "D12.776.705", "MH_TH": "NLM (2017)", "ST": "T116", "RN": "0", "PI": "Parkinson Disease (1992-2016)", "MS": "Proteins associated with sporadic or familial cases of PARKINSON DISEASE.", "PM": "2017", "HN": "2017", "MR": "20220712", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070579"}, {"RECTYPE": "D", "MH": "CYS2-HIS2 Zinc Fingers", "AQ": "DE GE IM PH RE", "ENTRY": "Zinc Fingers, CYS2HIS2", "MN": "G02.111.570.820.709.275.500.985.250", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Zinc Fingers (1991-2016)", "MS": "A zinc finger motif of approximately 30 amino acids with the general sequence X2-Cys-X2,4-Cys-X12-His-X3,4,5-His that forms a simple beta sheet-beta sheet-alpha helix fold stabilized by zinc ions. It recognizes and binds to a variety of eukaryotic DNA sequences and is very common among sequence-specific DNA BINDING PROTEINS and TRANSCRIPTION FACTORS.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070580"}, {"RECTYPE": "D", "MH": "Tripartite Motif Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tripartite Motif Protein|T116|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Proteins, Tripartite Motif", "MN": "D12.776.934", "MH_TH": "NLM (2017)", "ST": "T116", "RN": "0", "PI": "Carrier Proteins (2001-2016)", "MS": "A protein family defined by the presence of three ZINC FINGER domains, one of which is a RING FINGER DOMAIN, a coiled-coil region, and a highly variable C-terminal region. They function in many cellular processes including APOPTOSIS and CELL CYCLE regulation.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070584"}, {"RECTYPE": "D", "MH": "Cadherin Related Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Related Proteins, Cadherin", "MN": "D12.776.543.131", "MH_TH": "NLM (2017)", "ST": "T116", "RN": "0", "PI": "Cadherins (1995-2016)", "MS": "Membrane proteins that contain at least two typical consecutive CADHERIN motifs but typically more than cadherin or protocadherin proteins. Their overall domain organization also differs from those of cadherins and protocadherins, and contains different and unique cytoplasmic domains.", "PM": "2017", "HN": "2017", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070585"}, {"RECTYPE": "D", "MH": "Fiscal Policy", "AQ": "HI", "ENTRY": "Policy, Fiscal", "MN": "I01.655.125", "MH_TH": "NLM (2017)", "ST": "T064", "MS": "Use of government spending and taxation to influence the economy.", "PM": "2017", "HN": "2017", "MR": "20160608", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070586"}, {"RECTYPE": "D", "MH": "Mental Navigation Tests", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Tests, Mental Navigation", "MN": "F04.711.513.502", "MH_TH": "NLM (2017)", "ST": "T060", "MS": "Measures of spatial cognition and memory.", "PM": "2017", "HN": "2017", "MR": "20151124", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070587"}, {"RECTYPE": "D", "MH": "Talipes Cavus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pes Cavus|T190|NON|EQV|UNK (19XX)|870402|abcdef", "ENTRY": "High Arched Foot", "MN": "C16.131.621.585.512.500.681.500", "MH_TH": "UNK (19XX)", "ST": "T190", "PI": "Foot Deformities, Congenital (1964-2016)", "MS": "A foot deformity in which the arch of the foot is high and often the heel adducted.", "PM": "2017; see FOOT DEFORMITIES 1987-2016", "HN": "2017; use FOOT DEFORMITIES 1987-2016", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070589"}, {"RECTYPE": "D", "MH": "Solute Carrier Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Solute Carrier Protein|T116|NON|EQV|NLM (2022)|201006|abcdef", "ENTRY": "Proteins, Solute Carrier", "MN": "D12.776.543.585.937", "MH_TH": "NLM (2017)", "ST": "T116", "RN": "0", "PI": "Membrane Transport Proteins (2001-2016)", "MS": "A large diverse group of membrane transport proteins whose families are generally classified according to function. Most SLCs localize to the CELL MEMBRANE; however, some families such as SLC25, localize to MITOCHONDRIAL MEMBRANES or other ORGANELLES.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070590"}, {"RECTYPE": "D", "MH": "Metatarsal Valgus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Toeing Outs", "MN": "C05.330.663", "MH_TH": "NLM (2017)", "ST": "T190", "PI": "Metatarsus (1974-2016)", "MS": "A foot anomaly in which the forefoot is angled outward relative to the hindfoot.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070591"}, {"RECTYPE": "D", "MH": "Metatarsus Varus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Varus, Metatarsus", "MN": "C05.330.711", "MH_TH": "NLM (2017)", "ST": "T190", "PI": "Metatarsus (1964-2016)", "MS": "A foot anomaly in which the forefoot (METATARSUS) is angled inward relative to the heel.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070592"}, {"RECTYPE": "D", "MH": "Methyl CpG Binding Domain", "AQ": "DE GE IM PH RE", "ENTRY": "Methyl CpG DNA Binding Domain|T087|NON|EQV|NLM (2017)|151022|abcdef", "MN": "G02.111.570.820.709.275.750.438", "FX": "DNA Methylation", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "DNA-Binding Proteins (1993-2016)", "MS": "A protein domain of about 70 amino acids in length that folds into a sandwich structure consisting of a beta sheet, alpha helix, and C-terminal hairpin loop which forms a hydrophobic methylated-DNA binding patch. It binds to methylated CPG ISLANDS in eukaryotes and occurs with other DNA and CHROMATIN binding domains such as AT-HOOK MOTIFS in eukaryotic DNA BINDING PROTEINS.", "PM": "2017", "HN": "2017", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070593"}, {"RECTYPE": "D", "MH": "Coracoid Process", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Coracoid Processes", "MN": "A02.835.232.087.783.356", "MH_TH": "NLM (2017)", "ST": "T023", "PI": "Shoulder (1966-2016)", "MS": "A beak-like bone projection located at the lateral end of the superior anterior border of the SCAPULA.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070597"}, {"RECTYPE": "D", "MH": "Anterior Cruciate Ligament Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tears, ACL", "MN": "C26.558.554.213", "MH_TH": "NLM (2017)", "ST": "T037", "PI": "Knee Injuries (1974-2016)", "MS": "Sprain or tear injuries to the ANTERIOR CRUCIATE LIGAMENT of the knee.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000070598"}, {"RECTYPE": "D", "MH": "Shoulder Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tears, SLAP", "MN": "C26.803", "MH_TH": "NLM (2017)", "ST": "T037", "PI": "Shoulder (1966-2016)", "MS": "Injuries involving the SHOULDERS and SHOULDER JOINT.", "PM": "2017", "HN": "2017", "MR": "20210510", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070599"}, {"RECTYPE": "D", "MH": "Tibial Meniscus Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tibial Meniscus, Torn", "MN": "C26.558.781", "MH_TH": "NLM (2017)", "ST": "T037", "PI": "Menisci, Tibial/injuries (1967-2016)", "MS": "Injuries to the TIBIAL MENISCUS of the leg.", "PM": "2017", "HN": "2017", "MR": "20160706", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070600"}, {"RECTYPE": "D", "MH": "Diet, Carbohydrate Loading", "AQ": "AE CL EC EH HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Carbohydrate Loading Diets", "MN": "G07.203.650.240.120", "FX": "Dietary Carbohydrates", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Dietary Carbohydrates/administration & dosage (1986-2016)", "MS": "A diet rich in DIETARY CARBOHYDRATES.", "PM": "2017", "HN": "2017", "MR": "20160210", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070601"}, {"RECTYPE": "D", "MH": "Rib Cage", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Thoracic Cages", "MN": "A02.835.232.570", "MH_TH": "NLM (2017)", "ST": "T029", "PI": "Thorax (1963-2016)", "MS": "The bony thoracic enclosure consisting of the vertebral column; the RIBS; the STERNUM; and the COSTAL CARTILAGE.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070602"}, {"RECTYPE": "D", "MH": "Coxa Magna", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Femoral Head Deformities", "MN": "C05.116.296", "FX": "Slipped Capital Femoral Epiphyses", "MH_TH": "NLM (2017)", "ST": "T033", "PI": "Femur Head (1963-2016)", "MS": "Deformity of the hip characterized by enlargement and deformation of the FEMUR HEAD and FEMUR NECK, often with associated changes in the ACETABULUM. These changes may be secondary to other diseases (e.g.  LEGG-PERTHES DISEASE; ARTHRITIS; HIP DISLOCATION, CONGENITAL) or TRAUMA.", "PM": "2017", "HN": "2017", "MR": "20170316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070603"}, {"RECTYPE": "D", "MH": "Tarsal Coalition", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tarsal Synostoses", "MN": "C16.131.621.906.909", "MH_TH": "NLM (2017)", "ST": "T019", "PI": "Talus (1966-2016)", "MS": "Congenital, complete or partial fusion of the TARSAL BONES of the foot. PES PLANUS is usually a feature.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070604"}, {"RECTYPE": "D", "MH": "Aponeurosis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Aponeuroses|T024|NON|EQV|NLM (2017)|151030|abcdef", "MN": "A02.083", "MH_TH": "NLM (2017)", "ST": "T024", "PI": "Tendons (1966-2016)", "MS": "The flattened and/or expanded \u201ctendon-like\u201d dense fibrous connective tissue that connects skeletal muscles to each other or to bone.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000070606"}, {"RECTYPE": "D", "MH": "Morton Neuroma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neuromas, Intermetatarsal", "MN": "C23.888.592.612.664.275", "MH_TH": "NLM (2017)", "ST": "T047", "AN": "non-neoplastic", "PI": "Neuroma (1964-2016)", "MS": "A nerve inflammation in the foot caused by chronic compression of the plantar nerve between the METATARSAL BONES.", "PM": "2017", "HN": "2017", "MR": "20170620", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070607"}, {"RECTYPE": "D", "MH": "Nucleus Pulposus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A10.165.382.350.050.500", "MH_TH": "NLM (2017)", "ST": "T023", "PI": "Intervertebral Disc (1963-2016)", "MS": "Fibrocartilage inner core of the intervertebral disc. Prolapsed or bulged nucleus pulposus leads to INTERVERTEBRAL DISC DISPLACEMENT while proliferation of cells in the nucleus pulposus is associated with INTERVERTEBRAL DISC DEGENERATION.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070614"}, {"RECTYPE": "D", "MH": "Annulus Fibrosus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Anulus Fibrosus|T023|NON|EQV|NLM (2017)|151103|abcdef", "MN": "A10.165.382.350.050.250", "MH_TH": "NLM (2017)", "ST": "T023", "PI": "Intervertebral Disc (1963-2016)", "MS": "Outer portion of the intervertebral disc that surrounds the NUCLEUS PULPOSUS.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000070616"}, {"RECTYPE": "D", "MH": "Microtrauma, Physical", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Traumas, Physical Micro", "MN": "C26.599", "FX": "Cumulative Trauma Disorders", "MH_TH": "NLM (2017)", "ST": "T037", "PI": "Wounds and Injuries (1963-2016)", "MS": "Small injuries caused by external force applied to the body including bones, muscles, nerves and tendons.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070617"}, {"RECTYPE": "D", "MH": "Cystography", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Cystographies", "MN": "E01.370.390.830.500", "MH_TH": "NLM (2017)", "ST": "T060", "PI": "Urography (1963-2016)", "MS": "Radiography of the URINARY BLADDER.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070621"}, {"RECTYPE": "D", "MH": "Brain Contusion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cortical Contusions", "MN": "C26.974.250.500", "FX": "Brain Hemorrhage, Traumatic", "MH_TH": "NLM (1998)", "ST": "T037", "MS": "A bruise of the brain from an impact of the skull.", "PM": "2017; see BRAIN INJURIES 1998-2016", "HN": "2017; use BRAIN INJURIES 1998-2016", "MR": "20160120", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070624"}, {"RECTYPE": "D", "MH": "Brain Injuries, Diffuse", "DE": "BRAIN INJ DIFFUSE", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Diffuse Cerebral Injury", "MN": "C26.915.300.200.188", "MH_TH": "NLM (2000)", "ST": "T037", "MS": "Brain injuries occurring over a wide area instead of specific focal area.", "PM": "2017; see BRAIN INJURIES 2000-2016", "HN": "2017; use BRAIN INJURIES 2000-2016", "MR": "20160120", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000070625"}, {"RECTYPE": "D", "MH": "Chronic Traumatic Encephalopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Encephalopathy, Post-Traumatic, Chronic|T047|NON|EQV|NLM (2000)|991012|ENCEPHALOPATHY POSTTRAUMATIC CHRONIC|ENCEPH POST TRAUMATIC CHRONIC|abcdefsv", "ENTRY": "Post-Traumatic Encephalopathies", "MN": "C26.915.300.200.200.500", "FX": "Brain Concussion", "MH_TH": "NLM (2017)", "ST": "T047", "MS": "Degenerative brain disease linked to repetitive brain trauma. Progressive symptoms may include MEMORY LOSS; AGGRESSION; or DEPRESSION.", "PM": "2017; for CHRONIC POST-TRAUMATIC ENCEPHALOPATHY; ENCEPHALOPATHY, POST-TRAUMATIC, CHRONIC INJURY, BRAIN, CHRONIC; INJURY, BRAIN, CHRONIC; and TRAUMATIC ENCEPHALOPATHY, CHRONIC; CHRONIC ENCEPHALOPATHY, POST-CONCUSSIVE; ENCEPHALOPATHY, POST-CONCUSSIVE; and ENCEPHALOPATHY, POST-TRAUMATIC see BRAIN INJURIES 2000-2016", "HN": "2017; for CHRONIC POST-TRAUMATIC ENCEPHALOPATHY; ENCEPHALOPATHY, POST-TRAUMATIC, CHRONIC INJURY, BRAIN, CHRONIC; INJURY, BRAIN, CHRONIC; and TRAUMATIC ENCEPHALOPATHY, CHRONIC; CHRONIC ENCEPHALOPATHY, POST-CONCUSSIVE; ENCEPHALOPATHY, POST-CONCUSSIVE; and ENCEPHALOPATHY, POST-TRAUMATIC use BRAIN INJURIES 2000-2016", "MR": "20210312", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070627"}, {"RECTYPE": "D", "MH": "Closed Fracture Reduction", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Reductions, Fracture Closed", "MN": "E02.718.472.150", "FX": "Fractures, Closed", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Fracture Fixation (1963-2016)", "MS": "A procedure in which normal alignment of a fractured bone is restored by ORTHOPEDIC MANIPULATION without incision.", "PM": "2017", "HN": "2017", "MR": "20220712", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070628"}, {"RECTYPE": "D", "MH": "Diastasis, Muscle", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Myodiastases", "MN": "C26.289.288", "FX": "Diastasis, Bone", "MH_TH": "NLM (2017)", "ST": "T190", "PI": "Muscles (1963-2016)", "MS": "Abnormal separation of muscles.", "PM": "2017", "HN": "2017", "MR": "20170705", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070630"}, {"RECTYPE": "D", "MH": "Diastasis, Bone", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diastases, Bone", "MN": "C26.289.192", "MH_TH": "NLM (2017)", "ST": "T190", "PI": "Bone and Bones (1963-2016)", "MS": "Abnormal separation of bones, often from a LIGAMENT.", "PM": "2017", "HN": "2017", "MR": "20170705", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070631"}, {"RECTYPE": "D", "MH": "Hamstring Tendons", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tendons, Semitendinosus", "MN": "A02.880.307", "MH_TH": "NLM (2017)", "ST": "T023", "PI": "Tendons (1970-2016)", "MS": "A group of tendons that attach the HAMSTRING MUSCLES proximally to the PELVIS and to the TIBIA and FIBULA at the KNEE JOINT.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070632"}, {"RECTYPE": "D", "MH": "Hamstring Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Muscles, Hamstring", "MN": "A10.690.552.500.250", "MH_TH": "NLM (2017)", "ST": "T023", "PI": "Muscle, Skeletal (1965-2016)", "MS": "A group of muscles in the posterior THIGH area that are involved in connecting the KNEE JOINT and the PELVIS.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070633"}, {"RECTYPE": "D", "MH": "Non-Neuronal Cholinergic System", "AQ": "DE GE IM PH RE", "ENTRY": "Nonneuronal Cholinergic Systems", "MN": "G04.835.690", "FX": "Cholinergic Neurons", "MH_TH": "NLM (2017)", "ST": "T043", "PI": "Acetylcholine/metabolism (2001-2016)", "MS": "The system of ACETYLCHOLINE-synthesizing enzymes, transporters, receptors and degrading enzymes that characterize non-neuronal cholinergic cells such as airway and skin EPITHELIAL CELLS.", "PM": "2017", "HN": "2017", "MR": "20170512", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070634"}, {"RECTYPE": "D", "MH": "Punctal Plugs", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Silicone Punctal Plug", "MN": "E07.695.698", "MH_TH": "NLM (2017)", "ST": "T074", "PI": "Prostheses and Implants (1987-2016)", "MS": "Small devices that are inserted into the tear ducts (NASOLACRIMAL DUCTS). They are used to block the drainage of TEARS for the treatment of DRY EYE SYNDROMES.", "PM": "2017", "HN": "2017", "MR": "20160119", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070635"}, {"RECTYPE": "D", "MH": "Rotator Cuff Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tendinosis, Rotator Cuff", "MN": "C26.874.400", "FX": "Rotator Cuff Tear Arthropathy", "MH_TH": "NLM (2017)", "ST": "T037", "PI": "Tendon Injuries (1975-2016)", "MS": "Injuries to the ROTATOR CUFF of the shoulder joint.", "PM": "2017", "HN": "2017", "MR": "20200221", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070636"}, {"RECTYPE": "D", "MH": "Collateral Ligament, Ulnar", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ligaments, Ulnar Collateral", "MN": "A10.165.669.514.162.250", "MH_TH": "NLM (2017)", "ST": "T023", "PI": "Collateral Ligaments (1963-2016)", "MS": "The internal lateral ligament that travels from the medial aspect of the ELBOW uniting the distal aspect of the HUMERUS to the proximal aspect of the ULNA.", "PM": "2017", "HN": "2017", "MR": "20170620", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070637"}, {"RECTYPE": "D", "MH": "Ulnar Collateral Ligament Reconstruction", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Tommy Johns Surgery", "MN": "E04.617.900", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Elbow Joint (2002-2016)", "MS": "Surgical reconstruction of injured or insufficient ULNAR COLLATERAL LIGAMENT in the ELBOW JOINT.", "PM": "2017", "HN": "2017", "MR": "20220406", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070638"}, {"RECTYPE": "D", "MH": "Elbow Tendinopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tendinopathy, Elbow", "MN": "C26.874.800.500", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Tennis Elbow (1987-2016)", "MS": "Inflammation (tendinitis) or degeneration (tendinosis) of the tendons of the elbow.", "PM": "2017", "HN": "2017", "MR": "20220413", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070639"}, {"RECTYPE": "D", "MH": "Brain Injuries, Traumatic", "DE": "BRAIN INJ TRAUMATIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Traumatic Brain Injury|T037|NON|EQV|NLM (2000)|991108|TRAUMATIC BRAIN INJ|abcdefv", "ENTRY": "Traumatic Encephalopathies", "MN": "C26.915.300.200.194", "MH_TH": "NLM (2000)", "ST": "T037", "MS": "A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain.", "PM": "2017; use BRAIN INJURIES 2000-2016", "HN": "2017; use BRAIN INJURIES 2000-2016", "MR": "20160120", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000070642"}, {"RECTYPE": "D", "MH": "Rotator Cuff Tear Arthropathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Shoulder, Milwaukee", "MN": "C05.550.354.250", "FX": "Rotator Cuff Injuries", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Rotator Cuff/physiopathology (1963-2016)", "MS": "Rapidly destructive shoulder joint and bone disease found mainly in elderly, and predominantly in women. It is characterized by SHOULDER PAIN; JOINT INSTABILITY; and the presence of crystalline CALCIUM PHOSPHATES in the SYNOVIAL FLUID. It is associated with ROTATOR CUFF INJURIES.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070656"}, {"RECTYPE": "D", "MH": "Crystal Arthropathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Crystalline Arthropathy", "MN": "C05.550.354", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Gout (1990-2016)", "MS": "Joint disorders that are characterized by accumulation of microcrystals in and around the joint including in the SYNOVIAL FLUID. They are classified according to the chemical nature of the crystals such as CALCIUM PYROPHOSPHATE; basic CALCIUM PHOSPHATES; and monosodium urate (see URIC ACID).", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070657"}, {"RECTYPE": "D", "MH": "Vigna", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Rice Beans", "MN": "B01.875.800.575.912.250.401.976", "MH_TH": "NLM (2017)", "ST": "T002", "RN": "txid3913", "RR": "txid87088", "PI": "Fabaceae (1977-2016)", "MS": "Plant genus in the pea family (Fabaceae).", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070658"}, {"RECTYPE": "D", "MH": "Patient Comfort", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Comfort, Patient", "MN": "N02.421.585.683", "MH_TH": "NLM (2017)", "ST": "T058", "MS": "Patient care intended to prevent or relieve suffering in conditions that ensure optimal quality living.", "PM": "2017", "HN": "2017", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070659"}, {"RECTYPE": "D", "MH": "Wolfiporia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Fungus, Tuckahoe", "MN": "B01.300.179.120.760.845", "MH_TH": "NLM (2017)", "ST": "T004", "RN": "txid81055", "RR": "txid81056", "PI": "Poria (2008-2016)", "MS": "A genus of wood-decaying, edible fungi in the Polyporaceae family. Its type species is Wolfiporia extensa.", "PM": "2017; for MACROHYPORIA COCOS EXTENSA see POLYPORALES 2021-2022", "HN": "2017; for MACROHYPORIA COCOS EXTENSA use POLYPORALES 2021-2022", "MR": "20220711", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070660"}, {"RECTYPE": "D", "MH": "Enthesopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Enthesopathies", "MN": "C26.874.800.750", "MH_TH": "NLM (1995)", "ST": "T047", "MS": "A disorder occurring at the site of insertion of TENDONS or LIGAMENTS into bones or JOINT CAPSULES.", "PM": "2017; see RHEUMATIC DISEASES 1995-2016", "HN": "2017; use RHEUMATIC DISEASES 1995-2016", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070676"}, {"RECTYPE": "D", "MH": "Gentianales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.456", "MH_TH": "NLM (2017)", "ST": "T002", "RN": "txid4055", "PI": "Plants (2000-2016)", "MS": "An angiosperm plant order that includes the APOCYNACEAE; ASCLEPIADACEAE; GENTIANACEAE; LOGANIACEAE; and RUBIACEAE  families.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070677"}, {"RECTYPE": "D", "MH": "Buttermilk", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "ENTRY": "Milk, Butter", "MN": "J02.500.350.525.250", "MH_TH": "NLM (1998)", "ST": "T168", "MS": "A beverage made from cow's milk fermented by LACTIC ACID-producing bacteria, especially LACTOCOCCUS LACTIS and LACTOBACILLUS BULGARICUS.", "PM": "2017; see MILK 1998-2003 and CULTURED MILK PRODUCTS 2004-2016", "HN": "2017; use MILK 1998-2003 and CULTURED MILK PRODUCTS 2004-2016", "MR": "20210707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070696"}, {"RECTYPE": "D", "MH": "Kefir", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "ENTRY": "Kefir Grain", "MN": "J02.500.350.525.375", "MH_TH": "NLM (1998)", "ST": "T168", "MS": "A beverage made from milk fermented by a mixture of endogenous LACTIC ACID-producing yeast and bacteria (KEFIR GRAINS), many of which are PROBIOTICS. It should not be confused with KAFFIR LIME or KAFFIR CORN.", "PM": "2017; see MILK 1998-2003 and CULTURED MILK PRODUCTS 2004-2016", "HN": "2017; use MILK 1998-2003 and CULTURED MILK PRODUCTS 2004-2016", "MR": "20210707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070716"}, {"RECTYPE": "D", "MH": "Koumiss", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "MN": "J02.500.350.525.438", "MH_TH": "NLM (2017)", "ST": "T168", "PI": "Milk (1963-2016)", "MS": "A beverage made from horse's milk that is fermented by endogenous LACTIC ACID-producing bacteria and ETHANOL-producing yeast.", "PM": "2017", "HN": "2017", "MR": "20210707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070736"}, {"RECTYPE": "D", "MH": "School Teachers", "AQ": "CL HI LJ OG PX SN ST", "ENTRY": "Teachers, School", "MN": "M01.526.702.500", "EC": "education:Teacher Training", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Faculty (1963-2016)", "MS": "Members of staff responsible for TEACHING students in a school from pre-kindergarten through twelfth grade.", "PM": "2017; see FACULTY 1979-2016", "HN": "2017; use FACULTY 1979-2016", "MR": "20160928", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070777"}, {"RECTYPE": "D", "MH": "Perilipin-1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, Plin", "MN": "D12.776.157.464.500.500", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A lipid droplet protein that is expressed primarily by ADIPOCYTES of WHITE ADIPOSE TISSUE and BROWN ADIPOSE TISSUE. It co-localizes with MACROPHAGES and FOAM CELLS of artherosclerotic lesions and stabilizes LIPID DROPLETS by inhibiting HORMONE SENSITIVE LIPASE. It may also protect TRIGLYCERIDES against hydrolysis within the PLASMA MEMBRANE and modulate CHOLESTEROL ESTER HYDROLASE activity.", "PM": "2017; PERILIPIN-1 was indexed under CARRIER PROTEINS and PHOSPHOPROTEINS 1991-2016.", "HN": "2017 (1991)", "MR": "20160115", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070778"}, {"RECTYPE": "D", "MH": "Giant Cell Tumor of Tendon Sheath", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tenosynovitis, Nodular", "MN": "C05.651.869.762", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Soft Tissue Neoplasms (1976-2016)", "MS": "A tumor arising in the SYNOVIAL MEMBRANE; SYNOVIAL BURSA; or TENDON sheath. It is characterized by OSTEOCLAST-like GIANT CELLS; FOAM CELLS; pigmented HEMOSIDERIN-laden MACROPHAGES and inflammatory infiltrate. It is classified either as diffuse or localized tenosynovitis.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070779"}, {"RECTYPE": "D", "MH": "Perilipin-2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, Perilipin 2", "MN": "D12.776.157.464.500.750", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A perilipin that is expressed by many different cell types. It binds FATTY ACIDS and CHOLESTEROL,  stabilizes TRIGLYCERIDES, and localizes to both the surface and hydrophobic core of LIPID DROPLETS, as well as the ENDOPLASMIC RECTICULUM and PLASMA MEMBRANE in MACROPHAGES. It also plays a central role in the biogenesis of lipid droplets and FOAM CELLS and is highly expressed by macrophages at atherosclerotic lesions in human arteries along with the INFLAMMATION markers TNF-ALPHA; MCP-1 RECEPTOR; and IL-6.", "PM": "2017; PERILIPIN-2 was indexed under PEPTIDES 1998-2011; and under MEMBRANE PROTEINS 2011-2016", "HN": "2017 (1998)", "MR": "20160119", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070780"}, {"RECTYPE": "D", "MH": "Perilipin-3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, TIP47", "MN": "D12.776.157.464.500.875", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A perilipin that localizes to LIPID DROPLETS; CYTOPLASM; ENDOSOMES; and PLASMA MEMBRANE, especially in MACROPHAGES. It functions as a transporter of free fatty acids to lipid droplets to promote their biogenesis and growth. It is also required for the transport of the MANNOSE-6-PHOSPHATE RECEPTOR from endosomes to the TRANS-GOLGI NETWORK. Its structure consists of four helix bundles that interact with the hydrophobic lipid droplet surface.", "PM": "2017; PERILIPIN-3 was indexed under CARRIER PROTIENS 1983-2004; under DNA-BINDING PROTEINS, INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS, and PREGNANCY PROTEINS 1983-2011; and under VESICULAR TRANSPORT PROTEINS 2011-2016  1983-2011", "HN": "2017 (1983)", "MR": "20160119", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070796"}, {"RECTYPE": "D", "MH": "Perilipin-5", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, Perilipin 5", "MN": "D12.776.157.464.500.937", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Proteins (2006-2016)", "MS": "A perilipin that functions in LIPOGENESIS; LIPOLYSIS; and fatty acid oxidation in BROWN ADIPOSE TISSUE; heart, liver, and skeletal muscle. It recruits MITOCHONDRIA to the surface of LIPID DROPLETS where it functions in both the storage of fatty acids as TRIGLYCERIDES, and their release for mitochondrial fatty acid oxidation in response to metabolic needs.", "PM": "2017", "HN": "2017", "MR": "20160119", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070797"}, {"RECTYPE": "D", "MH": "Nogo Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reticulon 4 Protein", "MN": "D12.776.631.580.738", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "Myelin proteins that are expressed as three isoforms: Nogo-A, Nogo-B, and Nogo-C. These share a C-terminal reticulon homology domain (RHD), consisting of two hydrophobic membrane domains flanking a 66 amino acid (Nogo-66) hydrophilic region. A long transmembrane region allows conformations that either span the entire membrane or fold into a hairpin conformation. Nogo inhibits NEURITE outgrowth and modulates wiring and the restriction of SYNAPTIC PLASTICITY in the adult central nervous system. It also regulates neurite fasciculation, branching, and extension in the developing nervous system.", "PM": "2017; NOGO PROTEIN was indexed under MYELIN PROTEINS 2000-2016", "HN": "2017 (2000)", "MR": "20160711", "DA": "20160711", "DC": "1", "DX": "20170101", "UI": "D000070798"}, {"RECTYPE": "D", "MH": "Open Fracture Reduction", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Reductions, Fracture Open", "MN": "E04.555.300.690", "FX": "Fractures, Open", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Fracture Fixation (1963-2016)", "MS": "Restoration of normal alignment of a fractured bone via an OPERATIVE SURGICAL PROCEDURE.", "PM": "2017", "HN": "2017", "MR": "20220413", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070799"}, {"RECTYPE": "D", "MH": "Nogo Receptor 1", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Reticulon 4 Receptor", "MN": "D12.776.631.651.500", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (2004-2016)", "MS": "A high affinity receptor for myelin-associated inhibitors (MAIs) that include NOGO-A PROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; and MYELIN-ASSOCIATED GLYCOPROTEIN. It is expressed primarily by neurons in the brain and OLFACTORY BULBS. During embryonic development, it is expressed in the PERIPHERAL NERVOUS SYSTEM.  It localizes to GROWTH CONES and may inhibit neurite outgrowth following SPINAL INJURY.", "PM": "2017", "HN": "2017", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070816"}, {"RECTYPE": "D", "MH": "Nogo Receptor 2", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Reticulon 4 Receptor like 2 Protein", "MN": "D12.776.631.651.250", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (2003-2016)", "MS": "A Nogo receptor that binds to MYELIN-ASSOCIATED GLYCOPROTEIN. It localizes to the GROWTH CONES of neurons in the THALAMUS; CORTEX: AMYGDALA; OLFACTORY BULBS; and HYPOTHALAMUS.", "PM": "2017", "HN": "2017", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070817"}, {"RECTYPE": "D", "MH": "Discoidin Domain Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, Discoidin Domain", "MN": "D12.776.543.750.705.880.300", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "EC 2.7.10.1", "MS": "Receptor tyrosine kinases that bind COLLAGENS. They are characterized by the presence of extracellular DISCOIDIN DOMAINS that activate SIGNAL TRANSDUCTION PATHWAYS in response to collagen binding. They may also be cleaved by MATRIX METALLOPROTEINASES to mediate cell interactions with the EXTRACELLULAR MATRIX.", "PM": "2017; DISCOIDIN DOMAIN RECEPTORS was indexed under RECEPTORS, MITOGEN and RECEPTOR PROTEIN-TYROSINE KINASES 1999-2016", "HN": "2017 (1999)", "MR": "20210521", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070818"}, {"RECTYPE": "D", "MH": "Discoidin Domain Receptor 1", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Protein, DDR1", "MN": "D12.776.543.750.705.880.300.500", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "EC 2.7.10.1", "MS": "A discoidin domain receptor for FIBRILLAR COLLAGEN that functions in a variety of cellular processes. For example, it regulates cell attachment to the EXTRACELLULAR MATRIX, remodeling of the extracellular matrix, CELL MIGRATION; CELL DIFFERENTIATION; CELL PROLIFERATION; and CELL SURVIVAL.", "PM": "2017; DISCOIDIN DOMAIN RECEPTOR 1 was indexed under RECEPTORS, MITOGEN and RECEPTOR PROTEIN-TYROSINE KINASES 1999-2016", "HN": "2017 (1999)", "MR": "20210521", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070819"}, {"RECTYPE": "D", "MH": "Discoidin Domain Receptor 2", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Protein, DDR2", "MN": "D12.776.543.750.705.880.300.750", "MH_TH": "NLM (1999)", "ST": "T192", "RN": "EC 2.7.10.1", "MS": "A discoidin domain receptor for FIBRILLAR COLLAGEN and non-fibrillar COLLAGEN TYPE X. It functions in many cellular and developmental processes that include remodeling of the EXTRACELLULAR MATRIX; CELL MIGRATION; CELL DIFFERENTIATION; and CELL PROLIFERATION; as well as OSTEOGENESIS and the maturation of CHONDROCYTES.", "PM": "2017; DISCOIDIN DOMAIN RECEPTOR 2 was indexed under RECEPTORS, MITOGEN and RECEPTOR PROTEIN-TYROSINE KINASES 1999-2016", "HN": "2017 (1999)", "MR": "20210521", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070820"}, {"RECTYPE": "D", "MH": "Discoidins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Discoidin|T116|T123|NON|EQV|NLM (2022)|201015|abbcdef", "ENTRY": "Discoidin II", "MN": "D12.776.820.250", "MH_TH": "NLM (1980)", "ST": "T123", "RN": "0", "MS": "Lectins that were identified in DICTYOSTELIUM DISCOIDEUM. They bind to GALACTOSE and are involved in cell-substratum adhesion, maintenance of morphology during aggregation, and spore formation.", "PM": "2017; DISCOIDINS was indexed under PROTOZOAN PROTEINS 1998-2016; under LECTINS 2002-2016; under FUNGAL PROTEINS 1980-1998; and under CARRIER PROTEINS 1976-1983", "HN": "2017 (1980)", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070821"}, {"RECTYPE": "D", "MH": "Discoidin Domain", "AQ": "DE GE IM PH RE", "ENTRY": "Domains, Discoidin", "MN": "G02.111.570.820.709.275.750.219", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Protein Structure, Tertiary (1998-2016)", "MS": "A protein domain originally identified in DISCOIDINS. It occurs in a variety of unrelated proteins in multicellular organisms, where it recognizes different ligands with distinct biological functions. Structurally, it consists of two antiparallel beta sheets that form a \"jellyroll\" configuration stabilized by two intramolecular disulfide bonds. Sequence differences within this module determine ligand specificity; in DISCOIDIN DOMAIN RECEPTORS, it binds to FIBRILLAR COLLAGENS and NON-FIBRILLAR COLLAGENS.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070822"}, {"RECTYPE": "D", "MH": "Lysine Acetyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lysine Acetyltransferase|T116|T126|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "K Lysine Acetyltransferases", "MN": "D08.811.913.050.134.415", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 2.3.1.32", "PI": "Lysine (2003-2016)", "MS": "Acetyltransferases that can transfer an acyl group  to specific LYSINE residues within HISTONES (HISTONE ACETYLTRANSFERASES) and/or non-histone proteins.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070837"}, {"RECTYPE": "D", "MH": "Pharmacy Research", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Research, Pharmacy", "MN": "H02.646.375", "MH_TH": "NLM (2017)", "ST": "T091", "AN": "pharmacy research as a field or the progress or status of pharmacy research; do not add routinely for specific pharmacy research studies; do not confuse with PHARMACEUTICAL RESEARCH", "MS": "RESEARCH activity focused on PHARMACY.", "PM": "2017", "HN": "2017", "MR": "20170711", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070838"}, {"RECTYPE": "D", "MH": "Nuclear Pharmacy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Pharmacy, Nuclear", "MN": "H02.646.250", "FX": "Nuclear Medicine", "MH_TH": "NLM (2017)", "ST": "T091", "PI": "Nuclear Medicine (1975-2016)", "MS": "An application of PHARMACY involving the preparation and dispensing of radioactive materials for use in medications.", "PM": "2017", "HN": "2017", "MR": "20160208", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070840"}, {"RECTYPE": "D", "MH": "High Fidelity Simulation Training", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "MN": "I02.903.847.250", "FX": "Nursing Education Research", "MH_TH": "NLM (2017)", "ST": "T065", "PI": "Simulation Training (1999-2016)", "MS": "A controlled learning environment that closely represents reality.", "PM": "2017", "HN": "2017", "MR": "20160208", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070856"}, {"RECTYPE": "D", "MH": "Walk Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Six-Minute Walk Test|T060|NON|NRW|NLM (2021)|200115|abcdef", "ENTRY": "Walk Tests, Six-Minute", "MN": "E01.370.370.380.250.500", "MH_TH": "NLM (2017)", "ST": "T060", "PI": "Exercise Test (1986-2016)", "MS": "A measure of endurance tests that show how far and fast an individual can walk without stopping within a certain period of time.", "PM": "2017", "HN": "2017", "MR": "20200609", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070857"}, {"RECTYPE": "D", "MH": "Tensins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tensin|T116|T123|NON|EQV|NLM (1992)|151207|abbcdef", "MN": "D12.776.220.525.719", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A family of multidomain microfilament proteins that bind ACTIN FILAMENTS and INTEGRINS at FOCAL ADHESIONS. They generally consist of an N-terminal domain with homology to PHOSPHOTYROSINE PHOSPHATASE, a C2 DOMAIN; unique central regions rich in PROLINE; ALANINE; GLYCINE; and SERINE; an SH2 DOMAIN; and a C-terminal phosphotyrosine-binding region. They are involved in CELL MIGRATION; CELL ADHESION; SIGNAL TRANSDUCTION; and reorganization of the CYTOSKELETON.", "PM": "2017; TENSINS was indexed under MICROFILAMENT PROTEINS (1992-2016)", "HN": "2017 (1992)", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070876"}, {"RECTYPE": "D", "MH": "Bankart Lesions", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tears, Bankart", "MN": "C26.803.250.500", "MH_TH": "NLM (2017)", "ST": "T037", "PI": "Shoulder Dislocation (1988-2016)", "MS": "An anterior capsulolabral injury associated with a tear of the anteroinferior GLENOID LABRUM.", "PM": "2017", "HN": "2017", "MR": "20170601", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000070896"}, {"RECTYPE": "D", "MH": "Tenocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Tenocyte", "MN": "A11.329.840", "MH_TH": "NLM (2017)", "ST": "T025", "PI": "Tendons (1980-2016)", "MS": "Elongated FIBROBLASTS and fibrocytes that lie between the collagen fibers and form the TENDON proper.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070916"}, {"RECTYPE": "D", "MH": "Synoviocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Synoviocyte", "MN": "A11.329.835", "MH_TH": "NLM (2017)", "ST": "T025", "PI": "Synovial Membrane (1971-2016)", "MS": "Cells on the luminal surface of the SYNOVIAL MEMBRANE. Type A synoviocytes are MACROPHAGES responsible for waste removal from the joint cavity. Fibroblast-like type B synoviocytes are involved in production of joint matrix constituents (e.g., HYALURONAN; COLLAGEN; and FIBRONECTIN).", "PM": "2017", "HN": "2017", "MR": "20170601", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000070918"}, {"RECTYPE": "D", "MH": "MutL Proteins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "MutL Homologs|T116|T126|NON|NRW|NLM (2017)|151215|abbcdef", "MN": "D12.776.260.540", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.6.1.3", "PI": "DNA Repair (1982-2016)", "MS": "DNA repair proteins that include the bacterial MutL protein and its eukaryotic homologs. They consist of a conserved N-terminal region with weak ATPase activity, an endonuclease motif, and a C-terminal domain that forms MutL homodimers or heterodimers between MLH1 and the PMS1, MISMATCH REPAIR ENDONUCLEASE PMS2; or MLH3 proteins. These complexes function in DNA repair pathways, primarily DNA MISMATCH REPAIR, where MutL/MLH1 and the MUTS DNA MISMATCH-BINDING PROTEIN are targeted to damaged DNA.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070956"}, {"RECTYPE": "D", "MH": "MutL Protein Homolog 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "MutL Homolog 1|T116|T126|NON|EQV|NLM (2017)|151215|abbcdef", "MN": "D12.776.260.540.500", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.6.1.3", "PI": "Nuclear Proteins (1995-2016)", "MS": "Eukaryotic homolog of the bacterial MutL DNA MISMATCH REPAIR protein. It heterodimerizes with MISMATCH REPAIR ENDONUCLEASE PMS2 to form MutL alpha, which is recruited to DNA mismatch sites by the MUTS DNA MISMATCH-BINDING PROTEIN. Mutations in the human MLH1 gene are associated with COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070957"}, {"RECTYPE": "D", "MH": "Mismatch Repair Endonuclease PMS2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Postmeiotic Segregation Increased S. cerevisiae 2", "MN": "D12.776.260.540.250", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.6.1.3", "PI": "DNA Repair Enzymes (2001-2016)", "MS": "A MutL protein and component of the DNA MISMATCH REPAIR system. Its ENDONUCLEASE activity introduces SINGLE-STRAND DNA BREAKS which create entry points for EXO1 exonuclease to remove the strand containing the mismatch. It may also function in DNA DAMAGE signaling.", "PM": "2017", "HN": "2017", "MR": "20160301", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070976"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily G", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ABCG Transporter|T116|T123|NON|EQV|NLM (2022)|201007|abbcdef", "ENTRY": "Transporter, ABCG", "MN": "D12.776.543.585.100.228", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "ATP-Binding Cassette Transporters (2001-2016)", "MS": "A subfamily of ATP binding cassette transporters that function primarily in the transport of lipids and STEROLS across the CELL MEMBRANE. They also export UREA and various drugs resulting in MULTIDRUG RESISTANCE. They are smaller than most other ATP binding cassette proteins, consisting of six transmembrane alpha helices and a distinct N-terminal cytoplasmic ATP-binding domain, and function as homo- or heterodimers with other ABCG transporters.", "PM": "2019; see ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY G 2017-2018", "HN": "2019 (2017)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070996"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily G, Member 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CD338 Antigen|T116|T123|ABX|EQV|NLM (2017)|151218|abbcdef", "MN": "D12.776.543.585.100.228.500", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "ATP-Binding Cassette Transporters (1999-2016)", "MS": "ATP-binding cassette transporter, sub-family G protein that functions as a high capacity UREA exporter, transporter of STEROLS, and in the absorption and efflux of many drugs. Its efflux activity for ANTINEOPLASTIC AGENTS contributes to DRUG RESISTANCE. It functions as a homodimer and is expressed by cells in a variety of organs, as well as by NEOPLASTIC STEM CELLS.", "PM": "2019; see ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY G, MEMBER 2 2017-2018", "HN": "2019 (2017)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070997"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily G, Member 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "ATP Binding Cassette Transporter 8", "MN": "D12.776.543.585.100.228.250", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "ATP-Binding Cassette Transporters (2000-2016)", "MS": "ATP binding cassette transporter that functions primarily as a lipid and CHOLESTEROL exporter in MACROPHAGES.  It may also function in intracellular lipid transport and homoeostasis.", "PM": "2019; see ATP BINDING CASSETTER TRANSPORTER, SUB-FAMILY G, MEMBER 1 2017-2018", "HN": "2019 (2017)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000070998"}, {"RECTYPE": "D", "MH": "Hyperekplexia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperekplexias", "MN": "C10.228.590", "MH_TH": "NLM (2014)", "ST": "T047", "MS": "A neurological disorder characterized by an excessive startle reaction with ABNORMAL REFLEX;  MYOCLONIC JERKS; and MUSCLE HYPERTONIA.", "PM": "2017; see STIFF PERSON SYNDROME 2000-2016", "HN": "2017; use STIFF PERSON SYNDROME 2000-2016", "MR": "20160616", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071017"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily G, Member 5", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sterolin 1 Protein", "MN": "D12.776.543.585.100.228.750", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "Lipoproteins (2000-2016)", "MS": "ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY G protein that functions as a heterodimer with ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY G, MEMBER 8 in the selective transport of DIETARY CHOLESTEROL and PHYTOSTEROLS into and export out of ENTEROCYTES. It also functions in selective sterol excretion by the liver into bile.", "PM": "2019; see ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY G, MEMBER 5 2017-2018", "HN": "2019 (2017)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071018"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily G, Member 8", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sterolin 2 Protein", "MN": "D12.776.543.585.100.228.875", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "Lipoproteins (2000-2016)", "MS": "ATP-binding cassette transporter, sub-family G protein that functions as a heterodimer with ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY G, MEMBER 5 in the selective transport of DIETARY CHOLESTEROL and PHYTOSTEROLS into and export out of ENTEROCYTES. It also functions in selective sterol excretion by the liver into bile.", "PM": "2019; see ATP BINDING CASETTE TRANSPORTER, SUB-FAMILY G, MEMBER 8 2017-2018", "HN": "2019 (2017)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071019"}, {"RECTYPE": "D", "MH": "Hemochromatosis Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "HLA H Antigen", "MN": "D23.050.705.552.100.375", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1997-2016)", "MS": "A membrane protein and MHC class I antigen. It contains an IMMUNOGLOBULIN C1-SET DOMAIN and interacts with BETA 2-MICROGLOBULIN. It may also regulate the interaction of TRANSFERRIN with the TRANSFERRIN RECEPTOR. Mutations in the HFE gene are associated with cases of FAMILIAL HEMOCHROMATOSIS.", "PM": "2017", "HN": "2017", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071020"}, {"RECTYPE": "D", "MH": "Sentinel Lymph Node", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sentinel Lymph Nodes", "MN": "A15.382.520.604.412.750", "FX": "Sentinel Lymph Node Biopsy", "MH_TH": "NLM (2017)", "ST": "T023", "PI": "Sentinel Lymph Node Biopsy (1999-2016)", "MS": "First lymph node to receive drainage from the primary tumor. SENTINEL LYMPH NODE BIOPSY is performed to determine early METASTASIS status because cancer cells may appear first in the sentinel node.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071036"}, {"RECTYPE": "D", "MH": "Place Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Place Cells, Hippocampal", "MN": "A11.671.790.500", "MH_TH": "NLM (2017)", "ST": "T025", "PI": "Neurons (1979-2016)", "MS": "Pyramidal neurons in the HIPPOCAMPUS that play a role in cognitive representation of a specific location within a space.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071037"}, {"RECTYPE": "D", "MH": "Grid Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Grid Cell", "MN": "A11.671.322", "MH_TH": "NLM (2017)", "ST": "T025", "PI": "Neurons (2005-2016)", "MS": "Neurons in the ENTORHINAL CORTEX that project to the HIPPOCAMPUS. Grid cells and PLACE CELLS play a role in cognitive representation of spatial memory and navigation.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071038"}, {"RECTYPE": "D", "MH": "Perirhinal Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Brodmann's Area 36|T023|EPO|NRW|NLM (2022)|201008|abcdef", "ENTRY": "Perirhinal Cortices", "MN": "A08.186.211.200.885.287.500.863.574", "MH_TH": "NLM (2017)", "ST": "T023", "PI": "Cerebral Cortex (1983-2016)", "MS": "An area in the temporal lobe that is important for memory encoding and retrieval. It is bordered caudally by the parahippocampal cortex (see HIPPOCAMPUS) and ventrally and medially by the ENTORHINAL CORTEX.", "PM": "2017", "HN": "2017", "MR": "20210305", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071039"}, {"RECTYPE": "D", "MH": "Axon Initial Segment", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Trigger Zone, Axonal", "MN": "A11.671.501.145.250", "MH_TH": "NLM (2017)", "ST": "T026", "PI": "Axons (1973-2016)", "MS": "First segment of axon that connects distal axon segments to the neuronal CELL BODY at the axon hillock region. The axon initial segment is not protected by the MYELIN SHEATH and has properties critical for axonal growth. The axon initial segment and the axon hillock form an axonal trigger zone.", "PM": "2017", "HN": "2017", "MR": "20220708", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071040"}, {"RECTYPE": "D", "MH": "Esophageal Mucosa", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Mucosa, Oesophageal", "MN": "A10.615.550.146", "MH_TH": "NLM (2017)", "ST": "T024", "PI": "Esophagus (1963-2016)", "MS": "Circular innermost layer of the ESOPHAGUS wall that mediates esophageal PERISTALSIS which pushes ingested food bolus toward the stomach.", "PM": "2017", "HN": "2017", "MR": "20160301", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071041"}, {"RECTYPE": "D", "MH": "Anorectal Malformations", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stenosis, Anorectal", "MN": "C16.131.314.047", "MH_TH": "NLM (2017)", "ST": "T019", "MS": "Congenital defects in the anus and the rectum often involving the urinary and genital tracts.", "PM": "2017; ANORECTAL ANOMALIES and ANORECTAL ARTRESIA was under ANAL CANAL/abnormalities; ANUS, IMPERFORATE; and RECTUM/abnormalities, 2014-2016", "HN": "2017(2014)", "MR": "20190701", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071056"}, {"RECTYPE": "D", "MH": "Tardive Dyskinesia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tardive Dystonias", "MN": "C23.888.592.350.275.500", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Drug-related movement disorder characterized by uncontrollable movements in certain muscles. It is associated with a long-term exposure to certain neuroleptic medications (e.g., METOCLOPRAMIDE).", "PM": "2017; see MOVEMENT DISORDERS 2010-2016", "HN": "2017; use MOVEMENT DISORDERS 2010-2016", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071057"}, {"RECTYPE": "D", "MH": "Huntingtin Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "IT15 Protein|T116|T123|ABX|EQV|NLM (2017)|151223|abbcdef", "MN": "D12.776.441", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Nuclear Proteins (1994-2016)", "MS": "A protein that is highly expressed in the nervous system as well as other tissues; its size and structure vary due to polymorphisms. Expanded CAG TRINUCLEOTIDE REPEATS have been identified in the Huntingtin (HD) Gene of patients with HUNTINGTON DISEASE and are associated with abnormal PROTEIN AGGREGATES. Huntingtin interacts with proteins involved in a variety of gene expression and cellular processes; it is also essential for embryonic development.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071058"}, {"RECTYPE": "D", "MH": "Phage Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Phage Therapies", "MN": "E02.095.841", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Bacteriophages (1967-2016)", "MS": "Therapeutic use of BACTERIOPHAGES to treat diseases.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071059"}, {"RECTYPE": "D", "MH": "Breast Density", "AQ": "DE EH GE IM PH RE", "ENTRY": "Mammographic Densities", "MN": "G07.100.138", "MH_TH": "NLM (2017)", "ST": "T081", "PI": "Breast (1996-2016)", "MS": "Measurement of relative composition of different BREAST tissue types often determined from MAMMOGRAPHY; ULTRASONOGRAPHY; or MRI.", "PM": "2017; MAMMOGRAPHIC DENSITY was under BREAST NEOPLASMS and MAMMARY GLANDS, HUMAN/abnormalities, 2014-2016", "HN": "2017 (2014)", "MR": "20160226", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071060"}, {"RECTYPE": "D", "MH": "Traditional Pulse Diagnosis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Traditional Pulse Readings", "MN": "E01.370.503", "FX": "Pulse", "MH_TH": "NLM (2017)", "ST": "T060", "PI": "Pulse (1978-2016)", "MS": "Technique used in AYURVEDIC MEDICINE, and EAST ASIAN TRADITIONAL MEDICINE, in which reading PULSE is used in the diagnosis of diseases.", "PM": "2017", "HN": "2017", "MR": "20170707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071061"}, {"RECTYPE": "D", "MH": "Sutureless Surgical Procedures", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Sutureless Surgical Procedure", "MN": "E04.987.887", "FX": "Tissue Adhesives", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Suture Techniques (1964-2016)", "MS": "Surgical techniques in which SUTURES are not applied to surgical wounds.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071062"}, {"RECTYPE": "D", "MH": "Endoglin", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Antigen, CD105", "MN": "D12.776.543.750.250", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (2006-2016)", "MS": "A membrane glycoprotein and ANGIOGENESIS FACTOR that is expressed by cells of the VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; and MONOCYTES. It functions as a co-receptor for TRANSFORMING GROWTH FACTOR BETA and modulates CELL ADHESION. Mutations in the endoglin gene are associated with cases of HEREDITARY HEMORRHAGIC TELANGIECTASIA.", "PM": "2017", "HN": "2017", "MR": "20170524", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071063"}, {"RECTYPE": "D", "MH": "Alert Fatigue, Health Personnel", "AQ": "PC", "PRINT ENTRY": "Alarm Fatigue|T041|NON|EQV|NLM (2024)|220830|abcdef", "ENTRY": "Fatigue, Alarm", "MN": "N05.700.075", "MH_TH": "NLM (2017)", "ST": "T041", "PI": "Fatigue (2010-2016)", "MS": "Mental fatigue experienced by health care providers who encounter numerous alerts and reminders from the use of CLINICAL DECISION SUPPORT SYSTEMS. As the numbers of alerts and reminders designed to provide meaningful assistance to the patient care process increases, many health personnel may ignore them.", "PM": "2017", "HN": "2017", "MR": "20230518", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071064"}, {"RECTYPE": "D", "MH": "Standing Orders", "AQ": "CL ST", "ENTRY": "Standing Order", "MN": "N05.715.360.330.125.750", "MH_TH": "NLM (2017)", "ST": "T062", "PI": "Clinical Protocols (1991-2016)", "MS": "Medical procedures and prescriptions regarding treatment of a patient that can be exercised by other health care personnel when predetermined conditions have been met.", "PM": "2017", "HN": "2017", "MR": "20180702", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071065"}, {"RECTYPE": "D", "MH": "Patient Reported Outcome Measures", "PRINT ENTRY": "Patient-Reported Outcomes|T058|NON|REL|NLM (2021)|191119|abcdef", "ENTRY": "Outcome, Patient-Reported", "MN": "N06.850.520.308.980.344.500", "MH_TH": "NLM (2017)", "ST": "T081", "PI": "Patient Outcome Assessment (2013-2016)", "MS": "Assessment of the quality and effectiveness of health care as measured and directly reported by the patient.", "PM": "2017", "HN": "2017", "MR": "20200228", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071066"}, {"RECTYPE": "D", "MH": "Pneumonia, Necrotizing", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pneumonias, Necrotizing", "MN": "C08.730.610.608", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Pneumonia (1966-2016)", "MS": "Severe complication of pneumonia characterized by liquefaction of lung tissue.", "PM": "2017", "HN": "2017", "MR": "20190617", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071067"}, {"RECTYPE": "D", "MH": "Lipocalin-2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Neutrophil Gelatinase Associated Lipocalin", "MN": "D12.776.624.664.700.123", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Proto-Oncogene Proteins (2006-2016)", "MS": "A lipocalin of approximately 200 amino acids that functions as an iron transporter and is expressed by cells of BONE MARROW and many other cells with secretory functions. It is involved in APOPTOSIS and may function to limit pathogenic bacterial growth as part of the INNATE IMMUNE RESPONSE.", "PM": "2017", "HN": "2017", "MR": "20160301", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071068"}, {"RECTYPE": "D", "MH": "Multiple Chronic Conditions", "AQ": "CL DT EC EH EP MO NU PC PX RH TH", "ENTRY": "Chronic Illnesses, Multiple", "MN": "C23.550.291.500.500", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Chronic Disease (2008-2016)", "MS": "Two or more concurrent chronic physical, mental, or behavioral health problems in an individual.", "PM": "2017", "HN": "2017", "MR": "20190226", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071069"}, {"RECTYPE": "D", "MH": "Familial Multiple Lipomatosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Multiple Lipomas, Familial", "MN": "C18.452.584.718.625", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Lipomatosis (1973-2016)", "MS": "A rare autosomal disorder characterized by numerous encapsulated lipomas on the trunk and extremities. The lipomas are usually not painful but can cause pain when growing. In rare cases, one lipoma can become painful and progress to multiple painful lipomas; it is then referred to as Dercum's Disease Type III", "PM": "2017", "HN": "2017", "MR": "20160616", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071070"}, {"RECTYPE": "D", "MH": "Microaneurysm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Retinal Microaneurysms", "MN": "C14.907.055.817", "MH_TH": "NLM (2017)", "ST": "T047", "AN": "coordinate with specific site", "PI": "Aneurysm (1963-2016)", "MS": "Aneurysm of the MICROVASCULATURE. Charcot\u2013Bouchard aneurysms are aneurysms of the brain vasculature which is a common cause of CEREBRAL HEMORRHAGE. Retinal microaneurysm is an early diagnostic sign of DIABETIC RETINOPATHY.", "PM": "2017", "HN": "2017", "MR": "20160615", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071071"}, {"RECTYPE": "D", "MH": "Acute Febrile Encephalopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Febrile Encephalopathy", "MN": "C10.228.140.021", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Fever (1971-2016)", "MS": "Acute onset of fever accompanied by seizures, cerebral inflammation and a change in mental status (e.g., confusion, disorientation, and coma).", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071072"}, {"RECTYPE": "D", "MH": "Neonatal Sepsis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Sepsis, Neonatal Late-Onset", "MN": "C23.550.470.790.500.470", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Sepsis (1964-2016)", "MS": "Blood infection that occurs in an infant younger than 90 days old. Early-onset sepsis is seen in the first week of life and most often appears within 24 hours of birth. Late-onset occurs after 1 week and before 3 months of age.", "PM": "2017", "HN": "2017", "MR": "20190617", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071074"}, {"RECTYPE": "D", "MH": "Small Fiber Neuropathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Small Fibre Neuropathies", "MN": "C10.668.829.860", "MH_TH": "GHR (2014)", "ST": "T047", "MS": "Disorder of the peripheral nerves that primarily impair small nerve fibers. The affected small nerve fibers include myelinated A-delta fibers (see A FIBERS) and unmyelinated C FIBERS. Because these small fibers innervate skin and help control autonomic function, their neuropathy presents with neuropathic pain, reduced thermal and pain sensitivity, and autonomic dysfunction (e.g. abnormal sweating or facial flushing). Small fiber neuropathy can be idiopathic or associated with underlying diseases (e.g., AMYLOIDOSIS; DIABETES MELLITUS; SARCOIDOSIS; or VASCULITIS).", "PM": "2017; see ERYTHROMELALGIA 2014-2016", "HN": "2017; use ERYTHROMELALGIA 2014-2016", "MR": "20160226", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071075"}, {"RECTYPE": "D", "MH": "Network Meta-Analysis", "ENTRY": "Network Meta-Analyses", "MN": "N06.850.520.445.500.500", "MH_TH": "NLM (2017)", "ST": "T170", "PI": "Randomized Controlled Trials as Topic (2008-2016)", "MS": "Meta-analysis of randomized trials in which estimates of comparative treatment effects are visualized and interpreted from a network of interventions that may or may not have been evaluated directly against each other. Common considerations in network meta-analysis include conceptual and statistical heterogeneity and incoherence.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071076"}, {"RECTYPE": "D", "MH": "Surgical Oncology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Oncology, Surgical", "MN": "H02.403.810.796", "MH_TH": "NLM (2017)", "ST": "T091", "PI": "Neoplasms/surgery (1979-2016)", "MS": "A surgical specialty concerned with management of cancer.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071077"}, {"RECTYPE": "D", "MH": "Stenosis, Pulmonary Vein", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vein Stenosis, Pulmonary", "MN": "C14.907.798", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Constriction, Pathologic (1980-2016)", "MS": "Narrowing of the PULMONARY VEIN.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071078"}, {"RECTYPE": "D", "MH": "Stenosis, Pulmonary Artery", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stenoses, Pulmonary Artery", "MN": "C14.907.137.825", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Constriction, Pathologic (1963-2016)", "MS": "Narrowing of the PULMONARY ARTERIES.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071079"}, {"RECTYPE": "D", "MH": "Cortical Excitability", "AQ": "DE GE IM PH RE", "ENTRY": "Excitability, Cortical", "MN": "G11.561.200", "MH_TH": "NLM (2017)", "ST": "T060", "PI": "Transcranial Magnetic Stimulation (1992-2016)", "MS": "Measurable changes in activities in the CEREBRAL CORTEX upon a stimulation. A change in cortical excitability as measured by various techniques (e.g., TRANSCRANIAL MAGNETIC STIMULATION) is associated with brain disorders.", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071080"}, {"RECTYPE": "D", "MH": "Minimal Clinically Important Difference", "PRINT ENTRY": "Minimal Clinically Important Improvement|T081|NON|NRW|NLM (2023)|210930|abcdef", "MN": "N05.715.360.575.575.399.125.500", "MH_TH": "NLM (2017)", "ST": "T081", "PI": "Treatment Outcome (2001-2016)", "MS": "A statistically significant minimum set of clinical outcomes that demonstrates a clinical benefit of an intervention or treatment.", "PM": "2017", "HN": "2017", "MR": "20220413", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071081"}, {"RECTYPE": "D", "MH": "Single-Balloon Enteroscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Single Balloon Enteroscopy", "MN": "E04.502.250.250.250.080.500", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Endoscopy, Gastrointestinal (2003-2016)", "MS": "A balloon-assisted enteroscopy utilizing a flexible endoscope with one overtube balloon control unit.", "PM": "2017", "HN": "2017", "MR": "20160610", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071085"}, {"RECTYPE": "D", "MH": "Balloon Enteroscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Enteroscopy, Balloon", "MN": "E04.502.250.250.250.080", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Endoscopy, Gastrointestinal (2003-2016)", "MS": "An endoscopy of the small intestines accomplished while advancing the endoscope, which is assisted by one or two balloons", "PM": "2017", "HN": "2017", "MR": "20160616", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071087"}, {"RECTYPE": "D", "MH": "ADAMTS Proteins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adam Metallopeptidases With Thrombospondin Type 1 Motif Protein|T116|T126|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Protein, ADAMTSL", "MN": "D12.776.860.300.085", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.24.-", "PI": "ADAM Proteins (2006-2016)", "MS": "A subfamily of ADAM proteases that are distinguished by the presence of one or more THROMBOSPONDIN type-1 repeats (TSRs). These are three-strand motifs that contain characteristic TRYPTOPHAN, ARGININE, and CYSTEINE residues respectively. In contrast to ADAM proteins, which reside on CELL MEMBRANES, ADAMTS proteases are secreted and function in the EXTRACELLULAR MATRIX.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071096"}, {"RECTYPE": "D", "MH": "ADAMTS1 Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "ADAMTS 1 Protein", "MN": "D12.776.860.300.085.500", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.24.-", "PI": "ADAM Proteins (2006-2016)", "MS": "An ADAMTS protease that contains two disintegrin loops and three C-terminal thrombospondin (TS) motifs. It functions as an ANGIOGENESIS INHIBITOR as well as in normal tissue growth and fertility.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071097"}, {"RECTYPE": "D", "MH": "ADAMTS5 Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Aggrecanase 2", "MN": "D12.776.860.300.085.875", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.24.-", "PI": "ADAM Proteins (2006-2016)", "MS": "An ADAMTS protease that contains two C-terminal thrombospondin (TS) motifs. It functions primarily as an aggrecanase, cleaving AGGRECAN in CARTILAGE, and may be involved in the destruction of aggrecan in ARTHRITIS.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071116"}, {"RECTYPE": "D", "MH": "Laboratory Critical Values", "ENTRY": "Laboratory Critical Value", "MN": "E05.200.828", "MH_TH": "NLM (2017)", "ST": "T081", "PI": "Clinical Laboratory Techniques (1985-2016)", "MS": "Test results which deviate substantially from normal ranges of REFERENCE VALUES or other qualitative results. They trigger CLINICAL LABORATORY SERVICES to place a special alert to ensure PATIENT SAFETY.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071117"}, {"RECTYPE": "D", "MH": "ADAMTS7 Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "ADAMTS 7 Protein", "MN": "D12.776.860.300.085.937", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.24.-", "PI": "ADAM Proteins (2006-2016)", "MS": "An ADAMTS protease that contains four central and four C-terminal thrombospondin (TS) motifs. It binds to and degrades CARTILAGE OLIGOMERIC MATRIX PROTEIN.", "PM": "2017", "HN": "2017", "MR": "20160225", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071118"}, {"RECTYPE": "D", "MH": "ADAMTS9 Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "ADAMTS 9 Protein", "MN": "D12.776.860.300.085.968", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.24.-", "PI": "ADAM Proteins (2006-2016)", "MS": "An ADAMTS protease that contains 15 THROMBOSPONDIN (TS) motifs. It cleaves the PROTEOGLYCANS AGGRECAN and VERSICAN and also functions in protein transport from the ENDOPLASMIC RETICULUM to the GOLGI APPARATUS.", "PM": "2017", "HN": "2017", "MR": "20160705", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071119"}, {"RECTYPE": "D", "MH": "ADAMTS13 Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "von Willebrand Factor Cleaving Protease", "MN": "D12.776.860.300.085.813", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.24.87", "PI": "ADAM Proteins (2006-2016)", "MS": "An ADAMTS protease that contains eight thrombospondin (TS) motifs. It cleaves VON WILLEBRAND FACTOR to control vWF-mediated THROMBOSIS. Mutations in the ADAMTS13 gene have been identified in familial cases of PURPURA, THROMBOTIC THROMBOCYTOPENIC and defects in ADAMTS13 activity are associated with MYOCARDIAL INFARCTION; BRAIN ISCHEMIA; PRE-ECLAMPSIA; and MALARIA.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071120"}, {"RECTYPE": "D", "MH": "ADAMTS4 Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Aggrecanase 1", "MN": "D12.776.860.300.085.844", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.24.82", "MS": "An ADAMTS protease similar to ADAMTS5 PROTEIN. It contains a single C-terminal thrombospondin (TS) motif and cleaves AGGRECAN in CARTILAGE. It may also be involved in the destruction of aggrecan in ARTHRITIS.", "PM": "2017; ADAMTS4 PROTEIN was indexed under PROCOLLAGEN N-ENDOPEPTIDASE and ADAM PROTEINS 2006-2016; and under METALLOENDOPEPTIDASES 1999-2005", "HN": "2017 (1999)", "MR": "20160226", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071121"}, {"RECTYPE": "D", "MH": "Poly (ADP-Ribose) Polymerase-1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "PARP 1 Protein", "MN": "D08.811.913.400.725.115.690.420", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 2.4.2.30", "PI": "ADP Ribose Transferases (2006-2016)", "MS": "A poly(ADP-ribose) polymerase that contains two ZINC FINGERS in its N-terminal DNA-binding region. It modifies NUCLEAR PROTEINS involved in chromatin architecture and BASE EXCISION REPAIR with POLY ADENOSINE DIPHOSPHATE RIBOSE.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071137"}, {"RECTYPE": "D", "MH": "Promyelocytic Leukemia Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TRIM19 Protein|T116|T123|ABX|EQV|NLM (2017)|151231|abbcdef", "MN": "D12.776.934.500", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Tumor Suppressor Proteins (2008-2016)", "MS": "A tripartite motif protein that contains three ZINC FINGERS, including a RING FINGER DOMAIN, at its N-terminal. Several nuclear and one cytoplasmic isoforms result from alternative splicing of the PML gene; most nuclear isoforms localize to subnuclear structures (PML nuclear bodies) that are disrupted in ACUTE PROMYELOCYTIC LEUKEMIA cells.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071156"}, {"RECTYPE": "D", "MH": "Leucine-Rich Repeat Serine-Threonine Protein Kinase-2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Leucine Rich Repeat Serine Threonine Protein Kinase 2", "MN": "D12.776.705.750", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Protein-Serine-Threonine Kinases (2005-2016)", "MS": "A serine/threonine protein kinase with GTPase activity that contains 12 LEUCINE-rich repeats in its central region and 7 WD repeats C-terminal to its kinase and GTPase domains. It localizes to TRANSPORT VESICLES; the OUTER MITOCHONDRIAL MEMBRANE; and the GOLGI APPARATUS. It functions in PROTEIN TRANSPORT; regulates neuron morphology in the central nervous system, and also functions in the trafficking of SYNAPTIC VESICLES. Mutations in the LRRK2 gene have been identified in autosomal dominant cases of PARKINSON DISEASE (PARK8).", "PM": "2017", "HN": "2017", "MR": "20220712", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071158"}, {"RECTYPE": "D", "MH": "Forkhead Box Protein O1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Forkhead in Rhabdomyosarcoma Protein|T116|T123|NON|EQV|NLM (2017)|160104|abbcdef", "MN": "D12.776.930.977.249.250", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Forkhead Transcription Factors (2006-2016)", "MS": "A forkhead box transcription factor that is a major target of INSULIN signaling and regulator of metabolic homeostasis in response to OXIDATIVE STRESS. It binds to the insulin RESPONSE ELEMENT (IRE) and the related Daf-16 family binding element (DBE). Its activity is suppressed by insulin and it also regulates OSTEOBLAST proliferation, controls bone mass, and skeletal regulation of GLUCOSE metabolism. It promotes GLUCONEOGENESIS in HEPATOCYTES and regulates gene expression in ADIPOSE TISSUE. It is also an important CELL DEATH regulator. Chromosomal aberrations involving the FOXO1 gene occur in RHABDOMYOSARCOMA.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071161"}, {"RECTYPE": "D", "MH": "Trefoil Factors", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trefoil Protein|T116|T123|NON|EQV|NLM (2021)|200317|abbcdef", "ENTRY": "Protein, Trefoil", "MN": "D12.644.937", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Peptides (1992-2016)", "MS": "A family of small peptides expressed primarily by MUCOUS MEMBRANE EPITHELIAL CELLS in vertebrates. Their structure is highly conserved and is defined by a three-leaved (trefoil) domain of 42 or 43 amino acids; it includes six cysteines that create the trefoil structure through disulfide bridges. Trefoil peptides may form dimers with each other, or associate with MUCINS and other factors. They are important for maintaining epithelial integrity and for protection from noxious agents.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071162"}, {"RECTYPE": "D", "MH": "Trefoil Factor-1", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "pS2, Protein", "MN": "D12.644.937.500", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Tumor Suppressor Proteins (1997-2016)", "MS": "A 60 amino acid (6.5 kDa) trefoil factor that contains a single trefoil domain. It is expressed primarily by surface EPITHELIAL CELLS of the GASTRIC MUCOSA, where it associates with MUCIN 5AC.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071163"}, {"RECTYPE": "D", "MH": "Trefoil Factor-2", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Trefoil Factor 2", "MN": "D12.644.937.750", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A 106 amino acid (12 kDa) trefoil factor that contains two trefoil domains and associates with MUCIN-6. It is expressed in the GASTROINTESTINAL TRACT by cells of BRUNNER GLANDS; PYLORIC GLANDS and mucous neck cells. It inhibits GASTROINTESTINAL MOTILITY and GASTRIC ACID secretion and may help maintain the structural integrity of gastric mucus.", "PM": "2017; TREFOIL FACTOR-2 was indexed under PEPTIDES 2005-2016; under MUCINS 1992-2005; under MUSCLE PROTEINS 1992-2005; and under GROWTH SUBSTANCES 1992-2003", "HN": "2017 (1992)", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071164"}, {"RECTYPE": "D", "MH": "Trefoil Factor-3", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Trefoil Factor, Intestinal", "MN": "D12.644.937.875", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A 59 amino acid (6.6 kDa) trefoil factor that contains a single trefoil domain. It is expressed in all tissues with MUCOUS MEMBRANES, including GOBLET CELLS of the SMALL INTESTINE and LARGE INTESTINE. It associates with MUCIN-2 in the small intestine and may regulate epithelial CELL MIGRATION and WOUND HEALING.", "PM": "2017; TREFOIL FACTOR-3 was indexed under PEPTIDES 2006-2016; and under MUCINS and MUSCLE PROTEINS 1993-2005", "HN": "2017 (1992)", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071165"}, {"RECTYPE": "D", "MH": "Signaling Lymphocytic Activation Molecule Family", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Signaling Lymphocytic Activation Molecules|T116|T192|NON|EQV|NLM (2017)|160107|abbcdef", "MN": "D12.776.543.750.705.970", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (1997-2016)", "MS": "Type-I membrane glycoproteins that are expressed primarily on the surface of CD4 or CD8-positive T-CELLS; NATURAL KILLER CELLS; and some populations of B CELLS. They are characterized by an N-terminal, extracellular IMMUNOGLOBULIN-LIKE DOMAIN and a membrane-proximal IMMUNOGLOBULIN C2-SET DOMAIN. SLAMF receptors typically signal through homophilic interactions and are important for mediating the immune response and immune cell differentiation.", "PM": "2017", "HN": "2017", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071176"}, {"RECTYPE": "D", "MH": "Signaling Lymphocytic Activation Molecule Family Member 1", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Antigen, CD150", "MN": "D12.776.543.750.705.970.500", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "169535-43-7", "MS": "A 70-kDa SLAM family receptor that consists of an extracellular IMMUNOGLOBULIN-LIKE DOMAIN and an IMMUNOGLOBULIN C2-SET DOMAIN. It is expressed primarily by THYMOCYTES and activated T-LYMPHOCYTES, as well as by MACROPHAGES and DENDRITIC CELLS. It binds SLAMF1 receptors on other cells to mediate T-cell maturation and proliferation. It is also a receptor for the MEASLES VIRUS.", "PM": "2017; SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE FAMILY MEMBER 1 was indexed under RECEPTORS, CELL SURFACE and ANTIGENS, CD 2007-2016; and under GLYCOPROTEINS and IMMUNOGLOBULINS 1995-2006", "HN": "2017 (1995)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071177"}, {"RECTYPE": "D", "MH": "CD48 Antigen", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Surface Antigen, BCM1", "MN": "D12.776.543.750.705.970.250", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "MS": "A 40-45 KDa GPI-linked protein in the SLAM family that consists of two IMMUNOGLOBULIN C2-SET DOMAINS. It is expressed on the surface of a variety of cells with immune functions, including THYMOCYTES; mature B-LYMPHOCYTES and T-LYMPHOCYTES; NATURAL KILLER CELLS; DENDRITIC CELLS; MAST CELLS; and EOSINOPHILS. It  binds to CD2 and 2B4 (CD244) receptors to activate and modulate the immunologic response.", "PM": "2017; CD48 ANTIGEN was indexed under ANTIGENS, CD 2002-2016; and under ANTIGENS, DIFFERENTIATION 1990-2002", "HN": "2017 (1990)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071178"}, {"RECTYPE": "D", "MH": "Signaling Lymphocytic Activation Molecule Associated Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SLAM Associated Protein", "MN": "D12.776.476.024.426", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Intracellular Signaling Peptides and Proteins (2005-2016)", "MS": "A signal transducing adaptor protein that contains a single SH2 DOMAIN and is essential for the regulation of SLAM FAMILY RECEPTORS in the immune response. Mutations in the SLAM-associated protein gene have been identified in cases of X-LINKED LYMPHOPROLIFERATIVE DISEASE.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071179"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily B, Member 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TAP1, Peptide Transporter", "MN": "D12.776.543.585.450.074.500.500.250.250", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "ATP-Binding Cassette Transporters (1994-2016)", "MS": "An ATP-binding cassette, sub-family B protein (ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B) that functions in the transport of ANTIGENS from the CYTOPLASM to the ENDOPLASMIC RETICULUM for association with HISTOCOMPATIBILITY ANTIGENS CLASS I peptides. It also acts as a molecular scaffold for the final stage of MHC class I PROTEIN FOLDING.", "PM": "2019; see ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 2 2018; see ANTIGEN PEPTIDE TRANSPORTER-1 2017", "HN": "2019 (2017)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071181"}, {"RECTYPE": "D", "MH": "Autophagosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Phagophores|T026|NON|REL|NLM (2021)|190908|abcdef", "ENTRY": "Phagophore", "MN": "A11.284.430.214.190.875.190.700.500", "MH_TH": "NLM (2017)", "ST": "T026", "PI": "Phagosomes (1986-2016)", "MS": "Large spherical double-layered structures which function in AUTOPHAGY to engulf intracellular components such as ORGANELLES or pathogens. Their outer membrane then fuses with the LYSOSOME (forming the AUTOLYSOSOME) and the inner membrane and contents are digested by lysosomal HYDROLASES.", "PM": "2017", "HN": "2017", "MR": "20200609", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071182"}, {"RECTYPE": "D", "MH": "Autophagy-Related Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Autophagy-Related Protein|T116|T123|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Protein, Autophagy-Related", "MN": "D12.776.094", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Microtubule-Associated Proteins (2004-2016)", "MS": "Proteins and enzymes that function, often as components of MULTIPROTEIN COMPLEXES, to assemble AUTOPHAGOSOMES and carry out AUTOPHAGY.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071183"}, {"RECTYPE": "D", "MH": "Pharmacogenomic Variants", "AQ": "DE GE IM PH RE", "ENTRY": "Variants, Pharmacogenomic", "MN": "G05.365.795.446", "FX": "Precision Medicine", "MH_TH": "NLM (2017)", "ST": "T045", "PI": "Polymorphism, Genetic (1980-2016)", "MS": "Naturally occurring genetic variations associated with drug response (e.g., dosage, extent and rate of metabolic processes). While these variants are not markers for GENETIC PREDISPOSITION TO DISEASE they influence PHARMACOKINETICS and pharmacodynamics and often occur on genes encoding drug metabolism enzymes and transporters (e.g., ANGIOTENSIN CONVERTING ENZYME; CYTOCHROME P-450 CYP2D6).", "PM": "2017", "HN": "2017", "MR": "20160120", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071184"}, {"RECTYPE": "D", "MH": "Pharmacogenomic Testing", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "ENTRY": "Studies, Pharmacogenetic", "MN": "N02.421.726.233.221.500", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Pharmacogenetics (2001-2016)", "MS": "The detection of genetic variability (e.g., PHARMACOGENOMIC VARIANTS) relevant to PHARMACOGENETICS and PRECISION MEDICINE. The purpose of such genetic testing is to help determine the most effective treatment options and their optimum dosages with least potential risks for DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS.", "PM": "2017", "HN": "2017", "MR": "20160616", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071185"}, {"RECTYPE": "D", "MH": "Beclin-1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Coiled coil Myosin like Bcl2 interacting Protein", "MN": "D12.776.476.075.335", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (2006-2016)", "MS": "An autophagy related protein which functions as a core subunit of PHOSPHATIDYLINOSITOL 3-KINASE MULTIPROTEIN COMPLEXES. It mediates the formation of  phosphatidylinositol 3-phosphate and functions in AUTOPHAGY, where it is required for maturation of the AUTOPHAGOSOME. It also functions in ENDOCYTOSIS and CYTOKINESIS as part of a separate complex. Beclin-1 associates with INTRACELLULAR MEMBRANES and interacts with the PROTO-ONCOGENE PROTEINS C-BCL-2 and BCL-X PROTEIN.", "PM": "2017", "HN": "2017", "MR": "20160301", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071186"}, {"RECTYPE": "D", "MH": "Autophagy-Related Protein 5", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Autophagy Related Protein 5", "MN": "D12.776.094.250", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Microtubule-Associated Proteins (2004-2016)", "MS": "An autophagy-related protein that functions in AUTOPHAGOSOME biogenesis. It is conjugated to the ATG12 PROTEIN via a process that is similar to UBIQUITINATION and involves the ATG7 PROTEIN and ATG10 enzyme. The ATG12-ATG5 conjugate acts as an E3 UBIQUITIN LIGASE-like enzyme and is required for the localization of ATG8 PROTEINS to AUTOPHAGOSOME vesicle membranes and modification of membrane lipids.", "PM": "2017", "HN": "2017", "MR": "20160225", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071187"}, {"RECTYPE": "D", "MH": "Autophagy-Related Protein-1 Homolog", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Unc 51 Like Kinase 1", "MN": "D12.776.476.563.108", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Protein-Serine-Threonine Kinases (1998-2016)", "MS": "A serine/threonine-protein kinase that functions in AUTOPHAGY in response to starvation. It acts on the PHOSPHATIDYLINOSITOL 3-KINASE complex PIK3C3 to regulate AUTOPHAGOSOME formation. It also functions as both a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) and is activated by AMPK, which it also negatively regulates.", "PM": "2017", "HN": "2017", "MR": "20210528", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071189"}, {"RECTYPE": "D", "MH": "Autophagy-Related Protein 8 Family", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ATG8 Protein|T116|T123|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Protein, ATG8 Family", "MN": "D12.776.947.187", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Microtubule-Associated Proteins (1998-2016)", "MS": "UBIQUITIN-like modifier proteins that function in CYTOPLASM to VACUOLE transport (Cvt), vesicle transport within the GOLGI APPARATUS, and AUTOPHAGOSOME biogenesis. They are also required for selective autophagic degradation of the nucleus (nucleophagy) and MITOPHAGY.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071190"}, {"RECTYPE": "D", "MH": "Autophagy-Related Protein 12", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ubiquitin Like Protein ATG12", "MN": "D12.776.947.125", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Small Ubiquitin-Related Modifier Proteins (2008-2016)", "MS": "A UBIQUITIN-like modifier protein that functions in AUTOPHAGOSOME formation, CYTOPLASM to VACUOLE transport, MITOPHAGY, and nucleophagy. Conjugation with ATG5 PROTEIN or ATG10 is essential for its function. The ATG12-ATG5 conjugate acts as an E3 UBIQUITIN LIGASE-like enzyme for lipid modification of ATG8 FAMILY PROTEINS and their localization to vesicle membranes.", "PM": "2017", "HN": "2017", "MR": "20160225", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071192"}, {"RECTYPE": "D", "MH": "Autophagy-Related Protein 7", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ubiquitin Like Modifier Activating Enzyme ATG7", "MN": "D12.776.094.399", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 6.2.1.45", "PI": "Ubiquitin-Activating Enzymes (2006-2016)", "MS": "An autophagy related protein  that is similar to UBIQUITIN-ACTIVATING ENZYME E1. It functions in CYTOPLASM to VACUOLE transport (Cvt) and AUTOPHAGY by activating ATG12 PROTEIN for its conjugation with ATG5 PROTEIN, as well as the conjugation of ATG8 FAMILY PROTEINS with phosphatidylethanolamine for ATG8 association to Cvt vesicles and AUTOPHAGOSOME membranes. It is also required for the nitrogen starvation response in yeast, MITOPHAGY; and autophagic cell death induced by CASPASE 8 inhibition.", "PM": "2017", "HN": "2017", "MR": "20160225", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071193"}, {"RECTYPE": "D", "MH": "Camelidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "MN": "B01.050.150.900.649.313.500.190", "MH_TH": "NLM (2017)", "ST": "T008", "RN": "txid9835", "PI": "Camelus (1968-2016)", "MS": "The only extant family of the suborder Tylopoda (order Artiodactyla). Currently living members include domesticated species, DROMEDARIES (with one-hump); BACTRIAN CAMELS (with two humps); LLAMAS; ALPACAS, and wild feral camels; VICUNAS; and GUANACOS. Although they get nutrients from plants by rumination, they evolved separately from the RUMINANTS which have four-chambered stomachs. Camelidae have three-chambered stomachs.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071194"}, {"RECTYPE": "D", "MH": "Educational Personnel", "DE": "EDUC PERSONNEL", "AQ": "CL ED HI LJ OG PX SN ST", "ENTRY": "Personnel, Educational|T097|NON|EQV|UNK (19XX)|781226|PERSONNEL EDUC|abcdefv", "MN": "M01.526.702", "MH_TH": "UNK (19XX)", "ST": "T097", "PI": "Teaching (1972-2016)", "MS": "Professionals responsible for teaching in an institution or place of learning such as a school, college, vocational institute, or university.", "PM": "2017; see TEACHING 1979-2016", "HN": "2017; use TEACHING 1979-2016", "MR": "20160928", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071195"}, {"RECTYPE": "D", "MH": "Pyrin Domain", "AQ": "DE GE IM PH RE", "ENTRY": "Pyrin Domains", "MN": "G02.111.570.820.709.275.750.500.395.875", "FX": "Pyrin", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Protein Structure, Tertiary (2001-2016)", "MS": "A protein interaction domain of the death domain superfamily. It is characterized by a 6-helix bundle similar to those that occur in DEATH DOMAIN RECEPTORS. Pyrin domains are present in a variety of proteins, especially those that function in INFLAMMASOMES; AUTOPHAGY; and APOPTOSIS. They form homodimers or heterodimers with death domain proteins to facilitate the assembly of signaling complexes.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071196"}, {"RECTYPE": "D", "MH": "B30.2-SPRY Domain", "AQ": "DE GE IM PH RE", "ENTRY": "SPRY Domains", "MN": "G02.111.570.820.709.275.750.500.290", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Protein Structure, Tertiary (2002-2016)", "MS": "A protein interaction domain that is characterized by a bent \"beta-sandwich\" consisting of two antiparallel beta-sheets. It occurs in eukaryotic proteins, including many TRIPARTITE MOTIF PROTEINS, which function in a variety of cellular processes.", "PM": "2017", "HN": "2017", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071197"}, {"RECTYPE": "D", "MH": "Pyrin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TRIM20 Protein|T116|T123|ABX|EQV|NLM (2017)|160115|abbcdef", "MN": "D12.776.934.750", "FX": "Pyrin Domain", "MH_TH": "NLM (19XX)", "ST": "T123", "RN": "0", "MS": "A tripartite motif protein that consists of an N-terminal pyrin domain, a central coiled-coil region and B-box type ZINC FINGER, and C-terminal regions that mediate homotrimerization and interactions with other proteins (the B30.2/SPRY DOMAIN). It is expressed primarily by mature GRANULOCYTES and associates with the cytoskeleton in the perinuclear area as well as AUTOPHAGOSOMES, where it co-ordinates the assembly of AUTOPHAGY-RELATED PROTEINS and degradation of INFLAMMASOME components. It functions in INNATE IMMUNITY and INFLAMMATION; mutations in the Pyrin protein (MEFV) gene are associated with FAMILIAL MEDITERRANEAN FEVER.", "PM": "2017; PYRIN was indexed under PROTEINS 1997; and under CYTOSKELETAL PROTEINS 1998-2016", "HN": "2017 (1997)", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071198"}, {"RECTYPE": "D", "MH": "NLR Family, Pyrin Domain-Containing 3 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NLR Family, Pyrin Domain Containing 3 Protein", "MN": "D12.644.360.539.250", "FX": "Inflammasomes", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (2002-2016)", "MS": "An NLR protein that contains an N-terminal PYRIN DOMAIN and ATP-binding site and 9 C-terminal LEUCINE-rich repeats; it is expressed primarily by MACROPHAGES. It is a core component of the INFLAMMASOME and directs its assembly in response to pathogen infection and damage-associated stimuli. Mutations in the NLRP3 gene are associated with FAMILIAL COLD AUTOINFLAMMATORY SYNDROME.", "PM": "2017", "HN": "2017", "MR": "20170224", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071199"}, {"RECTYPE": "D", "MH": "Faculty, Pharmacy", "DE": "FACULTY PHARM", "AQ": "CL ED HI LJ OG PX SN", "ENTRY": "Pharmacy Faculty|T097|NON|EQV|NLM (1991)|900126|PHARM FACULTY|abcdefv", "MN": "M01.526.702.250.736", "MH_TH": "UNK (19XX)", "ST": "T097", "PI": "Faculty (1963-2016)", "MS": "Teaching and administrative staff having academic rank in a pharmacy school or department.", "PM": "2017; was heading 1968-1985, see FACULTY 1986-2016", "HN": "2017; was heading 1968-1985, use FACULTY 1986-2016", "MR": "20160208", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071216"}, {"RECTYPE": "D", "MH": "Infradian Rhythm", "AQ": "DE GE IM PH RE", "ENTRY": "Rhythms, Infradian", "MN": "G07.180.562.595", "MH_TH": "NLM (2017)", "ST": "T079", "PI": "Periodicity (1976-2016)", "MS": "A biological rhythm with a period longer than 24 hours.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071217"}, {"RECTYPE": "D", "MH": "Ultradian Rhythm", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Ultradian Cycles|T079|NON|NRW|UNK (19XX)|850618|abcdef", "ENTRY": "Ultradian Rhythms", "MN": "G07.180.562.797", "MH_TH": "NLM (2017)", "ST": "T079", "MS": "A biological rhythm with a period shorter than 24 hours.", "PM": "2017; for ULTRADIAN RHYTHMS see CIRCADIAN RHYTHM 2016; for ULTRADIAN CYCLES see ACTIVITY CYCLES 1985-2016", "HN": "2017; for ULTRADIAN RHYTHMS use CIRCADIAN RHYTHM 2016; for ULTRADIAN CYCLES use ACTIVITY CYCLES 1985-2016", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071218"}, {"RECTYPE": "D", "MH": "Global Burden of Disease", "AQ": "EH HI TD", "PRINT ENTRY": "Global Disease Burden|T081|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Global Disease Burdens", "MN": "N06.850.520.308.980.438.475.091", "MH_TH": "NLM (2017)", "ST": "T081", "PI": "Health Services Research (2010-2016)", "MS": "Use of various metrics to measure death and loss of health due to diseases, injuries and RISK FACTORS for all regions of the world.", "PM": "2017", "HN": "2017", "MR": "20210701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071219"}, {"RECTYPE": "D", "MH": "Pharmaceutical Research", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Research, Pharmaceutical", "MN": "H01.770.644.145.442", "MH_TH": "NLM (2017)", "ST": "T091", "AN": "pharmaceutical research as a field or the progress or status of pharmaceutical research; do not add routinely for specific pharmaceutical research studies; do not confuse with PHARMACY RESEARCH", "MS": "RESEARCH activity focused on pharmaceutical products and services.", "PM": "2017", "HN": "2017", "MR": "20160707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071220"}, {"RECTYPE": "D", "MH": "Enhancer of Zeste Homolog 2 Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lysine N Methyltransferase 6", "MN": "D12.776.930.780.890.200.250", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 2.1.1.43", "MS": "A histone-lysine N-methyltransferase and catalytic subunit of Polycomb Repressive Complex 2.  It methylates LYSINE 9 (H3K9me) and LYSINE 27 (H3K27me) of HISTONE H3, leading to transcriptional repression of the affected target gene. EZH2 also methylates non-histone proteins such as GATA4 TRANSCRIPTION FACTOR and the nuclear receptor RORA. It regulates CIRCADIAN CLOCKS via histone methylation of circadian protein gene PROMOTER REGIONS, and its repressive activity is also important for the identity and differentiation of EMBRYONIC STEM CELLS.", "PM": "2017; ENHANCER OF ZESTE HOMOLOG 2 was indexed under POLYCOMB REPRESSIVE COMPLEX 2 2013-2016, under DNA-BINDING PROTEINS and TRANSCRIPTION FACTORS 2005-2012, and under PROTEINS 2005", "HN": "2017 (2005)", "MR": "20180619", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071221"}, {"RECTYPE": "D", "MH": "Suppressor of Cytokine Signaling 1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Suppressor of Cytokine Signaling Protein 1", "MN": "D12.776.476.024.437.500", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Suppressor of Cytokine Signaling Proteins (2006-2016)", "MS": "A suppressor of cytokine signaling protein that consists of an N-terminal kinase-inhibitory region, a central SH2 DOMAIN, a characteristic C-terminal SOCS box (a 40-amino acid motif, which functions to recruit E3 UBIQUITIN-PROTEIN LIGASE COMPLEXES). SOCS1 functions as a negative regulator of CYTOKINES that signal through the JANUS KINASES-STAT 3 TRANSCRIPTION FACTOR (JAK/STAT3) pathway by inhibiting the activity of JANUS KINASES.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071222"}, {"RECTYPE": "D", "MH": "Suppressor of Cytokine Signaling 3 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, SOCS3", "MN": "D12.776.476.024.437.750", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1997-2016)", "MS": "A suppressor of cytokine signaling protein that consists of an N-terminal kinase-inhibitory region, a central SH2 DOMAIN, a characteristic C-terminal SOCS box (a 40-amino acid motif, which functions to recruit E3 UBIQUITIN-PROTEIN LIGASE COMPLEXES). SOCS3 inhibits cytokine signaling by binding to RECEPTOR PROTEIN-TYROSINE KINASES as well as CYTOKINE RECEPTOR GP130; ERYTHROPOIETIN RECEPTORS; INSULIN RECEPTOR; and the LEPTIN RECEPTOR. Its functions include suppression of ERYTHROPOIESIS in the fetal liver.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071223"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H5N8 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H5N8 subtype|T005|ABX|EQV|NLM (2024)|230223|abcdef", "ENTRY": "subtype, H5N8", "MN": "B04.820.480.968.405.400.598", "MH_TH": "NLM (2017)", "ST": "T005", "RN": "txid232441", "AN": "infection: coordinate with INFLUENZA, HUMAN in humans, or INFLUENZA IN BIRDS in birds, or ORTHOMYXOVIRIDAE INFECTIONS in other animals", "PI": "Influenza A virus (2013-2016)", "MS": "A subtype of INFLUENZA A VIRUS that is highly virulent in poultry and wild birds, but shows varying degrees of pathogenicity in mice. The H5N8 virus subtype has a polybasic amino acid motif at the HA cleavage site which explains its pathogenicity in birds, and expresses surface proteins HEMAGGLUTININ 5 and NEURAMINIDASE 8 which are typical of Highly Pathogenic Avian Influenza viruses.", "PM": "2017", "HN": "2017", "MR": "20230405", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071225"}, {"RECTYPE": "D", "MH": "Polyelectrolytes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polyelectrolyte|T109|NON|EQV|NLM (2021)|191129|abcdef", "ENTRY": "Polyelectrolytes, Conjugated", "MN": "D05.750.230", "MH_TH": "NLM (2017)", "ST": "T109", "RN": "0", "PI": "Polymers (2004-2016)", "MS": "Naturally occurring or artificially made water-soluble POLYMERS whose repeating units are ionizable. Polyelectrolytes demonstrate attributes that are typical of salts, such as electrical conductivity, and typical of  polymers, such as viscosity.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071228"}, {"RECTYPE": "D", "MH": "Perilipin-4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Perilipin 4", "MN": "D12.776.157.464.500.906", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Phosphoproteins (2004-2016)", "MS": "A perilipin protein characterized by an extensive 11-mer repeat region, which forms five adjacent alpha-helices. It is expressed primarily in WHITE ADIPOSE TISSUE and differentiating ADIPOCYTES, as well as skeletal muscle and heart.  It is soluble in the cytoplasm but re-localizes to the surface of LIPID DROPLETS under high lipid conditions.", "PM": "2017", "HN": "2017", "MR": "20160301", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071229"}, {"RECTYPE": "D", "MH": "Transcriptional Regulator ERG", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "V Ets Avian Erythroblastosis Virus E26 Oncogene Related Protein", "MN": "D12.776.930.900.625", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Trans-Activators (2008-2016)", "MS": "A trans-activator and member of the erythroblast transformation-specific family of transcriptions factors that contain a characteristic ETS MOTIF. It is required for PLATELET CELL ADHESION to the subendothelium and associates with CHIMERIC ONCOGENE PROTEINS in PROSTATE CANCER; EWING'S SARCOMA; and ACUTE MYELOID LEUKEMIA.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071230"}, {"RECTYPE": "D", "MH": "Carbonic Anhydrase IX", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Carbonic Anhydrase 9|T116|T126|NON|EQV|NLM (2017)|160122|abbcdef", "MN": "D23.050.285.196", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 4.2.1.1", "PI": "Carbonic Anhydrases (1994-2016)", "MS": "A carbonic anhydrase and transmembrane protein that consists of an N-terminal PROTEOGLYCAN-like domain, a catalytic region, a single-pass transmembrane domain, and a short intracellular tail. It functions as a dimer and is expressed primarily by cells of the GASTROINTESTINAL TRACT; BILE DUCT EPITHELIUM; and GALL BLADDER. It is expressed at high levels in many solid tumors, especially CLEAR CELL RENAL CARCINOMA, in response to CELL HYPOXIA.", "PM": "2017", "HN": "2017", "MR": "20160225", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071231"}, {"RECTYPE": "D", "MH": "Small Leucine-Rich Proteoglycans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Small Leucine-Rich Proteoglycan|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Small Leucine Rich Repeat Proteoglycans", "MN": "D12.776.860.300.806", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Proteoglycans (1996-2016)", "MS": "A proteoglycan family (SLRPs) that is defined by a central domain which consists of a variable number of repeats of the motif LXXLxLXXNxL, where L may be LEUCINE; ISOLEUCINE; VALINE; or other hydrophobic amino acids. The N-terminal contains four conserved CYSTEINE residues and may be modified depending on function. SLRPs provide structural support to the EXTRACELLULAR MATRIX and are critical for regulating its assembly and dynamics at CELL-MATRIX JUNCTIONS.", "PM": "2017", "HN": "2017", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071232"}, {"RECTYPE": "D", "MH": "Lumican", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lumican Proteoglycan|T116|T123|NON|EQV|NLM (2017)|160122|abbcdef", "MN": "D12.776.860.300.806.875", "MH_TH": "NLM (1978)", "ST": "T123", "RN": "0", "MS": "A small leucine-rich proteoglycan that contains 10 tandem leucine repeats and four N-linked sites within the leucine repeat region that may be substituted with KERATAN SULFATE. These properties and its horseshoe shape allow it to mediate interactions among COLLAGEN molecules within fibrils. It is expressed in most mesenchymal tissues as well as the CORNEA, where it functions to maintain transparency.", "PM": "2017; LUMICAN was indexed under KERATAN SULFATE and CHONDROITIN SULFATE PROTEOGLYCANS 1981-2016, and under KERATAN SULFATE/ANALOGS 1978-1981", "HN": "2017 (1978)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071234"}, {"RECTYPE": "D", "MH": "Fibromodulin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "FMOD Protein|T116|T123|ABX|EQV|NLM (2017)|160125|abbcdef", "MN": "D12.776.860.300.806.813", "MH_TH": "NLM (1989)", "ST": "T123", "RN": "126468-95-9", "MS": "A small leucine-rich proteoglycan that contains 4 KERATAN SULFATE chains within the leucine repeat region. It interacts with COLLAGEN TYPE I and COLLAGEN TYPE II fibrils and may function to control the rate of EXTRACELLULAR MATRIX assembly. It also sequesters TRANSFORMING GROWTH FACTOR BETA in the extracellular matrix.", "PM": "2017; FIBROMODULIN was indexed under PROTEOGLYCANS and EXTRACELLULAR MATRIX PROTEINS 2004-2016, and under CARRIER PROTEINS 1989-2004", "HN": "2017 (1989)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071235"}, {"RECTYPE": "D", "MH": "Fibronectin Type III Domain", "AQ": "DE GE IM PH RE", "ENTRY": "FN III Domains", "MN": "G02.111.570.820.709.275.750.250.500", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Protein Structure, Tertiary (1997-2016)", "MS": "A highly conserved immunoglobulin-like protein domain of about 100 amino acids that forms a beta sandwich structure.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071238"}, {"RECTYPE": "D", "MH": "Double-Stranded RNA Binding Motif", "AQ": "DE GE IM PH RE", "ENTRY": "Double Stranded RNA Binding Motif", "MN": "G02.111.570.820.709.275.500.869.250", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "RNA-Binding Proteins (1992-2016)", "MS": "An RNA-binding motif characterized by an alpha-beta-beta-beta-alpha fold that binds DOUBLE-STRANDED RNA. It occurs in many eukaryotic proteins as well as in bacterial and viral proteins.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071241"}, {"RECTYPE": "D", "MH": "Zika Virus Infection", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Congenital Zika Virus Infection|T047|EPO|NRW|NLM (2020)|190123|abcdef", "ENTRY": "Virus Infection, Zika", "MN": "C01.925.782.350.250.990", "MH_TH": "NLM (2016)", "ST": "T047", "PI": "Flavivirus\u00a0Infections\u00a0(1972-2015)", "MS": "A viral disease transmitted by the bite of AEDES mosquitoes infected with ZIKA VIRUS. Its mild DENGUE-like symptoms include fever, rash, headaches and ARTHRALGIA. The viral infection during pregnancy, in rare cases, is associated with congenital brain and ocular abnormalities, called Congenital Zika Syndrome, including MICROCEPHALY and may also lead to GUILLAIN-BARRE SYNDROME.", "PM": "2016", "HN": "2016", "MR": "20230601", "DA": "20160126", "DC": "1", "DX": "20160126", "UI": "D000071243"}, {"RECTYPE": "D", "MH": "Zika Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "ZikV|T005|ABB|EQV|NLM (2018)|161128|abcdef", "MN": "B04.820.578.344.350.995", "MH_TH": "NLM (2016)", "ST": "T005", "RN": "txid64320", "PI": "Flavivirus\u00a0(1964-2015)", "MS": "An arbovirus in the FLAVIVIRUS genus of the family FLAVIVIRIDAE. Originally isolated in the Zika Forest of UGANDA it has been introduced to Asia and the Americas.", "PM": "2016", "HN": "2016", "MR": "20200813", "DA": "20160126", "DC": "1", "DX": "20160126", "UI": "D000071244"}, {"RECTYPE": "D", "MH": "Mitochondrial Uncoupling Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Uncoupling Protein|T116|T123|NON|EQV|NLM (2021)|200117|abbcdef", "ENTRY": "Uncoupling Proteins, Mitochondrial", "MN": "D12.776.575.750.688", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Mitochondrial Proteins (1998-2016)", "MS": "Mitochondrial anion carrier proteins that function as dimers and form proton channels in the INNER MITOCHONDRIAL MEMBRANE which creates proton leaks and uncouples OXIDATIVE PHOSPHORYLATION from ATP synthesis, resulting in the generation of heat instead of ATP.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071245"}, {"RECTYPE": "D", "MH": "Uncoupling Protein 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Uncoupling Protein-2|T116|T123|NON|EQV|NLM (1997)|160126|abbcdef", "MN": "D12.776.575.750.688.750", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A mitochondrial uncoupling protein that is expressed in many tissues and exhibits the greatest expression in SKELETAL MUSCLE. It regulates mitochondrial ATP production and the generation of REACTIVE OXYGEN SPECIES.", "PM": "2017; UNCOUPLING PROTEIN-2 was indexed under ION CHANNELS and MITOCHONDRIAL PROTEINS 2006-2016, under MEMBRANE TRANSPORT PROTEINS 2004-2006, and under PROTEINS 1997-2003", "HN": "2017 (1997)", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071246"}, {"RECTYPE": "D", "MH": "Uncoupling Protein 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Uncoupling Protein-3|T116|T123|NON|EQV|NLM (1997)|160126|abbcdef", "MN": "D12.776.575.750.688.875", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A mitochondrial uncoupling protein that is expressed in heart and skeletal muscle tissues. It functions to regulate tissue respiration, energy balance, and THERMOGENESIS. Mutations in the UCP3 gene are associated with OBESITY.", "PM": "2017; UNCOUPLING PROTEIN 3 was indexed under ION CHANNELS and MITOCHONDRIAL PROTEINS 2006-2016, and under CARRIER PROTEINS 1997-2006", "HN": "2017 (1997)", "MR": "20160606", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071247"}, {"RECTYPE": "D", "MH": "Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 alpha", "MN": "D12.776.930.617.650", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (2004-2016)", "MS": "A transcriptional co-activator for NUCLEAR RECEPTORS. It is characterized by an N-terminal LxxLL sequence, a region that interacts with PPAR GAMMA, and a C-terminal RNA RECOGNITION MOTIF. It increases expression of MITOCHONDRIAL UNCOUPLING PROTEIN to regulate genes involved in metabolic reprogramming in response to dietary restriction and the integration of CIRCADIAN RHYTHMS with ENERGY METABOLISM.", "PM": "2017", "HN": "2017", "MR": "20160330", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071248"}, {"RECTYPE": "D", "MH": "Snail Family Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, Snail", "MN": "D12.776.930.815", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "MS": "A transcription factor family characterized by the presence of several  C-terminal CYS2-HIS2 ZINC FINGERS. They function in many developmental processes including the induction of the EPITHELIAL-MESENCHYMAL TRANSITION; maintenance of embryonic MESODERM; growth arrest, CELL SURVIVAL; and CELL MIGRATION.", "PM": "2017; SNAIL FAMILY TRANSCRIPTION FACTORS was indexed under TRANSCRIPTION FACTORS 1994-2016", "HN": "2017 (1994)", "MR": "20160226", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071250"}, {"RECTYPE": "D", "MH": "Extreme Environments", "ENTRY": "Extreme Environment", "MN": "G16.500.275.260", "MH_TH": "NLM (2017)", "ST": "T082", "PI": "Environment (1963-2016)", "MS": "An ENVIRONMENT which falls outside the range of tolerance for the survival of organisms that are not specifically adapted to survive or thrive in it. Examples of such environments are among the hottest and coldest places on earth.", "PM": "2017", "HN": "2017", "MR": "20160302", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071251"}, {"RECTYPE": "D", "MH": "Mentoring", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Coaching|T065|ACR|REL|NLM (2017)|160127|abcdef", "MN": "I02.588", "MH_TH": "NLM (2017)", "ST": "T065", "PI": "Mentors (1988-2016)", "MS": "The art and practice of training, guiding, COUNSELING, and providing support to a less experienced, trained, or knowledgeable person.", "PM": "2017", "HN": "2017", "MR": "20160302", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071252"}, {"RECTYPE": "D", "MH": "Metadata", "AQ": "CL EC ES HI SN ST TD", "ENTRY": "Metatag", "MN": "L01.399.250.590", "MH_TH": "NLM (2017)", "ST": "T066", "MS": "Structured data elements used to describe other data.", "PM": "2017", "HN": "2017", "MR": "20170703", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071253"}, {"RECTYPE": "D", "MH": "Uncoupling Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Uncoupling Protein, Mitochondrial", "MN": "D12.776.575.750.688.500", "MH_TH": "NLM (1983)", "ST": "T123", "RN": "0", "MS": "A mitochondrial uncoupling protein that is expressed in BROWN ADIPOSE TISSUE. It is critical for NONSHIVERING THERMOGENESIS to prevent heat loss in NEONATES.", "PM": "2017; UNCOULPING PROTEIN 1 was indexed under ION CHANNELS and MITOCHONDRIAL PROTEINS 2006-2016, and under CARRIER PROTEINS and MEMBRANE PROTEINS 1983-2006", "HN": "2017 (1983)", "MR": "20160606", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071256"}, {"RECTYPE": "D", "MH": "Emergence Delirium", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Postoperative Delirium|T048|NON|EQV|NLM (2023)|211014|abcdef", "ENTRY": "Post Operative Delirium", "MN": "F03.615.350.500", "MH_TH": "NLM (2017)", "ST": "T048", "PI": "Postoperative Complications (1967-2016)", "MS": "A form of DELIRIUM which occurs after GENERAL ANESTHESIA.", "PM": "2017", "HN": "2017", "MR": "20211018", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071257"}, {"RECTYPE": "D", "MH": "Harassment, Non-Sexual", "AQ": "CL EC EH ES HI LJ PC PX SN", "PRINT ENTRY": "Harassment, Nonsexual|T054|NON|EQV|NLM (1993)|920324|abcdef", "ENTRY": "Non Sexual Harassment", "MN": "F01.145.813.213", "MH_TH": "NLM (1997)", "ST": "T054", "AN": "SEXUAL HARASSMENT is also available", "PI": "Social Behavior (1969-2016)", "MS": "The act of systematic and/or continuous unwanted and irritating actions of a non-sexual nature, by a party or group against another. This behavior may include threats, BULLYING, taunts, blackmail, and demands.", "PM": "2017; see SOCIAL BEHAVIOR 1992-2016", "HN": "2017; use SOCIAL BEHAVIOR 1992-2016", "MR": "20160309", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071277"}, {"RECTYPE": "D", "MH": "Domestication", "ENTRY": "Taming, Animal", "MN": "J01.040.330", "MH_TH": "NLM (2017)", "ST": "T068", "MS": "A systematic process of adapting wild species of animals and plants into new environments often in close association or proximity to humans.", "PM": "2017", "HN": "2017", "MR": "20160302", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071278"}, {"RECTYPE": "D", "MH": "Government Employees", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Officials, Government", "MN": "M01.526.446", "MH_TH": "NLM (2017)", "ST": "T097", "MS": "Persons employed by the GOVERNMENT.", "PM": "2017", "HN": "2017", "MR": "20170524", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071296"}, {"RECTYPE": "D", "MH": "Acute Retroviral Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Retroviral Syndrome, Acute", "MN": "C20.673.480.044", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "HIV Infections (1991-2016)", "MS": "Early stage of HIV infection. Symptoms resemble INFLUENZA or INFECTIOUS MONONUCLEOSIS.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071297"}, {"RECTYPE": "D", "MH": "Body Remains", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Remains, Skeletal", "MN": "I01.198.780.937.883", "FX": "Forensic Anthropology", "MH_TH": "NLM (2017)", "ST": "T022", "MS": "The physical entity of a deceased human or animal.", "PM": "2017", "HN": "2017", "MR": "20160302", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071298"}, {"RECTYPE": "D", "MH": "Forkhead Box Protein O3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, FOXO3", "MN": "D12.776.930.977.249.125", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Forkhead Transcription Factors (2006-2016)", "MS": "A forkhead box transcription factor and transcriptional activator which triggers type 1 programmed cell death (APOPTOSIS) in the absence of APOPTOSIS INHIBITING PROTEINS, including neuronal cell death induced by OXIDATIVE STRESS. It recognizes and binds to the DNA sequence 5'-(AG)TAAA(TC)A-3' and also functions in post-transcriptional regulation of the c-MYC PROTO-ONCOGENE.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071316"}, {"RECTYPE": "D", "MH": "Nanog Homeobox Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Homeobox Protein, Nanog", "MN": "D12.776.930.542", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Homeodomain Proteins (2008-2016)", "MS": "A homeodomain protein and transcription regulator that functions in BLASTOCYST INNER CELL MASS and EMBRYONIC STEM CELL proliferation and CELL SELF RENEWAL. It confers pluripotency on embryonic stem cells and prevents their differentiation towards extraembryonic ENDODERM and trophectoderm (TROPHOBLAST) CELL LINEAGES.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071317"}, {"RECTYPE": "D", "MH": "Transcription Activator-Like Effectors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transcription Activator-Like Effector|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Transcription Activator Like Effectors", "MN": "D23.946.896.490", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "Virulence factors of pathogenic plant bacteria, such as XANTHOMONAS species, that bind to specific sequences in the PROMOTER REGIONS of host DNA to induce transcription of specific host genes.  Variations in the DNA binding domain of TALE family members account for the variations in DNA specificity. The TALE DNA-binding domains are used in various GENETIC TECHNIQUES by fusing them with various DNA modifying enzymes to detect and manipulate sequence-specific targeted DNA sites.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071336"}, {"RECTYPE": "D", "MH": "RNA-Binding Motifs", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "RNA-Binding Motif|T087|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "RNA Binding Motifs", "MN": "G02.111.570.820.709.275.500.869", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "RNA-Binding Proteins (1990-2016)", "MS": "Amino acid motifs that bind RNA.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071376"}, {"RECTYPE": "D", "MH": "RNA Recognition Motif", "AQ": "DE GE IM PH RE", "ENTRY": "Ribonucleoprotein Domains", "MN": "G02.111.570.820.709.275.500.869.500", "FX": "RNA Recognition Motif Proteins", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "RNA-Binding Proteins (1991-2016)", "MS": "An approximately 80 amino acid RNA binding motif that consists of four anti-parallel surface beta sheets and two alpha helices arranged in a beta-alpha-beta-beta-alpha-beta configuration. One of the surface beta sheets interacts with two or three specific RNA bases. Interactions between additional sequences and the RNA, as well as within the RNA recognition motif increase the affinity and specificity of the protein-RNA interaction.", "PM": "2017", "HN": "2017", "MR": "20170512", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071377"}, {"RECTYPE": "D", "MH": "Bunion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Bunions", "MN": "C05.330.488.050", "MH_TH": "UNK (19XX)", "ST": "T020", "AN": "note HALLUX VALGUS is also available", "MS": "Abnormal swelling of the inner aspect of the first metatarsal head affecting the first METATARSOPHALANGEAL JOINT.", "PM": "2017; see HALLUX VALGUS 1967-2016", "HN": "2017; use HALLUX VALGUS 1967-2016", "MR": "20160226", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071378"}, {"RECTYPE": "D", "MH": "Fibromatosis, Plantar", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Plantar Fibromatosis", "MN": "C17.800.321.063", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Foot Diseases (1963-2016)", "MS": "A fibromatosis of the plantar fascia characterized by thickening of the fibrous bands on the plantar aponeurosis in the sole of the foot and toes.", "PM": "2017", "HN": "2017", "MR": "20160226", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071380"}, {"RECTYPE": "D", "MH": "Aldehyde Dehydrogenase, Mitochondrial", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mitochondrial Aldehyde Dehydrogenase", "MN": "D12.776.575.093", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.2.1.3", "PI": "Aldehyde Dehydrogenase (1995-2016)", "MS": "An aldehyde dehydrogenase expressed in the mitochondrial matrix that is essential for the metabolism of ETHANOL.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071396"}, {"RECTYPE": "D", "MH": "Twist Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, Twist", "MN": "D12.776.930.125.906", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Twist-Related Protein 1 (2007-2016)", "MS": "A  highly-conserved family of basic helix-loop-helix (bHLH) transcription factors.  They function as dimers with other bHLH proteins and bind E-BOX ELEMENTS to control gene expression during EMBRYOGENESIS and the EPITHELIAL-MESENCHYMAL TRANSITION.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071416"}, {"RECTYPE": "D", "MH": "Twist-Related Protein 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Twist Related Protein 2", "MN": "D12.776.930.125.906.500", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Twist-Related Protein 1 (2005-2016)", "MS": "A twist family transcription factor that is expressed in MESODERM as well as the DERMIS during mammalian EMBRYOGENESIS. It is structurally and functionally similar to TWIST-RELATED PROTEIN 1; it also regulates OSTEOGENESIS and the expression of CYTOKINES in response to INFLAMMATION.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071417"}, {"RECTYPE": "D", "MH": "ETS Motif", "AQ": "DE GE IM PH RE", "ENTRY": "Helix Turn Helix, ETS Type Domain Containing", "MN": "G02.111.570.820.709.275.500.360.360.500", "FX": "Proto-Oncogene Protein c-ets-1", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Transcription Factors (1990-2016)", "MS": "A helix-turn-helix motif characterized by three alpha-helices and four-stranded beta-sheets arranged in the order alpha1-beta1-beta2-alpha2-alpha3-beta3-beta4. The third alpha-helix contacts the major groove of DNA. The ETS motif and the flanking amino acid sequences of Ets proteins influence the binding affinity, and the alteration of a single amino acid in the Ets domain can change its DNA binding specificity.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071419"}, {"RECTYPE": "D", "MH": "Life History Traits", "ENTRY": "Strategy, Life History", "MN": "G16.575", "FX": "Population Dynamics", "MH_TH": "NLM (2017)", "ST": "T081", "PI": "Life Cycle Stages (1963-2016)", "MS": "Morphological or behavioral traits influenced by various living conditions that a population encounters especially as it pertains to REPRODUCTION and survival of the population (see POPULATION DYNAMICS) such as age at first reproductive event, number and size of offspring, and lifespan.", "PM": "2017", "HN": "2017", "MR": "20210707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071421"}, {"RECTYPE": "D", "MH": "Inbreeding Depression", "AQ": "DE GE IM PH RE", "ENTRY": "Depression, Inbreeding", "MN": "G05.410", "MH_TH": "NLM (2017)", "ST": "T081", "PI": "Inbreeding (1974-2016)", "MS": "A reduced GENETIC VARIATION and GENETIC FITNESS due to INBREEDING.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071422"}, {"RECTYPE": "D", "MH": "Src Homology 2 Domain-Containing, Transforming Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Src Homology 2 Domain Containing, Transforming Protein 1", "MN": "D12.776.476.024.424.500", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "An SHC-signaling adaptor protein that transduces PHOSPHOTYROSINE-dependent signals downstream of RECEPTOR PROTEIN-TYROSINE KINASES and non-receptor tyrosine kinases. It is required for TGF-BETA-induced CELL MIGRATION; NEOLPASM INVASION; and METASTASIS of BREAST NEOPLASMS; its SH2 DOMAIN is essential for tumor survival. It also functions in signaling downstream of  ANGIOPOIETIN RECEPTOR TIE-2, regulating the migration of ENDOTHELIAL CELLS; and PHYSIOLOGIC NEOVASCULARIZATION.", "PM": "2017; see SHC SIGNALING ADAPTOR PROTEINS 2009-2016", "HN": "2017; use SHC SIGNALING ADAPTOR PROTEINS 2009-2016", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071425"}, {"RECTYPE": "D", "MH": "Src Homology 2 Domain-Containing, Transforming Protein 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Src Homology 2 Domain Containing, Transforming Protein 2", "MN": "D12.776.476.024.424.750", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "An SHC-signaling adaptor protein that links GROWTH FACTOR RECEPTORS to SIGNAL TRANSDUCTION PATHWAYS in neurons.", "PM": "2017; see SHC SIGNALING ADAPTOR PROTEINS 2009-2016", "HN": "2017; use SHC SIGNALING ADAPTOR PROTEINS 2009-2016", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071426"}, {"RECTYPE": "D", "MH": "Src Homology 2 Domain-Containing, Transforming Protein 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Src Homology 2 Domain Containing, Transforming Protein 3", "MN": "D12.776.476.024.424.875", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "An SHC-signaling adaptor protein that links GROWTH FACTOR RECEPTORS to SIGNAL TRANSDUCTION PATHWAYS in neurons, including NEUROTROPHINS signaling in the CENTRAL NERVOUS SYSTEM.", "PM": "2017; see SHC SIGNALING ADAPTOR PROTEINS 2009-2016", "HN": "2017; use SHC SIGNALING ADAPTOR PROTEINS 2009-2016", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071427"}, {"RECTYPE": "D", "MH": "Thermotolerance", "AQ": "DE GE IM PH RE", "ENTRY": "Tolerances, Heat", "MN": "G16.012.500.133.500", "FX": "Heat-Shock Response", "MH_TH": "NLM (2017)", "ST": "T040", "PI": "Hot Temperature (1964-2016)", "MS": "The ability of an organism to reduce susceptibility to heat shock, and adapt to HOT TEMPERATURE.", "PM": "2017", "HN": "2017", "MR": "20180206", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071436"}, {"RECTYPE": "D", "MH": "Axon Guidance", "AQ": "DE GE IM PH RE", "ENTRY": "Pathfinding, Axon", "MN": "G11.561.620.750.500", "FX": "Growth Cones", "MH_TH": "NLM (2017)", "ST": "T042", "PI": "Neurons (1978-2016)", "MS": "The mechanism by which a neuronal process outgrows toward a target led by the GROWTH CONE. Local guidance cues are provided by cell surface proteins that act on the growing axon.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071437"}, {"RECTYPE": "D", "MH": "Fatty Acid-Binding Protein 7", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mammary Derived Growth Inhibitor Related Protein", "MN": "D12.776.631.274", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (2005-2016)", "MS": "A fatty acid-binding protein expressed by ASTROCYTES during CENTRAL NERVOUS SYSTEM development, and by MALIGNANT GLIOMA cells. It is also expressed by ASTROCYTES in response to injury or ISCHEMIA, and may function in repair of the MYELIN SHEATH.", "PM": "2017", "HN": "2017", "MR": "20160520", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071438"}, {"RECTYPE": "D", "MH": "Pseudoautosomal Regions", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Pseudoautosomal Region|T086|NON|EQV|NLM (2017)|160216|abcdef", "MN": "G05.360.340.024.380.906", "MH_TH": "NLM (2017)", "ST": "T086", "PI": "Y Chromosome (1986-2016)", "MS": "Homologous chromosomal regions at either end of the X CHROMOSOME or Y CHROMOSOME. These two regions pair regularly at male MEIOSIS and undergo RECOMBINATION. Pseudoautosomal region 1 (PAR1) is located  at the tip of the short 'p' arms (Xp22 and Yp11) and Pseudoautosomal region 2 (PAR2) is located at the tip of the long 'q' arms (Xq28 and Yq12).", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071439"}, {"RECTYPE": "D", "MH": "Emotion-Focused Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Emotionally Focused Therapy|T061|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Therapy, Emotionally Focused", "MN": "F04.754.293", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Psychotherapy (2010-2016)", "MS": "Intervention that relies on free expression of emotions with coaching to enhance awareness of emotional experiences.", "PM": "2017", "HN": "2017", "MR": "20210512", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071441"}, {"RECTYPE": "D", "MH": "Taxis Response", "AQ": "CL DE ES PH RE", "ENTRY": "Taxis Responses", "MN": "G11.427.410.568.850", "MH_TH": "NLM (2017)", "ST": "T040", "MS": "A behavior in free-moving organism that results in motion or orientation toward or away from an external stimulus.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071442"}, {"RECTYPE": "D", "MH": "12E7 Antigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "T Cell Surface Glycoprotein E2", "MN": "D23.050.301.350.049", "MH_TH": "NLM (2018)", "ST": "T129", "RN": "0", "PI": "Cell Adhesion Molecules (2004-2016)", "MS": "A cell adhesion molecule that, in humans, is encoded by a gene on the PSEUDOAUTOSOMAL REGION of SEX CHROMOSOMES. It functions in CELL ADHESION of T-LYMPHOCYTES and ROSETTE FORMATION by ERYTHROCYTES. It is also involved in the migration of LEUKOCYTES through the ENDOTHELIUM BASEMENT MEMBRANE. The 12E7 antigen co-localizes with, but functions independently of PECAM-1.", "PM": "2018; see ANTIGENS, CD99 2017-2018", "HN": "2018 (2017)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071443"}, {"RECTYPE": "D", "MH": "Phototaxis", "AQ": "CL DE ES PH RE", "ENTRY": "Photokineses", "MN": "G11.427.410.568.850.875", "FX": "Phototropism", "MH_TH": "NLM (2017)", "ST": "T040", "PI": "Movement (1964-2016)", "MS": "A behavioral change that results in an organism moving or orienting toward or away from the light source.", "PM": "2017", "HN": "2017", "MR": "20160520", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071444"}, {"RECTYPE": "D", "MH": "Neuronal Outgrowth", "AQ": "DE GE IM PH RE", "ENTRY": "Neurite Outgrowth|T042|NON|EQV|NLM (2017)|160217|abcdef", "MN": "G11.561.620.750", "MH_TH": "NLM (2017)", "ST": "T042", "PI": "Axons (1969-2016)", "MS": "Formation of neuronal processes (AXONS; NEURITES) toward a target cell.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071446"}, {"RECTYPE": "D", "MH": "N-Myc Proto-Oncogene Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proto-Oncogene Protein, N-Myc", "MN": "D12.776.930.127.092.625", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Proto-Oncogene Proteins (2012-2016)", "MS": "A basic helix-loop-helix leucine zipper (bHLHZ) transcription factor and proto-oncogene protein that functions in cell growth and proliferation. In mammals, it is highly expressed in the brain during embryogenesis and is essential for brain development; it is not expressed in adult tissues. Amplification or overexpression of N-Myc occurs in at least 20% of tumors and is associated with a poor prognosis in cases of NEUROBLASTOMA; ALVEOLAR RHABDOMYOSARCOMA; SMALL CELL LUNG CARCINOMA; and neuroendocrine prostate cancer.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071447"}, {"RECTYPE": "D", "MH": "Axon Fasciculation", "AQ": "DE GE IM PH RE", "ENTRY": "Fasciculation, Neurite", "MN": "G11.561.620.750.250", "MH_TH": "NLM (2017)", "ST": "T042", "PI": "Axons (1983-2016)", "MS": "Process of organizing neighboring AXONS into a bundle or a fascicle during neurite outgrowth mediated by CELL ADHESION MOLECULES.", "PM": "2017", "HN": "2017", "MR": "20170601", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071448"}, {"RECTYPE": "D", "MH": "Proprotein Convertase 9", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proprotein Convertase, Subtilisin Kexin Type 9", "MN": "D08.811.277.656.959.350.718", "EC": "antagonists & inhibitors:PCSK9 Inhibitors", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.21.-", "PI": "Serine Endopeptidases (2003-2016)", "MS": "A proprotein convertase that is essential for CHOLESTEROL homeostasis. It binds to and is required for the lysosomal degradation of the LDL RECEPTOR (LDLR); the VLDL receptor, and the APOLIPOPROTEIN E RECEPTOR. It also regulates neuronal APOPTOSIS.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071449"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily B, Member 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tap2, Peptide Transporter", "MN": "D12.776.543.585.450.074.500.500.250.375", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "ATP-Binding Cassette Transporters (2004-2016)", "MS": "ATP-binding cassette, subfamily B, protein that functions in the transport of ANTIGENS from the CYTOPLASM to the ENDOPLASMIC RETICULUM for association with HISTOCOMPATIBILITY ANTIGENS CLASS I peptides. It functions as a heterodimer with ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 2.", "PM": "2019; see ATP-BINDING CASSETTE, SUB-FAMILY B, MEMBER 3 2018; see ANTIGEN PEPTIDE TRANSPORTER-2 2017", "HN": "2019 (2017)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071450"}, {"RECTYPE": "D", "MH": "Chitinase-3-Like Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "YLK 40 Protein", "MN": "D12.776.503.070", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Lectins (2003-2016)", "MS": "A lectin that binds CHITIN, but lacks chitinase activity. It may be involved in tissue remodeling and cellular responses to the environment, including the response of type 2 HELPER T-CELLS to INFLAMMATION and sensitization to ALLERGENS. Mutations in the CHI3L1 gene are associated with ASTHMA.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071451"}, {"RECTYPE": "D", "MH": "Sequestosome-1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ubiquitin Binding Protein p62", "MN": "D12.776.476.024.422", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Heat-Shock Proteins (1996-2016)", "MS": "A multidomain protein that is highly conserved among multicellular organisms. It contains a ZZ-type ZINC FINGER domain, C-terminal UBIQUITIN - associated (UBA) domain, and interacts with many other signaling proteins and enzymes including, atypical PROTEIN KINASE C; TNF RECEPTOR-ASSOCIATED FACTOR 6; subunits of the mTORC1 complex, and CASPASE-8. It functions in AUTOPHAGY as a receptor for the degradation of ubiquitinated substrates, and to co-ordinate signaling in response to OXIDATIVE STRESS.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071456"}, {"RECTYPE": "D", "MH": "DEAD Box Protein 58", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "RIG I like Receptor 1", "MN": "D08.811.913.696.445.735.720.249.750", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.6.4.13", "PI": "DEAD-box RNA Helicases (2006-2016)", "MS": "A DEAD-box RNA helicase that contains an N-terminal DEATH-LIKE DOMAIN, AAA+ ATPase domain, and C-terminal RNA HELICASE activity. It functions as an innate immune receptor through its recognition of viral nucleic acids. It also induces the expression of INTERFERON TYPE I and proinflammatory CYTOKINES. Its ligands include: 5'-triphosphorylated SINGLE-STRANDED RNA, DOUBLE-STRANDED RNA (dsRNA), and short dsRNA (less than 1 kb in length).", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071457"}, {"RECTYPE": "D", "MH": "Death Domain Superfamily", "AQ": "DE GE IM PH RE", "ENTRY": "Superfamily, Death Domain", "MN": "G02.111.570.820.709.275.750.500.395", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Protein Structure, Tertiary (2007-2016)", "MS": "A family of structurally-related protein interaction domains characterized by 6-helical closed bundle fold, with Greek key topology and an internal pseudo two-fold symmetry. Death-like domains occur in many proteins that are essential for APOPTOSIS, including CASPASE RECRUITMENT DOMAIN CONTAINING PROTEINS and DEATH DOMAIN RECEPTORS.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071458"}, {"RECTYPE": "D", "MH": "Death Domain", "AQ": "DE GE IM PH RE", "ENTRY": "Death Domains|T087|NON|EQV|NLM (2017)|160218|abcdef", "MN": "G02.111.570.820.709.275.750.500.395.500", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Receptors, Tumor Necrosis Factor (1995-2016)", "MS": "A conserved protein interaction domain of the death domain superfamily that is structurally similar to the DEATH EFFECTOR DOMAIN and CASPASE RECRUITMENT DOMAIN. Death domains bind each other to form oligomers and occur on DEATH DOMAIN RECEPTORS, where they are required for APOPTOSIS signaling and non-apoptotic functions.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071459"}, {"RECTYPE": "D", "MH": "Death Effector Domain", "AQ": "DE GE IM PH RE", "ENTRY": "Death Effector Domains", "MN": "G02.111.570.820.709.275.750.500.395.750", "FX": "Death Domain Receptor Signaling Adaptor Proteins", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Death Domain Receptor Signaling Adaptor Proteins (2007-2016)", "MS": "A homotypic protein interaction module of the death domain superfamily that is composed of a bundle of six alpha-helices. The death effector domain shares sequence and structural similarities with the DEATH DOMAIN and CASPASE RECRUITMENT DOMAIN. It occurs in many proteins with essential functions in APOPTOSIS.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071461"}, {"RECTYPE": "D", "MH": "Caspase Activation and Recruitment Domain", "AQ": "DE GE IM PH RE", "ENTRY": "Recruitment Domains, Caspase", "MN": "G02.111.570.820.709.275.750.500.395.250", "FX": "CARD Signaling Adaptor Proteins", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "CARD Signaling Adaptor Proteins (2006-2016)", "MS": "A homotypic protein interaction module of the death domain superfamily. It is composed of a bundle of six alpha-helices that is related in sequence and structure to the DEATH DOMAIN and DEATH EFFECTOR DOMAIN. The Caspase Activation and Recruitment Domain (CARD domain) typically associates with other CARD-containing proteins, forming either dimers or trimers. CARD domains may occur in isolation, or in combination with other domains in CARD signaling adaptor proteins and initiator CASPASES that function in APOPTOSIS.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071476"}, {"RECTYPE": "D", "MH": "Gubernaculum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Gubernacula|T018|NON|EQV|NLM (2017)|160219|abcdef", "MN": "A16.551", "FX": "Cryptorchidism", "MH_TH": "NLM (2017)", "ST": "T018", "PI": "Testis (1963-2016)", "MS": "An embryonic structure that helps guide proper descent of gonads into their final positions. It attaches the caudal end of the fetal GONADS to the developing SCROTUM in male and the labium majorum in female. It gives rise to the caudal ligaments of the gonad: the scrotal ligament in male and the uterine round and proper ovarian ligaments in female. It includes morphofunctional equivalent structures in non-mammals.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071477"}, {"RECTYPE": "D", "MH": "APOBEC Deaminases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Deaminases, APOBEC", "MN": "D08.811.277.151.486.250.500", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.5.4.5", "PI": "Cytidine Deaminase (1991-2016)", "MS": "A family of conserved cytidine deaminases that catalyze the DEAMINATION of CYTIDINE to URIDINE. They are characterized by N and C-terminal zinc-dependent catalytic domains and have important functions in RNA EDITING; EPIGENTIC PROCESSES; and the INNATE IMMUNE RESPONSE against viruses.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071478"}, {"RECTYPE": "D", "MH": "APOBEC-1 Deaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Deaminase, APOBEC1", "MN": "D08.811.277.151.486.250.500.500", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.5.4.36", "MS": "An APOBEC deaminase catalytic subunit of the apolipoprotein B (APOB) MESSENGER RNA (mRNA) editing enzyme complex that is involved in post-transcriptional editing of a CAA codon for GLYCINE to a UAA STOP CODON in the ApoB mRNA. It also functions in CGA (ARGININE) to UGA STOP CODON editing of NEUROFIBROMIN 1 mRNA and EPIGENETIC PROCESSES.", "PM": "2017; see APOLIPOPROTEIN B MRNA EDITING ENZYME 1991-2016", "HN": "2017; use APOLIPOPROTEIN B MRNA EDITING ENZYME 1991-2016", "MR": "20160418", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071479"}, {"RECTYPE": "D", "MH": "APOBEC-3G Deaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Deaminase, APOBEC3G", "MN": "D12.776.066.032", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.5.4.5", "PI": "Cytidine Deaminase (2007-2016)", "MS": "An APOBEC deaminase that functions as an inhibitor of RETROVIRIDAE replication and inhibits the mobility of RETROTRANSPOSONS via deaminase-dependent and independent mechanisms. It is selective for SINGLE-STRANDED DNA and does not deaminate double-stranded DNA or single or DOUBLE-STRANDED RNA. It exhibits potent antiviral activity against VIF PROTEIN deficient HIV-1 through the creation of hypermutations in the VIRAL DNA. It also has anti-viral activity against SIMIAN IMMUNODEFICIENCY VIRUSES and HEPATITIS B VIRUS.", "PM": "2017", "HN": "2017", "MR": "20210510", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071480"}, {"RECTYPE": "D", "MH": "AlkB Enzymes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Enzymes, AlkB", "MN": "D08.811.682.690.416.139", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.11.33", "PI": "Dioxygenases (2004-2016)", "MS": "A family of alpha- KETOGLUTARIC ACID and Fe(II)-dependent dioxygenases that are homologous to AlkB, an enzyme that repairs alkylated nucleic acids in E. coli. The mammalian homologs have diverse substrate specificities and functions that include DNA REPAIR, generating unique wobble modifications in URIDINE tRNA, demethylation of nucleotides in DNA and RNA, and demethylation of LYSINE residues on certain proteins, including ACTIN and histones (HISTONE CODE).", "PM": "2017", "HN": "2017", "MR": "20160628", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071496"}, {"RECTYPE": "D", "MH": "Immunogenicity, Vaccine", "AQ": "DE GE IM PH RE", "ENTRY": "Vaccine Immunogenicity", "MN": "G12.513", "MH_TH": "NLM (2017)", "ST": "T070", "PI": "Vaccines (1963-2016)", "MS": "The capacity of VACCINES to stimulate the ADAPTIVE IMMUNE RESPONSE to produce antibodies and antigen-specific T-CELL responses. It is typically measured in vaccinated individuals in observational studies setting.", "PM": "2017", "HN": "2017", "MR": "20210305", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071497"}, {"RECTYPE": "D", "MH": "AlkB Homolog 1, Histone H2a Dioxygenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Alpha Ketoglutarate Dependent Dioxygenase ABH1", "MN": "D08.811.682.690.416.139.500", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.11.33", "PI": "DNA Repair Enzymes (2005-2016)", "MS": "A dioxygenase and alkylation repair homolog that functions by oxidative demethylation in RNA and DNA REPAIR of substrates which contain 3-methylcytosine. It also functions as one of the HISTONE DEMETHYLASES involved in embryonic development and maintaining the pluripotency of EMBRYONIC STEM CELLS.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071498"}, {"RECTYPE": "D", "MH": "AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Alpha ketoglutarate Dependent Dioxygenase AlkB Homolog 2", "MN": "D08.811.682.690.416.139.750", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.11.33", "PI": "Dioxygenases (2004-2016)", "MS": "A dioxygenase and alkylation repair homolog that repairs alkylated DNA and RNA containing 1-methyladenine and 3-methylcytosine by oxidative demethylation. It can also repair alkylated DNA containing 1-ethenoadenine in vitro. It has highest affinity for double-stranded DNA.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071499"}, {"RECTYPE": "D", "MH": "AlkB Homolog 3, Alpha-Ketoglutarate-Dependent Dioxygenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Alpha Ketoglutarate Dependent Dioxygenase AlkB Homolog 3", "MN": "D08.811.682.690.416.139.875", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.11.-", "PI": "Dioxygenases (2006-2016)", "MS": "A dioxygenase and alkylation repair homolog that repairs alkylated DNA containing 1-methyladenine (1meA) and 3-methylcytosine (3meC) by oxidative demethylation. It has a strong preference for SINGLE-STRANDED DNA and may also act on RNA.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071500"}, {"RECTYPE": "D", "MH": "AlkB Homolog 4, Lysine Demethylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Alpha Ketoglutarate Dependent Dioxygenase Alkb Homolog 4", "MN": "D08.811.682.690.416.139.937", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.11.27", "PI": "Dioxygenases (2014-2016)", "MS": "A dioxygenase and alkylation repair homolog that mediates demethylation of ACTIN monomethylated at 'Lys-84' (K84me1).  Demethylation of actin LYSINE 84 (K84me1) is required for maintaining actin and MYOSIN dynamics to support normal cleavage furrow ingression during CYTOKINESIS and CELL MIGRATION. It may also be involved in transcription regulation.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071501"}, {"RECTYPE": "D", "MH": "AlkB Homolog 5, RNA Demethylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Demethylase ALKBH5, RNA", "MN": "D08.811.682.690.416.139.968", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.11.-", "PI": "Dioxygenases (2011-2016)", "MS": "A dioxygenase and alkylation repair homolog  that demethylates RNA by oxidative demethylation. It specifically demethylates N(6)-methyladenosine (m6A) RNA, the most common internal modification of MESSENGER RNA in higher eukaryotes.  It can also demethylate N(6)-methyladenosine in SINGLE-STRANDED DNA.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071502"}, {"RECTYPE": "D", "MH": "AlkB Homolog 8, tRNA Methyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "S Adenosyl L Methionine Dependent tRNA Methyltransferase ABH8", "MN": "D08.811.913.555.500.925.500", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.11.-", "MS": "A dioxygenase and alkylation repair homolog that catalyzes the methylation of 5-carboxymethyl URIDINE to 5-methylcarboxymethyl uridine at the wobble position of the ANTICODON loop in TRANSFER RNA (tRNA) via its methyltransferase domain. It has a preference for tRNA (ARGININE) and tRNA (GLUTAMATE), and does not bind tRNA (LYSINE).", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000071503"}, {"RECTYPE": "D", "MH": "Alpha-Ketoglutarate-Dependent Dioxygenase FTO", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "FTO, Alpha-Ketoglutarate-Dependent Dioxygenase", "MN": "D08.811.682.690.416.139.992", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.11.33", "PI": "Proteins (2008-2016)", "MS": "A dioxygenase that repairs alkylated DNA and RNA by oxidative demethylation. It has highest activity towards single-stranded RNA containing 3-methyluracil, followed by SINGLE-STRANDED DNA containing 3-methylthymine and specifically demethylates N(6)-methyladenosine (m6A) RNA, the most common internal modification of MESSENGER RNA (mRNA) in higher EUKARYOTES. It contributes to the regulation of the global metabolic rate, energy HOMEOSTASIS, as well as body fat accumulation by regulating the differentiation of ADIPOCYTES into BROWN FAT CELLS or WHITE FAT CELLS.", "PM": "2017", "HN": "2017", "MR": "20160628", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071516"}, {"RECTYPE": "D", "MH": "Liver X Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Oxysterols Receptor LXR Beta", "MN": "D12.776.826.194", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "0", "MS": "Nuclear receptors that bind OXYSTEROLS and function as heterodimers with RETINOID X RECEPTORS. They have important functions in regulating cholesterol homeostasis, ENERGY METABOLISM; INFLAMMATION; and the immune response.", "PM": "2017; LIVER X RECEPTORS was indexed under ORPHAN NUCLEAR RECEPTORS 2009-2016; and under DNA-BINDING PROTEINS and RECEPTORS, CYTOPLASMIC AND NUCLEAR  2002-2009", "HN": "2017 (2002)", "MR": "20160420", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071518"}, {"RECTYPE": "D", "MH": "Cortical Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Substantia Compacta|T024|NON|EQV|NLM (2017)|160224|abcdef", "MN": "A10.165.265.521", "MH_TH": "NLM (2017)", "ST": "T024", "PI": "Bone and Bones (1963-2016)", "MS": "A type of osseous tissue which makes up the outer layer of bone. It is dense, rigid, strong, and forms concentric lamellar OSTEONS.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071538"}, {"RECTYPE": "D", "MH": "Cancellous Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Trabecular Bones", "MN": "A10.165.265.414", "MH_TH": "NLM (2017)", "ST": "T024", "PI": "Bone and Bones (1963-2016)", "MS": "A type of osseous tissue which makes up the inner part of bone.  It has a spongy, honeycomb-like structure with struts or trabecula and contains the BONE MARROW. It has higher rate of BONE REMODELING turnover than CORTICAL BONE.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071556"}, {"RECTYPE": "D", "MH": "beta-Arrestins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Arrestins", "MN": "D12.776.543.090.525", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "Non-visual system arrestins that negatively regulate G-PROTEIN-COUPLED RECEPTORS (GPCRs) and may also function independently of GPCR signaling. They bind and recruit many different signaling factors, including MITOGEN-ACTIVATED PROTEIN KINASES; SRC-FAMILY-KINASES; and FILAMIN to GPCRs and may recognize different phosphorylation states of the receptors to determine the specificity of the cellular response to signaling.", "PM": "2017; BETA-ARRESTINS was indexed under ARRESTINS 1996-2016 and under ANTIGENS and EYE PROTEINS 1992-1996", "HN": "2017 (1992)", "MR": "20160809", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071557"}, {"RECTYPE": "D", "MH": "beta-Arrestin 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Arrestin 1B", "MN": "D12.776.543.090.525.500", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "MS": "A beta-arrestin that functions in the down-regulation of signaling by G-PROTEIN-COUPLED RECEPTORS. It is also a major regulator of INSULIN signaling via the ERK 1-2 PATHWAY, and many other signaling processes, especially in NEURONS and LEUKOCYTES.", "PM": "BETA-ARRESTIN 1 was indexed under ARRESTINS 1996-2016 and under ANTIGENS and EYE PROTEINS 1992-1996", "HN": "2017 (1992)", "MR": "20160809", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071559"}, {"RECTYPE": "D", "MH": "beta-Arrestin 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Arrestin 2", "MN": "D12.776.543.090.525.750", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A beta-arrestin that functions similarly to BETA-ARRESTIN 1 in regulating signaling by G-PROTEIN-COUPLED RECEPTORS. It is expressed at high levels in the central nervous system where it may regulate signaling by SYNAPTIC RECEPTORS.", "PM": "BETA-ARRESTIN 2 was indexed under ARRESTINS 1996-2016 and under ANTIGENS and EYE PROTEINS 1992-1996", "HN": "2017 (1992)", "MR": "20160809", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071560"}, {"RECTYPE": "D", "MH": "Fractures, Avulsion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sprain Fractures", "MN": "C26.404.038", "MH_TH": "NLM (2017)", "ST": "T037", "MS": "Tearing away of the CORTICAL BONE fragment at the location of a strong ligament or tendon attachment. The bone fragment detachment site often occurs near a soft site (e.g., GROWTH PLATE) at the base where LIGAMENTS; TENDONS; or JOINT CAPSULES attach. In younger patients it is most often caused by a sudden forceful pull on a tendon in the opposite direction of the bone movement. In the elderly it is associated with osteoporotic INSUFFICIENCY FRACTURES.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071562"}, {"RECTYPE": "D", "MH": "Crush Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injury, Crush", "MN": "C26.257", "FX": "Compartment Syndromes", "MH_TH": "NLM (2017)", "ST": "T037", "AN": "note entry term CRUSH FRACTURES: COMPRESSION FRACTURES is also available", "MS": "Excessive compression of parts of the body that causes muscle swelling, fracture, and/or neurological disturbances in the affected areas. Crush injury with systemic manifestations is referred to as CRUSH SYNDROME.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071576"}, {"RECTYPE": "D", "MH": "Abdominal Oblique Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Oblique Muscles, Internal", "MN": "A02.633.567.050.375", "MH_TH": "NLM (2017)", "ST": "T023", "PI": "Abdominal Wall (1965-2016)", "MS": "Muscles of the anterolateral abdominal wall consisting of the external oblique and the internal oblique muscles. The external abdominal oblique muscle fibers extend from lower thoracic ribs to the linea alba and the iliac crest. The internal abdominal oblique extend superomedially beneath the external oblique muscles.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071596"}, {"RECTYPE": "D", "MH": "CDX2 Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Homeobox Protein CDX 2", "MN": "D12.776.930.146", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "An antennapedia-like homeodomain transcription factor that regulates the expression of multiple genes in the INTESTINAL MUCOSA. It plays a critical role in many processes from early differentiation to maintenance of the intestinal epithelial lining of both the small and large intestine.", "PM": "2017; CDX2 TRANSCRIPTION FACTOR was indexed under TRANS-ACTIVATORS and HOMEODOMAIN PROTEINS 2005-2016; under TRANSCRIPTION FACTORS 1994-2005; and under DNA-BINDING PROTEINS 1994", "HN": "2017 (1994)", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071616"}, {"RECTYPE": "D", "MH": "Protein Deglycase DJ-1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Deglycase, Parkinsonism Associated", "MN": "D12.776.705.875", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.1.2.-", "PI": "Oncogene Proteins (1997-2016)", "MS": "A protein deglycase that repairs methylglyoxal- and glyoxal-glycated amino acids and proteins, releasing repaired proteins and lactate or glycolate. It deglycates CYSTEINE, ARGININE and LYSINE residues to reactivate proteins by reversing glycation and prevent the formation of ADVANCED GLYCATION END PRODUCTS. It protects cells against OXIDATIVE STRESS and CELL DEATH by functioning as an oxidative stress sensor and redox-sensitive MOLECULAR CHAPERONE and PROTEASE. Mutations in the PARK7 gene are associated with autosomal-recessive, early-onset PARKINSON DISEASE.", "PM": "2017", "HN": "2017", "MR": "20220712", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071617"}, {"RECTYPE": "D", "MH": "Protein Phosphatase 2C", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta, PP2C", "MN": "D12.776.476.559.716", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.1.3.16", "RR": "EC 3.1.3.43", "MS": "One of four major classes of mammalian serine/threonine specific protein phosphatases. Protein phosphatase 2C is a monomeric enzyme about 42 kDa in size. It shows broad substrate specificity dependent on divalent cations (mainly manganese and magnesium). Three isozymes are known in mammals: PP2C -alpha, -beta and -gamma. In yeast, there are four PP2C homologues: phosphatase PTC1 that have weak tyrosine phosphatase activity, phosphatase PTC2, phosphatase PTC3, and PTC4. Isozymes of PP2C also occur in Arabidopsis thaliana where the kinase-associated protein phosphatase (KAPP) containing a C-terminal PP2C domain, dephosphorylates Ser/Thr receptor-like kinase RLK5.", "PM": "2017; PROTEIN PHOSPHATASE 2C was indexed under PHOSPHOPROTEIN PHOSPHATASES 1993-2016", "HN": "2017 (2016)", "MR": "20210521", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071636"}, {"RECTYPE": "D", "MH": "Receptor, Notch3", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Notch 3 Receptor", "MN": "D12.776.930.770.875", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "0", "PI": "Receptors, Notch (2006-2016)", "MS": "A notch receptor characterized by a large extracellular domain containing 34 EPIDERMAL GROWTH FACTOR-like repeats. It functions to regulate CELL DIFFERENTIATION; APOPTOSIS; and CELL PROLIFERATION. Mutations in the EGF repeats of Notch-3 are associated with CADASIL.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071656"}, {"RECTYPE": "D", "MH": "Werner Syndrome Helicase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Werner Syndrome RecQ Like Helicase", "MN": "D12.776.660.720.750", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.6.4.12", "PI": "RecQ Helicases (2006-2016)", "MS": "A DNA-dependent helicase and 3'-5' exonuclease. It has  3'->5' exonuclease activity towards double-stranded DNA with a 5'-overhang and binds preferentially to DNA substrates containing alternate secondary structures, such as replication forks and HOLLIDAY JUNCTIONS. Mutations in the WRN gene are associated with WERNER SYNDROME.", "PM": "2017", "HN": "2017", "MR": "20170524", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071657"}, {"RECTYPE": "D", "MH": "Zinc Finger Protein GLI1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oncogene Protein, Glioma-Associated", "MN": "D12.776.930.900.700", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A transcriptional activator and oncogene protein that contains two CYS2-HIS2 ZINC FINGERS. Two isoforms are expressed; both regulate the expression of specific genes during development of craniofacial features, digits, the CENTRAL NERVOUS SYSTEM; and the GASTROINTESTINAL TRACT. They also regulate SONIC HEDGEHOG PROTEIN signaling and cell proliferation.", "PM": "2017; ZINC FINGER PROTEIN GLI1 was indexed under TRANS-ACTIVATORS and ONCOGENE PROTEINS 2006-2016 and under TRANSCRIPTION FACTORS 1993-2006", "HN": "2017 (1993)", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071676"}, {"RECTYPE": "D", "MH": "Histidine Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tele-Kinase, Protein-Histidine", "MN": "D08.811.913.696.620.682.424", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 2.7.13.1", "RR": "EC 2.7.13.3", "MS": "A member of the transferase superfamily of proteins. In the activated state, protein-histidine kinase autophosphorylates at a histidine residue, subsequently transferring high-energy phosphoryl groups to an aspartate residue of the response-regulator domain, which results in a conformational shift in the effector domain. Histidine kinases mediate signal transduction in a wide range of processes involving cellular adaptation to environmental stress.", "PM": "2017; PROTEIN-HISTIDINE KINASE was indexed under PROTEIN KINASES 1986-2016", "HN": "2017 (1986)", "MR": "20180620", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071677"}, {"RECTYPE": "D", "MH": "WD40 Repeats", "AQ": "DE GE IM PH RE", "ENTRY": "beta-Transducin Repeat", "MN": "G02.111.570.820.709.275.875.515", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Repetitive Sequences, Amino Acid (1999-2016)", "MS": "Protein interaction motifs of approximately 40 amino acids that usually terminate in TRYPTOPHAN and ASPARTIC ACID. They form characteristic beta-propeller structures and occur in many eukaryotic proteins that function in a variety of cellular processes. Proteins that contain WD40 repeats often function as assembly platforms for MULTIPROTEIN COMPLEXES.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071678"}, {"RECTYPE": "D", "MH": "Glycogen Synthase Kinase 3 beta", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "GSK 3beta", "MN": "D12.776.476.563.646.625.500", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A glycogen synthase kinase-3 type enzyme that functions in ENERGY METABOLISM; EMBRYONIC DEVELOPMENT; and NEUROGENESIS. It is also involved in PROTEIN BIOSYNTHESIS and regulates cell growth and proliferation as a component of the WNT SIGNALING PATHWAY and other signaling pathways. Certain polymorphisms in the GSK3B gene have been associated with PARKINSON DISEASE; ALZHEIMER DISEASE; and BIPOLAR DISORDER.", "PM": "2017; GLYCOGEN SYNTHASE KINASE 3 BETA was indexed under GLYCOGEN SYNTHASE KINASE 3 2002-2016", "HN": "2017 (2002)", "MR": "20210521", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071679"}, {"RECTYPE": "D", "MH": "Tartrate-Resistant Acid Phosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "V, Acid Phosphatase", "MN": "D12.776.476.559.862", "MH_TH": "NLM (2017)", "ST": "T130", "RN": "EC 3.1.3.2", "MS": "One of several acid phosphatases in humans, other mammals, plants, and a few prokaryotes. The protein fold of tartrate-resistant acid phosphatase (TRAP) resembles that of the catalytic domain of plant purple acid phosphatase and other serine/threonine-protein phosphatases that also contain a metallophosphoesterase domain. One gene produces the various forms which include purple acid phosphatases from spleen and other tissues. Tartrate-resistant acid phosphatase is a biomarker for pathological states in which it is over-expressed. Such conditions include GAUCHER DISEASE; HODGKIN DISEASE; BONE RESORPTION; and NEOPLASM METASTASIS.", "PM": "2017; TARTRATE-RESISTANT ACID PHOSPHATASE was indexed under ACID PHOSPHATASE and ISOENZYMES 1995-2016", "HN": "2017 (1995)", "MR": "20210521", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071681"}, {"RECTYPE": "D", "MH": "Sterile Alpha Motif", "AQ": "DE GE IM PH RE", "ENTRY": "Sterile Alpha Motifs", "MN": "G02.111.570.820.709.275.750.500.813", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Protein Structure, Tertiary (1998-2016)", "MS": "A putative protein interaction module, approximately 70 amino acids long, that forms a small five-helix bundle with two large interfaces which may homo- and hetero-oligomerize, or bind non-sterile-alpha motif targets. The sterile alpha motif is present in a wide variety of eukaryotic proteins that function in diverse biological processes.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071682"}, {"RECTYPE": "D", "MH": "Proteogenomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Researchs, Proteogenomic", "MN": "H01.181.122.738.500", "MH_TH": "NLM (2016)", "ST": "T091", "PI": "Proteomics (2004-2016)", "MS": "The systematic study of annotated genomic information to global protein expression in order to determine the relationship between genomic sequences and both expressed proteins and predicted protein sequences.", "PM": "2017; see PROTEOMICS 2016", "HN": "2017; use PROTEOMICS 2016", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071696"}, {"RECTYPE": "D", "MH": "Cellulite", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cellulites", "MN": "C23.888.885.281", "FX": "Cellulitis", "MH_TH": "NLM (2017)", "ST": "T184", "PI": "Obesity (1978-2016)", "MS": "Skin lumpiness or skin surface dimpling often seen on the thighs, buttocks and abdomen. It is due to protrusion of SUBCUTANEOUS FAT into the DERMIS layer of skin.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071697"}, {"RECTYPE": "D", "MH": "Latent Autoimmune Diabetes in Adults", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diabetes, Type 1.5", "MN": "C20.111.576", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Diabetes Mellitus, Type 2 (1994-2016)", "MS": "Autoimmune diabetes in adults with slowly progressive PANCREATIC BETA CELL failure and the presence of circulating autoantibodies to PANCREATIC ISLETS cell antigens.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071698"}, {"RECTYPE": "D", "MH": "Bilateral Vestibulopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vestibulopathy, Bilateral", "MN": "C23.888.592.057", "MH_TH": "NLM (2017)", "ST": "T184", "PI": "Vestibule, Labyrinth (1963-2016)", "MS": "Impairment of the vestibular function of both inner ears which can cause difficulties with balance, gait, VERTIGO, and visual blurring.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071699"}, {"RECTYPE": "D", "MH": "Cone-Rod Dystrophies", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rod-Cone Dystrophy|T047|NON|NRW|GHR (2014)|NLM (1990)|890328|abcdeef", "ENTRY": "Rod-Cone Dystrophies", "MN": "C16.320.290.152", "MH_TH": "NLM (2017)", "ST": "T047", "AN": "ROD CONE DYSTROPHIES see RETINITIS PIGMENTOSA is also available", "PI": "Retinitis Pigmentosa (1981-2016)", "MS": "Genetically heterogeneous and sometimes syndromic (e.g., BARDET BIEDL SYNDROME; and SPINOCEREBELLAR ATAXIA TYPE 7) retinopathies with initial RETINAL CONE involvement. They are characterized by decreased VISUAL ACUITY; COLOR VISION DEFECTS; progressive loss of peripheral vision and night blindness.", "PM": "2017; see RETINITIS PIGMENTOSA 2011-2016", "HN": "2017; use RETINITIS PIGMENTOSA 2011-2016", "MR": "20180630", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071700"}, {"RECTYPE": "D", "MH": "Regulatory Factor X Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, RFX", "MN": "D12.776.930.977.624", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "MS": "A family of eukaryotic transcription factors that recognize and bind to a highly-conserved cis-regulatory sequence (X-box) within the promoter region of MHC CLASS II GENES. They contain a conserved winged-helix DNA binding domain and function as homo or heterodimers.", "PM": "2017; REGULATORY FACTOR X TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEINS and TRANSCRIPTION FACTORS 1988-2016", "HN": "2017 (1988)", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071701"}, {"RECTYPE": "D", "MH": "Regulatory Factor X1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, RFX1", "MN": "D12.776.930.977.624.500", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A regulatory factor X transcription factor that is required for the expression of MHC CLASS II GENES. It also binds to inverted repeats of HEPATITIS B VIRUS DNA and is required for viral gene expression. RFX1 functions as a monomer or heterodimer with other RFX transcription factors.", "PM": "2017; see REGULATORY FACTOR X TRANSCRIPTION FACTORS 1988-2016", "HN": "2017; use REGULATORY X TRANSCRIPTION FACTORS (NM) 1988-2016", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071716"}, {"RECTYPE": "D", "MH": "X-Box Binding Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "XBP 1 Protein", "MN": "D12.776.930.127.937", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A basic leucine zipper transcription factor that regulates expression of MHC CLASS II GENES through its binding to a conserved X-box DNA sequence in the promoter region. It regulates the expression of genes involved in the UNFOLDED PROTEIN RESPONSE.", "PM": "2017; see REGULATORY FACTOR X TRANSCRIPTION FACTORS 1988-2016", "HN": "2017; use REGULATORY FACTOR X TRANSCRIPTION FACTORS (NM) 1988-2016", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071717"}, {"RECTYPE": "D", "MH": "Stromal Interaction Molecules", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stromal Interaction Molecule|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Molecule, Stromal Interaction", "MN": "D12.776.543.875", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1997-2016)", "MS": "Membrane-associated calcium-binding proteins that are characterized by N-terminal EF HAND MOTIFS and a STERILE ALPHA MOTIF. They function as sensors of ENDOPLASMIC RETICULUM calcium levels and translocate from the ER to the plasma membrane to activate CALCIUM CHANNELS in response to intracellular calcium depletion.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071736"}, {"RECTYPE": "D", "MH": "Stromal Interaction Molecule 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "STIM1 Protein|T116|T123|ACX|EQV|NLM (2017)|160304|abbcdef", "MN": "D12.776.543.875.500", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1997-2016)", "MS": "A stromal interaction molecule that functions in the regulation of calcium influx following depletion of intracellular calcium in the ENDOPLASMIC RETICULUM. It translocates to the plasma membrane upon calcium depletion where it activates the CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL ORAI1.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071737"}, {"RECTYPE": "D", "MH": "Stromal Interaction Molecule 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "STIM2 Protein|T116|T123|NON|EQV|NLM (2017)|160304|abbcdef", "MN": "D12.776.543.875.750", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Membrane Glycoproteins (2008-2016)", "MS": "A stromal interaction molecule that functions as a highly sensitive calcium sensor in the ENDOPLAMSIC RETICULUM and CYTOSOL. It can regulate CALCIUM RELEASE ACTIVATED CALCIUM CHANNELS in response to minor variations in intracellular calcium.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071738"}, {"RECTYPE": "D", "MH": "Calcium Release Activated Calcium Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Calcium Release Activated Calcium Channel|T116|T123|NON|EQV|NLM (2021)|200129|abbcdef", "ENTRY": "Channel, CRAC", "MN": "D12.776.543.585.400.150.740", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Calcium Channels (1995-2016)", "MS": "Specialized calcium channels that localize to the ENDOPLAMSIC RETICULUM and PLASMA MEMBRANE. They contain the pore subunit ORAI1 PROTEIN which is activated by STROMAL INTERACTION MOLECULES upon intracellular calcium depletion.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071739"}, {"RECTYPE": "D", "MH": "ORAI1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "ORAI Calcium Release Activated Calcium Modulator 1", "MN": "D12.776.543.585.400.150.740.500", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Calcium Channels (2008-2016)", "MS": "The pore-forming subunit of calcium release activated calcium channels. It is activated by STROMAL INTERACTION MOLECULE 1 upon intracellular calcium depletion.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071740"}, {"RECTYPE": "D", "MH": "ORAI2 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "ORAI Calcium Release Activated Calcium Modulator 2", "MN": "D12.776.543.585.400.150.740.750", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (2006-2016)", "MS": "A calcium release-activated calcium-like (CRAC-like) channel subunit which functions with STROMAL INTERACTION MOLECULE 1 to regulate cell calcium influx and increase (Ca2+)-selective current.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071741"}, {"RECTYPE": "D", "MH": "Soluble Guanylyl Cyclase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxide Receptors, Nitric", "MN": "D12.776.476.350.500", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "EC 4.6.1.2", "RR": "EC 4.6.1.2", "MS": "A mammalian enzyme composed of a heterodimer of alpha and beta subunits. Each subunit consists of four domains; N-terminal HNOX domain, PAS-like domain, a coiled-coil domain, and a C-terminal catalytic domain. All four domains are homologous proteins with a similar conformation of functional domains. Soluble guanylate cyclase catalyzes the formation of cyclic GMP from GTP, and is a key enzyme of the nitric oxide signaling pathway involved in the regulation of a variety of biological and physiological processes in mammals.", "PM": "2017; SOLUBLE GUANYLYL CYCLASE was indexed under GUANYLATE CYCLASE and RECEPTORS, CYTOPLASMIC AND NUCLEAR 2001-2016", "HN": "2017 (2016)", "MR": "20210521", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071756"}, {"RECTYPE": "D", "MH": "BTB-POZ Domain", "AQ": "DE GE IM PH RE", "ENTRY": "POZ Domains", "MN": "G02.111.570.820.709.275.750.500.343", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Protein Structure, Tertiary (1995-2016)", "MS": "A homodimerization protein interaction domain occurring at the N terminus of proteins that contain multiple copies of either CYS2-HIS2 ZINC FINGERS or KELCH REPEATS. It is characterized by a tightly intertwined dimer with an extensive hydrophobic interface. A surface-exposed groove lined with conserved amino acids is formed at the dimer interface, suggesting a peptide-binding site. Many BTB proteins are transcriptional regulators that are thought to regulate CHROMATIN structure.", "PM": "2017", "HN": "2017", "MR": "20160509", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071757"}, {"RECTYPE": "D", "MH": "Kelch Repeat", "AQ": "DE GE IM PH RE", "ENTRY": "Motifs, Kelch", "MN": "G02.111.570.820.709.275.875.273", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "Molecular Sequence Data (1994-2016)", "MS": "An amino acid sequence of about 50 residues long that is composed of X n-long repeats which form a four-stranded anti-parallel BETA-SHEET as a structural component, or blade, of a beta-propeller.", "PM": "2017", "HN": "2017", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071776"}, {"RECTYPE": "D", "MH": "SMARCB1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Swi Snf Related Matrix Associated Actin Dependent Regulator Of Chromatin Subfamily B Member 1", "MN": "D12.776.930.809", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (2006-2016)", "MS": "A component of the SWI-SNF CHROMATIN REMODELING complex that functions  as a PROTEIN PHOSPHATASE 1 regulator and to stabilize CHROMATIN at PROMOTER REGIONS. It is important for regulating CELL PROLIFERATION and CELL DIFFERENTIATION. Mutations in the SMARCB1 gene are associated with malignant RHABDOID TUMORS.", "PM": "2017", "HN": "2017", "MR": "20160428", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071796"}, {"RECTYPE": "D", "MH": "Butyrophilins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Butyrophilin|T116|T123|NON|EQV|NLM (1981)|160308|abbcdef", "MN": "D12.776.543.550.195", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A family of mammalian membrane glycoproteins characterized by extracellular IMMUNOGLOBULIN DOMAINS. Some members also have an intracellular B30.2-SPRY DOMAIN or SPRY DOMAIN. The butyrophilin protein (BTN) is expressed by MAMMARY GLAND EPITHELIUM during LACTATION; whereas other members are widely expressed in other tissues, including skeletal muscle, intestine, ERYTHROID CELLS (ERMAP protein); and nerve tissue (MYELIN-OLIGODENDROCYTE GLYCOPROTEIN).", "PM": "2017; BUTRYOPHILINS was indexed under MEMBRANE GLYCOPROTEINS 1988-2016 and under GLYCOPROTEINS 1981-1987", "HN": "2017 (1981)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071797"}, {"RECTYPE": "D", "MH": "Zinc Finger E-box-Binding Homeobox 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Zinc Finger E box Binding Homeobox 1", "MN": "D12.776.930.780.945", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (2004-2016)", "MS": "A transcription factor characterized by N-terminal and C-terminal CYS2-HIS2 ZINC FINGERS separated by a homeobox. It represses the expression of E-CADHERIN to induce the EPITHELIAL-MESENCHYMAL TRANSITION. It also represses PROTO-ONCOGENE PROTEINS C-BCL-6; regulates the cell type-specific expression of SODIUM-POTASSIUM-EXCHANGING ATPASE; and promotes neuronal differentiation.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071799"}, {"RECTYPE": "D", "MH": "Glycodelin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Progestagen Associated Endometrial Protein", "MN": "D12.776.780.426", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Pregnancy Proteins (1985-2016)", "MS": "A lipocalin that is the most abundant protein synthesized and secreted by the ENDOMETRIUM from mid-LUTEAL PHASE of the MENSTRUAL CYCLE through early PREGNANCY.", "PM": "2017", "HN": "2017", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071816"}, {"RECTYPE": "D", "MH": "Wnt-5a Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Wnt 5a Protein", "MN": "D23.529.984.050", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Wnt Proteins (2006-2016)", "MS": "A Wnt protein and ligand for FRIZZLED RECEPTORS that may function as an inhibitor or activator of the WNT SIGNALING PATHWAY. For example, it activates signaling in the presence of Frizzled-4 but is inhibitory when coupled with ROR2 TYROSINE KINASE. It is required for axis formation during EMBRYOGENESIS and inhibits the proliferation, migration, and invasiveness of cancer cells.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071818"}, {"RECTYPE": "D", "MH": "Virophages", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Virophage", "MN": "B04.280.950", "FX": "Satellite Viruses", "MH_TH": "NLM (2017)", "ST": "T005", "MS": "Circular, double-stranded DNA viruses that invade giant DNA viruses (GIANT VIRUSES) which infect eukaryotes.", "PM": "2017", "HN": "2017", "MR": "20200902", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071819"}, {"RECTYPE": "D", "MH": "Emergency Medical Dispatch", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Medical Dispatch, Emergency", "MN": "N02.421.297.043", "MH_TH": "NLM (2017)", "ST": "T057", "MS": "The mobilization of EMERGENCY CARE to the locations and people that need them.", "PM": "2017", "HN": "2017", "MR": "20171213", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071820"}, {"RECTYPE": "D", "MH": "Dystonin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "230 240 kDa Bullous Pemphigoid Antigen", "MN": "D12.776.220.790.625", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1995-2016)", "MS": "A plakin characterized by repeat sequences homologous to SPECTRIN and PLECTIN and C-terminal EF HAND MOTIFS. It functions as an integrator of INTERMEDIATE FILAMENTS, ACTIN and MICROTUBULES in cytoskeleton networks. It is required for anchoring intermediate filaments to the actin cytoskeleton in neural and muscle cells as well as anchoring KERATIN-containing intermediate filaments to HEMIDESMOSOMES in EPITHELIAL CELLS.", "PM": "2017", "HN": "2017", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071821"}, {"RECTYPE": "D", "MH": "Emergency Medical Dispatcher", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Medical Dispatchers, Emergency", "MN": "M01.526.485.349", "MH_TH": "NLM (2017)", "ST": "T097", "MS": "Professionals responsible for relaying calls for the deployment of EMERGENCY MEDICAL SERVICES.", "PM": "2017", "HN": "2017", "MR": "20171213", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071822"}, {"RECTYPE": "D", "MH": "Extremophiles", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Extremophile|T001|NON|EQV|NLM (2021)|191227|abcdef", "MN": "B05.256", "FX": "Extreme Environments", "MH_TH": "NLM (2017)", "ST": "T001", "MS": "Organisms specifically adapted to live in EXTREME ENVIRONMENTS.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071825"}, {"RECTYPE": "D", "MH": "Distracted Driving", "AQ": "EH LJ PC PX SN TD", "ENTRY": "Driving, Inattentive", "MN": "I03.125.474", "MH_TH": "NLM (2017)", "ST": "T056", "PI": "Automobile Driving (2007-2016)", "MS": "Behavior which detracts from the focus necessary to operate an automobile safely.", "PM": "2017", "HN": "2017", "MR": "20170711", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071826"}, {"RECTYPE": "D", "MH": "Professional Practice Gaps", "AQ": "CL EC EH ES HI LJ MT OG SN ST TD", "ENTRY": "Professional Practice Gap", "MN": "N05.300.643", "MH_TH": "NLM (2017)", "ST": "T058", "MS": "Difference between observed and ideal DELIVERY OF HEALTH CARE and healthcare outcomes that reflect the current state of knowledge.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071836"}, {"RECTYPE": "D", "MH": "Fibrillins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fibrillin|T116|T123|NON|EQV|NLM (1985)|160309|abbcdef", "MN": "D12.776.860.300.400", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A family of extracellular matrix glycoproteins that is structurally similar to  LATENT TGF-BETA BINDING PROTEINS, but contain additional TGF-beta binding domains, in addition to unique domains at their N and C-terminals. Fibrillins assemble into 10-12 nm MICROFIBRILS that function in a variety of cell interactions with the EXTRACELLULAR MATRIX and developmental processes such as ELASTIC TISSUE maintenance and assembly, and the targeting of growth factors to the extracellular matrix.", "PM": "2017; see FIBRILLIN 1985-2016", "HN": "2017; use FIBRILLIN 1985-2016", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071837"}, {"RECTYPE": "D", "MH": "Fibrillin-1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fibrillin 1", "MN": "D12.776.860.300.400.500", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "MS": "A fibrillin (FBN1) that functions as a structural support protein for MICROFIBRILS. It also regulates the maturation of OSTEOBLASTS by controlling the availability and concentration of TGF-BETA and BONE MORPHOGENETIC PROTEINS. Mutations in the FBN1 gene are associated with MARFAN SYNDROME.", "PM": "2017; see FIBRILLIN 1985-2016", "HN": "2017; use FIBRILLIN 1985-2016", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071838"}, {"RECTYPE": "D", "MH": "Fibrillin-2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fibrillin 2", "MN": "D12.776.860.300.400.750", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "MS": "A fibrillin (FBN2) that functions to regulate the assembly of ELASTIC FIBERS. Mutations in the FBN2 gene are associated with congenital contractural ARACHNODACTYLY.", "PM": "2017; see FIBRILLIN 1985-2016", "HN": "2017; use FIBRILLIN 1985-2016", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071840"}, {"RECTYPE": "D", "MH": "PAX6 Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, PAX6", "MN": "D12.776.930.700.813", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A paired box transcription factor that has important functions in the development of the eye, nose, central nervous system and pancreas. Mutations in the PAX6 gene are associated with ocular disorders such as ANIRIDIA.", "PM": "2017; PAX6 TRANSCRIPTION FACTOR was indexed under EYE PROTEINS; REPRESSOR PROTEINS; HOMEODOMAIN PROTEINS and PAIRED BOX TRANSCRIPTION FACTORS 2000-2016; under DNA-BINDING PROTEINS 1999-2000; and under TRANSCRIPTION FACTORS 1994-1999", "HN": "2017; use PAX6 PROTEIN (NM) 1994-2016", "MR": "20160415", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071841"}, {"RECTYPE": "D", "MH": "Tudor Domain", "AQ": "DE GE IM PH RE", "ENTRY": "Tudor Motifs", "MN": "G02.111.570.820.709.275.750.500.844", "MH_TH": "NLM (2017)", "ST": "T087", "PI": "RNA-Binding Proteins (1997-2016)", "MS": "A conserved, approximately 50 amino acid, protein sequence that adopts a characteristic strongly bent, five stranded anti-parallel beta-sheet barrel-like fold. The Tudor domain recognizes dimethylated ARGININE through its negatively-charged surface and occurs in many proteins that co-localize with RNA; RIBONUCLEOPROTEINS or SINGLE-STRANDED DNA complexes in the CELL NUCLEUS; MITOCHONDRIA; or KINETOCHORES.", "PM": "2017", "HN": "2017", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071856"}, {"RECTYPE": "D", "MH": "Tumor Suppressor p53-Binding Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tumor Suppressor p53 Binding Protein 1", "MN": "D12.776.664.235.950", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Intracellular Signaling Peptides and Proteins (2005-2016)", "MS": "A nuclear and cytoplasmic protein that associates with KINETOCHORES and contains a C-terminal TUDOR DOMAIN. It plays a critical role in the cellular response to DNA DAMAGE and localizes to DOUBLE-STRAND DNA BREAKS. It may also function in M PHASE CELL CYCLE CHECKPOINTS and as an enhancer of TUMOR SUPPRESSOR PROTEIN P53-mediated transcriptional activation.", "PM": "2017", "HN": "2017", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071857"}, {"RECTYPE": "D", "MH": "Epithelial Cell Adhesion Molecule", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tumor-Associated Antigen, GA733", "MN": "D23.050.301.350.263", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A cell adhesion molecule that is expressed on the membranes of nearly all EPITHELIAL CELLS, especially at the junctions between intestinal epithelial cells and intraepithelial LYMPHOCYTES. It also is expressed on the surface of ADENOCARCINOMA and epithelial tumor cells.  It may function in the MUCOSA through homophilic interactions to provide a barrier against infection. It also regulates the proliferation and differentiation of EMBRYONIC STEM CELLS.", "PM": "2017; EPITHELIAL CELL ADHESION MOLECULE was indexed under ANTIGENS, NEOPLASM and CELL ADHESION MOLECULES 1989-2016", "HN": "2017 (1989)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071858"}, {"RECTYPE": "D", "MH": "Prostaglandin-E Synthases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthases, Prostaglandin-E", "MN": "D08.811.399.475.600", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 5.3.99.3", "MS": "Oxidoreductases that catalyze the GLUTATHIONE-dependent oxidoreduction of PROSTAGLANDIN H2 to PROSTAGLANDIN E2.", "PM": "2017; PROSTAGLANDIN-E-SYNTHASES was indexed under INTRAMOLECULAR OXIDOREDUCTASES 1997-2016, under ISOMERASES 1977-1997, and under PROSTAGLANDINS E 1977-1982", "HN": "2017 (1977)", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071876"}, {"RECTYPE": "D", "MH": "Checkpoint Kinase 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinase, Chk1", "MN": "D12.776.476.563.143", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A serine/threonine-specific protein kinase which is encoded by the CHEK1 gene in humans. Checkpoint kinase 1 (also known as Chk1) coordinates DNA damage response and cell cycle checkpoint response. Under these conditions, activation of Chk1 results in the initiation of cell cycle checkpoints, cell cycle arrest, DNA repair and cell death, to prevent damaged cells from progressing through the cell cycle.", "PM": "2017; CHECKPOINT KINASE 1 was indexed under PROTEIN KINASES 2004-2016", "HN": "2017 (2004)", "MR": "20210521", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071877"}, {"RECTYPE": "D", "MH": "Medically Unexplained Symptoms", "ENTRY": "Unexplained Symptoms, Medically", "MN": "C23.888.541", "MH_TH": "NLM (2017)", "ST": "T184", "PI": "Somatoform Disorders (1985-2016)", "MS": "Persistent health symptoms which remain unexplained after a complete medical evaluation. A cluster of symptoms that consistently appear together but without a known cause are referred to as a MEDICALLY UNEXPLAINED SYNDROME (MUS).", "PM": "2017", "HN": "2017", "MR": "20160623", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071896"}, {"RECTYPE": "D", "MH": "AC133 Antigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Prominin Like PROML1", "MN": "D12.776.543.550.023", "FX": "Antigen-Antibody Reactions", "MH_TH": "NLM (2017)", "ST": "T129", "RN": "0", "MS": "A member of the prominin family, AC133 Antigen is a 5-transmembrane antigen occurring as several isoforms produced by alternative splicing which are processed into mature forms. In humans, it is expressed as a subset of CD34 (bright) human hematopoietic stem cells and CD34 positive leukemias. Functionally, it is associated with roles in cell differentiation, proliferation, and apoptosis. Specifically, it regulates the organization of apical plasma membrane in epithelial cells, disk morphogenesis during early retinal development, MAPK and Akt signaling pathways, and in cholesterol metabolism.", "PM": "2017; AC133 ANTIGEN was indexed under GLYCOPROTEINS, PEPTIDES and ANTIGENS, CD 1998-2016", "HN": "2017(1998)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071916"}, {"RECTYPE": "D", "MH": "Nipple Discharge", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Nipple Discharges", "MN": "A12.207.824", "FX": "Nipple Aspirate Fluid", "MH_TH": "NLM (2017)", "ST": "T031", "PI": "Nipples (1963-2016)", "MS": "Fluid that seeps out of one or both nipples of the breast.", "PM": "2017", "HN": "2017", "MR": "20160630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071936"}, {"RECTYPE": "D", "MH": "Cerebral Blood Volume", "AQ": "DE GE IM PH RE VE", "ENTRY": "Volume, Cerebral Blood", "MN": "G09.330.380.092.185", "MH_TH": "NLM (2017)", "ST": "T034", "PI": "Cerebrovascular Circulation (1967-2016)", "MS": "Volume of circulating blood in a region of the brain. It is a functional measure of the brain perfusion status which relates changes in this to changes in CEREBROVASULAR CIRCULATION that are often seen in brain diseases.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071937"}, {"RECTYPE": "D", "MH": "Fasciotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Fasciectomy|T061|NON|EQV|NLM (2017)|160324|abcdef", "MN": "E04.321", "FX": "Fascia", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Fascia/surgery (1965-2016)", "MS": "Surgical incision on the FASCIA. It is used to decompress compartment pressure (e.g. in COMPARTMENT SYNDROMES; circumferential burns and extremity injuries) or to release contractures (e.g. in DUPUYTREN'S CONTRACTURE).", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071938"}, {"RECTYPE": "D", "MH": "Stroke Rehabilitation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD", "ENTRY": "Rehabilitation, Stroke", "MN": "N02.421.784.511.500", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Stroke/rehabilitation (1982-2016)", "MS": "Restoration of functions to the maximum degree possible in a person or persons suffering from a stroke.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071939"}, {"RECTYPE": "D", "MH": "Nucleons", "AQ": "AE CL HI TU", "ENTRY": "Nucleon|T081|NON|EQV|NLM (2017)|160324|abcdef", "MN": "G01.249.660", "MH_TH": "NLM (2017)", "ST": "T081", "PI": "Elementary Particles (1970-2016)", "MS": "Subatomic particles that are either protons or neutrons.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071940"}, {"RECTYPE": "D", "MH": "Barium Enema", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Enema, Barium", "MN": "E02.319.347.500", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Enema (1963-2016)", "MS": "X-RAY examination of LOWER GASTROINTESTINAL TRACT. Imaging is done while a BARIUM COMPOUND (e.g., BARIUM SULFATE) fills the large intestine via the rectum as a CONTRAST MATERIAL.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071941"}, {"RECTYPE": "D", "MH": "Myocardial Contusions", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injury, Blunt Cardiac", "MN": "C26.974.250.875", "MH_TH": "NLM (2017)", "ST": "T037", "PI": "Heart Injuries (1964-2016)", "MS": "Bruise to the heart muscle due to blunt thoracic trauma.", "HN": "2017", "MR": "20181102", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071956"}, {"RECTYPE": "D", "MH": "Case Managers", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Managers, Case", "MN": "N02.360.215", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Case Management (1995-2016)", "MS": "Professionals who are in charge of assessment, planning, facilitation, care coordination, evaluation, and advocacy for options and services to meet a patient\u2019s and family\u2019s comprehensive health needs.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071959"}, {"RECTYPE": "D", "MH": "Breast Carcinoma In Situ", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Lobular Carcinoma In Situ|T191|NON|NRW|NLM (2017)|160325|abcdef", "MN": "C17.800.090.500.130", "FX": "Carcinoma, Lobular", "MH_TH": "NLM (2017)", "ST": "T191", "AN": "coordinate with BREAST NEOPLASMS", "PI": "Carcinoma, Lobular (1984-2016)", "MS": "A condition in which abnormal cells have not spread outside the duct, lobule, or nipple to other tissues of the breast. There are 3 types of breast carcinoma in situ: DUCTAL CARCINOMA IN SITU; LOBULAR CARCINOMA IN SITU; and PAGET DISEASE OF THE NIPPLE.", "PM": "2017", "HN": "2017", "MR": "20190429", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071960"}, {"RECTYPE": "D", "MH": "Gracilis Muscle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Muscles, Gracilis", "MN": "A02.633.567.425", "MH_TH": "NLM (2017)", "ST": "T023", "PI": "Thigh (1965-2016)", "MS": "A slender and most superficial muscle in the inner THIGH which originates at the ramus of the PUBIC BONE near the PUBIC SYMPHYSIS and inserts at the proximal medial TIBIA. Its function is to abduct thigh, flex knee, and rotate leg medially. It is a common  source of a MYOCUTANEOUS FLAP.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000071976"}, {"RECTYPE": "D", "MH": "Blood Culture", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Tests, Blood Culture", "MN": "E05.200.875.185", "MH_TH": "NLM (2017)", "ST": "T059", "PI": "Microbiological Techniques (1963-2016)", "MS": "Test to determine the presence of blood infection (e.g. SEPSIS; BACTEREMIA).", "PM": "2017", "HN": "2017", "MR": "20160601", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000071997"}, {"RECTYPE": "D", "MH": "S100 Calcium-Binding Protein A4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "S100 Calcium Binding Protein A4", "MN": "D12.776.157.125.750.813", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "S100 Proteins (2003-2016)", "MS": "An S100 protein characterized by four helix bundles that form N- and C-terminal EF HAND MOTIFS. It functions as a homodimer and interacts with both intracellular and extracellular signaling proteins. Aberrant S100A4 activity is associated with NEOPLASM METASTASIS; FIBROSIS; and RHEUMATOID ARTHRITIS.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000071999"}, {"RECTYPE": "D", "MH": "Acedapsone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diacetyldapsone|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|750725|abbcdeef", "ENTRY": "4,4' Diacetyldiaminodiphenylsulfone", "MN": "D02.886.590.263.050", "PA": "Leprostatic Agents", "MH_TH": "USAN (1970)", "ST": "T121", "N1": "Acetamide, N,N'-(sulfonyldi-4,1-phenylene)bis-", "RN": "0GZ72U84TN", "RR": "77-46-3 (Acedapsone)", "PI": "Sulfones (1972-1974)", "MS": "Acetylated sulfone that is slowly metabolized to give long-term, low blood levels of DAPSONE. It has antimicrobial and antimalarial action, but is mainly used as a depot leprostatic agent.", "PM": "91; was see under DAPSONE 1976-90", "HN": "91(76); was see under DAPSONE 1976-90", "MR": "20130708", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D000072"}, {"RECTYPE": "D", "MH": "NF-KappaB Inhibitor alpha", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha, NF-KappaB Inhibitor", "MN": "D12.776.930.326.500", "FX": "Ankyrin Repeat", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "139874-52-5", "MS": "An I-kappa B protein that inhibits the activity of dimeric NF-KAPPA B P50-REL complexes, sequesters transcription factor NF-kappaB as an inactive complex in the cytoplasm; and prevents NF-kappaB nuclear translocation and DNA binding.", "PM": "2017; NF-KAPPAB INHIBITOR ALPHA was indexed under DNA-BINDING PROTEINS 1999-2002 and under I-KAPPA B PROTEINS 2003-2016", "HN": "2017 (1991)", "MR": "20170630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072000"}, {"RECTYPE": "D", "MH": "Diet, Healthy", "AQ": "AE CL EC EH ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Prudent Diet|T055|NON|REL|NLM (2020)|190124|abcdef", "ENTRY": "Prudent Diets", "MN": "G07.203.650.240.629", "FX": "Orthorexia Nervosa", "MH_TH": "NLM (2020)", "ST": "T061", "PI": "Diet (1981-2016)", "MS": "Dietary patterns which have been found to be important in reducing disease risk.", "PM": "2019; was HEALTHY DIET 2017-2018", "HN": "2019 (2017)", "MR": "20210305", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072001"}, {"RECTYPE": "D", "MH": "Prion Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PrP Proteins|T116|T123|EQV|NLM (1995)|931207|abbdef", "ENTRY": "Prion Protein, Major", "MN": "D12.776.785.340", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "PI": "Prions (2006-2016)", "MS": "Membrane glycosylphosphatidylinositol-anchored glycoproteins that may aggregate into rod-like structures. The prion protein (PRNP) gene is characterized by five TANDEM REPEAT SEQUENCES that encode a highly unstable protein region of five octapeptide repeats. Mutations in the repeat region and elsewhere in this gene are associated with CREUTZFELDT-JAKOB DISEASE; FATAL FAMILIAL INSOMNIA; GERSTMANN-STRAUSSLER DISEASE; Huntington disease-like 1, and KURU.", "PM": "2017; for PRION PROTEINS see PRIONS 1991-2016", "HN": "2017: for PRION PROTEINS use PRIONS 1991-2016", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072002"}, {"RECTYPE": "D", "MH": "Deubiquitinating Enzymes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Deubiquitinating Enzyme|T116|T126|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Enzymes, Deubiquitinating", "MN": "D08.811.037", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.19.12", "PI": "Ubiquitin-Specific Proteases (2014-2016)", "MS": "Enzymes that remove UBIQUITIN from a protein substrate, including POLYUBIQUITIN, or from other molecules.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072017"}, {"RECTYPE": "D", "MH": "Audiologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Audiologist", "MN": "N02.360.170", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Audiology (1977-2016)", "MS": "Professionals skilled at diagnostic testing of hearing, HEARING IMPAIRMENT, and CORRECTION OF HEARING IMPAIRMENT by non-medical or non-surgical means.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072018"}, {"RECTYPE": "D", "MH": "Kelch-Like ECH-Associated Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kelch Like ECH Associated Protein 1", "MN": "D12.776.476.024.387", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Intracellular Signaling Peptides and Proteins (2004-2016)", "MS": "An adaptor protein characterized by an N-terminal BTB-POZ DOMAIN and six KELCH REPEATS that functions as a substrate for the E3 UBIQUITIN LIGASE complex. It negatively-regulates NF-E2-RELATED FACTOR 2 by targeting it for ubiquitination and degradation by the PROTEASOME. It also represses genes regulated by ANTIOXIDANT RESPONSE ELEMENTS.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072019"}, {"RECTYPE": "D", "MH": "Synthetic Lethal Mutations", "AQ": "DE GE IM PH RE", "ENTRY": "Mutations, Synthetic Lethal", "MN": "G05.365.590.917", "FX": "Genes, Lethal", "MH_TH": "NLM (2017)", "ST": "T028", "MS": "Mutations in genes which lead to cell or organism death when occurring in combination with mutations in one or more other genes.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072020"}, {"RECTYPE": "D", "MH": "Prophylactic Mastectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Prophylactic Mastectomies", "MN": "E04.625.500", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Prophylactic Surgical Procedures (2014-2016)", "MS": "Surgical removal of one or both breasts to prevent or reduce the risk of developing breast cancer in persons who may be predisposed.", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072036"}, {"RECTYPE": "D", "MH": "Cardiac Rehabilitation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD", "ENTRY": "Rehabilitations, Cardiovascular", "MN": "N02.421.784.244", "FX": "Recovery of Function", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Cardiovascular Diseases (1963-2016)", "MS": "Restoration of functions to the maximum degree possible in a person or persons suffering from a CARDIOVASCULAR DISEASE. It also includes cardiac conditioning and SECONDARY PREVENTION in patients with elevated cardiovascular risk profile.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072038"}, {"RECTYPE": "D", "MH": "Fracture Dislocation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fractures, Dislocation", "MN": "C26.404.026", "MH_TH": "NLM (2017)", "ST": "T037", "PI": "Joint Dislocations (1963-2016)", "MS": "Fracture of a bone near an articulation with concomitant dislocation of that joint.", "PM": "2017", "HN": "2017", "MR": "20170705", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072039"}, {"RECTYPE": "D", "MH": "Apolipoprotein A-V", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apolipoprotein A V", "MN": "D12.776.521.120.200.575", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins A (2006-2016)", "MS": "A minor apolipoprotein that associates with HIGH-DENSITY LIPOPROTEINS (HDL), VERY-LOW-DENSITY LIPOPROTEINS (VLDL), and CHYLOMICRONS. It regulates levels of plasma TRIGLYCERIDES by activating APOLIPOPROTEIN C-II LIPOPROTEIN LIPASE and inhibiting hepatic VLDL triglyceride hydrolysis.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072040"}, {"RECTYPE": "D", "MH": "PAX3 Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, PAX3", "MN": "D12.776.930.700.782", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1991-2016)", "MS": "A paired box transcription factor that functions in CELL PROLIFERATION; CELL MIGRATION; and APOPTOSIS. It also is involved in MYOGENESIS and neural development. Mutations in the PAX3 gene are associated with WAARDENBURG SYNDROME TYPE 1.", "PM": "2017", "HN": "2017", "MR": "20170224", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072041"}, {"RECTYPE": "D", "MH": "Salter-Harris Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Salter Harris Fractures", "MN": "C26.404.026.500", "MH_TH": "NLM (2017)", "ST": "T037", "MS": "Fractures involving a GROWTH PLATE.", "PM": "2017", "HN": "2017", "MR": "20170705", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072042"}, {"RECTYPE": "D", "MH": "Transcription Factor HES-1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, Hairy-Like", "MN": "D12.776.930.125.844", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Homeodomain Proteins (1994-2016)", "MS": "A basic-helix-loop-helix transcription factor that functions as a transcriptional repressor for genes transcribed by bHLH proteins. For example, it may negatively regulate MYOGENESIS by inhibiting MyoD1 and ASH1 proteins. It is also required for the stability of FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS and their localization to the cell nucleus in response to DNA DAMAGE.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072056"}, {"RECTYPE": "D", "MH": "Anesthetists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Anesthesia Assistants|T097|NON|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Assistants, Anesthesia", "MN": "N02.360.140", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Anesthesiology (1964-2016)", "MS": "Persons trained and certified to administer ANESTHETICS.", "PM": "2017; for ANESTHESIA ASSISTANTS see PHYSICIAN ASSISTANTS 1976-2016", "HN": "2017; for ANESTHESIA ASSISTANTS use PHYSICIAN ASSISTANTS 1976-2016", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072077"}, {"RECTYPE": "D", "MH": "Positron Emission Tomography Computed Tomography", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Scans, PET-CT", "MN": "E01.370.384.730.800.399.500", "MH_TH": "NLM (2017)", "ST": "T060", "PI": "Tomography, X-Ray Computed (1984-2016)", "MS": "An imaging technique that combines a POSITRON-EMISSION TOMOGRAPHY (PET) scanner and a CT X RAY scanner. This establishes a precise anatomic localization in the same session.", "PM": "2017", "HN": "2017", "MR": "20181214", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072078"}, {"RECTYPE": "D", "MH": "Patched Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, Patched", "MN": "D12.776.624.776.633", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A family of 12-pass transmembrane proteins originally identified in Drosophila that are receptors for HEDGEHOG PROTEINS. They have important roles in regulating CELL PROLIFERATION; CELL DIFFERENTIAION; and BODY PATTERNING and may also function as TUMOR SUPPRESSOR PROTEINS.", "PM": "2017; PATCHED RECEPTORS was indexed under RECEPTORS, CELL SURFACE 2006-2016 and under MEMBRANE PROTEINS 1996-2005", "HN": "2017 (1996)", "MR": "20160711", "DA": "20160711", "DC": "1", "DX": "20170101", "UI": "D000072079"}, {"RECTYPE": "D", "MH": "Anesthesiologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Physician Anesthetist", "MN": "N02.360.810.040", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Anesthesiology (1964-2016)", "MS": "Physicians specializing in ANESTHESIOLOGY.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072080"}, {"RECTYPE": "D", "MH": "Patched-1 Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor-1, Patched", "MN": "D12.776.624.776.633.500", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "0", "MS": "A patched receptor for several HEDGEHOG PROTEINS that associates with the SMOOTHENED RECEPTOR to modulate hedgehog signaling. It is also a TUMOR SUPPRESSOR PROTEIN; mutations in the patched-1 gene are associated with BASAL CELL NEVUS SYNDROME; SQUAMOUS CELL CARCNIOMA of the ESOPHAGUS; trichoepitheliomas, and CARCINOMA, TRANSITIONAL CELL of the URINARY BLADDER.", "PM": "2017; PATCHED-1 RECEPTOR was indexed under RECEPTORS, CELL SURFACE 2005-2016, and under MEMBRANE PROTEINS 1996-2005", "HN": "2017 (1996)", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072081"}, {"RECTYPE": "D", "MH": "Patched-2 Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Patched-2", "MN": "D12.776.624.776.633.750", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "0", "MS": "A patched receptor that may function redundantly with the PATCHED-1 RECEPTOR to modulate hedgehog signaling. It may also play a role in epidermal development and as a TUMOR SUPPRESSOR PROTEIN. Mutations in the patched-2 gene are associated with BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; and MEDULLOBLASTOMA.", "PM": "2017; 2017; PATCHED-2 RECEPTOR was indexed under RECEPTORS, CELL SURFACE 2005-2016, and under MEMBRANE PROTEINS 1996-2005", "HN": "2017 (1996)", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072082"}, {"RECTYPE": "D", "MH": "Dermatologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Dermatologist", "MN": "N02.360.810.215", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Dermatology (1963-2016)", "MS": "Physicians who specialize in treating disorders of the skin.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072085"}, {"RECTYPE": "D", "MH": "Smoothened Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, Smoothened", "MN": "D12.776.543.750.850.500.500", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "0", "PI": "Receptors, G-Protein-Coupled (2004-2016)", "MS": "A frizzled-like, G-protein-coupled receptor that associates with PATCHED RECEPTORS to transduce signals from HEDGEHOG PROTEINS and initiate hedgehog signaling to ZINC FINGER PROTEIN GLI1. It may normally inhibit signaling in the absence of SONIC HEDGEHOG PROTEIN binding to PATCHED RECEPTOR-1.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072086"}, {"RECTYPE": "D", "MH": "Occupational Therapists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Therapists, Occupational", "MN": "N02.360.710", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Occupational Therapy (1965-2016)", "MS": "Professionals trained to help individuals develop or regain skills needed to achieve independence in their lives.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072087"}, {"RECTYPE": "D", "MH": "Cardiologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Cardiologist", "MN": "N02.360.810.128", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Cardiology (1963-2016)", "MS": "Qualified medical professionals who specialize in preventing and treating disorders of the heart and CARDIOVASCULAR SYSTEM.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072096"}, {"RECTYPE": "D", "MH": "Endocrinologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Endocrinologist", "MN": "N02.360.810.303", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Endocrinology(1969-2016)", "MS": "Physicians who specialize in treating ENDOCRINE SYSTEM DISEASES.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072097"}, {"RECTYPE": "D", "MH": "Single Photon Emission Computed Tomography Computed Tomography", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Scans, SPECT CT", "MN": "E01.370.384.730.800.800.750", "MH_TH": "NLM (2017)", "ST": "T060", "PI": "Tomography, X-Ray Computed (2002-2016)", "MS": "An imaging technique using a device which combines TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON and TOMOGRAPHY, X-RAY COMPUTED in the same session.", "PM": "2017", "HN": "2017", "MR": "20160610", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072098"}, {"RECTYPE": "D", "MH": "Serrate-Jagged Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Serrate Jagged Proteins", "MN": "D23.529.930", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "Cell surface proteins that consist of multiple extracellular EPIDERMAL GROWTH FACTOR - like repeat sequences (EGF repeats), including calcium-binding EGF repeats. They function as transmembrane ligands for NOTCH RECEPTORS to control CELL DIFFERENTIATION during development.", "PM": "2017; SERRATE PROTEINS was indexed under CALCIUM-BINDING PROTEINS; MEMBRANE PROTEINS; AND INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 1991-2016", "HN": "2017 (1991)", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072099"}, {"RECTYPE": "D", "MH": "Jagged-1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Serrate 1 Protein", "MN": "D23.529.930.500", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A serrate-jagged protein that functions as a ligand for NOTCH RECEPTORS. It may regulate CELL DIFFERENTIATION in HEMATOPOIESIS and PHYSIOLOGIC ANGIOGENESIS. Mutations in the Jagged-1 gene are associated with ALAGILLE SYNDROME 1.", "PM": "2017; JAGGED-1 PROTEIN was indexed under CALCIUM-BINDING PROTEINS; MEMBRANE PROTEINS; AND INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 1991-2016", "HN": "2017 (1991)", "MR": "20170524", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072100"}, {"RECTYPE": "D", "MH": "Jagged-2 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Serrate 2 Protein", "MN": "D23.529.930.750", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A serrate-jagged protein that functions to modulate signal transduction from NOTCH RECEPTORS in CELL DIFFERENTIATION. It may also regulate the expression of CYTOKINES.", "PM": "2017; JAGGED-2 PROTEIN was indexed under CALCIUM-BINDING PROTEINS; MEMBRANE PROTEINS; AND INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 1991-2016", "HN": "2017 (1991)", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072101"}, {"RECTYPE": "D", "MH": "Gastroenterologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Hepatologist", "MN": "N02.360.810.438", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Gastroenterology (1963-2016)", "MS": "Physicians who specialize in treating diseases of the DIGESTIVE SYSTEM.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072102"}, {"RECTYPE": "D", "MH": "Oncologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Oncologist", "MN": "N02.360.810.699", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Medical Oncology (1978-2016)", "MS": "Physicians specializing in MEDICAL ONCOLOGY or its sub-specialties of RADIATION ONCOLOGY or SURGICAL ONCOLOGY.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072103"}, {"RECTYPE": "D", "MH": "Nephrologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Nephrologist", "MN": "N02.360.810.628", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Nephrology (1985-2016)", "MS": "Qualified medical professionals who specialize in treating KIDNEY DISEASES.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072104"}, {"RECTYPE": "D", "MH": "Superoxide Dismutase-1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cu-Zn Superoxide Dismutase|T116|T126|EQV|UNK (19XX)|830531|abbdef", "ENTRY": "Superoxide Dismutase, Cuprozinc", "MN": "D08.811.682.881.500", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.15.1.1", "RR": "EC 1.15.1.1", "MS": "A superoxide dismutase (SOD1) that requires copper and zinc ions for its activity to destroy SUPEROXIDE FREE RADICALS within the CYTOPLASM. Mutations in the SOD1 gene are associated with AMYOTROPHIC LATERAL SCLEROSIS-1.", "PM": "2017; SUPEROXIDE DISMUTASE -1 was indexed under SUPEROXIDE DISMUTASE 1998-2016; for CU-ZN SUPEROXIDE DISMUTASE, see SUPEROXIDE DISMUTASE 1983-2016", "HN": "2017 (1998); for CU-ZN SUPEROXIDE DISMUTASE, use SUPEROXIDE DISMUTASE 1983-2016", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072105"}, {"RECTYPE": "D", "MH": "Pulmonologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Pulmonologist", "MN": "N02.360.810.865", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Pulmonary Medicine (1989-2016)", "MS": "Physicians who specialize in treating disorders of the RESPIRATORY SYSTEM, especially diagnosing and treating diseases and defects of the lungs and bronchial tree.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072106"}, {"RECTYPE": "D", "MH": "Counselors", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Counselor", "MN": "M01.526.225", "MH_TH": "NLM (1978)", "ST": "T097", "PI": "Counseling (1963-2016)", "MS": "Professionals trained in providing information, guidance, and recommendations to individual clients or families to support their decision making and development of coping skills.", "PM": "2017: see COUNSELING 1978-2016", "HN": "2017; use COUNSELING 1978-2016", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072117"}, {"RECTYPE": "D", "MH": "Vaping", "AQ": "AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PC PP PX TD TH UR", "PRINT ENTRY": "THC Vaping|T055|ACX|EQV|NLM (2021)|200707|abcdef", "ENTRY": "Vapings, THC", "MN": "F01.145.805.500", "MH_TH": "NLM (2017)", "ST": "T055", "PI": "Smoking (2012-2016)", "MS": "Inhaling of vapors produced by ELECTRONIC NICOTINE DELIVERY SYSTEMS such as E-CIGARETTES.", "PM": "2017", "HN": "2017", "MR": "20200707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072137"}, {"RECTYPE": "D", "MH": "Mosquito Vectors", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Vectors, Mosquito", "MN": "N06.850.520.203.375.100.500.500", "MH_TH": "NLM (2017)", "ST": "T204", "PI": "Insect Vectors (1964-2016)", "MS": "Mosquitoes (members of the family CULICIDAE) that transmit pathogens or their intermediate forms from one host to another.", "PM": "2017", "HN": "2017", "MR": "20200612", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072138"}, {"RECTYPE": "D", "MH": "Giant Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, Giant", "MN": "B04.280.356", "MH_TH": "NLM (2017)", "ST": "T005", "PI": "DNA Viruses (1999-2016)", "MS": "DNA viruses that have genomes up to several megabases in length and infect primarily single-celled EUKARYOTES.", "PM": "2017", "HN": "2017", "MR": "20200902", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072139"}, {"RECTYPE": "D", "MH": "Rheumatologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Rheumatologist", "MN": "N02.360.810.888", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Rheumatology (1980-2016)", "MS": "Physicians who specialize in treating RHEUMATIC DISEASES.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072140"}, {"RECTYPE": "D", "MH": "Neurologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Neurologist", "MN": "N02.360.810.652", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Neurology (1963-2016)", "MS": "Qualified medical professionals who specialize in treating NERVOUS SYSTEM DISEASES.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072141"}, {"RECTYPE": "D", "MH": "Pathologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Pathologist", "MN": "N02.360.810.746", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Pathology (1963-2016)", "MS": "Physicians who assess changes in cellular or tissue structure and function to diagnose disease processes.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072142"}, {"RECTYPE": "D", "MH": "Pediatricians", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Pediatrician", "MN": "N02.360.810.758", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Pediatrics (1963-2016)", "MS": "Qualified medical professionals specializing in maintaining health and providing medical care to children from birth through adolescence.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072143"}, {"RECTYPE": "D", "MH": "Neonatologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Neonatologist", "MN": "N02.360.810.758.500", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Neonatology (1984-2016)", "MS": "Physicians who specialize in providing medical care to newborn infants.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072156"}, {"RECTYPE": "D", "MH": "Physiatrists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Physiatrist", "MN": "N02.360.810.764", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Physical and Rehabilitation Medicine (1964-2016)", "MS": "Physicians specializing in treating physical disorders and injuries affecting the brain, spinal cord, nerves, bones, joints, ligaments, muscles, and tendons.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072157"}, {"RECTYPE": "D", "MH": "Epidemiologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Epidemiologist", "MN": "N02.360.345", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Epidemiology (1964-2016)", "MS": "Qualified medical professionals who study the causes, incidence, and characteristic behavior of disease outbreaks or other health-related conditions and determine the interrelationships of hosts, agents, and environment related to the distribution and control of diseases.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072158"}, {"RECTYPE": "D", "MH": "Dynactin Complex", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dynein Associated Protein, 150 kDa", "MN": "D12.776.631.560.225", "MH_TH": "NLM (2017)", "ST": "T116", "RN": "0", "MS": "A multi-subunit protein of EUKARYOTIC CELLS. It functions in bidirectional intracellular transport of ORGANELLES and CYTOPLASMIC VESICLES by linking them to DYNEIN and KINESIN.", "PM": "2017; DYNACTIN COMPLEX was indexed under MICROTUBULE ASSOCIATED PROTEINS 1997-2016 and under MICROTUBULE PROTEINS 1992-1997", "HN": "2017 (1992)", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072159"}, {"RECTYPE": "D", "MH": "Tumor Protein p73", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p73, Tumor Protein", "MN": "D12.776.930.969", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A homolog of p53 TUMOR SUPPRESSOR PROTEIN that encodes full-length trans-activating and N-terminally-truncated (DeltaN) isoforms. Detection of splice variants and isoforms in the nervous system (human TELENCEPHALON, CHOROID PLEXUS; CEREBROSPINAL FLUID), embryonic tissue, human BREAST CANCER; OVARIAN CANCER, suggest roles in cellular differentiation.", "PM": "2017; TUMOR SUPPRESSOR PROTEIN p73 was indexed under GENES, TUMOR SUPPRESSOR 1997-2006 and under DNA-BINDING PROTEINS, NUCLEAR PROTEINS and TUMOR SUPPRESSOR PROTEINS 2007-2016", "HN": "2017 (1997)", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072160"}, {"RECTYPE": "D", "MH": "Orthopedic Surgeons", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Surgeons, Orthopedic", "MN": "N02.360.810.910.875", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Orthopedics (1963-2016)", "MS": "Physicians specializing in medical, surgical, and physical methods used to treat and correct deformities, diseases, and injuries to the skeletal system, its articulations, and associated structures.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072161"}, {"RECTYPE": "D", "MH": "Optometrists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Optometrist", "MN": "N02.360.725", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Optometry (1963-2016)", "MS": "Qualified professionals trained in primary eye and vision care, including measurement of visual abilities, diagnosing disorders of the visual system and provision of treatment such as prescriptions for correction of visual defects with lenses or glasses and vision therapy.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072162"}, {"RECTYPE": "D", "MH": "Ophthalmologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Ophthalmologist", "MN": "N02.360.810.705", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Ophthalmology (1963-2016)", "MS": "Qualified medical professionals specializing in medical and surgical treatment of defects and diseases of the eye.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072163"}, {"RECTYPE": "D", "MH": "Superconductivity", "AQ": "AE CL HI TU", "ENTRY": "Superconductor", "MN": "G01.358.500.875", "MH_TH": "NLM (2017)", "ST": "T081", "PI": "Electromagnetic Phenomena (1972-2016)", "MS": "The ability of an element or metallic alloy to allow the passage of ELECTRONS without ELECTRICAL RESISTANCE and expel MAGNETIC FIELDS below a certain threshold temperature called superconducting transition temperature.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072176"}, {"RECTYPE": "D", "MH": "Radiologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Radiologist", "MN": "N02.360.810.877", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Radiology (1963-2016)", "MS": "Physicians specializing in the use of x-ray and other forms of radiant energy to diagnose and treat disease.", "PM": "2017", "HN": "2017", "MR": "20200609", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072177"}, {"RECTYPE": "D", "MH": "Urologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Urologist", "MN": "N02.360.810.955", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Urology (1963-2016)", "MS": "Physicians specializing in the diagnosis, and treatment of diseases of the urinary tract in both sexes, and the genital tract in the male.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072178"}, {"RECTYPE": "D", "MH": "Interleukin-1 Receptor-Like 1 Protein", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Interleukin-33", "MN": "D12.776.543.750.705.852.420.300.375", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (2006-2016)", "MS": "A receptor for INTERLEUKIN-33 that is related structurally to the interleukin-1 receptor. It  contains three extracellular IMMUNOGLOBULIN-LIKE DOMAIN regions and associates with INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN upon binding IL-33 to initiate signaling. It may function in the response of HELPER T CELLS to INFLAMMATION.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072179"}, {"RECTYPE": "D", "MH": "Phosphoinositide Phosphatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphatases, Phosphoinositide", "MN": "D08.811.277.352.650.624", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.1.3.36", "PI": "Phosphoric Monoester Hydrolases (1999-2016)", "MS": "Phosphatases that catalyze the hydrolysis of phosphate groups on PHOSPHATIDYLINOSITOLS.", "PM": "2017", "HN": "2017", "MR": "20170512", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072180"}, {"RECTYPE": "D", "MH": "Inositol Polyphosphate 5-Phosphatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Inositol Triphosphate 5 Phosphatase", "MN": "D08.811.277.352.650.624.500", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.1.3.56", "RR": "EC 3.1.3.56", "MS": "Phosphoinositide phosphatases that catalyze the removal of the 5' phosphate from INOSITOL 1,4,5-TRISPHOSPHATE  or myo-inositol 1,3,4,5-tetrakisphosphate, resulting in inositol 1,4-bisphosphate and phosphate. They have important functions in the metabolism of INOSITOL PHOSPHATES and inositol 1,4,5-trisphosphate signaling pathways such as CALCIUM SIGNALING.", "PM": "2017; INOSITOL-POLYPHOSPHATE 5-PHOSPHATASE was indexed under PHOSPHORIC MONOESTER HYDROLASES 1987-2016", "HN": "2017 (1987)", "MR": "20170410", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072181"}, {"RECTYPE": "D", "MH": "Non-Medical Public and Private Facilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Non Medical Public and Private Facilities", "MN": "J03", "MH_TH": "NLM (2017)", "ST": "T073", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Spaces and needed equipment provided for a specific, non-medical  function or service used by the public or specific group of persons.", "PM": "2017", "HN": "2017", "MR": "20160708", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072182"}, {"RECTYPE": "D", "MH": "Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Src Homology 2 Domain Containing Inositol Phosphatases", "MN": "D08.811.277.352.650.624.750", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.1.3.86", "PI": "Phosphoric Monoester Hydrolases (1996-2016)", "MS": "Phosphoinositide phosphatases that catalyze the dephosphorylation (hydrolysis) of  phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P(3)) to produce PtdIns(3,4)P(2), which negatively regulates the PI3K ( 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASES) pathways. They contain an SH2 DOMAIN and STERILE ALPHA MOTIF and have important functions in regulating the immune response and other cellular processes in vertebrates.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072183"}, {"RECTYPE": "D", "MH": "Nurse Specialists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Specialists, Nurse", "MN": "N02.360.650.648", "MH_TH": "NLM (2017)", "ST": "T097", "MS": "Nursing professionals whose practice is limited to A particular area or discipline of medicine.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072184"}, {"RECTYPE": "D", "MH": "Fertilins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta, PH-30", "MN": "D12.776.395.550.331", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.24.-", "MS": "Sperm surface proteins involved in sperm-egg fusion. They consist of two subunits, fertilin alpha (ADAM1a) and beta (ADAM2), both of which belong to the metalloprotease-disintegrin protein family. The beta subunit does not have catalytic activity.", "PM": "2017; FERTILINS was indexed under ADAM PROTEINS and MEMBRANE GLYCOPROTEINS 2006-2016; and under METALLOENDOPEPTIDASES 1992-2005", "HN": "2017 (1992)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072196"}, {"RECTYPE": "D", "MH": "ADAM10 Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Disintegrin and Metalloproteinase Domain Containing Protein 10", "MN": "D12.776.395.033.250", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.24.81", "PI": "Membrane Proteins (2004-2016)", "MS": "A disintegrin and metalloproteinase domain-containing protein. It cleaves the membrane-bound precursor of TUMOR NECROSIS FACTOR-ALPHA between ALANINE 76 and VALINE 77 to its functional form, as well as several other CELL SURFACE PROTEINS to their soluble forms, including AMYLOID BETA-PROTEIN PRECURSOR and PRION PROTEIN.", "PM": "2017", "HN": "2017", "MR": "20170524", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000072197"}, {"RECTYPE": "D", "MH": "ADAM17 Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tumor Necrosis Factor alpha Converting Enzyme", "MN": "D12.776.395.033.375", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 3.4.24.86", "MS": "A disintegrin and metalloproteinase domain-containing protein that cleaves the membrane-bound precursor of TUMOR NECROSIS FACTOR-ALPHA to its mature form. It cleaves several other CELL SURFACE PROTEINS, including INTERLEUKIN-1 RECEPTOR TYPE II; TRANSFORMING GROWTH FACTOR ALPHA; L-SELECTIN; MUCIN-1; and AMYLOID BETA-PROTEIN PRECURSOR. It can also function as an activator of the Notch signaling pathway by mediating the cleavage of NOTCH RECEPTORS.", "PM": "2017; ADAM17 PROTEIN was indexed under ADAM PROTEINS 2005-2016, and under METALLOENDOPEPTIDASES 1996-2005", "HN": "2017 (1996)", "MR": "20170524", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000072198"}, {"RECTYPE": "D", "MH": "ADAM12 Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Meltrin alpha Protein", "MN": "D12.776.395.033.125", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.24.-", "RR": "EC 3.4.24.82", "MS": "A disintegrin and metalloproteinase domain-containing protein that is expressed as two alternatively-spliced forms: a long transmembrane form (ADAM12-L) and a short soluble form  (ADAM12-S). It modulates the cleavage of INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS and may also regulate CELL FUSION during MYOGENESIS.", "PM": "2017; ADAM12 PROTEIN was indexed under MEMBRANE PROTEINS and ADAM PROTEINS 2006-2016; and under METALLOENDOPEPTIDASES 1997-2005", "HN": "2017 (1997)", "MR": "20160527", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000072199"}, {"RECTYPE": "D", "MH": "Ku Autoantigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "X ray Repair Cross Complementing Protein 6", "MN": "D23.050.290.625", "MH_TH": "NLM (1986)", "ST": "T129", "RN": "EC 4.2.99.-", "RR": "EC 3.6.4.12", "MS": "An ATP-dependent DNA HELICASE that preferentially binds SINGLE-STRANDED DNA. It is a heterodimer consisting of an 80 kDa subunit (XRCC5) and 70 kDa subunit (XRCC6) that functions with DNA LIGASE IV in the repair of DOUBLE-STRANDED DNA BREAKS and V(D)J RECOMBINATION.", "PM": "2017; KU AUTOANTIGEN was indexed under DNA-BINDING PROTEINS and ANTIGENS, NUCLEAR 2003-2016; and under ANTIGENS, SURFACE 1986-1991 and NUCLEAR PROTEINS 1985-2003", "HN": "2017 (1986)", "MR": "20170524", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072200"}, {"RECTYPE": "D", "MH": "Zona Pellucida Glycoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Zona Pellucida Glycoprotein 3", "MN": "D12.776.543.750.981", "MH_TH": "NLM (1981)", "ST": "T123", "RN": "0", "MS": "Membrane glycoproteins that constitute the ZONA PELLUCIDA in mammals and function in the recognition and binding of SPERMATOZOA.", "PM": "2017; ZONA PELLUCIDA GLYCOPROTEINS was indexed under EGG PROTEINS 1982-2016; under MEMBRANE GLYCOPROTEINS 1993-2016; and under GLYCOPROTEINS 1981-1992", "HN": "2017 (1981)", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072216"}, {"RECTYPE": "D", "MH": "Endodontists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Endodontist", "MN": "N02.360.330.330.397", "MH_TH": "NLM (2016)", "ST": "T097", "PI": "Endodontics (1968-2016)", "MS": "Dentists specializing in the treatment of injuries and diseases of the DENTAL PULP.", "PM": "2017; see Dentists 2016", "HN": "2017; use Dentists 2016", "MR": "20230620", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072218"}, {"RECTYPE": "D", "MH": "Geriatricians", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Gerontologist", "MN": "N02.360.810.533", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Geriatrics (1969-2016)", "MS": "Physicians specializing in physiological and pathological aspects of aging and the aged, including the clinical problems of senescence and senility.", "PM": "2017", "HN": "2017", "MR": "20180710", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072219"}, {"RECTYPE": "D", "MH": "Otolaryngologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Otologist", "MN": "N02.360.810.734", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Otolaryngology (1964-2016)", "MS": "Physicians specializing in the treatment of disorders of the ear, nose, and throat.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072220"}, {"RECTYPE": "D", "MH": "Nurses, Neonatal", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Nurse, Neonatal", "MN": "N02.360.650.648.940.500", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Neonatal Nursing (1993-2016)", "MS": "Qualified nursing professionals specializing in care of newborn infants.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072221"}, {"RECTYPE": "D", "MH": "Nurses, Pediatric", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Pediatric Nurses", "MN": "N02.360.650.648.940", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Pediatric Nursing (1963-2016)", "MS": "Qualified nursing professionals specializing in the care of children from birth to adolescence.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072222"}, {"RECTYPE": "D", "MH": "Allergists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Allergist", "MN": "N02.360.810.020", "MH_TH": "NLM (2017)", "ST": "T097", "MS": "Physicians specializing in treating individuals with hypersensitivity to ALLERGENS.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000072223"}, {"RECTYPE": "D", "MH": "Bcl-2-Like Protein 11", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, BIM Bcl-2-Binding", "MN": "D12.776.624.664.700.025", "MH_TH": "NLM (1989)", "ST": "T123", "RN": "0", "MS": "A BCL-2-like protein that has a C-terminal BCL-2 homology (BH3) domain and forms heterodimers with other BCL-2 FAMILY PROTEINS. It is a strong inducer of APOPTOSIS and ANOIKIS; several isoforms are expressed (BimEL, Bim L, Bim-alpha, Bim-s; and Bim-gamma) that have different potencies for inducing apoptosis.", "PM": "2017; BCL-2-LIKE PROTEIN 11 was indexed under MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS; APOPTOSIS REGULATORY PROTEINS 2005-2016; and under CARRIER PROTEINS 1998-2005", "HN": "2017 (1998)", "MR": "20160711", "DA": "20160711", "DC": "1", "DX": "20170101", "UI": "D000072224"}, {"RECTYPE": "D", "MH": "Computed Tomography Angiography", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tomography Angiography, Computed", "MN": "E01.370.350.825.810.810.499", "MH_TH": "NLM (2017)", "ST": "T060", "PI": "Tomography, X-Ray Computed (1978-2016)", "MS": "A non-invasive method that uses a CT scanner for capturing images of blood vessels and tissues. A CONTRAST MATERIAL is injected, which helps produce detailed images that aid in diagnosing VASCULAR DISEASES.", "PM": "2017", "HN": "2017", "MR": "20181102", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072226"}, {"RECTYPE": "D", "MH": "Shoulder Prosthesis", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Shoulders, Prosthetic", "MN": "E07.695.400.852", "FX": "Arthroplasty, Replacement, Shoulder", "MH_TH": "NLM (2017)", "ST": "T074", "PI": "Shoulder Joint (1975-2016)", "MS": "Replacement for a SHOULDER JOINT.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072227"}, {"RECTYPE": "D", "MH": "Arthroplasty, Replacement, Shoulder", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Total Shoulder Replacements", "MN": "E04.650.110.299", "FX": "Shoulder Prosthesis", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Shoulder Joint (1975-2016)", "MS": "Replacement of the SHOULDER JOINT.", "PM": "2017", "HN": "2017", "MR": "20220406", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072228"}, {"RECTYPE": "D", "MH": "Posterior Cruciate Ligament Reconstruction", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "MN": "E04.617.101.557", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Posterior Cruciate Ligament/surgery (1991-2016)", "MS": "Rebuilding of the POSTERIOR CRUCIATE LIGAMENT to restore functional stability of the knee.", "PM": "2017", "HN": "2017", "MR": "20220406", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072229"}, {"RECTYPE": "D", "MH": "Sustained Virologic Response", "ENTRY": "Virologic Response, Sustained", "MN": "N05.715.360.575.575.800.665", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Treatment Outcome (1999-2016)", "MS": "The continuous, long-term suppression of VIRAL LOAD, generally to undetectable levels, as the result of treatment with ANTIVIRAL AGENTS.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072230"}, {"RECTYPE": "D", "MH": "In Vivo Dosimetry", "AQ": "EC ES HI LJ MT SN ST", "ENTRY": "In Vivo Dosimetries", "MN": "E05.799.638.511", "FX": "Body Burden", "EC": "instrumentation:Radiation Dosimeters", "MH_TH": "NLM (2017)", "ST": "T059", "PI": "Radiotherapy Dosage (1970-2016)", "MS": "A procedure to measure the amount of radiation absorbed by the body during RADIOTHERAPY by DOSIMETERS in the patient\u2019s skin or natural cavities.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072231"}, {"RECTYPE": "D", "MH": "Radiation Dosimeters", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Dosimeters, Radiation", "MN": "E07.710.725", "FX": "Radiation Monitoring", "MH_TH": "NLM (2017)", "ST": "T074", "PI": "Radiometry (1964-2016)", "MS": "Devices that measure exposure to IONIZING RADIATION.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072232"}, {"RECTYPE": "D", "MH": "Homer Scaffolding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Homer Protein|T116|NON|EQV|NLM (2022)|200928|abcdef", "ENTRY": "Scaffolding Proteins, Homer", "MN": "D12.776.476.024.381", "MH_TH": "NLM (2017)", "ST": "T116", "RN": "0", "MS": "Homer proteins belong to a family of adaptor and scaffold proteins which include Homer1, Homer2 and Homer3. Homer1 and Homer2 play a role in the regulation of calcium homeostasis, whereas Homer3 functions in stimulating changes in actin dynamics in neurons and T-cells. Homer proteins are best known as scaffold proteins at the post-synaptic density where they facilitate synaptic signaling. They function as a molecular switch in metabotropic glutamate receptor (MGluR) signaling, and are associated with human Fragile X syndrome.", "PM": "2017; HOMER PROTEIN was indexed under NEUROPEPTIDES 1997-2004, and under CARRIER PROTEINS 2005-2016", "HN": "2017 (1997)", "MR": "20210630", "DA": "20160711", "DC": "1", "DX": "20170101", "UI": "D000072233"}, {"RECTYPE": "D", "MH": "Donor Conception", "AQ": "AE CL EC ES HI IS LJ MO NU PX SN ST TD VE", "ENTRY": "Donor Conceptions", "MN": "E05.820.800.250", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Tissue Donors (2011-2016)", "MS": "Assisted reproductive techniques where eggs, sperm, both eggs and sperm (double donation), or embryos from donors are used.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072234"}, {"RECTYPE": "D", "MH": "Mating Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "alpha-Factor, Pheromone", "MN": "D23.641.200", "MH_TH": "NLM (2017)", "ST": "T125", "N1": "L-Tyrosine, L-tryptophyl-L-histidyl-L-tryptophyl-L-leucyl-L-glutaminyl-L-leucyl-L-lysyl-L-prolylglycyl-L-glutaminyl-L-prolyl-gamma-(methylsulfinyl)-L-alpha-aminobutyryl-", "RN": "61194-02-3", "MS": "A protein also known as pheromone mating factor that occurs on the surfaces of organisms such as yeast and fungi.", "PM": "2017; MATING FACTOR was indexed under PEPTIDES 1978-2016", "HN": "2017 (1978)", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072235"}, {"RECTYPE": "D", "MH": "Methyl-Accepting Chemotaxis Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Methyl-Accepting Chemotaxis Protein|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Proteins, Methyl-Accepting Chemotaxis", "MN": "D12.776.543.750.054", "FX": "Chemotaxis", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "Transmembrane sensor receptor proteins that are central components of the chemotactic systems of a number of motile bacterial species which include ESCHERICHIA COLI and SALMONELLA TYPHIMURIUM. Methyl-accepting chemotaxis proteins derive their name from a sensory adaptation process which involves methylation at several glutamyl residues in their cytoplasmic domain. Methyl-accepting chemotaxis proteins trigger chemotactic responses across spatial chemical gradients, causing organisms to move either toward favorable stimuli or away from toxic ones.", "PM": "2017; METHYL-ACCEPTING CHEMOTAXIS PROTEINS was indexed under BACTERIAL PROTEINS and MEMBRANE PROTEINS 1980 - 2016, and under METHYLTRANSFERASES from 1980 - 2016.", "HN": "2017 (1980)", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072236"}, {"RECTYPE": "D", "MH": "ERG1 Potassium Channel", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein-Potassium Channel, Kv11.1", "MN": "D12.776.543.585.400.750.900.249.500", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "One of three members of the ether-a-go-go (EAG) POTASSIUM CHANNELS gene family comprising ether-a-go-go (eag), eag-like (elk) and eag-related (erg) subfamilies. Ether-a-go-go-related gene 1 (ERG1) also known as KCNH2, encodes the pore-forming subunit of a rapidly activating-delayed rectifier potassium channel that plays an essential role in the final repolarization of ventricular action potential. Loss-of-function mutations in human hERG1 is associated with life-threatening ARRHYTHMIA.", "PM": "2017; ERG1 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005-2008, and under ETHER-A-GO-GO POTASSIUM CHANNELS 2009-2016", "HN": "2017 (2001)", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072237"}, {"RECTYPE": "D", "MH": "Oxygen Radical Absorbance Capacity", "ENTRY": "ORAC Methods", "MN": "E05.657", "FX": "Reactive Oxygen Species", "MH_TH": "NLM (2017)", "ST": "T081", "PI": "Reactive Oxygen Species (1993-2016)", "MS": "A measure of the ability of a substance, such as a food, to quench oxygen free radicals in vitro.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072257"}, {"RECTYPE": "D", "MH": "Tumor Hypoxia", "AQ": "DE GE IM PH RE", "ENTRY": "Tumor Hypoxias", "MN": "G04.270.300.500", "MH_TH": "NLM (2017)", "ST": "T043", "PI": "Neoplasms (1977-2016)", "MS": "Hypoxic conditions in tumor cells due to the tumor outgrowing its blood supply. It is associated with increased METASTASIS and resistance to RADIOTHERAPY and DRUG THERAPY.", "PM": "2017", "HN": "2017", "MR": "20200612", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072258"}, {"RECTYPE": "D", "MH": "Connexin 26", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta-2, Connexin", "MN": "D12.776.543.585.250.100", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "127120-53-0", "MS": "A gap junction protein encoded by the Gap Junction Beta 2 or GJB2 gene. In the cochlea and epidermis, its hexamers form channels between cells that open to allow cell-to-cell diffusion of small molecules as well as recycling of potassium. Mutations in Connexin 26 are associated with congenital SENSORINEURAL HEARING LOSS.", "PM": "2017; CONNEXIN 26 was indexed under CONNEXINS 1993-2016", "HN": "2017 (1993)", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072259"}, {"RECTYPE": "D", "MH": "RNA Splicing Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Splicing Factor|T116|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Splicing Factors, RNA", "MN": "D12.776.664.962.829", "FX": "snRNP Core Proteins", "MH_TH": "NLM (2017)", "ST": "T116", "RN": "0", "PI": "RNA-Binding Proteins (1989-2016)", "MS": "RNA-binding proteins that facilitate or inhibit RNA SPLICING.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072260"}, {"RECTYPE": "D", "MH": "Dishevelled Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dishevelled 3 Protein", "MN": "D12.776.476.024.330", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "MS": "A family of proteins that are key components of the WNT SIGNALING PATHWAY, where they function downstream of FRIZZLED RECEPTORS. They contain an N-terminal dishevelled-AXIN PROTEIN (DIX) domain, which mediates oligomerization; a central PDZ DOMAIN which binds to the frizzled receptor; and a C-terminal DEP domain which facilitates binding to the CELL MEMBRANE. Dishevelled proteins have important functions in CELL DIFFERENTIATION and establishing CELL POLARITY.", "PM": "2017; DISHEVELLED PROTEINS was indexed under ADAPTOR PROTEINS, SIGNAL TRANSDUCING 2006-2016; under PHOSPHOPROTEINS 1998-2016; and under PROTEINS 1994-1997", "HN": "2017 (1994)", "MR": "20170524", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072261"}, {"RECTYPE": "D", "MH": "Private Facilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Private Facility", "MN": "J03.700", "MH_TH": "NLM (2017)", "ST": "T073", "AN": "do not add as a coordinate with a specific facility unless the private aspect is emphasized", "MS": "Places designed, built, or installed to provide for a specific, non-medical function or service used by a specific, restricted group of persons.", "PM": "2017", "HN": "2017", "MR": "20160613", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072263"}, {"RECTYPE": "D", "MH": "Sports and Recreational Facilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "MN": "J03.925", "FX": "Health Resorts", "MH_TH": "NLM (2017)", "ST": "T073", "MS": "Places designed, built, or installed for LEISURE ACTIVITIES outside of the home.", "PM": "2017", "HN": "2017", "MR": "20160608", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072264"}, {"RECTYPE": "D", "MH": "Maximal Respiratory Pressures", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Respiratory Pressures, Maximum", "MN": "E01.370.386.700.550", "MH_TH": "NLM (2017)", "ST": "T034", "PI": "Respiratory Function Tests (1984-2016)", "MS": "A respiratory function test that includes the maximal inspiratory pressure and maximal expiratory pressure. It is determined by SPIROMETRY that measures the patient's RESIDUAL VOLUME and TOTAL LUNG CAPACITY and assesses the strength of RESPIRATORY MUSCLES.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072277"}, {"RECTYPE": "D", "MH": "Forkhead Box Protein M1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "FOXM1 Protein|T116|T123|ABX|EQV|NLM (2017)|160510|abbcdef", "MN": "D12.776.930.977.249.063", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Forkhead Transcription Factors (2006-2016)", "MS": "A forkhead box transcription factor that is expressed primarily in adult organs which contain proliferating cells such as the thymus, testis, ovary, and small intestine. It controls the expression of CELL CYCLE genes essential for DNA REPLICATION and MITOSIS, and also functions in DNA REPAIR.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072278"}, {"RECTYPE": "D", "MH": "Bacteria, Thermoduric", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Thermoduric Bacteria|T007|NON|EQV|NLM (2017)|160413|abcdef", "MN": "B03.135", "MH_TH": "NLM (2017)", "ST": "T007", "PI": "Milk/microbiology (1967-2016)", "MS": "Bacteria resistant to high temperatures, as in PASTEURIZATION.", "PM": "2017", "HN": "2017", "MR": "20200902", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072280"}, {"RECTYPE": "D", "MH": "Lymphadenopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lymphadenopathies", "MN": "C15.604.338", "MH_TH": "NLM (1998)", "ST": "T033", "MS": "Disease of LYMPH NODES which are abnormal in size, number or consistency.", "PM": "2017; see LYMPHATIC DISEASES 1998-2016", "HN": "2017; use LYMPHATIC DISEASES 1998-2016", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072281"}, {"RECTYPE": "D", "MH": "Extraintestinal Pathogenic Escherichia coli", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Extraintestinal Pathogenic E. coli|T007|ABX|EQV|NLM (2017)|160509|abcdef", "MN": "B03.660.250.150.180.100.580", "MH_TH": "NLM (2017)", "ST": "T007", "AN": "infection: coordinate with ESCHERICHIA COLI INFECTIONS", "PI": "Escherichia coli (2000-2016)", "MS": "Strains of Escherichia coli that possess virulence traits which allow them to invade, colonize, and induce disease in tissues outside of the GASTROINTESTINAL TRACT. They are a cause of URINARY TRACT INFECTIONS (UROPATHOGENIC ESCHERICHIA COLI); neonatal MENINGITIS; SEPSIS; PNEUMONIA; and SURGICAL WOUND INFECTION.", "PM": "2017", "HN": "2017", "MR": "20200902", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072282"}, {"RECTYPE": "D", "MH": "A549 Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cells, A549", "MN": "A11.436.054", "MH_TH": "NLM (2017)", "ST": "T025", "AN": "almost always NIM with no subheadings; check HUMAN; do not routinely add ADENOCARCINOMA, ALVEOLAR", "PI": "Cell Line, Tumor (2004-2016)", "MS": "An immortalized cell line derived from human ADENOCARCINOMA, ALVEOLAR basal epithelial cells isolated from the lungs of a male patient in 1972. The cell line is positive for KERATIN, can synthesize LECITHIN, and contains high levels of POLYUNSATURATED FATTY ACIDS in its PLASMA MEMBRANE. It is used as a model for PULMONARY ALVEOLI function and virus infections, as a TRANSFECTION host, and for PRECLINICAL DRUG EVALUATION.", "PM": "2017", "HN": "2017", "MR": "20160614", "DA": "20160706", "DC": "1", "DX": "20170101", "UI": "D000072283"}, {"RECTYPE": "D", "MH": "Bathroom Equipment", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Urinal", "MN": "E07.108", "FX": "Toilet Facilities", "MH_TH": "NLM (2017)", "ST": "T073", "MS": "Receptacles used for collection of human excrement.", "PM": "2017", "HN": "2017", "MR": "20171213", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072296"}, {"RECTYPE": "D", "MH": "Dioxins and Dioxin-like Compounds", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dioxins and Dioxin like Compounds", "MN": "D02.309", "MH_TH": "NLM (2017)", "ST": "T131", "RN": "0", "AN": "INDEXER: Do not use", "PI": "Dioxins (1968-2016)", "MS": "A group of toxic chemical compounds that share chemical structures and biological characteristics that are related to the potent carcinogen 2,3,7,8-tetrachlorodibenzo-p-dioxin.", "PM": "2017", "HN": "2017", "MR": "20160706", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072316"}, {"RECTYPE": "D", "MH": "Polychlorinated Dibenzodioxins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetrachlorodibenzodioxin|T109|NON|NRW|NLM (1975)|990101|abcdef", "ENTRY": "Tetrachlorodibenzo p dioxin", "MN": "D03.633.300.786", "MH_TH": "NLM (2017)", "ST": "T109", "RN": "0", "RR": "OHF2F5C0ZH", "MS": "Dibenzodioxin derivatives that contain multiple chloride atoms bound to the benzene ring structures.", "PM": "2017; TETRACHLORODIBENZODIOXIN was heading 1991-2016", "HN": "2017(1976)", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072317"}, {"RECTYPE": "D", "MH": "Dibenzofurans", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Furans, Dibenzo|T109|NON|EQV|NLM (2017)|160419|abcdef", "MN": "D03.633.300.258", "MH_TH": "NLM (2017)", "ST": "T109", "RN": "0", "PI": "Benzofurans (1980-2016)", "MS": "Compounds that include the structure of dibenzofuran.", "PM": "2017", "HN": "2017", "MR": "20160529", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072318"}, {"RECTYPE": "D", "MH": "Mucosal-Associated Invariant T Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Mucosal-Associated Invariant T Cell|T025|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Mucosal Associated Invariant T Cells", "MN": "A15.382.490.555.567.569.500.100", "MH_TH": "NLM (2017)", "ST": "T025", "PI": "T-Lymphocytes (2005-2016)", "MS": "A subset of T-lymphocytes that are present in large numbers at MUCOUS MEMBRANES and respond to INFECTIONS. They express a conserved invariant T-CELL RECEPTOR ALPHA-CHAIN that enables them to respond to infections by sensing RIBOFLAVIN metabolites of pathogens.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072336"}, {"RECTYPE": "D", "MH": "Dibenzofurans, Polychlorinated", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dibenzofurans, Chlorinated", "MN": "D03.633.300.258.500", "MH_TH": "NLM (2017)", "ST": "T109", "RN": "0", "MS": "Dibenzofurans that contain chloride atoms bound to the aromatic rings of the structure.", "PM": "2017; CHLORINATED DIBENZOFURANS was indexed under BENZOFURANS 1980-2016", "HN": "2017", "MR": "20170224", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072338"}, {"RECTYPE": "D", "MH": "Sexual and Gender Minorities", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "LGBTQIA|T098|ACR|EQV|NLM (2024)|230201|abcdef", "ENTRY": "Sexual Minority", "MN": "M01.270.988", "FX": "Homosexuality, Male", "MH_TH": "NLM (2018)", "ST": "T098", "PI": "Transsexualism (2001-2016)", "MS": "Individuals including lesbian, gay, bisexual, transgender, queer, intersex, gender non-conforming people, and other populations whose sexual orientation or GENDER IDENTITY and reproductive development is considered outside cultural, societal, or physiological norms.", "PM": "2018; was SEXUAL MINORITIES 2017; for BISEXUALS see BISEXUALITY 1996-2016; for LESBIANS use HOMOSEXUALITY, FEMALE 1995-2016; for HOMOSEXUALS use HOMOSEXUALITY 1989-2016; for QUEERS use HOMOSEXALITY 2016-2017; for GAYS use HOMOSEXUALITY 1995-2016", "HN": "2018; was SEXUAL MINORITIES 2017; for BISEXUALS use BISEXUALITY 1996-2016; for LESBIANS see HOMOSEXUALITY, FEMALE 1995-2016; for HOMOSEXUALS see HOMOSEXUALITY 1989-2016; for QUEERS see HOMOSEXALITY 2016-2017; for GAYS see HOMOSEXUALITY 1995-2016", "MR": "20230601", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072339"}, {"RECTYPE": "D", "MH": "NIMA-Interacting Peptidylprolyl Isomerase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peptidylprolyl Isomerase, Pin1", "MN": "D08.811.399.325.500.700", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "0", "RR": "EC 5.2.1.8", "MS": "A highly-conserved peptidyl-prolyl cis/trans isomerase (PPIase) that binds to and isomerizes specific phosphorylated SERINE- or THREONINE-PROLINE (pSer/Thr-Pro) motifs and causes conformational changes in certain proteins associated with the CELL CYCLE. It displays a preference for an acidic residue N-terminal to the isomerized proline bond and regulates MITOSIS, possibly by attenuating the mitosis-promoting activity of NIMA-RELATED KINASE 1.", "PM": "2017; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE was indexed under PEPTIDYLPROLYL ISOMERASE 1997-2016; and under AMINO ACID ISOMERASES 1996-1997", "HN": "2017 (1996)", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072340"}, {"RECTYPE": "D", "MH": "Parenchymal Tissue", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tissues, Parenchymal", "MN": "A10.806", "MH_TH": "NLM (2017)", "ST": "T024", "AN": "human and animal; PALISADE PARENCHYMA CELLS see MESOPHYLL CELLS is available for plants", "MS": "The tissue that constitutes the essential or functional part of an organ (e.g., parenchyma of lung, parenchyma of liver, or parenchyma of kidney).", "PM": "2017", "HN": "2017", "MR": "20160706", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072356"}, {"RECTYPE": "D", "MH": "Applied Behavior Analysis", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Behavior Analysis, Applied", "MN": "F04.754.137.131", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Behavior Therapy (2005-2016)", "MS": "Behavioral science applied with the aim of improving socially important issues such as behavior problems and learning. For individuals diagnosed with intellectual and developmental disabilities including AUTISM, techniques can be categorized as comprehensive or focused.", "PM": "2017", "HN": "2017", "MR": "20160603", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072357"}, {"RECTYPE": "D", "MH": "Work-Life Balance", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Work-Life Conflict|T041|NON|EQV|NLM (2023)|211125|abcdef", "ENTRY": "Work-Life Conflicts", "MN": "N04.452.677.650.438", "MH_TH": "NLM (2017)", "ST": "T041", "MS": "Complex ongoing balance between a person's working life and private life.", "PM": "2017", "HN": "2017", "MR": "20220531", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072358"}, {"RECTYPE": "D", "MH": "Trichodesmium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.585.950", "FX": "Nitrogen Fixation", "MH_TH": "NLM (2017)", "ST": "T007", "RN": "txid1205", "PI": "Cyanobacteria (1969-2016)", "MS": "A nitrogen-fixing genus of filamentous cyanobacteria that occurs in tropical and subtropical oceans.", "PM": "2017", "HN": "2017", "MR": "20200813", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072359"}, {"RECTYPE": "D", "MH": "Oxysterols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxysterol|T109|T123|NON|EQV|NLM (2017)|160420|abbcdef", "MN": "D10.570.938.208.825", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Hydroxycholesterols (1982-2016)", "MS": "Oxygenated derivatives of cholesterol or its sterol precursors. They are generated from sterol metabolism and the interaction of cholesterol with REACTIVE OXYGEN SPECIES.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072376"}, {"RECTYPE": "D", "MH": "Syk Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tyrosine Kinase, Spleen", "MN": "D12.776.476.568.650", "FX": "src Homology Domains", "MH_TH": "NLM (1992)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "An SH2 domain-containing non-receptor tyrosine kinase that regulates signal transduction downstream of a variety of receptors including B-CELL ANTIGEN RECEPTORS. It functions in both INNATE IMMUNITY and ADAPTIVE IMMUNITY and also mediates signaling in CELL ADHESION; OSTEOGENESIS; PLATELET ACTIVATION; and vascular development.", "PM": "2017; SYK KINASE was indexed under PROTEIN-TYROSINE KINASES and INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 2006-2016; and under ENZYME PRECURSORS 1992-2006", "HN": "2017 (1992)", "MR": "20210628", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072377"}, {"RECTYPE": "D", "MH": "Radiation Oncologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Radiation Oncologist", "MN": "N02.360.810.877.500", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Radiation Oncology (1994-2016)", "MS": "Physicians specializing in the treatment of cancer by RADIOTHERAPY.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072378"}, {"RECTYPE": "D", "MH": "NIMA-Related Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Never-in-Mitosis A Kinase|T116|T126|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Never in Mitosis A Kinases", "MN": "D12.776.476.563.581", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A highly conserved family of protein serine-threonine kinases that regulate the CELL CYCLE; MITOSIS; and the response to DNA DAMAGE. They are also involved in the assembly and function of microtubule-based structures such as CILIA and CENTRIOLES.", "PM": "2017; NIMA-RELATED KINASES was indexed under PROTEIN-SERINE-THREONINE KINASES and CELL CYCLE PROTEINS 2005-2016; and under PROTEIN KINASES 1991-2004", "HN": "2017 (1991)", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072379"}, {"RECTYPE": "D", "MH": "NIMA-Related Kinase 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NIMA Related Protein Kinase 1", "MN": "D12.776.476.563.581.500", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A NIMA-related kinase that functions in CELL CYCLE regulation, the control of CILIA assembly, and CENTROSOME duplication. It is activated at G2 PHASE CELL CYCLE CHECKPOINTS in response to DNA DAMAGE.", "PM": "2017; NIMA-RELATED KINASE-1 was indexed under PROTEIN-SERINE-THREONINE KINASES and CELL CYCLE PROTEINS 2004-2016, and under PROTEIN KINASES 1991-2004", "HN": "2017 (1991)", "MR": "20210521", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072380"}, {"RECTYPE": "D", "MH": "Endothelin-Converting Enzymes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Metalloprotease ECE 2", "MN": "D08.811.277.656.675.374.229", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.24.71", "MS": "Metalloendopeptidases which convert BIG ENDOTHELIN to ENDOTHELIN-1.", "PM": "2017; ENDOTHELIN CONVERTING ENZYMES was indexed under METALLOENDOPEPTIDASES and ASPARTIC ACID ENDOPEPTIDASES 1991-2016; and under PEPTIDE PEPTIDOHYDROLASES 1990-1991", "HN": "2017 (1990)", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072396"}, {"RECTYPE": "D", "MH": "Protein Structural Elements", "AQ": "DE GE IM PH RE", "ENTRY": "Structure Elements, Protein", "MN": "G02.111.570.820.709.275", "MH_TH": "NLM (2017)", "ST": "T082", "PI": "Protein Conformation (1981-2016)", "MS": "Distinguishing three-dimensional structures characteristically formed by homologous protein sequences.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072416"}, {"RECTYPE": "D", "MH": "Protein Domains", "AQ": "DE GE IM PH RE", "ENTRY": "Peptide Domains", "MN": "G02.111.570.820.709.610.500", "MH_TH": "NLM (2000)", "ST": "T082", "MS": "Discrete protein structural units that may fold independently of the rest of the protein and have their own functions.", "PM": "2017; see PROTEIN STRUCTURE, TERTIARY 2000-2016", "HN": "2017; use PROTEIN STRUCTURE, TERTIARY 2000-2016", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072417"}, {"RECTYPE": "D", "MH": "Transportation Facilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Transportation Facility", "MN": "J03.970", "MH_TH": "NLM (2017)", "ST": "T073", "MS": "Places such as AIRPORTS, bus stations, and train stations that are used for managing arriving and departing transport vehicles, and included facilities for handling passengers.", "PM": "2017", "HN": "2017", "MR": "20160616", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072436"}, {"RECTYPE": "D", "MH": "Calendars as Topic", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Calendars as Topics", "MN": "L01.462.500.682.263", "MH_TH": "NLM (2017)", "ST": "T170", "AN": "do not confuse with the Publication Type CALENDAR", "MS": "Works about documents or charts that show days, weeks, and months of a year.", "PM": "2017", "HN": "2017", "MR": "20220712", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072437"}, {"RECTYPE": "D", "MH": "Calendar", "ENTRY": "Calendars|T170|NON|EQV|NLM (2017)|160423|abcdef", "MN": "V02.220", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Calendars as a subject are indexed under the main heading CALENDARS AS TOPIC. INDEXER: Do not use", "MS": "Document or chart that shows days, weeks, and months of a year.", "HN": "2017", "MR": "20180702", "DA": "20160708", "DC": "2", "DX": "20170101", "UI": "D000072438"}, {"RECTYPE": "D", "MH": "Postcards as Topic", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Postcards as Topics", "MN": "L01.731", "MH_TH": "NLM (2017)", "ST": "T073", "AN": "do not confuse with Publication Type POSTCARD", "MS": "Works about cards on which a message may be written or printed for mailing without an envelope.", "PM": "2017", "HN": "2017", "MR": "20190705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072439"}, {"RECTYPE": "D", "MH": "Public Health Systems Research", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "N05.632", "MH_TH": "NLM (2017)", "ST": "T091", "MS": "A field of study that examines the organization, financing, and delivery of public health services within communities, and the impact of these services on public health.", "PM": "2017", "HN": "2017", "MR": "20160607", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072440"}, {"RECTYPE": "D", "MH": "DNA, Ancient", "AQ": "AN CH IP", "ENTRY": "Ancient DNA|T114|ABX|EQV|NLM (2017)|160423|abcdef", "MN": "D13.444.308.065", "MH_TH": "NLM (2017)", "ST": "T114", "RN": "0", "PI": "DNA (2001-2016)", "MS": "DNA isolated from fossils or other ancient specimens.", "PM": "2017", "HN": "2017", "MR": "20210615", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072441"}, {"RECTYPE": "D", "MH": "Orientation, Spatial", "AQ": "CL DE ES PH RE", "ENTRY": "Spatial Orientations", "MN": "F02.830.606.793", "MH_TH": "NLM (2017)", "ST": "T082", "PI": "Orientation (1964-2016)", "MS": "Change in position or alignment in response to an external stimulus.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072458"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP1 Family|T116|T126|ABX|EQV|NLM (2017)|160425|abbcdef", "MN": "D12.776.422.220.453.100", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.14.1", "PI": "Cytochrome P-450 Enzyme System (1999-2016)", "MS": "A cytochrome P450 enzyme family whose members function primarily in the metabolism of XENOBIOTICS, including drugs and POLYCYCLIC AROMATIC HYDROCARBONS.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072461"}, {"RECTYPE": "D", "MH": "Cognitive Remediation", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Remediation, Cognitive", "MN": "F04.754.137.365", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Behavior Therapy (2005-2016)", "MS": "Behavioral treatment that uses drill and practice, compensatory and adaptive strategies to facilitate improvement in targeted learning areas.", "PM": "2017", "HN": "2017", "MR": "20160606", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072466"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP2 Family|T116|T126|ABX|EQV|NLM (2017)|160425|abbcdef", "MN": "D12.776.422.220.453.491", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.14.1", "PI": "Cytochrome P-450 Enzyme System (1992-2016)", "MS": "A cytochrome P450 enzyme family that includes members which function in the metabolism of STEROIDS; COUMARINS; and NICOTINE.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072467"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 3", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP3 Family|T116|T126|NON|EQV|NLM (2017)|160425|abbcdef", "MN": "D12.776.422.220.453.860", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.14.1", "PI": "Cytochrome P-450 Enzyme System (2004-2016)", "MS": "A cytochrome P450 enzyme family that includes members with critical functions in the metabolism of drugs and SEX HORMONES.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072469"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 4", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP4 Family|T116|T126|ABX|EQV|NLM (2017)|160425|abbcdef", "MN": "D12.776.422.220.453.870", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.14.1", "PI": "Cytochrome P-450 Enzyme System (1991-2016)", "MS": "A cytochrome P450 enzyme family that includes members which function in the metabolism of FATTY ACIDS, especially ARACHIDONIC ACIDS and their derivatives.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072470"}, {"RECTYPE": "D", "MH": "Heterocyclic Compounds, Fused-Ring", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Heterocyclic Compounds, Fused Ring", "MN": "D03.633", "FX": "Heterocyclic Compounds, Bridged-Ring", "MH_TH": "NLM (2017)", "ST": "T104", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Heterocyclic Compounds (1966-2016)", "MS": "Multiple ring heterocyclic compounds containing two or more rings that share two atoms and one bond in common.", "PM": "2017", "HN": "2017", "MR": "20160608", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072471"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 6", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP6 Family|T116|T126|ABX|EQV|NLM (2017)|160425|abbcdef", "MN": "D12.776.422.220.453.880", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.14.1", "PI": "Cytochrome P-450 Enzyme System (1995-2016)", "MS": "A cytochrome P450 enzyme family that occurs in insects. Its members function in the metabolism of XENOBIOTICS.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072472"}, {"RECTYPE": "D", "MH": "Fused-Ring Compounds", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Fused Ring Compounds", "MN": "D04.210", "FX": "Polycyclic Aromatic Hydrocarbons", "MH_TH": "NLM (2017)", "ST": "T109", "RN": "0", "PI": "Polycyclic Compounds (1975-2016)", "MS": "Polycyclic compounds with adjacent rings that share the same two adjacent atoms.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072473"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 7", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP7 Family|T116|T126|ABX|EQV|NLM (2017)|160425|abbcdef", "MN": "D12.776.422.220.453.890", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.14.23", "PI": "Cholesterol 7-alpha-Hydroxylase (1992-2016)", "MS": "A cytochrome P450 enzyme family whose members function as steroid 7-alpha hydroxylases.", "PM": "2017", "HN": "2017", "MR": "20160601", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072474"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 8", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP8 Family|T116|T126|NON|EQV|NLM (2017)|160425|abbcdef", "MN": "D12.776.422.220.453.900", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 5.3.99.4", "PI": "Cytochrome P-450 Enzyme System (1999-2016)", "MS": "A cytochrome P450 enzyme family whose members include prostacyclin synthase and STEROID 12-ALPHA-HYDROXYLASE, which function in the biosynthesis of BILE ACIDS.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072475"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 11", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP11 Family|T116|T126|ABX|EQV|NLM (2017)|160425|abbcdef", "MN": "D12.776.422.220.453.484", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.15.4", "RR": "EC 1.14.15.6", "PI": "Steroid 11-beta-Hydroxylase (1993-2016)", "MS": "A cytochrome P450 enzyme family whose members localize to the INNER MITOCHONDRIAL MEMBRANE where they function in the biosynthesis of STEROIDS.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072476"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 12", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP12 Family|T116|T126|ABX|EQV|NLM (2017)|160425|abbcdef", "MN": "D12.776.422.220.453.485", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.14.1", "PI": "Cytochrome P-450 Enzyme System (1997-2016)", "MS": "A cytochrome P450 enzyme family that occurs in insects and is expressed in MITOCHONDRIA.", "PM": "2017", "HN": "2017", "MR": "20160630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072477"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 17", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP17 Family|T116|T126|NON|EQV|NLM (2017)|160425|abbcdef", "MN": "D12.776.422.220.453.487", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.14.32", "PI": "Steroid 17-alpha-Hydroxylase (1989-2016)", "MS": "A cytochrome P450 enzyme family that functions in the biosynthesis of STEROIDS and includes STEROID 17-ALPHA-HYDROXYLASE.", "PM": "2017", "HN": "2017", "MR": "20190705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072478"}, {"RECTYPE": "D", "MH": "Farms", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Vineyard", "MN": "J03.540.150", "MH_TH": "NLM (2016)", "ST": "T082", "MS": "Areas of land set aside to grow crops or raise LIVESTOCK.", "PM": "2017; see AGRICULTURE 2016", "HN": "2017; use AGRICULTURE 2016", "MR": "20170414", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072480"}, {"RECTYPE": "D", "MH": "DNA Ligase ATP", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ATP-Dependent DNA Ligase|T116|T126|NON|EQV|NLM (2022)|200803|abbcdef", "ENTRY": "Synthase ATP, Polydeoxyribonucleotide", "MN": "D08.811.464.754.600.500", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 6.5.1.1", "RR": "EC 6.5.1.1", "MS": "ATP-dependent cellular enzyme which catalyzes DNA replication, repair and recombination through formation of internucleotide ester bonds between phosphate and deoxyribose moieties. Vertebrate cells encode three well-characterized DNA ligases, DNA ligase I, III and IV, all of which are related in structure and sequence. DNA ligases either require ATP or NAD. However, archaebacterial, viral, and some eubacterial DNA ligases are ATP-dependent.", "PM": "2018; DNA LIGASE (ATP) was indexed under DNA LIGASES 1986-2016; DNA LIGASE IIIALPHA was indexed under DNA LIGASES 1991-2017", "HN": "2018 (1986)", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072481"}, {"RECTYPE": "D", "MH": "Retinoic Acid Receptor alpha", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "alpha 2, RAR", "MN": "D12.776.930.775.250", "MH_TH": "NLM (2017)", "ST": "T116", "RN": "0", "MS": "A nuclear receptor protein which belongs to a family of transcription regulators of ligand-responsive regulatory proteins which include steroid hormone receptors. In addition to a C-terminal ligand-binding domain, these nuclear receptors contain a highly-conserved N-terminal zinc-finger domain that mediates binding ligand-responsive elements.", "PM": "2017; RETINOIC ACID RECEPTOR ALPHA was indexed under RECEPTORS, RETINOIC ACID 1993-2016", "HN": "2017 (1993)", "MR": "20170619", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072482"}, {"RECTYPE": "D", "MH": "Placenta Growth Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Placenta Growth Factor, PLGF 4 Isoform", "MN": "D12.776.780.551", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "144589-93-5", "MS": "An angiogenic protein belonging to the Vascular Endothelial Growth Factor family of growth factors originally isolated and cloned from human placental cDNA library. There are four isoforms of PLGF 1-4 which result from alternative splicing. Placenta Growth Factor is secreted as a glycosylated homodimer which acts as a mitogen for endothelial cells, and its expression is markedly upregulated during hypoxia and in tissue inflammation and cancer.", "PM": "2017; PLACENTA GROWTH FACTOR was indexed under PREGNANCY PROTEINS 1991-2016", "HN": "2017 (1991)", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072483"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 19", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP19 Family|T116|T126|ABX|EQV|NLM (2017)|160426|abbcdef", "MN": "D12.776.422.220.453.489", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.14.1", "PI": "Aromatase (1991-2016)", "MS": "A cytochrome P450 enzyme family that includes AROMATASE, which functions in the biosynthesis of ESTROGENS.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072496"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 21", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP21 Family|T116|T126|ABX|EQV|NLM (2017)|160426|abbcdef", "MN": "D12.776.422.220.453.493", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.14.16", "PI": "Steroid 21-Hydroxylase (1989-2016)", "MS": "A cytochrome P450 enzyme family that includes STEROID 21-HYDROXYLASE, which functions in the biosynthesis of STEROIDS.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072497"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 24", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP24 Family|T116|T126|ABX|EQV|NLM (2017)|160426|abbcdef", "MN": "D12.776.422.220.453.496", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.15.16", "PI": "Vitamin D3 24-Hydroxylase (1993-2016)", "MS": "A cytochrome P450 enzyme family that includes VITAMIN D3 24-HYDROXYLASE.", "PM": "2017", "HN": "2017", "MR": "20160601", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072498"}, {"RECTYPE": "D", "MH": "Manufacturing and Industrial Facilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Plants, Manufacturing", "MN": "J03.540", "MH_TH": "NLM (2017)", "ST": "T073", "MS": "Places provided for the processing, fabrication, assembly, and production of a line of products, services, commodities, or merchandise.", "PM": "2017", "HN": "2017", "MR": "20160616", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072499"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 26", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cytochrome P450, CYP26", "MN": "D12.776.422.220.453.498", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.14.1", "PI": "Cytochrome P-450 Enzyme System (1997-2016)", "MS": "A cytochrome P450 enzyme family whose members function in the metabolism of RETINOIC ACID. It includes RETINOIC ACID 4-HYDROXYLASE.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072500"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 27", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CYP27 Family|T116|T126|ABX|EQV|NLM (2017)|160426|abbcdef", "MN": "D12.776.422.220.453.499", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.15.15", "PI": "Steroid Hydroxylases (1994-2016)", "MS": "A cytochrome P450 enzyme family whose members function in VITAMIN D metabolism and the biosynthesis of BILE ACIDS.", "PM": "2017", "HN": "2017", "MR": "20160601", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072501"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 46", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cytochrome P 450 CYP46", "MN": "D12.776.422.220.453.875", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.14.25", "PI": "Steroid Hydroxylases (1999-2016)", "MS": "A cytochrome P450 enzyme family that includes CHOLESTEROL 24-HYDROXYLASE, which is expressed primarily in the brain and functions in CHOLESTEROL metabolism.", "PM": "2017", "HN": "2017", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072503"}, {"RECTYPE": "D", "MH": "Cytochrome P450 Family 51", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Family, CYP51", "MN": "D12.776.422.220.453.878", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 1.14.14.154", "PI": "Cytochrome P-450 Enzyme System (1992-2016)", "MS": "A cytochrome P450 family that occurs in all EUKARYOTES. Its members function in the biosynthesis of STEROIDS and some are targets of ANTIFUNGAL AGENTS.", "PM": "2017", "HN": "2017", "MR": "20190705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072505"}, {"RECTYPE": "D", "MH": "Gardens", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Plant Nurseries|T073|NON|REL|NLM (2020)|190124|abcdef", "ENTRY": "Plant Nursery", "MN": "J03.320", "MH_TH": "NLM (2016)", "ST": "T073", "MS": "Places provided for the cultivation and/or display of PLANTS.", "PM": "2017; see AGRICULTURE 2016", "HN": "2017; use AGRICULTURE 2016", "MR": "20190530", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072506"}, {"RECTYPE": "D", "MH": "Retinoic Acid 4-Hydroxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Retinoic Acid Metabolizing Enzyme, CYP26B1", "MN": "D12.776.422.220.453.498.500", "MH_TH": "NLM (1996)", "ST": "T126", "RN": "EC 1.14.14.1", "RR": "EC 1.14.-", "MS": "A cytochrome P450 enzyme that resides in the ENDOPLASMIC RETICULUM. It catalyzes the conversion of trans-RETINOIC ACID to 4-hydroxyretinoic acid.", "PM": "2017; RETINOIC ACID 4-HYDROXYLASE was indexed under CYTOCHROME P-450 ENZYME SYSTEM 1996-2016", "HN": "2017 (1996)", "MR": "20160527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072516"}, {"RECTYPE": "D", "MH": "Cholesterol 24-Hydroxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cholesterol 24 Hydroxylase", "MN": "D12.776.422.220.453.915.025", "MH_TH": "NLM (1999)", "ST": "T126", "RN": "EC 1.14.14.25", "MS": "A steroid hydroxylase that functions in CHOLESTEROL homeostasis in the brain. It converts cholesterol into 24S-hydroxycholesterol, which is transported over the BLOOD-BRAIN BARRIER more rapidly than unmetabolized cholesterol.", "PM": "2017; CHOLESTEROL 24-HYDROXYLASE was indexed under STEROID HYDROXYLASES 1999-2016", "HN": "2017 (1999)", "MR": "20160601", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072556"}, {"RECTYPE": "D", "MH": "Homeobox Protein Nkx-2.5", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor Nkx 2.5", "MN": "D12.776.930.324", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1995-2016)", "MS": "A homeobox-containing transcription factor that functions in heart development. Mutations in the NKX2-5 gene are associated with ATRIAL SEPTAL DEFECTS and TETRALOGY OF FALLOT.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072576"}, {"RECTYPE": "D", "MH": "Moral Status", "ENTRY": "Status, Moral", "MN": "K01.752.566.479.417", "MH_TH": "NLM (2017)", "ST": "T078", "PI": "Morals (1980-2016)", "MS": "A philosophical description of intrinsic self-worth and dignity which bestows basic rights of life, liberty, and freedom from harm.", "PM": "2017", "HN": "2017", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072577"}, {"RECTYPE": "D", "MH": "Hepatitis A Virus Cellular Receptor 1", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "T Cell Immunoglobulin and Mucin Domain Containing Protein 1", "MN": "D12.776.543.750.830.187", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "0", "PI": "Receptors, Virus (2004-2016)", "MS": "An Ig domain-containing membrane receptor for HEPATITIS A VIRUS; EBOLA VIRUS; MARBURG VIRUS; and DENGUE VIRUS. It may also function to modulate ASTHMA and HYPERSENSITIVITY.", "PM": "2017", "HN": "2017", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072596"}, {"RECTYPE": "D", "MH": "Hepatitis A Virus Cellular Receptor 2", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "T Cell Immunoglobulin and Mucin Domain Containing Protein 3", "MN": "D12.776.543.750.830.219", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2017)", "ST": "T192", "RN": "0", "PI": "Receptors, Virus (2004-2016)", "MS": "An Ig domain-containing membrane receptor that is expressed by TH1 CELLS. It regulates the activation of MACROPHAGES and inhibits TH1-mediated auto- and alloimmune responses to promote IMMUNE TOLERANCE.", "PM": "2017", "HN": "2017", "MR": "20230316", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072597"}, {"RECTYPE": "D", "MH": "Tumor Necrosis Factor alpha-Induced Protein 3", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tumor Necrosis Factor alpha Induced Protein 3", "MN": "D12.776.476.938", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.4.19.12", "PI": "Nuclear Proteins (1992-2016)", "MS": "A UBIQUITIN editing enzyme that functions as both a ubiquitin ligase and deubiquitinase. It contains several ZINC FINGERS and functions in the immune response and INFLAMMATION by modulating signals from TNF-ALPHA; IL1-BETA; or pathogens via TOLL-LIKE RECEPTORS to terminate NF-KAPPA B activity.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072598"}, {"RECTYPE": "D", "MH": "Cardiorespiratory Fitness", "AQ": "HI PH PX", "ENTRY": "Fitness, Cardiorespiratory", "MN": "N01.400.545.500", "MH_TH": "NLM (2017)", "ST": "T078", "PI": "Physical Fitness (1967-2016)", "MS": "A measure of the functional capabilities of the heart, lungs and muscles, relative to the demands of specific exercise routines such as running or cycling.", "PM": "2017", "HN": "2017", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072599"}, {"RECTYPE": "D", "MH": "Meniscus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Menisci|T024|NON|EQV|NLM (2017)|160329|abcdef", "MN": "A10.165.382.350.163", "MH_TH": "NLM (2017)", "ST": "T024", "PI": "Cartilage (1963-2016)", "MS": "Crescent-shaped cartilaginous tissue interposed between two articulating bones.", "PM": "2017", "HN": "2017", "MR": "20170601", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072600"}, {"RECTYPE": "D", "MH": "Cannula", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Cannulae, Nasal", "MN": "E07.132.125", "MH_TH": "NLM (1978)", "ST": "T074", "PI": "Catheters (1963-2016)", "MS": "Short, hollow cylinders or tubes for insertion into a canal, vessel, or body cavity.", "PM": "2017; see Catheters (2011-2016)", "HN": "2017(1978)", "MR": "20160531", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000072601"}, {"RECTYPE": "D", "MH": "Peptidyl-Prolyl Cis-Trans Isomerase NIMA-Interacting 4", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peptidyl Prolyl Cis Trans Isomerase Pin4", "MN": "D12.776.260.650", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 5.2.1.8", "MS": "A NIMA-interacting peptidylprolyl isomerase. It binds to double-stranded DNA and functions in the biogenesis of RIBOSOMES.", "PM": "2017; PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 4 was indexed under PEPTIDYL ISOMERASE 1997-2016, and under AMINO ACID ISOMERASES 1996-1997", "HN": "2017 (1996)", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072621"}, {"RECTYPE": "D", "MH": "Cyclophilin C", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peptidyl Prolyl Cis Trans Isomerase C", "MN": "D12.776.827.344.300.750", "MH_TH": "NLM (1991)", "ST": "T126", "RN": "EC 5.2.1.8", "MS": "A peptidyl-prolyl cis-trans isomerase and member of the cyclophilin family. It catalyzes the cis-trans isomerization of imide-like peptide bonds that occur between PROLINE and other amino acids to facilitate PROTEIN FOLDING.", "PM": "2017; CYCLOPHILIN C was indexed under CYCLOPHILINS 2000-2016, under IMMUNOPHILINS 1999-2000, under PEPTIDYLPROLYL ISOMERASE 1998, under CARRIER PROTEINS 1991-1998, and under AMINO ACID ISOMERASES 1991-1997; PEPTIDYLPROLYL ISOMERASE C and ROTAMASE C were indexed under PEPTIDYLPROLYL ISOMERASE 1997-2016, and under AMINO ACID ISOMERASES 1996-1997", "HN": "2017 (1991)", "MR": "20230526", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072622"}, {"RECTYPE": "D", "MH": "PAX8 Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, PAX8", "MN": "D12.776.930.700.906", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "PI": "Trans-Activators (1993-2016)", "MS": "A paired box transcription factor that functions in the development of THYROCYTES and the control of thyroid-specific gene expression. Mutations in the PAX8 gene are associated with THYROID DYSGENESIS and THYROID NEOPLASMS.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072636"}, {"RECTYPE": "D", "MH": "Thyroid Epithelial Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Thyroid Follicular Cell", "MN": "A11.436.911", "MH_TH": "NLM (2017)", "ST": "T025", "PI": "Thyroid Gland/cytology (1967-2016)", "MS": "Epithelial cells of the THYROID GLAND that produce and secrete THYROXINE and TRIIODOTHYRONINE.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072637"}, {"RECTYPE": "D", "MH": "Patient Portals", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Web Portals, Patient", "MN": "E05.318.308.940.968.249.750", "MH_TH": "NLM (2017)", "ST": "T058", "PI": "Electronic Health Records (2010-2016)", "MS": "A secure online website that provides patients convenient 24-hour access to personal health information via an Internet connection.", "PM": "2017", "HN": "2017", "MR": "20170224", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072638"}, {"RECTYPE": "D", "MH": "Perfectionism", "MN": "F01.752.823", "MH_TH": "NLM (2017)", "ST": "T055", "MS": "A personality trait characterized by a person's striving for flawlessness and setting excessively high performance standards, accompanied by overly critical self-evaluations and concerns regarding others' evaluations.", "PM": "2017", "HN": "2017", "MR": "20160707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072639"}, {"RECTYPE": "D", "MH": "Interferon-Induced Helicase, IFIH1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Melanoma Differentiation Associated Protein 5", "MN": "D12.776.066.125", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 3.6.4.13", "PI": "DEAD-box RNA Helicases (2006-2016)", "MS": "A DEAD box RNA helicase that contains two N-terminal CASPASE ACTIVATION AND RECRUITMENT DOMAINS. It functions as a sensor of viral NUCLEIC ACIDS such as DOUBLE-STRANDED RNA and activates the INNATE IMMUNE RESPONSE by inducing the expression of INTERFERON-ALPHA and INTERFERON-BETA. It may also regulate cell growth and APOPTOSIS.", "PM": "2017", "HN": "2017", "MR": "20210510", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072640"}, {"RECTYPE": "D", "MH": "Medicare Access and CHIP Reauthorization Act of 2015", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Public Law 114 10", "MN": "N03.706.615.696.500", "MH_TH": "NLM (2017)", "ST": "T089", "AN": "CATALOGER: Use NAF entry", "MS": "An Act that amends Title XVIII of the Social Security Act to repeal the Medicare sustainable growth rate, that strengthens Medicare access by improving  physician payments, and that reauthorizes the Children's Health Insurance Program (CHIP).", "PM": "2017", "HN": "2017", "MR": "20160707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072641"}, {"RECTYPE": "D", "MH": "Study Guide", "MN": "V02.928", "MH_TH": "NLM (2017)", "ST": "T170", "AN": "This heading is used as a Publication Type. Study guides as a subject are indexed under the main heading STUDY GUIDES AS TOPIC. INDEXER: Do not use ", "MS": "Tool used to help facilitate learning and comprehension of a topic or to help prepare for an examination.", "HN": "2017", "MR": "20190710", "DA": "20160708", "DC": "2", "DX": "20170101", "UI": "D000072643"}, {"RECTYPE": "D", "MH": "Study Guides as Topic", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Study Guide as Topic|T073|NON|EQV|NLM (2017)|160511|abcdef", "MN": "I02.903.923", "MH_TH": "NLM (2020)", "ST": "T073", "AN": "do not confuse with Publication Type STUDY GUIDE", "MS": "Works about use of aids to help facilitate learning and comprehension of a topic or to help prepare for an examination.", "PM": "2017", "HN": "2017", "MR": "20190705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072644"}, {"RECTYPE": "D", "MH": "Cancer-Associated Fibroblasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Tumor-Associated Fibroblast", "MN": "A11.329.228.105", "MH_TH": "NLM (2017)", "ST": "T025", "PI": "Tumor Microenvironment (2010-2016)", "MS": "Subpopulation of heterogeneous fibroblasts within the TUMOR MICROENVIRONMENT that support NEOPLASTIC CELL TRANSFORMATION and NEOPLASTIC PROCESSES.", "PM": "2017", "HN": "2017", "MR": "20160610", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000072645"}, {"RECTYPE": "D", "MH": "Breast Cancer Lymphedema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Postmastectomy Lymphedemas", "MN": "C23.550.767.082", "FX": "Breast Neoplasms", "MH_TH": "NLM (2017)", "ST": "T191", "PI": "Postoperative Complications (1963-2016)", "MS": "Abnormal accumulation of lymph in the arm, shoulder and breast area associated with surgical treatment (e.g., MASTECTOMY) or radiation treatment of breast cancer.", "PM": "2017", "HN": "2017", "MR": "20170620", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072656"}, {"RECTYPE": "D", "MH": "ST Elevation Myocardial Infarction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "STEMI|T047|ACR|EQV|NLM (2017)|160512|abcdef", "MN": "C23.550.717.489.750.875", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Myocardial Infarction (1999-2016)", "MS": "A clinical syndrome defined by MYOCARDIAL ISCHEMIA symptoms; persistent elevation in the ST segments of the ELECTROCARDIOGRAM; and release of BIOMARKERS of myocardial NECROSIS (e.g., elevated TROPONIN levels). ST segment elevation in the ECG is often used in determining the treatment protocol (see also NON-ST ELEVATION MYOCARDIAL INFARCTION).", "PM": "2017", "HN": "2017", "MR": "20190701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072657"}, {"RECTYPE": "D", "MH": "Non-ST Elevated Myocardial Infarction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Non-ST-Elevation Myocardial Infarctions", "MN": "C23.550.717.489.750.469", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Myocardial Infarction (1999-2016)", "MS": "A myocardial infarction that does not produce elevations in the ST segments of the ELECTROCARDIOGRAM. ST segment elevation of the ECG is often used in determining the treatment protocol (see also ST Elevation Myocardial Infarction).", "PM": "2017", "HN": "2017", "MR": "20190701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072658"}, {"RECTYPE": "D", "MH": "Hypophysitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypophysitides", "MN": "C19.700.419", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Pituitary Diseases (1969-2016)", "MS": "Inflammation of the PITUITARY GLAND.", "PM": "2017", "HN": "2017", "MR": "20160531", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072659"}, {"RECTYPE": "D", "MH": "Teratozoospermia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Teratozoospermias", "MN": "C12.200.294.430.877", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Spermatozoa (1979-2016)", "MS": "Conditions in which sperm show abnormal morphology.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072660"}, {"RECTYPE": "D", "MH": "Ciliopathies", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ciliopathy", "MN": "C16.320.184", "FX": "Ciliary Motility Disorders", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Ciliary Motility Disorders (2009-2016)", "MS": "Genetic disorders caused by defects in genes related to the primary CILIUM; BASAL BODY; or CENTROSOME. Primary features may include obesity, SKELETAL DYSPLASIA; POLYDACTYLY and malformations that primarily involve the liver, eye or kidneys.", "PM": "2017", "HN": "2017", "MR": "20171214", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072661"}, {"RECTYPE": "D", "MH": "Margins of Excision", "ENTRY": "Tumor-Free Margin", "MN": "C23.149.625", "FX": "Biopsy", "MH_TH": "NLM (2017)", "ST": "T023", "MS": "The edges of tissue removed in a surgery for assessment of the effectiveness of a surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. When the margin is negative or not involved by tumor (e.g., CANCER) it suggests all of the tumor has been removed by the surgery.", "PM": "2017", "HN": "2017", "MR": "20160706", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072662"}, {"RECTYPE": "D", "MH": "Spontaneous Perforation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spontaneous Perforations", "MN": "C23.300.940", "MH_TH": "NLM (2017)", "ST": "T046", "AN": "includes spontaneous perforation unexplained or as a result of disease; coordinate with organ/diseases term", "PI": "Rupture, Spontaneous (1965-2016)", "MS": "A pathological hole in an organ, blood vessel or other soft part of the body, occurring in the absence of external force.", "PM": "2017", "HN": "2017", "MR": "20160707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072663"}, {"RECTYPE": "D", "MH": "Provitamins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Vitamin Precursor", "MN": "J02.500.681.500.600.500", "MH_TH": "NLM (2017)", "ST": "T127", "RN": "0", "MS": "Precursor forms of vitamins.", "PM": "2017", "HN": "2017", "MR": "20190705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072664"}, {"RECTYPE": "D", "MH": "National Center for Advancing Translational Sciences (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "National Center for Advancing Translational Sciences|T093|NON|EQV|NLM (2017)|160513|abcdef", "MN": "N03.540.348.500.500.600.650.496.175", "FX": "Translational Science, Biomedical", "MH_TH": "NLM (2017)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "MS": "A unit of the National Institutes of Health that seeks to catalyze the generation of innovative methods and technologies that will enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. The Center was established in 2011.", "PM": "2017", "HN": "2017", "MR": "20210707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072666"}, {"RECTYPE": "D", "MH": "National Center for Complementary and Integrative Health (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "National Center of Complementary and Alternative Medicine|T093|NON|EQV|NLM (2017)|160705|abcdef", "MN": "N03.540.348.500.500.600.650.496.188", "MH_TH": "NLM (2017)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "MS": "The mission of NCCIH is to define, through rigorous scientific investigation, the usefulness and safety of complementary and integrative health interventions and their roles in improving health and health care. The Center was established in 1999 and was known as NCCAM National Center of Complementary and Alternative Medicine until 2015.", "PM": "2017", "HN": "2017", "MR": "20161216", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072667"}, {"RECTYPE": "D", "MH": "Splicing Factor U2AF", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "U2AF, Splicing Factor", "MN": "D12.776.664.962.829.750", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "MS": "An RNA splicing factor that performs a critical function in both constitutive and enhancer-dependent RNA SPLICING. It recruits RIBONUCLEOPROTEIN, U2 SMALL NUCLEAR to the splice site and mediates interactions between it, the RNA molecule, and other splicing factors for accurate 3'-splice site selection.", "PM": "2017; SPLICING FACTOR U2AF was indexed under NUCLEAR PROTEINS and RIBONUCLEOPROTEINS 2004-2016, and under RNA-BINDING PROTEINS 1993-2004", "HN": "2017 (1993)", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072668"}, {"RECTYPE": "D", "MH": "Gene Editing", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "PRINT ENTRY": "Base Editing|T045|NON|NRW|NLM (2023)|220526|abcdef", "ENTRY": "Editing, Genome", "MN": "E05.393.420.270", "FX": "Mutagenesis, Site-Directed", "MH_TH": "NLM (2017)", "ST": "T045", "PI": "Genetic Engineering (2005-2016)", "MS": "Genetic engineering or molecular biology techniques that involve DNA REPAIR mechanisms for incorporating site-specific modifications into a cell's genome.", "PM": "2017", "HN": "2017", "MR": "20220712", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072669"}, {"RECTYPE": "D", "MH": "PTB-Associated Splicing Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Splicing Factor, PTB-Associated", "MN": "D12.776.664.962.829.282", "FX": "Polypyrimidine Tract-Binding Protein", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "MS": "An RNA splicing factor that also binds DNA. It is essential for pre-mRNA spicing in the formation of early SPLICEOSOMES and catalytic step II. It binds specifically to polypyrimidine tracts in INTRONS and is involved in the regulation of ALTERNATIVE SPLICING by SIGNAL TRANSDUCTION PATHWAYS.", "PM": "2017; PTB-ASSOCIATED SPLICING FACTOR was indexed under RNA-BINDING PROTEINS 1993-2016", "HN": "2017 (1993)", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072670"}, {"RECTYPE": "D", "MH": "Ankyloglossia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tongue Ties", "MN": "C07.160", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "A severe congenital restriction of TONGUE movement, resulting from fusion or adherence of the tongue to the floor of the mouth. In partial ankyloglossia (tongue-tie) the LINGUAL FRENUM is abnormally short, or is attached too close to the tip of the tongue. OMIM: 106280", "PM": "2017; see under Mouth Abnormalities 2013-2016", "HN": "2017; use under Mouth Abnormalities 2013-2016", "MR": "20160531", "DA": "20160629", "DC": "1", "DX": "20170101", "UI": "D000072676"}, {"RECTYPE": "D", "MH": "High-Intensity Interval Training", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Trainings, High-Intensity Interval", "MN": "I03.350.311.250", "MH_TH": "NLM (2017)", "ST": "T061", "PI": "Exercise (1995-2016)", "MS": "A cardiovascular exercise strategy with alternating short periods of intense anaerobic exercise with less-intense recovery periods.", "PM": "2017", "HN": "2017", "MR": "20180629", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072696"}, {"RECTYPE": "D", "MH": "Desegregation", "AQ": "HI LJ PX TD", "MN": "I01.880.735.820.500.250", "MH_TH": "NLM (1988)", "ST": "T064", "PI": "Race Relations (1988-2016)", "MS": "Ending segregation (separation) of different groups of people, usually based on race, in schools, housing, organizations, etc.", "PM": "2017; see Race RELATIONS 1988-2016", "HN": "2017; use Race RELATIONS 1988-2016", "MR": "20160707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072697"}, {"RECTYPE": "D", "MH": "Apartheid", "AQ": "CL EC HI LJ PX SN", "MN": "I01.880.735.820.500.125", "FX": "Racism", "MH_TH": "NLM (2015)", "ST": "T054", "MS": "A former political system in SOUTH AFRICA which enforced segregation in all forms, including physical, political, legal and economic discrimination, against all non-white, non-European racial groups.", "PM": "2017; see Race RELATIONS 1988-2016", "HN": "2017; use Race RELATIONS 1988-2016", "MR": "20170707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072698"}, {"RECTYPE": "D", "MH": "Social Segregation", "AQ": "HI PX TD", "ENTRY": "Segregation, Social", "MN": "I01.880.735.820", "MH_TH": "NLM (2017)", "ST": "T054", "MS": "Barriers based on group membership.", "MR": "20160707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072699"}, {"RECTYPE": "D", "MH": "Conservative Treatment", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Treatments, Conservative", "MN": "E02.197", "MH_TH": "NLM (2017)", "ST": "T061", "MS": "Therapeutic approaches that are limited, gradual, or well-established as opposed to radical methods.", "PM": "2017", "HN": "2017", "MR": "20160630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072700"}, {"RECTYPE": "D", "MH": "Cancer Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tumor-Related Pains", "MN": "C23.888.592.612.212", "MH_TH": "NLM (2017)", "ST": "T184", "AN": "not for treatment-related pain", "PI": "Pain (1983-2016)", "MS": "Pain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS.", "PM": "2017", "HN": "2017", "MR": "20170620", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072716"}, {"RECTYPE": "D", "MH": "Tertiary Lymphoid Structures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tertiary Lymphoid Structure", "MN": "C23.300.955", "MH_TH": "NLM (2017)", "ST": "T046", "MS": "Aggregates of immune cells formed near the sites of chronically inflamed, infected, or tumorous tissues.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072717"}, {"RECTYPE": "D", "MH": "Propofol Infusion Syndrome", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Propofol-Related Infusion Syndromes", "MN": "C25.100.844", "FX": "Propofol", "MH_TH": "NLM (2017)", "ST": "T047", "PI": "Propofol (1998-2016)", "MS": "Rare and often fatal drug complication which affects patients undergoing long-term treatment with high doses of PROPOFOL. It is characterized by METABOLIC ACIDOSIS; HYPERLIPIDEMIA; RHABDOMYOLYSIS; cardiovascular CIRCULATORY COLLAPSE; CARDIAC FAILURE; and KIDNEY FAILURE.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072736"}, {"RECTYPE": "D", "MH": "Myeloid-Derived Suppressor Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Myeloid Derived Suppressor Cell|T025|NON|EQV|NLM (2022)|201021|abcdef", "ENTRY": "Suppressor Cells, Myeloid-Derived", "MN": "A11.627.817", "MH_TH": "NLM (2017)", "ST": "T025", "PI": "Myeloid Cells (2005-2016)", "MS": "A heterogeneous, immature population of myeloid cells that can suppress the activity of T-CELLS and NATURAL KILLER CELLS in the INNATE IMMUNE RESPONSE and ADAPTIVE IMMUNE RESPONSE. They play important roles in ONCOGENESIS; INFLAMMATION; and INFECTION.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072737"}, {"RECTYPE": "D", "MH": "Nitrogen-Fixing Bacteria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.585", "MH_TH": "NLM (2017)", "ST": "T007", "PI": "Nitrogen Fixation (1966-2016)", "MS": "Bacteria that are capable of NITROGEN FIXATION.", "PM": "2017", "HN": "2017", "MR": "20200902", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072738"}, {"RECTYPE": "D", "MH": "Sentinel Species", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Sentinel Organism|T001|T098|NON|EQV|NLM (2022)|201006|abbcdef", "ENTRY": "Sentinel Plants|T001|T098|NON|NRW|NLM (2017)|160518|abbcdef", "MN": "B05.698", "FX": "Environmental Exposure", "MH_TH": "NLM (2017)", "ST": "T098", "PI": "Animals (1996-2016)", "MS": "Organisms used to determine measurable environmental risks or hazards to human health and or well-being, thereby serving as advance or early warning signs of impending danger to humans. Examples of sentinel species are monkeys, guinea pigs, and the fabled canary in the coal mine.", "PM": "2017", "HN": "2017", "MR": "20210630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072739"}, {"RECTYPE": "D", "MH": "Paternal Inheritance", "AQ": "DE GE IM PH RE", "ENTRY": "Paternally, Inherited", "MN": "G05.420.623", "FX": "Maternal Inheritance", "MH_TH": "NLM (2017)", "ST": "T045", "MS": "A form of inheritance where the traits of the offspring are paternal in origin due to the expression of extra-nuclear genetic material such as MITOCHONDRIAL DNA or Y chromosome genes. CENTRIOLES are also paternally inherited.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072740"}, {"RECTYPE": "D", "MH": "Maternal Inheritance", "AQ": "DE GE IM PH RE", "ENTRY": "Maternally, Inherited", "MN": "G05.420.275.750", "FX": "Paternal Inheritance", "MH_TH": "NLM (2017)", "ST": "T045", "PI": "Inheritance Patterns (2003-2016)", "MS": "Transmission of genetic characters, qualities, and traits, solely from maternal extra-nuclear elements such as MITOCHONDRIAL DNA or MATERNAL MESSENGER RNA.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072741"}, {"RECTYPE": "D", "MH": "Invasive Fungal Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Disseminated Fungal Infection|T047|NON|EQV|NLM (2021)|200210|abcdef", "ENTRY": "Mycoses, Invasive", "MN": "C01.150.703.492", "MH_TH": "NLM (2017)", "ST": "T047", "AN": "coordinate with specific fungal infection", "PI": "Mycoses (1976-2016)", "MS": "Mycoses which manifest as infections of deep tissue or blood.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072742"}, {"RECTYPE": "D", "MH": "Beta-Cryptoxanthin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Beta Cryptoxanthin", "MN": "D23.767.261.887.374.500", "MH_TH": "NLM (2000)", "ST": "T127", "RN": "0", "MS": "A mono-hydroxylated xanthophyll that is a provitamin A precursor.", "PM": "2017", "HN": "2017", "MR": "20170601", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072743"}, {"RECTYPE": "D", "MH": "Protein Conformation, alpha-Helical", "AQ": "DE GE PH RE", "PRINT ENTRY": "alpha-Helical Conformation, Protein|T082|NON|EQV|NLM (1993)|920414|abcdef", "ENTRY": "alpha-Helical Structure", "MN": "G02.111.570.820.709.600.020", "MH_TH": "NLM (1993)", "ST": "T082", "AN": "IM general only; coordinate NIM with specific protein", "MS": "A secondary structure of proteins that is a right-handed helix or coil, where each amino (N-H) group of the peptide backbone contributes a hydrogen bond to the carbonyl(C=O) group of the amino acid four residues N-terminal to it (n-4). It is the most common type of secondary structure.", "PM": "2017; see PROTEIN STRUCTURE, SECONDARY 1992-2016", "HN": "2017; use PROTEIN STRUCTURE, SECONDARY 1992-2016", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072756"}, {"RECTYPE": "D", "MH": "Protein Conformation, beta-Strand", "AQ": "DE GE PH RE", "PRINT ENTRY": "Protein Conformation, beta-Sheet|T082|NON|BRD|NLM (1993)|920414|abcdef", "ENTRY": "beta-Stranded Structure", "MN": "G02.111.570.820.709.600.750", "MH_TH": "NLM (1999)", "ST": "T082", "AN": "IM general only; coordinate NIM with specific protein", "MS": "A secondary structure of proteins where the amino (N-H) groups of a polypeptide backbone, three to ten amino acids in length, establish hydrogen bonds with the carbonyl (C=O) groups in the backbone of adjacent strands.  These may form a beta-sheet, where the side chains of the adjacent strands point in the same direction.", "PM": "2017; see PROTEIN STRUCTURE, SECONDARY 1992-2016", "HN": "2017; use PROTEIN STRUCTURE, SECONDARY 1992-2016", "MR": "20160705", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072757"}, {"RECTYPE": "D", "MH": "Vaccination Refusal", "AQ": "EH ES HI LJ PX SN TD", "ENTRY": "Vaccine Refusals", "MN": "N05.300.150.800.750.500", "FX": "Anti-Vaccination Movement", "MH_TH": "NLM (2017)", "ST": "T055", "PI": "Vaccination (2003-2016)", "MS": "Refusal to receive VACCINATION.", "PM": "2017", "HN": "2017", "MR": "20170620", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072758"}, {"RECTYPE": "D", "MH": "Biofortification", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Crops, Biofortified", "MN": "J01.040.227.250", "FX": "Food, Fortified", "MH_TH": "NLM (2017)", "ST": "T057", "PI": "Food, Fortified (2005-2016)", "MS": "Improving the NUTRITIONAL VALUE of plant foods by augmenting the plant's environment, by using PLANT BREEDING, or by GENETIC ENGINEERING plants to increase their ability to synthesize VITAMINS or uptake essential NUTRIENTS from the soil.", "PM": "2017", "HN": "2017", "MR": "20160630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072759"}, {"RECTYPE": "D", "MH": "Single Molecule Imaging", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Single Particle Tracking|T059|NON|BRD|NLM (2020)|190110|abcdef", "ENTRY": "Tracking, Single Particle", "MN": "E05.601.555.500", "MH_TH": "NLM (2017)", "ST": "T059", "PI": "Molecular Imaging (2010-2016)", "MS": "High resolution imaging techniques that allow visualization of individual molecules of proteins, lipids, or nucleic acids within cells or tissues.", "PM": "2017", "HN": "2017", "MR": "20190222", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072760"}, {"RECTYPE": "D", "MH": "Mycobiome", "AQ": "DE GE IM PH RE", "ENTRY": "Mycobiomes", "MN": "N06.230.124.049.100.500.750", "MH_TH": "NLM (2017)", "ST": "T004", "MS": "The full spectrum of FUNGI that exist within a particular biological niche such as an organism, soil, a body of water, etc.", "PM": "2017", "HN": "2017", "MR": "20180206", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072761"}, {"RECTYPE": "D", "MH": "Slit Lamp Microscopy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Slit Lamp Examinations", "MN": "E01.370.380.727", "MH_TH": "NLM (2017)", "ST": "T060", "PI": "Ophthalmoscopy (1964-2016)", "MS": "A procedure that uses a SLIT LAMP to examine structures in the front of the EYE, such as the CONJUNCTIVA; CORNEA; IRIS; and AQUEOUS HUMOR.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072776"}, {"RECTYPE": "D", "MH": "Host-Seeking Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Seeking Behaviors, Host", "MN": "G16.559", "MH_TH": "NLM (2017)", "ST": "T055", "MS": "Searching behavior by parasitic or commensal organisms, to find animals or plants that are a source of nourishment and habitation.", "PM": "2017", "HN": "2017", "MR": "20160630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072777"}, {"RECTYPE": "D", "MH": "Walking Speed", "AQ": "DE GE IM PH RE", "ENTRY": "Walking Speeds", "MN": "G11.427.410.568.900.750.500", "MH_TH": "NLM (2017)", "ST": "T081", "PI": "Walking (1990-2016)", "MS": "The rate at which steps are made while walking.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072797"}, {"RECTYPE": "D", "MH": "Stair Climbing", "AQ": "DE GE IM PH RE", "ENTRY": "Navigation, Stair", "MN": "I03.350.937.500", "MH_TH": "NLM (2017)", "ST": "T056", "MS": "Ascending or descending stairs.", "PM": "2017; for STAIR NAVIGATION see GAIT 2013-2016", "HN": "2017; for STAIR NAVIGATION use GAIT 2013-2016", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072799"}, {"RECTYPE": "D", "MH": "Eryptosis", "AQ": "DE GE IM PH RE", "ENTRY": "Suicidal Erythrocyte Deaths", "MN": "G04.146.954.035.295", "MH_TH": "NLM (2017)", "ST": "T043", "PI": "Cell Death (2006-2016)", "MS": "Suicidal death of ERYTHROCYTES which results in features typical of apoptotic nucleated cells such as cell shrinkage, membrane blebbing, and scrambling of cell membrane to expose membrane PHOSPHATIDYLSERINES, which triggers engulfment and degradation by MACROPHAGES.", "PM": "2017", "HN": "2017", "MR": "20190530", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072817"}, {"RECTYPE": "D", "MH": "Surgical Wound", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Wounds, Surgical", "MN": "C26.859", "MH_TH": "NLM (2017)", "ST": "T037", "PI": "Wound Healing (1963-2016)", "MS": "An incision made during a surgical procedure.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072836"}, {"RECTYPE": "D", "MH": "Chromothripsis", "AQ": "DE RE", "ENTRY": "Shattering, Chromosome", "MN": "G05.365.590.175.310", "FX": "Genomic Instability", "MH_TH": "NLM (2017)", "ST": "T049", "PI": "Chromosome Aberrations (2011-2016)", "MS": "Massive number of chromosomal rearrangements and shattering that occurs in cancer cells. The breakpoints are located within one chromosome or chromosome arm.", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072837"}, {"RECTYPE": "D", "MH": "Radiologic and Imaging Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Radiologic", "MN": "H02.478.676.772", "FX": "Radiology", "MH_TH": "NLM (2017)", "ST": "T091", "PI": "Specialties, Nursing (1981-2016)", "MS": "A nursing specialty that deals specifically with the care of patients undergoing diagnostic, neurological, cardiovascular, interventional, ultrasonography, computerized tomography, nuclear medicine, magnetic resonance, radiation oncology or other related procedures .", "PM": "2017", "HN": "2017", "MR": "20160701", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072856"}, {"RECTYPE": "D", "MH": "Psychosocial Support Systems", "PRINT ENTRY": "Psychosocial Support|T061|NON|BRD|NLM (2021)|200129|abcdef", "ENTRY": "Systems, Social Support", "MN": "I01.880.853.500.600.500", "MH_TH": "UNK (19XX)", "ST": "T095", "MS": "Organized efforts to address ongoing psychological and social problems of individuals, their partners, families and caregivers.", "PM": "2017", "HN": "2017", "MR": "20200618", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072858"}, {"RECTYPE": "D", "MH": "Ecological Momentary Assessment", "AQ": "HI SN ST", "ENTRY": "Samplings, Experience", "MN": "F04.711.336", "MH_TH": "NLM (2017)", "ST": "T060", "MS": "Repeated reports by a research participant of symptoms, affect, behavior, and cognition close in time to experience and in the participant's natural environment.", "PM": "2017", "HN": "2017", "MR": "20160707", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072860"}, {"RECTYPE": "D", "MH": "Phobia, Social", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Sociophobia|T048|NON|EQV|NLM (2023)|210921|abcdef", "ENTRY": "Sociophobias", "MN": "F03.080.725.500", "FX": "Anxiety", "MH_TH": "UNK (19XX)", "ST": "T048", "PI": "Phobic Disorders (1997-2016)", "MS": "Anxiety disorder characterized by the persistent and irrational fear, anxiety, or avoidance of social or performance situations.", "PM": "2017", "HN": "2017", "MR": "20220413", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072861"}, {"RECTYPE": "D", "MH": "Simplified Acute Physiology Score", "ENTRY": "SAPS III|T081|ABB|EQV|NLM (2017)|160601|abcdef", "MN": "N06.850.520.308.980.438.475.364.500.750", "MH_TH": "NLM (2017)", "ST": "T081", "PI": "Severity of Illness Index (1988-2016)", "MS": "A severity of disease classification system designed to measure the severity of disease for patients aged 15 and over admitted to intensive care units.", "PM": "2017", "HN": "2017", "MR": "20170703", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072878"}, {"RECTYPE": "D", "MH": "Morgue", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Morgues, Hospital", "MN": "N04.452.442.452.422.467", "MH_TH": "NLM (2017)", "ST": "T169", "MS": "Location where dead bodies are kept until they are buried or cremated.", "PM": "2017", "HN": "2017", "MR": "20190709", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072896"}, {"RECTYPE": "D", "MH": "Peripheral Blood Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Peripheral Stem Cell|T025|NON|EQV|NLM (2021)|200325|abcdef", "ENTRY": "Stem Cells, Peripheral", "MN": "A11.872.378.795", "EC": "transplantation:Peripheral Blood Stem Cell Transplantation", "MH_TH": "NLM (2017)", "ST": "T025", "PI": "Peripheral Blood Stem Cell Transplantation (1999-2016)", "MS": "Hematopoietic stem cells found in peripheral blood circulation.", "PM": "2017", "HN": "2017", "MR": "20200527", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072916"}, {"RECTYPE": "D", "MH": "Standardized Nursing Terminology", "ENTRY": "Terminology, Standardized Nursing", "MN": "L01.559.598.400.889", "MH_TH": "NLM (2017)", "ST": "T170", "PI": "Vocabulary, Controlled (1992-2016)", "MS": "Standardized terms used in the nursing field (e.g., NURSING INFORMATICS).", "PM": "2017", "HN": "2017", "MR": "20220712", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072917"}, {"RECTYPE": "D", "MH": "Fitness Trackers", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Trackers, Physical Fitness", "MN": "E07.305.906.250", "MH_TH": "NLM (2017)", "ST": "T073", "MS": "Devices used for measuring physical activity as an indication of HEALTH STATUS.", "PM": "2017", "HN": "2017", "MR": "20170630", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072936"}, {"RECTYPE": "D", "MH": "Adult Germline Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Spermatogonial Progenitor Cell", "MN": "A11.872.040.250", "MH_TH": "NLM (2014)", "ST": "T025", "MS": "Progenitor stem cells found in the testicles.", "PM": "2017(1994)", "HN": "2017(1994)", "MR": "20160701", "DA": "20160705", "DC": "1", "DX": "20170101", "UI": "D000072956"}, {"RECTYPE": "D", "MH": "Alaska Natives", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Native Alaskans|T098|NON|EQV|NLM (2017)|200826|abcdef", "ENTRY": "Peoples, Alaska's Indigenous", "MN": "M01.686.477.250.600.094", "FX": "Inuit", "MH_TH": "NLM (2017)", "ST": "T098", "AN": "specify ethnic group if pertinent; do not confuse with INUIT", "PI": "Inuits (1991-2016)", "MS": "Persons having origins in any indigenous people of ALASKA and their descendants.", "PM": "2017", "HN": "2017", "MR": "20230104", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072957"}, {"RECTYPE": "D", "MH": "Oogonial Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Ovarian Germline Stem Cell|T025|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Stem Cells, Oogonial", "MN": "A11.872.677", "MH_TH": "NLM (2014)", "ST": "T025", "MS": "Primordial germ cells found in embryonic OOGONIA and postnatal OVARIES.", "PM": "2017; see STEM CELLS 2014-2016", "HN": "2017(2014)", "MR": "20200527", "DA": "20160708", "DC": "1", "DX": "20170101", "UI": "D000072977"}, {"RECTYPE": "D", "MH": "Acenaphthenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.638.059", "MH_TH": "NLM (1972)", "ST": "T130", "RN": "0", "PI": "Naphthalenes (1966-1971)", "MS": "Tricyclic ethylene-bridged naphthalene derivatives. They are found in petroleum residues and coal tar and used as dye intermediates, in the manufacture of plastics, and in insecticides and fungicides.", "PM": "73", "HN": "73(72)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000073"}, {"RECTYPE": "D", "MH": "Refugee Camps", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Refugee Camp", "MN": "J03.340.825", "MH_TH": "NLM (1993)", "ST": "T082", "PI": "Refugees (1969-2017)", "MS": "Areas of shelter and protection for people who leave their own country or habitual residence to escape danger, persecution, or disaster.", "PM": "2018; see REFUGEES 1993-2017", "HN": "2018; use REFUGEES 1993-2017", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073017"}, {"RECTYPE": "D", "MH": "Mental Health Recovery", "AQ": "EC HI TD", "ENTRY": "Recovery, Mental Health", "MN": "N02.421.784.444", "MH_TH": "NLM (2018)", "ST": "T061", "MS": "Recovery from mental disorders and/or substance abuse. The process of change in which individuals improve their MENTAL HEALTH and wellness, live a self-directed life, and work to achieve their full potential.", "PM": "2018", "HN": "2018", "MR": "20161219", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073038"}, {"RECTYPE": "D", "MH": "Nitrosative Stress", "AQ": "DE GE IM PH RE", "ENTRY": "Stresses, Nitrosative", "MN": "G07.775.750.500", "FX": "Oxidative Stress", "MH_TH": "NLM (2018)", "ST": "T049", "PI": "Reactive Nitrogen Species (1996-2017)", "MS": "A metabolic excess of REACTIVE NITROGEN SPECIES, including NITRIC OXIDE and PEROXYNITRITE, that leads to damaging effects of oxidation and nitration.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073039"}, {"RECTYPE": "D", "MH": "Transactinide Series Elements", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Transactinides|T197|NON|EQV|NLM (2018)|160815|abcdef", "MN": "D01.496.749.305.935", "MH_TH": "NLM (2018)", "ST": "T197", "RN": "0", "MS": "A series of radioactive elements with atomic numbers greater than 103. Current members include Rutherfordium, atomic number 104, to and including Ununoctium, atomic number 118. All members are synthetic with short half-lives.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073056"}, {"RECTYPE": "D", "MH": "Aruba", "AQ": "EH EP", "MN": "Z01.639.040.109", "MH_TH": "NLM (1994)", "ST": "T083", "MS": "Island in the Caribbean Sea, north of Venezuela. In 1986 it became a separate, autonomous member of the Kingdom of the Netherlands.", "HN": "2018(1974)", "MR": "20171211", "DA": "20170711", "DC": "4", "DX": "20180101", "UI": "D000073076"}, {"RECTYPE": "D", "MH": "Curacao", "AQ": "EH EP", "MN": "Z01.107.084.225", "MH_TH": "NLM (2016)", "ST": "T083", "MS": "Constituent country within the Kingdom of the Netherlands. Full autonomy in internal affairs was granted in 2010. It is an island located in the Caribbean Sea - north of Venezuela. (from CIA World Factbook)", "HN": "2018(2016)", "MR": "20171211", "DA": "20170711", "DC": "4", "DX": "20180101", "UI": "D000073096"}, {"RECTYPE": "D", "MH": "Sint Maarten", "AQ": "EH EP", "ENTRY": "St. Maarten|T083|NON|EQV|NLM (2018)|160926|abcdef", "MN": "Z01.107.084.450", "MH_TH": "NLM (2018)", "ST": "T083", "PI": "Caribbean Region (2000-2017)", "MS": "Dutch part of the island of Saint Martin in the Caribbean Sea; Sint Maarten lies east of the US Virgin Islands.", "HN": "2018; use Netherlands 2016-2017", "MR": "20161219", "DA": "20170711", "DC": "4", "DX": "20180101", "UI": "D000073097"}, {"RECTYPE": "D", "MH": "Cancer Survivors", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Survivors of Childhood Cancer|T101|NON|NRW|NLM (2020)|190408|abcdef", "ENTRY": "Survivorship, Cancer", "MN": "M01.860.350", "MH_TH": "NLM (2018)", "ST": "T101", "PI": "Survivors (2014-2017)", "MS": "Persons who have experienced prolonged survival with or following malignant neoplastic disease.", "PM": "2018", "HN": "2018", "MR": "20210305", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073116"}, {"RECTYPE": "D", "MH": "Sao Tome and Principe", "AQ": "EH EP", "MN": "Z01.639.040.847", "MH_TH": "NLM (1983)", "ST": "T083", "MS": "Islands in the Gulf of Guinea, just north of the Equator, and west of Gabon.", "HN": "2018(1986)", "MR": "20220708", "DA": "20170711", "DC": "4", "DX": "20180101", "UI": "D000073136"}, {"RECTYPE": "D", "MH": "Caribbean Netherlands", "AQ": "EH EP", "MN": "Z01.639.040.619", "MH_TH": "NLM (2018)", "ST": "T083", "MS": "A group Caribbean islands including Bonaire, Sint Eustatius, and Saba.", "HN": "2018", "MR": "20161216", "DA": "20170711", "DC": "4", "DX": "20180101", "UI": "D000073137"}, {"RECTYPE": "D", "MH": "Naja", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Water Cobras", "MN": "B01.050.150.900.833.672.562.750.612", "FX": "Elapid Venoms", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8638", "RR": "txid8608", "PI": "Elapidae (1994-2017)", "MS": "A genus of elapid snakes, also known as cobras, that are indigenous to Africa, Central and Southern Asia, and adjacent islands such as Taiwan and the Philippines.", "PM": "2018; see ELAPIDAE 1994-2017", "HN": "2018; use ELAPIDAE 1994-2017", "MR": "20230531", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073156"}, {"RECTYPE": "D", "MH": "Naja naja", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Naja philippinensis|T014|NON|NRW|NLM (2024)|230309|abcdef", "ENTRY": "Spectacled Cobras", "MN": "B01.050.150.900.833.672.562.750.612.500", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid35670", "RR": "txid8659", "PI": "Elapidae (1994-2017)", "MS": "Species of cobra (Naja) indigenous to the Indian Subcontinent, Southern Asia, and adjacent islands.", "PM": "2018; see ELAPIDAE 1994-2017", "HN": "2018; use ELAPIDAE 1994-2017", "MR": "20230531", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073176"}, {"RECTYPE": "D", "MH": "Naja haje", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Egyptian Cobras", "MN": "B01.050.150.900.833.672.562.750.612.250", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8639", "PI": "Elapidae (1994-2017)", "MS": "A species of cobra (Naja) that is indigenous primarily to Northern Africa.", "PM": "2018; see ELAPIDAE 1994-2017", "HN": "2018; use ELAPIDAE 1994-2017", "MR": "20230531", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073177"}, {"RECTYPE": "D", "MH": "Dendroaspis", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Mamba|T014|NON|EQV|NLM (1994)|921015|abcdef", "ENTRY": "Mamba, Jameson's", "MN": "B01.050.150.900.833.672.562.750.419", "FX": "Elapid Venoms", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8617", "RR": "txid8624", "PI": "Elapidae (1994-2017)", "MS": "A genus of highly venomous elapid snake indigenous to sub-Saharan Africa.", "PM": "2018; see ELAPIDAE 1994-2017", "HN": "2018; use ELAPIDAE 1994-2017", "MR": "20230531", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073178"}, {"RECTYPE": "D", "MH": "Hemachatus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Rinkhals|T014|NON|EQV|NLM (2024)|230305|abcdef", "ENTRY": "Ringhals|T014|NON|EQV|NLM (1994)|921123|abcdef", "MN": "B01.050.150.900.833.672.562.750.516", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8625", "PI": "Elapidae (1994-2017)", "MS": "A genus of elapid snake indigenous to Southern Africa. It is closely related to the cobras (Naja) and is capable of spitting its venom.", "PM": "2018; see ELAPIDAE 1994-2017", "HN": "2018; use ELAPIDAE 1994-2017", "MR": "20230531", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073179"}, {"RECTYPE": "D", "MH": "Hydrophiidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Aipysurus|T014|NON|NRW|NLM (2024)|230305|abcdef", "ENTRY": "Snake, Sea", "MN": "B01.050.150.900.833.672.562.750.564", "FX": "Elapid Venoms", "MH_TH": "NLM (2017)", "ST": "T014", "RN": "txid292440", "RR": "txid8677", "PI": "Elapidae (1994-2017)", "MS": "A subfamily of marine elapid snakes comprising about 50 species with flattened oar-like tails used as sculls. They are found mostly in the coastal waters of south Asia and Australia. The largest reach a length of almost 9 feet but most species are only about a third as long. They are all venomous. (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp331-3; Moore: Poisonous Snakes of the World, 1980, p159)", "PM": "2018; see ELAPIDAE 1994-2017", "HN": "2018; use ELAPIDAE 1994-2017", "MR": "20230531", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073180"}, {"RECTYPE": "D", "MH": "Coral Snakes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Sinomicrurus|T014|NON|NRW|NLM (2024)|230302|abcdef", "ENTRY": "Sonoran Coral Snakes", "MN": "B01.050.150.900.833.672.562.750.319", "FX": "Elapid Venoms", "MH_TH": "NLM (2018)", "ST": "T014", "RR": "txid8634", "PI": "Elapidae (1994-2017)", "MS": "Elapid snakes indigenous to the Southern United States, Central, South America, East, South and Southeast Asia. They are generally less than 1 meter in length and have colored ring patterns.", "PM": "2018; see ELAPIDAE 1994-2017", "HN": "2018; use ELAPIDAE 1994-2017", "MR": "20230531", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073181"}, {"RECTYPE": "D", "MH": "Carbapenem-Resistant Enterobacteriaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Carbapenemase-Producing Enterobacteriaceae|T007|NON|EQV|NLM (2018)|160923|abcdef", "MN": "B03.660.250.150.097", "FX": "beta-Lactam Resistance", "MH_TH": "NLM (2018)", "ST": "T007", "AN": "infection: coordinate with ENTEROBACTERIACEAE INFECTIONS ", "PI": "beta-Lactam Resistance (2008-2017)", "MS": "Strains of Enterobacteriaceae that are resistant to CARBAPENEMS, primarily due to the acquisition of carbapenemase (BETA-LACTAMASE) genes.", "PM": "2018", "HN": "2018", "MR": "20200902", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073182"}, {"RECTYPE": "D", "MH": "Platelet-Rich Fibrin", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Platelet Rich Fibrin", "MN": "A15.145.693.600.500", "FX": "Fibrin Tissue Adhesive", "MH_TH": "NLM (2018)", "ST": "T122", "PI": "Fibrin (1991-2017)", "MS": "A fibrin matrix derived from platelet-rich plasma that contains high concentration of BLOOD PLATELETS; LEUKOCYTES; CYTOKINES; and GROWTH FACTORS. It is used in a variety of clinical and TISSUE ENGINEERING applications.", "PM": "2018", "HN": "2018", "MR": "20180629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073183"}, {"RECTYPE": "D", "MH": "Integrative Oncology", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E02.190.463", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Complementary Therapies (2007-2017)", "MS": "These evidence-based therapies to reduce symptoms associated with treatment of cancer.", "PM": "2018", "HN": "2018", "MR": "20161219", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073196"}, {"RECTYPE": "D", "MH": "Ophiophagus hannah", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "King Cobras", "MN": "B01.050.150.900.833.672.562.750.806", "FX": "Elapid Venoms", "MH_TH": "NLM (2018)", "ST": "T014", "RN": "txid8665", "PI": "Snakes (1970-2017)", "MS": "The longest of all venomous snakes and largest Elapid. It is not a member of the Naja genus, although its hood resembles the hood of Naja species. Its bite can deliver large quantities of neurotoxic and cardiotoxic venom, consisting primarily of ALPHA-NEUROTOXINS. King cobras are indigenous to forests of India and Southeast Asia.", "PM": "2018", "HN": "2018", "MR": "20230531", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073197"}, {"RECTYPE": "D", "MH": "Mental Status and Dementia Tests", "AQ": "HI SN ST", "PRINT ENTRY": "Neurocognitive Test|T170|NON|NRW|NLM (2021)|200601|abcdef", "ENTRY": "Mental Status Test", "MN": "F04.711.513.603", "MH_TH": "NLM (2018)", "ST": "T170", "PI": "Neuropsychological Tests (1987-2017)", "MS": "Tests designed to assess various aspects of neurocognitive function or dementia.", "PM": "2018", "HN": "2018", "MR": "20200617", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073216"}, {"RECTYPE": "D", "MH": "Wisconsin Card Sorting Test", "AQ": "HI SN ST", "ENTRY": "Modified Wisconsin Card Sorting Test|T170|NAM|NRW|NLM (2018)|160830|abcdef", "MN": "F04.711.513.919", "MH_TH": "NLM (2018)", "ST": "T170", "PI": "Neuropsychological Tests (1984-2017)", "MS": "A neuropsychological test designed to assess EXECUTIVE FUNCTION typically assigned to the FRONTAL LOBE (e.g., abstract thinking, and strategic planning). The subjects are asked to sort numbered response cards according to different principles and to alter their approach during testing.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073218"}, {"RECTYPE": "D", "MH": "Memory and Learning Tests", "AQ": "HI SN ST", "PRINT ENTRY": "Memory And Learning Test|T170|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Test of Memory and Learning|T170|NAM|NRW|NLM (2018)|160830|abcdef", "MN": "F04.711.513.401", "MH_TH": "NLM (2018)", "ST": "T170", "PI": "Neuropsychological Tests (1978-2017)", "MS": "Tests designed to evaluate general and specific areas of behaviors and abilities associated with memory and/or learning.", "PM": "2018", "HN": "2018", "MR": "20200527", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073219"}, {"RECTYPE": "D", "MH": "Wechsler Memory Scale", "AQ": "HI SN ST", "ENTRY": "Brief Cognitive Status Exam|T170|NAM|NRW|NLM (2018)|160830|abcdef", "MN": "F04.711.513.401.500", "MH_TH": "NLM (2018)", "ST": "T170", "PI": "Wechsler Scales (1974-2017)", "MS": "A neuropsychological test designed to assess different memory functions. It may incorporate an optional cognitive exam (Brief Cognitive Status Exam) that helps to assess memory related cognitive function.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073220"}, {"RECTYPE": "D", "MH": "Patient Health Questionnaire", "AQ": "CL EC SN ST", "ENTRY": "Two-Item Generalised Anxiety Disorder Scale|T170|NON|NRW|NLM (2020)|181004|abcdef", "MN": "N06.850.520.308.980.485", "MH_TH": "NLM (2018)", "ST": "T170", "AN": "restrict to evaluation of mental health status", "PI": "Surveys and Questionnaires (1995-2017)", "MS": "A self-administered version of the Primary Care Evaluation of Mental Disorders (PRIME-MD), a diagnostic tool containing modules on multiple mental health disorders including anxiety, alcohol, eating, and somatoform modules. The Patient Health Questionnaire (PHQ-9) is designed specifically for mood/depression scoring each of the 9 DSM-IV criteria based on the mood module from the original PRIME-MD. The Generalized Anxiety Disorder scale (GAD-7) scores 7 common anxiety symptoms.", "PM": "2018", "HN": "2018", "MR": "20181010", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073222"}, {"RECTYPE": "D", "MH": "Information Technology", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Technology, Information", "MN": "L01.479", "MH_TH": "NLM (2018)", "ST": "T068", "MS": "Interconnected system that is used in the automatic acquisition, storage, manipulation, movement, control, display, interchange, transmission, routing or reception of data or information, including computers, ancillary equipment, system software, support services, and related resources. (NAL Agricultural Thesaurus)", "PM": "2018", "HN": "2018", "MR": "20161219", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073256"}, {"RECTYPE": "D", "MH": "Models, Spatial Interaction", "ENTRY": "Spatial Interaction Models", "MN": "E05.599.835.893", "MH_TH": "NLM (2018)", "ST": "T078", "MS": "Estimates of the flow of people, material or information between locations in geographic space.", "PM": "2018", "HN": "2018", "MR": "20161219", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073276"}, {"RECTYPE": "D", "MH": "Self-Management", "AQ": "EC ED ES HI MT PX SN TD", "ENTRY": "Management, Self", "MN": "N02.421.784.760", "MH_TH": "NLM (1992)", "ST": "T058", "PI": "Self Care (2015-2017)", "MS": "Individual's ability to manage the symptoms, treatment, physical and psychosocial consequences and lifestyle changes inherent in living with a chronic condition. Efficacious self-management encompasses ability to monitor one's condition and to affect the cognitive, behavioral, and emotional responses necessary to maintain a satisfactory quality of life.", "PM": "2018; see Self Care 1992-2017", "HN": "2018; use Self Care 1992-2017", "MR": "20180630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073278"}, {"RECTYPE": "D", "MH": "Noncommunicable Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Noninfectious Disease", "MN": "C23.550.291.898", "MH_TH": "NLM (2018)", "ST": "T047", "MS": "Diseases which are typically non-infectious in origin and do not transmit from an affected individual to others. The four main types of noncommunicable diseases are CARDIOVASCULAR DISEASES (e.g., heart attacks and stroke), CANCER, chronic respiratory diseases (e.g., CHRONIC OBSTRUCTIVE PULMONARY DISEASE and ASTHMA) and DIABETES MELLITUS.", "PM": "2018", "HN": "2018", "MR": "20220523", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073296"}, {"RECTYPE": "D", "MH": "Manual Lymphatic Drainage", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Massage, Lymphatic Drainage", "MN": "E02.831.535.867.880.750.500", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Massage (1967-2017)", "MS": "The application of massage to control EDEMA and improve circulation by manually moving excess lymph out of a tissue.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073297"}, {"RECTYPE": "D", "MH": "Addiction Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychiatry, Addiction", "MN": "H02.403.007", "MH_TH": "NLM (2018)", "ST": "T091", "PI": "Substance-Related Disorders (1990-2017)", "MS": "A medical specialty focused on the diagnosis and treatment of ADDICTIVE BEHAVIOR disorders, including SUBSTANCE-RELATED DISORDERS and IMPULSE CONTROL DISORDERS; and the management of co-occurring medical and psychiatric conditions", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073316"}, {"RECTYPE": "D", "MH": "Obesity Management", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Systems, Obesity Management", "MN": "N04.590.607.250", "FX": "Obesity", "MH_TH": "NLM (2018)", "ST": "T058", "PI": "Obesity (1975-2017)", "MS": "An integrated professional approach to screening, evaluation, control, and reduction of abnormal WEIGHT GAIN.", "PM": "2018", "HN": "2018", "MR": "20200221", "DA": "20170712", "DC": "1", "DX": "20180101", "UI": "D000073319"}, {"RECTYPE": "D", "MH": "Psycho-Oncology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psycho Oncology", "MN": "H02.720.500", "MH_TH": "NLM (2018)", "ST": "T091", "MS": "A specialty which deals with the interrelationship of physical, psychological, social, behavioral, and ethical aspects of cancer. Psycho-oncology examines the behavioral and psychosocial factors that may influence the course of the disease, cancer risk, prevention, and detection.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073320"}, {"RECTYPE": "D", "MH": "Whole Genome Sequencing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Sequencing, Whole Genome", "MN": "E05.393.760.700.825", "MH_TH": "NLM (2018)", "ST": "T063", "PI": "Sequence Analysis, DNA (1995-2017)", "MS": "Techniques to determine the entire sequence of the GENOME of an organism or individual.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073336"}, {"RECTYPE": "D", "MH": "Pictorial Works as Topic", "AQ": "CL ED ES HI PX SN TD", "MN": "K01.093.701", "MH_TH": "NLM (2018)", "ST": "T170", "MS": "Works that discuss pictures but not technical drawings.", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073356"}, {"RECTYPE": "D", "MH": "Mycobacterium abscessus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mycobacteroides abscessus subsp. massiliense|T007|NON|NRW|NLM (2021)|190918|abcdef", "ENTRY": "Mycobacterium massiliense|T007|NON|NRW|NLM (2018)|160909|abcdef", "MN": "B03.510.460.400.410.552.552.720.050", "MH_TH": "NLM (2018)", "ST": "T007", "RN": "txid36809", "RR": "txid319705", "AN": "infection: coordinate IM with MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS (IM)", "PI": "Mycobacterium (1969-2017)", "MS": "A rapidly growing non-tuberculous environmental mycobacterium causing OPPORTUNISTIC INFECTION that infects the skin and subcutaneous tissues. It is associated with HEALTH CARE ASSOCIATED INFECTION and causes serious lung infections in persons with various chronic lung diseases.", "PM": "2018", "HN": "2018", "MR": "20200902", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073358"}, {"RECTYPE": "D", "MH": "Exome Sequencing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Transcriptome Sequencings, Complete", "MN": "E05.393.760.700.825.500", "MH_TH": "NLM (2023)", "ST": "T059", "PI": "Sequence Analysis, DNA (2010-2017)", "MS": "Techniques used to determine the sequences of EXONS of an organism or individual.", "PM": "2023; see WHOLE EXOME SEQUENCING 2018-2022", "HN": "2023 (2018)", "MR": "20220408", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073359"}, {"RECTYPE": "D", "MH": "Epileptic Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromic Epilepsy", "MN": "C10.228.140.490.493", "MH_TH": "NLM (2018)", "ST": "T047", "PI": "Epilepsy (1963-2017)", "MS": "EPILEPTIC SEIZURES that are of similar type and age of onset and have other similar features (e.g., clinical course, EEG findings, genetic association and neuropathology).", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073376"}, {"RECTYPE": "D", "MH": "Metal-Organic Frameworks", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Porous Coordination Polymer|T109|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Polymers, Porous Coordination", "MN": "D05.750.215", "MH_TH": "NLM (2018)", "ST": "T109", "RN": "0", "PI": "Organometallic Compounds (2005-2017)", "MS": "Supramolecular networks that consist of ordered arrangements of organic electron donor linkers (usually ditopic or polytopic organic carboxylates) and metal cations. They can have an extremely high surface area and adjustable pore size that allows for the insertion of other molecules capable of various functions such as catalysis, capture of carbon dioxide, and drug delivery.", "PM": "2018", "HN": "2018", "MR": "20200527", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073396"}, {"RECTYPE": "D", "MH": "Occupational Stress", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Workplace Abuse|T048|NON|REL|NLM (2022)|210104|abcdef", "ENTRY": "Workplace Stresses", "MN": "F02.830.900.666", "MH_TH": "NLM (2018)", "ST": "T048", "PI": "Stress, Psychological (1973-2017)", "MS": "Adverse psychological and behavioral reactions caused by the pressures and demands of employers or clients or other factors, such as the physical environment of the workplace, WORKPLACE VIOLENCE; or WORKPLACE BULLYING.", "PM": "2018", "HN": "2018", "MR": "20230531", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073397"}, {"RECTYPE": "D", "MH": "Demethylation", "AQ": "DE RE", "ENTRY": "Oxidative Demethylations", "MN": "G03.219.500", "MH_TH": "NLM (2018)", "ST": "T070", "MS": "Removal of one or more methyl groups from a chemical compound.", "PM": "2018", "HN": "2018", "MR": "20170628", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073398"}, {"RECTYPE": "D", "MH": "DNA Demethylation", "AQ": "DE RE", "ENTRY": "Demethylations, DNA", "MN": "G03.219.500.500", "MH_TH": "NLM (2018)", "ST": "T070", "PI": "DNA Methylation (1997-2017)", "MS": "Removal of methyl groups from DNA by enzymes (such as DIOXYGENASES and N-DEMETHYLASES) or by chemical reagents.", "PM": "2018", "HN": "2018", "MR": "20170628", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073399"}, {"RECTYPE": "D", "MH": "Dietary Sugars", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sugars, Dietary|T109|T168|NON|EQV|NLM (1997)|960301|abbcdef", "ENTRY": "Sugar, Dietary", "MN": "J02.500.362.831", "MH_TH": "NLM (1997)", "ST": "T168", "RN": "0", "AN": "/adv eff: coordinate with disease /etiol, not /chem ind; /ther use: coordinate with specific disease /diet ther", "PI": "Dietary Sucrose (1964-2017)", "MS": "MONOSACCHARIDES and DISACCHARIDES present in food, such as those present in fruits and vegetables and milk products, or those added to food such as DIETARY SUCROSE (table sugar) or HIGH FRUCTOSE CORN SYRUP.", "PM": "2018; see DIETARY SUCROSE 1997-2017", "HN": "2018; use DIETARY SUCROSE 1997-2017", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073417"}, {"RECTYPE": "D", "MH": "Microvascular Rarefaction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vascular Rarefactions", "MN": "C23.300.818", "MH_TH": "NLM (2018)", "ST": "T046", "MS": "The reduction in density of the MICROVASCULATURE.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073436"}, {"RECTYPE": "D", "MH": "Multitasking Behavior", "AQ": "DE ES PH RE", "ENTRY": "Multitasking Behaviors", "MN": "F01.145.666", "MH_TH": "NLM (2018)", "ST": "T055", "MS": "Simultaneous task performance, or switching between tasks in a concentrated period of time.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073456"}, {"RECTYPE": "D", "MH": "Data Warehousing", "AQ": "CL EC ES HI LJ MT SN ST TD", "ENTRY": "Warehousing, Data", "MN": "L01.470.688", "MH_TH": "NLM (2018)", "ST": "T066", "MS": "A system for storing electronic data derived from various sources.", "PM": "2018", "HN": "2018", "MR": "20190708", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073458"}, {"RECTYPE": "D", "MH": "Laticauda", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Sea Kraits", "MN": "B01.050.150.900.833.672.562.750.576", "MH_TH": "NLM (2018)", "ST": "T014", "RN": "txid8627", "PI": "Elapidae (1994-2017)", "MS": "A genus of semi-aquatic elapid snake that inhabits coastal waters of the tropical Indian and Western Pacific Oceans.", "PM": "2018; see ELAPIDAE 1994-2017", "HN": "2018; use ELAPIDAE 1994-2017", "MR": "20230531", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073476"}, {"RECTYPE": "D", "MH": "Frailty", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Debility|T046|NON|REL|NLM (2020)|190118|abcdef", "ENTRY": "Frailties", "MN": "C23.550.359", "FX": "Asthenia", "MH_TH": "NLM (2018)", "ST": "T046", "AN": "coordinate with FRAIL ELDERLY if pertinent", "PI": "Frail Elderly (1990-2017)", "MS": "A state of increased vulnerability to stressors, following declines in function and reserves across multiple physiologic systems, characterized by MUSCLE WEAKNESS; FATIGUE; slowed motor performance; low physical activity; and unintentional weight loss.", "PM": "2018", "HN": "2018", "MR": "20190222", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073496"}, {"RECTYPE": "D", "MH": "Contraceptive Effectiveness", "AQ": "SN", "ENTRY": "Failures, Contraceptive", "MN": "E02.875.194.573", "FX": "Pregnancy, Unplanned", "MH_TH": "NLM (2018)", "ST": "T081", "MS": "The rate of success or failure of a method of CONTRACEPTION; CONTRACEPTIVE AGENTS; or CONTRACEPTIVE DEVICES.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073516"}, {"RECTYPE": "D", "MH": "Biological Variation, Population", "AQ": "DE EH GE IM PH RE", "ENTRY": "Variations, Population Biological", "MN": "G16.117", "FX": "Reference Values", "MH_TH": "NLM (2018)", "ST": "T081", "MS": "Differences in measurable biological values, characteristics, or traits, among individuals of a population or between population groups.", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073537"}, {"RECTYPE": "D", "MH": "Burkholderiales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090", "MH_TH": "NLM (2018)", "ST": "T007", "RN": "txid80840", "PI": "Betaproteobacteria (2008-2017)", "MS": "An order of gram-negative bacteria of the class BETAPROTEOBACTERIA which include highly pathogenic species such as BURKHOLDERIA; BORDETELLA; and RALSTONIA.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073556"}, {"RECTYPE": "D", "MH": "Campylobacteraceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.150.235.250", "MH_TH": "NLM (2018)", "ST": "T007", "RN": "txid72294", "PI": "Campylobacter (1994-2017)", "MS": "A large and diverse group in the order CAMPYLOBACTERALES, individual species of which grow in aerobic and anaerobic conditions as free-living, commensal, or pathogenic forms.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073557"}, {"RECTYPE": "D", "MH": "Caryophyllales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Caryophyllale", "MN": "B01.875.800.575.912.250.198.500", "MH_TH": "NLM (2018)", "ST": "T002", "RN": "txid3524", "MS": "Diverse and ecologically specialized dicotyledonous flowering plants that include trees, annuals, shrubs, lianas, mangroves, stem or leaf succulents, and insectivores; acting as important food sources in many cases.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073559"}, {"RECTYPE": "D", "MH": "Chromadorea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Chromadoreas", "MN": "B01.050.500.500.294.400", "MH_TH": "NLM (2018)", "ST": "T204", "RN": "txid119089", "MS": "A class of invertebrate freshwater roundworms of the phylum NEMATODA. Most members are parasites with well-adapted body surfaces and sophisticated esophageal glands and pharynx.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073560"}, {"RECTYPE": "D", "MH": "Clostridiaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.353.625.375", "MH_TH": "NLM (2018)", "ST": "T007", "RN": "txid31979", "MS": "A non-sulfate spore-forming anaerobic family of Gram-positive bacteria, of the class clostridia.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073561"}, {"RECTYPE": "D", "MH": "Crotalinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Sistrurus|T014|NON|NRW|NLM (2024)|230303|abcdef", "ENTRY": "Viper, Pit", "MN": "B01.050.150.900.833.672.562.875.240", "MH_TH": "NLM (2018)", "ST": "T014", "RN": "txid8710", "RR": "txid8755", "MS": "A subfamily of snakes commonly known as pit vipers, crotaline snakes, or pit adders in the family VIPERIDAE. They are distinguished by a deep pit called a fossa or loreal, which functions as a heat-sensing organ located between the eye and nostril on either side of the head.", "PM": "2018; see Viperidae 1994-2017", "HN": "2018; use Viperidae 1994-2017", "MR": "20230531", "DA": "20170712", "DC": "1", "DX": "20180101", "UI": "D000073562"}, {"RECTYPE": "D", "MH": "Culicomorpha", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.720.500.500.750.712.500", "MH_TH": "NLM (2018)", "ST": "T204", "RN": "txid43786", "MS": "Insects of the order DIPTERA, suborder NEMATOCERA. They include mosquitoes, gnats, black flies, and true flies.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073563"}, {"RECTYPE": "D", "MH": "Desulfovibrionaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.900.360", "MH_TH": "NLM (2018)", "ST": "T007", "RN": "txid194924", "PI": "Desulfovibrio (2015-2017)", "MS": "A family of obligately anaerobic Gram-negative bacteria of the order Desulfovibrionales, class DELTAPROTEOBACTERIA. Majority are sulfate-reducing.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073564"}, {"RECTYPE": "D", "MH": "Eutheria", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Placental Mammal", "MN": "B01.050.150.900.649.313", "MH_TH": "NLM (2018)", "ST": "T015", "RN": "txid9347", "PI": "Mammals (1963-2017)", "MS": "Mammals which nourish their young in utero by means of a complex placenta, and give birth to their young alive. They include PRIMATES; CARNIVORA, WHALES; RUMINANTS; BATS; and RODENTS.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073566"}, {"RECTYPE": "D", "MH": "Fagales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.750", "MH_TH": "NLM (2018)", "ST": "T002", "RN": "txid3502", "MS": "Order of dicotyledonous flowering plants in the superorder ROSANAE, and class MAGNOLIOPSIDA. They include birch, beech, bayberry, and walnut species.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073567"}, {"RECTYPE": "D", "MH": "Feliformia", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Feliformias", "MN": "B01.050.150.900.649.313.750.377", "MH_TH": "NLM (2018)", "ST": "T015", "RN": "txid379583", "MS": "A suborder of cat-like mammals in the order CARNIVORA. Examples include HYENAS; MONGOOSES; CIVETS; and related species. They are distinguishable from dog-like carnivores.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073568"}, {"RECTYPE": "D", "MH": "Helicobacteraceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.150.235.500", "MH_TH": "NLM (2018)", "ST": "T007", "RN": "txid72293", "MS": "A family of Gram-negative bacteria of the order CAMPYLOBACTERALES that have a helical shape, and occur in the mammalian digestive track.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073569"}, {"RECTYPE": "D", "MH": "Laurales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Monimiale", "MN": "B01.875.800.575.912.250.595", "MH_TH": "NLM (2018)", "ST": "T002", "RN": "txid3432", "MS": "Order of flowering plants in the superorder Magnolianae. Common examples are bay laurel, AVOCADO; sassafras and CINNAMON.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073571"}, {"RECTYPE": "D", "MH": "Faith-Based Organizations", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Organizations, Faith-Based", "MN": "N03.540.297", "MH_TH": "NLM (2018)", "ST": "T095", "PI": "Charities (1966-2017)", "MS": "Organizations such as (1) congregations; (2) national networks, which include national denominations, their social service arms (for example, Catholic Charities, Lutheran Social Services), and networks of related organizations (such as YMCA and YWCA); and (3) freestanding religious organizations, which are incorporated separately from congregations and national networks. http://www.huduser.gov/portal/publications/faithbased.pdf", "PM": "2018", "HN": "2018", "MR": "20170114", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073576"}, {"RECTYPE": "D", "MH": "Shift Work Schedule", "AQ": "AE CL EC LJ PX SN ST", "ENTRY": "Work Schedule, Shift", "MN": "N04.452.677.650.250", "FX": "Work Schedule Tolerance", "MH_TH": "NLM (2018)", "ST": "T037", "PI": "Work Schedule Tolerance (1982-2017)", "MS": "Job schedule in which working hours deviate from the standard hours (e.g., evening shift, night shift or rotating shift).", "PM": "2018", "HN": "2018", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073577"}, {"RECTYPE": "D", "MH": "Stakeholder Participation", "AQ": "HI PX", "ENTRY": "Stakeholder Roles", "MN": "I03.743", "MH_TH": "NLM (2018)", "ST": "T054", "MS": "A process between an entity and those groups or individuals potentially or actually impacted by the actions of that entity over a range of activities and approaches.", "PM": "2018", "HN": "2018", "MR": "20180227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073597"}, {"RECTYPE": "D", "MH": "Health Risk Behaviors", "AQ": "CL DE ES PH RE", "ENTRY": "Risky Health Behaviors", "MN": "F01.145.488.250", "FX": "Risk-Taking", "MH_TH": "NLM (2018)", "ST": "T055", "AN": "coordinate with specific type of behavior (e.g. DRIVING UNDER THE INFLUENCE)", "PI": "Health Behavior (2006-2017)", "MS": "Pattern of behavior which predisposes certain individuals to increased risk for contracting disease or sustaining personal injury. These behaviors may cluster into a risky lifestyle.", "PM": "2018", "HN": "2018", "MR": "20170208", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073599"}, {"RECTYPE": "D", "MH": "Diet, High-Protein", "AQ": "AE CL EC EH HI IS MO MT NU PX SN ST TD VE", "ENTRY": "High-Protein Diets", "MN": "G07.203.650.240.269", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Dietary Proteins (1963-2017)", "MS": "A diet that includes foods with a high protein content.", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073600"}, {"RECTYPE": "D", "MH": "Dietary Approaches To Stop Hypertension", "AQ": "AE CL EC EH HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Diets, DASH", "MN": "G07.203.650.240.320", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Hypertension/diet therapy (1995-2017)", "MS": "Dietary recommendations that promote reduction in or prevention of high blood pressure. Recommendations include increasing intake of fruits and vegetables, and high-fiber, low-fat foods and reducing the intake of DIETARY SODIUM and high fat foods.", "PM": "2018", "HN": "2018", "MR": "20230630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073601"}, {"RECTYPE": "D", "MH": "Antimicrobial Stewardship", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Stewardship, Antimicrobial", "MN": "N05.700.900.300.500", "MH_TH": "NLM (2018)", "ST": "T058", "PI": "Drug Utilization Review (1995-2017)", "MS": "Programs and guidelines for selecting optimal ANTI-INFECTIVE AGENTS regimens in an effort to maintain antibiotic efficacy, reduce CROSS INFECTION related to ANTIBIOTIC RESISTANCE while managing satisfactory clinical and economic outcomes.", "PM": "2018", "HN": "2018", "MR": "20170410", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073602"}, {"RECTYPE": "D", "MH": "Spotted Fever Group Rickettsiosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Rickettsialpox|T047|NON|NRW|UNK (19XX)|810302|abcdef", "ENTRY": "Typhus, Queensland Tick", "MN": "C01.920.930.887", "MH_TH": "NLM (2018)", "ST": "T047", "AN": "coordinate IM with Rickettsia species if pertinent, but note specifics", "PI": "Rocky Mountain Spotted Fever (1963-2017)", "MS": "A group of arthropod-borne diseases caused by spotted fever bio-group members of RICKETTSIA. They are characterized by fever, headache, and petechial (spotted) rash.", "PM": "2018", "HN": "2018", "MR": "20190613", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073605"}, {"RECTYPE": "D", "MH": "Transfusion-Related Acute Lung Injury", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Transfusion Related Acute Lung Injury", "MN": "C20.920.500", "MH_TH": "NLM (2018)", "ST": "T046", "PI": "Transfusion Reaction (2014-2017)", "MS": "A rare but serious transfusion-related reaction in which fluid builds up in the lungs unrelated to excessively high infusion rate and/or volume (TRANSFUSION-ASSOCIATED CIRCULATORY OVERLOAD). Signs of Transfusion-Related Acute Lung Injury include pulmonary secretions; hypotension; fever; DYSPNEA; TACHYPNEA; TACHYCARDIA; and CYANOSIS.", "PM": "2018", "HN": "2018", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073617"}, {"RECTYPE": "D", "MH": "Varicella Zoster Virus Infection", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Congenital Varicella Syndrome|T047|NON|NRW|NLM (2018)|161007|abcdef", "MN": "C01.925.256.466.930", "MH_TH": "NLM (2018)", "ST": "T047", "AN": "CHICKENPOX; HERPES ZOSTER; and ENCEPHALITIS, HERPES ZOSTER are also available", "PI": "Herpesvirus 3, Human (1970-2017)", "MS": "Infection caused by HUMAN HERPES VIRUS 3 (e.g., CHICKENPOX and HERPES ZOSTER).", "PM": "2018", "HN": "2018", "MR": "20190618", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073618"}, {"RECTYPE": "D", "MH": "Pre-Analytical Phase", "AQ": "CL EC ES HI IS MT SN ST TD", "ENTRY": "Preanalytical Phases", "MN": "E01.370.225.955", "MH_TH": "NLM (2018)", "ST": "T062", "MS": "Laboratory processes prior to specimen analysis. These processes include study design, compliance of the subjects investigated, compliance in adherence to protocols, choice of specimens utilized and sample collection.", "PM": "2018", "HN": "2018", "MR": "20180613", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073623"}, {"RECTYPE": "D", "MH": "Symbolic Interactionism", "ENTRY": "Symbolic Interactionisms", "MN": "K01.752.798.750", "MH_TH": "NLM (2018)", "ST": "T054", "PI": "Symbolism (2005-2017)", "MS": "Theoretical approach to social processes with a fundamental concern with power phenomena. There is a focus on the analysis of culture, the influence of Foucault, and the development of feminist perspectives.", "PM": "2018", "HN": "2018", "MR": "20170114", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073624"}, {"RECTYPE": "D", "MH": "Oligodendrocyte Precursor Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Progenitors, Oligodendrocyte", "MN": "A11.872.653.500", "MH_TH": "NLM (2018)", "ST": "T025", "PI": "Oligodendroglia (1984-2017)", "MS": "Neuroglial cells that first appear during mid-embryogenesis in the central nervous system of mammals and give rise to OLIGODENDROCYTES. Mitotically-active populations remain through late adulthood and are capable of regenerating MYELIN lost to disease or injury.", "PM": "2018", "HN": "2018", "MR": "20170117", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073637"}, {"RECTYPE": "D", "MH": "Alphacoronavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "HKU10, Bat coronavirus", "MN": "B04.820.578.500.540.150.075", "MH_TH": "NLM (2018)", "ST": "T005", "RN": "txid693996", "RR": "txid694001", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS", "PI": "Coronaviridae (2011-2017)", "MS": "A genus of the family CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of mammals. Human alphacoronaviruses include Human coronavirus 229E and NL63. All members share the identical core transcription regulatory sequences of 5\u2019-CUAAAC-3\u2019 and most have 1 to 2 ORFs downstream to the N protein gene.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073638"}, {"RECTYPE": "D", "MH": "Alphacoronavirus 1", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.578.500.540.150.075.500", "MH_TH": "NLM (2018)", "ST": "T005", "RN": "txid693997", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS ", "PI": "Coronavirus (2011-2017)", "MS": "The type species of ALPHACORONAVIRUS genus causing gastroenteritis, peritonitis and respiratory diseases in dogs, cats and swine. Previously separate species TRANSMISSIBLE GASTROENTERITIS VIRUS; PORCINE RESPIRATORY CORONAVIRUS; CANINE CORONAVIRUS AND FELINE CORONAVIRUS merged into this species on the basis of similar genome nucleotide sequence and genome organization.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073639"}, {"RECTYPE": "D", "MH": "Betacoronavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Betacoronaviruses", "MN": "B04.820.578.500.540.150.113", "MH_TH": "NLM (2018)", "ST": "T005", "RN": "txid694002", "RR": "txid694008", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS", "PI": "Coronaviridae (2011-2017)", "MS": "A genus of the family CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of mostly mammals. Human betacoronaviruses include HUMAN ENTERIC CORONAVIRUS; HUMAN CORONAVIRUS OC43; MERS VIRUS; and SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS. Members have either core transcription regulatory sequences of 5\u2019-CUAAAC-3\u2019 or 5\u2019-CUAAAC-3\u2019 and mostly have no ORF downstream to the N protein gene.", "PM": "2018", "HN": "2018", "MR": "20220715", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073640"}, {"RECTYPE": "D", "MH": "Betacoronavirus 1", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Porcine hemagglutinating encephalomyelitis virus|T005|NON|NRW|NLM (1994)|921116|PORCINE HEMAGGLUTINATING ENCEPH VIRUS|abcdefv", "ENTRY": "Human enteric coronaviruses", "MN": "B04.820.578.500.540.150.113.500", "MH_TH": "NLM (2018)", "ST": "T005", "RN": "txid694003", "RR": "txid42005", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS", "PI": "Coronaviridae (2012-2017)", "MS": "The type species of BETACORONAVIRUS genus causing gastroenteritis respiratory diseases in mammals. Previously separate species HUMAN CORONAVIRUS OC43; BOVINE CORONAVIRUS; Human enteric coronavirus; Equine coronavirus; and Porcine hemagglutinating encephalomyelitis virus merged into this species on the basis of similar genome nucleotide sequence and genome organization.", "PM": "2018; for PORCINE HEMAGGLUTINATING ENCEPHALOMYELITIS VIRUS see CORONAVIRUS 1994-2017", "HN": "2018; for PORCINE HEMAGGLUTINATING ENCEPHALOMYELITIS VIRUS use CORONAVIRUS 1994-2017", "MR": "20200902", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073641"}, {"RECTYPE": "D", "MH": "Gammacoronavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Gammacoronaviruses", "MN": "B04.820.578.500.540.150.400", "MH_TH": "NLM (2018)", "ST": "T005", "RN": "txid694013", "RR": "txid694014", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS ", "PI": "Coronaviridae (2012-2017)", "MS": "A genus of the family CORONAVIRIDAE that causes respiratory or gastrointestinal disease in avian species (or birds). The type species, AVIAN CORONAVIRUS, includes the previously separate species TURKEY CORONAVIRUS; and INFECTIOUS BRONCHITIS VIRUS.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073642"}, {"RECTYPE": "D", "MH": "Healthy Aging", "AQ": "BL CF DE EH ES GE IM ME PA PH PX RE UR", "ENTRY": "Well, Aging", "MN": "F01.829.458.205.250", "MH_TH": "NLM (2018)", "ST": "T079", "PI": "Aging (1963-2017)", "MS": "The development and maintenance of optimal physical, mental, spiritual, and social well-being and function with advancing age.", "PM": "2018", "HN": "2018", "MR": "20170117", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073656"}, {"RECTYPE": "D", "MH": "Loss of Function Mutation", "AQ": "DE GE IM PH RE", "ENTRY": "Null Mutations", "MN": "G05.365.590.538", "MH_TH": "NLM (2018)", "ST": "T045", "PI": "Mutation (1989-2017)", "MS": "A mutation that causes a decrease in or elimination of a gene product's activity.", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073658"}, {"RECTYPE": "D", "MH": "Gain of Function Mutation", "AQ": "DE GE IM PH RE", "ENTRY": "Mutations, Activation", "MN": "G05.365.590.288", "MH_TH": "NLM (2018)", "ST": "T045", "PI": "Mutation (1993-2017)", "MS": "A mutation that results in an increase in a gene's activity or in acquiring a new molecular function or a new pattern of gene expression.", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073659"}, {"RECTYPE": "D", "MH": "Water Sports", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Water Sport", "MN": "I03.450.642.845.945", "MH_TH": "NLM (2018)", "ST": "T056", "MS": "Activities or games performed in a body of water.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073678"}, {"RECTYPE": "D", "MH": "Pancreatitis-Associated Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Regenerating Islet-Derived Protein|T116|T123|NON|EQV|NLM (2022)|201006|abbcdef", "ENTRY": "Regenerating Islet Derived Proteins", "MN": "D23.101.140.780", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "MS": "C-type lectins that restrict growth of bacteria in the intestinal epithelia and have bactericidal activity against gram-positive and gram-negative bacteria. They also regulate proliferation and differentiation of KERATINOCYTES following injury. Human pancreatitis-associated protein-1 (Reg3a) is overexpressed by pancreatic ACINAR CELLS in patients with CHRONIC PANCREATITIS. It is also highly expressed by pancreatic, bladder, and gastrointestinal cancer cells and may serve as a diagnostic biomarker.", "PM": "2018; PANCREATITIS-ASSOCIATED PROTEINS was indexed under PROTEINS 1992-1995, ACUTE-PHASE PROTEINS 1996-2001, CALCIUM-BINDING PROTEINS 2002 and LECTINS, C-TYPE 2003-2017", "HN": "2018 (1992)", "MR": "20210510", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073718"}, {"RECTYPE": "D", "MH": "2-Hydroxypropyl-beta-cyclodextrin", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta Hydroxypropylcyclodextrin", "MN": "D09.698.365.855.400.375.333.500", "MH_TH": "NLM (1987)", "ST": "T121", "RN": "1I96OHX6EK", "RR": "94035-02-6", "MS": "Derivative of beta-cyclodextrin that is used as an excipient for steroid drugs and as a lipid chelator.", "PM": "2018; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN was indexed under BETA-CYCLODEXTRINS 1987-2017", "HN": "2018(1987)", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073738"}, {"RECTYPE": "D", "MH": "Strobilurins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inhibitors, Quinone Outside", "MN": "D02.241.081.069.600.575", "MH_TH": "NLM (2018)", "ST": "T131", "RN": "0", "PI": "Methacrylates (1981-2017)", "MS": "Benzene or pyrimidine derivatives of methacrylic acid that block the Qo site of CYTOCHROME B. They are widely used as agricultural fungicides.", "PM": "2018", "HN": "2018", "MR": "20170117", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073739"}, {"RECTYPE": "D", "MH": "Nonlinear Optical Microscopy", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Raman Microscopy, Stimulated", "MN": "E05.595.717", "MH_TH": "NLM (2018)", "ST": "T059", "MS": "Microscopic imaging techniques that utilize nonlinear responses of light-matter interactions which occur with high-intensity illumination, such as from LASERS, and specialized light signal detection instrumentation to produce images without the need for dyes or fluorescent labels.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073758"}, {"RECTYPE": "D", "MH": "P-type ATPases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "P-type Adenosine Triphosphatase|T116|T126|NON|EQV|NLM (2021)|200227|abbcdef", "ENTRY": "Type Atpase, P", "MN": "D12.776.543.585.813", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.6.3.-", "PI": "Adenosine Triphosphatases (1992-2017)", "MS": "A highly conserved family of ATPases that facilitate the transport of lipids and cations across the plasma membrane. Structurally, they are elongated ALPHA-HELICES constituting five functionally distinct domains: three cytoplasmic domains A, N, and P which contain the catalytic sites, and two transmembrane domains. The N domain phosphorylates the P-domain at an invariant ASPARTATE residue, which, in turn, is dephosphorylated by the A domain.  The phosphorylation and dephosphorylation cycles drive conformational changes in the protein between two states (E1 and E2), which allow the substrate to access the other side of the membrane.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073779"}, {"RECTYPE": "D", "MH": "Second Harmonic Generation Microscopy", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Third Harmonic Generation Microscopy|T059|NON|REL|NLM (2018)|161129|abcdef", "MN": "E05.595.717.500", "MH_TH": "NLM (2018)", "ST": "T059", "MS": "A microscopic imaging technique that takes advantage of the process of harmonic generation that occurs when photons interact to generate new photons of a different wavelength. In second harmonic generation, two photons of the same wavelength and frequency, such as from a LASER, interact inside a medium and are converted to a photon of twice the frequency and half of the wavelength of the two incident photons. The light signals captured are used to produce images that are dependent on the unique optical properties of the material.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073798"}, {"RECTYPE": "D", "MH": "Pain, Procedural", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Procedural Pain", "MN": "C23.888.592.612.860", "MH_TH": "NLM (2018)", "ST": "T067", "PI": "Pain (1991-2017)", "MS": "Pain associated with examination, treatment or procedures.", "PM": "2018", "HN": "2018", "MR": "20170504", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073818"}, {"RECTYPE": "D", "MH": "Self-Directed Learning as Topic", "AQ": "CL DE ES PH RE", "ENTRY": "Self Directed Learning as Topic", "MN": "I02.903.771", "MH_TH": "NLM (2018)", "ST": "T052", "PI": "Learning (1966-2017)", "MS": "Process in which individuals take the initiative, in diagnosing their learning needs, formulating learning goals, identifying resources for learning, choosing and implementing learning strategies and evaluating learning outcomes (Knowles, 1975)", "PM": "2018", "HN": "2018", "MR": "20170114", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073819"}, {"RECTYPE": "D", "MH": "Scholarly Communication", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Scholarly Communications", "MN": "L01.143.910.500", "MH_TH": "NLM (2018)", "ST": "T170", "MS": "System through which research and other scholarly writings are created, evaluated for quality, disseminated to the scholarly community, and preserved for future use. It includes both formal means of communication, such as publication in peer-reviewed journals, and informal channels, such as electronic listservs. (from Association of College & Research Libraries, \u201cPrinciples and Strategies for the Reform of Scholarly Communication 1,\u201d 2003)", "PM": "2018", "HN": "2018", "MR": "20170124", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073820"}, {"RECTYPE": "D", "MH": "Trisomy 13 Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pataus Syndrome", "MN": "C16.320.180.923", "MH_TH": "ORD (2010)", "ST": "T019", "MS": "A chromosome disorder associated with TRISOMY of all or part of CHROMOSOME 13. Clinical manifestations include CONGENITAL HEART DEFECTS (e.g., PATENT DUCTUS ARTERIOSUS), facial malformations (e.g., CLEFT LIP; CLEFT PALATE; COLOBOMA; MICROPHTHALMIA); HYPOTONIA, digit malformations (e.g., POLYDACTYLY or SYNDACTYLY), and SEIZURES and severe INTELLECTUAL DISABILITY associated with NERVOUS SYSTEM MALFORMATIONS.", "PM": "2018; TRISOMY 13 SYNDROME was indexed under TRISOMY; CHROMOSOMES, HUMAN, PAIR 13; and CHROMOSOME DISORDERS 2010-2017", "HN": "2018(2010)", "MR": "20190701", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073839"}, {"RECTYPE": "D", "MH": "Copper-Transporting ATPases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Wilson Disease Cu-Binding P Type ATPase|T116|T126|ABX|NRW|NLM (1995)|181205|abbcdef", "ENTRY": "Wilson Disease Cu Binding P Type ATPase", "MN": "D12.776.543.585.813.500", "FX": "Menkes Kinky Hair Syndrome", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 7.2.2.8", "RR": "EC 3.6.3.54", "MS": "P-type ATPases which transport copper ions across membranes in prokaryotic and eukaryotic cells. They possess a conserved CYSTEINE-HISTIDINE-SERINE (CPx) amino acid motif within their transmembrane helices that functions in cation translocation and catalytic activation, and an N-terminal copper-binding CxxC motif that regulates enzyme activity. They play essential roles in intracellular copper homeostasis through regulating the uptake, efflux and storage of copper ions, and in cuproprotein biosynthesis.", "PM": "2018; COPPER-TRANSPORTING ATPASES was indexed under ADENOSINE TRIPHOSPHATASES and CATION TRANSPORT PROTEINS 1994-2017", "HN": "2018 (1994)", "MR": "20190429", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073840"}, {"RECTYPE": "D", "MH": "Trisomy 18 Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Trisomy 18 Syndromes", "MN": "C16.320.180.932", "MH_TH": "GHR (2014)", "ST": "T047", "MS": "A chromosome disorder associated with TRISOMY of all or part of CHROMOSOME 18. Clinical manifestations include INTRAUTERINE GROWTH RETARDATION; CLEFT PALATE; CONGENITAL HEART DEFECTS; MICROCEPHALY; MICROGNATHIA and clenched fists with overlapping fingers. Most affected fetuses do not survive to birth. Those who survive through their first year often have severe INTELLECTUAL DISABILITY.", "PM": "2018; TRISOMY 18 was indexed under CHROMOSOMES, HUMAN, PAIR 18; and TRISOMY 2014-2017", "HN": "2018", "MR": "20180523", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073842"}, {"RECTYPE": "D", "MH": "Equivalence Trial", "ENTRY": "Superiority Trial|T078|NON|NRW|NLM (2018)|170114|abcdef", "MN": "V03.175.250.500.500.125", "MH_TH": "NLM (2018)", "ST": "T078", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific equivalence trial; a different heading EQUIVALENCE TRIALS AS TOPIC is used for general design, methodology, economics, etc. of equivalence trials", "PI": "Randomized Controlled Trial (2006-2017)", "MS": "Trial that aims to show a new treatment is no better and no worse than the standard treatment.", "HN": "2018", "MR": "20180124", "DA": "20170711", "DC": "2", "DX": "20180101", "UI": "D000073843"}, {"RECTYPE": "D", "MH": "Tobacco, Waterpipe", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "ENTRY": "Water Pipe Tobacco", "MN": "J01.637.767.844.750", "MH_TH": "NLM (2018)", "ST": "T073", "PI": "Smoking (2014-2017)", "MS": "Flavored tobacco whose vapor or smoke is passed through a water basin before inhalation.", "PM": "2018", "HN": "2018", "MR": "20170503", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073846"}, {"RECTYPE": "D", "MH": "Smoking, Non-Tobacco Products", "AQ": "AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PC PP PX TD TH UR", "ENTRY": "Smokings, Non-Tobacco Products", "MN": "F01.145.805.250", "FX": "Heroin Dependence", "MH_TH": "NLM (2018)", "ST": "T055", "MS": "SMOKING of non-TOBACCO (or NICOTINE-containing) substances.", "PM": "2018", "HN": "2018", "MR": "20180702", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073847"}, {"RECTYPE": "D", "MH": "Survivorship", "MN": "F01.058.144.500", "FX": "Survivors", "MH_TH": "NLM (1980)", "ST": "T053", "MS": "Functional, psychosocial, emotional and spiritual domains and needs of patients and families following life-threatening disease or events.", "PM": "2018", "HN": "2018", "MR": "20170114", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073859"}, {"RECTYPE": "D", "MH": "Immune Privilege", "AQ": "DE GE IM PH RE", "ENTRY": "Immune Privileges", "MN": "G12.535.425.460", "MH_TH": "NLM (2018)", "ST": "T040", "PI": "Immune Tolerance (1990-2017)", "MS": "Phenomenon which occurs in certain tissue sites and organs (e.g., the ANTERIOR CHAMBER and CORNEA of the eye, brain PARENCHYMAL TISSUE and fetus) to tolerate a known antigen, thereby suppressing the inflammatory immune response. Foreign tissue grafts survive for prolonged periods when placed within such immune privileged sites and organs.", "PM": "2018", "HN": "2018", "MR": "20170118", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073860"}, {"RECTYPE": "D", "MH": "Apelin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.529.134", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Intercellular Signaling Peptides and Proteins (2006-2017)", "MS": "A 77 amino acid secreted endogenous ligand for the angiotensin II receptor-like 1 protein (APELIN RECEPTOR) that is proteolytically cleaved into four smaller peptides: Apelin-36, Apelin-31, Apelin-28, and Apelin-13. It inhibits entry of HIV into cells that express both APJ and CD4 ANTIGEN and is highly expressed in breast milk, where it may modulate the neonatal immune response.", "PM": "2018", "HN": "2018", "MR": "20170601", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073861"}, {"RECTYPE": "D", "MH": "Cigar Smoking", "AQ": "AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PC PP PX TD TH UR", "ENTRY": "Smoking, Cigar", "MN": "F01.145.958.875.500", "MH_TH": "NLM (2013)", "ST": "T055", "PI": "Smoking (1963-2017)", "MS": "The SMOKING of CIGARS.", "PM": "2018; see SMOKING 2013-2017", "HN": "2018; use SMOKING 2013-2017", "MR": "20180702", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073863"}, {"RECTYPE": "D", "MH": "Histone Deacetylase 6", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.087.520.350", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.5.1.98", "PI": "Histone Deacetylases (2001-2017)", "MS": "A class II histone deacetylase that removes acetyl groups from N-terminal LYSINES of HISTONE H2A; HISTONE H2B; HISTONE H3; and HISTONE H4. It plays a critical role in EPIGENETIC REPRESSION and regulation of GENETIC TRANSCRIPTION, as well as CELL MOTILITY through deacetylation of TUBULIN. It also targets misfolded proteins for clearance by AUTOPHAGY when MOLECULAR CHAPERONE-mediated folding is overwhelmed.", "PM": "2018", "HN": "2018", "MR": "20170117", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073864"}, {"RECTYPE": "D", "MH": "Cigarette Smoking", "AQ": "AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PC PP PX TD TH UR", "ENTRY": "Smoking, Cigarette", "MN": "F01.145.958.875.750", "MH_TH": "NLM (2008)", "ST": "T055", "PI": "Smoking (1963-2017)", "MS": "The SMOKING of CIGARETTES.", "PM": "2018; see SMOKING 2008-2017", "HN": "2018; use SMOKING 2008-2017", "MR": "20180702", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073865"}, {"RECTYPE": "D", "MH": "Water Pipe Smoking", "AQ": "AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PC PP PX TD TH UR", "ENTRY": "Smoking, Waterpipe", "MN": "F01.145.805.063.500", "MH_TH": "NLM (2018)", "ST": "T055", "PI": "Smoking (1963-2017)", "MS": "A process by which SMOKE produced from burning substance is mixed with flavor-altering substances and drawn through water or other liquid into the mouth.", "PM": "2018; see SMOKING 2013-2018", "HN": "2018; use SMOKING 2013-2018", "MR": "20180702", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073867"}, {"RECTYPE": "D", "MH": "Pipe Smoking", "AQ": "AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PC PP PX TD TH UR", "ENTRY": "Smoking, Pipe", "MN": "F01.145.805.063", "MH_TH": "NLM (2013)", "ST": "T055", "PI": "Smoking (1963-2017)", "MS": "SMOKING by use of a narrow conveying tube which feeds from an open cavity where smoked product is loaded and burned.", "PM": "2018; see SMOKING 2013-2017", "HN": "2018; use SMOKING 2013-2017", "MR": "20190503", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073868"}, {"RECTYPE": "D", "MH": "Tobacco Smoking", "AQ": "AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PC PP PX TD TH UR", "ENTRY": "Smoking, Tobacco|T055|NON|EQV|NLM (2010)|090625|abcdef", "MN": "F01.145.958.875", "MH_TH": "NLM (2008)", "ST": "T055", "PI": "Smoking (1963-2017)", "MS": "The process of SMOKING specific to TOBACCO.", "PM": "See SMOKING 2008-2018", "HN": "Use SMOKING 2008-2018", "MR": "20180702", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073869"}, {"RECTYPE": "D", "MH": "Triggering Receptor Expressed on Myeloid Cells-1", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Triggering Receptor Expressed on Myeloid Cells 1", "MN": "D12.776.543.750.705.985", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (2000-2017)", "MS": "An approximately 230 amino acid membrane glycoprotein characterized by an IMMUNOGLOBULIN V-SET DOMAIN in its N-terminal half. It is expressed by MONOCYTES and NEUTROPHILS in response to INFLAMMATION related to bacterial and fungal infections. It triggers the release of pro-inflammatory CHEMOKINES; CYTOKINES, and expression of cell activation markers and is a critical regulator of SEPTIC SHOCK.", "PM": "2018", "HN": "2018", "MR": "20230316", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073871"}, {"RECTYPE": "D", "MH": "Vascular Ring", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vascular Rings", "MN": "C16.131.240.850.984", "MH_TH": "NLM (2018)", "ST": "T190", "PI": "Vascular Malformations (1963-2017)", "MS": "Congenital vascular malformation in which the AORTA arch and its branches encircle the TRACHEA and ESOPHAGUS. Signs and symptoms include DYSPNEA; RESPIRATORY SOUNDS, especially with eating, DYSPHAGIA, persistent cough, and GASTROESOPHAGEAL REFLUX or may be asymptomatic. Two most common types are double aortic arch and right aortic arch. It may be associated with other anomalies (e.g., DIGEORGE SYNDROME).", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073872"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporters, ABCA", "MN": "D12.776.543.585.100.190", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "ATP-Binding Cassette Transporters (2001-2017)", "MS": "A large, highly conserved, subfamily of ATP binding cassette transporters structurally characterized by a membrane-spanning domain composed of six ALPHA-HELICES, a large extracellular loop, nucleotide-binding domain, and a conserved cytoplasmic 80 amino acid sequence. In humans, it includes ABCA1(ATP BINDING CASSETTE TRANSPORTER 1) through ABCA10, as well as ABCA12 and ABCA13.", "PM": "2019; see ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY A 2018", "HN": "2019 (2018)", "MR": "20230316", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073874"}, {"RECTYPE": "D", "MH": "Palm Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Oil, Palm", "MN": "D20.215.784.750.728", "MH_TH": "NLM (2018)", "ST": "T168", "RN": "5QUO05548Z", "MS": "Nutritive oil extracted from the fleshy mesocarp of the fruit of the African palm tree, Elaeis guineensis.", "PM": "2018; PALM OIL was indexed under PLANT OILS 1987-2017, and under OILS 1984-1986", "HN": "2018(1984)", "MR": "20170123", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073878"}, {"RECTYPE": "D", "MH": "Rice Bran Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Oil, Rice Bran", "MN": "D20.215.784.750.784", "MH_TH": "NLM (2018)", "ST": "T168", "RN": "LZO6K1506A", "MS": "OIL extracted from the hard outer brown layer of rice bran after the husk has been removed.", "PM": "2018; RICE BRAN OIL was indexed under PLANT OILS 1987-2017", "HN": "2018(1987)", "MR": "20230610", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073879"}, {"RECTYPE": "D", "MH": "Body Contouring", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgery, Body Lift", "MN": "E04.617.127", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Reconstructive Surgical Procedures (1988-2017)", "MS": "Plastic surgery to shape many areas of the body simultaneously. This may include LIPECTOMY or RHYTIDOPLASTY or both.", "PM": "2018", "HN": "2018", "MR": "20220406", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073880"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily A, Member 4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, ABCA4", "MN": "D12.776.543.585.100.190.750", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1988-2017)", "MS": "An ATP binding cassette sub-family A transporter that translocates 11-cis and all-trans isomers of N-retinylidene-phosphatidylethanolamine (RETINOIDS) from the extracellular surface to the cytoplasmic membrane surface of RETINAL ROD CELLS and RETINAL CONE CELLS. Mutations in the ABCA4 gene are associated with Stargardt Disease 1, a hereditary juvenile form of MACULAR DEGENERATION.", "PM": "2019; see ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY A, MEMBER 4 2018", "HN": "2019 (2018)", "MR": "20230316", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073882"}, {"RECTYPE": "D", "MH": "CX3C Chemokine Receptor 1", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, V28", "MN": "D12.776.543.750.830.700.315", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "0", "MS": "Receptor for CHEMOKINE CX3CL1 expressed by lymphocytes, neurons, and GLIAL CELLS. Its interaction with CX3CL1 mediates CELL ADHESION and CELL MIGRATION. It also functions as a co-receptor with the CD4 ANTIGEN for HIV-1 in vitro.", "PM": "2018; CX3C CHEMOKINE RECEPTOR 1 was indexed under RECEPTORS, CHEMOKINE and RECEPTORS, HIV 1997-2017", "HN": "2018 (1997)", "MR": "20170331", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073883"}, {"RECTYPE": "D", "MH": "C9orf72 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Guanine Nucleotide Exchange Factor C9orf72|T116|T123|NON|EQV|NLM (2022)|210628|abbcdef", "ENTRY": "Chromosome 9 Open Reading Frame 72 Protein|T116|T123|NON|EQV|NLM (2018)|161130|abbcdef", "MN": "D12.776.476.325.300.025", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Proteins (2011-2017)", "MS": "A widely-expressed guanine nucleotide exchange factor protein of approximately 400 to 500 amino acids. Its N-terminal region (DENN domain) interacts with RAB GTP-BINDING PROTEINS and may regulate AUTOPHAGY, as well as PROTEIN TRANSPORT to ENDOSOMES. Expansion of the GGGGCC hexanucleotide repeat in the first intron of the C9orf72 gene is associated with FRONTOTEMPORAL DEMENTIA with AMYOTROPHIC LATERAL SCLEROSIS (FTDALS1).", "PM": "2018", "HN": "2018", "MR": "20210628", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073885"}, {"RECTYPE": "D", "MH": "Scientific Experimental Error", "AQ": "CL ES HI LJ PX SN TD", "ENTRY": "Scientific Mistake", "MN": "N05.715.360.300.202.500", "FX": "Scientific Misconduct", "MH_TH": "NLM (2018)", "ST": "T080", "AN": "for intentional falsification of scientific data, use SCIENTIFIC MISCONDUCT", "PI": "Research (1963-2017)", "MS": "Deviation or aberration in the practical implementation of standard empirical procedures, distinct from MEDICAL ERRORS and SCIENTIFIC MISCONDUCT.", "PM": "2018", "HN": "2018", "MR": "20220429", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073886"}, {"RECTYPE": "D", "MH": "Vaccination Coverage", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Vaccination Coverages", "MN": "N02.421.726.930", "MH_TH": "NLM (2018)", "ST": "T058", "PI": "Vaccination (1973-2017)", "MS": "Rate of VACCINATION as defined by GEOGRAPHY and or DEMOGRAPHY.", "PM": "2018", "HN": "2018", "MR": "20170123", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073887"}, {"RECTYPE": "D", "MH": "Cell-Free Nucleic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Circulating Nucleic Acid|T114|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Ribonucleic Acid, Cell-Free", "MN": "D13.444.154", "FX": "Liquid Biopsy", "MH_TH": "NLM (2018)", "ST": "T114", "RN": "0", "PI": "DNA/blood (1998-2017)", "MS": "Nucleic acids (DNA or RNA) found circulating in SERUM; PLASMA; or other BODY FLUIDS.", "PM": "2018", "HN": "2018", "MR": "20200527", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073888"}, {"RECTYPE": "D", "MH": "Liquid Biopsy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Biopsy, Liquid", "MN": "E05.242.384.100.396", "FX": "Blood Specimen Collection", "MH_TH": "NLM (2018)", "ST": "T060", "AN": "usually NIM with specific organ /pathol + disease /diag or /pathol", "PI": "Biopsy (2011-2017)", "MS": "Obtaining material for pathological examination and analysis, from bodily fluids. Material retrieved includes CELL-FREE NUCLEIC ACIDS; CELL-DERIVED MICROPARTICLES; EXOSOMES; CIRCULATING NEOPLASM CELLS; and other circulating cells and CELLULAR STRUCTURES.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073890"}, {"RECTYPE": "D", "MH": "Health Information Interoperability", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Interoperability, Health Information", "MN": "L01.470.813", "MH_TH": "NLM (2018)", "ST": "T058", "MS": "Automatic and seamless exchange or cross-talk across HEALTH INFORMATION SYSTEMS.", "PM": "2018", "HN": "2018", "MR": "20180629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073892"}, {"RECTYPE": "D", "MH": "Sugars", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sugar|T109|NON|EQV|NLM (2018)|161230|abcdef", "MN": "D09.947", "MH_TH": "NLM (2018)", "ST": "T109", "RN": "0", "MS": "Short chain carbohydrate molecules that have hydroxyl groups attached to each carbon atom unit with the exception of one carbon that has a doubly-bond aldehyde or ketone oxygen. Cyclical sugar molecules are formed when the aldehyde or ketone groups respectively form a hemiacetal or hemiketal bond with one of the hydroxyl carbons. The three dimensional structure of the sugar molecule occurs in a vast array of biological and synthetic classes of specialized compounds including AMINO SUGARS; CARBASUGARS; DEOXY SUGARS; SUGAR ACIDS; SUGAR ALCOHOLS; and SUGAR PHOSPHATES.", "PM": "2018", "HN": "2018", "MR": "20170410", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073893"}, {"RECTYPE": "D", "MH": "Interdisciplinary Placement", "AQ": "HI LJ MT OG TD", "ENTRY": "Placements, Interdisciplinary", "MN": "I02.578", "MH_TH": "NLM (2018)", "ST": "T065", "MS": "Teaching strategy of shared learning based cross-discipline experiences and placements.", "PM": "2018", "HN": "2018", "MR": "20170302", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073919"}, {"RECTYPE": "D", "MH": "Cryobiology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Temperature Biology, Low", "MN": "H01.158.273.195", "MH_TH": "NLM (2018)", "ST": "T091", "AN": "use for the discipline only", "PI": "Freezing (1971-2017)", "MS": "The study of biological materials or systems subjected to temperatures below their normal range.", "PM": "2018", "HN": "2018", "MR": "20170317", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073920"}, {"RECTYPE": "D", "MH": "Child, Foster", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Youths, Foster", "MN": "M01.107", "FX": "Foster Home Care", "MH_TH": "NLM (2018)", "ST": "T098", "MS": "Individual who is unable to live safely with his or her family, usually due to abuse or neglect in the family home.", "PM": "2018", "HN": "2018", "MR": "20171208", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073921"}, {"RECTYPE": "D", "MH": "Child, Adopted", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Children Adopted", "MN": "M01.100", "FX": "Adoption", "MH_TH": "NLM (2018)", "ST": "T098", "MS": "Individual who becomes a child of a family by means of legal action.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073922"}, {"RECTYPE": "D", "MH": "Food Intolerance", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Intolerance, Food", "MN": "C23.888.821.387", "MH_TH": "NLM (2018)", "ST": "T042", "MS": "Digestive system disorder where a particular food irritates the digestive tract or cannot be properly digested (i.e., due to a lack of a digestive enzyme). It differs from FOOD HYPERSENSITIVITY which is an immune system disorder, usually due to specific proteins in food.  http://my.clevelandclinic.org/health/articles/problem-foods-is-it-an-allergy-or-intolerance.", "PM": "2018", "HN": "2018", "MR": "20170302", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073923"}, {"RECTYPE": "D", "MH": "Graphic Novels as Topic", "AQ": "HI", "ENTRY": "Manga as Topic|T073|NON|EQV|NLM (2018)|161224|abcdef", "MN": "L01.462.500.682.192.289.250.500", "MH_TH": "NLM (2018)", "ST": "T073", "AN": "do not confuse with the Publication Type GRAPHIC NOVEL", "PI": "Books, Illustrated (2015-2017)", "MS": "Works about book-length narratives told using a combination of words and sequential art, often presented in comic book style.", "PM": "2018", "HN": "2018", "MR": "20230531", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073924"}, {"RECTYPE": "D", "MH": "Biological Coevolution", "AQ": "DE GE IM PH RE", "ENTRY": "Coevolution, Biological", "MN": "G16.075.125", "MH_TH": "NLM (2018)", "ST": "T067", "PI": "Biological Evolution (1984-2017)", "MS": "The process of reciprocal evolutionary change occurring between pairs of species or among groups of species as they interact.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073930"}, {"RECTYPE": "D", "MH": "Adverse Outcome Pathways", "AQ": "EC EH HI LJ SN ST TD", "ENTRY": "Adverse Outcome Pathway", "MN": "N06.850.505.715.250", "FX": "Ecotoxicology", "MH_TH": "NLM (2018)", "ST": "T067", "PI": "Risk Assessment (2011-2017)", "MS": "Models connecting initiating events at the cellular and molecular level to population-wide impacts. Computational models may be at levels relating toxicology to adverse effects.", "PM": "2018", "HN": "2018", "MR": "20170302", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073931"}, {"RECTYPE": "D", "MH": "Food Addiction", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Food Addictions", "MN": "F03.400.813", "FX": "Pica", "MH_TH": "NLM (2018)", "ST": "T048", "PI": "Behavior, Addictive (2000-2017)", "MS": "A cluster of chemical dependencies to specific foods or food in general in which there develops a physical craving for these foods.", "PM": "2018", "HN": "2018", "MR": "20170228", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073932"}, {"RECTYPE": "D", "MH": "Narrative Medicine", "DE": "NARRATIVE MED", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Medicine, Narrative", "MN": "N05.715.520", "MH_TH": "NLM (2003)", "ST": "T078", "PI": "Narration (2003-2017)", "MS": "NARRATION as a tool to collect and interpret information on a patient's experience of illness", "PM": "2018", "HN": "2018", "MR": "20180629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073935"}, {"RECTYPE": "D", "MH": "Risk Evaluation and Mitigation", "AQ": "LJ OG ST", "ENTRY": "Elements to Assure Safe Use|T064|NON|NRW|NLM (2018)|161227|abcdef", "MN": "N06.850.505.715.750", "MH_TH": "NLM (2018)", "ST": "T064", "PI": "Risk Management (2008-2017)", "MS": "Strategies required by the US Food and Drug Administration (FDA) Amendments Act of 2007 when a question exists as to whether the benefits of a drug outweigh its risks. These constitute a safety plan with several potential components, including a medication guide, a communication plan, elements to ensure safe use and an implementation system to help guide the prescribers, pharmacists and patients.", "PM": "2018", "HN": "2018", "MR": "20170301", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073938"}, {"RECTYPE": "D", "MH": "Dysferlin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fer 1 like Protein 1", "MN": "D12.776.543.225", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Muscle Proteins (1998-2017)", "MS": "A membrane protein that contains multiple C2 DOMAINS. It is highly expressed in skeletal muscle and functions as a calcium ion sensor in SYNAPTIC VESICLE-PLASMA MEMBRANE fusion, as well as in SARCOLEMMA repair following mechanical stress. Mutations in the dysferlin (DYSF) gene are associated with several hereditary MUSCULAR DYSTROPHIES.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073939"}, {"RECTYPE": "D", "MH": "Transcription Factor 4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, TCF4", "MN": "D12.776.930.125.500.937", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (2008-2017)", "MS": "A basic helix-loop-helix leucine zipper transcription factor that functions in neuronal CELL DIFFERENTIATION. It dimerizes with other bHLH transcription factors and activates transcription through binding to E-BOX ELEMENTS containing 5'-ACANNTGT-3' or 5'-CCANNTGG-3' sequences. Mutations in the TCF-4 gene are associated with Pitt-Hopkins Syndrome, a severe developmental disorder.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073940"}, {"RECTYPE": "D", "MH": "T-Cell Acute Lymphocytic Leukemia Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, TAL1", "MN": "D12.776.930.125.829", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Proto-Oncogene Proteins (2005-2017)", "MS": "A basic helix-loop-helix transcription factor that plays a critical role in HEMATOPOIESIS and as a positive regulator in the differentiation of ERYTHROID CELLS. Chromosome translocations involving the TAL-1 gene are associated with T-CELL ACUTE LYMPHOCYTIC LEUKEMIA.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073942"}, {"RECTYPE": "D", "MH": "Neonicotinoids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Neonicotinoid|T109|NON|EQV|NLM (2018)|161228|abcdef", "MN": "D03.383.464", "MH_TH": "NLM (2018)", "ST": "T109", "RN": "0", "PI": "Nitro Compounds (1996-2017)", "MS": "A class of insecticides that are structurally similar to NICOTINE and have physiologically similar effects as agonists of NICOTINIC ACETYLCHOLINE RECEPTORS, but are less toxic to vertebrates. They are widely used in agriculture.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073943"}, {"RECTYPE": "D", "MH": "Prescription Drug Monitoring Programs", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Prescription Monitorings", "MN": "N02.421.668.320.600", "FX": "Prescription Drug Misuse", "MH_TH": "NLM (2018)", "ST": "T170", "MS": "Programs, usually run by state governments, that require pharmacists to collect and distribute data on the prescription and dispensation of CONTROLLED SUBSTANCES. They are intended to prevent the abuse of such substances by the patient, or their transfer to recreational users and drug dealers.", "PM": "2018", "HN": "2018", "MR": "20200617", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073958"}, {"RECTYPE": "D", "MH": "Academic Performance", "AQ": "EH HI PX SN ST TD", "ENTRY": "Test Scores, Educational", "MN": "I02.399.136", "FX": "Achievement", "MH_TH": "NLM (2018)", "ST": "T081", "PI": "Educational Measurement (1972-2017)", "MS": "A quantitative or qualitative measure of intellectual, scholarly, or scholastic accomplishment.", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073978"}, {"RECTYPE": "D", "MH": "F-Box-WD Repeat-Containing Protein 7", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "F Box and WD 40 Domain Containing Protein 7", "MN": "D12.776.167.242", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Ubiquitin-Protein Ligases (2006-2017)", "MS": "A component of SCF(FBW7) UBIQUITIN LIGASE that contains an F-box motif and multiple WD REPEATS. It recognizes and binds phosphorylated signals in several proteins involved in CELL PROLIFERATION and targets them to the SCF complex for UBIQUITINATION. Targets include CYCLIN E; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS C-MYC; and JNK MITOGEN-ACTIVATED PROTEIN KINASES.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073979"}, {"RECTYPE": "D", "MH": "Triose Sugar Alcohols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Alcohols, Triose Sugar", "MN": "D09.853.875", "MH_TH": "NLM (2018)", "ST": "T109", "RN": "0", "PI": "Glycerol (1998-2017)", "MS": "Sugar alcohol molecules that contain three carbons.", "PM": "2018", "HN": "2018", "MR": "20170410", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000073999"}, {"RECTYPE": "D", "MH": "Acenocoumarol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nicoumalone|T109|T121|NON|EQV|BAN (19XX)|761230|abbcdef", "ENTRY": "MiniSintrom", "MN": "D03.633.100.150.446.520.079", "PA": "Anticoagulants", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2H-1-Benzopyran-2-one, 4-hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-", "RN": "I6WP63U32H", "RR": "152-72-7 (Acenocoumarol)", "MS": "A coumarin that is used as an anticoagulant. Its actions and uses are similar to those of WARFARIN. (From Martindale, The Extra Pharmacopoeia, 30th ed, p233)", "MR": "20160624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000074"}, {"RECTYPE": "D", "MH": "Intercellular Adhesion Molecule-3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Intercellular Adhesion Molecule 3", "MN": "D23.050.301.350.494", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "MS": "A membrane glycoprotein and cell adhesion molecule expressed by LEUKOCYTES that contains multiple Ig-like domains. It is a ligand for LFA-1 (integrin alphaLbeta2) and integrin alpha-D/beta-2. Its interaction with LFA-1 may play a role in the PHAGOCYTOSIS of NEUTROPHILS by MACROPHAGES following APOPTOSIS.", "PM": "2018", "HN": "2018", "MR": "20230316", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074001"}, {"RECTYPE": "D", "MH": "DNA Polymerase gamma", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PolG-alpha|T116|T126|NON|EQV|NLM (2021)|200430|abbcdef", "ENTRY": "Polymerase, Mitochondrial DNA", "MN": "D12.776.575.280", "MH_TH": "NLM (1977)", "ST": "T126", "RN": "EC 2.7.7.7", "MS": "A DNA-directed DNA polymerase that functions in the replication of MITOCHONDRIAL DNA. Mutations in the gene that encodes this enzyme (POLG) are associated with some forms of OPHTHALMOPLEGIA, CHRONIC EXTERNAL PROGRESSIVE.", "PM": "2018; DNA POLYMERASE GAMMA was indexed under DNA-DIRECTED DNA POLYMERASE 1997-2017", "HN": "2018 (1997)", "MR": "20200622", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074002"}, {"RECTYPE": "D", "MH": "MDS1 and EVI1 Complex Locus Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Myelodysplasia Syndrome Associated Protein 1", "MN": "D12.776.930.419", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1990-2017)", "MS": "A DNA binding protein, transcriptional regulator, and proto-oncogene protein that contains 10 CYS2-HIS2 ZINC FINGERS. It functions as a positive or negative regulator of expression for target genes involved in organism development.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074008"}, {"RECTYPE": "D", "MH": "Tubular Sweat Gland Adenomas", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Syringocystadenoma, Papillary", "MN": "C04.557.470.550.175.900", "MH_TH": "NLM (2018)", "ST": "T191", "AN": "coordinate IM with SWEAT GLAND NEOPLASMS (IM)", "PI": "Adenoma, Sweat Gland (1966-2017)", "MS": "Various tubular forms of benign tumors of the SWEAT GLAND with glandular differentiation. Common types include syringocystadenoma papilliferum of the head and neck, and hidradenoma papilliferum of the vulva area. Hidradenoma papilliferum may be derived from mammary-like glands of the vulva.", "PM": "2018", "HN": "2018", "MR": "20180301", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074009"}, {"RECTYPE": "D", "MH": "Bone Marrow Stromal Antigen 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CD317 Antigens", "MN": "D12.776.543.550.418.150", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "GPI-Linked Proteins (1995-2017)", "MS": "A GPI-linked membrane glycoprotein and antiviral factor that functions as a homodimer. It is induced by INTERFERON-GAMMA and blocks the release of enveloped mammalian viruses by directly tethering nascent VIRAL PARTICLES to the membranes of infected cells.", "PM": "2018", "HN": "2018", "MR": "20230316", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074010"}, {"RECTYPE": "D", "MH": "Peptide Transporter 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, Pept-1", "MN": "D12.776.543.585.937.702", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "MS": "A proton-coupled symporter that transports OLIGOPEPTIDES and DIPEPTIDES. It localizes to the brush-border membrane of the INTESTINAL EPITHELIUM and plays a critical role in the assimilation of dietary proteins.", "PM": "2018; PEPTIDE TRANSPORTER 1 was indexed under SYMPORTERS 1994-2017", "HN": "2018 (1994)", "MR": "20170331", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074011"}, {"RECTYPE": "D", "MH": "B-Cell CLL-Lymphoma 10 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Bcl 10 Protein", "MN": "D12.776.476.075.358.140", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Adaptor Proteins, Signal Transducing (1999-2017)", "MS": "A signal transducing adaptor protein that contains an N-terminal CARD DOMAIN and functions in the ADAPTIVE IMMUNE RESPONSE. It promotes PRO-CASPASE-9 maturation and APOPTOSIS, activation of NF-KAPPA B, and is a substrate for MALT1 PARACASPASE.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074018"}, {"RECTYPE": "D", "MH": "T-Cell Intracellular Antigen-1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TIA-1, RNA-Binding Protein", "MN": "D12.776.664.962.829.875", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "RNA-Binding Proteins (1991-2017)", "MS": "An RNA-binding protein characterized by three RNA RECOGNITION MOTIFS. It binds to AU RICH ELEMENTS in the 3'-untranslated regions of mRNA and regulates alternative pre-RNA splicing and mRNA translation; it may also function in APOPTOSIS. Mutations in the TIA-1 gene are associated with WELANDER DISTAL MYOPATHY.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074019"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily B, Member 11", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Bile Salt Export Pump|T116|T123|NON|EQV|NLM (2018)|170104|abbcdef", "MN": "D12.776.543.585.450.074.500.500.250.438", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "ATP-Binding Cassette Transporters (1995-2017)", "MS": "ATP-binding cassette, subfamily B, protein (P-glycoproteins) that functions in the ATP-dependent secretion of BILE SALTS into the BILE CANALICULI of HEPATOCYTES. Mutations in the ABCB11 gene are associated with progressive familial intrahepatic cholestasis 2 (see CHOLESTASIS, INTRAHEPATIC).", "PM": "2019; see ATP BINDING CASSETTE SUBFAMILY B MEMBER 11 2018", "HN": "2019 (2018)", "MR": "20230316", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074020"}, {"RECTYPE": "D", "MH": "Interatrial Block", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Interatrial Conduction Delays", "MN": "C23.550.073.425.270", "MH_TH": "NLM (2018)", "ST": "T047", "PI": "Heart Block (1967-2017)", "MS": "Impaired or delayed impulse conduction between the right and left HEART ATRIA. Advanced interatrial blocks are often associated with arrhythmias (e.g., ATRIAL FLUTTER; and ATRIAL FIBRILLATION), direct conduction block via the Bachmann's bundle and concomitant left atrial enlargement. Syndrome of advanced interatrial block associated with SUPRAVENTRICULAR TACHYCARDIA is referred to as Bayes syndrome.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074021"}, {"RECTYPE": "D", "MH": "Anesthesia, Cardiac Procedures", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Cardiac Procedures Anesthesias", "MN": "E03.155.403", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Thoracic Surgery (1981-2017)", "MS": "A range of methods used to induce UNCONSCIOUSNESS; ANALGESIA; and MUSCLE RELAXATION during cardiac procedures.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074022"}, {"RECTYPE": "D", "MH": "Immunoturbidimetry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Turbidimetric Immunoassays", "MN": "E05.601.470.510", "MH_TH": "NLM (2018)", "ST": "T059", "PI": "Nephelometry and Turbidimetry (1979-2017)", "MS": "Immunochemical analysis which measures specific target antigen bound to antibody complex. Antibodies in assay form insoluble light scattering immune-aggregates which cause changes in the measured turbidity proportional to the concentration of the antigen.", "PM": "2018", "HN": "2018", "MR": "20230531", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074024"}, {"RECTYPE": "D", "MH": "TRPA1 Cation Channel", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Channel, TRPA1 Cation", "MN": "D12.776.543.585.400.901.250", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Transient Receptor Potential Channels (2006-2017)", "MS": "A highly conserved, non-selective TRP cation channel  that contains 14-17 ANKYRIN REPEATS. It functions in cold sensation and NOCICEPTION of endogenous inflammatory factors and volatile irritants. TRPA1 is also activated by CANNABINOIDS and may play a role in sound perception by hair cells of the inner ear.", "PM": "2018", "HN": "2018", "MR": "20170602", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074025"}, {"RECTYPE": "D", "MH": "Fatty Acid Binding Protein 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Muscle Fatty Acid Binding Protein", "MN": "D12.776.157.170.125", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Fatty Acid-Binding Proteins (2005-2017)", "MS": "A small cytosolic fatty-acid binding protein that forms a lipid-binding beta-barrel structure and is expressed by CARDIOMYOCYTES and at lower levels in brain tissue. It is released into plasma immediately following cardiac injury and may therefore serve as a useful biomarker for the early detection of MYOCARDIAL INFARCTION.", "PM": "2018", "HN": "2018", "MR": "20170601", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074026"}, {"RECTYPE": "D", "MH": "Staphylococcus capitis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Staphylococcus capitis urealyticus|T007|NON|REL|NLM (2018)|170106|abcdef", "MN": "B03.510.400.790.750.222", "MH_TH": "NLM (2018)", "ST": "T007", "RN": "txid29388", "RR": "txid74703", "AN": "infection: coordinate with STAPHYLOCOCCAL INFECTIONS", "PI": "Staphylococcus (1982-2017)", "MS": "A COAGULASE-negative species of STAPHYLOCOCCUS found on the skin and MUCOUS MEMBRANE of warm-blooded animals. Similar to STAPHYLOCOCCUS EPIDERMIDIS and STAPHYLOCOCCUS HAEMOLYTICUS, it is a nosocomial pathogen in NICU settings. Subspecies include generally antibiotic susceptible and BIOFILM negative capitis and antibiotic resistant and biofilm positive urealyticus isolates.", "PM": "2018", "HN": "2018", "MR": "20200527", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074039"}, {"RECTYPE": "D", "MH": "Receptors, Histamine H4", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, H4", "MN": "D12.776.543.750.720.480.750", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "0", "PI": "Receptors, Histamine (2001-2017)", "MS": "G-Protein-coupled histamine receptors that are expressed primarily in BONE MARROW as well as in peripheral tissues and organs. They are expressed by immune cells that include EOSINOPHILS; T-CELLS; DENDRITIC CELLS; and MAST CELLS.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074040"}, {"RECTYPE": "D", "MH": "Microorganisms, Genetically-Modified", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Genetically-Modified Microorganisms|T001|NON|EQV|NLM (2018)|170106|abcdef", "MN": "B05.620.368", "MH_TH": "NLM (2018)", "ST": "T001", "AN": "coordinate with specific microorganism /genet", "MS": "Microorganisms whose GENOME has been altered by GENETIC ENGINEERING.", "PM": "2018", "HN": "2018", "MR": "20170315", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074041"}, {"RECTYPE": "D", "MH": "Cerebral Intraventricular Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Intraventricular Hemorrhage, Cerebral", "MN": "C23.550.414.913.100.600", "MH_TH": "NLM (2018)", "ST": "T047", "PI": "Cerebral Ventricles (1963-2017)", "MS": "Bleeding within the CEREBRAL VENTRICLES. It is associated with intraventricular trauma, aneurysm, vascular malformations, hypertension and in VERY LOW BIRTH WEIGHT infants.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074042"}, {"RECTYPE": "D", "MH": "Night Eating Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Night Eating Syndromes", "MN": "F03.400.844", "MH_TH": "NLM (2018)", "ST": "T048", "AN": "coordinate with SLEEP WAKE DISORDERS if pertinent", "MS": "Little or no appetite for breakfast due to eating more food after dinner than during the meal and eating more than half of daily food intake after dinner hour.", "PM": "2018", "HN": "2018", "MR": "20170309", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074043"}, {"RECTYPE": "D", "MH": "Cytokine TWEAK", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TWEAK, Cytokine", "MN": "D23.529.374.750.155", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Tumor Necrosis Factors (2006-2017)", "MS": "A proteolytically-cleaved membrane glycoprotein and member of the TNF superfamily that is highly expressed in a variety of tissues including heart, pancreas, brain, and peripheral blood lymphocytes. The secreted extracellular form is a weak inducer of APOPTOSIS for some cell types and a ligand for the FN14 RECEPTOR. It mediates activation of NF-KAPPA-B and promotes ANGIOGENESIS and proliferation of ENDOTHELIAL CELLS, as well as expression of cytokines involved in INFLAMMATION.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074049"}, {"RECTYPE": "D", "MH": "TWEAK Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Tumor Necrosis Factor like Weak Inducer of Apoptosis Receptor", "MN": "D12.776.543.750.705.852.760.974", "MH_TH": "NLM (2001)", "ST": "T192", "RN": "0", "MS": "A receptor for TWEAK cytokine that is highly expressed by cells in the heart, placenta, and kidney. It plays a role in ANGIOGENESIS and the proliferation of endothelial cells; it may also modulate cellular adhesion to the extracellular matrix.", "PM": "2018; TWEAK RECEPTOR was indexed under RECEPTORS, TUMOR NECROSIS FACTOR 1999-2017", "HN": "2018 (1999)", "MR": "20170403", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074050"}, {"RECTYPE": "D", "MH": "Solute Carrier Family 22 Member 5", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, High-Affinity Carnitine", "MN": "D12.776.543.585.937.701.750", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Organic Cation Transport Proteins (2004-2017)", "MS": "A high-affinity, ATP-binding, co-transporter for CARNITINE that is highly expressed in kidney, skeletal muscle, heart, and placental tissues. It transports one sodium ion with one carnitine molecule. It has a lower affinity for other organic cations and transports them independently of sodium. Mutations in the SLC22A5 gene are associated with systemic carnitine deficiency.", "PM": "2018", "HN": "2018", "MR": "20170331", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074058"}, {"RECTYPE": "D", "MH": "Extracorporeal Shockwave Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Shock Wave", "MN": "E02.831.535.488", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "High-Energy Shock Waves/therapeutic use (1989-2017)", "MS": "A nonsurgical treatment that uses either HIGH-ENERGY SHOCK WAVES or low energy ACOUSTIC WAVES to treat various musculoskeletal conditions (e.g., PLANTAR FASCIITIS; TENNIS ELBOW). A probe placed on the skin conducts the shock waves thereby delivering a mechanical force to the body\u2019s tissues.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074059"}, {"RECTYPE": "D", "MH": "Bronchial Thermoplasty", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Thermoplasty, Bronchial", "MN": "E04.014.760.500.500", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Catheter Ablation (2005-2017)", "MS": "Thermal destruction of the excess bronchial SMOOTH MUSCLE tissue with heat delivered through a catheter assembly attached to a BRONCHOSCOPE. It is often used to control BRONCHIAL HYPERREACTIVITY in severe ASTHMA for better AIRWAY MANAGEMENT.", "PM": "2018", "HN": "2018", "MR": "20180630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074060"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily D", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporters, ABCD", "MN": "D12.776.543.585.100.209", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "ATP-Binding Cassette Transporters (1998-2017)", "MS": "A sub-family of ATP-binding cassette transporters that localize to the membranes of PEROXISOMES; ENDOPLASMIC RETICULUM; and LYSOSOMES. Members contain a transmembrane domain in their N-terminal half and generally function as homodimers in the transport of LIPIDS; BILE ACIDS; and VITAMIN B12. Mutations in some ABCD transporter genes are associated with PEROXISOMAL DISORDERS.", "PM": "2019; see ATP BINDING CASSETTE TRASPORTER, SUB-FAMILY D 2018", "HN": "2019 (2018)", "MR": "20230316", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074061"}, {"RECTYPE": "D", "MH": "Environmental Biomarkers", "AQ": "DE GE IM PH RE", "ENTRY": "Indicators, Biological", "MN": "N06.850.460.350.080.250", "MH_TH": "NLM (2018)", "ST": "T080", "RN": "0", "MS": "A factor associated with the well-being of living organisms that is used as a measure of environmental change and or influence. For example, aldehyde dehydrogenase expression in earthworm tissue is used as an indication of heavy metal pollution in soils. Distinguish from BIOMARKERS.", "PM": "2018", "HN": "2018", "MR": "20170713", "DA": "20170713", "DC": "1", "DX": "20180101", "UI": "D000074062"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily D, Member 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Adrenoleukodystrophy Protein|T116|T123|NON|EQV|NLM (2018)|170109|abbcdef", "MN": "D12.776.543.585.100.209.500", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "ATP-Binding Cassette Transporters (1998-2017)", "MS": "ATP-binding cassette transporter that functions in the import of long chain (13-21 carbons) and very long chain fatty acids (> 22 carbons), or their acyl-CoA-derivatives, into PEROXISOMES. Mutations in the ABCD1 gene are associated with the X-linked form of ADRENOLEUKODYSTROPHY.", "PM": "2019; see ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY D, MEMBER 1 2018", "HN": "2019 (2018)", "MR": "20230316", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074063"}, {"RECTYPE": "D", "MH": "Conservation of Water Resources", "AQ": "EC HI LJ MT SN TD", "ENTRY": "Water Resources Conservations", "MN": "N06.230.080.100", "FX": "Water Supply", "MH_TH": "NLM (2018)", "ST": "T057", "MS": "Preservation and or management of WATER RESOURCES especially under conditions of scarce supply.", "PM": "2018", "HN": "2018", "MR": "20200708", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074067"}, {"RECTYPE": "D", "MH": "Undifferentiated Connective Tissue Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Undifferentiated Connective Tissue Disease|T047|NON|EQV|NLM (2018)|170110|abcdef", "MN": "C20.111.904", "MH_TH": "NLM (2018)", "ST": "T047", "PI": "Connective Tissue Diseases (1979-2017)", "MS": "Diseases that exhibit signs and symptoms suggestive of a connective tissue disease that do not fulfill clinical or diagnostic criteria for any one defined disease but overlap with criteria of multiple such diseases. Commonly overlapping diseases include systemic autoimmune connective tissue diseases such as RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; and SYSTEMIC SCLEROSIS.", "PM": "2018", "HN": "2018", "MR": "20190429", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074079"}, {"RECTYPE": "D", "MH": "MutS Proteins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "MutS Protein|T116|T126|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Proteins, MutS Homolog", "MN": "D12.776.260.556", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.6.1.3", "PI": "MutS DNA Mismatch-Binding Protein (2006-2017)", "MS": "DNA repair proteins that include the bacterial MutS DNA mismatch-binding protein and its eukaryotic homologs that function in DNA MISMATCH REPAIR and recombination of DNA during MEIOSIS. MutS has a conserved mismatch recognition domain characterized by GxFxE, or similar AMINO ACID MOTIFS that also occur in eukaryotic homologs such as MSH1, MSH6, and MSH8. All MutS proteins also contain a highly-conserved ATP-binding domain and most have weak ATPase activity.", "PM": "2018", "HN": "2018", "MR": "20200527", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074080"}, {"RECTYPE": "D", "MH": "MutS Homolog 3 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mismatch Repair Protein 1|T116|T123|NON|EQV|NLM (2018)|170110|abbcdef", "MN": "D12.776.260.556.875", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "DNA-Binding Proteins (1993-2017)", "MS": "A MutS homolog protein and component of post-replicative DNA MISMATCH REPAIR. It forms a heterodimer with MUTS HOMOLOG 2 PROTEIN (MSH2) and recognizes large insertion-deletion loops up to 13 nucleotides in length. This directs downstream events such as strand discrimination, excision, and resynthesis.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074081"}, {"RECTYPE": "D", "MH": "Sodium-Hydrogen Exchanger 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sodium Hydrogen Exchanger 1", "MN": "D12.776.543.585.937.828.500", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Sodium-Hydrogen Exchangers (2004-2017)", "MS": "A sodium-hydrogen antiporter expressed by many cell types, especially on the basolateral surfaces of EPITHELIAL CELLS. It functions through an inward sodium ion chemical gradient to eliminate acids (protons) generated by metabolism and regulate intracellular pH. It is highly sensitive to AMILORIDE.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074082"}, {"RECTYPE": "D", "MH": "Sodium-Hydrogen Exchanger 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sodium Hydrogen Exchanger 3", "MN": "D12.776.543.585.937.828.750", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "MS": "A sodium-hydrogen antiporter expressed primarily by EPITHELIAL CELLS in the kidneys, it localizes to the apical membrane of the PROXIMAL KIDNEY TUBULE, where it functions in sodium and water reabsorption and possibly calcium homeostasis.  It also is expressed in heart, brain, and lung tissues and is resistant to AMILORIDE inhibition.", "PM": "2018; SODIUM-HYDROGEN EXCHANGER 3 was indexed under SODIUM-HYDROGEN EXCHANGERS 1994-2017", "HN": "2018 (1994)", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074083"}, {"RECTYPE": "D", "MH": "THP-1 Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "THP-1 Cell Lines", "MN": "A11.251.860.180.815", "MH_TH": "NLM (2018)", "ST": "T025", "AN": "almost always NIM with no subheadings; check HUMAN; do not routinely add LEUKEMIA, MONOCYTIC, ACUTE", "PI": "Monocytes (1988-2017)", "MS": "A human leukemia monocytic cell line derived from a patient with LEUKEMIA, MONOCYTIC, ACUTE. It is used as a model to study the function of MONOCYTES and MACROPHAGES, their signaling pathways, nutrient and drug transport.", "PM": "2018", "HN": "2018", "MR": "20170315", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074084"}, {"RECTYPE": "D", "MH": "Mice, Knockout, ApoE", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Mice, ApoE Knockout", "MN": "B01.050.150.900.649.313.992.635.505.500.800.500.512", "MH_TH": "NLM (2018)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mice, Knockout (1995-2017)", "MS": "Strains of mice that contain genetic disruptions (knockout) of APOLIPOPROTEINS E genes. They are used as models for ATHEROSCLEROSIS research.", "PM": "2018", "HN": "2018", "MR": "20200902", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074085"}, {"RECTYPE": "D", "MH": "Equivalence Trials as Topic", "ENTRY": "Non Inferiority Trials as Topic", "MN": "N06.850.520.450.250.250.365.500.250", "MH_TH": "NLM (2018)", "ST": "T078", "AN": "for general design, methodology, economics, etc. of equivalence trials; a different heading EQUIVALENCE TRIAL is used for reports of a specific equivalence trial ", "MS": "Works about trials that aim to show a new treatment is no better and no worse than the standard treatment.", "PM": "2018", "HN": "2018", "MR": "20180626", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074099"}, {"RECTYPE": "D", "MH": "Funeral Homes", "AQ": "EC HI LJ PX SN ST", "ENTRY": "Homes, Funeral", "MN": "J03.240", "MH_TH": "NLM (2018)", "ST": "T073", "MS": "Facilities for the preparation of the dead for burial or cremation, for the viewing of the body, and for funeral services.", "PM": "2018; see MORTUARY PRACTICE 1963-2017", "HN": "2018; use MORTUARY PRACTICE 1963-2017", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074100"}, {"RECTYPE": "D", "MH": "Cocaine Smoking", "AQ": "AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PC PP PX TD TH UR", "ENTRY": "Smoking, Crack Cocaine", "MN": "F01.145.805.250.250", "FX": "Cocaine-Related Disorders", "MH_TH": "NLM (2018)", "ST": "T055", "MS": "SMOKING of COCAINE.", "PM": "2018", "HN": "2018", "MR": "20180702", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074101"}, {"RECTYPE": "D", "MH": "Protein Kinase C-theta", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "PKC theta", "MN": "D12.776.476.563.725.075", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 2.7.11.13", "PI": "Protein Kinase C (1992-2017)", "MS": "A calcium-independent, phospholipid- and diacylglycerol-dependent, protein kinase C subtype that contains an N-terminal C2 DOMAIN and two diacylglycerol-binding ZINC FINGERS. It is expressed primarily by T-LYMPHOCYTES and localizes to IMMUNOLOGICAL SYNAPSES where it regulates downstream signaling for the activation, proliferation, and survival of mature T-cells. It plays a critical role in allergic, autoimmune, and alloimmune responses of TH2 CELLS and TH17 CELLS.", "PM": "2018", "HN": "2018", "MR": "20210521", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074121"}, {"RECTYPE": "D", "MH": "Short Stature Homeobox Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SHOXY Protein|T116|T123|ABX|EQV|NLM (2018)|170207|abbcdef", "MN": "D12.776.260.400.859", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Homeodomain Proteins (1997-2017)", "MS": "A homeodomain protein that is highly expressed in the nuclei of skeletal muscle, bone marrow, and osteogenic cells and has critical roles in growth and development. Its gene resides within PSEUDOAUTOSOMAL REGION 1 of X and Y chromosomes and mutations are associated with several growth disorders including LERI-WEIL SYNDROME; LANGER MESOMELIC DYSPLASIA; and SHORT STATURE, IDIOPATHIC, X-LINKED.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074122"}, {"RECTYPE": "D", "MH": "Circulating Tumor DNA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tumor DNA, Circulating", "MN": "D13.444.308.425.500", "MH_TH": "NLM (2018)", "ST": "T114", "RN": "0", "PI": "DNA, Neoplasm (2000-2017)", "MS": "DNA released from tumor cells that is found circulating in PLASMA; SERUM; or other BODY FLUIDS.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074141"}, {"RECTYPE": "D", "MH": "Kazal Motifs", "AQ": "DE GE IM PH RE", "ENTRY": "Motifs, Kazal", "MN": "G02.111.570.820.709.275.500.490", "MH_TH": "NLM (2018)", "ST": "T087", "PI": "Amino Acid Sequence (2004-2017)", "MS": "Highly conserved protein domains characteristic of SERINE PROTEASE INHIBITORS, KAZAL TYPE. They generally occur as tandem repeats, with each domain consisting of approximately 60 amino acids that form a large extended amino acid chain, two short ALPHA-HELICES, and a three-stranded anti-parallel BETA-SHEET. Kazal-like domains also occur in the extracellular portions of AGRIN.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074161"}, {"RECTYPE": "D", "MH": "Serine Peptidase Inhibitors, Kazal Type", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Serine Protease Inhibitors, Kazal Type|T116|T123|NON|EQV|NLM (2018)|170119|abbcdef", "MN": "D27.505.519.389.745.800.562", "FX": "Kazal Motifs", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Trypsin Inhibitor, Kazal Pancreatic (2000-2017)", "MS": "A family of serine peptidase inhibitors that occur in animals, some single-cell eukaryotes, and higher plants. They contain variable numbers of KAZAL MOTIFS and inhibit SERINE ENDOPEPTIDASES such as ACROSIN and TRYPSIN.", "PM": "2018", "HN": "2018", "MR": "20220712", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074162"}, {"RECTYPE": "D", "MH": "Serine Peptidase Inhibitor Kazal-Type 5", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Serine Protease Inhibitor Kazal Type 5", "MN": "D12.776.815.688.250", "FX": "Netherton Syndrome", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Proteinase Inhibitory Proteins, Secretory (2005-2017)", "MS": "A secreted serine peptidase inhibitor that consists of 15 KAZAL MOTIFS and inhibits KALLIKREINS KLK5, KLK7, and KLK14 as well as TRYPSIN. It plays important roles in protecting MUCOSA against infection and inflammation, and in maintaining the integrity of the skin. Mutations in the SPINK5 gene are associated with NETHERTON SYNDROME.", "PM": "2018", "HN": "2018", "MR": "20220712", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074163"}, {"RECTYPE": "D", "MH": "Nicotine Chewing Gum", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Nicotine Chewing Gums", "MN": "J02.500.140.200.500", "MH_TH": "NLM (2012)", "ST": "T203", "RN": "0", "MS": "Chewing gum which contains NICOTINE.", "PM": "2018", "HN": "2018", "MR": "20180419", "DA": "20170713", "DC": "1", "DX": "20180101", "UI": "D000074164"}, {"RECTYPE": "D", "MH": "Zinc Finger E-box Binding Homeobox 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Zinc Finger E box Binding Homeobox 2 Protein", "MN": "D12.776.930.780.918", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Repressor Proteins (2004-2017)", "MS": "A transcription factor that consists of 8 CYS2-HIS2 ZINC FINGERS flanking a central HOMEOBOX. It binds to the 5'-CACCT-3' DNA sequence located within E-BOX ELEMENTS of many genes essential for embryonic growth and development and regulates their activity; it represses transcription of the E-CADHERIN gene. Mutations in the ZEB2 gene are associated with MOWAT-WILSON SYNDROME.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074165"}, {"RECTYPE": "D", "MH": "Circulating MicroRNA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "MicroRNA, Circulating", "MN": "D13.444.735.790.552.500.500", "MH_TH": "NLM (2018)", "ST": "T116", "RN": "0", "PI": "MicroRNAs (2010-2017)", "MS": "MicroRNAs found in cell-free BODY FLUIDS such as SERUM; PLASMA; SALIVA; OR URINE.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074166"}, {"RECTYPE": "D", "MH": "Spastin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Spastic Paraplegia 4 Protein|T116|T126|NON|EQV|NLM (2018)|170120|abbcdef", "MN": "D12.776.631.560.480", "FX": "AAA Domain", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.6.4.3", "PI": "Adenosine Triphosphatases (1999-2017)", "MS": "An AAA ATPase that binds and severs MICROTUBULES. It specifically recognizes and cuts polyglutamylated microtubules with short polyglutamate tails to promote reorganization of cellular microtubule arrays and the release of microtubules from the CENTROSOME following nucleation. It is critical for the biogenesis and maintenance of complex microtubule arrays in AXONS; SPINDLE APPARATUS; and CILIA. Mutations in the spastin gene (SPAST) are associated with type 4 of HEREDITARY SPASTIC PARAPLEGIA.", "PM": "2018", "HN": "2018", "MR": "20170301", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074181"}, {"RECTYPE": "D", "MH": "AAA Domain", "AQ": "DE GE IM PH RE", "ENTRY": "P-Loops", "MN": "G02.111.570.820.709.275.500.913", "FX": "ATPases Associated with Diverse Cellular Activities", "MH_TH": "NLM (2018)", "ST": "T087", "PI": "Amino Acid Sequence (1990-2017)", "MS": "An approximately 250 amino acid domain common to AAA ATPases and AAA Proteins. It consists of a highly conserved N-terminal P-Loop ATPase subdomain with an alpha-beta-alpha conformation, and a less-conserved C-terminal subdomain with an all alpha conformation. The N-terminal subdomain includes Walker A and Walker B motifs which function in ATP binding and hydrolysis.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074182"}, {"RECTYPE": "D", "MH": "ATPases Associated with Diverse Cellular Activities", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "AAA+ Protease|T116|NON|NRW|NLM (2021)|191118|abcdef", "ENTRY": "Proteases, AAA+", "MN": "D12.776.157.025.750", "FX": "AAA Domain", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.6.4.-", "PI": "Adenosine Triphosphatases (1997-2017)", "MS": "A large highly conserved family of ATPases with diverse functions in cells that are characterized by the presence of a P-LOOP and a ring shape. They couple the energy generated by ATP hydrolysis to remodeling or mechanical translocation of their target molecules.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074183"}, {"RECTYPE": "D", "MH": "Katanin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.631.560.338", "FX": "AAA Domain", "MH_TH": "NLM (1993)", "ST": "T126", "RN": "EC 5.6.1.1", "MS": "An enzyme (AAA ATPase) consisting of the 60 kDa ATPase subunit (p60 subunit A1) which severs MICROTUBULES, and an 80 kDa accessory protein (p80 subunit B1), which targets the enzyme to the CENTROSOME. It releases microtubules from the mitotic SPINDLE POLES to allow depolymerization and poleward motion of chromosomes. It is also a regulator of microtubule dynamics in NEURONAL OUTGROWTH.", "PM": "2018; KATANIN was indexed under ADENOSINE TRIPHOSPHATASES 1993-2017", "HN": "2018 (1993)", "MR": "20190708", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074201"}, {"RECTYPE": "D", "MH": "Rumination, Digestive", "AQ": "DE GE IM PH RE", "ENTRY": "Digestive Rumination", "MN": "G10.261.190.400", "MH_TH": "NLM (2018)", "ST": "T040", "PI": "Digestion (1970-2017)", "MS": "Regurgitation and re-chewing of previously swallowed food in RUMINANTS.", "PM": "2018", "HN": "2018", "MR": "20170301", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074221"}, {"RECTYPE": "D", "MH": "Rumination, Cognitive", "AQ": "CL DE ES PH RE", "ENTRY": "Cognitive Rumination", "MN": "F02.463.188.878", "MH_TH": "NLM (2018)", "ST": "T041", "PI": "Cognition (1980-(2017)", "MS": "Obsessive thinking about an idea, situation, or choice.", "PM": "2018", "HN": "2018", "MR": "20170301", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074222"}, {"RECTYPE": "D", "MH": "Peanut Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Oil, Peanut", "MN": "D10.627.700.809", "MH_TH": "NLM (2018)", "ST": "T168", "RN": "0", "RR": "8002-03-7 (arachis oil)", "MS": "Oil derived from PEANUTS.", "PM": "2018; PEANUT OIL was indexed under PLANT OILS 1987-2017, and under OILS 1975-1986.Remove PMDAJul-11-2017DXJan-01-2018LRJun-19-2017", "HN": "2018 (1975)", "MR": "20230610", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074241"}, {"RECTYPE": "D", "MH": "Sunflower Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Seed Oil, Sunflower", "MN": "D20.215.784.750.910", "MH_TH": "NLM (2018)", "ST": "T168", "RN": "0", "RR": "8001-21-6 (sunflower seed oil)", "MS": "Oil derived from the seeds of SUNFLOWER plant, Helianthus.", "PM": "2018; SUNFLOWER OIL was indexed under PLANT OILS 1987-2017, and under OILS 1987-2017.", "HN": "2018(1980)", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074242"}, {"RECTYPE": "D", "MH": "Immune Reconstitution", "AQ": "EH GE IM PH RE", "ENTRY": "Immune Restoration|T040|NON|EQV|NLM (2018)|170124|abcdef", "MN": "G12.432", "FX": "Immune Reconstitution Inflammatory Syndrome", "MH_TH": "NLM (2018)", "ST": "T040", "PI": "Immunity (1968-2017)", "MS": "Regeneration of normal immune function after immune depleting procedures or infections (e.g., HEMATOPOIETIC STEM CELL TRANSPLANTATION). Delayed and incomplete reconstitution of the ADAPTIVE IMMUNE system in particular involving T-CELLS is associated with increase or relapse of infection.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074243"}, {"RECTYPE": "D", "MH": "Receptors, Enterotoxin", "AQ": "AD AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, Heat-Stable Enterotoxin", "MN": "D12.776.543.750.750.330", "EC": "agonists:Guanylyl Cyclase C Agonists", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "EC 4.6.1.2", "MS": "Guanylate cyclase-coupled receptors that bind bacterial ENTEROTOXINS, as well as the endogenous peptides guanylin and uroguanylin. Ligand binding stimulates production of CYCLIC GMP by EPITHELIAL CELLS of the intestinal lumen, altering barrier permeability and mucus secretion. Mutations in the gene (GUCY2C) encoding this receptor are associated with some cases of hereditary diarrhea (Diarrhea 6) and MECONIUM ILEUS.", "PM": "2018; RECEPTORS, ENTEROTOXIN was indexed under GUANYLATE CYCLASE 1981-2011; RECEPTORS, IMMUNOLOGIC 1981-1988; RECEPTORS, ENDOGENOUS SUBSTANCES 1989-1993; RECEPTORS, PEPTIDE 1994-2017 and RECEPTORS, GUANYLATE-CYCLASE COUPLED 2006-2017", "HN": "2018 (1981)", "MR": "20180620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074261"}, {"RECTYPE": "D", "MH": "Rapeseed Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Oil, Rapeseed", "MN": "D20.215.784.750.066", "MH_TH": "NLM (2018)", "ST": "T168", "RN": "0", "MS": "PLANT OILS derived from RAPESEED species known as BRASSICA NAPUS.", "PM": "2019; CANOLA OIL was indexed under PLANT OILS 1974-2017", "HN": "2019(2018)", "MR": "20200813", "DA": "20170712", "DC": "1", "DX": "20180101", "UI": "D000074262"}, {"RECTYPE": "D", "MH": "Coconut Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Oil, Coconut", "MN": "D10.627.700.186", "MH_TH": "NLM (2018)", "ST": "T168", "RN": "Q9L0O73W7L", "RR": "8001-31-8", "MS": "Oil derived from fruits of the coconut plant, COCOS NUCIFERA.", "PM": "2018; COCONUT OIL was indexed under PLANT OILS 1993-2017, and under DIETARY FATS 1982-1992.", "HN": "2018(1982)", "MR": "20230610", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074263"}, {"RECTYPE": "D", "MH": "Smoking Reduction", "AQ": "EC EH HI LJ MT PX SN", "ENTRY": "Reduction, Smoking", "MN": "F01.145.805.157", "FX": "Tobacco Use Cessation", "MH_TH": "NLM (2018)", "ST": "T053", "PI": "Smoking Cessation (1992-2017)", "MS": "A decrease in the incidence and frequency of SMOKING. Smoking reduction differs from SMOKING CESSATION in that the smoker continues to smoke albeit at a lesser frequency without quitting.", "PM": "2018", "HN": "2018", "MR": "20170619", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074264"}, {"RECTYPE": "D", "MH": "Materials Science", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sciences, Materials", "MN": "J01.897.461", "MH_TH": "NLM (2018)", "ST": "T090", "MS": "An interdisciplinary study of the microstructure and composition of various materials such as metals, semiconductors, ceramics, and polymers, in relation to their macromolecular physical and chemical properties. Materials science enables the custom creation of new materials with specific properties and uses.", "PM": "2018", "HN": "2018", "MR": "20170619", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074266"}, {"RECTYPE": "D", "MH": "Organism Hydration Status", "AQ": "DE GE IM PH RE", "ENTRY": "Water Status, Organism", "MN": "G07.670", "MH_TH": "NLM (2018)", "ST": "T081", "MS": "Quantitative measure of water or fluids contained in the body of a living organism.", "PM": "2018", "HN": "2018", "MR": "20170626", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074267"}, {"RECTYPE": "D", "MH": "Guanylyl Cyclase C Agonists", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Guanylate Cyclase C Agonists|T121|NON|EQV|NLM (2018)|170124|abcdef", "MN": "D27.505.954.483.590", "MH_TH": "NLM (2018)", "ST": "T121", "RN": "0", "PI": "Receptors, Guanylate Cyclase-Coupled (2006-2017)", "MS": "Compunds that bind to and activate GUANYLYL CYCLASE-C RECEPTORS.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074268"}, {"RECTYPE": "D", "MH": "Resonance Frequency Analysis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Resonance Frequency Analyses", "MN": "E06.780.758", "FX": "Osseointegration", "MH_TH": "NLM (2018)", "ST": "T060", "PI": "Dental Implants (1996-2017)", "MS": "A non-invasive assessment of the stability of tissue-embedded prosthetic devices such as dental implants.", "PM": "2018", "HN": "2018", "MR": "20190705", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074269"}, {"RECTYPE": "D", "MH": "Meconium Ileus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ileus, Meconium", "MN": "C06.405.469.531.788", "MH_TH": "NLM (2018)", "ST": "T033", "PI": "Meconium (1963-2017)", "MS": "Intestinal obstruction caused by congealed MECONIUM in the distal ILEUM and CECUM. It presents shortly after birth as a failure to pass meconium and frequently occurs in infants with CYSTIC FIBROSIS.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074270"}, {"RECTYPE": "D", "MH": "Endothelial Protein C Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Protein C", "MN": "D12.776.543.750.045", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (2006-2017)", "MS": "A glycosylated transmembrane receptor for PROTEIN C that is highly expressed by endothelial cells on the surface of large blood vessels in the heart and lungs.  It facilitates protein C activation by the THROMBIN and THROMBOMODULIN complex in blood coagulation.", "PM": "2018", "HN": "2018", "MR": "20230316", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074283"}, {"RECTYPE": "D", "MH": "Periphyton", "AQ": "DE GE IM PH RE", "ENTRY": "Periphytons", "MN": "N06.230.124.049.100.500.875", "MH_TH": "NLM (2018)", "ST": "T001", "MS": "A complex mixture of organisms (algae, cyanobacteria, heterotrophic microbes, detritus, etc.) clinging on the surfaces of plants and other objects projecting from the bottom sediments of aquatic ecosystems.", "PM": "2018", "HN": "2018", "MR": "20170619", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074284"}, {"RECTYPE": "D", "MH": "Smokers", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Vaper", "MN": "M01.808", "FX": "Non-Smokers", "MH_TH": "NLM (2018)", "ST": "T098", "PI": "Smoking (1963-2017)", "MS": "Persons with a history or habit of SMOKING.", "PM": "2018", "HN": "2018", "MR": "20180702", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074285"}, {"RECTYPE": "D", "MH": "Preliminary Data", "AQ": "EC SD", "ENTRY": "Project Data, Pilot", "MN": "N06.850.520.308.763", "MH_TH": "NLM (2018)", "ST": "T170", "MS": "First-released version of study results in a series of data collection efforts used for the purpose of generating further interest in and or funding of a research study.", "PM": "2018", "HN": "2018", "MR": "20170503", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074286"}, {"RECTYPE": "D", "MH": "TRPC6 Cation Channel", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Channel, TRPC6 Cation", "MN": "D12.776.543.585.400.901.500.500", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "TRPC Cation Channels (2006-2017)", "MS": "A non-selective, calcium permeant TRPC cation channel that contains four ANKYRIN REPEATS and is activated by DIACYLGLYCEROL independently of PROTEIN KINASE C. It is expressed in placenta, lung, spleen, ovary and the small intestine, as well as by PODOCYTES in the kidney glomerulus. Mutations in the TRPC6 gene are associated with FOCAL SEGMENTAL GLOMERULOSCLEROSIS type 2.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074287"}, {"RECTYPE": "D", "MH": "Discs Large Homolog 1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synapse Associated Protein 97", "MN": "D12.776.543.213", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (2006-2017)", "MS": "A signaling adaptor protein that contains three PDZ DOMAINS; an SH3 DOMAIN; and a GUANYLATE KINASE-like C-terminal region. It has an essential role in animal development and recruits ion channels, receptors, and signaling molecules to discrete plasma membrane regions of polarized cells in the HEART ATRIA MYOCARDIUM. It functions in the assembly of ADHERENS JUNCTIONS and regulation of CELL PROLIFERATION; synaptogenesis, LYMPHOCYTE ACTIVATION; and controls expression of KV4 POTASSIUM CHANNELS to regulate excitability of CARDIAC MYOCYTES.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074288"}, {"RECTYPE": "D", "MH": "High-Temperature Requirement A Serine Peptidase 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protease HTRA1, Serine", "MN": "D08.811.277.656.959.350.420", "FX": "PDZ Domains", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.4.21.-", "PI": "Serine Endopeptidases (2003-2017)", "MS": "A secreted serine protease that contains a Kazal domain-like region and a C-terminal PDZ domain. It has a broad range of targets that include EXTRACELLULAR MATRIX PROTEINS; PROTEOGLYCANS; and INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS. Mutations in the HTRA1 gene are associated with AGE-RELATED MACULAR DEGENERATION 7 and Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL).", "PM": "2018", "HN": "2018", "MR": "20170601", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074289"}, {"RECTYPE": "D", "MH": "Zinc Finger Protein Gli3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glioma Associated Oncogene Family Zinc Finger 3 Protein", "MN": "D12.776.930.780.972", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1990-2017)", "MS": "A zinc finger transcription factor that contains five CYS2-HIS2 ZINC FINGERS and binds to the GLI consensus sequence 5'-GGGTGGTC-3'. The full-length protein functions as a transcriptional activator whereas the truncated C-terminal form functions as a transcriptional repressor of the Sonic Hedgehog (Shh) signaling pathway; a balance between these two forms is critical for limb and digit development. GLI3 also plays a critical role in the differentiation and proliferation of CHONDROCYTES.", "PM": "2018", "HN": "2018", "MR": "20170227", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074290"}, {"RECTYPE": "D", "MH": "CD52 Antigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "HLA Bw52 Antigen", "MN": "D23.101.100.943", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Glycoproteins (1991-2017)", "MS": "A small GPI-linked glycoprotein expressed on the surface of normal and malignant B-CELLS; T-CELLS; MONOCYTES; MACROPHAGES; NK CELLS; and GRANULOCYTES. It is expressed densely and without modulation in many malignant T-cell neoplasms and therefore a target for antibody therapies (e.g., ALEMTUZUMAB).", "PM": "2018", "HN": "2018", "MR": "20230316", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074301"}, {"RECTYPE": "D", "MH": "Antineoplastic Agents, Immunological", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monoclonal Antibody Antineoplastics", "MN": "D27.505.954.248.384", "MH_TH": "NLM (2018)", "ST": "T129", "RN": "0", "PI": "Antineoplastic Agents (1986-2017)", "MS": "Antineoplastic agents containing immunological agents (e.g. MAbs). These pharmacologic preparations inhibit or prevent the proliferation of NEOPLASMS.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074322"}, {"RECTYPE": "D", "MH": "Alemtuzumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Monoclonal Antibody Campath 1H", "MN": "D12.776.377.715.548.114.224.200.375", "FX": "CD52 Antigen", "MH_TH": "NLM (2018)", "ST": "T129", "RN": "3A189DH42V", "MS": "An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.", "PM": "2018; ALEMTUZUMAB was indexed under ANTIBODIES, MONOCLONAL, 1995-2011 and under ANTIBODIES, MONOCLONAL, HUMANIZED, 2012-2017", "HN": "2018 (1995)", "MR": "20170410", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074323"}, {"RECTYPE": "D", "MH": "Ipilimumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "MDX CTLA 4", "MN": "D12.776.377.715.548.114.224.200.798", "FX": "CTLA-4 Antigen", "MH_TH": "NLM (2018)", "ST": "T129", "RN": "0", "RR": "6T8C155666", "MS": "An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.", "PM": "2018; IPILIMUMAB was indexed under ANTIBODIES, MONOCLONAL, 2012-2017", "HN": "2018(2012)", "MR": "20200228", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074324"}, {"RECTYPE": "D", "MH": "Dietary Exposure", "AQ": "AE AN CL EC ES HI LJ PC SN ST", "ENTRY": "Exposure, Dietary", "MN": "N06.850.460.350.040", "FX": "Foodborne Diseases", "MH_TH": "NLM (2018)", "ST": "T037", "PI": "Food Contamination (1979-2017)", "MS": "The exposure to potentially harmful factors such as trace heavy metals, chemicals, radiation, or toxins due to FOOD CONTAMINATION including DRINKING WATER contamination.", "PM": "2018", "HN": "2018", "MR": "20170224", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074341"}, {"RECTYPE": "D", "MH": "Sleep Latency", "AQ": "DE GE IM PH RE", "ENTRY": "Sleep Onset Latencies", "MN": "G11.561.803.377", "MH_TH": "NLM (2018)", "ST": "T033", "PI": "Sleep, REM (1978-2017)", "MS": "The time it takes to reach REM SLEEP. It is typically measured by POLYSOMNOGRAPHY or EEG as a part of various sleep pattern tests (e.g., multiple sleep latency test).", "PM": "2018", "HN": "2018", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074361"}, {"RECTYPE": "D", "MH": "Mass Drug Administration", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Mass Drug Administrations", "MN": "N06.850.780.200.600", "FX": "Mass Vaccination", "MH_TH": "NLM (2018)", "ST": "T061", "MS": "Administration of a medication to at-risk individuals in a population without individual diagnosis. It is often used in order to treat, control, and/or prevent spread of often endemic DISEASE OUTBREAKS such as NEGLECTED DISEASES in high disease burden areas.", "PM": "2018", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074381"}, {"RECTYPE": "D", "MH": "Greenhouse Gases", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Gas, Greenhouse", "MN": "D27.888.284.101.696", "FX": "Ozone Depletion", "MH_TH": "NLM (2018)", "ST": "T103", "RN": "0", "PI": "Gases (1997-2017)", "MS": "Gaseous elements, chemicals that are in the atmosphere that may contribute to GREENHOUSE EFFECT.", "PM": "2018", "HN": "2018", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074382"}, {"RECTYPE": "D", "MH": "Sexual Health", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "ENTRY": "Health, Sexual", "MN": "N01.400.663", "FX": "Sexual Dysfunctions, Psychological", "MH_TH": "NLM (2013)", "ST": "T078", "PI": "Sexuality (1997-2017)", "MS": "A state of physical, emotional, mental and social well-being in relation to SEXUALITY, according to the World Health Organization.", "PM": "2018; see REPRODUCTIVE HEALTH 2013-2017", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074384"}, {"RECTYPE": "D", "MH": "Food Ingredients", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Ingredients, Food", "MN": "J02.500.514", "MH_TH": "NLM (2018)", "ST": "T168", "RN": "0", "MS": "Substances included in prepared foods and beverages.", "PM": "2018", "HN": "2018", "MR": "20170628", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074385"}, {"RECTYPE": "D", "MH": "Gender-Based Violence", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Dowry Death|T053|NON|NRW|NLM (2020)|181218|abcdef", "ENTRY": "Violence, Gender-Based", "MN": "I01.198.240.856.463", "MH_TH": "NLM (2018)", "ST": "T053", "PI": "Violence (1995-2017)", "MS": "Violence based on gender that results in, or is likely to result in, physical, sexual or mental harm or suffering, including threats of such acts, coercion or arbitrary deprivation of liberty, whether occurring in public or in private life. (From www.who.int/topics/gender_based_violence/en/)", "PM": "2018", "HN": "2018", "MR": "20190114", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074386"}, {"RECTYPE": "D", "MH": "Early Goal-Directed Therapy", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Early Goal-Directed Therapies", "MN": "E02.760.190.203", "MH_TH": "NLM (2018)", "ST": "T061", "MS": "Critical care treatment using intensive monitoring and aggressive management of perioperative hemodynamics in high risk patients,", "PM": "2018", "HN": "2018", "MR": "20170708", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074388"}, {"RECTYPE": "D", "MH": "Therapeutic Index, Drug", "ENTRY": "Drug Therapeutic Indices", "MN": "N05.715.360.575.575.800.713.500", "MH_TH": "NLM (2018)", "ST": "T081", "PI": "Treatment Outcome (2002-2017)", "MS": "The ratio of the dose that produces toxicity to the dose that produces a clinically desired or effective response.", "PM": "2018", "HN": "2018", "MR": "20190530", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074389"}, {"RECTYPE": "D", "MH": "Peroxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Biogenesis Factors, Peroxisome", "MN": "D12.776.157.635", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1997-2017)", "MS": "Proteins that are essential for the assembly of PEROXISOMES. They recognize and transport cytoplasmic proteins that contain PEROXISOMAL TARGETING SIGNALS (PTS) to the peroxisome. Mutations in peroxin (PEX) genes are associated with several PEROXISOMAL DISORDERS.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074401"}, {"RECTYPE": "D", "MH": "Synovectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Synovium Resections", "MN": "E04.555.640", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Synovial Membrane/surgery (1965-2017)", "MS": "Surgical removal of the SYNOVIAL MEMBRANE.", "PM": "2018", "HN": "2018", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074402"}, {"RECTYPE": "D", "MH": "Meniscectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Resection, Meniscal", "MN": "E04.555.490", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Meniscus/surgery (1965-2017)", "MS": "Surgical incision of a torn MENISCUS.", "PM": "2018", "HN": "2018", "MR": "20230226", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074403"}, {"RECTYPE": "D", "MH": "Peroxisomal Targeting Signals", "AQ": "DE GE IM PH RE", "ENTRY": "Targeting Signals, Peroxisome", "MN": "G02.111.570.060.670.805", "MH_TH": "NLM (2018)", "ST": "T087", "RN": "0", "PI": "Amino Acid Sequence (1988-2017)", "MS": "Protein sorting signals that target proteins to PEROXISOMES.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074404"}, {"RECTYPE": "D", "MH": "Valosin Containing Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p97 Valosin Containing Protein", "MN": "D12.776.167.800", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.6.4.6", "MS": "A highly-conserved AAA ATPase that functions in the biogenesis of the transitional ENDOPLASMIC RETICULUM and fragmentation and reassembly of the GOLGI APPARATUS during MITOSIS. It also functions in a complex with UFD1L and NPLOC4 proteins to export misfolded ubiquitinated proteins from the endoplasmic reticulum and outer mitochondrial membrane to the cytoplasm for degradation by the PROTEASOME and also plays a role in AUTOPHAGY of ubiquitinated proteins. It occurs in neuronal INCLUSION BODIES from patients with AMYOTROPHIC LATERAL SCLEROSIS and LEWY BODIES from PARKINSON DISEASE patients.", "PM": "2018; VALOSIN CONTAINING PROTEIN was indexed under ADENOSINE TRIPHOSPHATASES and CELL CYCLE PROTEINS 1991-2017", "HN": "2018 (1991)", "MR": "20170602", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074405"}, {"RECTYPE": "D", "MH": "Mastoidectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Radical Mastoidectomy, Modified", "MN": "E04.580.450.375", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Mastoid (1963-2017)", "MS": "Surgical removal of the diseased cells from the MASTOID PROCESS. It often involves simultaneous resection and/or repair of the MIDDLE EAR and EAR DRUM in MIDDLE EAR CHOLESTEATOMAS and MASTOIDITIS.", "PM": "2018", "HN": "2018", "MR": "20170410", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074406"}, {"RECTYPE": "D", "MH": "SAP90-PSD95 Associated Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SAP90 PSD95 Associated Proteins", "MN": "D12.776.631.703", "FX": "Disks Large Homolog 4 Protein", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "MS": "Proteins expressed at SYNAPSES throughout the brain where they interact with different scaffolding proteins, cytoskeletal proteins, and signaling factors to assemble functional multiprotein complexes.", "PM": "2018; SAP90-PSD95 ASSOCIATED PROTEINS was indexed under NERVE TISSUE PROTEINS 1993-2017", "HN": "2018 (1993)", "MR": "20170531", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074407"}, {"RECTYPE": "D", "MH": "Aldo-Keto Reductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductases, Aldo-Keto", "MN": "D08.811.682.047.820.284", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 1.1.1.-", "PI": "Aldehyde Reductase (1976-2017)", "MS": "A family of NADPH-dependent oxidoreductases that reduce carbonyl substrates including sugar-aldehydes, KETOSTEROIDS; keto-prostaglandins, and QUINONES. They are monomers of approximately 37 KDa and are characterized by a parallel beta-8 (BETA SHEET)-alpha 8 (ALPHA HELICES)-barrel structure that contains the NADP binding site. This conformation favors aromatic and apolar substrates.", "PM": "2018", "HN": "2018", "MR": "20170406", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074408"}, {"RECTYPE": "D", "MH": "Carbonyl Reductase (NADPH)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, 13,14-dihydroprostaglandin F2alpha", "MN": "D08.811.682.047.820.289", "MH_TH": "NLM (1974)", "ST": "T126", "RN": "EC 1.1.1.184", "MS": "NADPH-dependent reductase that catalyzes the reduction of many carbonyl compounds including QUINONES; PROSTAGLANDINS; and XENOBIOTICS.", "PM": "2018; CARBONYL REDUCTASE (NADPH) was indexed under ALDEHYDE REDUCTASE 1975-2017", "HN": "2018 (1974)", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074409"}, {"RECTYPE": "D", "MH": "Fermented Foods", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Fermented Foods and Beverages|T168|NON|EQV|NLM (2020)|190124|abcdef", "ENTRY": "Foods, Fermented", "MN": "J02.350", "MH_TH": "NLM (2018)", "ST": "T168", "PI": "Fermentation (1970-2017)", "MS": "Foods that are prepared by using microorganisms to convert their components into various FERMENTATION end products. Some pickled foods are considered fermented foods as their pickling results from the microbial production of LACTIC ACID.", "PM": "2022;  see FERMENTED FOODS AND BEVERAGES 2020-2021; see FERMENTED FOODS 2018-2019", "HN": "2022 (2018)", "MR": "20210707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074421"}, {"RECTYPE": "D", "MH": "Aldo-Keto Reductase Family 1 Member C2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dihydrodiol Dehydrogenase Bile Acid Binding Protein", "MN": "D08.811.682.047.820.284.875", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 1.1.1.357", "PI": "Hydroxysteroid Dehydrogenases (2001-2017)", "MS": "Aldo-keto reductase that functions with 5-alpha and 5-beta-steroid reductases to convert steroid hormones into the 3-alpha or 5-alpha and 3-alpha or 5-beta-tetrahydrosteroid, including 5-ALPHA-DIHYDROTESTOSTERONE  to ANDROSTANE-3,17-DIOL. It also binds to BILE ACIDS. Mutations in the AKR1C2 gene are associated with Type 8 DISORDER OF SEX DEVELOPMENT, 46,XY (SRXY8).", "PM": "2018", "HN": "2018", "MR": "20180713", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074422"}, {"RECTYPE": "D", "MH": "Celastrales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.500", "MH_TH": "NLM (2018)", "ST": "T002", "RN": "txid233875", "PI": "Plants (1994-2017)", "MS": "A taxonomic order of plants within the class MAGNOLIOPSIDA, which includes the staff vine.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170712", "DC": "1", "DX": "20180101", "UI": "D000074423"}, {"RECTYPE": "D", "MH": "Rosanae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859", "MH_TH": "NLM (2018)", "ST": "T002", "MS": "A suborder of flowering plants of the class MAGNOLIOPSIDA which comprises two major groups, Eurosids I and II.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170712", "DC": "1", "DX": "20180101", "UI": "D000074424"}, {"RECTYPE": "D", "MH": "Aldo-Keto Reductase Family 1 Member C3", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Aldo Keto Reductase Family 1 Member C3", "MN": "D08.811.682.047.820.375.500", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 1.1.1.357", "PI": "Hydroxyprostaglandin Dehydrogenases (2004-2017)", "MS": "Aldo-keto reductase that functions as a bi-directional  17 BETA, 20 ALPHA-HYDROXYSTEROID DEHYDROGENASE. It catalyzes the reduction of PROSTAGLANDIN D2 and PROSTAGLANDIN H2, as well as the oxidation of  9alpha,11beta-PGF2 to prostaglandin D2. It can also interconvert estrogens, ANDROGENS; and PROGESTINS between their active forms and inactive metabolites.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074425"}, {"RECTYPE": "D", "MH": "Aldo-Keto Reductase Family 1 member B10", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Aldose Reductase Related Protein", "MN": "D08.811.682.047.820.284.813", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 1.1.1.-", "PI": "Aldehyde Reductase (1999-2017)", "MS": "Aldo-keto reductase that functions as an all-trans-retinaldehyde reductase. It also reduces aromatic and aliphatic ALDEHYDES.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074426"}, {"RECTYPE": "D", "MH": "Caryophyllanae", "MN": "B01.875.800.575.912.250.198", "MH_TH": "NLM (2018)", "ST": "T002", "MS": "Superorder of dicot plants in the class MAGNOLIOPSIDA.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170712", "DC": "1", "DX": "20180101", "UI": "D000074427"}, {"RECTYPE": "D", "MH": "Peroxisomal Biogenesis Factor 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peroxisome Assembly Factor 1", "MN": "D12.776.543.689", "FX": "RING Finger Domains", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "135847-86-8", "MS": "A multi-pass transmembrane protein that contains a C-terminal RING finger domain. It localizes to the PEROXISOME membrane and is essential for peroxisome biogenesis. Mutations in the PEX2 gene are associated with ZELLWEGER SYNDROME and INFANTILE REFSUM DISEASE.", "PM": "2018; see PEROXISOME ASSEMBLY FACTOR-1 1991-2017; PEROXISOMAL BIOGENESIS FACTOR 2 was indexed under MEMBRANE PROTEINS 1991-2017", "HN": "2018 (1991)", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074428"}, {"RECTYPE": "D", "MH": "Candida parapsilosis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mycotorula parapsilopsis|T004|NON|EQV|NLM (2021)|200318|abcdef", "ENTRY": "Candida parapsilosis Group|T004|NON|BRD|NLM (2018)|170217|abcdef", "MN": "B01.300.930.176.600", "MH_TH": "NLM (2018)", "ST": "T004", "RN": "txid5480", "RR": "txid273372", "AN": "infection: coordinate with CANDIDIASIS or its indentions ", "PI": "Candida (1965-2017)", "MS": "A species of MITOSPORIC FUNGI and opportunistic pathogen associated with its ability to form BIOFILMS in catheters and parenteral nutrition IV lines. C. parapsilosis complex includes closely related species C. orthopsilosis; and C. metapsilosis.", "PM": "2018", "HN": "2018", "MR": "20200902", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074429"}, {"RECTYPE": "D", "MH": "Keratectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Keratectomies", "MN": "E04.378", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Cornea (1963-2017)", "MS": "Surgical excision of a part of the CORNEA.", "PM": "2018", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074431"}, {"RECTYPE": "D", "MH": "Sphincterotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Sphincterotomies", "MN": "E04.515.750", "MH_TH": "NLM (2018)", "ST": "T061", "MS": "Surgical incision of a sphincter.", "PM": "2018", "HN": "2018", "MR": "20170410", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074432"}, {"RECTYPE": "D", "MH": "Myotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Myotomies", "MN": "E04.515", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Muscles/surgery (1965-2017)", "MS": "Surgical incision of the muscle.", "PM": "2018", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074433"}, {"RECTYPE": "D", "MH": "Heller Myotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Myotomy, Heller's", "MN": "E04.515.750.250", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Esophagus/surgery (1975-2017)", "MS": "Surgical incision of the lower esophageal sphincter near the CARDIA often used to treat ESOPHAGEAL ACHALASIA.", "PM": "2018", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074434"}, {"RECTYPE": "D", "MH": "Peroxisome-Targeting Signal 1 Receptor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptors, PTS1", "MN": "D12.776.157.635.750", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "MS": "A cytoplasmic receptor and peroxin that contains a series of TETRATRICOPEPTIDE REPEATS and binds to PEROXISOME TARGETING SIGNAL 1 (SKL-type). It is essential for protein import into PEROXISOMES; mutations in the PEX5 gene are associated with PEROXISOMAL DISORDERS such as ZELLWEGER SYNDROME.", "PM": "2018; PEROXISOME TARGETING SIGNAL 1 RECEPTOR was indexed under RECEPTORS, CYTOPLASMIC AND NUCLEAR 1996-2017, and under RECEPTORS, CELL SURFACE 1995", "HN": "2018 (1995)", "MR": "20181010", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074435"}, {"RECTYPE": "D", "MH": "Tetratricopeptide Repeat", "AQ": "DE GE IM PH RE", "ENTRY": "Tetratricopeptide Repeats", "MN": "G02.111.570.820.709.275.875.394", "MH_TH": "NLM (2018)", "ST": "T087", "PI": "Amino Acid Sequence (1991-2017)", "MS": "A structural motif present in a variety of proteins that mediates protein-protein interactions and assembly of multiprotein complexes. It consists of 3 to 16 tandem repeats of 34 amino acids, mostly of small and large hydrophobic residues, that form ALPHA-HELIX pairs.", "PM": "2018", "HN": "2018", "MR": "20170406", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074436"}, {"RECTYPE": "D", "MH": "Peroxisomal Targeting Signal 2 Receptor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptors, PTS2", "MN": "D12.776.157.635.625", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A cytoplasmic receptor and peroxin that contains a series of WD40 REPEATS and binds to PEROXISOME TARGETING SIGNAL 2. It is essential for protein import into PEROXISOMES; mutations in the human PEX7 gene are associated with PEROXISOMAL DISORDERS such as Type 1 CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC.", "PM": "2018; PEROXISOMAL TARGETING SIGNAL 2 RECEPTOR was indexed under RECEPTORS, CYTOPLASMIC AND NUCLEAR 1995-2017", "HN": "2018 (1995)", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074437"}, {"RECTYPE": "D", "MH": "Political Activism", "AQ": "TD", "ENTRY": "Social Activism|T054|NON|EQV|NLM (2018)|170530|abcdef", "MN": "I01.738.708", "FX": "Social Adjustment", "MH_TH": "NLM (2018)", "ST": "T054", "PI": "Politics (2002-2017)", "MS": "Active involvement in the political process including promoting, impeding or raising awareness of a certain issue or set of issues.", "PM": "2018", "HN": "2018", "MR": "20181012", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074439"}, {"RECTYPE": "D", "MH": "Fascism", "AQ": "CL EC HI PX SN", "MN": "I01.696.480", "MH_TH": "NLM (2018)", "ST": "T078", "PI": "National Socialism (2002-2017)", "MS": "Political movement which combines nationalism with demands for political and social renewal. Characteristics include militaristic nationalism, belief in a natural social hierarchy and the rule of elites, and the desire to create a \u201cpeople\u2019s community\u201d, in which individual interests would be subordinated to the good of the nation. (From www.britannica.com/topic/fascism)", "PM": "2018", "HN": "2018", "MR": "20170708", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074440"}, {"RECTYPE": "D", "MH": "Involuntary Treatment", "AQ": "CL ES HI LJ MT OG SD SN ST TD", "ENTRY": "Treatments, Involuntary", "MN": "I01.880.604.528", "MH_TH": "NLM (2018)", "ST": "T061", "MS": "Procedures, surgery, or other treatment without consent of person or persons receiving treatment.", "PM": "2018", "HN": "2018", "MR": "20180613", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074441"}, {"RECTYPE": "D", "MH": "Lysine Acetyltransferase 5", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "HIV 1 Tat Interactive Protein Tip60", "MN": "D08.811.913.050.134.415.500.062", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 2.3.1.48", "PI": "Histone Acetyltransferases (2005-2017)", "MS": "A catalytic subunit of the NuA4 histone acetyltransferase complex that functions in transcriptional activation of genes by acetylation of nucleosomal HISTONES H4 and H2A, altering nucleosome-DNA interactions and interaction of the modified histones with other activating transcription factors. It may control gene expression changes associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest; CELL AGING; APOPTOSIS; and DNA REPAIR. It is polyubiquitinated and degraded during HIV-1 infection through its interaction with the viral TAT PROTEIN.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074443"}, {"RECTYPE": "D", "MH": "Positive Regulatory Domain I-Binding Factor 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Positive Regulatory Domain I Binding Factor 1", "MN": "D12.776.930.780.904", "FX": "PR-SET Domains", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 2.1.1.-", "PI": "Repressor Proteins (1994-2017)", "MS": "A transcriptional repressor protein that contains an N-terminal PR-SET domain, four C-terminal CYS2-HIS2 ZINC FINGERS, and binds the PRDI element in the INTERFERON-BETA gene. It has methyltransferase activity and mediates gene transcription in tissue-specific innate and adaptive immune lymphocyte T-CELLS, repressing expression of proteins that promote exit of these tissue-specific T-cell populations from non-lymphoid organs.", "PM": "2018", "HN": "2018", "MR": "20170602", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074462"}, {"RECTYPE": "D", "MH": "PR-SET Domains", "AQ": "DE GE IM PH RE", "ENTRY": "SET Domains", "MN": "G02.111.570.820.709.275.750.477", "MH_TH": "NLM (2018)", "ST": "T087", "PI": "Histone-Lysine N-Methyltransferase (1996-2017)", "MS": "Highly conserved protein domains of approximately 130 to 140 amino acids. The SET domain was first identified in the Drosophila proteins (S)u(var)3-9, (E)nhancer-of-zeste and (T)rithorax and occurs in other proteins with a variety of functions, including histone-lysine N-methyltransferases. Structurally, it consists of BETA-SHEETS interspersed among loops and turns that result in an \"L\" shape. The most conserved motifs are a stretch at the C-terminal that contains a strictly conserved tyrosine residue and an adjacent loop that the C-terminal segment passes through to form a \"knot\". These motifs and especially the tyrosine residue are essential for S-ADENOSYLMETHIONINE binding and catalysis. The PR domain has high homology to the catalytic region of the SET domain and occurs at the N-terminal of PRDM proteins such as PRDM1 PROTEIN.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074463"}, {"RECTYPE": "D", "MH": "Thyroid Nuclear Factor 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Thyroid Specific Enhancer Binding Protein", "MN": "D12.776.930.888", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "MS": "A homeobox protein and transcription factor that localizes to the cell nucleus where it activates expression of thyroid specific genes such as THYROGLOBULIN and the THYROTROPIN RECEPTOR. It is critical for maintaining thyroid tissue in a differentiated state and also plays a role in lung development. Mutations in the NKX2-1 gene are associated with CHOREA, BENIGN HEREDITARY.", "PM": "2018; THYROID NUCLEAR FACTOR 1 was indexed under NUCLEAR PROTEINS and TRANSCRIPTION FACTORS 1990-2017", "HN": "2018 (1990)", "MR": "20170406", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074482"}, {"RECTYPE": "D", "MH": "Receptors, Kisspeptin-1", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, Kisspeptin 1", "MN": "D12.776.543.750.750.500", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "0", "PI": "Receptors, G-Protein-Coupled (2004-2017)", "MS": "G protein coupled receptors for the C-terminally amidated peptide of KISSPEPTIN-1. KISS1R plays an essential role in sexual development during puberty through its regulation of GONADOTROPIN-released hormones.", "PM": "2018", "HN": "2018", "MR": "20180620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074502"}, {"RECTYPE": "D", "MH": "Consumer Health Informatics", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Informatics, Consumer Health", "MN": "L01.313.187", "MH_TH": "NLM (2018)", "ST": "T068", "PI": "Informatics (2000-2017)", "MS": "The field devoted in Informatics from multiple consumer or patient views.", "PM": "2018", "HN": "2018", "MR": "20170708", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074522"}, {"RECTYPE": "D", "MH": "Suprachiasmatic Nucleus Neurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Suprachiasmatic Nucleus Neuron", "MN": "A11.671.947", "MH_TH": "NLM (2018)", "ST": "T025", "MS": "Neurons of the SUPRACHIASMATIC NUCLEUS.", "PM": "2018", "HN": "2018", "MR": "20180630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074523"}, {"RECTYPE": "D", "MH": "Solute Carrier Organic Anion Transporter Family Member 1B3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Liver Specific Organic Anion Transporter 2", "MN": "D12.776.543.585.937.950", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Organic Anion Transporters, Sodium-Independent (2002-2017)", "MS": "A sodium-independent organic anion transporter that functions in the uptake of various drugs and endogenous compounds including ESTRADIOL; TAUROCHOLATE; LEUKOTRIENE C4; and METHOTREXATE. It also functions in clearing BILE ACIDS and organic anions from the liver. Mutations in the SLCO1B3 gene are associated with Rotor Type HYPERBILIRUBINEMIA.", "PM": "2018", "HN": "2018", "MR": "20170406", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074542"}, {"RECTYPE": "D", "MH": "Receptor, Notch4", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Notch-4", "MN": "D12.776.930.770.937", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "0", "PI": "Receptors, Notch (2006-2017)", "MS": "A notch receptor and proto-oncogene protein characterized by a large extracellular domain that consists of 29 EPIDERMAL GROWTH FACTOR  - like repeat sequences (EGF repeats) and five ANKYRIN REPEATS. It functions as a receptor for SERRATE-JAGGED PROTEINS and Delta1 (DLK1) protein to control cell fate determination.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074562"}, {"RECTYPE": "D", "MH": "AAA Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "AAA Protein|T116|T126|NON|EQV|NLM (2022)|200720|abbcdef", "ENTRY": "Superfamily, AAA+", "MN": "D12.776.157.025", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.6.4.-", "PI": "Adenosine Triphosphatases (1995-2017)", "MS": "A large, highly conserved and functionally diverse superfamily of NTPases and nucleotide-binding proteins that are characterized by a conserved 200 to 250 amino acid nucleotide-binding and catalytic domain, the AAA+ module. They assemble into hexameric ring complexes that function in the energy-dependent remodeling of macromolecules. Members include ATPASES ASSOCIATED WITH DIVERSE CELLULAR ACTIVITIES.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074582"}, {"RECTYPE": "D", "MH": "Short Chain Dehydrogenase-Reductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Short-Chain Alcohol Dehydrogenase|T116|T126|NON|EQV|NLM (2021)|191122|abbcdef", "ENTRY": "Short Chain Dehydrogenase Reductases", "MN": "D08.811.682.047.820.900", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 1.1.1.-", "PI": "Alcohol Oxidoreductases (1995-2017)", "MS": "A large family of oxidoreductases that are predominantly NAD- or NADP-dependent and 250 to 350 amino acids in length. They generally consist of two PROTEIN DOMAINS: A catalytic N-terminal domain that binds the substrate, and a C-terminal coenzyme-binding domain.", "PM": "2018", "HN": "2018", "MR": "20200527", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074583"}, {"RECTYPE": "D", "MH": "WW Domain-Containing Oxidoreductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "WW Domain Containing Oxidoreductase", "MN": "D12.776.624.776.980", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 1.1.1.-", "PI": "Tumor Suppressor Proteins (2004-2017)", "MS": "A short chain oxidoreductase that contains two N-terminal WW DOMAINS and functions as a tumor suppressor and in APOPTOSIS. It is also required for bone development.", "PM": "2018", "HN": "2018", "MR": "20170406", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074584"}, {"RECTYPE": "D", "MH": "WW Domains", "AQ": "DE GE IM PH RE", "ENTRY": "Domains, WW", "MN": "G02.111.570.820.709.275.750.500.937", "MH_TH": "NLM (2018)", "ST": "T087", "PI": "Protein Structure, Tertiary (1999-2017)", "MS": "An approximately 40 amino acid protein domain that occurs in a variety of unrelated proteins and may be repeated up to four times in some proteins. It is characterized by two TRYPTOPHAN residues (WW) about 20 amino acids apart and folds into a stable triple-stranded BETA-SHEET. It binds PROLINE-RICH PROTEIN DOMAINS and PHOSPHOSERINE or PHOSPHOTHREONINE-containing protein domains that occur in many signal-transducing and cytoskeletal proteins such as DYSTROPHIN.", "PM": "2018", "HN": "2018", "MR": "20190705", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074585"}, {"RECTYPE": "D", "MH": "Remyelination", "AQ": "DE GE IM PH RE", "ENTRY": "Remyelinations", "MN": "G16.762.611.250", "MH_TH": "NLM (2018)", "ST": "T043", "MS": "The reforming of the MYELIN SHEATH around AXONS following loss due to injury or DEMYELINATING DISEASES.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074586"}, {"RECTYPE": "D", "MH": "Smoking Devices", "AQ": "CL EC HI MI PS RE SD SN ST VI", "ENTRY": "Smoking Device", "MN": "J01.637.767", "MH_TH": "NLM (2018)", "ST": "T073", "MS": "Gadgets, utensils, apparatuses or instruments used for SMOKING.", "PM": "2018", "HN": "2018", "MR": "20170503", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074602"}, {"RECTYPE": "D", "MH": "Smoking Pipes", "AQ": "CL EC HI MI PS RE SD SN ST VI", "ENTRY": "Smoking Pipe", "MN": "J01.637.767.750", "MH_TH": "NLM (2018)", "ST": "T073", "MS": "Devices used for SMOKING which convey SMOKE directly into the mouth.", "PM": "2018", "HN": "2018", "MR": "20170522", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074604"}, {"RECTYPE": "D", "MH": "Smoking Prevention", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Smoking Preventions", "MN": "N03.623.500.608.428.825.750", "MH_TH": "NLM (2018)", "ST": "T078", "PI": "Smoking (1978-2017)", "MS": "Efforts directed at preventing SMOKING of TOBACCO and non-tobacco products.", "PM": "2018", "HN": "2018", "MR": "20220708", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074606"}, {"RECTYPE": "D", "MH": "Opium Dependence", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Uses, Opium", "MN": "F03.900.647.500.800", "MH_TH": "NLM (2018)", "ST": "T048", "MS": "Strong physiological and emotional dependence on OPIUM.", "PM": "2018", "HN": "2018", "MR": "20181010", "DA": "20170713", "DC": "1", "DX": "20180101", "UI": "D000074607"}, {"RECTYPE": "D", "MH": "MYND Domains", "AQ": "DE GE IM PH RE", "ENTRY": "Zinc Finger MYND Type", "MN": "G02.111.570.820.709.275.750.500.474", "MH_TH": "NLM (2018)", "ST": "T087", "PI": "Protein Structure, Tertiary (1998-2017)", "MS": "Zinc finger domains (named for myeloid, Nervy and DEAF-1) that occur in a variety of eukaryotic proteins, including RUNT-RELATED TRANSCRIPTION FACTOR 1 . They are characterized by a cluster of cysteine and histidine residues with conserved spacing that forms the zinc-binding motif and have beta-beta-alpha (see BETA-SHEET and ALPHA-HELIX) topology, similar to LIM domains (see LIM DOMAIN PROTEINS) and RING FINGER DOMAINS. MYND domains function as protein interaction motifs and have affinity for PROLINE-RICH PROTEIN DOMAINS.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074608"}, {"RECTYPE": "D", "MH": "Marijuana Use", "AQ": "AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PX TD TH UR", "ENTRY": "Uses, Recreational Marijuana", "MN": "F03.900.643", "FX": "Marijuana Abuse", "MH_TH": "NLM (2018)", "ST": "T055", "PI": "Marijuana Smoking (1967-2017)", "MS": "Medicinal or recreational utilization of MARIJUANA.", "PM": "2018", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074609"}, {"RECTYPE": "D", "MH": "Dual Oxidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dual Oxidase|T116|T126|NON|EQV|NLM (2021)|200211|abbcdef", "ENTRY": "Proteins, Duox", "MN": "D12.776.543.653.500", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 1.11.1.-", "RR": "EC 1.6.3.1", "PI": "NADPH Oxidases (2001-2017)", "MS": "NADPH oxidases that contain two additional EF HAND MOTIFS and an N-terminal PEROXIDASE domain. They are expressed by THYROCYTES and EPITHELIAL CELLS of the kidney, liver, trachea, lung, and glandular tissues such as the testis, pancreas, and prostate. They are critical for the activity of THYROID PEROXIDASE and play a role in the production of thyroid hormones; they may also have antimicrobial activity through the generation of REACTIVE OXYGEN SPECIES.", "PM": "2018", "HN": "2018", "MR": "20200527", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074623"}, {"RECTYPE": "D", "MH": "NADPH Oxidase 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase 1, NADPH", "MN": "D12.776.543.653.750", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.6.3.-", "MS": "An NADPH oxidase that functions as a voltage-gated proton channel expressed by PHAGOCYTES, especially in the colon. It regulates intracellular pH, generates SUPEROXIDES upon activation by PHAGOCYTOSIS, and may play a role in INNATE IMMUNITY.", "PM": "2018; NADPH OXIDASE 1 was indexed under NADH, NADPH OXIDOREDUCTASES 1999-2017", "HN": "2018 (1999)", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074624"}, {"RECTYPE": "D", "MH": "Nephrolithotomy, Percutaneous", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Percutaneous Nephrolithotomy|T061|NON|EQV|NLM (1993)|910924|abcdef", "ENTRY": "Percutaneous Nephrolithotomies", "MN": "E04.950.774.638", "MH_TH": "NLM (1993)", "ST": "T061", "MS": "Surgical removal of large KIDNEY CALCULI by means of a percutaneous nephroscope which is passed into the KIDNEY PELVIS through a track created in the patient's back.", "PM": "2018; see PERCUTANEOUS NEPHROSTOMY (1993-2017)", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074642"}, {"RECTYPE": "D", "MH": "Nephrotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Pyelotomies", "MN": "E04.950.774.739", "MH_TH": "NLM (2018)", "ST": "T061", "AN": "note entry terms PYELOTOMY and PYELOSTOMY: coordinate with KIDNEY PELVIS /surg", "PI": "Nephrostomy, Percutaneous (1985-2017)", "MS": "Surgical incision into any part of the kidney.", "PM": "2018", "HN": "2018", "MR": "20170706", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074643"}, {"RECTYPE": "D", "MH": "NADPH Oxidase 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase 2, NADPH", "MN": "D12.776.543.653.875", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 1.6.3.-", "PI": "NADPH Oxidases (1997-2017)", "MS": "An NADPH oxidase that is expressed by PHAGOCYTES where it transfers electrons across the plasma membrane from cytosolic NADPH to molecular oxygen on the exterior. It regulates proton (H+) flux into resting phagocytes to control intracellular pH. Mutations in the CYBB gene are associated with X-LINKED CHRONIC GRANULOMATOUS DISEASE.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074662"}, {"RECTYPE": "D", "MH": "NADPH Oxidase 4", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase 4, NADPH", "MN": "D12.776.543.653.937", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 1.6.3.-", "PI": "NADPH Oxidases (2001-2017)", "MS": "An NADPH oxidase that is strongly expressed in the kidney. It forms a complex with CYBA-P22PHOX and produces intracellular SUPEROXIDES that may regulate cellular signaling in APOPTOSIS; BONE RESORPTION; and NF-KAPPA B activation.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074663"}, {"RECTYPE": "D", "MH": "NADPH Oxidase 5", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nox5 Protein|T116|T126|ABX|EQV|NLM (2018)|170306|abbcdef", "MN": "D12.776.543.653.968", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 1.6.3.-", "PI": "NADPH Oxidases (2001-2017)", "MS": "An NADPH oxidase that contains four EF HANDS and is expressed primarily by SPERMATOCYTES and LYMPHOCYTES, as well as by endothelial cells. It functions as a calcium-dependent proton channel to generate SUPEROXIDES that regulate cell growth, APOPTOSIS; and PHYSIOLOGIC ANGIOGENESIS.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074664"}, {"RECTYPE": "D", "MH": "Nephroureterectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Ureteronephrectomies", "MN": "E04.950.774.435.500", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Nephrectomy (1963-2017)", "MS": "Surgical removal of a kidney and adjoining ureter.", "PM": "2018", "HN": "2018", "MR": "20181102", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074682"}, {"RECTYPE": "D", "MH": "Proteostasis", "AQ": "DE GE IM PH RE", "ENTRY": "Proteostases", "MN": "G03.816", "FX": "Proteostasis Deficiencies", "MH_TH": "NLM (2018)", "ST": "T070", "PI": "Protein Folding (2006-2017)", "MS": "Regulation of the concentration, folding, interactions, and cellular localization of each of the proteins that comprise the PROTEOME.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074702"}, {"RECTYPE": "D", "MH": "Nematocera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.720.500.500.750.712", "MH_TH": "NLM (2018)", "ST": "T204", "RN": "txid7148", "PI": "Diptera (1963-2017)", "MS": "A suborder of insects which belong to the order DIPTERA. They include mosca, mosquito, gnats, black flies, true flies and long-horned flies.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074703"}, {"RECTYPE": "D", "MH": "Quasispecies", "AQ": "DE GE IM PH RE", "ENTRY": "Viral Quasi Species", "MN": "G05.365.897", "MH_TH": "NLM (2018)", "ST": "T070", "PI": "Genetic Variation (1989-2017)", "MS": "Variations among a population of a given species due to errors in replication of the genome that result in a distribution of non-identical members.", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074704"}, {"RECTYPE": "D", "MH": "Human Genetics", "DE": "HUMAN GENET", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Genetics, Human|T091|NON|EQV|UNK (19XX)|790529|GENET HUMAN|abcdefv", "MN": "H01.158.273.343.385", "MH_TH": "UNK (19XX)", "ST": "T091", "AN": "use for the discipline only; note that Medical Genetics is available for the subfield of human genetics dealing with genetic or hereditary disorders", "MS": "The scientific study of inherited human variation.", "PM": "2018; see GENETICS, MEDICAL 1980-2017", "HN": "2018; use GENETICS, MEDICAL 1980-2017", "MR": "20170705", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074705"}, {"RECTYPE": "D", "MH": "Sublimation, Chemical", "AQ": "DE RE", "ENTRY": "Chemical Sublimation", "MN": "G02.734.700", "MH_TH": "NLM (2018)", "ST": "T070", "MS": "The process of solids transforming into a gaseous state or vice versa, without passing through a liquid state.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074706"}, {"RECTYPE": "D", "MH": "Campylobacterales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.150.235", "MH_TH": "NLM (2018)", "ST": "T007", "RN": "txid213849", "MS": "Gram negative microaerophilic bacteria of the phylum PROTEOBACTERIA, class  EPSILONPROTEOBACTERIA.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074707"}, {"RECTYPE": "D", "MH": "Lateral Internal Sphincterotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Sphincterotomy, Lateral Internal", "MN": "E04.515.750.375", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Fissure in Ano/surgery (1963-2017)", "MS": "Surgical incision of the INTERNAL ANAL SPHINCTER typically in the treatment of FISSURE IN ANO; chronic ANAL FISSURE and FECAL INCONTINENCE.", "PM": "2018", "HN": "2018", "MR": "20181102", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074722"}, {"RECTYPE": "D", "MH": "Oncogene Addiction", "AQ": "GE", "ENTRY": "Addiction, Oncogenic", "MN": "C23.550.727.850", "MH_TH": "NLM (2018)", "ST": "T191", "PI": "Oncogenes (2002-2017)", "MS": "The dependence of tumor cells on a single oncogenic pathway or protein for their continued proliferation and survival.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074723"}, {"RECTYPE": "D", "MH": "Median Arcuate Ligament Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Dunbar", "MN": "C16.131.240.850.898", "MH_TH": "NLM (2017)", "ST": "T047", "MS": "Compression of the CELIAC ARTERY by the median arcuate ligament, a fibrous band of the DIAPHRAGM, causing abdominal pain after eating and weight loss. OMIM: 116870", "PM": "2018; MEDIAN ARCUATE LIGAMENT SYNDROME was indexed under CELIAC ARTERY and CONSTRICTION, PATHOLOGIC 2013-2017", "HN": "2018 (2013)", "MR": "20170406", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074742"}, {"RECTYPE": "D", "MH": "Hemodynamic Monitoring", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Monitoring, Hemodynamic", "MN": "E01.370.520.365", "MH_TH": "NLM (2018)", "ST": "T060", "PI": "Monitoring, Physiologic (1968-2017)", "MS": "Continuous measurement of the movement and forces of blood in the CARDIOVASCULAR SYSTEM.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074743"}, {"RECTYPE": "D", "MH": "ADP-Ribosylation", "AQ": "DE GE IM PH RE", "ENTRY": "Ribosylations, ADP", "MN": "G05.308.670.600.200", "FX": "ADP Ribose Transferases", "MH_TH": "NLM (2018)", "ST": "T044", "MS": "Post-translational modification of proteins with ADENOSINE DIPHOSPHATE RIBOSE.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074744"}, {"RECTYPE": "D", "MH": "Pterygota", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.720", "MH_TH": "NLM (2018)", "ST": "T204", "RN": "txid7496", "MS": "A subclass of winged insects belonging to the class Insecta.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074745"}, {"RECTYPE": "D", "MH": "Neoptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.720.500", "MH_TH": "NLM (2018)", "ST": "T204", "RN": "txid33340", "PI": "Insects (2007-2017)", "MS": "Modern insects belonging to the subclass PTERYGOTA, Many have the ability to fold their wings with exceptions being butterflies, moths, and a few others within the group.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074746"}, {"RECTYPE": "D", "MH": "Poly ADP Ribosylation", "AQ": "DE GE IM PH RE", "ENTRY": "Ribosylations, Poly ADP", "MN": "G05.308.670.600.200.500", "FX": "Poly(ADP-ribose) Polymerases", "MH_TH": "NLM (2018)", "ST": "T044", "MS": "Post-translational modification of proteins with POLY ADENOSINE DIPHOSPHATE RIBOSE.", "PM": "2018", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074747"}, {"RECTYPE": "D", "MH": "Holometabola", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.720.500.500", "MH_TH": "NLM (2018)", "ST": "T204", "RN": "txid33392", "PI": "Insects (1992-2017)", "MS": "A superorder of insects within the NEOPTERA that go through metamorphosis from egg to larva, pupa, and adult stages. Orders of MOSQUITOES; BEES; BUTTERFLIES; and FLEAS belong to this group.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074748"}, {"RECTYPE": "D", "MH": "Deubiquitinating Enzyme CYLD", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cylindromatosis, Deubiquitinating Enzyme", "MN": "D12.776.624.776.482", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.4.19.12", "PI": "Tumor Suppressor Proteins (2001-2017)", "MS": "A deubiquitinase and tumor-suppressor protein that specifically cleaves LYSINE-63-linked polyubiquitin chains and also has endodeubiquitinase activity. It functions to regulate NF-KAPPA B and WNT SIGNALING PATHWAY activity, contributing to cell survival, proliferation, and differentiation. Mutations in the CYLD gene are associated with cases of FAMILIAL CYLINDROMATOSIS.", "PM": "2018", "HN": "2018", "MR": "20170602", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074749"}, {"RECTYPE": "D", "MH": "Aeromonadales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.018", "MH_TH": "NLM (2018)", "ST": "T007", "RN": "txid135624", "PI": "Gammaproteobacteria (2008-2017)", "MS": "An order of Gram-negative bacteria in the class GAMMAPROTEOBACTERIA, phylum PROTEOBACTERIA, which include important pathogens.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074762"}, {"RECTYPE": "D", "MH": "Alethinophidia", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Alethinophidias", "MN": "B01.050.150.900.833.672.125", "MH_TH": "NLM (2018)", "ST": "T014", "PI": "Snakes (1966-2017)", "MS": "An infraorder of snakes in the order Serpentes that includes all snakes except blind snakes and thread snakes.", "PM": "2018", "HN": "2018", "MR": "20200902", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074764"}, {"RECTYPE": "D", "MH": "Dysbindin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hermansky Pudlak Syndrome 7 Protein", "MN": "D12.776.631.262", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Dystrophin-Associated Proteins (2001-2017)", "MS": "A dystrophin-associated protein and component of the Biogenesis of Lysosomal Organelles Complex-1 (BLOC-1 complex) which is essential for the formation of LYSOSOME - derived organelles such as platelet dense granules and MELANOSOMES. DTNBP1 is expressed primarily in the brain and neurons, where it functions with ADAPTOR PROTEIN COMPLEX 3 to transport membrane proteins to NEURITES and nerve terminals. It also regulates the release of neurotransmitters, transport of synaptic vesicles, and localization of DOPAMINE D2 RECEPTORS. Mutations in the DTNBP1 gene are associated with Type 7 HERMANSKY-PUDLAK SYNDROME and SCHIZOPHRENIA.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074765"}, {"RECTYPE": "D", "MH": "Dipsacales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Viburnale", "MN": "B01.875.800.575.912.250.328", "MH_TH": "NLM (2018)", "ST": "T002", "RN": "txid4199", "MS": "An order of dicotyledonous flowering plants which includes six families. It is best known for its ornamental plants such as LONICERA (honeysuckle), VIBURNUM (arrowwood and guelder rose), and SCABIOSA (scabious, or pincushion flower).", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074766"}, {"RECTYPE": "D", "MH": "Diapause", "AQ": "DE GE IM PH RE", "MN": "G07.345.500.550.500.250", "FX": "Torpor", "MH_TH": "NLM (2018)", "ST": "T040", "MS": "A period of arrested growth or development in animals that is triggered by external conditions, such as length of day, extreme temperatures, or reduced food availability. It can occur at the embryonic, larval, pupal, or adult stage, depending on the species.", "PM": "2018; for DIAPAUSE, INSECT see DIAPAUSE, INSECT 2014-2017", "HN": "2018", "MR": "20170414", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074767"}, {"RECTYPE": "D", "MH": "Treatment Adherence and Compliance", "AQ": "EH PX SN", "ENTRY": "Adherence, Treatment", "MN": "N05.300.150.800", "MH_TH": "NLM (2018)", "ST": "T055", "PI": "Patient Compliance (1963-2017)", "MS": "Extent to which the patient follows prescribed treatment such as keeping APPOINTMENTS AND SCHEDULES and MEDICATION ADHERENCE for desired therapeutic outcome. It implies active responsibility shared by patient and health care providers.", "PM": "2018", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074822"}, {"RECTYPE": "D", "MH": "One Health", "AQ": "EC ES HI LJ SN ST TD", "ENTRY": "One Medicine Initiative|T078|NON|REL|NLM (2017)|160610|abcdef", "MN": "N01.400.530", "MH_TH": "NLM (2017)", "ST": "T078", "MS": "An integrative effort of multiple disciplines working collaboratively and locally, nationally, and globally in all aspects of health care for humans, animals, and the environment.", "PM": "2018; see GLOBAL HEALTH 2017", "HN": "2018; use GLOBAL HEALTH 2017", "MR": "20180629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074823"}, {"RECTYPE": "D", "MH": "Work Engagement", "ENTRY": "Participations, Worker", "MN": "N04.452.677.896", "FX": "Return to Work", "MH_TH": "NLM (2018)", "ST": "T057", "PI": "Workplace (2006-2017)", "MS": "Extent to which members of a workplace perceive their emotional commitment to and involvement in the organization and its goals.", "PM": "2018", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074824"}, {"RECTYPE": "D", "MH": "Forkhead Box Protein L2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Forkhead Box L2 Protein|T116|T123|NON|EQV|NLM (2018)|170315|abbcdef", "MN": "D12.776.930.977.249.032", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Forkhead Transcription Factors (2006-2017)", "MS": "A forkhead box transcription factor that is expressed in the developing eyelid and during very early development of the gonad, prior to sex determination. It is essential for development of the ovary and inhibits SOX9 TRANSCRIPTION FACTOR to prevent differentiation to testes. It also induces APOPTOSIS in ovarian cells. Mutations in the FOXL2 gene are associated with BLEPHAROPHIMOSIS; Ptosis, and Epicanthus inversus (BPES with ovarian failure).", "PM": "2018", "HN": "2018", "MR": "20170522", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074842"}, {"RECTYPE": "D", "MH": "Salpingo-oophorectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Salpingo-oophorectomies", "MN": "E04.950.300.715.500", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Salpingectomy (2010-2017)", "MS": "Combined surgical resection of the fallopian tube and the ovary.", "PM": "2018", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074868"}, {"RECTYPE": "D", "MH": "Pyloromyotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Pyloromyotomies", "MN": "E04.515.375", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Pylorus (1963-2017)", "MS": "Surgical incision of the PYLORUS used to treat pyloric stenoses (e.g. INFANTILE HYPERTROPHIC PYLORIC STENOSIS).", "PM": "2018", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074882"}, {"RECTYPE": "D", "MH": "Vulvectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Vulvectomies", "MN": "E04.950.300.970", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Gynecologic Surgical Procedures (1984-2017)", "MS": "Surgical resection of the VULVA.", "PM": "2018", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074883"}, {"RECTYPE": "D", "MH": "Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Paracaspase, MALT1", "MN": "D08.811.464.938.750.233", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.4.22.-", "PI": "Neoplasm Proteins (1999-2017)", "MS": "A caspase-like cysteine endopeptidase that also exhibits ubiquitin ligase activity. It contains an N-terminal DEATH DOMAIN, two IMMUNOGLOBULIN-LIKE DOMAINS, and localizes to the perinuclear region of MONOCYTES, where it functions in activation of NF-KAPPA B; it also binds to and activates TRAF6. Chromosomal translocations involving the MALT1 and BIRC2 genes are associated with MALT LYMPHOMA, and mutations in the MALT1 gene are associated with Type 12 IMMUNODEFICIENCY SYNDROMES.", "PM": "2018", "HN": "2018", "MR": "20170522", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074884"}, {"RECTYPE": "D", "MH": "Amniotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Artificial Rupture of Membranes|T061|NON|EQV|NLM (2018)|170317|abcdef", "MN": "E04.520.252.968.500", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Labor, Induced (1965-2017)", "MS": "A method of inducing labor by deliberate rupture of the AMNION to cause the release of amniotic fluid.", "PM": "2018", "HN": "2018", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074885"}, {"RECTYPE": "D", "MH": "High-Temperature Requirement A Serine Peptidase 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Serine Protease, Omi", "MN": "D12.776.705.625", "FX": "PDZ Domains", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.4.21.108", "MS": "A serine peptidase that contains a C-terminal PDZ domain. It localizes to the mitochondrial membrane and intermembrane space, translocating to the cytoplasm following APOPTOSIS stimuli, such as UV irradiation; it promotes cell death by binding to and inhibiting INHIBITOR OF APOPTOSIS PROTEINS, resulting in an increase in activity of CASPASES. Mutations in the HTRA2 gene are associated with Type 13 PARKINSON DISEASE.", "PM": "2018; HIGH-TEMPERATURE REQUIREMENT A SERINE PEPTIDASE 2 was indexed under SERINE ENDOPEPTIDASES and MITOCHONDRIAL PROTEINS 2000-2017", "HN": "2018 (2000)", "MR": "20220712", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074923"}, {"RECTYPE": "D", "MH": "Nut and Peanut Hypersensitivity", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tree Nut and Peanut Allergy|T047|NON|EQV|NLM (2018)|170322|abcdef", "MN": "C20.543.480.370.572", "MH_TH": "NLM (2018)", "ST": "T047", "PI": "Peanut Hypersensitivity (2001-2017)", "MS": "Allergic reaction to tree nuts and peanuts, including other LEGUMES, that is triggered by the immune system. It includes co-sensitization to other food (e.g., sesame seed).", "PM": "2018", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074924"}, {"RECTYPE": "D", "MH": "Kounis Syndrome", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Myocardial Infarction, Allergic", "MN": "C20.543.560", "MH_TH": "NLM (2018)", "ST": "T047", "PI": "Drug Hypersensitivity (2005-2017)", "MS": "A disorder of cardiac function secondary to hypersensitivity reactions. It is characterized by coexistence of acute coronary syndromes and cardiac MAST CELL and PLATELET ACTIVATION. It may be induced by exposure to drugs (e.g., antibiotics, anesthetics, contrast media), food, and environmental triggers (e.g., insect bites and stings, poison ivy).", "PM": "2018", "HN": "2018", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074962"}, {"RECTYPE": "D", "MH": "Palaeoptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Paleoptera|T204|NON|EQV|NLM (2018)|170323|abcdef", "MN": "B01.050.500.131.617.720.750", "MH_TH": "NLM (2018)", "ST": "T204", "RN": "txid33339", "PI": "Insects (1963-2017)", "MS": "Infraclass of ancient winged insects belonging to the subclass PTERYGOTA.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000074982"}, {"RECTYPE": "D", "MH": "Acepromazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acetylpromazine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef", "ENTRY": "Maleate, Acepromazine", "MN": "D03.633.300.783.029", "PA": "Dopamine Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Ethanone, 1-(10-(3-(dimethylamino)propyl)-10H-phenothiazin-2-yl)-", "RN": "54EJ303F0R", "RR": "61-00-7 (Acepromazine)", "MS": "A phenothiazine that is used in the treatment of PSYCHOSES.", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000075"}, {"RECTYPE": "D", "MH": "Bestrophins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Bestrophin|T116|T123|NON|EQV|NLM (2022)|201013|abbcdef", "ENTRY": "Bestrophin 2", "MN": "D12.776.543.585.400.175.063", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Eye Proteins (1999-2017)", "MS": "A protein family characterized by a highly conserved N-terminus and four to six transmembrane helices; they function as bicarbonate permeable, calcium-activated chloride channels. Bestrophin-1 (BEST-1) and bestrophin-2 are highly expressed in human RETINAL PIGMENT EPITHELIUM cells and mutations in the BEST-1 gene are associated with VITELLIFORM MACULAR DYSTROPHY, TYPE 2.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075002"}, {"RECTYPE": "D", "MH": "Academic Failure", "AQ": "PX TD", "ENTRY": "Failures, Academic", "MN": "N01.824.196.125", "MH_TH": "NLM (2018)", "ST": "T080", "PI": "Educational Measurement (1966-2017)", "MS": "Student\u2019s unsuccessful attempt at academic achievement or a marked inadequacy in the areas of scholarship or study. This is not underachievement which is performance, usually in school work, poorer than that predicted from aptitude and/or intelligence testing.", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075022"}, {"RECTYPE": "D", "MH": "S100 Calcium Binding Protein A7", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "S100 A7 Protein", "MN": "D12.776.157.125.750.563", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "S100 Proteins (2010-2017)", "MS": "An S100 calcium binding protein that contains two EF HAND MOTIFS and also binds zinc. It is secreted via a non-classical secretory pathway and expressed by KERATINOCYTES and epithelial cells of the tongue. It has antimicrobial and immunomodulatory activities and is highly expressed in the skin of patients with PSORIASIS, as well as in bladder and skin epithelial carcinomas.", "PM": "2018", "HN": "2018", "MR": "20170524", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075023"}, {"RECTYPE": "D", "MH": "rhoC GTP-Binding Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "rhoC GTP Binding Protein", "MN": "D12.776.476.338.400.700.650", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "GTP-Binding Proteins (1991-2017)", "MS": "A rho GTP-binding protein that is prenylated (see PROTEIN PRENYLATION) at its C-terminus and cycles between the cytoplasm and plasma membrane, linking receptor signaling pathways with assembly of FOCAL ADHESIONS; STRESS FIBERS; and contractile ring formation during CYTOKINESIS. It is overexpressed in proliferating and metastatic tumor cells.", "PM": "2018", "HN": "2018", "MR": "20210521", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075024"}, {"RECTYPE": "D", "MH": "Sustainable Growth", "ENTRY": "Growths, Sustainable", "MN": "J01.839", "MH_TH": "NLM (2018)", "ST": "T068", "MS": "Achievement of an economic system that can continue to grow for the foreseeable future.", "PM": "2018", "HN": "2018", "MR": "20170709", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075042"}, {"RECTYPE": "D", "MH": "Pre-B-Cell Leukemia Transcription Factor 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pre B Cell Leukemia Transcription Factor 1", "MN": "D12.776.930.712", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Proto-Oncogene Proteins (1993-2017)", "MS": "A TALE-type homeodomain protein and transcription factor that binds the DNA sequence 5'-ATCAATCAA-3'. It forms a heterodimer with MEIS1 TRANSCRIPTION FACTOR and functions as a transcriptional activator of HOMEOBOX PROTEIN NKX-2.5 and ELONGIN A, and as a transcriptional repressor of CDKN2B PROTEIN, in the regulation of developmental and morphogenetic processes such as spleen and limb development. Chromosome translocations involving the PBX1 and TCF3 genes occur in cases of pre-B-cell ACUTE LYMPHOID LEUKEMIA.", "PM": "2018", "HN": "2018", "MR": "20170522", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075062"}, {"RECTYPE": "D", "MH": "Lilianae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618", "MH_TH": "NLM (2018)", "ST": "T002", "PI": "Liliaceae (2013-2017)", "MS": "A superorder of flowering plants (Angiosperms) which includes monocotyledonous plants.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075063"}, {"RECTYPE": "D", "MH": "Myeloid Ecotropic Viral Integration Site 1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, Meis1", "MN": "D12.776.930.462", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A TALE-type homeodomain protein and transcription factor that functions as a regulator of PAX6 PROTEIN expression and as an activator of PLATELET FACTOR 4 gene expression. It is essential for hematopoiesis, differentiation of MEGAKARYOCYTES, and vascular patterning. It may also have a role in the induction of myeloid leukemias.", "PM": "2018; MYELOID ECOTROPIC VIRAL INTEGRATION SITE 1 PROTEIN was indexed under NEOPLASM PROTEINS and HOMEODOMAIN PROTEINS 1995-2017", "HN": "2018 (1995)", "MR": "20170522", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075064"}, {"RECTYPE": "D", "MH": "Elongin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SIII, Transcription Factor", "MN": "D12.776.930.215", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "MS": "A heterotrimeric protein complex composed of 110 kDa elongin A, 18 kDa elongin B, and 15 kDa elongin C subunits. It functions as a positive regulator of RNA POLYMERASE II, increasing its rate of transcriptional elongation by suppressing transient pausing along the DNA template. Elongin A is the transcriptionally active component; elongins B and C enhance its activity.", "PM": "2018; ELONGIN was indexed under TRANSCRIPTION FACTORS 1995-2017", "HN": "2018 (1995)", "MR": "20170522", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075065"}, {"RECTYPE": "D", "MH": "Body Packing", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Stuffing, Body", "MN": "I01.880.735.191.026", "MH_TH": "NLM (2018)", "ST": "T055", "MS": "Concealing of drugs within the gastrointestinal tract or other body orifice for purposes of DRUG SMUGGLING or to avoid detection by law enforcement. Contraband other than drugs is also sometimes smuggled this way.", "PM": "2018", "HN": "2018", "MR": "20170623", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075066"}, {"RECTYPE": "D", "MH": "Substance Abuse, Oral", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Substance Abuses, Oral", "MN": "F03.900.809", "FX": "Body Packing", "MH_TH": "NLM (2018)", "ST": "T055", "MS": "Abuse, overuse, or misuse of a substance by ingestion.", "PM": "2018", "HN": "2018", "MR": "20170623", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075067"}, {"RECTYPE": "D", "MH": "Proof of Concept Study", "ENTRY": "Testing Proofs, Concept", "MN": "H01.770.644.578", "MH_TH": "NLM (2018)", "ST": "T170", "MS": "An empirical investigation which pertains to the development of prototypes or models that demonstrate the feasibility of novel concepts, ideas, principles, schema or their practical application.", "PM": "2018", "HN": "2018", "MR": "20170522", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075082"}, {"RECTYPE": "D", "MH": "Organic Cation Transporter 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Solute Carrier Family 22 Member 2|T116|T123|NON|EQV|NLM (2018)|170331|abbcdef", "MN": "D12.776.543.585.937.701.625", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Organic Cation Transport Proteins (2002-2017)", "MS": "Organic cation transporter consisting of twelve transmembrane domains and expressed primarily in the kidney. It transports a wide range of metabolites, drugs, and neurotransmitters from the blood to the KIDNEY TUBULES, including DOPAMINE; SEROTONIN; CHOLINE; and CISPLATIN.", "PM": "2018", "HN": "2018", "MR": "20170524", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075102"}, {"RECTYPE": "D", "MH": "Smoldering Multiple Myeloma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Smoldering Myelomas", "MN": "C20.683.780.838", "MH_TH": "NLM (2018)", "ST": "T191", "PI": "Multiple Myeloma (1980-2017)", "MS": "An asymptomatic and slow-growing PLASMA CELL dyscrasia characterized by presence of MYELOMA PROTEINS and clonal bone marrow plasma cells without end-organ damage (e.g., renal impairment). It is distinguished from MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE by a much higher risk of progression to symptomatic MULTIPLE MYELOMA.", "PM": "2018", "HN": "2018", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075122"}, {"RECTYPE": "D", "MH": "RUNX1 Translocation Partner 1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "RUNX1T1 Protein|T116|T123|ABX|EQV|NLM (2018)|170405|abbcdef", "MN": "D12.776.930.780.625.575", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (2008-2017)", "MS": "A transcriptional co-repressor that contains a MYND-type zinc finger (MYND DOMAIN) at its C-terminal and functions as a homo-oligomer. It associates with DNA-binding transcription factors, other repressor proteins, and HISTONE ACETYLTRANSFERASES to repress expression of genes involved in cell growth and differentiation such as MATRIX METALLOPROTEINASE 7 and TCF12. A CHROMOSOMAL TRANSLOCATION involving the RUNX1T1 and CORE BINDING FACTOR ALPHA 2 SUBUNIT (RUNX1) genes frequently occurs in cells of leukemia patients; the resulting fusion protein (AML1-ETO or RUNX1-RUNX1T1) plays a critical role in leukemogenesis.", "PM": "2018", "HN": "2018", "MR": "20170405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075142"}, {"RECTYPE": "D", "MH": "Abuse-Deterrent Formulations", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Abuse-Deterrent Formulation|T121|NON|EQV|NLM (2021)|200417|abcdef", "ENTRY": "Formulations, Abuse-Deterrent", "MN": "E05.916.250.500", "FX": "Drug Compounding", "MH_TH": "NLM (2018)", "ST": "T121", "RN": "0", "MS": "Drug formulations or delivery systems intended to discourage the abuse of CONTROLLED SUBSTANCES. These may include physical barriers to prevent chewing or crushing the drug; chemical barriers that prevent extraction of psychoactive ingredients; agonist-antagonist combinations to reduce euphoria associated with abuse; aversion, where controlled substances are combined with others that will produce an unpleasant effect if the patient manipulates the dosage form or exceeds the recommended dose; delivery systems that are resistant to abuse such as implants; or combinations of these methods.", "PM": "2018", "HN": "2018", "MR": "20200527", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075162"}, {"RECTYPE": "D", "MH": "Metallocenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ferrocenes|T109|NON|NRW|NLM (2018)|170501|abcdef", "MN": "D02.691.657", "FX": "Cyclopentanes", "MH_TH": "NLM (2018)", "ST": "T109", "RN": "0", "PI": "Organometallic Compounds (1970-2017)", "MS": "Organometallic compounds that generally consist of two cylcopentadiene ANIONS joined in their centers by a metallic cation such as NICKEL; IRON; or TITANIUM.", "PM": "2018", "HN": "2018", "MR": "20170522", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075163"}, {"RECTYPE": "D", "MH": "Agent Orange", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Orange, Agent", "MN": "D03.633.300.786.500", "MH_TH": "NLM (1980)", "ST": "T131", "N1": "(2,4,5-Trichlorophenoxy)acetic acid - (2,4-dichlorophenoxy)acetic acid (1:1)", "RN": "39277-47-9", "MS": "A herbicide that contains equal parts of 2,4-dichlorophenoxyacetic acid (2,4-D) and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), as well as traces of the contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.", "PM": "2018; AGENT ORANGE was indexed under POLYCHLORINATED DIBENZODIOXINS, 2,4-DICHLOROPHENOXYACETIC ACID, and 2,4,5-TRICHLOROPHENOXYACETIC ACID 1980-2017", "HN": "2018 (1980)", "MR": "20170524", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075182"}, {"RECTYPE": "D", "MH": "Contraindications", "ENTRY": "Physical Agent Contraindications", "MN": "E02.208", "MH_TH": "NLM (2018)", "ST": "T201", "AN": "general or unspecified; CONTRAINDICATIONS, DRUG and CONTRAINDICATIONS, PROCEDURE are also available; note entry term CONTRAINDICATIONS, PHYSICAL AGENT: coordinate with specific physical agent /adv eff or /ther use", "MS": "A condition or factor associated with a recipient that makes the use of a drug, procedure, or physical agent improper or inadvisable.  Contraindications may be absolute (life threatening) or relative (higher risk of complications in which benefits may outweigh risks).", "PM": "2018", "HN": "2018(1991)", "MR": "20170705", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075202"}, {"RECTYPE": "D", "MH": "Contraindications, Drug", "ENTRY": "Drug Contraindication", "MN": "E02.208.200", "FX": "Drug-Related Side Effects and Adverse Reactions", "MH_TH": "NLM (2018)", "ST": "T201", "AN": "coordinate with specific drug with /adv eff or /ther use", "MS": "A condition or factor associated with a recipient that makes the use of a specific drug improper or inadvisable.", "PM": "2018", "HN": "2018", "MR": "20170705", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075203"}, {"RECTYPE": "D", "MH": "Contraindications, Procedure", "ENTRY": "Therapeutic Procedure Contraindications", "MN": "E02.208.600", "MH_TH": "NLM (2018)", "ST": "T033", "AN": "coordinate with specific procedure /adv eff", "MS": "A condition or factor associated with a recipient that makes the use of a procedure improper or inadvisable.", "PM": "2018", "HN": "2018", "MR": "20170705", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075204"}, {"RECTYPE": "D", "MH": "Essential Hypertension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Primary Hypertension|T047|NON|EQV|NLM (2023)|210901|abcdef", "ENTRY": "Primary Hypertensions", "MN": "C14.907.489.165", "MH_TH": "NLM (2018)", "ST": "T047", "MS": "Hypertension that occurs without known cause, or preexisting renal disease. Associated polymorphisms for a number of genes have been identified, including AGT, GNB3, and ECE1. OMIM: 145500", "PM": "2018; HYPERTENSION, ESSENTIAL was indexed under HYPERTENSION 2013-2017", "HN": "2018(2013)", "MR": "20211018", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075222"}, {"RECTYPE": "D", "MH": "Poly-ADP-Ribose Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "pADPr Binding Proteins", "MN": "D12.776.660.720", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Protein Binding (1994-2017)", "MS": "Proteins that contain POLY-ADP RIBOSE BINDING MOTIFS. They include HISTONES and other proteins that function in DNA REPAIR, replication, gene transcription, and APOPTOSIS.", "PM": "2018", "HN": "2018", "MR": "20170524", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075223"}, {"RECTYPE": "D", "MH": "Cardiac Conduction System Disease", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Defect, Cardiac Conduction", "MN": "C14.280.123", "MH_TH": "NLM (2018)", "ST": "T047", "MS": "Diseases characterized by pathological irregularities in the HEART CONDUCTION SYSTEM. They may be associated with other heart diseases and syndromes (e.g., BRUGADA SYNDROME; NEUROMUSCULAR DISEASE, HEART BLOCKS), isolated or may result from injuries. You can have a conduction disorder without having an arrhythmia, but some arrhythmias arise from conduction disorders. OMIM: 601144.", "PM": "2018; CARDIAC CONDUCTION DEFECTS was indexed under BRUGADA SYNDROME 2013-2017", "HN": "2018(2013)", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075224"}, {"RECTYPE": "D", "MH": "Poly-ADP-Ribose Binding Motif", "AQ": "DE GE IM PH RE", "ENTRY": "pADPr Binding Motifs", "MN": "G02.111.570.820.709.275.500.695", "MH_TH": "NLM (2018)", "ST": "T087", "PI": "Protein Binding (2008-2017)", "MS": "A protein motif 22 to 26 amino acids in length that binds POLY(ADP RIBOSE) polymers through non-covalent interactions. It is characterized by basic and hydrophobic residues that frequently include ALANINE; VALINE; ISOLEUCINE; or LEUCINE and flank LYSINE and ARGININE amino acids.", "PM": "2018", "HN": "2018", "MR": "20170522", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075225"}, {"RECTYPE": "D", "MH": "Janus Kinase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Janus Kinase Inhibitor|T121|NON|EQV|NLM (2021)|191219|abcdef", "ENTRY": "Kinase Inhibitors, Janus", "MN": "D27.505.519.389.755.500", "MH_TH": "NLM (2018)", "ST": "T121", "RN": "0", "PI": "Protein Kinase Inhibitors (2009-2017)", "MS": "Agents that inhibit JANUS KINASES.", "PM": "2018", "HN": "2018", "MR": "20200527", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075242"}, {"RECTYPE": "D", "MH": "Apolipoproteins M", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apolipoprotein M|T116|T123|NON|EQV|NLM (2018)|170414|abbcdef", "MN": "D12.776.521.120.100", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Lipocalins (2008-2017)", "MS": "Apolipoproteins and lipocalins that occur in HIGH-DENSITY LIPOPROTEINS. They bind or transport lipids in the blood including sphingosine-1-phosphate, MYRISTIC ACID; STEARIC ACIDS; and ALL-TRANS-RETINOIC ACID.", "PM": "2018", "HN": "2018", "MR": "20190530", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075243"}, {"RECTYPE": "D", "MH": "Apelin Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Apelin", "MN": "D12.776.543.750.695.006", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "0", "PI": "Receptors, G-Protein-Coupled (2004-2017)", "MS": "G-protein coupled receptors for APELIN that function in a broad range of physiologic processes including blood pressure regulation and heart contractility. They also have an essential role in early embryo development for GASTRULATION and heart morphogenesis, and can also function as a CD4 co-receptor for HIV-1.", "PM": "2018", "HN": "2018", "MR": "20170601", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075244"}, {"RECTYPE": "D", "MH": "Hypoadrenocorticism, Familial", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "X-Linked Addison Disease", "MN": "C19.053.500.263.500", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Hereditary forms of Addison disease that may exhibit autosomal recessive or X-linked  inheritance. They are characterized by severe neurological symptoms, APNEA;  and death in infancy. OMIM: 240200", "PM": "2018; HYPOADRENOCORTICISM, FAMILIAL was indexed under ADRENAL INSUFFICIENCY 2010-2017", "HN": "2018(2010)", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075262"}, {"RECTYPE": "D", "MH": "Incivility", "AQ": "CL DE ES PC PH SN", "ENTRY": "Uncivil Behaviors", "MN": "I01.880.735.461", "MH_TH": "NLM (2018)", "ST": "T054", "PI": "Social Behavior (2001-2017)", "MS": "Low-intensity deviant behavior with ambiguous intent to harm the target, in violation of norms for mutual respect.", "PM": "2018", "HN": "2018", "MR": "20170524", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075282"}, {"RECTYPE": "D", "MH": "Connexin 30", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Gap Junction beta 6 Protein", "MN": "D12.776.543.585.250.150", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Connexins (1996-2017)", "MS": "A gap junction beta subunit that forms heteromeric hemichannels when paired with alpha subunits such as connexin-40 or CONNEXIN 43. Mutations in the connexin 30 gene (GJ6B) are associated with CLOUSTON'S SYNDROME and some hereditary forms of deafness.", "PM": "2018", "HN": "2018", "MR": "20170524", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075302"}, {"RECTYPE": "D", "MH": "Heavy Metal Poisoning", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Poisonings, Heavy Metal", "MN": "C25.723.522", "FX": "Metals, Heavy", "MH_TH": "NLM (2018)", "ST": "T037", "MS": "Poisoning that results from chronic or acute ingestion, injection, inhalation, or skin absorption of HEAVY METALS. Acute and chronic exposures can cause ANEMIA; KIDNEY and LIVER damage; PULMONARY EDEMA; MEMORY LOSS and behavioral changes; bone deformities in children; and MISCARRIAGE or PREMATURE LABOR in pregnant women.", "PM": "2018; HEAVY METAL TOXICITY was indexed under POISONING 2010-2017 and METALS, HEAVY/POISONING 2010-2017", "HN": "2018(2010)", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075322"}, {"RECTYPE": "D", "MH": "Animal Scales", "AQ": "AB AH CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE TR UL VI", "ENTRY": "Scales, Epidermal", "MN": "A17.100", "MH_TH": "NLM (2018)", "ST": "T023", "PI": "Skin (1963-2017)", "MS": "Tough, horny, brittle, smooth, striated or plate-like extensions of the stratum corneum or outer layer of the skin. It serves as a protective layer in fishes, reptiles, birds, and mammals.", "PM": "2018", "HN": "2018", "MR": "20180629", "DA": "20170712", "DC": "1", "DX": "20180101", "UI": "D000075342"}, {"RECTYPE": "D", "MH": "Leukocyte Immunoglobulin-like Receptor B1", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Leukocyte Immunoglobulin like Receptor B1", "MN": "D12.776.543.750.705.023", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1997-2017)", "MS": "A receptor for HISTOCOMPATIBILITY ANTIGENS CLASS I that also functions as a receptor for the UL18 protein, an MHC class I homolog expressed by human CYTOMEGALOVIRUS. It consists of four Ig-like C2 domains and is expressed primarily by B-cells and MONOCYTES, as well as DENDRITIC CELLS; its interaction with MHC1 functions to down-regulate the immune response.", "PM": "2018", "HN": "2018", "MR": "20170524", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075362"}, {"RECTYPE": "D", "MH": "Immunoglobulin Light-chain Amyloidosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Monoclonal Immunoglobulin Deposition Disease|T047|NON|EQV|NLM (2024)|230508|abcdef", "ENTRY": "Systemic Amyloidosis, Primary", "MN": "C20.683.780.565", "MH_TH": "NLM (2018)", "ST": "T047", "MS": "A nonproliferative disorder of PLASMA CELLS characterized by excessive production and misfolding of IMMUNOGLOBULIN LIGHT CHAINS that form insoluble amyloid fibrils (see AMYLOID DEPOSITS) in various tissues. Clinical features include LIVER FAILURE; MULTIPLE MYELOMA; NEPHROTIC SYNDROME; RESTRICTIVE CARDIOMYOPATHY, and neuropathies.", "PM": "2018; PRIMARY AMYLOIDOSIS was indexed under AMYLOIDOSIS 2010-2017", "HN": "2018(2010)", "MR": "20230609", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075363"}, {"RECTYPE": "D", "MH": "Deleted in Azoospermia 1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DAZ 1 Protein", "MN": "D12.776.664.962.813.375", "FX": "RNA Recognition Motif", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "RNA-Binding Proteins (1995-2017)", "MS": "An RNA recognition motif protein that is essential for SPERMATOGENESIS. It promotes entry of male GERM CELLS to MEIOSIS, possibly by regulating the translation of mRNAs. DAZ1 occurs within a cluster of similar genes on the Y CHROMOSOME that is prone to genetic deletions and duplications. Deletions in these genes, including DAZ1, are associated with AZOOSPERMIA and OLIGOSPERMIA.", "PM": "2018", "HN": "2018", "MR": "20170522", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075364"}, {"RECTYPE": "D", "MH": "Chemokine CCL18", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pulmonary and Activation Regulated Chemokine", "MN": "D23.529.374.200.600.075", "MH_TH": "NLM (2018)", "ST": "T129", "RN": "0", "PI": "Chemokines, CC (1998-2017)", "MS": "A CC-type chemokine highly expressed in the lungs, lymph nodes, placenta, and bone marrow; it is also expressed by DENDRITIC CELLS in the GERMINAL CENTER, and peripheral blood MACROPHAGES. It functions as a chemotactic factor that specifically attracts LYMPHOCYTES, especially B-Cells, into lymph node follicles, and naive T-cells towards dendritic cells and activated T-cells. It does not attract MONOCYTES or GRANULOCYTES.", "PM": "2018", "HN": "2018", "MR": "20170601", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075366"}, {"RECTYPE": "D", "MH": "Anoctamins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Family, TMEM16", "MN": "D12.776.543.585.400.175.032", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Chloride Channels (2009-2017)", "MS": "A family of transmembrane proteins that function primarily as calcium-activated chloride channels. Structurally, they form a homodimer where each subunit consists of eight transmembrane helices with the N and C terminals exposed to the cytosol. The regions between helices 5 and 7 may be important for ion pore formation and calcium ion binding.", "PM": "2018", "HN": "2018", "MR": "20170524", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075368"}, {"RECTYPE": "D", "MH": "Anoctamin-1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Anoctamin 1", "MN": "D12.776.543.585.400.175.032.500", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Chloride Channels (2003-2017)", "MS": "An anoctamin chloride channel expressed at high levels in the liver, skeletal muscle, and gastrointestinal muscles that functions in transepithelial anion transport and smooth muscle contraction. It is essential for the function of the INTERSTITIAL CELLS OF CAJAL and plays a major role in chloride conduction by airway epithelial cells and in tracheal cartilage development.", "PM": "2018", "HN": "2018", "MR": "20170524", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075369"}, {"RECTYPE": "D", "MH": "Receptors for Activated C Kinase", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "GNB2 RS1 Protein", "MN": "D12.776.826.313", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "Receptors for PROTEIN KINASE C that consist of seven WD40 REPEATS. They function in a wide variety of cellular and physiologic processes including the assembly of signaling complexes, protein translation, cell growth and proliferation, APOPTOSIS, and MUSCARINIC RECEPTOR transport. RACK1 depends on protein kinase C activity to translocate from the perinuclear region to the cell periphery and associates with the plasma membrane through interactions with KERATIN-1 and INTEGRIN BETA-1.", "PM": "2018; RECEPTORS FOR ACTIVATED C KINASE was indexed under RECEPTORS, CELL SURFACE 1992-2017", "HN": "2018 (1992)", "MR": "20170524", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075370"}, {"RECTYPE": "D", "MH": "S100 Calcium Binding Protein A6", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "S100 A6 Protein", "MN": "D12.776.167.481", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "S100 Proteins (2003-2017)", "MS": "An S100 calcium binding protein that contains two EF HAND MOTIFS and plays a role as a calcium sensor and modulator for many cellular processes such as CELL CYCLE progression; CELL MOTILITY and reorganization of the ACTIN CYTOSKELETON. Its expression is induced by growth factors and it is overexpressed in patients with ACUTE MYELOID LEUKEMIA.", "PM": "2018", "HN": "2018", "MR": "20170524", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075383"}, {"RECTYPE": "D", "MH": "Neuroticism", "AQ": "CL DE ES PH RE", "ENTRY": "Neuroticism Trait", "MN": "F01.752.723", "MH_TH": "OMIM (2013)", "ST": "T041", "MS": "Personality trait related to tendency to respond to threat, frustration or a loss with negative emotions (e.g., ANGER; ANXIETY; FRUSTRATION; embarrassment and sadness).", "PM": "2018; NEUROTICISM was indexed under ANXIETY DISORDERS 2013-2017", "HN": "2018(2013)", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075384"}, {"RECTYPE": "D", "MH": "Netrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Netrin Family|T116|T123|NON|EQV|NLM (2018)|170419|abbcdef", "MN": "D23.529.850.494", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Nerve Growth Factors (1994-2017)", "MS": "A family of extracellular proteins that are related structurally to LAMININ. They function as CHEMOTACTIC FACTORS for CELL MIGRATION and AXON GUIDANCE, acting as chemoattractants for some cell types, and as chemorepellents for others.", "PM": "2018", "HN": "2018", "MR": "20170522", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075385"}, {"RECTYPE": "D", "MH": "Netrin Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, Netrin-1", "MN": "D12.776.543.750.003", "MH_TH": "NLM (1997)", "ST": "T192", "RN": "0", "MS": "Cell surface receptors that bind NETRINS. They typically contain both IMMUNOGLOBULIN DOMAINS and FIBRONECTIN TYPE III DOMAINS and function to mediate CELL MIGRATION and AXON GUIDANCE.", "PM": "2018; NETRIN RECEPTORS was indexed under RECEPTORS, CELL SURFACE 1997-2017", "HN": "2018 (1997)", "MR": "20170524", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075386"}, {"RECTYPE": "D", "MH": "Smoking Water Pipes", "AQ": "CL EC HI MI PS RE SD SN ST VI", "ENTRY": "Waterpipes, Smoking", "MN": "J01.637.767.750.500", "FX": "Tobacco, Waterpipe", "MH_TH": "NLM (2018)", "ST": "T073", "PI": "Smoking (1989-2017)", "MS": "Pipes for smoking tobacco, cannabis, and other substances, in which smoke is drawn through water. Do not confuse with SMOKING PIPES.", "PM": "2018", "HN": "2018", "MR": "20230720", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075387"}, {"RECTYPE": "D", "MH": "Netrin-1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, Netrin-1", "MN": "D23.529.850.494.500", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "158651-98-0", "MS": "A netrin that binds the DCC RECEPTOR or UNC5 receptors, resulting respectively in axon attraction or repulsion. Its interaction with these receptors also prevents APOPTOSIS; it may function as a tumor suppressor protein.", "PM": "2018; NETRIN-1 was indexed under NERVE GROWTH FACTORS 1994-2017; and under TUMOR SUPPRESSOR PROTEINS 2002-2017", "HN": "2018 (1994)", "MR": "20170522", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075388"}, {"RECTYPE": "D", "MH": "DCC Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, DCC-Netrin-1", "MN": "D12.776.624.776.021", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "0", "PI": "Tumor Suppressor Proteins (2005-2017)", "MS": "A receptor for NETRIN-1 that contains four membrane distal (N-terminal) Ig-like C2 domains and six membrane proximal (C-terminal) fibronectin type III domains. It is expressed primarily in the nerve axons and differentiated intestinal cells and is required for AXON GUIDANCE, mediating axon attraction of neuronal GROWTH CONES; however, it may also trigger axon repulsion through association with the UNC5 netrin-1 receptor. DCC also induces APOPTOSIS when it is unbound from netrin-1.  Deletions of the DCC gene are observed in tumor metastases and the protein is not expressed in undifferentiated COLORECTAL CARCINOMA cells.", "PM": "2018", "HN": "2018", "MR": "20170524", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075389"}, {"RECTYPE": "D", "MH": "Channelrhodopsins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Channelrhodopsin|T116|T123|NON|EQV|NLM (2021)|191227|abbcdef", "MN": "D12.776.765.593.250", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "MS": "A subfamily of rhodopsin proteins that function as light-gated ion channels in GREEN ALGAE.", "PM": "2018", "HN": "2018", "MR": "20200527", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075402"}, {"RECTYPE": "D", "MH": "Semantic Web", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Web, Semantic", "MN": "L01.224.740", "MH_TH": "NLM (2018)", "ST": "T170", "PI": "Semantics (2002-2017)", "MS": "A framework for development and promotion of common data formats and exchange protocols linked in a way that can be read directly by computers. Semantic Web is a platform for sharing and reusing data across application, enterprise, and community boundaries, by linking concepts rather than just documents.", "PM": "2018", "HN": "2018", "MR": "20170712", "DA": "20170712", "DC": "1", "DX": "20180101", "UI": "D000075403"}, {"RECTYPE": "D", "MH": "Anti-Citrullinated Protein Antibodies", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Citrullinated Protein Autoantibodies|T129|NON|EQV|NLM (2023)|210924|abcdef", "ENTRY": "Antibody, Citrullinated Protein", "MN": "D12.776.377.715.548.114.323.095", "FX": "Citrulline", "MH_TH": "NLM (2018)", "ST": "T129", "RN": "0", "PI": "Autoantibodies (2005-2017)", "MS": "Autoantibodies to citrullinated-peptides and proteins.", "PM": "2018", "HN": "2018", "MR": "20220413", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075422"}, {"RECTYPE": "D", "MH": "Gene Drive Technology", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Technology, Gene Drive", "MN": "E05.393.420.175.500", "MH_TH": "NLM (2018)", "ST": "T063", "MS": "The techniques involved in creating and inserting synthetic selfish genetic elements called gene drives. Gene drives carry a \"payload gene\" and are designed to increase in frequency in the population over time, eventually to all members of the population.", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075423"}, {"RECTYPE": "D", "MH": "Transplantation, Haploidentical", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Transplantations, Haploidentical", "MN": "E04.936.864.350", "MH_TH": "NLM (2018)", "ST": "T061", "MS": "Transplantation between individuals who share a partial haplotype match.", "PM": "2018", "HN": "2018", "MR": "20170623", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075442"}, {"RECTYPE": "D", "MH": "Serum Albumin, Human", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Human, Albumin", "MN": "D12.776.124.727.906", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "ZIF514RVZR", "PI": "Serum Albumin (1966-2017)", "MS": "Serum albumin from humans. It is an essential carrier of both endogenous substances, such as fatty acids and BILIRUBIN, and of XENOBITOICS in the blood.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075462"}, {"RECTYPE": "D", "MH": "Bedridden Persons", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Persons, Non-Mobile", "MN": "M01.079", "FX": "Frail Elderly", "MH_TH": "NLM (2018)", "ST": "T101", "MS": "Persons unable or unwilling, or otherwise incapacitated and not able to leave the bed due to physical or mental conditions.", "PM": "2018", "HN": "2018", "MR": "20170705", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075482"}, {"RECTYPE": "D", "MH": "Population Health", "AQ": "CL HI SN", "MN": "N01.400.548", "MH_TH": "NLM (2018)", "ST": "T062", "MS": "The health outcomes of a group of individuals, including the distribution of such outcomes within the group. These populations are often geographic regions, such as nations or communities, but they can also be other groups. (From Am J Public Health. 2003 March; 93(3): 380\u2013383)", "PM": "2018", "HN": "2018", "MR": "20180430", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075485"}, {"RECTYPE": "D", "MH": "Adaptive Clinical Trials as Topic", "AQ": "AE CL EC ES HI IS LJ MT OG PX SN ST TD VE", "ENTRY": "Adaptive Clinical Trial as Topic|T062|NON|EQV|NLM (2018)|170612|abcdef", "MN": "N06.850.520.450.250.250.100", "MH_TH": "NLM (2018)", "ST": "T062", "AN": "for general design, methodology, economics, etc. of adaptive clinical trials; a different heading ADAPTIVE CLINICAL TRIAL is used for reports of a specific adaptive clinical trial", "MS": "Works about clinical studies in which a prospectively planned opportunity is included to modify trial designs and hypotheses based on analysis of data from subjects in the study.", "PM": "2018", "HN": "2018", "MR": "20180629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075522"}, {"RECTYPE": "D", "MH": "Long-Acting Reversible Contraception", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Reversible Contraception, Long-Acting", "MN": "E02.875.194.589", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Contraceptive Agents, Female (2006-2017)", "MS": "Prevention of CONCEPTION by devices, chemical substances or agents with contraceptive activity in females which last for years and can be removed.", "PM": "2018", "HN": "2018", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075523"}, {"RECTYPE": "D", "MH": "Prolotherapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Proliferation", "MN": "E02.190.777", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Injections, Intra-Articular (2000-2017)", "MS": "Treatment of MUSCULOSKELETAL PAIN by injecting a substance into a joint space, ligament, or tendon to promote the growth of new tissue.", "PM": "2018", "HN": "2018", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075527"}, {"RECTYPE": "D", "MH": "Aversive Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Taste Deterrents|T121|NON|EQV|NLM (2018)|170426|abcdef", "MN": "D27.720.744.179", "MH_TH": "NLM (2018)", "ST": "T121", "RN": "0", "MS": "Chemicals added to pharmacologic preparations, poisonous household goods, and other chemicals to discourage their abuse or consumption.", "PM": "2018", "HN": "2018", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075528"}, {"RECTYPE": "D", "MH": "Solitary Kidney", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Single Kidneys", "MN": "C23.300.925", "MH_TH": "NLM (2018)", "ST": "T033", "PI": "Urogenital Abnormalities (1963-2017)", "MS": "Either a single or a single functioning kidney due to NEPHRECTOMY, birth defects or other kidney diseases.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075529"}, {"RECTYPE": "D", "MH": "Organ Motion", "AQ": "DE GE IM PH RE", "MN": "G11.427.410.849", "MH_TH": "NLM (2018)", "ST": "T033", "PI": "Movement (1994-2017)", "MS": "Movement of internal organs due to physiological processes.", "PM": "2018", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075530"}, {"RECTYPE": "D", "MH": "Multifocal Intraocular Lenses", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Multifocal IOL", "MN": "E07.695.460.500", "MH_TH": "NLM (2018)", "ST": "T074", "PI": "Lenses, Intraocular (1983-2017)", "MS": "Artificially implanted lenses that direct light toward distant and near focal points allowing clear vision for a range of distances.", "PM": "2018", "HN": "2018", "MR": "20190530", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075542"}, {"RECTYPE": "D", "MH": "Charles Bonnet Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "MN": "F01.700.750.300.500", "MH_TH": "NLM (2018)", "ST": "T047", "PI": "Hallucinations (1969-2017)", "MS": "Repetitive visual hallucinations experienced mostly by elderly with diminished visual acuity or visual field loss, with awareness of the fictional nature of their hallucinations. It is not associated with delusions and other sensory hallucinations.", "PM": "2018", "HN": "2018", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075562"}, {"RECTYPE": "D", "MH": "Vasopeptidase Inhibitors", "AQ": "AA AD AE BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vasopeptidase Inhibitor|T121|NON|EQV|NLM (2022)|201023|abcdef", "ENTRY": "NEP ACE Inhibitors", "MN": "D27.505.519.389.745.085.500", "MH_TH": "NLM (2018)", "ST": "T121", "RN": "0", "PI": "Neprilysin/antagonists and inhibitors (1999-2017)", "MS": "A class of cardiovascular drugs indicated for hypertension and congestive heart failure that simultaneously inhibit both NEUTRAL ENDOPEPTIDASE and ANGIOTENSIN CONVERTING ENZYME. They increase the availability of NATRIURETIC PEPTIDES and BRADYKININ and inhibit production of ANGIOTENSIN II.", "PM": "2018", "HN": "2018", "MR": "20210630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075563"}, {"RECTYPE": "D", "MH": "Non-Point Source Pollution", "AQ": "AE AN CL EC ES HI LJ PC SN", "ENTRY": "Source Pollution, Nonpoint", "MN": "N06.850.460.790.205", "MH_TH": "NLM (2018)", "ST": "T069", "PI": "Water Pollution (2001-2017)", "MS": "Water pollution from a variety of diffuse sources carried over or through the ground and into water sources such as LAKES; RIVERS; WETLANDS; coastal waters; and GROUNDWATER. Such diffuse sources include roadways and parking lots (GASOLINE; HEAVY METALS; and motor oil), lawns or agricultural land (excess FERTILIZERS, livestock excrement, and PESTICIDES), landfill seepage, and construction sites (chemicals and trash used in construction processes).", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075602"}, {"RECTYPE": "D", "MH": "Injection Site Reaction", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injection Site Reactions", "MN": "C25.100.781", "MH_TH": "NLM (2018)", "ST": "T037", "PI": "Drug-Related Side Effects and Adverse Reactions (1969-2017)", "MS": "Adverse reactions that occur initially at the site of injection or infusion. Milder type is confined to a local allergic flare reaction. A more severe reaction is caused by extravasation of VESICANTS from the blood vessel at the site of injection and can cause damage to the surrounding tissue. In tumor flare reaction symptoms involve well beyond the injection site such as an increase in the tumor size and tumor markers levels, bone pain, and HYPERCALCEMIA.", "PM": "2018", "HN": "2018", "MR": "20190701", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075662"}, {"RECTYPE": "D", "MH": "Ion Mobility Spectrometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Spectrometry, Ion Mobility", "MN": "E05.196.867.427", "MH_TH": "NLM (2018)", "ST": "T059", "MS": "Techniques for separation and identification of ionized molecules based on their drift through a gas phase after being accelerated by an electric field. Their mobilities will be effected by their shape, size, and charge.", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075663"}, {"RECTYPE": "D", "MH": "Recidivism", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Criminal Recidivism|T055|NON|EQV|NLM (2022)|210122|abcdef", "ENTRY": "Recidivism, Criminal", "MN": "I01.198.240.679", "MH_TH": "NLM (2018)", "ST": "T055", "MS": "Repeated criminal behavior.", "PM": "2018", "HN": "2018", "MR": "20210312", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075665"}, {"RECTYPE": "D", "MH": "Procrastination", "AQ": "CL DE ES PH RE", "MN": "F02.463.617", "MH_TH": "NLM (2018)", "ST": "T053", "MS": "The deferment of actions or tasks to a later time, or to infinity.", "PM": "2018", "HN": "2018", "MR": "20170709", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075682"}, {"RECTYPE": "D", "MH": "T-Lymphoma Invasion and Metastasis-inducing Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TIAM 1 Protein", "MN": "D12.776.476.325.300.850", "FX": "Pleckstrin Homology Domains", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Guanine Nucleotide Exchange Factors (2007-2017)", "MS": "A Rho guanine nucleotide exchange factor that consists of two pleckstrin homology domains flanking central Ras-binding, Dbl-homology (DH) and PDZ domains. It stimulates GTP-GDP exchange of rho-like GTPases such as RAC1 PROTEIN; CDC42 PROTEIN; and RHOA PROTEIN, and functions to link extracellular signals to remodeling of the CYTOSKELETON for CELL ADHESION and CELL MOVEMENT.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075684"}, {"RECTYPE": "D", "MH": "COP9 Signalosome Complex", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Subunit 3, Signalosome", "MN": "D08.811.277.656.300.887.375", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 3.4.19.12", "MS": "A multiprotein complex that functions as a peptide hydrolase, or isopeptidase to cleave NEDD8 PROTEIN from the CULLIN and UBIQUITIN-PROTEIN LIGASES, controlling the activity of the ligases. It is highly conserved in eukaryotes and typically consists of 8 subunits (CSN 1-8 proteins). The COP9 signalosome was originally identified in plants, where it controls gene transcription in response to light.", "PM": "2018; COP9 SIGNALOSOME COMPLEX was indexed under PEPTIDE HYDROLASES and MULTIPROTEIN COMPLEXES 2006-207; under PROTEINS 1995-2005; and under PLANT PROTEINS 1995-1999; for COP9 SIGNALOSOME SUBUNIT 3 see SIGNALOSOME SUBUNIT 3 1998-2017; SIGNALOSOME SUBUNIT 3 was indexed under NUCLEAR PROTEINS and PROTEIN KINASES 1998-2017", "HN": "2018 (1995); for COP9 SIGNALOSOME SUBUNIT 3 use SIGNALOSOME SUBUNIT 3 1998-2017", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075686"}, {"RECTYPE": "D", "MH": "NEDD8 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ubiquitin like Protein NEDD8", "MN": "D12.776.947.218", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Ubiquitins (1993-2017)", "MS": "A ubiquitin-like protein that functions in CELL CYCLE regulation and embryogenesis. It is attached covalently to its substrates following activation by the UBIQUITIN-ACTIVATING ENZYME E1-UBA3 enzyme complex. NEDD8 attaches to CULLINS, activating their E3 UBIQUITIN LIGASE activity, to promote polyubiquitination and degradation of CYCLINS and regulatory proteins", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075687"}, {"RECTYPE": "D", "MH": "Nedd4 Ubiquitin Protein Ligases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Neuronal Precursor Cell Expressed Developmentally Down Regulated 4 Ligase", "MN": "D12.776.543.990.493.500", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 2.3.2.26", "MS": "E3 ubiquitin ligases that consist of four WW DOMAINS. They accept UBIQUITIN from E2 UBIQUITIN-CONJUGATING ENZYME as a thioester via their C-terminal HECT domains and transfer it specifically to the 63rd LYSINE residue (Lys-63) of target proteins. NEDD4 targets include many proteins and receptors with important functions for cell growth and homeostasis such as VEGFR-2; FGFR1 TYROSINE KINASE; and ERBB-4 RECEPTOR. They play a critical role in the internalization of these receptors, their degradation by LYSOSOMES, and also function as part of the ESCRT complex in VIRUS RELEASE.", "PM": "2018; NEDD4 UBIQUITIN PROTEIN LIGASES was indexed under UBIQUITIN-PROTEIN LIGASES and ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT 2005-2017; under LIGASES 1996-2004; and under CALCIUM-BINDING PROTEINS 1996-2003", "HN": "2018 (1996)", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075702"}, {"RECTYPE": "D", "MH": "Zinc Transporter 8", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "ZnT 8 Protein", "MN": "D12.776.543.585.937.975", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Cation Transport Proteins (2004-2017)", "MS": "A zinc efflux transporter highly expressed by ISLET CELLS of the pancreas. It functions in the accumulation of zinc in intracellular vesicles and may be involved in INSULIN maturation and storage processes. Variations in the SLC30A8 gene are associated with susceptibility to DIABETES MELLITUS, TYPE 2.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075703"}, {"RECTYPE": "D", "MH": "Toxin-Antitoxin Systems", "AQ": "DE GE IM PH RE", "ENTRY": "Toxin-Antitoxin System", "MN": "G06.773", "MH_TH": "NLM (2018)", "ST": "T070", "MS": "Mechanisms that allow bacteria and archaea to rapidly adapt to changing environmental conditions via a toxin, produced during adverse conditions, that inhibits a specific vital process, and a partner antitoxin that blocks the effects of the toxin, under normal growth conditions.", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075704"}, {"RECTYPE": "D", "MH": "Promyelocytic Leukemia Zinc Finger Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Zinc Finger and BTB Domain Containing 16 Protein|T116|T123|ABX|EQV|NLM (2018)|170509|abbcdef", "MN": "D12.776.930.375.625", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Kruppel-Like Transcription Factors (1995-2017)", "MS": "A Kruppel-type transcription factor consisting of an N-terminal BTB DOMAIN and nine CYS2-HIS2 ZINC FINGERS. It localizes to the nucleus and regulates cell cycle progression and gene expression for tissue development and homeostasis; it may also function as an epigenetic regulator through its interactions with HISTONE DEACETYLASE. Genetic rearrangements involving the ZBTB16 gene are associated with ACUTE PROMYELOCYTIC LEUKEMIA.", "PM": "2018", "HN": "2018", "MR": "20180521", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075722"}, {"RECTYPE": "D", "MH": "Kruppel-Like Factor 6", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kruppel Like Factor 6", "MN": "D12.776.930.375.563", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Trans-Activators (1997-2017)", "MS": "A Kruppel-like transcription factor that contains three C-terminal CYS2-HIS2 ZINC FINGERS and binds to GC RICH SEQUENCE (GC box) in upstream gene promoters. It functions as a transcriptional activator, tumor suppressor, and may regulate growth and development of B-cells.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075723"}, {"RECTYPE": "D", "MH": "Expression of Concern", "MN": "V01.405", "MH_TH": "NLM (2018)", "ST": "T170", "AN": "This heading is used as a Publication Type. CATALOGER: Do not use.  ", "MS": "A notification about the integrity of a published article that is typically written by an editor and should be labelled prominently in the item title. It is the responsibility of the editor to initiate appropriate investigative procedures, discover the outcome of the investigation, and notify readers of that outcome in a subsequent published item. The outcome may require the publication of a retraction notice.", "HN": "2018", "MR": "20170707", "DA": "20170711", "DC": "2", "DX": "20180101", "UI": "D000075742"}, {"RECTYPE": "D", "MH": "Chemokine CXCL16", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "CXCL16, Chemokine", "MN": "D23.529.374.200.120.075", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "0", "PI": "Receptors, Scavenger (2006-2017)", "MS": "A CXCR6 receptor-binding chemokine that functions as a scavenger receptor for oxidized low density lipoprotein (OxLDL) when expressed by MACROPHAGES. Its secreted, or cytokine form induces a strong chemotactic response for MONOCYTES when it is expressed by DENDRITIC CELLS.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075743"}, {"RECTYPE": "D", "MH": "Receptors, CXCR6", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Bonzo", "MN": "D12.776.543.750.830.475", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "0", "PI": "Receptors, Virus (2007-2017)", "MS": "CXCR receptors that are specific for CHEMOKINE CXCL16. They are expressed by lymphoid tissues, activated T-cells, and also function as co-receptors for SIMIAN IMMUNODEFICIENCY VIRUSES; HIV-2; and HIV-1 infection of MACROPHAGES.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075744"}, {"RECTYPE": "D", "MH": "rab27 GTP-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "rab27 GTP Binding Proteins", "MN": "D12.776.476.338.400.400.075", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "rab GTP-Binding Proteins (2000-2017)", "MS": "GTP-binding proteins associated with membranes, MELANOSOMES; LYSOSOMES; and late ENDOSOMES. They play a role in the release of cytotoxic SECRETORY GRANULES from lymphocytes and are required for granule maturation, as well as granule docking and priming at IMMUNOLOGICAL SYNAPSES.", "PM": "2018", "HN": "2018", "MR": "20210521", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075745"}, {"RECTYPE": "D", "MH": "Zinc Finger Protein Gli2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Gli2 Protein|T116|T123|ABX|EQV|NLM (1997)|170510|abbcdef", "MN": "D12.776.930.900.850", "FX": "Hedgehog Proteins", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "MS": "A transcriptional activator that contains five adjacent CYS2-HIS2 ZINC FINGERS. It functions in the hedgehog signaling pathway and is required for normal embryonic development. Mutations in the GLI2 gene are associated with type 9 HOLOPROSENCEPHALY and type 2 PALLISTER-HALL SYNDROME.", "PM": "2018; see GLI2 PROTEIN 1997-2017; ZINC FINGER PROTEIN GLI2 was indexed under KRUPPEL-LIKE TRANSCRIPTION FACTORS 2006-2017; under TRANSCRIPTION FACTORS 1999-2005; and under PROTEINS 1997-1998", "HN": "2018 (1997); use GLI2 PROTEIN 1997-2017", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075746"}, {"RECTYPE": "D", "MH": "Baculoviral IAP Repeat-Containing 3 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Inhibitor 2, Apoptosis", "MN": "D12.776.476.075.437.250", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 2.3.2.27", "PI": "Ubiquitin-Protein Ligases (2006-2017)", "MS": "A regulator of APOPTOSIS that functions as an E3 ubiquitin protein ligase. It contains three baculoviral IAP repeats in its N-terminal half, a CARD DOMAIN, and a RING finger domain at its C-terminus. It is highly expressed in fetal lung and kidney, and adult lymphoid tissues such as spleen, thymus, and peripheral blood lymphocytes. It functions in INFLAMMATION signaling, the INNATE IMMUNE RESPONSE, cell growth and proliferation, and metastasis of tumor cells.", "PM": "2018; for INHIBITOR OF APOPTOSIS 1 PROTEIN see INHIBITOR OF OF APOPTOSIS PROTEINS 2006-2017", "HN": "2018; for INHIBITOR OF APOPTOSIS 1 PROTEIN use INHIBITOR OF OF APOPTOSIS PROTEINS 2006-2017", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075747"}, {"RECTYPE": "D", "MH": "Interdisciplinary Research", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Team Sciences", "MN": "H01.770.644.287", "MH_TH": "NLM (2018)", "ST": "T170", "PI": "Research (1966-2017)", "MS": "Research combining mastery in distinct fields or disciplines that apply and exchange tools, concepts, ideas, data methods, or results around a common project.", "PM": "2018", "HN": "2018", "MR": "20181012", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075762"}, {"RECTYPE": "D", "MH": "Involuntary Fertility Control", "ENTRY": "Fertility Control, Involuntary", "MN": "I01.880.604.528.250", "MH_TH": "NLM (1980)", "ST": "T054", "MS": "Behavior that interferes with a woman's autonomous reproductive decision-making.", "PM": "2018; see COERCION 1980-2017", "HN": "2018; use COERCION 1980-2017", "MR": "20170708", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075764"}, {"RECTYPE": "D", "MH": "Cell Phone Use", "AQ": "AE EC EH ES HI LJ SN TD", "ENTRY": "Uses, Mobile Phone", "MN": "F01.145.813.537", "MH_TH": "NLM (2018)", "ST": "T054", "MS": "Utilization of wireless phones for communication.", "PM": "2018", "HN": "2018", "MR": "20170711", "DA": "20170712", "DC": "1", "DX": "20180101", "UI": "D000075782"}, {"RECTYPE": "D", "MH": "Angiopoietin-like Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Angiopoietin related Protein", "MN": "D23.529.100.050", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Angiopoietins (2004-2017)", "MS": "A family of proteins that is structurally similar to ANGIOPOIETINS but do not bind angiopoietin receptors. They are characterized by an amino-terminal coiled-coil domain, a linker region, and a carboxy-terminal FIBRINOGEN-like domain with the exception of ANGPTL8, which lacks the fibrinogen-like domain. They function in a variety of developmental and physiological processes, including INFLAMMATION, lipid metabolism, hematopoietic stem cell activity, and cancer metastasis.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075802"}, {"RECTYPE": "D", "MH": "Angiopoietin-Like Protein 4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein 4, Angiopoietin-Like", "MN": "D23.529.100.050.400", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "PI": "Blood Proteins (2000-2017)", "MS": "A secreted angiopoietin-like protein expressed under hypoxic conditions by ENDOTHELIAL CELLS. It inhibits cell proliferation, cell migration, and tubule formation; the inactive form accumulates in the endothelial EXTRACELLULAR MATRIX, reducing vascular leakage. ANGPTL4 has direct roles in regulating glucose and lipid metabolism, as well as INSULIN SENSITIVITY, and may also function as a regulator of angiogenesis and tumorigenesis.", "PM": "2022: see ANGIOPOIETIN-LIKE 4 PROTEIN 2018-2021", "HN": "2022(2018)", "MR": "20210627", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075803"}, {"RECTYPE": "D", "MH": "Zinc Finger Nucleases", "AQ": "AD AE AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Zinc-Finger Nuclease|T116|T126|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Nucleases, Zinc-Finger", "MN": "D12.776.828.300.990", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.1.-", "PI": "Endonucleases (2005-2017)", "MS": "Genetically engineered nucleases that cleave DNA at a defined distance from specific DNA sequences recognized by ZINC FINGER DNA-BINDING DOMAINS. They are composed of a DNA cleaving domain adapted from DNA endonucleases fused to a zinc finger DNA-binding domain.", "PM": "2018", "HN": "2018", "MR": "20200527", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075804"}, {"RECTYPE": "D", "MH": "Science in the Arts", "AQ": "HI", "ENTRY": "Science in Arts", "MN": "K01.093.796", "MH_TH": "NLM (2018)", "ST": "T078", "AN": "coordinate IM with scientific aspect (IM) + specific art heading (IM)", "MS": "Depiction of scientific issues or themes via the arts including visual, oral, or written forms of expression.", "PM": "2018", "HN": "2018", "MR": "20170709", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075862"}, {"RECTYPE": "D", "MH": "Science in Literature", "AQ": "HI", "ENTRY": "in Literatures, Science", "MN": "K01.517.864", "MH_TH": "NLM (2010)", "ST": "T078", "MS": "Literary works whose subject matter is science or about the profession of science and related areas.", "PM": "2018", "HN": "2018", "MR": "20170709", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075863"}, {"RECTYPE": "D", "MH": "Indochina", "AQ": "EH EP", "ENTRY": "French Indochina|T083|NON|EQV|NLM (2018)|170513|abcdef", "MN": "Z01.252.145.232", "MH_TH": "NLM (2018)", "ST": "T083", "MS": "Area in Southeastern Asia that comprises CAMBODIA, LAOS, and VIETNAM.", "HN": "2018", "MR": "20170709", "DA": "20170711", "DC": "4", "DX": "20180101", "UI": "D000075884"}, {"RECTYPE": "D", "MH": "Clinical Deterioration", "ENTRY": "Deterioration, Clinical", "MN": "C23.550.291.656.350", "MH_TH": "NLM (2018)", "ST": "T032", "MS": "A critical disease progression, often measured by a set of clinical parameters, which activates HOSPITAL RAPID RESPONSE TEAM.", "PM": "2018", "HN": "2018", "MR": "20170620", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075902"}, {"RECTYPE": "D", "MH": "Chemokine CCL26", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Eotaxin 3", "MN": "D23.529.374.200.110.125", "MH_TH": "NLM (2018)", "ST": "T129", "RN": "0", "PI": "Chemokines, CC (1999-2017)", "MS": "A C-C chemokine expressed by all tissues that functions as a chemoattractant for EOSINOPHILS and BASOPHILS. It binds to the CCR3 RECEPTOR.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075906"}, {"RECTYPE": "D", "MH": "Wildfires", "AQ": "CL EC HI LJ MO PC SN", "ENTRY": "Wildfire", "MN": "N06.230.216.875", "MH_TH": "NLM (2018)", "ST": "T070", "AN": "coordinate with DISASTERS if pertinent; specify geographic location", "PI": "Fires (1990-2017)", "MS": "Fires that occur outdoors in the natural environment caused by natural forces or human activity.", "PM": "2018", "HN": "2018", "MR": "20180630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075923"}, {"RECTYPE": "D", "MH": "X-linked Nuclear Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "X linked Nuclear Protein", "MN": "D08.811.399.340.375", "FX": "PHD Zinc Fingers", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.6.4.12", "PI": "Nuclear Proteins (1995-2017)", "MS": "ATP-dependent DNA helicase that contains two N-terminal ZINC FINGERS and C-terminal ATP-binding and helicase domains. It functions in the regulation of gene transcription and CHROMATIN REMODELING. ATRX undergoes cell-cycle dependent phosphorylation, which causes it to translocate from the NUCLEAR MATRIX to CHROMATIN; thus, it may change its role from gene regulation during INTERPHASE to ensuring proper chromosome segregation at MITOSIS. Mutations in the ATRX gene are associated with cases of X-LINKED MENTAL RETARDATION co-morbid with ALPHA-THALASSEMIA (ATRX syndrome).", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075924"}, {"RECTYPE": "D", "MH": "PHD Zinc Fingers", "AQ": "DE GE IM PH RE", "ENTRY": "Zinc Fingers, PHD", "MN": "G02.111.570.820.709.275.500.985.438", "MH_TH": "NLM (2018)", "ST": "T087", "PI": "Molecular Sequence Data (1995-2017)", "MS": "Zinc finger domains of approximately 50 to 80 amino acids in length that are characterized by a conserved Cysteine(3)-Histidine-Cysteine(4) amino acid motif which coordinates binding of two zinc ions. They are similar structurally to RING FINGER DOMAINS, with a globular fold topology of two BETA-SHEETS and an ALPHA-HELIX. PHD fingers occur in many proteins that function in chromatin-mediated gene expression and EPIGENETICS such as POLYCOMB-GROUP PROTEINS.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075925"}, {"RECTYPE": "D", "MH": "FERM Domains", "AQ": "DE GE IM PH RE", "ENTRY": "Superfamily, Band 4.1", "MN": "G02.111.570.820.709.275.750.500.422", "MH_TH": "NLM (2018)", "ST": "T087", "PI": "Protein Structure, Tertiary (1998-2017)", "MS": "Widely occuring protein domains that function to link signaling and CYTOSKELETAL PROTEINS to the PLASMA MEMBRANE. They occur mostly at the N-terminal region of proteins that contain them.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075926"}, {"RECTYPE": "D", "MH": "KRIT1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Krev Interaction Trapped Protein 1|T116|T123|NON|EQV|NLM (2018)|170515|abbcdef", "MN": "D12.776.631.560.465", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Proto-Oncogene Proteins (1997-2017)", "MS": "A microtubule-associated protein consisting of four ANKYRIN REPEATS and a C-terminal FERM DOMAIN. It links the CYTOSKELETON to CELL JUNCTIONS via integrin cytoplasmic domain-associated protein-1 and plays an important role in regulating cell proliferation and integrity of endothelial cell junctions. It is also involved in REACTIVE OXYGEN SPECIES metabolism. Mutations in the KRIT1 gene are associated with type I CEREBRAL CAVERNOUS MALFORMATIONS.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075927"}, {"RECTYPE": "D", "MH": "Intraepithelial Lymphocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Mucosal T Lymphocyte|T025|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "T Lymphocytes, Mucosal", "MN": "A15.382.490.555.567.569.500.050", "MH_TH": "NLM (2018)", "ST": "T025", "PI": "T-Lymphocytes (1977-2017)", "MS": "T Lymphocytes with limited diversity of receptors (e.g., ALPHA E INTEGRINS) in the epidermis of the skin and the mucosal linings. They recognize common microbes via T-CELL RECEPTORS and PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES and function as effector cells for INNATE IMMUNITY. Activation of intraepithelial lymphocytes is a marker for various gastrointestinal diseases (e.g., CELIAC DISEASE; HAIRY CELL LEUKEMIA; and ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA).", "PM": "2018", "HN": "2018", "MR": "20200527", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075942"}, {"RECTYPE": "D", "MH": "Apolipoproteins L", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apolipoprotein L Family|T116|T123|NON|EQV|NLM (2018)|170516|abbcdef", "MN": "D12.776.521.120.750", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins (2002-2017)", "MS": "A family of apolipoproteins occurring in humans that are structurally similar to B-CELL LEUKEMIA 2 FAMILY PROTEINS. In addition to their roles in cholesterol and lipid transport, they are expressed by MYELOID CELLS and ENDOTHELIAL CELLS during INFLAMMATION and may function to promote CELL DEATH.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075943"}, {"RECTYPE": "D", "MH": "Apolipoprotein L1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apolipoprotein L|T116|T123|NON|EQV|NLM (2018)|170516|abbcdef", "MN": "D12.776.521.120.750.500", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Lipoproteins, HDL (1997-2017)", "MS": "An ApoL protein highly expressed by the liver. It has anti-trypanosomal activity through its ability to permeabilize TRYPANOSOMA membranes. Mutations in the APOL1 gene are associated with type 4 FOCAL SEGMENTAL GLOMERULOSCLEROSIS .", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075944"}, {"RECTYPE": "D", "MH": "Cell Adhesion Molecule-1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Molecule-1, Cell Adhesion", "MN": "D23.050.301.350.115", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2018)", "ST": "T129", "RN": "0", "PI": "Immunoglobulins (2000-2017)", "MS": "A cell adhesion molecule that contains extracellular immunoglobulin V and C2 domains. It mediates homophilic and heterophilic cell-cell adhesion independently of calcium, and acts as a tumor suppressor in NON-SMALL-CELL LUNG CANCER (NSCLC) cells. Its interaction with NATURAL KILLER CELLS is important for their cytotoxicity and its expression by MAST CELLS plays a role in their interaction with neurons; it may also function in synapse assembly, nerve growth and differentiation.", "PM": "2018", "HN": "2018", "MR": "20230316", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075982"}, {"RECTYPE": "D", "MH": "Nectins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Poliovirus Receptor Related Protein 1", "MN": "D23.050.301.350.123", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A family of calcium-independent cell adhesion molecules of the immunoglobulin superfamily. They are expressed by most cell types and mediate both homotypic and heterotypic cell-cell adhesion. Nectins function in a variety of morphogenetic and developmental processes that include organogenesis of the eye, ear, tooth, and cerebral cortex; they also play roles in viral infection and cell proliferation.", "PM": "2018; NECTINS was indexed under CELL ADHESION MOLECULES 1999-2018", "HN": "2018 (1999)", "MR": "20230316", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000075983"}, {"RECTYPE": "D", "MH": "Acetabularia", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Acetabularias", "MN": "B01.875.150.133", "MH_TH": "NLM (1972)", "ST": "T002", "RN": "txid3136", "PI": "Algae, Green (1970-1971)", "MS": "A genus of green algae found in the Mediterranean and other warm seas.", "PM": "91; was see under ALGAE, GREEN 1972-90", "HN": "91(72); was see under ALGAE, GREEN 1972-90", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000076"}, {"RECTYPE": "D", "MH": "Hyaluronan Synthases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, Hyaluronic Acid", "MN": "D08.811.913.400.450.480.500", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 2.4.1.212", "MS": "Membrane-associated glucuronosyltransferases that catalyze the reaction of UDP-N-acetyl-D-glucosamine and UDP-D-glucuronate to produce HYALURONAN. HYALURONAN SYNTHASE 2 (HAS2) is essential for embryogenesis and its expression by tumor cells is associated with metastasis.", "PM": "2018; see HYALURONAN SYNTHASE 1976-2017; HYALURONAN SYNTHASES was indexed under GLUCURONOSYLTRANSFERASE 1976-2017", "HN": "2018 (1976); was HYALURONAN SYNTHASE 1976-2017", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076002"}, {"RECTYPE": "D", "MH": "Inhibitor of Growth Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "ING 1 Protein", "MN": "D12.776.660.494", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Tumor Suppressor Proteins (2005-2017)", "MS": "A nuclear protein and tumor suppressor that contains a C-terminal PHD ZINC FINGER. It is expressed in different isoforms in various tissues and interacts with TUMOR SUPPRESSOR PROTEIN P53 to negatively regulate cell growth. Reduced expression and chromosomal rearrangements of the ING1 gene are associated with different cancers including HEAD AND NECK NEOPLASMS.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076023"}, {"RECTYPE": "D", "MH": "Alcoholic Korsakoff Syndrome", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Wernicke-Korsakoff Syndrome, Alcoholic", "MN": "F03.900.100.050.250", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Korsakoff Syndrome (2001-2017)", "MS": "A neurological disorder characterized by inattentiveness and the inability to form short term memories. It is caused by THIAMINE DEFICIENCY due to chronic ALCOHOLISM.", "PM": "2018; see KORSAKOFF SYNDROME 2000-2017", "HN": "2018(2000); use KORSAKOFF SYNDROME 2000-2017", "MR": "20170707", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076042"}, {"RECTYPE": "D", "MH": "Drug Misuse", "AQ": "AE CL EC ES HI LJ MO NU PC PX SN TD", "ENTRY": "Over-the-Counter Drug Misuses", "MN": "F03.900.384", "MH_TH": "NLM (2018)", "ST": "T080", "PI": "Substance-Related Disorders (1966-2017)", "MS": "Use of a drug for a purpose not consistent with legal or medical guidelines.", "PM": "2018", "HN": "2018", "MR": "20230405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076064"}, {"RECTYPE": "D", "MH": "Travel-Related Illness", "ENTRY": "Travel-Related Sicknesses", "MN": "I03.883.855", "FX": "Motion Sickness", "MH_TH": "NLM (2018)", "ST": "T047", "MS": "Health problems associated with TRAVEL.", "PM": "2018", "HN": "2018", "MR": "20170710", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076082"}, {"RECTYPE": "D", "MH": "Involuntary Treatment, Psychiatric", "AQ": "CL ES HI LJ MT OG SD SN ST TD", "ENTRY": "Psychiatric Commitments, Involuntary", "MN": "I01.880.604.528.500", "MH_TH": "NLM (2018)", "ST": "T061", "MS": "Treatment of persons with MENTAL DISORDERS without the persons' consent.", "PM": "2018", "HN": "2018", "MR": "20180613", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076083"}, {"RECTYPE": "D", "MH": "Ubiquitin-Specific Peptidase 7", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ubiquitin-Specific Peptidase, Herpesvirus-Associated", "MN": "D08.811.277.656.300.887.875", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.4.19.12", "PI": "Ubiquitin Thiolesterase (2008-2017)", "MS": "A ubiquitinyl hydrolase that deubiquitinates several proteins with critical roles in DNA REPAIR, cell growth, and survival, including TUMOR SUPPRESSOR PROTEIN P53; MDM-2 PROTEIN; and PTEN PHOSPHOHYDROLASE. It also stabilizes herpesvirus 1 trans-acting transcriptional protein VMW110 during HSV-1 infection, contributing to its function as a TRANS-ACTIVATOR.", "PM": "2018", "HN": "2018", "MR": "20210510", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076084"}, {"RECTYPE": "D", "MH": "Biological Variation, Individual", "ENTRY": "Within-Subject Variations", "MN": "G16.115", "MH_TH": "NLM (2018)", "ST": "T081", "MS": "Differences in measurable biological values, characteristics, or traits, within one individual under different conditions for the individual such as fasting, season of the year, age, or state of wellness.", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076103"}, {"RECTYPE": "D", "MH": "Oligodendrocyte Transcription Factor 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "OLIG 2 Protein", "MN": "D12.776.930.125.782", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (2000-2017)", "MS": "A basic helix-loop-helix transcription factor that is required for differentiation of OLIGODENDROCYTES and motor neurons in the spinal cord, and development of somatic motor neurons in the hindbrain.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076104"}, {"RECTYPE": "D", "MH": "X-ray Repair Cross Complementing Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "X ray Repair Cross Complementing Protein 1", "MN": "D12.776.660.720.813", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "MS": "A poly(ADP)-ribose-binding protein that functions in the rejoining of DNA single-strand breaks that arise following treatment with alkylating agents or ionizing radiation. It interacts with DNA LIGASE III and POLY ADP RIBOSE POLYMERASE in BASE EXCISION REPAIR, and may also function in DNA processing and chromosome recombination in GERM CELLS.", "PM": "2018; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1 was indexed under DNA-BINDING PROTEINS 1994-2017", "HN": "2018 (1994)", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076105"}, {"RECTYPE": "D", "MH": "SAM Domain and HD Domain-Containing Protein 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SAM Domain and HD Domain Containing Protein 1", "MN": "D12.776.066.375", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.1.5.-", "RR": "EC 3.6.-", "PI": "Monomeric GTP-Binding Proteins (2004-2017)", "MS": "A host restriction triphosphorylhydrolase and dNTPase that contains an N-terminal STERILE ALPHA MOTIF and central, conserved ASPARTATE and HISTIDINE (HD) domain. It acts on single-stranded RNA, yielding deoxynucleosides and triphosphate, and functions in anti-viral defense through its dNTPase activity, reducing cellular dNTP levels below what is required for retroviral reverse transcription in DENDRITIC CELLS and MYELOID CELLS. It also has RIBONUCLEASE activity which blocks early replication of retroviruses such as HIV-1. Mutations in the SAMHD1 gene are associated with type 5 Aicardi-Goutieres syndrome (AGS5) and type 2 chilblain LUPUS (CHBL2).", "PM": "2018", "HN": "2018", "MR": "20210510", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076106"}, {"RECTYPE": "D", "MH": "Diet, High-Protein Low-Carbohydrate", "AQ": "AE CL EC EH HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Low-Carbohydrate Diets, High-Protein", "MN": "G07.203.650.240.269.500", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Diet, Carbohydrate-Restricted (2006-2017)", "MS": "A diet that consists mainly of foods with a high content of protein and limited amounts of CARBOHYDRATES.", "PM": "2018; for ATKINS DIET see DIET, CARBOHYDRATE-RESTRICTED 2006-2017; for SOUTH BEACH DIET see DIET, CARBOHYDRATE-RESTRICTED 2006-2017;", "HN": "2018; for ATKINS DIET use DIET, CARBOHYDRATE-RESTRICTED 2006-2017; for SOUTH BEACH DIET use DIET, CARBOHYDRATE-RESTRICTED 2006-2017;", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076107"}, {"RECTYPE": "D", "MH": "Disks Large Homolog 4 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synapse Associated Protein 90", "MN": "D12.776.631.224", "FX": "SAP90-PSD95 Associated Proteins", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (2005-2017)", "MS": "A neuronal protein consisting of three PDZ DOMAINS, an SH3 DOMAIN, and a C-terminal guanylate kinase-like region (see MAGUK PROTEINS). It localizes to the POST-SYNAPTIC DENSITY and associates with the cytoplasmic tail of NMDA RECEPTORS and SHAKER POTASSIUM CHANNELS, playing a critical role in NMDA receptor-mediated SYNAPTIC PLASTICITY.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076122"}, {"RECTYPE": "D", "MH": "DNA (Cytosine-5-)-Methyltransferase 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Enzyme, DNMT1", "MN": "D12.776.660.720.313", "FX": "Zinc Fingers", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.1.1.37", "MS": "A DNA (cytosine-5-)-methyltransferase that contains a central CxxC type zinc finger motif. It binds poly(ADP)-ribose and its expression is regulated by POLY (ADP-RIBOSE) POLYMERASE-1. DNMT1 methylates CpG residues, with a preference for hemimethylated DNA, and associates with DNA replication sites in S PHASE to maintain the methylation pattern in the newly synthesized strand, which is essential for EPIGENETIC PROCESSES. It also associates with CHROMATIN during G2 PHASE and MITOSIS to maintain DNA methylation independently of replication. It is responsible for maintaining methylation patterns established in development; mutations in the DNMT1 gene are associated with HEREDITARY SENSORY NEUROPATHY TYPE 1 class E.", "PM": "2018; DNA (CYTOSINE-5-)-METHYLTRASFERASE 1 was indexed under DNA (CYTOSINE-5-)-METHYLTRASFERASES 1999-2017", "HN": "2018 (1999)", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076123"}, {"RECTYPE": "D", "MH": "Virtual Reality", "ENTRY": "Virtual Realities, Instructional", "MN": "L01.296.555", "MH_TH": "NLM (2018)", "ST": "T066", "MS": "Using computer technology to create and maintain an environment and project a user's physical presence in that environment allowing the user to interact with it.", "PM": "2018", "HN": "2018", "MR": "20170709", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076142"}, {"RECTYPE": "D", "MH": "Egypt, Ancient", "AQ": "EH EP", "ENTRY": "Ancient Egypt|T083|NON|EQV|NLM (2019)|171129|abcdef", "MN": "Z01.586.035.325", "MH_TH": "NLM (2018)", "ST": "T083", "MS": "A civilization of ancient Northeastern Africa, concentrated along the lower reaches of the Nile River in the area of Egypt. It was active from 3100 B.C. until its conquest by Alexander the Great in 332 B.C.", "HN": "2018", "MR": "20180629", "DA": "20170711", "DC": "4", "DX": "20180101", "UI": "D000076144"}, {"RECTYPE": "D", "MH": "Greece, Ancient", "AQ": "EH EP", "ENTRY": "Ancient Greece|T083|NON|EQV|NLM (2019)|171220|abcdef", "MN": "Z01.586.035.519", "MH_TH": "NLM (2018)", "ST": "T083", "MS": "A civilization extant from about 1200 BC. to the death of Alexander the Great, in 323 B.C. It extended from the Greek city states to North Africa and eastward to the Indus River.", "HN": "2018", "MR": "20180124", "DA": "20170711", "DC": "4", "DX": "20180101", "UI": "D000076145"}, {"RECTYPE": "D", "MH": "Therapeutic Index", "ENTRY": "Index, Therapeutic", "MN": "N05.715.360.575.575.800.713", "MH_TH": "NLM (2018)", "ST": "T081", "MS": "An indicator of the benefits and risks of treatment.", "PM": "2018", "HN": "2018", "MR": "20190530", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076162"}, {"RECTYPE": "D", "MH": "Fanconi Anemia Complementation Group N Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Partner and Localizer of BRCA2 Protein|T116|T123|ABX|EQV|NLM (2018)|170530|abbcdef", "MN": "D12.776.660.323", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Tumor Suppressor Proteins (2006-2017)", "MS": "A Fanconi anemia complementation group protein that contains an N-terminal DNA-binding region and seven, C-terminal, WD REPEATS. It is an essential factor in HOMOLOGOUS RECOMBINATION DNA REPAIR through its interactions with BRCA2 PROTEIN; RAD51 RECOMBINASE; and BRCA1 PROTEIN. It functions as a molecular scaffold to localize and stabilize these proteins at homologous recombination sites. Mutations in the PALB2 gene are associated with FANCONI ANEMIA complementation group N; type 3 PANCREATIC NEOPLASMS; and susceptibility to BREAST CANCER.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076164"}, {"RECTYPE": "D", "MH": "Sp7 Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, Sp7", "MN": "D12.776.930.375.750.937", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (2003-2017)", "MS": "An Sp transcription factor that contains three CYS2-HIS2 ZINC FINGERS. It binds to GC RICH SEQUENCES and performs an essential function in regulating gene expression for differentiation of OSTEOBLASTS. Mutations in the SP7 gene are associated with type 12 OSTEOGENESIS IMPERFECTA.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076182"}, {"RECTYPE": "D", "MH": "Tripartite Motif-Containing Protein 28", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tripartite Motif Containing Protein 28", "MN": "D12.776.934.875", "FX": "RING Finger Domains", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 2.3.2.27", "PI": "Repressor Proteins (2004-2017)", "MS": "A tripartite motif protein consisting of an N-terminal RING finger, two B-box type ZINC FINGERS, and C-terminal PHD domain.  It functions as a transcriptional repressor by associating with Kruppel-association box domain (KRAB domain) transcription factors and has E3-SUMO-ligase activity towards itself and also sumoylates INTERFERON REGULATORY FACTOR-7 to reduce its activity as a transcriptional activator. It can also function as a ubiquitin protein ligase towards TUMOR SUPPRESSOR PROTEIN P53.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076183"}, {"RECTYPE": "D", "MH": "c-Mer Tyrosine Kinase", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "c Mer Tyrosine Kinase", "MN": "D12.776.624.664.700.037", "MH_TH": "NLM (2018)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptor Protein-Tyrosine Kinases (1999-2017)", "MS": "A receptor tyrosine kinase that transduces signals from EXTRACELLULAR MATRIX to the CYTOPLASM by binding ligands such as GALECTIN 3. It regulates many physiologic processes that include cell survival, migration, differentiation, and PHAGOCYTOSIS of apoptotic cells and ROD PHOTORECEPTORS in the RETINAL PIGMENT EPITHELIUM. Mutations in the MERTK gene are associated with type 38 RETINITIS PIGMENTOSA; it also plays a critical role as an inhibitor of TOLL-LIKE RECEPTORS signaling.", "PM": "2018", "HN": "2018", "MR": "20210520", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076202"}, {"RECTYPE": "D", "MH": "Animal Fur", "AQ": "AB AH CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE TR UL VI", "ENTRY": "Fur, Animal", "MN": "A17.360.148", "MH_TH": "NLM (2002)", "ST": "T017", "MS": "Usually densely-packed hairs on the skin of MAMMALS.", "PM": "2018; see Hair (1963-2017)", "HN": "2018; use Hair (1963-2017)", "MR": "20180629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076203"}, {"RECTYPE": "D", "MH": "WNK Lysine-Deficient Protein Kinase 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "WNK Lysine Deficient Protein Kinase 1", "MN": "D23.050.705.552.600.925", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Protein-Serine-Threonine Kinases (2005-2017)", "MS": "A serine-threonine kinase which plays an important role in the regulation of electrolyte homeostasis, cell signaling, survival, and proliferation. It functions as an activator and inhibitor of sodium-coupled chloride co-transporters and as an inhibitor of potassium-coupled chloride co-transporters. Mutations in the WNK1 gene are associated with type 2C PSEUDOHYPOALDOSTERONISM and type 2A HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES.", "PM": "2018", "HN": "2018", "MR": "20210628", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076204"}, {"RECTYPE": "D", "MH": "Ras Homolog Enriched in Brain Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Rheb Protein|T116|T123|ACX|EQV|NLM (2018)|170530|abbcdef", "MN": "D12.776.631.650.665", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Neuropeptides (2004-2017)", "MS": "A GTP-binding protein with low intrinsic GTPase activity that activates MTORC1 protein kinase activity.", "PM": "2018", "HN": "2018", "MR": "20210521", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076205"}, {"RECTYPE": "D", "MH": "Patient Generated Health Data", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Self Recorded Health Data", "MN": "E05.318.308.940.968.249.625", "MH_TH": "NLM (2018)", "ST": "T062", "PI": "Data Collection (2014-2017)", "MS": "Health-related data created, recorded, or gathered by patients, family members, or caregivers, to help address a health concern. Distinct from data generated in clinical settings and through encounters with providers.", "PM": "2018", "HN": "2018", "MR": "20170710", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076206"}, {"RECTYPE": "D", "MH": "Popular Culture", "PRINT ENTRY": "Mass Culture|T054|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Culture, Popular", "MN": "I01.880.853.100.628", "MH_TH": "NLM (2018)", "ST": "T054", "PI": "Culture (1992-2017)", "MS": "Choices and ways of doing things that predominate or are fashionable among ordinary people in a society during a point in time.", "PM": "2018", "HN": "2018", "MR": "20210512", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076207"}, {"RECTYPE": "D", "MH": "Mechanistic Target of Rapamycin Complex 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Complex, mTORC1", "MN": "D12.776.476.563.931.500", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "An evolutionarily conserved multiprotein complex that functions as a cellular energy sensor and regulator of protein synthesis for cell growth and proliferation. It consists of TOR SERINE-THREONINE KINASES; REGULATORY-ASSOCIATED PROTEIN OF MTOR (RAPTOR); MLST8 PROTEIN; and AKT1 substrate 1 protein. The activity of the complex is regulated by SIROLIMUS; INSULIN; GROWTH FACTORS; PHOSPHATIDIC ACIDS; some amino acids or amino acid derivatives, and OXIDATIVE STRESS.", "PM": "2018; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1 was indexed under MULTIPROTEIN COMPLEXES and TOR SERINE-THREONINE KINASES 2013-2017", "HN": "2018 (2013)", "MR": "20210521", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076222"}, {"RECTYPE": "D", "MH": "Regulatory-Associated Protein of mTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "mTOR Regulatory-Associated Protein", "MN": "D12.776.476.563.931.500.500", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Proteins (2002-2017)", "MS": "An adaptor protein component of the MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1 that forms stoichiometric complexes with TOR KINASES, which it negatively regulates. It functions as a positive regulator of RIBOSOMAL PROTEIN S6 KINASES.", "PM": "2018", "HN": "2018", "MR": "20210521", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076223"}, {"RECTYPE": "D", "MH": "Mechanistic Target of Rapamycin Complex 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Complex 2, TOR", "MN": "D12.776.476.563.931.750", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A multiprotein complex consisting of mTOR KINASE; MLST8 PROTEIN;  rapamycin-insensitive companion of mTOR protein (RICTOR PROTEIN); and PRR5 (proline-rich protein 5). Like mTORC1, it also regulates cell growth and proliferation in response to growth factors but may not be as sensitive to nutrient availability and is insensitive to SIROLIMUS. In contrast to mTORC1, it can regulate the ACTIN CYTOSKELETON through RHO GTPASES to promote the formation of STRESS FIBERS. The mTORC2 complex also plays a critical role in AKT1 PROTEIN KINASE phosphorylation and activation.", "PM": "2018; see TOR COMPLEX 2 2013-2017; MECHANISTIC TARGET OF RAPAMYCIN 2 COMPLEX was indexed under MULTIPROTEIN COMPLEXES and TOR SERINE-THREONINE KINASES 2013-2017", "HN": "2018 (2013)", "MR": "20210521", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076225"}, {"RECTYPE": "D", "MH": "Rapamycin-Insensitive Companion of mTOR Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Rapamycin Insensitive Companion of mTOR Protein", "MN": "D12.776.476.563.931.750.500", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (2004-2017)", "MS": "An adaptor protein subunit of MTORC2 COMPLEX. It functions as a structural component and is phosphorylated by RIBOSOMAL PROTEIN S6 KINASES, integrating signals for cell growth and proliferation, especially during embryonic development.", "PM": "2018", "HN": "2018", "MR": "20230609", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076226"}, {"RECTYPE": "D", "MH": "Stereolithography", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "ENTRY": "Stereolithographies", "MN": "L01.296.110.150.500.500", "MH_TH": "NLM (2018)", "ST": "T066", "MS": "A 3D printing technology where a computer-controlled moving laser beam is used to build up the required structure, layer by layer, from liquid POLYMERS that harden on contact with laser light (photopolymerization).", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076227"}, {"RECTYPE": "D", "MH": "MRE11 Homologue Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Homologue Protein, MRE11", "MN": "D12.776.660.720.495", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.1.-", "PI": "DNA-Binding Proteins (1999-2017)", "MS": "A component of the MRN complex along with Rad50 and Nibrin. Together, these perform a critical function in the repair of DOUBLE-STRANDED DNA BREAKS; RECOMBINATIONAL DNA REPAIR; maintenance of TELOMERE integrity and MEIOSIS. MRE11, which contains a poly(ADP)-ribose binding motif and associates with PARP1, possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity. Mutations in the MRE11 gene are associated with ATAXIA-TELANGIECTASIA-like disorder 1.", "PM": "2018", "HN": "2018", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076228"}, {"RECTYPE": "D", "MH": "mTOR Associated Protein, LST8 Homolog", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "G protein beta Subunit like Polypeptide", "MN": "D12.776.476.563.931.500.250", "MH_TH": "NLM (2020)", "ST": "T123", "RN": "0", "PI": "Proteins (2011-2017)", "MS": "An adaptor protein, consisting of seven WD REPEATS along its length, that functions as a component of the MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1 and mTORC2 COMPLEX. It interacts directly with mTOR to enhance its kinase activity and stabilizes the mTOR-RPTOR PROTEIN interaction in nutrient-poor conditions, favoring RPTOR inhibition of mTOR activity.", "PM": "2018", "HN": "2018", "MR": "20210521", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076242"}, {"RECTYPE": "D", "MH": "Lepisma", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Silverfish|T204|NON|NRW|NLM (2018)|170531|abcdef", "MN": "B01.050.500.131.617.576", "MH_TH": "NLM (2018)", "ST": "T204", "RN": "txid50585", "RR": "txid50586", "MS": "A small nocturnal wingless insect with tapering physical outline.", "PM": "2018", "HN": "2018", "MR": "20200813", "DA": "20170712", "DC": "1", "DX": "20180101", "UI": "D000076244"}, {"RECTYPE": "D", "MH": "Heterogeneous Nuclear Ribonucleoprotein A1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "hnRNP Protein A1|T116|T123|ABX|EQV|NLM (2003)|170531|abbcdef", "MN": "D12.776.664.962.813.750.100.500", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "MS": "A heterogeneous ribonucleoprotein that contains an RNA-BINDING MOTIF and has poly(ADP)ribose-binding capability. It functions in the packaging of pre-mRNA into hnRNP particles for export to the cytoplasm and may play a role in RNA SPLICING site selection.", "PM": "2018; see hnRNP A1 2003-2017; HETEROGENEOUS RIBONUCLEOPROTEIN A1 was indexed under HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B 2003-2017", "HN": "2018 (2003)", "MR": "20230405", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076245"}, {"RECTYPE": "D", "MH": "CCCTC-Binding Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DNA Binding Protein CTCF", "MN": "D12.776.930.780.563", "MH_TH": "NLM (2004)", "ST": "T116", "RN": "0", "MS": "A repressor protein with poly(ADP)-ribose binding activity that binds CHROMATIN and DNA; its structure consisting of 11 CYS2-HIS2 ZINC FINGERS allows it to recognize many different DNA target sites. It functions as a repressor by binding to INSULATOR ELEMENTS and preventing interaction between promoters and nearby enhancers and silencers. It plays a critical role in EPIGENETIC PROCESSES, including GENOMIC IMPRINTING.", "PM": "2018; CCCTC-BINDING FACTOR was indexed under REPRESSOR PROTEINS 2010-2017, under DNA-BINDING PROTEINS 1998-2009; and under TRANSCRIPTION FACTORS 1998-2004", "HN": "2018 (1998)", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076246"}, {"RECTYPE": "D", "MH": "Centromere Protein A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CENP A Protein", "MN": "D23.050.422.031", "MH_TH": "NLM (2000)", "ST": "T129", "RN": "0", "MS": "A 17 kDa, centromeric, poly(ADP)-ribose binding protein that is structurally similar to HISTONE H3 and localizes to NUCLEOSOMES within the CENTROMERE; specifically within the region that binds KINETOCHORES, where it replaces histone H3. It plays a critical role in recruiting kinetochore proteins and progression through MITOSIS, chromosome segregation, and CYTOKINESIS. It also binds sera from patients with some scleroderma-like AUTOIMMUNE DISEASES.", "PM": "2018; CENTROMERE PROTEIN A was indexed under AUTOANTIGENS 1987-2017 and CHROMOSOMAL PROTEINS, NON-HISTONE 1990-2017; and under NUCLEOPROTEINS 1987-1989", "HN": "2018 (1987)", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076247"}, {"RECTYPE": "D", "MH": "Sida Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Sida", "MN": "B01.875.800.575.912.250.859.821.500.777", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid108335", "PI": "Malvaceae (2000-2017)", "MS": "A genus of flowering plants in the family of mallows (MALVACEAE). Their common name is fanpetals.", "PM": "2018; see MALVACEAE 2003-2017", "HN": "2018; use MALVACEAE 2003-2017", "MR": "20210630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076248"}, {"RECTYPE": "D", "MH": "Heat Shock Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Plant Heat Shock Factor|T116|T123|NON|NRW|NLM (2021)|191119|abbcdef", "ENTRY": "Plant Heat Shock Factors|T116|T123|NON|NRW|NLM (2005)|170609|abbcdef", "MN": "D12.776.930.317", "FX": "Heat-Shock Proteins", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "MS": "Heat and cold stress-inducible, transcription factors that bind to inverted 5'-NGAAN-3' pentamer DNA sequences and are regulated by POLY-ADP-RIBOSYLATION. They play essential roles as transcriptional activators of the HEAT-SHOCK RESPONSE by inducing expression of large classes of MOLECULAR CHAPERONES and heat-shock proteins. They also function in DNA REPAIR; transcriptional reactivation of latent HIV-1; and pre-mRNA processing and nuclear export of HSP70 HEAT-SHOCK PROTEINS during heat stress.", "PM": "2018; see HEAT SHOCK TRANSCRIPTION FACTOR 1992-2017; HEAT SHOCK TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEINS and TRANSCRIPTION FACTORS 1992-2017", "HN": "2018 (1992)", "MR": "20200812", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076249"}, {"RECTYPE": "D", "MH": "Myristoylated Alanine-Rich C Kinase Substrate", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Myristoylated Alanine Rich C Kinase Substrate", "MN": "D12.776.660.720.496", "MH_TH": "NLM (1989)", "ST": "T123", "RN": "125267-21-2", "MS": "A membrane and ACTIN CYTOSKELETON associated, N-terminal myristoylated protein that binds CALMODULIN and is a prominent substrate for PROTEIN KINASE C. Both phosphorylation and poly(ADP)-ribosylation inhibit its F-ACTIN crosslinking activity; phosphorylation also causes MARCKS to relocate from the membrane to cytoplasm.", "PM": "2018; MYRISTOYLATED ALANINE-RICH C KINASE SUBSTRATE was indexed under MEMBRANE PROTEINS and INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 1989-2017", "HN": "2018 (1989)", "MR": "20170629", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076250"}, {"RECTYPE": "D", "MH": "Wearable Electronic Devices", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Wearable Computer|T073|NON|NRW|NLM (2024)|221019|abcdef", "ENTRY": "Wearable Technologies", "MN": "E07.305.906", "FX": "Motion Capture", "MH_TH": "NLM (2018)", "ST": "T073", "MS": "Electronic implements worn on  the body as an implant or as an accessory. Examples include wearable diagnostic devices, wearable ACTIVITY TRACKERS, wearable INFUSION PUMPS, wearable computing devices, SENSORY AIDS, and electronic pest repellents.", "PM": "2018", "HN": "2018", "MR": "20230226", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076251"}, {"RECTYPE": "D", "MH": "Communicable Diseases, Imported", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infectious Imported Diseases", "MN": "C23.550.291.531.875", "FX": "Travel-Related Illness", "MH_TH": "NLM (2018)", "ST": "T047", "MS": "Infectious diseases originating in one geographically delineated ecosystem that are carried (by travel or immigration) to another geographically delineated ecosystem by an infected individual, animal, or disease vector.", "PM": "2018", "HN": "2018", "MR": "20200527", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076263"}, {"RECTYPE": "D", "MH": "Composting", "AQ": "EC ES HI IS LJ MT SN ST", "ENTRY": "Compost|T167|NON|REL|NLM (2004)|030416|abcdef", "MN": "N06.850.860.510.900.600.200", "MH_TH": "NLM (2018)", "ST": "T068", "PI": "Soil (1963-2017)", "MS": "A process of waste disposal involving the conversion of green waste (i.e. leaves, organic matter, food waste, manure) into soil-enhancing matter.", "PM": "2018", "HN": "2018", "MR": "20170711", "DA": "20170712", "DC": "1", "DX": "20180101", "UI": "D000076282"}, {"RECTYPE": "D", "MH": "Citrullination", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Protein Deimination|T044|NON|EQV|NLM (2020)|181219|abcdef", "ENTRY": "Protein Arginine Deimination", "MN": "G05.308.670.600.300", "FX": "Protein-Arginine Deiminases", "MH_TH": "NLM (2018)", "ST": "T044", "PI": "Citrulline (1995-2017)", "MS": "Conversion of ARGININE residues in proteins into CITRULLINE residues by PROTEIN-ARGININE DEIMINASES.", "PM": "2018", "HN": "2018", "MR": "20190530", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076302"}, {"RECTYPE": "D", "MH": "Multimorbidity", "AQ": "TD", "MN": "N06.850.490.687.500", "MH_TH": "OBSSR (2016)", "ST": "T067", "MS": "The complex interactions of several co-existing diseases.", "PM": "2018", "HN": "2018", "MR": "20170709", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076322"}, {"RECTYPE": "D", "MH": "Protein-Arginine Deiminases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein L Arginine Iminohydrolases", "MN": "D08.811.277.721", "FX": "Citrullination", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 3.5.3.15", "MS": "A family of ENZYMES that, in the presence of calcium ion, converts ARGININE to CITRULLINE in proteins. There are five PAD isotypes in mammals.  In humans: they include PAD1, 2, 3, 4 and 6. They are encoded by five paralogous genes named PADI and clustered on human chromosome 1.", "PM": "2018; PROTEIN-ARGININE DEIMINASE was indexed as HYDROLASES 1987-2017", "HN": "2018 (1987)", "MR": "20190530", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076342"}, {"RECTYPE": "D", "MH": "Adaptive Clinical Trial", "MN": "V03.175.250.050", "MH_TH": "NLM (2018)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific adaptive clinical trial; a different heading ADAPTIVE CLINICAL TRIALS AS TOPIC is used for general design, methodology, economics, etc. of adaptive clinical trials", "MS": "Clinical study in which a prospectively planned opportunity is included to modify trial designs and hypotheses based on analysis of data from subjects in the study.", "HN": "2018", "MR": "20170705", "DA": "20170711", "DC": "2", "DX": "20180101", "UI": "D000076362"}, {"RECTYPE": "D", "MH": "Academic Success", "ENTRY": "Successes, Academic", "MN": "I02.399.136.500", "MH_TH": "NLM (2018)", "ST": "T080", "MS": "Level of engagement in educationally purposeful activities, satisfaction, acquisition of desired knowledge, skills, and competencies, persistence and attainment of educational outcomes.", "PM": "2018", "HN": "2018", "MR": "20170630", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076363"}, {"RECTYPE": "D", "MH": "Diverticular Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diverticular Disease", "MN": "C06.405.205.282", "FX": "Diverticulum", "MH_TH": "NLM (2018)", "ST": "T047", "PI": "Diverticulum (1968-2017)", "MS": "Diseases of the DIVERTICULUM often due to infection and/or inflammation (DIVERTICULITIS).", "PM": "2018", "HN": "2018", "MR": "20190617", "DA": "20170711", "DC": "1", "DX": "20180101", "UI": "D000076385"}, {"RECTYPE": "D", "MH": "Daphniphyllum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Daphniphyllum yunnanenses", "MN": "B01.875.800.575.912.250.890.500.500", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid4387", "RR": "txid482935", "PI": "Saxifragaceae (2003-2018)", "MS": "Broad-leaved evergreen shrub or small tree comprising several species. It is the only genus of the family DAPHNIPHYLLACEAE, class MAGNOLIOPSIDA.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076482"}, {"RECTYPE": "D", "MH": "Sustainable Development", "AQ": "EC HI LJ TD", "PRINT ENTRY": "Sustainable Development Goals|T081|NON|REL|NLM (2022)|210524|abcdef", "ENTRY": "Sustainable Development Goal", "MN": "N06.230.080.900", "MH_TH": "NLM (1994)", "ST": "T070", "MS": "A process of change in which the exploitation of resources, the direction of investments, the orientation of technological development; and institutional change are all in harmony and enhance both current and future potential to meet human needs and aspirations. (http://www.un-documents.net/ocf-02.htm#I)", "PM": "2019; 1994-2018 was Conservation of Natural Resources", "HN": "2019; 1994-2018 see Conservation of Natural Resources", "MR": "20210707", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076502"}, {"RECTYPE": "D", "MH": "Retention in Care", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Care Retention|T058|NON|EQV|NLM (2019)|171030|abcdef", "MN": "N02.421.585.169.671", "MH_TH": "NLM (2019)", "ST": "T058", "PI": "Continuity of Patient Care (2012-2018)", "MS": "Patient's regular engagement with medical care after initial entry into the system.", "PM": "2019", "HN": "2019", "MR": "20180810", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076522"}, {"RECTYPE": "D", "MH": "Clinical Observation Units", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Observation Unit", "MN": "N02.278.388.075", "MH_TH": "NLM (2019)", "ST": "T093", "MS": "A hospital unit that serves as a dedicated observation area for emergency room patients when a decision to admit or not is unclear. Also known as clinical decision units or short-stay observation units.", "PM": "2019", "HN": "2019", "MR": "20171211", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076542"}, {"RECTYPE": "D", "MH": "Nurses Improving Care for Health System Elders", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "NICHE Hospital Program", "MN": "N05.300.559", "MH_TH": "NLM (2019)", "ST": "T093", "AN": "CATALOGER: use NAF entry", "MS": "Nonprofit programs designed to address the complex needs of older adults and improve outcomes. They provide the principles, education and tools to support healthcare systems in transforming and achieving patient-centered care.", "PM": "2019", "HN": "2019", "MR": "20190528", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076562"}, {"RECTYPE": "D", "MH": "Mentalization", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Mentalizing|T041|NON|EQV|NLM (2010)|190219|abcdef", "MN": "F02.463.467", "MH_TH": "NLM (2019)", "ST": "T041", "MS": "The mental process by which an individual implicitly and explicitly interprets the actions of self and others as meaningful on the basis of intentional mental states such as personal desires, needs, feelings, beliefs, and reasons.", "PM": "2019", "HN": "2019", "MR": "20190510", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076563"}, {"RECTYPE": "D", "MH": "Population Health Management", "ENTRY": "Population Health Managements", "MN": "N05.300.570", "MH_TH": "NLM (2019)", "ST": "T058", "PI": "Population Health (2018)", "MS": "Community engagement, facility management, and organization, access to care that is timely and affordable; the availability of effective services, and high-quality primary health care. (World Health Organization)", "PM": "2019", "HN": "2019", "MR": "20180430", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076602"}, {"RECTYPE": "D", "MH": "Syndemic", "ENTRY": "Syndemics", "MN": "N06.850.490.937", "MH_TH": "NLM (2019)", "ST": "T078", "MS": "Synergistically-interacting health conditions producing excess disease occurrence in a population.", "PM": "2019", "HN": "2019", "MR": "20171229", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076603"}, {"RECTYPE": "D", "MH": "Physical Functional Performance", "ENTRY": "Physical Performances", "MN": "N01.400.545.750", "MH_TH": "NLM (2019)", "ST": "T040", "PM": "2019", "HN": "2019", "MR": "20171211", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076604"}, {"RECTYPE": "D", "MH": "Disenfranchised Grief", "ENTRY": "Grief, Disenfranchised", "MN": "F01.470.142.110.500", "MH_TH": "NLM (2019)", "ST": "T055", "PI": "Bereavement (1998-2018)", "MS": "Expression of grief that society limits or may not allow a person to express. Examples include the grief of parents for stillborn babies, of teachers for the death of students, of nurses for the death of patients, or for the loss of an animal companion. (from APA Dictionary of Psychology, 2nd ed.)", "PM": "2019", "HN": "2019", "MR": "20171211", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076605"}, {"RECTYPE": "D", "MH": "Saxifragales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Saxiphragales|T002|NON|EQV|NLM (2019)|170823|abcdef", "MN": "B01.875.800.575.912.250.890", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid41946", "MS": "Order of dicotyledonous flowering plants consisting of 16 families, 112 genera, and nearly 2,500 species.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076607"}, {"RECTYPE": "D", "MH": "Daphniphyllaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.890.500", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid4386", "MS": "Vascular plants of the order SAXIFRAGALES, class MAGNOLIOPSIDA, of which the sole genus is DAPHNIPHYLLUM.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076608"}, {"RECTYPE": "D", "MH": "Brugmansia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.908.500.097", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid301914", "PI": "Solanaceae (1963-2018)", "MS": "A genus of solanaceae that refers to small to mid-size trees with large, strong-smelling, trumpet-shaped flowers hanging downward. Most parts of the plant contain ATROPINE, SCOPOLAMINE HYDROBROMIDE and HYOSCYAMINE.", "PM": "2019; see SOLANACEAE 2002-2018", "HN": "2019(2002); use SOLANACEAE 2002-2018", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076609"}, {"RECTYPE": "D", "MH": "Genetic Profile", "ENTRY": "Profiles, Genotype", "MN": "G05.346.500", "MH_TH": "NLM (2019)", "ST": "T032", "MS": "A set of characteristics unique to the DNA of an individual organism or population obtained by analyzing small samples of biological material such as body tissues or fluids, used especially in the context of predicting susceptibility to a particular disease. For example, some populations have identifiable genetic profiles which put them at higher risk for cancer. Distinguish from GENETIC BACKGROUND and GENETIC VARIATION.", "PM": "2019", "HN": "2019", "MR": "20180614", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076610"}, {"RECTYPE": "D", "MH": "Malpighiales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Malesherbiales|T002|NON|REL|NLM (2021)|191121|abcdef", "ENTRY": "Malesherbiale", "MN": "B01.875.800.575.912.250.859.797", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid3646", "RR": "txid72384", "MS": "Order of flowering plants which includes many tropical species. Well-characterized members include SALICACEAE (willow family), VIOLACEAE (violet family), PASSIFLORACEAE (passion-flower family), EUPHORBIACEAE (spurge or croton family), RHIZOPHORACEAE (mangrove family), and ERYTHROXYLACEAE (coca family).", "PM": "2019; for Caryocaraceae see under Ericales 2017-2020; Theales 2009-2016", "HN": "2019; for Caryocaraceae was under Ericales 2017-2020; Theales 2009-2016", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076622"}, {"RECTYPE": "D", "MH": "Flacourtia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.797.875.450", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid112818", "MS": "A genus of flowering plants in the family SALICACEAE, order MALPHIGIALES. An example is the willow, also known as salix or saules (French).", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076623"}, {"RECTYPE": "D", "MH": "Built Environment", "AQ": "CL EC ES HI LJ OG PX SD SN ST TD", "ENTRY": "Built Environments", "MN": "N06.230.145.500", "MH_TH": "NLM (2018)", "ST": "T078", "MS": "The man-made physical elements of the environment (e.g., homes, buildings, streets, open spaces, and infrastructure). The built environment influences a person's level of physical activity and may have other impacts on health in a community.", "PM": "2019", "HN": "2019", "MR": "20200527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076624"}, {"RECTYPE": "D", "MH": "Dicentra", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.836.500.343", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid22680", "MS": "A genus of herbaceous plants with asymmetrically-shaped flowers and finely divided leaves, native to east Asia and North America.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076625"}, {"RECTYPE": "D", "MH": "Desulfovibrionales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.125.144", "MH_TH": "NLM (2019)", "ST": "T007", "RN": "txid213115", "MS": "An order of bacteria within the class DELTAPROTEOBACTERIA, of the phylum PROTEOBACTERIA, which comprises four families.", "PM": "2019", "HN": "2019", "MR": "20200813", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076642"}, {"RECTYPE": "D", "MH": "Maesa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.341.984.718", "MH_TH": "NLM (2008)", "ST": "T002", "RN": "txid59979", "MS": "A genus of flowering plants in the family PRIMULACEAE, order ERICALES.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076643"}, {"RECTYPE": "D", "MH": "Myrsine", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rapanea|T002|NON|EQV|NLM (2003)|010917|abcdef", "MN": "B01.875.800.575.912.250.341.984.746", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid59981", "MS": "A genus of flowering plants in the family PRIMULACEAE, found worldwide but primarily in tropical and subtropical regions.", "PM": "2019; see MYRSINACEAE 2003-2017", "HN": "2019(2003); use MYRSINACEAE 2003-2017", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076644"}, {"RECTYPE": "D", "MH": "Host Microbial Interactions", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Virus-Host Interactions|T070|NON|NRW|NLM (2022)|210201|abcdef", "ENTRY": "Virus-Host Interaction", "MN": "G16.527", "MH_TH": "NLM (2019)", "ST": "T070", "PI": "Host-Pathogen Interactions (2007-2018)", "MS": "Interactions between a host and microbe or microbiota.", "PM": "2019", "HN": "2019", "MR": "20210707", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076662"}, {"RECTYPE": "D", "MH": "Endurance Training", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Training, Endurance", "MN": "I03.350.311.188", "FX": "Physical Endurance", "MH_TH": "NLM (2019)", "ST": "T061", "PI": "Physical Endurance (1975-2018)", "MS": "Exercise programs of relatively long duration and moderate intensity, which enhance maximal oxygen uptake, increasing PHYSICAL STAMINA.", "PM": "2019", "HN": "2019", "MR": "20180712", "DA": "20180712", "DC": "1", "DX": "20190101", "UI": "D000076663"}, {"RECTYPE": "D", "MH": "Ranunculales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Ranunculale", "MN": "B01.875.800.575.912.250.836", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid41768", "MS": "An order of flowering plants also known as the buttercup family.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076664"}, {"RECTYPE": "D", "MH": "Ventilation-Perfusion Scan", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Ventilation-Perfusion Scintigraphies", "MN": "E01.370.386.700.963", "MH_TH": "NLM (2019)", "ST": "T060", "PI": "Ventilation-Perfusion Ratio (1963-2018)", "MS": "A two-part radionuclide imaging that measures VENTILATION-PERFUSION RATIO of the lungs often used to investigate PULMONARY EMBOLISM. Image acquisitions may be performed using various combinations of gamma camera, PET and SPECT scanning techniques.", "PM": "2019", "HN": "2019", "MR": "20171214", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076665"}, {"RECTYPE": "D", "MH": "Solanales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Sphenocleales|T002|NON|EQV|NLM (2019)|170907|abcdef", "MN": "B01.875.800.575.912.250.908", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid4069", "MS": "An order of flowering plants comprising tropical and temperate species, major crop plants such as potatoes, tomatoes, bell peppers, eggplants, tobacco, and the garden petunia. Its largest family is the SOLANACEAE.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076666"}, {"RECTYPE": "D", "MH": "Austrobaileyales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.103", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid82956", "MS": "Order of woody flowering plants which grow as trees and shrubs that include the genera, Illicium and Schisandra.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076667"}, {"RECTYPE": "D", "MH": "Preprints as Topic", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "as Topics, Pre-Prints", "MN": "L01.737.736", "MH_TH": "NLM (2019)", "ST": "T073", "AN": "do not confuse with the Publication Type PREPRINT", "PI": "Publishing (1998-2018)", "MS": "Works about scientific manuscripts made available prior to PEER REVIEW.", "PM": "2019", "HN": "2019", "MR": "20220712", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076682"}, {"RECTYPE": "D", "MH": "International Health Regulations", "AQ": "CL EC ES HI OG SN ST TD", "ENTRY": "International Health Regulation", "MN": "N03.706.615.473.250", "MH_TH": "NLM (2019)", "ST": "T064", "MS": "Regulations to prevent, protect against, control and provide a public health response to the international spread of disease in ways that are commensurate with and restricted to public health risks. (www.who.int/features/qa/39/en)", "PM": "2019", "HN": "2019", "MR": "20171211", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076702"}, {"RECTYPE": "D", "MH": "Drug Development", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Drug Target Prediction|T062|NON|REL|NLM (2020)|190510|abcdef", "ENTRY": "Target Prediction, Drug", "MN": "E05.290", "MH_TH": "NLM (2019)", "ST": "T062", "AN": "do not confuse with DRUG DISCOVERY which is the process of finding chemicals for potential therapeutic use", "MS": "The entire process of bringing a new drug to the market. It includes both preclinical and clinical testing, and regulatory approval.", "PM": "2019", "HN": "2019", "MR": "20210305", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076722"}, {"RECTYPE": "D", "MH": "Negative Results", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Null Result", "MN": "N06.850.520.308.544", "MH_TH": "NLM (2019)", "ST": "T170", "MS": "Subject matter related to research studies in which the data do not demonstrate any clear evidence of effect, especially if an effect was expected.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076723"}, {"RECTYPE": "D", "MH": "Collaborative Cross Mice", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Mouse, Diversity Outbred|T008|NON|REL|NLM (2019)|170927|abcdef", "MN": "B01.050.150.900.649.313.992.635.505.500.400.013", "MH_TH": "NLM (2019)", "ST": "T008", "PI": "Mice, Inbred Strains (2004-2018)", "MS": "Recombinant inbred strains of mice derived from an eight-way cross of eight genetically diverse, founder inbred strains, as a reference population for analyzing MULTIFACTORIAL INHERITANCE.", "PM": "2019", "HN": "2019", "MR": "20200902", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076724"}, {"RECTYPE": "D", "MH": "Synthetic Drugs", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Drugs, Synthetic", "MN": "D26.909", "MH_TH": "NLM (2019)", "ST": "T121", "RN": "0", "PI": "Street Drugs (2001-2018)", "MS": "Legal or illegal drugs created using SYNTHETIC CHEMISTRY TECHNIQUES.", "PM": "2019", "HN": "2019", "MR": "20171208", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076742"}, {"RECTYPE": "D", "MH": "Traffic-Related Pollution", "AQ": "AE AN EC ES HI LJ PC SN", "ENTRY": "Traffic Related Pollution", "MN": "N06.850.460.685", "FX": "Vehicle Emissions", "MH_TH": "NLM (2019)", "ST": "T069", "PI": "Air Pollution (1970-2018)", "MS": "Contamination of the ENVIRONMENT by VEHICLE EMISSIONS.", "PM": "2019", "HN": "2019", "MR": "20171213", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076764"}, {"RECTYPE": "D", "MH": "Race Factors", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Racial Factor", "MN": "N05.715.350.463", "FX": "Racial Groups", "MH_TH": "NLM (2019)", "ST": "T068", "MS": "A constituent element or influence that could be used in studies for racial disparities as variables such as those related to risk factors and disease and or differential access to services.", "PM": "2019", "HN": "2019", "MR": "20210713", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076782"}, {"RECTYPE": "D", "MH": "Adverse Childhood Experiences", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Traumatic Childhood Experiences|T078|NON|NRW|NLM (2022)|201030|abcdef", "ENTRY": "Traumatic Childhood Experience", "MN": "I01.880.853.050", "MH_TH": "NLM (2018)", "ST": "T078", "AN": "Human only; Early Life Stress in animals use STRESS, PSYCHOLOGICAL and/or STRESS, PHYSIOLOGICAL; for model animal, coordinate with ANIMAL DISEASE MODELS and specific human disease and ADVERSE CHILDHOOD EXPERIENCES.", "PI": "Violence (2000-2018)", "MS": "Deleterious experiences in first 18 years of life.", "PM": "2019", "HN": "2019", "MR": "20230526", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076783"}, {"RECTYPE": "D", "MH": "Pinealectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "MN": "E04.270.775", "FX": "Pinealoma", "MH_TH": "NLM (2019)", "ST": "T061", "PI": "Pineal Gland (1963-2018)", "MS": "Surgical removal of the PINEAL GLAND including resection of pineal tumor (PINEALOMA) and CYSTS.", "PM": "2019", "HN": "2019", "MR": "20171214", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076822"}, {"RECTYPE": "D", "MH": "Diagnostic Screening Programs", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Screening Program, Diagnostic", "MN": "N02.421.726.233.138", "MH_TH": "NLM (2019)", "ST": "T058", "PI": "Mass Screening (1963-2018)", "MS": "Services for the presumptive identification of unrecognized disease in an apparently healthy, asymptomatic population by means of tests, examinations or other procedures that can be applied rapidly and easily to the target population. (from World Health Organization http://www.who.int/cancer/prevention/diagnosis-screening/screening/en/ Oct. 24,2017)", "PM": "2019", "HN": "2019", "MR": "20171213", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076862"}, {"RECTYPE": "D", "MH": "Gray Literature", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Grey Literature|T170|NON|EQV|NLM (2019)|171211|abcdef", "MN": "L01.462.500.682.550", "MH_TH": "NLM (2019)", "ST": "T170", "MS": "Works that include publications such as reports, theses, conference papers, translations and limited circulation government documents which are not normally available through commercial publication sources. (LCSH)", "PM": "2019", "HN": "2019", "MR": "20220712", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076889"}, {"RECTYPE": "D", "MH": "UNESCO", "ENTRY": "United Nations Educational, Scientific and Cultural Organization|T092|NON|EQV|NLM (2012)|110405|abcdef", "MN": "N03.540.514.718.400", "MH_TH": "NLM (1978)", "ST": "T092", "AN": "CATALOGER: Use NAF entry", "MS": "An operating body of the UNITED NATIONS, responsible for coordinating international cooperation in education, science, culture and communication.", "PM": "2019; see UNITED NATIONS 1980-2018; INTERNATIONAL ORGANIZATIONS 1978-1979", "HN": "2019; was UNITED NATIONS 1980-2018; INTERNATIONAL ORGANIZATIONS 1978-1979", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076892"}, {"RECTYPE": "D", "MH": "Preprint", "ENTRY": "Preprints|T170|NON|EQV|NLM (2019)|171031|abcdef", "MN": "V02.630.500", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Preprints as a subject are indexed under the main heading PREPRINTS AS TOPIC. INDEXER: Do not use", "MS": "Scientific manuscript made available prior to PEER REVIEW.", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000076942"}, {"RECTYPE": "D", "MH": "Rickettsiales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783", "MH_TH": "NLM (2019)", "ST": "T007", "RN": "txid766", "PI": "Rickettsia (1963-2018)", "MS": "Order in class ALPHAPROTEOBACTERIA that are endosymbionts in eukaryotic cells. High morbidity and mortality are frequently associated with Rickettsiales transmitted by INSECT VECTORS.", "PM": "2019", "HN": "2019", "MR": "20200813", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076944"}, {"RECTYPE": "D", "MH": "Receptors, Chimeric Antigen", "AQ": "AD AG AI AN BL CH CL CS DE GE HI IM IP ME RE TU UL", "PRINT ENTRY": "Chimeric T-Cell Receptor|T116|T192|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "T-Cell Receptors, Chimeric", "MN": "D12.776.826.387.500", "FX": "Immunotherapy, Adoptive", "MH_TH": "NLM (2019)", "ST": "T192", "RN": "0", "AN": "for CAR-T Cell Therapy, coordinate with CHIMERIC ANTIGEN RECEPTOR THERAPY see IMMUNOTHERAPY, ADOPTIVE", "PI": "Recombinant Fusion Proteins (1993-2018)", "MS": "Synthetic cellular receptors that reprogram T-LYMPHOCYTES to selectively bind antigens.", "PM": "2019", "HN": "2019", "MR": "20210305", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076962"}, {"RECTYPE": "D", "MH": "Histone Methyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "N-Methyltransferase, Histone-Arginine", "MN": "D08.811.913.555.500.800.200", "MH_TH": "NLM (2019)", "ST": "T126", "RN": "EC 2.1.1.-", "RR": "EC 2.1.1.43", "MS": "Enzymes that catalyze the transfer of methyl groups to LYSINE or ARGININE residues of HISTONES, especially histone H3 and histone H4 proteins. They play a critical role in EPIGENETIC PROCESSES.", "PM": "2019; see HISTONE METHYLTRANSFERASE 1972-2018; for HISTONE-ARGININE N-METHYLTRANSFERASE see PROTEIN-ARGININE N-METHYLTRANSFERASES 2010-2018", "HN": "2019 (1972); for HISTONE-ARGININE N-METHYLTRANSFERASE use PROTEIN-ARGININE N-METHYLTRANSFERASES 2010-2018", "MR": "20180116", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076983"}, {"RECTYPE": "D", "MH": "Neonatal Brachial Plexus Palsy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Obstetrical Brachial Plexus Palsy|T047|NON|EQV|NLM (2019)|171114|abcdef", "MN": "C26.141.294", "MH_TH": "NLM (2019)", "ST": "T047", "PI": "Paralysis, Obstetric (1973-2018)", "MS": "Perinatal nerve injury involving the BRACHIAL PLEXUS involving a weak or paralyzed upper extremity.", "PM": "2019", "HN": "2019", "MR": "20180206", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076984"}, {"RECTYPE": "D", "MH": "Saporins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RIP Ribosome-Inactivating Protein|T116|T126|ACX|EQV|NLM (2022)|210426|abbcdef", "ENTRY": "Saporin S9 Protein", "MN": "D12.776.765.710.500.250", "FX": "Saponins", "MH_TH": "NLM (2019)", "ST": "T126", "RN": "EC 3.2.2.22", "MS": "Type 1 ribosome-inactivating proteins derived from SAPONARIA OFFICINALIS that function through endohydrolysis of the N-glycosidic bond at single ADENOSINE residues of 28S RIBOSOMAL RNA. They are used as IMMUNOTOXINS.", "PM": "2019; see SAPORIN 1985-2018", "HN": "2019 (1985)", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076985"}, {"RECTYPE": "D", "MH": "CRISPR-Associated Protein 9", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Enzyme, Cas9", "MN": "D12.776.212.500", "FX": "Gene Editing", "MH_TH": "NLM (2019)", "ST": "T126", "RN": "EC 3.1.-", "PI": "Endonucleases (2015-2018)", "MS": "An RNA-guided endodeoxyribonuclease that associates with CRISPR SEQUENCES in STREPTOCOCCUS PYOGENES and other bacteria where it participates in an adaptive immune function to cleave foreign DNA complimentary to small GUIDE RNA (sgRNAs). Structurally, Cas9 consists of an ALPHA-HELIX module and a nuclease module connected by a single helix. The nuclease module contains two enzymatic domains: RuvC, which cleaves non-target DNA strand, and an HNH nuclease domain, which cleaves the target strand. Specificity for the DNA target depends on the presence of a protospacer adjacent motif (PAM) sequence, a 2-6 nucleotide DNA sequence immediately following the sequence targeted by Cas9.", "PM": "2019", "HN": "2019", "MR": "20210707", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076987"}, {"RECTYPE": "D", "MH": "Sulfate Transporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sulphate Transporter|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Transporters, Sulphate", "MN": "D12.776.543.585.937.963", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "Anion Transport Proteins (2002-2018)", "MS": "Highly conserved families of transmembrane anion transporters that occur in both prokaryotes and eukaryotes. In humans, they are expressed by epithelial cells in a variety of tissues and participate in diverse physiologic functions such as cell motility and regulating the composition and acidity of body fluids. Some Slc13 family proteins function as sodium ion-coupled co-transporters of sulfate and other anions.", "PM": "2019", "HN": "2019", "MR": "20200527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000076988"}, {"RECTYPE": "D", "MH": "Acetabulum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cotyloid Cavities", "MN": "A02.835.232.043.825.108", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The part of the pelvis that comprises the pelvic socket where the head of FEMUR joins to form HIP JOINT (acetabulofemoral joint).", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000077"}, {"RECTYPE": "D", "MH": "GRADE Approach", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "GRADE Assessment|T081|NON|EQV|NLM (2019)|171116|abcdef", "MN": "N05.715.360.575.575.399.375", "MH_TH": "NLM (2019)", "ST": "T081", "MS": "A common, sensible, structured  and transparent approach to grading quality (or certainty) of evidence and strength of recommendations developed by the Grading of Recommendations Assessment, Development and Evaluation (short GRADE) working group.", "PM": "2019", "HN": "2019", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077002"}, {"RECTYPE": "D", "MH": "Sodium Sulfate Cotransporter", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NaSi 1 Cotransporter", "MN": "D12.776.543.585.937.963.500", "MH_TH": "NLM (1987)", "ST": "T123", "RN": "0", "MS": "A multi-pass protein that consists of 13 transmembrane helices. It is expressed primarily by renal epithelial cells and functions as a co-transporter of sodium and sulfate, to mediate sulfate reabsorption in the kidney.", "PM": "2019; SODIUM SULFATE COTRANSPORTER was indexed under CATION TRANSPORT PROTEINS and SYMPORTERS 2005-2018, and under CARRIER PROTEINS 1987-2004", "HN": "2019 (1987)", "MR": "20180619", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077003"}, {"RECTYPE": "D", "MH": "Tuberous Sclerosis Complex 1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hamartin|T116|T123|NON|EQV|NLM (1997)|171117|abbcdef", "MN": "D12.776.624.776.766", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An intracellular signaling and tumor suppressor protein that forms a complex with TUBEROUS SCLEROSIS COMPLEX 2 PROTEIN (TSC2) and other signaling factors to negatively regulate MTORC1 signaling and affect cell growth and proliferation. Structurally, it interacts with TSC2 through its N-terminal, which also contains GSK-3BETA phosphorylation sites and a RHO-KINASE activation domain. It also contains a C-terminal coiled-coil domain and ezrin-radixin-moesin (ERM) domain. Mutations in the TSC1 gene are associated with TUBEROUS SCLEROSIS.", "PM": "2019; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN was indexed under TUMOR SUPPRESSOR PROTEINS 2006-2018 and under PROTEINS 1997-2005", "HN": "2019 (1997)", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077004"}, {"RECTYPE": "D", "MH": "Tuberous Sclerosis Complex 2 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tuberous Sclerosis 2 Protein|T116|T123|NON|EQV|NLM (1994)|171117|abbcdef", "MN": "D12.776.624.776.769", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An intracellular signaling and tumor suppressor protein that forms a complex with TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN (TSC1) and other signaling factors to negatively regulate MTORC1 and affect cell growth and proliferation. It can also function as GTPASE-ACTIVATING PROTEIN (GAP) for RHEB GTPASE to activate mTORC1 independent of its role in the complex. Structurally, it interacts with TSC1 through its N-terminus, which also contains a leucine zipper and coiled-coil region. It also has multiple phosphorylation sites for different cell signaling kinases, a central coiled-coil region, a C-terminal GAP domain and CALMODULIN binding domain. Mutations in the TSC2 gene are associated with TUBEROUS SCLEROSIS.", "PM": "2019; TUBEROUS SCLEROSIS COMPLEX 2 PROTEIN was indexed under TUMOR SUPPRESSOR PROTEINS 2006-2018 and under REPRESSOR PROTEINS 1994-2005", "HN": "2019 (1994)", "MR": "20180619", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077005"}, {"RECTYPE": "D", "MH": "Survivin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Baculoviral IAP Repeat containing Protein 5", "MN": "D12.776.476.075.437.625", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "Neoplasm Proteins (1997-2018)", "MS": "An apoptosis inhibitory protein that contains a single baculoviral IAP repeat (BIR) domain. It associates with MICROTUBULES and functions to regulate cell proliferation as a component of the chromosome passage protein complex (CPC), performing essential roles for localization of the complex, chromosome alignment, segregation during MITOSIS and CYTOKINESIS, and assembly of the MITOTIC SPINDLE. It is expressed by fetal kidney and liver cells and highly expressed in ADENOCARCINOMA and high-grade LYMPHOMA.", "PM": "2019", "HN": "2019", "MR": "20180116", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077022"}, {"RECTYPE": "D", "MH": "Burnout, Psychological", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Psychological Burnout", "MN": "F02.830.900.333", "FX": "Karoshi Death", "MH_TH": "NLM (2019)", "ST": "T048", "PI": "Stress, Psychological (1977-2018)", "MS": "An excessive reaction to stress caused by one's environment that may be characterized by feelings of emotional and physical exhaustion, coupled with a sense of frustration and failure.", "PM": "2019", "HN": "2019", "MR": "20200708", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077062"}, {"RECTYPE": "D", "MH": "Birth Setting", "AQ": "HI NU SN TD", "ENTRY": "Settings, Birth", "MN": "G08.686.784.769.490.062", "MH_TH": "NLM (2019)", "ST": "T082", "MS": "Physical setting or location of birth.", "PM": "2019", "HN": "2019", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077085"}, {"RECTYPE": "D", "MH": "Apium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Celery|T002|NON|NRW|NLM (1998)|961106|abcdef", "ENTRY": "Wild Celeries", "MN": "B01.875.800.575.912.250.075.094", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid4044", "RR": "txid4045", "MS": "A genus comprising several species of flowering plants with global distribution in the family APIACEAE.", "PM": "2019; see APIUM GRAVEOLENS 2002-2018; for CELERY use APIACEAE 1998-2001", "HN": "2019(2002); for CELERY see APIACEAE 1998-2001", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077102"}, {"RECTYPE": "D", "MH": "Chlorophyceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Chlamydomonadales|T204|NON|NRW|NLM (2010)|090303|abcdef", "MN": "B01.875.150.511", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid3166", "RR": "txid3042", "MS": "A class of green algae in the subdivision CHLOROPHYTINA distinguished by its ultrastructural morphology. Some species have distinct arrangement of flagella.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077105"}, {"RECTYPE": "D", "MH": "Gait Analysis", "AQ": "AE CL ES HI IS MT SN ST TD VE", "ENTRY": "Gait Analyses", "MN": "N01.400.545.750.500", "MH_TH": "NLM (2019)", "ST": "T060", "PI": "Gait (1981-2018)", "MS": "Determination of the level of functional limitation that may be due to pathology, and evaluating rehabilitative intervention of the way in which the body moves from one point to another. Most often, this is done by walking.", "PM": "2019", "HN": "2019", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077107"}, {"RECTYPE": "D", "MH": "Public Expenditures", "AQ": "CL HI LJ MT OG SD SN ST TD", "ENTRY": "Expenditures, Public", "MN": "N03.219.840", "MH_TH": "NLM (2019)", "ST": "T064", "MS": "Expenses of public funds incurred by government bodies:  state, regional and local.", "PM": "2019", "HN": "2019", "MR": "20180623", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077108"}, {"RECTYPE": "D", "MH": "Disability Studies", "AQ": "SN ST TD", "MN": "I02.158.405.500", "MH_TH": "NLM (2019)", "ST": "T090", "PI": "Interdisciplinary Studies (2011-2018)", "MS": "Interdisciplinary programs of academic study that de-stigmatize disease, illness, and impairment.", "PM": "2019", "HN": "2019", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077109"}, {"RECTYPE": "D", "MH": "Sugammadex", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sugammadex Sodium|T109|T121|NON|NRW|FDA SRS (2018)|NLM (2008)|USAN (19XX)|171127|abbcdeeef", "MN": "D09.698.365.855.400.375.444.500", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Gamma-cyclodextrin, 6A,6B,6C,6D,6E,7F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,7F,6G,6H-octathio-", "RN": "361LPM2T56", "RR": "ERJ6X2MXV7", "MS": "A gamma-cyclodextrin that functions as a reversal agent for the neuromuscular blocker ROCURONIUM BROMIDE.", "PM": "2019; SUGAMMADEX was indexed under GAMMA-CYCLODEXTRINS 2002-2018", "HN": "2019 (2002)", "MR": "20180116", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077122"}, {"RECTYPE": "D", "MH": "Rocuronium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-(2-propen-1-yl)-1-pyrrolidiniumyl)-, 17-acetate, (2beta,3alpha,5alpha,16beta,17beta)-|T109|T121|NON|EQV|NLM (2020)|190408|abbcdef", "ENTRY": "ORG9426", "MN": "D04.210.500.054.040.783", "MH_TH": "NLM (1989)", "ST": "T121", "RN": "WRE554RFEZ", "RR": "I65MW4OFHZ", "MS": "An androstanol non-depolarizing neuromuscular blocking agent. It has a mono-quaternary structure and is a weaker nicotinic antagonist than PANCURONIUM.", "PM": "2019; ROCURONIUM was indexed under ANDROSTANOLS 1989-2018", "HN": "2019 (1989)", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077123"}, {"RECTYPE": "D", "MH": "Malvales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.821", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid41938", "MS": "An order of mostly woody plants in the superorder ROSANAE. Members of the MALVALES grow in various habitats around the world.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077142"}, {"RECTYPE": "D", "MH": "Docetaxel", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RP56976", "MN": "D02.455.849.291.850.389", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenepropanoic acid, beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, (2aR,4S,4aR,6R,9S,11S,12S,12aS,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,4a ,6,11-tetrahydroxy-8,12a,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (alphaR)-, hydrate (1:3)", "RN": "15H5577CQD", "RR": "699121PHCA", "MS": "A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER.", "PM": "2019; DOCETAXEL was indexed under TAXOIDS 1993-2018, and under ALKALOIDS 1991-1992", "HN": "2019 (1991)", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077143"}, {"RECTYPE": "D", "MH": "Clopidogrel", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Clopidogrel Mepha", "MN": "D03.633.100.928.500.500", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate", "RN": "A74586SNO7", "RR": "BL9VGG8BHW", "MS": "A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.", "PM": "2019; CLOPIDOGREL was indexed under TICLOPIDINE 1988-2018", "HN": "2019 (1988)", "MR": "20180709", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077144"}, {"RECTYPE": "D", "MH": "Sulfanilamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "4 aminobenzenesulfonamide", "MN": "D02.886.590.700.725.885", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-", "RN": "21240MF57M", "RR": "6101-31-1 (Hydrochloride)", "MS": "A short-acting sulfonamide used as an anti-infective agent. It has lower anti-bacterial activity than SULFAMETHOXAZOLE.", "PM": "2019; SULFANILAMIDE was indexed under SULFANILAMIDES 1983-2019", "HN": "2019 (1983)", "MR": "20230608", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077145"}, {"RECTYPE": "D", "MH": "Irinotecan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SN3811", "MN": "D03.132.151.425", "MH_TH": "NLM (1987)", "ST": "T121", "N1": "(1,4'-Bipiperidine)-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester", "RN": "7673326042", "RR": "0H43101T0J", "MS": "A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS.", "PM": "2019; IRINOTECAN was indexed under CAMPTOTHECIN 1987-2018", "HN": "2019 (1987)", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077146"}, {"RECTYPE": "D", "MH": "Myrtales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.833", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid41944", "MS": "Order of flowering plants distributed throughout the tropics and warmer regions of the world. The majority of these species belong to two families, Melastomataceae and Myrtaceae. Myrtales includes many trees (notably Eucalyptus), shrubs, such as the classic myrtle, several food, spices, and ornamental plants.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077148"}, {"RECTYPE": "D", "MH": "Sevoflurane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ultane|T109|T121|TRD|NRW|NLM (2001)|010910|abbcdef", "MN": "D02.455.526.510.788", "MH_TH": "USAN (1975)", "ST": "T121", "N1": "Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-", "RN": "38LVP0K73A", "MS": "A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.", "PM": "2019; SEVOFLURANE was indexed under METHYL ETHERS 1999-2019, under ETHERS 1983-1998, and under HYDROCARBONS, FLUORINATED 1975-1982", "HN": "2019 (1975)", "MR": "20220413", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077149"}, {"RECTYPE": "D", "MH": "Oxaliplatin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Platinum(2+) ethanedioate (1R,2R)-1,2-cyclohexanediamine (1:1:1)|T109|T121|NON|EQV|NLM (2020)|190626|abbcdef", "ENTRY": "ACT078", "MN": "D02.257.750", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "04ZR38536J", "RR": "61913-68-6 ((SP-4-3-(cis))-isomer)", "MS": "An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane, and with an oxalate ligand which is displaced to yield active oxaliplatin derivatives. These derivatives form inter- and intra-strand DNA crosslinks that inhibit DNA replication and transcription. Oxaliplatin is an antineoplastic agent that is often administered with FLUOROURACIL and FOLINIC ACID in the treatment of metastatic COLORECTAL NEOPLASMS.", "PM": "2019; OXALIPLATIN was indexed under ORGANOPLATINUM COMPOUNDS 1981-2018", "HN": "2019 (1981)", "MR": "20190705", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077150"}, {"RECTYPE": "D", "MH": "Olanzapine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "LY170052", "MN": "D03.633.100.079.080.738", "MH_TH": "USAN (1993)", "ST": "T121", "RN": "N7U69T4SZR", "RR": "X7S6Q4MHCB", "MS": "A benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy.", "PM": "2019; OLANZAPINE was indexed under BENZODIAZEPINES 1992-2018", "HN": "2019 (1992)", "MR": "20220718", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077152"}, {"RECTYPE": "D", "MH": "Progranulins", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "PC Cell Derived Growth Factor", "MN": "D23.529.917", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "RR": "134710-81-9", "PI": "Intercellular Signaling Peptides and Proteins (1999-2018)", "MS": "Cysteine-rich, precursor glycoproteins encoded by the granulin gene (GRN). They contain granulin-repeats separated by linker sequences that are cleaved by a variety of proteases to release the individual GRANULIN PEPTIDES. The mammalian progranulin is composed of a half-granulin repeat followed by 7 granulin repeats. The mammalian GRANULINS are named PARAGRANULIN and granulin 1-7 for their order in the progranulin propeptide. Progranulin has growth-factor like effects and is expressed over a broad range of tissues. Under-expression of progranulin is linked to neurodegenerative diseases including FRONTOTEMPORAL DEMENTIA and NEURONAL CEROID LIPOFUSCINOSIS, while over-expression is linked to metabolic diseases including OBESITY, and INSULIN RESISTANCE.", "PM": "2019; GRANULIN PRECURSOR PROTEIN was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2004-2018 and VIRAL PROTEINS1992-2003", "HN": "2019", "MR": "20190705", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077153"}, {"RECTYPE": "D", "MH": "Rosiglitazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Rosiglitazone Maleate|T109|T121|NON|NRW|FDA SRS (2017)|NLM (2000)|USAN (19XX)|171201|abbcdeeef", "MN": "D03.383.129.708.933.500", "FX": "Pioglitazone", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-", "RN": "05V02F2KDG", "RR": "KX2339DP44", "MS": "A thiazolidinedione that functions as a selective agonist for PPAR GAMMA. It improves INSULIN SENSITIVITY in adipose tissue, skeletal muscle, and the liver of patients with TYPE 2 DIABETES MELLITUS.", "PM": "2019; ROSIGLITAZONE was indexed under THIAZOLIDINEDIONES 2004-2018, and under THIAZOLES 1994-2003", "HN": "2019 (1994)", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077154"}, {"RECTYPE": "D", "MH": "Granulins", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Granulin|T116|T123|NON|EQV|NLM (2021)|200106|abbcdef", "ENTRY": "5, Granulin", "MN": "D23.529.917.500", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "RR": "148708-92-3", "AN": "do not confuse with the viral protein GRANULIN MATRIX PROTEINS see OCCLUSION BODY MATRIX PROTEINS", "PI": "Intercellular Signaling Peptides and Proteins (1992-2018)", "MS": "Small, cysteine-rich peptides generated by the proteolytic cleavage of progranulin. Granulin peptides are each composed of a granulin-motif, while paragranulin is composed of a half-granulin motif. The mammalian granulins are named granulin 1-7 for their sequence order in the progranulin propeptide, and are alternately named granulin G, F, B, A, C, D, and E; or epithelin 7, 6, 2, 1, 3, 4, and 5, i.e. granulin 1 aka granulin G aka epithelin 7, etc.", "PM": "2019", "HN": "2019", "MR": "20200527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077155"}, {"RECTYPE": "D", "MH": "Gefitinib", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ZD1839|T109|T121|LAB|NRW|NLM (2001)|010209|abbcdef", "MN": "D03.633.100.786.469", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "S65743JHBS", "MS": "A selective tyrosine kinase inhibitor for the EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) that is used for the treatment of locally advanced or metastatic NON-SMALL CELL LUNG CANCER.", "PM": "2019; GEFITINIB was indexed under QUINAZOLINES 2001-2018", "HN": "2019 (2001)", "MR": "20230804", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077156"}, {"RECTYPE": "D", "MH": "Sorafenib", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sorafenib N Oxide", "MN": "D03.383.725.547.530.750", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-", "RN": "9ZOQ3TZI87", "RR": "5XYK65KIGD", "MS": "A niacinamide and phenylurea derivative that inhibits multiple intracellular and cell surface kinases thought to be involved in ANGIOGENESIS, including RAF KINASES and VEGF RECEPTORS. It is used in the treatment of advanced RENAL CELL CARCINOMA and HEPATOCELLULAR CARCINOMA, and for treatment of THYROID CARCINOMA refractory to radioactive iodine therapy.", "PM": "2019; SORAFENIB was indexed under NIACINAMIDE and PHENYLUREA COMPOUNDS 2014-2018, and under BENZENESULFONATES and PYRIDINES 2003-2013", "HN": "2019 (2003)", "MR": "20200527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077157"}, {"RECTYPE": "D", "MH": "Neurolymphomatosis", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Primary Neurolymphomatoses", "MN": "C10.551.568", "MH_TH": "UNK (19XX)", "ST": "T191", "MS": "Infiltration of the nervous system by malignant lymphoma cells.", "PM": "2019; see Marek Disease 1975-2018", "HN": "2019(1975); use Marek Disease 1975-2018", "MR": "20190701", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077162"}, {"RECTYPE": "D", "MH": "Polylactic Acid-Polyglycolic Acid Copolymer", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PLGA Acid|T109|T122|ABX|EQV|NLM (2022)|210407|abbcdef", "ENTRY": "Polymers, PLG", "MN": "J01.637.051.720.728.780.500", "MH_TH": "NLM (1984)", "ST": "T122", "RN": "1SIA8062RS", "MS": "A co-polymer that consists of varying ratios of polylactic acid and polyglycolic acid. It is used as a matrix for drug delivery and for BONE REGENERATION.", "PM": "2019; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER was indexed under LACTIC ACID and POLYGLYCOLIC ACID 2009-2018, and under POLYMERS 1984-2008", "HN": "2019 (1984)", "MR": "20210701", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077182"}, {"RECTYPE": "D", "MH": "Occlusion Body Matrix Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Polyhedrin, Viral", "MN": "D12.776.964.970.650", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "AN": "note entry term GRANULIN MATRIX PROTEINS: do not confuse with GRANULINS", "MS": "Proteins that assemble into a crystalline polyhedral or ovicylindrical shape around insect viruses, including BACULOVIRIDAE and CYPOVIRUS.", "PM": "2019; for GRANULIN MATRIX PROTEINS see VIRAL MATRIX PROTEINS 1988-2018", "HN": "2019; for GRANULIN MATRIX PROTEINS use VIRAL MATRIX PROTEINS 1988-2018", "MR": "20180619", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077183"}, {"RECTYPE": "D", "MH": "Resveratrol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "trans Resveratrol 3 O sulfate", "MN": "D02.455.426.559.389.657.715.500", "MH_TH": "NLM (1989)", "ST": "T123", "N1": "1,3-Benzenediol, 5-((E)-2-(4-hydroxyphenyl)ethenyl)-", "RN": "Q369O8926L", "RR": "AUA0K06FSB", "MS": "A stilbene and non-flavonoid polyphenol produced by various plants including grapes and blueberries. It has anti-oxidant, anti-inflammatory, cardioprotective, anti-mutagenic, and anti-carcinogenic properties. It also inhibits platelet aggregation and the activity of several DNA HELICASES in vitro.", "PM": "2019; RESVERATROL was indexed under STILBENES 1989-2018", "HN": "2019 (1989)", "MR": "20190524", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077185"}, {"RECTYPE": "D", "MH": "Interferon alpha-2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sch30500", "MN": "D23.529.374.440.890.250.500", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "RR": "99210-65-8 (interferon alfa-2b)", "MS": "Alpha interferon encoded by the human IFNA2 gene. Recombinant forms are used in the treatment of CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; KAPOSI SARCOMA; MELANOMA; and HAIRY CELL LEUKEMIA.", "PM": "2019; see INTERFERON-ALPHA 2012-2018", "HN": "2019; use INTERFERON-ALPHA 2012-2018", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077190"}, {"RECTYPE": "D", "MH": "Wortmannin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MS54", "MN": "D04.210.500.054.079.129.891", "MH_TH": "NLM (1974)", "ST": "T123", "N1": "(1 alpha,11 alpha)-11-(Acetyloxy)-1-(methoxymethyl)-2-oxaandrosta-5,8-dieno(6,5,4-bc)furan- 3,7,17-trione", "RN": "XVA4O219QW", "RR": "19545-26-7 (Wortmannin)", "MS": "An androstadiene metabolite produced by the fungi PENICILLIUM funiculosum that inhibits PHOSPHATIDYLINOSITOL-3-KINASES and alloantigen-specific activation of T-LYMPHOCYTES in human tumor cell lines. It is widely used in CELL BIOLOGY research and has broad therapeutic potential.", "PM": "2019; WORTMANNIN was indexed under ANDROSTADIENES 1980-2018, and under COUMARINS and INDENES 1974-1979", "HN": "2019 (1974)", "MR": "20180619", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077191"}, {"RECTYPE": "D", "MH": "Adenocarcinoma of Lung", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Lung Adenocarcinomas", "MN": "C04.588.894.797.520.055", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with LUNG  NEOPLASMS (IM)", "MS": "A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.", "PM": "2019; ADENOCARCINOMA OF LUNG was indexed under ADENOCARCINOMA and LUNG NEOPLASMS 2009-2018", "HN": "2019 (2009)", "MR": "20180619", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077192"}, {"RECTYPE": "D", "MH": "Chlorophyll A", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Chlorophyll A2|T109|T123|NON|NRW|NLM (1981)|171207|abbcdef", "MN": "D04.345.783.374.140", "MH_TH": "NLM (1981)", "ST": "T123", "RN": "YF5Q9EJC8Y", "RR": "479-61-8 (Chlorophyll A)", "MS": "A form of chlorophyll that absorbs light in the violet to red spectrum (approximately 400-700 nm wavelength range) and reflects green light (500-570 nm wavelength), which imparts the characteristic green color to land plants. It is essential for oxygenic PHOTOSYNTHESIS.", "PM": "2019; CHLOROPHYLL A was indexed under CHLOROPHYLL 1981-2018", "HN": "2019 (1981)", "MR": "20200221", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077194"}, {"RECTYPE": "D", "MH": "Squamous Cell Carcinoma of Head and Neck", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Squamous Cell Carcinoma of the Nasal Cavity|T191|NON|NRW|NLM (2021)|191122|abcdef", "ENTRY": "Squamous Cell Carcinoma, Head And Neck|T191|EQV|OMIM (2013)|111115|abdef", "MN": "C04.588.443.177", "MH_TH": "NLM (2019)", "ST": "T191", "AN": "coordinate with HEAD AND NECK NEOPLASMS", "MS": "The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.", "PM": "2019; CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK was indexed under CARCINOMA, SQUAMOUS CELL and HEAD AND NECK NEOPLASMS 2009-2018", "HN": "2019 (2009)", "MR": "20210305", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077195"}, {"RECTYPE": "D", "MH": "Dispensatory", "ENTRY": "Dispensatories|T170|NON|EQV|NLM (2019)|171210|abcdef", "MN": "V02.314", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Dispensatories as a subject are indexed under the main heading DISPENSATORIES AS TOPIC. INDEXER: do not use", "MS": "Systematic description of the drugs and preparations used generally or in a specific setting.", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000077202"}, {"RECTYPE": "D", "MH": "Sodium-Glucose Transporter 2 Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sodium-Glucose Transporter 2 Inhibitor|T121|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Sodium Glucose Transporter 2 Inhibitors", "MN": "D27.505.696.422.750", "MH_TH": "NLM (2019)", "ST": "T121", "RN": "0", "MS": "Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077203"}, {"RECTYPE": "D", "MH": "Temozolomide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TMZ Bioshuttle", "MN": "D03.383.129.308.240.500", "MH_TH": "USAN (1985)", "ST": "T121", "RN": "YF1K15M17Y", "RR": "85622-93-1 (Temozolomide)", "MS": "A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.", "PM": "2019; TEMOZOLOMIDE was indexed under DACARBAZINE 1989-2019, and under IMIDAZOLES 1985-1988", "HN": "2019 (1985)", "MR": "20180111", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077204"}, {"RECTYPE": "D", "MH": "Pioglitazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pioglitazone Hydrochloride|T109|T121|NON|NRW|NLM (2020)|190430|abbcdef", "ENTRY": "U72107A", "MN": "D03.383.129.708.933.250", "FX": "Rosiglitazone", "MH_TH": "NLM (1989)", "ST": "T121", "RN": "X4OV71U42S", "RR": "JQT35NPK6C", "MS": "A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.", "PM": "2019; PIOGLITAZONE was indexed under THIAZOLIDINEDIONES 2004-2018, and under THIAZOLES 1989-2003", "HN": "2019 (1989)", "MR": "20190517", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077205"}, {"RECTYPE": "D", "MH": "Gabapentin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NovoGabapentin", "MN": "D12.125.190.350.225", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "6CW7F3G59X", "MS": "A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.", "PM": "2019; GABAPENTIN was indexed under AMINES, CYCLOHEXANECARBOXYLIC ACIDS, and GAMMA-AMINOBUTYRIC ACID 2005-2018; and under ACETIC ACIDS 1984-2004", "HN": "2019 (1984)", "MR": "20180116", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077206"}, {"RECTYPE": "D", "MH": "Chondrosarcoma, Clear Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Clear Cell Chondrosarcomas", "MN": "C04.557.450.795.300.140", "MH_TH": "NLM (2019)", "ST": "T191", "AN": "coordinate IM with BONE NEOPLASMS (IM) or specific precoordinated bone/neoplasm term (IM) or specific bone (IM) + BONE NEOPLASMS (IM) ", "PI": "Sarcoma, Clear Cell (2003-2018)", "MS": "A chondrosarcoma of adolescence to old age of the proximal EPIPHYSES of long bones. It has variably clear cytoplasm of the mostly neoplastic CHONDROCYTES with little intervening matrix.", "PM": "2019", "HN": "2019", "MR": "20180614", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077207"}, {"RECTYPE": "D", "MH": "Remifentanil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ultiva|T109|T121|TRD|NRW|AU|CA|DE|ES|FR|MX|UK|US|abbcdeeeeeeee", "MN": "D03.383.621.828", "MH_TH": "USAN (1992)", "ST": "T121", "N1": "1-Piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester", "RN": "P10582JYYK", "RR": "5V444H5WIC", "MS": "A piperidine-propionate derivative and opioid analgesic structurally related to FENTANYL. It functions as a short-acting MU OPIOID RECEPTOR agonist, and is used as an analgesic during induction or maintenance of general anesthesia, following surgery, during childbirth, and in mechanically ventilated patients under intensive care.", "PM": "2019; REMIFENTANIL was indexed under PIPERIDINES 1991-2018", "HN": "2019 (1991)", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077208"}, {"RECTYPE": "D", "MH": "Decitabine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NSC127716", "MN": "D13.570.800.286.300.500", "FX": "Cytarabine", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "776B62CQ27", "RR": "6U3LPL9PRN", "MS": "An azacitidine derivative and antineoplastic antimetabolite. It inhibits DNA methyltransferase to re-activate silent genes, limiting METASTASIS and NEOPLASM DRUG RESISTANCE. Decitabine is used in the treatment of MYELODISPLASTIC SYNDROMES, and ACUTE MYELOID LEUKEMIA.", "PM": "2019; DECITABINE was indexed under AZACITIDINE 1981-2018, and under DEOXYCITIDNE 1977-1980", "HN": "2019 (1977)", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077209"}, {"RECTYPE": "D", "MH": "Sunitinib", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sutent|T109|T121|TRD|NRW|NLM (2006)|060516|abbcdef", "MN": "D03.633.100.473.877", "MH_TH": "NLM (2006)", "ST": "T121", "RN": "V99T50803M", "RR": "LVX8N1UT73", "MS": "An indole and pyrrole derivative that inhibits VEGFR-2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA.", "PM": "2019; SUNITINIB was indexed under INDOLES and PYRROLES 2003-2018", "HN": "2019 (2003)", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077210"}, {"RECTYPE": "D", "MH": "Zoledronic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CGP42446", "MN": "D03.383.129.308.990", "MH_TH": "USAN (1997)", "ST": "T121", "RN": "6XC1PAD3KF", "RR": "70HZ18PH24", "MS": "An imidobisphosphonate inhibitor of BONE RESORPTION that is used for the treatment of malignancy-related HYPERCALCEMIA; OSTEITIS DEFORMANS; and OSTEOPOROSIS.", "PM": "2019; ZOLEDRONIC ACID was indexed under DIPHOSPHONATES and IMIDAZOLES 1994-2018", "HN": "2019 (1994)", "MR": "20190705", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077211"}, {"RECTYPE": "D", "MH": "Ropivacaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "LEA103", "MN": "D02.092.146.113.825", "FX": "Bupivacaine", "MH_TH": "USAN (1983)", "ST": "T121", "N1": "2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-", "RN": "7IO5LYA57N", "RR": "V910P86109", "MS": "An anilide used as a long-acting local anesthetic. It has a differential blocking effect on sensory and motor neurons.", "PM": "2019; ROPIVACAINE was indexed under AMIDES 1983-2018", "HN": "2019 (1983)", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077212"}, {"RECTYPE": "D", "MH": "Lamotrigine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "BW430C", "MN": "D03.383.931.480", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-", "RN": "U3H27498KS", "RR": "84057-84-1 (Lamotrigine)", "MS": "A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER.", "PM": "2019; LAMOTRIGINE was indexed under TRIAZINES 1986-2018", "HN": "2019 (1986)", "MR": "20180111", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077213"}, {"RECTYPE": "D", "MH": "Becaplermin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Recombinant Platelet Derived Growth Factor BB", "MN": "D23.529.910.650.500", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "1B56C968OA", "MS": "A recombinant human platelet-derived growth factor B-chain dimer used to promote WOUND HEALING by stimulating PHYSIOLOGIC ANGIOGENESIS.", "PM": "2019; BECAPLERMIN was indexed under PROTO-ONCOGENE PROTEINS C-SIS 2013-2018; under PLATELET-DERIVED GROWTH FACTOR 1992-2012; and under RECOMBINANT PROTEINS 1992-1994", "HN": "2019 (1992)", "MR": "20180116", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077214"}, {"RECTYPE": "D", "MH": "Clay", "AQ": "CH CL MI PS ST VI", "ENTRY": "Halloysites", "MN": "N06.230.600.250", "FX": "Calcium Aluminosilicate", "MH_TH": "NLM (1976)", "ST": "T197", "RN": "T1FAD4SS2M", "RR": "1302-87-0 (Clay)", "MS": "A naturally-occurring rock or soil constituent characterized by particles with a diameter of less than 0.005 mm. It is composed primarily of hydrous aluminum silicates, trace amounts of metal OXIDES, and organic matter.", "PM": "2019; CLAY was indexed under ALUMINUM SILICATES 1976-2018", "HN": "2019 (1976)", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077215"}, {"RECTYPE": "D", "MH": "Carcinoma, Ovarian Epithelial", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Ovarian Epithelial Carcinomas", "MN": "C19.391.630.705.350", "MH_TH": "NLM (2019)", "ST": "T191", "AN": "coordinate with OVARIAN NEOPLASMS", "MS": "A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer.", "PM": "2019; see OVARIAN EPITHELIAL CANCER 2010-2018; CARCINOMA, OVARIAN EPITHELIAL was indexed under NEOPLASMS, GLANDULAR AND EPITHELIAL and OVARIAN NEOPLASMS 2010-2018", "HN": "2019 (2010)", "MR": "20211018", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077216"}, {"RECTYPE": "D", "MH": "Calcitonin Gene-Related Peptide Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "GEPANT|T121|NON|NRW|NLM (2021)|191115|abcdef", "ENTRY": "Receptor Antagonists, CGRP", "MN": "D27.505.954.427.040.409", "FX": "Receptors, Calcitonin Gene-Related Peptide", "MH_TH": "NLM (2019)", "ST": "T121", "RN": "0", "MS": "Pharmacologic agents that block NOCICEPTIVE PAIN signaling from CALCITONIN GENE-RELATED PEPTIDE RECEPTORS. They may be useful for the treatment of pain associated with MIGRAINE DISORDERS and OSTEOARTHRITIS.", "PM": "2019", "HN": "2019", "MR": "20200527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077221"}, {"RECTYPE": "D", "MH": "Limonene", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "d Limonene", "MN": "D02.455.849.575.157.250", "MH_TH": "NLM (2019)", "ST": "T109", "RN": "9MC3I34447", "RR": "GFD7C86Q1W", "MS": "A naturally-occurring class of MONOTERPENES which occur as a clear colorless liquid at room temperature. Limonene is the major component in the oil of oranges which has many uses, including as flavor and fragrance. It is recognized as safe in food by the Food and Drug Administration (FDA).", "PM": "2019; LIMONENE was indexed under TERPENES and CYCLOHEXENES 1969-2018", "HN": "2019(1969)", "MR": "20190705", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077222"}, {"RECTYPE": "D", "MH": "Cyberbullying", "AQ": "CL DE ES PC PX SN", "PRINT ENTRY": "Virtual Bullying|T054|NON|EQV|NLM (2021)|200612|abcdef", "ENTRY": "On line Bullying", "MN": "I01.880.735.070.500", "MH_TH": "NLM (2012)", "ST": "T054", "PI": "Bullying (2012-2018)", "MS": "Bullying that takes place over digital devices like cell phones and computers. It includes sending, posting, or sharing negative, harmful, false, or mean content about someone else. It can include sharing personal or private information about someone else causing embarrassment or humiliation. (from https://www.stopbullying.gov)", "PM": "2019; see BULLYING 2018", "HN": "2019; use Bullying 2018", "MR": "20230405", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077224"}, {"RECTYPE": "D", "MH": "Caspian Sea", "ENTRY": "Caspian Lake|T083|NON|EQV|NLM (2019)|180430|abcdef", "MN": "G01.311.580.500", "MH_TH": "NLM (2019)", "ST": "T083", "MS": "The largest inland body of water, located between ASIA and EUROPE.", "HN": "2019", "MR": "20180527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077228"}, {"RECTYPE": "D", "MH": "Internet Access", "AQ": "EC ES SN TD", "PRINT ENTRY": "Web Access|T169|NON|EQV|NLM (2021)|200221|abcdef", "ENTRY": "Access, Web", "MN": "L01.224.230.110.500.625", "MH_TH": "NLM (2019)", "ST": "T169", "PI": "Internet (1999-2018)", "MS": "Ability to connect to access services available on the Internet.", "PM": "2019; INTERNET (1999-2018)", "HN": "2019; INTERNET (1999-2018)", "MR": "20200221", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077230"}, {"RECTYPE": "D", "MH": "Vinorelbine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "KW2307", "MN": "D03.633.100.496.500.500.681.827.915", "MH_TH": "NLM (1981)", "ST": "T121", "N1": "C'-Norvincaleukoblastine, 3',4'-didehydro-4'-deoxy-", "RN": "Q6C979R91Y", "RR": "71486-22-1 (Vinorelbine)", "MS": "A vinca alkaloid related to VINBLASTINE that is used as a first-line treatment for NON-SMALL CELL LUNG CANCER, or for advanced or metastatic BREAST CANCER refractory to treatment with ANTHRACYCLINES.", "PM": "2019; VINORELBINE was indexed under VINBLASTINE 1981-2018", "HN": "2019 (1981)", "MR": "20200527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077235"}, {"RECTYPE": "D", "MH": "Topiramate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "McN4853", "MN": "D09.947.875.465.354.500", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "0H73WJJ391", "RR": "97240-79-4 (Topiramate)", "MS": "A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss.", "PM": "2019; TOPIRAMATE was indexed under FRUCTOSE 1987-2018", "HN": "2019 (1987)", "MR": "20180619", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077236"}, {"RECTYPE": "D", "MH": "Arsenic Trioxide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tetra Arsenic Oxide", "MN": "D01.650.550.125", "MH_TH": "USAN (19XX)", "ST": "T197", "RN": "S7V92P67HO", "RR": "1327-53-3 (Arsenic Trioxide)", "MS": "An inorganic compound with the chemical formula As2O3 that is used for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA in patients who have relapsed from, or are resistant to, conventional drug therapy.", "PM": "2019; ARSENIC TRIOXIDE was indexed under ARSENICALS and OXIDES 1975-2018", "HN": "2019 (1975)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077237"}, {"RECTYPE": "D", "MH": "Meloxicam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Uticox|T109|T121|TRD|NRW|ES|041014|abbcdef", "MN": "D03.383.855.275", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "2H-1,2-Benzothiazine-3-carboximidic acid, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide", "RN": "VG2QF83CGL", "RR": "71125-38-7 (Meloxicam)", "MS": "A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.", "PM": "2019; MELOXICAM was indexed under THIAZOLES and THIAZINES 1990-2018", "HN": "2019 (1990)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077239"}, {"RECTYPE": "D", "MH": "Calcium Aluminosilicate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Clay, Calcium Aluminosilicate", "MN": "D01.837.725.700.760.050.250", "FX": "Clay", "MH_TH": "NLM (2015)", "ST": "T197", "RN": "3L00JH8411", "MS": "Aluminosilicate salts of calcium, the most common of which are CaAl2Si2O8 and Ca2Al2SiO7; a naturally occurring form in CLAY may be used to treat DIARRHEA.", "PM": "2019; CALCIUM ALUMINOSILICATE was indexed under ALUMINUM SILICATES 2015-2018", "HN": "2019 (2015)", "MR": "20180116", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077250"}, {"RECTYPE": "D", "MH": "Dialectical Behavior Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Dialectical Behavior Therapies", "MN": "F04.754.137.628", "MH_TH": "NLM (2019)", "ST": "T061", "PI": "Behavior Therapy (1998-2018)", "MS": "A flexible, stage-based therapy that combines principles of behavior therapy, cognitive behavior therapy, and MINDFULNESS. It concurrently promotes acceptance and change, especially with difficult-to-treat patients.", "PM": "2019", "HN": "2019", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077252"}, {"RECTYPE": "D", "MH": "Online Social Networking", "ENTRY": "Social Networking, Online", "MN": "L01.143.910.250", "MH_TH": "NLM (2019)", "ST": "T054", "MS": "Connectivity facilitated by computer-based communications among persons with family, work, or other common interests.", "PM": "2019", "HN": "2019", "MR": "20180527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077253"}, {"RECTYPE": "D", "MH": "Sleepiness", "AQ": "DE GE IM PH RE", "ENTRY": "Somnolence|T184|NON|EQV|NLM (2019)|180530|abcdef", "MN": "G11.561.803.754.917", "MH_TH": "NLM (2019)", "ST": "T184", "MS": "Compelling urge to sleep.", "PM": "2019", "HN": "2019", "MR": "20210706", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077260"}, {"RECTYPE": "D", "MH": "Carvedilol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Carvedilol, 14C labeled", "MN": "D03.633.300.148.125", "MH_TH": "USAN (1985)", "ST": "T121", "N1": "2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-", "RN": "0K47UL67F2", "RR": "N9A00DJ8CM", "MS": "A carbazole and propanol derivative that acts as a non-cardioselective beta blocker and vasodilator. It has blocking activity for ALPHA 1 ADRENERGIC RECEPTORS and, at higher doses, may function as a blocker of CALCIUM CHANNELS; it also has antioxidant properties. Carvedilol is used in the treatment of HYPERTENSION; ANGINA PECTORIS; and HEART FAILURE. It can also reduce the risk of death following MYOCARDIAL INFARCTION.", "PM": "2019; CARVEDILOL was indexed under CARBAZOLES and PROPANOLAMINES 1984-2019", "HN": "2019 (1984)", "MR": "20190222", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077261"}, {"RECTYPE": "D", "MH": "Ciona", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Sea Squirt, Transparent, Pacific|T008|NON|REL|NLM (2019)|180222|abcdef", "MN": "B01.050.500.272.727.150", "MH_TH": "NLM (2019)", "ST": "T008", "RN": "txid7718", "RR": "txid51511", "PI": "Urochordata (1988-2018)", "MS": "A genus of SEA SQUIRTS in the family Cionidae.", "PM": "2019", "HN": "2019", "MR": "20200813", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077262"}, {"RECTYPE": "D", "MH": "Calcium-Regulating Hormones and Agents", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Hormones, Calcium-Regulating", "MN": "D27.505.696.260", "MH_TH": "NLM (2019)", "ST": "T125", "RN": "0", "MS": "Hormones and molecules with calcium-regulating hormone-like actions that modulate OSTEOLYSIS and other extra-skeletal activities to maintain calcium homeostasis.", "PM": "2019", "HN": "2019", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077264"}, {"RECTYPE": "D", "MH": "Donepezil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Eranz|T109|T121|TRD|NRW|MX|041214|abbcdef", "MN": "D04.615.486.487.280", "MH_TH": "NLM (1992)", "ST": "T121", "N1": "1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-((1-(phenylmethyl)-4-piperidinyl)methyl)-", "RN": "8SSC91326P", "RR": "3O2T2PJ89D", "MS": "An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.", "PM": "2019; DONEPEZIL was indexed under INDANS and PIPERIDINES 1992-2018", "HN": "2019 (1992)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077265"}, {"RECTYPE": "D", "MH": "Moxifloxacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "BAY128039", "MN": "D03.633.100.810.835.322.327", "MH_TH": "NLM (1997)", "ST": "T195", "RN": "U188XYD42P", "RR": "C53598599T", "MS": "A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent.", "PM": "2019; MOXIFLOXACIN was indexed under FLUOROQUINOLONES 1997-2018", "HN": "2019 (1997)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077266"}, {"RECTYPE": "D", "MH": "Fulvestrant", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ZM182780", "MN": "D06.472.334.851.437.500.500", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "22X328QOC4", "RR": "129453-61-8 (Fulvestrant)", "MS": "An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer.", "PM": "2019; FULVESTRANT was indexed under ESTRADIOL/analogs & derivatives 1991-2019", "HN": "2019 (1991)", "MR": "20180619", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077267"}, {"RECTYPE": "D", "MH": "Pamidronate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Amino 1 hydroxypropane 1,1 diphosphonate", "MN": "D02.705.429.500.858", "MH_TH": "NLM (1979)", "ST": "T121", "RN": "OYY3447OMC", "RR": "MUA93Q6K1J", "MS": "An aminobisphosphonate that inhibits BONE RESORPTION and is used for the treatment of osteolytic lesions, bone pain, and severe HYPERCALCEMIA associated with malignancies.", "PM": "2019; PAMIDRONATE was indexed under DIPHOSPHONATES 1982-2018, and under PROPANOLAMINES 1979-1981", "HN": "2019 (1979)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077268"}, {"RECTYPE": "D", "MH": "Lenalidomide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Revlimid|T109|T121|TRD|NRW|NLM (2005)|050124|abbcdef", "MN": "D03.633.100.513.750.563", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "F0P408N6V4", "RR": "191732-72-6 (Lenalidomide)", "MS": "A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA.", "PM": "2019; LENALIDOMIDE was indexed under THALIDOMIDE/analogs & derivatives 2002-2018", "HN": "2019 (2002)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077269"}, {"RECTYPE": "D", "MH": "Exenatide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Peptide, Ex4", "MN": "D23.946.833.300", "MH_TH": "USAN (2003)", "ST": "T121", "RN": "9P1872D4OL", "RR": "141732-76-5 (Exenatide)", "MS": "A synthetic form of exendin-4, a 39-amino acid peptide isolated from the venom of the GILA MONSTER lizard (Heloderma suspectum). Exenatide increases CYCLIC AMP levels in pancreatic acinar cells and acts as a GLUCAGON-LIKE PEPTIDE-1 RECEPTOR (GLP-1) agonist and incretin mimetic, enhancing insulin secretion in response to increased glucose levels; it also suppresses inappropriate glucagon secretion and slows gastric emptying. It is used as an anti-diabetic and anti-obesity agent.", "PM": "2019; EXENATIDE was indexed under PEPTIDES and VENOMS 1992-2018", "HN": "2019 (1992)", "MR": "20230601", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077270"}, {"RECTYPE": "D", "MH": "Imiquimod", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R837", "MN": "D03.633.100.810.050.545", "MH_TH": "USAN (1988)", "ST": "T121", "N1": "1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-", "RN": "P1QW714R7M", "RR": "99011-02-6 (Imiquimod)", "MS": "A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial CARCINOMA, BASAL CELL; and ACTINIC KERATOSIS.", "PM": "2019; IMIQUIMOD was indexed under AMINOQUINOLINES 1988-2018", "HN": "2019 (1988)", "MR": "20230531", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077271"}, {"RECTYPE": "D", "MH": "Latent Class Analysis", "ENTRY": "Variable Modeling, Latent", "MN": "N06.850.520.830.250.338", "MH_TH": "NLM (2019)", "ST": "T081", "PI": "Statistics as Topic (2017-2018)", "MS": "A statistical algorithm used to analyze clusters of observed variables by constructing categorical unobserved or latent segment based on weighted analysis and the average probabilities. Such latent classes are used to infer variables whose relationships are not directly observed. In biomedical research, it is often used to categorize data that allows the determination of symptom clusters.", "PM": "2019", "HN": "2019", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077272"}, {"RECTYPE": "D", "MH": "Thyroid Cancer, Papillary", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Thyroid Carcinomas, Papillary", "MN": "C19.874.788.400", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with THYROID NEOPLASMS (IM)", "MS": "An ADENOCARCINOMA that originates from follicular cells of the THYROID GLAND and accounts for the majority of THYROID CANCER cases. Cells exhibit enlarged, oval, or elongated morphologies with clear, round, nuclei. Fusions of RET, NTRK1, TPM3, and PCM1 genes are associated with this cancer.", "PM": "2019; THYROID CANCER, PAPILLARY was indesed under THYROID NEOPLASMS and CARCINOMA, PAPILLARY 2010-2018", "HN": "2019 (2010)", "MR": "20180319", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077273"}, {"RECTYPE": "D", "MH": "Nasopharyngeal Carcinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Nasopharyngeal Carcinomas", "MN": "C09.775.549.650.500", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with NASOPHARYNGEAL NEOPLASMS (IM)", "MS": "A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.", "PM": "2019; NASOPHARYNGEAL CARCINOMA was indexed under CARCINOMA and NASOPHARYNGEAL NEOPLASMS 2010-2018", "HN": "2019 (2010)", "MR": "20180619", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077274"}, {"RECTYPE": "D", "MH": "Craniofacial Fibrous Dysplasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Skull Fibrous Dysplasias", "MN": "C05.116.099.708.375.286", "MH_TH": "NLM (2019)", "ST": "T047", "PI": "Fibrous Dysplasia of Bone (1969-2018)", "MS": "Mostly benign fibro-osseous proliferation of the facial bones and skull. It can be either monostotic (localized to a single bone) or polyostotic (localized to more than one bone) type.", "PM": "2019", "HN": "2019", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077275"}, {"RECTYPE": "D", "MH": "Lycopene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pro Lycopene", "MN": "D23.767.261.375", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "psi, psi-Carotene", "RN": "SB0N2N0WV6", "RR": "502-65-8 (Lycopene)", "MS": "A carotenoid and red pigment produced by tomatoes, other red fruits and vegetables, and photosynthetic algae. It is a key intermediate in the biosynthesis of other carotenoids, and has antioxidant, anti-carcinogenic, radioprotective, and anti-inflammatory properties.", "PM": "2019; LYCOPENE was indexed under CAROTENOIDS 1978-2018", "HN": "2019 (1978)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077276"}, {"RECTYPE": "D", "MH": "Esophageal Squamous Cell Carcinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Oesophageal Squamous Cell Carcinoma|T191|NON|EQV|NLM (2021)|191122|abcdef", "MN": "C06.405.249.205.500", "MH_TH": "OMIM (2013)", "ST": "T191", "AN": "coordinate with ESOPHAGEAL NEOPLASMS", "MS": "A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this cancer.", "PM": "2019; ESOPHAGEAL SQUAMOUS CELL CARCINOMA was indexed under CARCINOMA, SQUAMOUS CELL and ESOPHAGEAL NEOPLASMS 2012-2018; for OESOPHAGEAL SQUAMOUS CELL CARCINOMA see Squamous CELL CARCINOMA OF HEAD AND NECK 2021", "HN": "2019 (2012)", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077277"}, {"RECTYPE": "D", "MH": "RNA, Mitochondrial", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "mtRNA|T114|T123|ABB|EQV|NLM (2019)|180104|abbcdef", "MN": "D13.444.735.580", "MH_TH": "NLM (1984)", "ST": "T123", "RN": "0", "MS": "RNA molecules encoded by the MITOCHONDRIAL GENOME.", "PM": "2019; RNA, MITOCHONDRIAL was indexed under RNA 1984-2018", "HN": "2019 (1984)", "MR": "20180406", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077278"}, {"RECTYPE": "D", "MH": "Protein Carbamylation", "AQ": "DE GE IM PH RE", "ENTRY": "Protein Carbamylations", "MN": "G07.775.750.625", "MH_TH": "NLM (2019)", "ST": "T044", "PI": "Protein Processing, Post-Translational (2003-2018)", "MS": "Non-enzymatic addition of carbamoyl (-CONH2) on protein or amino acid functional groups from isocyanic acid or CARBAMOYL-PHOSPHATE. Carbamylation may induce a structural change that results in a functional loss and serves as a biomarker for protein aging and disease pathophysiology.", "PM": "2019", "HN": "2019", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077279"}, {"RECTYPE": "D", "MH": "Bone-Anchored Prosthesis", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD UL VE VI", "ENTRY": "Prosthesis, Osseo-Anchored", "MN": "E07.695.118", "FX": "Osseointegration", "MH_TH": "NLM (2019)", "ST": "T074", "PI": "Prostheses and Implants (1987-2018)", "MS": "A prosthesis designed to attach directly to the bone via fixtures implanted into the bone rather than a socket.", "PM": "2019", "HN": "2019", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077280"}, {"RECTYPE": "D", "MH": "Forensic Psychology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychology, Forensic|T090|NON|EQV|NLM (2019)|180105|abcdef", "MN": "I01.198.780.960", "MH_TH": "NLM (2019)", "ST": "T090", "PI": "Forensic Psychiatry (1980-2018)", "MS": "A specialty in professional psychology characterized by activities primarily intended to provide professional psychological expertise within the judicial and legal systems.", "PM": "2019", "HN": "2019", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077283"}, {"RECTYPE": "D", "MH": "Abciximab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Fab, Chimeric 7E3", "MN": "D12.776.377.715.548.680.650.125", "MH_TH": "USAN (1994)", "ST": "T129", "RN": "X85G7936GV", "RR": "143653-53-6 (Abciximab)", "MS": "A Fab fragment of the chimeric monoclonal antibody 7E3 that binds to the glycoprotein IIb-IIIa receptor of human platelets, and blocks PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX, potently inhibiting PLATELET AGGREGATION. It is used in treatment of refractory unstable angina, and for prevention of ischemic complications in patients undergoing percutaneous coronary procedures such as ANGIOPLASTY; ATHERECTOMY; or stenting.", "PM": "2019; ABCIXIMAB was indexed under ANTIBODIES, MONOCLONAL and IMMUNOGLOBULIN FAB FRAGMENTS 1994-2018", "HN": "2019 (1994)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077284"}, {"RECTYPE": "D", "MH": "Rimonabant", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Zimulti|T109|T121|TRD|NRW|NLM (2007)|071016|abbcdef", "MN": "D03.383.621.834", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-", "RN": "RML78EN3XE", "RR": "HL0V2LQZ09", "MS": "A pyrazole and piperidine derivative that acts as a selective cannabinoid type-1 receptor (CB1 RECEPTOR) antagonist. It inhibits the proliferation and maturation of ADIPOCYTES, improves lipid and glucose metabolism, and regulates food intake and energy balance. It is used in the management of OBESITY.", "PM": "2019; RIMONABANT was indexed under PYRAZOLES and PIPERIDINES 1994-2018", "HN": "2019 (1994)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077285"}, {"RECTYPE": "D", "MH": "Cetrimonium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Octylsulfonate, Hexadecyltrimethylammonium", "MN": "D02.675.276.190.500", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "1-Hexadecanaminium, N,N,N-trimethyl-", "RN": "Z7FF1XKL7A", "RR": "UC9PE95IBP", "MS": "Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.", "PM": "2019; CENTRIMONIUM was indexed under CENTRIMONIUM COMPOUNDS 1991-2018; under AMMONIUM COMPOUNDS 1969-1990; and under ALKANES 1972-1975", "HN": "2019 (1969)", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077286"}, {"RECTYPE": "D", "MH": "Levetiracetam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "alpha ethyl 2 oxo 1 Pyrrolidineacetamide", "MN": "D03.383.773.812.362", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphaS)-", "RN": "44YRR34555", "RR": "73HC18Y1LW", "MS": "A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent.", "PM": "2019; see ETIRACETAM 1980-2018; LEVETIRACETAM was indexed under PIRACETAM/analogs & derivatives 1980-2018", "HN": "2019 (1980)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077287"}, {"RECTYPE": "D", "MH": "Troglitazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CS045", "MN": "D03.633.100.150.240.612", "MH_TH": "USAN (1994)", "ST": "T121", "N1": "2,4-Thiazolidinedione, 5-((4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy)phenyl)methyl)-", "RN": "I66ZZ0ZN0E", "RR": "97322-87-7 (Troglitazone)", "MS": "A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.", "PM": "2019; TROGLITAZONE was indexed under CHROMANS and THIAZOLIDINEDIONES 2004-2018; and under THIAZOLES 1988-2003", "HN": "2019 (1988)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077288"}, {"RECTYPE": "D", "MH": "Letrozole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CGS20267", "MN": "D03.383.129.799.638", "MH_TH": "USAN (1994)", "ST": "T121", "N1": "Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-", "RN": "7LKK855W8I", "RR": "112809-51-5 (Letrozole)", "MS": "A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women.", "PM": "2019; LETROZOLE was indexed under NITRILES and TRIAZOLES 1991-2018", "HN": "2019 (1991)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077289"}, {"RECTYPE": "D", "MH": "Harmala Alkaloids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Alkaloids, Harmala", "MN": "D03.633.100.496.500.500.384", "MH_TH": "NLM (2019)", "ST": "T109", "RN": "0", "MS": "Structurally related ALKALOIDS derived from the seeds of PEGANUM HARMALA and other plant sources. They are associated with various pharmacologic and therapeutic effects.", "PM": "2019", "HN": "2019", "MR": "20200807", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077290"}, {"RECTYPE": "D", "MH": "Terbinafine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TDT067", "MN": "D04.615.638.953", "MH_TH": "USAN (1984)", "ST": "T121", "N1": "1-Naphthalenemethanamine, N-((2E)-6,6-dimethyl-2-hepten-4-yn-1-yl)-N-methyl-", "RN": "G7RIW8S0XP", "RR": "S76S370M70", "MS": "A naphthalene derivative that inhibits fungal SQUALENE EPOXIDASE and is used to treat DERMATOMYCOSES of the skin and nails.", "PM": "2019; TERBINAFINE was indexed under NAPHTHALENES 1984-2018", "HN": "2019 (1984)", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077291"}, {"RECTYPE": "D", "MH": "Receptor, Transforming Growth Factor-beta Type I", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Type I TGF beta Receptors", "MN": "D12.776.543.750.750.400.820.750", "MH_TH": "NLM (2019)", "ST": "T192", "RN": "EC 2.7.11.30", "MS": "A transmembrane serine-threonine kinase that forms a heteromeric complex with TYPE II TGF-BETA RECEPTORS to bind TGF-BETA and regulate a variety of physiological and pathological processes including CELL CYCLE ARREST; CELL PROLIFERATION; CELL DIFFERENTIATION; WOUND HEALING; EXTRACELLULAR MATRIX production, immunosuppression and ONCOGENESIS.", "PM": "2019; see TGF-BETA TYPE I RECEPTOR 1995-2018; RECEPTOR, TRANSFORMING GROWTH FACTOR-BETA TYPE I was indexed under PROTEIN-SERINE-THREONINE KINASES and RECEPTORS, TRANSFORMING GROWTH FACTOR BETA 2008-2018; under ACTIVIN RECEPTORS, TYPE I 1994-2018; and under PROTEIN-SERINE-THREONINE KINASES 1994-2001", "HN": "2019 (1994)", "MR": "20210521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077293"}, {"RECTYPE": "D", "MH": "Receptor, Transforming Growth Factor-beta Type II", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Type II TGF beta Receptors", "MN": "D12.776.543.750.750.400.820.875", "MH_TH": "NLM (2019)", "ST": "T192", "RN": "EC 2.7.11.30", "MS": "A transmembrane serine-threonine kinase that forms a heteromeric complex with TYPE I TGF-BETA RECEPTORS when bound to TGF-BETA. This receptor complex regulates a variety of physiological and pathological processes including CELL CYCLE ARREST; CELL PROLIFERATION; CELL DIFFERENTIATION; WOUND HEALING; EXTRACELLULAR MATRIX production, immunosuppression and ONCOGENESIS.", "PM": "2019; see TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR 1993-2018; RECEPTOR, TRANSFORMING GROWTH FACTOR-BETA TYPE II was indexed under PROTEIN-SERINE-THREONINE KINASES and RECEPTORS, TRANSFORMING GROWTH FACTOR BETA 1994-2018; and under RECEPTORS, ENDOGENOUS SUBSTANCES 1993", "HN": "2019 (1993)", "MR": "20210521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077294"}, {"RECTYPE": "D", "MH": "Urinary Bladder, Underactive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Underactivity, Detrusor", "MN": "C23.888.942.343.790", "FX": "Urinary Retention", "MH_TH": "NLM (2019)", "ST": "T184", "PI": "Urinary Bladder Diseases (1974-2018)", "MS": "Symptom of underactive detrusor muscle of the URINARY BLADDER that contracts with abnormally reduced strength or duration resulting in an incomplete and/or prolonged bladder emptying.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077295"}, {"RECTYPE": "D", "MH": "Niemann-Pick C1 Protein", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Niemann Pick C1 Protein", "MN": "D12.776.624.776.633.250", "MH_TH": "NLM (2019)", "ST": "T192", "RN": "0", "PI": "Membrane Glycoproteins (1997-2018)", "MS": "A transmembrane intracellular lipid transporter that helps trafficking lipids, particularly cholesterol, from late endosome/lysosome to the ER and plasma membrane. It may also play a role in other cellular cholesterol homeostasis and is an endosomal entry receptor for filoviruses including EBOLAVIRUS. Mutations in the NPC1 are associated with type C NIEMANN-PICK DISEASE.", "PM": "2019", "HN": "2019", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077296"}, {"RECTYPE": "D", "MH": "Pregnane X Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Steroid and Xenobiotic Receptor|T116|T192|NON|EQV|NLM (2019)|180202|abbcdef", "MN": "D12.776.930.778.175", "MH_TH": "NLM (1998)", "ST": "T192", "RN": "0", "MS": "Steroid receptor that binds and is activated by variety of endogenous compounds and XENOBIOTICS. It binds the response element in promoters of  genes that encode CYTOCHROME P450 3A4 and ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 proteins, and also activates the transcription of multiple genes involved in the metabolism and secretion of potentially harmful xenobiotics, drugs, and endogenous compounds. It is activated by the antibiotic RIFAMPICIN and various plant metabolites, such as hyperforin, guggulipid, colupulone, and ISOFLAVONES.", "PM": "2019; PREGNANE X RECEPTOR was indexed under RECEPTORS, STEROID 2007-2018; and under RECEPTORS, CYTOPLASMIC AND NUCLEAR 1998-2006", "HN": "2019 (1998)", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077297"}, {"RECTYPE": "D", "MH": "Flexural Strength", "AQ": "DE PH RE", "ENTRY": "Strengths, Fracture", "MN": "G01.374.604", "FX": "Materials Testing", "MH_TH": "NLM (2019)", "ST": "T081", "PI": "Stress, Mechanical (1982-2018)", "MS": "The maximum MECHANICAL STRESS that a heterogeneous material, subject to a bending load or flexure, can withstand before fracturing.", "PM": "2019", "HN": "2019", "MR": "20180226", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077298"}, {"RECTYPE": "D", "MH": "Healthcare-Associated Pneumonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Pneumonia, Nosocomial", "MN": "C23.550.291.875.500.500", "MH_TH": "NLM (2019)", "ST": "T047", "PI": "Pneumonia (1974-2018)", "MS": "Infection of the lung often accompanied by inflammation that is acquired through an interaction within a healthcare institution often through a therapeutic experience (e.g., use of catheters or ventilators).", "PM": "2019", "HN": "2019", "MR": "20190617", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077299"}, {"RECTYPE": "D", "MH": "Bosentan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro 470203", "MN": "D03.383.742.060", "MH_TH": "USAN (1995)", "ST": "T121", "N1": "Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)(2,2'-bipyrimidin)-4-yl)-", "RN": "Q326023R30", "RR": "XUL93R30K2", "MS": "A sulfonamide and pyrimidine derivative that acts as a dual endothelin receptor antagonist used to manage PULMONARY HYPERTENSION and SYSTEMIC SCLEROSIS.", "PM": "2019; BOSENTAN was indexed under SULFONAMIDES 1995-2018; and under RECEPTORS, ENDOTHELIN/antagonists 1994", "HN": "2019 (1994)", "MR": "20230608", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077300"}, {"RECTYPE": "D", "MH": "Sleep, Slow-Wave", "AQ": "DE GE IM PH RE", "ENTRY": "Stage 3, NREM", "MN": "G11.561.803.754.835", "MH_TH": "NLM (1998)", "ST": "T039", "MS": "A stage of sleep characterized by synchronized wave activity as observed in the ELECTROENCEPHALOGRAM; the waves exhibit a frequency of 0.5 to 2 Hz, and a peak-to-peak amplitude greater than 75 microvolts.", "PM": "2019; see SLEEP 1998-2018", "HN": "2019; use SLEEP 1998-2018", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077310"}, {"RECTYPE": "D", "MH": "Aggressive Driving", "AQ": "CL DE EH ES HI LJ PC PX SN TD", "ENTRY": "Driving, Aggressive", "MN": "I03.125.150", "MH_TH": "NLM (2019)", "ST": "T048", "PI": "Automobile Driving (2000-2018)", "MS": "Combination of moving traffic offenses so as to endanger other persons or property. (https://nhtsa.gov/Driving-Safety/Aggressive-Driving)", "PM": "2019", "HN": "2019", "MR": "20190510", "DA": "20180712", "DC": "1", "DX": "20190101", "UI": "D000077314"}, {"RECTYPE": "D", "MH": "Road Rage", "AQ": "CL DE EH ES HI LJ PC PH PX SN TD", "MN": "I03.125.824", "MH_TH": "NLM (2019)", "ST": "T048", "PI": "Automobile Driving (2000-2018)", "MS": "Extreme anger generated from a traffic incident or accident that leads to an assault with a motor vehicle or other dangerous weapon by the operator or passenger(s) of one motor vehicle on the operator or passenger(s) of another motor vehicle.", "PM": "2019", "HN": "2019", "MR": "20190501", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077315"}, {"RECTYPE": "D", "MH": "Extracellular Polymeric Substance Matrix", "AQ": "CH CL CY DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Polymeric Substance, Extracellular", "MN": "G06.120.500", "MH_TH": "NLM (2019)", "ST": "T030", "PI": "Polysaccharides, Bacterial (1985-2018)", "MS": "Extracellular matrix formed by secreted polymeric organic compounds by microorganisms. This secreted compound is mostly polysaccharides but may include proteins, lipids, and nucleic acids. The matrix facilitates attachment of microbes to form various BIOFILM communities.", "PM": "2019", "HN": "2019", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077317"}, {"RECTYPE": "D", "MH": "Density Functional Theory", "AQ": "HI", "PRINT ENTRY": "Time-Dependent Density Functional Theory Computations|T170|NON|NRW|NLM (2021)|200113|abcdef", "ENTRY": "Time Dependent Density Functional Theory Computations", "MN": "H01.671.579.800.500", "MH_TH": "NLM (2019)", "ST": "T170", "PI": "Quantum Theory (2002-2018)", "MS": "A theory that is used to describe the electronic ground state properties of matter. It forms the basis of methods in obtaining a solution to the Schrodinger equation for a many-body system, and to investigate the structural, magnetic, and electronic properties of molecules and materials.", "PM": "2019", "HN": "2019", "MR": "20200228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077318"}, {"RECTYPE": "D", "MH": "Pyrolysis", "AQ": "DE RE", "ENTRY": "Pyrolyses", "MN": "G02.785", "MH_TH": "NLM (2019)", "ST": "T070", "PI": "Incineration (2001-2018)", "MS": "High temperature decomposition without addition of extra air or oxygen. It yields syngas, bio-oil and bio-char.", "PM": "2019", "HN": "2019", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077319"}, {"RECTYPE": "D", "MH": "Biomineralization", "AQ": "DE GE IM PH RE", "ENTRY": "Bioprecipitations", "MN": "G11.427.578.050", "MH_TH": "NLM (2019)", "ST": "T038", "PI": "Minerals (1973-2018)", "MS": "Process by which living organisms produce MINERALS that accumulate into hardened tissues (e.g., bones, teeth and shells), and cellular nanostructures that sequester away into macromolecules. Biosynthesized minerals include CALCIUM CARBONATE; FLUOROAPATITE; HYDROXYAPATITE; and MAGNETITE.", "PM": "2019", "HN": "2019", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077320"}, {"RECTYPE": "D", "MH": "Deep Learning", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Learning, Hierarchical", "MN": "L01.224.050.375.605.500", "MH_TH": "NLM (2019)", "ST": "T066", "PI": "Artificial Intelligence (2001-2018)", "MS": "Supervised or unsupervised machine learning methods that use multiple layers of data representations generated by nonlinear transformations, instead of individual task-specific ALGORITHMS, to build and train neural network models.", "PM": "2019", "HN": "2019", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077321"}, {"RECTYPE": "D", "MH": "Alginic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Polymannuronic Guluronic Acid", "MN": "D09.811.922.400.250", "MH_TH": "USAN (1978)", "ST": "T122", "RN": "8C3Z4148WZ", "MS": "A polysaccharide and linear copolymer, consisting mainly of beta-1,4-linked D-mannuronic acid and alpha-1,4-linked L-glucuronic acid, that occurs in marine algae such as LAMINARIA, and in BIOFILMS produced by PSEUDOMONAS AERUGINOSA.", "PM": "2019; ALGINIC ACID was indexed under ALGINATES 1972-2018, under HEXURONIC ACIDS 1974-2018, and under GLUCURONIC ACID 2 0 0 0 - 2 0 1 8", "HN": "2019 (1972)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077322"}, {"RECTYPE": "D", "MH": "Salt Stress", "AQ": "DE GE IM PH RE", "ENTRY": "Stress, Salt", "MN": "G07.775.813", "MH_TH": "NLM (2019)", "ST": "T040", "PI": "Stress, Physiological (1967-2018)", "MS": "The condition that results from ion toxicity due to ion imbalances (e.g., excessive Na+ and deficiency in Mg++).", "PM": "2019", "HN": "2019", "MR": "20180206", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077323"}, {"RECTYPE": "D", "MH": "Crystalloid Solutions", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Crystalloid Solution|T121|NON|EQV|NLM (2022)|201015|abcdef", "ENTRY": "Solutions, Crystalloid", "MN": "D26.776.498.500", "MH_TH": "NLM (2005)", "ST": "T121", "RN": "0", "MS": "Isotonic solutions of mineral salts, such as RINGER'S LACTATE and SODIUM CHLORIDE (SALINE SOLUTION), used in FLUID THERAPY to rehydrate BLOOD VOLUME.", "PM": "2019; CRYSTALLOID SOLUTIONS was indexed under ISOTONIC SOLUTIONS 2007-2018; under PLASMA SUBSTITUTES 1982-2006; and under PIGMENTS 1974-1981", "HN": "2019 (1974)", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077324"}, {"RECTYPE": "D", "MH": "Ringer's Lactate", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Ringers Solution, Lactated", "MN": "D26.776.498.500.500", "FX": "Ringer's Solution", "MH_TH": "NLM (1981)", "ST": "T121", "RN": "0", "RR": "8022-63-7", "MS": "A crystalloid solution that contains SODIUM CHLORIDE; SODIUM LACTATE; POTASSIUM CHLORIDE; and CALCIUM CHLORIDE. It is used for FLUID THERAPY.", "PM": "2019; RINGER'S LACTATE was indexed under ISOTONIC SOLUTIONS 1981-2018", "HN": "2019 (1981)", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077325"}, {"RECTYPE": "D", "MH": "Agammaglobulinaemia Tyrosine Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tyrosine Kinase, Bruton's", "MN": "D12.776.476.568.025", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "A non-receptor tyrosine kinase that is essential for the development, maturation, and signaling of B-LYMPHOCYTES. It contains an N-terminal zinc finger motif and localizes primarily to the PLASMA MEMBRANE and nucleus of B-lymphocytes. Mutations in the gene that encode this kinase are associated with X-LINKED AGAMMAGLOBULINEMIA.", "PM": "2019; AGAMMAGLOBULINAEMIA TYROSINE KINASE was indexed under PROTEIN-TYROSINE KINASES 1993-2018", "HN": "2019 (1993)", "MR": "20210520", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077329"}, {"RECTYPE": "D", "MH": "Saline Solution", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Saline, Normal", "MN": "D26.776.498.500.750", "MH_TH": "UNK (19XX)", "ST": "T197", "RN": "0", "MS": "A crystalloid solution that contains 9.0g of SODIUM CHLORIDE per liter of water. It has a variety of uses, including: as a CONTACT LENS SOLUTION, in OPHTHALMIC SOLUTIONS and NASAL LAVAGE, in wound irrigation, and for FLUID THERAPY.", "PM": "2019; see SODIUM CHLORIDE 1978-2018", "HN": "2019; use SODIUM CHLORIDE 1978-2018", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077330"}, {"RECTYPE": "D", "MH": "Ringer's Solution", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Ringer Solution", "MN": "D26.776.498.750", "FX": "Ringer's Lactate", "MH_TH": "USAN (1977)", "ST": "T121", "RN": "8026-10-6", "MS": "An isotonic solution; the base contains SODIUM CHLORIDE; POTASSIUM CHLORIDE; and CALCIUM CHLORIDE. Other chemicals, such as SODIUM BICARBONATE or acetate salts may be added, as needed for pH buffering, or as an energy source.", "PM": "2019; RINGER'S SOLUTION was indexed under ISOTONIC SOLUTIONS 1977-2018", "HN": "2019 (1977)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077331"}, {"RECTYPE": "D", "MH": "Artesunate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SM804", "MN": "D02.455.849.765.211.500", "MH_TH": "USAN (1983)", "ST": "T121", "N1": "Butanedioic acid, mono((5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester", "RN": "60W3249T9M", "RR": "CN5E49Z611", "MS": "A water-soluble, semi-synthetic derivative of the sesquiterpene lactone artemisinin with anti-malarial, anti-schistosomiasis, antiviral, and potential anti-neoplastic activities", "PM": "2019; ARTESUNATE was indexed under ARTEMISININS 2009-2018; and under SESQUITERPENES 1983-2008", "HN": "2019 (1983)", "MR": "20230320", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077332"}, {"RECTYPE": "D", "MH": "Telmisartan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pritor|T109|T121|TRD|NRW|AU|ES|FR|030311|abbcdeeef", "MN": "D03.633.100.103.791", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "(1,1'-Biphenyl)-2-carboxylic acid, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-", "RN": "U5SYW473RQ", "MS": "A biphenyl compound and benzimidazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION.", "PM": "2019; TELMISARTAN was indexed under BENZIMIDAZOLES and BENZOATES 1993-2018", "HN": "2019 (1993)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077333"}, {"RECTYPE": "D", "MH": "Zolpidem", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Imidazo(1,2-a)pyridine-3-acetamide, N,N,6-trimethyl-2-(4-methylphenyl)-|T109|T121|NON|EQV|NLM (2020)|190408|abbcdef", "ENTRY": "Zolpi Lich", "MN": "D03.383.725.971", "MH_TH": "NLM (1985)", "ST": "T121", "RN": "7K383OQI23", "RR": "WY6W63843K", "MS": "An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.", "PM": "2019; ZOLPIDEM was indexed under PYRIDINES 1985-2018", "HN": "2019 (1985)", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077334"}, {"RECTYPE": "D", "MH": "Desflurane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Suprane|T109|T121|TRD|NRW|CA|DE|ES|MX|UK|US|041213|abbcdeeeeeef", "MN": "D02.455.526.510.213", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-", "RN": "CRS35BZ94Q", "MS": "A fluorinated ether that is used as a volatile anesthetic for maintenance of general anesthesia.", "PM": "2019; DESFLURANE was indexed under ISOFLURANE/analogs & derivatives 1987-2018", "HN": "2019 (1987)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077335"}, {"RECTYPE": "D", "MH": "Caspofungin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MK0991", "MN": "D12.644.641.311.500", "MH_TH": "NLM (2000)", "ST": "T121", "N1": "Tetradecanamide, N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-((2-aminoethyl)amino)-20-((1R)-3-amino-1-hydroxypropyl)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)tetracosahydro-2,11,15-trihyd roxy-6-((1R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxo-1H-dipyrrolo(2,1-c:2',1'-l)(1,4,7,10,13,16)hexaazacycloheneicosin-9-yl)-10,12-dimethyl-", "RN": "F0XDI6ZL63", "RR": "VUW370O5QE", "MS": "A cyclic lipopeptide echinocandin and beta-(1,3)-D-glucan synthase inhibitor that is used to treat internal or systemic MYCOSES.", "PM": "2019; CASPOFUNGIN was indexed under ECHINOCANDINS and LIPOPEPTIDES 2008-2018; under PEPTIDES, CYCLIC 2005-2007; and under PEPTIDES 1997-2004", "HN": "2019 (1997)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077336"}, {"RECTYPE": "D", "MH": "Vorinostat", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "N1 Hydroxy N8 phenyloctanediamide", "MN": "D02.241.511.372.690", "MH_TH": "USAN (2008)", "ST": "T121", "RN": "58IFB293JI", "MS": "A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.", "PM": "2019; VORINOSTAT was indexed under HYDROXAMIC ACIDS 1998-2018", "HN": "2019 (1998)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077337"}, {"RECTYPE": "D", "MH": "Latanoprost", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Xalatan|T109|T121|TRD|NRW|AU|CA|DE|ES|FR|IE|MX|NL|UK|US|000204|abbcdeeeeeeeeeef", "MN": "D23.469.700.670.587", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate", "RN": "6Z5B6HVF6O", "RR": "130209-82-4 (Latanoprost)", "MS": "A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.", "PM": "2019; LATANOPROST was indexed under PROSTAGLANDINS F, SYNTHETIC 1992-2018", "HN": "2019 (1992)", "MR": "20200206", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077338"}, {"RECTYPE": "D", "MH": "Leflunomide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "HWA486", "MN": "D03.383.129.385.475", "MH_TH": "USAN (1990)", "ST": "T121", "N1": "4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-", "RN": "G162GK9U4W", "RR": "75706-12-6 (Leflunomide)", "MS": "An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.", "PM": "2019; LEFLUNOMIDE was indexed under ISOXAZOLES 1991-2018; and under OXAZOLES 1985-1990", "HN": "2019 (1985)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077339"}, {"RECTYPE": "D", "MH": "Fluvastatin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "XU62320", "MN": "D10.251.450.300", "MH_TH": "USAN (1989)", "ST": "T121", "N1": "6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-, (3R,5S,6E)-", "RN": "4L066368AS", "RR": "PYF7O1FV7F", "MS": "An indole-heptanoic acid derivative that inhibits HMG COA REDUCTASE and is used to treat HYPERCHOLESTEROLEMIA. In contrast to other statins, it does not appear to interact with other drugs that inhibit CYP3A4.", "PM": "2019; FLUVASTATIN was indexed under FATTY ACIDS, MONOUNSATURED and INDOLES 1990-2018", "HN": "2019 (1990)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077340"}, {"RECTYPE": "D", "MH": "Lapatinib", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tykerb|T109|T121|TRD|NRW|NLM (2006)|060524|abbcdef", "MN": "D03.633.100.786.516", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "0VUA21238F", "RR": "G873GX646R", "MS": "A quinazoline derivative that inhibits EPIDERMAL GROWTH FACTOR RECEPTOR and HER2 (RECEPTOR, ERBB-2) tyrosine kinases. It is used for the treatment of advanced or metastatic breast cancer, where tumors overexpress HER2.", "PM": "2019; LAPATINIB was indexed under QUINAZOLINES 2004-2018", "HN": "2019 (2004)", "MR": "20230804", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077341"}, {"RECTYPE": "D", "MH": "Post-Lyme Disease Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Post-Lyme Disease", "MN": "C23.550.291.500.829.500", "MH_TH": "NLM (2019)", "ST": "T047", "PI": "Lyme Disease (1989-2018)", "MS": "A condition caused by long-lasting and ongoing infection with the spirochete Borrelia burgdorferi resulting in progressive inflammatory neurologic, neuromuscular, and dermatologic manifestations including ENCEPHALITIS; MYELITIS; acrodermatitis chronica atrophicans; and ARTHRITIS.", "PM": "2019", "HN": "2019", "MR": "20220413", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077342"}, {"RECTYPE": "D", "MH": "Verteporfin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Visudyne|T109|T121|TRD|NRW|AU|CA|DE|ES|FR|UK|US|000105|abbcdeeeeeeef", "MN": "D04.345.783.500.940", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "0X9PA28K43", "RR": "129497-78-5 (Verteporfin)", "MS": "A benzoporphyrin derivative that is used in PHOTOCHEMOTHERAPY to treat wet type MACULAR DEGENERATION.", "PM": "2019; VERTEPORFIN was indexed under PORPHYRINS 1996-2018", "HN": "2019 (1996)", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077362"}, {"RECTYPE": "D", "MH": "Anastrozole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ZD 1033", "MN": "D03.383.129.799.275", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1,3-Benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-", "RN": "2Z07MYW1AZ", "RR": "120511-73-1 (Anastrozole)", "MS": "A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women.", "PM": "2019; ANASTROZOLE was indexed under NITRILES and TRIAZOLES 1994-2018", "HN": "2019 (1994)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077384"}, {"RECTYPE": "D", "MH": "Silybin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hepar Pasc", "MN": "D03.633.100.150.266.450.268.777.500", "MH_TH": "NLM (1974)", "ST": "T121", "N1": "4H-1-Benzopyran-4-one, 2-((2R,3R)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-", "RN": "4RKY41TBTF", "RR": "853OHH1429", "MS": "The major active component of silymarin flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum; it is used in the treatment of HEPATITIS; LIVER CIRRHOSIS; and CHEMICAL AND DRUG INDUCED LIVER INJURY, and has antineoplastic activity; silybins A and B are diastereomers.", "PM": "2019; SILYBIN was indexed under SILYMARIN 2002-2018", "HN": "2019 (2002)", "MR": "20180507", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077385"}, {"RECTYPE": "D", "MH": "Pantoprazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SKF96022", "MN": "D03.633.100.103.034.625", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-", "RN": "D8TST4O562", "RR": "6871619Q5X", "MS": "2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.", "PM": "2019; PANTOPRAZOLE was indexed under 2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES 2007-2018; and under OMEPRAZOLE and SULFOXIDES 1990-2006", "HN": "2019 (1990)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077402"}, {"RECTYPE": "D", "MH": "Orlistat", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro 18 0647", "MN": "D02.540.529", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))-", "RN": "95M8R751W8", "RR": "96829-58-2 (Orlistat)", "MS": "A lactone derivative of LEUCINE that acts as a pancreatic lipase inhibitor to limit the absorption of dietary fat; it is used in the management of obesity.", "PM": "2019; ORLISTAT was indexed under LACTONES 1988-2018", "HN": "2019 (1988)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077403"}, {"RECTYPE": "D", "MH": "Cidofovir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "GS504", "MN": "D03.383.742.698.421.216", "MH_TH": "USAN (1994)", "ST": "T121", "N1": "Phosphonic acid, (((1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-", "RN": "JIL713Q00N", "RR": "M83JB37U61", "MS": "An acyclic nucleoside phosphonate that acts as a competitive inhibitor of viral DNA polymerases. It is used in the treatment of RETINITIS caused by CYTOMEGALOVIRUS INFECTIONS and may also be useful for treating HERPESVIRUS INFECTIONS.", "PM": "2019; CIDOFOVIR was indexed under CYTOSINE/analogs & derivatives 1989-2018; under ORGANOPHOSPHONATES 2005-2018; and under ORGANOPHOSPHORUS COMPOUNDS 1989-2004", "HN": "2019 (1989)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077404"}, {"RECTYPE": "D", "MH": "Irbesartan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SR47436", "MN": "D04.711.431", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1,3-Diazaspiro(4.4)non-1-en-4-one, 2-butyl-3-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-", "RN": "J0E2756Z7N", "RR": "138402-11-6 (Irbesartan)", "MS": "A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.", "PM": "2019; IRBESARTAN was indexed under BIPHENYL COMPOUNDS and TETRAZOLES 1993-2018", "HN": "2019 (1993)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077405"}, {"RECTYPE": "D", "MH": "History of Pharmacy", "ENTRY": "Pharmacy History", "MN": "K01.400.456", "MH_TH": "NLM (2019)", "ST": "T090", "PI": "Pharmacy (1963-2018)", "MS": "Study of the origins and development of the field of PHARMACY.", "PM": "2019", "HN": "2019", "MR": "20180614", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077406"}, {"RECTYPE": "D", "MH": "Cilostazol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pletal|T109|T121|TRD|NRW|US|010921|abbcdef", "MN": "D03.633.100.810.069", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2(1H)-Quinolinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-", "RN": "N7Z035406B", "RR": "73963-72-1 (Cilostazol)", "MS": "A quinoline and tetrazole derivative that acts as a phosphodiesterase type 3 inhibitor, with anti-platelet and vasodilating activity. It is used in the treatment of PERIPHERAL VASCULAR DISEASES; ISCHEMIC HEART DISEASE; and in the prevention of stroke.", "PM": "2019; CILOSTAZOL was indexed under TETRAZOLES 1985-2018", "HN": "2019 (1985)", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077407"}, {"RECTYPE": "D", "MH": "Modafinil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2-Benzhydrylsulfinylacetamide|T109|T121|NON|EQV|NLM (2023)|220411|abbcdef", "ENTRY": "R Modafinil", "MN": "D02.455.426.559.389.115.550", "MH_TH": "USAN (1986)", "ST": "T121", "RN": "R3UK8X3U3D", "RR": "V63XWA605I", "MS": "A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.", "PM": "2019; MODAFINIL was indexed under BENZHYDRYL COMPOUNDS 1986-2018", "HN": "2019 (1986)", "MR": "20220523", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077408"}, {"RECTYPE": "D", "MH": "Tamsulosin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "YM-617|T109|T121|LAB|NRW|NLM (1989)|abbcde", "MN": "D02.886.590.700.863", "MH_TH": "USAN (1994)", "ST": "T121", "N1": "5-((2R)-2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxy-benzenesulfonamide", "RN": "G3P28OML5I", "RR": "11SV1951MR", "MS": "A sulfonamide derivative and adrenergic alpha-1 receptor antagonist that is used to relieve symptoms of urinary obstruction caused by BENIGN PROSTATIC HYPERPLASIA.", "PM": "2019; TAMSULOSIN was indexed under SULFONAMIDES 1994-2018", "HN": "2019 (1994)", "MR": "20230608", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077409"}, {"RECTYPE": "D", "MH": "Aluminum Chloride", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Anhydrous Aluminum Chloride", "MN": "D01.210.450.150.025", "MH_TH": "USAN (19XX)", "ST": "T197", "RN": "3CYT62D3GA", "RR": "LIF1N9568Y", "MS": "A compound with the chemical formula AlCl3; the anhydrous salt is used as a catalyst in organic chemical synthesis, and hydrated salts are used topically as antiperspirants, and for the management of HYPERHYDROSIS.", "PM": "2019; ALUMINUM CHLORIDE was indexed under ALUMINUM COMPOUNDS and CHLORIDES 1994-2018; under ALUMINUM 1975-1993; and under CHLORIDES 1975-1981", "HN": "2019 (1975)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077410"}, {"RECTYPE": "D", "MH": "Enrofloxacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Endrofloxicin|T109|T121|NON|EQV|NLM (1987)|180125|abbcdef", "MN": "D03.633.100.810.835.322.304", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-", "RN": "3DX3XEK1BN", "RR": "93106-60-6 (Enrofloxacin)", "MS": "A fluoroquinolone antibacterial and antimycoplasma agent that is used in veterinary practice.", "PM": "2019; ENROFLOXACIN was indexed under FLUOROQUINOLONES 2006-2018; under QUINOLONES 1987-2005; under ANTI-INFECTIVE AGENTS, QUINOLONE 1988-1992; and under PIPERAZINES 1987-1988", "HN": "2019 (1987)", "MR": "20180228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077422"}, {"RECTYPE": "D", "MH": "Polidocanol", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Tetraethyleneglycol Lauryl Ethers", "MN": "J01.637.051.720.741.630", "MH_TH": "USAN (1974)", "ST": "T121", "N1": "3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol", "RN": "0AWH8BFG9A", "RR": "Z95S6G8201", "MS": "An alkyl polyglycol ether of LAURYL ALCOHOL, chemically defined as an alcohol ethoxylate having an average alkyl chain of 12\u201314 carbon atoms, and an ethylene oxide chain of 9 ethylene oxide units. It is used as a detergent, and medically as a local anesthetic, and as a sclerosing agent for the treatment of ESOPHAGEAL AND GASTRIC VARICES and VARICOSE VEINS.", "PM": "2019; POLIDOCANOL was indexed under POLYETHYLENE GLYCOLS 1974-2018", "HN": "2019 (1974)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077423"}, {"RECTYPE": "D", "MH": "Fondaparinux", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Quixidar|T109|T121|TRD|NRW|NLM (2003)|030313|abbcdef", "MN": "D09.698.629.429", "MH_TH": "NLM (2001)", "ST": "T121", "N1": "(2S,3S,4R,5R,6R)-6-((2R,3R,4R,5R,6R)-6-((2R,3S,4S,5R,6R)-2-carboxy-4-hydroxy-6-((2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl)oxy-5-sulfooxyoxan-3-yl)oxy-5-(sulfoamino)-4-sulfooxy-2-(sulfooxymethyl)oxan-3-yl)oxy-3-((2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl)oxy-4,5-dihydroxyoxane-2-carboxylic acid", "RN": "J177FOW5JL", "RR": "X0Q6N9USOZ", "MS": "Synthetic pentasaccharide that mediates the interaction of HEPARIN with ANTITHROMBINS and inhibits FACTOR Xa; it is used for prevention of VENOUS THROMBOEMBOLISM after surgery.", "PM": "2019; FONDAPARINUX was indexed under POLYSACCHARIDES 2001-2018", "HN": "2019 (2001)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077425"}, {"RECTYPE": "D", "MH": "Gastric Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Right Gastric Arteries", "MN": "A07.015.114.365", "MH_TH": "NLM (2019)", "ST": "T023", "PI": "Arteries (1970-2018)", "MS": "Any of several branches of the SPLENIC ARTERY distributed to the greater curvature of the stomach.", "PM": "2019", "HN": "2019", "MR": "20180621", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077426"}, {"RECTYPE": "D", "MH": "Lipoglycopeptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lipoglycopeptide|T116|NON|EQV|NLM (2021)|191121|abcdef", "MN": "D12.644.365.625", "MH_TH": "NLM (2019)", "ST": "T116", "RN": "0", "PI": "Glycopeptides (1990-2018)", "MS": "Glycopeptides that have an additional lipophilic side chains. Several semisynthetic lipoglycopeptide antibiotics are derived from naturally occurring lipoglycopeptide and glycopeptide antibiotics.", "PM": "2019", "HN": "2019", "MR": "20200527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077427"}, {"RECTYPE": "D", "MH": "GATA2 Deficiency", "AQ": "BL CF CI CL CO DF DG DH DI DT EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "MonoMac Syndromes", "MN": "C16.320.314", "MH_TH": "NLM (2019)", "ST": "T047", "PI": "GATA2 Transcription Factor (2011-2018)", "MS": "A rare disorder of the immune system with wide-ranging effects which include GATA2 Transcription Factor dysfunction, immunodeficiency, myelodysplastic syndrome (ineffective blood cell production), lung disease, and problems of the vascular and lymphatic system.", "PM": "2019", "HN": "2019", "MR": "20200206", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077428"}, {"RECTYPE": "D", "MH": "Nabumetone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Rhoxal nabumetone", "MN": "D02.522.296.650", "MH_TH": "USAN (1982)", "ST": "T121", "RN": "LW0TIW155Z", "RR": "42924-53-8 (Nabumetone)", "MS": "A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.", "PM": "2019; NABUMETONE was indexed under BUTANONES 1982-2018", "HN": "2019 (1982)", "MR": "20180410", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077430"}, {"RECTYPE": "D", "MH": "Oxaprozin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Wy 21,743", "MN": "D03.383.129.462.590", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "MHJ80W9LRB", "RR": "21256-18-8 (Oxaprozin)", "MS": "An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.", "PM": "2019; OXAPROZIN was indexed under PROPIONATES 1983-2018; under OXAZOLES 1980-1982; under PROPIONIC ACIDS 1979-1980; and under PROPIONATES 1975-1979", "HN": "2019 (1975)", "MR": "20180410", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077431"}, {"RECTYPE": "D", "MH": "Tapentadol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tapentadol Hydrochloride|T109|T121|NON|NRW|FDA SRS (2018)|NLM (2009)|180126|abbcdeef", "MN": "D02.455.426.559.389.657.926", "MH_TH": "USAN (2007)", "ST": "T121", "RN": "H8A007M585", "RR": "71204KII53", "MS": "An opioid analgesic, MU OPIOID RECEPTOR agonist, and noradrenaline reuptake inhibitor that is used in the treatment of moderate to severe pain, and of pain associated with DIABETIC NEUROPATHIES.", "PM": "2019; TAPENTADOL was indexed under PHENOLS 2007-2018", "HN": "2019 (2007)", "MR": "20180410", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077432"}, {"RECTYPE": "D", "MH": "Lidocaine, Prilocaine Drug Combination", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Topical Eutectic Like Mixture for Premature Ejaculation", "MN": "D26.310.454", "MH_TH": "NLM (2019)", "ST": "T121", "RN": "0", "MS": "A topical local anesthetic preparation that is composed of a mixture of lidocaine and prilocaine. It is used to provide anesthesia during minor surgery and for the treatment of PREMATURE EJACULATION.", "PM": "2019; see EMLA 1983-2018; LIDOCAINE, PRILOCAINE DRUG COMBINATION was indexed under LIDOCAINE and PRILOCAINE 1983-2018", "HN": "2019 (1983)", "MR": "20180410", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077442"}, {"RECTYPE": "D", "MH": "Acamprosate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "N Acetylhomotaurine, Monosodium Salt", "MN": "D02.886.645.600.055.850.400", "MH_TH": "NLM (1985)", "ST": "T121", "N1": "1-Propanesulfonic acid, 3-(acetylamino)-", "RN": "N4K14YGM3J", "RR": "77337-76-9 (Acamprosate)", "MS": "Structural analog of taurine that is used for the prevention of relapse in individuals with ALCOHOLISM.", "PM": "2019; ACAMPROSATE was indexed under TAURINE/analogs & derivatives 1985-2018", "HN": "2019 (1985)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077443"}, {"RECTYPE": "D", "MH": "Smoking Cessation Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D27.505.954.810", "FX": "Tobacco Use Cessation Devices", "MH_TH": "NLM (2019)", "ST": "T121", "RN": "0", "MS": "Substances that facilitate the cessation of tobacco smoking.", "PM": "2019", "HN": "2019", "MR": "20180620", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077444"}, {"RECTYPE": "D", "MH": "Carbamide Peroxide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrogen Peroxide, Urea", "MN": "D02.389.593.374.318", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Urea, compd. with hydrogen peroxide (H2O2) (1:1)", "RN": "31PZ2VAU81", "RR": "124-43-6 (Carbamide Peroxide)", "MS": "A urea peroxide compound that is commonly used in tooth whitening agents; topical anti-infective agents, and earwax remover.", "PM": "2019; CARBAMIDE PEROXIDE was indexed under PEROXIDES and UREA 2011-2018; under DRUG COMBINATIONS 1969-2010; under GELS 1969-1982; and under UREA 1974-1975", "HN": "2019 (1969)", "MR": "20230226", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077463"}, {"RECTYPE": "D", "MH": "Simendan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "OR 1855", "MN": "D03.383.710.802", "MH_TH": "USAN (1994)", "ST": "T121", "N1": "Propanedinitrile, 2-(2-(4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazinylidene)-", "RN": "349552KRHK", "RR": "C6T4514L4E", "MS": "A hydrazone and pyridazine derivative; the levo-form is a phosphodiesterase III inhibitor, calcium-sensitizing agent, and inotropic agent that is used in the treatment of HEART FAILURE.", "PM": "2019; SIMENDAN was indexed under HYDRAZONES and PYRIDAZINES 1992-2018", "HN": "2019 (1992)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077464"}, {"RECTYPE": "D", "MH": "Cabergoline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Galastop|T109|T121|TRD|NRW|NLM (1985)|abbcde", "MN": "D03.633.400.439.197", "MH_TH": "USAN (1994)", "ST": "T121", "N1": "Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propen-1-yl)-, (8beta)-", "RN": "LL60K9J05T", "RR": "81409-90-7 (Cabergoline)", "MS": "An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE.", "PM": "2019; CABERGOLINE was indexed under ERGOLINES 1985-2018", "HN": "2019 (1985)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077465"}, {"RECTYPE": "D", "MH": "Tirofiban", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "L700,462", "MN": "D12.125.072.050.875.875", "MH_TH": "USAN (1994)", "ST": "T121", "RN": "GGX234SI5H", "RR": "6H925F8O5J", "MS": "Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in the treatment of ACUTE CORONARY SYNDROME.", "PM": "2019; TIROFIBAN was indexed under TYROSINE/analogs&derivatives 1993-2018", "HN": "2019 (1993)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077466"}, {"RECTYPE": "D", "MH": "Carbon Fiber", "AQ": "AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "ENTRY": "Fibres, Carbon", "MN": "J01.637.051.720.150", "MH_TH": "NLM (1978)", "ST": "T122", "RN": "0", "MS": "Fiber with a diameter of approximately 5 to 10 micrometers that is composed mostly of carbon atoms. It has a variety of applications.", "PM": "2019; CARBON FIBER was indexed under CARBON 1978-2018", "HN": "2019 (1978)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077482"}, {"RECTYPE": "D", "MH": "Valacyclovir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "L-valyl Ester Acyclovir", "MN": "D03.633.100.759.758.399.454.250.650", "MH_TH": "USAN (1993)", "ST": "T121", "RN": "MZ1IW7Q79D", "RR": "G447S0T1VC", "MS": "A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES.", "PM": "2019; VALACYCLOVIR was indexed under ACYCLOVIR/analogs&derivatives 1994-2018", "HN": "2019 (1994)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077483"}, {"RECTYPE": "D", "MH": "Vemurafenib", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RG 7204", "MN": "D03.633.100.473.936", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1-Propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-", "RN": "207SMY3FQT", "MS": "An indole sulfonamide compound and inhibitor of BRAF KINASES that is used for the treatment of unresectable or metastatic MELANOMA.", "PM": "2019; VEMURAFENIB was indexed under INDOLES and SULFONAMIDES 2010-2018", "HN": "2019 (2010)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077484"}, {"RECTYPE": "D", "MH": "Meglumine Antimoniate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "N Methylglucamine Antimonate", "MN": "D09.853.813.550.800", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "1-Deoxy-1-(methylamino)glucitol antimonate(V)", "RN": "75G4TW236W", "RR": "133-51-7 (Meglumine Antimoniate)", "MS": "ANTIMONY salt of meglumine that is used in the treatment of LEISHMANIASIS.", "PM": "2019; MEGLUMINE ANTIMONATE was indexed under MEGLUMINE and ORGANOMETALLIC COMPOUNDS 1978-2018; under AMINO SUGARS 1974-1977; under SORBITOL/analogs 1975-1977; and under SORBITOL 1972-1975", "HN": "2019 (1972)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077485"}, {"RECTYPE": "D", "MH": "Ticagrelor", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Brilique|T114|T121|TRD|NRW|NLM (2011)|110531|abbcdef", "MN": "D13.570.800.096.815", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1,2-cyclopentanediol, 3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2,3-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-", "RN": "GLH0314RVC", "MS": "An adenosine triphosphate analogue and reversible P2Y12 PURINORECEPTOR antagonist that inhibits ADP-mediated PLATELET AGGREGATION. It is used for the prevention of THROMBOEMBOLISM by patients with ACUTE CORONARY SYNDROME or a history of MYOCARDIAL INFARCTION.", "PM": "2019; TICAGRELOR was indexed under ADENOSINE/analogs&derivatives 2005-2018", "HN": "2019 (2005)", "MR": "20180619", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077486"}, {"RECTYPE": "D", "MH": "Pramipexole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SND 919", "MN": "D03.633.100.185.514", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (S)-", "RN": "83619PEU5T", "RR": "4R2HD0M28N", "MS": "A benzothiazole derivative and dopamine agonist with antioxidant properties that is used in the treatment of PARKINSON DISEASE and RESTLESS LEGS SYNDROME.", "PM": "2019; PRAMIPEXOLE was indexed under BENZOTHIAZOLES 2007-2018; and under THIAZOLES 1989-2006", "HN": "2019 (1989)", "MR": "20230531", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077487"}, {"RECTYPE": "D", "MH": "Data Science", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sciences, Data-Driven", "MN": "L01.305", "FX": "Data Mining", "MH_TH": "NLM (2019)", "ST": "T090", "MS": "An interdisciplinary field involving processes, theories, concepts, tools, and technologies, that enable the review, analysis, and extraction of valuable knowledge and information from structured and unstructured (raw) data.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077488"}, {"RECTYPE": "D", "MH": "Piperazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "1,4 Piperazine", "MN": "D03.383.606.768", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "1RTM4PAL0V", "RR": "V1FWC6DPTK", "AN": "PIPERAZINES is also available", "MS": "An anti-nematodal agent effective against the intestinal nematodes ASCARIS LUMBRICOIDES (roundworm) and ENTEROBIUS VERMICULARIS (pinworm, threadworm).  It produces a neuromuscular block leading to flaccid muscle paralysis in susceptible worms, which are then dislodged from the gut and expelled in feces.", "PM": "2019; PIPERAZINE was indexed under PIPERAZINES 1982-2018", "HN": "2019 (1982)", "MR": "20190222", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077489"}, {"RECTYPE": "D", "MH": "Glymphatic System", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Virchow-Robin Space|T030|NON|REL|NLM (2021)|191119|abcdef", "ENTRY": "Virchow Robin Space", "MN": "A15.382.520.075", "MH_TH": "NLM (2019)", "ST": "T022", "PI": "Lymphatic System (2013-2018)", "MS": "A vascular waste clearance system in the brain analogous to the lymphatic system that facilitates transporting of solutes and waste products from CEREBROSPINAL FLUID (CSF) and brain INTERSTITIAL FLUID (ISF). CSF from the SUBARACHNOID SPACE enters the brain periarterial spaces, into the interstitium via channels (e.g., AQUAPORIN 4 PROTEIN) on astrocytic endfeet and exchanges with brain ISF before perivenous drainage of solutes and waste.", "PM": "2019", "HN": "2019", "MR": "20200527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077502"}, {"RECTYPE": "D", "MH": "Clinical Trial, Veterinary", "MN": "V03.175.375", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific veterinary clinical trial; a different heading CLINICAL TRIALS, VETERINARY AS TOPIC is used for general design, methodology, economics, etc. of veterinary clinical trials ", "PI": "Clinical Trial (1996-2018)", "MS": "A work that is a veterinary clinical study in which animal participants are assigned to receive one or more interventions so that researchers can evaluate the interventions on biomedical or health-related outcomes. The assignments are determined by the study protocol. Animal participants may receive diagnostic, therapeutic, or other types of interventions.", "HN": "2019", "MR": "20180614", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000077522"}, {"RECTYPE": "D", "MH": "Cefdinir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "FK482", "MN": "D03.633.100.300.249.169", "MH_TH": "USAN (19XX)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-2-(2-amino-4-thiazolyl)-2-(hydroxyimino)-1-oxoethyl)amino)-3-ethenyl-8-oxo-, (6R,7R)-", "RN": "CI0FAO63WC", "RR": "91832-40-5 (Cefdinir)", "MS": "A third-generation oral cephalosporin antibacterial agent that is used to treat bacterial infections of the respiratory tract and skin.", "PM": "2019; CEFDINIR was indexed under CEPHALOSPORINS 1988-2018", "HN": "2019 (1988)", "MR": "20230821", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077525"}, {"RECTYPE": "D", "MH": "Tropisetron", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Indole 3 carboxylic Acid Tropine Ester", "MN": "D03.633.100.473.896", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1H-Indole-3-carboxylic acid, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-", "RN": "6I819NIK1W", "RR": "A19338Q2YO", "MS": "An indole derivative and 5-HT3 RECEPTOR antagonist that is used for the prevention of nausea and vomiting.", "PM": "2019; TROPISETRON was indexed under INDOLES 1985-2018", "HN": "2019 (1985)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077526"}, {"RECTYPE": "D", "MH": "Eptifibatide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "7H-Pyrrolo(2,1-g)(1,2,5,8,11,14,17,20)dithiahexaazacyclotricosine-17-acetic acid, 3-(aminocarbonyl)-11-(4-((aminoiminomethyl)amino)butyl)docosahydro-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxo-, (3R,11S,17S,20S,25aS)-|T116|T121|NON|EQV|NLM (2020)|190408|abbcdef", "ENTRY": "Integrilin|T116|T121|TRD|NRW|CA|DE|ES|FR|IE|NL|UK|US|abbcdeeeeeeee", "MN": "D12.644.641.366", "MH_TH": "NLM (1994)", "ST": "T121", "RN": "NA8320J834", "MS": "Cyclic peptide that acts as a platelet glycoprotein IIB-IIIA antagonist, reversibly inhibiting the binding of FIBRINOGEN; VON WILLEBRAND FACTOR; and other adhesive molecules to the GPIIB-IIIA RECEPTORS of platelets. It is used in the management of UNSTABLE ANGINA and in patients undergoing coronary ANGIOPLASTY and stenting procedures.", "PM": "2019; EPTIFIBATIDE was indexed under PEPTIDES 1994-2018", "HN": "2019 (1994)", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077542"}, {"RECTYPE": "D", "MH": "Deferiprone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "3 Hydroxy 1,2 dimethyl 4 pyridinone", "MN": "D03.383.725.791.298", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "4(1H)-Pyridinone, 3-hydroxy-1,2-dimethyl-", "RN": "2BTY8KH53L", "RR": "30652-11-0 (Deferiprone)", "MS": "A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.", "PM": "2019; DEFERIPRONE was indexed under PYRIDONES 1985-2018", "HN": "2019 (1985)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077543"}, {"RECTYPE": "D", "MH": "Panitumumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Monoclonal Antibody, ABX-EGF", "MN": "D12.776.377.715.548.114.224.200.864", "MH_TH": "NLM (2005)", "ST": "T129", "N1": "Immunoglobulin, anti-(human epidermal growth factor receptor) (human monoclonal ABX-EGF heavy chain), disulfide with human monoclonal ABX-EGF light chain, dimer", "RN": "6A901E312A", "MS": "Recombinant human monoclonal antibody that binds to and inhibits the function of the EPIDERMAL GROWTH FACTOR RECEPTOR. It is used in the treatment of EGFR-expressing metastatic colorectal cancer that expresses wild-type ras gene (see GENES, RAS).", "PM": "2019; PANITUMUMAB was indexed under ANTIBODIES, MONOCLONAL 2005-2018", "HN": "2019 (2005)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077544"}, {"RECTYPE": "D", "MH": "Eplerenone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inspra|T109|T121|TRD|NRW|US|021015|abbcdef", "MN": "D04.210.500.745.745.329", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Spiro(cyclopenta(7,8)phenanthro(4b,5-b)oxirene-7(3H),2'(3'H)-furan)-10-carboxylic acid, 2,4,4',4a,5',5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-4a,6a-dimethyl-2,5'-dioxo-, methyl ester, (4aS,4bR,5aR,6aS,7 R,9aS,9bR,10R)-", "RN": "6995V82D0B", "MS": "A spironolactone derivative and selective ALDOSTERONE RECEPTOR antagonist that is used in the management of HYPERTENSION and CONGESTIVE HEART FAILURE, post-MYOCARDIAL INFARCTION.", "PM": "2019; EPLERENONE was indexed under SPIRONOLACTONE/analogs&derivatives 2000-2018", "HN": "2019 (2000)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077545"}, {"RECTYPE": "D", "MH": "Roscovitine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R roscovitine", "MN": "D03.633.100.759.776", "MH_TH": "NLM (1997)", "ST": "T121", "RN": "0ES1C2KQ94", "MS": "A purine derivative and competitive inhibitor of CYCLIN-DEPENDENT KINASES that has therapeutic potential as an antineoplastic and antiviral agent.", "PM": "2019; ROSCOVITINE was indexed under PURINES 1997-2018", "HN": "2019 (1997)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077546"}, {"RECTYPE": "D", "MH": "Crizotinib", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "PF2341066", "MN": "D03.383.725.050.263", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "2-Pyridinamine, 3-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-", "RN": "53AH36668S", "MS": "A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER.", "PM": "2010; CRIZOTINIB was indexed under PYRAZOLES and PYRIDINES 2010-2018", "HN": "2019 (2010)", "MR": "20230804", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077547"}, {"RECTYPE": "D", "MH": "Anaplastic Lymphoma Kinase", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Nucleophosmin Anaplastic Lymphoma Kinase", "MN": "D12.776.543.750.630.002", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "EC 2.7.10.1", "MS": "A receptor tyrosine kinase that is essential for development and differentiation of the nervous system in response to secreted growth factors. It phosphorylates the first tyrosine of the Y-x-x-x-Y-Y motif of targets that include PROTO-ONCOGENE PROTEINS C-CBL; INSULIN RECEPTOR SUBSTRATE-1; and MITOGEN-ACTIVATED PROTEIN KINASES, leading to activation of the MAPK signaling pathway and cell proliferation. A chromosomal aberration involving the ALK gene results in its constitutive expression in some cases of NON-HODGKIN LYMPHOMA.", "PM": "2019; ANAPLASTIC LYMPHOMA KINASE was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 2012-2018; and under PROTEIN-TYROSINE KINASES 1994-2011", "HN": "2019 (1994)", "MR": "20210520", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077548"}, {"RECTYPE": "D", "MH": "Artemether", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta Arthemeter", "MN": "D02.455.849.765.211.250", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "3,12-Epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-trimethyl-, (3R,5aS,6R,8aS,9R,10S,12R,12aR)-", "RN": "C7D6T3H22J", "RR": "80286-56-2", "MS": "An artemisinin derivative that is used in the treatment of MALARIA.", "PM": "2019; ARTEMETHER was indexed under ARTEMISININS 2006-2018; under SESQUITERPENES 1981-2005; and under PYRANS 1982-1988", "HN": "2019 (1982)", "MR": "20230320", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077549"}, {"RECTYPE": "D", "MH": "Ivabradine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "S162602", "MN": "D03.633.100.079.801", "MH_TH": "USAN (1994)", "ST": "T121", "N1": "2H-3-Benzazepin-2-one, 3-(3-((((7S)-3,4-dimethoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-", "RN": "3H48L0LPZQ", "RR": "155974-00-8 (Ivabradine)", "MS": "A benzazepine derivative and selective HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNELS inhibitor that lowers the heart rate. It is used in the treatment of CHRONIC STABLE ANGINA in patients unable to take BETA-ADRENERGIC BLOCKERS, and in the treatment of HEART FAILURE.", "PM": "2019; IVABRADINE was indexed under BENZAZEPINES 1994-2018", "HN": "2019 (1994)", "MR": "20180620", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077550"}, {"RECTYPE": "D", "MH": "Micafungin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Mycamine|T116|T121|TRD|NRW|NLM (2005)|051013|abbcdef", "MN": "D12.644.641.311.750", "MH_TH": "NLM (2002)", "ST": "T121", "RN": "R10H71BSWG", "RR": "IS1UP79R56", "MS": "A cyclic lipo-hexapeptide echinocandin antifungal agent that is used for the treatment and prevention of CANDIDIASIS.", "PM": "2019; MICAFUNGIN was indexed under ECHINOCANDINS and LIPOPEPTIDES 2009-2018; under LIPOPROTEINS 1999-2008; and under PEPTIDES, CYCLIC 1999-2007", "HN": "2019 (1999)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077551"}, {"RECTYPE": "D", "MH": "Basiliximab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Simulect|T116|T121|T129|TRD|NRW|NLM (1998)|abbbcde", "MN": "D12.776.377.715.548.114.224.200.407", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "9927MT646M", "MS": "A chimeric murine-human monoclonal antibody that functions as an INTERLEUKIN 2 RECEPTOR antagonist by binding to the alpha chain (CD25 ANTIGEN) of the interleukin-2 receptor on the surface of activated T-LYMPHOCYTES. It is used in the prevention of acute graft rejection episodes in patients undergoing renal transplantation.", "PM": "2019; BASILIXIMAB was indexed under ANTIBODIES, MONOCLONAL and RECOMBINANT FUSION PROTEINS 1998-2018", "HN": "2019 (1998)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077552"}, {"RECTYPE": "D", "MH": "Edaravone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MCI186", "MN": "D03.383.129.539.850.088.500", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "3H-pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-", "RN": "S798V6YJRP", "RR": "89-25-8 (Edaravone)", "MS": "An antipyrine derivative that functions as a free radical scavenger and neuroprotective agent. It is used in the treatment of AMYOTROPHIC LATERAL SCLEROSIS and STROKE.", "PM": "2019; see PHENYLMETHYLPYRAZOLONE 1970-2018; EDARAVONE was indexed under ANTIPYRINE/analogs&derivatives 1982-2018; and under PYRAZOLES 1970-1981", "HN": "2019 (1970)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077553"}, {"RECTYPE": "D", "MH": "Levobupivacaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Levobupivacaine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2017)|NLM (2004)|USAN (19XX)|180208|abbcdeeef", "MN": "D02.092.146.113.239.500", "MH_TH": "NLM (2003)", "ST": "T121", "N1": "2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (2S)-", "RN": "A5H73K9U3W", "RR": "J998RDZ51I", "MS": "S-enantiomer of bupivacaine that is used as a local anesthetic and for regional nerve blocks, including EPIDURAL ANESTHESIA.", "PM": "2019; LEVOBUPIVACAINE was indexed under BUPIVACAINE/analogs&derivatives 2003-2018", "HN": "2019 (2003)", "MR": "20180709", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077554"}, {"RECTYPE": "D", "MH": "Methylprednisolone Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Methylprednisolone 21 acetate", "MN": "D04.210.500.745.432.769.795.539.250", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-", "RN": "43502P7F0P", "RR": "53-36-1 (Methylprednisolone Acetate)", "MS": "Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.", "PM": "2019; METHYLPREDNISOLONE ACETATE was indexed under METHYLPREDNISOLONE/analogs&derivatives 1977-2018; and under METHYLPREDNISOLONE 1969-1976", "HN": "2019 (1969)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077555"}, {"RECTYPE": "D", "MH": "Alitretinoin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "9 cis Retinoic Acid", "MN": "D23.767.261.700.780.500", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "1UA8E65KDZ", "RR": "5300-03-8 (Alitretinoin)", "MS": "A retinoid that is used for the treatment of chronic hand ECZEMA unresponsive to topical CORTICOSTEROIDS. It is also used to treat cutaneous lesions associated with AIDS-related KAPOSI SARCOMA.", "PM": "2019; ALITRETINOIN was indexed under TRETINOIN 1997-2018", "HN": "2019 (1997)", "MR": "20200609", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077556"}, {"RECTYPE": "D", "MH": "Ibandronic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RPR102289A", "MN": "D02.705.429.500.844", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis-", "RN": "UMD7G2653W", "RR": "J12U072QL0", "MS": "Aminobisphosphonate that is a potent inhibitor of BONE RESORPTION. It is used in the treatment of HYPERCALCEMIA associated with malignancy, for the prevention of fracture and bone complications in patients with breast cancer and bone metastases, and for the treatment and prevention of POSTMENOPAUSAL OSTEOPOROSIS.", "PM": "2019; IBANDRONIC ACID was indexed under DIPHOSPHONATES 1992-2018", "HN": "2019 (1992)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077557"}, {"RECTYPE": "D", "MH": "Big Data", "AQ": "EC SD", "MN": "L01.313.500.750.300.092", "FX": "Datasets as Topic", "MH_TH": "NLM (2019)", "ST": "T170", "MS": "Extremely large amounts of data which require rapid and often complex computational analyses to reveal patterns, trends, and associations, relating to various facets of human and non-human entities.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077558"}, {"RECTYPE": "D", "MH": "Sodium Citrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trisodium Citrate Dihydrate|T109|T121|NON|NRW|FDA SRS (2013)|NLM (2013)|180209|abbcdeef", "MN": "D02.241.081.901.434.249.875", "MH_TH": "NLM (1996)", "ST": "T121", "RN": "1Q73Q2JULR", "RR": "RS7A450LGA", "MS": "Sodium salts of citric acid that are used as buffers and food preservatives. They are used medically as anticoagulants in stored blood, and for urine alkalization in the prevention of KIDNEY STONES.", "PM": "2019; SODIUM CITRATE was indexed under CITRATES 1996-2018", "HN": "2019 (1996)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077559"}, {"RECTYPE": "D", "MH": "Enfuvirtide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "T20, Peptide", "MN": "D23.050.327.520.330.500", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "19OWO1T3ZE", "MS": "A synthetic 36-amino acid peptide that corresponds to the heptad repeat sequence of HIV-1 gp41. It blocks HIV cell fusion and viral entry and is used with other anti-retrovirals for combination therapy of HIV INFECTIONS and AIDS.", "PM": "2019; ENFUVIRTIDE was indexed under PEPTIDE FRAGMENTS and HIV ENVELOPE PROTEIN GP41 2001-2018; and under ANTI-HIV AGENTS 1997-2000", "HN": "2019 (1997)", "MR": "20220413", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077560"}, {"RECTYPE": "D", "MH": "Daclizumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Ro 247375", "MN": "D12.776.377.715.548.114.224.200.766", "MH_TH": "USAN (1995)", "ST": "T129", "RN": "CUJ2MVI71Y", "RR": "152923-56-3 (Daclizumab)", "MS": "An anti-TAC (INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT) humanized monoclonal antibody (immunoglobulin G1 disulfide with human-mouse monoclonal clone 1H4 light chain, dimer) that is used in the treatment of ACUTE RELAPSING MULTIPLE SCLEROSIS.", "PM": "2019; DACLIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2018; and under ANTIBODIES, MONOCLONAL 1995-2011", "HN": "2019 (1995)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077561"}, {"RECTYPE": "D", "MH": "Valganciclovir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ganciclovir L valyl Ester", "MN": "D03.633.100.759.758.399.454.250.300.500", "MH_TH": "NLM (1999)", "ST": "T121", "N1": "L-Valine, 2-((2-amino-3,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester", "RN": "GCU97FKN3R", "RR": "4P3T9QF9NZ", "MS": "A ganciclovir prodrug and antiviral agent that is used to treat CYTOMEGALOVIRUS RETINITIS in patients with AIDS, and for the prevention of CYTOMEGALOVIRUS INFECTIONS in organ transplant recipients who have received an organ from a CMV-positive donor.", "PM": "2019; VALGANCICLOVIR was indexed under GANCICLOVIR/analogs & derivatives 1999-2018", "HN": "2019 (1999)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077562"}, {"RECTYPE": "D", "MH": "Norethindrone Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Estr-4-en-3-one, 17-(acetyloxy)-17-ethynyl-, (17beta)-|T109|T121|T125|NON|EQV|NLM (2020)|190708|abbbcdef", "ENTRY": "Norlutate|T109|T121|T125|TRD|NRW|NLM (1980)|abbbcde", "MN": "D04.210.500.668.651.693.651.500", "MH_TH": "USAN (1980)", "ST": "T125", "RN": "9S44LIC7OJ", "RR": "51-98-9 ((17alpha)-isomer)", "MS": "Acetate ester of norethindrone that is used as a long-term contraceptive (CONTRACEPTIVE AGENTS).", "PM": "2019; NORETHINDRONE ACETATE was indexed under NORETHINDRONE/analogs & derivatives 1980-2018", "HN": "2019 (1980)", "MR": "20190708", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077563"}, {"RECTYPE": "D", "MH": "Focused Assessment with Sonography for Trauma", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "eFAST Exams", "MN": "N04.590.874.500.500", "MH_TH": "NLM (2020)", "ST": "T060", "PI": "Ultrasonography (1999-2018)", "MS": "Rapid bedside ultrasound examination performed by medical personnel (surgeons, emergency physicians, paramedics and others), as a screening test for blood around the heart (PERICARDIAL EFFUSION) or abdominal organs (HEMOPERITONEUM) after trauma.", "PM": "2019", "HN": "2019", "MR": "20181010", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077564"}, {"RECTYPE": "D", "MH": "Amisulpride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sultopride Hydrochloride|T109|T121|NON|NRW|FDA SRS (2018)|NLM (1976)|180212|abbcdeef", "MN": "D02.455.426.559.389.127.085.084", "MH_TH": "NLM (1976)", "ST": "T121", "RN": "8110R61I4U", "RR": "AA0G3TW31W", "MS": "A benzamide derivative that is used as an antipsychotic agent for the treatment of schizophrenia. It is also used as an antidepressive agent.", "PM": "2019; see SULTOPRIDE 1976-2018; SULTOPRIDE was indexed under SULPIRIDE/analogs & derivatives 1976-2018", "HN": "2019 (1976)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077582"}, {"RECTYPE": "D", "MH": "Quinapril", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "PD 1094522", "MN": "D03.633.100.531.820.250", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3-Isoquinolinecarboxylic acid, 2-((2S)-2-(((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3S)-", "RN": "RJ84Y44811", "RR": "82586-55-8 (Quinapril)", "MS": "A tetrahydroisoquinoline derivative and ANGIOTENSIN CONVERTING ENZYME inhibitor that is used in the treatment of HYPERTENSION and HEART FAILURE.", "PM": "2019; QUINAPRIL was indexed under TETRAHYDROISOQUINOLINES 2004-2018 and under ISOQUINOLINES 1984-2003", "HN": "2019 (1984)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077583"}, {"RECTYPE": "D", "MH": "2-Methoxyestradiol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "2 Methoxyoestradiol", "MN": "D06.472.334.851.437.500.750", "MH_TH": "NLM (1980)", "ST": "T121", "N1": "Estra-1,3,5(10)-triene-3,17-diol, 2-methoxy-, (17beta)-", "RN": "6I2QW73SR5", "RR": "362-07-2 (2-Methoxyestradiol)", "MS": "A metabolite of estradiol that lacks estrogenic activity and inhibits TUBULIN polymerization. It has antineoplastic properties, including inhibition of angiogenesis and induction of APOPTOSIS.", "PM": "2019; 2-METHOXYESTRADIOL was indexed under ESTRADIOL/analogs & derivatives  1980-2018", "HN": "2019 (1980)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077584"}, {"RECTYPE": "D", "MH": "Terlipressin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "tri-Gly-8-Lys- Vasopressin", "MN": "D12.776.631.650.937.400.675", "MH_TH": "USAN (19XX)", "ST": "T125", "N1": "N-(N- (N-glycylglycyl)glycyl)-L-lysinevasopressin", "RN": "7Z5X49W53P", "RR": "14636-12-5 (Terlipressin)", "MS": "An inactive peptide prodrug that is slowly converted in the body to lypressin. It is used to control bleeding of ESOPHAGEAL VARICES and for the treatment of HEPATORENAL SYNDROME.", "PM": "2019; TERLIPRESSIN was indexed under LYPRESSIN/analogs & derivatives 1976-2018", "HN": "2019 (1976)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077585"}, {"RECTYPE": "D", "MH": "Natural Disasters", "AQ": "CL EC HI MO PC ST", "ENTRY": "Disasters, Natural", "MN": "N06.230.100.230", "MH_TH": "NLM (1972)", "ST": "T070", "PI": "Disasters (1993-2018)", "MS": "Disasters linked to natural hazards including widespread fires, floods, storms, earthquakes and drought.These events may result in significant damage and loss of lives.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077587"}, {"RECTYPE": "D", "MH": "Deferasirox", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ICL670A|T109|T121|LAB|NRW|NLM (2000)|001107|abbcdef", "MN": "D03.383.129.799.363", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "V8G4MOF2V9", "MS": "A triazole and benzoate derivative that acts as a selective iron chelator. It is used in the management of chronic IRON OVERLOAD due to blood transfusion or non-transfusion dependent THALASSEMIA.", "PM": "2019; DEFERASIROX was indexed under BENZOATES and TRIAZOLES 2000-2018", "HN": "2019 (2000)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077588"}, {"RECTYPE": "D", "MH": "Sulfathiazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzenesulfonamide, 4-amino-N-2-thiazolyl|T109|T121|NON|EQV|NLM (2020)|190408|abbcdef", "ENTRY": "Benzenesulfonamide, 4 amino N 2 thiazolyl", "MN": "D03.383.129.708.725.500", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "Y7FKS2XWQH", "RR": "PV16N742VM", "MS": "A sulfathiazole compound that is used as a short-acting anti-infective agent. It is no longer commonly used systemically due to its toxicity, but may still be applied topically in combination with other drugs for the treatment of vaginal and skin infections, and is still used in veterinary medicine.", "PM": "2019; SULFATHIAZOLE was indexed under SULFATHIAZOLES 1974-2018", "HN": "2019 (1974)", "MR": "20230608", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077589"}, {"RECTYPE": "D", "MH": "Mivacurium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "BWB1090U", "MN": "D03.633.100.531.430", "MH_TH": "NLM (1986)", "ST": "T121", "N1": "Isoquinolinium, 2,2'-((1,8-dioxo-4-octene-1,8-diyl)bis(oxy-3,1-propanediyl))bis(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-((3,4,5-trimethoxyphenyl)methyl))-, (1R,1'R)-", "RN": "77D66S9Q93", "RR": "600ZG213C3", "MS": "An isoquinoline derivative that is used as a short-acting non-depolarizing agent.", "PM": "2019; MIVACURIUM was indexed under ISOQUINOLINES 1993-2018; and under NEUROMUSCULAR NONDEPOLARIZING AGENTS 1986-1992", "HN": "2019 (1986)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077590"}, {"RECTYPE": "D", "MH": "Eucalyptol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "1,8 Epoxy p menthane", "MN": "D10.289.510.500.454", "FX": "Eucalyptus Oil", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2-Oxabicyclo(2.2.2)octane, 1,3,3-trimethyl-", "RN": "RV6J6604TK", "RR": "470-82-6 (Eucalyptol)", "MS": "A monoterpene and cyclohexanol derivative that is the major component of EUCALYPTUS OIL. It is used in mouthwash, insect repellent, and as a cough suppressant, and also is widely used as a flavoring agent and solvent. It has antimicrobial properties.", "PM": "2019; EUCALYPTOL was indexed under CYCLOHEXANOLS and MONOTERPENES 2002-2018; under MENTHOL/analogs 1982-2001; under EPOXY COMPOUNDS 1969-1982; and under TERPENES 1969-1977", "HN": "2019 (1969)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077591"}, {"RECTYPE": "D", "MH": "Maraviroc", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "UK427857", "MN": "D03.383.129.799.682", "MH_TH": "USAN (2005)", "ST": "T121", "N1": "Cyclohexanecarboxamide, 4,4-difluoro-N-((1S)-3-((3-exo)-3-(3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)-", "RN": "MD6P741W8A", "MS": "A cyclohexane and triazole derivative that acts as an antagonist of the CCR5 RECEPTOR. It prevents infection by HIV-1 virus strains which use CCR5 as a co-receptor for membrane fusion and cellular entry.", "PM": "2019; MARAVIROC was indexed under CYCLOHEXANES and TRIAZOLES 2005-2018", "HN": "2019 (2005)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077592"}, {"RECTYPE": "D", "MH": "Reboxetine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vestra|T109|T121|TRD|NRW|NLM (2001)|010918|abbcdef", "MN": "D03.383.533.640.682", "MH_TH": "NLM (1992)", "ST": "T121", "N1": "Morpholine, 2-((R)-(2-ethoxyphenoxy)phenylmethyl)-, (2R)-", "RN": "947S0YZ36I", "RR": "L94J81YNNY", "MS": "A morpholine derivative that is a selective and potent noradrenaline reuptake inhibitor; it is used in the treatment of DEPRESSIVE DISORDER.", "PM": "2019; REBOXETINE was indexed under MORPHOLINES 1992-2018", "HN": "2019 (1992)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077593"}, {"RECTYPE": "D", "MH": "Nivolumab", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "ONO4538", "MN": "D12.776.377.715.548.114.224.200.829", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "31YO63LBSN", "MS": "A genetically engineered, fully humanized immunoglobulin G4 monoclonal antibody that binds to the PD-1 RECEPTOR, activating an immune response to tumor cells. It is used as monotherapy or in combination with IPILIMUMAB for the treatment of advanced malignant MELANOMA. It is also used in the treatment of advanced or recurring NON-SMALL CELL LUNG CANCER; RENAL CELL CARCINOMA; and HODGKIN'S LYMPHOMA.", "PM": "2019; NIVOLUMAB was indexed under ANTIBODIES, MONOCLONAL 2010-2018", "HN": "2019 (2010)", "MR": "20200228", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077594"}, {"RECTYPE": "D", "MH": "Famciclovir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester)|T109|T121|NON|EQV|NLM (2020)|190408|abbcdef", "ENTRY": "BRL42810", "MN": "D03.633.100.759.138.703", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "QIC03ANI02", "RR": "104227-87-4 (Famciclovir)", "MS": "An aminopurine derivative and prodrug of penciclovir which is a competitive inhibitor of herpes simplex 2 DNA polymerase. It is used to treat HERPES SIMPLEX VIRUS INFECTION.", "PM": "2019; FAMCICLOVIR was indexed under 2-AMINOPURINE/analogs & derivatives 1989-2018", "HN": "2019 (1989)", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077595"}, {"RECTYPE": "D", "MH": "Thymalfasin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "alpha1 Thymosin", "MN": "D12.776.922.500", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "W0B22ISQ1C", "MS": "A thymus hormone polypeptide found in thymosin fraction 5 (a crude thymus gland extract) but now produced by synthesis. It is used alone or with interferon as an immunomodulator for the treatment of CHRONIC HEPATITIS B and HEPATITIS C. Thymalfasin is also used for the treatment of chemotherapy-induced immunosuppression, and to enhance the efficacy of influenza and hepatitis B vaccines in immunocompromised patients.", "PM": "2019; THYMALFASIN was indexed under THYMOSIN/analogs & derivatives 1984-2018; and under THYMOSIN/analogs 1980-1983", "HN": "2019 (1980)", "MR": "20180619", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077596"}, {"RECTYPE": "D", "MH": "Vildagliptin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NVP LAF237", "MN": "D03.383.773.953", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "I6B4B2U96P", "MS": "A pyrrolidine-carbonitrile derivative and potent inhibitor of DIPEPTIDYL PEPTIDASE 4 that is used in the treatment of TYPE 2 DIABETES MELLITUS.", "PM": "2019; VILDAGLIPTIN was indexed under NITRILES and PYRROLIDINES 2005-2018", "HN": "2019 (2005)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077597"}, {"RECTYPE": "D", "MH": "Tolvaptan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "OPC41061", "MN": "D03.633.100.079.875", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Benzamide, N-(4-((7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-3-methylphenyl)-2-methyl-", "RN": "21G72T1950", "RR": "150683-30-0 (Tolvaptan)", "MS": "A benzazepine derivative and selective VASOPRESSIN V2 RECEPTOR antagonist that is used to treat euvolemic and hypervolemic HYPONATREMIA. It is also used in the treatment of rapidly progressing AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE to slow the rate of cyst development and renal insufficiency.", "PM": "2019; TOLVAPTAN was indexed under BENZAZEPINES 1999-2019", "HN": "2019 (1999)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077602"}, {"RECTYPE": "D", "MH": "Nandrolone Decanoate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "19 nor 4 Androstene 17 beta ol 3 one 17 decanoate", "MN": "D06.472.334.851.968.976.500", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "H45187T098", "RR": "360-70-3 (Nandrolone Decanoate)", "MS": "Decanoic acid ester of nandrolone that is used as an anabolic agent to prevent or treat WASTING SYNDROME associated with severe chronic illness or HIV infection (HIV WASTING SYNDROME). It may also be used in the treatment of POSTMENOPAUSAL OSTEOPOROSIS.", "PM": "2019; NANDROLONE DECANOATE was indexed under NANDROLONE/ analogs & derivatives 1971-2018", "HN": "2019 (1971)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077603"}, {"RECTYPE": "D", "MH": "Fomepizole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "4 Methylpyrazole Monohydrochloride", "MN": "D03.383.129.539.344", "MH_TH": "USAN (1990)", "ST": "T121", "RN": "83LCM6L2BY", "RR": "7554-65-6 (Fomepizole)", "MS": "A pyrazole and competitive inhibitor of ALCOHOL DEHYDROGENASE that is used for the treatment of poisoning by ETHYLENE GLYCOL or METHANOL.", "PM": "2019; FOMEPIZOLE was indexed under PYRAZOLES 1975-2018", "HN": "2019 (1975)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077604"}, {"RECTYPE": "D", "MH": "Ferric Oxide, Saccharated", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "D-Glucaric acid, iron(2+) salt (1:1)|T109|T121|NON|EQV|NLM (2020)|190626|abbcdef", "ENTRY": "Saccharated Ferric Oxide", "MN": "D09.811.295.500", "MH_TH": "NLM (1974)", "ST": "T121", "RN": "FZ7NYF5N8L", "RR": "8047-67-4 (Ferric Oxide, Saccharated)", "MS": "A glucaric acid-iron conjugate that is used in the treatment of IRON-DEFICIENCY ANEMIA, including in patients with chronic kidney disease, when oral iron therapy is ineffective or impractical.", "PM": "2019; FERRIC OXIDE, SACCHARATED was indexed under FERRIC COMPOUNDS 1980-2018 and GLUCARIC ACID 1983-2018; under IRON and OXIDES1974-1979; and under SACCHARIN 1974-1982", "HN": "2019 (1974)", "MR": "20190701", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077605"}, {"RECTYPE": "D", "MH": "Trabectedin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ET743", "MN": "D03.633.100.531.820.781", "MH_TH": "USAN (2003)", "ST": "T121", "RN": "ID0YZQ2TCP", "RR": "114899-77-3 (Trabectedin)", "MS": "A complex structure that includes isoquinolines joined by a cyclic ester; it is a DNA-binding agent and guanine N2 alkylator derived from the marine tunicate, Ecteinascidia turbinata. Trabectedin is used for the treatment of advanced soft-tissue SARCOMA, after failure of ANTHRACYCLINES or IFOSFAMIDE drug therapy.", "PM": "2019; TRABECTIDIN was indexed under DIOXOLES and TETRAHYDROISOQUINOLINES 2007-2018; and under ISOQUINOLINES 1996-2018", "HN": "2019 (1996)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077606"}, {"RECTYPE": "D", "MH": "Icodextrin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Icodial|T109|T121|TRD|NRW|ES|030310|abbcdef", "MN": "D09.698.365.399", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "2NX48Z0A9G", "MS": "A glucan that is structurally related to maltodextrin, with more than 85% of its molecules having molecular weights between 1640 and 45 000 Daltons (Da), and a weight-average molecular weight of about 20 000 Da; it is used in dialysis fluids as an alternative to glucose-based solutions, and to reduce adhesions after gynecological or abdominal surgery. It has also been used as a vehicle for drugs given via the peritoneal cavity.", "PM": "2019; ICODEXTRIN was indexed under GLUCANS and GLUCOSE 1997-2018", "HN": "2019 (1997)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077607"}, {"RECTYPE": "D", "MH": "Aprepitant", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MK869", "MN": "D03.383.533.640.125", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "3H-1,2,4-Triazol-3-one, 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,4-dihydro-", "RN": "1NF15YR6UY", "MS": "A morpholine neurokinin-1 (NK1) receptor antagonist that is used in the management of nausea and vomiting caused by DRUG THERAPY, and for the prevention of POSTOPERATIVE NAUSEA AND VOMITING.", "PM": "2019; APREPITANT was indexed under MORPHOLINES 1998-2018", "HN": "2019 (1998)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077608"}, {"RECTYPE": "D", "MH": "O-(Chloroacetylcarbamoyl)fumagillol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TNP470", "MN": "D02.455.849.765.597", "MH_TH": "NLM (1991)", "ST": "T121", "RN": "X47GR46481", "RR": "129298-91-5 (O-(chloroacetylcarbamoyl)fumagillol)", "MS": "Semisynthetic analog of fumagillin (a cyclohexane-sesquiterpene antibiotic isolated from ASPERGILLUS FUMIGATUS) that inhibits angiogenesis.", "PM": "2019; O-(CHLOROACETYLCARBAMOYL)FUMAGILLOL was indexed under CYCLOHEXANES and SESQUITERPENES 1991-2018", "HN": "2019 (1991)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077609"}, {"RECTYPE": "D", "MH": "Bexarotene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Targretin|T109|T121|TRD|NRW|DE|FR|UK|US|abbcdeeee", "MN": "D04.615.638.960.423", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "A61RXM4375", "MS": "A rexinoid (an RXR-binding ligand), tetrahydronaphthalene derivative and RETINOID X RECEPTOR antagonist that is used in the treatment of CUTANEOUS T-CELL LYMPHOMA.", "PM": "2019; BEXAROTENE was indexed under TETRAHYDRONAPHTHALENES 1995-2018", "HN": "2019 (1995)", "MR": "20200609", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077610"}, {"RECTYPE": "D", "MH": "Artemether, Lumefantrine Drug Combination", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Lumefantrine, Artemether", "MN": "D26.310.110", "MH_TH": "NLM (2019)", "ST": "T121", "RN": "0", "MS": "Drug combination of artemether and lumefantrine that is used to treat PLASMODIUM FALCIPARUM MALARIA.", "PM": "2019; see ARTEMETHER-LUMEFANTRINE COMBINATION 2006-2018; ARTEMETHER, LUMEFANTRINE DRUG COMBINATION was indexed under DRUG COMBINATIONS; ETHANOLAMINES; FLUORENES; and ARTEMISININS 2006-2018", "HN": "2019 (2006)", "MR": "20230320", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077611"}, {"RECTYPE": "D", "MH": "Anidulafungin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "LY303366|T116|T121|LAB|NRW|NLM (1997)|abbcde", "MN": "D12.644.641.311.250", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "9HLM53094I", "MS": "Echinocandin antifungal agent that is used in the treatment of CANDIDEMIA and CANDIDIASIS.", "PM": "2019; ANIDULAFUNGIN was indexed under ECHINOCANDINS 1997-2018", "HN": "2019 (1997)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077612"}, {"RECTYPE": "D", "MH": "Etoricoxib", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MK0663", "MN": "D03.383.725.354", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "2,3'-Bipyridine, 5-chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-", "RN": "WRX4NFY03R", "RR": "202409-33-4 (Etoricoxib)", "MS": "A sulfone and pyridine derivative that acts as a cyclooxygenase-2 inhibitor. It is used as a NSAID for the treatment of pain associated with RHEUMATOID ARTHRITIS and ANKYLOSING SPONDYLITIS. It is also used for the short-term treatment of moderate postoperative dental pain.", "PM": "2019; ETORICOXIB was indexed under PYRIDINES and SULFONES 2001-2018", "HN": "2019 (2001)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077613"}, {"RECTYPE": "D", "MH": "Golgi Matrix Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Golgin|T116|NON|NRW|NLM (2021)|200311|abcdef", "ENTRY": "Protein, Golgi Matrix", "MN": "D12.776.407", "MH_TH": "NLM (2019)", "ST": "T116", "RN": "0", "PI": "Golgi Apparatus (2001-2018)", "MS": "Proteins on the cytoplasmic side of the GOLGI APPARATUS cisternae that tether the cisternae to each other or to the transport vesicles of the TRANS-GOLGI NETWORK to maintain the Golgi structure and function.", "PM": "2019", "HN": "2019", "MR": "20200527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077614"}, {"RECTYPE": "D", "MH": "Implementation Science", "ENTRY": "Implementation Sciences", "MN": "L01.143.320.400", "MH_TH": "NLM (2019)", "ST": "T090", "MS": "The study of methods to promote the adoption and integration of evidence-based practices, interventions and policies into routine health care and public health settings.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077626"}, {"RECTYPE": "D", "MH": "Family Separation", "ENTRY": "Separation, Family", "MN": "I01.880.853.150.446", "MH_TH": "NLM (2019)", "ST": "T054", "MS": "Geographic separation of members of a family.", "PM": "2019", "HN": "2019", "MR": "20180227", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077642"}, {"RECTYPE": "D", "MH": "Triclabendazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Egaten|T121|TRD|REL|NLM (2020)|190828|abcdef", "ENTRY": "Tremacide|T109|T121|TRD|NRW|AU|041203|abbcdef", "MN": "D03.633.100.103.925", "MH_TH": "USAN (1983)", "ST": "T121", "N1": "1H-Benzimidazole, 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-", "RN": "4784C8E03O", "RR": "68786-66-3 (Triclabendazole)", "MS": "Benzimidazole antiplatyhelmintic agent that is used for the treatment of FASCIOLIASIS and PARAGONIMIASIS.", "PM": "2019; TRICLABENDAZOLE was indexed under BENZIMIDAZOLES 1983-2018", "HN": "2019 (1983)", "MR": "20190828", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077682"}, {"RECTYPE": "D", "MH": "Cauda Equina Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cauda Equina Syndromes", "MN": "C10.668.829.800.750.150", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "Compressive lesion affecting the nerve roots of the CAUDA EQUINA (e.g., compression, herniation, inflammation, rupture, or stenosis), which controls the function of the bladder and bowel. Symptoms may include neurological dysfunction of bladder or bowels, loss of sexual sensation and altered sensation or paralysis in the lower extremities.", "PM": "2019; see Polyradiculopathy 2010-2018", "HN": "2019; use Polyradiculopathy 2010-2018", "MR": "20180614", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077684"}, {"RECTYPE": "D", "MH": "Tirapazamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "WIN59075", "MN": "D03.383.931.867", "MH_TH": "USAN (1992)", "ST": "T121", "N1": "1,2,4-Benzotriazin-3-amine, 1,4-dioxide", "RN": "1UD32YR59G", "RR": "27314-97-2 (Tirapazamine)", "MS": "A triazine derivative that introduces breaks into DNA strands in hypoxic cells, sensitizing tumor cells to the cytotoxic activity of other drugs and radiation.", "PM": "2019; TIRAPAZAMINE was indexed under TRIAZINES 1986-2018", "HN": "2019 (1986)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077704"}, {"RECTYPE": "D", "MH": "Screen Time", "ENTRY": "Screen Times", "MN": "I03.723", "MH_TH": "NLM (2019)", "ST": "T079", "MS": "Period of activities done in front of an electronic screen, such as watching TV, working on a computer, or playing video games.", "PM": "2019", "HN": "2019", "MR": "20180601", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077705"}, {"RECTYPE": "D", "MH": "Sitting Position", "ENTRY": "Sitting Positions", "MN": "G11.427.695.575", "MH_TH": "NLM (2017)", "ST": "T042", "PM": "2019; was Posture (2006-2018)", "HN": "2019; use Posture (2006-2018)", "MR": "20180623", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077708"}, {"RECTYPE": "D", "MH": "Self-Neglect", "AQ": "LJ PX SN", "ENTRY": "Self Neglect", "MN": "I03.050.625", "MH_TH": "NLM (2019)", "ST": "T055", "MS": "Profound inattention by individuals to their own health and hygiene.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077711"}, {"RECTYPE": "D", "MH": "Telbivudine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta L 2' Deoxythymidine", "MN": "D13.570.685.705.888", "MH_TH": "USAN (2002)", "ST": "T121", "N1": "2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-beta-L-erythro-pentofuranosyl)-5-methyl-", "RN": "2OC4HKD3SF", "MS": "A thymidine derivative and antiviral agent that inhibits DNA synthesis by HEPATITIS B VIRUS and is used for the treatment of CHRONIC HEPATITIS B.", "PM": "2019; TELBIVUDINE was indexed under THYMIDINE/analogs & derviatives 2014-2018; and under NUCLEOSIDES and PYRIMIDINONES 2004-2013", "HN": "2019 (2004)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077712"}, {"RECTYPE": "D", "MH": "17 alpha-Hydroxyprogesterone Caproate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Caproate, 17-alpha-Hydroxy-Progesterone", "MN": "D06.472.334.851.687.750.478.400.250", "MH_TH": "NLM (1979)", "ST": "T121", "N1": "Hexanoic acid, 3,20-dioxopregn-4-en-17-yl ester", "RN": "276F2O42F5", "RR": "630-56-8", "MS": "Hydroxyprogesterone derivative that acts as a PROGESTIN and is used to reduce the risk of recurrent MISCARRIAGE and of PREMATURE BIRTH. It is also used in combination with ESTROGEN in the management of MENSTRUATION DISORDERS.", "PM": "2019;see 17-ALPHA-HYDROXY-PROGESTERONE CAPROATE 2003-2018; 17-ALPHA-HYDROXYPROGESTERONE CAPROATE was indexed under HYDROXYPROGESTERONES 1979-2018", "HN": "2019 (1979)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077713"}, {"RECTYPE": "D", "MH": "Nateglinide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "AY4166", "MN": "D12.125.072.050.685.448", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-", "RN": "41X3PWK4O2", "RR": "105816-06-6 ((cis,D-Phe)-isomer)", "MS": "A phenylalanine and cyclohexane derivative that acts as a hypoglycemic agent by stimulating the release of insulin from the pancreas. It is used in the treatment of TYPE 2 DIABETES.", "PM": "2019; NATEGLINIDE was indexed under PHENYLALANINE/analogs & derivatives and CYCLOHEXANES 1989-2018", "HN": "2019 (1989)", "MR": "20180409", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077715"}, {"RECTYPE": "D", "MH": "Afatinib", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "BIBW 2992MA2", "MN": "D03.633.100.786.188", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-, (2E)-", "RN": "41UD74L59M", "RR": "V1T5K7RZ0B", "MS": "A quinazoline and butenamide derivative that acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER.", "PM": "2019; AFATINIB was indexed under QUINAZOLINES 2007-2018", "HN": "2019 (2007)", "MR": "20230804", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077716"}, {"RECTYPE": "D", "MH": "Ceftibuten", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SCH39720|T109|T195|LAB|NRW|NLM (1988)|abbcde", "MN": "D03.633.100.300.249.187", "MH_TH": "USAN (19XX)", "ST": "T195", "RN": "IW71N46B4Y", "RR": "97519-39-6 (Ceftibuten)", "MS": "A cephalosporin antibacterial agent that is used in the treatment of infections, including urinary-tract and respiratory-tract infections.", "PM": "2019; CEFTIBUTEN was indexed under CEPHALOSPORINS 1990-2018; and under ANTIBIOTICS, LACTAM 1988-1989", "HN": "2019 (1988)", "MR": "20180410", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077722"}, {"RECTYPE": "D", "MH": "Cefepime", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "BMY28142", "MN": "D03.633.100.300.249.173", "MH_TH": "USAN (19XX)", "ST": "T195", "N1": "Pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, hydroxide, inner salt, (6R-(6alpha,7beta(Z)))-", "RN": "807PW4VQE3", "RR": "I8X1O0607P", "MS": "A fourth-generation cephalosporin antibacterial agent that is used in the treatment of infections, including those of the abdomen, urinary tract, respiratory tract, and skin. It is effective against PSEUDOMONAS AERUGINOSA and may also be used in the empiric treatment of FEBRILE NEUTROPENIA.", "PM": "2019; CEFEPIME was indexed under CEPHALOSPORINS 1985-2018", "HN": "2019 (1985)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077723"}, {"RECTYPE": "D", "MH": "Piperacillin, Tazobactam Drug Combination", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tazobactam, Piperacillin -", "MN": "D26.310.625", "MH_TH": "NLM (2015)", "ST": "T195", "RN": "157044-21-8", "MS": "An antibiotic combination product of piperacillin and tazobactam, a penicillanic acid derivative with enhanced beta-lactamase inhibitory activity, that is used for the intravenous treatment of intra-abdominal, pelvic, and skin infections and for community-acquired pneumonia of moderate severity. It is also used for the treatment of PSEUDOMONAS AERUGINOSA INFECTIONS.", "PM": "2019; PIPERACILLIN, TAZOBACTAM DRUG COMBINATION was indexed under PIPERACILLIN and PENICILLANIC ACID 1994-2018", "HN": "2019 (1994)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077725"}, {"RECTYPE": "D", "MH": "Doripenem", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "S4661", "MN": "D03.633.100.300.124.150", "MH_TH": "USAN (19XX)", "ST": "T195", "N1": "1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3S,5S)-5-(((aminosulfonyl)amino)methyl)-3-pyrrolidinyl)thio)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-, (4R,5S,6S)-", "RN": "BHV525JOBH", "MS": "A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of infections such as HOSPITAL-ACQUIRED PNEUMONIA, and complicated intra-abdominal or urinary-tract infections, including PYELONEPHRITIS.", "PM": "2019; DORIPENEM was indexed under CARBAPENEMS 1996-2018", "HN": "2019 (1996)", "MR": "20180410", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077726"}, {"RECTYPE": "D", "MH": "Ertapenem", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Invanz|T109|T195|TRD|NRW|DE|MX|US|041215|abbcdeeef", "MN": "D03.633.100.300.124.225", "MH_TH": "NLM (2002)", "ST": "T195", "N1": "(4R,5R,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-yl)sulfanyl-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid", "RN": "G32F6EID2H", "RR": "2T90KE67L0", "MS": "A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of Gram-positive and Gram-negative bacterial infections including intra-abdominal infections, acute gynecological infections, complicated urinary tract infections, skin infections, and respiratory tract infections. It is also used to prevent infection in colorectal surgery.", "PM": "2019; ERTAPENEM was indexed under BETA-LACTAMS 2006-2018; and under LACTAMS 2002-2005", "HN": "2019 (2002)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077727"}, {"RECTYPE": "D", "MH": "Cilastatin, Imipenem Drug Combination", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MK 787 MK 791 mixture", "MN": "D26.310.356", "MH_TH": "NLM (2009)", "ST": "T121", "RN": "92309-29-0", "RR": "85960-17-4 (Na salt)", "MS": "Combination of imipenem and cilastatin that is used in the treatment of bacterial infections; cilastatin inhibits renal dehydropeptidase I to prolong the half-life and increase the tissue penetration of imipenem, enhancing its efficacy as an anti-bacterial agent.", "PM": "2019; CILASTATIN, IMIPENEM DRUG COMBINATION was indexed under CILASTATIN and IMIPENEM 1995-2018 and 1988-1994; under DRUG COMBINATIONS 1995-2018 and 1985-1994; and under CYCLOPROPANES and THIENAMYCINS 1985-1988", "HN": "2019 (1985)", "MR": "20180410", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077728"}, {"RECTYPE": "D", "MH": "Meropenem", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SM7338", "MN": "D03.633.100.300.124.300.750", "MH_TH": "USAN (19XX)", "ST": "T195", "N1": "1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4R-(3(3S*,5S*),4alpha,5beta,6beta(R*)))-", "RN": "FV9J3JU8B1", "RR": "96036-03-2 (Meropenem)", "MS": "A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients.", "PM": "2019; MEROPENEM was indexed under THIENAMYCINS 1989-2018", "HN": "2019 (1989)", "MR": "20180410", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077731"}, {"RECTYPE": "D", "MH": "Fidaxomicin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dificid|T121|TRD|NRW|NLM (2021)|200127|abcdef", "ENTRY": "Tiacumicin C|T109|T195|NON|NRW|NLM (1975)|180308|abbcdef", "MN": "D04.345.674.500.500", "MH_TH": "NLM (2010)", "ST": "T195", "RN": "Z5N076G8YQ", "RR": "56645-60-4 (Fidaxomicin)", "MS": "A narrow-spectrum macrolide antibacterial agent that is used in the treatment of diarrhea associated with CLOSTRIDIUM DIFFICILE INFECTION.", "PM": "2019; see LIPIARMYCIN 1975-2018; LIPIARMYCIN was indexed under AMINOGLYCOSIDES 1988-2018 and 1975-1985; and under ANTIBIOTICS and GLYCOSIDES 1986-1987", "HN": "2019 (1975)", "MR": "20200622", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077732"}, {"RECTYPE": "D", "MH": "Immunoglobulin G4-Related Disease", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Immunoglobulin G4-Related Sclerosing Disease|T047|NON|NRW|NLM (2021)|191120|abcdef", "ENTRY": "Sclerosing Disease, IgG4-Related", "MN": "C20.111.572", "MH_TH": "NLM (2019)", "ST": "T047", "PI": "Immunoglobulin G (2009-2018)", "MS": "A spectrum of systemic autoimmune diseases in which IMMUNOGLOBULIN G4 plays a pathophysiologic role. It can affect multiple organs in highly variable presentations, characterized by inflammatory lesions composed of IgG4-positive PLASMA CELLS, further infiltrated by T helper cells (T-LYMPHOCYTES, HELPER-INDUCER) when linked to progressive FIBROSIS and eventual organ damage.", "PM": "2019", "HN": "2019", "MR": "20200116", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077733"}, {"RECTYPE": "D", "MH": "Gatifloxacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "BMS206584", "MN": "D03.633.100.810.835.322.316", "MH_TH": "USAN (19XX)", "ST": "T195", "N1": "3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-", "RN": "L4618BD7KJ", "RR": "112811-59-3 (Gatifloxacin)", "MS": "A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.", "PM": "2019; GATIFLOXACIN was indexed under FLUOROQUINOLONES 1992-2018", "HN": "2019 (1992)", "MR": "20180410", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077734"}, {"RECTYPE": "D", "MH": "Gemifloxacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SB265805", "MN": "D03.633.100.810.835.322.322", "MH_TH": "NLM (2000)", "ST": "T195", "N1": "1,8-Naphthyridine-3-carboxylic acid, 7-((4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-", "RN": "OKR68Y0E4T", "RR": "X4S9F8RL01", "MS": "A naphthyridine and fluoroquinolone derivative antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used for the treatment of community-acquired pneumonia and acute bacterial infections associated with chronic bronchitis.", "PM": "2019; GEMIFLOXACIN was indexed under NAPHTHYRIDINES and FLUOROQUINOLONES 1997-2018", "HN": "2019 (1997)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077735"}, {"RECTYPE": "D", "MH": "Procalcitonin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Calcitonin 1", "MN": "D12.776.811.555", "MH_TH": "NLM (1981)", "ST": "T123", "RN": "0", "PI": "Calcitonin (1981-2018)", "MS": "A peptide prohormone precursor of CALCITONIN. It is normally present at low levels in serum, but is released into the bloodstream, primarily from neuroendocrine cells in the lungs and intestines, in response to INFLAMMATION and BACTERIAL INFECTIONS. It is a diagnostic marker for BACTEREMIA.", "PM": "2019; see CALCITONIN 1981-2018", "HN": "2019; use CALCITONIN 1981-2018", "MR": "20230405", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077740"}, {"RECTYPE": "D", "MH": "Diterpene Alkaloids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diterpene Alkaloid|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Alkaloids, Diterpene", "MN": "D03.132.301", "MH_TH": "NLM (2019)", "ST": "T109", "RN": "0", "PI": "Diterpenes (1963-2018)", "MS": "Alkaloids derived from diterpenes (e.g., KAURANES; CLERODANES) often containing the nitrogen bridge structures. These alkaloids may be divided into C18-, C19-, C20- and bis-diterpene types depending on the number of carbon atoms in their central framework. They are found most often in RANUNCULACEAE (e.g., ACONITUM and DELPHINIUM) and may possess analgesic, antiarrhythmic and anti-inflammatory activities. Some are cardiotoxic by blocking L-TYPE CALCIUM CHANNELS.", "PM": "2019", "HN": "2019", "MR": "20200527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077743"}, {"RECTYPE": "D", "MH": "Orthodontic Appliances, Fixed", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Retainers, Permanent", "MN": "E06.658.453.255", "MH_TH": "NLM (2019)", "ST": "T074", "PI": "Orthodontics (1963-2018)", "MS": "ORTHODONTIC APPLIANCES attached to the teeth by adhesive material which cannot be removed from the mouth by the patient. These devices apply force to the teeth and supporting structures, thereby producing changes which control their growth and development.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077744"}, {"RECTYPE": "D", "MH": "Dronedarone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SR 33589B|T109|T121|LAB|NRW|NLM (2007)|070712|abbcdef", "MN": "D03.633.100.127.075.500", "MH_TH": "NLM (1999)", "ST": "T121", "N1": "Methanesulfonamide, N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-", "RN": "JQZ1L091Y2", "MS": "A non-iodinated derivative of amiodarone that is used for the treatment of ARRHYTHMIA.", "PM": "2019; DRONEDARONE was indexed under AMIODARONE/analogs & derivatives 1999-2018", "HN": "2019 (1999)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077764"}, {"RECTYPE": "D", "MH": "Cone Dystrophy", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stationary Cone Dystrophies", "MN": "C11.768.216", "MH_TH": "NLM (2019)", "ST": "T047", "MS": "A general term which describes a group of rare eye disorders that affect the cone cells of the RETINA. Cone dystrophy can cause a variety of symptoms including decreased visual clarity or acuity when looking straight ahead (central vision), a reduced ability to see colors, and an increased sensitivity to light (PHOTOPHOBIA).", "PM": "2019", "HN": "2019", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077765"}, {"RECTYPE": "D", "MH": "Panobinostat", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NVP LBH589", "MN": "D03.633.100.473.746", "MH_TH": "USAN (2005)", "ST": "T121", "N1": "2-Propenamide, N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino) methyl)phenyl)-, (2E)-", "RN": "9647FM7Y3Z", "MS": "An indole and hydroxamic acid derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used as an antineoplastic agent in combination with BORTEZOMIB and DEXAMETHASONE for the treatment of MULTIPLE MYELOMA.", "PM": "2019; PANOBINOSTAT was indexed under HYDROXAMIC ACIDS and INDOLES 2005-2018", "HN": "2019 (2005)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077767"}, {"RECTYPE": "D", "MH": "Ciclopirox", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "HOE296", "MN": "D03.383.725.791.199", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "2(1H)-Pyridinone, 6-cyclohexyl-1-hydroxy-4-methyl-", "RN": "19W019ZDRJ", "RR": "50MD4SB4AP", "MS": "A cyclohexane and pyridinone derivative that is used for the treatment of fungal infections of the skin and nails, and for treatment of VAGINAL YEAST INFECTIONS.", "PM": "2019; CICLOPIROX was indexed under PYRIDONES 1976-2018", "HN": "2019 (1976)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077768"}, {"RECTYPE": "D", "MH": "Rilmenidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "S33413", "MN": "D03.383.129.462.778", "MH_TH": "NLM (1981)", "ST": "T121", "N1": "2-Oxazolamine, N-(dicyclopropylmethyl)-4,5-dihydro-", "RN": "P67IM25ID8", "RR": "59QD64Q32M", "MS": "Oxazole derivative that acts as an agonist for ALPHA-2 ADRENERGIC RECEPTORS and IMIDAZOLINE RECEPTORS. It is used in the treatment of HYPERTENSION.", "PM": "2019; RILMENIDINE was indexed under OXAZOLES 1981-2018", "HN": "2019 (1981)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077769"}, {"RECTYPE": "D", "MH": "Amifampridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ruzurgi|T121|TRD|NRW|NLM (2020)|190507|abcdef", "ENTRY": "3,4 Diaminopyridine", "MN": "D03.383.725.050.060.500", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "3,4-Pyridinediamine", "RN": "RU4S6E2G0J", "RR": "8HF8FIN815", "MS": "4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.", "PM": "2019; see 3,4-DIAMINOPYRIDINE 1978-2018; AMIFAMPRIDINE was indexed under 4-AMINOPYRIDINE/analogs & derivatives 1990-2018; under AMINOPYRIDINES 1978-1989; and under PYRIDINES 1978-1979", "HN": "2019 (1978)", "MR": "20190705", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077770"}, {"RECTYPE": "D", "MH": "Methantheline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vagantin|T109|T121|TRD|NRW|DE|041018|abbcdef", "MN": "D02.675.276.569", "MH_TH": "NLM (1994)", "ST": "T121", "N1": "Ethanaminium, N,N-diethyl-N-methyl-2-((9H-xanthen-9-ylcarbonyl)oxy)-", "RN": "36EI79TX7I", "RR": "5818-17-7 (Methantheline)", "MS": "A quaternary ammonium compound that acts as an antimuscarinic agent. It has been used in the treatment of PEPTIC ULCER, in gastrointestinal disorders associated with smooth muscle spasm, and in the management of urinary incontinence, and may also be used for the treatment of HYPERHIDROSIS.", "PM": "2019; METHANTHELINE was indexed under QUATERNARY AMMONIUM COMPOUNDS 2006-2018; and under AMMONIUM COMPOUNDS 1963-2005", "HN": "2019 (1963)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077771"}, {"RECTYPE": "D", "MH": "Shared Governance, Nursing", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Nursing Shared Governance", "MN": "N04.452.921", "MH_TH": "NLM (2019)", "ST": "T057", "PI": "Organization and Administration (2000-2018)", "MS": "Model of nursing practice with shared decision processes designed to integrate core values and beliefs that professional practice embraces, as a means of achieving quality care.", "PM": "2019", "HN": "2019", "MR": "20180527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077772"}, {"RECTYPE": "D", "MH": "Hospitals, Rehabilitation", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Rehabilitation Hospitals", "MN": "N02.421.784.411", "MH_TH": "NLM (2019)", "ST": "T093", "MS": "Free standing rehabilitation hospitals and rehabilitation units in acute care hospitals.  They provide an intensive inpatient rehabilitation program.", "PM": "2019", "HN": "2019", "MR": "20180527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077773"}, {"RECTYPE": "D", "MH": "Insurance, Vision", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Vision Insurance", "MN": "N03.219.521.576.343.750", "MH_TH": "NLM (2019)", "ST": "T058", "MS": "Insurance providing coverage for vision care.", "PM": "2019", "HN": "2019", "MR": "20180801", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077776"}, {"RECTYPE": "D", "MH": "Myopericytoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Myopericytomas", "MN": "C17.300.680.770", "MH_TH": "NLM (2019)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Neoplasms, Vascular Tissue (2003-2018)", "MS": "Rare myofibroma-like perivascular soft tissue tumor, usually benign, characterized by concentric perivascular proliferation.", "PM": "2019", "HN": "2019", "MR": "20190307", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077777"}, {"RECTYPE": "D", "MH": "Pancreatic Intraductal Neoplasms", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Pancreatic Intraductal Neoplasm", "MN": "C19.344.421.875", "MH_TH": "NLM (2019)", "ST": "T191", "PI": "Pancreatic Neoplasms (2002-2018)", "MS": "EPITHELIAL NEOPLASMS with pancreatic ductal differentiation that arise from the EXOCRINE PANCREAS and grow mostly within the PANCREATIC DUCTS. They are characterized by the presence of intraductal masses with mostly papillary growth pattern. Overt production of MUCIN within the pancreatic duct is associated with pancreatic intraductal papillary-mucinous neoplasm but not intraductal tubulopapillary neoplasm.", "PM": "2019", "HN": "2019", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077779"}, {"RECTYPE": "D", "MH": "Plastination", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Plastinations", "MN": "E05.760.400", "MH_TH": "NLM (2019)", "ST": "T059", "PI": "Plastic Embedding (1991-2018)", "MS": "Preservation technique in which epoxy polymers are used to preserve tissue or an organ resulting in anatomically authentic dry specimens often used in teaching of anatomy.", "PM": "2019", "HN": "2019", "MR": "20180614", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077780"}, {"RECTYPE": "D", "MH": "Axitinib", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inlyta|T109|T121|TRD|NRW|NLM (2013)|US|121024|abbcdeef", "MN": "D03.633.100.449.065", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Benzamide, N-methyl-2-((3-((E)-2-(2-pyridinyl)ethenyl)-1H-indazol-6-yl)thio)-", "RN": "C9LVQ0YUXG", "MS": "A benzamide and indazole derivative that acts as a TYROSINE KINASE inhibitor of the VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR. It is used in the treatment of advanced RENAL CELL CARCINOMA.", "PM": "2019; AXITINIB was indexed under IMIDAZOLES and INDAZOLES 2005-2018", "HN": "2019 (2005)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077784"}, {"RECTYPE": "D", "MH": "Tenecteplase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TNKase|T116|T121|T126|TRD|NRW|CA|US|041123|abbbcdeef", "MN": "D12.776.124.125.662.768.500", "MH_TH": "USAN (19XX)", "ST": "T126", "RN": "WGD229O42W", "RR": "EC 3.4.21.68", "MS": "A tissue plasminogen activator enzyme that acts as a fibrinolytic agent; it is used for the dissolution of blood clots, such as those that occur in acute MYOCARDIAL INFARCTION.", "PM": "2019; TENECTEPLASE was indexed under TISSUE PLASMINOGEN ACTIVATOR 1999-2018", "HN": "2019 (1999)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077785"}, {"RECTYPE": "D", "MH": "Torsemide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Torasemide|T109|T121|NON|EQV|INN (19XX)|NLM (1980)|180323|abbcdeef", "MN": "D03.383.725.905", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "3-Pyridinesulfonamide, N-(((1-methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-", "RN": "W31X2H97FB", "RR": "56211-40-6 (Torsemide)", "MS": "A pyridine and sulfonamide derivative that acts as a sodium-potassium chloride symporter inhibitor (loop diuretic). It is used for the treatment of EDEMA associated with CONGESTIVE HEART FAILURE; CHRONIC RENAL INSUFFICIENCY; and LIVER DISEASES. It is also used for the management of HYPERTENSION.", "PM": "2019; TORSEMIDE was indexed under SULFONAMIDES 1980-2018", "HN": "2019 (1980)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077786"}, {"RECTYPE": "D", "MH": "Dictionary, Classical", "MN": "V02.310.225", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Classical Dictionaries as a subject are indexed under the main heading DICTIONARIES, CLASSICAL AS TOPIC.  INDEXER: Do not use ", "MS": "A reference work containing a list of words related to the Greco-Roman World giving information about form, pronunciation, etymology, grammar, and meaning.", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000077803"}, {"RECTYPE": "D", "MH": "Dictionary, Medical", "MN": "V02.310.400", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Medical Dictionaries as a subject are indexed under the main heading DICTIONARIES, MEDICAL AS TOPIC. INDEXER: Do not use ", "MS": "A reference book containing a list of words related to medicine-usually in alphabetic order-giving information about form, pronunciation, etymology, grammar, and meaning.", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000077823"}, {"RECTYPE": "D", "MH": "Dictionary, Dental", "MN": "V02.310.363", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Dental Dictionaries as a subject are indexed under the main heading DICTIONARIES, DENTAL AS TOPIC. INDEXER: Do not use", "MS": "A reference book containing a list of words related to dentistry-usually in alphabetic order-giving information about form, pronunciation, etymology, grammar, and meaning.", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000077824"}, {"RECTYPE": "D", "MH": "Dictionary, Pharmaceutic", "MN": "V02.310.450", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Pharmaceutic Dictionaries as a subject are indexed under the main heading DICTIONARIES, PHARMACEUTIC AS TOPIC. INDEXER: Do not use  ", "MS": "A reference book containing a list of words related to pharmacy-usually in alphabetic order-giving information about form, pronunciation, etymology, grammar, and meaning.", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000077825"}, {"RECTYPE": "D", "MH": "Dictionary, Chemical", "MN": "V02.310.113", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Chemical Dictionaries as a subject are indexed under the main heading DICTIONARIES, CHEMICAL AS TOPIC.  INDEXER: Do not use", "MS": "A reference book containing a list of words related to chemistry-usually in alphabetic order-giving information about form, pronunciation, etymology, grammar, and meaning.", "HN": "2019", "MR": "20180701", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000077844"}, {"RECTYPE": "D", "MH": "Lipoabdominoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Lipoabdominoplasties", "MN": "E04.617.025.500", "MH_TH": "NLM (2019)", "ST": "T061", "MS": "Aesthetic surgical treatment of the abdominal region using LIPOSUCTION associated with ABDOMINOPLASTY.", "PM": "2019", "HN": "2019", "MR": "20220406", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077845"}, {"RECTYPE": "D", "MH": "Manuscript, Medical", "MN": "V02.630.250", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Medical Manuscripts as a subject are indexed under the main heading  MANUSCRIPTS, MEDICAL AS TOPIC. INDEXER: Do not use. CATALOGER: Do not use.", "MS": "Medical works prepared by hand including handwritten or typescript drafts of pre-publication papers or works not otherwise reproduced in multiple copies.", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000077862"}, {"RECTYPE": "D", "MH": "Homoharringtonine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Synribo|T109|T121|TRD|NRW|NLM (2019)|180427|abbcdef", "MN": "D03.633.400.624.500", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "Cephalotaxine, O3-((2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methyl-1-oxoheptyl)-", "RN": "6FG8041S5B", "RR": "84MI6OYN4Z", "MS": "Semisynthetic derivative of harringtonine that acts as a protein synthesis inhibitor and induces APOPTOSIS in tumor cells. It is used in the treatment of MYELOID LEUKEMIA, CHRONIC.", "PM": "2019; HOMOHARRINGTONINE was indexed under HARRINGTONINES 1978-2018; under ALKALOIDS and ANTINEOPLASTIC AGENTS 1972-1977; and under DIOXOLES 1972-1976", "HN": "2019 (1972)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077863"}, {"RECTYPE": "D", "MH": "Clofarabine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-|T114|T121|NON|EQV|NLM (2020)|190408|abbcdef", "ENTRY": "2 Chloro 2' fluoroarabino 2' deoxyadenosine", "MN": "D13.695.827.068.309", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "762RDY0Y2H", "RR": "123318-82-1 (Clofarabine)", "MS": "An adenine arabinonucleoside derivative that acts as an antineoplastic antimetabolite. It is used in the treatment of ACUTE LYMPHOID LEUKEMIA in pediatric patients who have relapsed.", "PM": "2019; CLOFARABINE was indexed under ADENINE NUCLEOTIDES and ARABINONUCLEOSIDES 1991-2018", "HN": "2019 (1991)", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077866"}, {"RECTYPE": "D", "MH": "Tolcapone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro407592", "MN": "D02.640.743.845", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-", "RN": "CIF6334OLY", "RR": "134308-13-7 (Tolcapone)", "MS": "A benzophenone and nitrophenol compound that acts as an inhibitor of CATECHOL O-METHYLTRANSFERASE, an enzyme involved in the metabolism of DOPAMINE and LEVODOPA. It is used in the treatment of PARKINSON DISEASE in patients for whom levodopa is ineffective or contraindicated.", "PM": "2019; TOLCAPONE was indexed under BENZOPHENONES and NITROPHENOLS 1990-2018", "HN": "2019 (1990)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077867"}, {"RECTYPE": "D", "MH": "Atrasentan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ABT627", "MN": "D03.633.100.115.300", "MH_TH": "NLM (2001)", "ST": "T121", "N1": "3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-, (2R,3R,4S)-", "RN": "V6D7VK2215", "RR": "E4G31X93ZA", "MS": "A pyrrolidine and benzodioxole derivative that acts a RECEPTOR, ENDOTHELIN A antagonist. It has therapeutic potential as an antineoplastic agent and for the treatment of DIABETIC NEPHROPATHIES.", "PM": "2019; ATRASENTAN was indexed under PYRROLIDINES 1996-2018", "HN": "2019 (1996)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077868"}, {"RECTYPE": "D", "MH": "Thiamethoxam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CGA293343", "MN": "D03.383.533.820", "MH_TH": "NLM (2000)", "ST": "T121", "N1": "4H-1,3,5-Oxadiazin-4-imine, 3-((2-chloro-5-thiazolyl)methyl)tetrahydro-5-methyl-N-nitro-", "RN": "747IC8B487", "RR": "153719-23-4 (Thiamethoxam)", "MS": "A nitro-oxazine and thiazole derivative that is used as a broad spectrum neonicotinoid insecticide.", "PM": "2019; THIAMETHOXAM was indexed under NITRO COMPOUNDS, OXAZINES, and THIAZOLES 2000-2018", "HN": "2019 (2000)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077922"}, {"RECTYPE": "D", "MH": "Societies, Veterinary", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Veterinary Hospital Society", "MN": "N03.540.828.919", "MH_TH": "NLM (2019)", "ST": "T094", "MS": "Organizations having institutional membership limited to veterinarians and veterinary institutions.", "PM": "2019", "HN": "2019", "MR": "20180615", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077923"}, {"RECTYPE": "D", "MH": "Palonosetron", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RS25259198", "MN": "D03.633.100.531.629", "MH_TH": "NLM (2000)", "ST": "T121", "N1": "1H-Benz(de)isoquinolin-1-one, 2-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-, (3aS)-", "RN": "5D06587D6R", "RR": "2UCB21ER4V", "MS": "Isoquinoline and quinuclidine derivative that acts as a 5-HT3 RECEPTOR antagonist. It is used in the prevention of nausea and vomiting induced by cytotoxic chemotherapy, and for the prevention of post-operative nausea and vomiting.", "PM": "2019; PALONOSETRON was indexed under ISOQUINOLINES and QUINUCLIDINES 1993-2018", "HN": "2019 (1993)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077924"}, {"RECTYPE": "D", "MH": "Alefacept", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "LFA 3 IgG1 Fusion Protein", "MN": "D12.776.828.300.100", "MH_TH": "USAN (2000)", "ST": "T129", "RN": "ELK3V90G6C", "RR": "222535-22-0 (Alefacept)", "MS": "A recombinant human fusion protein of LFA-3 antigen and immunoglobulin IGG1 that binds to CD2 ANTIGENS on memory T-LYMPHOCYTES, preventing their activation and proliferation. It is used in the management of moderate to severe chronic plaque PSORIASIS.", "PM": "2019; ALEFACEPT was indexed under RECOMBINANT FUSION PROTEINS 2000-2018", "HN": "2019 (2000)", "MR": "20230316", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077944"}, {"RECTYPE": "D", "MH": "Body-Weight Trajectory", "AQ": "EH", "ENTRY": "Weight Trajectories", "MN": "G07.345.249.314.120.200.463", "FX": "Weight Cycling", "MH_TH": "NLM (2019)", "ST": "T081", "MS": "A general pattern of body weight gain or loss over many years. Weight change trajectory is influenced by several determinants in children and adults.", "PM": "2019", "HN": "2019", "MR": "20210707", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077962"}, {"RECTYPE": "D", "MH": "Progression-Free Survival", "PRINT ENTRY": "Event-Free Survival|T081|NON|NRW|NLM (1995)|931216|abcdef", "ENTRY": "Survival, Progression-Free", "MN": "N06.850.520.830.998.825", "FX": "Disease-Free Survival", "MH_TH": "NLM (1995)", "ST": "T081", "PI": "Disease-Free Survival (1995-2018)", "MS": "Length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but the disease does not get worse.", "PM": "2019; see DISEASE-FREE SURVIVAL 1995-2018; for EVENT-FREE SURVIVAL see DISEASE-FREE SURVIVAL 1995-2018", "HN": "2019; use DISEASE-FREE SURVIVAL 1995-2018; for EVENT-FREE SURVIVAL use DISEASE-FREE SURVIVAL 1995-2018", "MR": "20180522", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000077982"}, {"RECTYPE": "D", "MH": "Posttraumatic Growth, Psychological", "AQ": "CL DE ES RE", "ENTRY": "Psychological Posttraumatic Growth", "MN": "F02.647", "MH_TH": "NLM (2019)", "ST": "T041", "PI": "Adaptation, Psychological (2004-2018)", "MS": "Positive change experienced as a result of the struggle with a major life crisis or a traumatic event.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078002"}, {"RECTYPE": "D", "MH": "Change Management", "AQ": "EC", "ENTRY": "Organizational Change Managements", "MN": "N04.452.610.125", "MH_TH": "NLM (2019)", "ST": "T058", "MS": "Processes, tools, and techniques involved in the management of ORGANIZATIONAL INNOVATION, the purpose of which is to help individuals and work groups make successful personal transitions which ensure overall successful outcomes.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078003"}, {"RECTYPE": "D", "MH": "Economic Status", "AQ": "HI SN TD", "MN": "N01.824.098", "MH_TH": "NLM (2019)", "ST": "T081", "PI": "Socioeconomic Factors (1970-2018)", "MS": "Personal or family variables such as household income, assets such as inherited wealth, savings, employment benefits, or ownership of homes or other property.", "PM": "2019", "HN": "2019", "MR": "20180525", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078022"}, {"RECTYPE": "D", "MH": "Leucanthemum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Leucanthemums", "MN": "B01.875.800.575.912.250.100.503", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid99071", "MS": "A genus of flowering plants in the family ASTERACEAE, mainly distributed in southern and central Europe, and on other continents as introduced species. Leucanthemum species include annuals and perennials grown for their daisy flowers, which are usually gleaming white with yellow centers.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078062"}, {"RECTYPE": "D", "MH": "Gestational Weight Gain", "AQ": "DE EH GE IM PH RE", "ENTRY": "Weight Retention, Postpartum", "MN": "G08.686.330", "FX": "Obesity, Maternal", "MH_TH": "NLM (2019)", "ST": "T040", "PI": "Weight Gain (1990-2018)", "MS": "Increase in body weight of the mother during the course of her PREGNANCY.", "PM": "2019", "HN": "2019", "MR": "20190530", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078064"}, {"RECTYPE": "D", "MH": "Aegilops", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.822.017", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid4480", "PI": "Triticum (2001-2018)", "MS": "A genus of grasses known generally as goatgrasses, presumed to be wild ancestors of domestic WHEAT. They belong to the grass family, POACEAE, and are distributed widely in Eurasia and North America.", "PM": "2019", "HN": "2019", "MR": "20210630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078065"}, {"RECTYPE": "D", "MH": "Lumefantrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "9H-Fluorene-4-methanol, 2,7-dichloro-9-((4-chlorophenyl)methylene)-alpha-((dibutylamino)methyl)-, (Z)-|T109|T121|NON|EQV|NLM (2020)|190408|abbcdef", "ENTRY": "Benflumetol, (-)-isomer|T109|T121|NON|NRW|NLM (1996)|180409|abbcdef", "MN": "D04.615.389.650", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "F38R0JR742", "RR": "82186-77-4 (Lumefantrine)", "MS": "A fluorene derivative that is used in combination with ARTEMETHER for the treatment of MALARIA (see ARTEMETHER-LUMEFANTRINE DRUG COMBINATION).", "PM": "2019; use BENFLUMETOL 1996-2000; LUMEFANTRINE was indexed under FLUORENES and ETHANOLAMINES 1996-2018", "HN": "2019 (1996)", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078102"}, {"RECTYPE": "D", "MH": "Eucalyptus Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Eucalyptus globulus Oil|T109|T123|NON|NRW|NLM (2019)|180214|abbcdef", "MN": "D20.215.784.750.033", "FX": "Eucalyptol", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "2R04ONI662", "MS": "An oily liquid that is extracted from the leaves of EUCALYPTUS trees.", "PM": "2019", "HN": "2019", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078122"}, {"RECTYPE": "D", "MH": "Tazobactam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "YTR830", "MN": "D03.633.100.300.750.687.750", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2S,3S,5R)-", "RN": "SE10G96M8W", "RR": "UXA545ABTT", "MS": "A penicillanic acid and sulfone derivative and potent BETA-LACTAMASE inhibitor that enhances the activity of other anti-bacterial agents against beta-lactamase producing bacteria.", "PM": "2019; TAZOBACTAM was indexed under PENICILLANIC ACIDS 1985-1993; and under PENICILLANIC ACIDS/analogs & derivatives 1994-2018", "HN": "2019 (1985)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078142"}, {"RECTYPE": "D", "MH": "Tobramycin, Dexamethasone Drug Combination", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tobramycin Dexamethasone Drug Combination", "MN": "D26.310.813", "MH_TH": "NLM (2019)", "ST": "T121", "RN": "0", "MS": "A topical preparation of tobramycin and dexamethasone that is used for treating or preventing superficial bacterial infections of the eye.", "PM": "2019", "HN": "2019", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078162"}, {"RECTYPE": "D", "MH": "Systematic Review", "PRINT ENTRY": "Umbrella Review|T170|NON|NRW|NLM (2024)|221230|abcdef", "ENTRY": "Review, Systematic|T170|NON|EQV|NLM (2019)|180413|abcdef", "MN": "V03.850", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Systematic reviews as a subject are indexed under the main heading SYSTEMATIC REVIEWS AS TOPIC", "MS": "A review of primary literature in health and health policy that attempts to identify, appraise, and synthesize all the empirical evidence that meets specified eligibility criteria to answer a given research question.  Its conduct uses explicit methods aimed at minimizing bias in order to produce more reliable findings regarding the effects of interventions for prevention, treatment, and rehabilitation that can be used to inform decision making.", "HN": "2019", "MR": "20230615", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000078182"}, {"RECTYPE": "D", "MH": "Oxindoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxindole Derivative|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Oxindoles, Macroline-Type", "MN": "D03.633.100.496.500.500.511", "MH_TH": "NLM (2019)", "ST": "T109", "RN": "0", "PI": "Indole Alkaloids (1963-2018)", "MS": "Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl and a carbonyl at the pyrrole ring typically at the 2-position.", "PM": "2019", "HN": "2019", "MR": "20200527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078183"}, {"RECTYPE": "D", "MH": "Systematic Reviews as Topic", "AQ": "MT ST", "PRINT ENTRY": "Umbrella Reviews as Topic|T170|NON|NRW|NLM (2024)|221230|abcdef", "ENTRY": "Reviews Systematic as Topic|T170|NON|EQV|NLM (2019)|180413|abcdef", "MN": "L01.462.500.682.759.575", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "do not confuse with the Publication Type SYSTEMATIC REVIEW  ", "MS": "Works about a review of primary literature in health and health policy that attempt to identify, appraise, and synthesize all the empirical evidence that meets specified eligibility criteria to answer a given research question. It's conducted using explicit methods aimed at minimizing bias in order to produce more reliable findings regarding the effects of interventions for prevention, treatment, and rehabilitation that can be used to inform decision making.", "PM": "2019", "HN": "2019", "MR": "20230615", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078202"}, {"RECTYPE": "D", "MH": "Tinzaparin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "3-phenyl- 2-Propenoic acid", "MN": "D09.698.373.400.300.800", "MH_TH": "USAN (1993)", "ST": "T121", "RN": "7UQ7X4Y489", "RR": "3S182ET3UA", "MS": "A low-molecular-weight heparin with anticoagulant properties that is used in the prevention and treatment of VENOUS THROMBOEMBOLISM, and to prevent clotting during EXTRACORPOREAL CIRCULATION.", "PM": "2019; TINZAPARIN was indexed under HEPARIN, LOW-MOLECULAR-WEIGHT 1993-2018", "HN": "2019 (1993)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078222"}, {"RECTYPE": "D", "MH": "5-Methoxypsoralen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "5 Methoxypsoralen", "MN": "D03.633.300.770.688", "MH_TH": "NLM (1980)", "ST": "T121", "RN": "4FVK84C92X", "RR": "484-20-8 (5-Methoxypsoralen)", "MS": "A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.", "PM": "2019; 5-METHOXYPSORALEN was indexed under METHOXSALEN/analogs & derivatives 1992-2018; and under METHOXSALEN 1980-1991", "HN": "2019 (1980)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078223"}, {"RECTYPE": "D", "MH": "Lenograstim", "AQ": "AA AD AE AN BI CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Lenograstim, Component 2|T116|T123|NON|NRW|NLM (1993)|180413|abbcdef", "MN": "D23.529.374.410.240.350.750", "MH_TH": "USAN (1992)", "ST": "T129", "RN": "6WS4C399GB", "RR": "130120-55-7 (Component 1)", "MS": "A recombinant granulocyte colony-stimulating factor that is used to treat or prevent NEUTROPENIA in patients receiving myelosuppressive cancer chemotherapy, for the preparation and collection of blood progenitor cells in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; and in the treatment of severe congenital neutropenia. Component 1 and Component 2 differ by absence or presence of Neu5Ac in 2-6 linkage to GalNAc side chain.", "PM": "2019; LENOGRASTIM was indexed under GRANULOCYTE COLONY-STIMULATING FACTOR and RECOMBINANT PROTEINS 1993-2018", "HN": "2019 (1993)", "MR": "20230316", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078224"}, {"RECTYPE": "D", "MH": "Rifaximin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "L105", "MN": "D04.345.295.750.850", "MH_TH": "USAN (19XX)", "ST": "T195", "N1": "2,7-(Epoxy(1,11,13)pentadecatrienoimino)furo(2'',3'':7',8')naphth(1',2':4,5)imidazo(1,2-a)pyridine-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, ( 2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-", "RN": "L36O5T016N", "MS": "A synthetic rifamycin derivative and anti-bacterial agent that is used for the treatment of GASTROENTERITIS caused by ESCHERICHIA COLI INFECTIONS. It may also be used in the treatment of HEPATIC ENCEPHALOPATHY.", "PM": "2019; RIFAXIMIN was indexed under RIFAMYCINS 1983-2018", "HN": "2019 (1983)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078262"}, {"RECTYPE": "D", "MH": "Data Aggregation", "ENTRY": "Aggregation, Data", "MN": "L01.399.250.213", "MH_TH": "NLM (1986)", "ST": "T066", "MS": "Process of searching, gathering, and presenting data in a summarized format.", "PM": "2019", "HN": "2019", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078303"}, {"RECTYPE": "D", "MH": "Tigecycline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "GAR936", "MN": "D04.615.562.900.937", "MH_TH": "USAN (19XX)", "ST": "T195", "N1": "2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((2-((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-", "RN": "70JE2N95KR", "MS": "A tetracycline derivative that acts as a protein synthesis inhibitor. It is used as an antibacterial agent for the systemic treatment of complicated skin and intra-abdominal infections. It is also used for the treatment of community-acquired pneumonia.", "PM": "2019; TIGECYCLINE was indexed under MINOCYCLINE/analogs & derivatives 1999-2018", "HN": "2019 (1999)", "MR": "20180619", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078304"}, {"RECTYPE": "D", "MH": "Zonisamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CI912", "MN": "D03.383.129.385.825", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1,2-Benzisoxazole-3-methanesulfonamide", "RN": "459384H98V", "RR": "68291-98-5 (mono-Na salt)", "MS": "A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.", "PM": "2019; ZONISAMIDE was indexed under ISOXAZOLES 1980-2018", "HN": "2019 (1980)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078305"}, {"RECTYPE": "D", "MH": "Clobazam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "LM2717", "MN": "D03.633.100.079.080.165", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 7-chloro-1-methyl-5-phenyl-", "RN": "2MRO291B4U", "RR": "22316-47-8 (Clobazam)", "MS": "A benzodiazepine derivative that is a long-acting GABA-A RECEPTOR agonist. It is used as an antiepileptic in the treatment of SEIZURES, including seizures associated with LENNOX-GASTAUT SYNDROME.  It is also used as an anxiolytic, for the short-term treatment of acute ANXIETY.", "PM": "2019; CLOBAZAM was indexed under BENZODIAZEPINES 1976-2018", "HN": "2019 (1976)", "MR": "20190429", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078306"}, {"RECTYPE": "D", "MH": "Tiagabine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tiagabine, (S)-isomer|T109|T121|NON|NRW|NLM (1989)|180417|abbcdef", "MN": "D03.383.621.566.500", "MH_TH": "NLM (1989)", "ST": "T121", "N1": "3-Piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl)-, (3R)-", "RN": "Z80I64HMNP", "RR": "DQH6T6D8OY", "MS": "A nipecotic acid derivative that acts as a GABA uptake inhibitor and anticonvulsant agent. It is used in the treatment of EPILEPSY, for refractory PARTIAL SEIZURES.", "PM": "2019; TIAGABINE was indexed under NIPECOTIC ACIDS 1989-2018", "HN": "2019 (1989)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078308"}, {"RECTYPE": "D", "MH": "Observational Study, Veterinary", "PRINT ENTRY": "Naturalistic Observation Study, Veterinary|T170|NON|REL|NLM (2024)|230419|abcdef", "MN": "V03.175.750", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific veterinary observational study; a different heading OBSERVATIONAL STUDIES, VETERINARY AS TOPIC is used for general design, methodology, economics, etc. of veterinary observational studies", "PI": "Observational Study (2013-2018)", "MS": "Reports on studies of the results of a clinical study in which animal subjects may receive diagnostic, therapeutic, or other types of interventions, where the investigator does not assign participants to specific interventions.", "HN": "2019", "MR": "20230531", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000078323"}, {"RECTYPE": "D", "MH": "Clinical Trial Protocol", "PRINT ENTRY": "Trial Protocol|T170|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Trial Protocols|T170|NON|EQV|NLM (2017)|151229|abcdef", "MN": "V03.175.313", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of the clinical trial protocol; a different heading CLINICAL TRIAL PROTOCOLS AS TOPIC is used for general design, methodology, economics, etc. of clinical trial protocols; do not confuse with CLINICAL PROTOCOLS; coordinate with the specific Clinical Trials as Topic term if pertinent", "MS": "The written description of a clinical study. It contains the study's objectives, design, and methods including subject target and/or enrollment criteria. It may also present relevant scientific background and statistical information.", "HN": "2019", "MR": "20200527", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000078325"}, {"RECTYPE": "D", "MH": "Data Visualization", "ENTRY": "Visualization, Data", "MN": "L01.143.288", "MH_TH": "NLM (2019)", "ST": "T068", "MS": "Facilitating understanding of the significance of data by placing it in a visual context. Patterns, trends and correlations that might go undetected in text-based data may be exposed and recognized easier.", "PM": "2019", "HN": "2019", "MR": "20180527", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078326"}, {"RECTYPE": "D", "MH": "Data Systems", "ENTRY": "Systems, Data", "MN": "L01.224.068.500", "MH_TH": "UNK (19XX)", "ST": "T170", "MS": "Organized collection of symbols and symbol-manipulating processes used to operate on such symbols.", "PM": "2019", "HN": "2019", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078327"}, {"RECTYPE": "D", "MH": "Felbamate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "W554", "MN": "D02.241.081.251.583.366", "MH_TH": "USAN (1992)", "ST": "T121", "N1": "1,3-Propanediol, 2-phenyl-, dicarbamate", "RN": "X72RBB02N8", "RR": "25451-15-4 (Felbamate)", "MS": "A PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA RECEPTORS. It is used as an anticonvulsant, primarily for the treatment of SEIZURES in severe refractory EPILEPSY.", "PM": "2019; FELBAMATE was indexed under PROPYLENE GLYCOLS and PHENYLCARBAMATES 1986-2018", "HN": "2019 (1986)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078328"}, {"RECTYPE": "D", "MH": "Workforce", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Workforces", "MN": "N04.452.525", "MH_TH": "NLM (2019)", "ST": "T057", "AN": " coordinate with specific discipline, occupation, service or program if pertinent; HEALTH WORKFORCE is also available", "MS": "The number of people working or available for work or service.", "PM": "2019(1968)", "HN": "2019(1968)", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078329"}, {"RECTYPE": "D", "MH": "Oxcarbazepine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trileptal|T109|T121|TRD|NRW|AU|CA|DE|ES|FR|IE|MX|NL|UK|US|010910|abbcdeeeeeeeeeef", "MN": "D03.633.300.240.127.500", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "5H-Dibenz(b,f)azepine-5-carboxamide, 10,11-dihydro-10-oxo-", "RN": "VZI5B1W380", "RR": "28721-07-5 (Oxcarbazepine)", "MS": "A carbamazepine derivative that acts as a voltage-gated sodium channel blocker. It is used for the treatment of PARTIAL SEIZURES with or without secondary generalization. It is also an inducer of CYTOCHROME P-450 CYP3A4.", "PM": "2019; OXCARBAZEPINE was indexed under CARBAMAZEPINE/analogs & derivatives 1982-2018", "HN": "2019 (1982)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078330"}, {"RECTYPE": "D", "MH": "Correlation of Data", "ENTRY": "Study, Correlation", "MN": "H01.548.832.500", "MH_TH": "NLM (1978)", "ST": "T081", "MS": "Determination of whether or not two variables are correlated. This means to study whether an increase or decrease in one variable corresponds to an increase or decrease in the other variable.", "PM": "2019; use Statistics as Topic 1978-2018", "HN": "2019(1979)", "MR": "20210330", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078331"}, {"RECTYPE": "D", "MH": "Data Analysis", "ENTRY": "Data Analyses", "MN": "H01.548.338", "MH_TH": "NLM (1978)", "ST": "T062", "MS": "Process of systematically applying statistical and/or logical techniques to describe and illustrate, condense and recap, and evaluate data (https://ori.hhs.gov/education).", "PM": "2019", "HN": "2019", "MR": "20180803", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078332"}, {"RECTYPE": "D", "MH": "Lacosamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "N benzyl AcMeOPrNH2", "MN": "D02.241.081.018.110.432", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)-", "RN": "563KS2PQY5", "MS": "An acetamide derivative that acts as a blocker of VOLTAGE-GATED SODIUM CHANNELS. It is used as an anticonvulsant, for adjunctive or monotherapy, in the treatment of PARTIAL SEIZURES.", "PM": "2019; LACOSAMIDE was indexed under ACETAMIDES 2000-2019", "HN": "2019 (2000)", "MR": "20180521", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078334"}, {"RECTYPE": "D", "MH": "Facilities and Services Utilization", "AQ": "EC HI LJ OG SN ST TD", "ENTRY": "Services Utilizations", "MN": "N06.850.520.830.375", "MH_TH": "NLM (2019)", "ST": "T057", "MS": "Extent of use of facilities or services. It includes overuse and underuse.", "PM": "2019", "HN": "2019", "MR": "20180614", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078336"}, {"RECTYPE": "D", "MH": "Procedures and Techniques Utilization", "AQ": "EC HI LJ OG SN ST TD", "ENTRY": "Utilizations, Technique", "MN": "N06.850.520.830.675", "MH_TH": "NLM (2019)", "ST": "T081", "MS": "Extent of use of procedures or techniques. It includes overuse and underuse.", "PM": "2019", "HN": "2019", "MR": "20180614", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078337"}, {"RECTYPE": "D", "MH": "Equipment and Supplies Utilization", "AQ": "EC HI LJ OG SN ST TD", "ENTRY": "Supplies Utilizations", "MN": "N05.715.360.750.338", "MH_TH": "NLM (2019)", "ST": "T081", "MS": "Extent of use of equipment or supplies. It includes overuse and underuse.", "PM": "2019", "HN": "2019", "MR": "20180614", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078338"}, {"RECTYPE": "D", "MH": "Disgust", "ENTRY": "Revulsion|T041|NON|REL|NLM (2019)|180430|abcdef", "MN": "F01.470.307", "MH_TH": "NLM (2019)", "ST": "T041", "PI": "Fear (1976-2018)", "MS": "A feeling of revulsion or strong disapproval aroused by something unpleasant or offensive.", "PM": "2019", "HN": "2019", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078382"}, {"RECTYPE": "D", "MH": "Conscientious Refusal to Treat", "AQ": "ES LJ SN", "ENTRY": "Refusal to Treat, Conscientious|T058|NON|EQV|NLM (2019)|180430|abcdef", "MN": "N05.300.100.675.500", "MH_TH": "NLM (2019)", "ST": "T058", "PI": "Refusal to Treat (1992-2018)", "MS": "Refusal of health professionals to provide medical services on the basis of moral or religious beliefs.", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078383"}, {"RECTYPE": "D", "MH": "Embarrassment", "MN": "F01.470.483.666.500", "MH_TH": "NLM (2019)", "ST": "T041", "PI": "Guilt (1979-2018)", "MS": "A feeling of self-consciousness, shame, or awkwardness.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078385"}, {"RECTYPE": "D", "MH": "Gun Violence", "AQ": "CL EC EH HI LJ PC PX SN TD", "ENTRY": "Violence, Gun", "MN": "I01.880.735.900.632", "MH_TH": "NLM (2019)", "ST": "T068", "MS": "Violence using any type of firearm.", "PM": "2019", "HN": "2019", "MR": "20230531", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078402"}, {"RECTYPE": "D", "MH": "Epidermal Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Epidermic Cell", "MN": "A11.409", "MH_TH": "NLM (2019)", "ST": "T025", "AN": "for epidermal cells of plants use PLANT EPIDERMIS /cytol", "PI": "Epidermis (1963-2018)", "MS": "Cells from the outermost, non-vascular layer (EPIDERMIS) of the skin.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078404"}, {"RECTYPE": "D", "MH": "Non-Smokers", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Nonsmoker", "MN": "M01.482", "FX": "Smokers", "MH_TH": "NLM (2019)", "ST": "T098", "MS": "Persons without a history of SMOKING.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078405"}, {"RECTYPE": "D", "MH": "Allogeneic Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE UL VI", "ENTRY": "Homologous Cell", "MN": "A11.047", "EC": "transplantation:Transplantation, Homologous", "MH_TH": "NLM (2019)", "ST": "T025", "MS": "Cells from genetically different individuals of the same species to be used for CELL- AND TISSUE-BASED THERAPY; ADOPTIVE CELL TRANSFER; or ADOPTIVE IMMUNOTHERAPY.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078422"}, {"RECTYPE": "D", "MH": "Therapeutic Alliance", "ENTRY": "Therapeutic Alliances", "MN": "F04.754.932", "MH_TH": "NLM (2019)", "ST": "T058", "MS": "A relational factor in counseling that includes three dimensions: goal consensus between counselor and client, collaboration on counseling-related tasks, and emotional bonding.  It is referred to as the working alliance between a therapist and a client in psychotherapy and closely correlated with positive client outcomes.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078462"}, {"RECTYPE": "D", "MH": "Child Labor", "AQ": "ES HI LJ SN", "MN": "N01.824.245.263", "MH_TH": "POPLINE (1978)", "ST": "T057", "MS": "Employment of MINORS in work that deprives children of their childhood, potential, dignity, and is harmful to their physical and mental development. (International Labor Organization, UN)", "PM": "2019; use Employment 1979-2018", "HN": "2019; see Employment 1979-2018", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078463"}, {"RECTYPE": "D", "MH": "Prior Authorization", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Prior Authorizations", "MN": "N03.219.521.576.343.944", "MH_TH": "NLM (2019)", "ST": "T078", "PI": "Reimbursement Mechanisms (1981-2018)", "MS": "A decision by a health insurer or plan that a health care service, treatment plan, prescription drug or durable medical equipment is medically necessary.", "PM": "2019", "HN": "2019", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078482"}, {"RECTYPE": "D", "MH": "Regenerative Endodontics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Regenerative Endodontic", "MN": "H02.163.876.213.500", "FX": "Regenerative Medicine", "MH_TH": "NLM (2019)", "ST": "T091", "PI": "Endodontics (2007-2018)", "MS": "A dental specialty concerned with biologically-based procedures designed to physiologically replace damaged tooth structures, including dentin and root structures, as well as cells of the pulp-dentin complex.", "PM": "2019", "HN": "2019", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078483"}, {"RECTYPE": "D", "MH": "Meat Proteins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Meat Protein|T116|NON|EQV|NLM (2019)|180507|abcdef", "MN": "J02.500.600.625", "MH_TH": "NLM (2019)", "ST": "T116", "RN": "0", "PI": "Dietary Proteins (1965-2018)", "MS": "Dietary proteins from MEAT.", "PM": "2019", "HN": "2019", "MR": "20190708", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078502"}, {"RECTYPE": "D", "MH": "Poultry Proteins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Poultry Protein", "MN": "J02.500.600.750.750", "MH_TH": "NLM (2019)", "ST": "T116", "RN": "0", "PI": "Poultry (1999-2018)", "MS": "Dietary proteins from POULTRY.", "PM": "2019", "HN": "2019", "MR": "20190708", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078503"}, {"RECTYPE": "D", "MH": "Fish Proteins, Dietary", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Proteins, Dietary Fish", "MN": "J02.500.600.875.550", "MH_TH": "NLM (2019)", "ST": "T116", "RN": "0", "PI": "Fish Proteins (2002-2018)", "MS": "Dietary protein from FISH.", "PM": "2019", "HN": "2019", "MR": "20190708", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078504"}, {"RECTYPE": "D", "MH": "Grain Proteins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Grain Protein|T116|NON|EQV|NLM (2019)|180508|abcdef", "MN": "J02.500.428.920.250", "MH_TH": "NLM (2019)", "ST": "T116", "RN": "0", "PI": "Plant Proteins (1977-2018)", "MS": "Dietary protein from EDIBLE GRAINS.", "PM": "2019", "HN": "2019", "MR": "20190322", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078522"}, {"RECTYPE": "D", "MH": "Proctectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Resections, Abdominoperineal", "MN": "E04.210.895", "MH_TH": "NLM (2019)", "ST": "T061", "PI": "Rectum/surgery (1968-2018)", "MS": "Surgical resection of the RECTUM.", "PM": "2019", "HN": "2019", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078542"}, {"RECTYPE": "D", "MH": "Fruit Proteins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Proteins, Fruit", "MN": "J02.500.428.920.125", "MH_TH": "NLM (2019)", "ST": "T116", "RN": "0", "PI": "Plant Proteins (1965-2018)", "MS": "Proteins found in FRUIT.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078562"}, {"RECTYPE": "D", "MH": "Nut Proteins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Proteins, Nut", "MN": "J02.500.428.920.375", "MH_TH": "NLM (2019)", "ST": "T116", "RN": "0", "PI": "Plant Proteins (1986-2018)", "MS": "Proteins from NUTS.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078563"}, {"RECTYPE": "D", "MH": "Shellfish Proteins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Shellfish Protein", "MN": "J02.500.600.875.700.500", "MH_TH": "NLM (2019)", "ST": "T116", "RN": "0", "PI": "Shellfish (1965-2018)", "MS": "Proteins found in SHELLFISH.", "PM": "2019", "HN": "2019", "MR": "20190708", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078582"}, {"RECTYPE": "D", "MH": "Sadness", "AQ": "CL DE ES PH PX RE", "ENTRY": "Unhappiness|T041|T048|NON|EQV|NLM (2019)|180514|abbcdef", "MN": "F01.470.933", "MH_TH": "NLM (2019)", "ST": "T048", "MS": "Feeling or showing sorrow; the sense of being unhappy. It is related to DEPRESSION but is not synonymous.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078602"}, {"RECTYPE": "D", "MH": "Secretagogues", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Secretogogues|T120|NON|EQV|NLM (2019)|180514|abcdef", "MN": "D27.505.696.937", "MH_TH": "NLM (2019)", "ST": "T120", "RN": "0", "MS": "Substances that stimulate the secretion of another substance.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078604"}, {"RECTYPE": "D", "MH": "Nutrients", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Nutrient", "MN": "J02.500.681", "MH_TH": "NLM (2007)", "ST": "T123", "PI": "Food (1963-2018)", "MS": "Various components of food that are required for nourishment.", "PM": "2019; see FOOD 2007-2018", "HN": "2019; use FOOD 2007-2018", "MR": "20190705", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078622"}, {"RECTYPE": "D", "MH": "Wool Fiber", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Woolen Fibers", "MN": "J01.637.836.649", "FX": "Wool", "MH_TH": "NLM (2019)", "ST": "T073", "AN": "WOOL is also available", "PI": "Wool (1963-2018)", "MS": "Filament, thread, or yarn produced from WOOL.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078623"}, {"RECTYPE": "D", "MH": "Euthanasia, Involuntary", "AQ": "ES HI LJ MT", "ENTRY": "Involuntary Euthanasia|T052|NON|EQV|BIOETHICS (1974)|770329|abcdef", "MN": "I01.198.240.250", "MH_TH": "UNK (19XX)", "ST": "T052", "AN": "Nazi Euthanasia Program goes here; coordinate with NATIONAL SOCIALISM", "MS": "The act or practice of killing or withholding life-sustaining treatment from a person with a medical condition, especially DISABLED PERSONS, without INFORMED CONSENT, despite the MENTAL COMPETENCY of the person to give consent.", "PM": "2019: see EUTHANASIA 1977-2018", "HN": "2019: use EUTHANASIA 1977-2018", "MR": "20220712", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078625"}, {"RECTYPE": "D", "MH": "Medical Countermeasures", "ENTRY": "Medical Countermeasure", "MN": "N06.850.780.588", "MH_TH": "NLM (2019)", "ST": "T061", "MS": "Regulated products (biologics, drugs, devices) that may be used in the event of a potential public health emergency stemming from a terrorist attack with a biological, chemical, or radiological/nuclear material, or a naturally occurring emerging disease.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078642"}, {"RECTYPE": "D", "MH": "Diaries as Topic", "ENTRY": "Diary as Topics", "MN": "K01.517.211.361", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "do not confuse with the Publication Type DIARY", "MS": "Works on or about records, usually private, of writers' experiences, observations, feelings, attitudes, etc. They may also be works marked in calendar order in which to note appointments and the like.", "PM": "2020; see DIARY AS TOPIC 2019", "HN": "2020(2019)", "MR": "20190501", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078646"}, {"RECTYPE": "D", "MH": "Collections as Topic", "ENTRY": "Collections as Topics", "MN": "L01.470.375", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "do not confuse with the Publication Type COLLECTION ", "MS": "Works about items gathered and assembled in some order to facilitate access or use.", "PM": "2019", "HN": "2019", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078662"}, {"RECTYPE": "D", "MH": "Egocentrism", "PRINT ENTRY": "Egocentricity|T041|NON|BRD|NLM (2021)|OBSSR (2021)|200515|abcdeef", "MN": "F01.752.747.792.379", "MH_TH": "NLM (2019)", "ST": "T041", "AN": "EGO is also available", "PI": "Self Concept (1972-2018)", "MS": "Self-centered preoccupation or concern regarding one's own needs, abilities, wishes, desires, or preferences.", "PM": "2019", "HN": "2019", "MR": "20210512", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078663"}, {"RECTYPE": "D", "MH": "Clinical Trials, Veterinary as Topic", "ENTRY": "Clinical Trials Veterinary as Topic|T061|T062|T170|NON|EQV|NLM (2019)|180529|abbbcdef", "MN": "N06.850.520.450.250.375", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "for general design, methodology, economics, etc. of veterinary clinical trials; a different heading CLINICAL TRIAL, VETERINARY is used for reports of a specific veterinary clinical trial ", "PI": "Clinical Trial (1996-2018)", "MS": "Works about clinical studies in which animal participants are assigned to receive one or more interventions so that researchers can evaluate the interventions on biomedical or health-related outcomes. The assignments are determined by the study protocol. Animal participants may receive diagnostic, therapeutic, or other types of interventions.", "PM": "2019", "HN": "2019", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078665"}, {"RECTYPE": "D", "MH": "Respect", "ENTRY": "Respect, Personal", "MN": "F01.100.907", "MH_TH": "NLM (2019)", "ST": "T055", "MS": "A feeling of deep admiration for someone or something elicited by their abilities, qualities, or achievements and regard for the feelings, wishes, or rights of others.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078682"}, {"RECTYPE": "D", "MH": "Radiofrequency Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Radiofrequency", "MN": "E02.808", "MH_TH": "NLM (2019)", "ST": "T061", "MS": "The use of RADIO WAVES to conduct therapeutic procedures. The specific frequency, dosage, and intensity used vary depending on the desired effects which include heating, electrical stimulation, or ablation of tissues.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078702"}, {"RECTYPE": "D", "MH": "Radiofrequency Ablation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Ablation, Radiofrequency", "MN": "E04.014.760", "MH_TH": "NLM (2019)", "ST": "T061", "PI": "Catheter Ablation (1991-2018)", "MS": "Removal of tissue using heat generated from electrodes delivering an alternating electrical current in the frequency of RADIO WAVES.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078703"}, {"RECTYPE": "D", "MH": "Quantitative Light-Induced Fluorescence", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Quantitative Light Induced Fluorescence", "MN": "E06.342.626", "MH_TH": "NLM (2019)", "ST": "T060", "PI": "Fluorescence (2000-2018)", "MS": "A FLUORESCENCE technique used in DENTISTRY for the analysis of mineral changes in DENTAL ENAMEL to detect early DENTAL CARIES, or for the evaluation other normal or pathological processes or lesions of the dental enamel.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078704"}, {"RECTYPE": "D", "MH": "PC-3 Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "PC-3 Cell", "MN": "A11.436.714", "MH_TH": "NLM (2019)", "ST": "T025", "AN": "almost always NIM with no subheadings; check HUMAN; do not routinely add  PROSTATIC NEOPLASMS or ADENOCARCINOMA", "PI": "Prostatic Neoplasms (1991-2018)", "MS": "An epithelial cell line initiated from a human bone metastasis of a grade IV prostatic ADENOCARCINOMA.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078722"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Interacting Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor Interacting Protein, 140 kDa|T116|T123|NON|EQV|NLM (1995)|180529|abbcdef", "MN": "D12.776.660.688", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A nuclear protein, characterized by multiple LXXLL motifs, that modulates activation of gene transcription by STEROID RECEPTORS, and transcriptional repression by NUCLEAR HORMONE RECEPTORS. It positively regulates gene expression of CIRCADIAN CLOCK PROTEINS AND PEPTIDES, including ARNTL TRANSCRIPTION FACTORS and CRYPTOCHROMES.", "PM": "2019; NUCLEAR RECEPTOR INTERACTING PROTEIN 1 was indexed under NUCLEAR PROTEINS and ADAPTOR PROTEINS, SIGNAL TRANSDUCING 1995-2018", "HN": "2019 (1995)", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078723"}, {"RECTYPE": "D", "MH": "Pea Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pea Protein", "MN": "J02.500.428.920.500", "MH_TH": "NLM (2019)", "ST": "T168", "RN": "0", "PI": "Plant Proteins, Dietary (1986-2018)", "MS": "Dietary proteins that are present in or isolated from the seeds of PISUM SATIVUM.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078724"}, {"RECTYPE": "D", "MH": "Substandard Drugs", "AQ": "AD AE AN BL CF CH CL CS EC HI IP ME PD PK PO RE SD TO TU UR", "PRINT ENTRY": "Substandard Medicine|T121|NON|EQV|NLM (2021)|200623|abcdef", "ENTRY": "Medicines, Substandard", "MN": "D26.894", "MH_TH": "NLM (2019)", "ST": "T121", "RN": "0", "MS": "Drugs formulations that do not meet established standards.", "PM": "2019", "HN": "2019", "MR": "20200625", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078742"}, {"RECTYPE": "D", "MH": "Forms as Topic", "MN": "L01.399.250.372", "MH_TH": "NLM (2008)", "ST": "T073", "AN": "do not confuse with the Publication Type FORM", "MS": "Works about documents used for acquiring particular information or for presenting particular information in a prescribed sequence and format, often with blank spaces or lines or other methods to prompt for insertion of the requested information.", "PM": "2019; see Records as Topic 2008-2018", "HN": "2019; use  Records as Topic 2008-2018", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078763"}, {"RECTYPE": "D", "MH": "Milnacipran", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "F2207", "MN": "D02.455.426.392.368.533.725", "MH_TH": "NLM (1986)", "ST": "T121", "N1": "Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, cis-(+-)-", "RN": "G56VK1HF36", "RR": "RNZ43O5WW5", "MS": "A cyclopropanecarboxamide serotonin and norepinephrine reuptake inhibitor (SNRI) that is used in the treatment of FIBROMYALGIA.", "PM": "2019; MILNACIPRAN was indexed under CYCLOPROPANES 1986-2018", "HN": "2019 (1986)", "MR": "20180703", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078764"}, {"RECTYPE": "D", "MH": "Vaccinology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.894", "MH_TH": "NLM (2019)", "ST": "T091", "PI": "Vaccines (1994-2018)", "MS": "Branch of medicine concerned with the development of vaccines to control disease by identifying genetic and other mechanisms and pathways that determine immune responses, and thereby provide new candidate vaccine approaches.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078782"}, {"RECTYPE": "D", "MH": "Standing Position", "ENTRY": "Standing Positions", "MN": "G11.427.695.600", "MH_TH": "OBSSR (2016)", "ST": "T042", "MS": "Human position in which the body is held in an upright orthostatic position and supported only by the feet.", "PM": "2019", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078783"}, {"RECTYPE": "D", "MH": "Vortioxetine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vortioxetine Hydrobromide|T109|T121|NON|NRW|FDA SRS (2013)|NLM (2013)|USAN (19XX)|180531|abbcdeeef", "MN": "D03.383.606.990", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "3O2K1S3WQV", "RR": "TKS641KOAY", "MS": "A piperazine derivative that acts as a serotonin reuptake inhibitor, as a 5-HT3 receptor antagonist, and 5-HT1A receptor agonist. It is used for the treatment of anxiety and depression.", "PM": "2019; VORTIOXETINE was indexed under PIPERAZINES and SULFIDES 2011-2018", "HN": "2019 (2011)", "MR": "20220718", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078784"}, {"RECTYPE": "D", "MH": "Mirtazapine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ORG3770", "MN": "D03.633.300.240.588", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "A051Q2099Q", "RR": "4685R51V7M", "MS": "A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.", "PM": "2019; MIRTAZAPINE was indexed under MIANSERIN/analogs & derivatives 1982-2018", "HN": "2019 (1982)", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078785"}, {"RECTYPE": "D", "MH": "Neuroglobin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.631.635", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "MS": "A vertebrate globin that is expressed predominantly in the brain where it is involved in oxygen transport. It protects neurons from APOPTOSIS during OXIDATIVE STRESS.", "PM": "2019; NEUROGLOBIN was indexed under GLOBINS and NERVE TISSUE PROTEINS 2000-2018", "HN": "2019 (2000)", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078787"}, {"RECTYPE": "D", "MH": "Polyacetylene Polymer", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alkene Polyacetylene|T109|T122|NON|EQV|NLM (2024)|230308|abbcdef", "ENTRY": "Polyacetylenes, Alkene", "MN": "J01.637.051.720.719", "MH_TH": "NLM (2019)", "ST": "T122", "RN": "0", "MS": "A conducting polyene polymer that consists of alternating single and double bonds. This ALKENE is formed by the oxidative polymerization of ACETYLENE (an ALKYNE).", "PM": "2019; see POLYACETYLENES 2007-2018", "HN": "2019; use POLYACETYLENES 2007-2018", "MR": "20230526", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078789"}, {"RECTYPE": "D", "MH": "Insulin Secretion", "AQ": "DE GE IM PH RE", "ENTRY": "Secretion, Insulin", "MN": "G07.475", "MH_TH": "NLM (2019)", "ST": "T042", "PI": "Insulin/secretion (1966-2018)", "MS": "Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels.", "PM": "2019", "HN": "2019", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078790"}, {"RECTYPE": "D", "MH": "Tandem Affinity Purification", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Tandem Affinity Chromatographies", "MN": "E05.196.181.400.170.750", "MH_TH": "NLM (2019)", "ST": "T059", "PI": "Chromatography, Affinity (2002-2018)", "MS": "A technique used to isolate specific interacting partners of MACROMOLECULAR COMPLEXES that have been assembled with a tagged component (bait) that interacts with other partners in the complex. The interacting bait component is labeled with a dual-affinity tag that allows for capture of the complex by IMMUNOPRECIPITATION, followed by purification of only the partners of the complex interacting with the bait by affinity chromatography.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078791"}, {"RECTYPE": "D", "MH": "Midkine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Amphiregulin Associated Protein", "MN": "D23.529.831", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "137497-38-2", "MS": "A developmentally regulated, HEPARIN-binding secreted growth factor homologous to pleiotrophin (PTN). It regulates cell proliferation through its interaction with ANAPLASTIC LYMPHOMA KINASE (ALK) and is involved in the formation of NEOINTIMA following arterial injury.", "PM": "2019; MIDKINE was indexed under CYTOKINES 2005-2018; and under CARRIER PROTEINS 1991-2004", "HN": "2019 (1991)", "MR": "20180619", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078792"}, {"RECTYPE": "D", "MH": "Ex-Smokers", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Exsmoker", "MN": "M01.219", "FX": "Smokers", "MH_TH": "NLM (2019)", "ST": "T098", "PI": "Smoking (1964-2018)", "MS": "Persons who do not smoke but that have a history of SMOKING.", "PM": "2019", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078822"}, {"RECTYPE": "D", "MH": "Cytoglobin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Histoglobin|T116|T123|NON|EQV|NLM (2001)|180612|abbcdef", "MN": "D12.776.422.316.381", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A globin protein that may protect cells from OXIDATIVE STRESS and function in intracellular oxygen storage and transfer.", "PM": "2019; see HISTOGLOBIN 2002-2007; CYTOGLOBIN was indexed under GLOBINS 2002-2018", "HN": "2019 (2002)", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078842"}, {"RECTYPE": "D", "MH": "Levomilnacipran", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Levomilnacipran Hydrochloride|T109|T121|NON|NRW|FDA SRS (2018)|NLM (2019)|USAN (19XX)|180530|abbcdeeef", "MN": "D02.455.426.392.368.533.725.500", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, (1S,2R)-", "RN": "UGM0326TXX", "RR": "371U2ZK31U", "MS": "The (1S,2R)-isomer of milnacipran that is used for the treatment of MAJOR DEPRESSIVE DISORDER.", "PM": "2019; see MILNACIPRAN 2013-2018", "HN": "2019; use MILNACIPRAN 2013-2018", "MR": "20180702", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078862"}, {"RECTYPE": "D", "MH": "Web Archives as Topic", "MN": "L01.224.230.110.500.875", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "do not confuse with the Publication Type WEB ARCHIVE", "MS": "Works about collections of preserved web pages.", "PM": "2019", "HN": "2019", "MR": "20180629", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078882"}, {"RECTYPE": "D", "MH": "Catalog, Drug", "MN": "V02.240.100.750", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Drug Catalogs as a subject are indexed under the main heading CATALOGS, DRUG AS TOPIC. INDEXER: Do not use ", "MS": "Lists of drugs for sale.", "HN": "2019", "MR": "20190501", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000078903"}, {"RECTYPE": "D", "MH": "Catalog, Union", "MN": "V02.240.313", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Union Catalogs as a subject are indexed under the main heading CATALOGS, UNION AS TOPIC. INDEXER: Do not use ", "MS": "Lists of books and other information sources held among a cooperating group of LIBRARIES.", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000078922"}, {"RECTYPE": "D", "MH": "Catalog, Commercial", "ENTRY": "Commercial Catalogs|T170|NON|EQV|NLM (2019)|180618|abcdef", "MN": "V02.240.100", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Commercial Catalogs as a subject are indexed under the main heading CATALOGS, COMMERCIAL AS TOPIC. INDEXER: Do not use ", "MS": "Lists of merchandise for sale.", "HN": "2019", "MR": "20180630", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000078925"}, {"RECTYPE": "D", "MH": "Formulary, Homeopathic", "ENTRY": "Formularies, Homeopathic|T170|NON|EQV|NLM (2019)|180618|abcdef", "MN": "V02.480.775", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Homeopathic Formularies as a subject are indexed under the main heading FORMULARIES, HOMEOPATHIC AS TOPIC. INDEXER: Do not use  ", "MS": "Work about Formulary concerned with HOMEOPATHIC REMEDIES.", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000078928"}, {"RECTYPE": "D", "MH": "Formulary, Hospital", "ENTRY": "Hospital Formularies|T170|NON|EQV|NLM (2019)|180618|abcdef", "MN": "V02.480.750", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Hospital Formularies  as a subject are indexed under the main heading FORMULARY, HOSPITAL AS TOPIC. INDEXER: Do not use", "MS": "Formulary concerned with PHARMACEUTICAL PREPARATIONS prescribed in hospitals.", "HN": "2019", "MR": "20190710", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000078929"}, {"RECTYPE": "D", "MH": "Pharmacopoeia, Homeopathic", "ENTRY": "Pharmacopoeias, Homeopathic|T170|NON|EQV|NLM (2019)|180618|abcdef", "MN": "V02.695.750", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Homeopathic Pharmacopoeias as a subject are indexed under the main heading PHARMACOPOEIAS, HOMEOPATHIC AS TOPIC. INDEXER: Do not use ", "MS": "Authoritative resource describing the composition, properties, manufacture, and quality control of HOMEOPATHIC REMEDIES.", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000078930"}, {"RECTYPE": "D", "MH": "Web Archive", "ENTRY": "Web Archives|T170|NON|EQV|NLM (2019)|180619|abcdef", "MN": "V02.260.700", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Web Archives as a subject are indexed under  the main the heading  WEB ARCHIVES AS TOPIC. INDEXER: Do not use", "MS": "Collection of preserved web pages.", "HN": "2019", "MR": "20180702", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000078942"}, {"RECTYPE": "D", "MH": "Formulary, Dental", "ENTRY": "Formularies, Dental|T170|NON|EQV|NLM (2019)|180702|abcdef", "MN": "V02.480.375", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Dental Formularies as a subject are indexed under the main heading FORMULARY, DENTAL AS TOPIC.  INDEXER: Do not use", "MS": "Works on or about reference lists of descriptions and uses of drugs related to oral medicine and dentistry.", "HN": "2019", "MR": "20190710", "DA": "20180709", "DC": "2", "DX": "20190101", "UI": "D000078984"}, {"RECTYPE": "D", "MH": "Clinical Trial Protocols as Topic", "MN": "N05.715.360.330.125.625", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "do not confuse with the Publication Type CLINICAL TRIAL PROTOCOL or with CLINICAL PROTOCOLS", "MS": "Works about the written descriptions of a clinical study. It contains the study's objectives, design, and methods including subject target and/or enrollment criteria. It may also present relevant scientific background and statistical information.", "PM": "2019", "HN": "2019", "MR": "20180709", "DA": "20180709", "DC": "1", "DX": "20190101", "UI": "D000078985"}, {"RECTYPE": "D", "MH": "Acetaldehyde", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ethanal|T109|NON|EQV|FDA SRS (2014)|NLM (1992)|910222|abcdeef", "MN": "D02.047.064", "MH_TH": "NLM (1966)", "ST": "T109", "N1": "Acetaldehyde", "RN": "GO1N1ZPR3B", "RR": "75-07-0 (Acetaldehyde)", "MS": "A colorless, flammable liquid used in the manufacture of acetic acid, perfumes, and flavors. It is also an intermediate in the metabolism of alcohol. It has a general narcotic action and also causes irritation of mucous membranes. Large doses may cause death from respiratory paralysis.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000079"}, {"RECTYPE": "D", "MH": "Maze Procedure", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Procedure, Maze IV", "MN": "E04.928.220.465", "MH_TH": "NLM (2020)", "ST": "T061", "PI": "Cardiac Surgical Procedures (1993-2019)", "MS": "A surgical treatment in which heart tissue is scarred (cut-and-sew method), excised or otherwise destroyed in an open chest approach to direct electrical signals through a more controlled path via the ATRIOVENTRICULAR NODE. It is often used to restore normal rhythms in ATRIAL FIBRILLATION.", "PM": "2020", "HN": "2020", "MR": "20181005", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079042"}, {"RECTYPE": "D", "MH": "Interpersonal Psychotherapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychotherapy, Interpersonal", "MN": "F04.754.506", "MH_TH": "NLM (2020)", "ST": "T061", "PI": "Psychotherapy (1994-2019)", "MS": "Interpersonal modification of psychodynamic psychotherapy. Therapy is present-focused and seeks to resolve problems in interpersonal relations. Aspects of attachment theory are used to analyze how past relationships affect current relationships.", "PM": "2020", "HN": "2020", "MR": "20181011", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079062"}, {"RECTYPE": "D", "MH": "Empowerment", "MN": "F01.658.780.500", "MH_TH": "NLM (2009)", "ST": "T068", "MS": "Process of increasing the capacity of individuals or groups to make choices and to transform those choices into desired actions as deigned by the individuals or groups.", "PM": "2020", "HN": "2020", "MR": "20181011", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079102"}, {"RECTYPE": "D", "MH": "Scope of Practice", "AQ": "ES HI LJ TD", "ENTRY": "Practice Scope", "MN": "F01.829.316.616.625.800", "MH_TH": "NLM (2020)", "ST": "T089", "MS": "The services that licensed professionals are deemed competent to perform, and permitted to undertake in keeping with the terms of their professional license.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079103"}, {"RECTYPE": "D", "MH": "Shared Medical Appointments", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Shared Medical Appointment", "MN": "N04.452.758.708.450.750", "MH_TH": "NLM (2020)", "ST": "T058", "PI": "Practice Management, Medical (2013-2019)", "MS": "Clinical encounters in which patients receive healthcare from one or more health professionals, in a group setting. These may include patient education and counseling, physical examination, and clinical support. Patients usually share a mutual attribute such as a medical condition.", "PM": "2020", "HN": "2020", "MR": "20181012", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079142"}, {"RECTYPE": "D", "MH": "Body Dissatisfaction", "AQ": "PX", "ENTRY": "Negative Body Images", "MN": "F01.752.747.792.110.500", "MH_TH": "NLM (2020)", "ST": "T041", "PI": "Self Concept (1976-2019)", "MS": "Person\u2019s negative thoughts about his or her own body.  This includes judgements about size and shape, muscle tone and generally involves a discrepancy between one's own body type and an ideal body type. (Grogan, 2008)", "PM": "2020", "HN": "2020", "MR": "20181011", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079182"}, {"RECTYPE": "D", "MH": "Disruptive Technology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Technology, Disruptive", "MN": "J01.897.200", "MH_TH": "NLM (2020)", "ST": "T067", "MS": "A process by which a product or service takes root initially in simple applications at the bottom of a market and then relentlessly moves up market, eventually displacing established competitors. (http://www.claytonchristensen.com/key-concepts)", "PM": "2020", "HN": "2020", "MR": "20181011", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079203"}, {"RECTYPE": "D", "MH": "Public Reporting of Healthcare Data", "ENTRY": "Reporting, Quality Data", "MN": "N05.700.712", "MH_TH": "NLM (2020)", "ST": "T064", "MS": "Required public availability of quality indicators data from health facilities.", "PM": "2020", "HN": "2020", "MR": "20181012", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079204"}, {"RECTYPE": "D", "MH": "Observational Studies, Veterinary as Topic", "AQ": "CL EC ES HI IS LJ MT PX ST", "MN": "N06.850.520.450.250.750", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "for general design, methodology, economics, etc. of veterinary observational studies; a different heading OBSERVATIONAL STUDY, VETERINARY is used for reports of a specific veterinary observational study", "MS": "Works about clinical studies in which animal subjects may receive diagnostic, therapeutic, or other types of interventions and where the investigator does not assign subjects  to specific interventions.", "PM": "2020", "HN": "2020", "MR": "20190620", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079223"}, {"RECTYPE": "D", "MH": "Demoralization", "MN": "F01.829.477.500", "MH_TH": "NLM (2020)", "ST": "T055", "PI": "Morale (1982-2019)", "MS": "Weakening of hope, courage, or confidence.", "PM": "2020", "HN": "2020", "MR": "20181012", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079224"}, {"RECTYPE": "D", "MH": "Psychological Distress", "ENTRY": "Distress, Psychological", "MN": "F01.470.315", "MH_TH": "NLM (2020)", "ST": "T055", "MS": "Negative emotional state characterized by physical and/or emotional discomfort, pain, or anguish.", "PM": "2020", "HN": "2020", "MR": "20230531", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079225"}, {"RECTYPE": "D", "MH": "Involuntary Commitment", "AQ": "ES HI LJ ST", "ENTRY": "Involuntary Commitments", "MN": "E02.760.415.640", "MH_TH": "BIOETHICS (1989)", "ST": "T061", "MS": "Non-voluntary institutionalization or isolation following refusal or failure to take medication, to complete treatment, or to adhere to infection control precautions, or behavior that may or does endanger self or others.", "PM": "2020; see COMMITMENT OF MENTALLY ILL 1977-2019", "HN": "2020; use COMMITMENT OF MENTALLY ILL 1977-2019", "MR": "20181012", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079243"}, {"RECTYPE": "D", "MH": "Dry Needling", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Needling, Dry", "MN": "E02.779.413", "MH_TH": "NLM (2020)", "ST": "T061", "MS": "Intervention that uses a thin filiform needle to penetrate the skin and stimulate underlying myofascial trigger points, muscular, and connective tissues for the management of neuromusculoskeletal pain and movement impairments.", "PM": "2020", "HN": "2020", "MR": "20181106", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079245"}, {"RECTYPE": "D", "MH": "Obesity, Maternal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Obesity in Pregnancy|T184|NON|EQV|NLM (2020)|180803|abcdef", "MN": "C23.888.144.699.500.125", "MH_TH": "NLM (2020)", "ST": "T184", "PI": "Obesity (1976-2019)", "MS": "BODY MASS INDEX in PREGNANT WOMEN that is excessively above the recommended cut-off.", "PM": "2020", "HN": "2020", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079262"}, {"RECTYPE": "D", "MH": "Vaccine-Preventable Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Vaccine-Preventable Disease", "MN": "C01.918", "MH_TH": "NLM (2020)", "ST": "T047", "MS": "Diseases for which vaccines exist that can confer partial or complete protection. (World Health Organization vaccine-safety-training.org)", "PM": "2020", "HN": "2020", "MR": "20190610", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079263"}, {"RECTYPE": "D", "MH": "Environmental Indicators", "AQ": "DE ES GE IM PH RE", "ENTRY": "Indicators, Environmental", "MN": "N06.850.460.350.080.625", "FX": "Environmental Biomarkers", "MH_TH": "NLM (2020)", "ST": "T070", "MS": "Data related to climate change, ozone layer depletion, eutrophication, acidification, toxic contamination, urban environmental quality, biodiversity, cultural landscapes, waste, water resources, forest resources, fish resources, and soil degradation including desertification and erosion. (from https://www.oecd.org/env/indicators-modelling-outlooks/37551205.pdfc).", "PM": "2020", "HN": "2020", "MR": "20190223", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079264"}, {"RECTYPE": "D", "MH": "Environmental Science", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sciences, Environmental", "MN": "H01.345", "MH_TH": "NLM (2020)", "ST": "T090", "MS": "Scientific discipline that studies external factors, both biotic (living) and abiotic (nonliving), to which an organism is exposed.", "PM": "2020", "HN": "2020(2004)", "MR": "20181011", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079265"}, {"RECTYPE": "D", "MH": "Vaccine Excipients", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Vaccine Excipient", "MN": "D27.720.744.770.419.500", "MH_TH": "NLM (2020)", "ST": "T167", "RN": "0", "MS": "Media added to a vaccine for a specific purpose. These include: preservatives to prevent contamination, adjuvants to stimulate a stronger immune response, and stabilizers. (From https://www.cdc.gov/vaccines pubs/pinkbook/downloads/appendices/b/excipient-table-2.pdf)", "PM": "2020", "HN": "2020", "MR": "20190620", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079282"}, {"RECTYPE": "D", "MH": "Necroptosis", "AQ": "DE GE IM PH RE", "MN": "G04.146.954.500", "MH_TH": "NLM (2020)", "ST": "T043", "AN": "do not confuse with NECROSIS the pathological process", "PI": "Necrosis (2005-2019)", "MS": "A form of regulated cell death initiated by perturbations of extracellular or intracellular homeostasis that trigger a specific cell death pathway involving the activation of RIPK3 and MLKL (mixed lineage kinase domain like pseudokinase). Morphological changes include cytoplasmic and organellar swelling, rupture of the PLASMA MEMBRANE, and CHROMATIN CONDENSATION.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079302"}, {"RECTYPE": "D", "MH": "Weight Prejudice", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Weight-Based Discrimination|T054|T055|NON|REL|NLM (2022)|210610|abbcdef", "ENTRY": "Weight-Based Discriminations", "MN": "F01.829.595.813", "MH_TH": "NLM (2020)", "ST": "T055", "MS": "Negative attitudes towards and beliefs about others because of their weight. These negative attitudes are manifested by stereotypes and/or prejudice towards people with weight over or under a cultural norm.", "PM": "2020", "HN": "2020", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079322"}, {"RECTYPE": "D", "MH": "Parthanatos", "AQ": "DE GE IM PH RE", "ENTRY": "PARP Dependent Cell Death", "MN": "G04.146.954.750", "MH_TH": "NLM (2020)", "ST": "T043", "PI": "Cell Death (2008-2019)", "MS": "A type of regulated cell death initiated by hyperactivation of POLY (ADP-RIBOSE) POLYMERASE-1 (PARP-1) as a consequence of DNA DAMAGE; OXIDATIVE STRESS; HYPOXIA; HYPOGLYCEMIA; or INFLAMMATION. This leads to DNA FRAGMENTATION and CHROMATIN condensation.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079323"}, {"RECTYPE": "D", "MH": "Internet-Based Intervention", "AQ": "EC HI LJ SN TD", "ENTRY": "Web-based Interventions", "MN": "L01.224.230.110.500.688", "MH_TH": "NLM (2020)", "ST": "T058", "PI": "Internet (1998-2019)", "MS": "Use of the INTERNET to facilitate the dissemination of health-related information and to connect patients to support.", "PM": "2020", "HN": "2020", "MR": "20190620", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079382"}, {"RECTYPE": "D", "MH": "National Program of Cancer Registries", "AQ": "SN ST", "ENTRY": "United States National Program of Cancer Registries|T093|NAM|EQV|NLM (2020)|180917|abcdef", "MN": "N03.540.348.500.500.600.650.225.760", "MH_TH": "NLM (2020)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; CATALOGER: Use NAF entry", "PI": "Registries (2007-2019)", "MS": "A unit of the United States Centers for Disease Control and Prevention that supports the collection of high-quality data on cancer occurrence (including the type, extent, and location of the cancer), the type of initial treatment, and outcomes.", "PM": "2020", "HN": "2020", "MR": "20190422", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079402"}, {"RECTYPE": "D", "MH": "Ferroptosis", "AQ": "DE GE IM PH RE", "ENTRY": "Oxytosis|T043|NON|REL|NLM (2020)|180817|abcdef", "MN": "G04.146.954.178", "MH_TH": "NLM (2020)", "ST": "T043", "PI": "Cell Death (2012-2019)", "MS": "A form of REGULATED CELL DEATH initiated by oxidative perturbations of the intracellular microenvironment that is under constitutive control by glutathione peroxidase 4 and can be inhibited by iron chelators and lipophilic antioxidants.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079403"}, {"RECTYPE": "D", "MH": "Regulated Cell Death", "AQ": "DE GE IM PH RE", "ENTRY": "Cell Death, Regulated", "MN": "G04.146.954", "MH_TH": "NLM (2020)", "ST": "T043", "AN": "general or unspecified, prefer specifics", "PI": "Cell Death (1998-2019)", "MS": "Genetically encoded mechanisms in multicellular and unicellular eukaryotes that function to eliminate cells that are superfluous either during development, or to maintain tissue and organism homeostasis; and cells that are irreversibly damaged, abnormal, and/or potentially harmful.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079404"}, {"RECTYPE": "D", "MH": "Tumor Necrosis Factor Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tumor Necrosis Factor-a (TNF-a) Inhibitor|T121|NON|NRW|NLM (2021)|191121|abcdef", "ENTRY": "Inhibitors, TNF", "MN": "D27.505.954.158.757", "MH_TH": "NLM (2020)", "ST": "T121", "RN": "0", "MS": "Compounds or agents that bind to and inhibit the synthesis or activity of TUMOR NECROSIS FACTOR-alpha. Such agents are used to treat inflammatory bowel diseases and other inflammatory diseases.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079424"}, {"RECTYPE": "D", "MH": "Genetic Introgression", "AQ": "DE ES GE IM PH RE", "ENTRY": "Introgressive Hybridizations", "MN": "G05.090.390.500", "FX": "Gene Flow", "MH_TH": "NLM (2020)", "ST": "T045", "MS": "The transfer of genetic material from one species to another by inter-species hybridization and repeated backcrossing.", "PM": "2020", "HN": "2020", "MR": "20181010", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079425"}, {"RECTYPE": "D", "MH": "Vector Borne Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Vectorborne Disease", "MN": "C01.920", "MH_TH": "NLM (2020)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Disease Vectors (1969-2019)", "MS": "Infectious diseases transmitted by DISEASE VECTORS.", "PM": "2020", "HN": "2020", "MR": "20230405", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079426"}, {"RECTYPE": "D", "MH": "Claustrum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Insular Claustrum|T023|NON|NRW|NLM (2020)|180829|abcdef", "MN": "A08.186.211.200.885.287.249.320", "MH_TH": "UNK (19XX)", "ST": "T023", "MS": "A gray matter lamina located underneath the inner NEOCORTEX lateral to the PUTAMEN and medial to the INSULAR CORTEX. It is considered to be a part of the basal ganglia. Extensive claustral projections exist to most cortices and subcortical structures including the AMYGDALA, the CAUDATE NUCLEUS, the HIPPOCAMPUS and the THALAMUS.", "PM": "2020; see BASAL GANGLIA (1978-2019)", "HN": "2020; use BASAL GANGLIA (1978-2019)", "MR": "20181005", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079482"}, {"RECTYPE": "D", "MH": "E-Cigarette Vapor", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vapor, Electronic Cigarette", "MN": "D26.255.165.055.173", "FX": "Vaping", "MH_TH": "NLM (2020)", "ST": "T167", "RN": "0", "AN": "coordinate with AIR POLLUTION if pertinent", "MS": "Complex mixture of vaporized chemicals emitted during SMOKING of E-CIGARETTES.", "PM": "2020", "HN": "2020", "MR": "20190304", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079522"}, {"RECTYPE": "D", "MH": "Narcotic-Related Disorders", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Narcotic Dependence|T048|NON|NRW|NLM (1998)|970319|abcdef", "ENTRY": "Narcotic-Related Disorder", "MN": "F03.900.647", "FX": "Narcotics", "MH_TH": "NLM (2020)", "ST": "T048", "MS": "Disorders related to or resulting from abuse or misuse of NARCOTICS.", "PM": "2020; NARCOTIC ABUSE see OPIOID-RELATED DISORDER 1997-2019", "HN": "2020; NARCOTIC ABUSE use OPIOID-RELATED DISORDER 1997-2019", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079524"}, {"RECTYPE": "D", "MH": "Immunogenic Cell Death", "AQ": "DE GE IM PH RE", "ENTRY": "Cell Death, Immunogenic", "MN": "G04.146.954.285", "MH_TH": "NLM (2020)", "ST": "T043", "PI": "Cell Death (2009-2019)", "MS": "A form of regulated cell death that results in release of specific DAMAGE ASSOCIATED MOLECULAR PATTERN MOLECULES which activate an ADAPTIVE IMMUNE RESPONSE. It can be initiated in any type of cell by a restricted set of stimuli, including viral infection, some chemotherapeutics or immunogenic radiation therapy.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079527"}, {"RECTYPE": "D", "MH": "Mitochondrial Transmembrane Permeability-Driven Necrosis", "AQ": "DE GE IM PH RE", "ENTRY": "Mitochondrial Transmembrane Permeability Driven Necrosis", "MN": "G04.146.954.393", "MH_TH": "NLM (2020)", "ST": "T043", "PI": "Cell Death (1993-2019)", "MS": "A form of regulated cell death that is initiated by specific perturbations of the intracellular microenvironment such as severe OXIDATIVE STRESS and cytosolic CALCIUM overload, which result in osmotic breakdown of the MITOCHONDRIAL MEMBRANES.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079530"}, {"RECTYPE": "D", "MH": "Tithonia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.100.906", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid105386", "MS": "A genus of flowering plants in the ASTERACEAE family. It is found in MEXICO; CENTRAL AMERICA; and SOUTHWESTERN UNITED STATES.", "PM": "2020; see ASTERACEAE 2003-2019", "HN": "2020; use ASTERACEAE 2003-2019", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079542"}, {"RECTYPE": "D", "MH": "Ligularia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.100.508", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid4239", "MS": "A genus of ornamental plants in the family ASTERACEAE, often found near water.", "PM": "2020; see ASTERACEAE 2003-2019", "HN": "2020; use ASTERACEAE 2003-2019", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079543"}, {"RECTYPE": "D", "MH": "Rumination Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rumination Disorders|T047|NON|EQV|NLM (1998)|970314|RUMINATION DIS|abcdefv", "ENTRY": "Rumination Syndromes", "MN": "F03.400.968", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Gastrointestinal Diseases (1966-2019)", "MS": "A gastrointestinal disorder characterized by repetitive and effortless regurgitation of ingested food from the stomach to the oral cavity in the early POSTPRANDIAL PERIOD. It is associated with functional gastrointestinal pathology (e.g., increased intra-gastric pressure) and psychiatric disorders (e.g., anxiety, depression). It is not limited to infants and distinct from GERD and VOMITING.", "PM": "2020; see FEEDING AND EATING DISORDERS OF CHILDHOOD 1998-2019", "HN": "2020(1998)", "MR": "20190617", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079562"}, {"RECTYPE": "D", "MH": "Globus Sensation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Globus Hystericus|T047|T048|NON|EQV|UNK (19XX)|800521|abbcdef", "ENTRY": "Sensation, Globus", "MN": "F03.875.300.500", "MH_TH": "NLM (2020)", "ST": "T048", "MS": "A feeling of a lump in the throat that occurs between meals in the absence of other gastrointestinal and motility disorders (e.g., DYSPHAGIA; GASTROESOPHAGEAL REFLUX).", "PM": "2020; see CONVERSION DISORDER 1980-2019", "HN": "2020; use CONVERSION DISORDER 1980-2019", "MR": "20181005", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079564"}, {"RECTYPE": "D", "MH": "Actinoplanes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.500.250", "MH_TH": "NLM (2020)", "ST": "T007", "RN": "txid1865", "MS": "A genus of zoospore-forming bacteria in the Micromonosporaceae family that is a source of many clinically important natural products.", "PM": "2020", "HN": "2020", "MR": "20200813", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079584"}, {"RECTYPE": "D", "MH": "Cell Encapsulation", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Cellular Encapsulation|T058|T059|T062|NON|EQV|NLM (2020)|181025|abbbcdef", "ENTRY": "Microencapsulations, Cell", "MN": "E05.481.500.311.500.500", "FX": "Cells, Immobilized", "MH_TH": "NLM (2020)", "ST": "T062", "MS": "The encapsulation of cells into semi-permeable microcapsules or MICROSPHERES that permits protection of encapsulated cells and allows passage of essential nutrients and release of a therapeutic product (e.g. INSULIN).", "PM": "2020", "HN": "2020", "MR": "20190801", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079585"}, {"RECTYPE": "D", "MH": "Sino-Nasal Outcome Test", "ENTRY": "Sinonasal Outcome Tests", "MN": "N06.850.520.308.980.344.500.500", "MH_TH": "NLM (2020)", "ST": "T058", "PI": "Surveys and Questionnaires (2002-2019)", "MS": "Patient-reported measure of outcome in sino-nasal disorders such as rhinosinusitis and nasal polyposis.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079602"}, {"RECTYPE": "D", "MH": "Rapid Sequence Induction and Intubation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Intubation, Rapid Sequence", "MN": "E05.497.578.737", "MH_TH": "NLM (2020)", "ST": "T061", "PI": "Intubation, Intratracheal (1987-2019)", "MS": "A method of maintaining airway patency and administering anesthesia during emergency situations when it cannot be determined if the patient is fasting or not; or in other instances where there is a risk of aspiration. The method includes a series of events that involve the administration of SEDATIVES to induce unconsciousness, followed by NEUROMUSCULAR BLOCK AGENTS to improve the intubating conditions, followed by endotracheal intubation.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079603"}, {"RECTYPE": "D", "MH": "Military Health", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "PRINT ENTRY": "Health of Military Personnel|T078|NON|EQV|NLM (2020)|190821|abcdef", "ENTRY": "Military Personnel Health", "MN": "N01.400.506", "FX": "Veterans Health", "MH_TH": "NLM (2020)", "ST": "T078", "MS": "The physical and mental conditions of MILITARY PERSONNEL and the MILITARY FAMILY.", "PM": "2020", "HN": "2020", "MR": "20220713", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079644"}, {"RECTYPE": "D", "MH": "Perioperative Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Perioperative", "MN": "H02.403.675", "MH_TH": "NLM (2020)", "ST": "T091", "MS": "A medical specialty concerned with the patient before and after surgical procedures.", "PM": "2020", "HN": "2020", "MR": "20181012", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079645"}, {"RECTYPE": "D", "MH": "Chronic Disease Indicators", "PRINT ENTRY": "Chronic Disease Surveillance|T081|NON|EQV|NLM (2020)|181030|abcdef", "ENTRY": "Surveillances, Chronic Disease", "MN": "N06.850.520.308.980.438.475.023", "MH_TH": "NLM (2020)", "ST": "T081", "MS": "A set of surveillance indicators of disease developed by consensus among the CDC, the Council of State and Territorial Epidemiologists, and the National Association of Chronic Disease Directors. It enables public health professionals and policymakers to retrieve uniformly defined state and selected metropolitan-level data for CHRONIC DISEASES and RISK FACTORS that impact public health.(https://www.cdc.gov/socialdeterminants/data/index.htm)", "PM": "2020", "HN": "2020", "MR": "20181210", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079662"}, {"RECTYPE": "D", "MH": "Continuous Renal Replacement Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Slow Continuous Ultrafiltration|T061|NON|NRW|NLM (2020)|181106|abcdef", "ENTRY": "Venovenous Hemofiltration, Continuous", "MN": "E04.292.438", "MH_TH": "NLM (2020)", "ST": "T061", "PI": "Renal Replacement Therapy (1993-2019)", "MS": "Procedures with continuous blood purification (e.g., dialysis, filtration or perfusion) via vascular access designed to mimic kidney function in kidney diseases (e.g., ACUTE RENAL FAILURE and poisoning).", "PM": "2020; for HEMOFILTRATION, CONTINUOUS ARTERIOVENOUS see HEMOFILTRATION 1988-2019", "HN": "2020; for HEMOFILTRATION, CONTINUOUS ARTERIOVENOUS use HEMOFILTRATION 1988-2019", "MR": "20190618", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079664"}, {"RECTYPE": "D", "MH": "Famine", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "MN": "J01.576.423.750.500", "FX": "Starvation", "MH_TH": "POPLINE (1986)", "ST": "T067", "MS": "The conditions when at least 20 per cent of households in an area face extreme food shortages with a limited ability to cope; acute malnutrition rates exceed 30 per cent; and the death rate exceeds two persons per day per 10,000 persons. (From news.un.org/en/story/2011/07/382342-when-food-security-crisis-becomes-famine)", "PM": "2020; 1986-2019 see STARVATION", "HN": "2020; 1986-2019 use STARVATION", "MR": "20190620", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079685"}, {"RECTYPE": "D", "MH": "Wastewater-Based Epidemiological Monitoring", "PRINT ENTRY": "Wastewater-Based Surveillance|T091|NON|EQV|NLM (2023)|220419|abcdef", "ENTRY": "Wastewater-Based Surveillances", "MN": "N06.850.520.460.500", "FX": "Environmental Monitoring", "MH_TH": "NLM (2020)", "ST": "T091", "PI": "Waste Water (2014-2019)", "MS": "Sampling of the liquids generated from industrial processes, sanitary fixtures and appliances, food handling, etc., to collect and analyze epidemiological information (such as pathogen levels, or concentrations of pesticides, pharmaceuticals, or other substances) from metabolic excretion products, household liquid wastes, and industrial wastes.", "PM": "2020", "HN": "2020", "MR": "20220523", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079686"}, {"RECTYPE": "D", "MH": "Biological Monitoring", "DE": "BIOL MONITORING", "AQ": "EC ES HI IS LJ MT SN ST", "ENTRY": "Monitoring, Biologic", "MN": "N06.850.780.375.175", "MH_TH": "UNK (19XX)", "ST": "T091", "PI": "Environmental Monitoring (1984-2019)", "MS": "Monitoring of the level of toxins, chemical pollutants, microbial contaminants, or other harmful substances in the bodies of living organisms, by DIAGNOSTIC IMAGING or by analyzing BLOOD; URINE; BREAST MILK; SALIVA, etc.", "PM": "2020; see ENVIRONMENTAL MONITORING 1985-2019", "HN": "2020; use ENVIRONMENTAL MONITORING 1985-2019", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079687"}, {"RECTYPE": "D", "MH": "Opioid-Induced Constipation", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Opioid-Induced Bowel Dysfunction|T047|NON|REL|NLM (2021)|191129|abcdef", "ENTRY": "Opioid-Induced Constipations", "MN": "F03.900.647.250", "MH_TH": "NLM (2020)", "ST": "T047", "MS": "CONSTIPATION associated with the use of OPIOIDS.", "PM": "2020", "HN": "2020", "MR": "20200116", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079689"}, {"RECTYPE": "D", "MH": "Postoperative Cognitive Complications", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Postoperative Dementia|T046|NON|REL|NLM (2023)|211013|abcdef", "ENTRY": "Postoperative Dementias", "MN": "F03.615.250.700.500", "MH_TH": "NLM (2020)", "ST": "T046", "MS": "COGNITIVE IMPAIRMENT or functional decline after a surgical procedure.", "PM": "2020", "HN": "2020", "MR": "20220708", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079690"}, {"RECTYPE": "D", "MH": "School Mental Health Services", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "School-Based Mental Health Services|T058|NON|NRW|NLM (2020)|181022|abcdef", "ENTRY": "School Based Mental Health Services", "MN": "N04.880", "MH_TH": "NLM (2020)", "ST": "T058", "PI": "School Health Services (1963-2019)", "MS": "Services which focus on the mental well-being of pre-college and pre-university students that include COUNSELING and therapy.", "PM": "2020", "HN": "2020", "MR": "20181211", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079691"}, {"RECTYPE": "D", "MH": "Pomegranate", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Pomegranates", "MN": "B01.875.800.575.912.250.859.833.500.625", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid22663", "MS": "A deciduous shrub or small tree in the family Lythraceae, order Myrtales, superorder Rosanae. It bears edible reddish-purple fruit berries with seeds and pulp produced from the ovary of a single flower.", "PM": "2020; see LYTHRACEAE 2001-2019", "HN": "2020; use LYTHRACEAE 2001-2019", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079702"}, {"RECTYPE": "D", "MH": "Cupping Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Cupping Treatment|T061|NON|EQV|NLM (2020)|181105|abcdef", "ENTRY": "Treatment, Cupping", "MN": "E02.190.233", "MH_TH": "NLM (2020)", "ST": "T061", "PI": "Medicine, Chinese Traditional (2013-2019)", "MS": "A traditional practice, most notably in traditional medicine, which involves placing cups on the skin to create suction believed to help increase blood flow and promote healing associated with chronic neck and low back pain in the short term (From National Center for Complementary and Integrative Health, https://nccih.nih.gov/news/cupping (Accessed 11/5/2018)).", "PM": "2020", "HN": "2020", "MR": "20190222", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079742"}, {"RECTYPE": "D", "MH": "Intermittent Renal Replacement Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Prolonged Intermittent Renal Replacement Therapy|T061|NON|REL|NLM (2020)|181106|abcdef", "ENTRY": "Venovenous Hemofiltration, Accelerated", "MN": "E04.292.636", "MH_TH": "NLM (2020)", "ST": "T061", "PI": "Renal Dialysis (1997-2019)", "MS": "Procedures with non-continuous blood purification (e.g., dialysis, filtration and/or perfusion) via vascular access by increasing blood flow rate compared to CONTINUOUS RRT.", "PM": "2020", "HN": "2020", "MR": "20190222", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079763"}, {"RECTYPE": "D", "MH": "Hybrid Renal Replacement Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Sustained Low-Efficiency Dialysis|T061|NON|NRW|NLM (2020)|181106|abcdef", "ENTRY": "Therapy, Hybrid Extracorporeal", "MN": "E04.292.573", "MH_TH": "NLM (2020)", "ST": "T061", "PI": "Renal Replacement Therapy (2001-2019)", "MS": "Procedures involving non-continuous blood purification (e.g., dialysis, filtration or perfusion) via vascular access with settings for dialysate and blood flow rates and treatment duration settings hybrid between CRRT TECHNIQUE and IRRT TECHNIQUE.", "PM": "2020", "HN": "2020", "MR": "20190618", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079782"}, {"RECTYPE": "D", "MH": "Data Management", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Data Administration|T057|NON|NRW|NLM (2020)|181113|abcdef", "ENTRY": "Management, Data", "MN": "L01.470.563", "FX": "Database Management Systems", "MH_TH": "NLM (2020)", "ST": "T057", "AN": "coordinate with specific type of data", "MS": "Processes that include acquiring, validating, storing, protecting, and processing data to ensure accessibility, reliability, and timeliness for users.", "PM": "2020", "HN": "2020", "MR": "20220712", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079803"}, {"RECTYPE": "D", "MH": "Extranodal Extension", "AQ": "DG DI DT GE IM PA PC PP RT TH UL", "PRINT ENTRY": "Tumor Deposit|T191|NON|REL|NLM (2020)|181114|abcdef", "ENTRY": "Tumor Deposits", "MN": "C23.550.727.650.280", "MH_TH": "NLM (2020)", "ST": "T191", "PI": "Lymphatic Metastasis (1999-2019)", "MS": "A penetration of LYMPH NODE metastatic cells through the nodal capsule into the perinodal fatty tissue used in a TUMOR STAGING system (the TNM staging system).", "PM": "2020", "HN": "2020", "MR": "20190222", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079822"}, {"RECTYPE": "D", "MH": "Securinega", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.797.438.781", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid300951", "MS": "A plant genus of the family EUPHORBIACEAE, order MALPIGHIALES. Members contain securinine and virosecurinine compounds.", "PM": "2020; see EUPHORBIACEAE 2003-2019", "HN": "2020; use EUPHORBIACEAE 2003-2019", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079883"}, {"RECTYPE": "D", "MH": "Copper Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Copper Transporters|T116|T123|NON|EQV|NLM (2020)|181205|abbcdef", "ENTRY": "Transporters, Copper", "MN": "D12.776.543.585.450.250.578", "MH_TH": "NLM (2020)", "ST": "T123", "RN": "0", "PI": "Copper (1997-2019)", "MS": "Membrane proteins that facilitate the transport of copper cations across biological membranes.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079922"}, {"RECTYPE": "D", "MH": "Copper Transporter 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SLC31A1 Protein|T116|T123|ABX|EQV|NLM (2020)|181205|abbcdef", "ENTRY": "Transporter, Copper Influx", "MN": "D12.776.543.585.937.762.500", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "MS": "A high-affinity, saturable copper transporter of the PLASMA MEMBRANE that functions in the absorption of dietary copper.", "PM": "2020; COPPER TRANSPORTER 1 was indexed under CATION TRANSPORT PROTEINS 2004-2019; and under MEMBRANE PROTEINS 1994-2003", "HN": "2020 (1994)", "MR": "20190116", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079923"}, {"RECTYPE": "D", "MH": "RNA, Circular", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "circRNAs|T114|T123|ABB|EQV|NLM (2020)|181206|abbcdef", "ENTRY": "RNAs, Circular", "MN": "D13.444.735.032", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "MS": "RNA molecules in which the 3' and 5' ends are covalently joined to form a closed continuous loop. They are resistant to digestion by EXORIBONUCLEASES.", "PM": "2020; RNA, CIRCULAR was indexed under RNA 1979-2019", "HN": "2020 (1979)", "MR": "20190117", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079962"}, {"RECTYPE": "D", "MH": "Brentuximab Vedotin", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "cAC10vcMMAE", "MN": "D12.776.377.715.548.114.224.200.469", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "7XL5ISS668", "RR": "914088-09-8", "MS": "Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA.", "PM": "2020; BRENTUXIMAB VEDOTIN was indexed under IMMUNOCONJUGATES 2010-2019", "HN": "2020 (2010)", "MR": "20190115", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079963"}, {"RECTYPE": "D", "MH": "Gemtuzumab", "AQ": "AD AE AN BL CF CH CL DE EC GE HI IM IP ME PD PK PO RE TO TU UL UR", "PRINT ENTRY": "Gemtuzumab-Ozogamicin|T116|T121|T129|NON|NRW|NLM (2009)|181206|abbbcdef", "ENTRY": "CMA676", "MN": "D12.776.377.715.548.114.224.200.790", "MH_TH": "NLM (2000)", "ST": "T129", "RN": "93NS566KF7", "RR": "8GZG754X6M", "MS": "Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA.", "PM": "2020; GEMTUZUMAB was indexed under AMINOGLYCOSIDES and ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2019; and under ANTIBODIES, MONOCLONAL 2000-2011", "HN": "2020 (2000)", "MR": "20190429", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000079982"}, {"RECTYPE": "D", "MH": "Acetals", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acetal|T109|NON|EQV|NLM (2021)|191118|abcdef", "MN": "D02.355.071", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Ethers (1966-1971)", "MS": "Diethers with the structure -C(OR'')(OR'''), where R'' and  R''' are not hydrogen. Mixed acetals have R'' and R''' groups which differ.", "PM": "74", "HN": "74(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000080"}, {"RECTYPE": "D", "MH": "Protein-Arginine Deiminase Type 4", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein-Arginine Deiminase Type IV|T116|T126|NON|EQV|NLM (2020)|181207|abbcdef", "MN": "D08.811.277.721.500", "FX": "Citrullination", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "EC 3.5.3.15", "MS": "A histone modification enzyme, which converts both ARGININE and monomethyl-arginine to CITRULLINE. It is one of several protein-arginine deiminase isoenzymes. It is a gene regulator involved in APOPTOSIS and CELL DIFFERENTIATION and a potential therapeutic target for the treatment of a variety of diseases.", "PM": "2020; for PEPTIDYLARGININE DEIMINASE TYPE IV use PROTEIN-ARGININE DEIMINASES 2004-2019; for PEPTIDYLARGININE DEIMINASE V use PROTEIN-ARGININE DEIMINASES 2003-2019", "HN": "2020 (2004)", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080002"}, {"RECTYPE": "D", "MH": "Cyclams", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetraazamacrocycles|T109|T123|NON|BRD|NLM (2020)|190110|abbcdef", "ENTRY": "Derivatives, Cyclam", "MN": "D04.345.077", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Lactams, Macrocyclic (2003-2019)", "MS": "Compounds made of fourteen-member tetraamine macrocycles which bind strongly to a wide range of metal ions.", "PM": "2020; see LACTAMS, MACROCYCLIC 2003-2019", "HN": "2020; use LACTAMS, MACROCYCLIC 2003-2019", "MR": "20190503", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080027"}, {"RECTYPE": "D", "MH": "Citizen Science", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Citizen Sciences", "MN": "N03.540.245.360.150", "FX": "Decision Making", "MH_TH": "NLM (2020)", "ST": "T062", "MS": "Voluntary public participation in the scientific process, addressing real-world problems in ways that may include formulating research questions, conducting scientific experiments, collecting and analyzing data, interpreting results, making new discoveries, developing technologies and applications, for solving complex problems. (From https://www.citizenscience.gov/)", "PM": "2020", "HN": "2020", "MR": "20190620", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080029"}, {"RECTYPE": "D", "MH": "Legal Epidemiology", "PRINT ENTRY": "Policy Surveillance|T078|NON|REL|NLM (2020)|190510|abcdef", "ENTRY": "Surveillance, Policy", "MN": "N06.850.698", "MH_TH": "NLM (2020)", "ST": "T078", "MS": "Scientific study of law as a factor in the cause, distribution, and prevention of disease and injury.  (From https://read.dukeupress.edu/jhppl/article/41/6/1151/40084/Policy-Surveillance-A-Vital-Public-Health-Practice).", "PM": "2020", "HN": "2020", "MR": "20190620", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080030"}, {"RECTYPE": "D", "MH": "Limited English Proficiency", "AQ": "LJ", "PRINT ENTRY": "Limited English Proficient|T078|NON|EQV|NLM (2020)|190114|abcdef", "ENTRY": "Proficients, Limited English", "MN": "L01.143.230.750", "MH_TH": "NLM (2020)", "ST": "T078", "MS": "Limited ability to communicate with or understand English.", "PM": "2020", "HN": "2020", "MR": "20190114", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080031"}, {"RECTYPE": "D", "MH": "Psychology, Positive", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Positive Psychology|T041|NON|EQV|NLM (2020)|181211|abcdef", "MN": "F04.096.628.057", "FX": "Optimism", "MH_TH": "NLM (2020)", "ST": "T041", "MS": "The scientific study of the strengths that enable individuals and communities to thrive. It is founded on the belief that people want to lead meaningful and fulfilling lives, to cultivate what is best within themselves, and to enhance their experiences of love, work, and play. (https://ppc.sas.upenn.edu/)", "PM": "2020", "HN": "2020", "MR": "20190114", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080032"}, {"RECTYPE": "D", "MH": "Public Nondiscrimination Policies", "ENTRY": "Public Nondiscrimination Policy", "MN": "I01.655.500.608.550", "MH_TH": "NLM (2020)", "ST": "T064", "MS": "Policies that include the existence of a body responsible for the articulation and implementation of a platform based on an equality perspective that requires the integration of race-ethnicity, differences in sexual orientation, as well as the demands and needs arising from differences within the executive. Its objective is to translate a programmatic vision into action and action axes that reflects the struggle for egalitarian social relations. (From http://bit.ly/28WAaYO)", "PM": "2020", "HN": "2020", "MR": "20190620", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080033"}, {"RECTYPE": "D", "MH": "Historical Trauma", "AQ": "CL CO DI DT EH EP ET GE HI MO NU PA PC PX RH TH", "PRINT ENTRY": "Transgenerational Trauma|T048|NON|EQV|NLM (2020)|190114|abcdef", "ENTRY": "Traumas, Transgenerational", "MN": "F03.950.750.375.500", "MH_TH": "NLM (2020)", "ST": "T048", "MS": "Clinical distress among descendants of survivors of mass trauma, as if they had suffered through the same extreme historic circumstances. Symptoms may persist through generations.", "PM": "2020", "HN": "2020", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080037"}, {"RECTYPE": "D", "MH": "Anomalous Left Coronary Artery", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C16.131.240.400.210.125", "MH_TH": "NLM (2020)", "ST": "T019", "PI": "Coronary Vessel Anomalies (1963-2019)", "MS": "Malformations of left CORONARY ARTERY where it is connected to the PULMONARY ARTERY instead of the AORTA.", "PM": "2020", "HN": "2020", "MR": "20190222", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080038"}, {"RECTYPE": "D", "MH": "Univentricular Heart", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Complex Single Ventricle|T019|NON|EQV|NLM (2020)|181213|abcdef", "ENTRY": "Ventricle, Complex Single", "MN": "C16.131.240.400.975", "MH_TH": "NLM (2020)", "ST": "T019", "PI": "Heart Ventricles/abnormalities (1976-2019)", "MS": "Rare congenital heart malformation with a single ventricle (HEART VENTRICLES) instead of the usual two.", "PM": "2020", "HN": "2020", "MR": "20190222", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080039"}, {"RECTYPE": "D", "MH": "Congenitally Corrected Transposition of the Great Arteries", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Congenitally Corrected Transposition of the Great Vessels|T019|NON|EQV|NLM (2020)|181213|abcdef", "ENTRY": "Transposition, Congenitally Corrected", "MN": "C16.131.240.400.915.150", "MH_TH": "NLM (2020)", "ST": "T019", "PI": "Transposition of Great Vessels (1966-2019)", "MS": "A rare heart defect that occurs when the HEART VENTRICLES and attached valves, the MITRAL VALVE and the TRICUSPID VALVE are reversed so that the AORTA and the PULMONARY ARTERY are connected to the wrong ventricle. Although the heart valves and the two great arteries, the PULMONARY ARTERY and the AORTA are transposed, the blood flows to the correct place because the ventricles are also reversed and therefore corrects the transposition. It often occurs with other structural heart abnormalities.", "PM": "2020; CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES was indexed under TRANSPOSITION OF GREAT VESSELS 2010-2019", "HN": "2020(2010)", "MR": "20220413", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080041"}, {"RECTYPE": "D", "MH": "Ado-Trastuzumab Emtansine", "AQ": "AD AE AN BL CF CH CL DE EC GE HI IM IP ME PD PK PO RE TO TU UL UR", "PRINT ENTRY": "Trastuzumab-DM1 Conjugate|T109|T116|T121|T129|NON|NRW|NLM (2010)|181213|abbbbcdef", "ENTRY": "huN901DM1", "MN": "D12.776.377.715.548.114.224.200.875.500", "MH_TH": "NLM (2013)", "ST": "T129", "RN": "SE2KH7T06F", "MS": "Immunotoxin that consists of humanized monoclonal anti-HER2 antibody TRASTUZUMAB covalently linked to anti-microtubule agent MAYTANSINOID DM1 for treatment of metastatic breast cancer in patients who previously received trastuzumab and a TAXANES, separately or in combination.", "PM": "2020; ADO-TRASTUZUMAB EMTANSINE was indexed under TRASTUZUMAB and MAYTANSINE 2012-2019 and under ANTIBODIES, MONOCLONAL 2010-2011", "HN": "2020 (2010)", "MR": "20190116", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080044"}, {"RECTYPE": "D", "MH": "Inotuzumab Ozogamicin", "AQ": "AD AE AN BL CF CH CL DE EC GE HI IM IP ME PD PK PO RE TO TU UL UR", "PRINT ENTRY": "Besponsa|T116|T121|T129|TRD|NRW|NLM (2020)|181213|abbbcdef", "ENTRY": "CMC 544", "MN": "D12.776.377.715.548.114.224.200.794", "MH_TH": "USAN (19XX)", "ST": "T129", "RN": "P93RUU11P7", "MS": "Immunotoxin that consists of anti-CD22 (CD22 ANTIGEN) humanized monoclonal antibody covalently linked to the antineoplastic antibiotic CALICHEAMICIN. It is used for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (LEUKEMIA, ACUTE LYMPHOBLASTIC).", "PM": "2020; INOTUZUMAB OZOGAMICIN was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2019 and under ANTIBODIES, MONOCLONAL (2004-2011)", "HN": "2020 (2004)", "MR": "20190116", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080045"}, {"RECTYPE": "D", "MH": "Hot Melt Extrusion Technology", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Hot Melt Extrusion|T057|NON|EQV|NLM (2020)|181217|abcdef", "MN": "J01.897.836.500", "MH_TH": "NLM (2020)", "ST": "T057", "MS": "Solvent-free method for preparing numerous types of drug delivery systems and dosage forms for active pharmaceutical ingredients that have solubility issues. It involves pumping polymeric materials at temperatures above their glass transition temperature to mix in active pharmaceutical ingredients with or without binders thus forming an amorphous product with an  increase in the dissolution profile for the active pharmaceutical ingredients.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080048"}, {"RECTYPE": "D", "MH": "Para-Athletes", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Wheelchair Athletes|T098|NON|NRW|NLM (2020)|181214|abcdef", "ENTRY": "Wheelchair Athlete", "MN": "M01.150.738", "MH_TH": "NLM (2020)", "ST": "T098", "PI": "Disabled Persons (1997-2019)", "MS": "Physically disabled individuals who have developed skills, physical stamina and strength to participate in SPORTS or other physical activities.", "PM": "2020", "HN": "2020", "MR": "20200618", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080050"}, {"RECTYPE": "D", "MH": "Community-Based Health Insurance", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Mutual Health Insurance|T058|NON|EQV|NLM (2020)|181214|abcdef", "ENTRY": "Mutual Health Insurances", "MN": "N03.219.521.576.343.108", "MH_TH": "NLM (2020)", "ST": "T058", "PI": "Insurance, Health (1996-2019)", "MS": "Low-cost HEALTH INSURANCE in which community, cooperative, mutual, and/or self-help resources are pooled to mitigate health risks and cover health care services in full or in part.", "PM": "2020", "HN": "2020", "MR": "20190503", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080051"}, {"RECTYPE": "D", "MH": "Opioid Epidemic", "AQ": "ET HI MO PC SN TD", "PRINT ENTRY": "Opioid Crisis|T047|NON|BRD|NLM (2020)|181214|abcdef", "ENTRY": "Opioid Epidemics", "MN": "N06.850.290.200.300", "MH_TH": "NLM (2020)", "ST": "T068", "PI": "Opioid-Related Disorders (2011-2019)", "MS": "Widespread use of OPIOIDS by disproportionately large numbers of individuals within a population, community, or region occurring within a relatively narrow window of time.", "PM": "2020", "HN": "2020", "MR": "20190503", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080052"}, {"RECTYPE": "D", "MH": "Pinales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Taxales|T002|NON|EQV|NLM (2020)|181214|abcdef", "MN": "B01.875.800.575.912.625", "MH_TH": "NLM (2020)", "ST": "T002", "RN": "txid1446380", "MS": "Order of Conifers of the class Pinopsida, subdivision Spermatophytina, and division Tracheophyta. The distinguishing attribute of the Pinales is the reproductive structure known as a cone.", "PM": "2020", "HN": "2020", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080054"}, {"RECTYPE": "D", "MH": "Araucariaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.625.500", "MH_TH": "NLM (2020)", "ST": "T002", "RN": "txid25664", "MS": "A family of dioecious or monoecious evergreen trees belonging to the order Pinales, subclass Pinidaes, with spirally arranged, narrow or broad leaves often with parallel veins.", "PM": "2020", "HN": "2020", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080056"}, {"RECTYPE": "D", "MH": "Araucaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Brazilian Pine|T002|NON|NRW|NLM (2020)|190506|abcdef", "ENTRY": "Pine, Brazilian", "MN": "B01.875.800.575.912.625.500.500", "MH_TH": "NLM (2020)", "ST": "T002", "RN": "txid25666", "RR": "txid56992", "MS": "A genus of evergreen conifer of the family Araucariaceae, order Pinales, that includes the monkey puzzle (Araucaria araucana).", "PM": "2020", "HN": "2020", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080057"}, {"RECTYPE": "D", "MH": "Araucaria araucana", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.625.500.500.250", "MH_TH": "NLM (2020)", "ST": "T002", "RN": "txid42754", "MS": "An evergreen tree commonly known as the monkey-puzzle tree. It grows to 1-1.5 m in diameter and 30-40 m in height, and is native to central and southern Chile, and western Argentina. Araucaria araucana is the hardiest among the conifers, and due to its longevity, is often described as a living fossil.", "PM": "2020", "HN": "2020", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080059"}, {"RECTYPE": "D", "MH": "Protein-Arginine Deiminase Type 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein-Arginine Deiminase Type I|T116|T126|NON|EQV|NLM (2020)|181221|abbcdef", "MN": "D08.811.277.721.250", "FX": "Citrullination", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "EC 3.5.3.15", "MS": "A peptidylarginine deiminase isoenzyme. It is a post-translational modification enzyme that catalyzes the conversion of protein-bound ARGININE residues to CITRULLINE residues in a CALCIUM ion-dependent manner. It functions within the epidermis, targeting INTERMEDIATE FILAMENTS; KERATINS; and filaggrin for CITRULLINATION to promote epidermal cornification.", "PM": "2020; for PEPTIDYLARGININE DEIMINASE TYPE I see HYDROLASES (1999-2019)", "HN": "2020 (1999)", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080062"}, {"RECTYPE": "D", "MH": "Protein-Arginine Deiminase Type 3", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein-Arginine Deiminase Type III|T116|T126|NON|EQV|NLM (2020)|190101|abbcdef", "MN": "D08.811.277.721.375", "FX": "Citrullination", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "EC 3.5.3.15", "MS": "A post-translational enzyme that catalyzes the conversion of protein bound arginine residues to CITRULLINE residues in a CALCIUM ion-dependent manner. PADI3 is a peptidylarginine deiminase isoenzyme expressed in epidermal tissue.", "PM": "2020; for PEPTIDYLARGININE DEIMINASE TYPE III see HYDROLASES 1999-2019", "HN": "2020 (1999)", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080063"}, {"RECTYPE": "D", "MH": "Protein-Arginine Deiminase Type 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein-Arginine Deiminase Type II|T116|T126|NON|EQV|NLM (2020)|181221|abbcdef", "MN": "D08.811.277.721.313", "FX": "Citrullination", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "EC 3.5.3.15", "PI": "Protein-Arginine Deiminases (2018-2019)", "MS": "A widely expressed isoenzyme of peptidylarginine deiminase, a post-translational modification enzyme that catalyzes the conversion of protein-bound ARGININE residues to CITRULLINE residues in a CALCIUM ion-dependent manner.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080064"}, {"RECTYPE": "D", "MH": "Protein-Arginine Deiminase Type 6", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein-Arginine Deiminase Type VI|T116|T126|NON|EQV|NLM (2020)|190101|abbcdef", "MN": "D08.811.277.721.438", "FX": "Citrullination", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "EC 3.5.3.15", "PI": "Protein-Arginine Deiminases (2018-2019)", "MS": "A peptidylarginine deiminase isoenzyme mainly expressed in egg and embryo tissues. It is a post-translational modification enzyme that catalyzes the conversion of protein-bound ARGININE residues to CITRULLINE residues in a CALCIUM ion-dependent manner.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080065"}, {"RECTYPE": "D", "MH": "Contraceptive Agents, Hormonal", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hormonal Contraceptive Agents|T121|NON|EQV|NLM (2020)|181218|abcdef", "MN": "D27.505.954.705.360.360", "FX": "Hormonal Contraception", "MH_TH": "NLM (2020)", "ST": "T121", "RN": "0", "PI": "Contraceptives, Oral, Hormonal (1986-2019)", "MS": "Contraceptive agents that act on the ENDOCRINE SYSTEM.", "PM": "2020", "HN": "2020", "MR": "20190226", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080066"}, {"RECTYPE": "D", "MH": "SLC31 Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Solute Carrier Family 31 Proteins|T116|T123|NON|EQV|NLM (2020)|181205|abbcdef", "MN": "D12.776.543.585.937.762", "MH_TH": "NLM (2020)", "ST": "T123", "RN": "0", "PI": "Cation Transport Proteins (1997-2019)", "MS": "Eukaryotic copper transport proteins that function primarily in the transport of dietary or environmental COPPER.", "PM": "2020", "HN": "2020", "MR": "20190225", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080083"}, {"RECTYPE": "D", "MH": "Calicheamicins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Calicheamicin|T109|T121|NON|NRW|NLM (2020)|181226|abbcdef", "MN": "D09.408.051.247", "MH_TH": "NLM (2020)", "ST": "T121", "RN": "0", "PI": "Enediynes (2007-2019)", "MS": "Enediyne aminoglycosides derived from the bacterium MICROMONOSPORA ECHINOSPORA that are used as antineoplastic antibiotics. They bind to DNA in both healthy and tumor cells, resulting in strand scission and cell death.", "PM": "2020", "HN": "2020", "MR": "20190225", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080084"}, {"RECTYPE": "D", "MH": "Emotional Regulation", "AQ": "CL DE ES PH", "PRINT ENTRY": "Emotional Self-Regulation|T041|NON|EQV|NLM (2020)|190506|abcdef", "ENTRY": "Self-Regulations, Emotional", "MN": "F01.470.311", "MH_TH": "NLM (2020)", "ST": "T041", "PI": "Emotions (1994-2019)", "MS": "The manifestation of an emotional response by which individuals influence the intensity, duration, valence, or manifestation of their response. Emotion regulation either precedes (avoidance, interpretation) or follows an emotion (suppression, reappraisal). Emotion regulation is distinct from coping (focuses primarily on decreasing a negative emotional experience), and can include increasing or decreasing both positive and negative emotions consciously or unconsciously.", "PM": "2020", "HN": "2020", "MR": "20190510", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080103"}, {"RECTYPE": "D", "MH": "Fertility Clinics", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Infertility Clinics|T073|NON|EQV|NLM (2020)|190225|abcdef", "ENTRY": "Infertility Clinic", "MN": "N02.278.204", "MH_TH": "NLM (2020)", "ST": "T073", "MS": "Health clinics offering fertility treatment services.", "PM": "2020", "HN": "2020", "MR": "20190507", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080104"}, {"RECTYPE": "D", "MH": "Relational Autonomy", "ENTRY": "Relational Autonomies", "MN": "N05.350.958.650.500", "MH_TH": "NLM (2020)", "ST": "T078", "PI": "Personal Autonomy (2010-2019)", "MS": "The social context within which all individuals exist and acknowledge the emotional and embodied aspects of decision-makers. The approach acknowledges the central role of others in decision-making, including clinicians, who have a responsibility to engage patients\u2019 and surrogates\u2019 emotional experiences.", "PM": "2020", "HN": "2020", "MR": "20190507", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080105"}, {"RECTYPE": "D", "MH": "Edible Films", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Edible Packaging|T073|NON|REL|NLM (2020)|181230|abcdef", "ENTRY": "Packagings, Edible", "MN": "J01.576.761.350", "MH_TH": "NLM (2020)", "ST": "T072", "MS": "Packaging materials that can be directly consumed. They provide barrier and protection, while enhancing quality and safety of food products. (Bourtoom, 2008).", "PM": "2020", "HN": "2020", "MR": "20190425", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080122"}, {"RECTYPE": "D", "MH": "Avoidant Restrictive Food Intake Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Food Neophobia|T048|NON|EQV|NLM (2020)|181231|abcdef", "ENTRY": "Neophobia, Food", "MN": "F03.400.157", "MH_TH": "NLM (2020)", "ST": "T048", "MS": "An eating or feeding disturbance (e.g., apparent lack of interest in eating or food; avoidance based on the sensory characteristics of food; concern about aversive consequences of eating) as manifested by persistent failure to meet appropriate nutritional and/or energy needs associated with one (or more) of the following: significant weight loss (or failure to achieve expected weight gain or faltering growth in children); significant nutritional deficiency; dependence on enteral feeding or oral nutritional supplements; or marked interference with psychosocial functioning. (from DSM-V)", "PM": "2020", "HN": "2020", "MR": "20210305", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080146"}, {"RECTYPE": "D", "MH": "Early Warning Score", "ENTRY": "Warning Scores, Early", "MN": "N06.850.520.308.980.438.475.364.500.375", "MH_TH": "NLM (2020)", "ST": "T033", "PI": "Severity of Illness Index (2008-2019)", "MS": "Tool for bedside evaluation based on five physiological parameters: SYSTOLIC PRESSURE, PULSE, RESPIRATORY RATE, BODY TEMPERATURE and AVPU (alert, voice, pain, unresponsive) score.", "PM": "2020", "HN": "2020", "MR": "20190425", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080162"}, {"RECTYPE": "D", "MH": "Extreme Weather", "ENTRY": "Weather, Extreme", "MN": "N06.230.300.100.725.193", "MH_TH": "NLM (2020)", "ST": "T067", "PI": "Weather (2014-2019)", "MS": "Events that have extreme values of important meteorological variables. Extreme is generally defined as either taking maximum values or exceedance above pre-existing high thresholds. Such events are generally rare; for example, extreme wind speeds exceeding the 100-year return value, which have a probability of only 0.01 of occurring in any particular year. (Stephenson, 2008)", "PM": "2020", "HN": "2020", "MR": "20190620", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080165"}, {"RECTYPE": "D", "MH": "Intersex Persons", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Person, Intersex", "MN": "M01.270.988.375", "MH_TH": "NLM (2013)", "ST": "T098", "MS": "Those individuals with INTERSEX CONDITIONS, with or without a desire to undergo SEX REASSIGNMENT PROCEDURES.", "PM": "2020; see Transgender Persons 2013-2019", "HN": "2020; was Transgender Persons 2013-2019", "MR": "20210706", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080183"}, {"RECTYPE": "D", "MH": "Hamman-Rich Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Acute Interstitial Pneumonitis|T047|NON|EQV|NLM (2020)|190104|abcdef", "ENTRY": "Pneumonitis, Acute Interstitial", "MN": "C08.381.483.652.500.500", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "Acute idiopathic interstitial pneumonitis characterized by diffuse PULMONARY ALVEOLI damage with uniform edematous connective tissue proliferation. It is often associated with extensive fibroblastic distortion of the lung parenchyma and leads to ADULT RESPIRATORY DISTRESS SYNDROME in later stages.", "PM": "for HAMMAN-RICH SYNDROME see PULMONARY FIBROSIS 1984-2019; for HAMMAN-RICH SYNDROME see IDIOPATHIC PULMONARY FIBROSIS 2010-2019", "HN": "2020; for HAMMAN-RICH SYNDROME use PULMONARY FIBROSIS 1984-2019; for HAMMAN-RICH SYNDROME use IDIOPATHIC PULMONARY FIBROSIS 2010-2019", "MR": "20210510", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080203"}, {"RECTYPE": "D", "MH": "Pancreaticobiliary Maljunction", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anomalous Pancreaticobiliary Junction|T019|NON|EQV|NLM (2023)|210827|abcdef", "ENTRY": "Pancreaticobiliary Maljunctions", "MN": "C16.131.314.778", "MH_TH": "NLM (2020)", "ST": "T019", "PI": "Pancreas/abnormalities (1981-2019)", "MS": "A group of anatomical variations in which the COMMON BILE DUCT and MAIN PANCREATIC DUCT are joined outside the duodenal wall often with abnormally long common channel rather than at the SPHINCTER OF ODDI.", "PM": "2020", "HN": "2020", "MR": "20211018", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080222"}, {"RECTYPE": "D", "MH": "Chronic Urticaria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Idiopathic Chronic Urticaria|T047|NON|NRW|NLM (2020)|190108|abcdef", "ENTRY": "Urticaria, Idiopathic Chronic", "MN": "C23.550.291.500.360", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Urticaria (1963-2019)", "MS": "Wheals (urticaria) and/or angioedema presented with daily symptoms lasting for more than 6 weeks. It may be classified into chronic spontaneous and chronic inducible urticaria depending on whether a specific trigger can be linked to the development of vascular reaction.", "PM": "2020", "HN": "2020", "MR": "20220523", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080223"}, {"RECTYPE": "D", "MH": "Animal Proteins, Dietary", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Proteins, Dietary Animal", "MN": "J02.500.428.159", "MH_TH": "NLM (2020)", "ST": "T116", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Meat (2010-2019)", "MS": "DIETARY PROTEINS derived from ANIMALS.", "PM": "2020", "HN": "2020", "MR": "20190503", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080224"}, {"RECTYPE": "D", "MH": "8-Hydroxy-2'-Deoxyguanosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "8OHdG|T114|ABB|EQV|NLM (2020)|190109|abcdef", "ENTRY": "8 Oxo Deoxyguanosine", "MN": "D13.570.583.454.240.500", "MH_TH": "NLM (2020)", "ST": "T114", "RN": "88847-89-6", "MS": "Common oxidized form of deoxyguanosine in which C-8 position of guanine base has a carbonyl group.", "PM": "2020; 8-OH-DG was indexed under DEOXYGUANOSINE1985-2019", "HN": "2020(1985)", "MR": "20190222", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080242"}, {"RECTYPE": "D", "MH": "Hormonal Contraception", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Male Hormonal Contraception|T061|NON|NRW|NLM (2020)|181218|abcdef", "ENTRY": "Hormonal Contraception, Male", "MN": "E02.875.194.581", "FX": "Contraceptive Agents, Hormonal", "MH_TH": "NLM (2020)", "ST": "T061", "PI": "Contraception (1963-2019)", "MS": "Contraceptive methods that utilize HORMONAL CONTRACEPTIVE AGENTS.", "PM": "2020", "HN": "2020", "MR": "20190225", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080282"}, {"RECTYPE": "D", "MH": "Cricket Sport", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Sports, Cricket", "MN": "I03.450.642.845.255", "MH_TH": "NLM (2020)", "ST": "T056", "PI": "Sports (1963-2019)", "MS": "A competitive sport played with a bat and ball between two teams of eleven players.", "PM": "2020", "HN": "2020", "MR": "20190506", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080304"}, {"RECTYPE": "D", "MH": "Pork Meat", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Pig Meat|T168|NON|EQV|NLM (2020)|190124|abcdef", "ENTRY": "Pork Meats", "MN": "J02.500.600.813.500", "MH_TH": "NLM (2020)", "ST": "T168", "PI": "Red Meat (1963-2019)", "MS": "MEAT or flesh of a pig (Sus scrofa) used as food.", "PM": "2020; see RED MEAT 2016-2019", "HN": "2020; use RED MEAT 2016-2019", "MR": "20190506", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080305"}, {"RECTYPE": "D", "MH": "Hydrogen Deuterium Exchange-Mass Spectrometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "HDX-MS|T059|NON|EQV|NLM (2020)|190124|abcdef", "ENTRY": "Hydrogen Deuterium Exchange Mass Spectrometry", "MN": "E05.196.566.550", "MH_TH": "NLM (2020)", "ST": "T059", "PI": "Deuterium Exchange Measurement (2003-2019)", "MS": "A mass spectrometry method utilizing hydrogen-deuterium exchange kinetics to study conformational and dynamic changes especially of proteins, such as interactions during ligand binding and allosteric effects during catalysis.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080307"}, {"RECTYPE": "D", "MH": "Cardio Ankle Vascular Index", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E01.370.370.680.500", "MH_TH": "NLM (2020)", "ST": "T060", "MS": "An index of ARTERIAL STIFFNESS obtained from PULSE WAVE VELOCITY measurements between the heart and the ankle.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080308"}, {"RECTYPE": "D", "MH": "DNA, Environmental", "AQ": "AN CH GE IP", "PRINT ENTRY": "Environmental DNA|T114|NON|EQV|NLM (2020)|190124|abcdef", "MN": "D13.444.308.577", "FX": "Metagenomics", "MH_TH": "NLM (2020)", "ST": "T114", "RN": "0", "PI": "DNA (1993-2019)", "MS": "DNA found in the ENVIRONMENT that is from the residual biological materials of the resident organisms.", "PM": "2022; see ENVIRONMENTAL DNA 2020-2021", "HN": "2022 (2020)", "MR": "20210707", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080309"}, {"RECTYPE": "D", "MH": "Smart Glasses", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Smartglasses|T073|NON|EQV|NLM (2020)|190125|abcdef", "ENTRY": "Worn Displays, Head", "MN": "L01.224.230.260.550.750", "MH_TH": "NLM (2020)", "ST": "T073", "PI": "Eyeglasses (2013-2019)", "MS": "Computerized eyewear with multiple technological applications for advanced computing and interoperability. Smart glasses are optimized to facilitate information and data access, capture, display, transfer, and manipulation.", "PM": "2020", "HN": "2020", "MR": "20190506", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080310"}, {"RECTYPE": "D", "MH": "Synesthesia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Lexical-Gustatory Synesthesia|T048|NON|NRW|NLM (2020)|190131|abcdef", "ENTRY": "Synesthesias, Lexical-Gustatory", "MN": "C10.597.606.762.850", "MH_TH": "OMIM (2013)", "ST": "T048", "MS": "The experience of involuntary sensory cross activation where the presentation of a particular stimulus elicits a secondary sensory-perceptual experience. It most commonly occurs in the association of color with linguistic stimuli such as letters, numbers, words, or music, but can also occur between other senses. Although synesthesia can be acquired or transient due to trauma or drug use, there is also a strong genetic component, with a prevalence of about 1 in 2,000 individuals and a female to male ratio of 6:1.", "PM": "2020; SYNESTHESIA was indexed under PERCEPTUAL DISORDERS 2011-2019", "HN": "2020(2011)", "MR": "20190506", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080311"}, {"RECTYPE": "D", "MH": "Cyclodialysis Clefts", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Traumatic Cyclodialysis|T037|NON|NRW|NLM (2020)|190211|abcdef", "ENTRY": "Persistent Cyclodialysis Cleft", "MN": "C11.941.160.241.250", "MH_TH": "NLM (2020)", "ST": "T033", "PI": "Eye Injuries (1966-2019)", "MS": "Finding of a separation of the CILIARY BODY in the SCLERAL SPUR region, creating aqueous outflow from the ANTERIOR CHAMBER into suprachoroidal space between the CHOROID and the SCLERA. Persistent cyclodialysis clefts may be associated with OCULAR HYPOTENSION and OPTIC DISC EDEMA.", "PM": "2020", "HN": "2020", "MR": "20190222", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080322"}, {"RECTYPE": "D", "MH": "Uveal Effusion Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Uveal Effusion Syndromes", "MN": "C11.941.160.241.500", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Choroid Diseases (1990-2019)", "MS": "Rare disease characterized by suprachoroidal fluid accumulation between the CHOROID and the SCLERA, annular detachment of the CHOROID, often with secondary RETINAL DETACHMENT; OPTIC DISK EDEMA, and minimal signs of UVEITIS and INTRAOCULAR PRESSURE changes.", "PM": "2020", "HN": "2020", "MR": "20190429", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080323"}, {"RECTYPE": "D", "MH": "Choroidal Effusions", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Suprachoroidal Space|T033|NON|REL|NLM (2020)|190211|abcdef", "ENTRY": "Effusion, Ciliochoroidal", "MN": "C11.941.160.241", "MH_TH": "NLM (2020)", "ST": "T033", "PI": "Choroid Diseases (1974-2019)", "MS": "Finding of fluid accumulation between the CHOROID and the SCLERA.", "PM": "2020", "HN": "2020", "MR": "20190408", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080324"}, {"RECTYPE": "D", "MH": "Meibomian Gland Dysfunction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "MG Dysfunction|T047|ABX|EQV|NLM (2020)|190212|abcdef", "ENTRY": "Meibomian Gland Dysfunctions", "MN": "C11.338.780", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Meibomian Glands (1980-2019)", "MS": "A chronic dysfunction of MEIBOMIAN GLANDS characterized by altered tear film stability and function due to a decrease or alteration in lipid quality/content in meibum. It is often associated with evaporative-type DRY EYE SYNDROME.", "PM": "2020", "HN": "2020", "MR": "20190408", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080343"}, {"RECTYPE": "D", "MH": "Optic Nerve Hypoplasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Superior Segmental Optic Nerve Hypoplasia|T047|NON|NRW|NLM (2020)|190212|abcdef", "ENTRY": "Hypoplasia, Optic Nerve", "MN": "C16.320.290.612", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Optic Nerve/abnormalities (1969-2019)", "MS": "A group of rare genetic disorders characterized by underdeveloped OPTIC NERVES, resulting in increased incidences of vision impairment, CONGENITAL NYSTAGMUS and STRABISMUS. It may be syndromic, and is often associated with CNS malformations.", "PM": "2020", "HN": "2020", "MR": "20190408", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080344"}, {"RECTYPE": "D", "MH": "Familial Exudative Vitreoretinopathies", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "XL-FEVR|T047|ABB|NRW|NLM (2020)|190212|abcdef", "ENTRY": "X Linked Familial Exudative Vitreoretinopathy", "MN": "C16.320.290.352", "MH_TH": "NLM (2020)", "ST": "T047", "MS": "A group of inherited disorders characterized by incomplete development of the retinal vasculature. Its severity can vary from complete blindness in infancy, to mild or no visual problems, where small areas of vascular defects are observable only by FLUORESCEIN ANGIOGRAPHY. Exudative vitreoretinopathy 1 is associated with mutations in the FZD4 gene.", "PM": "2020; FAMILIAL EXUDATIVE VITREORETINOPATHY was indexed under RETINAL DISEASES 2014-2019, and under EYE DISEASES, HEREDITARY 2019", "HN": "2020(2014)", "MR": "20190408", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080345"}, {"RECTYPE": "D", "MH": "Retinal Arterial Macroaneurysm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ruptured Retinal Arterial Macroaneurysm|T033|NON|NRW|NLM (2020)|190213|abcdef", "ENTRY": "Retinal Macroaneurysms", "MN": "C14.907.489.815.500", "MH_TH": "NLM (2020)", "ST": "T033", "PI": "Retinal Hemorrhage(1981-2019)", "MS": "An acquired dilation of the retinal artery often associated with systemic HYPERTENSION.", "PM": "2020", "HN": "2020", "MR": "20190408", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080346"}, {"RECTYPE": "D", "MH": "Stargardt Disease", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stargardt Disease 1|T047|NON|NRW|NLM (2020)|190214|abcdef", "ENTRY": "Stargardt Macular Degenerations", "MN": "C16.320.290.724", "MH_TH": "GHR (2014)", "ST": "T047", "MS": "A juvenile-onset macular dystrophy characterized by progressive loss of VISUAL ACUITY with normal acuity in peripheral VISUAL FIELDS. Other associated clinical features may include LIPOFUSCIN fundus autofluorescence, atrophy of the RETINAL PIGMENT EPITHELIUM, loss of color vision, PHOTOPHOBIA and PARACENTRAL SCOTOMA. Germline mutations in the ABCA4 gene have been identified in recessive and dominant diseases.", "PM": "2020; STARGARDT DISEASE was indexed under MACULAR DEGENERATION 2010-2019", "HN": "2020(2010)", "MR": "20190429", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080362"}, {"RECTYPE": "D", "MH": "White Dot Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Serpiginous Choroidopathy|T047|NON|NRW|NLM (2020)|190215|abcdef", "ENTRY": "White Dot Syndrome", "MN": "C11.941.879.780.900.650", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Retinal Diseases (1992-2019)", "MS": "A group of idiopathic multifocal posterior uveitis syndromes involving the CHOROID; RETINAL PIGMENT EPITHELIUM; and RETINA. They are characterized by multiple lesions of hypoautofluorescent dots in the FUNDUS OCULI and reduced VISUAL ACUITY. Several entities including BIRDSHOT CHORIORETINOPATHY are HLA-A ANTIGENS serotype A29 positive.", "PM": "2020", "HN": "2020", "MR": "20200206", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080363"}, {"RECTYPE": "D", "MH": "Multifocal Choroiditis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Choroiditis, Multifocal", "MN": "C11.941.879.780.900.650.500", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A multifocal uveitis syndrome involving the RETINAL PIGMENT EPITHELIUM and capillary layer of the CHOROID. It is characterized by chronic UVEITIS and multiple CHOROID lesions referred to as white dots, blurry vision, floaters, sensitivity to light, blind spots, and eye discomfort.", "PM": "2020; MULTIFOCAL CHOROIDITIS was indexed under CHOROIDITIS 2010-2019", "HN": "2020(2010)", "MR": "20190429", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080364"}, {"RECTYPE": "D", "MH": "Birdshot Chorioretinopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Birdshot Retinochoroidopathy|T047|NON|EQV|NLM (2020)|190215|abcdef", "ENTRY": "Retinochoroidopathy, Birdshot", "MN": "C20.111.303", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A form of chorioretinitis characterized by multiple small, cream-colored LESIONS, symmetrically scattered mainly around the OPTIC DISK. These lesions are the most distinctive sign and often appear at the level of the RETINAL PIGMENT EPITHELIUM but, on occasion, suggest an even deeper infiltration and may ultimately lead to visual loss. An association with HLA-A29 antigen (see HLA-A ANTIGENS) has been observed in nearly all patients.", "PM": "2020; BIRDSHOT CHORIORETINOPATHY was indexed under CHORIORETINITIS 2010-2019", "HN": "2020", "MR": "20190408", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080365"}, {"RECTYPE": "D", "MH": "Mental Foramen", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Mental Foramina|T029|NON|EQV|NLM (2020)|190219|abcdef", "MN": "A14.521.632.800", "MH_TH": "NLM (2020)", "ST": "T029", "PI": "Mandible (1965-2019)", "MS": "An opening on the anterolateral aspect of the MANDIBLE through which the mental nerve bundle and vessels exit.", "PM": "2020", "HN": "2020", "MR": "20190429", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080383"}, {"RECTYPE": "D", "MH": "Allergoids", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "PRINT ENTRY": "High Molecular Weight Allergoid|T121|NON|NRW|NLM (2020)|190425|abcdef", "ENTRY": "HMW GOID", "MN": "D23.050.063.500", "FX": "Desensitization, Immunologic", "MH_TH": "NLM (2020)", "ST": "T129", "RN": "0", "PI": "Antigens (1971-2019)", "MS": "Extracts of allergens, or purified allergens that have been chemically modified to reduce their ability to induce IGE-MEDIATED HYPERSENSITIVITY (allergenicity) while increasing their ability to induce IMMUNE TOLERANCE.", "PM": "2020; was indexed as PLANT EXTRACTS 1980-2019", "HN": "2020 (1980)", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080384"}, {"RECTYPE": "D", "MH": "Nanogels", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "PRINT ENTRY": "Nanocomposite Hydrogels|T073|NON|NRW|NLM (2020)|190220|abcdef", "ENTRY": "Hydrogel, Nanocomposite", "MN": "J01.637.512.600.596", "MH_TH": "NLM (2020)", "ST": "T073", "RN": "0", "PI": "Nanoparticles(2006-2019)", "MS": "Three-dimensional biocompatible materials formed by cross-linking a hydrophilic polymeric component (e.g., HYDROGELS). They are typically spherical particles in a size range of 20-250 nm when used for drug delivery applications.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080385"}, {"RECTYPE": "D", "MH": "Microgels", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "ENTRY": "Microgel", "MN": "J01.637.051.720.562", "MH_TH": "NLM (2020)", "ST": "T073", "RN": "0", "PI": "Gels (1973-2019)", "MS": "Three-dimensional biocompatible polymers in micrometer size range. They are typically spherical particles in a size range of 1-350 micrometers when used for drug delivery and 3D cell culture applications.", "PM": "2020", "HN": "2020", "MR": "20190429", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080386"}, {"RECTYPE": "D", "MH": "Locked-In Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ventral Pontine Syndrome|T047|NON|EQV|NLM (2020)|190225|abcdef", "ENTRY": "Ventral Pontine Syndromes", "MN": "C23.888.592.636.786.500", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "Acquired neuromuscular disorder characterized by complete paralysis of voluntary muscles and lower CRANIAL NERVES except for limited voluntary eye movements. It is due to various cerebrospinal disconnections at or near the PONS and the POSTERIOR CRANIAL FOSSA, typically secondary to pontine hemorrhage or infarct. Because cognitive function is intact it is sometimes referred to as a pseudocoma state.", "PM": "2020; see QUADRIPLEGIA 1981-2019", "HN": "2020(1981)", "MR": "20190429", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080422"}, {"RECTYPE": "D", "MH": "Universal Health Care", "PRINT ENTRY": "Universal Healthcare|T064|NON|EQV|NLM (2020)|190225|abcdef", "MN": "N04.940", "MH_TH": "NLM (2020)", "ST": "T064", "MS": "Access for all people to needed health services (including prevention, promotion, treatment, rehabilitation and palliation) of sufficient quality to be effective while also ensuring that the use of these services does not expose the user to financial hardship. (From https://www.who.int/healthsystems/universal_health_coverage/en/)", "PM": "2020", "HN": "2020", "MR": "20190620", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080423"}, {"RECTYPE": "D", "MH": "Cytokine Release Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypercytokinemia|T047|NON|EQV|NLM (2021)|200422|abcdef", "ENTRY": "Hypercytokinemias", "MN": "C23.550.835.900.356", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Syndrome(1991-2019)", "MS": "A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.", "PM": "2020", "HN": "2020", "MR": "20210510", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080424"}, {"RECTYPE": "D", "MH": "Social Integration", "AQ": "EH", "ENTRY": "Integration, Social", "MN": "N03.055.750", "MH_TH": "NLM (2020)", "ST": "T053", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "A dynamic and principled process where all members participate in dialogue to achieve and maintain peaceful social relations. It does not include coerced assimilation or forced integration. (from https://www.un.org/esa/socdev/sib/peacedialogue/soc_integration.htm)", "PM": "2020", "HN": "2020", "MR": "20220708", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080442"}, {"RECTYPE": "D", "MH": "Diffuse Intrinsic Pontine Glioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "DIPG, Diffuse Intrinsic Pontine Glioma|T191|ABX|EQV|NLM (2020)|190225|abcdef", "ENTRY": "DIPG Brain Tumor", "MN": "C10.551.240.250.400.200.500", "MH_TH": "NLM (2020)", "ST": "T191", "AN": "coordinate with BRAIN STEM NEOPLASMS", "PI": "Glioma (1986-2019)", "MS": "A rare, aggressive brain tumor that forms in the GLIAL CELLS in the PONS.", "PM": "2020", "HN": "2020", "MR": "20190429", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080443"}, {"RECTYPE": "D", "MH": "Phenomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Phenomic", "MN": "H01.158.273.343.775", "FX": "Phenotype", "MH_TH": "NLM (2020)", "ST": "T091", "PI": "Phenotype (1999-2019)", "MS": "The systematic study of how genetic information or GENOMICS translates into biochemical, metabolic and morphological traits of an organism.", "PM": "2020", "HN": "2020", "MR": "20190618", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080444"}, {"RECTYPE": "D", "MH": "Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Asthma-COPD Overlap Syndrome|T047|ABX|EQV|NLM (2020)|190225|abcdef", "ENTRY": "Overlap Syndrome, Asthma-COPD", "MN": "C23.550.291.500.875.500", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Asthma (2013-2019)", "MS": "Syndrome with clinical features of both ASTHMA and COPD.", "PM": "2020", "HN": "2020", "MR": "20210312", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080445"}, {"RECTYPE": "D", "MH": "Acyclic Monoterpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monoterpenes, Acyclic", "MN": "D02.455.849.575.125", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "PI": "Monoterpenes (2003-2019)", "MS": "Linear compounds that contain a single monoterpene unit.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080462"}, {"RECTYPE": "D", "MH": "Sand", "AQ": "CH CL MI PS ST VI", "ENTRY": "Sands", "MN": "N06.230.600.750", "MH_TH": "NLM (2020)", "ST": "T197", "RN": "0", "MS": "A hard granular material that is a component of soil. It is composed of very small pieces (between 0.06 and 2.0 millimeters in diameter) of disintegrating rock.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080463"}, {"RECTYPE": "D", "MH": "Enhanced Recovery After Surgery", "AQ": "ST", "PRINT ENTRY": "Enhanced Postsurgical Recovery|T061|NON|EQV|NLM (2020)|190304|abcdef", "ENTRY": "Recovery, Enhanced Postsurgical", "MN": "E04.604.125", "MH_TH": "NLM (2020)", "ST": "T061", "MS": "A protocol of components related to preadmission, preoperative, intraoperative, and postoperative care. The protocol is implemented with the goal of improving patient recovery, facilitating earlier discharge from the hospital, and potentially reducing health care costs without increasing complications or hospital readmissions. The protocol components may contribute to minimizing, and/or improving the response to, physiological stress associated with surgery.", "PM": "2020", "HN": "2020", "MR": "20190506", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080482"}, {"RECTYPE": "D", "MH": "Atomic Bomb Survivors", "AQ": "CL HI LJ PX SN", "PRINT ENTRY": "Hibakusha|T098|NON|NRW|NLM (2020)|190304|abcdef", "ENTRY": "Survivors, Atomic Bomb", "MN": "M01.860.325", "FX": "Radioactive Fallout", "MH_TH": "NLM (2020)", "ST": "T098", "MS": "Persons who survived exposure to RADIATION due to ATOMIC BOMBS.", "PM": "2020", "HN": "2020", "MR": "20190405", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080483"}, {"RECTYPE": "D", "MH": "Sudden Unexpected Death in Epilepsy", "AQ": "EH EP ET PA PC VE", "PRINT ENTRY": "SUDEP|T033|ACR|EQV|NLM (2020)|190305|abcdef", "MN": "C23.550.260.322.812", "MH_TH": "NLM (2020)", "ST": "T033", "PI": "Epilepsy (1989-2019)", "MS": "Sudden death in a patient with EPILEPSY associated with SEIZURES and seizure-related symptoms (e.g., APNEA; HYPOXEMIA) without other identifiable accidental causes (e.g., DROWNING; WOUNDS AND INJURIES).", "PM": "2020", "HN": "2020", "MR": "20190408", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080485"}, {"RECTYPE": "D", "MH": "Computational Chemistry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Chemistry, Computational", "MN": "H01.181.590", "FX": "Computational Biology", "MH_TH": "NLM (2020)", "ST": "T091", "MS": "A branch of chemistry that utilizes computers as well as principles of chemistry and mathematics to generate data and solve problems related to the properties, structures, and reactions of molecules and materials.", "PM": "2020", "HN": "2020", "MR": "20190404", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080486"}, {"RECTYPE": "D", "MH": "Internet of Things", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "MN": "L01.224.230.110.500.657", "MH_TH": "NLM (2020)", "ST": "T170", "PI": "Internet (2004-2019)", "MS": "Networking capability which facilitates information flow to and from objects and devices using the INTERNET.", "PM": "2020", "HN": "2020", "MR": "20190708", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080487"}, {"RECTYPE": "D", "MH": "Fictional Works as Topic", "MN": "L01.462.500.682.192.459", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "do not confuse with the Publication Type FICTIONAL WORK", "MS": "Works about creative writing, not presented as factual.", "PM": "2020", "HN": "2020", "MR": "20220712", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080503"}, {"RECTYPE": "D", "MH": "Trichothecenes, Type A", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Type A Trichothecenes|T109|NON|EQV|NLM (2020)|190307|abcdef", "ENTRY": "A Trichothecenes, Type", "MN": "D23.946.587.933.950", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "PI": "Trichothecenes (1991-2019)", "MS": "A subclass of Trichothecene derivatives that include the 12,13-epoxytrichothec-9-ene structure of the molecule with the C-8 position containing either no oxygen substitution, a hydroxyl group at C-8, or an ester function at C-8.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080505"}, {"RECTYPE": "D", "MH": "Sialyl Lewis X Antigen", "AQ": "AA AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Sialylated Lewis X Antigen|T088|T109|T129|NON|EQV|NLM (2020)|190307|abbbcdef", "ENTRY": "Sialyl Stage Specific Embryonic Antigen 1", "MN": "D23.101.140.075.050.500", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "MS": "A sialylated version of Lewis X antigen expressed on cell surfaces. It is a ligand for SELECTINS.", "PM": "2020; was indexed as LEWIS X ANTIGEN 2008-2019; was also indexed as OLIGOSACCHARIDES 1994-2019", "HN": "2020 (2008)", "MR": "20190709", "DA": "20190709", "DC": "1", "DX": "20200101", "UI": "D000080506"}, {"RECTYPE": "D", "MH": "Sapajus apella", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Tufted Capuchin Monkeys|T015|NON|EQV|NLM (2020)|190312|abcdef", "ENTRY": "Tufted Capuchin Monkey", "MN": "B01.050.150.900.649.313.988.400.600.150.170.560.500", "MH_TH": "NLM (2020)", "ST": "T015", "RN": "txid9515", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "PI": "Cebus (1963-2019)", "MS": "A species of the genus SAPAJUS, subfamily CEBINAE, family CEBIDAE, consisting of tufted capuchin monkeys with characteristic black head cap and sideburn coloration with tufts of dark fur above the ears. S. apella was known as Cebus apella and C. a. apella.", "PM": "2020", "HN": "2020", "MR": "20200813", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080522"}, {"RECTYPE": "D", "MH": "Sapajus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Yellow-Breasted Capuchin|T015|NON|NRW|NLM (2020)|190313|abcdef", "ENTRY": "Yellow-Breasted Capuchins", "MN": "B01.050.150.900.649.313.988.400.600.150.170.560", "MH_TH": "NLM (2020)", "ST": "T015", "RN": "txid1532884", "RR": "txid649471", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "PI": "Cebus (2010-2019)", "MS": "A genus of the family CEBIDAE, subfamily CEBINAE, consisting of capuchin monkeys with characteristic tufts of hair over the eyes and sides of the head. Many were formerly classified under genus CEBUS. Sapajus inhabits the forests of Central and South America.", "PM": "2020", "HN": "2020", "MR": "20200813", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080523"}, {"RECTYPE": "D", "MH": "Cebus capucinus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "White-Throated Capuchin|T015|NON|EQV|NLM (2020)|190313|abcdef", "ENTRY": "White-Throated Capuchins", "MN": "B01.050.150.900.649.313.988.400.600.150.170.120.500", "MH_TH": "NLM (2020)", "ST": "T015", "RN": "txid9516", "RR": "txid2715852", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "PI": "Cebus(1980-2019)", "MS": "A species of the genus CEBUS, family CEBIDAE, consisting of capuchin monkeys with white markings over most of frontal areas of the face, chest and upper arms.", "PM": "2020", "HN": "2020", "MR": "20211018", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080526"}, {"RECTYPE": "D", "MH": "Macaca fuscata", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Snow Monkey|T015|NON|EQV|NLM (2020)|190314|abcdef", "ENTRY": "Snow Monkeys", "MN": "B01.050.150.900.649.313.988.400.112.199.120.510.535", "MH_TH": "NLM (2020)", "ST": "T015", "RN": "txid9542", "RR": "txid9543", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "MS": "A species of the genus MACACA characterized by red naked face. M. fuscata is primarily ground-dwelling in forest and mountains often near hot springs in Japan.", "PM": "2020; see MACACA 1980-2019", "HN": "2020(1980)", "MR": "20200813", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080527"}, {"RECTYPE": "D", "MH": "Twinning, Embryonic", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Twinning, Embryo|T040|NON|EQV|NLM (2020)|190314|abcdef", "MN": "G08.686.784.170.104.625", "MH_TH": "NLM (2020)", "ST": "T040", "PI": "Twins (1963-2019)", "MS": "The development of two EMBRYOS in a single UTERUS at the same time.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080530"}, {"RECTYPE": "D", "MH": "Macaca arctoides", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Stump-Tailed Macaque|T015|NON|EQV|NLM (2020)|190315|abcdef", "ENTRY": "Stump-tailed Macaque, Brown", "MN": "B01.050.150.900.649.313.988.400.112.199.120.510.260", "MH_TH": "NLM (2020)", "ST": "T015", "RN": "txid9540", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "PI": "Macaca (1970-2019)", "MS": "A species of the genus MACACA inhabiting India, China, and other parts of southern Asia. The species is characterized by its thick brown fur covering most of its body except the face and short tail.", "PM": "2020", "HN": "2020", "MR": "20200813", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080531"}, {"RECTYPE": "D", "MH": "Alouatta caraya", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Paraguayan Black Howler Monkey|T015|EPO|EQV|NLM (2020)|190315|abcdef", "ENTRY": "Mono Aulladors", "MN": "B01.050.150.900.649.313.988.400.600.075.050.075.500", "MH_TH": "NLM (2020)", "ST": "T015", "RN": "txid9502", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "PI": "Alouatta (1970-2019)", "MS": "A species of the genus ALOUATTA, family ATELIDAE, inhabiting the forests of South America. Although sometimes known as black howler only adult males have black hair and adult females and juveniles are gold in color. Closely related A. pigra in Central America and A. nigerrima in the Amazon are also called black howlers.", "PM": "2020", "HN": "2020", "MR": "20200813", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080532"}, {"RECTYPE": "D", "MH": "Twinning, Dizygotic", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Dizygous Twinning|T040|NON|EQV|NLM (2020)|190315|abcdef", "ENTRY": "Twinning, Dizygous", "MN": "G08.686.784.170.104.625.500", "MH_TH": "NLM (2020)", "ST": "T040", "PI": "Twins, Dizygotic (1975-2019)", "MS": "The development of two genetically distinct EMBRYOS in a single UTERUS at the same time, from two separate OVA fertilized by two separate SPERMATOZOA.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080534"}, {"RECTYPE": "D", "MH": "Decision Making, Shared", "ENTRY": "Shared Decision Making", "MN": "I03.743.500", "MH_TH": "NLM (2012)", "ST": "T041", "PI": "Decision Making (2000-2019)", "MS": "Collaborative process of reaching a decision.", "PM": "2020", "HN": "2020", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080536"}, {"RECTYPE": "D", "MH": "Presbytini", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Trachypithecus|T015|NON|NRW|NLM (2020)|190318|abcdef", "ENTRY": "Snub-Nosed Monkey", "MN": "B01.050.150.900.649.313.988.400.112.199.150.575", "MH_TH": "NLM (2020)", "ST": "T015", "RR": "txid9573", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "MS": "The tribe of subfamily COLOBINAE, family CERCOPITHECIDAE. They are found in India, Indonesia, Malaysia, and Thailand.", "PM": "2020; for PRESBYTIS and PYGATHRIX see CERCOPITHECIDAE (1980-2019)", "HN": "2020; for PRESBYTIS and PYGATHRIX use CERCOPITHECIDAE (1980-2019)", "MR": "20200902", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080542"}, {"RECTYPE": "D", "MH": "Indriidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Woolly Lemurs|T015|NON|NRW|NLM (2020)|190319|abcdef", "ENTRY": "Woolly Lemur", "MN": "B01.050.150.900.649.313.988.700.354", "MH_TH": "UNK (19XX)", "ST": "T015", "RN": "txid30599", "RR": "txid34826", "MS": "A family of primates of the superfamily LEMUROIDEA, suborder STREPSIRRHINI containing genera AVAHI (woolly lemurs); INDRI; and PROPITHECUS (sifakas). The family is distributed in Madagascar.", "PM": "2020; see STREPSIRRHINI 1981-2019", "HN": "2020(1981)", "MR": "20200813", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080544"}, {"RECTYPE": "D", "MH": "Microplastics", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO", "PRINT ENTRY": "Plastic Nanoparticles|T073|NON|NRW|NLM (2020)|190321|abcdef", "ENTRY": "Plastic Nanoparticle", "MN": "J01.637.051.720.716.294", "FX": "Microspheres", "MH_TH": "NLM (2020)", "ST": "T073", "RN": "0", "PI": "Plastics (2006-2019)", "MS": "Plastic particles, less than 5 millimeters in diameter, that are generated from the degradation of larger pieces or are manufactured to be microstructures or smaller.", "PM": "2020", "HN": "2020", "MR": "20190708", "DA": "20190709", "DC": "1", "DX": "20200101", "UI": "D000080545"}, {"RECTYPE": "D", "MH": "Space Research", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Research, Space", "MN": "H01.770.644.966", "FX": "Exobiology", "MH_TH": "NLM (2020)", "ST": "T062", "MS": "Studies of interactions between living organisms and characteristics of the extraterrestrial environment. These studies specifically address the structure and function of living organisms in an extraterrestrial environment and interdependent relationships of organisms with each other and/or the extraterrestrial environment while also touching on the origin, evolution and potential for extraterrestrial life. (From www.nasa.gov/audience/foreducators/spacelife/)", "PM": "2020", "HN": "2020", "MR": "20190707", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080546"}, {"RECTYPE": "D", "MH": "Autophagic Cell Death", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Autophagy-Dependent Cell Death|T043|NON|EQV|NLM (2020)|190322|abcdef", "ENTRY": "Deaths, Autophagy-Dependent Cell", "MN": "G04.146.954.053", "MH_TH": "NLM (2006)", "ST": "T043", "AN": "do not confuse with AUTOPHAGY", "PI": "Autophagy (2001-2019)", "MS": "A major activation of the autophagic pathway, characterized by massive accumulation of AUTOPHAGOSOMES and CELL DEATH.", "PM": "2020; see Autophagy 2006-2019", "HN": "2020; use Autophagy 2006-2019", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080549"}, {"RECTYPE": "D", "MH": "Macroautophagy", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Xenophagy|T043|NON|NRW|NLM (2020)|190328|abcdef", "ENTRY": "Macro Autophagy", "MN": "G04.011.750", "MH_TH": "NLM (2017)", "ST": "T043", "PI": "Autophagy (1991-2019)", "MS": "The segregation of large parts of the cytoplasm, including ORGANELLES and PROTEIN AGGREGATES, into AUTOPHAGOSOMES and lysosomal degradation after fusion with LYSOSOMES.", "PM": "2020; see AUTOPHAGY 2017-2019", "HN": "2020; use AUTOPHAGY 2017-2019", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080550"}, {"RECTYPE": "D", "MH": "Microautophagy", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Piecemeal Microautophagy|T043|NON|NRW|NLM (2020)|190424|abcdef", "ENTRY": "Microautophagy, Piecemeal", "MN": "G04.011.875", "MH_TH": "NLM (2020)", "ST": "T043", "PI": "Autophagy (1981-2019)", "MS": "A type of autophagy in which the cytoplasmic entities, such as parts of CELL NUCLEI; damaged MITOCHONDRIA; and lipid droplets, are taken up by small vesicles such as VACUOLES or MULTIVESICULAR BODIES, and degraded by lysosomal digestion.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080551"}, {"RECTYPE": "D", "MH": "Universal Design", "AQ": "EC LJ SN ST TD", "PRINT ENTRY": "Human Centered Design|T078|NON|EQV|NLM (2020)|190510|abcdef", "ENTRY": "Universal Designs", "MN": "J01.293.910", "MH_TH": "NLM (2020)", "ST": "T078", "MS": "The design of products and environments to be usable by all people, to the greatest extent possible, without the need for adaption or specialized design.", "PM": "2020", "HN": "2020", "MR": "20190707", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080562"}, {"RECTYPE": "D", "MH": "Right to Health", "AQ": "CL EC ED ES HI LJ PX SN ST TD", "PRINT ENTRY": "Right to Healthcare|T064|NON|EQV|NLM (2020)|190325|abcdef", "ENTRY": "Rights, Healthcare", "MN": "N04.590.374.350.750", "MH_TH": "NLM (2020)", "ST": "T064", "PI": "Human Rights (1980-2019)", "MS": "Right to accessible health services physically within reach for all sections of the population, including children, adolescents, older persons, persons with disabilities and other vulnerable groups as well as financially and on the basis of non-discrimination. Accessibility also implies the right to seek, receive and impart health-related information in an accessible format for all, including persons with disabilities, but does not impair the right to have personal health data treated confidentially.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080564"}, {"RECTYPE": "D", "MH": "Ateles geoffroyi", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Geoffroy's Spider Monkey|T015|EPO|EQV|NLM (2020)|190326|abcdef", "ENTRY": "Spider Monkey, Geoffroy's", "MN": "B01.050.150.900.649.313.988.400.600.075.075.500", "MH_TH": "NLM (2020)", "ST": "T015", "RN": "txid9509", "RR": "txid795835", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "PI": "Atelinae(2006-2019)", "MS": "A species in the genus ATELES, subfamily ATELINAE, comprising several Mesoamerican spider monkeys including Geoffroy's spider monkey (Ateles geoffroyi geoffroyi). Sometimes referred to as Central American spider monkey, it inhabits rainforest from Mexico to Colombia.", "PM": "2020", "HN": "2020", "MR": "20200902", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080583"}, {"RECTYPE": "D", "MH": "Callicebus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Titi Monkeys|T015|NON|EQV|NLM (2020)|190320|abcdef", "ENTRY": "Titi Monkey", "MN": "B01.050.150.900.649.313.988.400.600.575.500", "MH_TH": "NLM (2007)", "ST": "T015", "RN": "txid9522", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "MS": "A genus of the subfamily CALLICEBINAE, family PITHECIIDAE, generally comprising of five species: C. barbarabrownae; C. coimbrai; C. melanochir; C. nigrifrons; C. personatus. Titi monkeys inhibit lower levels of the forest in South America.", "PM": "2020; see PITHECIIDAE 2007-2019", "HN": "2020; use PITHECIIDAE 2007-2019", "MR": "20200813", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080602"}, {"RECTYPE": "D", "MH": "Galagidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Squirrel Galagos|T015|NON|NRW|NLM (2020)|190327|abcdef", "ENTRY": "Squirrel Galago", "MN": "B01.050.150.900.649.313.988.700.277", "MH_TH": "NLM (2020)", "ST": "T015", "RN": "txid40297", "RR": "txid89671", "PI": "Primates (1965-2019)", "MS": "A family of Primates of the suborder Strepsirhini containing six genera. The family is widely distributed in Africa near Subsaharan region. The six genera are: Euoticus (needle-clawed galagos), GALAGO (bush babies), Galagoides (dwarf galagos), Otolemur (greater galagos), Paragalago and Sciurocheirus (squirrel galagos). All are primarily arboreal and nocturnal.", "PM": "2020;for EUOTICUS see under GALAGOS 1981-2019", "HN": "2020;for EUOTICUS use under GALAGOS 1981-2019", "MR": "20200902", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080623"}, {"RECTYPE": "D", "MH": "Chaperone-Mediated Autophagy", "AQ": "DE GE IM PH RE", "ENTRY": "Chaperone Mediated Autophagy", "MN": "G04.011.625", "MH_TH": "NLM (2020)", "ST": "T043", "PI": "Autophagy (2000-2019)", "MS": "A selective type of autophagy in which a specific set of cytosolic proteins are moved across the membrane of the LYSOSOMES by protein translocation, rather than by invagination of the lysosomal membrane. The proteins that will be degraded by chaperone-mediated autophagy (CMA) contain a CMA-targeting motif that, when exposed, is recognized by the cytosolic chaperone HSPA8 (aka Hsc70) and cochaperones which deliver the protein to LAMP2A monomers on the lysosome cell surface for translocation via the LAMP2A translocation complex. CMA is distinguished from CHAPERONE-ASSISTED-SELECTIVE AUTOPHAGY - a type of selective MACROAUTOPHAGY.", "PM": "2020", "HN": "2020", "MR": "20190708", "DA": "20190709", "DC": "1", "DX": "20200101", "UI": "D000080642"}, {"RECTYPE": "D", "MH": "Phospholipid Hydroperoxide Glutathione Peroxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Selenium-Dependent Glutathione Peroxidase Type-4|T116|T126|NON|EQV|NLM (2006)|190329|abbcdef", "ENTRY": "Selenium Dependent Glutathione Peroxidase Type 4", "MN": "D12.776.864.050.750", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "EC 1.11.1.12", "PI": "Glutathione Peroxidase (1990-2019)", "MS": "A selenoenzyme that converts GLUTATHIONE plus FATTY ACID HYDROPEROXIDES to GLUTATHIONE DISULFIDE plus hydroxy fatty acids and water.", "PM": "2020; was indexed as GLUTATHIONE PEROXIDASE 1990-2019", "HN": "2020 (1990)", "MR": "20220712", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080662"}, {"RECTYPE": "D", "MH": "Salads", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Salad|T168|NON|EQV|NLM (2020)|190521|abcdef", "MN": "J02.500.756", "MH_TH": "NLM (2020)", "ST": "T168", "PI": "Vegetables (1985-2019)", "MS": "A prepared mixture of cooked and/or raw vegetables, FRUIT, or other foods, garnished with a dressing CONDIMENT, and eaten as a MEAL or side dish.", "PM": "2020", "HN": "2020", "MR": "20190708", "DA": "20190709", "DC": "1", "DX": "20200101", "UI": "D000080682"}, {"RECTYPE": "D", "MH": "Edible Insects", "AQ": "AH CH CL CY DE EC EM EN GD GE HI IM IP ME MI PH PS PY RE SD ST UL VI", "PRINT ENTRY": "Insects As Food|T008|T168|NON|EQV|NLM (2020)|190521|abbcdef", "ENTRY": "Insects, Edible", "MN": "J02.500.463", "MH_TH": "NLM (2020)", "ST": "T168", "PI": "Insecta (1973-2019)", "MS": "Organisms of the INSECTA class that are used as food or are suitable as a nutritional source, especially by humans.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080702"}, {"RECTYPE": "D", "MH": "Shape Memory Alloys", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Shape-Memory Alloys|T122|T197|NON|EQV|NLM (2020)|190402|abbcdef", "ENTRY": "Shape-Memory Alloy", "MN": "J01.637.051.860.250", "MH_TH": "NLM (2020)", "ST": "T197", "RN": "0", "MS": "ALLOYS designed to recover their original shape upon heating.", "PM": "2020", "HN": "2020", "MR": "20190517", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080743"}, {"RECTYPE": "D", "MH": "Smart Materials", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Smart Material|T104|T122|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Polymer, Shape-Memory", "MN": "J01.637.051.860", "MH_TH": "NLM (2020)", "ST": "T122", "RN": "0", "MS": "Materials designed to change properties in response to changes in their environment adopting various predetermined shapes and/or functionalities.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080745"}, {"RECTYPE": "D", "MH": "Stimuli Responsive Polymers", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Stimulus-Responsive Polymers|T104|T122|NON|EQV|NLM (2020)|190402|abbcdef", "ENTRY": "Stimulus-Responsive Polymer", "MN": "J01.637.051.860.500", "MH_TH": "NLM (2020)", "ST": "T122", "RN": "0", "MS": "Polymeric materials designed to change properties in response to a stimulus.", "PM": "2020", "HN": "2020", "MR": "20190517", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080762"}, {"RECTYPE": "D", "MH": "Sea Level Rise", "AQ": "CL EC HI MO SN", "PRINT ENTRY": "Sea-Level Rise|T070|NON|EQV|NLM (2020)|190402|abcdef", "ENTRY": "Sea Levels, Rising", "MN": "G16.500.971.500", "MH_TH": "NLM (2020)", "ST": "T070", "MS": "An increase in the volume of the oceans and seas causing an elevation of the air-sea interface.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080763"}, {"RECTYPE": "D", "MH": "Horticulture", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Floriculture|T090|NON|NRW|NLM (2020)|190404|abcdef", "MN": "J01.040.498", "MH_TH": "NLM (2020)", "ST": "T090", "PI": "Gardening (1963-2019)", "MS": "Branch of agriculture which involves the cultivation of vegetables, flowers, or ornamental plants for food, industrial, medicinal, or aesthetic purposes. It does not include CROP PRODUCTION on a large scale.", "PM": "2020", "HN": "2020", "MR": "20190404", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080802"}, {"RECTYPE": "D", "MH": "Biosolids", "AQ": "AN LJ MI PS SN VI", "PRINT ENTRY": "Biosolid|T167|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D20.944.730.500", "MH_TH": "NLM (2020)", "ST": "T167", "RN": "0", "PI": "Sewage (1995-2019)", "MS": "Wastewater SLUDGE treated by processes such as COMPOSTING, anaerobic digestion, aerobic digestion, alkaline treatment, and PASTEURIZATION to remove HAZARDOUS CHEMICALS and pathogens.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080803"}, {"RECTYPE": "D", "MH": "Relative Energy Deficiency in Sport", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "RED-S Relative Energy Deficiency in Sport|T047|NON|EQV|NLM (2020)|190405|abcdef", "ENTRY": "RED-Ss", "MN": "F03.400.937", "MH_TH": "NLM (2020)", "ST": "T047", "MS": "Health disorders associated with low caloric intake of individuals involved in high-activity SPORTS.", "PM": "2020", "HN": "2020", "MR": "20190405", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080822"}, {"RECTYPE": "D", "MH": "Undiagnosed Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Undiagnosed Disease", "MN": "C23.550.291.968", "FX": "Delayed Diagnosis", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Rare Diseases (2008-2019)", "MS": "Rare and common diseases lacking a diagnosis.", "PM": "2020", "HN": "2020", "MR": "20190408", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080842"}, {"RECTYPE": "D", "MH": "Brain Regeneration", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Endogenous Regeneration of Brain|T042|NON|EQV|NLM (2020)|190408|abcdef", "ENTRY": "Regeneration, Brain", "MN": "G16.762.309", "MH_TH": "NLM (2020)", "ST": "T042", "MS": "Endogenous repair and regeneration of the brain.", "PM": "2020", "HN": "2020", "MR": "20200717", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080843"}, {"RECTYPE": "D", "MH": "Sugar-Sweetened Beverages", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Sweetened Drinks|T168|NON|REL|NLM (2020)|190408|abcdef", "ENTRY": "Sweetened Beverages, Sugar", "MN": "J02.200.772", "MH_TH": "NLM (2020)", "ST": "T168", "MS": "Liquids or drinks sweetened with added sugars of various forms.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190709", "DC": "1", "DX": "20200101", "UI": "D000080845"}, {"RECTYPE": "D", "MH": "Lactate Dehydrogenase 5", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lactate Dehydrogenase-M|T116|T126|NON|EQV|NLM (2020)|190409|abbcdef", "ENTRY": "M4LDH", "MN": "D08.811.682.047.551.400.500", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "EC 1.1.1.27.-", "MS": "A member of the LACTATE DEHYDROGENASES isozyme family, Lactate Dehydrogenase 5 is localized to liver and skeletal muscle cells where its expression increases in liver disease and striated muscle trauma respectively.", "PM": "2020; LACTATE DEHYDROGENASE 5 was indexed under L-LACTATE DEHYDROGENASE 2000-2019, and ISOENZYMES 2000-2019", "HN": "2020 (2000)", "MR": "20190531", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080864"}, {"RECTYPE": "D", "MH": "Formins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Formin Homology Proteins|T116|NON|EQV|NLM (2020)|190410|abcdef", "ENTRY": "Formins, Diaphanous-Related", "MN": "D12.776.220.525.333", "MH_TH": "NLM (2020)", "ST": "T116", "RN": "0", "PI": "Microfilament Proteins (1992-2019)", "MS": "A family of multidomain microfilament proteins associated with ACTIN FILAMENTS. They generally have multiple Formin-Homology domains (e.g., FH2 domain) and additionally have a RhoGTPase-binding domain and a diaphanous inhibitory domain. Formins and homologs are involved in actin reorganization.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080865"}, {"RECTYPE": "D", "MH": "Nucleobindins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleobindin-1 protein|T116|NON|NRW|NLM (2020)|190518|abcdef", "ENTRY": "protein, Nucleobindin-1", "MN": "D12.776.260.623", "MH_TH": "NLM (2020)", "ST": "T123", "RN": "0", "MS": "A DNA and calcium binding protein which plays a role in calcium homeostasis.", "PM": "2020; was indexed under GROWTH SUBSTANCES (1992-2003); see CALCIUM-BINDING PROTEINS 1993-1999; see DNA-BINDING PROTEINS 1993-1999, see NERVE TISSUE PROTEINS 1993-1999; see NUCLEOBINDIN 2000-2019", "HN": "2020 (2000)", "MR": "20190531", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080866"}, {"RECTYPE": "D", "MH": "Gingipain Cysteine Endopeptidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RGPB Protein|T116|ABX|NRW|NLM (2020)|190410|abcdef", "ENTRY": "RGP 2 Gingipain", "MN": "D08.811.277.656.262.500.468", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "0", "RR": "EC 3.4.22.47", "PI": "Cysteine Endopeptidases (1992-2019)", "MS": "Cysteine endoproteinases, from periodontal pathogen PORPHYROMONAS GINGIVALIS, acting as virulence factors associated with PERIODONTITIS. They are produced as pre-proproteins which mature into ARGININE and LYSINE specific endopeptidases.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080867"}, {"RECTYPE": "D", "MH": "Water Decolorization", "AQ": "EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Wastewater Decolorization|T052|NON|NRW|NLM (2020)|190410|abcdef", "ENTRY": "Water Decolorization, Waste", "MN": "N06.850.860.510.900.900.500", "FX": "Coloring Agents", "MH_TH": "NLM (2020)", "ST": "T052", "PI": "Waste Management (1996-2019)", "MS": "The removal of DYES; STAINS; or other COLORING AGENTS, natural or synthetic, from water sources by various processes such as ADSORPTION; BIOREMEDIATION; enzymatic digestion; and ELECTROLYSIS.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080868"}, {"RECTYPE": "D", "MH": "Jugular Foramina", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Jugular Foramen|T030|NON|EQV|NLM (2020)|190410|abcdef", "ENTRY": "Foramina, Jugular", "MN": "A02.835.232.781.750.400.500", "MH_TH": "NLM (2020)", "ST": "T030", "PI": "Skull (1964-2019)", "MS": "A pair of openings from the posterior cranial fossa through which the GLOSSOPHARYNGEAL NERVE; VAGUS NERVE; ACCESSORY NERVE and the internal JUGULAR VEINS pass.", "PM": "2020", "HN": "2020", "MR": "20190517", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080869"}, {"RECTYPE": "D", "MH": "R-Loop Structures", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "R-Loops|T114|NON|EQV|NLM (2020)|190410|abcdef", "ENTRY": "R-Loop Structure", "MN": "G05.360.580.690", "MH_TH": "NLM (2020)", "ST": "T114", "MS": "An RNA-DNA hybrid structure formed when newly transcribed RNA remains bound to its DNA template. Stability of R-loops may play a role in GENETIC INSTABILITY.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080870"}, {"RECTYPE": "D", "MH": "Movable Books", "PRINT ENTRY": "Paper Manikins|T073|NON|REL|NLM (2020)|190705|abcdef", "MN": "V02.535", "MH_TH": "NLM (2020)", "ST": "T073", "AN": "INDEXER: do not use", "MS": "Books having mechanisms or parts that move, or are moved by the reader.", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "2", "DX": "20200101", "UI": "D000080871"}, {"RECTYPE": "D", "MH": "Open Abdomen Techniques", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Open Abdomen Treatment|T061|NON|REL|NLM (2020)|190410|abcdef", "ENTRY": "Treatments, Open Abdomen", "MN": "E04.987.100.500", "MH_TH": "NLM (2020)", "ST": "T061", "MS": "Abdominal wound closure techniques in which the opening from a laparoscopic abdominal incision is left open, but covered, to reduce or prevent INTRA-ABDOMINAL HYPERTENSION.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080872"}, {"RECTYPE": "D", "MH": "Multifunctional Nanoparticles", "AQ": "AD AE AN CH CL EC HI ME MI PO PS RE SD SN ST TO TU UL VI", "PRINT ENTRY": "Two-Faced Nanoparticles|T073|NON|NRW|NLM (2020)|190411|abcdef", "ENTRY": "Two Faced Nanoparticles", "MN": "J01.637.512.600.525", "MH_TH": "NLM (2020)", "ST": "T073", "PI": "Nanoparticles (2005-2019)", "MS": "Nanoparticles that are engineered to have two or more physical properties.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080873"}, {"RECTYPE": "D", "MH": "Synucleinopathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "alpha-Synucleinopathies|T047|NON|EQV|NLM (2020)|190411|abcdef", "ENTRY": "alpha-Synucleinopathy", "MN": "C18.452.845.650", "FX": "alpha-Synuclein", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "alpha-Synuclein (1999-2019)", "MS": "Neurodegenerative disorders involving deposition of abnormal ALPHA-SYNUCLEIN in dopaminergic neurons and glial cells in the brain. Pathological aggregations of alpha-synuclein proteins results in LEWY BODIES and Lewy neurites; melanin granules in the SUBSTANTIA NIGRA and LOCUS COERULEUS; and glial cytoplasmic inclusions. Synucleinopathies are associated with mutation in the ALPHA-SYNUCLEIN (SNCA) gene on chromosome 4. PARKINSON DISEASE; LEWY BODY DISEASE with dementia; and MULTIPLE SYSTEM ATROPHY are prominent examples of synucleinopathy.", "PM": "2020", "HN": "2020", "MR": "20190517", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080874"}, {"RECTYPE": "D", "MH": "Ribosomal Protein L10", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Suppressor QM|T116|T123|NON|EQV|NLM (2020)|190411|abbcdef", "ENTRY": "Suppressor QM, Tumor", "MN": "A11.284.430.214.190.875.811.870.350", "MH_TH": "NLM (2020)", "ST": "T123", "MS": "A RIBOSOMAL PROTEIN which plays a crucial role in protein synthesis and embryonic brain development. Diseases associated with RPL10 mutations include Mental Retardation, X-Linked, Syndromic, 35 and Autism X-Linked 5.", "PM": "2020; RIBOSOMAL PROTEIN L10 was indexed under RIBOSOMAL PROTEINS 2002-2019", "HN": "2020 (2002)", "MR": "20190531", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080882"}, {"RECTYPE": "D", "MH": "Shoulder Dystocia", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fetal Shoulder Dystocia|T047|NON|NRW|NLM (2020)|190517|abcdef", "ENTRY": "Shoulder Dystocias", "MN": "C12.050.703.420.288.364", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Shoulder (1964-2019)", "MS": "Obstetric complication during OBSTETRIC DELIVERY in which exit of the fetus is delayed due to physical obstruction involving fetal shoulder(s).", "PM": "2020", "HN": "2020", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080883"}, {"RECTYPE": "D", "MH": "Infratemporal Fossa", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Fossa, Infratemporal", "MN": "A02.835.232.781.750.700", "MH_TH": "NLM (2020)", "ST": "T023", "AN": "NIM when merely locational; neoplasms: coordinate with SKULL BASE NEOPLASMS ", "MS": "The compartment that lies posterior to the MAXILLA and inferior to the side wall of the SKULL deep to the ramus of the MANDIBLE. It contains several FACIAL NERVES and the CAROTID ARTERIES and the JUGULAR VEINS.", "PM": "2020", "HN": "2020", "MR": "20190521", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080884"}, {"RECTYPE": "D", "MH": "Parapharyngeal Space", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Prestyloid Parapharyngeal Space|T023|NON|NRW|NLM (2020)|190412|abcdef", "ENTRY": "Pre styloid Compartment", "MN": "A02.835.232.781.750.850", "MH_TH": "NLM (2020)", "ST": "T023", "PI": "Skull Base (1963-2019)", "MS": "The deep neck space near the PHARYNX located anterior to the ptyergomandibular raphe,  posterior to the prevertebral fascia, inferior to the SKULL BASE, and superior to the HYOID BONE. Prestyloid parapharyngeal space contains cranial nerves IX, X, XI, XII and internal JUGULAR VEIN and internal CAROTID ARTERY.  Poststyloid parapharyngeal space contains AURICULARTEMPORAL NERVE and MAXILLARY ARTERY and ascending pharyngeal artery.", "PM": "2020", "HN": "2020", "MR": "20190517", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080886"}, {"RECTYPE": "D", "MH": "Diabulimia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Eating Disorder Diabetes Mellitus Type 1|T047|NON|EQV|NLM (2020)|190412|abcdef", "MN": "F03.400.375", "MH_TH": "NLM (2020)", "ST": "T047", "MS": "Eating disorder occurring typically in patients with DIABETES MELLITUS, TYPE 1 who restrict INSULIN intake in order to lose weight.", "PM": "2020", "HN": "2020", "MR": "20210510", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080887"}, {"RECTYPE": "D", "MH": "Specific Language Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Specific Language Impairment|T047|NON|EQV|NLM (2020)|190527|abcdef", "ENTRY": "Specific Language Impairments", "MN": "F03.625.374.188.350", "FX": "Language Development Disorders", "MH_TH": "NLM (2020)", "ST": "T047", "MS": "Language disorder that delays the mastery of oral language skills or  in children who have no hearing loss or other developmental delays.", "PM": "2020", "HN": "2020", "MR": "20230531", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080888"}, {"RECTYPE": "D", "MH": "Duocarmycins", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Duocarmycin|T121|T195|NON|EQV|NLM (2020)|190417|abbcdef", "MN": "D03.633.100.473.278", "MH_TH": "NLM (2020)", "ST": "T195", "RN": "0", "PI": "Pyrroles (1988-2019)", "MS": "A group of pyrroloindole compounds often with additional spirocyclic unit(s) and their analogs originally isolated from STREPTOMYCES. They bind DNA minor grooves with adenine-N3 alkylation activity.", "PM": "2020", "HN": "2020", "MR": "20190517", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080890"}, {"RECTYPE": "D", "MH": "Learning Health System", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Learning Healthcare System|T058|NON|EQV|NLM (2020)|190611|abcdef", "ENTRY": "Systems, Learning Healthcare", "MN": "N05.300.504", "MH_TH": "NLM (2020)", "ST": "T058", "MS": "A system in which internal data and experience are systematically integrated with external evidence and that knowledge is put into practice. As a result, patients get higher quality, safer, more efficient care, and health care delivery organizations become better places to work. (https://healthit.ahrq.gov/health-care-theme/learning-health-system)", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080891"}, {"RECTYPE": "D", "MH": "Mandibular Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mental Nerve Injuries|T037|NON|NRW|NLM (2020)|190416|abcdef", "ENTRY": "Nerve Injury, Masseteric", "MN": "C26.915.300.400.825.750", "MH_TH": "NLM (2020)", "ST": "T037", "PI": "Trigeminal Nerve Injuries (1991-2019)", "MS": "Traumatic injuries to the MANDIBULAR NERVE and its branches. Note that marginal mandibular nerve injury is a type of FACIAL NERVE INJURIES. Injuries to LINGUAL NERVE branch of mandibular nerve is LINGUAL NERVE INJURIES.", "PM": "2020", "HN": "2020", "MR": "20190517", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080902"}, {"RECTYPE": "D", "MH": "Dual Anti-Platelet Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Dual Anti-Platelet Therapies", "MN": "E02.319.310.537", "FX": "Platelet Aggregation Inhibitors", "MH_TH": "NLM (2020)", "ST": "T061", "PI": "Platelet Aggregation Inhibitors (2001-2019)", "MS": "Treatment with a combination of two types of antiplatelet agents to prevent blood clotting - usually ASPIRIN and another of the PLATELET AGGREGATION INHIBITORS.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080903"}, {"RECTYPE": "D", "MH": "Homeobox A10 Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Homeobox A10|T116|T123|NON|EQV|NLM (2020)|190417|abbcdef", "ENTRY": "Proteins, HOXA10", "MN": "D12.776.260.400.226", "MH_TH": "NLM (2020)", "ST": "T123", "RN": "0", "PI": "Homeodomain Proteins (2001-2019)", "MS": "Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis of tissues. They bind to the DNA sequence 5'-AA[AT]TTTTATTAC-3'.", "PM": "2020", "HN": "2020", "MR": "20190531", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080905"}, {"RECTYPE": "D", "MH": "Cerebellar Golgi Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Golgi Cells of the Cerebellum|T025|NON|EQV|NLM (2020)|190417|abcdef", "ENTRY": "Golgi Cells, Cerebellar", "MN": "A11.671.358.131", "MH_TH": "NLM (2020)", "ST": "T025", "PI": "Cerebellum (1967-2019)", "MS": "Inhibitory interneurons embedded in the granular layer of the CEREBELLAR CORTEX.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080906"}, {"RECTYPE": "D", "MH": "Single-Case Studies as Topic", "AQ": "CL EC ES HI IS LJ MT OG PX SN", "PRINT ENTRY": "Single-Subject Trial|T062|NON|EQV|NLM (2020)|190417|abcdef", "ENTRY": "Trials, Single-Subject", "MN": "N06.850.520.450.250.250.682", "MH_TH": "NLM (2020)", "ST": "T062", "PI": "Clinical Trials as Topic (2010-2019)", "MS": "Trials that consider an individual patient as the sole unit of observation in a study investigating the efficacy or side-effects of different interventions to determine the optimal intervention for an individual patient using objective data-driven criteria.", "PM": "2020", "HN": "2020", "MR": "20190707", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080907"}, {"RECTYPE": "D", "MH": "Broadly Neutralizing Antibodies", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "bnAbs|T116|T129|ABB|EQV|NLM (2020)|190418|abbcdef", "ENTRY": "Spectrum Antibodies, Broad", "MN": "D12.776.377.715.548.114.244.500", "MH_TH": "NLM (2020)", "ST": "T129", "RN": "0", "PI": "Antibodies, Neutralizing (2009-2019)", "MS": "Neutralizing antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent (e.g., HIV) by targeting several epitopes.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080908"}, {"RECTYPE": "D", "MH": "Carotid-Femoral Pulse Wave Velocity", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Carotid-Femoral Pulse Wave Velocities|T060|NON|EQV|NLM (2020)|190418|abcdef", "ENTRY": "Carotid Femoral Pulse Wave Velocity", "MN": "E01.370.370.680.750", "MH_TH": "NLM (2020)", "ST": "T060", "PI": "Pulse Wave Analysis (2012-2019)", "MS": "The transit time of an AORTIC PRESSURE wave between the COMMON CAROTID ARTERY and the COMMON FEMORAL ARTERY. It is a standard measure of ARTERIAL STIFFNESS.", "PM": "2020", "HN": "2020", "MR": "20190530", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080909"}, {"RECTYPE": "D", "MH": "Ambient Intelligence", "PRINT ENTRY": "Ambient-Assisted Living|T170|NON|NRW|NLM (2020)|190419|abcdef", "ENTRY": "Livings, Ambient-Assisted", "MN": "L01.224.900.910.500", "MH_TH": "NLM (2020)", "ST": "T170", "PI": "Artificial Intelligence (2003-2019)", "MS": "An emerging paradigm in which people are empowered through intelligent (digital) tools embedded in the surrounding environment. These tools proactively support human existence by being sensitive, adaptive, and responsive to the needs, habits, gestures, and emotions of individuals.", "PM": "2020", "HN": "2020", "MR": "20190531", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080910"}, {"RECTYPE": "D", "MH": "Cheminformatics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Chemoinformatics|T057|NON|EQV|NLM (2020)|190419|abcdef", "ENTRY": "Cheminformatic", "MN": "L01.313.062", "MH_TH": "NLM (2020)", "ST": "T057", "MS": "The use of computational and data retrieval techniques in understanding problems of chemistry. Cheminformatics strategies are useful in high throughput drug discovery.", "PM": "2020", "HN": "2020", "MR": "20190531", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080911"}, {"RECTYPE": "D", "MH": "Aldehyde Dehydrogenase 1 Family", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aldehyde Dehydrogenase 1|T116|T123|NON|NRW|NLM (2020)|190423|abbcdef", "MN": "D08.811.682.657.163.249.188", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "EC 1.2.1", "RR": "EC 1.2.1.3", "MS": "A subfamily of the aldehyde dehydrogenase family of enzymes involved in the synthesis of acetate from ethanol.", "PM": "2020; ALDEHYDE DEHYDROGENASE I was indexed under ALDEHYDE DEHYDROGENASES 1997-2011; under aldehyde dehydrogenase 1 2012 -2019", "HN": "2020(1997)", "MR": "20200609", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080924"}, {"RECTYPE": "D", "MH": "Microwave Imaging", "AQ": "AE CL HI TU", "PRINT ENTRY": "Microwave Tomography|T060|NON|EQV|NLM (2020)|190501|abcdef", "ENTRY": "Tomography, Microwave", "MN": "E01.370.350.536", "MH_TH": "NLM (2020)", "ST": "T060", "PI": "Microwaves (1986-2019)", "MS": "Use of MICROWAVES as a diagnostic tool.", "PM": "2020", "HN": "2020", "MR": "20190603", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080925"}, {"RECTYPE": "D", "MH": "Post-Cardiac Arrest Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Postresuscitation Disease|T047|NON|EQV|NLM (2020)|190430|abcdef", "ENTRY": "Postresuscitation Diseases", "MN": "C23.550.767.877.625", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Heart Arrest/complications(2008-2019)", "MS": "A reperfusion syndrome characterized by various pathophysiological processes after CARDIAC ARREST.  It may include post-cardiac arrest brain injury (HYPOXIA-ISCHEMIA, BRAIN), cardiocirculatory dysfunction, (e.g., systemic ISCHEMIA), HYPERGLYCEMIA; MULTIPLE ORGAN FAILURE and delayed death.", "PM": "2020", "HN": "2020", "MR": "20190701", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080942"}, {"RECTYPE": "D", "MH": "Bacterial Outer Membrane", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Outer Membrane, Bacterial", "MN": "A20.484", "MH_TH": "NLM (2020)", "ST": "T026", "PI": "Cell Membrane (1976-2019)", "MS": "The outermost cell envelope of GRAM-NEGATIVE BACTERIA composed of PHOSPHOLIPIDS; LIPOPOLYSACCHARIDES (LPS), and BACTERIAL OUTER MEMBRANE PROTEINS. The bacterial outer membrane LPS demonstrates cytotoxicity (see LIPID A and BACTERIAL O ANTIGEN).", "PM": "2020", "HN": "2020", "MR": "20190701", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080943"}, {"RECTYPE": "D", "MH": "Interosseous Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Membrane, Interosseous", "MN": "A10.165.560", "MH_TH": "NLM (2020)", "ST": "T024", "PI": "Connective Tissue (1985-2019)", "MS": "A sheet of fibrous connective tissue rich in COLLAGEN often linking two parallel bony structures forming a syndesmosis type joint. It provides longitudinal stability, TENSILE STRENGTH, and weight distribution/transfer and may allow limited movement in syndesmoses.", "PM": "2020", "HN": "2020", "MR": "20190701", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080944"}, {"RECTYPE": "D", "MH": "Lymph Node Ratio", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Ratio, Lymph Node", "MN": "E05.242.384.733", "MH_TH": "NLM (2020)", "ST": "T081", "PI": "Lymph Nodes (2001-2019)", "MS": "The ratio of metastatic to total examined LYMPH NODES.", "PM": "2020", "HN": "2020", "MR": "20190701", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080945"}, {"RECTYPE": "D", "MH": "Bone Marrow Failure Disorders", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bone Marrow Failure Syndromes|T047|NON|EQV|NLM (2020)|ORD (2010)|190502|abcdeef", "ENTRY": "Failure, Bone Marrow", "MN": "C15.378.190.223", "MH_TH": "NLM (2020)", "ST": "T047", "MS": "Inherited or acquired diseases characterized by insufficient and/or dysplastic blood cells.", "PM": "2020; BONE MARROW FAILURE SYNDROMES was indexed under ANEMIA, APLASTIC; BONE MARROW DISEASES; HEMOGLOBINURIA, PAROXYSMAL 2011-2019", "HN": "2020(2011)", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080983"}, {"RECTYPE": "D", "MH": "Congenital Bone Marrow Failure Syndromes", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Inherited Bone Marrow Failure Syndromes|T047|NON|EQV|NLM (2020)|190502|abcdef", "ENTRY": "BMF Syndrome, Inherited", "MN": "C16.614.183", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Bone Marrow (1964-2019)", "MS": "Inherited syndromes characterized by deficiency or absence of various blood cells due to mutations that affect HEMATOPOIETIC STEM CELLS development and proliferation.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000080984"}, {"RECTYPE": "D", "MH": "Acetamides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.081.018.110", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "Amides (1966-1970)", "MS": "Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.", "PM": "73", "HN": "73(71)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000081"}, {"RECTYPE": "D", "MH": "Sino-Japanese War", "PRINT ENTRY": "Sino-Japanese War 1937-1945|T078|NON|EQV|NLM (2020)|190306|abcdef", "ENTRY": "War, Sino-Japanese", "MN": "K01.400.504.968.725", "MH_TH": "NLM (2020)", "ST": "T078", "MS": "Military conflict involving China and Japan 1937 - 1945.", "PM": "2020", "HN": "2020", "MR": "20190506", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081002"}, {"RECTYPE": "D", "MH": "Shwachman-Diamond Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Shwachman-Bodian Syndrome|T047|EPO|EQV|GHR (2014)|NLM (2020)|ORD (2010)|190506|abcdeeef", "ENTRY": "Shwachman Diamond Oski Syndrome", "MN": "C18.452.584.718.875", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An inherited syndrome characterized by EXOCRINE PANCREATIC INSUFFICIENCY; hematologic abnormalities (e.g., bone marrow hypoplasia), and skeletal abnormalities (e.g., metaphyseal chondroplasia). GERMLINE MUTATIONS in the SBDS gene are associated with Shwachman-Diamond Syndrome.", "PM": "2020; SHWACHMAN-DIAMOND SYNDROME was indexed under BONE MARROW DISEASES; LIPOMATOSIS; and EXOCRINE PANCREATIC INSUFFICIENCY 2014-2019", "HN": "2020(2014)", "MR": "20210701", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081003"}, {"RECTYPE": "D", "MH": "Cyclopentane Monoterpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monoterpenes, Cyclopentane", "MN": "D02.455.849.575.188", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "PI": "Monoterpenes (2003-2019)", "MS": "Monoterpenes that include a cyclopentane ring in their structure.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081004"}, {"RECTYPE": "D", "MH": "Cyclohexane Monoterpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monoterpenes, Cyclohexane", "MN": "D02.455.849.575.157", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "PI": "Monoterpenes (2003-2019)", "MS": "Monoterpenes that include a cyclohexane ring in their structure.", "PM": "2020", "HN": "2020", "MR": "20190702", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081005"}, {"RECTYPE": "D", "MH": "Missed Diagnosis", "AQ": "AE CL EC ES HI LJ MO NU PC PX SN TD VE", "PRINT ENTRY": "Missing Diagnosis|T060|NON|EQV|NLM (2020)|190509|abcdef", "ENTRY": "Missing Diagnoses", "MN": "N02.421.450.280.500", "MH_TH": "NLM (2020)", "ST": "T060", "PI": "Diagnostic Errors (1993-2019)", "MS": "Failure to identify or diagnose a medical condition at the time a health professional is acquainted with the symptoms.", "PM": "2020", "HN": "2020", "MR": "20190701", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081006"}, {"RECTYPE": "D", "MH": "Cymenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cymene|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Menthanes, Benzenoid", "MN": "D02.455.849.575.219", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "PI": "Monoterpenes (2003-2019)", "MS": "A subclass of monoterpenes that contain a single benzene ring structure with an isopropyl group and one or more methyl groups.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081007"}, {"RECTYPE": "D", "MH": "Bicyclic Monoterpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thujanes|T109|NON|NRW|NLM (2020)|190606|abcdef", "ENTRY": "Monoterpenes, Bicyclic", "MN": "D02.455.849.575.141", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "PI": "Monoterpenes (2003-2019)", "MS": "Monoterpenes containing two ring structures that are joined either by bridgehead carbon atoms or fused ring structure.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081008"}, {"RECTYPE": "D", "MH": "Food Fussiness", "PRINT ENTRY": "Picky Eating|T053|NON|EQV|NLM (2020)|181231|abcdef", "ENTRY": "Fussiness, Food", "MN": "F01.145.407.458", "MH_TH": "NLM (2020)", "ST": "T053", "MS": "Patterns associated with eating including modes of feeding, rhythmic patterns of eating, and time intervals.", "PM": "2020", "HN": "2020", "MR": "20190506", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081010"}, {"RECTYPE": "D", "MH": "Hepatic Infarction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Liver Infarction|T047|NON|EQV|NLM (2020)|190506|abcdef", "ENTRY": "Liver Infarcts", "MN": "C23.550.717.489.500", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Liver Diseases (1963-2019)", "MS": "Formation of infarct resulting from obstruction of HEPATIC ARTERY and/or PORTAL VEIN most often after LIVER TRANSPLANTATION or hepatobiliary surgery.", "PM": "2020", "HN": "2020", "MR": "20190701", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081011"}, {"RECTYPE": "D", "MH": "Autoimmune Pancreatitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Type 2 Autoimmune Pancreatitis|T047|NON|NRW|NLM (2020)|190506|abcdef", "ENTRY": "Pancreatitis, IgG4-related", "MN": "C23.550.291.500.750.500", "FX": "Immunoglobulin G4-Related Disease", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Pancreatitis (1995-2019)", "MS": "Chronic pancreatitis associated with autoimmune diseases.", "PM": "2020", "HN": "2020", "MR": "20210312", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081012"}, {"RECTYPE": "D", "MH": "Suicide, Completed", "AQ": "CL EC EH ES HI LJ PX SN TD", "PRINT ENTRY": "Suicide, Fatal|T033|NON|EQV|NLM (2021)|200515|abcdef", "ENTRY": "Fatal Suicides", "MN": "I01.880.735.856.800", "MH_TH": "NLM (2020)", "ST": "T033", "PI": "Suicide (1965-2019)", "MS": "The successful attempt to kill oneself.", "PM": "2020", "HN": "2020", "MR": "20230531", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081013"}, {"RECTYPE": "D", "MH": "Dihydrostilbenoids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dihydrostilbenes|T109|NON|EQV|NLM (2020)|190607|abcdef", "ENTRY": "Derivatives, Dihydrostilbene", "MN": "D02.455.426.559.389.150.700.288", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "PI": "Stilbenes (1966-2019)(2019)", "MS": "Organic compounds characterized by the functional group 1,2-dihydrostilbene.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081014"}, {"RECTYPE": "D", "MH": "Ototoxicity", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Radiation-Induced Ototoxicity|T037|NON|NRW|NLM (2024)|230412|abcdef", "ENTRY": "Vestibulotoxicity, Drug-Induced", "MN": "G01.750.748.500.650", "MH_TH": "NLM (2020)", "ST": "T037", "PI": "Hearing Disorders/chemically induced (1980-2019)", "MS": "Damage to the EAR or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.", "PM": "2020", "HN": "2020", "MR": "20230412", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081015"}, {"RECTYPE": "D", "MH": "Sphingosine Phosphorylcholine Receptors", "DE": "SPHINGOSINE PHOSPHORYLCHOLINE RECEPT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Phosphorylcholine Receptors, Sphingosine", "MN": "D12.776.543.750.695.420.500.250", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "MS": "A subfamily of lysophospholipid receptors with specificity for lysophosphatidic acid.", "PM": "2020; see RECEPTORS, LYSOSPHINGOLIPID 2005-2019", "HN": "2020; use RECEPTORS, LYSOSPHINGOLIPID 2005-2019", "MR": "20190617", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081022"}, {"RECTYPE": "D", "MH": "Sphingosine-1-Phosphate Receptors", "DE": "SPHINGOSINE 1 PHOSPHATE RECEPT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Sphingosine-1-Phosphate Receptor 5|T116|T192|NON|NRW|NLM (2020)|190528|abbcdef", "ENTRY": "Sphingosine 1 Phosphate Receptors", "MN": "D12.776.543.750.695.420.500.500", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "MS": "A subfamily of lysophospholipid receptors with specificity for sphingosine-1-phosphate (e.g., FINGOLIMOD), sphinganine 1-phosphate, 4-hydroxysphinganine 1-phosphate.", "PM": "2020; see RECEPTORS, LYSOSPHINGOLIPID 2005-2019", "HN": "2020; use RECEPTORS, LYSOSPHINGOLIPID 2005-2019", "MR": "20200228", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081025"}, {"RECTYPE": "D", "MH": "Polyprenols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyprenol Derivatives|T109|NON|EQV|NLM (2020)|190607|abcdef", "ENTRY": "Derivatives, Polyprenol", "MN": "D02.455.849.728", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "PI": "Terpenes (1967-2019)", "MS": "Long chain isoprene compounds that include a hydroxyl group at the terminal carbon atom.", "PM": "2020", "HN": "2020", "MR": "20190703", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081026"}, {"RECTYPE": "D", "MH": "Toxic Optic Neuropathy", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ocular Toxicity|T037|NON|REL|NLM (2020)|190509|abcdef", "ENTRY": "Toxicity, Ocular", "MN": "G01.750.748.500.902", "MH_TH": "NLM (2020)", "ST": "T037", "PI": "Vision Disorders/chemically induced (1971-2019)", "MS": "Damage to the eye or its function (e.g., VISUAL IMPAIRMENT) due to OPTIC NERVE damage secondary to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.", "PM": "2020", "HN": "2020", "MR": "20190701", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081028"}, {"RECTYPE": "D", "MH": "Pulmonary Arterial Hypertension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypertension, Pulmonary Arterial", "MN": "C08.381.423.847", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Pulmonary Artery (1963-2019)", "MS": "A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY.", "PM": "2020", "HN": "2020", "MR": "20190617", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081029"}, {"RECTYPE": "D", "MH": "Myotoxicity", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Toxic Myopathies|T037|NON|EQV|NLM (2020)|190509|abcdef", "ENTRY": "Toxic Myopathy", "MN": "G01.750.748.500.411", "MH_TH": "NLM (2020)", "ST": "T037", "MS": "Damage to the muscle or its function secondary to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.", "PM": "2020", "HN": "2020", "MR": "20190701", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081030"}, {"RECTYPE": "D", "MH": "Fatty Acid Elongases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fatty Acid Elongation Enzyme|T116|T126|NON|EQV|NLM (2020)|190610|abbcdef", "ENTRY": "Proteins, ELOVL", "MN": "D08.811.913.050.134.343", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "EC 2.3.1.-", "MS": "Enzymes conserved from yeast to mammals which mediate elongation of FATTY ACIDS into very-long-chain fatty acids.", "PM": "2020; FATTY ACID ELONGASES was indexed under ACETYLTRANFERASES 2000-2019", "HN": "2020 (2000)", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081031"}, {"RECTYPE": "D", "MH": "Pancreatitis, Acute Hemorrhagic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhagic Pancreatitis|T047|NON|EQV|NLM (2020)|190510|abcdef", "ENTRY": "Pancreatitis, Hemorrhagic", "MN": "C06.689.750.325", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Pancreatitis (1963-2019)", "MS": "An acute INFLAMMATION of the PANCREAS in which the initial edematous pancreatitis evolved into necrosis accompanied by HEMORRHAGE.", "PM": "2020", "HN": "2020", "MR": "20210312", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081032"}, {"RECTYPE": "D", "MH": "Potassium Channels, Sodium-Activated", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sodium-Activated Potassium Channels|T116|T123|NON|EQV|NLM (2020)|190510|abbcdef", "ENTRY": "Sodium-Dependent Potassium Channels", "MN": "D12.776.543.585.400.750.950", "MH_TH": "NLM (2020)", "ST": "T123", "RN": "0", "PI": "Potassium Channels(1989-2019)", "MS": "Potassium channels whose activation is dependent on intracellular sodium concentrations.", "PM": "2020", "HN": "2020", "MR": "20190701", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081033"}, {"RECTYPE": "D", "MH": "Indigenous Peoples", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Native Peoples|T098|NON|EQV|NLM (2020)|190528|abcdef", "ENTRY": "Populations, Indigenous", "MN": "M01.270.968", "MH_TH": "NLM (2020)", "ST": "T098", "MS": "Descendants who self-identify as members of a group who inhabited a country or region at the time when people of different cultures or ethnic origins arrived. They often maintain their distinct language, culture, and beliefs.", "PM": "2020", "HN": "2020", "MR": "20210707", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081034"}, {"RECTYPE": "D", "MH": "Heterogeneous Nuclear Ribonucleoprotein D0", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "P37 AUF1 Protein|T116|T123|ABX|EQV|NLM (2020)|190805|abbcdef", "ENTRY": "AUF1 Protein, P37", "MN": "D12.776.664.962.813.750.300.500", "MH_TH": "NLM (2020)", "ST": "T123", "RN": "0", "MS": "Member of a subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs), heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) specifically binds RNA molecules that contain AU RICH ELEMENTS found within the 3'-UTR of many PROTO-ONCOGENES and CYTOKINES mRNAs. It functions as a transcription factor, binds to double- and single-stranded DNA sequences in a specific manner.", "PM": "2020; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D0 was indexed under RIBONUCLEOPROTEIN COMPLEX BINDING PROTEINS 1993-2002, under HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D 2001-2019", "HN": "2020 (2001)", "MR": "20230405", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081035"}, {"RECTYPE": "D", "MH": "Body Integrity Identity Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Xenomelia|T048|NON|EQV|NLM (2020)|190516|abcdef", "ENTRY": "Xenomelias", "MN": "F03.875.225", "MH_TH": "NLM (2020)", "ST": "T048", "MS": "Condition in which individuals desire the amputation of one or more healthy limbs or who desire a paralysis.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081042"}, {"RECTYPE": "D", "MH": "Heme-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heme-Binding Protein|T116|T123|NON|EQV|NLM (2020)|190513|abbcdef", "ENTRY": "Proteins, Heme-Binding", "MN": "D12.776.422.498", "MH_TH": "NLM (2020)", "ST": "T123", "RN": "0", "MS": "Metalloproteins that contain a HEME ligand as the prosthetic group.", "PM": "2020; HEME-BINDING PROTEIN was indexed under CARRIER PROTEINS 1984-2019, under HEMEPROTEINS 1986-2019", "HN": "2020(1984)", "MR": "20190801", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081062"}, {"RECTYPE": "D", "MH": "Phosphoinositide-3 Kinase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphoinositide-3 Kinase Inhibitor|T121|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Phosphoinositide 3 Kinase Inhibitors", "MN": "D27.505.519.389.736", "MH_TH": "NLM (2020)", "ST": "T121", "RN": "0", "MS": "Agents that inhibit PHOSPHOINOSITIDE-3 KINASE activity.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081082"}, {"RECTYPE": "D", "MH": "Accidental Injuries", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Accidental Injury|T037|NON|EQV|NLM (2020)|190513|abcdef", "ENTRY": "Injury, Accidental", "MN": "C26.040", "MH_TH": "NLM (2020)", "ST": "T037", "PI": "Accidents (1963-2019)", "MS": "Injuries resulting from events or circumstances that are unforeseen, unplanned, unanticipated, and without premeditation.", "PM": "2020", "HN": "2020", "MR": "20190702", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081084"}, {"RECTYPE": "D", "MH": "WAP Four-Disulfide Core Domain Protein 2", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "WFDC2 Protein|T116|T123|NON|EQV|NLM (2020)|190702|abbcdef", "ENTRY": "WAP Four Disulfide Core Domain Protein 2", "MN": "D12.776.298.500", "MH_TH": "NLM (2020)", "ST": "T123", "RN": "0", "MS": "A secreted 25-kDa glycoprotein member of the Whey-acidic-protein (WAP) four-disulfide core (WFDC) domain family with tissue specific expression in the EPIDIDYMIS. It is also expressed in a limited number of other organs which include female reproductive tract, breast tissue, kidney, regions of the respiratory tract and nasopharynx. The protein is a biomarker for epithelial ovarian cancer.", "PM": "2020", "HN": "2020", "MR": "20190801", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081102"}, {"RECTYPE": "D", "MH": "Epigenome", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Methylome|T028|NON|EQV|NLM (2020)|190513|abcdef", "ENTRY": "Methylomes, DNA", "MN": "G05.360.340.006", "FX": "Epigenesis, Genetic", "MH_TH": "NLM (2020)", "ST": "T028", "PI": "Genome, Human (2003-2019)", "MS": "A network of chemical compounds surrounding DNA that modify the genome without altering the DNA sequences and have a role in determining which genes are active in a cell.", "PM": "2020", "HN": "2020", "MR": "20190702", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081122"}, {"RECTYPE": "D", "MH": "Evidence-Based Pharmacy Practice", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Evidence-Based Pharmacy|T091|NON|EQV|NLM (2020)|190703|abcdef", "ENTRY": "Practices, Evidence-Based Pharmacy", "MN": "H02.646.125", "MH_TH": "NLM (2020)", "ST": "T091", "PI": "Pharmacy (1999-2019)", "MS": "The practice of pharmacy in which the pharmacist makes decisions, taking into account the best available current research evidence, the pharmacist's expertise, and the needs and preferences of the patient.", "PM": "2020", "HN": "2020", "MR": "20190703", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081142"}, {"RECTYPE": "D", "MH": "Cell Line Authentication", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Cell-Line Identification|T059|NON|EQV|NLM (2020)|190514|abcdef", "ENTRY": "Cell Line Identification", "MN": "E05.242.223.250", "MH_TH": "NLM (2020)", "ST": "T059", "MS": "Techniques used to characterize and confirm the identity of a CELL LINE. Characterization involves authentication to verify that it matches the original description of the cells and ensures that they are not cross-contaminated with another cell line. This is done to avoid attributing data incorrectly to the wrong cell line.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081163"}, {"RECTYPE": "D", "MH": "Drug Collateral Sensitivity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Collateral Sensitivity|T032|NON|EQV|NLM (2020)|190607|abcdef", "ENTRY": "Sensitivity, Drug Collateral", "MN": "G07.690.773.968.352", "MH_TH": "NLM (2020)", "ST": "T032", "PI": "Drug Resistance (1963-2019)", "MS": "Increase in sensitivity of an organism, disease, or tissue to one drug that develops following the loss of sensitivity (i.e. resistance) to another drug.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081164"}, {"RECTYPE": "D", "MH": "Noninvasive Prenatal Testing", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "PRINT ENTRY": "Prenatal cfDNA Screening|T060|NON|NRW|NLM (2020)|190515|abcdef", "ENTRY": "cfDNA Screening, Prenatal", "MN": "N02.421.726.233.221.375", "MH_TH": "NLM (2020)", "ST": "T060", "PI": "Prenatal Diagnosis (2012-2019)", "MS": "The analysis of cell-free fetal DNA or the DNA from fetal cells that are biopsied from a pregnant woman\u2019s blood, to screen for genetically-determined traits and genetic abnormalities.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081182"}, {"RECTYPE": "D", "MH": "Codon Usage", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Synonymous Codon Usage|T086|NON|EQV|NLM (2020)|190515|abcdef", "MN": "G05.360.335.355.113", "MH_TH": "NLM (2020)", "ST": "T086", "PI": "Codon (1979-2019)", "MS": "The frequency of occurrence, in a specific organism's DNA sequence, of one of several potential synonymous codons that code for a particular amino acid. Frequently, there is a nonrandom pattern (bias) in the usage of a particular codon or codons over other synonymous codons.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081183"}, {"RECTYPE": "D", "MH": "Blockchain", "AQ": "CL EC ES HI IS LJ SN ST TD", "PRINT ENTRY": "Block Chain|T066|NON|EQV|NLM (2020)|190516|abcdef", "ENTRY": "Blockchains", "MN": "N04.452.910.200.250", "MH_TH": "NLM (2020)", "ST": "T066", "MS": "Decentralized transaction and data management technology providing security, anonymity and data integrity without any third party control of transactions. Related research is focused on improving aspects  regarding privacy and security. (From PLoS One. 2016 Oct 3;11(10):e0163477)", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081186"}, {"RECTYPE": "D", "MH": "Right to Work", "AQ": "LJ", "PRINT ENTRY": "Right To Employment|T064|NON|EQV|NLM (2020)|190611|abcdef", "ENTRY": "Right to Works", "MN": "N03.706.437.694", "MH_TH": "NLM (2020)", "ST": "T064", "MS": "The right of individuals to work, to free choice of employment, to just and favorable conditions of work and to protection against unemployment.", "PM": "2020", "HN": "2020", "MR": "20190707", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081202"}, {"RECTYPE": "D", "MH": "Monoterpene Aldehydes and Ketones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Monoterpene Ketones|T109|NON|NRW|NLM (2020)|190520|abcdef", "ENTRY": "Ketones, Monoterpene", "MN": "D02.522.698", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "PI": "Monoterpenes (2001-2019)", "MS": "Monoterpene compounds that include a double bonded oxygen attached to the one or more of the carbon atoms.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081203"}, {"RECTYPE": "D", "MH": "Chromatin Immunoprecipitation Sequencing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "High-Throughput Sequencing of RNA Isolated by Crosslinking Immunoprecipitation|T063|NON|REL|NLM (2020)|190521|abcdef", "ENTRY": "Sequencing, Chromatin Immunoprecipitation", "MN": "E05.478.605.160.500", "MH_TH": "NLM (2020)", "ST": "T063", "PI": "Sequence Analysis, DNA (2007-2019)", "MS": "A technique for identifying the BINDING SITES on nucleic acid sequences that are associated with binding proteins.", "PM": "2020", "HN": "2020", "MR": "20190701", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081204"}, {"RECTYPE": "D", "MH": "Hair Analysis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Hair Mineral Analysis|T059|NON|NRW|NLM (2020)|190521|abcdef", "ENTRY": "Mineral Analysis, Hair", "MN": "E05.200.124.385", "FX": "Hair", "MH_TH": "NLM (2020)", "ST": "T059", "PI": "Hair/chemistry (1990-2019)", "MS": "Examination of hair by chemical, physical, or microscopic means.", "PM": "2020", "HN": "2020", "MR": "20200206", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081205"}, {"RECTYPE": "D", "MH": "Duration of Therapy", "PRINT ENTRY": "Duration of Treatment|T079|NON|EQV|NLM (2020)|190521|abcdef", "ENTRY": "Treatment Duration", "MN": "N02.421.585.287", "MH_TH": "NLM (2020)", "ST": "T079", "PI": "Time Factors (1967-2019)", "MS": "Planned or actual duration of various treatments or preventive measures.", "PM": "2020", "HN": "2020", "MR": "20190701", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081206"}, {"RECTYPE": "D", "MH": "Primary Immunodeficiency Diseases", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Primary Immunodeficiency Syndromes|T047|NON|EQV|NLM (2020)|190522|abcdef", "ENTRY": "Primary Immunodeficiency Syndrome", "MN": "C20.673.795", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Immunologic Deficiency Syndromes (1972-2019)", "MS": "Genetic immunologic deficiency diseases and syndromes due to mutations in genes involved in IMMUNITY generally characterized by an increased susceptibility to infectious diseases. They are often associated with AUTOIMMUNE DISEASE manifestations.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081207"}, {"RECTYPE": "D", "MH": "Hereditary Complement Deficiency Diseases", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Inherited Complement Deficiency Diseases|T047|NON|EQV|NLM (2020)|190523|abcdef", "ENTRY": "Complement Deficiency", "MN": "C20.673.795.500", "MH_TH": "NLM (2020)", "ST": "T047", "PI": "Immunologic Deficiency Syndromes (1971-2019)", "MS": "Genetic disorders due to mutations in genes involved in COMPLEMENT SYSTEM PROTEINS. They are often classified into distinct pathway of complement activation where causative mutations are found (e.g., classical pathway, lectin pathway, alternative pathway, and terminal complement pathway).", "PM": "2020", "HN": "2020", "MR": "20220523", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081208"}, {"RECTYPE": "D", "MH": "Monocyclic Sesquiterpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Monocyclic Sesquiterpene|T109|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Sesquiterpenes, Monocyclic", "MN": "D02.455.849.765.521", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "PI": "Sesquiterpenes(1974-2019)", "MS": "Sesquiterpene compounds that contain a single ring structure.", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081222"}, {"RECTYPE": "D", "MH": "Polycyclic Sesquiterpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Valeranes|T109|NON|NRW|NLM (2020)|190522|abcdef", "ENTRY": "Sesquiterpenes, Polycyclic", "MN": "D04.663", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "MS": "Sesquiterpenes that contain two or more ring structures", "PM": "2020", "HN": "2020", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081223"}, {"RECTYPE": "D", "MH": "Stilbestrols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxystilbene Derivatives|T109|NON|EQV|NLM (2020)|190523|abcdef", "ENTRY": "Hydroxyl Stilbenes", "MN": "D02.455.426.559.389.150.700.725", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "MS": "Stilbene derivatives the contain one or more hydroxyl groups attached to the benzene ring structures.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081225"}, {"RECTYPE": "D", "MH": "Sennosides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sennosides A and B Acids|T109|T121|NON|BRD|NLM (2020)|190523|abbcdef", "ENTRY": "Senokot|T109|T121|TRD|NRW|NLM (2013)|120113|abbcdef", "MN": "D20.215.784.500.860.500", "MH_TH": "NLM (2020)", "ST": "T121", "RN": "0", "RR": "F887D1637W", "MS": "Medications derived from SENNA EXTRACT that are used to treat CONSTIPATION.", "PM": "2020; SENNOSIDES was indexed under SENNA EXTRACT 1973-2019", "HN": "2020 (1973)", "MR": "20230607", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081226"}, {"RECTYPE": "D", "MH": "Neurosteroids", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neurosteroid|T125|NON|EQV|NLM (2020)|190701|abcdef", "ENTRY": "Steroid, Neuroactive", "MN": "D27.505.696.577.544", "MH_TH": "NLM (2010)", "ST": "T125", "RN": "0", "MS": "Endogenous compounds or drugs that affect neuronal excitability through modulation of specific ionotropic receptors (e.g., GABA-A RECEPTORS). Endogenous neurosteroids are steroid hormones de novo synthesized by neurons and glial cells from steroid metabolite precursors (e.g., PREGNENOLONE).", "PM": "2020; see under NEUROTRANSMITTER AGENTS 2010-2019", "HN": "2020(2010)", "MR": "20200527", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081227"}, {"RECTYPE": "D", "MH": "Artificially Sweetened Beverages", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Diet Drinks|T168|NON|BRD|NLM (2020)|190523|abcdef", "ENTRY": "Sweetened Beverages, Artificially", "MN": "J02.200.200", "MH_TH": "NLM (2020)", "ST": "T168", "PI": "Sweetening Agents (1966-2019)", "MS": "Beverages sweetened with SWEETENING AGENTS that are synthetic or artificial as opposed to naturally-occurring. Examples of sweetening agents include ASPARTAME, sucralose, and saccharin.", "PM": "2020", "HN": "2020", "MR": "20190708", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081229"}, {"RECTYPE": "D", "MH": "Forensic Entomology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "I01.198.780.906", "MH_TH": "NLM (2020)", "ST": "T090", "PI": "Forensic Medicine (1984-2019)", "MS": "The use of insects and related arthropods that inhabit decomposing corpses or remains in the conduct of medico-legal or medico-criminal investigations.", "PM": "2020", "HN": "2020", "MR": "20190708", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081230"}, {"RECTYPE": "D", "MH": "B-Cell Lymphoma 3 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-bcl-3 Protein|T116|T123|ABB|EQV|NLM (2020)|190524|abbcdef", "ENTRY": "c-bcl-3, Proto-Oncogene Proteins", "MN": "D12.776.930.714", "MH_TH": "NLM (2020)", "ST": "T123", "RN": "0", "MS": "A member of the I kappa B family, B-cell lymphoma 3-encoded (bcl-3) protein is involved in the regulation of TRANSCRIPTIONAL ACTIVATION of NF-KAPPA B target genes.", "PM": "2020; PROTO-ONCOGENE PROTEIN BCL-3 was indexed under PROTO-ONCOGENE PROTEINS and TRANSCRIPTION FACTORS 2006-2019", "HN": "2020", "MR": "20190801", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081242"}, {"RECTYPE": "D", "MH": "Sphingosine 1 Phosphate Receptor Modulators", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sphingosine Receptor Modulators|T121|NON|EQV|NLM (2020)|190524|abcdef", "MN": "D27.505.696.477.656.875", "MH_TH": "NLM (2020)", "ST": "T121", "RN": "0", "PI": "Receptors, Lysosphingolipid (2004-2019)", "MS": "Agents that affect the function of G-protein coupled SPHINGOSINE 1-PHOSPHATE RECEPTORS. Their binding to the receptors blocks lymphocyte migration and are often used as IMMUNOSUPPRESSANTS.", "PM": "2020", "HN": "2020", "MR": "20190702", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081243"}, {"RECTYPE": "D", "MH": "RNA-Seq", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Whole Transcriptome Shotgun Sequencing|T059|T063|NON|EQV|NLM (2020)|190524|abbcdef", "MN": "E05.393.760.710.500", "MH_TH": "NLM (2020)", "ST": "T063", "PI": "Transcriptome (2011-2019)", "MS": "High-throughput nucleotide sequencing techniques developed for determining and analyzing the composition of the TRANSCRIPTOME of a sample.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081246"}, {"RECTYPE": "D", "MH": "CSK Tyrosine-Protein Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-src Tyrosine Kinase|T116|T126|NON|EQV|NLM (2020)|190528|abbcdef", "ENTRY": "c-src, Protein-Tyrosine Kinase", "MN": "D12.776.476.568.800.158", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "Protein tyrosine kinases that phosphorylate tyrosine residues located in the C-terminal tails of SRC-FAMILY KINASES.", "PM": "2020", "HN": "2020", "MR": "20210521", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081247"}, {"RECTYPE": "D", "MH": "Allylbenzene Derivatives", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vinyl Toluene Derivatives|T109|NON|EQV|NLM (2020)|190611|abcdef", "MN": "D02.455.426.559.389.012", "FX": "Stilbenes", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "PI": "Benzene Derivatives (1968-2019)", "MS": "Compounds that include a single 1-phenyl-2-propene moiety in their structure.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081248"}, {"RECTYPE": "D", "MH": "Randomized Controlled Trial, Veterinary", "PRINT ENTRY": "Veterinary Randomized Controlled Trial|T062|T170|NON|EQV|NLM (2020)|190528|abbcdef", "MN": "V03.175.375.500", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific randomized veterinary clinical trial; a different heading CLINICAL TRIALS, VETERINARY AS TOPIC + RANDOMIZATION is used for general design, methodology, economics, etc. of randomized veterinary clinical trials ", "MS": "A work that reports on a clinical trial with animal subjects that involves at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.", "HN": "2020", "MR": "20190909", "DA": "20190708", "DC": "2", "DX": "20200101", "UI": "D000081262"}, {"RECTYPE": "D", "MH": "Perfusion Index", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Index, Perfusion", "MN": "E01.370.370.585", "FX": "Plethysmography", "MH_TH": "NLM (2020)", "ST": "T034", "MS": "The ratio of arterial blood flow (PULSATILE FLOW) to venous, capillary, and tissue blood flow  (non-pulsatile blood flow) - as measured regionally or peripherally.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081282"}, {"RECTYPE": "D", "MH": "Military Health Services", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "System, Military Health", "MN": "N04.452.523", "MH_TH": "NLM (2020)", "ST": "T058", "MS": "Services organized for the diagnosis and treatment of disease and the maintenance of health primarily of MILITARY PERSONNEL.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081322"}, {"RECTYPE": "D", "MH": "Veterans Health Services", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Health Services, Veterans", "MN": "N04.452.524", "MH_TH": "NLM (2020)", "ST": "T058", "MS": "Services organized for the diagnosis and treatment of diseases and maintenance of health primarily of VETERANS.", "PM": "2020", "HN": "2020", "MR": "20190707", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081324"}, {"RECTYPE": "D", "MH": "Nudiviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Oryctes Viruses|T005|NON|NRW|NLM (1991)|900424|abcdef", "ENTRY": "Oryctes Virus", "MN": "B04.525.573", "MH_TH": "NLM (2020)", "ST": "T005", "RN": "txid1511852", "RR": "txid92521", "PI": "DNA Viruses (2007-2019)", "MS": "A family of ARTHROPOD viruses, including INSECT VIRUSES and crustacean viruses. They are rod-shaped, enveloped, and circular dsDNA viruses that share structural and replication characteristics with BACULOVIRIDAE. Genera include Alphanudivirus and Betanudivirus.", "PM": "2020; for ORYCTES VIRUSES see BACULOVIRIDAE 1991-2019", "HN": "2020; for ORYCTES VIRUSES use BACULOVIRIDAE 1991-2019", "MR": "20200813", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081342"}, {"RECTYPE": "D", "MH": "Lipidomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Lipidome|T091|NON|NRW|NLM (2020)|190530|abcdef", "ENTRY": "Lipidomic", "MN": "H01.181.122.638.500", "MH_TH": "NLM (2020)", "ST": "T091", "PI": "Lipid Metabolism (2003-2019)", "MS": "A branch of metabolomics concerned with the study of global LIPIDS profiles in physiological systems.", "PM": "2020", "HN": "2020", "MR": "20190708", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081362"}, {"RECTYPE": "D", "MH": "Occlusion Bodies, Viral", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Viral Occlusion Body|T017|NON|EQV|NLM (2020)|190530|abcdef", "ENTRY": "Viruses, Occluded", "MN": "A21.125", "MH_TH": "NLM (2020)", "ST": "T017", "MS": "A polyhedral or ovocylindrical shaped matrix composed of a single crystalline protein (OCCLUSION BODY MATRIX PROTEINS) in which VIRIONS are embedded. It is distinguished from the area of the CYTOPLASM or CELL NUCLEUS in which virus components are being synthesized and assembled, known as VIRAL INCLUSION BODIES.", "PM": "2020", "HN": "2020", "MR": "20190708", "DA": "20190709", "DC": "1", "DX": "20200101", "UI": "D000081363"}, {"RECTYPE": "D", "MH": "Multiparametric Magnetic Resonance Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "mpMRI|T060|ABB|EQV|NLM (2020)|190530|abcdef", "ENTRY": "Multiparametric MRIs", "MN": "E01.370.350.825.500.755", "MH_TH": "NLM (2020)", "ST": "T060", "PI": "Magnetic Resonance Imaging (1999-2019)", "MS": "Magnetic Resonance Imaging technique that combines functional imaging techniques such as diffusion-weighted imaging (DWI), dynamic contrast-enhanced imaging and magnetic spectroscopy. This technique is widely used for active surveillance in prostate cancer imaging.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081364"}, {"RECTYPE": "D", "MH": "Pyruvate Dehydrogenase Acetyl-Transferring Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pyruvate Dehydrogenase Kinase|T116|T126|NON|EQV|NLM (2020)|190611|abbcdef", "ENTRY": "Pyruvate Dehydrogenase Acetyl Transferring Kinase", "MN": "D12.776.476.563.783", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "0", "RR": "XEX0252SGP", "MS": "A pyruvate dehydrogenase kinase isozyme located in the mitochondria which converts PYRUVATE to ACETYL CoA in the CITRIC ACID CYCLE, phosphorylates SERINE residues on pyruvate dehydrogenase using ATP, and plays a key role in the regulation of GLUCOSE and fatty acid metabolism.", "PM": "2021; see PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE 2020; was indexed under PROTEIN SERINE THREONINE KINASES 1972-2019", "HN": "2021(1972)", "MR": "20210521", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081382"}, {"RECTYPE": "D", "MH": "Quaternary Prevention", "AQ": "CL EC EH ES HI LJ MT OG SN ST TD", "ENTRY": "Quaternary Preventions", "MN": "N06.850.780.715", "FX": "Medical Overuse", "MH_TH": "NLM (2020)", "ST": "T058", "MS": "Actions taken to protect individuals (i.e. persons/patients) from unnecessary medical interventions that are likely to cause more harm than good.", "PM": "2020", "HN": "2020", "MR": "20190708", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081404"}, {"RECTYPE": "D", "MH": "Peptidyl-Prolyl Isomerase F", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptidylprolyl Isomerase F|T116|T126|NON|EQV|NLM (2024)|230320|abbcdef", "ENTRY": "Peptidyl Prolyl Isomerase F", "MN": "D12.776.827.344.300.875", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "0", "RR": "EC 5.2.1.8", "MS": "A member of the cyclophilins family of isomerases which plays a role in the regulation of the permeability transition pore in mitochondria. The protein has the alias name cyclophilin D which is also the alias name for the related protein Peptidyl-Prolyl Isomerase D.", "PM": "2024; was CYCLOPHILIN D 2020-2023", "HN": "2024 (2020)", "MR": "20230526", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081406"}, {"RECTYPE": "D", "MH": "Germinal Center Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Germinal Center Kinase Family|T116|T126|NON|EQV|NLM (2020)|190530|abbcdef", "ENTRY": "Kinases, Germinal Center", "MN": "D12.776.476.563.397", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "0", "RR": "EC 2.7.11.1", "MS": "Serine-threonine kinases characterized by an N-terminal STE20 kinase domain.", "PM": "GERMINAL CENTER KINASES was indexed under PROTEIN SERINE THREONINE KINASES 2004-2019", "HN": "2020", "MR": "20210521", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081410"}, {"RECTYPE": "D", "MH": "Augmented Reality", "PRINT ENTRY": "Mixed Reality|T170|NON|EQV|NLM (2020)|190531|abcdef", "ENTRY": "Reality, Mixed", "MN": "L01.296.055", "FX": "Surgery, Computer-Assisted", "MH_TH": "NLM (2020)", "ST": "T170", "PI": "User-Computer Interface (1995-2019)", "MS": "Technology in which images of virtual objects and/or other digital information are superimposed over the real time view of the physical objects providing a composite view with guides for carrying out a task with or on the physical objects.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081411"}, {"RECTYPE": "D", "MH": "Myosin VIIa", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Unconventional Myosin VIIa|T116|T126|NON|EQV|NLM (2020)|190531|abbcdef", "ENTRY": "protein, MYO7A", "MN": "D12.776.220.525.475.875", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "0", "RR": "EC 3.6.4.1", "MS": "Also referred to as unconventional myosin VIIa, these are actin-based motor molecules with ATPase activity that function in intracellular movements (e.g., HAIR CELLS, AUDITORY).", "PM": "2020", "HN": "2020", "MR": "20190801", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081412"}, {"RECTYPE": "D", "MH": "Exposome", "ENTRY": "Exposomes", "MN": "N06.850.460.350.096", "MH_TH": "NLM (2020)", "ST": "T051", "PI": "Environmental Exposure (2005-2019)", "MS": "The measure of all the exposures of an individual from all sources, including environmental and occupational sources, in a lifetime and how those exposures relate to health. (from https://www.cdc.gov/niosh/topics/exposome/ on 06/06/2019)", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081413"}, {"RECTYPE": "D", "MH": "Nanopore Sequencing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Sequencing, Nanopore", "MN": "E05.393.760.560", "MH_TH": "NLM (2020)", "ST": "T063", "PI": "Sequence Analysis, DNA (2006-2019)", "MS": "A sequencing protocol that drives nucleic acids (DNA or RNA) in an electric field through NANOPORES allowing single molecule sequence analysis.", "PM": "2020", "HN": "2020", "MR": "20190708", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081414"}, {"RECTYPE": "D", "MH": "Clinical Decision Rules", "ENTRY": "Rules, Clinical Prediction", "MN": "L01.313.500.750.190.190", "FX": "Practice Guidelines as Topic", "MH_TH": "NLM (2020)", "ST": "T170", "PI": "Decision Support Techniques (1991-2019)", "MS": "Scores or algorithms that correlate with clinically significant findings and that are used to predict an outcome, or suggest a diagnostic or therapeutic action.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190709", "DC": "1", "DX": "20200101", "UI": "D000081415"}, {"RECTYPE": "D", "MH": "SecA Proteins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SecA Protein|T126|NON|EQV|NLM (2020)|190531|abcdef", "ENTRY": "Proteins, SecA", "MN": "D08.811.277.040.025.494", "MH_TH": "NLM (2020)", "ST": "T126", "RN": "EC 7.4.2.4", "RR": "119129-39-4", "PI": "SEC Translocation Channels (2016-2019)", "MS": "ATPases that provide energy for the translocation of proteins across bacterial PLASMA MEMBRANES and THYLAKOID membranes, by the SEC TRANSLOCATION CHANNELS. SecA is a component of the bacterial preprotein translocase which is comprised of SecA, the SECYEG TRANSLOCON, and the accessory domain proteins SecD, SecF, YajC, and YidC.", "PM": "2020; was indexed under SEC TRANSLOCATION CHANNELS 2016-2019, ADENOSINE TRIPHOSPHATASES 2002-2019; and BACTERIAL PROTEINS 2005-2019", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081416"}, {"RECTYPE": "D", "MH": "Trichothecenes, Type B", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Type B Trichothecenes|T109|NON|EQV|NLM (2020)|190611|abcdef", "MN": "D23.946.587.933.975", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "PI": "Trichothecenes (1991-2019)", "MS": "A subclass of Trichothecene derivatives that include the 12,13-epoxytrichothec-9-ene structure with a keto (carbonyl) function at C-8.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081442"}, {"RECTYPE": "D", "MH": "Trichothecenes, Type C", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Type C Trichothecenes|T109|NON|EQV|NLM (2020)|190611|abcdef", "MN": "D23.946.587.933.987", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "PI": "Trichothecenes (1991-2019)", "MS": "A subclass of Trichothecene derivatives that includes the 12,13-epoxytrichothec-9-ene structure with an epoxide oxygen bond to the C7 and C8 carbon atoms.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081443"}, {"RECTYPE": "D", "MH": "Bioaccumulation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Biomagnification|T040|NON|NRW|NLM (2020)|190628|abcdef", "ENTRY": "Biomagnifications", "MN": "G07.690.725.015.500.187", "FX": "Chemically-Induced Disorders", "MH_TH": "NLM (2020)", "ST": "T040", "MS": "An increase in the concentration of an exogenous substance in the tissues of organisms higher than surrounding ENVIRONMENT. Accumulation of such XENOBIOTICS at successively higher levels up the FOOD CHAIN is called biomagnification. Bioaccumulation of toxic chemicals (e.g., Lead and DDT) may result in CHEMICALLY-INDUCED DISORDERS.", "PM": "2020", "HN": "2020", "MR": "20190701", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081482"}, {"RECTYPE": "D", "MH": "Squamous Intraepithelial Lesions", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Squamous Intraepithelial Lesion|T033|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Low Grade Squamous Intraepithelial Lesions", "MN": "C23.149.688", "MH_TH": "NLM (2015)", "ST": "T033", "MS": "A cytological test finding that shows abnormal lesions of SQUAMOUS EPITHELIAL cells.", "PM": "2020; see SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX 2015-2019", "HN": "2020 (2015)", "MR": "20210630", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081483"}, {"RECTYPE": "D", "MH": "Organoiron Compounds", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.691.713", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "MS": "Organic compounds that contain iron in carbon-to-iron chemical bond.", "PM": "2020", "HN": "2020", "MR": "20190705", "DA": "20190708", "DC": "1", "DX": "20200101", "UI": "D000081503"}, {"RECTYPE": "D", "MH": "Marathon Running", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Ultramarathon Running|T056|NON|REL|NLM (2021)|200612|abcdef", "ENTRY": "Running, Ultramarathon", "MN": "I03.450.642.845.610.660", "FX": "Track and Field", "MH_TH": "NLM (2021)", "ST": "T056", "PI": "Running (1964-2020)", "MS": "A sporting event in which participants run a distance of approximately 26.2 miles in a race.", "PM": "2021", "HN": "2021", "MR": "20200617", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081642"}, {"RECTYPE": "D", "MH": "Correctional Facilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Penal Institutions|T073|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Penal Institution", "MN": "J03.220", "MH_TH": "NLM (2021)", "ST": "T073", "AN": "specify geographic location if pertinent", "MS": "Places for the confinement of persons in lawful detention, including both persons awaiting trial under local jurisdiction and those persons convicted of crimes.", "PM": "2021", "HN": "2021", "MR": "20200526", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081682"}, {"RECTYPE": "D", "MH": "Jails", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Gaols|T073|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Jail", "MN": "J03.220.250", "MH_TH": "NLM (2021)", "ST": "T073", "AN": "specify geographic location if pertinent", "MS": "Place of confinement for persons held in lawful custody in a place under the jurisdiction of a local government such as a city or county for the confinement of persons awaiting trial or those convicted of misdemeanor crimes.", "PM": "2021", "HN": "2021", "MR": "20200225", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081702"}, {"RECTYPE": "D", "MH": "Betrayal", "AQ": "CL ES HI PX", "ENTRY": "Betrayals", "MN": "F01.829.401.023", "MH_TH": "NLM (2021)", "ST": "T041", "MS": "Act of violation of trust or confidence of a moral standard, etc.", "PM": "2021", "HN": "2021", "MR": "20191118", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081722"}, {"RECTYPE": "D", "MH": "Dentist's Role", "AQ": "HI PX", "PRINT ENTRY": "Role of Dentists|T057|NON|EQV|NLM (2021)|190917|abcdef", "ENTRY": "Roles, Dentists'", "MN": "F01.829.316.616.625.225", "MH_TH": "NLM (2021)", "ST": "T057", "PI": "Dentists (1966-2020)", "MS": "The expected function of a member of the dental profession.", "PM": "2021", "HN": "2021", "MR": "20191118", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081723"}, {"RECTYPE": "D", "MH": "Induced Demand", "AQ": "HI LJ ST TD", "PRINT ENTRY": "Induced Demand For Healthcare Services|T054|NON|BRD|NLM (2021)|191121|abcdef", "ENTRY": "Induced Demands", "MN": "N03.219.665", "MH_TH": "NLM (2021)", "ST": "T054", "MS": "Stimulating demand by providing or selling of sometimes unnecessary services to users accompanied by exercising power on behalf of service providers.", "PM": "2021", "HN": "2021", "MR": "20210126", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081724"}, {"RECTYPE": "D", "MH": "Human-Animal Interaction", "AQ": "CL DE ES", "PRINT ENTRY": "Human-Animal Relationship|T054|NON|REL|NLM (2021)|200526|abcdef", "ENTRY": "Relationships, Human-Animal", "MN": "F01.145.496", "MH_TH": "NLM (2021)", "ST": "T054", "MS": "Encompasses any situation where there is interchange between human(s) and animal(s) at an individual or cultural level. These interactions are diverse and idiosyncratic, and may be fleeting or profound. (https://www.avma.org/KB/Policies/Pages/The-Human-Animal-Bond.aspx accessed 8/22/2019).", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081762"}, {"RECTYPE": "D", "MH": "Interprofessional Education", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Education, Interprofessional", "MN": "I02.358.805", "MH_TH": "NLM (2021)", "ST": "T065", "PI": "Education, Professional (2010-2020)", "MS": "Education which encourages health professionals to learn their teammates' roles and responsibilities, making them better able to provide patient-centered care.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081784"}, {"RECTYPE": "D", "MH": "Service Animals", "AQ": "AB AH BL CF CL EC EM GD GE HI IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Service Dogs|T008|NON|NRW|NLM (2021)|200407|abcdef", "ENTRY": "Service Dog", "MN": "B01.050.050.116.812", "MH_TH": "NLM (2021)", "ST": "T008", "PI": "Dogs (1966-2020)", "MS": "Animals that have been trained to do work or perform tasks for an individual with a disability.  The task(s) performed by the animal must be directly related to the person's disability.  Emotional support, therapy, comfort, or companion animals are not considered service animals under the Americans With Disabilities Act.(www.ada.gov/regs2010/service_animal_qa.html, accessed 3/31/2020)", "PM": "2021", "HN": "2021", "MR": "20200902", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081822"}, {"RECTYPE": "D", "MH": "Logotherapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Logotherapies", "MN": "F04.754.528", "MH_TH": "NLM (2009)", "ST": "T061", "PI": "Psychotherapy (2009-2020)", "MS": "Directive existential psychotherapy that emphasizes the importance of meaning in the person's life.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081842"}, {"RECTYPE": "D", "MH": "Schema Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapy, Schema", "MN": "F04.754.834", "MH_TH": "NLM (2020)", "ST": "T061", "PI": "Psychotherapy (2000-2020)", "MS": "Therapy that emphasizes lifelong patterns, affective change techniques, and the therapeutic relationship. (https://www.apa.org/pubs/videos/4310804).", "PM": "2021; see Psychotherapy (2020)", "HN": "2021; use Psychotherapy (2020)", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081843"}, {"RECTYPE": "D", "MH": "Hyperspectral Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Hyperspectral Remote Sensing|T059|NON|NRW|NLM (2021)|190829|abcdef", "ENTRY": "Remote Sensing, Hyperspectral", "MN": "E05.196.867.381", "MH_TH": "NLM (2021)", "ST": "T059", "PI": "Spectrum Analysis (2001-2020)", "MS": "The use of SPECTROMETRY measurements (of radiance, reflectance, optical scattering, absorption, etc.) made for each point of an image, across the whole spectrum of a selected spectral range such as infrared, visual, ultraviolet, or X-rays. Hyperspectral images are analyzed to determine the make up and location of specific chemical compounds in the objects being imaged.", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081862"}, {"RECTYPE": "D", "MH": "Freedom of Religion", "AQ": "CL ES HI LJ SN ST TD", "PRINT ENTRY": "Religious Library|T078|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Religious Libraries", "MN": "I01.880.604.473.515", "MH_TH": "NLM (2021)", "ST": "T078", "MS": "The right to practice, worship, observe, and teach one's beliefs without external constraints.", "PM": "2021", "HN": "2021", "MR": "20210125", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081882"}, {"RECTYPE": "D", "MH": "Freedom of Movement", "AQ": "CL ES HI LJ SN ST TD", "PRINT ENTRY": "Right to Freedom of Movement|T068|NON|EQV|NLM (2021)|190903|abcdef", "MN": "I01.880.604.473.682", "MH_TH": "NLM (2021)", "ST": "T068", "PI": "Human Rights (1966-2020)", "MS": "The right to freedom of movement and residence within the borders of each state or nation. The right to leave any country and to return as provided in the Universal Declaration of Human Rights, Section 13, 1948.", "PM": "2021", "HN": "2021", "MR": "20200526", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081902"}, {"RECTYPE": "D", "MH": "Heteroplasmy", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Microheteroplasmy|T070|NON|NRW|NLM (2021)|190906|abcdef", "ENTRY": "Heteroplasmic Variations", "MN": "G05.365.461", "MH_TH": "NLM (2021)", "ST": "T070", "PI": "Genetic Variation (1986-2020)", "MS": "The occurrence of more than one organellar GENOME in the organelle population of a cell, tissue, or individual organism. It is due to the accumulation of different mutations that occur within the population of individual organelles of a cell.", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081942"}, {"RECTYPE": "D", "MH": "Crassulacean Acid Metabolism", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Crassulacean Acid Metabolism Photosynthesis|T039|NON|EQV|NLM (2021)|190908|abcdef", "MN": "G15.568.500", "MH_TH": "NLM (2021)", "ST": "T039", "MS": "A water-saving mode of photosynthesis whereby CARBON DIOXIDE (CO2) taken up during the nocturnal opening of stomata (STOMATA, PLANT) is fixed to produce malate, which is accumulated in VACUOLES overnight as malic acid and subsequently decarboxylated during the day with the resulting CO2 produced being re-fixed by RUBISCO and re-assimilated through the REDUCTIVE PENTOSE PHOSPHATE CYCLE. CAM photosynthesis is found mostly in plants in arid areas, but it is also found in aquatic plants and orchids.", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081962"}, {"RECTYPE": "D", "MH": "Laser Speckle Contrast Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E05.642.062", "MH_TH": "NLM (2021)", "ST": "T062", "MS": "Two-dimensional imaging created from the quantification of the blurring of speckle (randomly varying intensity patterns of light seen after it is scattered through a medium) that occurs spatially or temporally.  LSCI is used for measuring blood flow in tissues such as the retina, skin, and brain.", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081982"}, {"RECTYPE": "D", "MH": "Mediation Analysis", "PRINT ENTRY": "Mediating Variables|T169|NON|REL|NLM (2021)|190908|abcdef", "ENTRY": "Variables, Intermediary", "MN": "N06.850.520.830.400.500", "FX": "Causality", "MH_TH": "NLM (2021)", "ST": "T081", "MS": "A type of statistical analysis used to understand, clarify, and explain the relationship and pathway between a presumed cause (an independent variable) and effect (dependent variable) with respect to causal links (mediating variables) and/or to analyze the effect of an intervention (mediating factor/variable) on an outcome.", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000081983"}, {"RECTYPE": "D", "MH": "Acetaminophen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Paracetamol|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|740329|abbcdeeef", "ENTRY": "Anacin3", "MN": "D02.092.146.113.092.040", "PA": "Antipyretics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Acetamide, N-(4-hydroxyphenyl)-", "RN": "362O9ITL9D", "RR": "103-90-2 (Acetaminophen)", "MS": "Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.", "PM": "1965; for ACEPHEN see MECLOFENOXATE 1990-2002", "HN": "1965; for ACEPHEN use MECLOFENOXATE 1990-2002", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000082"}, {"RECTYPE": "D", "MH": "Sexual Trauma", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Sexual Abuse Trauma|T037|T048|NON|EQV|NLM (2021)|190920|abbcdef", "ENTRY": "Traumas, Sexual Abuse", "MN": "F03.950.750.438", "MH_TH": "NLM (2021)", "ST": "T048", "PI": "Sex Offenses (1964-2020)", "MS": "Physical and psychological injuries resulting from SEXUAL VIOLENCE.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082002"}, {"RECTYPE": "D", "MH": "Immune Checkpoint Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Programmed Death-Ligand 1 Inhibitors|T121|NON|NRW|NLM (2021)|191217|abcdef", "ENTRY": "Programmed Death Ligand 1 Inhibitors", "MN": "D27.505.954.248.384.500", "MH_TH": "NLM (2021)", "ST": "T121", "RN": "0", "PI": "Antineoplastic Agents (2017-2020)", "MS": "Drugs that block negative regulator IMMUNE CHECKPOINT proteins (e.g., PD-1 RECEPTOR and CTLA-4 ANTIGEN) thereby increasing suppressed immune activation in immunotherapies.", "PM": "2021", "HN": "2021", "MR": "20210629", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082082"}, {"RECTYPE": "D", "MH": "Immune Checkpoint Proteins", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stimulatory Checkpoint Molecules|T116|NON|NRW|NLM (2021)|191016|abcdef", "ENTRY": "Protein, Immune Checkpoint", "MN": "D23.383", "EC": "antagonists & inhibitors:Immune Checkpoint Inhibitors", "MH_TH": "NLM (2021)", "ST": "T116", "RN": "0", "MS": "Immunomodulators that regulate immune system either in stimulatory or inhibitory fashion allowing IMMUNE TOLERANCE. Activation of suppressed immune system (IMMUNOSUPPRESSION (PHYSIOLOGY)) in immunotherapy by IMMUNE CHECKPOINT INHIBITORS often targets inhibitory checkpoint molecules.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082102"}, {"RECTYPE": "D", "MH": "Internal Hernia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Transomental Hernia|T190|NON|NRW|NLM (2021)|191016|abcdef", "ENTRY": "Winslow Hernia Foramen", "MN": "C23.300.707.960", "MH_TH": "NLM (2021)", "ST": "T190", "PI": "Hernia (1963-2020)", "MS": "A protrusion of an internal abdominal organ through a hole in an anatomical structure such as a muscle or a membrane. For instance, in paraduodenal hernia the SMALL INTESTINE herniates through an opening in the MESENTERIES. It includes intra-abdominal and diaphragmatic hernias. In abdominal hernia a protrusion occurs through a weak spot in the muscle of the ABDOMINAL WALL.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082122"}, {"RECTYPE": "D", "MH": "Paraduodenal Hernia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Right Paraduodenal Hernia|T190|NON|NRW|NLM (2021)|191016|abcdef", "ENTRY": "Right Paraduodenal Hernias", "MN": "C23.300.707.960.750", "MH_TH": "NLM (2021)", "ST": "T190", "PI": "Hernia (1963-2020)", "MS": "A protrusion of the SMALL INTESTINE through an opening in the MESENTERY.", "PM": "2021", "HN": "2021", "MR": "20200228", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082123"}, {"RECTYPE": "D", "MH": "Mast Cell Stabilizers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mast Cells Stabilizers|T120|NON|EQV|NLM (2021)|191017|abcdef", "ENTRY": "Stabilizers, Mast Cells", "MN": "D27.505.954.158.636", "MH_TH": "NLM (2021)", "ST": "T120", "RN": "0", "PI": "Mast Cells/drug effects (1981-2020)", "MS": "Compounds that prevent the release of inflammatory mediators from MAST CELLS.", "PM": "2021", "HN": "2021", "MR": "20210707", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082142"}, {"RECTYPE": "D", "MH": "Diagnostic Reference Levels", "ENTRY": "Reference Levels, Diagnostic", "MN": "N06.850.810.250.090", "MH_TH": "NLM (2021)", "ST": "T081", "PI": "Radiation Dosage (2000-2020)", "MS": "Radiological values used as guides to indicate whether the radiation dosage or amount of radiopharmaceutical being given to a patient is unusually high or unusually low for the specific medical imaging procedure.", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082162"}, {"RECTYPE": "D", "MH": "Clonal Hematopoiesis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Idiopathic Cytopenias of Undetermined Significance|T043|NON|NRW|NLM (2021)|191023|abcdef", "ENTRY": "Hematopoiesis, Clonal", "MN": "G09.188.343.207", "MH_TH": "NLM (2021)", "ST": "T043", "PI": "Hematopoiesis (1989-2020)", "MS": "Expansion of blood cells arising from mutant HEMATOPOIETIC STEM CELLS often related to aging. Mutations on epigenetic regulator genes are common in clonal hematopoiesis and may be a risk factor for HEMATOLOGIC NEOPLASMS and other cardiovascular diseases. When variant allele fraction is at least 2% and is present in the absence of severe cytopenias it is referred to as clonal hematopoiesis of indeterminate potential (CHIP).", "PM": "2021", "HN": "2021", "MR": "20220413", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082182"}, {"RECTYPE": "D", "MH": "Digital Technology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Digital Electronics|T090|NON|BRD|NLM (2021)|191025|abcdef", "ENTRY": "Technology, Digital", "MN": "J01.897.160", "FX": "Analog-Digital Conversion", "MH_TH": "NLM (2021)", "ST": "T090", "MS": "The design and development of devices and procedures that collect, store, analyze, manipulate, and display numerically encoded information, usually via processes encoded in the binary number system.", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082222"}, {"RECTYPE": "D", "MH": "Kimura Disease", "DE": "KIMURA DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Kimura's Disease|T047|NON|EQV|NLM (2021)|191025|abcdef", "ENTRY": "Lymphogranuloma, Eosinophilic Hyperplastic", "MN": "C15.604.315.459", "FX": "Angiolymphoid Hyperplasia with Eosinophilia", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "A chronic inflammatory disease characterized by benign enlargement of cervical LYMPH NODE and SALIVARY GLANDS with increased levels of IMMUNOGLOBULIN E. Unlike ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA it involves eosinophil infiltrates in lymph node and salivary glands and mostly found in Asian males.", "PM": "2021; see ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA 1984-2020", "HN": "2021; use ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA 1984-2020", "MR": "20210510", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082242"}, {"RECTYPE": "D", "MH": "Compulsive Exercise", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Exercise, Compulsive", "MN": "I03.350.062", "MH_TH": "NLM (2021)", "ST": "T055", "PI": "Behavior (1995-2020)", "MS": "Obsessive, excessive unhealthy levels of activity performed on a regular basis that overrides social activities and basic responsibilities and leads to anxiety when circumstances prevent exercise.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082262"}, {"RECTYPE": "D", "MH": "Food Security", "AQ": "CL EC ES HI LJ MT SN ST", "ENTRY": "Security, Food", "MN": "J01.576.423.750.875", "MH_TH": "NLM (2012)", "ST": "T080", "PI": "Food Supply (2012-2020)", "MS": "Access generally by all in a community to enough nutritious food for an active, healthy life. (from http://www.fns.usda.gov/fsec/ accessed 4/22/2011).", "PM": "2021; see FOOD SUPPLY 2012-2020", "HN": "2021; use FOOD SUPPLY (2012-2020)", "MR": "20210630", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000082302"}, {"RECTYPE": "D", "MH": "Psychotherapists", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Psychotherapists, Clinical", "MN": "M01.526.485.858", "MH_TH": "NLM (2015)", "ST": "T097", "MS": "Trained professionals who treat mental or emotional problems using psychological rather than solely using medical methods.", "PM": "2021", "HN": "2021", "MR": "20200430", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082383"}, {"RECTYPE": "D", "MH": "Actinomadura", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Streptomycoides|T007|NON|EQV|NLM (2021)|200227|abcdef", "MN": "B03.510.024.049.025", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1988", "AN": "infection: coordinate with probably MADURA FOOT, otherwise coordinate with ACTINOMYCETALES INFECTIONS", "PI": "Actinomycetales (1969-2020)", "MS": "A genus of gram-positive bacteria in the family Thermomonosporaceae, order ACTINOMYCETALES. It is a filamentous bacterium found in soil and is a causative agent for MADURA FOOT.", "PM": "2021", "HN": "2021", "MR": "20200902", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082403"}, {"RECTYPE": "D", "MH": "Internet Addiction Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Social Media Addiction|T048|NON|NRW|NLM (2021)|191211|abcdef", "ENTRY": "Social Media Addictions", "MN": "F01.145.527.100.120.875.500", "MH_TH": "NLM (2021)", "ST": "T048", "PI": "Behavior, Addictive (2010-2020)", "MS": "Problematic, compulsive Internet use that results in significant impairment of person's function in daily life.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082424"}, {"RECTYPE": "D", "MH": "Plant Defense Against Herbivory", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Plant Resistance to Herbivory|T039|NON|EQV|NLM (2021)|191112|abcdef", "ENTRY": "Tolerance, Host-Plant", "MN": "G15.579", "MH_TH": "NLM (2021)", "ST": "T039", "MS": "Traits developed in plants that help them avoid being used as host plants or food sources; or to tolerate and recover from HERBIVORY. Traits may be mechanical or chemical such as those that affect accessibility (thorns, thick husks, etc.), attractiveness to herbivore (odor, color, texture, etc.), digestibility (toxins, lignins, etc.), and movement in response to touch.", "PM": "2021", "HN": "2021", "MR": "20200722", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082462"}, {"RECTYPE": "D", "MH": "Sanitary Surveys, Water Supply", "AQ": "ST", "PRINT ENTRY": "Sanitary Surveys|T064|NON|BRD|NLM (2021)|191112|abcdef", "ENTRY": "Surveys, Sanitary", "MN": "N06.850.520.308.975", "FX": "Health Surveys", "MH_TH": "NLM (2021)", "ST": "T064", "PI": "Water Quality (2012-2020)", "MS": "Review of public systems to assess their capability to supply safe drinking water. (From: https://www.epa.gov/dwreginfo/sanitary-surveys).", "PM": "2021", "HN": "2021", "MR": "20211202", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082463"}, {"RECTYPE": "D", "MH": "Workhouses", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Poorhouses|T073|NON|REL|NLM (1996)|191113|abcdef", "ENTRY": "Workhouse", "MN": "J03.340.030.500", "MH_TH": "NLM (2021)", "ST": "T073", "MS": "An establishment offering relief for the destitute poor in an area, funded from the local poor tax, which provided some combination of communal accommodation and a requirement for inmates, particularly the able-bodies, to perform work. (from Workhouses.org.uk accessed 12/11/2019).", "PM": "2021; see Poorhouses (1996-2020)", "HN": "2021; use Poorhouses (1996-2020)", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082483"}, {"RECTYPE": "D", "MH": "Amycolatopsis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.024.049.075", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1813", "PI": "Actinomycetales (1994-2020)", "MS": "A genus of high GC content gram positive bacteria of the family Pseudonocardiaceae in the order Pseudonocardiales. It is known for producing the antibiotics epoxyquinomycin, VANCOMYCIN, and RISTOCETIN which are used in treating various infections.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082502"}, {"RECTYPE": "D", "MH": "Open Field Test", "AQ": "DE PH RE", "PRINT ENTRY": "Open Field Maze Test|T059|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Test, Open Field", "MN": "F02.463.425.874.500.875", "MH_TH": "NLM (2021)", "ST": "T059", "PI": "Maze Learning (2007-2020)", "MS": "A maze test in which an animal is placed in an open chamber designed to assess anxiety and exploratory behavior by movement patterns. In novel object recognition test various objects are added to open field to assess exploration and memory.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082563"}, {"RECTYPE": "D", "MH": "Elevated Plus Maze Test", "PRINT ENTRY": "Elevated Plus-Maze|T059|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Maze, Elevated Plus", "MN": "F02.463.425.874.500.500", "MH_TH": "NLM (2021)", "ST": "T059", "PI": "Maze Learning (1997-2020)", "MS": "A maze test in which an animal is placed on the center of elevated platform and is allowed to choose one of four arms configured like a plus sign. Animals are inherently wary of open elevated areas and tend to avoid the open arms.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082564"}, {"RECTYPE": "D", "MH": "Molecularly Imprinted Polymers", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Polymer, Molecularly Imprinted", "MN": "J01.637.051.720.573", "MH_TH": "NLM (2021)", "ST": "T122", "RN": "0", "PI": "Molecular Imprinting (1989-2020)", "MS": "Synthetic polymeric matrices with artificial molecular recognition sites generated by MOLECULAR IMPRINTING TECHNIQUE. It can specifically bind target molecules (e.g., antibodies, enzymes or receptors).", "PM": "2021", "HN": "2021", "MR": "20200206", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082582"}, {"RECTYPE": "D", "MH": "Developmental Dysplasia of the Hip", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hip Dislocation, Developmental|T047|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Hip Dysplasia, Developmental", "MN": "C16.131.621.297", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Hip Dislocation, Congenital (1992-2020)", "MS": "Dislocation of the HIP JOINT from an abnormal FEMORAL HEAD to the ACETABULUM relationship. It is most often due to ligamentous laxity, abnormal positioning of the joint and various other developmental, congenital factors, and method of delivery (e.g., OLIGOHYDRAMNIOS). When dislocation is diagnosed in neonates it is referred to as CONGENITAL HIP DYSPLASIA.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082602"}, {"RECTYPE": "D", "MH": "Preoperative Exercise", "AQ": "PH PX", "PRINT ENTRY": "Preoperative Rehabilitation|T061|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Rehabilitation, Preoperative", "MN": "N02.421.585.722.850", "MH_TH": "NLM (2021)", "ST": "T061", "PI": "Exercise (1996-2020)", "MS": "Various physical exercises implemented before a surgery designed for better TREATMENT OUTCOME.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082622"}, {"RECTYPE": "D", "MH": "Caldicellulosiruptor", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.353.563", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid44000", "PI": "Firmicutes (2015-2020)", "MS": "A genus of thermophilic, anaerobic, gram-positive, and non-spore forming bacteria in the order Thermoanaerobacterales and phylum FIRMICUTES. It is known for fermenting CELLULOSE and hemicellulose from plants and for its role in producing BIOFUELS.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082623"}, {"RECTYPE": "D", "MH": "Brain Cortical Thickness", "PRINT ENTRY": "Grey Matter Thickness|T081|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Thickness, Grey Matter", "MN": "E05.629.375", "FX": "Cerebral Cortical Thinning", "MH_TH": "NLM (2021)", "ST": "T081", "PI": "Cerebral Cortex (2005-2020)", "MS": "Measurements of the thickness of the CEREBRAL CORTEX often detected automatically from medical imaging. Abnormal changes in cortical thickness (e.g., CORTICAL THINNING) are potential biomarkers for various neuropathologies.", "PM": "2021", "HN": "2021", "MR": "20210707", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082642"}, {"RECTYPE": "D", "MH": "Cerebral Cortical Thinning", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cortical Thinning|T033|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Thinning, Cortical", "MN": "C23.888.592.206", "FX": "Brain Cortical Thickness", "MH_TH": "NLM (2021)", "ST": "T033", "PI": "Cerebral Cortex (1973-2020)", "MS": "Decrease in CEREBRAL CORTICAL THICKNESS.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082643"}, {"RECTYPE": "D", "MH": "Microvascular Density", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Vascular Density|T033|NON|BRD|NLM (2021)|191121|abcdef", "ENTRY": "Microvessel Density Measurements", "MN": "G09.330.480", "MH_TH": "NLM (2021)", "ST": "T033", "PI": "Microcirculation (1986-2020)", "MS": "Measured density of MICROVESSELS in a given field of area. It is a surrogate BIOMARKER used for many physiological and pathophysiological processes such as angiogenesis, neovascularization, disease and tumor progressions.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082644"}, {"RECTYPE": "D", "MH": "Magnetic Iron Oxide Nanoparticles", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO UL VI", "PRINT ENTRY": "Superparamagnetic Iron Oxide Nanoparticles|T130|T197|NON|NRW|NLM (2021)|191125|abbcdef", "ENTRY": "Superparamagnetic Iron Nanoparticle", "MN": "J01.637.512.600.500.144", "FX": "Drug Carriers", "MH_TH": "NLM (2021)", "ST": "T197", "PI": "Nanoparticles (2005-2020)", "MS": "Synthesized nanoparticles related to iron oxide crystalline structures with magnetic properties useful for biomedical applications. Examples include hematite, magnetite and maghemite nanoparticles.", "PM": "2021", "HN": "2021", "MR": "20210707", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082662"}, {"RECTYPE": "D", "MH": "Clostridioides", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.353.625.657", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1870884", "PI": "Clostridiales (2016-2020)", "MS": "A genus of an obligate anaerobic, gram-positive, spore-forming rod bacteria in the family Peptostreptococcacea and the order CLOSTRIDIALES. Known cause of  inflammation of the colon and profuse diarrhea.", "PM": "2021", "HN": "2021", "MR": "20210510", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082682"}, {"RECTYPE": "D", "MH": "Default Mode Network", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Default-Mode Network|T017|NON|EQV|NLM (2021)|191129|abcdef", "ENTRY": "Network, Default-Mode", "MN": "A08.612.300", "MH_TH": "NLM (2021)", "ST": "T017", "PI": "Neural Pathways (2008-2020)", "MS": "Brain regions which are functionally-connected that are active during resting state and deactivated when engaged in task- or attention-oriented behavioral activities as seen in cognitive imaging studies often with fMRI.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082702"}, {"RECTYPE": "D", "MH": "Photothermal Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Photothermal", "MN": "E02.774.834", "MH_TH": "NLM (2021)", "ST": "T061", "MS": "Application of LOCAL HYPERTHERMIA within a specific tissue using electromagnetic radiation to convert light/laser into heat often coupled with PHOTOSENSITIZER including nanoparticle.", "PM": "2021", "HN": "2021", "MR": "20200228", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082703"}, {"RECTYPE": "D", "MH": "Sexual Selection", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Intersexual Selection|T045|NON|EQV|NLM (2021)|191129|abcdef", "ENTRY": "Sexual Selections", "MN": "G05.783.500", "FX": "Sex Characteristics", "MH_TH": "NLM (2021)", "ST": "T045", "PI": "Selection, Genetic (1963-2020)", "MS": "A type of natural selection in which members of one sex choose to mate with members of the other sex that have genetically different components.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082723"}, {"RECTYPE": "D", "MH": "Heart Disease Risk Factors", "PRINT ENTRY": "Risk Factors for Heart Disease|T080|NON|EQV|NLM (2021)|200123|abcdef", "ENTRY": "Score, Cardiovascular Risk", "MN": "N06.850.520.830.600.800.725.500", "MH_TH": "NLM (2021)", "ST": "T080", "PI": "Risk Factors (1987-2020)", "MS": "Aspects of personal behavior or lifestyle, environmental exposure, inherited conditions and characteristics, which are determined to be associated with HEART DISEASES.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082742"}, {"RECTYPE": "D", "MH": "Amblyomma", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Tropical Bont Tick|T204|NON|NRW|NLM (2021)|191129|abcdef", "ENTRY": "Tropical Bont Ticks", "MN": "B01.050.500.131.166.132.832.400.100", "MH_TH": "NLM (2021)", "ST": "T204", "RN": "txid6942", "RR": "txid6943", "PI": "Ixodidae (1964-2020)", "MS": "A genus of hardbacked TICKS, in the family IXODIDAE. It includes the lone star tick, Amblyomma americanum, and the Gulf Coast tick, Amblyomma maculatum, in the Americas. Amblyomma americanum is the primary vector of EHRLICHIA CHAFFEENSIS and EHRLICHIA EWINGII which cause EHRLICHIOSIS. Other Amblyomma-associated diseases include TULAREMIA and RICKETTSIOSIS.", "PM": "2021", "HN": "2021", "MR": "20210209", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082762"}, {"RECTYPE": "D", "MH": "Rhizopus oryzae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rhizopus tritici|T004|NON|EQV|NLM (2021)|200318|abcdef", "MN": "B01.300.300.500.800.500", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid64495", "RR": "txid126589", "PI": "Rhizopus (1963-2020)", "MS": "A species of zygomycetous fungi of the genus RHIZOPUS, family MUCORACEAE, and order MUCORALES. It may cause MUCORMYCOSIS in IMMUNOSUPPRESSED HOSTS.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082763"}, {"RECTYPE": "D", "MH": "Warburg Effect, Oncologic", "AQ": "DE RE", "PRINT ENTRY": "Aerobic Glycolysis, Oncologic|T191|NON|EQV|NLM (2021)|191210|abcdef", "ENTRY": "Oncologic Warburg Effect", "MN": "G04.270.810", "MH_TH": "NLM (2021)", "ST": "T191", "PI": "Glycolysis (1981-2020)", "MS": "An observation in neoplastic cellular transformation, characterized by an increased glucose uptake via glycolytic activities resulting in an increased LACTATE production under aerobic microenvironment.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082802"}, {"RECTYPE": "D", "MH": "Ovarian Torsion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Adnexal Torsion|T047|NON|REL|NLM (2021)|191212|abcdef", "ENTRY": "Torsions, Ovarian", "MN": "C23.300.970.625", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Ovarian Diseases (1966-2020)", "MS": "A condition that occurs when an ovary twists around the ligaments that hold it in place. This twisting can cut off blood flow. It usually affects only one ovary.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082843"}, {"RECTYPE": "D", "MH": "Aortic Valve Disease", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aortic Valvular Heart Disorder|T047|NON|EQV|NLM (2021)|191216|abcdef", "ENTRY": "Valve Disorder, Aortic", "MN": "C14.280.484.048", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Heart Valve Diseases (1963-2020)", "MS": "Diseases involving the AORTIC VALVE functionality. Aortic valve disease often results in a backward and/or regurgitated blood flow into the LEFT VENTRICLE or a decreased blood flow from the heart. It includes congenital (e.g., bicuspid aortic valve), syndromic, and acquired (e.g., age-related, infection-associated) conditions.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082862"}, {"RECTYPE": "D", "MH": "Bicuspid Aortic Valve Disease", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Two-Raphe Bicuspid Aortic Valve|T047|NON|NRW|NLM (2023)|210901|abcdef", "ENTRY": "Valve, Bicuspid Aortic", "MN": "C16.131.240.400.186", "MH_TH": "NLM (2021)", "ST": "T047", "MS": "Congenital heart valve defects where the AORTIC VALVE has two instead of normal three cusps. It is often associated with AORTIC REGURGITATION and AORTIC INSUFFICIENCY.", "PM": "2021; see under HEART VALVE DISEASES and AORTIC VALVE/ab 2014-2020", "HN": "2021; use under HEART VALVE DISEASES and AORTIC VALVE/ab 2014-2020", "MR": "20211018", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082882"}, {"RECTYPE": "D", "MH": "Quadricuspid Aortic Valve", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Quadricuspid Aortic Valvular Disease|T019|NON|EQV|NLM (2021)|191216|abcdef", "ENTRY": "Quadricuspid Aortic Valves", "MN": "C16.131.240.400.817", "MH_TH": "NLM (2021)", "ST": "T019", "PI": "Heart Valve Diseases (1968-2020)", "MS": "Congenital malformation where the AORTIC VALVE has four instead of three cusps. It is often associated with AORTIC REGURGITATION and AORTIC VALVE STENOSIS.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082902"}, {"RECTYPE": "D", "MH": "Aortico-Ventricular Tunnel", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aortoventricular Tunnel|T019|NON|EQV|NLM (2021)|191216|abcdef", "ENTRY": "Ventricular Tunnels, Aortic-Right", "MN": "C16.131.240.400.118", "MH_TH": "NLM (2021)", "ST": "T019", "PI": "Heart Defects, Congenital (1965-2020)", "MS": "Congenital anomaly characterized by an extra-cardiac channel connecting the AORTA either to the right or left HEART VENTRICLE.", "PM": "2021", "HN": "2021", "MR": "20210510", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082903"}, {"RECTYPE": "D", "MH": "HIV Testing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "HIV-AIDS Testing|T060|NON|NRW|NLM (2021)|191231|abcdef", "ENTRY": "Testing, HIV-AIDS", "MN": "E05.200.875.408", "FX": "HIV Seroprevalence", "MH_TH": "NLM (2021)", "ST": "T060", "AN": "coordinate with HIV Infections/*diag or AIDS /*diag and specific test if pertinent", "MS": "Diagnosis of HIV INFECTIONS by assaying bodily fluids or tissues for the presence of HIV ANTIBODIES; HIV ANTIGENS; or the VIRAL RNA of HIV.", "PM": "2021", "HN": "2021", "MR": "20210305", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082922"}, {"RECTYPE": "D", "MH": "Dehalococcoides", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.275.575", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid61434", "PI": "Chloroflexi (2003-2020)", "MS": "A genus of organohalide-respiring bacteria in the class Dehalococcoidia and phylum CHLOROFLEXI. It can dehalogenate toxic compounds such as TETRACHLOROETHENE into less harmful chemical forms.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082942"}, {"RECTYPE": "D", "MH": "Toona", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Toonas", "MN": "B01.875.800.575.912.250.715.750", "MH_TH": "NLM (2021)", "ST": "T002", "RN": "txid67917", "PI": "Meliaceae (2002-2020)", "MS": "A plant genus of the family MELIACEAE. Several members were formerly classified under CEDRELA (e.g., Toona sinensis formerly Cedrela sinensis) and produces various LIMONOIDS (e.g., toonins).", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000082982"}, {"RECTYPE": "D", "MH": "Acetanilides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "N-Phenylacetamides|T109|NON|EQV|NLM (2005)|040105|abcdef", "MN": "D02.092.146.113.092", "FX": "Benzeneacetamides", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Compounds based on N-phenylacetamide, that are similar in structure to 2-PHENYLACETAMIDES. They are precursors of many other compounds. They were formerly used as ANALGESICS and ANTIPYRETICS, but often caused lethal METHEMOGLOBINEMIA.", "OL": "use ACETANILIDES to search ACETANILIDE 1968-78 & ACETANILID 1966-67", "PM": "79; was ACETANILIDE 1968-78, was ACETANILID 1963-67", "HN": "79; was ACETANILIDE 1968-78, was ACETANILID 1963-67", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000083"}, {"RECTYPE": "D", "MH": "Timbre Perception", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Tone Perception|T041|NON|EQV|NLM (2021)|191220|abcdef", "ENTRY": "Tone Perceptions", "MN": "G07.888.125.937", "MH_TH": "NLM (2021)", "ST": "T041", "MS": "An ability to perceive and distinguish sound sources based on tonal quality or sound color (e.g., overtone).", "PM": "2021", "HN": "2021", "MR": "20200528", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083002"}, {"RECTYPE": "D", "MH": "Colitis-Associated Neoplasms", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Colitis-Associated Colorectal Cancer|T191|NON|EQV|NLM (2021)|200221|abcdef", "ENTRY": "Neoplasm, Colitis-Associated", "MN": "C06.405.469.491.307.180.400", "MH_TH": "NLM (2021)", "ST": "T191", "PI": "Colorectal Neoplasms (2002-2020)", "MS": "Colonic neoplasms associated with chronic inflammation conditions such as ULCERATIVE COLITIS and CROHN DISEASE.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083023"}, {"RECTYPE": "D", "MH": "Dickeya", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.139", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid204037", "PI": "Gammaproteobacteria (2005-2020)", "MS": "A genus of gram-negative bacteria in the family Pectobacteriaceae and the order Enterobacterales. Species of this genus are known phytopathogens that cause various diseases in plants such as POTATOES. It is closely related to PECTOBACTERIUM CHRYSANTHEMI.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083042"}, {"RECTYPE": "D", "MH": "Analytic Hierarchy Process", "PRINT ENTRY": "Analytical Hierarchy Process|T170|NON|EQV|NLM (2021)|191227|abcdef", "ENTRY": "Processes, Analytical Hierarchy", "MN": "L01.313.500.750.190.095", "MH_TH": "NLM (2021)", "ST": "T170", "MS": "A technique or tool used to analyze choices for complex decisions, by organizing them, for analysis, into a tree structure.", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083062"}, {"RECTYPE": "D", "MH": "Popliteal Artery Entrapment Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Popliteal Artery Entrapment|T047|NON|REL|NLM (2021)|200103|abcdef", "ENTRY": "Popliteal Artery Entrapments", "MN": "C14.907.137.671", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Popliteal Artery (1965-2020)", "MS": "Entrapment of the POPLITEAL ARTERY in the LEG due to an abnormal course of the artery often associated with onset of development and/or overuse of the gastrocnemius or popliteus muscles on the back of the leg. It is most often associated with runners and other athletes with enlarged calf muscle that compresses the POPLITEAL ARTERY.", "PM": "2021", "HN": "2021", "MR": "20220523", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083082"}, {"RECTYPE": "D", "MH": "Laminopathies", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "LMNA-Linked Diseases|T047|ABX|EQV|NLM (2021)|200107|abcdef", "ENTRY": "Laminopathy", "MN": "C16.320.488", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Neuromuscular Diseases (2002-2020)", "MS": "Congenital neuromuscular and muscular dystrophy diseases associated with mutations in the LAMIN TYPE A (Lamin A/C or LMNA gene). It includes CARDIOMYOPATHY, DILATED, 1A; CHARCOT-MARIE-TOOTH DISEASE, type 2B1; EMERY-DREIFUSS MUSCULAR DYSTROPHY, types 2 and 3; HUTCHINSON-GILFORD PROGERIA SYNDROME; LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; Malouf syndrome; Mandibuloacral dysplasia; LMNA-related muscular dystrophy; Restrictive dermopathy, lethal; Heart-hand syndrome, Slovenian type.", "PM": "2021", "HN": "2021", "MR": "20200228", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083083"}, {"RECTYPE": "D", "MH": "Reinjuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subsequent Injuries|T037|NON|REL|NLM (2021)|200107|abcdef", "ENTRY": "injuries, Repeated", "MN": "C26.741", "MH_TH": "NLM (2021)", "ST": "T037", "PI": "Wounds and Injuries (1992-2020)", "MS": "Damage inflicted on the same body part as a previous injury.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083102"}, {"RECTYPE": "D", "MH": "Vancomycin-Resistant Staphylococcus aureus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Vancomycin-Resistant S. aureus|T007|ABX|EQV|NLM (2021)|200107|abcdef", "MN": "B03.510.400.790.750.100.750", "FX": "Vancomycin Resistance", "MH_TH": "NLM (2021)", "ST": "T007", "AN": "infection: coordinate with STAPHYLOCOCCAL INFECTIONS or specifics", "PI": "Vancomycin Resistance (1999-2020)", "MS": "Isolates of the Staphylococcus aureus that are resistant to the antibiotic VANCOMYCIN. The S. aureus becomes resistant by acquiring plasmids carrying genes for VANCOMYCIN RESISTANCE. Vancomycin\u2010intermediate S. aureus has low-level vancomycin resistance requiring an intermediate concentration of vancomycin between sensitive and resistant isolates. These S. aureus with reduced susceptibility to vancomycin and related GLYCOPEPTIDE antibiotics are often seen in HEALTHCARE ASSOCIATED INFECTIONS.", "PM": "2021", "HN": "2021", "MR": "20200902", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083123"}, {"RECTYPE": "D", "MH": "X-Linked Emery-Dreifuss Muscular Dystrophy", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "XMPMA|T047|ABB|REL|OMIM (2013)|200107|abcdef", "ENTRY": "X-Linked Scapuloperoneal Syndrome", "MN": "C16.320.577.350.500", "MH_TH": "NLM (2005)", "ST": "T047", "MS": "Emery-Dreifuss muscular dystrophy associated with mutations on emerin (EMD gene) or four and a half LIM domains 1 (FHL1 gene) both located on X chromosome.", "PM": "2021", "HN": "2021", "MR": "20210510", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083143"}, {"RECTYPE": "D", "MH": "Autosomal Emery-Dreifuss Muscular Dystrophy", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hauptmann Thannhauser Muscular Dystrophy", "MN": "C16.320.577.350.250", "MH_TH": "NLM (2021)", "ST": "T047", "MS": "Emery-Dreifuss muscular dystrophy associated with mutations on LAMINS (LMNA gene).", "PM": "2021", "HN": "2021", "MR": "20200228", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083144"}, {"RECTYPE": "D", "MH": "Mitochondrial Permeability Transition Pore", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "mPTP Protein|T116|T123|ABX|EQV|NLM (2021)|200107|abbcdef", "MN": "D12.776.575.750.563", "MH_TH": "NLM (2021)", "ST": "T123", "RN": "0", "MS": "A multiprotein inner mitochondrial complex which opens only under certain pathological conditions (e.g., OXIDATIVE STRESS) uncoupling the membrane leading to APOPTOSIS and MITOCHONDRIAL TRANSMEMBRANE PERMEABILITY-DRIVEN NECROSIS particularly in CARDIOMYOCYTES during MYOCARDIAL REPERFUSION INJURY.", "PM": "Mitochondrial Permeability Transition Pore was indexed under MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS 2007-2020; ION CHANNELS 2003-2006; MEMBRANE PROTEINS 1999-2002; CYCLOSPORINS 1999-2000", "HN": "2021(1999)", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083162"}, {"RECTYPE": "D", "MH": "Chronic Exertional Compartment Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.550.291.500.282", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Compartment Syndromes (1982-2020)", "MS": "Compartment syndrome characterized by pain in muscle groups with elevated compartment pressures due most often exercise training in athletes. Most often encountered chronic exertional compartment syndrome is in the anterior or deep posterior compartments of the lower leg in athletes in training similar to POPLITEAL ARTERY ENTRAPMENT SYNDROME.", "PM": "2021", "HN": "2021", "MR": "20210312", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083182"}, {"RECTYPE": "D", "MH": "Cardiometabolic Risk Factors", "ENTRY": "Risk Factors, Cardiometabolic", "MN": "N06.850.520.830.600.800.725.500.500", "FX": "Metabolic Syndrome", "MH_TH": "NLM (2021)", "ST": "T080", "PI": "Risk Factors (2006-2020)", "MS": "A cluster of personal behavior or lifestyle, environmental exposure, inborn or inherited conditions and characteristics, which, on the basis of epidemiological evidence,  is known to be associated with CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083202"}, {"RECTYPE": "D", "MH": "Ischemic Stroke", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wake-up Stroke|T047|NON|NRW|NLM (2021)|200113|abcdef", "ENTRY": "Wake-up Strokes", "MN": "C14.907.253.855.400", "FX": "Thrombosis", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Stroke (1963-2020)", "MS": "Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin.", "PM": "2021", "HN": "2021", "MR": "20200228", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083242"}, {"RECTYPE": "D", "MH": "Thrombotic Stroke", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Acute Thrombotic Stroke|T047|NON|NRW|NLM (2021)|200109|abcdef", "ENTRY": "Thrombotic Strokes", "MN": "C14.907.253.855.400.750", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Thrombosis (1974-2020)", "MS": "A type of ischemic stroke resulting from obstruction due to a BLOOD CLOT formed within in a CEREBRAL ARTERY often associated with ATHEROSCLEROSIS. A stroke due to a blood clot in a cerebral vein is a venous infarction (see VENOUS INFARCTION, BRAIN).", "PM": "2021", "HN": "2021", "MR": "20200110", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083244"}, {"RECTYPE": "D", "MH": "Embolic Stroke", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cardioembolic Stroke|T047|NON|NRW|NLM (2021)|200110|abcdef", "ENTRY": "Strokes, Embolic", "MN": "C14.907.253.855.400.375", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Stroke (1980-2020)", "MS": "An ischemic stroke due to a blood clot, emboli or other types of blockage which forms somewhere other than the brain and subsequently travels near and restricts blood flow to the brain. Most often the origin of the clot is from the heart and is referred to as cardioembolic stroke.", "PM": "2021", "HN": "2021", "MR": "20200228", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083262"}, {"RECTYPE": "D", "MH": "Social Cognition", "AQ": "EH", "ENTRY": "Cognition, Social", "MN": "F02.463.593.752.500", "MH_TH": "NLM (2021)", "ST": "T041", "MS": "Perception, interpretation, and categorizing self  judgement of one's own social behaviors and group position and those of others.", "PM": "2021", "HN": "2021", "MR": "20200707", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083282"}, {"RECTYPE": "D", "MH": "Hemorrhagic Stroke", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subarachnoid Hemorrhagic Stroke|T047|NON|NRW|NLM (2021)|200113|abcdef", "ENTRY": "Subarachnoid Hemorrhagic Strokes", "MN": "C14.907.253.855.300", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Stroke (1964-2020)", "MS": "Stroke due to rupture of a weakened blood vessel in the brain (e.g., CEREBRAL HEMISPHERES; CEREBELLUM; SUBARACHNOID SPACE).", "PM": "2021", "HN": "2021", "MR": "20210209", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083302"}, {"RECTYPE": "D", "MH": "Health Belief Model", "PRINT ENTRY": "Health Belief Models|T170|NON|EQV|NLM (2021)|200221|abcdef", "ENTRY": "Model, Health Belief", "MN": "E05.599.695.275", "MH_TH": "NLM (2021)", "ST": "T170", "PI": "Models, Psychological (1991-2020)", "MS": "A model which is based on certain predictors of a person\u2019s perception of threat severity, susceptibility, interventional benefits and self-efficacy about a health threat that can be used to promote and educate health behavior.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083342"}, {"RECTYPE": "D", "MH": "Transtheoretical Model", "PRINT ENTRY": "Stages of Change|T062|T170|NON|EQV|NLM (2021)|200113|abbcdef", "ENTRY": "Model, Transtheoretical", "MN": "E05.599.925", "MH_TH": "NLM (2021)", "ST": "T170", "PI": "Models, Psychological (1992-2020)", "MS": "A model which is based on a theory that people don\u2019t change at once but instead rely on multiple stages of readiness to change. Each stage in turn is associated with strategies for progressing through that stage.", "PM": "2021; for Transtheoretical Model of Behavior Change see under Biobehavioral Sciences 2019-2020", "HN": "2021; for Transtheoretical Model of Behavior Change was under Biobehavioral Sciences 2019-2020", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083362"}, {"RECTYPE": "D", "MH": "Uncinate Fasciculus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Fasciculus Uncinatus|T023|NON|EQV|NLM (2021)|200113|abcdef", "ENTRY": "Uncinatus, Fasciculus", "MN": "A08.186.211.200.885.287.500.863.712", "MH_TH": "NLM (2021)", "ST": "T023", "PI": "White Matter (2014-2020)", "MS": "A hook-shaped WHITE MATTER axon tract that connects the uncus and pole of the TEMPORAL LOBE, the LIMBIC SYSTEM and the FRONTAL LOBE. It innervates AMYGDALA proper.", "PM": "2021", "HN": "2021", "MR": "20200228", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083382"}, {"RECTYPE": "D", "MH": "Persistent Left Superior Vena Cava", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Superior Vena Caval Duplication|T033|T190|NON|NRW|NLM (2021)|200113|abbcdef", "ENTRY": "SVC, Bilateral", "MN": "C16.131.240.850.902", "MH_TH": "NLM (2021)", "ST": "T019", "PI": "Vena Cava, Superior (1963-2020)", "MS": "Finding of the SUPERIOR VENA CAVA on the left instead of the usual right side of the ASCENDING AORTA. In bilateral superior vena cava it is found on both sides.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083402"}, {"RECTYPE": "D", "MH": "Virome", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Virus Microbiome|T005|NON|EQV|NLM (2021)|200113|abcdef", "ENTRY": "Virus Microbiomes", "MN": "N06.230.124.049.100.500.937", "MH_TH": "NLM (2021)", "ST": "T005", "MS": "All of the VIRUSES that exist within a particular biological niche such as an organism or specific location of the organism, soil, a body of water, etc.", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083422"}, {"RECTYPE": "D", "MH": "Vertebral Body", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Vertebral Pedicles|T023|NON|REL|NLM (2021)|200114|abcdef", "ENTRY": "Vertebral Pedicle", "MN": "A02.835.232.834.946", "MH_TH": "NLM (2021)", "ST": "T023", "PI": "Spine (1963-2020)", "MS": "Main portion of the vertebra which bears majority of the weight.", "PM": "2021", "HN": "2021", "MR": "20210510", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083442"}, {"RECTYPE": "D", "MH": "Persistent Organic Pollutants", "AQ": "AE BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO UR", "PRINT ENTRY": "Persistent Organic Pollutant|T131|NON|EQV|NLM (2021)|200114|abcdef", "ENTRY": "Pollutants, Persistent Organic", "MN": "D27.888.284.429", "MH_TH": "NLM (2021)", "ST": "T131", "RN": "0", "PI": "Environmental Pollutants (1994-2020)", "MS": "Toxic chemicals that persist for long periods of time in the ENVIRONMENT and that contaminate ECOSYSTEMS where they are released and where they are transported to by wind, water, and the FOOD CHAIN.", "PM": "2021", "HN": "2021", "MR": "20200721", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083462"}, {"RECTYPE": "D", "MH": "Social Network Analysis", "ENTRY": "Social Network Analyses", "MN": "I01.880.866.500", "MH_TH": "NLM (2021)", "ST": "T062", "MS": "A set of methods that identify the ties or relationships linking each member of a group to every other member.", "PM": "2021", "HN": "2021", "MR": "20200429", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083482"}, {"RECTYPE": "D", "MH": "Social Interaction", "AQ": "CL DE EH ES", "PRINT ENTRY": "Social Functioning|T054|NON|REL|NLM (2021)|200115|abcdef", "ENTRY": "Social Functionings", "MN": "F01.829.401.716", "MH_TH": "BIOETHICS (1974)", "ST": "T054", "PI": "Interpersonal Relations (1978-2020)", "MS": "Process involving reciprocal response between two or more individuals. This includes the development of cooperation and competition, the influence of status and social roles, and the dynamics of group behavior, leadership, and conformity. Persistent social interaction between specific individuals leads to the formation of social relationships.", "PM": "2021; see Interpersonal Relations 1978-2020", "HN": "2021; was Interpersonal Relations 1978-2020", "MR": "20200429", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083505"}, {"RECTYPE": "D", "MH": "Mechanical Tests", "AQ": "EC IS MT SN ST", "PRINT ENTRY": "Mechanical Testing|T169|NON|EQV|NLM (2021)|200115|abcdef", "ENTRY": "Tests, Mechanical", "MN": "E05.570.500", "MH_TH": "NLM (2021)", "ST": "T169", "MS": "Evaluation of mechanical properties of material or a device.", "PM": "2021", "HN": "2021", "MR": "20210707", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083522"}, {"RECTYPE": "D", "MH": "Test Anxiety", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Pre-Exam Anxiety|T041|NON|EQV|NLM (2021)|200115|abcdef", "ENTRY": "Stress, Exam", "MN": "F01.470.132.650.500", "FX": "Test Anxiety Scale", "MH_TH": "NLM (2021)", "ST": "T041", "PI": "Anxiety (1963-2020)", "MS": "Anxiety related to situations where abilities or knowledge are being tested.", "PM": "2021", "HN": "2021", "MR": "20200721", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083563"}, {"RECTYPE": "D", "MH": "Lyngbya", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.355", "FX": "Lyngbya Toxins", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid28073", "PI": "Cyanobacteria (1971-2020)", "MS": "A unicellular, photosynthetic genus of CYANOBACTERIA belonging to the family Oscillatoriaceae. It is a known cause of seaweed dermatitis and also Ciguatera poisoning when ingested.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083582"}, {"RECTYPE": "D", "MH": "Psychosocial Functioning", "ENTRY": "Functioning, Psychosocial", "MN": "N06.850.505.400.425.756", "MH_TH": "NLM (2021)", "ST": "T033", "PI": "Psychology, Developmental (2015-2020)", "MS": "Level of and variations in social and emotional activity or behaviors.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083623"}, {"RECTYPE": "D", "MH": "Psychosocial Intervention", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Psychological Intervention|T061|NON|EQV|NLM (2021)|200115|abcdef", "ENTRY": "Psychosocial Interventions", "MN": "F04.754.715", "MH_TH": "NLM (2021)", "ST": "T061", "PI": "Psychotherapy (2010-2020)", "MS": "Psychological and social interventions by providers including psychologists, psychiatrists, social workers, counselors/therapists, primary care and other nonpsychiatric physicians, nurses, physical and occupational therapists, religious leaders, lay and peer providers, paraprofessionals and caregivers, and automated providers (e.g. internet/audio/video-delivered interventions). Combinations of provider options are sometimes used.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083626"}, {"RECTYPE": "D", "MH": "Social Comparison", "ENTRY": "Social Comparisons", "MN": "F01.752.747.792.962", "MH_TH": "NLM (2021)", "ST": "T041", "PI": "Self Concept (2010-2020)", "MS": "Perception of one's abilities and attitudes in relation to those of others in a process that plays a significant role in self-image and subjective well-being.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083642"}, {"RECTYPE": "D", "MH": "Social Inclusion", "ENTRY": "Inclusion, Social", "MN": "F01.145.813.745", "MH_TH": "NLM (2021)", "ST": "T054", "MS": "The process of improving the basis on which individuals and groups take part in society by improving the ability, opportunity, and dignity of those disadvantaged.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083644"}, {"RECTYPE": "D", "MH": "Social Evolution", "ENTRY": "Evolution, Social", "MN": "F01.145.813.653", "MH_TH": "NLM (2021)", "ST": "T054", "PI": "Biological Evolution (1970-2020)", "MS": "The process of cumulative change that arises over successive generations in social interactions, especially between individuals of the same species.", "PM": "2021", "HN": "2021", "MR": "20210209", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000083645"}, {"RECTYPE": "D", "MH": "Social Factors", "ENTRY": "Social Factor", "MN": "I01.880.853.996.877", "MH_TH": "NLM (2021)", "ST": "T090", "MS": "Social and  cultural phenomena and influences that affect behavior.", "PM": "2021", "HN": "2021", "MR": "20200429", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083663"}, {"RECTYPE": "D", "MH": "Opiate Overdose", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Opioid Overdose|T037|NON|EQV|NLM (2021)|191129|abcdef", "ENTRY": "Overdose, Opioid", "MN": "F03.900.647.500.700", "MH_TH": "NLM (2021)", "ST": "T037", "PI": "Opioid-Related Disorders (1973-2020)", "MS": "Accidental or deliberate use of an OPIOID in excess of normal dosage. It includes overdose for prescription and illicit opioids.", "PM": "2021", "HN": "2021", "MR": "20230531", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083682"}, {"RECTYPE": "D", "MH": "Economic Factors", "ENTRY": "Economic Factor", "MN": "I01.880.853.996.134", "MH_TH": "OBSSR (2022)", "ST": "T081", "MS": "Measures of available financial and material resources.", "PM": "2021; see ECONOMICS (1994-2020)", "HN": "2021", "MR": "20210630", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000083684"}, {"RECTYPE": "D", "MH": "Social Defeat", "ENTRY": "Defeat, Social", "MN": "F01.145.813.627", "MH_TH": "NLM (2021)", "ST": "T054", "MS": "Conflict between members of the same species that generates emotional and psychological stress and increased social distance.", "PM": "2021", "HN": "2021", "MR": "20201204", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083703"}, {"RECTYPE": "D", "MH": "Bacillus thuringiensis Toxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bt Toxins|T116|ABX|EQV|NLM (2021)|200128|abcdef", "ENTRY": "Toxins, B. thuringiensis", "MN": "D23.946.123.090", "MH_TH": "NLM (2021)", "ST": "T116", "RN": "0", "PI": "Endotoxins (1981-2020)", "MS": "Endotoxins produced by BACILLUS THURINGIENSIS used in transgenic plants and insecticides. When eaten by a susceptible insect they are protease activated in the insect midgut resulting in death from bacterial septicemia.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083722"}, {"RECTYPE": "D", "MH": "Chilopoda", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Scolopendrids|T204|NON|NRW|NLM (2021)|200130|abcdef", "ENTRY": "Scolopendrid Centipede", "MN": "B01.050.500.131.266", "MH_TH": "NLM (2021)", "ST": "T204", "RN": "txid7540", "RR": "txid60154", "PI": "Arthropods (1968-2020)", "MS": "Class of Arthropoda in the subphylum Myriapoda which comprises centipedes and millipedes. Chilopoda or centipedes are characterized by long multi-segmented bodies with each segment with a pair of legs. Most centipedes are predatory and venomous. While centipede bites typically only cause pain, irritation and allergic reactions they sometimes cause acute HYPERTENSION and MYOCARDIAL ISCHEMIA.", "PM": "2021", "HN": "2021", "MR": "20200807", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083802"}, {"RECTYPE": "D", "MH": "Microbacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.775", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid33882", "PI": "Actinobacteria (1967-2020)", "MS": "A genus of gram-positive, heat-resistant BACTERIA belonging to the family Microbacteriaceae and phylum ACTINOBACTERIA. Similar to CORYNEBACTERIACEAE, it is found in dairy products and the mammalian intestinal tract.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083822"}, {"RECTYPE": "D", "MH": "Masked Mycotoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bound Mycotoxins|T123|NON|REL|NLM (2021)|200130|abcdef", "MN": "D23.946.587.559", "MH_TH": "NLM (2021)", "ST": "T123", "RN": "0", "PI": "Mycotoxins (1969-2020)", "MS": "Fungal toxins masked by other macromolecules thereby reducing detection levels of such mycotoxins.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083842"}, {"RECTYPE": "D", "MH": "Sexual Arousal", "PRINT ENTRY": "Sexual Excitement|T042|NON|EQV|NLM (2021)|201109|abcdef", "ENTRY": "Excitement, Sexual", "MN": "G11.561.035.369", "FX": "Sexual Dysfunctions, Psychological", "MH_TH": "NLM (2021)", "ST": "T042", "MS": "Physiological arousal elicited by sexual contact or by other erotic stimulation resulting in impulses being transmitted through the central nervous system.The impulses also trigger the release of sex hormones, dilation of the arteries supplying the genital areas, and inhibition of vasoconstrictor centers of the lumbar nerves.", "PM": "2021", "HN": "2021", "MR": "20201109", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083942"}, {"RECTYPE": "D", "MH": "Nocardioides", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.887", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1839", "PI": "Actinobacteria (1978-2020)", "MS": "A genus of aerobic Gram-positive high G+C DNA content bacteria in the family Nocardioidaceae and the phylum ACTINOBACTERIA. Members can utilize a wide range of carbon and nitrogen sources including ethene and VINYL CHLORIDE.", "PM": "2021", "HN": "2021", "MR": "20210209", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000083962"}, {"RECTYPE": "D", "MH": "Acetate Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kinase, Acetate", "MN": "D08.811.913.696.630.025", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "ATP:acetate phosphotransferase", "RN": "EC 2.7.2.1", "RR": "9027-42-3 (CAS RN)", "PI": "Phosphotransferases, ATP (1974-1978)", "MS": "An enzyme that catalyzes reversibly the phosphorylation of acetate in the presence of a divalent cation and ATP with the formation of acetylphosphate and ADP. It is important in the glycolysis process. EC 2.7.2.1.", "PM": "91; was see under PHOSPHOTRANSFERASES, ATP 1979-90", "HN": "91(79); was see under PHOSPHOTRANSFERASES, ATP 1979-90", "MR": "20030709", "DA": "19771208", "DC": "1", "DX": "19910101", "UI": "D000084"}, {"RECTYPE": "D", "MH": "Tinea cruris", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Jock Itch|T047|NON|EQV|NLM (2021)|200206|abcdef", "ENTRY": "Jock Itchs", "MN": "C17.800.838.208.883.608", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Tinea (1964-2020)", "MS": "Fungal infection of the groin. The main causative fungus is TRICHOPHYTON.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084002"}, {"RECTYPE": "D", "MH": "Skeletal Muscle Enlargement", "AQ": "DE GE IM PH RE", "ENTRY": "Skeletal Muscle Enlargements", "MN": "G11.427.578.590.500", "FX": "Muscle, Skeletal", "MH_TH": "NLM (2021)", "ST": "T042", "PI": "Muscle Development (1969-2020)", "MS": "An increase in SKELETAL MUSCLE mass in normal muscle development. In human adults it results primarily from an increase in the size of SKELETAL MUSCLE FIBERS unlike in muscle hyperplasia where an increase in the number of skeletal muscle fibers is a major factor.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084062"}, {"RECTYPE": "D", "MH": "Reinfection", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Recurrent Infection|T067|NON|NRW|NLM (2021)|200211|abcdef", "ENTRY": "Reinfections", "MN": "C23.550.291.937.250", "FX": "Latent Infection", "MH_TH": "NLM (2021)", "ST": "T067", "PI": "Recurrence (1986-2020)", "MS": "Infection by the same infectious agent following a recovery. Reinfection may be by a different strain or  the same strain.", "PM": "2021", "HN": "2021", "MR": "20210510", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084063"}, {"RECTYPE": "D", "MH": "Return of Spontaneous Circulation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Unassisted Return of Spontaneous Circulation|T042|NON|REL|NLM (2021)|200211|abcdef", "ENTRY": "Spontaneous Circulation Return", "MN": "G09.330.100.847", "MH_TH": "NLM (2021)", "ST": "T042", "PI": "Resuscitation (2011-2020)", "MS": "Recovery of blood circulation reestablishing blood pressure and pulse after CARDIAC ARREST. Timeline and quality of care post-return of spontaneous circulation impacts cognitive RECOVERY OF FUNCTION in CARDIAC REHABILITATION.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084102"}, {"RECTYPE": "D", "MH": "Cardiac Papillary Fibroelastoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Papillary Fibroelastoma|T191|NON|EQV|NLM (2021)|200211|abcdef", "ENTRY": "Papillary Fibroelastomas", "MN": "C14.280.459.250", "MH_TH": "NLM (2021)", "ST": "T191", "PI": "Heart Valve Diseases (2003-2020)", "MS": "Primary tumors, predominantly of the CARDIAC VALVES, characterized by multiple papillary frond structures. Although histologically benign, they may result in complications (e.g., valve dysfunction, EMBOLISM; STROKE; and SUDDEN DEATH).", "PM": "2021", "HN": "2021", "MR": "20200807", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084122"}, {"RECTYPE": "D", "MH": "Multidimensional Scaling Analysis", "PRINT ENTRY": "Multidimensional Scaling|T081|NON|EQV|NLM (2021)|200211|abcdef", "ENTRY": "Scaling, Multidimensional", "MN": "N06.850.520.830.250.507", "MH_TH": "NLM (2021)", "ST": "T081", "PI": "Cluster Analysis (1995-2020)", "MS": "A method of providing a visual representation of similarities among a set of data by plotting a map of perceived similarities on a set of vectors in p-dimensional space such that distances among them correspond to a function of the input matrix.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084142"}, {"RECTYPE": "D", "MH": "Orientia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.875.650.450", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid69474", "PI": "Proteobacteria (1995-2020)", "MS": "A genus of intracellular, gram-negative obligate bacteria belonging to the family RICKETTSIACEAE and the phylum PROTEOBACTERIA. This genus also includes ORIENTIA TSUTSUGAMUSHI which is a known cause of SCRUB TYPHUS transmitted to humans by various TROMBICULID MITES.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084162"}, {"RECTYPE": "D", "MH": "Chemotherapy-Related Cognitive Impairment", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Chemotherapy-Related Cognitive Dysfunction|T048|NON|EQV|NLM (2021)|200218|abcdef", "ENTRY": "Cognitive Impairments, Chemotherapy-Related", "MN": "F03.615.250.700.250", "MH_TH": "NLM (2021)", "ST": "T048", "PI": "Cognitive Dysfunction (2004-2020)", "MS": "The diminished or impaired mental and/or intellectual function associated with the chemical treatment of cancer.", "PM": "2021", "HN": "2021", "MR": "20200723", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084202"}, {"RECTYPE": "D", "MH": "Phormidium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.631", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1198", "PI": "Cyanobacteria (1970-2020)", "MS": "A genus of filamentous, sheathed CYANOBACTERIA in the family Oscillatoriaceae that is found mostly in aquatic environments and is similar to the genera LYNGBYA and PLECTONEMA.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084242"}, {"RECTYPE": "D", "MH": "Hyperthermic Intraperitoneal Chemotherapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Intraperitoneal Hyperthermic Chemotherapy|T061|NON|EQV|NLM (2021)|200228|abcdef", "ENTRY": "Intraperitoneal Hyperthermic Chemotherapies", "MN": "E02.565.370", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Hyperthermia, Induced (1996-2020)", "MS": "A cancer treatment that involves filling the abdominal cavity with heated chemotherapy drugs. It is performed after the surgeon removes tumors or lesions from the abdominal area, to kill any cancer cells that remain after surgery and reduce the risk for cancer recurrence. (From: https://www.mdanderson.org/treatment-options/hyperthermic-intraperitoneal-chemotherapy.html; Feb, 20, 2020).", "PM": "2021; see HYPERTHERMIA, INDUCED 2018-2020", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084262"}, {"RECTYPE": "D", "MH": "HaCaT Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Human Adult Low-Calcium High-Temperature Keratinocytes|T025|NON|EQV|NLM (2021)|200225|abcdef", "ENTRY": "Human Adult Low Calcium High Temperature Keratinocytes", "MN": "A11.436.397.500", "MH_TH": "NLM (2021)", "ST": "T025", "PI": "Keratinocytes (1993-2020)", "MS": "A spontaneously transformed human epithelial cell line developed from a long-term primary culture of human adult skin KERATINOCYTES. As it maintains an epidermal differentiation capacity, it has been used as a model for keratinization studies. (From:J Cell Biol. 1988 Mar;106(3):761-71.)", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084282"}, {"RECTYPE": "D", "MH": "Semicircular Canal Dehiscence", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Superior Semicircular Canal Dehiscence Syndrome|T047|NON|NRW|NLM (2021)|200304|abcdef", "MN": "C09.218.568.900.663", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Labyrinth Diseases (1999-2020)", "MS": "A vestibular disorder caused by a pathologic third window into the BONY LABYRINTH (in contrast to the normal ROUND WINDOW OF EAR and the OVAL WINDOW OF EAR). It can present with autophony, sound- or pressure-induced VERTIGO, and chronic disequilibrium among other vestibulocochlear symptoms.(From: Semin Neurol. 2020 Jan 27; 48: 58-65.)", "PM": "2021", "HN": "2021", "MR": "20200723", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084322"}, {"RECTYPE": "D", "MH": "Vestibulocochlear Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Vestibulocochlear Physiology|T042|NON|EQV|NLM (2021)|200220|abcdef", "ENTRY": "Physiological Phenomenon, Vestibulocochlear", "MN": "G07.888", "MH_TH": "NLM (2021)", "ST": "T042", "PI": "Ear/physiology (1963-2020)", "MS": "Processes and properties of the VESTIBULOCOCHLEAR SYSTEM and the CRANIAL NERVE VIII.", "PM": "2021", "HN": "2021", "MR": "20200723", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084323"}, {"RECTYPE": "D", "MH": "Drug Elimination Routes", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Drug Excretion Routes|T169|NON|NRW|NLM (2021)|200221|abcdef", "ENTRY": "Excretion Routes, Drug", "MN": "G07.690.725.297", "MH_TH": "NLM (2021)", "ST": "T169", "AN": "general or unspecified; prefer specifics; coordinate with specific drug /pharmacokin", "PI": "Pharmacokinetics (1964-2020)", "MS": "Various processes through which administered drugs are discharged from the body.", "PM": "2021", "HN": "2021", "MR": "20200723", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084342"}, {"RECTYPE": "D", "MH": "Internet Use", "AQ": "EC ES SN TD", "PRINT ENTRY": "Web Use|T169|NON|EQV|NLM (2021)|200221|abcdef", "ENTRY": "Use, Web", "MN": "L01.224.230.110.500.673", "MH_TH": "NLM (2021)", "ST": "T169", "PI": "Internet (1999-2020)", "MS": "Utilization of the Internet and its services.", "PM": "2021", "HN": "2021", "MR": "20200221", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084362"}, {"RECTYPE": "D", "MH": "Pseudonocardia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.943", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1847", "PI": "Actinobacteria (1979-2020)", "MS": "A genus of high GC-content ACTINOBACTERIA in the family Pseudonocardiaceae. This genus is known for its antibiotic properties which aid in the protection of leafcutter ANTS from parasites in the fungus they cultivate.", "PM": "2021", "HN": "2021", "MR": "20210209", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084382"}, {"RECTYPE": "D", "MH": "Renibacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.500.750", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1645", "PI": "Actinobacteria (1991-2020)", "MS": "A genus of high GC-content, Gram-positive ACTINOBACTERIA in the family MICROCOCCACEAE. The type species of this genus, Renibacterium salmoninarum, is known to cause bacterial kidney disease in SALMONIDS.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084402"}, {"RECTYPE": "D", "MH": "Tannerella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.080.850", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid195950", "AN": "infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS", "PI": "Bacteroidetes (2002-2020)", "MS": "A genus of anaerobic, gram-negative bacteria in the family Tannerellaceae and phylum BACTEROIDETES. TANNERELLA FORSYTHIA, a known species of this genus, is a cause of PERIODONTAL DISEASES and associated with ESOPHAGEAL CANCER and BACTERIAL VAGINOSIS.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084422"}, {"RECTYPE": "D", "MH": "Thermomonospora", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.971", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid2019", "PI": "Actinobacteria (1969-2020)", "MS": "A genus of high GC content ACTINOBACTERIA in the family Thermomonosporaceae. Species of this genus, Thermomonospora fusca and Thermomonospora curvata, are known for their roles in the industrial production of enzymes including CELLULASE.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084442"}, {"RECTYPE": "D", "MH": "Morris Water Maze Test", "AQ": "DE PH RE", "PRINT ENTRY": "Morris Water Maze|T059|EPO|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Water-Maze Procedures", "MN": "F02.463.425.874.500.750", "MH_TH": "NLM (2020)", "ST": "T059", "MS": "A maze test often used to evaluate spatial learning and memory in rodent models by measuring the time it takes for a submerged platform in an open swimming arena to be found.", "PM": "2021; for Morris Water Maze Test see under Maze Learning 2020", "HN": "2021; for Morris Water Maze Test was under Maze Learning 2020", "MR": "20210209", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084443"}, {"RECTYPE": "D", "MH": "Thermotoga", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.748", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid2335", "PI": "Gram-Negative Anaerobic Bacteria (1988-2020)", "MS": "A genus of anaerobic, gram-negative bacteria in the family Thermotogaceae and phylum Thermotogae. Species of this genus such as THERMOTOGA MARITIMA and THERMOTOGA NEAPOLITANA are known to live in high-temperature environments and also play a role in HYDROGEN production.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084444"}, {"RECTYPE": "D", "MH": "Hyperthermia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperpyrexia|T184|NON|NRW|NLM (2023)|210830|abcdef", "ENTRY": "Hyperthermias", "MN": "C26.522.750", "FX": "Malignant Hyperthermia", "MH_TH": "UNK (19XX)", "ST": "T184", "MS": "An abnormal elevation of body temperature, usually as a result of inability to regulate core body temperature due to non-pathologic factors.", "PM": "2021; for Hyperthermia use under Heat Stroke 1985-2020", "HN": "2021; for Hyperthermia was under Heat Stroke 1985-2020", "MR": "20211018", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084462"}, {"RECTYPE": "D", "MH": "Phytoplasma Disease", "AQ": "CL EC ET GE HI IM LJ MI PC PS SN", "PRINT ENTRY": "Witches' Broom Disease|T047|NON|NRW|NLM (2021)|200305|abcdef", "ENTRY": "Witches' Broom Diseases", "MN": "G15.610.350", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Plant Diseases (1974-2020)", "MS": "Plant diseases caused by PHYTOPLASMA bacteria.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084482"}, {"RECTYPE": "D", "MH": "Plant Necrosis and Chlorosis", "AQ": "CI CL EC ET GE HI IM LJ MI PC PS SN TH VI", "PRINT ENTRY": "Plant Necrosis|T047|NON|NRW|NLM (2021)|200305|abcdef", "ENTRY": "Plant Necroses", "MN": "G15.610.525", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Plant Diseases (1963-2020)", "MS": "Plant diseases affecting mostly leaves where either plant cells or tissues are dead and/or collapsed (necrosis) or yellowed due to loss of CHLOROPHYLL (chlorosis).", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084483"}, {"RECTYPE": "D", "MH": "Cell Competition", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Tumor Suppressive Cell Competition|T045|NON|NRW|NLM (2021)|200305|abcdef", "ENTRY": "Competition, Cell-Cell", "MN": "G04.033", "MH_TH": "NLM (2021)", "ST": "T043", "PI": "Cell Communication (2004-2020)", "MS": "A cellular process that selectively eliminates cells with mutations from further development through short-range cell-cell interaction.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084502"}, {"RECTYPE": "D", "MH": "T Follicular Helper Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Tfh Cells|T025|ABX|EQV|NLM (2021)|200309|abcdef", "ENTRY": "Tfh Cell", "MN": "A15.382.490.555.567.569.500.400.450", "MH_TH": "NLM (2021)", "ST": "T025", "PI": "T-Lymphocytes, Helper-Inducer(2004-2020)", "MS": "A specialized subpopulation of CD4+ T cells involved in formation of GERMINAL CENTER. Tfh cells are mostly located in secondary lymphoid organs, e.g., TONSIL; SPLEEN and LYMPH NODES. They are CD4 ANTIGEN; CD45 ANTIGEN; B-CELL LYMPHOMA 6 PROTEIN; CXCR5 RECEPTORS; ICOS INDUCIBLE T-CELL CO-STIMULATOR; and PD1 RECEPTOR positive.", "PM": "2021", "HN": "2021", "MR": "20200807", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084522"}, {"RECTYPE": "D", "MH": "Eye-Tracking Technology", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "PRINT ENTRY": "Gazetracking System|T073|NON|REL|NLM (2021)|200310|abcdef", "ENTRY": "Technology, Eye-Tracking", "MN": "E01.370.405.312.642", "MH_TH": "NLM (2021)", "ST": "T060", "PI": "Eye Movements (1983-2020)", "MS": "Techniques used for EYE MOVEMENT MEASUREMENTS, which capture and measure a person\u2019s EYE MOVEMENT and/or EYE GAZE.", "PM": "2021", "HN": "2021", "MR": "20220523", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084542"}, {"RECTYPE": "D", "MH": "Retinyl Esters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Retinyl Ester|T109|T123|NON|EQV|NLM (2021)|200311|abbcdef", "ENTRY": "Ester, Retinyl", "MN": "D23.767.261.700.735", "MH_TH": "NLM (2021)", "ST": "T123", "RN": "0", "PI": "Vitamin A (1964-2020)", "MS": "A carboxylic ester of retinol formed by condensation of the hydroxy group of retinol with a carboxy group.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084562"}, {"RECTYPE": "D", "MH": "Tumor-Associated Macrophages", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Tumor-Associated Macrophage|T025|NON|EQV|NLM (2021)|200420|abcdef", "ENTRY": "Tumor Associated Macrophages", "MN": "A15.382.680.397.815", "MH_TH": "NLM (2021)", "ST": "T025", "PI": "Macrophages (1986-2020)", "MS": "Various macrophages found in TUMOR MICROENVIRONMENT. They may interact with tumor cells to influence growth and NEOPLASTIC PROCESSES.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084582"}, {"RECTYPE": "D", "MH": "Sympathoadrenal System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sympathoadrenal Medullary System|T029|NON|NRW|NLM (2021)|200311|abcdef", "ENTRY": "System, Sympatho-Adrenal", "MN": "A08.800.050.800.850", "MH_TH": "NLM (2021)", "ST": "T022", "PI": "Sympathetic Nervous System (1967-2020)", "MS": "A connection of the SYMPATHETIC NERVOUS SYSTEM and the ADRENAL MEDULLA of the ADRENAL GLANDS. Intra-adrenal connection from the medulla to the cortex connects the system to other neuroendocrine systems, which in concert participate in FLIGHT REACTION in stress situations. CATECHOLAMINES are the principle hormone in the system.", "PM": "2021", "HN": "2021", "MR": "20220429", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084602"}, {"RECTYPE": "D", "MH": "Sestrins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sestrin Proteins|T116|T126|NON|EQV|NLM (2021)|200311|abbcdef", "MN": "D08.811.682.732.962", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "0", "PI": "Peroxidases (2007-2020)", "MS": "Alkylhydroperoxide reductases induced by the P53 TUMOR SUPPRESSOR PROTEIN. They may be involved in anti-OXIDATIVE STRESS response by regenerating oxidized PEROXIREDOXINS.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084622"}, {"RECTYPE": "D", "MH": "Fungal Genus Humicola", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Genus Humicola|T004|NON|EQV|NLM (2021)|200313|abcdef", "ENTRY": "Humicola, Genus", "MN": "B01.300.107.800.390", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid5526", "PI": "Sordariales (2013-2020)", "MS": "A genus of ascomycetous fungi of the family Chaetomiaceae, order SORDARIALES, and phylum ASCOMYCOTA. Humicola fungi develop lateral CONIDIA and form minimally developed or no conidiophores.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084642"}, {"RECTYPE": "D", "MH": "Puccinia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.179.487", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid5296", "PI": "Basidiomycota (1963-2020)", "MS": "A genus of fungi in the family Pucciniaceae, order Pucciniales, and phylum BASIDIOMYCOTA. Puccinia fungi are causative agents for some plant fungal rust diseases such as cereal rust caused by Puccinia graminis.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084643"}, {"RECTYPE": "D", "MH": "Aureobasidium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.107.160", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid5579", "PI": "Ascomycota (1976-2020)", "MS": "A genus of fungi in the family Saccotheciaceae, order Dothideales, and phylum ASCOMYCOTA. Aureobasidium fungi are cosmopolitan and form black hyphae when colony is aged. Aureobasidium pullulans is best known and is one of the causative agents of PHAEOHYPHOMYCOSIS.", "PM": "2021", "HN": "2021", "MR": "20201204", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084644"}, {"RECTYPE": "D", "MH": "Batrachochytrium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Batrachochytrium dendrobatidis|T004|NON|NRW|NLM (2013)|120315|abcdef", "MN": "B01.300.283.500", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid100474", "RR": "txid109871", "PI": "Chytridiomycota (2002-2020)", "MS": "A genus of fungi in the order Rhizophydiales, class Chytridiomycetes and phylum CHYTRIDIOMYCOTA. Batrachochytrium fungi are chytrid fungi found in aquatic habitats. Many are parasitic including Batrachochytrium dendrobatidis which is causative agent for chytrid disease in aquatic invertebrates.", "PM": "2021; for BATRACHOCHYTRIUM DENDROBATIDIS see CHYTRIDIOMYCOTA (2013-2020)", "HN": "2021; for BATRACHOCHYTRIUM DENDROBATIDIS use CHYTRIDIOMYCOTA (2013-2020)", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084662"}, {"RECTYPE": "D", "MH": "Phellinus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.179.115", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid40470", "PI": "Basidiomycota (1971-2020)", "MS": "A genus of fungi in the family Hymenochaetaceae, class Hymenochaetales and phylum BASIDIOMYCOTA. Phellinus fungi are basidiomycetes which form large shelf-shaped mushrooms. Phellinus linteus (now Tropicoporus linteus) is a medicinal mushroom which produces compounds such as hispidin, a phenolic compound with antioxidant properties.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084682"}, {"RECTYPE": "D", "MH": "Curvularia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.381.279", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid5502", "PI": "Ascomycota (1973-2020)", "MS": "A genus of fungi in the family Pleosporaceae, order Pleosporales and phylum ASCOMYCOTA. Curvularia fungi are plant pathogens, mostly on grasses (POACEAE) and were formerly a part of the Bipolaris, Cochliobolus and Curvularia complex.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084702"}, {"RECTYPE": "D", "MH": "Return to School", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Schools, Return to", "MN": "I02.689", "MH_TH": "NLM (2021)", "ST": "T080", "PI": "Education (1966-2020)", "MS": "Resumption of educational activity following a hiatus or period of absence.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084722"}, {"RECTYPE": "D", "MH": "Phoma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Peyronellaea|T004|NON|EQV|NLM (2021)|200313|abcdef", "MN": "B01.300.107.700", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid37463", "AN": "infection: coordinate with probably PHAEOHYPHOMYCOSIS, otherwise coordinate with MYCOSES", "PI": "Ascomycota (1969-2020)", "MS": "A genus of fungi in the family Didymellaceae, order Pleosporales and phylum ASCOMYCOTA. Phoma fungi are ascomycetes commonly found in soil and aquatic environments including  water distribution systems. Opportunistic superficial infection with Phoma fungi is PHAEOHYPHOMYCOSIS.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084723"}, {"RECTYPE": "D", "MH": "Mycosphaerella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.107.613", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid41254", "PI": "Ascomycota (1986-2020)", "MS": "A genus of fungi in the family Mycosphaerellaceae, order Dothideomycetes and phylum ASCOMYCOTA. Mycosphaerella are endophytic fungi and causative agents for plant fungal diseases such as leaf blight and root and leaf rots.", "PM": "2021", "HN": "2021", "MR": "20210209", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084724"}, {"RECTYPE": "D", "MH": "Phomopsis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.107.708", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid34399", "PI": "Ascomycota (1986-2020)", "MS": "A genus of fungi in the family Valsaceae, order Diaporthales and phylum ASCOMYCOTA. Phomopsis fungi are ascomycetes found in the soil and plants and are causative agents for plant fungal diseases such as leaf blight and fruit rots.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084725"}, {"RECTYPE": "D", "MH": "Bipolaris", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.381.114", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid33194", "AN": "infection: coordinate with MYCOSES or PHAEOHYPHOMYCOSIS if pertinent", "PI": "Ascomycota (1986-2020)", "MS": "A genus of fungi in the family Pleosporaceae, order Pleosporales and phylum ASCOMYCOTA. Bipolaris fungi are ascomycetes and plant pathogens, mostly on POACEAE and some monocot crops. They are also causative agent for PHAEOHYPHOMYCOSIS and were formerly a part of the Bipolaris, Cochliobolus and CURVULARIA complex.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084727"}, {"RECTYPE": "D", "MH": "Leptosphaeria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.107.538", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid5021", "PI": "Ascomycota (1963-2020)", "MS": "A genus of fungi in the family Leptosphaeriaceae, order Pleosporales and phylum ASCOMYCOTA. Leptosphaeria fungi are filamentous ascomycetes mostly found in soil and rarely associated with opportunistic MYCETOMA.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084744"}, {"RECTYPE": "D", "MH": "Erysiphe", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.107.280", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid5121", "PI": "Ascomycota (1965-2020)", "MS": "A genus of fungi in the family Erysiphaceae, class Leotiomycetes and phylum ASCOMYCOTA. Erysiphe fungi are plant pathogens associated with powdery mildew.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084745"}, {"RECTYPE": "D", "MH": "Viral Protease Inhibitors", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Virus Protease Inhibitors|T109|T121|NON|EQV|NLM (2021)|200407|abbcdef", "ENTRY": "Viral Protease Inhibitor", "MN": "D27.505.954.122.388.769", "MH_TH": "NLM (2021)", "ST": "T121", "RN": "0", "PI": "Enzyme Inhibitors (1979-2020)", "MS": "Compounds that specifically inhibit PROTEOLYTIC ENZYMES that are encoded by VIRUSES.", "PM": "2021", "HN": "2021", "MR": "20220413", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084762"}, {"RECTYPE": "D", "MH": "Quick Diagnosis Units", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Drive-in Testing|T093|NON|EQV|NLM (2021)|200422|abcdef", "ENTRY": "Units, Quick Diagnosis", "MN": "N02.278.388.720", "MH_TH": "NLM (2021)", "ST": "T093", "MS": "Alternatives to conventional hospitalization for the diagnosis of suspected serious diseases allowing coordinated diagnostic procedures.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084782"}, {"RECTYPE": "D", "MH": "Recreational Drug Use", "AQ": "LJ PX SN TD", "ENTRY": "Recreational Drug Uses", "MN": "F01.145.683", "MH_TH": "NLM (2021)", "ST": "T055", "MS": "Occasional or habitual non-prescribed, not health-related use of substances.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084783"}, {"RECTYPE": "D", "MH": "Caregiver Burden", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Caregiving Stress|T067|NON|EQV|NLM (2024)|230421|abcdef", "ENTRY": "Stress, Caregiving", "MN": "F01.145.126.990.551", "FX": "Caregivers", "MH_TH": "NLM (2021)", "ST": "T067", "AN": "SOCIAL DETERMINANTS OF HEALTH is available", "PI": "Caregivers (1992-2020)", "MS": "The stresses or associated emotional responses experienced by CAREGIVERS when caring for the mentally or physically disabled.", "PM": "2021", "HN": "2021", "MR": "20230531", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000084802"}, {"RECTYPE": "D", "MH": "Gender Equity", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Gender Inequity|T078|NON|NRW|NLM (2023)|220204|abcdef", "ENTRY": "Inequity, Gender", "MN": "N01.224.425.394.250", "MH_TH": "OBSSR (2022)", "ST": "T078", "MS": "Fairness of treatment for men and women according to their respective needs. This may include equal treatment or treatment that is different but which is considered equivalent in terms of rights, benefits, obligations, and opportunities. (United Nations Educational, Scientific and Cultural Organization)", "PM": "2021", "HN": "2021", "MR": "20230614", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084803"}, {"RECTYPE": "D", "MH": "Auricularia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.179.105", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid5230", "PI": "Basidiomycota (1967-2020)", "MS": "A genus of fungi in the family Auriculariaceae, order Auriculariales and phylum BASIDIOMYCOTA. Auricularia fungi are basidiomycetes which are gelatinous, ear-shaped mushrooms in decaying wood.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084822"}, {"RECTYPE": "D", "MH": "Cercospora", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.107.220", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid29002", "PI": "Ascomycota (1963-2020)", "MS": "A genus of fungi in the family Mycosphaerellaceae, order Capnodiales and phylum ASCOMYCOTA. Cercospora fungi are ascomycete and causative agents for plant fungal diseases such as leaf spots. Cercospora species produce the phytotoxin cercosporin and have no known sexual stage.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084823"}, {"RECTYPE": "D", "MH": "Hericium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.179.108", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid40459", "PI": "Basidiomycota (1973-2020)", "MS": "A genus of fungi in the family Hericiaceae, order Russulales, and phylum BASIDIOMYCOTA. Hericium fungi are basidiomycetes with distinctive white fruiting body that resembles icicles such as in lion's mane mushroom, Hericium erinaceus.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084824"}, {"RECTYPE": "D", "MH": "Fonsecaea", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.107.411", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid40354", "PI": "Ascomycota (1965-2020)", "MS": "A genus of fungi in the family Herpotrichiellaceae, order Chaetothyriales, and phylum ASCOMYCOTA. Fonsecaea fungi are ascomycetes sometimes associated with CHROMOBLASTOMYCOSIS.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084825"}, {"RECTYPE": "D", "MH": "Trauma Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Trauma", "MN": "N02.421.533.944", "MH_TH": "NLM (2021)", "ST": "T091", "PI": "Specialties, Nursing (1974-2020)", "MS": "Specialization in the care of patients who suffer an acute injury or illness, whether it is accidental or intentional. It includes skills in caring for patients of all ages-from newborn to the elderly. Examples of cases that may be involved are: traffic accidents, or other wounds or injuries.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084826"}, {"RECTYPE": "D", "MH": "Inonotus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.179.109", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid40468", "PI": "Basidiomycota (1974-2020)", "MS": "A genus of fungi in the family Hymenochaetaceae, order Hymenochaetales, and phylum BASIDIOMYCOTA. Inonotus fungi are basidiomycetes and include medicinal mushrooms such as chaga mushroom (Inonotus obliquus).", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084827"}, {"RECTYPE": "D", "MH": "Fungal Genus Venturia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Fungus Venturia|T004|NON|EQV|NLM (2021)|200316|abcdef", "ENTRY": "Venturia, Fungus", "MN": "B01.300.107.456", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid5024", "PI": "Ascomycota (1965-2020)", "MS": "A genus of fungi in the family Venturiaceae, order Venturiales, and phylum ASCOMYCOTA. Venturia fungi are ascomycetes and causative agents for plant fungal diseases such as apple scab caused by Venturia inaequalis.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084828"}, {"RECTYPE": "D", "MH": "Pestalotiopsis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.381.684", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid37840", "PI": "Xylariales (1964-2020)", "MS": "A genus of fungi in the family Sporocadaceae, order XYLARIALES, and phylum ASCOMYCOTA. Pestalotiopsis fungi are ascomycetes and causative agents for plant fungal diseases such as tip blight.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084842"}, {"RECTYPE": "D", "MH": "Ceratocystis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.107.210", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid5157", "PI": "Ascomycota (1963-2020)", "MS": "A genus of fungi in the family Ceratocystidaceae, order Microascales, and phylum ASCOMYCOTA. Ceratocystis fungi are ascomycetes and causative agents for plant fungal diseases such as root rot.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084843"}, {"RECTYPE": "D", "MH": "Drug Tapering", "AQ": "CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Dose Tapering|T061|NON|EQV|NLM (2021)|200417|abcdef", "ENTRY": "Taperings, Dose", "MN": "E02.319.309", "MH_TH": "NLM (2021)", "ST": "T061", "MS": "Gradual discontinuation or reduction of a therapeutic dose of a particular drug over a period of time.", "PM": "2021", "HN": "2021", "MR": "20200708", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000084862"}, {"RECTYPE": "D", "MH": "Developmental Disability Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Developmental Disability", "MN": "N02.421.533.175", "MH_TH": "NLM (2021)", "ST": "T058", "PI": "Specialties, Nursing (1974-2020)", "MS": "Providing care for special needs patients with intellectual or other developmental needs.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084882"}, {"RECTYPE": "D", "MH": "Food Insecurity", "AQ": "EC", "PRINT ENTRY": "Food Rationing|T080|NON|BRD|NLM (2022)|201227|abcdef", "ENTRY": "Rationing, Food", "MN": "J01.576.423.750.688", "MH_TH": "NLM (2021)", "ST": "T080", "PI": "Food (1990-2020)", "MS": "Limited or uncertain availability of nutritionally adequate and safe foods or limited or uncertain ability to acquire acceptable foods in safe and socially acceptable ways.", "PM": "2021", "HN": "2021", "MR": "20210118", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000084884"}, {"RECTYPE": "D", "MH": "Sustenance", "MN": "J02.750", "FX": "Nutritional Requirements", "MH_TH": "NLM (2021)", "ST": "T070", "MS": "Food and water regarded as a source of strength and requirements for life.", "PM": "2021", "HN": "2021", "MR": "20210706", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084902"}, {"RECTYPE": "D", "MH": "Resistant Starch", "AQ": "AD AE AN CL DF EC HI ME MI PD PO PS RE SD SN ST TO TU VI", "MN": "J02.500.400.750", "MH_TH": "NLM (2021)", "ST": "T168", "RN": "0", "PI": "Starch (1984-2020)", "MS": "Dietary starch and related high-molecular carbohydrate incapable of enzymatic hydrolysis in the SMALL INTESTINE and instead ferments in the COLON, producing SHORT-CHAIN FATTY ACIDS by-products.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084922"}, {"RECTYPE": "D", "MH": "Nasoalveolar Molding", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Nasal Alveolar Molding|T061|NON|EQV|NLM (2021)|200317|abcdef", "ENTRY": "Therapy, NAM", "MN": "N02.421.585.722.775.500", "MH_TH": "NLM (2021)", "ST": "T061", "MS": "A presurgical facial orthotic treatment for patients with bilateral and unilateral CLEFT LIP and CLEFT PALATE. The treatment uses NASOALVEOLAR MOLDING DEVICES designed to reduce the cleft gap, reposition the alveolar segments to improve nasal symmetry, shaping and lessening the severity of the cleft deformity before primary palatoplasty, cheiloplasty, and RHINOPLASTY.", "PM": "2021", "HN": "2021", "MR": "20220408", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000084982"}, {"RECTYPE": "D", "MH": "Acetates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acetic Acid Esters|T109|NON|NRW|NLM (1997)|960130|abcdef", "ENTRY": "Esters, Acetic Acid", "MN": "D10.251.400.045", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure.", "PM": "1966; see ACETIC ACIDS 1975-1990, see ACETIC ACID ESTERS 1991-1996, for ACETIC ACIDS see ACETIC ACIDS 1968-2012", "HN": "1966", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D000085"}, {"RECTYPE": "D", "MH": "Glycemic Control", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Blood Glucose Control|T061|NON|EQV|NLM (2021)|200320|abcdef", "ENTRY": "Glucose Control, Blood", "MN": "E02.491", "MH_TH": "NLM (2021)", "ST": "T061", "PI": "Blood Glucose (1974-2020)", "MS": "Strategies used for regulating BLOOD GLUCOSE levels. Such strategies include administration of INSULIN; DIETARY MODIFICATION; and EXERCISE.", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085002"}, {"RECTYPE": "D", "MH": "Surgical Navigation Systems", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Systems, Surgical Navigation", "MN": "E07.858.724", "MH_TH": "NLM (2021)", "ST": "T074", "PI": "Surgery, Computer-Assisted (2002-2020)", "MS": "Hardware and software tools that coordinate the use of imaging data (IMAGE INTERPRETATION, COMPUTER ASSISTED) to provide measurements for the planning of surgery and guidance of instruments during operating procedures in COMPUTER-ASSISTED SURGERY.", "PM": "2021", "HN": "2021", "MR": "20200723", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085022"}, {"RECTYPE": "D", "MH": "Receptors, Coronavirus", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Coronavirus Spike Binding Site|T116|T192|NON|EQV|NLM (2021)|200320|abbcdef", "ENTRY": "Receptor, Coronavirus", "MN": "D12.776.543.750.830.363", "FX": "Angiotensin-Converting Enzyme 2", "MH_TH": "NLM (2021)", "ST": "T192", "RN": "0", "PI": "Receptors, Virus (1979-2020)", "MS": "A broad class of cell surface proteins that bind specifically to VIRAL SPIKE PROTEINS found on a CORONAVIRUS. The attachment of the virus is the first step of a process that leads to CORONAVIRUS INFECTIONS.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085064"}, {"RECTYPE": "D", "MH": "Bacteriophage Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Phage Receptors|T116|T192|NON|EQV|UNK (19XX)|780519|abbcdef", "ENTRY": "Receptors, Bacteriophage", "MN": "D12.776.543.750.830.062", "FX": "Receptors, Virus", "MH_TH": "NLM (2021)", "ST": "T192", "RN": "0", "AN": "do not confuse with PHAGE ATTACHMENT SITES see ATTACHMENT SITES, MICROBIOLOGICAL", "MS": "Receptors on the bacterial cell surface which are recognized by BACTERIOPHAGES.", "PM": "2021; see RECEPTORS, VIRUS  1979-2020", "HN": "2021; use RECEPTORS,VIRUS 1979-2020", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085082"}, {"RECTYPE": "D", "MH": "Positive-Strand RNA Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Sense-Strand RNA Viruses|T005|NON|EQV|NLM (2021)|200415|abcdef", "ENTRY": "Sense-Strand RNA Virus", "MN": "B04.820.578", "MH_TH": "NLM (2021)", "ST": "T005", "PI": "RNA Viruses (1966-2020)", "MS": "RNA viruses that have their genetic material encoded in the form of single-stranded, positive-sense RNA. Unlike RETROVIRUSES they do not employ DNA intermediates in their life-cycle.", "PM": "2021", "HN": "2021", "MR": "20200902", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085102"}, {"RECTYPE": "D", "MH": "Severe Fever with Thrombocytopenia Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection|T047|NON|EQV|NLM (2021)|200323|abcdef", "ENTRY": "Virus Infection, SFTS", "MN": "C01.925.782.147.905", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Bunyaviridae Infections (2011-2020)", "MS": "A tick-borne infection with SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME BUNYAVIRUS of the genus Phlebovirus. It is associated with fever, THROMBOCYTOPENIA; LEUKOCYTOPENIA, and multiorgan dysfunction. It is found in parts of Asia including China, Japan, Korea and Vietnam and can be transmitted from infected domestic animals and humans.", "PM": "2021", "HN": "2021", "MR": "20210209", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085142"}, {"RECTYPE": "D", "MH": "Routinely Collected Health Data", "PRINT ENTRY": "Wearable Device Data|T062|NON|REL|NLM (2023)|220504|abcdef", "ENTRY": "Health Data, Routinely-Collected", "MN": "N05.425.210.750", "FX": "Registries", "MH_TH": "NLM (2021)", "ST": "T062", "PI": "Health Care Surveys (1990-2020)", "MS": "Data collected for purposes other than research. Examples include health administrative data, electronic health record data, and disease or clinical registry data.", "PM": "2021", "HN": "2021", "MR": "20220711", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085143"}, {"RECTYPE": "D", "MH": "Deportation", "ENTRY": "Deportations", "MN": "I01.880.604.583.133", "MH_TH": "NLM (2021)", "ST": "T064", "PI": "Jurisprudence (1975-2020)", "MS": "Removal of a foreign national from a country.", "PM": "2021", "HN": "2021", "MR": "20200708", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000085182"}, {"RECTYPE": "D", "MH": "Emotional Abuse", "AQ": "EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Psychological Abuse|T048|NON|EQV|NLM (2021)|200421|abcdef", "ENTRY": "Psychological Abuses", "MN": "I01.880.735.305", "MH_TH": "NLM (2021)", "ST": "T048", "MS": "Nonphysical abuse as defined as a pattern of behavior in which one person deliberately and repeatedly subjects another to nonphysical acts that are detrimental to behavioral and affective functioning and overall mental well-being. (APA Dictionary of Psychology, accessed 4/21/2020).", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000085202"}, {"RECTYPE": "D", "MH": "Water Insecurity", "PRINT ENTRY": "Water Scarcity|T070|NON|REL|NLM (2021)|200324|abcdef", "ENTRY": "Water Scarcities", "MN": "J02.200.418.750", "MH_TH": "NLM (2021)", "ST": "T070", "MS": "The lack of reliable access to adequate quantities of acceptable quality water for sustaining livelihoods, human and well-being. (from https://www.unwater.org/publications accessed3/34/2020).", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085222"}, {"RECTYPE": "D", "MH": "Viral Proteases", "AQ": "AD AE AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Viral Proteolytic Enzymes|T116|T126|NON|EQV|NLM (2021)|200324|abbcdef", "ENTRY": "Proteolytic Enzymes, Viral", "MN": "D12.776.964.900.500", "EC": "antagonists & inhibitors:Viral Protease Inhibitors", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "EC 3.4.-", "PI": "Viral Proteins (1965-2020)", "MS": "A broad category of proteolytic enzymes that are produced by VIRUSES. They play a role in the viral life cycle by processing viral proteins and possibly acting on host cell proteins.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085242"}, {"RECTYPE": "D", "MH": "Self-Testing", "ENTRY": "Self Testing", "MN": "I03.733", "MH_TH": "NLM (2021)", "ST": "T055", "PI": "Self Care (2010-2020)", "MS": "Process whereby a person who wants to know his or her health status collects a specimen, performs a test and interprets the test result in private.", "PM": "2021", "HN": "2021", "MR": "20200619", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085263"}, {"RECTYPE": "D", "MH": "High Reliability Organizations", "ENTRY": "Organizations, High Reliability", "MN": "N03.540.468", "MH_TH": "NLM (2021)", "ST": "T092", "PI": "Organizations (1970-2020)", "MS": "Organizations operating complex, high-hazard domains for extended periods without serious accidents or catastrophic failures. The concept of high reliability  extends beyond standardization. High reliability organizations cultivate resilience by relentlessly prioritizing safety over other performance pressures. (from https://psnet.ahrq.gov/primer/high-reliability accessed 3/25/2020).", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000085264"}, {"RECTYPE": "D", "MH": "Teleworking", "AQ": "CL EC LJ ME SN ST TD", "PRINT ENTRY": "Telework|T057|NON|EQV|NLM (2021)|200326|abcdef", "ENTRY": "Workplace, Flexible", "MN": "N04.452.677.650.313", "MH_TH": "NLM (2021)", "ST": "T057", "MS": "Arrangement under which an employee performs the duties and responsibilities of such employee's position, and other authorized activities, from an approved worksite other than the location from which the employee would otherwise work. (from https://www.opm.gov/FAQs/QA.aspx?fid=b48bf83b-440c-4f1e-a88c-3cdc9d802ac8&pid=75346675-3b92-4aec-831d-58cf5b0e86d2 accessed 3/26/2020).", "PM": "2021", "HN": "2021", "MR": "20230531", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085326"}, {"RECTYPE": "D", "MH": "Latent Infection", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Reactivation Infection|T067|NON|NRW|NLM (2021)|200421|abcdef", "ENTRY": "Reactivation, Infection", "MN": "C01.550", "FX": "Virus Latency", "MH_TH": "NLM (2021)", "ST": "T047", "PI": "Infections (1963-2020)", "MS": "Delayed infection of the host by a dormant or inactive pathogen.", "PM": "2021; for REACTIVATED INFECTION see REINFECTION 2021", "HN": "2021; for REACTIVATED INFECTION use REINFECTION 2021", "MR": "20210510", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085343"}, {"RECTYPE": "D", "MH": "Gender Role", "AQ": "EH HI PX TD", "PRINT ENTRY": "Sex Role|T054|NON|EQV|NLM (1986)|750630|abcdef", "ENTRY": "Women's Roles", "MN": "F01.829.750.500", "MH_TH": "UNK (19XX)", "ST": "T054", "PI": "Gender Identity (1991-2020)", "MS": "Social role encompassing a range of behaviors and attitudes that are considered acceptable based on person's biological sex.", "PM": "2021", "HN": "2021", "MR": "20230703", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085402"}, {"RECTYPE": "D", "MH": "Functional Status", "PRINT ENTRY": "Functional Independence|T056|NON|NRW|NLM (2021)|200407|abcdef", "ENTRY": "Status, Functional", "MN": "N06.850.505.400.425.175", "MH_TH": "NLM (2021)", "ST": "T056", "PI": "Health Status (1980-2020)", "MS": "Ability regarding basic physical and cognitive activities such as walking or reaching, focusing attention, and communicating, as well as the routine activities of daily living, including eating, bathing, dressing, transferring, and toileting; and life situations such as school or play for children and, for adults, work outside the home or maintaining a household. (from https://www.ncvhs.hhs.gov/wp-content/uploads/2017/08/010617rp.pdf)", "PM": "2021", "HN": "2021", "MR": "20200708", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000085542"}, {"RECTYPE": "D", "MH": "Treatment Switching", "ENTRY": "Switching, Treatment", "MN": "N06.850.520.915", "MH_TH": "NLM (2021)", "ST": "T058", "AN": "use only in the context of a randomized controlled trial", "MS": "When patients in a randomized clinical trial switch from the treatment initially assigned to them to another treatment, typically from the control to experimental treatment.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085582"}, {"RECTYPE": "D", "MH": "Hyperferritinemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ultrahyperferritinemia|T033|NON|NRW|NLM (2021)|200403|abcdef", "ENTRY": "Ultrahyperferritinemias", "MN": "C18.452.565.300", "MH_TH": "NLM (2021)", "ST": "T033", "PI": "Iron Overload (2001-2020)", "MS": "A finding of elevated serum level of FERRITIN. It is often associated with IRON OVERLOAD, repeated blood transfusions, malignancy, iron metabolic syndromes, virus infection, liver injury or dysfunction, and renal failure. Hyperferritinemia in iron metabolic syndromes (e.g., Still's diseases, and HEMOPHAGOCYTIC SYNDROME) is referred to as dysmetabolic hyperferritinemia.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085583"}, {"RECTYPE": "D", "MH": "Food Deserts", "ENTRY": "Food Desert", "MN": "J02.750.500", "MH_TH": "NLM (2021)", "ST": "T067", "PI": "Food Supply (2014-2020)", "MS": "Areas characterized by relatively poor access to healthy and affordable food.", "PM": "2021", "HN": "2021", "MR": "20200708", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000085584"}, {"RECTYPE": "D", "MH": "Spray Drying", "ENTRY": "Spray Dryings", "MN": "E05.916.920", "MH_TH": "NLM (2021)", "ST": "T068", "AN": "use only for drugs, not for food", "MS": "Method of drying liquids and liquid suspensions to prepare drugs in their final dehydrated powder form.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085642"}, {"RECTYPE": "D", "MH": "Working Dogs", "AQ": "AB AH BL CF CL EC EM GD GE HI IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Sniffer Dogs|T008|NON|NRW|NLM (2021)|200407|abcdef", "ENTRY": "Working Dogs, Military", "MN": "B01.050.050.116.906", "MH_TH": "NLM (2021)", "ST": "T008", "PI": "Dogs (1966-2020)", "MS": "Dogs that are trained to perform practical tasks, as opposed to PETS or companion dogs.", "PM": "2021", "HN": "2021", "MR": "20200902", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085682"}, {"RECTYPE": "D", "MH": "Coronavirus Protease Inhibitors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protease Inhibitors, Coronavirus", "MN": "D27.505.954.122.388.769.250", "MH_TH": "NLM (2021)", "ST": "T121", "RN": "0", "PI": "Protease Inhibitors (1966-2020)", "MS": "Protease inhibitors that specifically inhibit one or more of the proteases that are produced by CORONAVIRUSES.", "PM": "2021", "HN": "2021", "MR": "20220413", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085683"}, {"RECTYPE": "D", "MH": "Deltacoronavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Deltacoronaviruses|T005|NON|EQV|NLM (2021)|200407|abcdef", "MN": "B04.820.578.500.540.150.257", "MH_TH": "NLM (2018)", "ST": "T005", "RN": "txid1159901", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS", "MS": "A genus of Coronavirus that occurs primarily in BIRDS and PIGS.", "PM": "2021; see CORONAVIRUS 2016-2020", "HN": "2021: use CORONAVIRUS 2016-2020", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085686"}, {"RECTYPE": "D", "MH": "Therapy Animals", "AQ": "AB AH BL CF CL EC EM GD GE HI IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Therapy Dogs|T008|NON|NRW|NLM (2021)|200407|abcdef", "ENTRY": "Therapy Dog, Pet", "MN": "B01.050.050.116.859", "FX": "Animal Assisted Therapy", "MH_TH": "NLM (2021)", "ST": "T008", "MS": "Therapy animals visit hospitals, nursing homes, hospices, schools, and other places where people may be facing health challenges or stressors to provide an emotional or mental health benefit by their presence.  They may also be used to assist physical and occupational therapists.  Therapy animals are generally registered, trained, and screened, but are not covered by laws as are service animals.", "PM": "2021", "HN": "2021", "MR": "20200902", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085703"}, {"RECTYPE": "D", "MH": "Physical Distancing", "AQ": "EC LJ MT PX TD", "PRINT ENTRY": "Social Distancing|T061|NON|EQV|NLM (2021)|200708|abcdef", "ENTRY": "Distancing, Social", "MN": "N06.850.780.200.688", "MH_TH": "NLM (2021)", "ST": "T061", "PI": "Quarantine (1966-2020)", "MS": "Maintaining recommended amount of spatial separation between self and others.", "PM": "2021", "HN": "2021", "MR": "20221214", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000085762"}, {"RECTYPE": "D", "MH": "Prolyl Oligopeptidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Prolyl Oligopeptidase|T116|T126|NON|EQV|NLM (2021)|200409|abbcdef", "ENTRY": "Post Proline Endopeptidase", "MN": "D08.811.277.656.300.760.637", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "EC 3.4.21.26", "RR": "OJQ0VJ822N", "MS": "A family of serine proteases with specificity for proline-specific cleavage of peptides that are not longer than 30 amino acids. In humans it is broadly distributed in all tissues with higher activity found in the brain.", "PM": "2021; PROLYL OLIGOPEPTIDASES was indexed under SERINE ENDOPEPTIDASES 1988-2020; PEPTIDE PEPTIDOHYDROLASES 1980-1987; and under PROLINE 1977-1980", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085822"}, {"RECTYPE": "D", "MH": "Imaging Genomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Radiogenomics (Imaging)|T091|NON|EQV|NLM (2021)|200408|abcdef", "ENTRY": "Genomics, Imaging", "MN": "H02.403.740.663", "FX": "Radiation Genomics", "MH_TH": "NLM (2021)", "ST": "T091", "MS": "The field of study investigating the relationship between imaging features, identified during various imaging procedures, and the presence of various genetic or molecular markers of particular disorders and diseases.", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085843"}, {"RECTYPE": "D", "MH": "Radiation Genomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Radiogenomics (Radiometry)|T091|NON|EQV|NLM (2021)|200408|abcdef", "ENTRY": "Genomics, Radiation", "MN": "H02.403.740.669", "FX": "Imaging Genomics", "MH_TH": "NLM (2021)", "ST": "T091", "PI": "Radiation Tolerance (2006-2020)", "MS": "The study of the association between patient genomic data and the response to IONIZING RADIATION.", "PM": "2021; MESOTHELIOMA, MALIGNANT was indexed under LUNG NEOPLASMS and MESOTHELIOMA 2013-2020", "HN": "2021 (2013)", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085844"}, {"RECTYPE": "D", "MH": "Military Deployment", "AQ": "HI LJ PX SN TD", "ENTRY": "Deployment, Military", "MN": "I03.946.225.125", "MH_TH": "NLM (2019)", "ST": "T057", "PI": "Military Personnel (2000-2020)", "MS": "The movement of MILITARY PERSONNEL and support structures to designated areas for the purpose of performing of military duties in support of a mission.", "PM": "2021: see MILITARY PERSONNEL 2000-2020", "HN": "2021: use MILITARY PERSONNEL 2000-2020", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085883"}, {"RECTYPE": "D", "MH": "Soil Erosion", "AQ": "EC HI PC SN", "ENTRY": "Erosion, Soil", "MN": "G16.500.870", "FX": "Landslides", "MH_TH": "NLM (2021)", "ST": "T070", "MS": "The displacement of significant quantities of SOIL from an area by wind or rainwater runoff.", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085902"}, {"RECTYPE": "D", "MH": "Metal Workers", "PRINT ENTRY": "Welders|T090|NON|EQV|NLM (2021)|200421|abcdef", "ENTRY": "Workers, Steel", "MN": "M01.526.590", "MH_TH": "NLM (2021)", "ST": "T090", "PI": "Occupational Groups (2000-2020)", "MS": "Craftspersons who take ordinary types of flat metal and make them into specialized products for various duct and ventilation systems, as well as architectural and specialized metal fabrication.", "PM": "2021", "HN": "2021", "MR": "20200619", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085924"}, {"RECTYPE": "D", "MH": "Waiting Rooms", "PRINT ENTRY": "Waiting Room|T082|NON|EQV|NLM (2021)|200409|abcdef", "ENTRY": "Rooms, Waiting", "MN": "N02.278.956", "MH_TH": "NLM (2021)", "ST": "T082", "MS": "Area for the use of persons such as clients, patients or visitors before an appointment or service.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085925"}, {"RECTYPE": "D", "MH": "Tourism", "MN": "I03.883.694", "MH_TH": "NLM (2021)", "ST": "T068", "PI": "Travel (1990-2020)", "MS": "Travel for pleasure.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085926"}, {"RECTYPE": "D", "MH": "Supermarkets", "PRINT ENTRY": "Grocery Stores|T073|NON|EQV|NLM (2021)|200409|abcdef", "ENTRY": "Supermarket", "MN": "J01.576.423.750.937", "MH_TH": "NLM (2021)", "ST": "T073", "PI": "Food Supply (2004-2020)", "MS": "Self-service retail markets selling groceries, fresh produce, meats and other foods.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085943"}, {"RECTYPE": "D", "MH": "Team Sports", "ENTRY": "Team Sport", "MN": "I03.450.642.845.880", "MH_TH": "NLM (2021)", "ST": "T056", "PI": "Sports (1975-2020)", "MS": "Organized recreational activities involving individuals.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085944"}, {"RECTYPE": "D", "MH": "Angiotensin-Converting Enzyme 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Angiotensin-Converting Enzyme-Related Carboxypeptidase|T116|T126|NON|EQV|NLM (2021)|200410|abbcdef", "ENTRY": "Carboxypeptidase, Angiotensin-Converting Enzyme-Related", "MN": "D08.811.277.656.350.245.042", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "EC 3.4.17.23", "MS": "A transmembrane glycoprotein with an extracellular catalytic domain which functions as a carboxypeptidase. It cleaves a single C-terminal residue from a distinct range of substrates. The catalytic efficiency is 400-fold higher with ANGIOTENSIN II as a substrate than with ANGIOTENSIN I. Angiotensin-converting enzyme 2 is also is a functional receptor for the spike glycoprotein (SPIKE PROTEIN, CORONAVIRUS) of the CORONAVIRUSES SARS-COV, SARS-COV2, and HCOV-NL63.", "PM": "2021; ACE2 ENZYME was indexed as CARBOXYPEPTIDASES 2000-2006; and PEPTIDYL-DIPEPTIDASE A 2007-2020", "HN": "2021 (2000)", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085962"}, {"RECTYPE": "D", "MH": "Rhamnogalacturonans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "MN": "D20.215.784.500.618.500", "MH_TH": "NLM (2021)", "ST": "T109", "RN": "0", "PI": "Pectins (1991-2020)", "MS": "Types of polysaccharides that are components of the plant cell wall pectin matrix.  Rhamnogalacturonan I is characterized by a backbone of the repeating disaccharide (4)-alpha-D-galacturonic acid-(1,2)-alpha-L-rhamnose-(1,-) with many of the rhamnose residues substituted at C-4 with side chains of various neutral sugars linked together in various ways.  Rhamnogalacturonan II type is complex, highly branched polysaccharide where the backbone consists exclusively of D-galacturonic acid units.", "PM": "2021", "HN": "2021", "MR": "20200609", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000085982"}, {"RECTYPE": "D", "MH": "Acetazolamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "HumaZolamide", "MN": "D03.383.129.708.867.060", "PA": "Diuretics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Acetamide, N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)-", "RN": "O3FX965V0I", "RR": "59-66-5 (Acetazolamide)", "MS": "One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)", "MR": "20160624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000086"}, {"RECTYPE": "D", "MH": "Mesothelioma, Malignant", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Mesothelioma, Malignant Pleural|T191|NON|NRW|NLM (2021)|200410|abcdef", "ENTRY": "Pleural Mesotheliomas, Malignant", "MN": "C08.785.640.350", "MH_TH": "OMIM (2013)", "ST": "T191", "PI": "Mesothelioma (2013-2020)", "MS": "A type of mesothelioma with a tendency to metastasize.  Most tumors originate from either the PLEURA or PERITONEUM, tumors may also originate in the PERICARDIUM or testicular tissue. It is associated with ASBESTOS exposure. Somatic mutations identified in WT1, BCL10, CDKN2A, NF2, and BAP1 genes are associated with the malignancy. OMIM: 156240.", "PM": "2021; MESOTHELIOMA, MALIGNANT indexed as LUNG NEOPLASMS and MESOTHELIOMA 2013-2020", "HN": "2021", "MR": "20210510", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086002"}, {"RECTYPE": "D", "MH": "Chain of Infection", "AQ": "PC VE", "ENTRY": "Infection Chain", "MN": "N06.850.520.203", "MH_TH": "NLM (2021)", "ST": "T078", "PI": "Epidemiology (2002-2020)", "MS": "A sequence of infection transmission from infectious agent leaving DISEASE RESERVOIR or host through a portal of exit, conveyed by some mode of transmission, and entering through a portal of entry to infect a susceptible host.", "PM": "2021", "HN": "2021", "MR": "20200617", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086003"}, {"RECTYPE": "D", "MH": "3C Viral Proteases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "3Cpro Proteinases|T116|T126|ABX|EQV|NLM (2021)|200521|abbcdef", "ENTRY": "Viral Proteases, 3C-like", "MN": "D12.776.964.900.500.500", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "EC 3.4.22.28", "RR": "EC 3.4.22.28", "PI": "Viral Proteins (1965-2020)", "MS": "A class of cysteine proteases which play an essential role in VIRUS REPLICATION. They cleave precursor viral POLYPROTEINS to produce functional proteins and enzymes. In addition, they cleave certain host cell proteins such as EUKARYOTIC INITIATION FACTOR-4G.", "PM": "2021", "HN": "2021", "MR": "20230612", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086042"}, {"RECTYPE": "D", "MH": "Viral Papain-like Proteases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Viral Papain like Proteases", "MN": "D12.776.964.900.500.750", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "EC 3.4.22.-", "PI": "Peptide Hydrolases (1965-2020) / Viral Proteins (1965-2020)", "MS": "A subclass of cysteine endopeptidases found in VIRUSES that share structural similarities with PAPAIN.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086062"}, {"RECTYPE": "D", "MH": "Viroporin Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Viroporins|T116|T123|NON|EQV|NLM (2021)|200414|abbcdef", "ENTRY": "Viral Pore Forming Proteins", "MN": "D12.776.964.970.880.970", "MH_TH": "NLM (2021)", "ST": "T123", "RN": "0", "MS": "Viral proteins that assemble into oligomeric ION CHANNELS which can facilitate the transfer of viral materials across the CELL MEMBRANE.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086082"}, {"RECTYPE": "D", "MH": "Akkermansia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.930.500", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid239934", "PI": "Verrucomicrobia (2004-2020)", "MS": "A genus of gram-negative, anaerobic bacteria in the phylum VERRUCOMICROBIA and the family Akkermansiaceae. This genus includes the species Akkermansia muciniphila which is known for residing in the human intestinal tract and having effects on human metabolism.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086102"}, {"RECTYPE": "D", "MH": "Negative-Sense RNA Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Group V Single-Stranded RNA Viruses|T005|NON|EQV|NLM (2021)|200417|abcdef", "ENTRY": "RNA Viruses, Negative-Sense", "MN": "B04.820.480", "MH_TH": "NLM (2021)", "ST": "T005", "PI": "RNA Viruses (1966-2020)", "MS": "RNA viruses that have their genetic material encoded in the form of single-stranded, negative-sense RNA. Unlike RETROVIRUSES they do not employ DNA intermediates in their life-cycle", "PM": "2021", "HN": "2021", "MR": "20200902", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086103"}, {"RECTYPE": "D", "MH": "Double Stranded RNA Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "dsRNA Viruses|T005|ACX|EQV|NLM (2021)|200417|abcdef", "ENTRY": "dsRNA Virus", "MN": "B04.820.223", "MH_TH": "NLM (2021)", "ST": "T005", "RN": "txid35325", "PI": "RNA Viruses (1966-2020)", "MS": "RNA viruses that have their genetic material encoded in the form of double-stranded RNA.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086122"}, {"RECTYPE": "D", "MH": "Aquifex", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.025", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid2713", "PI": "Gram-Negative Bacteria (2013-2020)", "MS": "A thermophilic, gram-negative genus of bacteria in the phylum Aquificae and the family Aquificaceae. Rod-shaped and non-spore forming, this genus is known to grow near underwater volcanoes or hot springs.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086142"}, {"RECTYPE": "D", "MH": "Clavibacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.663", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1573", "PI": "Actinobacteria (1984-2020)", "MS": "A genus of high GC content, Gram-positive aerobic bacteria in the family Microbacteriaceae and phylum ACTINOBACTERIA. This genus contains some phytopathogenic coryneform (club-shaped) bacteria causing stunting diseases in plants.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086162"}, {"RECTYPE": "D", "MH": "Dermatophilus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Dermatophylus|T007|NON|EQV|NLM (2021)|200423|abcdef", "MN": "B03.510.460.400.400.049.719", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1862", "PI": "Actinobacteria (2010-2020)", "MS": "A genus of high GC content, Gram-positive, aerobic bacteria in the family Dermatophilaceae and phylum ACTINOBACTERIA. Type species Dermatophilus congolensis is a known causative agent for dermatophilosis in humans and animals.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086182"}, {"RECTYPE": "D", "MH": "Exiguobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.353.500.100.309", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid33986", "PI": "Bacillaceae (1994-2020)", "MS": "A genus of gram-negative bacteria in the phylum FIRMICUTES and the order BACILLALES. This genus is known for its ability to survive in a wide range of temperatures and plays a role in the diet of the MEALWORM.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086183"}, {"RECTYPE": "D", "MH": "Liberibacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Candidatus Liberibacter|T007|NON|EQV|NLM (2021)|200526|abcdef", "MN": "B03.660.050.662.347", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid34019", "PI": "Rhizobiaceae (2005-2020)", "MS": "A genus of gram-negative ALPHAPROTEOBACTERIA in the family RHIZOBIACEAE that is a known plant pathogen transmitted by PSYLLIDS.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086202"}, {"RECTYPE": "D", "MH": "Mediterranea", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Genus Mediterranea|T007|NON|EQV|NLM (2022)|210316|abcdef", "MN": "B03.440.080.094.389", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1926659", "PI": "Bacteroidaceae (2017-2020)", "MS": "A genus of gram-negative, anaerobic bacteria in the phylum BACTEROIDETES and family BACTEROIDACEAE. This genus includes the type species Mediterranea massiliensis, which resides in the human colon.", "PM": "2021", "HN": "2021", "MR": "20210510", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086222"}, {"RECTYPE": "D", "MH": "Neglecta", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.353.625.774", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1924105", "PI": "Firmicutes (2007-2020)", "MS": "A genus of gram-positive, anaerobic bacteria in the order CLOSTRIDIALES and phylum FIRMICUTES. This genus is known for the type species Neglecta timonensis which was discovered in the stool of a patient with DIABETES MELLITUS, TYPE 2.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086242"}, {"RECTYPE": "D", "MH": "Nocardiopsis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.915", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid2013", "PI": "Actinobacteria (1996-2020)", "MS": "A genus of gram-positive bacteria in the phylum ACTINOBACTERIA and family Nocardiopsaceae. This genus occurs in saline and alkaline soils, and is known for producing antimicrobial compounds such as thiopeptides.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086262"}, {"RECTYPE": "D", "MH": "Pannus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.622", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1427526", "MS": "A genus of CYANOBACTERIA in the family Synechococcaceae that is free-floating and occurs in various water environments attaching to algae and submersed plants.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086282"}, {"RECTYPE": "D", "MH": "Planktothrix", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.641", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid54304", "PI": "Cyanobacteria (2000-2020)", "MS": "A genus of CYANOBACTERIA in the order Oscillatoriales and family Microcoleaceae. Type species of this genus are found in lakes of the Northern Hemisphere and are known producers of hepatotoxins and MICROCYSTINS.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086302"}, {"RECTYPE": "D", "MH": "Rappaport", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.080.775", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1955421", "PI": "Gammaproteobacteria (1967-2020)", "MS": "A genus of gram-negative GAMMAPROTEOBACTERIA in the family CARDIOBACTERIACEAE.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086322"}, {"RECTYPE": "D", "MH": "Sorangium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.125.500.658", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid39643", "PI": "Myxococcales (1975-2020)", "MS": "A genus of gram-negative, soil-dwelling DELTAPROTEOBACTERIA in the order MYXOCOCCALES that has gliding motility.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086323"}, {"RECTYPE": "D", "MH": "Thermobifida", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.957", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid83677", "PI": "Actinobacteria (2000-2020)", "MS": "A genus of thermophilic, gram-positive ACTINOBACTERIA in the family Nocardiopsaceae that is rod-shaped and found in decaying organic matter. This genus plays a major role in the degradation of plant cell walls.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086324"}, {"RECTYPE": "D", "MH": "Thermosynechococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.813", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid146785", "PI": "Cyanobacteria (2001-2020)", "MS": "A genus of thermophilic, unicellular CYANOBACTERIA in the family Synechococcaceae that is photosynthetic.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086325"}, {"RECTYPE": "D", "MH": "Xylophilus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.941", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid54066", "PI": "Xanthomonadaceae (1990-2020)", "MS": "A genus of gram-negative, aerobic BETAPROTEOBACTERIA in the order Burkholderiales that is a known cause of diseases in plants.", "PM": "2021", "HN": "2021", "MR": "20200813", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086326"}, {"RECTYPE": "D", "MH": "Models, Biopsychosocial", "PRINT ENTRY": "Biopsychosocial Model|T170|NON|EQV|NLM (2021)|200116|abcdef", "ENTRY": "Model, Biopsychosocial", "MN": "E05.599.063", "MH_TH": "NLM (2021)", "ST": "T170", "MS": "A systematic integration of biological, psychological, and social approaches to the study of mental health and specific mental disorders.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086342"}, {"RECTYPE": "D", "MH": "COVID-19", "AQ": "BL CF CI CL CN CO DG DH DI EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Severe Acute Respiratory Syndrome Coronavirus 2 Infection|T047|NON|EQV|NLM (2022)|210316|abcdef", "ENTRY": "Virus Infection, COVID-19", "MN": "C08.730.610.763.500", "FX": "SARS-CoV-2", "EC": "drug therapy:COVID-19 Drug Treatment", "MH_TH": "NLM (2020)", "ST": "T047", "MS": "A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.", "PM": "2021; for COVID-19 see PNEUMONIA, VIRAL; CORONAVIRUS INFECTIONS; and PANDEMICS 2020", "HN": "2021(2020)", "MR": "20220714", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086382"}, {"RECTYPE": "D", "MH": "SARS-CoV-2", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Wuhan Seafood Market Pneumonia Virus|T005|EPO|EQV|NLM (2021)|200430|abcdef", "ENTRY": "Viruses, COVID19", "MN": "B04.820.578.500.540.150.113.937.500", "MH_TH": "NLM (2021)", "ST": "T005", "RN": "txid2697049", "MS": "A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis.", "PM": "2021; for SARS-COV-2 see under BETACORONAVIRUS 2020", "HN": "2021(2020)", "MR": "20220523", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086402"}, {"RECTYPE": "D", "MH": "Coronavirus RNA-Dependent RNA Polymerase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RNA-Dependent RNA Polymerases, Coronavirus|T116|T126|NON|EQV|NLM (2021)|200430|abbcdef", "ENTRY": "RNA Polymerase, Coronavirus", "MN": "D12.776.964.900.750.250", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "EC 2.7.7.48", "RR": "EC 2.7.7.48", "MS": "RNA-Dependent RNA Polymerases found in species of CORONAVIRIDAE.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086422"}, {"RECTYPE": "D", "MH": "Coronavirus Nucleocapsid Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleocapsid Protein, Coronavirus|T116|T123|NON|EQV|NLM (2021)|200521|abbcdef", "ENTRY": "Nucleocapsid Proteins, Coronavirus", "MN": "D12.776.964.970.600.700", "MH_TH": "NLM (2021)", "ST": "T123", "RN": "0", "MS": "Nucleocapsid proteins from species of the CORONAVIRIDAE virus family.", "PM": "2021; CORONAVIRUS NUCLEOCAPSID PROTEINS was indexed under NUCLEOCAPSID PROTEINS 1996-2020", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086462"}, {"RECTYPE": "D", "MH": "Viral Genome Packaging", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Virus Genome Packaging|T045|NON|EQV|NLM (2021)|200527|abcdef", "ENTRY": "Virus Packaging", "MN": "G06.920.925.950.500", "MH_TH": "NLM (2021)", "ST": "T045", "PI": "Virus Assembly (1996-2020)", "MS": "Folding of the viral genomic nucleic acid into the VIRUS PARTICLE.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086482"}, {"RECTYPE": "D", "MH": "Viral Packaging Sequence", "AQ": "DE GE PH RE", "PRINT ENTRY": "Virus Packaging Signal Sequence|T086|T114|NON|EQV|NLM (2021)|200505|abbcdef", "ENTRY": "Virus Packaging Sequences", "MN": "G05.360.080.689.905", "MH_TH": "NLM (2021)", "ST": "T114", "PI": "Base Sequence (1985-2020)", "MS": "Specific sequences in the viral nucleic acid that are involved in packaging the viral genome (VIRAL GENOME PACKAGING) into the VIRUS PARTICLES.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086502"}, {"RECTYPE": "D", "MH": "Financial Stress", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Socioeconomic Adversity|T041|NON|EQV|NLM (2024)|230420|abcdef", "ENTRY": "Toxicity, Financial", "MN": "F01.145.126.990.643", "MH_TH": "OBSSR (2016)", "ST": "T041", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "PI": "Stress, Psychological (2015-2020)", "MS": "Stress arising from personal financial concerns. (www.cancer.gov/publications/dictionaries/cancer-terms/def/financial-stress).", "PM": "2021", "HN": "2021", "MR": "20230531", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086522"}, {"RECTYPE": "D", "MH": "Carnivorous Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Insectivorous Plants|T002|NON|NRW|NLM (2021)|200506|abcdef", "ENTRY": "Plant, Insectivorous", "MN": "B01.650.080", "MH_TH": "NLM (2021)", "ST": "T002", "MS": "Plants adapted to trap and kill insects and other non-plant organisms, deriving nutrients from trapped organisms.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086523"}, {"RECTYPE": "D", "MH": "Calliphoridae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Blowflies|T204|NON|EQV|NLM (2021)|200506|abcdef", "ENTRY": "Blowfly", "MN": "B01.050.500.131.617.720.500.500.750.155", "MH_TH": "NLM (2021)", "ST": "T204", "RN": "txid7371", "PI": "Diptera (1964-2020)", "MS": "A family of the superfamily Oestroidea in the order Diptera. Several species are major livestock pests causing MYIASIS by parasitic maggots.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086542"}, {"RECTYPE": "D", "MH": "Anosmia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Loss of Smell|T184|NON|EQV|NLM (2021)|200423|abcdef", "ENTRY": "Smell Loss", "MN": "C23.888.592.763.550.500", "MH_TH": "NLM (1963)", "ST": "T184", "MS": "Complete or severe loss of the subjective sense of smell. Loss of smell may be caused by many factors such as a cold, allergy, OLFACTORY NERVE DISEASES, viral RESPIRATORY TRACT INFECTIONS (e.g., COVID-19), aging and various neurological disorders (e.g., ALZHEIMER DISEASE).", "PM": "2021; for ANOSMIA see under OLFACTION DISORDERS (1963-2020)", "HN": "2021(1963)", "MR": "20210510", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086582"}, {"RECTYPE": "D", "MH": "Pangolins", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Smutsia|T015|NON|NRW|NLM (2021)|200612|abcdef", "ENTRY": "Scaly Anteater", "MN": "B01.050.150.900.649.313.976", "MH_TH": "NLM (2021)", "ST": "T015", "RN": "txid9971", "RR": "txid9973", "AN": "do not confuse entry term SCALY ANTEATERS with ANTEATERS see VERMILINGUA", "MS": "Solitary, chiefly burrowing and nocturnal mammals of the order Pholidota. They have bodies, tails and heads encased in sharp scales, which protect them when rolled up into a ball when threatened. Also called scaly anteaters, pangolins are myrmecophagous mainly eating ants and termites and are distributed in the warmer parts of the Asia and the Africa continents. Chinese pangolins are a potential intermediate DISEASE RESERVOIR of COVID-19 virus, SARS-CoV-2.", "PM": "2021", "HN": "2021", "MR": "20210702", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086642"}, {"RECTYPE": "D", "MH": "COVID-19 Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "SARS2 Vaccines|T121|T129|ACX|EQV|NLM (2021)|200514|abbcdef", "ENTRY": "Virus Vaccines, COVID19", "MN": "D20.215.894.899.085", "MH_TH": "NLM (2021)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (2020)", "MS": "Vaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086663"}, {"RECTYPE": "D", "MH": "Indigenous Canadians", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Native Canadians|T098|NON|EQV|NLM (2021)|200515|abcdef", "ENTRY": "Natives, Canadian", "MN": "M01.686.477.250.600.375", "MH_TH": "NLM (2021)", "ST": "T098", "MS": "The three groups of indigenous aboriginal peoples of Canada. These include First Nations, Inuit and M\u00e9tis. These are three distinct peoples with unique histories, languages, cultural practices and spiritual beliefs.", "PM": "2021", "HN": "2021", "MR": "20220708", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000086682"}, {"RECTYPE": "D", "MH": "Practice Patterns, Pharmacists'", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Practice Pattern, Pharmacist|T057|NON|EQV|NLM (2021)|200513|abcdef", "ENTRY": "Practice Patterns, Pharmacists", "MN": "N05.300.575", "MH_TH": "NLM (2021)", "ST": "T057", "PI": "Drug Prescriptions (1977-2020)", "MS": "Patterns of practice related to how PHARMACISTS prepare or compound PRESCRIPTION DRUGS as especially influenced by cost of the service requested and provided.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086702"}, {"RECTYPE": "D", "MH": "Rhinorrhea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Runny Nose|T184|NON|EQV|NLM (2021)|200513|abcdef", "ENTRY": "Nose, Runny", "MN": "C23.888.852.834", "MH_TH": "NLM (2021)", "ST": "T184", "PI": "Rhinitis (1966-2020)", "MS": "Excess nasal drainage.", "PM": "2021", "HN": "2021", "MR": "20200527", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086722"}, {"RECTYPE": "D", "MH": "Clinical Reasoning", "PRINT ENTRY": "Clinical Judgement|T078|NON|EQV|NLM (2021)|200513|abcdef", "ENTRY": "Reasoning, Clinical", "MN": "E01.055.500", "MH_TH": "NLM (2021)", "ST": "T078", "PI": "Thinking (1985-2020)", "MS": "Process by which clinicians collect signs and process information to understand the patient's medical situation or problem, and then plan and implement appropriate medical interventions.", "PM": "2021", "HN": "2021", "MR": "20200708", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000086723"}, {"RECTYPE": "D", "MH": "COVID-19 Testing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Severe Acute Respiratory Syndrome Coronavirus 2 Testing|T059|T060|NON|EQV|NLM (2021)|200514|abbcdef", "ENTRY": "Virus Testing, COVID19", "MN": "E05.200.312", "MH_TH": "NLM (2021)", "ST": "T060", "MS": "Diagnosis of COVID-19 by assaying bodily fluids or tissues for the presence of COVID-19 antibodies, SARS-COV-2 antigens or the VIRAL RNA of SARS-COV-2.", "PM": "2021", "HN": "2021", "MR": "20200617", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086742"}, {"RECTYPE": "D", "MH": "Automated Facial Recognition", "AQ": "EC ES HI IS MT SN ST TD", "PRINT ENTRY": "Facial Recognition, Automated|T066|NON|EQV|NLM (2021)|200514|abcdef", "ENTRY": "Technology, Facial Recognition", "MN": "N04.452.910.099.250", "FX": "Facial Recognition", "MH_TH": "NLM (2010)", "ST": "T066", "AN": "FACIAL RECOGNITION is also available", "PI": "Facial Recognition (2011-2020)", "MS": "Electronic identification of a human based on attributes of the face.", "PM": "2021; see BIOMETRIC IDENTIFICATION 2009-2020", "HN": "2021; use BIOMETRIC IDENTIFICATION 2009-2020", "MR": "20200623", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086762"}, {"RECTYPE": "D", "MH": "Coronavirus 3C Proteases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mpro Protein, Coronavirus|T116|T126|ABX|EQV|NLM (2021)|200514|abbcdef", "ENTRY": "Proteinases, Coronavirus 3C", "MN": "D12.776.964.900.500.500.500", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "EC 3.4.22.28", "PI": "Peptide Hydrolases (1965-2020) / Viral Proteins (1965-2020)", "MS": "3C proteases that occur in species of CORONAVIRIDAE.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086782"}, {"RECTYPE": "D", "MH": "Disease Hotspot", "PRINT ENTRY": "Transmission Hotspot|T067|NON|EQV|NLM (2021)|200515|abcdef", "ENTRY": "Transmission Hotspots", "MN": "N06.850.290.100", "MH_TH": "NLM (2021)", "ST": "T067", "PI": "Disease Outbreaks (2010-2020)", "MS": "Areas of increased disease risk, prevalence, incidence or higher efficiency of transmission.", "PM": "2021", "HN": "2021", "MR": "20200708", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000086822"}, {"RECTYPE": "D", "MH": "User-Centered Design", "PRINT ENTRY": "Usability Testing|T170|NON|EQV|NLM (2021)|200708|abcdef", "ENTRY": "User-Centered Designs", "MN": "L01.224.900.900", "MH_TH": "NLM (2021)", "ST": "T170", "MS": "Design process using input from users regarding systems, devices, or software.", "PM": "2021", "HN": "2021", "MR": "20200708", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000086825"}, {"RECTYPE": "D", "MH": "Uridylate-Specific Endoribonucleases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ENDOU|T116|T126|ABB|EQV|NLM (2021)|200515|abbcdef", "ENTRY": "Uridylate Specific Endoribonucleases", "MN": "D08.811.277.352.700.350.850.500", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "EC 3.1.-", "MS": "Endoribonucleases that cleave RNA at 5'-polyuridine locations within the RNA strand.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086842"}, {"RECTYPE": "D", "MH": "Coronavirus M Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "M Protein, Coronavirus|T116|T123|NON|EQV|NLM (2021)|200515|abbcdef", "ENTRY": "Membrane Proteins, Coronavirus", "MN": "D12.776.964.970.880.940.500", "MH_TH": "NLM (2021)", "ST": "T123", "RN": "0", "MS": "Viral matrix proteins found in species of CORONAVIRIDAE.", "PM": "2021; CORONAVIRUS M PROTEINS was indexed under VIRAL MATRIX PROTEINS (2020)", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086862"}, {"RECTYPE": "D", "MH": "Coronavirus Papain-Like Proteases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Papain-Like Proteinase 3, Coronavirus|T116|T126|NON|NRW|NLM (2021)|200517|abbcdef", "ENTRY": "Papain-Like Proteases, Coronavirus", "MN": "D12.776.964.900.500.750.500", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "EC 3.4.22.2", "RR": "EC 3.4.22.2", "PI": "Peptide Hydrolases (1965-2020) / Viral Proteins (1965-2020)", "MS": "Papain-like proteases that occur in species of CORONAVIRIDAE. Some species have more than one papain-like protease gene.", "PM": "2021; CORONAVIRUS PAPAIN-LIKE PROTEASES was indexed under PAPAIN & VIRAL NONSTRUCTURAL PROTEINS 2020", "HN": "2021", "MR": "20220112", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086882"}, {"RECTYPE": "D", "MH": "Viral Replicase Complex Proteins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Viral Replicases|T116|T126|NON|REL|NLM (2021)|200516|abbcdef", "ENTRY": "Replicases, Viral", "MN": "D12.776.964.900.750", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "0", "MS": "Viral genome-encoded enzymes that facilitate the replication of RNA VIRUSES.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086902"}, {"RECTYPE": "D", "MH": "ADP-Ribose 1''-Phosphate Phosphatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Appr1p Phosphatase|T116|T126|ABB|EQV|NLM (2021)|200517|abbcdef", "ENTRY": "Phosphatases, ADP-Ribose 1''-Phosphate", "MN": "D08.811.277.352.650.030", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "EC 3.1.3.84", "PI": "Phosphoric Monoester Hydrolases (1995-2020)", "MS": "Enzymes that are highly specific for hydrolysis of the D-ribose 1 phosphate bond of ADP-D-ribose 1''-phosphate to produce ADP-D-ribose and phosphate ion.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086922"}, {"RECTYPE": "D", "MH": "Viral Envelope", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Virus Envelope|T026|NON|EQV|NLM (2021)|200517|abcdef", "ENTRY": "Virus Envelopes", "MN": "A21.249.750", "MH_TH": "NLM (2021)", "ST": "T026", "MS": "Bilayer lipid membrane acquired by VIRAL PARTICLES during VIRAL MORPHOGENESIS. Although the LIPIDS of the viral envelope are host derived, various virus-encoded INTEGRAL MEMBRANE PROTEINS, i.e. VIRAL ENVELOPE PROTEINS are incorporated there.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086942"}, {"RECTYPE": "D", "MH": "Viral Zoonoses", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Zoonotic Viral Infections|T047|NON|EQV|NLM (2021)|200518|abcdef", "ENTRY": "Zoonotic Viral Infection", "MN": "C22.969.500", "MH_TH": "NLM (2021)", "ST": "T047", "AN": "not a routine coordinate for every zoonotic viral infection; index only when discussed; coordinate with specific infection term and with animal disease term if pertinent", "MS": "Viral infections that may be transmitted between non-human animals and HUMANS.", "PM": "2021", "HN": "2021", "MR": "20210510", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086965"}, {"RECTYPE": "D", "MH": "Bacterial Zoonoses", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Zoonotic Spillover, Bacterial|T047|NON|NRW|NLM (2021)|200616|abcdef", "ENTRY": "Zoonotic Spillovers, Bacterial", "MN": "C22.969.250", "MH_TH": "NLM (2021)", "ST": "T047", "AN": "not a routine coordinate for every zoonotic bacterial infection; index only when discussed; coordinate with specific infection term and with animal disease term if pertinent", "MS": "Bacterial infections that may be transmitted between non-human animals and HUMANS.", "PM": "2021", "HN": "2021", "MR": "20210510", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086966"}, {"RECTYPE": "D", "MH": "Host Adaptation", "AQ": "DE GE IM PH RE", "ENTRY": "Adaptation, Host", "MN": "G16.527.200.190", "MH_TH": "NLM (2021)", "ST": "T045", "PI": "Adaptation, Biological (1990-2020)", "MS": "Genetic changes that allow an infectious organism to develop a symbiotic relationship with the organism they infect or jump a species barrier to infect a new host organism.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086967"}, {"RECTYPE": "D", "MH": "Coronavirus Envelope Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Coronavirus Membrane Protein E1|T116|T123|NON|NRW|NLM (2022)|210426|abbcdef", "ENTRY": "Envelope Proteins, Coronavirus", "MN": "D12.776.964.970.880.163", "MH_TH": "NLM (2021)", "ST": "T116", "RN": "0", "MS": "Membrane proteins in the VIRAL ENVELOPE of CORONAVIRUSES.", "PM": "2021", "HN": "2021", "MR": "20210630", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086968"}, {"RECTYPE": "D", "MH": "Viral Replication Compartments", "AQ": "CH CL DE EN IM ME PA PH RE UL", "PRINT ENTRY": "Zippered Endoplasmic Reticulum Double-Membrane Spherules|T026|NON|NRW|NLM (2021)|200527|abcdef", "ENTRY": "Zippered Endoplasmic Reticulum Double Membrane Spherules", "MN": "G06.920.400.500", "FX": "Virus Replication", "MH_TH": "NLM (2021)", "ST": "T026", "MS": "Sites in the host cell where the virus induces the formation of cellular assemblies for the replication of the VIRAL GENOME.", "PM": "2021", "HN": "2021", "MR": "20200811", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086969"}, {"RECTYPE": "D", "MH": "Blood-Borne Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Blood Borne Infections|T047|NON|EQV|NLM (2021)|200519|abcdef", "ENTRY": "Infection, Blood-Borne", "MN": "C23.550.291.531.500", "FX": "Blood-Borne Pathogens", "MH_TH": "NLM (2021)", "ST": "T047", "AN": "general or unspecified; prefer specifics; add as a coordinate with other infection terms when the infection is discussed as blood-borne by the author", "PI": "Communicable Diseases (1997-2020)", "MS": "Diseases due to or propagated by body fluids from hosts whose BLOOD has been contaminated with pathogens.", "PM": "2021", "HN": "2021", "MR": "20200617", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000086982"}, {"RECTYPE": "D", "MH": "Viral Transcription", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Virus Transcription|T045|NON|EQV|NLM (2021)|200526|abcdef", "ENTRY": "Transcription, Virus", "MN": "G02.111.873.875", "FX": "Genes, tat", "MH_TH": "NLM (2021)", "ST": "T045", "PI": "Transcription, Genetic (1972-2020)", "MS": "The biosynthesis of subgenomic viral RNAs, transcribed from the VIRAL GENOME.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000087002"}, {"RECTYPE": "D", "MH": "Identity Recognition", "AQ": "DE ES PH RE", "ENTRY": "Recognition, Identity", "MN": "F02.463.593.524.250", "FX": "Biometric Identification", "MH_TH": "OBSSR (2016)", "ST": "T054", "MS": "Ability to identify another individual by their facial, vocal, and other bodily features or distinguishing characteristics such as BODY HEIGHT; EYE COLOR; a birth mark or TATTOO; or GAIT.", "PM": "2021; see FACIAL RECOGNITION 2016-2020", "HN": "2021; use FACIAL RECOGNITION 2016-2020", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000087023"}, {"RECTYPE": "D", "MH": "Voice Recognition", "AQ": "DE ES PH RE", "PRINT ENTRY": "Voice Identification|T041|NON|REL|NLM (2021)|200528|abcdef", "ENTRY": "Voice Emotion Recognitions", "MN": "G07.888.125.937.500", "FX": "Speech Recognition Software", "MH_TH": "NLM (2021)", "ST": "T041", "MS": "Ability to identify an individual vocal patterns and expressions.", "PM": "2021", "HN": "2021", "MR": "20200622", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000087024"}, {"RECTYPE": "D", "MH": "Pegivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human Pegivirus|T005|NON|NRW|NLM (2021)|200605|abcdef", "ENTRY": "Pegiviruses, Human", "MN": "B04.820.578.344.588", "MH_TH": "NLM (2021)", "ST": "T005", "RN": "txid1307799", "RR": "txid1758225", "AN": "infection: coordinate with FLAVIVIRIDAE INFECTIONS", "PI": "Flaviviridae (1996-2020)", "MS": "A genus of virus in the family FLAVIVIRIDAE. While pegivirus are mostly non-pathogenic, pegivirus coinfections are sometimes associated with NON-HODGKIN LYMPHOMA in human and a viral hepatitis Theiler\u2019s disease in horses.", "PM": "2021", "HN": "2021", "MR": "20210209", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000087082"}, {"RECTYPE": "D", "MH": "Mania", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Manic Episode|T048|NON|NRW|NLM (2021)|200612|abcdef", "ENTRY": "Manic Episodes", "MN": "F01.700.548", "MH_TH": "NLM (1981)", "ST": "T048", "MS": "A state of elevated excitement with over-activity sometimes accompanied with psychotic symptoms (e.g., PSYCHOMOTOR AGITATION, inflated SELF ESTEEM and flight of ideas). It is often associated with mental disorders (e.g., CYCLOTHYMIC DISORDER; and BIPOLAR DISEASES).", "PM": "2021; for MANIA and HYPOMANIA see under BIPOLAR DISEASES 1981-2020", "HN": "2021(1981)", "MR": "20200617", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000087122"}, {"RECTYPE": "D", "MH": "COVID-19 Nucleic Acid Testing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "SARS-CoV2 RT-PCR Testing|T059|T060|ABX|NRW|NLM (2021)|200612|abbcdef", "ENTRY": "Testing, SARS-CoV2 RT-PCR", "MN": "E05.200.312.500", "MH_TH": "NLM (2021)", "ST": "T060", "MS": "Diagnosis of COVID-19 by assaying bodily fluids or tissues for the presence of the VIRAL RNA of SARS-COV-2.", "PM": "2021", "HN": "2021", "MR": "20200617", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000087123"}, {"RECTYPE": "D", "MH": "COVID-19 Serological Testing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Serology Testing for COVID-19|T059|T060|ACX|EQV|NLM (2021)|200612|abbcdef", "ENTRY": "Testing, SARS-COV-2 Antigen", "MN": "E05.478.594.760.258", "MH_TH": "NLM (2021)", "ST": "T060", "MS": "Diagnosis of COVID-19 by assaying bodily fluids or tissues for the presence antibodies specific to SARS-COV-2 or its antigens.", "PM": "2021", "HN": "2021", "MR": "20200618", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000087124"}, {"RECTYPE": "D", "MH": "N95 Respirators", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "N95 Masks|T074|NON|EQV|NLM (2021)|200619|abcdef", "ENTRY": "Respirator, N95", "MN": "J01.637.708.560.937.500", "MH_TH": "NLM (2021)", "ST": "T074", "PI": "Respiratory Protective Devices (2000-2020)", "MS": "Respiratory protective devices designed to achieve a close seal around the nose and mouth to maintain efficient filtration of aerosolized particles and droplets. They are often fitted for the prevention of the spread of infections (e.g. COVID19) or to administer inhaled anesthetics or other gases.", "PM": "2021", "HN": "2021", "MR": "20220714", "DA": "20200707", "DC": "1", "DX": "20210101", "UI": "D000087162"}, {"RECTYPE": "D", "MH": "Pseudoscience", "ENTRY": "Pseudosciences", "MN": "I01.880.735.646", "MH_TH": "NLM (2021)", "ST": "T078", "MS": "System of theories, assumptions, and methods erroneously regarded as based on science.", "PM": "2021", "HN": "2021", "MR": "20200708", "DA": "20200709", "DC": "1", "DX": "20210101", "UI": "D000087222"}, {"RECTYPE": "D", "MH": "Bias, Implicit", "PRINT ENTRY": "Unconscious Bias|T041|NON|EQV|NLM (2022)|200810|abcdef", "ENTRY": "Bias, Unconscious", "MN": "F01.829.595.312", "MH_TH": "NLM (2022)", "ST": "T041", "PI": "Prejudice (2017-2021)", "MS": "The attitudes or stereotypes that affect understanding, actions, and decisions in an unconscious manner. These biases which include favorable and unfavorable assessments, are activated involuntarily without individual's intentional control. (from https://www.jointcommission.org/-/media/deprecated-unorganized/imported-assets/tjc/system-folders/joint-commission-online/quick_safety_issue_23_apr_2016pdf.pdf?db=web&hash=A5852411BCA02D1A918284EBAA775988)", "PM": "2022", "HN": "2022", "MR": "20210115", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087302"}, {"RECTYPE": "D", "MH": "Self-Compassion", "PRINT ENTRY": "Self-Forgiveness|T041|NON|NRW|NLM (2022)|201223|abcdef", "ENTRY": "Self Forgiveness", "MN": "F02.463.551.500", "MH_TH": "NLM (2022)", "ST": "T041", "PI": "Mindfulness (2021)", "MS": "Being kind and understanding toward oneself in times of pain or failure, perceiving one's own suffering as part of a larger human experience, and holding painful feelings and thoughts in mindful awareness. (from Rev General Psychology, 15(4), 289\u2013303. https://doi.org/10.1037/a0025754 accessed 8/11/2020)", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087342"}, {"RECTYPE": "D", "MH": "Sluggish Cognitive Tempo", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Sluggish Cognitive Tempos", "MN": "F03.625.094.650", "MH_TH": "NLM (2022)", "ST": "T048", "PI": "Attention Deficit and Disruptive Behavior Disorders  (2010-2021)", "MS": "Defined by a constellation of caregiver-reported symptoms that includes daydreaming, difficulty initiating and sustaining effort, lethargy, and physical underactivity. These symptoms have been observed in both typically developing children and in some children with Attention-Deficit/Hyperactivity Disorder (ADHD), especially those with the predominantly inattentive presentation. (J Abnormal Child Psychology; 46: Jan 2018.127). .", "PM": "2022", "HN": "2022", "MR": "20210118", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087346"}, {"RECTYPE": "D", "MH": "Information Avoidance", "PRINT ENTRY": "Information Denial|T041|NON|REL|NLM (2022)|200811|abcdef", "ENTRY": "Denial, Information", "MN": "F01.393.537", "FX": "Avoidance Learning", "MH_TH": "NLM (2022)", "ST": "T041", "MS": "Choosing to not obtain knowledge even if having the information could be to one's benefit.", "PM": "2022", "HN": "2022", "MR": "20210118", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087366"}, {"RECTYPE": "D", "MH": "Rugby", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Rugby, Union Play|T056|NON|EQV|NLM (2022)|210118|abcdef", "ENTRY": "Union Play Rugby", "MN": "I03.450.642.845.608", "MH_TH": "NLM (1990)", "ST": "T056", "MS": "Team sport game played on a rectangular field with an oval ball by two teams of 15 players (in Rugby Union Play) or 13 players (in Rugby League Play).", "PM": "2022; see FOOTBALL 1990-2021", "HN": "2022(1990)", "MR": "20210118", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087402"}, {"RECTYPE": "D", "MH": "Three Finger Toxins", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tschuditoxin-l|T123|NON|NRW|NLM (2022)|200916|abcdef", "ENTRY": "Tschuditoxin l", "MN": "D23.946.833.850.325.600", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "PI": "Elapid Venoms (1997-2021)", "MS": "A super-family of non-enzymatic proteins found in ELAPIDAE VENOMS. They possess a unique tertiary structure resembling a hand with three fingers and have diverse biological activities due to sequence and structural variations; some are ALPHA-NEUROTOXINS that bind NICOTINIC ACETYLCHOLINE RECEPTORS.", "PM": "2022", "HN": "2022", "MR": "20220429", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087443"}, {"RECTYPE": "D", "MH": "Citizenship", "PRINT ENTRY": "Naturalization|T064|NON|NRW|NLM (2022)|201222|abcdef", "ENTRY": "Naturalizations", "MN": "N03.706.437.326", "MH_TH": "NLM (2022)", "ST": "T064", "MS": "Status of a person recognized under the law of a sovereign nation as a member of or belonging to that nation.", "PM": "2022", "HN": "2022", "MR": "20210115", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087482"}, {"RECTYPE": "D", "MH": "Brain-Gut Axis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Microbiota-Gut-Brain Axis|T022|NON|REL|NLM (2022)|200909|abcdef", "ENTRY": "Microbiota Gut Brain Axis", "MN": "G11.561.138", "FX": "Gastrointestinal Microbiome", "MH_TH": "NLM (2022)", "ST": "T022", "PI": "Gastrointestinal Tract (2003-2021)", "MS": "An interactive network between the GASTROINTESTINAL TRACT (gut) and the brain principally mediated through the ENTERIC NERVOUS SYSTEM. Control of the gut activities during stress, for instance, is mediated by activation of neuroendocrine hormones (e.g., CORTICOTROPIN-RELEASING FACTOR). Conversely, INTESTINAL MICROBIOTA associate with the CENTRAL NERVOUS SYSTEM through the axis via microorganism-derived products (e.g., UROCORTINS). Some functional GASTROINTESTINAL DISORDERS (e.g., IRRITABLE BOWEL SYNDROME) have dysregulated brain-gut axis.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087502"}, {"RECTYPE": "D", "MH": "mRNA Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "taRNA Vaccine|T114|NON|NRW|NLM (2024)|230203|abcdef", "ENTRY": "Vaccines, RNA", "MN": "D23.050.865.450.500", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Vaccines, DNA (2001-2021)", "MS": "Vaccines formulated with recombinant mRNAs which are taken up by the host cells that translate the mRNA and present the translated proteins to the immune system as antigens in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigen.", "PM": "2022", "HN": "2022", "MR": "20230516", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087503"}, {"RECTYPE": "D", "MH": "Nucleic Acid-Based Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polynucleotide Vaccines|T114|T121|T129|NON|BRD|NLM (1997)|960307|abbbcdef", "ENTRY": "Vaccines, Polynucleotide", "MN": "D23.050.865.450", "MH_TH": "NLM (2022)", "ST": "T129", "RN": "0", "MS": "Vaccines formulated with nucleic acids specific for a target antigen. They are designed to induce antibody production against the target by host.", "PM": "2022; for NUCLEIC ACID VACCINES and POLYNUCLEOTIDE VACCINES see VACCINES, DNA 1997-2021", "HN": "2022(1997)", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087504"}, {"RECTYPE": "D", "MH": "Diaschisis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Focal Diaschisis|T047|NON|NRW|NLM (2022)|200909|abcdef", "ENTRY": "Diaschisis, Focal", "MN": "C10.228.140.390", "MH_TH": "NLM (2022)", "ST": "T047", "PI": "Cerebellar Diseases (1984-2021)", "MS": "Loss or decreased brain function within intact region of the brain distant from the site of the lesion.", "PM": "2022", "HN": "2022", "MR": "20210305", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087505"}, {"RECTYPE": "D", "MH": "Vaccine Development", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Development, Vaccine", "MN": "E05.952", "MH_TH": "NLM (2022)", "ST": "T062", "PI": "Drug Development (1986-2021)", "MS": "The entire process of introducing a new vaccine for use in VACCINATION including pre-clinical development, testing in CONTROLLED CLINICAL TRIAL, manufacturing, approval/licensing and distribution.", "PM": "2022", "HN": "2022", "MR": "20210305", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087506"}, {"RECTYPE": "D", "MH": "Vaccine Efficacy", "AQ": "SN", "PRINT ENTRY": "Vaccine Effectiveness|T081|NON|REL|NLM (2022)|200909|abcdef", "ENTRY": "Efficacy, Vaccine", "MN": "E05.952.500", "MH_TH": "NLM (2022)", "ST": "T081", "PI": "Vaccines (1966-2021)", "MS": "A measurement of disease risk reduction among vaccinated compared to unvaccinated persons under ideal conditions such as in a clinical trial. Such disease reduction measured under typical field conditions is vaccine effectiveness. In contrast vaccine potency is measured in an assay to ensure proper dosing and storage of vaccines whereas vaccine immunogenicity measures its ability to induce an immune response in a vaccinated individual in observational studies.", "PM": "2022", "HN": "2022", "MR": "20210305", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087507"}, {"RECTYPE": "D", "MH": "Healthy Life Expectancy", "AQ": "EH HI TD", "PRINT ENTRY": "Health-Adjusted Life Years|T081|NON|REL|NLM (2022)|200909|abcdef", "ENTRY": "Life Year, Health-Adjusted", "MN": "N06.850.520.308.985.450.500", "MH_TH": "NLM (2022)", "ST": "T081", "PI": "Life Expectancy (1991-2021)", "MS": "The expected number of remaining years of life spent in good health from a particular age, assuming current rates of mortality and morbidity.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087508"}, {"RECTYPE": "D", "MH": "Disability-Adjusted Life Years", "AQ": "EH HI TD", "PRINT ENTRY": "Years Lived With Disability|T081|NON|NRW|NLM (2022)|200909|abcdef", "ENTRY": "Life Years, Disability-Adjusted", "MN": "N06.850.520.308.985.450.250", "MH_TH": "NLM (2022)", "ST": "T081", "PI": "Life Expectancy (1996-2021)", "MS": "It is the sum of years of life lost due to PREMATURE MORTALITY and the number of years lived with disability, due to disease or health condition in a population. This is a measurement of BURDEN OF DISEASE.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087509"}, {"RECTYPE": "D", "MH": "Artificial Virus-Like Particles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Artificial Virus|T017|NON|EQV|NLM (2022)|200909|abcdef", "ENTRY": "Virus-Like Particles, Artificial", "MN": "A21.063", "MH_TH": "NLM (2022)", "ST": "T017", "PI": "Virion (1975-2021)", "MS": "Artificially prepared viral sub-particles devoid of viral genetic material. They are often formed by self-assembly of exogenously expressed viral proteins and are often used for a vaccine development, cell expression and bioprocessing platforms.", "PM": "2022", "HN": "2022", "MR": "20210305", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087511"}, {"RECTYPE": "D", "MH": "Cyanobacteria Toxins", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyanotoxins|T123|T131|NON|EQV|NLM (2022)|200910|abbcdef", "ENTRY": "Neurotoxin, Cyanobacterial", "MN": "D23.946.123.257", "FX": "Toxoids", "MH_TH": "NLM (2022)", "ST": "T131", "RN": "0", "PI": "Toxins, Biological (1992-2021)", "MS": "Toxic secondary metabolites produced CYANOBACTERIA.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087522"}, {"RECTYPE": "D", "MH": "Endotoxin Tolerance", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Endotoxin Desensitization|T040|NON|EQV|NLM (2022)|200910|abcdef", "ENTRY": "Tolerance, Endotoxin", "MN": "G12.535.425.290", "MH_TH": "NLM (2022)", "ST": "T040", "PI": "Immune Tolerance (1963-2021)", "MS": "Reduced capacity to respond to subsequent ENDOTOXIN challenges after an initial exposure. It is characterized by reduced responsiveness of INNATE IMMUNE RESPONSES, a shift from pro- to anti-inflammatory cell phenotype and impaired ANTIGEN PRESENTATION.", "PM": "2022", "HN": "2022", "MR": "20220429", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087523"}, {"RECTYPE": "D", "MH": "Radiation Fibrosis Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Radiation-Induced Fibrosis|T037|T047|NON|EQV|NLM (2022)|200910|abbcdef", "ENTRY": "Radiation Induced Fibrosis", "MN": "N06.850.810.300.360.222", "MH_TH": "NLM (2022)", "ST": "T047", "PI": "Radiation Pneumonitis (2013-2021)", "MS": "Radiation-induced fibrosis due to increased production of FIBRIN. Its symptoms include CERVICAL DYSTONIA, difficulty with speech and swallowing, swelling in the radiation field and TRISMUS.", "PM": "2022; see RADIATION PNEUMONITIS 1994-2021", "HN": "2022(1994)", "MR": "20210305", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087525"}, {"RECTYPE": "D", "MH": "Umbilical Cord Clamping", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Umbilical Cord Milking|T061|NON|REL|NLM (2022)|200910|abcdef", "ENTRY": "Transfusion, Placental", "MN": "E04.520.252.980", "MH_TH": "NLM (2022)", "ST": "T061", "PI": "Umbilical Cord (1988-2021)", "MS": "Method of placing clamps on the UMBILICAL CORD before cutting after birth.", "PM": "2022", "HN": "2022", "MR": "20210514", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087526"}, {"RECTYPE": "D", "MH": "Uremic Toxins", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uremic Retention Solutes|T131|NON|NRW|NLM (2022)|200910|abcdef", "MN": "D23.946.710", "MH_TH": "NLM (2022)", "ST": "T131", "RN": "0", "PI": "Uremia (1970-2021)", "MS": "Biological solutes retained and accumulated due to kidney impairment that contribute to uremia/chronic kidney disease.", "PM": "2022", "HN": "2022", "MR": "20210305", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087527"}, {"RECTYPE": "D", "MH": "Anthropogenic Effects", "PRINT ENTRY": "Human Impacts|T068|NON|EQV|NLM (2022)|201216|abcdef", "ENTRY": "Stressors, Anthropogenic", "MN": "G16.500.075", "MH_TH": "NLM (2022)", "ST": "T068", "MS": "Environmental alterations resulting from human activities.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087602"}, {"RECTYPE": "D", "MH": "Cell Culture Techniques, Three Dimensional", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Three-Dimensional Cell Culture|T059|NON|EQV|NLM (2023)|220408|abcdef", "ENTRY": "Three-Dimensional Cell Cultures", "MN": "E05.481.500.249.312", "MH_TH": "NLM (2022)", "ST": "T059", "PI": "Cell Culture Techniques (2005-2021)", "MS": "Methods for growing cells in a way that they form three-dimensional shapes, such as on a three-dimensionally shaped substrate or as free-falling aggregates in stirred liquids.", "PM": "2022", "HN": "2022", "MR": "20220408", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087603"}, {"RECTYPE": "D", "MH": "Insular Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Visceral Cortex|T023|NON|REL|NLM (2022)|201007|abcdef", "ENTRY": "Visceral Cortices", "MN": "A08.186.211.200.885.287.500.364", "MH_TH": "NLM (2015)", "ST": "T023", "MS": "A pyramidal shaped region of cerebral cortex located deep below the lateral fissure in PRIMATES. It is surrounded by the SUPERIOR TEMPORAL GYRUS, the rostral PARIETAL LOBE, the INFERIOR FRONTAL GYRUS and the ORBITAL GYRI. It is the primary gustatory cortex and is involved in sensorimotor and somatosensory as well as socioemotional functions.", "PM": "2022; see CEREBRAL CORTEX 1979-2021", "HN": "2022(1979)", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087623"}, {"RECTYPE": "D", "MH": "Primary Visual Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Visual Cortex V1|T023|NON|EQV|NLM (2022)|201007|abcdef", "ENTRY": "Visual Cortex, Primary", "MN": "A08.186.211.200.885.287.500.814.953.500", "MH_TH": "NLM (2015)", "ST": "T023", "AN": "do not confuse entry term STRIATE CORTEX with CORPUS STRIATUM (basal ganglia)", "MS": "An area comprised of parts of OCCIPITAL LOBE and the CALCARINE SULCUS of the visual cortex in humans with direct connectivity to the LATERAL GENICULATE NUCLEUS. It is the end organ where visual stimuli are received in the visual cortex.", "PM": "2022; see VISUAL CORTEX 1979-2021", "HN": "2022(1979)", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087642"}, {"RECTYPE": "D", "MH": "Dorsolateral Prefrontal Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "DLPFC|T023|ABB|EQV|NLM (2022)|201007|abcdef", "ENTRY": "Dorsolateral Prefrontal Cortices", "MN": "A08.186.211.200.885.287.500.270.700.750", "MH_TH": "NLM (2016)", "ST": "T023", "MS": "The upper surfaces of the prefrontal cortex comprising the rostral parts of the superior frontal gyrus and the middle frontal gyrus. It is involved in EXECUTIVE FUNCTION.", "PM": "2022; see PREFRONTAL CORTEX 2016-2021", "HN": "2022(2016)", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087643"}, {"RECTYPE": "D", "MH": "Centenarians", "AQ": "PH PX SN", "PRINT ENTRY": "Supercentenarians|T100|NON|REL|NLM (2024)|220922|abcdef", "ENTRY": "Supercentenarian", "MN": "M01.060.116.100.080.500", "MH_TH": "UNK (19XX)", "ST": "T100", "PI": "Aged (1987-2021)", "MS": "Persons 100 years of age and older.", "PM": "2022; see AGED, 80 AND OVER 1987-2020; see CENTENARIANS, NONAGENARIAN, AND OCTOGENARIAN 1987-95", "HN": "2022(1987)", "MR": "20230531", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087662"}, {"RECTYPE": "D", "MH": "Octogenarians", "AQ": "PH PX SN", "ENTRY": "Octogenarian", "MN": "M01.060.116.100.080.750", "MH_TH": "UNK (19XX)", "ST": "T100", "MS": "Persons 80 to 89 years of age.", "PM": "2022; OCTOGENARIANS was CENTENARIAN, NONAGENARIAN, & OCTOGENARIAN 1987-95, was AGED, 80 AND OVER 1987-2020", "HN": "2022; OCTOGENARIANS was CENTENARIAN, NONAGENARIAN, & OCTOGENARIAN 1987-95, was AGED, 80 AND OVER 1987-2020", "MR": "20210115", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087742"}, {"RECTYPE": "D", "MH": "Disinformation", "PRINT ENTRY": "Fake News|T170|NON|EQV|NLM (2022)|210126|abcdef", "ENTRY": "News, Fake", "MN": "L01.143.790.500", "MH_TH": "NLM (2022)", "ST": "T170", "MS": "False information deliberately and often covertly spread in order to influence public opinion or obscure the truth. (https://www.merriam-webster.com/dictionary/disinformation)", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087862"}, {"RECTYPE": "D", "MH": "Video-Assisted Techniques and Procedures", "PRINT ENTRY": "Video Assisted Techniques|T061|NON|EQV|NLM (2022)|210119|abcdef", "ENTRY": "Video Assisted Techniques and Procedures", "MN": "E05.956", "MH_TH": "NLM (2022)", "ST": "T061", "MS": "Techniques or procedures performed with visualization via video transmission.", "PM": "2022", "HN": "2022", "MR": "20210119", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087882"}, {"RECTYPE": "D", "MH": "Sound Recordings", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "PRINT ENTRY": "Sound Recording|T066|NON|EQV|NLM (2022)|201027|abcdef", "ENTRY": "Recording, Sound", "MN": "L01.462.500.820.090.793", "MH_TH": "NLM (2022)", "ST": "T066", "MS": "The storing of sound signals on various media such as cylinders, analog discs, digital discs, tapes, and wires.[LCSH, 10/27/2020]", "PM": "2022", "HN": "2022", "MR": "20220426", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000087983"}, {"RECTYPE": "D", "MH": "Mentalization-Based Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Mentalization-Based Treatment|T061|NON|EQV|NLM (2022)|201118|abcdef", "ENTRY": "Treatments, Mentalization-Based", "MN": "F04.754.539", "MH_TH": "NLM (2022)", "ST": "T061", "PI": "Mentalization (2019-2021)", "MS": "Mentalization-based therapy (MBT) is a type of long-term psychotherapy that is based on the use of MENTALIZATION.", "PM": "Mentalization 2019-2021", "HN": "Mentalization 2019-2021", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088042"}, {"RECTYPE": "D", "MH": "Candida auris", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "C auris|T004|NON|EQV|NLM (2024)|230331|abcdef", "MN": "B01.300.107.795.095.363", "MH_TH": "NLM (2018)", "ST": "T004", "RN": "txid498019", "AN": "infection: coordinate with CANDIDIASIS or its indentions", "MS": "A species of yeast in genus Candida. C. auris infection is most often associated with immunocompromised patients in healthcare settings. INVASIVE CANDIDIASIS and colonization pose a treatment challenge when multidrug resistant strains are involved.", "PM": "2022; see CANDIDA 2018-2021", "HN": "2022(2018)", "MR": "20230530", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088063"}, {"RECTYPE": "D", "MH": "Elite Controllers", "AQ": "CL HI LJ PX SN", "PRINT ENTRY": "Viremic Controllers|T101|NON|EQV|NLM (2022)|201130|abcdef", "ENTRY": "Viremic Controller", "MN": "M01.860.375", "FX": "Asymptomatic Diseases", "MH_TH": "NLM (2022)", "ST": "T101", "PI": "HIV Long-Term Survivors (2009-2021)", "MS": "Infected individuals with naturally low levels of pathogen replication (e.g., HIV LONG-TERM SURVIVORS with low VIRAL LOAD of HIV) and remain healthy. Some elite controllers have immune systems which prevent disease progression (e.g., high CD4 COUNTS). Studies of how they remain disease-free may contribute to development of new therapeutic approaches and targets.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088064"}, {"RECTYPE": "D", "MH": "Fermented Beverages", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Pulque|T168|NON|NRW|NLM (2022)|201120|abcdef", "ENTRY": "Pulques", "MN": "J02.350.594", "MH_TH": "NLM (2020)", "ST": "T168", "PI": "Beverages (1986-2021)", "MS": "Beverages that are prepared by using microorganisms to convert their components into various FERMENTATION end products.", "PM": "2022; see FERMENTED FOODS AND BEVERAGES 2020-2021", "HN": "2022; use FERMENTED FOODS AND BEVERAGES 2020-2021", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088082"}, {"RECTYPE": "D", "MH": "Orthorexia Nervosa", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Orthorexia|T048|NON|EQV|NLM (2022)|201123|abcdef", "ENTRY": "Nervosa, Orthorexia", "MN": "F03.400.860", "FX": "Diet, Healthy", "MH_TH": "NLM (2022)", "ST": "T048", "PI": "Feeding and Eating Disorders (2004-2021)", "MS": "An eating disorder that is characterized by the pathological obsession with HEALTHY EATING.", "PM": "2022", "HN": "2022", "MR": "20210305", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088102"}, {"RECTYPE": "D", "MH": "Ex utero Intrapartum Treatment Procedures", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ex-utero Intrapartum Treatment Procedures|T061|NON|EQV|NLM (2022)|210701|abcdef", "ENTRY": "Procedure, EXIT-to-Resection", "MN": "E04.520.252.500.575", "MH_TH": "NLM (2022)", "ST": "T061", "PI": "Fetal Therapies (2005-2021)", "MS": "Prenatal interventions to manage fetal anomalies or FETAL DISEASES ex utero while maintaining the uteroplacental circulation during obstetric delivery. EXIT procedures are divided into EXIT-to-airway; EXIT-to-ECMO; and EXIT-to-resection.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088103"}, {"RECTYPE": "D", "MH": "Cytoplasmic Ribonucleoprotein Granules", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Ribonucleoprotein Granules|T026|NON|EQV|NLM (2022)|201123|abcdef", "ENTRY": "Ribonucleoprotein Granules, Neuronal", "MN": "A11.284.430.214.190.875.190.190.384", "MH_TH": "NLM (2022)", "ST": "T026", "PI": "Cytoplasmic Granules (1967-2021)", "MS": "Non-membranous subcompartments containing RIBONUCLEOPROTEIN complexes. They are found in the CYTOPLASM and often share multiple protein and/or RNA components. Membraneless RNP subcompartments found in the nucleus are referred to as nuclear bodies (e.g., PARASPECKLES).", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088123"}, {"RECTYPE": "D", "MH": "Processing Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "P-Bodies|T026|ABX|EQV|NLM (2022)|201123|abcdef", "ENTRY": "Processing Body", "MN": "A11.284.430.214.190.875.190.190.384.500", "MH_TH": "NLM (2022)", "ST": "T026", "PI": "Cytoplasmic Granules (2005-2021)", "MS": "Cytoplasmic RNP granules constitutively found in eukaryotic cells. Various proteins related to RNA regulation including RNA decay are found in P-bodies. P-bodies and STRESS GRANULES both sequester inactive mRNPs via different pathways. In P-bodies mRNAs from the stalled translational machinery are deadenylated and condensed for sequestration.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088142"}, {"RECTYPE": "D", "MH": "Stress Granules", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Stress Granule", "MN": "A11.284.430.214.190.875.190.190.384.750", "MH_TH": "NLM (2022)", "ST": "T026", "PI": "Cytoplasmic Granules (2011-2021)", "MS": "Cytoplasmic granules composed of RIBONUCLEOPROTEINS which form only when stress-activated pathways stall translation initiation. Stress granules and processing bodies both sequester inactive mRNPs. Stress granules clear mRNPs through autophagy and may interact with P-BODIES.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088162"}, {"RECTYPE": "D", "MH": "Promyelocytic Leukemia Nuclear Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Promyelocytic Leukemia Protein Body|T026|NON|EQV|NLM (2022)|201124|abcdef", "ENTRY": "PML Nuclear Body", "MN": "A11.284.430.106.279.345.574.875", "MH_TH": "NLM (2022)", "ST": "T026", "PI": "Promyelocytic Leukemia Protein (2008-2021)", "MS": "Spherical intranuclear membraneless bodies nucleated by PROMYELOCYTIC LEUKEMIA PROTEIN and various other proteins containing small ubiquitin-related modifier (SUMO) interaction motif (SIM) and/or sumoylated proteins (e.g., Sp100 protein). Promyelocytic leukemia nuclear bodies regulate posttranslational modifications of partner proteins (e.g., SUMOYLATION) which in turn lead to modulation of various biological processes.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088182"}, {"RECTYPE": "D", "MH": "Nuclear Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Transcriptional Droplets|T026|NON|BRD|NLM (2022)|210524|abcdef", "ENTRY": "Transcriptional Droplet", "MN": "A11.284.430.106.279.345.574", "MH_TH": "NLM (2022)", "ST": "T026", "PI": "Cell Nucleus (1973-2021)", "MS": "Dynamic intranucleoplasmic membraneless structures which concentrate various nuclear factors.  Nuclear bodies exchange components with NUCLEOPLASM and participate in various RNA metabolisms unlike nuclear INCLUSION BODIES which aggregate most often foreign or inactive pathological biomolecules.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088202"}, {"RECTYPE": "D", "MH": "Nuclear Speckles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Splicing Speckles|T026|NON|EQV|NLM (2022)|201124|abcdef", "ENTRY": "Splicing Speckle", "MN": "A11.284.430.106.279.345.574.813", "MH_TH": "NLM (2022)", "ST": "T026", "PI": "Cell Nucleus (2002-2021)", "MS": "Membraneless intranucleoplasmic subcompartments or nuclear domains in which proteins related to RNA metabolism (e.g., SPLICING FACTORS) are dynamically localized.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088203"}, {"RECTYPE": "D", "MH": "Paraspeckles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Paraspeckle", "MN": "A11.284.430.106.279.345.574.844", "MH_TH": "NLM (2022)", "ST": "T026", "PI": "RNA, Long Noncoding (2017-2021)", "MS": "Nuclear bodies in which architectural LONG NCRNAS (e.g., NEAT1) sequester various regulatory proteins regulating gene expression including RNA modification (e.g., A-to-I RNA EDITING) and MICRORNAS maturation.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088242"}, {"RECTYPE": "D", "MH": "Germ Cell Ribonucleoprotein Granules", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Z-Granules|T026|NON|NRW|NLM (2022)|201125|abcdef", "ENTRY": "Z-Granule, Germline", "MN": "A11.284.430.214.190.875.190.190.384.250", "MH_TH": "NLM (2022)", "ST": "T026", "PI": "Germ Cells (1996-2021)", "MS": "Cytoplasmic structures organized by RIBONUCLEOPROTEINS involved in RNA regulation in GERM CELLS.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088262"}, {"RECTYPE": "D", "MH": "Mandibular Canal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Trifid Mandibular Canals|T030|NON|NRW|NLM (2022)|201125|abcdef", "ENTRY": "Trifid Mandibular Canal", "MN": "A02.835.232.781.324.502.632.365", "MH_TH": "NLM (2022)", "ST": "T030", "PI": "Mandible (1983-2021)", "MS": "Internal aspect of the mandible from the MENTAL FORAMEN to the mandibular foramen which serves as the conduit for the INFERIOR ALVEOLAR NERVE and the inferior alveolar artery and vein. Bifid and trifid mandibular canals are normal anatomical variants.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088263"}, {"RECTYPE": "D", "MH": "Corticobasal Degeneration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Corticobasal Syndrome|T047|NON|EQV|NLM (2022)|201125|abcdef", "ENTRY": "Cortico basal Ganglionic Degeneration", "MN": "C10.574.945.312", "MH_TH": "NLM (2022)", "ST": "T047", "PI": "Neurodegenerative Diseases (1994-2021)", "MS": "Rare progressive neurological disorder characterized by Parkinsonism, cortical atrophy of multiple areas of the brain including the cerebral cortex and the basal ganglia, cognitive dysfunction and eye movement abnormalities.", "PM": "2022", "HN": "2022", "MR": "20210305", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088282"}, {"RECTYPE": "D", "MH": "HIV Non-Progressors", "AQ": "CL HI LJ PX SN", "PRINT ENTRY": "HIV-1 Long-Term Nonprogressors|T101|ABX|NRW|NLM (2022)|201130|abcdef", "ENTRY": "Viremic Controllers, HIV", "MN": "M01.860.400.500", "MH_TH": "NLM (1999)", "ST": "T101", "MS": "HIV-positive individuals with low VIRAL LOAD of HIV who never develop AIDS even without antiviral treatment.", "PM": "2022; see HIV LONG_TERM SURVIVORS 1999-2021", "HN": "2022(1999)", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088302"}, {"RECTYPE": "D", "MH": "Vascular Depression", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subcortical Ischemic Depression|T047|NON|EQV|NLM (2022)|201130|abcdef", "ENTRY": "Depression, Vascular", "MN": "F03.600.300.887", "MH_TH": "NLM (2022)", "ST": "T047", "PI": "Depressive Disorder (2009-2021)", "MS": "Late-life depression associated with clinical or MRI defined cerebrovascular pathology.", "PM": "2022", "HN": "2022", "MR": "20210514", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088323"}, {"RECTYPE": "D", "MH": "Aerosolized Particles and Droplets", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Spray Aerosol|T167|NON|NRW|NLM (2022)|201202|abcdef", "ENTRY": "Nuclei, Droplet", "MN": "D20.065", "FX": "Aerosols", "MH_TH": "NLM (2022)", "ST": "T167", "RN": "0", "PI": "Aerosols (1963-2021)", "MS": "A suspension of tiny particles or liquid droplets (< 5-10 microns) in the air. They sometimes cause adverse health effects when inhaled or absorbed.", "PM": "2022", "HN": "2022", "MR": "20210305", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088342"}, {"RECTYPE": "D", "MH": "Respiratory Aerosols and Droplets", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Respiratory Droplets and Aerosols|T031|NON|EQV|NLM (2022)|201202|abcdef", "ENTRY": "Nucleus, Expiratory Droplet", "MN": "A12.207.876", "MH_TH": "NLM (2022)", "ST": "T031", "PI": "Aerosols (1966-2021)", "MS": "Physiological aerosols and droplets expelled during coughing, sneezing, speaking and exhalation. Depending on the size, aerodynamic distribution or concentration they may play a role in transmission of infectious respiratory diseases.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088343"}, {"RECTYPE": "D", "MH": "Opsonization", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Opsonophagocytosis|T043|NON|REL|NLM (2022)|210514|abcdef", "ENTRY": "Opsonophagocytoses", "MN": "G12.688.750", "FX": "Opsonin Proteins", "MH_TH": "NLM (2022)", "ST": "T043", "PI": "Phagocytosis (1982-2021)", "MS": "The process of recognizing and targeting particles by binding with OPSONINS (e.g., IgM, C1 and IgG) for phagocytosis or for antibody-dependent cell cytotoxicity.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088362"}, {"RECTYPE": "D", "MH": "Trogocytosis", "AQ": "DE GE IM PH RE", "ENTRY": "Trogocytoses", "MN": "G12.888", "MH_TH": "NLM (2022)", "ST": "T043", "PI": "Phagocytosis (2010-2021)", "MS": "Process in which parts of target cell membrane is actively chopped up or gnawed and transferred to monocytes. Although similar to PHAGOCYTOSIS it does not involve engulfing.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088383"}, {"RECTYPE": "D", "MH": "MINOCA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myocardial Infarction with Nonobstructive Coronary Arteries|T047|NON|EQV|NLM (2022)|201207|abcdef", "ENTRY": "Myocardial Infarction with Non obstructive Coronary Arteries", "MN": "C23.550.717.489.750.328", "MH_TH": "NLM (2022)", "ST": "T047", "PI": "Myocardial Infarction (2020-2021)", "MS": "Myocardial infarction in the absence of obstructive coronary artery disease. CORONARY CIRCULATION disruption is due to various other factors such as ATHEROSCLEROTIC PLAQUE and CORONARY VASOSPASM.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088442"}, {"RECTYPE": "D", "MH": "Microneme", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Sarconeme|T026|NON|EQV|NLM (2022)|201207|abcdef", "ENTRY": "Sarconemes", "MN": "A11.284.430.214.190.875.190.880.810.500", "MH_TH": "NLM (2022)", "ST": "T026", "PI": "Toxoplasma (2005-2021)", "MS": "Secretory organelle in the apical complex of parasitic phylum APICOMPLEXA (e.g., TOXOPLASMA GONDII). Microneme plays a role in junction formation between the parasite and the host cell by releasing micronemal proteins, which bind to receptors on the host cell surface enabling parasite attachment.", "PM": "2022", "HN": "2022", "MR": "20210305", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088462"}, {"RECTYPE": "D", "MH": "Dense Core Vesicles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Small Dense-Core Vesicles|T026|NON|NRW|NLM (2022)|201208|abcdef", "ENTRY": "Vesicle, Large Dense-Core", "MN": "A11.284.430.214.190.875.190.880.810.250", "MH_TH": "NLM (2001)", "ST": "T026", "MS": "Membrane-bound electron-dense organelles, 50\u2013200 nm in size found in neurons and endocrine cells.  Dense core vesicles package cargo molecules (NEUROPEPTIDES; NEUROTRANSMITTERS and MiRNAs) in a granular internal matrix. Neuronal dense core vesicles release their cargo content by EXOCYTOSIS.", "PM": "2022; see SECRETORY VESICLES 2001-2021", "HN": "2022(2001)", "MR": "20210804", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088482"}, {"RECTYPE": "D", "MH": "Lamellar Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Odland Bodies|T026|EPO|EQV|NLM (2022)|201208|abcdef", "ENTRY": "Membrane-Coating Granule", "MN": "A11.284.430.214.190.875.190.880.810.375", "MH_TH": "NLM (2022)", "ST": "T026", "MS": "Endolysosomal organelles surrounded by multi-lamellar MEMBRANE LIPIDS. They are involved in diverse functions in storage and secretion of cellular LIPIDS. Lamellar bodies in the TYPE 2 PNEUMOCYTES produce and secrete PULMONARY SURFACTANT (e.g., DIPALMITOYL PHOSPHATIDYLCHOLINE). Lamellar bodies in the skin produce and secrete neutral lipids to provide hydrophobic barrier. Pathological accumulation of lamellar bodies are also known in lipid storage diseases (e.g.,LCAT DEFICIENCY;  and HERMANSKY-PUDLAK SYNDROME).", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088502"}, {"RECTYPE": "D", "MH": "Overdiagnosis", "AQ": "EC LJ PC SN TD", "PRINT ENTRY": "Pseudodisease, Overdiagnosed|T058|NON|EQV|NLM (2022)|210507|abcdef", "ENTRY": "Pseudodiseases, Overdiagnosed", "MN": "N05.300.565", "FX": "Medicalization", "MH_TH": "NLM (2016)", "ST": "T058", "MS": "The labeling of a person with a disease or abnormal condition that would not have caused the person harm if left undiscovered, creating new diagnoses by medicalizing ordinary life experiences, or expanding existing diagnoses by lowering thresholds or widening criteria without evidence of improved outcomes. Individuals derive no clinical benefit from overdiagnosis although they may experience physical, psychological or financial harm.", "PM": "2022; see MEDICAL OVERUSE 2016-2021", "HN": "2022(2016)", "MR": "20221215", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088522"}, {"RECTYPE": "D", "MH": "Anticoagulation Reversal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Reversal of Anticoagulation|T061|NON|EQV|NLM (2022)|201216|abcdef", "ENTRY": "Reversals, Anticoagulation", "MN": "E02.520.045", "MH_TH": "NLM (2022)", "ST": "T061", "PI": "Hemorrhage/drug therapy (2008-2021)", "MS": "Treatment strategies used to manage bleeding events that occur during the use of ANTICOAGULANTS.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088542"}, {"RECTYPE": "D", "MH": "Aquatic Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Water Tai Chi Therapy|T061|NON|NRW|NLM (2022)|210420|abcdef", "ENTRY": "Therapy, Water Exercise", "MN": "E02.831.535.492.250", "FX": "Balneology", "MH_TH": "NLM (2022)", "ST": "T061", "PI": "Hydrotherapy (1966-2021)", "MS": "Physical therapy administered while the body is immersed in an aquatic environment.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088543"}, {"RECTYPE": "D", "MH": "Exergaming", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Virtual Reality Exercise|T056|NON|EQV|NLM (2022)|201221|abcdef", "ENTRY": "Virtual Reality Exercises", "MN": "L01.224.900.930.500", "FX": "Telerehabilitation", "MH_TH": "NLM (2022)", "ST": "T056", "PI": "Video Games (2009-2021)", "MS": "Videogaming that involves the player's whole body in physical exercises in order to play the videogames.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088544"}, {"RECTYPE": "D", "MH": "Persistent Infection", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Long Term Infection|T047|NON|EQV|NLM (2022)|210507|abcdef", "ENTRY": "Persistent Infections", "MN": "C23.550.291.902", "FX": "Chronic Disease", "MH_TH": "NLM (2022)", "ST": "T047", "AN": "coordinate with specific infection", "PI": "Infections (1963-2021)", "MS": "Infection which lasts for a long period with continuous display of clinical features. Persistent infection arises due to inability of host cells to clear primary infections completely. When persistent infections are cleared so that infection symptoms are under control they are often referred to as chronic infections. LATENT INFECTIONS are infections in which manifestation of clinical symptoms appear later.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088562"}, {"RECTYPE": "D", "MH": "Antigenic Drift and Shift", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Antigenic Shift and Drift|T044|NON|EQV|NLM (2022)|201222|abcdef", "ENTRY": "Shift, Antigenic", "MN": "G16.075.300.500", "MH_TH": "NLM (2022)", "ST": "T044", "PI": "Antigenic Variation (1990-2021)", "MS": "Changes in the ANTIGEN population by slow and minor (antigenic drift) or sudden and major mutations (antigenic shift). Accumulation of minor mutations in antigenic drift over time may require development of new vaccine (e.g., seasonal FLU VACCINES). Antigenic shift on the other hand is less common but may result in emergence of a new subtype or species and sometimes pandemics (e.g., H1N1 pandemics in 2009 and 2018 and COVID-19) due to lack of HERD IMMUNITY to the newly emerged novel pathogen.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088603"}, {"RECTYPE": "D", "MH": "Nonagenarians", "AQ": "PH PX SN", "ENTRY": "Nonagenarian", "MN": "M01.060.116.100.080.625", "MH_TH": "NLM (2022)", "ST": "T100", "MS": "Persons between 90 and 99 years old.", "PM": "2022", "HN": "2022", "MR": "20220429", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088642"}, {"RECTYPE": "D", "MH": "Adolescent Mothers", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Teenage Mothers|T099|NON|EQV|NLM (2022)|201225|abcdef", "ENTRY": "Teenage Mother", "MN": "M01.620.630.100", "FX": "Pregnancy in Adolescence", "MH_TH": "NLM (2022)", "ST": "T099", "AN": "human only", "PI": "Mothers (2000-2021)", "MS": "Mothers aged less than 19 years at the time of child's conception or birth.", "PM": "2022", "HN": "2022", "MR": "20220713", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088662"}, {"RECTYPE": "D", "MH": "Autonomous Vehicles", "AQ": "CL EC ES HI LJ SN ST", "PRINT ENTRY": "Self-Driving Vehicles|T073|NON|EQV|NLM (2022)|201226|abcdef", "ENTRY": "Vehicles, Self-Driving", "MN": "J01.937.500.300", "MH_TH": "NLM (2022)", "ST": "T073", "AN": "self-driving cars: coordinate with AUTOMOBILES", "PI": "Motor Vehicles (2010-2021)", "MS": "Vehicles controlled by automatic directions and instructions.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088684"}, {"RECTYPE": "D", "MH": "Cognitive Restructuring", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Cognitive Reframing|T041|NON|EQV|NLM (2022)|201226|abcdef", "ENTRY": "Restructurings, Cognitive", "MN": "F04.754.137.350.375", "MH_TH": "NLM (2022)", "ST": "T041", "MS": "A technique drawn from COGNITIVE BEHAVIOR THERAPY that helps an individual to identify, challenge and alter stress-inducing thought patterns and beliefs.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088686"}, {"RECTYPE": "D", "MH": "Unmanned Aerial Devices", "AQ": "CL EC ES HI IS LJ SN ST", "PRINT ENTRY": "Unmanned Aerial Vehicles|T066|NON|EQV|NLM (2022)|210706|abcdef", "ENTRY": "Vehicles, Unmanned Aerial", "MN": "J01.937.285.100.550", "MH_TH": "NLM (2022)", "ST": "T066", "MS": "Powered,  aerial  vehicles  that  do  not  carry  a  human  operator,  use aerodynamic  forces  to  provide  vehicle  lift,  can  fly  autonomously  or  be  piloted remotely,  can  be  expendable  or  recoverable,  and  can  carry  a  lethal  or  nonlethal payload. (https://apps.dtic.mil/sti/pdfs/ADA467807 pdf accessed 12/27/2020)", "PM": "2022", "HN": "2022", "MR": "20210708", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088722"}, {"RECTYPE": "D", "MH": "Environmentalism", "AQ": "CL EC ED ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Environmental Advocacy|T054|NON|EQV|NLM (2022)|201227|abcdef", "ENTRY": "Environmental Advocacies", "MN": "N06.230.206", "MH_TH": "NLM (2022)", "ST": "T054", "PI": "Politics (2005-2021)", "MS": "Advocacy for the preservation, restoration, or improvement of the natural environment. It aims to reduce the impact of human activities on the earth and its inhabitants.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088724"}, {"RECTYPE": "D", "MH": "Genomic Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Genomic", "MN": "H02.403.200.550", "MH_TH": "NLM (2022)", "ST": "T091", "PI": "Precision Medicine (2010-2021)", "MS": "A medical discipline using genomic information about an individual as part of their clinical care (e.g. for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use.  (From www.genome.gov/health/Genomics-and-Medicine accessed 12/28/2020)", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088744"}, {"RECTYPE": "D", "MH": "Hospital to Home Transition", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Hospital to Home|T058|NON|EQV|NLM (2022)|210126|abcdef", "ENTRY": "Hospital to Homes", "MN": "N02.421.585.169.094", "MH_TH": "NLM (2022)", "ST": "T058", "MS": "Patient-centered hospital discharge to home planning and transition.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088745"}, {"RECTYPE": "D", "MH": "Listening Effort", "AQ": "CL DE PH RE", "ENTRY": "Listening Efforts", "MN": "G07.888.125.375", "MH_TH": "NLM (2022)", "ST": "T041", "PI": "Auditory Perception (2010-2021)", "MS": "The deliberate allocation of mental resources to overcome obstacles in goal pursuit when carrying out a task, with listening effort applied more when tasks involved listening. (From Pichora-Fuller et al.2016)", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088746"}, {"RECTYPE": "D", "MH": "Mirror Movement Therapy", "AQ": "AE CL EC ES HI IS MT NU PX SN ST TD VE", "PRINT ENTRY": "Mirror Therapy|T061|NON|EQV|NLM (2022)|210223|abcdef", "ENTRY": "Therapy, Mirror Movement", "MN": "E02.831.535.680", "MH_TH": "NLM (2022)", "ST": "T061", "PI": "Physical Therapy Modalities (2010-2021)", "MS": "Rehabilitation therapy in which a mirror is placed between the arms or legs so that the image of a moving non-affected limb gives the illusion of normal movement in the affected limb. This stimulates different brain regions for movement, sensation, and pain. (www.cochrane.org/CD008449 access 12/28/2020)", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088762"}, {"RECTYPE": "D", "MH": "Psychological First Aid", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "First Aid, Psychological", "MN": "F04.408.525.500", "MH_TH": "NLM (2022)", "ST": "T061", "PI": "Emergency Services, Psychiatric (1996-2021)", "MS": "Early psychosocial intervention approach used during or after traumatic life events as disasters, accidents, terrorist attacks causing negative effects on individual and/or society. It focuses on determining basic physical and mental needs of individuals in major events.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088782"}, {"RECTYPE": "D", "MH": "Nordic Walking", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Pole Walking|T056|NON|EQV|NLM (2022)|201229|abcdef", "ENTRY": "Walking, Pole", "MN": "I03.450.642.845.940.500", "MH_TH": "NLM (2022)", "ST": "T056", "PI": "Walking (2008-2021)", "MS": "Form of brisk walking, utilizing walking poles, which actively engages the trunk and upper limbs during walking, maintaining the natural gait, while the hands are performing an open\u2013close cycle in an alternating manner.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088783"}, {"RECTYPE": "D", "MH": "HCV NS3-4A Protease Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "NS3 4A Protease Inhibitors|T116|T121|NON|EQV|NLM (2022)|210413|abbcdef", "MN": "D27.505.954.122.388.769.375", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Hepatitis C (1995-2021)", "MS": "A direct acting antiviral compound that inhibits hcv ns3-4a protease. It is used to treat chronic HEPATITIS C.", "PM": "2022", "HN": "2022", "MR": "20220523", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088802"}, {"RECTYPE": "D", "MH": "Serial Infection Interval", "ENTRY": "Serial Infection Intervals", "MN": "N06.850.490.844", "MH_TH": "NLM (2022)", "ST": "T079", "MS": "The interval of time between the onset of symptoms in the primary and secondary case. The serial interval is one of the significant epidemiological measures that determine the spread of infectious disease.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088822"}, {"RECTYPE": "D", "MH": "Vaccination Hesitancy", "AQ": "EH ES HI LJ PX SN TD", "PRINT ENTRY": "Vaccine Hesitancy|T055|NON|EQV|NLM (2022)|201230|abcdef", "ENTRY": "Vaccine Hesitancies", "MN": "N05.300.150.800.750.500.500", "MH_TH": "NLM (2022)", "ST": "T055", "MS": "Delay in acceptance of vaccination despite availability.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088823"}, {"RECTYPE": "D", "MH": "Microaggression", "AQ": "CL DE ES PH RE", "MN": "F01.145.813.045.500", "MH_TH": "NLM (2022)", "ST": "T055", "PI": "Aggression (2000-2021)", "MS": "Brief verbal, behavioral, or situational indignities that communicate hostile, derogatory, or negative slights or insults. It may may be intentional or implicit. Three subtypes have been identified: microassaults, which are purposefully discriminatory actions; microinsults, which are subtle snubs that devalue a person\u2019s identity; and microinvalidations, which are unintentional exclusions or negations of an individual\u2019s thoughts. (dictionary.apa.org/microaggression 12/30/2020)", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088828"}, {"RECTYPE": "D", "MH": "Interleukin Inhibitors", "AQ": "AA AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Interleukin Inhibitor|T121|NON|EQV|NLM (2022)|210413|abcdef", "MN": "D27.505.696.477.656.563", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Interleukin-2 (1977-2021)", "MS": "IMMUNOSUPPRESSIVE AGENTS which inhibit the action of INTERLEUKINS.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088902"}, {"RECTYPE": "D", "MH": "Overtreatment", "AQ": "EC LJ PC SN TD", "PRINT ENTRY": "Over-treatment|T058|T061|NON|EQV|NLM (2022)|210106|abbcdef", "ENTRY": "Overtreatments", "MN": "N05.300.150.395.450.188", "MH_TH": "NLM (2016)", "ST": "T061", "MS": "Remedial treatment or preventive procedures of a disease which is done too frequently or excessively often from OVERDIAGNOSIS.", "PM": "2022; see MEDICAL OVERUSE 2016-2021", "HN": "2022(2016)", "MR": "20210305", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088922"}, {"RECTYPE": "D", "MH": "Technology Addiction", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Video Game Addiction|T048|NON|NRW|NLM (2022)|210126|abcdef", "ENTRY": "Video Game Addictions", "MN": "F01.145.527.100.120.875", "MH_TH": "NLM (2022)", "ST": "T048", "PI": "Behavior, Addictive (2010-2021)", "MS": "The inability to overcome a desire to have contact with and use technology and electronic devices.", "PM": "2022", "HN": "2022", "MR": "20220429", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088942"}, {"RECTYPE": "D", "MH": "Antifibrotic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Anti-Fibrotic Agents|T121|NON|EQV|NLM (2022)|210413|abcdef", "ENTRY": "Agents, Anti-Fibrotic", "MN": "D27.505.954.158.273", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "MS": "These agents are used to reduce FIBROSIS affecting organs and formation of scar TISSUES such as in SCLERODERMA patients.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088962"}, {"RECTYPE": "D", "MH": "Coral Bleaching", "AQ": "AE AN CL EC HI PC SN ST", "ENTRY": "Bleaching, Coral", "MN": "G16.500.188", "FX": "Coral Reefs", "MH_TH": "NLM (2022)", "ST": "T070", "PI": "Anthozoa (1997-2021)", "MS": "The process whereby large extents of CORAL rapidly pale through loss of their algal endosymbionts via destabilization of the coral\u2013algal SYMBIOSIS. (from https://doi.org/10.1111/mec.15337, January 11, 2021)", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000088982"}, {"RECTYPE": "D", "MH": "Acetic Anhydrides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Anhydrides, Acetic", "MN": "D02.241.081.018.193", "MH_TH": "NLM (1979)", "ST": "T130", "RN": "0", "PI": "Anhydrides (1966-1978)", "MS": "Compounds used extensively as acetylation, oxidation and dehydrating agents and in the modification of proteins and enzymes.", "PM": "91; was see under ACETIC ACIDS 1979-90", "HN": "91(79); was see under ACETIC ACIDS 1979-90", "MR": "20120703", "DA": "19771208", "DC": "1", "DX": "19910101", "UI": "D000089"}, {"RECTYPE": "D", "MH": "Andrographis paniculata", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Chirata|T002|NON|EQV|NLM (2022)|210112|abcdef", "MN": "B01.875.800.575.912.250.583.040.044.500", "MH_TH": "NLM (2022)", "ST": "T002", "RN": "txid175694", "PI": "Andrographis (2000-2021)", "MS": "A plant species in the genus Andrographis, family Acanthaceae. Its bitter tasting leaves have been used in traditional medicine and contain labdane-type diterpene lactone andrographolide.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089002"}, {"RECTYPE": "D", "MH": "Brucea javanica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rhus javanica|T002|NON|EQV|NLM (2022)|210112|abcdef", "ENTRY": "Brucea, Java", "MN": "B01.875.800.575.912.250.898.111.500", "MH_TH": "NLM (2022)", "ST": "T002", "RN": "txid210348", "PI": "Brucea (1998-2021)", "MS": "A plant species in the genus Brucea and the family SIMAROUBACEAE. It was formerly classified in the family ANACARDIACEAE. Its seeds have been used as traditional medicine and contain various QUASSINS including bruceines and brusatol.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089003"}, {"RECTYPE": "D", "MH": "Coptis chinensis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Huang-Lian|T002|NON|EQV|NLM (2022)|210212|abcdef", "ENTRY": "Huang Lian", "MN": "B01.875.800.575.912.250.836.750.229.500", "MH_TH": "NLM (2022)", "ST": "T002", "RN": "txid261450", "PI": "Coptis (1964-2021)", "MS": "A plant species of the genus COPTIS and family RANUNCULACEAE. Dried rhizome (huang-lian) has been used in TRADITIONAL CHINESE MEDICINE. It contains isoquinoline ALKALOIDS (e.g., BERBERINE and coptisine).", "PM": "2022", "HN": "2022", "MR": "20210702", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089042"}, {"RECTYPE": "D", "MH": "Biosecurity", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Bio-Security|T057|NON|EQV|NLM (2022)|210125|abcdef", "ENTRY": "Bio Security", "MN": "N04.452.910.150", "FX": "Containment of Biohazards", "MH_TH": "NLM (2022)", "ST": "T057", "MS": "Institutional and personal security measures designed to prevent the loss, theft, misuse, diversion or intentional release of pathogens and toxins.(from https://www.who.int/influenza/pip/BiosecurityandBiosafety_EN_20Mar2018.pdf February,24, 2021)", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089062"}, {"RECTYPE": "D", "MH": "Body Odor", "PRINT ENTRY": "Bromhidrosis|T184|NON|EQV|NLM (2022)|210118|abcdef", "ENTRY": "Odors, Body", "MN": "C23.888.104", "MH_TH": "NLM (2022)", "ST": "T184", "PI": "Odorants (1975-2021)", "MS": "Strong or unusual odor related to the body. Occasional abnormal body odor may be a temporary effect of a metabolic change.", "PM": "2022", "HN": "2022", "MR": "20210119", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089083"}, {"RECTYPE": "D", "MH": "Infodemic", "ENTRY": "Infodemics", "MN": "L01.143.443.500", "MH_TH": "NLM (2022)", "ST": "T170", "MS": "Typically refers to a rapid and far-reaching spread of both accurate and inaccurate information about something, such as a disease. As facts, rumors, and fears mix and disperse, it becomes difficult to learn essential information about an issue. (from Merriam Webster Dictionary)", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089102"}, {"RECTYPE": "D", "MH": "Adolescent Fathers", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Teenager Fathers|T099|NON|EQV|NLM (2022)|210125|abcdef", "ENTRY": "Teenager Father", "MN": "M01.620.390.500", "FX": "Pregnancy in Adolescence", "MH_TH": "NLM (2022)", "ST": "T099", "AN": "human only", "PI": "Fathers (1981-2022)", "MS": "Fathers initially aged less than 19 years at the time of child's birth.", "PM": "2022", "HN": "2022", "MR": "20220708", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089122"}, {"RECTYPE": "D", "MH": "Fractional Exhaled Nitric Oxide Testing", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Fractional Exhaled Nitric Oxide|T060|NON|REL|NLM (2022)|210126|abcdef", "ENTRY": "Test, FeNO", "MN": "E01.370.100.500", "FX": "Nitric Oxide", "MH_TH": "NLM (2022)", "ST": "T060", "MS": "Test to measure the levels of NITRIC OXIDE (an ENDOTHELIUM-DEPENDENT RELAXING FACTOR) in the exhaled air. FeNO test is used to determine levels of inflammation in the pulmonary ENDOTHELIUM often associated with endothelium associated diseases, e.g., ASTHMA.", "PM": "2022", "HN": "2022", "MR": "20210312", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089142"}, {"RECTYPE": "D", "MH": "Genitourinary Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Impotence Agents|T121|NON|NRW|NLM (2022)|210126|abcdef", "ENTRY": "Tract Agents, Genitourinary", "MN": "D27.505.954.493", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Urinary Tract Infections (1971-2021)", "MS": "Drugs used in treatment of medical conditions found in REPRODUCTIVE ORGANS and the URINARY TRACT such as URINARY INCONTINENCE; ERECTILE DYSFUNCTION; and PRETERM LABOR prevention.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089162"}, {"RECTYPE": "D", "MH": "Axial Spondyloarthritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "AxSpA|T047|ACR|EQV|NLM (2022)|210127|abcdef", "ENTRY": "Spondyloarthritis, Axial", "MN": "C05.550.114.865.800.744", "MH_TH": "NLM (2022)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Spondylitis, Ankylosing (2006-2021)", "MS": "A spectrum of chronic inflammatory conditions affecting the axial joints (e.g., SPINE), characterized by pain, stiffness of joints (ANKYLOSIS), reduced mobility and inflammation. When joint inflammation and damage are visible on regular X-rays it is called ANKYLOSING SPONDYLITIS; otherwise it is referred to as NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS. HLA-B27 ANTIGEN is a biomarker and IL-23/IL-17 pathway a potential therapeutic target for axial and other related spondyloarthritis.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089183"}, {"RECTYPE": "D", "MH": "Non-Radiographic Axial Spondyloarthritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nr-axSpA|T047|ABB|EQV|NLM (2022)|210128|abcdef", "ENTRY": "Spondyloarthritis, Non-Radiographic Axial", "MN": "C05.550.114.865.800.744.250", "MH_TH": "NLM (2022)", "ST": "T047", "PI": "Spondylitis, Ankylosing (2008-2021)", "MS": "Chronic inflammatory conditions affecting the axial joints which cannot be detectable on x-rays. It is characterized by pain, stiffness of joints and inflammation. Non-radiographic axial spondyloarthritis can have symptoms onset before the age of 45 and progress to more severe ANKYLOSING SPONDYLITIS over time.", "PM": "2022", "HN": "2022", "MR": "20210312", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089202"}, {"RECTYPE": "D", "MH": "Senescence-Associated Secretory Phenotype", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Senescent Cell SASP|T043|NON|EQV|NLM (2022)|210129|abcdef", "ENTRY": "Senescent Cell SASPs", "MN": "G07.345.124.130.445", "MH_TH": "NLM (2018)", "ST": "T043", "MS": "A paracrine pro-inflammatory phenotype developed in senescing cells. The senescence-associated secretory phenotype (SASP) results from the inflammatory, proteolytic and growth factor enriched SECRETOME of many types of senescent cells which leads to tissue repair or tissue and organ damage over time and links SASP to age-related disorders.", "PM": "2022; see CELLULAR SENESCENCE 2018-2021", "HN": "2022; use CELLULAR SENESCENCE 2018-2021", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089262"}, {"RECTYPE": "D", "MH": "Secretome", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Secretomes|T123|NON|EQV|NLM (2022)|210129|abcdef", "ENTRY": "Secretomes, Protein", "MN": "G03.500.500", "MH_TH": "NLM (2022)", "ST": "T123", "MS": "The set of all the soluble factors and extracellular vesicles secreted into the extracellular space by cells, or an organ or organism. In some studies the secretome only refers to the proteins secreted into the extracellular space.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089282"}, {"RECTYPE": "D", "MH": "Senotherapeutics", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Senotherapeutic Agents|T121|NON|EQV|NLM (2022)|210201|abcdef", "ENTRY": "Seno Therapeutic Agents", "MN": "D27.505.954.803", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Cellular Senescence (2016-2021)", "MS": "Chemical agents which induce the removal (by apoptotic or non-apoptotic cell death) or immune-mediated clearance of senescent cells, or the neutralization of the detrimental effects of the SENESCENCE-ASSOCIATED SECRETORY PHENOTYPE.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089322"}, {"RECTYPE": "D", "MH": "Geroscience", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Anti-Aging Research|T091|NON|NRW|NLM (2022)|210201|abcdef", "ENTRY": "Research, Anti-Aging", "MN": "H02.403.355.500", "MH_TH": "NLM (2022)", "ST": "T091", "PI": "Aging (2014-2021)", "MS": "The study of the BIOLOGY; BIOCHEMISTRY; and PHYSIOLOGY of AGING and the AGED and age-related diseases such as CARDIOVASCULAR DISEASES; DIABETES MELLITUS; and CANCER, as well as debilitating conditions like ARTHRITIS; FATIGUE; and FRAILTY.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089323"}, {"RECTYPE": "D", "MH": "Canonical Correlation Analysis", "PRINT ENTRY": "Canonical Variate|T081|NON|REL|NLM (2022)|210201|abcdef", "ENTRY": "Variate, Canonical", "MN": "N06.850.520.830.150.500.250", "MH_TH": "NLM (2022)", "ST": "T081", "MS": "Mathematical procedure that transforms vectors of variables into canonical variate pairs and finds their correlation to describe strength of association.", "PM": "2022; for CANONICAL CORRELATION see MULTIVARIATE ANALYSIS", "HN": "2022(2021)", "MR": "20210511", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089342"}, {"RECTYPE": "D", "MH": "Oxygen Saturation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "SpO2|T201|ABB|NRW|NLM (2022)|210205|abcdef", "ENTRY": "Saturation, Oxygen", "MN": "G03.707", "MH_TH": "NLM (2022)", "ST": "T201", "PI": "Oxygen (1963-2021)", "MS": "Extent to which HEMOGLOBIN is saturated with OXYGEN typically as measured in arterial blood. It can be measured by various methods (e.g., PULSE OXYMETER, blood gas analysis). A low blood oxygen saturation level indicates a condition called HYPOXEMIA.", "PM": "2022", "HN": "2022", "MR": "20220112", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089382"}, {"RECTYPE": "D", "MH": "Antiglaucoma Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiglaucoma Medications|T121|NON|EQV|NLM (2022)|210505|abcdef", "ENTRY": "Medications, Antiglaucoma", "MN": "D27.505.954.069", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Glaucoma (1986-2021)", "MS": "Agents used to preserve visual function by decreasing INTRAOCULAR PRESSURE (IOP) by targeting the AQUEOUS HUMOR.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089502"}, {"RECTYPE": "D", "MH": "Adjuvants, Vaccine", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaccine Adjuvants|T109|T121|NON|EQV|NLM (2022)|210226|abbcdef", "MN": "D27.720.744.064.500", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Administration, Cutaneous (1975-2021)", "MS": "Substances consisting of different components, e.g. aluminum salts, EMULSIONS such as MF59 and AS03, Toll-like receptor (TLR) agonist or combinations of IMMUNOPOTENTIATORS (QS-21 and MPL in AS01), that helps increase the magnitude of an ADAPTIVE IMMUNE RESPONSE to a VACCINE.", "PM": "2022", "HN": "2022", "MR": "20220429", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089582"}, {"RECTYPE": "D", "MH": "Doublecortin Domain Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Doublecortins|T116|T123|NON|EQV|NLM (2022)|210301|abbcdef", "ENTRY": "Doublecortin like Proteins", "MN": "D12.776.220.600.450.125", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "MS": "A family of microtubule-associated proteins that share in common a tandem repeat of evolutionarily conserved protein domains initially found in DOUBLECORTIN PROTEIN.", "PM": "2022; see MICROTUBULE-ASSOCIATED PROTEINS 1998-2021", "HN": "2022(1998)", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089622"}, {"RECTYPE": "D", "MH": "Doublecortin Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lissencephaly, X-Linked Protein|T116|T123|NON|EQV|NLM (2022)|210607|abbcdef", "ENTRY": "X-Linked Protein Lissencephaly", "MN": "D12.776.631.560.113", "FX": "Classical Lissencephalies and Subcortical Band Heterotopias", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "MS": "A microtubule-associated protein that is primarily found in neuronal precursor cells and immature NEURONS in embryonic and adult cortical structures.", "PM": "2022; DOUBLECORTIN PROTEIN was indexed under MICROTUBULE-ASSOCIATED PROTEINS; and NEUROPEPTIDES 1998-2021", "HN": "2022(1998)", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089662"}, {"RECTYPE": "D", "MH": "Cellular Automata", "PRINT ENTRY": "Cellular Automaton|T066|T077|NON|EQV|NLM (2022)|210304|abbcdef", "ENTRY": "Models, Cellular Automation", "MN": "L01.224.160.187", "MH_TH": "NLM (2022)", "ST": "T077", "PI": "Models, Theoretical (1986-2021)", "MS": "Space-oriented dynamic modeling ALGORITHMS acting in an array of cells, whose temporal states evolve based on the rules (algorithms) of the automata. They are used to model complex dynamic systems for study and analysis in a variety of scientific fields.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089682"}, {"RECTYPE": "D", "MH": "Fibroblast Growth Factor-23", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fibroblast Growth Factor 23|T116|T123|NON|EQV|NLM (2022)|210304|abbcdef", "MN": "D12.644.276.624.600", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "7Q7P4S7RRE", "PI": "Fibroblast Growth Factors (2000-2021)", "MS": "A specific fibrobroblast growth factor that is primarily synthesized by OSTEOCYTES and OSTEOBLASTS. It is involved in regulating phosphate homeostasis and renal phosphate excretion.", "PM": "2022; see FIBROBLAST GROWTH FACTORS 2000-2021", "HN": "2022", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089703"}, {"RECTYPE": "D", "MH": "Doublecortin-Like Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Doublecortin-Like Kinase Proteins|T116|T126|NON|EQV|NLM (2022)|210603|abbcdef", "ENTRY": "Proteins, Doublecortin-Like Kinase", "MN": "D12.776.476.563.275", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "EC 2.7.1.11", "RR": "EC 2.7.1.11", "PI": "Intracellular Signaling Peptides and Proteins (1999-2021)", "MS": "A family of doublecortin domain-containing serine-threonine kinases that were originally identified in neuronal cells.", "PM": "2022", "HN": "2022", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089742"}, {"RECTYPE": "D", "MH": "Multidrug Resistance-Associated Protein 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Multidrug-Resistance Associated Protein 2|T116|T123|NON|EQV|NLM (2022)|210308|abbcdef", "ENTRY": "Transport Protein, MRP2", "MN": "D12.776.543.585.450.074.500.500.500.750", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "RR": "4AF605U6JN", "PI": "Multidrug Resistance-Associated Proteins (1997-2021)", "MS": "An ATP-BINDING CASSETTE TRANSPORTERS subfamily protein that is localized on the canalicular membrane of HEPATOCYTES, as well as on the apical membrane of EPITHELIAL CELLS of the DUODENUM, JEJUNUM and PROXIMAL RENAL TUBULE.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089762"}, {"RECTYPE": "D", "MH": "Defective Interfering Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Synthetic Defective Interfering Viruses|T005|NON|NRW|NLM (2022)|210309|abcdef", "ENTRY": "Virus, Defective Interfering", "MN": "B04.265.135", "MH_TH": "UNK (19XX)", "ST": "T005", "MS": "Naturally occurring or synthetically made defective mutant viral genomes and particles which are incompetent in independent replication and interfere with normal VIRUS REPLICATION. Some synthetic defective interfering genomes may stimulate INNATE IMMUNE RESPONSE and are candidates for potential vaccine and therapeutic approaches for virus infections.", "PM": "2022; see Defective Viruses 1988-2021", "HN": "2022(1988)", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089783"}, {"RECTYPE": "D", "MH": "Chronic Limb-Threatening Ischemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Critical Limb Ischemia|T047|NON|EQV|NLM (2022)|210310|abcdef", "ENTRY": "Limb-Threatening Ischemia, Chronic", "MN": "C23.550.513.178", "MH_TH": "NLM (2022)", "ST": "T047", "PI": "Ischemia (1975-2021)", "MS": "A severe form of peripheral artery disease in which a hypoperfusion of the BLOOD through an organ or tissue is caused by occlusion of peripheral arterial vessels. It is associated with the presence of chronic ischemic rest pain, ulceration or GANGRENE.", "PM": "2022", "HN": "2022", "MR": "20210312", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089802"}, {"RECTYPE": "D", "MH": "Myofascial Release Therapy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Myofascial Treatment|T061|NON|EQV|NLM (2022)|210310|abcdef", "ENTRY": "Treatment, Myofascial Release", "MN": "E02.831.535.867.880.750.750", "MH_TH": "NLM (2022)", "ST": "T061", "PI": "Massage (2008-2021)", "MS": "A massage therapy which focuses on releasing MUSCLE TIGHTNESS often used to relieve muscular pain from myofascial tissues (e.g., MYOFASCIAL PAIN SYNDROME).", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089803"}, {"RECTYPE": "D", "MH": "Shelterin Complex", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Telosome|T026|NON|EQV|NLM (2022)|210310|abcdef", "ENTRY": "Telosomes", "MN": "G05.360.160.845.500", "MH_TH": "NLM (2022)", "ST": "T026", "RN": "0", "PI": "Telomere-Binding Proteins (2005-2021)", "MS": "A TELOMERE cap complex consisting of telomere-specific proteins in association with telomeric DNA such as telomeric dsDNA-sDNA junction. They are involved in the protection of chromosome ends and TELOMERASE regulation and play a role in CELLULAR SENESCENCE and ageing-related pathology. In general it consists of six mostly TELOMERE-BINDING PROTEINS (POT1, RAP1, TIN2, TPP1, TRF1, and TRF2).", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089804"}, {"RECTYPE": "D", "MH": "Birth Cohort", "ENTRY": "Cohort, Birth", "MN": "M01.060.261", "FX": "Cohort Studies", "MH_TH": "NLM (2022)", "ST": "T100", "MS": "Persons classified by a particular year or a specific time period of birth.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089822"}, {"RECTYPE": "D", "MH": "Life Course Perspective", "PRINT ENTRY": "Life Course Theory|T078|NON|EQV|NLM (2022)|210312|abcdef", "ENTRY": "Theory, Life Course", "MN": "F02.970.250", "MH_TH": "NLM (2022)", "ST": "T078", "MS": "An approach to analyze one\u2019s life within the framework of various circumstances experienced in a given society throughout entirety of life.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089823"}, {"RECTYPE": "D", "MH": "Xenotropic and Polytropic Retrovirus Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Xenotropic Murine Leukemia Virus Receptors|T116|T192|NON|EQV|NLM (2022)|210326|abbcdef", "ENTRY": "X MLV Receptor", "MN": "D12.776.543.750.830.925", "MH_TH": "NLM (2022)", "ST": "T192", "RN": "0", "MS": "A cell surface receptor involved in G-protein recruitment and G-protein-coupled signal transduction. The receptor also plays a role in phosphate homeostasis.", "PM": "2022; XENOTROPIC AND POLYTROPIC RETROVIRUS RECEPTOR was indexed under RECEPTORS, VIRUS 2001-2021, and under RECEPTORS, G-PROTEIN-COUPLED 1999-2000", "HN": "2022 (1999)", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089842"}, {"RECTYPE": "D", "MH": "Haptic Technology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Touch Feedback Technology|T090|NON|EQV|NLM (2022)|210316|abcdef", "ENTRY": "Touch Feedback Technologies", "MN": "L01.296.555.500", "FX": "Nonverbal Communication", "MH_TH": "NLM (2022)", "ST": "T090", "MS": "The study of the use of touch and KINESTHESIS in order to produce HAPTIC COMPUTER INTERFACES that will allow users to interact with digital objects by kinesthetic feedback, force feedback, and tactile feedback.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089862"}, {"RECTYPE": "D", "MH": "Antimicrobial Peptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antimicrobial Peptide|T116|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Peptide, Antimicrobial", "MN": "D12.644.066", "MH_TH": "NLM (2021)", "ST": "T116", "RN": "0", "PI": "Pore Forming Cytotoxic Proteins (1985-2021)", "MS": "Small peptides that play an important role in early innate and induced defenses against invading microbes. Most have positive overall charges and are referred to as cationic antimicrobial peptides.", "PM": "2022; see PORE FORMING CYTOTOXIC PROTEINS 2006-2021", "HN": "2022(2021)", "MR": "20210804", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089882"}, {"RECTYPE": "D", "MH": "Haptic Interfaces", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Haptic Glove|T073|NON|NRW|NLM (2022)|210416|abcdef", "ENTRY": "Interfaces, Haptic", "MN": "L01.224.230.260.115.625", "MH_TH": "NLM (2022)", "ST": "T073", "PI": "User-Computer Interface (1996-2021)", "MS": "Computer peripherals that enable users to interact three dimensionally with objects in virtual environments, or with equipment being teleoperated, by receiving kinesthetic, tactile, and force feedback.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089922"}, {"RECTYPE": "D", "MH": "Viral Pseudotyping", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Virus Pseudotyping|T059|NON|EQV|NLM (2022)|210507|abcdef", "ENTRY": "Virus, Pseudotyped", "MN": "E05.393.880", "MH_TH": "NLM (2022)", "ST": "T059", "PI": "Neutralization Tests  (1968-2021)", "MS": "Technique in which endogenous ENVELOPE PROTEINS have been replaced by use of a chimeric vector. For instance a viral vector with SIMIAN IMMUNODEFICIENCY VIRUS can be coated with the VIRAL ENVELOPE PROTEINS from Vesicular stomatitus virus. Use of these types of vectors are useful in developing NEUTRALIZATION TESTS by enabling infection of almost universal set of host cells.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089942"}, {"RECTYPE": "D", "MH": "Sleep Quality", "ENTRY": "Sleep Qualities", "MN": "F02.830.855.734.500", "FX": "Polysomnography", "MH_TH": "NLM (2022)", "ST": "T038", "PI": "Sleep (2010-2021)", "MS": "Satisfaction with the sleep experience, integrating aspects of sleep initiation, sleep maintenance, sleep quantity, and refreshment upon awakening.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089943"}, {"RECTYPE": "D", "MH": "Core Stability", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Core Balance|T040|NON|EQV|NLM (2022)|210316|abcdef", "ENTRY": "Stability, Core", "MN": "G11.561.790.541.595.500", "MH_TH": "NLM (2022)", "ST": "T040", "PI": "Postural Balance (2003-2021)", "MS": "A POSTURE in which an ideal body mass distribution is achieved for the ABDOMINAL CORE. Abdominal core stability and balance provides the body an ability to maintain equilibrium and control of the SPINE and PELVIC REGION during movement.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089944"}, {"RECTYPE": "D", "MH": "Salvia hispanica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Salvia columbariae|T002|NON|REL|NLM (2022)|210316|abcdef", "ENTRY": "Plant, Chia", "MN": "B01.875.800.575.912.250.583.520.922.375", "MH_TH": "NLM (2022)", "ST": "T002", "RN": "txid49212", "RR": "txid95165", "PI": "Salvia (2002-2021)", "MS": "A plant species of the Salvia genus known for its seeds which are used in foods and supplements. Common name chia sometimes includes Salvia columbariae.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089945"}, {"RECTYPE": "D", "MH": "Reynoutria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Reynoutria \u00d7 bohemica|T002|NON|NRW|NLM (2022)|210316|abcdef", "ENTRY": "Reynoutrias", "MN": "B01.875.800.575.912.250.825.569", "MH_TH": "NLM (2022)", "ST": "T002", "RN": "txid655516", "RR": "txid429719", "MS": "Genus of flowering herbaceous perennial plants and vines in the family Polygonaceae. Some sources include plants formerly classified under Fallopia here under Reynoutria.", "PM": "2022", "HN": "2022", "MR": "20210520", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089962"}, {"RECTYPE": "D", "MH": "Besnoitia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.043.075.189.250.750.275", "FX": "Coccidiosis", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid94642", "MS": "An apicomplexan parasitic genus of the family SARCOCYSTIDAE. Infection by Besnoitia is BESNOITIASIS.", "PM": "2022; use Sarcocystidae 1992-2021", "HN": "2022(1992)", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089963"}, {"RECTYPE": "D", "MH": "Anticoagulant Reversal Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antithrombotic Reversal Agents|T121|NON|EQV|NLM (2022)|210316|abcdef", "ENTRY": "Reversal Drugs, Anticoagulant", "MN": "D27.505.954.502.270.463.046", "FX": "Antidotes", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Anticoagulants(1998-2021)/Hemorrhage/drug therapy(2008-2021)", "MS": "Agents that have the potential to reverse specific anticoagulation therapies.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089964"}, {"RECTYPE": "D", "MH": "Erythema Ab Igne", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C26.200.413", "MH_TH": "NLM (2022)", "ST": "T033", "PI": "Erythema (1966-2021)", "MS": "A cutaneous finding caused by prolonged heat exposure (e.g., space heater) and local heat injury (e.g., caused by LASER THERAPY). It is characterized by epidermal atrophy, reticular hyperpigmentation, and telangiectatic dermatosis.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089965"}, {"RECTYPE": "D", "MH": "ADP-Ribosylation Factor 6", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ARF6 Protein|T116|T126|NON|EQV|NLM (2022)|210413|abbcdef", "ENTRY": "Protein, ARF6", "MN": "D12.776.476.338.400.100.050", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "0", "RR": "EC 3.6.5.2", "MS": "A member of GTP-binding protein of the large ras superfamily involved in regulation of membrane trafficking by modulating ENDOCYTOSIS and ACTIN CYTOSKELETON remodeling.", "PM": "2022; ADP RIBOSYLATION FACTOR 6 was indexed under RIBOSYLATION FACTORS 1995-2021", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089982"}, {"RECTYPE": "D", "MH": "Escitalopram", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Lexapro|T109|T121|TRD|NRW|NLM (2008)|061130|abbcdef", "MN": "D03.633.100.127.203", "MH_TH": "NLM (2003)", "ST": "T121", "RN": "4O4S742ANY", "MS": "S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder.", "PM": "2022; ESCITALOPRAM was indexed under CITALOPRAM 2001-2021", "HN": "2022 (2001)", "MR": "20220718", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000089983"}, {"RECTYPE": "D", "MH": "Acetoacetates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.522.585.175", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Salts and derivatives of acetoacetic acid.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000090"}, {"RECTYPE": "D", "MH": "Stromal Vascular Fraction", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Autologous Adipose Stromal Vascular Fraction|T026|NON|NRW|NLM (2022)|210317|abcdef", "ENTRY": "Vascular Fraction, Stromal", "MN": "A11.872.590.500.500", "MH_TH": "NLM (2022)", "ST": "T026", "MS": "A fraction of ADIPOSE TISSUE prepared to enrich in STEM CELLS with the capacity for multi-lineage differentiation. It is used in various applications for its tissue regeneration and immunomodulation activities.", "PM": "2022; for Adipose-Derived Mesenchymal Stem Cells see Mesenchymal Stem Cells 2019-2021", "HN": "2022 (2019)", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090002"}, {"RECTYPE": "D", "MH": "Blood Flow Restriction Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Blood Flow Restriction Training|T061|NON|EQV|NLM (2022)|210507|abcdef", "ENTRY": "Therapy, BFR", "MN": "E02.831.535.483.125", "MH_TH": "NLM (2022)", "ST": "T061", "PI": "Exercise (2007-2021)", "MS": "A technique which combines low intensity exercise with blood flow occlusion by use of a cuff. The cuff is placed close to the muscle being exercised thereby recreating a HYPOXIA to mimic the effects of high intensity exercise.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090003"}, {"RECTYPE": "D", "MH": "Ambulatory Care Sensitive Conditions", "AQ": "CL EC ES HI LJ OG SN ST TD", "MN": "N06.850.520.308.980.438.475.012", "FX": "Quality of Health Care", "MH_TH": "NLM (2022)", "ST": "T080", "PI": "Ambulatory Care (1996-2021)", "MS": "Various health conditions in OUTPATIENT CARE settings for which adequate management, treatment and interventions delivered in the ambulatory care setting could potentially prevent HOSPITALIZATION.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090004"}, {"RECTYPE": "D", "MH": "Epidemiological Models", "PRINT ENTRY": "Susceptible Infected Susceptible Model|T170|NON|NRW|NLM (2022)|210317|abcdef", "ENTRY": "SIS Models", "MN": "E05.599.395.121", "MH_TH": "NLM (2022)", "ST": "T170", "MS": "Mathematical models of the transmission of infectious diseases. They predict spread of a disease by incorporating disease-related (e.g., infectious agent, mode of transmission, latent period, infectious period) and abiotic factors (e.g., social, cultural, demographic, and geographic factors).", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090005"}, {"RECTYPE": "D", "MH": "Molybdenum Cofactors", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pterin-based Molybdenum Cofactors|T109|NON|NRW|NLM (2022)|210523|abcdef", "ENTRY": "Pterin based Molybdenum Cofactors", "MN": "D08.211.532", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "MS": "Enzyme co-factors that contain MOLYBDENUM. They play an essential role in a variety of cellular REDOX reactions.", "PM": "2022", "HN": "2022", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090006"}, {"RECTYPE": "D", "MH": "CLC-2 Chloride Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ClC-2 Chloride Channel|T116|T123|NON|EQV|NLM (2022)|210326|abbcdef", "ENTRY": "ClC 2 Chloride Channel", "MN": "D12.776.543.585.400.175.094", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "MS": "One of the nine mammalian members of the CHLORIDE CHANNEL family involved in chloride ion transport.It has several functions including the regulation of cell volume, membrane potential stabilization, signal transduction and transepithelial transport.", "PM": "2022; CLC-2 CHLORIDE CHANNELS was indexed under CHLORIDE CHANNELS 1997-2021", "HN": "2022 (1995)", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090007"}, {"RECTYPE": "D", "MH": "Chemometrics", "AQ": "HI IS MT", "PRINT ENTRY": "Chemometry|T062|NON|EQV|NLM (2022)|210416|abcdef", "ENTRY": "Chemometric Analyses", "MN": "N06.850.505.300", "MH_TH": "NLM (2022)", "ST": "T062", "MS": "The use of statistical and mathematical methods to analyze chemical observations and phenomena, such as epidemiological analysis of spectroscopically identified bacteria or QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090022"}, {"RECTYPE": "D", "MH": "Metallothionein 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Metallothionein-III|T116|T123|NON|EQV|NLM (2022)|210317|abbcdef", "ENTRY": "MT III", "MN": "D12.776.631.540", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "MS": "A metallothionein that exhibits neuroinhibitory activity and is involved in the repair of neuronal damage.", "PM": "2022; METALLOTHIONEIN 3 was indexed under GROWTH INHIBITORS 1995-2021", "HN": "2022 (1993)", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090023"}, {"RECTYPE": "D", "MH": "Sentiment Analysis", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Sentiment Classification|T066|NON|EQV|NLM (2022)|210318|abcdef", "ENTRY": "Sentiment Classifications", "MN": "L01.470.625.750", "MH_TH": "NLM (2022)", "ST": "T066", "PI": "Social Media (2013-2021)", "MS": "A data mining technique in which subjective information such as sentiments, OPINIONS, and attitudes are extracted and analyzed from data.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090042"}, {"RECTYPE": "D", "MH": "Abdominal Core", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Core, Abdominal", "MN": "A01.923.112", "MH_TH": "NLM (2022)", "ST": "T029", "PI": "Abdomen (1986-2021)", "MS": "The torso region located deep within the abdominal area involved in attaching the TORSO to the SPINE and the PELVIC FLOOR. Muscles in the abdominal core are important in POSTURAL BALANCE, spine stability and protection against BACK INJURIES.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090043"}, {"RECTYPE": "D", "MH": "Rapid On-site Evaluation", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "ROSE Techniques|T060|ACX|EQV|NLM (2022)|210318|abcdef", "ENTRY": "Technique, ROSE", "MN": "N04.590.874.500.750", "FX": "Endoscopic Ultrasound-Guided Fine Needle Aspiration", "MH_TH": "NLM (2022)", "ST": "T060", "PI": "Cytodiagnosis (1990-2021)", "MS": "A rapid laboratory service provided onsite at clinical settings (e.g., DIAGNOSTIC IMAGING suites) typically for cytomorphologic features on FINE-NEEDLE ASPIRATION.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090044"}, {"RECTYPE": "D", "MH": "Kruppel-Like Factor 4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Krueppel-Like-Factor 4|T116|T121|NON|EQV|NLM (2022)|210318|abbcdef", "ENTRY": "Protein, Klf4", "MN": "D12.776.930.375.532", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "MS": "A member of zinc finger-containing transcription factors that belongs to the KRUPPEL-LIKE FACTOR family, involved in the regulation of diverse cellular processes such as cell growth, proliferation, differentiation, and APOPTOSIS.", "PM": "2022; KRUPPLE LIKE FACROR 4 was indexed under KRUPPLE LIKE TRANSCRIPTION FACTORS 1999-2021", "HN": "2022 (1997)", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090062"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Mas", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Proto-Oncogene Proteins C-Mas-1|T116|T192|NON|EQV|NLM (2022)|210324|abbcdef", "ENTRY": "Proto Oncogene Proteins C Mas 1", "MN": "D12.776.624.664.700.166", "MH_TH": "NLM (2022)", "ST": "T192", "RN": "0", "MS": "A protein that is encoded by the MAS1 gene. It is a receptor for ANGIOTENSIN 1-7 and acts as an antagonist of ANGIOTENSIN-2 TYPE 1 RECEPTOR.", "PM": "2022; PROTO-ONCOGENE PROTEINS C-MAS-1 was indexed under PROTO-ONCOGENE PROTEINS/RECEPTORS, G-PROTEIN-COUPLED 1988-2021, and under NEOPLASM PROTEINS 1986-1994", "HN": "2022 (1986)", "MR": "20210629", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090063"}, {"RECTYPE": "D", "MH": "Climate Models", "PRINT ENTRY": "Climate Simulation|T170|NON|REL|NLM (2022)|210318|abcdef", "ENTRY": "Simulations, Climate", "MN": "I01.320.250", "MH_TH": "NLM (2022)", "ST": "T170", "MS": "Computer representations that simulate or predict the behavior or activity of WEATHER systems, processes, or phenomena.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090082"}, {"RECTYPE": "D", "MH": "Antiviral Restriction Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Restriction Factors, Antiviral|T116|T123|NON|EQV|NLM (2022)|210319|abbcdef", "MN": "D12.776.066", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "MS": "A broad category of endogenous host cellular factors upregulated in response to pathogens (i.e., INTERFERON-stimulated genes) and recruited to interfere with VIRAL REPLICATION and/or trigger host antiviral CELLULAR IMMUNE RESPONSE.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090103"}, {"RECTYPE": "D", "MH": "Dacryocystography", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Dacryocystographies", "MN": "E01.370.350.240", "MH_TH": "NLM (2022)", "ST": "T060", "PI": "Lacrimal Apparatus/diagnostic imaging (1964-2021)", "MS": "An image guided examination of the NASOLACRIMAL APPARATUS including NASOLACRIMAL DUCT.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090104"}, {"RECTYPE": "D", "MH": "Livedoid Vasculopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "White Atrophy|T047|NON|EQV|NLM (2023)|210827|abcdef", "ENTRY": "Vasculopathy, Livedoid", "MN": "C17.800.862.406", "MH_TH": "NLM (2022)", "ST": "T047", "PI": "Skin Diseases, Vascular (1998-2021)", "MS": "A rare cutaneous thrombotic disease due to occlusion of dermal vessels. It is characterized by purpuric maculae and ulcerations especially during summer which form scars called atrophie blanche. It is more associated with other syndromes (e.g., PROTEIN C DEFICIENCY; HYPERHOMOCYSTEINEMIA). Livedo reticularis with systemic involvement and stroke is SNEDDON SYNDROME.", "PM": "2022", "HN": "2022", "MR": "20211018", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090122"}, {"RECTYPE": "D", "MH": "Viperin Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Virus Inhibitory Protein Endoplasmic Reticulum-Associated Interferon-Inducible|T116|T123|NON|EQV|NLM (2022)|210319|abbcdef", "ENTRY": "Virus Inhibitory Protein Endoplasmic Reticulum Associated Interferon Inducible", "MN": "D12.776.066.500", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "MS": "A highly conserved IFN-inducible protein with a wide range of antiviral activities by binding to the VIRAL N PROTEIN.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090123"}, {"RECTYPE": "D", "MH": "Intestinal Failure", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Failure, Intestinal", "MN": "C06.405.469.462", "MH_TH": "NLM (2022)", "ST": "T047", "PI": "Intestinal Diseases (1980-2021)", "MS": "Various intestinal diseases functionally defined as having reduced intestine function requiring PARENTERAL NUTRITION.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090124"}, {"RECTYPE": "D", "MH": "European Alpine Region", "AQ": "EH EP", "PRINT ENTRY": "Alps Mountain Region|T083|NON|EQV|NLM (2022)|210422|abcdef", "MN": "Z01.542.025", "MH_TH": "NLM (2022)", "ST": "T083", "AN": "do not confuse with ALPINE TUNDRA see TUNDRA", "MS": "A territory which encompasses eight European countries: Austria, France, Germany, Italy, Liechtenstein, Monaco, Slovenia and Switzerland. The height of the Alpine mountain ridges range up to Mont Blanc at 15,782 feet above sea level, and its altitude decreases from west to east.", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "4", "DX": "20220101", "UI": "D000090142"}, {"RECTYPE": "D", "MH": "Medication Review", "ENTRY": "Reviews, Medication", "MN": "N04.590.659", "MH_TH": "NLM (2022)", "ST": "T061", "MS": "A structured evaluation of a patient\u2018s medicines with the aim of optimizing medicines use and improving health outcomes, detecting drug related problems and recommending interventions.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090143"}, {"RECTYPE": "D", "MH": "Cognitive Psychology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychology, Cognitive", "MN": "F04.096.628.255.750", "MH_TH": "NLM (2022)", "ST": "T091", "PI": "Psychology (2000-2021)", "MS": "Branch of psychology that explores the operation of mental processes related to perceiving, attending, thinking, language, and memory, mainly through inferences from behavior. (APA Dictionary of Psychology. https://dictionary.apa.org/cognitive-psychology, accessed 3/22/2021).", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090182"}, {"RECTYPE": "D", "MH": "Zn-Alpha-2-Glycoprotein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Zn-Alpha(2)-GP|T116|NON|EQV|NLM (2022)|210322|abcdef", "ENTRY": "Zn Alpha 2 Glycoprotein", "MN": "D23.529.024.875", "MH_TH": "NLM (2022)", "ST": "T116", "RN": "0", "MS": "A soluble protein that stimulates LIPOLYSIS in ADIPOCYTES and causes the extensive fat losses associated with some advanced cancers.", "PM": "2022; ZN-ALPHA-2-GLYCOPROTEIN was indexed under SEMINAL PLASMA PROTEINS 1979-2021, and under METALLOPROTEINS (1976-2001) / PROTEINS (1986-2001)", "HN": "2022 (1977)", "MR": "20230316", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090203"}, {"RECTYPE": "D", "MH": "Mesothelin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Megakaryocyte Potentiating Factor|T116|T123|NON|EQV|NLM (2022)|210322|abbcdef", "ENTRY": "Potentiating Factor, Megakaryocyte", "MN": "D23.050.301.609", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "J27WDC343N", "MS": "An ANTIGEN present on the surface of certain types of normal cells and overexpressed in several human tumors, including OVARIAN CANCER.", "PM": "2022; MESOTHELIN was indexed under GPI LINKED PROTEINS 1989-2021, and under MEMBRANE GLYCOPROTEINS 2006-2011 / Proteins 1987-2005", "HN": "2022", "MR": "20230316", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090204"}, {"RECTYPE": "D", "MH": "DNA Methyltransferase 3A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNMT3A Protein|T116|T126|ABX|EQV|NLM (2022)|210609|abbcdef", "ENTRY": "Protein, DNMT3A", "MN": "D08.811.913.555.500.350.100.500.750", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "EC 2.1.1.37", "MS": "A methyltransferase that catalyzes the addition of a methyl group to CYTOSINE residues of CpG dinucleotides and is required for genome-wide de novo DNA METHYLATION.", "PM": "2022; DNA METHYLTRANSFERASE 3A was indexed under DNA(CYTOSINE-5-)-METHYLTRANSFERASES 2001-2021", "HN": "2022 (1999)", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090205"}, {"RECTYPE": "D", "MH": "Gaslighting", "PRINT ENTRY": "Medical Gaslighting|T054|NON|NRW|NLM (2022)|210322|abcdef", "ENTRY": "Gaslighting, Medical", "MN": "L01.143.790.750", "MH_TH": "NLM (2022)", "ST": "T054", "MS": "Form of emotional or psychological abuse where an individual (or a group) makes someone question their perceptions of reality\u2014including their memories, their thoughts, and the events taking place around them. It often exploits \u201cgender-based stereotypes and structural and institutional inequalities..", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090206"}, {"RECTYPE": "D", "MH": "Gamification", "MN": "L01.224.900.340", "MH_TH": "NLM (2022)", "ST": "T073", "MS": "Application of game mechanics to non-game contexts  to engage audiences and to inject some entertainment  into mundane activities besides generating motivational and cognitive benefits.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090208"}, {"RECTYPE": "D", "MH": "Low-Value Care", "ENTRY": "Low Value Care", "MN": "N03.219.151.725", "MH_TH": "NLM (2022)", "ST": "T058", "MS": "Medical services, including tests and procedures, that should not be performed given their potential for harm or the existence of comparably effective and often less expensive alternatives.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090222"}, {"RECTYPE": "D", "MH": "Computerized Adaptive Testing", "AQ": "MT", "ENTRY": "Testing, Computerized Adaptive", "MN": "I02.594.500", "MH_TH": "NLM (2022)", "ST": "T065", "PI": "Needs Assessment (2000-2021)", "MS": "Testing administered with level of difficulty l is tailored to the test taker.", "PM": "2022", "HN": "2022", "MR": "20210706", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090242"}, {"RECTYPE": "D", "MH": "Nucleophosmin", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein B23|T116|T123|NON|EQV|NLM (2022)|210323|abbcdef", "ENTRY": "Protein, NO38", "MN": "D12.776.660.694", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "117896-08-9", "MS": "Predominantly localized in the CELL NUCLEOLUS, involved in diverse cellular processes such as ribosome biogenesis, cytoplasmic-nuclear trafficking, centrosome duplication, and regulation of p53.", "PM": "2022; NUCLEOPHOSMIN was indexed under RIBONUCLEOPROTEINS 1981-1987, and under  NUCLEAR PROTEINS 1983-2021", "HN": "2022 (1981)", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090243"}, {"RECTYPE": "D", "MH": "Hunting", "AQ": "CL EC ED ES HI IN LJ PX SN ST TD", "PRINT ENTRY": "Trapping|T056|NON|NRW|NLM (2022)|210323|abcdef", "MN": "I03.450.642.637", "MH_TH": "NLM (2022)", "ST": "T056", "AN": "human activity only; check tag humans", "MS": "Finding or capturing animals for food or sport.", "PM": "2022", "HN": "2022", "MR": "20211119", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090262"}, {"RECTYPE": "D", "MH": "Leucine-Rich Repeat Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Leucine-Rich Repeat Protein|T116|T123|NON|EQV|NLM (2022)|210323|abbcdef", "ENTRY": "Repeat Proteins, Leucine-Rich", "MN": "D12.776.529", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "MS": "A protein with a three-dimensional structure that forms an alpha/beta horseshoe fold. It is found in a large number of proteins with diverse functions, including in INNATE IMMUNITY RESPONSE and NERVOUS SYSTEM.", "PM": "2022; LEUCINE-RICH REPEAT PROTEINS was indexed under PROTEINS 1999-2021", "HN": "2022 (1997)", "MR": "20220429", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090263"}, {"RECTYPE": "D", "MH": "UDP-Glucuronosyltransferase 1A9", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Uridine Diphosphate-Glucuronosyltransferase 1A9|T116|T126|NON|EQV|NLM (2022)|210608|abbcdef", "ENTRY": "UGT1A9 UDP-Glucuronosyltransferase", "MN": "D08.811.913.400.450.480.750", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "EC 2.4.1.17", "RR": "3318TFY23Q", "MS": "A PPAR alpha and PPAR gamma target gene. The enzyme plays an important role in elimination and DETOXIFICATION of drugs, XENOBIOTICS, and metabolizing endogenous compounds, including CATECHOLESTROGENS and FIBRATES.", "PM": "2022;UDP-GLUCURONOSYLTRANSFERASE indexed under GLUCURONOSYLTRANSFERASE 2002-2021", "HN": "2022 (2000)", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090264"}, {"RECTYPE": "D", "MH": "Klotho Proteins", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "beta-Klotho Proteins|T116|T126|NON|NRW|NLM (2022)|210521|abbcdef", "ENTRY": "beta Klotho Proteins", "MN": "D12.776.543.750.750.400.370.250", "MH_TH": "NLM (2022)", "ST": "T192", "RN": "EC 3.2.1.31", "MS": "Membrane bound glucuronidase enzymes that may play a role in activation of FIBROBLAST GROWTH FACTORS, and in the regulation of a variety of cell signaling pathways.", "PM": "2022; see GLUCOURONIDASE 1997-2021", "HN": "2022", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090265"}, {"RECTYPE": "D", "MH": "Chromobox Protein Homolog 5", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heterochromatin-Specific Nonhistone Chromosomal Protein HP-1|T116|T123|NON|EQV|NLM (2022)|210323|abbcdef", "ENTRY": "HP 1 Protein", "MN": "D12.776.664.235.300", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "107283-02-3", "MS": "A protein located within beta-heterochromatin that is involved in suppression of POSITION EFFECT VARIEGATION.", "PM": "2022; HETEROCHROMATIN-SPECIFIC NONHISTONE CHROMOSOMAL PROTEIN HP-1 was indexed under CHROMOSOMAL PROTEINS, NON-HISTONE 1993-2021", "HN": "2022 (1991)", "MR": "20210625", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090266"}, {"RECTYPE": "D", "MH": "Mast Cell Activation Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "nc-MCAS|T047|NON|EQV|NLM (2022)|210325|abcdef", "ENTRY": "nc MCAS", "MN": "C20.762.500", "MH_TH": "NLM (2018)", "ST": "T047", "MS": "A clinically and genetically heterogeneous group of mast cell disorders in which there is aberrant release of mast cell mediators with little to no accompanying proliferation of MAST CELLS.", "PM": "2022; for MAST CELL ACTIVATION SYNDROME see MASTOCYTOSIS 2018-2021", "HN": "2022; for MAST CELL ACTIVATION SYNDROME use MASTOCYTOSIS 2018-2021", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090267"}, {"RECTYPE": "D", "MH": "Predatory Journals as Topic", "PRINT ENTRY": "Predatory Journals|T073|T170|NON|EQV|NLM (2022)|210324|abbcdef", "ENTRY": "Predatory Journal", "MN": "L01.462.500.682.829.678.500", "MH_TH": "NLM (2022)", "ST": "T170", "MS": "Works about medical journals that publish articles online with little or no peer review, low academic standards, and little credibility. (from Can Fam Physician. 2019 Feb; 65(2):92).", "PM": "2022", "HN": "2022", "MR": "20220712", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090282"}, {"RECTYPE": "D", "MH": "Focal Facial Dermal Dysplasias", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Setleis Syndrome|T047|EPO|NRW|NLM (2022)|210324|abcdef", "ENTRY": "Type 4 FFDDs", "MN": "C17.800.827.250.568", "MH_TH": "NLM (2022)", "ST": "T047", "PI": "Ectodermal Dysplasia (1979-2021)", "MS": "A heterogenous group of genetic disorders characterized by scar-like atrophic lesions on the temple region of the head including preauricular area. Location of skin defects is likely related to defects in fusion of embryonic facial prominences during development of the face. Focal facial dermal dysplasia (FFDD) is generally divided into four subtypes according to the location of the lesions and inheritance pattern: FFDD1 (Brauer syndrome); FFDD2 (Brauer-Setleis syndrome); FFDD3 (Setleis syndrome); and FFDD4. Mutations in TWIST2 Protein and/or CYP26C1 (see CYP26 FAMILY) are associated with FFDD3, and 4.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090303"}, {"RECTYPE": "D", "MH": "Homeobox Protein Nkx-2.2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nkx2.2 Protein|T116|T123|NON|EQV|NLM (2022)|210324|abbcdef", "ENTRY": "Protein, Nkx2.2", "MN": "D12.776.930.321", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "MS": "A homeobox-containing transcription factor that functions in INSULIN-SECRETING CELLS. Mutations in the NKX2-2 gene are associated with MATURITY-ONSET DIABETES OF THE YOUNG and OLIGODENDROGLIOMA.", "PM": "2022; NKX2.2 PROTEIN was indexed under HOMEODOMAIL PROTEINS and ZEBRAFISH PROTEINS 1997-2021", "HN": "2022 (1995)", "MR": "20211119", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090322"}, {"RECTYPE": "D", "MH": "Mannose Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptor, Mannose|T116|T192|NON|EQV|NLM (2022)|210324|abbcdef", "ENTRY": "Receptor, Mannose-Fucose", "MN": "D12.776.543.750.002", "MH_TH": "NLM (2022)", "ST": "T192", "RN": "0", "MS": "A member of a family of endocytic receptors. Highly expressed on human macrophages, involved in regulating endocytosis, phagocytosis, and immune responses.", "PM": "2022; MANNOSE RECEPTOR was indexed under RECEPTORS, CELL SURFACE 1982-1984 and under RECEPTORS, IMMUNOLOGIC 1985-1993", "HN": "2022 (1982)", "MR": "20210629", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090323"}, {"RECTYPE": "D", "MH": "Tumor Protein, Translationally-Controlled 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Translationally-Controlled Tumor Protein|T116|T129|NON|EQV|NLM (2022)|210324|abbcdef", "ENTRY": "Tumor Protein, Translationally-Controlled", "MN": "D12.776.624.720", "MH_TH": "NLM (2022)", "ST": "T129", "RN": "0", "MS": "A highly expressed protein in tumor cells, encoded by Tpt1 gene. It's involved in various cellular activities including protein synthesis, calcium-binding, MICROTUBULE stabilization, growth, and cell survival.  Also, Tpt1 identified as a direct target gene of P53 tumor suppression.", "PM": "2022; TUMOR PROTEIN, TRANSLATIONALLY-CONTROLLED 1 was indexed under BIOMARKERS, TUMOR 1987-2021; under CALCIUM-BINDING PROTEINS 1997-2002; under GROWTH SUBSTANCES 1995-2002; under LYMPHOKINES 1985-2002; and under NEOPLASM PROTEINS 1994-2002", "HN": "2022 (1985)", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090324"}, {"RECTYPE": "D", "MH": "Plant Cone", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Strobilus|T002|NON|NRW|NLM (2022)|210325|abcdef", "ENTRY": "Spore Cone", "MN": "A18.024.625", "MH_TH": "NLM (2022)", "ST": "T002", "MS": "Any conical shaped aerial plant structure with scales or bracts arranged spirally around axis. It includes familiar seed cones of PINE TREE and other GYMNOSPERMS, pollen cones (e.g., microstrobilus), spore capsules in HORSETAIL and CLUBMOSS and mature female catkins or seed cones of ALDER and BIRCH trees. Cone  morphology is important in gymnosperm classification.", "PM": "2022", "HN": "2022", "MR": "20210510", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090342"}, {"RECTYPE": "D", "MH": "Mast Cell Activation Disorders", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Primary Mast Cell Activation Disorders|T047|NON|NRW|NLM (2022)|210325|abcdef", "ENTRY": "Mast-Cell Diseases", "MN": "C20.762", "MH_TH": "NLM (2022)", "ST": "T047", "MS": "A spectrum of primary, secondary, and idiopathic disorders involving MAST CELLS and characterized by an aberrant release of mast cell mediators which result in multiple and variable inflammatory and allergic symptoms. These disorders are associated with various mutations in tyrosine kinase KIT (PROTO-ONCOGENE PROTEINS C-KIT) and other genes, underlying conditions, and responses to allergic or non-allergic triggers of mast cell stimulation and degranulation such as local anesthetics, lactam antibiotics, muscle relaxants, specific foods, environmental toxins, physical conditions such as vibration, cold, pressure, and stress.", "PM": "2022; for MAST CELL ACTIVATION DISEASE see MASTOCYTOSIS 2018-2021", "HN": "2022; for MAST CELL ACTIVATION DISEASE use MASTOCYTOSIS 2018-2021", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090362"}, {"RECTYPE": "D", "MH": "Prolonged Grief Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Persistent Complex Bereavement Disorder|T048|NON|EQV|NLM (2024)|230419|abcdef", "ENTRY": "Prolonged Grief Disorders", "MN": "F03.950.625", "MH_TH": "NLM (2022)", "ST": "T048", "MS": "Severe and disabling grief reactions that do not remit in the 12 months after the death of a significant other. The core of the diagnosis includes persistent yearning or missing the deceased, and preoccupation with the circumstance of the death. (Carmassi, Clinical Handbook of Bereavement and Grief Reactions, 2018)", "PM": "2022", "HN": "2022", "MR": "20230825", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090382"}, {"RECTYPE": "D", "MH": "Digit Ratios", "AQ": "DE GE RE", "PRINT ENTRY": "Finger Length Ratio|T032|NON|NRW|NLM (2022)|210416|abcdef", "ENTRY": "Ratios, Finger Length", "MN": "N06.850.505.200.100.550", "MH_TH": "NLM (2022)", "ST": "T081", "PI": "Fingers/anatomy (2002-2021)", "MS": "Ratio between lengths of fingers and/or toes that is sometimes characteristic of an exposure to ENDOCRINE DISRUPTORS during FETAL DEVELOPMENT.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090402"}, {"RECTYPE": "D", "MH": "Dissolved Organic Matter", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dissolved Organic Phosphorus|T109|NON|NRW|NLM (2022)|210416|abcdef", "ENTRY": "Phosphorus, Dissolved Organic", "MN": "D20.313", "MH_TH": "NLM (2022)", "ST": "T109", "RN": "0", "MS": "A heterogeneous class of water-soluble compounds containing covalently bound CARBON that are derived from a variety of biological and geological sources during the biogeochemical cycling of carbon (CARBON CYCLE).", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090422"}, {"RECTYPE": "D", "MH": "Infodemiology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Infoveillance|T090|NON|NRW|NLM (2022)|210330|abcdef", "MN": "L01.313.750.500", "MH_TH": "NLM (2022)", "ST": "T090", "MS": "The study of determinants and distribution of health information and misinformation in electronic media to inform public heath and public policy in the prevention, detection, and management of INFODEMICS.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090462"}, {"RECTYPE": "D", "MH": "Iron Deficiencies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sideropenia|T046|NON|EQV|NLM (2022)|210330|abcdef", "ENTRY": "Sideropenias", "MN": "C18.452.565.400", "MH_TH": "NLM (2022)", "ST": "T046", "AN": "ANEMIA, IRON-DEFICIENCY is also available", "MS": "Deficient amounts of iron in the body as a result of blood loss, diets deficient in iron, or an iron uptake or storage disorder.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090463"}, {"RECTYPE": "D", "MH": "Laboratories, Clinical", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Laboratory, Clinical", "MN": "N02.278.487.205", "FX": "Clinical Laboratory Techniques", "MH_TH": "NLM (2022)", "ST": "T093", "PI": "Laboratories (1963-2021)", "MS": "Facilities equipped to carry out CLINICAL LABORATORY TECHNIQUES.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090464"}, {"RECTYPE": "D", "MH": "Light Pollution", "AQ": "AE AN EC ES HI LJ PC SN", "PRINT ENTRY": "Skyglow|T069|NON|REL|NLM (2022)|210330|abcdef", "ENTRY": "Pollution, Light", "MN": "N06.850.460.505", "FX": "Chronobiology Disorders", "MH_TH": "NLM (2022)", "ST": "T069", "PI": "Lighting (1990-2021)", "MS": "The inappropriate or excessive use of artificial lighting at night.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090465"}, {"RECTYPE": "D", "MH": "Phase Variation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Phasevarions|T028|NON|REL|NLM (2022)|210401|abcdef", "ENTRY": "Variation, Phase", "MN": "G05.365.693", "MH_TH": "NLM (2022)", "ST": "T044", "MS": "An adaptive mechanism used by microbes to avoid detection by the host or adapt to changes in environment by randomly and rapidly switch on and off of a gene by various mechanisms between on and off phases. For instance, drug tolerant MYCOBACTERIUM TUBERCULOSIS arises through rapid reversible mutations in the glpK gene through phase variation.", "PM": "2022", "HN": "2022", "MR": "20220429", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090502"}, {"RECTYPE": "D", "MH": "Mass Gatherings", "PRINT ENTRY": "Public Demonstrations|T054|NON|REL|NLM (2022)|210405|abcdef", "ENTRY": "Public Demonstration", "MN": "F01.145.875.281.500", "MH_TH": "NLM (2022)", "ST": "T054", "PI": "Crowding (2000-2021)", "MS": "Organized or spontaneous events where the number of people attending is sufficient to strain the planning and response resources of the community hosting the event. (WHO, 2008). These events include the gathering of people as the result of natural disasters or conflict.", "PM": "2022", "HN": "2022", "MR": "20220413", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090522"}, {"RECTYPE": "D", "MH": "Homozygous Familial Hypercholesterolemia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "HoFH|T047|ABB|EQV|NLM (2022)|210407|abcdef", "ENTRY": "Hypercholesterolemias, Homozygous Familial", "MN": "C18.452.648.398.481.500", "FX": "Receptors, LDL", "MH_TH": "NLM (2022)", "ST": "T047", "PI": "Hypercholesterolemia (1966-2021) / Hyperlipidemia/familial & genetic (1966-2021)", "MS": "A rare inherited genetic disorder, one form of HYPERLIPOPROTEINEMIA TYPE II, characterized by high level of LOW-DENSITY LIPOPROTEIN (LDL) which if not treated could elevate the chance of heart attack at an early age.", "PM": "2022", "HN": "2022", "MR": "20220413", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090542"}, {"RECTYPE": "D", "MH": "Luciferins", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Luciferin|T109|NON|EQV|NLM (2022)|210407|abcdef", "MN": "D02.578", "MH_TH": "NLM (2022)", "ST": "T109", "RN": "0", "PI": "Luciferases (1976-2021)", "MS": "Organic substances found in organisms that generate BIOLUMINESCENCE such as FIREFLY LUCIFERIN that produces light when oxidized to the excited oxyluciferin by the action of the enzyme LUCIFERASE.", "PM": "2022", "HN": "2022", "MR": "20210629", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090562"}, {"RECTYPE": "D", "MH": "Collagen Type I, alpha 1 Chain", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Type I Collagen alpha 1|T116|T123|NON|EQV|NLM (2022)|210409|abbcdef", "ENTRY": "Protein, COL1A1", "MN": "D05.750.078.280.300.100.500", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "MS": "A fibrillar collagen found predominantly in BONE and SKIN.", "PM": "2022; COLLAGEN TYPE I, ALPHA 1 CHAIN was indexed under COLLAGEN 2000-2003, under COLLAGEN TYPE I, 2004-2021", "HN": "2022 (2000)", "MR": "20210625", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090602"}, {"RECTYPE": "D", "MH": "Mitochondrial Precursor Protein Import Complex Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Translocases of the Inner Membrane Complex|T116|NON|NRW|NLM (2022)|210413|abcdef", "ENTRY": "Translocases, Mitochondrial Preprotein", "MN": "D12.776.575.750.594", "MH_TH": "NLM (2022)", "ST": "T116", "RN": "0", "MS": "Multiprotein complexes that mediate import and sorting of mitochondrial preproteins into one of the four mitochondrial subcompartments: the outer membrane, the intermembrane space, the inner membrane, and the matrix. Mitochondrial protein import machinery includes translocase of the outer membrane (TOM) complex, translocases of the inner membrane (TIM) complex, beta\u2010barrel pathway complex, the mitochondrial intermembrane space import and assembly (MIA) pathway complex, carrier proteins of the inner membrane and the TIM23 complex and sorting and assembly machinery (SAM) complex.", "PM": "2022; for TOM COMPLEX see CARRIER PROTEINS 2006-2021", "HN": "2022(2006)", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090622"}, {"RECTYPE": "D", "MH": "Anaerobic Ammonia Oxidation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Anammox|T067|ACR|EQV|NLM (2022)|210414|abcdef", "ENTRY": "Ammonia Oxidation, Anaerobic", "MN": "G16.500.768.125", "MH_TH": "NLM (2022)", "ST": "T067", "PI": "Oxidation-Reduction (2001-2021)", "MS": "A process facilitated by specialized bacteria (PLANCTOMYCETES) involving the oxidation of ammonia to gaseous nitrogen by using nitrite as the electron acceptor.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090642"}, {"RECTYPE": "D", "MH": "Planctomycetes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Planctomycetota|T007|NON|EQV|NLM (2022)|210414|abcdef", "MN": "B03.440.619", "MH_TH": "NLM (2022)", "ST": "T007", "RN": "txid203682", "PI": "Planctomycetales (2011-2021)", "MS": "A phylum of gram-negative bacteria with complex cytoplasmic membrane invaginations and crateriform structures of outer membrane. Members living in anoxic waters and sediments carry out ANAEROBIC AMMONIA OXIDATION.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090643"}, {"RECTYPE": "D", "MH": "Schizophrenia, Treatment-Resistant", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Treatment-Resistant Schizophrenia|T048|NON|EQV|NLM (2022)|210414|abcdef", "ENTRY": "Treatment Resistant Schizophrenia", "MN": "F03.700.750.650", "MH_TH": "NLM (2022)", "ST": "T048", "PI": "Schizophrenia (1987-2021)", "MS": "A subset of schizophrenia with an inadequate response in target symptoms following treatment with two or more ANTIPSYCHOTICS.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090663"}, {"RECTYPE": "D", "MH": "Neuro-Oncological Ventral Antigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ventral Neuron-Specific Protein 1|T116|T129|NON|NRW|NLM (2022)|210415|abbcdef", "ENTRY": "Ventral Neuron Specific Protein 1", "MN": "D12.776.664.962.448", "MH_TH": "NLM (2022)", "ST": "T129", "RN": "0", "MS": "They are RNA-BINDING PROTEINS involved in mRNA processing. These are essential in gene regulation, including splicing, translation, transport, stability, and degradation of RNA.", "PM": "2022; NOVA  ANTIGEN was indexed under ANTIGENS, NEOPLASM 1993-2017, RIBONUCLEOPROTEINS 1993-2002, NERVE TISSUE PROTEINS 1993-2021, and RNA-BINDING PROTEINS 1993-2021", "HN": "2022 (1993)", "MR": "20210629", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090682"}, {"RECTYPE": "D", "MH": "Hippo Signaling Pathway", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Hippo Signaling|T043|NON|EQV|NLM (2022)|210415|abcdef", "ENTRY": "Signaling Pathway, Hippo", "MN": "G04.835.300", "MH_TH": "NLM (2022)", "ST": "T043", "MS": "A signaling pathway that plays a key role in regulating tissue and organ growth. The name derives from the protein kinase Hippo (Hpo) found in DROSOPHILA; where mutations of the Hpo gene result in tissue overgrowth and the hippopotamus phenotype.", "PM": "2022; see PROTEIN-SERINE-THREONINE KINASES 1995-2021", "HN": "2022", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090683"}, {"RECTYPE": "D", "MH": "Constitutive Androstane Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Constitutive Androstane Receptor beta|T116|T192|NON|NRW|NLM (2022)|210419|abbcdef", "ENTRY": "Receptor, Constitutive Active", "MN": "D12.776.826.060", "MH_TH": "NLM (2022)", "ST": "T192", "RN": "0", "RR": "438XLITDI3", "MS": "A member of the nuclear receptor superfamily (subfamily 1, group I, member 3 [NR1i3]) involved, along with PREGNANE X RECEPTOR, in regulation of cellular responses to the exogenous and endogenous chemicals such as detoxification of XENOBIOTICS.", "PM": "2022; CONSTITUTIVE ANDROSTANE RECEPTOR was indexed under RECEPTOR, CYTOPLASMIC AND NUCLEAR 2002-2021, and under TRANSCRIPTION FACTORS 2000-2009", "HN": "2022 (2000)", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090702"}, {"RECTYPE": "D", "MH": "Dihydroorotate Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dihydroorotate-Ubiquinone Oxidoreductase|T116|T126|NON|NRW|NLM (2022)|210419|abbcdef", "ENTRY": "Reductase, Dihydro-Orotate-Cytochrome C", "MN": "D08.811.682.660.313", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "0", "RR": "EC 1.3.5.2", "MS": "An oxidoreductase that catalyzes the conversion of DIHYDROOROTATE to orotate with QUINONE as an electron acceptor in the biosynthesis of PYRIMIDINES.", "PM": "2022; DIHYDROOROTATE DEHYDROGENASE was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 1992-2021, and under OXIDOREDUCTASES 1990-2003", "HN": "2022 (1990)", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090722"}, {"RECTYPE": "D", "MH": "Serine-Threonine Kinase 3", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "STK3 Protein Serine Threonine Kinase|T116|T126|ABX|EQV|NLM (2022)|210420|abbcdef", "ENTRY": "Serine Threonine Kinase 3", "MN": "D12.776.476.563.897", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "An intracellular-signaling kinase that plays a role in regulating APOPTOSIS.", "PM": "2022", "HN": "2022", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090742"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2J2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NADPH-Dependent Arachidonic Acid Epoxygenase|T116|T126|NON|BRD|NLM (2022)|210420|abbcdef", "ENTRY": "NADPH Dependent Arachidonic Acid Epoxygenase", "MN": "D12.776.422.220.453.005", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "EC 1.14.14.1", "MS": "A cytochrome P450 enzyme involved in oxidizing POLYUNSATURATED FATTY ACIDS (PUFA) to PUFA epoxides which function as potent lipid mediators. This enzyme, encoded by CYP2J2 gene, metabolizes ARACHIDONIC ACID to epoxyeicosatrienoic acids (EETs) which produce biological effects including VASODILATION.", "PM": "2022; ARACHIDONATE EPOXYGENASE was indexed under CYTOCHROME P-450 ENZYME SYSTEM 1987-2021, and under OXYGENASES 1985-2008", "HN": "2022 (1985)", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090762"}, {"RECTYPE": "D", "MH": "Nanoparticle Drug Delivery System", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Nanoparticle Based Drug Delivery System|T121|NON|EQV|NLM (2022)|210423|abcdef", "ENTRY": "Systems, Nano-Drug Delivery", "MN": "E02.319.300.380.800", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Technology, Pharmaceutical (1982-2021)", "MS": "Engineered NANOPARTICLES with unique physiochemical properties which improve drug BIOAVAILABILITY and site specific drug delivery.", "PM": "2022", "HN": "2022", "MR": "20210629", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090783"}, {"RECTYPE": "D", "MH": "rab7 GTP-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ras-Related Protein Rab-7|T116|T126|NON|EQV|NLM (2022)|210423|abbcdef", "ENTRY": "ras Related Protein Rab 7", "MN": "D12.776.476.338.400.400.600", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "0", "RR": "152989-05-4", "MS": "A small family of rab GTP-binding proteins that play a key role in membrane trafficking in the late endocytic and autophagic pathways.", "PM": "2022; for RAB7 GTP-BINDING PROTEINS was indexed under RAB GTP-BINDING PROTEINS 2000-2021", "HN": "2022(2000)", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090802"}, {"RECTYPE": "D", "MH": "mu-Crystallins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "THBP Protein|T116|T126|ABX|EQV|NLM (2022)|210602|abbcdef", "ENTRY": "mu-Crystallin, Ketimine Reductase", "MN": "D12.776.306.366.888", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "EC 1.5.1.25", "RR": "147681-64-9", "MS": "A subclass of crystallins expressed highly in lens of diurnal Australian MARSUPIALS and in neural tissue, muscle, and kidney in humans. It is not a structural protein accounting for the transparency of the human lens unlike other crystallins but instead plays a role in thyroid hormone bioavailability. It is also a cerebral ketimine reductase which reduces cyclic imines (e.g., DELTA(1)-PIPERIDINE-2-CARBOXYLIC ACID; CYSTATHIONINE KETIMINE and LANTHIONINE KETIMINE) in mammalian brain. Mutations in mu-crystallins are associated with an autosomal dominant NONSYNDROMIC DEAFNESS.", "PM": "2022; for CRYSTALLIN MU see under CRYSTALLINS (1992-2021)", "HN": "2022(1992)", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090803"}, {"RECTYPE": "D", "MH": "Ribosomal Protein L3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "L3 Ribosomal Protein|T116|T123|NON|EQV|NLM (2022)|210426|abbcdef", "ENTRY": "Protein, L3 Ribosomal", "MN": "D12.776.835.965", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "MS": "It is a ribosomal protein that plays a crucial role in protein synthesis.", "PM": "2022; RIBOSOMAL PROTEIN L3 was indexed under RIBOSOMAL PROTEINS 1983-2021", "HN": "2022 (1981)", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090822"}, {"RECTYPE": "D", "MH": "Neuroinflammatory Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuroinflammatory Disorders|T047|NON|EQV|NLM (2022)|210603|abcdef", "ENTRY": "Neuroinflammatory Disorder", "MN": "C23.550.470.544", "MH_TH": "NLM (2022)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Inflammation (1998-2021)", "MS": "Diseases characterized by inflammation of the nervous tissue.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090862"}, {"RECTYPE": "D", "MH": "Thromboinflammation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Immunothrombosis|T047|NON|EQV|NLM (2022)|210428|abcdef", "MN": "C23.550.470.895", "MH_TH": "NLM (2022)", "ST": "T047", "PI": "Thrombosis (2012-2021)", "MS": "Thrombosis with associated inflammation due to crosstalk between HEMOSTASIS and INNATE IMMUNE RESPONSES modulated by PLATELETS. It is associated with many diseases such as COVID-19; SICKLE CELL ANEMIA; and THROMBOPHLEBITIS.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090882"}, {"RECTYPE": "D", "MH": "Designed Ankyrin Repeat Proteins", "AQ": "AD AE AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DARPins|T116|ACX|EQV|NLM (2022)|210429|abcdef", "MN": "J01.637.087.375", "MH_TH": "NLM (2022)", "ST": "T116", "RN": "0", "PI": "Ankyrin Repeat (2001-2021)", "MS": "Genetically engineered antibody MIMETIC PROTEINS, derived from ANKYRIN PROTEINS. They offer advantages over antibodies because of their highly specific target PROTEIN BINDING with high affinity and specificity.", "PM": "2022", "HN": "2022", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090922"}, {"RECTYPE": "D", "MH": "Delta-5 Fatty Acid Desaturase", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fatty Acid Delta-5-Desaturase|T116|T126|NON|EQV|NLM (2022)|210430|abbcdef", "ENTRY": "Fatty Acid Delta 5 Desaturase", "MN": "D08.811.682.690.708.392.390", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "0", "RR": "EC 1.14.99.-", "MS": "A fatty acid desaturase that is a rate-limiting enzyme for the conversion from dihomo-gamma-linolenic acid and EICOSATETRAENOATE (ETA) in the synthesis of ARACHIDONIC ACID and EICOSAPENTAENOATE (EPA). It is also involved in the biosynthesis of unsaturated fatty acids from the polyunsaturated fatty acids (PUFA), LINOLEIC ACID (LA), and ALPHA LINOLENIC ACID (ALA) precursors and plays an important role in the metabolism of inflammatory lipids including PROSTAGLANDIN E2.", "PM": "2022; DELTA-5 FATTY ACID DESATURASE was indexed under FATTY ACID DESATURASES 1982-2021", "HN": "2022 (1981)", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090943"}, {"RECTYPE": "D", "MH": "Translational Science, Biomedical", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Translational Science|T091|NON|EQV|NLM (2022)|210429|abcdef", "ENTRY": "Translations, Knowledge", "MN": "H01.158.945", "FX": "National Center for Advancing Translational Sciences (U.S.)", "MH_TH": "NLM (2022)", "ST": "T091", "AN": "TRANSLATIONAL RESEARCH, BIOMEDICAL is also available", "PI": "Translational Research, Biomedical (2008-2021)", "MS": "The field of investigation which seeks to understand the scientific and operational principles underlying each step of the translational process to increase the efficiency and effectiveness of translational research in all therapeutic areas. (from Nat Rev Drug Discov 2018 Jul;17(7):455-456)", "PM": "2022; for TRANSLATIONAL MEDICAL SCIENCE see TRANSLATIONAL RESEARCH, BIOMEDICAL 2012-2021", "HN": "2022 (2012)", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090963"}, {"RECTYPE": "D", "MH": "BNT162 Vaccine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tozinameran|T121|NON|NRW|NLM (2022)|211202|abcdef", "ENTRY": "Vaccine, Pfizer Covid-19", "MN": "D23.050.865.450.500.750", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "RR": "N38TVC63NU", "MS": "mRNA vaccine against SARS-CoV-2 developed by Pfizer and BioNTech.", "PM": "2022; see COVID-19 Vaccines 2021", "HN": "2022(2021)", "MR": "20211202", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090982"}, {"RECTYPE": "D", "MH": "2019-nCoV Vaccine mRNA-1273", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "mRNA-1273.211|T121|NON|NRW|NLM (2022)|211202|abcdef", "ENTRY": "mRNA-1273, 2019-nCoV Vaccine", "MN": "D23.050.865.450.500.500", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "EPK39PL4R4", "MS": "mRNA vaccine against SARS-CoV-2, developed by Moderna.", "PM": "2022; 2019-NCOV VACCINE MRNA-1273 was indexed under COVID-19 VACCINES 2021", "HN": "2022(2021)", "MR": "20230522", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090983"}, {"RECTYPE": "D", "MH": "Ad26COVS1", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Johnson & Johnson Covid-19 Vaccine|T121|NON|EQV|NLM (2022)|211202|abcdef", "ENTRY": "Johnson & Johnson Covid 19 Vaccine", "MN": "D20.215.894.899.085.125", "MH_TH": "NLM (2021)", "ST": "T121", "RN": "JT2NS6183B", "MS": "A viral vector vaccine  designed against SARS-CoV-2 developed by Johnson & Johnson. Its vector encodes the SARS-CoV-2 Spike protein.", "PM": "2022; AD26COVS1 was indexed under COVID-19 VACCINES 2021", "HN": "2022", "MR": "20211202", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090984"}, {"RECTYPE": "D", "MH": "ChAdOx1 nCoV-19", "AQ": "AA AD AE AG AI BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaxzevria|T121|TRD|NRW|NLM (2023)|211216|abcdef", "ENTRY": "nCoV-19, ChAdOx1", "MN": "D20.215.894.899.085.063", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "B5S3K2V0G8", "MS": "A viral vector vaccine against SARS-CoV-2 developed by AstraZeneca. Its vector encodes the SARS-CoV-2 Spike protein.", "PM": "2022; ChAdOx1 nCoV-19 VACCINE was indexed under COVID-19 VACCINES 2021", "HN": "2022(2021)", "MR": "20220414", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000090985"}, {"RECTYPE": "D", "MH": "Acetobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.755.050.010", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid434", "AN": "do not confuse with ACETOBACTERIUM", "MS": "A species of gram-negative bacteria of the family ACETOBACTERACEAE found in FLOWERS and FRUIT. Cells are ellipsoidal to rod-shaped and straight or slightly curved.", "PM": "1966", "HN": "1966", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D000091"}, {"RECTYPE": "D", "MH": "Economic Stability", "AQ": "HI", "PRINT ENTRY": "Economic Instability|T067|NON|REL|OBSSR (2022)|210503|abcdef", "ENTRY": "Stability, Economic", "MN": "I01.880.853.996.134.500", "MH_TH": "OBSSR (2022)", "ST": "T067", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "An absence of excessive economic fluctuations which allows people the ability to access resources.", "PM": "2022", "HN": "2022", "MR": "20220713", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091002"}, {"RECTYPE": "D", "MH": "Housing Instability", "PRINT ENTRY": "Residential Eviction|T080|NON|REL|NLM (2023)|220204|abcdef", "ENTRY": "Residential Evictions", "MN": "N01.824.363", "MH_TH": "OBSSR (2022)", "ST": "T080", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "PI": "Housing (2010-2021)", "MS": "This  encompasses a number of challenges, such as having trouble paying rent, living in overcrowded conditions, moving frequently, living with friends or relatives out of necessity, being unhoused, or spending the bulk of household income (>50%) on housing. (https://www.healthypeople.gov/2020/topics-objectives/topic/social-determinants-health/interventions-resources/housing-instability)", "PM": "2022", "HN": "2022", "MR": "20220711", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091003"}, {"RECTYPE": "D", "MH": "Reelin Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Reeler Protein|T116|T126|NON|EQV|NLM (2022)|210511|abbcdef", "ENTRY": "Protein, Reelin", "MN": "D23.050.301.350.663", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "0", "RR": "EC 3.4.21.-", "MS": "It is an EXTRACELLULAR MATRIX serine protease that plays an important role in the development of the central nervous system. It regulates neuronal migration and microtubule function.", "PM": "2022; REELIN PROTEIN was indexed under NERVE TISSUE PROTEINS 1997-2021", "HN": "2022 (1995)", "MR": "20230316", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091042"}, {"RECTYPE": "D", "MH": "Gamma Secretase Inhibitors and Modulators", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gamma Secretase Modulators|T121|NON|NRW|NLM (2022)|210507|abcdef", "ENTRY": "Secretase Modulators, Gamma", "MN": "D27.505.519.389.315", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Amyloid Precursor Protein Secretases (1995-2021)", "MS": "Agents that suppress GAMMA-SECRETASE by inhibiting or modulating its activities. Targeted enzymatic activities include its involvement in accumulation of toxic AMYLOID BETA-PEPTIDES (e.g., A\u03b242) in ALZHEIMER DISEASE and activation of NOTCH RECEPTOR mediated SIGNAL PATHWAYS in certain cancer types.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091062"}, {"RECTYPE": "D", "MH": "Angiomotins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Angiomotin-Like Proteins|T116|T123|NON|REL|NLM (2022)|210507|abbcdef", "ENTRY": "Angiomotin Like Proteins", "MN": "D12.776.476.024.087", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (2001-2021)", "MS": "A class of intracellular signaling proteins that were originally identified as inhibitors of ANGIOSTATIN activity. They play a role in cell signaling pathways such as those involving G-PROTEINS and the HIPPO-SIGNALING PATHWAY.", "PM": "2022", "HN": "2022", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091082"}, {"RECTYPE": "D", "MH": "Decellularized Extracellular Matrix", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Decellularized ECM|T122|ABX|EQV|NLM (2022)|210507|abcdef", "ENTRY": "Matrix, Decellularized Extracellular", "MN": "J01.637.051.130.535", "MH_TH": "NLM (2022)", "ST": "T122", "RN": "0", "PI": "Extracellular Matrix (2011-2021)", "MS": "A biomaterial with a network of macromolecules with varying composition and organization of tissue-specific proteins and polysaccharides. It is prepared from organs and tissues by decellularization (e.g., with a detergent) to mimic native microenvironment for tissue-specific functions.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091083"}, {"RECTYPE": "D", "MH": "YAP-Signaling Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Yes-Associated Proteins|T116|T123|NON|EQV|NLM (2022)|210528|abbcdef", "ENTRY": "Yes Associated Proteins", "MN": "D12.776.476.024.750", "FX": "Transcriptional Coactivator with PDZ-Binding Motif Proteins", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "MS": "Signal transducing adaptor proteins that were initially identified by their association with YES PROTO-ONCOGENE PROTEIN. They are downstream components of the HIPPO-SIGNALING PATHWAY, and act as transcriptional co-activators for TEAD TRANSCRIPTION FACTORS.", "PM": "2022", "HN": "2022", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091102"}, {"RECTYPE": "D", "MH": "Afrotheria", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Macroscelidea|T015|NON|NRW|NLM (2022)|210510|abcdef", "ENTRY": "Shrew, Elephant", "MN": "B01.050.150.900.649.313.250", "MH_TH": "NLM (2022)", "ST": "T015", "RN": "txid311790", "RR": "txid9389", "PI": "Eutheria (1999-2021)", "MS": "A placental mammal superorder that contains ELEPHANTS; MANATEES; DUGONGS; SIRENIANS; HYRAXES; AARDVARKS; elephant shrews (Macroscelidea); TENRECS; Golden moles (Chrysochloridae). Largely classified based on DNA sequence afrotherian mammals are diverse in morphology but share some common anatomical features (e.g., appearance of four\u2010lobed ALLANTOIS and long and mobile snout).", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091122"}, {"RECTYPE": "D", "MH": "Orycteropodidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Orycteropus afer|T015|NON|NRW|NLM (2022)|210510|abcdef", "ENTRY": "Orycteropus afers", "MN": "B01.050.150.900.649.313.250.125", "MH_TH": "NLM (2022)", "ST": "T015", "RN": "txid9815", "RR": "txid9818", "MS": "An order of placental mammals in the superorder AFROTHERIA found in Africa. It has single species Orycteropus afer.", "PM": "2022; for AARDVARKS see EUTHERIA 1998-2021", "HN": "2022(1998)", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091123"}, {"RECTYPE": "D", "MH": "Tenrecidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Tenrecinae|T015|NON|NRW|NLM (2022)|210510|abcdef", "ENTRY": "Tenrecs, Lesser Hedgehog", "MN": "B01.050.150.900.649.313.250.875", "MH_TH": "NLM (2022)", "ST": "T015", "RN": "txid9369", "RR": "txid94438", "MS": "A placental mammal family in superorder Afrotheria.", "PM": "2022; for ECHINOPS TELFAIRI see EUTHERIA 2003-2021", "HN": "2022(2003)", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091124"}, {"RECTYPE": "D", "MH": "Vermilingua", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Tamandua|T015|NON|NRW|NLM (2022)|210510|abcdef", "MN": "B01.050.150.900.649.313.999.475", "MH_TH": "NLM (2022)", "ST": "T015", "RN": "txid948952", "RR": "txid9350", "MS": "A placental mammalian suborder of anteaters. For spiny anteater see TACHYGLOSSIDAE; and for scaly anteaters, PANGOLINS.", "PM": "2022; for ANTEATERS see EUTHERIA 2018-2021 and MAMMALS 1963-2017.", "HN": "2022(1998)", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091142"}, {"RECTYPE": "D", "MH": "AMP-Activated Protein Kinase Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "AMPK Kinase|T116|T126|ABX|EQV|NLM (2022)|210511|abbcdef", "ENTRY": "AMP PK Reactivators", "MN": "D12.776.476.563.074", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "EC 2.7.11.3", "MS": "Protein Serine-threonine kinases that phosphorylate the 63-kDa subunit of AMP-ACTIVATED PROTEIN KINASES. This action results in reactivation of AMP-ACTIVATED PROTEIN KINASE activity and downstream signaling aimed at decreased metabolism.", "PM": "2022; AMP-ACTIVATED PROTEIN KINASE KINASE was indexed under PROTEIN KINASES 1994-2021", "HN": "2022(1994)", "MR": "20210627", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091162"}, {"RECTYPE": "D", "MH": "Medicine, Persian", "AQ": "AE EC HI IS MT PX SN ST TD", "PRINT ENTRY": "Persian Traditional Medicine|T091|NON|EQV|NLM (2022)|210511|abcdef", "MN": "I01.076.201.450.654.694", "MH_TH": "NLM (2022)", "ST": "T091", "AN": "traditional practice only; not for modern medicine in Iran (= MEDICINE + IRAN); MEDICINE, ARABIC is also available; follow author's terminology; Avicenna (also called Ibn Sina) is indexed as Avicenna + BIOGRAPHY + HISTORY OF MEDICINE, MEDIEVAL", "PI": "Medicine, East Asian Traditional (1978-2021)", "MS": "Traditional concepts of medicine and associated methods reflected in medicine in PERSIA.", "PM": "2022", "HN": "2022", "MR": "20220708", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091182"}, {"RECTYPE": "D", "MH": "Health Disparate Minority and Vulnerable Populations", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Minority Populations|T098|NON|NRW|NLM (2023)|220613|abcdef", "ENTRY": "Population, Minority", "MN": "M01.270", "MH_TH": "NLM (2024)", "ST": "T098", "AN": "INDEXER: Do not use; CATALOGER: Do not use", "MS": "Groups of persons whose special circumstantial characteristics (e.g., SOCIAL DETERMINANTS OF HEALTH) make them a minority, vulnerable, and frequently subjected to conditions with limited levels of access to health care and other opportunities.", "PM": "2023; see Health Disparity, Minority and Vulnerable Populations 2022", "HN": "2023; use Health Disparity, Minority and Vulnerable Populations 2022", "MR": "20230119", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091202"}, {"RECTYPE": "D", "MH": "MTOR Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rapalogs|T121|TRD|REL|NLM (2022)|210512|abcdef", "ENTRY": "Inhibitors, MTOR", "MN": "D27.505.954.248.538", "FX": "TOR Serine-Threonine Kinases", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Protein Kinase Inhibitors(2000-2021)", "MS": "Agents that inhibit the activity of TOR SERINE-THREONINE KINASES.", "PM": "2022", "HN": "2022", "MR": "20220714", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091203"}, {"RECTYPE": "D", "MH": "Ribosomal Protein S9", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "S9 Ribosomal Protein|T116|T123|NON|EQV|NLM (2022)|210513|abbcdef", "ENTRY": "S9, Ribosomal Protein", "MN": "D12.776.835.982", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "MS": "It is a protein that encodes a RIBOSOMAL PROTEIN which is a component of the 40S subunit. It belongs to the S4P family of ribosomal proteins.", "PM": "2022; RIBOSOMAL PROTEIN S9 was indexed under RIBOSOMAL PROTEINS 1983-2021", "HN": "2022 (1981)", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091243"}, {"RECTYPE": "D", "MH": "Immunological Memory Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Memory Cells, Immunological|T025|NON|EQV|NLM (2022)|210513|abcdef", "ENTRY": "Memory Cell, Immunological", "MN": "A11.118.637.555.567.269", "MH_TH": "NLM (2022)", "ST": "T025", "PI": "Lymphocytes (1969-2021)", "MS": "Antigen-specific immunologic cells which have a potential to form IMMUNOLOGIC MEMORY providing a rapid and robust response against a second encounter with the same antigen. Immunologic memory cells typically include B-Lymphocytes T-Lymphocytes and sometimes adaptive NK cells. Building immunologic memory cells is a basis of how a vaccine affords immunity to a specific pathogen.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091244"}, {"RECTYPE": "D", "MH": "Memory B Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Memory B-Lymphocytes|T025|NON|EQV|NLM (2022)|210514|abcdef", "ENTRY": "Memory B-Lymphocyte", "MN": "A15.382.490.555.567.562.450.650", "MH_TH": "NLM (2022)", "ST": "T025", "PI": "B-Lymphocytes (1979-2021)", "MS": "A subset of activated B cells generated in response to primary immune challenge or immunization which are capable of giving rise to antibody-secreting cells upon re-challenge (see IMMUNOLOGIC MEMORY). Memory B cells feature many discrete properties indicative of differentiation through ISOTYPE SWITCHING and/or IMMUNOGLOBULIN SOMATIC HYPERMUTATION for rapid and robust recall of specific antibody responses.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091245"}, {"RECTYPE": "D", "MH": "Memory T Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Virtual Memory T Cells|T025|NON|NRW|NLM (2022)|210513|abcdef", "ENTRY": "T Lymphocytes, Memory", "MN": "A15.382.490.555.567.569.500.075", "MH_TH": "NLM (2022)", "ST": "T025", "PI": "T-Lymphocytes (1974-2021)", "MS": "A subset of activated T cells generated in response to primary immune challenge or immunization upon re-challenge (see IMMUNOLOGIC MEMORY). Memory T cells feature many discrete properties indicative of various differentiation such as expression pattern of CCR7 RECEPTORS and can be divided into central memory and effector memory T cells.", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091246"}, {"RECTYPE": "D", "MH": "TEA Domain Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TEAD Transcription Factors|T116|T123|ABX|EQV|NLM (2022)|210514|abbcdef", "MN": "D12.776.930.882", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1988-2021)", "MS": "A family of transcription factors that share a conserved TEA DNA binding domain.", "PM": "2022", "HN": "2022", "MR": "20210628", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091262"}, {"RECTYPE": "D", "MH": "Vestibular System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vestibular Systems", "MN": "A09.923", "MH_TH": "NLM (2022)", "ST": "T022", "PI": "Vestibule, Labyrinth (1965-2021)", "MS": "The VESTIBULAR APPARATUS in the inner ear, the eye, the CENTRAL NERVOUS SYSTEM and various nerves, tracts and nuclei connecting them as they relate to PROPRIOCEPTION and SPATIAL ORIENTATION. Dysfunction in the vestibular system is associated with various diseases (e.g., VESTIBULAR DISEASES; LABYRINTH DISEASES; VESTIBULAR NEURONITIS; BENIGN PAROXYSMAL POSITIONAL VERTIGO; and MOTION SICKNESS).", "PM": "2022", "HN": "2022", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091282"}, {"RECTYPE": "D", "MH": "Protein Kinase D2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PRKD2 Protein|T116|T126|ABX|EQV|NLM (2022)|210514|abbcdef", "ENTRY": "Enzyme, PKD2", "MN": "D12.776.476.563.750", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "0", "RR": "EC 2.7.1.-", "MS": "A SERINE-THREONINE PROTEIN KINASE that is activated in response to OXIDATIVE STRESS.", "PM": "2022; PROTEIN KINASE D2 was indexed under PROTEIN KINASES 2003-2021", "HN": "2022 (2001)", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091283"}, {"RECTYPE": "D", "MH": "Nitrate Transporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nrt2 Protein, Plant|T116|T123|NON|NRW|NLM (2022)|210514|abbcdef", "ENTRY": "Transporters, Nitrate", "MN": "D12.776.765.519", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "RR": "135229-17-3", "MS": "Plant proteins that participate in the active uptake of NITRATE from soil and its transport throughout the plant.", "PM": "2022; NITRATE TRANSPORTERS was indexed under ANION TRANSPORT PROTEINS 1995-2021", "HN": "2022 (1993)", "MR": "20210629", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091285"}, {"RECTYPE": "D", "MH": "Angiopoietin-Like Protein 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Angiopoietin-Related Protein 2|T116|T123|NON|EQV|NLM (2022)|210608|abbcdef", "ENTRY": "Angiopoietin Related Protein 2", "MN": "D23.529.100.050.200", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "PI": "Angiopoietin-like Proteins (2004-2021)", "MS": "A circulating angiopoietin-like protein that is  expressed in a variety of tissues in response to HYPOXIA. It acts by inducing angiogenesis and endothelial cell migration.", "PM": "2022", "HN": "2022", "MR": "20210627", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091302"}, {"RECTYPE": "D", "MH": "Angiopoietin-Like Protein 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Angiopoietin Like Protein 3", "MN": "D23.529.100.050.300", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "PI": "Angiopoietin-like Proteins (2004-2021)", "MS": "An angiopoietin-like protein that plays a role in regulation of LIPOPROTEIN metabolism.", "PM": "2022", "HN": "2022", "MR": "20210627", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091303"}, {"RECTYPE": "D", "MH": "Angiopoietin-Like Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Angioarrestin|T116|T123|NON|EQV|NLM (2022)|210519|abbcdef", "ENTRY": "Angiopoietin Like Protein 1", "MN": "D23.529.100.050.100", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "PI": "Angiopoietins (2009-2021)", "MS": "The first member of the Angiopoietin-like protein family to be discovered. It is considered a key endogenous ANTIANGIOGENIC AGENT which inhibits the proliferation, migration, tube formation, and adhesion of ENDOTHELIAL CELLS.", "PM": "2022", "HN": "2022", "MR": "20210627", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091304"}, {"RECTYPE": "D", "MH": "Angiopoietin-Like Protein 8", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Betatrophin|T116|T123|NON|EQV|NLM (2022)|210519|abbcdef", "ENTRY": "Angiopoietin Like Protein 8", "MN": "D23.529.100.050.800", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "PI": "Angiopoietin-like Proteins (2012-2021)", "MS": "A nutritionally-regulated factor found in the LIVER. It plays a role in lipid metabolism and VLDL secretion in the liver. It was originally called betatrophin due to its suspected role as a peptide hormone that stimulates beta cell proliferation.", "PM": "2022", "HN": "2022", "MR": "20210627", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091306"}, {"RECTYPE": "D", "MH": "Angiopoietin-Like Protein 7", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Angiopoietin Like Protein 7", "MN": "D23.529.100.050.700", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "PI": "Angiopoietin-like Proteins (2008-2021)", "MS": "An angiopoietin-like protein that is expressed in NERVE TISSUE, KERATOCONUS corneas, TRABECULAR MESHWORK.", "PM": "2022", "HN": "2022", "MR": "20210627", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091307"}, {"RECTYPE": "D", "MH": "Angiopoietin-Like Protein 6", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Angiopoietin-Related Protein 5|T116|T123|NON|EQV|NLM (2022)|210608|abbcdef", "ENTRY": "Angiopoietin Related Protein 5", "MN": "D23.529.100.050.550", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "PI": "Angiopoietin-like Proteins (2003-2021)", "MS": "An angiopoietin-like protein that is expressed in LIVER and involved in regulation of BLOOD GLUCOSE; LIPID METABOLISM; and ENERGY METABOLISM.", "PM": "2022", "HN": "2022", "MR": "20210627", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091308"}, {"RECTYPE": "D", "MH": "Centaurea benedicta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thistle, Blessed|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Thistles, Blessed", "MN": "B01.875.800.575.912.250.100.188.500", "MH_TH": "NLM (2022)", "ST": "T002", "RN": "txid50282", "PI": "CNICUS (2003-2021)", "MS": "A plant species of the genus CENTAUREA and family ASTERACEAE. Members contain sesquiterpene lactone CNICIN.", "HN": "2022(2003)", "MR": "20210804", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091322"}, {"RECTYPE": "D", "MH": "Psychogenic Nonepileptic Seizures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Psychogenic Pseudoseizure|T184|NON|EQV|NLM (2022)|210517|abcdef", "ENTRY": "Seizure, Psychogenic Nonepileptic", "MN": "C23.888.592.742.357", "MH_TH": "NLM (2005)", "ST": "T184", "PI": "Seizures (1995-2021)", "MS": "Seizures caused by psychological factors without electrophysiological epileptic changes.", "PM": "2022", "HN": "2022", "MR": "20220413", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091323"}, {"RECTYPE": "D", "MH": "Endoplasmic Reticulum Chaperone BiP", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Molecular Chaperone GRP78|T116|T123|NON|EQV|NLM (2022)|210517|abbcdef", "ENTRY": "Protein, HSPA5", "MN": "D12.776.580.216.375.100", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "RR": "YCYIS6GADR", "MS": "An ENDOPLASMIC RETICULUM  specific chaperone of the HSP70 family. They are involved in  folding and oligomerization of secreted and membrane proteins and ENDOPLASMIC RETICULUM STRESS related UNFOLDED PROTEIN RESPONSE.", "PM": "2022; for MOLECULAR CHAPERONE GRP78 see under HEAT-SHOCK PROTEINS 2008-2021", "HN": "2022(2008)", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091342"}, {"RECTYPE": "D", "MH": "Organocopper Compounds", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Organocopper Complexes|T109|T121|NON|EQV|NLM (2022)|210628|abbcdef", "ENTRY": "Oxide, Copper-Cuprous", "MN": "D02.691.319", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Organometallic Compounds (1972-2021)", "MS": "Organic compounds that contain COPPER as an integral part on the molecule.", "PM": "2022", "HN": "2022", "MR": "20210708", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091343"}, {"RECTYPE": "D", "MH": "Filaggrin Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stratum Corneum Basic Protein Precursor|T116|NON|NRW|NLM (2022)|210517|abcdef", "ENTRY": "Proteins, Filaggrin", "MN": "D12.776.631.658.500", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "PI": "Intermediate Filament Proteins (1982-2021)", "MS": "S100 proteins that aggregate KERATINS. Filaggrin precursor proteins are localized in keratohyalin granules and processed into individual functional filaggrin molecules during terminal epidermis differentiation. Mutations in fillagrins are associated with ICHTHYOSIS VULGARIS.", "PM": "2022; FILAGRIN was indexed under INTERMEDIATE FILAMENT PROTEINS 1984-2021; and under PROTEINS 1981-1983", "HN": "2022(1981)", "MR": "20230609", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091344"}, {"RECTYPE": "D", "MH": "Protein Glutamine gamma Glutamyltransferase 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transglutaminase II|T116|T126|NON|EQV|NLM (2022)|210603|abbcdef", "ENTRY": "Transglutaminase, Tissue-Type", "MN": "D08.811.913.050.200.800.650", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "EC 2.3.2.13", "AN": "distinguish from GAMMA-GLUTAMYLTRANSPEPTIDASE which is involved with glutathione metabolism", "MS": "Calcium-dependent acyltransferase that catalyzes cross-linking of proteins at a GLUTAMINE in one chain with primary amine such as in LYSINE in another chain. In addition it can also accept monoamine substrates to catalyze post-translational modifications (e.g., protein serotonylation).", "PM": "2022; see under TRANSGLUTAMINASESE 1999-2021", "HN": "2022(1999)", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091345"}, {"RECTYPE": "D", "MH": "Tripeptidyl-Peptidase 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tripeptidyl-Peptidase I|T116|T126|NON|EQV|NLM (2022)|210517|abbcdef", "ENTRY": "Protein, TPP1", "MN": "D08.811.277.656.959.780", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "0", "RR": "EC 3.4.14.9", "MS": "Lysosomal Serine proteases that release N-terminal tripeptide from a polypeptide and cleave peptides between hydrophobic residues. An enzyme that in humans encoded by the TPP1 gene. It is involved in the degradation of bone collagen. Mutations in this gene are associated with the CEROID LIPOFUSCINOSIS, NEURONAL, 2; and SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE CEROID LIPOFUSCINOSIS, NEURONAL, 2; AND SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7.", "PM": "2022; TRIPEPTIDYL-PEPTIDASES 1 was indexed under AMINOPEPTIDASES, DIPEPTIDYL-PEPTIDYL-PEPTIDASES and under SERINE PROTEASES 1995-2021", "HN": "2022 (1993)", "MR": "20220429", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091346"}, {"RECTYPE": "D", "MH": "PCSK9 Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PCSK9 Inhibitors, Cardiovascular|T121|NON|NRW|NLM (2022)|210630|abcdef", "ENTRY": "Inhibitors, Cardiovascular PCSK9", "MN": "D27.505.954.557.500.202.685", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Anticholesteremic Agents (2018-2021)", "MS": "Agents that inhibit Proprotein Convertase Subtilisin/Kexin Type 9 (see PROPROTEIN CONVERTASE 9 (PCSK9)), an enzyme that plays an important role in the degradation of the LDL receptors. It favors LDL catabolism and reduces plasma LDL-cholesterol (LDL_C) level.", "PM": "2022", "HN": "2022", "MR": "20210708", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091362"}, {"RECTYPE": "D", "MH": "Protocadherins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ncPcdhs|T116|ABB|NRW|NLM (2022)|210518|abcdef", "ENTRY": "Receptors, Cadherin-Related Neuronal", "MN": "D23.050.301.350.200.750", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "PI": "Cadherins (1995-2021)", "MS": "Members of cadherin superfamily involved in cell adhesion and cell-cell interactions in neural development. They are subdivided into clustered (cPcdhs) and non-clustered protocadherin (ncPcdhs) depending whether their genes are tandemly arranged in vertebrates.", "PM": "2022", "HN": "2022", "MR": "20230316", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091363"}, {"RECTYPE": "D", "MH": "Transcriptional Coactivator with PDZ-Binding Motif Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "WW Domain-Containing Transcription Regulator Protein 1|T116|T123|ABX|EQV|NLM (2022)|210607|abbcdef", "ENTRY": "WW Domain Containing Transcription Regulator Protein 1", "MN": "D12.776.476.024.484", "MH_TH": "NLM (2022)", "ST": "T123", "RN": "0", "AN": "do not confuse with tafazzin/TAZ protein", "PI": "Transcription Factors (2010-2021)", "MS": "A family of signal transducing adaptor proteins that are similar in structure and function to YAP-SIGNALING PROTEINS. They are components of the HIPPO-SIGNALING PATHWAY, and may act as transcriptional co-activators for TEAD TRANSCRIPTION FACTORS.", "PM": "2022", "HN": "2022", "MR": "20210701", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091364"}, {"RECTYPE": "D", "MH": "Census Tract", "PRINT ENTRY": "Census District|T062|NON|EQV|NLM (2022)|210607|abcdef", "ENTRY": "Tracts, Census", "MN": "N06.850.520.830.933.249.500", "MH_TH": "OBSSR (2022)", "ST": "T062", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "Small, relatively permanent statistical subdivisions of a county or equivalent entity that are updated by local participants prior to each decennial census as part of the U. S. Census Bureau's Participant Statistical Areas Program.(https://www.census.gov/programs-surveys/geography/about/glossary.html#par_textimage_13)", "PM": "2022", "HN": "2022", "MR": "20220615", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091368"}, {"RECTYPE": "D", "MH": "Immunomodulating Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Immunomodulatory IMiDE Drugs|T121|NON|NRW|NLM (2022)|210608|abcdef", "ENTRY": "Drugs, Immunomodulatory IMiDE", "MN": "D27.505.696.477.396", "MH_TH": "NLM (2022)", "ST": "T121", "RN": "0", "PI": "Immunosuppressive Agents (1982-2021)", "MS": "Agents that alter the response of the immune system by activating (IMMUNOSTIMULANT) or suppressing (IMMUNOSUPPRESSIVE) the immune system and may help the body fight cancer, infection, or other diseases.", "PM": "2022", "HN": "2022", "MR": "20210629", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091369"}, {"RECTYPE": "D", "MH": "Environmental Justice", "ENTRY": "Justice, Environmental", "MN": "K01.752.566.869.250", "MH_TH": "OBSSR (2022)", "ST": "T078", "AN": "SOCIAL DETERMINANTS OF HEALTH is available", "MS": "The fair treatment and meaningful involvement of all people regardless of race, color, national origin, or income, with respect to the development, implementation, and enforcement of environmental laws, regulations, and policies. (www.epa.gov/environmentaljustice/learn-about-environmental-justice)", "PM": "2022", "HN": "2022", "MR": "20220713", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091383"}, {"RECTYPE": "D", "MH": "Plant Senescence", "AQ": "DE GE PH RE", "PRINT ENTRY": "Plant Cellular Senescence|T040|NON|NRW|NLM (2022)|210518|abcdef", "ENTRY": "Senescences, Flower", "MN": "G15.589.500", "MH_TH": "NLM (2022)", "ST": "T040", "PI": "Plant Physiological Phenomena (1967-2021)", "MS": "In plants, similarly as in animals, an age-dependent irreversible process of changes leading to the arrest of CELL DIVISION and/or PROGRAMMED CELL DEATH.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091385"}, {"RECTYPE": "D", "MH": "Prohibitins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Prohibitin|T116|T121|NON|BRD|NLM (1991)|210603|abbcdef", "MN": "D12.776.575.844", "MH_TH": "NLM (2022)", "ST": "T116", "RN": "0", "MS": "Ubiquitously expressed conserved proteins associated with multiple functions including APOPTOSIS; CELL PROLIFERATION, regulations of various immune and mitochondrial functions, and cellular stress responses. Prohibitin 1 and prohibitin 2 form a ring-shaped complex in the INNER MITOCHONDRIAL MEMBRANE.", "PM": "2022; PROHIBITIN (now PROHIBITINS) was indexed under REPRESSOR PROTEINS 1991-2021", "HN": "2022(1991)", "MR": "20210630", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091402"}, {"RECTYPE": "D", "MH": "Cell Death Reversal", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Reversal of Apoptosis|T043|NON|NRW|NLM (2022)|210519|abcdef", "ENTRY": "Reversal, Necroptosis", "MN": "G04.146.477", "MH_TH": "NLM (2022)", "ST": "T043", "MS": "Recovery of cells from one of the activated pathways of regulated cell death.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091442"}, {"RECTYPE": "D", "MH": "Community Support", "AQ": "EC HI LJ MT PX ST TD", "ENTRY": "Support, Community", "MN": "N02.421.143.212.150", "FX": "Social Determinants of Health", "MH_TH": "OBSSR (2022)", "ST": "T054", "AN": "SOCIAL DETERMINANTS OF HEALTH is available", "PI": "Social Support (1981-2021)", "MS": "Community support systems that may be organized through extended family members, friends, neighbors, religious organizations, community programs, cultural and ethnic organizations, or other support groups or organizations. (https://www.lawinsider.com/dictionary/community-support-systems)", "PM": "2022", "HN": "2022", "MR": "20220713", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091443"}, {"RECTYPE": "D", "MH": "Community Resources", "ENTRY": "Resource, Community", "MN": "N03.055", "MH_TH": "OBSSR (2022)", "ST": "T078", "AN": "Note several more specific community health-related terms such as COMMUNITY HEALTH SERVICES and COMMUNITY HEALTH CENTERS are available", "MS": "The financial, material, and/or human assets of a community which have the potential to improve the QUALITY OF LIFE in community.", "PM": "2022", "HN": "2022", "MR": "20220713", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091444"}, {"RECTYPE": "D", "MH": "Deep Eutectic Solvents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Natural Deep Eutectic Solvents|T120|NON|NRW|NLM (2022)|210519|abcdef", "ENTRY": "Solvents, Deep Eutectic", "MN": "D27.720.844.250", "FX": "Green Chemistry Technology", "MH_TH": "NLM (2022)", "ST": "T120", "RN": "0", "PI": "Solvents (2014-2021)", "MS": "A fluid that is generally composed of two or three safe (cheap, non-toxic, renewable, and biodegradable) components that are capable of self-association, often through hydrogen bond interactions, to form a liquid close to the eutectic composition, i.e., the molar ratio of the components which has the lowest melting point (eutectic point).", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091463"}, {"RECTYPE": "D", "MH": "Social Vulnerability", "ENTRY": "Vulnerability, Social", "MN": "I01.880.853.919", "FX": "Vulnerable Populations", "MH_TH": "OBSSR (2022)", "ST": "T078", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "The characteristics of a person or community that affect their capacity to anticipate, confront, repair, and recover from the effects of a natural or human-caused disaster.(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC71 79070/)", "PM": "2022", "HN": "2022", "MR": "20220708", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091482"}, {"RECTYPE": "D", "MH": "Access to Healthy Foods", "AQ": "CL EC ES HI LJ MT SN ST", "PRINT ENTRY": "Healthy Food Availability|T080|NON|EQV|OBSSR (2022)|210520|abcdef", "ENTRY": "Healthy Foods Availability", "MN": "J01.576.423.750.875.500", "MH_TH": "OBSSR (2022)", "ST": "T080", "AN": "coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "Convenient availability to affordable foods that support healthy eating patterns. Access may be limited due to having a limited income or living far away from sources of healthful and affordable food.", "PM": "2022", "HN": "2022", "MR": "20220713", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091483"}, {"RECTYPE": "D", "MH": "Network Pharmacology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Systems Pharmacology|T062|NON|EQV|NLM (2022)|210520|abcdef", "ENTRY": "Pharmacology, Systems", "MN": "E05.290.563.500", "FX": "Systems Biology", "MH_TH": "NLM (2022)", "ST": "T062", "MS": "A systems-based pharmacologic discovery process used to predict the multiple targets of multiple drugs in a complex mixture such as CHINESE HERBAL DRUGS.  It involves analytical detection of chemicals plus prediction of pharmacologic activity and protein targets for each compound in the mixture and aggregating the net physiological effect.", "PM": "2022", "HN": "2022", "MR": "20220523", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091484"}, {"RECTYPE": "D", "MH": "Social Structure", "ENTRY": "Structures, Social", "MN": "I01.880.761", "MH_TH": "OBSSR (2022)", "ST": "T054", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "The complex of relationships and systems that organize and regulate interpersonal phenomena in a group or society. The social structure of a group includes its norms and roles and the status, attraction, and communication relations that link one member to another (see group structure). The social structure of a society includes the complex of relations among its constituent individuals, groups, institutions, customs, and mores. (https://dictionary.apa.org/social\u2010structure)", "PM": "2022", "HN": "2022", "MR": "20220708", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091485"}, {"RECTYPE": "D", "MH": "Child Poverty", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Childhood Poverty|T068|NON|EQV|NLM (2022)|210629|abcdef", "ENTRY": "Poverty, Childhood", "MN": "I01.880.735.634.500", "MH_TH": "OBSSR (2022)", "ST": "T068", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "A situation of children (ages 0-17 inclusive) living in households with income below the U.S. Department of Health and Human Services Federal Poverty Threshold, often leading to a lack of food, sanitation, shelter, health care and education needed to survive and thrive.", "PM": "2022", "HN": "2022", "MR": "20220713", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091486"}, {"RECTYPE": "D", "MH": "Ostracism", "AQ": "PX", "MN": "I01.880.853.748.595", "MH_TH": "OBSSR (2022)", "ST": "T054", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "An extreme form of rejection in which one is excluded and ignored in the presence of others.", "PM": "2022 see SOCIAL ISOLATION 2021", "HN": "2022", "MR": "20220708", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091488"}, {"RECTYPE": "D", "MH": "Social Deprivation", "PRINT ENTRY": "Social Deprivation Index|T081|NON|REL|OBSSR (2022)|210520|abcdef", "ENTRY": "Social Deprivations", "MN": "I01.880.853.748.877", "MH_TH": "OMIM (2014)", "ST": "T078", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "Limited access to society's resources due to poverty. discrimination, or other disadvantage. Conditions based on seven demographic characteristics collected in the American Community Survey (ACS): often include percent living in poverty, percent with less than 12 years of education,  percent of single parent households, percent living in rented housing unit, percent living in overcrowded housing unit, percent of households without a car, and percent of non-employed adults under the age of 65 years.(https://dictionary.apa.org/socialdeprivation).", "PM": "2022", "HN": "2022", "MR": "20220708", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091489"}, {"RECTYPE": "D", "MH": "Home Environment", "PRINT ENTRY": "Social Housing Conditions|T078|NON|NRW|NLM (2022)|210608|abcdef", "ENTRY": "Social Housing Condition", "MN": "N06.850.505.400.800.300", "FX": "Built Environment", "MH_TH": "OBSSR (2022)", "ST": "T078", "AN": "coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "Aspects of peoples\u2019 living conditions that may and can impact people's health and/or well-being. These factors may be physical (e.g., housing quality) or social circumstances (e.g., living alone).", "PM": "2022", "HN": "2022", "MR": "20220713", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091502"}, {"RECTYPE": "D", "MH": "Housing Quality", "PRINT ENTRY": "Housing Conditions|T080|NON|EQV|OBSSR (2022)|210608|abcdef", "ENTRY": "Quality, Housing", "MN": "N06.230.145.500.500", "MH_TH": "OBSSR (2022)", "ST": "T080", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "Physical condition of a person\u2019s home as well as the quality of the social and physical environment in which the home is located. Aspects of housing quality include air quality, home safety, space per individual, and the presence of mold, asbestos, or lead. Housing quality is affected by factors like a home\u2019s design and age.(https://www.healthypeople.gov/2020/topics-objectives/topic/social-determinants-health/interventions-resources/quality-of-housing)", "PM": "2022", "HN": "2022", "MR": "20220713", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091522"}, {"RECTYPE": "D", "MH": "Neighborhood Characteristics", "AQ": "CL HI SN", "PRINT ENTRY": "Neighborhood Safety|T080|NON|NRW|OBSSR (2022)|210522|abcdef", "ENTRY": "Safety, Neighborhood", "MN": "N06.850.505.400.800.775", "MH_TH": "OBSSR (2022)", "ST": "T080", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH; specify geographic location if pertinent ", "PI": "Residence Characteristics (2007-2021)", "MS": "Characteristics that may describe the demographic, social, built environment, or economic characteristics of a geographic area in which people live and can affect health and well-being of neighborhood residents. Neighborhood environments include the physical environment (unsafe air/water), built environment   (sidewalks/greenspace) and the social environment (safety, sense of community).", "PM": "2022", "HN": "2022", "MR": "20220713", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091542"}, {"RECTYPE": "D", "MH": "Perceived Discrimination", "AQ": "EH ES PX", "ENTRY": "Discrimination, Perceived", "MN": "F02.463.593.752.250", "MH_TH": "OBSSR (2022)", "ST": "T041", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OFF HEALTH", "PI": "Social Perception (1969-2021)", "MS": "Perception of being treated badly or unfairly on the basis of race, ethnicity, gender, age, religion, physical appearance, sexual orientation, or other characteristics. This includes perceived discrimination in health care settings.", "PM": "2022", "HN": "2022", "MR": "20220708", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091563"}, {"RECTYPE": "D", "MH": "Sociodemographic Factors", "ENTRY": "Sociodemographic Factor", "MN": "I01.880.853.965", "MH_TH": "OBSSR (2022)", "ST": "T078", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "PI": "Socioeconomic Factors  (1971-2021)", "MS": "Indicators used to describe individuals in terms of age, race/ethnicity, sex, gender, primary language educational attainment, employment status, income, profession, marital status, total number of persons living in the house and living arrangements, and similar factors.", "PM": "2022", "HN": "2022", "MR": "20220708", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091569"}, {"RECTYPE": "D", "MH": "Biomolecular Condensates", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Membraneless Organelles|T026|NON|EQV|NLM (2022)|210523|abcdef", "ENTRY": "Organelles, Membraneless", "MN": "A11.284.037", "MH_TH": "NLM (2022)", "ST": "T026", "PI": "Organelles (2015-2021)", "MS": "Membraneless intracellular compartments formed through liquid-liquid phase separation from the surrounding CYTOPLASM or nucleoplasm or by the concentration of proteins and nucleic acids into droplets as they aggregate on static cellular structures such as CELL MEMBRANES. Examples include CELL NUCLEOLI; STRESS GRANULES; PARASPECKLES; HISTONE LOCUS BODIES; and POSTSYNAPTIC DENSITIES.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091582"}, {"RECTYPE": "D", "MH": "Weight Cycling", "AQ": "DE GE IM PH RE", "ENTRY": "Cycling, Weight", "MN": "G07.345.249.314.120.200.963.500", "FX": "Body-Weight Trajectory", "MH_TH": "NLM (2022)", "ST": "T184", "MS": "Repeated cycles of weight loss followed by weight gain.", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091622"}, {"RECTYPE": "D", "MH": "Urogenital Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Genitourinary Diseases|T047|NON|EQV|NLM (2022)|210608|abcdef", "ENTRY": "Urogenital Disease", "MN": "C12", "MH_TH": "NLM (2022)", "ST": "T047", "AN": "general or unspecified; MALE UROGENITAL DISEASES and FEMALE UROGENITAL DISEASES are available ", "PI": "Male Urogenital Diseases (1963-2021)", "MS": "Pathological processes of the URINARY TRACT and the reproductive system (GENITALIA).", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091642"}, {"RECTYPE": "D", "MH": "Genital Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Genital Disease", "MN": "C12.100", "MH_TH": "NLM (2022)", "ST": "T047", "AN": "general or unspecified; GENITAL DISEASES, MALE and GENITAL DISEASES, FEMALE are available", "PI": "Genital Diseases, Male (1963-2021)", "MS": "Pathological processes involving the reproductive tract (GENITALIA).", "PM": "2022", "HN": "2022", "MR": "20210707", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091662"}, {"RECTYPE": "D", "MH": "Health Inequities", "PRINT ENTRY": "Health Inequalities|T080|NON|EQV|NLM (2023)|220109|abcdef", "ENTRY": "Inequity, Health", "MN": "N01.224.425.394", "MH_TH": "OBSSR (2022)", "ST": "T080", "AN": "coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "Differences in health status and in the distribution of health resources between different population groups, arising from the social conditions in which people are born, grow, live, work and age (https://www.who.int/news-room/facts-in-pictures/detail/health-inequities-and-their-causes#:~:text=Health%20inequities%20are%20differences%20in,right%20mix%20of%20government%20policies.)", "PM": "2022", "HN": "2022", "MR": "20230531", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091682"}, {"RECTYPE": "D", "MH": "Intersectional Framework", "PRINT ENTRY": "Intersectionality|T058|NON|EQV|OBSSR (2016)|210519|abcdef", "ENTRY": "Intersectional Frameworks", "MN": "I01.880.453", "MH_TH": "OBSSR (2022)", "ST": "T058", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "Interconnections of social categorizations such as race, class, and gender, creating overlapping and interdependent systems of discrimination or disadvantage.", "PM": "2022", "HN": "2022", "MR": "20220708", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091702"}, {"RECTYPE": "D", "MH": "Systemic Racism", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Systematic Racism|T054|NON|EQV|NLM (2023)|211111|abcdef", "ENTRY": "Systematic Racisms", "MN": "I01.880.735.820.500.500.500", "MH_TH": "OBSSR (2022)", "ST": "T054", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "Processes of racism that are embedded in laws (local, state, and federal), policies, and practices of society and its institutions that provide advantages to racial groups deemed as superior, while differentially oppressing, disadvantaging, or otherwise neglecting racial groups viewed as inferior. Differential access to the goods, services, and opportunities of society by race. Institutionalized racism is normative, sometimes legalized, and often manifests as inherited disadvantage. It is structural, having been codified in our institutions of custom, practice, and law, so there need not be an identifiable perpetrator. (ttps://www.cdc.gov/chronicdisease/programs\u2010impact/sdoh.htm)", "PM": "2022", "HN": "2022", "MR": "20220713", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091722"}, {"RECTYPE": "D", "MH": "Social Status", "PRINT ENTRY": "Social Stratification|T054|NON|NRW|OBSSR (2022)|210609|abcdef", "ENTRY": "Stratification, Social", "MN": "I01.880.761.500", "MH_TH": "OBSSR (2022)", "ST": "T054", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "The relative prestige, authority, and privilege of an individual or group.", "PM": "2022", "HN": "2022", "MR": "20220708", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091743"}, {"RECTYPE": "D", "MH": "Ethnic and Racial Minorities", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Racial Minorities|T098|NON|NRW|OBSSR (2016)|210630|abcdef", "ENTRY": "Racial Minority", "MN": "I01.880.853.125", "MH_TH": "OBSSR (2016)", "ST": "T098", "AN": "coordinate with specific ethnic group or racial group if pertinent; for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "Socially constructed groups of people who differ in race, color or national, religious, or cultural origin from the dominant group and is often the majority population of the country in which they live. Ethnic minority groups generally share a common sense of identity and common characteristics such as language, religion, tribe, nationality, race, or a combination thereof.", "PM": "2022", "HN": "2022", "MR": "20220713", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091762"}, {"RECTYPE": "D", "MH": "Social Cohesion", "AQ": "EH", "PRINT ENTRY": "Shared Community|T054|NON|REL|NLM (2023)|211026|abcdef", "ENTRY": "Solidarity, Group", "MN": "N06.850.505.400.800.775.500", "MH_TH": "OBSSR (2022)", "ST": "T054", "AN": "SOCIAL DETERMINANTS OF HEALTH is available", "PI": "Interpersonal Relations (2000-2021)", "MS": "Strength of relationships and the sense of belongingness and solidarity among members of a community (https://www.healthypeople.gov/2020/topics-objectives/topic/social-determinants-health/interventions-resources/social-cohesion).", "PM": "2022", "HN": "2022", "MR": "20220713", "DA": "20210709", "DC": "1", "DX": "20220101", "UI": "D000091782"}, {"RECTYPE": "D", "MH": "Drought Resistance", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Drought Tolerance|T032|NON|NRW|NLM (2023)|210805|abcdef", "ENTRY": "Tolerance, Drought", "MN": "G15.150", "FX": "Droughts", "MH_TH": "NLM (2023)", "ST": "T032", "PI": "Droughts (2009-2022)", "MS": "The ability of a plant to adapt in a drought environment and tolerate a reduction in available water.", "PM": "2023", "HN": "2023", "MR": "20220719", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000091902"}, {"RECTYPE": "D", "MH": "Cognitive Training", "AQ": "CL EC ED ES HI IS LJ MT OG PX SN ST TD", "PRINT ENTRY": "Cognitive Rehabilitation|T061|NON|EQV|NLM (2023)|210808|abcdef", "ENTRY": "Training, Memory", "MN": "N02.421.784.511.250", "MH_TH": "NLM (2023)", "ST": "T061", "PI": "Cognitive Dysfunction (2012-2022)", "MS": "A non-pharmacological form of treatment focusing on guided practice on tasks that target specific cognitive functions. These functions include memory, attention, and problem-solving. (from Cochrane.org/CD013069/DEMENTIA_cognitive-training-people-mild-moderate-dementia)", "PM": "2023", "HN": "2023", "MR": "20211128", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000091942"}, {"RECTYPE": "D", "MH": "Dental Care Team", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Oral Care Team|T058|NON|EQV|NLM (2023)|210810|abcdef", "ENTRY": "Teams, Dental Care", "MN": "N04.590.715.275", "MH_TH": "NLM (2023)", "ST": "T058", "PI": "Patient Care Team (2000-2022)", "MS": "Care of dental patients by a multidisciplinary team usually organized under the leadership of a dentist; each member of the team has specific responsibilities and the whole team contributes to the oral care of the patient.", "PM": "2023", "HN": "2023", "MR": "20211128", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000091982"}, {"RECTYPE": "D", "MH": "Acetohexamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Gamadiabet|T109|T121|TRD|NRW|ES|020719|abbcdef", "MN": "D02.886.590.795.071", "PA": "Hypoglycemic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-acetyl-N-((cyclohexylamino)carbonyl)-", "RN": "QGC8W08I6I", "RR": "968-81-0 (Acetohexamide)", "MS": "A sulfonylurea hypoglycemic agent that is metabolized in the liver to 1-hydrohexamide.", "PM": "66", "HN": "66(64)", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000092"}, {"RECTYPE": "D", "MH": "Document Analysis", "ENTRY": "Document Analyses", "MN": "H01.770.644.241.850.375", "MH_TH": "NLM (2023)", "ST": "T062", "MS": "A form of qualitative research that uses a systematic procedure to analyze documentary evidence and answer specific research questions.", "PM": "2023", "HN": "2023", "MR": "20211128", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092002"}, {"RECTYPE": "D", "MH": "Artificial Life", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Life, Artificial", "MN": "H01.770.644.081", "MH_TH": "NLM (2023)", "ST": "T062", "PI": "Synthetic Biology (2018-2022)", "MS": "Research involving the synthesis of life and life-like phenomena and the application of such techniques toward the enhancement of our theoretical understanding of life and life-like phenomena, studied through the use of computer programs.", "PM": "2023", "HN": "2023", "MR": "20211201", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092003"}, {"RECTYPE": "D", "MH": "Tyrosine Kinase Inhibitors", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tyrosine Protein Kinase Inhibitors|T121|NON|EQV|NLM (2023)|210810|abcdef", "ENTRY": "Kinase Inhibitors, Tyrosine", "MN": "D27.505.519.389.755.875", "MH_TH": "NLM (2023)", "ST": "T121", "RN": "0", "PI": "Protein Kinase Inhibitors (1992-2022)", "MS": "Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES.", "PM": "2023; use TYROSINE PROTEIN KINASE INHIBITORS 2023", "HN": "2023; use TYROSINE PROTEIN KINASE INHIBITORS 2023", "MR": "20230526", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000092004"}, {"RECTYPE": "D", "MH": "Insulin Secretagogues", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Meglitinide Analogues|T121|NON|NRW|NLM (2023)|211029|abcdef", "ENTRY": "Secretogogues, Insulin", "MN": "D27.505.696.422.625", "MH_TH": "NLM (2023)", "ST": "T121", "RN": "0", "PI": "Insulin (1971-2022)", "MS": "Hypoglycemic agents that stimulate INSULIN SECRETION from the PANCREATIC BETA CELL to decrease postprandial BLOOD GLUCOSE.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000092005"}, {"RECTYPE": "D", "MH": "Information Motivation Behavioral Skills Model", "PRINT ENTRY": "Information-Motivation-Behavioral Skills Model|T170|NON|EQV|NLM (2023)|211128|abcdef", "ENTRY": "Skills Models, Information-Motivation-Behavioral", "MN": "E05.599.695.413", "MH_TH": "NLM (2023)", "ST": "T170", "PI": "Models, Psychological (2010-2022)", "MS": "A model for understanding patient behaviors, recognizes three constructs\u2014information, motivation, and behavioral skills\u2014needed to engage in a given health behavior, as specific individual determinants of behavior and behavioral change (Fisher & Fisher; Norton, 2009).", "PM": "2023", "HN": "2023", "MR": "20211128", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092024"}, {"RECTYPE": "D", "MH": "Rapid Diagnostic Tests", "AQ": "CL EC ES HI IS MT PX SN ST TD VE", "PRINT ENTRY": "Rapid Diagnostics|T060|NON|EQV|NLM (2023)|211103|abcdef", "ENTRY": "Rapid Diagnostic", "MN": "N04.590.874.500.625", "MH_TH": "NLM (2023)", "ST": "T060", "PI": "Clinical Laboratory Techniques (2020-2022)", "MS": "Diagnostic assays designed for use at the point-of-care (POC) that can be adapted for use in low-resource settings. These tests are low-cost, simple to operate and read, sensitive, specific, stable at high temperatures, and works in a short period of time.", "PM": "2023", "HN": "2023", "MR": "20211202", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092025"}, {"RECTYPE": "D", "MH": "Bronchiolitis Obliterans Syndrome", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Obstructive Chronic Lung Allograft Dysfunction|T047|NON|EQV|NLM (2023)|210826|abcdef", "ENTRY": "Syndrome, Bronchiolitis Obliterans", "MN": "C20.452.500", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Bronchiolitis Obliterans (1995-2022)", "MS": "Bronchiolitis obliterans complication from allogenic HEMATOPOIETIC STEM CELL TRANSPLANTATION and LUNG TRANSPLANTATION.", "PM": "2023", "HN": "2023", "MR": "20230226", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092122"}, {"RECTYPE": "D", "MH": "Organizing Pneumonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Secondary Organizing Pneumonia|T047|NON|NRW|NLM (2023)|210826|abcdef", "ENTRY": "Secondary Organizing Pneumonias", "MN": "C08.381.495.146.135.140.600", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Cryptogenic Organizing Pneumonia (1995-2022)", "MS": "Any obstructive lung disease characterized by consolidated formation of GRANULATION TISSUE polyps within ALVEOLAR DUCTS AND ALVEOLI. It is classified as either primary (cryptogenic organizing pneumonia) or secondary organizing pneumonia. Secondary organizing pneumonia after transplantation is called bronchiolitis obliterans syndrome.", "PM": "2023", "HN": "2023", "MR": "20211018", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092124"}, {"RECTYPE": "D", "MH": "PPAR-gamma Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Peroxisome Proliferator-Activated Receptor-gamma Agonist|T109|T121|NON|EQV|NLM (2023)|210826|abbcdef", "ENTRY": "gamma Agonist, PPAR", "MN": "D27.505.696.422.688", "MH_TH": "NLM (2023)", "ST": "T121", "RN": "0", "PI": "PPAR gamma (2004-2022)", "MS": "Hypoglycemic agents that specifically target PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA. They increase tissue sensitivity to the insulin action and are used to treat TYPE 2 DIABETES MELLITUS.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000092126"}, {"RECTYPE": "D", "MH": "Platypnea Orthodeoxia Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Platypnea-Orthodeoxia Syndrome|T047|NON|EQV|NLM (2023)|210826|abcdef", "ENTRY": "Syndrome, Platypnea-Orthodeoxia", "MN": "C23.888.852.371.698", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Hypoxia (1992-2022)", "MS": "Orthostatic dyspnea and fall of oxygen blood saturation when standing up which regress by assuming lying position.", "PM": "2023", "HN": "2023", "MR": "20211018", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092129"}, {"RECTYPE": "D", "MH": "Urticaria, Solar", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Solar Urticaria|T047|NON|EQV|NLM (2023)|210826|abcdef", "MN": "C23.550.291.500.360.500.750", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Urticaria (1963-2022)", "MS": "Chromophore-dependent photodermatosis triggered by UV and visible light.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092130"}, {"RECTYPE": "D", "MH": "Pancreas Divisum", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Reverse Pancreatic Divisum|T019|NON|NRW|NLM (2023)|210827|abcdef", "ENTRY": "Pancreatic Divisums", "MN": "C16.131.314.667", "MH_TH": "NLM (2023)", "ST": "T019", "PI": "Pancreatic Ducts (1980-2022)", "MS": "Anatomic variants in PANCREATIC DUCTS characterized by failure of fusion of the ventral and dorsal endodermal buds. Pancreas divisum results in inadequate or no communication between dorsal and ventral ducts. While most cases are asymptomatic, it may be associated with recurrent PANCREATITIS.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092142"}, {"RECTYPE": "D", "MH": "Crystalluria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Crystallurias", "MN": "C23.888.942.169", "FX": "Urinary Calculi", "MH_TH": "NLM (2023)", "ST": "T184", "PI": "Urine (1965-2022)", "MS": "Crystals in the URINE found in urinary sediment analysis. Urinary crystalline may be formed from various metabolites (e.g., CALCIUM\u00a0OXALATES;\u00a0CALCIUM\u00a0PHOSPHATES;\u00a0URATES) and drugs (e.g., SULPHADIAZINE;\u00a0ACYCLOVIR; and\u00a0TRIAMTERENE).", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092162"}, {"RECTYPE": "D", "MH": "Tympanosclerosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tympanic Calcification|T047|NON|EQV|NLM (2023)|210827|abcdef", "ENTRY": "Tympanosclerosis, Intratympanic", "MN": "C09.218.951", "MH_TH": "NLM (2013)", "ST": "T047", "MS": "Calcification of the TYMPANIC MEMBRANE and MIDDLE EAR most often associated with chronic OTITIS MEDIA.", "PM": "2023; see MYRINGOSCLEROSIS 2013-2022", "HN": "2023(2013)", "MR": "20211018", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092163"}, {"RECTYPE": "D", "MH": "Lagophthalmos", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paralytic Lagophthalmos|T184|NON|NRW|NLM (2023)|210827|abcdef", "ENTRY": "Lagophthalmos, Paralytic", "MN": "C11.338.714", "MH_TH": "NLM (2023)", "ST": "T184", "PI": "Eyelid Diseases (1975-2022)", "MS": "Inability to close eyelids completely.", "PM": "2023", "HN": "2023", "MR": "20211018", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092164"}, {"RECTYPE": "D", "MH": "Pharmacophore", "PRINT ENTRY": "Pharmacophore Modeling|T104|NON|EQV|NLM (2023)|211117|abcdef", "ENTRY": "Modelings, Pharmacophore", "MN": "E05.599.595.750", "MH_TH": "NLM (2023)", "ST": "T104", "MS": "A three-dimensional representation of a molecule that is used for modeling recognition of ligands and macromolecular targets.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000092165"}, {"RECTYPE": "D", "MH": "Calcinosis Cutis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Metastatic Calcinosis Cutis|T046|NON|NRW|NLM (2023)|210830|abcdef", "ENTRY": "Cutaneous Calcifications", "MN": "C18.452.174.130.093", "MH_TH": "NLM (2023)", "ST": "T046", "PI": "Calcinosis (1963-2022)", "MS": "Pathological deposition of calcium in the skin and subcutaneous tissue. Excessive calcification of the skin may be associated with underlying diseases that cause tissue damage (e.g., EHLERS-DANLOS\u00a0SYNDROME; PSEUDOXANTHOMA ELASTICUM; ROTHMUND-THOMSON SYNDROME; and WERNER SYNDROME) or that cause abnormal calcium and phosphate metabolism (e.g., CALCIPHYLAXIS; CHRONIC\u00a0KIDNEY\u00a0FAILURE; HYPERPARATHYROIDISM; and SARCOIDOSIS).", "PM": "2023", "HN": "2023", "MR": "20211018", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092182"}, {"RECTYPE": "D", "MH": "Apical Hypertrophic Cardiomyopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Left Ventricular Apical Hypertrophic Cardiomyopathy|T047|NON|NRW|NLM (2023)|210830|abcdef", "ENTRY": "Hypertrophic Cardiomyopathy, Apical", "MN": "C14.280.238.100.250", "MH_TH": "NLM (2023)", "ST": "T046", "PI": "Cardiomyopathy, Hypertrophic (1980-2022)", "MS": "A hypertrophic cardiomyopathy characterized by apical hypertrophy, typically LEFT VENTRICULAR HYPERTROPHY (described as \"ace of spades\" sign), and deep T-wave inversions in EKG. Clinical symptoms include minor symptoms such as CHEST PAIN; DYSPNEA; and SYNCOPE to more complex symptoms such as ATRIAL FIBRILLATION; VENTRICULAR FIBRILLATION; MYOCARDIAL INFARCTION and CONGESTIVE HEART FAILURE. A transient left ventricular apical hypertrophy is sometimes associated with TAKOTSUBO CARDIOMYOPATHY.", "PM": "2023", "HN": "2023", "MR": "20211018", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092183"}, {"RECTYPE": "D", "MH": "Nerve Conduction Studies", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Nerve Conduction Velocity Tests|T060|NON|NRW|NLM (2023)|210830|abcdef", "ENTRY": "Tests, Nerve Conduction", "MN": "E01.370.405.525", "MH_TH": "NLM (2023)", "ST": "T060", "PI": "Neural Conduction (1963-2022)", "MS": "Electrical tests to analyze the function of peripheral nerves by measuring various characteristics of NERVE CONDUCTION such as amplitude, velocity, and latency.", "PM": "2023", "HN": "2023", "MR": "20220408", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092184"}, {"RECTYPE": "D", "MH": "Exercise-Induced Allergies", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wheat-Dependent Exercise-Induced Anaphylaxis|T047|NON|NRW|NLM (2023)|210831|abcdef", "ENTRY": "Wheat Dependent Exercise Induced Anaphylaxis", "MN": "C20.543.480.363", "FX": "Vocal Cord Dysfunction", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Physical Exertion (1971-2022)", "MS": "Allergic reactions following a period of exercise. Elevated serum HISTAMINE and TRYPTASE levels and cutaneous MAST CELL degranulation are often associated with post-exertional allergic reactions which sometimes are triggered only in combination with prior consumption of a specific food such as wheat. Allergic symptoms produced post-exercise range from skin eruption, asthma, bronchospasm, and anaphylaxis.", "PM": "2023", "HN": "2023", "MR": "20211018", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092202"}, {"RECTYPE": "D", "MH": "Focal Cortical Dysplasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Taylor's FCD|T019|EPO|NRW|NLM (2023)|210831|abcdef", "ENTRY": "Taylors FCD", "MN": "C16.131.666.507.400.125", "MH_TH": "NLM (2023)", "ST": "T019", "PI": "Malformations of Cortical Development (2007-2022)", "MS": "Abnormal, non-neoplastic cell proliferation of the CEREBRAL CORTEX confined to an area in any lobe. Focal cortical dysplasia in the temporal lobe is associated with TEMPORAL LOBE EPILEPSY.", "PM": "2023", "HN": "2023", "MR": "20211018", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092222"}, {"RECTYPE": "D", "MH": "Hippocampal Sclerosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mesial Temporal Sclerosis|T047|NON|NRW|NLM (2024)|220915|abcdef", "ENTRY": "Sclerosis, Mesial Temporal", "MN": "C16.131.666.507.400.187", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Sclerosis (1975-2022)", "MS": "Neuronal loss in the hippocampal regions of CA1 and CA4 and less severely CA2 and CA3. Additional loss of hippocampal stratum radiatum, hippocampal atrophy and ASTROGLIOSIS are common. Hippocampal sclerosis is associated with intractable TEMPORAL LOBE EPILEPSY.", "PM": "2023", "HN": "2023", "MR": "20230426", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092223"}, {"RECTYPE": "D", "MH": "Dopaminergic Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Vesicular Monoamine Transporter Type 2 Imaging|T060|NON|NRW|NLM (2023)|210831|abcdef", "ENTRY": "Transporter Imagings, Dopamine", "MN": "E05.629.875.750", "MH_TH": "NLM (2023)", "ST": "T060", "PI": "Dopamine (1996-2022)", "MS": "Functional brain imaging techniques that utilize various RADIONUCLIDE TRACERS that bind to different targets in the SYNAPSES of DOPAMINERGIC NEURONS.", "PM": "2023", "HN": "2023", "MR": "20220408", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092224"}, {"RECTYPE": "D", "MH": "Tuberculosis, Extrapulmonary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Extrapulmonary Tuberculosis|T047|NON|EQV|NLM (2023)|210831|abcdef", "ENTRY": "Tuberculosis, Extra-Pulmonary", "MN": "C01.150.252.410.040.552.846.617", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Tuberculosis (1963-2022)", "MS": "MYCOBACTERIUM infections of organs other than the lung.", "PM": "2023", "HN": "2023", "MR": "20211018", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092225"}, {"RECTYPE": "D", "MH": "Ventricular Outflow Obstruction, Left", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Left Ventricular Outflow Tract Obstruction|T047|NON|EQV|NLM (2023)|210901|abcdef", "ENTRY": "Obstruction, LVOT", "MN": "C14.280.955.875", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "Occlusion of the outflow tract in the LEFT VENTRICLE of the heart.", "PM": "2023; see Ventricular Outflow Obstruction 1988-2022", "HN": "2023(1988)", "MR": "20211018", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092242"}, {"RECTYPE": "D", "MH": "Ventricular Outflow Obstruction, Right", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Right Ventricular Outflow Tract Obstruction|T047|NON|EQV|NLM (2023)|210901|abcdef", "ENTRY": "RVOT Obstructions", "MN": "C14.280.955.937", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "Occlusion of the outflow tract in the RIGHT VENTRICLE of the heart.", "PM": "2023; see Ventricular Outflow Obstruction 1988-2022", "HN": "2023", "MR": "20220711", "DA": "20220711", "DC": "1", "DX": "20230101", "UI": "D000092243"}, {"RECTYPE": "D", "MH": "Isolated Systolic Hypertension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Systolic Hypertension|T047|T184|NON|REL|NLM (2023)|210901|abbcdef", "ENTRY": "Systolic Hypertensions", "MN": "C14.907.489.165.500", "MH_TH": "NLM (2023)", "ST": "T184", "PI": "Hypertension (1981-2022)", "MS": "Hypertension with elevated systolic and normal diastolic blood pressure. It is the most common subtype in the elderly and is related to VASCULAR STIFFNESS and ATHEROSCLEROTIC PLAQUE buildup.", "PM": "2023", "HN": "2023", "MR": "20211018", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092244"}, {"RECTYPE": "D", "MH": "Ultrasonography, Carotid Arteries", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ultrasonography, Carotid Artery|T060|NON|EQV|NLM (2023)|210901|abcdef", "ENTRY": "Ultrasounds, Carotid", "MN": "E01.370.350.850.708", "FX": "Carotid Arteries", "MH_TH": "NLM (2023)", "ST": "T060", "PI": "Ultrasonography (1974-2022)", "MS": "Ultrasound imaging of the CAROTID ARTERIES to measure their morphological components such as arterial wall shape and thickness; ATHEROSCLEROTIC PLAQUE; and STENOSIS. BLOOD CIRCULATION in the carotid is visualized via DOPPLER ULTRASONOGRAPHY.", "PM": "2023", "HN": "2023", "MR": "20220408", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092262"}, {"RECTYPE": "D", "MH": "Multiple Amputations, Traumatic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Multiple Limb Amputations, Traumatic|T037|NON|NRW|NLM (2023)|211014|abcdef", "ENTRY": "Traumatic Multiple Amputations", "MN": "C26.062.500", "MH_TH": "NLM (2023)", "ST": "T037", "AN": "by accident or injury; do not confuse with MULTIPLE AMPUTATION, SURGICAL (see AMPUTATION, SURGICAL), a surgical procedure; /surg: consider also REPLANTATION", "MS": "The loss of part of, or all of, more than one limb, or other appendages of the body due to injury or disease.", "PM": "2023", "HN": "2023", "MR": "20220408", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092283"}, {"RECTYPE": "D", "MH": "MDA-MB-231 Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "MDA-MB-231 Cell Line|T025|ABX|EQV|NLM (2023)|210903|abcdef", "ENTRY": "MDA-MB-231 Cell Lines", "MN": "A11.251.860.180.630", "MH_TH": "NLM (2023)", "ST": "T025", "PI": "Cell Line, Tumor (1989-2022)", "MS": "A human breast cancer cell line that was derived in 1973 from the MALIGNANT PLEURAL EFFUSION of a patient with stage III BREAST CARCINOMA and was characterized as being of breast cancer origin.", "PM": "2023", "HN": "2023", "MR": "20211124", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092302"}, {"RECTYPE": "D", "MH": "M Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Tonsillar M Cells|T025|NON|NRW|NLM (2023)|210920|abcdef", "ENTRY": "Tonsillar M Cell", "MN": "A11.436.578", "MH_TH": "NLM (2023)", "ST": "T025", "PI": "Intestinal Mucosa (1981-2022)", "MS": "A distinct lineage of epithelial cells, present in MUCOSAL TISSUE, that is responsible for the immune sensing and capture of luminal bacteria and other microparticles. They deliver these microparticles, via TRANSCYTOSIS, to lymphoid tissue for efficient mucosal as well as systemic immune responses. Inflammation-induced M cells arising in response to inflammatory conditions may provide microbial access to tissues without normal M cell-associated immune surveillance tissue.", "PM": "2023", "HN": "2023", "MR": "20211124", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092303"}, {"RECTYPE": "D", "MH": "Polypoidal Choroidal Vasculopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polypoidal Choroidal Neovascularization|T033|NON|NRW|NLM (2023)|210917|abcdef", "ENTRY": "Vasculopathy, Polypoidal Choroidal", "MN": "C23.550.589.500.145.500", "MH_TH": "NLM (2023)", "ST": "T046", "PI": "Choroidal Neovascularization (2002-2022)", "MS": "A CHOROID neovascularization characterized by serosanguineous retinal pigment epithelial detachment and leakage of serous exudate sometimes associated with aneurysmal polypoidal lesions.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092342"}, {"RECTYPE": "D", "MH": "Single-Cell Gene Expression Analysis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Single-Cell Transcriptome Analysis|T059|T063|NON|EQV|NLM (2023)|210923|abbcdef", "ENTRY": "Transcriptome Analysis, Single-Cell", "MN": "E05.393.332.375", "MH_TH": "NLM (2023)", "ST": "T063", "AN": "for entry term SINGLE-CELL RNA-SEQ, coordinate with RNA-SEQ", "PI": "Single-Cell Analysis (2010-2022)", "MS": "Assaying the products of GENETIC TRANSCRIPTION in individual cells.", "PM": "2023", "HN": "2023", "MR": "20220407", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092386"}, {"RECTYPE": "D", "MH": "Venom Hypersensitivity", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wasp Sting Hypersensitivity|T047|NON|NRW|NLM (2023)|210924|abcdef", "ENTRY": "Wasp Sting Hypersensitivities", "MN": "C20.543.480.952", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Insect Bites and Stings (1966-2022)", "MS": "Allergic reaction to venoms in insect bites and stings that is triggered by the immune system (i.e., HISTAMINE RELEASE).", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000092422"}, {"RECTYPE": "D", "MH": "Limbal Stem Cell Deficiency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C11.204.720", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Corneal Diseases (1997-2022)", "MS": "Loss or disturbance of limbal STEM CELL function in the CORNEAL LIMBUS resulting in inability to self-renew CORNEAL EPITHELIUM and conjunctivalized corneal surface.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092423"}, {"RECTYPE": "D", "MH": "Kinesiophobia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Phobia, Movement|T048|NON|EQV|NLM (2023)|210927|abcdef", "ENTRY": "Pain Related Activity Avoidance", "MN": "F03.080.725.375", "MH_TH": "NLM (2023)", "ST": "T048", "PI": "Phobic Disorders (2003-2022)", "MS": "Anxiety disorder of persistent and irrational fear of movement following an injury. It is related to perceived disability due to injury and CATASTROPHIZING in fear of (anticipated) PAIN and possibility of REINJURY.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092442"}, {"RECTYPE": "D", "MH": "Knee Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tibial Tuberosity Fractures|T037|NON|NRW|NLM (2023)|210927|abcdef", "ENTRY": "Tuberosity Fractures, Tibial", "MN": "C26.558.554.625", "MH_TH": "NLM (2023)", "ST": "T037", "PI": "Knee Injuries (1963-2022)", "MS": "Fractures of bones at the KNEE and the KNEE JOINT.", "PM": "2023", "HN": "2023", "MR": "20230110", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092443"}, {"RECTYPE": "D", "MH": "Patella Fracture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Kneecap Fractures|T037|NON|EQV|NLM (2023)|210927|abcdef", "ENTRY": "Patella Fractures", "MN": "C26.404.525.375", "MH_TH": "NLM (2023)", "ST": "T037", "MS": "Fractures of the PATELLA.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000092462"}, {"RECTYPE": "D", "MH": "Tibial Plateau Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Medial Tibial Plateau Fractures|T037|NON|NRW|NLM (2023)|210928|abcdef", "ENTRY": "Tibial Plateau Fracture", "MN": "C26.558.857.500", "MH_TH": "NLM (2023)", "ST": "T037", "PI": "Tibial Fractures (1988-2022)", "MS": "Fractures in the proximal portion of the TIBIA which acts as articular surface in the KNEE. They are often associated with knee ligament injuries (e.g., ACL TEARS).", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092463"}, {"RECTYPE": "D", "MH": "Elbow Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Elbow Joint Injuries|T037|NON|REL|NLM (2023)|210928|abcdef", "ENTRY": "Joint Injury, Elbow", "MN": "C26.088.134", "MH_TH": "NLM (2023)", "ST": "T037", "PI": "Elbow Joint (1963-2022)", "MS": "Injuries involving the ELBOW and ELBOW JOINT.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092464"}, {"RECTYPE": "D", "MH": "Radial Head and Neck Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Radial Neck and Head Fractures|T037|NON|EQV|NLM (2023)|210928|abcdef", "ENTRY": "Radial Neck Fracture", "MN": "C26.404.562.678", "MH_TH": "NLM (2023)", "ST": "T037", "PI": "Radius Fractures (1964-2022)", "MS": "Fractures of the proximal head and/or neck of the RADIUS bone near the ELBOW JOINT.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092467"}, {"RECTYPE": "D", "MH": "Bromodomain Containing Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Bromodomain-Containing Proteins|T116|NON|EQV|NLM (2023)|210928|abcdef", "ENTRY": "Proteins, Bromodomain-Containing", "MN": "D12.776.930.900.100", "MH_TH": "NLM (2023)", "ST": "T116", "RN": "0", "PI": "Nuclear Proteins (2001-2022)", "MS": "Non-histone chromosomal proteins that regulate GENE EXPRESSION through a variety of mechanisms including recognizing acetylated HISTONE LYSINE residues and through transcriptional machinery regulation.", "PM": "2023", "HN": "2023 (2001)", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000092468"}, {"RECTYPE": "D", "MH": "Olecranon Fracture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Olecranon Process Fractures|T037|NON|EQV|NLM (2023)|210929|abcdef", "ENTRY": "Fracture, Olecranon Process", "MN": "C26.404.937.773", "MH_TH": "NLM (2023)", "ST": "T037", "PI": "Ulna Fractures (1963-2022)", "MS": "Fractures of the OLECRANON PROCESS at the ELBOW JOINT.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092470"}, {"RECTYPE": "D", "MH": "Elbow Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Proximal Ulna Fractures|T037|NON|NRW|NLM (2023)|210929|abcdef", "ENTRY": "Ulna Fracture, Proximal", "MN": "C26.404.020", "MH_TH": "NLM (2023)", "ST": "T037", "PI": "Fractures, Bone (2006-2022)", "MS": "Fractures of the distal HUMERUS and the proximal ULNA and the RADIUS at the ELBOW JOINT, including the head, anatomic and surgical necks, and tuberosities.", "PM": "2023", "HN": "2023", "MR": "20230110", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092482"}, {"RECTYPE": "D", "MH": "Humeral Fractures, Distal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Trochlear Fractures, Humerus|T037|NON|NRW|NLM (2023)|210929|abcdef", "ENTRY": "Trochlear Fracture, Humerus", "MN": "C26.404.500.500", "MH_TH": "NLM (2023)", "ST": "T037", "PI": "Humerus (1994-2022)", "MS": "Fractures of the distal HUMERUS at the ELBOW JOINT.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092483"}, {"RECTYPE": "D", "MH": "Renin Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Renin Inhibitor|T121|NON|EQV|NLM (2023)|210929|abcdef", "ENTRY": "Renin Inhibitors, Direct", "MN": "D27.505.519.389.745.753", "MH_TH": "NLM (2023)", "ST": "T121", "RN": "0", "PI": "Renin (1967-2022)", "MS": "Agents that inhibit the activity of RENIN and cause VASODILATION.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000092502"}, {"RECTYPE": "D", "MH": "Wrist Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Smith Fracture|T037|EPO|NRW|NLM (2023)|210929|abcdef", "ENTRY": "Wrist Fracture", "MN": "C26.404.968", "MH_TH": "NLM (2023)", "ST": "T037", "PI": "Wrist Injuries (1968-2022)", "MS": "Fractures of the CARPAL BONES, the distal ULNA and/or RADIUS at the WRIST.", "PM": "2023", "HN": "2023", "MR": "20230110", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000092503"}, {"RECTYPE": "D", "MH": "Fibula Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Maisonneuve Fracture Dislocation|T037|EPO|NRW|NLM (2023)|210929|abcdef", "ENTRY": "Shaft Fracture, Fibula", "MN": "C26.404.023", "MH_TH": "NLM (2023)", "ST": "T037", "PI": "Fractures, Bone (1963-2022)", "MS": "Fractures of the FIBULA.", "PM": "2023", "HN": "2023", "MR": "20220711", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092504"}, {"RECTYPE": "D", "MH": "Clinical Relevance", "PRINT ENTRY": "Clinical Significance|T081|NON|EQV|NLM (2023)|210930|abcdef", "ENTRY": "Significance, Clinical", "MN": "N05.715.360.575.575.399.125", "FX": "Confidence Intervals", "MH_TH": "NLM (2023)", "ST": "T081", "MS": "Criteria to determine whether a finding (e.g., clinical examination, lab test, imaging results) requires a medical intervention for meaningful improvement in outcome often to avoid OVERDIAGNOSIS and/or OVERTREATMENT.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092522"}, {"RECTYPE": "D", "MH": "Femoral Fractures, Distal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Medial Femoral Condyle Fractures|T037|NON|NRW|NLM (2023)|210930|abcdef", "ENTRY": "Fracture, Distal Femur", "MN": "C26.558.276.213", "MH_TH": "NLM (2023)", "ST": "T037", "MS": "Fractures of the distal FEMUR from the articular surface in the KNEE to the condylar region of the femur. A subset with a coronal-plane fracture of the distal femur condyle(s) is Hoffa Fracture.", "PM": "2023", "HN": "2023", "MR": "20230531", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000092524"}, {"RECTYPE": "D", "MH": "Hoffa Fracture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hoffa Fragment|T037|EPO|EQV|NLM (2023)|210930|abcdef", "ENTRY": "Fragment, Hoffa", "MN": "C26.558.554.625.250", "MH_TH": "NLM (2023)", "ST": "T037", "PI": "Femoral Fractures (1994-2022)", "MS": "Coronal plane fractures of the FEMUR condyle at the KNEE.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000092525"}, {"RECTYPE": "D", "MH": "Proximal Femoral Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Proximal Femur Fractures|T037|NON|EQV|NLM (2023)|210930|abcdef", "ENTRY": "Proximal Femur Fracture", "MN": "C26.558.276.425.500.500", "MH_TH": "NLM (2023)", "ST": "T037", "PI": "Hip Fractures (1965-2022)", "MS": "Fractures of the proximal FEMUR at the HIP.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000092526"}, {"RECTYPE": "D", "MH": "Dust Mite Allergy", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "House Dust Mite Hypersensitivity|T047|NON|EQV|NLM (2023)|210924|abcdef", "ENTRY": "Hypersensitivity, Dust Mite", "MN": "C20.543.480.680.443.500.500", "FX": "Antigens, Dermatophagoides", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Mites (1970-2022)", "MS": "Allergic rhinitis due to HOUSE DUST MITE ALLERGENS (e.g., Der p 1 of HOUSE DUST MITES) that is triggered by the immune system.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000092542"}, {"RECTYPE": "D", "MH": "Allergic Fungal Sinusitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Sphenoid Allergic Fungal Sinusitis|T047|NON|NRW|NLM (2023)|211001|abcdef", "ENTRY": "Sinusitis, Allergic Fungal", "MN": "C20.543.480.680.038", "MH_TH": "NLM (2023)", "ST": "T047", "AN": "coordinate with specific fungal infection", "PI": "Respiratory Hypersensitivity (1968-2022)", "MS": "Fungal infection in the PARANASAL SINUSES characterized by common allergy respiratory symptoms, recurrent NASAL POLYPS and/or ASTHMA with buildup of allergic MUCIN.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000092562"}, {"RECTYPE": "D", "MH": "Drug Fever", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Drug-Induced Hyperthermia|T047|NON|EQV|NLM (2023)|211004|abcdef", "ENTRY": "Hyperthermia, Drug-Induced", "MN": "C25.100.468.690", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Fever (1964-2022)", "MS": "Drug-induced fever.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000092582"}, {"RECTYPE": "D", "MH": "FODMAP Diet", "AQ": "AE CL EC EH ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Low-FODMAP Diet|T078|NON|REL|NLM (2023)|211006|abcdef", "ENTRY": "Low-FODMAP Diets", "MN": "G07.203.650.240.333.500", "MH_TH": "NLM (2023)", "ST": "T078", "PI": "Diet, Carbohydrate-Restricted (2012-2022)", "MS": "A type of elimination diet restricting from foods with fermentable oligosaccharides, disaccharides, monosaccharides, and polyols, to help determine if specific foods containing these carbohydrates are triggering symptoms of IRRITABLE BOWEL SYNDROME.", "PM": "2023", "HN": "2023", "MR": "20220407", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092622"}, {"RECTYPE": "D", "MH": "Schlemm's Canal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sinus Venosus Sclerae|T023|NON|EQV|NLM (2023)|211025|abcdef", "ENTRY": "Schlemms Canal", "MN": "A09.371.060.217.659.250", "MH_TH": "NLM (2023)", "ST": "T023", "PI": "Cornea (1966-2022)", "MS": "A circular vascular-like structure in the anterior chamber of the eye bounded anterolaterally by the internal scleral sulcus and posteriorly by the trabecular meshwork. It is a part of a pathway where the AQUEOUS HUMOR from the ANTERIOR CHAMBER of the eye passes through the TRABECULAR MESHWORK, drains into the lumen of Schlemm\u2019s canal, and subsequently returns to blood circulation into the veins of the SCLERA.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092662"}, {"RECTYPE": "D", "MH": "Meibomitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Meibomianitis|T047|NON|EQV|NLM (2023)|211101|abcdef", "MN": "C11.338.133.500", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Blepharitis (1993-2022)", "MS": "An inflammation of MEIBOMIAN GLANDS.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000092663"}, {"RECTYPE": "D", "MH": "Sigesbeckia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "St. Paul's Wort|T002|NON|EQV|NLM (2023)|211012|abcdef", "ENTRY": "St. Pauls Wort", "MN": "B01.875.800.575.912.250.100.808", "MH_TH": "NLM (2023)", "ST": "T002", "RN": "txid183075", "PI": "Asteraceae (2002-2022)", "MS": "A plant genus of the family ASTERACEAE. It has been used in traditional herbal medicine and commonly referred to as St. Paul's wort. It produces an unpleasant smell and is sometimes referred to as pig pungent weed.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092664"}, {"RECTYPE": "D", "MH": "Motion Capture", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Optical Motion Capture|T060|NON|NRW|NLM (2023)|211012|abcdef", "ENTRY": "Movement Capture, Biomechanical", "MN": "L01.280.960.200", "FX": "Wearable Electronic Devices", "MH_TH": "NLM (2023)", "ST": "T060", "MS": "Technological process of recording the MOTION and MOVEMENT of objects (e.g., surgical instrument in robotic surgery), body parts (e.g., EYE MOVEMENT), animals or people.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092682"}, {"RECTYPE": "D", "MH": "Chronic Kidney Diseases of Uncertain Etiology", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mesoamerican Nephropathy|T047|NON|EQV|NLM (2023)|211013|abcdef", "ENTRY": "Uncertain Etiology CKD", "MN": "C24.080.183", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Renal Insufficiency, Chronic (2014-2022)", "MS": "Chronic kidney diseases not associated with traditional RISK FACTORS, e.g., TYPE 2 DIABETES MELLITUS and HYPERTENSION, but rather with infectious diseases, exposure to environmental toxins, or other unknown factors. They are most prevalent in agricultural communities of DEVELOPING COUNTRIES.", "PM": "2023", "HN": "2023", "MR": "20220711", "DA": "20220711", "DC": "1", "DX": "20230101", "UI": "D000092702"}, {"RECTYPE": "D", "MH": "Electroporation Therapies", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Therapeutic Use of Electroporation|T061|NON|EQV|NLM (2023)|211014|abcdef", "ENTRY": "Therapy, Electroporation", "MN": "E05.301.500.750", "MH_TH": "NLM (2023)", "ST": "T061", "PI": "Electroporation (1998-2022)", "MS": "Treatment modalities that use pulsed electrical currents to permeabilize cell membranes and thereby enhance uptake of substances into cells of the body.", "PM": "2023", "HN": "2023", "MR": "20220407", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092722"}, {"RECTYPE": "D", "MH": "Irreversible Electroporation Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Pulse Field Ablation|T061|NON|NRW|NLM (2023)|211014|abcdef", "ENTRY": "Therapy, Irreversible Electroporation", "MN": "E05.301.500.750.750", "MH_TH": "NLM (2023)", "ST": "T061", "PI": "Electroporation (2010-2022)", "MS": "The use of a dose of electricity that causes the pores that are formed  in CELL MEMBRANES during ELECTROPORATION to remain open long enough to trigger CELL DEATH. It is sometimes used in conjunction with ELECTROCHEMOTHERAPY.", "PM": "2023", "HN": "2023", "MR": "20220408", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092723"}, {"RECTYPE": "D", "MH": "Elimination Diets", "AQ": "AE CL EC EH ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Elimination Diet|T078|NON|EQV|NLM (2023)|211015|abcdef", "ENTRY": "Diets, Elimination", "MN": "G07.203.650.240.333", "MH_TH": "NLM (2023)", "ST": "T078", "PI": "Food Hypersensitivity (1963-2022)", "MS": "Temporary dietary restrictions designed to help identify specific foods or FOOD ADDITIVES that trigger ALLERGIC REACTIONS, symptoms of DIGESTIVE SYSTEM DISORDERS, or other adverse food reactions.", "PM": "2023", "HN": "2023", "MR": "20220407", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092724"}, {"RECTYPE": "D", "MH": "Diversity, Equity, Inclusion", "PRINT ENTRY": "Inclusion, Diversity, Equality, Accessibility|T077|NON|REL|NLM (2023)|220815|abcdef", "MN": "I01.880.853.100.450.500", "MH_TH": "NLM (2023)", "ST": "T077", "PI": "Cultural Diversity (1996-2022)", "MS": "Developing and ensuring compliance with laws, regulations, and policies that support civil rights, equity, diversity, and inclusion. Executive Order 13985 (Advancing Racial Equity and Support for Underserved Communities Through the Federal Government), which established that affirmatively advancing equity, civil rights, racial justice, and equal opportunity is the responsibility of the whole of our Government.", "PM": "2023", "HN": "2023", "MR": "20220815", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092783"}, {"RECTYPE": "D", "MH": "Family Support", "AQ": "EC HI LJ MT PX SN TD", "PRINT ENTRY": "Family Encouragement|T054|NON|EQV|NLM (2023)|211026|abcdef", "ENTRY": "Support, Family", "MN": "I01.880.853.500.600.375", "MH_TH": "NLM (2023)", "ST": "T054", "PI": "Social Support (1983-2022)", "MS": "Support systems that provide assistance and encouragement between and among members of a FAMILY.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092802"}, {"RECTYPE": "D", "MH": "Family Structure", "AQ": "EH HI", "PRINT ENTRY": "Stepparent Family|T099|NON|NRW|NLM (2023)|211027|abcdef", "ENTRY": "Structure, Family", "MN": "N06.850.505.400.400.580", "MH_TH": "NLM (2023)", "ST": "T099", "PI": "Family Characteristics (1963-2022)", "MS": "Structural nature of relationships among members of a household typically in reference to a MINOR residing in the same home. More broadly any organizational framework that determines family membership, and the functions and hierarchical position of family members (https://eric.ed.gov/?qt=Family+Structure&ti=Family+Structure).", "PM": "2023; for STEPFAMILY and FAMILY, RECONSTITUTED see FAMILY 1996-2022; for MATRIARCHY and PATRIARCHY see FAMILY CHARACTERISTICS 1995-2022", "HN": "2023; for STEPFAMILY and FAMILY, RECONSTITUTED use FAMILY 1996-2022; for MATRIARCHY and PATRIARCHY use FAMILY CHARACTERISTICS 1995-2022", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092822"}, {"RECTYPE": "D", "MH": "Extended Family", "AQ": "EH HI", "PRINT ENTRY": "Multigenerational Household|T099|NON|EQV|NLM (2023)|211027|abcdef", "ENTRY": "Multigenerational Households", "MN": "N06.850.505.400.400.580.500", "MH_TH": "POPLINE (1978)", "ST": "T099", "MS": "A household with members of at least three generations.", "PM": "2023; see FAMILY 1979-2022", "HN": "2023; use FAMILY 1979-2022", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092842"}, {"RECTYPE": "D", "MH": "Tobacco Control", "AQ": "EC HI LJ TD", "PRINT ENTRY": "Tobacco Regulation|T089|NON|NRW|NLM (2023)|211027|abcdef", "ENTRY": "Tobacco Regulations", "MN": "N03.623.500.608.428.825", "MH_TH": "NLM (2023)", "ST": "T089", "PI": "Smoking (1990-2022)", "MS": "Policies, regulations and programs implemented to encourage SMOKING PREVENTION and reduce TOBACCO USE DISORDER by various measures, e.g., TOBACCO INDUSTRY regulation, SMOKE-FREE POLICY and SMOKE CESSATION programs .", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092843"}, {"RECTYPE": "D", "MH": "Psychological Well-Being", "AQ": "LJ PX", "PRINT ENTRY": "Psychological Wellness|T080|NON|REL|NLM (2023)|211027|abcdef", "ENTRY": "Wellness, Psychological", "MN": "N06.850.505.400.425.837.500", "MH_TH": "NLM (2023)", "ST": "T080", "PI": "Quality of Life (1992-2022)", "MS": "Condition of existence, or state of awareness, in which psychological needs are satisfied", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092862"}, {"RECTYPE": "D", "MH": "Access to Primary Care", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Accessible Primary Care|T080|NON|REL|NLM (2023)|211027|abcdef", "ENTRY": "Primary Care, Accessible", "MN": "N05.300.430.188", "FX": "Primary Health Care", "MH_TH": "NLM (2023)", "ST": "T080", "PI": "Primary Health Care (1979-2022)", "MS": "The degree to which individuals are inhibited or facilitated in their ability to gain entry to and to receive PRIMARY CARE.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000092863"}, {"RECTYPE": "D", "MH": "Suicide Prevention", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Suicide Awareness|T061|NON|REL|NLM (2023)|211027|abcdef", "ENTRY": "Suicide Preventions", "MN": "N02.421.726.843", "MH_TH": "NLM (2023)", "ST": "T061", "PI": "Suicide (1963-2022)", "MS": "Specific strategies for averting suicides. These include mental HEALTH PROMOTION and monitoring PSYCHOLOGICAL WELL-BEING and other intervention programs targeting susceptible individuals.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092864"}, {"RECTYPE": "D", "MH": "Social Group", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Social Unit|T092|NON|EQV|NLM (2023)|211028|abcdef", "ENTRY": "Unit, Social", "MN": "N03.540.805", "MH_TH": "NLM (2023)", "ST": "T092", "PI": "Social Behavior (1968-2022)", "MS": "A collection of two or more people who share a common identity as defined by beliefs, codes of conduct, CULTURE and SOCIAL NORMS.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092882"}, {"RECTYPE": "D", "MH": "Collective Efficacy", "AQ": "PX", "PRINT ENTRY": "Team Efficacy|T054|NON|EQV|NLM (2023)|211029|abcdef", "ENTRY": "Team Efficacies", "MN": "N06.850.505.400.800.775.250", "MH_TH": "NLM (2023)", "ST": "T054", "PI": "Self Efficacy (1999-2022)", "MS": "A group belief and perception in its ability to complete a task successfully. It includes shared belief it can control deviant behavior of a member.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092885"}, {"RECTYPE": "D", "MH": "Low Socioeconomic Status", "AQ": "HI", "PRINT ENTRY": "Low Socioeconomic Level|T080|NON|EQV|NLM (2023)|211028|abcdef", "ENTRY": "Status, Low Socioeconomic", "MN": "N01.824.782.337", "MH_TH": "NLM (2023)", "ST": "T080", "MS": "Socioeconomic status with relatively low income and/or assets (POVERTY) and EDUCATIONAL LEVEL.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092886"}, {"RECTYPE": "D", "MH": "Working Conditions", "AQ": "CL EC HI LJ OG PX SN ST TD", "PRINT ENTRY": "Workplace Environment|T082|NON|NRW|NLM (2023)|211029|abcdef", "ENTRY": "Workplace Environments", "MN": "N04.452.677.975.500", "MH_TH": "NLM (2023)", "ST": "T082", "PI": "Workplace (1993-2022)", "MS": "Conditions of a WORKPLACE such as weather (e.g., indoor or outdoor), safety (e.g., exposure to hazardous materials), environment and workplace culture and management style.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092922"}, {"RECTYPE": "D", "MH": "Group Dynamics", "AQ": "PX", "PRINT ENTRY": "Social Loafing|T054|NON|NRW|NLM (2023)|211028|abcdef", "ENTRY": "Social Loafings", "MN": "F01.829.316.223", "MH_TH": "NLM (2023)", "ST": "T054", "PI": "Group Processes (1963-2022)", "MS": "Processes of change in any social group from formation to functioning. It includes various forces that drive relationship among members and interaction with other groups.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092923"}, {"RECTYPE": "D", "MH": "Resource-Limited Settings", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Resource Limited Regions|T080|NON|EQV|NLM (2023)|211102|abcdef", "ENTRY": "Settings, Resource-Limited", "MN": "N05.300.420.550", "FX": "Wilderness Medicine", "MH_TH": "NLM (2023)", "ST": "T080", "PI": "Health Resources (1990-2022)", "MS": "Environments with barriers to quality critical care characterized by lack of epidemiological data and context-specific evidence for medical decision-making, deficiencies in health systems organization and resources, and institutional obstacles to implementation of life-saving interventions.", "PM": "2023", "HN": "2023", "MR": "20230530", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000092943"}, {"RECTYPE": "D", "MH": "Tattoo Removal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tattoo Removals", "MN": "E04.014.520.775", "MH_TH": "NLM (2023)", "ST": "T061", "MS": "Procedures to remove a tattoo. They may include laser surgery, excisional surgery, dermabrasion, or application of topical agents.", "PM": "2023", "HN": "2023", "MR": "20220719", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000092945"}, {"RECTYPE": "D", "MH": "Theory of Planned Behavior", "PRINT ENTRY": "Theory of Reasoned Action|T077|NON|BRD|NLM (2023)|211220|abcdef", "ENTRY": "Theory, Planned Behavior", "MN": "F02.985", "MH_TH": "NLM (2023)", "ST": "T077", "MS": "The construct in which intentions to perform behaviors of different kinds can be predicted with high accuracy from attitudes toward the behavior, subjective norms, and perceived behavioral control; and these intentions, together with perceptions of behavioral control, account for considerable variance in actual behavior. (from Ajzen, Organizational Behavior and Human Decision Processes, V.50, Issue 2, p.179-211.)", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000092963"}, {"RECTYPE": "D", "MH": "Food, Processed", "AQ": "CL EC ES HI LJ MT SN ST", "PRINT ENTRY": "Ultra-Processed Foods|T168|NON|EQV|NLM (2023)|211220|abcdef", "ENTRY": "Ultra-Processed Food", "MN": "J02.500.523", "MH_TH": "NLM (2023)", "ST": "T168", "PI": "Food (2010-2022)", "MS": "Any raw agricultural commodity that has been subject to washing, cleaning, milling, cutting, chopping, heating, pasteurizing, blanching, cooking, canning, freezing, drying, dehydrating, mixing, packaging or other procedures that alter the food from its natural state. (from  A Guide to Federal Terms and Acronyms. Lanham, MD: Government Institutes.1991)", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000092965"}, {"RECTYPE": "D", "MH": "Acetoin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acetylmethylcarbinol|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "3H-2B butanone|T109|T123|NON|EQV|NLM (2009)|070204|abbcdef", "MN": "D02.522.296.100", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "2-Butanone, 3-hydroxy-", "RN": "BG4D34CO2H", "RR": "513-86-0 (Acetoin)", "PI": "Butanones (1970-1974)", "MS": "A product of fermentation. It is a component of the butanediol cycle in microorganisms. In mammals it is oxidized to carbon dioxide.", "PM": "1991; 3-HYDROXY-2-BUTANONE was indexed under ACETOIN 2008, & under BUTANONES 2007", "HN": "1991(1975)", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000093"}, {"RECTYPE": "D", "MH": "Partial Weight-Bearing", "AQ": "PH", "ENTRY": "Weight-Bearing, Partial", "MN": "G01.374.965.500", "MH_TH": "NLM (2023)", "ST": "T042", "PI": "Weight-Bearing (2022)", "MS": "The  state of supporting a body to simulate partial or applied load.", "PM": "2023", "HN": "2023", "MR": "20220711", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000093002"}, {"RECTYPE": "D", "MH": "Motorized Mobility Scooter", "PRINT ENTRY": "Scooter Motorized|T073|NON|EQV|NLM (2023)|211109|abcdef", "ENTRY": "Scooters, Motorized Mobility", "MN": "E07.796.980.500", "MH_TH": "NLM (2023)", "ST": "T073", "MS": "A device ridden while seated that usually has three or four wheels, is typically propelled by an electric motor, and is used by those with limited or impaired mobility.", "PM": "2023", "HN": "2023", "MR": "20220531", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093102"}, {"RECTYPE": "D", "MH": "Bridge Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapies, Bridge", "MN": "E02.134", "MH_TH": "NLM (2023)", "ST": "T061", "PI": "Treatment Outcome (2000-2022)", "MS": "Treatment used in a transition between former and new therapeutic regimes.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000093142"}, {"RECTYPE": "D", "MH": "Comprehensive Metabolic Panel", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Comprehensive Metabolic Panel Testing|T059|T060|NON|EQV|NLM (2023)|211210|abbcdef", "ENTRY": "Testings, CMP", "MN": "E05.200.124.100.174", "MH_TH": "NLM (2023)", "ST": "T060", "PI": "Diagnostic Tests, Routine (2012-2022)", "MS": "A series of blood tests on one panel that measure the body's chemical balance and metabolism.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000093182"}, {"RECTYPE": "D", "MH": "Cytology", "AQ": "CL EC ED ES HI IS LJ OG SN ST TD", "PRINT ENTRY": "Cytopathology|T060|NON|NRW|NLM (2023)|211210|abcdef", "ENTRY": "Cytopathologies", "MN": "H02.403.650.500.500", "EC": "methods:Cytological Techniques", "MH_TH": "NLM (2023)", "ST": "T091", "AN": "the discipline only (education, history, etc); for cytological structures use the qualifer /cytol with specific anatomical term or organism; for pathological structures use the qualifer /pathol with specific anatomical term", "MS": "The study of single cell as a unit of living organisms. Cytopathology, a branch of this discipline, studies structural changes of cells in diseases and is used in diagnosing diseases.", "PM": "2023; CYTOLOGY was indexed under CELL BIOLOGY 1984-2022", "HN": "2023 (1984)", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000093222"}, {"RECTYPE": "D", "MH": "Interleukin-6 Inhibitors", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "IL6 inhibitors|T121|NON|EQV|NLM (2023)|211210|abcdef", "ENTRY": "inhibitors, IL6", "MN": "D27.505.696.477.656.594", "MH_TH": "NLM (2023)", "ST": "T121", "RN": "0", "PI": "Interleukin-6 (2008-2022)", "MS": "Immunosuppressive agents which inhibit the action of INTERLEUKIN-6.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000093242"}, {"RECTYPE": "D", "MH": "Limbal Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Limbal Epithelial Stem Cells of the Cornea|T025|NON|EQV|NLM (2023)|211123|abcdef", "ENTRY": "Stem Cells, Limbal", "MN": "A11.872.040.750", "MH_TH": "NLM (2023)", "ST": "T025", "PI": "Limbus Corneae (1992-2022)", "MS": "Adult somatic stem cells found in the basal epithelial layer of the LIMBUS CORNEAE.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093282"}, {"RECTYPE": "D", "MH": "Non-Muscle Invasive Bladder Neoplasms", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Non-Muscle-Invasive Bladder Cancer|T191|NON|EQV|NLM (2023)|211123|abcdef", "ENTRY": "Non Muscle Invasive Bladder Neoplasms", "MN": "C12.950.983.945.500", "MH_TH": "NLM (2023)", "ST": "T191", "PI": "Urinary Bladder Neoplasms (2004-2022)", "MS": "A urothelial carcinoma found in the tissue that lines the inner surface of the bladder. The bladder muscle is not involved.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000093284"}, {"RECTYPE": "D", "MH": "Lymphocyte Activation Gene 3 Protein", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Lymphocyte Activation Gene 3 Proteins|T116|T129|NON|EQV|NLM (2023)|220204|abbcdef", "ENTRY": "CD223 Antigens", "MN": "D23.101.100.894.121", "FX": "Lymphocyte Activation", "MH_TH": "NLM (2023)", "ST": "T129", "RN": "0", "PI": "Lymphocyte Activation (1998-2022)", "MS": "A CD4-related protein with high affinity cell surface binding to MHC class II. It functions in downregulation of T cell proliferation following binding to MHC class II molecules.", "PM": "2023; LYMPHOCYTE ACTIVATION GENE 3 PROTEIN was indexed under ANTIGENS, CD 1993-2022", "HN": "2023 (1992)", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000093322"}, {"RECTYPE": "D", "MH": "Prorenin Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Renin Receptor|T192|NON|EQV|NLM (2023)|220714|abcdef", "ENTRY": "Receptor, Renin", "MN": "D12.776.543.750.608", "MH_TH": "NLM (2023)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (2002-2022)", "MS": "Single-pass transmembrane receptor protein that plays an important role in ANGIOTENSIN II production and cellular responses to RENIN.", "PM": "2023; PRORENIN RECEPTOR was indexed under RECEPTOR, CELL SURFACE 2002-2022", "HN": "2023 (2002)", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000093342"}, {"RECTYPE": "D", "MH": "Dietary Advanced Glycation End Products", "AQ": "AD AE AG AI AN BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Maillard Reaction Products, Dietary|T109|T123|NON|EQV|NLM (2023)|211210|abbcdef", "ENTRY": "AGEs, Dietary", "MN": "J02.500.356", "MH_TH": "NLM (2023)", "ST": "T123", "RN": "0", "PI": "Glycation End Products, Advanced (2004-2022)", "MS": "Advanced glycation end products (AGEs) present in food. They are absorbed by the GASTROINTESTINAL SYSTEM and contribute to the body's total AGEs. The food BROWNING REACTION, such as occurs during food processing or cooking with high heat (frying, broiling, grilling, roasting, etc.) accelerates the formation of AGEs in food.", "PM": "2023", "HN": "2023", "MR": "20220406", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093362"}, {"RECTYPE": "D", "MH": "Schinus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Peppertree, California|T002|EPO|NRW|NLM (2003)|011010|abcdef", "ENTRY": "California Peppertree", "MN": "B01.875.800.575.912.250.044.686", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43850", "MS": "A plant genus of the family ANACARDIACEAE.", "PM": "2023; see ANACARDIACEAE 2003-2022", "HN": "2023(2003)", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093382"}, {"RECTYPE": "D", "MH": "Glycated Serum Proteins", "AQ": "AA AD AE AG AI AN CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serum Protein, Glycosylated|T116|T123|NON|EQV|NLM (2023)|211220|abbcdef", "ENTRY": "Serum Proteins, Glycosylated", "MN": "D23.946.381.625.500", "MH_TH": "NLM (2023)", "ST": "T123", "RN": "0", "MS": "Proteins in serum that have undergone, in vivo, non-enzymatic modification with reducing sugars via the MAILLARD REACTION. They are analyzed to measure control of HYPERGLYCEMIA.", "PM": "2023; GLYCOSYLATED SERUM PROTEIN now GLYCATED SERUM PROTEINS was indexed under BLOOD PROTEINS and GLYCOPROTEINS 1981-2022", "HN": "2023", "MR": "20230316", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093422"}, {"RECTYPE": "D", "MH": "Glycated Serum Albumin", "AQ": "AA AD AE AG AI AN CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serum Albumin, Glycosylated|T116|T123|NON|EQV|NLM (2023)|211220|abbcdef", "ENTRY": "Serum Glycated Albumin", "MN": "D23.946.381.625.500.500", "MH_TH": "NLM (2023)", "ST": "T123", "RN": "0", "MS": "Serum albumin that has undergone, in vivo, spontaneous, non-enzymatic modification with reducing sugars via the MAILLARD REACTION. They are analyzed to measure control of HYPERGLYCEMIA.", "PM": "2023; GLYCATED SERUM ALBUMIN was indexed under SERUM ALBUMIN 1981-2022 and GLYCATION END PRODUCTS, ADVANCED 2021-2022", "HN": "2023", "MR": "20230316", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093423"}, {"RECTYPE": "D", "MH": "COVID-19 Drug Treatment", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Coronavirus Disease-19 Drug Treatment|T061|NON|EQV|NLM (2023)|211228|abcdef", "ENTRY": "Treatment, COVID-19 Drug", "MN": "E02.319.231", "MH_TH": "NLM (2023)", "ST": "T061", "MS": "The use of DRUGS to treat COVID19 or its symptoms.", "PM": "2023; COVID19 DRUG TREATMENT was indexed under DRUG THERAPY 2020-2021, and under COVID-19 2020-2021", "HN": "2023 (2020)", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000093485"}, {"RECTYPE": "D", "MH": "COVID-19 Serotherapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "SARS-CoV-2 Convalescent Serum Treatment|T061|NON|NRW|NLM (2023)|211229|abcdef", "ENTRY": "Therapy, COVID19 Serum", "MN": "E05.478.550.520.050.200", "MH_TH": "NLM (2023)", "ST": "T061", "MS": "Transfer of blood plasma derived from patients who have recovered from COVID-19 to non-immune hosts.", "PM": "2023; COVID-19 SEROTHERAPY was indexed under COVID-19 2020-2022, and IMMUNIZATION, PASSIVE 2020-2022", "HN": "2023 (2020)", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000093522"}, {"RECTYPE": "D", "MH": "Gemcitabine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gemicitabine|T114|T121|NON|EQV|NLM (2023)|220104|abbcdef", "ENTRY": "Hydrochloride, Gemcitabine", "MN": "D03.383.742.680.245.500.775", "MH_TH": "NLM (2023)", "ST": "T121", "RN": "0", "MS": "A deoxycytidine antimetabolite used as an antineoplastic agent.", "PM": "2023; GEMCITABINE was indexed under DEOXYCYTIDINE 1988-2022", "HN": "2023 (1988)", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000093542"}, {"RECTYPE": "D", "MH": "Phalloplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Reconstructive Penis Surgery|T061|NON|EQV|NLM (2023)|220111|abcdef", "ENTRY": "Surgery, Reconstructive Penis", "MN": "E04.617.575", "FX": "Penile Transplantation", "MH_TH": "NLM (2023)", "ST": "T061", "PI": "Penis/surgery (1965-2022)", "MS": "Surgery to restore, reconstruct, or improve the shape or appearance of a damaged, misshapen, or missing PENIS due to injury, disease, or developmental abnormalities.", "PM": "2023", "HN": "2023", "MR": "20220406", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093562"}, {"RECTYPE": "D", "MH": "Lacticaseibacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.450.606", "MH_TH": "NLM (2023)", "ST": "T007", "PI": "Lactobacillus (1963-2022)", "MS": "A genus of gram-positive, non-motile, homofermentative, oxidase negative, rod-shaped bacteria occurring widely in nature. Its species previously were referred to as Lactobacillus casei group. The genus harbors several species that are used as starter cultures in dairy fermentations and as probiotics.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093622"}, {"RECTYPE": "D", "MH": "Uterine Didelphys", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Uterus Didelphys with Imperforated Vagina|T019|NON|NRW|NLM (2023)|220111|abcdef", "ENTRY": "Uterus, Didelphic", "MN": "C12.050.351.500.852.667.500", "MH_TH": "NLM (2023)", "ST": "T019", "PI": "Urogenital Abnormalities (1965-2022)", "MS": "An abnormality in which the MULLARIAN DUCTS do not properly join to form a single uterus during embryological development instead resulting in complete duplication of uterine horns and duplication of the cervix. Double uterus is associated with double cervix and vagina and sometimes renal agenesis.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000093642"}, {"RECTYPE": "D", "MH": "Uterine Duplication Anomalies", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Double Womb|T019|NON|EQV|NLM (2023)|220111|abcdef", "ENTRY": "Womb, Double", "MN": "C16.131.939.957", "MH_TH": "NLM (2023)", "ST": "T019", "PI": "Urogenital Abnormalities (1964-2022)", "MS": "A group of anomalies in which the UTERUS is duplicated due to abnormal fusion of the MULLERIAN DUCT during embryonic development.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000093662"}, {"RECTYPE": "D", "MH": "Bicornuate Uterus", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Double Uterus and Longitudinal Vaginal Septum|T019|NON|NRW|NLM (2023)|220111|abcdef", "ENTRY": "Uterus, Bicornuate Unicollis", "MN": "C12.050.351.500.852.667.250", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Urogenital Abnormalities (1963-2022)", "MS": "A congenital uterine anomaly in which the UTERUS is divided into two uterine horns with a significant cleft at the uterine fundus due to partial fusion of the MULLERIAN DUCTS. Bicornuate uterus is sometimes associated with a longitudinal vaginal septum and abnormal development of renal tracts.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000093663"}, {"RECTYPE": "D", "MH": "Septate Uterus", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Uterine Septum|T019|NON|EQV|NLM (2023)|220112|abcdef", "ENTRY": "Uterus, Subseptate", "MN": "C12.050.351.500.852.667.375", "MH_TH": "NLM (2023)", "ST": "T019", "PI": "Urogenital Abnormalities (2004-2022)", "MS": "A congenital duplication of the UTERUS in which a septum is formed separating the uterus. The partitioning septum can also separate the CERVIX and VAGINA.", "PM": "2023", "HN": "2023", "MR": "20221028", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000093665"}, {"RECTYPE": "D", "MH": "Penile Transplantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Penis Transplantation|T061|NON|EQV|NLM (2023)|220111|abcdef", "ENTRY": "Transplantation, Penis", "MN": "E04.936.864.850.750", "FX": "Phalloplasty", "MH_TH": "NLM (2023)", "ST": "T061", "PI": "Penis/transplantation (2003-2022)", "MS": "Surgical transference of the PENIS (or the PENIS and SCROTUM together) as a complete organ and the composite of many tissue types, from one individual to another.", "PM": "2023", "HN": "2023", "MR": "20220406", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093667"}, {"RECTYPE": "D", "MH": "Value-Based Health Care", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Value-Based Healthcare|T058|NON|EQV|NLM (2023)|220112|abcdef", "ENTRY": "Value-Based Healthcares", "MN": "N05.300.915", "MH_TH": "NLM (2023)", "ST": "T058", "PI": "Delivery of Health Care (2016-2022)", "MS": "Health system model designed to maximize value for patients. Value based healthcare often emphasizes better patient outcomes for healthcare cost through best practices (e.g., preventive screening, quality incentives).", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000093683"}, {"RECTYPE": "D", "MH": "Immunonutrition Diet", "AQ": "AE CL EC EH ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Immunonutrition|T168|NON|REL|NLM (2023)|220113|abcdef", "ENTRY": "Immunonutrition Diets", "MN": "G07.203.650.240.732", "MH_TH": "NLM (2023)", "ST": "T168", "PI": "Enteral Nutrition (1992-2022)", "MS": "Diets supplemented with nutrients that beneficially stimulate the IMMUNE RESPONSE and improve control of inflammatory processes.", "PM": "2023", "HN": "2023", "MR": "20220406", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093702"}, {"RECTYPE": "D", "MH": "Breakthrough Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vaccine Breakthrough Infections|T047|NON|NRW|NLM (2023)|220119|abcdef", "ENTRY": "Vaccine Breakthrough Infection", "MN": "C23.550.291.219", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Infections (1963-2022)", "MS": "Infections by the same infectious agent (e.g., virus, fungus) occurring during exposure to prophylaxis, vaccine and treatment.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093742"}, {"RECTYPE": "D", "MH": "Random Forest", "PRINT ENTRY": "Random Forest Classification|T170|NON|EQV|NLM (2023)|220119|abcdef", "ENTRY": "Random Forests", "MN": "L01.224.050.843", "MH_TH": "NLM (2023)", "ST": "T170", "PI": "Algorithms (2004-2022)", "MS": "An algorithm used in decision analysis and MACHINE LEARNING that uses a set of trees to combine output of multiple, randomly generated DECISION TREES. The final class of each tree is aggregated and evaluated by weighted values to construct the final classifier.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093743"}, {"RECTYPE": "D", "MH": "Antiglycation Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiglycative Agents|T120|NON|EQV|NLM (2023)|220119|abcdef", "ENTRY": "Anti Glycation Agent", "MN": "D27.505.519.182", "MH_TH": "NLM (2023)", "ST": "T120", "RN": "0", "MS": "Compounds that reduce the non-enzymatic glycation of proteins, lipids, and nucleic acids AND thus reducing the formation of ADVANCED GLYCATION END-PRODUCTS.", "PM": "2023", "HN": "2023", "MR": "20220407", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093744"}, {"RECTYPE": "D", "MH": "Correctional Facilities Personnel", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Prison Guards|T097|NON|NRW|NLM (2023)|220120|abcdef", "ENTRY": "Workers, Correctional", "MN": "M01.526.199", "MH_TH": "NLM (2023)", "ST": "T097", "PI": "Prisons (1986-2022)", "MS": "Persons who work at JAILS; PRISONS; or other CORRECTIONAL INSTITUTIONS.", "PM": "2023", "HN": "2023", "MR": "20220406", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093762"}, {"RECTYPE": "D", "MH": "Intermittent Fasting", "AQ": "AE BL CF ME PH PX UR", "PRINT ENTRY": "Time Restricted Fasting|T055|NON|NRW|NLM (2023)|220120|abcdef", "ENTRY": "Time Restricted Feedings", "MN": "G07.203.650.353.400.500", "MH_TH": "NLM (2019)", "ST": "T055", "PI": "Fasting (1963-2022)", "MS": "Alternating between fasting for an extended period of time during the day and eating during a restricted time for the day.", "PM": "2023; see FASTING 2019-2022; for TIME RESTRICTED FEEDING see FASTING 2019-2022", "HN": "2023; use FASTING 2019-2022; for TIME RESTRICTED FEEDING use FASTING 2019-2022", "MR": "20230526", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093763"}, {"RECTYPE": "D", "MH": "Lysimachia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yellow Loosestrife|T002|NON|NRW|NLM (2023)|220120|abcdef", "ENTRY": "Yellow Loosestrifes", "MN": "B01.875.800.575.912.250.341.984.690", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid59977", "RR": "txid191068", "MS": "A plant genus of the family  PRIMULACEAE. Lysimachia are used for  herbal medicinal purposes. Common name loosestrife refers to members of Lysimachia (e.g., yellow loosestrife) and another plant family Lythrum (purple loosestrife).", "PM": "2023; see PRIMULACEAE 2004-2022", "HN": "2023; use PRIMULACEAE 2004-2022", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093782"}, {"RECTYPE": "D", "MH": "Matrines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sophoridine|T109|T121|NON|NRW|FDA SRS (2015)|INN (19XX)|NLM (1982)|220121|abbcdeeef", "ENTRY": "Matrine type Alkaloids", "MN": "D03.132.722.500", "MH_TH": "NLM (2023)", "ST": "T109", "RN": "0", "RR": "W5S1M800J7", "MS": "Tetracyclic bis-quinolizidine alkaloids found in the family LEGUMINOSAE, mainly in the genus SOPHORA.", "PM": "2023; MATRINE was indexed under ALKALOIDS and QUINOLIZINES 1982-2022", "HN": "2023(1982)", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093842"}, {"RECTYPE": "D", "MH": "Quinolizidine Alkaloids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Quinolizidine Alkaloid|T109|NON|EQV|NLM (2023)|220121|abcdef", "ENTRY": "Quinolizidine Alkaloid, Lupine", "MN": "D03.633.100.834.737.250", "MH_TH": "NLM (2023)", "ST": "T109", "RN": "0", "PI": "Quinolizidines (2008-2022)", "MS": "Alkaloids containing QUINOLIZIDINE ring structure. They are found in the genistoid legumes of FABACEAE (formerly Leguminosae) including genera LUPINUS and SOPHORA.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093843"}, {"RECTYPE": "D", "MH": "Glycated Proteins", "AQ": "AD AE AG AI AN BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Glycated", "MN": "D23.946.381.625", "MH_TH": "NLM (2023)", "ST": "T116", "RN": "0", "MS": "Advanced glycation end products formed from the spontaneous, non-enzymatic reaction of sugars with free amino groups in proteins. In the past, a glycosylated protein sometimes referred to a glycated protein.  GLYCOSYLATED PROTEINS is now restricted to proteins glycosylated by GLYCOSYLTRANSFERASES or via specialized organic chemistry reactions.", "PM": "2023", "HN": "2023", "MR": "20230316", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093844"}, {"RECTYPE": "D", "MH": "Sophora flavescens", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sophora angustifolia|T002|NON|REL|NLM (2023)|220121|abcdef", "ENTRY": "flavescens, Sophora", "MN": "B01.875.800.575.912.250.401.734.500", "MH_TH": "NLM (2023)", "ST": "T002", "RN": "txid49840", "PI": "Sophora (1995-2022)", "MS": "A Sophora species commonly used as medicinal herb and is main source of quinolizidine alkaloid MATRINES. It is a perennial with yellow flowers.", "PM": "2023", "HN": "2023", "MR": "20221207", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093845"}, {"RECTYPE": "D", "MH": "Sophora japonica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Styphnolobium japonicum|T002|NON|EQV|NLM (2023)|220121|abcdef", "ENTRY": "Tree, Japanese Pagoda", "MN": "B01.875.800.575.912.250.401.734.750", "MH_TH": "NLM (2023)", "ST": "T002", "RN": "txid3897", "PI": "Sophora (2002-2022)", "MS": "A member of the family FABACEAE, native to the FAR EAST and used in traditional medicine. Sophora japonica yellow flower bud and dried fruit extracts  are rich in FLAVONOIDS, e.g., SOPHORICOSIDE and RUTIN.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093846"}, {"RECTYPE": "D", "MH": "Socioeconomic Disparities in Health", "PRINT ENTRY": "Socioeconomic Disparity|T080|NON|BRD|NLM (2023)|220204|abcdef", "ENTRY": "Socioeconomic Disadvantages", "MN": "N01.224.425.394.875", "MH_TH": "NLM (2023)", "ST": "T080", "AN": "SOCIAL DETERMINANTS OF HEALTH is available", "PI": "Socioeconomic Factors (1986-2022)", "MS": "Differences in health based on socioeconomic status. Socioeconomic-based health disparities often begins early in life due to various SOCIOECONOMIC FACTORS, e.g. social, economic and educational statuses that limit potential or realized access to resources for maintaining health.", "PM": "2023", "HN": "2023", "MR": "20230405", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093862"}, {"RECTYPE": "D", "MH": "Residential Segregation", "AQ": "EC HI LJ PX SN TD", "PRINT ENTRY": "Neighborhood Racial Ethnic Composition|T054|NON|REL|NLM (2023)|220204|abcdef", "ENTRY": "Segregation, Residential", "MN": "N06.850.505.400.800.775.375", "MH_TH": "NLM (2023)", "ST": "T054", "PI": "Residence Characteristics (1970-2022)", "MS": "Spatial separation of HOUSING within a geographic area based on racial, ethnic, nationality and other SOCIOECONOMIC FACTORS.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093863"}, {"RECTYPE": "D", "MH": "Layer-by-Layer Nanoparticles", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "PRINT ENTRY": "LbL Nanoparticles|T073|ABX|EQV|NLM (2023)|220207|abcdef", "ENTRY": "Self-Assembly Nanoparticle, Layer-by-Layer", "MN": "J01.637.512.075", "MH_TH": "NLM (2023)", "ST": "T073", "PI": "Nanoparticles (2005-2022)", "MS": "Nanostructures fabricated by assembly of ordered layers of known compositions primarily through electro-static interactions. Such nanoparticles can be used for targeted delivery of complex components in ordered release patterns.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093882"}, {"RECTYPE": "D", "MH": "Mixed Dementias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Multiple-Etiology Dementias|T047|NON|EQV|NLM (2023)|220207|abcdef", "ENTRY": "Multiple-Etiology Dementia", "MN": "F03.615.400.756", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Dementia (1976-2022)", "MS": "Dementias caused by multiple etiologies, e.g., ALZHEIMER DISEASE, and VASCULAR DEMENTIA and/or LEWY BODY DISEASE.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093902"}, {"RECTYPE": "D", "MH": "Congenital Cranial Dysinnervation Disorders", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Congenital Innervation Dysgenesis Syndrome|T047|NON|EQV|NLM (2023)|220208|abcdef", "ENTRY": "Congenital Fibrosis Syndrome", "MN": "C16.131.666.198", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Ocular Motility Disorders (2003-2022)", "MS": "Congenital neurodevelopmental diseases characterized by abnormal eye, eyelid, and facial movements. Congenital cranial dysinnervation disorders (CCDDs) are caused by abnormal innervation of CRANIAL NERVES (e.g., CNs III, IV and VI) resulting in aplasia or hypoplasia of the ocular and facial musculature involved in EYE MOVEMENTS.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000093922"}, {"RECTYPE": "D", "MH": "Information Sources", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Sources of Information|T170|NON|EQV|NLM (2023)|220211|abcdef", "ENTRY": "Data Sources|T081|NON|REL|NLM (1986)|861231|abcdef", "MN": "L01.462", "MH_TH": "NLM (2023)", "ST": "T170", "MS": "Various communications media, information centers, information services that are are utilized to obtain information.", "PM": "2023; for DATA SOURCES see INFORMATION STORAGE AND RETRIEVAL 1986-2022", "HN": "2023; for DATA SOURCES use INFORMATION STORAGE AND RETRIEVAL 1986-2022", "MR": "20220712", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000093983"}, {"RECTYPE": "D", "MH": "Acetoin Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Diacetyl Reductase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Reductase, Diacetyl", "MN": "D08.811.682.047.820.200", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Acetoin:NAD+ oxidoreductase", "RN": "EC 1.1.1.-", "RR": "EC 1.1.1.304", "PI": "Butanones (1972-1974)", "MS": "An enzyme that catalyzes the conversion of acetoin to diacetyl in the presence of NAD.", "PM": "91; was see under ALCOHOL OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under ALCOHOL OXIDOREDUCTASES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000094"}, {"RECTYPE": "D", "MH": "Post-Acute COVID-19 Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Post-COVID Conditions|T047|NON|EQV|NLM (2023)|220303|abcdef", "ENTRY": "Post-COVID Condition", "MN": "C23.550.291.500.829.375", "MH_TH": "NLM (2023)", "ST": "T047", "MS": "Post acute stage of COVID-19 virus infection. Persistent symptoms may include FATIGUE; DYSPNEA; and MEMORY LOSS.", "PM": "2023; see under COVID-19/complication (2020-2021)", "HN": "2023(2020)", "MR": "20230226", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094024"}, {"RECTYPE": "D", "MH": "Post-Infectious Disorders", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Post-Infectious Disease Syndrome|T047|NON|EQV|NLM (2023)|220419|abcdef", "ENTRY": "Syndrome, Post-Infectious Disease", "MN": "C23.550.291.500.829", "MH_TH": "NLM (2023)", "ST": "T047", "MS": "Debilitating disorder characterized by fatigue and other symptoms related to cognitive, autonomous, and immune dysfunction experienced in the aftermath of infections.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094025"}, {"RECTYPE": "D", "MH": "Lupanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lupane-Type Triterpenoids|T109|NON|EQV|NLM (2023)|220304|abcdef", "ENTRY": "Triterpenoids, Lupane-Type", "MN": "D02.455.849.919.530.600", "MH_TH": "NLM (2020)", "ST": "T109", "RN": "0", "MS": "Pentacyclic triterpenes with isopropyl and its derivatives at the C19 position. It is initially biosynthesized by cyclization of oxidosqualene to lupeol.", "PM": "2023; see\u00a0Pentacyclic Triterpenes 2020-2022", "HN": "2023(2020)", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094042"}, {"RECTYPE": "D", "MH": "Betulinic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Betulic Acid|T109|T121|NON|EQV|NLM (2023)|220304|abbcdef", "ENTRY": "3 Epi betulinic Acid", "MN": "D02.455.849.919.530.600.500", "MH_TH": "NLM (2023)", "ST": "T121", "RN": "4G6A18707N", "MS": "A lupane-type triterpene derivative of betulin which was originally isolated from BETULA or birch tree. It has anti-inflammatory, anti-HIV and antineoplastic activities.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094062"}, {"RECTYPE": "D", "MH": "Polyhydroxybutyrates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Poly(hydroxybutyrates)|T109|NON|EQV|NLM (2023)|220310|abcdef", "ENTRY": "3 Hydroxybutanoic Acid Homopolymers", "MN": "D10.751.500", "MH_TH": "NLM (2023)", "ST": "T109", "RN": "0", "PI": "Butyric Acid (1988-2022)", "MS": "A thermostable biopolymer with repeating hydroxybutyryl units. It is typically the most abundant polyhydroxyalkanoate in microbes with PHA granules.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094122"}, {"RECTYPE": "D", "MH": "Low Anterior Resection Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.550.767.550", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Postoperative Complications (2011-2022)", "MS": "Postoperative complication after removal of the RECTUM (low anterior resection surgery or resection surgery to the lower part of the COLON). It includes disordered rectum function, e.g., frequent BOWEL MOVEMENT; FECAL INCONTINENCE; and CONSTIPATION.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094123"}, {"RECTYPE": "D", "MH": "Plant Systemic Acquired Resistance", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Systemic Acquired Resistance, Plant|T039|NON|EQV|NLM (2023)|220311|abcdef", "ENTRY": "Systemic Resistances, Induced", "MN": "G15.630.625", "MH_TH": "NLM (2023)", "ST": "T039", "PI": "Gene Expression Regulation, Plant (1996-2022)", "MS": "A plant defense mechanism in which a plant pathogen-associated molecular pattern effector is detected through various receptors, e.g., PATTERN RECOGNITION RECEPTORS, which in turn induces fortified, primed defense in plant immune reaction. It confers long lasting and long distance plant immune defense against a broad spectrum of pathogens using various plant defense hormones or metabolites, e.g., SALICYLIC ACID and N-HYDROXYPIPECOLIC ACID, as signals to distant leaves for heightened immune state to counteract and limit subsequent infection.", "PM": "2023", "HN": "2023", "MR": "20220413", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094142"}, {"RECTYPE": "D", "MH": "Case Reports as Topic", "MN": "L01.559.423.906.654.500", "MH_TH": "NLM (2023)", "ST": "T033", "MS": "Clinical presentations that may be followed by evaluative studies that eventually lead to a diagnosis.", "PM": "2023", "HN": "2023", "MR": "20220711", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094143"}, {"RECTYPE": "D", "MH": "Phytoalexins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Terpenoid Phytoalexins|T123|NON|NRW|NLM (2023)|220314|abcdef", "ENTRY": "Phytoalexins, Terpenoid", "MN": "D23.946.618", "FX": "Secondary Metabolism", "MH_TH": "NLM (2023)", "ST": "T131", "RN": "0", "MS": "Secondary metabolites produced and accumulated by plants infected with microbial pathogen or otherwise under abiotic stress. Phytoalexins are structurally diverse but in common play a role in triggering PLANT SYSTEMIC ACQUIRED RESISTANCE.", "PM": "2023; see under SESQUITERPENES 1976-2022", "HN": "2023(1976)", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094162"}, {"RECTYPE": "D", "MH": "Microphysiological Systems", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Organs on Chips|T075|NON|EQV|NLM (2024)|220815|abcdef", "ENTRY": "Organs on Chip", "MN": "E07.305.343.500.500", "FX": "Tissue Engineering", "MH_TH": "NLM (2023)", "ST": "T075", "PI": "Lab-On-A-Chip Devices (2014-2022)", "MS": "Devices designed to recapitulate tissue or organ-level physiology and architect by combining MICROFLUIDICS; MICROFABRICATION; and 3D CELL CULTURE. Microphysiological systems mimic interconnections important in physiological or pathophysiological states of organ(s) and are often used for instance in HIGH THROUGHPUT SCREENING of drugs and factors important in disease modeling.", "PM": "2023", "HN": "2023", "MR": "20230601", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094182"}, {"RECTYPE": "D", "MH": "Asian American Native Hawaiian and Pacific Islander", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Asian Americans Pacific Islanders|T098|NON|EQV|NLM (2023)|220314|abcdef", "MN": "M01.270.906", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Native Hawaiian or Other Pacific Islander (1997-2022)", "MS": "Members of Asian American, Native Hawaiian, and Pacific Islander community.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094202"}, {"RECTYPE": "D", "MH": "Dropped Head Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chin-on-Chest Deformity|T047|NON|EQV|NLM (2023)|220315|abcdef", "ENTRY": "Dropped Head Syndromes", "MN": "C23.888.592.608.593.500", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Muscle Weakness (1996-2022)", "MS": "Condition characterized by sagging of the head due to severe NECK MUSCLES weakness in the back of the neck. It may result in severe cervical KYPHOSIS called chin-on-chest deformity. Dropped head syndrome is most often associated with other diseases, e.g., PARKINSON'S DISEASE; STROKES; HEAD AND NECK CANCER; and ANKYLOSING SPONDYLITIS.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094222"}, {"RECTYPE": "D", "MH": "Medium Spiny Neurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Striatal Medium-Sized Spiny Neurons|T025|NON|EQV|NLM (2023)|220315|abcdef", "ENTRY": "Striatal Medium Sized Spiny Neurons", "MN": "A11.671.650.535", "FX": "Corpus Striatum", "MH_TH": "NLM (2023)", "ST": "T025", "PI": "Neurons (1983-2022)", "MS": "Medium sized, inhibitory GABAergic neurons in the CORPUS STRIATUM with highly developed dendritic trees. They are divided into neurons expressing DOPAMINE D1 RECEPTORS which project preferentially to the SUBSTANTIA NIGRA PARS RETICULATA and neurons expressing DOPAMINE D2 RECEPTORS which project preferentially to the lateral part of the GLOBUS PALLIDUS. Medium spiny neurons are preferentially lost in HUNTINGTON DISEASE.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094242"}, {"RECTYPE": "D", "MH": "Proteolysis Targeting Chimera", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "VHL-Based PROTACs|T130|ACX|NRW|NLM (2023)|220315|abcdef", "ENTRY": "VHL Based PROTACs", "MN": "D27.720.470.410.210.500", "MH_TH": "NLM (2023)", "ST": "T130", "RN": "0", "PI": "Proteolysis (2015-2022)", "MS": "Bifunctional molecules that are designed to recruit E3 UBIQUITIN LIGASE to a specific target protein. Proteolysis targeting chimera consist of a target protein ligand connected via a linker to an E3 ligand. They promote association of E3 with specific target proteins tagged for degradation via the PROTEASOME.", "PM": "2023", "HN": "2023", "MR": "20230405", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094243"}, {"RECTYPE": "D", "MH": "Schaffer Collaterals", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Schaffer Collateral|T023|EPO|EQV|NLM (2021)|191122|abcdef", "MN": "A11.671.501.145.875", "MH_TH": "NLM (2015)", "ST": "T023", "MS": "The main axon connection from the CA3 PYRAMIDAL CELL AREA to the CA1 PYRAMIDAL CELL AREA in the HIPPOCAMPUS. Schaffer collaterals are important in memory, learning and activity-related NEURONAL PLASTICITY.", "PM": "2023; see HIPPOCAMPUS 2015-2022", "HN": "2023(2015)", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094282"}, {"RECTYPE": "D", "MH": "Human Papillomavirus Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human Papillomavirus|T005|NON|EQV|NLM (2021)|200131|abcdef", "ENTRY": "Virus, Human Papillomavirus", "MN": "B04.613.204.655.450", "MH_TH": "NLM (2016)", "ST": "T005", "RN": "txid10566", "MS": "A large group of viruses that cause HUMAN PAPILLOMAVIRUS INFECTION, e.g., GENITAL WARTS and cancer of the CERVIX; VAGINA; VULVA; ANUS; or OROPHARYNX. Most common clinically important human papilloma viruses are taxonomically members of ALPHAPAPILLOMAVIRUS and GAMMAPAPILLOMAVIRUS.", "PM": "2023; see ALPHAPAPILLOMAVIRUS 2016-2022", "HN": "2023; use ALPHAPAPILLOMAVIRUS 2016-2022", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094302"}, {"RECTYPE": "D", "MH": "Piwi-Interacting RNA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "piRNAs|T114|T123|ABB|EQV|NLM (2023)|220428|abbcdef", "ENTRY": "RNA, Piwi Interacting", "MN": "D13.444.735.790.552.875.500", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "RNA, Small Interfering (2006-2022)", "MS": "A  class of small RNAs that are 24\u201331 nucleotides in length. They associate with  the PIWI SUBFAMILY OF ARGONAUTE PROTEINS to form effector complexes known as piRNA-induced silencing complexes, which repress transposons via transcriptional or posttranscriptional mechanisms and maintain germline genome integrity. In addition to their  role in transposon silencing, piRNAs in diverse organisms function in the regulation of cellular genes.", "PM": "2023; see RNA,SMALL INTERFERING 2008-2022", "HN": "2023; use RNA,SMALL INTERFERING 2008-2022", "MR": "20220711", "DA": "20220711", "DC": "1", "DX": "20230101", "UI": "D000094322"}, {"RECTYPE": "D", "MH": "Sperm Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Spermatozoa Proteins|T116|NON|EQV|NLM (2023)|220329|abcdef", "ENTRY": "Tail Proteins, Sperm", "MN": "D12.776.869.500", "MH_TH": "NLM (2023)", "ST": "T116", "RN": "0", "PI": "Spermatozoa (1972-2022)", "MS": "Proteins found in sperm. Sperm-specific proteins have important roles in FERTILIZATION including SPERM MOTILITY and SPERM-OVUM INTERACTIONS. Sperm-specific proteins are also important for early EMBRYO DEVELOPMENT.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094323"}, {"RECTYPE": "D", "MH": "Carbohydrate Binding Modules", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Xylan Binding Domain|T087|NON|NRW|NLM (2023)|220713|abcdef", "ENTRY": "Xylan Binding Domains", "MN": "G02.111.570.820.709.275.750.157", "MH_TH": "NLM (2023)", "ST": "T087", "MS": "Contiguous amino acid sequences within a carbohydrate-active enzyme with discrete folds having carbohydrate binding activity. They are classified into 43 different families based on AMINO ACID SEQUENCE, binding specificity, and structure.", "PM": "2023", "HN": "2023", "MR": "20220713", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094342"}, {"RECTYPE": "D", "MH": "Anabolic Androgenic Steroids", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Anabolic Steroid|T121|NON|EQV|NLM (2022)|201007|abcdef", "ENTRY": "Steroids, Anabolic Androgenic", "MN": "D06.472.334.851.968.250", "MH_TH": "NLM (2023)", "ST": "T121", "RN": "0", "PI": "Anabolic Agents(1974-2022)", "MS": "Synthetic, or human-made, variations of the male sex hormone testosterone often misused by athletes to enhance performance.", "PM": "2023; for ANABOLIC STEROIDS see TESTOSTERONE CONGENERS 2017-2022", "HN": "2023; for ANABOLIC STEROID use TESTOSTERONE CONGENERS 2017-2022", "MR": "20220713", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094343"}, {"RECTYPE": "D", "MH": "Blood Donation", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Platelet Donation|T058|NON|REL|NLM (2023)|220504|abcdef", "ENTRY": "Platelet Donations", "MN": "N02.421.911.100", "FX": "Plateletpheresis", "MH_TH": "NLM (1978)", "ST": "T058", "PI": "Blood Donors (1963-2022)", "MS": "Voluntary giving of BLOOD.", "PM": "2023; see BLOOD DONORS 1978-2022", "HN": "2023; use BLOOD DONORS 1978-2022", "MR": "20220711", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094345"}, {"RECTYPE": "D", "MH": "Sleep Duration", "AQ": "DE RE", "PRINT ENTRY": "Total Sleep Time|T038|NON|EQV|NLM (2023)|220323|abcdef", "ENTRY": "Sleep Quantities", "MN": "G11.561.803.189", "MH_TH": "NLM (2023)", "ST": "T038", "PI": "Sleep (1964-2022)", "MS": "Total number of hours of sleep in a day.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094362"}, {"RECTYPE": "D", "MH": "Epigenetic Memory", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Transgenerational Epigenetic Memory|T045|NON|NRW|NLM (2023)|220323|abcdef", "ENTRY": "Transcriptional Memory, Epigenetic", "MN": "G05.308.203.280", "MH_TH": "NLM (2023)", "ST": "T045", "PI": "Epigenesis, Genetic (2002-2022)", "MS": "Various mechanisms by which a stable propagation of changes in gene expression that is passed from egg and sperm to the embryo persists via epigenetic changes, e.g., DNA METHYLATION pattern changes.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094363"}, {"RECTYPE": "D", "MH": "Myotendinous Junction", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Musculotendinous Junction|T024|NON|EQV|NLM (2023)|220323|abcdef", "ENTRY": "Myotendinous Junctions", "MN": "A02.734", "MH_TH": "NLM (2023)", "ST": "T024", "PI": "Tendons (1970-2022)", "MS": "A specialized interface between muscle and tendon through which most contractile force is transmitted. It consists of elaborate surface folding called interdigitations involving EXTRACELLULAR MATRIX and terminal SARCOMERES.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094364"}, {"RECTYPE": "D", "MH": "Hypothalamic-Pituitary-Gonadal Axis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hypothalamic-Pituitary-Gonadal Endocrine Axis|T022|NON|EQV|NLM (2023)|220323|abcdef", "ENTRY": "Hypothalamic Pituitary Gonadal Endocrine Axis", "MN": "A08.713.357.250", "MH_TH": "NLM (2023)", "ST": "T022", "PI": "Hypothalamo-Hypophyseal System (1973-2022)", "MS": "A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS, the PITUITARY GLAND and the GONADS. It plays a central role in endocrine regulation of gonadal function including release of hormones: GNRH; LUTEINIZING HORMONE; FOLLICLE-STIMULATING HORMONE and TESTOSTERONE.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094365"}, {"RECTYPE": "D", "MH": "Local Field Potential Measurement", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Intracerebral Local Field Potential Measurement|T060|NON|EQV|NLM (2023)|220502|abcdef", "ENTRY": "Measurement, Intracerebral LFP", "MN": "E01.370.405.353", "MH_TH": "NLM (2023)", "ST": "T060", "PI": "Action Potentials (2001-2022)", "MS": "Recording of brain electrical activities recorded by a small-size electrode in the brain. It measures electric potential in the extracellular medium around neurons generated by small electric currents of local origin.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094382"}, {"RECTYPE": "D", "MH": "T-Cell Exhaustion", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "T-Lymphocyte Exhaustion|T046|NON|EQV|NLM (2024)|221007|abcdef", "ENTRY": "T-Lymphocyte Exhaustions", "MN": "G12.590.500", "FX": "T-Cell Senescence", "MH_TH": "NLM (2023)", "ST": "T046", "MS": "Progressive deterioration of  T-cell function due to chronic antigen stimulation and inflammatory signals, e.g., CHRONIC INFECTION and CANCER. T-cell exhaustion is characterized by weakened immune system, e.g., dysfunctional MEMORY T CELLS differentiation and EPIGENETIC REPRESSION of IMMUNOLOGIC MEMORY effector functions.", "PM": "2023", "HN": "2023", "MR": "20221117", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094383"}, {"RECTYPE": "D", "MH": "Trained Immunity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Trained Innate Immunity|T032|NON|EQV|NLM (2023)|220324|abcdef", "ENTRY": "Trained Innate Immunities", "MN": "G12.450.564.904", "MH_TH": "NLM (2023)", "ST": "T032", "PI": "Immunity, Innate (2011-2022)", "MS": "Ability of the INNATE IMMUNITY system to form IMMUNOLOGIC MEMORY and provide enhanced defense against subsequent secondary infections. In trained immunity, long-term adaptation of innate immune cells occurs through EPIGENETIC PROCESSES and metabolic CELLULAR REPROGRAMMING to form long term immunologic memory.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094384"}, {"RECTYPE": "D", "MH": "Symbiont Induced Cytoplasmic Incompatibility", "AQ": "DE GE IM PH RE", "MN": "G16.527.200.095", "MH_TH": "NLM (2023)", "ST": "T070", "MS": "A naturally occurring reproductive phenomenon of INVERTEBRATES in which only certain combination of crosses result in viable embryos due to incompatibility between sperm and egg cells that is caused by differences in intracellular parasites (symbionts). For example, a maternally inherited symbiont bacteria, e.g., WOLBACHIA, induces changes in sperm of the host, causing mitotic defects in the fertilized embryo only in crosses between symbiotic males and females harboring a different or no symbiont.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094402"}, {"RECTYPE": "D", "MH": "Proteotoxic Stress", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Proteostasis Stress|T049|NON|EQV|NLM (2023)|220325|abcdef", "ENTRY": "Stress, Proteotoxic", "MN": "G07.775.782", "MH_TH": "NLM (2023)", "ST": "T049", "PI": "Stress, Physiological (2005-2022)", "MS": "Stressors and conditions which disturb PROTEOSTASIS. Dysfunctional responses to proteotoxic stress are associated with CELL DEATH; CELL SENESCENCE; \u00a0CANCER\u00a0and PROTEINOPATHY.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094403"}, {"RECTYPE": "D", "MH": "Ocean Acidification", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Seawater Acidification|T070|NON|EQV|NLM (2023)|220325|abcdef", "ENTRY": "Acidification, Seawater", "MN": "G16.500.777", "MH_TH": "NLM (2023)", "ST": "T070", "PI": "Seawater (2005-2022)", "MS": "Reduction in OCEAN WATER overall pH. Ocean acidification is linked to CORAL BLEACHING and may disturb other marine BIODIVERSITY.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094404"}, {"RECTYPE": "D", "MH": "RNA Replication", "AQ": "DE GE IM PH RE", "ENTRY": "Replication, RNA", "MN": "G06.920.925.470", "FX": "RNA-Directed DNA Polymerase", "MH_TH": "NLM (2023)", "ST": "T045", "AN": "VIRUS REPLICATION is also available; consider also RNA, VIRAL /biosyn", "PI": "Virus Replication (1967-2022)", "MS": "The process by which a VIRAL RNA molecule is duplicated.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094405"}, {"RECTYPE": "D", "MH": "Innate Immunity Recognition", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Surveillance Immunity|T032|NON|REL|NLM (2023)|220325|abcdef", "ENTRY": "Triggered Immunity, Effector", "MN": "G12.450.564.530", "MH_TH": "NLM (2023)", "ST": "T032", "PI": "Immunity, Innate (2006-2022)", "MS": "Innate immunity systems which recognize presence of pathogens either through detection of damages associated with pathogen effector, e.g., pathogenic toxins and pore formation (effector triggered immunity) or though detection of molecular patterns common to many types of microbes (PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES) through PATTERN RECOGNITION RECEPTORS.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094406"}, {"RECTYPE": "D", "MH": "Chronotype", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Morningness Eveningness Preferences|T032|NON|EQV|NLM (2023)|220325|abcdef", "ENTRY": "Preference, Morningness Eveningness", "MN": "G07.180.562.190.500", "MH_TH": "NLM (2023)", "ST": "T032", "PI": "Circadian Rhythm (1990-2022)", "MS": "The natural inclination or preference of time of day in which an individual or an organism has the most activity, particularly as it relates to sleeping pattern and circadian sleep-wake preferences.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094407"}, {"RECTYPE": "D", "MH": "Obesity Paradox", "PRINT ENTRY": "Body Mass Index Paradox|T080|NON|REL|NLM (2023)|220325|abcdef", "ENTRY": "Paradox, Obesity", "MN": "N06.850.520.830.600.800.725.500.750", "MH_TH": "NLM (2023)", "ST": "T080", "PI": "Obesity (2002-2022)", "MS": "An observation that high BODY MASS INDEX is sometimes associated with lower CARDIOVASCULAR DISEASE mortality in certain population, e.g., ELDERLY.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094408"}, {"RECTYPE": "D", "MH": "Ribosome Shunting", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Shunting, Ribosome|T045|NON|EQV|NLM (2023)|220325|abcdef", "ENTRY": "Shunting, Ribosomal", "MN": "G05.308.385.500", "MH_TH": "NLM (2023)", "ST": "T045", "MS": "Viral mechanisms of translational programming in which ribosomes reach the start codon bypassing or shunting over large segments of the 5\u2032 UTR of  VIRAL RNA. Ribosome shunting allows host translational machinery to engage polycistronic transcripts similar to RIBOSOMAL FRAMESHIFTING, and use of INTERNAL RIBOSOME ENTRY SITES.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094409"}, {"RECTYPE": "D", "MH": "Secondary Data Analysis", "ENTRY": "Secondary Data Analyses", "MN": "N06.850.520.830.300.500", "MH_TH": "NLM (2023)", "ST": "T081", "PI": "Data Analysis (2017-2022)", "MS": "Analysis or reanalysis of existing data collected by someone else usually  for a different purpose.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094422"}, {"RECTYPE": "D", "MH": "Volume Electron Microscopy", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "vEM Volume Electron Microscopy|T059|ABX|EQV|NLM (2023)|220328|abcdef", "ENTRY": "Volume Electron Microscopies", "MN": "L01.224.308.705", "MH_TH": "NLM (2023)", "ST": "T059", "PI": "Microscopy, Electron (1983-2022)", "MS": "Electron microscopy techniques designed to reconstruct 3-D images at micrometer volume scales at nanometer (nm) level resolutions. Volume electron microscopy uses various techniques to render, segment and reconstruct 3-D images from stacked sequential 2-D images of incremental z-planes.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094443"}, {"RECTYPE": "D", "MH": "Wildlife Trade", "AQ": "CL EC ED ES HI LJ PX SN ST TD", "PRINT ENTRY": "Wildlife Trafficking|T055|NON|EQV|NLM (2023)|220329|abcdef", "ENTRY": "Wildlife Traffickings", "MN": "I03.915", "FX": "Crime", "MH_TH": "NLM (2023)", "ST": "T055", "PI": "Commerce (2002-2022)", "MS": "Commerce of non-domesticated WILD ANIMALS or plants. Wildlife trade, particularly illegal trades, threaten ECOSYSTEMS and drives up SPECIES EXTINCTION. It also increases chance of emerging ZOONOSES.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094462"}, {"RECTYPE": "D", "MH": "Transurethral Resection of Bladder", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transurethral Resection of Bladder Tumor|T061|NON|EQV|NLM (2023)|220329|abcdef", "ENTRY": "Bladder Transurethral Resections", "MN": "E04.950.774.790", "MH_TH": "NLM (2023)", "ST": "T061", "PI": "Urinary Bladder Neoplasms (1964-2022)", "MS": "Surgical removal of tumor in the BLADDER with resectoscope inserted through the URETHRA.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094463"}, {"RECTYPE": "D", "MH": "Chronic Inducible Urticaria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vibratory Urticaria|T047|NON|NRW|NLM (2023)|220502|abcdef", "ENTRY": "Vibratory Urticarias", "MN": "C23.550.291.500.360.500", "MH_TH": "NLM (2020)", "ST": "T047", "MS": "Chronic urticaria with identified triggering factor which is either physical, e.g., vibratory urticaria, or non-physical, e.g., aquagenic urticaria.", "PM": "2023; see CHRONIC URTICARIA 2020-2022, for URTICARIA, AQUAGENIC see under UTTICARIA 2013-2022", "HN": "2023; use CHRONIC URTICARIA 2020-2022, for URTICARIA, AQUAGENIC use under UTTICARIA 2013-2022", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094482"}, {"RECTYPE": "D", "MH": "Gynecologists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Gynecologist", "MN": "N02.360.810.557", "MH_TH": "NLM (2023)", "ST": "T097", "PI": "Gynecology (1963-2022)", "MS": "Qualified medical professionals who specialize in GYNECOLOGY.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094502"}, {"RECTYPE": "D", "MH": "Obstetricians", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Obstetrician", "MN": "N02.360.810.664", "MH_TH": "NLM (2023)", "ST": "T097", "PI": "Obstetrics (1963-2022)", "MS": "Qualified medical professionals who specialize in OBSTETRICS.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094503"}, {"RECTYPE": "D", "MH": "Corneal Cross-Linking", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Transepithelial Corneal Cross-Linking|T061|NON|NRW|NLM (2023)|220330|abcdef", "ENTRY": "Transepithelial Corneal Cross-Linkings", "MN": "E02.774.722.218", "MH_TH": "NLM (2023)", "ST": "T061", "PI": "Photochemotherapy (2008-2022)", "MS": "An ophthalmic treatment used to prevent weakening or bulging of the CORNEA in corneal ECTASIA, e.g., post-LASIK ectasia, KERATOCONUS and pellucid marginal corneal degeneration. It uses UV-A and RIBOFLAVIN to crosslink and strengthen COLLAGEN fibers within the cornea.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094504"}, {"RECTYPE": "D", "MH": "Evidence Gaps", "PRINT ENTRY": "Research Gaps|T078|NON|REL|NLM (2023)|220412|abcdef", "ENTRY": "Research Gap", "MN": "N05.425.171", "FX": "Evidence-Based Practice", "MH_TH": "NLM (2023)", "ST": "T078", "AN": "coordinate with specific field, disease, or topic if pertinent", "MS": "Areas where little or no evidence from impact evaluations and SYSTEMATIC REVIEWS is available and where future research should be focused (from https://openknowledge.worldbank.org/handle/10986/16941).", "PM": "2023", "HN": "2023", "MR": "20220711", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094505"}, {"RECTYPE": "D", "MH": "Ribosome Profiling", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Translation Profiling|T059|NON|EQV|NLM (2023)|220428|abcdef", "ENTRY": "tRNA Captures, Ribosome-Bound", "MN": "E05.393.760.710.250", "MH_TH": "NLM (2023)", "ST": "T059", "PI": "Ribosomes (2009-2022)", "MS": "A technique of mRNA sequence analysis that is used to determine which mRNAs are being actively translated. This technique relies on sequencing of RIBOSOME protected mRNA fragments (so-called ribosomal footprints) allowing the indication of the exact positions of ribosomes on transcripts.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094506"}, {"RECTYPE": "D", "MH": "Infant, Large for Gestational Age", "AQ": "BL CF GD IM ME PH PX UR", "PRINT ENTRY": "Large-for-Gestational-Age Infant|T102|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "Large-for-Gestational-Age Infants", "MN": "M01.060.703.520.230", "MH_TH": "NLM (2023)", "ST": "T102", "AN": "check the tag INFANT, NEWBORN; do not confuse with FETAL MACROSOMIA or INFANT, POSTMATURE ", "PI": "Fetal Macrosomia (1987-2022)", "MS": "Infants whose BIRTH WEIGHT is larger than the 90th percentile for a given gestational age.", "PM": "2023", "HN": "2023", "MR": "20220711", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094522"}, {"RECTYPE": "D", "MH": "Combined Antibody Therapeutics", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "PRINT ENTRY": "Antibody Cocktail|T129|NON|EQV|NLM (2023)|220331|abcdef", "ENTRY": "Therapeutics, Combined Antibody", "MN": "D26.310.358", "FX": "Immunotherapy", "MH_TH": "NLM (2023)", "ST": "T129", "RN": "0", "PI": "Antibodies, Monoclonal (1987-2022)", "MS": "Combinations of monoclonal antibodies used therapeutically to modulate the IMMUNE SYSTEM.", "PM": "2023", "HN": "2023", "MR": "20220713", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094523"}, {"RECTYPE": "D", "MH": "Gasdermins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cancer Associated Gasdermin-Domain Containing (GSDMDC) Proteins|T116|T123|NON|EQV|NLM (2023)|220429|abbcdef", "MN": "D12.776.543.585.400.464", "MH_TH": "NLM (2023)", "ST": "T123", "RN": "0", "MS": "A  family of pore-forming effector proteins that cause membrane permeabilization and PYROPTOSIS.. Gasdermin-induced pyroptosis plays a prominent role in many HEREDITARY DISEASES and autoinflammatory disorders as well as in CANCER.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094524"}, {"RECTYPE": "D", "MH": "Capillary Isoelectric Focusing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "iCIEF|T059|ABB|NRW|NLM (2023)|220401|abcdef", "ENTRY": "Isoelectric Focusing, Capillary", "MN": "E05.301.300.663.250", "MH_TH": "NLM (2023)", "ST": "T059", "PI": "Isoelectric Focusing (2011-2022)", "MS": "Isoelectric focusing in capillary gels instead of slab gels. Capillary gel electrophoresis generally allows higher resolution, higher detection sensitivity and easier integration with other separation and detection techniques.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094542"}, {"RECTYPE": "D", "MH": "Olfactory Training", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Smell Training|T061|NON|EQV|NLM (2023)|220404|abcdef", "ENTRY": "Training, Smell", "MN": "E02.662", "MH_TH": "NLM (2023)", "ST": "T061", "PI": "Olfaction Disorders (2009-2022)", "MS": "A non-surgical and non-pharmacological exercise treatment designed to  manage OLFACTORY DISORDERS.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094562"}, {"RECTYPE": "D", "MH": "Global Longitudinal Strain", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Right Ventricular Global Longitudinal Strain|T034|NON|NRW|NLM (2023)|220405|abcdef", "ENTRY": "Strains, Global Longitudinal", "MN": "G09.330.380.375", "MH_TH": "NLM (2023)", "ST": "T034", "PI": "Ventricular Function, Left (2004-2022)", "MS": "Global longitudinal strain (GLS) is a measure of ventricular function derived from 2-dimensional echocardiographic images by quantifying the relative length change in myocardial length between end-diastole and end-systole. GLS is used to predict cardiovascular outcomes and has been proposed to be a better measure of cardiac dysfunction than VENTRICULAR EJECTION FRACTION.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094582"}, {"RECTYPE": "D", "MH": "Developmental Defects of Enamel", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Developmental Dental Enamel Defects|T047|NON|EQV|NLM (2023)|220406|abcdef", "ENTRY": "Enamel Developmental Defects", "MN": "C16.131.850.800.295", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Dental Enamel Hypoplasia (1963-2022)", "MS": "Defects in normal AMELOGENESIS caused by any local, systemic, environmental, or genetic factors. Enamel defects resulting from demineralization of normally developed DENTAL ENAMEL is referred to as TOOTH DEMINERALIZATION.", "PM": "2023", "HN": "2023", "MR": "20230226", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094602"}, {"RECTYPE": "D", "MH": "Dental Enamel Hypomineralization", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tooth Hypomineralization|T047|NON|EQV|NLM (1998)|960723|abcdef", "ENTRY": "Tooth Hypomineralizations", "MN": "C16.131.850.800.295.500", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Dental Enamel Hypoplasia (1963-2022)", "MS": "Reduced mineralization disorder of the DENTAL ENAMEL during development resulting in qualitative defects, e.g., discolored or chalky (soft) enamel.", "PM": "2023; for TOOTH HYPOMINERALIZATION see TOOTH DEMINERALIZATION 1992-2022", "HN": "2023; for TOOTH HYPOMINERALIZATION see TOOTH DEMINERALIZATION 1992-2022; for MOLAR INCISOR HYPOMINERALIZATION use DENTAL ENAMEL HYPOPLASIA 1966-2022", "MR": "20230226", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094603"}, {"RECTYPE": "D", "MH": "Molar Hypomineralization", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Incisor Molar Hypomineralization|T047|NON|NRW|NLM (2024)|220930|abcdef", "ENTRY": "Molar Incisor Hypomineralizations", "MN": "C16.131.850.800.295.500.750", "MH_TH": "NLM (2023)", "ST": "T047", "MS": "A type of developmental disturbance of AMELOGENESIS involving MOLARS of any type (obligatory) plus other teeth sometimes. It is characterized by demarcated enamel opacities with unknown systemic causation (idiopathic).", "PM": "2023; for MOLAR INCISOR HYPOMINERALIZATION see DENTAL ENAMEL HYPOPLASIA", "HN": "2023; for MOLAR INCISOR HYPOMINERALIZATION use DENTAL ENAMEL HYPOPLASIA", "MR": "20230226", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094604"}, {"RECTYPE": "D", "MH": "Popliteal Artery Aneurysm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Popliteal Aneurysm|T047|T190|NON|EQV|NLM (2023)|220408|abbcdef", "ENTRY": "Popliteal Artery Aneurysms", "MN": "C14.907.055.863", "MH_TH": "NLM (2023)", "ST": "T190", "AN": "dissecting aneurysm: coordinate with DISSECTION, BLOOD VESSEL; rupture: coordinate with ANEURYSM, RUPTURED", "PI": "Popliteal Artery (1963-2022)", "MS": "An abnormal balloon- or sac-like dilatation in the wall of the POPLITEAL ARTERY located behind the KNEE JOINT.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094622"}, {"RECTYPE": "D", "MH": "Ehlers-Danlos Syndrome, Type IV", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vascular Type Ehlers-Danlos Syndrome|T019|T047|ACR|EQV|NLM (2023)|220408|abbcdef", "ENTRY": "Vascular Ehlers-Danlos Syndromes", "MN": "C17.800.827.260.500", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "A subtype of Ehlers-Danlos syndrome (EDS) characterized by vascular pathologies, e.g., AORTIC DISSECTION in addition to common EDS findings, e.g., hyperextensible skin and joints, skin fragility and reduced wound healing capability. It is associated with mutations in collagen type III alpha 1 chain gene (COLLAGEN TYPE III).", "PM": "2023; use EHLERS-DANLOS SYNDROME 2008-2022", "HN": "2023; see EHLERS-DANLOS SYNDROME 2008-2022", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094623"}, {"RECTYPE": "D", "MH": "Aortic Aneurysm, Thoracoabdominal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "TAA Thoracoabdominal Aortic Aneurysm|T190|NON|EQV|NLM (2023)|220408|abcdef", "ENTRY": "Thoracoabdominal Aortic Aneurysms", "MN": "C14.907.109.139.075.500", "MH_TH": "NLM (2008)", "ST": "T190", "AN": "dissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE", "MS": "An abnormal balloon- or sac-like dilatation in the wall of ABDOMINAL AORTA at the aortic hiatus.", "PM": "2023; see AORTIC ANEURYSM, THORACIC 2008-2022", "HN": "2023; use AORTIC ANEURYSM, THORACIC 2008-2022", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094624"}, {"RECTYPE": "D", "MH": "Aneurysm, Ascending Aorta", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ascending Aortic Aneurysm|T190|NON|EQV|NLM (2023)|220408|abcdef", "ENTRY": "Ascending Aortic Aneurysms", "MN": "C14.907.109.139.125.500", "MH_TH": "NLM (2023)", "ST": "T190", "AN": "dissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE", "PI": "Aortic Aneurysm  (1964-2022)", "MS": "An abnormal balloon- or sac-like dilatation in the wall of the ASCENDING AORTA.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094625"}, {"RECTYPE": "D", "MH": "Aneurysm, Aortic Arch", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aortic Arch Aneurysm|T047|T190|NON|EQV|NLM (2023)|220408|abbcdef", "ENTRY": "Arch Aneurysm, Aortic", "MN": "C14.907.109.139.125.250", "MH_TH": "NLM (2023)", "ST": "T190", "PI": "Aortic Aneurysm, Thoracic (1992-2022)", "MS": "An abnormal balloon- or sac-like dilatation in the wall of the AORTIC ARCH.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094626"}, {"RECTYPE": "D", "MH": "Descending Thoracic Aortic Aneurysm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aneurysm, Descending Thoracic Aorta|T190|NON|EQV|NLM (2023)|220408|abcdef", "MN": "C14.907.109.139.125.750", "MH_TH": "NLM (2023)", "ST": "T190", "AN": "dissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE", "PI": "Aortic Aneurysm, Thoracic (1993-2022)", "MS": "An abnormal balloon- or sac-like dilatation in the wall of the DESCENDING THORACIC AORTA.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094627"}, {"RECTYPE": "D", "MH": "Aortic Root Aneurysm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aneurysm, Aortic Root|T047|T190|NON|EQV|NLM (2023)|220408|abbcdef", "ENTRY": "Aortic Root Aneurysms", "MN": "C14.907.109.139.125.375", "MH_TH": "NLM (2023)", "ST": "T190", "AN": "dissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE", "PI": "Aortic Aneurysm, Thoracic (1993-2022)", "MS": "An abnormal balloon- or sac-like dilatation in the wall of the AORTIC ROOT.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094628"}, {"RECTYPE": "D", "MH": "Dissection, Thoracic Aorta", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thoracic Aortic Dissection|T047|T190|NON|EQV|NLM (2023)|220408|abbcdef", "ENTRY": "Thoracic Aortic Dissections", "MN": "C14.907.109.070.500.128", "MH_TH": "NLM (2023)", "ST": "T190", "PI": "Aortic Dissection (1979-2022)", "MS": "Dissection or a tear of the THORACIC AORTA. It includes aortic root dissection, ascending aortic dissection, aortic arch dissection and descending thoracic aortic dissection.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094629"}, {"RECTYPE": "D", "MH": "Dissection, Ascending Aorta", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dissection, Aortic Root|T047|NON|NRW|NLM (2023)|220408|abcdef", "ENTRY": "Root Dissection, Aortic", "MN": "C14.907.109.070.500.128.500", "MH_TH": "NLM (2023)", "ST": "T190", "PI": "Aortic Dissection (1990-2022)", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094630"}, {"RECTYPE": "D", "MH": "Dissection, Abdominal Aorta", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thoracoabdominal Aortic Dissection|T047|T190|NON|NRW|NLM (2023)|220408|abbcdef", "ENTRY": "Thoracoabdominal Aortic Dissections", "MN": "C14.907.109.070.500.064", "MH_TH": "NLM (2023)", "ST": "T190", "PI": "Aortic Dissection (1981-2022)", "MS": "Dissection or a tear of the ABDOMINAL AORTA. It includes thoracoabdominal aortic dissection at the aortic hiatus.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094631"}, {"RECTYPE": "D", "MH": "Thymic Stromal Lymphopoietin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TSLP Cytokine|T116|T129|ABX|EQV|NLM (2023)|220408|abbcdef", "ENTRY": "Stromal Lymphopoietin, Thymic", "MN": "D23.529.374.656", "MH_TH": "NLM (2023)", "ST": "T129", "RN": "GT0IL38SP4", "MS": "A pleiotropic cytokine involved in INFLAMMATION and immunoregulation. Thymic stromal lymphopoietin can activate MAST CELLS; DENDRITIC CELLS; and T-LYMPHOCYTES, and is produced by various cell types, including epithelial and dendritic cells..", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094632"}, {"RECTYPE": "D", "MH": "beta-Galactoside alpha-2,3-Sialyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-D-Galactoside 3-alpha-Sialyltransferase|T116|T126|NON|EQV|NLM (1982)|220426|abbcdef", "ENTRY": "beta1-3GalNAc alpha-2,3-Sialyltransferase, CMP-Neu5Ac-GAl", "MN": "D08.811.913.400.800.500", "MH_TH": "NLM (1982)", "ST": "T126", "RN": "EC 2.4.99.4", "RR": "EC 2.4.99.9", "MS": "Sialyltransferases that catalyze the transfer of N-ACETYLNEURAMINIC ACID from CYTIDINE MONOPHOSPHATE N-ACETYLNEURAMINIC ACID to the 3-OH of the GALACTOSE residue of N-GLYCANS.", "PM": "2023; was indexed as SIALYLTRANSFERASES 1982-2022", "HN": "2023", "MR": "20220712", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094663"}, {"RECTYPE": "D", "MH": "Seminal Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Semen Proteins|T116|NON|EQV|NLM (2023)|220412|abcdef", "ENTRY": "Proteins, Seminal", "MN": "D12.776.869", "MH_TH": "NLM (2023)", "ST": "T116", "RN": "0", "PI": "Seminal Plasma Proteins (2002-2022)", "MS": "Proteins found in semen. Seminal proteins are composed of SEMINAL PLASMA PROTEINS and SPERM PROTEINS.", "PM": "2023", "HN": "2023", "MR": "20220711", "DA": "20220711", "DC": "1", "DX": "20230101", "UI": "D000094664"}, {"RECTYPE": "D", "MH": "Dissection, Blood Vessel", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dissection Artery|T020|NON|NRW|NLM (2023)|220413|abcdef", "ENTRY": "Dissection, Arterial", "MN": "C14.907.055.448", "MH_TH": "NLM (2017)", "ST": "T047", "AN": "coordinate with specific aneurysm term if available; otherwise coordinate with specific vessel or precoordinated vascular disease", "MS": "A tear or separation of the layers by a blood vessel typically involving vessels under pressure, i.e., ARTERIES, e.g., AORTA. Tearing of the TUNICA INTIMA layer of a blood vessel may lead to interstitial HEMORRHAGE. Dissection between the tunica intima and TUNICA MEDIA causes luminal occlusion. Dissection at the media, or between the media and the outer ADVENTITIA causes aneurismal dilation.", "PM": "2023; see ANEURYSM, DISSECTING 2017-2022", "HN": "2023; use ANEURYSM, DISSECTING 2017-2022", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094665"}, {"RECTYPE": "D", "MH": "Aortic Intramural Hematoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intramural Hematoma Aorta|T020|NON|EQV|NLM (2023)|220413|abcdef", "ENTRY": "Intramural Hematoma, Aortic", "MN": "C23.550.414.838.175", "MH_TH": "NLM (2023)", "ST": "T020", "PI": "Hematoma (1995-2022)", "MS": "An atypical form of AORTIC DISSECTION in which subintimal dissection of the aortic TUNICA MEDIA without initial laceration of the aortic TUNICA INTIMA. It may begin from a rupture of the VASA VASORUM feeding aortic media.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094666"}, {"RECTYPE": "D", "MH": "Penetrating Atherosclerotic Ulcer", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Penetrating Ulcer Aorta|T047|NON|EQV|NLM (2023)|220413|abcdef", "ENTRY": "Ulcer, Penetrating Atherosclerotic", "MN": "C14.907.613", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Penetrating Atherosclerotic Ulcer (1986-2022)", "MS": "Ulceration of the AORTA by an ATHEROSCLEROTIC PLAQUE by penetrating through and disrupting the internal elastic lamina of the TUNICA INTIMA.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094667"}, {"RECTYPE": "D", "MH": "Endovascular Aneurysm Repair", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Thoracic Endovascular Repair|T061|NON|NRW|NLM (2024)|220819|abcdef", "ENTRY": "Thoracic Endovascular Repairs", "MN": "E04.650.200.500", "MH_TH": "NLM (2023)", "ST": "T061", "PI": "Endovascular Procedures (1996-2022)", "MS": "A minimally invasive surgical technique to repair aneurysms through the lumen of a blood vessel.", "PM": "2023", "HN": "2023", "MR": "20230601", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094682"}, {"RECTYPE": "D", "MH": "Acute Aortic Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Aortic Syndromes, Acute", "MN": "C14.907.109.070", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Aortic Diseases (2001-2022)", "MS": "A group of aortic diseases presented with acute chest pain. It commonly includes AORTIC DISSECTION; AORTIC INTRAMURAL HEMATOMA; PENETRATING ATHEROSCLEROTIC ULCER and sometimes aortic aneurysms.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094683"}, {"RECTYPE": "D", "MH": "Navajo People", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Navajo Nation, Arizona, New Mexico, and Utah|T098|NON|EQV|NLM (2023)|220809|abcdef", "ENTRY": "Navajo, Dine", "MN": "M01.686.477.250.600.531", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Indians, North American (1963-2022)", "MS": "Southern Athabaskan-speaking Native American people generally associated with the Southwestern states. Navajo Nation is the largest Native American territory in the United States.", "PM": "2023", "HN": "2023", "MR": "20220809", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094684"}, {"RECTYPE": "D", "MH": "Pima People", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Pima Indians|T098|NON|EQV|NLM (2023)|220413|abcdef", "ENTRY": "Pima Peoples", "MN": "M01.686.477.250.600.687", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Indians, North American (1966-2022)", "MS": "O\u02bcodham-speaking Native American people generally associated with Southwestern Arizona.", "PM": "2023", "HN": "2023", "MR": "20220809", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094685"}, {"RECTYPE": "D", "MH": "Cost-Effectiveness Analysis", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Cost Effectiveness Ratio|T080|NON|REL|NLM (2023)|220415|abcdef", "ENTRY": "Ratio, Cost Effectiveness", "MN": "N03.219.151.285", "MH_TH": "NLM (2015)", "ST": "T057", "MS": "A method of comparing the cost of a program with its expected outcomes that are qualitative in nature. Cost effectiveness compares alternative ways to achieve a specific set of results.", "PM": "2023; see COST-BENEFIT ANALYSIS 2015-2022", "HN": "2023; use COST-BENEFIT ANALYSIS 2015-2022", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094703"}, {"RECTYPE": "D", "MH": "RNA, Guide, CRISPR-Cas Systems", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tracrRNA|T114|NON|NRW|NLM (2023)|220415|abcdef", "ENTRY": "Guide RNA, Single", "MN": "D13.444.735.790.552.563", "FX": "CRISPR-Cas Systems", "MH_TH": "NLM (2023)", "ST": "T114", "RN": "0", "AN": "do not confuse with RNA, GUIDE, KINETOPLASTIDA; do not confuse sgRNA (SINGLE-GUIDE RNA) with sgRNA (SUBGENOMIC RNA)", "PI": "RNA, Guide, CRISPR-Cas Systems (2008-2022)", "MS": "A component of CRISPR-Cas SYSTEMS. Cas endodeoxyribonucleases assemble with a guide RNA complex, a hybrid of CRISPR RNA (crRNA) and transactivating crRNA (tracrRNA) molecules, to form an active complex that cleaves DNA. crRNA and tracrRNA can be synthetically fused into a single RNA molecule, namely single guide RNA. Synthetic sgRNA is used with CRISPR-Cas SYSTEMS for targeted GENE EDITING.", "PM": "2023", "HN": "2023", "MR": "20220711", "DA": "20220711", "DC": "1", "DX": "20230101", "UI": "D000094704"}, {"RECTYPE": "D", "MH": "Sinistral Portal Hypertension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Segmental Portal Hypertension|T047|NON|EQV|NLM (2023)|220420|abcdef", "ENTRY": "Sinistral Portal Hypertensions", "MN": "C06.552.494.707", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Hypertension, Portal (1993-2022)", "MS": "Portal hypertension of the SPLENIC VEIN due to occlusion caused by pancreatic pathology such as PANCREATIC PSEUDOCYST and PANCRATIC CANCER. Sinistral portal hypertension is associated with GASTRIC VARICES and acute HEMATEMESIS.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094723"}, {"RECTYPE": "D", "MH": "Idiopathic Noncirrhotic Portal Hypertension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Porto-Sinusoidal Vascular Diseases|T047|NON|NRW|NLM (2023)|220420|abcdef", "ENTRY": "Vascular Disease, Porto-Sinusoidal", "MN": "C06.552.494.561", "MH_TH": "NLM (2023)", "ST": "T047", "PI": "Hypertension, Portal (1971-2022)", "MS": "Portal hypertension without known risk factors for hypertension, e.g., HEPATIC CIRRHOSIS and SCHISTOSOMIASIS. Idiopathic Noncirrhotic Portal Hypertension is most often associated with pathology in the PORTAL SYSTEM vasculature.", "PM": "2023", "HN": "2023", "MR": "20220523", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094724"}, {"RECTYPE": "D", "MH": "Processing Speed", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Psychomotor Speed|T079|NON|REL|NLM (2023)|220420|abcdef", "ENTRY": "Speed, Psychomotor Processing", "MN": "F02.830.628", "MH_TH": "NLM (2023)", "ST": "T079", "PI": "Reaction Time (1972-2022)", "MS": "The time it takes to understand and do a mental task. Unlike REACTION TIME processing speed does not necessarily include a motor component in response. Processing speed is tested by most NEUROPSYCHOLOGICAL TESTS.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094725"}, {"RECTYPE": "D", "MH": "Secreted Frizzled-Related Proteins", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "sFRPS|T116|T192|ABB|EQV|NLM (2023)|220421|abbcdef", "ENTRY": "Soluble Frizzled Related Proteins", "MN": "D12.776.476.800", "FX": "Frizzled Receptors", "MH_TH": "NLM (2023)", "ST": "T192", "RN": "0", "PI": "Intracellular Signaling Peptides and Proteins (1997-2022)", "MS": "Soluble and secreted frizzled-related proteins which function as modulators of WNT SIGNALING PATHWAY.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000094742"}, {"RECTYPE": "D", "MH": "Subgenomic RNA", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "sgmRNA|T114|ABB|EQV|NLM (2023)|220422|abcdef", "ENTRY": "mRNA, Subgenomic", "MN": "D13.444.735.828.500", "FX": "CRISPR-Cas Systems", "MH_TH": "NLM (2023)", "ST": "T114", "RN": "0", "AN": "do not confuse sgRNA (SUBGENOMIC RNA) with sgRNA (SINGLE-GUIDE RNA see RNA, GUIDE, CRISPR-Cas SYSTEMS)", "PI": "RNA, Viral (1981-2022)", "MS": "RNA that results from VIRUS REPLICATION of partial genomic regions. The process may involve specific internal transcriptional initiation and termination sites.", "PM": "2023", "HN": "2023", "MR": "20220711", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094762"}, {"RECTYPE": "D", "MH": "Phytosomes", "MN": "J01.637.087.500.709", "MH_TH": "NLM (2023)", "ST": "T109", "RN": "0", "MS": "Lipid-based vesicular drug delivery systems that are structurally related to LIPOSOMES. Unlike LIPOSOMES, PHYTOSOMES have their active ingredient as a part of their lipid membrane itself.", "PM": "2023", "HN": "2023", "MR": "20220713", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094764"}, {"RECTYPE": "D", "MH": "Glutathione Peroxidase GPX1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glutathione Peroxidase 1|T116|T126|NON|EQV|NLM (2023)|220422|abbcdef", "ENTRY": "Glutathione Peroxidase, GPX1", "MN": "D12.776.864.050.500", "MH_TH": "NLM (2023)", "ST": "T126", "RN": "EC 1.11.1.9", "RR": "EC 1.11.1.9", "MS": "One of the most abundant isoenzymes of the glutathione peroxidase family. Located in the cytosol and mitochondria, it catalyzes the reduction of HYDROGEN PEROXIDE to water,  functioning to limit the accumulation of hydrogen peroxide and modulating processes that utilize hydrogen peroxide; and also the reduction of other organic hydroperoxides to their corresponding alcohols.", "PM": "2023; was indexed as GLUTATHIONE PEROXIDASE 1999-2021", "HN": "2023 (1999)", "MR": "20220712", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094765"}, {"RECTYPE": "D", "MH": "Combat Medics", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Field Medical Service Technicians|T097|NON|EQV|NLM (2023)|220608|abcdef", "ENTRY": "Medics, Combat", "MN": "N02.360.067.150.500", "MH_TH": "NLM (2023)", "ST": "T097", "PI": "Military Personnel (1987-2022)", "MS": "Individuals trained to provide medical care in a military operational or combat environment.", "PM": "2023", "HN": "2023", "MR": "20220713", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094767"}, {"RECTYPE": "D", "MH": "DNA Polymerase iota", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "POLiota|T116|T126|ACX|EQV|NLM (2023)|220422|abbcdef", "ENTRY": "RAD30B|T116|T126|EQV|NLM (2000)|001109|abbdef", "MN": "D08.811.913.696.445.308.300.493", "MH_TH": "NLM (2023)", "ST": "T126", "RN": "EC 2.7.7.7", "MS": "A highly error-prone DNA polymerase. It is a member of the Y-family of DNA polymerases that are DNA DAMAGE tolerant and involved in TRANSLESION DNA SYNTHESIS. DNA polymerase iota is an orthologue of yeast Rad30. Its replication fidelity is template dependent and favors Hoogsteen base-pairing at its active site.", "PM": "2023; was indexed as DNA-DIRECTED DNA POLYMERASE 2000-2022", "HN": "2023 (2000)", "MR": "20230526", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094769"}, {"RECTYPE": "D", "MH": "Paramedicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Emergency Paramedicine|T091|NON|NRW|NLM (2023)|220429|abcdef", "ENTRY": "Paramedicines, Emergency", "MN": "H02.010.563", "FX": "Paramedics", "MH_TH": "NLM (2023)", "ST": "T091", "PI": "Emergency Medical Services (2005-2022)", "MS": "A domain of practice and health profession that specialises across a range of settings including, but not limited to, emergency and primary care. Paramedics work in a variety of clinical settings such as EMERGENCY MEDICAL SERVICES, ambulance services, hospitals and clinics as well as non-clinical roles, such as education, leadership, public health and research. PARAMEDICS possess complex knowledge and skills, a broad scope of practice and are an essential part of the healthcare system. Depending on location, paramedics may practice under medical direction or independently, often in unscheduled, unpredictable or dynamic settings. (from J Multidiscip Healthc 2021 Dec 30;14:3561-3570)", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094782"}, {"RECTYPE": "D", "MH": "Paramedics", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Paramedics, Emergency|T097|NON|NRW|UNK (19XX)|830613|abcdef", "ENTRY": "Personnel, Paramedical", "MN": "N02.360.067.715", "FX": "Paramedicine", "MH_TH": "NLM (1984)", "ST": "T097", "PI": "Allied Health Personnel (1971-2022)", "MS": "Health care workers who perform tasks which must otherwise be performed by a physician or other health professional, in a variety of clinical settings such as EMERGENCY MEDICAL SERVICES, ambulance services, hospitals and clinics as well as non-clinical roles, such as education, leadership, public health and research. Paramedics may practice under medical direction or independently, often in unscheduled, unpredictable or dynamic settings.", "PM": "2023; see ALLIED HEALTH PERSONNEL 1984-2022", "HN": "2023; use ALLIED HEALTH PERSONNEL 1984-2022", "MR": "20220712", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094783"}, {"RECTYPE": "D", "MH": "beta-D-Galactoside alpha 2-6-Sialyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Galactosyl(1-4)N-Acetylglucosaminide alpha(2-6)-Sialyltransferase|T116|NON|REL|NLM (1981)|220505|abcdef", "ENTRY": "beta Galactoside alpha2,6 Sialyltransferase", "MN": "D08.811.913.400.800.250", "MH_TH": "NLM (1981)", "ST": "T126", "RN": "EC 2.4.99.1", "MS": "Sialyltransferases that catalyze the transfer of N-ACETYLNEURAMINIC ACID from CYTIDINE MONOPHOSPHATE N-ACETYLNEURAMINIC ACID to the 6-OH of the GALACTOSE residue of N-GLYCANS.", "PM": "2023; was indexed as SIALYLTRANSFERASES 1981-2022", "HN": "2023", "MR": "20220712", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094802"}, {"RECTYPE": "D", "MH": "African People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Africans|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "People, African", "MN": "M01.686.254", "MH_TH": "NLM (2023)", "ST": "T098", "MS": "People native to or inhabitants of AFRICA.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094842"}, {"RECTYPE": "D", "MH": "North African People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Northern Africans|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "Persons, Northern African", "MN": "M01.686.461.500", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Africa, Northern (1963-2022)", "MS": "People native to or inhabitants of NORTH AFRICA including ALGERIA; EGYPT; LIBYA; MOROCCO; TUNISIA and the CANARY ISLANDS.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094843"}, {"RECTYPE": "D", "MH": "Sub-Saharan African People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Sub-Saharans|T098|EPO|EQV|NLM (2023)|220504|abcdef", "ENTRY": "Sub-Saharan African Persons", "MN": "M01.686.254.750", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Africa South of the Sahara (1963-2022)", "MS": "People native to or inhabitants of SUB-SAHARAN AFRICA including\u00a0ANGOLA; BENIN; BOTSWANA; BURKINA FASO; BURUNDI; CABO VERDE; CAMEROON; CENTRAL AFRICAN REPUBLIC; CHAD; CONGO; COTE D'IVOIRE; DEMOCRATIC REPUBLIC OF THE CONGO; DJIBOUTI; EQUATORIAL GUINEA; ERITREA; ESWATINI; ETHIOPIA; GABON; GAMBIA; GHANA; GUINEA; GUINEA-BISSAU; KENYA; LESOTHO; LIBERIA; MALAWI; MALI; MAURITANIA; MOZAMBIQUE; NAMIBIA; NIGER; NIGERIA; RWANDA; SAO TOME AND PRINCIPE; SENEGAL; SIERRA LEONE; SOMALIA; SOUTH AFRICA; SOUTH SUDAN; SUDAN; TANZANIA; TOGO; UGANDA; ZAMBIA; and ZIMBABWE.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094844"}, {"RECTYPE": "D", "MH": "Central African People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Middle Africans|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "Persons, Middle African", "MN": "M01.686.254.750.500", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Central African Republic (1964-2022)", "MS": "People native to or inhabitants of the CENTRAL AFRICA including CAMEROON; CENTRAL AFRICAN REPUBLIC; CHAD; CONGO; DEMOCRATIC REPUBLIC OF THE CONGO; EQUATORIAL GUINEA; GABON; and SAO TOME AND PRINCIPE. It includes indigenous peoples in the Congo Basin. Sometimes people native or inhabitants of the country of Central African Republic are referred to as Central Africans.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094845"}, {"RECTYPE": "D", "MH": "East African People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Eastern Africans|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "Persons, Eastern African", "MN": "M01.686.254.750.750", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Africa, Eastern (1985-2022)", "MS": "People native to or inhabitants of EASTERN AFRICA including BURUNDI, DJIBOUTI, ERITREA, ETHIOPIA, KENYA, RWANDA, SOMALIA, SOUTH SUDAN, SUDAN, TANZANIA, and UGANDA and islands COMOROS; MADAGASCAR and SEYCHELLES.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094846"}, {"RECTYPE": "D", "MH": "Southern African People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Southern Africans|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "Southern African Persons", "MN": "M01.686.254.750.875", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Africa, Southern (1970-2022)", "MS": "People native to or inhabitants of SOUTHERN AFRICA including ANGOLA; BOTSWANA; EWATINI; LESOTHO; MALAWI; MOZAMBIQUE; NAMIBIA; SOUTH AFRICA; ZAMBIA; and ZIMBABWE.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094847"}, {"RECTYPE": "D", "MH": "West African People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Western Africans|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "Western African Persons", "MN": "M01.686.254.750.937", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Africa, Western (1971-2022)", "MS": "People native to or inhabitants of WEST AFRICA (western part of the sub-Saharan Africa) including BENIN; BURKINA FASO; CABO VERDE; IVORY COAST; GAMBIA; GHANA; GUINEA; GUINEA-BISSAU; LIBERIA; MALI; MAURITANIA; NIGER; NIGERIA; SENEGAL; SIERRA LEONE; TOGO and CAPE VERDE ISLANDS.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094848"}, {"RECTYPE": "D", "MH": "Central Asian People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Central Asians|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "Person, Central Asian", "MN": "M01.686.330.375", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Asia, Central (1970-2022)", "MS": "People native to or inhabitants of CENTRAL ASIA including KAZAKHSTAN; KYRGYZSTAN; TAJIKISTAN; TURKMENISTAN and UZBEKISTAN.", "PM": "2023", "HN": "2023", "MR": "20220713", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094850"}, {"RECTYPE": "D", "MH": "North Asian People", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Siberians|T098|NON|NRW|NLM (2023)|220504|abcdef", "ENTRY": "Siberian Peoples", "MN": "M01.686.330.625", "MH_TH": "NLM (2023)", "ST": "T098", "MS": "People native to or inhabitants of the NORTHERN ASIA including SIBERIA .", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000094852"}, {"RECTYPE": "D", "MH": "South Asian People", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Southern Asians|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "Southern Asian Persons", "MN": "M01.686.330.875.500", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Asia (1980-2022)", "MS": "People native to or inhabitants of SOUTHERN ASIA including AFGHANISTAN; BANGLADESH; BHUTAN; INDIA; MALDIVES; NEPAL; PAKISTAN and SRI LANKA", "PM": "2023", "HN": "2023", "MR": "20221103", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000094853"}, {"RECTYPE": "D", "MH": "European People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Europeans|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "Persons, European", "MN": "M01.686.445", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Europe (1963-2022)", "MS": "People native to or inhabitants of EUROPE.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094854"}, {"RECTYPE": "D", "MH": "Eastern European People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Slavic Peoples|T098|NON|REL|NLM (2023)|220610|abcdef", "ENTRY": "Persons, Eastern European", "MN": "M01.686.445.500", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Europe, Eastern (1963-2022)", "MS": "People native to or inhabitants of EASTERN EUROPE including ALBANIA; BOSNIA AND HERZEGOVINA; BULGARIA; CROATIA; CZECH REPUBLIC; ESTONIA; HUNGARY; KOSOVO; LATVIA; LITHUANIA; MOLDOVA; MONTENEGRO; POLAND; REPUBLIC OF NORTH MACEDONIA; REPUBLIC OF BELARUS; ROMANIA; RUSSIA; SERBIA; SLOVAKIA; SLOVENIA; and UKRAINE.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094855"}, {"RECTYPE": "D", "MH": "Scandinavians and Nordic People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Scandinavians|T098|NON|NRW|NLM (2023)|220504|abcdef", "ENTRY": "Peoples, Nordic", "MN": "M01.686.445.750", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Europe (1963-2022)", "MS": "People native to or inhabitants of the SCANDINAVIAN AND NORDIC COUNTRIES.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094857"}, {"RECTYPE": "D", "MH": "North American People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "North Americans|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "Persons, North American", "MN": "M01.686.477", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "North America (1963-2022)", "MS": "People native to or inhabitants of NORTH AMERICA.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094858"}, {"RECTYPE": "D", "MH": "Caribbean People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "West Indian People|T098|NON|REL|NLM (2023)|220610|abcdef", "ENTRY": "West Indian Peoples", "MN": "M01.686.413", "MH_TH": "NLM (2023)", "ST": "T098", "MS": "People native to or inhabitants of islands in the Caribbean Sea or CARIBBEAN including ANTIGUA AND BARBUDA; ARUBA; BAHAMAS; BARBADOS; BRITISH VIRGIN ISLANDS; CARIBBEAN NETHERLANDS; CUBA; CURACAO; DOMINICA; DOMINICAN REPUBLIC; GRENADA; GUADELOUPE; HAITI; JAMAICA; MARTINIQUE; PUERTO RICO; SAINT KITTS AND NEVIS; SAINT LUCIA; SAINT VINCENT AND THE GRENADINES; SINT MAARTEN; TRINIDAD AND TOBAGO; and UNITED STATES VIRGIN ISLANDS.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000094859"}, {"RECTYPE": "D", "MH": "South American People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "South Americans|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "South American Peoples", "MN": "M01.686.685", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "South America (1963-2022)", "MS": "People native to or inhabitants of SOUTH AMERICA including ARGENTINA; BOLIVIA; BRAZIL; CHILE; COLOMBIA; ECUADOR; FRENCH GUIANA; GUYANA; PARAGUAY; PERU; SURINAME; URUGUAY; and VENEZUELA.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000094860"}, {"RECTYPE": "D", "MH": "Australasian People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Australasians|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "People, Australasian", "MN": "M01.686.493.500", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Australasia (1966-2022)", "MS": "People native to or inhabitants of AUSTRALASIA including AUSTRALIA and NEW ZEALAND.", "PM": "2023", "HN": "2023", "MR": "20220721", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094861"}, {"RECTYPE": "D", "MH": "Oceanians", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Oceanic Ancestry Group|T098|HIST|REL|NLM (2004)|220721|abcdef", "ENTRY": "People, Oceanian", "MN": "M01.686.493", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Oceania (1963-2022)", "MS": "People native to or inhabitants of OCEANIA including MICRONESIA; MELANESIA; POLYNESIA; AUSTRALIA and NEW ZEALAND.", "PM": "2023; OCEANIC ANCESTRY GROUP was a heading 2004-2021, see NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER 2022", "HN": "2023(2004)", "MR": "20221208", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094862"}, {"RECTYPE": "D", "MH": "Middle Eastern and North Africans", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "MENAs|T098|ACR|EQV|NLM (2023)|220504|abcdef", "MN": "M01.686.461", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Middle East (1987-2022)", "MS": "People native to or inhabitants of the MIDDLE EAST and NORTH AFRICA.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094863"}, {"RECTYPE": "D", "MH": "Middle Eastern People", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Southwestern Asians|T098|NON|EQV|NLM (2023)|220505|abcdef", "ENTRY": "Southwestern Asian Persons", "MN": "M01.686.461.250", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Middle East (1963-2022)", "MS": "People native to or inhabitants of MIDDLE EAST including BAHRAIN; IRAN; IRAQ; ISRAEL; JORDAN; KUWAIT; LEBANON; OMAN; PALESTINIAN TERRITORIES; QATAR; SAUDI ARABIA; SYRIA; TURKEY; UNITED ARAB EMIRATES; and YEMEN.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000094864"}, {"RECTYPE": "D", "MH": "West Asian People", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Western Asians|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "Western Asian Persons", "MN": "M01.686.330.875", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Asia, Western (1966-2022)", "MS": "People native to or inhabitants of WESTERN ASIA including BANGLADESH; BHUTAN; INDIA; IRAN; IRAQ; ISRAEL; JORDAN; KUWAIT; LEBANON; MALDIVES; NEPAL; OMAN; PALESTINIAN TERRITORIES; PAKISTAN; QATAR; SAUDI ARABIA; SRI LANKA; SYRIA; TURKEY; UNITED ARAB EMIRATES and YEMEN.", "PM": "2023", "HN": "2023", "MR": "20231107", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000094865"}, {"RECTYPE": "D", "MH": "Central American People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Central Americans|T098|NON|EQV|NLM (2023)|220504|abcdef", "ENTRY": "Persons, Central American", "MN": "M01.686.429", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Central America (1978-2022)", "MS": "People native to or inhabitants of CENTRAL AMERICA including BELIZE; COSTA RICA; EL SALVADOR; GUATEMALA; HONDURAS; NICARAGUA; and PANAMA.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094866"}, {"RECTYPE": "D", "MH": "Blood Banking", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Banking, Blood", "MN": "N02.421.911.050", "FX": "Hematologic Tests", "MH_TH": "NLM (2023)", "ST": "T058", "PI": "Blood Banks (1966-2022)", "MS": "The administrative procedures and methods required for collecting, characterizing and storing blood or plasma in BLOOD BANKS.", "PM": "2023; see BLOOD BANKS 1966-2022", "HN": "2023; use BLOOD BANKS 1966-2022", "MR": "20220711", "DA": "20220712", "DC": "1", "DX": "20230101", "UI": "D000094902"}, {"RECTYPE": "D", "MH": "Nociceptin Receptor", "PRINT ENTRY": "Receptors, ORL1|T116|T192|NON|EQV|NLM (2023)|220518|abbcdef", "ENTRY": "Receptors, Orphanin FQ", "MN": "D12.776.543.750.750.555.610.887", "MH_TH": "NLM (2023)", "ST": "T192", "RN": "0", "RR": "DVO6VKD7IJ", "PI": "Receptors, Opioid (1996-2022)", "MS": "A member of the opioid subfamily of the G PROTEIN-COUPLED RECEPTORS. It is the receptor for the endogenous neuropeptide nociceptin. It functions in modulating NOCICEPTION and the perception of pain.", "PM": "2023; NOCICEPTIN RECEPTOR was indexed under RECEPTORS, OPIOID 1996-2022", "HN": "2023 (1996)", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000094942"}, {"RECTYPE": "D", "MH": "Axl Receptor Tyrosine Kinase", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.624.664.700.013", "MH_TH": "NLM (2023)", "ST": "T192", "RN": "0", "RR": "EC 2.7.10.1", "MS": "A member of the Tyro3-Axl-Mer (TAM) RECEPTOR PROTEIN-TYROSINE KINASES subfamily. Involved in several cellular functions including growth, migration, cell aggregation, and anti-inflammation.", "PM": "2023; AXL RECEPTOR TYROSINE KINASE was indexed under RECEPTOR PROTEIN-TYROSINE KINASES, PROTO-ONCOGENE PROTEINS 1999-2022", "HN": "2023 (1999)", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000094963"}, {"RECTYPE": "D", "MH": "Military Sexual Trauma", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Traumas, Military Sexual", "MN": "F03.950.750.438.500", "MH_TH": "NLM (2023)", "ST": "T048", "PI": "Veterans (2006-2022)", "MS": "Physical and psychological injuries resulting from SEXUAL VIOLENCE during MILITARY service.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000094964"}, {"RECTYPE": "D", "MH": "Synthetic Cathinone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Synthetic Cathinones|T109|T121|NON|EQV|NLM (2023)|220524|abbcdef", "ENTRY": "Salts, Psychoactive Bath", "MN": "D02.522.818.890", "MH_TH": "NLM (2023)", "ST": "T121", "RN": "0", "RR": "E7LD6JMR0L", "PI": "Alkaloids (2011-2022)", "MS": "A propiophenone derivative chemically related to cathinone, a substance found in the KHAT plant.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000094982"}, {"RECTYPE": "D", "MH": "Acetolactate Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Acetolactate Synthetase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Synthetase, Acetolactate", "MN": "D12.776.331.049", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Acetolactate pyruvate-lyase (carboxylating)", "RN": "EC 2.2.1.6", "RR": "9027-45-6 (CAS RN)", "PI": "Pyruvates (1972-1974)", "MS": "A flavoprotein enzyme that catalyzes the formation of acetolactate from 2 moles of PYRUVATE in the biosynthesis of VALINE and the formation of acetohydroxybutyrate from pyruvate and alpha-ketobutyrate in the biosynthesis of ISOLEUCINE. This enzyme was formerly listed as EC 4.1.3.18.", "PM": "91; was see under KETOACID-LYASES 1975-90", "HN": "91(75); was see under KETOACID-LYASES 1975-90", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000095"}, {"RECTYPE": "D", "MH": "Delta Catenin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neurojungin|T116|T123|NON|NRW|NLM (2023)|220610|abbcdef", "ENTRY": "Protein, Catenin p120ctn", "MN": "D12.776.220.145.875", "MH_TH": "NLM (2023)", "ST": "T123", "RN": "0", "MS": "A CATENIN protein that plays a critical role in cell adhesion and tissue morphogenesis by regulating the surface stability of C-, E-, and N- CADHERINS.", "PM": "2023; DELTA CATENIN was indexed under CATENINS 1994-2022", "HN": "2023 (1994)", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000095002"}, {"RECTYPE": "D", "MH": "Interferon Lambda", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Type III Interferons|T116|T123|NON|EQV|NLM (2023)|220526|abbcdef", "ENTRY": "Interferons, Type III", "MN": "D23.529.374.440.946", "MH_TH": "NLM (2023)", "ST": "T123", "RN": "0", "MS": "A specific type of interferon that is similar to  INTERFERON TYPE I. It primarily functions at barrier epithelial surface, such as the respiratory tract and blood brain barrier", "PM": "2023; INTERFERON TYPE III was indexed under INTERFERONS 2018-2022", "HN": "2023 (2018)", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000095022"}, {"RECTYPE": "D", "MH": "Forensic Microbiology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Postmortem Microbiology|T090|NON|REL|NLM (2023)|220609|abcdef", "ENTRY": "Sciences, Microbial Forensic", "MN": "I01.198.780.945", "MH_TH": "NLM (2023)", "ST": "T090", "PI": "Forensic Sciences (2002-2022)", "MS": "The scientific discipline dedicated to analyzing evidence from BIOTERRORISM, biocrime, HOAX, or inadvertent microorganism/toxin release for attribution purposes.", "PM": "2023", "HN": "2023", "MR": "20230615", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000095024"}, {"RECTYPE": "D", "MH": "Urinary Sediment Analysis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Urinary Sediment Analyses", "MN": "E05.200.124.810.500", "MH_TH": "NLM (2023)", "ST": "T059", "MS": "Microscopic visualization and/or chemical analysis of the sediments in URINE.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000095025"}, {"RECTYPE": "D", "MH": "Antiracism", "AQ": "CL EC ED ES HI IN LJ PX SN ST TD", "PRINT ENTRY": "Anti-Racism|T078|NON|EQV|NLM (2023)|220527|abcdef", "ENTRY": "Anti Racism", "MN": "N05.350.958.750.500", "FX": "Racism", "MH_TH": "NLM (2023)", "ST": "T078", "MS": "Beliefs, actions or intentions, and policies that oppose RACISM or discrimination  based on RACE.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000095026"}, {"RECTYPE": "D", "MH": "Overtraining Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Over-Training Syndrome|T047|NON|EQV|NLM (2023)|220708|abcdef", "ENTRY": "Syndrome, Overtraining", "MN": "C23.888.369.750", "MH_TH": "NLM (2023)", "ST": "T047", "MS": "An accumulation of training and/or non-training stress resulting in short-term decrement in performance capacity with or without related physiological and psychological signs and symptoms of maladaptation in which restoration of performance capacity may take from several weeks to several months.(from  Curr Sports Med Rep. May-Jun 2015;14(3):157-8)", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000095027"}, {"RECTYPE": "D", "MH": "Multiomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Panomics|T091|NON|EQV|NLM (2024)|220830|abcdef", "ENTRY": "Pan Omics", "MN": "L01.313.124.500", "MH_TH": "NLM (2023)", "ST": "T091", "MS": "The study of a variety of data sets, such as TRANSCRIPTOME; PROTEOME; METABOLOME; or MICROBIOME, that are generated from the same biological source, like a cell type or organ, during normal versus diseased states, or other comparable instances.", "PM": "2023", "HN": "2023", "MR": "20221214", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000095028"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase-Activating Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "P34CDC2 Activating Kinase|T116|T126|NON|NRW|NLM (2023)|220610|abbcdef", "ENTRY": "Kinase-Activating Kinase, Cyclin-Dependent", "MN": "D12.776.476.563.646.500.992", "MH_TH": "NLM (2023)", "ST": "T126", "RN": "EC 2.7.11.22", "MS": "A highly-conserved cyclin-dependent kinase that activates other CYCLIN DEPENDENT KINASES and plays a key role in regulation of the CELL CYCLE.", "PM": "2023; CYCLIN-DEPENDENT KINASE-ACTIVATING KINASE was indexed under CYCLIN-DEPENDENT KINASES 1990-2022", "HN": "2023 (1990)", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000095043"}, {"RECTYPE": "D", "MH": "Anticoagulation Bridge", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Anticoagulation Bridge Therapy|T061|NON|EQV|NLM (2023)|220601|abcdef", "ENTRY": "Therapy, Anticoagulation Bridge", "MN": "E02.134.500", "MH_TH": "NLM (2023)", "ST": "T061", "PI": "Anticoagulants (2009-2022)", "MS": "A peri-operative bridge therapy procedure in patients with high risk THROMBOEMBOLIC events and the risk of bleeding.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000095062"}, {"RECTYPE": "D", "MH": "Traditional Medicine Practitioners", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Witch Doctor, African|T097|NON|REL|NLM (1998)|960801|abcdef", "ENTRY": "Witch Doctors, African", "MN": "N02.360.858", "FX": "Shamanism", "MH_TH": "NLM (2023)", "ST": "T097", "PI": "Medicine, Traditional (1971-2022)", "MS": "Health personnel using systems of medicine based on cultural beliefs and practices handed down from generation to generation, including mystical and magical rituals (SPIRITUAL THERAPIES); TRADITIONAL MEDICINE; PHYTOTHERAPY; HERBAL MEDICINE; and other treatments which may not be explained by modern medicine.", "PM": "2023", "HN": "2023", "MR": "20220712", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000095083"}, {"RECTYPE": "D", "MH": "Asia, Southern", "AQ": "EH EP", "PRINT ENTRY": "South Asia|T083|NON|EQV|NLM (2023)|220701|abcdef", "ENTRY": "Southern Asia|T083|NAM|EQV|POPLINE (1983)|861231|abcdef", "MN": "Z01.252.245.782", "MH_TH": "NLM (2023)", "ST": "T083", "PI": "Asia (1969-2022)", "MS": "The geographical designation for the countries of AFGHANISTAN; BANGLADESH; BHUTAN; INDIA; MALDIVES; NEPAL; PAKISTAN; and SRI LANKA.", "HN": "2023(1983); for BRITISH INDIAN OCEAN TERRITORY use AFRICA, EASTERN 1983-2022", "MR": "20221031", "DA": "20220708", "DC": "4", "DX": "20230101", "UI": "D000095143"}, {"RECTYPE": "D", "MH": "Maldives", "AQ": "EH EP", "MN": "Z01.252.245.782.906", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "Country in southern Asia, an island in the Indian Ocean. The capital is city of Male.", "HN": "2023; use INDIAN OCEAN ISLANDS 1978-2022", "MR": "20220708", "DA": "20220708", "DC": "4", "DX": "20230101", "UI": "D000095164"}, {"RECTYPE": "D", "MH": "Population Groups, US", "AQ": "CL ED EH ES GE HI LJ PX SN", "PRINT ENTRY": "US Population Groups|T098|NON|EQV|NLM (2023)|220706|abcdef", "ENTRY": "US Population Group", "MN": "M01.686.477.625", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Population Groups (1963-2022)", "MS": "Individuals classified according US federal government used for US federal data on race and ethnicity. Race and ethnicity terms are self-identified social construct. MeSH may contain outdated and offensive population terms only to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.", "PM": "2023", "HN": "2023", "MR": "20220708", "DA": "20220708", "DC": "1", "DX": "20230101", "UI": "D000095165"}, {"RECTYPE": "D", "MH": "Pacific Island People", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Polynesians|T098|NON|NRW|NLM (2023)|220708|abcdef", "ENTRY": "Polynesian Peoples", "MN": "M01.686.493.500.800", "MH_TH": "NLM (2023)", "ST": "T098", "MS": "Persons having origins in any of PACIFIC ISLANDS. Note that OMB category NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER is available for United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.", "PM": "2023", "HN": "2023", "MR": "20220714", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000095188"}, {"RECTYPE": "D", "MH": "White", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Whites|T098|NON|EQV|POPLINE (1978)|220713|abcdef", "MN": "M01.686.877.500", "MH_TH": "OMB (2023)", "ST": "T098", "AN": "use only for the United States populations. WHITE PEOPLE is also available", "MS": "A person having origins in any of the white racial groups of Europe, the Middle East and North Africa (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.", "PM": "2023; see CAUCASIAN RACE 1963-1977, WHITES 1978-2003, CAUCASOID RACE 1978-2003, EUROPEAN CONTINENTAL ANCESTRY GROUP 2004-2021, WHITES 2022", "HN": "2023; use CAUCASIAN RACE 1963-1977, WHITES 1978-2003, CAUCASOID RACE 1978-2003, EUROPEAN CONTINENTAL ANCESTRY GROUP 2004-2021, WHITES 2022", "MR": "20221207", "DA": "20220714", "DC": "1", "DX": "20230101", "UI": "D000095223"}, {"RECTYPE": "D", "MH": "Southeast Asian People", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Southeastern Asians|T098|NON|EQV|NLM (2023)|220713|abcdef", "ENTRY": "Southeastern Asian Peoples", "MN": "M01.686.330.750", "MH_TH": "NLM (2023)", "ST": "T098", "PI": "Asia, Southeastern (1964-2022)", "MS": "People native to or inhabitants of SOUTHEASTERN ASIA including BORNEO; BRUNEI; CAMBODIA; INDONESIA; LAOS; MALAYSIA; the MEKONG VALLEY; MYANMAR (formerly Burma), the PHILIPPINES; SINGAPORE; THAILAND; and VIETNAM. It includes people native or inhabitants of the MEKONG VALLEY.", "PM": "2023; for BURMESE see ASIANS 2013-2022; for CAMBODIANS see ASIANS 2013-2022; for THAI see ASIANS 2013-2022; for VIETNAMESE see ASIANS 2013-2022", "HN": "2023; for BURMESE use ASIANS 2013-2022; for CAMBODIANS use ASIANS 2013-2022; for THAI use ASIANS 2013-2022; for VIETNAMESE use ASIANS 2013-2022", "MR": "20221103", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000095224"}, {"RECTYPE": "D", "MH": "East Asian People", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Far East Asians|T098|NON|EQV|NLM (2023)|220713|abcdef", "ENTRY": "People, Eastern Asian", "MN": "M01.686.330.500", "MH_TH": "NLM (2023)", "ST": "T098", "PM": "2023; for CHINESE see ASIANS 1981-2022, for JAPANESE use ASIANS 2004-2022; for KOREANS use ASIANS 2004-2022", "HN": "2023; for CHINESE use ASIANS 1981-2022, for JAPANESE use ASIANS 2004-2022; for KOREANS use ASIANS 2004-2022", "MR": "20220713", "DA": "20220713", "DC": "1", "DX": "20230101", "UI": "D000095225"}, {"RECTYPE": "D", "MH": "Australian Aboriginal and Torres Strait Islander Peoples", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Torres Strait Islanders|T098|NON|NRW|NLM (2023)|220723|abcdef", "ENTRY": "Torres Strait Islander", "MN": "M01.686.493.500.500", "MH_TH": "NLM (2023)", "ST": "T098", "MS": "The two groups of indigenous aboriginal peoples of Australia. They include Aboriginal Australians and Torres Strait Islanders. These are two distinct peoples with unique histories, languages, cultural practices and spiritual beliefs.", "PM": "2023; for ABORIGINES, AUSTRALIAN see NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER 2022, see OCEANIC ANCESTRY GROUP 2006-2021; for AUSTRALOID RACE see NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER 2022, see OCEANIC ANCESTRY GROUP 2004-2021, see AUSTRALOID RACE 1978-2003, see AUSTRALIAN RACE 1963-1977", "HN": "2023", "MR": "20220723", "DA": "20220721", "DC": "1", "DX": "20220721", "UI": "D000095283"}, {"RECTYPE": "D", "MH": "Maori People", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "M\u0101ori People|T098|NON|EQV|NLM (2024)|230119|abcdef", "ENTRY": "People, M\u0101ori", "MN": "M01.686.493.500.800.400", "MH_TH": "NLM (2023)", "ST": "T098", "MS": "The indigenous aboriginal people of New Zealand.", "PM": "2023; see OCEANIC ANCESTRY GROUP 2021, see NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER 2022", "HN": "2023", "MR": "20230612", "DA": "20220721", "DC": "1", "DX": "20220721", "UI": "D000095284"}, {"RECTYPE": "D", "MH": "Anthrones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Anthranones|T109|NON|EQV|NLM (2024)|220808|abcdef", "MN": "D04.615.125.380", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "MS": "Anthracenes with one ketone group, typically 9,10-dihydroanthracene carrying an oxo group at C-9.", "PM": "2024; see ANTHRACENES 2004-2023", "HN": "2024; use ANTHRACENES 2004-2023", "MR": "20230607", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095322"}, {"RECTYPE": "D", "MH": "Dietary Patterns", "AQ": "CL DE EH ES PH PX RE", "PRINT ENTRY": "Food Patterns|T055|NON|EQV|NLM (2024)|220909|abcdef", "ENTRY": "Patterns, Food", "MN": "G07.203.650.353.350", "MH_TH": "NLM (2024)", "ST": "T055", "PI": "Diet (1963-2023)", "MS": "Foods and beverages that an individual or group of humans or animals habitually consume.", "PM": "2024", "HN": "2024", "MR": "20221215", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095362"}, {"RECTYPE": "D", "MH": "Trace Amine-Associated Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Trace Amine Associated Receptor|T116|T192|NON|EQV|NLM (2024)|220907|abbcdef", "ENTRY": "Trace Amine Associated Receptors", "MN": "D12.776.543.750.695.600.500", "FX": "Receptors, Biogenic Amine", "MH_TH": "NLM (2024)", "ST": "T192", "RN": "0", "PI": "Receptors, G-Protein-Coupled (2005-2023)", "MS": "G-protein coupled receptors that interact with trace amine compounds (e.g., P-OCTOPAMINE; BETA-PHENYLETHYLALMINE; TRYPTAMINE; P-TYRAMINE) which are present at low tissue levels in mammals. Most human trace amine-associated receptors are expressed in olfactory epithelium neurons.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095383"}, {"RECTYPE": "D", "MH": "Pathologic Complete Response", "PRINT ENTRY": "In Full Remission|T033|NON|REL|NLM (2024)|220819|abcdef", "ENTRY": "Pathologic Complete Responses", "MN": "N05.715.360.575.575.800.427", "MH_TH": "NLM (2024)", "ST": "T033", "PI": "Treatment Outcome (1993-2023)", "MS": "The disappearance of all signs of a disease upon REMISSION INDUCTION as supported by pathological examination.", "PM": "2024", "HN": "2024", "MR": "20230226", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095384"}, {"RECTYPE": "D", "MH": "Truck Drivers", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Truck Driver", "MN": "M01.526.959", "MH_TH": "NLM (2024)", "ST": "T097", "MS": "Persons skilled or qualified to operate trucks.", "PM": "2024", "HN": "2024", "MR": "20230530", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095402"}, {"RECTYPE": "D", "MH": "Psychological Safety", "AQ": "CL EC HI LJ OG PX SN ST TD", "ENTRY": "Safety, Psychological", "MN": "F04.096.628.829.500", "MH_TH": "NLM (2024)", "ST": "T082", "PI": "Organizational Culture(2008-2023)", "MS": "An environment where people are able to act and engage without fear of punishment or humiliation from others.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095422"}, {"RECTYPE": "D", "MH": "Photomechanical Print", "MN": "V02.697.500", "MH_TH": "NLM (2024)", "ST": "T073", "MS": "Printed image made using photographic images.", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "2", "DX": "20240101", "UI": "D000095463"}, {"RECTYPE": "D", "MH": "RNA, Competitive Endogenous", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ceRNA|T114|ABB|EQV|NLM (2024)|220829|abcdef", "ENTRY": "RNA, Competing Endogenous", "MN": "D13.444.735.477", "MH_TH": "NLM (2024)", "ST": "T114", "RN": "0", "PI": "RNA, Long Noncoding (2013-2023)", "MS": "Coding or noncoding RNAs which regulate the expression of other RNA transcripts by competing for shared MICRORNAS.", "PM": "2024", "HN": "2024", "MR": "20230613", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095482"}, {"RECTYPE": "D", "MH": "Super Enhancers", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Superenhancers|T114|T123|NON|EQV|NLM (2024)|221027|abbcdef", "ENTRY": "Superenhancer", "MN": "G05.360.340.024.340.137.750.249.882", "MH_TH": "NLM (2024)", "ST": "T123", "PI": "Enhancer Elements, Genetic (2023)", "MS": "Large clusters of transcriptional enhancers which drive expression of genes that define cell identity.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095483"}, {"RECTYPE": "D", "MH": "Bulk Drugs", "AQ": "AD AN BL CF CH CL CS EC HI IP ME RE SD ST UR", "PRINT ENTRY": "Bulk Drug Substances|T121|NON|EQV|NLM (2024)|220829|abcdef", "ENTRY": "Pharmaceutical Ingredients, Active", "MN": "D26.025", "MH_TH": "NLM (2024)", "ST": "T121", "RN": "0", "MS": "Any substance that is represented for use in a drug and that, when used in the manufacturing, processing, or packaging of a drug, becomes an active ingredient or a finished dosage form of the drug. Does not include intermediates used in the synthesis of such substances.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095485"}, {"RECTYPE": "D", "MH": "Cognitive Reflection", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Reflective Thinking|T041|NON|EQV|NLM (2024)|220829|abcdef", "ENTRY": "Thinking, Reflective", "MN": "F02.463.188.318", "MH_TH": "NLM (2024)", "ST": "T041", "MS": "Deliberate and careful consideration of previous actions, events, experiences, or decisions and the thinking that accompanied these activities. (https://eric.ed.gov/?qt=reflection&ts=on&td=on&ti=Reflection).", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095486"}, {"RECTYPE": "D", "MH": "Nicotine Replacement Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Nicotine Replacement", "MN": "E02.319.597", "FX": "Tobacco Use Cessation Devices", "MH_TH": "NLM (2024)", "ST": "T061", "MS": "Replacing NICOTINE from TOBACCO with an alternate source in order to reduce the severity of tobacco withdrawal during TOBACCO USE CESSATION.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095488"}, {"RECTYPE": "D", "MH": "Dashboard Systems", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Health Dashboard|T073|NON|NRW|NLM (2024)|221012|abcdef", "ENTRY": "Health Dashboards", "MN": "N04.452.515.110.500", "MH_TH": "NLM (2024)", "ST": "T170", "MS": "A platform that integrates multiple datasets, data structures, and sources into a single interface that is easily visualized and understood.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095489"}, {"RECTYPE": "D", "MH": "Tuft Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Caveolated Cells|T025|NON|EQV|NLM (2024)|220830|abcdef", "ENTRY": "Tuft Cell", "MN": "A11.671.650.915.500.900", "MH_TH": "NLM (2024)", "ST": "T025", "PI": "Epithelial Cells (1973-2023)", "MS": "Epithelial chemosensory cells with apical microvilli. They are found in many different organs and they share characteristics with the chemosensory cells in taste buds. These cells can be activated by infections in the gastrointestinal tract.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095491"}, {"RECTYPE": "D", "MH": "Comic Book", "ENTRY": "Comic Books|T170|NON|EQV|NLM (2018)|170301|abcdef", "MN": "V02.700.225", "MH_TH": "NLM (2020)", "ST": "T170", "MS": "Narrative works that employ sequential art, and often prose, to tell a story. (https://id.loc.gov/authorities/genreForms)", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "2", "DX": "20240101", "UI": "D000095493"}, {"RECTYPE": "D", "MH": "Lacanian Theory", "ENTRY": "Theory, Lacanian", "MN": "F02.739.594", "MH_TH": "NLM (2024)", "ST": "T170", "PI": "Psychological Theory (2000-2023)", "MS": "Psychoanalytic theory begun by Jacques Lacan as a philosophical linguistic re-interpretation of Freud's original teachings.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095494"}, {"RECTYPE": "D", "MH": "Phase Separation", "AQ": "DE RE", "ENTRY": "Separations, Phase", "MN": "G01.618", "MH_TH": "NLM (2024)", "ST": "T070", "MS": "Processes by which homogeneous mixtures of immiscible components (solids, liquids, or gases) separate into distinct phases.", "PM": "2024", "HN": "2024", "MR": "20221215", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095496"}, {"RECTYPE": "D", "MH": "Magnetic Resonance Myelography", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "MRI Myelography|T060|ABX|EQV|NLM (2024)|220831|abcdef", "ENTRY": "T2-Weighted MRMs, Heavily", "MN": "E05.629.937.505.500", "MH_TH": "NLM (2024)", "ST": "T060", "PI": "Myelography (1994-2023)", "MS": "A modified magnetic resonance imaging method for generating myelogram like images, characterized by high signal intensity of the CEREBROSPINAL FLUID, which permits visualization of spinal subarachnoid spaces and nerve root sheaths.", "PM": "2024", "HN": "2024", "MR": "20221215", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095497"}, {"RECTYPE": "D", "MH": "Mandatory Vaccination", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Vaccine Mandate|T064|NON|EQV|NLM (2024)|220901|abcdef", "ENTRY": "Vaccine Mandates", "MN": "N03.706.657.750", "MH_TH": "NLM (2024)", "ST": "T064", "MS": "Vaccination compelled by direct or indirect threat of restrictions in cases of non-compliance.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095498"}, {"RECTYPE": "D", "MH": "Enhancer RNAs", "AQ": "AA AD AE AG AI BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "eRNAs|T114|T123|ABB|EQV|NLM (2024)|220901|abbcdef", "ENTRY": "RNA, Enhancer", "MN": "D13.444.735.790.100", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "PI": "Enhancer Elements, Genetic (2011-2023)", "MS": "Noncoding RNAs transcribed from ENHANCER SEQUENCES.", "PM": "2024", "HN": "2024", "MR": "20230226", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095499"}, {"RECTYPE": "D", "MH": "Diet, Plant-Based", "AQ": "AE CL EC EH ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Plant-Based Nutrition|T061|NON|BRD|NLM (2020)|181214|abcdef", "ENTRY": "Plant-Based Diets", "MN": "G07.203.650.240.278", "FX": "Vegetarians", "MH_TH": "NLM (2020)", "ST": "T061", "PI": "Diet, Vegetarian (2001-2023)", "MS": "A diet that emphasizes consumption of plant foods, such as grains, fruits, vegetables, nuts, and LEGUMES while reducing intake of animal-based foods.", "PM": "2024; see DIET, VEGETARIAN 2020-2023", "HN": "2024; use DIET, VEGETARIAN 2020-2023", "MR": "20221214", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095500"}, {"RECTYPE": "D", "MH": "Cytopenia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cytopenias", "MN": "C15.378.243", "MH_TH": "NLM (2024)", "ST": "T046", "MS": "A deficiency in or reduction of the number of blood cells.", "PM": "2024", "HN": "2024", "MR": "20230226", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095542"}, {"RECTYPE": "D", "MH": "Epicardial Adipose Tissue", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Pericoronary Fat Tissue|T024|NON|REL|NLM (2024)|220913|abcdef", "ENTRY": "Tissue, Pericoronary Fat", "MN": "A10.165.114.915", "MH_TH": "NLM (2024)", "ST": "T024", "PI": "Pericardium (2003-2023)", "MS": "A fat deposit localized between the MYOCARDIUM and the visceral layer of the serous PERICARDIUM. Epicardial adipose tissue is a risk factor for various CARDIOVASCULAR DISEASES.", "PM": "2024", "HN": "2024", "MR": "20230226", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095543"}, {"RECTYPE": "D", "MH": "Propionyl-Coenzyme A Carboxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Propionyl-CoA Carboxylase|T116|T126|ABX|EQV|NLM (2004)|abbcde", "ENTRY": "Propionyl Coenzyme A Carboxylase", "MN": "D08.811.464.257.050.500", "EC": "deficiency:Propionic Acidemia", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 6.4.1.3", "PI": "Methylmalonyl-CoA Decarboxylase (1979-2023)", "MS": "Mitochondrial carboxylase that is involved in the catabolism of odd chain fatty acids and branched amino acids. Dysfunction of propionyl-CoA carboxylase leads to the inherited metabolic disorder PROPIONIC ACIDEMIA. In bacteria it is an ATP-dependent carboxylase in CO2 fixation reactions where propionyl-CoA is converted to (S)-methylmalonyl-CoA.", "PM": "2024; see Methylmalonyl-CoA Decarboxylase 2004-2023", "HN": "2024; use Methylmalonyl-CoA Decarboxylase 2004-2023", "MR": "20230226", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095562"}, {"RECTYPE": "D", "MH": "Disaster Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Disaster", "MN": "N02.421.533.188", "FX": "Disaster Medicine", "MH_TH": "NLM (2024)", "ST": "T091", "AN": "Use only for nursing provided at disaster sites; EMERGENCY NURSING is also available", "PI": "Disasters (1967-2023)", "MS": "The specialty or practice of nursing in the care of patients at the site of a disaster.", "PM": "2024", "HN": "2024", "MR": "20230522", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095582"}, {"RECTYPE": "D", "MH": "Continuous Glucose Monitoring", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Continuous Glucose Monitoring Device|T074|NON|REL|NLM (2024)|230315|abcdef", "ENTRY": "Monitorings, Continuous Glucose", "MN": "E05.200.124.100.203", "MH_TH": "NLM (2024)", "ST": "T060", "PI": "Blood Glucose(1981-2023)", "MS": "GLUCOSE MONITORING that measures interstitial glucose concentration continuously throughout the entire day and night. It does not replace traditional HOME BLOOD GLUCOSE MONITORING.", "PM": "2024", "HN": "2024", "MR": "20230823", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095583"}, {"RECTYPE": "D", "MH": "Angucyclines and Angucyclinones", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Angucyclinones|T109|NON|NRW|NLM (2024)|220915|abcdef", "ENTRY": "Angucyclinones and Angucyclines", "MN": "D04.615.149.401", "FX": "Anthraquinones", "MH_TH": "NLM (2024)", "ST": "T109", "RN": "0", "MS": "Polycyclic aromatic polyketides with tetracyclic angular benz(a)anthracene skeletons. Angucyclines and related angucyclinones are produced by Actinomycetes, e.g., STREPTOMYCES, using type II polyketide synthase involving condensation of acetyl CoA and 9 malonyl-CoA.", "PM": "2024", "HN": "2024", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095602"}, {"RECTYPE": "D", "MH": "Benzoisochromanequinones", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzoisochromanequinone Antibiotics|T109|T195|NON|NRW|NLM (2024)|220916|abbcdef", "MN": "D04.345.674.375", "MH_TH": "NLM (2024)", "ST": "T109", "RN": "0", "MS": "Polycyclic aromatic polyketides with tricyclic benzoisochrome quinone skeletons. Benzoisochromanequinones are produced by Actinobacteria, e.g., STREPTOMYCES COELICOLOR, using type II minimal polyketide synthase involving condensation of 8 malonyl-CoA in actinorhodin pathway.", "PM": "2024", "HN": "2024", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095622"}, {"RECTYPE": "D", "MH": "Pradimicins and Benanomicins", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pradimicins|T109|T195|NON|NRW|NLM (2024)|220919|abbcdef", "ENTRY": "Pradimicin Type Polyphenols", "MN": "D09.408.051.059.825", "MH_TH": "NLM (2024)", "ST": "T109", "RN": "0", "MS": "Polycyclic aromatic polyketides with pentacyclic angular dihydrobenzo(a)naphthacenequinone skeletons. Pradimicin- and related benanomicin-type polyphenols are produced by Actinobacteria, e.g., ACTINOMADURA, using type II polyketide synthase involving condensation of one acetyl-CoA and nine malonyl-CoA. Pradimicins and benanomicins have an amino acid (e.g., D-ALANINE) and often a 5-O-sugar and bind to terminal D-mannosides of the cell wall of various fungi, e.g., CANDIDA. In addition to antifungal activity many pradimicins and benanomicins have anti-HIV activities.", "PM": "2024", "HN": "2024", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095643"}, {"RECTYPE": "D", "MH": "Intestinal Barrier Function", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Intestinal Permeability|T039|NON|NRW|NLM (2024)|220920|abcdef", "ENTRY": "Permeability, Intestinal", "MN": "G10.261.454", "FX": "Intestinal Absorption", "MH_TH": "NLM (2024)", "ST": "T039", "PI": "Permeability (1963-2023)", "MS": "The role of the intestinal wall as a selective barrier defending against infiltration of bacteria and toxic molecules while allowing the passage or transport of nutrients, electrolytes, and water.", "PM": "2024", "HN": "2024", "MR": "20221117", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095644"}, {"RECTYPE": "D", "MH": "Polyether Polyketides", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyether Ionophores|T109|T121|NON|NRW|NLM (2024)|220921|abbcdef", "MN": "D04.345.674.625", "MH_TH": "NLM (2024)", "ST": "T109", "RN": "0", "MS": "Polycyclic polyketides with distinctive ladder shaped multiple polyether motifs. In STREPTOMYCES polycyclic polyketide backbones are assembled by type I modular polyketide synthases which then are modified by epoxidase and epoxide hydrolase to achieve their stereochemistry. Polyether ionophore antibiotics coordinate alkali metal cations with their multiple oxygen atoms which disturbs sodium/potassium concentration gradient. They are widely used to treat and control COCCIDIOSIS. Structurally related MARINE LADDER POLYETHERS are neurotoxins.", "PM": "2024", "HN": "2024", "MR": "20230226", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095662"}, {"RECTYPE": "D", "MH": "Polyether Toxins", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Marine Polyether Toxins|T109|NON|EQV|NLM (2024)|220921|abcdef", "MN": "D23.946.580.800", "MH_TH": "NLM (2024)", "ST": "T109", "RN": "0", "PI": "Marine Toxins (1992-2023)", "MS": "Polycyclic polyether polyketides most often produced by marine organisms, e.g., DINOFLAGELLATES. Many polyether marine toxins are ionophores and neurotoxins and responsible for seafood poisoning.", "PM": "2024", "HN": "2024", "MR": "20230607", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095702"}, {"RECTYPE": "D", "MH": "Amphidinols", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amphidinol|T109|NON|EQV|NLM (2024)|230330|abcdef", "MN": "D23.946.580.080", "MH_TH": "NLM (2024)", "ST": "T109", "RN": "0", "PI": "Macrolides (1991-2023)", "MS": "Long linear polyketides with polyol groups and polyolefins and core motifs of two tetrahydropyran rings produced by marine dinoflagellates such as AMPHIDINIUM. Many amphidinols are hemolytic toxins with antifungal and other cytotoxic activities.", "PM": "2024", "HN": "2024", "MR": "20230414", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095722"}, {"RECTYPE": "D", "MH": "Red Light", "AQ": "AE", "ENTRY": "Light, Red", "MN": "G01.750.770.578.809", "FX": "Photochemotherapy", "EC": "therapeutic use:Phototherapy", "MH_TH": "NLM (2024)", "ST": "T070", "PI": "Light (1963-2023)", "MS": "That portion of the electromagnetic spectrum with wavelengths between 620 to 750 nm. Red light is used therapeutically to improve the appearance of SKIN by reducing wrinkles, scars, redness, and ACNE. It is often used in conjunction with PHOTOSENSITIZING AGENTS for PHOTOCHEMOTHERAPY.", "PM": "2024", "HN": "2024", "MR": "20230316", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095742"}, {"RECTYPE": "D", "MH": "Blue Light", "AQ": "AE", "ENTRY": "Light, Blue", "MN": "G01.750.770.578.220", "EC": "therapeutic use:Phototherapy", "MH_TH": "NLM (2024)", "ST": "T070", "PI": "Light (1963-2023)", "MS": "That portion of the electromagnetic spectrum with wavelengths between 450 to 495 nm. Exposure to blue light at night can suppress the secretion of melatonin, disrupt sleep, and cause shifts in CIRCADIAN RHYTHM.", "PM": "2024", "HN": "2024", "MR": "20230316", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095743"}, {"RECTYPE": "D", "MH": "Medecins Sans Frontieres", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "M\u00e9decins Sans Fronti\u00e8res|T093|NON|EQV|NLM (2024)|220926|abcdef", "MN": "N03.540.630.780.403", "MH_TH": "NLM (2024)", "ST": "T093", "AN": "INDEXER: Do not use. CATALOGER: Use NAF entry", "MS": "An international humanitarian medical non-governmental organization of French origin that provides emergency aid and medical care around the globe.", "PM": "2024", "HN": "2024", "MR": "20230316", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095744"}, {"RECTYPE": "D", "MH": "Inferior Olivary Complex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Principal Olive|T023|NON|NRW|NLM (2024)|220927|abcdef", "ENTRY": "Principal Olives", "MN": "A08.186.211.132.810.591.750.250", "MH_TH": "NLM (2024)", "ST": "T023", "PI": "Olivary Nucleus (2008-2023)", "MS": "A brainstem nucleus in the superior medulla and a part of the OLIVARY NUCLEUS complex. Inferior olivary complex integrates motor and proprioceptive inputs and provides feedback to cerebellar neurons.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095746"}, {"RECTYPE": "D", "MH": "Olivary Degeneration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Olivary Nucleus Degeneration|T047|NON|EQV|NLM (2024)|220927|abcdef", "ENTRY": "Olivary Nucleus Degenerations", "MN": "C10.574.672", "FX": "Olivopontocerebellar Atrophies", "MH_TH": "NLM (2024)", "ST": "T047", "PI": "Olivary Nucleus (1970-2023)", "MS": "Degeneration of the OLIVARY NUCLEUS typically involving INFERIOR OLIVARY COMPLEX. It is associated with various syndromes and neurodegenerative disorders including hypertrophic olivary degeneration secondary to a Guillain-Mollaret triangle lesion.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095747"}, {"RECTYPE": "D", "MH": "Immunoinformatics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Systems Immunology|T091|NON|REL|NLM (2024)|220929|abcdef", "ENTRY": "Immunology, Systems", "MN": "L01.313.124.250", "MH_TH": "NLM (2024)", "ST": "T091", "PI": "Computational Biology (2002-2023)", "MS": "The interface between INFORMATICS and IMMUNOLOGY. Otherwise known as computational immunology, it is the use of computational methods and resources for studying IMMUNE SYSTEM PHENOMENA.", "PM": "2024", "HN": "2024", "MR": "20221117", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095763"}, {"RECTYPE": "D", "MH": "Oral Frenectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Tongue Tie Release|T061|NON|NRW|NLM (2024)|221004|abcdef", "ENTRY": "Tongue Tie Releases", "MN": "E06.645.225", "FX": "Breast Feeding", "MH_TH": "NLM (2024)", "ST": "T061", "PI": "Labial Frenum (1964-2023)", "MS": "Surgical procedures to release or remove abnormally short or tightly attached frenum (e.g., LINGUAL FRENUM or LABIAL FRENUM) associated with a pathological condition (e.g., TONGUE TIE  and lip tie).", "PM": "2024", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095782"}, {"RECTYPE": "D", "MH": "ProTides", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Prodrug Nucleotides|T114|T121|NON|EQV|NLM (2024)|230602|abbcdef", "ENTRY": "Pro Tides", "MN": "D26.675.500", "MH_TH": "NLM (2024)", "ST": "T121", "RN": "0", "MS": "A class of prodrugs consisting of a 5'-nucleoside monophosphate in which the two hydroxyl groups are masked with an amino acid ester and an aryloxy component which once in the cell is enzymatically metabolized to deliver free 5'-monophosphate, and further transformed to the active 5'-triphosphate form of the nucleoside analogue.", "PM": "2024", "HN": "2024", "MR": "20230602", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095802"}, {"RECTYPE": "D", "MH": "Immune System Exhaustion", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Poly-Lymphocyte Exhaustion|T046|NON|NRW|NLM (2024)|221007|abcdef", "ENTRY": "Poly Lymphocyte Exhaustion", "MN": "G12.590", "MH_TH": "NLM (2024)", "ST": "T046", "MS": "A spectrum of functional deterioration in various lymphocyte populations that is induced by continuous antigenic stimulation. There are overlapping similarities with CELLULAR SENESCENCE; IMMUNOSENESCENCE; T-CELL SENESCENCE; and CLONAL ANERGY.", "PM": "2024", "HN": "2024", "MR": "20221117", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095842"}, {"RECTYPE": "D", "MH": "T-Cell Senescence", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "T-Lymphocyte Senescence|T038|NON|EQV|NLM (2024)|221007|abcdef", "ENTRY": "T Lymphocyte Senescence", "MN": "G12.460.500.500", "FX": "T-Cell Exhaustion", "MH_TH": "NLM (2023)", "ST": "T038", "PI": "Cellular Senescence (1997-2023)", "MS": "Permanent G1 CELL CYCLE ARREST of the T-cell, resulting from ageing, oncogene activation, telomere degradation, epigenomic changes, or exposure to stressful stimuli including reactive-oxygen species, ionizing radiation, or certain chemicals.", "PM": "2024", "HN": "2024", "MR": "20230602", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095843"}, {"RECTYPE": "D", "MH": "Open Waste Burning", "AQ": "AE AN CL EC ES HI LJ MT PC SN ST", "PRINT ENTRY": "Open Burning|T052|NON|EQV|NLM (2024)|221011|abcdef", "ENTRY": "Waste Burnings, Open", "MN": "N06.850.860.510.900.600.500.500", "FX": "Persian Gulf Syndrome", "MH_TH": "NLM (2024)", "ST": "T052", "MS": "Incineration of materials such as GARBAGE or HAZARDOUS WASTES as in an open-air fire such as in a fire pit, barrel, or outdoor fireplace where AIR POLLUTANTS are not captured or contained.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095865"}, {"RECTYPE": "D", "MH": "Meat Substitutes", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Vegan Meat|T168|NON|EQV|NLM (2024)|221011|abcdef", "ENTRY": "Vegan Meats", "MN": "J02.500.631", "MH_TH": "NLM (2024)", "ST": "T168", "MS": "Bacterial, fungal, algal or plant-based alternatives to MEAT from animals.", "PM": "2024", "HN": "2024", "MR": "20230602", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095866"}, {"RECTYPE": "D", "MH": "Melanogenesis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Phaeomelanogenesis|T040|NON|NRW|NLM (2024)|221025|abcdef", "MN": "G04.536", "MH_TH": "NLM (2024)", "ST": "T040", "AN": "animal only: for human, use MELANIN/ biosyn", "PI": "Melanins/metabolism (1963-2023)", "MS": "The biosynthesis of MELANINS in insects and higher animals. The key chemical step of melanogenesis is the initial conversion of TYROSINE to DOPAQUINONE by TYROSINASE, distinguishing melanogenesis from pathways for melanin synthesis in plants.  Melanogenesis is complex process involving several stages from the formation of MELANOCYTES during EMBRYONIC DEVELOPMENT to the synthesis of MELANINS in the MELANOSOMES and their distribution via transport of the melanosomes to surrounding KERATINOCYTES.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095868"}, {"RECTYPE": "D", "MH": "Mental Health Teletherapy", "AQ": "CL EC ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Teletherapy, Mental Health|T058|NON|EQV|NLM (2024)|221013|abcdef", "MN": "N04.590.374.800.275", "FX": "Distance Counseling", "MH_TH": "NLM (2024)", "ST": "T058", "MS": "Providing mental health services via TELECOMMUNICATIONS.", "PM": "2024", "HN": "2024", "MR": "20230602", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095882"}, {"RECTYPE": "D", "MH": "Avatar", "PRINT ENTRY": "Humanoid Avatar|T066|NON|NRW|NLM (2024)|221018|abcdef", "ENTRY": "Humanoid Avatars", "MN": "L01.296.555.250", "FX": "Caricature", "MH_TH": "NLM (2024)", "ST": "T066", "MS": "A computer representation of users in a computer-generated world. Avatar technology is used in various applications such as in education, exercise, gaming and training.", "PM": "2024", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095902"}, {"RECTYPE": "D", "MH": "Pre-Registration Publication", "PRINT ENTRY": "Registered Reports|T078|NON|EQV|NLM (2024)|221031|abcdef", "ENTRY": "Selections, Frontloading Editorial", "MN": "L01.737.640.500", "MH_TH": "NLM (2024)", "ST": "T078", "MS": "Editorial decisions based on rigorous evaluation of submitted research question and methodology but before the research is conducted and a final submission is available.", "PM": "2024", "HN": "2024", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095962"}, {"RECTYPE": "D", "MH": "Channa punctatus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Spotted Snakehead|T013|NON|EQV|NLM (2024)|221101|abcdef", "ENTRY": "Spotted Snakeheads", "MN": "B01.050.150.900.493.105", "MH_TH": "NLM (2024)", "ST": "T013", "RN": "txid304456", "PI": "Fishes (1965-2023)", "MS": "A species of fish in the snakehead family Channidae, known as the spotted snakehead.", "PM": "2024", "HN": "2024", "MR": "20230226", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095982"}, {"RECTYPE": "D", "MH": "Bacterial Lysates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bacterial Extracts|T123|NON|REL|NLM (2024)|221202|abcdef", "ENTRY": "Lysates, Bacterial", "MN": "D20.215.057", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "PI": "Cell Extracts (1991-2023)", "MS": "Extracts derived from BACTERIA.", "PM": "2024", "HN": "2024", "MR": "20230316", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000095983"}, {"RECTYPE": "D", "MH": "Acetone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.522.064", "PA": "Solvents", "MH_TH": "NLM (1966)", "ST": "T109", "N1": "2-Propanone", "RN": "1364PS73AF", "RR": "67-64-1 (Acetone)", "AN": "ACETONEMIA and ACETONURIA see KETOSIS are also available", "MS": "A colorless liquid used as a solvent and an antiseptic. It is one of the ketone bodies produced during ketoacidosis.", "MR": "20150625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000096"}, {"RECTYPE": "D", "MH": "Physician Engagement", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Physician Satisfaction|T057|T058|NON|REL|NLM (2024)|221202|abbcdef", "ENTRY": "Satisfaction, Physician", "MN": "N05.300.568", "FX": "Burnout, Professional", "MH_TH": "NLM (2024)", "ST": "T058", "PI": "Physicians (2002-2023)", "MS": "A strategy to create more positive, stable relationships between health care organizations and physicians. The goal is to increase efficiency and productivity, improve PATIENT CARE and safety, create higher physician satisfaction and retention, and reduce operational costs.", "PM": "2024", "HN": "2024", "MR": "20230316", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096002"}, {"RECTYPE": "D", "MH": "Hypertensive Crisis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypertensive Urgency|T047|T184|NON|REL|NLM (2024)|230104|abbcdef", "ENTRY": "Urgency, Hypertensive", "MN": "C14.907.489.723", "MH_TH": "NLM (2024)", "ST": "T184", "PI": "Hypertension (1966-2023)", "MS": "A severe, acute increase in BLOOD PRESSURE that may result in STROKE or MYOCARDIAL ISCHEMIA.", "PM": "2024", "HN": "2024", "MR": "20230316", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096003"}, {"RECTYPE": "D", "MH": "Symptom Burden", "ENTRY": "Burden, Symptom", "MN": "N06.850.520.308.980.438.475.364.750", "FX": "Sickness Impact Profile", "MH_TH": "NLM (2024)", "ST": "T080", "CX": "Cost of Illness; Patient Acuity; Health Status", "MS": "The subjective, quantifiable prevalence, frequency, and severity of symptoms placing a physiologic burden on patients and producing multiple negative, physical, and emotional patient responses.", "PM": "2024", "HN": "2024", "MR": "20230316", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096042"}, {"RECTYPE": "D", "MH": "Post-Exercise Recovery", "AQ": "PH PX SN ST TD", "PRINT ENTRY": "Recovery From Exercise|T040|T056|NON|EQV|NLM (2024)|221108|abbcdef", "ENTRY": "Recovery, Post-Workout", "MN": "I03.350.421", "FX": "Rest", "EC": "methods:Post-Exercise Recovery Techniques", "MH_TH": "NLM (2024)", "ST": "T056", "PI": "Exercise (1989-2023)", "MS": "The subsequent return to a resting or recovered state following a bout of exercise as the body adapts to the stress associated with exercise, replenishes muscle glycogen, and repairs body tissue.", "PM": "2024", "HN": "2024", "MR": "20230316", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096062"}, {"RECTYPE": "D", "MH": "Post-Exercise Recovery Techniques", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Techniques, Post-Exercise Recovery", "MN": "E02.831.535.966", "MH_TH": "NLM (2024)", "ST": "T061", "MS": "Therapeutic modalities following a bout of exercise to reduce markers of muscle damage, soreness, fatigue, and inflammation.", "PM": "2024", "HN": "2024", "MR": "20230316", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096063"}, {"RECTYPE": "D", "MH": "Sterilizing Immunity", "AQ": "DE GE IM PH RE", "ENTRY": "Immunity, Sterilizing", "MN": "G12.450.850", "MH_TH": "NLM (2024)", "ST": "T039", "MS": "A type of immunity involving NEUTRALIZING ANTIBODIES that completely prevents a disease-causing pathogen from establishing an infection, including ASYMTOMATIC INFECTIONS.", "PM": "2024", "HN": "2024", "MR": "20230316", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096064"}, {"RECTYPE": "D", "MH": "Public Health Infrastructure", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Public Health Infrastructures|T078|NON|EQV|NLM (2024)|230131|abcdef", "ENTRY": "Infrastructures, Public Health", "MN": "N02.814", "FX": "Health Resources", "MH_TH": "NLM (2024)", "ST": "T078", "PI": "Health Care Facilities, Manpower, and Services (2023)", "MS": "Systems built on capacity of workforce, information systems, organizational resources and include public health programs, policies and resources that enable public health agencies to perform their core functions and essential services.", "PM": "2024", "HN": "2024", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096102"}, {"RECTYPE": "D", "MH": "Comic Books as Topic", "MN": "L01.462.500.682.192.289.250", "MH_TH": "NLM (2018)", "ST": "T073", "AN": "INDEXER: Do not use", "MS": "Works about narrative works that employ sequential art, and often prose, to tell a story. (LCSH, 2023)", "PM": "2024", "HN": "2024", "MR": "20230305", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096103"}, {"RECTYPE": "D", "MH": "Biocuration", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Biocurations", "MN": "L01.313.124.125", "FX": "Medical Informatics Computing", "MH_TH": "NLM (2024)", "ST": "T091", "PI": "Databases, Genetic (2009-2023)", "MS": "Translation and integration of biological information into databases or other resources that allow integration of the scientific literature as well as large datasets, enabling both humans and computers to access the data.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096104"}, {"RECTYPE": "D", "MH": "BNT162b5", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pfizer-BioNTech COVID-19 Vaccine, Bivalent|T129|NON|BRD|NLM (2024)|221219|abcdef", "ENTRY": "Pfizer BioNTech COVID 19 Vaccine, Bivalent", "MN": "D23.050.865.450.500.875", "MH_TH": "NLM (2024)", "ST": "T129", "RN": "0", "MS": "A combined mRNA vaccine, developed by Pfizer and BioNTech against SARS-CoV-2 with a mixture of the original strain of SARS-CoV-2 and BA.4 and BA.5 lineages of the omicron variant of SARS-CoV-2.", "PM": "2024", "HN": "2024", "MR": "20230522", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096106"}, {"RECTYPE": "D", "MH": "Mitochondrial Processing Peptidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mitochondrial Processing Protease|T116|T126|NON|EQV|NLM (2024)|221202|abbcdef", "ENTRY": "beta MPP", "MN": "D12.776.575.758", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 3.4.24.64", "MS": "A hetero-dimeric protein consisting of two subunits, alpha and beta, which are referred to as PMPCA and PMPCB in humans. It plays an essential role in removing the N-terminal targeting peptidase from precursor proteins imported into the mitochondria.", "PM": "2024; MITOCHONDRIAL PROCESSING PEPTIDASE was indexed under METALLOENDOPEPTIDASES, 1990-2023", "HN": "2024 (1990)", "MR": "20230522", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096122"}, {"RECTYPE": "D", "MH": "Melanoma, Cutaneous Malignant", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Familial Atypical Mole-Malignant Melanoma Syndrome|T047|NON|NRW|NLM (2024)|221207|abcdef", "ENTRY": "Syndromes, FAMMM", "MN": "C17.800.882.534", "MH_TH": "NLM (2024)", "ST": "T047", "MS": "A primary melanoma that originates from atypical skin MELANOCYTES, especially from acquired and congenital MELANOCYTIC NEVI, and DYSPLASTIC NEVI.", "PM": "2024; MELANOMA, CUTANEOUS MALIGNANT was indexed under MELANOMA and SKIN NEOPLASMS 2012-2023", "HN": "2024 (2012)", "MR": "20230522", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096142"}, {"RECTYPE": "D", "MH": "Treatment Delay", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Delayed Treatment|T058|NON|EQV|NLM (2024)|230601|abcdef", "ENTRY": "Treatments, Delayed", "MN": "N02.421.585.928.500", "FX": "Time-to-Treatment", "MH_TH": "NLM (2019)", "ST": "T058", "PI": "Time-to-Treatment (2019-2023)", "MS": "A longer or slower than expected, or desired, amount of time between onset of symptoms and initiation of therapy.", "PM": "2024; see TIME-TO-TREATMENT 2019-2023", "HN": "2024; use TIME-TO-TREATMENT 2019-2023", "MR": "20230602", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096182"}, {"RECTYPE": "D", "MH": "Protein Subunit Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaccines, Subunit, Protein|T121|T129|NON|EQV|NLM (2024)|230201|abbcdef", "ENTRY": "Vaccines, Recombinant Protein", "MN": "D20.215.894.860.900.633", "MH_TH": "NLM (2024)", "ST": "T129", "RN": "0", "PI": "Vaccines, Subunit (1983-2023)", "MS": "Vaccines that contain polypeptide chains, which are derived from specific pathogen's protein subunits.", "PM": "2024", "HN": "2024", "MR": "20230516", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096202"}, {"RECTYPE": "D", "MH": "Disability Discrimination", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Ableism|T054|NON|NRW|NLM (2024)|230315|abcdef", "ENTRY": "Discrimination, Disability", "MN": "F01.145.813.629.531", "MH_TH": "NLM (2022)", "ST": "T054", "MS": "Discrimination against persons with physical, intellectual, or psychiatric disabilities.", "PM": "2024", "HN": "2024", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096222"}, {"RECTYPE": "D", "MH": "Gender-Nonconforming Persons", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Non-Binary Persons|T098|NON|EQV|NLM (2024)|230314|abcdef", "ENTRY": "Peoples, Gender Non-conforming", "MN": "M01.270.988.188", "FX": "Transgender Persons", "MH_TH": "NLM (2024)", "ST": "T098", "PI": "Sexual and Gender Minorities (2018-2023)", "MS": "Individuals whose external manifestation of their gender identity does not conform to society\u2019s expectations of GENDER ROLES. Persons whose gender expression differs from conventional expectations of masculinity and femininity.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096224"}, {"RECTYPE": "D", "MH": "Dignity Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Dignity Psychotherapy|T061|NON|EQV|NLM (2024)|221228|abcdef", "ENTRY": "Therapy, Dignity", "MN": "F04.754.286", "MH_TH": "NLM (2024)", "ST": "T061", "PI": "Psychotherapy (2015-2023)", "MS": "Evidence-based psychotherapeutic modality for patients who are classified as terminally ill. Such patients may have loss of autonomy, severe physical pain, and challenging existential and spiritual experience, which contribute to disintegration of patient's sense of self.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096225"}, {"RECTYPE": "D", "MH": "Honor-Based Violence", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Honor Killing|T054|NON|NRW|NLM (2024)|221229|abcdef", "ENTRY": "Violence, Honor-Based", "MN": "I01.198.240.856.463.500", "MH_TH": "NLM (2024)", "ST": "T054", "MS": "Crimes against a family member which are, or have been, justified by the perpetrators to protect the honor of the family. The targets may be children or adults of either gender.", "PM": "2024", "HN": "2024", "MR": "20230524", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096242"}, {"RECTYPE": "D", "MH": "Psychiatrists", "AQ": "CL EC ED ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Psychiatrist|T097|NON|EQV|NLM (2021)|191115|abcdef", "MN": "N02.360.810.843", "MH_TH": "UNK (19XX)", "ST": "T097", "PI": "Psychiatry (1979-2023)", "MS": "Qualified medical professionals specializing in maintaining MENTAL HEALTH and treating MENTAL DISORDERS.", "PM": "2024", "HN": "2024", "MR": "20230605", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096244"}, {"RECTYPE": "D", "MH": "Health Services for Prisoners", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Prisoner's Health Services|T058|NON|EQV|NLM (2024)|221231|abcdef", "ENTRY": "Services, Prisoner's Health", "MN": "N02.421.755", "MH_TH": "NLM (2024)", "ST": "T058", "PI": "Prisons (1966-2023)", "MS": "Health services provided for PRISONERS. The services include the promotion of health and the delivery of health care.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096245"}, {"RECTYPE": "D", "MH": "Power Plant Operators", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Power Plant Workers|T097|NON|NRW|NLM (2024)|221229|abcdef", "ENTRY": "Workers, Power Plant", "MN": "M01.526.780", "MH_TH": "NLM (2024)", "ST": "T097", "PI": "Occupational Groups (2023)", "MS": "Operators of industrial equipment to generate electrical power.", "PM": "2024", "HN": "2024", "MR": "20230824", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096246"}, {"RECTYPE": "D", "MH": "Medicine, Thai Traditional", "AQ": "AE EC HI IS MT PX SN ST TD", "PRINT ENTRY": "Traditional Thai Massage|T058|NON|NRW|NLM (2024)|230301|abcdef", "ENTRY": "Traditional, Thai Medicine", "MN": "I01.076.201.450.654.762", "MH_TH": "NLM (2024)", "ST": "T058", "PI": "Medicine, Traditional (2010-2023)", "MS": "A system of traditional medicine which is based on the beliefs and practices of the Thai culture.", "PM": "2024", "HN": "2024", "MR": "20230630", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096262"}, {"RECTYPE": "D", "MH": "Voting", "AQ": "LJ SN TD", "PRINT ENTRY": "Voters|T098|NON|NRW|NLM (2024)|221230|abcdef", "MN": "I01.738.902", "MH_TH": "UNK (19XX)", "ST": "T078", "PI": "Politics (1986-2023)", "MS": "Method by which an individual or a group, such as in a meeting or an electorate, can engage for the purpose of making a collective decision or expressing an opinion.", "PM": "2024; see Politics 1986-2023", "HN": "2024", "MR": "20230606", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096264"}, {"RECTYPE": "D", "MH": "Himalayas", "AQ": "EH EP", "PRINT ENTRY": "Himalayan Mountains|T083|NON|EQV|NLM (2024)|230130|abcdef", "MN": "Z01.252.245.782.813", "MH_TH": "NLM (2024)", "ST": "T083", "MS": "Mountain system in southern Asia that forms a barrier between the Plateau of Tibet to the north and the plains of the Indian subcontinent to the south. It constitutes the greatest mountain system on Earth and includes more than 110 peaks rising to elevations above 24,000 feet, including Mount Everest. The system extends some 1,550 miles to west and covers about 230,000 sq miles. Between the eastern and western extremities are several provinces of INDIA and the kingdoms of NEPAL and BHUTAN. The glaciers and snows are the source of 19 major rivers, including the Indus, Ganges (Ganga), and Brahmaputra. (www.britannica.com/place/Himalayas, accessed 12/30/2022)", "HN": "2024", "MR": "20230615", "DA": "20230726", "DC": "4", "DX": "20240101", "UI": "D000096266"}, {"RECTYPE": "D", "MH": "Deaf Culture", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Deaf Community|T077|NON|REL|NLM (2024)|221231|abcdef", "ENTRY": "Deaf Cultures", "MN": "I01.880.853.100.450.250", "MH_TH": "NLM (2024)", "ST": "T077", "PI": "Deafness (2023)", "MS": "Networking and deep connections within the Deaf community. Valuing the sign language of the region and supporting sign language use in educational settings, support of bilingual ASL/English programs,  and use of technology to overcome traditional communication barriers. (https://nationaldeafcenter.org/resource-items/deaf-community-introduction/)", "PM": "2024", "HN": "2024", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096282"}, {"RECTYPE": "D", "MH": "Brain Drain", "AQ": "CL HI LJ SN TD", "PRINT ENTRY": "Human Capital Flight|T052|NON|BRD|NLM (2024)|230130|abcdef", "ENTRY": "Human Capital Flights", "MN": "N06.850.505.400.700.525.500.500", "FX": "Foreign Professional Personnel", "MH_TH": "NLM (2024)", "ST": "T052", "PI": "Emigration and Immigration (1987-2023)", "MS": "A phenomenon of concern for migrant-sending countries, particularly for small countries where high-skilled emigration rates are highest. include those with sought after technical, professional and other skills. Economic theory suggests a number of possible benefits, in addition to costs, from skilled emigration. (From https://openknowledge.worldbank.org/handle/10986/3878?show=full).", "PM": "(2024)", "HN": "Emigration and Immigration (1987-2024)", "MR": "20230615", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096283"}, {"RECTYPE": "D", "MH": "Task Shifting", "AQ": "CL EC ED ES HI LJ PH PX SN ST TD", "ENTRY": "Shifting, Task", "MN": "I03.946.506", "MH_TH": "NLM (2024)", "ST": "T068", "MS": "The rational redistribution of tasks among health workforce teams. World Health Organization. https://apps.who.int/iris/handle/10665/43821.", "PM": "2024", "HN": "2024", "MR": "20230315", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096286"}, {"RECTYPE": "D", "MH": "Mitochondria Associated Membranes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Mitochondrial Organizing Structure|T026|NON|NRW|NLM (2024)|230417|abcdef", "ENTRY": "Organizing Structure, Mitochondrial", "MN": "A11.284.835.514.349.500", "MH_TH": "NLM (2024)", "ST": "T026", "PI": "Mitochondrial Membranes (2008-2023)", "MS": "Specialized areas of the endoplasmic reticulum in close physical contact with MITOCHONDRIA. These inter-organelle contact sites participate in the regulation of various processes such as MITOCHONDRIAL DYNAMICS; CALCIUM SIGNALING; ENERGY METABOLISM and INFLAMMATION.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096322"}, {"RECTYPE": "D", "MH": "Endothelial-Mesenchymal Transition", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Endothelial-Mesenchymal Transformation|T043|NON|EQV|NLM (2024)|230112|abcdef", "ENTRY": "Transition, Endothelial-Mesenchymal", "MN": "G04.356.500.500", "MH_TH": "NLM (2024)", "ST": "T043", "PI": "Epithelial-Mesenchymal Transition (2005-2023)", "MS": "Phenotypic changes of ENDOTHELIAL CELLS to MESENCHYME type during development or during disease states such as INFLAMMATION; CANCER; FIBROSIS or CARDIOVASCULAR DISEASE.", "PM": "2024", "HN": "2024", "MR": "20230316", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096382"}, {"RECTYPE": "D", "MH": "Maggot Debridement Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Maggot Therapy|T061|NON|EQV|NLM (2024)|230112|abcdef", "ENTRY": "Therapy, Maggot Debridement", "MN": "E02.095.533", "MH_TH": "NLM (2024)", "ST": "T061", "PI": "Larva (1995-2023)", "MS": "Medical use of live MAGGOTS for cleaning non-healing wounds.", "PM": "2024", "HN": "2024", "MR": "20230316", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096383"}, {"RECTYPE": "D", "MH": "Vernalization", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Vernalisation|T039|NON|EQV|NLM (2024)|230123|abcdef", "ENTRY": "Stratification, Seed", "MN": "G15.589.750", "MH_TH": "NLM (2024)", "ST": "T039", "PI": "Gene Expression Regulation, Plant (2000-2023)", "MS": "The process of thermal induction in plants in which flowering is promoted by prolonged exposure to COLD TEMPERATURE.", "PM": "2024", "HN": "2024", "MR": "20230316", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096384"}, {"RECTYPE": "D", "MH": "Non-Medical Prescribing", "AQ": "CI EC HI NU SN ST VE", "PRINT ENTRY": "Supplementary Prescribing|T058|NON|EQV|NLM (2024)|230113|abcdef", "ENTRY": "Prescribing, Supplementary", "MN": "N02.421.668.778.875", "MH_TH": "NLM (2024)", "ST": "T058", "MS": "Prescribing by a healthcare professional other than a doctor or dentist.", "PM": "2024", "HN": "2024", "MR": "20230703", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096402"}, {"RECTYPE": "D", "MH": "Fundulus heteroclitus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Mummichog|T013|NON|EQV|NLM (2002)|000808|abcdef", "ENTRY": "Mummichogs", "MN": "B01.050.150.900.493.850.280.500.500", "MH_TH": "NLM (2002)", "ST": "T013", "RN": "txid8078", "RR": "txid571281", "MS": "A killifish species in topminnows genus Fundulus which is native to Atlantic saltwater marshes and tidal creeks. It is commonly known as mummichog or Atlantic killifish. Fundulus heteroclitus is a model organism for toxicogenomics and related fields because of its high resistance to environmental toxins; short intervals between spawning (10 days); large number of eggs (up to 300 each spawning) and relatively long lifespan (4 years).", "PM": "2024; see Fundulidae 2002-2023", "HN": "2024(2002)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096403"}, {"RECTYPE": "D", "MH": "Genetic Risk Score", "AQ": "CL EH EP", "PRINT ENTRY": "Polygenic Risk Score|T033|NON|NRW|NLM (2024)|230116|abcdef", "ENTRY": "Scores, Polygenic Risk", "MN": "N06.850.520.830.600.800.725.250", "MH_TH": "NLM (2024)", "ST": "T033", "PI": "Genetic Predisposition to Disease (1999-2023)", "MS": "Estimate of an individual's genetic liability to a trait or disease, calculated according to their genotype profile and relevant genome-wide association study data. (from Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc. 2020 Sep;15(9):2759.)", "PM": "2024", "HN": "2024", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096442"}, {"RECTYPE": "D", "MH": "Angiogenesis", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE TR UL VI", "ENTRY": "Angiogeneses", "MN": "G09.330.020", "FX": "Neovascularization, Physiologic", "MH_TH": "NLM (2024)", "ST": "T039", "PI": "Neovascularization, Pathologic (1978-2023)", "MS": "Formation of new blood vessels, which is controlled by chemical signals in the body, such as VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF). This process involves the migration, growth, and differentiation of ENDOTHELIAL CELLS, which line the inside wall of blood vessels.", "PM": "2024", "HN": "2024", "MR": "20230522", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096482"}, {"RECTYPE": "D", "MH": "Host Tropism", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Species Tropism|T039|NON|EQV|NLM (2024)|230201|abcdef", "ENTRY": "Tropisms, Species", "MN": "G16.527.200.380.500", "MH_TH": "NLM (2017)", "ST": "T039", "MS": "The specificity of certain pathogens for infecting a particular type of cell or tissue.", "PM": "2024; HOST TROPISM was indexed under VIRAL TROPISM 2009-2023", "HN": "2024 (2009)", "MR": "20230522", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096502"}, {"RECTYPE": "D", "MH": "Periostin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "POSTN Protein|T116|T123|NON|EQV|NLM (2024)|230522|abbcdef", "MN": "D12.776.860.300.773", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "PI": "Cell Adhesion Molecules (1990-2023)", "MS": "A multifunctional extracellular matrix protein that modulates CELL ADHESION to induce attachment to the EXTRACELLULAR MATRIX and CELL MIGRATION. It has a role INFLAMMATION and NEOPLASM METASTASIS", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096562"}, {"RECTYPE": "D", "MH": "Spirooxindoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Spiro-Oxindoles|T109|NON|EQV|NLM (2024)|230523|abcdef", "ENTRY": "Spiro Oxindoles", "MN": "D04.711.900", "MH_TH": "NLM (2024)", "ST": "T109", "RN": "0", "PI": "Spiro Compounds (1966-2023)", "MS": "Compounds that consist of cycloalkyl or heterocyclic moieties fused at the C-3 position of an oxindole. Their applications include use as scaffolds in drug design processes.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096563"}, {"RECTYPE": "D", "MH": "Compulsive Sexual Behavior Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Sexual Obsession|T048|NON|EQV|NLM (2024)|230306|abcdef", "ENTRY": "Sexual Obsessions", "MN": "F03.835.750.500", "MH_TH": "NLM (2024)", "ST": "T048", "PI": "Compulsive Behavior (2018-2023)", "MS": "Persistent pattern of failure to control intense, repetitive sexual impulses or urges resulting in repetitive sexual behavior. Symptoms may include repetitive sexual activities becoming a central focus of the person\u2019s life to the point of neglecting health and personal care or other interests, activities and responsibilities; numerous unsuccessful efforts to significantly reduce repetitive sexual behavior; and continued repetitive sexual behavior despite adverse consequences or deriving little or no satisfaction from it. (https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1630268048)", "PM": "2024", "HN": "Compulsive Behavior (2018-2024)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096583"}, {"RECTYPE": "D", "MH": "Overlapping Surgery", "AQ": "AE CL EC ED ES LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Simultaneous Surgery|T061|NON|REL|NLM (2024)|230124|abcdef", "ENTRY": "Surgery, Simultaneous", "MN": "E04.582", "FX": "Surgeons", "MH_TH": "NLM (2024)", "ST": "T061", "MS": "SURGICAL PROCEDURES performed on two or more patients that overlap in their start and finish times, but the critical portions or those activities which require the skill and expertise of the primary surgeon do not overlap. The primary surgeon initiates and participates in another operation when the surgeon has completed the critical portions of the first procedure and is no longer an essential participant in the final phase of the first operation.", "PM": "2024", "HN": "2024", "MR": "20230417", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096584"}, {"RECTYPE": "D", "MH": "Green Light", "AQ": "AE", "ENTRY": "Light, Green", "MN": "G01.750.770.578.836.500", "EC": "therapeutic use:Phototherapy", "MH_TH": "NLM (2024)", "ST": "T070", "PI": "Light (1966-2023)", "MS": "That portion of the electromagnetic spectrum with wavelengths between 495 to 570 nm.", "PM": "2024", "HN": "2024", "MR": "20230417", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096585"}, {"RECTYPE": "D", "MH": "Daphnia magna", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.365.150.200.500", "MH_TH": "NLM (2024)", "ST": "T204", "RN": "txid35525", "PI": "Daphnia (1972-2023)", "MS": "A relatively large freshwater water flea with characteristic transparent chitin CARAPACE that extends into the head shields. It is found both in ephemeral rock pools, ponds and lakes. Daphnia magna is a model system for various ecological, ecotoxicological and biomedical studies.", "PM": "2024", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096602"}, {"RECTYPE": "D", "MH": "Daphnia pulex", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Daphnia pulicaria|T204|NON|REL|NLM (2024)|230505|abcdef", "ENTRY": "Water Flea, Common", "MN": "B01.050.500.131.365.150.200.750", "MH_TH": "NLM (2023)", "ST": "T204", "RN": "txid6669", "RR": "txid35523", "PI": "Daphnia (1972-2023)", "MS": "A freshwater water flea with distinctly stout middle pecten of the postabdominal claw and small symmetrical polygonal markings on the rostrum. D. pulex and several closely related species such as D. pulicaria belong to what is sometimes known as D. pulex complex and can hybridize. Daphnia pulex is found ubiquitously and is often the most common species in ephemeral pools and is a model system for various ecological, ecotoxicological and biomedical studies.", "PM": "2024", "HN": "2024", "MR": "20230620", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096604"}, {"RECTYPE": "D", "MH": "Ceriodaphnia dubia", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Ceriodaphnia richardi|T204|NON|EQV|NLM (2024)|230126|abcdef", "MN": "B01.050.500.131.365.150.100", "MH_TH": "NLM (2024)", "ST": "T204", "RN": "txid117530", "PI": "Cladocera (1987-2023)", "MS": "A freshwater water flea in genus Ceriodaphnia, family Daphniidae, suborder Cladocera. It has postabdominal claw with central pecten, absent rostrum and cervical sinus. It is often used as an indicator organism in toxicological bioassays of FRESHWATERS.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096622"}, {"RECTYPE": "D", "MH": "Receptor, Serotonin, 5-HT1F", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Serotonin 1F Receptors|T116|NON|REL|NLM (1997)|230131|abcdef", "ENTRY": "Serotonin 5-HT1F Receptors", "MN": "D12.776.543.750.720.850.100.600", "EC": "antagonists & inhibitors:Serotonin 5-HT1 Receptor Antagonists", "MH_TH": "NLM (2024)", "ST": "T116", "RN": "0", "PI": "Receptors, Serotonin (1997-2023)", "MS": "A serotonin receptor subtype found in the GLOBUS PALLIDUS; HIPPOCAMPUS; PUTAMEN; SUBSTANTIA NIGRA; and TRIGEMINAL NUCLEUS, SPINAL that can modulate the release of CALCITONIN GENE-RELATED PEPTIDE from these nerves. Unlike 5-HT1B RECEPTORS, the activation of 5-HT1F receptors does not cause VASOCONSTRICTION. 5-HT1F receptor antagonists are used for the treatment of MIGRAINE.", "PM": "2024; serotonin 1F receptor was indexed under SEROTONIN RECEPTORS 1997-2023", "HN": "2024 (1997)", "MR": "20230417", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096642"}, {"RECTYPE": "D", "MH": "Ramucirumab", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "LY3009806|T116|T121|T129|LAB|NRW|NLM (2020)|190823|abbbcdef", "MN": "D12.776.377.715.548.114.224.200.866", "MH_TH": "NLM (2024)", "ST": "T129", "RN": "D99YVK4L0X", "MS": "A humanized monoclonal antibody and antagonist of VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 (VEGFR2).", "PM": "2024; RAMUCIRUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2009-2023", "HN": "2024 (2009)", "MR": "20230517", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096662"}, {"RECTYPE": "D", "MH": "Non-Erosive Reflux Disease", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Non-Erosive GERD|T047|NON|EQV|NLM (2024)|230131|abcdef", "ENTRY": "Reflux Diseases, Non-Erosive", "MN": "C06.405.117.119.500.484.750", "MH_TH": "NLM (2024)", "ST": "T047", "PI": "Gastroesophageal Reflux (2001-2023)", "MS": "A type of gastroesophageal reflux disease with acid reflux-related symptoms, but that does not affect the integrity of the ESOPHAGEAL MUCOSA.", "PM": "2024", "HN": "2024", "MR": "20230517", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096663"}, {"RECTYPE": "D", "MH": "Home Schooling", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Homeschooling|T065|NON|EQV|NLM (2024)|230524|abcdef", "ENTRY": "Schooling, Home", "MN": "I02.531", "MH_TH": "NLM (2024)", "ST": "T065", "MS": "It is a program of regular, thorough instruction during the school year in the studies usually taught in public and private schools to children of the same age. (https://dsd.maryland.gov/regulations/pages/13a.10.01.01.aspx)", "PM": "2024", "HN": "2024", "MR": "20231117", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096682"}, {"RECTYPE": "D", "MH": "Aflatoxin Poisoning", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aflatoxin Toxicity|T037|NON|EQV|NLM (2024)|230201|abcdef", "ENTRY": "Toxicity, Aflatoxin", "MN": "C25.723.680.131", "MH_TH": "NLM (2024)", "ST": "T037", "PI": "Mycoses (1965-2023)", "MS": "Poisoning by AFLATOXINS most often associated with NAUSEA, abdominal pain, hepatotoxicity, immunosuppression, HEPATOCELLULAR CARCINOMA and sometimes death.", "PM": "2024", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096702"}, {"RECTYPE": "D", "MH": "Cold Urticaria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Urticaria, Cold", "MN": "C20.543.480.904.766", "MH_TH": "NLM (2024)", "ST": "T047", "PI": "Urticaria (1963-2023)", "MS": "Various skin flares developing after exposure to cold temperature. While most are characterized by a limited episodic cutaneous condition characterized by URTICARIAL WHEALS, such as in allergic urticaria, other types are more severe and generalized and rarely familial, e.g., cryopyrin-associated periodic syndromes.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096703"}, {"RECTYPE": "D", "MH": "Cannabinoid Hyperemesis Syndrome", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Cannabis Hyperemesis Syndrome|T048|NON|EQV|NLM (2024)|230201|abcdef", "ENTRY": "Syndrome, Cannabis Hyperemesis", "MN": "F03.900.635.500", "MH_TH": "NLM (2024)", "ST": "T048", "PI": "Marijuana Abuse (2009-2023)", "MS": "Recurrent vomiting accompanied by nausea, abdominal pain and sometimes compulsive hot bathing behavior in chronic CANNABIS abuse.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096704"}, {"RECTYPE": "D", "MH": "Excoriation Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Skin Picking Disorder|T048|NON|EQV|NLM (2024)|230201|abcdef", "ENTRY": "Skin Picking, Pathologic", "MN": "F03.250.150", "MH_TH": "NLM (2024)", "ST": "T048", "PI": "Self-Injurious Behavior (1994-2023)", "MS": "Compulsion to pick one's skin.", "PM": "2024", "HN": "2024", "MR": "20230414", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096705"}, {"RECTYPE": "D", "MH": "Cystitis, Hemorrhagic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhagic Cystitis|T047|NON|EQV|NLM (2024)|230202|abcdef", "MN": "C12.950.829.495.250", "MH_TH": "NLM (2024)", "ST": "T047", "PI": "Hemorrhage (1963-2023)", "MS": "A diffuse inflammation of the URINARY BLADDER characterized by HEMATURIA due to bleeding from the bladder mucosa. Hemorrhagic cystitis is most often associated with infections, e.g., HUMAN ADENOVIRUS INFECIONS, but may also be due to other noninfectious etiologies: CHEMOTHERAPY with certain drugs, e.g., CYCLOPHOSPHAMIDE and IFOSFAMIDE, and RADIOTHERAPY.", "PM": "2024", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096722"}, {"RECTYPE": "D", "MH": "CEACAM1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nonspecific Cross-Reacting Antigen 160|T116|T129|NON|EQV|NLM (2024)|230202|abbcdef", "ENTRY": "protein, C-CAM", "MN": "D23.050.301.350.107", "MH_TH": "NLM (2024)", "ST": "T129", "RN": "0", "PI": "Antigens, CD (2002-2023)", "MS": "A cell adhesion protein that is cross-reactive with CARCINOEMBRYONIC ANTIGEN, involved in regulating VEGFR2 signaling pathway and insulin functions. Also, play a role as coinhibitory receptor in immune response and as an activator during angiogenesis.", "PM": "2024", "HN": "2024", "MR": "20230522", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096723"}, {"RECTYPE": "D", "MH": "Mosquito-Borne Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Mosquito-Borne Viral Diseases|T047|NON|NRW|NLM (2024)|230202|abcdef", "ENTRY": "Viral Disease, Mosquito-Borne", "MN": "C01.920.852", "MH_TH": "NLM (2021)", "ST": "T047", "MS": "Infectious diseases transmitted by mosquito vectors. Mosquito-borne human viral diseases include Chikungunya, Dengue, viral encephalitis (e.g., Japanese and St. Louis types), West Nile, Yellow fever, Zika virus infections. Mosquito-borne human parasitic diseases include malaria and lymphatic filariasis. Equine encephalomyelitis and dirofilariasis are mosquito-borne viral diseases mostly in animals.", "PM": "2024; see Vector Borne Diseases 2021-2023", "HN": "2024(2023)", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096724"}, {"RECTYPE": "D", "MH": "Acute Care Surgery", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Trauma Surgery|T091|NON|REL|NLM (2024)|230414|abcdef", "ENTRY": "Trauma Surgeries", "MN": "H02.403.810.104", "MH_TH": "NLM (2024)", "ST": "T091", "MS": "Surgical specialty generally encompassing emergency general surgery, surgical critical care and trauma care. Acute care surgery is a component of general surgery related to care of patients with acute, life-threatening or potentially life-threatening surgical conditions.", "PM": "2024", "HN": "2024", "MR": "20230703", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096725"}, {"RECTYPE": "D", "MH": "Interferon gamma Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptor, Interferon gamma|T116|T192|NON|EQV|NLM (2024)|230203|abbcdef", "ENTRY": "gamma Receptors, Interferon", "MN": "D12.776.543.750.705.852.400.250", "MH_TH": "NLM (2024)", "ST": "T192", "RN": "0", "MS": "A heterodimeric receptor composed of two subunits IFNGR1 and IFNGR2. Activated IFNGR1 subunit is believed to form a docking site for SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1). IFNGR2 associates with IFNGR1 to form a receptor for the cytokine interferon gamma (IFNG).", "PM": "2024; INTERFERON GAMMA RECEPTOR was indexed under RECEPTORS, INTERFERON 1993-2023", "HN": "2024 (1993)", "MR": "20230517", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096743"}, {"RECTYPE": "D", "MH": "Ross River Virus Infection", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Ross River Virus Disease|T047|NON|EQV|NLM (2024)|230203|abcdef", "MN": "C01.925.782.930.100.685", "MH_TH": "NLM (2020)", "ST": "T047", "MS": "Virus diseases caused by Ross River virus of the ALPHAVIRUS genus. It is the most common endemic arboviral infection in Australia.", "PM": "2024; see Alphavirus Infections 2020-2023", "HN": "2024(2020)", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096745"}, {"RECTYPE": "D", "MH": "Aberrant Motor Behavior in Dementia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Wandering in Dementia|T184|NON|NRW|NLM (2024)|230206|abcdef", "ENTRY": "Wandering, Dementia", "MN": "F01.145.126.050", "MH_TH": "NLM (2024)", "ST": "T184", "MS": "Aberrant motor behaviors leading to inappropriate or purposeless activities in people with dementia. Aberrant motor behaviors in people with dementia include aggression, agitation, refusal to care and wandering.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096762"}, {"RECTYPE": "D", "MH": "Pandemic Preparedness", "AQ": "EC HI MT OG SN ST TD", "PRINT ENTRY": "Pandemic Response Plan|T064|NON|EQV|NLM (2024)|230206|abcdef", "ENTRY": "Response Plan, Pandemic", "MN": "N06.850.780.200.625", "MH_TH": "NLM (2024)", "ST": "T064", "PI": "Disaster Planning (2005-2023)", "MS": "Various plans outlined for the care of casualties and the maintenance of services in a PANDEMIC. Pandemic preparedness plan includes CAPACITY BUILDING in flexible infrastructure and SENTINEL SURVEILLANCE.", "PM": "2024", "HN": "2024", "MR": "20230414", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096763"}, {"RECTYPE": "D", "MH": "Insulin-Like Peptides", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peripheral Insulin-Like Peptides|T116|NON|NRW|NLM (2024)|230206|abcdef", "ENTRY": "Peripheral Insulin Like Peptides", "MN": "D23.529.742", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "PI": "Insulin (1979-2023)", "MS": "Peptides that include INSULIN-LIKE GROWTH FACTOR 1 (IGF1), and IGF2. They influence brain development through their effects on CELL PROLIFERATION; CELL SURVIVAL; and NEUROGENESIS. They also influence post-embryonic development by serving as HORMONES; NEUROTRANSMITTERS, and GROWTH FACTORS.", "PM": "for INSULIN-LIKE GROWTH FACTORS see SOMATOMEDINS 2022-2024", "HN": "for INSULIN-LIKE GROWTH FACTORS use SOMATOMEDINS 2022-2024", "MR": "20230517", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096764"}, {"RECTYPE": "D", "MH": "Education, Biological and Biomedical Sciences, Graduate", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Graduate Education, Biomedical Sciences|T065|NON|BRD|NLM (2024)|230206|abcdef", "MN": "I02.358.337.125", "MH_TH": "NLM (2024)", "ST": "T065", "MS": "Educational programs for graduates entering a master\u2019s or PhD level biological and biomedical science graduate programs.", "PM": "2024", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096782"}, {"RECTYPE": "D", "MH": "Postdoctoral Training", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Postdoctoral Fellows Training|T065|NON|EQV|NLM (2024)|230206|abcdef", "ENTRY": "Training, Postdoctoral Fellows", "MN": "I02.358.337.125.500", "MH_TH": "NLM (2024)", "ST": "T065", "PI": "Education, Graduate (1963-2023)", "MS": "Training for terminal degree holders in biological and biomedical science specialties who have already obtained a doctoral degree.", "PM": "2024", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096783"}, {"RECTYPE": "D", "MH": "Neurexins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D23.050.301.350.250.760", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1992-2023)", "MS": "Presynaptic cell-adhesion molecules that bind postsynaptic NEUROLIGINS to form calcium-dependent trans-synaptic adhesions. Neurexins recruit synaptic scaffolding proteins via their PDZ DOMAINS. Distribution and interaction with neuroligins are regulated by ALTERNATIVE SPLICING. Alterations in genes encoding neurexins are associated with cognitive diseases such AUTISM SPECTRUM DISORDER; SCHIZOPHRENIA and Pitt-Hopkins-like syndrome 2.", "PM": "2024", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096784"}, {"RECTYPE": "D", "MH": "Neuroligins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neuroligin|T116|T123|NON|EQV|NLM (2024)|230414|abbcdef", "MN": "D23.050.301.350.250.520.894", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1992-2023)", "MS": "Postsynaptic cell-adhesion molecules that bind presynaptic NEUREXINS to form calcium-dependent trans-synaptic adhesions. Neuroligins recruit synaptic scaffolding proteins (e.g., PSD-95) via their PDZ DOMAIN. The distribution and interaction with neurexins are regulated by ALTERNATIVE SPLICING. Alterations in genes encoding neuroligins or neurexins are associated with cognitive diseases such as AUTISM SPECTRUM DISORDER.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096785"}, {"RECTYPE": "D", "MH": "Imprinting Disorders", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Imprinting Syndromes|T047|NON|EQV|NLM (2024)|230208|abcdef", "ENTRY": "Syndrome, Imprinting", "MN": "C16.320.447", "MH_TH": "NLM (2024)", "ST": "T047", "PI": "Genomic Imprinting (2021-2023)", "MS": "Disorders caused by transcriptional silencing of one parental gene allele (imprinted gene). Imprinted genes show genetic expression from only one parent of the gene pair through epigenetic processes with no change in the DNA sequence.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096803"}, {"RECTYPE": "D", "MH": "Chronic Cough", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Persistent Cough|T184|NON|EQV|NLM (2024)|230209|abcdef", "ENTRY": "Persistent Coughs", "MN": "C23.888.852.293.500", "MH_TH": "NLM (2024)", "ST": "T184", "PI": "Cough (1963-2023)", "MS": "Cough lasting for greater than 8 weeks in adults potentially impacting HEALTH-RELATED QUALITY OF LIFE. Chronic cough generally is associated with eosinophilic airway inflammation (e.g., asthma (COUGH-VARIANT ASTHMA) and non-asthmatic BRONCHITIS, upper airway disorders, GERD and cough hypersensitivity syndrome).", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096822"}, {"RECTYPE": "D", "MH": "Cough-Variant Asthma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cough-Variant Asthmas", "MN": "C20.543.480.680.095.688", "MH_TH": "NLM (2024)", "ST": "T047", "PI": "Asthma (1982-2023)", "MS": "Asthma which is characterized by CHRONIC COUGH that is nonproductive without other asthmatic symptoms, e.g., WHEEZING, and PAROXYSMAL DYSPNEA. Cough-variant asthma is accompanied by AIRWAY HYPERSENSITIVITY and may progress to classical asthma without treatment.", "PM": "2024", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096823"}, {"RECTYPE": "D", "MH": "Rhinosinusitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rhino-sinusitis|T047|NON|EQV|NLM (2024)|230209|abcdef", "ENTRY": "Rhino sinusitis", "MN": "C09.603.799.955", "MH_TH": "NLM (2024)", "ST": "T047", "PI": "Sinusitis (1964-2023)", "MS": "Obstruction of sinus drainage into the NASAL CAVITY and inflammation of the NASAL MUCOSA in the PARANASAL SINUSES.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096825"}, {"RECTYPE": "D", "MH": "Cavernous Sinus Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cavernous Sinus Syndrome|T047|NON|EQV|NLM (2024)|230209|abcdef", "MN": "C10.228.140.232", "MH_TH": "NLM (2024)", "ST": "T047", "PI": "Cavernous Sinus (1983-2023)", "MS": "Disease processes of the CAVERNOUS SINUS.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096826"}, {"RECTYPE": "D", "MH": "Oppositional Defiant Disorder", "DE": "OPPOSITIONAL DEFIANT DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Defiant Disorder, Oppositional", "MN": "F03.625.094.475", "MH_TH": "NLM (1998)", "ST": "T048", "MS": "A repetitive and persistent pattern of behavior that develops in childhood and is characterized as recurrent disobedient, overall negative or agitated mood, a quarrelsome attitude or being vengeful toward authority figures. Unlike in conduct disorder defiant behaviors in oppositional defiant disorders typically do not involve aggression, destruction, theft, or deceit. Oppositional defiant disorder, CONDUCT DISORDER and ATTENTION DEFICIT AND HYPERACTIVITY DISORDER sometimes co-occur.", "PM": "2024; see Attention Deficit and Disruptive Behavior Disorders 1998-2023", "HN": "2024", "MR": "20230414", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096865"}, {"RECTYPE": "D", "MH": "Micropeptides", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "smORF-Encoded Peptides|T116|ACX|EQV|NLM (2024)|230215|abcdef", "ENTRY": "smORF Encoded Peptides", "MN": "D12.888", "MH_TH": "NLM (2024)", "ST": "T116", "RN": "0", "PI": "Peptides (1993-2023)", "MS": "Polypeptides 100 amino acids or less in length that are encoded by SHORT OPEN READING FRAME.", "PM": "2024; see PEPTIDES 2023", "HN": "2024(2023)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096903"}, {"RECTYPE": "D", "MH": "In Vitro Meat", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Laboratory-Grown Meat|T168|NON|EQV|NLM (2024)|230215|abcdef", "ENTRY": "Meats, Laboratory-Grown", "MN": "J02.500.600.250", "MH_TH": "NLM (2024)", "ST": "T168", "MS": "Meat produced by growing MUSCLE CELLS isolated from animal muscle tissue, in THREE-DIMENSIONAL CELL CULTURE.", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096904"}, {"RECTYPE": "D", "MH": "K Cl- Cotransporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Solute carrier family 12 member 7|T116|NON|NRW|NLM (2024)|230330|abcdef", "ENTRY": "Protein, SLC12A7", "MN": "D12.776.543.585.937.657", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A subclass of symporters that specifically transport POTASSIUM and CHLORIDE ions across cellular membranes. Potassium chloride cotransporters play roles in regulating cell volume and intracellular chloride concentration.", "PM": "2024; see SYMPORTERS 2002-2023, see CARRIER PROTEINS 1989-2001", "HN": "2024(1989)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096922"}, {"RECTYPE": "D", "MH": "Frataxin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Friedreich Ataxia Protein|T116|T123|NON|EQV|NLM (2024)|230216|abbcdef", "ENTRY": "Protein, Friedreich Ataxia", "MN": "D12.776.575.609", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A protein involved in the transfer of iron and sulfur to iron-sulfur cluster (ISC) assembly complex for de novo synthesis of a [2Fe-2S] cluster, the first step of the mitochondrial iron-sulfur protein biogenesis. Deficiency leads to the neurodegenerative disease FRIEDREICH ATAXIA.", "PM": "2024; FRATAXIN was indexed under IRON-BINDING PROTEINS 1996-2023", "HN": "2024 (1996)", "MR": "20230517", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096923"}, {"RECTYPE": "D", "MH": "Emergency Room Visits", "AQ": "EC HI LJ OG SN TD", "PRINT ENTRY": "Hospital Emergency Department Visits|T058|NON|EQV|NLM (2024)|230308|abcdef", "ENTRY": "Visits, Emergency Room", "MN": "N04.452.289.500", "MH_TH": "NLM (2024)", "ST": "T058", "MS": "Visits made by patients to hospital emergency rooms for diagnosis and treatment.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096924"}, {"RECTYPE": "D", "MH": "Solute Carrier Family 12", "ENTRY": "SLC12A Transporters|T116|ABX|EQV|NLM (2014)|130313|abcdef", "MN": "D12.776.543.585.450.625.875", "MH_TH": "NLM (2014)", "ST": "T116", "RN": "0", "MS": "Inorganic cation-chloride cotransporters mediating the movement of inorganic SODIUM and/or POTASSIUM cations, coupled to the movement of CHLORIDE anions. The solute carrier 12 (SLC12) family can be divided into Na+-dependent SLC12A1-A3 (NKCC1, NKCC2, and NCC) and Na+-independent SLC12A4-A7 (KCC1-KCC4).", "PM": "2024", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096925"}, {"RECTYPE": "D", "MH": "Benzenesulfonamides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzosulfonamides|T109|NON|EQV|NLM (2024)|230217|abcdef", "MN": "D02.886.590.700.090", "MH_TH": "NLM (2024)", "ST": "T109", "RN": "0", "RR": "98-10-2", "MS": "A group of compounds that contain sulfonamide group S-linked to a benzene ring. Many benzenesulfonamide derivatives are pharmaceuticals (e.g., BOSENTAN; SULFAPYRIDINE; and SULFADIAZINE; CELECOXIB) as their sulfonamide moiety target various enzymes (e.g., CARBONIC ANHYDRASES; ACETYLCHOLINESTERASE; BUTYRYLCHOLINESTERASE; and CYCLOOXYNENASE 2).", "PM": "2024; see under SULFONAMIDES 1983-2023", "HN": "2024(1983)", "MR": "20230609", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096926"}, {"RECTYPE": "D", "MH": "AIRE Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Autoimmune Regulator Protein|T116|T123|NON|EQV|NLM (2024)|230221|abbcdef", "ENTRY": "Regulator Protein, Autoimmune", "MN": "D12.776.930.123", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A transcriptional regulator primarily expressed in medullary thymic epithelial cells. It plays an important role in immunity by regulating the expression of a wide array of SELF-ANTIGENS and negative selection of autoreactive T-cells in the thymus.  Deficiency in this protein induces a rare autosomal-recessive disease called AUTOIMMUNE POLYENDOCRINOPATHY-CANDIDIASIS-ECTODERMAL DYSTROPHY.", "PM": "2024; AIRE PROTEIN was indexed under TRANSCRIPTION FACTORS 1997-2023", "HN": "2024 (1997)", "MR": "20230516", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096927"}, {"RECTYPE": "D", "MH": "Treatment Effect Heterogeneity", "PRINT ENTRY": "Heterogeneous Treatment Effects|T080|NON|EQV|NLM (2024)|230217|abcdef", "ENTRY": "Treatment Effects Heterogeneity", "MN": "N05.715.360.575.575.800.737", "MH_TH": "NLM (2024)", "ST": "T080", "PI": "Treatment Outcome (2004-2023)", "MS": "The varying of responses to a given intervention or treatment that occurs across patients or patient subgroups.", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096962"}, {"RECTYPE": "D", "MH": "Translesion DNA Synthesis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Translesional Synthesis Pathway|T045|NON|EQV|NLM (2024)|230221|abcdef", "ENTRY": "Trans Lesional DNA Replication", "MN": "G05.226.380.500", "MH_TH": "NLM (2024)", "ST": "T045", "PI": "DNA Replication (1985-2023)", "MS": "DNA damage tolerant, error-prone DNA replication by specialized DNA POLYMERASES that can accommodate damaged bases in their active sites and insert NUCLEOTIDES in the strand directly opposite the DNA DAMAGE.", "PM": "2024", "HN": "2024", "MR": "20230412", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096963"}, {"RECTYPE": "D", "MH": "Nudix Hydrolases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nudix Proteins|T116|T126|NON|EQV|NLM (2024)|230218|abbcdef", "ENTRY": "Nucleoside Diphosphates Linked to Moiety X Hydrolases", "MN": "D08.811.277.040.600.600", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 3.6.1.-", "MS": "A group of Mg2+/Mn2+-dependent mainly pyrophosphohydrolases that hydrolyzes structures of NUcleoside DIphosphate linked to another moiety X to nucleoside monophosphate and X-Phosphate. Nudix hydrolases share conserved Nudix box (GX5EX7REUXEEXGU) and degrade variety of substrates including oxidized nucleotides (e.g., MutT) and metabolic intermediates (e.g., THIAMINE PYROPHOSPHATASE). In humans, Nudix superfamily proteins such as MutT proteins participate in DNA damage repairs. Mutations on a nudix hydrolase (NUDT15) are associated with a PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS disorder called THPM2, and mutations in nudix hydrolase (NUDT2) are associated with IDDPN, a developmental intellectual disorder.", "PM": "2024; see under PYROPHOSPHATASES 1998-2023", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096964"}, {"RECTYPE": "D", "MH": "Brainwashing", "AQ": "ES HI", "PRINT ENTRY": "Mind Control|T068|NON|EQV|NLM (2024)|230219|abcdef", "ENTRY": "Mind Controls", "MN": "L01.143.762.500", "FX": "Coercion", "MH_TH": "UNK (19XX)", "ST": "T068", "MS": "A broad class of intense and often coercive tactics intended to produce profound changes in attitudes, beliefs, and emotions. Targets of such tactics have typically been prisoners of war and members of religious cults. (From https://dictionary.apa.org/brainwashing)", "PM": "2024", "HN": "2024", "MR": "20230524", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096965"}, {"RECTYPE": "D", "MH": "Workforce Diversity", "PRINT ENTRY": "Workplace Diversity|T078|NON|REL|NLM (2024)|230219|abcdef", "ENTRY": "Workplace Diversities", "MN": "N04.452.677.975.500.500", "MH_TH": "NLM (2024)", "ST": "T078", "MS": "Diversity encompasses the range of similarities and differences each individual brings to the workplace, including but not limited to national origin, language, race, color, disability, ethnicity, gender, age, religion, sexual orientation, gender identity, socioeconomic status, veteran status, and family structures. (hud.gov/program_offices/administration/admabout/diversity_inclusion/definitions#diversity)", "PM": "2024", "HN": "2024", "MR": "20230524", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096966"}, {"RECTYPE": "D", "MH": "Unvaccinated Persons", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Non-Immunized Persons|T098|NON|REL|NLM (2024)|230220|abcdef", "ENTRY": "Unvaccinated Person", "MN": "M01.927", "MH_TH": "NLM (2024)", "ST": "T098", "MS": "People who have not been vaccinated against a communicable disease.", "PM": "2024", "HN": "2024", "MR": "20230524", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096967"}, {"RECTYPE": "D", "MH": "Urea Transporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Urea Transporter Proteins|T116|T123|NON|EQV|NLM (2024)|230320|abbcdef", "ENTRY": "Transporter B, Urea", "MN": "D12.776.543.585.937.969", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1996-2023)", "MS": "Transmembrane carrier proteins responsible for urea movement across the cell membrane. Urea transporters are divided into renal tubular/testicular type (urea transporter 2 consisting of (UT) A1 to A5, encoded by SLC14A2 gene) and erythrocyte type (urea transporter 2 or UT-B1 encoded by the SLC14A1 gene). In humans mutations on the SLC14A1 gene determines KIDD BLOOD-GROUP SYSTEM.", "PM": "2024", "HN": "2024", "MR": "20230602", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096982"}, {"RECTYPE": "D", "MH": "Ginkgo Extract", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Extract, Ginkgo", "MN": "D20.215.784.500.375", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "Preparations of GINKGO BILOBA. They contain various ANTIOXIDANTS including FLAVONOIDS and TERPENES (e.g., XANTHOPHYLLS).", "PM": "2024", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096983"}, {"RECTYPE": "D", "MH": "Calponins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Calponin Family Proteins|T116|NON|EQV|NLM (2024)|230221|abcdef", "MN": "D12.776.220.525.268", "MH_TH": "NLM (2024)", "ST": "T116", "RN": "0", "PI": "Microfilament Proteins (1990-2023)", "MS": "A family of actin binding proteins mostly in smooth muscle. Calponins include most abundant alpha-calponin (h1 or basic); beta-calponin; neutral calponin (h2 calponin); acidic calponin, SM22, and transgelin. Calponin family members have N-terminal single Calponin Homology (CH) domain and multiple C-terminus 23-amino acids long calponin-like repeats called CLICK-23. Calponins participate in modulation of smooth muscle contraction by binding to ACTINS (F- and G-Actins), CALMODULIN and TROPOMYSIN.", "PM": "2024", "HN": "2024", "MR": "20230607", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000096985"}, {"RECTYPE": "D", "MH": "Acetonitriles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methyl Cyanides|T109|T130|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Nitriles, Ethane", "MN": "D02.626.080", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "0", "PI": "Nitriles (1969-1974)", "MS": "Compounds in which a methyl group is attached to the cyano moiety.", "PM": "75", "HN": "75", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D000097"}, {"RECTYPE": "D", "MH": "Gap Junction beta-1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gap Junction beta1 Protein|T116|T123|NON|EQV|NLM (2024)|230330|abbcdef", "ENTRY": "Protein, GJB1", "MN": "D12.776.543.585.250.600", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A GAP JUNCTION beta subunit containing four transmembrane domains expressed in myelinating SCHWANN CELLS and is localized to peripheral MYELIN (e.g., noncompact myelin in the paranode and Schmitt-Lanterman incisures). Mutations in the human gene GJB1 are associated with X-linked CHARCOT-MARIE-TOOTH DISEASE type 1 (CMT1X).", "PM": "2024; see under CONNEXINS 1993-2023", "HN": "2024(1993)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097002"}, {"RECTYPE": "D", "MH": "Gap Junction alpha-5 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gap Junction alpha5 Protein|T116|T123|NON|EQV|NLM (2024)|230330|abbcdef", "ENTRY": "Protein, GJA5", "MN": "D12.776.543.585.250.400", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A GAP JUNCTION alpha subunit containing four transmembrane domains expressed in the atrial myocardium and ventricular HEART CONDUCTION SYSTEM including PURKINJE FIBERS. Mutations in the human gene GJA5 are associated with cardiac conduction abnormalities such as a familial ATRIAL FIBRILLATION.", "PM": "2024; see CONNEXINS 2010-2023", "HN": "2024(2010)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097003"}, {"RECTYPE": "D", "MH": "Gap Junction delta-2 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gap Junction Protein delta 2|T116|T123|NON|EQV|NLM (2024)|230330|abbcdef", "ENTRY": "Protein, GJD2", "MN": "D12.776.543.585.250.800", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A GAP JUNCTION delta subunit containing four transmembrane domains expressed in the PANCREATIC BETA CELLS, retinal CONE PHOTORECEPTOR CELLS, hippocampal INTERNEURONS, and dendrites in the OLIVARY NUCLEUS and THALAMIC NUCLEI.", "PM": "2024; see CONNEXINS 2000-2023", "HN": "2024(2000)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097004"}, {"RECTYPE": "D", "MH": "Gap Junction alpha-4 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gap Junction alpha4 Protein|T116|T123|NON|EQV|NLM (2024)|230330|abbcdef", "ENTRY": "Protein, GJA4", "MN": "D12.776.543.585.250.300", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A GAP JUNCTION alpha subunit containing four transmembrane domains expressed in the adipose cells and myocardium. Mutations in the human gene GJA4 are risk factors for ATHEROSCLEROSIS and MYOCARDIAL INFARCTION.", "PM": "2024; see CONNEXINS 2008-2023", "HN": "2024(2008)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097006"}, {"RECTYPE": "D", "MH": "Nanovaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nanovaccine|T121|T129|NON|EQV|NLM (2024)|230222|abbcdef", "ENTRY": "Vaccines, Nanoparticle", "MN": "E02.319.300.380.800.500", "MH_TH": "NLM (2024)", "ST": "T129", "RN": "0", "PI": "Nanoparticles (2010-2023)", "MS": "Vaccines that use NANOPARTICLES as carriers and IMMUNOLOGIC ADJUVANTS.", "PM": "2024", "HN": "2024", "MR": "20230517", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097007"}, {"RECTYPE": "D", "MH": "Deltainfluenzavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Orthomyxoviruses Type D|T005|NON|EQV|NLM (1997)|960326|abcdef", "ENTRY": "Influenza D viruses", "MN": "B04.820.480.968.430", "MH_TH": "NLM (2024)", "ST": "T005", "RN": "txid1511083", "RR": "txid1511084", "MS": "A genus of the family ORTHOMYXOVIRIDAE comprising viruses similar to type C, lacking NEURAMINIDASE and using hemagglutinin-esterase fusion (HEF) protein for attachment. Unlike in other influenza virus genera viral NEP is not produced via alternatively spliced non-structural protein mRNA (NS1). Deltainfluenzavirus mostly infect nonhuman hosts, e.g., cattle and swine and in human causes acute febrile respiratory tract infection. Influenza D virus is the type species.", "PM": "2024; see THOGOTOVIRUS 2002-2023, THOGOTO-LIKE VIRUSES 1997-2001, ORTHOMYXOVIRUSES TYPE D 1994-1996", "HN": "2024(1994)", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097023"}, {"RECTYPE": "D", "MH": "Acylphosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carbamyl Phosphate Phosphatase|T116|NON|NRW|NLM (2024)|230223|abcdef", "ENTRY": "Phosphohydrolase, Acylphosphate", "MN": "D08.811.277.040.019", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 3.6.1.7", "MS": "An enzyme that catalyzes the conversion of an acylphosphate and water to a carboxylate and phosphate.", "PM": "2024; ACYLPHOSPHATASE was indexed under ACID ANHYDRIDE HYDROLASES 1973-2023", "HN": "2024 (1973)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097024"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H5N6 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H5N6 subtype|T005|ABX|EQV|NLM (2024)|230223|abcdef", "ENTRY": "subtype, H5N6", "MN": "B04.820.480.968.405.400.552", "MH_TH": "NLM (2024)", "ST": "T005", "RN": "txid329376", "PI": "Influenza A virus (2015-2023)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 5 and neuraminidase 6. The H5N6 subtype, frequently referred to as the bird flu virus, is endemic in wild birds and very contagious among both domestic (POULTRY) and wild birds. H5N6 does not usually infect humans, but some cases have been reported with high mortality rate similar to another highly pathogenic avian influenza A(H5) virus H5N1 AVIAN INFLUENZA VIRUS.", "PM": "2024", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097025"}, {"RECTYPE": "D", "MH": "Treatment Interruption", "AQ": "EH ES PX SN", "PRINT ENTRY": "Structured Treatment Interruption|T058|NON|EQV|NLM (2024)|230224|abcdef", "ENTRY": "Treatment, Interrupted", "MN": "N05.300.150.800.688", "MH_TH": "NLM (2024)", "ST": "T058", "PI": "HIV Infections (1999-2023)", "MS": "A deliberate decision between the patient and health care provider to stop medication for a defined period of time and for a specific clinical purpose.", "PM": "2024", "HN": "2024", "MR": "20230517", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097042"}, {"RECTYPE": "D", "MH": "Interleukin-22", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ILTIF|T116|T129|ABB|EQV|NLM (2024)|230224|abbcdef", "ENTRY": "Zcyto18, Cytokine", "MN": "D23.529.374.465.925", "MH_TH": "NLM (2024)", "ST": "T129", "RN": "0", "MS": "An interleukin that plays a critical role in modulating tissue responses during inflammation, and in WOUND HEALING.", "PM": "2024; INTERLEUKIN-22 was indexed under INTERLEUKINS 2000-2023", "HN": "2024 (2000)", "MR": "20230517", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097043"}, {"RECTYPE": "D", "MH": "Kir5.1 Channel", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "KCNJ16 Protein|T116|T123|NON|EQV|NLM (2024)|230228|abbcdef", "ENTRY": "Protein, KCNJ16", "MN": "D12.776.543.585.400.750.450.525", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "An inwardly-rectifying potassium channel that allows potassium to flow into rather than out of a cell. It selectively co-assembles with two other inward-rectifier type potassium channels, Kir4.1 or Kir4.2, to form heteromeric channels.", "PM": "2024; KIR5.1 CHANNEL was indexed under POTASSIUM CHANNELS, INWARDLY RECTIFYING 2004-2023", "HN": "2024 (2004)", "MR": "20230517", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097062"}, {"RECTYPE": "D", "MH": "Bioenhancers", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Biopotentiators|T120|NON|EQV|NLM (2024)|230228|abcdef", "ENTRY": "Enhancer, Bioavailability", "MN": "D27.720.744.064.750", "MH_TH": "NLM (2024)", "ST": "T120", "RN": "0", "MS": "Agents that are used to increase the BIOAVAILABILITY and bioefficacy of a drug, without any therapeutic activity of its own.", "PM": "2024", "HN": "2024", "MR": "20230522", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097082"}, {"RECTYPE": "D", "MH": "Digital Health", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Digital Health Technology|T066|NON|NRW|NLM (2024)|230301|abcdef", "ENTRY": "Health, Digital", "MN": "N05.300.291", "FX": "Wearable Electronic Devices", "MH_TH": "NLM (2024)", "ST": "T066", "PI": "Telemedicine (1998-2023)", "MS": "Use of digital technologies in medicine and other health professions to manage illnesses and health risks and to promote wellness; includes the use of WEARABLE DEVICES; HEALTH INFORMATION TECHNOLOGY; ELECTRONIC HEALTH RECORDS; TELEMEDICINE; and PERSONALIZED MEDICINE.", "PM": "2024", "HN": "2024", "MR": "20230417", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097103"}, {"RECTYPE": "D", "MH": "DNA Damage Tolerance", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Replication Template Switching|T045|NON|NRW|NLM (2024)|230302|abcdef", "ENTRY": "Template Switching, Replication", "MN": "G05.226.380", "FX": "DNA Repair", "MH_TH": "NLM (2024)", "ST": "T045", "MS": "Strategies that cells use to continue DNA replication when replicative DNA polymerases stall at DNA damage-blocked replication forks. These DNA damage tolerant replication mechanisms bypass the DNA DAMAGE, which may be repaired subsequently by various DNA REPAIR mechanisms.", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097122"}, {"RECTYPE": "D", "MH": "Rosmarinic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rosmarinic Acid, (R-(E))-Isomer|T109|T121|NON|NRW|NLM (2024)|230302|abbcdef", "ENTRY": "Acid, Rosmarinic", "MN": "D02.455.426.559.389.657.410.100.500", "MH_TH": "NLM (2024)", "ST": "T121", "RN": "MQE6XG29YI", "MS": "A polyphenol compound that naturally occurs in rosemary with ANTIOXIDANT and anti-inflammatory properties.\u00a0", "PM": "2024; ROSMARINIC ACID was indexed under CINNAMATES and DEPSIDES 1984-2023", "HN": "2024 (1984)", "MR": "20230626", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097123"}, {"RECTYPE": "D", "MH": "Bothrops atrox", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Trimeresurus atrox|T014|NON|EQV|NLM (2024)|230302|abcdef", "ENTRY": "Lancehead, Common", "MN": "B01.050.150.900.833.672.562.875.240.375.500", "MH_TH": "NLM (2024)", "ST": "T014", "RN": "txid8725", "MS": "A species of venomous pit viper of the BOTHROPS genus. Bothrops atrox are found in the tropical lowlands of northern South America east of the Andes and Trinidad where it is called mapepire balsain. B. atrox is more commonly called common lancehead and fer-de-lance. BATROXOBIN is usually isolated from B. atrox venom.", "PM": "2024; see BOTHROPS 1994-2023", "HN": "2024(1994)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097142"}, {"RECTYPE": "D", "MH": "Bothrops asper", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Terciopelo|T014|NON|EQV|NLM (2024)|230303|abcdef", "ENTRY": "Terciopelos", "MN": "B01.050.150.900.833.672.562.875.240.375.750", "MH_TH": "NLM (2023)", "ST": "T014", "RR": "txid8722", "MS": "A species of venomous pit viper of the BOTHROPS genus. Bothrops asper are found in Mexico, Central America and northern South America including Trinidad. B. asper is commonly called terciopelo.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097143"}, {"RECTYPE": "D", "MH": "Bungarus multicinctus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Many-Banded Krait|T014|NON|EQV|NLM (2024)|230303|abcdef", "ENTRY": "Many-Banded Kraits", "MN": "B01.050.150.900.833.672.562.750.225.500", "MH_TH": "NLM (2024)", "ST": "T014", "RN": "txid8616", "RR": "txid2726435", "PI": "Bungarus (1963-2023)", "MS": "A venomous elapid snake species of BUNGARUS genus found in the marshlands of Southeast Asia and central and southern China. Its common name many-banded krait refers to the numerous white bands across its body. B. multicinctus venom is BUNGAEOTIXINS.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097144"}, {"RECTYPE": "D", "MH": "Bothrops jararaca", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Jararaca Snake|T014|NON|EQV|NLM (2024)|230303|abcdef", "ENTRY": "Snake, Jararaca", "MN": "B01.050.150.900.833.672.562.875.240.375.875", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8724", "MS": "A species of venomous snakes of the BOTHROPS genus. Bothrops jararaca is found in South America and commonly called jararaca.", "PM": "2024; see BOTHROPS 1994-2023", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097145"}, {"RECTYPE": "D", "MH": "Bothrops jararaca Venom", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE ST TO TU UR", "PRINT ENTRY": "Jararhagin|T116|T131|NON|NRW|NLM (2024)|230303|abbcdef", "ENTRY": "Venom, Jararaca", "MN": "D23.946.833.850.960.200.158", "MH_TH": "NLM (2021)", "ST": "T131", "RN": "0", "RR": "EC 3.4.24.-", "PI": "Crotalid Venoms (1963-2023)", "MS": "Snake venoms isolated from BOTHROPS JARARACA. B. jararaca venoms contain a hemorrhagic metalloproteinase toxn jararhagin which binds to VON WILLEBRAND FACTOR.", "PM": "2024", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097146"}, {"RECTYPE": "D", "MH": "Excision Repair", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Transcription-Coupled Repair|T045|NON|NRW|NLM (2024)|230320|abcdef", "ENTRY": "Excision Repair, Transcription-Coupled", "MN": "G05.219.460", "MH_TH": "NLM (1991)", "ST": "T045", "PI": "DNA Repair (1974-2023)", "MS": "A major DNA repair mechanism in which defective regions in one strand are excised and resynthesized using the complementary base pairing information in the intact strand.", "PM": "2024; see DNA REPAIR 1991-2023", "HN": "2024; use DNA REPAIR 1991-2023", "MR": "20230824", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097147"}, {"RECTYPE": "D", "MH": "Community of Practice", "ENTRY": "Practice Community", "MN": "L01.143.910.125", "MH_TH": "NLM (2024)", "ST": "T078", "MS": "Core concept of learning and knowledge management, a repository where knowledge is developed, maintained and reproduced. It is an important platform for knowledge sharing within an organization or among peers in other settings.", "PM": "2024", "HN": "2024", "MR": "20230524", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097163"}, {"RECTYPE": "D", "MH": "Narcissistic Personality Disorder", "DE": "NARCISSISTIC PERSONALITY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Pathological Narcissism|T048|NON|EQV|NLM (2024)|230524|abcdef", "ENTRY": "Personality Disorder, Narcissistic", "MN": "F03.675.500", "MH_TH": "NLM (1998)", "ST": "T048", "MS": "A pattern of grandiosity, need for admiration, and lack of empathy. (ncbi.nlm.nih.gov/books/NBK556001/)", "PM": "See Personality Disorders 1998-2023: 2024", "HN": "See Personality Disorders 1998-2023: 2024", "MR": "20230524", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097165"}, {"RECTYPE": "D", "MH": "Fluoride Treatment", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Fluoride Application, Topical|T061|NON|EQV|NLM (2024)|230306|abcdef", "ENTRY": "Treatments, Fluoride", "MN": "E06.761.382.500", "FX": "Fluorides, Topical", "MH_TH": "NLM (2024)", "ST": "T061", "MS": "The topical application of fluorides, usually in pastes, gels, varnishes, TOOTHPASTES or MOUTHWASHES,   to reduce the incidence of DENTAL CARIES. Fluoride Treatment may occur in the dental office or at home. (https://jada.ada.org/article/S0002-8177(14)62166-8/fulltext)", "PM": "2024", "HN": "2024", "MR": "20230615", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097182"}, {"RECTYPE": "D", "MH": "Viperinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Viper, True", "MN": "B01.050.150.900.833.672.562.875.875", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8690", "MS": "A subfamily of snakes commonly known as true vipers or crotaline snakes in the family VIPERIDAE. They are distinguished from sister subfamily CROTALINAE or pit vipers by their lack the heat-sensing pit organs.", "PM": "2024; see VIPERIDAE 1994-2023", "HN": "2024(1994)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097183"}, {"RECTYPE": "D", "MH": "Echis", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.833.672.562.875.875.750", "MH_TH": "NLM (2024)", "ST": "T014", "RN": "txid8699", "PI": "Viperidae (1993-2023)", "MS": "A genus of vipers found in Africa, Arabia and India. Echis snakes include venomous saw-scale viper and carpet viper.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097185"}, {"RECTYPE": "D", "MH": "Vipera", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.833.672.562.875.875.875", "MH_TH": "NLM (2024)", "ST": "T014", "RN": "txid8703", "PI": "Viperidae (1963-2023)", "MS": "A genus of venomous and viviparous vipers in subfamily VIPERINAE. Vipera are found in Africa, Europe and Asia.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097186"}, {"RECTYPE": "D", "MH": "Bitis", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Gaboon Viper|T014|NON|NRW|NLM (1994)|921015|abcdef", "ENTRY": "Viper, Gaboon", "MN": "B01.050.150.900.833.672.562.875.875.125", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8691", "RR": "txid8694", "MS": "A genus of Viperinae subfamily. Bitis snakes are found in Africa and Arabia. Bitis includes African puff adder (Bitis arietans) and horned adder (Bitis caudalis).", "PM": "2024; see VIPERIDAE 1994-2023", "HN": "2024(1994)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097187"}, {"RECTYPE": "D", "MH": "Radiomics", "ENTRY": "Radiomic", "MN": "E01.370.350.705", "MH_TH": "NLM (2024)", "ST": "T060", "MS": "Extraction of a large number of features from patient images using data characterization algorithms to uncover tumoral patterns and characteristics that improve diagnosis.", "PM": "2024", "HN": "2024", "MR": "20230517", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097188"}, {"RECTYPE": "D", "MH": "Cerastes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.833.672.562.875.875.250", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8696", "MS": "A genus of Viperinae found mostly in Africa, Arabia and India with characteristic horny scale over each eye. Cerastes genus includes Saharan sand viper (Cerastes vipera) and horned desert viper (Cerastes cerastes).  A desert sidewinder Crotalus cerastes also has horny scale over its eyes but is a species in sister subfamily Crotalinae and found in Southwest American desert.", "PM": "2024; see VIPERIDAE 1994-2023", "HN": "2024(1994)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097189"}, {"RECTYPE": "D", "MH": "ATP-Binding Cassette Sub-Family B Member 4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphatidylcholine Translocator ABCB4|T116|T123|NON|EQV|NLM (2024)|230307|abbcdef", "ENTRY": "protein, Pgp2", "MN": "D12.776.543.585.450.074.500.500.250.719", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "An ATP-binding cassette, sub-family B protein that functions in translocating PHOSPHATIDYLCHOLINES from the inner to the outer leaflet of the canalicular membrane of the HEPATOCYTES.", "PM": "2024; P-GLYCOPROTEIN 2 was indexed under ATP-BINDING CASSETTE TRANSPORTER, SUBFAMILY B 1999-2023", "HN": "2024 (1999)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097202"}, {"RECTYPE": "D", "MH": "Venomous Snakes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Poisonous Snakes|T014|NON|REL|NLM (2024)|230309|abcdef", "ENTRY": "Venomous Snake", "MN": "B01.050.150.900.833.672.562", "MH_TH": "NLM (2024)", "ST": "T014", "PI": "Snakes (1963-2023)", "MS": "Snakes that produce SNAKE VENOMS. Venomous snakes are most often members of ELAPIDAE (e.g., cobras) including sea snakes in HYDROPHIINAE and VIPERIDAE (e.g., vipers).", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097222"}, {"RECTYPE": "D", "MH": "Efferocytosis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Apoptotic Cell Clearance|T043|NON|EQV|NLM (2024)|230505|abcdef", "ENTRY": "Clearances, Apoptotic Cell", "MN": "G12.450.564.809.500.500", "MH_TH": "NLM (2024)", "ST": "T043", "MS": "Phagocytosis and clearance of apoptotic cells.", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097242"}, {"RECTYPE": "D", "MH": "Percutaneous Collagen Induction", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Skin Needling|T061|NON|EQV|NLM (2024)|230309|abcdef", "ENTRY": "Needling, Skin", "MN": "E02.831.535.950", "MH_TH": "NLM (2024)", "ST": "T061", "MS": "An alternative treatment for skin dysfunctions that stimulates COLLAGEN production by encouraging normal WOUND HEALING that occurs after any trauma by inducing microlesions.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097244"}, {"RECTYPE": "D", "MH": "Ursolic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ursolic Acid, (3beta)-Isomer, Monopotassium Salt|T109|T121|NON|NRW|NLM (1974)|230309|abbcdef", "ENTRY": "Oleanolate, Sodium", "MN": "D02.455.849.919.650.800", "MH_TH": "NLM (1974)", "ST": "T121", "RN": "P3M2575F3F", "RR": "LVB19G8AUT", "MS": "A pentacyclic triterpene that co-occurs with its isomer OLEANOLIC ACID in several plant species, and occurs in large amounts in FRUITS (such as CRANBERRIES; PEARS; PLUMS; and OLIVES), MEDICINAL HERBS, and other plants.", "PM": "2024; URSOLIC ACID was indexed under OLEANOLIC ACID/analogs & derivatives 1974-2023", "HN": "2024 (1974)", "MR": "20230320", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097245"}, {"RECTYPE": "D", "MH": "Heloderma suspectum", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Reticulate Gila Monster|T014|NON|NRW|NLM (2024)|230316|abcdef", "ENTRY": "Reticulate Gila Monsters", "MN": "B01.050.150.900.833.393.250", "MH_TH": "NLM (2024)", "ST": "T014", "RN": "txid8554", "RR": "txid709964", "MS": "Large nocturnal, venomous lizard found in the deserts of the Southwestern United States and northern Mexico. A synthetic version of Gila monster venom component exendin-4 is EXENATIDE.", "PM": "2024; see LIZARDS 2017-2023", "HN": "2024", "MR": "20230405", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097282"}, {"RECTYPE": "D", "MH": "Peptidyl-Prolyl Isomerase D", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PPIase D|T116|T126|NON|EQV|NLM (2024)|230320|abbcdef", "ENTRY": "Peptidyl Prolyl Isomerase D", "MN": "D12.776.827.344.300.813", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 5.2.1.8", "PI": "Peptidyl-Prolyl Isomerase F (1993-2023)", "MS": "A cytoplasmic cyclophilin with molecular chaperoning properties. It is found along with other MOLECULAR CHAPERONES, in steroid aporeceptor complexes and plays a role in maintaining the nonnative folding-competent intermediate state of the steroid aporeceptors. The protein has the alias name cyclophilin D which is also the alias name for the related protein Peptidyl-Prolyl Isomerase F.", "PM": "2024; see CYCLOPHILIN D 2020-2023", "HN": "2024; use PEPTIDYL-PROLYL ISOMERASE F 2020-2023", "MR": "20230602", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097322"}, {"RECTYPE": "D", "MH": "Edible Seaweeds", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B05.080.750.225", "MH_TH": "NLM (2024)", "ST": "T204", "MS": "Various seaweeds either wild-harvested or cultured (AQUACULTURE) for direct human consumption.", "PM": "2024; for NORI see PORPHYRA 2004-2023", "HN": "2024(2004)", "MR": "20230606", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097342"}, {"RECTYPE": "D", "MH": "CD68 Molecule", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Scavenger Receptor Class D, Member 1|T116|T123|NON|EQV|NLM (2024)|230324|abbcdef", "ENTRY": "Lysosomal Associated Membrane Protein 4", "MN": "D23.101.100.900.023", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A single-pass type 1 transmembrane glycoprotein that localizes to LYSOSOMES; ENDOSOMES; and cell surface CELL MEMBRANES. It is a member of the lysosomal associated membrane glycoprotein family and the scavenger receptor family. The highly glycosylated extracellular domain binds to tissue- and organ-specific LECTINS or SELECTINS.", "PM": "2024; was indexed as ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC and ANTIGENS, CD 1991-2023", "HN": "2024 (1991)", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097382"}, {"RECTYPE": "D", "MH": "Centrosomal Associated Proteins", "AQ": "AD AE AG AI AN BI BL CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Centrosome Proteins|T116|T123|NON|EQV|NLM (2024)|230328|abbcdef", "ENTRY": "Proteins, Centrosome", "MN": "D12.776.220.148", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "PI": "Centrosome (1995-2023)", "MS": "Proteins that are localized in the CENTROSOME. They help with processes such as MITOSIS and CELL MOTILITY.", "PM": "2024", "HN": "2024", "MR": "20230613", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097402"}, {"RECTYPE": "D", "MH": "Peroxidasin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peroxidasins|T116|T123|NON|EQV|NLM (2024)|230328|abbcdef", "MN": "D12.776.860.300.779", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A peroxidase originally isolated from DROSOPHILA that catalyzes the oxidation of bromide by hydrogen peroxide and generates hypobromite as a reactive intermediate. Its functions include a role in EXTRACELLULAR MATRIX assembly of COLLAGEN TYPE IV; LAMININ; and FIBRONECTIN.", "PM": "2024: PEROXIDASIN was indexed under PEROXIDASE and EXTRACELLULAR MATRIX PROTEINS 1994-2023", "HN": "2024 (1994)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097423"}, {"RECTYPE": "D", "MH": "Amphidinolides", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Iriomoteolides|T109|NON|REL|NLM (2024)|230330|abcdef", "MN": "D04.345.674.500.250", "MH_TH": "NLM (2024)", "ST": "T109", "RN": "0", "PI": "Macrolides (1991-2023)", "MS": "Complex macrolides produced by marine dinoflagellates such as AMPHIDINIUM. Many amphidinolides and related iriomoteolides are cytotoxic which disturb MICROTUBULE activities.", "PM": "2024", "HN": "2024", "MR": "20230601", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097442"}, {"RECTYPE": "D", "MH": "DNA Polymerase theta", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA Polymerase POLQ|T116|T126|ACX|EQV|NLM (2024)|230509|abbcdef", "ENTRY": "theta, DNA Polymerase", "MN": "D08.811.913.696.445.308.300.622", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 2.7.7.-", "MS": "A specialized DNA polymerase that in humans is encoded by the POLQ gene. It is involved in DNA repair pathways, including DNA END-JOINING REPAIR and RECOMBINATIONAL DNA REPAIR.", "PM": "2024; DNA POLYMERASE THETA was indexed under DNA-DIRECTED DNA POLYMERASE 1999-2023", "HN": "2024 (1999)", "MR": "20230530", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097462"}, {"RECTYPE": "D", "MH": "Bioactive Peptides, Dietary", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Food-Derived Bioactive Peptides|T116|T123|NON|EQV|NLM (2024)|230403|abbcdef", "ENTRY": "Food-Derived Bioactive Peptide", "MN": "J02.500.428.540", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "PI": "Peptides (2003-2023)", "MS": "Peptides that are derived from dietary protein and which can modulate physiological functions.", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097482"}, {"RECTYPE": "D", "MH": "delta-1-Pyrroline-5-Carboxylate Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "P5CR Enzyme|T116|T126|ABX|EQV|NLM (2024)|230404|abbcdef", "ENTRY": "delta 1 Pyrroline 5 Carboxylate Reductase", "MN": "D08.811.682.662.695.500", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 1.5.1.2", "MS": "An enzyme that catalyzes the\u00a0last step in proline biosynthesis which catalyzes the NADPH-dependent reduction of delta-1-pyrroline-5-carboxylate to L-Proline.", "PM": "2024; DELTA-1-PYRROLINE-5-CARBOXYLATE REDUCTASE was indexed under PYRROLINE CARBOXYLATE REDUCTASES 1986-2023", "HN": "2024 (1986)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097502"}, {"RECTYPE": "D", "MH": "Neuroserpin", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SERPINI1 Protein|T116|T121|NON|EQV|NLM (2024)|230531|abbcdef", "ENTRY": "SERPIN I1", "MN": "D12.776.872.488", "MH_TH": "NLM (2024)", "ST": "T121", "RN": "EX4Y4AYE7A", "MS": "An inhibitory serpin that inhibits PLASMINOGEN ACTIVATORS (tPA) in the brain.", "PM": "2024; NEUROSERPIN was indexed under NEUROPEPTIDES and SERPINS 1996-2023", "HN": "2024 (1996)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097522"}, {"RECTYPE": "D", "MH": "Myrmecophytes", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Myrmecophytic Plants|T002|NON|EQV|NLM (2024)|230406|abcdef", "ENTRY": "Plant, Myrmecophytic", "MN": "B01.650.305", "MH_TH": "NLM (2024)", "ST": "T002", "MS": "Plants that host ANTS by providing shelter in specialized nesting structures or domatia (e.g., Beltian or Mullerian bodies) and sometimes provide food (e.g., food and pearl bodies; and EXTRAFLORAL NECTARS). Ant colony in turn provides the host plant with defense against encroaching foliage, nutrients via waste by-product and help with SEED DISPERSAL.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097543"}, {"RECTYPE": "D", "MH": "Hemosiderosis, Pulmonary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Secondary Pulmonary Hemosiderosis|T047|NON|NRW|NLM (2024)|230405|abcdef", "ENTRY": "Pulmonary Hemosiderosis, Secondary", "MN": "C18.452.565.500.500.500", "MH_TH": "NLM (2024)", "ST": "T047", "MS": "Iron deposition within the lung. Primary pulmonary hemosiderosis is characterized by HEMOPTYSIS; IRON-DEFICIENCY ANEMIA, and diffuse pulmonary hemorrhage as seen as transient pulmonary infiltrates on RADIOGRAPHY. Even though large amounts of iron are laid down in the lung, with normal or increased total body iron, anemia occurs because of inability of the erythron to use iron sequestered in pulmonary MACROPHAGES.", "PM": "2024; see Hemosiderosis 2010-2023, Lung Diseases 2010-2023", "HN": "2024(2010)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097545"}, {"RECTYPE": "D", "MH": "Left Atrial Appendage Closure", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Left Atrial Appendage Occlusion Intervention|T061|NON|EQV|NLM (2024)|230405|abcdef", "ENTRY": "LAA Closures", "MN": "E05.157.250.582", "MH_TH": "NLM (2024)", "ST": "T061", "PI": "Cardiac Catheterization (2011-2023)", "MS": "A procedure that blocks the left ATRIAL APPENDAGE to reduce the risk of MYOCARDIAL INFARCTION associated with ATRIAL FIBRILLATION (AF). The left atrial appendage is often the site of BLOOD CLOT formation in AF.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097546"}, {"RECTYPE": "D", "MH": "Tibiofemoral Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Tibiofibular Joint|T030|NON|EQV|NLM (2024)|230405|abcdef", "ENTRY": "Tibiofibular Joints", "MN": "A02.835.583.475.825", "MH_TH": "NLM (2024)", "ST": "T030", "PI": "Knee Joint (1986-2023)", "MS": "The articulation between the articular surfaces of the TIBIA and the FEMUR.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097547"}, {"RECTYPE": "D", "MH": "Cardio-Oncology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Cardiovascular Oncology|T091|NON|EQV|NLM (2024)|230504|abcdef", "ENTRY": "Oncology, Cardiovascular", "MN": "H02.403.429.515.125", "MH_TH": "NLM (2024)", "ST": "T091", "PI": "Medical Oncology (2010-2023)", "MS": "The study, diagnosis, and treatment of CARDIOTOXICITY in patients who undergo treatment for cancer.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097562"}, {"RECTYPE": "D", "MH": "Chelidonium majus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Greater Celandine|T002|NON|EQV|NLM (2024)|230406|abcdef", "ENTRY": "Greater Celandines", "MN": "B01.875.800.575.912.250.836.500.249.500", "MH_TH": "NLM (2024)", "ST": "T002", "RN": "txid71251", "RR": "txid1622166", "PI": "Chelidonium (1964-2023)", "MS": "A plant species of the family PAPAVERACEAE. The common name greater celandine is similar to lesser celandine (Ficaria verna), and celandine poppy (Stylophorum diphyllum). It has been used in folk medicine and its latex contains biologically active compounds including BENZOPHENANTHRIDINES alkaloids (e.g., Chelerythrine).", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097563"}, {"RECTYPE": "D", "MH": "Iodothyronine Deiodinase Type II", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Type II Iodothyronine Deiodinase|T116|T126|NON|EQV|NLM (2024)|230406|abbcdef", "ENTRY": "Type II 5' Deiodinase", "MN": "D08.811.682.732.525.500", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 1.11.1.-", "MS": "An enzyme responsible for T4 (3,5,3',5'-tetraiodothyronine) to T3 (3,5,3'-TRIIODOTHYRONINE) conversion. May contribute to increasing T3 THYROID HORMONE production in patients with GRAVES DISEASE.", "PM": "2024; IODOTHYRONINE DEIODINASE TYPE II was indexed under IODIDE PEROXIDASE 1996-2023", "HN": "2024 (1996)", "MR": "20230530", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097564"}, {"RECTYPE": "D", "MH": "Cyclophanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclophane|T109|NON|EQV|NLM (2024)|230406|abcdef", "MN": "D02.455.426.559.542", "MH_TH": "NLM (2024)", "ST": "T109", "RN": "0", "PI": "Hydrocarbons, Cyclic (1987-2023)", "MS": "Hydrocarbons consisting of aromatic unit(s) and cross-linked ansa chain(s), derived from two nonadjacent positions of the aromatic ring(s), e.g., p-cyclophane and m-cyclophane.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097566"}, {"RECTYPE": "D", "MH": "Pleuromutilins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pleuromutilin Antibiotics|T109|T195|NON|EQV|NLM (2024)|230406|abbcdef", "ENTRY": "Drosophilin B|T109|T195|EQV|NLM (1973)|abbde", "MN": "D02.455.849.291.564", "MH_TH": "NLM (2024)", "ST": "T195", "RN": "0", "RR": "3DE4A80MZ1", "MS": "A tricyclic diterpene natural product isolated from Pleurotus mutilus (now referred to as Clitopilus scyphoides). Possesses modest antibacterial activity against primarily gram-positive bacterial organisms.", "PM": "2024: PLEUROMUTILIN was indexed under DITERPENES and POLYCYCLIC COMPOUNDS 1975-2023, and under CYCLOPARAFFINS and GLYCOLATES 1973-1975", "HN": "2024 (1973)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097567"}, {"RECTYPE": "D", "MH": "Matrix Gla Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Matrix gamma-Carboxyglutamic Acid Protein|T116|T123|NON|EQV|NLM (2024)|230427|abbcdef", "ENTRY": "Gla Protein, Matrix", "MN": "D12.776.860.300.716", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "AN": "Do not confuse with OSTEOCALCIN.", "MS": "A 79-residue, vitamin K-dependent protein containing a single disulfide bond & 4.8 gamma-carboxyglutamate (Gla) residues.", "PM": "2024: MATRIX GLA PROTEIN was indexed under EXTRACELLULAR MATRIX PROTEINS and CALCIUM-BINDING PROTEINS 1986-2023", "HN": "2024 (1986)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097568"}, {"RECTYPE": "D", "MH": "Cefpirome", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cefpirome Sulfate|T109|T195|NON|NRW|NLM (2024)|230412|abbcdef", "ENTRY": "Sulfate, Cefpirome", "MN": "D03.633.100.300.249.181", "MH_TH": "NLM (2024)", "ST": "T195", "RN": "S72Q2F09HY", "MS": "A fourth-generation cephalosporin antibacterial agent. Appears to be more active in vitro against Staphylococci, some Enterococci, some ENTEROBACTERIACEAE, and PSEUDOMONAS AERUGINOSA.Cefpirome has a pyridinium group attached to C-3 position of its cephalosporin core.", "PM": "2024; CEFPIROME was indexed under CEPHALOSPORINS 1983-2023", "HN": "2024 (1983)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097572"}, {"RECTYPE": "D", "MH": "Red Fluorescent Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "dsFP593|T116|T123|EQV|NLM (2000)|000928|abbdef", "MN": "D12.776.532.755", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "Protein analogs and derivatives of the Disocosoma red fluorescent protein that emit a red-orange light (FLUORESCENCE) when excited with ULTRAVIOLET RAYS. They are used as REPORTER GENES and FLUORESCENT PROBES for MICROSCOPY of living cells and organisms.", "PM": "2024: RED FLUORESCENT PROTEIN was indexed under LUMINESCENT PROTEINS 2000-2023.", "HN": "2024 (2000)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097573"}, {"RECTYPE": "D", "MH": "Eukaryotic Translation Initiation Factor 5A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Eukaryotic Initiation Factor-4D|T116|T123|NON|EQV|NLM (2024)|230427|abbcdef", "ENTRY": "eIF5A protein|T116|T123|EQV|NLM (2002)|020522|abbdef", "MN": "D12.776.835.725.868.750.500", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A component of eukaryotic initiation factor 5A that is involved in the elongation, termination, and stimulation of peptide bond formation. This factor is essential for cell proliferation", "PM": "2024: EUKARYOTIC TRANSLATION INITIATION FACTOR 5A was indexed under PEPTIDE INITIATION FACTORS and RNA-BINDING PROTEINS 1980-2023", "HN": "2024", "MR": "20230613", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097574"}, {"RECTYPE": "D", "MH": "Homeobox Protein PITX2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pituitary Homeobox 2 Protein|T116|T123|NON|EQV|NLM (2024)|230427|abbcdef", "MN": "D12.776.930.320", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "184787-43-7", "MS": "A homeodomain transcription factor involved in cardiac development.", "PM": "2024: HOMEOBOX PROTEIN PITX2 was indexed under TRANSCRIPTION FACTORS and HOMEODOMAIN PROTEINS 1996-2023", "HN": "2024 (1996)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097577"}, {"RECTYPE": "D", "MH": "Fire Ants", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Solenopsis richteri|T204|NON|NRW|NLM (2024)|230407|abcdef", "ENTRY": "Imported Fire Ant", "MN": "B01.050.500.131.617.720.500.500.875.205.500", "MH_TH": "NLM (2024)", "ST": "T204", "RR": "txid30203", "PI": "Ants (1963-2023)", "MS": "Two members of ant genus Solenopsis in the family Formicidae, order Hymenoptera, accidentally introduced into the United States at Mobile, Alabama. Fire ants are now found in many states from California to Florida. Fire ant bites typically cause a burning sensation, welts and blisters but can cause systemic or life-threatening reactions.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097582"}, {"RECTYPE": "D", "MH": "Ceftaroline", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Zinforo|T109|TRD|NRW|NLM (2024)|230407|abcdef", "ENTRY": "TAK 599", "MN": "D03.633.100.300.249.186", "MH_TH": "NLM (2024)", "ST": "T195", "RN": "H36Z0FHR8K", "MS": "A fifth-generation cephalosporin antibacterial agent that is used to treat skin infections caused by bacteria in adults and newborns. Ceftaroline has a 1,3-thiazolidine ring attached to the C-7 position of its cephalosporin core.", "PM": "2024; CEFTAROLINE was indexed under CEPHALOSPORINS 2004-2023", "HN": "2024 (2004)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097583"}, {"RECTYPE": "D", "MH": "DNA Methyltransferase 3B", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.913.555.500.350.100.500.625", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "0", "RR": "EC 2.1.1.37", "MS": "A DNA (cytosine 5) Methyltransferase that has an essential role in the establishment of DNA methylation patterns during development.", "PM": "2024: DNA METHYLTRANSFERASE 3B was indexed under DNA (CYTOSINE-5-)-METHYLTRANSFERASES 1999-2023", "HN": "2024 (1999)", "MR": "20230613", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097584"}, {"RECTYPE": "D", "MH": "SS-B Antigen", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Sjogren's Syndrome-B Antigen|T116|T129|NON|EQV|NLM (2024)|230508|abbcdef", "ENTRY": "SS B Antigen", "MN": "D23.050.422.875", "MH_TH": "NLM (2024)", "ST": "T129", "RN": "0", "MS": "Nuclear autoantigens implicated in nascent RNA protection. It is a target of AUTOANTIBODIES in patients with SJOGREN'S SYNDROME.", "PM": "2024: SS-B ANTIGEN was indexed under AUTOANTIGENS and RIBONUCLEOPROTEINS 1982-2023, and under ANTIGENS 1982-1985", "HN": "2024 (1982)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097585"}, {"RECTYPE": "D", "MH": "Cefozopran", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cefozopran Hydrochloride|T109|NON|NRW|NLM (2024)|230531|abcdef", "ENTRY": "SCE2787", "MN": "D03.633.100.300.249.179", "MH_TH": "NLM (2024)", "ST": "T195", "RN": "1LG87K28LW", "MS": "A fourth-generation cephalosporin antibacterial agent with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. Cefozopran has a 1-methyltetrazolethiol (MTT) moiety at C-3 of its cephalosporin core.", "PM": "2024; CEFOZOPRAN was indexed under CEPHALOSPORINS 1991-2023", "HN": "2024 (1991)", "MR": "20230706", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097586"}, {"RECTYPE": "D", "MH": "Sterol O-Acyltransferase 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SOAT2 Protein|T116|T126|NON|EQV|NLM (2024)|230526|abbcdef", "MN": "D08.811.913.050.799.500", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 2.3.1.26", "RR": "EC 2.3.1.26", "MS": "A sterol O-acyltransferase that catalyzes reaction of Acyl-CoA and cholesterol into CoA and cholesterol ester. It is a distinct enzyme from Acetyl-CoA C-Acetyltransferase 2, which is also referred to as ACAT2.", "PM": "2024: STEROL O-ACYLTRANSFERASE 2 was indexed under STEROL O-ACYLTRANSFERASE 2001-2023", "HN": "2024 (2001)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097587"}, {"RECTYPE": "D", "MH": "Cefiderocol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fetroja|T109|TRD|NRW|NLM (2024)|230410|abcdef", "ENTRY": "S649266", "MN": "D27.720.832.500.410.750.500", "MH_TH": "NLM (2024)", "ST": "T195", "RN": "SZ34OMG6E8", "MS": "A siderophore cephalosporin with enhanced activity against GRAM-NEGATIVE AEROBIC BACTERIA.", "PM": "2024; CEFIDEROCOL was indexed under CEPHALOSPORINS 2016-2023", "HN": "2024 (2016)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097602"}, {"RECTYPE": "D", "MH": "Dyrk Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 4B|T116|T126|NON|NRW|NLM (2024)|230427|abbcdef", "ENTRY": "Kinases, Dyrk", "MN": "D12.776.476.568.037", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 2.7.1.-", "MS": "PROTEIN KINASES that can phosphorylate aromatic amino acid residue TYROSINE as well as aliphatic amino acid residues SERINE and THREONINE.", "PM": "2024: DYRK KINASE was indexed under PROTEIN-TYROSINE KINASES and PROTEIN SERINE-THREONINE KINASES 2001-2023, and under PROTEIN KINASES 1996-2000", "HN": "2024 (1996)", "MR": "20230613", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097603"}, {"RECTYPE": "D", "MH": "Ficolins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "M-Ficolin|T116|T123|NON|NRW|NLM (2024)|230427|abbcdef", "MN": "D12.776.503.210", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "Soluble oligomeric defense proteins with lectin-like activity. They initiate the LECTIN pathway of COMPLEMENT ACTIVATION through attached serine proteases and a primitive OPSONIZATION.", "PM": "2024: FICOLIN was indexed under LECTINS 2004-2023, and under CARRIER PROTEINS 1993-2004", "HN": "2024 (1993)", "MR": "20230613", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097604"}, {"RECTYPE": "D", "MH": "Sigma-1 Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptor 1, Sigma|T116|T192|NON|EQV|NLM (2024)|230427|abbcdef", "MN": "D12.776.543.750.750.555.610.775.500", "MH_TH": "NLM (2024)", "ST": "T192", "RN": "0", "MS": "A sigma receptor that regulates neuroinflammation, neurotransmitters, neurogenesis, ENDOPLASMIC RETICULUM stress and MITOCHONDRIA function.", "PM": "2024: SIGMA-1 RECEPTOR was indexed under RECEPTORS, SIGMA 1997-2023", "HN": "2024 (1997)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097605"}, {"RECTYPE": "D", "MH": "Exportin 1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Exportin 1|T116|T192|NON|EQV|NLM (2024)|230427|abbcdef", "ENTRY": "XPO1 protein|T116|T192|EQV|NLM (1992)|abbde", "MN": "D12.776.826.090", "MH_TH": "NLM (2024)", "ST": "T192", "RN": "0", "MS": "A karyopherin that functions in nuclear export of proteins and several classes of RNAs.", "PM": "see KARYOPHERINS 2021-2023", "HN": "2024: use KARYOPHERINS 2021-2023", "MR": "20230609", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097606"}, {"RECTYPE": "D", "MH": "Homeobox Protein SIX3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sine Oculis Homeobox Homolog 3 Protein|T116|T123|NON|EQV|NLM (2024)|230508|abbcdef", "MN": "D12.776.631.530", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A homeodomain protein that functions in embryonic eye and forebrain development.", "PM": "2024: SINE OCULIS HOMEOBOX HOMOLOG 3 PROTEIN was indexed under EYE PROTEINS and NERVE TISSUE PROTEINS and HOMEODOMAIN PROTEINS 1996-2023", "HN": "2024 (1996)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097607"}, {"RECTYPE": "D", "MH": "UDP Xylose-Protein Xylosyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-D-Xylosyltransferase|T116|T126|NON|EQV|NLM (2024)|230427|abbcdef", "ENTRY": "UDPxylosyltransferase|T116|T126|NRW|NLM (1977)|abbde", "MN": "D08.811.913.400.725.925", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 2.4.2.26", "RR": "EC 2.4.2.26", "MS": "A pentosyltransferase that initiates a series of post-translational modifications necessary for transport and secretion of proteoglycans. It is a key enzyme for glycosylation of the proteoglycan core.", "PM": "2024: UDP XYLOSE-PROTEIN XYLOSYLTRANSFERASE was indexed under PENTOSYLTRANSFERASES 1980-2023, and under CHONDROITIN 1975-1980, and under UDP SUGARS 1974-1975, and under UDP XYLOSE 1975-1980, and under XYLOSE 1974-1975; UDPXYLOSYLTRANSFERASE was indexed under PENTOSYLTRANSFERASES 1982-2023, and under URIDINE DIPHOSPHATE XYLOSE 1977-1982", "HN": "2024 (1974)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097608"}, {"RECTYPE": "D", "MH": "Haemaphysalis longicornis", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Long Horned Tick|T204|NON|EQV|NLM (2024)|230411|abcdef", "ENTRY": "Tick, Long Horned", "MN": "B01.050.500.131.166.132.832.400.313", "MH_TH": "NLM (2024)", "ST": "T204", "RN": "txid44386", "PI": "Ticks (1973-2023)", "MS": "A species of tick (TICKS) in the family IXODIDAE, distributed in AUSTRALASIA but establishing in the Eastern UNITED STATES. It is an aggressive biter and can cause severe infestations in livestock. It is also a known/suspected vector of various livestock and human diseases.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097622"}, {"RECTYPE": "D", "MH": "Cefpodoxime", "PRINT ENTRY": "Cefpodoxime Sodium Salt|T109|T195|NON|EQV|NLM (2024)|230411|abbcdef", "ENTRY": "U76,253A", "MN": "D03.633.100.300.249.176", "MH_TH": "NLM (2024)", "ST": "T195", "RN": "7R4F94TVGY", "MS": "A third-generation cephalosporin antibiotic. Cefpodoxime contains a methoxy group at C-3 of its cephalosporin core.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097623"}, {"RECTYPE": "D", "MH": "Rabphilin-3A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.631.656", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A putative target protein for RAB3A GTP-BINDING PROTEIN. Implicated in regulated secretion, particularly in neurotransmitter release.", "PM": "2024: RABPHILIN-3A was indexed under NERVE TISSUE PROTEINS and VESICULAR TRANSPORT PROTEINS and ADAPTOR PROTEINS, SIGNAL TRANSDUCING 2006-2023, and under RAB-GTP-BINDING PROTEINS 2000-2005, and under GTP-BINDING PROTEINS 1993-1999.", "HN": "2024 (1993)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097624"}, {"RECTYPE": "D", "MH": "HLA-E Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "HLA E Antigens|T116|T129|NON|EQV|NLM (2024)|230508|abbcdef", "ENTRY": "HLA-E*01:03 antigen|T116|T129|NRW|NLM (2012)|110525|abbdef", "MN": "D23.050.705.552.100.850", "MH_TH": "NLM (2024)", "ST": "T129", "RN": "0", "MS": "Class I human histocompatibility (HLA) antigens encoded by genes at the E locus on chromosome 6. They bind a restricted subset of peptides derived from the leader peptides of other class I molecules. They primarily are involved with down-regulating cytolytic activity of NK CELLS and restricting non-canonical CD8-POSITIVE T LYMPHOCYTES.", "PM": "2024: HLA-E ANTIGEN was indexed under HISTOCOMPATIBILITY ANTIGENS CLASS I 1989-2023, and under HLA ANTIGENS 1988-1988", "HN": "2024 (1988)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097625"}, {"RECTYPE": "D", "MH": "Cefpodoxime Proxetil", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "U-76252|T109|T195|LAB|NRW|NLM (2024)|230411|abbcdef", "ENTRY": "U76252", "MN": "D03.633.100.300.249.176.500", "MH_TH": "NLM (2024)", "ST": "T195", "RN": "2TB00A1Z7N", "MS": "A prodrug of its active metabolite CEFPODOXIME.", "PM": "2024; CEFPODOXIME PROXETIL was indexed under CEFTIZOXIME 1987-2023 and CEPHALOSPORINS 1987-1989", "HN": "2024 (1987)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097627"}, {"RECTYPE": "D", "MH": "Chemokine Receptor D6", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "D6 Chemokine Receptor|T116|T126|NON|EQV|NLM (2024)|230427|abbcdef", "ENTRY": "Receptor, D6 Chemokine", "MN": "D12.776.543.750.705.852.125.150.050", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "0", "PI": "Receptors, Chemokine (1998-2023)", "MS": "A broad-specificity receptor for inflammatory CC CHEMOKINE.", "PM": "2024", "HN": "2024", "MR": "20230613", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097628"}, {"RECTYPE": "D", "MH": "Nociceptin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Orphanin FQ|T116|T123|NON|EQV|NLM (2024)|230427|abbcdef", "MN": "D12.776.631.650.575.640", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "7AYI9N34FF", "MS": "A pronociceptive peptide that acts as a specific endogenous agonist to the NOCICEPTIN RECEPTOR.", "PM": "NOCICEPTIN was indexed under OPIOID PEPTIDES 1995-2023", "HN": "2024 (1995)", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097629"}, {"RECTYPE": "D", "MH": "Inosine Triphosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Inosine Triphosphate Pyrophosphohydrolase|T116|T126|NON|EQV|NLM (2024)|230427|abbcdef", "ENTRY": "ITPase|T116|T126|EQV|NLM (1975)|abbde", "MN": "D08.811.277.040.600.500", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 3.6.1.-", "MS": "A pyrophosphatase that catalyzes the conversion of inosine triphosphate and deoxy-inosine triphosphate to inosine monophosphate and deoxy-inosine monophosphate, respectively.", "PM": "2024: INOSINE TRIPHOSPHATASE was indexed under PYROPHOSPHATASES 1983-2023, and under PHOSPHODIESTERASES and PYROPHOSPHATASES and INOSINE NUCLEOTIDES 1975-1979, and under INOSINE TRIPHOSPHATE 1975-1982", "HN": "2024 (1975)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097630"}, {"RECTYPE": "D", "MH": "Galactoside 2-alpha-L-fucosyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Secretor Blood Group alpha-2-fucosyltransferase|T116|T126|NON|NRW|NLM (2024)|230508|abbcdef", "ENTRY": "beta-galactoside alpha1,2-fucosyltransferase|T116|T126|EQV|NLM (1977)|abbde", "MN": "D08.811.913.400.450.300.500", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 2.4.1.69", "MS": "Catalyzes the transfer of L-fucose to the terminal galactose residue of glycoconjugates through an alpha-(1,2) linkage leading to H antigen synthesis.", "PM": "2024: GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE was indexed under FUCOSYLTRANSFERASES 1980-2023, and under HEXOSYLTRANSFERASES 1977-1979", "HN": "2024 (1977)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097631"}, {"RECTYPE": "D", "MH": "GADD45 Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Growth Arrest and DNA-Damage-Inducible 45 gamma Protein|T116|T123|NON|NRW|NLM (2024)|230508|abbcdef", "MN": "D12.776.660.338", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "Nuclear proteins that act as critical stress sensors that mediate various cellular responses, including DNA REPAIR; CELL CYCLE ARREST; and APOPTOSIS.", "PM": "2024: GADD45 PROTEIN was indexed under INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 2005-2023, and under PROTEINS 1994-2005", "HN": "2024 (1994)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097642"}, {"RECTYPE": "D", "MH": "Dexpramipexole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "R-(+)-Pramipexole|T109|T121|NON|EQV|NLM (2024)|230412|abbcdef", "ENTRY": "SND919CL2x|T109|T121|LAB|NRW|NLM (2006)|060330|abbcdef", "MN": "D03.633.100.185.111", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "WI638GUS96", "MS": "The (R)-(+) enantiomer of PRAMIPEXOLE. Dexpramipexole has lower affinity for DOPAMINE RECEPTORS than pramipexole.", "PM": "2024; see PRAMIPEXOLE 2019-2023", "HN": "2024; use PRAMIPEXOLE 2019-2023", "MR": "20230615", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097662"}, {"RECTYPE": "D", "MH": "Lobesia botrana", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "European Grapevine Moth|T204|EPO|EQV|NLM (2024)|230412|abcdef", "ENTRY": "Moth, European Grapevine", "MN": "B01.050.500.131.617.720.500.500.937.650.313", "MH_TH": "NLM (2024)", "ST": "T204", "RN": "txid209534", "PI": "Moths (1974-2023)", "MS": "A species of tortrix or leafroller moths of the family Tortricidae. These insects cause significant agricultural damage throughout the world feeding on the flower or fruit of host plants, most often grapes (VITIS VINIFERA).", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097663"}, {"RECTYPE": "D", "MH": "Flighted Spongy Moth Complex", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Porthetria umbrosa|T204|NON|NRW|NLM (2024)|230412|abcdef", "ENTRY": "Spongy Moth, Asian", "MN": "B01.050.500.131.617.720.500.500.937.650.050", "MH_TH": "NLM (2024)", "ST": "T204", "RR": "txid871934", "MS": "Asian moths known to cause extensive damage in trees and shrubs by defoliation. Flighted spongy moth complex females are active fliers unlike spongy moths of European origin, enabling their rapid spread.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097664"}, {"RECTYPE": "D", "MH": "Helicoverpa armigera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Tobacco Budworm|T204|NON|EQV|NLM (2024)|230412|abcdef", "ENTRY": "Worm, Corn Ear", "MN": "B01.050.500.131.617.720.500.500.937.650.207", "MH_TH": "NLM (2024)", "ST": "T204", "PI": "Moths (1993-2023)", "MS": "Widely distributed old world bollworm which bore into the wide variety of host\u2019s flowers and fruit and feed within the plant. Old world bollworm was detected in Puerto Rico in 2014 and Florida in 2015 but now eradicated in the United States.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097666"}, {"RECTYPE": "D", "MH": "Polyamine Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Spermine Oxidase|T116|T126|NON|EQV|NLM (2024)|230427|abbcdef", "MN": "D08.811.682.662.611", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 1.5.3.-", "MS": "An FAD-dependent enzyme in the polyamine catabolism pathway that generates hydrogen peroxide. Present with high activity in most tissues of vertebrate organisms.", "PM": "2024: POLYAMINE OXIDASE was indexed under OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS 1980-2023, and under POLYAMINES 1977-1980", "HN": "2024 (1977)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097667"}, {"RECTYPE": "D", "MH": "Pseudomonas aeruginosa Exotoxin A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ToxA protein, Pseudomonas aeruginosa|T116|T126|NON|EQV|NLM (2024)|230427|abbcdef", "ENTRY": "PE40 toxin|T116|NRW|NLM (2022)|220829|abdef", "MN": "D23.946.896.245", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 2.4.2.31", "MS": "An NAD-dependent ADP-ribosyltransferase that catalyzes the transfer of the ADP ribosyl moiety of oxidized NAD onto elongation factor 2 (EF-2) thus arresting protein synthesis. Commonly used as the toxin in immunotoxins.", "PM": "PSEUDOMONAS AERUGINOSA EXOTOXIN A was indexed under BACTERIAL TOXINS, EXOTOXINS, ADP RIBOSE TRANSFERASES and VIRULENCE FACTORS 2022-2023", "HN": "2024 (2022)", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097668"}, {"RECTYPE": "D", "MH": "Dammaranes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dammarane-Type Triterpenes|T109|NON|EQV|NLM (2024)|230508|abcdef", "ENTRY": "Triterpenes, Dammarane-Type", "MN": "D02.455.849.919.208", "MH_TH": "NLM (2024)", "ST": "T109", "RN": "0", "RR": "M2KL5345JT", "MS": "Tetracyclic triterpenes named after dammar resin, a natural resin first isolated from tropical trees of the DIPTEROCARPACEAE family.", "PM": "2024: DAMMARANE was indexed under TRITERPENES 2001-2023, and under STEROIDS 1997-2001.", "HN": "2024 (1997)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097669"}, {"RECTYPE": "D", "MH": "Cefprozil", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cefprozil Sulfate|T121|T195|NON|BRD|NLM (2024)|230412|abbcdef", "ENTRY": "Sulfate, Cefprozil", "MN": "D03.633.100.300.249.183", "MH_TH": "NLM (2024)", "ST": "T121", "RN": "4W0459ZA4V", "MS": "A second-generation cephalosporin antibacterial agent. Cefprozil has a phenyl ring at the C-3 position of its cephalosporin core.", "PM": "2024; CEFPROZIL was indexed under CEPHALOSPORINS 1987-2023", "HN": "2024 (1987)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097670"}, {"RECTYPE": "D", "MH": "Lamin B Receptor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p58 Receptor, Lamin B|T116|T192|NON|EQV|NLM (2024)|230427|abbcdef", "ENTRY": "Receptor, Lamin B", "MN": "D12.776.826.187", "FX": "Receptors, KIR", "MH_TH": "NLM (2024)", "ST": "T192", "RN": "0", "MS": "A 58 kDa membrane protein and delta(14)-sterol reductase that is found in the NUCLEAR ENVELOPE. Deficiencies of this receptor cause PELGER-HUET ANOMALY.", "PM": "2024: LAMIN B RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1990-1993, and under RECEPTORS, CYTOPLASMIC AND NUCLEAR 1993-2023", "HN": "2024 (1990)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097682"}, {"RECTYPE": "D", "MH": "Poison Frogs", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Venomous Frogs|T011|NON|REL|NLM (2024)|230413|abcdef", "ENTRY": "Venomous Frog", "MN": "B01.050.150.900.090.180.659", "MH_TH": "NLM (2024)", "ST": "T011", "PI": "Anura (1963-2023)", "MS": "Frogs that sequester and secrete POISONS (e.g., BATRACHOTOXINS). Poison frogs include Australian\u00a0Pseudophryne, Central and South American\u00a0Dendrobates, Epipedobates, and\u00a0Phyllobates and Madagascan Mantella. Melanophyrniscus\u00a0is a poison toad in the family of Bufonidae.\u00a0All poison dart frogs are from rain forest of western Colombia and are members of Phyllobates.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097702"}, {"RECTYPE": "D", "MH": "Cohesins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cohesin Protein Complex|T116|T123|NON|NRW|NLM (2024)|230427|abbcdef", "MN": "D12.776.664.235.350", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "Protein complex constituents that bind chromosomes from late G1 until the metaphase - anaphase transition. The cohesin complex regulates sister chromatid cohesion, HOMOLOGOUS RECOMBINATION and DNA looping.", "PM": "2024: COHESINS was indexed under CHROMOSOMAL PROTEINS, NON-HISTONE and CELL CYCLE PROTEINS 2008-2023, and under FUNGAL PROTEINS 1999-2006, and under NUCLEAR PROTEINS 1999-2008", "HN": "2024 (1999)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097722"}, {"RECTYPE": "D", "MH": "Myokines", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Myokine|T116|T123|NON|EQV|NLM (2024)|230509|abbcdef", "MN": "D23.529.841", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "PI": "Cytokines (2007-2023)", "MS": "Signaling proteins that are synthesized and released by muscle fibers in response to exercise or other forms of physical activity.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097724"}, {"RECTYPE": "D", "MH": "Patient-Ventilator Asynchrony", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Patient-Ventilator Dyssynchrony|T046|NON|EQV|NLM (2024)|230417|abcdef", "ENTRY": "Patient Ventilator Dyssynchrony", "MN": "C23.888.852.770", "MH_TH": "NLM (2024)", "ST": "T046", "PI": "Respiration, Artificial (1999-2023)", "MS": "A time mismatch between patient's inspiratory effort and MECHANICAL VENTILATOR's inspiratory time.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097742"}, {"RECTYPE": "D", "MH": "Parthenium hysterophorus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Santa Maria Feverfew|T002|EPO|EQV|NLM (2024)|230417|abcdef", "ENTRY": "Feverfew, Santa Maria", "MN": "B01.875.800.575.912.250.100.519", "FX": "Tanacetum parthenium", "MH_TH": "NLM (2024)", "ST": "T002", "RN": "txid183063", "PI": "Asteraceae (1994-2023)", "MS": "An annual species in the family ASTERACEA, genus Parthenium which sometimes is referred to as feverfew, not to be confused with the medicinal herb often cultivated in the garden, TANACETUM PARTHENIUM. Parthenium hysterophorus is an invasive allelopathic weed indigenous to the Caribbean, Central and South America and has similar rosette stage structures as COMMON RAGWEED. It contains sesquiterpene lactones including parthenin which is poisonous to grazing animals and allergenic and irritant, causing Parthenium dermatitis in humans.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097762"}, {"RECTYPE": "D", "MH": "Polypeptide N-acetylgalactosaminyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein-UDPacetylgalactosaminyltransferase|T116|T126|NON|EQV|NLM (2024)|230508|abbcdef", "ENTRY": "Synthase, Globoside", "MN": "D08.811.913.400.100.200.650", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 2.4.1.41", "MS": "Family of enzymes that catalyze the formation of GalNAcAlpha1-serine/threonine linkages in glycoproteins.", "PM": "2024: POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE was indexed under N-ACETYLGALACTOSAMINYLTRANSFERASES 1992-2023, and under GALACTOSYLTRANSFERASES 1977-1992, and under HEXOSYLTRANSFERASES and GALACTOSAMINE 1972-1977, and under TRANSFERASES and GALACTOSE and HEXOSAMINES 1970-1972", "HN": "2024 (1970)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097763"}, {"RECTYPE": "D", "MH": "ETS Translocation Variant 6 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ETS Variant Gene 6 (TEL Oncogene) Protein|T116|T123|NON|EQV|NLM (2024)|230427|abbcdef", "MN": "D12.776.930.780.766", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A transcriptional repressor in the ETS transcription factor family. Contains a unique ETS domain and HLH domain that can interfere with protein-protein interactions.", "PM": "2024: ETS TRANSLOCATION VARIANT 6 PROTEIN was indexed under REPRESSOR PROTEINS and PROTO-ONCOGENE PROTEINS C-ETS 2005-2023, and DNA-BINDING PROTEINS and NUCLEAR PROTEINS 1994-2005, and under TRANSCRIPTION FACTORS 1994-2001", "HN": "2024 (1994)", "MR": "20230613", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097764"}, {"RECTYPE": "D", "MH": "Puberty Suppression", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD", "PRINT ENTRY": "Puberty Blocking|T061|NON|EQV|NLM (2024)|230417|abcdef", "ENTRY": "Suppressions, Puberty", "MN": "N05.300.361.250", "MH_TH": "NLM (2024)", "ST": "T061", "MS": "A non-intensive, reversible medical intervention achieved by using compounds that mimic the actions of GONADOTROPIN-RELEASING HORMONE (GnRH), which in turn slows or stops the physical changes associated with puberty such as the development of breasts or facial hair.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097765"}, {"RECTYPE": "D", "MH": "RAC2 GTP-Binding Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.338.400.700.100.750", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 3.6.1.-", "MS": "A small rac GTP-binding protein that forms one of the components of the NADPH oxidase enzyme system.", "PM": "2024: RAC2 GTP-BINDING PROTEIN was indexed under RAC GTP-BINDING PROTEINS 2000-2023, and under GTP-BINDING PROTEINS 1991-1999.", "HN": "2024 (1991)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097766"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase Kinase Kinase 11", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mixed Lineage Kinase-3|T116|T126|NON|EQV|NLM (2024)|230427|abbcdef", "MN": "D12.776.476.563.554.650", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 2.7.11.25", "MS": "A MAP kinase kinase kinase that activates the SAPK/JNK and p38/ERK SIGNAL TRANSDUCTION pathways. It has multiple interaction domains, including a Cdc42 binding motif.", "PM": "2024: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 11 was indexed under MAP KINASE KINASE KINASES 2000-2023, and under PROTEIN-SERINE-THREONINE KINASES 1997-1999", "HN": "2024 (1997)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097767"}, {"RECTYPE": "D", "MH": "Retinoic Acid Receptor gamma", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "RAR gamma3|T116|T192|NRW|NLM (2000)|001025|abbdef", "MN": "D12.776.930.775.375", "MH_TH": "NLM (2024)", "ST": "T192", "RN": "0", "MS": "A retinoic acid receptor that regulates transcriptional activity by heterodimerizing with nuclear RETINOID X RECEPTORS.", "PM": "2024: RETINOIC ACID RECEPTOR GAMMA was indexed under RECEPTORS, RETINOIC ACID 1993-2023.", "HN": "2024 (1993)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097768"}, {"RECTYPE": "D", "MH": "Puberty Inhibitors", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Puberty Blockers|T121|NON|EQV|NLM (2024)|230417|abcdef", "ENTRY": "Inhibitors, Puberty", "MN": "D27.505.696.399.450.783", "MH_TH": "NLM (2024)", "ST": "T121", "RN": "0", "MS": "Agents that are used to temporarily suppress puberty in adolescents.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097770"}, {"RECTYPE": "D", "MH": "NF-kappaB-Inducing Kinase", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nuclear Factor kappa B Kinase|T116|T126|NON|EQV|NLM (2024)|230418|abbcdef", "ENTRY": "Protein, NIK", "MN": "D12.776.476.563.579", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 2.7.11.25", "MS": "A protein serine-threonine kinase that catalyzes the activation of canonical and non-canonical NF-kappaB pathways.", "PM": "2024; NF-KAPPAB-INDUCING KINASE was indexed under PROTEIN SERINE-THREONINE KINASES 1994-2023", "HN": "2024 (1994)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097782"}, {"RECTYPE": "D", "MH": "Altmetrics", "AQ": "HI", "PRINT ENTRY": "Altmetrics Score|T081|NON|REL|NLM (2024)|230526|abcdef", "ENTRY": "Study, Almetric", "MN": "L01.462.750.183.291.250", "MH_TH": "NLM (2024)", "ST": "T062", "PI": "Bibliometrics (2013-2023)", "MS": "Non-traditional journal impact measures that include tracking of downloads; mentions in SOCIAL MEDIA, NEWS reports, BLOGS, and online ENCYCLOPEDIAS; links in bookmarking services and online reference managers; and crowd-based reviews.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097783"}, {"RECTYPE": "D", "MH": "Metabolic Reprogramming", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Metabolism Reprogramming|T039|NON|EQV|NLM (2024)|230418|abcdef", "ENTRY": "Reprogramming, Metabolism", "MN": "G05.135.500", "MH_TH": "NLM (2024)", "ST": "T039", "MS": "Various cellular responses cells undergo in order to sustain energy production under cellular METABOLIC STRESS. Oncogenic metabolic reprogramming is one of the hallmarks of cancer progression and metastasis.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097784"}, {"RECTYPE": "D", "MH": "Forensic Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Forensic Radiology|T059|NON|NRW|NLM (2024)|230418|abcdef", "ENTRY": "Radiology, Forensic", "MN": "I01.198.780.922", "FX": "Postmortem Imaging", "MH_TH": "NLM (2024)", "ST": "T059", "MS": "The use of various imaging and image enhancement techniques in forensic investigative disciplines. It often includes FORENSIC MEDICINE platforms such as X-RAYS; CT XRAY; and MRI.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097785"}, {"RECTYPE": "D", "MH": "Soft Computing", "AQ": "CL EC ES HI IS LJ MT OG SD SN ST TD", "MN": "L01.224.850", "MH_TH": "NLM (2024)", "ST": "T066", "PI": "Algorithms (1987-2023)", "MS": "Computing that deals with approximate models and gives solutions to complex real-life problems. Has greater tolerance for imprecision, uncertainty, partial truth, and approximations. Based on techniques such as FUZZY LOGIC, genetic algorithms, NEURAL NETWORKS, COMPUTER, MACHINE LEARNING, and EXPERT SYSTEMS.", "PM": "2024", "HN": "2024", "MR": "20230609", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097786"}, {"RECTYPE": "D", "MH": "Incarceration", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Solitary Confinement of Prisoners|T068|NON|REL|NLM (2024)|230526|abcdef", "ENTRY": "Prisoners Solitary Confinements", "MN": "I01.880.735.433", "MH_TH": "NLM (2024)", "ST": "T068", "PI": "Prisoners (1963-2023)", "MS": "The state of being imprisoned or confined.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097787"}, {"RECTYPE": "D", "MH": "Academia", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "MN": "I02.079", "MH_TH": "NLM (2024)", "ST": "T057", "MS": "The environment concerned with the pursuit of research, education, and scholarship.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097788"}, {"RECTYPE": "D", "MH": "Glucagon-Like Peptide-1 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Incretin Mimetics|T109|T121|NON|EQV|NLM (2024)|230418|abbcdef", "ENTRY": "Glucagon Like Peptide 1 Receptor Agonists", "MN": "D27.505.696.422.125", "MH_TH": "NLM (2024)", "ST": "T121", "RN": "0", "PI": "Glucagon-Like Peptide-1 Receptor (1993-2023)", "MS": "Compounds that stimulate the activity of GLUCAGON-LIKE PEPTIDE-1 RECEPTOR. Glucagon-like peptide-1 receptor agonists are used to treat TYPE 2 DIABETES and OBESITY.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097789"}, {"RECTYPE": "D", "MH": "Secreted Aspartic Proteases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Secreted Aspartyl Proteases|T116|T126|NON|EQV|NLM (2024)|230418|abbcdef", "ENTRY": "Proteases, Secreted Aspartyl", "MN": "D08.811.277.656.074.500.890", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 3.4.23", "PI": "Aspartic Acid Endopeptidases (1998-2023)", "MS": "Enzymes that are produced and secreted by organisms, including bacterial and fungi.They are involved in a variety of biological processes, such as nutrient acquisition, pathogenesis of candida, and host tissue invasion.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097790"}, {"RECTYPE": "D", "MH": "Degrons", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "PEST Sequence|T087|NON|NRW|NLM (2024)|230505|abcdef", "ENTRY": "Sequences, PEST", "MN": "G02.111.570.820.709.275.625", "MH_TH": "NLM (2024)", "ST": "T087", "MS": "Minimal elements within a protein that are sufficient for recognition and degradation by a proteolytic apparatus. Inherent degrons are comprised of short linear amino acid sequences and secondary protein structural features that increase the affinity to E3 LIGASE; and are involved in regulating the specificity and timing of PROTEIN DEGRADATION. Acquired degrons are mostly transient and conferred by post-translational modifications of specific amino acids within proteins. (From Mol Cell. 2016 Sep 15;63(6):1055-65)", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097791"}, {"RECTYPE": "D", "MH": "Tissue Inhibitor of Metalloproteinase-4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tissue Inhibitor of Metalloproteinase 4|T116|T123|NON|EQV|NLM (2024)|230427|abbcdef", "MN": "D12.776.815.875.775", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "An inhibitor of matrix metalloproteinases involved in regulation of PLATELET AGGREGATION and recruitment.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097792"}, {"RECTYPE": "D", "MH": "Legumins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Legumin Protein|T116|T123|NON|EQV|NLM (2024)|230523|abbcdef", "ENTRY": "Protein, Legumin", "MN": "D12.776.765.510", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "CASEIN-like globular storage proteins from leguminous seeds such as peas.", "PM": "see LEGUMIN PROTEIN, PLANT 1978-2023", "HN": "2024: LEGUMINS was LEGUMIN PROTEIN, PLANT 1978-2023", "MR": "20230609", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097793"}, {"RECTYPE": "D", "MH": "Kalinin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nicein|T116|T123|NON|EQV|NLM (2024)|230508|abbcdef", "ENTRY": "LAMB3 protein|T116|T123|NRW|NLM (2004)|040620|abbdef", "MN": "D12.776.860.300.675.500", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "An epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. Consists of 3 subunits (A, B2, & B1).", "PM": "2024: KALININ was indexed under CELL ADHESION MOLECULES 1992-2023", "HN": "2024 (1992)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097794"}, {"RECTYPE": "D", "MH": "ATPase Inhibitory Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Na-K ATPase Inhibitor|T116|T123|NON|NRW|NLM (2024)|230427|abbcdef", "MN": "D12.776.575.140", "MH_TH": "NLM (2024)", "ST": "T121", "RN": "0", "MS": "CA(2+) MG(2+)-ATPASE inhibitor found in membranes of mammalian ERYTHROCYTES.", "PM": "2024: ATPASE INHIBITORY PROTEIN was indexed under PROTEINS 1982-2023, and under PLANT PROTEINS 1978-1982, and under ADENOSINE TRIPHOSPHATASE/antagonists&inhibitors 1978-1981", "HN": "2024 (1978)", "MR": "20230613", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097795"}, {"RECTYPE": "D", "MH": "Nucleolin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "C23 Protein|T116|T123|NON|EQV|NLM (2024)|230612|abbcdef", "MN": "D12.776.664.962.450", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "Phosphoprotein found in nucleoli, on the cell membrane, and in cytoplasm of all higher eukaryotes. They act as a receptor for some viruses, bacteria, and toxins.", "PM": "2024: NUCLEOLIN was indexed under RNA-BINDING PROTEINS and PHOSPHOPROTEINS 1998-2023, and under NUCLEAR PROTEINS 1986-1997, and under NUCLEOPROTEINS 1986-1987", "HN": "2024 (1986)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097796"}, {"RECTYPE": "D", "MH": "Glyphosate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Yerbimat|T109|T131|NON|NRW|NLM (2024)|230508|abbcdef", "ENTRY": "Roundup|T109|T131|TRD|NRW|NLM (1976)|abbcde", "MN": "D12.125.481.400", "MH_TH": "NLM (2024)", "ST": "T131", "RN": "4632WW1X5A", "RR": "40465-90-5", "MS": "Active compound in herbicidal formulations that inhibits 3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE.", "PM": "2024: GLYPHOSATE was indexed under GLYCINE/analogs&derivatives 1976-2023", "HN": "2024 (1976)", "MR": "20230828", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097797"}, {"RECTYPE": "D", "MH": "Food Loss and Waste", "AQ": "AE AN CL EC ST", "PRINT ENTRY": "Food Waste and Loss|T068|T069|NON|EQV|NLM (2024)|230418|abbcdef", "ENTRY": "Waste, Food", "MN": "N06.850.460.710.285", "MH_TH": "NLM (2024)", "ST": "T069", "RN": "0", "PI": "Food (1969-2023)", "MS": "Reductions in edible FOOD post-harvesting anywhere along the food supply chain, e.g., due to spoilage, improper storage, excessive food preparation, resulting in REFUSE DISPOSAL of potentially useful food mass.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097798"}, {"RECTYPE": "D", "MH": "CD83 Antigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cell Surface Protein HB15|T116|T129|NON|EQV|NLM (2024)|230419|abbcdef", "MN": "D23.101.100.110.783", "MH_TH": "NLM (2024)", "ST": "T129", "RN": "0", "MS": "A glycoprotein member of the immunoglobulin superfamily that is primarily expressed on the surface of DENDRITIC CELLS. It is believed to play a role in ANTIGEN PRESENTATION and CELL-TO-CELL INTERACTION following LYMPHOCYTE ACTIVATION.", "PM": "2024; CD83 ANTIGEN was index under IMMUNOGLOBULINS, MEMBRANE GLYCOPROTEINS and ANTIGENS,CD 1995-2023", "HN": "2024 (1995)", "MR": "20230530", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097802"}, {"RECTYPE": "D", "MH": "Ganglionic Eminence", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Ventricular Eminences|T018|NON|EQV|NLM (2024)|230419|abcdef", "ENTRY": "Ventricular Eminence", "MN": "A16.254.875", "MH_TH": "NLM (2024)", "ST": "T018", "MS": "A transitory embryonic structure that appears during the 5th week post-fertilization. The ganglionic eminence plays an important in the development of the nervous system by guiding tangential cell and axon migration during embryonic development and give rise to BASAL GANGLIA and cortical GABAergic and thalamic and olfactory INTERNEURONS.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097803"}, {"RECTYPE": "D", "MH": "Collagen Type XVII", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Type XVII Collagen|T116|T129|NON|EQV|NLM (2024)|230427|abbcdef", "MN": "D23.050.422.093", "MH_TH": "NLM (2024)", "ST": "T129", "RN": "0", "MS": "A 220 kDa non-fibrillar collagen and basement membrane component. It is involved in healing wounds of the EPITHELIUM, CORNEAL.", "PM": "2024: COLLAGEN TYPE XVII was indexed under AUTOANTIGENS and NON-FIBRILLAR COLLAGENS 2005-2023, and under COLLAGEN 1986-2004, and under ANTIGENS, SURFACE 1984-1985", "HN": "2024 (1984)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097805"}, {"RECTYPE": "D", "MH": "GluK2 Kainate Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Ionotropic Glutamate Receptor GluR6|T116|T192|NON|EQV|NLM (2024)|230427|abbcdef", "ENTRY": "Receptors, GluR6 Kainate", "MN": "D12.776.543.750.720.200.450.400.200.500", "MH_TH": "NLM (2024)", "ST": "T192", "RN": "0", "MS": "A high-affinity KAINATE and GLUTAMATE receptor that functions as ligand-gated ion channel in the CENTRAL NERVOUS SYSYEM and plays an essential role in NEURONAL PLASTICITY.", "PM": "2024: GLUK2 KAINATE RECEPTOR was indexed under RECEPTORS, KAINIC ACID 1996-2023", "HN": "2024 (1996)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097806"}, {"RECTYPE": "D", "MH": "Intracameral Injection", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Intracameral (IC) Injection|T061|ABX|EQV|NLM (2024)|230419|abcdef", "ENTRY": "Intracameral Injections", "MN": "E02.319.267.530.475.250", "MH_TH": "NLM (2024)", "ST": "T061", "MS": "A medical procedure in which medication is delivered directly into the ANTERIOR CHAMBER of the eye.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097807"}, {"RECTYPE": "D", "MH": "GluK3 Kainate Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "GluR7 Receptor|T116|T192|NON|EQV|NLM (2024)|230427|abbcdef", "ENTRY": "Receptor, GluR7", "MN": "D12.776.543.750.720.200.450.400.200.750", "MH_TH": "NLM (2024)", "ST": "T192", "RN": "0", "MS": "A high-affinity KAINATE and GLUTAMATE receptor that functions as ligand-gated ion channel in the CENTRAL NERVOUS SYSYEM and modulates excitatory synaptic transmission.", "PM": "2024: GLUK3 KAINATE RECEPTOR was indexed under RECEPTORS, KAINIC ACID 1995-2023", "HN": "2024 (1995)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097808"}, {"RECTYPE": "D", "MH": "Transcription Factor MTF-1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Metal-Responsive Transcription Factor-1|T116|T123|NON|EQV|NLM (2024)|230427|abbcdef", "MN": "D12.776.930.919", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A zinc dependent transcription factor involved in the regulation of intracellular signaling pathways. Regulates the expression of two streams of genes functioning in metal homeostasis and anti-oxidative response.", "PM": "2024: TRANSCRIPTION FACTOR MTF-1 was indexed under DNA-BINDING PROTEINS and TRANSCRIPTION FACTORS 1993-2023", "HN": "2024 (1993)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097809"}, {"RECTYPE": "D", "MH": "Thyroid Hormone-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Triiodothyronine-Binding Protein p55|T116|T123|NON|NRW|NLM (2024)|230508|abbcdef", "MN": "D12.776.543.935", "FX": "Thyroxine-Binding Proteins", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "AN": "Do not confuse with C-TERMINAL BINDING PROTEIN.", "MS": "Membrane-bound proteins found in the ENDOPLASMIC RETICULUM of CULTURED CELLS and NEOPLASMS. They were identified originally based on their capacity to bind THYROID HORMONE.", "PM": "2024: THYROID HORMONE-BINDING PROTEINS was indexed under CARRIER PROTEINS and MEMBRANE PROTEINS and THYROID HORMONES 1987-2023", "HN": "2024 (1987)", "MR": "20230822", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097810"}, {"RECTYPE": "D", "MH": "Carbohydrate Sulfotransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Keratan Sulfurtransferase|T116|T126|NON|NRW|NLM (2024)|230427|abbcdef", "ENTRY": "KSGal6ST|T116|T126|NRW|NLM (1999)|abbde", "MN": "D08.811.913.817.400.650", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "EC 2.8.2.-", "MS": "Transmembrane enzymes of the Golgi network that recognize glycans attached to LIPIDS and PROTEINS passing through the secretory pathway.", "PM": "2024: CARBOHYDRATE SULFOTRANSFERASES was indexed under SULFOTRANSFERASES 1999-2023", "HN": "2024 (1999)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097811"}, {"RECTYPE": "D", "MH": "Psychological Growth", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Stress-Related Growth|T055|NON|NRW|NLM (2024)|230419|abcdef", "ENTRY": "Stress Related Growth", "MN": "F01.058.736", "MH_TH": "NLM (2024)", "ST": "T055", "PI": "Adaptation, Psychological (1963-2023)", "MS": "A process of actively learning and adapting to new ways to function following a challenging life crisis.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097812"}, {"RECTYPE": "D", "MH": "Coping Skills", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Social Coping|T055|NON|NRW|NLM (2024)|230419|abcdef", "ENTRY": "Strategy, Coping", "MN": "F04.754.137.436", "MH_TH": "NLM (1992)", "ST": "T055", "MS": "Various techniques for actively managing a stressful event or situation.", "PM": "2024; see Adaptation, Psychological 1992-2023", "HN": "2024(1992)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097813"}, {"RECTYPE": "D", "MH": "Job Security", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "PRINT ENTRY": "Job Tenure|T080|NON|REL|NLM (2024)|230419|abcdef", "ENTRY": "Tenure, Job", "MN": "N01.824.245.475", "MH_TH": "NLM (2024)", "ST": "T080", "MS": "The extent to which job separations are involuntary. The primary measure of job security is the rate of job loss (https://www.bls.gov/osmr/research-papers/2002/pdf/ec020050.pdf).", "PM": "2024; for Employment Insecurity see Employment 2017-2023", "HN": "2024(2017)", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097814"}, {"RECTYPE": "D", "MH": "Emotional Exhaustion", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Emotional Fatigue|T055|NON|EQV|NLM (2024)|230419|abcdef", "ENTRY": "Fatigue, Emotional", "MN": "F02.830.900.459", "MH_TH": "NLM (2024)", "ST": "T055", "MS": "A state of feeling emotionally overextended and drained.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097815"}, {"RECTYPE": "D", "MH": "Media Exposure", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Social Media Exposure|T054|NON|NRW|NLM (2024)|230420|abcdef", "ENTRY": "Social Media Exposures", "MN": "L01.462.500.636", "MH_TH": "NLM (2024)", "ST": "T054", "PI": "Communications Media (1979-2023)", "MS": "The extent to which individuals encounter messages and content via COMMUNICATION MEDIA.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097822"}, {"RECTYPE": "D", "MH": "Role Conflict", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Role Strain|T055|NON|REL|NLM (2024)|230420|abcdef", "ENTRY": "Strain, Role", "MN": "F01.658.209.500", "MH_TH": "NLM (2024)", "ST": "T055", "PI": "Conflict, Psychological (1967-2023)", "MS": "A state of tension or distress that occurs when fulfilling roles of one status making it difficult to fulfill the roles of another.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097823"}, {"RECTYPE": "D", "MH": "Medical Neglect", "ENTRY": "Neglect, Medical", "MN": "I01.880.735.191.127", "MH_TH": "NLM (2024)", "ST": "T080", "PI": "Child Abuse (1989-2023)", "MS": "Failure to seek timely and appropriate care or allow such care for medical, dental or psychological needs by family members, legal guardian and other caregivers. Negligence by professionals is PROFESSIONAL NEGLIGENCE.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097824"}, {"RECTYPE": "D", "MH": "Elastin-Like Polypeptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Elastin-Like Polypeptides (ELPs)|T116|ABX|EQV|NLM (2024)|230420|abcdef", "ENTRY": "Polypeptides, Elastin-Like", "MN": "E02.319.300.380.388", "MH_TH": "NLM (2024)", "ST": "T116", "RN": "0", "PI": "Elastin (2003-2023)", "MS": "Synthetic biopolymers that are formed by repeating amino acid sequences that are naturally found in TROPOELASTIN. They are useful for various purposes, including DRUG DELIVERY SYSTEMS, TISSUE SCAFFOLDS, and ANTINEOPLASTIC AGENTS.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097825"}, {"RECTYPE": "D", "MH": "Social Genomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Sociogenomics|T091|NON|EQV|NLM (2024)|230420|abcdef", "ENTRY": "Sociogenomic", "MN": "H01.158.273.343.350.850", "MH_TH": "NLM (2024)", "ST": "T091", "PI": "Genomics (2002-2023)", "MS": "Field of genetics studying correlates between variations in SOCIOLOGICAL FACTORS and differences in GENOME-wide GENE EXPRESSION REGULATION.", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097826"}, {"RECTYPE": "D", "MH": "Stemona Alkaloids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Stemonaceae Alkaloids|T109|NON|EQV|NLM (2024)|230421|abcdef", "MN": "D03.132.795", "MH_TH": "NLM (2024)", "ST": "T109", "RN": "0", "MS": "Structurally related ALKALOIDS derived from the plants of the monocotyledonous family STEMONACEAE, characterized by the presence of a pyrrolo(1,2-a)azepine or a pyrido(1,2-a)azepine nucleus.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097843"}, {"RECTYPE": "D", "MH": "Subjective Stress", "AQ": "CL DE ES PH RE", "ENTRY": "Subjective Stresses", "MN": "F02.830.900.833", "MH_TH": "NLM (2024)", "ST": "T055", "PI": "Stress, Psychological (1969-2023)", "MS": "Perceptions of PSYCHOLOGICAL STRESS based on the individual's own personal values, beliefs and past and current experiences and circumstances.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097844"}, {"RECTYPE": "D", "MH": "Protein Phosphatase Inhibitory Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Phosphatase Inhibitor Proteins|T116|NON|EQV|NLM (2024)|230421|abcdef", "MN": "D12.776.476.561", "MH_TH": "NLM (2024)", "ST": "T116", "RN": "0", "MS": "A group of proteins that control the activity of PROTEIN PHOSPHATASES.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097847"}, {"RECTYPE": "D", "MH": "Indolosesquiterpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Indole Sesquiterpenes|T109|NON|EQV|NLM (2024)|230508|abcdef", "ENTRY": "Sesquiterpenes, Indole", "MN": "D04.663.250", "MH_TH": "NLM (2024)", "ST": "T109", "RN": "0", "PI": "Sesquiterpenes (1974-2023)", "MS": "Sesquiterpene compounds that contain an INDOLE.", "PM": "2024", "HN": "2024", "MR": "20230609", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097848"}, {"RECTYPE": "D", "MH": "UK Biobank", "AQ": "CL EC ES HI LJ SD SN ST TD", "MN": "L01.470.750.750.753", "MH_TH": "NLM (2024)", "ST": "T170", "AN": "CATALOGER: Use NAF entry  ", "MS": "A biomedical database and research resource that contains genetic and health data on participants aged 40-69 years with a roughly even number of men and women recruited between 2006 and 2010 throughout the UK.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097849"}, {"RECTYPE": "D", "MH": "Extravillous Trophoblasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Trophoblast, Extravillous", "MN": "A16.710.802.500", "MH_TH": "NLM (2024)", "ST": "T018", "PI": "Trophoblasts (1989-2023)", "MS": "Differentiated trophoblast cells originally from trophoblastic cell columns of anchoring CHORIONIC VILLI of the DECIDUA basalis of the PLACENTA. Extravillous trophoblasts invade into the uterine structures, attaching the placenta to the UTERUS. They are also found in chorionic plate, MYOMETRIUM, and spiral arteries.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097862"}, {"RECTYPE": "D", "MH": "Ectodermal Placodes", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Otic Placodes|T018|NON|NRW|NLM (2024)|230423|abcdef", "ENTRY": "Placode, Otic", "MN": "A16.216", "MH_TH": "NLM (2024)", "ST": "T018", "PI": "Ectoderm (1963-2023)", "MS": "A series of thickened ECTODERM patches in the developing cranial region that appears during week 4 in human embryo. Ectodermal placodes are the primordium of many ectodermal sensory systems including the INNER EAR, the EYE LENS, the OLFACTORY EPITHELIUM, as well as the PITUITARY GLAND and THYROID GLAND.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097863"}, {"RECTYPE": "D", "MH": "Undertreatment", "AQ": "EC LJ PC SN TD", "PRINT ENTRY": "Under-Treatment|T058|T061|NON|EQV|NLM (2024)|230424|abbcdef", "ENTRY": "Undertreatments", "MN": "N05.300.150.395.725", "MH_TH": "NLM (2024)", "ST": "T061", "MS": "Remedial treatment or preventive procedures of a disease which is done too infrequently or not enough to control disease diagnosis or treatment. Many factors contribute to medical undertreatment including lack of ACCESS TO HEALTH SERVICES and PATIENT PREFERENCE.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097864"}, {"RECTYPE": "D", "MH": "Neuroanesthesia", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Neurosurgical Anesthesia|T090|NON|EQV|NLM (2024)|230509|abcdef", "ENTRY": "Neurosurgical Anesthesias", "MN": "E03.155.837", "MH_TH": "NLM (2024)", "ST": "T090", "PI": "Anesthesia (1969-2023)", "MS": "Anesthesia methods that are used for neurologic medical procedures.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097867"}, {"RECTYPE": "D", "MH": "Polo-like Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.563.616", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "0", "PI": "Protein Serine-Threonine Kinases (1993-2023)", "MS": "Protein serine-threonine kinases which regulate entry into M phase, spindle pole biogenesis and function, mitotic chromosome dynamics, mitotic exit, and cytokinesis. They contain a characteristic Polo-box protein interaction domain.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097868"}, {"RECTYPE": "D", "MH": "Polo-Like Kinase 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Polo Like Kinase 1", "MN": "D12.776.476.563.616.500", "MH_TH": "NLM (2024)", "ST": "T126", "RN": "0", "RR": "LRQ0Y7262H", "MS": "Plays a crucial role in the regulation of proliferative activity of normal and malignant cells. Proposed as a new target for antineoplastic treatment strategies.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097869"}, {"RECTYPE": "D", "MH": "Geriatric Anesthesia", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Anesthesia, Geriatrics|T061|NON|EQV|NLM (2024)|230424|abcdef", "ENTRY": "Geriatrics Anesthesias", "MN": "E03.155.253", "MH_TH": "NLM (2024)", "ST": "T061", "PI": "Anesthesia (1968-2023)", "MS": "Conducting anesthesia procedures in AGED adults, typically those aged 65 years and older.", "PM": "2024", "HN": "2024", "MR": "20230706", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097870"}, {"RECTYPE": "D", "MH": "Solute Carrier Family 44, Member 2 Protein", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SLC44A2 Protein|T116|T123|NON|EQV|NLM (2024)|230424|abbcdef", "MN": "D12.776.575.750.719", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "A mitochondrion and plasma membrane protein that enables choline transmembrane transporter activity.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097871"}, {"RECTYPE": "D", "MH": "Pediatric Anesthesia", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Anesthesia, Pediatric|T061|NON|EQV|NLM (2024)|230424|abcdef", "MN": "E03.155.422", "MH_TH": "NLM (2024)", "ST": "T061", "PI": "Anesthesia (1967-2023)", "MS": "Conducting anesthesia procedures in infants, children, and adolescents.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097872"}, {"RECTYPE": "D", "MH": "Postmortem Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Postmortem Radiological Imaging|T060|NON|NRW|NLM (2024)|230424|abcdef", "ENTRY": "Tomography, Postmortem Computed", "MN": "I01.198.780.937.120.500", "FX": "Forensic Imaging", "MH_TH": "NLM (2024)", "ST": "T060", "PI": "Autopsy (2003-2023)", "MS": "The generation of images of the body's structures, organs, and tissues after death.", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097873"}, {"RECTYPE": "D", "MH": "beta Lactam Antibiotics", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Lactam Antibiotics|T121|NON|EQV|NLM (2024)|230425|abcdef", "ENTRY": "Lactam Antibiotics, beta", "MN": "D27.505.954.122.085.386", "MH_TH": "NLM (2024)", "ST": "T121", "RN": "0", "PI": "Anti-Bacterial Agents (1967-2023)", "MS": "Bactericidal agents that contain a beta-lactam ring in their chemical structure. They inhibit bacterial cell wall synthesis by binding to PENICILLIN-BINDING PROTEINS, preventing the synthesis of peptidoglycan in bacterial cell walls.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097902"}, {"RECTYPE": "D", "MH": "Two-Pore Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Two-Pore Channel|T116|T123|NON|EQV|NLM (2024)|230425|abbcdef", "MN": "D12.776.543.585.400.950", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "PI": "Calcium Channels (1989-2023)", "MS": "Ligand-gated cation-selective ION CHANNELS located in ENDOSOMES and LYSOSOMES of plant and animal cells.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097903"}, {"RECTYPE": "D", "MH": "First Generation Cephalosporins", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "First Generation Cephalosporin|T121|NON|EQV|NLM (2024)|230425|abcdef", "ENTRY": "Generation Cephalosporin, First", "MN": "D27.505.954.122.085.386.500", "MH_TH": "NLM (2024)", "ST": "T121", "RN": "0", "PI": "Cephalosporins (1981-2023)", "MS": "CEPHALOSPORIN agents with excellent coverage against gram-positive cocci, such as STAPHYLOCOCCUS  and STREPTOCOCCUS. They have some activity against the gram-negative bacteria, but in general, gram-negative activity is decreased compared to 2nd, 3rd, and 4th generation cephalosporins.", "PM": "2024", "HN": "2024", "MR": "20230706", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097904"}, {"RECTYPE": "D", "MH": "Roundabout Proteins", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Roundabout 1 Protein|T116|T192|NON|NRW|NLM (2024)|230427|abbcdef", "MN": "D12.776.543.750.916", "MH_TH": "NLM (2024)", "ST": "T192", "RN": "0", "MS": "A family of single-pass transmembrane receptors that act as the cognate receptors for the secreted guidance factor Slit emanating from central nervous system midlines.", "PM": "2024: ROUNDABOUT PROTEIN was indexed under RECEPTORS, IMMUNOLOGIC and NERVE TISSUE PROTEINS 2005-2023, and under TUMOR SUPPRESSOR PROTEINS 2004-2004", "HN": "2024 (2004)", "MR": "20230614", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097905"}, {"RECTYPE": "D", "MH": "RNA Methylation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "m7G RNA Methylation|T045|NON|NRW|NLM (2024)|230505|abcdef", "ENTRY": "m7G RNA Methylations", "MN": "G05.308.700.475", "MH_TH": "NLM (2024)", "ST": "T045", "PI": "Methylation (1963-2023)", "MS": "The addition of a methyl group to one of the NITROGEN atoms on a NUCLEOTIDE base in an RNA molecule.", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097906"}, {"RECTYPE": "D", "MH": "Mass Shooting Events", "AQ": "CL EC EH HI LJ PC PX SN TD", "PRINT ENTRY": "Shooting Spree|T055|T068|NON|EQV|NLM (2024)|230425|abbcdef", "ENTRY": "Sprees, Shooting", "MN": "N06.230.100.160.500", "FX": "Wounds, Gunshot", "MH_TH": "NLM (2024)", "ST": "T068", "PI": "Mass Casualty Incidents (2008-2023)", "MS": "A mass killing by firearm that consists of 3 or more killings in a single incident (H.R.2076 \u2013 112th U.S. Congress (2011-2012): Investigative Assistance for Violent Crimes Act of 2012).", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097907"}, {"RECTYPE": "D", "MH": "Retrograde Ejaculation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Retrograde Ejaculations", "MN": "C12.200.294.150.750", "MH_TH": "NLM (2024)", "ST": "T047", "PI": "Ejaculation(2023)", "MS": "The flow of SEMINAL FLUID, from the posterior URETHRA, backwards into the BLADDER. Causes include injuries such as from SPINAL CORD INJURIES; DIABETIC NEUROPATHIES; surgeries in adjacent tissues such as AORTIC ANEURYSM surgeries and transurethral bladder neck incisions; or drug side effects.", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097908"}, {"RECTYPE": "D", "MH": "Second Generation Cephalosporins", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Second-Generation Cephalosporins|T121|NON|EQV|NLM (2024)|230426|abcdef", "ENTRY": "Cephalosporins, Second-Generation", "MN": "D27.505.954.122.085.386.750", "MH_TH": "NLM (2024)", "ST": "T121", "RN": "0", "PI": "Cephalosporins (1980-2023)", "MS": "Agents with less activity against gram-positive cocci than FIRST GENERATION CEPHALOSPORINS but have increased activity against gram-negative bacilli.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097909"}, {"RECTYPE": "D", "MH": "Ejaculatory Dysfunction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ejaculatory Incompetence|T047|NON|NRW|NLM (2024)|230505|abcdef", "ENTRY": "Incompetences, Ejaculatory", "MN": "C12.200.294.150", "MH_TH": "NLM (2024)", "ST": "T047", "MS": "The inability in males to ejaculate, or to have a normal time to EJACULATION.", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097910"}, {"RECTYPE": "D", "MH": "Third Generation Cephalosporins", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Third Generation Cephalosporin|T121|NON|EQV|NLM (2024)|230426|abcdef", "ENTRY": "Generation Cephalosporins, Third", "MN": "D27.505.954.122.085.386.875", "MH_TH": "NLM (2024)", "ST": "T121", "RN": "0", "PI": "Cephalosporins (1981-2023)", "MS": "Agents that are structurally similar to other CEPHALOSPORINS but have a broader spectrum of activity against bacteria than the first and second generation cephalosporins. These agents cover more resistant STREPTOCOCCUS, STAPHYLOCOCCUS, gram-positive anaerobes, and more resistant strains of HAEMOPHILUS, NEISSERIA, PROTEUS, ESCHERICHIA COLI, and KLEBSIELLA (HNPEK).", "PM": "2024", "HN": "2024", "MR": "20230710", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097911"}, {"RECTYPE": "D", "MH": "Toll-Like Receptor Agonists", "PRINT ENTRY": "Toll-Like Receptor Agonist|T121|NON|EQV|NLM (2024)|230426|abcdef", "ENTRY": "Toll Like Receptor Agonists", "MN": "D27.505.696.477.396.500", "MH_TH": "NLM (2024)", "ST": "T121", "RN": "0", "PI": "Toll-Like Receptors (2001-2023)", "MS": "Agents that stimulate TOLL-LIKE RECEPTOR signaling, and the activity of both the INNATE IMMUNE RESPONSE and ADAPTIVE IMMUNITY.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097912"}, {"RECTYPE": "D", "MH": "Quantitative Phase Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Quantitative Phase Microscopy|T059|NON|NRW|NLM (2024)|230426|abcdef", "ENTRY": "Phase Imaging, Quantitative", "MN": "E05.595.513.784", "MH_TH": "NLM (2024)", "ST": "T059", "MS": "Contrast imaging generated from the measurements of phase shift changes of light waves as they pass through transparent objects of varying thickness and refractivity.", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097913"}, {"RECTYPE": "D", "MH": "Liquid Chromatography-Mass Spectrometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ultra-Performance Liquid Chromatography-Mass Spectrometry|T059|NON|NRW|NLM (2024)|230612|abcdef", "ENTRY": "Ultra Performance Liquid Chromatography Mass Spectrometry", "MN": "E05.196.566.575", "MH_TH": "NLM (2024)", "ST": "T059", "PI": "Mass Spectrometry (1970-2023)", "MS": "A microanalytical technique combining mass spectrometry and liquid chromatography for the qualitative as well as quantitative determinations of compounds.", "PM": "2024", "HN": "2024", "MR": "20230612", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097922"}, {"RECTYPE": "D", "MH": "Paraptosis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Caspase-Independent Programmed Cell Death|T043|NON|EQV|NLM (2024)|230505|abcdef", "ENTRY": "Caspase Independent Programmed Cell Death", "MN": "G04.146.954.625", "MH_TH": "NLM (2024)", "ST": "T043", "PI": "Apoptosis (2004-2023)", "MS": "A type of programmed cell death resembling NECROSIS, with mitochondrial and ENDOPLASMIC RETICULUM swelling and accumulation of CYTOPLASMIC VACUOLES. Distinctive morphological changes to the CELL NUCLEUS are absent.", "PM": "2024", "HN": "2024", "MR": "20230526", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097924"}, {"RECTYPE": "D", "MH": "Hearing Loss, Hidden", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Noise-Induced Cochlear Synaptopathy|T184|NON|REL|NLM (2024)|230505|abcdef", "ENTRY": "Synaptopathy, Noise-Induced Cochlear", "MN": "C23.888.592.763.393.341.975", "MH_TH": "NLM (2024)", "ST": "T184", "PI": "Hearing Loss (2011-2023)", "MS": "Hearing loss that is difficult to diagnose by standard hearing tests as it most often pertains to difficulties in hearing only in certain situations such as in noisy environments.", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097942"}, {"RECTYPE": "D", "MH": "Gender-Affirming Care", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Gender-Confirming Care|T058|NON|EQV|NLM (2024)|230507|abcdef", "ENTRY": "Healthcare, Gender-Affirming", "MN": "N05.300.361", "MH_TH": "NLM (2024)", "ST": "T058", "PI": "Transgender Persons (2016-2023)", "MS": "A supportive healthcare, consisting of medical, surgical, mental health, and non-medical services for TRANSGENDER PERSONS and GENDER-NONCONFORMING PERSONS. Medical and psychosocial gender affirming healthcare practices may lower rates of adverse mental health outcomes, build SELF ESTEEM, and improve overall QUALITY OF LIFE for transgender and gender diverse youth (https://opa.hhs.gov/sites/default/files/2022-03/gender-affirming-care-young-people-march-2022.pdf).", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097962"}, {"RECTYPE": "D", "MH": "ERRalpha Estrogen-Related Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Estrogen-Related Receptor alpha|T116|T123|NON|EQV|NLM (2024)|230508|abbcdef", "ENTRY": "ERRalpha|T116|T123|EQV|NLM (1996)|abbde", "MN": "D12.776.930.778.350.500", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "MS": "An orphan nuclear receptor that belongs to the ERR subfamily. It has enriched expression in tissues with high oxidative metabolic capacity.", "PM": "2024: ERRALPHA ESTROGEN-RELATED RECEPTOR was indexed under RECEPTORS, ESTROGEN 2007-2023, and under RECEPTORS, CYTOPLASMIC AND NUCLEAR 1996-2006", "HN": "2024 (1996)", "MR": "20230615", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000097983"}, {"RECTYPE": "D", "MH": "Acetophenones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.522.120", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of the simplest aromatic ketone acetophenone (of general formula C6H5C(O)CH3).", "MR": "20161101", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000098"}, {"RECTYPE": "D", "MH": "Time Pressure", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Time Constraint|T048|NON|EQV|NLM (2024)|230510|abcdef", "ENTRY": "Time Pressures", "MN": "F02.830.900.916", "MH_TH": "NLM (2024)", "ST": "T048", "PI": "Time Factors (1969-2023)", "MS": "Sense of time urgency to complete a task. This sense of time urgency creates psychological pressure affecting performance (https://www.nrc.gov/docs/ML2112/ML21127A272.pdf).", "PM": "2024", "HN": "2024", "MR": "20230531", "DA": "20230726", "DC": "1", "DX": "20240101", "UI": "D000098002"}, {"RECTYPE": "D", "MH": "Acetoxyacetylaminofluorene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acetoxyfluorenylacetamide|T109|T131|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "N Acetoxy N acetyl 2 aminofluorene", "MN": "D04.615.389.050.060", "PA": "Alkylating Agents", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Acetamide, N-(acetyloxy)-N-9H-fluoren-2-yl-", "RN": "6098-44-8", "PI": "Fluorenes (1966-1974)", "MS": "An alkylating agent that forms DNA ADDUCTS at the C-8 position in GUANINE, resulting in single strand breaks. It has demonstrated carcinogenic action.", "PM": "91; was see under 2-ACETYLAMINOFLUORENE/analogs & derivatives 1980-90; was see under FLUORENES 1975-79", "HN": "91(75); was see under 2-ACETYLAMINOFLUORENE/analogs & derivatives 1980-90; was see under FLUORENES 1975-79", "MR": "20120703", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000099"}, {"RECTYPE": "D", "MH": "Acetrizoic Acid", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Sodium, Acetrizoate", "MN": "D02.455.426.559.389.127.375.880.020", "PA": "Contrast Media", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-", "RN": "24256BQV7M", "RR": "85-36-9 (Acetrizoic Acid)", "MS": "An iodinated radiographic contrast medium used as acetrizoate sodium in HYSTEROSALPINGOGRAPHY.", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000100"}, {"RECTYPE": "D", "MH": "Acetyl-CoA C-Acetyltransferase", "DS": "ACETYL COA ACETYLTRANSFERASE C", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Acetyl-CoA Acetyltransferase|T116|T126|EQV|NLM (1998)|961203|abbdef", "ENTRY": "Thiolase, Acetoacetyl CoA", "MN": "D08.811.913.050.134.025", "FX": "Acetyl-CoA C-Acyltransferase", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Acetyl-CoA:acetyl-CoA C-acetyltransferase", "RN": "EC 2.3.1.9", "RR": "9027-46-7 (CAS RN)", "AN": "do not confuse with ACETYL-COA C-ACYLTRANSFERASE", "PI": "Acetyltransferases (1973-1974)", "MS": "An enzyme that catalyzes the formation of acetoacetyl-CoA from two molecules of ACETYL COA. Some enzymes called thiolase or thiolase-I have referred to this activity or to the activity of ACETYL-COA C-ACYLTRANSFERASE.", "PM": "1998; see ACETYL-COA ACETYLTRANSFERASE 1991-1997; see ACETYLTRANSFERASES 1975-1990", "HN": "1998(1975)", "MR": "20190701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000101"}, {"RECTYPE": "D", "MH": "Acetyl-CoA C-Acyltransferase", "DS": "ACETYL COA ACYLTRANSFERASE C", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Ketothiolase|T116|T126|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "beta Ketothiolase", "MN": "D08.811.913.050.080", "FX": "Acetyl-CoA C-Acetyltransferase", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Acyl-CoA:acetyl-CoA C-acyltransferase", "RN": "EC 2.3.1.16", "RR": "9029-97-4 (CAS RN)", "AN": "do not confuse with ACETYL-COA C-ACETYLTRANSFERASE", "PI": "Acyltransferases (1973-1974)", "MS": "Enzyme that catalyzes the final step of fatty acid oxidation in which ACETYL COA is released and the CoA ester of a fatty acid two carbons shorter is formed.", "PM": "98; use ACETYL COA ACYLTRANSFERASE 1991-97, ACYLTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000102"}, {"RECTYPE": "D", "MH": "Acetyl-CoA Carboxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Acetyl Coenzyme A Carboxylase|T116|T126|NON|EQV|UNK (19XX)|760317|abbcdef", "ENTRY": "Carboxylase, Acetyl-CoA", "MN": "D08.811.641.249", "MH_TH": "NLM (1973)", "ST": "T126", "N1": "Acetyl-CoA:carbon-dioxide ligase (ADP-forming)", "RN": "EC 6.4.1.2", "RR": "EC 6.3.4.14", "MS": "A carboxylating enzyme that catalyzes the conversion of ATP, acetyl-CoA, and HCO3- to ADP, orthophosphate, and malonyl-CoA. It is a biotinyl-protein that also catalyzes transcarboxylation. The plant enzyme also carboxylates propanoyl-CoA and butanoyl-CoA (From Enzyme Nomenclature, 1992) EC 6.4.1.2.", "PM": "91; was see under LIGASES 1973-90", "HN": "91(73); was see under LIGASES 1973-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000103"}, {"RECTYPE": "D", "MH": "Acetyl-CoA Hydrolase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Acetyl-CoA Deacylase|T116|T126|EQV|UNK (19XX)|770517|abbdef", "ENTRY": "Hydrolase, Acetyl-CoA", "MN": "D08.811.277.352.897.075", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "Acetyl-CoA hydrolase", "RN": "EC 3.1.2.1", "PI": "Thiolester Hydrolases (1973-1977)", "MS": "An enzyme that catalyzes reversibly the hydrolysis of acetyl-CoA to yield CoA and acetate. The enzyme is involved in the oxidation of fatty acids. EC 3.1.2.1.", "PM": "91; was see under THIOLESTER HYDROLASES 1978-90", "HN": "91(78); was see under THIOLESTER HYDROLASES 1978-90", "MR": "20030709", "DA": "19770517", "DC": "1", "DX": "19910101", "UI": "D000104"}, {"RECTYPE": "D", "MH": "Acetyl Coenzyme A", "AQ": "AA AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Acetyl CoA|T109|T114|T123|NON|EQV|UNK (19XX)|760317|abbbcdef", "ENTRY": "Coenzyme A, Acetyl", "MN": "D13.695.827.068.382.300.020", "MH_TH": "NLM (1973)", "ST": "T123", "N1": "Coenzyme A, S-acetate", "RN": "72-89-9", "AN": "do not confuse with ACYL COENZYME A", "PI": "Coenzyme A (1966-1972)", "MS": "Acetyl CoA participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. It also acts as a biological acetylating agent.", "PM": "78; was see under COENZYME A 1975-77", "HN": "78(73); was see under COENZYME A 1975-77", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D000105"}, {"RECTYPE": "D", "MH": "Acetate-CoA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Acetyl CoA Synthetase|T116|T126|EQV|UNK (19XX)|760517|abbdef", "ENTRY": "Thiokinase, Acetate", "MN": "D08.811.464.267.500.200", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "Acetate:CoA ligase (AMP-forming)", "RN": "EC 6.2.1.1", "RR": "9012-31-1 (CAS RN)", "PI": "Coenzyme A Synthetases (1974-1975)", "MS": "An enzyme that catalyzes the formation of CoA derivatives from ATP, acetate, and CoA to form AMP, pyrophosphate, and acetyl CoA. It acts also on propionates and acrylates. EC 6.2.1.1.", "OL": "use ACETATE-COA LIGASE to search ACETYL COENZYME A SYNTHETASE 1991-94", "PM": "95; was ACETYL COENZYME A SYNTHETASE 1991-94; was see under COENZYME A SYNTHETASES 1976-90", "HN": "95; was ACETYL COENZYME A SYNTHETASE 1991-94; was see under COENZYME A SYNTHETASES 1976-90", "MR": "20130709", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D000106"}, {"RECTYPE": "D", "MH": "Acetylation", "AQ": "DE RE", "ENTRY": "Acetylations", "MN": "G03.040.052", "MH_TH": "NLM (1973)", "ST": "T070", "AN": "almost never IM; enzymatic acetylation: coord NIM with ACETYLTRANSFERASES (IM) + substrate (NIM) or specific acetyltransferase (IM)", "PI": "Chemistry, Organic (1966-1972)", "MS": "Formation of an acetyl derivative. (Stedman, 25th ed)", "PM": "91; was see under CHEMISTRY, ORGANIC 1973-90", "HN": "91(73); was see under CHEMISTRY, ORGANIC 1973-90", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000107"}, {"RECTYPE": "D", "MH": "Acetylcarnitine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Medosan|T109|T121|TRD|NRW|NLM (2004)|abbcde", "ENTRY": "Carnitine, Acetyl", "MN": "D02.092.877.883.099.090", "PA": "Vitamin B Complex", "MH_TH": "NLM (1978)", "ST": "T127", "N1": "1-Propanaminium, 2-(acetyloxy)-3-carboxy-N,N,N-trimethyl-, inner salt", "RN": "6DH1W9VH8Q", "RR": "3040-38-8 ((R)-isomer)", "PI": "Carnitine (1966-1977)", "MS": "An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.", "PM": "1991; see CARNITINE 1978-1990; MEDOSAN was indexed under ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1988-2003", "HN": "1991(1978); use CARNITINE 1978-1990; for MEDOSAN use ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL (NM) 1988-2003", "MR": "20160705", "DA": "19770517", "DC": "1", "DX": "19910101", "UI": "D000108"}, {"RECTYPE": "D", "MH": "Acetylcholine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Perchlorate, Acetylcholine", "MN": "D02.092.211.111", "PA": "Vasodilator Agents", "FX": "Receptors, Cholinergic", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl-", "RN": "N9YNS0M02X", "RR": "C12HG588IF", "MS": "A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system.", "PM": "1998; MIOCHOL (now ACETYLCHOLINE) was indexed under ACETYLCHOLINE & MANNITOL 1981-97; CHLOROACETYLCHOLINE was indexed under ACETYLCHOLINE 1975-2000 & under CHLORINE 1974-1975; BROMOACETYLCHOLINE was indexed under ACETYLCHOLINE/analogs & derivatives 1974-2000 & ACETYLCHOLINE 1969-1974", "HN": "1998; for MIOCHOL use ACETYLCHOLINE (NM) 1981-1997; for CHLOROACETYLCHOLINE use ACETYLCHOLINE (NM) 1969-2000; for BROMOACETYLCHOLINE use ACETYLCHOLINE (NM) 1969-2000", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D000109"}, {"RECTYPE": "D", "MH": "Acetylcholinesterase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hydrolase, Acetylcholine", "MN": "D08.811.277.352.100.170.176", "EC": "antagonists & inhibitors:Cholinesterase Inhibitors", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Acetylcholine acetylhydrolase", "RN": "EC 3.1.1.7", "AN": "reactivation or reactivators: coordinate with CHOLINESTERASE REACTIVATORS ", "MS": "An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7.", "MR": "20050707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000110"}, {"RECTYPE": "D", "MH": "Acetylcysteine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mercapturic Acid|T116|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740329|abbcdeef", "ENTRY": "Zinc, Acetylcysteine", "MN": "D12.125.166.230.259", "PA": "Free Radical Scavengers", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "L-Cysteine, N-acetyl-", "RN": "WYQ7N0BPYC", "RR": "NRD80R06FB", "MS": "The N-acetyl derivative of CYSTEINE. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates.", "PM": "66", "HN": "66(64)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000111"}, {"RECTYPE": "D", "MH": "Acetyldigitoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Desglucolanatosides A|T109|T121|NON|EQV|UNK (19XX)|790223|abbcdef", "ENTRY": "alpha Acetyldigitoxin", "MN": "D09.408.180.261.336.259", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "RR": "0ZV4Q4L2FU", "AN": "do not confuse with ACETYLDIGOXINS", "MS": "Cardioactive derivatives of lanatoside A or of DIGITOXIN. They are used for fast digitalization in congestive heart failure.", "OL": "use ACETYLDIGITOXINS to search ACETYLDIGITOXIN 1975-79 & DIGITOXIN 1966-74", "PM": "91; was see under DIGITOXIN 1980-90; was ACETYLDIGITOXIN see under DIGITOXIN 1966-79", "HN": "91(80); was see under DIGITOXIN 1980-90; was ACETYLDIGITOXIN see under DIGITOXIN 1966-79", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000112"}, {"RECTYPE": "D", "MH": "Acetyldigoxins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Desglucolanatosides C|T109|T121|NON|EQV|UNK (19XX)|780316|abbcdef", "ENTRY": "von ct, digox", "MN": "D09.408.180.261.436.050", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1979)", "ST": "T121", "RN": "0", "RR": "P7K44M64CW", "AN": "Digitalis glycosides; do not confuse with ACETYLDIGITOXINS; alpha isomer & beta isomer go here", "PI": "Digoxin (1966-1978)", "MS": "Alpha- or beta-acetyl derivatives of DIGOXIN or lanatoside C from Digitalis lanata. They are better absorbed and longer acting than digoxin and are used in congestive heart failure.", "PM": "91; was see under DIGOXIN 1979-90", "HN": "91(79); was see under DIGOXIN 1979-90", "MR": "20160628", "DA": "19780316", "DC": "1", "DX": "19910101", "UI": "D000113"}, {"RECTYPE": "D", "MH": "Acetylene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethyne|T109|NON|EQV|NLM (2024)|230308|abcdef", "MN": "D02.455.326.397.259", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "OC7TV75O83", "RR": "74-86-2 (Acetylene)", "MS": "The simplest two carbon alkyne with the formula HCCH.", "MR": "20230526", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000114"}, {"RECTYPE": "D", "MH": "Acetylesterase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Acetylase|T116|T126|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Esterase, Acid", "MN": "D08.811.277.352.100.050", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Acetic-ester acetylhydrolase", "RN": "EC 3.1.1.6", "MS": "An enzyme that catalyzes the conversion of acetate esters and water to alcohols and acetate. EC 3.1.1.6.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000115"}, {"RECTYPE": "D", "MH": "Acetylgalactosamine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "N Acetyl D Galactosamine", "MN": "D09.067.342.356.050", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Galactose, 2-(acetylamino)-2-deoxy-", "RN": "KM15WK8O5T", "RR": "31022-50-1 (Acetylgalactosamine)", "PI": "Galactosamine (1973-1974)", "MS": "The N-acetyl derivative of galactosamine.", "PM": "91; was see under GALACTOSAMINE 1975-90", "HN": "91(75); was see under GALACTOSAMINE 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000116"}, {"RECTYPE": "D", "MH": "Acetylglucosamine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-N-Acetylglucosamine|T109|T123|NON|EQV|NLM (2024)|230202|abbcdef", "ENTRY": "beta N Acetylglucosamine", "MN": "D09.067.342.531.050", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "D-Glucose, 2-(acetylamino)-2-deoxy-", "RN": "V956696549", "RR": "7512-17-6 (Acetylglucosamine)", "PI": "Glucosamine (1973-1974)", "MS": "The N-acetyl derivative of glucosamine.", "PM": "91; was see under GLUCOSAMINE 1975-90", "HN": "91(75); was see under GLUCOSAMINE 1975-90", "MR": "20230516", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000117"}, {"RECTYPE": "D", "MH": "Acetylglucosaminidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "N-Acetyl-beta-D-glucosaminidase|T116|T126|NON|EQV|UNK (19XX)|840411|ACETYL BETA GLUCOSAMINIDASE|abbcdefs", "ENTRY": "beta N Acetylglucosaminidase", "MN": "D08.811.277.450.483.180.500", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.2.1.52", "AN": "do not confuse with BETA-N-ACETYLHEXOSAMINIDASES", "PI": "Glucosaminidase (1972-1974)", "MS": "A beta-N-Acetylhexosaminidase that catalyzes the hydrolysis of terminal, non-reducing 2-acetamido-2-deoxy-beta-glucose residues in chitobiose and higher analogs as well as in glycoproteins. Has been used widely in structural studies on bacterial cell walls and in the study of diseases such as MUCOLIPIDOSIS and various inflammatory disorders of muscle and connective tissue.", "PM": "91; was see under GLUCOSAMINIDASE 1975-90", "HN": "91(75); was see under GLUCOSAMINIDASE 1975-90", "MR": "20070709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000118"}, {"RECTYPE": "D", "MH": "Acetylmuramyl-Alanyl-Isoglutamine", "DE": "AMAIG", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Muramyl Dipeptide|T116|T121|T129|NON|EQV|UNK (19XX)|800514|abbbcdef", "ENTRY": "N Acetylmuramyl L Alanyl D Isoglutamine", "MN": "D12.644.233.050", "PA": "Adjuvants, Immunologic", "MH_TH": "NLM (1979)", "ST": "T129", "N1": "D-alpha-Glutamine, N2-(N-(N-acetylmuramoyl)-L-alanyl)-", "RN": "53678-77-6", "PI": "Polysaccharides (1966-1970)", "MS": "Peptidoglycan immunoadjuvant originally isolated from bacterial cell wall fragments; also acts as pyrogen and may cause arthritis; stimulates both humoral and cellular immunity.", "PM": "83; was see under GLYCOPEPTIDES 1979-82", "HN": "83(79); was see under GLYCOPEPTIDES 1979-82", "MR": "20040707", "DA": "19780201", "DC": "1", "DX": "19830101", "UI": "D000119"}, {"RECTYPE": "D", "MH": "Acecainide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acetylprocainamide|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1996)|940819|abbcdeef", "ENTRY": "N Acetylprocainamide", "MN": "D02.455.426.559.389.127.085.033", "PA": "Anti-Arrhythmia Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzamide, 4-(acetylamino)-N-(2-(diethylamino)ethyl)-", "RN": "910Q707V6F", "RR": "B9K738KX14", "PI": "Procainamide (1966-1974) /analogs & derivatives (1975-1979)", "MS": "A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.", "PM": "96; was ACETYLPROCAINAMIDE 1980-95 (see under PROCAINAMIDE 1980-90)", "HN": "96; was ACETYLPROCAINAMIDE 1980-95 (see under PROCAINAMIDE 1980-90)", "MR": "20130708", "DA": "19790227", "DC": "1", "DX": "19910101", "UI": "D000120"}, {"RECTYPE": "D", "MH": "Acetylserotonin O-Methyltransferase", "DS": "ACETYLSEROTONIN METHYLTRANSFERASE O", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hydroxyindole O-Methyltransferase|T116|T126|NON|EQV|UNK (19XX)|741111|HYDROXYINDOLE METHYLTRANSFERASE O|abbcdefs", "ENTRY": "Oxyindol O Methyltransferase", "MN": "D08.811.913.555.500.100", "MH_TH": "NLM (2008)", "ST": "T126", "N1": "S-Adenosyl-L-methionine:N-acetylserotonin O-methyltransferase", "RN": "EC 2.1.1.4", "RR": "9029-77-0 (CAS RN)", "PI": "Serotonin (1974)", "MS": "An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to N-acetylserotonin to form N-acetyl-5-methoxytryptamine (MELATONIN).", "PM": "2008; see ACETYLSEROTONIN N-METHYLTRANSFERASE 1998-2007, see ACETYLSEROTONIN METHYLTRANSFERASE 1991-1997, see METHYLTRANSFERASES 1975-1990", "HN": "2008(1975)", "MR": "20070709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000121"}, {"RECTYPE": "D", "MH": "Acetylthiocholine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "(2-Mercaptoethyl)trimethylammonium Acetate|T109|T121|NON|EQV|UNK (19XX)|800813|abbcdef", "MN": "D02.886.489.789.030", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Ethanaminium, 2-(acetylthio)-N,N,N-trimethyl-", "RN": "4468-05-7", "PI": "Sulfhydryl Compounds (1973-1974)", "MS": "An agent used as a substrate in assays for cholinesterases, especially to discriminate among enzyme types.", "PM": "91; was see under CHOLINE 1975-90", "HN": "91(75); was see under CHOLINE 1975-90", "MR": "20070709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000122"}, {"RECTYPE": "D", "MH": "Acetyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Acetyltransferase|T116|T126|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D08.811.913.050.134", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 2.3.1.-", "RR": "9012-30-0 (CAS RN)", "PI": "Acyltransferases (1966-1972)", "MS": "Enzymes catalyzing the transfer of an acetyl group, usually from acetyl coenzyme A, to another compound. EC 2.3.1.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000123"}, {"RECTYPE": "D", "MH": "Achievement", "PRINT ENTRY": "Accomplishment|T055|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Achievements", "MN": "F02.784.629.054", "MH_TH": "POPLINE (1978)", "ST": "T055", "MS": "Success in bringing an effort to the desired end; the degree or level of success attained in some specified area (esp. scholastic) or in general.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000124"}, {"RECTYPE": "D", "MH": "Achilles Tendon", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tendons, Calcaneal", "MN": "A02.880.176", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "rupture: coordinate ACHILLES TENDON /inj with RUPTURE", "MS": "Tendon that connects the muscles in the back of the calf to the HEEL BONE.", "MR": "20160505", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000125"}, {"RECTYPE": "D", "MH": "Achlorhydria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypochlorhydria|T046|NON|REL|NLM (1991)|900213|abcdef", "MN": "C18.452.076.087", "FX": "Gastric Juice", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "A lack of HYDROCHLORIC ACID in GASTRIC JUICE despite stimulation of gastric secretion.", "OL": "use ACHLORHYDRIA to search ACHYLIA GASTRICA 1966-78", "PM": "ACHYLIA GASTRICA was see under ACHLORHYDRIA 1963-78", "HN": "ACHYLIA GASTRICA was see under ACHLORHYDRIA 1963-78", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D000126"}, {"RECTYPE": "D", "MH": "Acholeplasma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.074.150", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid2147", "PI": "Mycoplasma (1966-1975)", "MS": "A genus of gram-negative organisms including saprophytic and parasitic or pathogenic species.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D000127"}, {"RECTYPE": "D", "MH": "Acholeplasma laidlawii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mycoplasma laidlawii|T007|NON|EQV|UNK (19XX)|750711|abcdef", "MN": "B03.440.860.074.150.500", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid2148", "AN": "in sewage, dung, soil & animals", "PI": "Mycoplasma (1966-1971)", "MS": "An organism originally isolated from sewage, manure, humus, and soil, but recently found as a parasite in mammals and birds.", "OL": "use ACHOLEPLASMA LAIDLAWII to search MYCOPLASMA LAIDLAWII 1972-75", "PM": "76; was MYCOPLASMA LAIDLAWII 1972-75", "HN": "76; was MYCOPLASMA LAIDLAWII 1972-75", "MR": "20200813", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D000128"}, {"RECTYPE": "D", "MH": "Acholeplasmataceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.074", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid2146", "AN": "free-living saphrophytes & mammalian & avian parasites", "PI": "Mycoplasmataceae (1975)", "MS": "Gram-negative organisms including apparently free-living saphrophytes as well as mammalian and avian parasites, and possibly pathogens.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D000129"}, {"RECTYPE": "D", "MH": "Achondroplasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Severe Achondroplasia with Developmental Delay and Acanthosis Nigricans|T047|NON|REL|GHR (2014)|NLM (2012)|100712|abcdeef", "ENTRY": "Syndromes, Skeleton-Skin-Brain", "MN": "C16.320.240.500", "FX": "Receptor, Fibroblast Growth Factor, Type 3", "MH_TH": "ORD (2010)", "ST": "T019", "MS": "An autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, GENU VARUM, and trident hand. (Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM#100800, April 20, 2001)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000130"}, {"RECTYPE": "D", "MH": "Acid Etching, Dental", "DE": "ACID ETCHING DENT", "AQ": "AE CL EC ES HI IS MT PX SN ST TD VE", "PRINT ENTRY": "Dental Acid Etching|T061|NON|EQV|NLM (1991)|900409|DENT ACID ETCHING|abcdefv", "ENTRY": "Etching, Dental Acid|T061|NON|EQV|NLM (1991)|900209|ETCHING DENT ACID|abcdefv", "MN": "E06.931.475.111", "MH_TH": "NLM (1977)", "ST": "T061", "PI": "Phosphoric Acids (1968-1976)", "MS": "Preparation of TOOTH surfaces and DENTAL MATERIALS with etching agents, usually phosphoric acid, to roughen the surface to increase adhesion or osteointegration.", "PM": "91; was see under BONDING, DENTAL 1977-90", "HN": "91(77); was see under BONDING, DENTAL 1977-90", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D000134"}, {"RECTYPE": "D", "MH": "Acid Phosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Acid beta Glycerophosphatase", "MN": "D08.811.277.352.650.025", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Orthophosphoric-monoester phosphohydrolase (acid optimum)", "RN": "EC 3.1.3.2", "RR": "9001-77-8 (CAS RN)", "AN": "/defic permitted: TN 222; prostate-specific acid phosphatase (PROSTATE + ACID PHOSPHATASE): do not confuse with PROSTATE-SPECIFIC ANTIGEN, a serine proteinase", "MS": "An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.2.", "OL": "use ACID PHOSPHATASE to search BLOOD ACID PHOSPHATASE 1966-67", "PM": "/blood was BLOOD ACID PHOSPHATASE 1963-67", "HN": "/blood was BLOOD ACID PHOSPHATASE 1963-67", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D000135"}, {"RECTYPE": "D", "MH": "Acid-Base Equilibrium", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Anion Gap|T034|T070|NON|REL|UNK (19XX)|800509|abbcdef", "ENTRY": "Gaps, Anion", "MN": "G09.188.050", "FX": "Hydrogen-Ion Concentration", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "consider also ACID-BASE IMBALANCE", "MS": "The balance between acids and bases in the BODY FLUIDS. The pH (HYDROGEN-ION CONCENTRATION) of the arterial BLOOD provides an index for the total body acid-base balance.", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000136"}, {"RECTYPE": "D", "MH": "Acid-Base Imbalance", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Imbalances, Acid-Base", "MN": "C18.452.076", "MH_TH": "NLM (1976)", "ST": "T046", "PI": "Acid-Base Equilibrium (1966-1975)", "MS": "Disturbances in the ACID-BASE EQUILIBRIUM of the body.", "PM": "76", "HN": "76; was NON MESH before 1976", "CATSH": "CAT LIST", "MR": "19910617", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D000137"}, {"RECTYPE": "D", "MH": "Acidosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Metabolic Acidoses", "MN": "C18.452.076.176", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000138"}, {"RECTYPE": "D", "MH": "Acidosis, Lactic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lactic Acidosis|T046|T047|NON|EQV|UNK (19XX)|860418|abbcdef", "MN": "C18.452.076.176.180", "FX": "Hyperlactatemia", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Lactates (1966-1986)", "MS": "Acidosis caused by accumulation of lactic acid more rapidly than it can be metabolized. It may occur spontaneously or in association with diseases such as DIABETES MELLITUS; LEUKEMIA; or LIVER FAILURE.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D000140"}, {"RECTYPE": "D", "MH": "Acidosis, Renal Tubular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Type II Renal Tubular Acidosis|T047|NON|NRW|NLM (1998)|970519|abcdef", "ENTRY": "RTAs, Proximal Type", "MN": "C18.452.076.176.210", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "A group of genetic disorders of the KIDNEY TUBULES characterized by the accumulation of metabolically produced acids with elevated plasma chloride, hyperchloremic metabolic ACIDOSIS. Defective renal acidification of URINE (proximal tubules) or low renal acid excretion (distal tubules) can lead to complications such as HYPOKALEMIA, hypercalcinuria with NEPHROLITHIASIS and NEPHROCALCINOSIS, and RICKETS.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000141"}, {"RECTYPE": "D", "MH": "Acidosis, Respiratory", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Respiratory Acidosis|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Respiratory Acidoses", "MN": "C18.452.076.176.310", "MH_TH": "NLM (1967)", "ST": "T047", "PI": "Acidosis (1966)", "MS": "Respiratory retention of carbon dioxide. It may be chronic or acute.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000142"}, {"RECTYPE": "D", "MH": "Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acid|T103|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D01.029", "MH_TH": "NLM (1966)", "ST": "T103", "RN": "0", "AN": "general or unspecified; prefer specifics; do not use for specific acids, acid-fast bacteria, acid reactions, etc.", "MS": "Chemical compounds which yield hydrogen ions or protons when dissolved in water, whose hydrogen can be replaced by metals or basic radicals, or which react with bases to form salts and water (neutralization). An extension of the term includes substances dissolved in media other than water. (Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000143"}, {"RECTYPE": "D", "MH": "Acids, Acyclic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acyclic Acids|T109|NON|EQV|NLM (1998)|961216|abcdef", "MN": "D02.241.081", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Carboxylic acids that have open-chain molecular structures as opposed to ring-shaped structures.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000144"}, {"RECTYPE": "D", "MH": "Acids, Aldehydic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aldehydic Acids|T109|NON|EQV|NLM (1998)|961216|abcdef", "MN": "D02.241.152", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Dicarboxylic acids in which one of the carboxyl groups (-COOH) has been replaced by an aldehyde group (-CHO).", "PM": "98", "HN": "98; use explode 1967-97", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000145"}, {"RECTYPE": "D", "MH": "Acids, Carbocyclic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbocyclic Acids|T109|NON|EQV|NLM (1998)|961216|abcdef", "MN": "D02.241.223", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics; do not confuse with CARBOXYLIC ACIDS", "MS": "Carboxylic acids that have a homocyclic ring structure in which all the ring atoms are carbon.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "19980909", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000146"}, {"RECTYPE": "D", "MH": "Acids, Heterocyclic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Heterocyclic Acids|T109|NON|EQV|NLM (1998)|961216|abcdef", "MN": "D03.066", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A class of acids containing a ring structure in which at least one atom other than CARBON is incorporated.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "20040719", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000147"}, {"RECTYPE": "D", "MH": "Acids, Noncarboxylic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Noncarboxylic Acids|T197|NON|EQV|NLM (1998)|961216|abcdef", "MN": "D01.029.260", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Inorganic acids with a non metal, other than carbon, attached to hydrogen, or an acid radical containing no carbon.", "PM": "98", "HN": "98; use explode 1968-97", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000148"}, {"RECTYPE": "D", "MH": "Acidulated Phosphate Fluoride", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Phosphate Fluoride, Acidulated|T122|T197|NON|EQV|UNK (19XX)|760414|abbcdef", "ENTRY": "Fluoride, Acidulated Phosphate", "MN": "J01.637.051.223.015", "MH_TH": "NLM (1977)", "ST": "T197", "N1": "Phosphoric acid, mixt. with sodium fluoride (NaF)", "RN": "39456-59-2", "PI": "Phosphates (1966-1976)", "MS": "A sodium fluoride solution, paste or powder, which has been acidulated to pH 3 to 4 and buffered with a phosphate. It is used in the prevention of dental caries.", "PM": "91; was see under SODIUM FLUORIDE 1984-90; was see under FLUORIDES 1977-83", "HN": "91(77); was see under SODIUM FLUORIDE 1984-90; was see under FLUORIDES 1977-83", "MR": "20130708", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D000149"}, {"RECTYPE": "D", "MH": "Acinetobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mima|T007|NON|NRW|NLM (1992)|910402|abcdef", "MN": "B03.660.250.530.050", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid469", "PI": "Alcaligenes (1974)", "MS": "A genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity.", "OL": "search ALCALIGENES 1974; use ACINETOBACTER to search MIMAE 1966-91, HERELLA 1976-91, & COLLOIDES 1976-91", "PM": "76; was see under ACHROMOBACTER 1974-75; HERELLEA was HERELLA see ACINETOBACTER 1976-91; MIMA was MIMAE see ACINETOBACTER 1976-91; MIMAE was heading 1963-75; COLLOIDES was see ACINETOBACTER 1976-91", "HN": "76(75); was see under ACHROMOBACTER 1974-75; HERELLEA was HERELLA see ACINETOBACTER 1976-91; MIMA was MIMAE see ACINETOBACTER 1976-91; MIMAE was heading 1963-75; COLLOIDES was see ACINETOBACTER 1976-91", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D000150"}, {"RECTYPE": "D", "MH": "Acinetobacter Infections", "DE": "ACINETOBACTER INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Mimae Infections|T047|NON|EQV|UNK (19XX)|760414|MIMAE INFECT|abcdefv", "ENTRY": "Mimae Infection", "MN": "C01.150.252.400.560.022", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "gram-neg bact infect", "PI": "Acinetobacter (1966-1967)", "MS": "Infections with bacteria of the genus ACINETOBACTER.", "OL": "use ACINETOBACTER INFECTIONS to search MIMAE INFECTIONS 1968-76", "PM": "77; was MIMAE INFECTIONS 1968-76", "HN": "77; was MIMAE INFECTIONS 1968-76", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D000151"}, {"RECTYPE": "D", "MH": "Acne Vulgaris", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Acne|T047|NON|BRD|NLM (1993)|920402|abcdef", "MN": "C17.800.794.111", "FX": "Hidradenitis Suppurativa", "MH_TH": "POPLINE (1978)", "ST": "T047", "MS": "A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors.", "OL": "use ACNE VULGARIS to search ACNE 1966-92", "PM": "93; was ACNE 1963-92", "HN": "93; was ACNE 1963-92", "CATSH": "CAT LIST", "MR": "20180117", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D000152"}, {"RECTYPE": "D", "MH": "Acne Keloid", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Keloidal Acne|T047|NON|EQV|NLM (1993)|920406|abcdef", "ENTRY": "Papillaris Capillitius, Dermatitis", "MN": "C17.800.329.500.261", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "acneiform eruption with keloid scarring", "MS": "A type of acneiform disorder in which secondary pyogenic infection in and around pilosebaceous structures ends in keloidal scarring. It manifests as persistent folliculitis of the back of the neck associated with occlusion of the follicular orifices. It is most often encountered in black or Asian men.", "OL": "search FOLLICULITIS 1966-74", "PM": "91; was see under FOLLICULITIS 1975-90", "HN": "91(75); was see under FOLLICULITIS 1975-90", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000153"}, {"RECTYPE": "D", "MH": "Aconitate Hydratase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Isocitrate Hydro-Lyase|T116|T126|NON|EQV|UNK (19XX)|770517|abbcdef", "ENTRY": "Isocitrate Hydro Lyase", "MN": "D08.811.520.241.300.050", "MH_TH": "NLM (1973)", "ST": "T126", "N1": "Citrate(isocitrate) hydro-lyase", "RN": "EC 4.2.1.3", "RR": "9024-25-3 (CAS RN)", "PI": "Hydro-Lyases (1966-1972)", "MS": "An enzyme that catalyzes the reversible hydration of cis-aconitate to yield citrate or isocitrate. It is one of the citric acid cycle enzymes. EC 4.2.1.3.", "PM": "78; was see under HYDRO-LYASES 1975-77", "HN": "78(73); was see under HYDRO-LYASES 1975-77", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D000154"}, {"RECTYPE": "D", "MH": "Aconitic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pyrocitric Acid|T109|NON|NRW|UNK (19XX)|800813|abcdef", "MN": "D02.241.081.901.177", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "1-Propene-1,2,3-tricarboxylic acid", "RN": "93371T1BXP", "RR": "499-12-7 (Aconitic Acid)", "MS": "A tricarboxylic acid with the formula (COOH)-CH2-C(COOH)=CH-COOH.", "PM": "91; was see under TRICARBOXYLIC ACIDS 1973-90", "HN": "91(73); was see under TRICARBOXYLIC ACIDS 1973-90", "MR": "20180521", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000156"}, {"RECTYPE": "D", "MH": "Aconitine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aconitane-3,8,13,14,15-pentol, 20-ethyl-1,6,16-trimethoxy-4-(methoxymethyl)-, 8-acetate 14-benzoate, (1alpha,3alpha,6alpha,14alpha,15alpha,16beta)-|T109|T121|NON|EQV|NLM (2020)|190517|abbcdef", "ENTRY": "Acetylbenzoyl aconine", "MN": "D03.132.301.030", "PA": "Voltage-Gated Sodium Channel Agonists", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "X8YN71D5WC", "RR": "302-27-2 (Aconitine)", "AN": "ACONITE (see ACONITUM) is also available", "PI": "Aconite (1972-1974)", "MS": "A C19 norditerpenoid alkaloid (DITERPENES) from the root of ACONITUM; DELPHINIUM and larkspurs. It activates VOLTAGE-GATED SODIUM CHANNELS. It has been used to induce ARRHYTHMIAS in experimental animals and it has anti-inflammatory and anti-neuralgic properties.", "PM": "91; was see under ACONITE 1975-90", "HN": "91(75); was see under ACONITE 1975-90", "MR": "20190618", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000157"}, {"RECTYPE": "D", "MH": "Acoustic Impedance Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tympanometry|T060|NON|BRD|UNK (19XX)|770420|abcdef", "ENTRY": "Tests, Electroacoustic Impedance", "MN": "E01.370.382.375.050", "MH_TH": "NLM (1978)", "ST": "T060", "PI": "Tympanic Membrane (1966-1977)", "MS": "Objective tests of middle ear function based on the difficulty (impedance) or ease (admittance) of sound flow through the middle ear. These include static impedance and dynamic impedance (i.e., tympanometry and impedance tests in conjunction with intra-aural muscle reflex elicitation). This term is used also for various components of impedance and admittance (e.g., compliance, conductance, reactance, resistance, susceptance).", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D000158"}, {"RECTYPE": "D", "MH": "Vestibulocochlear Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Eighth Cranial Nerve|T023|NON|EQV|NLM (1998)|960731|abcdef", "ENTRY": "Vestibulocochlear Nerves", "MN": "A08.800.800.120.910", "EC": "injuries:Vestibulocochlear Nerve Injuries", "MH_TH": "NLM (1994)", "ST": "T023", "MS": "The 8th cranial nerve. The vestibulocochlear nerve has a cochlear part (COCHLEAR NERVE) which is concerned with hearing and a vestibular part (VESTIBULAR NERVE) which mediates the sense of balance and head position. The fibers of the cochlear nerve originate from neurons of the SPIRAL GANGLION and project to the cochlear nuclei (COCHLEAR NUCLEUS). The fibers of the vestibular nerve arise from neurons of Scarpa's ganglion and project to the VESTIBULAR NUCLEI.", "PM": "2000; see ACOUSTIC NERVE 1963-1999; for VESTIBULOCOCHLEAR NERVE see ACOUSTIC NERVE 1963-1999", "HN": "2000(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000159"}, {"RECTYPE": "D", "MH": "Vestibulocochlear Nerve Diseases", "DE": "VESTIBULOCOCHLEAR NERVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vestibular Nerve Diseases|T047|NON|NRW|NLM (2000)|991103|VESTIBULAR NERVE DIS|abcdefv", "ENTRY": "Vestibulocochlear Nerve Disease", "MN": "C10.292.910", "FX": "Hearing Loss, Central", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coordinate IM with COCHLEAR NERVE (IM) for cochlear nerve disease or with VESTIBULAR NERVE (IM) for vestibular nerve disease: neoplasms: coordinate IM with CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM)", "PI": "Vestibular Nerve (1966-1978)", "MS": "Pathological processes of the VESTIBULOCOCHLEAR NERVE, including the branches of COCHLEAR NERVE and VESTIBULAR NERVE. Common examples are VESTIBULAR NEURITIS, cochlear neuritis, and ACOUSTIC NEUROMA. Clinical signs are varying degree of HEARING LOSS; VERTIGO; and TINNITUS.", "PM": "2000; see ACOUSTIC NERVE DISEASES 1980-1999, use PERIPHERAL NERVE DISEASES 1979", "HN": "2000(1979)", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19780522", "DC": "1", "DX": "19800101", "UI": "D000160"}, {"RECTYPE": "D", "MH": "Acoustic Stimulation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Stimulation, Auditory|T060|T061|NON|EQV|NLM (1992)|901002|abbcdef", "MN": "E05.723.136", "FX": "Music Therapy", "MH_TH": "NLM (1973)", "ST": "T061", "PI": "Sound (1966-1971)", "MS": "Use of sound to elicit a response in the nervous system.", "PM": "73", "HN": "73(72)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000161"}, {"RECTYPE": "D", "MH": "Acoustics", "AQ": "IS", "ENTRY": "Acoustic", "MN": "H01.671.031", "FX": "Speech Acoustics", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "in speech & hearing research & for the environment (home, hospital, facilities, theater, etc.)", "MS": "The branch of physics that deals with sound and sound waves. In medicine it is often applied in procedures in speech and hearing studies. With regard to the environment, it refers to the characteristics of a room, auditorium, theatre, building, etc. that determines the audibility or fidelity of sounds in it. (From Random House Unabridged Dictionary, 2d ed)", "MR": "19950313", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000162"}, {"RECTYPE": "D", "MH": "Acquired Immunodeficiency Syndrome", "DE": "ACQUIRED IMMUNODEFIC SYNDROME", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Immunologic Deficiency Syndrome, Acquired|T047|NON|EQV|UNK (19XX)|830318|IMMUNOL DEFIC SYNDROME ACQUIRED|abcdefv", "ENTRY": "Syndromes, Acquired Immunodeficiency", "MN": "C20.673.480.040", "FX": "Lymphoma, AIDS-Related", "MH_TH": "POPLINE (1986)", "ST": "T047", "AN": "caused by HIV; coord IM with HIV-1 or HIV-2 (IM) if pertinent; /epidemiol: consider also HIV SEROPREVALENCE; AIDS-RELATED OPPORTUNISTIC INFECTIONS is available if particularly discussed: see note there; for lymphoma with AIDS, use LYMPHOMA, AIDS-RELATED", "PI": "Immunologic Deficiency Syndromes (1979-1982)", "MS": "An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19830318", "DC": "1", "DX": "19830101", "UI": "D000163"}, {"RECTYPE": "D", "MH": "Acremonium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Cephalosporium|T004|NON|EQV|UNK (19XX)|850211|abcdef", "ENTRY": "Cephalosporiums", "MN": "B01.300.381.025", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid5043", "AN": "infection: coordinate IM with MYCOSES (IM) or specific mycosis (IM)", "MS": "A mitosporic fungal genus with many reported ascomycetous teleomorphs. Cephalosporin antibiotics are derived from this genus.", "PM": "86; see CEPHALOSPORIUM 1963-85", "HN": "86(63)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D000164"}, {"RECTYPE": "D", "MH": "Acridine Orange", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tetramethyl Acridine Diamine|T109|T130|NON|EQV|UNK (19XX)|780201|abbcdef", "ENTRY": "Orange, Rhoduline", "MN": "D03.633.300.046.250.150", "PA": "Mutagens", "MH_TH": "NLM (1979)", "ST": "T130", "RN": "F30N4O6XVV", "RR": "65-61-2 (N,N,N',N'-Tetramethyl-3,6-Acridinediamine Hydrochloride)", "PI": "Dimethylamines (1974)", "MS": "A cationic cytochemical stain specific for cell nuclei, especially DNA. It is used as a supravital stain and in fluorescence cytochemistry. It may cause mutations in microorganisms.", "PM": "1979; EUCHRYSINE was indexed under AMINOACRIDINES 1979-1980", "HN": "1979", "MR": "20160527", "DA": "19780201", "DC": "1", "DX": "19790101", "UI": "D000165"}, {"RECTYPE": "D", "MH": "Acridines", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Acridine|T109|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D03.633.300.046", "MH_TH": "NLM (2017)", "ST": "T109", "RN": "0", "MS": "Compounds that include the structure of acridine.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000166"}, {"RECTYPE": "D", "MH": "Acriflavine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Xanthacridinum|T109|T121|T130|NON|EQV|UNK (19XX)|761223|abbbcdef", "ENTRY": "2,8-Diamino-10-Methylacridinium Chloride Mixture With 2,8-Diaminoacridine|T109|T121|T130|NON|EQV|NLM (2014)|130221|abbbcdef", "MN": "D03.633.300.046.250.177", "PA": "Intercalating Agents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Acridinium, 3,6-diamino-10-methyl-, chloride, mixt. with 3,6-acridinediamine", "RN": "1T3A50395T", "RR": "8048-52-0 (Acriflavine)", "MS": "3,6-Diamino-10-methylacridinium chloride mixt. with 3,6-acridinediamine. Fluorescent dye used as a local antiseptic and also as a biological stain. It intercalates into nucleic acids thereby inhibiting bacterial and viral replication.", "OL": "search ACRIDINES 1966-74", "PM": "91; was see under AMINOACRIDINES 1982-90; was see under ACRIDINES 1963-81", "HN": "91(75); was see under AMINOACRIDINES 1982-90; was see under ACRIDINES 1963-81", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000167"}, {"RECTYPE": "D", "MH": "Acrocephalosyndactylia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Saethre-Chotzen Syndrome|T019|T047|EPO|NRW|GHR (2014)|NLM (1997)|OMIM (2013)|ORD (2010)|960620|abbcdeeeef", "ENTRY": "Type V Acrocephalosyndactyly", "MN": "C16.131.621.906.819.100", "FX": "Twist-Related Protein 1", "MH_TH": "NLM (1966)", "ST": "T019", "MS": "Congenital craniostenosis with syndactyly.", "CATSH": "CAT LIST", "MR": "20160718", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000168"}, {"RECTYPE": "D", "MH": "Acrodermatitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Infantile Papular Acrodermatitis|T047|NON|NRW|NLM (1999)|980223|abcdef", "ENTRY": "Syndromes, Papulovesicular Acrolocated", "MN": "C17.800.804.066", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "dermatitis of hands or feet so do not bother to coord with HAND DERMATOSES or FOOT DERMATOSES unless particularly discussed", "MS": "Inflammation involving the skin of the extremities, especially the hands and feet. Several forms are known, some idiopathic and some hereditary. The infantile form is called Gianotti-Crosti syndrome.", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000169"}, {"RECTYPE": "D", "MH": "Acrodynia", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Swift Disease|T037|EPO|EQV|UNK (19XX)|840615|SWIFT DIS|abcdefv", "ENTRY": "Swifts Disease", "MN": "C25.723.522.875.500.100", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "A condition seen primarily in childhood, most often resulting from chronic exposure to MERCURY COMPOUNDS which may result in encephalopathy and POLYNEUROPATHY. Clinical features include pain, swelling and pinkish discoloration of the fingers and toes, weakness in the extremities, extreme irritability, HYPERESTHESIA, and alterations in level of consciousness. (From Menkes, Textbook of Child Neurology, 5th ed, p603)", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000170"}, {"RECTYPE": "D", "MH": "Acrolein", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Aldehyde, Ethylene", "MN": "D02.047.122", "MH_TH": "NLM (1973)", "ST": "T130", "N1": "2-Propenal", "RN": "7864XYD3JJ", "RR": "107-02-8 (Acrolein)", "MS": "Unsaturated three-carbon aldehyde.", "OL": "search ALDEHYDES 1966-72", "PM": "91; was see under ALDEHYDES 1973-90", "HN": "91(73); was see under ALDEHYDES 1973-90", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000171"}, {"RECTYPE": "D", "MH": "Acromegaly", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Somatotropin Hypersecretion Syndrome (Acromegaly)|T047|NON|EQV|NLM (2000)|991104|SOMATOTROPIN HYPERSECRET SYNDROME ACROMEGALY|abcdefv", "ENTRY": "Syndromes, Somatotropin Hypersecretion (Acromegaly)", "MN": "C19.700.355.179", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coordinate with GROWTH HORMONE in animals or HUMAN GROWTH HORMONE in humans if pertinent ", "MS": "A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000172"}, {"RECTYPE": "D", "MH": "Acromioclavicular Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Ligaments, Coracoacromial", "MN": "A02.835.583.032", "MH_TH": "NLM (1975)", "ST": "T030", "AN": "dislocation: coordinate with JOINT DISLOCATIONS", "PI": "Shoulder Joint (1966-1974)", "MS": "The gliding joint formed by the outer extremity of the CLAVICLE and the inner margin of the ACROMION PROCESS of the SCAPULA.", "OL": "search SHOULDER JOINT 1966-74", "PM": "79; was see under SHOULDER JOINT 1965-78, was see under SHOULDER 1963-64", "HN": "79(75); was see under SHOULDER JOINT 1965-78, was see under SHOULDER 1963-64", "MR": "20160706", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D000173"}, {"RECTYPE": "D", "MH": "Acromion", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Acromions", "MN": "A02.835.232.087.783.261", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "The lateral extension of the spine of the SCAPULA and the highest point of the SHOULDER.", "OL": "search SCAPULA 1966-74", "PM": "91; was see under SCAPULA 1975-90", "HN": "91(75); was see under SCAPULA 1975-90", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000174"}, {"RECTYPE": "D", "MH": "Acronine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acronycine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Acronycin|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D03.633.300.046.109.077", "PA": "Antineoplastic Agents, Phytogenic", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "7H-Pyrano(2,3-c)acridin-7-one, 3,12-dihydro-6-methoxy-3,3,12-trimethyl-", "RN": "QE0G097358", "RR": "7008-42-6 (Acronine)", "AN": "/biosyn permitted if by plant", "PI": "Alkaloids (1971-1974)", "MS": "A pyrano-acridone alkaloid found in RUTACEAE plants.", "PM": "91; was see under ALKALOIDS 1975-90", "HN": "91(75); was see under ALKALOIDS 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000175"}, {"RECTYPE": "D", "MH": "Acrosin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Acrosomal proteinase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "proteinase, Acrosomal", "MN": "D08.811.277.656.959.350.030", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.4.21.10", "PI": "Peptide Peptidohydrolases (1973-1974)", "MS": "A trypsin-like enzyme of spermatozoa which is not inhibited by alpha 1 antitrypsin.", "PM": "91; was see under SERINE PROTEINASES 1975-90", "HN": "91(75); was see under SERINE ENDOPEPTIDASES 1975-90", "MR": "20090706", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000176"}, {"RECTYPE": "D", "MH": "Acrosome", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Acrosomes", "MN": "A11.497.760.400.100", "FX": "Acrosome Reaction", "MH_TH": "NLM (1975)", "ST": "T026", "MS": "The cap-like structure covering the anterior portion of SPERM HEAD. Acrosome, derived from LYSOSOMES, is a membrane-bound organelle that contains the required hydrolytic and proteolytic enzymes necessary for sperm penetration of the egg in FERTILIZATION.", "PM": "91; was see under SPERMATOZOA 1975-90", "HN": "91(75); was see under SPERMATOZOA 1975-90", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000177"}, {"RECTYPE": "D", "MH": "Acrylamides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.081.069.094", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "AN": "ACRYLAMIDE is also available", "PI": "Acrylates (1966-1970)", "MS": "Colorless, odorless crystals that are used extensively in research laboratories for the preparation of polyacrylamide gels for electrophoresis and in organic synthesis, and polymerization. Some of its polymers are used in sewage and wastewater treatment, permanent press fabrics, and as soil conditioning agents.", "PM": "73", "HN": "73(71)", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000178"}, {"RECTYPE": "D", "MH": "Acrylates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.081.069", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of acrylic acid (the structural formula CH2=CHCO2H), including its salts and esters.", "PM": "66", "HN": "66", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000179"}, {"RECTYPE": "D", "MH": "Acrylic Resins", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Acrylic Resin|T122|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Resins, Acrylic", "MN": "J01.637.051.720.716.822.111", "FX": "Dental Materials", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "MS": "Polymers of high molecular weight which are derived from acrylic acid, methacrylic acid or other related compounds and are capable of being molded and then hardened to form useful components.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000180"}, {"RECTYPE": "D", "MH": "Acrylonitrile", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vinyl Cyanide|T109|T131|NON|EQV|UNK (19XX)|760413|abbcdef", "ENTRY": "Cyanide, Vinyl", "MN": "D02.626.095", "PA": "Carcinogens", "MH_TH": "NLM (1977)", "ST": "T131", "N1": "2-Propenenitrile", "RN": "MP1U0D42PE", "RR": "107-13-1 (Acrylonitrile)", "PI": "Vinyl Compounds (1973-1976)", "MS": "A highly poisonous compound used widely in the manufacture of plastics, adhesives and synthetic rubber.", "PM": "91; see NITRILES 1977-90", "HN": "91(77)", "MR": "20130708", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D000181"}, {"RECTYPE": "D", "MH": "ACTH Syndrome, Ectopic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ectopic ACTH Syndrome|T047|EQV|UNK (19XX)|790529|abdef", "ENTRY": "Syndromes, Ectopic ACTH", "MN": "C04.730.713.317", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "coordinate with precoordinated organ/neoplasm term  + histological type of neoplasm  ", "PI": "Adrenocorticotropic Hormone (1966-1979)", "MS": "Symptom complex due to ACTH production by non-pituitary neoplasms.", "PM": "91; was see under NEOPLASTIC ENDOCRINE-LIKE SYNDROMES 1980-90", "HN": "91(80); was see under NEOPLASTIC ENDOCRINE-LIKE SYNDROMES 1980-90", "CATSH": "CAT LIST", "MR": "20180614", "DA": "19790529", "DC": "1", "DX": "19910101", "UI": "D000182"}, {"RECTYPE": "D", "MH": "Actihaemyl", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Solcoseryl|T109|T121|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "S 1021|T109|T121|T123|LAB|NRW|UNK (19XX)|800731|abbbcdef", "MN": "D20.777.050", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Actihaemyl", "RN": "37239-28-4", "PI": "Tissue Extracts (1973-1974)", "MS": "An extract from calf blood containing inorganic salts, amino acids, polypeptides and purines, but no proteins nor antigenic substances or blood group characteristics. Its exact composition is unknown. It has been proposed as a radiation-protective agent.", "PM": "91; was see under TISSUE EXTRACTS 1975-90", "HN": "91(75); was see under TISSUE EXTRACTS 1975-90", "MR": "20160628", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000183"}, {"RECTYPE": "D", "MH": "Acting Out", "MN": "F01.393.047", "MH_TH": "NLM (1968)", "ST": "T055", "PI": "Psychoanalytic Therapy (1966-1967)", "MS": "Expressing unconscious emotional conflicts or feelings, often of hostility or love, through overt behavior.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000184"}, {"RECTYPE": "D", "MH": "Actinin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-Actinin|T116|T123|NON|NRW|UNK (19XX)|840416|abbcdef", "ENTRY": "beta Actinin", "MN": "D12.776.220.525.250", "MH_TH": "NLM (1976)", "ST": "T123", "N1": "Actinins, alpha-", "RN": "11003-00-2", "AN": "a muscle & microfilament protein; /biosyn /physiol permitted", "PI": "Muscle Proteins (1970-1975)", "MS": "A protein factor that regulates the length of R-actin. It is chemically similar, but immunochemically distinguishable from actin.", "PM": "85; was see under MUSCLE PROTEINS 1976-84", "HN": "85(76); was see under MUSCLE PROTEINS 1976-84", "MR": "20060705", "DA": "19750723", "DC": "1", "DX": "19850101", "UI": "D000185"}, {"RECTYPE": "D", "MH": "Actinium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.025", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Actinium", "RN": "NIK1K0956U", "RR": "7440-34-8 (Actinium)", "MS": "A trivalent radioactive element and the prototypical member of the actinide family. It has the atomic symbol Ac, and atomic number 89. Its principal isotope is 227 and it decays primarily by beta-emission.", "MR": "20170421", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000186"}, {"RECTYPE": "D", "MH": "Actinobacillosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Actinobacilloses", "MN": "C22.039", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "a vet dis entity caused by Actinobacillus lignieresii: do not confuse with ACTINOBACILLUS INFECTIONS; check tag ANIMALS", "PI": "Cattle Diseases (1966-1967)", "MS": "A disease characterized by suppurative and granulomatous lesions in the respiratory tract, upper alimentary tract, skin, kidneys, joints, and other tissues. Actinobacillus lignieresii infects cattle and sheep while A. equuli infects horses and pigs.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000187"}, {"RECTYPE": "D", "MH": "Actinobacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.550.050", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid713", "MS": "A genus of PASTEURELLACEAE described as gram-negative, nonsporeforming, nonmotile, facultative anaerobes. Most members are found both as pathogens and commensal organisms in the respiratory, alimentary, and genital tracts of animals.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000188"}, {"RECTYPE": "D", "MH": "Actinobacillus Infections", "DE": "ACTINOBACILLUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Actinobacillus", "MN": "C01.150.252.400.700.030", "MH_TH": "NLM (1972)", "ST": "T047", "AN": "do not confuse with ACTINOBACILLOSIS, a specific vet dis entity caused by A. lignieresii", "PI": "Actinobacillus (1966-1971)", "MS": "Infections with bacteria of the genus ACTINOBACILLUS.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000189"}, {"RECTYPE": "D", "MH": "Actinomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.049.178", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1654", "MS": "A genus of gram-positive, rod-shaped bacteria whose organisms are nonmotile. Filaments that may be present in certain species are either straight or wavy and may have swollen or clubbed heads.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000190"}, {"RECTYPE": "D", "MH": "Actinomycetaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.049", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid2049", "AN": "a family of the order ACTINOMYCETALES", "PI": "Actinomycetales (1966-1974)", "MS": "A family of bacteria including numerous parasitic and pathogenic forms.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D000191"}, {"RECTYPE": "D", "MH": "Actinomycetales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Coryneform Group|T007|NON|REL|UNK (1992)|910415|abcdef", "MN": "B03.510.024.049", "MH_TH": "NLM (1967)", "ST": "T007", "RN": "txid2037", "RR": "txid1653", "MS": "An order of gram-positive, primarily aerobic BACTERIA that tend to form branching filaments.", "OL": "use ACTINOMYCETALES to search ACTINOMYCETES 1966; CORYNEBACTERIACEAE 1975-91; CORYNEFORM GROUP 1976-91", "PM": "67; was ACTINOMYCETES 1963-66; CORYNEBACTERIACEAE was heading 1975-91 (see under CORYNEFORM GROUP 1976-90); CORYNEFORM GROUP was heading 1976-91", "HN": "67; was ACTINOMYCETES 1963-66; CORYNEBACTERIACEAE was heading 1975-91 (see under CORYNEFORM GROUP 1976-90); CORYNEFORM GROUP was heading 1976-91", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000192"}, {"RECTYPE": "D", "MH": "Actinomycetales Infections", "DE": "ACTINOMYCETALES INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Actinomycete Infections|T047|NON|EQV|UNK (19XX)|780322|ACTINOMYCETE INFECT|abcdefv", "ENTRY": "Infection, Actinomycete", "MN": "C01.150.252.410.040", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "gram-pos bact infect by organism of the order ACTINOMYCETALES; do not confuse with ACTINOMYCOSIS, infection by genus ACTINOMYCES", "PI": "Actinomycetales (1966-1971)", "MS": "Infections with bacteria of the order ACTINOMYCETALES.", "OL": "use ACTINOMYCETALES INFECTIONS to search ACTINOMYCETE INFECTIONS 1972-76", "PM": "77; was ACTINOMYCETE INFECTIONS 1972-76", "HN": "77; was ACTINOMYCETE INFECTIONS 1972-76", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000193"}, {"RECTYPE": "D", "MH": "Actinomycosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Actinomyces Infections|T047|NON|EQV|NLM (1992)|910412|ACTINOMYCES INFECT|abcdefv", "ENTRY": "Infection, Actinomyces", "MN": "C01.150.252.410.040.137", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Infections with bacteria of the genus ACTINOMYCES.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000196"}, {"RECTYPE": "D", "MH": "Actinomycosis, Cervicofacial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C17.800.838.765.110", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A form of ACTINOMYCOSIS characterized by slow-growing inflammatory lesions of the lymph nodes that drain the mouth (lumpy jaw), reddening of the overlying skin, and intraperitoneal abscesses.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000197"}, {"RECTYPE": "D", "MH": "Spectinomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Actinospectacin|T109|T195|NON|EQV|FDA SRS (2014)|NLM (1993)|920312|abbcdeef", "ENTRY": "Spectam, Ferkel", "MN": "D09.408.051.836", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "4H-Pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, (2R-(2alpha,4abeta,5abeta,6beta,7beta,8beta,9alpha,9aalpha,10abeta))-", "RN": "93AKI1U6QF", "RR": "HWT06H303Z", "MS": "An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of GONORRHEA.", "OL": "use SPECTINOMYCIN to search ACTINOSPECTACIN 1966-92 (as Prov 1966-72)", "PM": "93; see ACTINOSPECTACIN 1965-92 (Prov 1965-72); SPECTINOMYCIN was see ACTINOSPECTACIN 1978-92", "HN": "93; was ACTINOSPECTACIN 1973-92; SPECTINOMYCIN was see ACTINOSPECTACIN 1978-92", "MR": "20180301", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000198"}, {"RECTYPE": "D", "MH": "Actins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "G-Actin|T116|T123|NON|NRW|UNK (19XX)|850605|abbcdef", "ENTRY": "gamma Actin", "MN": "D12.776.220.525.255", "MH_TH": "NLM (1971)", "ST": "T123", "RN": "0", "PI": "Muscle Proteins (1966-1970)", "MS": "Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-actin) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle.", "OL": "use ACTINS to search ACTIN 1971-81 (as Prov 1971-72)", "PM": "82; was ACTIN 1973-81", "HN": "82; was ACTIN 1971-81 (Prov 1971-72)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000199"}, {"RECTYPE": "D", "MH": "Action Potentials", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Spike Potentials|T043|NON|REL|NLM (1998)|961010|abcdef", "ENTRY": "Spike Potential", "MN": "G11.561.570.100", "FX": "Neural Conduction", "MH_TH": "NLM (1967)", "ST": "T043", "AN": "do not confuse with SYNAPTIC POTENTIALS see SYNAPTIC TRANSMISSION", "PI": "Electrophysiology (1966)", "MS": "Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli.", "PM": "68", "HN": "68(67)", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000200"}, {"RECTYPE": "D", "MH": "Activation Analysis", "DE": "ACTIVATION ANAL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Analyses, Activation", "MN": "E05.196.039", "MH_TH": "NLM (1963)", "ST": "T059", "AN": "usually NIM", "MS": "A method of chemical analysis based on the detection of characteristic radionuclides following a nuclear bombardment. It is also known as radioactivity analysis. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "67", "HN": "67(63)", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000201"}, {"RECTYPE": "D", "MH": "Activator Appliances", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Orthodontic Appliances, Activator|T074|NON|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "Orthodontic Appliance, Activator", "MN": "E06.658.453.578.100", "MH_TH": "NLM (1975)", "ST": "T074", "MS": "Loose-fitting removable orthodontic appliances which redirect the pressures of the facial and masticatory muscles onto the teeth and their supporting structures to produce improvements in tooth arrangements and occlusal relations.", "PM": "91; was see under ORTHODONTIC APPLIANCES, REMOVABLE 1975-90", "HN": "91(75); was see under ORTHODONTIC APPLIANCES, REMOVABLE 1975-90", "CATSH": "CAT LIST", "MR": "20000621", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D000202"}, {"RECTYPE": "D", "MH": "Activities of Daily Living", "AQ": "CL PX", "PRINT ENTRY": "Limitation of Activity, Chronic|T080|NON|NRW|UNK (19XX)|780112|abcdef", "ENTRY": "Living Activity, Daily", "MN": "N02.421.784.110", "FX": "Sickness Impact Profile", "MH_TH": "NLM (1968)", "ST": "T061", "PI": "Rehabilitation (1966-1967)", "MS": "The performance of the basic activities of self care, such as dressing, ambulation, or eating.", "OL": "use ACTIVITIES OF DAILY LIVING to search SELF CARE 1979-80", "PM": "68; SELF CARE (REHABILITATION) was SELF CARE see ACTIVITIES OF DAILY LIVING 1979-80", "HN": "68; SELF CARE (REHABILITATION) was SELF CARE see ACTIVITIES OF DAILY LIVING 1979-80", "CATSH": "CAT LIST", "MR": "20161219", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000203"}, {"RECTYPE": "D", "MH": "Activity Cycles", "AQ": "DE ES GE IM PH RE", "ENTRY": "Cycles, Activity", "MN": "G07.180.562.797.500", "MH_TH": "NLM (1975)", "ST": "T079", "MS": "Bouts of physical irritability or movement alternating with periods of quiescence. It includes biochemical activity and hormonal activity which may be cellular. These cycles are shorter than 24 hours and include sleep-wakefulness cycles and the periodic activation of the digestive system.", "OL": "search CIRCADIAN RHYTHM 1968-74", "PM": "91; was see under CIRCADIAN RHYTHM 1975-90", "HN": "91(75); was see under CIRCADIAN RHYTHM 1975-90", "CATSH": "CAT LIST", "MR": "20160309", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000204"}, {"RECTYPE": "D", "MH": "Actomyosin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.210.500.154", "MH_TH": "NLM (1971)", "ST": "T123", "N1": "Actomyosins", "RN": "9013-26-7", "AN": "a muscle protein; /biosyn /physiol permitted", "PI": "Muscle Proteins (1966-1970)", "MS": "A protein complex of actin and MYOSINS occurring in muscle. It is the essential contractile substance of muscle.", "OL": "search MUSCLE PROTEINS 1966-70", "PM": "73; was see under MUSCLE PROTEINS 1963-72", "HN": "73(71); was see under MUSCLE PROTEINS 1963-72", "MR": "20010803", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000205"}, {"RECTYPE": "D", "MH": "Actuarial Analysis", "DE": "ACTUARIAL ANAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Analyses, Actuarial", "MN": "N06.850.520.830.100", "MH_TH": "NLM (1979)", "ST": "T057", "MS": "The application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability, or death. It may include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19780508", "DC": "1", "DX": "19790101", "UI": "D000206"}, {"RECTYPE": "D", "MH": "Acute Disease", "DE": "ACUTE DIS", "AQ": "CL EC EP MO NU PX RH TH", "ENTRY": "Diseases, Acute", "MN": "C23.550.291.125", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "IM general only; usually NIM with specific disease IM", "MS": "Disease having a short and relatively severe course.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000208"}, {"RECTYPE": "D", "MH": "Acute-Phase Proteins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Reactants, Acute-Phase|T116|T123|NON|EQV|UNK (19XX)|860414|abbcdef", "ENTRY": "Reactants, Acute Phase", "MN": "D12.776.124.050", "MH_TH": "NLM (1987)", "ST": "T123", "RN": "0", "AN": "blood proteins; /biosyn /drug eff /physiol permitted", "PI": "Glycoproteins (1966-1986)", "MS": "Proteins that are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. These proteins can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumor markers.", "PM": "87", "HN": "87", "MR": "20200527", "DA": "19860414", "DC": "1", "DX": "19870101", "UI": "D000209"}, {"RECTYPE": "D", "MH": "Acute-Phase Reaction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Response, Acute-Phase|T033|T046|NON|EQV|UNK (19XX)|860325|abbcdef", "ENTRY": "State, Acute-Phase", "MN": "C23.550.470.099", "MH_TH": "NLM (1987)", "ST": "T046", "AN": "note category: in presence of a disease, use /etiol, not /compl", "PI": "Inflammation (1966-1986)", "MS": "An early local inflammatory reaction to insult or injury that consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma.", "OL": "use ACUTE-PHASE REACTION to search ACUTE PHASE REACTION 1987-91", "PM": "92; was ACUTE PHASE REACTION 1987-91 (see under INFLAMMATION 1987-90)", "HN": "92; was ACUTE PHASE REACTION 1987-91 (see under INFLAMMATION 1987-90)", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19860325", "DC": "1", "DX": "19910101", "UI": "D000210"}, {"RECTYPE": "D", "MH": "Acyclovir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acycloguanosine|T114|T121|NON|EQV|UNK (19XX)|820505|abbcdef", "ENTRY": "Wellcome248U", "MN": "D03.633.100.759.758.399.454.250", "PA": "Antiviral Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-", "RN": "X4HES1O11F", "RR": "927L42J563", "PI": "Guanine (1966-1982)", "MS": "A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes.", "PM": "83", "HN": "83", "MR": "20160701", "DA": "19820505", "DC": "1", "DX": "19830101", "UI": "D000212"}, {"RECTYPE": "D", "MH": "Acyl Carrier Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, Acyl Carrier", "MN": "D12.776.157.050", "MH_TH": "NLM (1978)", "ST": "T123", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Carrier Proteins (1971-1977)", "MS": "Consists of a polypeptide chain and 4'-phosphopantetheine linked to a serine residue by a phosphodiester bond. Acyl groups are bound as thiol esters to the pantothenyl group. Acyl carrier protein is involved in every step of fatty acid synthesis by the cytoplasmic system.", "PM": "78", "HN": "78", "MR": "19920522", "DA": "19770520", "DC": "1", "DX": "19780101", "UI": "D000213"}, {"RECTYPE": "D", "MH": "Acyl Coenzyme A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Long-Chain Acyl CoA|T109|T114|EQV|UNK (19XX)|770520|abbdef", "ENTRY": "Long Chain Acyl CoA", "MN": "D13.695.827.068.382.300", "MH_TH": "NLM (1978)", "ST": "T114", "RN": "0", "AN": "do not confuse with ACETYL COENZYME A", "PI": "Coenzyme A (1966-1977)", "MS": "S-Acyl coenzyme A. Fatty acid coenzyme A derivatives that are involved in the biosynthesis and oxidation of fatty acids as well as in ceramide formation.", "PM": "78", "HN": "78", "MR": "20160527", "DA": "19770520", "DC": "1", "DX": "19780101", "UI": "D000214"}, {"RECTYPE": "D", "MH": "Acylation", "AQ": "DE GE IM PH RE", "MN": "G03.040", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "almost never IM; enzymatic acylation: coord NIM with ACYLTRANSFERASES (IM) + substrate (NIM) or specific acyltransferase (IM); ACETYLATION & ACETYLTRANSFERASES are also available", "PI": "Chemistry, Organic (1966-1970)", "MS": "The addition of an organic acid radical into a molecule.", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000215"}, {"RECTYPE": "D", "MH": "N-Acylneuraminate Cytidylyltransferase", "DS": "ACYLNEURAMINATE Z", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CMP-N-Acetylneuraminic Acid Synthetase|T116|T126|EQV|UNK (19XX)|741111|CMP ACETYLNEURAMINIC ACID SYNTHETASE N|abbdefs", "ENTRY": "Synthetase, CMP-Sialic Acid", "MN": "D08.811.913.696.445.035", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "CTP:N-acylneuraminate cytidylyltransferase", "RN": "EC 2.7.7.43", "RR": "9067-82-7 (CAS RN)", "PI": "Nucleotidyltransferases (1973-1974)", "MS": "An enzyme that forms CMP-acylneuraminic acids, which donate the N-acylneuraminic acid residues to the terminal sugar residue of a ganglioside or glycoprotein. EC 2.7.7.43.", "PM": "98; see ACYLNEURAMINATE CYTIDYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90", "HN": "98(75); see NUCLEOTIDYLTRANSFERASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000216"}, {"RECTYPE": "D", "MH": "Acyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Acyltransferase|T116|T126|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D08.811.913.050", "MH_TH": "NLM (1964)", "ST": "T126", "RN": "EC 2.3.-", "MS": "Enzymes from the transferase class that catalyze the transfer of acyl groups from donor to acceptor, forming either esters or amides. (From Enzyme Nomenclature 1992) EC 2.3.", "PM": "64", "HN": "64", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D000217"}, {"RECTYPE": "D", "MH": "Adamantane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Diamantane|T109|NON|EQV|NLM (1996)|940906|abcdef", "MN": "D02.455.426.392.368.075", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "Tricyclo(3.3.1.1(3,7))decane", "RN": "PJY633525U", "RR": "281-23-2 (Adamantane)", "AN": "a cycloparaffin", "PI": "Cycloparaffins (1966-1974)", "MS": "A tricyclo bridged hydrocarbon.", "OL": "use ADAMANTANE to search DIAMANTANE 1975-95", "PM": "80; was see under BRIDGED COMPOUNDS 1975-79; DIAMANTANE was see ADAMANTANE 1975-95", "HN": "80(75); was see under BRIDGED COMPOUNDS 1975-79; DIAMANTANE was see ADAMANTANE 1975-95", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19800101", "UI": "D000218"}, {"RECTYPE": "D", "MH": "Adams-Stokes Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stokes-Adams Attacks|T047|EPO|EQV|UNK (19XX)|860418|abcdef", "ENTRY": "Syndrome, Stokes-Adams", "MN": "C23.550.073.425.025", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "A condition of fainting spells caused by heart block, often an atrioventricular block, that leads to BRADYCARDIA and drop in CARDIAC OUTPUT. When the cardiac output becomes too low, the patient faints (SYNCOPE). In some cases, the syncope attacks are transient and in others cases repetitive and persistent.", "PM": "65; was see under HEART BLOCK 1963-64", "HN": "65(63); was see under HEART BLOCK 1963-64", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000219"}, {"RECTYPE": "D", "MH": "Adaptation, Biological", "DE": "ADAPTATION BIOL", "AQ": "DE ES GE IM PH RE", "ENTRY": "Biologic Adaptation", "MN": "G16.012", "FX": "Adaptation, Physiological", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "much of biological adaptation will be ADAPTATION, PHYSIOLOGICAL as more specific", "MS": "Changes in biological features that help an organism cope with its ENVIRONMENT. These changes include physiological (ADAPTATION, PHYSIOLOGICAL), phenotypic and genetic changes.", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000220"}, {"RECTYPE": "D", "MH": "Adaptation, Ocular", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Light Adaptation|T042|NON|NRW|NLM (1996)|950216|abcdef", "ENTRY": "Ocular Adaptations", "MN": "G14.020", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "adjustment of eye to variations in intensity of light; do not confuse with ACCOMMODATION, OCULAR, adjustment of lens to distance", "MS": "The adjustment of the eye to variations in the intensity of light. Light adaptation is the adjustment of the eye when the light threshold is increased; DARK ADAPTATION when the light is greatly reduced. (From Cline et al., Dictionary of Visual Science, 4th ed)", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000221"}, {"RECTYPE": "D", "MH": "Adaptation, Physiological", "DE": "ADAPTATION PHYSIOL", "AQ": "DE GE IM PH RE", "ENTRY": "Plasticity, Phenotypic", "MN": "G16.012.500", "MH_TH": "NLM (1966)", "ST": "T040", "AN": "ADAPTATION, PSYCHOLOGICAL is also available", "MS": "The non-genetic biological changes of an organism in response to challenges in its ENVIRONMENT.", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000222"}, {"RECTYPE": "D", "MH": "Adaptation, Psychological", "DE": "ADAPTATION PSYCHOL", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Psychological Recovery|T055|NON|REL|NLM (2024)|230420|abcdef", "ENTRY": "Recovery, Psychological", "MN": "F01.058", "FX": "Social Adjustment", "MH_TH": "NLM (1966)", "ST": "T055", "AN": "human & animal", "MS": "A state of harmony between internal needs and external demands and the processes used in achieving this condition. (From APA Thesaurus of Psychological Index Terms, 8th ed).", "PM": "2021, see SOCIAL ADJUSTMENT (1986-2020)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000223"}, {"RECTYPE": "D", "MH": "Addison Disease", "DE": "ADDISON DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Primary Adrenocortical Insufficiencies", "MN": "C20.111.163", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "An adrenal disease characterized by the progressive destruction of the ADRENAL CORTEX, resulting in insufficient production of ALDOSTERONE and HYDROCORTISONE. Clinical symptoms include ANOREXIA; NAUSEA; WEIGHT LOSS; MUSCLE WEAKNESS; and HYPERPIGMENTATION of the SKIN due to increase in circulating levels of ACTH precursor hormone which stimulates MELANOCYTES.", "PM": "2005; see ADDISON'S DISEASE 1966-2004", "HN": "2005 (1963)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D000224"}, {"RECTYPE": "D", "MH": "Adenine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitamin B 4|T114|T123|NON|EQV|NLM (1998)|970311|VITAMIN B A 04|abbcdefs", "ENTRY": "B 4, Vitamin", "MN": "D03.633.100.759.138", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "1H-Purin-6-amine", "RN": "JAC85A2161", "RR": "73-24-5 (Adenine)", "AN": "/biosyn/physiol permitted", "MS": "A purine base and a fundamental unit of ADENINE NUCLEOTIDES.", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000225"}, {"RECTYPE": "D", "MH": "Mitochondrial ADP, ATP Translocases", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenine Nucleotide Translocase|T116|T123|NON|BRD|NLM (1976)|990101|abbcdef", "ENTRY": "Mitochondrial ADP ATP Carriers", "MN": "D12.776.575.750.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "9068-80-8", "PI": "Nucleotidyltransferases (1972-1975)", "MS": "A class of nucleotide translocases found abundantly in mitochondria that function as integral components of the inner mitochondrial membrane. They facilitate the exchange of ADP and ATP between the cytosol and the mitochondria, thereby linking the subcellular compartments of ATP production to those of ATP utilization.", "PM": "2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1991-2002 & NUCLEOTIDYLTRANSFERASES 1976-1990", "HN": "2003(1976)", "MR": "20151124", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D000226"}, {"RECTYPE": "D", "MH": "Adenine Nucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adenosine Phosphates|T114|NON|EQV|UNK (19XX)|770401|abcdef", "ENTRY": "Phosphates, Adenosine", "MN": "D13.695.827.068", "MH_TH": "NLM (1966)", "ST": "T114", "RN": "0", "AN": "/biosyn /physiol permitted", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000227"}, {"RECTYPE": "D", "MH": "Adenine Phosphoribosyltransferase", "DE": "APRT", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transphosphoribosidase|T116|T126|NON|EQV|UNK (19XX)|750822|abbcdef", "ENTRY": "Pyrophosphorylase, AMP", "MN": "D08.811.913.400.725.100", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "AMP:pyrophosphate phospho-D-ribosyltransferase", "RN": "EC 2.4.2.7", "RR": "9027-80-9 (CAS RN)", "PI": "Pyrophosphoric Acids (1972-1974)", "MS": "An enzyme catalyzing the formation of AMP from adenine and phosphoribosylpyrophosphate. It can act as a salvage enzyme for recycling of adenine into nucleic acids. EC 2.4.2.7.", "PM": "91; was see under PENTOSYLTRANSFERASES 1975-90", "HN": "91(75); was see under PENTOSYLTRANSFERASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000228"}, {"RECTYPE": "D", "MH": "Dependovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Dependoparvovirus|T005|NON|EQV|NLM (2023)|210811|abcdef", "ENTRY": "Viruses, Adeno Associated", "MN": "B04.280.580.650.170", "MH_TH": "NLM (1979)", "ST": "T005", "RN": "txid10803", "RR": "txid272636", "AN": "infection: coordinate with PARVOVIRIDAE INFECTIONS ", "PI": "Viruses (1966)", "MS": "A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, which are dependent on a coinfection with helper adenoviruses or herpesviruses for their efficient replication. The type species is Adeno-associated virus 2.", "OL": "use DEPENDOVIRUS to search ADENO-ASSOCIATED VIRUSES 1979-93; use SATELLITE VIRUSES 1975-78; use PARVOVIRIDAE to search DEPENDOVIRUS 1992-93", "PM": "94; was ADENO-ASSOCIATED VIRUSES 1979-93; was ADENO-ASSOCIATED VIRUSES see SATELLITE VIRUSES 1975-78; DEPENDOVIRUS was see PARVOVIRIDAE 1992-93", "HN": "94; was ADENO-ASSOCIATED VIRUSES 1979-93; was ADENO-ASSOCIATED VIRUSES see SATELLITE VIRUSES 1975-78; DEPENDOVIRUS was see PARVOVIRIDAE 1992-93", "MR": "20211018", "DA": "19771205", "DC": "1", "DX": "19790101", "UI": "D000229"}, {"RECTYPE": "D", "MH": "Adenocarcinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Carcinoma, Tubular|T191|NON|NRW|NLM (1994)|930326|abcdef", "ENTRY": "Tubular Carcinomas", "MN": "C04.557.470.200.025", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with precoord organ/neopl term (IM)", "MS": "A malignant epithelial tumor with a glandular organization.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000230"}, {"RECTYPE": "D", "MH": "Adenocarcinoma, Papillary", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Papillary Adenocarcinomas", "MN": "C04.557.470.200.025.085", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term ", "MS": "An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000231"}, {"RECTYPE": "D", "MH": "Adenofibroma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Adenofibromas", "MN": "C04.557.470.625.050", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "do not confuse with FIBROADENOMA; coordinate with precoordinated organ/neoplasm term ", "MS": "A benign neoplasm composed of glandular and fibrous tissues, with a relatively large proportion of glands. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000232"}, {"RECTYPE": "D", "MH": "Adenoidectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Adenoidectomies", "MN": "E04.580.068", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Excision of the adenoids. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000233"}, {"RECTYPE": "D", "MH": "Adenoids", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Tonsil, Pharyngeal|T023|NON|EQV|NLM (1998)|960711|abcdef", "ENTRY": "Tonsils, Pharyngeal", "MN": "A15.382.520.604.100", "FX": "Adenoidectomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A collection of lymphoid nodules on the posterior wall and roof of the NASOPHARYNX.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000234"}, {"RECTYPE": "D", "MH": "Adenolymphoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Warthin Tumor|T191|EPO|EQV|UNK (19XX)|800509|abcdef", "ENTRY": "Tumor, Warthin", "MN": "C04.557.435.075", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A benign tumor characterized histologically by tall columnar epithelium within a lymphoid tissue stroma. It is usually found in the salivary glands, especially the parotid.", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000235"}, {"RECTYPE": "D", "MH": "Adenoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Adenoma, Trabecular|T191|NON|REL|NLM (1994)|930326|abcdef", "ENTRY": "Trabecular Adenomas", "MN": "C04.557.470.035", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "general or unspecified; prefer specifics; coordinate with precoordinated organ/neoplasm term ", "MS": "A benign epithelial tumor with a glandular organization.", "CATSH": "CAT LIST", "MR": "19991109", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000236"}, {"RECTYPE": "D", "MH": "Adenoma, Basophil", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Basophilic Adenomas", "MN": "C04.557.580.625.650.075", "FX": "Pituitary Neoplasms", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with PITUITARY NEOPLASMS", "MS": "A small tumor of the anterior lobe of the pituitary gland whose cells stain with basic dyes. It may give rise to excessive secretion of ACTH, resulting in CUSHING SYNDROME. (Dorland, 27th ed)", "OL": "use ADENOMA, BASOPHIL to search ADENOMA, BASOPHILIC 1966-93", "PM": "94; was ADENOMA, BASOPHILIC 1963-93", "HN": "94; was ADENOMA, BASOPHILIC 1963-93", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D000237"}, {"RECTYPE": "D", "MH": "Adenoma, Chromophobe", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Chromophobe Adenomas", "MN": "C04.557.580.625.650.095", "FX": "Pituitary Neoplasms", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with PITUITARY NEOPLASMS (IM)", "MS": "A benign tumor of the anterior pituitary in which the cells do not stain with acidic or basic dyes.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000238"}, {"RECTYPE": "D", "MH": "Adenoma, Acidophil", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Adenoma, Eosinophilic|T191|NON|EQV|NLM (1994)|930329|abcdef", "ENTRY": "Eosinophilic Adenomas", "MN": "C04.557.580.625.650.025", "FX": "Pituitary Neoplasms", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with PITUITARY NEOPLASMS ", "MS": "A benign tumor, usually found in the anterior lobe of the pituitary gland, whose cells stain with acid dyes. Such pituitary tumors may give rise to excessive secretion of growth hormone, resulting in gigantism or acromegaly. A specific type of acidophil adenoma may give rise to nonpuerperal galactorrhea. (Dorland, 27th ed)", "OL": "use ADENOMA, ACIDOPHIL to search ADENOMA, EOSINOPHILIC 1966-93", "PM": "94; was ADENOMA, EOSINOPHILIC 1963-93", "HN": "94; was ADENOMA, EOSINOPHILIC 1963-93", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D000239"}, {"RECTYPE": "D", "MH": "Adenosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Adenoscan|T114|T121|TRD|NRW|NLM (2015)|131203|abbcdef", "MN": "D13.570.800.096", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "Adenosine", "RN": "K72T3FS567", "RR": "58-61-7 (Adenosine)", "PI": "Nucleosides (1966-1971)", "MS": "A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.", "OL": "search NUCLEOSIDES 1966-71", "PM": "72; was see under NUCLEOSIDES 1963-71", "HN": "72; was see under NUCLEOSIDES 1963-71", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000241"}, {"RECTYPE": "D", "MH": "Cyclic AMP", "DE": "CYCL AMP", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adenosine Cyclic 3',5'-Monophosphate|T114|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|790522|ADENOSINE CYCLIC MONOPHOSPHATE 03 05|abbcdeefs", "ENTRY": "Monophosphate, Adenosine Cyclic", "MN": "D13.695.827.068.395", "FX": "Receptors, Cyclic AMP", "MH_TH": "POPLINE (1984)", "ST": "T123", "N1": "Adenosine, cyclic 3',5'-(hydrogen phosphate)", "RN": "E0399OZS9N", "RR": "86594-34-5 ((R)-isomer)", "PI": "Adenine Nucleotides (1966-1968)", "MS": "An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH.", "OL": "use CYCLIC AMP to search ADENOSINE CYCLIC MONOPHOSPHATE & ADENOSINE CYCLIC 2',3'-MONOPHOSPHATE 1980-93 & ADENOSINE CYCLIC-3',5'-MONOPHOSPHATE 1968-79 (as Prov 1968-71)", "PM": "94; was ADENOSINE CYCLIC MONOPHOSPHATE 1980-93, was ADENOSINE CYCLIC-3',5'-MONOPHOSPHATE 1978-79, was ADENOSINE CYCLIC 3',5' MONOPHOSPHATE 1972-77; CYCLIC AMP was see ADENOSINE CYCLIC MONOPHOSPHATE 1976-93; ADENOSINE CYCLIC 2',3'-MONOPHOSPHATE was see ADENOSINE CYCLIC MONOPHOSPHATE 1980-93", "HN": "94; was ADENOSINE CYCLIC MONOPHOSPHATE 1980-93, was ADENOSINE CYCLIC-3',5'-MONOPHOSPHATE 1978-79, was ADENOSINE CYCLIC 3',5' MONOPHOSPHATE 1968-77 (Prov 1968-71); CYCLIC AMP was see ADENOSINE CYCLIC MONOPHOSPHATE 1976-93; ADENOSINE CYCLIC 2',3'-MONOPHOSPHATE was see ADENOSINE CYCLIC MONOPHOSPHATE 1980-93", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000242"}, {"RECTYPE": "D", "MH": "Adenosine Deaminase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenosine Aminohydrolase|T116|T126|NON|EQV|UNK (19XX)|741125|abbcdef", "ENTRY": "Deaminase, Adenosine", "MN": "D08.811.277.151.486.075", "EC": "antagonists & inhibitors:Adenosine Deaminase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Adenosine aminohydrolase", "RN": "EC 3.5.4.4", "AN": "/defic: consider also SEVERE COMBINED IMMUNODEFICIENCY or SCID", "PI": "Aminohydrolases (1972-1974)", "MS": "An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA.", "PM": "91; was see under NUCLEOSIDE DEAMINASES 1975-90", "HN": "91(75); was see under NUCLEOSIDE DEAMINASES 1975-90", "MR": "20100625", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D000243"}, {"RECTYPE": "D", "MH": "Adenosine Diphosphate", "AQ": "AA AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "MgADP|T114|T123|ABB|NRW|NLM (1990)|890512|abbcdef", "ENTRY": "Pyrophosphate, Adenosine", "MN": "D13.695.827.068.124", "MH_TH": "NLM (1971)", "ST": "T123", "N1": "Adenosine 5'-(trihydrogen diphosphate)", "RN": "61D2G4IYVH", "RR": "58-64-0 (Adenosine Diphosphate)", "PI": "Adenine Nucleotides (1966-1970)", "MS": "Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position.", "PM": "73", "HN": "73(71)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000244"}, {"RECTYPE": "D", "MH": "Adenosine Diphosphate Glucose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adenosine Pyrophosphateglucose|T109|T114|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Pyrophosphateglucose, Adenosine", "MN": "D13.695.827.708.070.075", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Adenosine 5'-(trihydrogen diphosphate), P'-alpha-D-glucopyranosyl ester", "RN": "2140-58-1", "PI": "Nucleoside Diphosphate Sugars (1973-1974)", "MS": "Serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants.", "PM": "90; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000245"}, {"RECTYPE": "D", "MH": "Adenosine Diphosphate Ribose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adenosine Diphosphoribose|T109|T114|T123|NON|EQV|UNK (19XX)|790522|abbbcdef", "ENTRY": "Ribose, Adenosine Diphosphate", "MN": "D13.695.827.708.070.125", "MH_TH": "NLM (1980)", "ST": "T123", "N1": "Adenosine 5'-(trihydrogen diphosphate), P'-5-ester with D-ribose", "RN": "20762-30-5", "PI": "Ribose (1966-1974) /AA (1975-1979)", "MS": "An ester formed between the aldehydic carbon of RIBOSE and the terminal phosphate of ADENOSINE DIPHOSPHATE. It is produced by the hydrolysis of nicotinamide-adenine dinucleotide (NAD) by a variety of enzymes, some of which transfer an ADP-ribosyl group to target proteins.", "PM": "87; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1980-86", "HN": "87(80); was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1980-86", "MR": "20160527", "DA": "19790522", "DC": "1", "DX": "19870101", "UI": "D000246"}, {"RECTYPE": "D", "MH": "Adenosine Diphosphate Sugars", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ADP Sugars|T109|T114|EQV|UNK (19XX)|760507|abbdef", "ENTRY": "Sugars, Adenosine Diphosphate", "MN": "D13.695.827.708.070", "MH_TH": "NLM (1975)", "ST": "T114", "RN": "0", "PI": "Nucleoside Diphosphate Sugars (1973-1974)", "MS": "Esters formed between the aldehydic carbon of sugars and the terminal phosphate of adenosine diphosphate.", "PM": "91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000247"}, {"RECTYPE": "D", "MH": "Adenosine Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kinase, Adenosine", "MN": "D08.811.913.696.620.010", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "ATP:adenosine 5'-phosphotransferase", "RN": "EC 2.7.1.20", "RR": "9027-72-9 (CAS RN)", "PI": "Phosphotransferases, ATP (1974)", "MS": "An enzyme that catalyzes the formation of ADP plus AMP from adenosine plus ATP. It can serve as a salvage mechanism for returning adenosine to nucleic acids. EC 2.7.1.20.", "PM": "91; was see under PHOSPHOTRANSFERASES, ATP 1975-90", "HN": "91(75); was see under PHOSPHOTRANSFERASES, ATP 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000248"}, {"RECTYPE": "D", "MH": "Adenosine Monophosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adenylic Acid|T114|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Phosphate Disodium, Adenosine", "MN": "D13.695.827.068.180", "MH_TH": "NLM (1971)", "ST": "T123", "N1": "5'-Adenylic acid", "RN": "415SHH325A", "RR": "T1WZ11DSRN", "PI": "Adenine Nucleotides (1966-1970)", "MS": "Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position.", "OL": "to search ADENYLIC ACIDS use ADENOSINE MONOPHOSPHATE 1971-73, ADENOSINE MONOPHOSPHATE & ADENINE NUCLEOTIDES 1971-72, & ADENINE NUCLEOTIDES 1966-70", "PM": "73; ADENYLIC ACID was ADENYLIC ACIDS see under ADENINE NUCLEOTIDES 1963-72", "HN": "73(71); ADENYLIC ACID was ADENYLIC ACIDS see under ADENINE NUCLEOTIDES 1963-72", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000249"}, {"RECTYPE": "D", "MH": "Adenosine Phosphosulfate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adenylyl Sulfate|T114|T123|NON|EQV|UNK (19XX)|780310|abbcdef", "ENTRY": "Sulfate, Adenylyl", "MN": "D13.695.827.068.180.080", "MH_TH": "NLM (1979)", "ST": "T123", "N1": "5'-Adenylic acid, monoanhydride with sulfuric acid", "RN": "485-84-7", "PI": "Sulfuric Acids (1966-1975)", "MS": "5'-Adenylic acid, monoanhydride with sulfuric acid. The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonyms: adenosine sulfatophosphate; APS.", "PM": "91; was see under ADENOSINE MONOPHOSPHATE 1979-90", "HN": "91(79); was see under ADENOSINE MONOPHOSPHATE 1979-90", "MR": "20160527", "DA": "19780306", "DC": "1", "DX": "19910101", "UI": "D000250"}, {"RECTYPE": "D", "MH": "Adenosine Triphosphatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenosinetriphosphatase|T116|T126|NON|NRW|NLM (1966)|990101|abbcdef", "ENTRY": "Triphosphatase, Adenosine", "MN": "D08.811.277.040.025", "MH_TH": "NLM (2007)", "ST": "T126", "N1": "ATP phosphohydrolase", "RN": "EC 3.6.1.-", "RR": "EC 3.6.1.3", "MS": "A group of enzymes which catalyze the hydrolysis of ATP. The hydrolysis reaction is usually coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA.", "PM": "2007; see ADENOSINE TRIPHOSPHATASES 1993-2006, see ADENOSINE TRIPHOSPHATASE 1963-1992, DNA-DEPENDENT ADENOSINETRIPHOSPHATASES was indexed under ADENOSINETRIPHOSPHATASE & DNA HELICASES 1980-2006", "HN": "2007(1963)", "MR": "20150707", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D000251"}, {"RECTYPE": "D", "MH": "Calcium-Transporting ATPases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Calcium Adenosinetriphosphatase|T116|T126|NON|EQV|UNK (19XX)|880603|abbcdef", "ENTRY": "Triphosphatase, Calcium Adenosine", "MN": "D12.776.543.585.813.250", "FX": "Calcium Channels", "MH_TH": "NLM (2007)", "ST": "T126", "N1": "ATP phosphohydrolase (Ca(2+)-transporting)", "RN": "EC 7.2.2.10", "AN": "general; prefer specifics", "PI": "Calcium (1966-1978)", "MS": "Cation-transporting proteins that utilize the energy of ATP hydrolysis for the transport of CALCIUM. They differ from CALCIUM CHANNELS which allow calcium to pass through a membrane without the use of energy.", "PM": "2007; see CA(2+)-TRANSPORTING ATPASE 1994-2006, see ADENOSINE TRIPHOSPHATASE, CALCIUM 1979-1992, see CALCIUM PUMP 1992-1993,", "HN": "2007(1993)", "MR": "20190705", "DA": "19780306", "DC": "1", "DX": "19790101", "UI": "D000252"}, {"RECTYPE": "D", "MH": "Sodium-Potassium-Exchanging ATPase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sodium-Potassium Pump|T116|T126|NON|EQV|NLM (1994)|930211|NA K PUMP|abbcdefv", "ENTRY": "Sodium Potassium Pump", "MN": "D12.776.543.585.813.750", "MH_TH": "NLM (2008)", "ST": "T126", "N1": "ATP phosphohydrolase (Na(+)-K(+)-transporting)", "RN": "EC 7.2.2.13", "PI": "Sodium (1966-1978)", "MS": "An enzyme that catalyzes the active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane ATPase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients.", "PM": "2008; see NA(+)-K(+)-EXCHANGING ATPASE 1994-2007, see NA(+) K(+)-TRANSPORTING ATPASE 1993; see SODIUM-POTASSIUM PUMP 1992-93; see ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM 1979-1992", "HN": "2008(1978)", "MR": "20190705", "DA": "19780306", "DC": "1", "DX": "19790101", "UI": "D000254"}, {"RECTYPE": "D", "MH": "Adenosine Triphosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "MnATP|T114|T123|NON|NRW|NLM (2002)|abbcde", "ENTRY": "ATP MgCl2", "MN": "D13.695.827.068.236", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Adenosine 5'-(tetrahydrogen triphosphate)", "RN": "8L70Q75FXE", "RR": "56842-80-9", "MS": "An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.", "PM": "1998; CHROMIUM ADENOSINE TRIPHOSPHATE was indexed under ADENOSINE TRIPHSOPHATE 1974-1997 and CHROMIUM 1974-1982; MANGANESE ATP was indexed under ADENOSINE TRIPHOSPHATE 1981-2001", "HN": "1998; for CHROMIUM ADENOSINE TRIPHOSPHATE use ADENOSINE TRIPHOSPHATE (NM) 1974-1997; for MANGANESE ATP use ADENOSINE TRIPHOSPHATE (NM) 1981-2001", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D000255"}, {"RECTYPE": "D", "MH": "Adenoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Ichtadenoviruses", "MN": "B04.280.030", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid10508", "RR": "txid691957", "MS": "A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases.", "OL": "use ADENOVIRIDAE to search ADENOVIRUSES 1975-80 & ADENOVIRUS 1966-74", "PM": "81; was ADENOVIRUSES 1975-80, was ADENOVIRUS 1963-74", "HN": "81; was ADENOVIRUSES 1975-80, was ADENOVIRUS 1963-74", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D000256"}, {"RECTYPE": "D", "MH": "Adenoviridae Infections", "DE": "ADENOVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Adenovirus Infections|T047|NON|EQV|NLM (1994)|930525|ADENOVIRUS INFECT|abcdefv", "ENTRY": "Infection, Adenovirus", "MN": "C01.925.256.076", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Virus diseases caused by the ADENOVIRIDAE.", "OL": "use ADENOVIRIDAE INFECTIONS to search ADENOVIRUS INFECTIONS 1966-93", "PM": "94; was ADENOVIRUS INFECTIONS 1963-93", "HN": "94; was ADENOVIRUS INFECTIONS 1963-93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D000257"}, {"RECTYPE": "D", "MH": "Adenovirus Infections, Human", "DE": "ADENOVIRUS INFECT HUMAN", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Pharyngo-Conjunctival Fever|T047|NON|NRW|UNK (19XX)|760517|abcdef", "ENTRY": "Pharyngo Conjunctival Fever", "MN": "C01.925.256.076.045", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Respiratory and conjunctival infections caused by 33 identified serotypes of human adenoviruses.", "OL": "use ADENOVIRUS INFECTIONS, HUMAN to search PHARYNGO-CONJUNCTIVAL FEVER 1977-present; use ADENOVIRUS INFECTIONS 1966-76", "PM": "91; was see under ADENOVIRUS INFECTIONS 1977-90; PHARYNGO-CONJUNCTIVAL FEVER was see under ADENOVIRUS INFECTIONS 1963-76", "HN": "91(77); was see under ADENOVIRUS INFECTIONS 1977-90; PHARYNGO-CONJUNCTIVAL FEVER was see under ADENOVIRUS INFECTIONS 1963-76", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000258"}, {"RECTYPE": "D", "MH": "Aviadenovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Avian Adenoviruses|T005|NON|EQV|NLM (1994)|921106|abcdef", "ENTRY": "Avian Adenovirus", "MN": "B04.280.030.100", "MH_TH": "NLM (1977)", "ST": "T005", "RN": "txid10552", "AN": "infection: coord IM with ADENOVIRIDAE INFECTIONS (IM); DUCK ADENOVIRUS A see ATADENOVIRUS and TURKEY ADENOVIRUS 3 and TURKEY ADENOVIRUS A see SIADENOVIRUS are also available", "PI": "Adenoviruses (1966-1974)", "MS": "A genus of ADENOVIRIDAE that infects birds. The type species is FOWL ADENOVIRUS A.", "PM": "1994; see ADENOVIRUSES, AVIAN 1990-93, see ADENOVIRIDAE 1981-1990, see ADENOVIRUSES 1977-1980", "HN": "1994(1977)", "MR": "20200813", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D000259"}, {"RECTYPE": "D", "MH": "Adenoviruses, Human", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "APC Viruses|T005|NON|EQV|UNK (19XX)|760416|abcdef", "ENTRY": "Human Adenoviruses", "MN": "B04.280.030.500.350", "MH_TH": "NLM (1977)", "ST": "T005", "PI": "Adenoviridae (1966-1974)", "MS": "Species of the genus MASTADENOVIRUS, causing a wide range of diseases in humans. Infections are mostly asymptomatic, but can be associated with diseases of the respiratory, ocular, and gastrointestinal systems. Serotypes (named with Arabic numbers) have been grouped into species designated Human adenovirus A-G.", "PM": "1977; for APC VIRUS (Adenoidal-Pharyngeal-Conjunctival virus) see ADENOVIRUSES 1975-1976, see ADENOVIRUS 1963-1974", "HN": "1977", "MR": "20200902", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D000260"}, {"RECTYPE": "D", "MH": "Adenoviruses, Simian", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Simian Adenoviruses|T005|NON|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "Simian Adenovirus", "MN": "B04.280.030.500.700", "MH_TH": "NLM (1975)", "ST": "T005", "AN": "species of the genus Mastadenovirus; infection: coord IM with ADENOVIRIDAE INFECTIONS (IM)", "MS": "Species of the genus MASTADENOVIRUS associated with respiratory and enteric infections in primate hosts.", "PM": "91; was see under ADENOVIRIDAE 1981-90; was see under ADENOVIRUSES 1975-80", "HN": "91(75); was see under ADENOVIRIDAE 1981-90; was see under ADENOVIRUSES 1975-80", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D000261"}, {"RECTYPE": "D", "MH": "Adenylyl Cyclases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenylate Cyclase|T116|T126|NON|EQV|NLM (1968)|990101|abbcdef", "ENTRY": "Synthetase, 3',5'-cyclic AMP", "MN": "D12.776.476.050", "EC": "antagonists & inhibitors:Adenylyl Cyclase Inhibitors", "MH_TH": "NLM (2016)", "ST": "T126", "N1": "ATP pyrophosphate-lyase (cyclizing)", "RN": "EC 4.6.1.1", "PI": "Enzymes (1966-1967)", "MS": "Enzymes of the lyase class that catalyze the formation of CYCLIC AMP and pyrophosphate from ATP.", "PM": "2016; see ADENYLATE CYCLASE 1998-2015, see ADENYL CYCLASE 1972-97", "HN": "2016(68)", "MR": "20210520", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000262"}, {"RECTYPE": "D", "MH": "Adenylate Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myokinase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Transphosphorylase, ATP-AMP", "MN": "D08.811.913.696.650.025", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "ATP:AMP phosphotransferase", "RN": "EC 2.7.4.3", "RR": "9013-02-9 (CAS RN)", "PI": "Phosphotransferases, ATP (1974)", "MS": "An enzyme that catalyzes the phosphorylation of AMP to ADP in the presence of ATP or inorganic triphosphate. EC 2.7.4.3.", "PM": "91; was see under PHOSPHOTRANSFERASES, ATP 1975-90", "HN": "91(75); was see under PHOSPHOTRANSFERASES, ATP 1975-90", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000263"}, {"RECTYPE": "D", "MH": "Adenylosuccinate Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenylosuccinase|T116|T126|NON|EQV|UNK (19XX)|780516|abbcdef", "ENTRY": "Lyase, Adenylosuccinate", "MN": "D08.811.520.232.300.200", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "N(6)-(1,2-Dicarboxyethyl)AMP AMP-lyase", "RN": "EC 4.3.2.2", "RR": "9027-81-0 (CAS RN)", "PI": "Succinates (1966-1978)", "MS": "An enzyme that, in the course of purine ribonucleotide biosynthesis, catalyzes the conversion of 5'-phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole to 5'-phosphoribosyl-4-carboxamide-5-aminoimidazole and the conversion of adenylosuccinic acid to AMP. EC 4.3.2.2.", "PM": "91; was see under LYASES 1979-90", "HN": "91(79); was see under LYASES 1979-90", "MR": "20030709", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D000264"}, {"RECTYPE": "D", "MH": "Adenylosuccinate Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, Succino-AMP", "MN": "D08.811.464.259.100", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "IMP:L-aspartate ligase (GDP-forming)", "RN": "EC 6.3.4.4", "RR": "9023-57-8 (CAS RN)", "PI": "Ligases (1966-1978)", "MS": "A carbon-nitrogen ligase. During purine ribonucleotide biosynthesis, this enzyme catalyzes the synthesis of adenylosuccinate from GTP; IMP; and aspartate with the formation of orthophosphate and GDP. EC 6.3.4.4.", "PM": "98; see ADENYLOSUCCINATE SYNTHETASE 1991-97; see LIGASES 1979-90", "HN": "98(79)", "MR": "20030709", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D000265"}, {"RECTYPE": "D", "MH": "Adenylyl Imidodiphosphate", "DE": "APPNHP", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "gamma-Imino-ATP|T114|T121|EQV|UNK (19XX)|750630|abbdef", "ENTRY": "gamma Imino ATP", "MN": "D13.695.827.068.236.050", "MH_TH": "NLM (1976)", "ST": "T121", "N1": "5'-Adenylic acid, monoanhydride with imidodiphosphoric acid", "RN": "25612-73-1", "PI": "Phosphoric Acids (1973-1974)", "MS": "5'-Adenylic acid, monoanhydride with imidodiphosphoric acid. An analog of ATP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It is a potent competitive inhibitor of soluble and membrane-bound mitochondrial ATPase and also inhibits ATP-dependent reactions of oxidative phosphorylation.", "PM": "91; was see under ADENOSINE TRIPHOSPHATE 1976-90", "HN": "91(76); was see under ADENOSINE TRIPHOSPHATE 1976-90", "MR": "20160527", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D000266"}, {"RECTYPE": "D", "MH": "Tissue Adhesions", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tissue Adhesions, Surgery-Induced", "MN": "C23.550.355.274.840", "MH_TH": "NLM (2009)", "ST": "T047", "AN": "IM GEN only; coordinate NIM with organ/disease term", "MS": "Pathological processes consisting of the union of the opposing surfaces of a wound.", "PM": "2009; was ADHESIONS 1978-2008", "HN": "2009 (1978)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D000267"}, {"RECTYPE": "D", "MH": "Adhesiveness", "AQ": "DE RE", "ENTRY": "Adhesivenesses", "MN": "G02.860.139", "FX": "Platelet Adhesiveness", "MH_TH": "NLM (1969)", "ST": "T070", "AN": "NIM", "PI": "Surface Properties (1966-1968)", "MS": "A property of the surface of an object that makes it stick to another surface.", "PM": "74", "HN": "74(69)", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000268"}, {"RECTYPE": "D", "MH": "Adhesives", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Glues|T073|NON|REL|UNK (19XX)|770418|abcdef", "ENTRY": "Mucilage, Adhesive", "MN": "J01.637.016", "FX": "Tissue Adhesives", "MH_TH": "NLM (1978)", "ST": "T122", "RN": "0", "AN": "coordinate IM with DENTURE RETENTION (IM) for denture adhesives; spray adhesives: coordinate IM with AEROSOLS (NIM) if pertinent; BONE CEMENTS & DENTAL CEMENTS are also available; do not confuse entry term MUCILAGES, ADHESIVE with PLANT MUCILAGE", "MS": "Substances that cause the adherence of two surfaces. They include glues (properly collagen-derived adhesives), mucilages, sticky pastes, gums, resins, or latex.", "PM": "78", "HN": "78", "MR": "20120703", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D000269"}, {"RECTYPE": "D", "MH": "Adie Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Holmes-Adie Syndrome|T047|EPO|EQV|NLM (1990)|OMIM (2013)|ORD (2010)|890322|abcdeeef", "ENTRY": "Syndrome, Holmes-Adie", "MN": "C11.710.800.180", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A syndrome characterized by a TONIC PUPIL that occurs in combination with decreased lower extremity reflexes. The affected pupil will respond more briskly to accommodation than to light (light-near dissociation) and is supersensitive to dilute pilocarpine eye drops, which induce pupillary constriction. Pathologic features include degeneration of the ciliary ganglion and postganglionic parasympathetic fibers that innervate the pupillary constrictor muscle. (From Adams et al., Principles of Neurology, 6th ed, p279)", "PM": "2000; see ADIE'S SYNDROME 1963-1999", "HN": "2000 (1963)", "CATSH": "CAT LIST", "MR": "20220419", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D000270"}, {"RECTYPE": "D", "MH": "Adipates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adipic Acids|T109|NON|REL|NLM (1966)|990101|abcdef", "ENTRY": "Acids, Hexanedioic", "MN": "D02.241.081.337.052", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "MS": "Derivatives of adipic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a 1,6-carboxy terminated aliphatic structure.", "PM": "2013; see ADIPIC ACIDS 1975-2013; see ADIPIC ACID 1963-1974", "HN": "2013(1975)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "20130101", "UI": "D000272"}, {"RECTYPE": "D", "MH": "Adipose Tissue", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Fatty Tissue|T024|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Tissue, Fatty", "MN": "A10.165.114", "FX": "Skinfold Thickness", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000273"}, {"RECTYPE": "D", "MH": "Adiposis Dolorosa", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dercum's Disease|T047|EPO|EQV|GHR (2014)|UNK (19XX)|740329|DERCUMS DIS|abcdeefv", "ENTRY": "Tissue Rheumatisms, Adipose", "MN": "C18.452.584.718.500", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A rare disease characterized by multiple tumor-like fatty deposits that press on nerves in various sites causing pain and weakness. Often these lipoma-like structures are located on the trunk and limbs but not on the face and hands.", "CATSH": "CAT LIST", "MR": "20150708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000274"}, {"RECTYPE": "D", "MH": "Adjustment Disorders", "DE": "ADJUSTMENT DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Transient Situational Disturbance|T048|NON|NRW|UNK (19XX)|830606|abcdef", "ENTRY": "Transient Situational Disturbances", "MN": "F03.950.500", "FX": "Emotional Adjustment", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "Maladaptive reactions to identifiable psychosocial stressors occurring within a short time after onset of the stressor. They are manifested by either impairment in social or occupational functioning or by symptoms (depression, anxiety, etc.) that are in excess of a normal and expected reaction to the stressor.", "OL": "use ADJUSTMENT DISORDERS to search DEPRESSION, REACTIVE 1966-80 (as Prov 1966-68)", "PM": "81; was DEPRESSION, REACTIVE 1969-80", "HN": "81; was DEPRESSION, REACTIVE 1966-80 (Prov 1966-68)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D000275"}, {"RECTYPE": "D", "MH": "Adjuvants, Immunologic", "DE": "ADJUVANTS IMMUNOL", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Immunostimulants|T121|T129|NON|EQV|UNK (19XX)|781215|abbcdef", "ENTRY": "Immunological Adjuvants", "MN": "D27.505.696.477.067", "FX": "Adjuvants, Pharmaceutic", "MH_TH": "NLM (1965)", "ST": "T129", "RN": "0", "MS": "Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.", "PM": "65", "HN": "65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000276"}, {"RECTYPE": "D", "MH": "Adjuvants, Pharmaceutic", "DE": "ADJUVANTS PHARM", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Pharmaceutical Adjuvants|T120|NON|EQV|NLM (1994)|930122|abcdef", "MN": "D27.720.744.064", "FX": "Adjuvants, Immunologic", "MH_TH": "NLM (1975)", "ST": "T120", "RN": "0", "PI": "Pharmaceutic Aids (1968-1974)", "MS": "Agents that aid or increase the action of the principle drug (DRUG SYNERGISM) or that affect the absorption, mechanism of action, metabolism, or excretion of the primary drug (PHARMACOKINETICS) in such a way as to enhance its effects.", "OL": "search PHARMACEUTIC AIDS 1969-74", "PM": "75; was see under PHARMACEUTIC AIDS 1969-74", "HN": "75; was see under PHARMACEUTIC AIDS 1969-74", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D000277"}, {"RECTYPE": "D", "MH": "Administration, Buccal", "DE": "ADMIN BUCCAL", "PRINT ENTRY": "Drug Administration, Buccal|T061|NON|EQV|UNK (19XX)|870507|DRUG ADMIN BUCCAL|abcdefv", "ENTRY": "Drug Administrations, Buccal", "MN": "E02.319.267.120.040", "MH_TH": "NLM (1988)", "ST": "T061", "AN": "usually NIM ", "PI": "Cheek (1966-1987)", "MS": "Administration of a soluble dosage form between the cheek and gingiva. It may involve direct application of a drug onto the buccal mucosa, as by painting or spraying.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19870507", "DC": "1", "DX": "19880101", "UI": "D000278"}, {"RECTYPE": "D", "MH": "Administration, Cutaneous", "DE": "ADMIN CUTANEOUS", "PRINT ENTRY": "Transdermal Administration|T061|NON|NRW|UNK (19XX)|860625|TRANSDERMAL ADMIN|abcdefv", "ENTRY": "Transdermal Administrations", "MN": "E02.319.267.120.060", "FX": "Skin Absorption", "MH_TH": "NLM (1987)", "ST": "T061", "AN": "NIM but only if discussed: do not index here routinely for every cutaneously administered drug", "PI": "Administration, Topical (1966-1986)", "MS": "The application of suitable drug dosage forms to the skin for either local or systemic effects.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19860625", "DC": "1", "DX": "19870101", "UI": "D000279"}, {"RECTYPE": "D", "MH": "Administration, Inhalation", "DE": "ADMIN INHALATION", "PRINT ENTRY": "Respiratory Drug Administration|T061|NON|EQV|UNK (19XX)|860604|RESPIRATORY DRUG ADMIN|abcdefv", "ENTRY": "Therapy, Drug Aerosol", "MN": "E02.319.267.050", "FX": "Respiratory Tract Absorption", "MH_TH": "NLM (1987)", "ST": "T061", "AN": "usually NIM ", "PI": "Respiratory Therapy (1978-1986)", "MS": "The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20140606", "DA": "19860604", "DC": "1", "DX": "19870101", "UI": "D000280"}, {"RECTYPE": "D", "MH": "Administration, Intranasal", "DE": "ADMIN INTRANASAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Drug Administration, Intranasal|T061|NON|EQV|UNK (19XX)|740329|DRUG ADMIN INTRANASAL|abcdefv", "ENTRY": "Nasal Administrations", "MN": "E02.319.267.120.655.500", "FX": "Nebulizers and Vaporizers", "MH_TH": "NLM (1973)", "ST": "T061", "PI": "specific drug/administration & dosage (1966-1972)", "MS": "Delivery of medications through the nasal mucosa.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000281"}, {"RECTYPE": "D", "MH": "Administration, Intravaginal", "DE": "ADMIN INTRAVAGINAL", "PRINT ENTRY": "Vaginal Drug Administration|T061|NON|NRW|UNK (19XX)|860604|VAGINAL DRUG ADMIN|abcdefv", "ENTRY": "Vaginal Instillations", "MN": "E02.319.267.120.500", "FX": "Vaginal Creams, Foams, and Jellies", "MH_TH": "NLM (1987)", "ST": "T061", "AN": "usually NIM ", "PI": "Vaginal Creams, Foams and Jellies (1975-1986)", "MS": "The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories.", "PM": "90; was see under ADMINISTRATION, TOPICAL 1987-89", "HN": "90(87); was see under ADMINISTRATION, TOPICAL 1987-89", "CATSH": "CAT LIST", "MR": "20140606", "DA": "19860604", "DC": "1", "DX": "19900101", "UI": "D000282"}, {"RECTYPE": "D", "MH": "Administration, Intravesical", "DE": "ADMIN INTRAVESICAL", "PRINT ENTRY": "Intravesical Drug Administration|T061|NON|EQV|UNK (19XX)|860604|INTRAVESICAL DRUG ADMIN|abcdefv", "ENTRY": "Intravesical Instillations", "MN": "E02.319.267.120.505", "MH_TH": "NLM (1987)", "ST": "T061", "AN": "usually NIM ", "PI": "Bladder (1966-1986)", "MS": "The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19860604", "DC": "1", "DX": "19870101", "UI": "D000283"}, {"RECTYPE": "D", "MH": "Administration, Oral", "DE": "ADMIN ORAL", "PRINT ENTRY": "Drug Administration, Oral|T061|NON|EQV|UNK (19XX)|740329|DRUG ADMIN ORAL|abcdefv", "ENTRY": "Oral Drug Administrations", "MN": "E02.319.267.100", "MH_TH": "NLM (1970)", "ST": "T061", "AN": "usually NIM ", "PI": "specific drug/administration & dosage (1966-1969)", "MS": "The giving of drugs, chemicals, or other substances by mouth.", "PM": "73", "HN": "73(70)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000284"}, {"RECTYPE": "D", "MH": "Administration, Rectal", "DE": "ADMIN RECTAL", "PRINT ENTRY": "Rectal Drug Administration|T061|NON|EQV|UNK (19XX)|860604|RECTAL DRUG ADMIN|abcdefv", "ENTRY": "Rectal Instillations", "MN": "E02.319.267.120.655.750", "FX": "Suppositories", "MH_TH": "NLM (1987)", "ST": "T061", "AN": "NIM but only if discussed: do not index here routinely for every rectally administered drug", "PI": "Suppositories (1966-1986)", "MS": "The insertion of drugs into the rectum, usually for confused or incompetent patients, like children, infants, and the very old or comatose.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19860604", "DC": "1", "DX": "19870101", "UI": "D000285"}, {"RECTYPE": "D", "MH": "Administration, Sublingual", "DE": "ADMIN SUBLINGUAL", "PRINT ENTRY": "Sublingual Drug Administration|T061|NON|EQV|UNK (19XX)|870507|SUBLINGUAL DRUG ADMIN|abcdefv", "ENTRY": "Sublingual Drug Administrations", "MN": "E02.319.267.100.878", "MH_TH": "NLM (1988)", "ST": "T061", "AN": "usually NIM ", "PI": "Administration, Oral (1971-1987)", "MS": "Administration of a soluble dosage form by placement under the tongue.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19870507", "DC": "1", "DX": "19880101", "UI": "D000286"}, {"RECTYPE": "D", "MH": "Administration, Topical", "DE": "ADMIN TOPICAL", "PRINT ENTRY": "Drug Administration, Topical|T061|NON|EQV|UNK (19XX)|740329|DRUG ADMIN TOPICAL|abcdefv", "ENTRY": "Topical Drug Administrations", "MN": "E02.319.267.120", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "general; prefer specifics; \"topical\" in titles frequently means ADMINISTRATION, CUTANEOUS", "MS": "The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000287"}, {"RECTYPE": "D", "MH": "Administrative Personnel", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Administrators|T097|NON|NRW|BIOETHICS (1978)|781204|abcdef", "ENTRY": "Policy Maker", "MN": "M01.526.070", "MH_TH": "POPLINE (1978)", "ST": "T097", "PI": "Organization and Administration (1966-1967)", "MS": "Individuals responsible for the development of policy and supervision of the execution of plans and functional operations.", "PM": "68", "HN": "68", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000288"}, {"RECTYPE": "D", "MH": "Admitting Department, Hospital", "DE": "ADMITTING DEP HOSP", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Hospital Admitting Department|T093|NON|EQV|UNK (19XX)|770519|HOSP ADMITTING DEP|abcdefv", "ENTRY": "Offices, Hospital Admissions", "MN": "N04.452.442.452.422.040", "MH_TH": "NLM (1977)", "ST": "T093", "MS": "Hospital department responsible for the flow of patients and the processing of admissions, discharges, transfers, and also most procedures to be carried out in the event of a patient's death.", "PM": "91; was see under HOSPITAL DEPARTMENTS 1977-90", "HN": "91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90", "MR": "20190709", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D000289"}, {"RECTYPE": "D", "MH": "Adnexa Uteri", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Uterine Appendages|T023|NON|EQV|NLM (2003)|011119|abcdef", "ENTRY": "Uterine Appendage", "MN": "A05.360.319.114", "FX": "Adnexal Diseases", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Appendages of the UTERUS which include the FALLOPIAN TUBES, the OVARY, and the supporting ligaments of the uterus (BROAD LIGAMENT; ROUND LIGAMENT).", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000290"}, {"RECTYPE": "D", "MH": "Adnexal Diseases", "DE": "ADNEXAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Adnexal", "MN": "C12.100.250.056", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases of the uterine appendages (ADNEXA UTERI) including diseases involving the OVARY, the FALLOPIAN TUBES, and ligaments of the uterus (BROAD LIGAMENT; ROUND LIGAMENT).", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000291"}, {"RECTYPE": "D", "MH": "Pelvic Inflammatory Disease", "DE": "PELVIC INFLAMM DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Adnexitis|T047|NON|NRW|NLM (1963)|990101|abcdef", "ENTRY": "Pelvic Inflammatory Diseases", "MN": "C12.100.250.056.750", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "female only: note category; \"male adnexitis\": index under GENITAL DISEASES, MALE or PELVIC INFECTION", "MS": "A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.", "PM": "2003; see ADNEXITIS 1963-2002", "HN": "2003 (1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20030101", "UI": "D000292"}, {"RECTYPE": "D", "MH": "Adolescent", "AQ": "LJ PH", "PRINT ENTRY": "Youth|T100|NON|BRD|NLM (1987)|740329|abcdef", "ENTRY": "Youths", "MN": "M01.060.057", "FX": "Minors", "EC": "psychology:Psychology, Adolescent", "MH_TH": "NLM (2003)", "ST": "T100", "AN": "almost always check tag: NIM; see Manual Chapter 9", "MS": "A person 13 to 18 years of age.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000293"}, {"RECTYPE": "D", "MH": "Adolescent Behavior", "AQ": "CL DE EH ES HI PH PX RE", "PRINT ENTRY": "Behavior, Adolescent|T055|NON|EQV|UNK (19XX)|800507|abcdef", "ENTRY": "Behaviors, Adolescent", "MN": "F01.145.022", "FX": "Adolescent Development", "MH_TH": "NLM (1981)", "ST": "T055", "AN": "check also tag ADOLESCENCE", "PI": "Adolescent Psychology (1967-1980)", "MS": "Any observable response or action of an adolescent.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19800507", "DC": "1", "DX": "19810101", "UI": "D000294"}, {"RECTYPE": "D", "MH": "Adolescent Medicine", "DE": "ADOLESCENT MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Adolescent|T091|NON|EQV|NLM (1991)|891129|MED ADOLESCENT|abcdefv", "MN": "H02.403.014", "FX": "Adolescent Health Services", "MH_TH": "NLM (1980)", "ST": "T091", "AN": "a specialty but may  also be used for very general articles on adolescent diseases", "PI": "Adolescence (1966-1979)", "MS": "A branch of medicine pertaining to the diagnosis and treatment of diseases occurring during the period of ADOLESCENCE.", "PM": "80", "HN": "80", "MR": "20150629", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D000295"}, {"RECTYPE": "D", "MH": "Adolescent Psychiatry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychiatry, Adolescent", "MN": "H02.403.690.080", "MH_TH": "POPLINE (1994)", "ST": "T091", "AN": "specialty: not for mental disorders in adolescents (= MENTAL DISORDERS + check tag ADOLESCENT) ", "PI": "Psychoanalysis (1966)", "MS": "The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders in individuals 13-18 years.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000296"}, {"RECTYPE": "D", "MH": "Psychology, Adolescent", "DE": "PSYCHOL ADOLESCENT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Adolescent Psychology|T091|NON|EQV|NLM (1966)|990101|ADOLESCENT PSYCHOL|abcdefv", "MN": "F04.096.628.065", "FX": "Psychology, Developmental", "MH_TH": "UNK (19XX)", "ST": "T091", "AN": "use for the specialty and also for articles on the way a normal adolescent thinks & acts", "MS": "Field of psychology involving the study of normal and abnormal behavior of adolescents. It includes mental processes as well as observable responses.", "PM": "1967; see ADOLESCENT PSYCHOLOGY 1967-2014", "HN": "1967; use ADOLESCENT PSYCHOLOGY 1967-2014", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000297"}, {"RECTYPE": "D", "MH": "Adolescent, Hospitalized", "AQ": "ED PX SN", "ENTRY": "Hospitalized Adolescents", "MN": "M01.643.050", "FX": "Adolescent, Institutionalized", "MH_TH": "NLM (1983)", "ST": "T101", "AN": "not for dis in adolescent in hosp for diag or ther: use only for hospitalized adolescents as a psychol, sociol or social entity; check also tag ADOLESCENT", "PI": "Hospitalization (1966-1982)", "MS": "Adolescent hospitalized for short term care.", "PM": "83", "HN": "83", "MR": "20020702", "DA": "19820428", "DC": "1", "DX": "19830101", "UI": "D000298"}, {"RECTYPE": "D", "MH": "Adolescent, Institutionalized", "AQ": "ED PX SN", "PRINT ENTRY": "Institutionalized Adolescent|T101|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Institutionalized Adolescents", "MN": "M01.643.154", "MH_TH": "NLM (1983)", "ST": "T101", "AN": "check also tag ADOLESCENT", "PI": "Residential Facilities (1968-1982)", "MS": "An adolescent who is receiving long-term in-patient services or who resides in an institutional setting.", "PM": "83", "HN": "83", "MR": "20020702", "DA": "19820428", "DC": "1", "DX": "19830101", "UI": "D000299"}, {"RECTYPE": "D", "MH": "Adoption", "AQ": "EH LJ PX", "ENTRY": "Adoptions", "MN": "I01.880.853.150.140", "MH_TH": "POPLINE (1981)", "ST": "T054", "MS": "Voluntary acceptance of a child of other parents to be as one's own child, usually with legal confirmation.", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000300"}, {"RECTYPE": "D", "MH": "Adosterol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "6-Iodomethylnorcholesterol|T109|T130|NON|EQV|UNK (19XX)|780516|IODOMETHYLNORCHOLESTEROL 06|abbcdefs", "ENTRY": "NP59", "MN": "D10.570.938.073", "MH_TH": "NLM (1979)", "ST": "T130", "N1": "19-Norcholest-5(10)-en-3-ol, 6-(iodomethyl)-, (3beta,6beta)-", "RN": "55623-03-5", "PI": "Sterols (1966-1978)", "MS": "A sterol usually substituted with radioactive iodine. It is an adrenal cortex scanning agent with demonstrated high adrenal concentration and superior adrenal imaging.", "PM": "91; was see under CHOLESTEROL 1989-90; was see under STEROLS 1979-88", "HN": "91(79); was see under CHOLESTEROL 1989-90; was see under STEROLS 1979-88", "MR": "20160527", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D000301"}, {"RECTYPE": "D", "MH": "Adrenal Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cortex, Adrenal", "MN": "A06.300.071.140", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "PITUITARY-ADRENAL SYSTEM is available", "PI": "Adrenal Glands (1966-1974)", "MS": "The outer layer of the adrenal gland. It is derived from MESODERM and comprised of three zones (outer ZONA GLOMERULOSA, middle ZONA FASCICULATA, and inner ZONA RETICULARIS) with each producing various steroids preferentially, such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and ANDROSTENEDIONE. Adrenal cortex function is regulated by pituitary ADRENOCORTICOTROPIN.", "OL": "search ADRENAL GLANDS 1966-74", "PM": "78,63-67; was see under ADRENAL GLANDS 1968-77", "HN": "78(75)63-67; was see under ADRENAL GLANDS 1968-77", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D000302"}, {"RECTYPE": "D", "MH": "Adrenal Cortex Diseases", "DE": "ADRENAL CORTEX DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Adrenal Cortex", "MN": "C19.053.098", "MH_TH": "NLM (1975)", "ST": "T047", "PI": "Adrenal Gland Diseases (1966-1974)", "MS": "Pathological processes of the ADRENAL CORTEX.", "OL": "search ADRENAL GLAND DISEASES 1966-74", "PM": "79,63-67; was see under ADRENAL GLAND DISEASES 1975-78", "HN": "79(75)63-67; was see under ADRENAL GLAND DISEASES 1975-78", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D000303"}, {"RECTYPE": "D", "MH": "Adrenal Cortex Function Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E01.370.374.050", "MH_TH": "NLM (1975)", "ST": "T060", "MS": "Examinations that evaluate and monitor hormone production in the adrenal cortex.", "OL": "search PITUITARY-ADRENAL FUNCTION TESTS 1966-74", "PM": "91,63-67; was see under PITUITARY-ADRENAL FUNCTION TESTS 1975-90; was heading 1963-67", "HN": "91(75)63-67; was see under PITUITARY-ADRENAL FUNCTION TESTS 1975-90; was heading 1963-67", "CATSH": "CAT LIST", "MR": "20150522", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000304"}, {"RECTYPE": "D", "MH": "Adrenal Cortex Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Corticosteroids|T109|T125|NON|EQV|UNK (19XX)|750101|abbcdef", "ENTRY": "Hormones, Adrenal Cortex", "MN": "D06.472.040", "FX": "Receptors, Glucocorticoid", "MH_TH": "POPLINE (1978)", "ST": "T125", "RN": "0", "AN": "general or unspecified; prefer specifics; /defic: consider also ADRENAL GLAND HYPOFUNCTION", "MS": "HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000305"}, {"RECTYPE": "D", "MH": "Adrenal Cortex Neoplasms", "DE": "ADRENAL CORTEX NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cancer of Adrenal Cortex|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Adrenal Cortex", "MN": "C19.344.078.265", "MH_TH": "NLM (1975)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "PI": "Adrenal Gland Neoplasms (1966-1974)", "MS": "Tumors or cancers of the ADRENAL CORTEX.", "OL": "search ADRENAL GLAND NEOPLASMS 1966-74", "PM": "79,63-67; was see under ADRENAL GLAND NEOPLASMS 1975-78", "HN": "79(75)63-67; was see under ADRENAL GLAND NEOPLASMS 1975-78", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D000306"}, {"RECTYPE": "D", "MH": "Adrenal Gland Diseases", "DE": "ADRENAL GLAND DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Gland Diseases, Adrenal", "MN": "C19.053", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general; prefer specifics; coordinate IM with ADRENAL MEDULLA (IM) for diseases of adrenal medulla; for adrenal hyperplasia see note at ADRENAL GLANDS", "MS": "Pathological processes of the ADRENAL GLANDS.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000307"}, {"RECTYPE": "D", "MH": "Adrenocortical Hyperfunction", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypercorticism|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Hyperfunction, Adrenocortical", "MN": "C19.053.800", "FX": "Hyperandrogenism", "EC": "congenital:Adrenal Hyperplasia, Congenital", "MH_TH": "NLM (2005)", "ST": "T047", "AN": "do not confuse with ADRENAL GLAND HYPOFUNCTION; non-congenital adrenal hyperplasia: index under ADRENAL GLANDS /pathol (IM) + HYPERPLASIA (NIM)", "MS": "Excess production of ADRENAL CORTEX HORMONES such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. Hyperadrenal syndromes include CUSHING SYNDROME; HYPERALDOSTERONISM; and VIRILISM.", "PM": "2005; see ADRENAL GLAND HYPERFUNCTION 1968-2004", "HN": "2005 (1968)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000308"}, {"RECTYPE": "D", "MH": "Adrenal Insufficiency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Adrenal Gland Hypofunction|T047|NON|EQV|NLM (1968)|990101|abcdef", "ENTRY": "Hypofunction, Adrenal Gland", "MN": "C19.053.500", "FX": "Adrenal Cortex Hormones", "MH_TH": "NLM (2005)", "ST": "T047", "AN": "do not confuse with ADRENAL GLAND HYPERFUNCTION", "MS": "Conditions in which the production of adrenal CORTICOSTEROIDS falls below the requirement of the body. Adrenal insufficiency can be caused by defects in the ADRENAL GLANDS, the PITUITARY GLAND, or the HYPOTHALAMUS.", "PM": "2005; see ADRENAL GLAND HYPOFUNCTION 1968-2004", "HN": "2005 (1968)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000309"}, {"RECTYPE": "D", "MH": "Adrenal Gland Neoplasms", "DE": "ADRENAL GLAND NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Adrenal Cancer|T191|NON|NRW|NLM (2000)|ORD (2010)|991108|abcdeef", "ENTRY": "Neoplasms, Adrenal", "MN": "C19.344.078", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the ADRENAL GLANDS.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000310"}, {"RECTYPE": "D", "MH": "Adrenal Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Glands, Adrenal", "MN": "A06.300.071", "FX": "Adrenalectomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000311"}, {"RECTYPE": "D", "MH": "Adrenal Hyperplasia, Congenital", "DE": "ADRENAL HYPERPLASIA CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperplasias, Congenital Adrenal", "MN": "C19.391.119.090.500", "FX": "Virilism", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders.", "OL": "use ADRENAL HYPERPLASIA, CONGENITAL to search ADRENOGENITAL SYNDROME 1966-79", "PM": "80; was ADRENOGENITAL SYNDROME 1963-79", "HN": "80; was ADRENOGENITAL SYNDROME 1963-79", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D000312"}, {"RECTYPE": "D", "MH": "Adrenal Medulla", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Medullas, Adrenal", "MN": "A06.300.071.265", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The inner portion of the adrenal gland. Derived from ECTODERM, adrenal medulla consists mainly of CHROMAFFIN CELLS that produces and stores a number of NEUROTRANSMITTERS, mainly adrenaline (EPINEPHRINE) and NOREPINEPHRINE. The activity of the adrenal medulla is regulated by the SYMPATHETIC NERVOUS SYSTEM.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000313"}, {"RECTYPE": "D", "MH": "Adrenal Rest Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Adrenal Cortical Rest Tumor|T191|NON|EQV|UNK (19XX)|810519|abcdef", "ENTRY": "Tumors, Adrenal Rest", "MN": "C04.557.470.035.232", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with tissue-specific neoplasms such as TESTICULAR NEOPLASMS (IM)", "MS": "Neoplasm derived from displaced cells (rest cells) of the primordial ADRENAL GLANDS, generally in patients with CONGENITAL ADRENAL HYPERPLASIA. Adrenal rest tumors have been identified in TESTES; LIVER; and other tissues. They are dependent on ADRENOCORTICOTROPIN for growth and adrenal steroid secretion.", "OL": "use ADRENAL REST TUMOR to search ADRENAL CORTICAL REST TUMOR 1966-81", "PM": "82; was ADRENAL CORTICAL REST TUMOR 1963-81", "HN": "82; was ADRENAL CORTICAL REST TUMOR 1963-81", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19820101", "UI": "D000314"}, {"RECTYPE": "D", "MH": "Adrenalectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Adrenalectomies", "MN": "E04.270.115", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "excision of entire adrenal; enucleation: see note under ADRENAL MEDULLA", "MS": "Excision of one or both adrenal glands. (From Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000315"}, {"RECTYPE": "D", "MH": "Adrenergic alpha-Agonists", "DE": "ADREN ALPHA AG", "DS": "ADRENERGIC AGONISTS ALPHA", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "alpha-Adrenergic Receptor Agonists|T121|NON|EQV|UNK (19XX)|740329|ALPHA ADREN RECEPT AGON|abcdefv", "ENTRY": "alpha-Receptor Agonists, Adrenergic", "MN": "D27.505.696.577.050.100.100", "MH_TH": "NLM (1969)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; do not confuse with ADRENERGIC ALPHA-ANTAGONISTS", "PI": "Sympathomimetics (1966-1968)", "MS": "Drugs that selectively bind to and activate alpha adrenergic receptors.", "OL": "use ADRENERGIC ALPHA-AGONISTS to search ADRENERGIC ALPHA RECEPTOR AGONISTS 1969-94 (as Prov 1969-72)", "PM": "95; was ADRENERGIC ALPHA RECEPTOR AGONISTS 1973-94", "HN": "95; was ADRENERGIC ALPHA RECEPTOR AGONISTS 1969-94 (Prov 1969-72)", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000316"}, {"RECTYPE": "D", "MH": "Adrenergic alpha-Antagonists", "DE": "ADREN ALPHA ANTAG", "DS": "ADRENERGIC ANTAGONISTS ALPHA", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "alpha-Blockers, Adrenergic|T121|NON|EQV|IOM (1990)|890417|ALPHA BLOCK ADREN|abcdefv", "ENTRY": "alpha-Receptor Blockaders, Adrenergic", "MN": "D27.505.696.577.050.200.100", "MH_TH": "NLM (1969)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; do not confuse with ADRENERGIC ALPHA-AGONISTS", "PI": "Sympatholytics (1966-1968)", "MS": "Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.", "OL": "use ADRENERGIC ALPHA-ANTAGONISTS to search ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1969-94 (as Prov 1969-72)", "PM": "95; was ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1973-94", "HN": "95; was ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1969-94 (Prov 1969-72)", "MR": "20180614", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000317"}, {"RECTYPE": "D", "MH": "Adrenergic beta-Agonists", "DE": "ADREN BETA AG", "DS": "ADRENERGIC AGONISTS BETA", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Adrenergic Receptor Agonists|T121|NON|EQV|UNK (19XX)|740329|BETA ADREN RECEPT AGON|abcdefv", "ENTRY": "beta-Receptor Agonists, Adrenergic", "MN": "D27.505.696.577.050.100.200", "MH_TH": "NLM (1969)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; do not confuse with ADRENERGIC BETA-ANTAGONISTS", "PI": "Sympathomimetics (1966-1968)", "MS": "Drugs that selectively bind to and activate beta-adrenergic receptors.", "OL": "use ADRENERGIC BETA-AGONISTS to search ADRENERGIC BETA RECEPTOR AGONISTS 1969-94 (as Prov 1969-72)", "PM": "95; was ADRENERGIC BETA RECEPTOR AGONISTS 1973-94", "HN": "95; was ADRENERGIC BETA RECEPTOR AGONISTS 1969-94 (Prov 1969-72)", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000318"}, {"RECTYPE": "D", "MH": "Adrenergic beta-Antagonists", "DE": "ADREN BETA ANTAG", "DS": "ADRENERGIC ANTAGONISTS BETA", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Blockers, Adrenergic|T121|NON|EQV|IOM (1990)|890417|BETA BLOCKERS ADREN|abcdefv", "ENTRY": "beta-Receptor Blockaders, Adrenergic", "MN": "D27.505.696.577.050.200.200", "MH_TH": "NLM (1969)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; do not confuse with ADRENERGIC BETA-AGONISTS", "PI": "Sympatholytics (1966-1968)", "MS": "Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.", "OL": "use ADRENERGIC BETA-ANTAGONISTS to search ADRENERGIC BETA RECEPTOR BLOCKADERS 1973-94 (as Prov 1969-72)", "PM": "95: was ADRENERGIC BETA RECEPTOR BLOCKADERS 1973-94", "HN": "95: was ADRENERGIC BETA RECEPTOR BLOCKADERS 1969-94 (Prov 1969-72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000319"}, {"RECTYPE": "D", "MH": "Adrenergic Fibers", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Sympathetic Fibers|T024|NON|EQV|UNK (19XX)|760427|abcdef", "ENTRY": "Sympathetic Fiber", "MN": "A11.671.501.075", "FX": "Adrenergic Neurons", "MH_TH": "NLM (1977)", "ST": "T024", "AN": "ADRENERGIC NEURONS is also available", "PI": "Sympathetic Nervous System (1966-1976)", "MS": "Nerve fibers liberating catecholamines at a synapse after an impulse.", "PM": "77", "HN": "77", "MR": "20110624", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D000320"}, {"RECTYPE": "D", "MH": "Adrenergic Agonists", "DE": "ADREN AG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adrenomimetics|T121|NON|EQV|NLM (1995)|940406|abcdef", "ENTRY": "Receptor Agonist, Adrenergic", "MN": "D27.505.696.577.050.100", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "do not confuse with ADRENERGIC ANTAGONISTS", "PI": "Sympathomimetics (1966-1974)", "MS": "Drugs that bind to and activate adrenergic receptors.", "OL": "use ADRENERGIC AGONISTS to search ADRENERGIC RECEPTOR AGONISTS 1975-94", "PM": "95; was ADRENERGIC RECEPTOR AGONISTS 1975-94", "HN": "95; was ADRENERGIC RECEPTOR AGONISTS 1975-94", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D000322"}, {"RECTYPE": "D", "MH": "Adrenochrome", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.767.061", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "1H-Indole-5,6-dione, 2,3-dihydro-3-hydroxy-1-methyl-", "RN": "70G54NQL71", "RR": "54-06-8 (Adrenochrome)", "AN": "/physiol permitted", "MS": "Pigment obtained by the oxidation of epinephrine.", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000323"}, {"RECTYPE": "D", "MH": "Adrenocorticotropic Hormone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Corticotropin|T116|T123|T125|NON|EQV|NLM (1966)|990101|abbbcdef", "ENTRY": "Hormone, Adrenocorticotropic", "MN": "D12.776.631.650.405.935.531.500", "PA": "Hormones", "FX": "Receptors, Corticotropin", "MH_TH": "NLM (1994)", "ST": "T125", "RN": "9002-60-2", "MS": "An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP).", "PM": "2007; see CORTICOTROPIN 1994-2006, see ADRENOCORTICOTROPIC HORMONE 1987-1993, see CORTICOTROPIN 1963-1986", "HN": "2007, 1987-1993 (1963)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D000324"}, {"RECTYPE": "D", "MH": "Adrenodoxin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.556.579.374.375.025", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Adrenodoxins", "RN": "12687-22-8", "AN": "an iron-sulfur protein", "PI": "Metalloproteins (1974)", "MS": "An iron-sulfur protein which serves as an electron carrier in enzymatic steroid hydroxylation reactions in adrenal cortex mitochondria. The electron transport system which catalyzes this reaction consists of adrenodoxin reductase, NADP, adrenodoxin, and cytochrome P-450.", "PM": "75", "HN": "75", "MR": "20020702", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D000325"}, {"RECTYPE": "D", "MH": "Adrenoleukodystrophy", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "X-Linked Adrenoleukodystrophy|T047|NON|EQV|GHR (2014)|NLM (2000)|ORD (2010)|991103|abcdeeef", "ENTRY": "X Linked Adrenoleukodystrophy", "MN": "C19.053.500.270", "FX": "ATP-Binding Cassette Transporters", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with ADRENOLEUKODYSTROPHY, NEONATAL see PEROXISOMAL DISORDERS", "PI": "Demyelinating Diseases (1966-1982)", "MS": "An X-linked recessive disorder characterized by the accumulation of saturated very long chain fatty acids in the LYSOSOMES of ADRENAL CORTEX and the white matter of CENTRAL NERVOUS SYSTEM. This disease occurs almost exclusively in the males. Clinical features include the childhood onset of ATAXIA; NEUROBEHAVIORAL MANIFESTATIONS; HYPERPIGMENTATION; ADRENAL INSUFFICIENCY; SEIZURES; MUSCLE SPASTICITY; and DEMENTIA. The slowly progressive adult form is called adrenomyeloneuropathy. The defective gene ABCD1 is located at Xq28, and encodes the adrenoleukodystrophy protein (ATP-BINDING CASSETTE TRANSPORTERS).", "PM": "1991; see CEREBRAL SCLEROSIS, DIFFUSE 1983-1990", "HN": "1991(1983)", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19820427", "DC": "1", "DX": "19910101", "UI": "D000326"}, {"RECTYPE": "D", "MH": "Adsorption", "AQ": "DE GE IM PH RE", "ENTRY": "Adsorptions", "MN": "G02.020", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "almost never IM", "MS": "The adhesion of gases, liquids, or dissolved solids onto a surface. It includes adsorptive phenomena of bacteria and viruses onto surfaces as well. ABSORPTION into the substance may follow but not necessarily.", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000327"}, {"RECTYPE": "D", "MH": "Adult", "AQ": "PX", "ENTRY": "Adults|T100|NON|EQV|BIOETHICS (1989)|770317|abcdef", "MN": "M01.060.116", "MH_TH": "POPLINE (1978)", "ST": "T100", "AN": "almost always check tag: NIM no qualifiers; see Manual Chapter 9", "MS": "A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.", "PM": "66", "HN": "66", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000328"}, {"RECTYPE": "D", "MH": "Advertising", "AQ": "CL EC ES HI LJ MT SN ST TD", "PRINT ENTRY": "Advertising as Topic|T057|NON|EQV|NLM (2008)|070621|abcdef", "ENTRY": "Advertisings", "MN": "L01.143.050", "MH_TH": "NLM (2020)", "ST": "T057", "AN": "medical advertising: do not coordinate with MEDICINE; coordinate with subject of advertising & medium if relevant; do not confuse with Publication Type ADVERTISEMENT", "MS": "Works about the act or practice of calling public attention to a product, service, need, etc., especially by paid announcements in newspapers, magazines, on radio, or on television. (Random House Unabridged Dictionary, 2d ed)", "PM": "2008; see ADVERTISING 1963-2007", "HN": "2008(1963)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D000329"}, {"RECTYPE": "D", "MH": "Aedes", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Aede", "MN": "B01.050.500.131.617.720.500.500.750.712.500.875.100", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid7158", "AN": "mosquito; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111", "MS": "A genus of mosquitoes (CULICIDAE) frequently found in tropical and subtropical regions. YELLOW FEVER and DENGUE are two of the diseases that can be transmitted by species of this genus.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000330"}, {"RECTYPE": "D", "MH": "Aequorin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Aequorine|T116|T126|T130|NON|EQV|UNK (19XX)|841002|abbbcdef", "MN": "D12.776.532.020", "PA": "Luminescent Agents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Aequorins", "RN": "50934-79-7", "PI": "Proteins (1972-1974)", "MS": "A photoprotein isolated from the bioluminescent jellyfish Aequorea. It emits visible light by an intramolecular reaction when a trace amount of calcium ion is added. The light-emitting moiety in the bioluminescence reaction is believed to be 2-amino-3-benzyl-5-(p-hydroxyphenyl)pyrazine (AF-350).", "PM": "91; was see under LUMINESCENT PROTEINS 1979-90; was see under PROTEINS 1975-78", "HN": "91(75); was see under LUMINESCENT PROTEINS 1979-90; was see under PROTEINS 1975-78", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000331"}, {"RECTYPE": "D", "MH": "Aerobiosis", "AQ": "DE GE IM PH RE", "ENTRY": "Aerobioses", "MN": "G03.049", "MH_TH": "NLM (1971)", "ST": "T040", "AN": "almost never IM", "MS": "Life or metabolic reactions occurring in an environment containing oxygen.", "PM": "91; was see under METABOLISM 1971-90", "HN": "91(71); was see under METABOLISM 1971-90", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000332"}, {"RECTYPE": "D", "MH": "Aeromonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.450.019.025", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid642", "AN": "infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs singly, in pairs, or in short chains. Its organisms are found in fresh water and sewage and are pathogenic to humans, frogs, and fish.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000333"}, {"RECTYPE": "D", "MH": "Aerophagy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Air Swallowing|T046|T184|NON|EQV|UNK (19XX)|800507|abbcdef", "ENTRY": "Swallowing, Air", "MN": "C23.888.821.061", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Spasmodic swallowing of air.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000334"}, {"RECTYPE": "D", "MH": "Aerosol Propellants", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Propellants, Aerosol", "MN": "D26.255.165.055.055", "MH_TH": "NLM (1973)", "ST": "T120", "RN": "0", "AN": "IM; coord with propellant if relevant (IM); D25-26 qualif with discretion", "PI": "specific chemical (1966-1972)", "MS": "Compressed gases or vapors in a container which, upon release of pressure and expansion through a valve, carry another substance from the container. They are used for cosmetics, household cleaners, and so on. Examples are BUTANES; CARBON DIOXIDE; FLUOROCARBONS; NITROGEN; and PROPANE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "91; was see under AEROSOLS 1973-90; was in Cat D & J 1973-82", "HN": "91(73); was see under AEROSOLS 1973-90; was in Cat D & J 1973-82", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000335"}, {"RECTYPE": "D", "MH": "Aerosols", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Aerosol|T104|NON|EQV|NLM (2021)|191121|abcdef", "MN": "D26.255.165.055", "MH_TH": "NLM (1966)", "ST": "T104", "RN": "0", "AN": "IM for general only, qualif permitted; NIM (no qualif) with specific drug IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in aerosol form, not the aerosol", "MS": "Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents.", "HN": "was in Cat D & J 1973-82, was in Cat D only 1963-72", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000336"}, {"RECTYPE": "D", "MH": "Aerospace Medicine", "DE": "AEROSPACE MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Space Medicine|T091|NON|NRW|UNK (19XX)|790529|SPACE MED|abcdefv", "ENTRY": "Medicine, Space|T091|NON|NRW|NLM (1991)|891128|MED SPACE|abcdefv", "MN": "H02.403.029", "FX": "Space Flight", "MH_TH": "NLM (1980)", "ST": "T091", "AN": "specialty; med, physiol or psychol aspects of AVIATION go here but med, physiol or psychol aspects of space flight go under SPACE FLIGHT or other space related terms: Manual 28.8; DF: AEROSPACE MED", "PI": "Space Flight (1975-1979)", "MS": "That branch of medicine dealing with the studies and effects of flight through the atmosphere or in space upon the human body and with the prevention or cure of physiological or psychological malfunctions arising from these effects. (from NASA Thesaurus)", "OL": "search SPACE FLIGHT 1975-79; use AEROSPACE MEDICINE to search AVIATION MEDICINE 1966-74; use AEROSPACE MEDICINE + DENTISTRY to search AVIATION DENTISTRY 1966-79", "PM": "80; was see SPACE FLIGHT 1975-79; AVIATION MEDICINE was heading 1963-79; AVIATION DENTISTRY was heading 1965-79", "HN": "80; was see SPACE FLIGHT 1975-79; AVIATION MEDICINE was heading 1963-79; AVIATION DENTISTRY was heading 1965-79", "MR": "20170711", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D000337"}, {"RECTYPE": "D", "MH": "beta-Aminoethyl Isothiourea", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "beta-Aminoethylisothiuronium Dihydrobromide|T109|T121|NON|NRW|NLM (2001)|000511|abbcdef", "ENTRY": "beta Aminoethylisothiuronium Monohydrobromide", "MN": "D02.886.904.100", "PA": "Radiation-Protective Agents", "MH_TH": "NLM (2001)", "ST": "T121", "RN": "151-16-6", "RR": "871-25-0", "MS": "A radiation-protective agent that can inhibit DNA damage by binding to the DNA. It also increases the susceptibility of blood cells to complement-mediated lysis.", "PM": "2001; see AET 1967-2000; for S-(2-AMINOETHYL)ISOTHIOTHIOUREA see ISOTHIUREA, (BETA-AMINOETHYL) 1997-2000", "HN": "2001(1967); for S-(2-AMINOETHYL)ISOTHIOTHIOUREA use ISOTHIUREA, (BETA-AMINOETHYL) (NM) 1997-2000", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20010101", "UI": "D000338"}, {"RECTYPE": "D", "MH": "Affect", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Mood|T041|NON|REL|UNK (19XX)|870430|abcdef", "ENTRY": "Moods", "MN": "F01.470.047", "MH_TH": "NLM (1964)", "ST": "T041", "MS": "The feeling-tone accompaniment of an idea or mental representation. It is the most direct psychic derivative of instinct and the psychic representative of the various bodily changes by means of which instincts manifest themselves.", "PM": "65; was see under EMOTIONS 1963-64", "HN": "65(64); was see under EMOTIONS 1963-64", "CATSH": "CAT LIST", "MR": "19920325", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000339"}, {"RECTYPE": "D", "MH": "Affective Disorders, Psychotic", "DE": "AFFECTIVE DIS PSYCHOTIC", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Psychoses, Affective|T048|NON|EQV|UNK (19XX)|800521|abcdef", "ENTRY": "Psychotic Mood Disorder", "MN": "F03.700.150", "MH_TH": "NLM (1981)", "ST": "T048", "MS": "Disorders in which the essential feature is a severe disturbance in mood (depression, anxiety, elation, and excitement) accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc.", "OL": "use AFFECTIVE DISORDERS, PSYCHOTIC to search DEPRESSION, REACTIVE, PSYCHOTIC 1977-80; search AFFECTIVE DISTURBANCES under AFFECTIVE SYMPTOMS 1969-80", "PM": "81; DEPRESSION, REACTIVE, PSYCHOTIC was see under PSYCHOSES 1977-80; AFFECTIVE DISTURBANCES was heading 1969-80", "HN": "81; DEPRESSION, REACTIVE, PSYCHOTIC was see under PSYCHOSES 1977-80; AFFECTIVE DISTURBANCES was heading 1969-80", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19800521", "DC": "1", "DX": "19810101", "UI": "D000341"}, {"RECTYPE": "D", "MH": "Affective Symptoms", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Emotional Disturbances|T048|T184|NON|BRD|UNK (19XX)|740329|abbcdef", "ENTRY": "Symptoms, Affective", "MN": "F01.145.126.100", "MH_TH": "NLM (1969)", "ST": "T184", "AN": "human only; do not confuse with AFFECTIVE DISORDERS: read MeSH definitions & follow text", "PI": "Emotions (1966-1968)", "MS": "Mood or emotional responses dissonant with or inappropriate to the behavior and/or stimulus.", "OL": "use AFFECTIVE SYMPTOMS to search AFFECTIVE DISTURBANCES 1969-80", "PM": "81; was AFFECTIVE DISTURBANCES 1969-80", "HN": "81; was AFFECTIVE DISTURBANCES 1969-80", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D000342"}, {"RECTYPE": "D", "MH": "Afferent Loop Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Afferent Loop", "MN": "C23.550.767.050", "MH_TH": "NLM (1969)", "ST": "T047", "PI": "Dumping Syndrome (1966-1968)", "MS": "A complication of gastrojejunostomy (BILLROTH II PROCEDURE), a reconstructive GASTROENTEROSTOMY. It is caused by acute (complete) or chronic (intermittent) obstruction of the afferent jejunal loop due to HERNIA, intussusception, kinking, VOLVULUS, etc. It is characterized by PAIN and VOMITING of BILE-stained fluid.", "OL": "search DUMPING SYNDROME 1966-68", "PM": "70; was see under DUMPING SYNDROME 1963-69", "HN": "70(69); was see under DUMPING SYNDROME 1963-69", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D000343"}, {"RECTYPE": "D", "MH": "Afferent Pathways", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Pathways, Afferent", "MN": "A08.612.220", "MH_TH": "NLM (1976)", "ST": "T023", "AN": "coord NIM with origin (IM) + termination (IM)", "PI": "specific sensory receptor", "MS": "Nerve structures through which impulses are conducted from a peripheral part toward a nerve center.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "19920325", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D000344"}, {"RECTYPE": "D", "MH": "Affinity Labels", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Affinity Labeling Reagents|T130|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Reagents, Affinity Labeling", "MN": "D27.720.470.410.080", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "0", "AN": "D25-26 qualif; use with caution: few apply", "PI": "Indicators and Reagents (1968-1974)", "MS": "Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D000345"}, {"RECTYPE": "D", "MH": "Afghanistan", "AQ": "EH EP", "MN": "Z01.252.245.782.250", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "Country located north and west of Pakistan, and east of Iran. The capital is Kabul.", "MR": "20220708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000346"}, {"RECTYPE": "D", "MH": "Afibrinogenemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fibrinogen Deficiency|T047|NON|NRW|UNK (19XX)|740329|FIBRINOGEN DEFIC|abcdefv", "ENTRY": "Hypofibrinogenemias, Congenital", "MN": "C16.320.099.056", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A deficiency or absence of FIBRINOGEN in the blood.", "CATSH": "CAT LIST", "MR": "20180613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000347"}, {"RECTYPE": "D", "MH": "Aflatoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Aflatoxin|T109|T131|NON|EQV|UNK (19XX)|760905|abbcdef", "MN": "D23.946.587.142", "PA": "Poisons", "MH_TH": "NLM (1965)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTITOXINS", "MS": "Furano-furano-benzopyrans that are produced by ASPERGILLUS from STERIGMATOCYSTIN. They are structurally related to COUMARINS and easily oxidized to an epoxide form to become ALKYLATING AGENTS. Members of the group include AFLATOXIN B1; aflatoxin B2, aflatoxin G1, aflatoxin G2; AFLATOXIN M1; and aflatoxin M2.", "OL": "use AFLATOXINS to search AFLATOXIN 1966-74", "PM": "75; was AFLATOXIN 1967-74", "HN": "75; was AFLATOXIN 1965-74 (Prov 1965-66)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000348"}, {"RECTYPE": "D", "MH": "Africa", "AQ": "EH EP", "MN": "Z01.058", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "for the continent or unspecified only: prefer smaller geographic subdivisions, as AFRICA, NORTHERN; AFRICA, CENTRAL; etc.", "MS": "The continent south of EUROPE, east of the ATLANTIC OCEAN and west of the INDIAN OCEAN.", "MR": "20151124", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000349"}, {"RECTYPE": "D", "MH": "Africa, Central", "AQ": "EH EP", "ENTRY": "Central Africa|T083|NAM|EQV|NLM (2009)|080325|abcdef", "MN": "Z01.058.290.100", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a geographic area; prefer specific countries", "MS": "The geographical area of Africa comprising CAMEROON; CENTRAL AFRICAN REPUBLIC; CHAD; CONGO; DEMOCRATIC REPUBLIC OF THE CONGO; EQUATORIAL GUINEA; GABON; and SAO TOME AND PRINCIPE.", "MR": "20220708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000350"}, {"RECTYPE": "D", "MH": "Africa, Eastern", "AQ": "EH EP", "ENTRY": "Eastern Africa|T083|NAM|EQV|NLM (1983)|861231|abcdef", "MN": "Z01.058.290.120", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a geographic area; prefer specific countries", "MS": "The geographical area of Africa comprising BURUNDI, DJIBOUTI, ERITREA, ETHIOPIA, KENYA, RWANDA, SOMALIA, SOUTH SUDAN, SUDAN, TANZANIA, and UGANDA.", "MR": "20220708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000351"}, {"RECTYPE": "D", "MH": "Africa, Northern", "AQ": "EH EP", "PRINT ENTRY": "Sahara|T083|NAM|NRW|NLM (1994)|930119|abcdef", "ENTRY": "Northern Africa|T083|NAM|EQV|NLM (1994)|861231|abcdef", "MN": "Z01.058.266", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a geographic area; prefer specific countries; titles often refer to the Maghreb or Maghrib, the Arabic name for Algeria, Morocco, Tunisia & sometimes Libya collectively: check text for possible specificity, otherwise index under AFRICA, NORTHERN", "MS": "The geographical area of Africa comprising ALGERIA; EGYPT; LIBYA; MOROCCO and TUNISIA. It includes also the vast deserts and oases of the Sahara. It is often referred to as North Africa or the Maghreb.", "MR": "20180629", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000352"}, {"RECTYPE": "D", "MH": "Africa, Southern", "AQ": "EH EP", "ENTRY": "Southern Africa|T083|NAM|EQV|NLM (1983)|861231|abcdef", "MN": "Z01.058.290.175", "MH_TH": "NLM (1966)", "ST": "T083", "MS": "The geographical area of Africa comprising ANGOLA; BOTSWANA; LESOTHO; MALAWI; MOZAMBIQUE; NAMIBIA; SOUTH AFRICA; SWAZILAND; ZAMBIA; and ZIMBABWE.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000353"}, {"RECTYPE": "D", "MH": "Africa, Western", "AQ": "EH EP", "ENTRY": "Western Africa|T083|NAM|EQV|NLM (1983)|861231|abcdef", "MN": "Z01.058.290.190", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a geographic area: prefer specific countries", "MS": "The geographical area of Africa comprising BENIN; BURKINA FASO; CABO VERDE, COTE D'IVOIRE (formerly  Ivory Coast); GAMBIA; GHANA; GUINEA; GUINEA-BISSAU; LIBERIA; MALI; MAURITANIA; NIGER; NIGERIA; SENEGAL; SIERRA LEONE; and TOGO.", "MR": "20220708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000354"}, {"RECTYPE": "D", "MH": "African Horse Sickness", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Equine Plague|T047|NON|EQV|NLM (1998)|960807|abcdef", "ENTRY": "Sicknesses, African Horse", "MN": "C22.488.088", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "caused by an Orbivirus; in horses, mules & donkeys; if in horses don't forget also HORSES (NIM) & check tag ANIMALS; if in mules or donkeys, coord IM with EQUIDAE (IM) & check tag ANIMALS", "PI": "Reovirus Infections (1968-1979)", "MS": "An insect-borne reovirus infection of horses, mules and donkeys in Africa and the Middle East; characterized by pulmonary edema, cardiac involvement, and edema of the head and neck.", "PM": "98; see AFRICAN HORSESICKNESS 1970-97", "HN": "98", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D000355"}, {"RECTYPE": "D", "MH": "African Horse Sickness Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.223.719.550.050", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid40050", "MS": "A species of ORBIVIRUS that causes disease in horses, mules, and donkeys. Via its principal vector CULICOIDES, it can also infect dogs, elephants, camels, cattle, sheep, goats, and, in special circumstances, humans.", "PM": "98; see AFRICAN HORSESICKNESS VIRUS 1991-97, see REOVIRIDAE 1981-90, see REOVIRUSES 1975-80", "HN": "98(75)", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000356"}, {"RECTYPE": "D", "MH": "African Swine Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Swine Fever, African|T047|EPO|EQV|NLM (2002)|010420|abcdef", "ENTRY": "Wart-Hog Diseases", "MN": "C22.905.072", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "do not confuse with SWINE FEVER see CLASSICAL SWINE FEVER", "PI": "Virus Diseases (1966-1969)", "MS": "A sometimes fatal ASFIVIRUS infection of pigs, characterized by fever, cough, diarrhea, hemorrhagic lymph nodes, and edema of the gallbladder. It is transmitted between domestic swine by direct contact, ingestion of infected meat, or fomites, or mechanically by biting flies or soft ticks (genus Ornithodoros).", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D000357"}, {"RECTYPE": "D", "MH": "African Swine Fever Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Wart-Hog Disease Virus|T005|NON|EQV|UNK (19XX)|741205|WART HOG DIS VIRUS|abcdefv", "ENTRY": "Wart Hog Disease Virus", "MN": "B04.280.049.035", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid10497", "PI": "DNA Viruses (1966-1974)", "MS": "The lone species of the genus Asfivirus. It infects domestic and wild pigs, warthogs, and bushpigs. Disease is endemic in domestic swine in many African countries and Sardinia. Soft ticks of the genus Ornithodoros are also infected and act as vectors.", "PM": "91; was see under IRIDOVIRIDAE 1981-90; was see under IRIDOVIRUSES 1978-80; was see under DNA VIRUSES 1975-77", "HN": "91(75); was see under IRIDOVIRIDAE 1981-90; was see under IRIDOVIRUSES 1978-80; was see under DNA VIRUSES 1975-77", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D000358"}, {"RECTYPE": "D", "MH": "Aftercare", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "ENTRY": "Programs, Postabortal", "MN": "N04.590.233.727.210.063", "FX": "Halfway Houses", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "medical, nursing, psychiatric care after discharge from a hospital or other health facility; differentiate from REHABILITATION which is for getting a person back to pre-illness work or other activity", "PI": "Progressive Patient Care (1966-1967)", "MS": "The care and treatment of a convalescent patient, especially that of a patient after surgery.", "OL": "use AFTERCARE to search AFTER CARE 1968-93", "PM": "94; was AFTER CARE 1968-93", "HN": "94; was AFTER CARE 1968-93", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000359"}, {"RECTYPE": "D", "MH": "Afterimage", "AQ": "CL DE ES PH RE", "ENTRY": "Afterimages", "MN": "G14.040", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "differentiate from FIGURAL AFTEREFFECT which is displacement of (usually) geometric pattern in shape & space; while both are in the field of perception, AFTERIMAGE is likely to be in ophthalmol jrnls, FIGURAL AFTEREFFECT, in psychol jrnls", "MS": "Continuation of visual impression after cessation of stimuli causing the original image.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000360"}, {"RECTYPE": "D", "MH": "Agammaglobulinemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypogammaglobulinemia|T047|NON|REL|GHR (2014)|UNK (19XX)|770616|abcdeef", "ENTRY": "Hypogammaglobulinemias", "MN": "C20.673.088", "FX": "Protein-Losing Enteropathies", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "DYSGAMMAGLOBULINEMIA is also available", "MS": "An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000361"}, {"RECTYPE": "D", "MH": "Agar", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU UL", "MN": "D09.698.360.041", "PA": "Culture Media", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "Agar", "RN": "9002-18-0", "MS": "A complex sulfated polymer of galactose units, extracted from Gelidium cartilagineum, Gracilaria confervoides, and related red algae. It is used as a gel in the preparation of solid culture media for microorganisms, as a bulk laxative, in making emulsions, and as a supporting medium for immunodiffusion and immunoelectrophoresis.", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000362"}, {"RECTYPE": "D", "MH": "Agaricales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mushrooms|T004|NON|EQV|NLM (1999)|971210|abcdef", "ENTRY": "Mushroom", "MN": "B01.300.179.100", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5338", "RR": "txid5339", "PI": "Basidiomycetes (1966-1974)", "MS": "An extensive order of basidiomycetous fungi whose fruiting bodies are commonly called mushrooms.", "PM": "1986; for MUSHROOMS see BASIDOMYCETES 1986-1998, see MUSHROOMS 1963-1985; for AGARICACEAE see AGARICACEAE 1975-1985, see MUSHROOMS 1963-1974", "HN": "1986(1975); for MUSHROOMS use BASIDIOMYCOTA 1963-1998; for AGARICACEAE use BASIDIOMYCOTA 1966-1974", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19750101", "UI": "D000363"}, {"RECTYPE": "D", "MH": "Agaricus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.179.100.105", "MH_TH": "NLM (1986)", "ST": "T004", "RN": "txid5340", "AN": "a basidiomycete", "PI": "Basidiomycetes (1966-1985)", "MS": "A basidiomycetous fungal genus of the family Agaricaceae, order Agaricales, which includes the field mushroom (A. campestris) and the commercial mushroom (A. bisporus).", "PM": "91; was see under AGARICALES 1986-90", "HN": "91(86); was see under AGARICALES 1986-90", "MR": "20200813", "DA": "19850208", "DC": "1", "DX": "19910101", "UI": "D000364"}, {"RECTYPE": "D", "MH": "Age Determination by Skeleton", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Skeletal Age Measurement|T060|NON|REL|UNK (19XX)|740329|abcdef", "ENTRY": "Skeletal Maturation Indices", "MN": "E01.370.350.700.050", "MH_TH": "NLM (1967)", "ST": "T060", "MS": "Establishment of the age of an individual by examination of their skeletal structure.", "OL": "use AGE DETERMINATION BY SKELETON to search SKELETAL AGE MEASUREMENT 1966", "PM": "67; was SKELETAL AGE MEASUREMENT 1965-66", "HN": "67; was SKELETAL AGE MEASUREMENT 1965-66", "CATSH": "CAT LIST", "MR": "20170531", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000365"}, {"RECTYPE": "D", "MH": "Age Determination by Teeth", "AQ": "MT VE", "MN": "E06.623.500", "MH_TH": "NLM (1964)", "ST": "T060", "MS": "A means of identifying the age of an animal or human through tooth examination.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20150522", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000366"}, {"RECTYPE": "D", "MH": "Age Factors", "ENTRY": "Factors, Age", "MN": "N06.850.490.250", "MH_TH": "POPLINE (1978)", "ST": "T079", "AN": "usually NIM; human & animal; do not confuse with AGE DISTRIBUTION or AGING", "PI": "Aging (1966-1967)", "MS": "Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.", "OL": "use AGE DISTRIBUTION and SEX DISTRIBUTION to search AGE-SEX DISTRIBUTION 1994 forward; use AGE FACTORS to search AGE-SEX DISTRIBUTION 1990-92", "PM": "68; AGE-SEX DISTRIBUTION was see AGE FACTORS 1990-92", "HN": "68; AGE-SEX DISTRIBUTION was see AGE FACTORS 1990-92", "MR": "20160208", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000367"}, {"RECTYPE": "D", "MH": "Aged", "AQ": "PH PX SN", "PRINT ENTRY": "Elderly|T100|NON|EQV|NLM (1989)|900405|abcdef", "MN": "M01.060.116.100", "FX": "Retirement", "MH_TH": "POPLINE (1978)", "ST": "T100", "AN": "almost always check tag: NIM no qualifiers; see Manual Chapter 9; differentiate from AGING, a physiological process, & AGE FACTORS & AGE DISTRIBUTION, statistical concepts", "MS": "A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available.", "PM": "1966; was see under GERIATRICS 1963-65", "HN": "1966; was see under GERIATRICS 1963-65", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000368"}, {"RECTYPE": "D", "MH": "Aged, 80 and over", "DE": "AGED 80", "AQ": "PH PX SN", "PRINT ENTRY": "Oldest Old|T100|NON|EQV|UNK (19XX)|860325|abcdef", "MN": "M01.060.116.100.080", "MH_TH": "POPLINE (1987)", "ST": "T100", "AN": "almost always check tag: NIM no qualifiers; see Manual Chapter 9", "PI": "Aged (1966-1986)", "MS": "Persons 80 years of age and older.", "PM": "87; CENTENARIANS, NONAGENARIANS, & OCTOGENARIANS were CENTENARIAN, NONAGENARIAN, & OCTOGENARIAN 1987-95", "HN": "87; CENTENERIANS, NONAGENARIANS, & OCTOGENARIANS were CENTENARIAN, NONAGENARIAN, & OCTOGENARIAN 1987-95", "MR": "20210115", "DA": "19860325", "DC": "1", "DX": "19870101", "UI": "D000369"}, {"RECTYPE": "D", "MH": "Ageusia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Taste-Blindness|T184|NON|REL|NLM (2000)|991104|abcdef", "ENTRY": "Taste Loss", "MN": "C23.888.592.763.861.184", "MH_TH": "NLM (1975)", "ST": "T184", "AN": "do not confuse with DYSGEUSIA, distortion of sense of taste", "MS": "Complete or severe loss of the subjective sense of taste, frequently accompanied by OLFACTION DISORDERS.", "PM": "1991; see TASTE DISORDERS 1975-1990", "HN": "1991(1975)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000370"}, {"RECTYPE": "D", "MH": "Agglutination", "AQ": "DE GE IM PH RE", "MN": "G12.122.100", "FX": "Agglutination Tests", "MH_TH": "NLM (1966)", "ST": "T044", "AN": "NIM", "MS": "The clumping together of suspended material resulting from the action of AGGLUTININS.", "CATSH": "CAT LIST", "MR": "20160209", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000371"}, {"RECTYPE": "D", "MH": "Agglutination Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Agglutination", "MN": "E05.478.594.760.050", "FX": "Agglutination", "MH_TH": "NLM (1966)", "ST": "T059", "MS": "Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed)", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000372"}, {"RECTYPE": "D", "MH": "Agglutinins", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Agglutinin|T129|NON|EQV|NLM (2021)|191118|abcdef", "MN": "D27.505.954.502.270.232", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "PI": "Antibodies (1966-1972)", "MS": "A substance that makes particles (such as bacteria or cells) stick together to form a clump or a mass.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000373"}, {"RECTYPE": "D", "MH": "Aggression", "AQ": "CL DE ES PH PX RE", "ENTRY": "Aggressions", "MN": "F01.145.813.045", "MH_TH": "NLM (1986)", "ST": "T055", "MS": "Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism.", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000374"}, {"RECTYPE": "D", "MH": "Aging", "AQ": "BL CF DE EH ES GE IM ME PA PH PX RE UR", "PRINT ENTRY": "Senescence|T040|T079|NON|NRW|UNK (19XX)|740329|abbcdef", "ENTRY": "Biological Aging|T040|T079|NON|NRW|POPLINE (1981)|861231|BIOL AGING|abbcdefv", "MN": "G07.345.124", "FX": "Skin Aging", "MH_TH": "NLM (1966)", "ST": "T079", "AN": "human & animal; IM; aging process anywhere between birth & old age; differentiation from other age-related terms; \"aging\" of lower organisms, cultures, drugs, etc. is probably TIME FACTORS; AGING, PREMATURE is also available", "MS": "The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000375"}, {"RECTYPE": "D", "MH": "Agmatine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "1 Amino 4 guanidinobutane", "MN": "D02.078.370.060", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Guanidine, (4-aminobutyl)-", "RN": "70J407ZL5Q", "RR": "306-60-5 (Agmatine)", "PI": "Guanidines (1968-1974)", "MS": "Decarboxylated arginine, isolated from several plant and animal sources, e.g., pollen, ergot, herring sperm, octopus muscle.", "PM": "91; was see under GUANIDINES 1975-90", "HN": "91(75); was see under GUANIDINES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000376"}, {"RECTYPE": "D", "MH": "Agnosia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Visual Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Visuospatial Agnosias", "MN": "F01.700.750.100", "MH_TH": "ORD (2010)", "ST": "T048", "AN": "coordinate IM with type of stimulus that is not recognized (IM)", "MS": "Loss of the ability to comprehend the meaning or recognize the importance of various forms of stimulation that cannot be attributed to impairment of a primary sensory modality. Tactile agnosia is characterized by an inability to perceive the shape and nature of an object by touch alone, despite unimpaired sensation to light touch, position, and other primary sensory modalities.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000377"}, {"RECTYPE": "D", "MH": "Agonistic Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Behaviors, Agonistic", "MN": "F01.145.126.125.100", "MH_TH": "NLM (1975)", "ST": "T054", "MS": "Any behavior associated with conflict between two individuals.", "OL": "search AGGRESSION 1968-74", "PM": "91; was see under AGGRESSION 1975-90", "HN": "91(75); was see under AGGRESSION 1975-90", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000378"}, {"RECTYPE": "D", "MH": "Agoraphobia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Phobia, Open Spaces|T048|NON|EQV|NLM (2023)|210921|abcdef", "ENTRY": "Open Spaces Phobia", "MN": "F03.080.725.250", "MH_TH": "NLM (1975)", "ST": "T048", "MS": "Obsessive, persistent, intense fear of places or situations from which escape might be difficult or embarrassing.", "PM": "90; was see under PHOBIC DISORDERS 1981-89; was see under PHOBIAS 1968-80", "HN": "90(75); was see under PHOBIC DISORDERS 1981-89; was see under PHOBIAS 1968-80", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D000379"}, {"RECTYPE": "D", "MH": "Agranulocytosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Granulocytopenia|T033|T047|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Granulocytopenias", "MN": "C15.378.553.546.184", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000380"}, {"RECTYPE": "D", "MH": "Agraphia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Pure Agraphia|T048|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Pure Agraphias", "MN": "F03.625.562.700.125", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "Loss or impairment of the ability to write (letters, syllables, words, or phrases) due to an injury to a specific cerebral area or occasionally due to emotional factors. This condition rarely occurs in isolation, and often accompanies APHASIA. (From Adams et al., Principles of Neurology, 6th ed, p485; APA, Thesaurus of Psychological Index Terms, 1994)", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000381"}, {"RECTYPE": "D", "MH": "Agricultural Workers' Diseases", "DE": "AGRICULTURAL WORKERS DIS", "AQ": "BL CF CI CL DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Workers' Diseases, Agricultural", "MN": "C24.080", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific dis (IM); specify geog if pertinent", "MS": "Diseases in persons engaged in cultivating and tilling soil, growing plants, harvesting crops, raising livestock, or otherwise engaged in husbandry and farming. The diseases are not restricted to farmers in the sense of those who perform conventional farm chores: the heading applies also to those engaged in the individual activities named above, as in those only gathering harvest or in those only dusting crops.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000382"}, {"RECTYPE": "D", "MH": "Agriculture", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Agronomy|T090|NON|EQV|NLM (2023)|220426|abcdef", "ENTRY": "Development, Agricultural", "MN": "J01.040", "FX": "Agricultural Inoculants", "MH_TH": "NLM (1978)", "ST": "T090", "MS": "The science, art or practice of cultivating soil, producing crops, and raising livestock.", "MR": "20220711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000383"}, {"RECTYPE": "D", "MH": "Aid to Families with Dependent Children", "DE": "AFDC", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Family Allowance", "MN": "N03.219.521.346.506.849.095", "MH_TH": "NLM (1975)", "ST": "T064", "AN": "treed under SOCIAL SECURITY; specify geog", "MS": "Financial assistance provided by the government to indigent families with dependent children who meet certain requirements as defined by the Social Security Act, Title IV, in the U.S.", "OL": "search PUBLIC ASSISTANCE 1968-74", "PM": "78; was see under PUBLIC ASSISTANCE 1968-77", "HN": "78(75); was see under PUBLIC ASSISTANCE 1968-77", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D000385"}, {"RECTYPE": "D", "MH": "AIDS-Related Complex", "DE": "AIDS RELAT COMPLEX", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Lymphadenopathy Syndrome|T047|NON|EQV|UNK (19XX)|860618|abcdef", "ENTRY": "Syndromes, Lymphadenopathy", "MN": "C20.673.480.080", "MH_TH": "POPLINE (1988)", "ST": "T047", "AN": "coordinate with HIV-1 or HIV-2 if pertinent", "PI": "Acquired Immunodeficiency Syndrome (1983-1986)", "MS": "A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (ARC) from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi's sarcoma, signaling the transition to the full-blown AIDS.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D000386"}, {"RECTYPE": "D", "MH": "Ainhum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dactylolysis Spontanea|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Spontaneous Dactylolyses", "MN": "C05.116.264.143", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Spontaneous autoamputation of the fourth or fifth toe.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000387"}, {"RECTYPE": "D", "MH": "Air", "AQ": "AN LJ PS ST", "MN": "N06.230.300.100.150", "EC": "virology:Air Microbiology", "MH_TH": "NLM (1966)", "ST": "T167", "AN": "do not confuse with ATMOSPHERE or OXYGEN", "MS": "The mixture of gases present in the earth's atmosphere consisting of oxygen, nitrogen, carbon dioxide, and small amounts of other gases.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000388"}, {"RECTYPE": "D", "MH": "Air Conditioning", "AQ": "AE EC ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Climate Control|T068|NON|BRD|NLM (1995)|931126|abcdef", "ENTRY": "Revitalizations, Air", "MN": "N06.230.150.050", "MH_TH": "NLM (1966)", "ST": "T068", "MS": "The maintenance of certain aspects of the environment within a defined space to facilitate the function of that space; aspects controlled include air temperature and motion, radiant heat level, moisture, and concentration of pollutants such as dust, microorganisms, and gases. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000389"}, {"RECTYPE": "D", "MH": "Air Ionization", "AQ": "DE RE", "ENTRY": "Ionizations, Air", "MN": "N06.230.300.100.150.100", "MH_TH": "NLM (1965)", "ST": "T070", "MS": "The dissociation of molecules in the air into positive and negative ions under the influence of an electric field.", "PM": "70", "HN": "70(65)", "MR": "20160219", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D000390"}, {"RECTYPE": "D", "MH": "Air Microbiology", "DE": "AIR MICROBIOL", "AQ": "ST", "ENTRY": "Microbiology, Air|T067|NON|EQV|UNK (19XX)|860101|MICROBIOL AIR|abcdefv", "MN": "N06.850.425.110", "MH_TH": "NLM (1966)", "ST": "T067", "AN": "coordinate with specific bacterium, virus or fungus ", "MS": "The presence of bacteria, viruses, and fungi in the air. This term is not restricted to pathogenic organisms.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000391"}, {"RECTYPE": "D", "MH": "Air Movements", "ENTRY": "Movements, Air", "MN": "N06.230.300.100.150.185", "MH_TH": "NLM (1972)", "ST": "T070", "AN": "WIND is also available but see note there", "PI": "Weather (1966-1971)", "MS": "The motion of air currents.", "PM": "74", "HN": "74(72)", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000392"}, {"RECTYPE": "D", "MH": "Air Pollutants", "AQ": "AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO UR", "PRINT ENTRY": "Air Pollutant|T131|NON|EQV|NLM (2021)|191230|abcdef", "ENTRY": "Pollutants, Environmental Air", "MN": "D27.888.284.101", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "specify pollutant if pertinent", "PI": "Air Pollution (1966-1974)", "MS": "Any substance in the air which could, if present in high enough concentration, harm humans, animals, vegetation or materials. Substances include GASES; PARTICULATE MATTER; and volatile ORGANIC CHEMICALS.", "PM": "1975; for AIR POLLUTANTS, ENVIRONMENTAL see AIR POLLUTANTS, ENVIRONMENTAL 1984-2006", "HN": "1975", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D000393"}, {"RECTYPE": "D", "MH": "Air Pollutants, Occupational", "DE": "AIR POLLUTANTS OCCUP", "AQ": "AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO UR", "PRINT ENTRY": "Occupational Air Pollutants|T131|NON|EQV|UNK (19XX)|770425|OCCUP AIR POLLUTANTS|abcdefv", "ENTRY": "Pollutants, Occupational Air", "MN": "D27.888.284.101.268", "FX": "Gas Scavengers", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "specify pollutant or occupation if pertinent", "MS": "Toxic air-borne matter related to work performed They are usually produced by the specific nature of the occupation.", "PM": "84; was see under AIR POLLUTANTS 1975-83", "HN": "84(75); was see under AIR POLLUTANTS 1975-83", "MR": "20170602", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D000395"}, {"RECTYPE": "D", "MH": "Air Pollutants, Radioactive", "AQ": "AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO UR", "ENTRY": "Pollutants, Radioactive Air", "MN": "D27.888.284.101.393", "FX": "Air Pollution, Radioactive", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "specify radiopollutant if pertinent", "MS": "Pollutants present in air which exhibit radioactivity.", "PM": "91; was see under AIR POLLUTANTS 1975-90", "HN": "91(75); was see under AIR POLLUTANTS 1975-90", "MR": "20170601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000396"}, {"RECTYPE": "D", "MH": "Air Pollution", "AQ": "AE AN EC ES HI LJ PC SN", "ENTRY": "Pollution, Air", "MN": "N06.850.460.100", "MH_TH": "NLM (1966)", "ST": "T069", "AN": "includes pollen in the air (coordinate with POLLEN)", "MS": "The presence of contaminants or pollutant substances in the air (AIR POLLUTANTS) that interfere with human health or welfare, or produce other harmful environmental effects. The substances may include GASES; PARTICULATE MATTER; or volatile ORGANIC CHEMICALS.", "MR": "20170414", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000397"}, {"RECTYPE": "D", "MH": "Air Pollution, Radioactive", "AQ": "AE AN EC ES HI LJ PC SN", "ENTRY": "Pollution, Radioactive Air", "MN": "N06.850.810.080", "FX": "Air Pollutants, Radioactive", "MH_TH": "NLM (1966)", "ST": "T069", "AN": "IM; coord with specific source of radiation (IM); specify geog if pertinent", "MS": "Contamination of air with radioactive substances.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000398"}, {"RECTYPE": "D", "MH": "Air Pressure", "ENTRY": "Pressures, Air", "MN": "N06.230.300.100.185.100", "MH_TH": "NLM (1975)", "ST": "T070", "MS": "The force per unit area that the air exerts on any surface in contact with it. Primarily used for articles pertaining to air pressure within a closed environment.", "OL": "search ATMOSPHERIC PRESSURE 1966-74", "PM": "91; was see under ATMOSPHERIC PRESSURE 1975-90", "HN": "91(75); was see under ATMOSPHERIC PRESSURE 1975-90", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000399"}, {"RECTYPE": "D", "MH": "Air Sacs", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Swimbladder|T023|NON|EQV|UNK (19XX)|800512|abcdef", "ENTRY": "Swimbladders", "MN": "A13.048", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "in birds, fish, insects & mammals; sacculitis in veterinary animals: coord IM with RESPIRATORY TRACT DISEASES/vet (IM) or RESPIRATORY TRACT INFECTIONS/vet (IM)", "PI": "Bronchi (1966-1967)", "MS": "Thin-walled sacs or spaces which function as a part of the respiratory system in birds, fishes, insects, and mammals.", "OL": "use AIR SACS to search AIR BLADDER 1968-80", "PM": "68; AIR BLADDER was heading 1968-80", "HN": "68; AIR BLADDER was heading 1968-80", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000400"}, {"RECTYPE": "D", "MH": "Aircraft", "AQ": "CL EC ES HI IS LJ SN ST", "PRINT ENTRY": "Helicopters|T073|NON|NRW|UNK (19XX)|860325|abcdef", "ENTRY": "Seats, Ejection", "MN": "J01.937.285.100", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "A weight-carrying structure for navigation of the air that is supported either by its own buoyancy or by the dynamic action of the air against its surfaces. (Webster, 1973)", "OL": "use AIRCRAFT to search EJECTION SEATS 1966-82", "PM": "EJECTION SEATS was heading 1963-82", "HN": "EJECTION SEATS was heading 1963-82", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D000401"}, {"RECTYPE": "D", "MH": "Airway Obstruction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Choking|T046|T184|NON|NRW|UNK (19XX)|810519|abbcdef", "ENTRY": "Obstructions, Airway", "MN": "C08.618.846.185", "FX": "Respiratory Aspiration", "MH_TH": "NLM (1971)", "ST": "T047", "PI": "Respiratory Tract Diseases (1966-1970)", "MS": "Any hindrance to the passage of air into and out of the lungs.", "PM": "72", "HN": "72(71)", "CATSH": "CAT LIST", "MR": "20221215", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000402"}, {"RECTYPE": "D", "MH": "Airway Resistance", "AQ": "DE ES GE IM PH RE", "ENTRY": "Resistances, Airway", "MN": "G09.772.060", "FX": "Respiratory Mechanics", "MH_TH": "NLM (1970)", "ST": "T042", "PI": "Respiratory System/physiology (1966-1970)", "MS": "Physiologically, the opposition to flow of air caused by the forces of friction. As a part of pulmonary function testing, it is the ratio of driving pressure to the rate of air flow.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D000403"}, {"RECTYPE": "D", "MH": "Ajmaline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Wolfina|T109|T121|TRD|NRW|US|020722|abbcdef", "MN": "D03.633.100.496.500.500.681.077", "PA": "Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (1971)", "ST": "T121", "N1": "Ajmalan-17,21-diol, (17R,21alpha)-", "RN": "1PON08459R", "RR": "4360-12-7 (Ajmaline)", "PI": "Rauwolfia (1966-1970)", "MS": "An alkaloid found in the root of RAUWOLFIA SERPENTINA, among other plant sources. It is a class 1-A antiarrhythmic agent that apparently acts by changing the shape and threshold of cardiac action potentials.", "PM": "73", "HN": "73(71)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000404"}, {"RECTYPE": "D", "MH": "Akinetic Mutism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mutism, Akinetic|T048|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Vigils, Coma", "MN": "C10.228.140.042", "FX": "Persistent Vegetative State", "MH_TH": "NLM (1971)", "ST": "T048", "PI": "Mutism (1966-1970)", "MS": "A syndrome characterized by a silent and inert state without voluntary motor activity despite preserved sensorimotor pathways and vigilance. Bilateral FRONTAL LOBE dysfunction involving the anterior cingulate gyrus and related brain injuries are associated with this condition. This may result in impaired abilities to communicate and initiate motor activities. (From Adams et al., Principles of Neurology, 6th ed, p348; Fortschr Neurol Psychiatr 1995 Feb;63(2):59-67)", "PM": "1971", "HN": "1971", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D000405"}, {"RECTYPE": "D", "MH": "AKR murine leukemia virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "AKR Virus|T005|ACX|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Viruses, AKR", "MN": "B04.820.650.375.525.050", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11791", "AN": "infection: coordinate IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + LEUKEMIA, EXPERIMENTAL (IM) or LEUKEMIA (IM) (for spontaneous leukemia)", "MS": "A strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) isolated from spontaneous leukemia in AKR strain mice.", "PM": "2002; see AKR VIRUS 1991-2001, see MOUSE LEUKEMIA VIRUSES 1975-1990; for GROSS VIRUS use GROSS VIRUS 1966-2006", "HN": "2002 (1975)", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D000406"}, {"RECTYPE": "D", "MH": "Alabama", "AQ": "EH EP", "MN": "Z01.107.567.875.750.100", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A state in the southeastern region of the United States. The capital is Montgomery.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000407"}, {"RECTYPE": "D", "MH": "Alamethicin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D12.644.641.040", "PA": "Uncoupling Agents", "MH_TH": "NLM (1975)", "ST": "T195", "N1": "Alamethicin", "RN": "27061-78-5", "PI": "Peptides, Cyclic (1973-1974)", "MS": "A cyclic nonadecapeptide antibiotic that can act as an ionophore and is produced by strains of Trichoderma viride. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)", "PM": "91; was see under ANTIBIOTICS 1975-90", "HN": "91(75); was see under ANTIBIOTICS 1975-90", "MR": "20070709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000408"}, {"RECTYPE": "D", "MH": "Alanine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L-Isomer Alanine", "MN": "D12.125.042", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "(L)-Alanine", "RN": "OF5P57N2ZX", "RR": "6898-94-8", "AN": "BETA-ALANINE is also available", "MS": "A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000409"}, {"RECTYPE": "D", "MH": "Alanine Transaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SGPT|T116|T126|ABB|NRW|UNK (19XX)|740329|abbcdef", "ENTRY": "Transaminase, Glutamic-Pyruvic", "MN": "D08.811.913.477.700.100", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "L-Alanine:2-oxoglutarate aminotransferase", "RN": "EC 2.6.1.2", "MS": "An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2.", "PM": "98; see ALANINE AMINOTRANSFERASE 1966-97; for GLUTAMIC-PYRUVIC TRANSMINASE see ALANINE 1963", "HN": "98(66)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000410"}, {"RECTYPE": "D", "MH": "Alanine Racemase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Racemase, Alanine", "MN": "D08.811.399.894.200.200", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "Alanine racemase", "RN": "EC 5.1.1.1", "RR": "9024-06-0 (CAS RN)", "PI": "Amino Acid Isomerases (1970-1975)", "MS": "A pyridoxal-phosphate protein that reversibly catalyzes the conversion of L-alanine to D-alanine. EC 5.1.1.1.", "PM": "91; was see under AMINO ACID ISOMERASES 1976-90", "HN": "91(76); was see under AMINO ACID ISOMERASES 1976-90", "MR": "20030709", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D000411"}, {"RECTYPE": "D", "MH": "Alanine-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Alanyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961105|abbdef", "ENTRY": "Synthetase, Alanyl-tRNA", "MN": "D08.811.464.263.200.050", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Alanine:tRNA(Ala) ligase (AMP-forming)", "RN": "EC 6.1.1.7", "PI": "Amino Acyl T RNA Synthetases (1973-1974)", "MS": "An enzyme that activates alanine with its specific transfer RNA. EC 6.1.1.7.", "PM": "98; see ALANYL T RNA SYNTHETASE 1991-97; see AMINOACYL T RNA SYNTHETASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000412"}, {"RECTYPE": "D", "MH": "Alaska", "AQ": "EH EP", "PRINT ENTRY": "Aleutian Islands|T083|NAM|NRW|NLM (1994)|920820|abcdef", "MN": "Z01.107.567.875.580.100", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State of the UNITED STATES OF AMERICA bounded on the east by Canada and on the north, west, and south by the Pacific Ocean and the Bering Sea.", "MR": "20160608", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000413"}, {"RECTYPE": "D", "MH": "Albania", "AQ": "EH EP", "MN": "Z01.542.248.020", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "in translations of historical articles use spelling People's Republic, not Peoples' nor Peoples", "MS": "A country in Europe, on the Adriatic Sea. The capital is Tirana", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000415"}, {"RECTYPE": "D", "MH": "Alberta", "AQ": "EH EP", "MN": "Z01.107.567.176.064", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a province of Canada", "MS": "A province of western Canada, lying between the provinces of British Columbia and Saskatchewan. Its capital is Edmonton. It was named in honor of Princess Louise Caroline Alberta, the fourth daughter of Queen Victoria. (From Webster's New Geographical Dictionary, 1988, p26 & Room, Brewer's Dictionary of Names, 1992, p12)", "MR": "19950217", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000416"}, {"RECTYPE": "D", "MH": "Albinism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C18.452.648.100.102", "FX": "Chediak-Higashi Syndrome", "MH_TH": "NLM (1966)", "ST": "T019", "AN": "general or unspecified; prefer specifics", "MS": "General term for a number of inherited defects of amino acid metabolism in which there is a deficiency or absence of pigment in the eyes, skin, or hair.", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000417"}, {"RECTYPE": "D", "MH": "Albumins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Albumin|T116|T123|NON|EQV|NLM (2021)|191113|abbcdef", "MN": "D12.776.034", "FX": "Receptors, Albumin", "EC": "urine:Albuminuria", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating.", "MR": "20200114", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000418"}, {"RECTYPE": "D", "MH": "Albuminuria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Albuminurias", "MN": "C23.888.942.750.269", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "The presence of albumin in the urine, an indicator of KIDNEY DISEASES.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000419"}, {"RECTYPE": "D", "MH": "Albuterol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Salbutamol|T109|T121|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|UNK (19XX)|740329|abbdeeeef", "ENTRY": "Ventolin|T109|T121|TRD|NRW|UNK (19XX)|820519|abbcdef", "MN": "D02.092.471.683.061", "PA": "Tocolytic Agents", "FX": "Formoterol Fumarate", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-", "RN": "QF8SVZ843E", "RR": "51022-70-9 (Albuterol Sulfate)", "MS": "A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.", "PM": "74", "HN": "74", "MR": "20150526", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000420"}, {"RECTYPE": "D", "MH": "Alcaligenes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.344.050", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid507", "AN": "ALCALIGENES EUTROPHA see CUPRIAVIDUS NECATOR is available; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "MS": "A genus of gram-negative, aerobic, motile bacteria that occur in water and soil. Some are common inhabitants of the intestinal tract of vertebrates. These bacteria occasionally cause opportunistic infections in humans.", "PM": "1976; see ACHROMOBACTER 1963-1975", "HN": "1976 (1963)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D000421"}, {"RECTYPE": "D", "MH": "Alchemy", "MN": "K01.672.148", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "no qualif", "MS": "Form of chemistry concerned with discovering methods for transmuting base metals into gold and with finding an elixir for eternal youth.", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000422"}, {"RECTYPE": "D", "MH": "Alcian Blue", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Blue, Alcian", "MN": "D03.633.100.473.050", "PA": "Coloring Agents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Alcian Blue", "RN": "P4448TJR7J", "RR": "12040-44-7 (Alcian Blue)", "PI": "Onium Compounds (1974)", "MS": "A copper-containing dye used as a gelling agent for lubricants, for staining of bacteria and for the dyeing of histiocytes and fibroblasts in vivo.", "PM": "91; was see under INDOLES 1975-90", "HN": "91(75); was see under INDOLES 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000423"}, {"RECTYPE": "D", "MH": "Alcohol Amnestic Disorder", "DE": "ALCOHOL AMNESTIC DIS", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Amnestic Psychosis, Alcohol-Induced|T048|NON|EQV|NLM (2000)|991103|AMNESTIC PSYCHOSIS ALCOHOL IND|abcdefv", "ENTRY": "Psychosis, Alcohol-Induced Dysmnesic", "MN": "F03.900.100.050", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "A mental disorder associated with chronic ethanol abuse (ALCOHOLISM) and nutritional deficiencies characterized by short term memory loss, confabulations, and disturbances of attention. (Adams et al., Principles of Neurology, 6th ed, p1139)", "OL": "use ALCOHOL AMNESTIC DISORDER to search KORSAKOFF'S SYNDROME 1966-80", "PM": "81; was KORSAKOFF'S SYNDROME 1963-80", "HN": "81; was KORSAKOFF'S SYNDROME 1963-80", "CATSH": "CAT LIST", "MR": "20170519", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D000425"}, {"RECTYPE": "D", "MH": "Alcohol Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidoreductase, Alcohol-NAD+", "MN": "D08.811.682.047.820.250", "MH_TH": "NLM (1987)", "ST": "T126", "N1": "Alcohol:NAD+ oxidoreductase", "RN": "EC 1.1.1.1", "AN": "a specific enzyme; do not confuse with ALCOHOL OXIDOREDUCTASES", "PI": "Alcohol Oxidoreductases (1966-1986)", "MS": "A zinc-containing enzyme which oxidizes primary and secondary alcohols or hemiacetals in the presence of NAD. In alcoholic fermentation, it catalyzes the final step of reducing an aldehyde to an alcohol in the presence of NADH and hydrogen.", "PM": "87", "HN": "87", "MR": "20130708", "DA": "19860409", "DC": "1", "DX": "19870101", "UI": "D000426"}, {"RECTYPE": "D", "MH": "Alcohol Deterrents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Deterrents, Alcohol", "MN": "D27.505.954.427.020", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "consider also ALCOHOLISM /drug ther", "MS": "Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism.", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000427"}, {"RECTYPE": "D", "MH": "Alcohol Drinking", "AQ": "AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PC PP PX TD TH UR", "PRINT ENTRY": "Drinking, Alcohol|T055|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Intake, Alcohol", "MN": "F01.145.317.269", "FX": "Temperance", "MH_TH": "POPLINE (1981)", "ST": "T055", "PI": "Alcoholic Beverages (1966-1968)", "MS": "Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D000428"}, {"RECTYPE": "D", "MH": "Alcohol Oxidoreductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ketone Reductase|T116|T126|NON|EQV|NLM (2021)|200123|abbcdef", "ENTRY": "Reductases, Ketone", "MN": "D08.811.682.047", "MH_TH": "NLM (1964)", "ST": "T126", "RN": "EC 1.1.-", "MS": "A subclass of enzymes which includes all dehydrogenases acting on primary and secondary alcohols as well as hemiacetals. They are further classified according to the acceptor which can be NAD+ or NADP+ (subclass 1.1.1), cytochrome (1.1.2), oxygen (1.1.3), quinone (1.1.5), or another acceptor (1.1.99).", "PM": "64", "HN": "64", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D000429"}, {"RECTYPE": "D", "MH": "Alcohol Withdrawal Delirium", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Delirium Tremens|T047|NON|EQV|UNK (19XX)|800521|abcdef", "ENTRY": "Hallucinosis, Alcohol Withdrawal", "MN": "F03.900.825.500", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "An acute organic mental disorder induced by cessation or reduction in chronic alcohol consumption. Clinical characteristics include CONFUSION; DELUSIONS; vivid HALLUCINATIONS; TREMOR; agitation; insomnia; and signs of autonomic hyperactivity (e.g., elevated blood pressure and heart rate, dilated pupils, and diaphoresis). This condition may occasionally be fatal. It was formerly called delirium tremens. (From Adams et al., Principles of Neurology, 6th ed, p1175)", "OL": "use ALCOHOL WITHDRAWAL DELIRIUM to search DELIRIUM TREMENS 1975-80 & use PSYCHOSES, ALCOHOLIC 1966-74", "PM": "91; was see under PSYCHOSES, ALCOHOLIC 1981-90; was DELIRIUM TREMENS see under PSYCHOSES, ALCOHOLIC 1963-80", "HN": "91(81); was see under PSYCHOSES, ALCOHOLIC 1981-90; was DELIRIUM TREMENS see under PSYCHOSES, ALCOHOLIC 1963-80", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000430"}, {"RECTYPE": "D", "MH": "Ethanol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alcohol, Ethyl|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1998)|970115|abbcdeef", "ENTRY": "Ethyl Alcohol", "MN": "D02.033.375", "PA": "Solvents", "FX": "Alcoholic Beverages", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "3K9958V90M", "RR": "64-17-5 (Ethanol)", "MS": "A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.", "PM": "98; see ALCOHOL, ETHYL 1963-97", "HN": "98(63)", "MR": "20200317", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000431"}, {"RECTYPE": "D", "MH": "Methanol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alcohol, Methyl|T109|T131|NON|EQV|FDA SRS (2014)|NLM (1998)|970115|abbcdeef", "ENTRY": "Methyl Alcohol", "MN": "D02.033.623", "PA": "Solvents", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Methanol", "RN": "Y4S76JWI15", "RR": "IG663U5EMC", "AN": "for wood alcohol", "MS": "A colorless, flammable liquid used in the manufacture of FORMALDEHYDE and ACETIC ACID, in chemical synthesis, antifreeze, and as a solvent. Ingestion of methanol is toxic and may cause blindness.", "PM": "98; see ALCOHOL, METHYL 1966-97", "HN": "98;", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000432"}, {"RECTYPE": "D", "MH": "1-Propanol", "DS": "PROPANOL 01", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "n-Propanol|T109|NON|EQV|FDA SRS (2014)|NLM (1998)|970429|PROPANOL N|abcdeefs", "ENTRY": "Propyl Alcohol", "MN": "D02.033.755.600", "EC": "analogs & derivatives:Propanols", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "96F264O9SV", "RR": "71-23-8 (1-Propanol)", "MS": "A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate.", "PM": "98; see ALCOHOL, PROPYL 1963-97", "HN": "98(63)", "MR": "20190405", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000433"}, {"RECTYPE": "D", "MH": "Alcoholic Beverages", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "ENTRY": "Beverages, Alcoholic", "MN": "J02.200.100", "MH_TH": "NLM (1966)", "ST": "T168", "MS": "Drinkable liquids containing ETHANOL.", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000434"}, {"RECTYPE": "D", "MH": "Alcoholic Intoxication", "DE": "ALCOHOLIC INTOX", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intoxication, Alcoholic|T037|T048|NON|EQV|UNK (19XX)|810514|INTOX ALCOHOLIC|abbcdefv", "ENTRY": "Drunkennesses", "MN": "F03.900.100.300", "MH_TH": "NLM (1966)", "ST": "T048", "AN": "human & animal", "MS": "An acute brain syndrome which results from the excessive ingestion of ETHANOL or ALCOHOLIC BEVERAGES.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000435"}, {"RECTYPE": "D", "MH": "Alcoholics Anonymous", "AQ": "EC HI OG", "ENTRY": "Anonymous, Alcoholics", "MN": "N03.540.782.270", "MH_TH": "NLM (1974)", "ST": "T095", "AN": "CATALOGER: use NAF entry", "MS": "An organization of self-proclaimed alcoholics who meet frequently to reinforce their practice of abstinence.", "PM": "74", "HN": "74", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000436"}, {"RECTYPE": "D", "MH": "Alcoholism", "AQ": "BL CF CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ethanol Abuse|T048|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Use Disorders, Alcohol", "MN": "F03.900.100.350", "FX": "Temperance", "EC": "congenital:Fetal Alcohol Spectrum Disorders", "MH_TH": "OMIM (2013)", "ST": "T048", "MS": "A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000437"}, {"RECTYPE": "D", "MH": "Alcohols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.033", "MH_TH": "POPLINE (1984)", "ST": "T109", "RN": "0", "MS": "Alkyl compounds containing a hydroxyl group. They are classified according to relation of the carbon atom: primary alcohols, R-CH2OH; secondary alcohols, R2-CHOH; tertiary alcohols, R3-COH. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000438"}, {"RECTYPE": "D", "MH": "Pentanols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pentyl Alcohols|T109|NON|EQV|NLM (1998)|970428|abcdef", "ENTRY": "Amyl Alcohols", "MN": "D10.289.640", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Alcohols (1966-1971)", "MS": "Isomeric forms and derivatives of pentanol (C5H11OH).", "PM": "98; see ALCOHOLS, AMYL 1974-97", "HN": "98(72)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000439"}, {"RECTYPE": "D", "MH": "Butanols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Butanol|T109|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Butyl Alcohols", "MN": "D10.289.110", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "AN": "1-BUTANOL and TERT-BUTYL ALCOHOL also available", "PI": "Alcohols (1966-1971)", "MS": "Isomeric forms and derivatives of butanol (C4H9OH).", "PM": "98; see ALCOHOLS, BUTYL 1972-97", "HN": "98(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000440"}, {"RECTYPE": "D", "MH": "Hexanols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxyhexane|T109|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Hexyl Alcohols", "MN": "D10.289.510", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "MS": "Isomeric forms and derivatives of hexanol (C6H11OH).", "PM": "98; see ALCOHOLS, HEXYL 1974-97", "HN": "98(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000441"}, {"RECTYPE": "D", "MH": "Octanols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alcohols, Octyl|T109|NON|EQV|NLM (1998)|970610|abcdef", "ENTRY": "Octyl Alcohols", "MN": "D10.289.600", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "AN": "1-OCTANOL is also available", "MS": "Isomeric forms and derivatives of octanol (C8H17OH).", "PM": "98; see ALCOHOLS, OCTYL 1974-97", "HN": "98(72)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000442"}, {"RECTYPE": "D", "MH": "Alcuronium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diallylnortoxiferine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Dichloride, N,N'-Diallylnortoxiferinium", "MN": "D03.633.100.531.820.687.050", "PA": "Nicotinic Antagonists", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Toxiferine I, 4,4'-didemethyl-4,4'-di-2-propenyl-", "RN": "S8U3J5W06N", "RR": "490DW6501Y", "PI": "Toxiferine (1972-1974)", "MS": "A non-depolarizing skeletal muscle relaxant similar to TUBOCURARINE. It is used as an anesthesia adjuvant.", "OL": "use ALCURONIUM to search ALLOFERIN 1978-93", "PM": "91; was see under TOXIFERINE 1975-90; ALLOFERIN was see ALCURONIUM 1978-93", "HN": "91(75); was see under TOXIFERINE 1975-90; ALLOFERIN was see ALCURONIUM 1978-93", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000443"}, {"RECTYPE": "D", "MH": "Aldehyde Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "D-Glucuronolactone Dehydrogenase|T116|T126|NON|EQV|UNK (19XX)|840411|GLUCURONOLACTONE DEHYDROGENASE D|abbcdefs", "ENTRY": "Dehydrogenase, D-Glucuronolactone", "MN": "D08.811.682.657.163.249", "MH_TH": "NLM (1985)", "ST": "T126", "N1": "Aldehyde:NAD+ oxidoreductase", "RN": "EC 1.2.1.3", "PI": "Aldehyde Oxidoreductases (1980-1984)", "MS": "An enzyme that oxidizes an aldehyde in the presence of NAD+ and water to an acid and NADH. This enzyme was formerly classified as EC 1.1.1.70.", "PM": "85", "HN": "85", "MR": "20070709", "DA": "19840411", "DC": "1", "DX": "19850101", "UI": "D000444"}, {"RECTYPE": "D", "MH": "Aldehyde Oxidoreductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aldehyde Oxidoreductase|T116|T126|NON|EQV|NLM (2022)|201007|abbcdef", "ENTRY": "Oxidoreductases, Aldehyde", "MN": "D08.811.682.657.163", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 1.2.-", "PI": "Oxidoreductases (1966-1972)", "MS": "Oxidoreductases that are specific for ALDEHYDES.", "PM": "73", "HN": "73", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000445"}, {"RECTYPE": "D", "MH": "Aldehyde-Lyases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Aldehyde Lyases", "MN": "D08.811.520.224.062", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 4.1.2.-", "MS": "Enzymes that catalyze a reverse aldol condensation. A molecule containing a hydroxyl group and a carbonyl group is cleaved at a C-C bond to produce two smaller molecules (ALDEHYDES or KETONES). EC 4.1.2.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000446"}, {"RECTYPE": "D", "MH": "Aldehydes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aldehyde|T109|NON|EQV|NLM (2021)|191219|abcdef", "MN": "D02.047", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Organic compounds containing a carbonyl group in the form -CHO.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000447"}, {"RECTYPE": "D", "MH": "Aldicarb", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "UC21149", "MN": "D02.241.081.251.046", "PA": "Insecticides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Propanal, 2-methyl-2-(methylthio)-, O-((methylamino)carbonyl)oxime", "RN": "8V071SH05P", "RR": "116-06-3 (Aldicarb)", "PI": "Insecticides (1966-1971)", "MS": "Carbamate derivative used as an insecticide, acaricide, and nematocide.", "PM": "91; was see under INSECTICIDES, CARBAMATE 1972-90", "HN": "91(72); was see under INSECTICIDES, CARBAMATE 1972-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000448"}, {"RECTYPE": "D", "MH": "Aldehyde Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aldose Reductase|T116|T126|NON|EQV|NLM (1992)|910114|abbcdef", "ENTRY": "Reductase, Xylose", "MN": "D08.811.682.047.820.284.500", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "Alditol:NAD(P)+ 1-oxidoreductase", "RN": "EC 1.1.1.21", "PI": "Sugar Alcohols (1972-1975)", "MS": "An enzyme that catalyzes reversibly the oxidation of an aldose to an alditol. It possesses broad specificity for many aldoses. EC 1.1.1.21.", "OL": "use ALDEHYDE REDUCTASE to search ALDOSE REDUCTASE 1976-91", "PM": "92; was ALDOSE REDUCTASE 1976-91 (see under SUGAR ALCOHOL DEHYDROGENASES 1978-90, see under ALCOHOL OXIDOREDUCTASES 1976-77)", "HN": "92; was ALDOSE REDUCTASE 1976-91 (see under SUGAR ALCOHOL DEHYDROGENASES 1978-90, see under ALCOHOL OXIDOREDUCTASES 1976-77)", "MR": "20170524", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D000449"}, {"RECTYPE": "D", "MH": "Aldosterone", "AQ": "AA AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Aldosterone, (11 beta,17 alpha)-Isomer|T109|T121|T125|NON|NRW|NLM (1999)|990913|abbbcdef", "MN": "D06.472.040.585.353.118", "FX": "Renin-Angiotensin System", "EC": "antagonists & inhibitors:Mineralocorticoid Receptor Antagonists", "MH_TH": "NLM (1966)", "ST": "T125", "N1": "Pregn-4-en-18-al, 11,21-dihydroxy-3,20-dioxo-, (11beta)-", "RN": "4964P6T9RB", "RR": "52-39-1 (Aldosterone)", "AN": "/defic: consider also HYPOALDOSTERONISM; consider also RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM see RENIN-ANGIOTENSIN SYSTEM & do not index under ALDOSTERONE unless particularly discussed", "MS": "A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium.", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000450"}, {"RECTYPE": "D", "MH": "Mineralocorticoid Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mineralocorticoid Receptor Antagonist|T121|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Receptor Antagonists, Mineralocorticoid", "MN": "D27.505.696.560.500.726.249", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "PI": "Aldosterone (1966-1977)", "MS": "Drugs that bind to and block the activation of MINERALOCORTICOID RECEPTORS by MINERALOCORTICOIDS such as ALDOSTERONE.", "PM": "2013; see ALDOSTERONE ANTAGONISTS 1966-2012", "HN": "2013(1963)", "MR": "20200527", "DA": "19770517", "DC": "1", "DX": "19780101", "UI": "D000451"}, {"RECTYPE": "D", "MH": "Aldrin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isodrin|T109|T131|NON|REL|UNK (19XX)|841002|abbcdef", "MN": "D02.455.526.439.042", "PA": "Insecticides", "MH_TH": "NLM (1971)", "ST": "T131", "N1": "1,4:5,8-Dimethanonaphthalene, 1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-, (1alpha,4alpha,4abeta,5alpha,8alpha,8abeta)-", "RN": "OZE3CLY605", "RR": "309-00-2 (Aldrin)", "PI": "Insecticides (1966-1970)", "MS": "A highly poisonous substance that was formerly used as an insecticide. The manufacture and use has been discontinued in the U.S. (From Merck Index, 11th ed)", "PM": "73", "HN": "73(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000452"}, {"RECTYPE": "D", "MH": "Aleutian Mink Disease", "DE": "ALEUTIAN MINK DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Mink Disease, Aleutian", "MN": "C22.062", "FX": "Chediak-Higashi Syndrome", "MH_TH": "NLM (1971)", "ST": "T047", "AN": "caused by a parvovirus; don't forget also MINK (NIM) & check tag ANIMALS", "PI": "Virus Diseases (1966-1970)", "MS": "A slow progressive disease of mink caused by the ALEUTIAN MINK DISEASE VIRUS. It is characterized by poor reproduction, weight loss, autoimmunity, hypergammaglobulinemia, increased susceptibility to bacterial infections, and death from renal failure. The disease occurs in all color types, but mink which are homozygous recessive for the Aleutian gene for light coat color are particularly susceptible.", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D000453"}, {"RECTYPE": "D", "MH": "Aleutian Mink Disease Virus", "DE": "ALEUTIAN MINK DIS VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Aleutian Disease Virus|T005|EPO|EQV|NLM (1991)|900413|ALEUTIAN DIS VIRUS|abcdefv", "ENTRY": "Aleutian Mink Disease Parvovirus|T005|NON|EQV|NLM (1997)|950927|abcdef", "MN": "B04.280.580.650.040.050", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid28314", "MS": "A species of PARVOVIRUS that causes a disease in mink, mainly those homozygous for the recessive Aleutian gene which determines a desirable coat color.", "PM": "97,75-93; was ALEUTIAN MINK DISEASE PARVOVIRUS 1994-96; was see under PARVOVIRIDAE 1986-90, see under VERTEBRATE VIRUSES, UNCLASSIFIED 1975-85", "HN": "97,75-93; was ALEUTIAN MINK DISEASE PARVOVIRUS 1994-96; was see under PARVOVIRIDAE 1986-90, see under VERTEBRATE VIRUSES, UNCLASSIFIED 1975-85", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000454"}, {"RECTYPE": "D", "MH": "Medicago sativa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lucerne|T002|NON|EQV|UNK (19XX)|740329|abcdef", "MN": "B01.875.800.575.912.250.401.590.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3879", "PI": "Alfalfa (1963-2001)", "MS": "A plant species of the family FABACEAE widely cultivated for ANIMAL FEED.", "PM": "2002; see ALFALFA 1963-2001", "HN": "2002(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D000455"}, {"RECTYPE": "D", "MH": "Cyanobacteria", "DE": "CYANOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Cyanophyceae|T007|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Blue-Green Algae|T007|NON|EQV|UNK (19XX)|880708|abcdef", "MN": "B03.440.475.100", "FX": "Phytoplankton", "MH_TH": "NLM (1970)", "ST": "T007", "RN": "txid1117", "AN": "general or unspecified; prefer specifics; do not confuse entry term CYANOPHYCEAE with CYANOPHORA", "PI": "Algae (1966-1969)", "MS": "A phylum of oxygenic photosynthetic bacteria comprised of unicellular to multicellular bacteria possessing CHLOROPHYLL a and carrying out oxygenic PHOTOSYNTHESIS. Cyanobacteria are the only known organisms capable of fixing both CARBON DIOXIDE (in the presence of light) and NITROGEN. Cell morphology can include nitrogen-fixing heterocysts and/or resting cells called akinetes. Formerly called blue-green algae, cyanobacteria were traditionally treated as ALGAE.", "OL": "use CYANOBACTERIA to search ALGAE, BLUE-GREEN & CYANOPHYTA 1970-91", "PM": "92; was ALGAE, BLUE-GREEN 1970-91; CYANOBACTERIA was see ALGAE, BLUE-GREEN 1978-91; CYANOPHYTA was see ALGAE, BLUE-GREEN 1970-91", "HN": "92; was ALGAE, BLUE-GREEN 1970-91; CYANOBACTERIA was see ALGAE, BLUE-GREEN 1978-91; CYANOPHYTA was see ALGAE, BLUE-GREEN 1970-91", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D000458"}, {"RECTYPE": "D", "MH": "Phaeophyceae", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Phaeophyta|T204|NON|EQV|NLM (2004)|030128|abcdef", "ENTRY": "Brown Algae|T204|NON|EQV|NLM (2004)|030228|abcdef", "MN": "B01.750.600", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid2870", "AN": "general or unspecified; prefer specifics", "PI": "Algae (1966-1970)", "MS": "A class of predominantly marine EUKARYOTA, commonly known as brown algae, having CHROMATOPHORES containing carotenoid PIGMENTS, BIOLOGICAL. ALGINATES and phlorotannins occur widely in all major orders. They are considered the most highly evolved algae because of their well-developed multicellular organization and structural complexity.", "PM": "2011; see PHAEOPHYTA 2004-2023, ALGAE, BROWN 1991-2003, see ALGAE 1971-1990", "HN": "2011 (1971)", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000459"}, {"RECTYPE": "D", "MH": "Chlorophyta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Algae, Green|T002|NON|EQV|NLM (1970)|990101|abcdef", "ENTRY": "Green Algae|T002|NON|EQV|NLM (1992)|900911|abcdef", "MN": "B01.875.150", "FX": "Phytoplankton", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid3041", "AN": "general or unspecified; prefer specifics", "PI": "Algae (1966-1969)", "MS": "A phylum of photosynthetic EUKARYOTA bearing double membrane-bound plastids containing chlorophyll a and b. They comprise the classical green algae, and represent over 7000 species that live in a variety of primarily aquatic habitats. Only about ten percent are marine species, most live in freshwater.", "PM": "70", "HN": "70", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D000460"}, {"RECTYPE": "D", "MH": "Rhodophyta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Red Algae|T002|NON|EQV|NLM (2011)|091124|abcdef", "MN": "B01.715", "FX": "Seaweed", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid2763", "AN": "general or unspecified; prefer specifics", "PI": "Algae (1966-1970)", "MS": "Red algae whose color results from predominace of the red pigment (PHYCOERYTHRIN). However, if this pigment is destroyed, the algae can appear purple, brown, green, or yellow. Two important substances found in the cell walls of red algae are AGAR and CARRAGEENAN. Some rhodophyta are notable SEAWEED (macroalgae).", "PM": "2011; see ALGAE, RED 1974-2010", "HN": "2011 (1971)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000461"}, {"RECTYPE": "D", "MH": "Algeria", "AQ": "EH EP", "MN": "Z01.058.266.104", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in northern Africa bordering the Mediterranean Sea, between MOROCCO and TUNISIA. Its capital is Algiers.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000462"}, {"RECTYPE": "D", "MH": "Algestone Acetophenide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pregn-4-ene-3,20-dione, 16,17-((1-phenylethylidene)bis(oxy))-, (16alpha(R))-|T109|T121|T125|NON|EQV|NLM (2020)|190626|abbbcdef", "ENTRY": "Acetophenide, Dihydroxyprogesterone", "MN": "D04.210.500.745.745.654.829.025.025", "PA": "Progestins", "MH_TH": "USAN (1969)", "ST": "T125", "RN": "OL7KC2O3OT", "RR": "24356-94-3 (Algestone Acetophenide)", "MS": "A progesterone that has been used in ESTRUS SYNCHRONIZATION and has been evaluated as an injectable contraceptive in combination with estradiol enanthate. It is also applied topically as an anti-inflammatory and in the treatment of ACNE.", "PM": "74", "HN": "74", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000463"}, {"RECTYPE": "D", "MH": "Alginates", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU UL", "ENTRY": "Calcium Alginate, Sodium", "MN": "D09.698.068", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "RR": "C269C4G2ZQ", "MS": "Salts and esters of ALGINIC ACID that are used as HYDROGELS; DENTAL IMPRESSION MATERIALS, and as absorbent materials for surgical dressings (BANDAGES, HYDROCOLLOID). They are also used to manufacture MICROSPHERES and NANOPARTICLES for DIAGNOSTIC REAGENT KITS and DRUG DELIVERY SYSTEMS.", "PM": "2019; for ALGINATE see ALGINIC ACID 1972-2018; for XANTALGIN see ALGINIC ACID 1972-2018; for BARIUM ALGINATE see ALGINIC ACID 2003-2018; for CALCIUM ALGINATE see ALGINIC ACID 1972-2018; for CALGINAT see ALGINIC ACID 1972-2018; for COPPER ALGINATE see ALGINIC ACID 1972-2018; for POTASSIUM ALGINATE see ALGINIC ACID 1972-2018; for SODIUM ALGINATE see ALGINIC ACID 1972-2018; for ALLOID G see ALGINIC ACID 1972-2018; for KALROSTAT and KALROSTAT 2 see ALGINIC ACID 1972-2018; for KALTOSTAT see ALGINIC ACID 1972-2018; for SODIUM CALCIUM ALGINATE see ALGINIC ACID 1972-2018; for VOCOLOID see ALGINIC ACID 1972-2018", "HN": "2019 (1966)", "MR": "20180227", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000464"}, {"RECTYPE": "D", "MH": "Algorithms", "ENTRY": "Algorithm", "MN": "L01.224.050", "MH_TH": "NLM (1987)", "ST": "T170", "MS": "A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task.", "PM": "87", "HN": "87", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D000465"}, {"RECTYPE": "D", "MH": "Alkadienes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pentadienes|T109|NON|NRW|NLM (1998)|961219|abcdef", "MN": "D02.455.326.271.665.146", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Acyclic branched or unbranched hydrocarbons having two carbon-carbon double bonds.", "PM": "74", "HN": "74", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000466"}, {"RECTYPE": "D", "MH": "Alkalies", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alkali|T197|NON|EQV|NLM (1994)|920730|abcdef", "ENTRY": "Alkalis|T197|NON|EQV|NLM (1994)|920730|abcdef", "MN": "D01.045", "FX": "Hypercalcemia", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "singular form is \"alkali\"; /adv eff: consider also MILK-ALKALI SYNDROME see HYPERCALCEMIA", "MS": "Usually a hydroxide of lithium, sodium, potassium, rubidium or cesium, but also the carbonates of these metals, ammonia, and the amines. (Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000468"}, {"RECTYPE": "D", "MH": "Alkaline Phosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.352.650.035", "FX": "Hypophosphatasia", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Orthophosphoric-monoester phosphohydrolase (alkaline optimum)", "RN": "EC 3.1.3.1", "RR": "9001-78-9 (CAS RN)", "AN": "/defic: consider also HYPOPHOSPHATASIA", "MS": "An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.", "OL": "use ALKALINE PHOSPHATASE to search BLOOD ALKALINE PHOSPHATASE 1966-67", "PM": "/blood was BLOOD ALKALINE PHOSPHATASE 1963-67", "HN": "/blood was BLOOD ALKALINE PHOSPHATASE 1963-67", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D000469"}, {"RECTYPE": "D", "MH": "Alkaloids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Plant Alkaloids|T109|NON|NRW|NLM (2014)|130111|abcdef", "ENTRY": "Alkaloids, Plant", "MN": "D03.132", "MH_TH": "POPLINE (1984)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specific groups or specific alkaloid; note entry term Plant Alkaloids: coordinate with specific plant if pertinent", "MS": "Organic nitrogenous bases. Many alkaloids of medical importance occur in the animal and vegetable kingdoms, and some have been synthesized. (Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000470"}, {"RECTYPE": "D", "MH": "Alkalosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Alkaloses", "MN": "C18.452.076.354", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A pathological condition that removes acid or adds base to the body fluids.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000471"}, {"RECTYPE": "D", "MH": "Alkalosis, Respiratory", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Respiratory Alkalosis|T046|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Respiratory Alkaloses", "MN": "C18.452.076.354.271", "MH_TH": "NLM (1971)", "ST": "T046", "AN": "excess loss of CO2 from body", "PI": "Hyperventilation (1966-1970)", "MS": "A state due to excess loss of carbon dioxide from the body. (Dorland, 27th ed)", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000472"}, {"RECTYPE": "D", "MH": "Alkanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alkane|T109|NON|EQV|NLM (2021)|191118|abcdef", "MN": "D02.455.326.146", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "The generic name for the group of aliphatic hydrocarbons Cn-H2n+2. They are denoted by the suffix -ane. (Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "66", "HN": "66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000473"}, {"RECTYPE": "D", "MH": "Alkaptonuria", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Alcaptonurias", "MN": "C18.452.648.100.187", "FX": "Homogentisate 1,2-Dioxygenase", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An inborn error of amino acid metabolism resulting from a defect in the enzyme HOMOGENTISATE 1,2-DIOXYGENASE, an enzyme involved in the breakdown of PHENYLALANINE and TYROSINE. It is characterized by accumulation of HOMOGENTISIC ACID in the urine, OCHRONOSIS in various tissues, and ARTHRITIS.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000474"}, {"RECTYPE": "D", "MH": "Alkenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pentenes|T109|NON|NRW|NLM (1998)|961219|abcdef", "MN": "D02.455.326.271", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Unsaturated hydrocarbons of the type Cn-H2n, indicated by the suffix -ene. (Grant & Hackh's Chemical Dictionary, 5th ed, p408)", "PM": "66", "HN": "66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000475"}, {"RECTYPE": "D", "MH": "Alkanesulfonates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alkyl Sulfonates|T109|NON|EQV|NLM (1994)|930510|abcdef", "ENTRY": "Sulfonates, Alkyl", "MN": "D02.886.645.600.055.050", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "PI": "Sulfonic Acids (1966-1972)", "MS": "Organic esters or salts of sulfonic acid derivatives containing an aliphatic hydrocarbon radical.", "OL": "use ALKANESULFONATES to search ALKYL SULFONATES 1973-93", "PM": "94; was ALKYL SULFONATES 1973-93", "HN": "94; was ALKYL SULFONATES 1973-93", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000476"}, {"RECTYPE": "D", "MH": "Alkylating Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alkylator|T121|T130|T131|NON|EQV|NLM (2021)|200417|abbbcdef", "ENTRY": "Agents, Alkylating", "MN": "D27.888.569.035", "MH_TH": "NLM (1964)", "ST": "T131", "RN": "0", "MS": "Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases.", "PM": "66", "HN": "66(64)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000477"}, {"RECTYPE": "D", "MH": "Alkylation", "AQ": "DE GE IM PH RE", "ENTRY": "Alkylations", "MN": "G03.059", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "almost never IM; enzymatic alkylation: coord NIM with TRANSFERASES (IM) + substrate (NIM); METHYLATION & METHYLTRANSFERASES are also available", "MS": "The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000478"}, {"RECTYPE": "D", "MH": "Alkylmercury Compounds", "DE": "ALKYLMERCURY CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alkylmercurials|T109|T131|NON|EQV|UNK (19XX)|760414|abbcdef", "ENTRY": "Mercury Compounds, Alkyl", "MN": "D02.691.750.100", "MH_TH": "NLM (1977)", "ST": "T131", "RN": "0", "PI": "Organometallic Compounds (1968-1976)", "MS": "Organic mercury compounds in which the mercury is attached to an alkyl group.", "OL": "use ALKYLMERCURY COMPOUNDS to search ALKYL MERCURY COMPOUNDS 1977-79", "PM": "80; was ALKYL MERCURY COMPOUNDS 1977-79", "HN": "80; was ALKYL MERCURY COMPOUNDS 1977-79", "MR": "20110624", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D000479"}, {"RECTYPE": "D", "MH": "Alkynes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alkyne|T109|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Acetylenes|T109|NON|EQV|NLM (2007)|051201|abcdef", "MN": "D02.455.326.397", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2.", "PM": "66", "HN": "66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000480"}, {"RECTYPE": "D", "MH": "Allantoin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "HerpecinL", "MN": "D03.383.129.308.432.555.105", "PA": "Dermatologic Agents", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "Urea, (2,5-dioxo-4-imidazolidinyl)-", "RN": "344S277G0Z", "RR": "97-59-6 (Allantoin)", "MS": "A urea hydantoin that is found in URINE and PLANTS and is used in dermatological preparations.", "PM": "72", "HN": "72(64)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000481"}, {"RECTYPE": "D", "MH": "Allantois", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Membrane, Allantoic", "MN": "A16.254.750.147", "FX": "Chorioallantoic Membrane", "MH_TH": "NLM (1975)", "ST": "T018", "MS": "An extra-embryonic membranous sac derived from the YOLK SAC of REPTILES; BIRDS; and MAMMALS. It lies between two other extra-embryonic membranes, the AMNION and the CHORION. The allantois serves to store urinary wastes and mediate exchange of gas and nutrients for the developing embryo.", "OL": "search FETAL MEMBRANES 1966-74", "PM": "91; was see under FETAL MEMBRANES 1975-90", "HN": "91(75); was see under FETAL MEMBRANES 1975-90", "MR": "20070711", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000482"}, {"RECTYPE": "D", "MH": "Alleles", "PRINT ENTRY": "Allelomorphs|T028|NON|EQV|NLM (1998)|960725|abcdef", "ENTRY": "Allelomorph", "MN": "G05.360.340.024.340.030", "MH_TH": "NLM (1968)", "ST": "T028", "PI": "Genes (1966-1967)", "MS": "Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000483"}, {"RECTYPE": "D", "MH": "Allergens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Allergen|T129|NON|EQV|NLM (2017)|160328|abcdef", "MN": "D23.050.063", "FX": "Fungi", "MH_TH": "NLM (1965)", "ST": "T129", "RN": "0", "MS": "Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE).", "PM": "65", "HN": "65", "MR": "20160613", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000485"}, {"RECTYPE": "D", "MH": "Allergy and Immunology", "DE": "ALLERGY IMMUNOLOGY", "AQ": "CL EC ED ES HI IS LJ OG SN ST TD", "PRINT ENTRY": "Immunology|T091|NON|NRW|UNK (19XX)|790529|IMMUNOL|abcdefv", "ENTRY": "Specialty, Allergy", "MN": "H02.403.044", "EC": "methods:Immunologic Techniques", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use IMMUNE SYSTEM PHENOMENA or specifics treed under it for immunologic processes and properties; use HYPERSENSITIVITY or specifics treed under it for allergic conditions; the qualifier / immunol is available for use with specific anatomical terms, organisms, diseases, etc", "MS": "A medical specialty concerned with the hypersensitivity of the individual to foreign substances and protection from the resultant infection or disorder.", "OL": "use ALLERGY AND IMMUNOLOGY to search IMMUNOLOGY 1966-79; search RADIATION IMMUNOLOGY under RADIATION EFFECTS 1966", "PM": "80; IMMUNOLOGY was heading 1963-79; RADIATION IMMUNOLOGY was heading 1964-66", "HN": "80; IMMUNOLOGY was heading 1963-79; RADIATION IMMUNOLOGY was heading 1964-66", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D000486"}, {"RECTYPE": "D", "MH": "Allethrins", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, 2-methyl-4-oxo-3-(2-propenyl)-2-cyclopenten-1-yl ester|T109|NON|NRW|NLM (2020)|190626|abcdef", "MN": "D02.455.849.575.188.750.272", "PA": "Insecticides", "MH_TH": "NLM (1996)", "ST": "T131", "RN": "0", "RR": "584-79-2", "PI": "Pyrethrum (1966-1971)", "MS": "Synthetic analogs of the naturally occurring insecticides cinerin, jasmolin, and pyrethrin. (From Merck Index, 11th ed)", "PM": "2020; was ALLETHRIN 1972-2019", "HN": "2020(1972)", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000487"}, {"RECTYPE": "D", "MH": "Allied Health Personnel", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Child Life Specialist|T097|NON|NRW|NLM (2024)|220901|abcdef", "ENTRY": "Workers, Healthcare Support", "MN": "N02.360.067", "MH_TH": "BIOETHICS (1995)", "ST": "T097", "PI": "Health Occupations (1966-1970)", "MS": "Health care workers specially trained and licensed to assist and support the work of health professionals. Often used synonymously with paramedical personnel, the term generally refers to all health care workers who perform tasks which must otherwise be performed by a physician or other health professional.", "PM": "71", "HN": "71", "MR": "20230824", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D000488"}, {"RECTYPE": "D", "MH": "Alligators and Crocodiles", "DE": "ALLIGATORS CROCODILES", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Crocodiles|T014|NON|NRW|UNK (19XX)|741211|abcdef", "ENTRY": "Crocodiles and Alligators", "MN": "B01.050.150.900.833.100", "MH_TH": "NLM (1975)", "ST": "T014", "RR": "txid8497", "MS": "Large, long-tailed reptiles, including caimans, of the order Loricata.", "PM": "91; was see under REPTILES 1975-90", "HN": "91(75); was see under REPTILES 1975-90", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D000489"}, {"RECTYPE": "D", "MH": "Allium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Alliaceae|T002|NON|BRD|NLM (1998)|961021|abcdef", "MN": "B01.875.800.575.912.250.618.100.050.060", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid4678", "RR": "txid40553", "PI": "Vegetables (1966-1985)", "MS": "A genus of the plant family Amaryllidaceae. Many produce pungent, often bacteriostatic and physiologically active compounds and are used as VEGETABLES; CONDIMENTS; and medicament, the latter in traditional medicine.", "PM": "86", "HN": "86", "MR": "20210630", "DA": "19850503", "DC": "1", "DX": "19860101", "UI": "D000490"}, {"RECTYPE": "D", "MH": "Allophanate Hydrolase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hydrolase, Allophanate", "MN": "D08.811.277.087.060", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Urea-1-carboxylate amidohydrolase", "RN": "EC 3.5.1.54", "PI": "Urea (1974)", "MS": "An enzyme that catalyzes the hydrolysis of allophanic acid to two molecules of ammonia plus two molecules of \"active carbon dioxide\". EC 3.5.1.54.", "PM": "91; was see under AMIDOHYDROLASES 1975-90", "HN": "91(75); was see under AMIDOHYDROLASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000492"}, {"RECTYPE": "D", "MH": "Allopurinol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Zyloric|T109|T121|TRD|NRW|DE|ES|FR|IE|NL|UK|030716|abbcdeeeeeef", "MN": "D03.633.100.759.160", "PA": "Gout Suppressants", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-", "RN": "63CZ7GJN5I", "RR": "315-30-0 (Allopurinol)", "PI": "Xanthine Oxidase (1966)", "MS": "A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.", "PM": "68", "HN": "68(67)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000493"}, {"RECTYPE": "D", "MH": "Allosteric Regulation", "DE": "ALLOSTERIC REG", "AQ": "DE GE IM PH RE", "ENTRY": "Regulations, Allosteric", "MN": "G02.111.044", "FX": "Allosteric Site", "MH_TH": "NLM (1971)", "ST": "T044", "AN": "almost never IM", "PI": "Kinetics (1966-1970)", "MS": "The modification of the reactivity of ENZYMES by the binding of effectors to sites (ALLOSTERIC SITES) on the enzymes other than the substrate BINDING SITES.", "PM": "78; was see under BIOCHEMISTRY 1975-77", "HN": "78(71); was see under BIOCHEMISTRY 1975-77", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D000494"}, {"RECTYPE": "D", "MH": "Allosteric Site", "AQ": "DE GE IM PH RE", "ENTRY": "Sites, Allosteric", "MN": "G02.111.570.120.147", "FX": "Allosteric Regulation", "MH_TH": "NLM (1975)", "ST": "T169", "MS": "A site on an enzyme which upon binding of a modulator, causes the enzyme to undergo a conformational change that may alter its catalytic or binding properties.", "OL": "search BINDING SITES 1968-74", "PM": "91; was see under BINDING SITES 1975-90", "HN": "91(75); was see under BINDING SITES 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000495"}, {"RECTYPE": "D", "MH": "Alloxan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.742.698.122", "MH_TH": "NLM (1966)", "ST": "T195", "N1": "2,4,5,6(1H,3H)-Pyrimidinetetrone", "RN": "6SW5YHA5NG", "RR": "50-71-5 (Alloxan)", "AN": "for ALLOXAN DIABETES, index ALLOXAN only if the chemical is particularly discussed", "MS": "Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000496"}, {"RECTYPE": "D", "MH": "Alloys", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Alloy", "MN": "J01.637.051.058", "MH_TH": "NLM (1965)", "ST": "T197", "RN": "0", "MS": "A mixture of metallic elements or compounds with other metallic or metalloid elements in varying proportions.", "PM": "65", "HN": "65", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000497"}, {"RECTYPE": "D", "MH": "Allyl Compounds", "DE": "ALLYL CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Allyl", "MN": "D02.455.326.271.122", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "Alkenes (1966-1970)", "MS": "Alkenes with the general formula H2C=CH-CH2-R.", "PM": "73", "HN": "73(71)", "MR": "20151201", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000498"}, {"RECTYPE": "D", "MH": "Allylamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "3-Aminopropylene|T109|T121|T131|NON|EQV|UNK (19XX)|750701|AMINOPROPYLENE 03|abbbcdefs", "ENTRY": "3 Aminopropylene", "MN": "D02.455.326.271.122.100", "MH_TH": "NLM (1976)", "ST": "T131", "N1": "2-Propen-1-amine", "RN": "48G762T011", "RR": "107-11-9 (Allylamine)", "PI": "Amines (1974-1975)", "MS": "Possesses an unusual and selective cytotoxicity for VASCULAR SMOOTH MUSCLE cells in dogs and rats. Useful for experiments dealing with arterial injury, myocardial fibrosis or cardiac decompensation.", "PM": "91; was see under AMINES 1976-90", "HN": "91(76); was see under AMINES 1976-90", "MR": "20130708", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D000499"}, {"RECTYPE": "D", "MH": "Allylestrenol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Turinal|T109|T121|TRD|NRW|UNK (19XX)|811209|abbcdef", "MN": "D04.210.500.365.415.050", "PA": "Progestins", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Estr-4-en-17-ol, 17-(2-propenyl)-, (17beta)-", "RN": "I47VB5DZ8O", "RR": "432-60-0 (Allylestrenol)", "PI": "Hydroxysteroids (1973-1974)", "MS": "A synthetic steroid with progestational activity.", "PM": "91; was see under ESTRENES 1975-90", "HN": "91(75); was see under ESTRENES 1975-90", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000500"}, {"RECTYPE": "D", "MH": "Allylglycine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "2-Amino-4-Pentenoic Acid|T116|T121|NON|EQV|UNK (19XX)|800917|abbcdef", "MN": "D12.125.481.100", "PA": "GABA Antagonists", "MH_TH": "NLM (1980)", "ST": "T121", "N1": "4-Pentenoic acid, 2-amino-", "RN": "1069-48-3", "PI": "Glycine (1966-1974) /antagonists & inhibitors (1975-1979)", "MS": "An inhibitor of glutamate decarboxylase and an antagonist of GAMMA-AMINOBUTYRIC ACID. It is used to induce convulsions in experimental animals.", "PM": "91; was see under GLYCINE 1980-90", "HN": "91(80); was see under GLYCINE 1980-90", "MR": "20010803", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D000501"}, {"RECTYPE": "D", "MH": "Allylisopropylacetamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "2 Isopropyl 4 Pentenamide", "MN": "D02.455.326.271.122.272", "MH_TH": "NLM (1973)", "ST": "T109", "N1": "4-Pentenamide, 2-(1-methylethyl)-", "RN": "299-78-5", "MS": "An allylic compound that acts as a suicide inactivator of CYTOCHROME P450 by covalently binding to its heme moiety or surrounding protein.", "PM": "91; was see under ACETAMIDES 1973-90", "HN": "91(73); was see under ACETAMIDES 1973-90", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000502"}, {"RECTYPE": "D", "MH": "Almanacs as Topic", "AQ": "HI", "ENTRY": "Almanacs as Topics", "MN": "L01.462.500.682.192.836.072", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "for medical almanacs, do not coordinate with MEDICINE; do not confuse with Publication Type ALMANACS", "MS": "Works on publications, usually annual, containing a calendar for the coming year, the times of such events and phenomena as anniversaries, sunrises, sunsets, phases of the moon, tides, meteorological, and other statistical information and related topics or useful and interesting facts relating to countries of the world, sports, entertainment, population groups, etc.", "PM": "1963", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D000503"}, {"RECTYPE": "D", "MH": "Aloe", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Aloe vera|T002|NON|NRW|NLM (2000)|991103|abcdef", "MN": "B01.875.800.575.912.250.618.100.970.500", "MH_TH": "NLM (1964)", "ST": "T002", "RN": "txid25641", "RR": "txid34199", "AN": "HESPERALOE see AGAVACEAE is also available", "MS": "A plant genus of the family ASPHODELACEAE which is used medicinally. It contains anthraquinone glycosides such as aloin-emodin or aloe-emodin (EMODIN).", "PM": "91,63-77; was see under PLANTS, MEDICINAL 1978-90; was heading 1963-77", "HN": "91(78)63; was see under PLANTS, MEDICINAL 1978-90; was heading 1963-77; was in Cat B & D 1963-77", "MR": "20220715", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D000504"}, {"RECTYPE": "D", "MH": "Alopecia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pseudopelade|T047|NON|NRW|NLM (1992)|900905|abcdef", "ENTRY": "Male Pattern Alopecia", "MN": "C23.300.035", "MH_TH": "POPLINE (1978)", "ST": "T184", "MS": "Absence of hair from areas where it is normally present.", "CATSH": "CAT LIST", "MR": "20160226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000505"}, {"RECTYPE": "D", "MH": "Alopecia Areata", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Alopecia Circumscripta|T047|NON|EQV|NLM (2012)|ORD (2010)|090313|abcdeef", "MN": "C17.800.329.937.122.147", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Loss of scalp and body hair involving microscopically inflammatory patchy areas.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000506"}, {"RECTYPE": "D", "MH": "Mucinosis, Follicular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Alopecia Mucinosa|T047|NON|EQV|NLM (1993)|920406|abcdef", "ENTRY": "Mucinoses, Follicular", "MN": "C17.800.794.550", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "a sebaceous gland dis", "MS": "A disease of the pilosebaceous unit, presenting clinically as grouped follicular papules or plaques with associated hair loss. It is caused by mucinous infiltration of tissues, and usually involving the scalp, face, and neck. It may be primary (idiopathic) or secondary to mycosis fungoides or reticulosis.", "OL": "use MUCINOSIS, FOLLICULAR to search ALOPECIA MUCINOSA 1966-92", "PM": "93; was ALOPECIA MUCINOSA 1965-92 (see under ALOPECIA 1965-90)", "HN": "93; was ALOPECIA MUCINOSA 1965-92 (see under ALOPECIA 1965-90)", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000507"}, {"RECTYPE": "D", "MH": "Alouatta", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Monkey, Howler|T015|NON|EQV|UNK (19XX)|800512|abcdef", "ENTRY": "Monkeys, Howler", "MN": "B01.050.150.900.649.313.988.400.600.075.050.075", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9499", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "MS": "A genus of the subfamily ALOUATTINAE, family ATELIDAE, inhabiting the forests of Central and South America. Howlers travel in groups and define their territories by howling accompanied by vigorously shaking and breaking branches.", "OL": "use ALOUATTA to search HOWLER MONKEYS 1975-80", "PM": "91; was see under CEBIDAE 1981-90; was HOWLER MONKEYS see under MONKEYS 1975-80", "HN": "91(81); was see under CEBIDAE 1981-90; was HOWLER MONKEYS see under MONKEYS 1975-80", "MR": "20200813", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000508"}, {"RECTYPE": "D", "MH": "alpha-Fetoproteins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Fetoproteins", "MN": "D23.101.140.050", "FX": "Anencephaly", "MH_TH": "POPLINE (1979)", "ST": "T123", "RN": "0", "PI": "Fetal Proteins (1970-1974)", "MS": "The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life.", "OL": "use ALPHA-FETOPROTEINS to search ALPHA FETOPROTEINS 1975-95", "PM": "96; was ALPHA FETOPROTEINS 1975-95 (see under FETAL GLOBULINS 1975-76)", "HN": "96; was ALPHA FETOPROTEINS 1975-95 (see under FETAL GLOBULINS 1975-76)", "MR": "20150626", "DA": "19741111", "DC": "1", "DX": "19770101", "UI": "D000509"}, {"RECTYPE": "D", "MH": "Alpha-Globulins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Alpha Globulins", "MN": "D12.776.377.715.085", "MH_TH": "NLM (1964)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Serum proteins that have the most rapid migration during ELECTROPHORESIS. This subgroup of globulins is divided into faster and slower alpha(1)- and alpha(2)-globulins.", "OL": "use ALPHA-GLOBULINS to search ALPHA GLOBULIN 1966-74", "PM": "75; was ALPHA GLOBULIN 1965-74", "HN": "75; was ALPHA GLOBULIN 1964-74 (Prov 1964)", "MR": "20000621", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000510"}, {"RECTYPE": "D", "MH": "alpha-Macroglobulins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-Macrofetoproteins|T116|T123|NON|EQV|UNK (19XX)|750701|abbcdef", "ENTRY": "alpha Macroglobulins", "MN": "D12.776.377.715.647.100", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "0", "PI": "alpha Globulins (1974-1975)", "MS": "Glycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters.", "OL": "use ALPHA-MACROGLOBULINS to search ALPHA MACROGLOBULINS 1976-95", "PM": "96; was ALPHA MACROGLOBULINS 1976-95", "HN": "96; was ALPHA MACROGLOBULINS 1976-95", "MR": "20170629", "DA": "19750718", "DC": "1", "DX": "19760101", "UI": "D000511"}, {"RECTYPE": "D", "MH": "Alpha Particles", "AQ": "AE CL HI TU", "PRINT ENTRY": "Alpha Rays|T070|T072|NON|REL|UNK (19XX)|840302|abbcdef", "ENTRY": "Rays, Alpha", "MN": "G01.750.750.055", "MH_TH": "NLM (1966)", "ST": "T072", "MS": "Positively charged particles composed of two protons and two NEUTRONS, i.e. equivalent to HELIUM nuclei, which are emitted during disintegration of heavy ISOTOPES. Alpha rays have very strong ionizing power, but weak penetrability.", "PM": "66", "HN": "66", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000512"}, {"RECTYPE": "D", "MH": "Alpha Rhythm", "AQ": "DE GE IM PH RE", "ENTRY": "Rhythms, Alpha", "MN": "G11.561.127.500", "MH_TH": "NLM (1972)", "ST": "T042", "PI": "Electroencephalography (1966-1971)", "MS": "Brain waves characterized by a relatively high voltage or amplitude and a frequency of 8-13 Hz. They constitute the majority of waves recorded by EEG registering the activity of the parietal and occipital lobes when the individual is awake, but relaxed with the eyes closed.", "PM": "74", "HN": "74(72)", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000513"}, {"RECTYPE": "D", "MH": "alpha 1-Antichymotrypsin", "DS": "ALPHA ANTICHYMOTRYPSIN 01", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha 1 Antichymotrypsin", "MN": "D12.776.872.030", "PA": "Serine Proteinase Inhibitors", "MH_TH": "NLM (1987)", "ST": "T123", "RN": "0", "PI": "Protease Inhibitors (1979-1986)", "MS": "Glycoprotein found in alpha(1)-globulin region in human serum. It inhibits chymotrypsin-like proteinases in vivo and has cytotoxic killer-cell activity in vitro. The protein also has a role as an acute-phase protein and is active in the control of immunologic and inflammatory processes, and as a tumor marker. It is a member of the serpin superfamily.", "PM": "87", "HN": "87", "MR": "20230316", "DA": "19860414", "DC": "1", "DX": "19870101", "UI": "D000514"}, {"RECTYPE": "D", "MH": "alpha 1-Antitrypsin", "DS": "ALPHA ANTITRYPSIN A 01", "AQ": "AD AE AG AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha 1-Proteinase Inhibitor|T116|T121|T123|NON|EQV|NLM (1990)|890426|ALPHA PROTEINASE INHIBITOR 01|ALPHA 1 PROTEINASE INHIB|abbbcdefsv", "ENTRY": "alpha 1 Proteinase Inhibitor", "MN": "D12.776.872.035", "PA": "Trypsin Inhibitors", "FX": "alpha 1-Antitrypsin Deficiency", "EC": "deficiency:alpha 1-Antitrypsin Deficiency", "MH_TH": "NLM (1974)", "ST": "T123", "RN": "0", "MS": "Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES.", "PM": "74", "HN": "74", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000515"}, {"RECTYPE": "D", "MH": "alpha-Amylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-Amylase|T116|T126|NON|EQV|USAN (1962)|990101|abbcdef", "ENTRY": "alpha Amylases", "MN": "D08.811.277.450.066.050", "MH_TH": "NLM (2009)", "ST": "T126", "N1": "1,4-alpha-D-Glucan glucanohydrolase", "RN": "EC 3.2.1.1", "RR": "9000-90-2 (CAS RN)", "PI": "Amylases (1966-1977)", "MS": "Enzymes that catalyze the endohydrolysis of 1,4-alpha-glycosidic linkages in STARCH; GLYCOGEN; and related POLYSACCHARIDES and OLIGOSACCHARIDES containing 3 or more 1,4-alpha-linked D-glucose units.", "PM": "2009; see ALPHA-AMYLASE 1984-2008, see AMYLASES 1978-1983", "HN": "2009(1978)", "MR": "20160705", "DA": "19770415", "DC": "1", "DX": "19840101", "UI": "D000516"}, {"RECTYPE": "D", "MH": "alpha-Chlorohydrin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "alpha-Chlorhydrin|T109|T121|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "alpha-Monochlorohydrin, Glycerol", "MN": "D02.033.455.706.100", "PA": "Chemosterilants", "MH_TH": "POPLINE (1978)", "ST": "T121", "N1": "1,2-Propanediol, 3-chloro-", "RN": "96-24-2", "RR": "60827-45-4 ((S)-isomer)", "PI": "Propanediols (1969-1974)", "MS": "A chlorinated PROPANEDIOL with antifertility activity in males used as a chemosterilant in rodents.", "PM": "91; was see under CHLOROHYDRINS 1975-90", "HN": "91(75); was see under CHLOROHYDRINS 1975-90", "MR": "20140625", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D000517"}, {"RECTYPE": "D", "MH": "Eflornithine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "alpha-Difluoromethylornithine|T116|T121|NON|EQV|NLM (1991)|900319|abbcdef", "ENTRY": "alpha Difluoromethylornithine", "MN": "D12.125.095.765.340", "PA": "Trypanocidal Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Ornithine, 2-(difluoromethyl)-", "RN": "ZQN1G5V6SR", "RR": "96020-91-6 (mono-HCl, monohydrate)", "PI": "Ornithine/analogs & derivatives (1975-1986)", "MS": "An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.", "PM": "1991; see ALPHA-DIFLUOROMETHYLORNITHINE 1987-1990", "HN": "1991; use ALPHA-DIFLUOROMETHYLORNITHINE 1987-1990", "MR": "20180521", "DA": "19860603", "DC": "1", "DX": "19870101", "UI": "D000518"}, {"RECTYPE": "D", "MH": "alpha-Galactosidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Galactosidases", "MN": "D08.811.277.450.410.050", "FX": "Fabry Disease", "EC": "deficiency:Fabry Disease", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "alpha-D-galactoside galactohydrolase", "RN": "EC 3.2.1.22", "PI": "Galactosidases (1966-1978)", "MS": "An enzyme that catalyzes the hydrolysis of terminal, non-reducing alpha-D-galactose residues in alpha-galactosides including galactose oligosaccharides, galactomannans, and galactolipids.", "OL": "use ALPHA-GALACTOSIDASE to search ALPHA-GALACTOSIDASES & MELIBIASES 1978-93; use GALACTOSIDASES to search MELIBIASE 1966-78", "PM": "94; was ALPHA-GALACTOSIDASES 1978-93 (see under GALACTOSIDASES 1978-90); MELIBIASES was see ALPHA-GALACTOSIDASE 1978-93; MELIBIASE was see GALACTOSIDASES 1975-78, was see GALACTOSIDASE 1963-74", "HN": "94; was ALPHA-GALACTOSIDASES 1978-93 (see under GALACTOSIDASES 1978-90); MELIBIASES was see ALPHA-GALACTOSIDASES 1978-93; MELIBIASE was see GALACTOSIDASES 1975-78, was see GALACTOSIDASE 1963-74", "MR": "20180702", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D000519"}, {"RECTYPE": "D", "MH": "alpha-Glucosidases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Maltases|T116|T126|NON|EQV|UNK (19XX)|770329|abbcdef", "ENTRY": "alpha-Glucosidase, Neutral", "MN": "D08.811.277.450.420.050", "FX": "Glycogen Storage Disease Type II", "EC": "antagonists & inhibitors:Glycoside Hydrolase Inhibitors", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "alpha-D-Glucoside glucohydrolases", "RN": "EC 3.2.1.20", "AN": "defic/: consider also GLYCOGEN STORAGE DISEASE TYPE II", "PI": "Glucosidases (1966-1977)", "MS": "Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of alpha-1,4-glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II.", "PM": "1987; see GLUCOSIDASES 1978-1986, for LYSOSOMAL ALPHA-GLUCOSIDASE & ACID MALTASE see GLUCAN 1,4-ALPHA-GLUCOSIDASE 1978-2006", "HN": "1987(1978)", "MR": "20200527", "DA": "19770415", "DC": "1", "DX": "19870101", "UI": "D000520"}, {"RECTYPE": "D", "MH": "alpha-MSH", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "alpha-Melanocyte-Stimulating Hormone|T116|T123|T125|NON|EQV|UNK (19XX)|870505|abbbcdef", "ENTRY": "alpha-Melanocyte-Stimulating Hormone, Desacetyl", "MN": "D12.776.631.650.460.050", "PA": "Hormones", "MH_TH": "NLM (1988)", "ST": "T125", "N1": "alpha-Melanotropin", "RN": "581-05-5", "PI": "MSH (1966-1987)", "MS": "A 13-amino acid peptide derived from proteolytic cleavage of ADRENOCORTICOTROPIC HORMONE, the N-terminal segment of ACTH. ACTH (1-13) is amidated at the C-terminal to form ACTH (1-13)NH2 which in turn is acetylated to form alpha-MSH in the secretory granules. Alpha-MSH stimulates the synthesis and distribution of MELANIN in MELANOCYTES in mammals and MELANOPHORES in lower vertebrates.", "PM": "1988; ACTH (1-13) was indexed under PEPTIDE FRAGMENTS & ALPHA-MSH 1981-2006", "HN": "1988 (1981)", "MR": "20190429", "DA": "19870505", "DC": "1", "DX": "19880101", "UI": "D000521"}, {"RECTYPE": "D", "MH": "Alphaprodine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prodine|T109|T121|NON|BRD|UNK (19XX)|760317|abbcdef", "ENTRY": "Hydrochloride, Alphaprodine", "MN": "D03.383.621.040", "PA": "Narcotics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "4-Piperidinol, 1,3-dimethyl-4-phenyl-, propanoate (ester), cis-", "RN": "001O2254AC", "RR": "CO51Q2EI5Z", "MS": "An opioid analgesic chemically related to and with an action resembling that of MEPERIDINE, but more rapid in onset and of shorter duration. It has been used in obstetrics, as pre-operative medication, for minor surgical procedures, and for dental procedures. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1067)", "PM": "65", "HN": "65(64)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000522"}, {"RECTYPE": "D", "MH": "Algestone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pregn-4-ene-3,20-dione, 16,17-dihydroxy-, (16alpha)-|T109|T121|T125|NON|EQV|NLM (2020)|190626|abbbcdef", "ENTRY": "16 alpha,17-Dihydroxypregn-4-ene-3,20-dione|T109|T121|T125|NON|EQV|NLM (2007)|060314|abbbcdef", "MN": "D04.210.500.745.745.654.829.025", "PA": "Progestins", "MH_TH": "INN (19XX)", "ST": "T125", "RN": "3JEB53B3WT", "RR": "595-77-7 (Algestone)", "MS": "A synthetic progestational dihydroxy derivative of PROGESTERONE. Its acetonide possesses anti-inflammatory properties.", "OL": "use ALGESTONE to search ALPHASONE 1974-90; use ALGESTONE to search DIHYDROXYPROGESTERONE 1977-present & use ALGESTONE ACETOPHENIDE 1966-76 (as Prov 1966-73)", "PM": "91; was ALPHASONE see under ALGESTONE ACETOPHENIDE/analogs & derivatives 1975-90; was ALPHASONE see under ALGESTONE ACETOPHENIDE 1974; DIHYDROXYPROGESTERONE was see ALGESTONE ACETOPHENIDE 1975-76, was see under ALGESTONE ACETOPHENIDE 1974", "HN": "91(75); was ALPHASONE see under ALGESTONE ACETOPHENIDE/analogs & derivatives 1975-90; was ALPHASONE see under ALGESTONE ACETOPHENIDE 1974; DIHYDROXYPROGESTERONE was see ALGESTONE ACETOPHENIDE 1975-76, was see under ALGESTONE ACETOPHENIDE 1974, was heading 1964-73 (Prov)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000523"}, {"RECTYPE": "D", "MH": "Alphavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Sagiyama virus|T005|EPO|NRW|NLM (2002)|010514|abcdef", "ENTRY": "Group A Arboviruses", "MN": "B04.820.578.875.054", "MH_TH": "NLM (1981)", "ST": "T005", "RN": "txid11019", "RR": "txid59303", "PI": "Arboviruses (1966-1980)", "MS": "A genus of TOGAVIRIDAE, also known as Group A arboviruses. They are serologically related to each other and are transmitted by mosquitoes. The type species is the SINDBIS VIRUS.", "OL": "use ALPHAVIRUS to search ALPHAVIRUSES 1981-93; use ARBOVIRUSES 1978-80", "PM": "94; was ALPHAVIRUSES 1981-93; ALPHAVIRUSES was see ARBOVIRUSES 1978-80", "HN": "94; was ALPHAVIRUSES 1981-93; ALPHAVIRUSES was see ARBOVIRUSES 1978-80", "MR": "20230405", "DA": "19800514", "DC": "1", "DX": "19810101", "UI": "D000524"}, {"RECTYPE": "D", "MH": "Alprazolam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alprazolan|T109|T121|NON|EQV|NLM (1990)|890609|abbcdef", "ENTRY": "U31,889", "MN": "D03.633.100.079.080.030", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-", "RN": "YU55MQ3IZY", "RR": "28981-97-7 (Alprazolam)", "PI": "Benzodiazepines (1975-1986)", "MS": "A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)", "PM": "87", "HN": "87", "MR": "20170117", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D000525"}, {"RECTYPE": "D", "MH": "Alprenolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "H5628", "MN": "D02.092.063.624.698.055", "PA": "Sympatholytics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyl)phenoxy)-", "RN": "877K5MQ27W", "RR": "2502C2OIRK", "PI": "Sympatholytics (1966-1971)", "MS": "One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.", "PM": "73", "HN": "73(72)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000526"}, {"RECTYPE": "D", "MH": "Alprostadil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prostaglandin E1|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|880602|PROSTAGLANDIN E 01|abbcdeefs", "ENTRY": "Lipo PGE1", "MN": "D23.469.050.175.725.250.100", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-", "RN": "F5TD010360", "RR": "745-65-3 (Alprostadil)", "PI": "Prostaglandins E (1975-1985)", "MS": "A potent vasodilator agent that increases peripheral blood flow.", "PM": "86; VASOPROSTAN (now ALPROSTADIL) was indexed under VASODILATOR AGENTS 1995-97", "HN": "86; see VASOPROSTAN (NM) 1995-97", "MR": "20170224", "DA": "19850308", "DC": "1", "DX": "19860101", "UI": "D000527"}, {"RECTYPE": "D", "MH": "Alternaria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Alternarias", "MN": "B01.300.381.075", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5598", "MS": "A mitosporic Loculoascomycetes fungal genus including several plant pathogens and at least one species which produces a highly phytotoxic antibiotic. Its teleomorph is Lewia.", "PM": "91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85", "HN": "91(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D000528"}, {"RECTYPE": "D", "MH": "Complementary Therapies", "DE": "COMPLEMENTARY THER", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Medicine, Complementary|T091|NON|NRW|NLM (1996)|950301|MED COMPLEMENTARY|abcdefv", "ENTRY": "Therapies, Complementary", "MN": "E02.190", "MH_TH": "NLM (1996)", "ST": "T061", "AN": "General or unspecified; prefer specifics; not for \"alternative health care delivery system\" (= DELIVERY OF HEALTH CARE) or specific health service.", "MS": "Therapeutic practices which are not currently considered an integral part of conventional allopathic medical practice. They may lack biomedical explanations but as they become better researched some (PHYSICAL THERAPY MODALITIES; DIET; ACUPUNCTURE) become widely accepted whereas others (humors, radium therapy) quietly fade away, yet are important historical footnotes. Therapies are termed as Complementary when used in addition to conventional treatments and as Alternative when used instead of conventional treatment.", "PM": "2002; see ALTERNATIVE MEDICINE (1986-2001)", "HN": "2002(1986)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19850225", "DC": "1", "DX": "19860101", "UI": "D000529"}, {"RECTYPE": "D", "MH": "Alfaxalone Alfadolone Mixture", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CT1341", "MN": "D04.210.500.745.558.050", "MH_TH": "NLM (2001)", "ST": "T121", "N1": "Pregnane-11,20-dione, 21-(acetyloxy)-3-hydroxy-, (3alpha,5alpha)-, mixt. with (3alpha,5alpha)-3-hydroxypregnane-11,20-dione", "RN": "8067-82-1", "PI": "Pregnanediones (1974)", "MS": "A 3:1 mixture of alfaxalone with alfadolone acetate that previously had been used as a general anesthetic. It is no longer actively marketed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1445)", "PM": "2000; see ALTHESIN 1980-2000 & PREGNANEDIONES 1975-79", "HN": "2001(1975)", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D000530"}, {"RECTYPE": "D", "MH": "Altitude", "ENTRY": "Altitudes", "MN": "N06.230.058", "FX": "Mountaineering", "MH_TH": "NLM (1986)", "ST": "T081", "MS": "A vertical distance measured from a known level on the surface of a planet or other celestial body.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000531"}, {"RECTYPE": "D", "MH": "Altitude Sickness", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mountain Sickness|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Sickness, Mountain", "MN": "C08.618.020", "FX": "Hypoxia", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Multiple symptoms associated with reduced oxygen at high ALTITUDE.", "OL": "search ANOXIA 1966-74", "PM": "91; was see under ANOXIA 1975-90", "HN": "91(75); was see under ANOXIA 1975-90", "CATSH": "CAT LIST", "MR": "20160718", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000532"}, {"RECTYPE": "D", "MH": "Altruism", "PRINT ENTRY": "Prosocial Behavior|T054|NON|REL|NLM (2021)|200115|abcdef", "ENTRY": "Prosocial Behaviors", "MN": "F01.145.813.090", "FX": "Gift Giving", "MH_TH": "BIOETHICS (1974)", "ST": "T054", "PI": "Social Behavior (1969-1977)", "MS": "Belief or practice of selfless concern for others.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20200429", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D000533"}, {"RECTYPE": "D", "MH": "Alum Compounds", "DE": "ALUM CPDS", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Compounds, Alum", "MN": "D01.875.800.800.850.025", "MH_TH": "NLM (1975)", "ST": "T197", "RN": "0", "PI": "Sulfates (1973-1974)", "MS": "Aluminum metal sulfate compounds used medically as astringents and for many industrial purposes. They are used in veterinary medicine for the treatment of ulcerative stomatitis, leukorrhea, conjunctivitis, pharyngitis, metritis, and minor wounds.", "OL": "use ALUM COMPOUNDS to search ALUMINUM AMMONIUM SULFATE & ALUMINUM POTASSIUM SULFATE 1975-93", "PM": "91; was see under ALUMINUM 1975-90; ALUMINUM AMMONIUM SULFATE & ALUMINUM POTASSIUM SULFATE were see ALUM COMPOUNDS 1975-93", "HN": "91(75); was see under ALUMINUM 1975-90; ALUMINUM AMMONIUM SULFATE & ALUMINUM POTASSIUM SULFATE were see ALUM COMPOUNDS 1975-93", "MR": "19930604", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000534"}, {"RECTYPE": "D", "MH": "Aluminum", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aluminium|T196|NON|EQV|NLM (2024)|221128|abcdef", "ENTRY": "Aluminum 27", "MN": "D01.552.547.050", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "CPD4NFA903", "RR": "7429-90-5 (Aluminum)", "MS": "A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98.", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000535"}, {"RECTYPE": "D", "MH": "Aluminum Hydroxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydrated Alumina|T121|T197|NON|EQV|FDA SRS (2014)|UNK (19XX)|770516|abbcdeef", "ENTRY": "Hydroxide, Aluminum", "MN": "D01.248.497.158.459.075", "PA": "Antacids", "MH_TH": "NLM (1978)", "ST": "T197", "N1": "Aluminum hydroxide (Al(OH)3)", "RN": "5QB0T2IUN0", "RR": "21645-51-2 (Aluminum Hydroxide)", "PI": "Hydroxides (1966-1977)", "MS": "A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc.", "OL": "use ALUMINUM HYDROXIDE to search ALUMINUM HYDROXIDE GEL 1972-77 (as Prov 1972); use ANTACIDS 1966-71", "PM": "78; ALUMINUM HYDROXIDE GEL was heading 1973-77; ALUMINUM GELS was see under ANTACIDS 1963-72", "HN": "78; ALUMINUM HYDROXIDE GEL was heading 1972-77 (Prov 1972); ALUMINUM GELS was see under ANTACIDS 1963-72", "MR": "20160705", "DA": "19770516", "DC": "1", "DX": "19780101", "UI": "D000536"}, {"RECTYPE": "D", "MH": "Aluminum Oxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alumina|T197|NON|EQV|FDA SRS (2014)|UNK (19XX)|770331|abcdeef", "ENTRY": "Oxide, Aluminum", "MN": "D01.650.550.050", "MH_TH": "NLM (1978)", "ST": "T197", "N1": "Aluminum oxide (Al2O3)", "RN": "LMI26O6933", "RR": "1344-28-1 (Aluminum Oxide)", "PI": "Oxides (1966-1977)", "MS": "An oxide of aluminum, occurring in nature as various minerals such as bauxite, corundum, etc. It is used as an adsorbent, desiccating agent, and catalyst, and in the manufacture of dental cements and refractories.", "PM": "91; was see under ALUMINUM 1978-90", "HN": "91(78); was see under ALUMINUM 1978-90", "MR": "20130708", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D000537"}, {"RECTYPE": "D", "MH": "Aluminum Silicates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aluminum Silicate|T197|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Silicates, Aluminum", "MN": "D01.837.725.700.760.050", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "\"numerous types of clay\"", "MS": "Any of the numerous types of clay which contain varying proportions of Al2O3 and SiO2. They are made synthetically by heating aluminum fluoride at 1000-2000 degrees C with silica and water vapor. (From Hawley's Condensed Chemical Dictionary, 11th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000538"}, {"RECTYPE": "D", "MH": "Alveolar Process", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Alveolar Ridge|T023|NON|NRW|NLM (1998)|960710|abcdef", "ENTRY": "Ridge, Alveolar", "MN": "A14.549.167.646.094", "FX": "Dental Arch", "MH_TH": "NLM (1965)", "ST": "T023", "AN": "dis: coord with JAW DISEASES or specific precoord jaw dis (IM); for /surg, prefer ALVEOLECTOMY or ALVEOLOPLASTY", "MS": "The thickest and spongiest part of the maxilla and mandible hollowed out into deep cavities for the teeth.", "PM": "65", "HN": "65", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000539"}, {"RECTYPE": "D", "MH": "Alveolar Ridge Augmentation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Maxillary Ridge Augmentation|T061|NON|NRW|UNK (19XX)|790427|abcdef", "ENTRY": "Ridge Augmentations, Maxillary", "MN": "E06.645.550.100", "MH_TH": "NLM (1980)", "ST": "T061", "PI": "Mandibular Diseases/surgery (1966-1979)", "MS": "Preprosthetic surgery involving rib, cartilage, or iliac crest bone grafts, usually autologous, or synthetic implants for rebuilding the alveolar ridge.", "PM": "91; was see under SURGERY, ORAL, PREPROSTHETIC 1980-90", "HN": "91(80); was see under SURGERY, ORAL, PREPROSTHETIC 1980-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19790427", "DC": "1", "DX": "19910101", "UI": "D000540"}, {"RECTYPE": "D", "MH": "Alveolectomy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Alveolectomies", "MN": "E06.645.550.110", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "do not confuse with ALVEOLOPLASTY", "MS": "Subtotal or complete excision of the alveolar process of the maxilla or mandible. (Dorland, 28th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000541"}, {"RECTYPE": "D", "MH": "Alveolitis, Extrinsic Allergic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pneumonitis, Hypersensitivity|T047|NON|EQV|NLM (1993)|920122|abcdef", "ENTRY": "Pneumonitides, Hypersensitivity", "MN": "C20.543.480.680.075", "MH_TH": "NLM (1977)", "ST": "T047", "PI": "Respiratory Hypersensitivity (1966-1976)", "MS": "A common interstitial lung disease caused by hypersensitivity reactions of PULMONARY ALVEOLI after inhalation of and sensitization to environmental antigens of microbial, animal, or chemical sources. The disease is characterized by lymphocytic alveolitis and granulomatous pneumonitis.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D000542"}, {"RECTYPE": "D", "MH": "Alveoloplasty", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Alveoloplasties", "MN": "E06.645.550.120", "FX": "Denture, Complete, Immediate", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "do not confuse with ALVEOLECTOMY", "MS": "Conservative contouring of the alveolar process, in preparation for immediate or future denture construction. (Dorland, 28th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000543"}, {"RECTYPE": "D", "MH": "Alzheimer Disease", "DE": "ALZHEIMER DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Senile Dementia, Alzheimer Type|T047|EPO|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Senile Dementia", "MN": "F03.615.400.100", "FX": "tau Proteins", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)", "PM": "1998; see ALZHEIMER'S DISEASE 1984-1997, see DEMENTIA, PRESENILE 1967-1983, see PSYCHOSES, PRESENILE 1963-1966; for DEMENTIA PRESENILE and DEMENTIA, PRIMARY DEGENERATIVE, SENILE see DEMENTIA 1981-1999; for DEMENTIA, SENILE see DEMENTIA 1966-1999", "HN": "1998(1963); for DEMENTIA, PRESENILE and DEMENTIA, PRIMARY DEGENERATIVE SENILE use DEMENTIA 1981-1999; for DEMENTIA SENILE use DEMENTIA 1966-1999", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D000544"}, {"RECTYPE": "D", "MH": "Amanita", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Amanitas", "MN": "B01.300.179.100.110", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid41955", "AN": "a poisonous basidiomycete; coord NIM for MUSHROOM POISONING (IM) by Amanita", "MS": "A genus of fungi of the family Agaricaceae, order Agaricales; most species are poisonous.", "PM": "91; was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85", "HN": "91(75); was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D000545"}, {"RECTYPE": "D", "MH": "Amanitins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amanitin|T116|T131|NON|EQV|NLM (2021)|200319|abbcdef", "MN": "D23.946.587.175", "PA": "Poisons", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTITOXINS", "PI": "Peptides, Cyclic (1974)", "MS": "Cyclic peptides extracted from carpophores of various mushroom species. They are potent inhibitors of RNA polymerases in most eukaryotic species, blocking the production of mRNA and protein synthesis. These peptides are important in the study of transcription. Alpha-amanitin is the main toxin from the species Amanitia phalloides, poisonous if ingested by humans or animals.", "PM": "75", "HN": "75", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D000546"}, {"RECTYPE": "D", "MH": "Amantadine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Amantadine", "MN": "D02.455.426.100.050.035", "PA": "Dopamine Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Tricyclo(3.3.1.13,7)decan-1-amine", "RN": "BF4C9Z1J53", "RR": "M6Q1EO9TD0", "MS": "An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.", "PM": "68", "HN": "68(65)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000547"}, {"RECTYPE": "D", "MH": "Amaranth Dye", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Red Dye No. 2|T109|T130|T131|NON|NRW|UNK (19XX)|760317|RED DYE NO 02|RED DYE NO 2|abbbcdefsv", "ENTRY": "Compound, AR27", "MN": "D04.615.638.555.200", "PA": "Indicators and Reagents", "MH_TH": "NLM (2002)", "ST": "T131", "N1": "2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-((4-sulfo-1-naphthalenyl)azo)-, trisodium salt", "RN": "915-67-3", "AN": "AMARANTH PLANT see AMARANTHUS is also available", "PI": "Naphthalenesulfonates (1974)", "MS": "A sulfonic acid-based naphthylazo dye used as a coloring agent for foodstuffs and medicines and as a dye and chemical indicator. It was banned by the FDA in 1976 for use in foods, drugs, and cosmetics. (From Merck Index, 11th ed)", "PM": "2002; see AMARANTH 1991-2001, see AZO COMPOUNDS 1975-1990; for FD&C NO. 2 see AMARANTH 1975-1993; for ACID RED 27 see AZO COMPOUNDS 2005-2017; for C.I. ACID RED 27 see AZO COMPOUNDS and NAPHTHALENES 2005-2017", "HN": "1991(1975)", "MR": "20180517", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000548"}, {"RECTYPE": "D", "MH": "Ambenonium Chloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chloride, Ambenonium", "MN": "D02.675.276.046", "PA": "Parasympathomimetics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenemethanaminium, N,N'-((1,2-dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl))bis(2-chloro-N,N-diethyl)-, dichloride", "RN": "51FOB87G3I", "RR": "115-79-7 (Ambenonium Chloride)", "MS": "A quaternary ammonium compound that is an inhibitor of cholinesterase activity with actions similar to those of NEOSTIGMINE, but of longer duration. Ambenonium is given by mouth in the treatment of myasthenia gravis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1112)", "OL": "use AMBENONIUM CHLORIDE to search AMBESTIGMINUM 1977-94", "PM": "65; AMBESTIGMINUM was see AMBENONIUM CHLORIDE 1977-94", "HN": "65; AMBESTIGMINUM was see AMBENONIUM CHLORIDE 1977-94", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000549"}, {"RECTYPE": "D", "MH": "Amblyopia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lazy Eye|T047|NON|REL|NLM (2000)|991104|abcdef", "ENTRY": "Suppression Amblyopias", "MN": "C23.888.592.763.941.073", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A nonspecific term referring to impaired vision. Major subcategories include stimulus deprivation-induced amblyopia and toxic amblyopia. Stimulus deprivation-induced amblyopia is a developmental disorder of the visual cortex. A discrepancy between visual information received by the visual cortex from each eye results in abnormal cortical development. STRABISMUS and REFRACTIVE ERRORS may cause this condition. Toxic amblyopia is a disorder of the OPTIC NERVE which is associated with ALCOHOLISM, tobacco SMOKING, and other toxins and as an adverse effect of the use of some medications.", "CATSH": "CAT LIST", "MR": "20040719", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000550"}, {"RECTYPE": "D", "MH": "Ambroxol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bromhexine Metabolite VIII|T109|T121|NON|EQV|UNK (19XX)|760414|BROMHEXINE METABOLITE 08|abbcdefs", "ENTRY": "stasHustenl\u00f6ser", "MN": "D02.092.384.175.100", "PA": "Expectorants", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Cyclohexanol, 4-(((2-amino-3,5-dibromophenyl)methyl)amino)-, trans-", "RN": "200168S0CL", "RR": "18683-91-5 (Ambroxol)", "PI": "Cyclohexylamines (1974)", "MS": "A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.", "PM": "91; was see under BROMHEXINE 1977-90", "HN": "91(77); was see under BROMHEXINE 1977-90", "MR": "20180705", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D000551"}, {"RECTYPE": "D", "MH": "Ambulances", "AQ": "CL EC ES HI LJ OG SD SN ST", "PRINT ENTRY": "Mobile Emergency Units|T073|NON|BRD|UNK (19XX)|820426|abcdef", "ENTRY": "Units, Mobile Emergency", "MN": "N02.421.297.879.100", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "A vehicle equipped for transporting patients in need of emergency care.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000552"}, {"RECTYPE": "D", "MH": "Ambulatory Care", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "PRINT ENTRY": "Outpatient Health Services|T058|NON|BRD|NLM (1992)|910429|OUTPATIENT HEALTH SERV|abcdefv", "ENTRY": "Visits, Clinic", "MN": "N02.421.585.106", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "Health care services provided to patients on an ambulatory basis, rather than by admission to a hospital or other health care facility. The services may be a part of a hospital, augmenting its inpatient services, or may be provided at a free-standing facility.", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000553"}, {"RECTYPE": "D", "MH": "Ambulatory Care Facilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Outpatient Clinics|T073|T093|NON|EQV|UNK (19XX)|820430|abbcdef", "ENTRY": "Urgent Care Clinic", "MN": "N02.278.035", "MH_TH": "NLM (1979)", "ST": "T093", "PI": "Health Facilities (1968-1978)", "MS": "Those facilities which administer health services to individuals who do not require hospitalization or institutionalization.", "OL": "use AMBULATORY CARE FACILITIES to search AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82 & HEALTH CENTERS 1979", "PM": "83; was AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82; was HEALTH CENTERS 1979", "HN": "83; was AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82; was HEALTH CENTERS 1979", "MR": "20090706", "DA": "19780426", "DC": "1", "DX": "19790101", "UI": "D000554"}, {"RECTYPE": "D", "MH": "Ambulatory Care Information Systems", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Ambulatory Information Systems|T170|NON|EQV|NLM (2020)|190709|abcdef", "ENTRY": "Information Systems, Ambulatory", "MN": "N04.452.515.360.050", "MH_TH": "NLM (1987)", "ST": "T170", "AN": "IM", "MS": "Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of ambulatory care services and facilities.", "PM": "91; was see under INFORMATION SYSTEMS 1987-90", "HN": "91(87); was see under INFORMATION SYSTEMS 1987-90", "MR": "20190709", "DA": "19860617", "DC": "1", "DX": "19910101", "UI": "D000555"}, {"RECTYPE": "D", "MH": "Ambulatory Surgical Procedures", "DE": "AMBULATORY SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgery, Outpatient|T061|NON|EQV|UNK (19XX)|790425|SURG OUTPATIENT|abcdefv", "ENTRY": "Surgeries, Outpatient", "MN": "E04.030", "FX": "Surgicenters", "MH_TH": "NLM (1980)", "ST": "T061", "AN": "outpatient surg performed in MD's office, surgicenter or hosp", "PI": "Outpatient Clinics, Hospital (1966-1979)", "MS": "Surgery performed on an outpatient basis. It may be hospital-based or performed in an office or surgicenter.", "PM": "98; see AMBULATORY SURGERY 1980-97", "HN": "98(80)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19790425", "DC": "1", "DX": "19800101", "UI": "D000556"}, {"RECTYPE": "D", "MH": "Ambystoma", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Ambystoma tigrinum|T011|NON|NRW|NLM (2010)|081222|abcdef", "ENTRY": "Tiger Salamanders", "MN": "B01.050.150.900.090.608.080.068", "MH_TH": "NLM (1972)", "ST": "T011", "RN": "txid8295", "RR": "txid8305", "AN": "NIM with no qualifiers when an experimental animal", "PI": "Urodela (1966-1971)", "MS": "A genus of the Ambystomatidae family. The best known species are the axolotl AMBYSTOMA MEXICANUM and the closely related tiger salamander Ambystoma tigrinum. They may retain gills and remain aquatic without developing all of the adult characteristics. However, under proper changes in the environment they metamorphose.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000557"}, {"RECTYPE": "D", "MH": "Ambystoma mexicanum", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Axolotl|T011|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "mexicanums, Ambystoma", "MN": "B01.050.150.900.090.608.080.068.525", "MH_TH": "NLM (1981)", "ST": "T011", "RN": "txid8296", "AN": "NIM with no qualifiers when an experimental animal", "PI": "Ambystoma (1972-1980)", "MS": "A salamander found in Mexican mountain lakes and accounting for about 30 percent of the urodeles used in research. The axolotl remains in larval form throughout its life, a phenomenon known as neoteny.", "PM": "1991; see AMBYSTOMA 1981-1990; for AXOLOTL see AMBYSTOMA 1972-2009", "HN": "1991(1981); for AXOLOTL use AMBYSTOMA 1972-2009", "MR": "20200813", "DA": "19800402", "DC": "1", "DX": "19910101", "UI": "D000558"}, {"RECTYPE": "D", "MH": "Ambystomatidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Salamander, Mole|T011|NON|NRW|UNK (19XX)|800402|abcdef", "ENTRY": "Salamanders, Mole", "MN": "B01.050.150.900.090.608.080", "MH_TH": "NLM (1981)", "ST": "T011", "RN": "txid8294", "RR": "txid8306", "AN": "NIM when experimental animal", "MS": "A family of the class Urodela which includes 4 living genera, about 33 species, and occurs only in North America. Adults are usually terrestrial, but the larval forms are aquatic.", "PM": "81", "HN": "81", "MR": "20200813", "DA": "19800402", "DC": "1", "DX": "19810101", "UI": "D000559"}, {"RECTYPE": "D", "MH": "Amdinocillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mecillinam|T109|T195|NON|EQV|BAN (19XX)|FDA SRS (2015)|INN (19XX)|840302|abbcdeeef", "ENTRY": "FL1060", "MN": "D03.633.100.300.750.124", "PA": "Anti-Infective Agents, Urinary", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((hexahydro-1H-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-", "RN": "V10579P3QZ", "RR": "32887-01-7", "PI": "Thiazoles (1966-1972)", "MS": "An amidinopenicillanic acid derivative with broad spectrum antibacterial action.", "OL": "use AMDINOCILLIN to search MECILLINAM 1978-84", "PM": "85; was MECILLINAM see under PENICILLANIC ACIDS 1978-84; AMDINOCILLIN PIVOXIL was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84", "HN": "85; was MECILLINAM see under PENICILLANIC ACIDS 1978-84", "MR": "20160527", "DA": "19770422", "DC": "1", "DX": "19850101", "UI": "D000560"}, {"RECTYPE": "D", "MH": "Amdinocillin Pivoxil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pivmecillinam|T109|T195|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|840302|abbcdeeef", "ENTRY": "Pivoxil, Amdinocillin", "MN": "D03.633.100.300.750.124.036", "PA": "Anti-Infective Agents, Urinary", "MH_TH": "USAN (1981)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((hexahydro-1H-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (2S-(2alpha,5alpha,6beta))-", "RN": "1WAM1OQ30B", "RR": "48FX7N21H2", "PI": "Thiazoles (1966-1977)", "MS": "Pivaloyloxymethyl ester of amdinocillin that is well absorbed orally, but broken down to amdinocillin in the intestinal mucosa. It is active against gram-negative organisms and used as for amdinocillin.", "OL": "use AMDINOCILLIN PIVOXIL to search PIVMECILLINAM 1978-84", "PM": "91; was see under AMDINOCILLIN 1985-90; was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84", "HN": "91(85); was see under AMDINOCILLIN 1985-90; was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84", "MR": "20170524", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D000561"}, {"RECTYPE": "D", "MH": "Amebiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Iodamoebiasis|T047|NON|NRW|UNK (19XX)|850322|abcdef", "ENTRY": "Iodamoebiases", "MN": "C01.610.752.049", "FX": "Amebicides", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "caused by \"any of various amebae\"; /drug ther: consider also AMEBICIDES; note X ref ABSCESS, AMEBIC: LIVER ABSCESS, AMEBIC is also available", "MS": "Infection with any of various amebae. It is an asymptomatic carrier state in most individuals, but diseases ranging from chronic, mild diarrhea to fulminant dysentery may occur.", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000562"}, {"RECTYPE": "D", "MH": "Amebicides", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Amoebicides|T121|NON|EQV|NLM (1990)|891115|abcdef", "MN": "D27.505.954.122.250.100.055", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal.", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000563"}, {"RECTYPE": "D", "MH": "Ameloblastoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Ameloblastomas", "MN": "C04.557.695.065", "FX": "Ameloblasts", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "benign or malignant; coordinate IM with probably JAW NEOPLASMS (IM) or precoordinated jaw/neoplasm term (IM)", "MS": "An immature epithelial tumor of the JAW originating from the epithelial rests of Malassez or from other epithelial remnants of the ENAMEL from the developmental period. It is a slowly growing tumor, usually benign, but displays a marked propensity for invasive growth.", "PM": "1965; see ADAMANTINOMA 1963-1964", "HN": "1965 (1963)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000564"}, {"RECTYPE": "D", "MH": "Ameloblasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Ameloblast", "MN": "A11.436.107", "FX": "Ameloblastoma", "MH_TH": "NLM (1965)", "ST": "T025", "MS": "Cylindrical epithelial cells in the innermost layer of the ENAMEL ORGAN. Their functions include contribution to the development of the dentinoenamel junction by the deposition of a layer of the matrix, thus producing the foundation for the prisms (the structural units of the DENTAL ENAMEL), and production of the matrix for the enamel prisms and interprismatic substance. (From Jablonski's Dictionary of Dentistry, 1992)", "PM": "65", "HN": "65", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000565"}, {"RECTYPE": "D", "MH": "Amelogenesis", "AQ": "DE GE IM PH RE", "ENTRY": "Amelogeneses", "MN": "G07.345.500.325.377.750.190", "MH_TH": "NLM (1965)", "ST": "T042", "AN": "formation of dent enamel; DENTINOGENESIS, formation of dentin, is also available", "MS": "The elaboration of dental enamel by ameloblasts, beginning with its participation in the formation of the dentino-enamel junction to the production of the matrix for the enamel prisms and interprismatic substance. (Jablonski, Dictionary of Dentistry, 1992).", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000566"}, {"RECTYPE": "D", "MH": "Amelogenesis Imperfecta", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Congenital Enamel Hypoplasia|T019|T047|NON|EQV|GHR (2014)|NLM (2014)|130501|abbcdeef", "MN": "C16.131.850.800.295.250", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "A clinically and genetically heterogeneous group of hereditary conditions characterized by malformed DENTAL ENAMEL, usually involving DENTAL ENAMEL HYPOPLASIA and/or TOOTH HYPOMINERALIZATION.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000567"}, {"RECTYPE": "D", "MH": "Amenorrhea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Postpartum Amenorrheas", "MN": "C23.550.568.500", "FX": "Oligomenorrhea", "MH_TH": "POPLINE (1978)", "ST": "T184", "AN": "\"postpartum amenorrhea\" is indexed under AMENORRHEA (IM) + PUERPERIUM (IM) & not LACTATION unless lactation is particularly discussed", "MS": "Absence of menstruation.", "CATSH": "CAT LIST", "MR": "19991109", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000568"}, {"RECTYPE": "D", "MH": "Americas", "AQ": "EH EP", "ENTRY": "America|T083|NAM|EQV|NLM (1996)|950324|abcdef", "MN": "Z01.107", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "too general; avoid; prefer specific continents or countries; titles saying \"American\" are likely to be indexed to UNITED STATES, not here", "MS": "The general name for NORTH AMERICA; CENTRAL AMERICA; and SOUTH AMERICA unspecified or combined.", "HN": "96; was AMERICA 1975-95", "MR": "20010725", "DA": "19990101", "DC": "4", "DX": "19960101", "UI": "D000569"}, {"RECTYPE": "D", "MH": "American Cancer Society", "AQ": "EC HI OG", "ENTRY": "Society, American Cancer", "MN": "N03.540.630.780.080", "MH_TH": "NLM (1975)", "ST": "T093", "AN": "add UNITED STATES or specific state;  CATALOGER: Use NAF entry", "PI": "specific neoplasm", "MS": "A voluntary organization concerned with the prevention and treatment of cancer through education and research.", "OL": "search VOLUNTARY HEALTH AGENCIES 1967-74", "PM": "91; was see under VOLUNTARY HEALTH AGENCIES 1975-90", "HN": "91(75); was see under VOLUNTARY HEALTH AGENCIES 1975-90", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000570"}, {"RECTYPE": "D", "MH": "American Dental Association", "DE": "ADA", "AQ": "EC HI OG", "ENTRY": "Dental Association, American", "MN": "N03.540.828.506.274", "MH_TH": "NLM (1966)", "ST": "T094", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "MS": "Professional society representing the field of dentistry.", "PM": "66", "HN": "66", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000571"}, {"RECTYPE": "D", "MH": "American Heart Association", "DE": "AMERICAN HEART ASSOC", "AQ": "EC HI OG", "ENTRY": "Heart Associations, American", "MN": "N03.540.630.780.110", "MH_TH": "NLM (1975)", "ST": "T093", "AN": "add UNITED STATES or specific state; CATALOGER: Use NAF entry", "PI": "Voluntary Health Agencies (1966-1974)", "MS": "A voluntary organization concerned with the prevention and treatment of heart and vascular diseases.", "OL": "search VOLUNTARY HEALTH AGENCIES 1967-74", "PM": "91; was see under VOLUNTARY HEALTH AGENCIES 1975-90", "HN": "91(75); was see under VOLUNTARY HEALTH AGENCIES 1975-90", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000572"}, {"RECTYPE": "D", "MH": "American Hospital Association", "DE": "AHA", "AQ": "EC HI OG", "ENTRY": "Association, American Hospital|T094|NON|EQV|NLM (1997)|951003|ASSOC AMERICAN HOSP|abcdefv", "MN": "N03.540.828.540.080", "MH_TH": "NLM (1978)", "ST": "T094", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "MS": "A professional society in the United States whose membership is composed of hospitals.", "PM": "78", "HN": "78", "MR": "20150605", "DA": "19770505", "DC": "1", "DX": "19780101", "UI": "D000573"}, {"RECTYPE": "D", "MH": "American Medical Association", "DE": "AMA", "AQ": "EC HI OG", "PRINT ENTRY": "AMA - American Medical Association|T094|ABX|EQV|NLM (2020)|190318|abcdef", "ENTRY": "Medical Association, American", "MN": "N03.540.828.589.274", "MH_TH": "NLM (1966)", "ST": "T094", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "MS": "Professional society representing the field of medicine.", "PM": "66", "HN": "66", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000574"}, {"RECTYPE": "D", "MH": "American Nurses' Association", "DE": "ANA", "AQ": "EC HI OG", "ENTRY": "Nurses' Associations, American", "MN": "N03.540.828.672.274", "MH_TH": "NLM (1965)", "ST": "T094", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "MS": "Professional society representing the field of nursing.", "PM": "67", "HN": "67(65)", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000575"}, {"RECTYPE": "D", "MH": "Americium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.037", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Americium", "RN": "VW92PHU2UY", "RR": "7440-35-9 (Americium)", "MS": "A completely man-made radioactive actinide with atomic symbol Am, and atomic number 95. Its valence can range from +3 to +6. Because of its nonmagnetic ground state, it is an excellent superconductor. It is also used in bone mineral analysis and as a radiation source for radiotherapy.", "MR": "20170421", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000576"}, {"RECTYPE": "D", "MH": "Amides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amide|T109|NON|EQV|NLM (2021)|191219|abcdef", "MN": "D02.065", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000577"}, {"RECTYPE": "D", "MH": "Amidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.078", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of oxoacids RnE(=O)OH in which the hydroxy group is replaced by an amino group and the oxo group is replaced by =NR. Amidines include carboxamidines, sulfinamidines and phosphinamidines.", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000578"}, {"RECTYPE": "D", "MH": "Amidinotransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transamidinases|T116|T126|NON|EQV|UNK (19XX)|750822|abbcdef", "MN": "D08.811.913.555.150", "MH_TH": "NLM (1974)", "ST": "T126", "RN": "EC 2.1.4.-", "MS": "Enzymes of a subclass of TRANSFERASES that catalyze the transfer of an amidino group from donor to acceptor. EC 2.1.4.", "PM": "74", "HN": "74(73)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000579"}, {"RECTYPE": "D", "MH": "Amido Black", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "C.I.20470", "MN": "D04.615.638.555.220", "PA": "Coloring Agents", "MH_TH": "NLM (1976)", "ST": "T130", "N1": "2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3-((4-nitrophenyl)azo)-6-(phenylazo)-, disodium salt", "RN": "SZT789770M", "RR": "85294-31-1 (di-Li salt)", "PI": "Nitrobenzenes (1974-1975)", "MS": "A dye used to stain proteins in electrophoretic techniques. It is used interchangeably with its acid form.", "OL": "use AMIDO BLACK to search ACID BLACK 1, NAPHTHOL BLUE BLACK, & C.I. ACID BLACK 1 1976-93", "PM": "91; was see under AZO COMPOUNDS 1976-90; ACID BLACK 1, NAPHTHOL BLUE BLACK, & C.I. ACID BLACK 1 were see AMIDO BLACK 1976-93", "HN": "91(76); was see under AZO COMPOUNDS 1976-90; ACID BLACK 1, NAPHTHOL BLUE BLACK, & C.I. ACID BLACK 1 were see AMIDO BLACK 1976-93", "MR": "20130708", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D000580"}, {"RECTYPE": "D", "MH": "Amidohydrolases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Amidohydrolase|T116|T126|NON|EQV|NLM (2021)|191118|abbcdef", "MN": "D08.811.277.087", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.5.-", "MS": "Any member of the class of enzymes that catalyze the cleavage of amide bonds and result in the addition of water to the resulting molecules.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000581"}, {"RECTYPE": "D", "MH": "Amidophosphoribosyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphoribosyl Pyrophosphate Amidotransferase|T116|T126|NON|EQV|UNK (19XX)|750211|abbcdef", "ENTRY": "Pyrophosphate Amidotransferase, Phosphoribosyl", "MN": "D08.811.913.400.725.130", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "5-Phosphoribosylamine:pyrophosphate phospho-alpha-D-ribosyltransferase (glutamate-amidating)", "RN": "EC 2.4.2.14", "RR": "9031-82-7 (CAS RN)", "PI": "Pyrophosphoric Acids (1974)", "MS": "An enzyme, involved in the early steps of purine nucleotide biosynthesis, that catalyzes the formation of 5-phosphoribosylamine from glutamine and phosphoribosylpyrophosphate. EC 2.4.2.14.", "PM": "91; was see under PENTOSYLTRANSFERASES 1975-90", "HN": "91(75); was see under PENTOSYLTRANSFERASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000582"}, {"RECTYPE": "D", "MH": "Amikacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Amikacin", "MN": "D09.408.051.476.060", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-", "RN": "84319SGC3C", "RR": "N6M33094FD", "PI": "Kanamycin (1973-1974)", "MS": "A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.", "PM": "87; was see under KANAMYCIN 1975-86", "HN": "87(75); was see under KANAMYCIN 1975-86", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D000583"}, {"RECTYPE": "D", "MH": "Amiloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trom, Amiduret", "MN": "D03.383.679.149", "PA": "Epithelial Sodium Channel Blockers", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-", "RN": "7DZO8EB0Z3", "RR": "FZJ37245UC", "PI": "Pyrazines (1966-1971)", "MS": "A pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with DIURETICS to spare POTASSIUM loss. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p705)", "PM": "86; was see under PYRAZINES 1975-85", "HN": "86(72); was see under PYRAZINES 1975-85, was Prov 1972-74", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D000584"}, {"RECTYPE": "D", "MH": "Aminacrine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Acridinamine|T109|T121|T130|T131|NON|EQV|UNK (19XX)|790228|abbbbcdef", "ENTRY": "Hydrochloride, Aminoacridine", "MN": "D03.633.300.046.250.200", "PA": "Mutagens", "MH_TH": "FDA SRS (2014)", "ST": "T131", "N1": "9-Acridinamine", "RN": "78OY3Z0P7Z", "RR": "OR5RM3Q5QL", "PI": "Acridines (1966-1979)", "MS": "A highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA. It is also used as an intracellular pH indicator.", "PM": "91; was see under AMINOACRIDINES 1980-90", "HN": "91(80); was see under AMINOACRIDINES 1980-90", "MR": "20170524", "DA": "19790228", "DC": "1", "DX": "19910101", "UI": "D000585"}, {"RECTYPE": "D", "MH": "Amination", "AQ": "DE GE IM PH RE", "ENTRY": "Aminations", "MN": "G03.068", "FX": "Deamination", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "almost never IM; enzymatic amination: coord NIM with TRANSAMINASES (IM) + substrate (NIM) or specific transaminase (IM)", "PI": "Chemistry, Organic (1966-1970)", "MS": "The creation of an amine. It can be produced by the addition of an amino group to an organic compound or reduction of a nitro group.", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000586"}, {"RECTYPE": "D", "MH": "Oxidoreductases Acting on CH-NH Group Donors", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Secondary Amine Oxidoreductases|T116|T126|NON|EQV|NLM (2006)|050311|abbcdef", "ENTRY": "Oxidoreductases, Secondary Amine", "MN": "D08.811.682.662", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.5.-", "AN": "do not confuse with OXIDOREDUCTASES ACTING ON CH-NH2 GROUP DONORS", "PI": "Oxidoreductases (1966-1974)", "MS": "Enzymes catalyzing the dehydrogenation of secondary amines, introducing a C=N double bond as the primary reaction. In some cases this is later hydrolyzed.", "PM": "2006; see AMINE OXIDOREDUCTASES 1975-2005", "HN": "2006(1975)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D000587"}, {"RECTYPE": "D", "MH": "Amines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amine|T109|NON|EQV|NLM (2021)|191231|abcdef", "MN": "D02.092", "MH_TH": "POPLINE (1984)", "ST": "T109", "RN": "0", "MS": "A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000588"}, {"RECTYPE": "D", "MH": "Amino Acid Chloromethyl Ketones", "DE": "AACK", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Peptide Chloromethyl Ketones|T116|T121|NON|EQV|UNK (19XX)|760516|abbcdef", "ENTRY": "Ketones, Peptide Chloromethyl", "MN": "D12.125.065", "PA": "Serine Proteinase Inhibitors", "MH_TH": "NLM (1977)", "ST": "T121", "RN": "0", "PI": "specific amino acid (1966-1976)", "MS": "Inhibitors of SERINE ENDOPEPTIDASES and sulfhydryl group-containing enzymes. They act as alkylating agents and are known to interfere in the translation process.", "PM": "77; TOSYLLYSINE CHLOROMETHYL KETONE was see under LYSINE 1975-76; TOSYLPHENYLALANYL CHLOROMETHYL KETONE was see under PHENYLALANINE 1975-76", "HN": "77", "MR": "19991109", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D000590"}, {"RECTYPE": "D", "MH": "Amino Acid Isomerases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Amino Acid Racemase|T116|T126|NON|NRW|NLM (2021)|200417|abbcdef", "ENTRY": "Racemases, Amino Acid", "MN": "D08.811.399.894.200", "MH_TH": "NLM (1972)", "ST": "T126", "RN": "EC 5.1.1.-", "PI": "specific amino acid (1966-1971)", "MS": "Enzymes that catalyze either the racemization or epimerization of chiral centers within amino acids or derivatives. EC 5.1.1.", "PM": "74", "HN": "74(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000591"}, {"RECTYPE": "D", "MH": "Amino Acid Metabolism, Inborn Errors", "DE": "AA METAB INBORN ERR", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Amino Acidopathies, Congenital|T047|NON|EQV|NLM (2000)|991108|AMINO ACIDOPATHIES CONGEN|abcdefv", "ENTRY": "Inborn Amino Acidopathy", "MN": "C18.452.648.100", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific amino acid /metab (IM)", "MS": "Disorders affecting amino acid metabolism. The majority of these disorders are inherited and present in the neonatal period with metabolic disturbances (e.g., ACIDOSIS) and neurologic manifestations. They are present at birth, although they may not become symptomatic until later in life.", "PM": "1965; PROTEIN METABOLISM DISORDERS was heading 1963-1964", "HN": "1965; PROTEIN METABOLISM DISORDERS was heading 1963-1964", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000592"}, {"RECTYPE": "D", "MH": "Amino Acid Oxidoreductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidoreductases, Amino Acid", "MN": "D08.811.682.664.500", "MH_TH": "NLM (1964)", "ST": "T126", "RN": "EC 1.4.-", "MS": "A class of enzymes that catalyze oxidation-reduction reactions of amino acids.", "OL": "use AMINO ACID OXIDOREDUCTASES to search AMINOACID OXIDOREDUCTASES 1966-73", "PM": "74; was AMINOACID OXIDOREDUCTASES 1964-73", "HN": "74; was AMINOACID OXIDOREDUCTASES 1964-73", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D000594"}, {"RECTYPE": "D", "MH": "Amino Acid Sequence", "DE": "AMINO ACID SEQ", "AQ": "DE GE PH RE", "PRINT ENTRY": "Protein Structure, Primary|T087|NON|EQV|NLM (1993)|920327|abcdef", "ENTRY": "Structures, Primary Protein", "MN": "L01.462.750.245.667.060", "MH_TH": "NLM (1966)", "ST": "T087", "AN": "IM general; coordinate NIM with specific protein or peptide; when to index with MOLECULAR SEQUENCE DATA: see note there", "MS": "The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000595"}, {"RECTYPE": "D", "MH": "Amino Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amino Acid|T116|T123|NON|EQV|NLM (2021)|191113|abbcdef", "ENTRY": "Acids, Amino", "MN": "D12.125", "FX": "Receptors, Amino Acid", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "/urine permitted but consider also RENAL AMINOACIDURIAS", "MS": "Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins.", "PM": "/metabolism was AMINO ACID METABOLISM 1965; /metabolism was AMINO ACID METABOLISM see under PROTEIN METABOLISM 1963-64", "HN": "/metabolism was AMINO ACID METABOLISM 1965; /metabolism was AMINO ACID METABOLISM see under PROTEIN METABOLISM 1963-64", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D000596"}, {"RECTYPE": "D", "MH": "Amino Acids, Branched-Chain", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Branched-Chain Amino Acid|T116|T123|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Branched-Chain Amino Acids", "MN": "D12.125.070", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "PI": "Amino Acids (1966-1978)", "MS": "Amino acids which have a branched carbon chain.", "PM": "79", "HN": "79", "MR": "20200527", "DA": "19780516", "DC": "1", "DX": "19790101", "UI": "D000597"}, {"RECTYPE": "D", "MH": "Amino Acids, Cyclic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclic Amino Acids|T116|NON|EQV|NLM (1998)|961216|abcdef", "ENTRY": "Acids, Cyclic Amino", "MN": "D12.125.072", "MH_TH": "NLM (1966)", "ST": "T116", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A class of amino acids characterized by a closed ring structure.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "19970626", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000598"}, {"RECTYPE": "D", "MH": "Amino Acids, Diamino", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diamino Amino Acids|T116|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Acids, Dibasic Amino", "MN": "D12.125.095", "MH_TH": "NLM (1974)", "ST": "T116", "RN": "0", "PM": "74; DIAMINOPIMELIC ACID was see under PIMELIC ACIDS 1975-79", "HN": "74", "MR": "19920507", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000599"}, {"RECTYPE": "D", "MH": "Amino Acids, Dicarboxylic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dicarboxylic Amino Acids|T116|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Acids, Dicarboxylic Amino", "MN": "D12.125.119", "MH_TH": "NLM (1974)", "ST": "T116", "RN": "0", "PM": "74", "HN": "74", "MR": "19920507", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000600"}, {"RECTYPE": "D", "MH": "Amino Acids, Essential", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Essential Amino Acids|T116|T123|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Amino Acid, Essential", "MN": "D12.125.142", "MH_TH": "NLM (1974)", "ST": "T123", "RN": "0", "MS": "Amino acids that are not synthesized by the human body in amounts sufficient to carry out physiological functions. They are obtained from dietary foodstuffs.", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000601"}, {"RECTYPE": "D", "MH": "Amino Acids, Peptides, and Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12", "RH": "D12 - AMINO ACIDS, PEPTIDES, AND PROTEINS", "MH_TH": "NLM (1974)", "ST": "T116", "RN": "0", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Amino acids and chains of amino acids connected by peptide linkages.", "PM": "98", "HN": "98; use explode", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000602"}, {"RECTYPE": "D", "MH": "Amino Acids, Sulfur", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfur Amino Acids|T116|T123|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Amino Acid, Sulfur", "MN": "D12.125.166", "MH_TH": "NLM (1974)", "ST": "T123", "RN": "0", "PM": "74", "HN": "74", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000603"}, {"RECTYPE": "D", "MH": "Amino Acyl-tRNA Synthetases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Amino Acyl-tRNA Ligases|T116|T126|ACX|EQV|NLM (1972)|990101|abbcdef", "ENTRY": "Synthetases, Amino Acyl-tRNA", "MN": "D08.811.464.263.200", "FX": "Transfer RNA Aminoacylation", "MH_TH": "NLM (2001)", "ST": "T126", "RN": "EC 6.1.1.-", "PI": "Ligases (1966-1971)", "MS": "A subclass of enzymes that aminoacylate AMINO ACID-SPECIFIC TRANSFER RNA with their corresponding AMINO ACIDS.", "PM": "2005; see AMINO ACYL-TRNA LIGASES 1998-2004, see AMINO ACYL T RNA SYNTHETASES 1972-1997", "HN": "2005(1972); use LIGASES 1966-1971", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000604"}, {"RECTYPE": "D", "MH": "Amino Alcohols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Alcohols, Amino", "MN": "D02.092.063", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds possessing both a hydroxyl (-OH) and an amino group (-NH2).", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000605"}, {"RECTYPE": "D", "MH": "Amino Sugars", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amino Sugar|T109|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Sugars, Amino", "MN": "D09.067", "FX": "Aminoglycosides", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "SUGARS containing an amino group. GLYCOSYLATION of other compounds with these amino sugars results in AMINOGLYCOSIDES.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000606"}, {"RECTYPE": "D", "MH": "Aminoacetonitrile", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycinonitrile|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D02.626.080.085", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Acetonitrile, amino-", "RN": "3739OQ10IJ", "RR": "540-61-4 (Aminoacetonitrile)", "PI": "Nitriles (1968-1974)", "MS": "Cyanomethylamine.", "PM": "91; was see under ACETONITRILES 1975-90", "HN": "91(75); was see under ACETONITRILES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000607"}, {"RECTYPE": "D", "MH": "Renal Aminoacidurias", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aminoaciduria, Renal|T047|NON|EQV|NLM (1965)|990101|abcdef", "ENTRY": "Renal Aminoaciduria", "MN": "C16.320.831.885", "FX": "Urine", "MH_TH": "NLM (2007)", "ST": "T047", "AN": "coordinate IM with specific amino acid /urine (IM)", "MS": "A group of inherited kidney disorders characterized by the abnormally elevated levels of AMINO ACIDS in URINE. Genetic mutations of transport proteins result in the defective reabsorption of free amino acids at the PROXIMAL RENAL TUBULES. Renal aminoaciduria are classified by the specific amino acid or acids involved.", "PM": "2007; see AMINOACIDURIA, RENAL 1965-2006, see AMINOACIDURIA 1963-1964", "HN": "2007 (1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000608"}, {"RECTYPE": "D", "MH": "Aminoacridines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.046.250", "MH_TH": "NLM (1980)", "ST": "T121", "RN": "0", "PI": "Acridines (1966-1979)", "MS": "Acridines which are substituted in any position by one or more amino groups or substituted amino groups.", "PM": "80; ACRIFLAVINE was see under ACRIDINES 1963-81; NITRACRINE was see under ACRIDINES 1975-80; TACRINE was see under ACRIDINES 1975-83", "HN": "80", "MR": "20160527", "DA": "19790221", "DC": "1", "DX": "19800101", "UI": "D000609"}, {"RECTYPE": "D", "MH": "Aminobiphenyl Compounds", "DE": "AMINOBIPHENYL CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Biphenylamines|T109|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Compounds, Aminobiphenyl", "MN": "D02.455.426.559.389.185.060", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Biphenyl Compounds (1972-1974)", "MS": "Biphenyl compounds substituted in any position by one or more amino groups. Permitted are any substituents except fused rings.", "PM": "75", "HN": "75", "MR": "19920507", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D000611"}, {"RECTYPE": "D", "MH": "4-Aminobutyrate Transaminase", "DS": "AMINOBUTYRATE TRANSAMINASE 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Alanine Ketoglutarate Aminotransferase|T116|T126|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "beta Alanine Ketoglutarate Aminotransferase", "MN": "D08.811.913.477.700.200", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "4-Aminobutanoate:2-oxoglutarate aminotransferase", "RN": "EC 2.6.1.19", "RR": "9037-67-6 (CAS RN)", "PI": "Aminotransferases (1974)", "MS": "An enzyme that converts brain gamma-aminobutyric acid (GAMMA-AMINOBUTYRIC ACID) into succinate semialdehyde, which can be converted to succinic acid and enter the citric acid cycle. It also acts on beta-alanine. EC 2.6.1.19.", "PM": "98; see AMINOBUTYRATE AMINOTRANSFERASE 1984-97, see AMINOTRANSFERASES 1975-83", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D000612"}, {"RECTYPE": "D", "MH": "Aminobutyrates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aminobutyric Acids|T116|T123|NON|REL|NLM (1966)|990101|abbcdef", "ENTRY": "Acids, Aminobutyric", "MN": "D12.125.190", "FX": "Receptors, GABA-A", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Derivatives of BUTYRIC ACID that contain one or more amino groups attached to the aliphatic structure. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the aminobutryrate structure.", "PM": "1975;see AMINOBUTYRIC ACIDS 1975-2013, see AMINOBUTYRIC ACID 1963-1974", "HN": "1975(2013)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D000613"}, {"RECTYPE": "D", "MH": "Aminocaproates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aminocaproic Acids|T116|T121|NON|REL|NLM (1963)|990101|abbcdef", "ENTRY": "Derivatives, Aminohexanoic Acid", "MN": "D12.125.213", "MH_TH": "NLM (2014)", "ST": "T109", "RN": "0", "MS": "Amino derivatives of caproic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the amino caproic acid structure.", "PM": "1975; see AMINOCAPROIC ACIDS 1975-2013. see AMINOCAPROIC ACID 1964-1974", "HN": "2014(1975)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D000614"}, {"RECTYPE": "D", "MH": "Aminoethylphosphonic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ciliatine|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|760317|abbcdeef", "ENTRY": "Acid, Aminoethylphosphonic", "MN": "D02.705.429.249", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Phosphonic acid, (2-aminoethyl)-", "RN": "AH00YJQ334", "RR": "2041-14-7 (Aminoethylphosphonic Acid)", "PI": "Phosphonic Acids (1973-1974)", "MS": "An organophosphorus compound isolated from human and animal tissues.", "PM": "91; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90", "HN": "91(75); was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000615"}, {"RECTYPE": "D", "MH": "Aminoglutethimide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Orimeten|T109|T121|TRD|NRW|DE|ES|FR|NL|UK|890607|abbcdeeeeef", "MN": "D03.383.621.808.425.100", "PA": "Aromatase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,6-Piperidinedione, 3-(4-aminophenyl)-3-ethyl-", "RN": "0O54ZQ14I9", "RR": "125-84-8 (Aminoglutethimide)", "MS": "An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.", "PM": "73", "HN": "73(66)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000616"}, {"RECTYPE": "D", "MH": "Aminoglycosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aminoglycoside|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D09.408.051", "FX": "Amino Sugars", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000617"}, {"RECTYPE": "D", "MH": "Aminohippuric Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Aminohippuric", "MN": "D02.455.426.559.389.127.085.067", "MH_TH": "NLM (1965)", "ST": "T130", "RN": "0", "MS": "A group of glycine amides of aminobenzoic acids.", "OL": "use AMINOHIPPURIC ACIDS to search AMINOHIPPURIC ACID 1966-76", "PM": "77; was AMINOHIPPURIC ACID 1965-76", "HN": "77; was AMINOHIPPURIC ACID 1965-76", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000618"}, {"RECTYPE": "D", "MH": "Aminohydrolases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.151", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.5.4.-", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000619"}, {"RECTYPE": "D", "MH": "Aminoimidazole Carboxamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Carboxamide, Aminoimidazole", "MN": "D03.383.129.308.030", "MH_TH": "NLM (1978)", "ST": "T130", "N1": "1H-Imidazole-4-carboxamide, 5-amino-", "RN": "360-97-4", "PI": "Imidazoles (1966-1977)", "MS": "An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases.", "PM": "91; was see under IMIDAZOLES 1978-90", "HN": "91(78); was see under IMIDAZOLES 1978-90", "MR": "20160527", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D000620"}, {"RECTYPE": "D", "MH": "Aminoisobutyric Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Aminoisobutyric", "MN": "D12.125.190.055", "MH_TH": "NLM (1966)", "ST": "T116", "RN": "0", "MS": "A group of compounds that are derivatives of the amino acid 2-amino-2-methylpropanoic acid.", "OL": "use AMINOISOBUTYRIC ACIDS to search AMINOISOBUTYRIC ACID 1966-82", "PM": "83; was AMINOISOBUTYRIC ACID 1963-82", "HN": "83; was AMINOISOBUTYRIC ACID 1963-82", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19830101", "UI": "D000621"}, {"RECTYPE": "D", "MH": "Aminolevulinic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "5-Amino Levulinic Acid|T116|T123|NON|NRW|NLM (2024)|230427|abbcdef", "ENTRY": "Levulinic Acid, 5-Amino", "MN": "D12.125.262", "PA": "Photosensitizing Agents", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Pentanoic acid, 5-amino-4-oxo-", "RN": "88755TAZ87", "RR": "V35KBM8JGR", "MS": "A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.", "PM": "91; see LEVULINIC ACIDS 1975-90; see LEVULINIC ACID 1973-74", "HN": "91(73)", "MR": "20230609", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000622"}, {"RECTYPE": "D", "MH": "Porphobilinogen Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aminolevulinic Acid Dehydratase|T116|T126|NON|EQV|NLM (1998)|961115|abbcdef", "ENTRY": "delta Aminolevulinic Acid Dehydratase", "MN": "D08.811.520.241.300.550", "MH_TH": "NLM (1973)", "ST": "T126", "N1": "5-Aminolevulinate hydro-lyase (adding 5-aminolevulinate and cyclizing)", "RN": "EC 4.2.1.24", "RR": "9036-37-7 (CAS RN)", "PI": "Hydro-Lyases (1966-1972)", "MS": "An enzyme that catalyzes the formation of porphobilinogen from two molecules of 5-aminolevulinic acid. EC 4.2.1.24.", "PM": "98; see AMINOLEVULINIC ACID DEHYDRATASE 1978-97, see HYDRO-LYASES 1973-77", "HN": "98(73)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D000623"}, {"RECTYPE": "D", "MH": "5-Aminolevulinate Synthetase", "DS": "AMINOLEVULINATE SYNTHETASE 05", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "delta-Aminolevulinate Synthase|T116|T126|NON|EQV|NLM (1998)|970501|abbcdef", "ENTRY": "delta Aminolevulinic Acid Synthetase", "MN": "D08.811.913.050.276", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "Succinyl-CoA:glycine C-Succinyltransferase (decarboxylating)", "RN": "EC 2.3.1.37", "RR": "9037-14-3 (CAS RN)", "PI": "Acyltransferases (1966-1971)", "MS": "An enzyme of the transferase class that catalyzes condensation of the succinyl group from succinyl coenzyme A with glycine to form delta-aminolevulinate. It is a pyridoxyal phosphate protein and the reaction occurs in mitochondria as the first step of the heme biosynthetic pathway. The enzyme is a key regulatory enzyme in heme biosynthesis. In liver feedback is inhibited by heme. EC 2.3.1.37.", "PM": "98; see AMINOLEVULINIC ACID SYNTHETASE 1972-97", "HN": "98(72)", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000624"}, {"RECTYPE": "D", "MH": "Aminooxyacetic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aminooxyacetate|T109|T121|NON|NRW|UNK (19XX)|741111|abbcdef", "ENTRY": "Acid, Aminooxyacetic", "MN": "D02.241.081.018.207", "PA": "GABA Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Acetic acid, (aminooxy)-", "RN": "14I68GI3OQ", "RR": "645-88-5 (Aminooxyacetic Acid)", "PI": "Hydroxylamines (1972-1974)", "MS": "A compound that inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma-aminobutyric acid in tissues.", "PM": "91; was see under ACETIC ACIDS 1975-90", "HN": "91(75); was see under ACETIC ACIDS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000625"}, {"RECTYPE": "D", "MH": "Aminopeptidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aminopeptidase|T116|T126|NON|EQV|NLM (2021)|200113|abbcdef", "MN": "D08.811.277.656.350.100", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.4.11.-", "MS": "A subclass of EXOPEPTIDASES that act on the free N terminus end of a polypeptide liberating a single amino acid residue. EC 3.4.11.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000626"}, {"RECTYPE": "D", "MH": "Aminophenols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxyanilines|T109|NON|EQV|UNK (19XX)|771208|abcdef", "MN": "D02.455.426.559.389.657.050", "MH_TH": "NLM (1979)", "ST": "T109", "RN": "0", "PI": "Phenols (1966-1978)", "MS": "Phenols substituted in any position by an amino group.", "PM": "79; PHENETIDINE was see under ANILINE COMPOUNDS 1975-78", "HN": "79", "MR": "20120703", "DA": "19771208", "DC": "1", "DX": "19790101", "UI": "D000627"}, {"RECTYPE": "D", "MH": "Aminophylline", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Theophyllin EDAratiopharm", "MN": "D26.310.048", "PA": "Purinergic P1 Receptor Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, compd. with 1,2-ethanediamine (2:1)", "RN": "27Y3KJK423", "RR": "317-34-0 (Aminophylline)", "MS": "A drug combination that contains THEOPHYLLINE and ethylenediamine. It is more soluble in water than theophylline but has similar pharmacologic actions. It's most common use is in bronchial asthma, but it has been investigated for several other applications.", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000628"}, {"RECTYPE": "D", "MH": "Aminopropionitrile", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Aminopropionitrile|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|820330|abbcdeef", "ENTRY": "beta Aminopropionitrile", "MN": "D02.626.151", "FX": "Lathyrism", "MH_TH": "NLM (1964)", "ST": "T130", "N1": "Propanenitrile, 3-amino-", "RN": "151-18-8", "MS": "Reagent used as an intermediate in the manufacture of beta-alanine and pantothenic acid.", "PM": "72", "HN": "72(64)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000629"}, {"RECTYPE": "D", "MH": "Aminopterin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Aminopterin", "MN": "D03.633.100.733.631.192", "PA": "Folic Acid Antagonists", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "L-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)amino)benzoyl)-", "RN": "JYB41CTM2Q", "RR": "FZU1QI13O9", "MS": "A folic acid derivative used as a rodenticide that has been shown to be teratogenic.", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000630"}, {"RECTYPE": "D", "MH": "Aminopyridines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aminopyridine|T109|NON|EQV|NLM (2021)|191120|abcdef", "MN": "D03.383.725.050", "MH_TH": "NLM (1979)", "ST": "T109", "RN": "0", "AN": "= pyridinamines & pyridylamines", "PI": "Pyridines (1966-1978)", "MS": "Pyridines substituted in any position with an amino group. May be hydrogenated but must retain at least one double bond.", "PM": "79; METHAPYRILENE was see under PYRIDINES 1975-78, was see under ANTIHISTAMINICS 1963-74; PHENAZOPYRIDINE & PYRILAMINE were see under PYRIDINES 1975-78", "HN": "79", "MR": "20210630", "DA": "19771208", "DC": "1", "DX": "19790101", "UI": "D000631"}, {"RECTYPE": "D", "MH": "Aminopyrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dipyrine|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Dimethyl N aminoantipyrine", "MN": "D03.383.129.539.850.077", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "3H-Pyrazol-3-one, 4-(dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-", "RN": "01704YP3MO", "RR": "58-15-1 (Aminopyrine)", "AN": "do not confuse entry term DIPYRINE with DIPYRONE", "MS": "A pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of AGRANULOCYTOSIS. A breath test with 13C-labeled aminopyrine has been used as a non-invasive measure of CYTOCHROME P-450 metabolic activity in LIVER FUNCTION TESTS.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000632"}, {"RECTYPE": "D", "MH": "Aminopyrine N-Demethylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "N-Demethylase, Aminopyrine", "MN": "D08.811.682.662.582.276", "MH_TH": "NLM (1972)", "ST": "T126", "RN": "EC 1.5.3.-", "PI": "Oxidoreductases, N-Demethylating", "PM": "74", "HN": "74(72)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000633"}, {"RECTYPE": "D", "MH": "Aminoquinolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.810.050", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Quinolines (1968-1974)", "MS": "Quinolines substituted in any position by one or more amino groups.", "PM": "75", "HN": "75", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D000634"}, {"RECTYPE": "D", "MH": "Aminorex", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aminoxafen|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Menocil|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef", "MN": "D03.383.129.462.050", "MH_TH": "USAN (1963)", "ST": "T121", "N1": "2-Oxazolamine, 4,5-dihydro-5-phenyl-", "RN": "2SH16612I9", "RR": "2207-50-3 (Aminorex)", "PI": "Oxazoles (1968-1974)", "MS": "An amphetamine-like anorectic agent. It may cause pulmonary hypertension.", "PM": "91; was see under OXAZOLES 1975-90", "HN": "91(75); was see under OXAZOLES 1975-90", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000635"}, {"RECTYPE": "D", "MH": "Aminosalicylic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Aminosalicylic", "MN": "D02.455.426.559.389.657.410.595.100", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "AMINOSALICYLIC ACID is also available", "MS": "A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions.", "OL": "use AMINOSALICYLIC ACIDS to search AMINOSALICYLIC ACID 1966-76", "PM": "77; was AMINOSALICYLIC ACID 1963-76", "HN": "77; was AMINOSALICYLIC ACID 1963-76", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D000636"}, {"RECTYPE": "D", "MH": "Transaminases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transaminase|T116|T126|NON|EQV|NLM (2021)|191227|abbcdef", "MN": "D08.811.913.477.700", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 2.6.1.-", "RR": "9031-66-7 (CAS RN)", "MS": "A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1.", "PM": "98; see AMINOTRANSFERASES 1963-97; for TRANSAMINASES see AMINOTRANSFERASES 1974-97", "HN": "98(63)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000637"}, {"RECTYPE": "D", "MH": "Amiodarone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SKF 33134A", "MN": "D03.633.100.127.075", "PA": "Vasodilator Agents", "MH_TH": "USAN (1987)", "ST": "T121", "N1": "Methanone, (2-butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl)-", "RN": "N3RQ532IUT", "RR": "976728SY6Z", "PI": "Iodobenzoates (1973-1974)", "MS": "An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.", "PM": "87; was see under BENZOFURANS 1975-86", "HN": "87(75); was see under BENZOFURANS 1975-86", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D000638"}, {"RECTYPE": "D", "MH": "Amitriptyline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RPh, Amitriptylin", "MN": "D04.615.181.384.100", "PA": "Antidepressive Agents, Tricyclic", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Propanamine, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-", "RN": "1806D8D52K", "RR": "87987-25-5 (phosphate (1:1))", "MS": "Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.", "PM": "64", "HN": "64(63)", "MR": "20170224", "DA": "19991108", "DC": "1", "DX": "19640101", "UI": "D000639"}, {"RECTYPE": "D", "MH": "Amitrole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aminotriazole|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|810512|abbcdeef", "ENTRY": "3-Amino-1,2,4-triazole|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|800730|abbcdeef", "MN": "D03.383.129.799.100", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "1H-1,2,4-Triazol-3-amine", "RN": "ZF80H5GXUF", "RR": "61-82-5 (Amitrole)", "PI": "Triazoles (1966-1971)", "MS": "A non-selective post-emergence, translocated herbicide. According to the Seventh Annual Report on Carcinogens (PB95-109781, 1994) this substance may reasonably be anticipated to be a carcinogen. (From Merck Index, 12th ed) It is an irreversible inhibitor of CATALASE, and thus impairs activity of peroxisomes.", "PM": "91; was see under TRIAZOLES 1972-90", "HN": "91(72); was see under TRIAZOLES 1972-90", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000640"}, {"RECTYPE": "D", "MH": "Ammonia", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D01.625.050", "FX": "Ammonium Hydroxide", "MH_TH": "NLM (1966)", "ST": "T197", "N1": "Ammonia", "RN": "7664-41-7", "MS": "A colorless alkaline gas. It is formed in the body during decomposition of organic materials during a large number of metabolically important reactions. Note that the aqueous form of ammonia is referred to as AMMONIUM HYDROXIDE.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000641"}, {"RECTYPE": "D", "MH": "Ammonia-Lyases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ammonia-Lyase|T116|T126|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Lyase, Ammonia", "MN": "D08.811.520.232.400", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 4.3.1.-", "PI": "Lyases (1966-1972)", "MS": "Enzymes that catalyze the formation of a carbon-carbon double bond by the elimination of AMMONIA. EC 4.3.1.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000642"}, {"RECTYPE": "D", "MH": "Ammonium Chloride", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chloride, Ammonium", "MN": "D01.625.062.249", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Ammonium chloride ((NH4)Cl)", "RN": "01Q9PC255D", "RR": "54450-56-5 ((NH4)HCl2)", "MS": "An acidifying agent that has expectorant and diuretic effects. Also used in etching and batteries and as a flux in electroplating.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000643"}, {"RECTYPE": "D", "MH": "Quaternary Ammonium Compounds", "DE": "QUATERNARY AMMONIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Quaternary Ammonium Compound|T109|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Compound, Quaternary Ammonium", "MN": "D02.675.276", "FX": "Quinolinium Compounds", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Derivatives of ammonium compounds, NH4+ Y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups. These are distinguished from IMINES which are RN=CR2.", "PM": "2006; see AMMONIUM COMPOUNDS 1963-2005", "HN": "2006(1963)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D000644"}, {"RECTYPE": "D", "MH": "Ammonium Sulfate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Ammonium", "MN": "D01.875.800.800.850.050", "MH_TH": "NLM (1971)", "ST": "T197", "N1": "Sulfuric acid diammonium salt", "RN": "SU46BAM238", "RR": "7783-20-2 (Ammonium Sulfate)", "PI": "Ammonium Compounds (1966-1970)", "MS": "Sulfuric acid diammonium salt. It is used in CHEMICAL FRACTIONATION of proteins.", "PM": "74", "HN": "74(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000645"}, {"RECTYPE": "D", "MH": "Ammotherapy", "DE": "AMMOTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Sand Baths|T061|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Sandbath", "MN": "E02.565.020", "MH_TH": "NLM (1986)", "ST": "T061", "MS": "Treatment by application of hot sand.", "PM": "91,63-85; was see under HYPERTHERMIA, INDUCED 1986-90; was heading 1963-85", "HN": "91(86)63; was see under HYPERTHERMIA, INDUCED 1986-90; was heading 1963-85", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000646"}, {"RECTYPE": "D", "MH": "Amnesia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Temporary Amnesias", "MN": "F03.615.200", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "Pathologic partial or complete loss of the ability to recall past experiences (AMNESIA, RETROGRADE) or to form new memories (AMNESIA, ANTEROGRADE). This condition may be of organic or psychologic origin. Organic forms of amnesia are usually associated with dysfunction of the DIENCEPHALON or HIPPOCAMPUS. (From Adams et al., Principles of Neurology, 6th ed, pp426-7)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000647"}, {"RECTYPE": "D", "MH": "Amnesia, Retrograde", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Retrograde Amnesia|T041|T048|NON|EQV|NLM (2000)|991108|abbcdef", "ENTRY": "Retrograde Memory Losses", "MN": "F03.615.200.150", "MH_TH": "NLM (1976)", "ST": "T048", "PI": "Amnesia (1966-1975)", "MS": "Loss of the ability to recall information that had been previously encoded in memory prior to a specified or approximate point in time. This process may be organic or psychogenic in origin. Organic forms may be associated with CRANIOCEREBRAL TRAUMA; CEREBROVASCULAR ACCIDENTS; SEIZURES; DEMENTIA; and a wide variety of other conditions that impair cerebral function. (From Adams et al., Principles of Neurology, 6th ed, pp426-9)", "PM": "1991; was see under AMNESIA 1976-1990", "HN": "1991(1976); was see under AMNESIA 1976-1990", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D000648"}, {"RECTYPE": "D", "MH": "Amniocentesis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Amniocenteses", "MN": "E05.242.384.050", "FX": "Chorionic Villi Sampling", "MH_TH": "POPLINE (1978)", "ST": "T060", "PI": "Punctures (1966-1970)", "MS": "Percutaneous transabdominal puncture of the uterus during pregnancy to obtain amniotic fluid. It is commonly used for fetal karyotype determination in order to diagnose abnormal fetal conditions.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20150707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000649"}, {"RECTYPE": "D", "MH": "Amnion", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Amniotic Membrane|T018|NON|EQV|NLM (2006)|041021|abcdef", "ENTRY": "Membranes, Amniotic", "MN": "A16.254.750.277", "FX": "Fetoscopy", "MH_TH": "NLM (1966)", "ST": "T018", "MS": "The innermost membranous sac that surrounds and protects the developing embryo which is bathed in the AMNIOTIC FLUID. Amnion cells are secretory EPITHELIAL CELLS and contribute to the amniotic fluid.", "MR": "20070711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000650"}, {"RECTYPE": "D", "MH": "Amniotic Band Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Streeter Syndrome|T047|EPO|EQV|UNK (19XX)|820419|abcdef", "ENTRY": "Syndrome, Streeter", "MN": "C16.614.042", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "constriction bands in newborn inf; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "specific anatomic heading/abnormalities (1966-1982)", "MS": "A disorder present in the newborn infant in which constriction rings or bands, causing soft tissue depressions, encircle digits, extremities, or limbs and sometimes the neck, thorax, or abdomen. They may be associated with intrauterine amputations.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19820419", "DC": "1", "DX": "19830101", "UI": "D000652"}, {"RECTYPE": "D", "MH": "Amniotic Fluid", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Amniotic Fluid Index|T081|NON|REL|NLM (2000)|991105|abcdef", "ENTRY": "Indices, Amniotic Fluid", "MN": "A16.378.149", "FX": "Polyhydramnios", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "A clear, yellowish liquid that envelopes the FETUS inside the sac of AMNION. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or substances in this fluid can be removed for prenatal diagnostic tests (AMNIOCENTESIS).", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000653"}, {"RECTYPE": "D", "MH": "Amobarbital", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pentymal|T109|T121|TRD|NRW|UNK (19XX)|761230|abbcdef", "ENTRY": "Sodium, Amobarbital", "MN": "D03.383.742.698.253.077", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-", "RN": "GWH6IJ239E", "RR": "G0313KNC7D", "MS": "A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)", "MR": "20170117", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000654"}, {"RECTYPE": "D", "MH": "Amodiaquine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Amodiaquine", "MN": "D03.633.100.810.050.060", "PA": "Antimalarials", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Phenol, 4-((7-chloro-4-quinolinyl)amino)-2-((diethylamino)methyl)-", "RN": "220236ED28", "RR": "K6PW2S574L", "MS": "A 4-aminoquinoline compound with anti-inflammatory properties.", "PM": "AMODIACHIN was see AMODIAQUINE 1978-95", "HN": "AMODIACHIN was see AMODIAQUINE 1978-95", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D000655"}, {"RECTYPE": "D", "MH": "Amoeba", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Ameba|T204|NON|EQV|UNK (19XX)|740329|abcdef", "MN": "B01.046.500.100.700.089", "FX": "Amebicides", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5774", "MS": "A genus of ameboid protozoa. Characteristics include a vesicular nucleus and the formation of several PSEUDOPODIA, one of which is dominant at a given time. Reproduction occurs asexually by binary fission.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000656"}, {"RECTYPE": "D", "MH": "Amoxapine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CL67,772", "MN": "D03.633.300.347.500.040", "PA": "Selective Serotonin Reuptake Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(1-piperazinyl)-", "RN": "R63VQ857OT", "RR": "14028-44-5 (Amoxapine)", "PI": "Piperazines (1971-1974)", "MS": "The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.", "PM": "91; was see under DIBENZOXAZEPINES 1975-90", "HN": "91(75); was see under DIBENZOXAZEPINES 1975-90", "MR": "20220718", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D000657"}, {"RECTYPE": "D", "MH": "Amoxicillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxyampicillin|T109|T195|NON|NRW|UNK (19XX)|790223|abbcdef", "ENTRY": "BRL2333", "MN": "D03.633.100.300.750.750.050.050", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "RN": "804826J2HU", "RR": "9EM05410Q9", "PI": "Penicillins (1972-1974)", "MS": "A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.", "PM": "80; was see under AMPICILLIN 1975-79", "HN": "80(75); was see under AMPICILLIN 1975-79", "MR": "20181005", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D000658"}, {"RECTYPE": "D", "MH": "AMP Deaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenylate Deaminase|T116|T126|NON|EQV|UNK (19XX)|741114|abbcdef", "ENTRY": "Deaminase, Myoadenylate", "MN": "D08.811.277.151.653.060", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "AMP aminohydrolase", "RN": "EC 3.5.4.6", "PI": "Aminohydrolases (1974)", "MS": "An enzyme that catalyzes the deamination of AMP to IMP. EC 3.5.4.6.", "PM": "91; was see under NUCLEOTIDE DEAMINASES 1975-90", "HN": "91(75); was see under NUCLEOTIDE DEAMINASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000659"}, {"RECTYPE": "D", "MH": "Amphetamine", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "l-Amphetamine|T109|T121|NON|REL|UNK (19XX)|770311|AMPHETAMINE A L|abbcdefs", "ENTRY": "levo Amphetamine", "MN": "D02.092.471.683.152.110", "PA": "Sympathomimetics", "EC": "analogs & derivatives:Amphetamines", "MH_TH": "BAN (19XX)", "ST": "T121", "N1": "Benzeneethanamine, alpha-methyl-, (+-)-", "RN": "CK833KGX7E", "RR": "6DPV8NK46S", "MS": "A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000661"}, {"RECTYPE": "D", "MH": "Amphetamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.092.471.683.152", "FX": "Central Nervous System Stimulants", "MH_TH": "NLM (1976)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics; do not confuse with AMPHETAMINE, a specific chemical", "PI": "Amphetamine (1966-1975)", "MS": "Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20040719", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D000662"}, {"RECTYPE": "D", "MH": "Amphibians", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Amphibia|T011|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Amphibian", "MN": "B01.050.150.900.090", "FX": "Amphibian Proteins", "MH_TH": "NLM (2002)", "ST": "T011", "RN": "txid8292", "AN": "general or unspecified; prefer specific available genera; NIM when experimental animal", "MS": "VERTEBRATES belonging to the class amphibia such as frogs, toads, newts and salamanders that live in a semiaquatic environment.", "PM": "2009; see AMPHIBIA 1963-2008", "HN": "2009 (1963)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D000663"}, {"RECTYPE": "D", "MH": "Amphibian Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE TO TU UR", "PRINT ENTRY": "Toad Venoms|T123|T131|NON|NRW|UNK (19XX)|770418|abbcdef", "ENTRY": "Venoms, Toad", "MN": "D23.946.833.033", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTIVENINS; /enzymol permitted; coord IM with specific amphibian (IM or NIM)", "PI": "Venoms (1966-1977)", "MS": "Venoms produced by frogs, toads, salamanders, etc. The venom glands are usually on the skin of the back and contain cardiotoxic glycosides, cholinolytics, and a number of other bioactive materials, many of which have been characterized. The venoms have been used as arrow poisons and include bufogenin, bufotoxin, bufagin, bufotalin, histrionicotoxins, and pumiliotoxin.", "PM": "78", "HN": "78", "MR": "20050630", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D000664"}, {"RECTYPE": "D", "MH": "Ampholyte Mixtures", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Pharmalytes|T130|TRD|NRW|NLM (2023)|220401|abcdef", "ENTRY": "Ampholytes, Carrier", "MN": "D27.720.470.280.060", "MH_TH": "NLM (1980)", "ST": "T130", "RN": "0", "RR": "70322-21-3", "PI": "Isoelectric Focusing (1970-1979)", "MS": "Such mixtures of amphoteric electrolytes or buffers that provide a continuous range of pH in an electric field; used for separating proteins by their isoelectric points, i.e., by isoelectric focusing.", "PM": "1991(1980); use under BUFFERS 1980-1990; for SERVALYTE use under ELECTROLYTES (1997-2022)", "HN": "1991(1980); see under BUFFERS 1980-1990; for SERVALYTE see under ELECTROLYTES (1997-2022)", "MR": "20220523", "DA": "19790227", "DC": "1", "DX": "19910101", "UI": "D000665"}, {"RECTYPE": "D", "MH": "Amphotericin B", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Fungizone|T109|T195|TRD|NRW|UNK (19XX)|801120|abbcdef", "MN": "D02.540.576.500.500", "PA": "Antiprotozoal Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "14,39-Dioxabicyclo(33.3.1)nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid, 33-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-", "RN": "7XU7A7DROE", "RR": "1397-89-3 (Amphotericin B)", "MS": "Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.", "PM": "98; AMPHOCIL (now AMPHOTERICIN B) was indexed under AMPHOTERICIN B/*analogs & derivatives & CHOLESTEROL ESTERS 1992-97", "HN": "98; for AMPHOCIL use AMPHOTERICIN B (NM) 1992-97", "MR": "20171208", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000666"}, {"RECTYPE": "D", "MH": "Ampicillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Penicillin, Aminobenzyl|T109|T195|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Trihydrate, Ampicillin", "MN": "D03.633.100.300.750.750.050", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))-", "RN": "7C782967RD", "RR": "JFN36L5S8K", "MS": "Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.", "PM": "65", "HN": "65(64)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000667"}, {"RECTYPE": "D", "MH": "Ampicillin Resistance", "AQ": "DE EH GE IM PH RE", "ENTRY": "Resistances, Ampicillin", "MN": "G07.690.773.984.269.347.500.600.050", "MH_TH": "NLM (1988)", "ST": "T032", "PI": "Drug Resistance, Microbial (1966-1987)", "MS": "Nonsusceptibility of a microbe to the action of ampicillin, a penicillin derivative that interferes with cell wall synthesis.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19870509", "DC": "1", "DX": "19880101", "UI": "D000668"}, {"RECTYPE": "D", "MH": "Amplifiers, Electronic", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Electronic Amplifiers", "MN": "E07.305.061", "MH_TH": "NLM (2009)", "ST": "T073", "MS": "Electronic devices that increase the magnitude of a signal's power level or current.", "PM": "2009; see AMPLIFIERS 1967-2008", "HN": "2009 (1967)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000669"}, {"RECTYPE": "D", "MH": "Amprolium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "No\u00e9 Socopharm Hydrochloride", "MN": "D03.383.725.676.152", "PA": "Coccidiostats", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "H2T307KMZR", "RR": "95CO6N199Q", "PI": "Picolines (1966-1971)", "MS": "A veterinary coccidiostat that interferes with THIAMINE metabolism.", "OL": "use AMPROLIUM to search AMPROL 1975-81", "PM": "91; was see under PICOLINES 1981-90; was AMPROL see under PICOLINES 1979-80 & see under PICOLINE/analogs & derivatives 1975-78", "HN": "91(81); was see under PICOLINES 1981-90; was AMPROL see under PICOLINES 1979-80 & see under PICOLINE/analogs & derivatives 1975-78", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000670"}, {"RECTYPE": "D", "MH": "Amputation, Surgical", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Amputation Procedures|T061|NON|EQV|NLM (2023)|211014|abcdef", "ENTRY": "Surgical Multiple Amputations", "MN": "E04.555.080", "MH_TH": "NLM (2023)", "ST": "T061", "AN": "a surgical procedure: do not confuse with AMPUTATION, TRAUMATIC OR MULTIPLE AMPUTATION, TRAUMATIC", "MS": "The surgical removal of part of, or all of, a limb or other appendage or outgrowth of the body.", "PM": "2023; see AMPUTATION 1966-2022", "HN": "2023 (1966)", "CATSH": "CAT LIST", "MR": "20220408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000671"}, {"RECTYPE": "D", "MH": "Amputation Stumps", "AQ": "AH BS DG IN IR MI PA PP PS RE SU VE VI", "ENTRY": "Stumps, Amputation", "MN": "A01.378.100", "FX": "Phantom Limb", "MH_TH": "NLM (1966)", "ST": "T020", "MS": "The part of a limb or tail following AMPUTATION, SURGICAL that is proximal to the amputated section.", "CATSH": "CAT LIST", "MR": "20220715", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000672"}, {"RECTYPE": "D", "MH": "Amputation, Traumatic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Traumatic Amputations", "MN": "C26.062", "FX": "Replantation", "MH_TH": "NLM (1972)", "ST": "T037", "AN": "by accident or injury: do not confuse with AMPUTATION (see AMPUTATION, SURGICAL), a surgical procedure; /surg: consider also REPLANTATION", "PI": "Amputation (1966-1971)", "MS": "Loss of a limb or other bodily appendage by accidental injury.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000673"}, {"RECTYPE": "D", "MH": "Amputees", "AQ": "CL ED HI LJ PX RH SN", "PRINT ENTRY": "Multiple Amputees|T101|NON|NRW|NLM (2023)|211014|abcdef", "ENTRY": "Amputees, Multiple", "MN": "M01.150.100", "MH_TH": "NLM (1966)", "ST": "T101", "AN": "do not coord ARM (NIM) or LEG (NIM) unless specifically relevant", "MS": "Persons who have lost part of, or all of, a limb or other appendage of their body.", "MR": "20220408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000674"}, {"RECTYPE": "D", "MH": "Ampyrone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aminoantipyrine|T109|T121|T130|NON|EQV|UNK (19XX)|790430|abbbcdef", "ENTRY": "4 Aminophenazone", "MN": "D03.383.129.539.850.077.025", "PA": "Indicators and Reagents", "MH_TH": "NLM (1980)", "ST": "T130", "N1": "3H-Pyrazol-3-one, 4-amino-1,2-dihydro-1,5-dimethyl-2-phenyl-", "RN": "0M0B7474RA", "RR": "83-07-8 (Ampyrone)", "AN": "an analgesic & non-steroidal anti-inflamm agent", "PI": "Antipyrine (1966-1974) /analogs & derivatives (1975-1979)", "MS": "A metabolite of AMINOPYRINE with analgesic and anti-inflammatory properties. It is used as a reagent for biochemical reactions producing peroxides or phenols. Ampyrone stimulates LIVER MICROSOMES and is also used to measure extracellular water.", "PM": "91; was see under ANTIPYRINE 1980-90", "HN": "91(80); was see under ANTIPYRINE 1980-90", "MR": "20160527", "DA": "19790430", "DC": "1", "DX": "19910101", "UI": "D000675"}, {"RECTYPE": "D", "MH": "Amrinone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Win40680", "MN": "D03.383.725.050.085", "PA": "Vasodilator Agents", "MH_TH": "USAN (1977)", "ST": "T121", "N1": "(3,4'-Bipyridin)-6(1H)-one, 5-amino-", "RN": "JUT23379TN", "RR": "60719-84-8 (Amrinone)", "PI": "Pyridines (1966-1978)", "MS": "A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.", "PM": "87", "HN": "87", "MR": "20170524", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D000676"}, {"RECTYPE": "D", "MH": "Amsacrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "m-AMSA|T109|T121|ABB|EQV|UNK (19XX)|860603|AMSA M|abbcdefs", "ENTRY": "meta AMSA", "MN": "D03.633.300.046.250.225", "PA": "Intercalating Agents", "MH_TH": "USAN (1980)", "ST": "T121", "N1": "Methanesulfonamide, N-(4-(9-acridinylamino)-3-methoxyphenyl)-", "RN": "00DPD30SOY", "RR": "51264-14-3", "PI": "Aminoacridines (1980-1986)", "MS": "An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.", "PM": "87", "HN": "87", "MR": "20160527", "DA": "19860603", "DC": "1", "DX": "19870101", "UI": "D000677"}, {"RECTYPE": "D", "MH": "Amygdalin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitamin B17|T109|T121|ABX|EQV|NLM (2022)|200827|abbcdef", "ENTRY": "Mandelonitrile beta Gentiobioside", "MN": "D09.408.348.050", "PA": "Antineoplastic Agents, Phytogenic", "MH_TH": "NLM (1976)", "ST": "T121", "N1": "Benzeneacetonitrile, alpha-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-, (R)-", "RN": "214UUQ9N0H", "RR": "29883-15-6 (Amygdalin)", "AN": "/biosyn permitted if by plant", "PI": "Nitriles (1968-1975)", "MS": "A cyanogenic glycoside found in the seeds of Rosaceae.", "OL": "use AMYGDALIN to search LAETRILE 1975-78", "PM": "79; was see under NITRILES 1976-78; LAETRILE was see AMYGDALIN 1979-95, see under NITRILES 1975-78;", "HN": "79(76); was see under NITRILES 1976-78; LAETRILE was see AMYGDALIN 1979-95, see under NITRILES 1975-78", "MR": "20200925", "DA": "19750723", "DC": "1", "DX": "19790101", "UI": "D000678"}, {"RECTYPE": "D", "MH": "Amygdala", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Amygdaloid Body|T023|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Nucleus, Intercalated Amygdaloid", "MN": "A08.186.211.200.885.287.249.152", "MH_TH": "UNK (19XX)", "ST": "T023", "MS": "Almond-shaped group of basal nuclei anterior to the INFERIOR HORN OF THE LATERAL VENTRICLE of the TEMPORAL LOBE. The amygdala is part of the limbic system.", "PM": "2000; see AMYGDALOID BODY 1966-1996; for AMYGDALA see AMYGDALOID BODY 1979-1999", "HN": "2000(1966)", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000679"}, {"RECTYPE": "D", "MH": "Amyl Nitrite", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nitrite, Amyl", "MN": "D02.633.025", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "8017-89-8", "MS": "A vasodilator that is administered by inhalation. It is also used recreationally due to its supposed ability to induce euphoria and act as an aphrodisiac.", "MR": "20000621", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000680"}, {"RECTYPE": "D", "MH": "Amylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Diastase|T116|T126|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Amylase|T116|T126|NON|EQV|UNK (19XX)|770127|abbcdef", "MN": "D08.811.277.450.066", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.2.1.-", "AN": "amylase isoenzymes: index under AMYLASES + ISOENZYMES, not ISOAMYLASE; amylases/blood: consider HYPERAMYLASEMIA", "MS": "A group of amylolytic enzymes that cleave starch, glycogen, and related alpha-1,4-glucans. (Stedman, 25th ed) EC 3.2.1.-.", "OL": "use AMYLASES to search AMYLASE 1966-77", "PM": "78; was AMYLASE 1963-77", "HN": "78; was AMYLASE 1963-77", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D000681"}, {"RECTYPE": "D", "MH": "Amyloid", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Amyloid Fibril|T116|T123|NON|NRW|NLM (2021)|200106|abbcdef", "ENTRY": "Substance, Amyloid", "MN": "D12.776.049", "FX": "Amyloidosis", "MH_TH": "NLM (1968)", "ST": "T123", "RN": "0", "AN": "PLAQUE, AMYLOID is also available", "MS": "A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease.", "OL": "use AMYLOID to search AMYLOID SUBSTANCE 1966-67 (as Cat C heading)", "PM": "68; was AMYLOID SUBSTANCE 1963-67", "HN": "68; was AMYLOID SUBSTANCE 1963-67 (Cat C heading only 1966-67, Cat A heading only 1963-64)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000682"}, {"RECTYPE": "D", "MH": "Serum Amyloid P-Component", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Amyloid P Component|T116|T123|NON|EQV|NLM (1987)|990101|abbcdef", "ENTRY": "Serum Amyloid P Component", "MN": "D12.776.395.690", "MH_TH": "UNK (19XX)", "ST": "T123", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Amyloid (1966-1986)", "MS": "Amyloid P component is a small, non-fibrillar glycoprotein found in normal serum and in all amyloid deposits. It has a pentagonal (pentaxin) structure. It is an acute phase protein, modulates immunologic responses, inhibits ELASTASE, and has been suggested as an indicator of LIVER DISEASE.", "PM": "87", "HN": "87", "MR": "20230316", "DA": "19860414", "DC": "1", "DX": "19870101", "UI": "D000683"}, {"RECTYPE": "D", "MH": "Serum Amyloid A Protein", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serum A Related Protein|T116|T129|NON|EQV|UNK (19XX)|780516|SERUM A RELAT PROTEIN|abbcdefv", "ENTRY": "Amyloid A Protein Related Serum Component", "MN": "D12.776.124.050.725", "MH_TH": "NLM (2005)", "ST": "T129", "RN": "0", "PI": "Blood Proteins (1966-1978)", "MS": "An ACUTE PHASE REACTION protein present in low concentrations in normal sera, but found at higher concentrations in sera of older persons and in patients with AMYLOIDOSIS. It is the circulating precusor of amyloid A protein, which is found deposited in AA type AMYLOID FIBRILS.", "PM": "2005; see AMYLOID PROTEIN SAA 1987-2004; see AMYLOID 1979-1986; for AMYLOID PROTEIN AA see AMYLOID PROTEIN AA 1988-2004; AMYLOID PROTEIN AA PRECURSOR was indexed under AMYLOID PROTEIN AA & APOLIPOPROTEINS 1996-2004", "HN": "2005(1979)", "MR": "20130709", "DA": "19780516", "DC": "1", "DX": "19870101", "UI": "D000685"}, {"RECTYPE": "D", "MH": "Amyloidosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Amyloidoses", "MN": "C18.452.845.500", "FX": "Paraproteinemias", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coord IM with organ/dis precoord (IM); /genet: consider also AMYLOIDOSIS, HEREDITARY", "MS": "A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000686"}, {"RECTYPE": "D", "MH": "Amylopectin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D09.698.365.855.194", "MH_TH": "NLM (1974)", "ST": "T123", "N1": "Amylopectin", "RN": "9037-22-3", "MS": "A highly branched glucan in starch.", "PM": "74", "HN": "74", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000687"}, {"RECTYPE": "D", "MH": "Amylose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D09.698.365.855.361", "MH_TH": "NLM (1974)", "ST": "T109", "N1": "Amylose", "RN": "9005-82-7", "MS": "An unbranched glucan in starch.", "PM": "74", "HN": "74", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000688"}, {"RECTYPE": "D", "MH": "Amyotrophic Lateral Sclerosis", "DE": "ALS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Motor Neuron Disease, Amyotrophic Lateral Sclerosis|T047|NON|EQV|GHR (2014)|NLM (2000)|991108|MOTOR NEURON DIS AMYOTROPHIC LATERAL SCLEROSIS|abcdeefv", "ENTRY": "Sclerosis, Amyotrophic Lateral", "MN": "C18.452.845.800.050", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)", "CATSH": "CAT LIST", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000690"}, {"RECTYPE": "D", "MH": "Anabasine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neonicotine|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "MN": "D03.383.621.050", "PA": "Insecticides", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Pyridine, 3-(2-piperidinyl)-, (S)-", "RN": "LMS11II2LO", "RR": "494-52-0 (Anabasine)", "PI": "Pyridines (1973-1974)", "MS": "A piperidine botanical insecticide.", "PM": "91; was see under PIPERIDINES 1975-90", "HN": "91(75); was see under PIPERIDINES 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000691"}, {"RECTYPE": "D", "MH": "Anaerobiosis", "AQ": "DE GE IM PH RE", "ENTRY": "Metabolisms, Anaerobic", "MN": "G03.078", "MH_TH": "NLM (1971)", "ST": "T040", "AN": "almost never IM", "PI": "Oxygen (1966-1970)", "MS": "The complete absence, or (loosely) the paucity, of gaseous or dissolved elemental oxygen in a given place or environment. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)", "PM": "91; was see under METABOLISM 1971-90", "HN": "91(71); was see under METABOLISM 1971-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000693"}, {"RECTYPE": "D", "MH": "Anal Gland Neoplasms", "DE": "ANAL GLAND NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "PRINT ENTRY": "Perianal Gland Neoplasms|T191|NON|EQV|UNK (19XX)|740329|PERIANAL GLAND NEOPL|abcdefv", "ENTRY": "Perianal Gland Neoplasm", "MN": "C22.073", "MH_TH": "NLM (1968)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM); do not confuse with ANUS NEOPLASMS; coord with ANAL SACS for anal sac neoplasms; don't forget check tag ANIMALS", "PI": "Anus Neoplasms (1966-1967)", "MS": "Tumors or cancer of the anal gland.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000694"}, {"RECTYPE": "D", "MH": "Anal Sacs", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Anal Sac", "MN": "A13.073", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "for neopl, coord with ANAL GLAND NEOPLASMS", "PI": "Carnivora (1966-1967)", "MS": "A pair of anal glands or sacs, located on either side of the ANUS, that produce and store a dark, foul-smelling fluid in carnivorous animals such as MEPHITIDAE and DOGS. The expelled fluid is used as a defensive repellent (in skunks) or a material to mark territory (in dogs).", "PM": "68", "HN": "68", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000695"}, {"RECTYPE": "D", "MH": "Central Nervous System Stimulants", "DE": "CNS STIMULANTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Central Stimulant|T121|NON|EQV|NLM (2022)|201014|abcdef", "ENTRY": "Stimulants, Central", "MN": "D27.505.954.427.220", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.", "OL": "use CENTRAL NERVOUS SYSTEM STIMULANTS to search ANALEPTICS 1966-94", "PM": "95; was ANALEPTICS 1963-94; CENTRAL NERVOUS SYSTEM STIMULANTS was see ANALEPTICS 1985-94", "HN": "95; was ANALEPTICS 1963-94; CENTRAL NERVOUS SYSTEM STIMULANTS was see ANALEPTICS 1985-94", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19950101", "UI": "D000697"}, {"RECTYPE": "D", "MH": "Analgesia", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Analgesias", "MN": "E03.091", "FX": "Pain", "MH_TH": "POPLINE (1978)", "ST": "T061", "MS": "Methods of PAIN relief that may be used with or in place of ANALGESICS.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000698"}, {"RECTYPE": "D", "MH": "Pain Insensitivity, Congenital", "DE": "PAIN INSENSITIVITY CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pain Indifference, Congenital|T047|NON|EQV|NLM (2000)|991108|PAIN INDIFFERENCE CONGEN|abcdefv", "ENTRY": "Congenital Pain Indifferences", "MN": "C16.320.775", "FX": "Pain", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "A syndrome characterized by indifference to PAIN despite the ability to distinguish noxious from non-noxious stimuli. Absent corneal reflexes and INTELLECTUAL DISABILITY may be associated. Familial forms with autosomal recessive and autosomal dominant patterns of inheritance have been described. (Adams et al., Principles of Neurology, 6th ed, p1343)", "OL": "use PAIN INSENSITIVITY, CONGENITAL to search ANALGESIA, CONGENITAL 1966-95 (as Prov 1966-72)", "PM": "96; was ANALGESIA, CONGENITAL 1973-95; PAIN INSENSITIVITY, CONGENITAL was see ANALGESIA, CONGENITAL 1973-95", "HN": "96; was ANALGESIA, CONGENITAL 1964-95 (Prov 1964-72); PAIN INSENSITIVITY, CONGENITAL was see ANALGESIA, CONGENITAL 1973-95", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000699"}, {"RECTYPE": "D", "MH": "Analgesics", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antinociceptive Agents|T123|NON|REL|UNK (19XX)|770421|abcdef", "ENTRY": "Drugs, Analgesic", "MN": "D27.505.954.427.040", "FX": "Pain", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specific groups", "MS": "Compounds capable of relieving pain without the loss of CONSCIOUSNESS.", "OL": "use ANALGESICS to search ANALGESICS AND ANTIPYRETICS 1966-77", "PM": "78; ANALGESICS AND ANTIPYRETICS was heading 1963-77", "HN": "78; ANALGESICS AND ANTIPYRETICS was heading 1963-77", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000700"}, {"RECTYPE": "D", "MH": "Analgesics, Opioid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Opioids|T121|T131|NON|NRW|NLM (1993)|920502|abbcdef", "ENTRY": "Partial Agonists, Opioid", "MN": "D27.505.954.427.210.600.500", "FX": "Opioid-Related Disorders", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Analgesics (1966-1974)", "MS": "Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.", "OL": "use ANALGESICS, OPIOID to search ANALGESICS, ADDICTIVE 1975-94", "PM": "95; was ANALGESICS, ADDICTIVE 1975-94", "HN": "95; was ANALGESICS, ADDICTIVE 1975-94", "MR": "20200409", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D000701"}, {"RECTYPE": "D", "MH": "Analog-Digital Conversion", "ENTRY": "Conversions, Analogue-Digital", "MN": "L01.224.230.260.280.080", "FX": "Digital Technology", "MH_TH": "NLM (1964)", "ST": "T066", "MS": "The process of converting analog data to discrete, digital form.", "PM": "73", "HN": "73(64)", "MR": "20200722", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000703"}, {"RECTYPE": "D", "MH": "Analysis of Variance", "DE": "ANAL VARIANCE", "PRINT ENTRY": "ANOVA|T081|ABB|EQV|NLM (1990)|890509|abcdef", "ENTRY": "Variance Analyses", "MN": "N06.850.520.830.150", "MH_TH": "NLM (1968)", "ST": "T081", "AN": "usually NIM", "PI": "Statistics (1966-1967)", "MS": "A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.", "PM": "74", "HN": "74(68)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000704"}, {"RECTYPE": "D", "MH": "Anaphase", "AQ": "DE GE IM PH RE", "ENTRY": "Anaphases", "MN": "G05.113.220.781.050", "MH_TH": "NLM (1978)", "ST": "T079", "AN": "coordinate with specific cell /cytol; permitted with microorganisms", "PI": "Mitosis (1968-1977)", "MS": "The phase of cell nucleus division following METAPHASE, in which the CHROMATIDS separate and migrate to opposite poles of the spindle.", "PM": "81; was see under CELL CYCLE 1978-80", "HN": "81(78); was see under CELL CYCLE 1978-80", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19770510", "DC": "1", "DX": "19810101", "UI": "D000705"}, {"RECTYPE": "D", "MH": "Anaphylatoxins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Anaphylatoxin|T116|T123|T131|NON|EQV|NLM (1990)|890418|abbbcdef", "MN": "D12.776.124.486.274.024", "PA": "Immunologic Factors", "MH_TH": "NLM (1977)", "ST": "T131", "RN": "0", "PI": "specific complement (1975-1976)", "MS": "Serum peptides derived from certain cleaved COMPLEMENT PROTEINS during COMPLEMENT ACTIVATION. They induce smooth MUSCLE CONTRACTION; mast cell HISTAMINE RELEASE; PLATELET AGGREGATION; and act as mediators of the local inflammatory process. The order of anaphylatoxin activity from the strongest to the weakest is C5a, C3a, C4a, and C5a des-arginine.", "PM": "90; was see under PEPTIDES 1977-89", "HN": "90(77); was see under PEPTIDES 1977-89", "MR": "20180702", "DA": "19760519", "DC": "1", "DX": "19900101", "UI": "D000706"}, {"RECTYPE": "D", "MH": "Anaphylaxis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Shock, Anaphylactic|T047|NON|REL|UNK (19XX)|740329|abcdef", "ENTRY": "Shock, Anaphylactoid", "MN": "C20.543.480.099", "FX": "SRS-A", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.", "CATSH": "CAT LIST", "MR": "20200110", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000707"}, {"RECTYPE": "D", "MH": "Anaplasia", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Anaplasias", "MN": "C23.550.727.045", "MH_TH": "NLM (1977)", "ST": "T191", "AN": "IM GEN only; coord NIM with organ /pathol (IM); note CARCINOMA, ANAPLASTIC see CARCINOMA: do not coord with ANAPLASIA unless anaplasia is particularly discussed", "MS": "Loss of structural differentiation and useful function of neoplastic cells.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D000708"}, {"RECTYPE": "D", "MH": "Anaplasma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.500.050", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid768", "MS": "A genus of gram-negative bacteria whose organisms are obligate parasites of vertebrates. Species are transmitted by arthropod vectors with the host range limited to ruminants. Anaplasma marginale is the most pathogenic species and is the causative agent of severe bovine anaplasmosis.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000709"}, {"RECTYPE": "D", "MH": "Anaplasmataceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Ehrlichieae|T007|NON|EQV|NLM (1992)|990101|abcdef", "MN": "B03.660.050.783.500", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid942", "PI": "Bacteria (1966-1974)", "MS": "A family of bacteria in the order RICKETTSIALES which inhabit RED BLOOD CELLS and other types of cells, causing disease in both animals and humans.", "PM": "1975", "HN": "1975", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D000710"}, {"RECTYPE": "D", "MH": "Anaplasmataceae Infections", "DE": "ANAPLASMATACEAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Haemobartonellosis|T047|NON|NRW|UNK (19XX)|790104|abcdef", "ENTRY": "Infection, Anaplasmataceae", "MN": "C01.150.252.400.054", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "rickettsial infect", "PI": "Rickettsial Infections (1975-1976)", "MS": "Infections with bacteria of the family ANAPLASMATACEAE.", "OL": "use ANAPLASMATACEAE INFECTIONS to search HAEMOBARTONELLOSIS 1977-79", "PM": "77; HAEMOBARTONELLOSIS was heading 1977-79", "HN": "77; HAEMOBARTONELLOSIS was heading 1977-79", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D000711"}, {"RECTYPE": "D", "MH": "Anaplasmosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Infections, Anaplasma", "MN": "C22.085", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "usually animal", "MS": "A disease usually in cattle caused by parasitization of the red blood cells by bacteria of the genus ANAPLASMA.", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000712"}, {"RECTYPE": "D", "MH": "Anastomosis, Roux-en-Y", "DE": "ROUX EN Y", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Roux-en-Y Loop|T061|NON|EQV|UNK (19XX)|870318|abcdef", "ENTRY": "Roux-en-Y Loops", "MN": "E04.210.070", "MH_TH": "NLM (1988)", "ST": "T061", "AN": "coordinate with specific organ /surg; do not routinely add as a coordinate with GASTRIC BYPASS", "PI": "specific digestive system organ or disease/surgery (1966-1987)", "MS": "A Y-shaped surgical anastomosis of any part of the digestive system which includes the small intestine as the eventual drainage site.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19870318", "DC": "1", "DX": "19880101", "UI": "D000713"}, {"RECTYPE": "D", "MH": "Anastomosis, Surgical", "DE": "ANASTOMOSIS SURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Anastomosis|T061|NON|EQV|UNK (19XX)|870316|SURG ANASTOMOSIS|abcdefv", "ENTRY": "Surgical Anastomoses", "MN": "E04.035", "FX": "Anastomotic Leak", "MH_TH": "NLM (1988)", "ST": "T061", "AN": "coordinate NIM with specific organ /surg", "PI": "specific surgical technique (1966-1987)", "MS": "Surgical union or shunt between ducts, tubes or vessels. It may be end-to-end, end-to-side, side-to-end, or side-to-side.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19870316", "DC": "1", "DX": "19880101", "UI": "D000714"}, {"RECTYPE": "D", "MH": "Anatomy", "DE": "ANAT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Anatomies", "MN": "H01.158.100", "FX": "Dissection", "MH_TH": "NLM (1984)", "ST": "T091", "AN": "the discipline only (education, history, etc); for anatomical structures, use the qualifier / anat with specific anatomical terms or organisms", "MS": "A branch of biology dealing with the structure of organisms.", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000715"}, {"RECTYPE": "D", "MH": "Anatomy, Artistic", "DE": "ANAT ARTISTIC", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Artistic Anatomies", "MN": "K01.093.410.100", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "use for the discipline (education, history, etc) only; anatomical atlases go under ATLASES AS TOPIC (IM) + ANATOMY, ARTISTIC (IM)", "MS": "The study of the structures of organisms for applications in art: drawing, painting, sculpture, illustration, etc.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000716"}, {"RECTYPE": "D", "MH": "Anatomy, Comparative", "DE": "ANAT COMPARATIVE", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Comparative Anatomies", "MN": "H01.158.100.154", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "The comparative study of animal structure with regard to homologous organs or parts. (Stedman, 25th ed)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000717"}, {"RECTYPE": "D", "MH": "Anatomy, Regional", "DE": "ANAT REGIONAL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Regional Anatomies", "MN": "H01.158.100.216", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "the discipline only (education, history, etc); for anatomical structures, use the qualifier / anat with specific organ or organism", "MS": "The anatomical study of specific regions or parts of organisms, emphasizing the relationship between the various structures (e.g. muscles, nerves, skeletal, cardiovascular, etc.).", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000718"}, {"RECTYPE": "D", "MH": "Anatomy, Veterinary", "DE": "ANAT VET", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Veterinary Anatomy|T091|NON|EQV|NLM (1990)|890501|VET ANAT|abcdefv", "ENTRY": "Veterinary Anatomies", "MN": "H01.158.100.279", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use for the discipline (education, history, etc) only", "MS": "The study of the anatomical structures of animals.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000719"}, {"RECTYPE": "D", "MH": "Ancillary Services, Hospital", "DE": "ANCILLARY SERV HOSP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Services, Hospital Ancillary|T058|NON|EQV|NLM (1996)|940811|SERV HOSP ANCILLARY|abcdefv", "ENTRY": "Service, Hospital Ancillary", "MN": "N04.452.442.452.060", "MH_TH": "NLM (1984)", "ST": "T058", "MS": "Those support services other than room, board, and medical and nursing services that are provided to hospital patients in the course of care. They include such services as laboratory, radiology, pharmacy, and physical therapy services.", "PM": "91; was see under HOSPITAL ADMINISTRATION 1984-90", "HN": "91(84); was see under HOSPITAL ADMINISTRATION 1984-90", "MR": "20190709", "DA": "19830610", "DC": "1", "DX": "19910101", "UI": "D000720"}, {"RECTYPE": "D", "MH": "Ancrod", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Agkistrodon rhodostoma Venom Protease|T116|T121|T126|NON|EQV|NLM (1991)|900320|abbbcdef", "ENTRY": "Arvin IRC50", "MN": "D23.946.833.850.960.200.050", "PA": "Fibrinolytic Agents", "MH_TH": "USAN (1975)", "ST": "T126", "RN": "EC 3.4.21.-", "RR": "9046-56-4 (CAS RN)", "PI": "Venoms (1972-1974)", "MS": "An enzyme fraction from the venom of the Malayan pit viper, Agkistrodon rhodostoma. It catalyzes the hydrolysis of a number of amino acid esters and a limited proteolysis of fibrinogen. It is used clinically to produce controlled defibrination in patients requiring anticoagulant therapy. EC 3.4.21.-.", "OL": "use ANCROD to search ARVIN 1975-77", "PM": "78; was ARVIN see under PEPTIDE PEPTIDOHYDROLASES 1975-77; ARVIN was see ANCROD 1978-95", "HN": "78; was ARVIN see under ENDOPEPTIDASES 1975-77; ARVIN was see ANCROD 1978-95", "MR": "20160705", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D000721"}, {"RECTYPE": "D", "MH": "Ancylostoma", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Hookworm, Old World|T204|NON|NRW|UNK (19XX)|780127|abcdef", "ENTRY": "Old World Hookworms", "MN": "B01.050.500.500.294.400.968.100.100", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid29169", "RR": "txid51022", "MS": "A genus of nematode intestinal parasites that consists of several species. A. duodenale is the common hookworm in humans. A. braziliense, A. ceylonicum, and A. caninum occur primarily in cats and dogs, but all have been known to occur in humans.", "OL": "use ANCYLOSTOMA to search UNCINARIA DUODENALE 1979-92", "PM": "ANCYLOSTOMA DUODENALE was UNCINARIA DUODENALE 1979-92", "HN": "ANCYLOSTOMA DUODENALE was UNCINARIA DUODENALE 1979-92", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D000722"}, {"RECTYPE": "D", "MH": "Ancylostomatoidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Uncinaria stenocephala|T204|NON|NRW|UNK (19XX)|780127|abcdef", "ENTRY": "stenocephalas, Uncinaria", "MN": "B01.050.500.500.294.400.968.100", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid2572558", "RR": "txid66064", "MS": "A superfamily of nematode parasitic hookworms consisting of four genera: ANCYLOSTOMA; NECATOR; Bunostomum; and Uncinaria. ANCYLOSTOMA and NECATOR occur in humans and other mammals. Bunostomum is common in ruminants and Uncinaria in wolves, foxes, and dogs.", "OL": "use ANCYLOSTOMATOIDEA to search HOOKWORMS 1966-85", "PM": "86; was HOOKWORMS 1963-85", "HN": "86; was HOOKWORMS 1963-85", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D000723"}, {"RECTYPE": "D", "MH": "Ancylostomiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Ancylostomiases", "MN": "C01.610.335.508.700.775.455.154", "MH_TH": "NLM (1968)", "ST": "T047", "PI": "Hookworm Infections (1966-1967)", "MS": "Infection of humans or animals with hookworms of the genus ANCYLOSTOMA. Characteristics include anemia, dyspepsia, eosinophilia, and abdominal swelling.", "OL": "search HOOKWORM INFECTIONS 1966-67", "PM": "68; was see under HOOKWORM INFECTION 1963-67", "HN": "68; was see under HOOKWORM INFECTION 1963-67", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000724"}, {"RECTYPE": "D", "MH": "Andorra", "AQ": "EH EP", "MN": "Z01.542.049", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "a country lying between France & Spain", "MS": "A principality in the Pyrenees between France and Spain. Its capital is also called Andorra. (From Webster's New Geographical Dictionary, 1988, p50)", "MR": "19950217", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000725"}, {"RECTYPE": "D", "MH": "Androgen Antagonists", "DE": "ANDROGEN ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiandrogens|T121|NON|EQV|UNK (19XX)|770517|abcdef", "ENTRY": "Effects, Antiandrogen", "MN": "D27.505.696.399.450.065", "MH_TH": "NLM (1978)", "ST": "T121", "RN": "0", "AN": "note entry term ANTI-ANDROGEN EFFECT: use only for the antiandrogen effect of a chemical substance", "PI": "specific androgen (1966-1977)", "MS": "Compounds which inhibit or antagonize the biosynthesis or actions of androgens.", "PM": "78", "HN": "78", "MR": "20200527", "DA": "19770517", "DC": "1", "DX": "19780101", "UI": "D000726"}, {"RECTYPE": "D", "MH": "Androgen-Binding Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, Androgen-Binding", "MN": "D12.776.157.065", "FX": "Sex Hormone-Binding Globulin", "MH_TH": "NLM (1980)", "ST": "T123", "RN": "0", "PI": "Receptors, Endogenous Substances (1973-1976)", "MS": "Carrier proteins produced in the Sertoli cells of the testis, secreted into the seminiferous tubules, and transported via the efferent ducts to the epididymis. They participate in the transport of androgens. Androgen-binding protein has the same amino acid sequence as SEX HORMONE-BINDING GLOBULIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications.", "PM": "2000; see ANDROGEN-BINDING PROTEINS 1986-1999, see CARRIER PROTEINS 1980-85", "HN": "2000(1980)", "MR": "20050729", "DA": "19790523", "DC": "1", "DX": "19860101", "UI": "D000727"}, {"RECTYPE": "D", "MH": "Androgens", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Androgen Receptor Agonist|T121|T125|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Receptor Agonists, Androgen", "MN": "D27.505.696.399.472.161", "FX": "Receptors, Androgen", "EC": "antagonists & inhibitors:Androgen Antagonists", "MH_TH": "NLM (1963)", "ST": "T125", "RN": "0", "AN": "deficiency: consider also HYPOGONADISM & other gonadal disorders; note entry term ANDROGEN EFFECT: use only for the androgen effect of a chemical substance", "MS": "Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.", "PM": "1963", "HN": "1963", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000728"}, {"RECTYPE": "D", "MH": "Androstadienes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.054.079.129", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "Derivatives of the steroid androstane having two double bonds at any site in any of the rings.", "OL": "search ANDROSTENES 1973-74", "PM": "75; was see under ANDROSTENES 1973-74", "HN": "75; was see under ANDROSTENES 1973-74", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D000730"}, {"RECTYPE": "D", "MH": "Androstanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.054", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "do not confuse with ANDROSTENES", "MS": "The family of steroids from which the androgens are derived.", "PM": "68", "HN": "68", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000731"}, {"RECTYPE": "D", "MH": "Androstanols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxyandrostanes|T109|NON|EQV|UNK (19XX)|790523|abcdef", "MN": "D04.210.500.054.040", "MH_TH": "NLM (1980)", "ST": "T109", "RN": "0", "AN": "do not confuse with ANDROSTENOLS", "PI": "Steroids (1966-1967)", "MS": "Androstanes and androstane derivatives which are substituted in any position with one or more hydroxyl groups.", "PM": "80", "HN": "80", "MR": "20160527", "DA": "19790523", "DC": "1", "DX": "19800101", "UI": "D000732"}, {"RECTYPE": "D", "MH": "Androstatrienes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.054.079.229", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "Derivatives of the steroid androstane having three double bonds at any site in any of the rings.", "OL": "search ANDROSTENES 1973-74", "PM": "75; was see under ANDROSTENES 1973-74", "HN": "75; was see under ANDROSTENES 1973-74", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D000733"}, {"RECTYPE": "D", "MH": "Androstenediols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.054.079.429.154", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with ANDROSTANE-3,17-DIOL", "PI": "Androstenols (1974)", "MS": "Unsaturated androstane derivatives which are substituted with two hydroxy groups in any position in the ring system.", "OL": "search ANDROSTENOLS 1974 & ANDROSTENES 1973", "PM": "75; was see under ANDROSTENOLS 1974; was see under ANDROSTENES 1973", "HN": "75; was see under ANDROSTENOLS 1974; was see under ANDROSTENES 1973", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D000734"}, {"RECTYPE": "D", "MH": "Androstenedione", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "delta 4 Androstenedione", "MN": "D06.472.334.851.968.875", "MH_TH": "NLM (1974)", "ST": "T125", "N1": "Androst-4-ene-3,17-dione", "RN": "409J2J96VR", "RR": "63-05-8 (Androstenedione)", "MS": "A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL.", "PM": "74", "HN": "74(73)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000735"}, {"RECTYPE": "D", "MH": "Androstenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.054.079", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "AN": "do not confuse with ANDROSTANES", "PI": "Androstanes (1968-1972)", "MS": "Unsaturated derivatives of the steroid androstane containing at least one double bond at any site in any of the rings.", "PM": "73", "HN": "73", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000736"}, {"RECTYPE": "D", "MH": "Androstenols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxyandrostenes|T109|NON|EQV|UNK (19XX)|740329|abcdef", "MN": "D04.210.500.054.079.429", "MH_TH": "NLM (1967)", "ST": "T109", "RN": "0", "AN": "do not confuse with ANDROSTANOLS", "MS": "Unsaturated androstanes which are substituted with one or more hydroxyl groups in any position in the ring system.", "OL": "use ANDROSTENOLS to search ANDROSTENOL 1966-73 (as Prov)", "PM": "74", "HN": "74; was ANDROSTENOL 1963-73 (Prov)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000737"}, {"RECTYPE": "D", "MH": "Androsterone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "5 alpha Androstan 3 alpha ol 17 one", "MN": "D06.472.334.851.968.937", "MH_TH": "NLM (1966)", "ST": "T125", "N1": "Androstan-17-one, 3-hydroxy-, (3alpha,5alpha)-", "RN": "C24W7J5D5R", "RR": "8TR252Z538", "MS": "A metabolite of TESTOSTERONE or ANDROSTENEDIONE with a 3-alpha-hydroxyl group and without the double bond. The 3-beta hydroxyl isomer is epiandrosterone.", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000738"}, {"RECTYPE": "D", "MH": "Anecdotes as Topic", "AQ": "HI", "ENTRY": "Anecdotes as Topics", "MN": "K01.517.067", "FX": "Narration", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with Publication Type ANECDOTES", "MS": "Works about brief accounts or narratives of an incident or event.", "PM": "19662008; see ANECDOTES 1963-2007", "HN": "2008(1963)", "MR": "20161216", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D000739"}, {"RECTYPE": "D", "MH": "Anemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Anemias", "MN": "C15.378.050", "FX": "Hepcidins", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000740"}, {"RECTYPE": "D", "MH": "Anemia, Aplastic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aplastic Anaemia|T047|NON|EQV|NLM (2020)|190501|abcdef", "ENTRY": "Hypoplastic Anemias", "MN": "C15.378.190.223.250", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000741"}, {"RECTYPE": "D", "MH": "Anemia, Dyserythropoietic, Congenital", "DE": "ANEMIA DYSERYTHROPOIETIC CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "HEMPAS|T047|ABB|NRW|OMIM (2013)|UNK (19XX)|810515|abcdeef", "ENTRY": "HEMPAS Anemias", "MN": "C16.320.070.095", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Erythropoiesis (1966-1979)", "MS": "A familial disorder characterized by ANEMIA with multinuclear ERYTHROBLASTS, karyorrhexis, asynchrony of nuclear and cytoplasmic maturation, and various nuclear abnormalities of bone marrow erythrocyte precursors (ERYTHROID PRECURSOR CELLS). Type II is the most common of the 3 types; it is often referred to as HEMPAS, based on the Hereditary Erythroblast Multinuclearity with Positive Acidified Serum test.", "PM": "1991; see ANEMIA, HEMOLYTIC, CONGENITAL 1980-1990", "HN": "1991(1980); use ANEMIA, HEMOLYTIC, CONGENITAL 1980-1990", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19790423", "DC": "1", "DX": "19910101", "UI": "D000742"}, {"RECTYPE": "D", "MH": "Anemia, Hemolytic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemolytic Anemia|T047|NON|EQV|NLM (2008)|060809|abcdef", "ENTRY": "Microangiopathic Hemolytic Anemias", "MN": "C15.378.050.141", "EC": "congenital:Anemia, Hemolytic, Congenital", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified: prefer specifics", "MS": "A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).", "PM": "ANEMIA, HEMOLYTIC, ACQUIRED was heading 1968-81, was ANEMIA, ACQUIRED HEMOLYTIC 1965-67; ANEMIA, CHEMICAL INDUCED HEMOLYTIC & ANEMIA, SECONDARY ACQUIRED HEMOLYTIC were headings 1965-67; ; for MICROANGIOPATHIC HEMOLYTIC ANEMIA see PURPURA, THROMBOTIC THROMBOCYTOPENIC 2012", "HN": "ANEMIA, HEMOLYTIC, ACQUIRED was heading 1968-81, was ANEMIA, ACQUIRED HEMOLYTIC 1965-67; ANEMIA, CHEMICAL INDUCED HEMOLYTIC & ANEMIA, SECONDARY ACQUIRED HEMOLYTIC were headings 1965-67; for MICROANGIOPATHIC HEMOLYTIC ANEMIA use PURPURA, THROMBOTIC THROMBOCYTOPENIC 2012", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D000743"}, {"RECTYPE": "D", "MH": "Anemia, Hemolytic, Autoimmune", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemolytic Anemia, Autoimmune|T047|NON|EQV|NLM (2006)|050511|abcdef", "ENTRY": "Haemolytic Anaemia, Autoimmune", "MN": "C20.111.175", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS.", "PM": "1968; see ANEMIA, IDIOPATHIC ACQUIRED HEMOLYTIC 1965-1967", "HN": "1968; use ANEMIA, IDIOPATHIC ACQUIRED HEMOLYTIC 1965-1967", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000744"}, {"RECTYPE": "D", "MH": "Anemia, Hemolytic, Congenital", "DE": "ANEMIA HEMOLYTIC CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anemia, Hemolytic, Hereditary|T047|NON|EQV|NLM (1998)|960716|abcdef", "ENTRY": "Hereditary Hemolytic Anemias", "MN": "C16.320.070", "MH_TH": "NLM (1968)", "ST": "T047", "MS": "Hemolytic anemia due to various intrinsic defects of the erythrocyte.", "OL": "use ANEMIA, HEMOLYTIC, CONGENITAL to search ANEMIA, CONGENITAL HEMOLYTIC 1966-67", "PM": "68; was ANEMIA, CONGENITAL HEMOLYTIC 1965-67, was ANEMIA, CONGENITAL HEMOLYTIC see SPHEROCYTOSIS, HEREDITARY 1963-64; ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC was heading 1968-81, was ANEMIA, CONGENITAL NON-SPHEROCYTIC HEMOLYTIC 1965-67", "HN": "68; was ANEMIA, CONGENITAL HEMOLYTIC 1965-67, was ANEMIA, CONGENITAL HEMOLYTIC see SPHEROCYTOSIS, HEREDITARY 1963-64", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000745"}, {"RECTYPE": "D", "MH": "Anemia, Hemolytic, Congenital Nonspherocytic", "DE": "ANEMIA HEMOL CONGEN NONSPHER", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hemolytic Anemia, Congenital Nonspherocytic|T047|NON|EQV|NLM (1991)|900427|HEMOLYTIC ANEMIA CONGEN NONSPHEROCYTIC|abcdefv", "MN": "C16.320.070.100", "MH_TH": "NLM (1968)", "ST": "T047", "MS": "Any one of a group of congenital hemolytic anemias in which there is no abnormal hemoglobin or spherocytosis and in which there is a defect of glycolysis in the erythrocyte. Common causes include deficiencies in GLUCOSE-6-PHOSPHATE ISOMERASE; PYRUVATE KINASE; and GLUCOSE-6-PHOSPHATE DEHYDROGENASE.", "OL": "use ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC to search ANEMIA, CONGENITAL NON-SPHEROCYTIC HEMOLYTIC 1966-67", "PM": "91,68; was see under ANEMIA, HEMOLYTIC, CONGENITAL 1982-90; was heading 1968-81; was ANEMIA, CONGENITAL NONSPHEROCYTIC HEMOLYTIC 1965-67", "HN": "91(82)68; was see under ANEMIA, HEMOLYTIC, CONGENITAL 1982-90; was heading 1968-81; was ANEMIA, CONGENITAL NONSPHEROCYTIC HEMOLYTIC 1965-67", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000746"}, {"RECTYPE": "D", "MH": "Anemia, Hypochromic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chlorosis|T047|NON|NRW|UNK (19XX)|880518|abcdef", "ENTRY": "Hypochromic Anemias", "MN": "C15.378.050.196", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse entry term CHLOROSIS with PLANT NECROSIS AND CHLOROSIS", "MS": "Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393)", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000747"}, {"RECTYPE": "D", "MH": "Anemia, Macrocytic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Macrocytic Anemias", "MN": "C15.378.050.252", "FX": "FIGLU Test", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Anemia characterized by larger than normal erythrocytes, increased mean corpuscular volume (MCV) and increased mean corpuscular hemoglobin (MCH).", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000748"}, {"RECTYPE": "D", "MH": "Anemia, Megaloblastic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Megaloblastic Anemias", "MN": "C15.378.050.252.196", "FX": "Megaloblasts", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A disorder characterized by the presence of ANEMIA, abnormally large red blood cells (megalocytes or macrocytes), and MEGALOBLASTS.", "OL": "search ANEMIA, MACROCYTIC 1966-74", "PM": "91; was see under ANEMIA, MACROCYTIC 1975-90", "HN": "91(75); was see under ANEMIA, MACROCYTIC 1975-90", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000749"}, {"RECTYPE": "D", "MH": "Anemia, Myelophthisic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anemia, Leukoerythroblastic|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Myelophthisic Anemias", "MN": "C15.378.190.636.085", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Anemia characterized by appearance of immature myeloid and nucleated erythrocytes in the peripheral blood, resulting from infiltration of the bone marrow by foreign or abnormal tissue.", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000750"}, {"RECTYPE": "D", "MH": "Anemia, Neonatal", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neonatal Anemias", "MN": "C16.614.053", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "check the tag INFANT, NEWBORN ", "PI": "Infant, Newborn, Diseases (1966-1967)", "MS": "The mildest form of erythroblastosis fetalis in which anemia is the chief manifestation.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000751"}, {"RECTYPE": "D", "MH": "Anemia, Pernicious", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anemia, Addison's|T047|EPO|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Anemia, Addisons", "MN": "C18.654.521.500.133.699.923.280", "FX": "Schilling Test", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a type of megaloblastic anemia", "MS": "A megaloblastic anemia occurring in children but more commonly in later life, characterized by histamine-fast achlorhydria, in which the laboratory and clinical manifestations are based on malabsorption of vitamin B 12 due to a failure of the gastric mucosa to secrete adequate and potent intrinsic factor. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000752"}, {"RECTYPE": "D", "MH": "Anemia, Refractory", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Refractory Anemia|T047|NON|EQV|UNK (19XX)|850606|abcdef", "ENTRY": "Refractory Anemias", "MN": "C15.378.190.625.062", "MH_TH": "NLM (1986)", "ST": "T047", "PI": "Anemia, Aplastic (1966-1985)", "MS": "A severe sometimes chronic anemia, usually macrocytic in type, that does not respond to ordinary antianemic therapy.", "OL": "search ANEMIA, APLASTIC 1975-85", "PM": "86; was see ANEMIA, APLASTIC 1975-85", "HN": "86; was see ANEMIA, APLASTIC 1975-85", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D000753"}, {"RECTYPE": "D", "MH": "Anemia, Refractory, with Excess of Blasts", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Refractory Anemia with Excess of Blasts|T047|NON|EQV|UNK (19XX)|850606|abcdef", "ENTRY": "Smouldering Leukemia", "MN": "C15.378.190.625.062.080", "MH_TH": "NLM (1986)", "ST": "T047", "PI": "Anemia, Aplastic (1966-1985)", "MS": "Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D000754"}, {"RECTYPE": "D", "MH": "Anemia, Sickle Cell", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemoglobin S Disease|T047|NON|EQV|GHR (2014)|NLM (1998)|ORD (2010)|960730|HEMOGLOBIN S DIS|abcdeeefv", "ENTRY": "Sickle Cell Disorder", "MN": "C16.320.365.155", "FX": "Antisickling Agents", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "PL 92-294: Natl Sickle Cell Anemia Control Act; sickle cell dis goes here unless specifically HEMOGLOBIN SC DISEASE or HEMOGLOBIN C DISEASE or SICKLE CELL TRAIT or THALASSEMIA; /drug ther: consider also ANTISICKLING AGENTS", "MS": "A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000755"}, {"RECTYPE": "D", "MH": "Anemia, Sideroblastic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sideroblastic Anemias", "MN": "C15.378.190.625.070", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Anemia characterized by the presence of erythroblasts containing excessive deposits of iron in the marrow.", "OL": "use ANEMIA, SIDEROBLASTIC to search ANEMIA, SIDEROBLASTIC REFRACTORY 1966 (as Prov 1966)", "PM": "67", "HN": "67; was ANEMIA, SIDEROBLASTIC REFRACTORY 1963-66 (Prov 1966)", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000756"}, {"RECTYPE": "D", "MH": "Anencephaly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aprosencephaly|T019|NON|NRW|GHR (2014)|NLM (2000)|991103|abcdeef", "ENTRY": "Partial Anencephalies", "MN": "C16.131.666.680.196", "FX": "alpha-Fetoproteins", "MH_TH": "ORD (2010)", "ST": "T019", "MS": "A malformation of the nervous system caused by failure of the anterior neuropore to close. Infants are born with intact spinal cords, cerebellums, and brainstems, but lack formation of neural structures above this level. The skull is only partially formed but the eyes are usually normal. This condition may be associated with folate deficiency. Affected infants are only capable of primitive (brain stem) reflexes and usually do not survive for more than two weeks. (From Menkes, Textbook of Child Neurology, 5th ed, p247)", "OL": "use ANENCEPHALY to search ANENCEPHALUS 1966-78", "PM": "79; was ANENCEPHALUS 1966-78", "HN": "79; was ANENCEPHALUS 1964-78 (Prov 1964-65)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000757"}, {"RECTYPE": "D", "MH": "Anesthesia", "AQ": "AE CL EC ES HI MO MT NU PX SN ST TD VE", "MN": "E03.155", "FX": "Anesthetics", "EC": "instrumentation:Anesthesiology:instrumentation", "MH_TH": "POPLINE (1978)", "ST": "T061", "AN": "Manual 26.21+", "MS": "A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.", "CATSH": "CAT LIST", "MR": "20180124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000758"}, {"RECTYPE": "D", "MH": "Adjuvants, Anesthesia", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Anesthesia Adjuvants|T121|NON|EQV|NLM (1999)|980515|abcdef", "ENTRY": "Adjuvants, Anesthetic", "MN": "D27.505.954.427.010", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "IM; coord with specific adjuvant (IM) & specific type of anesthesia (IM)", "MS": "Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage.", "PM": "99; see ANESTHESIA ADJUVANTS 1963-98", "HN": "99(63)", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000759"}, {"RECTYPE": "D", "MH": "Anesthesia and Analgesia", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Analgesia and Anesthesia", "MN": "E03", "RH": "E3 - PROCEDURES AND TECHNIQUES-ANESTHETIC AND ANALGESIC", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Medical methods of either relieving pain caused by a particular condition or removing the sensation of pain during a surgery or other medical procedure.", "HN": "98; use explode 1971-97", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000760"}, {"RECTYPE": "D", "MH": "Anesthesia Department, Hospital", "DE": "ANESTH DEP HOSP", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Hospital Anesthesia-Resuscitation Department|T093|NON|BRD|UNK (19XX)|770519|HOSP ANESTH RESUSCITATION DEP|abcdefv", "ENTRY": "Hospital Anesthesia-Resuscitation Departments", "MN": "N04.452.442.452.422.070", "MH_TH": "NLM (1977)", "ST": "T093", "PI": "Hospital Departments (1968-Jul 1977)", "MS": "Hospital department responsible for the administration of functions and activities pertaining to the delivery of anesthetics.", "PM": "91; was see under HOSPITAL DEPARTMENTS 1977-90", "HN": "91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90", "MR": "20190709", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D000761"}, {"RECTYPE": "D", "MH": "Anesthesia Recovery Period", "PRINT ENTRY": "Recovery Period, Anesthesia|T079|NON|EQV|UNK (19XX)|850228|abcdef", "ENTRY": "Recovery Periods, Anesthesia", "MN": "N02.421.585.753.750.055", "FX": "Postanesthesia Nursing", "MH_TH": "NLM (1986)", "ST": "T079", "PI": "Postoperative Care (1966-1985)", "MS": "The period of emergence from general anesthesia, where different elements of consciousness return at different rates.", "PM": "91; was see under POSTOPERATIVE PERIOD 1986-90", "HN": "91(86); was see under POSTOPERATIVE PERIOD 1986-90", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19850228", "DC": "1", "DX": "19910101", "UI": "D000762"}, {"RECTYPE": "D", "MH": "Anesthesia, Caudal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Anesthesia, Sacral Epidural|T061|NON|EQV|UNK (19XX)|741211|abcdef", "ENTRY": "Sacral Epidural Anesthesia", "MN": "E03.155.086.131.100", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "/educ: coord IM (no qualif) with ANESTHESIOLOGY /educ (NIM)", "MS": "Epidural anesthesia administered via the sacral canal.", "PM": "91; was see under ANESTHESIA, EPIDURAL 1975-90", "HN": "91(75); was see under ANESTHESIA, EPIDURAL 1975-90", "CATSH": "CAT LIST", "MR": "19930220", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D000763"}, {"RECTYPE": "D", "MH": "Anesthesia, Closed-Circuit", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Closed-Circuit Anesthesia|T061|NON|EQV|UNK (19XX)|860620|abcdef", "ENTRY": "Rebreathing Anesthesias", "MN": "E03.155.197.197.280", "MH_TH": "NLM (1987)", "ST": "T061", "AN": "/educ: coord IM (no qualif) with ANESTHESIOLOGY /educ (NIM)", "PI": "Anesthesia, Inhalation (1966-1986)", "MS": "Inhalation anesthesia where the gases exhaled by the patient are rebreathed as some carbon dioxide is simultaneously removed and anesthetic gas and oxygen are added so that no anesthetic escapes into the room. Closed-circuit anesthesia is used especially with explosive anesthetics to prevent fires where electrical sparking from instruments is possible.", "PM": "91; was see under ANESTHESIA, INHALATION 1987-90", "HN": "91(87); was see under ANESTHESIA, INHALATION 1987-90", "CATSH": "CAT LIST", "MR": "19920325", "DA": "19860620", "DC": "1", "DX": "19910101", "UI": "D000764"}, {"RECTYPE": "D", "MH": "Anesthesia, Conduction", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Anesthesia, Regional|T061|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Regional Anesthesia", "MN": "E03.155.086", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Injection of an anesthetic to inhibit nerve transmission in a specific part of the body.", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000765"}, {"RECTYPE": "D", "MH": "Anesthesia, Dental", "DE": "ANESTHESIA DENT", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Dental Anesthesia|T061|NON|EQV|IOM (1990)|890414|DENT ANESTHESIA|abcdefv", "MN": "E06.045", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "A range of methods used to reduce pain and anxiety during dental procedures.", "OL": "use ANESTHESIA, DENTAL to search ANESTHESIA, INTRALIGAMENTAL, DENTAL 1984-92", "PM": "ANESTHESIA, INTRALIGAMENTAL, DENTAL was see ANESTHESIA, DENTAL 1984-92", "HN": "ANESTHESIA, INTRALIGAMENTAL, DENTAL was see ANESTHESIA, DENTAL 1984-92", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D000766"}, {"RECTYPE": "D", "MH": "Anesthesia, Epidural", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Epidural Anesthesia|T061|NON|EQV|UNK (19XX)|880602|abcdef", "ENTRY": "Peridural Anesthesias", "MN": "E03.155.086.131", "MH_TH": "NLM (1971)", "ST": "T061", "PI": "Anesthesia, Obstetrical (1966-1970)", "MS": "Procedure in which an anesthetic is injected into the epidural space.", "PM": "72", "HN": "72(71)", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000767"}, {"RECTYPE": "D", "MH": "Anesthesia, General", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "General Anesthesias", "MN": "E03.155.197", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Procedure in which patients are induced into an unconscious state through use of various medications so that they do not feel pain during surgery.", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000768"}, {"RECTYPE": "D", "MH": "Anesthesia, Inhalation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Insufflation Anesthesia|T061|NON|NRW|UNK (19XX)|860604|abcdef", "ENTRY": "Inhalation Anesthesia", "MN": "E03.155.197.197", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "/educ: coord IM (no qualif) with ANESTHESIOLOGY /educ (NIM)", "MS": "Anesthesia caused by the breathing of anesthetic gases or vapors or by insufflating anesthetic gases or vapors into the respiratory tract.", "CATSH": "CAT LIST", "MR": "19930220", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000769"}, {"RECTYPE": "D", "MH": "Anesthesia, Endotracheal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Anesthesia, Intratracheal|T061|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Intratracheal Anesthesias", "MN": "E03.155.197.197.640", "MH_TH": "NLM (2016)", "ST": "T061", "MS": "Procedure in which an anesthetic such as a gas or mixture of gases is inhaled through a tube into the lungs.", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000770"}, {"RECTYPE": "D", "MH": "Anesthesia, Intravenous", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Intravenous Anesthesias", "MN": "E03.155.308", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Process of administering an anesthetic through injection directly into the bloodstream.", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000771"}, {"RECTYPE": "D", "MH": "Anesthesia, Local", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Anesthesia, Infiltration|T061|NON|NRW|NLM (1996)|940711|abcdef", "ENTRY": "Infiltration Anesthesia", "MN": "E03.155.086.231", "FX": "Anesthetics, Local", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "A blocking of nerve conduction to a specific area by an injection of an anesthetic agent.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000772"}, {"RECTYPE": "D", "MH": "Anesthesia, Obstetrical", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Paracervical Blocks", "MN": "E03.155.364", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "A variety of anesthetic methods such as EPIDURAL ANESTHESIA used to control the pain of childbirth.", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000773"}, {"RECTYPE": "D", "MH": "Anesthesia, Rectal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Rectal Anesthesias", "MN": "E03.155.197.364", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Procedure involving the instillation of an anesthetic into the rectum.", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000774"}, {"RECTYPE": "D", "MH": "Anesthesia, Spinal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Spinal Anesthesias", "MN": "E03.155.086.331", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Procedure in which an anesthetic is injected directly into the spinal cord.", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000775"}, {"RECTYPE": "D", "MH": "Anesthesiology", "DE": "ANESTHESIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.066", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "A specialty concerned with the study of anesthetics and anesthesia.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000776"}, {"RECTYPE": "D", "MH": "Anesthetics", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Anesthetic|T121|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Effects, Anesthetic", "MN": "D27.505.954.427.210.100", "FX": "Anesthesia", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specific groups; use no qualifiers for anesthetics when used to produce anesthesia; coordinate with type of anesthesia: Manual 26.21+; policy: Manual 25.20+", "MS": "Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000777"}, {"RECTYPE": "D", "MH": "Anesthetics, Dissociative", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dissociative Anesthetics|T121|NON|EQV|NLM (1995)|940526|abcdef", "MN": "D27.505.954.427.210.100.035.075.035", "MH_TH": "NLM (1971)", "ST": "T121", "RN": "0", "AN": "intravenous anesthetics inducing selective loss of some sensations, leaving others intact", "PI": "Anesthetics (1966-1970)", "MS": "Intravenous anesthetics that induce a state of sedation, immobility, amnesia, and marked analgesia. Subjects may experience a strong feeling of dissociation from the environment. The condition produced is similar to NEUROLEPTANALGESIA, but is brought about by the administration of a single drug. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed)", "PM": "91; was see under ANESTHETICS 1971-90", "HN": "91(71); was see under ANESTHETICS 1971-90", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000778"}, {"RECTYPE": "D", "MH": "Anesthetics, Local", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Local Anesthetic|T121|NON|EQV|NLM (2021)|191219|abcdef", "ENTRY": "Topical Anesthetics", "MN": "D27.505.954.427.210.100.200", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "see note at ANESTHETICS", "MS": "Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000779"}, {"RECTYPE": "D", "MH": "Anestrus", "AQ": "BL CF DE GE IM ME PH RE UR", "MN": "G08.686.195.249", "MH_TH": "NLM (1975)", "ST": "T079", "AN": "non-primate mammals only", "MS": "A state of sexual inactivity in female animals exhibiting no ESTROUS CYCLE. Causes of anestrus include pregnancy, presence of offspring, season, stress, and pathology.", "PM": "91; was see under ESTRUS 1975-90", "HN": "91(75); was see under ESTRUS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000780"}, {"RECTYPE": "D", "MH": "Anethole Trithione", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trithioparamethoxyphenylpropene|T109|T121|NON|EQV|UNK (19XX)|760416|abbcdef", "ENTRY": "Trithione, Anethole", "MN": "D02.886.753.077", "MH_TH": "NLM (1977)", "ST": "T121", "N1": "3H-1,2-Dithiole-3-thione, 5-(4-methoxyphenyl)-", "RN": "QUY32964DJ", "RR": "532-11-6 (Anethole Trithione)", "PI": "Thiones (1974-1975)", "MS": "Choleretic used to allay dry mouth and constipation due to tranquilizers.", "PM": "91; was see under ANISOLES 1977-90", "HN": "91(77); was see under ANISOLES 1977-90", "MR": "20160705", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D000781"}, {"RECTYPE": "D", "MH": "Aneuploidy", "ENTRY": "Cells, Aneuploid", "MN": "G05.700.131", "MH_TH": "NLM (1968)", "ST": "T049", "PI": "Chromosome Abnormalities (1966-1967)", "MS": "The chromosomal constitution of cells which deviate from the normal by the addition or subtraction of CHROMOSOMES, chromosome pairs, or chromosome fragments. In a normally diploid cell (DIPLOIDY) the loss of a chromosome pair is termed nullisomy (symbol: 2N-2), the loss of a single chromosome is MONOSOMY (symbol: 2N-1), the addition of a chromosome pair is tetrasomy (symbol: 2N+2), the addition of a single chromosome is TRISOMY (symbol: 2N+1).", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000782"}, {"RECTYPE": "D", "MH": "Aneurysm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Saccular Aneurysm|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Fusiform Aneurysms", "MN": "C14.907.055", "MH_TH": "NLM (1966)", "ST": "T190", "MS": "Pathological outpouching or sac-like dilatation in the wall of any blood vessel (ARTERIES or VEINS) or the heart (HEART ANEURYSM). It indicates a thin and weakened area in the wall which may later rupture. Aneurysms are classified by location, etiology, or other characteristics.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000783"}, {"RECTYPE": "D", "MH": "Aortic Dissection", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dissecting Aneurysm Aorta|T020|NON|EQV|NLM (2023)|220413|abcdef", "ENTRY": "Dissection, Aortic", "MN": "C14.907.109.070.500", "MH_TH": "NLM (2018)", "ST": "T020", "AN": "dissection of the ABDOMINAL AORTA: coordinate with AORTIC ANEURYSM, ABDOMINAL; dissection of the THORACIC AORTA: coordinate with AORTIC ANEURYSM, THORACIC", "PI": "Aortic Aneurysm (1966-1976)", "MS": "A tear in the inner layer of the AORTA leading to interstitial HEMORRHAGE, and splitting (dissecting) of the aortic TUNICA MEDIA layer. It typically begins with a tear in the TUNICA INTIMA layer.", "PM": "2023; see ANEURYSM, DISSECTING 1977-2022", "HN": "2023; use ANEURYSM, DISSECTING 1977-2022", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D000784"}, {"RECTYPE": "D", "MH": "Aneurysm, Infected", "DE": "ANEURYSM INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Mycotic Aneurysm|T047|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Mycotic Aneurysms", "MN": "C14.907.055.131", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "coordinate IM with specific bacteria or fungal infection (IM); note entry terms ANEURYSM, BACTERIAL, and ANEURYSM, MYCOTIC: do not coordinate with BACTERIAL INFECTIONS or MYCOSES if the specific bacterium or fungus is not specified,", "MS": "Aneurysm due to growth of microorganisms in the arterial wall, or infection arising within preexisting arteriosclerotic aneurysms.", "OL": "use ANEURYSM, INFECTED to search ANEURYSM, MYCOTIC 1966-86 (as Prov 1966-69)", "PM": "87; was ANEURYSM, MYCOTIC 1970-86", "HN": "87; was ANEURYSM, MYCOTIC 1964-86 (Prov 1964-69)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D000785"}, {"RECTYPE": "D", "MH": "Anger", "AQ": "CL DE ES PH RE", "ENTRY": "Angers", "MN": "F01.470.093", "MH_TH": "NLM (1969)", "ST": "T041", "AN": "human & animal", "PI": "Hostility (1968)", "MS": "A strong emotional feeling of displeasure aroused by being interfered with, injured or threatened.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "19920325", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000786"}, {"RECTYPE": "D", "MH": "Angina Pectoris", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stenocardia|T047|T184|NON|EQV|UNK (19XX)|860418|abbcdef", "ENTRY": "Stenocardias", "MN": "C23.888.592.612.233.500", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000787"}, {"RECTYPE": "D", "MH": "Angina Pectoris, Variant", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Prinzmetal Angina|T047|T184|EPO|EQV|NLM (2002)|ORD (2010)|001121|abbcdeef", "ENTRY": "Variant Angina Pectoris", "MN": "C23.888.592.612.233.500.150.150", "MH_TH": "NLM (1977)", "ST": "T184", "PI": "Angina Pectoris (1966-1976)", "MS": "A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the ELECTROCARDIOGRAM, but with preserved exercise capacity.", "PM": "84; was see under CORONARY VASOSPASM 1982-83, was see under ANGINA PECTORIS 1977-81", "HN": "84(77); was see under CORONARY VASOSPASM 1982-83, was see under ANGINA PECTORIS 1977-81", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19760427", "DC": "1", "DX": "19840101", "UI": "D000788"}, {"RECTYPE": "D", "MH": "Angina, Unstable", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myocardial Preinfarction Syndrome|T047|NON|REL|UNK (19XX)|830503|abcdef", "ENTRY": "Unstable Anginas", "MN": "C23.888.592.612.233.500.150", "MH_TH": "NLM (1984)", "ST": "T184", "PI": "Coronary Disease (1966-1983)", "MS": "Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.", "PM": "91; was see under ANGINA PECTORIS 1984-90", "HN": "91(84); was see under ANGINA PECTORIS 1984-90", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19830503", "DC": "1", "DX": "19910101", "UI": "D000789"}, {"RECTYPE": "D", "MH": "Angiocardiography", "DE": "ANGIOCARDIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Angiocardiographies", "MN": "E01.370.370.380.050", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "do not confuse with CORONARY ANGIOGRAPHY; coordinate with disease /diag image", "MS": "Radiography of the heart and great vessels after injection of a contrast medium.", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000790"}, {"RECTYPE": "D", "MH": "Angiography", "DE": "ANGIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Arteriography|T060|NON|REL|UNK (19XX)|750116|ARTERIOGR|abcdefv", "ENTRY": "Arteriographies", "MN": "E01.370.370.050", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "coordinate with specific blood vessel /diag image; note several specific angiography terms are available", "MS": "Radiography of blood vessels after injection of a contrast medium.", "CATSH": "CAT LIST", "MR": "20160706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000792"}, {"RECTYPE": "D", "MH": "Angioid Streaks", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Streaks, Angioid", "MN": "C11.768.094", "FX": "Retina", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "Small breaks in the elastin-filled tissue of the retina.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000793"}, {"RECTYPE": "D", "MH": "Angiokeratoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Angiokeratomas", "MN": "C04.557.645.115", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with SKIN NEOPLASMS (IM) + site (IM or NIM) if relevant", "MS": "A vascular, horny neoplasm of the skin characterized by TELANGIECTASIS and secondary epithelial changes including acanthosis and hyperkeratosis.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000794"}, {"RECTYPE": "D", "MH": "Fabry Disease", "DE": "FABRY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Angiokeratoma Corporis Diffusum|T047|NON|EQV|GHR (2014)|NLM (1992)|OMIM (2013)|ORD (2010)|900912|abcdeeeef", "ENTRY": "alpha Galactosidase A Deficiency Disease", "MN": "C18.452.648.595.554.825.200", "FX": "alpha-Galactosidase", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse entry term ANDERSON-FABRY DISEASE with ANDERSEN'S DISEASE", "PI": "Angiokeratoma (1966-1972)", "MS": "An X-linked inherited metabolic disease caused by a deficiency of lysosomal ALPHA-GALACTOSIDASE A. It is characterized by intralysosomal accumulation of globotriaosylceramide and other GLYCOSPHINGOLIPIDS in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders.", "PM": "1999; see FABRY'S DISEASE 1992-1998; see ANGIOKERATOMA CORPORIS DIFFUSUM 1973-1991; for FABRY'S DISEASE see ANGIOKERATOMA CORPORIS DIFFUSUM 1974-1991", "HN": "1999(1973)", "CATSH": "CAT LIST", "MR": "20230825", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000795"}, {"RECTYPE": "D", "MH": "Angiolymphoid Hyperplasia with Eosinophilia", "DE": "ALHE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Granuloma, Pseudopyogenic|T047|NON|NRW|UNK (19XX)|840529|abcdef", "ENTRY": "Pseudopyogenic Granulomas", "MN": "C17.800.060", "FX": "Kimura Disease", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Eosinophilia (1966-1984)", "MS": "Solitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells.", "PM": "85", "HN": "85", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19840529", "DC": "1", "DX": "19850101", "UI": "D000796"}, {"RECTYPE": "D", "MH": "Angiomatosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Angiomatoses", "MN": "C14.907.077", "FX": "Telangiectasia, Hereditary Hemorrhagic", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with precoordinated organ disease term (IM)", "MS": "A condition with multiple tumor-like lesions caused either by congenital or developmental malformations of BLOOD VESSELS, or reactive vascular proliferations, such as in bacillary angiomatosis. Angiomatosis is considered non-neoplastic.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000798"}, {"RECTYPE": "D", "MH": "Angioedema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Urticaria, Giant|T046|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Urticarias, Giant", "MN": "C20.543.480.904.066", "MH_TH": "UNK (19XX)", "ST": "T046", "AN": "/genet: consider also ANGIOEDEMAS, HEREDITARY", "MS": "Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx.", "PM": "2008; see ANGIONEUROTIC EDEMA 1963-2007", "HN": "2008 (1963)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D000799"}, {"RECTYPE": "D", "MH": "Angioplasty, Balloon", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Balloon Angioplasty|T061|NON|EQV|UNK (19XX)|810223|abcdef", "ENTRY": "Transluminal Arterial Dilations", "MN": "E05.157.016.060", "MH_TH": "NLM (1982)", "ST": "T061", "PI": "specific arterial occlusive disease (1966-1981)", "MS": "Use of a balloon catheter for dilation of an occluded artery. It is used in treatment of arterial occlusive diseases, including renal artery stenosis and arterial occlusions in the leg. For the specific technique of BALLOON DILATION in coronary arteries, ANGIOPLASTY, BALLOON, CORONARY is available.", "OL": "use ANGIOPLASTY, BALLOON to search ANGIOPLASTY, TRANSLUMINAL 1982-92", "PM": "93; was ANGIOPLASTY, TRANSLUMINAL 1982-92; ANGIOPLASTY, BALLOON was see ANGIOPLASTY, TRANSLUMINAL 1982-92", "HN": "93; was ANGIOPLASTY, TRANSLUMINAL 1982-92; ANGIOPLASTY, BALLOON was see ANGIOPLASTY, TRANSLUMINAL 1982-92", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19810223", "DC": "1", "DX": "19820101", "UI": "D000800"}, {"RECTYPE": "D", "MH": "Angiostrongylus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.294.400.968.588.080", "MH_TH": "NLM (1981)", "ST": "T204", "RN": "txid6312", "AN": "infection: coordinate with STRONGYLIDA INFECTIONS; coordinate with specific helminth terms (ANTIGENS, HELMINTH, etc.) if pertinent", "PI": "Metastrongyloidea (1966-1980)", "MS": "A genus of parasitic nematodes of the superfamily METASTRONGYLOIDEA. Two species, ANGIOSTRONGYLUS CANTONENSIS and A. vasorum, infest the lungs of rats and dogs, respectively. A. cantonensis is transmissible to man where it causes frequently fatal infection of the central nervous system.", "PM": "91; was see under METASTRONGYLOIDEA 1981-90", "HN": "91(81); was see under METASTRONGYLOIDEA 1981-90", "MR": "20200813", "DA": "19800328", "DC": "1", "DX": "19910101", "UI": "D000801"}, {"RECTYPE": "D", "MH": "Angiotensin Amide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Angiotensinamide|T116|T121|T125|NON|EQV|INN (19XX)|900427|abbbcdef", "ENTRY": "Angiotensin II, 1-Asparagine-5-valine", "MN": "D23.469.050.050.050.050", "PA": "Vasoconstrictor Agents", "MH_TH": "USAN (1962)", "ST": "T125", "N1": "Angiotensin II, 1-L-asparagine-5-L-valine-", "RN": "53-73-6", "PI": "Angiotensin II (1966-1974)", "MS": "The octapeptide amide of bovine angiotensin II used to increase blood pressure by vasoconstriction.", "OL": "search ANGIOTENSIN II 1966-74", "PM": "91,66-73; was see under ANGIOTENSIN II/analogs & derivatives 1975-90; was see under ANGIOTENSIN II 1974; was heading 1966-73", "HN": "91(75)66-73; was see under ANGIOTENSIN II/analogs & derivatives 1975-90; was see under ANGIOTENSIN II 1974; was heading 1966-73", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000802"}, {"RECTYPE": "D", "MH": "Angiotensin I", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.469.050.050.025", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Angiotensin I", "RN": "9041-90-1", "PI": "Angiotensin II (1966-1977)", "MS": "A decapeptide that is cleaved from precursor angiotensinogen by RENIN. Angiotensin I has limited biological activity. It is converted to angiotensin II, a potent vasoconstrictor, after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME.", "PM": "87; was see under ANGIOTENSINS 1978-86", "HN": "87(78); was see under ANGIOTENSINS 1978-86", "MR": "20160705", "DA": "19770609", "DC": "1", "DX": "19870101", "UI": "D000803"}, {"RECTYPE": "D", "MH": "Angiotensin II", "AQ": "AA AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Angiotensin II, Val(5)-|T116|T121|T123|NON|NRW|NLM (2000)|991108|abbbcdef", "ENTRY": "Angiotensin II, 5-L-Isoleucine", "MN": "D23.469.050.050.050", "PA": "Vasoconstrictor Agents", "FX": "Renin-Angiotensin System", "MH_TH": "INN (19XX)", "ST": "T123", "N1": "Angiotensin II", "RN": "11128-99-7", "RR": "4474-91-3 (human)", "MS": "An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.", "PM": "1974; see ANGIOTENSIN 1971-1973, see ANGIOTENSIN 1967-1970; ANGIOTENSIN was heading 1964-1978, was HYPERTENSIN 1963 (HYPERTENSIN see ANGIOTENSIN 1964-1965, see ANGIOTENSIN AMIDE 1966-1973); ANGIOTENSIN II, ILE(5)- was indexed under ANGIOTENSIN II 1981-1999, and ISOLEUCINE 1975-1981", "HN": "1974(1963); for ANGIOTENSIN II, ILE(5)- use ANGIOTENSIN II (NM) 1974-1999", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000804"}, {"RECTYPE": "D", "MH": "Angiotensin III", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Des Aspartyl Angiotensin II", "MN": "D23.469.050.050.075", "MH_TH": "NLM (1977)", "ST": "T123", "N1": "Angiotensin II, 1-de-L-aspartic acid-", "RN": "12687-51-3", "PI": "Angiotensin II (1966-1976)", "MS": "A heptapeptide formed from ANGIOTENSIN II after the removal of an amino acid at the N-terminal by AMINOPEPTIDASE A. Angiotensin III has the same efficacy as ANGIOTENSIN II in promoting ALDOSTERONE secretion and modifying renal blood flow, but less vasopressor activity (about 40%).", "PM": "91; was see under ANGIOTENSIN II 1977-90", "HN": "91(77); was see under ANGIOTENSIN II 1977-90", "MR": "20151123", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D000805"}, {"RECTYPE": "D", "MH": "Angiotensin-Converting Enzyme Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Kininase II Inhibitors|T121|NON|EQV|UNK (19XX)|870504|KININASE II INHIB|abcdefv", "ENTRY": "Inhibitors, Angiotensin Converting Enzyme", "MN": "D27.505.519.389.745.085", "MH_TH": "NLM (1988)", "ST": "T121", "RN": "0", "PI": "Kininase II/antagonists & inhibitors (1973-1987)", "MS": "A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.", "OL": "use TEPROTIDE to search ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR 1991-93", "PM": "88; ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR was see TEPROTIDE 1991-93", "HN": "88; ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR was see TEPROTIDE 1991-93", "MR": "20200527", "DA": "19870504", "DC": "1", "DX": "19880101", "UI": "D000806"}, {"RECTYPE": "D", "MH": "Angiotensinogen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SERPINA8|T116|T123|NON|EQV|NLM (2021)|200429|abbcdef", "ENTRY": "Tetradecapeptide, Renin Substrate", "MN": "D12.776.872.020", "PA": "Serine Proteinase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Angiotensinogen (protein renin substrate)", "RN": "11002-13-4", "PI": "Protein Precursors (1971-1974)", "MS": "An alpha-globulin of about 453 amino acids, depending on the species. It is produced by the liver in response to lowered blood pressure and secreted into blood circulation. Angiotensinogen is the inactive precursor of the ANGIOTENSINS produced in the body by successive enzyme cleavages. Cleavage of angiotensinogen by RENIN yields the decapeptide ANGIOTENSIN I. Further cleavage of angiotensin I (by ANGIOTENSIN CONVERTING ENZYME) yields the potent vasoconstrictor octapeptide ANGIOTENSIN II; and then, via other enzymes, other angiotensins also involved in the hemodynamic-regulating RENIN-ANGIOTENSIN SYSTEM.", "PM": "87; was see under ANGIOTENSINS 1975-86", "HN": "87(75); was see under ANGIOTENSINS 1975-86", "MR": "20200609", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D000808"}, {"RECTYPE": "D", "MH": "Angiotensins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Angiotensin|T116|T121|T123|NON|EQV|UNK (19XX)|770428|abbbcdef", "MN": "D23.469.050.050", "FX": "Renin-Angiotensin System", "MH_TH": "NLM (1964)", "ST": "T123", "RN": "0", "PI": "Angiotensin III (1977)", "MS": "Oligopeptides which are important in the regulation of blood pressure (VASOCONSTRICTION) and fluid homeostasis via the RENIN-ANGIOTENSIN SYSTEM. These include angiotensins derived naturally from precursor ANGIOTENSINOGEN, and those synthesized.", "PM": "1978; for ANGIOTENSIN see ANGIOTENSIN II 1978-1999", "HN": "1978; for ANGIOTENSIN use ANGIOTENSIN II 1978-1999", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D000809"}, {"RECTYPE": "D", "MH": "Angola", "AQ": "EH EP", "MN": "Z01.058.290.175.095", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in southern Africa, southwest of DEMOCRATIC REPUBLIC OF THE CONGO and west of ZAMBIA. Its capital is Luanda.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000810"}, {"RECTYPE": "D", "MH": "Anguilla", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Anguillas", "MN": "B01.050.150.900.493.338.282", "MH_TH": "NLM (1972)", "ST": "T013", "RN": "txid7935", "PI": "Eels (1966-1971)", "MS": "A genus in the Family Anguillidae, Order Anguilliformes, that includes fresh water eels.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000811"}, {"RECTYPE": "D", "MH": "Anhydrides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Anhydride|T109|NON|EQV|NLM (2021)|191121|abcdef", "MN": "D02.113", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Chemical compounds derived from acids by the elimination of a molecule of water.", "PM": "66", "HN": "66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000812"}, {"RECTYPE": "D", "MH": "Anilides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.092.146.113", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Any aromatic amide obtained by acylation of aniline.", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000813"}, {"RECTYPE": "D", "MH": "Aniline Compounds", "DE": "ANILINE CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenylamines|T109|NON|EQV|UNK (19XX)|750708|abcdef", "ENTRY": "Compounds, Aniline", "MN": "D02.092.146", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds that include the aminobenzene structure.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000814"}, {"RECTYPE": "D", "MH": "Aniline Hydroxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hydroxylase, Aniline", "MN": "D12.776.422.220.453.010.050", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.14.14.-", "AN": "a cytochrome P-450 enzyme", "PI": "Hydroxylases (1973-1974)", "MS": "A drug-metabolizing, cytochrome P-450 enzyme which catalyzes the hydroxylation of aniline to hydroxyaniline in the presence of reduced flavoprotein and molecular oxygen. EC 1.14.14.-.", "PM": "91; was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76", "HN": "91(75); was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000815"}, {"RECTYPE": "D", "MH": "Aniline Mustard", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Mustard, Aniline", "MN": "D02.455.526.728.650.050", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "NLM (1976)", "ST": "T121", "N1": "Benzenamine, N,N-bis(2-chloroethyl)-", "RN": "CUJ6745Z9J", "RR": "553-27-5 (Aniline Mustard)", "PI": "Nitrogen Mustard Compounds (1970-1975)", "MS": "Alkylating anti-neoplastic agent.", "PM": "1991; N,N-BIS-(2-CHOLOROETHYL)ANILINE was indexed under ANILINE MUSTARD 2005-2008, & under ANILINE COMPOUNDS (2005)", "HN": "1991(1976)", "MR": "20130708", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D000816"}, {"RECTYPE": "D", "MH": "Anilino Naphthalenesulfonates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Naphthalenesulfonates, Anilino", "MN": "D04.615.638.555.282", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "A class of organic compounds which contain an anilino (phenylamino) group linked to a salt or ester of naphthalenesulfonic acid. They are frequently used as fluorescent dyes and sulfhydryl reagents.", "PM": "74", "HN": "74", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000817"}, {"RECTYPE": "D", "MH": "Animals", "PRINT ENTRY": "Metazoa|T008|NON|REL|NLM (2009)|080317|abcdef", "ENTRY": "Animalia|T008|NON|EQV|NLM (2004)|020925|abcdef", "MN": "B01.050", "MH_TH": "NLM (2004)", "ST": "T008", "RR": "txid33208", "AN": "NIM as check tag; Manual 18.7+; relation to /vet: Manual 19.8.81", "MS": "Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.", "PM": "2004", "HN": "2004 (1974); was check tag only (not a descriptor) 1974-2003", "MR": "20200902", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D000818"}, {"RECTYPE": "D", "MH": "Animal Communication", "ENTRY": "Communications, Animal", "MN": "F01.145.113.055", "FX": "Vocalization, Animal", "MH_TH": "NLM (1968)", "ST": "T054", "PI": "Communication (1966-1967)", "MS": "Communication between animals involving the giving off by one individual of some chemical or physical signal, that, on being received by another, influences its behavior.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000819"}, {"RECTYPE": "D", "MH": "Animal Diseases", "DE": "ANIMAL DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Diseases, Animal|T047|NON|EQV|NLM (1991)|891129|DIS ANIMAL|abcdefv", "MN": "C22", "RH": "C22 - DISEASES-ANIMAL", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified only; coordinate  with specific animal (IM); do not index when a  disease/vet is indexed (e.g. STREPTOCOCCAL INFECTIONS /vet) or when a disease term treed under ANIMAL DISEASES  is indexed (e.g. FOOT ROT; DOG DISEASES); do not index for experimental studies of disease in animals", "MS": "Diseases that occur in VERTEBRATE animals.", "PM": "66; was see under VETERINARY MEDICINE & ZOONOSES 1963-65", "HN": "66; was see under VETERINARY MEDICINE & ZOONOSES 1963-65", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000820"}, {"RECTYPE": "D", "MH": "Animal Feed", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Fodders", "MN": "J02.500.300.100", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "differentiate from ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA & DIET", "MS": "Foodstuff used especially for domestic and laboratory animals, or livestock.", "PM": "68", "HN": "68(66)", "MR": "20141218", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000821"}, {"RECTYPE": "D", "MH": "Animal Husbandry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Husbandry, Animal", "MN": "J01.040.090", "FX": "Veterinary Medicine", "MH_TH": "NLM (1976)", "ST": "T090", "PI": "Agriculture (1966-1975)", "MS": "The science of breeding, feeding and care of domestic animals; includes housing and nutrition.", "PM": "76", "HN": "76", "MR": "19890613", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D000822"}, {"RECTYPE": "D", "MH": "Animal Identification Systems", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Systems, Animal Identification", "MN": "E05.035", "MH_TH": "NLM (1978)", "ST": "T170", "AN": "does not include classif or taxonomy: for individual animals only", "MS": "Procedures for recognizing individual animals and certain identifiable characteristics pertaining to them; includes computerized methods, ear tags, etc.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "19920526", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D000823"}, {"RECTYPE": "D", "MH": "Animal Nutritional Physiological Phenomena", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Animal Nutritional Physiology Phenomena|T040|NON|EQV|NLM (2009)|080701|abcdef", "ENTRY": "Physiology, Veterinary Nutritional", "MN": "G07.203.650.161", "FX": "Animal Nutrition Sciences", "MH_TH": "NLM (2009)", "ST": "T040", "AN": "differentiate from ANIMAL FEED & DIET; ANIMAL NUTRITION SCIENCES is available for the discipline", "PI": "Nutrition (1966-1967)", "MS": "Nutritional physiology of animals.", "PM": "2009; see ANIMAL NUTRITION PHYSIOLOGY 2007-2008, see ANIMAL NUTRITION 1968-2006", "HN": "2009(1968)", "CATSH": "CAT LIST", "MR": "20160928", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000824"}, {"RECTYPE": "D", "MH": "Animal Structures", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Structures, Animal", "MN": "A13", "RH": "A13 - ANATOMY-ANIMAL STRUCTURES", "MH_TH": "NLM (1966)", "ST": "T017", "AN": "avoid: too general; prefer specifics", "PI": "specific animal/anatomy & histology (1966-1997)", "MS": "Organs and other anatomical structures of non-human vertebrate and invertebrate animals.", "PM": "1998; for ANIMAL ORGANS see ANIMAL 1986-2003", "HN": "1998 (1967); for ANIMAL ORGANS use ANIMALS 1986-2003", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D000825"}, {"RECTYPE": "D", "MH": "Animal Testing Alternatives", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Alternatives to Animal Testing|T062|NON|EQV|UNK (19XX)|840611|abcdef", "ENTRY": "Testing Alternatives, Animal", "MN": "E05.017.080.100", "MH_TH": "BIOETHICS (1989)", "ST": "T062", "MS": "Procedures, such as TISSUE CULTURE TECHNIQUES; mathematical models; etc., when used or advocated for use in place of the use of animals in research or diagnostic laboratories.", "PM": "85", "HN": "85", "MR": "20080708", "DA": "19840611", "DC": "1", "DX": "19850101", "UI": "D000826"}, {"RECTYPE": "D", "MH": "Animal Welfare", "AQ": "EC ES HI LJ OG SN ST TD", "ENTRY": "Welfare, Animal", "MN": "I01.880.604.100", "FX": "Euthanasia, Animal", "MH_TH": "NLM (1986)", "ST": "T052", "MS": "The protection of animals in laboratories or other specific environments by promoting their health through better nutrition, housing, and care.", "PM": "1986", "HN": "1986", "MR": "20030724", "DA": "19850225", "DC": "1", "DX": "19860101", "UI": "D000827"}, {"RECTYPE": "D", "MH": "Animal Population Groups", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Population Groups, Animal", "MN": "B01.050.050", "MH_TH": "NLM (2001)", "ST": "T096", "AN": "general or unspecified; prefer specifics", "MS": "Animals grouped according to ecological, morphological or genetic populations.", "PM": "2004; see ANIMALS 1963-2003", "HN": "2004 (1963)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D000828"}, {"RECTYPE": "D", "MH": "Animals, Domestic", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Farm Animals|T008|NON|NRW|NLM (1993)|910924|abcdef", "ENTRY": "Farm Animal", "MN": "B01.050.050.116", "MH_TH": "NLM (1966)", "ST": "T008", "AN": "general or unspecified; DOMESTICATION is also available", "MS": "Animals which have become adapted through breeding in captivity to a life intimately associated with humans. They include animals domesticated by humans to live and breed in a tame condition on farms or ranches for economic reasons, including LIVESTOCK (specifically CATTLE; SHEEP; HORSES; etc.), POULTRY; and those raised or kept for pleasure and companionship, e.g., PETS; or specifically DOGS; CATS; etc.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000829"}, {"RECTYPE": "D", "MH": "Animals, Laboratory", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Laboratory Animals|T008|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Laboratory Animal", "MN": "B01.050.050.199", "FX": "Laboratory Animal Science", "MH_TH": "NLM (1963)", "ST": "T008", "AN": "general or unspecified; prefer specifics", "MS": "Animals used or intended for use in research, testing, or teaching.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000830"}, {"RECTYPE": "D", "MH": "Animals, Newborn", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Animals, Neonatal|T008|NON|EQV|NLM (2007)|060308|abcdef", "ENTRY": "Newborn Animals", "MN": "B01.050.050.282", "MH_TH": "NLM (1966)", "ST": "T008", "AN": "NIM when experimental animal", "MS": "Refers to animals in the period of time just after birth.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000831"}, {"RECTYPE": "D", "MH": "Animals, Poisonous", "DE": "ANIMALS POIS", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Venomous Animals|T008|NON|REL|NLM (2024)|230314|abcdef", "ENTRY": "Venomous Animal", "MN": "B01.050.050.286", "MH_TH": "NLM (1968)", "ST": "T008", "AN": "coordinate with specific poisonous animal", "PI": "Animals (1966-1967)", "MS": "Animal population groups that produce BIOLOGICAL TOXINS.", "PM": "68", "HN": "68", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000832"}, {"RECTYPE": "D", "MH": "Animals, Suckling", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Suckling Animals", "MN": "B01.050.050.293", "MH_TH": "NLM (1979)", "ST": "T015", "AN": "suckled by mother or by bottle; coord with specific suckling; NIM when exper animal; suckling of animals (the act, as in the eff of suckling on animal physiol) goes under LACTATION; do not forget also to check tag ANIMALS", "MS": "Young, unweaned mammals. Refers to nursing animals whether nourished by their biological mother, foster mother, or bottle fed.", "PM": "87; was see under ANIMALS 1979-86", "HN": "87(79); was see under ANIMALS 1979-86", "MR": "20200902", "DA": "19780504", "DC": "1", "DX": "19870101", "UI": "D000833"}, {"RECTYPE": "D", "MH": "Animals, Wild", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Animals, Nondomesticated|T008|NON|REL|NLM (2020)|190501|abcdef", "ENTRY": "Wild Animals", "MN": "B01.050.050.300", "MH_TH": "NLM (1978)", "ST": "T008", "AN": "general or unspecified; do not  routinely add as a coordinate  with animals ordinarily considered wild such as LIONS; BEARS; etc.", "PI": "Animals (1966-1977)", "MS": "Animals considered to be wild or feral or not adapted for domestic use. It does not include wild animals in zoos for which ANIMALS, ZOO is available.", "PM": "87; was see under ANIMALS 1978-86", "HN": "87(78); was see under ANIMALS 1978-86", "MR": "20200902", "DA": "19770512", "DC": "1", "DX": "19870101", "UI": "D000835"}, {"RECTYPE": "D", "MH": "Animals, Zoo", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Zoo Animals", "MN": "B01.050.050.448", "MH_TH": "NLM (1968)", "ST": "T008", "AN": "coordinate with specific zoo animal", "PI": "Animals (1966-1967)", "MS": "Animal population groups or individual animals that reside in captivity at a zoological park.", "PM": "68", "HN": "68", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000836"}, {"RECTYPE": "D", "MH": "Anion Exchange Resins", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Anion Exchange Resin|T121|T122|T130|NON|EQV|NLM (2021)|200304|abbbcdef", "ENTRY": "Resins, Anion Exchange", "MN": "D27.720.470.420.050", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "0", "MS": "High-molecular-weight insoluble polymers that contain functional cationic groups capable of undergoing exchange reactions with anions.", "OL": "search ION EXCHANGE RESINS 1966-74", "PM": "91; was see under ION EXCHANGE RESINS 1975-90", "HN": "91(75); was see under ION EXCHANGE RESINS 1975-90", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000837"}, {"RECTYPE": "D", "MH": "Anions", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Anion|T196|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D01.248.497.158", "MH_TH": "NLM (1974)", "ST": "T196", "RN": "0", "AN": "GEN or unspecified; prefer specifics", "MS": "Negatively charged atoms, radicals or groups of atoms which travel to the anode or positive pole during electrolysis.", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000838"}, {"RECTYPE": "D", "MH": "Aniseikonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C11.744.116", "MH_TH": "NLM (1964)", "ST": "T184", "AN": "refractive error in which each eye sees a different size & shape of an object", "MS": "A condition in which the ocular image of an object as seen by one eye differs in size and shape from that seen by the other.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "19930806", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000839"}, {"RECTYPE": "D", "MH": "Anisoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylphenyl Ethers|T109|NON|EQV|UNK (19XX)|750208|abcdef", "ENTRY": "Ethers, Methylphenyl", "MN": "D02.455.426.559.389.657.654.158", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "Phenols (1966-1970)", "MS": "A group of compounds that are derivatives of methoxybenzene and contain the general formula R-C7H7O.", "OL": "use ANISOLES to search ANISOLE 1971-72 (as Prov)", "PM": "73", "HN": "73; was ANISOLE 1971-72 (Prov)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000840"}, {"RECTYPE": "D", "MH": "Anisomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Flagecidin|T109|T195|TRD|NRW|NLM (1996)|940720|abbcdef", "MN": "D03.383.773.050", "PA": "Protein Synthesis Inhibitors", "MH_TH": "NLM (1975)", "ST": "T195", "N1": "3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R-(2alpha,3alpha,4beta))-", "RN": "6C74YM2NGI", "RR": "22862-76-6 (Anisomycin)", "PI": "Pyrrolidines (1968-1974)", "MS": "An antibiotic isolated from various Streptomyces species. It interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system.", "PM": "91; was see under PYRROLIDINES 1975-90; FLAGECIDIN was see ANISOMYCIN 1975-95", "HN": "91(75); was see under PYRROLIDINES 1975-90; FLAGECIDIN was see ANISOMYCIN 1975-95", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000841"}, {"RECTYPE": "D", "MH": "Ankle", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "Tarsus|T029|NON|EQV|NLM (1988)|990101|abcdef", "ENTRY": "Ankles", "MN": "A01.378.610.050", "FX": "Tarsal Bones", "EC": "injuries:Ankle Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "primates only; use TARSUS, ANIMAL for non-primate vertebrates; differentiate from ANKLE JOINT; ANKLE BONES see TARSAL BONES is also available; do not confuse X ref TARSUS with tarsus or tarsal referring to the eyelid", "MS": "The region of the lower limb between the FOOT and the LEG.", "PM": "1963; see ANKLE INJURIES to search ANKLE/injuries 1966-91; for TARSUS see TARSUS 1988-2001", "HN": "1963; use ANKLE INJURIES to search ANKLE/injuries 1966-91", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D000842"}, {"RECTYPE": "D", "MH": "Ankle Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Tibiofibular Syndesmoses", "MN": "A02.835.583.378.062", "FX": "Ankle", "EC": "injuries:Ankle Injuries", "MH_TH": "NLM (1965)", "ST": "T030", "AN": "primates only; differentiation from ANKLE", "MS": "The joint that is formed by the inferior articular and malleolar articular surfaces of the TIBIA; the malleolar articular surface of the FIBULA; and the medial malleolar, lateral malleolar, and superior surfaces of the TALUS.", "OL": "use ANKLE INJURIES to search ANKLE JOINT/injuries 1966-91", "PM": "65; /injuries was ANKLE JOINT/injuries 1965-91", "HN": "65; /injuries was ANKLE JOINT/injuries 1965-91", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000843"}, {"RECTYPE": "D", "MH": "Ankylosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ankyloses", "MN": "C05.550.069", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Fixation and immobility of a joint.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000844"}, {"RECTYPE": "D", "MH": "Annelida", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Worms, Segmented|T204|NON|EQV|NLM (1998)|970203|abcdef", "ENTRY": "Worm, Segmented", "MN": "B01.050.500.091", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6340", "AN": "general or unspecified; prefer specifics", "MS": "A phylum of metazoan invertebrates comprising the segmented worms, and including marine annelids (POLYCHAETA), freshwater annelids, earthworms (OLIGOCHAETA), and LEECHES. Only the leeches are of medical interest. (Dorland, 27th ed)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000845"}, {"RECTYPE": "D", "MH": "Anniversaries and Special Events", "DE": "ANNIVERSARIES SPECIAL EVENTS", "PRINT ENTRY": "Dedications|T052|NON|NRW|UNK (19XX)|770505|abcdef", "ENTRY": "Special Event", "MN": "N04.452.822.070", "MH_TH": "NLM (1977)", "ST": "T051", "AN": "do not index here for anniversaries, centennials, etc. in historical articles; do not coordinate here for ANNIVERSARY REACTION", "MS": "Occasions to commemorate an event or occasions designated for a specific purpose.", "PM": "91; was see under PUBLIC RELATIONS 1977-90", "HN": "91(Aug 77); was see under PUBLIC RELATIONS 1977-90", "MR": "20060705", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D000846"}, {"RECTYPE": "D", "MH": "Annual Reports as Topic", "MN": "N04.452.070", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "coordinate with specific organization or society + geographic term if pertinent; do not confuse with Publication Type ANNUAL REPORT", "MS": "Works on annual statements reviewing the status of the administrative and operational functions and accomplishments of an institution or organization.", "PM": "2008; see ANNUAL REPORTS 1991-2007; see ORGANIZATION AND ADMINISTRATION 1977-1990", "HN": "2008(1977)", "MR": "20180713", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D000847"}, {"RECTYPE": "D", "MH": "Anodontia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Total Anodontia|T019|NON|NRW|NLM (2024)|221019|abcdef", "ENTRY": "Total Anodontias", "MN": "C16.131.850.800.100", "MH_TH": "NLM (1965)", "ST": "T019", "AN": "congen absence of teeth; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; congen absence of one or more teeth: do not confuse with JAW, EDENTULOUS (total lack of teeth in either jaw through disease or extraction), JAW, EDENTULOUS, PARTIALLY (partial lack in either jaw) or MOUTH, EDENTULOUS (total lack of teeth in both jaws through disease or extraction)", "MS": "Congenital absence of the teeth. It may involve all (total anodontia) or only some of the teeth (partial anodontia, hypodontia), or six or more of the teeth (oligodontia) and both the deciduous and the permanent dentition, or only teeth of the permanent dentition.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000848"}, {"RECTYPE": "D", "MH": "Anomia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Dysnomia|T048|NON|EQV|NLM (1998)|970312|abcdef", "ENTRY": "Nominal Dysphasias", "MN": "C23.888.592.604.150.500.090", "MH_TH": "NLM (1980)", "ST": "T048", "AN": "inability to name objects: do not confuse with ANOMIE (\"state of social disorganization & demoralization in society...\", often called \"anomia\")", "PI": "Aphasia (1966-1979)", "MS": "A language dysfunction characterized by the inability to name people and objects that are correctly perceived. The individual is able to describe the object in question, but cannot provide the name. This condition is associated with lesions of the dominant hemisphere involving the language areas, in particular the TEMPORAL LOBE. (From Adams et al., Principles of Neurology, 6th ed, p484)", "PM": "1991; see under APHASIA 1980-1990, see APHASIA 1975-1979", "HN": "1991(1980); use APHASIA 1975-1979", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19781214", "DC": "1", "DX": "19910101", "UI": "D000849"}, {"RECTYPE": "D", "MH": "Anomie", "PRINT ENTRY": "Social Disorganization|T054|NON|BRD|UNK (19XX)|740329|abcdef", "ENTRY": "Social Disorganizations", "MN": "I01.880.853.450.283", "FX": "Social Behavior Disorders", "MH_TH": "NLM (1971)", "ST": "T054", "AN": "do not confuse with ANOMIA (\"inability to name objects\")", "PI": "Social Problems (1968-1970)", "MS": "A state of social disorganization and demoralization in society which is largely the result of disharmony between cultural goals and the means for attaining them. This may be reflected in the behavior of the individual in many ways - non-conformity, social withdrawal, deviant behavior, etc.", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D000850"}, {"RECTYPE": "D", "MH": "Anonyms and Pseudonyms", "DE": "ANONYMS PSEUDONYMS", "PRINT ENTRY": "Pseudonyms|T170|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Pseudonym", "MN": "L01.559.598.400.556.283", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "Designations for persons whose names are not known or who wish to remain anonymous (anonyms) and for persons who wish to conceal or obscure their identity by assuming a fictitious name (pseudonyms).", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000851"}, {"RECTYPE": "D", "MH": "Anopheles", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Anopheles gambiae|T204|NON|NRW|NLM (2005)|040213|abcdef", "MN": "B01.050.500.131.617.720.500.500.750.712.500.875.120", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid7164", "RR": "txid7165", "AN": "mosquito; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111", "MS": "A genus of mosquitoes (CULICIDAE) that are known vectors of MALARIA.", "PM": "1966; for ANOPHELES GAMBIAE see ANOPHELES GAMBIAE 2005-2017", "HN": "1966", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000852"}, {"RECTYPE": "D", "MH": "Anophthalmos", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Anophthalmias", "MN": "C16.131.384.159", "MH_TH": "NLM (1966)", "ST": "T019", "AN": "absence of one or both eyes; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Congenital absence of the eye or eyes.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000853"}, {"RECTYPE": "D", "MH": "Anoplura", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sucking Lice|T204|NON|EQV|NLM (1998)|960710|abcdef", "ENTRY": "Sucking Louses", "MN": "B01.050.500.131.617.690.060", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid30005", "RR": "txid364330", "AN": "do not use /drug eff for insecticides: TN 111", "PI": "Lice (1966-1971)", "MS": "An order of insects comprising the sucking lice, which are blood-sucking ectoparasites of mammals. Recognized families include: Echinphthiriidae, Haematopinidae, and Pediculidae. The latter contains the medically important genera affecting humans: PEDICULUS and PHTHIRUS.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000854"}, {"RECTYPE": "D", "MH": "Anorexia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Anorexias", "MN": "C23.888.821.108", "FX": "Anorexia Nervosa", "MH_TH": "NLM (1975)", "ST": "T184", "AN": "ANOREXIA NERVOSA is also available", "MS": "The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.", "PM": "91; was see under EATING DISORDERS 1975-90", "HN": "91(75); was see under EATING DISORDERS 1975-90", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000855"}, {"RECTYPE": "D", "MH": "Anorexia Nervosa", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Nervosas, Anorexia", "MN": "F03.400.125", "FX": "Body Dysmorphic Disorders", "MH_TH": "NLM (1966)", "ST": "T048", "AN": "ANOREXIA is also available", "MS": "An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994)", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000856"}, {"RECTYPE": "D", "MH": "Olfaction Disorders", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Smell Dysfunction|T047|NON|NRW|NLM (2021)|OBSSR (2021)|200423|abcdeef", "ENTRY": "Smell Disorder", "MN": "C23.888.592.763.550", "FX": "Olfactory Nerve Diseases", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "Impaired ability to smell. This may be caused by OLFACTORY NERVE DISEASES; PARANASAL SINUS DISEASES; viral RESPIRATORY TRACT INFECTIONS; CRANIOCEREBRAL TRAUMA; SMOKING; and other conditions.", "PM": "2000; see ANOSMIA 1963-1999", "HN": "2000(1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000857"}, {"RECTYPE": "D", "MH": "Anovulation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Anovulations", "MN": "G08.686.784.690.080", "MH_TH": "NLM (1975)", "ST": "T047", "PI": "Ovulation (1966-1974)", "MS": "Suspension or cessation of OVULATION in animals or humans with follicle-containing ovaries (OVARIAN FOLLICLE). Depending on the etiology, OVULATION may be induced with appropriate therapy.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D000858"}, {"RECTYPE": "D", "MH": "Hypoxia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Oxygen Deficiency|T046|NON|EQV|UNK (19XX)|740329|OXYGEN DEFIC|abcdefv", "ENTRY": "Oxygen Deficiencies", "MN": "C23.888.852.079", "FX": "Hypoxia-Ischemia, Brain", "MH_TH": "UNK (19XX)", "ST": "T046", "AN": "do not confuse with HYPEROXIA; restrict to disease or clinical state in humans and vertebrates: do not use for anoxic or hypoxic state in invertebrates or micro-organisms (= OXYGEN or ANAEROBIOSIS); FETAL HYPOXIA, HYPOXIA, BRAIN and CELL HYPOXIA are also available", "MS": "Sub-optimal OXYGEN levels in the ambient air of living organisms.", "PM": "2017; for HYPOXIA see ANOXIA 1999-2016", "HN": "2017 (1966)", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000860"}, {"RECTYPE": "D", "MH": "Anserine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Beta Alanyl 3 Methylhistidine", "MN": "D12.644.456.345.159", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "L-Histidine, N-beta-alanyl-3-methyl-", "RN": "HDQ4N37UGV", "RR": "584-85-0 (Anserine)", "MS": "A dipeptide containing BETA-ALANINE.", "OL": "search DIPEPTIDES 1967-74 & PEPTIDES 1966", "PM": "91; was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66", "HN": "91(75); was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66", "MR": "20170208", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000861"}, {"RECTYPE": "D", "MH": "Ant Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE TO TU UR", "PRINT ENTRY": "Formicoidea Venoms|T123|T131|NON|EQV|UNK (19XX)|770426|abbcdef", "ENTRY": "Venoms, Formicoidea", "MN": "D23.946.833.065.055", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTIVENINS; /enzymol permitted", "PI": "Venoms (1966-1977)", "MS": "Venoms from the superfamily Formicoidea, Ants. They may contain protein factors and toxins, histamine, enzymes, and alkaloids and are often allergenic or immunogenic.", "PM": "91; was see under ARTHROPOD VENOMS 1978-90", "HN": "91(78); was see under ARTHROPOD VENOMS 1978-90", "MR": "20050630", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D000862"}, {"RECTYPE": "D", "MH": "Antacids", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antacid|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Agents, Alkalinizing", "MN": "D27.505.954.483.080", "FX": "Anti-Ulcer Agents", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000863"}, {"RECTYPE": "D", "MH": "Antarctic Regions", "AQ": "EH EP", "PRINT ENTRY": "Southern Pacific Ocean|T083|NON|NRW|NLM (2022)|201030|abcdef", "ENTRY": "Antarctica|T083|NON|EQV|NLM (2018)|170623|abcdef", "MN": "Z01.158", "MH_TH": "NLM (1966)", "ST": "T083", "MS": "The continent lying around the South Pole and the southern waters of the Atlantic, Pacific, and Indian Oceans. It includes the Falkland Islands Dependencies. (From Webster's New Geographical Dictionary, 1988, p55)", "MR": "20210630", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D000864"}, {"RECTYPE": "D", "MH": "Antazoline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenazoline|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Phosphate, Antazoline", "MN": "D03.383.129.308.040", "PA": "Histamine H1 Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1H-Imidazole-2-methanamine, 4,5-dihydro-N-phenyl-N-(phenylmethyl)-", "RN": "DHA8014SS1", "RR": "VPR5FPH326", "PI": "Imidazoles (1968-1975)", "MS": "An antagonist of histamine H1 receptors.", "PM": "91; was see under IMIDAZOLES 1975-90", "HN": "91(75); was see under IMIDAZOLES 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000865"}, {"RECTYPE": "D", "MH": "Antelopes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Hippotragines|T015|NON|BRD|UNK (19XX)|860418|abcdef", "ENTRY": "Hippotragine", "MN": "B01.050.150.900.649.313.500.380.100", "MH_TH": "NLM (1975)", "ST": "T015", "AN": "includes dik-dik, eland, gazelle, gnu, hartebeest, impala, springbok, wildebeest", "MS": "Any of various ruminant mammals of the order Bovidae. They include numerous species in Africa and the American pronghorn.", "PM": "91; was see under ARTIODACTYLA 1975-90", "HN": "91(75); was see under ARTIODACTYLA 1975-90", "MR": "20200902", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000866"}, {"RECTYPE": "D", "MH": "Anterior Chamber", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Chambers, Anterior", "MN": "A09.371.060.067", "MH_TH": "NLM (1964)", "ST": "T023", "MS": "The space in the eye, filled with aqueous humor, bounded anteriorly by the cornea and a small portion of the sclera and posteriorly by a small portion of the ciliary body, the iris, and that part of the crystalline lens which presents through the pupil. (Cline et al., Dictionary of Visual Science, 4th ed, p109)", "PM": "66; was see under AQUEOUS HUMOR 1963-65", "HN": "66(64); was see under AQUEOUS HUMOR 1963-65", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000867"}, {"RECTYPE": "D", "MH": "Anterior Compartment Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anterior Tibial Syndrome|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Tibial Syndromes, Anterior", "MN": "C14.907.303.063", "MH_TH": "NLM (1972)", "ST": "T047", "AN": "in tibia; note X ref: restricted to anterior muscle", "PI": "Vascular Diseases (1966-1971)", "MS": "Rapid swelling, increased tension, pain, and ischemic necrosis of the muscles of the anterior tibial compartment of the leg, often following excessive PHYSICAL EXERTION.", "PM": "91,72-80; was see under COMPARTMENT SYNDROMES 1981-90; was heading 1972-80", "HN": "91(81)72; was see under COMPARTMENT SYNDROMES 1981-90; was heading 1972-80", "CATSH": "CAT LIST", "MR": "20080709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000868"}, {"RECTYPE": "D", "MH": "Anterior Eye Segment", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Segments, Anterior Eye", "MN": "A09.371.060", "MH_TH": "NLM (1985)", "ST": "T023", "AN": "do not confuse with ANTERIOR CHAMBER", "PI": "Eye (1966-1984)", "MS": "The front third of the eyeball that includes the structures between the front surface of the cornea and the front of the VITREOUS BODY.", "PM": "85", "HN": "85", "MR": "20070709", "DA": "19840430", "DC": "1", "DX": "19850101", "UI": "D000869"}, {"RECTYPE": "D", "MH": "Anterior Horn Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Ventral Horn Neurons|T025|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Ventral Horn Neuron", "MN": "A11.671.655.500.050", "MH_TH": "NLM (1964)", "ST": "T025", "MS": "MOTOR NEURONS in the anterior (ventral) horn of the SPINAL CORD which project to SKELETAL MUSCLES.", "OL": "search MOTOR NEURONS 1966-74", "PM": "91; was see under MOTOR NEURONS 1973-90", "HN": "91(64); was see under MOTOR NEURONS 1964-90 (Prov 1964-72)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000870"}, {"RECTYPE": "D", "MH": "Anthelmintics", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vermifuges|T121|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Antihelmintics|T121|NON|EQV|NLM (2009)|071023|abcdef", "MN": "D27.505.954.122.250.075", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specific groups", "MS": "Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000871"}, {"RECTYPE": "D", "MH": "Anthocyanins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Leucoanthocyanidins|T109|NON|NRW|NLM (2003)|020628|abcdef", "MN": "D23.767.124", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A group of FLAVONOIDS derived from FLAVONOLS, which lack the ketone oxygen at the 4-position. They are glycosylated versions of cyanidin, pelargonidin or delphinidin. The conjugated bonds result in blue, red, and purple colors in flowers of plants.", "PM": "1963", "HN": "1963", "MR": "20210304", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D000872"}, {"RECTYPE": "D", "MH": "Anthracenes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D04.615.125", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "entry term ANTHRONES: for two ketone groups use ANTHRAQUINONES", "MS": "A group of compounds with three aromatic rings joined in linear arrangement.", "MR": "20230607", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000873"}, {"RECTYPE": "D", "MH": "Anthracosilicosis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Anthracosilicoses", "MN": "C24.800.834.201", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not coordinate with OCCUPATIONAL DISEASES", "MS": "A form of pneumoconiosis caused by inhalation of dust that contains both CARBON and crystalline SILICON DIOXIDE. These foreign matters induce fibrous nodule formation in the lung.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000874"}, {"RECTYPE": "D", "MH": "Anthralin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dithranol|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|741111|abbcdeeef", "ENTRY": "FNA, Ditranol", "MN": "D04.615.125.380.500", "PA": "Dermatologic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "U8CJK0JH5M", "RR": "480-22-8 (Anthralin)", "PI": "Anthracenes (1968-1974)", "MS": "An anthracene derivative that disrupts function and structure of MITOCHONDRIA and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.", "PM": "87; was see under ANTHRACENES 1975-86", "HN": "87(75); was see under ANTHRACENES 1975-86", "MR": "20230607", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D000875"}, {"RECTYPE": "D", "MH": "Anthramycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Antramycin|T109|T195|NON|EQV|FDA SRS (2014)|INN (19XX)|940825|abbcdeef", "MN": "D03.633.300.060", "PA": "Antibiotics, Antineoplastic", "MH_TH": "USAN (1966)", "ST": "T195", "N1": "2-Propenamide, 3-(5,10,11,11a-tetrahydro-9,11-dihydroxy-8-methyl-5-oxo-1H-pyrrolo(2,1-c)(1,4)benzodiazepin-2-yl)-, (11R-(2(E),11alpha,11abeta))-", "RN": "0WZD9Y66WN", "RR": "4803-27-4 (Anthramycin)", "PI": "Pyrroles (1972-1974)", "MS": "A broad-spectrum spectrum antineoplastic antibiotic isolated from Streptomyces refuineus var. thermotolerans. It has low toxicity, some activity against Trichomonas and Endamoeba, and inhibits RNA and DNA synthesis. It binds irreversibly to DNA.", "PM": "91; was see under BENZODIAZEPINONES 1975-90", "HN": "91(75); was see under BENZODIAZEPINONES 1975-90", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D000876"}, {"RECTYPE": "D", "MH": "Anthranilate Phosphoribosyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphoribosylanthranilate Pyrophosphorylase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Pyrophosphorylase, Phosphoribosylanthranilate", "MN": "D08.811.913.400.725.160", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "N-(5-Phospho-D-ribosyl)-anthranilate:pyrophosphate phospho-alpha-D-ribosyltransferase", "RN": "EC 2.4.2.18", "RR": "9059-35-2 (CAS RN)", "PI": "Pyrophosphoric Acids (1972-1974)", "MS": "An enzyme that catalyzes the formation of N-5'-phosphoribosylanthranilic acid from anthranilate and phosphoribosylpyrophosphate, the first step in tryptophan synthesis in E. coli. It exists in a complex with ANTHRANILATE SYNTHASE in bacteria. EC 2.4.2.18.", "PM": "91; was see under PENTOSYLTRANSFERASES 1975-90", "HN": "91(75); was see under PENTOSYLTRANSFERASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D000877"}, {"RECTYPE": "D", "MH": "Anthranilate Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Anthranilate Synthetase|T116|T126|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Synthetase, Anthranilate", "MN": "D08.811.600.085", "MH_TH": "NLM (1974)", "ST": "T126", "N1": "Chorismate pyruvate-lyase (amino-accepting)", "RN": "EC 4.1.3.27", "RR": "9031-59-8 (CAS RN)", "MS": "An enzyme that catalyzes the formation of anthranilate (o-aminobenzoate) and pyruvic acid from chorismate and glutamine. Anthranilate is the biosynthetic precursor of tryptophan and numerous secondary metabolites, including inducible plant defense compounds. EC 4.1.3.27.", "PM": "74", "HN": "74", "MR": "20040719", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D000878"}, {"RECTYPE": "D", "MH": "Anthraquinones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dianthrones|T109|NON|NRW|NLM (2024)|220808|abcdef", "ENTRY": "Derivative, Anthraquinone", "MN": "D04.615.125.380.625", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds based on ANTHRACENES which contain two KETONES in any position. Substitutions can be in any position except on the ketone groups.", "PM": "1966", "HN": "1966", "MR": "20230607", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000880"}, {"RECTYPE": "D", "MH": "Anthrax", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Bacillus anthracis Infections", "MN": "C01.150.252.410.090.072", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An acute infection caused by the spore-forming bacteria BACILLUS ANTHRACIS. It commonly affects hoofed animals such as sheep and goats. Infection in humans often involves the skin (cutaneous anthrax), the lungs (inhalation anthrax), or the gastrointestinal tract. Anthrax is not contagious and can be treated with antibiotics.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000881"}, {"RECTYPE": "D", "MH": "Haplorhini", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Monkeys|T015|NON|NRW|UNK (19XX)|800522|abcdef", "ENTRY": "Monkey", "MN": "B01.050.150.900.649.313.988.400", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid376913", "RR": "txid314293", "AN": "note entry terms; specific terms for many Old World & New World  monkeys are available", "MS": "A suborder of PRIMATES consisting of six families: CEBIDAE (some New World monkeys), ATELIDAE (some New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), CALLITRICHINAE (marmosets and tamarins), and HOMINIDAE (humans and great apes).", "OL": "use HAPLORHINI to search ANTHROPOIDEA 1975-91 & MONKEYS 1966-80; use PRIMATES to search ANTHROPOIDS 1966-74", "PM": "92; was ANTHROPOIDEA 1981-91; was ANTHROPOIDS see under PRIMATES 1963-80; MONKEYS was heading 1963-80", "HN": "92; was ANTHROPOIDEA 1981-91; was ANTHROPOIDS see under PRIMATES 1963-80; MONKEYS was heading 1963-80", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D000882"}, {"RECTYPE": "D", "MH": "Anthropology", "DE": "ANTHROPOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "I01.076", "FX": "Hominidae", "MH_TH": "POPLINE (1984)", "ST": "T090", "AN": "HOMINIDAE is available as taxonomic Man", "MS": "The science devoted to the comparative study of man.", "CATSH": "CAT LIST", "MR": "19991228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000883"}, {"RECTYPE": "D", "MH": "Anthropology, Cultural", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Ethnography|T090|NON|NRW|NLM (1993)|911106|abcdef", "ENTRY": "Material Cultures", "MN": "I01.076.201", "FX": "Qualitative Research", "MH_TH": "NLM (1978)", "ST": "T090", "AN": "IM as the discipline (education, history, etc) only; NIM with no qualifiers as a coordinate", "PI": "Mongoloid Race (1966-1967)", "MS": "Study of social phenomena which characterize the learned, shared, and transmitted social activities of particular ethnic groups with focus on the causes, consequences, and complexities of human social and cultural variability.", "PM": "68", "HN": "68", "MR": "20181011", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000884"}, {"RECTYPE": "D", "MH": "Anthropology, Physical", "DE": "ANTHROPOL PHYSICAL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Physical Anthropology|T090|NON|EQV|NLM (1994)|920821|PHYSICAL ANTHROPOL|abcdefv", "MN": "I01.076.368", "FX": "Genetics, Medical", "MH_TH": "NLM (1968)", "ST": "T090", "AN": "index IM for the specialty; NIM as a coordinate", "PI": "Genetics, Medical (1966-1967)", "MS": "The comparative science dealing with the physical characteristics of humans as related to their origin, evolution, and development in the total environment.", "PM": "68", "HN": "68", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D000885"}, {"RECTYPE": "D", "MH": "Anthropometry", "AQ": "HI IS MT", "MN": "N06.850.505.200.100", "FX": "Body Weights and Measures", "MH_TH": "POPLINE (1978)", "ST": "T062", "AN": "primate only; consider also specific terms under BODY WEIGHTS AND MEASURES", "MS": "The technique that deals with the measurement of the size, weight, and proportions of the human or other primate body.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000886"}, {"RECTYPE": "D", "MH": "Anthroposophy", "AQ": "HI PX", "MN": "K01.844.058", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "Knowledge of the nature of man. A spiritual and mystical doctrine that grew out of theosophy and derives mainly from the philosophy of Rudolph Steiner, Austrian social philosopher (1861-1925). (Webster, 3d ed)", "PM": "1967,1963-1965", "HN": "1967(1963)", "CATSH": "CAT LIST", "MR": "20210304", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000887"}, {"RECTYPE": "D", "MH": "Antibodies, Anti-Idiotypic", "DE": "ANTIBODIES ANTI ID", "DS": "ANTIBODIES ANTIIDIOTYPIC", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Antiglobulins|T129|NON|BRD|UNK (19XX)|740329|abcdef", "ENTRY": "Internal Image Antibodies", "MN": "D12.776.377.715.548.114.071", "PA": "Immunologic Factors", "FX": "Molecular Mimicry", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "MS": "Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.", "OL": "use ANTIBODIES, ANTI-IDIOTYPIC to search ANTI-ANTIBODIES 1966-89", "PM": "90; was ANTI-ANTIBODIES 1967-89", "HN": "90; was ANTI-ANTIBODIES 1966-89 (Prov 1966)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000888"}, {"RECTYPE": "D", "MH": "Anti-Arrhythmia Agents", "DS": "ANTIARRHYTHMIA AGENTS", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Myocardial Depressants|T121|NON|REL|UNK (19XX)|750711|abcdef", "ENTRY": "Drugs, Antiarrhythmic", "MN": "D27.505.954.411.097", "FX": "Calcium Channel Blockers", "MH_TH": "NLM (1976)", "ST": "T121", "RN": "0", "AN": "consider also ARRHYTHMIAS, CARDIAC /drug ther", "MS": "Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.", "OL": "use ANTI-ARRHYTHMIA AGENTS to search MYOCARDIAL DEPRESSANTS 1966-75", "PM": "76; was MYOCARDIAL DEPRESSANTS 1963-75", "HN": "76; was NON MESH before 1976; MYOCARDIAL DEPRESSANTS was heading 1963-75", "MR": "20200527", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D000889"}, {"RECTYPE": "D", "MH": "Anti-Infective Agents", "DE": "ANTI INFECT AGENTS", "DS": "ANTIINFECTIVE AGENTS", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Microbicides|T121|NON|NRW|NLM (2003)|010912|abcdef", "ENTRY": "Anti Microbial Agents", "MN": "D27.505.954.122", "FX": "Antiprotozoal Agents", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specific groups", "MS": "Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000890"}, {"RECTYPE": "D", "MH": "Anti-Infective Agents, Local", "DE": "ANTI INFECT AGENTS LOCAL", "DS": "ANTIINFECTIVE AGENTS LOCAL", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Microbicides, Topical|T121|NON|NRW|NLM (2003)|010912|abcdef", "ENTRY": "Topical Microbicides", "MN": "D27.505.954.122.187", "FX": "Disinfectants", "MH_TH": "NLM (1967)", "ST": "T121", "RN": "0", "MS": "Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects.", "OL": "use ANTI-INFECTIVE AGENTS, LOCAL to search ANTISEPTICS 1966; search ANTISEPTICS, HALOGEN & ANTISEPTICS, MERCURIAL & ANTISEPTICS, QUATERNARY AMMONIUM under ANTI-INFECTIVE AGENTS 1966", "PM": "67; ANTISEPTICS & ANTISEPTICS, HALOGEN & ANTISEPTICS, MERCURIAL & ANTISEPTICS, QUATERNARY AMMONIUM were headings 1963-66", "HN": "67; ANTISEPTICS & ANTISEPTICS, HALOGEN & ANTISEPTICS, MERCURIAL & ANTISEPTICS, QUATERNARY AMMONIUM were headings 1963-66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000891"}, {"RECTYPE": "D", "MH": "Anti-Infective Agents, Urinary", "DE": "ANTI INFECT AGENTS URINARY", "DS": "ANTIINFECTIVE AGENTS URINARY", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiseptics, Urinary|T121|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Urinary Antiseptics", "MN": "D27.505.954.122.237", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "consider also URINARY TRACT INFECTIONS /drug ther", "MS": "Substances capable of killing agents causing urinary tract infections or of preventing them from spreading.", "PM": "66", "HN": "66", "MR": "20210708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000892"}, {"RECTYPE": "D", "MH": "Anti-Inflammatory Agents", "DE": "ANTI INFLAMM AGENTS", "DS": "ANTIINFLAMMATORY AGENTS", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiinflammatory Agent|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Anti Inflammatory Agents", "MN": "D27.505.954.158", "MH_TH": "NLM (1964)", "ST": "T121", "RN": "0", "AN": "do not confuse with INFLAMMATION MEDIATORS", "MS": "Substances that reduce or suppress INFLAMMATION.", "PM": "66", "HN": "66(64)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000893"}, {"RECTYPE": "D", "MH": "Anti-Inflammatory Agents, Non-Steroidal", "DE": "NSAID", "DS": "ANTIINFLAMMATORY AGENTS NONSTEROIDAL", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nonsteroidal Anti-Inflammatory Agent|T121|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Nonsteroidal Antiinflammatory Agents", "MN": "D27.505.954.329.030", "MH_TH": "NLM (1987)", "ST": "T121", "RN": "0", "PI": "Anti-Inflammatory Agents (1966-1986)", "MS": "Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.", "OL": "use ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL to search ANALGESICS, ANTI-INFLAMMATORY 1975-89", "PM": "87; ANALGESICS, ANTI-INFLAMMATORY was heading 1975-89", "HN": "87; ANALGESICS, ANTI-INFLAMMATORY was heading 1975-89", "MR": "20210630", "DA": "19860623", "DC": "1", "DX": "19870101", "UI": "D000894"}, {"RECTYPE": "D", "MH": "Anti-Ulcer Agents", "DS": "ANTIULCER AGENTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Drugs, Anti-Ulcer", "MN": "D27.505.954.483.203", "FX": "Histamine H2 Antagonists", "MH_TH": "NLM (1977)", "ST": "T121", "RN": "0", "AN": "restrict to gastrointestinal ulcers", "PI": "Gastrointestinal Agents (1966-1976)", "MS": "Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.", "PM": "77", "HN": "77", "MR": "20050630", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D000897"}, {"RECTYPE": "D", "MH": "Antibiosis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Microbial Antagonism|T070|NON|EQV|UNK (19XX)|860619|abcdef", "ENTRY": "Microbial Antagonisms", "MN": "G16.062", "MH_TH": "NLM (1965)", "ST": "T070", "MS": "A natural association between organisms that is detrimental to at least one of them. This often refers to the production of chemicals by one microorganism that is harmful to another.", "PM": "72", "HN": "72(65)", "CATSH": "CAT LIST", "MR": "20160219", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000898"}, {"RECTYPE": "D", "MH": "Aurodox", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Goldinodox|T109|T121|NON|EQV|UNK (19XX)|800331|abbcdef", "ENTRY": "X 5108", "MN": "D02.455.326.271.665.155", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1976)", "ST": "T121", "N1": "Mocimycin, 1-methyl-", "RN": "12704-90-4", "PI": "Pyridones (1974-1975)", "MS": "Antibiotic obtained from a Streptomyces variant considered as possibly effective against Streptococcus pyogenes infections. It may promote growth in poultry.", "OL": "use AURODOX to search ANTIBIOTIC X 5108 1976-90", "PM": "91; was ANTIBIOTIC X 5108 see under ANTIBIOTICS 1976-90", "HN": "91(76); was ANTIBIOTIC X 5108 see under ANTIBIOTICS 1976-90", "MR": "20040707", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D000899"}, {"RECTYPE": "D", "MH": "Anti-Bacterial Agents", "DS": "ANTIBACTERIAL AGENTS", "AQ": "AD AE AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bacteriocide|T195|NON|NRW|NLM (2021)|191119|abcdef", "ENTRY": "Compounds, Anti-Bacterial", "MN": "D27.505.954.122.085", "MH_TH": "NLM (2004)", "ST": "T195", "RN": "0", "MS": "Substances that inhibit the growth or reproduction of BACTERIA.", "PM": "2004; see ANTIBIOTICS 1963-2003", "HN": "2004(1963)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000900"}, {"RECTYPE": "D", "MH": "Antibiotics, Antineoplastic", "DE": "ANTIBIOTICS ANTINEOPL", "AQ": "AD AE AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cytotoxic Antibiotics|T121|NON|NRW|UNK (19XX)|740320|CYTOTOX ANTIBIOTICS|abcdefv", "ENTRY": "Antibiotics, Cytotoxic|T121|NON|NRW|NLM (1996)|950316|ANTIBIOTICS CYTOTOX|abcdefv", "MN": "D27.505.954.248.106", "MH_TH": "NLM (1967)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Antineoplastic Agents (1966)", "MS": "Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.", "PM": "67", "HN": "67", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000903"}, {"RECTYPE": "D", "MH": "Antibiotics, Antitubercular", "AQ": "AD AE AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Antitubercular Antibiotics", "MN": "D27.505.954.122.085.255.135", "MH_TH": "NLM (1975)", "ST": "T195", "RN": "0", "PI": "Antitubercular Agents (1966-1974)", "MS": "Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic.", "PM": "75", "HN": "75", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D000904"}, {"RECTYPE": "D", "MH": "Antibodies", "AQ": "AD AE AN BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "MN": "D12.776.377.715.548.114", "PA": "Immunologic Factors", "FX": "Antigen-Antibody Reactions", "EC": "deficiency:Immunologic Deficiency Syndromes", "MH_TH": "POPLINE (1978)", "ST": "T129", "RN": "0", "MS": "Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).", "MR": "20180124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000906"}, {"RECTYPE": "D", "MH": "Antibodies, Bacterial", "DE": "ANTIBODIES BACT", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Bacterial Antibodies|T116|T129|NON|EQV|UNK (19XX)|740329|BACT ANTIBODIES|abbcdefv", "MN": "D12.776.377.715.548.114.125", "PA": "Immunologic Factors", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "AN": "coordinate with specific bacterium /immunol; do not coordinate with ANTIBODY FORMATION for /biosyn", "PI": "Antibodies (1966-1972)", "MS": "Immunoglobulins produced in a response to BACTERIAL ANTIGENS.", "PM": "73", "HN": "73", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000907"}, {"RECTYPE": "D", "MH": "Antibodies, Fungal", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Fungal Antibodies|T116|T129|NON|EQV|UNK (19XX)|740329|abbcdef", "MN": "D12.776.377.715.548.114.179", "PA": "Immunologic Factors", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "AN": "coordinate IM with specific fungus /immunol (IM); do not coordinate with ANTIBODY FORMATION for /biosyn", "PI": "Antibodies (1966-1972)", "MS": "Immunoglobulins produced in a response to FUNGAL ANTIGENS.", "PM": "73", "HN": "73", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000908"}, {"RECTYPE": "D", "MH": "Antibodies, Helminth", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Helminth Antibodies|T129|NON|EQV|UNK (19XX)|870320|abcdef", "MN": "D12.776.377.715.548.114.185", "PA": "Immunologic Factors", "MH_TH": "NLM (1988)", "ST": "T129", "RN": "0", "AN": "coordinate IM with specific helminth /immunol (IM); do not coordinate with ANTIBODY FORMATION for /biosyn", "PI": "IgE (1971-1987)", "MS": "Immunoglobulins produced in a response to HELMINTH ANTIGENS.", "PM": "88", "HN": "88", "MR": "20100625", "DA": "19870320", "DC": "1", "DX": "19880101", "UI": "D000909"}, {"RECTYPE": "D", "MH": "Antibodies, Heterophile", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Xenoantibodies|T116|T129|NON|EQV|NLM (1990)|890110|abbcdef", "ENTRY": "Xenogenic Antibodies", "MN": "D12.776.377.715.548.114.191", "PA": "Immunologic Factors", "MH_TH": "NLM (1964)", "ST": "T129", "RN": "0", "AN": "do not coordinate with ANTIBODY FORMATION for /biosyn", "MS": "Antibodies elicited in a different species from which the antigen originated. These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are Forssman, Hanganutziu-Deicher (H-D), and Paul-Bunnell (P-B). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification.", "PM": "1987; see ANTIBODIES, HETEROTYPIC 1964-1986; FORSSMAN ANTIBODY was indexed under ANTIBODIES, HETEROPHILE 1985-2004", "HN": "1987 (1964)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000910"}, {"RECTYPE": "D", "MH": "Antibodies, Monoclonal", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "PRINT ENTRY": "Monoclonal Antibody|T129|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Antibody, Monoclonal", "MN": "D12.776.377.715.548.114.224", "PA": "Immunologic Factors", "FX": "Hybridomas", "MH_TH": "NLM (1982)", "ST": "T129", "RN": "0", "AN": "do not coordinate with ANTIBODY FORMATION for biosyn; ANTIBODY-TOXIN CONJUGATES is available as a toxin carrier: see note there", "PI": "B Lymphocytes (1975-1981)", "MS": "Antibodies produced by a single clone of cells.", "PM": "82", "HN": "82", "MR": "20200116", "DA": "19810520", "DC": "1", "DX": "19820101", "UI": "D000911"}, {"RECTYPE": "D", "MH": "Antibodies, Neoplasm", "DE": "ANTIBODIES NEOPL", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Tumor Antibodies|T129|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Antibodies, Tumor", "MN": "D12.776.377.715.548.114.240", "PA": "Immunologic Factors", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "AN": "coordinate IM with required neoplasm terms with /immunol (IM); do not coordinate with ANTIBODY FORMATION for /biosyn", "PI": "Antibodies (1966-1972)", "MS": "Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS.", "PM": "73", "HN": "73", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000912"}, {"RECTYPE": "D", "MH": "Antibodies, Protozoan", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Protozoan Antibodies|T129|NON|EQV|UNK (19XX)|870316|abcdef", "MN": "D12.776.377.715.548.114.252", "PA": "Immunologic Factors", "MH_TH": "NLM (1988)", "ST": "T129", "RN": "0", "AN": "coordinate IM with specific protozoan /immunol (IM); do not coordinate with ANTIBODY FORMATION for /biosyn", "PI": "Antigens, Protozoan/immunology (1985-1987)", "MS": "Immunoglobulins produced in a response to PROTOZOAN ANTIGENS.", "PM": "88", "HN": "88", "MR": "20100625", "DA": "19870316", "DC": "1", "DX": "19880101", "UI": "D000913"}, {"RECTYPE": "D", "MH": "Antibodies, Viral", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Viral Antibodies|T116|T129|NON|EQV|UNK (19XX)|740329|abbcdef", "MN": "D12.776.377.715.548.114.254", "PA": "Immunologic Factors", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "AN": "coordinate IM with specific virus /immunol (IM); do not coordinate with ANTIBODY FORMATION for /biosyn", "PI": "Antibodies (1966-1972)", "MS": "Immunoglobulins produced in response to VIRAL ANTIGENS.", "PM": "73", "HN": "73", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000914"}, {"RECTYPE": "D", "MH": "Antibody Affinity", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Avidity, Antibody|T081|NON|NRW|UNK (19XX)|771202|abcdef", "ENTRY": "Avidities, Antibody", "MN": "G12.122.125", "MH_TH": "NLM (1979)", "ST": "T081", "AN": "do not confuse with BINDING SITES, ANTIBODY or ANTIGENIC DETERMINANTS", "PI": "Binding Sites, Antibody (1973-1978)", "MS": "A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of \"avidity,\" which refers to the strength of the antigen-antibody bond after formation of reversible complexes.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19771202", "DC": "1", "DX": "19790101", "UI": "D000915"}, {"RECTYPE": "D", "MH": "Antibody Diversity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Germ Line Theory|T078|NON|NRW|UNK (19XX)|790223|abcdef", "ENTRY": "Theory, Germ Line", "MN": "G12.500.199", "MH_TH": "NLM (1980)", "ST": "T044", "PI": "Antibody Specificity (1970-1979)", "MS": "The phenomenon of immense variability characteristic of ANTIBODIES. It enables the IMMUNE SYSTEM to react specifically against the essentially unlimited kinds of ANTIGENS it encounters. Antibody diversity is accounted for by three main theories: (1) the Germ Line Theory, which holds that each antibody-producing cell has genes coding for all possible antibody specificities, but expresses only the one stimulated by antigen; (2) the Somatic Mutation Theory, which holds that antibody-producing cells contain only a few genes, which produce antibody diversity by mutation; and (3) the Gene Rearrangement Theory, which holds that antibody diversity is generated by the rearrangement of IMMUNOGLOBULIN VARIABLE REGION gene segments during the differentiation of the ANTIBODY-PRODUCING CELLS.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19790223", "DC": "1", "DX": "19800101", "UI": "D000916"}, {"RECTYPE": "D", "MH": "Antibody Formation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Antibody Response|T043|NON|EQV|NLM (1998)|960725|abcdef", "ENTRY": "Responses, Antibody", "MN": "G12.450.050.370.250", "FX": "Clonal Selection, Antigen-Mediated", "MH_TH": "NLM (1966)", "ST": "T043", "AN": "general only: do not use as coordinate for formation of specific antibodies", "MS": "The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS.", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000917"}, {"RECTYPE": "D", "MH": "Antibody Specificity", "AQ": "DE GE IM PH RE", "ENTRY": "Specificity, Antibody", "MN": "G12.100", "FX": "T-Cell Antigen Receptor Specificity", "MH_TH": "NLM (1970)", "ST": "T044", "AN": "coord IM with specific antibody (IM)", "PI": "Antibodies (1966-1969)", "MS": "The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.", "PM": "72", "HN": "72(70)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000918"}, {"RECTYPE": "D", "MH": "Antibody-Coated Bacteria Test, Urinary", "DE": "ACBU", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Urinary Antibody Coated Bacteria Test", "MN": "E05.478.594.049", "MH_TH": "NLM (1980)", "ST": "T059", "PI": "Urinary Tract Infections (1974-1979)", "MS": "Fluorescent antibody technique for visualizing antibody-bacteria complexes in urine. The presence or absence of antibody-coated bacteria in urine correlates with localization of urinary tract infection in the kidney or bladder, respectively.", "PM": "91; was see under FLUORESCENT ANTIBODY TECHNIQUE 1980-90", "HN": "91(80); was see under FLUORESCENT ANTIBODY TECHNIQUE 1980-90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19790307", "DC": "1", "DX": "19910101", "UI": "D000919"}, {"RECTYPE": "D", "MH": "Antibody-Dependent Cell Cytotoxicity", "DE": "ANTIBODY DEPENDENT CELL CYTOTOX", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Cytotoxicity, Antibody-Dependent Cell|T043|NON|EQV|UNK (19XX)|770513|CYTOTOX ANTIBODY DEPENDENT CELL|abcdefv", "ENTRY": "Cytoxicity, Antibody-Dependent Cell", "MN": "G12.287.070", "MH_TH": "NLM (1978)", "ST": "T043", "PI": "Lymphocytes (1966-1977)", "MS": "The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a \"killer\" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19770513", "DC": "1", "DX": "19780101", "UI": "D000920"}, {"RECTYPE": "D", "MH": "Antibody-Producing Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Immunoglobulin-Secreting Cells|T025|NON|NRW|UNK (19XX)|860618|IG SECRET CELLS|abcdefv", "ENTRY": "Immunoglobulin-Secreting Cell", "MN": "A15.382.032", "FX": "Hemolytic Plaque Technique", "MH_TH": "NLM (1970)", "ST": "T025", "PI": "Antibody Formation (1966-1969)", "MS": "Cells of the lymphoid series that can react with antigen to produce specific cell products called antibodies. Various cell subpopulations, often B-lymphocytes, can be defined, based on the different classes of immunoglobulins that they synthesize.", "PM": "72", "HN": "72(70)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000921"}, {"RECTYPE": "D", "MH": "Immunotoxins", "AQ": "AD AE AN BL CF CH CL DE EC GE HI IM IP ME PD PK PO RE TO TU UL UR", "PRINT ENTRY": "Toxins, Targeted|T121|NON|BRD|UNK (19XX)|860325|abcdef", "ENTRY": "Toxin, Targeted", "MN": "D27.888.569.279", "PA": "Immunologic Factors", "MH_TH": "NLM (1987)", "ST": "T129", "RN": "0", "AN": "coordinate IM with specific toxin (IM) + specific immune substance (NIM)", "PI": "Ricin (1978-1985)", "MS": "Semisynthetic conjugates of various toxic molecules, including RADIOACTIVE ISOTOPES and bacterial or plant toxins, with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; and ANTIGENS. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect.", "OL": "use IMMUNOTOXINS to search ANTIBODY-TOXIN CONJUGATES 1987-89", "PM": "90; was ANTIBODY-TOXIN CONJUGATES 1987-89", "HN": "90; was ANTIBODY-TOXIN CONJUGATES 1987-89", "MR": "20210630", "DA": "19860325", "DC": "1", "DX": "19870101", "UI": "D000922"}, {"RECTYPE": "D", "MH": "Anticestodal Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Taeniacides|T121|NON|NRW|UNK (19XX)|741018|abcdef", "ENTRY": "Agents, Scolicidal", "MN": "D27.505.954.122.250.075.100.040", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Anthelmintics (1966-1974)", "MS": "Agents used to treat tapeworm infestations in man or animals.", "HN": "1975", "MR": "20180201", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D000923"}, {"RECTYPE": "D", "MH": "Anticholesteremic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hypocholesteremic Agents|T121|NON|REL|UNK (19XX)|740329|abcdef", "ENTRY": "Drugs, Anticholesteremic", "MN": "D27.505.954.557.500.202", "MH_TH": "NLM (1964)", "ST": "T121", "RN": "0", "MS": "Substances used to lower plasma CHOLESTEROL levels.", "PM": "66", "HN": "66(64)", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000924"}, {"RECTYPE": "D", "MH": "Anticoagulants", "DE": "ANTICOAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Anticoagulant Drug|T121|NON|EQV|NLM (2022)|201007|abcdef", "ENTRY": "Thrombin Inhibitors, Indirect", "MN": "D27.505.954.502.119", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Agents that prevent BLOOD CLOTTING.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000925"}, {"RECTYPE": "D", "MH": "Anticodon", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Anticodons", "MN": "G05.360.335.060", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "MS": "The sequential set of three nucleotides in TRANSFER RNA that interacts with its complement in MESSENGER RNA, the CODON, during translation in the ribosome.", "OL": "search RNA, TRANSFER 1974", "PM": "91; was see under RNA, TRANSFER 1975-90", "HN": "91(75); was see under RNA, TRANSFER 1975-90", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000926"}, {"RECTYPE": "D", "MH": "Anticonvulsants", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiepileptic Drug|T121|NON|REL|NLM (2021)|191121|abcdef", "ENTRY": "Drugs, Antiepileptic", "MN": "D27.505.954.427.080", "FX": "Seizures", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Drugs used to prevent SEIZURES or reduce their severity.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000927"}, {"RECTYPE": "D", "MH": "Antidepressive Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thymoleptics|T121|NON|NRW|UNK (19XX)|771118|abcdef", "ENTRY": "Medication, Antidepressant", "MN": "D27.505.954.427.700.122", "FX": "Monoamine Oxidase Inhibitors", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specific groups", "MS": "Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.", "OL": "use ANTIDEPRESSIVE AGENTS to search PSYCHIC ENERGIZERS 1966-94; use ANTIDEPRESSIVE AGENTS & TRANQUILIZING AGENTS to search THYMOLEPTICS 1969-78", "PM": "66; PSYCHIC ENERGIZERS was see ANTIDEPRESSIVE AGENTS 1963-94; THYMOLEPTICS was see TRANQUILIZING AGENTS 1969-78", "HN": "66; PSYCHIC ENERGIZERS was see ANTIDEPRESSIVE AGENTS 1963-94; THYMOLEPTICS was see TRANQUILIZING AGENTS 1969-78", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000928"}, {"RECTYPE": "D", "MH": "Antidepressive Agents, Tricyclic", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tricyclic Antidepressive Agents|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Tricyclic Antidepressants", "MN": "D27.505.954.427.700.122.055", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Antidepressive Agents (1968-1974)", "MS": "Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.", "PM": "75", "HN": "75", "MR": "20210630", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D000929"}, {"RECTYPE": "D", "MH": "Antidiarrheals", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiperistaltics|T121|NON|REL|NLM (1996)|941116|abcdef", "ENTRY": "Drugs, Antiperistaltic", "MN": "D27.505.954.483.161", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "consider also DIARRHEA /drug ther", "PI": "Gastrointestinal Agents (1967-1974)", "MS": "Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.", "OL": "search GASTROINTESTINAL AGENTS 1969-74", "PM": "75; was see under GASTROINTESTINAL AGENTS 1969-74", "HN": "75; was see under GASTROINTESTINAL AGENTS 1969-74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D000930"}, {"RECTYPE": "D", "MH": "Antidotes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Theriacs|T121|NON|EQV|NLM (2004)|030128|abcdef", "MN": "D27.720.799.037", "FX": "Cholinesterase Reactivators", "MH_TH": "NLM (1964)", "ST": "T121", "RN": "0", "MS": "Agents counteracting or neutralizing the action of POISONS.", "PM": "66", "HN": "66(64)", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000931"}, {"RECTYPE": "D", "MH": "Antiemetics", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiemetic Drug|T121|NON|EQV|NLM (2022)|201007|abcdef", "ENTRY": "Effects, Antiemetic", "MN": "D27.505.954.483.200", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "note entry term ANTIEMETIC EFFECT: use only for the antiemetic effect of a chemical substance", "MS": "Drugs used to prevent NAUSEA or VOMITING.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000932"}, {"RECTYPE": "D", "MH": "Antifibrinolytic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiplasmins|T121|NON|NRW|UNK (19XX)|781215|abcdef", "ENTRY": "Inhibitors, Plasmin", "MN": "D27.505.954.502.270.463.091", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.", "PM": "66", "HN": "66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000933"}, {"RECTYPE": "D", "MH": "Antifoaming Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Foam Retardants|T120|NON|NRW|UNK (19XX)|760413|abcdef", "ENTRY": "Retardants, Foam", "MN": "D27.720.877.048", "MH_TH": "NLM (1977)", "ST": "T120", "RN": "0", "PI": "Surface-Active Agents (1966-1976)", "MS": "Agents used to prevent the formation of foam or to treat flatulence or bloat.", "PM": "91; was see under SURFACE-ACTIVE AGENTS 1977-90", "HN": "91(77); was see under SURFACE-ACTIVE AGENTS 1977-90", "MR": "20130708", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D000934"}, {"RECTYPE": "D", "MH": "Antifungal Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fungicides, Therapeutic|T121|NON|EQV|UNK (19XX)|740329|FUNGICIDES THER|abcdefv", "ENTRY": "Antifungal Antibiotics", "MN": "D27.505.954.122.136", "FX": "Fungicides, Industrial", "MH_TH": "NLM (1967)", "ST": "T121", "RN": "0", "AN": "used in therapy: differentiate from FUNGICIDES, INDUSTRIAL; for resistance to antifungal agents, DRUG RESISTANCE, FUNGAL and DRUG RESISTANCE, MULTIPLE, FUNGAL are available", "MS": "Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.", "PM": "1967; for ANTIBIOTICS, ANTIFUNGAL see ANTIBIOTICS, ANTIFUNGAL 1967-2009", "HN": "1967", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000935"}, {"RECTYPE": "D", "MH": "Antigen-Antibody Complex", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immune Complex|T116|T129|NON|EQV|NLM (1993)|911218|abbcdef", "ENTRY": "Complexes, Immune", "MN": "D23.050.101", "PA": "Immunologic Factors", "FX": "Immune Complex Diseases", "MH_TH": "NLM (1970)", "ST": "T129", "RN": "0", "PI": "Antigens (1966-1969)", "MS": "The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES.", "PM": "72", "HN": "72(70)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000936"}, {"RECTYPE": "D", "MH": "Antigen-Antibody Reactions", "AQ": "DE GE IM PH RE", "ENTRY": "Reactions, Antigen-Antibody", "MN": "G12.122", "FX": "Hypersensitivity, Immediate", "MH_TH": "NLM (1984)", "ST": "T044", "MS": "The processes triggered by interactions of ANTIBODIES with their ANTIGENS.", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000937"}, {"RECTYPE": "D", "MH": "Antigen-Presenting Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Immunologic Accessory Cells|T025|NON|EQV|NLM (1991)|891213|IMMUNOL ACCESSORY CELLS|abcdefv", "ENTRY": "Cells, Antigen-Presenting", "MN": "A15.382.066", "FX": "Lymphocyte Activation", "MH_TH": "NLM (1985)", "ST": "T025", "PI": "T Lymphocytes (1973-1984)", "MS": "A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors.", "PM": "85", "HN": "85", "MR": "20200527", "DA": "19840530", "DC": "1", "DX": "19850101", "UI": "D000938"}, {"RECTYPE": "D", "MH": "Epitopes", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Epitope|T129|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Specificity, Antigenic", "MN": "D23.050.550", "FX": "Molecular Mimicry", "MH_TH": "NLM (1970)", "ST": "T129", "RN": "0", "PI": "Antigens (1966-1969)", "MS": "Sites on an antigen that interact with specific antibodies.", "PM": "96; was ANTIGENIC DETERMINANTS 1972-95", "HN": "96; was ANTIGENIC DETERMINANTS 1970-95 (as Prov 1970-71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000939"}, {"RECTYPE": "D", "MH": "Antigenic Variation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Variation, Antigenic|T044|NON|EQV|UNK (19XX)|870511|abcdef", "ENTRY": "Variation, Antigen", "MN": "G12.500.249", "MH_TH": "NLM (1988)", "ST": "T044", "AN": "microbes only; ANTIBODY DIVERSITY is also available", "PI": "Variation (Genetics) (1966-1987)", "MS": "Change in the surface ANTIGEN of a microorganism. There are two different types. One is a phenomenon, especially associated with INFLUENZA VIRUSES, where they undergo spontaneous variation both as slow antigenic drift and sudden emergence of new strains (antigenic shift). The second type is when certain PARASITES, especially trypanosomes, PLASMODIUM, and BORRELIA, survive the immune response of the host by changing the surface coat (antigen switching). (From Herbert et al., The Dictionary of Immunology, 4th ed)", "PM": "1988", "HN": "1988", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19870511", "DC": "1", "DX": "19880101", "UI": "D000940"}, {"RECTYPE": "D", "MH": "Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Antigen|T129|NON|EQV|NLM (1988)|870509|abcdef", "MN": "D23.050", "FX": "Receptors, Antigen", "MH_TH": "POPLINE (1994)", "ST": "T129", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Substances that are recognized by the immune system and induce an immune reaction.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000941"}, {"RECTYPE": "D", "MH": "Antigens, Bacterial", "DE": "ANTIGENS BACT", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Bacterial Antigens|T129|NON|EQV|UNK (19XX)|740329|BACT ANTIGENS|abcdefv", "ENTRY": "Antigen, Bacterial", "MN": "D23.050.161", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "AN": "coordinate with specific bacterium /immunol ", "PI": "Polysaccharides, Bacterial (1966-1970)", "MS": "Substances elaborated by bacteria that have antigenic activity.", "OL": "use ANTIGENS, BACTERIAL to search BACTERIAL ANTIGENS 1971-72 (as Prov)", "PM": "73", "HN": "73; was BACTERIAL ANTIGENS 1971-72 (Prov)", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000942"}, {"RECTYPE": "D", "MH": "Antigens, Differentiation", "DE": "ANTIGENS DIFFER", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Marker Antigens|T129|NON|EQV|UNK (19XX)|870313|abcdef", "ENTRY": "Marker, Differentiation", "MN": "D23.101.100", "MH_TH": "NLM (1988)", "ST": "T129", "RN": "0", "AN": "general or unspecified; prefer specific groups and specific differentiation antigens; note entry term LEU ANTIGENS but several specific Leu antigens are also available", "PI": "specific cell or tissue (1966-1987)", "MS": "Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation.", "OL": "use ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE to search DIFFERENTIATION ANTIGENS, HAIRY CELL LEUKEMIA 1988-91; use ANTIGENS, DIFFERENTIATION to search LEU ANTIGENS 1989 to present; use ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988", "PM": "88; DIFFERENTIATION ANTIGENS, HAIRY CELL LEUKEMIA was see ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-91; LEU ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988", "HN": "88; DIFFERENTIATION ANTIGENS, HAIRY CELL LEUKEMIA was see ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-91; LEU ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988", "MR": "20200527", "DA": "19870313", "DC": "1", "DX": "19880101", "UI": "D000943"}, {"RECTYPE": "D", "MH": "Antigens, Differentiation, B-Lymphocyte", "DE": "B CELL DIFFER ANTIGENS", "DS": "ANTIGENS DIFFERENTIATION LYMPHO B", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Plasma Cell Antigens PC-1|T129|NRW|UNK (19XX)|870413|PLASMA CELL ANTIGENS PC 001|abdefs", "ENTRY": "Plasma Cell Antigens PC 1", "MN": "D23.101.100.150", "MH_TH": "NLM (1988)", "ST": "T129", "RN": "0", "PI": "Cell Differentiation (1966-1987)", "MS": "Membrane antigens associated with maturation stages of B-lymphocytes, often expressed in tumors of B-cell origin.", "OL": "use ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE to search ANTIGENS, DIFFERENTIATION B LYMPHOCYTE 1988-89", "PM": "90; was ANTIGENS, DIFFERENTIATION, B LYMPHOCYTE 1988-89", "HN": "90; was ANTIGENS, DIFFERENTIATION, B LYMPHOCYTE 1988-89", "MR": "20050630", "DA": "19870413", "DC": "1", "DX": "19880101", "UI": "D000944"}, {"RECTYPE": "D", "MH": "Antigens, Differentiation, T-Lymphocyte", "DS": "ANTIGENS DIFFERENTIATION LYMPHO T", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "T6 Antigens|T116|T129|NRW|UNK (19XX)|870313|T AAC ANTIGENS 06|abbdefs", "ENTRY": "T-Lymphocyte Leu Antigens", "MN": "D23.101.100.894", "MH_TH": "NLM (1988)", "ST": "T129", "RN": "0", "PI": "T-Lymphocytes (1973-1987)", "MS": "Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function.", "OL": "use ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE to search T8 ANTIGENS 1988-92 & ANTIGENS, DIFFERENTIATION T LYMPHOCYTE 1988-89", "PM": "90; was ANTIGENS, DIFFERENTIATION, T LYMPHOCYTE 1988-89; T8 ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92", "HN": "90; was ANTIGENS, DIFFERENTIATION, T LYMPHOCYTE 1988-89; T8 ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92", "MR": "20050630", "DA": "19870313", "DC": "1", "DX": "19880101", "UI": "D000945"}, {"RECTYPE": "D", "MH": "Antigens, Fungal", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Fungal Antigens|T129|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Antigen, Fungal", "MN": "D23.050.202", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "AN": "coord IM with specific fungus /immunol (IM)", "PI": "Antigens (1966-1972)", "MS": "Substances of fungal origin that have antigenic activity.", "PM": "73", "HN": "73", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000946"}, {"RECTYPE": "D", "MH": "Antigens, Helminth", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Helminth Antigens|T129|NON|EQV|UNK (19XX)|840502|abcdef", "MN": "D23.050.223", "MH_TH": "NLM (1985)", "ST": "T129", "RN": "0", "AN": "coord IM with specific helminth /immunol (IM)", "PI": "Antigens, Surface (1979-1984)", "MS": "Any part or derivative of a helminth that elicits an immune reaction. The most commonly seen helminth antigens are those of the schistosomes.", "PM": "85", "HN": "85", "MR": "20050630", "DA": "19840502", "DC": "1", "DX": "19850101", "UI": "D000947"}, {"RECTYPE": "D", "MH": "Histocompatibility Antigens Class II", "DS": "HISTOCOMPATIBILITY ANTIGENS CLASS 02", "AQ": "AD AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "MHC II Peptide|T116|T129|NON|EQV|NLM (2022)|200930|abbcdef", "ENTRY": "Peptides, MHC II", "MN": "D23.050.705.552.410", "FX": "Genes, MHC Class II", "MH_TH": "NLM (1981)", "ST": "T129", "RN": "0", "AN": "human & animal; see also HLA ANTIGENS & specifics for human", "PI": "Isoantigens (1973-1980)", "MS": "Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen.", "PM": "1989; see ANTIGENS, IMMUNE RESPONSE 1981-88", "HN": "1989 (1973); use ANTIGENS, IMMUNE RESPONSE 1981-88", "MR": "20230316", "DA": "19800513", "DC": "1", "DX": "19810101", "UI": "D000949"}, {"RECTYPE": "D", "MH": "Antigens, Ly", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Ly Antigens|T129|EQV|UNK (19XX)|810520|abdef", "MN": "D23.101.100.920", "MH_TH": "NLM (1982)", "ST": "T129", "RN": "0", "PI": "T Lymphocytes (1975-1981)", "MS": "A group of lymphocyte surface antigens located on mouse LYMPHOCYTES. Specific Ly antigens are useful markers for distinguishing subpopulations of lymphocytes.", "PM": "82", "HN": "82", "MR": "20080708", "DA": "19810520", "DC": "1", "DX": "19820101", "UI": "D000950"}, {"RECTYPE": "D", "MH": "Antigens, Neoplasm", "DE": "ANTIGENS NEOPL", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Tumor Antigens|T129|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Antigens, Tumor", "MN": "D23.050.285", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "AN": "coord IM with required neopl coords with /immunol (IM); Manual 24.4.4.1+", "PI": "specific neoplasm/immunology (1966-1972)", "MS": "Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000951"}, {"RECTYPE": "D", "MH": "Antigens, Polyomavirus Transforming", "DE": "PVTA", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Simian Sarcoma Virus Proteins|T116|T129|NON|NRW|UNK (19XX)|870507|abbcdef", "ENTRY": "Tumor Antigens, Polyomavirus", "MN": "D23.050.327.062.090", "MH_TH": "NLM (1988)", "ST": "T129", "RN": "0", "AN": " coordinate with specific polyoma virus /immunol", "PI": "Viral Proteins (1966-1985)", "MS": "Polyomavirus antigens which cause infection and cellular transformation. The large T antigen is necessary for the initiation of viral DNA synthesis, repression of transcription of the early region and is responsible in conjunction with the middle T antigen for the transformation of primary cells. Small T antigen is necessary for the completion of the productive infection cycle.", "PM": "88", "HN": "88", "MR": "20220413", "DA": "19870507", "DC": "1", "DX": "19880101", "UI": "D000952"}, {"RECTYPE": "D", "MH": "Antigens, Protozoan", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Protozoan Antigens|T129|NON|EQV|UNK (19XX)|840620|abcdef", "MN": "D23.050.293", "MH_TH": "NLM (1985)", "ST": "T129", "RN": "0", "AN": "coord IM with specific protozoan /immunol (IM)", "PI": "Antigens, Surface (1979-1984)", "MS": "Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered.", "PM": "85", "HN": "85", "MR": "20220413", "DA": "19840502", "DC": "1", "DX": "19850101", "UI": "D000953"}, {"RECTYPE": "D", "MH": "Antigens, Surface", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Surface Markers, Immunological|T129|NON|EQV|UNK (19XX)|840502|SURFACE MARKERS IMMUNOL|abcdefv", "ENTRY": "Surface Antigens, Cell", "MN": "D23.050.301", "MH_TH": "NLM (1979)", "ST": "T129", "RN": "0", "AN": "coord NIM with specific antigen/organism heading (IM)", "PI": "Antigens (1966-1978)", "MS": "Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated.", "PM": "79", "HN": "79", "MR": "20050630", "DA": "19780501", "DC": "1", "DX": "19790101", "UI": "D000954"}, {"RECTYPE": "D", "MH": "Antigens, T-Independent", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Thymus-Independent Antigens|T129|NON|EQV|UNK (19XX)|810520|abcdef", "ENTRY": "Thymus Independent Antigens", "MN": "D23.050.324", "MH_TH": "NLM (1982)", "ST": "T129", "RN": "0", "PI": "T Lymphocytes (1973-1981)", "MS": "Antigens which may directly stimulate B lymphocytes without the cooperation of T lymphocytes.", "PM": "82", "HN": "82", "MR": "20050630", "DA": "19810520", "DC": "1", "DX": "19820101", "UI": "D000955"}, {"RECTYPE": "D", "MH": "Antigens, Viral", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Viral Antigens|T129|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Antigen, Viral", "MN": "D23.050.327", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "AN": "coord IM with specific virus /immunol (IM)", "PI": "Viruses/immunology (1966-1972)", "MS": "Substances elaborated by viruses that have antigenic activity.", "PM": "73", "HN": "73", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000956"}, {"RECTYPE": "D", "MH": "Antigens, Viral, Tumor", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Virus Transforming Antigens|T129|NON|EQV|UNK (19XX)|870508|abcdef", "ENTRY": "Viral Neoplasm Antigens", "MN": "D23.050.327.062", "MH_TH": "NLM (1984)", "ST": "T129", "RN": "0", "AN": "coord IM with specific virus /immunol (IM)", "PI": "Antigens, Viral (1973-1983)", "MS": "Those proteins recognized by antibodies from serum of animals bearing tumors induced by viruses; these proteins are presumably coded for by the nucleic acids of the same viruses that caused the neoplastic transformation.", "PM": "84", "HN": "84", "MR": "20220413", "DA": "19830610", "DC": "1", "DX": "19840101", "UI": "D000957"}, {"RECTYPE": "D", "MH": "Antigua and Barbuda", "AQ": "EH EP", "PRINT ENTRY": "Barbuda and Antigua|T083|NAM|EQV|NLM (1992)|911102|abcdef", "MN": "Z01.639.880.050", "MH_TH": "NLM (1983)", "ST": "T083", "MS": "Islands in the Lesser Antilles, within the Leeward Islands. ANTIGUA, BARBUDA, and Redonda, an uninhabited island, constitute the independent state of ANTIGUA AND BARBUDA. The capital is St. Johns.", "MR": "20120703", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D000958"}, {"RECTYPE": "D", "MH": "Antihypertensive Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antihypertensive Drug|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Drugs, Antihypertensive", "MN": "D27.505.954.411.162", "FX": "Vasodilator Agents", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "not for ocular hypertension", "MS": "Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000959"}, {"RECTYPE": "D", "MH": "Hypolipidemic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hypolipidemic Drug|T121|NON|EQV|NLM (2021)|200304|abcdef", "ENTRY": "Drugs, Hypolipidemic", "MN": "D27.505.954.557.500", "MH_TH": "NLM (1990)", "ST": "T121", "RN": "0", "MS": "Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS.", "PM": "2010", "HN": "2010(1966)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000960"}, {"RECTYPE": "D", "MH": "Antilymphocyte Serum", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Lymphocytotoxic Antibodies|T116|T129|NON|NRW|UNK (19XX)|780501|abbcdef", "ENTRY": "Serums, Antilymphocyte", "MN": "D20.215.401.203", "PA": "Immunosuppressive Agents", "MH_TH": "NLM (1968)", "ST": "T129", "RN": "0", "AN": "antithymocyte & anti-theta serum: index ANTILYMPHOCYTE SERUM + T LYMPHOCYTES /immunol; \"lymphocytotoxin\": index CYTOTOXINS + LYMPHOCYTES but note entry term LYMPHOCYTOTOXIC ANTIBODIES for antibodies to lymphocytes", "PI": "Lymphocytes (1966-1967)", "MS": "Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION.", "OL": "search LYMPHOCYTOTOXINS under LYMPHOTOXINS 1978", "PM": "70; LYMPHOCYTOTOXINS was see LYMPHOTOXINS 1978", "HN": "70(68); LYMPHOCYTOTOXINS was see LYMPHOTOXINS 1978", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D000961"}, {"RECTYPE": "D", "MH": "Antimalarials", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antimalarial Drug|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Drugs, Antimalarial", "MN": "D27.505.954.122.250.100.085", "FX": "Antirheumatic Agents", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000962"}, {"RECTYPE": "D", "MH": "Antimetabolites", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antimetabolite|T121|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D27.888.569.042", "MH_TH": "POPLINE (1978)", "ST": "T121", "RN": "0", "MS": "Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000963"}, {"RECTYPE": "D", "MH": "Antimetabolites, Antineoplastic", "DE": "ANTIMETAB ANTINEOPL", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antineoplastic Antimetabolites|T121|NON|EQV|NLM (1996)|950122|ANTINEOPL ANTIMETAB|abcdefv", "MN": "D27.888.569.042.030", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "TN 4: relation to ANTINEOPLASTIC AGENTS", "PI": "Antineoplastic Agents (1966-1974)", "MS": "Antimetabolites that are useful in cancer chemotherapy.", "PM": "75", "HN": "75", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D000964"}, {"RECTYPE": "D", "MH": "Antimony", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.050", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Antimony", "RN": "9IT35J3UV3", "RR": "7440-36-0 (Antimony)", "MS": "A metallic element that has the atomic symbol Sb, atomic number 51, and atomic weight 121.75. It is used as a metal alloy and as medicinal and poisonous salts. It is toxic and an irritant to the skin and the mucous membranes.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000965"}, {"RECTYPE": "D", "MH": "Antimony Potassium Tartrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tartar Emetic|T109|T121|NON|EQV|UNK (19XX)|750630|abbcdef", "ENTRY": "Tartrate, Antimony Potassium", "MN": "D02.121", "PA": "Schistosomicides", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Antimonate(2-), bis(mu-(2,3-dihydroxybutanedioato(4-)-O1,O2:O3,O4))di-, dipotassium, trihydrate, stereoisomer", "RN": "DL6OZ476V3", "RR": "28300-74-5 (Antimony Potassium Tartrate)", "PI": "Tartrates (1969-1975)", "MS": "A schistosomicide possibly useful against other parasites. It has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects.", "PM": "91; was see under ANTIMONY 1976-90", "HN": "91(76); was see under ANTIMONY 1976-90", "MR": "20190701", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D000966"}, {"RECTYPE": "D", "MH": "Antimony Sodium Gluconate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sodium Stibogluconate|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|NLM (1994)|921013|abbcdeeef", "ENTRY": "Stibogluconate, Sodium", "MN": "D09.811.308.060", "PA": "Schistosomicides", "MH_TH": "NLM (1977)", "ST": "T121", "RN": "V083S0159D", "PI": "Gluconates (1970-1976)", "MS": "Antimony complex where the metal may exist in either the pentavalent or trivalent states. The pentavalent gluconate is used in leishmaniasis. The trivalent gluconate is most frequently used in schistosomiasis.", "OL": "use ANTIMONY SODIUM GLUCONATE to search ANTIMONY SODIUM GLUCONATES 1977-93", "PM": "94; was ANTIMONY SODIUM GLUCONATES 1991-93 (see under GLUCONATES 1977-90); SODIUM STIBOGLUCONATE was STIBOGLUCONATE SODIUM 1977-93", "HN": "94; was ANTIMONY SODIUM GLUCONATES 1991-93 (see under GLUCONATES 1977-90); SODIUM STIBOGLUCONATE was STIBOGLUCONATE SODIUM 1977-93", "MR": "20190701", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D000967"}, {"RECTYPE": "D", "MH": "Antimycin A", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Butanoic acid, 2(or 3)-methyl-, 3-((3-(formylamino)-2-hydroxybenzoyl)amino)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester|T109|T195|NON|EQV|NLM (2024)|221027|abbcdef", "ENTRY": "Antimycin A1|T109|T195|NON|NRW|UNK (19XX)|840918|abbcdef", "MN": "D02.540.576.500.750", "PA": "Antifungal Agents", "MH_TH": "NLM (1964)", "ST": "T195", "RN": "642-15-9", "MS": "An antibiotic substance produced by Streptomyces species. It inhibits mitochondrial respiration and may deplete cellular levels of ATP. Antimycin A1 has been used as a fungicide, insecticide, and miticide. (From Merck Index, 12th ed)", "PM": "66", "HN": "66(64)", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000968"}, {"RECTYPE": "D", "MH": "Antinematodal Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nematocides|T121|NON|EQV|UNK (19XX)|750716|abcdef", "ENTRY": "Drugs, Antinematodal", "MN": "D27.505.954.122.250.075.080", "MH_TH": "NLM (1976)", "ST": "T121", "RN": "0", "AN": "consider also NEMATODA /drug eff & NEMATODE INFECTIONS /drug ther or pertinent specifics", "PI": "Anthelmintics (1966-1973)", "MS": "Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice.", "OL": "use ANTINEMATODAL AGENTS to search NEMATOCIDES 1974-75", "PM": "76; was see under ANTHELMINTICS 1975; NEMATOCIDES was heading 1974-75", "HN": "76(75); was see under ANTHELMINTICS 1975; NEMATOCIDES was heading 1974-75", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D000969"}, {"RECTYPE": "D", "MH": "Antineoplastic Agents", "DE": "ANTINEOPL AGENTS", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cancer Chemotherapy Drug|T121|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Drugs, Cancer Chemotherapy", "MN": "D27.505.954.248", "FX": "Tumor Lysis Syndrome", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "/admin: various administration procedures are available, as CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHEMOEMBOLIZATION, THERAPEUTIC and INFUSIONS, INTRA-ARTERIAL; for combined anticancer agents, ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS is available; Manual 24.4.2.1+", "MS": "Substances that inhibit or prevent the proliferation of NEOPLASMS.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000970"}, {"RECTYPE": "D", "MH": "Antineoplastic Combined Chemotherapy Protocols", "AQ": "AD AE AI AN BL CF CH CL CS EC HI IM ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Drug Combinations, Antineoplastic|T061|NON|EQV|NLM (1990)|890405|DRUG COMBINATIONS ANTINEOPL|abcdefv", "ENTRY": "Protocols, Cancer Chemotherapy", "MN": "E02.319.310.037", "MH_TH": "NLM (2002)", "ST": "T061", "AN": "coordinate IM with specific antineoplastic agents (IM or NIM)", "PI": "Drug Therapy, Combination (1974-1983)", "MS": "The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.", "PM": "2002; see ANTINEOPLASTIC AGENTS, COMBINED (1984-2001)", "HN": "2002(1984)", "MR": "20150623", "DA": "19830617", "DC": "1", "DX": "19840101", "UI": "D000971"}, {"RECTYPE": "D", "MH": "Antineoplastic Agents, Phytogenic", "DE": "ANTINEOPL AGENTS PHYTOGENIC", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antineoplastics, Botanical|T121|NON|EQV|UNK (19XX)|741226|ANTINEOPL BOTANIC|abcdefv", "ENTRY": "Phytogenic Antineoplastics", "MN": "D27.505.954.248.179", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Antineoplastic Agents (1966-1974)", "MS": "Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity.", "OL": "use ANTINEOPLASTIC AGENTS, PHYTOGENIC to search ANTINEOPLASTICS, PHYTOGENIC 1975", "PM": "76; was ANTINEOPLASTICS, PHYTOGENIC 1975", "HN": "76; was ANTINEOPLASTICS, PHYTOGENIC 1975", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D000972"}, {"RECTYPE": "D", "MH": "Antibodies, Antinuclear", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Antinuclear Factors|T116|T129|NON|EQV|NLM (1990)|890413|abbcdef", "ENTRY": "Factor, Antinuclear", "MN": "D12.776.377.715.548.114.323.204", "PA": "Immunologic Factors", "FX": "Collagen Diseases", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "AN": "coordinate with specific nuclear antigen; do not coordinate with ANTIBODY FORMATION for /biosyn", "MS": "Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease.", "OL": "use ANTIBODIES, ANTINUCLEAR to search ANTINUCLEAR FACTORS 1966-89 (Prov 1966-69)", "PM": "90; was ANTINUCLEAR FACTORS 1970-89", "HN": "90; was ANTINUCLEAR FACTORS 1966-89 (Prov 1966-69)", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D000974"}, {"RECTYPE": "D", "MH": "Antioxidants", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PH PK PO RE SD ST TO TU", "PRINT ENTRY": "Endogenous Antioxidants|T039|T123|NON|REL|NLM (2022)|210423|abbcdef", "ENTRY": "Antioxidants, Endogenous", "MN": "D27.720.799.047", "FX": "Pharmaceutic Aids", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "note entry term ANTIOXIDANT EFFECT: use only for the antioxidant effect of a chemical substance", "MS": "Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.", "MR": "20210625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000975"}, {"RECTYPE": "D", "MH": "Antipain", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.644.456.120", "PA": "Protease Inhibitors", "MH_TH": "NLM (1980)", "ST": "T121", "N1": "L-Valinamide, N2-(((1-carboxy-2-phenylethyl)amino)carbonyl)-L-arginyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-", "RN": "37691-11-5", "AN": "nothing to do with pain: a bacterial protease inhibitor", "PI": "Protease Inhibitors (1979)", "MS": "An oligopeptide produced by various bacteria which acts as a protease inhibitor.", "PM": "91; was see under OLIGOPEPTIDES 1980-90", "HN": "91(80); was see under OLIGOPEPTIDES 1980-90", "MR": "19950608", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D000976"}, {"RECTYPE": "D", "MH": "Antiparasitic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Parasiticides|T121|NON|EQV|NLM (1996)|950301|abcdef", "ENTRY": "Drugs, Antiparasitic", "MN": "D27.505.954.122.250", "MH_TH": "NLM (1974)", "ST": "T121", "RN": "0", "MS": "Drugs used to treat or prevent parasitic infections.", "OL": "use ANTIPROTOZOAL AGENTS to search PARASITICIDES 1966", "PM": "96; PARASITICIDES was heading 1963-66", "HN": "96; was NON MESH 1967-95; PARASITICIDES was heading 1963-66", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D000977"}, {"RECTYPE": "D", "MH": "Antiparkinson Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Drugs, Antiparkinson", "MN": "D27.505.954.427.090.050", "MH_TH": "NLM (1972)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Parkinsonism/drug therapy (1966-1972)", "MS": "Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.", "OL": "use ANTIPARKINSON AGENTS to search ANTIPARKINSON DRUGS 1972-75 (as Prov 1972) & PARASYMPATHOLYTICS 1966-71", "PM": "76; was ANTIPARKINSON DRUGS 1973-75; was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72", "HN": "76; was ANTIPARKINSON DRUGS 1972-75 (Prov 1972); was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D000978"}, {"RECTYPE": "D", "MH": "alpha-2-Antiplasmin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha 2-Plasmin Inhibitor|T116|T129|NON|EQV|UNK (19XX)|790523|ALPHA PLASMIN INHIBITOR 02|ALPHA 2 PLASMIN INHIB|abbcdefsv", "ENTRY": "alpha 2 Plasmin Inhibitor", "MN": "D12.776.872.050", "PA": "Serine Proteinase Inhibitors", "MH_TH": "NLM (2000)", "ST": "T129", "RN": "0", "PI": "Fibrinolysin/antagonists & inhibitors (1968-1979)", "MS": "A member of the serpin superfamily found in plasma that inhibits the lysis of fibrin clots which are induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 that migrates in the alpha 2 region in immunoelectrophoresis. It is the principal plasmin inactivator in blood, rapidly forming a very stable complex with plasmin.", "PM": "2010; see ANTIPLASMIN 1980-2009", "HN": "2010(1980)", "MR": "20230316", "DA": "19790523", "DC": "1", "DX": "19800101", "UI": "D000979"}, {"RECTYPE": "D", "MH": "Antiplatyhelmintic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Drugs, Antiplatyhelmintic", "MN": "D27.505.954.122.250.075.100", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "consider also PLATYHELMINTHS /drug eff or pertinent specifics", "PI": "Anthelmintics (1966-1974)", "MS": "Agents used to treat cestode, trematode, or other flatworm infestations in man or animals.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D000980"}, {"RECTYPE": "D", "MH": "Antiprotozoal Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Agents, Antiprotozoal", "MN": "D27.505.954.122.250.100", "MH_TH": "NLM (1967)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specific groups ", "MS": "Substances that are destructive to protozoans.", "PM": "67", "HN": "67", "MR": "20090710", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000981"}, {"RECTYPE": "D", "MH": "Antipruritics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antipruritic Drug|T121|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Drugs, Antipruritic", "MN": "D27.505.954.444.075", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "MS": "Agents, usually topical, that relieve itching (pruritus).", "OL": "search DERMATOLOGIC AGENTS 1967-74", "PM": "91; was see under DERMATOLOGIC AGENTS 1975-90", "HN": "91(75); was see under DERMATOLOGIC AGENTS 1975-90", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000982"}, {"RECTYPE": "D", "MH": "Antipyrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenazone|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|741114|abbcdeeef", "ENTRY": "Pyramidone|T109|T121|TRD|NRW|UNK (19XX)|811209|abbcdef", "MN": "D03.383.129.539.850.088", "PA": "Anti-Inflammatory Agents, Non-Steroidal", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3H-Pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-2-phenyl-", "RN": "T3CHA1B51H", "RR": "60-80-0 (Antipyrine)", "MS": "An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000983"}, {"RECTYPE": "D", "MH": "Antisepsis", "AQ": "HI IS MT ST", "MN": "N06.850.780.200.450.150", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "differentiate from ASEPSIS: ANTISEPSIS is the destruction of pathogens, ASEPSIS is the prev of their invasion", "MS": "The destruction of germs causing disease.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000985"}, {"RECTYPE": "D", "MH": "Antisickling Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Desickling Agents|T121|NON|NRW|UNK (19XX)|760412|abcdef", "ENTRY": "Agents, Desickling", "MN": "D27.505.954.502.135", "MH_TH": "NLM (1977)", "ST": "T121", "RN": "0", "AN": "consider also ANEMIA, SICKLE CELL /drug ther", "PI": "Hemoglobins, Abnormal (1966-1974)", "MS": "Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions.", "PM": "77", "HN": "77", "MR": "20050630", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D000986"}, {"RECTYPE": "D", "MH": "Antisocial Personality Disorder", "DE": "ANTISOCIAL PERSONALITY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Sociopathic Personality|T048|NON|EQV|UNK (19XX)|750716|abcdef", "ENTRY": "Sociopathic Personalities", "MN": "F03.675.050", "FX": "Conduct Disorder", "MH_TH": "NLM (1963)", "ST": "T048", "MS": "A personality disorder whose essential feature is a pervasive pattern of disregard for, and violation of, the rights of others that begins in childhood or early adolescence and continues into adulthood. The individual must be at least age 18 and must have a history of some symptoms of CONDUCT DISORDER before age 15. (From DSM-IV, 1994).", "OL": "use ANTISOCIAL PERSONALITY DISORDER to search ANTISOCIAL PERSONALITY 1976-80 & SOCIOPATHIC PERSONALITY 1966-75", "PM": "81; was ANTISOCIAL PERSONALITY 1976-80, was SOCIOPATHIC PERSONALITY 1963-75", "HN": "81; was ANTISOCIAL PERSONALITY 1976-80, was ANTISOCIAL PERSONALITY see under SOCIOPATHIC PERSONALITY 1969-75; SOCIOPATHIC PERSONALITY was heading 1963-75", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D000987"}, {"RECTYPE": "D", "MH": "Antispermatogenic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sperm Maturation Blocking Agents|T121|NON|NRW|POPLINE (1981)|910328|SPERM MATURATION BLOCK AGENTS|abcdefv", "ENTRY": "Effects, Antispermatogenic", "MN": "D27.888.569.071", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Spermatogenesis/drug effects (1971-1974)", "MS": "Agents, either mechanical or chemical, which destroy spermatozoa in the male genitalia and block spermatogenesis.", "OL": "use ANTISPERMATOGENIC AGENTS to search SPERM MATURATION BLOCKING AGENTS 1975-91", "PM": "75; SPERM MATURATION BLOCKING AGENTS was heading 1975-91", "HN": "75; SPERM MATURATION BLOCKING AGENTS was heading 1975-91", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D000988"}, {"RECTYPE": "D", "MH": "Antistreptolysin", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Antistreptolysin O|T129|NON|NRW|UNK (19XX)|810728|abcdef", "MN": "D12.776.377.715.548.114.125.288", "PA": "Immunologic Factors", "MH_TH": "NLM (1966)", "ST": "T129", "N1": "Antistreptolysin", "RN": "9006-92-2", "MS": "Antibodies specific to STREPTOLYSINS which indicate STREPTOCOCCAL INFECTIONS.", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000989"}, {"RECTYPE": "D", "MH": "Antithrombin III", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heparin Cofactor I|T116|T129|NON|EQV|UNK (19XX)|780207|abbcdef", "ENTRY": "Heparin Co Factor I", "MN": "D23.113.025", "PA": "Antithrombins", "EC": "deficiency:Antithrombin III Deficiency", "MH_TH": "INN (19XX)", "ST": "T129", "RN": "9000-94-6", "MS": "A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.", "PM": "1979; see HEPARIN CO-FACTOR 1975-1978; KYBERNIN was indexed under ANTITHROMBIN III 1992-2010", "HN": "1979", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D000990"}, {"RECTYPE": "D", "MH": "Antithrombins", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Direct Thrombin Inhibitor|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Thrombin Inhibitors, Direct", "MN": "D27.505.954.502.119.500", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "AN": "ANTITHROMBIN PROTEINS is also available", "MS": "Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins.", "PM": "see ANTITHROMBIN 1964-1966", "HN": "2011(1964)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D000991"}, {"RECTYPE": "D", "MH": "Antitoxins", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Antitoxin|T121|T129|NON|EQV|NLM (2021)|200129|abbcdef", "MN": "D20.215.401.601", "PA": "Immunologic Factors", "FX": "Antidotes", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "AN": "coordinate IM with specific toxin (IM or NIM)", "MS": "Antisera from immunized animals that is purified and used as a passive immunizing agent against specific BACTERIAL TOXINS.", "PM": "66; TOXINS AND ANTITOXINS was heading 1963-65", "HN": "66; TOXINS AND ANTITOXINS was heading 1963-65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000992"}, {"RECTYPE": "D", "MH": "Antitreponemal Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antisyphilitic Agents|T121|NON|NRW|NLM (1996)|940801|abcdef", "ENTRY": "Drugs, Antitreponemal", "MN": "D27.505.954.122.085.222", "MH_TH": "NLM (1974)", "ST": "T121", "RN": "0", "MS": "Agents used to treat infections with bacteria of the genus TREPONEMA. This includes SYPHILIS & YAWS.", "PM": "96", "HN": "96; was NON MESH 1975-95", "MR": "20050720", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D000993"}, {"RECTYPE": "D", "MH": "Antitrichomonal Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Drugs, Antitrichomonal", "MN": "D27.505.954.122.250.100.115", "MH_TH": "NLM (1965)", "ST": "T121", "RN": "0", "AN": "consider also TRICHOMONAS /drug eff & TRICHOMONAS INFECTIONS /drug ther or pertinent specifics", "MS": "Agents used to treat trichomonas infections.", "PM": "72", "HN": "72(66)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D000994"}, {"RECTYPE": "D", "MH": "Antitubercular Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tuberculostatic Agents|T121|NON|EQV|UNK (19XX)|741230|abcdef", "ENTRY": "Drug, Antitubercular", "MN": "D27.505.954.122.085.255", "FX": "Tuberculosis, Multidrug-Resistant", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "consider also MYCOBACTERIUM TUBERCULOSIS /drug eff & TUBERCULOSIS /drug ther", "MS": "Drugs used in the treatment of tuberculosis. They are divided into two main classes: \"first-line\" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and \"second-line\" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000995"}, {"RECTYPE": "D", "MH": "Antitussive Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cough Suppressant|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Suppressants, Cough", "MN": "D27.505.954.796.090", "FX": "Expectorants", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000996"}, {"RECTYPE": "D", "MH": "Antivenins", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Antivenom|T121|T129|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Anti Venoms", "MN": "D20.215.401.601.163", "PA": "Immunologic Factors", "FX": "Antidotes", "MH_TH": "NLM (1963)", "ST": "T129", "RN": "0", "AN": "coordinate IM with specific venom", "MS": "Antisera used to counteract poisoning by animal VENOMS, especially SNAKE VENOMS.", "PM": "65", "HN": "65(63)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D000997"}, {"RECTYPE": "D", "MH": "Antiviral Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antivirals|T121|NON|EQV|NLM (1996)|940819|abcdef", "ENTRY": "Drugs, Antiviral", "MN": "D27.505.954.122.388", "FX": "Virus Inactivation", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "for resistance to antiviral agents, DRUG RESISTANCE, VIRAL and DRUG RESISTANCE, MULTIPLE, VIRAL are available", "MS": "Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D000998"}, {"RECTYPE": "D", "MH": "Antlers", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Antler", "MN": "A13.507.288", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "a type of horn, on males of the deer family", "MS": "The horn of an animal of the deer family, typically present only in the male. It differs from the HORNS of other animals in being a solid, generally branched bony outgrowth that is shed and renewed annually. The word antler comes from the Latin anteocularis, ante (before) + oculus (eye). (From Webster, 3d ed)", "OL": "search HORNS 1968-74", "PM": "91; was see under HORNS 1975-90", "HN": "91(75); was see under HORNS 1975-90", "MR": "19950313", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D000999"}, {"RECTYPE": "D", "MH": "Ants", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Ant", "MN": "B01.050.500.131.617.720.500.500.875.205", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid36668", "AN": "/microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111", "MS": "Insects of the family Formicidae, very common and widespread, probably the most successful of all the insect groups. All ants are social insects, and most colonies contain three castes, queens, males, and workers. Their habits are often very elaborate and a great many studies have been made of ant behavior. Ants produce a number of secretions that function in offense, defense, and communication. (From Borror, et al., An Introduction to the Study of Insects, 4th ed, p676)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001000"}, {"RECTYPE": "D", "MH": "Anura", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Toads and Frogs|T011|NON|EQV|UNK (19XX)|800402|TOADS FROGS|abcdefv", "ENTRY": "Toads, Fire-Bellied", "MN": "B01.050.150.900.090.180", "MH_TH": "NLM (1981)", "ST": "T011", "RN": "txid8342", "RR": "txid8344", "AN": "NIM with no qualifiers when experimental animal", "PI": "Amphibia (1966-1980)", "MS": "An order of the class Amphibia, which includes several families of frogs and toads. They are characterized by well developed hind limbs adapted for jumping, fused head and trunk and webbed toes. The term \"toad\" is ambiguous and is properly applied only to the family Bufonidae.", "OL": "use ANURA to search FROGS & TOADS 1966-80", "PM": "81; FROGS & TOADS were headings 1964-80", "HN": "81; FROGS & TOADS were headings 1964-80", "MR": "20200902", "DA": "19800402", "DC": "1", "DX": "19810101", "UI": "D001001"}, {"RECTYPE": "D", "MH": "Anuria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Anurias", "MN": "C12.950.934.070", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with OLIGURIA, diminished amount", "MS": "Absence of urine formation. It is usually associated with complete bilateral ureteral (URETER) obstruction, complete lower urinary tract obstruction, or unilateral ureteral obstruction when a solitary kidney is present.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001002"}, {"RECTYPE": "D", "MH": "Anal Canal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Anus|T023|NON|NRW|NLM (1966)|990101|abcdef", "ENTRY": "Sphincters, Anal", "MN": "A03.556.249.249.070", "FX": "Proctoscopy", "MH_TH": "NLM (2004)", "ST": "T023", "CX": "consider also terms at PROCT-", "MS": "The terminal segment of the LARGE INTESTINE, beginning from the ampulla of the RECTUM and ending at the anus.", "MR": "20170414", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001003"}, {"RECTYPE": "D", "MH": "Anus Diseases", "DE": "ANUS DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Anus", "MN": "C06.405.469.860.101", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases involving the ANUS.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001004"}, {"RECTYPE": "D", "MH": "Anus Neoplasms", "DE": "ANUS NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cancer of Anus|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Anus", "MN": "C06.405.469.860.180.500.040", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "do not confuse with ANAL GLAND NEOPLASMS (in animals only); coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the ANAL CANAL.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001005"}, {"RECTYPE": "D", "MH": "Anus, Imperforate", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Atresia, Anal|T019|T047|NON|EQV|NLM (1998)|960725|abbcdef", "ENTRY": "Imperforate Anus", "MN": "C16.131.314.094", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "A congenital abnormality characterized by the persistence of the anal membrane, resulting in a thin membrane covering the normal ANAL CANAL. Imperforation is not always complete and is treated by surgery in infancy. This defect is often associated with NEURAL TUBE DEFECTS; MENTAL RETARDATION; and DOWN SYNDROME.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001006"}, {"RECTYPE": "D", "MH": "Anxiety", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Anxiousness|T041|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Social Anxieties", "MN": "F01.470.132", "FX": "Phobia, Social", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "human & animal; differentiate from ANXIETY DISORDERS, a psychiatric diagnosis", "MS": "Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001007"}, {"RECTYPE": "D", "MH": "Anxiety Disorders", "DE": "ANXIETY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Neuroses, Anxiety|T048|NON|NRW|UNK (19XX)|800521|abcdef", "ENTRY": "States, Neurotic Anxiety", "MN": "F03.080", "FX": "Anxiety", "MH_TH": "NLM (1966)", "ST": "T048", "AN": "differentiate from ANXIETY", "MS": "Persistent and disabling ANXIETY.", "OL": "use ANXIETY DISORDERS to search NEUROSES, ANXIETY 1966-80", "PM": "81; was NEUROSES, ANXIETY 1963-80", "HN": "81; was NEUROSES, ANXIETY 1963-80", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D001008"}, {"RECTYPE": "D", "MH": "Anxiety, Castration", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Castration Complex|T048|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Complices, Castration", "MN": "F01.470.132.150", "MH_TH": "NLM (1965)", "ST": "T048", "MS": "Anxiety due to fantasized injuries to or loss of the genitals.", "PM": "70", "HN": "70(65)", "CATSH": "CAT LIST", "MR": "20040719", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D001009"}, {"RECTYPE": "D", "MH": "Anxiety, Separation", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Separation Anxiety Disorder|T048|NON|EQV|NLM (1998)|970317|SEPARATION ANXIETY DIS|abcdefv", "ENTRY": "Separation Anxiety", "MN": "F03.625.047", "MH_TH": "NLM (1968)", "ST": "T048", "PI": "Child Psychology (1966-1967)", "MS": "Anxiety experienced by an individual upon separation from a person or object of particular significance to the individual.", "OL": "use ANXIETY, SEPARATION to search HOMESICKNESS 1975-78; use EMOTIONS 1966-74", "PM": "68; HOMESICKNESS was see under EMOTIONS 1963-74", "HN": "68; HOMESICKNESS was see under ANXIETY, SEPARATION 1975-78, was see under EMOTIONS 1963-74", "CATSH": "CAT LIST", "MR": "20150707", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001010"}, {"RECTYPE": "D", "MH": "Aorta", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Aortas", "MN": "A07.015.114.056", "FX": "Coronary Artery Bypass", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The main trunk of the systemic arteries.", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001011"}, {"RECTYPE": "D", "MH": "Aorta, Abdominal", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Aortas, Abdominal", "MN": "A07.015.114.056.205", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "coord NIM with aortic dis terms (IM)", "MS": "The aorta from the DIAPHRAGM to the bifurcation into the right and left common iliac arteries.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001012"}, {"RECTYPE": "D", "MH": "Aorta, Thoracic", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sinotubular Junction|T023|NON|NRW|NLM (2023)|220525|abcdef", "ENTRY": "Sinotubular Junctions", "MN": "A07.015.114.056.372", "MH_TH": "NLM (1963)", "ST": "T023", "AN": "diseases: coordinate with AORTIC DISEASES or specifics", "MS": "The portion of the descending aorta proceeding from the arch of the aorta and extending to the DIAPHRAGM, eventually connecting to the ABDOMINAL AORTA.", "PM": "1963; for ASCENDING AORTA see AORTA 1963-2022", "HN": "1963; for ASCENDING AORTA use AORTA 1963-2022", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001013"}, {"RECTYPE": "D", "MH": "Aortic Aneurysm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Aortic Aneurysms", "MN": "C14.907.109.139", "MH_TH": "NLM (1966)", "ST": "T190", "MS": "An abnormal balloon- or sac-like dilatation in the wall of AORTA.", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001014"}, {"RECTYPE": "D", "MH": "Aortic Arch Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Aortic Arch", "MN": "C14.907.109.239", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Conditions resulting from abnormalities in the arteries branching from the ASCENDING AORTA, the curved portion of the aorta. These syndromes are results of occlusion or abnormal blood flow to the head-neck or arm region leading to neurological defects and weakness in an arm. These syndromes are associated with vascular malformations; ATHEROSCLEROSIS; TRAUMA; and blood clots.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001015"}, {"RECTYPE": "D", "MH": "Aortic Bodies", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Vagal Body|T023|NON|EQV|NLM (1994)|921006|abcdef", "ENTRY": "Vagale, Glomus", "MN": "A11.671.650.915.500.600.050", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "do not confuse with PARA-AORTIC BODIES", "MS": "Small clusters of chemoreceptive and supporting cells located near the ARCH OF THE AORTA; the PULMONARY ARTERIES; and the CORONARY ARTERIES. The aortic bodies sense PH; CARBON DIOXIDE; and OXYGEN concentrations in the BLOOD and participate in the control of RESPIRATION. The aortic bodies should not be confused with the PARA-AORTIC BODIES in the abdomen (which are sometimes also called aortic bodies).", "OL": "search PARAGANGLIA, NONCHROMAFFIN 1966-74", "PM": "91; was see under PARAGANGLIA, NONCHROMAFFIN 1975-90", "HN": "91(75); was see under PARAGANGLIA, NONCHROMAFFIN 1975-90", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001016"}, {"RECTYPE": "D", "MH": "Aortic Coarctation", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Coarctations, Aortic", "MN": "C16.131.240.400.090", "MH_TH": "ORD (2010)", "ST": "T019", "MS": "A birth defect characterized by the narrowing of the AORTA that can be of varying degree and at any point from the transverse arch to the iliac bifurcation. Aortic coarctation causes arterial HYPERTENSION before the point of narrowing and arterial HYPOTENSION beyond the narrowed portion.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001017"}, {"RECTYPE": "D", "MH": "Aortic Diseases", "DE": "AORTIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Aortic", "MN": "C14.907.109", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes involving any part of the AORTA.", "CATSH": "CAT LIST", "MR": "20090710", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001018"}, {"RECTYPE": "D", "MH": "Aortic Rupture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aortic Aneurysm, Ruptured|T037|T047|NON|NRW|NLM (1993)|920514|abbcdef", "ENTRY": "Ruptures, Aortic", "MN": "C26.761.125", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "do not coordinate with RUPTURE, SPONTANEOUS unless particularly discussed & then only NIM", "MS": "The tearing or bursting of the wall along any portion of the AORTA, such as thoracic or abdominal. It may result from the rupture of an aneurysm or it may be due to TRAUMA.", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001019"}, {"RECTYPE": "D", "MH": "Aortic Stenosis, Subvalvular", "DE": "AORTIC STENOSIS SUBVALV", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subvalvular Aortic Stenosis|T047|NON|EQV|NLM (2001)|ORD (2010)|000228|SUBVALV AORTIC STENOSIS|abcdeefv", "ENTRY": "Subvalvular Stenosis, Aortic", "MN": "C14.280.955.249.070", "MH_TH": "NLM (2001)", "ST": "T047", "MS": "A pathological constriction occurring in the region below the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.", "OL": "search CARDIOMYOPATHY, HYPERTROPHIC 1967-74", "PM": "91; was see under CARDIOMYOPATHY, HYPERTROPHIC 1986-90; was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85", "HN": "91(75); was see under CARDIOMYOPATHY, HYPERTROPHIC 1986-90; was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001020"}, {"RECTYPE": "D", "MH": "Aortic Valve", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Valves, Aortic", "MN": "A07.541.510.110", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "dis: coord IM with HEART VALVE DISEASES (IM) but note specific aortic valve dis; atresia: index AORTIC VALVE /abnorm", "MS": "The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle.", "OL": "search AORTIC VALVE DISEASES under HEART VALVE DISEASES 1966", "PM": "AORTIC VALVE DISEASES was heading 1963-66", "HN": "AORTIC VALVE DISEASES was heading 1963-66", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001021"}, {"RECTYPE": "D", "MH": "Aortic Valve Insufficiency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aortic Valve Incompetence|T047|NON|EQV|UNK (19XX)|860418|abcdef", "ENTRY": "Regurgitation, Aortic", "MN": "C14.280.484.048.500", "MH_TH": "NLM (1967)", "ST": "T047", "PI": "Heart Valve Diseases (1966)", "MS": "Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).", "PM": "67; AORTIC REGURGITATION was REGURGITATION, AORTIC VALVE 1963-92", "HN": "67; AORTIC REGURGITATION was REGURGITATION, AORTIC VALVE 1963-92", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001022"}, {"RECTYPE": "D", "MH": "Aortic Valve Prolapse", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Valve Prolapses, Aortic", "MN": "C14.280.484.400.100", "MH_TH": "NLM (1988)", "ST": "T047", "PI": "Aortic Valve Insufficiency (1967-1987)", "MS": "The downward displacement of the cuspal or pointed end of the trileaflet AORTIC VALVE causing misalignment of the cusps. Severe valve distortion can cause leakage and allow the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to aortic regurgitation.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19870430", "DC": "1", "DX": "19880101", "UI": "D001023"}, {"RECTYPE": "D", "MH": "Aortic Valve Stenosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aortic Stenosis|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Valve Stenosis, Aortic", "MN": "C14.280.955.249", "FX": "Cardiomyopathy, Hypertrophic", "MH_TH": "NLM (1967)", "ST": "T047", "MS": "A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.", "OL": "use AORTIC VALVE STENOSIS to search AORTIC STENOSIS 1966; search AORTIC VALVE DISEASES under HEART VALVE DISEASES 1966", "PM": "67; was AORTIC STENOSIS 1963-66; AORTIC VALVE DISEASES was heading 1963-66", "HN": "67; was AORTIC STENOSIS 1963-66; AORTIC VALVE DISEASES was heading 1963-66", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001024"}, {"RECTYPE": "D", "MH": "Aortitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Aortitides", "MN": "C14.907.940.080", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Arteritis (1966-1979)", "MS": "Inflammation of the wall of the AORTA.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19790424", "DC": "1", "DX": "19800101", "UI": "D001025"}, {"RECTYPE": "D", "MH": "Coronary Artery Bypass", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Bypass, Coronary Artery|T061|NON|EQV|NLM (1990)|890413|abcdef", "ENTRY": "Coronary Artery Bypasses", "MN": "E04.928.220.520.220", "MH_TH": "IOM (1990)", "ST": "T061", "PI": "Myocardial Infarct/surgery (1966-1971)", "MS": "Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion.", "OL": "use CORONARY ARTERY BYPASS to search AORTOCORONARY BYPASS 1972-89 (Prov 1972)", "PM": "90; was AORTOCORONARY BYPASS 1973-89", "HN": "90; was AORTOCORONARY BYPASS 1973-89 (Prov 1972)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001026"}, {"RECTYPE": "D", "MH": "Aortography", "DE": "AORTOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Aortographies", "MN": "E01.370.370.050.070", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Radiographic visualization of the aorta and its branches by injection of contrast media, using percutaneous puncture or catheterization procedures.", "PM": "66; was see under ANGIOGRAPHY 1963-65", "HN": "66; was see under ANGIOGRAPHY 1963-65", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001027"}, {"RECTYPE": "D", "MH": "Aortopulmonary Septal Defect", "DE": "AORTOPULM SEPTAL DEFECT", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Septal Defects, Aortopulmonary|T019|NON|EQV|NLM (1992)|900925|SEPTAL DEFECTS AORTOPULM|abcdefv", "MN": "C16.131.240.400.560.098", "MH_TH": "NLM (1984)", "ST": "T019", "PI": "Pulmonary Artery/abnormalities (1966-1983)", "MS": "A developmental abnormality in which the spiral (aortopulmonary) septum failed to completely divide the TRUNCUS ARTERIOSUS into ASCENDING AORTA and PULMONARY ARTERY. This abnormal communication between the two major vessels usually lies above their respective valves (AORTIC VALVE; PULMONARY VALVE).", "PM": "91; was see under HEART DEFECTS, CONGENITAL 1984-90", "HN": "91(84); was see under HEART DEFECTS, CONGENITAL 1984-90", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19830531", "DC": "1", "DX": "19910101", "UI": "D001028"}, {"RECTYPE": "D", "MH": "Aotus trivirgatus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Night Monkey, Northern|T015|NON|EQV|NLM (1992)|901102|abcdef", "ENTRY": "Northern Night Monkeys", "MN": "B01.050.150.900.649.313.988.400.600.037.092", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9505", "AN": "index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)", "MS": "A species in the family AOTIDAE, inhabiting the forested regions of Central and South America (from Panama to the Amazon). Vocalizations occur primarily at night when they are active, thus they are also known as Northern night monkeys.", "OL": "use AOTUS TRIVIRGATUS to search NIGHT MONKEYS 1975-80", "PM": "91; was see under CEBIDAE 1981-90; was NIGHT MONKEYS see under MONKEYS 1975-80", "HN": "91(81); was see under CEBIDAE 1981-90; was NIGHT MONKEYS see under MONKEYS 1975-80", "MR": "20200813", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D001029"}, {"RECTYPE": "D", "MH": "Apamin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.946.833.065.115.060", "MH_TH": "NLM (1978)", "ST": "T131", "N1": "Apamin", "RN": "24345-16-2", "AN": "/antag permitted but consider also ANTIVENINS", "PI": "Venoms (1966-1977)", "MS": "A highly neurotoxic polypeptide from the venom of the honey bee (Apis mellifera). It consists of 18 amino acids with two disulfide bridges and causes hyperexcitability resulting in convulsions and respiratory paralysis.", "PM": "91; was see under BEE VENOMS 1978-90", "HN": "91(78); was see under BEE VENOMS 1978-90", "MR": "20150331", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D001030"}, {"RECTYPE": "D", "MH": "Apatites", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Apatite|T197|NON|EQV|NLM (2021)|191219|abcdef", "MN": "D01.695.625.675.650.075.025", "MH_TH": "NLM (1964)", "ST": "T197", "RN": "0", "AN": "a group of phosphate minerals", "MS": "A group of phosphate minerals that includes ten mineral species and has the general formula X5(YO4)3Z, where X is usually calcium or lead, Y is phosphorus or arsenic, and Z is chlorine, fluorine, or OH-. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "66", "HN": "66(64)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001031"}, {"RECTYPE": "D", "MH": "Apazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Azapropazone|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|UNK (19XX)|741111|abbcdeeeef", "ENTRY": "Dihydrate, Apazone", "MN": "D03.383.931.190", "PA": "Uricosuric Agents", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "1H-Pyrazolo(1,2-a)(1,2,4)benzotriazine-1,3(2H)-dione, 5-(dimethylamino)-9-methyl-2-propyl-", "RN": "K2VOT966ZI", "RR": "BF18764H96", "PI": "Triazines (1971-1974)", "MS": "An anti-inflammatory agent used in the treatment of rheumatoid arthritis. It also has uricosuric properties and has been used to treat gout.", "PM": "91; was see under TRIAZINES 1975-90", "HN": "91(75); was see under TRIAZINES 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001032"}, {"RECTYPE": "D", "MH": "Apgar Score", "ENTRY": "Score, Apgar", "MN": "E01.370.600.050", "MH_TH": "NLM (1971)", "ST": "T032", "AN": "check the tags HUMANS & INFANT, NEWBORN", "PI": "Physical Examination (1966-1970)", "MS": "A method, developed by Dr. Virginia Apgar, to evaluate a newborn's adjustment to extrauterine life. Five items - heart rate, respiratory effort, muscle tone, reflex irritability, and color - are evaluated 60 seconds after birth and again five minutes later on a scale from 0-2, 0 being the lowest, 2 being normal. The five numbers are added for the Apgar score. A score of 0-3 represents severe distress, 4-7 indicates moderate distress, and a score of 7-10 predicts an absence of difficulty in adjusting to extrauterine life.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001034"}, {"RECTYPE": "D", "MH": "Aphakia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aphakic Eye, Traumatic|T190|NON|NRW|NLM (2021)|191018|abcdef", "ENTRY": "Traumatic Aphakic Eyes", "MN": "C11.510.103", "MH_TH": "NLM (1978)", "ST": "T190", "PI": "Lens, Crystalline (1966-1977)", "MS": "Absence of crystalline lens totally or partially from field of vision, from any cause except after cataract extraction. Aphakia is mainly congenital or as result of LENS DISLOCATION AND SUBLUXATION.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19770411", "DC": "1", "DX": "19780101", "UI": "D001035"}, {"RECTYPE": "D", "MH": "Aphakia, Postcataract", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aphakic Eye, Postcataract|T020|NON|EQV|NLM (2021)|191018|abcdef", "ENTRY": "Postcataract Aphakic Eyes", "MN": "C11.510.103.110", "FX": "Pseudophakia", "MH_TH": "NLM (1978)", "ST": "T020", "PI": "Lens, Crystalline (1966-1977)", "MS": "Absence of the crystalline lens resulting from cataract extraction.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19770411", "DC": "1", "DX": "19780101", "UI": "D001036"}, {"RECTYPE": "D", "MH": "Aphasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Word Deafness|T048|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Syntactical Aphasias", "MN": "C23.888.592.604.150.500.800.100", "FX": "Landau-Kleffner Syndrome", "MH_TH": "NLM (1966)", "ST": "T048", "AN": "general or unspecified; prefer specifics", "MS": "A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.", "PM": "1963; for APHASIA, ACQUIRED see APHASIA, ACQUIRED 1991-1995, see APHASIA 1980-1990", "HN": "1963", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D001037"}, {"RECTYPE": "D", "MH": "Aphasia, Broca", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Dysphasia, Broca|T048|EPO|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Verbal Aphasia Syndromes", "MN": "C23.888.592.604.150.500.800.100.100", "MH_TH": "NLM (1980)", "ST": "T048", "AN": "do not confuse with APHASIA, WERNICKE", "PI": "Aphasia (1966-1979)", "MS": "An aphasia characterized by impairment of expressive LANGUAGE (speech, writing, signs) and relative preservation of receptive language abilities (i.e., comprehension). This condition is caused by lesions of the motor association cortex in the FRONTAL LOBE (BROCA AREA and adjacent cortical and white matter regions).", "PM": "1991; see APHASIA 1980-1990", "HN": "1991(1980)", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19781214", "DC": "1", "DX": "19910101", "UI": "D001039"}, {"RECTYPE": "D", "MH": "Aphasia, Wernicke", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Wernicke Aphasia|T048|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Wernicke's Fluent Aphasia", "MN": "C23.888.592.604.150.500.800.100.166", "MH_TH": "NLM (1980)", "ST": "T048", "AN": "do not confuse with APHASIA, BROCA where subject understands language but cannot express it", "PI": "Aphasia (1966-1979)", "MS": "Impairment in the comprehension of speech and meaning of words, both spoken and written, and of the meanings conveyed by their grammatical relationships in sentences. It is caused by lesions that primarily affect Wernicke's area, which lies in the posterior perisylvian region of the temporal lobe of the dominant hemisphere. (From Brain & Bannister, Clinical Neurology, 7th ed, p141; Kandel et al., Principles of Neural Science, 3d ed, p846)", "PM": "1991; see APHASIA 1980-1990", "HN": "1991(1980)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19781214", "DC": "1", "DX": "19910101", "UI": "D001041"}, {"RECTYPE": "D", "MH": "Aphids", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Schizaphis|T204|NON|NRW|NLM (1999)|980408|abcdef", "ENTRY": "Schizaphi", "MN": "B01.050.500.131.617.412.165", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid27482", "RR": "txid13261", "AN": "do not use /drug eff for insecticides: TN 111", "PI": "Insects (1966-1971)", "MS": "A family (Aphididae) of small insects, in the suborder Sternorrhyncha, that suck the juices of plants. Important genera include Schizaphis and Myzus. The latter is known to carry more than 100 virus diseases between plants.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001042"}, {"RECTYPE": "D", "MH": "Aphonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spastic Aphonia|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Voice Absences", "MN": "C23.888.592.979.100", "MH_TH": "NLM (1969)", "ST": "T184", "PI": "Voice (1966-1968)", "MS": "Complete loss of phonation due to organic disease of the larynx or to nonorganic (i.e., psychogenic) causes.", "PM": "1972; see VOICE 1963-1971", "HN": "1972(1963)", "CATSH": "CAT LIST", "MR": "19991123", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001044"}, {"RECTYPE": "D", "MH": "Aphorisms and Proverbs as Topic", "AQ": "HI", "ENTRY": "Proverbs as Topics", "MN": "K01.517.116", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with the Publication Type APHORISMS AND PROVERBS", "MS": "Works about short popular sayings effectively expressing or astutely professing general truths or useful thoughts.", "PM": "2008; see APHORISMS AND PROVERBS 1963-2007", "HN": "2008(1963)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D001045"}, {"RECTYPE": "D", "MH": "Aphrodisiacs", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aphrodisiac|T120|NON|EQV|NLM (2021)|200220|abcdef", "ENTRY": "Effects, Aphrodisiac", "MN": "D27.505.954.427.220.045", "MH_TH": "NLM (1966)", "ST": "T120", "RN": "0", "MS": "Chemical agents or ODORANTS that stimulate sexual desires. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001046"}, {"RECTYPE": "D", "MH": "Apicoectomy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Apicoectomies", "MN": "E06.645.100", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Excision of the apical portion of a tooth through an opening made in the overlying labial, buccal, or palatal alveolar bone. (Dorland, 28th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001047"}, {"RECTYPE": "D", "MH": "Aplysia", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Aplysias", "MN": "B01.050.500.644.400.060", "MH_TH": "NLM (1978)", "ST": "T204", "RN": "txid6499", "AN": "mollusk; /microbiol /parasitol /virol permitted", "PI": "Mollusca (1966-1977)", "MS": "An opisthobranch mollusk of the order Anaspidea. It is used frequently in studies of nervous system development because of its large identifiable neurons. Aplysiatoxin and its derivatives are not biosynthesized by Aplysia, but acquired by ingestion of Lyngbya (seaweed) species.", "PM": "78", "HN": "78", "MR": "20200813", "DA": "19770513", "DC": "1", "DX": "19780101", "UI": "D001048"}, {"RECTYPE": "D", "MH": "Apnea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Apneas", "MN": "C23.888.852.130", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A transient absence of spontaneous respiration.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001049"}, {"RECTYPE": "D", "MH": "Apocrine Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Glands, Apocrine", "MN": "A17.815.830.206", "FX": "Sweating", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "SWEAT and SWEATING are also available", "MS": "Large, branched, specialized sweat glands that empty into the upper portion of a HAIR FOLLICLE instead of directly onto the SKIN.", "OL": "search SWEAT GLANDS 1971-74", "PM": "91; was see under SWEAT GLANDS 1975-90", "HN": "91(75); was see under SWEAT GLANDS 1975-90", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001050"}, {"RECTYPE": "D", "MH": "Apoenzymes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Apoenzyme|T116|T126|NON|EQV|NLM (2007)|051129|abbcdef", "MN": "D12.776.070.290", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "0", "AN": "IM general only; coordinate NIM with specific enzyme (IM)", "MS": "The protein components of enzyme complexes (HOLOENZYMES). An apoenzyme is the holoenzyme minus any cofactors (ENZYME COFACTORS) or prosthetic groups required for the enzymatic function.", "OL": "search APOPROTEINS 1974", "PM": "91; was see under APOPROTEINS 1975-90", "HN": "91(75); was see under APOPROTEINS 1975-90", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001051"}, {"RECTYPE": "D", "MH": "Apoferritins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Light Chain, Ferritin", "MN": "D12.776.556.579.249.290", "MH_TH": "NLM (2007)", "ST": "T123", "N1": "Ferritins, apo-", "RN": "9013-31-4", "RR": "EC 1.16.3.1", "MS": "The protein components of ferritins. Apoferritins are shell-like structures containing nanocavities and ferroxidase activities. Apoferritin shells are composed of 24 subunits, heteropolymers in vertebrates and homopolymers in bacteria. In vertebrates, there are two types of subunits, light chain and heavy chain. The heavy chain contains the ferroxidase activity.", "PM": "2007; see APOFERRITIN 1991-2006, see FERRITIN 1975-1990; H-FERRITIN was indexed under FERRITIN 1972-2006; L-FERRITIN was indexed under FERRITIN 1996-2006", "HN": "2007 (1975); for H-FERRITIN use FERRITIN (NM) 1972-2006; for L-FERRITIN use FERRITIN (NM) 1996-2006", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001052"}, {"RECTYPE": "D", "MH": "Apolipoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apolipoprotein|T116|T123|NON|EQV|UNK (19XX)|870504|abbcdef", "MN": "D12.776.521.120", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "PI": "specific lipoprotein (1972-1976)", "MS": "Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES.", "PM": "77", "HN": "77", "MR": "20060705", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D001053"}, {"RECTYPE": "D", "MH": "Apolipoproteins A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Apo-A|T116|T123|ABB|EQV|UNK (19XX)|840525|abbcdef", "ENTRY": "ApoA|T116|T123|ABB|EQV|UNK (19XX)|840525|abbcdef", "MN": "D12.776.521.120.200", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "AN": "do not confuse with APOLIPOPROTEIN (A)", "PI": "Apolipoproteins (1977-1984)", "MS": "Structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS), including APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II. They can modulate the activity of LECITHIN CHOLESTEROL ACYLTRANSFERASE. These apolipoproteins are low in atherosclerotic patients. They are either absent or present in extremely low plasma concentration in TANGIER DISEASE.", "PM": "85", "HN": "85", "MR": "20060705", "DA": "19840525", "DC": "1", "DX": "19850101", "UI": "D001054"}, {"RECTYPE": "D", "MH": "Apolipoproteins B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Apo-B|T116|T123|ABB|EQV|UNK (19XX)|840525|abbcdef", "ENTRY": "Apoproteins B|T116|T123|NON|BRD|UNK (19XX)|840525|abbcdef", "MN": "D12.776.521.120.300", "FX": "Abetalipoproteinemia", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins (1977-1984)", "MS": "Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA.", "OL": "use APOLIPOPROTEINS B to search APOLIPOPROTEIN B 1985-93", "PM": "85; APOLIPOPROTEIN B was see APOLIPOPROTEINS B 1985-93", "HN": "85; APOLIPOPROTEIN B was see APOLIPOPROTEINS B 1985-93", "MR": "20060705", "DA": "19840525", "DC": "1", "DX": "19850101", "UI": "D001055"}, {"RECTYPE": "D", "MH": "Apolipoproteins C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Apo-C|T116|T123|ABB|EQV|UNK (19XX)|840530|abbcdef", "ENTRY": "Apoproteins C|T116|T123|NON|BRD|UNK (19XX)|840530|abbcdef", "MN": "D12.776.521.120.400", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins (1977-1984)", "MS": "A group of apolipoproteins that can readily exchange among the various classes of lipoproteins (HDL; VLDL; CHYLOMICRONS). After lipolysis of TRIGLYCERIDES on VLDL and chylomicrons, Apo-C proteins are normally transferred to HDL. The subtypes can modulate remnant binding to receptors, LECITHIN CHOLESTEROL ACYLTRANSFERASE, or LIPOPROTEIN LIPASE.", "OL": "use APOLIPOPROTEINS C to search APOLIPOPROTEIN C 1985-93", "PM": "85; APOLIPOPROTEIN C was see APOLIPOPROTEINS C 1985-93", "HN": "85; APOLIPOPROTEIN C was see APOLIPOPROTEINS C 1985-93", "MR": "20060705", "DA": "19840530", "DC": "1", "DX": "19850101", "UI": "D001056"}, {"RECTYPE": "D", "MH": "Apolipoproteins E", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Apo-E|T116|T123|ABB|EQV|UNK (19XX)|840525|abbcdef", "ENTRY": "Isoproteins, Apolipoprotein E", "MN": "D12.776.521.120.500", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins (1977-1984)", "MS": "A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III.", "PM": "1985; APOLIPOPROTEIN E ISOPROTEINS was indexed under APOLIPOPROTEINS E 1985-2006 & under APOLIPOPROTEINS 1983-1984", "HN": "1985; for APOLIPOPROTEIN E ISOPROTEINS use APOLIPOPROTEINS E 1985-2006 & use APOLIPOPROTEINS 1983-1984", "MR": "20060705", "DA": "19840525", "DC": "1", "DX": "19850101", "UI": "D001057"}, {"RECTYPE": "D", "MH": "Apomorphine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Apomorphin Teclapharm", "MN": "D03.633.400.095.290", "PA": "Emetics", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)-", "RN": "N21FAR7B4S", "RR": "F39049Y068", "MS": "A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use.", "OL": "use APOMORPHINE/analogs & derivatives to search APOMORPHINE DERIVATIVES 1975-77; use APOMORPHINE 1969-74", "PM": "APOMORPHINE DERIVATIVES was see under APOMORPHINE 1969-77", "HN": "APOMORPHINE DERIVATIVES was see under APOMORPHINE 1969-77", "MR": "20180301", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001058"}, {"RECTYPE": "D", "MH": "Apoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apoprotein|T116|T123|NON|EQV|NLM (2007)|051129|abbcdef", "MN": "D12.776.070", "MH_TH": "NLM (1972)", "ST": "T123", "RN": "0", "PI": "specific enzyme or protein (1966-1971)", "MS": "The protein components of a number of complexes, such as enzymes (APOENZYMES), ferritin (APOFERRITINS), or lipoproteins (APOLIPOPROTEINS).", "PM": "74", "HN": "74(72)", "MR": "20060707", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001059"}, {"RECTYPE": "D", "MH": "Aporphines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.400.095", "MH_TH": "NLM (1969)", "ST": "T109", "RN": "0", "PI": "Apomorphine (1966-1968)", "MS": "Dibenzoquinolines derived in plants from (S)-reticuline (BENZYLISOQUINOLINES).", "PM": "69", "HN": "69", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D001060"}, {"RECTYPE": "D", "MH": "Appalachian Region", "AQ": "EH EP", "ENTRY": "Appalachia|T083|NAM|EQV|NLM (1990)|890520|abcdef", "MN": "Z01.107.567.875.075", "MH_TH": "NLM (1975)", "ST": "T083", "AN": "index specific states as needed but use APPALACHIAN REGION when text uses the term & when the region is the intent of the author; CATALOGER: Use for 4 or more states", "MS": "A geographical area of the United States with no definite boundaries but comprising northeastern Alabama, northwestern Georgia, northwestern South Carolina, western North Carolina, eastern Kentucky, eastern Tennessee, western Virginia, West Virginia, western Maryland, southwestern Pennsylvania, southern Ohio, and southern New York.", "HN": "75", "MR": "20150605", "DA": "19990101", "DC": "4", "DX": "19750101", "UI": "D001061"}, {"RECTYPE": "D", "MH": "Appendectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Appendectomies", "MN": "E04.210.078", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Surgical removal of the vermiform appendix. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001062"}, {"RECTYPE": "D", "MH": "Appendiceal Neoplasms", "DE": "APPENDICEAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cancer of Appendix|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Appendiceal", "MN": "C06.405.469.491.184.290", "FX": "Pseudomyxoma Peritonei", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the APPENDIX.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001063"}, {"RECTYPE": "D", "MH": "Appendicitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Appendicitis, Ruptured", "MN": "C06.405.469.110.207", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Acute inflammation of the APPENDIX. Acute appendicitis is classified as simple, gangrenous, or perforated.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001064"}, {"RECTYPE": "D", "MH": "Appendix", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Appendix, Vermiform", "MN": "A03.556.249.249.209.290", "FX": "Appendectomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A worm-like blind tube extension from the CECUM.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001065"}, {"RECTYPE": "D", "MH": "Appetite", "AQ": "DE EH GE IM PH RE", "ENTRY": "Appetites", "MN": "G10.261.390.070", "FX": "Craving", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "Natural recurring desire for food. Alterations may be induced by APPETITE DEPRESSANTS or APPETITE STIMULANTS.", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001066"}, {"RECTYPE": "D", "MH": "Appetite Depressants", "DE": "APPETITE DEPRESS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Appetite-Suppressant Drug|T121|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Suppressants, Appetite", "MN": "D27.505.954.203.155", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Agents that are used to suppress appetite.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001067"}, {"RECTYPE": "D", "MH": "Feeding and Eating Disorders", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Appetite Disorders|T048|NON|NRW|UNK (19XX)|880608|APPETITE DIS|abcdefv", "ENTRY": "Feeding Disorder", "MN": "F03.400", "MH_TH": "NLM (2016)", "ST": "T048", "AN": "in children, use FEEDING AND EATING DISORDERS OF CHILDHOOD if related to mental disorder", "MS": "A group of disorders characterized by physiological and psychological disturbances in appetite or food intake.", "PM": "2016; see EATING AND FEEDING DISORDERS 1989-2015,  see APPETITE DISORDERS 1963-1988", "HN": "2016 (1983)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19890101", "UI": "D001068"}, {"RECTYPE": "D", "MH": "Appetite Regulation", "DE": "APPETITE REG", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Food Intake Regulation|T040|NON|NRW|UNK (19XX)|880608|FOOD INTAKE REG|abcdefv", "ENTRY": "Regulations, Food Intake", "MN": "G10.261.390.070.290", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "Physiologic mechanisms which regulate or control the appetite and food intake.", "PM": "72", "HN": "72(66)", "CATSH": "CAT LIST", "MR": "20160125", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001069"}, {"RECTYPE": "D", "MH": "Appetitive Behavior", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Searching Behavior|T055|NON|EQV|NLM (1998)|970320|abcdef", "ENTRY": "Searching Behaviors", "MN": "F01.145.113.111", "FX": "Ceremonial Behavior", "MH_TH": "NLM (1968)", "ST": "T055", "AN": "usually animal; introduct phase of instinctive behav; nothing to do with APPETITE, the desire for food", "PI": "Behavior (1966-1967)", "MS": "Animal searching behavior. The variable introductory phase of an instinctive behavior pattern or sequence, e.g., looking for food, or sequential courtship patterns prior to mating.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001070"}, {"RECTYPE": "D", "MH": "Appointments and Schedules", "DE": "APPOINTMENTS SCHEDULES", "PRINT ENTRY": "Schedules, Patient|T058|T079|NON|NRW|UNK (19XX)|780508|abbcdef", "ENTRY": "Schedules and Appointments", "MN": "N04.452.095", "MH_TH": "NLM (1968)", "ST": "T079", "PI": "Outpatient Clinics, Hospital (1966-1967)", "MS": "The different methods of scheduling patient visits, appointment systems, individual or group appointments, waiting times, waiting lists for hospitals, walk-in clinics, etc.", "PM": "68", "HN": "68", "MR": "19910610", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001071"}, {"RECTYPE": "D", "MH": "Apraxias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ideational Apraxia|T048|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Verbal Dyspraxias, Developmental", "MN": "F01.700.875.350", "MH_TH": "NLM (2000)", "ST": "T048", "MS": "A group of cognitive disorders characterized by the inability to perform previously learned skills that cannot be attributed to deficits of motor or sensory function. The two major subtypes of this condition are ideomotor (see APRAXIA, IDEOMOTOR) and ideational apraxia, which refers to loss of the ability to mentally formulate the processes involved with performing an action. For example, dressing apraxia may result from an inability to mentally formulate the act of placing clothes on the body. Apraxias are generally associated with lesions of the dominant PARIETAL LOBE and supramarginal gyrus. (From Adams et al., Principles of Neurology, 6th ed, pp56-7)", "PM": "2000; see APRAXIA 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D001072"}, {"RECTYPE": "D", "MH": "Aprindine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Fiboran|T109|T121|TRD|NRW|ES|FR|NL|020802|abbcdeeef", "MN": "D04.615.486.487.060", "PA": "Voltage-Gated Sodium Channel Blockers", "MH_TH": "USAN (1973)", "ST": "T121", "N1": "1,3-Propanediamine, N-(2,3-dihydro-1H-inden-2-yl)-N',N'-diethyl-N-phenyl-", "RN": "5Y48085P9Q", "RR": "37640-71-4 (Aprindine)", "PI": "Indenes (1973-1975)", "MS": "A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.", "PM": "91; was see under INDENES 1975-90", "HN": "91(75); was see under INDENES 1975-90", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001073"}, {"RECTYPE": "D", "MH": "Propoxur", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "O Isopropoxyphenylmethylcarbamate", "MN": "D02.241.081.251.583.788", "PA": "Insecticides", "MH_TH": "UNK (19XX)", "ST": "T131", "N1": "Phenol, 2-(1-methylethoxy)-, methylcarbamate", "RN": "BFH029TL73", "RR": "114-26-1 (Propoxur)", "PI": "Insecticides (1966-1971)", "MS": "A carbamate insecticide.", "PM": "2001; see APROCARB 1972-2000", "HN": "2001(1972)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001074"}, {"RECTYPE": "D", "MH": "Aptitude", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Talent|T041|NON|REL|UNK (19XX)|780503|abcdef", "ENTRY": "Talents", "MN": "F02.784.629.131", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "The ability to acquire general or special types of knowledge or skill.", "OL": "use APTITUDE to search TALENT 1966-78", "HN": "TALENT was see under APTITUDE 1963-78", "CATSH": "CAT LIST", "MR": "19920325", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001076"}, {"RECTYPE": "D", "MH": "Aptitude Tests", "AQ": "HI SN ST", "ENTRY": "Tests, Aptitude", "MN": "F04.711.141", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Primarily non-verbal tests designed to predict an individual's future learning ability or performance.", "CATSH": "CAT LIST", "MR": "19920325", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001077"}, {"RECTYPE": "D", "MH": "APUD Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cells, APUD", "MN": "A11.382.249", "FX": "Enteroendocrine Cells", "MH_TH": "NLM (1978)", "ST": "T025", "AN": "named APUD from Amine Precursor Uptake & Decarboxylation; use term only when used by author", "MS": "Cells with the capacity to take up and decarboxylate the amine precursors DIHYDROXYPHENYLALANINE or 5-HYDROXYTRYPTOPHAN. This is a property of endocrine cells of neural and non-neural origin. APUDOMA is a general term collectively applied to tumors associated with APUD cells.", "PM": "78", "HN": "78", "MR": "20150622", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D001078"}, {"RECTYPE": "D", "MH": "Apudoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Apudomas", "MN": "C04.557.580.625.650.135", "FX": "Multiple Endocrine Neoplasia", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A general term collectively applied to tumors associated with the APUD CELLS series, irrespective of their specific identification.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20190307", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D001079"}, {"RECTYPE": "D", "MH": "Apurinic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Apurinic", "MN": "D13.695.740.050", "MH_TH": "NLM (1975)", "ST": "T114", "N1": "Apurinic acid", "RN": "11002-22-5", "PI": "Pyrimidine Nucleotides (1974)", "MS": "Hydrolysate of DNA in which purine bases have been removed.", "PM": "91; was see under POLYNUCLEOTIDES 1975-90", "HN": "91(75); was see under POLYNUCLEOTIDES 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001080"}, {"RECTYPE": "D", "MH": "Apyrase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenosine Diphosphatase|T116|T126|NON|EQV|UNK (19XX)|750630|abbcdef", "ENTRY": "Phosphohydrolase, ADP", "MN": "D08.811.277.040.050", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "ATP diphosphohydrolase", "RN": "EC 3.6.1.5", "RR": "9000-95-7 (CAS RN)", "PI": "Phosphatases (1974-1975)", "MS": "A calcium-activated enzyme that catalyzes the hydrolysis of ATP to yield AMP and orthophosphate. It can also act on ADP and other nucleoside triphosphates and diphosphates. EC 3.6.1.5.", "PM": "91; was see under PHOSPHATASES 1976-90; ATP-DIPHOSPHATASE was ATP DIPHOSPHATASE 1976-93", "HN": "91(76); was see under PHOSPHATASES 1976-90; ATP-DIPHOSPHATASE was ATP DIPHOSPHATASE 1976-93", "MR": "20030709", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D001081"}, {"RECTYPE": "D", "MH": "Aqueous Humor", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Intraocular Fluid|T031|NON|EQV|NLM (1998)|961106|abcdef", "ENTRY": "Intraocular Fluids", "MN": "A12.207.270.040", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "in the eye", "MS": "The clear, watery fluid which fills the anterior and posterior chambers of the eye. It has a refractive index lower than the crystalline lens, which it surrounds, and is involved in the metabolism of the cornea and the crystalline lens. (Cline et al., Dictionary of Visual Science, 4th ed, p319)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001082"}, {"RECTYPE": "D", "MH": "Arabia", "AQ": "EH EP", "MN": "Z01.586.035.100", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a hist name; do not confuse with SAUDI ARABIA nor with ARAB WORLD, the culture & civilization; Manual 36.13", "MS": "The great peninsula of southwest Asia comprising most of the present countries of the Middle East. It has been known since the first millennium B.C. In early times it was divided into Arabia Petraea, the northwest part, the only part ever conquered, becoming a Roman province; Arabia Deserta, the northern part between Syria and Mesopotamia; and Arabia Felix, the main part of the peninsula but by some geographers restricted to modern Yemen. (From Webster's New Geographical Dictionary, 1988, p63)", "MR": "20040719", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001083"}, {"RECTYPE": "D", "MH": "Vidarabine Phosphate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vidarabine Monophosphate|T114|T121|NON|EQV|UNK (19XX)|780516|abbcdef", "ENTRY": "Phosphate, Vidarabine", "MN": "D13.695.667.138.925", "PA": "Antiviral Agents", "MH_TH": "USAN (1979)", "ST": "T121", "N1": "9H-Purin-6-amine, 9-(5-O-phosphono-beta-D-arabinofuranosyl)-", "RN": "106XV160TZ", "RR": "29984-33-6 (Vidarabine Phosphate)", "PI": "Vidarabine (1975-1978)", "MS": "An adenosine monophosphate analog in which ribose is replaced by an arabinose moiety. It is the monophosphate ester of VIDARABINE with antiviral and possibly antineoplastic properties.", "PM": "96; was ARABINOFURANOSYLADENINE MONOPHOSPHATE 1979-95 (see under ARABINONUCLEOTIDES 1979-90)", "HN": "96; was ARABINOFURANOSYLADENINE MONOPHOSPHATE 1979-95 (see under ARABINONUCLEOTIDES 1979-90)", "MR": "20160601", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D001084"}, {"RECTYPE": "D", "MH": "Arabinofuranosylcytosine Triphosphate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cytosine Arabinoside Triphosphate|T114|T121|NON|EQV|UNK (19XX)|780516|abbcdef", "ENTRY": "Triphosphate, Cytosine Arabinoside", "MN": "D13.695.740.246.050", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "NLM (1979)", "ST": "T121", "N1": "2(1H)-Pyrimidinone, 4-amino-1-(5-O-(hydroxy((hydroxy(phosphonooxy)phosphinyl)oxy)phosphinyl)-beta-D-arabinofuranosyl)-", "RN": "13191-15-6", "PI": "Cytarabine (1966-1978)", "MS": "A triphosphate nucleotide analog which is the biologically active form of CYTARABINE. It inhibits nuclear DNA synthesis.", "PM": "91; was see under ARABINONUCLEOTIDES 1979-90", "HN": "91(79); was see under ARABINONUCLEOTIDES 1979-90", "MR": "20160527", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D001085"}, {"RECTYPE": "D", "MH": "Arabinofuranosyluracil", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uracil Arabinoside|T114|T123|NON|EQV|UNK (19XX)|750701|abbcdef", "ENTRY": "Uracil, 1-beta-D-Arabinofuranosyl", "MN": "D13.570.685.852.150", "MH_TH": "NLM (1976)", "ST": "T123", "N1": "2,4(1H,3H)-Pyrimidinedione, 1-beta-D-arabinofuranosyl-", "RN": "3083-77-0", "AN": "/biosyn /physiol permitted", "PI": "Uridine/analogs & derivatives (1975)", "MS": "A pyrimidine nucleoside formed in the body by the deamination of CYTARABINE.", "PM": "91; was see under URIDINE/analogs & derivatives 1978-90; was see under PYRIMIDINE NUCLEOSIDES 1976-77", "HN": "91(76); was see under URIDINE/analogs & derivatives 1978-90; was see under PYRIMIDINE NUCLEOSIDES 1976-77", "MR": "20160527", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D001086"}, {"RECTYPE": "D", "MH": "Arabinonucleosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Arabinofuranosylnucleosides|T114|NON|EQV|UNK (19XX)|780517|abcdef", "MN": "D13.570.065", "MH_TH": "NLM (1979)", "ST": "T114", "RN": "0", "PI": "specific nucleoside (1966-1978)", "MS": "Nucleosides containing arabinose as their sugar moiety.", "PM": "79", "HN": "79", "MR": "19920507", "DA": "19780517", "DC": "1", "DX": "19790101", "UI": "D001087"}, {"RECTYPE": "D", "MH": "Arabinonucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Arabinofuranosylnucleotides|T114|NON|EQV|UNK (19XX)|780516|abcdef", "MN": "D13.695.065", "MH_TH": "NLM (1979)", "ST": "T114", "RN": "0", "PI": "specific nucleotide (1966-1978)", "MS": "Nucleotides containing arabinose as their sugar moiety.", "PM": "79", "HN": "79", "MR": "19920507", "DA": "19780516", "DC": "1", "DX": "19790101", "UI": "D001088"}, {"RECTYPE": "D", "MH": "Arabinose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L Arabinose", "MN": "D09.947.875.627.166", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Arabinose", "RN": "B40ROO395Z", "RR": "147-81-9 (Arabinose)", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001089"}, {"RECTYPE": "D", "MH": "Arachidonate Lipoxygenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lipoxygenases, Arachidonate", "MN": "D12.776.556.579.374.568.500", "MH_TH": "NLM (1987)", "ST": "T126", "RN": "EC 1.13.11.-", "PI": "Oxygenases (1966-1973)", "MS": "Enzymes catalyzing the oxidation of arachidonic acid to hydroperoxyarachidonates. These products are then rapidly converted by a peroxidase to hydroxyeicosatetraenoic acids. The positional specificity of the enzyme reaction varies from tissue to tissue. The final lipoxygenase pathway leads to the leukotrienes. EC 1.13.11.- .", "PM": "87", "HN": "87", "MR": "20100625", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D001091"}, {"RECTYPE": "D", "MH": "Arachidonate 12-Lipoxygenase", "DS": "ARACHIDONATE LIPOXYGENASE 12", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "12-Lipoxygenase|T116|T126|NON|EQV|UNK (19XX)|860616|LIPOXYGENASE A 12|abbcdefs", "ENTRY": "Arachidonic Acid 12 Lipoxygenase", "MN": "D12.776.556.579.374.568.500.025", "EC": "antagonists & inhibitors:Lipoxygenase Inhibitors", "MH_TH": "NLM (1987)", "ST": "T126", "N1": "Arachidonate:oxygen 12-oxidoreductase", "RN": "EC 1.13.11.31", "PI": "Oxygenases (1966-1973)", "MS": "An enzyme that catalyzes the oxidation of arachidonic acid to yield 12-hydroperoxyarachidonate (12-HPETE) which is itself rapidly converted by a peroxidase to 12-hydroxy-5,8,10,14-eicosatetraenoate (12-HETE). The 12-hydroperoxides are preferentially formed in PLATELETS.", "PM": "91; was see under ARACHIDONATE LIPOXYGENASES 1987-90", "HN": "91(87); was see under ARACHIDONATE LIPOXYGENASES 1987-90", "MR": "20100625", "DA": "19860616", "DC": "1", "DX": "19910101", "UI": "D001092"}, {"RECTYPE": "D", "MH": "Arachidonate 15-Lipoxygenase", "DS": "ARACHIDONATE LIPOXYGENASE 15", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "15-Lipoxygenase|T116|T126|NON|EQV|UNK (19XX)|860616|LIPOXYGENASE A 15|abbcdefs", "ENTRY": "Arachidonic Acid 15 Lipoxygenase", "MN": "D12.776.556.579.374.568.500.030", "EC": "antagonists & inhibitors:Lipoxygenase Inhibitors", "MH_TH": "NLM (1987)", "ST": "T126", "N1": "Arachidonate:oxygen 15-oxidoreductase", "RN": "EC 1.13.11.33", "PI": "Oxygenases (1966-1973)", "MS": "An enzyme that catalyzes the oxidation of arachidonic acid to yield 15-hydroperoxyarachidonate (15-HPETE) which is rapidly converted to 15-hydroxy-5,8,11,13-eicosatetraenoate (15-HETE). The 15-hydroperoxides are preferentially formed in NEUTROPHILS and LYMPHOCYTES.", "PM": "91; was see under ARACHIDONATE LIPOXYGENASES 1987-90", "HN": "91(87); was see under ARACHIDONATE LIPOXYGENASES 1987-90", "MR": "20100625", "DA": "19860616", "DC": "1", "DX": "19910101", "UI": "D001093"}, {"RECTYPE": "D", "MH": "Arachidonate 5-Lipoxygenase", "DS": "ARACHIDONATE LIPOXYGENASE 05", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "5-Lipoxygenase|T116|T126|NON|EQV|UNK (19XX)|860616|LIPOXYGENASE A 05|abbcdefs", "ENTRY": "Synthetase, Leukotriene A4", "MN": "D12.776.556.579.374.568.500.020", "EC": "antagonists & inhibitors:Lipoxygenase Inhibitors", "MH_TH": "NLM (1987)", "ST": "T126", "N1": "Arachidonate:oxygen 5-oxidoreductase", "RN": "EC 1.13.11.34", "PI": "Oxygenases (1966-1973)", "MS": "An enzyme that catalyzes the oxidation of arachidonic acid to yield 5-hydroperoxyarachidonate (5-HPETE) which is rapidly converted by a peroxidase to 5-hydroxy-6,8,11,14-eicosatetraenoate (5-HETE). The 5-hydroperoxides are preferentially formed in leukocytes.", "PM": "91; was see under ARACHIDONATE LIPOXYGENASES 1987-90", "HN": "91(87); was see under ARACHIDONATE LIPOXYGENASES 1987-90", "MR": "20100625", "DA": "19860616", "DC": "1", "DX": "19910101", "UI": "D001094"}, {"RECTYPE": "D", "MH": "Arachidonic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Eicosatetraenoic Acids|T109|NON|BRD|UNK (19XX)|760520|abcdef", "ENTRY": "Acids, Eicosatetraenoic", "MN": "D10.251.355.310.166", "MH_TH": "NLM (1967)", "ST": "T109", "RN": "0", "AN": "do not confuse with ARACHIDONIC ACID", "PI": "Fatty Acids, Essential (1966)", "OL": "use ARACHIDONIC ACIDS to search ARACHIDONIC ACID 1967-74; use FATTY ACIDS, ESSENTIAL to search ARACHIDONIC ACID 1966", "PM": "75; was ARACHIDONIC ACID 1967-74, was ARACHIDONIC ACID see under FATTY ACIDS, ESSENTIAL 1963-66", "HN": "75; was ARACHIDONIC ACID 1967-74, was ARACHIDONIC ACID see under FATTY ACIDS, ESSENTIAL 1963-66", "MR": "20150625", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001095"}, {"RECTYPE": "D", "MH": "Arachnid Vectors", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Vectors, Arachnid", "MN": "N06.850.520.203.375.100.100", "MH_TH": "NLM (1971)", "ST": "T204", "AN": "coord IM with specific arachnid (IM); specify both infecting organism & vector if pertinent; in the rickettsial-tick-dog relationship, the tick is the arachnid vector, not the dog", "PI": "Arthropod Vectors (1966-1970)", "MS": "Members of the class Arachnida, especially SPIDERS; SCORPIONS; MITES; and TICKS; which transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.", "PM": "74", "HN": "74(71)", "MR": "20200612", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001096"}, {"RECTYPE": "D", "MH": "Arachnida", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Arachnidas", "MN": "B01.050.500.131.166", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6854", "MS": "A class of Arthropoda that includes SPIDERS; TICKS; MITES; and SCORPIONS.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001097"}, {"RECTYPE": "D", "MH": "Spider Bites", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Loxoscelism|T037|NON|NRW|NLM (2024)|230314|abcdef", "ENTRY": "Spider Bite", "MN": "C26.176.790", "FX": "Spider Venoms", "MH_TH": "NLM (2014)", "ST": "T037", "MS": "The effects, both local and systemic, caused by the bites of SPIDERS.", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001098"}, {"RECTYPE": "D", "MH": "Arachnoid", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Arachnoids", "MN": "A08.186.566.166", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A delicate membrane enveloping the brain and spinal cord. It lies between the PIA MATER and the DURA MATER. It is separated from the pia mater by the subarachnoid cavity which is filled with CEREBROSPINAL FLUID.", "PM": "2015; for TENTORIUM CEREBELLI see SPINAL CORD 2015-2019", "HN": "2015; for TENTORIUM CEREBELLI use SPINAL CORD 2015-2019", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001099"}, {"RECTYPE": "D", "MH": "Arachnoiditis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Inflammations, Arachnoid Membrane", "MN": "C10.586.625.097", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Meningitis (1966)", "MS": "Acute or chronic inflammation of the arachnoid membrane of the meninges most often involving the spinal cord or base of the brain. This term generally refers to a persistent inflammatory process characterized by thickening of the ARACHNOID membrane and dural adhesions. Associated conditions include prior surgery, infections, trauma, SUBARACHNOID HEMORRHAGE, and chemical irritation. Clinical features vary with the site of inflammation, but include cranial neuropathies, radiculopathies, and myelopathies. (From Joynt, Clinical Neurology, 1997, Ch48, p25)", "PM": "1967", "HN": "1967", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001100"}, {"RECTYPE": "D", "MH": "Arbaprostil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "15-Methylprostaglandin E2|T109|T121|NON|EQV|UNK (19XX)|790523|METHYLPROSTAGLANDIN E2 A 15|abbcdefs", "ENTRY": "U42842", "MN": "D23.469.700.660.050", "PA": "Anti-Ulcer Agents", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-15-methyl-9-oxo-, (5Z,11alpha,13E,15R)-", "RN": "M6B59S6MEF", "RR": "55028-70-1 (Arbaprostil)", "PI": "Prostaglandins, Synthetic (1977)", "MS": "A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and can inhibit the growth of experimental tumors.", "OL": "use ARBAPROSTIL to search 15-METHYLPROSTAGLANDIN E2 METHYL ESTER & METHYLDINOPROSTONE 1980-93", "PM": "91; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; 15-METHYLPROSTAGLANDIN E2 METHYL ESTER & METHYLDINOPROSTONE were see ARBAPROSTIL 1980-93", "HN": "91(80); was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; 15-METHYLPROSTAGLANDIN E2 METHYL ESTER & METHYLDINOPROSTONE were see ARBAPROSTIL 1980-93", "MR": "20150608", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D001101"}, {"RECTYPE": "D", "MH": "Arbovirus Infections", "DE": "ARBOVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Arbovirus", "MN": "C01.925.081", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Infections caused by arthropod-borne viruses, general or unspecified.", "PM": "65; was ARBORVIRUS INFECTIONS 1963-64", "HN": "65; was ARBORVIRUS INFECTIONS 1963-64", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001102"}, {"RECTYPE": "D", "MH": "Arboviruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Arthropod-Borne Viruses|T005|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Viruses, Arthropod-Borne", "MN": "B04.080", "FX": "Togaviridae", "MH_TH": "NLM (1965)", "ST": "T005", "AN": "general or unspecified; prefer specifics; from ARthropod-BOrne; infection equals ARBOVIRUS INFECTIONS", "MS": "Arthropod-borne viruses. A non-taxonomic designation for viruses that can replicate in both vertebrate hosts and arthropod vectors. Included are some members of the following families: ARENAVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; TOGAVIRIDAE; and FLAVIVIRIDAE. (From Dictionary of Microbiology and Molecular Biology, 2nd ed)", "OL": "use ARBOVIRUSES to search ARBOVIRUS 1966-74", "PM": "75; was ARBOVIRUS 1965-74, was ARBORVIRUSES 1963-64; CAPIM GROUP VIRUSES was see under ARBOVIRUSES 1975-80", "HN": "75; was ARBOVIRUS 1965-74, was ARBORVIRUSES 1963-64; CAPIM GROUP VIRUSES was see under ARBOVIRUSES 1975-80", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001103"}, {"RECTYPE": "D", "MH": "Arbutin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.408.348.075", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "beta-D-Glucopyranoside, 4-hydroxyphenyl", "RN": "C5INA23HXF", "RR": "497-76-7 (Arbutin)", "OL": "search PLANTS, MEDICINAL 1966-74", "PM": "91; was see under GLYCOSIDES 1976-90; was see under UVA URSI 1963-75", "HN": "91(75); was see under GLYCOSIDES 1976-90; was see under UVA URSI 1963-75", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001104"}, {"RECTYPE": "D", "MH": "Archaea", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Archaeobacteria|T194|NON|EQV|NLM (1998)|960930|ARCHAEOBACT|abcdefv", "ENTRY": "Archebacteria|T194|NON|EQV|NLM (1992)|910418|ARCHEBACT|abcdefv", "MN": "B02", "RH": "B2 - ORGANISMS-ARCHAEA", "MH_TH": "NLM (1981)", "ST": "T194", "RN": "txid2157", "AN": "in taxonomy, one of the 3 domains of life along with BACTERIA & Eucarya", "PI": "Bacteria (1966-1980)", "MS": "One of the three domains of life (the others being BACTERIA and Eukarya), formerly called Archaebacteria under the taxon Bacteria, but now considered separate and distinct. They are characterized by: (1) the presence of characteristic tRNAs and ribosomal RNAs; (2) the absence of peptidoglycan cell walls; (3) the presence of ether-linked lipids built from branched-chain subunits; and (4) their occurrence in unusual habitats. While archaea resemble bacteria in morphology and genomic organization, they resemble eukarya in their method of genomic replication. The domain contains at least four kingdoms: CRENARCHAEOTA; EURYARCHAEOTA; NANOARCHAEOTA; and KORARCHAEOTA.", "PM": "98; see ARCHAEOBACTERIA 1992-97, see ARCHAEBACTERIA 1991, see BACTERIA 1981-90; ARCHAEA was see ARCHAEOBACTERIA 1995-97", "HN": "98(81); ARCHAEA was see ARCHAEOBACTERIA 1995-97", "MR": "20200813", "DA": "19800402", "DC": "1", "DX": "19910101", "UI": "D001105"}, {"RECTYPE": "D", "MH": "Archaeology", "DE": "ARCHAEOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Bioarchaeology|T091|NON|NRW|NLM (2017)|160420|abcdef", "MN": "I01.076.201.208", "FX": "Paleography", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "Study of the ancient and recent human or animal past through material remains. It analyzes the physical remains of the past in pursuit of a broad and comprehensive understanding of human culture.", "MR": "20171208", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001106"}, {"RECTYPE": "D", "MH": "Architectural Accessibility", "DE": "ARCHITECTURAL ACCESS", "AQ": "CL EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Ramps|T073|NON|NRW|UNK (19XX)|770505|abcdef", "ENTRY": "Ramp", "MN": "J01.086.339.070", "MH_TH": "NLM (1977)", "ST": "T080", "PI": "Architecture (1966-Jul 1977)", "MS": "Designs for approaching areas inside or outside facilities.", "PM": "91; was see under FACILITY DESIGN AND CONSTRUCTION 1977-90", "HN": "91(Aug 77); was see under FACILITY DESIGN AND CONSTRUCTION 1977-90", "MR": "20180629", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D001107"}, {"RECTYPE": "D", "MH": "Architecture", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "J01.086", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "Works on the art and science of designing buildings and structures, design of the total built environment, including town planning, urban design, and landscape architecture.", "PM": "2008; see ARCHITECTURE 1963-2007", "HN": "2008(1963)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D001108"}, {"RECTYPE": "D", "MH": "Archives", "AQ": "HI", "ENTRY": "Archive", "MN": "L01.462.625.208", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "A collection of historical documents or records providing information about places, institutions, or groups of people; also the place where such records are kept.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001109"}, {"RECTYPE": "D", "MH": "Arctic Regions", "AQ": "EH EP", "MN": "Z01.208", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "note spelling: arctic: neither spelled nor pronounced \"artic\"", "MS": "The Arctic Ocean and the lands in it and adjacent to it. It includes Point Barrow, Alaska, most of the Franklin District in Canada, two thirds of Greenland, Svalbard, Franz Josef Land, Lapland, Novaya Zemlya, and Northern Siberia. (Webster's New Geographical Dictionary, 1988, p66)", "MR": "20090730", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001110"}, {"RECTYPE": "D", "MH": "Arcuate Nucleus of Hypothalamus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Infundibular Nucleus|T023|NON|EQV|UNK (19XX)|820423|abcdef", "ENTRY": "Nucleus, Infundibular", "MN": "A08.186.211.200.317.357.352.081", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Hypothalamus (1966-1982)", "MS": "A nucleus located in the middle hypothalamus in the most ventral part of the THIRD VENTRICLE near the entrance of the infundibular recess. Its small cells are in close contact with the EPENDYMA.", "PM": "2015; see ARCUATE NUCLEUS 1983-2014", "HN": "2015; use ARCUATE NUCLEUS 1983-2014", "MR": "20180630", "DA": "19820423", "DC": "1", "DX": "19830101", "UI": "D001111"}, {"RECTYPE": "D", "MH": "Arcus Senilis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Corneal Arcus|T020|NON|EQV|NLM (1990)|OMIM (2013)|890217|abcdeef", "ENTRY": "Arcus, Corneal", "MN": "C11.204.299.070", "MH_TH": "OMIM (2013)", "ST": "T020", "AN": "cholesterol or hyalin deposits in cornea causing opacity; frequent in those over 50", "MS": "A corneal disease in which there is a deposition of phospholipid and cholesterol in the corneal stroma and anterior sclera.", "PM": "91; was see under CORNEAL OPACITY 1990; was see under EYE DISEASES 1964-89", "HN": "91(64); was see under CORNEAL OPACITY 1990; was see under EYE DISEASES 1964-89", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001112"}, {"RECTYPE": "D", "MH": "Area Health Education Centers", "DE": "AREA HEALTH EDUC CENTERS", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Area Health Education Center|T093|NON|EQV|UNK (19XX)|790323|AHEC|abcdefv", "MN": "I02.783.495.125", "MH_TH": "NLM (1975)", "ST": "T093", "AN": "specify geog if pertinent", "MS": "Education centers authorized by the Comprehensive Health Manpower Training Act, 1971, for the training of health personnel in areas where health needs are the greatest. May be used for centers other than those established by the United States act.", "PM": "91; was see under SCHOOLS, HEALTH OCCUPATIONS 1975-90", "HN": "91(75); was see under SCHOOLS, HEALTH OCCUPATIONS 1975-90", "MR": "20190524", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D001113"}, {"RECTYPE": "D", "MH": "Areca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Betel Nut|T121|NON|REL|NLM (2003)|010824|abcdef", "ENTRY": "catechus, Areca", "MN": "B01.875.800.575.912.250.093.088", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid115440", "RR": "txid184783", "AN": "Betel may go here or under PIPER BETLE; 'catechu' may go here or under ACACIA CATECHU see ACACIA; check text", "MS": "A plant genus of the family ARECACEAE. Members contain ARECOLINE and CATECHIN. The leaves and nuts have been used as masticatories, stimulants, and astringents in traditional medicine. The common name of betel is also used for PIPER BETLE. The common name of catechu is sometimes used for ACACIA CATECHU.", "PM": "91,63-85; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85", "HN": "91(86)63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001114"}, {"RECTYPE": "D", "MH": "Arecoline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylarecaidin|T109|T121|NON|EQV|UNK (19XX)|800523|abbcdef", "ENTRY": "Arecolin|T109|T121|NON|EQV|UNK (19XX)|800523|abbcdef", "MN": "D03.383.725.547.292", "PA": "Cholinergic Agonists", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester", "RN": "4ALN5933BH", "RR": "63-75-2 (Arecoline)", "PI": "Parasympatholytics (1966-1968)", "MS": "An alkaloid obtained from the betel nut (Areca catechu), fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors. It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands.", "OL": "search NICOTINIC ACID 1969-71 & PARASYMPATHOMIMETICS 1966-68", "PM": "73; was see under NICOTINIC ACID 1969-72, was see under PARASYMPATHOMIMETICS 1963-68; ARECHOLIN was see ARECOLINE 1981-95", "HN": "73(72); was see under NICOTINIC ACID 1969-72, was see under PARASYMPATHOMIMETICS 1963-68; ARECHOLIN was see ARECOLINE 1981-95", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001115"}, {"RECTYPE": "D", "MH": "Arenaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Reptarenaviruses", "MN": "B04.820.480.500", "MH_TH": "NLM (1978)", "ST": "T005", "RN": "txid11617", "RR": "txid1653395", "PI": "RNA Viruses (1966-1977)", "MS": "A family of RNA viruses naturally infecting rodents and consisting of one genus (ARENAVIRUS) with two groups: Old World Arenaviruses (ARENAVIRUSES, OLD WORLD) and New World Arenaviruses (ARENAVIRUSES, NEW WORLD). Infection in rodents is persistent and silent. Vertical transmission is through milk-, saliva-, or urine-borne routes. Horizontal transmission to humans, monkeys, and other animals is important.", "OL": "use ARENAVIRIDAE to search ARENAVIRUSES 1978-80", "PM": "81; was ARENAVIRUSES 1978-80", "HN": "81; was ARENAVIRUSES 1978-80", "MR": "20200813", "DA": "19770504", "DC": "1", "DX": "19780101", "UI": "D001116"}, {"RECTYPE": "D", "MH": "Arenaviridae Infections", "DE": "ARENAVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Arenavirus Infections|T047|NON|NRW|NLM (1994)|930511|ARENAVIRUS INFECT|abcdefv", "ENTRY": "Infection, Arenavirus", "MN": "C01.925.782.082", "MH_TH": "NLM (1981)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Virus Diseases (1966-1980)", "MS": "Virus diseases caused by the ARENAVIRIDAE.", "OL": "use ARENAVIRIDAE INFECTIONS to search ARENAVIRUS INFECTIONS 1981-93", "PM": "94; was ARENAVIRUS INFECTIONS 1981-93", "HN": "94; was ARENAVIRUS INFECTIONS 1981-93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19800513", "DC": "1", "DX": "19810101", "UI": "D001117"}, {"RECTYPE": "D", "MH": "Argentina", "AQ": "EH EP", "MN": "Z01.107.757.077", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "Country located in southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001118"}, {"RECTYPE": "D", "MH": "Arginase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, Liver-Derived Inhibitory", "MN": "D08.811.277.913.292", "FX": "Hyperargininemia", "EC": "deficiency:Hyperargininemia", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "L-Arginine amidinohydrolase", "RN": "EC 3.5.3.1", "MS": "A ureahydrolase that catalyzes the hydrolysis of arginine or canavanine to yield L-ornithine (ORNITHINE) and urea. Deficiency of this enzyme causes HYPERARGININEMIA. EC 3.5.3.1.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001119"}, {"RECTYPE": "D", "MH": "Arginine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrate DL-Arginine Acetate", "MN": "D12.125.142.087", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "L-Arginine", "RN": "94ZLA3W45F", "RR": "F7LTH1E20Y", "AN": "/biosyn /defic /physiol permitted", "MS": "An essential amino acid that is physiologically active in the L-form.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001120"}, {"RECTYPE": "D", "MH": "Lysine Carboxypeptidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Kininase I|T116|T126|NON|EQV|UNK (19XX)|810512|abbcdef", "ENTRY": "Inactivator, Anaphylatoxin", "MN": "D08.811.277.656.675.555.750", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.4.17.3", "PI": "Peptides (1972-1974)", "MS": "A metallocarboxypeptidase that removes C-terminal basic amino acid from peptides and proteins, with preference shown for lysine over arginine. It is a plasma zinc enzyme that inactivates bradykinin and anaphylatoxins.", "PM": "1997; see ARGININE CARBOXYPEPTIDASE 1991-1996, see CARBOXYPEPTIDASES 1975-1990; for KININASE I see CARBOXYPEPTIDASES 1975-1981", "HN": "1997 (1975)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001121"}, {"RECTYPE": "D", "MH": "Arginine Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kinase, Arginine", "MN": "D08.811.913.696.640.025", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "ATP:L-arginine N-phosphotransferase", "RN": "EC 2.7.3.3", "RR": "9026-70-4 (CAS RN)", "PI": "Phosphotransferases, ATP (1974-1978)", "MS": "An enzyme that catalyzes the phosphorylation of the guanidine nitrogen of arginine in the presence of ATP and a divalent cation with formation of phosphorylarginine and ADP. EC 2.7.3.3.", "PM": "91; was see under PHOSPHOTRANSFERASES, ATP 1979-90", "HN": "91(79); was see under PHOSPHOTRANSFERASES, ATP 1979-90", "MR": "20030709", "DA": "19771208", "DC": "1", "DX": "19910101", "UI": "D001122"}, {"RECTYPE": "D", "MH": "Argininosuccinate Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Argininosuccinase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Lyase, Argininosuccinate", "MN": "D08.811.520.232.300.400", "FX": "Argininosuccinic Aciduria", "EC": "deficiency:Argininosuccinic Aciduria", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "N-(L-Argininosuccinate) arginine-lyase", "RN": "EC 4.3.2.1", "RR": "9027-34-3 (CAS RN)", "PI": "Succinates (1973-1974)", "MS": "An enzyme of the urea cycle which splits argininosuccinate to fumarate plus arginine. Its absence leads to the metabolic disease ARGININOSUCCINIC ACIDURIA in man. EC 4.3.2.1.", "PM": "1991; see LYASES 1975-1990", "HN": "1991(1975); use LYASES 1975-1990", "MR": "20090706", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001123"}, {"RECTYPE": "D", "MH": "Argininosuccinate Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, Argininosuccinate", "MN": "D08.811.464.259.300", "FX": "Citrullinemia", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Citrulline:L-aspartate ligase (AMP-forming)", "RN": "EC 6.3.4.5", "RR": "9023-58-9 (CAS RN)", "AN": "/defic: consider also CITRULLINEMIA", "PI": "Succinates (1973-1974)", "MS": "An enzyme of the urea cycle that catalyzes the formation of argininosuccinic acid from citrulline and aspartic acid in the presence of ATP. Absence or deficiency of this enzyme causes the metabolic disease CITRULLINEMIA in humans. EC 6.3.4.5.", "PM": "98; see ARGININOSUCCINATE SYNTHETASE 1991-97; see LIGASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001124"}, {"RECTYPE": "D", "MH": "Argininosuccinic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Argininosuccinic", "MN": "D12.125.095.104.075", "MH_TH": "NLM (1976)", "ST": "T123", "N1": "L-Aspartic acid, N-(((4-amino-4-carboxybutyl)amino)iminomethyl)-, (S)-", "RN": "2387-71-5", "PI": "Succinates (1971-1975)", "MS": "This amino acid is formed during the urea cycle from citrulline, aspartate and ATP. This reaction is catalyzed by argininosuccinic acid synthetase.", "PM": "91; was see under ARGININE 1976-90", "HN": "91(76); was see under ARGININE 1976-90", "MR": "20120703", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D001125"}, {"RECTYPE": "D", "MH": "Arginine-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Arginyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961105|abbdef", "ENTRY": "Synthetase, Arginyl-tRNA", "MN": "D08.811.464.263.200.100", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Arginine:tRNA(Arg)ligase (AMP-forming)", "RN": "EC 6.1.1.19", "PI": "Arginine (1973-1974)", "MS": "An enzyme that activates arginine with its specific transfer RNA. EC 6.1.1.19.", "PM": "98; see ARGINYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001126"}, {"RECTYPE": "D", "MH": "Arginine Vasopressin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vasopressin, Arginine|T116|T121|T125|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Arg Vasopressin", "MN": "D12.776.631.650.937.100", "PA": "Vasoconstrictor Agents", "MH_TH": "UNK (19XX)", "ST": "T125", "N1": "Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2, cyclic 1-6 disulfide", "RN": "113-79-1", "RR": "4R069M4O1P", "PI": "Vasopressins (1966-1974)", "MS": "The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.", "PM": "2007; see ARGIPRESSIN 1979-2006", "HN": "2007 (1979)", "MR": "20151123", "DA": "19741111", "DC": "1", "DX": "19790101", "UI": "D001127"}, {"RECTYPE": "D", "MH": "Argon", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Argon 40", "MN": "D01.362.641.113", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Argon", "RN": "67XQY1V3KH", "RR": "7440-37-1 (Argon)", "MS": "A noble gas with the atomic symbol Ar, atomic number 18, and atomic weight 39.948. It is used in fluorescent tubes and wherever an inert atmosphere is desired and nitrogen cannot be used.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001128"}, {"RECTYPE": "D", "MH": "Argyria", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Argyrias", "MN": "C25.723.522.313", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "caused by prolonged use of silver salts", "MS": "A permanent ashen-gray discoloration of the skin, conjunctiva, and internal organs resulting from long-continued use of silver salts. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001129"}, {"RECTYPE": "D", "MH": "Arizona", "AQ": "EH EP", "MN": "Z01.107.567.875.760.100", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State of the UNITED STATES OF AMERICA bounded on the east by New Mexico, on the north by Utah, on the west by Nevada and California, and on the south by Mexico.", "MR": "20160628", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001130"}, {"RECTYPE": "D", "MH": "Arkansas", "AQ": "EH EP", "MN": "Z01.107.567.875.750.110", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State of the UNITED STATES OF AMERICA bounded on the north by Missouri, on the east by Tennessee and Mississippi, on the south by Louisiana, and on the west by Oklahoma and Texas.", "MR": "20160608", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001131"}, {"RECTYPE": "D", "MH": "Arm", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU TR VI", "ENTRY": "Upper Arms", "MN": "A01.378.800.075", "FX": "Forelimb", "EC": "injuries:Arm Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "primates only; FOREARM is also available; NIM when merely locational", "MS": "The superior part of the upper extremity between the SHOULDER and the ELBOW.", "MR": "20160615", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001132"}, {"RECTYPE": "D", "MH": "Bones of Upper Extremity", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Upper Extremity Bones", "MN": "A02.835.232.087", "MH_TH": "NLM (1974)", "ST": "T023", "AN": "avoid: too general; prefer specifics; permitted with all vertebrates; Manual 21.58", "PI": "specific bones of arm (1966-1997)", "MS": "The bones of the upper and lower ARM. They include the CLAVICLE and SCAPULA.", "PM": "98", "HN": "98; use explode 1975-97", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001133"}, {"RECTYPE": "D", "MH": "Arm Injuries", "DE": "ARM INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injury, Arm", "MN": "C26.088", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "general or unspecified; prefer specifics", "MS": "General or unspecified injuries involving the UPPER ARM and the FOREARM.", "CATSH": "CAT LIST", "MR": "20160614", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001134"}, {"RECTYPE": "D", "MH": "Armadillos", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Armadillo", "MN": "B01.050.150.900.649.313.999.200", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9359", "MS": "Burrowing, chiefly nocturnal mammals of the family Dasypodidae having bodies and heads encased in small bony plates. They are widely distributed in the warmer parts of the Americas.", "PM": "91; was see under EDENTATA 1975-90", "HN": "91(75); was see under EDENTATA 1975-90", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001135"}, {"RECTYPE": "D", "MH": "Armenia", "AQ": "EH EP", "PRINT ENTRY": "Armenian S.S.R.|T083|NAM|EQV|NLM (1993)|991012|abcdef", "ENTRY": "Armenian SSR|T083|NAM|EQV|NLM (1993)|920422|abcdef", "MN": "Z01.586.950.099", "MH_TH": "POPLINE (1993)", "ST": "T083", "AN": "includes present and historical contexts", "MS": "An ancient country in western Asia, by the twentieth century divided among the former USSR, Turkey, and Iran. It was attacked at various times from before the 7th century B.C. to 69 B.C. by Assyrians, Medes, Persians, the Greeks under Alexander, and the Romans. It changed hands frequently in wars between Neo-Persian and Roman Empires from the 3d to 7th centuries and later under Arabs, Seljuks, Byzantines, and Mongols. In the 19th century Armenian nationalism arose but suffered during Russo-Turkish hostilities. It became part of the Soviet Republic in 1921, with part remaining under Turkey. (Webster's New Geographical Dictionary, 1988)", "OL": "use ARMENIA to search ARMENIAN S.S.R 1982-92 & ARMENIAN SSR 1975-81", "HN": "ARMENIAN S.S.R. was heading 1982-92; was ARMENIAN SSR 1975-81", "MR": "20170717", "DA": "19990101", "DC": "4", "DX": "19750101", "UI": "D001136"}, {"RECTYPE": "D", "MH": "Armin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ethyl-p-Nitrophenyl Ethylphosphonate|T109|T121|NON|EQV|NLM (2001)|000508|abbcdef", "MN": "D02.705.429.374", "PA": "Cholinesterase Inhibitors", "MH_TH": "NLM (1979)", "ST": "T121", "RN": "H39MRI1X2O", "RR": "8053-54-1 (other CAS number)", "PI": "Organophosphorus Compounds (1971-1978)", "MS": "A reversible organophosphorus cholinesterase inhibitor. It also affects the presynaptic membrane and inhibits membrane postsynaptic cholinergic receptors. The compound had former use as a miotic.", "PM": "91; was see under ORGANOPHOSPHORUS COMPOUNDS 1979-90", "HN": "91(79); was see under ORGANOPHOSPHORUS COMPOUNDS 1979-90", "MR": "20130708", "DA": "19780517", "DC": "1", "DX": "19910101", "UI": "D001138"}, {"RECTYPE": "D", "MH": "Arnold-Chiari Malformation", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Type IV Arnold Chiari Malformation", "MN": "C16.131.666.680.291", "MH_TH": "ORD (2010)", "ST": "T019", "AN": "do not confuse with CHIARI'S SYNDROME see BUDD-CHIARI SYNDROME", "MS": "A group of congenital malformations involving the brainstem, cerebellum, upper spinal cord, and surrounding bony structures. Type II is the most common, and features compression of the medulla and cerebellar tonsils into the upper cervical spinal canal and an associated MENINGOMYELOCELE. Type I features similar, but less severe malformations and is without an associated meningomyelocele. Type III has the features of type II with an additional herniation of the entire cerebellum through the bony defect involving the foramen magnum, forming an ENCEPHALOCELE. Type IV is a form a cerebellar hypoplasia. Clinical manifestations of types I-III include TORTICOLLIS; opisthotonus; HEADACHE; VERTIGO; VOCAL CORD PARALYSIS; APNEA; NYSTAGMUS, CONGENITAL; swallowing difficulties; and ATAXIA. (From Menkes, Textbook of Child Neurology, 5th ed, p261; Davis, Textbook of Neuropathology, 2nd ed, pp236-46)", "PM": "2000; see ARNOLD-CHIARI DEFORMITY 1963-1999; for ARNOLD-CHIARI MALFORMATION see ARNOLD-CHIARI DEFORMITY 1963-1999", "HN": "2000(1963)", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001139"}, {"RECTYPE": "D", "MH": "Aroclors", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Aroclor|T109|T131|TRD|NRW|UNK (19XX)|760905|abbcdef", "MN": "D02.455.526.439.785.292", "PA": "Environmental Pollutants", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "indust chem, a widespread environ pollutant; TN 111: eff on insects; CHLORODIPHENYL (54% CHLORINE); is also available", "MS": "Industrial chemicals which have become widespread environmental pollutants. Each aroclor is a mixture of chlorinated biphenyls (1200 series) or chlorinated terphenyls (5400 series) or a combination of both (4400 series).", "OL": "search POLYCHLOROBIPHENYL COMPOUNDS 1973-74", "PM": "91; was see under POLYCHLOROBIPHENYL COMPOUNDS 1975-90", "HN": "91(75); was see under POLYCHLOROBIPHENYL COMPOUNDS 1975-90", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001140"}, {"RECTYPE": "D", "MH": "Aromatase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochrome P-450(AROM)|T116|T126|EQV|UNK (19XX)|870507|CYTOCHROME P 450 AROM|abbdefs", "ENTRY": "Protein, CYP19", "MN": "D12.776.422.220.453.915.099", "EC": "antagonists & inhibitors:Aromatase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.14.14.1", "PI": "Oxidoreductases (1972-1974)", "MS": "An enzyme that catalyzes the desaturation (aromatization) of the ring A of C19 androgens and converts them to C18 estrogens. In this process, the 19-methyl is removed. This enzyme is membrane-bound, located in the endoplasmic reticulum of estrogen-producing cells of ovaries, placenta, testes, adipose, and brain tissues. Aromatase is encoded by the CYP19 gene, and functions in complex with NADPH-FERRIHEMOPROTEIN REDUCTASE in the cytochrome P-450 system.", "PM": "86; was see under OXIDOREDUCTASES 1975-85", "HN": "86(75); was see under OXIDOREDUCTASES 1975-85", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D001141"}, {"RECTYPE": "D", "MH": "Aromatic-L-Amino-Acid Decarboxylases", "DE": "AAAD", "DS": "AROMATIC AMINO ACID DECARBOXYLASES L", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aromatic Amino Acid Decarboxylases|T116|T126|NON|EQV|NLM (1998)|961115|abbcdef", "ENTRY": "Decarboxylases, Aromatic-L-Amino-Acid", "MN": "D08.811.520.224.125.100", "EC": "antagonists & inhibitors:Aromatic Amino Acid Decarboxylase Inhibitors", "MH_TH": "NLM (1980)", "ST": "T126", "N1": "Aromatic-L-amino-acid carboxy-lyase", "RN": "EC 4.1.1.28", "RR": "9042-64-2 (CAS RN)", "PI": "Dopa Decarboxylase (1966-1979)", "MS": "An enzyme group with broad specificity. The enzymes decarboxylate a range of aromatic amino acids including dihydroxyphenylalanine (DOPA DECARBOXYLASE); TRYPTOPHAN; and HYDROXYTRYPTOPHAN.", "PM": "98; see AROMATIC AMINO ACID DECARBOXYLASES 1980-97", "HN": "98(80)", "MR": "20200527", "DA": "19790221", "DC": "1", "DX": "19800101", "UI": "D001142"}, {"RECTYPE": "D", "MH": "Arousal", "AQ": "CL DE ES GE PH RE", "PRINT ENTRY": "Vigilance, Cortical|T041|NON|NRW|UNK (19XX)|780426|abcdef", "ENTRY": "Cortical Vigilance", "MN": "G11.561.035", "MH_TH": "NLM (1964)", "ST": "T041", "AN": "human & animal", "MS": "Cortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001143"}, {"RECTYPE": "D", "MH": "Arrhythmias, Cardiac", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dysrhythmia, Cardiac", "MN": "C23.550.073", "FX": "Electric Countershock", "MH_TH": "NLM (2008)", "ST": "T046", "AN": "general: prefer specifics", "MS": "Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.", "PM": "2008; see ARRHYTHMIA 1963-2007", "HN": "2008 (1963)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D001145"}, {"RECTYPE": "D", "MH": "Arrhythmia, Sinus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sinus Arrhythmia|T033|T046|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Sinus Arrhythmias", "MN": "C23.550.073.093", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "sinus parasystole: coordinate IM with PARASYSTOLE (IM)", "MS": "Irregular HEART RATE caused by abnormal function of the SINOATRIAL NODE. It is characterized by a greater than 10% change between the maximum and the minimum sinus cycle length or 120 milliseconds.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001146"}, {"RECTYPE": "D", "MH": "Arsanilic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "p Aminophenylarsonic Acid", "MN": "D02.129.030", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "UDX9AKS7GM", "RR": "UC2409302Q", "PI": "Arsenicals (1966-1978)", "MS": "An arsenical which has been used as a feed additive for enteric conditions in pigs and poultry. It causes blindness and is ototoxic and nephrotoxic in animals.", "PM": "91; was see under ARSENICALS 1979-90", "HN": "91(79); was see under ARSENICALS 1979-90", "MR": "20190701", "DA": "19780517", "DC": "1", "DX": "19910101", "UI": "D001147"}, {"RECTYPE": "D", "MH": "Arsenamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thioarsenite|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|771005|abbcdeef", "ENTRY": "Caparsolate|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef", "MN": "D02.129.040", "PA": "Filaricides", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Acetic acid, 2,2'-(((4-(aminocarbonyl)phenyl)arsinidene)bis(thio))bis-", "RN": "VMF4ELY9TZ", "RR": "531-72-6 (Arsenamide)", "PI": "Sulfides (1973-1974)", "MS": "Proposed chemotherapeutic agent against filaria and trichomonas.", "PM": "91; was see under ARSENICALS 1975-90", "HN": "91(75); was see under ARSENICALS 1975-90", "MR": "20190701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001148"}, {"RECTYPE": "D", "MH": "Arsenates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D01.248.497.158.050", "MH_TH": "NLM (1975)", "ST": "T104", "RN": "0", "AN": "do not confuse with ARSENITES", "MS": "Inorganic or organic salts and esters of arsenic acid.", "OL": "search ARSENATES 1968-74", "PM": "91; was see under ARSENIC 1975-90", "HN": "91(75); was see under ARSENIC 1975-90", "MR": "20190627", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001149"}, {"RECTYPE": "D", "MH": "Arsenazo III", "DS": "ARSENAZO 03", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D02.172.040", "PA": "Indicators and Reagents", "MH_TH": "NLM (1980)", "ST": "T130", "N1": "2,7-Naphthalenedisulfonic acid, 3,6-bis((2-arsonophenyl)azo)-4,5-dihydroxy-", "RN": "1668-00-4", "PI": "Indicators and Reagents (1966-1979)", "MS": "Metallochrome indicator that changes color when complexed to the calcium ion under physiological conditions. It is used to measure local calcium ion concentrations in vivo.", "PM": "91; was see under AZO COMPOUNDS 1980-90", "HN": "91(80); was see under AZO COMPOUNDS 1980-90", "MR": "20190701", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D001150"}, {"RECTYPE": "D", "MH": "Arsenic", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK RE SD ST TO TU UR", "ENTRY": "Arsenic 75", "MN": "D01.268.513.249", "EC": "poisoning:Arsenic Poisoning", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Arsenic", "RN": "N712M78A8G", "RR": "7440-38-2 (Arsenic)", "MS": "A shiny gray element with atomic symbol As, atomic number 33, and atomic weight 75. It occurs throughout the universe, mostly in the form of metallic arsenides. Most forms are toxic. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), arsenic and certain arsenic compounds have been listed as known carcinogens. (From Merck Index, 11th ed)", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001151"}, {"RECTYPE": "D", "MH": "Arsenicals", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TU UR", "PRINT ENTRY": "Arsenic Compounds|T104|NON|EQV|NLM (1996)|940825|ARSENIC CPDS|abcdefv", "ENTRY": "Compounds, Arsenic", "MN": "D02.129", "PA": "Sulfhydryl Reagents", "EC": "toxicity:Arsenic Poisoning", "MH_TH": "NLM (1966)", "ST": "T104", "RN": "0", "AN": "inorganic or organic arsenic cpds", "MS": "Inorganic or organic compounds that contain arsenic.", "PM": "ARSENIC COMPOUNDS was heading 1994-95", "HN": "ARSENIC COMPOUNDS was heading 1994-95", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001152"}, {"RECTYPE": "D", "MH": "Arsphenamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Arsenobenzol, Sodium", "MN": "D02.129.050", "PA": "Antitreponemal Agents", "MH_TH": "NLM (1968)", "ST": "T121", "N1": "Phenol, 4,4'-(1,2-diarsenediyl)bis(2-amino)-, dihydrochloride", "RN": "139-93-5", "MS": "An organoarsenic compound that was commonly used for treating SYPHILIS and other diseases.", "OL": "use ARSPHENAMINE to search ARSPHENAMINES 1966-67", "PM": "68; was ARSPHENAMINES 1963-67", "HN": "68; was ARSPHENAMINES 1963-67", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001153"}, {"RECTYPE": "D", "MH": "Art", "AQ": "HI", "ENTRY": "Arts", "MN": "K01.093", "FX": "Medicine in the Arts", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "works of art, the field of fine arts, artistic production; ART THERAPY is also available", "MS": "Processes and results of aesthetic expression.", "MR": "20180308", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001154"}, {"RECTYPE": "D", "MH": "Art Therapy", "DE": "ART THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapies, Art", "MN": "F04.754.070", "MH_TH": "NLM (1974)", "ST": "T061", "MS": "The use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioral disorders.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001155"}, {"RECTYPE": "D", "MH": "Artemia", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Shrimp, Brine|T204|NON|EQV|NLM (2003)|011017|abcdef", "ENTRY": "Shrimps, Brine", "MN": "B01.050.500.131.365.060.050", "MH_TH": "NLM (1979)", "ST": "T204", "RN": "txid6660", "AN": "note entry term BRINE SHRIMP: several other shrimp terms are available; check text and MeSH; unspecified shrimp as food is probably PENAEIDAE", "PI": "Shrimp (1972-1978)", "MS": "A genus of CRUSTACEA of the order ANOSTRACA, found in briny pools and lakes and often cultured for fish food. It has 168 chromosomes and differs from most crustaceans in that its blood contains hemoglobin.", "PM": "79", "HN": "79", "MR": "20200813", "DA": "19780320", "DC": "1", "DX": "19790101", "UI": "D001156"}, {"RECTYPE": "D", "MH": "Arterial Occlusive Diseases", "DE": "ARTERIAL OCCLUSIVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Arterial Occlusion|T033|NON|REL|NLM (2023)|210924|abcdef", "ENTRY": "Occlusive Disease, Arterial", "MN": "C14.907.137", "MH_TH": "NLM (1973)", "ST": "T047", "AN": "general; prefer specifics; coordinate with specific artery if pertinent", "PI": "Vascular Diseases (1966-1972)", "MS": "Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001157"}, {"RECTYPE": "D", "MH": "Arteries", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Artery", "MN": "A07.015.114", "FX": "Endarterectomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The vessels carrying blood away from the heart.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001158"}, {"RECTYPE": "D", "MH": "Arterio-Arterial Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fistulas, Arterio-Arterial", "MN": "C23.300.575.950.150", "MH_TH": "NLM (1987)", "ST": "T190", "AN": "coordinate IM with specific arteries (IM) or precoordinate artery/disease term (IM); if congenital use /abnorm on the arteries and /congen on the artery/disease term and fistula", "PI": "specific arteries (1966-1986)", "MS": "Abnormal communication between two ARTERIES that may result from injury or occur as a congenital abnormality.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D001159"}, {"RECTYPE": "D", "MH": "Arterioles", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Arteriole", "MN": "A07.015.461.080", "MH_TH": "NLM (1978)", "ST": "T023", "AN": "IM GEN only; NIM as coord with specific organ /blood supply (IM)", "PI": "specific artery", "MS": "The smallest divisions of the arteries located between the muscular arteries and the capillaries.", "PM": "91; was see under ARTERIES 1978-90", "HN": "91(78); was see under ARTERIES 1978-90", "MR": "20180630", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D001160"}, {"RECTYPE": "D", "MH": "Arteriosclerosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Arterioscleroses", "MN": "C14.907.137.126", "FX": "Embolism, Cholesterol", "MH_TH": "NLM (1963)", "ST": "T046", "AN": "general; prefer specifics; do not confuse with ARTERIOLOSCLEROSIS", "MS": "Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.", "PM": "1964", "HN": "1964", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D001161"}, {"RECTYPE": "D", "MH": "Arteriosclerosis Obliterans", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Obliterans, Arteriosclerosis", "MN": "C14.907.137.126.114", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001162"}, {"RECTYPE": "D", "MH": "Arteriovenous Anastomosis", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Arteriovenous Anastomose", "MN": "A07.015.461.085", "MH_TH": "NLM (1964)", "ST": "T023", "AN": "note category: do not confuse with ARTERIOVENOUS FISTULA", "MS": "A vessel that directly interconnects an artery and a vein, and that acts as a shunt to bypass the CAPILLARY BEDS. Not to be confused with SURGICAL ANASTOMOSIS or ARTERIOVENOUS FISTULA.", "PM": "66", "HN": "66(64)", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001163"}, {"RECTYPE": "D", "MH": "Arteriovenous Fistula", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Arteriovenous Aneurysm|T190|NON|NRW|NLM (1991)|900309|abcdef", "ENTRY": "Fistulas, Arteriovenous", "MN": "C23.300.575.950.250", "FX": "Arteriovenous Malformations", "MH_TH": "NLM (1967)", "ST": "T190", "MS": "An abnormal direct communication between an artery and a vein without passing through the CAPILLARIES. An A-V fistula usually leads to the formation of a dilated sac-like connection, arteriovenous aneurysm. The locations and size of the shunts determine the degree of effects on the cardiovascular functions such as BLOOD PRESSURE and HEART RATE.", "OL": "use ARTERIOVENOUS FISTULA to search FISTULA, ARTERIOVENOUS 1966", "PM": "67; was FISTULA, ARTERIOVENOUS 1963-66", "HN": "67; was FISTULA, ARTERIOVENOUS 1963-66", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001164"}, {"RECTYPE": "D", "MH": "Arteriovenous Malformations", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Malformations, Arteriovenous", "MN": "C16.131.240.850.750", "FX": "Hemangioma", "MH_TH": "NLM (1969)", "ST": "T019", "AN": "general or unspecified; coordinate IM with specific artery /abnorm (IM) + specific vein /abnorm (IM) or use specific available precoordinated arterial or venous abnormalities (IM)", "PI": "Arteriovenous Fistula/congenital (1966-1968)", "MS": "Abnormal formation of blood vessels that shunt arterial blood directly into veins without passing through the CAPILLARIES. They usually are crooked, dilated, and with thick vessel walls. A common type is the congenital arteriovenous fistula. The lack of blood flow and oxygen in the capillaries can lead to tissue damage in the affected areas.", "PM": "73", "HN": "73(69)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001165"}, {"RECTYPE": "D", "MH": "Arteriovenous Shunt, Surgical", "DE": "ARTERIOVENOUS SHUNT SURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Arteriovenous Shunts", "MN": "E04.100.814.868.249", "MH_TH": "NLM (1970)", "ST": "T061", "PI": "Arteriovenous Fistula (1966-1969)", "MS": "Surgical shunt allowing direct passage of blood from an artery to a vein. (From Dorland, 28th ed)", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D001166"}, {"RECTYPE": "D", "MH": "Arteritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Inflammation, Arterial", "MN": "C14.907.940.090", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general, unspecified; coordinate IM with specific artery (IM)", "MS": "INFLAMMATION of any ARTERIES.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001167"}, {"RECTYPE": "D", "MH": "Arthritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polyarthritis|T047|NON|REL|NLM (1993)|911107|abcdef", "ENTRY": "Polyarthritides", "MN": "C05.550.114", "FX": "Arthritis, Psoriatic", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Acute or chronic inflammation of JOINTS.", "PM": "1977; see ARTHRITIS, RHEUMATOID 1975-1976", "HN": "1977(1966)", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001168"}, {"RECTYPE": "D", "MH": "Arthritis, Experimental", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Arthritis, Collagen-Induced|T050|NON|NRW|NLM (2002)|010103|abcdef", "ENTRY": "Collagen-Induced Arthritis", "MN": "E05.598.500.249", "MH_TH": "NLM (2002)", "ST": "T050", "AN": "coord with specific type of arthritis if pertinent", "PI": "Arthritis, Rheumatoid (1966-1974)", "MS": "ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN.", "PM": "1991; see ARTHRITIS 1977-90; see ARTHRITIS, RHEUMATOID 1975-76", "HN": "1991(77); use ARTHRITIS 1977-90; use ARTHRITIS, RHEUMATOID 1975-76", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19760505", "DC": "1", "DX": "19910101", "UI": "D001169"}, {"RECTYPE": "D", "MH": "Arthritis, Infectious", "DE": "ARTHRITIS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Arthritis, Viral|T047|NON|NRW|UNK (19XX)|880602|abcdef", "ENTRY": "Viral Arthritis", "MN": "C05.550.114.099", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "coordinate IM with specific infection (IM) + site (IM)", "MS": "Arthritis caused by BACTERIA; RICKETTSIA; MYCOPLASMA; VIRUSES; FUNGI; or PARASITES.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001170"}, {"RECTYPE": "D", "MH": "Arthritis, Juvenile", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Still's Disease, Juvenile-Onset|T047|EPO|NRW|NLM (1992)|901221|STILLS DIS JUVENILE ONSET|abcdefv", "ENTRY": "Stills Disease, Juvenile-Onset", "MN": "C20.111.198", "MH_TH": "NLM (2014)", "ST": "T047", "AN": "note entry term STILL'S DISEASE, JUVENILE-ONSET: STILL'S DISEASE, ADULT-ONSET is also available", "MS": "Arthritis in children, with onset before 16 years of age. The terms juvenile rheumatoid arthritis (JRA) and juvenile idiopathic arthritis (JIA) refer to classification systems for chronic arthritis in children. Only one subtype of juvenile arthritis (polyarticular-onset, rheumatoid factor-positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent.", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001171"}, {"RECTYPE": "D", "MH": "Arthritis, Rheumatoid", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rheumatoid Arthritis|T047|NON|EQV|NLM (2000)|OMIM (2013)|991109|abcdeef", "MN": "C20.111.199", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001172"}, {"RECTYPE": "D", "MH": "Arthrobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.074", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1663", "AN": "in soil", "MS": "A genus of asporogenous bacteria isolated from soil that displays a distinctive rod-coccus growth cycle.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001173"}, {"RECTYPE": "D", "MH": "Arthrodesis", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Arthrodeses", "MN": "E04.555.100", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The surgical fixation of a joint by a procedure designed to accomplish fusion of the joint surfaces by promoting the proliferation of bone cells. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001174"}, {"RECTYPE": "D", "MH": "Arthrography", "DE": "ARTHROGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Arthrographies", "MN": "E01.370.350.700.070", "MH_TH": "NLM (1986)", "ST": "T060", "PI": "specific joint/RA (1967-1985)", "MS": "Roentgenography of a joint, usually after injection of either positive or negative contrast medium.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19850607", "DC": "1", "DX": "19860101", "UI": "D001175"}, {"RECTYPE": "D", "MH": "Arthrogryposis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myodystrophia Fetalis Deformans|T019|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Syndrome, Rossi", "MN": "C16.131.621.077", "MH_TH": "NLM (1963)", "ST": "T019", "AN": "\"persistent flexure or contracture of a joint\"; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Persistent flexure or contracture of a joint.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20181102", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001176"}, {"RECTYPE": "D", "MH": "Arthropathy, Neurogenic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Charcot's Joint|T047|EPO|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Neurogenic Arthropathy", "MN": "C05.550.186", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Chronic progressive degeneration of the stress-bearing portion of a joint, with bizarre hypertrophic changes at the periphery. It is probably a complication of a variety of neurologic disorders, particularly TABES DORSALIS, involving loss of sensation, which leads to relaxation of supporting structures and chronic instability of the joint. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19940524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001177"}, {"RECTYPE": "D", "MH": "Arthroplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Widening, Bone Tunnel", "MN": "E04.617.101", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Surgical reconstruction of a joint to relieve pain or restore motion.", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001178"}, {"RECTYPE": "D", "MH": "Arthropod Vectors", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Vectors, Arthropod", "MN": "N06.850.520.203.375.100", "MH_TH": "NLM (1964)", "ST": "T204", "AN": "coord IM with specific arthropod (IM); specify both infecting organism & vector if pertinent; ARACHNID VECTORS and INSECT VECTORS are also avail", "MS": "Arthropods, other than insects and arachnids, which transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.", "PM": "64", "HN": "64", "MR": "20200612", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D001179"}, {"RECTYPE": "D", "MH": "Arthropod Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE TO TU UR", "PRINT ENTRY": "Insect Venoms|T123|T131|NON|NRW|NLM (2021)|200131|abbcdef", "ENTRY": "Venoms, Insect", "MN": "D23.946.833.065", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTIVENINS; /enzymol permitted; coord IM with specific arachnid or insect (IM or NIM) but note available specifics: ANT VENOMS; BEE VENOMS; SCORPION VENOMS; SPIDER VENOMS & WASP VENOMS & their indentions", "PI": "Venoms (1966-1977)", "MS": "Venoms from animals of the phylum ARTHROPODA. Those most investigated are from SCORPIONS and SPIDERS of the class Arachnidae and from ant, bee, and wasp families of the INSECTA order HYMENOPTERA. The venoms contain protein toxins, enzymes, and other bioactive substances and may be lethal to man.", "PM": "78", "HN": "78", "MR": "20200807", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D001180"}, {"RECTYPE": "D", "MH": "Arthropods", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Arthropod", "MN": "B01.050.500.131", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6656", "MS": "Members of the phylum Arthropoda, composed of organisms having a hard, jointed exoskeleton and paired jointed legs. It includes the class INSECTS and the subclass ARACHNIDA, many species of which are important medically as parasites or as vectors of organisms capable of causing disease in man.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001181"}, {"RECTYPE": "D", "MH": "Arthroscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Arthroscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES ARTHROSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Arthroscopic", "MN": "E04.555.113", "FX": "Arthroscopes", "MH_TH": "NLM (1982)", "ST": "T061", "AN": "/ instrum permitted but consider also ARTHROSCOPES", "PI": "other joint heading", "MS": "Endoscopic examination, therapy and surgery of the joint.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19810415", "DC": "1", "DX": "19820101", "UI": "D001182"}, {"RECTYPE": "D", "MH": "Arthus Reaction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Arthus Phenomenon|T047|EPO|EQV|NLM (1993)|920107|abcdef", "ENTRY": "Reaction, Arthus", "MN": "C20.543.520.175", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "note category; an inflamm skin reaction to antibody excess", "MS": "A dermal inflammatory reaction produced under conditions of antibody excess, when a second injection of antigen produces intravascular antigen-antibody complexes which bind complement, causing cell clumping, endothelial damage, and vascular necrosis.", "OL": "use ARTHUS REACTION to search ARTHUS PHENOMENON 1966-92", "PM": "93; was ARTHUS PHENOMENON 1966-92", "HN": "93; was ARTHUS PHENOMENON 1966-92 (Prov 63-65)", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001183"}, {"RECTYPE": "D", "MH": "Articulation Disorders", "DE": "ARTICULATION DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Speech Articulation Disorders|T048|T184|NON|EQV|NLM (2000)|991103|SPEECH ARTICULATION DIS|abbcdefv", "ENTRY": "Unintelligible Articulations", "MN": "C23.888.592.604.150.500.800.150", "MH_TH": "NLM (1979)", "ST": "T184", "AN": "note categories: \"articulation\" refers to speech, not to joints", "MS": "Disorders of the quality of speech characterized by the substitution, omission, distortion, and addition of phonemes.", "PM": "1979", "HN": "1979", "CATSH": "CAT LIST", "MR": "20050729", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D001184"}, {"RECTYPE": "D", "MH": "Artificial Intelligence", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Machine Intelligence|T057|T066|NON|EQV|NLM (1997)|960620|abbcdef", "ENTRY": "Vision Systems, Computer", "MN": "L01.224.050.375", "FX": "Heuristics", "MH_TH": "NLM (1986)", "ST": "T066", "PI": "Computers (1966-1985)", "MS": "Theory and development of COMPUTER SYSTEMS which perform tasks that normally require human intelligence. Such tasks may include speech recognition, LEARNING; VISUAL PERCEPTION; MATHEMATICAL COMPUTING; reasoning, PROBLEM SOLVING, DECISION-MAKING, and translation of language.", "PM": "86", "HN": "86", "MR": "20170703", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D001185"}, {"RECTYPE": "D", "MH": "Artificial Limbs", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Limbs, Artificial|T074|NON|EQV|NLM (1998)|970211|abcdef", "ENTRY": "Prosthesis, Limb", "MN": "E07.858.442.050", "MH_TH": "NLM (1966)", "ST": "T074", "AN": "coord ARM or LEG (NIM) if pertinent", "MS": "Prosthetic replacements for arms, legs, and parts thereof.", "CATSH": "CAT LIST", "MR": "20040719", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001186"}, {"RECTYPE": "D", "MH": "Artificial Organs", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Organs, Artificial", "MN": "E07.858.082", "MH_TH": "BIOETHICS (1989)", "ST": "T074", "AN": "usually to replace function, as HEART, ARTIFICIAL or KIDNEY, ARTIFICIAL: do not confuse with PROSTHESES AND IMPLANTS which is usually cosmetic; not for injections, like silicones, to replace substance; coord IM with specific organ (IM) with no qualif but note available precoords", "MS": "Devices intended to replace non-functioning organs. They may be temporary or permanent. Since they are intended always to function as the natural organs they are replacing, they should be differentiated from PROSTHESES AND IMPLANTS and specific types of prostheses which, though also replacements for body parts, are frequently cosmetic (EYE, ARTIFICIAL) as well as functional (ARTIFICIAL LIMBS).", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001187"}, {"RECTYPE": "D", "MH": "Artiodactyla", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Peccaries", "MN": "B01.050.150.900.649.313.500", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid91561", "RR": "txid9832", "AN": "general or unspecified; prefer specifics", "MS": "An order of mammals which consists of the even-toed ungulates and includes both RUMINANTS and SWINE.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001188"}, {"RECTYPE": "D", "MH": "Aryl Hydrocarbon Hydroxylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Monooxygenases, Xenobiotic", "MN": "D12.776.422.220.453.010", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.14.14.1", "RR": "EC 1.14.14.1", "PI": "Polycyclic Hydrocarbons (1974)", "MS": "A large group of cytochrome P-450 (heme-thiolate) monooxygenases that complex with NAD(P)H-FLAVIN OXIDOREDUCTASE in numerous mixed-function oxidations of aromatic compounds. They catalyze hydroxylation of a broad spectrum of substrates and are important in the metabolism of steroids, drugs, and toxins such as PHENOBARBITAL, carcinogens, and insecticides.", "PM": "75", "HN": "75", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D001189"}, {"RECTYPE": "D", "MH": "Arylsulfonates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfonates, Aryl", "MN": "D02.886.645.600.080.050", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Organic sulfonic acid esters or salts which contain an aromatic hydrocarbon radical.", "OL": "use ARYLSULFONATES to search ARYL SULFONATES 1974-93", "PM": "94; was ARYL SULFONATES 1974-93", "HN": "94; was ARYL SULFONATES 1974-93", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001190"}, {"RECTYPE": "D", "MH": "Arylamine N-Acetyltransferase", "DS": "ARYLAMINE ACETYLTRANSFERASE N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Arylamine Acetyltransferases|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef", "ENTRY": "N-Acetyltransferase, Arylamine", "MN": "D08.811.913.050.134.138", "MH_TH": "NLM (1980)", "ST": "T126", "N1": "Acetyl-CoA:arylamine N-acetyltransferase", "RN": "EC 2.3.1.5", "RR": "9027-33-2 (CAS RN)", "AN": "do not confuse with ARYLALKYLAMINE N-ACETYLTRANSFERASE", "PI": "Serotonin (1966-1974) /analogs & derivatives (1975-1979)", "MS": "An enzyme that catalyzes the transfer of acetyl groups from ACETYL-COA to arylamines. It can also catalyze acetyl transfer between arylamines without COENZYME A and has a wide specificity for aromatic amines, including SEROTONIN. However, arylamine N-acetyltransferase should not be confused with the enzyme ARYLALKYLAMINE N-ACETYLTRANSFERASE which is also referred to as SEROTONIN ACETYLTRANSFERASE.", "PM": "1998; see ARYLAMINE ACETYLTRANSFERASE 1991-1997; see ACETYLTRANSFERASES 1980-1990", "HN": "1998(1980)", "MR": "20190701", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D001191"}, {"RECTYPE": "D", "MH": "Arylsulfatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Arylsulphatase|T116|T126|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Sulfohydrolase, Arylsulfate", "MN": "D08.811.277.352.827.070", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Aryl-sulfate sulfohydrolase", "RN": "EC 3.1.6.1", "PI": "Sulfatases (1973-1974)", "MS": "Enzymes that catalyze the hydrolysis of a phenol sulfate to yield a phenol and sulfate. Arylsulfatase A, B, and C have been separated. A deficiency of arylsulfatases is one of the causes of metachromatic leukodystrophy (LEUKODYSTROPHY, METACHROMATIC). EC 3.1.6.1.", "PM": "91; was see under SULFATASES 1975-90", "HN": "91(75); was see under SULFATASES 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001192"}, {"RECTYPE": "D", "MH": "Arytenoid Cartilage", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cartilages, Arytenoid", "MN": "A04.329.591.085", "MH_TH": "NLM (1980)", "ST": "T023", "PI": "Laryngeal Cartilages (1966-1979)", "MS": "One of a pair of small pyramidal cartilages that articulate with the lamina of the CRICOID CARTILAGE. The corresponding VOCAL LIGAMENT and several muscles are attached to it.", "PM": "91; was see under LARYNGEAL CARTILAGES 1980-90", "HN": "91(80); was see under LARYNGEAL CARTILAGES 1980-90", "MR": "20080708", "DA": "19781221", "DC": "1", "DX": "19910101", "UI": "D001193"}, {"RECTYPE": "D", "MH": "Asbestos", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D01.837.725.700.760.070", "PA": "Carcinogens", "MH_TH": "NLM (1969)", "ST": "T197", "N1": "Asbestos", "RN": "1332-21-4", "AN": "general or unspecified; prefer specifics; /tox: consider also ASBESTOSIS; disease: coordinate with ASBESTOS /tox and disease /etiol, not disease /chem ind; asbestos fibers: coordinate with MINERAL FIBERS ", "PI": "Minerals (1966-1968)", "MS": "Asbestos. Fibrous incombustible mineral composed of magnesium and calcium silicates with or without other elements. It is relatively inert chemically and used in thermal insulation and fireproofing. Inhalation of dust causes asbestosis and later lung and gastrointestinal neoplasms.", "PM": "70", "HN": "70(69)", "MR": "19950531", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D001194"}, {"RECTYPE": "D", "MH": "Asbestosis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulmonary Fibrosis - from Asbestos Exposure|T047|NON|NRW|NLM (2011)|ORD (2010)|100119|abcdeef", "ENTRY": "Asbestoses", "MN": "C24.800.127", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not coordinate with OCCUPATIONAL DISEASES; for emphasis on presence of asbestos fibers, MINERAL FIBERS is available: see note there", "MS": "A form of pneumoconiosis caused by inhalation of asbestos fibers which elicit potent inflammatory responses in the parenchyma of the lung. The disease is characterized by interstitial fibrosis of the lung, varying from scattered sites to extensive scarring of the alveolar interstitium.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001195"}, {"RECTYPE": "D", "MH": "Ascariasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Ascaris", "MN": "C01.610.335.508.700.100.070", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "nematode infect caused by ASCARIS; do not confuse with ACARIASIS, mite infestation or ASCARIDIASIS, infection with ASCARIDIA; coord IM with species (IM)", "MS": "Infection by nematodes of the genus ASCARIS. Ingestion of infective eggs causes diarrhea and pneumonitis. Its distribution is more prevalent in areas of poor sanitation and where human feces are used for fertilizer.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001196"}, {"RECTYPE": "D", "MH": "Ascaridia", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Ascaridia galli|T204|NON|NRW|NLM (1993)|911107|abcdef", "ENTRY": "gallus, Ascaridia", "MN": "B01.050.500.500.294.400.500.090", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid46684", "RR": "txid46685", "PI": "Nematoda (1966-1971)", "MS": "A genus of nematode worms in the superfamily Heterakoidea. A. galli and A. lineata are important intestinal parasites of domestic fowl.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001197"}, {"RECTYPE": "D", "MH": "Ascaridiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Ascaridiases", "MN": "C01.610.335.508.700.100.080", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "nematode infect caused by ASCARIDIA; do not confuse with ASCARIASIS (caused by ASCARIS) or ACARIASIS (caused by ACARI or ACARUS) or with ASCARIDIDA INFECTIONS", "MS": "Infection with nematodes of the genus ASCARIDIA. This condition usually occurs in fowl, often manifesting diarrhea.", "OL": "search ASCARIASIS 1968-74", "PM": "91; was see under NEMATODE INFECTIONS 1979-90; was see under ASCARIASIS 1968-78", "HN": "91(75); was see under NEMATODE INFECTIONS 1979-90; was see under ASCARIASIS 1968-78", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001198"}, {"RECTYPE": "D", "MH": "Ascaridoidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Parascaris|T204|NON|NRW|NLM (2007)|050804|abcdef", "ENTRY": "Parascari", "MN": "B01.050.500.500.294.400.500.100", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid33256", "RR": "txid6258", "AN": "do not confuse with the genera ASCARIDIA and ASCARIS; infection: coordinate IM with ASCARIDIDA INFECTIONS (IM); coordinate with specific helminth term (ANTIGENS, HELMINTH; etc) if pertinent", "PI": "Nematoda (1966-1974)", "MS": "A superfamily of polymyarian nematode worms. An important characteristic of this group is the presence of three prominent lips around the mouth of the organism.", "OL": "use ASCARIDOIDEA to search ASCAROIDEA 1975-85", "PM": "86; was ASCAROIDEA 1975-85", "HN": "86; was ASCAROIDEA 1975-85", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D001199"}, {"RECTYPE": "D", "MH": "Ascaris", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Ascari", "MN": "B01.050.500.500.294.400.500.100.108", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6251", "MS": "A genus of nematodes of the superfamily ASCARIDOIDEA whose species usually inhabit the intestine.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001200"}, {"RECTYPE": "D", "MH": "Ascites", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.550.081", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "do not index here for routine liver cirrhosis or Ehrlich ascites tumor; text must discuss ascites especially; chylous ascites: index CHYLOPERITONEUM", "MS": "Accumulation or retention of free fluid within the peritoneal cavity.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001201"}, {"RECTYPE": "D", "MH": "Ascitic Fluid", "AQ": "CH CY DE DG EN IM ME MI PA PH PS RE VI", "PRINT ENTRY": "Peritoneal Fluid|T031|NON|REL|NLM (1990)|890331|abcdef", "ENTRY": "Peritoneal Fluids", "MN": "A12.207.119", "FX": "Peritoneal Lavage", "MH_TH": "NLM (1968)", "ST": "T031", "PI": "Ascites (1966-1967)", "MS": "The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY.", "OL": "use ASCITIC FLUID to search PERITONEAL FLUID 1968-89", "PM": "68", "HN": "68; was in Cat A 1968-83; PERITONEAL EFFUSION was PERITONEAL FLUID see under ASCITIC FLUID 1968-83", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001202"}, {"RECTYPE": "D", "MH": "Ascomycota", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Sclerotinia|T004|NON|NRW|UNK (19XX)|850208|abcdef", "ENTRY": "Sclerotinias", "MN": "B01.300.107", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid4890", "RR": "txid5179", "AN": "general or unspecified; prefer specifics; infection: coordinate with MYCOSES or specific mycosis ", "MS": "A phylum of fungi which have cross-walls or septa in the mycelium. The perfect state is characterized by the formation of a saclike cell (ascus) containing ascospores. Most pathogenic fungi with a known perfect state belong to this phylum.", "PM": "99; see ASCOMYCETES 1963-98; for COCHLIOBOLUS & SCLEROTINA see ASCOMYCETES 1975-85", "HN": "99(75)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D001203"}, {"RECTYPE": "D", "MH": "Ascorbate Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ascorbino Dehydrogenase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Oxidase, L-Ascorbate", "MN": "D08.811.682.180", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Ascorbate:oxygen oxidoreductase", "RN": "EC 1.10.3.3", "PI": "Oxidoreductases (1973-1974)", "MS": "An enzyme that converts ascorbic acid to dehydroascorbic acid. EC 1.10.3.3.", "PM": "91; was see under OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under OXIDOREDUCTASES 1975-90", "MR": "20070709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001204"}, {"RECTYPE": "D", "MH": "Ascorbic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitamin C|T109|T121|T127|NON|EQV|FDA SRS (2014)|UNK (19XX)|740329|abbbcdeef", "ENTRY": "di-L-Ascorbate, Magnesium", "MN": "D09.811.100", "PA": "Vitamins", "EC": "deficiency:Ascorbic Acid Deficiency", "MH_TH": "USP (19XX)", "ST": "T127", "N1": "L-Ascorbic acid", "RN": "PQ6CK8PD0R", "RR": "S033EH8359", "MS": "A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant.", "PM": "/therapeutic use was ASCORBIC ACID, THERAPEUTIC 1965", "HN": "/therapeutic use was ASCORBIC ACID, THERAPEUTIC 1965", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D001205"}, {"RECTYPE": "D", "MH": "Ascorbic Acid Deficiency", "DE": "ASCORBIC ACID DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vitamin C Deficiency|T047|NON|EQV|NLM (1994)|921110|abcdef", "ENTRY": "Vitamin C Deficiencies", "MN": "C18.654.521.500.133.115", "FX": "Scurvy", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A condition due to a dietary deficiency of ascorbic acid (vitamin C), characterized by malaise, lethargy, and weakness. As the disease progresses, joints, muscles, and subcutaneous tissues may become the sites of hemorrhage. Ascorbic acid deficiency frequently develops into SCURVY in young children fed unsupplemented cow's milk exclusively during their first year. It develops also commonly in chronic alcoholism. (Cecil Textbook of Medicine, 19th ed, p1177)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001206"}, {"RECTYPE": "D", "MH": "Asepsis", "AQ": "HI IS MT ST", "MN": "N06.850.780.200.450.150.160", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "differentiate from ANTISEPSIS: ANTISEPSIS is the destruction of pathogens, ASEPSIS is the prev of their invasion", "MS": "The prevention of access by infecting organisms to the locus of potential infection.", "OL": "search ANTISEPSIS 1966-74", "PM": "91; was see under ANTISEPSIS 1975-90", "HN": "91(75); was see under ANTISEPSIS 1975-90", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001207"}, {"RECTYPE": "D", "MH": "Asia", "AQ": "EH EP", "MN": "Z01.252", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "several geog subdivisions & all Asiatic countries are available as headings", "MS": "The largest of the continents. It was known to the Romans more specifically as what we know today as Asia Minor. The name comes from at least two possible sources: from the Assyrian asu (to rise) or from the Sanskrit usa (dawn), both with reference to its being the land of the rising sun, i.e., eastern as opposed to Europe, to the west. (From Webster's New Geographical Dictionary, 1988, p82 & Room, Brewer's Dictionary of Names, 1992, p34)", "MR": "20220708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001208"}, {"RECTYPE": "D", "MH": "Asia, Central", "AQ": "EH EP", "MN": "Z01.252.100", "MH_TH": "NLM (1982)", "ST": "T083", "AN": "a geog area; prefer specific countries", "MS": "The geographical area of Asia comprising KAZAKHSTAN; KYRGYZSTAN; TAJIKISTAN; TURKMENISTAN; and UZBEKISTAN. The desert region of Kara Kum (Qara Qum) is largely in Turkmenistan and the desert region of Kyzyl Kum (Kizil Kum or Qizil Qum), is in Uzbekistan and Kazakhstan. (From Webster's New Geographical Dictionary, 1988, p233, 590, 636)", "HN": "82", "MR": "20010725", "DA": "19810227", "DC": "4", "DX": "19820101", "UI": "D001209"}, {"RECTYPE": "D", "MH": "Asia, Southeastern", "AQ": "EH EP", "PRINT ENTRY": "Southeast Asia|T083|NAM|EQV|NLM (1992)|910611|abcdef", "ENTRY": "Southeastern Asia|T083|NAM|EQV|POPLINE (1983)|861231|abcdef", "MN": "Z01.252.145", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a geog area; prefer specific countries", "MS": "The geographical area of Asia comprising BORNEO; BRUNEI; CAMBODIA; INDONESIA; LAOS; MALAYSIA; the MEKONG VALLEY; MYANMAR (formerly Burma), the PHILIPPINES; SINGAPORE; THAILAND; and VIETNAM.", "MR": "20010725", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001210"}, {"RECTYPE": "D", "MH": "Asia, Western", "AQ": "EH EP", "ENTRY": "Western Asia|T083|NAM|EQV|POPLINE (1983)|861231|abcdef", "MN": "Z01.252.245", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a geog area; prefer specific countries; MIDDLE EAST is also available", "MS": "The geographical designation for the countries of the MIDDLE EAST and the countries BANGLADESH; BHUTAN; INDIA; NEPAL; PAKISTAN; and SRI LANKA. (From Random House Unabridged Dictionary, 2d ed, 1993 & Webster's New Geographical Dictionary, 1988)", "MR": "20010725", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001211"}, {"RECTYPE": "D", "MH": "Asialoglycoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Asialoglycoprotein|T116|T123|NON|EQV|NLM (2022)|200803|abbcdef", "ENTRY": "Glycoproteins, Desialylated", "MN": "D12.776.395.140", "FX": "Asialoglycoprotein Receptor", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "PI": "Glycoproteins (1966-1984)", "MS": "Endogenous glycoproteins from which SIALIC ACID has been removed by the action of sialidases. They bind tightly to the ASIALOGLYCOPROTEIN RECEPTOR which is located on hepatocyte plasma membranes. After internalization by adsorptive ENDOCYTOSIS they are delivered to LYSOSOMES for degradation. Therefore receptor-mediated clearance of asialoglycoproteins is an important aspect of the turnover of plasma glycoproteins. They are elevated in serum of patients with HEPATIC CIRRHOSIS or HEPATITIS.", "PM": "85", "HN": "85", "MR": "20230316", "DA": "19840530", "DC": "1", "DX": "19850101", "UI": "D001212"}, {"RECTYPE": "D", "MH": "Asian", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Korean Americans|T098|NON|NRW|NLM (2005)|040406|abcdef", "ENTRY": "Vietnamese American", "MN": "M01.686.477.625.594.563", "MH_TH": "OMB (2023)", "ST": "T098", "AN": "despite entry terms, specify CHINA /ethnol, JAPAN /ethnol, KOREA /ethnol, or other Asian country with /ethnol when pertinent", "PI": "specific state (1966-1980)", "MS": "A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the-classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.", "PM": "2023; see ASIAN AMERICANS 1981-2022", "HN": "2023; use ASIAN AMERICANS 1981-2022", "MR": "20220713", "DA": "19800512", "DC": "1", "DX": "19810101", "UI": "D001213"}, {"RECTYPE": "D", "MH": "Asparaginase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "medac, Asparaginase", "MN": "D08.811.277.087.116", "PA": "Antineoplastic Agents", "MH_TH": "USAN (1970)", "ST": "T126", "N1": "L-Asparagine amidohydrolase", "RN": "EC 3.5.1.1", "PI": "Amidohydrolases (1966-1967)", "MS": "A hydrolase enzyme that converts L-asparagine and water to L-aspartate and NH3. EC 3.5.1.1.", "PM": "68", "HN": "68", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001215"}, {"RECTYPE": "D", "MH": "Asparagine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L-Asparagine|T116|T123|NON|EQV|NLM (2000)|991104|abbcdef", "MN": "D12.125.154.049", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Asparagine", "RN": "7006-34-0", "RR": "70-47-3 (L-isomer)", "AN": "/biosyn /physiol permitted", "MS": "A non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from ASPARTIC ACID and AMMONIA by asparagine synthetase. (From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed)", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001216"}, {"RECTYPE": "D", "MH": "Aspartate-Ammonia Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Asparagine Synthase|T116|T126|NON|EQV|NLM (1995)|940302|abbcdef", "ENTRY": "Synthetase, Asparagine", "MN": "D08.811.464.259.200.200", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Aspartate:ammonia ligase (AMP-forming)", "RN": "EC 6.3.1.1", "RR": "9023-69-2 (CAS RN)", "PI": "Ligases (1973-1974)", "MS": "An enzyme that catalyzes the formation of asparagine from ammonia and aspartic acid, in the presence of ATP. EC 6.3.1.1.", "OL": "use ASPARTATE-AMMONIA LIGASE to search ASPARAGINE SYNTHETASE 1975-94", "PM": "95: was ASPARAGINE SYNTHETASE 1975-94 (see under LIGASES 1975-90)", "HN": "95; was ASPARAGINE SYNTHETASE 1975-94 (see under LIGASES 1975-90)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001217"}, {"RECTYPE": "D", "MH": "Aspartame", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Aspartylphenylalanine Methyl Ester|T116|NON|EQV|UNK (19XX)|820505|abcdef", "ENTRY": "TriSweet", "MN": "D12.644.456.345.190", "PA": "Sweetening Agents", "MH_TH": "USAN (1971)", "ST": "T116", "N1": "L-Phenylalanine, N-L-alpha-aspartyl-, 1-methyl ester", "RN": "Z0H242BBR1", "RR": "22839-47-0 (Aspartame)", "PI": "Phenylalanine (1974)", "MS": "Flavoring agent sweeter than sugar, metabolized as PHENYLALANINE and ASPARTIC ACID.", "PM": "91; was see under DIPEPTIDES 1975-90", "HN": "91(75); was see under DIPEPTIDES 1975-90", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001218"}, {"RECTYPE": "D", "MH": "Aspartate Aminotransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SGOT|T116|T126|ABB|REL|UNK (19XX)|740329|abbcdef", "ENTRY": "Transaminase, Serum Glutamic-Oxaloacetic", "MN": "D08.811.913.477.700.225", "MH_TH": "NLM (2002)", "ST": "T126", "N1": "L-Aspartate:2-oxoglutarate aminotransaminase", "RN": "EC 2.6.1.1", "AN": "note specifics", "MS": "Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.", "PM": "2002; see ASPARTATE TRANSAMINASE 1998-2002, see ASPARTATE AMINOTRANSFERASE 1963-1997", "HN": "2002(1963)", "MR": "20150708", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D001219"}, {"RECTYPE": "D", "MH": "Aspartate Ammonia-Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fumaric Aminase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Aspartate Ammonia Lyase", "MN": "D08.811.520.232.400.200", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Aspartate ammonia-lyase", "RN": "EC 4.3.1.1", "RR": "9027-30-9 (CAS RN)", "PI": "Aspartic Acid (1973-1974)", "MS": "An enzyme that catalyzes the conversion of aspartic acid to ammonia and fumaric acid in plants and some microorganisms. EC 4.3.1.1.", "PM": "91; was see under AMMONIA-LYASES 1975-90", "HN": "91(75); was see under AMMONIA-LYASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001220"}, {"RECTYPE": "D", "MH": "Aspartate Carbamoyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aspartate Transcarbamylase|T116|T126|NON|EQV|UNK (19XX)|760317|abbcdef", "ENTRY": "Transcarbamylase, Aspartate", "MN": "D08.811.913.555.275.200", "MH_TH": "NLM (1964)", "ST": "T126", "N1": "Carbamoyl-phosphate:L-aspartate carbamoyltransferase", "RN": "EC 2.1.3.2", "RR": "9012-49-1 (CAS RN)", "MS": "An enzyme that catalyzes the conversion of carbamoyl phosphate and L-aspartate to yield orthophosphate and N-carbamoyl-L-aspartate. (From Enzyme Nomenclature, 1992) EC 2.1.3.2.", "PM": "73", "HN": "73", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001221"}, {"RECTYPE": "D", "MH": "Aspartate Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aspartokinase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Kinase, Aspartyl", "MN": "D08.811.913.696.630.050", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "ATP:L-aspartate 4-phosphotransferase", "RN": "EC 2.7.2.4", "RR": "9012-50-4 (CAS RN)", "PI": "Phosphotransferases, ATP (1974)", "MS": "An enzyme that catalyzes the formation of beta-aspartyl phosphate from aspartic acid and ATP. Threonine serves as an allosteric regulator of this enzyme to control the biosynthetic pathway from aspartic acid to threonine. EC 2.7.2.4.", "PM": "91; was see under PHOSPHOTRANSFERASES, ATP 1975-90", "HN": "91(75); was see under PHOSPHOTRANSFERASES, ATP 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001222"}, {"RECTYPE": "D", "MH": "Aspartate-Semialdehyde Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Semiaspartate Aldehyde Dehydrogenase|T116|T126|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Dehydrogenase, Semiaspartate Aldehyde", "MN": "D08.811.682.657.163.374", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "L-Aspartate-4-semialdehyde:NADP+ oxidoreductase (phosphorylating)", "RN": "EC 1.2.1.11", "MS": "An enzyme that catalyzes the conversion of L-aspartate 4-semialdehyde, orthophosphate, and NADP+ to yield L-4-aspartyl phosphate and NADPH. EC 1.2.1.11.", "PM": "65", "HN": "65", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001223"}, {"RECTYPE": "D", "MH": "Aspartic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L Aspartic Acid", "MN": "D12.125.427.040", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "L-Aspartic Acid", "RN": "30KYC7MIAI", "RR": "T9680JD4IY", "AN": "D-ASPARTIC ACID is also available", "MS": "One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.", "OL": "use ASPARTIC ACID (NM) to search ISOASPARTIC ACID 1990-92", "PM": "93; ISOASPARTIC ACID was indexed under ASPARTIC ACID 1990-92", "HN": "93; ISOASPARTIC ACID was (NM) 1990-92", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D001224"}, {"RECTYPE": "D", "MH": "Aspartokinase Homoserine Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Homoserine Dehydrogenase, Aspartokinase", "MN": "D08.811.913.696.630.050.050", "MH_TH": "NLM (1976)", "ST": "T126", "RN": "EC 2.7.2.4", "RR": "EC 1.1.1.3", "PI": "Phosphotransferases, ATP (1974-1975)", "MS": "A bifunctional protein consisting of aspartokinase, and homoserine dehydrogenase activities. It is found primarily in BACTERIA and in PLANTS.", "PM": "91; was see under MULTIENZYME COMPLEXES 1976-90", "HN": "91(76); was see under MULTIENZYME COMPLEXES 1976-90", "MR": "20130708", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D001225"}, {"RECTYPE": "D", "MH": "Aspartate-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aspartyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961105|abbdef", "ENTRY": "Synthetase, Aspartyl-tRNA", "MN": "D08.811.464.263.200.150", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Aspartate:tRNA-(Asp) ligase (AMP-forming)", "RN": "EC 6.1.1.12", "PI": "Aspartic Acid (1973-1974)", "MS": "An enzyme that activates aspartic acid with its specific transfer RNA. EC 6.1.1.12.", "PM": "98; see ASPARTYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001226"}, {"RECTYPE": "D", "MH": "Aspartylglucosylaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aspartylglycosamine Amidohydrolase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Deaspartylase, Aspartylglucosylamine", "MN": "D08.811.277.087.125", "EC": "deficiency:Aspartylglucosaminuria", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "N(4)-(beta-N-Acetyl-D-glucosaminyl)-L-asparagine amidohydrolase", "RN": "EC 3.5.1.26", "PI": "Glucosamine (1970-1974)", "MS": "An enzyme that catalyzes the conversion of N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine and water to N-acetyl-beta-D-glucosaminylamine and L-aspartate. It acts only on asparagine-oligosaccharides containing one amino acid, i.e. the ASPARAGINE has free alpha-amino and alpha-carboxyl groups. (From Enzyme Nomenclature, 1992)", "PM": "91; was see under AMIDOHYDROLASES 1975-90", "HN": "91(75); was see under AMIDOHYDROLASES 1975-90", "MR": "20080708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001227"}, {"RECTYPE": "D", "MH": "Aspergillosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Aspergillus", "MN": "C01.150.703.080", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "specify species if pertinent; coordinate with precoordinated organ/disease term; note PULMONARY ASPERGILLOSIS and specifics and NEUROASPERGILLOSIS are also available", "MS": "Infections with fungi of the genus ASPERGILLUS.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001228"}, {"RECTYPE": "D", "MH": "Aspergillosis, Allergic Bronchopulmonary", "DE": "ABPA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Allergic Bronchopulmonary Aspergillosis|T047|NON|EQV|OMIM (2013)|ORD (2010)|UNK (19XX)|780519|ALLERGIC BRONCHOPULM ASPERG|abcdeeefv", "ENTRY": "Bronchopulmonary Allergic Aspergillosis", "MN": "C20.543.480.680.085", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not coordinate with BRONCHIAL DISEASES", "PI": "Respiratory Hypersensitivity (1966-1978)", "MS": "Hypersensitivity reaction (ALLERGIC REACTION) to fungus ASPERGILLUS in an individual with long-standing BRONCHIAL ASTHMA. It is characterized by pulmonary infiltrates, EOSINOPHILIA, elevated serum IMMUNOGLOBULIN E, and skin reactivity to Aspergillus antigen.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D001229"}, {"RECTYPE": "D", "MH": "Aspergillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.381.081", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid5052", "AN": "general or unspecified; prefer specific genera; infection equals ASPERGILLOSIS", "MS": "A genus of mitosporic fungi containing about 100 species and eleven different teleomorphs in the family Trichocomaceae.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001230"}, {"RECTYPE": "D", "MH": "Aspergillus flavus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Petromyces flavus|T004|NON|EQV|NLM (2021)|200318|abcdef", "MN": "B01.300.381.081.170", "FX": "Aflatoxins", "MH_TH": "NLM (1972)", "ST": "T004", "RN": "txid5059", "AN": "infection: coordinate with ASPERGILLOSIS", "PI": "Aspergillus (1966-1971)", "MS": "A species of imperfect fungi which grows on peanuts and other plants and produces the carcinogenic substance aflatoxin. It is also used in the production of the antibiotic flavicin.", "PM": "74", "HN": "74(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001231"}, {"RECTYPE": "D", "MH": "Aspergillus fumigatus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Sartorya fumigata|T004|NON|EQV|NLM (2021)|200318|abcdef", "MN": "B01.300.381.081.295", "MH_TH": "NLM (1972)", "ST": "T004", "RN": "txid746128", "AN": "infection: coordinate with ASPERGILLOSIS", "PI": "Aspergillus (1966-1971)", "MS": "A species of imperfect fungi from which the antibiotic fumigatin is obtained. Its spores may cause respiratory infection in birds and mammals.", "PM": "74", "HN": "74(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001232"}, {"RECTYPE": "D", "MH": "Aspergillus nidulans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Aspergillus nidulellus|T004|NON|EQV|NLM (2021)|200318|abcdef", "ENTRY": "Emericella nidulans|T004|NON|EQV|NLM (2003)|011011|abcdef", "MN": "B01.300.381.081.420", "MH_TH": "NLM (1972)", "ST": "T004", "RN": "txid162425", "AN": "infection: coordinate with ASPERGILLOSIS", "PI": "Aspergillus (1966-1971)", "MS": "A species of imperfect fungi from which the antibiotic nidulin is obtained. Its teleomorph is Emericella nidulans.", "PM": "74", "HN": "1974(1972); for EMERICELLA NIDULANS was EMERICELLA (2003-2020)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001233"}, {"RECTYPE": "D", "MH": "Aspergillus niger", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Aspergillus lacticoffeatus|T004|NON|EQV|NLM (2021)|200318|abcdef", "MN": "B01.300.381.081.450", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5061", "AN": "infection: coordinate with ASPERGILLOSIS", "PI": "Aspergillus (1966-1974)", "MS": "An imperfect fungus causing smut or black mold of several fruits and vegetables such as grapes, apricots, onions, and peanuts, and is a common contaminant of food.", "PM": "78; see ASPERGILLUS 1975-77", "HN": "78(75)", "MR": "20210209", "DA": "19741212", "DC": "1", "DX": "19780101", "UI": "D001234"}, {"RECTYPE": "D", "MH": "Aspergillus ochraceus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.381.081.480", "MH_TH": "NLM (1986)", "ST": "T004", "RN": "txid40380", "PI": "Aspergillus (1966-1985)", "MS": "An imperfect fungus that produces ochratoxins which contaminates EDIBLE GRAIN and coffee beans.", "PM": "91; was see under ASPERGILLUS 1986-90", "HN": "91(86); was see under ASPERGILLUS 1986-90", "MR": "20210630", "DA": "19850211", "DC": "1", "DX": "19910101", "UI": "D001235"}, {"RECTYPE": "D", "MH": "Aspergillus oryzae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Eurotium oryzae|T004|NON|EQV|NLM (2021)|200318|abcdef", "MN": "B01.300.381.081.500", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5062", "MS": "An imperfect fungus present on most agricultural seeds and often responsible for the spoilage of seeds in bulk storage. It is also used in the production of fermented food or drink, especially in Japan.", "PM": "91; see ASPERGILLUS 1975-90", "HN": "91(75)", "MR": "20200527", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D001236"}, {"RECTYPE": "D", "MH": "Asphyxia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Suffocation|T033|T046|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Suffocations", "MN": "C26.103", "EC": "congenital:Asphyxia Neonatorum", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "A pathological condition caused by lack of oxygen, manifested in impending or actual cessation of life.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001237"}, {"RECTYPE": "D", "MH": "Asphyxia Neonatorum", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C16.614.092", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; tag INFANT, NEWBORN", "MS": "Respiratory failure in the newborn. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001238"}, {"RECTYPE": "D", "MH": "Inhalation", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Inhaling|T042|NON|EQV|NLM (1990)|890520|abcdef", "ENTRY": "Respiratory Inspiration", "MN": "G09.772.705.700.390", "MH_TH": "NLM (2004)", "ST": "T042", "MS": "The act of BREATHING in.", "PM": "2004; see ASPIRATION 1991-2003; was see under RESPIRATION 1966-1990", "HN": "2004(1966); was see under RESPIRATION 1966-1990", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001239"}, {"RECTYPE": "D", "MH": "Aspirations, Psychological", "ENTRY": "Psychological Aspirations", "MN": "F02.784.629.155", "MH_TH": "NLM (2020)", "ST": "T041", "PI": "Motivation (1966-1974)", "MS": "Strong desires to accomplish something. This usually pertains to greater values or high ideals.", "PM": "1975", "HN": "2020 (1975); was ASPIRATIONS (PSYCHOLOGY) 1975-2019", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D001240"}, {"RECTYPE": "D", "MH": "Aspirin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acetylsalicylic Acid|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740329|abbcdeef", "ENTRY": "Acid, Acetylsalicylic", "MN": "D02.455.426.559.389.657.410.595.176", "PA": "Platelet Aggregation Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzoic acid, 2-(acetyloxy)-", "RN": "R16CO5Y76E", "RR": "50-78-2 (Aspirin)", "MS": "The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)", "PM": "65; was ACETYLSALICYLIC ACID 1963-64", "HN": "65; was ACETYLSALICYLIC ACID 1963-64", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001241"}, {"RECTYPE": "D", "MH": "Assertiveness", "ENTRY": "Assertivenesses", "MN": "F01.752.049", "MH_TH": "NLM (1980)", "ST": "T055", "AN": "assertiveness training: coordinate with BEHAVIOR THERAPY ", "PI": "Aggression (1966-1979)", "MS": "Strongly insistent, self-assured, and demanding behavior.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19790411", "DC": "1", "DX": "19800101", "UI": "D001242"}, {"RECTYPE": "D", "MH": "Assisted Circulation", "DE": "ASSISTED CIRC", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Circulation, Assisted|T061|NON|EQV|NLM (1994)|921001|CIRC ASSISTED|abcdefv", "MN": "E04.050", "FX": "Heart-Assist Devices", "MH_TH": "NLM (1967)", "ST": "T061", "AN": "do not confuse with EXTRACORPOREAL CIRCULATION or its specifics", "PI": "Heart-Lung Machine (1966)", "MS": "Pumping that aids the natural activity of the heart. (Dorland, 27th ed)", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001243"}, {"RECTYPE": "D", "MH": "Association", "DE": "ASSOC", "ENTRY": "Associations", "MN": "F04.754.720.346", "FX": "Word Association Tests", "MH_TH": "NLM (1965)", "ST": "T041", "AN": "a psychological or learning context", "MS": "A functional relationship between psychological phenomena of such nature that the presence of one tends to evoke the other; also, the process by which such a relationship is established.", "PM": "66", "HN": "66(65)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001244"}, {"RECTYPE": "D", "MH": "Association Learning", "DE": "ASSOC LEARNING", "AQ": "CL DE ES PH RE", "ENTRY": "Learnings, Association", "MN": "F02.463.425.069.296", "MH_TH": "NLM (1975)", "ST": "T041", "MS": "The principle that items experienced together enter into a connection, so that one tends to reinstate the other.", "OL": "search LEARNING 1966-74", "PM": "91; was see under LEARNING 1975-90", "HN": "91(75); was see under LEARNING 1975-90", "CATSH": "CAT LIST", "MR": "19940512", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001245"}, {"RECTYPE": "D", "MH": "Astatine", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.496.749.305.110", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Astatine", "RN": "XI595HAL7H", "RR": "7440-68-8 (Astatine)", "MS": "Astatine. A radioactive halogen with the atomic symbol At, and atomic number 85. Its isotopes range in mass number from 200 to 219 and all have an extremely short half-life. Astatine may be of use in the treatment of hyperthyroidism because it emits ALPHA PARTICLES.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001246"}, {"RECTYPE": "D", "MH": "Asthenia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.089", "FX": "Neurasthenia", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "NEUROCIRCULATORY ASTHENIA is also available", "MS": "Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.", "CATSH": "CAT LIST", "MR": "20170601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001247"}, {"RECTYPE": "D", "MH": "Asthenopia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Visual Fatigue|T047|NON|EQV|NLM (1995)|930913|abcdef", "ENTRY": "Fatigue, Eye", "MN": "C11.093", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "ocular fatigue", "MS": "Term generally used to describe complaints related to refractive error, ocular muscle imbalance, including pain or aching around the eyes, burning and itchiness of the eyelids, ocular fatigue, and headaches.", "OL": "use ASTHENOPIA to search EYESTRAIN 1966-67", "PM": "EYESTRAIN was heading 1963-67", "HN": "EYESTRAIN was heading 1963-67", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001248"}, {"RECTYPE": "D", "MH": "Asthma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bronchial Asthma|T047|NON|EQV|UNK (19XX)|840210|abcdef", "ENTRY": "Asthmas", "MN": "C20.543.480.680.095", "FX": "Anti-Asthmatic Agents", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "note specifics; ASTHMA, CARDIAC see DYSPNEA, PAROXYSMAL is also available; in historical literature consider indexing \"phthisic\" here; \"phthisis\" probably goes under TUBERCULOSIS, PULMONARY", "MS": "A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001249"}, {"RECTYPE": "D", "MH": "Asthma, Exercise-Induced", "DE": "ASTHMA EXERCISE IND", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Exercise-Induced Bronchospasm|T047|NON|NRW|UNK (19XX)|780512|EXERCISE IND BRONCHOSPASM|abcdefv", "ENTRY": "Exercise-Induced Bronchospasms", "MN": "C20.543.480.680.095.110", "FX": "Vocal Cord Dysfunction", "MH_TH": "NLM (1979)", "ST": "T047", "PI": "Exertion (1966-1978)", "MS": "Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it).", "PM": "91; was see under ASTHMA 1979-90", "HN": "91(79); was see under ASTHMA 1979-90", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19780512", "DC": "1", "DX": "19910101", "UI": "D001250"}, {"RECTYPE": "D", "MH": "Astigmatism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Oblique Astigmatism|T047|NON|NRW|NLM (2023)|210910|abcdef", "ENTRY": "Oblique Astigmatisms", "MN": "C11.744.212", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "Unequal or irregular curvature of the CORNEA (Corneal astigmatism) and/or the EYE LENS (Lenticular astigmatism) resulting in  REFRACTIVE ERROR.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001251"}, {"RECTYPE": "D", "MH": "Astringents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Astringent|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Effects, Astringent", "MN": "D27.505.954.444.100", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Agents, usually topical, that cause the contraction of tissues for the control of bleeding or secretions.", "OL": "use ASTRINGENTS to search ANTIPERSPIRANTS 1985-94", "PM": "ANTIPERSPIRANTS was see ASTRINGENTS 1985-94", "HN": "ANTIPERSPIRANTS was see ASTRINGENTS 1985-94", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001252"}, {"RECTYPE": "D", "MH": "Astrocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Astroglial Cells|T025|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Cell, Astroglial", "MN": "A11.650.200", "FX": "Blood-Brain Barrier", "MH_TH": "NLM (1975)", "ST": "T025", "PI": "Neuroglia (1966-1974)", "MS": "A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from \"star\" cells) are irregularly shaped with many long processes, including those with \"end feet\" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and \"reactive astrocytes\" (along with MICROGLIA) respond to injury.", "OL": "search NEUROGLIA 1966-74", "PM": "79; was see under NEUROGLIA 1963-78", "HN": "79(75); was see under NEUROGLIA 1963-78", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D001253"}, {"RECTYPE": "D", "MH": "Astrocytoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pleomorphic Xanthoastrocytomas|T191|NON|NRW|NLM (2023)|210831|abcdef", "ENTRY": "Xanthoastrocytoma, Pleomorphic", "MN": "C04.557.580.625.600.380.080", "MH_TH": "OMIM (2013)", "ST": "T191", "AN": "coordinate with precoordinated CENTRAL NERVOUS SYSTEM neoplasm term + site; Grades I-III go here, with pathology; for ASTROCYTOMA, GRADE IV see GLIOBLASTOMA; for SUBEPENDYMAL ASTROCYTOMA see GLIOMA, SUBEPENDYMAL; for MIXED OLIGODENDROGLIOMA-ASTROCYTOMA see OLIGODENDROGLIOMA", "MS": "Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)", "PM": "1963; for ASTROCYTOMA, SUBEPENDYMAL GIANT CELL see GLIOMA 1994-1999", "HN": "1963; for ASTROCYTOMA, SUBEPENDYMAL GIANT CELL use GLIOMA 1994-1999", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D001254"}, {"RECTYPE": "D", "MH": "Astrology", "DE": "ASTROL", "AQ": "HI PX", "MN": "K01.672.296", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "System of thought regarding forecasting of earthly and human events through the observation and interpretation of the fixed stars and planetary bodies.", "MR": "20180201", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001255"}, {"RECTYPE": "D", "MH": "Astronomy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.671.065", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use ASTRONOMICAL PHENOMENA or specifics treed under it for properties and processes of matter in outer space (stars, planets, comets etc)", "MS": "The science concerned with celestial bodies and the observation and interpretation of the radiation received in the vicinity of the earth from the component parts of the universe (McGraw Hill Dictionary of Scientific and Technical Terms, 5th ed)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001256"}, {"RECTYPE": "D", "MH": "Mamastrovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human astrovirus|T005|NON|NRW|NLM (2007)|050829|abcdef", "ENTRY": "astroviruses, Human", "MN": "B04.820.578.250.500", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid249588", "RR": "txid1868658", "AN": "infection: coordinate IM with ASTROVIRIDAE INFECTIONS (IM)", "PI": "Vertebrate Viruses, Unclassified (1975-1978)", "MS": "A genus of small, circular RNA viruses in the family ASTROVIRIDAE. They cause GASTROENTERITIS and are found in the stools of several vertebrates including humans. Transmission is by the fecal-oral route and there are at least eight human serotypes. The type species is Human astrovirus.", "PM": "2007; see ASTROVIRUS 1997-2006, see ASTROVIRUSES 1991-1996, see VERTEBRATE VIRUSES, UNCLASSIFIED 1979-1990", "HN": "2007 (1979)", "MR": "20200813", "DA": "19780320", "DC": "1", "DX": "19910101", "UI": "D001257"}, {"RECTYPE": "D", "MH": "Ataxia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Incoordination|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Truncal Ataxias", "MN": "C23.888.592.350.090", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.", "CATSH": "CAT LIST", "MR": "20021114", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001259"}, {"RECTYPE": "D", "MH": "Ataxia Telangiectasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Louis-Bar Syndrome|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|740329|abcdeeeef", "ENTRY": "Syndrome, Louis-Bar", "MN": "C20.673.795.250", "MH_TH": "NLM (1968)", "ST": "T047", "PI": "Ataxia (1966-1967)", "MS": "An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATION. Affected individuals are prone to recurrent sinobronchopulmonary infections, lymphoreticular neoplasms, and other malignancies. Serum ALPHA-FETOPROTEINS are usually elevated. (Menkes, Textbook of Child Neurology, 5th ed, p688) The gene for this disorder (ATM) encodes a cell cycle checkpoint protein kinase and has been mapped to chromosome 11 (11q22-q23).", "PM": "1968", "HN": "1968", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001260"}, {"RECTYPE": "D", "MH": "Pulmonary Atelectasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lung Collapse|T047|NON|EQV|NLM (2009)|080110|abcdef", "ENTRY": "Resorption Pulmonary Atelectases", "MN": "C08.381.730", "MH_TH": "NLM (2009)", "ST": "T047", "MS": "Absence of air in the entire or part of a lung, such as an incompletely inflated neonate lung or a collapsed adult lung. Pulmonary atelectasis can be caused by airway obstruction, lung compression, fibrotic contraction, or other factors.", "PM": "2009; see ATELECTASIS 1963-2008; for ATELECTASIS, CONGESTIVE see RESPIRATORY DISTRESS SYNDROME, ADULT 1976-2008", "HN": "2009 (1963); for ATELECTASIS, CONGESTIVE use RESPIRATORY DISTRESS SYNDROME, ADULT 1976-2008", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D001261"}, {"RECTYPE": "D", "MH": "Atenolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ICI66082", "MN": "D02.092.063.624.698.070", "PA": "Sympatholytics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzeneacetamide, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-", "RN": "50VV3VW0TI", "RR": "29122-68-7 (Atenolol)", "PI": "Propanolamines (1974)", "MS": "A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.", "PM": "84; was see under PROPANOLAMINES 1978-83; was ICI 66082 see under PROPANOLAMINES 1975-77", "HN": "84(78); was see under PROPANOLAMINES 1978-83; was ICI 66082 see under PROPANOLAMINES 1975-77", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D001262"}, {"RECTYPE": "D", "MH": "Athetosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Athetoid Movements|T184|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Movements, Athetoid", "MN": "C23.888.592.350.110", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A dyskinesia characterized by an inability to maintain the fingers, toes, tongue, or other body parts in a stable position, resulting in continuous slow, sinusoidal, and flowing involuntary movements. This condition is frequently accompanied by CHOREA, where it is referred to as choreoathetosis. Athetosis may occur as a manifestation of BASAL GANGLIA DISEASES or DRUG TOXICITY. (From Adams et al., Principles of Neurology, 6th ed, p76)", "CATSH": "CAT LIST", "MR": "20050713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001264"}, {"RECTYPE": "D", "MH": "Athletic Injuries", "DE": "ATHLETIC INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sports Injuries|T037|NON|EQV|NLM (1998)|961216|SPORTS INJ|abcdefv", "ENTRY": "Sports Injury", "MN": "C26.115", "MH_TH": "NLM (1968)", "ST": "T037", "AN": "general or unspecified; prefer specific sport /inj; when general, coordinate with specific injury; distinguish from SPORTS MEDICINE; TENNIS ELBOW is available but see note there", "PI": "Sports (1966-1967)", "MS": "Injuries incurred during participation in competitive or non-competitive sports.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001265"}, {"RECTYPE": "D", "MH": "Atlantic Islands", "AQ": "EH EP", "ENTRY": "St. Helena|T083|NAM|NRW|NLM (1987)|861231|abcdef", "MN": "Z01.639.040", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "note specifics here and under CARIBBEAN REGION", "MS": "Widely scattered islands in the Atlantic Ocean as far north as the AZORES and as far south as the South Sandwich Islands, with the greatest concentration found in the CARIBBEAN REGION. They include Annobon Island, Ascension, Canary Islands, Falkland Islands, Fernando Po (also called Isla de Bioko and Bioko), Gough Island, Madeira, Sao Tome and Principe, Saint Helena, and Tristan da Cunha.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001266"}, {"RECTYPE": "D", "MH": "Atlantic Ocean", "AQ": "EH EP", "MN": "Z01.756.092", "MH_TH": "NLM (1987)", "ST": "T083", "MS": "Body of water separating North and South America from Africa and Europe.", "HN": "87", "MR": "20161219", "DA": "19860402", "DC": "4", "DX": "19870101", "UI": "D001267"}, {"RECTYPE": "D", "MH": "Atlanto-Axial Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Joints, Atlantoaxial", "MN": "A02.835.583.097", "MH_TH": "NLM (1983)", "ST": "T030", "PI": "Axis (1966-1982)", "MS": "The joint involving the CERVICAL ATLAS and axis bones.", "PM": "83", "HN": "83", "MR": "20080709", "DA": "19820426", "DC": "1", "DX": "19830101", "UI": "D001268"}, {"RECTYPE": "D", "MH": "Atlanto-Occipital Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Atloido-Occipital Joint|T030|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Joints, Atloido-Occipital", "MN": "A02.835.583.101", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "The point of articulation between the OCCIPITAL BONE and the CERVICAL ATLAS.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001269"}, {"RECTYPE": "D", "MH": "Cervical Atlas", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Atlas, Cervical|T023|NON|EQV|NLM (2009)|070725|abcdef", "ENTRY": "Vertebras, C1", "MN": "A02.835.232.834.151.500", "MH_TH": "NLM (2009)", "ST": "T023", "MS": "The first cervical vertebra.", "PM": "2009; see ATLAS 1963-2008", "HN": "2009 (1963)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D001270"}, {"RECTYPE": "D", "MH": "Atlases as Topic", "AQ": "HI", "ENTRY": "Atlases as Topics", "MN": "L01.462.500.682.192.836.147", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "anatomical atlases: index ATLASES AS TOPIC + ANATOMY, ARTISTIC; do not confuse with the Publication Type ATLAS", "MS": "Works about collections of illustrative plates and charts..", "PM": "2008; see ATLASES 1963-2007", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D001271"}, {"RECTYPE": "D", "MH": "Atmosphere", "AQ": "AN CH", "ENTRY": "Atmospheres", "MN": "N06.230.300.100", "MH_TH": "NLM (1972)", "ST": "T070", "AN": "/anal /chem permitted", "PI": "Extraterrestrial Environment (1966-1971)", "MS": "The gaseous envelope surrounding a planet or similar body. (From Random House Unabridged Dictionary, 2d ed)", "PM": "74", "HN": "74(72)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001272"}, {"RECTYPE": "D", "MH": "Atmosphere Exposure Chambers", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Exposure Chambers, Atmosphere", "MN": "E07.079", "MH_TH": "NLM (1973)", "ST": "T074", "MS": "Experimental devices used in inhalation studies in which a person or animal is either partially or completely immersed in a chemically controlled atmosphere.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001273"}, {"RECTYPE": "D", "MH": "Atmospheric Pressure", "ENTRY": "Pressures, Atmospheric", "MN": "N06.230.300.100.185", "FX": "Hypoxia", "MH_TH": "NLM (1966)", "ST": "T070", "MS": "The pressure at any point in an atmosphere due solely to the weight of the atmospheric gases above the point concerned.", "MR": "20160718", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001274"}, {"RECTYPE": "D", "MH": "ATP Citrate (pro-S)-Lyase", "DS": "ATP CITRATE LYASE PRO S", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Citrate Cleavage Enzyme|T116|T126|NON|EQV|UNK (19XX)|760324|abbcdef", "ENTRY": "Synthase, ATP Citrate", "MN": "D08.811.913.050.331", "MH_TH": "NLM (1973)", "ST": "T126", "N1": "ATP:citrate oxaloacetate-lyase ((pro-S)-CH2COO(-)--acetyl-CoA) (ATP-dephosphorylating)", "RN": "EC 2.3.3.8", "RR": "9027-95-6 (CAS RN)", "PI": "Lyases (1966-1972)", "MS": "An enzyme that, in the presence of ATP and COENZYME A, catalyzes the cleavage of citrate to yield acetyl CoA, oxaloacetate, ADP, and ORTHOPHOSPHATE. This reaction represents an important step in fatty acid biosynthesis. This enzyme was formerly listed as EC 4.1.3.8.", "PM": "98; see ATP CITRATE LYASE 1977-97; see KETOACID-LYASES 1973-76", "HN": "98(73)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D001275"}, {"RECTYPE": "D", "MH": "ATP Phosphoribosyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphoribosyl-ATP Pyrophosphorylase|T116|T126|EQV|UNK (19XX)|750711|abbdef", "ENTRY": "Pyrophosphorylase, Phosphoribosyl-ATP", "MN": "D08.811.913.400.725.200", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "1-(5-Phospho-D-ribosyl)-ATP:pyrophosphate phospho-alpha-D- ribosyltransferase", "RN": "EC 2.4.2.17", "RR": "9031-46-3 (CAS RN)", "PI": "Pyrophosphoric Acids (1971-1975)", "MS": "An enzyme that catalyzes the first step of the pathway for histidine biosynthesis in Salmonella typhimurium. ATP reacts reversibly with 5-phosphoribosyl-1-pyrophosphate to yield N-1-(5'-phosphoribosyl)-ATP and pyrophosphate. EC 2.4.2.17.", "PM": "91; was see under PENTOSYLTRANSFERASES 1976-90", "HN": "91(76); was see under PENTOSYLTRANSFERASES 1976-90", "MR": "20030709", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D001276"}, {"RECTYPE": "D", "MH": "GTP Pyrophosphokinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stringent Factor|T116|T126|NON|EQV|UNK (19XX)|790523|abbcdef", "ENTRY": "Pyrophosphotransferase, ATP-Guanosine Phosphate", "MN": "D08.811.913.696.175.300", "MH_TH": "NLM (1980)", "ST": "T126", "N1": "ATP:GTP 3'-pyrophosphotransferase", "RN": "EC 2.7.6.5", "RR": "63690-89-1 (CAS RN)", "PI": "Ribosomal Proteins (1975-1979)", "MS": "An enzyme that catalyzes reversibly the transfer of a pyrophosphate group from ATP to the 3'-OH group of GDP or GTP with the formation of guanosine 3'-diphosphate 5'-diphosphate or guanosine 3'-diphosphate 5'-triphosphate and AMP. The enzyme, also called stringent factor, is located in the relA gene in stringent strains of bacteria. The above synthesis is induced by mRNA and uncharged tRNA which is bound to the aminoacyl-t-RNA binding site of the ribosome by a codon-specific association. EC 2.7.6.5.", "OL": "use GTP PYROPHOSPHOKINASE to search ATP-GUANOSINE PHOSPHATE PYROPHOSPHOTRANSFERASE 1980-91", "PM": "92; was ATP-GUANOSINE PHOSPHATE PYROPHOSPHOTRANSFERASE 1980-91 (see under PHOSPHOTRANSFERASES, ATP 1980-90)", "HN": "92; was ATP-GUANOSINE PHOSPHATE PYROPHOSPHOTRANSFERASE 1980-91 (see under PHOSPHOTRANSFERASES, ATP 1980-90)", "MR": "20030709", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D001277"}, {"RECTYPE": "D", "MH": "Atractyloside", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Atractylic Acid|T109|T131|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Acid, Atractylic", "MN": "D09.408.105", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-((2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-beta-D-glucopyranosyl)oxy)-, (2beta,4alpha,15alpha)-", "RN": "17754-44-8", "PI": "Phenanthrenes (1973-1974)", "MS": "A glycoside of a kaurene type diterpene that is found in some plants including Atractylis gummifera (ATRACTYLIS); COFFEE; XANTHIUM, and CALLILEPIS. Toxicity is due to inhibition of ADENINE NUCLEOTIDE TRANSLOCASE.", "PM": "91; was see under GLYCOSIDES 1975-90", "HN": "91(75); was see under GLYCOSIDES 1975-90", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001278"}, {"RECTYPE": "D", "MH": "Atracurium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Atracurium Dibesylate|T109|T121|NON|NRW|UNK (19XX)|860602|abbcdef", "ENTRY": "Besilate, Atracurium", "MN": "D03.633.100.531.085.061", "PA": "Nicotinic Antagonists", "MH_TH": "NLM (19XX)", "ST": "T121", "N1": "Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl))-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-", "RN": "2GQ1IRY63P", "RR": "64228-81-5 (besylate)", "PI": "Isoquinolines (1966-1986)", "MS": "A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.", "PM": "87", "HN": "87", "MR": "20170524", "DA": "19860714", "DC": "1", "DX": "19870101", "UI": "D001279"}, {"RECTYPE": "D", "MH": "Atrazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Gesamprim|T109|T121|TRD|NRW|NLM (1998)|961121|abbcdef", "MN": "D03.383.931.247", "PA": "Herbicides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "1,3,5-Triazine-2,4-diamine, 6-chloro-N-ethyl-N'-(1-methylethyl)-", "RN": "QJA9M5H4IM", "RR": "1912-24-9 (Atrazine)", "PI": "Triazines (1966-1971)", "MS": "A selective triazine herbicide. Inhalation hazard is low and there are no apparent skin manifestations or other toxicity in humans. Acutely poisoned sheep and cattle may show muscular spasms, fasciculations, stiff gait, increased respiratory rates, adrenal degeneration, and congestion of the lungs, liver, and kidneys. (From The Merck Index, 11th ed)", "PM": "74", "HN": "74(72)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001280"}, {"RECTYPE": "D", "MH": "Atrial Fibrillation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Auricular Fibrillation|T033|T046|NON|EQV|GHR (2014)|UNK (19XX)|830503|abbcdeef", "ENTRY": "Persistent Atrial Fibrillations", "MN": "C23.550.073.198", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "do not confuse with ATRIAL FLUTTER", "MS": "Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.", "OL": "use ATRIAL FIBRILLATION to search AURICULAR FIBRILLATION 1966-83", "PM": "84; was AURICULAR FIBRILLATION 1963-83", "HN": "84; was AURICULAR FIBRILLATION 1963-83", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D001281"}, {"RECTYPE": "D", "MH": "Atrial Flutter", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Auricular Flutter|T033|T046|NON|EQV|UNK (19XX)|830503|abbcdef", "ENTRY": "Flutters, Auricular", "MN": "C23.550.073.248", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "do not confuse with ATRIAL FIBRILLATION", "MS": "Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).", "OL": "use ATRIAL FLUTTER to search AURICULAR FLUTTER 1966-83", "PM": "84; was AURICULAR FLUTTER 1963-83", "HN": "84; was AURICULAR FLUTTER 1963-83", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D001282"}, {"RECTYPE": "D", "MH": "Atrioventricular Node", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "AV Node|T023|NON|EQV|NLM (1991)|891228|abcdef", "ENTRY": "Nodes, Atrioventricular", "MN": "A07.541.409.147", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "A small nodular mass of specialized muscle fibers located in the interatrial septum near the opening of the coronary sinus. It gives rise to the atrioventricular bundle of the conduction system of the heart.", "OL": "search HEART CONDUCTION SYSTEM 1966-74", "PM": "91; was see under HEART CONDUCTION SYSTEM 1975-90", "HN": "91(75); was see under HEART CONDUCTION SYSTEM 1975-90", "MR": "19920325", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001283"}, {"RECTYPE": "D", "MH": "Atrophy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Atrophies", "MN": "C23.300.070", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "NIM; coord with organ/pathol (IM)", "MS": "Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001284"}, {"RECTYPE": "D", "MH": "Atropine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Atropine", "MN": "D03.605.869.229.199", "PA": "Parasympatholytics", "EC": "analogs & derivatives:Atropine Derivatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzeneacetic acid, alpha-(hydroxymethyl)- 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester endo-(+-)-", "RN": "7C0697DR9I", "RR": "KAE4PSB0Z3", "MS": "An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine.", "PM": "1975", "HN": "1975", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D001285"}, {"RECTYPE": "D", "MH": "Atropine Derivatives", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Atropines|T109|NON|EQV|NLM (2014)|130607|abcdef", "MN": "D03.605.869.229", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Tropanes (1966-1974)", "MS": "Analogs and derivatives of atropine.", "OL": "search TROPANES 1969-74", "PM": "78; was see under ATROPINE 1975-77, was see under TROPANES 1969-74; N-ISOPROPYLATROPINE was see under ATROPINE 1975-77", "HN": "78(75); was see under ATROPINE 1975-77, was see under TROPANES 1969-74", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D001286"}, {"RECTYPE": "D", "MH": "Attachment Sites, Microbiological", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Phage Attachment Sites|T114|NON|NRW|NLM (1992)|901109|abcdef", "ENTRY": "Phage Attachment Site", "MN": "G05.360.340.024.079", "FX": "Virus Integration", "MH_TH": "NLM (1991)", "ST": "T123", "AN": "do not confuse with VIRUS ATTACHMENT or RECEPTORS, VIRUS", "PI": "Recombination, Genetic (1968-1979)", "MS": "Specific loci on both the bacterial DNA (attB) and the phage DNA (attP) which delineate the sites where recombination takes place between them, as the phage DNA becomes integrated (inserted) into the BACTERIAL DNA during LYSOGENY.", "PM": "2006; see ATTACHMENT SITES (MICROBIOLOGY) 1991-2006, see LYSOGENY 1980-1990", "HN": "2006 (1980)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D001287"}, {"RECTYPE": "D", "MH": "Attention", "AQ": "CL DE PH RE", "PRINT ENTRY": "Social Attention|T041|NON|NRW|NLM (2021)|200118|abcdef", "ENTRY": "Selective Attentions", "MN": "F02.830.104.214", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "Focusing on certain aspects of current experience to the exclusion of others. It is the act of heeding or taking notice or concentrating.", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001288"}, {"RECTYPE": "D", "MH": "Attention Deficit Disorder with Hyperactivity", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Minimal Brain Dysfunction|T048|NON|BRD|UNK (19XX)|800521|abcdef", "ENTRY": "Syndromes, Hyperkinetic", "MN": "F03.625.094.150", "MH_TH": "NLM (1969)", "ST": "T048", "AN": "not confined to children; do not confuse with HYPERKINESIS; may appear in the literature as ADDH or ADHD", "PI": "Brain Damage, Chronic (1966-1968)", "MS": "A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late   adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)", "OL": "use ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY to search HYPERKINETIC SYNDROME 1981-83 & MINIMAL BRAIN DYSFUNCTION 1969-80 (as Prov 1969-72)", "PM": "84; was HYPERKINETIC SYNDROME 1981-83; was MINIMAL BRAIN DYSFUNCTION 1973-80", "HN": "84; was HYPERKINETIC SYNDROME 1981-83; was MINIMAL BRAIN DYSFUNCTION 1969-80 (Prov 1969-72)", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001289"}, {"RECTYPE": "D", "MH": "Attitude", "AQ": "EH", "PRINT ENTRY": "Sentiment|T041|NON|REL|NLM (2022)|210318|abcdef", "ENTRY": "Sentiments", "MN": "F01.100", "FX": "Set, Psychology", "MH_TH": "POPLINE (1978)", "ST": "T041", "MS": "An enduring, learned predisposition to behave in a consistent way toward a given class of objects, or a persistent mental and/or neural state of readiness to react to a certain class of objects, not as they are but as they are conceived to be.", "PM": "65; was see under BEHAVIOR 1963-64", "HN": "65(64); was see under BEHAVIOR 1963-64", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001290"}, {"RECTYPE": "D", "MH": "Attitude of Health Personnel", "AQ": "EH", "ENTRY": "Staff Attitudes", "MN": "N05.300.100", "MH_TH": "NLM (1968)", "ST": "T041", "PI": "Attitude (1966-1967)", "MS": "Attitudes of personnel toward their patients, other professionals, toward the medical care system, etc.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001291"}, {"RECTYPE": "D", "MH": "Attitude to Computers", "AQ": "EH", "ENTRY": "to Computers, Attitude", "MN": "F01.100.100", "MH_TH": "NLM (1987)", "ST": "T041", "AN": "/ethnol permitted", "MS": "The attitude and behavior associated with an individual using the computer.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D001292"}, {"RECTYPE": "D", "MH": "Attitude to Death", "AQ": "EH", "ENTRY": "Death, Attitudes to", "MN": "N05.300.125", "MH_TH": "NLM (1974)", "ST": "T041", "MS": "Conceptual response of the person to the various aspects of death, which are based on individual psychosocial and cultural experience.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001293"}, {"RECTYPE": "D", "MH": "Attitude to Health", "AQ": "EH", "ENTRY": "Health, Attitude to", "MN": "N05.300.150", "FX": "Sick Role", "MH_TH": "NLM (1968)", "ST": "T054", "AN": "includes attitude to disease", "PI": "Attitude (1966-1967)", "MS": "Public attitudes toward health, disease, and the medical care system.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001294"}, {"RECTYPE": "D", "MH": "Atypical Bacterial Forms", "DE": "ATYPICAL BACT FORMS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Bacterial Forms, Atypical|T007|NON|EQV|NLM (1992)|901102|BACT FORMS ATYPICAL|abcdefv", "MN": "B05.110", "MH_TH": "NLM (1975)", "ST": "T007", "PI": "Bacteria (1966-1974)", "MS": "Microorganisms that have undergone greater changes than normal in morphology, physiology, or cultural characteristics.", "PM": "75", "HN": "75", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D001295"}, {"RECTYPE": "D", "MH": "Audiovisual Aids", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Visual Aids|T073|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Visual Aid", "MN": "L01.462.500.820.090", "MH_TH": "POPLINE (1978)", "ST": "T073", "AN": "TEACHING MATERIALS is also available", "MS": "Auditory and visual instructional materials.", "PM": "96; was AUDIO-VISUAL AIDS 1963-95", "HN": "96; was AUDIO-VISUAL AIDS 1963-95", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D001296"}, {"RECTYPE": "D", "MH": "Audioanalgesia", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Audioanalgesias", "MN": "E03.091.214", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Method of pain control in which auditory stimulation including music, white noise, and environmental sounds are used.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001297"}, {"RECTYPE": "D", "MH": "Audiology", "DE": "AUDIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.010.150", "FX": "Otolaryngology", "MH_TH": "NLM (1978)", "ST": "T091", "AN": "use for the specialty only; do not confuse with HEARING (physiologic process) or HEARING TESTS or AUDIOMETRY (a specific type of hearing test); AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION is also available", "PI": "Hearing (1966-1977)", "MS": "Allied medical specialty that studies hearing and hearing impairment.", "OL": "search HEARING 1966-74", "PM": "78; was see under HEARING 1963-74", "HN": "78; was see under HEARING 1963-74", "MR": "20160705", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D001298"}, {"RECTYPE": "D", "MH": "Audiometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Audiometries", "MN": "E01.370.382.375.060", "FX": "Acoustic Impedance Tests", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "The testing of the acuity of the sense of hearing to determine the thresholds of the lowest intensity levels at which an individual can hear a set of tones. The frequencies between 125 and 8000 Hz are used to test air conduction thresholds and the frequencies between 250 and 4000 Hz are used to test bone conduction thresholds.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001299"}, {"RECTYPE": "D", "MH": "Audiometry, Evoked Response", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Evoked Response Audiometry|T060|NON|EQV|UNK (19XX)|790221|abcdef", "ENTRY": "Response Audiometry, Evoked", "MN": "E01.370.382.375.060.050", "FX": "Evoked Potentials, Auditory, Brain Stem", "MH_TH": "NLM (1980)", "ST": "T060", "PI": "Evoked Potentials (1967-1979)", "MS": "A form of electrophysiologic audiometry in which an analog computer is included in the circuit to average out ongoing or spontaneous brain wave activity. A characteristic pattern of response to a sound stimulus may then become evident. Evoked response audiometry is known also as electric response audiometry.", "PM": "86; was see under AUDIOMETRY 1980-85", "HN": "86(80); was see under AUDIOMETRY 1980-85", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19790221", "DC": "1", "DX": "19860101", "UI": "D001300"}, {"RECTYPE": "D", "MH": "Audiometry, Pure-Tone", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Audiometry, Bekesy|T060|EPO|NRW|UNK (19XX)|781214|abcdef", "ENTRY": "Pure-Tone Audiometry", "MN": "E01.370.382.375.060.055", "MH_TH": "NLM (1980)", "ST": "T060", "PI": "Audiometry (1966-1979)", "MS": "Measurement of hearing based on the use of pure tones of various frequencies and intensities as auditory stimuli.", "PM": "91; was see under AUDIOMETRY 1980-90", "HN": "91(80); was see under AUDIOMETRY 1980-90", "CATSH": "CAT LIST", "MR": "20010813", "DA": "19781214", "DC": "1", "DX": "19910101", "UI": "D001301"}, {"RECTYPE": "D", "MH": "Audiometry, Speech", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Speech Audiometry", "MN": "E01.370.382.375.060.060", "MH_TH": "NLM (1980)", "ST": "T060", "PI": "Speech (1966-1979)", "MS": "Measurement of the ability to hear speech under various conditions of intensity and noise interference using sound-field as well as earphones and bone oscillators.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19781214", "DC": "1", "DX": "19800101", "UI": "D001302"}, {"RECTYPE": "D", "MH": "Auditory Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Heschl's Gyrus|T023|NON|NRW|NLM (2022)|201009|abcdef", "ENTRY": "Transverse Temporal Gyrus", "MN": "A08.186.211.200.885.287.500.863.297", "FX": "Auditory Diseases, Central", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "diseases: coordinate with AUDITORY DISEASES, CENTRAL", "PI": "Hearing (1966-1967)", "MS": "The region of the cerebral cortex that receives the auditory radiation from the MEDIAL GENICULATE BODY.", "PM": "70", "HN": "70(68)", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D001303"}, {"RECTYPE": "D", "MH": "Auditory Diseases, Central", "DE": "AUDITORY DIS CENTRAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Central Auditory Diseases|T047|NON|EQV|NLM (2000)|991103|CENTRAL AUDITORY DIS|abcdefv", "ENTRY": "Dysfunctions, Central Auditory", "MN": "C10.228.140.068", "MH_TH": "NLM (1980)", "ST": "T047", "MS": "Disorders of hearing or auditory perception due to pathological processes of the AUDITORY PATHWAYS in the CENTRAL NERVOUS SYSTEM. These include CENTRAL HEARING LOSS and AUDITORY PERCEPTUAL DISORDERS.", "PM": "1980", "HN": "1980", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19781222", "DC": "1", "DX": "19800101", "UI": "D001304"}, {"RECTYPE": "D", "MH": "Auditory Fatigue", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Temporary Threshold Shift, Auditory|T041|NON|REL|UNK (19XX)|781214|abcdef", "ENTRY": "Fatigues, Auditory", "MN": "G07.888.125.173.095", "MH_TH": "NLM (1980)", "ST": "T041", "PI": "Hearing (1966-1967)", "MS": "Loss of sensitivity to sounds as a result of auditory stimulation, manifesting as a temporary shift in auditory threshold. The temporary threshold shift, TTS, is expressed in decibels.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19781214", "DC": "1", "DX": "19800101", "UI": "D001305"}, {"RECTYPE": "D", "MH": "Auditory Pathways", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Pathways, Auditory", "MN": "A08.612.220.110", "FX": "Auditory Diseases, Central", "MH_TH": "NLM (1971)", "ST": "T023", "AN": "diseases: coordinate with AUDITORY DISEASES, CENTRAL", "PI": "Central Nervous System (1966-1970)", "MS": "NEURAL PATHWAYS and connections within the CENTRAL NERVOUS SYSTEM, beginning at the hair cells of the ORGAN OF CORTI, continuing along the eighth cranial nerve, and terminating at the AUDITORY CORTEX.", "PM": "72", "HN": "72(71)", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001306"}, {"RECTYPE": "D", "MH": "Auditory Perception", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Auditory Processing|T041|NON|EQV|NLM (2021)|200103|abcdef", "ENTRY": "Processing, Auditory", "MN": "G07.888.125", "FX": "Auditory Perceptual Disorders", "MH_TH": "NLM (1967)", "ST": "T041", "AN": "differentiate from HEARING: auditory perception takes place in the brain, hearing takes place in the ear", "PI": "Perception (1966)", "MS": "The process whereby auditory stimuli are selected, organized, and interpreted by the organism.", "PM": "68", "HN": "68(67)", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001307"}, {"RECTYPE": "D", "MH": "Auditory Perceptual Disorders", "DE": "AUDITORY PERCEPTUAL DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Perceptual Disorders, Auditory|T048|NON|EQV|NLM (2000)|991103|PERCEPTUAL DIS AUDITORY|abcdefv", "ENTRY": "Psychoacoustical Disorder", "MN": "F03.615.250.100", "FX": "Auditory Perception", "MH_TH": "ORD (2010)", "ST": "T048", "PI": "Perceptual Disorders (1969-1979)", "MS": "Acquired or developmental cognitive disorders of AUDITORY PERCEPTION characterized by a reduced ability to perceive information contained in auditory stimuli despite intact auditory pathways. Affected individuals have difficulty with speech perception, sound localization, and comprehending the meaning of inflections of speech.", "PM": "91; was see under PERCEPTUAL DISORDERS 1980-90", "HN": "91(80); was see under PERCEPTUAL DISORDERS 1980-90", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19781214", "DC": "1", "DX": "19910101", "UI": "D001308"}, {"RECTYPE": "D", "MH": "Auditory Threshold", "AQ": "CL DE ES PH RE", "ENTRY": "Thresholds, Auditory", "MN": "G07.888.125.173", "FX": "Audiometry", "MH_TH": "NLM (1968)", "ST": "T081", "PI": "Hearing (1966-1967)", "MS": "The audibility limit of discriminating sound intensity and pitch.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001309"}, {"RECTYPE": "D", "MH": "Auranofin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SK&F39162", "MN": "D02.691.675.249.150", "PA": "Antirheumatic Agents", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "Gold, (1-thio-beta-D-glucopyranose 2,3,4,6-tetraacetato-S)(triethylphosphine)-", "RN": "3H04W2810V", "RR": "34031-32-8 (Auranofin)", "PI": "Gold Thioglucose/analogs & derivatives (1975-1986)", "MS": "An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.", "PM": "87", "HN": "87", "MR": "20160705", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D001310"}, {"RECTYPE": "D", "MH": "Aurintricarboxylic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aurintricarboxylate|T109|T121|T130|NON|NRW|UNK (19XX)|741111|abbbcdef", "ENTRY": "Acid, Aurintricarboxylic", "MN": "D02.241.223.268.070", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy-", "RN": "4431-00-9", "RR": "93480-02-5 (Ca (1:3) salt)", "PI": "Phenols (1972-1974)", "MS": "A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues.", "PM": "91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90", "HN": "91(75); was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90", "MR": "20000621", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001312"}, {"RECTYPE": "D", "MH": "Aurovertins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Aurovertin|T109|T123|T130|NON|EQV|UNK (19XX)|790223|abbbcdef", "MN": "D03.383.663.075", "PA": "Uncoupling Agents", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "0", "PI": "Antibiotics (1968-1974)", "MS": "Very toxic and complex pyrone derivatives from the fungus Calcarisporium arbuscula. They bind to and inhibit mitochondrial ATPase, thereby uncoupling oxidative phosphorylation. They are used as biochemical tools.", "OL": "use AUROVERTINS to search AUROVERTIN 1975-79", "PM": "91; was see under PYRANS 1980-90; was AUROVERTIN see under ANTIBIOTICS 1975-79", "HN": "91(80); was see under PYRANS 1980-90; was AUROVERTIN see under ANTIBIOTICS 1975-79", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001313"}, {"RECTYPE": "D", "MH": "Auscultation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Auscultations", "MN": "E01.370.600.060", "FX": "Stethoscopes", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "/instrum: STETHOSCOPES is also available", "MS": "Act of listening for sounds within the body.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001314"}, {"RECTYPE": "D", "MH": "Australia", "AQ": "EH EP", "ENTRY": "Christmas Island (Australia)|T083|NAM|NRW|POPLINE (1983)|861231|abcdef", "MN": "Z01.678.100.373", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "each of the states is available; do not confuse with AUSTRALASIA", "MS": "The smallest continent and an independent country, comprising six states and two territories. Its capital is Canberra.", "MR": "20150623", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001315"}, {"RECTYPE": "D", "MH": "Austria", "AQ": "EH EP", "MN": "Z01.542.088", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country located in Central Europe, north of Italy and Slovenia. The capital is Vienna.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001317"}, {"RECTYPE": "D", "MH": "Authoritarianism", "ENTRY": "Authoritarianisms", "MN": "F01.752.098", "MH_TH": "BIOETHICS (1993)", "ST": "T055", "MS": "The personality pattern or syndrome consisting of behavioral and attitudinal characteristics reflecting a preoccupation with the factors of power and authority in interpersonal relationships.", "CATSH": "CAT LIST", "MR": "19950523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001318"}, {"RECTYPE": "D", "MH": "Authorship", "AQ": "HI ST", "ENTRY": "Authorships", "MN": "L01.559.423.906.215", "FX": "Plagiarism", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "do not confuse with WRITING or PUBLISHING", "MS": "The profession of writing. Also the identity of the writer as the creator of a literary production.", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001319"}, {"RECTYPE": "D", "MH": "Autistic Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Kanner's Syndrome|T048|EPO|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Kanners Syndrome", "MN": "F03.625.164.113.500", "MH_TH": "NLM (1971)", "ST": "T048", "PI": "Schizophrenia, Childhood (1966-1970)", "MS": "A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)", "OL": "use AUTISM, INFANTILE to search AUTISM, EARLY INFANTILE 1971-80; use SCHIZOPHRENIA, CHILDHOOD 1968-70", "PM": "1999; see AUTISM INFANTILE 1981-1998; see AUTISM, EARLY INFANTILE 1971-1980; see SCHIZOPHRENIA, CHILDHOOD 1968-1970; AUTISM was heading 1966-1998", "HN": "1981(1966)", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D001321"}, {"RECTYPE": "D", "MH": "Autoanalysis", "DE": "AUTOANAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Autoanalyses", "MN": "E05.059", "MH_TH": "NLM (1967)", "ST": "T059", "AN": "NIM", "PI": "Computers (1966)", "MS": "Method of analyzing chemicals using automation.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001322"}, {"RECTYPE": "D", "MH": "Autoantibodies", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Autoantibody|T129|NON|EQV|NLM (2023)|210924|abcdef", "MN": "D12.776.377.715.548.114.323", "PA": "Immunologic Factors", "FX": "Autoimmunity", "MH_TH": "POPLINE (1984)", "ST": "T129", "RN": "0", "AN": "do not confuse with ANTIBODIES, ANTI-IDIOTYPIC", "MS": "Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001323"}, {"RECTYPE": "D", "MH": "Autoantigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Self-Antigens|T129|NON|EQV|NLM (2001)|000516|abcdef", "ENTRY": "Self Antigens", "MN": "D23.050.422", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "PI": "Antigens (1966-1972)", "MS": "Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response.", "PM": "87; was see under ANTIGENS 1973-86", "HN": "87(73); was see under ANTIGENS 1973-86", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D001324"}, {"RECTYPE": "D", "MH": "Autobiographies as Topic", "PRINT ENTRY": "Autobiography as Topic|T170|NON|EQV|NLM (2011)|100425|abcdef", "ENTRY": "as Topic, Autobiographies", "MN": "K01.517.211.215", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "use only for autobiography as a subject; for autobiographies of persons use the Publication Type AUTOBIOGRAPHY", "MS": "Works about self-described narratives of a person's life.", "PM": "2011; see AUTOBIOGRAPHY 1963-2010", "HN": "2011 (1963)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "20110101", "UI": "D001325"}, {"RECTYPE": "D", "MH": "Autogenic Training", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Training, Autogenic", "MN": "F04.754.424.386", "MH_TH": "NLM (1963)", "ST": "T061", "AN": "a psychother technique", "MS": "Technique based on muscle relaxation during self-hypnotic exercises. It is used in conjunction with psychotherapy.", "PM": "66", "HN": "66(63)", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001326"}, {"RECTYPE": "D", "MH": "Autoimmune Diseases", "DE": "AUTOIMMUNE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Autoimmune", "MN": "C20.111", "FX": "Autoimmunity", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM is available", "MS": "Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001327"}, {"RECTYPE": "D", "MH": "Autolysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Autolyses", "MN": "C23.550.260.224.617.236", "MH_TH": "NLM (1968)", "ST": "T046", "AN": "restrict to humans and higher animals; BACTERIOLYSIS is also available", "PI": "Postmortem Changes (1966-1967)", "MS": "The spontaneous disintegration of tissues or cells by the action of their own autogenous enzymes.", "PM": "72", "HN": "72(68)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001329"}, {"RECTYPE": "D", "MH": "Electronic Data Processing", "AQ": "CL EC ES HI IS LJ MT OG SD SN ST TD", "PRINT ENTRY": "Optical Readers|T073|NON|REL|UNK (19XX)|860618|abcdef", "ENTRY": "Processing, Information", "MN": "L01.224.085", "MH_TH": "UNK (19XX)", "ST": "T066", "AN": "general or unspecified only; prefer specific informatics & computer terms", "MS": "Applications that store and process large quantities of data.", "PM": "2019; see AUTOMATIC DATA PROCESSING 1966-2018", "HN": "2019(1996)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001330"}, {"RECTYPE": "D", "MH": "Automation", "AQ": "CL EC ES HI IS LJ MT SN ST", "ENTRY": "Automations", "MN": "J01.897.104", "MH_TH": "NLM (1966)", "ST": "T066", "MS": "Controlled operation of an apparatus, process, or system by mechanical or electronic devices that take the place of human organs of observation, effort, and decision. (From Webster's Collegiate Dictionary, 1993)", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001331"}, {"RECTYPE": "D", "MH": "Automatism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "MN": "F02.463.425.179.149", "MH_TH": "NLM (1966)", "ST": "T055", "MS": "Automatic, mechanical, and apparently undirected behavior which is outside of conscious control.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001332"}, {"RECTYPE": "D", "MH": "Automobile Driver Examination", "DE": "AUTO DRIVER EXAM", "AQ": "HI LJ PX SN", "ENTRY": "Examinations, Automobile Driver", "MN": "I03.125.299", "MH_TH": "NLM (1966)", "ST": "T064", "MS": "Government required written and driving test given to individuals prior to obtaining an operator's license.", "MR": "19940512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001333"}, {"RECTYPE": "D", "MH": "Automobile Driving", "AQ": "ED LJ PX SN ST", "ENTRY": "Drivings, Automobile", "MN": "I03.125", "FX": "Motor Vehicles", "MH_TH": "NLM (1964)", "ST": "T056", "MS": "The effect of environmental or physiological factors on the driver and driving ability. Included are driving fatigue, and the effect of drugs, disease, and physical disabilities on driving.", "PM": "67", "HN": "67(64)", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001334"}, {"RECTYPE": "D", "MH": "Vehicle Emissions", "AQ": "AN LJ PC PO TO", "PRINT ENTRY": "Vehicular Emission|T131|NON|EQV|NLM (2021)|200210|abcdef", "ENTRY": "Traffic Related Pollutants", "MN": "D20.832", "PA": "Air Pollutants", "FX": "Traffic-Related Pollution", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "MS": "Gases, fumes, vapors, and ODORANTS escaping from the cylinders of a gasoline or diesel internal-combustion engine. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed & Random House Unabridged Dictionary, 2d ed)", "PM": "96; was AUTOMOBILE EXHAUST 1963-95", "HN": "96; was AUTOMOBILE EXHAUST 1963-95; was in Cat G only 1968-74, was in Cat G & J 1963-67", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D001335"}, {"RECTYPE": "D", "MH": "Automobiles", "AQ": "CL EC ES HI LJ SN ST", "PRINT ENTRY": "Cars|T073|NON|EQV|NLM (2020)|190503|abcdef", "ENTRY": "Car", "MN": "J01.937.500.100", "FX": "Seat Belts", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "A usually four-wheeled automotive vehicle designed for passenger transportation.", "MR": "20190510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001336"}, {"RECTYPE": "D", "MH": "Autonomic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Autonomic", "MN": "D27.505.696.663.050", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; note entry term AUTONOMIC EFFECT: use only for the autonomic effect of a chemical substance", "MS": "Agents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc.", "OL": "use AUTONOMIC AGENTS to search AUTONOMIC DRUGS 1966-81", "PM": "82; was AUTONOMIC DRUGS 1963-81", "HN": "82; was AUTONOMIC DRUGS 1963-81", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19820101", "UI": "D001337"}, {"RECTYPE": "D", "MH": "Autonomic Fibers, Postganglionic", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Postganglionic Autonomic Fibers", "MN": "A11.671.501.100", "MH_TH": "NLM (1971)", "ST": "T023", "AN": "do not confuse with AUTONOMIC FIBERS, PREGANGLIONIC", "PI": "Ganglia, Autonomic (1966-1970)", "MS": "Nerve fibers which project from cell bodies of AUTONOMIC GANGLIA to SYNAPSES on target organs.", "PM": "71", "HN": "71", "MR": "19930618", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D001338"}, {"RECTYPE": "D", "MH": "Autonomic Fibers, Preganglionic", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Preganglionic Autonomic Fibers", "MN": "A11.671.501.234.060", "MH_TH": "NLM (1971)", "ST": "T023", "AN": "do not confuse with AUTONOMIC FIBERS, POSTGANGLIONIC", "PI": "Ganglia, Autonomic (1966-1970)", "MS": "NERVE FIBERS which project from the central nervous system to AUTONOMIC GANGLIA. In the sympathetic division most preganglionic fibers originate with neurons in the intermediolateral column of the SPINAL CORD, exit via ventral roots from upper thoracic through lower lumbar segments, and project to the paravertebral ganglia; there they either terminate in SYNAPSES or continue through the SPLANCHNIC NERVES to the prevertebral ganglia. In the parasympathetic division the fibers originate in neurons of the BRAIN STEM and sacral spinal cord. In both divisions the principal transmitter is ACETYLCHOLINE but peptide cotransmitters may also be released.", "PM": "71", "HN": "71", "MR": "20160418", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D001339"}, {"RECTYPE": "D", "MH": "Autonomic Nerve Block", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Sympathetic Nerve Block|T061|NON|REL|UNK (19XX)|810227|abcdef", "ENTRY": "Sympathetic Nerve Blocks", "MN": "E04.525.210.550.500", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "NERVE BLOCK is also available; coordinate with substance used to induce the block with no qualifiers if particularly discussed", "MS": "Interruption of sympathetic pathways, by local injection of an anesthetic agent, at any of four levels: peripheral nerve block, sympathetic ganglion block, extradural block, and subarachnoid block.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001340"}, {"RECTYPE": "D", "MH": "Autonomic Nervous System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Visceral Nervous Systems", "MN": "A08.800.050", "FX": "Visceral Afferents", "MH_TH": "NLM (1966)", "ST": "T022", "MS": "The ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS.", "MR": "19930621", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001341"}, {"RECTYPE": "D", "MH": "Autonomic Nervous System Diseases", "DE": "AUTONOMIC NERVOUS SYSTEM DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sympathetic Nervous System Diseases|T047|NON|NRW|NLM (2000)|991108|SYMPATHETIC NERVOUS SYSTEM DIS|abcdefv", "ENTRY": "Segmental Autonomic Dysfunctions", "MN": "C10.177", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Nervous System Diseases (1966-1980)", "MS": "Diseases of the AUTONOMIC NERVOUS SYSTEM, including sympathetic, parasympathetic, and enteric nervous systems.", "PM": "1981; was AUTONOMIC SYSTEM DISEASES (NON MESH) before 1981, for DYSAUTONOMIA see AUTONOMIC NERVOUS SYSTEM DISEASES 1989-2008, PRIMARY DYSAUTONOMIAS 2009-2022", "HN": "1981; was AUTONOMIC SYSTEM DISEASES (NON MESH) before 1981, for DYSAUTONOMIA use AUTONOMIC NERVOUS SYSTEM DISEASES 1989-2008, PRIMARY DYSAUTONOMIAS 2009-2022", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D001342"}, {"RECTYPE": "D", "MH": "Autophagy", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Ribophagy|T043|NON|NRW|NLM (2020)|190328|abcdef", "ENTRY": "ER Phagy", "MN": "G04.011", "MH_TH": "NLM (2006)", "ST": "T043", "AN": "general or unspecified; note specifics; do not confuse with AUTOPHAGIC CELL DEATH, a form of regulated cell death", "PI": "Phagocytosis (1966-1978)", "MS": "The segregation and degradation of various cytoplasmic constituents via engulfment by MULTIVESICULAR BODIES; VACUOLES; or AUTOPHAGOSOMES and their digestion by LYSOSOMES. It plays an important role in BIOLOGICAL METAMORPHOSIS and in the removal of bone by OSTEOCLASTS. Defective autophagy is associated with various diseases, including NEURODEGENERATIVE DISEASES and cancer.", "PM": "2006; see AUTOPHAGOCYTOSIS 1991-2005, PHAGOCYTOSIS 1979-1990", "HN": "2006(1979)", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19780320", "DC": "1", "DX": "19910101", "UI": "D001343"}, {"RECTYPE": "D", "MH": "Autopsy", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Postmortem Examinations", "MN": "I01.198.780.937.120", "MH_TH": "NLM (1994)", "ST": "T060", "MS": "Postmortem examination of the body.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001344"}, {"RECTYPE": "D", "MH": "Autoradiography", "DE": "AUTORADIOGR", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Radioautography|T059|NON|EQV|UNK (19XX)|740329|RADIOAUTOGR|abcdefv", "MN": "E05.799.256", "MH_TH": "NLM (1973)", "ST": "T059", "MS": "The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed)", "OL": "use AUTORADIOGRAPHY to search RADIOAUTOGRAPHY 1966-72", "PM": "73; was RADIOAUTOGRAPHY 1963-72", "HN": "73; was RADIOAUTOGRAPHY 1963-72", "CATSH": "CAT LIST", "MR": "20160311", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001345"}, {"RECTYPE": "D", "MH": "Autosuggestion", "ENTRY": "Autosuggestions", "MN": "F04.754.424.771.299", "MH_TH": "NLM (1975)", "ST": "T041", "MS": "Suggestion coming from the subject himself.", "OL": "search SUGGESTION 1966-74", "PM": "91; was see under SUGGESTION 1975-90", "HN": "91(75); was see under SUGGESTION 1975-90", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001346"}, {"RECTYPE": "D", "MH": "Aversive Therapy", "DE": "AVERSIVE THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapies, Aversive", "MN": "F04.754.137.174", "MH_TH": "NLM (1970)", "ST": "T061", "PI": "Behavior Therapy (1966-1969)", "MS": "A treatment that suppresses undesirable behavior by simultaneously exposing the subject to unpleasant consequences.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "19950531", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D001348"}, {"RECTYPE": "D", "MH": "Encephalomyelitis Virus, Avian", "DE": "ENCEPH VIRUS AVIAN", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Epidemic Tremor Virus|T005|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Avian Encephalomyelitis-like Virus", "MN": "B04.820.578.750.227", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid70796", "AN": "infection: coord IM with PICORNAVIRIDAE INFECTIONS (IM)", "MS": "A tentative species in the genus HEPATOVIRUS infecting primarily young chicks, but also found in turkeys, pheasants, and guinea fowl. It causes a fatal neuronal degeneration and is transmitted by mechanical contact.", "OL": "use ENCEPHALOMYELITIS VIRUS, AVIAN to search AVIAN ENCEPHALOMYELITIS VIRUS 1975-93", "PM": "94; was AVIAN ENCEPHALOMYELITIS VIRUS 1975-93 (see under ENTEROVIRUSES 1975-90)", "HN": "94; was AVIAN ENCEPHALOMYELITIS VIRUS 1975-93 (see under ENTEROVIRUSES 1975-90)", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001350"}, {"RECTYPE": "D", "MH": "Infectious bronchitis virus", "DE": "INFECT BRONCHITIS VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Avian Infectious Bronchitis Virus|T005|NON|EQV|NLM (1994)|921117|AVIAN INFECT BRONCHITIS VIRUS|abcdefv", "ENTRY": "bronchitis viruses, Infectious", "MN": "B04.820.578.500.540.150.400.750", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11120", "AN": "infection: coord IM with CORONAVIRUS INFECTIONS (IM)", "MS": "A species of CORONAVIRUS causing infections in chickens and possibly pheasants. Chicks up to four weeks old are the most severely affected.", "PM": "2002; see INFECTIOUS BRONCHITIS VIRUS, AVIAN 1994-2001, see AVIAN INFECTIOUS BRONCHITIS VIRUS 1991-1993, see CORONAVIRIDAE 1981-1990, see CORONAVIRUSES 1975-1980", "HN": "2002 (1975)", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001351"}, {"RECTYPE": "D", "MH": "Herpesvirus 1, Gallid", "DS": "HERPESVIRUS GALLID 01", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Avian Infectious Laryngotracheitis Virus|T005|NON|EQV|NLM (1994)|930302|AVIAN INFECT LARYNGOTRACHEITIS VIRUS|abcdefv", "ENTRY": "Infectious Laryngotracheitis Virus, Avian|T005|NON|EQV|NLM (1994)|930325|INFECT LARYNGOTRACHEITIS VIRUS AVIAN|abcdefv", "MN": "B04.280.382.100.374.450", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid10386", "AN": "do not confuse with HERPESVIRUS 2, GALLID; infection: coord IM with HERPESVIRIDAE INFECTIONS (IM)", "MS": "The type species of the genus ILTOVIRUS found on every continent and affecting mainly chickens and occasionally pheasants.", "OL": "use HERPESVIRUS 1, GALLID to search AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS 1975-93", "PM": "94; was AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80)", "HN": "94; was AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D001352"}, {"RECTYPE": "D", "MH": "Avian Leukosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Leukosis, Avian|T050|T191|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Leukoses, Avian", "MN": "C22.131.094", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "don't forget also BIRDS (NIM) or specific bird (IM) & check tag ANIMALS", "MS": "A group of transmissible viral diseases of chickens and turkeys. Liver tumors are found in most forms, but tumors can be found elsewhere.", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001353"}, {"RECTYPE": "D", "MH": "Avian Leukosis Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Rous-Associated Virus|T005|EPO|REL|UNK (19XX)|750101|abcdef", "ENTRY": "Viruses, Avian Lymphomatosis", "MN": "B04.820.650.070.100", "MH_TH": "NLM (2016)", "ST": "T005", "RN": "txid11864", "RR": "txid11865", "MS": "The type species of ALPHARETROVIRUS producing latent or manifest lymphoid leukosis in fowl.", "PM": "2007; see LEUKOSIS VIRUS, AVIAN 1994-2006, see AVIAN LEUKOSIS VIRUSES 1975-1993, see AVIAN LEUKOSIS VIRUS 1963-1974; for LEUKEMIA VIRUS, AVIAN see AVIAN LEUKOSIS VIRUSES 1978-1993; for LEUKEMIA VIRUS, AVIAN & LYMPHOMATOSIS VIRUS, AVIAN see AVIAN LEUKOSIS VIRUSES 1975-1977, see AVIAN LEUKOSIS VIRUS 1963-1974", "HN": "2007, 1963-1974", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D001354"}, {"RECTYPE": "D", "MH": "Alpharetrovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Type C Avian Retroviruses|T005|NON|EQV|NLM (1997)|960326|abcdef", "ENTRY": "Viruses, Avian Leukosis-Sarcoma", "MN": "B04.820.650.070", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid153057", "RR": "txid11861", "AN": "infection: coordinate IM with AVIAN LEUKOSIS (IM) or SARCOMA, AVIAN (IM), but if not so specified coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) if pertinent; index also BIRDS or POULTRY (NIM) or specific bird or fowl (IM)", "MS": "A genus of the family RETROVIRIDAE with type C morphology, that causes malignant and other diseases in wild birds and domestic fowl.", "PM": "2002; see RETROVIRUSES TYPE C, AVIAN 1997-2001, see RETROVIRUSES, ALV-RELATED 1994-1996, see AVIAN LEUKOSIS-SARCOMA VIRUSES 1966-1993; for RETROVIRUSES TYPE C, AVIAN see RETROVIRUSES TYPE C, AVIAN 1997-2001, see RETROVIRUSES, ALV-RELATED 1994-1996; for AVIAN ERYTHROBLASTOSIS VIRUS see ERYTHROBLASTOSIS VIRUS, AVIAN 1991-2006, see AVIAN LEUKOSIS VIRUSES 1975-1990, see AVIAN LEUKOSIS VIRUS 1963-1974", "HN": "2002 (1966)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001355"}, {"RECTYPE": "D", "MH": "Reticuloendotheliosis virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "T Virus|T005|NON|NRW|UNK (19XX)|741111|abcdef", "ENTRY": "Virus, T", "MN": "B04.820.650.375.700.700", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11636", "AN": "do not confuse entry term T VIRUS with T-PHAGES; infection: coord IM with RETROVIRIDAE INFECTIONS (IM) and TUMOR VIRUS INFECTIONS (IM)", "MS": "A species in the group RETICULOENDOTHELIOSIS VIRUSES, AVIAN of the genus GAMMARETROVIRUS that causes a chronic neoplastic and a more acute immunosuppressive disease in fowl.", "PM": "2002; see RETICULOENDOTHELIOSIS VIRUS, AVIAN 1994-2001, see AVIAN RETICULOENDOTHELIOSIS VIRUS 1991-1993, see RETROVIRIDAE 1981-1990, see LEUKOVIRUSES 1978-1980, see LEUKEMOGENIC VIRUSES 1975-1977", "HN": "2002 (1975)", "MR": "20200902", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001356"}, {"RECTYPE": "D", "MH": "Sarcoma, Avian", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "PRINT ENTRY": "Sarcoma, Rous|T050|T191|EPO|REL|UNK (19XX)|740330|abbcdef", "ENTRY": "Sarcomas, Avian", "MN": "C22.131.800", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "don't forget also BIRDS or POULTRY (NIM) or specific bird or fowl (IM)", "MS": "Connective tissue tumors, affecting primarily fowl, that are usually caused by avian sarcoma viruses.", "OL": "use SARCOMA, AVIAN to search AVIAN SARCOMA 1983-93 & ROUS SARCOMA 1966-82", "PM": "94; was AVIAN SARCOMA 1983-93; was ROUS SARCOMA 1963-82", "HN": "94; was AVIAN SARCOMA 1983-93; was ROUS SARCOMA 1963-82", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D001357"}, {"RECTYPE": "D", "MH": "Avian Sarcoma Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Sarcoma Viruses, Avian|T005|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "viruses, Fujinami sarcoma", "MN": "B04.820.650.070.120", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11876", "RR": "txid11885", "AN": "infection: coordinate IM with SARCOMA, AVIAN (IM) + BIRDS or POULTRY (NIM) or specific bird or fowl (IM)", "MS": "Group of alpharetroviruses (ALPHARETROVIRUS) producing sarcomata and other tumors in chickens and other fowl and also in pigeons, ducks, and RATS.", "PM": "2007; see SARCOMA VIRUSES, AVIAN 1994-2006, see AVIAN SARCOMA VIRUSES 1983-1993, see ROUS SARCOMA VIRUS 1963-1982; for CHICKEN SARCOMA VIRUS B77 see CHICKEN SARCOMA VIRUS B77 1991-1993, see AVIAN SARCOMA VIRUSES 1983-1990, see ROUS SARCOMA VIRUS 1975-1982", "HN": "2007 (1963); for CHICKEN SARCOMA VIRUS B77 see CHICKEN SARCOMA VIRUS B77 1991-1993, see AVIAN SARCOMA VIRUSES 1983-1990, see ROUS SARCOMA VIRUS 1975-1982", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D001358"}, {"RECTYPE": "D", "MH": "Aviation", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Parachuting|T056|T057|NON|NRW|UNK (19XX)|820429|abbcdef", "ENTRY": "Traffic Control, Air", "MN": "J01.937.285", "FX": "Aircraft", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "for medical, physiological, psychological aspect of flying index AEROSPACE MEDICINE: Manual 28.7", "MS": "Design, development, manufacture, and operation of heavier-than-air AIRCRAFT.", "OL": "use AVIATION to search PARACHUTING 1966-82", "PM": "PARACHUTING was heading 1963-82", "HN": "PARACHUTING was heading 1963-82", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001359"}, {"RECTYPE": "D", "MH": "Avidin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "MN": "D12.776.395.175", "FX": "Biotin", "MH_TH": "NLM (1973)", "ST": "T123", "N1": "Avidins", "RN": "1405-69-2", "MS": "A specific protein in egg albumin that interacts with BIOTIN to render it unavailable to mammals, thereby producing biotin deficiency.", "OL": "search OVALBUMIN 1969-72", "PM": "87; was see under OVALBUMIN 1969-86", "HN": "87(73); was see under OVALBUMIN 1969-86", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D001360"}, {"RECTYPE": "D", "MH": "Avitaminosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vitamin Deficiency|T047|NON|REL|UNK (19XX)|740329|VITAMIN DEFIC|abcdefv", "ENTRY": "Vitamin Deficiencies", "MN": "C18.654.521.500.133", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "includes hypovitaminosis; general or unspecified; prefer specifics; avitaminosis A equals VITAMIN A DEFICIENCY, etc.", "MS": "A condition due to a deficiency of one or more essential vitamins. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001361"}, {"RECTYPE": "D", "MH": "Avoidance Learning", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Aversive Learning|T041|NON|EQV|NLM (2023)|210803|abcdef", "ENTRY": "Learning, Avoidance", "MN": "F02.463.785.373.173", "FX": "Escape Reaction", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "A response to a cue that is instrumental in avoiding a noxious experience.", "CATSH": "CAT LIST", "MR": "20211128", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001362"}, {"RECTYPE": "D", "MH": "Awards and Prizes", "DE": "AWARDS PRIZES", "ENTRY": "Prizes and Awards", "MN": "K01.150", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "awards & prizes in field of medicine: do not coordinate with MEDICINE but coordinate with specific medical specialty or other field ", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001363"}, {"RECTYPE": "D", "MH": "Awareness", "AQ": "CL DE ES PH RE", "ENTRY": "Situational Awarenesses", "MN": "F02.463.188.150", "MH_TH": "NLM (1975)", "ST": "T041", "MS": "The act of \"taking account\" of an object or state of affairs. It does not imply assessment of, nor attention to the qualities or nature of the object.", "PM": "91; was see under COGNITION 1975-90", "HN": "91(75); was see under COGNITION 1975-90", "CATSH": "CAT LIST", "MR": "20150708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001364"}, {"RECTYPE": "D", "MH": "Axilla", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Underarm|T029|NON|EQV|NLM (2016)|150205|abcdef", "MN": "A01.378.800.090", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "Area of the human body underneath the SHOULDER JOINT, also known as the armpit or underarm.", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001365"}, {"RECTYPE": "D", "MH": "Axillary Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Axillary Arteries", "MN": "A07.015.114.085", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The continuation of the subclavian artery; it distributes over the upper limb, axilla, chest and shoulder.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001366"}, {"RECTYPE": "D", "MH": "Axillary Vein", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Axillary", "MN": "A07.015.908.077", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The venous trunk of the upper limb; a continuation of the basilar and brachial veins running from the lower border of the teres major muscle to the outer border of the first rib where it becomes the subclavian vein.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001367"}, {"RECTYPE": "D", "MH": "Axis, Cervical Vertebra", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Epistropheus|T023|T032|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Vertebra Axis, Cervical", "MN": "A02.835.232.834.151.383", "MH_TH": "NLM (2016)", "ST": "T032", "MS": "The second cervical vertebra.", "PM": "2016; see AXIS 1966-2015", "HN": "2016 (1966)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001368"}, {"RECTYPE": "D", "MH": "Axons", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Axon", "MN": "A11.671.501.145", "FX": "Axotomy", "MH_TH": "NLM (1966)", "ST": "T026", "AN": "NERVE FIBERS is available; giant squid axon: coord IM with SQUID (NIM)", "MS": "Nerve fibers that are capable of rapidly conducting impulses away from the neuron cell body.", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001369"}, {"RECTYPE": "D", "MH": "Axonal Transport", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Axoplasmic Transport|T043|NON|EQV|NLM (1996)|941007|abcdef", "ENTRY": "Transports, Axoplasmic", "MN": "G11.561.050", "MH_TH": "NLM (1969)", "ST": "T043", "PI": "Cytoplasmic Streaming (1967-1968)", "MS": "The directed transport of ORGANELLES and molecules along nerve cell AXONS. Transport can be anterograde (from the cell body) or retrograde (toward the cell body). (Alberts et al., Molecular Biology of the Cell, 3d ed, pG3)", "PM": "96; was AXOPLASMIC FLOW 1972-95", "HN": "96; was AXOPLASMIC FLOW 1972-95 (Prov 1969-71)", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001370"}, {"RECTYPE": "D", "MH": "trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride", "DS": "TRANSBISCHLOROBENZAMINOMETHYLCYCLOHEXANE DIHYDROCHLORIDE 01 04 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "AY9944 A 7", "MN": "D02.455.426.392.368.367.900", "PA": "Anticholesteremic Agents", "MH_TH": "NLM (2005)", "ST": "T121", "N1": "1,4-Cyclohexanedimethanamine, N,N'-bis((2-chlorophenyl)methyl)-, dihydrochloride, trans-", "RN": "366-93-8", "PI": "Methylamines (1972-1974)", "MS": "An anti-cholesteremic agent that inhibits delta 7-reductase, delta 14 reductase, and sterol biosynthesis.", "PM": "2005; see AY-9944 1991-2004; see CYCLOHEXANES 1975-1990", "HN": "2005(1975)", "MR": "20151124", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D001371"}, {"RECTYPE": "D", "MH": "Aza Compounds", "DE": "AZA CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Aza", "MN": "D02.145", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "AN": "do not confuse with AZO COMPOUNDS", "PI": "specific parent compound (1972-1973)", "MS": "Organic chemicals where carbon atoms have been replaced by nitrogen atoms.", "PM": "74", "HN": "74(72)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001372"}, {"RECTYPE": "D", "MH": "Azacosterol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "20,25-Diazacholesterol|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|770329|DIAZACHOLESTEROL 20 25|abbcdeefs", "ENTRY": "Dihydrochloride, Diazacholesterol", "MN": "D10.570.938.208.070", "PA": "Anticholesteremic Agents", "MH_TH": "NLM (1978)", "ST": "T121", "N1": "Androst-5-en-3-ol, 17-((3-(dimethylamino)propyl)methylamino)-, (3beta,17beta)-", "RN": "EPT876J73A", "RR": "313-05-3 (Azacosterol)", "PI": "Cholesterol (1966-1977)", "MS": "Diaza derivative of cholesterol which acts as a hypocholesteremic agent by blocking delta-24-reductase, which causes the accumulation of desmosterol.", "PM": "91; was see under CHOLESTEROL 1978-90", "HN": "91(78); was see under CHOLESTEROL 1978-90", "MR": "20160701", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D001373"}, {"RECTYPE": "D", "MH": "Azacitidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Azacytidine|T114|T121|NON|EQV|NLM (1996)|941123|abbcdef", "ENTRY": "NSC102816", "MN": "D13.570.800.286.300", "PA": "Enzyme Inhibitors", "MH_TH": "USAN (1978)", "ST": "T121", "N1": "1,3,5-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-", "RN": "M801H13NRU", "RR": "320-67-2 (Azacitidine)", "PI": "Triazines (1966-1971)", "MS": "A pyrimidine analogue that inhibits DNA methyltransferase, impairing DNA methylation. It is also an antimetabolite of cytidine, incorporated primarily into RNA. Azacytidine has been used as an antineoplastic agent.", "PM": "96; was AZACYTIDINE 1974-95", "HN": "96; was AZACYTIDINE 1972-95 (Prov 1972-73)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001374"}, {"RECTYPE": "D", "MH": "Azaguanine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Guanazolo|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|780517|abbcdeef", "ENTRY": "8 Azaguanine", "MN": "D03.633.100.759.758.399.454.300", "PA": "Antimetabolites, Antineoplastic", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "7H-1,2,3-Triazolo(4,5-d)pyrimidin-7-one, 5-amino-1,4-dihydro-", "RN": "Q150359I72", "RR": "134-58-7 (Azaguanine)", "MS": "One of the early purine analogs showing antineoplastic activity. It functions as an antimetabolite and is easily incorporated into ribonucleic acids.", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001375"}, {"RECTYPE": "D", "MH": "Azaperone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R1929", "MN": "D02.522.352.110", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1-Butanone, 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-", "RN": "19BV78AK7W", "RR": "1649-18-9 (Azaperone)", "PI": "Pyridines (1971-1974)", "MS": "A butyrophenone used in the treatment of PSYCHOSES.", "PM": "91; was see under BUTYROPHENONES 1975-90", "HN": "91(75); was see under BUTYROPHENONES 1975-90", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001376"}, {"RECTYPE": "D", "MH": "Azaserine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Azeserine|T116|T195|NON|EQV|UNK (19XX)|760422|abbcdef", "ENTRY": "O Diazoacetyl L serine", "MN": "D12.125.154.800.500", "PA": "Immunosuppressive Agents", "MH_TH": "USAN (1968)", "ST": "T195", "N1": "L-Serine, diazoacetate (ester)", "RN": "87299V3Q9W", "RR": "115-02-6 (Azaserine)", "AN": "/biosyn permitted", "MS": "Antibiotic substance produced by various Streptomyces species. It is an inhibitor of enzymatic activities that involve glutamine and is used as an antineoplastic and immunosuppressive agent.", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001377"}, {"RECTYPE": "D", "MH": "Azasteroids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Azasteroid|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Azasteroids, 4-", "MN": "D04.210.500.925.100", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Steroids (1968-1974)", "MS": "Steroidal compounds in which one or more carbon atoms in the steroid ring system have been substituted with nitrogen atoms.", "PM": "91; was see under STEROIDS, HETEROCYCLIC 1975-90", "HN": "91(75); was see under STEROIDS, HETEROCYCLIC 1975-90", "MR": "20210701", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D001378"}, {"RECTYPE": "D", "MH": "Azathioprine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Azathioprine", "MN": "D13.570.900.111", "PA": "Immunosuppressive Agents", "MH_TH": "USP (19XX)", "ST": "T131", "N1": "1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-", "RN": "MRK240IY2L", "RR": "AM94R510MS", "MS": "An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)", "PM": "66", "HN": "66(64)", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001379"}, {"RECTYPE": "D", "MH": "Azauridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "6 Azauridine", "MN": "D13.570.800.892.176", "PA": "Dermatologic Agents", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "1,2,4-Triazine-3,5(2H,4H)-dione, 2-beta-D-ribofuranosyl-", "RN": "7BVB29RCPR", "RR": "54-25-1 (Azauridine)", "PI": "Uridine (1966-1971)", "MS": "A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.", "PM": "73", "HN": "73(72)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001380"}, {"RECTYPE": "D", "MH": "Azepines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hexamethyleneimines|T109|NON|EQV|UNK (19XX)|770520|abcdef", "MN": "D03.383.066", "FX": "Dibenzazepines", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Seven membered heterocyclic rings containing a NITROGEN atom.", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001381"}, {"RECTYPE": "D", "MH": "Azerbaijan", "AQ": "EH EP", "PRINT ENTRY": "Azerbaijan S.S.R.|T083|NAM|EQV|NLM (1993)|920422|abcdef", "ENTRY": "Azerbaijan SSR|T083|NAM|EQV|NLM (1993)|920422|abcdef", "MN": "Z01.542.900.120", "MH_TH": "NLM (1993)", "ST": "T083", "MS": "A country located in Southwestern Asia, bordering the Caspian Sea, between Iran and Russia, with a small European portion north of the Caucasus range. The capital is Baku.", "OL": "use AZERBAIJAN to search AZERBAIJAN S.S.R. 1982-92", "HN": "93; was AZERBAIJAN S.S.R. 1982-92; was heading 1963-81", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "19930101", "UI": "D001382"}, {"RECTYPE": "D", "MH": "Azetidinecarboxylic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Azetidine 3 carboxylic Acid", "MN": "D12.125.072.401.200", "MH_TH": "NLM (1975)", "ST": "T116", "N1": "2-Azetidinecarboxylic acid", "RN": "5GZ3E0L9ZU", "RR": "56Y8G819O3", "PI": "Imino Acids (1974)", "MS": "A proline analog that acts as a stoichiometric replacement of proline. It causes the production of abnormal proteins with impaired biological activity.", "PM": "1991; AZETIDINECARBOXYLIC ACID was indexed under AZETINES 1975-1990", "HN": "1991(1975)", "MR": "20180702", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001383"}, {"RECTYPE": "D", "MH": "Azetidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.082.301", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with AZETINES", "OL": "search AZETINES 1974", "PM": "91; was see under AZETINES 1975-90", "HN": "91(75); was see under AZETINES 1975-90", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001384"}, {"RECTYPE": "D", "MH": "Azetines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.082", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "do not confuse with AZETIDINES", "PM": "74", "HN": "74", "MR": "19920507", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001385"}, {"RECTYPE": "D", "MH": "Azides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Azide|T104|NON|EQV|NLM (2021)|200113|abcdef", "MN": "D02.159", "MH_TH": "NLM (1966)", "ST": "T104", "RN": "0", "MS": "Organic or inorganic compounds that contain the -N3 group.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001386"}, {"RECTYPE": "D", "MH": "Azinphosmethyl", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Azinphos Methyl", "MN": "D02.886.300.692.060", "PA": "Insecticides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Phosphorodithioic acid, O,O-dimethyl S-((4-oxo-1,2,3-benzotriazin-3(4H)-yl)methyl) ester", "RN": "265842EWUV", "RR": "86-50-0 (Azinphosmethyl)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides (1966-1971)", "MS": "An organothiophosphorus cholinesterase inhibitor. It has been used as an acaricide and as an insecticide.", "PM": "91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90", "HN": "91(72); was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001387"}, {"RECTYPE": "D", "MH": "Aziridines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethyleneimines|T109|NON|EQV|UNK (19XX)|760317|abcdef", "ENTRY": "Saturated Azacyclopropanes", "MN": "D03.383.097.217", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "AZACYCLOPROPANES, UNSATURATED see AZIRINES is available", "MS": "Saturated azacyclopropane compounds. They include compounds with substitutions on CARBON or NITROGEN atoms.", "OL": "search AZIRINES 1966-74", "PM": "90;66-67; was see under AZIRINES 1975-89; was heading 1966-67", "HN": "90(75)66-67; was see under AZIRINES 1975-89; was heading 1966-67", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D001388"}, {"RECTYPE": "D", "MH": "Azirines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Unsaturated Azacyclopropanes", "MN": "D03.383.097", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "AZACYCLOPROPANES, SATURATED see AZIRIDINES is available", "MS": "Unsaturated azacyclopropane compounds that are three-membered heterocycles of a nitrogen and two carbon atoms.", "PM": "68; AZIRIDINES was heading 1966-67", "HN": "68", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001389"}, {"RECTYPE": "D", "MH": "Azlocillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Azlocillin", "MN": "D03.633.100.300.750.750.050.075", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1976)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(((((2-oxo-1-imidazolidinyl)carbonyl)amino)phenylacetyl)amino)-, (2S-(2alpha,5alpha,6beta(S*)))-", "RN": "HUM6H389W0", "RR": "DWV1EFW947", "PI": "Penicillins (1966-1984)", "MS": "A semisynthetic ampicillin-derived acylureido penicillin.", "PM": "85", "HN": "85", "MR": "20170524", "DA": "19840524", "DC": "1", "DX": "19850101", "UI": "D001390"}, {"RECTYPE": "D", "MH": "Azo Compounds", "DE": "AZO CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Azo Dye|T109|NON|NRW|NLM (2021)|191114|abcdef", "ENTRY": "Dyes, Azo", "MN": "D02.172", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with AZA COMPOUNDS", "MS": "Organic chemicals where aryl or alkyl groups are joined by two nitrogen atoms through a double bond (R-N=N-R'; R and R' may be either aryl or alkyl). They may be used as DYES.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001391"}, {"RECTYPE": "D", "MH": "Azocines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.113", "MH_TH": "NLM (1964)", "ST": "T109", "RN": "0", "PM": "66", "HN": "66(64)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001392"}, {"RECTYPE": "D", "MH": "Azoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Azole|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D03.383.129", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Five membered rings containing a NITROGEN atom.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001393"}, {"RECTYPE": "D", "MH": "Azores", "AQ": "EH EP", "MN": "Z01.639.040.218", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a group of 9 Atlantic islands off the coast of Portugal", "MS": "A group of nine islands and several islets belonging to Portugal in the north Atlantic Ocean off the coast of Portugal. The islands are named after the acores, the Portuguese for goshawks, living there in abundance. (Webster's New Geographical Dictionary, 1988, p102 & Room, Brewer's Dictionary of Names, 1992, p42)", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001394"}, {"RECTYPE": "D", "MH": "Azotobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.580.022", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid352", "AN": "in soil & water", "MS": "A genus of gram-negative, aerobic bacteria found in soil and water. Its organisms occur singly, in pairs or irregular clumps, and sometimes in chains of varying lengths.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001395"}, {"RECTYPE": "D", "MH": "Azoxymethane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.172.080", "PA": "Carcinogens", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Diazene, dimethyl-, 1-oxide", "RN": "MO0N1J0SEN", "RR": "25843-45-2 (Azoxymethane)", "AN": "a carcinogen", "PI": "Nitrogen Oxides (1973-1974)", "MS": "A potent carcinogen and neurotoxic compound. It is particularly effective in inducing colon carcinomas.", "PM": "91; was see under AZO COMPOUNDS 1975-90", "HN": "91(75); was see under AZO COMPOUNDS 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D001397"}, {"RECTYPE": "D", "MH": "Aztreonam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SQ26,776", "MN": "D03.633.100.300.500.044", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Propanoic acid, 2-(((1-(2-amino-4-thiazolyl)-2-((2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino)-2-oxoethylidene)amino)oxy)-2-methyl-, (2S-(2alpha,3beta(Z)))-", "RN": "G2B4VE5GH8", "RR": "78110-38-0 (Aztreonam)", "AN": "do not use /biosyn unless by living matter", "PI": "Antibiotics, Lactam (1983-1985)", "MS": "A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.", "PM": "86", "HN": "86", "MR": "20170524", "DA": "19850614", "DC": "1", "DX": "19860101", "UI": "D001398"}, {"RECTYPE": "D", "MH": "Azure Stains", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Giemsa Stain|T109|T130|EPO|NRW|UNK (19XX)|750630|abbcdef", "ENTRY": "Stains, Azure", "MN": "D03.633.300.783.080", "PA": "Coloring Agents", "MH_TH": "NLM (1976)", "ST": "T130", "RN": "0", "PI": "Staining (1966-1975)", "MS": "PHENOTHIAZINES with an amino group at the 3-position that are green crystals or powder. They are used as biological stains.", "PM": "91; was see under PHENOTHIAZINES 1976-90", "HN": "91(76); was see under PHENOTHIAZINES 1976-90", "MR": "20180705", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D001399"}, {"RECTYPE": "D", "MH": "Azurin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "MN": "D12.776.556.080", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Azurin (Pseudomonas fluorescens protein)", "RN": "12284-43-4", "AN": "a bact protein; /drug eff /ultrastruct permitted", "PI": "Metalloproteins (1973-1974)", "MS": "A bacterial protein from Pseudomonas, Bordetella, or Alcaligenes which operates as an electron transfer unit associated with the cytochrome chain. The protein has a molecular weight of approximately 16,000, contains a single copper atom, is intensively blue, and has a fluorescence emission band centered at 308nm.", "PM": "91; was see under BACTERIAL PROTEINS 1975-90", "HN": "91(75); was see under BACTERIAL PROTEINS 1975-90", "MR": "19920507", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001400"}, {"RECTYPE": "D", "MH": "Azygos Vein", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Azygos", "MN": "A07.015.908.106", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A vein which arises from the right ascending lumbar vein or the vena cava, enters the thorax through the aortic orifice in the diaphragm, and terminates in the superior vena cava.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001401"}, {"RECTYPE": "D", "MH": "B-Lymphocytes", "DS": "LYMPHOCYTES B", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Bursa-Dependent Lymphocytes|T025|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Lymphocytes, Bursa-Dependent", "MN": "A15.382.490.555.567.562", "FX": "Lymphocyte Cooperation", "MH_TH": "NLM (1973)", "ST": "T025", "PI": "Lymphocytes (1966-1972)", "MS": "Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.", "PM": "90; was B LYMPHOCYTES 1973-89", "HN": "90; was B LYMPHOCYTES 1973-89", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001402"}, {"RECTYPE": "D", "MH": "Babesia", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Piroplasma|T204|NON|EQV|UNK (19XX)|750212|abcdef", "ENTRY": "Piroplasmas", "MN": "B01.043.075.600.580.070", "MH_TH": "NLM (1974)", "ST": "T204", "RN": "txid5864", "MS": "A genus of tick-borne protozoan parasites that infests the red blood cells of mammals, including humans. There are many recognized species, and the distribution is world-wide.", "PM": "74", "HN": "74", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001403"}, {"RECTYPE": "D", "MH": "Babesiosis", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Piroplasmosis|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Piroplasmoses", "MN": "C22.674.710.122", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Protozoan Infections (1966-1967)", "MS": "A group of tick-borne diseases of mammals including ZOONOSES in humans. They are caused by protozoa of the genus BABESIA, which parasitize erythrocytes, producing hemolysis. In the U.S., the organism's natural host is mice and transmission is by the deer tick IXODES SCAPULARIS.", "OL": "use BABESIOSIS to search BABESIASIS 1968-81", "PM": "82; was BABESIASIS 1968-81", "HN": "82; was BABESIASIS 1968-81", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001404"}, {"RECTYPE": "D", "MH": "Reflex, Babinski", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Paradoxical Extensor Reflex, Great Toe|T033|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Reflex, Babinski's", "MN": "G11.561.731.618", "FX": "Reflex, Abnormal", "MH_TH": "NLM (1975)", "ST": "T033", "MS": "A reflex found in normal infants consisting of dorsiflexion of the HALLUX and abduction of the other TOES in response to cutaneous stimulation of the plantar surface of the FOOT. In adults, it is used as a diagnostic criterion, and if present is a NEUROLOGIC MANIFESTATION of dysfunction in the CENTRAL NERVOUS SYSTEM.", "PM": "1991; see REFLEX 1990, see REFLEX, ABNORMAL 1975-1989", "HN": "1991(1975)", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001405"}, {"RECTYPE": "D", "MH": "Bacillaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.158", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid186817", "AN": "pathogenic & non-pathogenic", "PI": "Bacteria (1966-1974)", "MS": "A family of bacteria which produce endospores. They are mostly saprophytes from soil, but a few are insect or animal parasites or pathogens.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D001406"}, {"RECTYPE": "D", "MH": "Bacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Bacillus bacterium|T007|NON|NRW|NLM (2021)|200323|abcdef", "MN": "B03.510.460.410.158.218", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1386", "RR": "txid1409", "AN": "specific genus: do not confuse with \"bacillus\" as \"bacterium\"", "MS": "A genus of BACILLACEAE that are spore-forming, rod-shaped cells. Most species are saprophytic soil forms with only a few species being pathogenic.", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001407"}, {"RECTYPE": "D", "MH": "Bacillus anthracis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.158.218.151", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1392", "MS": "A species of bacteria that causes ANTHRAX in humans and animals.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001408"}, {"RECTYPE": "D", "MH": "Bacillus cereus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.158.218.252", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1396", "AN": "in soil, dust, plants", "MS": "A species of rod-shaped bacteria that is a common soil saprophyte. Its spores are widespread and multiplication has been observed chiefly in foods. Contamination may lead to food poisoning.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001409"}, {"RECTYPE": "D", "MH": "Bacillus megaterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Bacillus megatherium|T007|NON|EQV|UNK (19XX)|781218|abcdef", "MN": "B03.510.460.410.158.218.500", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1404", "AN": "same as B. megatherium; in soil, water, dust, decomposing material", "MS": "A species of bacteria whose spores vary from round to elongate. It is a common soil saprophyte.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001410"}, {"RECTYPE": "D", "MH": "Geobacillus stearothermophilus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Bacillus thermoliquefaciens|T007|NON|EQV|NLM (2021)|200305|abcdef", "MN": "B03.510.460.410.158.400.400", "MH_TH": "NLM (2010)", "ST": "T007", "RN": "txid1422", "PI": "Bacillus (1966-1974)", "MS": "A species of GRAM-POSITIVE ENDOSPORE-FORMING BACTERIA in the family BACILLACEAE, found in soil, hot springs, Arctic waters, ocean sediments, and spoiled food products.", "PM": "2010; see BACILLUS STEAROTHERMOPHILUS 1975-2009", "HN": "2010 (1975)", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D001411"}, {"RECTYPE": "D", "MH": "Bacillus subtilis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Natto Bacteria|T007|NON|NRW|NLM (2004)|030507|abcdef", "ENTRY": "Bacillus subtilis var. natto|T007|NON|NRW|NLM (2004)|030507|abcdef", "MN": "B03.510.460.410.158.218.725", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1423", "RR": "txid86029", "MS": "A species of gram-positive bacteria that is a common soil and water saprophyte.", "MR": "20230522", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001412"}, {"RECTYPE": "D", "MH": "Bacillus thuringiensis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Thuricide|T007|TRD|NRW|UNK (19XX)|800821|abcdef", "MN": "B03.510.460.410.158.218.800", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid1428", "AN": "pathogenic for insects", "PI": "Bacillus (1966-1974)", "MS": "A species of gram-positive bacteria which may be pathogenic for certain insects. It is used for the biological control of the Gypsy moth.", "PM": "75", "HN": "75", "MR": "20200902", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D001413"}, {"RECTYPE": "D", "MH": "Bacitracin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Zinc, Bacitracin", "MN": "D12.644.641.075", "PA": "Anti-Infective Agents, Local", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Bacitracin", "RN": "1405-87-4", "RR": "1405-89-6 (zinc complex)", "MS": "A complex of cyclic peptide antibiotics produced by the Tracy-I strain of Bacillus subtilis. The commercial preparation is a mixture of at least nine bacitracins with bacitracin A as the major constituent. It is used topically to treat open infections such as infected eczema and infected dermal ulcers. (From Goodman and Gilman, The Pharmacological Basis of Therapeutics, 8th ed, p1140)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001414"}, {"RECTYPE": "D", "MH": "Back", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "MN": "A01.923.176", "EC": "injuries:Back Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "The rear surface of an upright primate from the shoulders to the hip, or the dorsal surface of tetrapods.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001415"}, {"RECTYPE": "D", "MH": "Back Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Backache|T184|NON|EQV|NLM (1993)|911009|abcdef", "ENTRY": "Vertebrogenic Pain Syndromes", "MN": "C23.888.592.612.107", "FX": "Low Back Pain", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "general or unspecified; prefer specifics; \"lombo-sciatique\" in French texts is indexed under LOW BACK PAIN and SCIATICA ", "MS": "Acute or chronic pain located in the posterior regions of the THORAX; LUMBOSACRAL REGION; or the adjacent regions.", "OL": "use BACK PAIN to search BACKACHE 1966-92", "PM": "93; was BACKACHE 1963-92", "HN": "93; was BACKACHE 1963-92", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D001416"}, {"RECTYPE": "D", "MH": "Background Radiation", "DE": "BACKGROUND RAD", "AQ": "AE", "PRINT ENTRY": "Natural Radiation|T070|NON|EQV|UNK (19XX)|840224|NATURAL RAD|abcdefv", "ENTRY": "Radiations, Natural", "MN": "G01.750.750.115", "MH_TH": "NLM (1971)", "ST": "T070", "PI": "Radioactivity (1966-1970)", "MS": "Radiation from sources other than the source of interest. It is due to cosmic rays and natural radioactivity in the environment.", "PM": "91; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1975", "HN": "91(71); was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1975", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001417"}, {"RECTYPE": "D", "MH": "Baclofen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chlorophenyl GABA|T116|T121|EQV|UNK (19XX)|790223|abbdef", "ENTRY": "PMSBaclofen", "MN": "D02.241.081.114.500.350.100", "PA": "Muscle Relaxants, Central", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-", "RN": "H789N3FKE8", "RR": "1134-47-0 (Baclofen)", "PI": "Chlorobenzenes (1974)", "MS": "A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.", "PM": "80; was see under AMINOBUTYRIC ACIDS 1975-79", "HN": "80(75); was see under AMINOBUTYRIC ACIDS 1975-79", "MR": "20160705", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D001418"}, {"RECTYPE": "D", "MH": "Bacteria", "DE": "BACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PY RE UL VI", "PRINT ENTRY": "Eubacteria|T007|NON|EQV|NLM (2004)|021122|abcdef", "MN": "B03", "RH": "B3 - ORGANISMS-BACTERIA", "FX": "Pili, Sex", "EC": "physiology:Bacterial Physiological Phenomena", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid2", "MS": "One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.", "PM": "1963", "HN": "1963", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D001419"}, {"RECTYPE": "D", "MH": "Bacteria, Aerobic", "DE": "BACT AEROBIC", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Aerobic Bacteria|T007|NON|EQV|UNK (19XX)|830603|AEROBIC BACT|abcdefv", "MN": "B03.120", "MH_TH": "NLM (1984)", "ST": "T007", "AN": "general; prefer specifics; do not use as a routine coordinate with a specific aerobic bacterium; infection: coordinate IM with BACTERIAL INFECTIONS (IM)", "PI": "Bacteria (1966-1983)", "MS": "Bacteria which require oxygen in order to grow and survive.", "PM": "84", "HN": "84", "MR": "20200902", "DA": "19830603", "DC": "1", "DX": "19840101", "UI": "D001420"}, {"RECTYPE": "D", "MH": "Bacteria, Anaerobic", "DE": "BACT ANAEROBIC", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Anaerobic Bacteria|T007|NON|EQV|UNK (19XX)|830603|ANAEROBIC BACT|abcdefv", "MN": "B03.130", "MH_TH": "NLM (1984)", "ST": "T007", "AN": "general; prefer specifics; do not use as a routine coordinate with a specific anaerobic bacterium; facultatively anaerobic bacteria: index only here & not also under BACTERIA, AEROBIC; infection: coordinate IM with BACTERIAL INFECTIONS (IM)", "PI": "Bacteria (1966-1983)", "MS": "Bacteria that can survive and grow in the complete, or nearly complete absence of oxygen.", "PM": "84", "HN": "84", "MR": "20200902", "DA": "19830603", "DC": "1", "DX": "19840101", "UI": "D001421"}, {"RECTYPE": "D", "MH": "Bacterial Adhesion", "DE": "BACT ADHESION", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Adhesion, Bacterial|T040|NON|EQV|UNK (19XX)|860619|ADHESION BACT|abcdefv", "ENTRY": "Bacterial Adhesions|T040|NON|EQV|NLM (1992)|901020|BACT ADHESIONS|abcdefv", "MN": "G06.099.050", "FX": "Adhesins, Bacterial", "MH_TH": "NLM (1987)", "ST": "T040", "AN": "do not confuse with ADHESINS, BACTERIAL", "PI": "Pili, Bacterial (1980-1986)", "MS": "Physicochemical property of fimbriated (FIMBRIAE, BACTERIAL) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D001422"}, {"RECTYPE": "D", "MH": "Bacterial Infections and Mycoses", "DE": "BACT INFECT MYCOSES", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C01.150", "RH": "C1 - DISEASES-BACTERIAL AND FUNGAL", "MH_TH": "NLM (1974)", "ST": "T047", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Infections caused by bacteria and fungi, general, specified, or unspecified.", "PM": "98", "HN": "98; use explode 1975-98", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001423"}, {"RECTYPE": "D", "MH": "Bacterial Infections", "DE": "BACT INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Bacterial Disease|T047|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Bacterial Diseases", "MN": "C01.150.252", "MH_TH": "NLM (1972)", "ST": "T047", "AN": "general or unspecified; prefer specifics; many texts saying \"sepsis\" mean BACTERIAL INFECTIONS: check text", "PI": "Infection (1966-1971)", "MS": "Infections by bacteria, general or unspecified.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001424"}, {"RECTYPE": "D", "MH": "Bacterial Outer Membrane Proteins", "DE": "BACT OUTER MEMBRANE PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Outer Membrane Proteins, Bacterial|T116|T123|NON|EQV|UNK (19XX)|840530|OUTER MEMBRANE PROTEINS BACT|abbcdefv", "ENTRY": "Outer Membrane Lipoproteins, Bacterial|T116|T123|NON|NRW|UNK (19XX)|840530|OUTER MEMBRANE LIPOPROTEINS BACT|abbcdefv", "MN": "D12.776.543.100", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "AN": "coord IM with specific protein (IM) + specific gram-negative bacterium (IM)", "PI": "Membrane Proteins (1977-1984)", "MS": "Proteins isolated from the outer membrane of Gram-negative bacteria.", "PM": "85", "HN": "85", "MR": "20050630", "DA": "19840530", "DC": "1", "DX": "19850101", "UI": "D001425"}, {"RECTYPE": "D", "MH": "Bacterial Proteins", "DE": "BACT PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gene Products, Bacterial|T116|T123|NON|EQV|NLM (1991)|900126|GENE PRODUCTS BACT|abbcdefv", "ENTRY": "Proteins, Bacterial|T116|T123|NON|EQV|NLM (1992)|901102|PROTEINS BACT|abbcdefv", "MN": "D12.776.097", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "coordinate with specific protein + bacterium but note the specific bacterial proteins that are available", "MS": "Proteins found in any species of bacterium.", "OL": "use BACTERIAL PROTEINS (NM) to search GENE PROTEINS, BACTERIAL 1981-93", "PM": "GENE PROTEINS, BACTERIAL was indexed under BACTERIAL PROTEINS 1981-93", "HN": "GENE PROTEINS, BACTERIAL was (NM) 1981-93", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D001426"}, {"RECTYPE": "D", "MH": "Bacterial Toxins", "DE": "BACT TOXINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bacterial Toxin|T123|T131|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Toxin, Bacterial", "MN": "D23.946.123", "MH_TH": "NLM (1977)", "ST": "T131", "RN": "0", "AN": "general or unspecified: prefer specifics; coordinate IM with specific bacterium (IM); / antag permitted but consider also ANTITOXINS", "PI": "Toxins (1966-1976)", "MS": "Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases.", "PM": "77", "HN": "77; was NON MESH before 1977", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D001427"}, {"RECTYPE": "D", "MH": "Bacterial Vaccines", "DE": "BACT VACCINES", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME MI PD PK PO RE SD ST TO TU UR VI", "ENTRY": "Vaccines, Bacterial|T121|T129|NON|EQV|NLM (1992)|901103|VACCINES BACT|abbcdefv", "MN": "D20.215.894.135", "MH_TH": "NLM (1965)", "ST": "T129", "RN": "0", "AN": "for specifics not indented here coordinate with specific bacterium /immunol ", "MS": "Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.", "PM": "65", "HN": "65", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001428"}, {"RECTYPE": "D", "MH": "Bacteriochlorophylls", "AQ": "AD AE AG AI AN BI CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU", "ENTRY": "Bacteriochlorophyll|T109|T123|NON|EQV|NLM (1991)|891012|abbcdef", "MN": "D12.776.752.249", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Chlorophyll (1974)", "MS": "Pyrrole containing pigments found in photosynthetic bacteria.", "PM": "91; was see under CHLOROPHYLL 1975-90", "HN": "91(75); was see under CHLOROPHYLL 1975-90", "MR": "20200221", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001429"}, {"RECTYPE": "D", "MH": "Bacteriocins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lantibiotic|T116|T123|NON|NRW|NLM (2021)|191115|abbcdef", "ENTRY": "Lantibiotics|T116|T123|NON|NRW|NLM (2006)|050103|abbcdef", "MN": "D12.776.543.695.110", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1965)", "ST": "T123", "RN": "0", "MS": "Substances elaborated by specific strains of bacteria that are lethal against other strains of the same or related species. They are protein or lipopolysaccharide-protein complexes used in taxonomy studies of bacteria.", "HN": "68(65)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001430"}, {"RECTYPE": "D", "MH": "Bacteriological Techniques", "DE": "BACTERIOL TECHNIQUES", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Techniques, Bacteriologic", "MN": "E05.200.875.150", "FX": "Culture Media", "MH_TH": "NLM (1966)", "ST": "T059", "MS": "Techniques used in studying bacteria.", "OL": "use BACTERIOLOGICAL TECHNIQUES to search BACTERIOLOGICAL TECHNICS 1966-90", "PM": "91; was BACTERIOLOGICAL TECHNICS 1963-90", "HN": "91; was BACTERIOLOGICAL TECHNICS 1963-90", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001431"}, {"RECTYPE": "D", "MH": "Bacteriology", "DE": "BACTERIOL", "AQ": "CL EC ED ES HI IS LJ OG SN ST TD", "MN": "H01.158.273.540.177", "FX": "Infectious Disease Medicine", "EC": "methods:Bacteriological Techniques", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use BACTERIAL PHYSIOLOGICAL PHENOMENA or specifics treed under it for biological processes and properties of bacteria", "MS": "The study of the structure, growth, function, genetics, and reproduction of bacteria, and BACTERIAL INFECTIONS.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001432"}, {"RECTYPE": "D", "MH": "Bacteriolysis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Bacteriolyses", "MN": "G06.099.115", "FX": "Lysostaphin", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "coord with specific bacterium", "MS": "Rupture of bacterial cells due to mechanical force, chemical action, or the lytic growth of BACTERIOPHAGES.", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001433"}, {"RECTYPE": "D", "MH": "Bacteriophage Typing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Typing, Bacteriophage|T059|NON|EQV|UNK (19XX)|880603|abcdef", "ENTRY": "Typing, Phage", "MN": "E05.200.875.150.125.150", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "policy: Manual 22.24.4", "MS": "A technique of bacterial typing which differentiates between bacteria or strains of bacteria by their susceptibility to one or more bacteriophages.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001434"}, {"RECTYPE": "D", "MH": "Bacteriophages", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Phages|T005|NON|EQV|NLM (1993)|911009|abcdef", "ENTRY": "Phage", "MN": "B04.123", "FX": "Lysogeny", "MH_TH": "NLM (1966)", "ST": "T005", "MS": "Viruses whose hosts are bacterial cells.", "OL": "use BACTERIOPHAGES to search BACTERIOPHAGE 1966-74", "PM": "75; was BACTERIOPHAGE 1963-74", "HN": "75; was BACTERIOPHAGE 1963-74", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D001435"}, {"RECTYPE": "D", "MH": "Bacteriorhodopsins", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "ENTRY": "Bacteriorhodopsin|T116|T126|NON|EQV|NLM (1976)|990101|abbcdef", "MN": "D12.776.752.812.249", "FX": "Purple Membrane", "MH_TH": "NLM (2002)", "ST": "T126", "N1": "Bacteriorhodopsins", "RN": "53026-44-1", "AN": "do not confuse with BACTERIAL RHODOPSINS see RHODOPSINS, MICROBIAL", "PI": "Retinal Pigments (1974-1975)", "MS": "Rhodopsins found in the PURPLE MEMBRANE of halophilic archaea such as HALOBACTERIUM HALOBIUM. Bacteriorhodopsins function as an energy transducers, converting light energy into electrochemical energy via PROTON PUMPS.", "PM": "2002; see BACTERIORHODOPSIN 1977-2001, see CAROTENOIDS 1976-1986", "HN": "2002(1976)", "MR": "20050630", "DA": "19750718", "DC": "1", "DX": "19870101", "UI": "D001436"}, {"RECTYPE": "D", "MH": "Bacteriuria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Bacteriurias", "MN": "C12.950.892.219", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "differentiate from URINE/microbiol; coordinate IM with specific bacterium (IM) and specific bacterial infection (IM)", "MS": "The presence of bacteria in the urine which is normally bacteria-free. These bacteria are from the URINARY TRACT and are not contaminants of the surrounding tissues. Bacteriuria can be symptomatic or asymptomatic. Significant bacteriuria is an indicator of urinary tract infection.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001437"}, {"RECTYPE": "D", "MH": "Bacteroidaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.194", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid815", "PI": "Bacteria (1966-1974)", "MS": "A family of gram-negative bacteria found primarily in the intestinal tracts and mucous membranes of warm-blooded animals. Its organisms are sometimes pathogenic.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D001438"}, {"RECTYPE": "D", "MH": "Bacteroides", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.194.152", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid816", "MS": "A genus of gram-negative, anaerobic, rod-shaped bacteria. Its organisms are normal inhabitants of the oral, respiratory, intestinal, and urogenital cavities of humans, animals, and insects. Some species may be pathogenic.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001439"}, {"RECTYPE": "D", "MH": "Bacteroides fragilis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.194.152.400", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid817", "AN": "infection: coord IM with BACTEROIDES INFECTIONS (IM)", "PI": "Bacteroides (1966-1975)", "MS": "Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D001441"}, {"RECTYPE": "D", "MH": "Bacteroides Infections", "DE": "BACTEROIDES INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Bacteroides", "MN": "C01.150.252.400.110.109", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "gram-neg bact infect", "PI": "Bacteroides (1966-1967)", "MS": "Infections with bacteria of the genus BACTEROIDES.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001442"}, {"RECTYPE": "D", "MH": "Prevotella melaninogenica", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Bacteroides melaninogenicus|T007|NON|EQV|NLM (1995)|931222|abcdef", "MN": "B03.440.425.410.194.640.500", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid28132", "AN": "infection: coord IM with BACTEROIDACEAE INFECTIONS (IM)", "PI": "Bacteroides (1966-1975)", "MS": "A species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium has been isolated from the mouth, urine, feces, and infections of the mouth, soft tissue, respiratory tract, urogenital tract, and intestinal tract. It is pathogenic, but usually in association with other kinds of organisms.", "OL": "use PREVOTELLA MELANINOGENICA to search BACTEROIDES MELANINOGENICUS 1976-94", "PM": "95; was BACTEROIDES MELANINOGENICUS 1976-94 (see under BACTEROIDES 1976-90)", "HN": "95; was BACTEROIDES MELANINOGENICUS 1976-94 (see under BACTEROIDES 1976-90)", "MR": "20200813", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D001443"}, {"RECTYPE": "D", "MH": "Bahamas", "AQ": "EH EP", "MN": "Z01.639.880.100", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "a chain of islands in the West Indies", "MS": "A chain of islands, cays, and reefs in the West Indies, lying southeast of Florida and north of Cuba. It is an independent state, called also the Commonwealth of the Bahamas or the Bahama Islands. The name likely represents the local name Guanahani, itself of uncertain origin. (From Webster's New Geographical Dictionary, 1988, p106 & Room, Brewer's Dictionary of Names, 1992, p45)", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001444"}, {"RECTYPE": "D", "MH": "Bahrain", "AQ": "EH EP", "MN": "Z01.252.245.500.175", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "a state in the Persian Gulf", "MS": "An independent state, an archipelago in the western Persian Gulf, northwest of Qatar. It comprises low-lying islands of Bahrain (the largest), Muharraq, Sitra, and several islets. It has extensive oil fields. The name comes from the Arabic al-bahrayn, \"the two seas\", with reference to its lying in the middle of a bay with its \"two seas\" east and west of it. (From Webster's New Geographical Dictionary, 1988, p107 & Room, Brewer's Dictionary of Names, 1992, p45)", "HN": "75", "MR": "20150527", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D001445"}, {"RECTYPE": "D", "MH": "Balanitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Balanitides", "MN": "C12.200.294.494.136", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the head of the PENIS, glans penis.", "PM": "1966", "HN": "1966", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001446"}, {"RECTYPE": "D", "MH": "Balantidiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, B. coli", "MN": "C06.405.469.452.146", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Infection by parasites of the genus BALANTIDIUM. The presence of Balantidium in the LARGE INTESTINE leads to DIARRHEA; DYSENTERY; and occasionally ULCER.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001447"}, {"RECTYPE": "D", "MH": "Balantidium", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Balantidiums", "MN": "B01.043.185.375.650.650.153", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid71584", "MS": "A genus of protozoa parasitic in the digestive tract of vertebrate or invertebrate hosts. Asexual multiplication is accomplished by transverse binary fission. Its organisms are ovoidal in shape and have a ciliated covering over the entire body.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001448"}, {"RECTYPE": "D", "MH": "Balkan Nephropathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nephropathy, Balkan|T047|EPO|EQV|UNK (19XX)|810223|abcdef", "ENTRY": "Nephropathy, Balkan Endemic", "MN": "C12.950.419.570.643.150", "MH_TH": "NLM (1982)", "ST": "T047", "AN": "do not specify geography unless particularly discussed", "PI": "Pyelonephritis (1966-1969)", "MS": "A form of chronic interstitial nephritis that is endemic to limited areas of BULGARIA, the former YUGOSLAVIA, and ROMANIA. It is characterized by a progressive shrinking of the KIDNEYS that is often associated with uroepithelial tumors.", "PM": "1991; see NEPHRITIS, INTERSTITIAL 1982-90; for Danubian Endemic Familial Nephropathy see Hemorrhagic Fever with Renal Syndrome 2012", "HN": "1991(1982); use NEPHRITIS, INTERSTITIAL 1982-90; for Danubian Endemic Familial Nephropathy use Hemorrhagic Fever with Renal Syndrome 2012", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19810223", "DC": "1", "DX": "19910101", "UI": "D001449"}, {"RECTYPE": "D", "MH": "Ballistocardiography", "DE": "BALLISTOCARDIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Ballistocardiographies", "MN": "E01.370.370.380.100", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Technique of graphic representation of the movements of the body imparted by the ballistic forces (recoil and impact) associated with cardiac contraction and ejection of blood and with the deceleration of blood flow through the large blood vessels. These movements, quantitatively very minute, are translated by a pickup device (transducer) into an electrical potential which is suitably amplified and recorded on a conventional electrocardiograph or other recording machine.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001450"}, {"RECTYPE": "D", "MH": "Balneology", "DE": "BALNEOL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Balneotherapy|T061|NON|NRW|UNK (19XX)|850228|BALNEOTHER|abcdefv", "MN": "E02.056", "FX": "Mineral Waters", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "differentiate from HYDROTHERAPY where emphasis is on plain water (not natural mineral water; see note there); coordinate with MINERAL WATERS as appropriate", "MS": "Therapy by various hot or warm baths in natural mineral waters, spas, or \"cures\". It includes not only bathing in, but also drinking the waters, but it does not include whirlpool baths (HYDROTHERAPY).", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001452"}, {"RECTYPE": "D", "MH": "Balsams", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D20.215.721.500.219", "MH_TH": "NLM (1966)", "ST": "T167", "RN": "0", "MS": "Resinous substances which most commonly originate from trees. In addition to resins, they contain oils, cinnamic acid and BENZOIC ACID.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001453"}, {"RECTYPE": "D", "MH": "Baltic States", "AQ": "EH EP", "MN": "Z01.542.248.136", "MH_TH": "NLM (1975)", "ST": "T083", "AN": "= ESTONIA; LATVIA & LITHUANIA collectively", "MS": "The collective name for the republics of ESTONIA; LATVIA; and LITHUANIA on the eastern shore of the Baltic Sea. (Webster's New Geographical Dictionary, 1988, p111)", "HN": "75", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "19750101", "UI": "D001454"}, {"RECTYPE": "D", "MH": "Bambermycins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Moenomycins|T109|T195|NON|EQV|UNK (19XX)|780316|abbcdef", "ENTRY": "Menomycin|T109|T195|NON|EQV|NLM (1990)|890124|abbcdef", "MN": "D09.698.718.220", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1972)", "ST": "T195", "N1": "Bambermycin", "RN": "11015-37-5", "PI": "Glycolipids (1966-1978)", "MS": "Antibiotic complex obtained from Streptomyces bambergiensis containing mainly Moenomycins A and C. They are used as feed additives and growth promoters for poultry, swine, and cattle.", "PM": "91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1979-90", "HN": "91(79); was see under ANTIBIOTICS, AMINOGLYCOSIDE 1979-90", "MR": "20040707", "DA": "19780316", "DC": "1", "DX": "19910101", "UI": "D001455"}, {"RECTYPE": "D", "MH": "Anion Exchange Protein 1, Erythrocyte", "DS": "ANION EXCHANGE PROTEIN ERYTHROCYTE 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Erythrocyte Membrane Band 3 Protein|T116|T123|NON|EQV|UNK (19XX)|830531|ERYTHROCYTE MEMBRANE BAND PROTEIN 03|abbcdefs", "ENTRY": "Protein, EPB3", "MN": "D12.776.543.585.937.776.249.500", "FX": "Spherocytosis, Hereditary", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1977-1983)", "MS": "A major integral transmembrane protein of the ERYTHROCYTE MEMBRANE. It is the anion exchanger responsible for electroneutral transporting in CHLORIDE IONS in exchange of BICARBONATE IONS allowing CO2 uptake and transport from tissues to lungs by the red blood cells. Genetic mutations that result in a loss of the protein function have been associated with type 4 HEREDITARY SPHEROCYTOSIS.", "PM": "2002; see BAND 3 PROTEIN 1984-2000; AE1 ANION EXCHANGER, AE1 CHLORIDE-BICARBONATE EXCHANGER, AE1 Cl- HCO3- EXCHANGER & AE1 GENE PRODUCT were indexed under ANTIPORTERS 1998-2001", "HN": "2002(1984); for AE1 ANION EXCHANGER, AE1 CHLORIDE-BICARBONATE EXCHANGER, AE1 Cl- HCO3- EXCHANGER & AE1 GENE PRODUCT use CHLORIDE-BICARBONATE ANTIPORTERS (NM) 1998-2001", "MR": "20190524", "DA": "19830531", "DC": "1", "DX": "19840101", "UI": "D001457"}, {"RECTYPE": "D", "MH": "Bandages", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Dressings|T074|NON|REL|UNK (19XX)|740329|abcdef", "ENTRY": "Dressing", "MN": "E07.101", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "Material used for wrapping or binding any part of the body.", "OL": "Use CLOTHING to search ELASTIC STOCKINGS & STOCKINGS, COMPRESSION 1982-89", "PM": "ELASTIC STOCKINGS & STOCKINGS, COMPRESSION were see CLOTHING 1982-89", "HN": "ELASTIC STOCKINGS & STOCKINGS, COMPRESSION were see CLOTHING 1982-89", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001458"}, {"RECTYPE": "D", "MH": "Bangladesh", "AQ": "EH EP", "MN": "Z01.252.245.782.500", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "A country in Southern Asia, bordering the Bay of Bengal, between Burma and India. The capital is Dhaka.", "HN": "73", "MR": "20220708", "DA": "19990101", "DC": "4", "DX": "19730101", "UI": "D001459"}, {"RECTYPE": "D", "MH": "Barbados", "AQ": "EH EP", "MN": "Z01.639.880.140", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island in the Lesser Antilles in the West Indies", "MS": "An island in the Lesser Antilles in the West Indies. It is chiefly of coral formation with no good harbors and only small streams. It was probably discovered by the Portuguese in the sixteenth century. The name was given by 16th-century Spanish explorers from barbados, the plural for \"bearded\", with reference to the beard-like leaves or trails of moss on the trees that grew there in abundance. (From Webster's New Geographical Dictionary, 1988, p116 & Room, Brewer's Dictionary of Names, 1992, p49)", "HN": "75", "MR": "20120703", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D001460"}, {"RECTYPE": "D", "MH": "Barbering", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Barberings", "MN": "J01.576.082", "FX": "Barber Surgeons", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "The occupation concerned with the cutting and dressing of the hair of customers and, of men, the shaving and trimming of the beard and mustache. (From Random House Unabridged Dictionary, 2d ed)", "MR": "19950531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001461"}, {"RECTYPE": "D", "MH": "Barbital", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethylbarbital|T109|T121|NON|EQV|UNK (19XX)|750630|abbcdef", "ENTRY": "Veronal|T109|T121|TRD|NRW|UNK (19XX)|820903|abbcdef", "MN": "D03.383.742.698.253.150", "PA": "Hypnotics and Sedatives", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5-diethyl-", "RN": "5WZ53ENE2P", "RR": "57-44-3 (Barbital)", "PI": "Barbiturates (1968-1975)", "MS": "A long-acting barbiturate that depresses most metabolic processes at high doses. It is used as a hypnotic and sedative and may induce dependence. Barbital is also used in veterinary practice for central nervous system depression.", "PM": "91; was see under BARBITURATES 1976-90", "HN": "91(76); was see under BARBITURATES 1976-90", "MR": "20170524", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D001462"}, {"RECTYPE": "D", "MH": "Barbiturates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.742.698.253", "FX": "Hypnotics and Sedatives", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.", "PM": "/adverse effects /poisoning /toxicity were BARBITURATE TOXICOLOGY 1963-65", "HN": "/adv eff-pois-tox was BARBITURATE TOXICOLOGY 1963-65", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001463"}, {"RECTYPE": "D", "MH": "Barium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.062", "FX": "Barium Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Barium", "RN": "24GP945V5T", "RR": "7440-39-3 (Barium)", "MS": "An element of the alkaline earth group of metals. It has an atomic symbol Ba, atomic number 56, and atomic weight 138. All of its acid-soluble salts are poisonous.", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001464"}, {"RECTYPE": "D", "MH": "Barium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Barium", "MN": "D01.496.749.075", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1987)", "MS": "Unstable isotopes of barium that decay or disintegrate emitting radiation. Ba atoms with atomic weights 126-129, 131, 133, and 139-143 are radioactive barium isotopes.", "PM": "88", "HN": "88", "MR": "20170703", "DA": "19870331", "DC": "1", "DX": "19880101", "UI": "D001465"}, {"RECTYPE": "D", "MH": "Barium Sulfate", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Sulfate, Barium", "MN": "D01.875.800.800.850.075", "PA": "Contrast Media", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Sulfuric acid, barium salt (1:1)", "RN": "25BB7EKE2E", "RR": "7727-43-7 (Barium Sulfate)", "AN": "for enema, use BARIUM SULFATE not BARIUM", "MS": "A compound used as an x-ray contrast medium that occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield.", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001466"}, {"RECTYPE": "D", "MH": "Hordeum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Barley|T002|T168|NON|REL|NLM (1975)|990101|abbcdef", "ENTRY": "Hordeum vulgare|T002|NON|NRW|NLM (2003)|011010|abcdef", "MN": "B01.875.800.575.912.250.822.481", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid4512", "RR": "txid4513", "MS": "A plant genus of the family POACEAE. The EDIBLE GRAIN, barley, is widely used as food.", "PM": "2003; see BARLEY 1991-2002, CEREALS 1985-1990, GRAIN 1963-1984", "HN": "2003; use BARLEY 1991-2002, CEREALS 1985-1990, GRAIN 1963-1984", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001467"}, {"RECTYPE": "D", "MH": "Thoracica", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sessilia|T204|NON|NRW|NLM (2003)|011017|abcdef", "ENTRY": "Thoracicas", "MN": "B01.050.500.131.365.880", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6676", "RR": "txid6677", "PI": "Crustacea (1966-1971)", "MS": "A superorder of marine CRUSTACEA, free swimming in the larval state, but permanently fixed as adults. There are some 800 described species, grouped in several genera, and comprising of two major orders of barnacles: stalked (Pedunculata) and sessile (Sessilia).", "PM": "2003; see BARNACLES 1972-2002", "HN": "2003 (1972)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001468"}, {"RECTYPE": "D", "MH": "Barotrauma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Barotraumas", "MN": "C26.120", "FX": "High Pressure Neurological Syndrome", "MH_TH": "NLM (1979)", "ST": "T037", "AN": "inj caused by pressure changes: not restricted to ear; IM; coord with organ injured by pressure with /inj; also available is BLAST INJURIES", "PI": "Pressure (1966-1978)", "MS": "Injury following pressure changes; includes injury to the eustachian tube, ear drum, lung and stomach.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D001469"}, {"RECTYPE": "D", "MH": "Barrett Esophagus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Esophagus, Barrett|T047|EPO|EQV|UNK (19XX)|800404|abcdef", "ENTRY": "Metaplasias, Barrett", "MN": "C06.405.117.102", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Esophagitis, Peptic (1966-1980)", "MS": "A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.", "PM": "89; was see under ESOPHAGEAL DISEASES 1981-88", "HN": "89(81); was see under ESOPHAGEAL DISEASES 1981-88", "CATSH": "CAT LIST", "MR": "20170707", "DA": "19800404", "DC": "1", "DX": "19890101", "UI": "D001471"}, {"RECTYPE": "D", "MH": "Bartholin's Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Bartholin's Gland|T023|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Glands, Bartholin's", "MN": "A10.336.095", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Mucus-secreting glands situated on the posterior and lateral aspect of the vestibule of the vagina.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001472"}, {"RECTYPE": "D", "MH": "Bartonella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rochalimaea|T007|NON|EQV|NLM (1996)|950315|abcdef", "MN": "B03.660.050.030.040", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid773", "MS": "A genus of gram-negative bacteria characteristically appearing in chains of several segmenting organisms. It occurs in man and arthropod vectors and is found only in the Andes region of South America. This genus is the etiologic agent of human bartonellosis. The genus Rochalimaea, once considered a separate genus, has recently been combined with the genus Bartonella as a result of high levels of relatedness in 16S rRNA sequence data and DNA hybridization data.", "PM": "ROCHALIMAEA was heading 1995", "HN": "ROCHALIMAEA was heading 1995", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001473"}, {"RECTYPE": "D", "MH": "Bartonella Infections", "DE": "BARTONELLA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Verruga Peruana|T047|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Rochalimaea Infection", "MN": "C01.150.252.400.126.100", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Infections by the genus BARTONELLA. Bartonella bacilliformis can cause acute febrile anemia, designated Oroya fever, and a benign skin eruption, called verruga peruana. BARTONELLA QUINTANA causes TRENCH FEVER, while BARTONELLA HENSELAE is the etiologic agent of bacillary angiomatosis (ANGIOMATOSIS, BACILLARY) and is also one of the causes of CAT-SCRATCH DISEASE.", "PM": "ROCHALIMAEA INFECTIONS was heading 1995", "HN": "ROCHALIMAEA INFECTIONS was heading 1995", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001474"}, {"RECTYPE": "D", "MH": "Bartonellaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.030", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid772", "PI": "Bacteria (1966-1974)", "MS": "A family of small gram-negative bacteria whose organisms are parasites of erythrocytes in man and other vertebrates and the etiologic agents of several diseases.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D001475"}, {"RECTYPE": "D", "MH": "Bartonellaceae Infections", "DE": "BARTONELLACEAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Bartonellaceae", "MN": "C01.150.252.400.126", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "gram-neg bact infect", "PI": "Rickettsial Infections (1966-1976)", "MS": "Infections with bacteria of the family BARTONELLACEAE.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D001476"}, {"RECTYPE": "D", "MH": "Bartter Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Bartter's", "MN": "C19.053.800.604.249", "FX": "Sodium-Potassium-Chloride Symporters", "MH_TH": "NLM (2005)", "ST": "T047", "MS": "A group of disorders caused by defective salt reabsorption in the ascending LOOP OF HENLE. It is characterized by severe salt-wasting, HYPOKALEMIA; HYPERCALCIURIA; metabolic ALKALOSIS, and hyper-reninemic HYPERALDOSTERONISM without HYPERTENSION. There are several subtypes including ones due to mutations in the renal specific SODIUM-POTASSIUM-CHLORIDE SYMPORTERS.", "PM": "2005; see BARTTER'S DISEASE 1991-2004, see HYPERALDOSTERONISM 1975-1990", "HN": "2005 (1975)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001477"}, {"RECTYPE": "D", "MH": "Basal Cell Nevus Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nevus Syndrome, Basal Cell|T191|NON|EQV|UNK (19XX)|860418|abcdef", "ENTRY": "Syndrome, Gorlin-Goltz", "MN": "C16.320.700.175", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm (IM or NIM) only if pertinent; do not confuse entry term GORLIN-GOLTZ SYNDROME with GOLTZ- GORLIN SYNDROME see FOCAL DERMAL HYPOPLASIA", "PI": "specific jaw neoplasm (1967-1979)", "MS": "Hereditary disorder consisting of multiple basal cell carcinomas, odontogenic keratocysts, and multiple skeletal defects, e.g., frontal and temporoparietal bossing, bifurcated and splayed ribs, kyphoscoliosis, fusion of vertebrae, and cervicothoracic spina bifida. Genetic transmission is autosomal dominant.", "PM": "91; was see under CARCINOMA, BASAL CELL 1980-90", "HN": "91(80); was see under CARCINOMA, BASAL CELL 1980-90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19790425", "DC": "1", "DX": "19910101", "UI": "D001478"}, {"RECTYPE": "D", "MH": "Basal Ganglia", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Ganglia, Basal|T023|NON|EQV|NLM (1991)|891213|abcdef", "ENTRY": "Nuclei, Basal", "MN": "A08.186.211.200.885.287.249", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Large subcortical nuclear masses derived from the telencephalon and located in the basal regions of the cerebral hemispheres.", "OL": "use BASAL GANGLIA to search GANGLIA, BASAL 1966-81", "PM": "82; was GANGLIA, BASAL 1963-81", "HN": "82; was GANGLIA, BASAL 1963-81; CLAUSTRUM was see under GANGLIA, BASAL 1963-78", "MR": "20181005", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001479"}, {"RECTYPE": "D", "MH": "Basal Ganglia Diseases", "DE": "BASAL GANGLIA DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Extrapyramidal Disorders|T047|NON|BRD|UNK (19XX)|780517|EXTRAPYRAMIDAL DIS|abcdefv", "ENTRY": "Lenticulostriate Disorder", "MN": "C10.228.140.079", "MH_TH": "NLM (1972)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with specific site ", "PI": "specific anatomic site (1966-1971)", "MS": "Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.", "PM": "79; was EXTRAPYRAMIDAL DISORDERS 1974-78", "HN": "79; was EXTRAPYRAMIDAL DISORDERS 1972-78 (Prov 1972-73)", "CATSH": "CAT LIST", "MR": "20050712", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001480"}, {"RECTYPE": "D", "MH": "Basal Metabolism", "DE": "BASAL METAB", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Metabolism, Basal|T040|T060|T201|NON|EQV|NLM (1992)|910512|METAB BASAL|abbbcdefv", "ENTRY": "Resting Metabolic Rates", "MN": "G03.295.154", "FX": "Secondary Metabolism", "MH_TH": "NLM (1966)", "ST": "T201", "MS": "Metabolism (e.g., heat production) of an organism in an inactive, awake, fasting state. It may be determined directly by means of a calorimeter or indirectly by calculating the end products of oxidation within the organism or from the amount of oxygen utilized.", "CATSH": "CAT LIST", "MR": "20171208", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001481"}, {"RECTYPE": "D", "MH": "Base Composition", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Guanine + Cytosine Composition|T081|NON|NRW|NLM (2003)|010928|GUANINE CYTOSINE COMPOSITION|abcdefs", "ENTRY": "Ratios, Base", "MN": "G02.111.080", "FX": "Isochores", "MH_TH": "NLM (1980)", "ST": "T081", "MS": "The relative amounts of the PURINES and PYRIMIDINES in a nucleic acid.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19790524", "DC": "1", "DX": "19800101", "UI": "D001482"}, {"RECTYPE": "D", "MH": "Base Sequence", "DE": "BASE SEQ", "AQ": "DE GE PH RE", "PRINT ENTRY": "RNA Sequence|T086|T114|NRW|NLM (1993)|920326|RNA SEQ|abbdefv", "ENTRY": "Sequences, RNA", "MN": "L01.462.750.245.667.080", "MH_TH": "NLM (1971)", "ST": "T114", "PI": "specific nucleic acid (1966-1970)", "MS": "The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.", "PM": "78; was see under BIOCHEMISTRY 1975-77", "HN": "78(71); was see under BIOCHEMISTRY 1975-77", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D001483"}, {"RECTYPE": "D", "MH": "Baseball", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Softball|T056|NON|NRW|NLM (1990)|890324|abcdef", "ENTRY": "Softballs|T073|NON|REL|NLM (1997)|960415|abcdef", "MN": "I03.450.642.845.110", "MH_TH": "NLM (1977)", "ST": "T056", "AN": "/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1", "PI": "Sports (1966-1976)", "MS": "A competitive nine-member team sport including softball.", "PM": "90; was see under SPORTS 1977-89", "HN": "90(77); was see under SPORTS 1977-89", "MR": "19960610", "DA": "19760519", "DC": "1", "DX": "19900101", "UI": "D001484"}, {"RECTYPE": "D", "MH": "Basement Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Lamina Reticularis|T024|NON|NRW|NLM (2024)|221027|abcdef", "ENTRY": "Reticularis, Lamina", "MN": "A11.284.295.310.070", "MH_TH": "NLM (1965)", "ST": "T024", "AN": "do not confuse entry term BASAL LAMINA with \"lamina basalis\", the basal plate of the embryonic neural tube", "MS": "A darkly stained mat-like EXTRACELLULAR MATRIX (ECM) that separates cell layers, such as EPITHELIUM from ENDOTHELIUM or a layer of CONNECTIVE TISSUE. The ECM layer that supports an overlying EPITHELIUM or ENDOTHELIUM is called basal lamina. Basement membrane (BM) can be formed by the fusion of either two adjacent basal laminae or a basal lamina with an adjacent reticular lamina of connective tissue. BM, composed mainly of TYPE IV COLLAGEN; glycoprotein LAMININ; and PROTEOGLYCAN, provides barriers as well as channels between interacting cell layers.", "PM": "67", "HN": "67(65)", "MR": "20230522", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001485"}, {"RECTYPE": "D", "MH": "Bashkiria", "AQ": "EH EP", "PRINT ENTRY": "Bashkortostan|T083|NON|EQV|NLM (1999)|980306|abcdef", "MN": "Z01.542.248.775.150", "MH_TH": "NLM (1975)", "ST": "T083", "MS": "A political subdivision of eastern RUSSIA located within Europe. It consists of a plateau and mountainous area of the Southern Urals. (From Webster's New Geographical Dictionary, 1997)", "HN": "75", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "19750101", "UI": "D001486"}, {"RECTYPE": "D", "MH": "Basidiomycota", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Basidiomycetes|T004|NON|EQV|NLM (1999)|971119|abcdef", "ENTRY": "Basidiomycotas", "MN": "B01.300.179", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid5204", "AN": "general or unspecified; prefer specifics", "MS": "A phylum of fungi that produce their sexual spores (basidiospores) on the outside of the basidium. It includes forms commonly known as mushrooms, boletes, puffballs, earthstars, stinkhorns, bird's-nest fungi, jelly fungi, bracket or shelf fungi, and rust and smut fungi.", "PM": "99; see BASIDIOMYCETES 1963-98", "HN": "99", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D001487"}, {"RECTYPE": "D", "MH": "Basilar Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Basilar Arteries", "MN": "A07.015.114.106", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The artery formed by the union of the right and left vertebral arteries; it runs from the lower to the upper border of the pons, where it bifurcates into the two posterior cerebral arteries.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001488"}, {"RECTYPE": "D", "MH": "Basilar Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Membranes, Basilar", "MN": "A10.615.179.124", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "A basement membrane in the cochlea that supports the hair cells of the ORGAN OF CORTI, consisting keratin-like fibrils. It stretches from the SPIRAL LAMINA to the basilar crest. The movement of fluid in the cochlea, induced by sound, causes displacement of the basilar membrane and subsequent stimulation of the attached hair cells which transform the mechanical signal into neural activity.", "OL": "use LABYRINTH to search BASILAR MEMBRANE 1966-74", "PM": "91; was see under COCHLEA 1990; was see under LABYRINTH 1960-89", "HN": "91(75); was see under COCHLEA 1990; was see under LABYRINTH 1960-89", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001489"}, {"RECTYPE": "D", "MH": "Basketball", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Netballs|T073|NON|REL|NLM (2020)|190401|abcdef", "ENTRY": "Basketballs|T073|NON|REL|NLM (1997)|960415|abcdef", "MN": "I03.450.642.845.117", "MH_TH": "NLM (1987)", "ST": "T056", "AN": "/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1", "PI": "Sports (1966-1986)", "MS": "A competitive team sport played on a rectangular court having a raised basket at each end.", "PM": "90; was see under SPORTS 1987-89", "HN": "90(87); was see under SPORTS 1987-89", "MR": "20190530", "DA": "19860325", "DC": "1", "DX": "19900101", "UI": "D001490"}, {"RECTYPE": "D", "MH": "Basophils", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Basophil", "MN": "A15.382.490.315.120", "MH_TH": "NLM (1966)", "ST": "T025", "MS": "Granular leukocytes characterized by a relatively pale-staining, lobate nucleus and cytoplasm containing coarse dark-staining granules of variable size and stainable by basic dyes.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001491"}, {"RECTYPE": "D", "MH": "Bass", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Serranidae|T013|NON|NRW|NLM (2006)|050114|abcdef", "ENTRY": "Perch, White", "MN": "B01.050.150.900.493.602.105", "MH_TH": "NLM (1987)", "ST": "T013", "RR": "txid46260", "PI": "Fishes (1966-1986)", "MS": "Common name for FISHES belonging to the order Perciformes and occurring in three different families.", "PM": "91; was see under PERCIFORMES 1987-90", "HN": "91(87); was see under PERCIFORMES 1987-90", "MR": "20200902", "DA": "19860415", "DC": "1", "DX": "19910101", "UI": "D001492"}, {"RECTYPE": "D", "MH": "Bathing Beaches", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Beaches, Bathing", "MN": "J03.925.080", "MH_TH": "NLM (1966)", "ST": "T083", "MS": "Beaches, both natural and man-made, used for bathing and other activities.", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001493"}, {"RECTYPE": "D", "MH": "Baths", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Bath", "MN": "E02.056.110", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "for personal hygiene or med treatment; at home or in hosp, often not plain water (see note on HYDROTHERAPY), usually with additives; do not confuse with BALNEOLOGY (see note there); general only or unspecified; prefer specifics; note MUD BATHS see MUD THERAPY & SAND BATHS see AMMOTHERAPY; bathing in seawater is probably CLIMATOTHERAPY", "MS": "The immersion or washing of the body or any of its parts in water or other medium for cleansing or medical treatment. It includes bathing for personal hygiene as well as for medical purposes with the addition of therapeutic agents, such as alkalines, antiseptics, oil, etc.", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001494"}, {"RECTYPE": "D", "MH": "Batrachotoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Batrachotoxin B|T109|T131|NON|EQV|UNK (19XX)|820902|abbcdef", "MN": "D23.946.833.033.112", "MH_TH": "NLM (1974)", "ST": "T131", "RN": "0", "AN": "from frogs; /antag permitted but consider also ANTITOXINS", "MS": "Batrachotoxin is the 20-alpha-bromobenzoate of batrachotoxin A; they are toxins from the venom of a small Colombian frog, Phyllobates aurotaenia, cause release of acetylcholine, destruction of synaptic vesicles and depolarization of nerve and muscle fibers.", "PM": "74", "HN": "74", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001496"}, {"RECTYPE": "D", "MH": "Battered Child Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Battered Child", "MN": "F03.950.750.124", "FX": "Child Abuse", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "A clinical condition resulting from repeated physical and psychological injuries inflicted on a child by the parents or caregivers.", "OL": "search CHILD ABUSE 1966-74", "PM": "91; was see under CHILD ABUSE 1975-90", "HN": "91(75); was see under CHILD ABUSE 1975-90", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001497"}, {"RECTYPE": "D", "MH": "3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester", "DS": "PYRIDINECARBOXYLIC ACID 03 1 4 DIHYDRO 2 6 DIMETHYL 5 NITRO 4 2 TRIFLUOROMETHYL PHENYL METHYL ESTER", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R5417, Bay", "MN": "D03.383.725.547.900", "PA": "Calcium Channel Agonists", "MH_TH": "NLM (2005)", "ST": "T121", "N1": "3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester", "RN": "71145-03-4", "RR": "98791-67-4 ((+)-isomer)", "AN": "a calcium channel agonist", "PI": "Pyridines (1966-1974)", "MS": "A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool.", "PM": "87", "HN": "87", "MR": "20160527", "DA": "19860602", "DC": "1", "DX": "19870101", "UI": "D001498"}, {"RECTYPE": "D", "MH": "Bayes Theorem", "PRINT ENTRY": "Bayesian Prediction|T081|EPO|REL|UNK (19XX)|860620|abcdef", "ENTRY": "Theorem, Bayes", "MN": "N06.850.520.830.600.200", "MH_TH": "NLM (1975)", "ST": "T081", "AN": "IM general only", "PI": "Probability (1966-1974)", "MS": "A theorem in probability theory named for Thomas Bayes (1702-1761). In epidemiology, it is used to obtain the probability of disease in a group of people with some characteristic on the basis of the overall rate of that disease and of the likelihood of that characteristic in healthy and diseased individuals. The most familiar application is in clinical decision analysis where it is used for estimating the probability of a particular diagnosis given the appearance of some symptoms or test result.", "OL": "search PROBABILITY 1968-74", "PM": "91; was see under PROBABILITY 1975-90", "HN": "91(75); was see under PROBABILITY 1975-90", "CATSH": "CAT LIST", "MR": "20210326", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001499"}, {"RECTYPE": "D", "MH": "BCG Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Calmette Guerin Bacillus Vaccine|T121|T129|EPO|EQV|UNK (19XX)|780201|abbcdef", "ENTRY": "Vaccine, Calmette's", "MN": "D20.215.894.135.825.100", "PA": "Adjuvants, Immunologic", "FX": "Mycobacterium bovis", "MH_TH": "NLM (1975)", "ST": "T129", "RN": "0", "MS": "An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.", "PM": "1979; see TUBERCULOSIS VACCINES 1974-1978", "HN": "1979 (1974)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D001500"}, {"RECTYPE": "D", "MH": "Bdellovibrio", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.125.050", "MH_TH": "NLM (1977)", "ST": "T007", "RN": "txid958", "PI": "Bacteria (1966-1976)", "MS": "A genus of bacteria capable of developing within other bacteria.", "PM": "77", "HN": "77", "MR": "20200813", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D001501"}, {"RECTYPE": "D", "MH": "Beak", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Bill, Avian|T023|NON|NRW|NLM (1996)|940728|abcdef", "ENTRY": "Bills, Avian", "MN": "A13.114", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "not restricted to birds", "PI": "Birds (1966-1967)", "MS": "In some animals, the jaws together with their horny covering. The beak usually refers to the bill of birds in which the whole varies greatly in form according of the food and habits of the bird. While the beak refers most commonly to birds, the anatomical counterpart is found also in the turtle, squid, and octopus. (From Webster, 3d ed & Storer, et al., General Zoology, 6th ed, p491, 755)", "PM": "68", "HN": "68", "MR": "19950313", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001502"}, {"RECTYPE": "D", "MH": "Ursidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Ursus|T015|NON|NRW|NLM (1998)|961025|abcdef", "ENTRY": "Spectacled Bears", "MN": "B01.050.150.900.649.313.750.250.761", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9632", "RR": "txid9645", "AN": "note entry terms PANDAS, GIANT and PANDAS, GREATER: PANDAS, LESSER see AILURIDAE is also available", "MS": "The family of carnivorous or omnivorous bears, having massive bodies, coarse heavy fur, relatively short limbs, and almost rudimentary tails.", "PM": "2005; see BEARS 1991-2004, see CARNIVORA 1975-1990; for PANDAS, GREATER see CARNIVORA 1997", "HN": "2005 (1975); for PANDAS, GREATER use CARNIVORA 1997", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D001503"}, {"RECTYPE": "D", "MH": "Beauty", "MN": "K01.752.210.304", "MH_TH": "NLM (1975)", "ST": "T080", "MS": "Characteristics or attributes of persons or things which elicit pleasurable feelings.", "OL": "search ESTHETICS 1966-74", "PM": "91,63-66; was see under ESTHETICS 1967-90; was heading 1963-66", "HN": "91(75)63; was see under ESTHETICS 1967-90; was heading 1963-66", "CATSH": "CAT LIST", "MR": "19900501", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001504"}, {"RECTYPE": "D", "MH": "Beauty Culture", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Culture, Beauty", "MN": "J01.576.112", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "An industry that creates products and procedures designed to enhance physical appearance and aesthetic appeal.", "MR": "20151130", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001505"}, {"RECTYPE": "D", "MH": "Beckwith-Wiedemann Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wiedemann-Beckwith Syndrome (WBS)|T019|T047|ABX|EQV|GHR (2014)|NLM (2010)|ORD (2010)|090225|abbcdeeef", "ENTRY": "Wiedemann-Beckwith Syndromes (WBS)", "MN": "C16.320.447.375", "FX": "Silver-Russell Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Tongue/abnormalities (1966-1974)", "MS": "A syndrome of multiple defects characterized primarily by umbilical hernia (HERNIA, UMBILICAL); MACROGLOSSIA; and GIGANTISM; and secondarily by visceromegaly; HYPOGLYCEMIA; and ear abnormalities.", "PM": "1983", "HN": "1983", "CATSH": "CAT LIST", "MR": "20230414", "DA": "19820426", "DC": "1", "DX": "19830101", "UI": "D001506"}, {"RECTYPE": "D", "MH": "Beclomethasone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Beclomethasone Dipropionate|T109|T121|NON|NRW|FDA SRS (2014)|JAN (19XX)|USAN (1973)|USP (19XX)|760517|abbcdeeeef", "ENTRY": "Dipropionate, Beclomethasone", "MN": "D04.210.500.883.154", "PA": "Glucocorticoids", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 9-chloro-11,17,21-trihydroxy-16-methyl-, (11beta,16beta)-", "RN": "KGZ1SLC28Z", "RR": "5B307S63B2", "PI": "Pregnanetriol (1966-1972)", "MS": "An anti-inflammatory, synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of ASTHMA.", "PM": "1977; BECODISK was indexed under HYDROCORTICOSTEROIDS 1997-2008", "HN": "1977(1973)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D001507"}, {"RECTYPE": "D", "MH": "Bed Conversion", "AQ": "EC ES HI LJ SN ST TD", "PRINT ENTRY": "Swing Beds|T058|NON|REL|UNK (19XX)|810226|abcdef", "ENTRY": "Swing Bed", "MN": "N03.349.650.250.080", "MH_TH": "NLM (1982)", "ST": "T058", "AN": "from one type of care service to another", "PI": "Hospital Planning (1968-1981)", "MS": "The reallocation of beds from one type of care service to another, as in converting acute care beds to long term care beds.", "PM": "91; was see under HEALTH FACILITY PLANNING 1982-90", "HN": "91(82); was see under HEALTH FACILITY PLANNING 1982-90", "MR": "19930916", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D001508"}, {"RECTYPE": "D", "MH": "Bed Occupancy", "AQ": "CL EC ES HI LJ MT SN ST TD", "ENTRY": "Occupancy, Bed", "MN": "N02.278.050", "FX": "Hospital Bed Capacity", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "coord IM with specific hosp or department (IM) + geog if pertinent", "MS": "A measure of inpatient health facility use based upon the average number or proportion of beds occupied for a given period of time.", "PM": "78", "HN": "78", "MR": "20180629", "DA": "19770505", "DC": "1", "DX": "19780101", "UI": "D001509"}, {"RECTYPE": "D", "MH": "Bed Rest", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Rests, Bed", "MN": "E02.075", "MH_TH": "NLM (1977)", "ST": "T061", "AN": "do not confuse with IMMOBILIZATION: TN 166", "PI": "Rest (1966-1976)", "MS": "Confinement of an individual to bed for therapeutic or experimental reasons.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "19920325", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D001510"}, {"RECTYPE": "D", "MH": "Bedbugs", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Cimex|T204|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Bedbug", "MN": "B01.050.500.131.617.412.420.150.100", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid30079", "RR": "txid79782", "AN": "do not use /drug eff for insecticides: TN 111", "MS": "Parasitic bugs of the family CIMICIDAE. Female bed bugs lay eggs in a sheltered locations such as in mattress seams. Adults and nymphal instars of Cimex feed on warm-blooded hosts. Cimex lectularius and Cimex hemipterus are implicated in human infestations.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001511"}, {"RECTYPE": "D", "MH": "Bedding and Linens", "DE": "BEDDING LINENS", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Linens|T073|NON|NRW|UNK (19XX)|741105|abcdef", "ENTRY": "Linens and Bedding", "MN": "J01.494.221", "MH_TH": "NLM (1963)", "ST": "T073", "AN": "includes all bedclothes & towels, washcloths, gowns, pajamas", "MS": "Articles of cloth, usually cotton or rayon and other synthetic or cotton-blend fabrics, used in households, hospitals, physicians' examining rooms, nursing homes, etc., for sheets, pillow cases, toweling, gowns, drapes, and the like.", "PM": "68", "HN": "68(63)", "CATSH": "CAT LIST", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001512"}, {"RECTYPE": "D", "MH": "Beds", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Mattresses|T073|NON|REL|UNK (19XX)|840620|abcdef", "ENTRY": "Bed", "MN": "E07.325.220", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Equipment on which one may lie and sleep, especially as used to care for the hospital patient.", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001513"}, {"RECTYPE": "D", "MH": "Bee Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE TO TU UR", "PRINT ENTRY": "Honeybee Venoms|T123|T131|NON|NRW|NLM (2021)|200129|abbcdef", "ENTRY": "Venoms, Honeybee", "MN": "D23.946.833.065.115", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTIVENINS; /ther use: coordinate with APITHERAPY", "PI": "Venoms (1966-1977)", "MS": "Toxins obtained from Apis mellifera (honey bee) and related species. They contain various enzymes, polypeptide toxins, and other substances, some of which are allergenic or immunogenic or both. These venoms were formerly used in rheumatism to stimulate the pituitary-adrenal system.", "PM": "78", "HN": "78", "MR": "20200527", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D001514"}, {"RECTYPE": "D", "MH": "Beer", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "ENTRY": "Beers", "MN": "J02.350.594.500", "MH_TH": "NLM (1966)", "ST": "T168", "MS": "An alcoholic beverage usually made from malted cereal grain (as barley), flavored with hops, and brewed by slow fermentation.", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001515"}, {"RECTYPE": "D", "MH": "Bees", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Honey Bee Drone|T204|NON|NRW|NLM (2023)|220323|abcdef", "ENTRY": "Honey Bee, European", "MN": "B01.050.500.131.617.720.500.500.875.387", "FX": "Propolis", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid34735", "RR": "txid7460", "AN": "does not include WASPS; for stings, coordinate with INSECT BITES AND STINGS", "MS": "Insect members of the superfamily Apoidea, found almost everywhere, particularly on flowers. About 3500 species occur in North America. They differ from most WASPS in that their young are fed honey and pollen rather than animal food.", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001516"}, {"RECTYPE": "D", "MH": "Coleoptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Beetles|T204|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Beetle", "MN": "B01.050.500.131.617.720.500.500.375", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid7041", "AN": "for killing beetles with insecticides, see note at INSECTICIDES", "MS": "Order of winged insects also known as beetles comprising over 350,000 species in 150 families. They possess hard bodies with mouthparts adapted for chewing.", "PM": "2018; see BEETLES 1963-2017", "HN": "2018(1963)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D001517"}, {"RECTYPE": "D", "MH": "Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Processes, Acceptance", "MN": "F01.145", "FX": "Genetics, Behavioral", "MH_TH": "POPLINE (1978)", "ST": "T055", "AN": "human only; general or unspecified; prefer specifics; BEHAVIOR, ANIMAL is also available", "MS": "The observable response of a man or animal to a situation.", "CATSH": "CAT LIST", "MR": "20170711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001519"}, {"RECTYPE": "D", "MH": "Behavior and Behavior Mechanisms", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Behavior And Behavior Mechanism|T054|NON|EQV|NLM (2021)|191121|abcdef", "MN": "F01", "RH": "F1 - BEHAVIOR AND BEHAVIOR MECHANISMS", "MH_TH": "NLM (1974)", "ST": "T054", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "PI": "Defense Mechanisms (1966-1997)", "MS": "The observable response made to a situation and the unconscious processes underlying it.", "PM": "1998", "HN": "1998", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001520"}, {"RECTYPE": "D", "MH": "Behavior Therapy", "DE": "BEHAVIOR THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Conditioning Therapy|T061|NON|EQV|OBSSR (2021)|UNK (19XX)|740329|CONDITIONING THER|abcdeefv", "ENTRY": "Treatment, Behavior", "MN": "F04.754.137", "FX": "Behavior Control", "MH_TH": "OBSSR (2021)", "ST": "T061", "AN": "assertiveness training: coordinate with ASSERTIVENESS; SOCIAL DETERMINANTS OF HEALTH is available ", "MS": "The application of modern theories of learning and conditioning in the treatment of behavior disorders.", "OL": "use BEHAVIOR THERAPY to search BEHAVIOR MODIFICATION 1974-78", "PM": "66", "HN": "66(64); BEHAVIOR MODIFICATION was see under BEHAVIOR THERAPY 1974-78", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001521"}, {"RECTYPE": "D", "MH": "Behavior, Animal", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Autotomy Animal|T053|NON|NRW|NLM (2021)|200612|abcdef", "ENTRY": "Animal Behaviors", "MN": "F01.145.113", "MH_TH": "NLM (1964)", "ST": "T053", "MS": "The observable response an animal makes to any situation.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20200617", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D001522"}, {"RECTYPE": "D", "MH": "Mental Disorders", "DE": "MENTAL DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Psychiatric Illness|T048|NON|EQV|NLM (2020)|190501|abcdef", "ENTRY": "Severe Mental Disorders", "MN": "F03", "RH": "F3 - MENTAL DISORDERS", "FX": "Mentally Ill Persons", "MH_TH": "NLM (1998)", "ST": "T048", "MS": "Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.", "CATSH": "CAT LIST", "MR": "20200221", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001523"}, {"RECTYPE": "D", "MH": "Behavioral Medicine", "DE": "BEHAVIORAL MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Psychology, Health|T091|NON|NRW|NLM (1997)|960327|PSYCHOL HEALTH|abcdefv", "ENTRY": "Psychologies, Health", "MN": "H02.403.090", "MH_TH": "NLM (1983)", "ST": "T091", "MS": "The interdisciplinary field concerned with the development and integration of behavioral and biomedical science, knowledge, and techniques relevant to health and illness and the application of this knowledge and these techniques to prevention, diagnosis, treatment, and rehabilitation.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19820428", "DC": "1", "DX": "19830101", "UI": "D001524"}, {"RECTYPE": "D", "MH": "Behavioral Sciences", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Proxemics|T055|NON|NRW|NLM (1997)|960416|abcdef", "ENTRY": "Sciences, Behavioral", "MN": "F04.096", "MH_TH": "NLM (1969)", "ST": "T090", "AN": "use for the specialty only", "PI": "specific discipline", "MS": "Disciplines concerned with the study of human and animal behavior.", "PM": "1969; PROXEMICS was heading 1975-96 (see under SPATIAL BEHAVIOR 1975-90 and 1997-2014)", "HN": "1969;  PROXEMICS was heading 1975-96 (see under SPATIAL BEHAVIOR 1975-90 and 1997-2014)", "CATSH": "CAT LIST", "MR": "20140616", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D001525"}, {"RECTYPE": "D", "MH": "Behavioral Symptoms", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Symptoms, Behavioral", "MN": "F01.145.126", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "general or unspecified; prefer specifics; do not confuse with BEHAVIOR", "MS": "Observable manifestations of impaired psychological functioning.", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "20040719", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001526"}, {"RECTYPE": "D", "MH": "Behaviorism", "AQ": "HI", "ENTRY": "Behaviorisms", "MN": "F02.739.138", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "a school of psychology: do not confuse with BEHAVIOR", "MS": "A psychologic theory, developed by John Broadus Watson, concerned with studying and measuring behaviors that are observable.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001527"}, {"RECTYPE": "D", "MH": "Behcet Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Triple-Symptom Complex|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Triple Symptom Complices", "MN": "C17.800.862.150", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "in translations spell Beh\u00e7et's, not Behcet's", "MS": "Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.", "PM": "2003; see BEHCET'S SYNDROME 1963-2002", "HN": "2003 (1963)", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "20030101", "UI": "D001528"}, {"RECTYPE": "D", "MH": "Belgium", "AQ": "EH EP", "MN": "Z01.542.115", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in Western Europe, bordering the North Sea, between France and the Netherlands. The capital is Brussels.", "MR": "20160708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001530"}, {"RECTYPE": "D", "MH": "Belize", "AQ": "EH EP", "PRINT ENTRY": "British Honduras|T083|NAM|EQV|UNK (19XX)|770427|abcdef", "MN": "Z01.107.169.133", "MH_TH": "NLM (1977)", "ST": "T083", "MS": "A country in CENTRAL AMERICA, bordering the Caribbean Sea, between GUATEMALA and MEXICO.", "OL": "use BELIZE to search BRITISH HONDURAS 1966-77", "HN": "78; was BRITISH HONDURAS 1966-77", "MR": "20190429", "DA": "19990101", "DC": "4", "DX": "19780101", "UI": "D001531"}, {"RECTYPE": "D", "MH": "Atropa belladonna", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Belladonna|T002|NON|EQV|NLM (1986)|990101|abcdef", "ENTRY": "belladonna, Atropa", "MN": "B01.875.800.575.912.250.908.500.049.222", "FX": "Belladonna Alkaloids", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid33113", "AN": "BLACK NIGHTSHADE see SOLANUM NIGRUM is also available", "MS": "A plant species of the genus ATROPA, family SOLANACEAE that contains ATROPINE; SCOPOLAMINE; BELLADONNA ALKALOIDS and other SOLANACEOUS ALKALOIDS. Some species in this genus are called deadly nightshade which is also a common name for SOLANUM.", "PM": "2003; see BELLADONA 1991-2003, see PLANTS, TOXIC 1986-1990, see BELLADONA 1963-1985", "HN": "2003(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001532"}, {"RECTYPE": "D", "MH": "Belladonna Alkaloids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Alkaloids, Belladonna", "MN": "D03.132.889.180", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Tropanes (1968-1974)", "MS": "Alkaloids obtained from various plants, especially the deadly nightshade (Atropa belladonna), variety acuminata; atropine, hyoscyamine and scopolamine are classical, specific antimuscarinic agents with many pharmacologic actions; used mainly as antispasmodics.", "OL": "search TROPANES 1969-74", "PM": "76; was see under BELLADONNA 1975-76, was see under TROPANES 1969-74", "HN": "76(75); was see under BELLADONNA 1975-76, was see under TROPANES 1969-74", "MR": "19920508", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D001533"}, {"RECTYPE": "D", "MH": "Bemegride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methetharimide|T109|T121|NON|EQV|UNK (19XX)|770317|abbcdef", "ENTRY": "Megimide|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef", "MN": "D03.383.725.791.100", "PA": "Respiratory System Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2,6-Piperidinedione, 4-ethyl-4-methyl-", "RN": "57DQA39DO2", "RR": "64-65-3 (Bemegride)", "MS": "A CNS stimulant that is used to induce convulsions in experimental animals. It has also been used as a respiratory stimulant and in the treatment of barbiturate overdose.", "PM": "ETHYLMETHYLGLUTARIMIDE was see under ANALEPTICS 1963", "HN": "ETHYLMETHYLGLUTARIMIDE was see under ANALEPTICS 1963", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D001534"}, {"RECTYPE": "D", "MH": "Benactyzine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Lucidil|T109|T121|TRD|NRW|UK|040112|abbcdef", "MN": "D02.241.511.085.140", "PA": "Parasympatholytics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 2-(diethylamino)ethyl ester", "RN": "595EG71R3F", "RR": "302-40-9 (Benactyzine)", "MS": "A centrally acting muscarinic antagonist. Benactyzine has been used in the treatment of depression and is used in research to investigate the role of cholinergic systems on behavior.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001535"}, {"RECTYPE": "D", "MH": "Bence Jones Protein", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, Bence Jones", "MN": "D12.776.377.715.548.900.120", "PA": "Immunologic Factors", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "9006-99-9", "MS": "An abnormal protein with unusual thermosolubility characteristics that is found in the urine of patients with MULTIPLE MYELOMA.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001536"}, {"RECTYPE": "D", "MH": "Bencyclane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "compositu, Dilangio", "MN": "D02.455.426.392.368.284.100", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Propanamine, N,N-dimethyl-3-((1-(phenylmethyl)cycloheptyl)oxy)-", "RN": "6I97Z6S135", "RR": "OZN2MG334O", "PI": "Dimethylamines (1974)", "MS": "A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.", "PM": "91; was see under CYCLOHEPTANES 1975-90", "HN": "91(75); was see under CYCLOHEPTANES 1975-90", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001537"}, {"RECTYPE": "D", "MH": "Bender-Gestalt Test", "AQ": "HI SN ST", "ENTRY": "Test, Bender-Gestalt", "MN": "F04.711.647.138", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "A psychological test consisting of nine geometric designs on cards. The subject is asked to redraw them from memory after each one is presented individually.", "CATSH": "CAT LIST", "MR": "19920526", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001538"}, {"RECTYPE": "D", "MH": "Bendroflumethiazide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bendrofluazide|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|770425|abbcdeef", "ENTRY": "Neo NaClex", "MN": "D03.633.100.174.138", "PA": "Sodium Chloride Symporter Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-dioxide", "RN": "5Q52X6ICJI", "RR": "73-48-3 (Bendroflumethiazide)", "MS": "A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001539"}, {"RECTYPE": "D", "MH": "Benin", "AQ": "EH EP", "PRINT ENTRY": "Dahomey|T083|NAM|EQV|UNK (19XX)|781219|abcdef", "ENTRY": "Republic of Benin|T083|NAM|EQV|NLM (2009)|080326|abcdef", "MN": "Z01.058.290.190.200", "MH_TH": "NLM (1980)", "ST": "T083", "MS": "A country in western Africa, south of NIGER and between TOGO and NIGERIA. Its capital is Porto-Novo.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001541"}, {"RECTYPE": "D", "MH": "Benomyl", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Fundazol|T109|T131|TRD|REL|UNK (19XX)|820120|abbcdef", "MN": "D03.633.100.103.140", "PA": "Tubulin Modulators", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Carbamic acid, (1-((butylamino)carbonyl)-1H-benzimidazol-2-yl)-, methyl ester", "RN": "TLW21058F5", "RR": "17804-35-2 (Benomyl)", "PI": "Carbamates (1972-1974)", "MS": "A systemic agricultural fungicide used for control of certain fungal diseases of stone fruit.", "PM": "91; was see under CARBAMATES 1975-90", "HN": "91(75); was see under CARBAMATES 1975-90", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D001542"}, {"RECTYPE": "D", "MH": "Benperidol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Benperidolneuraxpharm", "MN": "D02.522.352.155", "PA": "Dopamine Antagonists", "MH_TH": "USAN (1963)", "ST": "T121", "N1": "2H-Benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl)-1,3-dihydro-", "RN": "97O6X78C53", "RR": "2062-84-2 (Benperidol)", "MS": "A butyrophenone with general properties similar to those of HALOPERIDOL. It has been used in the treatment of aberrant sexual behavior. (From Martindale, The Extra Pharmacopoeia, 30th ed, p567)", "PM": "66", "HN": "66", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001544"}, {"RECTYPE": "D", "MH": "Benserazide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Seryltrihydroxybenzylhydrazine|T109|T121|NON|EQV|UNK (19XX)|780208|abbcdef", "ENTRY": "Ro 44602", "MN": "D02.442.175", "PA": "Enzyme Inhibitors", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "DL-Serine, 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide", "RN": "762OS3ZEJU", "RR": "322-35-0 (Benserazide)", "PI": "Serine (1966-1972)", "MS": "An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.", "OL": "use BENSERAZIDE to search SERYLTRIHYDROXY BENZYLHYDRAZINE 1973-78 (as Prov 73-74)", "PM": "91; was see under HYDRAZINES 1979-90; was SERYLTRIHYDROXY BENZYLHYDRAZINE see under HYDRAZINES 1975-78", "HN": "91(79); was see under HYDRAZINES 1979-90; was SERYLTRIHYDROXY BENZYLHYDRAZINE see under HYDRAZINES 1973-78 (Prov 1973-74)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001545"}, {"RECTYPE": "D", "MH": "Bentonite", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Montmorillonite|T197|NON|BRD|FDA SRS (2014)|NLM (1994)|930106|abcdeef", "ENTRY": "Montmorrillonite|T197|NON|BRD|NLM (1994)|930106|abcdef", "MN": "D01.837.725.700.760.050.100", "PA": "Antidotes", "MH_TH": "NLM (1973)", "ST": "T197", "RN": "1302-78-9", "RR": "A585MN1H2L", "PI": "Aluminum Silicates (1966-1972)", "MS": "A colloidal, hydrated aluminum silicate that swells 12 times its dry size when added to water.", "OL": "use ALUMINUM SILICATES to search BENTONITE 1966-72", "PM": "73; was see ALUMINUM SILICATES 1963-72; MONTMORILLONITE was MONTMORRILLONITE 1977-93", "HN": "73; was see ALUMINUM SILICATES 1963-72; MONTMORILLONITE was MONTMORRILLONITE 1977-93", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001546"}, {"RECTYPE": "D", "MH": "Benzaldehydes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.047.222", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Aldehydes (1966-1971)", "MS": "Compounds that consist of a benzene ring with a formyl group. They occur naturally in the seeds of many fruits and are used as FLAVORING AGENTS and fragrances, as well as precursors in pharmaceutical and plastics manufacturing.", "PM": "74", "HN": "74(72)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001547"}, {"RECTYPE": "D", "MH": "Benzalkonium Compounds", "DE": "BENZALKONIUM CPDS", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Benzalkonium Chloride|T109|T121|NON|NRW|BAN (19XX)|INN (19XX)|JAN (19XX)|NLM (1996)|941130|abbcdeeeef", "ENTRY": "Compounds, Benzalkonium", "MN": "D02.675.276.080", "PA": "Preservatives, Pharmaceutical", "MH_TH": "NLM (1964)", "ST": "T121", "RN": "0", "RR": "8001-54-5 (benzalkonium chloride)", "MS": "A mixture of alkylbenzyldimethylammonium compounds. It is a bactericidal quaternary ammonium detergent used topically in medicaments, deodorants, mouthwashes, as a surgical antiseptic, and as a as preservative and emulsifier in drugs and cosmetics.", "OL": "use BENZALKONIUM COMPOUNDS to search BENZALKONIUM 1981-83 & BENZALKONIUM CHLORIDE 1966-80 (as Prov 1966-67)", "PM": "84; was BENZALKONIUM 1981-83, was BENZALKONIUM CHLORIDE 1968-80, was BENZALKONIUM CHLORIDE see under ANTI-INFECTIVE AGENTS, LOCAL 1967, was BENZALKONIUM CHLORIDE see under ANTISEPTICS, QUATERNARY AMMONIUM 1964-66, was BENZALKONIUM see under ANTISEPTICS, QUATERNARY AMMONIUM 1963", "HN": "84; was BENZALKONIUM 1981-83, was BENZALKONIUM CHLORIDE 1964-80 (Prov 1964-67) see under ANTI-INFECTIVE AGENTS, LOCAL 1967, was BENZALKONIUM CHLORIDE see under ANTISEPTICS, QUATERNARY AMMONIUM 1964-66, was BENZALKONIUM see under ANTISEPTICS, QUATERNARY AMMONIUM 1963", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001548"}, {"RECTYPE": "D", "MH": "Benzamides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.127.085", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "PI": "Benzoates (1966-1972)", "MS": "BENZOIC ACID amides.", "OL": "use BENZAMIDES to search TRIMETHOBENZAMIDE 1966-84", "PM": "73; TRIMETHOBENZAMIDE was heading 1963-84", "HN": "73; TRIMETHOBENZAMIDE was heading 1963-84", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001549"}, {"RECTYPE": "D", "MH": "Benzamidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.078.100", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "peptidase inhib", "PI": "Benzene Derivatives (1972-1974)", "MS": "Amidines substituted with a benzene group. Benzamidine and its derivatives are known as peptidase inhibitors.", "PM": "91; was see under AMIDINES 1975-90", "HN": "91(75); was see under AMIDINES 1975-90", "MR": "19920508", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001550"}, {"RECTYPE": "D", "MH": "Benz(a)Anthracenes", "DS": "BENZANTHRACENES A", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Naphthanthracenes|T109|T131|NON|EQV|NLM (2005)|040105|abbcdef", "MN": "D04.615.149", "MH_TH": "NLM (2005)", "ST": "T131", "RN": "0", "MS": "Four fused benzyl rings with three linear and one angular, that can be viewed as a benzyl-phenanthrenes. Compare with NAPHTHACENES which are four linear rings.", "PM": "2005; see BENZANTHRACENES 1963-2005", "HN": "2005(1963)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D001551"}, {"RECTYPE": "D", "MH": "Benzazepines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.079", "FX": "Dibenzazepines", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Compounds with BENZENE fused to AZEPINES.", "PM": "68", "HN": "68", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001552"}, {"RECTYPE": "D", "MH": "Benzbromarone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Benzbromaron Ratiopharm", "MN": "D03.633.100.127.110", "PA": "Uricosuric Agents", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "Methanone, (3,5-dibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)-", "RN": "4POG0RL69O", "RR": "3562-84-3 (Benzbromarone)", "PI": "Bromine (1973-1974)", "MS": "Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.", "PM": "91; was see under BENZOFURANS 1975-90", "HN": "91(75); was see under BENZOFURANS 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001553"}, {"RECTYPE": "D", "MH": "Benzene", "AQ": "AD AE AI AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Benzol|T109|T131|NON|EQV|UNK (19XX)|790507|abbcdef", "ENTRY": "Cyclohexatriene|T109|T131|NON|EQV|NLM (1996)|950330|abbcdef", "MN": "D02.455.426.559.389.023", "EC": "analogs & derivatives:Benzene Derivatives", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Benzene", "RN": "J64922108F", "RR": "71-43-2 (Benzene)", "AN": "do not confuse with benzil or benzal", "MS": "Toxic, volatile, flammable liquid hydrocarbon byproduct of coal distillation. It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. Benzene causes central nervous system damage acutely and bone marrow damage chronically and is carcinogenic. It was formerly used as parasiticide.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001554"}, {"RECTYPE": "D", "MH": "Benzene Derivatives", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Derivatives, Benzene", "MN": "D02.455.426.559.389", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PI": "Benzene (1966-1967)", "MS": "Organic compounds derived from BENZENE.", "PM": "68", "HN": "68", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001555"}, {"RECTYPE": "D", "MH": "Hexachlorocyclohexane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "gamma-Benzene Hexachloride|T109|T131|NON|NRW|UNK (19XX)|760517|abbcdef", "ENTRY": "gamma Hexachlorocyclohexane", "MN": "D02.455.526.439.600", "PA": "Insecticides", "MH_TH": "UNK (19XX)", "ST": "T131", "N1": "Cyclohexane, 1,2,3,4,5,6-hexachloro-, (1alpha,2alpha,3beta,4alpha,5alpha,6beta)-", "RN": "59NEE7PCAB", "RR": "58-89-9 (Lindane)", "AN": "do not confuse entry term BENZENE HEXACHLORIDE with HEXACHLOROBENZENE", "MS": "Any of several polyhalogenated organic compounds consisting of a six-carbon ring with one chlorine and one hydrogen attached to each carbon.", "PM": "2019; see BENZENE HEXACHLORIDE 1963-95; LINDANE 1995-2018", "HN": "2019(1996); use BENZENE HEXACHLORIDE 1963-95; LINDANE 1995-2018", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D001556"}, {"RECTYPE": "D", "MH": "Benzenesulfonates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.886.645.600.080.050.100", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Organic salts and esters of benzenesulfonic acid.", "PM": "74", "HN": "74", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001557"}, {"RECTYPE": "D", "MH": "Benzethonium", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "PuriClens", "MN": "D02.675.276.090", "PA": "Anti-Infective Agents, Local", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Benzenemethanaminium, N,N-dimethyl-N-(2-(2-(4-(1,1,3,3-tetramethylbutyl)phenoxy)ethoxy)ethyl)-, chloride", "RN": "1VU15B70BP", "RR": "PH41D05744", "PI": "Phenyl Ethers (1974)", "MS": "Bactericidal cationic quaternary ammonium surfactant used as a topical anti-infective agent. It is an ingredient in medicaments, deodorants, mouthwashes, etc., and is used to disinfect apparatus, etc., in the food processing and pharmaceutical industries, in surgery, and also as a preservative. The compound is toxic orally as a result of neuromuscular blockade.", "OL": "use BENZETHONIUM to search BENZETHONIUM COMPOUNDS 1975-80", "PM": "91; was see under AMMONIUM COMPOUNDS 1981-90; was BENZETHONIUM CHLORIDE see under AMMONIUM COMPOUNDS 1975-80", "HN": "91(81); was see under AMMONIUM COMPOUNDS 1981-90; was BENZETHONIUM CHLORIDE see under AMMONIUM COMPOUNDS 1975-80", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001558"}, {"RECTYPE": "D", "MH": "Benzhydryl Compounds", "DE": "BENZHYDRYL CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diphenylmethyl Compounds|T109|NON|EQV|UNK (19XX)|770401|DIPHENYLMETHYL CPDS|abcdefv", "ENTRY": "Compounds, Diphenylmethyl", "MN": "D02.455.426.559.389.115", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Benzyl Compounds (1972-1974)", "MS": "Compounds which contain the methyl radical substituted with two benzene rings. Permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.", "PM": "75", "HN": "75", "MR": "19920508", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D001559"}, {"RECTYPE": "D", "MH": "Benzidines", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Biphenyldiamines|T109|T131|NON|EQV|UNK (19XX)|760421|abbcdef", "MN": "D02.455.426.559.389.185.100", "FX": "Carcinogens", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "MS": "Very toxic industrial chemicals. They are absorbed through the skin, causing lethal blood, bladder, liver, and kidney damage and are potent, broad-spectrum carcinogens in most species.", "OL": "use BENZIDINES to search BENZIDINE 1975-77; use BIPHENYL COMPOUNDS 1966-74", "PM": "77; was BENZIDINE see under AMINOBIPHENYL COMPOUNDS 1975-76, was BENZIDINE see under BIPHENYL COMPOUNDS 1966-74; 3,3'-DIAMINOBENZIDINE & DIANISIDINE were see under AMINOBIPHENYL COMPOUNDS 1975-76", "HN": "77; was BENZIDINE see under AMINOBIPHENYL COMPOUNDS 1975-76, was BENZIDINE see under BIPHENYL COMPOUNDS 1966-74", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D001560"}, {"RECTYPE": "D", "MH": "Benzilates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.511.085", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of benzylic acid, including its salts and esters,", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001561"}, {"RECTYPE": "D", "MH": "Benzimidazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.103", "FX": "Imidazoles", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds with a BENZENE fused to IMIDAZOLES.", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001562"}, {"RECTYPE": "D", "MH": "Benzo(a)pyrene", "DS": "BENZOPYRENE A", "AQ": "AA AD AE AI AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "3,4-Benzopyrene|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|840411|BENZOPYRENE AA 0304|abbcdeefs", "ENTRY": "3,4 Benzpyrene", "MN": "D04.615.799.306.300", "FX": "Bay-Region, Polycyclic Aromatic Hydrocarbon", "MH_TH": "NLM (1985)", "ST": "T131", "N1": "Benzo(a)pyrene", "RN": "3417WMA06D", "RR": "50-32-8 (Benzo(a)pyrene)", "PI": "Benzopyrenes (1966-1984)", "MS": "A potent mutagen and carcinogen. It is a public health concern because of its possible effects on industrial workers, as an environmental pollutant, an as a component of tobacco smoke.", "PM": "85", "HN": "85", "MR": "20130708", "DA": "19840411", "DC": "1", "DX": "19850101", "UI": "D001564"}, {"RECTYPE": "D", "MH": "Benzoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzoate|T109|NON|NRW|NLM (1999)|980202|abcdef", "ENTRY": "Acids, Benzoic", "MN": "D02.455.426.559.389.127", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of BENZOIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxybenzene structure.", "PM": "1963; see BENZOIC ACIDS 1999-2012; BENZOATE was indexed under BENZOATES 1980-1998", "HN": "1963", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D001565"}, {"RECTYPE": "D", "MH": "Benzocaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethyl Aminobenzoate|T109|T121|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Methanesulfonate, Benzocaine", "MN": "D02.455.426.559.389.127.020.937.687", "PA": "Anesthetics, Local", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzoic acid, 4-amino-, ethyl ester", "RN": "U3RSY48JW5", "RR": "OG625Z9LEO", "MS": "A surface anesthetic that acts by preventing transmission of impulses along NERVE FIBERS and at NERVE ENDINGS.", "PM": "65; was ETHYL AMINOBENZOATE 1963-64", "HN": "65; was ETHYL AMINOBENZOATE 1963-64", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001566"}, {"RECTYPE": "D", "MH": "Benzocycloheptenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.181", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Compounds consisting of the cycloheptene ring with one or two BENZENE rings fused to it.", "PM": "68", "HN": "68", "MR": "20161101", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001567"}, {"RECTYPE": "D", "MH": "Benzodiazepines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Benzodiazepine Compounds|T109|T121|NON|EQV|NLM (2005)|040514|BENZODIAZEPINE CPDS|abbcdefv", "MN": "D03.633.100.079.080", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "12794-10-4", "RR": "M0Q7802G2B", "AN": "do not confuse with BENZODIAZEPINONES", "PI": "Benzazepines (1968-1974)", "MS": "A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring.", "PM": "75", "HN": "75", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D001569"}, {"RECTYPE": "D", "MH": "Benzodiazepinones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.079.080.070", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "do not confuse with BENZODIAZEPINES", "PM": "74", "HN": "74", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001570"}, {"RECTYPE": "D", "MH": "Benzoflavones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Benzoflavone", "MN": "D03.633.100.150.266.450.175", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1979)", "ST": "T121", "RN": "0", "PI": "Flavones (1966-1978)", "MS": "Organic compounds containing a BENZENE ring attached to a flavone group. Some of these are potent arylhydrocarbon hydroxylase inhibitors. They may also inhibit the binding of NUCLEIC ACIDS to BENZOPYRENES and related compounds. The designation includes all isomers; the 7,8-isomer is most frequently encountered.", "PM": "91; was see under FLAVONES 1979-90", "HN": "91(79); was see under FLAVONES 1979-90", "MR": "20160527", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D001571"}, {"RECTYPE": "D", "MH": "Benzofurans", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Coumarones|T109|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Diphenylbenzofuran|T109|NON|NRW|UNK (19XX)|781219|abcdef", "MN": "D03.633.100.127", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds that contain a BENZENE ring fused to a furan ring.", "PM": "66", "HN": "66", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001572"}, {"RECTYPE": "D", "MH": "Benzoin", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "2 hydroxy 1,2 diphenylethanone", "MN": "D02.522.120.100", "MH_TH": "NLM (1963)", "ST": "T130", "N1": "Ethanone, 2-hydroxy-1,2-diphenyl-", "RN": "L7J6A1NE81", "RR": "119-53-9 (Benzoin)", "MS": "A white crystalline compound prepared by condensation of benzaldehyde in potassium cyanide and used in organic syntheses. This should not be confused with benzoin gum from STYRAX.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001573"}, {"RECTYPE": "D", "MH": "Benzolamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CL11366", "MN": "D03.383.129.708.867.120", "PA": "Carbonic Anhydrase Inhibitors", "MH_TH": "NLM (1976)", "ST": "T121", "N1": "1,3,4-Thiadiazole-2-sulfonamide, 5-((phenylsulfonyl)amino)-", "RN": "FC5AAH89R5", "RR": "3368-13-6 (Benzolamide)", "PI": "Thiadiazoles (1972-1975)", "MS": "Selective renal carbonic anhydrase inhibitor. It may also be of use in certain cases of respiratory failure.", "PM": "91; was see under THIADIAZOLES 1976-90", "HN": "91(76); was see under THIADIAZOLES 1976-90", "MR": "20160527", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D001574"}, {"RECTYPE": "D", "MH": "Benzomorphans", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Benzomorphan|T109|T121|NON|NRW|UNK (19XX)|840416|abbcdef", "MN": "D04.615.723.795.106", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "analgesics", "MS": "Morphine derivatives of the methanobenzazocine family that act as potent analgesics.", "OL": "use BENZOMORPHANS to search BENZOMORPHAN 1975-84; use MORPHINANS 1973-74 & BRIDGED COMPOUNDS 1966-72", "PM": "91; was see under MORPHINANS 1985-90; was BENZOMORPHAN see under MORPHINANS 1973-84 & see under BRIDGED COMPOUNDS 1966-72", "HN": "91(85); was see under MORPHINANS 1985-90; was BENZOMORPHAN see under MORPHINANS 1973-84 & see under BRIDGED COMPOUNDS 1966-72", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001575"}, {"RECTYPE": "D", "MH": "Benzophenoneidum", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Auramine O|T109|T121|T130|TRD|NRW|UNK (19XX)|741111|abbbcdef", "MN": "D02.092.146.215", "PA": "Disinfectants", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Benzenamine, 4,4'-carbonimidoylbis(N,N-dimethyl)-, monohydrochloride", "RN": "2465-27-2", "PI": "Imines (1972-1974)", "MS": "An aniline dye used as a disinfectant and an antiseptic agent. It is weakly fluorescing and binds specifically to certain proteins.", "PM": "91; was see under ANILINE COMPOUNDS 1975-90; PYOCTANIUM AUREUM was see BENZOPHENONEIUM 1975-95", "HN": "91(75); was see under ANILINE COMPOUNDS 1975-90; PYOCTANIUM AUREUM was see BENZOPHENONEIDUM 1975-95", "MR": "20160628", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001576"}, {"RECTYPE": "D", "MH": "Benzophenones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.522.223", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PI": "Ketones (1966-1967)", "MS": "Derivatives of benzophenone (with the structural formula phenyl-(C=O)-phenyl).", "PM": "68", "HN": "68", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001577"}, {"RECTYPE": "D", "MH": "Benzopyrans", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chromenes|T109|NON|EQV|NLM (2003)|020108|abcdef", "MN": "D03.633.100.150", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with BENZOPYRENES", "MS": "Compounds with a core of fused benzo-pyran rings.", "PM": "66", "HN": "66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001578"}, {"RECTYPE": "D", "MH": "Benzopyrene Hydroxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Benzopyrene-3-Monooxygenase|T116|T126|NON|EQV|UNK (19XX)|741111|BENZOPYRENE MONOOXYGENASE 003|abbcdefs", "ENTRY": "Hydroxylase, Benzopyrene", "MN": "D12.776.422.220.453.010.110", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.14.14.-", "AN": "a cytochrome", "PI": "Hydroxylases (1968-1974)", "MS": "A drug-metabolizing, cytochrome P-448 (P-450) enzyme which catalyzes the hydroxylation of benzopyrene to 3-hydroxybenzopyrene in the presence of reduced flavoprotein and molecular oxygen. Also acts on certain anthracene derivatives. An aspect of EC 1.14.14.1.", "PM": "91; was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76", "HN": "91(75); was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D001579"}, {"RECTYPE": "D", "MH": "Benzopyrenes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Benzpyrene|T109|T131|NON|NRW|UNK (19XX)|800917|abbcdef", "MN": "D04.615.799.306", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "do not confuse with BENZOPYRANS", "MS": "A class of chemicals that contain an anthracene ring with a naphthalene ring attached to it.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001580"}, {"RECTYPE": "D", "MH": "Benzothiadiazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.174", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Heterocyclic compounds of a ring with SULFUR and two NITROGEN atoms fused to a BENZENE ring. Members inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS and are used as DIURETICS.", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001581"}, {"RECTYPE": "D", "MH": "Benzothiepins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.197", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PM": "68", "HN": "68", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001582"}, {"RECTYPE": "D", "MH": "Benzoxazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzoxazole|T109|NON|EQV|NLM (2021)|200106|abcdef", "MN": "D03.633.100.221", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "includes benzoxazolines, benzoxazolidines", "PM": "66", "HN": "66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001583"}, {"RECTYPE": "D", "MH": "Benzoxepins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.245", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PM": "68", "HN": "68", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001584"}, {"RECTYPE": "D", "MH": "Benzoyl Peroxide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzoyl Superoxide|T109|T121|NON|EQV|UNK (19XX)|750630|abbcdef", "ENTRY": "Superoxide, Diphenylglyoxal", "MN": "D02.455.426.559.389.127.133", "PA": "Dermatologic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "W9WZN9A0GM", "RR": "94-36-0 (Benzoyl Peroxide)", "PI": "Peroxides (1972-1975)", "MS": "A peroxide derivative that has been used topically for BURNS and as a dermatologic agent in the treatment of ACNE and POISON IVY DERMATITIS. It is used also as a bleach in the food industry.", "PM": "91; was see under PEROXIDES 1976-90", "HN": "91(76); was see under PEROXIDES 1976-90", "MR": "20130708", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D001585"}, {"RECTYPE": "D", "MH": "Benzoylarginine Nitroanilide", "DE": "BAPA", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "N-alpha-Benzoyl-DL-arginine-4-nitroanilide|T116|T130|NON|NRW|NLM (1994)|921026|ALPHA BENZOYLARGININENITROANILIDE N DL 04|abbcdefs", "ENTRY": "Nitroanilide, Benzoylarginine", "MN": "D12.125.095.104.100", "PA": "Chromogenic Compounds", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Benzamide, N-(4-((aminoiminomethyl)amino)-1-(((4-nitrophenyl)amino)carbonyl)butyl)-, (+-)-", "RN": "911-76-2", "RR": "911-77-3 (mono-HCl)", "PI": "Nitro Compounds (1971-1974)", "MS": "A chromogenic substrate that permits direct measurement of peptide hydrolase activity, e.g., papain and trypsin, by colorimetry. The substrate liberates p-nitroaniline as a chromogenic product.", "OL": "use BENZOYLARGININE NITROANILIDE (NM) to search N-BENZOYLARGINYL-4-NITROANILIDE 1988-93", "PM": "91; was see under ARGININE 1975-90; N-BENZOYLARGINYL-4-NITROANILIDE was indexed under BENZOYLARGININE NITROANILIDE 1993 & ARGININE/*analogs & derivatives 1988-92", "HN": "91(75); was see under ARGININE 1975-90; N-BENZOYLARGINYL-4-NITROANILIDE was (NM) 1988-93", "MR": "20151123", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001586"}, {"RECTYPE": "D", "MH": "Benzoylarginine-2-Naphthylamide", "DE": "BANA", "DS": "BENZOYLARGININE NAPHTHYLAMIDE 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzoylarginine beta-Naphthylamide|T116|T130|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "beta-Naphthylamide, Benzoylarginine", "MN": "D12.125.095.104.095", "MH_TH": "NLM (1976)", "ST": "T130", "N1": "Benzamide, N-(4-((aminoiminomethyl)amino)-1-((2-naphthalenylamino)carbonyl)butyl)-, (+-)-", "RN": "305-09-9", "PI": "Naphthalenes (1973-1975)", "MS": "An enzyme substrate which permits the measurement of peptide hydrolase activity, e.g. trypsin and thrombin. The enzymes liberate 2-naphthylamine, which is measured by colorimetric procedures.", "OL": "use BENZOYLARGININE-2-NAPHTHYLAMIDE to search BENZOYLARGININE BETA NAPHTHYLAMIDE 1976", "PM": "91; was see under ARGININE 1977-90; was BENZOYLARGININE BETA NAPHTHYLAMIDE see under ARGININE 1976", "HN": "91(77); was see under ARGININE 1977-90; was BENZOYLARGININE BETA NAPHTHYLAMIDE see under ARGININE 1976", "MR": "20010725", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D001587"}, {"RECTYPE": "D", "MH": "Benzoylcholine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.675.276.232.100", "MH_TH": "NLM (1976)", "ST": "T109", "N1": "Ethanaminium, 2-(benzoyloxy)-N,N,N-trimethyl-", "RN": "2208-04-0", "PI": "Choline (1968-1974) /AA (1975)", "MS": "The benzoic acid ester of choline.", "PM": "91; was see under CHOLINE 1976-90", "HN": "91(76); was see under CHOLINE 1976-90", "MR": "20120703", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D001588"}, {"RECTYPE": "D", "MH": "Benzphetamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Didrex|T109|T121|TRD|NRW|UNK (19XX)|US|861119|abbcdeef", "MN": "D02.092.471.683.152.619.307", "PA": "Sympathomimetics", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Benzeneethanamine, N,alpha-dimethyl-N-(phenylmethyl)-, (S)-", "RN": "0M3S43XK27", "RR": "156-08-1 (Benzphetamine)", "MS": "A sympathomimetic agent with properties similar to DEXTROAMPHETAMINE. It is used in the treatment of obesity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222)", "PM": "91; was see under PHENETHYLAMINES 1966-90", "HN": "91(66); was see under PHENETHYLAMINES 1966-90", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001589"}, {"RECTYPE": "D", "MH": "Benztropine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "PMS Benztropine", "MN": "D03.605.869.270", "PA": "Parasympatholytics", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "8-Azabicyclo(3.2.1)octane, 3-(diphenylmethoxy)-8-methyl-, endo-", "RN": "1NHL2J4X8K", "RR": "WMJ8TL7510", "PI": "Tropanes (1972-1990)", "MS": "A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.", "PM": "1991; see TROPANES 1972-1990; BENZATROPINE METHANESULFONATE was indexed under BENZOTROPINE 1977-2005", "HN": "1991(1972); use TROPANES 1972-1990", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001590"}, {"RECTYPE": "D", "MH": "Benzydamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzindamine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Sun Benz", "MN": "D03.633.100.449.130", "PA": "Anti-Inflammatory Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Propanamine, N,N-dimethyl-3-((1-(phenylmethyl)-1H-indazol-3-yl)oxy)-", "RN": "4O21U048EF", "RR": "K2GI407R4Q", "PI": "Pyrazoles (1968-1973)", "MS": "A benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects. It is used to reduce post-surgical and post-traumatic pain and edema and to promote healing. It is also used topically in treatment of RHEUMATIC DISEASES and INFLAMMATION of the mouth and throat.", "PM": "91; was see under PYRAZOLES 1975-90", "HN": "91(75); was see under PYRAZOLES 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001591"}, {"RECTYPE": "D", "MH": "Benzyl Alcohols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenylmethanols|T109|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Alcohols, Benzyl", "MN": "D02.455.426.559.389.140.200", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "BENZYL ALCOHOL also available", "PI": "Benzyl Compounds (1972-1974)", "MS": "Alcohols derived from the aryl radical (C6H5CH2-) and defined by C6H5CHOH. The concept includes derivatives with any substituents on the benzene ring.", "PM": "91; was see under BENZYL COMPOUNDS 1975-90", "HN": "91(75); was see under BENZYL COMPOUNDS 1975-90", "MR": "19970620", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001592"}, {"RECTYPE": "D", "MH": "Benzyl Compounds", "DE": "BENZYL CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Benzyl", "MN": "D02.455.426.559.389.140", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "Benzene Derivatives (1968-1970)", "MS": "Benzene derivatives that contain a benzyl group with the general formula Phenyl-CH2-R.", "PM": "72", "HN": "72(71)", "MR": "20151201", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001593"}, {"RECTYPE": "D", "MH": "Benzyl Viologen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Viologen, Benzyl", "MN": "D03.383.725.762.925.100", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "4,4'-Bipyridinium, 1,1'-bis(phenylmethyl)-", "RN": "13096-46-3", "AN": "an indicator", "PI": "Pyridinium Compounds (1970-1974)", "MS": "1,1'-Bis(phenylmethyl)4,4'-bipyridinium dichloride. Oxidation-reduction indicator.", "PM": "91; was see under PYRIDINIUM COMPOUNDS 1975-90", "HN": "91(75); was see under PYRIDINIUM COMPOUNDS 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001594"}, {"RECTYPE": "D", "MH": "Benzylamine Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Clorgyline-Resistant Amine", "MN": "D08.811.682.664.750.100", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.4.3.-", "PI": "Monoamine Oxidase (1973-1974)", "MS": "An aspect of monoamine oxidase, EC 1.4.3.4. Catalyzes the oxidation of benzylamine to form benzaldehyde, ammonia and hydrogen peroxide.", "PM": "91; was see under MONOAMINE OXIDASE 1975-90", "HN": "91(75); was see under MONOAMINE OXIDASE 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001595"}, {"RECTYPE": "D", "MH": "Benzylamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "alpha-Aminotoluene|T109|T130|NON|NRW|UNK (19XX)|760517|abbcdef", "ENTRY": "alpha Aminotoluene", "MN": "D02.455.426.559.389.140.210", "MH_TH": "NLM (1976)", "ST": "T109", "RN": "0", "PI": "Benzyl Compounds (1974-1975)", "MS": "Toluenes in which one hydrogen of the methyl group is substituted by an amino group. Permitted are any substituents on the benzene ring or the amino group.", "PM": "87; was see under AMINES 1976-86", "HN": "87(76); was see under AMINES 1976-86", "MR": "19920508", "DA": "19750723", "DC": "1", "DX": "19870101", "UI": "D001596"}, {"RECTYPE": "D", "MH": "Benzylidene Compounds", "DE": "BENZYLIDENE CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenylmethylene Derivatives|T109|NON|EQV|NLM (2020)|190523|abcdef", "ENTRY": "Derivatives, Phenylmethylene", "MN": "D02.455.426.559.389.150", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "= benzals", "PI": "Benzene Derivatives (1968-1974)", "MS": "Compounds which include a double-bonded carbon atom that is directly attached to a benzene ring. While this category is named after the highly reactive compound benzylidene, the compounds listed under it occur through a variety of synthetic pathways.", "PM": "75", "HN": "75", "MR": "20210630", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D001597"}, {"RECTYPE": "D", "MH": "Bephenium Compounds", "DE": "BEPHENIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Derivatives, Bephenium", "MN": "D02.675.276.102", "PA": "Antinematodal Agents", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Analogs or derivatives of bephenium (N,N-dimethyl-N-(2-phenoxyethyl)benzenemethanaminium).", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001598"}, {"RECTYPE": "D", "MH": "Berberine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Umbellatine|T109|T121|NON|EQV|NLM (2001)|000510|abbcdef", "MN": "D03.633.400.168.100", "MH_TH": "NLM (1976)", "ST": "T121", "N1": "Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-", "RN": "0I8Y3P32UF", "RR": "2086-83-1 (Berberine)", "PI": "Dioxoles (1972-1974)", "MS": "An alkaloid from Hydrastis canadensis L., Berberidaceae. It is also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal.", "PM": "91; was see under BERBINES 1976-90", "HN": "91(76); was see under BERBINES 1976-90", "MR": "20160527", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D001599"}, {"RECTYPE": "D", "MH": "Berberine Alkaloids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Berbines|T109|NON|EQV|NLM (1969)|990101|abcdef", "ENTRY": "Alkaloids, Berberine", "MN": "D03.633.400.168", "MH_TH": "NLM (2001)", "ST": "T109", "RN": "0", "PI": "Alkaloids (1966-1968)", "MS": "A group of related plant alkaloids that contain the BERBERINE heterocyclic ring structure.", "PM": "2001; see BERBINES 1969-2000", "HN": "2001(1969)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D001600"}, {"RECTYPE": "D", "MH": "Bereavement", "ENTRY": "Bereavements", "MN": "F01.470.142", "FX": "Grief", "MH_TH": "NLM (1988)", "ST": "T041", "AN": "human & animal", "PI": "Grief (1968-1987)", "MS": "Refers to the whole process of grieving and mourning and is associated with a deep sense of loss and sadness.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19910620", "DA": "19870314", "DC": "1", "DX": "19880101", "UI": "D001601"}, {"RECTYPE": "D", "MH": "Beriberi", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C18.654.521.500.133.699.827.223", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by THIAMINE DEFICIENCY", "MS": "A disease caused by a deficiency of thiamine (vitamin B1) and characterized by polyneuritis, cardiac pathology, and edema. The epidemic form is found primarily in areas in which white (polished) rice is the staple food, as in Japan, China, the Philippines, India, and other countries of southeast Asia. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001602"}, {"RECTYPE": "D", "MH": "Berkelium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.075", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Berkelium", "RN": "2YQA718KUU", "RR": "7440-40-6 (Berkelium)", "MS": "A man-made radioactive actinide with atomic symbol Bk, atomic number 97, and atomic weight 247. Its valence can be +3 or +4. Twelve isotopes have been produced with mass numbers 240-251.", "MR": "20170421", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001603"}, {"RECTYPE": "D", "MH": "Berlin", "AQ": "EH EP", "MN": "Z01.542.315.182", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "includes East or West Berlin; for historical or modern Berlin", "MS": "The capital of Germany.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001604"}, {"RECTYPE": "D", "MH": "Bermuda", "AQ": "EH EP", "MN": "Z01.639.040.390", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "a British colony in the North Atlantic", "MS": "A British colony in the western North Atlantic Ocean about 640 miles east southeast of Cape Hatteras, North Carolina. It comprises a group of about 300 islands of which only about 20 are inhabited. It is called also the Bermuda Islands or the Bermudas. It was named for the Spanish explorer Juan Bermudez who visited the islands in 1515. (From Webster's New Geographical Dictionary, 1988, p140 & Room, Brewer's Dictionary of Names, 1992, p61)", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001605"}, {"RECTYPE": "D", "MH": "Bernard-Soulier Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Giant Platelet Syndrome|T047|NON|EQV|ORD (2010)|UNK (19XX)|850311|abcdeef", "ENTRY": "Syndromes, Giant Platelet", "MN": "C16.320.099.080", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Blood Platelet Disorders (1967-1985)", "MS": "A familial coagulation disorder characterized by a prolonged bleeding time, unusually large platelets, and impaired prothrombin consumption.", "PM": "1991; see BLOOD PLATELET DISORDERS 1986-1990", "HN": "1991(1986)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19850311", "DC": "1", "DX": "19910101", "UI": "D001606"}, {"RECTYPE": "D", "MH": "Berylliosis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Beryllium Disease|T047|NON|BRD|UNK (19XX)|780519|BERYLLIUM DIS|abcdefv", "ENTRY": "Beryllioses", "MN": "C24.800.225", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "do not coordinate with OCCUPATIONAL DISEASES", "PI": "Pneumoconiosis (1966-1978)", "MS": "A form of pneumoconiosis caused by inhaled rare metal BERYLLIUM or its soluble salts which are used in a wide variety of industry including alloys, ceramics, radiographic equipment, and vacuum tubes. Berylliosis is characterized by an acute inflammatory reaction in the upper airway leading to BRONCHIOLITIS; PULMONARY EDEMA; and pneumonia.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D001607"}, {"RECTYPE": "D", "MH": "Beryllium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK RE SD ST TO TU UR", "MN": "D01.552.547.080", "EC": "poisoning:Berylliosis", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Beryllium", "RN": "OW5102UV6N", "RR": "7440-41-7 (Beryllium)", "MS": "An element with the atomic symbol Be, atomic number 4, and atomic weight 9.01218. Short exposure to this element can lead to a type of poisoning known as BERYLLIOSIS.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001608"}, {"RECTYPE": "D", "MH": "Beta-Globulins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Beta Globulins", "MN": "D12.776.377.715.182", "MH_TH": "NLM (1963)", "ST": "T123", "RN": "0", "MS": "Serum proteins with an electrophoretic mobility that falls between ALPHA-GLOBULINS and GAMMA-GLOBULINS.", "OL": "use BETA-GLOBULINS to search BETA GLOBULIN 1966-74", "PM": "75; was BETA GLOBULIN 1965-74", "HN": "75; was BETA GLOBULIN 1963-74 (Prov 1963-64)", "MR": "20050701", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001609"}, {"RECTYPE": "D", "MH": "Beta Particles", "AQ": "AE CL HI TU", "PRINT ENTRY": "Beta Rays|T070|NON|REL|NLM (1985)|990101|abcdef", "ENTRY": "Rays, Beta", "MN": "G01.750.750.125", "MH_TH": "UNK (19XX)", "ST": "T070", "PI": "Radiation (1966-1984)", "MS": "High energy POSITRONS or ELECTRONS ejected from a disintegrating atomic nucleus.", "PM": "2010; BETA RAYS 1985-2009", "HN": "2010 (1985)", "MR": "20110624", "DA": "19840224", "DC": "1", "DX": "19850101", "UI": "D001610"}, {"RECTYPE": "D", "MH": "Beta Rhythm", "AQ": "DE GE IM PH RE", "ENTRY": "Rhythms, Beta", "MN": "G11.561.127.750", "MH_TH": "NLM (1975)", "ST": "T042", "MS": "Brain waves with frequency between 15-30 Hz seen on EEG during wakefulness and mental activity.", "PM": "91; was see under ELECTROENCEPHALOGRAPHY 1975-90", "HN": "91(75); was see under ELECTROENCEPHALOGRAPHY 1975-90", "CATSH": "CAT LIST", "MR": "20140616", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D001611"}, {"RECTYPE": "D", "MH": "beta 2-Microglobulin", "DS": "BETA MICROGLOBULIN 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thymotaxin|T116|T129|NON|EQV|NLM (1991)|900302|abbcdef", "ENTRY": "beta 2 Microglobulin", "MN": "D23.050.705.552.100.175", "MH_TH": "NLM (1975)", "ST": "T129", "RN": "0", "PI": "Beta Globulins (1973-1974)", "MS": "An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants.", "PM": "1991; see BETA 2 MICROGLOBULIN 1984-1990; BETA 2-MICROGLOBULIN was indexed under BETA GLOBULINS 1975-1983", "HN": "1991 (1975); use BETA 2 MICROGLOBULIN 1984-1990", "MR": "20230316", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D001613"}, {"RECTYPE": "D", "MH": "beta-Amylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Amylase", "MN": "D08.811.277.450.066.100", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "1,4-alpha-D-Glucan maltohydrolase", "RN": "EC 3.2.1.2", "PI": "Amylases (1966-1977)", "MS": "An enzyme that catalyzes the hydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides so as to remove successive beta-maltose units from the non-reducing ends of the chains. EC 3.2.1.2.", "PM": "91; was see under AMYLASES 1978-90", "HN": "91(78); was see under AMYLASES 1978-90", "MR": "20030709", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D001614"}, {"RECTYPE": "D", "MH": "beta-Endorphin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Endorphin, beta|T116|T123|NON|EQV|UNK (19XX)|870504|abbcdef", "ENTRY": "beta Endorphin", "MN": "D12.776.631.650.575.241.080", "PA": "Neurotransmitter Agents", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "60617-12-1", "PI": "Peptides (1966-1977)", "MS": "A 31-amino acid peptide that is the C-terminal fragment of BETA-LIPOTROPIN. It acts on OPIOID RECEPTORS and is an analgesic. Its first four amino acids at the N-terminal are identical to the tetrapeptide sequence of METHIONINE ENKEPHALIN and LEUCINE ENKEPHALIN.", "PM": "1988; BETA-ENDORPHIN (1-31) was indexed under BETA-ENDORPHIN & PEPTIDE FRAGMENTS 1985-2006", "HN": "1988 (1985)", "MR": "20151123", "DA": "19870504", "DC": "1", "DX": "19880101", "UI": "D001615"}, {"RECTYPE": "D", "MH": "beta-Galactosidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lactases|T116|T126|NON|EQV|UNK (19XX)|770331|abbcdef", "ENTRY": "beta Galactosidases", "MN": "D08.811.277.450.410.100", "FX": "Gangliosidosis, GM1", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "beta-D-Galactoside galactohydrolase", "RN": "EC 3.2.1.23", "AN": "/defic: consider also LACTOSE INTOLERANCE and GANGLIOSIDOSIS, GM1", "PI": "Galactosidases (1966-1977)", "MS": "A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1.", "OL": "use BETA-GALACTOSIDASE to search BETA-GALACTOSIDASES 1978-91", "PM": "92; was BETA-GALACTOSIDASES 1978-91 (see under GALACTOSIDASES 1978-90)", "HN": "92; was BETA-GALACTOSIDASES 1978-91 (see under GALACTOSIDASES 1978-90)", "MR": "20160705", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D001616"}, {"RECTYPE": "D", "MH": "beta-Glucosidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cellobiases|T116|T126|NON|EQV|UNK (19XX)|770329|abbcdef", "ENTRY": "beta-D-Glucosidase, Emulsion", "MN": "D08.811.277.450.420.200.100", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "beta-D-Glucoside glucohydrolase", "RN": "EC 3.2.1.21", "PI": "Glucosidases (1966-1977)", "MS": "An exocellulase with specificity for a variety of beta-D-glycoside substrates. It catalyzes the hydrolysis of terminal non-reducing residues in beta-D-glucosides with release of GLUCOSE.", "OL": "use BETA-GLUCOSIDASE to search BETA-GLUCOSIDASES 1978-91", "PM": "92; was BETA-GLUCOSIDASES 1978-91 (see under GLUCOSIDASES 1978-90)", "HN": "92; was BETA-GLUCOSIDASES 1978-91 (see under GLUCOSIDASES 1978-90)", "MR": "20030709", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D001617"}, {"RECTYPE": "D", "MH": "beta-Lactamases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Lactamases", "MN": "D08.811.277.087.180", "EC": "antagonists & inhibitors:beta-Lactamase Inhibitors", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "beta-Lactamhydrolase", "RN": "EC 3.5.2.6", "PI": "Penicillinase (1966-1978)", "MS": "Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins.", "PM": "79", "HN": "79", "MR": "20140610", "DA": "19780516", "DC": "1", "DX": "19790101", "UI": "D001618"}, {"RECTYPE": "D", "MH": "beta-N-Acetylhexosaminidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-N-Acetylhexosaminidase|T116|T126|NON|EQV|NLM (1987)|990101|BETA ACETYLHEXOSAMINIDASE N|abbcdefs", "ENTRY": "beta N Acetylhexosaminidases", "MN": "D08.811.277.450.483.180", "FX": "Tay-Sachs Disease", "MH_TH": "NLM (2008)", "ST": "T126", "N1": "beta-N-Acetyl-D-hexosaminide N-acetylhexosaminohydrolase", "RN": "EC 3.2.1.52", "AN": "do not confuse with ACETYLGLUCOSAMINIDASE; /defic: consider also TAY SACHS DISEASE and SANDHOFF DISEASE", "PI": "Hexosaminidases (1971-1986)", "MS": "A hexosaminidase specific for non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. It acts on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES. Two specific mammalian isoenzymes of beta-N-acetylhexoaminidase are referred to as HEXOSAMINIDASE A and HEXOSAMINIDASE B. Deficiency of the type A isoenzyme causes TAY-SACHS DISEASE, while deficiency of both A and B isozymes causes SANDHOFF DISEASE. The enzyme has also been used as a tumor marker to distinguish between malignant and benign disease.", "PM": "2008; see BETA-N-ACETYL-D-HEXOSAMINIDASE 1988-2007", "HN": "2008(1988)", "MR": "20070709", "DA": "19860602", "DC": "1", "DX": "19870101", "UI": "D001619"}, {"RECTYPE": "D", "MH": "beta-Thromboglobulin", "DE": "BETA TG", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Thromboglobulin", "MN": "D23.529.374.200.070", "MH_TH": "NLM (1980)", "ST": "T123", "RN": "0", "PI": "Beta Globulins (1966-1979)", "MS": "A platelet-specific protein which is released when platelets aggregate. Elevated plasma levels have been reported after deep venous thrombosis, pre-eclampsia, myocardial infarction with mural thrombosis, and myeloproliferative disorders. Measurement of beta-thromboglobulin in biological fluids by radioimmunoassay is used for the diagnosis and assessment of progress of thromboembolic disorders.", "PM": "87; was see under BETA GLOBULINS 1980-86", "HN": "87(80); was see under BETA GLOBULINS 1980-86", "MR": "20180701", "DA": "19790523", "DC": "1", "DX": "19870101", "UI": "D001620"}, {"RECTYPE": "D", "MH": "Betahistine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "PT9", "MN": "D03.383.725.086", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Pyridineethanamine, N-methyl-", "RN": "X32KK4201D", "RR": "64335-09-7 (di-HBr)", "MS": "A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.", "PM": "91; was see under PYRIDINES 1967-90", "HN": "91(67); was see under PYRIDINES 1967-90", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001621"}, {"RECTYPE": "D", "MH": "Betaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxyneurine|T109|T121|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Stea16", "MN": "D02.675.276.125", "PA": "Lipotropic Agents", "MH_TH": "NLM (1964)", "ST": "T121", "N1": "Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt", "RN": "3SCV180C9W", "RR": "JK8U8K4D6K", "MS": "A naturally occurring compound that has been of interest for its role in osmoregulation. As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1341)", "PM": "68", "HN": "68(64)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001622"}, {"RECTYPE": "D", "MH": "Betamethasone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Flubenisolone|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef", "ENTRY": "Cellestoderm|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef", "MN": "D04.210.500.908.093", "PA": "Glucocorticoids", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11beta,16beta)-", "RN": "9842X06Q6M", "RR": "378-44-9 (Betamethasone)", "MS": "A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724)", "PM": "64", "HN": "64(63)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D001623"}, {"RECTYPE": "D", "MH": "Betamethasone Valerate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Flubenisolonvalerate|T109|T121|NON|EQV|UNK (19XX)|750630|abbcdef", "ENTRY": "Valerate, Betamethasone", "MN": "D04.210.500.908.093.150", "PA": "Glucocorticoids", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-, (11beta,16beta)-", "RN": "9IFA5XM7R2", "RR": "2152-44-5 (Betamethasone Valerate)", "PI": "Valerates (1974-1975)", "MS": "The 17-valerate derivative of BETAMETHASONE. It has substantial topical anti-inflammatory activity and relatively low systemic anti-inflammatory activity.", "PM": "91; was see under BETAMETHASONE 1976-90", "HN": "91(76); was see under BETAMETHASONE 1976-90", "MR": "20160527", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D001624"}, {"RECTYPE": "D", "MH": "Betazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ametazole|T109|T121|NON|EQV|BAN (19XX)|741111|abbcdef", "ENTRY": "Monohydrochloride, Betazole", "MN": "D03.383.129.539.100", "PA": "Histamine Agonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1H-Pyrazole-3-ethanamine", "RN": "1C065P542O", "RR": "138-92-1 (di-HCl)", "PI": "Pyrazoles (1968-1974)", "MS": "A histamine H2 agonist used clinically to test gastric secretory function.", "PM": "91; was see under PYRAZOLES 1975-90", "HN": "91(75); was see under PYRAZOLES 1975-90", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001625"}, {"RECTYPE": "D", "MH": "Bethanechol Compounds", "DE": "BETHANECHOL CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Bethanechol", "MN": "D02.675.276.148", "MH_TH": "NLM (1964)", "ST": "T121", "RN": "0", "AN": "BETHANECHOL is also available", "MS": "Quaternary ammonium compounds that include BETHANECHOL.", "OL": "use BETHANECHOL COMPOUNDS to search BETHANECHOL 1966-67 (as Prov 1966-67) & URECHOLINE CHLORIDE 1968-76", "PM": "68", "HN": "68; was BETHANECHOL 1964-67 (Prov); URECHOLINE was URECHOLINE CHLORIDE see under BETHANECHOL COMPOUNDS 1968-76", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001626"}, {"RECTYPE": "D", "MH": "Bethanidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Bethanidine", "MN": "D02.078.370.120", "PA": "Sympatholytics", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Guanidine, N,N'-dimethyl-N''-(phenylmethyl)-", "RN": "W8S3YM7AUU", "RR": "J4THI5N7O2", "PI": "Guanidines (1968-1974)", "MS": "A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear.", "PM": "91; was see under GUANIDINES 1975-90", "HN": "91(75); was see under GUANIDINES 1975-90", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001627"}, {"RECTYPE": "D", "MH": "Beverages", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "ENTRY": "Beverage", "MN": "J02.200", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "general or unspecified; note several specific types of beverages are available", "MS": "Liquids that are suitable for drinking. (From Merriam Webster Collegiate Dictionary, 10th ed)", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001628"}, {"RECTYPE": "D", "MH": "Bezafibrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Beza Puren", "MN": "D02.455.426.559.389.657.654.305.249", "PA": "Hypolipidemic Agents", "MH_TH": "USAN (1978)", "ST": "T121", "N1": "Propanoic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl-", "RN": "Y9449Q51XH", "RR": "41859-67-0 (Bezafibrate)", "PI": "Phenylbutyrates (1977-1978)", "MS": "An antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW DENSITY LIPOPROTEINS and increases HIGH DENSITY LIPOPROTEINS.", "PM": "84", "HN": "84", "MR": "20170117", "DA": "19830317", "DC": "1", "DX": "19840101", "UI": "D001629"}, {"RECTYPE": "D", "MH": "Bezoars", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Trichobezoars|T167|NON|NRW|UNK (19XX)|790412|abcdef", "ENTRY": "Trichobezoar", "MN": "C26.392.183", "MH_TH": "NLM (1966)", "ST": "T167", "AN": "concretions from ingested foreign matter; coord IM with organ (IM), not organ/dis: Manual 21.39", "MS": "Concretions of swallowed hair, fruit or vegetable fibers, or similar substances found in the alimentary canal.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001630"}, {"RECTYPE": "D", "MH": "Bhutan", "AQ": "EH EP", "MN": "Z01.252.245.782.750", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "a kingdom in the eastern Himalayas", "MS": "A kingdom in the eastern Himalayas on the northeast border of India, bounded on the north by Tibet, on the east by Assam, on the south by Assam and West Bengal, and on the west by Sikkim and Tibet. From 1720 to 1970 it was under Chinese or Indian domination. In 1971 it became a member of the United Nations. The name comes from the Sanskrit bhota, the name for Tibet, + anta, end, with reference to its location at the southern extremity of Tibet. (From Webster's New Geographical Dictionary, 1988, p144 & Room, Brewer's Dictionary of Names, 1992, p64)", "MR": "20220708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001631"}, {"RECTYPE": "D", "MH": "Bibenzyls", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bisbenzyls|T109|NON|EQV|NLM (2020)|190524|abcdef", "MN": "D02.455.426.559.389.140.308", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Compounds that include 1,2-diphenylethane in their structure.", "PM": "68", "HN": "68", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001632"}, {"RECTYPE": "D", "MH": "Bible", "ENTRY": "Scriptural Interpretations", "MN": "K01.517.172", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "Old and New Testament only: does not include Koran (index under ISLAM + specific aspect discussed in article); includes Talmud; CATALOGER: Use NAF entry", "MS": "The book composed of writings generally accepted by Christians as inspired by God and of divine authority. (Webster, 3d ed)", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001633"}, {"RECTYPE": "D", "MH": "Bibliographies as Topic", "PRINT ENTRY": "Bibliography as Topic|T170|NON|EQV|NLM (2008)|070622|abcdef", "ENTRY": "as Topics, Bibliography", "MN": "L01.462.750.183", "FX": "Documentation", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "do not confuse with Publication Type BIBLIOGRAPHY; for bibliography on specific subject, index under subject (IM) + the Publication Type BIBLIOGRAPHY; differentiate from LITERATURE; medical bibliography: see note on BIBLIOGRAPHY OF MEDICINE; lists of books: consider also BOOK SELECTION", "MS": "Works about lists of books, articles, and other publications.", "PM": "2008; see BIBLIOGRAPHY 1963-2007", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D001634"}, {"RECTYPE": "D", "MH": "Bibliography of Medicine", "DE": "BIBLIOG MED", "ENTRY": "Medicine Bibliography", "MN": "L01.462.750.183.224", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "IM for bibliography of medicine as a subject; do not use for specific medical subjects: use BIBLIOGRAPHIES AS TOPIC instead but see note there", "MS": "A list of works, documents, and other publications on medical subjects and topics of interest to the field of medicine.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001635"}, {"RECTYPE": "D", "MH": "Bibliography, Descriptive", "DE": "BIBLIOG DESCRIPTIVE", "ENTRY": "Descriptive Bibliography|T170|NON|EQV|NLM (1995)|931124|DESCRIPTIVE BIBLIOG|abcdefv", "MN": "L01.462.750.183.190", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "INDEXER: Do not use", "MS": "The area of bibliography which makes known precisely the material conditions of books, i.e., the full name of the author, the exact title of the work, the date and place of publication, the publisher's and printer's names, the format, the pagination, typographical particulars, illustrations, and the price, and for old books, other characteristics such as the kind of paper, binding, etc. It is also called analytical bibliography and physical bibliography. (Harrod's Librarians' Glossary, 7th ed)", "PM": "INSCRIPTIONS was heading 1963-65", "HN": "INSCRIPTIONS was heading 1963-65", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001636"}, {"RECTYPE": "D", "MH": "Bibliography, National", "DE": "BIBLIOG NATIONAL", "ENTRY": "National Bibliography|T170|NON|EQV|NLM (1995)|931124|NATIONAL BIBLIOG|abcdefv", "MN": "L01.462.500.682.099.183", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "INDEXER: Do not use", "MS": "A bibliography which lists all the books and other publications published, or distributed in significant quantity, in a particular country. Sometimes the term is used with respect to the new publications published within a specific period, and sometimes with respect to all those published within a lengthy period of many years. It is also used to indicate a bibliography of publications about a country (whether written by its nationals or not) and those written in the language of the country as well as those published in it. (Harrod's Librarians' Glossary, 7th ed)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001637"}, {"RECTYPE": "D", "MH": "Bibliotherapy", "DE": "BIBLIOTHER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Bibliotherapies", "MN": "F04.754.168", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "A form of supportive psychotherapy in which the patient is given carefully selected material to read.", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001638"}, {"RECTYPE": "D", "MH": "Bicarbonates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydrogen Carbonates|T197|NON|EQV|NLM (1994)|930106|abcdef", "ENTRY": "Ions, Carbonic Acid", "MN": "D01.248.497.158.165.100", "PA": "Buffers", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "RR": "HN1ZRA3Q20", "MS": "Inorganic salts that contain the -HCO3 radical. They are an important factor in determining the pH of the blood and the concentration of bicarbonate ions is regulated by the kidney. Levels in the blood are an index of the alkali reserve or buffering capacity.", "OL": "use BICARBONATES (NM) to search BICARBONATE ION 1981-93", "PM": "BICARBONATE ION was indexed under BICARBONATES 1981-93", "HN": "BICARBONATE ION was (NM) 1981-93", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001639"}, {"RECTYPE": "D", "MH": "Bicuculline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "6-(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)furo(3,4-e)1,3-benzodioxol-8(6H)one|T109|T121|NON|EQV|NLM (1995)|940329|abbcdef", "MN": "D03.633.100.531.085.077", "PA": "GABA-A Receptor Antagonists", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Furo(3,4-e)-1,3-benzodioxol-8(6H)-one, 6-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (R-(R*,S*))-", "RN": "Y37615DVKC", "RR": "485-49-4 (Bicuculline)", "PI": "Isoquinolines (1971-1974)", "MS": "An isoquinoline alkaloid obtained from Dicentra cucullaria and other plants. It is a competitive antagonist for GABA-A receptors.", "PM": "80; was see under ISOQUINOLINES 1975-79", "HN": "80(75); was see under ISOQUINOLINES 1975-79", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D001640"}, {"RECTYPE": "D", "MH": "Bicuspid", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Premolar|T023|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Premolars", "MN": "A14.549.167.860.150", "MH_TH": "NLM (1965)", "ST": "T023", "AN": "between the canine & molar teeth; NIM when merely locational", "MS": "One of the eight permanent teeth, two on either side in each jaw, between the canines (CUSPID) and the molars (MOLAR), serving for grinding and crushing food. The upper have two cusps (bicuspid) but the lower have one to three. (Jablonski, Dictionary of Dentistry, 1992, p822)", "PM": "65", "HN": "65", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001641"}, {"RECTYPE": "D", "MH": "Bicycling", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "MN": "I03.450.642.845.140", "MH_TH": "NLM (1983)", "ST": "T056", "PI": "Exertion (1966-1982)", "MS": "The use of a bicycle for transportation or recreation. It does not include the use of a bicycle in studying the body's response to physical exertion (BICYCLE ERGOMETRY TEST see EXERCISE TEST).", "PM": "90; was see under SPORTS 1983-89", "HN": "90(83); was see under SPORTS 1983-89", "MR": "19970620", "DA": "19820428", "DC": "1", "DX": "19900101", "UI": "D001642"}, {"RECTYPE": "D", "MH": "Bridged Bicyclo Compounds", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bicyclo Compounds|T109|NON|REL|NLM (1975)|990101|BICYCLO CPDS|abcdefv", "ENTRY": "Bicyclo Compounds, Bridged", "MN": "D04.075.080", "MH_TH": "NLM (2017)", "ST": "T109", "RN": "0", "MS": "Saturated alicyclic hydrocarbon molecules consisting of two rings that have two non-adjacent atoms in common.", "PM": "2017; was see under BRIDGED COMPOUNDS 1975-1990", "HN": "2017(1975)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001643"}, {"RECTYPE": "D", "MH": "Bifidobacterium", "DE": "BIFIDOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.100", "MH_TH": "NLM (1984)", "ST": "T007", "RN": "txid1678", "AN": "infection: coordinate with BIFIDOBACTERIALES INFECTIONS ", "PI": "Actinomycetales (1967-1974)", "MS": "A rod-shaped, gram-positive, non-acid-fast, non-spore-forming, non-motile bacterium that is a genus of the family Bifidobacteriaceae, order Bifidobacteriales, class ACTINOBACTERIA. It inhabits the intestines and feces of humans as well as the human vagina.", "PM": "84", "HN": "84", "MR": "20200813", "DA": "19830310", "DC": "1", "DX": "19840101", "UI": "D001644"}, {"RECTYPE": "D", "MH": "Biguanides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Biguanide|T109|NON|EQV|NLM (2021)|200113|abcdef", "MN": "D02.078.370.141", "MH_TH": "NLM (1965)", "ST": "T109", "RN": "0", "MS": "Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.", "PM": "66", "HN": "66(65)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001645"}, {"RECTYPE": "D", "MH": "Bile", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Sludge, Biliary|T031|NON|NRW|NLM (1996)|950109|abcdef", "MN": "A12.200.087", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum.", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001646"}, {"RECTYPE": "D", "MH": "Bile Acids and Salts", "DE": "BILE ACIDS SALTS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bile Salts|T109|T123|NON|NRW|UNK (19XX)|770312|abbcdef", "ENTRY": "Salts, Bile", "MN": "D04.210.500.105", "PA": "Gastrointestinal Agents", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001647"}, {"RECTYPE": "D", "MH": "Bile Canaliculi", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Canaliculus, Bile", "MN": "A03.620.150.125", "MH_TH": "NLM (1981)", "ST": "T023", "AN": "also called \"bile capillaries\"", "PI": "Bile Ducts, Intrahepatic (1966-1980)", "MS": "Minute intercellular channels that occur between liver cells and carry bile towards interlobar bile ducts. Also called bile capillaries.", "OL": "search BILE DUCTS, INTRAHEPATIC 1980", "PM": "91; was see under BILE DUCTS, INTRAHEPATIC 1981-90; was see BILE DUCTS, INTRAHEPATIC 1980", "HN": "91(81); was see under BILE DUCTS, INTRAHEPATIC 1981-90; was see BILE DUCTS, INTRAHEPATIC 1980", "MR": "19900413", "DA": "19800409", "DC": "1", "DX": "19910101", "UI": "D001648"}, {"RECTYPE": "D", "MH": "Bile Duct Diseases", "DE": "BILE DUCT DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Duct Diseases, Bile", "MN": "C06.130.120", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "specific bile duct", "MS": "Diseases in any part of the ductal system of the BILIARY TRACT from the smallest BILE CANALICULI to the largest COMMON BILE DUCT.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D001649"}, {"RECTYPE": "D", "MH": "Bile Duct Neoplasms", "DE": "BILE DUCT NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cancer of Bile Duct|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Bile Duct", "MN": "C06.301.120.250", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with specific bile duct (IM) + histol type of neopl (IM)", "MS": "Tumors or cancer of the BILE DUCTS.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001650"}, {"RECTYPE": "D", "MH": "Cholestasis, Extrahepatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Extrahepatic Cholestasis|T047|NON|EQV|NLM (2004)|021115|abcdef", "ENTRY": "Extrahepatic Biliary Stasis", "MN": "C06.130.120.135.150", "FX": "Jaundice, Obstructive", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "coord IM with specific bile duct (IM) or specific precoord bile duct dis (IM)", "PI": "specific extrahepatic bile duct (1966-1979)", "MS": "Impairment of bile flow in the large BILE DUCTS by mechanical obstruction or stricture due to benign or malignant processes.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D001651"}, {"RECTYPE": "D", "MH": "Bile Ducts", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ducts, Bile", "MN": "A03.159.183", "FX": "Portoenterostomy, Hepatic", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The channels that collect and transport the bile secretion from the BILE CANALICULI, the smallest branch of the BILIARY TRACT in the LIVER, through the bile ductules, the bile ducts out the liver, and to the GALLBLADDER for storage.", "MR": "20160809", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001652"}, {"RECTYPE": "D", "MH": "Bile Ducts, Intrahepatic", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Intrahepatic Bile Ducts", "MN": "A03.620.150", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "do not confuse with BILE DUCTS, EXTRAHEPATIC; do not confuse with HEPATIC DUCT, COMMON, the external junction of right & left hepatic ducts; diseases: coord IM with BILE DUCT DISEASES (IM); neopl: coord IM with BILE DUCT NEOPLASMS (IM); inflammation: coord IM with CHOLANGITIS (IM); BILE DUCT OBSTRUCTION, INTRAHEPATIC see CHOLESTASIS, INTRAHEPATIC is also available", "MS": "Passages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct.", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001653"}, {"RECTYPE": "D", "MH": "Bile Pigments", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Pigments, Bile", "MN": "D23.767.193", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Linear TETRAPYRROLES that give a characteristic color to BILE including: BILIRUBIN; BILIVERDIN; and bilicyanin.", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001654"}, {"RECTYPE": "D", "MH": "Bile Reflux", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Reflux, Bile", "MN": "C06.405.748.240.140", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Gastritis (1966-1980)", "MS": "Retrograde bile flow. Reflux of bile can be from the duodenum to the stomach (DUODENOGASTRIC REFLUX); to the esophagus (GASTROESOPHAGEAL REFLUX); or to the PANCREAS.", "PM": "91; was see under BILIARY TRACT DISEASES 1981-90", "HN": "91(81); was see under BILIARY TRACT DISEASES 1981-90", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19800404", "DC": "1", "DX": "19910101", "UI": "D001655"}, {"RECTYPE": "D", "MH": "Biliary Atresia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Atresia, Biliary|T019|T047|NON|EQV|NLM (1995)|940105|abbcdef", "ENTRY": "Atresia, Intrahepatic Biliary", "MN": "C16.131.314.125", "FX": "Portoenterostomy, Hepatic", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Bile Ducts/abnormalities (1966-1986)", "MS": "Progressive destruction or the absence of all or part of the extrahepatic BILE DUCTS, resulting in the complete obstruction of BILE flow. Usually, biliary atresia is found in infants and accounts for one third of the neonatal cholestatic JAUNDICE.", "PM": "1987", "HN": "1987", "CATSH": "CAT LIST", "MR": "20180521", "DA": "19860403", "DC": "1", "DX": "19870101", "UI": "D001656"}, {"RECTYPE": "D", "MH": "Biliary Dyskinesia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gallbladder Dyskinesia|T047|NON|NRW|NLM (2005)|031021|abcdef", "ENTRY": "Gallbladder Dyskinesias", "MN": "C06.130.120.250.098", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A motility disorder characterized by biliary COLIC, absence of GALLSTONES, and an abnormal GALLBLADDER ejection fraction. It is caused by gallbladder dyskinesia and/or SPHINCTER OF ODDI DYSFUNCTION.", "CATSH": "CAT LIST", "MR": "20050801", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001657"}, {"RECTYPE": "D", "MH": "Biliary Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fistulas, Biliary", "MN": "C23.300.575.185.150", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "coord IM with specific precoord biliary tract/dis heading (IM); fistula policy: Manual 23.19+", "MS": "Abnormal passage in any organ of the biliary tract or between biliary organs and other organs.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001658"}, {"RECTYPE": "D", "MH": "Biliary Tract", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE UL VI", "ENTRY": "Tree, Biliary", "MN": "A03.159", "FX": "Cholecystography", "EC": "surgery:Biliary Tract Surgical Procedures", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The BILE DUCTS and the GALLBLADDER.", "MR": "20160318", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001659"}, {"RECTYPE": "D", "MH": "Biliary Tract Diseases", "DE": "BILIARY TRACT DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tract Diseases, Biliary", "MN": "C06.130", "FX": "Cholangiography", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; biliary empyema equals EMPYEMA and BILIARY TRACT DISEASES or if of gallbladder, EMPYEMA, GALLBLADDER see CHOLECYSTITIS; inflammatory disease equals CHOLECYSTITIS or CHOLANGITIS; calculi equals BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS", "MS": "Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001660"}, {"RECTYPE": "D", "MH": "Biliary Tract Neoplasms", "DE": "BILIARY TRACT NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cancer of Biliary Tract|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Biliary Tract", "MN": "C06.301.120", "MH_TH": "NLM (1980)", "ST": "T191", "AN": "general or unspecified; prefer specifics; coordinate with histological type of neoplasm ", "PI": "Gallbladder Neoplasms (1966-1979)", "MS": "Tumors or cancer in the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D001661"}, {"RECTYPE": "D", "MH": "Biliary Tract Surgical Procedures", "DE": "BILIARY TRACT SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Biliary Surgical Procedures|T061|NON|EQV|NLM (1998)|970210|BILIARY SURG PROCEDURES|abcdefv", "ENTRY": "Surgical Procedures, Biliary Tract|T061|NON|EQV|NLM (1998)|970210|SURG PROCEDURES BILIARY TRACT|abcdefv", "MN": "E04.210.120", "MH_TH": "NLM (1988)", "ST": "T061", "AN": "general or unspecified only: prefer specific organ with /surg or specific biliary surgical technique", "PI": "Biliary Tract/surgery (1966-1987)", "MS": "Any surgical procedure performed on the biliary tract.", "PM": "98; see BILIARY TRACT SURGERY 1988-97", "HN": "98(88)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19870323", "DC": "1", "DX": "19880101", "UI": "D001662"}, {"RECTYPE": "D", "MH": "Bilirubin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "delta Bilirubin", "MN": "D23.767.193.184", "PA": "Antioxidants", "FX": "Hyperbilirubinemia", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "21H-Biline-8,12-dipropanoic acid, 2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-", "RN": "RFM9X3LJ49", "RR": "93891-87-3 (di-Na salt)", "AN": "BILIRUBIN ENCEPHALOPATHY see KERNICTERUS is available", "MS": "A bile pigment that is a degradation product of HEME.", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001663"}, {"RECTYPE": "D", "MH": "Biliverdine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uteroverdine|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|750630|abbcdeef", "ENTRY": "alpha, Biliverdin IX", "MN": "D23.767.193.184.200", "MH_TH": "NLM (1976)", "ST": "T123", "N1": "21H-Biline-8,12-dipropanoic acid, 3,18-diethenyl-1,19,22,24-tetrahydro-2,7,13,17-tetramethyl-1,19-dioxo-", "RN": "O9MIA842K9", "RR": "114-25-0 (Biliverdine)", "AN": "a bile pigment in amphibia & birds but not in normal human bile; /biosyn /physiol permitted", "PI": "Bilirubin (1969-1975)", "MS": "1,3,6,7-Tetramethyl-4,5-dicarboxyethyl-2,8-divinylbilenone. Biosynthesized from hemoglobin as a precursor of bilirubin. Occurs in the bile of AMPHIBIANS and of birds, but not in normal human bile or serum.", "PM": "91; was see under BILIRUBIN 1976-90", "HN": "91(76); was see under BILIRUBIN 1976-90", "MR": "20160527", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D001664"}, {"RECTYPE": "D", "MH": "Binding Sites", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Combining Site|T120|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Sites, Combining", "MN": "G02.111.570.120", "FX": "Receptors, Cell Surface", "MH_TH": "NLM (1968)", "ST": "T120", "AN": "usually NIM; do not use as substitute for chemistry or metabolic mechanism of binding; do not coordinate with receptors terms unless specifically discussed", "PI": "Enzymes (1966-1967)", "MS": "The parts of a macromolecule that directly participate in its specific combination with another molecule.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001665"}, {"RECTYPE": "D", "MH": "Binding Sites, Antibody", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Paratopes|T129|NON|EQV|NLM (1993)|910916|abcdef", "ENTRY": "Paratope", "MN": "G12.125", "FX": "Antibody Affinity", "MH_TH": "NLM (1973)", "ST": "T129", "PI": "Binding Sites (1968-1972)", "MS": "Local surface sites on antibodies which react with antigen determinant sites on antigens (EPITOPES.) They are formed from parts of the variable regions of FAB FRAGMENTS.", "PM": "73", "HN": "73; was in Cat D only 1973-76", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001666"}, {"RECTYPE": "D", "MH": "Binding, Competitive", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Competitive Binding|T044|NON|EQV|UNK (19XX)|740329|abcdef", "MN": "G02.111.570.120.309", "MH_TH": "NLM (1973)", "ST": "T044", "PI": "Binding Sites (1968-1972)", "MS": "The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001667"}, {"RECTYPE": "D", "MH": "Biochemical Phenomena", "DE": "BIOCHEM PHENOMENA", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Biochemical Processes|T044|NON|NRW|NLM (2009)|080118|abcdef", "ENTRY": "Processes, Biochemical", "MN": "G02.111", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "PI": "Biochemistry (1966-1997)", "MS": "The chemical processes, enzymatic activities, and pathways of living things and related temporal, dimensional, qualitative, and quantitative concepts.", "PM": "1998; for BIOCHEMICAL PROCESSES see  BIOCHEMICAL PROCESSES 2009-2016", "HN": "1998; use explode 1970-1997", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001669"}, {"RECTYPE": "D", "MH": "Biochemistry", "DE": "BIOCHEM", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.181.122", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use BIOCHEMICAL PHENOMENA or specifics treed under it for chemical processes and reactions of biological systems", "MS": "The study of the composition, chemical structures, and chemical reactions of living things.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001671"}, {"RECTYPE": "D", "MH": "Biocompatible Materials", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Biomaterials|T122|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Material, Hemocompatible", "MN": "J01.637.051.130", "FX": "Materials Testing", "MH_TH": "NLM (1972)", "ST": "T122", "RN": "0", "PI": "Prosthesis (1966-1971)", "MS": "Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function.", "PM": "73", "HN": "73(72)", "MR": "20180614", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001672"}, {"RECTYPE": "D", "MH": "Biodegradation, Environmental", "AQ": "DE RE", "PRINT ENTRY": "Phytoremediation|T069|NON|NRW|NLM (2007)|051006|abcdef", "ENTRY": "Pollution Natural Attenuation", "MN": "N06.850.460.375.500", "MH_TH": "NLM (2007)", "ST": "T069", "AN": "NIM when specific substance is IM; do not confuse with BIOTRANSFORMATION: see note there; for PHYTOREMEDIATION coordinate with PLANTS", "PI": "appropriate material", "MS": "Elimination of ENVIRONMENTAL POLLUTANTS; PESTICIDES and other waste using living organisms, usually involving intervention of environmental or sanitation engineers.", "PM": "2007; see BIODEGRADATION 1978-2006; see SANITARY ENGINEERING 1975-1977;", "HN": "2007(1969)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D001673"}, {"RECTYPE": "D", "MH": "Bioelectric Energy Sources", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Power Sources, Bioelectric|T073|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Sources, Bioelectric Power", "MN": "E07.305.124.150", "MH_TH": "NLM (1974)", "ST": "T073", "AN": "includes ionic concentration cells, biogalvanic cells, etc; do not confuse entry term BIOFUEL CELLS with BIOFUELS", "MS": "Electric power supply devices which convert biological energy, such as chemical energy of metabolism or mechanical energy of periodic movements, into electrical energy.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001674"}, {"RECTYPE": "D", "MH": "Bioethics", "AQ": "ED HI TD", "ENTRY": "Ethics, Health Care", "MN": "N05.350.200", "FX": "Ethics, Medical", "MH_TH": "BIOETHICS (1989)", "ST": "T091", "AN": "specialty; for issues in bioethics use BIOETHICAL ISSUES or its specifics; ETHICISTS is also available", "PI": "Ethics, Medical (1966-1977)", "MS": "A branch of applied ethics that studies the value implications of practices and developments in life sciences, medicine, and health care.", "PM": "78", "HN": "78", "MR": "20150622", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D001675"}, {"RECTYPE": "D", "MH": "Biofeedback, Psychology", "AQ": "CL DE ES IS MT PH RE", "PRINT ENTRY": "Feedback, Psychophysiologic|T061|NON|EQV|UNK (19XX)|760414|FEEDBACK PSYCHOPHYSIOL|abcdefv", "ENTRY": "Psychology Biofeedbacks", "MN": "F04.754.308.500", "FX": "Feedback", "MH_TH": "NLM (2010)", "ST": "T061", "AN": "FEEDBACK, PSYCHOLOGICAL is also available", "PI": "Feedback (1966-1976)", "MS": "The therapy technique of providing the status of one's own AUTONOMIC NERVOUS SYSTEM function (e.g., skin temperature, heartbeats, brain waves) as visual or auditory feedback in order to self-control related conditions (e.g., hypertension, migraine headaches).", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D001676"}, {"RECTYPE": "D", "MH": "Organelle Biogenesis", "ENTRY": "Organelle Biogeneses", "MN": "G16.645", "FX": "Origin of Life", "MH_TH": "NLM (2016)", "ST": "T070", "AN": "distinguish from biogenesis in the context of ORIGIN OF LIFE", "MS": "The natural growth and development within living CELLS.", "PM": "2016; see BIOGENESIS 1979-2015, for BIOGENESIS, MITOCHONDRIAL see MITOCHONDRIAL TURNOVER 2013-2105", "HN": "2016(1979); for BIOGENESIS, MITOCHONDRIAL use MITOCHONDRIAL TURNOVER 2013-2015", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001678"}, {"RECTYPE": "D", "MH": "Biogenic Amines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amines, Biogenic|T109|T121|T123|T125|NON|EQV|UNK (19XX)|880531|abbbbcdef", "ENTRY": "Amine, Biogenic", "MN": "D02.092.211", "FX": "Receptors, Biogenic Amine", "MH_TH": "NLM (1971)", "ST": "T125", "RN": "0", "AN": "general or unspecified; prefer specific biogenic amine group term or specific biogenic amine ", "PI": "Amines (1966-1970)", "MS": "A group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects (e.g., histamine, serotonin, epinephrine, tyramine). Those derived from aromatic amino acids, and also their synthetic analogs (e.g., amphetamine), are of use in pharmacology.", "PM": "73", "HN": "73(71)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001679"}, {"RECTYPE": "D", "MH": "Biographies as Topic", "PRINT ENTRY": "Biography as Topic|T170|NON|EQV|NLM (2008)|070622|abcdef", "MN": "K01.517.211", "FX": "Autobiographies as Topic", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "use only for biography as a subject; memoirs as a subject go under AUTOBIOGRAPHIES AS TOPIC. For biographies of persons use the Publication Type BIOGRAPHY", "MS": "Works about a written account of a person's life and the branch of literature concerned with the lives of people.", "PM": "2008; see BIOGRAPHY 1963-2007", "HN": "2008(1963)", "MR": "20190710", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D001680"}, {"RECTYPE": "D", "MH": "Biological Assay", "DE": "BIOL ASSAY", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Bioassay|T059|NON|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Biological Assays", "MN": "E05.091", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "assays using living-matter intermediate; check text: not all \"bioassays\" are MeSH term BIOLOGICAL ASSAY", "MS": "A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc.", "CATSH": "CAT LIST", "MR": "19920325", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001681"}, {"RECTYPE": "D", "MH": "Biological Availability", "DE": "BIOL AVAILABILITY", "PRINT ENTRY": "Physiologic Availability|T081|NON|EQV|UNK (19XX)|790530|PHYSIOL AVAILABILITY|abcdefv", "ENTRY": "Physiologic Availabilities", "MN": "G07.690.725.129", "MH_TH": "NLM (1975)", "ST": "T081", "AN": "coordinate NIM with specific drug /pharmacokin ", "PI": "Pharmacology (1966-1969)", "MS": "The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.", "OL": "use BIOLOGICAL AVAILABILITY to search AVAILABILITY EQUIVALENCY 1980-86, BIOLOGIC AVAILABILITY & PHYSIOLOGIC AVAILABILITY 1975-79, & BIOPHARMACEUTICS 1970-74", "PM": "79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; AVAILABILITY EQUIVALENCY & PHYSIOLOGIC AVAILABILITY were see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOLOGICAL AVAILABILITY 1980-86", "HN": "79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; PHYSIOLOGIC AVAILABILITY was see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOPHARMACEUTICS 1970-79 and see under BIOLOGICAL AVAILABILITY 1980-86", "CATSH": "CAT LIST", "MR": "20160616", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D001682"}, {"RECTYPE": "D", "MH": "Biological Clocks", "DE": "BIOL CLOCKS", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Pacemakers, Biological|T040|NON|NRW|UNK (19XX)|850619|PACEMAKERS BIOL|abcdefv", "ENTRY": "Pacemaker, Biological", "MN": "G07.180.562.094", "FX": "Sleep Disorders, Circadian Rhythm", "MH_TH": "NLM (1964)", "ST": "T040", "MS": "The physiological mechanisms that govern the rhythmic occurrence of certain biochemical, physiological, and behavioral phenomena.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001683"}, {"RECTYPE": "D", "MH": "Biological Dressings", "DE": "BIOL DRESSINGS", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Xenograft Dressings|T074|NON|NRW|UNK (19XX)|800515|abcdef", "ENTRY": "Xenograft Dressings, Porcine", "MN": "E07.101.150", "MH_TH": "NLM (1978)", "ST": "T074", "AN": "do not specify source unless especially discussed & do not coordinate with TRANSPLANTATION, HETEROLOGOUS", "PI": "Skin/transplantation (1966-1977)", "MS": "Human or animal tissue used as temporary wound coverings.", "PM": "91; was see under BANDAGES 1978-90", "HN": "91(78); was see under BANDAGES 1978-90", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D001684"}, {"RECTYPE": "D", "MH": "Biological Factors", "DE": "BIOL FACTORS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Factors, Biologic", "MN": "D23", "RH": "D23 - BIOLOGICAL FACTORS", "FX": "Biological Products", "MH_TH": "NLM (1974)", "ST": "T123", "RN": "0", "AN": "differentiate from BIOLOGICAL PRODUCTS", "MS": "Endogenously synthesized compounds that influence biological processes not otherwise classified under ENZYMES; HORMONES or HORMONE ANTAGONISTS.", "PM": "1989; was Non-MeSH before 1989; BIOLOGICAL AGENTS was a heading 2012-2013, now BIOLOGICAL PRODUCTS", "HN": "1989; was Non-MeSH before 1989; BIOLOGICAL AGENTS was a heading 2012-2013, now BIOLOGICAL PRODUCTS", "MR": "20230526", "DA": "19990101", "DC": "1", "DX": "19890101", "UI": "D001685"}, {"RECTYPE": "D", "MH": "Biological Phenomena", "DE": "BIOL PHENOMENA", "AQ": "DE GE IM RE", "PRINT ENTRY": "Biological Processes|T070|NON|NRW|NLM (2009)|080319|abcdef", "ENTRY": "Processes, Biological", "MN": "G16", "RH": "G16 - BIOLOGICAL PHENOMENA", "MH_TH": "NLM (1974)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "Biological processes, properties, and characteristics of the whole organism in human, animal, microorganisms, and plants, and of the biosphere.", "PM": "1998; for BIOLOGICAL PROCESSES see BIOLOGICAL PROCESSES 2009-2016", "HN": "1998; use explode 1970-1997", "CATSH": "CAT LIST", "MR": "20160511", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001686"}, {"RECTYPE": "D", "MH": "Biological Products", "DE": "BIOL PRODUCTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Natural Products|T123|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Product, Natural", "MN": "D20.215", "FX": "Biological Factors", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "differentiate from BIOLOGICAL FACTORS; /ther use: consider the context of the article and the intent of the author and coordinate with disease /ther or /drug ther", "MS": "Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay.", "PM": "2014; for NATURAL PRODUCTS also see BIOLOGICAL FACTORS 2000-2005", "HN": "2014(1966); for NATURAL PRODUCTS also use BIOLOGICAL FACTORS 2000-2005", "MR": "20200409", "DA": "19990101", "DC": "1", "DX": "20140101", "UI": "D001688"}, {"RECTYPE": "D", "MH": "Biological Psychiatry", "DE": "BIOL PSYCHIATRY", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Psychiatry, Biological|T091|NON|EQV|UNK (19XX)|830610|PSYCHIATRY BIOL|abcdefv", "ENTRY": "Psychiatry, Biologic", "MN": "H02.403.690.100", "MH_TH": "NLM (1984)", "ST": "T091", "PI": "Psychiatry (1966-1983)", "MS": "An interdisciplinary science concerned with studies of the biological bases of behavior - biochemical, genetic, physiological, and neurological - and applying these to the understanding and treatment of mental illness.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19830610", "DC": "1", "DX": "19840101", "UI": "D001689"}, {"RECTYPE": "D", "MH": "Biological Science Disciplines", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Life Sciences|T090|NON|EQV|NLM (1991)|900417|abcdef", "ENTRY": "Sciences, Life", "MN": "H01.158", "MH_TH": "NLM (2009)", "ST": "T090", "AN": "BIOLOGY is also available", "PI": "Biology (1975-1990)", "MS": "All of the divisions of the natural sciences dealing with the various aspects of the phenomena of life and vital processes. The concept includes anatomy and physiology, biochemistry and biophysics, and the biology of animals, plants, and microorganisms. It should be differentiated from BIOLOGY, one of its subdivisions, concerned specifically with the origin and life processes of living organisms.", "PM": "2009; see BIOLOGICAL SCIENCES 1991-2008; for BIOLOGICAL SCIENCES see BIOLOGY 1990", "HN": "2009 (1991); use BIOLOGY 1975-1990", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001690"}, {"RECTYPE": "D", "MH": "Biological Therapy", "DE": "BIOL THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Biologic", "MN": "E02.095", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "MS": "Treatment of diseases with biological materials or biological response modifiers, such as the use of GENES; CELLS; TISSUES; organs; SERUM; VACCINES; and humoral agents.", "PM": "98", "HN": "98; use explode 1976-97", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001691"}, {"RECTYPE": "D", "MH": "Biological Transport", "DE": "BIOL TRANSPORT", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Transport, Biological|T043|NON|EQV|UNK (19XX)|740329|TRANSPORT BIOL|abcdefv", "ENTRY": "Transport, Biologic", "MN": "G03.143", "FX": "Proton-Motive Force", "MH_TH": "NLM (1964)", "ST": "T043", "AN": "usually NIM; coordinate with endogenous substance /metab or exogenous substance /pharmacokin ", "MS": "The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001692"}, {"RECTYPE": "D", "MH": "Biological Transport, Active", "DE": "BIOL TRANSPORT ACTIVE", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Uphill Transport|T039|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Transport, Uphill", "MN": "G03.143.310", "FX": "Ion Pumps", "MH_TH": "NLM (1966)", "ST": "T039", "AN": "usually NIM; coordinate with endogenous substance /metab or exogenous substance /pharmacokin", "MS": "The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001693"}, {"RECTYPE": "D", "MH": "Biological Warfare", "DE": "BIOL WARFARE", "AQ": "CL EC EH ES HI LJ MT PC PX SN TD", "PRINT ENTRY": "Biowarfare|T052|NON|EQV|NLM (2022)|210208|abcdef", "ENTRY": "Warfare, Biologic", "MN": "I01.880.735.950.500.226", "FX": "Violence", "MH_TH": "BIOETHICS (1989)", "ST": "T052", "MS": "The use of biological agents in warfare. This includes the malevolent use of BACTERIA; VIRUSES; or other BIOLOGICAL TOXINS against people, ANIMALS; or PLANTS.", "OL": "use BIOLOGICAL WARFARE to search BACTERIAL WARFARE 1966-78", "HN": "BACTERIAL WARFARE was see under BIOLOGICAL WARFARE 1963-78", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001694"}, {"RECTYPE": "D", "MH": "Biology", "DE": "BIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.158.273", "MH_TH": "POPLINE (1978)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use BIOLOGICAL PHENOMENA or specifics treed under it for biological characteristics and processes of organisms and of the biosphere; note broader heading BIOLOGICAL SCIENCE DISCIPLINES is also available", "MS": "One of the BIOLOGICAL SCIENCE DISCIPLINES concerned with the origin, structure, development, growth, function, genetics, and reproduction of animals, plants, and microorganisms.", "MR": "20081126", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001695"}, {"RECTYPE": "D", "MH": "Biomechanical Phenomena", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Kinematics|T070|NON|NRW|NLM (1999)|980226|abcdef", "ENTRY": "Phenomenas, Biomechanic", "MN": "G01.374.089", "MH_TH": "NLM (2014)", "ST": "T070", "PI": "Biophysics (1966-1967)", "MS": "The properties, processes, and behavior of biological systems under the action of mechanical forces.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001696"}, {"RECTYPE": "D", "MH": "Biomedical and Dental Materials", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "J01.637.051", "RH": "D25 - BIOMEDICAL AND DENTAL MATERIALS", "MH_TH": "NLM (1974)", "ST": "T122", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Substances used in biomedicine or dentistry predominantly for their physical, as opposed to chemical, properties.", "PM": "98", "HN": "98; use explode 1974-97", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001697"}, {"RECTYPE": "D", "MH": "Biomedical Engineering", "DE": "BIOMED ENGINEERING", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Engineering, Clinical|T091|NON|NRW|NLM (1994)|920817|ENGINEERING CLIN|abcdefv", "ENTRY": "Engineering, Biomedical|T091|NON|EQV|NLM (1994)|920817|ENGINEERING BIOMED|abcdefv", "MN": "J01.293.140", "FX": "Medical Informatics Applications", "MH_TH": "NLM (1968)", "ST": "T091", "MS": "Application of principles and practices of engineering science to biomedical research and health care.", "PM": "68", "HN": "68", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001698"}, {"RECTYPE": "D", "MH": "Biometry", "AQ": "HI IS MT", "PRINT ENTRY": "Biometrics|T062|NON|EQV|NLM (2022)|210317|abcdef", "ENTRY": "Biometric Analyses", "MN": "N06.850.505.200", "MH_TH": "NLM (1966)", "ST": "T062", "MS": "The use of statistical and mathematical methods to analyze biological observations and phenomena.", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001699"}, {"RECTYPE": "D", "MH": "Biomphalaria", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Australorbis|T204|NON|EQV|UNK (19XX)|780302|abcdef", "ENTRY": "Biomphalarias", "MN": "B01.050.500.644.400.750.185", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid6525", "RR": "txid6526", "AN": "freshwater snail; /microbiol /parasitol /virol permitted", "PI": "Snails (1966-1971)", "MS": "A genus of planorbid freshwater snails, species of which are intermediate hosts of Schistosoma mansoni.", "OL": "use BIOMPHALARIA to search AUSTRALORBIS GLABRATUS 1972-78", "PM": "72", "HN": "72; AUSTRALORBIS GLABRATUS was see under BIOMPHALARIA 1972-78", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001700"}, {"RECTYPE": "D", "MH": "Bionics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Bionic", "MN": "H01.671.293.159", "FX": "Cybernetics", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "MS": "The study of systems, particularly electronic systems, which function after the manner of, in a manner characteristic of, or resembling living systems. Also, the science of applying biological techniques and principles to the design of electronic systems.", "PM": "70", "HN": "70(66)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D001701"}, {"RECTYPE": "D", "MH": "Biopharmaceutics", "DE": "BIOPHARM", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Pharmaceutic", "MN": "H02.628.049", "FX": "Drug Compounding", "MH_TH": "NLM (1970)", "ST": "T091", "AN": "use for the specialty and as an NIM coordinate", "PI": "Pharmacology (1966-1969)", "MS": "The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D001702"}, {"RECTYPE": "D", "MH": "Biophysics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Mechanobiology|T091|NON|NRW|NLM (2014)|130122|abcdef", "MN": "H01.671.100", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use BIOPHYSICAL PHENOMENA or specifics treed under it for biophysical characteristics and processes of biological systems", "MS": "The study of PHYSICAL PHENOMENA and PHYSICAL PROCESSES as applied to living things.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001703"}, {"RECTYPE": "D", "MH": "Biopolymers", "AQ": "AD AE AG AI AN BI BL CF CH CL DF EC GE HI IM IP ME PD PH PK PO RE TO TU UR", "PRINT ENTRY": "Bioplastics|T109|T123|NON|EQV|NLM (2023)|220310|abbcdef", "ENTRY": "Biopolymer", "MN": "J01.637.051.720.099", "FX": "RNA", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "IM GEN only", "PI": "Macromolecular Substances (1975-2004)", "MS": "Polymers synthesized by living organisms. They play a role in the formation of macromolecular structures and are synthesized via the covalent linkage of biological molecules, especially AMINO ACIDS; NUCLEOTIDES; and CARBOHYDRATES.", "PM": "1991; see MACROMOLECULAR SYSTEMS 1975-1990", "HN": "1991(1975); use MACROMOLECULAR SUBSTANCES 1975-1990", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001704"}, {"RECTYPE": "D", "MH": "Bioprosthesis", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Xenograft Bioprosthesis|T074|NON|NRW|UNK (19XX)|800515|abcdef", "ENTRY": "Xenograft Bioprosthesis, Porcine", "MN": "E07.695.100", "FX": "Transplants", "MH_TH": "NLM (1979)", "ST": "T074", "AN": "coordinate IM with specific prosthetic term (IM) as BIOPROSTHESIS + HEART VALVE PROSTHESIS; do not specify source of biological material unless especially discussed & do not coordinate with TRANSPLANTATION, HETEROLOGOUS", "PI": "Heart Valve Prosthesis (1966-1978)", "MS": "Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20170103", "DA": "19780503", "DC": "1", "DX": "19790101", "UI": "D001705"}, {"RECTYPE": "D", "MH": "Biopsy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Biopsies", "MN": "E05.242.384.100", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "usually NIM with specific organ /pathol + disease /diag and/or /pathol", "MS": "Removal and pathologic examination of specimens from the living body.", "CATSH": "CAT LIST", "MR": "20170414", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001706"}, {"RECTYPE": "D", "MH": "Biopsy, Needle", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Puncture Biopsy|T060|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Puncture Biopsies", "MN": "E05.242.384.100.119", "MH_TH": "NLM (1973)", "ST": "T060", "AN": "usually NIM with specific organ /pathol + disease /diag and/or /pathol", "PI": "Biopsy (1966-1972)", "MS": "Removal and examination of tissue obtained through a transdermal needle inserted into the specific region, organ, or tissue being analyzed.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20170321", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001707"}, {"RECTYPE": "D", "MH": "Biopterins", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "L-threo-Biopterin|T109|T123|NON|REL|NLM (2024)|221006|abbcdef", "ENTRY": "L threo Biopterin", "MN": "D08.211.090", "MH_TH": "NLM (2024)", "ST": "T123", "RN": "0", "RR": "22150-76-1", "AN": "/defic /physiol permitted", "PI": "Pteridines (1970-1974)", "MS": "Pterin derivatives based on 2-amino-6-(1,2-dihydroxypropyl)-4(1H)-pteridinone. Biopterins are natural products that have been considered as growth factors for some insects. Biopterins are cofactors for the AROMATIC AMINO ACID hydroxylases and NITRIC OXIDE SYNTHASE. Deficiencies in BIOPTERINS metabolism (e.g., lowered TETRAHYDROBIOPTERIN) are associated with neurological deterioration (e.g., HYPERPHENYLALANINAEMIA).", "PM": "2024; see BIOPTERIN 1987-2013, PTERIDINES 1975-1986", "HN": "2024(1987); use PTERIDINES 1975-1986", "MR": "20230727", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D001708"}, {"RECTYPE": "D", "MH": "Biotechnology", "DE": "BIOTECHNOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Biotechnologies", "MN": "J01.897.120", "FX": "Recombinant Proteins", "MH_TH": "NLM (1987)", "ST": "T091", "MS": "Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction.", "PM": "87", "HN": "87", "MR": "20090710", "DA": "19860327", "DC": "1", "DX": "19870101", "UI": "D001709"}, {"RECTYPE": "D", "MH": "Biotin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitamin H|T109|T127|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Roche, Biotine", "MN": "D08.211.096", "PA": "Vitamin B Complex", "FX": "Multiple Carboxylase Deficiency", "MH_TH": "USP (19XX)", "ST": "T127", "N1": "1H-Thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS-(3aalpha,4beta,6aalpha))-", "RN": "6SO6U10H04", "RR": "58-85-5 (Biotin)", "AN": "/ther use: coordinate disease with /drug ther, not /diet ther; deficiency: coordinate BIOTIN /defic (IM) with VITAMIN B DEFICIENCY (IM)", "MS": "A water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001710"}, {"RECTYPE": "D", "MH": "Biotransformation", "AQ": "DE GE IM PH RE", "MN": "G07.690.725.225", "MH_TH": "NLM (1966)", "ST": "T040", "AN": "restrict to chemical changes of exogenous substances; IM general only; coordinate NIM with specific drug /pharmacokin (IM) or /metab; do not confuse with BIODEGRADATION, ENVIRONMENTAL", "MS": "The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.", "PM": "70", "HN": "70(66)", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D001711"}, {"RECTYPE": "D", "MH": "Biperiden", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Biperiden", "MN": "D03.605.084.500.332", "PA": "Parasympatholytics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1-Piperidinepropanol, alpha-bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-", "RN": "0FRP6G56LD", "RR": "K35N76CUHF", "MS": "A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.", "PM": "91; was see under PIPERIDINES 1966-90", "HN": "91(66); was see under PIPERIDINES 1966-90", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001712"}, {"RECTYPE": "D", "MH": "Biphenyl Compounds", "DE": "BIPHENYL CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Biphenyl", "MN": "D02.455.426.559.389.185", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings.", "MR": "20161129", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001713"}, {"RECTYPE": "D", "MH": "Bipolar Disorder", "DE": "BIPOLAR DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Type 2 Bipolar Disorder|T048|NON|NRW|NLM (2023)|220401|abcdef", "ENTRY": "Psychosis, Manic Depressive", "MN": "F03.600.150.500", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.", "PM": "81; see PSYCHOSES, MANIC-DEPRESSIVE 1963-80; see MANIC DISORDER 1984-97; for MANIC DISORDER see AFFECTIVE DISORDERS, PSYCHOTIC 1981-83", "HN": "81(63)", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D001714"}, {"RECTYPE": "D", "MH": "Bird Diseases", "DE": "BIRD DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Diseases, Bird", "MN": "C22.131", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "IM GEN or unspecified; coord IM with specific dis /vet (IM) or specific bird dis (IM); coord IM with specific bird (IM); for abnormalities or injuries, index under BIRDS /abnorm or BIRDS /inj; don't forget also BIRDS (NIM) if no specific bird is indexed; also check tag ANIMALS; differentiate from POULTRY DISEASES on basis of distinction between BIRDS & POULTRY shown under BIRDS; DF: BIRD DIS", "MS": "Diseases of birds not considered poultry, therefore usually found in zoos, parks, and the wild. The concept is differentiated from POULTRY DISEASES which is for birds raised as a source of meat or eggs for human consumption, and usually found in barnyards, hatcheries, etc.", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001715"}, {"RECTYPE": "D", "MH": "Bird Fancier's Lung", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pneumonitis, Hypersensitivity, Avian|T047|NON|EQV|NLM (1993)|920123|abcdef", "ENTRY": "Pneumonitides, Avian Hypersensitivity", "MN": "C24.125", "MH_TH": "NLM (1977)", "ST": "T047", "PI": "Respiratory Hypersensitivity (1966-1976)", "MS": "A form of alveolitis or pneumonitis due to an acquired hypersensitivity to inhaled avian antigens, usually proteins in the dust of bird feathers and droppings.", "PM": "91; was see under ALVEOLITIS, EXTRINSIC ALLERGIC 1977-90", "HN": "91(77); was see under ALVEOLITIS, EXTRINSIC ALLERGIC 1977-90", "CATSH": "CAT LIST", "MR": "20230526", "DA": "19760505", "DC": "1", "DX": "19910101", "UI": "D001716"}, {"RECTYPE": "D", "MH": "Birds", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Aves|T012|NON|EQV|NLM (2005)|030930|abcdef", "ENTRY": "Bird", "MN": "B01.050.150.900.248", "FX": "Avian Proteins", "MH_TH": "NLM (1966)", "ST": "T012", "RN": "txid8782", "AN": "General or unspecified; prefer specifics; differentiate from POULTRY: Manual 22.29", "MS": "Warm-blooded VERTEBRATES possessing FEATHERS and belonging to the class Aves.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001717"}, {"RECTYPE": "D", "MH": "Birefringence", "PRINT ENTRY": "Double Refraction|T070|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Refractions, Double", "MN": "G01.590.080", "MH_TH": "NLM (1964)", "ST": "T070", "AN": "usually NIM", "MS": "The property of nonisotropic media, such as crystals, whereby a single incident beam of light traverses the medium as two beams, each plane-polarized, the planes being at right angles to each other. (Cline et al., Dictionary of Visual Science, 4th ed)", "PM": "68", "HN": "68(64)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001718"}, {"RECTYPE": "D", "MH": "Birth Certificates", "AQ": "HI LJ", "ENTRY": "Records, Birth", "MN": "N06.850.520.308.940.250", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "IM", "MS": "Official certifications by a physician recording the individual's birth date, place of birth, parentage and other required identifying data which are filed with the local registrar of vital statistics.", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001719"}, {"RECTYPE": "D", "MH": "Birth Injuries", "DE": "BIRTH INJ", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injury, Birth", "MN": "C26.141", "MH_TH": "NLM (1973)", "ST": "T037", "MS": "Mechanical or anoxic trauma incurred by the infant during labor or delivery.", "OL": "use BIRTH INJURIES to search BIRTH INJURY 1966-72", "PM": "73; was BIRTH INJURY 1963-72", "HN": "73; was BIRTH INJURY 1963-72", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001720"}, {"RECTYPE": "D", "MH": "Birth Intervals", "AQ": "EH PX SN", "PRINT ENTRY": "Birth Spacing|T079|NON|EQV|NLM (1980)|781219|abcdef", "ENTRY": "Pregnancy Interval", "MN": "N01.224.361.150", "MH_TH": "NLM (1980)", "ST": "T079", "AN": "human only; may be used in physiol or family planning context", "PI": "Family Planning (1968-1979)", "MS": "The lengths of intervals between births to women in the population.", "OL": "use BIRTH INTERVALS to search CHILD SPACING 1979-92", "PM": "80; CHILD SPACING was see BIRTH INTERVALS 1979-92", "HN": "80; CHILD SPACING was see BIRTH INTERVALS 1979-92", "MR": "20030709", "DA": "19781219", "DC": "1", "DX": "19800101", "UI": "D001721"}, {"RECTYPE": "D", "MH": "Birth Order", "AQ": "PX", "ENTRY": "First Births", "MN": "N06.850.505.400.400.160", "MH_TH": "POPLINE (1978)", "ST": "T081", "AN": "IM", "MS": "The sequence in which children are born into the family.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001722"}, {"RECTYPE": "D", "MH": "Birth Rate", "AQ": "EH TD", "PRINT ENTRY": "Natality|T081|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Rate, Fertility", "MN": "N06.850.520.308.985.775.500", "MH_TH": "NLM (1967)", "ST": "T081", "AN": "specify geographic location if pertinent", "PI": "Vital Statistics (1966)", "MS": "The number of births in a given population per year or other unit of time.", "PM": "1967: see POPULATION & VITAL STATISTICS 1963-1966; for AGE-SPECIFIC BIRTH RATE & AGE-SPECIFIC FERTILITY RATE see MATERNAL AGE 1980", "HN": "1967: use POPULATION & VITAL STATISTICS 1963-1966; for AGE-SPECIFIC BIRTH RATE & AGE-SPECIFIC FERTILITY RATE use MATERNAL AGE 1980", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001723"}, {"RECTYPE": "D", "MH": "Birth Weight", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Birthweight|T032|NON|EQV|NLM (2022)|210122|abcdef", "ENTRY": "Weights, Birth", "MN": "G07.345.249.314.120.186", "FX": "Infant, Very Low Birth Weight", "MH_TH": "NLM (1963)", "ST": "T032", "AN": "IM", "MS": "The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001724"}, {"RECTYPE": "D", "MH": "Bis(Chloromethyl) Ether", "DS": "BISCHLOROMETHYL ETHER", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Dichloromethyl Ether|T109|T131|NON|EQV|UNK (19XX)|771213|abbcdef", "ENTRY": "Ether, Dichloromethyl", "MN": "D02.355.601.250", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Methane, oxybis(chloro)-", "RN": "77382IHE37", "RR": "542-88-1 (Bis(Chloromethyl) Ether)", "PI": "Methyl Ethers (1974)", "MS": "A substance that is an irritant to the eyes and respiratory tract and may be carcinogenic.", "OL": "use BIS(CHLOROMETHYL) ETHER to search DICHLOROMETHYL ETHER 1975-78", "PM": "91; was see under METHYL ETHERS 1979-90; was DICHLOROMETHYL ETHER see under METHYL ETHERS 1975-78", "HN": "91(79); was see under METHYL ETHERS 1979-90; was DICHLOROMETHYL ETHER see under METHYL ETHERS 1975-78", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001725"}, {"RECTYPE": "D", "MH": "Bisacodyl", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ratio Bisacodyl", "MN": "D02.455.426.559.389.657.239.132", "PA": "Cathartics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Phenol, 4,4'-(2-pyridinylmethylene)bis-, diacetate (ester)", "RN": "10X0709Y6I", "RR": "T0I8L1B7J6", "PI": "Cresols (1966-1971)", "MS": "A diphenylmethane stimulant laxative used for the treatment of CONSTIPATION and for bowel evacuation. (From Martindale, The Extra Pharmacopoeia, 30th ed, p871)", "PM": "91; was see under CRESOLS 1972-90", "HN": "91(72); was see under CRESOLS 1972-90", "MR": "20170117", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001726"}, {"RECTYPE": "D", "MH": "Bisexuality", "AQ": "CL DE EH ES HI PH PX RE SN", "MN": "G08.686.867.200", "FX": "Sexual and Gender Minorities", "MH_TH": "NLM (1988)", "ST": "T054", "AN": "note category: do not confuse with HERMAPHRODITISM see DISORDERS OF SEX DEVELOPMENT", "PI": "Sex Behavior (1966-1987)", "MS": "The sexual attraction or relationship between members of both the same and the opposite SEX.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20170118", "DA": "19870430", "DC": "1", "DX": "19880101", "UI": "D001727"}, {"RECTYPE": "D", "MH": "Dicumarol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bishydroxycoumarin|T109|T121|NON|EQV|NLM (1996)|941129|abbcdef", "ENTRY": "Dicoumarol|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|820120|abbcdeef", "MN": "D03.633.100.150.446.520.203", "PA": "Uncoupling Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy)-", "RN": "7QID3E7BG7", "RR": "66-76-2 (Dicumarol)", "MS": "An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases.", "PM": "96; was BISHYDROXYCOUMARIN 1963-95; DICUMAROL was see BISHYDROXYCOUMARIN 1963-95", "HN": "96; was BISHYDROXYCOUMARIN 1963-95; DICUMAROL was see BISHYDROXYCOUMARIN 1963-95", "MR": "20160529", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D001728"}, {"RECTYPE": "D", "MH": "Bismuth", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.100", "PA": "Antacids", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Bismuth", "RN": "U015TT5I8H", "RR": "7440-69-9 (Bismuth)", "MS": "A metallic element that has the atomic symbol Bi, and atomic number 83. Its principal isotope is Bismuth 209.", "OL": "use BISMUTH to search BISMUTH-ARSENIC COMPOUNDS 1963-91", "PM": "BISMUTH-ARSENIC COMPOUNDS was heading 1963-91", "HN": "BISMUTH-ARSENIC COMPOUNDS was heading 1963-91", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001729"}, {"RECTYPE": "D", "MH": "Bisphosphoglycerate Mutase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Diphosphoglyceromutase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Synthase, Bisphosphoglycerate", "MN": "D08.811.399.520.750.250", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "3-Phospho-D-glycerate 1,2-phosphomutase", "RN": "EC 5.4.2.4", "PI": "Phosphotransferases (1973-1974)", "MS": "An enzyme that catalyzes the transfer of phosphate from C-3 of 1,3-diphosphoglycerate to C-2 of 3-phosphoglycerate, forming 2,3-diphosphoglycerate. EC 5.4.2.4.", "OL": "use BISPHOSPHOGLYCERATE MUTASE to search BISPHOSPHOGLYCEROMUTASE 1975-92", "PM": "93; was BISPHOSPHOGLYCEROMUTASE 1975-92 (see under PHOSPHOTRANSFERASES 1975-90)", "HN": "93; was BISPHOSPHOGLYCEROMUTASE 1975-92 (see under PHOSPHOTRANSFERASES)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001731"}, {"RECTYPE": "D", "MH": "Bite Force", "PRINT ENTRY": "Occlusal Force|T169|NON|EQV|UNK (19XX)|830615|abcdef", "ENTRY": "Occlusal Forces", "MN": "E06.276.125", "MH_TH": "NLM (1984)", "ST": "T169", "PI": "Masticatory Muscles (1966-1983)", "MS": "The force applied by the masticatory muscles in dental occlusion.", "PM": "91; was see under DENTAL OCCLUSION 1984-90", "HN": "91(84); was see under DENTAL OCCLUSION 1984-90", "CATSH": "CAT LIST", "MR": "19900413", "DA": "19830615", "DC": "1", "DX": "19910101", "UI": "D001732"}, {"RECTYPE": "D", "MH": "Bites and Stings", "DE": "BITES STINGS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stings|T037|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Sting", "MN": "C26.176", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "coordinate IM with biter (IM) but note specifics are available", "MS": "Injuries inflicted by the TEETH or poisoning caused by VENOMS of animals.", "CATSH": "CAT LIST", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001733"}, {"RECTYPE": "D", "MH": "Bites, Human", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Human Bites", "MN": "C26.176.071", "MH_TH": "NLM (1972)", "ST": "T037", "AN": "the human is biting, not being bitten; don't forget to check tag HUMANS", "PI": "Bites and Stings (1966-1971)", "MS": "Bites inflicted by humans.", "PM": "91; was see under BITES AND STINGS 1972-90", "HN": "91(72); was see under BITES AND STINGS 1972-90", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001734"}, {"RECTYPE": "D", "MH": "Bithionol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Bitin|T109|T121|TRD|NRW|UNK (19XX)|831020|abbcdef", "MN": "D02.455.426.559.389.657.120", "PA": "Antiplatyhelmintic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Phenol, 2,2'-thiobis(4,6-dichloro)-", "RN": "AMT77LS62O", "RR": "97-18-7 (Bithionol)", "PI": "Sulfides (1971-1974)", "MS": "Halogenated anti-infective agent that is used against trematode and cestode infestations.", "PM": "91; was see under PHENOLS 1975-90", "HN": "91(75); was see under PHENOLS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001735"}, {"RECTYPE": "D", "MH": "Biureas", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.065.950.117", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PI": "Hydrazines (1966-1967)", "MS": "Biurea and its derivatives with the general formula C2H6N4O2. Biurea is a degradation product of azodicarbonamide, a common bleaching agent in cereal flour preparation.", "PM": "68", "HN": "68", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001736"}, {"RECTYPE": "D", "MH": "Biuret", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Carbamylurea|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "MN": "D02.065.950.130", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Imidodicarbonic diamide", "RN": "89LJ369D1H", "RR": "108-19-0 (Biuret)", "PI": "Urea (1968-1974)", "MS": "Used as feed supplement for sheep and cattle since it is a good non-protein nitrogen source. In strongly alkaline solution biuret gives a violet color with copper sulfate.", "PM": "91; was see under UREA 1975-90", "HN": "91(75); was see under UREA 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001737"}, {"RECTYPE": "D", "MH": "Biuret Reaction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Reactions, Biuret", "MN": "E05.196.085", "MH_TH": "NLM (1975)", "ST": "T059", "AN": "do not confuse with BIURET: biuret reaction or method no longer uses BIURET as signif reagent", "MS": "A reaction characterized by a violet color upon the addition of copper sulfate to all compounds with two amide or peptide bonds linked directly or through an intermediate carbon atom. Used in the detection and estimation of proteins and peptides having more than two amino acids.", "PM": "91; was see under CHEMISTRY, ANALYTICAL 1975-90", "HN": "91(75); was see under CHEMISTRY, ANALYTICAL 1975-90", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D001738"}, {"RECTYPE": "D", "MH": "BK Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Polyomavirus, BK|T005|EPO|EQV|NLM (2002)|010307|abcdef", "ENTRY": "Polyomavirus BK, Human", "MN": "B04.613.204.670.615.100", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid1891762", "AN": "infection: coord IM with POLYOMAVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "MS": "A species of POLYOMAVIRUS apparently infecting over 90% of children but not clearly associated with any clinical illness in childhood. The virus remains latent in the body throughout life and can be reactivated under certain circumstances.", "OL": "use POLYOMAVIRUS HOMINIS 1 to search BK VIRUS 1975-93", "PM": "2002; see POLYOMAVIRUS HOMINIS 1 1994-2001, see BK VIRUS 1991-1993, see POLYOMAVIRUSES 1978-1990, see POLYOMA VIRUS 1975-1977", "HN": "2002, 1975-1993", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001739"}, {"RECTYPE": "D", "MH": "Black Widow Spider", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Southern Black Widow Spider|T204|NON|EQV|NLM (2024)|230314|abcdef", "ENTRY": "Widow Spider, Black", "MN": "B01.050.500.131.166.803.200", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid6924", "AN": "/microbiol /parasitol /virol permitted; bite: coord IM with SPIDER BITES (IM)", "MS": "A venomous New World spider with an hourglass-shaped red mark on the abdomen.", "PM": "91; was see under SPIDERS 1975-90", "HN": "91(75); was see under SPIDERS 1975-90", "MR": "20230405", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D001740"}, {"RECTYPE": "D", "MH": "Black or African American", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Negroes|T098|HIST|REL|UNK (19XX)|750724|abcdef", "ENTRY": "Black American", "MN": "M01.686.477.625.594.594", "MH_TH": "OMB (2023)", "ST": "T098", "AN": "use only for the United States population groups. BLACK PEOPLE is also available", "MS": "A person having origins in any of the black racial groups of Africa (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.", "PM": "2023; see NEGROES 1963-1975, BLACKS 1976-2003, AFRICAN AMERICANS 2004-2022", "HN": "2023(2004); for BLACKS use BLACK PEOPLE 2004-2022", "MR": "20230426", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D001741"}, {"RECTYPE": "D", "MH": "Blackwater Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Malaria, Hemolytic|T047|NON|EQV|NLM (1992)|910205|abcdef", "ENTRY": "Malarias, Hemolytic", "MN": "C01.920.852.750.650.228", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "do not confuse with BLACK FEVER see LEISHMANIASIS, VISCERAL or AMAZON BLACK FEVER see HEPATITIS D", "MS": "A complication of MALARIA, FALCIPARUM characterized by the passage of dark red to black urine.", "PM": "1991; see MALARIA 1975-1990", "HN": "1991(1975)", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001742"}, {"RECTYPE": "D", "MH": "Urinary Bladder", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Bladder|T023|NON|EQV|NLM (1963)|990101|abcdef", "ENTRY": "Detrusor Muscles, Bladder", "MN": "A05.810.890", "FX": "Urinary Catheterization", "MH_TH": "NLM (2007)", "ST": "T023", "CX": "consider also terms at CYST- and VESIC-", "MS": "A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION.", "PM": "2007; see BLADDER 1963-2006", "HN": "2007 (1963)", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D001743"}, {"RECTYPE": "D", "MH": "Urinary Bladder Calculi", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Vesical Calculi|T031|T046|NON|EQV|UNK (19XX)|880607|abbcdef", "ENTRY": "Vesical Calculus", "MN": "C23.300.175.850.875", "MH_TH": "NLM (2007)", "ST": "T046", "AN": "chemical composition of calculi: use /chem; /ultrastruct permitted", "MS": "Stones in the URINARY BLADDER; also known as vesical calculi, bladder stones, or cystoliths.", "PM": "2007; see BLADDER CALCULI 1966-2006", "HN": "2007 (1966)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D001744"}, {"RECTYPE": "D", "MH": "Urinary Bladder Diseases", "DE": "URINARY BLADDER DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bladder Diseases|T047|NON|EQV|NLM (1963)|990101|BLADDER DIS|abcdefv", "ENTRY": "Urinary Bladder Disease", "MN": "C12.950.829", "MH_TH": "NLM (2007)", "ST": "T047", "MS": "Pathological processes of the URINARY BLADDER.", "PM": "2007; see BLADDER DISEASES 1963-2006", "HN": "2007 (1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D001745"}, {"RECTYPE": "D", "MH": "Bladder Exstrophy", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Urinary Bladder Exstrophies", "MN": "C16.131.939.132", "MH_TH": "NLM (1963)", "ST": "T019", "MS": "A birth defect in which the URINARY BLADDER is malformed and exposed, inside out, and protruded through the ABDOMINAL WALL. It is caused by closure defects involving the top front surface of the bladder, as well as the lower abdominal wall; SKIN; MUSCLES; and the pubic bone.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001746"}, {"RECTYPE": "D", "MH": "Urinary Bladder Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vesical Fistula|T046|T190|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Vesical Fistulas", "MN": "C23.300.575.825.250", "MH_TH": "NLM (2007)", "ST": "T190", "AN": "fistula policy: Manual 23.19+; VESICOVAGINAL FISTULA is available", "MS": "An abnormal passage in the URINARY BLADDER or between the bladder and any surrounding organ.", "PM": "2007; see BLADDER FISTULA 1966-2006", "HN": "2007; use BLADDER FISTULA 1966-2006", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D001747"}, {"RECTYPE": "D", "MH": "Urinary Bladder Neck Obstruction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bladder Neck Obstruction|T047|T190|NON|EQV|NLM (1966)|990101|abbcdef", "ENTRY": "Bladder Outlet Obstruction|T047|T190|NON|EQV|NLM (2007)|051003|abbcdef", "MN": "C12.950.829.601", "MH_TH": "NLM (2007)", "ST": "T190", "MS": "Blocked urine flow through the bladder neck, the narrow internal urethral opening at the base of the URINARY BLADDER. Narrowing or strictures of the URETHRA can be congenital or acquired. It is often observed in males with enlarged PROSTATE glands.", "PM": "2007; see BLADDER NECK OBSTRUCTION 1966-2006", "HN": "2007 (1966)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D001748"}, {"RECTYPE": "D", "MH": "Urinary Bladder Neoplasms", "DE": "URINARY BLADDER NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cancer of Bladder|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Urinary Bladder Neoplasm", "MN": "C12.950.983.945", "MH_TH": "NLM (2007)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM)", "MS": "Tumors or cancer of the URINARY BLADDER.", "PM": "2007; see BLADDER NEOPLASMS 1963-2006", "HN": "2007 (1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D001749"}, {"RECTYPE": "D", "MH": "Urinary Bladder, Neurogenic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neurogenic Bladder|T047|NON|EQV|NLM (2000)|991105|abcdef", "ENTRY": "Uninhibited Neurogenic Bladder", "MN": "C23.888.592.900", "MH_TH": "NLM (2007)", "ST": "T047", "MS": "Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.", "PM": "2007; see BLADDER, NEUROGENIC 1966-2006", "HN": "2007 (1966)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D001750"}, {"RECTYPE": "D", "MH": "Blade Implantation", "AQ": "AE CL EC ED ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Implantations, Blade", "MN": "E06.780.314.310.340", "MH_TH": "NLM (1979)", "ST": "T061", "PI": "Dental Implantation, Endosseous (1977-1978)", "MS": "Insertion of an endosseous implant with a narrow wedge-shaped infrastructure extending through the oral mucosa into the mouth and bearing openings or vents through which tissue grows to obtain retention.", "OL": "search DENTAL IMPLANTATION 1974", "PM": "91; was see under DENTAL IMPLANTATION, ENDOSSEOUS 1979-80; ENDOSSEOUS BLADE IMPLANTS was see under DENTAL IMPLANTATION 1974", "HN": "91(79); was see under DENTAL IMPLANTATION, ENDOSSEOUS 1979-90; ENDOSSEOUS BLADE IMPLANTS was see under DENTAL IMPLANTATION 1974", "CATSH": "CAT LIST", "MR": "20200221", "DA": "19780123", "DC": "1", "DX": "19910101", "UI": "D001751"}, {"RECTYPE": "D", "MH": "Blast Crisis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Blast Phase|T047|NON|EQV|UNK (19XX)|860326|abcdef", "ENTRY": "Phases, Blast", "MN": "C23.550.727.098.500.110", "FX": "Lymphocyte Activation", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "coordinate IM with specific neoplasm term /pathol (IM); note category; do not confuse with BLAST TRANSFORMATION see LYMPHOCYTE ACTIVATION; blast transformation in chronic myelogenous leukemia goes here not at LYMPHOCYTE ACTIVATION", "MS": "An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19860326", "DC": "1", "DX": "19870101", "UI": "D001752"}, {"RECTYPE": "D", "MH": "Blast Injuries", "DE": "BLAST INJ", "AQ": "BL CF CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injury, Blast", "MN": "C26.120.126", "MH_TH": "NLM (1973)", "ST": "T037", "AN": "various body inj from waves of high-pressure velocity; /compl permitted but do not confuse with /pathol", "MS": "Injuries resulting when a person is struck by particles impelled with violent force from an explosion. Blast causes pulmonary concussion and hemorrhage, laceration of other thoracic and abdominal viscera, ruptured ear drums, and minor effects in the central nervous system. (From Dorland, 27th ed)", "OL": "use BLAST INJURIES to search BLAST INJURY 1966-72", "PM": "73; was BLAST INJURY 1963-72", "HN": "73; was BLAST INJURY 1963-72", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001753"}, {"RECTYPE": "D", "MH": "Blastocladiella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Blastocladiellas", "MN": "B01.300.230.150", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid4807", "MS": "A genus of aquatic fungi of the family Blastocladiaceae, order Blastocladiales, used in the study of zoospore formation.", "PM": "91; see MASTIGOMYCOTINA 1986-90, see PHYCOMYCETES 1963-85", "HN": "91; use CHYTRIDIOMYCOTA 1986-90, use FUNGI 1963-85", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001754"}, {"RECTYPE": "D", "MH": "Blastocyst", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Embryo, Preimplantation|T018|NON|EQV|UNK (19XX)|790418|abcdef", "ENTRY": "Preimplantation Embryos", "MN": "A16.254.500", "EC": "transplantation:Embryo Transfer", "MH_TH": "NLM (1974)", "ST": "T018", "AN": "Mammalian only; non-mammalian, use BLASTULA; /transpl: coordinate BLASTOCYST (NIM with no qualifiers) + EMBRYO TRANSFER (IM); do not confuse with BLASTOCYTES see BLASTOMERES", "MS": "A post-MORULA preimplantation mammalian embryo that develops from a 32-cell stage into a fluid-filled hollow ball of over a hundred cells. A blastocyst has two distinctive tissues. The outer layer of trophoblasts gives rise to extra-embryonic tissues. The inner cell mass gives rise to the embryonic disc and eventual embryo proper.", "PM": "74", "HN": "74", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001755"}, {"RECTYPE": "D", "MH": "Blastoderm", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Blastoderms", "MN": "A16.331.024", "MH_TH": "NLM (1975)", "ST": "T018", "PI": "Germ Layers (1966-1974)", "MS": "A layer of cells lining the fluid-filled cavity (blastocele) of a BLASTULA, usually developed from a fertilized insect, reptilian, or avian egg.", "OL": "search GERM LAYERS 1968-74", "PM": "80; was see under BLASTOCYST 1975-79, was see under GERM LAYERS 1968-74", "HN": "80(75); was see under BLASTOCYST 1975-79, was see under GERM LAYERS 1968-74", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D001756"}, {"RECTYPE": "D", "MH": "Blastomeres", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Blastocytes|T018|NON|BRD|UNK (19XX)|790417|abcdef", "ENTRY": "Blastomere", "MN": "A16.094", "MH_TH": "NLM (1980)", "ST": "T018", "AN": "do not confuse entry term BLASTOCYTES with BLASTOCYST", "PI": "Zygote (1975-1979)", "MS": "Undifferentiated cells resulting from cleavage of a fertilized egg (ZYGOTE). Inside the intact ZONA PELLUCIDA, each cleavage yields two blastomeres of about half size of the parent cell. Up to the 8-cell stage, all of the blastomeres are totipotent. The 16-cell MORULA contains outer cells and inner cells.", "PM": "80", "HN": "80", "MR": "20150707", "DA": "19790417", "DC": "1", "DX": "19800101", "UI": "D001757"}, {"RECTYPE": "D", "MH": "Blastomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Blastomycoides dermatitidis|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Blastomyces dermatitidis|T004|NON|NRW|NLM (1999)|980417|abcdef", "MN": "B01.300.381.125", "FX": "Onygenales", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid229219", "RR": "txid5039", "MS": "A genus of onygenacetous mitosporic fungi whose perfect state is Ajellomyces (see ONYGENALES). The species Blastomyces dermatitidis (perfect state is Ajellomyces dermatitidis) causes blastomycosis.", "MR": "20200811", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001758"}, {"RECTYPE": "D", "MH": "Blastomycosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Blastomycosis, North American|T047|EPO|NRW|ORD (2010)|UNK (19XX)|760515|abcdeef", "ENTRY": "North American Blastomycosis", "MN": "C17.800.838.208.055", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "fungus dis; do not confuse entry term BLASTOMYCOSIS, NORTH AMERICAN with BLASTOMYCOSIS, SOUTH AMERICAN see PARACOCCIDIOIDOMYCOSIS", "MS": "A fungal infection that may appear in two forms: 1, a primary lesion characterized by the formation of a small cutaneous nodule and small nodules along the lymphatics that may heal within several months; and 2, chronic granulomatous lesions characterized by thick crusts, warty growths, and unusual vascularity and infection in the middle or upper lobes of the lung.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001759"}, {"RECTYPE": "D", "MH": "Bleeding Time", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Template Bleeding Time|T059|NON|NRW|NLM (1998)|970318|abcdef", "ENTRY": "Tolerance Tests, Aspirin", "MN": "G09.188.087", "FX": "Platelet Activation", "MH_TH": "NLM (1980)", "ST": "T034", "AN": "usually NIM", "PI": "Thrombocytosis (1966-1979)", "MS": "Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function.", "PM": "91; was see under PLATELET FUNCTION TESTS 1980-90", "HN": "91(80); was see under PLATELET FUNCTION TESTS 1980-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19790307", "DC": "1", "DX": "19910101", "UI": "D001760"}, {"RECTYPE": "D", "MH": "Bleomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Bleomycin", "MN": "D12.644.233.110", "PA": "Antibiotics, Antineoplastic", "MH_TH": "UK", "ST": "T195", "RN": "11056-06-7", "RR": "M62KK37O40", "AN": "a glycopeptide antineoplastic antibiotic", "PI": "Antibiotics, Antineoplastic (1967-1970)", "MS": "A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors.", "PM": "96; was BLEOMYCINS 1981-95, was BLEOMYCIN 1974-80", "HN": "96; was BLEOMYCINS 1981-95, was BLEOMYCIN 1972-80 (Prov 1972-73)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001761"}, {"RECTYPE": "D", "MH": "Blepharitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Blepharitides", "MN": "C11.338.133", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Inflammation of the eyelids.", "PM": "91; was see under EYELID DISEASES 1965-90", "HN": "91(65); was see under EYELID DISEASES 1965-90", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001762"}, {"RECTYPE": "D", "MH": "Blepharoptosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ptosis, Eyelid|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Ptoses, Eyelid", "MN": "C11.338.204", "FX": "Blepharoplasty", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "drooping eyelid", "MS": "Drooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001763"}, {"RECTYPE": "D", "MH": "Blepharospasm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Blepharospasms", "MN": "C11.338.250", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "spasm of eyelid musc", "MS": "Excessive winking; tonic or clonic spasm of the orbicularis oculi muscle.", "PM": "91; was see under EYELID DISEASES 1975-90", "HN": "91(75); was see under EYELID DISEASES 1975-90", "CATSH": "CAT LIST", "MR": "19930525", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D001764"}, {"RECTYPE": "D", "MH": "Blind Loop Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Stagnant Loop", "MN": "C18.452.603.145", "MH_TH": "NLM (1969)", "ST": "T047", "PI": "Malabsorption Syndromes (1966-1968)", "MS": "A malabsorption syndrome that is associated with a blind loop in the upper SMALL INTESTINE that is characterized by the lack of peristaltic movement, stasis of INTESTINAL CONTENTS, and the overgrowth of BACTERIA. Such bacterial overgrowth interferes with BILE SALTS action, FATTY ACIDS processing, MICROVILLI integrity, and the ABSORPTION of nutrients such as VITAMIN B12 and FOLIC ACID.", "PM": "73", "HN": "73(69)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001765"}, {"RECTYPE": "D", "MH": "Blindness", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Unilateral Blindness|T047|NON|NRW|NLM (2020)|190501|abcdef", "ENTRY": "Visual Loss, Sudden", "MN": "C23.888.592.763.941.162", "FX": "Vision, Low", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001766"}, {"RECTYPE": "D", "MH": "Blinking", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Winking|T042|NON|NRW|NLM (1998)|960724|abcdef", "ENTRY": "Reflexes, Orbicularis Oculi", "MN": "G14.152", "MH_TH": "NLM (1981)", "ST": "T042", "PI": "Reflex (1966-1980)", "MS": "Brief closing of the eyelids by involuntary normal periodic closing, as a protective measure, or by voluntary action.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19800404", "DC": "1", "DX": "19810101", "UI": "D001767"}, {"RECTYPE": "D", "MH": "Blister", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vesication|T020|T184|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Vesications", "MN": "C23.300.122", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "FEVER BLISTER see HERPES LABIALIS is also available", "MS": "Visible accumulations of fluid within or beneath the epidermis.", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001768"}, {"RECTYPE": "D", "MH": "Blood", "AQ": "DE DG IM ME MI PS RE VI", "MN": "A15.145", "FX": "Occult Blood", "EC": "physiology:Blood Physiological Phenomena", "MH_TH": "NLM (1966)", "ST": "T031", "CX": "consider also terms at HEM-", "MS": "The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001769"}, {"RECTYPE": "D", "MH": "Blood Bactericidal Activity", "AQ": "DE GE IM PH RE", "ENTRY": "Blood Bactericidal Activities", "MN": "G12.450.564.204", "FX": "Serum Bactericidal Test", "MH_TH": "NLM (1965)", "ST": "T042", "MS": "The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST.", "PM": "70", "HN": "70(65)", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D001770"}, {"RECTYPE": "D", "MH": "Blood Banks", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Blood Bank", "MN": "N02.278.065.200", "FX": "Blood Preservation", "EC": "methods:Blood Banking", "MH_TH": "NLM (1966)", "ST": "T093", "MS": "Centers for collecting, characterizing and storing blood or plasma.", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001771"}, {"RECTYPE": "D", "MH": "Blood Cell Count", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Blood Count, Complete|T059|NON|REL|NLM (1993)|911024|abcdef", "ENTRY": "Numbers, Blood Cell", "MN": "G09.188.105", "MH_TH": "NLM (1966)", "ST": "T081", "AN": "general or unspecified; prefer specifics; \"blood picture\" probably goes here or under specifics; coordinate with disease /blood, not /physiopathol", "MS": "The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES.", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001772"}, {"RECTYPE": "D", "MH": "Blood Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Blood Corpuscles|T025|NON|EQV|NLM (2008)|070205|abcdef", "ENTRY": "Corpuscles, Blood", "MN": "A15.145.229", "MH_TH": "NLM (1966)", "ST": "T025", "AN": "general; prefer specifics; \"blood picture\" probably goes here or under BLOOD CELL COUNT", "MS": "The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001773"}, {"RECTYPE": "D", "MH": "Blood Chemical Analysis", "DE": "BLOOD CHEM ANAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Chemical Analyses, Blood", "MN": "E05.200.124.100", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "general only: prefer specific substance with / blood; emphasis is on technique: not for \"blood chemistry\"", "MS": "An examination of chemicals in the blood.", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001774"}, {"RECTYPE": "D", "MH": "Blood Circulation", "DE": "BLOOD CIRC", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Blood Flow|T039|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Flow, Blood", "MN": "G09.330.100", "FX": "Pulsatile Flow", "MH_TH": "NLM (1966)", "ST": "T039", "MS": "The movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM.", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001775"}, {"RECTYPE": "D", "MH": "Blood Circulation Time", "DE": "BLOOD CIRC TIME", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Times, Blood Circulation", "MN": "E01.370.370.120", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "usually NIM; coordinate with disease /physiopathol, not /blood", "MS": "Determination of the shortest time interval between the injection of a substance in the vein and its arrival at some distant site in sufficient concentration to produce a recognizable end result. It represents approximately the inverse of the average velocity of blood flow between two points.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001776"}, {"RECTYPE": "D", "MH": "Blood Coagulation", "DE": "BLOOD COAG", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Blood Clotting|T042|NON|EQV|NLM (1996)|950330|abcdef", "ENTRY": "Clotting, Blood", "MN": "G09.188.390.150", "FX": "Whole Blood Coagulation Time", "MH_TH": "NLM (1966)", "ST": "T042", "MS": "The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot.", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001777"}, {"RECTYPE": "D", "MH": "Blood Coagulation Disorders", "DE": "BLOOD COAG DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Disorder, Blood Coagulation", "MN": "C15.378.100", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; see also THROMBOSIS; EMBOLISM and specifics; /genet: consider also BLOOD COAGULATION DISORDERS, INHERITED", "MS": "Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.", "CATSH": "CAT LIST", "MR": "20040719", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001778"}, {"RECTYPE": "D", "MH": "Blood Coagulation Factors", "DE": "BLOOD COAG FACTORS", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Coagulation Factors|T116|T123|NON|EQV|UNK (19XX)|860620|COAG FACTORS|abbcdefv", "ENTRY": "Factors, Clotting", "MN": "D23.119", "FX": "Coagulants", "EC": "deficiency:Coagulation Protein Disorders", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Endogenous substances, usually proteins, that are involved in the blood coagulation process.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001779"}, {"RECTYPE": "D", "MH": "Blood Coagulation Tests", "DE": "BLOOD COAG TESTS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Test, Blood Coagulation", "MN": "E05.200.625.115", "FX": "Blood Coagulation", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "general or unspecified; prefer specifics; usually NIM; coordinate with disease /blood, not /physiopathol", "MS": "Laboratory tests for evaluating the individual's clotting mechanism.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001780"}, {"RECTYPE": "D", "MH": "Blood Component Removal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Pheresis|T061|NON|EQV|UNK (19XX)|850617|abcdef", "ENTRY": "Removal, Blood Component", "MN": "E02.120", "FX": "Hematopoietic Stem Cell Mobilization", "MH_TH": "NLM (1981)", "ST": "T061", "AN": "general or unspecified; prefer specifics; erythrocytapheresis, erythrapheresis: coordinate with ERYTHROCYTE TRANSFUSION", "MS": "Any procedure in which blood is withdrawn from a donor, a portion is separated and retained, at the same time the remainder is returned to the donor.", "PM": "86; PLATELETPHERESIS was see under CELL SEPARATION 1981-85; was see under BLOOD TRANSFUSION 1979-80; was see PLASMAPHERESIS 1978", "HN": "86; was NON MESH before 1986", "CATSH": "CAT LIST", "MR": "20190903", "DA": "19800512", "DC": "1", "DX": "19860101", "UI": "D001781"}, {"RECTYPE": "D", "MH": "Blood Donors", "AQ": "CL ED ES HI LJ PX SD SN", "ENTRY": "Donors, Blood", "MN": "M01.898.313", "FX": "Phlebotomy", "MH_TH": "POPLINE (1994)", "ST": "T098", "MS": "Individuals supplying blood or blood components for transfer to histocompatible recipients.", "MR": "20220711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001782"}, {"RECTYPE": "D", "MH": "Blood Flow Velocity", "AQ": "DE ES GE IM PH RE VE", "ENTRY": "Velocity, Blood Flow", "MN": "G09.330.380.630.080", "MH_TH": "NLM (1966)", "ST": "T169", "AN": "usually NIM; coordinate with disease / physiopathol, not / blood; do not confuse with PULSE WAVE VELOCITY see PULSE WAVE ANASLYSIS", "MS": "A value equal to the total volume flow divided by the cross-sectional area of the vascular bed.", "HN": "was in Cat E only 1963-85", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D001783"}, {"RECTYPE": "D", "MH": "Blood Gas Analysis", "DE": "BLOOD GAS ANAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Gas Analysis, Blood", "MN": "E05.200.124.100.100", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "for determ of oxygen & carbon dioxide in the blood; NIM; coord with disease /blood, not /physiopathol", "MS": "Measurement of oxygen and carbon dioxide in the blood.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001784"}, {"RECTYPE": "D", "MH": "Blood Gas Monitoring, Transcutaneous", "DE": "TCPO2", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Transcutaneous Oximetry|T060|NON|NRW|UNK (19XX)|860620|abcdef", "ENTRY": "Transcutaneous Oximetries", "MN": "E05.200.124.100.100.600.100", "MH_TH": "NLM (1987)", "ST": "T060", "AN": "NIM; coord with disease /blood, not /physiopathol; when IM, do not coord with OXYGEN /blood or CARBON DIOXIDE /blood", "PI": "Partial Pressure (1966-1986)", "MS": "The noninvasive measurement or determination of the partial pressure (tension) of oxygen and/or carbon dioxide locally in the capillaries of a tissue by the application to the skin of a special set of electrodes. These electrodes contain photoelectric sensors capable of picking up the specific wavelengths of radiation emitted by oxygenated versus reduced hemoglobin.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19860620", "DC": "1", "DX": "19870101", "UI": "D001785"}, {"RECTYPE": "D", "MH": "Blood Glucose", "AQ": "AN BI CH DE GE IM IP ME PH RE", "PRINT ENTRY": "Glucose, Blood|T109|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Sugar, Blood", "MN": "D09.947.875.359.448.500", "FX": "Hypoglycemia", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Glucose in blood.", "OL": "use BLOOD GLUCOSE to search BLOOD SUGAR 1966-79", "PM": "80; was BLOOD SUGAR 1963-79", "HN": "80; was BLOOD SUGAR 1963-79", "MR": "20220718", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D001786"}, {"RECTYPE": "D", "MH": "Blood Group Incompatibility", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rh Incompatibility|T047|NON|NRW|NLM (2023)|220325|abcdef", "ENTRY": "Rh Incompatibilities", "MN": "G12.186", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with specific blood group ", "MS": "An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984).", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001787"}, {"RECTYPE": "D", "MH": "Blood Grouping and Crossmatching", "DE": "BLOOD GROUPING CROSSMATCHING", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Crossmatching, Blood|T059|NON|NRW|UNK (19XX)|790427|abcdef", "ENTRY": "Typing, Blood", "MN": "E05.760.833.230.250.250", "MH_TH": "NLM (1980)", "ST": "T059", "PI": "specific blood-group system (1966-1979)", "MS": "Testing erythrocytes to determine presence or absence of blood-group antigens, testing of serum to determine the presence or absence of antibodies to these antigens, and selecting biocompatible blood by crossmatching samples from the donor against samples from the recipient. Crossmatching is performed prior to transfusion.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19790427", "DC": "1", "DX": "19800101", "UI": "D001788"}, {"RECTYPE": "D", "MH": "Blood Group Antigens", "AQ": "AD AE AN BI BL CF CH CL EC GE HI IM IP ME PD PH PO TO TU UL UR", "PRINT ENTRY": "Blood Groups|T170|NON|REL|NLM (1966)|990101|abcdef", "ENTRY": "Groups, Blood", "MN": "D23.050.705.230", "FX": "Isoantibodies", "MH_TH": "NLM (2004)", "ST": "T129", "RN": "0", "AN": "human or animal; blood group of animal: coordinate animal /blood (not /immunol) + BLOOD GROUP ANTIGENS; blood group in a disease: coord BLOOD GROUP ANTIGENS or specific blood group + disease /blood, not /immunol nor /genet", "MS": "Sets of cell surface antigens located on BLOOD CELLS. They are usually membrane GLYCOPROTEINS or GLYCOLIPIDS that are antigenically distinguished by their carbohydrate moieties.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001789"}, {"RECTYPE": "D", "MH": "Blood Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Blood Physiology|T042|NON|EQV|NLM (1966)|990101|BLOOD PHYSIOL|abcdefv", "ENTRY": "Processes, Blood Physiological", "MN": "G09.188", "MH_TH": "NLM (2009)", "ST": "T042", "AN": "general or unspecified; prefer specifics", "PI": "Blood/physiology (1966-1997)", "MS": "Physiological processes and properties of the BLOOD.", "PM": "2009; see BLOOD PHYSIOLOGY 1998-2008; for BLOOD PHYSIOLOGICAL PROCESSES see BLOOD PHYSIOLOGICAL PROCESSES 2004-2016", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001790"}, {"RECTYPE": "D", "MH": "Blood Platelet Disorders", "DE": "BLOOD PLATELET DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombocytopathy|T047|NON|EQV|UNK (19XX)|850325|abcdef", "ENTRY": "Thrombocytopathies", "MN": "C15.378.140", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "do not use as coord for platelet factor defic: use COAGULATION PROTEIN DISORDERS", "MS": "Disorders caused by abnormalities in platelet count or function.", "OL": "use BLOOD PLATELET DISORDERS to search THROMBOCYTOPATHY 1966-85", "PM": "67; THROMBOCYTOPATHY was see under BLOOD PLATELET DISORDERS 1967-85, was heading 1963-66", "HN": "67(64); THROMBOCYTOPATHY was see under BLOOD PLATELET DISORDERS 1967-85, was heading 1963-66", "CATSH": "CAT LIST", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001791"}, {"RECTYPE": "D", "MH": "Blood Platelets", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Thrombocytes|T023|T025|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Thrombocyte", "MN": "A15.145.229.188", "FX": "Thrombocytosis", "EC": "transplantation:Platelet Transfusion", "MH_TH": "NLM (1966)", "ST": "T025", "CX": "consider also terms at PLATELET and THROMBOCYT-", "MS": "Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation.", "MR": "19950222", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001792"}, {"RECTYPE": "D", "MH": "Blood Preservation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Preservations, Blood", "MN": "E05.760.833.230", "FX": "Hematologic Tests", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "preserv of whole blood or specific cellular elements; coord IM with specific cell (IM); cryopreservation of blood: coord IM with CRYOPRESERVATION (IM)", "MS": "The process by which blood or its components are kept viable outside of the organism from which they are derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism).", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001793"}, {"RECTYPE": "D", "MH": "Blood Pressure", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Systolic Pressure|T040|NON|NRW|NLM (2002)|000714|abcdef", "ENTRY": "Pressures, Systolic", "MN": "G09.330.380.076", "FX": "Hypotension", "MH_TH": "NLM (1999)", "ST": "T040", "AN": "general; note specifics;  pressure within a specific vessel: coordinate vessel / physiol (IM) + BLOOD PRESSURE (NIM); do not add SYSTOLE; DIASTOLE; or PULSE unless particularly discussed; with diseases coordinate IM with disease / physiopathol (IM), not / blood (IM); differentiate from HYPERTENSION & HYPOTENSION", "MS": "PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001794"}, {"RECTYPE": "D", "MH": "Blood Pressure Determination", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Determination, Blood Pressure", "MN": "E01.370.600.100", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "see note at BLOOD PRESSURE", "MS": "Techniques used for measuring BLOOD PRESSURE.", "CATSH": "CAT LIST", "MR": "20151130", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001795"}, {"RECTYPE": "D", "MH": "Blood Protein Disorders", "DE": "BLOOD PROTEIN DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Protein Disorders, Blood", "MN": "C15.378.147", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Hematologic diseases caused by structural or functional defects of BLOOD PROTEINS.", "CATSH": "CAT LIST", "MR": "20151202", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001796"}, {"RECTYPE": "D", "MH": "Blood Protein Electrophoresis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Hemoglobin Electrophoresis|T059|NON|NRW|NLM (2021)|191018|abcdef", "ENTRY": "Protein Electrophoresis, Blood", "MN": "E05.301.300.049", "FX": "Immunoelectrophoresis", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "electrophoresis of hemoglobin goes here + HEMOGLOBINS /analysis", "MS": "Electrophoresis applied to BLOOD PROTEINS.", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001797"}, {"RECTYPE": "D", "MH": "Blood Proteins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serum Proteins|T116|T123|NON|REL|POPLINE (1978)|740329|abbcdef", "ENTRY": "Proteins, Serum", "MN": "D12.776.124", "FX": "Serpins", "MH_TH": "NLM (1984)", "ST": "T123", "RN": "0", "MS": "Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001798"}, {"RECTYPE": "D", "MH": "Blood Sedimentation", "AQ": "CL DE EC ES HI IS MT RE SN ST TD VE", "PRINT ENTRY": "Erythrocyte Sedimentation|T059|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Sedimentation, Erythrocyte", "MN": "E05.200.625.125", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "/drug eff /rad eff permitted; coordinate with disease /blood, not /physiopathol", "MS": "Measurement of rate of settling of ERYTHROCYTES in blood.", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001799"}, {"RECTYPE": "D", "MH": "Blood Specimen Collection", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Specimen Collections, Blood", "MN": "E05.200.998.110", "FX": "Liquid Biopsy", "MH_TH": "BIOETHICS (1991)", "ST": "T060", "AN": "includes \"handling\"", "MS": "The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc.", "CATSH": "CAT LIST", "MR": "20170628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001800"}, {"RECTYPE": "D", "MH": "Blood Stains", "ENTRY": "Stains, Blood", "MN": "I01.198.780.937.206", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "Antigenic characteristics and DNA fingerprint patterns identified from blood stains. Their primary value is in criminal cases.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001801"}, {"RECTYPE": "D", "MH": "Blood Substitutes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Red Cell Substitutes|T121|NON|NRW|UNK (19XX)|800402|abcdef", "ENTRY": "Substitutes, Red Cell", "MN": "J01.637.087.249", "FX": "Bloodless Medical and Surgical Procedures", "MH_TH": "NLM (1981)", "ST": "T121", "RN": "0", "AN": "PLASMA SUBSTITUTES is also available", "PI": "Plasma Substitutes (1968-1980)", "MS": "Substances that are used in place of blood, for example, as an alternative to BLOOD TRANSFUSIONS after blood loss to restore BLOOD VOLUME and oxygen-carrying capacity to the blood circulation, or to perfuse isolated organs.", "OL": "search PLASMA SUBSTITUTES 1966-80", "PM": "81; was see PLASMA SUBSTITUTES 1963-80", "HN": "81; was see PLASMA SUBSTITUTES 1963-80", "MR": "20100625", "DA": "19800402", "DC": "1", "DX": "19810101", "UI": "D001802"}, {"RECTYPE": "D", "MH": "Blood Transfusion", "AQ": "CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Transfusions, Blood", "MN": "E02.095.135", "FX": "Blood Grouping and Crossmatching", "EC": "adverse effects:Transfusion Reaction", "MH_TH": "POPLINE (1994)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "MS": "The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001803"}, {"RECTYPE": "D", "MH": "Blood Transfusion, Autologous", "DE": "BLOOD TRANSFUSION AUTOL", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Autotransfusion|T061|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Autotransfusions", "MN": "E02.095.135.164", "FX": "Operative Blood Salvage", "MH_TH": "NLM (1971)", "ST": "T061", "AN": "/adv eff: coordinate with TRANSFUSION REACTION if pertinent", "PI": "Blood Transfusion (1966-1970)", "MS": "Reinfusion of blood or blood products derived from the patient's own circulation. (Dorland, 27th ed)", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20170811", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D001804"}, {"RECTYPE": "D", "MH": "Blood Transfusion, Intrauterine", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Intrauterine Transfusion|T061|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Transfusions, Intrauterine Blood", "MN": "E02.467.500", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "coordinate with specific type of transfusion if pertinent; /adv eff: coordinate with TRANSFUSION REACTION if pertinent", "MS": "In utero transfusion of BLOOD into the FETUS for the treatment of FETAL DISEASES, such as fetal erythroblastosis (ERYTHROBLASTOSIS, FETAL).", "PM": "68", "HN": "68(65)", "CATSH": "CAT LIST", "MR": "20170811", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001805"}, {"RECTYPE": "D", "MH": "Blood Urea Nitrogen", "PRINT ENTRY": "BUN|T059|ABB|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Urea Nitrogen, Blood", "MN": "E05.200.124.100.115", "MH_TH": "NLM (1964)", "ST": "T059", "AN": "note category; AZOTEMIA is available for the disease", "MS": "The urea concentration of the blood stated in terms of nitrogen content. Serum (plasma) urea nitrogen is approximately 12% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001806"}, {"RECTYPE": "D", "MH": "Blood Vessel Prosthesis", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Vascular Prosthesis|T074|NON|EQV|UNK (19XX)|860325|abcdef", "ENTRY": "Vessel Prosthesis, Blood", "MN": "E07.695.110", "FX": "Blood Vessel Prosthesis Implantation", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "Device constructed of either synthetic or biological material that is used for the repair of injured or diseased blood vessels.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001807"}, {"RECTYPE": "D", "MH": "Blood Vessels", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE TR UL VI", "ENTRY": "Vessels, Blood", "MN": "A07.015", "FX": "Vasomotor System", "EC": "surgery:Vascular Surgical Procedures", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at ANGI-, VASA-, VASC-, and VASO-", "MS": "Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins).", "PM": "/transplantation was BLOOD VESSEL TRANSPLANTATION 1963-65", "HN": "/transplantation was BLOOD VESSEL TRANSPLANTATION 1963-65", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001808"}, {"RECTYPE": "D", "MH": "Blood Viscosity", "AQ": "DE ES GE IM PH RE", "ENTRY": "Viscosity, Blood", "MN": "G09.330.380.630.110", "FX": "Hemorheology", "MH_TH": "NLM (1966)", "ST": "T039", "AN": "coordinate IM with disease /blood (IM), not /physiopathol", "MS": "The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA.", "CATSH": "CAT LIST", "MR": "20150625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001809"}, {"RECTYPE": "D", "MH": "Blood Volume", "AQ": "DE ES GE IM PH RE VE", "ENTRY": "Volumes, Blood", "MN": "G09.330.380.092", "FX": "Hypovolemia", "MH_TH": "NLM (1966)", "ST": "T032", "AN": "PLASMA VOLUME; ERYTHROCYTE VOLUME; & ERYTHROCYTE VOLUME, PACKED are also available; coordinate IM with disease /physiopathol (IM), not /blood", "MS": "Volume of circulating BLOOD. It is the sum of the PLASMA VOLUME and ERYTHROCYTE VOLUME.", "CATSH": "CAT LIST", "MR": "20150625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001810"}, {"RECTYPE": "D", "MH": "Blood Volume Determination", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Volume Determinations, Blood", "MN": "E01.370.370.150", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "NIM; coord with disease /physiopathol, not /blood", "MS": "Method for determining the circulating blood volume by introducing a known quantity of foreign substance into the blood and determining its concentration some minutes later when thorough mixing has occurred. From these two values the blood volume can be calculated by dividing the quantity of injected material by its concentration in the blood at the time of uniform mixing. Generally expressed as cubic centimeters or liters per kilogram of body weight.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001811"}, {"RECTYPE": "D", "MH": "Blood-Brain Barrier", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hemato-Encephalic Barrier|T042|NON|EQV|UNK (19XX)|740329|HEMATOENCEPHALIC BARRIER|abcdefs", "ENTRY": "Hemato-Encephalic Barriers", "MN": "A08.186.211.035", "FX": "Capillary Permeability", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "coord IM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM)", "MS": "Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue.", "PM": "66; was HEMATO-ENCEPHALIC BARRIER 1963-65", "HN": "66; was HEMATO-ENCEPHALIC BARRIER 1963-65", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001812"}, {"RECTYPE": "D", "MH": "Blood-Retinal Barrier", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Retinal-Blood Barrier|T042|NON|EQV|NLM (2004)|030317|abcdef", "ENTRY": "Retinal-Blood Barriers", "MN": "A09.371.729.055", "FX": "Capillary Permeability", "MH_TH": "NLM (1987)", "ST": "T042", "AN": "coord IM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM)", "PI": "Retinal Vessels (1966-1986)", "MS": "A specialized transport barrier, in the EYE, formed by the retinal pigment EPITHELIUM, and the ENDOTHELIUM of the BLOOD VESSELS of the RETINA. TIGHT JUNCTIONS joining adjacent cells keep the barrier between cells continuous.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19860407", "DC": "1", "DX": "19870101", "UI": "D001813"}, {"RECTYPE": "D", "MH": "Blood-Testis Barrier", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Testis-Blood Barrier|T042|NON|EQV|NLM (2004)|030317|abcdef", "ENTRY": "Testis-Blood Barriers", "MN": "A07.045", "FX": "Capillary Permeability", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "coord IM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM)", "PI": "Testis (1966-1974)", "MS": "A specialized barrier, in the TESTIS, between the interstitial BLOOD compartment and the adluminal compartment of the SEMINIFEROUS TUBULES. The barrier is formed by layers of cells from the VASCULAR ENDOTHELIUM of the capillary BLOOD VESSELS, to the SEMINIFEROUS EPITHELIUM of the seminiferous tubules. TIGHT JUNCTIONS form between adjacent SERTOLI CELLS, as well as between the ENDOTHELIAL CELLS.", "PM": "76; was see under TESTIS 1975", "HN": "76(75); was see under TESTIS 1975", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19760101", "UI": "D001814"}, {"RECTYPE": "D", "MH": "Bloodletting", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E02.800.558.500", "FX": "Phlebotomy", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "restrict to hist articles or hist contexts: modern counterpart is PHLEBOTOMY", "MS": "Puncture of a vein to draw blood for therapeutic purposes. Bloodletting therapy has been used in Talmudic and Indian medicine since the medieval time, and was still practiced widely in the 18th and 19th centuries. Its modern counterpart is PHLEBOTOMY.", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001815"}, {"RECTYPE": "D", "MH": "Bloom Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bloom-Torre-Machacek Syndrome|T019|T047|EPO|EQV|GHR (2014)|ORD (2010)|UNK (19XX)|810223|abbcdeeef", "ENTRY": "Telangiectatic Erythema, Congenital", "MN": "C20.673.795.313", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Telangiectasis (1966-1981)", "MS": "An autosomal recessive disorder characterized by telangiectatic ERYTHEMA of the face, photosensitivity, DWARFISM and other abnormalities, and a predisposition toward developing cancer. The Bloom syndrome gene (BLM) encodes a RecQ-like DNA helicase.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19810223", "DC": "1", "DX": "19820101", "UI": "D001816"}, {"RECTYPE": "D", "MH": "Bluetongue", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Tongue, Blue", "MN": "C22.836.120", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "caused by a reovirus; usually animal; check tag ANIMALS; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES", "PI": "Virus Diseases/veterinary (1966-1967)", "MS": "A reovirus infection, chiefly of sheep, characterized by a swollen blue tongue, catarrhal inflammation of upper respiratory and gastrointestinal tracts, and often by inflammation of sensitive laminae of the feet and coronet.", "OL": "use BLUETONGUE to search BLUE TONGUE 1968-93 (as Prov 1968-73)", "PM": "94; was BLUE TONGUE 1974-93", "HN": "94; was BLUE TONGUE 1968-93 (Prov 1968-73)", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001819"}, {"RECTYPE": "D", "MH": "Bluetongue virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Ovine Catarrhal Fever Virus|T005|NON|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "Bluetongue Viruses", "MN": "B04.820.223.719.550.100", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid40051", "MS": "The type species of ORBIVIRUS causing a serious disease in sheep, especially lambs. It may also infect wild ruminants and other domestic animals.", "OL": "use BLUETONGUE VIRUS to search BLUE TONGUE VIRUS 1975-93", "PM": "94; was BLUE TONGUE VIRUS 1975-93 (see under REOVIRIDAE 1981-90, see under REOVIRUSES 1975-80)", "HN": "94; was BLUE TONGUE VIRUS 1975-93 (see under REOVIRIDAE 1981-90, see under REOVIRUSES 1975-80)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D001820"}, {"RECTYPE": "D", "MH": "Blushing", "AQ": "CL DE ES PH PX RE", "ENTRY": "Blushings", "MN": "F02.830.158", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "note category: do not confuse with FLUSHING", "MS": "Involuntary reddening, especially of the face, associated with feelings of embarrassment, confusion or shame.", "CATSH": "CAT LIST", "MR": "20090730", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001821"}, {"RECTYPE": "D", "MH": "Body Burden", "ENTRY": "Burdens, Body", "MN": "N06.850.460.200", "FX": "Pesticide Residues", "MH_TH": "NLM (1971)", "ST": "T081", "AN": "usually NIM", "PI": "Radiation Monitoring (1966-1970)", "MS": "The total amount of a chemical, metal or radioactive substance present at any time after absorption in the body of man or animal.", "PM": "73; only radioactive substances 1973-77", "HN": "73(71); only radioactive substances 1971-77", "CATSH": "CAT LIST", "MR": "20160613", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001822"}, {"RECTYPE": "D", "MH": "Body Composition", "AQ": "DE GE IM PH RE", "ENTRY": "Compositions, Body", "MN": "G07.100.049", "FX": "Anthropometry", "MH_TH": "NLM (1966)", "ST": "T032", "MS": "The relative amounts of various components in the body, such as percentage of body fat.", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001823"}, {"RECTYPE": "D", "MH": "Body Constitution", "AQ": "DE EH GE IM PH RE", "ENTRY": "Constitutions, Body", "MN": "G07.100", "MH_TH": "NLM (1966)", "ST": "T081", "MS": "The physical characteristics of the body, including the mode of performance of functions, the activity of metabolic processes, the manner and degree of reactions to stimuli, and power of resistance to the attack of pathogenic organisms.", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001824"}, {"RECTYPE": "D", "MH": "Body Fluid Compartments", "AQ": "CH DE DG EN GE IM ME MI PH PS RE VI", "ENTRY": "Fluid Compartments, Body", "MN": "A12.207.180", "MH_TH": "NLM (1978)", "ST": "T030", "PI": "Body Water (1974-1977)", "MS": "The two types of spaces between which water and other body fluids are distributed: extracellular and intracellular.", "PM": "91; was see under BODY FLUIDS 1978-90", "HN": "91(78); was see under BODY FLUIDS 1978-90", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D001825"}, {"RECTYPE": "D", "MH": "Body Fluids", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Fluids, Body", "MN": "A12.207", "FX": "Radioisotope Dilution Technique", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "Liquid components of living organisms.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001826"}, {"RECTYPE": "D", "MH": "Body Height", "AQ": "DE EH GE IM PH RE", "ENTRY": "Heights, Body", "MN": "G07.345.249.314.100", "MH_TH": "NLM (1963)", "ST": "T081", "AN": "human only; for height or length of animals use animal /anat (IM) + BIOMETRY (NIM)", "MS": "The distance from the sole to the crown of the head with body standing on a flat surface and fully extended.", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001827"}, {"RECTYPE": "D", "MH": "Body Image", "AQ": "PX", "PRINT ENTRY": "Body Identity|T080|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Schema, Body", "MN": "F02.463.593.112", "MH_TH": "NLM (1966)", "ST": "T080", "MS": "Individuals' concept of their own bodies.", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001828"}, {"RECTYPE": "D", "MH": "Body Regions", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Regions, Body", "MN": "A01", "RH": "A1 - ANATOMY-BODY REGIONS", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "INDEXER: Do not use", "PI": "specific region (1966-1997)", "MS": "Anatomical areas of the body.", "PM": "98", "HN": "98; use explode 1971-97", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001829"}, {"RECTYPE": "D", "MH": "Body Surface Area", "AQ": "VE", "ENTRY": "Surface Areas, Body", "MN": "G07.100.100.231", "MH_TH": "NLM (1967)", "ST": "T081", "PI": "Anthropometry (1966)", "MS": "The two dimensional measure of the outer layer of the body.", "PM": "70", "HN": "70(67)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D001830"}, {"RECTYPE": "D", "MH": "Body Temperature", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Organ Temperature|T032|NON|NRW|UNK (19XX)|850617|abcdef", "ENTRY": "Temperatures, Organ", "MN": "G07.110", "FX": "Thermometers", "MH_TH": "POPLINE (1978)", "ST": "T032", "MS": "The measure of the level of heat of a human or animal.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001831"}, {"RECTYPE": "D", "MH": "Body Temperature Changes", "ENTRY": "Temperature Changes, Body", "MN": "C23.888.119", "MH_TH": "NLM (1974)", "ST": "T184", "AN": "INDEXER: Do not use", "PI": "Body Temperature (1966-1997)", "MS": "Significant alterations in temperature of the human body, above or below 98.6 degrees F. or 37 degrees C. when taken orally.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001832"}, {"RECTYPE": "D", "MH": "Body Temperature Regulation", "DE": "BODY TEMPERATURE REG", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Thermoregulation|T040|NON|EQV|UNK (19XX)|740329|THERMOREG|abcdefv", "ENTRY": "Thermoregulations", "MN": "G16.012.500.535", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "The processes of heating and cooling that an organism uses to control its temperature.", "CATSH": "CAT LIST", "MR": "20160219", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001833"}, {"RECTYPE": "D", "MH": "Body Water", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Water, Body", "MN": "A12.207.200", "MH_TH": "NLM (1972)", "ST": "T031", "AN": "do not confuse with EXTRACELLULAR FLUID", "PI": "Water (1966-1971)", "MS": "Fluids composed mainly of water found within the body.", "PM": "74", "HN": "74(72)", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001834"}, {"RECTYPE": "D", "MH": "Body Weight", "AQ": "DE EH GE IM PH RE", "ENTRY": "Weights, Body", "MN": "G07.345.249.314.120", "FX": "Obesity", "MH_TH": "NLM (1963)", "ST": "T081", "MS": "The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001835"}, {"RECTYPE": "D", "MH": "Body Weight Changes", "ENTRY": "Weight Changes, Body", "MN": "G07.345.249.314.120.200", "MH_TH": "NLM (1974)", "ST": "T184", "AN": "INDEXER: Do not use", "PI": "Body Weight (1966-1997)", "MS": "A clinical manifestation consisting of alterations in an individual's weight from his or her norm.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001836"}, {"RECTYPE": "D", "MH": "Body Weights and Measures", "DE": "BODY WEIGHTS MEASURES", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Measures, Body", "MN": "G07.100.100", "FX": "Anthropometry", "MH_TH": "NLM (1974)", "ST": "T081", "AN": "general or unspecified; prefer specifics; do not confuse with BODY WEIGHT", "PI": "Anthropometry (1966-1997)", "MS": "Measurements of the height, weight, length, area, etc., of the human and animal body or its parts.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001837"}, {"RECTYPE": "D", "MH": "Bolivia", "AQ": "EH EP", "MN": "Z01.107.757.136", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in central South America, located southwest of Brazil.", "MR": "20160531", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001838"}, {"RECTYPE": "D", "MH": "Bombesin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Dihydrochloride, Bombesin", "MN": "D23.946.833.033.137", "PA": "Neurotransmitter Agents", "FX": "Receptors, Bombesin", "MH_TH": "NLM (1975)", "ST": "T125", "N1": "5-oxoPro-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-MetNH2", "RN": "PX9AZU7QPK", "RR": "33910-70-2 (di-HCl)", "PI": "Peptides (1966-1974)", "MS": "A tetradecapeptide originally obtained from the skins of toads Bombina bombina and B. variegata. It is also an endogenous neurotransmitter in many animals including mammals. Bombesin affects vascular and other smooth muscle, gastric secretion, and renal circulation and function.", "PM": "86; was see under PEPTIDES 1975-85", "HN": "86(75); was see under PEPTIDES 1975-85", "MR": "20151123", "DA": "19741111", "DC": "1", "DX": "19860101", "UI": "D001839"}, {"RECTYPE": "D", "MH": "Dental Bonding", "DE": "DENT BONDING", "AQ": "AE CL EC ES HI IS MT NU PX SN ST TD VE", "PRINT ENTRY": "Cure of Orthodontic Adhesives|T061|NON|NRW|NLM (2009)|071003|abcdef", "ENTRY": "Orthodontic Adhesives Cure", "MN": "E06.095", "MH_TH": "NLM (1971)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "PI": "Surface Properties (1966-1970)", "MS": "An adhesion procedure for orthodontic attachments, such as plastic DENTAL CROWNS. This process usually includes the application of an adhesive material (DENTAL CEMENTS) and letting it harden in-place by light or chemical curing.", "OL": "use DENTAL BONDING to search BONDING, DENTAL 1971-90 (as Prov 1971)", "PM": "91; was BONDING, DENTAL 1972-90", "HN": "91(71); was BONDING, DENTAL 1971-90 (Prov 1971)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001840"}, {"RECTYPE": "D", "MH": "Human-Animal Bond", "PRINT ENTRY": "Pet-Human Bonding|T054|NON|NRW|NLM (1983)|820428|abcdef", "ENTRY": "Human-Pet Bondings", "MN": "F01.145.496.500", "FX": "Pets", "MH_TH": "NLM (2021)", "ST": "T054", "AN": "coordinate with specific animal pet; check tags ANIMALS & HUMAN", "MS": "The emotional attachment of individuals to animals.", "PM": "91; was see under OBJECT ATTACHMENT 1983-90", "HN": "91(83); was see under OBJECT ATTACHMENT 1983-90", "CATSH": "CAT LIST", "MR": "20200526", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D001841"}, {"RECTYPE": "D", "MH": "Bone and Bones", "DE": "BONE BONES", "AQ": "AB AH BS CH CY DE DG EM EN IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Bone and Bone|T024|NON|EQV|NLM (2022)|200817|abcdef", "ENTRY": "Tissues, Bone", "MN": "A10.165.265", "FX": "Osteotomy", "EC": "transplantation:Bone Transplantation", "MH_TH": "NLM (1966)", "ST": "T024", "CX": "consider also terms at OSSI- and OSTE-", "MS": "A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.", "OL": "use BONE TRANSPLANTATION to search BONE AND BONES/transplantation 1966-89", "PM": "/transplantation was BONE TRANSPLANTATION 1963-65; was BONE AND BONES/transplantation 1966-89", "HN": "/transplantation was BONE TRANSPLANTATION 1963-65; was BONE AND BONES/transplantation 1966-89", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001842"}, {"RECTYPE": "D", "MH": "Bone Cements", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Bone Pastes|T122|NON|EQV|NLM (1997)|950817|abcdef", "ENTRY": "Pastes, Bone", "MN": "J01.637.051.720.716.822.300", "MH_TH": "NLM (1972)", "ST": "T122", "RN": "0", "AN": "coordinate with specific material if relevant ", "PI": "Tissue Adhesives (1966-1971)", "MS": "Adhesives used to fix prosthetic devices to bones and to cement bone to bone in difficult fractures. Synthetic resins are commonly used as cements. A mixture of monocalcium phosphate, monohydrate, alpha-tricalcium phosphate, and calcium carbonate with a sodium phosphate solution is also a useful bone paste.", "PM": "72", "HN": "72", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001843"}, {"RECTYPE": "D", "MH": "Bone Conduction", "AQ": "DE GE IM PH RE", "ENTRY": "Hearing, Bone Conduction", "MN": "G11.561.790.263.398", "MH_TH": "NLM (1964)", "ST": "T042", "AN": "do not confuse with OSTEOCONDUCTION", "MS": "Transmission of sound waves through vibration of bones in the SKULL to the inner ear (COCHLEA). By using bone conduction stimulation and by bypassing any OUTER EAR or MIDDLE EAR abnormalities, hearing thresholds of the cochlea can be determined. Bone conduction hearing differs from normal hearing which is based on air conduction stimulation via the EAR CANAL and the TYMPANIC MEMBRANE.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001844"}, {"RECTYPE": "D", "MH": "Bone Cysts", "AQ": "BL BS CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subchondral Cysts|T047|NON|BRD|UNK (19XX)|860623|abcdef", "ENTRY": "Subchondral Cyst", "MN": "C05.116.070", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific bone (IM)", "MS": "Benign unilocular lytic areas in the proximal end of a long bone with well defined and narrow endosteal margins. The cysts contain fluid and the cyst walls may contain some giant cells. Bone cysts usually occur in males between the ages 3-15 years.", "OL": "use BONE CYSTS to search BONE CYST 1966-79", "PM": "80; was BONE CYST 1963-79", "HN": "80; was BONE CYST 1963-79", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D001845"}, {"RECTYPE": "D", "MH": "Bone Development", "AQ": "DE GE IM PH RE", "ENTRY": "Bone Growth|T042|NON|NRW|NLM (2002)|010109|abcdef", "MN": "G11.427.578.050.500", "MH_TH": "NLM (1965)", "ST": "T042", "AN": "OSTEOGENESIS is also available", "MS": "The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20180206", "DA": "19780621", "DC": "1", "DX": "19650101", "UI": "D001846"}, {"RECTYPE": "D", "MH": "Bone Diseases", "DE": "BONE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Bone", "MN": "C05.116", "FX": "Fractures, Bone", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases of BONES.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001847"}, {"RECTYPE": "D", "MH": "Bone Diseases, Developmental", "DE": "BONE DIS DEVELOPMENTAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bone Dysplasias|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Dysplasias, Bone", "MN": "C05.116.099", "MH_TH": "NLM (1970)", "ST": "T047", "PI": "Bone Diseases (1966-1969)", "MS": "Diseases resulting in abnormal GROWTH or abnormal MORPHOGENESIS of BONES.", "PM": "70; HYPERTELORISM was see under CRANIOFACIAL DYSOSTOSIS 1963-84", "HN": "70", "CATSH": "CAT LIST", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D001848"}, {"RECTYPE": "D", "MH": "Bone Diseases, Endocrine", "DE": "BONE DIS ENDOCRINE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Endocrine Bone Diseases", "MN": "C19.149", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "General or unspecified; prefer specifics; coordinate IM with specific endocrine disease (IM)", "PI": "Endocrine Diseases (1966-1997)", "MS": "Diseases of the bones related to hyperfunction or hypofunction of the endocrine glands.", "PM": "98", "HN": "98; use explode 1971-97", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001849"}, {"RECTYPE": "D", "MH": "Bone Diseases, Infectious", "DE": "BONE DIS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infectious Bone Diseases", "MN": "C05.116.165", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with specific organism/infection term if pertinent", "PI": "Orthopedics (1966-1997)", "MS": "Bone diseases caused by pathogenic microorganisms.", "PM": "98", "HN": "98; use explode 1971-97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001850"}, {"RECTYPE": "D", "MH": "Bone Diseases, Metabolic", "DE": "BONE DIS METAB", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Osteopenia|T047|NON|NRW|UNK (19XX)|860408|abcdef", "ENTRY": "Osteopenias", "MN": "C18.452.104", "FX": "Bone Density", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Bone Diseases (1966-1979)", "MS": "Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.", "PM": "80", "HN": "80; was NON MESH before 1980", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D001851"}, {"RECTYPE": "D", "MH": "Bone Lengthening", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Lengthening, Bone", "MN": "E04.555.120", "FX": "Tissue Expansion", "MH_TH": "NLM (1972)", "ST": "T061", "AN": "not restricted to long bones; coordinate IM with specific bone /surg (IM) or specific disease /surg (IM)", "PI": "specific bone/surgery (1966-1971)", "MS": "Increase in the longest dimension of a bone to correct anatomical deficiencies, congenital, traumatic, or as a result of disease. The lengthening is not restricted to long bones. The usual surgical methods are internal fixation and distraction.", "OL": "search LEG LENGTHENING under LEG LENGTH INEQUALITY 1966-71 (as Prov 1966)", "PM": "72; LEG LENGTHENING was heading 1967-71", "HN": "72; LEG LENGTHENING was heading 1964-71 (Prov 1964-66)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001852"}, {"RECTYPE": "D", "MH": "Bone Marrow", "AQ": "AB AH BS CH DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Yellow Marrow|T023|NON|NRW|NLM (1991)|900316|abcdef", "ENTRY": "Marrow, Yellow", "MN": "A15.382.216", "EC": "transplantation:Bone Marrow Transplantation", "MH_TH": "BIOETHICS (1989)", "ST": "T023", "CX": "consider also terms at MYEL-", "MS": "The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.", "OL": "use BONE MARROW /CY + BONE MARROW /qualif to search BONE MARROW CELLS /same qualif 1966-77, e.g., search BONE MARROW CELLS /DE under BONE MARROW /CY + BONE MARROW /DE", "PM": "65; BONE MARROW CELLS was heading 1965-77; /transplantation was BONE MARROW TRANSPLANTATION 1964-65, was BONE MARROW/transplantation 1966-89", "HN": "65; BONE MARROW CELLS was heading 1965-77; /transplantation was BONE MARROW TRANSPLANTATION 1964-65, was BONE MARROW/transplantation 1966-89", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001853"}, {"RECTYPE": "D", "MH": "Bone Marrow Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE UL VI", "ENTRY": "Marrow Cells, Bone", "MN": "A15.378.316", "FX": "Bone Marrow Examination", "EC": "transplantation:Bone Marrow Transplantation", "MH_TH": "NLM (1965)", "ST": "T025", "PI": "Bone Marrow/cytology (1978-1997)", "MS": "Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells.", "PM": "1998; 1965-1977", "HN": "1998(1966)", "MR": "20210304", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D001854"}, {"RECTYPE": "D", "MH": "Bone Marrow Diseases", "DE": "BONE MARROW DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Marrow Diseases, Bone", "MN": "C15.378.190", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases involving the BONE MARROW.", "CATSH": "CAT LIST", "MR": "20151202", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001855"}, {"RECTYPE": "D", "MH": "Bone Marrow Examination", "DE": "BONE MARROW EXAM", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Examinations, Bone Marrow", "MN": "E05.200.625.135", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "usually NIM", "MS": "Removal of bone marrow and evaluation of its histologic picture.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001856"}, {"RECTYPE": "D", "MH": "Bone Matrix", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Matrix, Bone", "MN": "A10.165.265.166", "MH_TH": "NLM (1972)", "ST": "T024", "PI": "Bone and Bones (1966-1971)", "MS": "Extracellular substance of bone tissue consisting of COLLAGEN fibers, ground substance, and inorganic crystalline minerals and salts.", "PM": "72", "HN": "72", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001857"}, {"RECTYPE": "D", "MH": "Bone Nails", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Bone Pins|T074|NON|EQV|NLM (1991)|891227|abcdef", "ENTRY": "Pins, Bone", "MN": "E07.858.690.725.460.249", "FX": "Bone Wires", "MH_TH": "NLM (1971)", "ST": "T074", "AN": "note entry term BONE PINS", "MS": "Rods of bone, metal, or other material used for fixation of the fragments or ends of fractured bones.", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001858"}, {"RECTYPE": "D", "MH": "Bone Neoplasms", "DE": "BONE NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cancer of Bone|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Bone", "MN": "C05.116.231", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "general or unspecified; prefer specific precoordinate; do not confuse with NEOPLASMS, BONE TISSUE (neoplasms composed of bone tissue); coordinate with specific bone and histological type of neoplasm", "MS": "Tumors or cancer located in bone tissue or specific BONES.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001859"}, {"RECTYPE": "D", "MH": "Bone Plates", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Plates, Bone", "MN": "E07.858.690.725.460.374", "MH_TH": "NLM (1971)", "ST": "T074", "MS": "Implantable fracture fixation devices attached to bone fragments with screws to bridge the fracture gap and shield the fracture site from stress as bone heals. (UMDNS, 1999)", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001860"}, {"RECTYPE": "D", "MH": "Bone Regeneration", "AQ": "DE ES GE IM PH RE", "ENTRY": "Regenerations, Bone", "MN": "G16.762.150.150", "FX": "Fracture Healing", "MH_TH": "NLM (1965)", "ST": "T042", "AN": "not for callus formation (= BONY CALLUS with required qualifiers); not for fracture healing (= FRACTURE HEALING); do not confuse OSTEOCONDUCTION with BONE CONDUCTION", "MS": "Renewal or repair of lost bone tissue. It excludes BONY CALLUS formed after BONE FRACTURES but not yet replaced by hard bone.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001861"}, {"RECTYPE": "D", "MH": "Bone Resorption", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Osteoclastic Bone Loss|T042|NON|EQV|UNK (19XX)|860408|abcdef", "ENTRY": "Resorptions, Bone", "MN": "G11.427.213.150", "FX": "Osteoclasts", "MH_TH": "NLM (1964)", "ST": "T042", "MS": "Bone loss due to osteoclastic activity.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001862"}, {"RECTYPE": "D", "MH": "Bone Screws", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Screws, Bone", "MN": "E07.858.690.725.460.437", "FX": "Bone Wires", "MH_TH": "NLM (1971)", "ST": "T074", "AN": "do not confuse with BONE PINS see BONE NAILS", "PI": "Fracture Fixation, Intramedullary (1970)", "MS": "Specialized devices used in ORTHOPEDIC SURGERY to repair bone fractures.", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001863"}, {"RECTYPE": "D", "MH": "Bone Wires", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Kirschner Wires|T074|EPO|NRW|NLM (1991)|900522|abcdef", "ENTRY": "Wires, Kirschner", "MN": "E07.858.690.725.460.468", "FX": "Bone Screws", "MH_TH": "NLM (1986)", "ST": "T074", "AN": "do not confuse with BONE PINS see BONE NAILS", "PI": "Fracture Fixation, Internal (1970-1985)", "MS": "Steel wires, often threaded through the skin, soft tissues, and bone, used to fix broken bones. Kirschner wires or apparatus also includes the application of traction to the healing bones through the wires.", "PM": "91; was see under ORTHOPEDIC FIXATION DEVICES 1986-90", "HN": "91(86); was see under ORTHOPEDIC FIXATION DEVICES 1986-90", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19850607", "DC": "1", "DX": "19910101", "UI": "D001864"}, {"RECTYPE": "D", "MH": "Bongkrekic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Flavotoxin A|T109|T121|NON|EQV|NLM (1991)|900404|abbcdef", "ENTRY": "Bongkrekate|T109|T121|NON|NRW|UNK (19XX)|850528|abbcdef", "MN": "D02.241.081.337.075", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "2,4,8,10,14,18,20-Docosaheptaenedioic acid, 20-(carboxymethyl)-6-methoxy-2,5,17-trimethyl-, (R-(R*,S*-(E,Z,Z,E,E,Z,E)))-", "RN": "11076-19-0", "PI": "Pseudomonas (1968-1974)", "MS": "An antibiotic produced by Pseudomonas cocovenenans. It is an inhibitor of MITOCHONDRIAL ADP, ATP TRANSLOCASES. Specifically, it blocks adenine nucleotide efflux from mitochondria by enhancing membrane binding.", "PM": "91; was see under ANTIBIOTICS 1975-90", "HN": "91(75); was see under ANTIBIOTICS 1975-90", "MR": "20030730", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001865"}, {"RECTYPE": "D", "MH": "Book Classification", "DE": "BOOK CLASS", "AQ": "CL EC ES HI MT SN ST TD", "ENTRY": "Classifications, Book", "MN": "L01.462.750.819.250.150", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "A general term covering bibliographical and bibliothecal classifications. It mostly refers to library CLASSIFICATION for arrangement of books and documents on the shelves. (Harrod's Librarians' Glossary, 7th ed, p85)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001867"}, {"RECTYPE": "D", "MH": "Book Collecting", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Collecting, Book", "MN": "L01.583.182", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "Seeking, locating, acquiring, organizing, cataloging, displaying, storing, and maintaining whatever books are of interest to a given individual collector.", "MR": "20171211", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001868"}, {"RECTYPE": "D", "MH": "Book Imprints", "AQ": "HI", "ENTRY": "Imprints, Book", "MN": "L01.737.150.159", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Information relating to the publication, printing, distribution, issue, release, or production of a book.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001869"}, {"RECTYPE": "D", "MH": "Book Industry", "DE": "BOOK INDUST", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Industries, Book", "MN": "L01.737.150", "FX": "Publishing", "MH_TH": "NLM (1966)", "ST": "T092", "MS": "The aggregate enterprise of manufacturing and technically producing books. (From Random House Unabridged Dictionary, 2d ed)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001870"}, {"RECTYPE": "D", "MH": "Book Ornamentation", "AQ": "HI", "ENTRY": "Ornamentations, Book", "MN": "L01.462.500.682.192.178", "MH_TH": "NLM (1966)", "ST": "T170", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001871"}, {"RECTYPE": "D", "MH": "Book Prices", "MN": "L01.737.150.340.250", "MH_TH": "NLM (1966)", "ST": "T081", "MS": "Amount paid to purchase individual volumes or set from a bookseller.", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001872"}, {"RECTYPE": "D", "MH": "Book Reviews as Topic", "MN": "L01.462.500.682.150", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "use for articles on book reviews as a subject; do not confuse with the Publication Type BOOK REVIEW", "MS": "Works about critical analyses of books or other monographic works.", "PM": "2008; see BOOK REVIEWS 1963-2007", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D001873"}, {"RECTYPE": "D", "MH": "Book Selection", "ENTRY": "Selections, Book", "MN": "L01.462.750.220", "MH_TH": "NLM (1966)", "ST": "T052", "AN": "no qualif; lists of books probably go here but consider also BIBLIOGRAPHIES AS TOPIC", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001874"}, {"RECTYPE": "D", "MH": "Bookbinding", "AQ": "CL EC ES HI LJ MT SD SN ST TD", "MN": "L01.737.150.317", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "Joining together of a number of leaves or folios (most frequently of paper, parchment, or vellum) within covers to form a codex or book.", "MR": "20171211", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001875"}, {"RECTYPE": "D", "MH": "Bookplates as Topic", "AQ": "HI", "ENTRY": "Bookplates as Topics", "MN": "L01.462.500.682.192.234", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "designed labels showing ownership of a book; medical bookplates: do not coordinate with MEDICINE; coordinate IM with subject (IM) if relevant; bookplates of famous medical & non-medical figures: coordinate IM with required biographical and historical headings & check tags; do not confuse with Publication Type BOOKPLATE", "MS": "Works about labels pasted in books to mark their ownership and sometimes to indicate their location in a library.", "PM": "2008; see BOOKPLATES 1963-2007", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D001876"}, {"RECTYPE": "D", "MH": "Books", "AQ": "HI", "ENTRY": "Book Chapters", "MN": "L01.462.500.682.192", "FX": "Bibliotherapy", "EC": "classification:Book Classification", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "Non-periodical written or printed works consisting of sheets of pages fastened or bound together within covers.", "PM": "64", "HN": "64", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D001877"}, {"RECTYPE": "D", "MH": "Books, Illustrated", "AQ": "HI", "PRINT ENTRY": "Illustrated Books|T073|T170|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Illustrations, Book", "MN": "L01.462.500.682.192.289", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "coordinate with subject or type of illustration; do not confuse entry term BOOK ILLUSTRATION with the Publication Type BOOK ILLUSTRATIONS ", "MS": "Books containing photographs, prints, drawings, portraits, plates, diagrams, facsimiles, maps, tables, or other representations or systematic arrangement of data designed to elucidate or decorate its contents. (From The ALA Glossary of Library and Information Science, 1983, p114)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001878"}, {"RECTYPE": "D", "MH": "Bookselling", "AQ": "CL EC ES HI LJ MT SD SN ST TD", "MN": "L01.737.150.340", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "Making books available for purchase.", "MR": "20171211", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001879"}, {"RECTYPE": "D", "MH": "Boranes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Boron Hydrides|T104|NON|EQV|NLM (1994)|930210|abcdef", "ENTRY": "Hydrides, Boron", "MN": "D02.203.087", "MH_TH": "NLM (1968)", "ST": "T104", "RN": "0", "AN": "collective name for boron hydrides (do not confuse with BOROHYDRIDES); do not confuse with BORATES or CAMPHANES", "PI": "Boron (1966-1967)", "MS": "The collective name for the boron hydrides, which are analogous to the alkanes and silanes. Numerous boranes are known. Some have high calorific values and are used in high-energy fuels. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "68", "HN": "68", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001880"}, {"RECTYPE": "D", "MH": "Borates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Borate|T104|NON|EQV|NLM (2021)|191118|abcdef", "MN": "D02.203.130.075", "MH_TH": "NLM (1966)", "ST": "T104", "RN": "0", "AN": "do not confuse with BORANES", "MS": "Inorganic or organic salts and esters of boric acid.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001881"}, {"RECTYPE": "D", "MH": "Border Disease", "DE": "BORDER DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Border Diseases", "MN": "C22.836.160", "MH_TH": "NLM (1985)", "ST": "T047", "AN": "caused by a pestivirus; border refers to the English-Welsh border where there is a high mortal among sheep from this dis; usually animal; check tag ANIMALS; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES", "PI": "Sheep Diseases (1966-1984)", "MS": "Congenital disorder of lambs caused by a virus closely related to or identical with certain strains of bovine viral diarrhea virus.", "PM": "91; was see under SHEEP DISEASES 1985-90", "HN": "91(85); was see under SHEEP DISEASES 1985-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19840406", "DC": "1", "DX": "19910101", "UI": "D001882"}, {"RECTYPE": "D", "MH": "Borderline Personality Disorder", "DE": "BORDERLINE PERSONALITY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Personality Disorder, Borderline|T048|NON|EQV|UNK (19XX)|800521|PERSONALITY DIS BORDERLINE|abcdefv", "ENTRY": "Personality Disorders, Borderline", "MN": "F03.675.100", "MH_TH": "NLM (1981)", "ST": "T048", "AN": "\"borderline\" is a psychiatric diag: follow text", "MS": "A personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. (DSM-IV)", "PM": "90; was see under PERSONALITY DISORDERS 1981-89", "HN": "90(81); was see under PERSONALITY DISORDERS 1981-89", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19800521", "DC": "1", "DX": "19900101", "UI": "D001883"}, {"RECTYPE": "D", "MH": "Bordetella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.344.425", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid517", "MS": "A genus of gram-negative aerobic bacteria whose cells are minute coccobacilli. It consists of both parasitic and pathogenic species.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001884"}, {"RECTYPE": "D", "MH": "Bordetella Infections", "DE": "BORDETELLA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Bordetella", "MN": "C01.150.252.400.143", "MH_TH": "NLM (1972)", "ST": "T047", "AN": "gram-neg bact infect", "PI": "Bordetella (1966-1971)", "MS": "Infections with bacteria of the genus BORDETELLA.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001885"}, {"RECTYPE": "D", "MH": "Bordetella pertussis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Haemophilus pertussis|T007|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Hemophilus pertussis|T007|NON|EQV|NLM (1992)|910402|abcdef", "MN": "B03.660.075.090.344.425.600", "FX": "Virulence Factors, Bordetella", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid520", "MS": "A species of gram-negative, aerobic bacteria that is the causative agent of WHOOPING COUGH. Its cells are minute coccobacilli that are surrounded by a slime sheath.", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001886"}, {"RECTYPE": "D", "MH": "Boredom", "ENTRY": "Boredoms", "MN": "F01.470.192", "MH_TH": "NLM (1969)", "ST": "T041", "PI": "Motivation (1966-1968)", "MS": "A psychological state resulting from any activity that lacks motivation, or from enforced continuance in an uninteresting situation.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "19890427", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D001887"}, {"RECTYPE": "D", "MH": "Boric Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Boric", "MN": "D02.203.130", "MH_TH": "NLM (1968)", "ST": "T197", "RN": "0", "PI": "Borates (1966-1967)", "MS": "Inorganic and organic derivatives of boric acid either B(OH)3 or, preferably H3BO3.", "PM": "68", "HN": "68", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001888"}, {"RECTYPE": "D", "MH": "Borinic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Borinic", "MN": "D02.203.187", "MH_TH": "NLM (1968)", "ST": "T104", "RN": "0", "AN": "do not confuse with BORONIC ACIDS or BORIC ACIDS", "PI": "Boron (1966-1967)", "MS": "Inorganic or organic compounds that contain the general structure R2B(OH).", "PM": "68", "HN": "68", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001889"}, {"RECTYPE": "D", "MH": "Borna Disease", "DE": "BORNA DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "MN": "C22.152", "MH_TH": "NLM (1970)", "ST": "T047", "PI": "Virus Diseases (1966-1969)", "MS": "An encephalomyelitis of horses, sheep and cattle caused by BORNA DISEASE VIRUS.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D001890"}, {"RECTYPE": "D", "MH": "Borna disease virus", "DE": "BORNA DIS VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Near East Equine Encephalomyelitis Virus|T005|EPO|EQV|UNK (19XX)|741205|NEAR EAST EQUINE ENCEPH VIRUS|abcdefv", "ENTRY": "Encephalomyelitis Virus, Enzootic|T005|NON|EQV|NLM (1995)|940210|ENCEPH VIRUS ENZOOTIC|abcdefv", "MN": "B04.820.480.937.149.135", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid12455", "MS": "A species in the genus Bornavirus, family BORNAVIRIDAE, causing a rare and usually fatal encephalitic disease in horses and other domestic animals and possibly deer. Its name derives from the city in Saxony where the condition was first described in 1894, but the disease occurs in Europe, N. Africa, and the Near East.", "PM": "91; was see under VERTEBRATE VIRUSES, UNCLASSIFIED 1981-90; was see under ENCEPHALITIS VIRUSES 1977-80; was see under ARBOVIRUSES 1975-76", "HN": "91(75); was see under VERTEBRATE VIRUSES, UNCLASSIFIED 1981-90; was see under ENCEPHALITIS VIRUSES 1977-80; was see under ARBOVIRUSES 1975-76", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D001891"}, {"RECTYPE": "D", "MH": "Camphanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fenchanes|T109|NON|NRW|NLM (2020)|190506|abcdef", "MN": "D04.075.080.500.234", "MH_TH": "UNK (19XX)", "ST": "T109", "RN": "0", "AN": "do not confuse with BORANES; includes bornenes", "PI": "Terpenes (1970-1971)", "MS": "Crystalline saturated MONOTERPENES, precursors of borneols and CAMPHENE.", "PM": "2020; see BORNANES 1972-2019", "HN": "2020(1972)", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001892"}, {"RECTYPE": "D", "MH": "Borneo", "AQ": "EH EP", "MN": "Z01.639.160", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "an island in the Malay Archipelago; 3d largest island in the world", "MS": "An island in the Malay Archipelago, east of Sumatra, north of Java, and west of Celebes. It is the third largest island in the world. Its name is a Portuguese alteration of BRUNEI, located on it. (From Webster's New Geographical Dictionary, 1988, p163; Room, Brewer's Dictionary of Names, 1992, p73)", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001893"}, {"RECTYPE": "D", "MH": "Borohydrides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Borohydride|T104|NON|EQV|NLM (2021)|191121|abcdef", "MN": "D02.203.087.050", "MH_TH": "NLM (1971)", "ST": "T104", "RN": "0", "AN": "do not confuse with boron hydrides, the collective name for BORANES", "PI": "Boron Compounds (1968-1970)", "MS": "A class of inorganic or organic compounds that contain the borohydride (BH4-) anion.", "PM": "73", "HN": "73(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001894"}, {"RECTYPE": "D", "MH": "Boron", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Boron 11", "MN": "D01.268.513.500", "PA": "Trace Elements", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Boron", "RN": "N9E3X5056Q", "RR": "7440-42-8 (Boron)", "MS": "A trace element with the atomic symbol B, atomic number 5, and atomic weight [10.806; 10.821]. Boron-10, an isotope of boron, is used as a neutron absorber in BORON NEUTRON CAPTURE THERAPY.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001895"}, {"RECTYPE": "D", "MH": "Boron Compounds", "DE": "BORON CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Boron", "MN": "D02.203", "MH_TH": "NLM (1968)", "ST": "T104", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Boron (1966-1967)", "MS": "Inorganic or organic compounds that contain boron as an integral part of the molecule.", "PM": "68", "HN": "68", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001896"}, {"RECTYPE": "D", "MH": "Boronic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Boronic Acid|T104|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Acids, Boronic", "MN": "D02.203.200", "MH_TH": "NLM (1968)", "ST": "T104", "RN": "0", "AN": "do not confuse with BORINIC ACIDS", "PI": "Boron (1966-1967)", "MS": "Inorganic or organic compounds that contain the basic structure RB(OH)2.", "PM": "68", "HN": "68", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001897"}, {"RECTYPE": "D", "MH": "Borrelia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.851.595.193", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid138", "MS": "A genus of gram-negative, anaerobic, helical bacteria, various species of which produce RELAPSING FEVER in humans and other animals.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001898"}, {"RECTYPE": "D", "MH": "Borrelia Infections", "DE": "BORRELIA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Borrelia", "MN": "C01.150.252.400.794.352", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Infections with bacteria of the genus BORRELIA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001899"}, {"RECTYPE": "D", "MH": "Boston", "AQ": "EH EP", "MN": "Z01.433.210", "MH_TH": "NLM (1970)", "ST": "T083", "PI": "Massachusetts (1966-1969)", "MS": "City located in Massachusetts.", "HN": "70", "MR": "20160628", "DA": "19990101", "DC": "4", "DX": "19700101", "UI": "D001900"}, {"RECTYPE": "D", "MH": "Botany", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Botanies", "MN": "H01.158.273.118", "FX": "Plants", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "MS": "The study of the origin, structure, development, growth, function, genetics, and reproduction of plants.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001901"}, {"RECTYPE": "D", "MH": "Botswana", "AQ": "EH EP", "PRINT ENTRY": "Kalahari|T083|NAM|NRW|NLM (1998)|960815|abcdef", "MN": "Z01.058.290.175.230", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in southern Africa, between NAMIBIA and ZAMBIA. It was formerly called Bechuanaland. Its capital is Gaborone. The Kalahari Desert is in the west and southwest.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001902"}, {"RECTYPE": "D", "MH": "Bottle Feeding", "AQ": "AE CL EC EH HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Bottlefed|T054|NON|EQV|NLM (2021)|200612|abcdef", "ENTRY": "Bottlefeeding|T054|NON|EQV|NLM (1992)|911102|abcdef", "MN": "G07.203.650.353.099", "MH_TH": "NLM (1981)", "ST": "T054", "AN": "human & animal", "PI": "Infant Nutrition (1966-1974)", "MS": "Use of nursing bottles for feeding. Applies to humans and animals.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20200617", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D001903"}, {"RECTYPE": "D", "MH": "Botulinum Antitoxin", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Antitoxin, Botulism", "MN": "D20.215.401.601.276", "PA": "Immunologic Factors", "MH_TH": "NLM (1972)", "ST": "T129", "RN": "0", "PI": "Antitoxins (1966-1971)", "MS": "Antiserum given therapeutically in BOTULISM.", "PM": "73", "HN": "73(72)", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001904"}, {"RECTYPE": "D", "MH": "Botulinum Toxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Clostridium botulinum Toxins|T121|T126|T131|NON|EQV|UNK (19XX)|850617|abbbcdef", "ENTRY": "Toxins, Clostridium botulinum", "MN": "D23.946.123.179", "PA": "Neurotoxins", "FX": "Botulism", "MH_TH": "NLM (1969)", "ST": "T131", "RN": "EC 3.4.24.69", "AN": "/antag permitted but consider also BOTULINUM ANTITOXIN", "PI": "Toxins (1966-1968)", "MS": "Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS.", "OL": "use BOTULINUM TOXINS to search BOTULINUM TOXIN 1969-77 (as Prov 1969-71)", "PM": "78; was BOTULINUM TOXIN 1972-77", "HN": "78; was BOTULINUM TOXIN 1969-77 (Prov 1969-71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001905"}, {"RECTYPE": "D", "MH": "Botulism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Botulism, Infantile|T037|T047|NON|NRW|NLM (2000)|991103|abbcdef", "ENTRY": "Wound Botulisms", "MN": "C25.723.415.151", "FX": "Botulinum Toxins", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coordinate IM with specific Clostridium botulinum type (IM) if pertinent", "MS": "A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS (including respiratory paralysis), blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes (e.g., food-borne, infant, wound, and others). (From Adams et al., Principles of Neurology, 6th ed, p1208)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001906"}, {"RECTYPE": "D", "MH": "Boutonneuse Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Mediterranean Spotted Fever|T047|EPO|EQV|NLM (1991)|900329|abcdef", "ENTRY": "Spotted Fever, Mediterranean", "MN": "C01.920.930.887.250", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "caused by RICKETTSIA CONORII", "MS": "A febrile disease of the Mediterranean area, the Crimea, Africa, and India, caused by infection with RICKETTSIA CONORII.", "OL": "search RICKETTSIAL INFECTIONS 1966-74", "PM": "87; was see under RICKETTSIACEAE INFECTIONS 1977-86; was see under RICKETTSIAL DISEASES 1965-76; was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64", "HN": "87(75); was see under RICKETTSIACEAE INFECTIONS 1977-86; was see under RICKETTSIAL DISEASES 1965-76; was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64", "CATSH": "CAT LIST", "MR": "20190613", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D001907"}, {"RECTYPE": "D", "MH": "Diarrhea Viruses, Bovine Viral", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Diarrhea Virus, Bovine Viral|T005|NON|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Viruses, Bovine Diarrhea", "MN": "B04.820.578.344.700.150", "MH_TH": "NLM (2002)", "ST": "T005", "MS": "A group of viruses in the genus PESTIVIRUS, causing diarrhea, fever, oral ulcerations, hemorrhagic syndrome, and various necrotic lesions among cattle and other domestic animals. The two species (genotypes), BVDV-1 and BVDV-2 , exhibit antigenic and pathological differences. The historical designation, BVDV, consisted of both (then unrecognized) genotypes.", "PM": "2002; see DIARRHEA VIRUS, BOVINE VIRAL 1994-2001, see BOVINE DIARRHEA VIRUS 1991-1993, see PESTIVIRUSES 1981-1990, see RNA VIRUSES 1975-1980", "HN": "2002 (1975)", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D001908"}, {"RECTYPE": "D", "MH": "Leukemia Virus, Bovine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Cattle Leukemia Virus|T005|NON|EQV|UNK (19XX)|760517|abcdef", "ENTRY": "Virus, Cattle Leukemia", "MN": "B04.820.650.200.600", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid11901", "MS": "The type species of DELTARETROVIRUS that causes a form of bovine lymphosarcoma (ENZOOTIC BOVINE LEUKOSIS) or persistent lymphocytosis.", "OL": "use LEUKEMIA VIRUS, BOVINE to search BOVINE LEUKEMIA VIRUS 1977-93 & CATTLE LEUKEMIA VIRUS 1975-76", "PM": "94; was BOVINE LEUKEMIA VIRUS 1977-93 (see under RETROVIRIDAE 1981-90, see under LEUKOVIRUSES 1978-80, see under LEUKEMOGENIC VIRUSES 1977); was CATTLE LEUKEMIA VIRUS see under LEUKEMOGENIC VIRUSES 1975-76", "HN": "94; was BOVINE LEUKEMIA VIRUS 1977-93 (see under RETROVIRIDAE 1981-90, see under LEUKOVIRUSES 1978-80, see under LEUKEMOGENIC VIRUSES 1977); was CATTLE LEUKEMIA VIRUS see under LEUKEMOGENIC VIRUSES 1975-76", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D001909"}, {"RECTYPE": "D", "MH": "Herpesvirus 2, Bovine", "DS": "HERPESVIRUS BOVINE 02", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Bovine Ulcerative Mammillitis Virus|T005|NON|EQV|NLM (1994)|930301|abcdef", "ENTRY": "Viruses, Bovine Mamillitis", "MN": "B04.280.382.100.750.200", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid10295", "AN": "do not confuse with HERPESVIRUS 1, BOVINE; infection: coord IM with HERPES SIMPLEX (IM)", "MS": "A species of SIMPLEXVIRUS causing mammillitis in cattle in Great Britain and South Africa.", "OL": "use HERPESVIRUS 2, BOVINE to search BOVINE ULCERATIVE MAMMILLITIS VIRUS 1975-93; search ALLERTON VIRUS INFECTIONS under LUMPY SKIN DISEASE 1970-76", "PM": "94; was BOVINE ULCERATIVE MAMMILLITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80); ALLERTON VIRUS INFECTIONS was indexed under LUMPY SKIN DISEASE 1970-76", "HN": "94; was BOVINE ULCERATIVE MAMMILLITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80); ALLERTON VIRUS INFECTIONS was indexed under LUMPY SKIN DISEASE 1970-76", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D001911"}, {"RECTYPE": "D", "MH": "Bovine Virus Diarrhea-Mucosal Disease", "DE": "BOVINE VIRUS DIARRHEA MUCOSAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Mucosal Disease, Bovine Viral Diarrhea|T047|NON|EQV|NLM (2002)|010510|MUCOSAL DIS BOVINE VIRAL DIARRHEA|abcdefv", "ENTRY": "Bovine Virus Diarrhea Mucosal Disease|T047|NON|EQV|UNK (19XX)|771207|abcdef", "MN": "C22.196.106", "MH_TH": "NLM (1972)", "ST": "T047", "PI": "Virus Diseases/veterinary (1966-1971)", "MS": "Acute disease of cattle caused by the bovine viral diarrhea viruses (DIARRHEA VIRUSES, BOVINE VIRAL). Often mouth ulcerations are the only sign but fever, diarrhea, drop in milk yield, and loss of appetite are also seen. Severity of clinical disease varies and is strain dependent. Outbreaks are characterized by low morbidity and high mortality.", "PM": "91; was see under CATTLE DISEASES 1972-90", "HN": "91(72); was see under CATTLE DISEASES 1972-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001912"}, {"RECTYPE": "D", "MH": "Bowen's Disease", "DE": "BOWENS DIS", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Disease, Bowen's", "MN": "C04.557.470.700.400.130", "MH_TH": "NLM (1975)", "ST": "T191", "AN": "coordinate with SKIN NEOPLASMS", "MS": "A persistent progressive non-elevated red scaly or crusted plaque which is due to an intradermal carcinoma and is potentially malignant. Atypical squamous cells proliferate through the whole thickness of the epidermis. The lesions may occur anywhere on the skin surface or on mucosal surfaces. The cause most frequently found is trivalent arsenic compounds. Freezing, cauterization or diathermy coagulation is often effective. (From Rook et al., Textbook of Dermatology, 4th ed, pp2428-9)", "OL": "search CARCINOMA, SQUAMOUS CELL 1969-74", "PM": "91; was see under CARCINOMA, SQUAMOUS CELL 1981-90; was see under CARCINOMA, EPIDERMOID 1969-80", "HN": "91(75); was see under CARCINOMA, SQUAMOUS CELL 1981-90; was see under CARCINOMA, EPIDERMOID 1969-80", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001913"}, {"RECTYPE": "D", "MH": "Boxing", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Boxings", "MN": "I03.450.642.845.210", "MH_TH": "NLM (1966)", "ST": "T056", "AN": "/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1", "MS": "A two-person sport in which the fists are skillfully used to attack and defend.", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001914"}, {"RECTYPE": "D", "MH": "Braces", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Brace", "MN": "E07.858.442.743.319", "MH_TH": "NLM (1966)", "ST": "T074", "AN": "do not confuse with ORTHODONTIC BRACKETS", "MS": "Orthopedic appliances used to support, align, or hold parts of the body in correct position. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001915"}, {"RECTYPE": "D", "MH": "Brachial Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Brachial Arteries", "MN": "A07.015.114.139", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The continuation of the axillary artery; it branches into the radial and ulnar arteries.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001916"}, {"RECTYPE": "D", "MH": "Brachial Plexus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Plexus, Brachial", "MN": "A08.800.800.720.050", "FX": "Thoracic Outlet Syndrome", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The large network of nerve fibers which distributes the innervation of the upper extremity. The brachial plexus extends from the neck into the axilla. In humans, the nerves of the plexus usually originate from the lower cervical and the first thoracic spinal cord segments (C5-C8 and T1), but variations are not uncommon.", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001917"}, {"RECTYPE": "D", "MH": "Brachytherapy", "DE": "BRACHYTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Radiotherapy, Surface|T061|NON|NRW|UNK (19XX)|790307|RADIOTHER SURFACE|abcdefv", "ENTRY": "Therapy, Radioisotope Plaque", "MN": "E02.815.150", "MH_TH": "NLM (1980)", "ST": "T061", "AN": "a type of radiother", "PI": "specific radioisotope/administration & dosage/therapeutic use (1966-1979)", "MS": "A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19790307", "DC": "1", "DX": "19800101", "UI": "D001918"}, {"RECTYPE": "D", "MH": "Bradycardia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bradyarrhythmia|T033|T046|NON|EQV|NLM (1991)|900404|abbcdef", "ENTRY": "Bradycardias", "MN": "C23.550.073.300", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "ATHLETIC BRADYCARDIA see  CARDIOMEGALY, EXERCISE-INDUCED is available", "MS": "Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001919"}, {"RECTYPE": "D", "MH": "Bradykinin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Arg Pro Pro Gly Phe Ser Pro Phe Arg", "MN": "D23.529.812.169", "PA": "Vasodilator Agents", "FX": "Receptors, Bradykinin", "MH_TH": "NLM (1966)", "ST": "T125", "N1": "Bradykinin", "RN": "S8TIM42R2W", "RR": "76123-99-4 ((2-D-Pro-7-D-Pro)-isomer)", "MS": "A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter.", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001920"}, {"RECTYPE": "D", "MH": "Brain", "AQ": "AB AH BS CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Encephalon|T023|NON|EQV|NLM (2001)|991129|abcdef", "MN": "A08.186.211", "FX": "Psychosurgery", "EC": "transplantation:Brain Tissue Transplantation", "MH_TH": "BIOETHICS (1989)", "ST": "T023", "CX": "consider also terms at CEREBR- and ENCEPHAL-", "MS": "The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.", "PM": "/enzymology was BRAIN ENZYMOLOGY 1964-65; /physiology was BRAIN PHYSIOLOGY 1965; BRAIN ELECTROPHYSIOLOGY was heading 1964-65", "HN": "/enzymology was BRAIN ENZYMOLOGY 1964-65; /physiology was BRAIN PHYSIOLOGY 1965; BRAIN ELECTROPHYSIOLOGY was heading 1964-65", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D001921"}, {"RECTYPE": "D", "MH": "Brain Abscess", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Sterile Brain Abscesses", "MN": "C10.228.228.090", "FX": "Empyema, Subdural", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific infection (IM) + specific CNS infection term (IM) + site/disease term (IM) if pertinent", "MS": "A circumscribed collection of purulent exudate in the brain, due to bacterial and other infections. The majority are caused by spread of infected material from a focus of suppuration elsewhere in the body, notably the PARANASAL SINUSES, middle ear (see EAR, MIDDLE); HEART (see also ENDOCARDITIS, BACTERIAL), and LUNG. Penetrating CRANIOCEREBRAL TRAUMA and NEUROSURGICAL PROCEDURES may also be associated with this condition. Clinical manifestations include HEADACHE; SEIZURES; focal neurologic deficits; and alterations of consciousness. (Adams et al., Principles of Neurology, 6th ed, pp712-6)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001922"}, {"RECTYPE": "D", "MH": "Brain Chemistry", "DE": "BRAIN CHEM", "AQ": "DE GE IM PH RE", "ENTRY": "Chemistries, Brain", "MN": "G03.185", "MH_TH": "NLM (1965)", "ST": "T044", "AN": "differentiate from BRAIN /metab; consider also /chem with specific parts of the brain but probably as NIM with BRAIN CHEMISTRY (IM) if site is merely locational & illustrative", "MS": "Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001923"}, {"RECTYPE": "D", "MH": "Brain Concussion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cerebral Concussion|T037|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Severe Concussions", "MN": "C26.974.382.200", "MH_TH": "NLM (1963)", "ST": "T037", "MS": "A nonspecific term used to describe transient alterations or loss of consciousness following closed head injuries. The duration of UNCONSCIOUSNESS generally lasts a few seconds, but may persist for several hours. Concussions may be classified as mild, intermediate, and severe. Prolonged periods of unconsciousness (often defined as greater than 6 hours in duration) may be referred to as post-traumatic coma (COMA, POST-HEAD INJURY). (From Rowland, Merritt's Textbook of Neurology, 9th ed, p418)", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20160226", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001924"}, {"RECTYPE": "D", "MH": "Brain Damage, Chronic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Encephalopathy, Chronic|T047|NON|EQV|NLM (2000)|991108|ENCEPH CHRONIC|abcdefv", "ENTRY": "Chronic Brain Damage", "MN": "C23.550.291.500.063", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord with specific condition causing damage if pertinent", "MS": "A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.", "CATSH": "CAT LIST", "MR": "20210312", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001925"}, {"RECTYPE": "D", "MH": "Brain Death", "AQ": "BL CF CL DG DI IM LJ ME PA PP UR VE", "PRINT ENTRY": "Coma Depasse|T046|NON|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Death, Brain", "MN": "C23.550.260.159", "MH_TH": "NLM (1969)", "ST": "T046", "PI": "Death (1966-1968)", "MS": "A state of prolonged irreversible cessation of all brain activity, including lower brain stem function with the complete absence of voluntary movements, responses to stimuli, brain stem reflexes, and spontaneous respirations. Reversible conditions which mimic this clinical state (e.g., sedative overdose, hypothermia, etc.) are excluded prior to making the determination of brain death. (From Adams et al., Principles of Neurology, 6th ed, pp348-9)", "PM": "1972", "HN": "1972(1969)", "CATSH": "CAT LIST", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D001926"}, {"RECTYPE": "D", "MH": "Brain Diseases", "DE": "BRAIN DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intracranial Central Nervous System Disorders|T047|NON|EQV|NLM (2000)|991103|INTRACRANIAL CNS DIS|abcdefv", "ENTRY": "Intracranial CNS Disorder", "MN": "C10.228.140", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001927"}, {"RECTYPE": "D", "MH": "Brain Diseases, Metabolic", "DE": "BRAIN DIS METAB", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Metabolic Disorders, Brain|T047|NON|EQV|NLM (2000)|991104|METAB DIS BRAIN|abcdefv", "ENTRY": "Metabolic Encephalopathy, Acquired", "MN": "C18.452.132", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "general or unspecified, prefer specifics  ", "PI": "Brain Diseases (1966-1976)", "MS": "Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary (i.e., disorders intrinsic to the brain) and secondary (i.e., extracranial) metabolic conditions that adversely affect cerebral function.", "PM": "1977", "HN": "1977; was NON MESH before 1977", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D001928"}, {"RECTYPE": "D", "MH": "Brain Edema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vasogenic Cerebral Edema|T046|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Swelling, Brain", "MN": "C10.228.140.187", "FX": "Intracranial Hypertension", "MH_TH": "NLM (1964)", "ST": "T046", "MS": "Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6)", "PM": "1965", "HN": "1965(1964)", "CATSH": "CAT LIST", "MR": "19991104", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001929"}, {"RECTYPE": "D", "MH": "Brain Injuries", "DE": "BRAIN INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Brain Lacerations|T037|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Lacerations, Brain", "MN": "C26.915.300.200", "MH_TH": "NLM (1973)", "ST": "T037", "AN": "general or unspecified; consider also /inj with specific parts of the brain; do not confuse with CRANIOCEREBRAL TRAUMA", "MS": "Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.", "PM": "1981; see BRAIN INJURIES 1981-1999, see BRAIN INJURIES, ACUTE 1973-1980, see BRAIN INJURY, ACUTE 1963-1972; for BRAIN CONTUSION see BRAIN CONCUSSION 1998-1999", "HN": "1981(1963); for BRAIN CONTUSION use BRAIN CONCUSSION 1998-1999", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D001930"}, {"RECTYPE": "D", "MH": "Brain Mapping", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Topographic Brain Mapping|T060|T062|NON|NRW|IOM (1990)|890413|abbcdef", "ENTRY": "Mapping, Topographic Brain", "MN": "E05.629.875.500", "MH_TH": "NLM (1964)", "ST": "T062", "AN": "coordinate with specific part of brain/ physiol", "MS": "Imaging techniques used to colocalize sites of brain functions or physiological activity with brain structures.", "PM": "68", "HN": "68(64)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D001931"}, {"RECTYPE": "D", "MH": "Brain Neoplasms", "DE": "BRAIN NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Neoplasms, Intracranial|T191|NON|BRD|NLM (2000)|991104|NEOPL INTRACRANIAL|abcdefv", "ENTRY": "Tumor, Brain", "MN": "C10.551.240.250", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with specific site in brain + histological type of neoplasm", "MS": "Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001932"}, {"RECTYPE": "D", "MH": "Brain Stem", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Truncus Cerebrus", "MN": "A08.186.211.132", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The part of the brain that connects the CEREBRAL HEMISPHERES with the SPINAL CORD. It consists of the MESENCEPHALON; PONS; and MEDULLA OBLONGATA.", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001933"}, {"RECTYPE": "D", "MH": "Branchial Region", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Visceral Arches|T018|NON|NRW|NLM (1991)|891220|abcdef", "ENTRY": "Regions, Branchial", "MN": "A16.142", "MH_TH": "NLM (1966)", "ST": "T018", "AN": "branchial arch syndrome: index under BRANCHIAL REGION (IM) + SYNDROME (NIM)", "MS": "A region, of SOMITE development period, that contains a number of paired arches, each with a mesodermal core lined by ectoderm and endoderm on the two sides. In lower aquatic vertebrates, branchial arches develop into GILLS. In higher vertebrates, the arches forms outpouchings and develop into structures of the head and neck. Separating the arches are the branchial clefts or grooves.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001934"}, {"RECTYPE": "D", "MH": "Branchioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Branchial Cyst|T191|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Cysts, Branchial Cleft", "MN": "C04.182.117", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "neoplastic; includes branchial inclusion cyst, branchial chondroma, branchial fistula; coordinate with HEAD AND NECK NEOPLASMS", "MS": "A tumor derived from branchial epithelium or branchial rests. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001935"}, {"RECTYPE": "D", "MH": "Moraxella catarrhalis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Moraxella (Branhamella) catarrhalis|T007|NON|EQV|NLM (1988)|990101|abcdef", "MN": "B03.660.250.530.525.200", "MH_TH": "UNK (19XX)", "ST": "T007", "RN": "txid480", "AN": "infection: coord IM with MORAXELLACEAE INFECTIONS (IM)", "PI": "Neisseriaceae (1975-1987)", "MS": "Gram-negative aerobic cocci of low virulence that colonize the nasopharynx and occasionally cause MENINGITIS; BACTEREMIA; EMPYEMA; PERICARDITIS; and PNEUMONIA.", "PM": "2020; was MORAXELLA (BRANHAMELLA) CATARRHALIS 1992-2019; was BRANHAMELLA CATARRHALIS 1988-1991; for MORAXELLA (BRANHAMELLA) CATARRHALIS see BRANHAMELLA CATARRHALIS 1988-1991", "HN": "2020 (1988) was MORAXELLA (BRANHAMELLA) CATARRHALIS 1992-2019; was BRANHAMELLA CATARRHALIS 1988-1991; for MORAXELLA (BRANHAMELLA) CATARRHALIS use BRANHAMELLA CATARRHALIS 1988-1991", "MR": "20200128", "DA": "19870507", "DC": "1", "DX": "19880101", "UI": "D001936"}, {"RECTYPE": "D", "MH": "Brassica", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Kale|T168|NON|REL|NLM (1998)|961107|abcdef", "ENTRY": "Collard Greens", "MN": "B01.875.800.575.912.250.157.200", "MH_TH": "NLM (1978)", "ST": "T002", "RN": "txid3705", "PI": "Plants, Edible (1966-1977)", "MS": "A plant genus of the family Cruciferae. It contains many species and cultivars used as food including cabbage, cauliflower, broccoli, Brussel sprouts, kale, collard greens, MUSTARD PLANT; (B. alba, B. junica, and B. nigra), turnips (BRASSICA NAPUS) and rapeseed (BRASSICA RAPA).", "PM": "78", "HN": "78", "MR": "20210630", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D001937"}, {"RECTYPE": "D", "MH": "Brazil", "AQ": "EH EP", "MN": "Z01.107.757.176", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country located on the eastern coast of South America, located between Colombia and Peru, that borders the Atlantic Ocean. It is bordered on the north by Venezuela, Guyana, Suriname, and French Guiana, on the south by Uruguay, and on the west by Argentina. The capital is Brasilia.", "MR": "20160531", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001938"}, {"RECTYPE": "D", "MH": "Bread", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Breads", "MN": "J02.500.100", "MH_TH": "NLM (1966)", "ST": "T168", "MS": "Baked food product made of flour or meal that is moistened, kneaded, and sometimes fermented. A major food since prehistoric times, it has been made in various forms using a variety of ingredients and methods.", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001939"}, {"RECTYPE": "D", "MH": "Breast", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Breasts", "MN": "A01.236", "FX": "Mastectomy", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at MAMMA- and MAST-", "MS": "In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.", "MR": "20160809", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001940"}, {"RECTYPE": "D", "MH": "Breast Diseases", "DE": "BREAST DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Endocrine Breast Disease", "MN": "C17.800.090", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes of the BREAST.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001941"}, {"RECTYPE": "D", "MH": "Breast Feeding", "AQ": "AE EC EH ES HI IS MT PX SN TD", "PRINT ENTRY": "Wet Nursing|T040|NON|REL|NLM (2021)|200612|abcdef", "ENTRY": "Sharing, Milk", "MN": "G07.203.650.353.199", "FX": "Milk, Human", "MH_TH": "NLM (1978)", "ST": "T055", "AN": "human only; /adv eff: refers to effect on infant or mother", "MS": "The nursing of an infant at the breast.", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001942"}, {"RECTYPE": "D", "MH": "Breast Neoplasms", "DE": "BREAST NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cancer of Breast|T191|NON|NRW|GHR (2014)|NLM (2000)|991103|abcdeef", "ENTRY": "Tumor, Breast", "MN": "C17.800.090.500", "FX": "Breast Cancer Lymphedema", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "human only; BREAST NEOPLASMS, MALE is also available; for animal, index MAMMARY NEOPLASMS, ANIMAL or MAMMARY NEOPLASMS, EXPERIMENTAL; coordinate IM with histological type of neoplasm (IM)", "MS": "Tumors or cancer of the human BREAST.", "CATSH": "CAT LIST", "MR": "20180614", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001943"}, {"RECTYPE": "D", "MH": "Breath Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Breathalyzer Tests|T060|TRD|NRW|UNK (19XX)|860325|abcdef", "ENTRY": "Tests, Breathalyzer", "MN": "E01.370.100", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "NIM", "MS": "Any tests done on exhaled air.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20210312", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001944"}, {"RECTYPE": "D", "MH": "Breathing Exercises", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Respiratory Muscle Training|T061|NON|EQV|NLM (1996)|941208|abcdef", "ENTRY": "Training, Respiratory Muscle", "MN": "E02.779.474.124", "FX": "Yoga", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Therapeutic exercises aimed to deepen inspiration or expiration or even to alter the rate and rhythm of respiration.", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001945"}, {"RECTYPE": "D", "MH": "Breech Presentation", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Presentation, Breech|T047|T082|NON|EQV|UNK (19XX)|780119|abbcdef", "ENTRY": "Presentation, Frank Breech", "MN": "G08.686.784.769.326.520.150", "MH_TH": "NLM (1975)", "ST": "T082", "AN": "check the tags FEMALE & PREGNANCY", "PI": "Labor Presentation (1966-1974)", "MS": "A malpresentation of the FETUS at near term or during OBSTETRIC LABOR with the fetal cephalic pole in the fundus of the UTERUS. There are three types of breech: the complete breech with flexed hips and knees; the incomplete breech with one or both hips partially or fully extended; the frank breech with flexed hips and extended knees.", "OL": "search LABOR PRESENTATION 1966-74", "PM": "85; was see under LABOR PRESENTATION 1963-84", "HN": "85(75); was see under LABOR PRESENTATION 1963-84", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D001946"}, {"RECTYPE": "D", "MH": "Breeding", "AQ": "EC HI LJ MT SN ST", "ENTRY": "Breedings", "MN": "G05.090", "MH_TH": "NLM (1966)", "ST": "T040", "AN": "animals only; PLANT BREEDING is also available", "MS": "The production of offspring by selective mating or HYBRIDIZATION, GENETIC in animals or plants.", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001947"}, {"RECTYPE": "D", "MH": "Brenner Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Ovary Brenner Tumor", "MN": "C19.391.630.705.265", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with OVARIAN NEOPLASMS (IM)", "MS": "A smooth, solid or cystic fibroepithelial (FIBROEPITHELIAL NEOPLASMS) tumor, usually found in the OVARIES but can also be found in the adnexal region and the KIDNEYS. It consists of a fibrous stroma with nests of epithelial cells that sometimes resemble the transitional cells lining the urinary bladder. Brenner tumors generally are benign and asymptomatic. Malignant Brenner tumors have been reported.", "CATSH": "CAT LIST", "MR": "20210607", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001948"}, {"RECTYPE": "D", "MH": "Bretylium Compounds", "DE": "BRETYLIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Bretylium", "MN": "D02.092.877.096.333", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Benzylammonium compounds with the formula Br-phenyl-CN+R3 that include BRETYLIUM TOSYLATE.", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001949"}, {"RECTYPE": "D", "MH": "Bretylium Tosylate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ornid|T109|T121|TRD|NRW|UNK (19XX)|800731|abbcdef", "MN": "D02.092.877.096.333.150", "PA": "Antihypertensive Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1)", "RN": "78ZP3YR353", "RR": "61-75-6 (Bretylium Tosylate)", "PI": "Bretylium Compounds (1969-1975)", "MS": "An agent that blocks the release of adrenergic transmitters and may have other actions. It was formerly used as an antihypertensive agent, but is now proposed as an anti-arrhythmic.", "PM": "91; was see under BRETYLIUM COMPOUNDS 1976-90", "HN": "91(76); was see under BRETYLIUM COMPOUNDS 1976-90", "MR": "20160701", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D001950"}, {"RECTYPE": "D", "MH": "Brevibacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.550", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1696", "AN": "in soil, water, dairy prod & decaying matter", "MS": "A gram-positive organism found in dairy products, fresh and salt water, marine organisms, insects, and decaying organic matter.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001951"}, {"RECTYPE": "D", "MH": "Bridged-Ring Compounds", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bridged Compounds|T109|NON|EQV|NLM (1966)|990101|BRIDGED CPDS|abcdefv", "ENTRY": "Bridged Ring Compounds", "MN": "D04.075", "FX": "Polycyclic Aromatic Hydrocarbons", "MH_TH": "NLM (2017)", "ST": "T109", "RN": "0", "MS": "Cyclic hydrocarbons that contain multiple rings which share one or more bridgehead connections.", "PM": "2017; see BRIDGED COMPOUNDS 1966-2017", "HN": "2017(1966)", "MR": "20160609", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001952"}, {"RECTYPE": "D", "MH": "Brinolase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Brinase|T116|T121|T126|NON|EQV|INN (19XX)|741111|abbbcdef", "MN": "D08.811.277.656.300.099", "PA": "Fibrinolytic Agents", "MH_TH": "USAN (1971)", "ST": "T126", "RN": "EC 3.4.99.-", "PI": "Peptide Hydrolases (1972-1974)", "MS": "A fibrinolytic and thrombolytic enzyme from Aspergillus oryzae. EC 3.4.99.-.", "PM": "91; was see under PEPTIDE HYDROLASES 1975-90", "HN": "91(75); was see under PEPTIDE HYDROLASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001954"}, {"RECTYPE": "D", "MH": "British Columbia", "AQ": "EH EP", "MN": "Z01.107.567.176.160", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a province of Canada on the Pacific coast", "MS": "A province of Canada on the Pacific coast. Its capital is Victoria. The name given in 1858 derives from the Columbia River which was named by the American captain Robert Gray for his ship Columbia which in turn was named for Columbus. (From Webster's New Geographical Dictionary, 1988, p178 & Room, Brewer's Dictionary of Names, 1992, p81-2)", "MR": "19950217", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D001955"}, {"RECTYPE": "D", "MH": "Broad Ligament", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ligaments, Broad", "MN": "A10.165.669.170", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "A broad fold of peritoneum that extends from the side of the uterus to the wall of the pelvis.", "OL": "search ADNEXA UTERI 1966-74", "PM": "91; was see under ADNEXA UTERI 1975-90", "HN": "91(75); was see under ADNEXA UTERI 1975-90", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001956"}, {"RECTYPE": "D", "MH": "Broadsides as Topic", "AQ": "HI", "ENTRY": "Broadside as Topic|T170|NON|EQV|NLM (2008)|070622|abcdef", "MN": "L01.462.500.682.236", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with the Publication Type BROADSIDE", "MS": "Works about published pieces of paper or other material, usually printed on one side and intended to be read unfolded and usually intended to be posted, publicly distributed, or sold, e.g., proclamations, handbills, newssheets, etc.", "PM": "2008; see BROADSIDES 1963-2007", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D001957"}, {"RECTYPE": "D", "MH": "Brocresine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NSD1055", "MN": "D02.455.426.559.389.657.239.180", "PA": "Enzyme Inhibitors", "MH_TH": "USAN (1967)", "ST": "T121", "N1": "Phenol, 5-((aminooxy)methyl)-2-bromo-", "RN": "11F6O06WN0", "RR": "555-65-7 (Brocresine)", "PI": "Hydroxylamines (1971-1974)", "MS": "A histidine decarboxylase inhibitor.", "PM": "91; was see under CRESOLS 1975-90", "HN": "91(75); was see under CRESOLS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001958"}, {"RECTYPE": "D", "MH": "Bromates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bromate|T197|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D01.248.497.158.100", "MH_TH": "NLM (1971)", "ST": "T197", "RN": "0", "PI": "Bromine (1966-1970)", "MS": "Negative ions or salts derived from bromic acid, HBrO3.", "PM": "91; was see under BROMINE 1971-90", "HN": "91(71); was see under BROMINE 1971-90", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001959"}, {"RECTYPE": "D", "MH": "Bromazepam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Von Ct, Bromazep", "MN": "D03.633.100.079.080.070.110", "PA": "GABA Modulators", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "2H-1,4-Benzodiazepin-2-one, 7-bromo-1,3-dihydro-5-(2-pyridinyl)-", "RN": "X015L14V0O", "RR": "1812-30-2 (Bromazepam)", "PI": "Pyridines (1974)", "MS": "One of the BENZODIAZEPINES that is used in the treatment of ANXIETY DISORDERS.", "PM": "91; was see under BENZODIAZEPINE TRANQUILIZERS 1975-90", "HN": "91(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001960"}, {"RECTYPE": "D", "MH": "Bromcresol Green", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tetrabromocresolsulfonphthalein|T109|T130|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Green, Bromocresol", "MN": "D02.886.590.887.140", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis(2,6-dibromo-3-methyl)-, S,S-dioxide", "RN": "8YGN0Y942M", "RR": "76-60-8 (Bromcresol Green)", "PI": "Tosyl Compounds (1974)", "MS": "An indicator and reagent. It has been used in serum albumin determinations and as a pH indicator.", "PM": "91; was see under CRESOLS 1975-90", "HN": "91(75); was see under CRESOLS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001961"}, {"RECTYPE": "D", "MH": "Bromcresol Purple", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Purple, Bromocresol", "MN": "D02.886.590.887.150", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis(2-bromo-6-methyl)-, S,S-dioxide", "RN": "201C22C3EC", "RR": "115-40-2 (Bromcresol Purple)", "PI": "Tosyl Compounds (1973-1974)", "MS": "An indicator and reagent. It has been used for several purposes including the determination of serum albumin concentrations", "PM": "91; was see under CRESOLS 1975-90", "HN": "91(75); was see under CRESOLS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001962"}, {"RECTYPE": "D", "MH": "Bromelains", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Bromelins|T116|T121|T126|NON|EQV|UNK (19XX)|760317|abbbcdef", "ENTRY": "BromelainPOS", "MN": "D08.811.277.656.300.200.096", "MH_TH": "USAN (1962)", "ST": "T126", "RN": "9001-00-7", "RR": "EC 3.4.22.33 (fruit bromelain)", "MS": "Protein-digesting and milk-clotting enzymes found in PINEAPPLE fruit juice and stem tissue. Enzymes from the two sources are distinguished as fruit bromelain and stem bromelain. This enzyme was formerly listed as EC 3.4.22.4.", "PM": "67; was see under PEPTIDE PEPTIDOHYDROLASES 1963-66", "HN": "67(65); was see under ENDOPEPTIDASES 1963-66", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001963"}, {"RECTYPE": "D", "MH": "Bromhexine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "von ct, bromhexin", "MN": "D02.092.384.175", "PA": "Expectorants", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-", "RN": "Q1J152VB1P", "RR": "YC2ZOM3Z8V", "MS": "A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)", "PM": "74", "HN": "74", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001964"}, {"RECTYPE": "D", "MH": "Bromides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bromide|T197|NON|EQV|NLM (2021)|191227|abcdef", "MN": "D01.248.497.158.125", "PA": "Anticonvulsants", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "only for inorganic cpds or bromide ion", "MS": "Salts of hydrobromic acid, HBr, with the bromine atom in the 1- oxidation state. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001965"}, {"RECTYPE": "D", "MH": "Bromine", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Bromine 79", "MN": "D01.268.380.112", "FX": "Bromine Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Bromine", "RN": "SBV4XY874G", "RR": "7726-95-6 (Bromine)", "MS": "A halogen with the atomic symbol Br, atomic number 35, and atomic weight 79.904. It is a volatile reddish-brown liquid that gives off suffocating vapors, is corrosive to the skin, and may cause severe gastroenteritis if ingested.", "MR": "20170707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001966"}, {"RECTYPE": "D", "MH": "Bromine Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Bromine", "MN": "D01.496.749.090", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1987)", "MS": "Unstable isotopes of bromine that decay or disintegrate emitting radiation. Br atoms with atomic weights 74-78, 80, and 82-90 are radioactive bromine isotopes.", "PM": "88", "HN": "88", "MR": "20170703", "DA": "19870406", "DC": "1", "DX": "19880101", "UI": "D001967"}, {"RECTYPE": "D", "MH": "Bromisovalum", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bromovalerylurea|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Sedes A|T109|T121|TRD|NRW|UNK (19XX)|850528|abbcdef", "MN": "D02.065.950.160", "PA": "Hypnotics and Sedatives", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Butanamide, N-(aminocarbonyl)-2-bromo-3-methyl-", "RN": "469GW8R486", "RR": "496-67-3 (Bromisovalum)", "PI": "Valerates (1972-1974)", "MS": "A sedative and mild hypnotic with potentially toxic effects.", "PM": "91; was see under UREA 1975-90", "HN": "91(75); was see under UREA 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001968"}, {"RECTYPE": "D", "MH": "Bromobenzenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.526.368.150", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Hydrocarbons, Halogenated (1969-1974)", "MS": "Derivatives of benzene in which one or more hydrogen atoms on the benzene ring are replaced by bromine atoms.", "PM": "75", "HN": "75", "MR": "19920508", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D001969"}, {"RECTYPE": "D", "MH": "Bromobenzoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Bromobenzoic", "MN": "D02.455.426.559.389.127.150", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Benzoates (1966-1974)", "MS": "Benzoic acid or benzoic acid esters substituted with one or more bromine atoms.", "PM": "75", "HN": "75", "MR": "20120703", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D001970"}, {"RECTYPE": "D", "MH": "Bromocriptine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bromocryptin|T109|T121|NON|EQV|UNK (19XX)|760429|abbcdef", "ENTRY": "Methanesulfonate, 2-Bromoergocryptine", "MN": "D03.633.400.562.100", "PA": "Hormone Antagonists", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)-", "RN": "3A64E3G5ZO", "RR": "FFP983J3OD", "PI": "Ergot Alkaloids (1966-1974)", "MS": "A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.", "OL": "use BROMOCRIPTINE to search 2-BROMOERGOCRYPTINE 1975-80", "PM": "81; was 2-BROMOERGOCRYPTINE 1978-80, was 2-BROMOERGOCRYPTINE see under ERGOTOXINE 1977, was 2-BROMOERGOCRYPTINE see under ERGOLINES 1975-76", "HN": "81; was 2-BROMOERGOCRYPTINE 1978-80, was 2-BROMOERGOCRYPTINE see under ERGOTOXINE 1977, was 2-BROMOERGOCRYPTINE see under ERGOLINES 1975-76", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D001971"}, {"RECTYPE": "D", "MH": "Bromodeoxycytidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "5 Bromo 2' Deoxycytidine", "MN": "D13.570.685.245.500.250", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Cytidine, 5-bromo-2'-deoxy-", "RN": "1022-79-3", "PI": "Deoxycytidine (1974)", "MS": "5-Bromo-2'-deoxycytidine. Can be incorporated into DNA in the presence of DNA polymerase, replacing dCTP.", "PM": "91; was see under DEOXYCYTIDINE 1975-90", "HN": "91(75); was see under DEOXYCYTIDINE 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001972"}, {"RECTYPE": "D", "MH": "Bromodeoxyuridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Broxuridine|T114|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|UNK (19XX)|800523|abbcdeeef", "ENTRY": "Deoxyriboside, Bromouracil", "MN": "D13.570.685.852.300.150", "PA": "Radiation-Sensitizing Agents", "MH_TH": "NLM (1965)", "ST": "T121", "N1": "Uridine, 5-bromo-2'-deoxy-", "RN": "G34N38R2N1", "RR": "59-14-3 (Bromodeoxyuridine)", "MS": "A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.", "PM": "66", "HN": "66(65)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001973"}, {"RECTYPE": "D", "MH": "Bromosuccinimide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Succinbromimide|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "N Bromosuccinimide", "MN": "D03.383.773.812.852.150", "FX": "Succinates", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "2,5-Pyrrolidinedione, bromo-", "RN": "K8G1F2UCJF", "RR": "39660-53-2 (Bromosuccinimide)", "PI": "Succinimides (1972-1974)", "MS": "A brominating agent that replaces hydrogen atoms in benzylic or allylic positions. It is used in the oxidation of secondary alcohols to ketones and in controlled low-energy brominations. (From Miall's Dictionary of Chemistry, 5th ed; Hawley's Condensed Chemical Dictionary, 12th ed,).", "PM": "91; was see under SUCCINIMIDES 1975-90", "HN": "91(75); was see under SUCCINIMIDES 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001974"}, {"RECTYPE": "D", "MH": "Bromotrichloromethane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trichlorobromomethane|T109|T131|NON|EQV|UNK (19XX)|760305|abbcdef", "MN": "D02.455.526.439.224.200", "MH_TH": "NLM (1976)", "ST": "T131", "N1": "Methane, bromotrichloro-", "RN": "IKJ30QXM63", "RR": "75-62-7 (Bromotrichloromethane)", "PI": "Chloroform (1974) /AA (1975)", "MS": "A potent liver poison. In rats, bromotrichloromethane produces about three times the degree of liver microsomal lipid peroxidation as does carbon tetrachloride.", "PM": "91; was see under CHLOROFORM 1976-90", "HN": "91(76); was see under CHLOROFORM 1976-90", "MR": "20130708", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D001975"}, {"RECTYPE": "D", "MH": "Bromouracil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "5 Bromouracil", "MN": "D03.383.742.698.875.237", "PA": "Mutagens", "MH_TH": "NLM (1971)", "ST": "T131", "N1": "2,4(1H,3H)-Pyrimidinedione, 5-bromo-", "RN": "4HK400G5UO", "RR": "51-20-7 (Bromouracil)", "AN": "an antimetabolite", "PI": "Uracil (1966-1970)", "MS": "5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms.", "PM": "74", "HN": "74(71)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D001976"}, {"RECTYPE": "D", "MH": "Brompheniramine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "para-Bromdylamine|T109|T121|NON|EQV|UNK (19XX)|760626|abbcdef", "ENTRY": "para Bromdylamine", "MN": "D03.383.725.620.129", "PA": "Histamine H1 Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-", "RN": "H57G17P2FN", "RR": "IXA7C9ZN03", "MS": "Histamine H1 antagonist used in treatment of allergies, rhinitis, and urticaria.", "PM": "91; was see under PYRIDINES 1966-90", "HN": "91(66); was see under PYRIDINES 1966-90", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D001977"}, {"RECTYPE": "D", "MH": "Bromphenol Blue", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Blue, Tetrabromophenol", "MN": "D02.886.590.887.180", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis(2,6-dibromo)-, S,S-dioxide", "RN": "0R2969YC90", "RR": "115-39-9 (Bromphenol Blue)", "PI": "Tosyl Compounds (1972-1974)", "MS": "A dye that has been used as an industrial dye, a laboratory indicator, and a biological stain.", "PM": "91; was see under PHENOLS 1975-90", "HN": "91(75); was see under PHENOLS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001978"}, {"RECTYPE": "D", "MH": "Bromthymol Blue", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Dibromothymolsulfonphthalein|T109|T130|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Blue, Bromthymol", "MN": "D02.886.590.887.200", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis(2-bromo-3-methyl-6-(1-methylethyl))-, S,S-dioxide", "RN": "VGU4LM0H96", "RR": "76-59-5 (Bromthymol Blue)", "PI": "Tosyl Compounds (1974)", "MS": "A pH sensitive dye that has been used as an indicator in many laboratory reactions.", "PM": "91; was see under THYMOL 1975-90", "HN": "91(75); was see under THYMOL 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D001979"}, {"RECTYPE": "D", "MH": "Bronchi", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Bronchus, Tertiary", "MN": "A04.411.125", "FX": "Bronchoscopy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI.", "MR": "20160809", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001980"}, {"RECTYPE": "D", "MH": "Bronchial Arteries", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Bronchial Artery", "MN": "A07.015.114.158", "MH_TH": "NLM (1963)", "ST": "T023", "MS": "Left bronchial arteries arise from the thoracic aorta, the right from the first aortic intercostal or the upper left bronchial artery; they supply the bronchi and the lower trachea.", "PM": "66", "HN": "66(63)", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001981"}, {"RECTYPE": "D", "MH": "Bronchial Diseases", "DE": "BRONCHIAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Bronchial", "MN": "C08.127", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases involving the BRONCHI.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001982"}, {"RECTYPE": "D", "MH": "Bronchial Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fistulas, Bronchial", "MN": "C23.300.575.687.225", "MH_TH": "NLM (1966)", "ST": "T020", "AN": "fistula policy: Manual 23.19+", "MS": "An abnormal passage or communication between a bronchus and another part of the body.", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001983"}, {"RECTYPE": "D", "MH": "Bronchial Neoplasms", "DE": "BRONCHIAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasm, Bronchial", "MN": "C08.785.520.100", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "not for bronchial carcinoma (= CARCINOMA, BRONCHIAL see CARCINOMA, BRONCHOGENIC + LUNG NEOPLASMS), nor bronchogenic carcinoma (= CARCINOMA, BRONCHOGENIC + LUNG NEOPLASMS) nor bronchiolar carcinoma (= CARCINOMA, BRONCHIOLAR + LUNG NEOPLASMS); coordinate IM with histological type of neoplasm (IM)", "MS": "Tumors or cancer of the BRONCHI.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001984"}, {"RECTYPE": "D", "MH": "Bronchial Provocation Tests", "DE": "BP TESTS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Provocation Tests, Bronchial|T060|NON|EQV|UNK (19XX)|790308|abcdef", "ENTRY": "Tests, Inhalation Provocation", "MN": "E01.370.386.700.125", "MH_TH": "NLM (1980)", "ST": "T060", "PI": "specific respiratory function test (1966-1979)", "MS": "Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19790308", "DC": "1", "DX": "19800101", "UI": "D001985"}, {"RECTYPE": "D", "MH": "Bronchial Spasm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bronchospasm|T047|T184|NON|EQV|UNK (19XX)|780519|abbcdef", "ENTRY": "Spasms, Bronchial", "MN": "C08.127.321", "MH_TH": "NLM (1963)", "ST": "T184", "MS": "Spasmodic contraction of the smooth muscle of the bronchi.", "PM": "64", "HN": "64(63)", "CATSH": "CAT LIST", "MR": "19910613", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D001986"}, {"RECTYPE": "D", "MH": "Bronchiectasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Varicose Bronchiectasis|T047|NON|NRW|NLM (2023)|220215|abcdef", "ENTRY": "Varicose Bronchiectases", "MN": "C08.127.384", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "bronchial dilatation", "MS": "Persistent abnormal dilatation of the bronchi.", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001987"}, {"RECTYPE": "D", "MH": "Bronchiolitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Bronchiolitides", "MN": "C08.730.099.135", "MH_TH": "NLM (1988)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Bronchopneumonia (1966-1987)", "MS": "Inflammation of the BRONCHIOLES.", "OL": "search BRONCHIOLITIS, VIRAL 1966 (as Prov)", "PM": "88", "HN": "88; 64-66 (Prov)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19870327", "DC": "1", "DX": "19880101", "UI": "D001988"}, {"RECTYPE": "D", "MH": "Bronchiolitis Obliterans", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bronchiolitis, Proliferative|T047|NON|NRW|UNK (19XX)|870402|abcdef", "ENTRY": "Proliferative Bronchiolitides", "MN": "C08.381.495.146.135.140", "MH_TH": "NLM (1988)", "ST": "T047", "AN": "do not confuse with BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA see CRYPTOGENIC ORGANIZING PNEUMONIA", "PI": "Bronchopneumonia (1966-1987)", "MS": "Inflammation of the BRONCHIOLES leading to an obstructive lung disease. Bronchioles are characterized by fibrous granulation tissue with bronchial exudates in the lumens. Clinical features include a nonproductive cough and DYSPNEA.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19870402", "DC": "1", "DX": "19880101", "UI": "D001989"}, {"RECTYPE": "D", "MH": "Bronchiolitis, Viral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Viral Bronchiolitis", "MN": "C08.730.099.135.321", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "coord IM with specific virus dis (IM)", "MS": "An acute inflammatory disease of the lower RESPIRATORY TRACT, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are PARAINFLUENZA VIRUS TYPE 3; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; and METAPNEUMOVIRUS.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D001990"}, {"RECTYPE": "D", "MH": "Bronchitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Bronchitides", "MN": "C08.730.099", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "tuberculous bronchitis: index under TUBERCULOSIS, PULMONARY & not also under BRONCHITIS unless particularly discussed; BRONCHIOLITIS is also available", "MS": "Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001991"}, {"RECTYPE": "D", "MH": "Bronchoalveolar Lavage Fluid", "DE": "BALF", "AQ": "CH CY IM MI PS VI", "PRINT ENTRY": "Lung Lavage Fluid|T031|NON|EQV|UNK (19XX)|870402|abcdef", "ENTRY": "Pulmonary Lavage Fluids", "MN": "E05.927.100.500", "MH_TH": "NLM (1988)", "ST": "T031", "AN": "do not confuse with BRONCHOALVEOLAR LAVAGE, the irrigation technique", "PI": "Pulmonary Alveoli (1971-1987)", "MS": "Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19870402", "DC": "1", "DX": "19880101", "UI": "D001992"}, {"RECTYPE": "D", "MH": "Bronchodilator Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Broncholytic Agent|T121|NON|NRW|NLM (2021)|191219|abcdef", "ENTRY": "Effects, Broncholytic", "MN": "D27.505.954.796.050.100", "MH_TH": "NLM (1963)", "ST": "T121", "RN": "0", "AN": "note entry term BRONCHODILATOR EFFECT: use only for the bronchodilator effect of a chemical substance", "MS": "Agents that cause an increase in the expansion of a bronchus or bronchial tubes.", "PM": "65", "HN": "65(63)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001993"}, {"RECTYPE": "D", "MH": "Bronchogenic Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Bronchial Cyst|T019|NON|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Cysts, Bronchogenic", "MN": "C16.131.740.195", "MH_TH": "NLM (1987)", "ST": "T019", "AN": "non-neoplastic", "PI": "Mediastinal Cyst (1966-1986)", "MS": "A usually spherical cyst, arising as an embryonic out-pouching of the foregut or trachea. It is generally found in the mediastinum or lung and is usually asymptomatic unless it becomes infected.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "19940512", "DA": "19860623", "DC": "1", "DX": "19870101", "UI": "D001994"}, {"RECTYPE": "D", "MH": "Bronchography", "DE": "BRONCHOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Bronchographies", "MN": "E01.370.386.100", "MH_TH": "NLM (1963)", "ST": "T060", "MS": "Radiography of the bronchial tree after injection of a contrast medium.", "PM": "64", "HN": "64(63)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D001995"}, {"RECTYPE": "D", "MH": "Bronchopneumonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pneumonias, Bronchial", "MN": "C08.730.610.127", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the lung parenchyma that is associated with BRONCHITIS, usually involving lobular areas from TERMINAL BRONCHIOLES to the PULMONARY ALVEOLI. The affected areas become filled with exudate that forms consolidated patches.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001996"}, {"RECTYPE": "D", "MH": "Bronchopulmonary Dysplasia", "DE": "BRONCHOPULM DYSPLASIA", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dysplasia, Bronchopulmonary", "MN": "C16.614.521.125", "MH_TH": "NLM (1982)", "ST": "T047", "AN": "restrict to newborn infants; for lung injury caused by mechanical ventilation in other age groups, use VENTILATOR-INDUCED LUNG INJURY", "PI": "Respiratory Tract Diseases (1966-1981)", "MS": "A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19810519", "DC": "1", "DX": "19820101", "UI": "D001997"}, {"RECTYPE": "D", "MH": "Bronchopulmonary Sequestration", "DE": "BRONCHOPULM SEQUESTRATION", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulmonary Sequestration|T019|NON|EQV|UNK (19XX)|740329|PULM SEQUESTRATION|abcdefv", "ENTRY": "Sequestrations, Pulmonary|T019|NON|EQV|NLM (1992)|900925|SEQUESTRATIONS PULM|abcdefv", "MN": "C16.131.740.214", "MH_TH": "NLM (1964)", "ST": "T019", "MS": "A developmental anomaly in which a mass of nonfunctioning lung tissue lacks normal connection with the tracheobroncheal tree and receives an anomalous blood supply originating from the descending thoracic or abdominal aorta. The mass may be extralobar, i.e., completely separated from normally connected lung, or intralobar, i.e., partly surrounded by normal lung.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D001998"}, {"RECTYPE": "D", "MH": "Bronchoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Bronchoscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES BRONCHOSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Bronchoscopic", "MN": "E04.928.600.080", "FX": "Catheterization, Peripheral", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "/ instrum permitted but consider also BRONCHOSCOPES", "MS": "Endoscopic examination, therapy or surgery of the bronchi.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D001999"}, {"RECTYPE": "D", "MH": "Bronchospirometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Bronchospirometries", "MN": "E01.370.386.700.750.100", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "NIM", "MS": "Spirometric technique in which the volume of air breathed in the right and left lung is recorded separately.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002000"}, {"RECTYPE": "D", "MH": "Adipose Tissue, Brown", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hibernating Gland|T024|NON|NRW|NLM (1998)|960730|abcdef", "ENTRY": "Tissue, Brown Adipose", "MN": "A10.165.114.322", "MH_TH": "NLM (1996)", "ST": "T024", "PI": "Adipose Tissue (1966-1967)", "MS": "A thermogenic form of adipose tissue composed of BROWN ADIPOCYTES. It is found in newborns of many species including humans, and in hibernating mammals. Brown fat is richly vascularized, innervated, and densely packed with MITOCHONDRIA which can generate heat directly from the stored lipids.", "PM": "2007; see BROWN FAT 1968-2006", "HN": "2007 (1968)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002001"}, {"RECTYPE": "D", "MH": "Brucella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.070.100", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid234", "MS": "A genus of gram-negative, aerobic bacteria that causes BRUCELLOSIS. Its cells are nonmotile coccobacilli and are animal parasites and pathogens. The bacterium is transmissible to humans through contact with infected dairy products or tissue.", "PM": "1963", "HN": "1963", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D002002"}, {"RECTYPE": "D", "MH": "Brucella abortus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Bacterium abortus|T007|NON|EQV|NLM (2021)|190919|abcdef", "ENTRY": "Brucella melitensis biovar abortus|T007|NON|EQV|NLM (2004)|021017|abcdef", "MN": "B03.660.050.070.100.100", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid235", "MS": "A species of the genus BRUCELLA whose natural hosts are cattle and other bovidae. Abortion and placentitis are frequently produced in the pregnant animal. Other mammals, including humans, may be infected.", "MR": "20200128", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002003"}, {"RECTYPE": "D", "MH": "Brucella Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccine, Brucella", "MN": "D20.215.894.135.134", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "AN": "coord IM with specific Brucella /immunol (IM)", "MS": "A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002004"}, {"RECTYPE": "D", "MH": "Brucellosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Undulant Fever|T047|NON|EQV|ORD (2010)|UNK (19XX)|740329|abcdeef", "ENTRY": "Pulmonary Brucellosis", "MN": "C01.150.252.400.167", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "for entry term BRUCELLOSIS, PULMONARY, coordinate with LUNG DISEASES or specifics", "MS": "Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002006"}, {"RECTYPE": "D", "MH": "Brucellosis, Bovine", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Bang's Disease|T047|EPO|EQV|UNK (19XX)|740329|BANGS DIS|abcdefv", "ENTRY": "Disease, Bang's", "MN": "C22.196.148", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "in cattle only: if transmitted to man, use BRUCELLOSIS for the human; don't forget also CATTLE (NIM) & check tag ANIMALS", "MS": "A disease of cattle caused by bacteria of the genus BRUCELLA leading to abortion in late pregnancy. BRUCELLA ABORTUS is the primary infective agent.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002007"}, {"RECTYPE": "D", "MH": "Brugia", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Brugias", "MN": "B01.050.500.500.294.400.937.463.088", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid6278", "AN": "infection: check text for probable lymphatic involvement & coord IM with ELEPHANTIASIS, FILARIAL (IM); coord with specific helminth term (ANTIGENS, HELMINTH, etc) if pertinent; /drug eff: consider FILARICIDES", "MS": "A filarial worm of Southeast Asia, producing filariasis and elephantiasis in various mammals including man. It was formerly included in the genus WUCHERERIA.", "OL": "search FILARIOIDEA 1969-74", "PM": "86; was see under FILARIOIDEA 1969-85", "HN": "86(75); was see under FILARIOIDEA 1969-85", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D002009"}, {"RECTYPE": "D", "MH": "Brunei", "AQ": "EH EP", "MN": "Z01.252.145.130", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "a sultanate on the northeast coast of Borneo", "MS": "An independent sultanate on the northeast coast of Borneo. Its chief products are oil and natural gas. Its name is Hindi, coming from the Sanskrit bhumi, land or region. It gave its name Brunei to Borneo. (From Webster's New Geographical Dictionary, 1988, p183 & Room, Brewer's Dictionary of Names, 1992, p82)", "HN": "75", "MR": "19950217", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D002010"}, {"RECTYPE": "D", "MH": "Brunner Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Brunner's Gland|T023|NON|EQV|NLM (2022)|200817|abcdef", "ENTRY": "Glands, Brunner's", "MN": "A03.556.875.249.322", "MH_TH": "NLM (2004)", "ST": "T023", "MS": "The abundant submucosal mucous glands in the DUODENUM. These glands secrete BICARBONATE IONS; GLYCOPROTEINS; and PEPSINOGEN II.", "PM": "2004; see BRUNNER'S GLANDS 1991-2003, see DUODENUM 1975-1990", "HN": "2004 (1991)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002011"}, {"RECTYPE": "D", "MH": "Bruxism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Teeth Grinding Disorder|T047|NON|EQV|NLM (2001)|991202|TEETH GRINDING DIS|abcdefv", "ENTRY": "Teeth Grinding Disorders", "MN": "F01.470.315.500", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "SLEEP BRUXISM is also available", "MS": "A disorder characterized by grinding and clenching of the teeth.", "PM": "65; was see under MASTICATION 1963-64", "HN": "65; was see under MASTICATION 1963-64", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002012"}, {"RECTYPE": "D", "MH": "Bryozoa", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Zoophytes|T204|NON|EQV|NLM (1993)|920206|abcdef", "ENTRY": "Zoophyte", "MN": "B01.050.500.217", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid10205", "AN": "a phylum of tiny aquatic colonial animals; /microbiol /parasitol /virol permitted", "MS": "A phylum of small sessile aquatic animals living as small tufted colonies. Some appear like hydroids or corals, but their internal structure is more advanced. Most bryozoans are matlike, forming thin encrustations on rocks, shells, or kelp. (Storer & Stebbins, General Zoology, 6th ed, p443)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002013"}, {"RECTYPE": "D", "MH": "Bucrylate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Isobutylcyanoacrylate|T109|T122|NON|EQV|UNK (19XX)|790503|abbcdef", "ENTRY": "alpha-Cyanoacrylate, Isobutyl", "MN": "J01.637.051.919.367.341.110", "PA": "Tissue Adhesives", "MH_TH": "USAN (1969)", "ST": "T122", "N1": "2-Propenoic acid, 2-cyano-, 2-methylpropyl ester", "RN": "2HJV1F859Z", "RR": "1069-55-2 (Bucrylate)", "MS": "Cyanoacrylate tissue adhesive also used to occlude blood vessels supplying neoplastic or other diseased tissue.", "OL": "use BUCRYLATE to search ISOBUTYLCYANOACRYLATE 1975-79; use CYANOACRYLATES 1972-74", "PM": "91; was see under CYANOACRYLATES 1980-90; was ISOBUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79", "HN": "91(80); was see under CYANOACRYLATES 1980-90; was ISOBUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002015"}, {"RECTYPE": "D", "MH": "Buddhism", "AQ": "HI PX", "ENTRY": "Ethics, Buddhist", "MN": "K01.844.117", "MH_TH": "POPLINE (1978)", "ST": "T078", "AN": "IM; specify geog if pertinent", "MS": "The teaching ascribed to Gautama Buddha (ca. 483 B.C.) holding that suffering is inherent in life and that one can escape it into nirvana by mental and moral self-purification. (Webster, 3d ed)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002016"}, {"RECTYPE": "D", "MH": "Budgets", "AQ": "CL ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Budgetary Control|T057|NON|NRW|UNK (19XX)|770505|abcdef", "ENTRY": "Controls, Budgetary", "MN": "N03.219.463.060", "MH_TH": "NLM (1978)", "ST": "T170", "MS": "Detailed financial plans for carrying out specific activities for a certain period of time. They include proposed income and expenditures.", "PM": "90; was see under FINANCIAL MANAGEMENT 1978-89", "HN": "90(78); was see under FINANCIAL MANAGEMENT 1978-89", "MR": "19980610", "DA": "19770505", "DC": "1", "DX": "19900101", "UI": "D002017"}, {"RECTYPE": "D", "MH": "Bufanolides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Bufadienolides|T109|NON|NRW|UNK (19XX)|880719|abcdef", "MN": "D04.210.500.155.580.064", "PA": "Cardiotonic Agents", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "includes bufenolides, bufatrienolides", "MS": "Cyclopentanophenanthrenes with a 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. They are found in BUFONIDAE and often possess cardiotonic properties.", "PM": "68", "HN": "68", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002018"}, {"RECTYPE": "D", "MH": "Bufexamac", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "p Butoxyphenylacethydroxamic Acid", "MN": "D02.455.426.559.389.048.088", "PA": "Anti-Inflammatory Agents, Non-Steroidal", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzeneacetamide, 4-butoxy-N-hydroxy-", "RN": "4T3C38J78L", "RR": "2438-72-4 (Bufexamac)", "PI": "Phenylacetates (1971-1974)", "MS": "A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally.", "PM": "91; was see under HYDROXAMIC ACIDS 1975-90", "HN": "91(75); was see under HYDROXAMIC ACIDS 1975-90", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002019"}, {"RECTYPE": "D", "MH": "Buffaloes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Water Buffaloes|T015|NON|NRW|NLM (1991)|900319|abcdef", "ENTRY": "Buffalo, Water", "MN": "B01.050.150.900.649.313.500.380.135", "MH_TH": "NLM (1968)", "ST": "T015", "RR": "txid9969", "AN": "do not confuse with BUFFALO, AMERICAN see BISON", "PI": "Cattle (1966-1967)", "MS": "Ruminants of the family Bovidae consisting of Bubalus arnee and Syncerus caffer. This concept is differentiated from BISON, which refers to Bison bison and Bison bonasus.", "PM": "68", "HN": "68", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002020"}, {"RECTYPE": "D", "MH": "Buffers", "PRINT ENTRY": "Buffer|T123|T130|NON|EQV|NLM (2021)|200117|abbcdef", "MN": "D27.720.470.280", "MH_TH": "NLM (1964)", "ST": "T130", "RN": "0", "AN": "almost never IM", "MS": "A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer.", "PM": "67", "HN": "67(64)", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002021"}, {"RECTYPE": "D", "MH": "Bufo arenarum", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Toad, Argentine|T011|NON|EQV|UNK (19XX)|800402|abcdef", "ENTRY": "Toads, Argentine", "MN": "B01.050.150.900.090.180.210.080", "MH_TH": "NLM (1972)", "ST": "T011", "RN": "txid38577", "AN": "NIM when experimental animal", "PI": "Anura (1966-1971)", "MS": "A species of the true toads, Bufonidae, found in South America.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002022"}, {"RECTYPE": "D", "MH": "Bufo bufo", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Toad, Common|T011|NON|EQV|UNK (19XX)|800402|abcdef", "ENTRY": "Toads, Common", "MN": "B01.050.150.900.090.180.210.108", "MH_TH": "NLM (1972)", "ST": "T011", "RN": "txid8384", "AN": "NIM when experimental animal ", "PI": "Anura (1966-1971)", "MS": "A species of the true toads, Bufonidae, widely distributed in the United States and Europe.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002023"}, {"RECTYPE": "D", "MH": "Bufo marinus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Toad, Marine|T011|NON|EQV|UNK (19XX)|800402|abcdef", "ENTRY": "Toads, Marine", "MN": "B01.050.150.900.090.180.210.580", "MH_TH": "NLM (1972)", "ST": "T011", "RN": "txid8386", "AN": "NIM with no qualifiers when experimental animal", "PI": "Anura (1966-1971)", "MS": "A species of the true toads, Bufonidae, becoming fairly common in the southern United States and almost pantropical. The secretions from the skin glands of this species are very toxic to animals.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002024"}, {"RECTYPE": "D", "MH": "Bufonidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Toads, True|T011|NON|EQV|UNK (19XX)|800508|abcdef", "ENTRY": "True Toads", "MN": "B01.050.150.900.090.180.210", "MH_TH": "NLM (1972)", "ST": "T011", "RN": "txid8382", "RR": "txid8383", "AN": "toads including genera Bufo, Ansonia, Nectophrynoides & Atelopus; NIM when exper animal: no qualif; when IM, qualif permitted", "PI": "Anura (1966-1971)", "MS": "The family of true toads belonging to the order Anura. The genera include Bufo, Ansonia, Nectophrynoides, and Atelopus.", "OL": "use BUFONIDAE to search BUFO 1972-80", "PM": "81; was BUFO 1972-80", "HN": "81; was BUFO 1972-80", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002025"}, {"RECTYPE": "D", "MH": "Buformin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Butylbiguanide|T109|T121|NON|EQV|UNK (19XX)|760520|abbcdef", "ENTRY": "Retard, Silubin", "MN": "D02.078.370.141.075", "PA": "Hypoglycemic Agents", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "Imidodicarbonimidic diamide, N-butyl-", "RN": "W2115E9C7B", "RR": "692-13-7 (Buformin)", "PI": "Butanes (1973-1974)", "MS": "An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.", "PM": "91; was see under BIGUANIDES 1975-90", "HN": "91(75); was see under BIGUANIDES 1975-90", "MR": "20160705", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002026"}, {"RECTYPE": "D", "MH": "Bufotenin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mappine|T109|T121|T123|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|781215|abbbbcdeef", "ENTRY": "N,N Dimethyl 5 hydroxytryptamine", "MN": "D23.946.833.033.163", "PA": "Serotonin Antagonists", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "1H-Indol-5-ol, 3-(2-(dimethylamino)ethyl)-", "RN": "0A31347TZK", "RR": "487-93-4 (Bufotenin)", "AN": "/biosyn permitted if by toads, mushrooms, etc.", "MS": "A hallucinogenic serotonin analog found in frog or toad skins, mushrooms, higher plants, and mammals, especially in the brains, plasma, and urine of schizophrenics. Bufotenin has been used as a tool in CNS studies and misused as a psychedelic.", "OL": "search HALLUCINOGENS 1966-74", "PM": "91; was see under SEROTONIN 1975-90; was see under HALLUCINOGENS 1966-74", "HN": "91(75); was see under SEROTONIN 1975-90; was see under HALLUCINOGENS 1966-74", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002027"}, {"RECTYPE": "D", "MH": "Building Codes", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Codes, Building", "MN": "N02.278.200.100", "MH_TH": "NLM (1984)", "ST": "T089", "AN": "coord IM with type of facility (IM)", "PI": "Safety (1975-1983)", "MS": "Standards or regulations for construction which are designed to ensure safety against electrical hazards, fires, etc.", "PM": "91; was see under FACILITY DESIGN AND CONSTRUCTION 1984-90", "HN": "91(84); was see under FACILITY DESIGN AND CONSTRUCTION 1984-90", "MR": "19920325", "DA": "19830606", "DC": "1", "DX": "19910101", "UI": "D002028"}, {"RECTYPE": "D", "MH": "Bulbourethral Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cowper's Glands|T023|EPO|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Glands, Cowper's", "MN": "A10.336.197", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Glands situated on each side of the prostate that secrete a fluid component of the seminal fluid into the urethra.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002030"}, {"RECTYPE": "D", "MH": "Bulgaria", "AQ": "EH EP", "MN": "Z01.542.248.180", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey. The capital is Sofia.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D002031"}, {"RECTYPE": "D", "MH": "Bulimia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Eating, Binge", "MN": "C23.888.821.645.500", "FX": "Bulimia Nervosa", "MH_TH": "NLM (1987)", "ST": "T184", "AN": "BULIMIA NERVOSA is also available", "PI": "Hyperphagia (1981-1986)", "MS": "Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as \"ox hunger\".", "OL": "search HYPERPHAGIA 1981-86", "PM": "87; was see HYPERPHAGIA 1981-86", "HN": "87; was see HYPERPHAGIA 1981-86", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19860530", "DC": "1", "DX": "19870101", "UI": "D002032"}, {"RECTYPE": "D", "MH": "Bulinus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.644.400.750.323", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid157969", "AN": "freshwater snail; /microbiol /parasitol /virol permitted", "PI": "Snails (1966-1971)", "MS": "A genus of small freshwater snails of the order Pulmonata, found throughout Africa and the Middle East, where it is a vector of SCHISTOSOMA HAEMATOBIUM.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002033"}, {"RECTYPE": "D", "MH": "Bumetanide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "PF1593", "MN": "D02.886.590.700.150", "PA": "Sodium Potassium Chloride Symporter Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-", "RN": "0Y2S3XUQ5H", "RR": "28395-03-1 (Bumetanide)", "PI": "Phenyl Ethers (1974)", "MS": "A sulfamyl diuretic.", "PM": "91; was see under DIURETICS, SULFAMYL 1975-90", "HN": "91(75); was see under DIURETICS, SULFAMYL 1975-90", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002034"}, {"RECTYPE": "D", "MH": "Bunaftine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bunaphtide|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|770418|abbcdeef", "ENTRY": "Bunaphtine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|770418|abbcdeef", "MN": "D04.615.638.120", "PA": "Anti-Arrhythmia Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Naphthalenecarboxamide, N-butyl-N-(2-(diethylamino)ethyl)-", "RN": "GH09PRQ3FU", "RR": "32421-46-8 (Bunaftine)", "AN": "an anti-arrhythmic", "PI": "Naphthalenes (1966-1977)", "MS": "N-Butyl-N-(2-(diethylamino)ethyl)-1-naphthamide. A proposed antiarrhythmic that prolongs myocardial refractory period and stabilizes cell membranes.", "PM": "91; was see under NAPHTHALENES 1978-90", "HN": "91(78); was see under NAPHTHALENES 1978-90", "MR": "20130708", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D002035"}, {"RECTYPE": "D", "MH": "Bundle of His", "AQ": "AB AH CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Atrioventricular Bundle|T023|NON|EQV|UNK (19XX)|850311|abcdef", "ENTRY": "Kent His Bundle", "MN": "A07.541.409.273", "FX": "Bundle-Branch Block", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "Small band of specialized CARDIAC MUSCLE fibers that originates in the ATRIOVENTRICULAR NODE and extends into the membranous part of the interventricular septum. The bundle of His, consisting of the left and the right bundle branches, conducts the electrical impulses to the HEART VENTRICLES in generation of MYOCARDIAL CONTRACTION.", "OL": "search HEART CONDUCTION SYSTEM 1966-74", "PM": "91; was see under HEART CONDUCTION SYSTEM 1975-90", "HN": "91(75); was see under HEART CONDUCTION SYSTEM 1975-90", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002036"}, {"RECTYPE": "D", "MH": "Bundle-Branch Block", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fascicular Block|T047|NON|NRW|UNK (19XX)|800324|abcdef", "ENTRY": "Right Bundle-Branch Blocks", "MN": "C23.550.073.425.100", "FX": "Bundle of His", "MH_TH": "ORD (2010)", "ST": "T046", "MS": "A form of heart block in which the electrical stimulation of HEART VENTRICLES is interrupted at either one of the branches of BUNDLE OF HIS thus preventing the simultaneous depolarization of the two ventricles.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002037"}, {"RECTYPE": "D", "MH": "Bungarotoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "kappa Bungarotoxin", "MN": "D23.946.833.850.325.139", "MH_TH": "NLM (1974)", "ST": "T131", "RN": "0", "AN": "from the krait, a snake; /antag permitted but consider also ANTIVENINS; alpha-bungarotoxin & beta-bungarotoxin go here", "MS": "Neurotoxic proteins from the venom of the banded or Formosan krait (Bungarus multicinctus, an elapid snake). alpha-Bungarotoxin blocks nicotinic acetylcholine receptors and has been used to isolate and study them; beta- and gamma-bungarotoxins act presynaptically causing acetylcholine release and depletion. Both alpha and beta forms have been characterized, the alpha being similar to the large, long or Type II neurotoxins from other elapid venoms.", "PM": "74", "HN": "74(73)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002038"}, {"RECTYPE": "D", "MH": "Levobunolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ratio Levobunolol", "MN": "D04.615.638.960.446.500", "PA": "Sympatholytics", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "1(2H)-Naphthalenone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, (S)-", "RN": "G6317AOI7K", "RR": "O90S49LDHH", "PI": "Sympatholytics (1966-1971)", "MS": "The L-Isomer of bunolol.", "OL": "use LEVOBUNOLOL to search BUNOLOL 1972-90 (as Prov 1972)", "PM": "91; was BUNOLOL 1973-90", "HN": "91(72); was BUNOLOL 1972-90 (Prov 1972)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002040"}, {"RECTYPE": "D", "MH": "Bunyamwera virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Chittoor virus|T005|EPO|NRW|UNK (19XX)|741211|abcdef", "ENTRY": "Bunyamwera Group Viruses|T005|EPO|BRD|NLM (1975)|990101|abcdef", "MN": "B04.820.480.750.640.147", "MH_TH": "UNK (19XX)", "ST": "T005", "RN": "txid35304", "RR": "txid80942", "AN": "infection: coord IM with BUNYAVIRIDAE INFECTIONS (IM)", "MS": "A species in the ORTHOBUNYAVIRUS genus of the family BUNYAVIRIDAE. A large number of serotypes or strains exist in many parts of the world. They are transmitted by mosquitoes and infect humans in some areas.", "PM": "2002; see BUNYAMWERA VIRUS GROUP 1991-2001, see BUNYAVIRIDAE 1981-1990, see ARBOVIRUSES 1975-80", "HN": "2002 (1975)", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D002042"}, {"RECTYPE": "D", "MH": "Bunyaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.480.750", "MH_TH": "NLM (1981)", "ST": "T005", "RN": "txid1980416", "PI": "Bunyamwera Group Viruses (1975-1980)", "MS": "A family of viruses, mainly arboviruses, consisting of a single strand of RNA. Virions are enveloped particles 90-120 nm diameter. The complete family contains over 300 members arranged in five genera: ORTHOBUNYAVIRUS; HANTAVIRUS; NAIROVIRUS; PHLEBOVIRUS; and TOSPOVIRUS.", "PM": "81", "HN": "81", "MR": "20200813", "DA": "19800521", "DC": "1", "DX": "19810101", "UI": "D002043"}, {"RECTYPE": "D", "MH": "Bunyaviridae Infections", "DE": "BUNYAVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Bunyavirus Infections|T047|NON|NRW|NLM (1992)|910307|BUNYAVIRUS INFECT|abcdefv", "ENTRY": "Virus Infection, Oropouche", "MN": "C01.925.782.147", "MH_TH": "NLM (1981)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Arbovirus Infections (1966-1980)", "MS": "Virus diseases caused by the BUNYAVIRIDAE.", "OL": "use BUNYAVIRIDAE INFECTIONS to search BUNYAVIRUS INFECTIONS 1981-91", "PM": "92; was BUNYAVIRUS INFECTIONS 1981-91", "HN": "92; was BUNYAVIRUS INFECTIONS 1981-91", "CATSH": "CAT LIST", "MR": "20230602", "DA": "19800513", "DC": "1", "DX": "19810101", "UI": "D002044"}, {"RECTYPE": "D", "MH": "Bupivacaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Bupivacain RPR", "MN": "D02.092.146.113.239", "PA": "Anesthetics, Local", "FX": "Ropivacaine", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-", "RN": "Y8335394RO", "RR": "7TQO7W3VT8", "PI": "Anesthetics, Local (1966-1970)", "MS": "A widely used local anesthetic agent.", "HN": "1973 (1971)", "MR": "20180111", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002045"}, {"RECTYPE": "D", "MH": "Bupranolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "KL255", "MN": "D02.092.063.624.698.146", "PA": "Antihypertensive Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Propanol, 1-(2-chloro-5-methylphenoxy)-3-((1,1-dimethylethyl)amino)-, hydrochloride, (+-)-", "RN": "858YGI5PIT", "RR": "23284-25-5 (Bupranolol)", "PI": "Propanolamines (1974-1978)", "MS": "An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.", "PM": "91; was see under PROPANOLAMINES 1979-90", "HN": "91(79); was see under PROPANOLAMINES 1979-90", "MR": "20160705", "DA": "19780201", "DC": "1", "DX": "19910101", "UI": "D002046"}, {"RECTYPE": "D", "MH": "Buprenorphine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RX6029M", "MN": "D04.615.723.795.150", "PA": "Narcotics", "FX": "Opiate Substitution Treatment", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5alpha,7alpha(S))-", "RN": "40D3SCR4GZ", "RR": "56W8MW3EN1", "AN": "for buprenorphine maintenance treatment, coordinate with OPIATE SUBSTITUTION TREATMENT", "PI": "Morphine (1966-1968)", "MS": "A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.", "PM": "87; was see under MORPHINANS 1979-86", "HN": "87(79); was see under MORPHINANS 1979-86", "MR": "20170524", "DA": "19780317", "DC": "1", "DX": "19870101", "UI": "D002047"}, {"RECTYPE": "D", "MH": "Burial", "AQ": "EC ES HI LJ MT SN ST", "ENTRY": "Burials", "MN": "I01.076.201.450.550.150", "MH_TH": "NLM (1975)", "ST": "T052", "MS": "The act or ceremony of putting a corpse into the ground or a vault, or into the sea; or the inurnment of CREMAINS.", "OL": "search MORTUARY PRACTICE 1966-74", "PM": "91; was see under MORTUARY PRACTICE 1975-90", "HN": "91(75); was see under MORTUARY PRACTICE 1975-90", "MR": "20081016", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002048"}, {"RECTYPE": "D", "MH": "Burimamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.886.904.200", "PA": "Histamine H2 Antagonists", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Thiourea, N-(4-(1H-imidazol-4-yl)butyl)-N'-methyl-", "RN": "TN5A4OD2TV", "RR": "34970-69-9 (Burimamide)", "PI": "Thiourea (1972-1974)", "MS": "An antagonist of histamine that appears to block both H2 and H3 histamine receptors. It has been used in the treatment of ulcers.", "PM": "91; was see under THIOUREA 1975-90", "HN": "91(75); was see under THIOUREA 1975-90", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002049"}, {"RECTYPE": "D", "MH": "Burkina Faso", "AQ": "EH EP", "PRINT ENTRY": "Upper Volta|T083|NAM|EQV|UNK (19XX)|850507|abcdef", "ENTRY": "Burkina Fasso|T083|NAM|EQV|UNK (19XX)|850507|abcdef", "MN": "Z01.058.290.190.245", "MH_TH": "NLM (1986)", "ST": "T083", "MS": "A republic in western Africa, south and east of MALI and west of NIGER. Its capital is Ouagadougou. It was formerly called Upper Volta until 1984.", "HN": "1986; was UPPER VOLTA 1963-1985", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19860101", "UI": "D002050"}, {"RECTYPE": "D", "MH": "Burkitt Lymphoma", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Lymphoma, Burkitt|T191|EPO|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Tumor, Burkitt's", "MN": "C20.683.515.761.480.150.165", "MH_TH": "ORD (2010)", "ST": "T191", "MS": "A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.", "PM": "1998; see BURKITT'S LYMPHOMA 1968-1997; for LEUKEMIA, B-CELL, ACUTE & BURKITT LEUKEMIA see LEUKEMIA, B-CELL, ACUTE 1989-2007; for BURKITT TUMOR see BURKITT'S TUMOR 1968-1997; for LYMPHOMA, BURKITT see LYMPHOMA, BURKITT'S 1968-1997", "HN": "1998 (1968)", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002051"}, {"RECTYPE": "D", "MH": "Myanmar", "AQ": "EH EP", "PRINT ENTRY": "Burma|T083|NAM|EQV|NLM (1993)|910926|abcdef", "ENTRY": "Myanma|T083|NAM|EQV|NLM (1993)|910926|abcdef", "MN": "Z01.252.145.570", "MH_TH": "POPLINE (1986)", "ST": "T083", "AN": "capital Rangoon became Yangon when Burma became Myanmar in 1989.", "MS": "A republic of southeast Asia, northwest of Thailand, long familiar as Burma. Its capital is Yangon, formerly Rangoon. Inhabited by people of Mongolian stock and probably of Tibetan origin, by the 3d century A.D. it was settled by Hindus. The modern Burmese state was founded in the 18th century but was in conflict with the British during the 19th century. Made a crown colony of Great Britain in 1937, it was granted independence in 1947. In 1989 it became Myanmar. The name comes from myanma, meaning the strong, as applied to the Burmese people themselves. (From Webster's New Geographical Dictionary, 1988, p192 & Room, Brewer's Dictionary of Names, 1992, p367)", "OL": "use MYANMAR to search BURMA 1968-92", "HN": "93; was BURMA 1968-92", "MR": "19950608", "DA": "19990101", "DC": "4", "DX": "19930101", "UI": "D002052"}, {"RECTYPE": "D", "MH": "Burn Units", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Burn Centers|T093|NON|BRD|UNK (19XX)|810226|abcdef", "ENTRY": "Units, Burn", "MN": "N02.278.388.493.160", "MH_TH": "NLM (1982)", "ST": "T093", "PI": "Intensive Care Units (1966-1981)", "MS": "Specialized hospital facilities which provide intensive care for burn patients.", "PM": "91; was see under INTENSIVE CARE UNITS 1982-90", "HN": "91(82); was see under INTENSIVE CARE UNITS 1982-90", "MR": "19920325", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D002053"}, {"RECTYPE": "D", "MH": "Burning Mouth Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Burning Mouth", "MN": "C07.465.114", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "\"painful oral symptoms assoc with a burning sensation\"", "PI": "Mouth Diseases (1966-1967)", "MS": "A group of painful oral symptoms associated with a burning or similar sensation. There is usually a significant organic component with a degree of functional overlay; it is not limited to the psychophysiologic group of disorders.", "PM": "91; was see under MOUTH DISEASES 1968-90", "HN": "91(68); was see under MOUTH DISEASES 1968-90", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002054"}, {"RECTYPE": "D", "MH": "Burnout, Professional", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Professional Burnout", "MN": "F02.830.900.333.500", "MH_TH": "NLM (1983)", "ST": "T048", "PI": "Stress, Psychological (1969-1982)", "MS": "An excessive stress reaction to one's occupational or professional environment. It may be characterized by feelings of emotional and physical exhaustion, coupled with a sense of frustration and failure.", "PM": "1990; see STRESS, PSYCHOLOGICAL 1983-1989", "HN": "1990 (1983); use STRESS, PSYCHOLOGICAL 1983-1989", "CATSH": "CAT LIST", "MR": "20180116", "DA": "19820427", "DC": "1", "DX": "19900101", "UI": "D002055"}, {"RECTYPE": "D", "MH": "Burns", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Burn", "MN": "C26.200", "EC": "chemically induced:Burns, Chemical", "MH_TH": "POPLINE (1978)", "ST": "T037", "AN": "general or unspecified; prefer specifics; \"thermal injury\"; burn shock: coordinate with SHOCK, TRAUMATIC ", "MS": "Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002056"}, {"RECTYPE": "D", "MH": "Burns, Chemical", "DE": "BURNS CHEM", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Chemical Burn", "MN": "C26.200.156", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Burns caused by contact with or exposure to CAUSTICS or strong ACIDS.", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002057"}, {"RECTYPE": "D", "MH": "Burns, Electric", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Electric Burns|T037|NON|EQV|NLM (1992)|901017|abcdef", "ENTRY": "Electric Burn", "MN": "C26.324.323", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Burns produced by contact with electric current or from a sudden discharge of electricity.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002058"}, {"RECTYPE": "D", "MH": "Burns, Inhalation", "DE": "BURNS INHAL", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Inhalation Burns|T037|NON|EQV|UNK (19XX)|880502|INHAL BURNS|abcdefv", "ENTRY": "Inhalation Burn", "MN": "C26.200.322", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "resp tract burns from heat or chemicals; SMOKE INHALATION INJURY is also available", "MS": "Burns of the respiratory tract caused by heat or inhaled chemicals.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002059"}, {"RECTYPE": "D", "MH": "Bursa of Fabricius", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Fabricius Bursa", "MN": "A15.382.520.604.114", "MH_TH": "NLM (1965)", "ST": "T023", "MS": "An epithelial outgrowth of the cloaca in birds similar to the thymus in mammals. It atrophies within 6 months after birth and remains as a fibrous remnant in adult birds. It is composed of lymphoid tissue and prior to involution, is the site of B-lymphocyte maturation.", "PM": "66", "HN": "66(65)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002060"}, {"RECTYPE": "D", "MH": "Bursa, Synovial", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Synovial Bursas", "MN": "A02.835.583.156", "MH_TH": "NLM (1965)", "ST": "T023", "MS": "A fluid-filled sac lined with SYNOVIAL MEMBRANE that provides a cushion between bones, tendons and/or muscles around a joint.", "PM": "65", "HN": "65", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002061"}, {"RECTYPE": "D", "MH": "Bursitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pes Anserine Bursitis|T047|NON|NRW|NLM (2020)|190118|abcdef", "ENTRY": "Shoulder, Frozen", "MN": "C05.550.251", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with specific joint", "MS": "Inflammation or irritation of a SYNOVIAL BURSA, the fibrous sac that acts as a cushion between moving structures of bones, muscles, tendons or skin.", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002062"}, {"RECTYPE": "D", "MH": "Burundi", "AQ": "EH EP", "PRINT ENTRY": "Urundi|T083|NAM|EQV|NLM (1998)|960816|abcdef", "MN": "Z01.058.290.120.180", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in eastern Africa bounded on the north by RWANDA and on the south by TANZANIA. Its capital is Bujumbura.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D002063"}, {"RECTYPE": "D", "MH": "Buserelin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "HOE766", "MN": "D12.776.631.650.405.740.320.100", "PA": "Fertility Agents, Female", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-", "RN": "PXW8U3YXDV", "RR": "68630-75-1 (Buserelin Acetate)", "PI": "Pituitary Hormone Releasing Hormones (1968-1973)", "MS": "A potent synthetic analog of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications.", "OL": "use BUSERELIN to search BUSERELIN ACETATE 1984-91", "PM": "92; was BUSERELIN ACETATE 1984-91; BUSERELIN was see BUSERELIN ACETATE 1984-91", "HN": "92; was BUSERELIN ACETATE 1984-91; BUSERELIN was see BUSERELIN ACETATE 1984-91", "MR": "20160701", "DA": "19830404", "DC": "1", "DX": "19840101", "UI": "D002064"}, {"RECTYPE": "D", "MH": "Buspirone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ratio Buspirone", "MN": "D04.711.120", "PA": "Serotonin Receptor Agonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-", "RN": "TK65WKS8HL", "RR": "36505-84-7 (Buspirone)", "PI": "Spiro Compounds (1973-1982)", "MS": "An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.", "PM": "88", "HN": "88", "MR": "20170524", "DA": "19870504", "DC": "1", "DX": "19880101", "UI": "D002065"}, {"RECTYPE": "D", "MH": "Busulfan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Busulphan|T109|T121|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|761230|abbbcdeef", "ENTRY": "Wellcome, Busulfan", "MN": "D02.886.645.600.055.050.510.100", "PA": "Myeloablative Agonists", "MH_TH": "USP (19XX)", "ST": "T131", "N1": "1,4-Butanediol, dimethanesulfonate", "RN": "G1LN9045DK", "RR": "55-98-1 (Busulfan)", "MS": "An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002066"}, {"RECTYPE": "D", "MH": "Butaclamol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Butaclamol", "MN": "D04.615.181.384.230", "PA": "Dopamine Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "RN": "A7A2802VNL", "RR": "8TUG8SF12T", "PI": "Dibenzocycloheptenes (1968-1977)", "MS": "A benzocycloheptapyridoisoquinolinol that has been used as an antipsychotic, especially in schizophrenia.", "PM": "91; was see under DIBENZOCYCLOHEPTENES 1978-90", "HN": "91(78); was see under DIBENZOCYCLOHEPTENES 1978-90", "MR": "20130708", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D002069"}, {"RECTYPE": "D", "MH": "Butadienes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Butadiene Derivative|T109|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Derivatives, Butadiene", "MN": "D02.455.326.271.665.146.240", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Four carbon unsaturated hydrocarbons containing two double bonds.", "OL": "use BUTADIENES to search BUTADIENE 1966-77", "PM": "78; was BUTADIENE 1963-77", "HN": "78; was BUTADIENE 1963-77", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D002070"}, {"RECTYPE": "D", "MH": "Butylene Glycols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dihydroxybutanes|T109|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Glycols, Butylene", "MN": "D02.033.455.125", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Glycols (1969-1974)", "MS": "4-carbon straight chain aliphatic hydrocarbons substituted with two hydroxyl groups. The hydroxyl groups cannot be on the same carbon atom.", "PM": "98; see BUTANEDIOLS 1975-97", "HN": "98(75)", "MR": "19970620", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D002072"}, {"RECTYPE": "D", "MH": "Butanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isobutanes|T109|NON|NRW|UNK (19XX)|770520|abcdef", "MN": "D02.455.326.146.216", "FX": "Cyclobutanes", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "PI": "Alkanes (1966-1972)", "MS": "Four-carbon alkanes with the formula C4H10.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002073"}, {"RECTYPE": "D", "MH": "Butanones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.522.296", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PI": "Ketones (1966-1967)", "MS": "Derivatives of butanone, also known as methyl ethyl ketone (with structural formula CH3COC2H5).", "PM": "68", "HN": "68", "MR": "20161101", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002074"}, {"RECTYPE": "D", "MH": "Butirosin Sulfate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Butirosins|T109|T195|NON|BRD|NLM (1996)|940720|abbcdef", "ENTRY": "Sulphate, Butirosin", "MN": "D09.408.051.120", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1976)", "ST": "T195", "RN": "51022-98-1", "RR": "BC4D059GIG", "PI": "Antibiotics (1973-1974)", "MS": "A water-soluble aminoglycosidic antibiotic complex isolated from fermentation filtrates of Bacillus circulans. Two components (A and B) have been separated from the complex. Both are active against many gram-positive and some gram-negative bacteria.", "PM": "96; was BUTIROSINS 1975-95 (see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90)", "HN": "96; was BUTIROSINS 1975-95 (see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90)", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002076"}, {"RECTYPE": "D", "MH": "Butorphanol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "BC2627", "MN": "D04.615.723.795.165", "PA": "Narcotics", "MH_TH": "USAN (1974)", "ST": "T121", "N1": "Morphinan-3,14-diol, 17-(cyclobutylmethyl)-", "RN": "QV897JC36D", "RR": "42408-82-2 (Butorphanol)", "PI": "Morphinans (1969-1978)", "MS": "A synthetic morphinan analgesic with narcotic antagonist action. It is used in the management of severe pain.", "PM": "91; was see under MORPHINANS 1979-90", "HN": "91(79); was see under MORPHINANS 1979-90", "MR": "20170524", "DA": "19780501", "DC": "1", "DX": "19910101", "UI": "D002077"}, {"RECTYPE": "D", "MH": "Butoxamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Butoxamine", "MN": "D02.092.471.683.221", "PA": "Sympatholytics", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Benzenemethanol, alpha-(1-((1,1-dimethylethyl)amino)ethyl)-2,5-dimethoxy-", "RN": "0NM31M53PW", "RR": "5696-15-1 (Butoxamine Hydrochloride)", "PI": "Antilipemic Agents (1966-1972)", "MS": "A beta-2 selective adrenergic antagonist. It is used primarily in animal and tissue experiments to characterize BETA-2 ANDRENERGIC RECEPTORS.", "PM": "91; was see under PROPANOLAMINES 1973-90", "HN": "91(73); was see under PROPANOLAMINES 1973-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002078"}, {"RECTYPE": "D", "MH": "Butter", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Butters", "MN": "J02.500.375.200", "MH_TH": "NLM (1966)", "ST": "T168", "N1": "Butter", "RN": "8029-34-3", "AN": "a dairy product & dietary fat; MARGARINE is also available", "MS": "The fatty portion of milk, separated as a soft yellowish solid when milk or cream is churned. It is processed for cooking and table use. (Random House Unabridged Dictionary, 2d ed)", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002079"}, {"RECTYPE": "D", "MH": "Butterflies", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Butterfly", "MN": "B01.050.500.131.617.720.500.500.937.200", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid37572", "AN": "/microbiol /parasitol /virol permitted", "MS": "Slender-bodies diurnal insects having large, broad wings often strikingly colored and patterned.", "PM": "91; was see under LEPIDOPTERA 1975-90", "HN": "91(75); was see under LEPIDOPTERA 1975-90", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D002080"}, {"RECTYPE": "D", "MH": "Buttocks", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "Gluteal Region|T029|NON|BRD|UNK (19XX)|740329|abcdef", "ENTRY": "Regions, Gluteal", "MN": "A01.378.610.100", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "usually NIM as site", "MS": "Either of two fleshy protuberances at the lower posterior section of the trunk or HIP in humans and primate on which a person or animal sits, consisting of gluteal MUSCLES and fat.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002081"}, {"RECTYPE": "D", "MH": "Butylamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.326.146.216.500", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Isomeric amines of butane, where an amino group replaces a hydrogen on one of the four carbons. They include isobutylamine, n-Butylamine, sec-Butylamine, and tert-Butylamine.", "PM": "66", "HN": "66", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002082"}, {"RECTYPE": "D", "MH": "Butylated Hydroxyanisole", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Butylhydroxyanisole|T109|T121|NON|EQV|UNK (19XX)|781215|abbcdef", "ENTRY": "Nipantiox 1F", "MN": "D02.455.426.559.389.657.654.158.324", "PA": "Carcinogens", "MH_TH": "BAN (19XX)", "ST": "T121", "N1": "Phenol, (1,1-dimethylethyl)-4-methoxy-", "RN": "25013-16-5", "MS": "Mixture of 2- and 3-tert-butyl-4-methoxyphenols that is used as an antioxidant in foods, cosmetics, and pharmaceuticals.", "OL": "search ANISOLES 1973-74", "PM": "87; was see under ANISOLES 1973-86", "HN": "87(75); was see under ANISOLES 1973-86", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D002083"}, {"RECTYPE": "D", "MH": "Butylated Hydroxytoluene", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Butylhydroxytoluene|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|790227|abbcdeef", "ENTRY": "Hydroxytoluene, Butylated", "MN": "D02.455.426.559.389.657.239.216", "PA": "Antioxidants", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Phenol, 2,6-bis(1,1-dimethylethyl)-4-methyl-", "RN": "1P9D0Z171K", "RR": "128-37-0 (Butylated Hydroxytoluene)", "AN": "consider IONONES if C13-norisoprenoid or ionanes are discussed", "PI": "Cresols (1966-1974)", "MS": "A di-tert-butyl PHENOL with antioxidant properties.", "OL": "search CRESOLS 1973-74", "PM": "80; was see under CRESOLS 1973-79", "HN": "80(75); was see under CRESOLS 1973-79", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D002084"}, {"RECTYPE": "D", "MH": "Butylhydroxybutylnitrosamine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "N Nitrosobutyl 4 hydroxybutylamine", "MN": "D02.654.442.100", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "1-Butanol, 4-(butylnitrosoamino)-", "RN": "3817-11-6", "PI": "Nitrosamines (1974)", "MS": "A substituted carcinogenic nitrosamine.", "PM": "91; was see under NITROSAMINES 1975-90", "HN": "91(75); was see under NITROSAMINES 1975-90", "MR": "20000622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002085"}, {"RECTYPE": "D", "MH": "Butylscopolammonium Bromide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Scopolaminebutylbromide|T109|T121|NON|EQV|UNK (19XX)|750630|abbcdef", "ENTRY": "N-Butylbromide, Hyoscine", "MN": "D03.605.869.822.200", "PA": "Parasympatholytics", "MH_TH": "NLM (1976)", "ST": "T121", "N1": "3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-", "RN": "2Z3E1OF81V", "RR": "149-64-4 (Butylscopolammonium Bromide)", "PI": "Scopolamine Derivatives (1975)", "MS": "Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of the gastrointestinal tract.", "PM": "91; was see under SCOPOLAMINE DERIVATIVES 1978-90; was see under SCOPOLAMINE 1976-77", "HN": "91(76); was see under SCOPOLAMINE DERIVATIVES 1978-90; was see under SCOPOLAMINE 1976-77", "MR": "20160527", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D002086"}, {"RECTYPE": "D", "MH": "Butyrates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "n-Butyrate|T109|NON|NRW|NLM (1999)|980105|BUTYRATE N|abcdefs", "ENTRY": "n Butyrate", "MN": "D10.251.400.143", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of BUTYRIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxypropane structure.", "PM": "1963; for BUTYRIC ACIDS see SUTYRIC ACIDS 1999-2012, BUTYRATE and N-BUTYRATE were indexed under BUTYRIC ACIDS 1975-1998", "HN": "1963", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D002087"}, {"RECTYPE": "D", "MH": "Butyrophenones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.522.352", "FX": "Antipsychotic Agents", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds containing phenyl-1-butanone.", "PM": "66", "HN": "66", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002090"}, {"RECTYPE": "D", "MH": "Butyrylcholinesterase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pseudocholinesterase|T116|T126|NON|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "Butyrylthiocholinesterase|T116|T126|NON|NRW|UNK (19XX)|810427|abbcdef", "MN": "D08.811.277.352.100.170.250", "EC": "antagonists & inhibitors:Cholinesterase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.1.1.8", "PI": "Cholinesterases (1973-1974)", "MS": "An aspect of cholinesterase (EC 3.1.1.8).", "PM": "91; was see under CHOLINESTERASES 1975-90", "HN": "91(75); was see under CHOLINESTERASES 1975-90", "MR": "20170315", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002091"}, {"RECTYPE": "D", "MH": "Butyrylthiocholine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "S Butyrylthiocholine Iodide", "MN": "D02.886.489.789.200", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Ethanaminium, N,N,N-trimethyl-2-((1-oxobutyl)thio)-", "RN": "4555-00-4", "PI": "Sulfhydryl Compounds (1972-1974)", "MS": "A sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and thiocholine. It is used as a reagent in the determination of butyrylcholinesterase activity.", "PM": "91; was see under CHOLINE 1975-90", "HN": "91(75); was see under CHOLINE 1975-90", "MR": "20070709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002092"}, {"RECTYPE": "D", "MH": "Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide", "DS": "BENZENAMINIUM 4 4 3 OXO 1 5 PENTANEDIYL BIS N N DIMETHYL N 2 PROPENYL DIBROMIDE", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "BW284C51|T109|T121|LAB|NRW|UNK (19XX)|741111|abbcdef", "MN": "D02.092.146.290", "MH_TH": "NLM (2005)", "ST": "T121", "N1": "Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl)-, dibromide", "RN": "402-40-4", "PI": "Ketones (1971-1974)", "MS": "Proposed cholinesterase inhibitor.", "PM": "2005; see BW 284 C 51 1991-2004; see ANILINE COMPOUNDS 1975-1990", "HN": "2005(1975)", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002093"}, {"RECTYPE": "D", "MH": "Republic of Belarus", "AQ": "EH EP", "PRINT ENTRY": "Byelorussian S.S.R.|T083|NAM|REL|NLM (1993)|920422|abcdef", "ENTRY": "Byelorussian SSR|T083|NAM|REL|NLM (1993)|920422|abcdef", "MN": "Z01.542.248.700", "MH_TH": "NLM (2011)", "ST": "T083", "MS": "A country in Eastern Europe, east of Poland. The capital is Minsk.", "HN": "2011; use BYELARUS 1993-2010, use BYELORUSSIAN S.S.R. 1982-1992, use BELORUSSIA 1963-1981", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "20110101", "UI": "D002094"}, {"RECTYPE": "D", "MH": "Byssinosis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Byssinoses", "MN": "C24.800.323", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not coordinate with OCCUPATIONAL DISEASES", "PI": "Pneumoconiosis (1966-1968)", "MS": "A condition of BRONCHOCONSTRICTION resulting from hypersensitive reaction to inhaled dust during the initial processing of cotton, flax, or hemp in the textile industry. Symptoms include wheezing and tightness in the chest.", "PM": "74", "HN": "74(69)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002095"}, {"RECTYPE": "D", "MH": "C-Peptide", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proinsulin C-Peptide|T116|T123|NON|EQV|NLM (2007)|060327|abbcdef", "ENTRY": "Proinsulin C Peptide", "MN": "D12.644.548.586.200.500.250", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "PI": "Proinsulin (1975-1976)", "MS": "The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin.", "PM": "84; was see under PEPTIDES 1977-83", "HN": "84(77); was see under PEPTIDES 1977-83", "MR": "20110624", "DA": "19760416", "DC": "1", "DX": "19840101", "UI": "D002096"}, {"RECTYPE": "D", "MH": "C-Reactive Protein", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "hsCRP|T116|T129|ABB|EQV|NLM (2021)|191025|abbcdef", "ENTRY": "High Sensitivity C Reactive Protein", "MN": "D12.776.124.486.157", "MH_TH": "NLM (1966)", "ST": "T129", "N1": "Proteins, specific or class, C-reactive", "RN": "9007-41-4", "AN": "an acute phase protein; /drug eff /ultrastruct permitted", "MS": "A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP).", "MR": "20210209", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002097"}, {"RECTYPE": "D", "MH": "Cacao", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "ENTRY": "Plant, Cocoa", "MN": "B01.875.800.575.912.250.859.821.500.164", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid3641", "RR": "txid3640", "AN": "CHOCOLATE  is also available", "MS": "A tree of the family MALVACEAE, order MALVALES, whose seeds are processed to yield cocoa and CHOCOLATE.", "PM": "2019(1963)", "HN": "2019(1963)", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002099"}, {"RECTYPE": "D", "MH": "Cachexia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.144.828.250", "FX": "Wasting Syndrome", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "WASTING SYNDROME is also available: do not make diagnosis, use words of text", "MS": "General ill health, malnutrition, and weight loss, usually associated with chronic disease.", "CATSH": "CAT LIST", "MR": "20220520", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002100"}, {"RECTYPE": "D", "MH": "Cacodylic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Dimethylarsinic", "MN": "D02.129.100", "PA": "Herbicides", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Arsinic acid, dimethyl-", "RN": "AJ2HL7EU8K", "RR": "75-60-5 (Cacodylic Acid)", "PI": "Arsenicals (1969-1974)", "MS": "An arsenical that has been used as a dermatologic agent and as an herbicide.", "PM": "91; was see under ARSENICALS 1975-90", "HN": "91(75); was see under ARSENICALS 1975-90", "MR": "20190701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002101"}, {"RECTYPE": "D", "MH": "Cadaver", "ENTRY": "Corpses", "MN": "C23.550.260.224", "MH_TH": "NLM (1966)", "ST": "T015", "AN": "NIM for cadaveric organs in transplantation; do not index here routinely for postmortem studies; article must be on cadavers as a corpse; AUTOPSY is available for the procedure and / pathol is available with diseases and tissues for postmortem pathology", "MS": "A dead body, usually a human body.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002102"}, {"RECTYPE": "D", "MH": "Cadaverine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "1,5 Pentanediamine", "MN": "D02.092.782.258.174", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "L90BEN6OLL", "RR": "462-94-2 (Cadaverine)", "PI": "Polyamines (1971-1972)", "MS": "A foul-smelling diamine formed by bacterial DECARBOXYLATION of LYSINE. It is also an intermediate secondary metabolite in lysine-derived alkaloid biosynthetic pathways (e.g., QUINOLIZIDINES and LYCOPODIUM).", "PM": "91; was see under DIAMINES 1973-90", "HN": "91(73); was see under DIAMINES 1973-90", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002103"}, {"RECTYPE": "D", "MH": "Cadmium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK RE SD ST TO TU UR", "MN": "D01.552.544.137", "FX": "Cadmium Radioisotopes", "EC": "poisoning:Cadmium Poisoning", "MH_TH": "POPLINE (1978)", "ST": "T196", "N1": "Cadmium", "RN": "00BH33GNGH", "RR": "7440-43-9 (Cadmium)", "MS": "An element with atomic symbol Cd, atomic number 48, and atomic weight 112.41. It is a metal and ingestion will lead to CADMIUM POISONING.", "OL": "search CADMIUM/PO under CADMIUM POISONING 1966-76", "HN": "/poisoning was used for indexing 1966-76", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D002104"}, {"RECTYPE": "D", "MH": "Cadmium Poisoning", "DE": "CADMIUM POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Itai-Itai|T037|NON|EQV|UNK (19XX)|760427|abcdef", "ENTRY": "Poisonings, Cadmium", "MN": "C25.723.522.625", "MH_TH": "NLM (1977)", "ST": "T037", "AN": "occup cadmium pois: coord IM with OCCUPATIONAL DISEASES (IM) but not also ENVIRONMENTAL EXPOSURE (see note there)", "MS": "Poisoning occurring after exposure to cadmium compounds or fumes. It may cause gastrointestinal syndromes, anemia, or pneumonitis.", "OL": "use CADMIUM POISONING to search CADMIUM/poisoning 1966-76", "PM": "77; was CADMIUM/poisoning 1966-76", "HN": "77; was CADMIUM/poisoning 1966-76", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D002105"}, {"RECTYPE": "D", "MH": "Cadmium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Cadmium", "MN": "D01.496.749.108", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1987)", "MS": "Unstable isotopes of cadmium that decay or disintegrate emitting radiation. Cd atoms with atomic weights 103-105, 107, 109, 115, and 117-119 are radioactive cadmium isotopes.", "PM": "88", "HN": "88", "MR": "20170703", "DA": "19870406", "DC": "1", "DX": "19880101", "UI": "D002106"}, {"RECTYPE": "D", "MH": "Caenorhabditis", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Caenorhabditides", "MN": "B01.050.500.500.294.400.875.660.250", "MH_TH": "NLM (1979)", "ST": "T204", "RN": "txid6237", "AN": "a genus of nematodes used in exper", "PI": "Nematoda (1966-1978)", "MS": "A genus of small free-living nematodes. Two species, CAENORHABDITIS ELEGANS and C. briggsae are much used in studies of genetics, development, aging, muscle chemistry, and neuroanatomy.", "PM": "79", "HN": "79", "MR": "20200813", "DA": "19780302", "DC": "1", "DX": "19790101", "UI": "D002107"}, {"RECTYPE": "D", "MH": "Ceruletide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cerulein|T116|T121|T123|NON|EQV|UNK (19XX)|800703|abbbcdef", "ENTRY": "FI6934", "MN": "D12.644.456.241", "MH_TH": "USAN (1980)", "ST": "T123", "N1": "Caerulein", "RN": "888Y08971B", "RR": "17650-98-5 (Caerulein)", "AN": "do not confuse entry term CERULEIN with CERULENIN", "PI": "Peptides (1966-1971)", "MS": "A specific decapeptide obtained from the skin of Hila caerulea, an Australian amphibian. Caerulein is similar in action and composition to CHOLECYSTOKININ. It stimulates gastric, biliary, and pancreatic secretion; and certain smooth muscle. It is used in paralytic ileus and as diagnostic aid in pancreatic malfunction.", "PM": "2013; see CAERULEIN 1972-2013", "HN": "2013(1972)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002108"}, {"RECTYPE": "D", "MH": "Caffeic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Caffeic", "MN": "D02.241.223.200.054", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Cinnamates (1968-1974)", "MS": "A class of phenolic acids related to chlorogenic acid, p-coumaric acid, vanillic acid, etc., which are found in plant tissues. It is involved in plant growth regulation.", "PM": "91; was see under CINNAMATES 1975-90", "HN": "91(75); was see under CINNAMATES 1975-90", "MR": "20120703", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002109"}, {"RECTYPE": "D", "MH": "Caffeine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "QuickPep", "MN": "D03.633.100.759.758.824.175", "PA": "Purinergic P1 Receptor Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-", "RN": "3G6A5W338E", "RR": "58-08-2 (Caffeine)", "MS": "A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002110"}, {"RECTYPE": "D", "MH": "Calcaneus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Heel Bone|T023|NON|EQV|NLM (2002)|010315|abcdef", "ENTRY": "Bone, Heel", "MN": "A02.835.232.043.300.710.300", "FX": "Heel", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "do not confuse with HEEL, the area", "MS": "The largest of the TARSAL BONES which is situated at the lower and back part of the FOOT, forming the HEEL.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002111"}, {"RECTYPE": "D", "MH": "Calcifediol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "25-Hydroxyvitamin D 3|T109|T127|NON|EQV|UNK (19XX)|820504|HYDROXYVITAMIN D 03 25|abbcdefs", "ENTRY": "Monohydrate, 25-Hydroxycholecalciferol", "MN": "D10.570.938.146.478.250", "PA": "Vitamins", "MH_TH": "USP (19XX)", "ST": "T127", "N1": "9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, (3beta,5Z,7E)-", "RN": "P6YZ13C99Q", "RR": "T0WXW8F54E", "AN": "deficiency: coordinate CALCIFEDIOL /defic (IM) with VITAMIN D DEFICIENCY (IM)", "PI": "Hydroxycholecalciferols (1972-1982)", "MS": "The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.", "PM": "83", "HN": "83", "MR": "20170524", "DA": "19820504", "DC": "1", "DX": "19830101", "UI": "D002112"}, {"RECTYPE": "D", "MH": "Calcification, Physiologic", "DE": "CALCIFICATION PHYSIOL", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Bone Mineralization|T042|NON|NRW|NLM (1990)|881130|abcdef", "ENTRY": "Physiological Calcification", "MN": "G11.427.578.050.500.175", "FX": "Osteogenesis", "MH_TH": "NLM (1965)", "ST": "T042", "AN": "TOOTH CALCIFICATION is also available", "MS": "Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts.", "PM": "65; was CALCIFICATION 1963-64", "HN": "65; was CALCIFICATION 1963-64", "CATSH": "CAT LIST", "MR": "20180206", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002113"}, {"RECTYPE": "D", "MH": "Calcinosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Calcification, Pathologic|T047|NON|EQV|UNK (19XX)|740329|CALCIFICATION PATHOL|abcdefv", "ENTRY": "Tumoral Calcinosis", "MN": "C18.452.174.130", "FX": "Chondrocalcinosis", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with organ/diseases term; for calcinosis of the heart, coordinate with CARDIOMYOPATHIES, not HEART DISEASES", "MS": "Pathologic deposition of calcium salts in tissues.", "PM": "CALCIPHYLAXIS was heading 1965-83", "CATSH": "CAT LIST", "MR": "20160613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002114"}, {"RECTYPE": "D", "MH": "Calciphylaxis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Calcific Uraemic Arteriolopathy|T047|NON|NRW|NLM (2023)|210830|abcdef", "ENTRY": "Uraemic Arteriolopathy, Calcific", "MN": "C18.452.174.130.186", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification.", "PM": "91,63-83; was see under CALCINOSIS 1984-90", "HN": "91(84)63; was see under CALCINOSIS 1984-90", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002115"}, {"RECTYPE": "D", "MH": "Calcitonin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thyrocalcitonin|T116|T125|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Ciba 47175BA", "MN": "D12.776.631.650.095", "PA": "Bone Density Conservation Agents", "FX": "Receptors, Calcitonin", "MH_TH": "USAN (1967)", "ST": "T125", "N1": "Calcitonin", "RN": "9007-12-9", "MS": "A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults.", "OL": "use CALCITONIN to search THYROCALCITONIN 1966-73", "PM": "74,66-67; was THYROCALCITONIN 1968-73", "HN": "74,66-67; was THYROCALCITONIN 1968-73 & 1964-65 (Prov 1964-65)", "MR": "20180522", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002116"}, {"RECTYPE": "D", "MH": "Calcitriol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "1,25-Dihydroxyvitamin D3|T109|T121|T125|NON|EQV|FDA SRS (2014)|UNK (19XX)|810512|DIHYDROXYVITAMIN D3 01 25|abbbcdeefs", "ENTRY": "MC 1288", "MN": "D10.570.938.146.478.387.300", "PA": "Vitamins", "FX": "Receptors, Calcitriol", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1alpha,3beta,5Z,7E)-", "RN": "FXC9231JVH", "RR": "32222-06-3 (Calcitriol)", "AN": "deficiency: coordinate CALCITRIOL /defic (IM) with VITAMIN D DEFICIENCY (IM)", "PI": "Hydroxycholecalciferols (1972-1973)", "MS": "The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.", "PM": "82", "HN": "82", "MR": "20220708", "DA": "19810512", "DC": "1", "DX": "19820101", "UI": "D002117"}, {"RECTYPE": "D", "MH": "Calcium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Factor IV|T123|T196|NON|EQV|UNK (19XX)|750101|abbcdef", "ENTRY": "Factor IV, Coagulation", "MN": "D23.119.100", "FX": "Hypocalcemia", "MH_TH": "POPLINE (1984)", "ST": "T196", "N1": "Calcium", "RN": "SY7Q814VUP", "RR": "7440-70-2 (Calcium)", "MS": "A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.", "PM": "/metabolism was CALCIUM METABOLISM 1965", "HN": "/metabolism was CALCIUM METABOLISM 1965", "MR": "20180613", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D002118"}, {"RECTYPE": "D", "MH": "Calcium Carbonate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Carbonate, Calcium", "MN": "D01.578.200", "PA": "Antacids", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Carbonic acid calcium salt (1:1)", "RN": "H0G9379FGK", "RR": "471-34-1 (Calcium Carbonate)", "AN": "occurs in nature as chalk, limestone or marble; used in med as a buffer in hemodialysis", "MS": "Carbonic acid calcium salt (CaCO3). An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement.", "PM": "65", "HN": "65", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002119"}, {"RECTYPE": "D", "MH": "Calcium Channel Agonists", "DE": "CALCIUM CHANNEL AG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Calcium Channel Agonists, Exogenous|T121|NON|NRW|UNK (19XX)|870323|abcdef", "ENTRY": "Channel Agonists, Calcium", "MN": "D27.505.954.411.793.205", "EC": "antagonists & inhibitors:Calcium Channel Blockers", "MH_TH": "NLM (1988)", "ST": "T121", "RN": "0", "PI": "Ion Channels (1979-1987)", "MS": "Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in VASCULAR SMOOTH MUSCLE and/or CARDIAC MUSCLE cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture.", "PM": "88", "HN": "88", "MR": "20180522", "DA": "19870323", "DC": "1", "DX": "19880101", "UI": "D002120"}, {"RECTYPE": "D", "MH": "Calcium Channel Blockers", "DE": "CA CHANNEL BLOCK", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Exogenous Calcium Inhibitor|T121|NON|NRW|NLM (2021)|191120|abcdef", "ENTRY": "Inhibitor, Exogenous Calcium", "MN": "D27.505.954.411.192", "FX": "Vasodilator Agents", "MH_TH": "NLM (1982)", "ST": "T121", "RN": "0", "PI": "Ion Channels (1979-1981)", "MS": "A class of drugs that act by selective inhibition of calcium influx through cellular membranes.", "OL": "use CALCIUM CHANNEL BLOCKERS to search CALCIUM ANTAGONISTS, EXOGENOUS 1982", "PM": "83; was CALCIUM ANTAGONISTS, EXOGENOUS 1982", "HN": "83; was CALCIUM ANTAGONISTS, EXOGENOUS 1982", "MR": "20200527", "DA": "19810512", "DC": "1", "DX": "19820101", "UI": "D002121"}, {"RECTYPE": "D", "MH": "Calcium Chloride", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Calcium Chloride, Anhydrous|T197|NON|NRW|FDA SRS (2014)|NLM (2001)|000330|abcdeef", "MN": "D01.210.450.150.150", "MH_TH": "NLM (1965)", "ST": "T197", "N1": "Calcium chloride", "RN": "M4I0D6VV5M", "RR": "OFM21057LP", "MS": "A salt used to replenish calcium levels, as an acid-producing diuretic, and as an antidote for magnesium poisoning.", "PM": "65", "HN": "65", "MR": "20180521", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002122"}, {"RECTYPE": "D", "MH": "Calcium Dobesilate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dobesilate Calcium|T109|T121|NON|EQV|NLM (1994)|921119|abbcdef", "ENTRY": "Dobesilate, Calcium", "MN": "D02.886.645.600.080.050.100.075", "PA": "Hemostatics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenesulfonic acid, 2,5-dihydroxy-, calcium salt (2:1)", "RN": "5921X1560Q", "RR": "86928-25-8 (Ca salt (1:1))", "PI": "Hydroquinones (1972-1974)", "MS": "A drug used to reduce hemorrhage in diabetic retinopathy.", "PM": "91; was see under BENZENESULFONATES 1975-90", "HN": "91(75); was see under BENZENESULFONATES 1975-90", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002123"}, {"RECTYPE": "D", "MH": "Calcium Fluoride", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Fluoride, Calcium", "MN": "D01.303.350.300.150", "MH_TH": "NLM (1965)", "ST": "T197", "N1": "Calcium fluoride (CaF2)", "RN": "O3B55K4YKI", "RR": "7789-75-5 (Calcium Fluoride)", "MS": "Calcium fluoride. Occurring in nature as the mineral fluorite or fluorspar. It is the primary source of fluorine and its compounds. Pure calcium fluoride is used as a catalyst in dehydration and dehydrogenation and is used to fluoridate drinking water. (From Merck Index, 11th ed)", "PM": "65", "HN": "65", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002124"}, {"RECTYPE": "D", "MH": "Calcium Gluconate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Gluconate, Calcium", "MN": "D09.811.308.200", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "D-Gluconic acid, calcium salt (2:1)", "RN": "SQE6VB453K", "RR": "299-28-5 (Calcium Gluconate)", "PI": "Gluconates (1966-1978)", "MS": "The calcium salt of gluconic acid. The compound has a variety of uses, including its use as a calcium replenisher in hypocalcemic states.", "PM": "91; was see under GLUCONATES 1979-90", "HN": "91(79); was see under GLUCONATES 1979-90", "MR": "20160705", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D002125"}, {"RECTYPE": "D", "MH": "Calcium Hydroxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydroxide, Calcium", "MN": "D01.248.497.158.459.150", "PA": "Bone Cements", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Calcium hydroxide (Ca(OH)2)", "RN": "PF5DZW74VN", "RR": "1305-62-0 (Calcium Hydroxide)", "PI": "Hydroxides (1966)", "MS": "A white powder prepared from lime that has many medical and industrial uses. It is in many dental formulations, especially for root canal filling.", "PM": "67", "HN": "67", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002126"}, {"RECTYPE": "D", "MH": "Calcium Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Calcium", "MN": "D01.552.539.288.500", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable calcium atoms that have the same atomic number as the element calcium, but differ in atomic weight. Ca-42-44, 46, and 48 are stable calcium isotopes.", "MR": "20170421", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002127"}, {"RECTYPE": "D", "MH": "Calcium Metabolism Disorders", "DE": "CALCIUM METAB DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Disorders, Calcium Metabolism", "MN": "C18.452.174", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002128"}, {"RECTYPE": "D", "MH": "Calcium Oxalate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trihydrate, Calcium Oxalate", "MN": "D02.241.081.337.593.750.500", "EC": "analogs & derivatives:Oxalates", "MH_TH": "NLM (1979)", "ST": "T109", "N1": "Ethanedioic acid, calcium salt", "RN": "2612HC57YE", "RR": "5794-28-5 (Ca (1:1) salt, mono-H2O)", "AN": "OXALATES is also available", "PI": "Oxalates (1966-1978)", "MS": "The calcium salt of oxalic acid, occurring in the urine as crystals and in certain calculi.", "PM": "79", "HN": "79", "MR": "20130708", "DA": "19771209", "DC": "1", "DX": "19790101", "UI": "D002129"}, {"RECTYPE": "D", "MH": "Calcium Phosphates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phosphates, Calcium", "MN": "D01.695.625.675.650.075", "MH_TH": "NLM (1964)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Calcium salts of phosphoric acid. These compounds are frequently used as calcium supplements.", "PM": "65", "HN": "65(64)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002130"}, {"RECTYPE": "D", "MH": "Calcium Pyrophosphate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Calcium Diphosphate|T197|NON|EQV|FDA SRS (2014)|UNK (19XX)|760414|abcdeef", "ENTRY": "Pyrophosphate, Monohydrate Calcium", "MN": "D01.695.625.675.650.775.150.150", "FX": "Chondrocalcinosis", "MH_TH": "NLM (1977)", "ST": "T197", "N1": "Diphosphoric acid, calcium salt", "RN": "X69NU20D19", "RR": "7790-76-3 (calcium salt (1:2))", "PI": "Pyrophosphates (1966-1976)", "MS": "An inorganic pyrophosphate which affects calcium metabolism in mammals. Abnormalities in its metabolism occur in some human diseases, notably HYPOPHOSPHATASIA and pseudogout (CHONDROCALCINOSIS).", "PM": "91; was see under PYROPHOSPHATES 1977-90", "HN": "91(77); was see under PYROPHOSPHATES 1977-90", "MR": "20130708", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D002131"}, {"RECTYPE": "D", "MH": "Calcium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Calcium", "MN": "D01.552.539.288.500.325", "MH_TH": "NLM (1974)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "MS": "Unstable isotopes of calcium that decay or disintegrate emitting radiation. Ca atoms with atomic weights 39, 41, 45, 47, 49, and 50 are radioactive calcium isotopes.", "OL": "search CALCIUM ISOTOPES 1966-73", "PM": "74", "HN": "74", "MR": "20170421", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002132"}, {"RECTYPE": "D", "MH": "Calcium Sulfate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Plaster of Paris|T122|T197|EPO|NRW|FDA SRS (2014)|UNK (19XX)|790530|abbcdeef", "ENTRY": "Stone, Artificial Dental|T122|T197|NON|NRW|NLM (1991)|900116|STONE ARTIFICIAL DENT|abbcdefv", "MN": "D01.875.800.800.850.125", "PA": "Dental Materials", "MH_TH": "NLM (1966)", "ST": "T197", "N1": "Sulfuric acid, calcium salt (1:1)", "RN": "WAT0DDB505", "RR": "7778-18-9 (Calcium Sulfate)", "MS": "A calcium salt that is used for a variety of purposes including: building materials, as a desiccant, in dentistry as an impression material, cast, or die, and in medicine for immobilizing casts and as a tablet excipient. It exists in various forms and states of hydration. Plaster of Paris is a mixture of powdered and heat-treated gypsum.", "OL": "use CALCIUM SULFATE to search PLASTER OF PARIS 1966-79", "PM": "80; PLASTER OF PARIS was heading 1963-79", "HN": "80; PLASTER OF PARIS was heading 1963-79", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D002133"}, {"RECTYPE": "D", "MH": "Calcium-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Calcium-Binding Protein|T116|T192|NON|EQV|NLM (2021)|191231|abbcdef", "ENTRY": "Protein, Calcium-Binding", "MN": "D12.776.157.125", "MH_TH": "NLM (1980)", "ST": "T192", "RN": "0", "AN": "RECEPTORS, CALCIUM-SENSING is also available", "PI": "Proteins (1966-1970)", "MS": "Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS.", "PM": "80; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT & CALCIUM-DEPENDENT REGULATOR were see under CARRIER PROTEINS 1979", "HN": "80", "MR": "20200527", "DA": "19790523", "DC": "1", "DX": "19800101", "UI": "D002135"}, {"RECTYPE": "D", "MH": "Calcium, Dietary", "AQ": "AD AE AG AI AN BL CF CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dietary Calcium|T197|NON|EQV|UNK (19XX)|740329|abcdef", "MN": "D01.146.395", "PA": "Bone Density Conservation Agents", "EC": "chemistry:Calcium:chemistry", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "/adv eff: coordinate with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther", "MS": "Calcium compounds in DIETARY SUPPLEMENTS or in food that supply the body with calcium.", "PM": "1966", "HN": "1966", "MR": "20220408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002136"}, {"RECTYPE": "D", "MH": "Calculi", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Calculus", "MN": "C23.300.175", "FX": "Lithotripsy", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "general or unspecified; prefer specifics; coordinate with organ/diseases term; chemolysis of calculi: coordinate disease with /ther, not /drug ther", "MS": "An abnormal concretion occurring mostly in the urinary and biliary tracts, usually composed of mineral salts. Also called stones.", "OL": "to search for chem composition of calculi, use CALCULI/anal 1987-1990 & CALCULI/metab 1966-86", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002137"}, {"RECTYPE": "D", "MH": "Calibration", "AQ": "ST", "ENTRY": "Calibrations", "MN": "E05.978.155", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "NIM; coordinate with specific scale (IM) if relevant", "MS": "Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output.", "PM": "91; was see under WEIGHTS AND MEASURES 1978-90", "HN": "91(78); was see under WEIGHTS AND MEASURES 1978-90", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D002138"}, {"RECTYPE": "D", "MH": "Caliciviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Neboviruses", "MN": "B04.820.578.298", "MH_TH": "NLM (1979)", "ST": "T005", "RN": "txid11974", "RR": "txid696855", "PI": "Picornaviridae (1966-1978)", "MS": "A family of RNA viruses infecting a broad range of animals. Most individual species are restricted to their natural hosts. They possess a characteristic six-pointed starlike shape whose surfaces have cup-shaped (chalice) indentions. Transmission is by contaminated food, water, fomites, and occasionally aerosolization of secretions. Genera include LAGOVIRUS; NORWALK-LIKE VIRUSES; SAPPORO-LIKE VIRUSES; and VESIVIRUS.", "OL": "use CALICIVIRIDAE to search CALICIVIRUSES 1979-81 & 1993", "PM": "82; was CALICIVIRUSES 1979-81; CALICIVIRUSES was see CALICIVIRIDAE 1993", "HN": "82; was CALICIVIRUSES 1979-81; CALICIVIRUSES was see CALICVIRIDAE 1993", "MR": "20200813", "DA": "19771202", "DC": "1", "DX": "19790101", "UI": "D002139"}, {"RECTYPE": "D", "MH": "California", "AQ": "EH EP", "MN": "Z01.107.567.875.760.200", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "LOS ANGELES is also available", "MS": "State bounded on the east by Nevada and Arizona, on the south by Mexico and the Pacific Ocean on the south and west, and on the north by Oregon.", "MR": "20160628", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D002140"}, {"RECTYPE": "D", "MH": "Encephalitis Virus, California", "DE": "ENCEPH VIRUS CALIFORNIA", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Tahyna virus|T005|EPO|NRW|UNK (19XX)|741230|abcdef", "ENTRY": "La Crosse Encephalitis Virus|T005|NON|EQV|NLM (2018)|161011|abcdef", "MN": "B04.820.480.750.640.300", "MH_TH": "UNK (19XX)", "ST": "T005", "RN": "txid35305", "RR": "txid45270", "MS": "A species in the ORTHOBUNYAVIRUS genus of the family BUNYAVIRIDAE. Serotypes are found in temperate and arctic regions and each is closely associated with a single species of vector mosquito. The vertebrate hosts are usually small mammals but several serotypes infect humans.", "PM": "2002: see CALIFORNIA GROUP VIRUSES 1991-2001, see BUNYAVIRIDAE 1981-1990, see ENCEPHALITIS VIRUSES 1977-1980; for CALIFORNIA VIRUS see ARBOVIRUSES 1975-1976", "HN": "2002 (1977)", "MR": "20200813", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002141"}, {"RECTYPE": "D", "MH": "Californium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.156", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Californium", "RN": "975X05H15A", "RR": "7440-71-3 (Californium)", "MS": "A man-made radioactive actinide with atomic symbol Cf, atomic number 98, and atomic weight 251. Its valence can be +2 or +3. Californium has medical use as a radiation source for radiotherapy.", "MR": "20170424", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002142"}, {"RECTYPE": "D", "MH": "Callitrichinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Mico Genus|T015|NON|NRW|NLM (2020)|190327|abcdef", "ENTRY": "Mico, Genus", "MN": "B01.050.150.900.649.313.988.400.600.150.150", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9480", "RR": "txid2681187", "AN": "index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)", "PI": "Anthropoidea (1966-1974)", "MS": "A subfamily in the family CEBIDAE that consists of four genera: CALLITHRIX (marmosets), CALLIMICO (Goeldi's monkey), LEONTOPITHECUS (lion tamarins), and SAGUINUS (long-tusked tamarins). The members of this family inhabit the tropical forests of South and Central America.", "PM": "2006; see CALLITRICHINAE 1992-2005, see CALLITHRICIDAE 1981-1991, see MARMOSETS 1975-1980; for CEBUELLA use under CALLITHRIX 1981-2019", "HN": "2006 (1975)", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D002143"}, {"RECTYPE": "D", "MH": "Callithrix", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Marmosets|T015|NON|EQV|NLM (1992)|901128|abcdef", "ENTRY": "Short-Tusked Marmosets", "MN": "B01.050.150.900.649.313.988.400.600.150.150.114", "MH_TH": "NLM (1981)", "ST": "T015", "RN": "txid9481", "RR": "txid9483", "AN": "index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)", "PI": "Callithricidae (1975-1980)", "MS": "A genus of the subfamily CALLITRICHINAE occurring in forests of Brazil and Bolivia and containing seventeen species.", "PM": "1992; see CALLITHRICIDAE 1981-1991; for CEBUELLA see CALLITRICHIDAE 1981-2005", "HN": "1992 (1981); for CEBUELLA use CALLITRICHIDAE 1981-2005", "MR": "20200813", "DA": "19800507", "DC": "1", "DX": "19910101", "UI": "D002144"}, {"RECTYPE": "D", "MH": "Callosities", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Corns|T020|NON|REL|NLM (1993)|920331|abcdef", "ENTRY": "Callosity", "MN": "C17.800.428.200", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "callous goes here: do not confuse with BONY CALLUS, post-fract bone formation", "MS": "Localized hyperplasia of the horny layer of the epidermis due to pressure or friction. (Dorland, 27th ed)", "OL": "use CALLOSITIES to search CORNS 1975-92", "PM": "CORNS was heading 1975-92 (see under CALLOSITIES 1975-90)", "HN": "CORNS was heading 1975-92 (see under CALLOSITIES 1975-90)", "CATSH": "CAT LIST", "MR": "19991129", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D002145"}, {"RECTYPE": "D", "MH": "Bony Callus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Callus|T024|NON|EQV|NLM (1973)|990101|abcdef", "ENTRY": "Callus, Bony", "MN": "A10.165.265.200", "FX": "Osteogenesis", "MH_TH": "NLM (2000)", "ST": "T024", "PI": "Fractures (1966-1972)", "MS": "The bony deposit formed between and around the broken ends of BONE FRACTURES during normal healing.", "PM": "2000; see CALLUS 1973-1999, see FRACTURES 1963-1972", "HN": "2000(1973)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002146"}, {"RECTYPE": "D", "MH": "Calmodulin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Calcium-Dependent Regulator|T116|T123|NON|EQV|UNK (19XX)|830404|CALCIUM DEPENDENT REG|abbcdefv", "ENTRY": "Regulator, Calcium Dependent", "MN": "D12.776.476.387.249", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "AN": "a calcium-binding protein; /biosyn /physiol permitted", "PI": "Enzyme Activation (1969-1978)", "MS": "A heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels.", "OL": "use CALMODULIN to search CALCIUM-DEPENDENT REGULATOR 1979-83", "PM": "84; was CALCIUM-DEPENDENT REGULATOR see under CALCIUM-BINDING PROTEINS 1980-83; was CALCIUM-DEPENDENT REGULATOR see under CARRIER PROTEINS 1979", "HN": "84; was CALCIUM-DEPENDENT REGULATOR see under CALCIUM-BINDING PROTEINS 1980-83; was CALCIUM-DEPENDENT REGULATOR see under CARRIER PROTEINS 1979", "MR": "20170630", "DA": "19780308", "DC": "1", "DX": "19840101", "UI": "D002147"}, {"RECTYPE": "D", "MH": "Calmodulin-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Calspectin|T116|T123|NON|NRW|UNK (19XX)|850425|abbcdef", "ENTRY": "Proteins, Calmodulin-Binding", "MN": "D12.776.157.142", "MH_TH": "NLM (1986)", "ST": "T123", "RN": "0", "AN": "/biosyn /drug eff /physiol permitted", "PI": "Phosphoprotein Phosphatases (1982-1985)", "MS": "Proteins which bind calmodulin. They are found in many tissues and have a variety of functions including F-actin cross-linking properties, inhibition of cyclic nucleotide phosphodiesterase and calcium and magnesium ATPases.", "PM": "86", "HN": "86", "MR": "20050630", "DA": "19850425", "DC": "1", "DX": "19860101", "UI": "D002148"}, {"RECTYPE": "D", "MH": "Energy Intake", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Calorie Intake|T081|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Intake, Energy", "MN": "G07.203.650.240.340", "MH_TH": "NLM (1997)", "ST": "T081", "PI": "Nutrition (1966-1976)", "MS": "Total number of calories taken in daily whether ingested or by parenteral routes.", "PM": "1997: was CALORIC INTAKE 1977-96 (see under DIET 1977-83)", "HN": "1997: was CALORIC INTAKE 1977-96 (see under DIET 1977-83)", "CATSH": "CAT LIST", "MR": "20220713", "DA": "19760416", "DC": "1", "DX": "19840101", "UI": "D002149"}, {"RECTYPE": "D", "MH": "Caloric Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Barany Test|T060|EPO|NRW|NLM (1993)|911101|abcdef", "ENTRY": "Tests, Caloric", "MN": "E01.370.382.900.150", "MH_TH": "NLM (1975)", "ST": "T060", "AN": "vestib funct test using heat or cold; note X ref: spell in titles & transl with accents: B\u00e1r\u00e1ny", "MS": "Elicitation of a rotatory nystagmus by stimulating the semicircular canals with water or air which is above or below body temperature. In warm caloric stimulation a rotatory nystagmus is developed toward the side of the stimulated ear; in cold, away from the stimulated side. Absence of nystagmus indicates the labyrinth is not functioning.", "PM": "91; see VESTIBULAR FUNCTION TESTS 1975-90; BARANY TEST was BARANY'S TEST 1993-97", "HN": "91(75); BARANY TEST was BARANY'S TEST 1993-97", "CATSH": "CAT LIST", "MR": "20010813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D002150"}, {"RECTYPE": "D", "MH": "Calorimetry", "AQ": "CL EC HI IS MT SN ST TD VE", "MN": "E05.196.131", "MH_TH": "NLM (1965)", "ST": "T059", "MS": "The measurement of the quantity of heat involved in various processes, such as chemical reactions, changes of state, and formations of solutions, or in the determination of the heat capacities of substances. The fundamental unit of measurement is the joule or the calorie (4.184 joules). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002151"}, {"RECTYPE": "D", "MH": "Calorimetry, Differential Scanning", "DE": "CALORIMETRY DIFFER SCAN", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Differential Thermal Analysis, Calorimetric|T059|NON|EQV|UNK (19XX)|760412|DIFFER THERMAL ANAL CALORIMETRIC|abcdefv", "ENTRY": "Scanning Calorimetry, Differential", "MN": "E05.196.370.310", "MH_TH": "NLM (1977)", "ST": "T059", "PI": "Calorimetry (1966-1976)", "MS": "Differential thermal analysis in which the sample compartment of the apparatus is a differential calorimeter, allowing an exact measure of the heat of transition independent of the specific heat, thermal conductivity, and other variables of the sample.", "PM": "91; was see under CALORIMETRY 1977-90", "HN": "91(77); was see under CALORIMETRY 1977-90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D002152"}, {"RECTYPE": "D", "MH": "Calorimetry, Indirect", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Calorimetry, Respiration|T059|NON|EQV|UNK (19XX)|741212|abcdef", "ENTRY": "Respiration Calorimetry", "MN": "E05.196.131.655", "MH_TH": "NLM (1975)", "ST": "T059", "AN": "an anal chem technique; NIM", "MS": "Calculation of the energy expenditure in the form of heat production of the whole body or individual organs based on respiratory gas exchange.", "PM": "91; was see under CALORIMETRY 1975-90", "HN": "91(75); was see under CALORIMETRY 1975-90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D002153"}, {"RECTYPE": "D", "MH": "Calpain", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Calcium-Dependent Neutral Proteinase|T116|T126|NON|EQV|UNK (19XX)|850425|abbcdef", "ENTRY": "Proteinase, Calcium-Dependent Neutral", "MN": "D08.811.277.656.300.200.120", "MH_TH": "NLM (1986)", "ST": "T126", "RN": "EC 3.4.22.-", "RR": "EC 3.4.22.53", "AN": "/biosyn /physiol permitted", "PI": "Peptide Peptidohydrolases (1966-1985)", "MS": "Cysteine proteinase found in many tissues. Hydrolyzes a variety of endogenous proteins including NEUROPEPTIDES; CYTOSKELETAL PROTEINS; proteins from SMOOTH MUSCLE; CARDIAC MUSCLE; liver; platelets; and erythrocytes. Two subclasses having high and low calcium sensitivity are known. Removes Z-discs and M-lines from myofibrils. Activates phosphorylase kinase and cyclic nucleotide-independent protein kinase. This enzyme was formerly listed as EC 3.4.22.4.", "PM": "86", "HN": "86", "MR": "20160628", "DA": "19850425", "DC": "1", "DX": "19860101", "UI": "D002154"}, {"RECTYPE": "D", "MH": "Calsequestrin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.210.500.220", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "0", "PI": "Muscle Proteins (1974-1975)", "MS": "Acidic protein found in SARCOPLASMIC RETICULUM that binds calcium to the extent of 700-900 nmoles/mg. It plays the role of sequestering calcium transported to the interior of the intracellular vesicle.", "PM": "91; was see under MUSCLE PROTEINS 1976-90", "HN": "91(76); was see under MUSCLE PROTEINS 1976-90", "MR": "20000622", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D002155"}, {"RECTYPE": "D", "MH": "Calymmatobacterium", "DE": "CALYMMATOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Donovania|T007|NON|EQV|UNK (19XX)|760414|abcdef", "MN": "B03.660.250.150.095", "MH_TH": "NLM (1977)", "ST": "T007", "RR": "txid39824", "AN": "infection: probably GRANULOMA INGUINALE, otherwise coord IM with ENTEROBACTERIACEAE INFECTIONS (IM) + GRANULOMA or specific granuloma if pertinent", "PI": "Granuloma Inguinale (1966-1976)", "MS": "A genus of bacteria causing GRANULOMA INGUINALE and other granulomatous lesions.", "PM": "1977, 1963-1965", "HN": "1977(1963)", "MR": "20210304", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D002157"}, {"RECTYPE": "D", "MH": "Cambendazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Noviben|T109|T121|TRD|NRW|UNK (19XX)|820519|abbcdef", "MN": "D03.633.100.103.190", "PA": "Antinematodal Agents", "MH_TH": "USAN (1970)", "ST": "T121", "N1": "Carbamic acid, (2-(4-thiazolyl)-1H-benzimidazol-5-yl)-, 1-methylethyl ester", "RN": "079X63S3DU", "RR": "26097-80-3 (Cambendazole)", "PI": "Thiazoles (1971-1974)", "MS": "A nematocide effective against a variety of gastrointestinal parasites in cattle, sheep, and horses.", "PM": "91; was see under BENZIMIDAZOLES 1975-90", "HN": "91(75); was see under BENZIMIDAZOLES 1975-90", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002159"}, {"RECTYPE": "D", "MH": "Cambodia", "AQ": "EH EP", "PRINT ENTRY": "Khmer Republic|T083|NAM|EQV|POPLINE (1986)|761231|abcdef", "MN": "Z01.252.145.182", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country located in Southeastern Asia, bordering the Gulf of Thailand, between Thailand, Vietnam, and Laos. The capital is Phnom Penh.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D002160"}, {"RECTYPE": "D", "MH": "Camelids, New World", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Llamas|T015|NON|NRW|UNK (19XX)|741211|abcdef", "ENTRY": "Vicuna", "MN": "B01.050.150.900.649.313.500.190.090", "MH_TH": "NLM (1975)", "ST": "T015", "RR": "txid9844", "MS": "Camelidae of the Americas. The extant species are those originating from South America and include alpacas, llamas, guanicos, and vicunas.", "PM": "91; was see under ARTIODACTYLA 1975-90", "HN": "91(75); was see under ARTIODACTYLA 1975-90", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D002161"}, {"RECTYPE": "D", "MH": "Camelus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Dromedary|T015|NON|NRW|UNK (19XX)|741118|abcdef", "ENTRY": "Dromedaries", "MN": "B01.050.150.900.649.313.500.190.180", "MH_TH": "NLM (2017)", "ST": "T015", "RN": "txid9836", "RR": "txid9838", "PI": "Artiodactyla (1966-1967)", "MS": "Two-toed, hoofed mammals with four legs, a big-lipped snout, and a humped back belonging to the family Camelidae. They are native to North Africa, and Western and Central Asia.", "PM": "2017; see CAMELS 1968-2016", "HN": "2017 (1968)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002162"}, {"RECTYPE": "D", "MH": "Cameroon", "AQ": "EH EP", "PRINT ENTRY": "Republic of Cameron|T083|NAM|EQV|NLM (2009)|080303|abcdef", "ENTRY": "United Republic of Cameroon|T083|NAM|EQV|NLM (1996)|940801|abcdef", "MN": "Z01.058.290.100.110", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in central Africa lying east of CHAD and the CENTRAL AFRICAN REPUBLIC and west of NIGERIA. The capital is Yaounde.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D002163"}, {"RECTYPE": "D", "MH": "Camphor", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Camphor, (1S)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef", "MN": "D04.075.080.500.234.326", "PA": "Anti-Infective Agents, Local", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Bicyclo(2.2.1)heptan-2-one, 1,7,7-trimethyl-", "RN": "76-22-2", "RR": "464-49-3 ((1R)-isomer)", "MS": "A bicyclic monoterpene ketone found widely in plants, especially CINNAMOMUM CAMPHORA. It is used topically as a skin antipruritic and as an anti-infective agent.", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002164"}, {"RECTYPE": "D", "MH": "Camping", "AQ": "CL EC ES HI LJ PX SN ST TD", "MN": "I03.450.642.159", "MH_TH": "NLM (1966)", "ST": "T056", "MS": "Living outdoors as a recreational activity.", "MR": "19920507", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002165"}, {"RECTYPE": "D", "MH": "Camptothecin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Camptothecine|T109|T121|NON|EQV|NLM (1990)|890609|abbcdef", "MN": "D03.132.151", "PA": "Topoisomerase I Inhibitors", "MH_TH": "NLM (1973)", "ST": "T121", "N1": "1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-", "RN": "XT3Z54Z28A", "RR": "7689-03-4 (Camptothecin)", "PI": "Antineoplastic Agents (1966-1972)", "MS": "An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity.", "PM": "73", "HN": "73", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002166"}, {"RECTYPE": "D", "MH": "Campylobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.150.235.250.500", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid194", "PI": "Vibrio (1968-1975)", "MS": "A genus of bacteria found in the reproductive organs, intestinal tract, and oral cavity of animals and man. Some species are pathogenic.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D002167"}, {"RECTYPE": "D", "MH": "Campylobacter fetus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Vibrio fetus|T007|NON|EQV|UNK (19XX)|750731|abcdef", "MN": "B03.660.150.235.250.500.220", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid196", "AN": "causes abortion in cattle & sheep; infection: coord IM with CAMPYLOBACTER INFECTIONS (IM)", "PI": "Vibrio (1966-1971)", "MS": "A species of bacteria present in man and many kinds of animals and birds, often causing infertility and/or abortion.", "OL": "use CAMPYLOBACTER FETUS to search VIBRIO FETUS 1972-83 (as Prov 1972-73)", "PM": "84; was see under CAMPYLOBACTER 1976-83; was VIBRIO FETUS 1974-75", "HN": "84(76); was see under CAMPYLOBACTER 1976-83; was VIBRIO FETUS 1972-75 (Prov 1972-73)", "MR": "20200128", "DA": "19750801", "DC": "1", "DX": "19840101", "UI": "D002168"}, {"RECTYPE": "D", "MH": "Campylobacter Infections", "DE": "CAMPYLOBACTER INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Campylobacter Infection|T047|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Infection, Campylobacter", "MN": "C01.150.252.400.177", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "gram-neg bact infect", "PI": "Vibrio Infections (1968-1976)", "MS": "Infections with bacteria of the genus CAMPYLOBACTER.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D002169"}, {"RECTYPE": "D", "MH": "Canada", "AQ": "EH EP", "MN": "Z01.107.567.176", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "each of the provinces & territories is available as a heading", "MS": "The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.", "MR": "19991103", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D002170"}, {"RECTYPE": "D", "MH": "Canaries", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Serinus|T012|NON|EQV|NLM (2004)|021119|abcdef", "ENTRY": "Canary", "MN": "B01.050.150.900.248.620.750.250.150", "MH_TH": "NLM (1968)", "ST": "T012", "RN": "txid9134", "PI": "Birds (1966-1967)", "MS": "Any of several Old World finches of the genus Serinus.", "PM": "68", "HN": "68", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002171"}, {"RECTYPE": "D", "MH": "Canavanine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D12.125.311", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "L-Homoserine, O-((aminoiminomethyl)amino)-", "RN": "3HZV514J4B", "RR": "543-38-4 (Canavanine)", "AN": "an amino acid", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002172"}, {"RECTYPE": "D", "MH": "Cancer Care Facilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospitals, Cancer|T073|T093|NON|NRW|UNK (19XX)|840515|HOSP CANCER|abbcdefv", "ENTRY": "Hospital, Cancer", "MN": "N02.278.421.556.070", "FX": "Oncology Service, Hospital", "MH_TH": "NLM (1977)", "ST": "T093", "MS": "Institutions specializing in the care of cancer patients.", "PM": "91; was see under HOSPITALS, SPECIAL Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITALS, SPECIAL 1977-90", "MR": "19920507", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D002173"}, {"RECTYPE": "D", "MH": "Candicidin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Levorin|T109|T195|TRD|NRW|UNK (19XX)|810514|abbcdef", "ENTRY": "Vanobid|T109|T195|TRD|NRW|NLM (1990)|881229|abbcdef", "MN": "D02.540.576.500.968", "PA": "Antifungal Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Candicidin", "RN": "1403-17-4", "RR": "5190Y348H9", "PI": "Polyenes (1974)", "MS": "Mixture of antifungal heptaene macrolides from Streptomyces griseus or Actinomyces levoris used topically in candidiasis. The antibiotic complex is composed of candicidins A, B, C, and D, of which D is the major component.", "OL": "use CANDICIDIN to search LEVORIN 1978-89", "PM": "91; was see under ANTIBIOTICS, MACROLIDE 1990; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89; LEVORIN was see under ANTIBIOTICS, ANTIFUNGAL 1978-81", "HN": "91(75); was see under ANTIBIOTICS, MACROLIDE 1990; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89; LEVORIN was see under ANTIBIOTICS, ANTIFUNGAL 1978-81", "MR": "20150622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002174"}, {"RECTYPE": "D", "MH": "Candida", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Torulopsis utilis|T004|NON|REL|NLM (1998)|970523|abcdef", "ENTRY": "Monilias", "MN": "B01.300.930.176", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid5475", "RR": "txid4903", "MS": "A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; VULVOVAGINAL CANDIDIASIS; and CANDIDIASIS, ORAL (THRUSH).", "PM": "TORULOPSIS was heading 1974-85", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002175"}, {"RECTYPE": "D", "MH": "Candida albicans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Syringospora albicans|T004|NON|EQV|NLM (2021)|200318|abcdef", "MN": "B01.300.930.176.326", "MH_TH": "NLM (1973)", "ST": "T004", "RN": "txid5476", "AN": "infection: coordinate with CANDIDIASIS or its indentions ", "PI": "Candida (1966-1971)", "MS": "A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis).", "PM": "73", "HN": "73(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002176"}, {"RECTYPE": "D", "MH": "Candidiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Moniliasis|T047|NON|EQV|UNK (19XX)|800512|abcdef", "ENTRY": "Moniliases", "MN": "C01.150.703.160", "MH_TH": "POPLINE (1990)", "ST": "T047", "AN": "CANDIDIASIS, INVASIVE and CANDIDEMIA are also available", "MS": "Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)", "OL": "use CANDIDIASIS to search MONILIASIS 1966-80", "PM": "81; was MONILIASIS 1963-80", "HN": "81; was MONILIASIS 1963-80", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D002177"}, {"RECTYPE": "D", "MH": "Candidiasis, Chronic Mucocutaneous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Mucocutaneous Candidiasis, Chronic", "MN": "C23.550.291.500.250", "MH_TH": "NLM (1981)", "ST": "T047", "AN": "fungus dis of skin; do not bother to coord with CANDIDA or CANDIDA ALBICANS", "PI": "Candidiasis, Cutaneous (1966-1980)", "MS": "A clinical syndrome characterized by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy.", "PM": "91; was see under CANDIDIASIS 1981-90", "HN": "91(81); was see under CANDIDIASIS 1981-90", "CATSH": "CAT LIST", "MR": "20210312", "DA": "19800512", "DC": "1", "DX": "19910101", "UI": "D002178"}, {"RECTYPE": "D", "MH": "Candidiasis, Cutaneous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Moniliasis, Cutaneous|T047|NON|EQV|UNK (19XX)|800513|abcdef", "MN": "C17.800.838.208.170", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "fungus dis of skin; do not bother to coord with CANDIDA or CANDIDA ALBICANS", "MS": "Candidiasis of the skin manifested as eczema-like lesions of the interdigital spaces, perleche, or chronic paronychia. (Dorland, 27th ed)", "OL": "use CANDIDIASIS, CUTANEOUS to search MONILIASIS, CUTANEOUS 1966-80", "PM": "81; was MONILIASIS, CUTANEOUS 1963-80", "HN": "81; was MONILIASIS, CUTANEOUS 1963-80", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D002179"}, {"RECTYPE": "D", "MH": "Candidiasis, Oral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Thrush|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Oral Moniliasis", "MN": "C07.465.130", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "fungus dis of mouth; do not bother to coord with CANDIDA or CANDIDA ALBICANS", "MS": "Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)", "OL": "use CANDIDIASIS, ORAL to search MONILIASIS, ORAL 1966-80", "PM": "81; was MONILIASIS, ORAL 1963-80", "HN": "81; was MONILIASIS, ORAL 1963-80", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D002180"}, {"RECTYPE": "D", "MH": "Candidiasis, Vulvovaginal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Vaginitis, Monilial|T047|NON|NRW|NLM (1998)|960716|abcdef", "ENTRY": "Yeast Infections, Vaginal", "MN": "C12.100.250.944.902.737.500", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Infection of the VULVA and VAGINA with a fungus of the genus CANDIDA.", "OL": "use CANDIDIASIS, VULVOVAGINAL to search MONILIASIS, VULVOVAGINAL 1966-80", "PM": "81; was MONILIASIS, VULVOVAGINAL 1963-80", "HN": "81; was MONILIASIS, VULVOVAGINAL 1963-80", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D002181"}, {"RECTYPE": "D", "MH": "Candy", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Confection|T168|NON|EQV|NLM (1998)|961004|abcdef", "ENTRY": "Confections", "MN": "J02.500.140", "MH_TH": "NLM (1966)", "ST": "T168", "MS": "Sweet food products combining cane or beet sugars with other carbohydrates and chocolate, milk, eggs, and various flavorings. In the United States, candy refers to both sugar- and cocoa-based confections and is differentiated from sweetened baked goods; elsewhere the terms sugar confectionary, chocolate confectionary, and flour confectionary (meaning goods such as cakes and pastries) are used.", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002182"}, {"RECTYPE": "D", "MH": "Canes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Walking Sticks|T074|NON|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "Walking Stick", "MN": "E07.858.442.250", "MH_TH": "NLM (1975)", "ST": "T074", "MS": "Sticks used as walking aids. The canes may have three or four prongs at the end of the shaft.", "PM": "91; was see under ORTHOPEDIC EQUIPMENT 1975-90", "HN": "91(75); was see under ORTHOPEDIC EQUIPMENT 1975-90", "CATSH": "CAT LIST", "MR": "19920507", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D002183"}, {"RECTYPE": "D", "MH": "Herpesvirus 1, Canid", "DS": "HERPESVIRUS CANID 01", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Canine Tracheobronchitis Virus|T005|NON|EQV|NLM (1994)|930302|abcdef", "ENTRY": "Tracheobronchitis Viruses, Canine", "MN": "B04.280.382.100.900.420", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid170325", "AN": "infect: coord IM with HERPESVIRIDAE INFECTIONS (IM)", "MS": "A species of VARICELLOVIRUS virus that causes a disease in newborn puppies.", "OL": "use HERPESVIRUS 1, CANID to search CANINE TRACHEOBRONCHITIS VIRUS & CANINE HERPESVIRUS 1975-93", "PM": "94; was CANINE TRACHEOBRONCHITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-90); CANINE HERPESVIRUS was see CANINE TRACHEOBRONCHITIS VIRUS 1975-93", "HN": "94; was CANINE TRACHEOBRONCHITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80); CANINE HERPESVIRUS was see CANINE TRACHEOBRONCHITIS VIRUS 1975-93", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D002184"}, {"RECTYPE": "D", "MH": "Cannabidiol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-|T109|T121|T123|NON|EQV|NLM (2021)|200526|abbbcdef", "ENTRY": "Epidiolex|T109|T121|TRD|REL|NLM (2017)|181026|abbcdef", "MN": "D02.455.849.090.100", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "19GBJ60SN5", "RR": "13956-29-1 (Cannabidiol)", "PI": "Terpenes (1973-1974)", "MS": "Compound isolated from Cannabis sativa extract.", "PM": "91; was see under CANNABINOIDS 1977-90; was see under CANNABIS 1975-76", "HN": "91(75); was see under CANNABINOIDS 1977-90; was see under CANNABIS 1975-76", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002185"}, {"RECTYPE": "D", "MH": "Cannabinoids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cannabinoid|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D02.455.849.090", "FX": "Receptors, Cannabinoid", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "PI": "Cannabis (1966-1976)", "MS": "Compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL.", "PM": "77", "HN": "77", "MR": "20200527", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D002186"}, {"RECTYPE": "D", "MH": "Cannabinol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.849.090.110", "MH_TH": "NLM (1977)", "ST": "T121", "N1": "6H-Dibenzo(b,d)pyran-1-ol, 6,6,9-trimethyl-3-pentyl-", "RN": "7UYP6MC9GH", "RR": "521-35-7 (Cannabinol)", "PI": "Tetrahydrocannabinol (1975-1976)", "MS": "A physiologically inactive constituent of Cannabis sativa L.", "PM": "91; was see under CANNABINOIDS 1977-90", "HN": "91(77); was see under CANNABINOIDS 1977-90", "MR": "20130708", "DA": "19760521", "DC": "1", "DX": "19910101", "UI": "D002187"}, {"RECTYPE": "D", "MH": "Cannabis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hemp|T167|NON|NRW|NLM (1993)|910924|abcdef", "ENTRY": "Plants, Hemp", "MN": "B01.875.800.575.912.250.859.937.055.500", "FX": "Marijuana Smoking", "MH_TH": "NLM (1966)", "ST": "T002", "RN": "txid3482", "RR": "txid3483", "MS": "The plant genus in the Cannabaceae plant family, Urticales order, Hamamelidae subclass. The flowering tops are called many slang terms including pot, marijuana, hashish, bhang, and ganja. The stem is an important source of hemp fiber.", "HN": "was in Cat B & D 1963-76", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002188"}, {"RECTYPE": "D", "MH": "Marijuana Abuse", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Marijuana Dependence|T048|NON|REL|NLM (1999)|980303|abcdef", "ENTRY": "Disorder, Cannabis-Related", "MN": "F03.900.635", "MH_TH": "NLM (1990)", "ST": "T048", "PI": "Substance Abuse (1968-1980)", "MS": "Use of marijuana associated with abnormal psychological, social, and or occupational functioning.", "OL": "use MARIJUANA ABUSE to search CANNABIS ABUSE 1981-89", "PM": "90; was CANNABIS ABUSE 1981-89", "HN": "90; was CANNABIS ABUSE 1981-89", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19800521", "DC": "1", "DX": "19810101", "UI": "D002189"}, {"RECTYPE": "D", "MH": "Cannibalism", "AQ": "EH HI PX", "ENTRY": "Cannibalisms", "MN": "F01.145.113.547.200", "MH_TH": "NLM (1977)", "ST": "T054", "AN": "animal and human", "MS": "Eating other individuals of one's own species.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D002190"}, {"RECTYPE": "D", "MH": "Canrenoic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Potassium Canrenoate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|760520|abbcdeef", "ENTRY": "SC14266", "MN": "D04.210.500.745.432.100", "PA": "Mineralocorticoid Receptor Antagonists", "MH_TH": "NLM (1996)", "ST": "T121", "RN": "87UG89VA9K", "RR": "M671F9NLEA", "PI": "Pregnadienes (1974)", "MS": "A synthetic pregnadiene derivative with anti-aldosterone activity.", "PM": "2014; see CANRENOATE POTASSIUM 1991-2014; see PREGNADIENES 1975-1990", "HN": "2014(1975)", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002191"}, {"RECTYPE": "D", "MH": "Canrenone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SC9376", "MN": "D04.210.500.745.432.120", "PA": "Mineralocorticoid Receptor Antagonists", "MH_TH": "USAN (1967)", "ST": "T121", "N1": "Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone, (17alpha)-", "RN": "78O20X9J0U", "RR": "976-71-6 (Canrenone)", "PI": "Pregnadienes (1974)", "MS": "A synthetic pregnadiene compound with anti-aldosterone activity.", "PM": "91; was see under PREGNADIENES 1975-90", "HN": "91(75); was see under PREGNADIENES 1975-90", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002192"}, {"RECTYPE": "D", "MH": "Cantharidin", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Cantharides|T204|NON|REL|UNK (19XX)|771005|abcdef", "ENTRY": "Cantharidine|T109|T121|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|771005|abbbcdeef", "MN": "D03.633.100.127.125", "PA": "Irritants", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "4,7-Epoxyisobenzofuran-1,3-dione, hexahydro-3a,7a-dimethyl-, (3aalpha,4beta,7beta,7aalpha)-", "RN": "IGL471WQ8P", "RR": "56-25-7 (Cantharidin)", "MS": "A toxic compound, isolated from the Spanish fly or blistering beetle (Lytta (Cantharis) vesicatoria) and other insects. It is a potent and specific inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). This compound can produce severe skin inflammation, and is extremely toxic if ingested orally.", "OL": "use CANTHARIDIN to search CANTHARIDES 1966-78", "PM": "79; was CANTHARIDES 1963-78", "HN": "79; was CANTHARIDES 1963-78", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D002193"}, {"RECTYPE": "D", "MH": "Capgras Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Syndrome, Capgras", "MN": "F03.700.300", "MH_TH": "NLM (1982)", "ST": "T048", "AN": "a psychosis wherein patient thinks familiar persons are doubles of themselves or imposters", "PI": "Psychoses (1966-1981)", "MS": "A psychotic disorder characterized by the patient's belief that acquaintances or closely related persons have been replaced by doubles or imposters.", "PM": "91; was see under PSYCHOTIC DISORDERS 1982-90", "HN": "91(82); was see under PSYCHOTIC DISORDERS 1982-90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D002194"}, {"RECTYPE": "D", "MH": "Capillaria", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Skrjabinocapillaria|T204|NON|EQV|NLM (2020)|190121|abcdef", "ENTRY": "Skrjabinocapillarias", "MN": "B01.050.500.500.294.100.275.780.180", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid119095", "RR": "txid1457282", "AN": "infection: coordinate with ENOPLIDA INFECTIONS; coordinate with specific precoordinated helminth terms (e.g., ANTIGENS, HELMINTH) if pertinent", "MS": "A genus of trichuroid nematodes parasitic in the liver and intestines of many mammals and birds. Two species, C. hepatica and C. philippinensis, produce often fatal infections in man.", "OL": "search TRICHUROIDEA 1966-74; use CAPILLARIA to search HEPATICOLA HEPATICA 1975-78 & use TRICHUROIDEA 1966-74", "PM": "91; was see under TRICHUROIDEA 1967-90, was see under TRICHINELLOIDEA 1963-66; HEPATICOLA HEPATICA was see under TRICHUROIDEA 1967-78, was see under TRICHINELLOIDEA 1963-66", "HN": "91(75); was see under TRICHUROIDEA 1967-90, was see under TRICHINELLOIDEA 1963-66; HEPATICOLA HEPATICA was see under TRICHUROIDEA 1967-78, was see under TRICHINELLOIDEA 1963-66", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002195"}, {"RECTYPE": "D", "MH": "Capillaries", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sinusoidal Bed", "MN": "A07.015.461.165", "FX": "Capillary Action", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "coordinate with specific organ /blood supply; LYMPHATIC CAPILLARIES is also available", "MS": "The minute vessels that connect arterioles and venules.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002196"}, {"RECTYPE": "D", "MH": "Capillary Action", "AQ": "DE RE", "PRINT ENTRY": "Capillarity|T070|NON|BRD|NLM (1966)|990101|abcdef", "ENTRY": "Capillarities", "MN": "G02.860.327", "FX": "Capillaries", "MH_TH": "NLM (2012)", "ST": "T070", "MS": "A phenomenon in which the surface of a liquid where it contacts a solid is elevated or depressed, because of the relative attraction of the molecules of the liquid for each other and for those of the solid. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "2012; see CAPILLARITY 1966-2011", "HN": "2012 (1966)", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "20120101", "UI": "D002197"}, {"RECTYPE": "D", "MH": "Capillary Fragility", "AQ": "DE ES GE IM PH RE", "ENTRY": "Fragility, Capillary", "MN": "G09.330.160", "MH_TH": "NLM (1968)", "ST": "T042", "PI": "Capillary Resistance (1966-1967)", "MS": "The susceptibility of CAPILLARIES, under conditions of increased stress, to leakage.", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D002198"}, {"RECTYPE": "D", "MH": "Capillary Permeability", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Vascular Permeability|T042|NON|BRD|NLM (1993)|911106|abcdef", "ENTRY": "Vascular Permeabilities", "MN": "G09.330.165", "FX": "Transendothelial and Transepithelial Migration", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "coord IM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM)", "MS": "The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement.", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002199"}, {"RECTYPE": "D", "MH": "Capillary Resistance", "AQ": "DE ES GE IM PH RE", "ENTRY": "Resistances, Capillary", "MN": "G09.330.380.921.327", "MH_TH": "NLM (1986)", "ST": "T042", "MS": "The vascular resistance to the flow of BLOOD through the CAPILLARIES portions of the peripheral vascular bed.", "PM": "91,63-85; was see under VASCULAR RESISTANCE 1986-90; was heading 1963-85", "HN": "91(86)63; was see under VASCULAR RESISTANCE 1986-90; was heading 1963-85", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002200"}, {"RECTYPE": "D", "MH": "Capital Expenditures", "AQ": "CL ES HI LJ SN ST TD", "ENTRY": "Expenditures, Capital", "MN": "N03.219.151.450.200", "MH_TH": "NLM (1977)", "ST": "T058", "AN": "not restricted to health care; usually NIM", "MS": "Those funds disbursed for facilities and equipment, particularly those related to the delivery of health care.", "PM": "91; was see under ECONOMICS Aug 1977-90", "HN": "91(Aug 77); was see under ECONOMICS 1977-90", "MR": "20180614", "DA": "19770512", "DC": "1", "DX": "19910101", "UI": "D002201"}, {"RECTYPE": "D", "MH": "Capital Financing", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Funding, Capital|T057|NON|EQV|UNK (19XX)|790529|abcdef", "ENTRY": "Capital Fundings", "MN": "N03.219.463.085", "MH_TH": "NLM (1980)", "ST": "T057", "PI": "Financial Management (1978-1979)", "MS": "Institutional funding for facilities and for equipment which becomes a part of the assets of the institution.", "PM": "91; was see under FINANCIAL MANAGEMENT 1980-90", "HN": "91(80); was see under FINANCIAL MANAGEMENT 1980-90", "MR": "19991103", "DA": "19790529", "DC": "1", "DX": "19910101", "UI": "D002202"}, {"RECTYPE": "D", "MH": "Capital Punishment", "AQ": "HI LJ MT SN TD", "PRINT ENTRY": "Electrocution, Judicial|T089|NON|NRW|NLM (1998)|960719|abcdef", "ENTRY": "Punishments, Capital", "MN": "I01.880.604.160", "MH_TH": "BIOETHICS (1989)", "ST": "T089", "AN": "entry term ELECTROCUTION, JUDICIAL: do not index also under the electricity aspect unless particularly discussed", "MS": "The use of the death penalty for certain crimes.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002203"}, {"RECTYPE": "D", "MH": "Capitation Fee", "AQ": "CL ES HI LJ OG SN ST TD", "PRINT ENTRY": "Fee, Capitation|T081|NON|EQV|UNK (19XX)|770505|abcdef", "ENTRY": "Fees, Capitation", "MN": "N03.219.442.090", "MH_TH": "NLM (1977)", "ST": "T081", "AN": "\"capitation\" refers to \"a fixed per capita amt without regard to no. or nature of serv provided\"", "MS": "A method of payment for health services in which an individual or institutional provider is paid a fixed, per capita amount without regard to the actual number or nature of services provided to each patient.", "PM": "91; was see under FEES AND CHARGES Aug 1977-90", "HN": "91(Aug 77); was see under FEES AND CHARGES 1977-90", "MR": "19970620", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D002204"}, {"RECTYPE": "D", "MH": "Caplan Syndrome", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Caplans Syndrome", "MN": "C24.800.340", "MH_TH": "NLM (2009)", "ST": "T047", "AN": "do not coordinate with OCCUPATIONAL DISEASES", "MS": "A condition characterized by the presence of RHEUMATOID ARTHRITIS associated with a specific form of pneumoconiosis, often in coal miners and asbestos workers.", "PM": "2009; see CAPLAN'S SYNDROME 1991-2008, see PNEUMOCONIOSIS 1984-1990, see CAPLAN'S SYNDROME 1963-1983", "HN": "2009 (1984); 1963-1983", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002205"}, {"RECTYPE": "D", "MH": "Capnocytophaga", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.450.340", "MH_TH": "NLM (1982)", "ST": "T007", "RN": "txid1016", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Cytophagaceae (1975-1981)", "MS": "A gram-negative gliding bacterium isolated from the oral cavity. It is a pathogen often causing PERIODONTITIS.", "PM": "91; was see under CYTOPHAGACEAE 1982-90", "HN": "91(82); was see under CYTOPHAGACEAE 1982-90", "MR": "20200813", "DA": "19810520", "DC": "1", "DX": "19910101", "UI": "D002206"}, {"RECTYPE": "D", "MH": "Capreomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Capreomycin Sulfate|T116|T195|NON|NRW|USAN (1962)|USP (19XX)|990101|abbcdeef", "ENTRY": "Capromycin|T116|T195|NON|EQV|NLM (1994)|920924|abbcdef", "MN": "D12.644.641.142", "PA": "Protein Synthesis Inhibitors", "MH_TH": "INN (19XX)", "ST": "T195", "RN": "11003-38-6", "RR": "1405-37-4", "PI": "Antitubercular Agents (1966-1971)", "MS": "Cyclic peptide antibiotic similar to VIOMYCIN. It is produced by Streptomyces capreolus.", "PM": "2009; see CAPREOMYCIN SULFATE 1996-2007, see CAPREOMYCIN 1974-1995; see CAPREOMYCIN 1978-1993", "HN": "2009(1996)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002207"}, {"RECTYPE": "D", "MH": "Caproates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hexanoates|T109|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Derivatives, Hexanoic Acid", "MN": "D10.251.400.326", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of caproic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a carboxy terminated six carbon aliphatic structure.", "PM": "1966; for HEXANOIC ACIDS see HEXANOIC ACIDS 1991-2012", "HN": "1966", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002208"}, {"RECTYPE": "D", "MH": "Caprolactam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aminocaproic Lactam|T130|T195|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Lactam, Aminocaproic", "MN": "D03.383.411.200", "MH_TH": "NLM (1975)", "ST": "T195", "N1": "2H-Azepin-2-one, hexahydro-", "RN": "6879X594Z8", "RR": "105-60-2 (Caprolactam)", "PI": "Azepines (1968-1974)", "MS": "Cyclic amide of caproic acid used in manufacture of synthetic fibers of the polyamide type. Can cause local irritation.", "PM": "91; was see under AZEPINES 1975-90", "HN": "91(75); was see under AZEPINES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002209"}, {"RECTYPE": "D", "MH": "Caprylates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Octanoates|T109|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Acids, Octanoic", "MN": "D10.251.122", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of caprylic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a carboxy terminated eight carbon aliphatic structure.", "PM": "1966; for OCTANOIC ACIDS see OCTANOIC ACIDS 1976-2013", "HN": "1966", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002210"}, {"RECTYPE": "D", "MH": "Capsaicin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NGX4010", "MN": "D10.251.355.325.190", "PA": "Sensory System Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (E)-", "RN": "S07O44R1ZM", "RR": "404-86-4 (Capsaicin)", "PI": "Fatty Acids, Unsaturated (1973-1974)", "MS": "An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS.", "PM": "1984; see FATTY ACIDS, UNSATURATED 1975-1983; NGX-4010 was indexed under CAPSAICIN 2009", "HN": "1984(1975)", "MR": "20180630", "DA": "19741127", "DC": "1", "DX": "19840101", "UI": "D002211"}, {"RECTYPE": "D", "MH": "Capsicum", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Red Pepper|T002|T168|NON|REL|NLM (1998)|961107|abbcdef", "ENTRY": "Sweet Peppers", "MN": "B01.875.800.575.912.250.908.500.145", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid4071", "RR": "txid4072", "AN": "BLACK PEPPER and WHITE PEPPER see PIPER NIGRUM  are also available", "MS": "A plant genus of the family SOLANACEAE. The hot peppers yield CAPSAICIN, which activates VANILLOID RECEPTORS. Several varieties have sweet or pungent edible fruits that are used as vegetables when fresh and spices when the pods are dried.", "PM": "91,63-85; was see under PLANTS, EDIBLE 1986-90; was heading 1963-85", "HN": "91(86)63; was see under PLANTS, EDIBLE 1986-90; was heading 1963-85", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002212"}, {"RECTYPE": "D", "MH": "Capsid", "AQ": "CH CL DE EN IM ME PA PH RE UL", "PRINT ENTRY": "Prohead|T017|NON|REL|NLM (2021)|200527|abcdef", "ENTRY": "Proheads", "MN": "A21.249.500.250", "MH_TH": "NLM (1975)", "ST": "T017", "AN": "CAPSID PROTEINS is also available", "PI": "Viral Proteins (1968-1974)", "MS": "The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape.", "PM": "84; was see under VIRAL PROTEINS 1975-83", "HN": "84(75); was see under VIRAL PROTEINS 1975-83", "MR": "20200723", "DA": "19741111", "DC": "1", "DX": "19840101", "UI": "D002213"}, {"RECTYPE": "D", "MH": "Capsules", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Microcapsules|T122|NON|NRW|UNK (19XX)|840223|abcdef", "MN": "D26.255.150", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "AN": "IM for general only; NIM (no qualif) with specific drug IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in capsule form, not the capsule; note entry term MICROCAPSULES: do not confuse with MICROENCAPSULATION see DRUG COMPOUNDING", "MS": "Hard or soft soluble containers used for the oral administration of medicine.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002214"}, {"RECTYPE": "D", "MH": "Captan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "N Trichloromethylthio 4 cyclohexane 1,2 dicarboximide", "MN": "D03.633.100.513.124", "PA": "Fungicides, Industrial", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "1H-Isoindole-1,3(2H)-dione, 3a,4,7,7a-tetrahydro-2-((trichloromethyl)thio)-", "RN": "EOL5G26Q9F", "RR": "133-06-2 (Captan)", "PI": "Pesticides (1966-1971)", "MS": "One of the phthalimide fungicides.", "PM": "74", "HN": "74(72)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002215"}, {"RECTYPE": "D", "MH": "Captopril", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SQ14534", "MN": "D12.125.072.401.623.270", "PA": "Antihypertensive Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "L-Proline, 1-(3-mercapto-2-methyl-1-oxopropyl)-, (S)-", "RN": "9G64RSX1XD", "RR": "63250-36-2 ((R)-isomer)", "PI": "Proline (1966-1974) /antagonists & inhibitors (1975-1979)", "MS": "A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.", "OL": "use CAPTOPRIL to search SQ 14225 1980-93", "PM": "86; was see under PROLINE 1980-85; SQ 14225 was see CAPTOPRIL 1980-93", "HN": "86(80); was see under PROLINE 1980-85; SQ 14225 was see CAPTOPRIL 1980-93", "MR": "20130708", "DA": "19790523", "DC": "1", "DX": "19860101", "UI": "D002216"}, {"RECTYPE": "D", "MH": "Carbachol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbamylcholine|T109|T121|NON|BRD|UNK (19XX)|741217|abbcdef", "ENTRY": "Carbachol, Isopto", "MN": "D02.675.276.232.115", "PA": "Miotics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Ethanaminium, 2-((aminocarbonyl)oxy)-N,N,N-trimethyl-, chloride", "RN": "8Y164V895Y", "RR": "54Z8M50D6Q", "MS": "A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002217"}, {"RECTYPE": "D", "MH": "Carbadox", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Mecadox|T109|T121|T131|TRD|NRW|UNK (19XX)|801205|abbbcdef", "MN": "D03.633.100.857.140", "PA": "Mutagens", "MH_TH": "USAN (1968)", "ST": "T131", "N1": "Hydrazinecarboxylic acid, (2-quinoxalinylmethylene)-, methyl ester, N,N'-dioxide", "RN": "M2X04R2E2Y", "RR": "6804-07-5 (Carbadox)", "PI": "Quinoxalines (1973-1974)", "MS": "An antibacterial agent that has been used in veterinary practice for treating swine dysentery and enteritis and for promoting growth. However, its use has been prohibited in the UK following reports of carcinogenicity and mutagenicity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p125)", "PM": "91; was see under QUINOXALINES 1975-90", "HN": "91(75); was see under QUINOXALINES 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002218"}, {"RECTYPE": "D", "MH": "Carbamates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbamate|T109|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Acids, Carbamic", "MN": "D02.241.081.251", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of carbamic acid, H2NC(=O)OH. Included under this heading are N-substituted and O-substituted carbamic acids. In general carbamate esters are referred to as urethanes, and polymers that include repeating units of carbamate are referred to as POLYURETHANES. Note however that polyurethanes are derived from the polymerization of ISOCYANATES and the singular term URETHANE refers to the ethyl ester of carbamic acid.", "OL": "use CARBAMATES to search TYBAMATE 1966-84 (as Prov 1966-72)", "PM": "TYBAMATE was heading 1973-84", "HN": "TYBAMATE was heading 1965-84 (Prov 1965-72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D002219"}, {"RECTYPE": "D", "MH": "Carbamazepine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tegretol|T109|T121|TRD|NRW|UNK (19XX)|820203|abbcdef", "MN": "D03.633.300.240.127", "PA": "Cytochrome P-450 CYP3A Inducers", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "5H-Dibenz(b,f)azepine-5-carboxamide", "RN": "33CM23913M", "RR": "78M1RMW7Q8", "PI": "Azepines (1966-1967)", "MS": "A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.", "PM": "1972", "HN": "1972 (1968)", "MR": "20180521", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002220"}, {"RECTYPE": "D", "MH": "Carbamyl Phosphate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phosphate, Dilithium Carbamyl", "MN": "D02.705.400.100", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Carbamic acid, monoanhydride with phosphoric acid", "RN": "590-55-6", "PI": "Organophosphorus Compounds (1973-1974)", "MS": "The monoanhydride of carbamic acid with PHOSPHORIC ACID. It is an important intermediate metabolite and is synthesized enzymatically by CARBAMYL-PHOSPHATE SYNTHASE (AMMONIA) and CARBAMOYL-PHOSPHATE SYNTHASE (GLUTAMINE-HYDROLYZING).", "PM": "91; was see under CARBAMATES 1975-90", "HN": "91(75); was see under CARBAMATES 1975-90", "MR": "20120703", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002221"}, {"RECTYPE": "D", "MH": "Carbamoyl-Phosphate Synthase (Ammonia)", "DE": "AMMONIA CP SYNTHASE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carbamoyl Phosphate Synthetase I|T116|T126|NON|EQV|NLM (2000)|991108|abbcdef", "ENTRY": "Synthetase I, Carbamoylphosphate", "MN": "D08.811.464.259.350", "FX": "Carbamoyl-Phosphate Synthase I Deficiency Disease", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Carbon dioxide:ammonia ligase (ADP-forming, carbamate-phosphorylating)", "RN": "EC 6.3.4.16", "RR": "9026-23-7 (CAS RN)", "AN": "/defic: consider CARBAMOYL-PHOSPHATE SYNTHETASE I DEFICIENCY DISEASE", "PI": "Phosphotransferases, ATP (1974)", "MS": "An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and ammonia. This enzyme is specific for arginine biosynthesis or the urea cycle. Absence or lack of this enzyme may cause CARBAMOYL-PHOSPHATE SYNTHASE I DEFICIENCY DISEASE. EC 6.3.4.16.", "PM": "98; see CARBAMYL PHOSPHATE SYNTHASE (AMMONIA) 1989-97; see LIGASES 1981-88; see PHOSPHOTRANSFERASES, ATP 1975-80", "HN": "98(75)", "MR": "20160628", "DA": "19741119", "DC": "1", "DX": "19890101", "UI": "D002222"}, {"RECTYPE": "D", "MH": "Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing)", "DE": "GLUTAMINE CP SYNTHASE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carbamyl Phosphate Synthase (Glutamine)|T116|T126|NON|EQV|NLM (1998)|961105|abbcdef", "ENTRY": "Synthetase II, Carbamoylphosphate", "MN": "D08.811.464.259.400.300", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Carbon dioxide:L-glutamine amido-ligase (ADP-forming, carbamate-phosphorylating)", "RN": "EC 6.3.5.5", "RR": "37233-48-0 (CAS RN)", "PI": "Phosphotransferases, ATP (1974)", "MS": "An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and glutamine. This enzyme is important in the de novo biosynthesis of pyrimidines. EC 6.3.5.5.", "PM": "98; see CARBAMYL PHOSPHATE SYNTHASE (GLUTAMINE) 1989-97; see LIGASES 1981-88; see PHOSPHOTRANSFERASES, ATP 1975-80", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19890101", "UI": "D002223"}, {"RECTYPE": "D", "MH": "Carbanilides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diphenylurea Compounds|T109|NON|EQV|UNK (19XX)|770401|DIPHENYLUREA CPDS|abcdefv", "ENTRY": "Compounds, Diphenylurea", "MN": "D02.455.426.559.389.703.202", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Urea (1970-1971)", "MS": "Compounds consisting of two phenyl groups joined by a urea. Derivatives may be used as ANTIPARASITIC AGENTS.", "PM": "74", "HN": "74(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002224"}, {"RECTYPE": "D", "MH": "Carbazilquinone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carboquone|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|790606|abbcdeef", "ENTRY": "Esquinon|T109|T121|TRD|NRW|UNK (19XX)|831020|abbcdef", "MN": "D03.383.097.217.300", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "2,5-Cyclohexadiene-1,4-dione, 2-(2-((aminocarbonyl)oxy)-1-methoxyethyl)-3,6-bis(1-aziridinyl)-5-methyl-", "RN": "1CB0HBT12C", "RR": "24279-91-2 (Carbazilquinone)", "PI": "Quinones (1972-1974)", "MS": "An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.", "PM": "91; was see under AZIRINES 1975-90", "HN": "91(75); was see under AZIRINES 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002225"}, {"RECTYPE": "D", "MH": "Carbazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.148", "MH_TH": "NLM (1969)", "ST": "T109", "RN": "0", "PI": "Azoles (1966-1968)", "MS": "Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.", "OL": "search AZOLES 1966-68", "PM": "69; was see under AZOLES 1963-68", "HN": "69; was see under AZOLES 1963-68", "MR": "20190222", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D002227"}, {"RECTYPE": "D", "MH": "Carbenicillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carboxybenzyl Penicillin|T109|T195|NON|EQV|UNK (19XX)|790606|abbcdef", "ENTRY": "Penicillin, Carboxybenzyl", "MN": "D03.633.100.300.750.750.170", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxyphenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-", "RN": "G42ZU72N5G", "RR": "9TS4B3H261", "PI": "Penicillins (1966-1970)", "MS": "Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function.", "PM": "73", "HN": "73(71)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002228"}, {"RECTYPE": "D", "MH": "Carbenoxolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbenoxalone|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Glycyrrhetinic Acid 3 O hemisuccinate", "MN": "D02.455.849.919.530.444.250", "PA": "Anti-Ulcer Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Olean-12-en-29-oic acid, 3-(3-carboxy-1-oxopropoxy)-11-oxo-, (3beta,20beta)-", "RN": "MM6384NG73", "RR": "F1MP7242Z5", "AN": "/biosyn permitted if by plant", "PI": "Triterpenes (1974)", "MS": "An agent derived from licorice root. It is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity.", "PM": "1991; see GLYCYRRHETINIC ACID 1979-1990, see TRITERPENES 1975-1978; for 18ALPHA-CARBENOXOLONE was indexed under CARBENOXOLONE (NM) 1995-2002", "HN": "1991(1975); for 18ALPHA-CARBENOXOLONE use CARBENOXOLONE (NM) 1995-2002", "MR": "20160701", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002229"}, {"RECTYPE": "D", "MH": "Carbidopa", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methyldopahydrazine|T109|T121|NON|EQV|UNK (19XX)|790530|abbcdef", "ENTRY": "MK486", "MN": "D02.455.426.559.389.657.166.175.200.538.200", "PA": "Dopamine Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate, (S)-", "RN": "MNX7R8C5VO", "RR": "38821-49-7 (Carbidopa)", "PI": "Methyldopa (1972-1974)", "MS": "An inhibitor of DOPA DECARBOXYLASE that prevents conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no anti-parkinson activity by itself.", "OL": "use CARBIDOPA to search METHYLDOPAHYDRAZINE 1973-79 (as Prov 1973-74)", "PM": "80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79", "HN": "80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79; was METHYLDOPAHYDRAZINE 1973-74 (Prov)", "MR": "20180619", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D002230"}, {"RECTYPE": "D", "MH": "Carbimazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Neomercazole|T109|T121|TRD|NRW|NLM (1998)|961112|abbcdef", "MN": "D03.383.129.308.108", "PA": "Antithyroid Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester", "RN": "8KQ660G60G", "RR": "22232-54-8 (Carbimazole)", "PI": "Thyroid Antagonists (1966-1967)", "MS": "An imidazole antithyroid agent. Carbimazole is metabolized to METHIMAZOLE, which is responsible for the antithyroid activity.", "PM": "73", "HN": "73(68)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002231"}, {"RECTYPE": "D", "MH": "Carbocyanines", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Carbocyanine|T109|T130|NON|EQV|NLM (2021)|191119|abbcdef", "MN": "D02.455.326.397.300", "PA": "Coloring Agents", "MH_TH": "NLM (1976)", "ST": "T130", "RN": "0", "PI": "Quinolines (1972-1975)", "MS": "Compounds that contain three methine groups. They are frequently used as cationic dyes used for differential staining of biological materials.", "PM": "91; was see under QUINOLINES 1976-90", "HN": "91(76); was see under QUINOLINES 1976-90", "MR": "20200527", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D002232"}, {"RECTYPE": "D", "MH": "Carbocysteine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "S Carboxymethylcysteine", "MN": "D12.125.166.230.310", "PA": "Expectorants", "MH_TH": "USAN (1975)", "ST": "T121", "N1": "Cysteine, S-(carboxymethyl)-", "RN": "740J2QX53R", "RR": "2387-59-9 (Carbocysteine)", "PI": "Amino Acids, Sulfur (1974)", "MS": "A compound formed when iodoacetic acid reacts with sulfhydryl groups in proteins. It has been used as an anti-infective nasal spray with mucolytic and expectorant action.", "OL": "use CARBOCYSTEINE to search CARBOXYMETHYLCYSTEINE 1975-79", "PM": "91; was see under CYSTEINE 1980-90; was CARBOXYMETHYLCYSTEINE see under CYSTEINE 1975-79", "HN": "91(80); was see under CYSTEINE 1980-90; was CARBOXYMETHYLCYSTEINE see under CYSTEINE 1975-79", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002233"}, {"RECTYPE": "D", "MH": "Carbodiimides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbodiimide|T109|NON|EQV|NLM (2021)|191118|abcdef", "MN": "D02.491.203", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "AN": "do not confuse CARBODIIMIDES (a group term) with \"carbodiimide\" (a specific chemical)", "PI": "Imines (1966-1972)", "MS": "Compounds with the general formula RN=C=NR, where R is a hydrocarbyl group.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002234"}, {"RECTYPE": "D", "MH": "Carbofuran", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NIA10242", "MN": "D02.241.081.251.583.166", "PA": "Insecticides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "7-Benzofuranol, 2,3-dihydro-2,2-dimethyl-, methylcarbamate", "RN": "SKF77S6Y67", "RR": "1563-66-2 (Carbofuran)", "PI": "Insecticides (1966-1971)", "MS": "A cholinesterase inhibitor that is used as a systemic insecticide, an acaricide, and nematocide. (From Merck Index, 11th ed)", "PM": "91; was see under INSECTICIDES, CARBAMATE 1972-90", "HN": "91(72); was see under INSECTICIDES, CARBAMATE 1972-90", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002235"}, {"RECTYPE": "D", "MH": "Carbohydrate Conformation", "DE": "CARB CONFORMATION", "AQ": "DE RE", "PRINT ENTRY": "Carbohydrate Linkage|T078|NON|REL|UNK (19XX)|790524|abcdef", "ENTRY": "Linkages, Carbohydrate", "MN": "G02.111.570.820.235", "MH_TH": "NLM (1980)", "ST": "T082", "PI": "Molecular Conformation (1973-1979)", "MS": "The characteristic 3-dimensional shape of a carbohydrate.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19790524", "DC": "1", "DX": "19800101", "UI": "D002236"}, {"RECTYPE": "D", "MH": "Carbohydrate Dehydrogenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carbohydrate Oxidoreductases|T116|T126|NON|EQV|UNK (19XX)|770329|abbcdef", "ENTRY": "Oxidoreductases, Carbohydrate", "MN": "D08.811.682.047.150", "MH_TH": "NLM (1978)", "ST": "T126", "RN": "EC 1.1.-", "PI": "Alcohol Oxidoreductases (1966-1977)", "MS": "Reversibly catalyze the oxidation of a hydroxyl group of carbohydrates to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.; EC 1.1.2.; and 1.1.99.", "PM": "78; FRUCTURONATE REDUCTASE, PHOSPHOGLYCERATE DEHYDROGENASE, TAGATURONATE REDUCTASE & URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE were see under ALCOHOL OXIDOREDUCTASES 1975-77", "HN": "78", "MR": "20060705", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D002237"}, {"RECTYPE": "D", "MH": "Carbohydrate Epimerases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carbohydrate Isomerases|T116|T126|NON|EQV|NLM (1998)|970411|abbcdef", "ENTRY": "Isomerases, Carbohydrate", "MN": "D08.811.399.894.500", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 5.1.3.-", "PI": "Isomerases (1966-1972)", "MS": "Enzymes that catalyze the epimerization of chiral centers within carbohydrates or their derivatives. EC 5.1.3.", "PM": "73", "HN": "73", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002238"}, {"RECTYPE": "D", "MH": "Carbohydrate Metabolism, Inborn Errors", "DE": "CARB METAB INBORN ERR", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Carbohydrate Metabolism, Inborn Error|T047|NON|EQV|NLM (1991)|900524|CARBOHYDRATE METAB INBORN ERR|abcdefv", "MN": "C18.452.648.202", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "coordinate with specific carbohydrate /metab but note specifics", "MS": "Dysfunctions of CARBOHYDRATE METABOLISM resulting from inborn genetic mutations that are inherited or acquired in utero.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002239"}, {"RECTYPE": "D", "MH": "Carbohydrate Sequence", "DE": "CARB SEQ", "AQ": "DE GE PH RE", "ENTRY": "Sequences, Carbohydrate", "MN": "L01.462.750.245.667.160", "MH_TH": "NLM (1980)", "ST": "T088", "MS": "The sequence of carbohydrates within POLYSACCHARIDES; GLYCOPROTEINS; and GLYCOLIPIDS.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19790524", "DC": "1", "DX": "19800101", "UI": "D002240"}, {"RECTYPE": "D", "MH": "Carbohydrates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Carbohydrate|T109|NON|EQV|NLM (2017)|160412|abcdef", "MN": "D09", "RH": "D9 - CARBOHYDRATES", "FX": "Dietary Carbohydrates", "EC": "metabolism:Carbohydrate Metabolism", "MH_TH": "NLM (1994)", "ST": "T109", "RN": "0", "MS": "A class of organic compounds composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n. The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES.", "PM": "/metabolism was CARBOHYDRATE METABOLISM 1963-65", "HN": "/metabolism was CARBOHYDRATE METABOLISM 1963-65", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D002241"}, {"RECTYPE": "D", "MH": "Carbolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrido(4,3-b)Indole|T109|NON|EQV|NLM (2021)|191231|abcdef", "ENTRY": "Beta Carbolines", "MN": "D03.633.300.154", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Pyridines (1969-1974)", "MS": "A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles.", "PM": "86; was see under INDOLES 1975-85", "HN": "86(75); was see under INDOLES 1975-85", "MR": "20210628", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D002243"}, {"RECTYPE": "D", "MH": "Carbon", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Carbon, Vitreous", "MN": "D01.268.150", "FX": "Carbon Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Carbon", "RN": "7440-44-0", "MS": "A nonmetallic element with atomic symbol C, atomic number 6, and atomic weight [12.0096; 12.0116]. It may occur as several different allotropes including DIAMOND; CHARCOAL; and GRAPHITE; and as SOOT from incompletely burned fuel.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002244"}, {"RECTYPE": "D", "MH": "Carbon Dioxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbonic Anhydride|T123|T197|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Dioxide, Carbon", "MN": "D01.650.550.200", "FX": "Hypocapnia", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Carbon dioxide", "RN": "142M471B3J", "RR": "124-38-9 (Carbon Dioxide)", "MS": "A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002245"}, {"RECTYPE": "D", "MH": "Carbon Disulfide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Disulfide, Carbon", "MN": "D01.875.350.850.074", "MH_TH": "NLM (1966)", "ST": "T197", "N1": "Carbon disulfide", "RN": "S54S8B99E8", "RR": "75-15-0 (Carbon Disulfide)", "MS": "A colorless, flammable, poisonous liquid, CS2. It is used as a solvent, and is a counterirritant and has local anesthetic properties but is not used as such. It is highly toxic with pronounced CNS, hematologic, and dermatologic effects.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002246"}, {"RECTYPE": "D", "MH": "Carbon Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbon Isotope|T196|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Isotopes, Carbon", "MN": "D01.496.123", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable carbon atoms that have the same atomic number as the element carbon but differ in atomic weight. C-13 is a stable carbon isotope.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002247"}, {"RECTYPE": "D", "MH": "Carbon Monoxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PH PK RE SD ST TO TU UR", "ENTRY": "Monoxide, Carbon", "MN": "D01.650.550.250", "PA": "Gasotransmitters", "EC": "poisoning:Carbon Monoxide Poisoning", "MH_TH": "USAN (19XX)", "ST": "T197", "N1": "CO", "RN": "7U1EE4V452", "RR": "630-08-0 (Carbon Monoxide)", "AN": "a poisonous gas; /tox permitted but consider also CARBON MONOXIDE POISONING", "MS": "Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002248"}, {"RECTYPE": "D", "MH": "Carbon Monoxide Poisoning", "DE": "CARBON MONOXIDE POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Illuminating Gas Poisoning|T037|NON|NRW|UNK (19XX)|771205|ILLUMINATING GAS POIS|abcdefv", "ENTRY": "Poisonings, Illuminating Gas", "MN": "C25.723.455.245", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Toxic asphyxiation due to the displacement of oxygen from oxyhemoglobin by carbon monoxide.", "OL": "use CARBON MONOXIDE POISONING to search ILLUMINATING GAS POISONING 1969-78", "HN": "ILLUMINATING GAS POISONING was see under CARBON MONOXIDE POISONING 1969-78", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D002249"}, {"RECTYPE": "D", "MH": "Carbon Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Carbon", "MN": "D01.496.749.154", "MH_TH": "NLM (1974)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "MS": "Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes.", "OL": "search CARBON ISOTOPES 1966-73", "PM": "74", "HN": "74", "MR": "20170424", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002250"}, {"RECTYPE": "D", "MH": "Carbon Tetrachloride", "DE": "CCL4", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Tetrachloride, Carbon", "MN": "D02.455.526.439.150", "EC": "poisoning:Carbon Tetrachloride Poisoning", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Methane, tetrachloro-", "RN": "CL2T97X0V0", "RR": "56-23-5 (Carbon Tetrachloride)", "AN": "/tox permitted but consider also CARBON TETRACHLORIDE POISONING", "MS": "A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002251"}, {"RECTYPE": "D", "MH": "Carbon Tetrachloride Poisoning", "DE": "CARBON TETRACHLORIDE POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Poisonings, Carbon Tetrachloride", "MN": "C25.723.177", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Poisoning that results from ingestion, injection, inhalation, or skin absorption of CARBON TETRACHLORIDE.", "CATSH": "CAT LIST", "MR": "20160119", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002252"}, {"RECTYPE": "D", "MH": "Carbonated Beverages", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "ENTRY": "Soft Drink", "MN": "J02.200.300", "MH_TH": "NLM (1975)", "ST": "T168", "MS": "Drinkable liquids combined with or impregnated with CARBON DIOXIDE.", "OL": "search BEVERAGES 1966-74", "PM": "91; was see under BEVERAGES 1975-90", "HN": "91(75); was see under BEVERAGES 1975-90", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002253"}, {"RECTYPE": "D", "MH": "Carbonates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbonate|T197|NON|EQV|NLM (2021)|200106|abcdef", "MN": "D01.248.497.158.165", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Salts or ions of the theoretical carbonic acid, containing the radical CO2(3-). Carbonates are readily decomposed by acids. The carbonates of the alkali metals are water-soluble; all others are insoluble. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002254"}, {"RECTYPE": "D", "MH": "Carbonic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Carbonic", "MN": "D01.200.275", "MH_TH": "NLM (1975)", "ST": "T197", "N1": "Carbonic acid", "RN": "463-79-6", "AN": "\"the hypothetical acid of carbon dioxide & water\"", "MS": "Carbonic acid (H2C03). The hypothetical acid of carbon dioxide and water. It exists only in the form of its salts (carbonates), acid salts (hydrogen carbonates), amines (carbamic acid), and acid chlorides (carbonyl chloride). (From Grant & Hackh's Chemical Dictionary, 5th ed)", "OL": "search CARBON DIOXIDE 1966-74", "PM": "91; was see under CARBONATES 1975-90; was see under CARBON DIOXIDE 1963-74", "HN": "91(75); was see under CARBONATES 1975-90; was see under CARBON DIOXIDE 1963-74", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002255"}, {"RECTYPE": "D", "MH": "Carbonic Anhydrases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carbonic Anhydrase|T116|T126|NON|EQV|NLM (1992)|910312|abbcdef", "ENTRY": "Dehydratase, Carbonate", "MN": "D08.811.520.241.300.150", "EC": "antagonists & inhibitors:Carbonic Anhydrase Inhibitors", "MH_TH": "NLM (2002)", "ST": "T126", "N1": "Carbonate hydro-lyase", "RN": "EC 4.2.1.1", "RR": "9001-03-0 (CAS RN)", "AN": "note specifics", "MS": "A family of zinc-containing enzymes that catalyze the reversible hydration of carbon dioxide. They play an important role in the transport of CARBON DIOXIDE from the tissues to the LUNG. EC 4.2.1.1.", "PM": "2002; see CARBONATE DEHYDRATASE 1992-2001, see CARBONIC ANHYDRASE 1963-1991", "HN": "2002(1963)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D002256"}, {"RECTYPE": "D", "MH": "Carbonic Anhydrase Inhibitors", "DE": "CARBONIC ANHYDRASE INHIB", "DS": "CARBONIC ANHYDRASE Z INHIBITORS", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carboxyanhydrase Inhibitor|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Inhibitors, Carboxyanhydrase", "MN": "D27.505.519.389.200", "MH_TH": "NLM (1964)", "ST": "T121", "RN": "0", "MS": "A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES.", "PM": "65", "HN": "65(64)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002257"}, {"RECTYPE": "D", "MH": "Carbonyl Cyanide m-Chlorophenyl Hydrazone", "DS": "CARBONYL CYANIDE CHLOROPHENYL HYDRAZONE M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Propanedinitrile, ((3-chlorophenyl)hydrazono)-|T109|T130|NON|EQV|NLM (2022)|210317|abbcdef", "ENTRY": "Carbonylcyanide 4 Chlorophenylhydrazone", "MN": "D02.626.260", "PA": "Proton Ionophores", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "555-60-2", "RR": "946-76-9", "PI": "Nitriles (1970-1974)", "MS": "A proton ionophore. It is commonly used as an uncoupling agent and inhibitor of photosynthesis because of its effects on mitochondrial and chloroplast membranes.", "PM": "1991; see NITRILES 1975-1990", "HN": "1991(1975)", "MR": "20210520", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002258"}, {"RECTYPE": "D", "MH": "Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone", "DS": "CARBONYL CYANIDE TRIFLUOROMETHOXYPHENYLHYDRAZONE P", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "FCCP|T109|T121|ABB|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "para-Trifluoromethoxyphenylhydrazone, Carbonyl Cyanide", "MN": "D02.626.270", "PA": "Proton Ionophores", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Propanedinitrile, ((4-(trifluoromethoxy)phenyl)hydrazono)-", "RN": "370-86-5", "PI": "Nitriles (1973-1974)", "MS": "A proton ionophore that is commonly used as an uncoupling agent in biochemical studies.", "PM": "91; was see under NITRILES 1975-90", "HN": "91(75); was see under NITRILES 1975-90", "MR": "20110624", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002259"}, {"RECTYPE": "D", "MH": "Carboprost", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "15-Methylprostaglandin F2alpha|T109|T121|NON|EQV|UNK (19XX)|790523|METHYLPROSTAGLANDIN F2ALPHA A 15|abbcdefs", "ENTRY": "15 Methylprostaglandin F2alpha", "MN": "D23.469.700.670.150", "PA": "Oxytocics", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5Z,9alpha,11alpha,13E,15S)-", "RN": "7B5032XT6O", "RR": "35700-23-3 (Carboprost)", "PI": "Prostaglandins, Synthetic (1977)", "MS": "A nonsteroidal abortifacient agent that is effective in both the first and second trimesters of PREGNANCY.", "OL": "use CARBOPROST to search METHYLDINOPROST & 15-METHYLPROSTAGLANDIN F2ALPHA METHYL ESTER 1980-93", "PM": "91; was see under PROSTAGLANDINS F, SYNTHETIC 1980-90; METHYLDINOPROST & 15-METHYLPROSTAGLANDIN F2ALPHA METHYL ESTER were see CARBOPROST 1980-93", "HN": "91(80); was see under PROSTAGLANDINS F, SYNTHETIC 1980-90; METHYLDINOPROST & 15-METHYLPROSTAGLANDIN F2ALPHA METHYL ESTER were see CARBOPROST 1980-93", "MR": "20150608", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D002260"}, {"RECTYPE": "D", "MH": "Carboxin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "D735", "MN": "D03.383.517.200", "PA": "Fungicides, Industrial", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "1,4-Oxathiin-3-carboxamide, 5,6-dihydro-2-methyl-N-phenyl-", "RN": "5A8K850HDE", "RR": "5234-68-4 (Carboxin)", "PI": "Oxathiins (1972-1974)", "MS": "A systemic agricultural fungicide and seed treatment agent.", "PM": "91; was see under ANILIDES 1975-90", "HN": "91(75); was see under ANILIDES 1975-90", "MR": "20160426", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002261"}, {"RECTYPE": "D", "MH": "Carboxy-Lyases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Decarboxylases|T116|T126|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Carboxy Lyases", "MN": "D08.811.520.224.125", "MH_TH": "NLM (1964)", "ST": "T126", "RN": "EC 4.1.1.-", "MS": "Enzymes that catalyze the addition of a carboxyl group to a compound (carboxylases) or the removal of a carboxyl group from a compound (decarboxylases). EC 4.1.1.", "OL": "use CARBOXY-LYASES & LIGASES to search CARBOXYLASES 1966-74", "PM": "64; was DECARBOXYLASES 1963; CARBOXYLASES was see under CARBOXY-LYASES & LIGASES 1964-74, was heading 1963", "HN": "64; was DECARBOXYLASES 1963; CARBOXYLASES was see under CARBOXY-LYASES & LIGASES 1964-74, was heading 1963", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D002262"}, {"RECTYPE": "D", "MH": "Carboxyhemoglobin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carbomonoxyhemoglobin|T116|T123|NON|EQV|UNK (19XX)|800624|abbcdef", "ENTRY": "Carboxyhemoglobin C|T116|T123|NON|NRW|UNK (19XX)|830914|abbcdef", "MN": "D12.776.422.316.762.149", "MH_TH": "NLM (1973)", "ST": "T123", "N1": "Hemoglobins, carbonyl-", "RN": "9061-29-4", "PM": "87; was see under HEMOGLOBINS 1975-86", "HN": "87(73); was see under HEMOGLOBINS 1975-86", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D002263"}, {"RECTYPE": "D", "MH": "Carboxylic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carboxylic Acid|T109|NON|EQV|NLM (2021)|191227|abcdef", "ENTRY": "Acids, Carboxylic", "MN": "D02.241", "MH_TH": "POPLINE (1984)", "ST": "T109", "RN": "0", "AN": "do not confuse with CARBOCYCLIC ACIDS see ACIDS, CARBOCYCLIC", "PI": "Fatty Acids (1966-1970)", "MS": "Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic.", "PM": "73", "HN": "73(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002264"}, {"RECTYPE": "D", "MH": "Carboxylic Ester Hydrolases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carboxylesterases|T116|T126|NON|EQV|UNK (19XX)|750715|abbcdef", "ENTRY": "Hydrolases, Carboxylic Ester", "MN": "D08.811.277.352.100", "MH_TH": "NLM (1976)", "ST": "T126", "RN": "EC 3.1.1.-", "PI": "Esterases (1972-1975)", "MS": "Enzymes which catalyze the hydrolysis of carboxylic acid esters with the formation of an alcohol and a carboxylic acid anion.", "PM": "76; ALDONOLACTONASE, CHOLESTEROL ESTERASE, DEHYDROASCORBATASE, MONOACYLGLYCEROL LIPASES & NAPHTHOL AS D ESTERASE were see under ESTERASES 1975", "HN": "76", "MR": "20060705", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D002265"}, {"RECTYPE": "D", "MH": "Carboxymethylcellulose Sodium", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Carboxymethylcellulose|T109|NON|BRD|NLM (1975)|990101|abcdef", "ENTRY": "Sodium, Croscarmellose", "MN": "D09.698.365.180.663.329", "PA": "Laxatives", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "K679OBS311", "RR": "9004-32-4", "PI": "Methylcellulose (1966-1974)", "MS": "A cellulose derivative which is a beta-(1,4)-D-glucopyranose polymer. It is used as a bulk laxative and as an emulsifier and thickener in cosmetics and pharmaceuticals and as a stabilizer for reagents.", "OL": "search METHYLCELLULOSE 1966-74", "PM": "91; was see under METHYLCELLULOSE 1975-90", "HN": "91(75); was see under METHYLCELLULOSE 1975-90", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002266"}, {"RECTYPE": "D", "MH": "Muramoylpentapeptide Carboxypeptidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carboxypeptidase Transpeptidase|T116|T126|NON|EQV|NLM (1997)|951213|abbcdef", "ENTRY": "Transpeptidase, Carboxypeptidase", "MN": "D08.811.277.656.350.245.500", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.4.17.8", "PI": "Peptidoglycan (1974)", "MS": "Enzyme which catalyzes the peptide cross-linking of nascent CELL WALL; PEPTIDOGLYCAN.", "PM": "97; was CARBOXYPEPTIDASE TRANSPEPTIDASE 1975-96 (see under CARBOXYPEPTIDASES 1975-86); MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE was see CARBOXYPEPTIDASE TRANSPEPTIDASE 1979-96", "HN": "97; was CARBOXYPEPTIDASE TRANSPEPTIDASE 1975-96 (see under CARBOXYPEPTIDASES 1975-86); MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE was see CARBOXYPEPTIDASE TRANSPEPTIDASE 1979-96", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D002267"}, {"RECTYPE": "D", "MH": "Carboxypeptidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carboxypeptidase|T116|T126|NON|EQV|NLM (2021)|191115|abbcdef", "MN": "D08.811.277.656.350.245", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.4.-", "AN": "general or unspecified; prefer specifics", "MS": "Enzymes that act at a free C-terminus of a polypeptide to liberate a single amino acid residue.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002268"}, {"RECTYPE": "D", "MH": "Carbuncle", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Carbuncles", "MN": "C17.800.838.765.770.270.200", "FX": "Furunculosis", "MH_TH": "NLM (1966)", "ST": "T020", "MS": "An infection of cutaneous and subcutaneous tissue that consists of a cluster of boils. Commonly, the causative agent is STAPHYLOCOCCUS AUREUS. Carbuncles produce fever, leukocytosis, extreme pain, and prostration.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002270"}, {"RECTYPE": "D", "MH": "Carbutamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfaninylbutylurea|T109|T121|NON|EQV|UNK (19XX)|770117|abbcdef", "ENTRY": "Oranyl|T109|T121|TRD|NRW|UNK (19XX)|811023|abbcdef", "MN": "D02.886.590.795.204", "PA": "Hypoglycemic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-((butylamino)carbonyl)-", "RN": "E3K8P4869P", "RR": "339-43-5 (Carbutamide)", "MS": "A sulfonylurea antidiabetic agent with similar actions and uses to CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002271"}, {"RECTYPE": "D", "MH": "Carcinoembryonic Antigen", "DE": "CEA", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "CD66e Antigen|T129|ACX|EQV|NLM (2002)|001128|CD 066 E ANTIGEN|abcdefs", "ENTRY": "CD66e Antigens", "MN": "D23.101.140.300", "MH_TH": "NLM (1974)", "ST": "T129", "RN": "0", "MS": "A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment.", "PM": "74", "HN": "74(73)", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002272"}, {"RECTYPE": "D", "MH": "Carcinogens", "AQ": "AD AI AN CH CL CS EC HI IP ME PD PK RE SD ST TO", "PRINT ENTRY": "Tumor Promoters|T131|NON|NRW|UNK (19XX)|810513|abcdef", "ENTRY": "Promoters, Tumor", "MN": "D27.888.569.100", "FX": "Oncogenic Viruses", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "Manual 24.5.6.2+", "MS": "Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002273"}, {"RECTYPE": "D", "MH": "Carcinogens, Environmental", "DE": "CARCINOGENS ENVIR", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Environmental Carcinogens|T131|NON|EQV|NLM (1996)|950327|ENVIR CARCINOGENS|abcdefv", "MN": "D27.888.569.100.125", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "PI": "Carcinogens (1966-1974)", "MS": "Carcinogenic substances that are found in the environment.", "PM": "75", "HN": "75", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D002274"}, {"RECTYPE": "D", "MH": "Carcinoid Heart Disease", "DE": "CARCINOID HEART DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Heart Diseases, Carcinoid", "MN": "C14.280.104", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Cardiac manifestation of gastrointestinal CARCINOID TUMOR that metastasizes to the liver. Substances secreted by the tumor cells, including SEROTONIN, promote fibrous plaque formation in ENDOCARDIUM and its underlying layers. These deposits cause distortion of the TRICUSPID VALVE and the PULMONARY VALVE eventually leading to STENOSIS and valve regurgitation.", "OL": "search MALIGNANT CARCINOID SYNDROME 1966-74", "PM": "91; was see under MALIGNANT CARCINOID SYNDROME 1964-90", "HN": "91(75)(64-72); was see under MALIGNANT CARCINOID SYNDROME 1964-90 (Prov 1964-72)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002275"}, {"RECTYPE": "D", "MH": "Carcinoid Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Carcinoid, Goblet Cell|T191|NON|REL|NLM (1994)|930326|abcdef", "ENTRY": "Tumors, Carcinoid", "MN": "C04.557.580.625.650.200", "MH_TH": "NLM (1968)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term; consider also MALIGNANT CARCINOID SYNDROME or CARCINOID HEART DISEASE", "MS": "A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)", "OL": "use CARCINOID TUMOR to search ARGENTAFFINOMA 1966-67", "PM": "68; was ARGENTAFFINOMA 1963-67", "HN": "68; was ARGENTAFFINOMA 1963-67", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002276"}, {"RECTYPE": "D", "MH": "Carcinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Epithelioma|T191|NON|EQV|UNK (19XX)|810515|abcdef", "ENTRY": "Undifferentiated Carcinomas", "MN": "C04.557.470.200", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "do not use for \"cancer\" routinely: use only for carcinoma as a histological type; coordinate with precoordinated organ/neoplasm term; entry term CARCINOMA, ANAPLASTIC: do not coordinate with ANAPLASIA unless anaplasia is particularly discussed", "MS": "A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for \"cancer.\"", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002277"}, {"RECTYPE": "D", "MH": "Carcinoma in Situ", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Carcinoma, Preinvasive|T191|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Preinvasive Carcinoma", "MN": "C04.557.470.200.240", "MH_TH": "NLM (1973)", "ST": "T191", "AN": "coord IM with precoord organ/neopl term (IM)", "PI": "Carcinoma (1966-1972)", "MS": "A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002278"}, {"RECTYPE": "D", "MH": "Carcinoma 256, Walker", "DS": "CARCINOMA A 256 WALKER", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "PRINT ENTRY": "Carcinosarcoma 256, Walker|T050|T191|EPO|EQV|UNK (19XX)|740329|CARCINOSARCOMA A 256 WALKER|abbcdefs", "ENTRY": "Walker Carcinosarcoma 256", "MN": "C04.619.045", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002279"}, {"RECTYPE": "D", "MH": "Carcinoma, Basal Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Ulcer, Rodent|T191|NON|EQV|NLM (1998)|961213|abcdef", "ENTRY": "Ulcers, Rodent", "MN": "C04.557.470.565.165", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with probably SKIN NEOPLASMS; entry term RODENT ULCER: do not coordinate with ULCER", "MS": "A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002280"}, {"RECTYPE": "D", "MH": "Carcinoma, Basosquamous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Carcinomas, Basosquamous", "MN": "C04.557.470.565.170", "MH_TH": "NLM (1966)", "ST": "T191", "AN": " coordinate with probably SKIN NEOPLASMS", "MS": "A skin carcinoma that histologically exhibits both basal and squamous elements. (From Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002281"}, {"RECTYPE": "D", "MH": "Adenocarcinoma, Bronchiolo-Alveolar", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Carcinoma, Bronchiolo-Alveolar|T191|NON|EQV|NLM (1992)|910308|abcdef", "ENTRY": "Carcinomas, Bronchioloalveolar", "MN": "C04.588.894.797.520.055.500", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with LUNG NEOPLASMS (IM)", "MS": "A carcinoma derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli. Involvement may be uniformly diffuse and massive, or nodular, or lobular. The neoplastic cells are cuboidal or columnar and form papillary structures. Mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells. Metastases in regional lymph nodes, and in even more distant sites, are known to occur, but are infrequent. (From Stedman, 25th ed)", "PM": "1994; see CARCINOMA, BRONCHIOLAR 1963-1993", "HN": "1994; use CARCINOMA, BRONCHIOLAR 1963-1993", "CATSH": "CAT LIST", "MR": "20180319", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D002282"}, {"RECTYPE": "D", "MH": "Carcinoma, Bronchogenic", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Carcinoma, Bronchial|T191|NON|EQV|UNK (19XX)|810515|abcdef", "ENTRY": "Carcinomas, Bronchogenic", "MN": "C08.785.520.100.220", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with LUNG NEOPLASMS (IM), not BRONCHIAL NEOPLASMS; do not confuse entry term CARCINOMA, BRONCHIAL with BRONCHIAL NEOPLASMS", "MS": "Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.", "CATSH": "CAT LIST", "MR": "20090710", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002283"}, {"RECTYPE": "D", "MH": "Carcinoma, Brown-Pearce", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "PRINT ENTRY": "Epithelioma, Brown-Pearce|T191|EPO|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Epithelioma, Brown Pearce", "MN": "C04.619.124", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "A transplantable EPITHELIAL CELL neoplasm of rabbits.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002284"}, {"RECTYPE": "D", "MH": "Carcinoma, Intraductal, Noninfiltrating", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Ductal Carcinoma In Situ|T191|NON|EQV|NLM (1999)|971014|abcdef", "ENTRY": "Noninfiltrating Intraductal Carcinomas", "MN": "C04.557.470.615.275", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "intraductal refers to mammary ducts only; do not confuse entry term CARCINOMA, INTRADUCTAL with CARCINOMA, DUCTAL; CARCINOMA, DUCTAL, BREAST; or CARCINOMA, PANCREATIC DUCTAL; coordinate IM with BREAST NEOPLASMS (IM)", "MS": "A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.", "OL": "use CARCINOMA, INTRADUCTAL, NONINFILTRATING to search CARCINOMA, DUCTAL 1966-93", "PM": "94; was CARCINOMA, DUCTAL 1963-93", "HN": "94; was CARCINOMA, DUCTAL 1963-93", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D002285"}, {"RECTYPE": "D", "MH": "Carcinoma, Ehrlich Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "PRINT ENTRY": "Ehrlich Ascites Tumor|T050|T191|EPO|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Tumor, Ehrlich Ascites", "MN": "C04.619.169", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "note entry term: do not also index under ASCITES", "MS": "A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002286"}, {"RECTYPE": "D", "MH": "Carcinoma, Krebs 2", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "ENTRY": "Krebs 2 Carcinoma", "MN": "C04.619.214", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "A transplantable neoplasm of mice.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002287"}, {"RECTYPE": "D", "MH": "Adenocarcinoma, Mucinous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Carcinoma, Mucinous|T191|NON|EQV|NLM (1994)|930330|abcdef", "ENTRY": "Mucinous Carcinomas", "MN": "C04.557.470.590.075", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "also called \"mucoid\" or \"mucous\" carcinoma; coordinate with precoordinated organ/neoplasm term ", "MS": "An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)", "OL": "use ADENOCARCINOMA, MUCINOUS to search CARCINOMA, MUCINOUS 1981-93 & CARCINOMA, COLLOID 1966-80", "PM": "94; was CARCINOMA, MUCINOUS 1981-93; CARCINOMA, COLLOID was heading 1963-80", "HN": "94; was CARCINOMA, MUCINOUS 1981-93; CARCINOMA, COLLOID was heading 1963-80", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D002288"}, {"RECTYPE": "D", "MH": "Carcinoma, Non-Small-Cell Lung", "DE": "NSCLC", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Non-Small-Cell Lung Carcinoma|T191|NON|EQV|UNK (19XX)|860623|NONSMALL CELL LUNG CARCINOMA|abcdefs", "ENTRY": "Non-Small-Cell Lung Carcinomas", "MN": "C08.785.520.100.220.500", "FX": "Carcinoma, Squamous Cell", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with LUNG NEOPLASMS (IM); CARCINOMA, LARGE CELL and SMALL CELL LUNG CARCINOMA are also available", "PI": "Lung Neoplasms (1966-1986)", "MS": "A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.", "OL": "use CARCINOMA, NON-SMALL-CELL LUNG to search CARCINOMA, NON-SMALL CELL LUNG 1987-93", "PM": "94; was CARCINOMA, NON-SMALL CELL LUNG 1987-93", "HN": "94; was CARCINOMA, NON-SMALL CELL LUNG 1987-93", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19860623", "DC": "1", "DX": "19870101", "UI": "D002289"}, {"RECTYPE": "D", "MH": "Carcinoma, Papillary", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Papillary Carcinomas", "MN": "C04.557.470.700.360", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002291"}, {"RECTYPE": "D", "MH": "Carcinoma, Renal Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Renal Carcinoma|T191|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Tumor, Grawitz", "MN": "C12.950.983.535.160", "MH_TH": "NLM (1985)", "ST": "T191", "AN": "coordinate IM with KIDNEY NEOPLASMS (IM)", "PI": "Kidney Neoplasms (1966-1984)", "MS": "A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.", "PM": "85", "HN": "85", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19840529", "DC": "1", "DX": "19850101", "UI": "D002292"}, {"RECTYPE": "D", "MH": "Adenocarcinoma, Scirrhous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Carcinoma, Scirrhous|T191|NON|EQV|NLM (1994)|930330|abcdef", "ENTRY": "Scirrhous Carcinomas", "MN": "C04.557.470.200.025.095", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term ", "MS": "An adenocarcinoma with a hard (Greek skirrhos, hard) structure owing to the formation of dense connective tissue in the stroma. (From Dorland, 27th ed)", "OL": "use ADENOCARCINOMA, SCIRRHOUS to search CARCINOMA, SCIRRHOUS 1966-93", "PM": "94; was CARCINOMA, SCIRRHOUS 1963-93", "HN": "94; was CARCINOMA, SCIRRHOUS 1963-93", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D002293"}, {"RECTYPE": "D", "MH": "Carcinoma, Squamous Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Carcinoma, Squamous|T191|NON|EQV|NLM (1994)|930326|abcdef", "ENTRY": "Squamous Cell Carcinomas", "MN": "C04.557.470.700.400", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "MS": "A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)", "OL": "use CARCINOMA, SQUAMOUS CELL to search CARCINOMA, EPIDERMOID 1966-80", "PM": "81; was CARCINOMA, EPIDERMOID 1963-80", "HN": "81; was CARCINOMA, EPIDERMOID 1963-80", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002294"}, {"RECTYPE": "D", "MH": "Carcinoma, Transitional Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Transitional Cell Carcinomas", "MN": "C04.557.470.200.430", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "MS": "A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002295"}, {"RECTYPE": "D", "MH": "Carcinosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Carcinosarcomas", "MN": "C04.557.450.795.290", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002296"}, {"RECTYPE": "D", "MH": "Cardanolides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.155", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "do not confuse with CARDENOLIDES", "MS": "The aglycone constituents of CARDIAC GLYCOSIDES. The ring structure is basically a cyclopentanoperhydrophenanthrene nucleus attached to a lactone ring at the C-17 position.", "PM": "68", "HN": "68", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002297"}, {"RECTYPE": "D", "MH": "Cardenolides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cardenolide|T109|NON|EQV|NLM (2021)|200227|abcdef", "MN": "D04.210.500.155.580.130", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "AN": "includes cardadienolides & cardatrienolides; do not confuse with CARDANOLIDES", "PI": "Cardanolides (1968-1976)", "MS": "C(23)-steroids with methyl groups at C-10 and C-13 and a five-membered lactone at C-17. They are aglycone constituents of CARDIAC GLYCOSIDES and must have at least one double bond in the molecule. The class includes cardadienolides and cardatrienolides. Members include DIGITOXIN and DIGOXIN and their derivatives and the STROPHANTHINS.", "PM": "77", "HN": "77", "MR": "20200527", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D002298"}, {"RECTYPE": "D", "MH": "Cardia", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cardias", "MN": "A03.556.875.875.163", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "That part of the STOMACH close to the opening from ESOPHAGUS into the stomach (cardiac orifice), the ESOPHAGOGASTRIC JUNCTION. The cardia is so named because of its closeness to the HEART. Cardia is characterized by the lack of acid-forming cells (GASTRIC PARIETAL CELLS).", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002299"}, {"RECTYPE": "D", "MH": "Cardiac Care Facilities", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Facility, Cardiac Care", "MN": "N02.278.421.556.110", "MH_TH": "NLM (1977)", "ST": "T093", "MS": "Institutions specializing in the care of patients with heart disorders.", "PM": "91; was see under HOSPITALS, SPECIAL Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITALS, SPECIAL 1977-90", "MR": "19920507", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D002300"}, {"RECTYPE": "D", "MH": "Cardiac Glycosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cardiotonic Steroids|T109|T121|NON|EQV|UNK (19XX)|760422|abbcdef", "ENTRY": "Steroids, Cardiotonic", "MN": "D09.408.180", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Cyclopentanophenanthrenes with a 5- or 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. Plants they come from have long been used in congestive heart failure. They increase the force of cardiac contraction without significantly affecting other parameters, but are very toxic at larger doses. Their mechanism of action usually involves inhibition of the NA(+)-K(+)-EXCHANGING ATPASE and they are often used in cell biological studies for that purpose.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002301"}, {"RECTYPE": "D", "MH": "Cardiac Output", "AQ": "DE ES GE IM PH RE", "ENTRY": "Outputs, Cardiac", "MN": "G09.330.380.124", "MH_TH": "NLM (1964)", "ST": "T033", "AN": "a physiol concept: do not confuse with the C14 diseases CARDIAC OUTPUT, HIGH or CARDIAC OUTPUT, LOW", "MS": "The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat).", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002302"}, {"RECTYPE": "D", "MH": "Cardiac Output, Low", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Low Cardiac Output Syndrome|T046|NON|REL|NLM (1998)|960716|abcdef", "ENTRY": "Output, Low Cardiac", "MN": "C23.888.192", "MH_TH": "NLM (1980)", "ST": "T046", "AN": "note category: do not confuse with CARDIAC OUTPUT, a physiological concept; note entry term LOW CARDIAC OUTPUT SYNDROME: do not add SYNDROME", "PI": "Cardiac Output (1966-1979)", "MS": "A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19790424", "DC": "1", "DX": "19800101", "UI": "D002303"}, {"RECTYPE": "D", "MH": "Cardiac Pacing, Artificial", "AQ": "AE CL EC ES HI MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Pacing, Cardiac, Artificial|T061|T066|NON|EQV|UNK (19XX)|770418|abbcdef", "ENTRY": "Pacings, Artificial Cardiac", "MN": "E02.331.200", "FX": "Pacemaker, Artificial", "EC": "instrumentation:Pacemaker, Artificial", "MH_TH": "NLM (1978)", "ST": "T066", "PI": "Pacemaker, Artificial (1966-1977)", "MS": "Regulation of the rate of contraction of the heart muscles by an artificial pacemaker.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20150706", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D002304"}, {"RECTYPE": "D", "MH": "Cardiac Tamponade", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pericardial Tamponade|T047|NON|EQV|NLM (2008)|060926|abcdef", "ENTRY": "Tamponades, Pericardial", "MN": "C14.280.155", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Compression of the heart by accumulated fluid (PERICARDIAL EFFUSION) or blood (HEMOPERICARDIUM) in the PERICARDIUM surrounding the heart. The affected cardiac functions and CARDIAC OUTPUT can range from minimal to total hemodynamic collapse.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002305"}, {"RECTYPE": "D", "MH": "Cardiac Volume", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Heart Volume|T033|T040|NON|EQV|NLM (1991)|900411|abbcdef", "ENTRY": "Volumes, Heart", "MN": "G09.330.380.249", "FX": "Stroke Volume", "MH_TH": "NLM (1968)", "ST": "T040", "PI": "Heart/physiology (1966-1967)", "MS": "The volume of the HEART, usually relating to the volume of BLOOD contained within it at various periods of the cardiac cycle. The amount of blood ejected from a ventricle at each beat is STROKE VOLUME.", "PM": "72", "HN": "72(68)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002306"}, {"RECTYPE": "D", "MH": "Cardiography, Impedance", "DE": "CARDIOGR IMPEDANCE", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Plethysmography, Impedance, Transthoracic|T060|NON|EQV|UNK (19XX)|771123|PLETHYSMOGR IMPEDANCE TRANSTHORACIC|abcdefv", "ENTRY": "Transthoracic Impedances", "MN": "E01.370.370.610.610.200", "MH_TH": "NLM (1979)", "ST": "T060", "PI": "Plethysmography, Impedance (1966-1978)", "MS": "A type of impedance plethysmography in which bioelectrical impedance is measured between electrodes positioned around the neck and around the lower thorax. It is used principally to calculate stroke volume and cardiac volume, but it is also related to myocardial contractility, thoracic fluid content, and circulation to the extremities.", "PM": "91; was see under PLETHYSMOGRAPHY, IMPEDANCE 1979-90", "HN": "91(79); was see under PLETHYSMOGRAPHY, IMPEDANCE 1979-90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19771123", "DC": "1", "DX": "19910101", "UI": "D002307"}, {"RECTYPE": "D", "MH": "Cardiolipins", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Diphosphatidylglycerols|T109|NON|BRD|UNK (19XX)|760515|abcdef", "MN": "D23.050.550.480.330", "FX": "Syphilis Serodiagnosis", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Phospholipids (1966-1971)", "MS": "Acidic phospholipids composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol. They occur primarily in mitochondrial inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS.", "OL": "search CARDIOLIPINS & PHOSPHATIDYLGLYCEROLS 1975-76", "PM": "73; DIPHOSPHATIDYL GLYCEROLS was see PHOSPHATIDYL GLYCEROLS 1975-76", "HN": "73(72); DIPHOSPHATIDYL GLYCEROLS was see PHOSPHATIDYL GLYCEROLS 1975-76", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002308"}, {"RECTYPE": "D", "MH": "Cardiology", "DE": "CARDIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Specialty, Cardiovascular Disease", "MN": "H02.403.429.163", "FX": "Vascular Diseases", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use for the discipline (education, history, etc) only; corresponding disease term is CARDIOVASCULAR DISEASES or specifics", "MS": "The study of the heart, its physiology, and its functions.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002309"}, {"RECTYPE": "D", "MH": "Cardiomyopathy, Alcoholic", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Alcoholic Cardiomyopathy|T047|NON|EQV|UNK (19XX)|780519|abcdef", "MN": "C25.775.100.087.250", "MH_TH": "NLM (1979)", "ST": "T047", "PI": "Myocardial Diseases (1966-1978)", "MS": "Disease of CARDIAC MUSCLE resulting from chronic excessive alcohol consumption. Myocardial damage can be caused by: (1) a toxic effect of alcohol; (2) malnutrition in alcoholics such as THIAMINE DEFICIENCY; or (3) toxic effect of additives in alcoholic beverages such as COBALT. This disease is usually manifested by DYSPNEA and palpitations with CARDIOMEGALY and congestive heart failure (HEART FAILURE).", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D002310"}, {"RECTYPE": "D", "MH": "Cardiomyopathy, Dilated", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dilated Cardiomyopathy|T047|NON|EQV|UNK (19XX)|840424|abcdef", "ENTRY": "Idiopathic Dilated Cardiomyopathy", "MN": "C16.320.488.750", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "note entry term CARDIOMYOPATHY, CONGESTIVE: do not confuse with HEART FAILURE", "PI": "Myocardial Diseases (1979-1983)", "MS": "A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.", "PM": "2005; see CARDIOMYOPATHY, CONGESTIVE 1986-2004, see HEART FAILURE, CONGESTIVE 1984-1985", "HN": "2005 (1984)", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19830531", "DC": "1", "DX": "19860101", "UI": "D002311"}, {"RECTYPE": "D", "MH": "Cardiomyopathy, Hypertrophic", "DE": "SUBVALV STENOSIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cardiomyopathy, Hypertrophic Obstructive|T047|NON|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Obstructive Cardiomyopathy, Hypertrophic", "MN": "C14.280.484.048.750.070.160", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with CARDIAC HYPERTROPHY see CARDIOMEGALY", "MS": "A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).", "OL": "use CARDIOMYOPATHY, HYPERTROPHIC to search IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1966-85", "PM": "86; was IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1966-85", "HN": "86; was IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1966-85", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002312"}, {"RECTYPE": "D", "MH": "Cardiomyopathy, Restrictive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Restrictive Cardiomyopathy", "MN": "C14.280.238.160", "MH_TH": "NLM (1986)", "ST": "T047", "PI": "Myocardial Diseases (1979-1985)", "MS": "A form of CARDIAC MUSCLE disease in which the ventricular walls are excessively rigid, impeding ventricular filling. It is marked by reduced diastolic volume of either or both ventricles but normal or nearly normal systolic function. It may be idiopathic or associated with other diseases (ENDOMYOCARDIAL FIBROSIS or AMYLOIDOSIS) causing interstitial fibrosis.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19850311", "DC": "1", "DX": "19860101", "UI": "D002313"}, {"RECTYPE": "D", "MH": "Cardioplegic Solutions", "DE": "CARDIOPLEGIC SOL", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Solutions, Cardioplegic", "MN": "D27.720.752.322", "MH_TH": "NLM (1988)", "ST": "T121", "RN": "0", "AN": "coordinate with specific drug in solution ", "PI": "Isotonic Solutions (1966-1987)", "MS": "Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery.", "PM": "88", "HN": "88", "MR": "20130708", "DA": "19870504", "DC": "1", "DX": "19880101", "UI": "D002314"}, {"RECTYPE": "D", "MH": "Cardiopulmonary Bypass", "DE": "CARDIOPULM BYPASS", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Heart-Lung Bypass|T061|NON|EQV|UNK (19XX)|741125|abcdef", "ENTRY": "Heart-Lung Bypasses", "MN": "E04.292.413", "FX": "Heart-Lung Machine", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "diverts blood from right atrium; HEART BYPASS, LEFT which diverts blood from left atrium is also available; /instrum: consider HEART-LUNG MACHINE", "PI": "Extracorporeal Circulation (1967-1976)", "MS": "Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs.", "OL": "search EXTRACORPOREAL CIRCULATION 1967-74", "PM": "77; was see under EXTRACORPOREAL CIRCULATION 1967-76", "HN": "77(75); was see under EXTRACORPOREAL CIRCULATION 1967-76", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D002315"}, {"RECTYPE": "D", "MH": "Cardiotonic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Myocardial Stimulants|T121|NON|EQV|UNK (19XX)|790228|abcdef", "ENTRY": "Stimulant, Myocardial", "MN": "D27.720.799.080", "MH_TH": "NLM (1980)", "ST": "T121", "RN": "0", "AN": "do not confuse with CARDIOTOXINS", "PI": "specific drug or agent (1966-1979)", "MS": "Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).", "PM": "80", "HN": "80", "MR": "20200527", "DA": "19790228", "DC": "1", "DX": "19800101", "UI": "D002316"}, {"RECTYPE": "D", "MH": "Cardiovascular Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cardiovascular Drug|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Drug, Cardiovascular", "MN": "D27.505.954.411", "MH_TH": "NLM (1979)", "ST": "T121", "RN": "0", "MS": "Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.", "OL": "consider also CARDIOVASCULAR SYSTEM /DE", "PM": "79", "HN": "79; was NON MESH before 1979", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D002317"}, {"RECTYPE": "D", "MH": "Cardiovascular Diseases", "DE": "CARDIOVASC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH UR VE VI", "PRINT ENTRY": "Major Adverse Cardiac Events|T047|NON|NRW|NLM (2023)|220404|abcdef", "ENTRY": "Event, Cardiac", "MN": "C14", "RH": "C14 - DISEASES-CARDIOVASCULAR", "EC": "rehabilitation:Cardiac Rehabilitation", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general, prefer specifics", "MS": "Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002318"}, {"RECTYPE": "D", "MH": "Cardiovascular System", "DE": "CARDIOVASC SYSTEM", "AQ": "AH CH CY DE DG EM EN GD IM IN IR ME MI PA PP PS RE UL VI", "ENTRY": "Circulatory Systems", "MN": "A07", "RH": "A7 - ANATOMY-CARDIOVASCULAR SYSTEM", "FX": "Blood Circulation", "EC": "surgery:Cardiovascular Surgical Procedures", "MH_TH": "NLM (1966)", "ST": "T022", "AN": "general or unspecified; prefer specifics; /abnorm equals CARDIOVASCULAR ABNORMALITIES but consider also specific artery or vein with /abnorm", "MS": "The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002319"}, {"RECTYPE": "D", "MH": "Cardiovascular Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Cardiovascular Physiology|T042|NON|EQV|NLM (1966)|990101|CARDIOVASC PHYSIOL|abcdefv", "ENTRY": "Processes, Cardiovascular Physiological", "MN": "G09.330", "MH_TH": "NLM (2009)", "ST": "T042", "AN": "general or unspecified; prefer specifics", "PI": "Cardiovascular System/physiology (1966-1997)", "MS": "Processes and properties of the CARDIOVASCULAR SYSTEM as a whole or of any of its parts.", "PM": "2009; see CARDIOVASCULAR PHYSIOLOGY 1998-2008; for  CARDIOVASCULAR PHYSIOLOGICAL PROCESSES see CARDIOVASCULAR PHYSIOLOGICAL PROCESSES 2009-2016", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20160616", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D002320"}, {"RECTYPE": "D", "MH": "Career Choice", "ENTRY": "Choices, Career", "MN": "F02.463.785.373.346.400", "MH_TH": "NLM (1975)", "ST": "T041", "MS": "Selection of a type of occupation or profession.", "PM": "83; was see under CHOICE BEHAVIOR 1981-82 & DECISION MAKING 1975-80", "HN": "83(75); was see under CHOICE BEHAVIOR 1981-82 & DECISION MAKING 1975-80", "CATSH": "CAT LIST", "MR": "20160226", "DA": "19741111", "DC": "1", "DX": "19830101", "UI": "D002321"}, {"RECTYPE": "D", "MH": "Career Mobility", "PRINT ENTRY": "Job Ladders|T080|NON|NRW|NLM (1991)|900409|abcdef", "ENTRY": "Mobility, Career", "MN": "N01.824.547.330", "MH_TH": "NLM (1972)", "ST": "T080", "PI": "specific occupation (1966-1971)", "MS": "The upward or downward mobility in an occupation or the change from one occupation to another.", "PM": "74", "HN": "74(72)", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002322"}, {"RECTYPE": "D", "MH": "Carfecillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbenicillin Phenyl Sodium|T109|T195|NON|NRW|FDA SRS (2014)|USAN (1973)|770418|abbcdeef", "ENTRY": "Sodium Salt, Carfecillin", "MN": "D03.633.100.300.750.750.170.200", "PA": "Anti-Infective Agents, Urinary", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((1,3-dioxo-3-phenoxy-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-", "RN": "9UU4XDB74X", "RR": "27025-49-6 (Carfecillin)", "PI": "Penicillins (1966-1972)", "MS": "The phenyl ester of CARBENICILLIN that, upon oral administration, is broken down in the intestinal mucosa to the active antibacterial. It is used for urinary tract infections.", "PM": "91; was see under CARBENICILLIN 1978-90", "HN": "91(78); was see under CARBENICILLIN 1978-90", "MR": "20160527", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D002323"}, {"RECTYPE": "D", "MH": "Caricatures as Topic", "AQ": "CL ES HI PX SN TD", "ENTRY": "Caricatures as Topics", "MN": "K01.093.206", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "coordinate with subject or person with required biography and history headings & check tags; do not confuse with the Publication Type CARICATURES; CARTOON AS TOPIC is also available", "MS": "Works about portraying in a critical or facetious way a real individual or group, or a figure representing a social, political, ethnic, or racial type. (Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed)", "PM": "2008; see CARICATURES 1963-2007", "HN": "2008(1963)", "MR": "20180713", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D002325"}, {"RECTYPE": "D", "MH": "Cariogenic Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Agents, Cariogenic", "MN": "J01.637.051.187", "FX": "Diet, Cariogenic", "MH_TH": "NLM (1965)", "ST": "T120", "RN": "0", "MS": "Substances that promote DENTAL CARIES.", "PM": "65", "HN": "65", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002326"}, {"RECTYPE": "D", "MH": "Cariostatic Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Effects, Cariostatic", "MN": "J01.637.051.223", "FX": "Fluoridation", "MH_TH": "NLM (1965)", "ST": "T121", "RN": "0", "AN": "note entry term CARIOSTATIC EFFECT: use only for the cariostatic effect of a chemical", "MS": "Substances that inhibit or arrest DENTAL CARIES formation. (Boucher's Clinical Dental Terminology, 4th ed)", "PM": "65", "HN": "65", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002327"}, {"RECTYPE": "D", "MH": "Carisoprodol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isopropylmeprobamate|T109|T121|NON|EQV|UNK (19XX)|770317|abbcdef", "ENTRY": "Vanadom|T109|T121|TRD|NRW|US|041208|abbcdef", "MN": "D02.241.081.251.165", "PA": "Muscle Relaxants, Central", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Carbamic acid, (1-methylethyl)-, 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester", "RN": "21925K482H", "RR": "78-44-4 (Carisoprodol)", "MS": "A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002328"}, {"RECTYPE": "D", "MH": "Carmine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Natural Red 4|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|750630|abbcdeef", "ENTRY": "Dye, Cochineal", "MN": "D04.615.125.380.625.200", "PA": "Food Coloring Agents", "MH_TH": "NLM (1976)", "ST": "T130", "N1": "2-Anthracenecarboxylic acid, 7-beta-D-glucopyranosyl-9,10-dihydro-3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-", "RN": "CID8Z8N95N", "RR": "476-39-1 (carminic acid)", "PI": "Calcium (1972-1975)", "MS": "Coloring matter from the insect Coccus cacti L. It is used in foods, pharmaceuticals, toiletries, etc., as a dye, and also has use as a microscopic stain and biological marker.", "PM": "1991; CARMIC ACID was indexed under CARMINE 1977-2013, see ANTHRAQUINONES 1976-1990", "HN": "1991(1976)", "MR": "20230607", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D002329"}, {"RECTYPE": "D", "MH": "Carmustine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "BCNU|T109|T121|ABB|EQV|FDA SRS (2014)|UNK (19XX)|740329|abbcdeef", "ENTRY": "Nitrumon|T109|T121|TRD|NRW|UNK (19XX)|801205|abbcdef", "MN": "D02.654.692.247", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Urea, N,N'-bis(2-chloroethyl)-N-nitroso-", "RN": "U68WG3173Y", "RR": "154-93-8 (Carmustine)", "PI": "Urea (1966-1971)", "MS": "A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)", "PM": "73", "HN": "73(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002330"}, {"RECTYPE": "D", "MH": "Carnitine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L Carnitine", "MN": "D02.092.877.883.099", "MH_TH": "USAN (19XX)", "ST": "T123", "N1": "1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (R)-", "RN": "S7UI8SM58A", "RR": "541-15-1", "MS": "A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism.", "PM": "66; was see under VITAMIN B COMPLEX 1963-65", "HN": "66(64); was see under VITAMIN B COMPLEX 1963-65", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002331"}, {"RECTYPE": "D", "MH": "Carnitine O-Acetyltransferase", "DS": "CARNITINE ACETYLTRANSFERASE O", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carnitine Acetyltransferase|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef", "ENTRY": "O-Acetyltransferase, Carnitine", "MN": "D08.811.913.050.350.170", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Acetyl-CoA:carnitine O-acetyltransferase", "RN": "EC 2.3.1.7", "RR": "9029-90-7 (CAS RN)", "AN": "do not confuse with CARNITINE ACYLTRANSFERASES", "PI": "Carnitine (1973-1974)", "MS": "An enzyme that catalyzes the formation of O-acetylcarnitine from acetyl-CoA plus carnitine. EC 2.3.1.7.", "PM": "98; see CARNITINE ACETYLTRANSFERASE 1991-97; see ACETYLTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002332"}, {"RECTYPE": "D", "MH": "Carnitine Acyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Translocase, Carnitine-Acylcarnitine", "MN": "D08.811.913.050.350", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 2.3.1.-", "RR": "39386-49-7 (CAS RN)", "AN": "do not confuse with CARNITINE ACETYLTRANSFERASE see CARNITINE O-ACETYLTRANSFERASE", "PI": "Acyltransferases (1972-1974)", "MS": "Acyltransferases in the inner mitochondrial membrane that catalyze the reversible transfer of acyl groups from acyl-CoA to L-carnitine and thereby mediate the transport of activated fatty acids through that membrane. EC 2.3.1.", "PM": "91; was see under ACYLTRANSFERASES 1975-90", "HN": "91(75); was see under ACYLTRANSFERASES 1975-90", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002333"}, {"RECTYPE": "D", "MH": "Carnitine O-Palmitoyltransferase", "DS": "CARNITINE PALMITOYLTRANSFERASE O", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carnitine Palmitoyltransferase|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef", "ENTRY": "Transferase, Palmitoylcarnitine", "MN": "D08.811.913.050.350.200", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Palmitoyl-CoA:L-carnitine O-palmitoyltransferase", "RN": "EC 2.3.1.21", "RR": "9068-41-1 (CAS RN)", "PI": "Palmitic Acids (1973-1974)", "MS": "An enzyme that catalyzes reversibly the conversion of palmitoyl-CoA to palmitoylcarnitine in the inner mitochondrial membrane. EC 2.3.1.21.", "PM": "98; see CARNITINE PALMITOYLTRANSFERASE 1991-97; see ACYLTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002334"}, {"RECTYPE": "D", "MH": "Carnivora", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "MN": "B01.050.150.900.649.313.750", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid33554", "AN": "general or unspecified; prefer specifics", "MS": "An order of MAMMALS, usually flesh eaters with appropriate dentition. Suborders include the terrestrial carnivores Fissipedia, and the aquatic carnivores CANIFORMIA.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002335"}, {"RECTYPE": "D", "MH": "Carnosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "beta Alanylhistidine", "MN": "D12.776.631.650.100", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "L-Histidine, N-beta-alanyl-", "RN": "8HO6PVN24W", "RR": "5II09M0I3L", "MS": "A naturally occurring dipeptide neuropeptide found in muscles.", "OL": "search DIPEPTIDES 1967-74 & PEPTIDES 1966", "PM": "91; was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66", "HN": "91(75); was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002336"}, {"RECTYPE": "D", "MH": "Carotenoids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetraterpenes|T109|NON|NRW|NLM (2020)|190524|abcdef", "ENTRY": "Derivatives, Tetraterpene", "MN": "D23.767.261", "PA": "Antioxidants", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "36-88-4", "MS": "The general name for a group of fat-soluble pigments found in green, yellow, and leafy vegetables, and yellow fruits. They are aliphatic hydrocarbons containing 4 terpene subunits.", "PM": "1966; for CAROTENE see CAROTENE 1966-2001", "HN": "1966", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002338"}, {"RECTYPE": "D", "MH": "Carotid Arteries", "AQ": "AB AH CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Carotid Artery", "MN": "A07.015.114.186", "FX": "Ultrasonography, Carotid Arteries", "EC": "injuries:Carotid Artery Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery.", "MR": "20220408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002339"}, {"RECTYPE": "D", "MH": "Carotid Artery Diseases", "DE": "CAROTID ARTERY DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Internal Carotid Artery Disease|T047|NON|NRW|NLM (2022)|201015|abcdef", "ENTRY": "Disorders, Carotid Artery", "MN": "C14.907.253.123", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; coordinate IM with CAROTID ARTERY, COMMON; CAROTID ARTERY, INTERNAL or CAROTID ARTERY, EXTERNAL (IM) if pertinent", "MS": "Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002340"}, {"RECTYPE": "D", "MH": "Carotid Artery Thrombosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombosis, Carotid Artery|T047|NON|EQV|NLM (1999)|980218|abcdef", "ENTRY": "Carotid Artery Thromboses", "MN": "C14.907.355.590.213.206", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "coordinate IM with specific carotid artery (IM) if pertinent", "MS": "Blood clot formation in any part of the CAROTID ARTERIES. This may produce CAROTID STENOSIS or occlusion of the vessel, leading to TRANSIENT ISCHEMIC ATTACK; CEREBRAL INFARCTION; or AMAUROSIS FUGAX.", "PM": "1964", "HN": "1964", "CATSH": "CAT LIST", "MR": "20150608", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D002341"}, {"RECTYPE": "D", "MH": "Carotid Artery, External", "AQ": "AB AH CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "External Carotid Artery", "MN": "A07.015.114.186.200.210", "EC": "injuries:Carotid Artery Injuries", "MH_TH": "NLM (1972)", "ST": "T023", "AN": "dis: coord IM with CAROTID ARTERY DISEASES (IM); inj: coord IM with CAROTID ARTERY INJURIES (IM) or specifics (IM)", "PI": "Carotid Arteries (1966-1971)", "MS": "Branch of the common carotid artery which supplies the exterior of the head, the face, and the greater part of the neck.", "PM": "74", "HN": "74(72)", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002342"}, {"RECTYPE": "D", "MH": "Carotid Artery, Internal", "AQ": "AB AH CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Internal Carotid Artery", "MN": "A07.015.114.186.200.230", "EC": "injuries:Carotid Artery Injuries", "MH_TH": "NLM (1972)", "ST": "T023", "AN": "dis: coord IM with CAROTID ARTERY DISEASES (IM); inj: coord IM with CAROTID ARTERY INJURIES (IM) or specifics (IM)", "PI": "Carotid Arteries (1966-1971)", "MS": "Branch of the common carotid artery which supplies the anterior part of the brain, the eye and its appendages, the forehead and nose.", "PM": "74", "HN": "74(72)", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002343"}, {"RECTYPE": "D", "MH": "Carotid Body", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Glomus Caroticum|T023|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Carotid Bodies", "MN": "A11.671.650.915.500.600.150", "FX": "Carotid Body Tumor", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "a nonchromaffin paraganglion", "MS": "A small cluster of chemoreceptive and supporting cells located near the bifurcation of the internal carotid artery. The carotid body, which is richly supplied with fenestrated capillaries, senses the pH, carbon dioxide, and oxygen concentrations in the blood and plays a crucial role in their homeostatic control.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002344"}, {"RECTYPE": "D", "MH": "Carotid Body Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Paraganglioma, Carotid Body|T191|NON|EQV|NLM (1994)|OMIM (2013)|930326|abcdeef", "ENTRY": "Tumors, Carotid Body", "MN": "C04.557.580.625.650.700.705.220", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "organ/neoplasm & histological coordinates not necessary", "MS": "Benign paraganglioma at the bifurcation of the COMMON CAROTID ARTERIES. It can encroach on the parapharyngeal space and produce dysphagia, pain, and cranial nerve palsies.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002345"}, {"RECTYPE": "D", "MH": "Carotid Sinus", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sinus, Carotid", "MN": "A07.015.114.186.456", "FX": "Pressoreceptors", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The dilated portion of the common carotid artery at its bifurcation into external and internal carotids. It contains baroreceptors which, when stimulated, cause slowing of the heart, vasodilatation, and a fall in blood pressure.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002346"}, {"RECTYPE": "D", "MH": "Carps", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Grass Carp|T013|NON|NRW|NLM (2002)|000913|abcdef", "ENTRY": "Silver Carps", "MN": "B01.050.150.900.493.200.244.248", "MH_TH": "NLM (2002)", "ST": "T013", "RR": "txid7962", "MS": "Common name for a number of different species of fish in the family Cyprinidae. This includes, among others, the common carp, crucian carp, grass carp, and silver carp.", "PM": "2002; see CARP 1991-2001, see CYPRINIDAE 1975-90", "HN": "2002 (1975)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002347"}, {"RECTYPE": "D", "MH": "Carpal Bones", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Carpal Bone", "MN": "A02.835.232.087.319.150", "MH_TH": "NLM (1972)", "ST": "T023", "AN": "do not confuse with WRIST (the area) or WRIST JOINT; see note on CARPUS, ANIMAL; /inj permitted: not necessarily WRIST INJURIES", "PI": "Wrist Joint (1966-1971)", "MS": "The eight bones of the wrist: SCAPHOID BONE; LUNATE BONE; TRIQUETRUM BONE; PISIFORM BONE; TRAPEZIUM BONE; TRAPEZOID BONE; CAPITATE BONE; and HAMATE BONE.", "PM": "72", "HN": "72", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002348"}, {"RECTYPE": "D", "MH": "Carpal Tunnel Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Entrapment Neuropathy, Carpal Tunnel|T047|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Syndromes, Carpal Tunnel", "MN": "C26.844.150.206", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "Entrapment of the MEDIAN NERVE in the carpal tunnel, which is formed by the flexor retinaculum and the CARPAL BONES. This syndrome may be associated with repetitive occupational trauma (CUMULATIVE TRAUMA DISORDERS); wrist injuries; AMYLOID NEUROPATHIES; rheumatoid arthritis (see ARTHRITIS, RHEUMATOID); ACROMEGALY; PREGNANCY; and other conditions. Symptoms include burning pain and paresthesias involving the ventral surface of the hand and fingers which may radiate proximally. Impairment of sensation in the distribution of the median nerve and thenar muscle atrophy may occur. (Joynt, Clinical Neurology, 1995, Ch51, p45)", "PM": "1965", "HN": "1965(1963)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002349"}, {"RECTYPE": "D", "MH": "Carpus, Animal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Animal Carpus", "MN": "A13.395.248", "MH_TH": "NLM (1975)", "ST": "T029", "AN": "TN 117 & table: animal extremities", "MS": "The region corresponding to the human WRIST in non-human ANIMALS.", "OL": "search FORELIMB 1968-74", "PM": "91; was see under FORELIMB 1975-90", "HN": "91(75); was see under FORELIMB 1975-90", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002350"}, {"RECTYPE": "D", "MH": "Carrageenan", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "lambda Carrageenan", "MN": "D09.698.152", "FX": "Chondrus", "MH_TH": "NLM (1964)", "ST": "T123", "N1": "Carrageenan", "RN": "9000-07-1", "MS": "A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES.", "PM": "66", "HN": "66(64)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002351"}, {"RECTYPE": "D", "MH": "Carrier Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transport Proteins|T116|T123|NON|EQV|UNK (19XX)|760515|abbcdef", "ENTRY": "Proteins, Carrier", "MN": "D12.776.157", "MH_TH": "NLM (1971)", "ST": "T123", "RN": "0", "PI": "Proteins (1966-1970)", "MS": "Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes.", "PM": "73", "HN": "73(71)", "MR": "20210611", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002352"}, {"RECTYPE": "D", "MH": "Carrier State", "AQ": "BL CF CL CN DG DH DI DT EC EH EN EP IM ME MI NU PA PC PP PS PX TH TM UR VE VI", "PRINT ENTRY": "Superspreader Carrier|T078|NON|REL|NLM (2022)|210601|abcdef", "ENTRY": "Superspreader Carriers", "MN": "N06.850.520.169", "MH_TH": "NLM (1963)", "ST": "T046", "MS": "The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002353"}, {"RECTYPE": "D", "MH": "Carteolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "OPC1085", "MN": "D03.633.100.810.835.188", "PA": "Sympatholytics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2(1H)-Quinolinone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-", "RN": "8NF31401XG", "RR": "51781-21-6 (mono HCl)", "PI": "Quinolines (1966-1978)", "MS": "A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.", "PM": "91; was see under PROPANOLAMINES 1979-90", "HN": "91(79); was see under PROPANOLAMINES 1979-90", "MR": "20160527", "DA": "19780501", "DC": "1", "DX": "19910101", "UI": "D002354"}, {"RECTYPE": "D", "MH": "Carticaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Articaine|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|NLM (1991)|900116|abbcdeeef", "ENTRY": "Hydrochloride, Carticaine", "MN": "D03.383.903.150", "PA": "Anesthetics, Local", "MH_TH": "BAN (19XX)", "ST": "T121", "N1": "2-Thiophenecarboxylic acid, 4-methyl-3-((1-oxo-2-(propylamino)propyl)amino)-, methyl ester", "RN": "D3SQ406G9X", "RR": "23964-58-1 (Carticaine)", "PI": "Thiophenes (1966-1978)", "MS": "A thiophene-containing local anesthetic pharmacologically similar to MEPIVACAINE.", "PM": "91; was see under THIOPHENES 1979-90", "HN": "91(79); was see under THIOPHENES 1979-90", "MR": "20170524", "DA": "19780317", "DC": "1", "DX": "19910101", "UI": "D002355"}, {"RECTYPE": "D", "MH": "Cartilage", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cartilages", "MN": "A10.165.382", "FX": "Chondroitin", "MH_TH": "NLM (1966)", "ST": "T024", "AN": "general: prefer specifics; inflammation (chondritis) is likely to be OSTEOCHONDRITIS", "CX": "consider also terms at CHONDRO-", "MS": "A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002356"}, {"RECTYPE": "D", "MH": "Cartilage Diseases", "DE": "CARTILAGE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chondromalacia|T047|NON|NRW|NLM (2009)|070918|abcdef", "ENTRY": "Chondromalacias", "MN": "C17.300.182", "FX": "Osteochondritis", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "general; inflammatory disease (chondritis) is likely to be OSTEOCHONDRITIS", "PI": "Osteochondritis (1966-1967)", "MS": "Pathological processes involving the chondral tissue (CARTILAGE).", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002357"}, {"RECTYPE": "D", "MH": "Cartilage, Articular", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cartilages, Articular", "MN": "A02.835.583.192", "MH_TH": "NLM (1965)", "ST": "T024", "AN": "inflammation (chondritis) is likely to be OSTEOCHONDRITIS", "MS": "A protective layer of firm, flexible cartilage over the articulating ends of bones. It provides a smooth surface for joint movement, protecting the ends of long bones from wear at points of contact.", "PM": "65", "HN": "65", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002358"}, {"RECTYPE": "D", "MH": "Cartoons as Topic", "AQ": "CL ES HI PX SN TD", "ENTRY": "Cartoons as Topics", "MN": "K01.093.206.332", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with Publication Type CARTOONS; CARICATURE AS TOPIC is also available", "MS": "Works about images used to comment on such things as contemporary events, social habits, or political trends; usually executed in a broad or abbreviated manner.", "PM": "2008; see CARTOONS 1991-2007, see CARICATURES 1975-1990", "HN": "2008(1975)", "MR": "20180713", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002359"}, {"RECTYPE": "D", "MH": "Carubicin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Karminomycin|T109|T121|NON|EQV|UNK (19XX)|790606|abbcdef", "ENTRY": "NSC180024", "MN": "D09.408.051.059.200.150", "PA": "Topoisomerase II Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Carminomycin", "RN": "E7437K3983", "RR": "52794-97-5 (HCl)", "PI": "Naphthacenes (1966-1974)", "MS": "A very toxic anthracycline-type antineoplastic related to DAUNORUBICIN, obtained from Actinomadura carminata.", "OL": "use CARUBICIN to search CARMINOMYCIN 1975-83", "PM": "91; was see under DAUNORUBICIN/analogs & derivatives 1984-90; was CARMINOMYCIN see under DAUNORUBICIN 1980-83 & see under ANTIBIOTICS, ANTINEOPLASTIC 1975-79", "HN": "91(84); was see under DAUNORUBICIN/analogs & derivatives 1984-90; was CARMINOMYCIN see under DAUNORUBICIN 1980-83 & see under ANTIBIOTICS, ANTINEOPLASTIC 1975-79", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002360"}, {"RECTYPE": "D", "MH": "Case Reports", "ENTRY": "Case Study|T170|NON|REL|NLM (1978)|781219|abcdef", "MN": "V03.100", "MH_TH": "BIOETHICS (1991)", "ST": "T170", "AN": "This heading is used as a Publication Type. permitted for veterinary case reports but not for historical articles; Case reports as a form of writing are indexed under MEDICAL RECORDS or specific records term (IM). CATALOGER: do not use for institutional case reports. Use instead the heading ORGANIZATIONAL CASE STUDIES", "MS": "Clinical presentations that may be followed by evaluative studies that eventually lead to a diagnosis.", "HN": "2008(1966)", "MR": "20150605", "DA": "19990101", "DC": "2", "DX": "20080101", "UI": "D002363"}, {"RECTYPE": "D", "MH": "Caseins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gamma-Casein|T116|T123|NON|NRW|NLM (2021)|191121|abbcdef", "ENTRY": "kappa Caseins", "MN": "D12.776.744.150", "PA": "Chelating Agents", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "A mixture of related phosphoproteins occurring in milk and cheese. The group is characterized as one of the most nutritive milk proteins, containing all of the common amino acids and rich in the essential ones.", "OL": "use CASEINS to search CASEIN 1966-81", "PM": "82; was CASEIN 1963-81", "HN": "82; was CASEIN 1963-81", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19820101", "UI": "D002364"}, {"RECTYPE": "D", "MH": "Manihot", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Tapioca|T168|NON|REL|UNK (19XX)|850516|abcdef", "ENTRY": "esculenta, Manihot", "MN": "B01.875.800.575.912.250.859.797.438.535", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid3982", "RR": "txid3983", "AN": "ARROWROOT see MARANTACEAE is also available", "MS": "A plant genus of the family EUPHORBIACEAE that is perennial with conspicuous, almost palmate leaves like those of RICINUS but more deeply parted into five to nine lobes. It is a source of a starch after removal of the cyanogenic glucosides. The common name of Arrowroot is also used with Maranta (MARANTACEAE). The common name of yuca is also used for YUCCA.", "PM": "2003; see CASSAVA 1991-2002, see PLANTS, EDIBLE 1986-1990, see CASSAVA 1963-1985", "HN": "2003(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002365"}, {"RECTYPE": "D", "MH": "Cassia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Indian Laburnum|T002|NON|NRW|NLM (2003)|010830|abcdef", "ENTRY": "fistulas, Cassia", "MN": "B01.875.800.575.912.250.401.100", "FX": "Senna Extract", "MH_TH": "NLM (1978)", "ST": "T002", "RN": "txid53851", "RR": "txid53852", "AN": "CASSIA SENNA; CASSIA ANGUSTIFOLIA and CASSIA OCCIDENTALIS see SENNA PLANT are also available", "PI": "Senna (1966-1977)", "MS": "A plant genus of the family FABACEAE. Many species of this genus, including the medicinal C. senna and C. angustifolia, have been reclassified into the Senna genus (SENNA PLANT) and some to CHAMAECRISTA.", "PM": "91; was see under PLANTS, MEDICINAL 1978-90", "HN": "91(78); was see under PLANTS, MEDICINAL 1978-90", "MR": "20210630", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D002366"}, {"RECTYPE": "D", "MH": "Ricinus communis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ricinus sanguineus|T002|NON|EQV|NLM (2024)|230503|abcdef", "ENTRY": "Plants, Castor Oil", "MN": "B01.875.800.575.912.250.859.797.438.650.300", "FX": "Castor Oil", "MH_TH": "NLM (2024)", "ST": "T002", "RN": "txid3988", "MS": "A species in the family EUPHORBIACEAE that is the source of CASTOR OIL.", "OL": "search RICINUS 1966-74", "PM": "1991; was see under RICINUS 1975-1990; use CASTOR BEAN 1991-2023", "HN": "1991(1975); was see under RICINUS 1975-1990; use CASTOR BEAN 1991-2023", "MR": "20230526", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002367"}, {"RECTYPE": "D", "MH": "Castor Oil", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oil, Castor", "MN": "D20.215.784.750.132", "PA": "Cathartics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Castor oil", "RN": "8001-79-4", "MS": "Oil obtained from seeds of Ricinus communis that is used as a cathartic and as a plasticizer.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002368"}, {"RECTYPE": "D", "MH": "Castration", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Gonadectomies", "MN": "E04.950.165", "FX": "Eunuchism", "MH_TH": "POPLINE (1978)", "ST": "T061", "AN": "prefer OVARIECTOMY or ORCHIECTOMY", "MS": "Surgical removal or artificial destruction of gonads.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002369"}, {"RECTYPE": "D", "MH": "Casts, Surgical", "DE": "CASTS SURG", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Plastic Casts|T074|NON|NRW|NLM (1991)|900517|abcdef", "ENTRY": "Plastic Cast", "MN": "E07.858.690.725.430.500", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "Dressings made of fiberglass, plastic, or bandage impregnated with plaster of paris used for immobilization of various parts of the body in cases of fractures, dislocations, and infected wounds. In comparison with plaster casts, casts made of fiberglass or plastic are lightweight, radiolucent, able to withstand moisture, and less rigid.", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002370"}, {"RECTYPE": "D", "MH": "Cat Diseases", "DE": "CAT DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Feline Disease", "MN": "C22.180", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "IM GEN or unspecified; coord IM with specific dis /vet (IM) or specific cat dis (IM); for abnormalities or injuries, index under CATS /abnorm or CATS /inj; does not include diseases of the so-called \"big cats\" (LIONS; CHEETAHS; tigers, panthers, etc.); don't forget also check tags CATS (NIM) & ANIMALS", "MS": "Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002371"}, {"RECTYPE": "D", "MH": "Cat-Scratch Disease", "DE": "CAT SCRATCH DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Inoculation Lymphoreticulosis|T047|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Scratch Fever, Cat", "MN": "C15.604.315.249", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coord IM with AFIPIA (IM) or BARTONELLA HENSELAE (IM) if appropriate", "MS": "A self-limiting bacterial infection of the regional lymph nodes caused by AFIPIA felis, a gram-negative bacterium recently identified by the Centers for Disease Control and Prevention and by BARTONELLA HENSELAE. It usually arises one or more weeks following a feline scratch, with raised inflammatory nodules at the site of the scratch being the primary symptom.", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002372"}, {"RECTYPE": "D", "MH": "Cyclic AMP Receptor Protein", "DE": "CYCLIC AMP RECEPT PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Catabolite Gene Activator Proteins|T116|T123|NON|EQV|NLM (1994)|930107|abbcdef", "ENTRY": "Receptor Proteins, cAMP", "MN": "D12.776.930.165", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "Transcription, Genetic (1978-1987)", "MS": "A transcriptional regulator in prokaryotes which, when activated by binding cyclic AMP, acts at several promoters. Cyclic AMP receptor protein was originally identified as a catabolite gene activator protein. It was subsequently shown to regulate several functions unrelated to catabolism, and to be both a negative and a positive regulator of transcription. Cell surface cyclic AMP receptors are not included (CYCLIC AMP RECEPTORS), nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins, which are the regulatory subunits of CYCLIC AMP-DEPENDENT PROTEIN KINASES.", "OL": "use CYCLIC AMP RECEPTOR PROTEIN to search CATABOLITE GENE ACTIVATOR PROTEINS 1988-93; use RECEPTORS, CYCLIC AMP to search CATABOLITE GENE ACTIVATOR PROTEINS & CATABOLITE ACTIVATOR PROTEIN 1987 & CATABOLIC GENE ACTIVATORS 1977-87", "PM": "94; was CATABOLITE GENE ACTIVATOR PROTEINS 1988-93; CYCLIC AMP RECEPTOR PROTEIN was see CATABOLITE GENE ACTIVATOR PROTEIN 1990-93; CATABOLITE GENE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLITE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLIC GENE ACTIVATORS was see RECEPTORS, CYCLIC AMP 1977-87", "HN": "94; was CATABOLITE GENE ACTIVATOR PROTEINS 1988-93; CYCLIC AMP RECEPTOR PROTEIN was see CATABOLITE GENE ACTIVATOR PROTEIN 1990-93; CATABOLITE GENE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLITE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLIC GENE ACTIVATORS was see RECEPTORS, CYCLIC AMP 1977-87", "MR": "19970620", "DA": "19870511", "DC": "1", "DX": "19880101", "UI": "D002373"}, {"RECTYPE": "D", "MH": "Catalase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mn Catalase|T116|T126|NON|NRW|UNK (19XX)|840305|abbcdef", "MN": "D08.811.682.732.332", "PA": "Antioxidants", "EC": "deficiency:Acatalasia", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 1.11.1.6", "MS": "An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002374"}, {"RECTYPE": "D", "MH": "Catalepsy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Flexibility, Waxy|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Waxy Flexibility", "MN": "C23.888.592.350.200", "FX": "Freezing Reaction, Cataleptic", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "do not confuse with CATAPLEXY", "MS": "A condition characterized by inactivity, decreased responsiveness to stimuli, and a tendency to maintain an immobile posture. The limbs tend to remain in whatever position they are placed (waxy flexibility). Catalepsy may be associated with PSYCHOTIC DISORDERS (e.g., SCHIZOPHRENIA, CATATONIC), nervous system drug toxicity, and other conditions.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002375"}, {"RECTYPE": "D", "MH": "Cataloging", "AQ": "CL EC ES HI MT SN ST TD", "MN": "L01.462.750.819.250", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "Activities performed in the preparation of bibliographic records for CATALOG. It is carried out according to a set of rules and contains information enabling the user to know what is available and where items can be found.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002376"}, {"RECTYPE": "D", "MH": "Catalogs as Topic", "ENTRY": "as Topics, Catalogs", "MN": "L01.462.500.682.290", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "general or unspecified; prefer specifics; do not confuse with Publication Type CATALOG", "MS": "Works about ordered compilations of item descriptions and sufficient information to afford access to them.", "PM": "2008; see CATALOGS 1963-2007", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D002377"}, {"RECTYPE": "D", "MH": "Catalog, Bookseller", "PRINT ENTRY": "Catalogs, Booksellers'|T073|NON|EQV|NLM (1966)|990101|abcdef", "MN": "V02.240.100.500", "MH_TH": "NLM (2019)", "ST": "T073", "AN": "This heading is used as a Publication Type. Works on Booksellers Catalogs as a subject are indexed under the main heading CATALOGS AS TOPIC and BOOKSELLING. INDEXER: Do not use", "MS": "Lists of books for sale by a specific seller.", "MR": "20190501", "DA": "19990101", "DC": "2", "DX": "19660101", "UI": "D002378"}, {"RECTYPE": "D", "MH": "Catalogs, Commercial as Topic", "ENTRY": "Commercial Catalogs as Topic|T073|T170|NON|EQV|NLM (2019)|180618|abbcdef", "MN": "L01.462.500.682.290.183", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "do not confuse with the Publication Type CATALOG, COMMERCIAL", "MS": "Works about lists of merchandise for sale.", "PM": "2019; see CATALOGS, COMMERCIAL", "HN": "2019(1966)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002379"}, {"RECTYPE": "D", "MH": "Catalogs, Drug as Topic", "ENTRY": "Drug Catalogs as Topic|T073|NON|EQV|NLM (2019)|180617|abcdef", "MN": "L01.462.500.682.290.283", "MH_TH": "NLM (2019)", "ST": "T073", "AN": "do not confuse with the Publication Type CATALOG, DRUG ", "MS": "Works about lists of drugs for sale.", "PM": "2019; see CATALOGS, DRUG 1966-2018", "HN": "2019(1966)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002380"}, {"RECTYPE": "D", "MH": "Catalogs, Library", "ENTRY": "Library Catalogs", "MN": "L01.462.500.682.290.383", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "Lists of material available  in a library arranged in order with bibliographical METADATA for the purpose of identification and retrieval.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002381"}, {"RECTYPE": "D", "MH": "Catalog, Publisher", "PRINT ENTRY": "Publishers' Catalogs|T073|NON|EQV|NLM (1992)|901227|abcdef", "MN": "V02.240.100.875", "MH_TH": "NLM (2019)", "ST": "T073", "AN": "This heading is used as a Publication Type. Works on Publishers Catalogs as a subject are indexed under the main heading CATALOGS AS TOPIC and PUBLISHING.  INDEXER: Do not use ", "MS": "Lists of books or other titles produced by a specific entity.", "MR": "20190501", "DA": "19990101", "DC": "2", "DX": "19660101", "UI": "D002382"}, {"RECTYPE": "D", "MH": "Catalogs, Union as Topic", "ENTRY": "Union Catalog as Topic|T073|T170|NON|EQV|NLM (2019)|180618|abbcdef", "MN": "L01.462.500.682.290.483", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "do not confuse with the Publication Type CATALOG, UNION", "MS": "Works about lists of books and other information sources held among a cooperating group of LIBRARIES.", "PM": "2019; was CATALOGS, UNION 1966-2018", "HN": "2019(1966); was CATALOGS, UNION 1966-2018", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002383"}, {"RECTYPE": "D", "MH": "Catalysis", "AQ": "DE RE", "ENTRY": "Catalyses", "MN": "G02.130", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "NIM; BIOCATALYSIS is also available", "MS": "The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction.", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002384"}, {"RECTYPE": "D", "MH": "Cataplexy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tonelessness Syndrome|T047|NON|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Tonelessness Syndromes", "MN": "F03.870.400.800.200.750.500", "FX": "Catalepsy", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with CATALEPSY", "MS": "A condition characterized by transient weakness or paralysis of somatic musculature triggered by an emotional stimulus or physical exertion. Cataplexy is frequently associated with NARCOLEPSY. During a cataplectic attack, there is a marked reduction in muscle tone similar to the normal physiologic hypotonia that accompanies rapid eye movement sleep (SLEEP, REM). (From Adams et al., Principles of Neurology, 6th ed, p396)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002385"}, {"RECTYPE": "D", "MH": "Cataract", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT TH UR VE VI", "PRINT ENTRY": "Pseudoaphakia|T047|NON|NRW|NLM (1998)|960822|abcdef", "ENTRY": "Pseudoaphakias", "MN": "C11.510.245", "EC": "surgery:Cataract Extraction", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "lens opacity; do not confuse entry term PSEUDOAPHAKIA (a synonym for membranous cataract) with PSEUDOPHAKIA, the presence of an intraocular lens after cataract extraction", "MS": "Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002386"}, {"RECTYPE": "D", "MH": "Cataract Extraction", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Enzymatic Zonulolysis|T061|NON|REL|NLM (1997)|960412|abcdef", "ENTRY": "Zonulolysis, Enzymatic", "MN": "E04.540.825.249", "FX": "Pseudophakia", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The removal of a cataractous CRYSTALLINE LENS from the eye.", "PM": "ENZYMATIC ZONULOLYSIS was heading 1963-96", "HN": "ENZYMATIC ZONULOLYSIS was heading 1963-96", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D002387"}, {"RECTYPE": "D", "MH": "Catastrophic Illness", "AQ": "CL EC EP MO NU PX RH TH", "ENTRY": "Illnesses, Catastrophic", "MN": "C23.550.291.250", "FX": "Insurance, Major Medical", "MH_TH": "NLM (1982)", "ST": "T047", "AN": "coordinate with specific disease if pertinent", "MS": "An acute or prolonged illness usually considered to be life-threatening or with the threat of serious residual disability. Treatment may be radical and is frequently costly.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19810226", "DC": "1", "DX": "19820101", "UI": "D002388"}, {"RECTYPE": "D", "MH": "Catatonia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Schizophreniform Catatonias", "MN": "F01.700.165", "FX": "Catalepsy", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002389"}, {"RECTYPE": "D", "MH": "Catchment Area, Health", "AQ": "EC LJ SN", "PRINT ENTRY": "Health Service Area|T083|NON|EQV|UNK (19XX)|790601|HEALTH SERV AREA|abcdefv", "ENTRY": "Service Areas, Health", "MN": "N06.850.505.400.800.200", "MH_TH": "NLM (2020)", "ST": "T083", "MS": "A geographic area defined and served by a health program or institution.", "PM": "1978", "HN": "2020 (1978); was CATCHMENT AREA (HEALTH) 1978-2019", "MR": "20181010", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D002391"}, {"RECTYPE": "D", "MH": "Catechin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Catechuic Acid|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|760412|abbcdeef", "ENTRY": "KB53", "MN": "D03.633.100.150.266.450.206", "MH_TH": "NLM (1977)", "ST": "T121", "N1": "2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-trans)-", "RN": "8R1V1STN48", "RR": "490-46-0 (Epicatechin)", "PI": "Catechols (1973-1976)", "MS": "An antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms.", "PM": "87; was see under BENZOPYRANS 1977-86", "HN": "87(77); was see under BENZOPYRANS 1977-86", "MR": "20180702", "DA": "19760413", "DC": "1", "DX": "19870101", "UI": "D002392"}, {"RECTYPE": "D", "MH": "Estrogens, Catechol", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Catechol Estrogens|T109|T125|NON|EQV|NLM (1994)|920811|abbcdef", "ENTRY": "Catecholestrogens|T109|T125|NON|EQV|NLM (1994)|930323|abbcdef", "MN": "D06.472.334.851.437.984", "MH_TH": "NLM (1982)", "ST": "T125", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "specific estrogen (1966-1981)", "MS": "2- or 4-Hydroxyestrogens. Substances that are physiologically active in mammals, especially in the control of gonadotropin secretion. Physiological activity can be ascribed to either an estrogenic action or interaction with the catecholaminergic system.", "OL": "use ESTROGENS, CATECHOL to search CATECHOL ESTROGENS 1982-93", "PM": "94; was CATECHOL ESTROGENS 1982-93; ESTROGENS, CATECHOL was see CATECHOL ESTROGENS 1982-93", "HN": "94; was CATECHOL ESTROGENS 1982-93; ESTROGENS, CATECHOL was see CATECHOL ESTROGENS 1982-93", "MR": "20120703", "DA": "19810513", "DC": "1", "DX": "19820101", "UI": "D002393"}, {"RECTYPE": "D", "MH": "Catechol O-Methyltransferase", "DS": "CATECHOL METHYLTRANSFERASE O", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "O-Methyltransferase, Catechol", "MN": "D08.811.913.555.500.250", "EC": "antagonists & inhibitors:Catechol O-Methyltransferase Inhibitors", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "S-Adenosyl-L-methionine:catechol O-methyltransferase", "RN": "EC 2.1.1.6", "PI": "Transferase (1966-1971)", "MS": "Enzyme that catalyzes the movement of a methyl group from S-adenosylmethionone to a catechol or a catecholamine.", "PM": "98; see CATECHOL METHYLTRANSFERASE 1974-97", "HN": "98(72)", "MR": "20140610", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002394"}, {"RECTYPE": "D", "MH": "Catecholamines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sympathins|T109|T123|NON|EQV|UNK (19XX)|740329|abbcdef", "MN": "D02.455.426.559.389.657.166.175", "FX": "Receptors, Catecholamine", "MH_TH": "NLM (1978)", "ST": "T123", "RN": "0", "MS": "A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002395"}, {"RECTYPE": "D", "MH": "Catechols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ortho-Dihydroxybenzenes|T109|NON|EQV|UNK (19XX)|770520|abcdef", "ENTRY": "ortho Dihydroxybenzenes", "MN": "D02.455.426.559.389.657.166", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A group of 1,2-benzenediols that contain the general formula R-C6H5O2.", "OL": "use CATECHOLS to search CATECHOL 1966-74", "PM": "75; was CATECHOL 1963-74", "HN": "75; was CATECHOL 1963-74", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D002396"}, {"RECTYPE": "D", "MH": "Catfishes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Siluriformes|T013|NON|EQV|NLM (2002)|000809|abcdef", "ENTRY": "Catfish, Colombian", "MN": "B01.050.150.900.493.080", "MH_TH": "NLM (1991)", "ST": "T013", "RN": "txid7995", "RR": "txid93620", "AN": "BULLHEAD CATFISHES, and CHANNEL CATFISH see ICTALURIDAE are also available; entry term EREMOPHILUS MUTISII: EREMOPHILA PLANT, and EREMOPHILA ALPESTRIS see SONGBIRDS are also available", "PI": "Fishes (1966-1986)", "MS": "Common name of the order Siluriformes. This order contains many families and over 2,000 species, including venomous species. Heteropneustes and Plotosus genera have dangerous stings and are aggressive. Most species are passive stingers.", "PM": "2002; see CATFISH 1987-2001", "HN": "2002 (1987)", "MR": "20200813", "DA": "19860415", "DC": "1", "DX": "19870101", "UI": "D002397"}, {"RECTYPE": "D", "MH": "Catgut", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Catguts", "MN": "E07.858.690.820.250", "MH_TH": "NLM (1979)", "ST": "T123", "PI": "Sutures (1966-1978)", "MS": "Sterile collagen strands obtained from healthy mammals. They are used as absorbable surgical ligatures and are frequently impregnated with chromium or silver for increased strength. They tend to cause tissue reaction.", "PM": "91; was see under SUTURES 1979-90", "HN": "91(79); was see under SUTURES 1979-90", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19780201", "DC": "1", "DX": "19910101", "UI": "D002398"}, {"RECTYPE": "D", "MH": "Catharsis", "ENTRY": "Catharses", "MN": "F04.754.720.107.333", "MH_TH": "NLM (1975)", "ST": "T041", "MS": "The release of ideas, thoughts, and repressed material from the unconscious, accompanied by an emotional response and relief. (From Dorland, 28th ed)", "OL": "search ABREACTION 1969-74", "PM": "91; was see under ABREACTION 1975-90", "HN": "91(75); was see under ABREACTION 1975-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002399"}, {"RECTYPE": "D", "MH": "Cathartics", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Purgatives|T121|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Solutions, Bowel Preparation", "MN": "D27.505.954.483.396", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Agents that are used to stimulate evacuation of the bowels.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002400"}, {"RECTYPE": "D", "MH": "Cathepsin B", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteinase, Cathepsin B-Like", "MN": "D08.811.277.656.300.200.133", "MH_TH": "NLM (1987)", "ST": "T126", "RN": "EC 3.4.22.1", "PI": "Cathepsins (1966-1986)", "MS": "A lysosomal cysteine proteinase with a specificity similar to that of PAPAIN. The enzyme is present in a variety of tissues and is important in many physiological and pathological processes. In pathology, cathepsin B has been found to be involved in DEMYELINATION; EMPHYSEMA; RHEUMATOID ARTHRITIS, and NEOPLASM INVASIVENESS.", "PM": "87", "HN": "87", "MR": "20090706", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D002401"}, {"RECTYPE": "D", "MH": "Cathepsin D", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.656.300.048.180", "MH_TH": "NLM (1985)", "ST": "T126", "RN": "EC 3.4.23.5", "PI": "Cathepsins (1966-1984)", "MS": "An intracellular proteinase found in a variety of tissue. It has specificity similar to but narrower than that of pepsin A. The enzyme is involved in catabolism of cartilage and connective tissue. EC 3.4.23.5. (Formerly EC 3.4.4.23).", "PM": "85", "HN": "85", "MR": "20090706", "DA": "19840524", "DC": "1", "DX": "19850101", "UI": "D002402"}, {"RECTYPE": "D", "MH": "Cathepsins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cathepsin|T116|T126|NON|EQV|UNK (19XX)|780518|abbcdef", "MN": "D08.811.277.656.224", "MH_TH": "NLM (1963)", "ST": "T126", "RN": "EC 3.4.-", "AN": "note specifics", "MS": "A group of lysosomal proteinases or endopeptidases found in aqueous extracts of a variety of animal tissues. They function optimally within an acidic pH range. The cathepsins occur as a variety of enzyme subtypes including SERINE PROTEASES; ASPARTIC PROTEINASES; and CYSTEINE PROTEASES.", "OL": "use CATHEPSINS to search CATHEPSIN 1966-78", "PM": "79; was CATHEPSIN 1965-78", "HN": "79; was CATHEPSIN 1963-78 (Prov 1963-64)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002403"}, {"RECTYPE": "D", "MH": "Catheterization", "DE": "CATH", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Cannulation|T061|NON|REL|UNK (19XX)|760512|abcdef", "ENTRY": "Catheterizations", "MN": "E05.157", "FX": "Venous Cutdown", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "MS": "Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002404"}, {"RECTYPE": "D", "MH": "Catheterization, Central Venous", "DE": "CATH CENTRAL VENOUS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Venous Catheterization, Central|T060|T061|NON|EQV|NLM (1991)|900515|VENOUS CATH CENTRAL|abbcdefv", "ENTRY": "Venous Catheterizations, Central", "MN": "E05.157.313", "FX": "Venous Cutdown", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Catheters, Indwelling (1978-1987)", "MS": "Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19870509", "DC": "1", "DX": "19880101", "UI": "D002405"}, {"RECTYPE": "D", "MH": "Catheterization, Peripheral", "DE": "CATH PERIPHERAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Venous Catheterization, Peripheral|T060|T061|NON|NRW|NLM (1991)|900515|VENOUS CATH PERIPHERAL|abbcdefv", "ENTRY": "Venous Catheterizations, Peripheral", "MN": "E05.157.375", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Heart Catheterization (1966-1987)", "MS": "Insertion of a catheter into a peripheral artery, vein, or airway for diagnostic or therapeutic purposes.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19870509", "DC": "1", "DX": "19880101", "UI": "D002406"}, {"RECTYPE": "D", "MH": "Catheterization, Swan-Ganz", "DE": "CATH SWAN GANZ", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Swan-Ganz Catheterization|T060|EPO|EQV|UNK (19XX)|870509|SWAN GANZ CATH|abcdefv", "ENTRY": "Swan Ganz Catheterization", "MN": "E05.157.375.165", "FX": "Pulmonary Wedge Pressure", "MH_TH": "NLM (1988)", "ST": "T060", "PI": "Heart Catheterization (1971-1987)", "MS": "Placement of a balloon-tipped catheter into the pulmonary artery through the antecubital, subclavian, and sometimes the femoral vein. It is used to measure pulmonary artery pressure and pulmonary artery wedge pressure which reflects left atrial pressure and left ventricular end-diastolic pressure. The catheter is threaded into the right atrium, the balloon is inflated and the catheter follows the blood flow through the tricuspid valve into the right ventricle and out into the pulmonary artery.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19870509", "DC": "1", "DX": "19880101", "UI": "D002407"}, {"RECTYPE": "D", "MH": "Catheters, Indwelling", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Implantable Catheters|T074|NON|NRW|NLM (1990)|890512|abcdef", "ENTRY": "Indwelling Catheters", "MN": "E07.132.500", "FX": "Infusion Pumps, Implantable", "MH_TH": "NLM (1975)", "ST": "T074", "AN": "coordinate with specific site (NIM) if pertinent", "PI": "Urinary Catheterization (1966-1974)", "MS": "Catheters designed to be left within an organ or passage for an extended period of time.", "OL": "use CATHETERS, INDWELLING to search INDWELLING CATHETER 1975-77; use URINARY CATHETERIZATION 1966-74", "PM": "78; was INDWELLING CATHETER see under URINARY CATHETERIZATION 1963-77", "HN": "78; was INDWELLING CATHETER see under URINARY CATHETERIZATION 1963-77", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D002408"}, {"RECTYPE": "D", "MH": "Cathexis", "MN": "F01.393.246.250", "MH_TH": "NLM (1975)", "ST": "T041", "MS": "Attachment, conscious or unconscious, of emotional feeling and significance to an idea, object or most commonly a person.", "OL": "search DISPLACEMENT (PSYCHOLOGY) 1974", "PM": "91; was see under DISPLACEMENT (PSYCHOLOGY) 1975-90", "HN": "91(75); was see under DISPLACEMENT (PSYCHOLOGY) 1975-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002409"}, {"RECTYPE": "D", "MH": "Catholicism", "AQ": "HI PX", "ENTRY": "Roman Catholic Ethic", "MN": "K01.844.188.250", "MH_TH": "POPLINE (1978)", "ST": "T078", "AN": "IM; specify geog if pertinent", "MS": "The Christian faith, practice, or system of the Catholic Church, specifically the Roman Catholic, the Christian church that is characterized by a hierarchic structure of bishops and priests in which doctrinal and disciplinary authority are dependent upon apostolic succession, with the pope as head of the episcopal college. (From Webster, 3d ed; American Heritage Dictionary, 2d college ed)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002410"}, {"RECTYPE": "D", "MH": "Cation Exchange Resins", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Cation Exchange Resin|T122|T130|NON|EQV|NLM (2022)|200824|abbcdef", "ENTRY": "Resins, Cation Exchange", "MN": "D27.720.470.420.275", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "0", "MS": "High molecular weight insoluble polymers which contain functional anionic groups that are capable of undergoing exchange reactions with cations.", "OL": "search ION EXCHANGE RESINS 1966-74", "PM": "91; was see under ION EXCHANGE RESINS 1975-90", "HN": "91(75); was see under ION EXCHANGE RESINS 1975-90", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002411"}, {"RECTYPE": "D", "MH": "Cations", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cation|T104|NON|EQV|NLM (2021)|191230|abcdef", "MN": "D01.248.497.300", "MH_TH": "NLM (1978)", "ST": "T104", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Ions (1966-1977)", "MS": "Positively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis.", "PM": "78", "HN": "78", "MR": "20200527", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D002412"}, {"RECTYPE": "D", "MH": "Cations, Divalent", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Divalent Cations|T104|NON|EQV|NLM (2008)|060612|abcdef", "MN": "D01.248.497.300.333", "MH_TH": "NLM (1973)", "ST": "T104", "RN": "0", "AN": "general only: prefer specifics", "PI": "specific element(1966-1972)", "MS": "Positively charged atoms, radicals or groups of atoms with a valence of plus 2, which travel to the cathode or negative pole during electrolysis.", "PM": "73", "HN": "73", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002413"}, {"RECTYPE": "D", "MH": "Cations, Monovalent", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Monovalent Cation|T104|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Monovalent Cations", "MN": "D01.248.497.300.459", "MH_TH": "NLM (1973)", "ST": "T104", "RN": "0", "AN": "IM general or unspecified only; prefer specifics", "PI": "specific element ( - )", "MS": "Positively charged atoms, radicals or group of atoms with a valence of plus 1, which travel to the cathode or negative pole during electrolysis.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002414"}, {"RECTYPE": "D", "MH": "Cats", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Felis domesticus|T015|NON|EQV|NLM (2005)|030805|abcdef", "ENTRY": "Domestic Cat", "MN": "B01.050.150.900.649.313.750.377.750.250.125", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid9685", "AN": "check tag: no qualifiers; restrict to domestic cat", "CX": "consider also terms at FELINE", "MS": "The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002415"}, {"RECTYPE": "D", "MH": "Cattell Personality Factor Questionnaire", "AQ": "HI SN ST", "MN": "F04.711.647.513.146", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "Self report questionnaire which yields 16 scores on personality traits, such as reserved vs. outgoing, humble vs. assertive, etc.", "OL": "search PERSONALITY INVENTORY 1968-74", "PM": "91; was see under PERSONALITY INVENTORY 1975-90", "HN": "91(75); was see under PERSONALITY INVENTORY 1975-90", "CATSH": "CAT LIST", "MR": "19920507", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002416"}, {"RECTYPE": "D", "MH": "Cattle", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Zebu|T015|NON|NRW|NLM (2003)|011116|abcdef", "ENTRY": "Zebus", "MN": "B01.050.150.900.649.313.500.380.271", "MH_TH": "NLM (1966)", "ST": "T015", "RR": "txid9915", "AN": "not for all Bovidae: only cows, yaks & zebus", "CX": "consider also terms at BOVINE", "MS": "Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002417"}, {"RECTYPE": "D", "MH": "Cattle Diseases", "DE": "CATTLE DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Diseases, Cattle", "MN": "C22.196", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "IM GEN or unspecified; coord IM with specific dis /vet (IM) or specific cattle dis (IM); for abnormalities or injuries, index under CATTLE /abnorm or CATTLE /inj; includes diseases of yaks & zebus but does not include diseases of BISON or BUFFALOES; don't forget also check tags CATTLE (NIM) & ANIMALS", "MS": "Diseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus.", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002418"}, {"RECTYPE": "D", "MH": "Cauda Equina", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Filum Terminale|T023|NON|NRW|UNK (19XX)|780522|abcdef", "ENTRY": "Terminale, Filum", "MN": "A08.800.800.720.725.150", "FX": "Spinal Cord", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "disease: coordinate IM with PERIPHERAL NERVOUS SYSTEM DISEASES (IM); neoplasms: coordinate IM with PERIPHERAL NERVOUS SYSTEM NEOPLASMS (IM); cauda equina syndrome: CAUDA EQUINA SYNDROME see POLYRADICULOPATHY is available", "MS": "The lower part of the SPINAL CORD consisting of the lumbar, sacral, and coccygeal nerve roots.", "OL": "use CAUDA EQUINA to search FILUM TERMINALE 1966-78", "PM": "FILUM TERMINALE was see under CAUDA EQUINA 1963-78", "HN": "FILUM TERMINALE was see under CAUDA EQUINA 1963-78", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002420"}, {"RECTYPE": "D", "MH": "Caudate Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nucleus, Caudate", "MN": "A08.186.211.200.885.287.249.487.550.184", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain.", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002421"}, {"RECTYPE": "D", "MH": "Causalgia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Complex Regional Pain Syndrome Type II|T047|NON|EQV|NLM (2000)|991103|CRPS II|abcdefv", "ENTRY": "Syndromes, Causalgia", "MN": "C10.668.829.600.200", "MH_TH": "NLM (1971)", "ST": "T047", "AN": "coord IM with specific nerve (IM)", "PI": "Neuralgia (1966-1970)", "MS": "A complex regional pain syndrome characterized by burning pain and marked sensitivity to touch (HYPERESTHESIA) in the distribution of an injured peripheral nerve. Autonomic dysfunction in the form of sudomotor (i.e., sympathetic innervation to sweat glands), vasomotor, and trophic skin changes may also occur. (Adams et al., Principles of Neurology, 6th ed, p1359)", "PM": "1991; was see under NEURALGIA 1971-1990", "HN": "1991(1971); was see under NEURALGIA 1971-1990", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002422"}, {"RECTYPE": "D", "MH": "Cause of Death", "AQ": "TD", "ENTRY": "Death Causes", "MN": "N06.850.520.308.985.550.250", "MH_TH": "NLM (1988)", "ST": "T078", "AN": "note categories; do not use for cause of death in every clinical case; restrict to cause of death as an epidemiological consideration: \"mortality by cause of death\", \"certification of cause of death\"; probably IM in such cases; coord NIM with specific disease /mortal (IM); specify geog if pertinent", "PI": "Mortality (1966-1987)", "MS": "Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19870513", "DC": "1", "DX": "19880101", "UI": "D002423"}, {"RECTYPE": "D", "MH": "Caustics", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Corrosives|T131|NON|BRD|NLM (1998)|970114|abcdef", "MN": "D27.888.569.185", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "caustic injury: index CAUSTICS /tox + BURNS, CHEMICAL + organ /inj; see also note on ESOPHAGEAL STENOSIS", "MS": "Strong alkaline chemicals that destroy soft body tissues resulting in a deep, penetrating type of burn, in contrast to corrosives, that result in a more superficial type of damage via chemical means or inflammation. Caustics are usually hydroxides of light metals. SODIUM HYDROXIDE and potassium hydroxide are the most widely used caustic agents in industry. Medically, they have been used externally to remove diseased or dead tissues and destroy warts and small tumors. The accidental ingestion of products (household and industrial) containing caustic ingredients results in thousands of injuries per year.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002424"}, {"RECTYPE": "D", "MH": "Cautery", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Cauterizations", "MN": "E04.014.170", "FX": "Electrocoagulation", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "coordinate with organ or disease /surg", "MS": "The application of a caustic substance, a hot instrument, an electric current, or other agent to control bleeding while removing or destroying tissue.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002425"}, {"RECTYPE": "D", "MH": "Cavernous Sinus", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Sinus, Cavernous", "MN": "A07.015.908.224.334", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "An irregularly shaped venous space in the dura mater at either side of the sphenoid bone.", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002426"}, {"RECTYPE": "D", "MH": "Cebidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Platyrrhina|T015|NON|EQV|UNK (19XX)|800507|abcdef", "ENTRY": "Platyrrhinas", "MN": "B01.050.150.900.649.313.988.400.600.150", "MH_TH": "NLM (1981)", "ST": "T015", "RN": "txid9498", "AN": "index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)", "MS": "A family of New World monkeys in the infraorder PLATYRRHINI, consisting of nine subfamilies: ALOUATTINAE; AOTINAE; Atelinae; Callicebinae; CALLIMICONINAE; CALLITRICHINAE; CEBINAE; Pithecinae; and SAIMIRINAE. They inhabit the forests of South and Central America, comprising the largest family of South American monkeys.", "PM": "81", "HN": "81", "MR": "20200813", "DA": "19800507", "DC": "1", "DX": "19810101", "UI": "D002427"}, {"RECTYPE": "D", "MH": "Cebus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "White-Fronted Capuchin|T015|NON|EQV|NLM (2020)|190325|abcdef", "ENTRY": "White-Fronted Capuchins", "MN": "B01.050.150.900.649.313.988.400.600.150.170.120", "MH_TH": "NLM (1981)", "ST": "T015", "RN": "txid9513", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES; CEBUS ELEGANS, CEBUS FLAVIUS and CEBUS XANTHOSTERNOS see SAPAJUS are also available; CEBUS APELLA see SAPAJUS  APELLA is also available", "PI": "Anthropoidea (1966-1980)", "MS": "A genus of the family CEBIDAE, subfamily CEBINAE, consisting of gracile or untufted capuchin species. Tufted capuchins belong to genus SAPAJUS. Members include C. capucinus, C. nigrivultatus, and C. albifrons. Cebus inhabits the forests of Central and South Americas.", "PM": "91; was see under CEBIDAE 1981-90", "HN": "91(81); was see under CEBIDAE 1981-90", "MR": "20210630", "DA": "19800507", "DC": "1", "DX": "19910101", "UI": "D002428"}, {"RECTYPE": "D", "MH": "Cecal Diseases", "DE": "CECAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Cecal", "MN": "C06.405.469.110", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological developments in the CECUM.", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002429"}, {"RECTYPE": "D", "MH": "Cecal Neoplasms", "DE": "CECAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cecal Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Cecal", "MN": "C06.405.469.491.184", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the CECUM.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002430"}, {"RECTYPE": "D", "MH": "Cecostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Tube Cecostomy|T061|NON|NRW|UNK (19XX)|870319|abcdef", "ENTRY": "Tube Cecostomies", "MN": "E04.579.338.175", "FX": "Surgical Stomas", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Cecum/surgery (1966-1987)", "MS": "Surgical construction of an opening into the CECUM with a tube through the ABDOMINAL WALL (tube cecostomy) or by skin level approach, in which the cecum is sewn to the surrounding PERITONEUM. Its primary purpose is decompression of colonic obstruction.", "PM": "91; was see under ENTEROSTOMY 1988-90", "HN": "91(88); was see under ENTEROSTOMY 1988-90", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19870319", "DC": "1", "DX": "19910101", "UI": "D002431"}, {"RECTYPE": "D", "MH": "Cecum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cecums", "MN": "A03.556.249.249.209", "FX": "Cecostomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The blind sac or outpouching area of the LARGE INTESTINE that is below the entrance of the SMALL INTESTINE. It has a worm-like extension, the vermiform APPENDIX.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002432"}, {"RECTYPE": "D", "MH": "Cefaclor", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "S6472", "MN": "D03.633.100.300.249.200.155", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "RN": "69K7K19H4L", "RR": "53994-73-3 (Cefaclor)", "PI": "Cephalosporins (1966-1979)", "MS": "Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN.", "PM": "1991; CEFACLOR was indexed under CEPHALEXIN 1980-1990", "HN": "1991 (1980)", "MR": "20180521", "DA": "19790301", "DC": "1", "DX": "19910101", "UI": "D002433"}, {"RECTYPE": "D", "MH": "Cefadroxil", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "S 578", "MN": "D03.633.100.300.249.200.165", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "RN": "280111G160", "RR": "Q525PA8JJB", "PI": "Cephalosporins (1966-1971)", "MS": "Long-acting, broad-spectrum, water-soluble, CEPHALEXIN derivative.", "HN": "1984", "MR": "20180521", "DA": "19830610", "DC": "1", "DX": "19840101", "UI": "D002434"}, {"RECTYPE": "D", "MH": "Cefamandole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compound 83405|T109|T121|LAB|NRW|UNK (19XX)|800731|abbcdef", "MN": "D03.633.100.300.249.150", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1973)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R*)))-", "RN": "5CKP8C2LLI", "RR": "34444-01-4 (Cefamandole)", "PI": "Cephalosporins (1966-1977)", "MS": "Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate.", "PM": "84; was see under CEPHALOSPORINS 1978-83", "HN": "84(78); was see under CEPHALOSPORINS 1978-83", "MR": "20160527", "DA": "19770422", "DC": "1", "DX": "19840101", "UI": "D002435"}, {"RECTYPE": "D", "MH": "Cefatrizine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SKF60771", "MN": "D03.633.100.300.249.200.165.125", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1975)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-((1H-1,2,3-triazol-4-ylthio)methyl)-, (6R-(6alpha,7beta(R*)))-", "RN": "8P4W949T8K", "RR": "51627-14-6 (Cefatrizine)", "PI": "Cephalosporins (1966-1977)", "MS": "Orally active semisynthetic cephalosporin antibiotic with broad-spectrum activity.", "PM": "91; was see under CEPHALOSPORINS 1978-90", "HN": "91(78); was see under CEPHALOSPORINS 1978-90", "MR": "20160527", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D002436"}, {"RECTYPE": "D", "MH": "Cefazolin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cephazolin|T109|T195|NON|EQV|BAN (19XX)|741111|abbcdef", "ENTRY": "Sodium, Cephazolin", "MN": "D03.633.100.300.249.160", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-((1H-tetrazol-1-ylacetyl)amino)-, (6R-trans)-", "RN": "IHS69L0Y4T", "RR": "P380M0454Z", "PI": "Thiadiazoles (1973-1974)", "MS": "A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.", "PM": "80; was see under CEPHALOSPORINS 1975-79", "HN": "80(75); was see under CEPHALOSPORINS 1975-79", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D002437"}, {"RECTYPE": "D", "MH": "Cefoperazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "T 1551", "MN": "D03.633.100.300.249.150.160", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R*)))-", "RN": "7U75I1278D", "RR": "62893-20-3 (Na salt)", "PI": "Cephalosporins (1966-1983)", "MS": "Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections.", "PM": "84", "HN": "84", "MR": "20170524", "DA": "19830404", "DC": "1", "DX": "19840101", "UI": "D002438"}, {"RECTYPE": "D", "MH": "Cefotaxime", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Cefotaxime", "MN": "D03.633.100.300.249.190.190", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(Z)))-", "RN": "N2GI8B1GK7", "RR": "64485-93-4 (mono-Na salt)", "PI": "Cephalosporins (1966-1981)", "MS": "Semisynthetic broad-spectrum cephalosporin.", "PM": "82", "HN": "82", "MR": "20170524", "DA": "19810513", "DC": "1", "DX": "19820101", "UI": "D002439"}, {"RECTYPE": "D", "MH": "Cefoxitin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Cefoxitin", "MN": "D03.633.100.300.249.250.222", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1973)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-methoxy-8-oxo-7-((2-thienylacetyl)amino)-, (6R-cis)-", "RN": "6OEV9DX57Y", "RR": "Q68050H03T", "PI": "Cephalosporins (1974)", "MS": "A semisynthetic cephamycin antibiotic resistant to beta-lactamase.", "PM": "80; was see under CEPHALOSPORINS 1975-79", "HN": "80(75); was see under CEPHALOSPORINS 1975-79", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19800101", "UI": "D002440"}, {"RECTYPE": "D", "MH": "Cefsulodin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Cefsulodin", "MN": "D03.633.100.300.249.185", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "Pyridinium, 4-(aminocarbonyl)-1-((2-carboxy-8-oxo-7-((phenylsulfoacetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, monosodium salt, (6R-(6alpha,7beta(R*)))-", "RN": "OV42LHE42B", "RR": "62587-73-9 (Cefsulodin)", "PI": "Cephalosporins (1966-1984)", "MS": "A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients.", "PM": "85", "HN": "85", "MR": "20170524", "DA": "19840524", "DC": "1", "DX": "19850101", "UI": "D002441"}, {"RECTYPE": "D", "MH": "Ceftazidime", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "LY139381", "MN": "D03.633.100.300.249.210.150", "MH_TH": "USP (19XX)", "ST": "T195", "RN": "9M416Z9QNR", "RR": "DZR1ENT301", "PI": "Cephalosporins (1966-1984)", "MS": "Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.", "HN": "1985", "MR": "20230811", "DA": "19840524", "DC": "1", "DX": "19850101", "UI": "D002442"}, {"RECTYPE": "D", "MH": "Ceftriaxone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro139904", "MN": "D03.633.100.300.249.190.190.155", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, (6R-(6alpha,7beta(Z)))-", "RN": "75J73V1629", "RR": "R598PB148Q", "PI": "Cephalosporins (1966-1981)", "MS": "A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears.", "PM": "1986", "HN": "1986", "MR": "20230811", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D002443"}, {"RECTYPE": "D", "MH": "Cefuroxime", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Zinacef|T109|T195|TRD|NRW|UNK (19XX)|861119|abbcdef", "MN": "D03.633.100.300.249.188", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1984)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))-", "RN": "O1R9FJ93ED", "RR": "55268-75-2 (Cefuroxime)", "PI": "Cephalosporins (1966-1979)", "MS": "Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.", "PM": "91; was see under CEPHALOSPORINS 1980-90", "HN": "91(80); was see under CEPHALOSPORINS 1980-90", "MR": "20180410", "DA": "19790301", "DC": "1", "DX": "19910101", "UI": "D002444"}, {"RECTYPE": "D", "MH": "Celiac Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Celiac Arteries", "MN": "A07.015.114.207", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The arterial trunk that arises from the abdominal aorta and after a short course divides into the left gastric, common hepatic and splenic arteries.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002445"}, {"RECTYPE": "D", "MH": "Celiac Disease", "DE": "CELIAC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sprue, Nontropical|T047|NON|EQV|NLM (2004)|030501|abcdef", "ENTRY": "Nontropical Sprue", "MN": "C18.452.603.250", "FX": "Wheat Hypersensitivity", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "do not confuse with SPRUE, TROPICAL", "MS": "A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002446"}, {"RECTYPE": "D", "MH": "Celiac Plexus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Solar Plexus|T023|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Plexus, Solar", "MN": "A08.800.800.060.150", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "the largest autonomic plexus; in the abdomen", "MS": "A complex network of nerve fibers including sympathetic and parasympathetic efferents and visceral afferents. The celiac plexus is the largest of the autonomic plexuses and is located in the abdomen surrounding the celiac and superior mesenteric arteries.", "MR": "19930618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002447"}, {"RECTYPE": "D", "MH": "Cell Adhesion", "AQ": "DE ES GE IM PH RE", "ENTRY": "Cell Adhesions", "MN": "G04.022", "MH_TH": "NLM (1970)", "ST": "T043", "AN": "permitted with micro-organisms but BACTERIAL ADHESION is available", "PI": "Cytology (1966-1969)", "MS": "Adherence of cells to surfaces or to other cells.", "PM": "72", "HN": "72(70)", "CATSH": "CAT LIST", "MR": "20160125", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002448"}, {"RECTYPE": "D", "MH": "Cell Aggregation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Cell Aggregations", "MN": "G04.198.251", "MH_TH": "NLM (1965)", "ST": "T043", "AN": "NIM; not for micro-organisms", "MS": "The phenomenon by which dissociated cells intermixed in vitro tend to group themselves with cells of their own type.", "PM": "68", "HN": "68(65)", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002449"}, {"RECTYPE": "D", "MH": "Cell Communication", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Cell-to-Cell Interaction|T043|NON|EQV|NLM (1998)|960802|CELL CELL INTERACTION|abcdefv", "ENTRY": "Interactions, Cell-to-Cell", "MN": "G04.085", "FX": "Signal Transduction", "MH_TH": "NLM (1978)", "ST": "T043", "AN": "not for micro-organisms", "PI": "Intercellular Junctions (1970-1977)", "MS": "Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19770516", "DC": "1", "DX": "19780101", "UI": "D002450"}, {"RECTYPE": "D", "MH": "Cell Compartmentation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Compartmentations, Cell", "MN": "G04.128", "MH_TH": "NLM (1978)", "ST": "T043", "AN": "permitted with micro-organisms", "MS": "A partitioning within cells due to the selectively permeable membranes which enclose each of the separate parts, e.g., mitochondria, lysosomes, etc.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19770301", "DC": "1", "DX": "19780101", "UI": "D002451"}, {"RECTYPE": "D", "MH": "Cell Count", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Cell Number|T034|NON|EQV|UNK (19XX)|790524|abcdef", "ENTRY": "Numbers, Cell", "MN": "G04.140", "FX": "Sperm Count", "MH_TH": "NLM (1969)", "ST": "T034", "AN": "usually NIM; not for micro-organisms", "PI": "Cytology (1966-1968)", "MS": "The number of CELLS of a specific kind, usually measured per unit volume or area of sample.", "OL": "use CELL COUNT to search CELL NUMBER 1978-79", "PM": "73; CELL NUMBER was heading 1978-79", "HN": "73(69); CELL NUMBER was heading 1978-79", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002452"}, {"RECTYPE": "D", "MH": "Cell Cycle", "AQ": "DE GE IM PH RE", "ENTRY": "Division Cycles, Cell", "MN": "G04.144", "FX": "Genes, cdc", "MH_TH": "NLM (1978)", "ST": "T043", "AN": "coordinate with specific cell /cytol; permitted with microorganisms", "PI": "Mitosis (1968-1977)", "MS": "The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19770504", "DC": "1", "DX": "19780101", "UI": "D002453"}, {"RECTYPE": "D", "MH": "Cell Differentiation", "DE": "CELL DIFFER", "AQ": "DE GE IM PH RE", "ENTRY": "Differentiations, Cell", "MN": "G04.152", "FX": "Cell Lineage", "MH_TH": "NLM (1964)", "ST": "T043", "AN": "not for micro-organisms; CELL DEDIFFERENTIATION and CELL TRANSDIFFERENTIATION are also available", "MS": "Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002454"}, {"RECTYPE": "D", "MH": "Cell Division", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "M Phase|T043|NRW|NLM (1991)|900220|abdef", "ENTRY": "Phases, M", "MN": "G07.345.249.410.750.500", "FX": "Genes, cdc", "MH_TH": "NLM (1966)", "ST": "T043", "AN": "coordinate with specific cell /cytol; permitted with microorganisms; for cell division of cytoplasm only, use CYTOKINESIS; note entry term M PHASE: MITOTIC M PHASE and MEIOTIC M PHASE are also available", "MS": "The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.", "PM": "1963; for M PHASE see MITOSIS 1991-2004", "HN": "1963 for M PHASE use MITOSIS 1991-2004", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D002455"}, {"RECTYPE": "D", "MH": "Cell Extracts", "AQ": "AD AE AG AI AN CH CL CS EC GE HI IM IP PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cell Extract|T026|NON|EQV|NLM (2021)|200319|abcdef", "ENTRY": "Extracts, Cell", "MN": "D20.777.162", "MH_TH": "NLM (1977)", "ST": "T026", "RN": "0", "AN": "extracts of cells or cell fractions containing uncharacterized factors; do not confuse with chemical substances \"extracted\" from cells; not for micro-organisms", "PI": "Tissue Extracts (1966-1976)", "MS": "Preparations of cell constituents or subcellular materials, isolates, or substances.", "PM": "91; was see under TISSUE EXTRACTS 1977-90", "HN": "91(77); was see under TISSUE EXTRACTS 1977-90", "MR": "20200527", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D002457"}, {"RECTYPE": "D", "MH": "Cell Fractionation", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Fractionations, Cell", "MN": "E05.242.251", "FX": "Subcellular Fractions", "MH_TH": "NLM (1971)", "ST": "T059", "AN": "do not confuse with CELL SEPARATION; NIM, no qualif; when IM, /instrum /methods permitted; permitted with micro-organisms", "PI": "Cytology (1966-1970)", "MS": "Techniques to partition various components of the cell into SUBCELLULAR FRACTIONS.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002458"}, {"RECTYPE": "D", "MH": "Cell Fusion", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Fusions, Cell", "MN": "G04.155", "FX": "Hybrid Cells", "MH_TH": "NLM (1971)", "ST": "T062", "PI": "Cytology (1966-1970)", "MS": "Fusion of somatic cells in vitro or in vivo, which results in somatic cell hybridization.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002459"}, {"RECTYPE": "D", "MH": "Cell Line", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Lines, Cell", "MN": "A11.251.210", "MH_TH": "NLM (1969)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMALS or HUMAN; do not routinely add tissue or organ; policy: Manual 21.57, 22.26.1", "PI": "Tissue Culture (1966-1968)", "MS": "Established cell cultures that have the potential to propagate indefinitely.", "PM": "72", "HN": "72(69)", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002460"}, {"RECTYPE": "D", "MH": "Cell Line, Transformed", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Transformed Cell Line|T025|NON|EQV|UNK (19XX)|870511|abcdef", "ENTRY": "Transformed Cell Lines", "MN": "A11.251.210.172", "FX": "Cell Transformation, Viral", "MH_TH": "NLM (1988)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMALS or HUMAN; do not routinely add tissue or organ", "PI": "Tissue Culture (1966-1976)", "MS": "Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals.", "PM": "88", "HN": "88", "MR": "20030730", "DA": "19870511", "DC": "1", "DX": "19880101", "UI": "D002461"}, {"RECTYPE": "D", "MH": "Cell Membrane", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Plasma Membrane|T026|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Plasma Membranes", "MN": "A11.284.149", "FX": "Synaptic Membranes", "MH_TH": "NLM (1964)", "ST": "T026", "AN": "coordinate with specific cell /ultrastruct; permitted with micro-organisms", "MS": "The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.", "PM": "65", "HN": "65(64)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002462"}, {"RECTYPE": "D", "MH": "Cell Membrane Permeability", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Permeability, Cell Membrane|T043|NON|EQV|UNK (19XX)|740329|abcdef", "MN": "G04.175", "FX": "Ionophores", "MH_TH": "NLM (1965)", "ST": "T043", "AN": "coord with substance /pharmacokin (IM) or /metab (IM); for cell membrane only; intracellular membrane permeability: index INTRACELLULAR MEMBRANES + specific organelle + PERMEABILITY", "MS": "A quality of cell membranes which permits the passage of solvents and solutes into and out of cells.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002463"}, {"RECTYPE": "D", "MH": "Cell Migration Inhibition", "DE": "CELL MIGRATION INHIB", "AQ": "DE GE IM PH RE", "ENTRY": "Inhibitions, Chemotaxis", "MN": "G04.198.337", "FX": "Macrophage Migration-Inhibitory Factors", "MH_TH": "NLM (1971)", "ST": "T059", "AN": "coordinate with specific cell/immunol; do not confuse with LEUKOCYTE ADHERENCE INHIBITION TEST", "PI": "Tissue Culture (1966-1970)", "MS": "Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated LEUKOCYTES or MACROPHAGES. Specific CELL MIGRATION ASSAYS have been developed to estimate levels of migration inhibitory factors, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms.", "PM": "72", "HN": "72(71)", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002464"}, {"RECTYPE": "D", "MH": "Cell Movement", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Movement, Cell|T043|NON|EQV|UNK (19XX)|850225|abcdef", "ENTRY": "Movements, Cell", "MN": "G07.568.500.180", "FX": "Cell Tracking", "MH_TH": "NLM (1968)", "ST": "T043", "AN": "not for microorganisms; do not confuse with CYTOKINESIS or CYTOPLASMIC STREAMING", "PI": "specific cell or tissue/cytology (1966-1967)", "MS": "The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D002465"}, {"RECTYPE": "D", "MH": "Cell Nucleolus", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Plasmosome|T026|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Plasmosomes", "MN": "A11.284.430.106.279.345.175", "FX": "Nucleolus Organizer Region", "MH_TH": "NLM (1965)", "ST": "T026", "MS": "Within most types of eukaryotic CELL NUCLEUS, a distinct region, not delimited by a membrane, in which some species of rRNA (RNA, RIBOSOMAL) are synthesized and assembled into ribonucleoprotein subunits of ribosomes. In the nucleolus rRNA is transcribed from a nucleolar organizer, i.e., a group of tandemly repeated chromosomal genes which encode rRNA and which are transcribed by RNA polymerase I. (Singleton & Sainsbury, Dictionary of Microbiology & Molecular Biology, 2d ed)", "PM": "67", "HN": "67(65)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002466"}, {"RECTYPE": "D", "MH": "Cell Nucleus", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "ENTRY": "Nucleus, Cell", "MN": "A11.284.430.214.190.875.117", "FX": "Karyometry", "EC": "transplantation:Nuclear Transfer Techniques", "MH_TH": "NLM (1966)", "ST": "T026", "MS": "Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002467"}, {"RECTYPE": "D", "MH": "Cell Physiological Phenomena", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Cell Physiology|T043|NON|EQV|NLM (1966)|990101|CELL PHYSIOL|abcdefv", "ENTRY": "Processes, Cell Physiological", "MN": "G04", "RH": "G4 - CELL PHYSIOLOGICAL PHENOMENA", "MH_TH": "NLM (2009)", "ST": "T043", "AN": "general or unspecified; prefer specifics", "PI": "Cells/physiology (1968-1997)", "MS": "Cellular processes, properties, and characteristics.", "PM": "2009; see CELL PHYSIOLOGY 1998-2008; for CELL PHYSIOLOGICCAL PROCESSES see CELL PHYSIOLOGICCAL PROCESSES 2009-2016", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D002468"}, {"RECTYPE": "D", "MH": "Cell Separation", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Cell Segregation|T059|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Separations, Cell", "MN": "E05.242.363", "FX": "Plasmapheresis", "MH_TH": "NLM (1972)", "ST": "T059", "AN": "do not confuse with CELL FRACTIONATION; not for micro-organisms; FLUORESCENCE-ACTIVATED CELL SORTING see FLOW CYTOMETRY is also available", "MS": "Techniques for separating distinct populations of cells.", "PM": "74", "HN": "74(72)", "CATSH": "CAT LIST", "MR": "20151216", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002469"}, {"RECTYPE": "D", "MH": "Cell Survival", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Cell Viability|T043|NON|EQV|NLM (1991)|900305|abcdef", "ENTRY": "Viability, Cell", "MN": "G04.346", "MH_TH": "NLM (1971)", "ST": "T043", "AN": "NIM; not for micro-organisms", "PI": "specific cell (1966-1970)", "MS": "The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.", "PM": "76; was see under CYTOLOGY 1975", "HN": "76(71); was see under CYTOLOGY 1975", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D002470"}, {"RECTYPE": "D", "MH": "Cell Transformation, Neoplastic", "DE": "CELL TRANSFORM NEOPL", "AQ": "CH CI CL DE GE IM ME PA RE UL", "PRINT ENTRY": "Neoplastic Transformation, Cell|T191|NON|EQV|UNK (19XX)|740329|NEOPL TRANSFORM CELL|abcdefv", "ENTRY": "Tumorigenic Transformations", "MN": "C23.550.727.098.500", "FX": "Antigens, Differentiation", "MH_TH": "NLM (1968)", "ST": "T191", "AN": "do not confuse with CELL DIFFERENTIATION, a normal process in morphogenesis", "PI": "Neoplasms, Experimental (1966-1967)", "MS": "Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D002471"}, {"RECTYPE": "D", "MH": "Cell Transformation, Viral", "DE": "CELL TRANSFORM VIRAL", "AQ": "DE ES GE IM PH RE", "ENTRY": "Viral Cell Transformations", "MN": "G06.920.143", "FX": "Antigens, Viral, Tumor", "MH_TH": "NLM (1978)", "ST": "T045", "AN": "do not confuse with CYTOPATHOGENIC EFFECT, VIRAL ", "PI": "Neoplasms, Experimental (1966-1967)", "MS": "An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19770513", "DC": "1", "DX": "19780101", "UI": "D002472"}, {"RECTYPE": "D", "MH": "Cell Wall", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Walls, Cell", "MN": "A11.284.183", "MH_TH": "NLM (1966)", "ST": "T026", "MS": "The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents.", "PM": "67", "HN": "67(66)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002473"}, {"RECTYPE": "D", "MH": "Cell-Free System", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Systems, Cellfree", "MN": "A11.284.835.168", "MH_TH": "NLM (1967)", "ST": "T075", "AN": "for study of subcellular fractions; not for micro-organisms; NIM; use A 11 qualif discreetly", "MS": "A fractionated cell extract that maintains a biological function. A subcellular fraction isolated by ultracentrifugation or other separation techniques must first be isolated so that a process can be studied free from all of the complex side reactions that occur in a cell. The cell-free system is therefore widely used in cell biology. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p166)", "PM": "91; was see under SUBCELLULAR FRACTIONS 1967-90", "HN": "91(67); was see under SUBCELLULAR FRACTIONS 1967-90", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002474"}, {"RECTYPE": "D", "MH": "Cellobiose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "4 O beta D Glucopyranosyl D glucopyranose", "MN": "D09.947.750.200", "MH_TH": "NLM (1979)", "ST": "T123", "N1": "D-Glucopyranose, 4-O-beta-D-glucopyranosyl-", "RN": "16462-44-5", "PI": "Disaccharides (1966-1978)", "MS": "A disaccharide consisting of two glucose units in beta (1-4) glycosidic linkage. Obtained from the partial hydrolysis of cellulose.", "PM": "91; was see under DISACCHARIDES 1979-90", "HN": "91(79); was see under DISACCHARIDES 1979-90", "MR": "20170410", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D002475"}, {"RECTYPE": "D", "MH": "Cellophane", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Cellophanes", "MN": "J01.637.118", "MH_TH": "NLM (1966)", "ST": "T122", "N1": "Cellophane", "RN": "9005-81-6", "MS": "A generic name for film produced from wood pulp by the viscose process. It is a thin, transparent sheeting of regenerated cellulose, moisture-proof and sometimes dyed, and used chiefly as food wrapping or as bags for dialysis. (Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002476"}, {"RECTYPE": "D", "MH": "Cells", "AQ": "CH CL CY DE EN IM ME MI PA PS RE UL VI", "ENTRY": "Cell", "MN": "A11", "RH": "A11 - ANATOMY-CELLS", "EC": "transplantation:Cell Transplantation", "MH_TH": "NLM (1972)", "ST": "T025", "PI": "Cytology (1966-1971)", "MS": "The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.", "PM": "1972; was see under CYTOLOGY 1963-71", "HN": "1972; was see under CYTOLOGY 1963-71", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002477"}, {"RECTYPE": "D", "MH": "Cells, Cultured", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Cultured Cells|T025|NON|EQV|UNK (19XX)|870508|abcdef", "ENTRY": "Cultured Cell", "MN": "A11.251", "FX": "Diffusion Chambers, Culture", "MH_TH": "NLM (1972)", "ST": "T025", "AN": "note category: do not confuse with CELL CULTURE TECHNIQUES (Cat E); not for bact or other micro-organisms; almost always NIM with no subheadings; check HUMANS or ANIMALS; do not routinely add tissue or organ; TUMOR CELLS, CULTURED is available", "PI": "Tissue Culture (1966-1971)", "MS": "Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.", "PM": "72", "HN": "72", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002478"}, {"RECTYPE": "D", "MH": "Inclusion Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Cytoplasmic Inclusions|T026|NON|NRW|NLM (1994)|930222|abcdef", "ENTRY": "Inclusions, Cytoplasmic", "MN": "A11.284.420", "MH_TH": "NLM (1970)", "ST": "T026", "AN": "for bacteria, coordinate IM with specific bacterium (IM); for viruses, INCLUSION BODIES, VIRAL is available", "PI": "Cytoplasmic Granules (1966-1969)", "MS": "A generic term for any circumscribed mass of foreign (e.g., lead or viruses) or metabolically inactive materials (e.g., ceroid or MALLORY BODIES), within the cytoplasm or nucleus of a cell. Inclusion bodies are in cells infected with certain filtrable viruses, observed especially in nerve, epithelial, or endothelial cells. (Stedman, 25th ed)", "OL": "use INCLUSION BODIES to search CELLULAR INCLUSIONS 1972-93 (as Prov 1970-71)", "PM": "94; was CELLULAR INCLUSIONS 1972-93; INCLUSION BODIES was see CELLULAR INCLUSIONS 1972-93", "HN": "94; was CELLULAR INCLUSIONS 1970-93 (Prov 1970-71); INCLUSION BODIES was see CELLULAR INCLUSIONS 1972-93", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002479"}, {"RECTYPE": "D", "MH": "Cellulase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endo-1,4-beta-Glucanase|T116|T126|NON|EQV|UNK (19XX)|760523|ENDO BETA GLUCANASE 01 04|abbcdefs", "ENTRY": "beta 1,4 Glucan 4 Glucanohydrolase", "MN": "D08.811.277.450.420.200.200", "MH_TH": "NLM (1973)", "ST": "T126", "N1": "1,4-(1,3;1,4)-beta-D-Glucan-4-glucanohydrolase", "RN": "EC 3.2.1.4", "AN": "CELLULASES is also available", "PI": "Glycoside Hydrolases (1966-1972)", "MS": "An endocellulase with specificity for the hydrolysis of 1,4-beta-glucosidic linkages in CELLULOSE, lichenin, and cereal beta-glucans.", "PM": "77", "HN": "77(73)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D002480"}, {"RECTYPE": "D", "MH": "Cellulitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Phlegmon|T046|NON|NRW|UNK (19XX)|771123|abcdef", "MN": "C23.550.470.756.200", "FX": "Cellulite", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "in French literature \"cellulite\" can be CELLULITE or CELLULITIS", "MS": "An acute, diffuse, and suppurative inflammation of loose connective tissue, particularly the deep subcutaneous tissues, and sometimes muscle, which is most commonly seen as a result of infection of a wound, ulcer, or other skin lesions.", "OL": "use CELLULITIS to search PHLEGMON 1966-78", "PM": "PHLEGMON was heading 1963-78", "HN": "PHLEGMON was heading 1963-78", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D002481"}, {"RECTYPE": "D", "MH": "Cellulose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Cellulose", "MN": "J01.637.051.720.099.500", "FX": "Paper", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Cellulose", "RN": "9004-34-6", "MS": "A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002482"}, {"RECTYPE": "D", "MH": "Cellulose, Oxidized", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Cellulosic Acid|T109|T121|NON|EQV|UNK (19XX)|790606|abbcdef", "ENTRY": "Oxidized Cellulose", "MN": "D09.698.365.180.200", "PA": "Hemostatics", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "0", "MS": "A cellulose of varied carboxyl content retaining the fibrous structure. It is commonly used as a local hemostatic and as a matrix for normal blood coagulation.", "PM": "1991; see CELLULOSE 1976-1990; see HEMOSTATICS 1963-1975; OXYCELLULOSE was indexed under METHYLCELLULOSE/AA 1977-2014", "HN": "1991(1975); for OXYCELLULOSE use HYPROMELLOSE DERIVATIVES 2000-2014", "MR": "20140617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002483"}, {"RECTYPE": "D", "MH": "Cementation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Cementations", "MN": "E06.095.170", "FX": "Dental Cements", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "The joining of objects by means of a cement (e.g., in fracture fixation, such as in hip arthroplasty for joining of the acetabular component to the femoral component). In dentistry, it is used for the process of attaching parts of a tooth or restorative material to a natural tooth or for the attaching of orthodontic bands to teeth by means of an adhesive.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "19920507", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002484"}, {"RECTYPE": "D", "MH": "Cementoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Periapical Fibrous Dysplasias", "MN": "C04.557.695.210", "MH_TH": "NLM (1972)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Odontogenic Tumors (1966-1971)", "MS": "An odontogenic fibroma in which cells have developed into cementoblasts and which consists largely of cementum.", "OL": "use ODONTOGENIC TUMORS to search CEMENTOMA 1966-71 (as Prov 1972-74)", "PM": "91; was see under ODONTOGENIC TUMORS 1980-90; was see under ODONTOGENIC TUMOR 1975-79", "HN": "91(72); was see under ODONTOGENIC TUMORS 1980-90; was see under ODONTOGENIC TUMOR 1972-79(Prov 1972-74)", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002485"}, {"RECTYPE": "D", "MH": "Centchroman", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compound 6720", "MN": "D03.633.100.150.240.225", "PA": "Estrogen Antagonists", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Pyrrolidine, 1-(2-(4-(3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl)phenoxy)ethyl)-, trans-", "RN": "31477-60-8", "PI": "Pyrrolidines (1974)", "MS": "A non-steroidal anti-fertility agent with anti-hormonal properties.", "PM": "91; was see under BENZOPYRANS 1975-90", "HN": "91(75); was see under BENZOPYRANS 1975-90", "MR": "20160528", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002486"}, {"RECTYPE": "D", "MH": "Centers for Disease Control and Prevention, U.S.", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "United States Centers for Disease Control and Prevention|T093|NAM|EQV|NLM (1994)|921230|UNITED STATES CENTERS DIS CONTROL PREV|abcdefv", "ENTRY": "United States Centers for Disease Control|T093|NAM|EQV|NLM (1994)|930108|abcdef", "MN": "N03.540.348.500.500.600.650.225", "MH_TH": "NLM (2020)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; CATALOGER: Use NAF entry", "MS": "An agency of the UNITED STATES PUBLIC HEALTH SERVICE that conducts and supports programs for the prevention and control of disease and provides consultation and assistance to health departments and other countries.", "PM": "2020; see CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.) 1994-2019; see CENTERS FOR DISEASE CONTROL (U.S.) 1983-93, see CENTER FOR DISEASE CONTROL 1982, see UNITED STATES CENTER FOR DISEASE CONTROL 1978-81; UNITED STATES CENTERS FOR DISEASE CONTROL was see CENTERS FOR DISEASE CONTROL (U.S.) 1983-93", "HN": "2020 (1983); was CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.) 1994-2019; was CENTERS FOR DISEASE CONTROL (U.S.) 1983-1993, was CENTER FOR DISEASE CONTROL 1982, was UNITED STATES CENTER FOR DISEASE CONTROL 1978-81; UNITED STATES CENTERS FOR DISEASE CONTROL was see CENTERS FOR DISEASE CONTROL (U.S.) 1983-93", "MR": "20181010", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D002487"}, {"RECTYPE": "D", "MH": "Central African Republic", "AQ": "EH EP", "ENTRY": "Ubangi-Shari|T083|NAM|EQV|NLM (1996)|940801|abcdef", "MN": "Z01.058.290.100.120", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in central Africa south of CHAD and SUDAN, north of DEMOCRATIC REPUBLIC OF THE CONGO, and east of CAMEROON. The capital is Bangui.", "MR": "20130709", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D002488"}, {"RECTYPE": "D", "MH": "Central America", "AQ": "EH EP", "MN": "Z01.107.169", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "A region of southern NORTH AMERICA extending from the southern border of MEXICO to the northern border of COLOMBIA. It separates the Caribbean Sea from the Pacific Ocean and is linked to SOUTH AMERICA by the Isthmus of Panama.", "MR": "20151124", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D002489"}, {"RECTYPE": "D", "MH": "Central Nervous System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Systems, Central Nervous", "MN": "A08.186", "MH_TH": "POPLINE (1984)", "ST": "T022", "AN": "prefer BRAIN or SPINAL CORD; \"CNS effects\" or \"central effects\" of drugs in texts usually means BRAIN /drug eff, not CNS /drug eff", "MS": "The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002490"}, {"RECTYPE": "D", "MH": "Central Nervous System Agents", "DE": "CNS AGENTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Central Nervous System Drugs|T121|NON|EQV|NLM (1995)|940401|CNS DRUGS|abcdefv", "MN": "D27.505.954.427", "MH_TH": "NLM (1979)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics ", "MS": "A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into \"specific\" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and \"nonspecific\" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252)", "OL": "consider also CENTRAL NERVOUS SYSTEM /DE & BRAIN /DE", "PM": "79", "HN": "79; was NON MESH before 1979", "MR": "20050815", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D002491"}, {"RECTYPE": "D", "MH": "Central Nervous System Depressants", "DE": "CNS DEPRESS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Depressants, CNS", "MN": "D27.505.954.427.210", "MH_TH": "NLM (1979)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics ", "MS": "A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents).", "OL": "consider also CENTRAL NERVOUS SYSTEM /DE + DEPRESSION, CHEMICAL or BRAIN /DE + DEPRESSION, CHEMICAL", "PM": "79", "HN": "79; was NON MESH before 1979", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D002492"}, {"RECTYPE": "D", "MH": "Central Nervous System Diseases", "DE": "CNS DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Central Nervous System Disorder|T047|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Central Nervous System Disorders|T047|NON|EQV|NLM (2000)|991103|abcdef", "MN": "C10.228", "MH_TH": "BIOETHICS (1989)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002493"}, {"RECTYPE": "D", "MH": "Central Nervous System Infections", "DE": "CNS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "CNS Infections|T047|NON|EQV|NLM (2020)|190226|abcdef", "ENTRY": "Infections, CNS", "MN": "C10.228.228", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with specific site/disease term if pertinent", "PI": "Infection (1967-1997)", "MS": "Pathogenic infections of the brain, spinal cord, and meninges. DNA VIRUS INFECTIONS; RNA VIRUS INFECTIONS; BACTERIAL INFECTIONS; MYCOPLASMA INFECTIONS; SPIROCHAETALES INFECTIONS; fungal infections; PROTOZOAN INFECTIONS; HELMINTHIASIS; and PRION DISEASES may involve the central nervous system as a primary or secondary process.", "PM": "1998", "HN": "1998; use explode 1971-1997", "CATSH": "CAT LIST", "MR": "20190611", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D002494"}, {"RECTYPE": "D", "MH": "Central Supply, Hospital", "DE": "CENTRAL SUPPLY HOSP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Central Supply|T093|NON|EQV|UNK (19XX)|770519|HOSP CENTRAL SUPPLY|abcdefv", "ENTRY": "Central Supplies, Hospital", "MN": "N04.452.442.452.422.260", "MH_TH": "NLM (1968)", "ST": "T093", "AN": "do not confuse with CENTRALIZED HOSPITAL SERVICES", "MS": "Hospital department responsible for receiving, storing, and distributing medical and surgical supplies and equipment.", "OL": "use CENTRAL SUPPLY, HOSPITAL to search HOSPITAL CENTRAL SUPPLY 1968-77", "PM": "78; was HOSPITAL CENTRAL SUPPLY 1968-77", "HN": "78; was HOSPITAL CENTRAL SUPPLY 1968-77", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002495"}, {"RECTYPE": "D", "MH": "Central Venous Pressure", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Venous Pressure, Central|T033|T040|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Venous Pressures, Central", "MN": "G09.330.380.076.732.336", "MH_TH": "NLM (1970)", "ST": "T040", "PI": "Veins (1966-1969)", "MS": "The blood pressure in the central large VEINS of the body. It is distinguished from peripheral venous pressure which occurs in an extremity.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D002496"}, {"RECTYPE": "D", "MH": "Centralized Hospital Services", "DE": "CENTRALIZED HOSP SERV", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Hospital Services, Centralized|T058|NON|EQV|UNK (19XX)|770519|HOSP SERV CENTRALIZED|abcdefv", "ENTRY": "Services, Hospital Centralized", "MN": "N04.452.442.452.110", "MH_TH": "NLM (1977)", "ST": "T058", "AN": "do not confuse with CENTRAL SUPPLY, HOSPITAL", "MS": "The coordination of services in one area of a facility to improve efficiency.", "PM": "91; was see under HOSPITAL ADMINISTRATION Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL ADMINISTRATION 1977-90", "MR": "20190709", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D002497"}, {"RECTYPE": "D", "MH": "Centrifugation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E05.181", "FX": "Ultracentrifugation", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "as a lab technique & to simulate gravitational eff in space; NIM", "MS": "Process of using a rotating machine to generate centrifugal force to separate substances of different densities, remove moisture, or simulate gravitational effects. It employs a large motor-driven apparatus with a long arm, at the end of which human and animal subjects, biological specimens, or equipment can be revolved and rotated at various speeds to study gravitational effects. (From Websters, 10th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002498"}, {"RECTYPE": "D", "MH": "Centrifugation, Density Gradient", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Gradient Centrifugations, Density", "MN": "E05.196.941.336", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "a type of ultracentrif; NIM; index sucrose density gradient centrif here but ignore SUCROSE", "MS": "Separation of particles according to density by employing a gradient of varying densities. At equilibrium each particle settles in the gradient at a point equal to its density. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002499"}, {"RECTYPE": "D", "MH": "Centrifugation, Isopycnic", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Isopycnic Centrifugation", "MN": "E05.196.941.336.253", "MH_TH": "NLM (1975)", "ST": "T059", "MS": "A technique used to separate particles according to their densities in a continuous density gradient. The sample is usually mixed with a solution of known gradient materials and subjected to centrifugation. Each particle sediments to the position at which the gradient density is equal to its own. The range of the density gradient is usually greater than that of the sample particles. It is used in purifying biological materials such as proteins, nucleic acids, organelles, and cell types.", "OL": "search CENTRIFUGATION, DENSITY GRADIENT 1968-74", "PM": "91; was see under CENTRIFUGATION, DENSITY GRADIENT 1975-90", "HN": "91(75); was see under CENTRIFUGATION, DENSITY GRADIENT 1975-90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002500"}, {"RECTYPE": "D", "MH": "Centrifugation, Zonal", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Zonal Centrifugations", "MN": "E05.196.941.336.419", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "a type of density gradient centrif; NIM", "MS": "Centrifugation using a rotating chamber of large capacity in which to separate cell organelles by density-gradient centrifugation. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002501"}, {"RECTYPE": "D", "MH": "Centrioles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Centriole|T026|NON|EQV|NLM (2014)|130325|abcdef", "MN": "A11.284.430.214.190.750.820.500.500.130", "MH_TH": "NLM (1979)", "ST": "T026", "PI": "Organoids (1966-1978)", "MS": "Self-replicating, short, fibrous, rod-shaped organelles. Each centriole is a short cylinder containing nine pairs of peripheral microtubules, arranged so as to form the wall of the cylinder.", "PM": "85; was see under ORGANOIDS 1979-84", "HN": "85(79); was see under ORGANOIDS 1979-84", "MR": "20130708", "DA": "19780310", "DC": "1", "DX": "19850101", "UI": "D002502"}, {"RECTYPE": "D", "MH": "Centromere", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Centromeres", "MN": "G05.360.160.165", "FX": "DNA, Satellite", "MH_TH": "NLM (1978)", "ST": "T026", "PI": "Chromosomes (1966-1977)", "MS": "The clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division.", "PM": "91; was see under CHROMOSOMES 1978-90", "HN": "91(78); was see under CHROMOSOMES 1978-90", "MR": "20080708", "DA": "19770429", "DC": "1", "DX": "19910101", "UI": "D002503"}, {"RECTYPE": "D", "MH": "Meclofenoxate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Centrophenoxine|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1991)|900509|abbcdeef", "ENTRY": "Meclofenoxate Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2003)|020515|abbcdeef", "MN": "D02.241.511.316.495", "PA": "Nootropic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Acetic acid, (4-chlorophenoxy)-, 2-(dimethylamino)ethyl ester, hydrochloride", "RN": "C76QQ2I0RG", "RR": "5BK3070BDY", "MS": "An ester of DIMETHYLAMINOETHANOL and para-chlorophenoxyacetic acid.", "OL": "use MECLOFENOXATE to search CENTROPHENOXINE 1975-90; use ACETIC ACIDS 1966-74 (as Prov 1966-67)", "PM": "91; was CENTROPHENOXINE see under GLYCOLATES 1975-90 & see under ACETIC ACIDS 1968-74; MECLOFENOXATE was see CENTROPHENOXINE 1977-90", "HN": "91(65); was CENTROPHENOXINE see under GLYCOLATES 1975-90 & see under ACETIC ACIDS 1965-74 (Prov 1965-67); MECLOFENOXATE was see CENTROPHENOXINE 1977-90", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002504"}, {"RECTYPE": "D", "MH": "Cephacetrile", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cefacetrile|T109|T195|NON|EQV|FDA SRS (2014)|UNK (19XX)|790606|abbcdeef", "ENTRY": "Sodium, Cephacetrile", "MN": "D03.633.100.300.249.190", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-((cyanoacetyl)amino)-8-oxo-, monosodium salt, (6R-trans)-", "RN": "FDM21QQ344", "RR": "87TH1FJY1N", "PI": "Nitriles (1973-1974)", "MS": "A derivative of 7-aminocephalosporanic acid.", "PM": "91; was see under CEPHALOSPORINS 1975-90", "HN": "91(75); was see under CEPHALOSPORINS 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002505"}, {"RECTYPE": "D", "MH": "Cephalexin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Palitrex|T109|T195|TRD|NRW|UNK (19XX)|821129|abbcdef", "MN": "D03.633.100.300.249.200", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "RN": "OBN7UDS42Y", "RR": "86589-33-5 (hemi-H2O)", "PI": "Cephalosporins (1966-1971)", "MS": "A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.", "HN": "1973 (1972)", "MR": "20180521", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002506"}, {"RECTYPE": "D", "MH": "Cephaloglycin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dihydrate, Cephaloglycin", "MN": "D03.633.100.300.249.200.180", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-, (6R-(6alpha,7beta(R*)))-", "RN": "NE7R11LA95", "RR": "3577-01-3 (Cephaloglycin)", "MS": "A cephalorsporin antibiotic.", "PM": "73", "HN": "73(72)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002507"}, {"RECTYPE": "D", "MH": "Cephalometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Craniometry|T060|NON|NRW|NLM (1966)|990101|abcdef", "MN": "N06.850.505.200.100.300", "MH_TH": "NLM (1965)", "ST": "T060", "MS": "The measurement of the dimensions of the HEAD.", "PM": "1965; for CRANIOMETRY see CRANIOMETRY 1966-2004", "HN": "1965", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002508"}, {"RECTYPE": "D", "MH": "Cephaloridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ceporin|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef", "MN": "D03.633.100.300.249.210", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Pyridinium, 1-((2-carboxy-8-oxo-7-((2-thienylacetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, (6R-trans)-", "RN": "LVZ1VC61HB", "RR": "50-59-9 (Cephaloridine)", "MS": "A cephalosporin antibiotic.", "PM": "68", "HN": "68(66)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002509"}, {"RECTYPE": "D", "MH": "Cephalosporinase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Lactamase II|T116|T126|NON|EQV|UNK (1990)|760517|BETA LACTAMASE 02|abbcdefs", "ENTRY": "beta-Lactamase, Cephalosporin", "MN": "D08.811.277.087.180.229", "EC": "antagonists & inhibitors:beta-Lactamase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.5.2.-", "OL": "search AMIDOHYDROLASES 1968-74", "PM": "91; was see under BETA-LACTAMASES 1979-90; was see under AMIDOHYDROLASES 1968-78", "HN": "91(75); was see under BETA-LACTAMASES 1979-90; was see under AMIDOHYDROLASES 1968-78", "MR": "20140610", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002510"}, {"RECTYPE": "D", "MH": "Cephalosporins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cephalosporin Antibiotic|T195|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Cephalosporin Antibiotics", "MN": "D03.633.100.300.249", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1965)", "ST": "T195", "RN": "0", "MS": "A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.", "PM": "66", "HN": "66(65)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002511"}, {"RECTYPE": "D", "MH": "Cephalothin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sodium Cephalothin|T109|T195|NON|NRW|FDA SRS (2014)|USAN (1965)|USP (19XX)|741125|abbcdeeef", "ENTRY": "Salt, Cephalothin Monosodium", "MN": "D03.633.100.300.249.190.210", "PA": "Anti-Bacterial Agents", "MH_TH": "FDA SRS (2014)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, (6R-trans)-", "RN": "R72LW146E6", "RR": "C22G6EYP8B", "MS": "A cephalosporin antibiotic.", "PM": "66", "HN": "66(63)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002512"}, {"RECTYPE": "D", "MH": "Cephamycins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cephamycin|T195|NON|EQV|NLM (2021)|200319|abcdef", "ENTRY": "Cephamycin Antibiotics", "MN": "D03.633.100.300.249.250", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1975)", "ST": "T195", "RN": "0", "PI": "Methyl Ethers (1974)", "MS": "Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.", "PM": "84; was see under CEPHALOSPORINS 1975-83", "HN": "84(75); was see under CEPHALOSPORINS 1975-83", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D002513"}, {"RECTYPE": "D", "MH": "Cephapirin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Salt, Cephapirin Monosodium", "MN": "D03.633.100.300.249.190.230", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1975)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-(((4-pyridinylthio)acetyl)amino)-, (6R-trans)-", "RN": "89B59H32VN", "RR": "431LFF7I7J", "PI": "Sulfides (1972-1974)", "MS": "Cephalosporin antibiotic, partly plasma-bound, that is effective against gram-negative and gram-positive organisms.", "PM": "91; was see under CEPHALOSPORINS 1975-90", "HN": "91(75); was see under CEPHALOSPORINS 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002514"}, {"RECTYPE": "D", "MH": "Cephradine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SQ11436", "MN": "D03.633.100.300.249.200.185", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-", "RN": "F1BC02I72W", "RR": "58456-86-3 (dihydrate)", "PI": "Cyclohexane (1972-1974)", "MS": "A semi-synthetic cephalosporin antibiotic.", "PM": "91; was see under CEPHALOSPORINS 1975-90", "HN": "91(75); was see under CEPHALOSPORINS 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002515"}, {"RECTYPE": "D", "MH": "Ceramics", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Ceramic", "MN": "J01.637.153", "MH_TH": "NLM (1967)", "ST": "T122", "AN": "not restricted to dentistry", "PI": "Minerals (1966)", "MS": "Products made by baking or firing nonmetallic minerals (clay and similar materials). In making dental restorations or parts of restorations the material is fused porcelain. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed & Boucher's Clinical Dental Terminology, 4th ed)", "PM": "73", "HN": "73(67)", "MR": "20150710", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002516"}, {"RECTYPE": "D", "MH": "Galactosylgalactosylglucosylceramidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ceramide Trihexosidase|T116|T126|NON|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "Trihexosidase, Ceramide", "MN": "D08.811.277.450.410.150", "MH_TH": "UNK (19XX)", "ST": "T126", "N1": "D-Galactosyl-D-galactosyl-D-glucosyl-N-acylsphingosine galactohydrolase", "RN": "EC 3.2.1.47", "PI": "Galactosidase (1972-1974)", "MS": "An enzyme that catalyzes the hydrolysis of a ceramidetrihexoside to a ceramidedihexoside plus galactose.", "PM": "91; was see under GALACTOSIDASES 1975-90", "HN": "91(75); was see under GALACTOSIDASES 1975-90", "MR": "20080708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002517"}, {"RECTYPE": "D", "MH": "Ceramides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ceramide|T109|T123|NON|EQV|NLM (2021)|191113|abbcdef", "MN": "D10.570.877.360.612.200", "FX": "Fabry Disease", "MH_TH": "NLM (1972)", "ST": "T123", "RN": "0", "AN": "carbohydrate ceramides: index under CEREBROSIDES (one carbohydrate group) or NEUTRAL GLYCOSPHINGOLIPIDS (more than one carbohydrate group)", "PI": "Glycols (1966-1971)", "MS": "Members of the class of neutral glycosphingolipids. They are the basic units of SPHINGOLIPIDS. They are sphingoids attached via their amino groups to a long chain fatty acyl group. They abnormally accumulate in FABRY DISEASE.", "PM": "72", "HN": "72", "MR": "20200409", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002518"}, {"RECTYPE": "D", "MH": "Ceratopogonidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Midges, Biting|T204|NON|EQV|UNK (19XX)|800519|abcdef", "ENTRY": "Midge, Biting", "MN": "B01.050.500.131.617.720.500.500.750.712.500.500", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid41819", "RR": "txid41820", "AN": "for killing Ceratopogonidae with insecticides, see note at INSECTICIDES ; gall midges: index NEMATOCERA", "MS": "A family of biting midges, in the order DIPTERA. It includes the genus Culicoides which transmits filarial parasites pathogenic to man and other primates.", "OL": "use CERATOPOGONIDAE to search CULICOIDES 1966-80; search MIDGES under DIPTERA 1975-80", "PM": "81; was see CULICOIDES 1975-80; CULICOIDES was heading 1963-80; MIDGES was see under DIPTERA 1975-80", "HN": "81; was see CULICOIDES 1975-80; CULICOIDES was heading 1963-80; MIDGES was see under DIPTERA 1975-80", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D002519"}, {"RECTYPE": "D", "MH": "Cercopithecidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Monkeys, Old World|T015|NON|EQV|UNK (19XX)|800507|abcdef", "ENTRY": "World Monkey, Old", "MN": "B01.050.150.900.649.313.988.400.112.199", "MH_TH": "NLM (1981)", "ST": "T015", "RN": "txid9527", "RR": "txid36231", "AN": "a family of Old World monkeys: do not confuse with CERCOPITHECINAE, a subfamily; NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "MS": "The family of Old World monkeys and baboons consisting of two subfamilies: CERCOPITHECINAE and COLOBINAE. They are found in Africa and part of Asia.", "PM": "81", "HN": "81", "MR": "20200902", "DA": "19800507", "DC": "1", "DX": "19810101", "UI": "D002520"}, {"RECTYPE": "D", "MH": "Cercopithecus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "MN": "B01.050.150.900.649.313.988.400.112.199.120.126", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9533", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "PI": "Monkeys (1966-1974)", "MS": "A genus of Old World monkeys found in Africa although some species have been introduced into the West Indies. This genus is composed of at least twenty species: C. AETHIOPS, C. ascanius, C. campbelli, C. cephus, C. denti, C. diana, C. dryas, C. erythrogaster, C. erythrotis, C. hamlyni, C. lhoesti, C. mitis, C. mona, C. neglectus, C. nictitans, C. petaurista, C. pogonias, C. preussi, C. salongo, and C. wolfi.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D002521"}, {"RECTYPE": "D", "MH": "Chlorocebus aethiops", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Vervet Monkey|T015|NON|NRW|NLM (1992)|901128|abcdef", "ENTRY": "Vervet Monkeys", "MN": "B01.050.150.900.649.313.988.400.112.199.120.126.110", "MH_TH": "NLM (2016)", "ST": "T015", "RN": "txid9534", "RR": "txid60710", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "MS": "A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research.", "PM": "2020; see CERCOPITHECUS 1981-1990; for CERCOPITHECUS PYGERYTHRUS & CERCOPITHECUS SABEUS see CERCOPITHECUS 1975-1980; see CERCOPITHECUS AETHIOPS 1991-2019", "HN": "2020(1981); see under CERCOPITHECUS 1981-1990; for CERCOPITHECUS PYGERYTHRUS & CERCOPITHECUS SABEUS see under CERCOPITHECUS 1975-1980; see under CERCOPITHECUS AETHIOPS 1991-2019", "MR": "20210510", "DA": "19800507", "DC": "1", "DX": "19910101", "UI": "D002522"}, {"RECTYPE": "D", "MH": "Edible Grain", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Cereals|T002|T168|NON|NRW|NLM (1966)|990101|abbcdef", "ENTRY": "Grains, Edible", "MN": "J02.500.775.500", "MH_TH": "NLM (2016)", "ST": "T168", "MS": "SEEDS used as a major nutritional source, most often the grain from the POACEAE family.", "PM": "2016; see CEREALS 1966-2015; GRAIN & MALT were headings 1963-84", "HN": "2016 (1966); GRAIN & MALT were headings 1963-84", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D002523"}, {"RECTYPE": "D", "MH": "Cerebellar Ataxia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dysmetria|T033|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Incoordinations, Cerebellar", "MN": "C23.888.592.350.090.200", "MH_TH": "NLM (1968)", "ST": "T184", "AN": "DENTATE CEREBELLAR ATAXIA see MYOCLONIC CEREBELLAR DYSSYNERGIA is also available; ATAXIAS, HEREDITARY see SPINOCEREBELLAR DEGENERATION is also available", "PI": "Cerebellar Diseases (1966-1967)", "MS": "Incoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target (dysmetria), a tremor that occurs during attempted movements (intention TREMOR), impaired force and rhythm of diadochokinesis (rapidly alternating movements), and GAIT ATAXIA. (From Adams et al., Principles of Neurology, 6th ed, p90)", "PM": "1968", "HN": "1968", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002524"}, {"RECTYPE": "D", "MH": "Cerebellar Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cortex, Cerebellar", "MN": "A08.186.211.132.810.428.200.212", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "diseases: coordinate IM with CEREBELLAR DISEASES (IM)", "MS": "The superficial GRAY MATTER of the CEREBELLUM. It consists of two main layers, the stratum moleculare and the stratum granulosum.", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002525"}, {"RECTYPE": "D", "MH": "Cerebellar Diseases", "DE": "CEREBELLAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cerebellum Diseases|T047|NON|EQV|NLM (2000)|991103|CEREBELLUM DIS|abcdefv", "ENTRY": "Syndrome, Cerebellar", "MN": "C10.228.140.252", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002526"}, {"RECTYPE": "D", "MH": "Myoclonic Cerebellar Dyssynergia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ramsay Hunt Cerebellar Syndrome|T047|EPO|EQV|UNK (19XX)|760512|abcdef", "ENTRY": "Myoclonic Cerebellar Dyssynergias", "MN": "C16.320.400.780.500", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "do not confuse entry term RAMSAY HUNT CEREBELLAR SYNDROME with RAMSAY HUNT AURICULAR SYNDROME see HERPES ZOSTER OTICUS or RAMSAY HUNT PARALYSIS SYNDROME see PARKINSONIAN DISORDERS", "PI": "Cerebellar Diseases (1966-1969)", "MS": "A condition marked by progressive CEREBELLAR ATAXIA combined with MYOCLONUS usually presenting in the third decade of life or later. Additional clinical features may include generalized and focal SEIZURES, spasticity, and DYSKINESIAS. Autosomal recessive and autosomal dominant patterns of inheritance have been reported. Pathologically, the dentate nucleus and brachium conjunctivum of the CEREBELLUM are atrophic, with variable involvement of the spinal cord, cerebellar cortex, and basal ganglia. (From Joynt, Clinical Neurology, 1991, Ch37, pp60-1)", "PM": "2000; see CEREBELLAR DYSSYNERGIA 1991-1999; see CEREBELLAR ATAXIA 1970-1990", "HN": "2000(1970); use CEREBELLAR ATAXIA 1970-1990", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002527"}, {"RECTYPE": "D", "MH": "Cerebellar Neoplasms", "DE": "CEREBELLAR NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Malignant Cerebellar Neoplasms|T191|NON|NRW|NLM (2000)|991103|MALIGNANT CEREBELLAR NEOPL|abcdefv", "ENTRY": "Tumor, Cerebellar", "MN": "C10.551.240.250.400.300", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Primary or metastatic neoplasms of the CEREBELLUM. Tumors in this location frequently present with ATAXIA or signs of INTRACRANIAL HYPERTENSION due to obstruction of the fourth ventricle. Common primary cerebellar tumors include fibrillary ASTROCYTOMA and cerebellar HEMANGIOBLASTOMA. The cerebellum is a relatively common site for tumor metastases from the lung, breast, and other distant organs. (From Okazaki & Scheithauer, Atlas of Neuropathology, 1988, p86 and p141)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002528"}, {"RECTYPE": "D", "MH": "Cerebellar Nuclei", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Nucleus Globosus|T023|NON|NRW|NLM (1998)|961010|abcdef", "ENTRY": "Nucleus, Medial Cerebellar", "MN": "A08.186.211.132.810.428.200.337", "MH_TH": "NLM (1971)", "ST": "T023", "AN": "diseases: coordinate IM with CEREBELLAR DISEASES (IM)", "PI": "Cerebellum (1966-1970)", "MS": "Four clusters of neurons located deep within the WHITE MATTER of the CEREBELLUM, which are the nucleus dentatus, nucleus emboliformis, nucleus globosus, and nucleus fastigii.", "PM": "71", "HN": "71", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D002529"}, {"RECTYPE": "D", "MH": "Cerebellopontine Angle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cerebellopontile Angle|T030|NON|EQV|NLM (1990)|881229|abcdef", "ENTRY": "Cerebellopontine Angles", "MN": "A08.186.211.132.810.428.200.462", "MH_TH": "NLM (1966)", "ST": "T030", "AN": "diseases: coord IM with CEREBELLAR DISEASES (IM); neopl: coord (IM) with CEREBELLAR NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "Junction between the cerebellum and the pons.", "OL": "use CEREBELLOPONTINE ANGLE to search CEREBELLOPONTILE ANGLE 1966-89", "PM": "90; was CEREBELLOPONTILE ANGLE 1966-89", "HN": "90; was CEREBELLOPONTILE ANGLE 1966-89", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D002530"}, {"RECTYPE": "D", "MH": "Cerebellum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cerebella|T023|NON|EQV|NLM (2022)|220211|abcdef", "ENTRY": "Parencephalons", "MN": "A08.186.211.132.810.428.200", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The part of brain that lies behind the BRAIN STEM in the posterior base of skull (CRANIAL FOSSA, POSTERIOR). It is also known as the \"little brain\" with convolutions similar to those of CEREBRAL CORTEX, inner white matter, and deep cerebellar nuclei. Its function is to coordinate voluntary movements, maintain balance, and learn motor skills.", "MR": "20220211", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002531"}, {"RECTYPE": "D", "MH": "Intracranial Aneurysm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mycotic Aneurysm, Intracranial|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Mycotic Aneurysms, Intracranial", "MN": "C14.907.253.560.300", "MH_TH": "UNK (19XX)", "ST": "T190", "MS": "Abnormal outpouching in the wall of intracranial blood vessels. Most common are the saccular (berry) aneurysms located at branch points in CIRCLE OF WILLIS at the base of the brain. Vessel rupture results in SUBARACHNOID HEMORRHAGE or INTRACRANIAL HEMORRHAGES. Giant aneurysms (>2.5 cm in diameter) may compress adjacent structures, including the OCULOMOTOR NERVE. (From Adams et al., Principles of Neurology, 6th ed, p841)", "PM": "2000; see CEREBRAL ANEURYSM 1969-1999; for CEREBRAL ANEURYSM see CEREBRAL ANEURYSM 1966-1999", "HN": "2000(1969)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D002532"}, {"RECTYPE": "D", "MH": "Cerebral Angiography", "DE": "CEREBRAL ANGIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Angiography, Cerebral|T060|NON|EQV|NLM (1992)|910401|ANGIOGR CEREBRAL|abcdefv", "ENTRY": "Cerebral Angiographies", "MN": "E05.629.937.180", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Radiography of the vascular system of the brain after injection of a contrast medium.", "CATSH": "CAT LIST", "MR": "20160318", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002533"}, {"RECTYPE": "D", "MH": "Hypoxia, Brain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypoxic Encephalopathy|T046|NON|NRW|NLM (2000)|991104|HYPOXIC ENCEPH|abcdefv", "ENTRY": "Hypoxic Encephalopathies", "MN": "C23.888.852.079.797", "MH_TH": "NLM (2000)", "ST": "T046", "AN": "do not confuse with BRAIN ISCHEMIA, a reduced blood supply", "MS": "A reduction in brain oxygen supply due to ANOXEMIA (a reduced amount of oxygen being carried in the blood by HEMOGLOBIN), or to a restriction of the blood supply to the brain, or both. Severe hypoxia is referred to as anoxia and is a relatively common cause of injury to the central nervous system. Prolonged brain anoxia may lead to BRAIN DEATH or a PERSISTENT VEGETATIVE STATE. Histologically, this condition is characterized by neuronal loss which is most prominent in the HIPPOCAMPUS; GLOBUS PALLIDUS; CEREBELLUM; and inferior olives.", "PM": "2000; see CEREBRAL ANOXIA 1963-1999", "HN": "2000(1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D002534"}, {"RECTYPE": "D", "MH": "Cerebral Aqueduct", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Aqueduct of Sylvius|T023|EPO|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Sylvius Aqueduct", "MN": "A08.186.211.140.187", "FX": "Cerebral Ventriculography", "MH_TH": "NLM (1971)", "ST": "T023", "PI": "Cerebral Ventricles (1966-1970)", "MS": "Narrow channel in the MESENCEPHALON that connects the third and fourth CEREBRAL VENTRICLES.", "PM": "71", "HN": "71", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D002535"}, {"RECTYPE": "D", "MH": "Cerebral Arteries", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cerebral Artery", "MN": "A07.015.114.228", "FX": "Cerebral Angiography", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "general; prefer specifics; do not use for arteries of non-cerebral parts of the brain, as cerebellar artery (= CEREBELLUM/blood supply + ARTERIES); /abnorm: consider also INTRACRANIAL ARTERIOVENOUS MALFORMATIONS", "MS": "The arterial blood vessels supplying the CEREBRUM.", "OL": "use CEREBRAL ANGIOGRAPHY to search CEREBRAL ARTERIES/radiography 1975-94", "PM": "/radiography was CEREBRAL ANGIOGRAPHY 1975-94", "HN": "/radiography was CEREBRAL ANGIOGRAPHY 1975-94", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D002536"}, {"RECTYPE": "D", "MH": "Intracranial Arteriosclerosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intracranial Atherosclerosis|T047|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Intracranial Atheroscleroses", "MN": "C14.907.253.560.350", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.", "PM": "2000; see CEREBRAL ARTERIOSCLEROSIS 1963-1999", "HN": "2000(1963)", "CATSH": "CAT LIST", "MR": "20090730", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D002537"}, {"RECTYPE": "D", "MH": "Intracranial Arteriovenous Malformations", "DE": "INTRACRANIAL AVM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intracranial Arteriovenous Malformations, Congenital|T019|NON|EQV|NLM (2000)|991103|INTRACRANIAL ARTERIOVENOUS MALFORMATIONS CONGEN|abcdefv", "ENTRY": "Malformations, Intracranial Arteriovenous", "MN": "C16.131.666.190.500", "MH_TH": "UNK (19XX)", "ST": "T019", "AN": "coordinate IM with ARTERIOVENOUS FISTULA (IM)", "PI": "Cerebrovascular Disorders (1966-1972)", "MS": "Congenital vascular anomalies in the brain characterized by direct communication between an artery and a vein without passing through the CAPILLARIES. The locations and size of the shunts determine the symptoms including HEADACHES; SEIZURES; STROKE; INTRACRANIAL HEMORRHAGES; mass effect; and vascular steal effect.", "PM": "2000; see CEREBRAL ARTERIOVENOUS MALFORMATIONS 1973-1999; for INTRACRANIAL ARTERIOVENOUS MALFORMATIONS see CEREBRAL ARTERIOVENOUS MALFORMATIONS 1974-1999", "HN": "2000(1973)", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002538"}, {"RECTYPE": "D", "MH": "Cerebral Arterial Diseases", "DE": "CEREBRAL ARTERIAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cerebral Artery Diseases|T047|NON|EQV|NLM (1966)|990101|CEREBRAL ARTERY DIS|abcdefv", "ENTRY": "Diseases, Cerebral Artery", "MN": "C14.907.253.560.200", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coordinate IM with specific cerebral artery (IM); see note at CEREBRAL ARTERIES for scope of \"cerebral arteries\"", "MS": "Pathological conditions of intracranial ARTERIES supplying the CEREBRUM. These diseases often are due to abnormalities or pathological processes in the ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; and POSTERIOR CEREBRAL ARTERY.", "PM": "2000; see CEREBRAL ARTERY DISEASES 1963-1999", "HN": "2000(1963)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D002539"}, {"RECTYPE": "D", "MH": "Cerebral Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Plate, Cortical", "MN": "A08.186.211.200.885.287.500", "FX": "Electroencephalography", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "/surg: probably CEREBRAL DECORTICATION", "MS": "The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions.", "OL": "use CEREBRAL CORTEX to search INSULA OF REIL 1968-78", "PM": "INSULA OF REIL was see under CEREBRAL CORTEX 1968-78", "HN": "INSULA OF REIL was see under CEREBRAL CORTEX 1968-78", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002540"}, {"RECTYPE": "D", "MH": "Cerebral Decortication", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Decortication, Cerebral Cortex|T061|T062|NON|EQV|NLM (1990)|890215|abbcdef", "ENTRY": "Decortications, Cerebral Cortex", "MN": "E04.525.160", "MH_TH": "NLM (1965)", "ST": "T062", "AN": "\"partial or total removal, ablation or destruction of the cerebral cortex; may be chemical\"; usually exper; coord IM or NIM with specific part of brain with probably /physiol (IM)", "MS": "Partial or total removal, ablation, or destruction of the cerebral cortex; may be chemical. It is not used with animals that do not possess a cortex, i.e., it is used only with mammals.", "OL": "use CEREBRAL DECORTICATION to search CEREBRAL CORTEX DECORTICATION 1966-81", "PM": "82; was CEREBRAL CORTEX DECORTICATION 1965-81", "HN": "82; was CEREBRAL CORTEX DECORTICATION 1965-81", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002541"}, {"RECTYPE": "D", "MH": "Intracranial Embolism and Thrombosis", "DE": "INTRACRANIAL EMBOLISM THROMBOSIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cerebral Embolism and Thrombosis|T047|NON|NRW|NLM (1966)|990101|CEREBRAL EMBOLISM THROMBOSIS|abcdefv", "ENTRY": "Embolism and Thrombosis, Brain|T047|NON|NRW|NLM (2000)|991108|EMBOLISM THROMBOSIS BRAIN|abcdefv", "MN": "C14.907.355.590.213", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Embolism or thrombosis involving blood vessels which supply intracranial structures. Emboli may originate from extracranial or intracranial sources. Thrombosis may occur in arterial or venous structures.", "PM": "2000; see CEREBRAL EMBOLISM AND THROMBOSIS 1963-1999", "HN": "2000(1963)", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D002542"}, {"RECTYPE": "D", "MH": "Cerebral Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intracerebral Hemorrhage|T046|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Parenchymal Hemorrhages, Cerebral", "MN": "C23.550.414.913.100", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "coordinate with specific site if pertinent but note specifics", "MS": "Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.", "CATSH": "CAT LIST", "MR": "20170313", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002543"}, {"RECTYPE": "D", "MH": "Cerebral Infarction", "DE": "CEREBRAL INFARCT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subcortical Infarction|T047|NON|NRW|NLM (2000)|991104|SUBCORTICAL INFARCT|abcdefv", "ENTRY": "Subcortical Infarctions", "MN": "C23.550.717.489.250.200", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Infarction (1966-1978)", "MS": "The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).", "PM": "1979", "HN": "1979", "CATSH": "CAT LIST", "MR": "20190628", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D002544"}, {"RECTYPE": "D", "MH": "Brain Ischemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ischemic Encephalopathy|T047|NON|EQV|NLM (2000)|991104|ISCHEMIC ENCEPH|abcdefv", "ENTRY": "Ischemic Encephalopathies", "MN": "C14.907.253.092", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "ISCHEMIC ATTACK, TRANSIENT is available", "PI": "Ischemia (1966-1978)", "MS": "Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.", "PM": "2000; see CEREBRAL ISCHEMIA 1979-1999", "HN": "2000(1979)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19771208", "DC": "1", "DX": "19790101", "UI": "D002545"}, {"RECTYPE": "D", "MH": "Ischemic Attack, Transient", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Transient Ischemic Attack|T047|NON|EQV|UNK (19XX)|850311|abcdef", "ENTRY": "Transient Ischemic Attacks", "MN": "C14.907.253.092.836", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coordinate with specific site in the brain if pertinent", "MS": "Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)", "PM": "2000; see CEREBRAL ISCHEMIA, TRANSIENT 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D002546"}, {"RECTYPE": "D", "MH": "Cerebral Palsy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spastic Diplegia|T047|NON|REL|NLM (1995)|931123|abcdef", "ENTRY": "Spastic Diplegias", "MN": "C10.228.140.140.254", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not index under MUSCLE SPASTICITY unless especially discussed & then only NIM", "MS": "A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)", "CATSH": "CAT LIST", "MR": "20030725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002547"}, {"RECTYPE": "D", "MH": "Cerebral Revascularization", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "STA-MCA Bypass|T061|NRW|UNK (19XX)|790308|abdef", "ENTRY": "STA-MCA Bypasses", "MN": "E04.494.150", "MH_TH": "NLM (1980)", "ST": "T061", "PI": "specific cerebrovascular disorder/surgery (1966-1979)", "MS": "Microsurgical revascularization to improve intracranial circulation. It usually involves joining the extracranial circulation to the intracranial circulation but may include extracranial revascularization (e.g., subclavian-vertebral artery bypass, subclavian-external carotid artery bypass). It is performed by joining two arteries (direct anastomosis or use of graft) or by free autologous transplantation of highly vascularized tissue to the surface of the brain.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19790308", "DC": "1", "DX": "19800101", "UI": "D002548"}, {"RECTYPE": "D", "MH": "Diffuse Cerebral Sclerosis of Schilder", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Schilder Disease|T047|EPO|EQV|OMIM (2013)|UNK (19XX)|840615|SCHILDER DIS|abcdeefv", "ENTRY": "Syndrome, Alpers-Huttenlocher", "MN": "C20.111.258.250.175", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "A rare central nervous system demyelinating condition affecting children and young adults. Pathologic findings include a large, sharply defined, asymmetric focus of myelin destruction that may involve an entire lobe or cerebral hemisphere. The clinical course tends to be progressive and includes dementia, cortical blindness, cortical deafness, spastic hemiplegia, and pseudobulbar palsy. Concentric sclerosis of Balo is differentiated from diffuse cerebral sclerosis of Schilder by the pathologic finding of alternating bands of destruction and preservation of myelin in concentric rings. Alpers' Syndrome refers to a heterogeneous group of diseases that feature progressive cerebral deterioration and liver disease. (From Adams et al., Principles of Neurology, 6th ed, p914; Dev Neurosci 1991;13(4-5):267-73)", "PM": "2000; see CEREBRAL SCLEROSIS, DIFFUSE 1963-1999; for ENCEPHALITIS PERIAXIALIS see ENCEPHALITIS PERIAXIALIS 1963-1999; for BALO'S DISEASE, ENCEPHALITIS PERIAXIALIS DIFFUSA, MYELINOCLASTIC DIFFUSE SCLEROSIS, & SCHILDER'S DISEASE see ENCEPHALITIS PERIAXIALIS 1990-1999", "HN": "2000(1963)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D002549"}, {"RECTYPE": "D", "MH": "Cerebral Veins", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Vein of Galen|T023|EPO|NRW|UNK (19XX)|860418|abcdef", "ENTRY": "Veins, Thalamostriate", "MN": "A07.015.908.155", "FX": "Cerebral Angiography", "MH_TH": "NLM (1987)", "ST": "T023", "MS": "Veins draining the cerebrum.", "PM": "87", "HN": "87", "MR": "20180630", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D002550"}, {"RECTYPE": "D", "MH": "Cerebral Ventricle Neoplasms", "DE": "CEREBRAL VENTRICLE NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Ventricular Tumors, Brain|T191|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Ventricular Tumor, Brain", "MN": "C10.551.240.250.200", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Neoplasms located in the brain ventricles, including the two lateral, the third, and the fourth ventricle. Ventricular tumors may be primary (e.g., CHOROID PLEXUS NEOPLASMS and GLIOMA, SUBEPENDYMAL), metastasize from distant organs, or occur as extensions of locally invasive tumors from adjacent brain structures.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002551"}, {"RECTYPE": "D", "MH": "Cerebral Ventricles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Foramen of Monro|T030|EPO|NRW|UNK (19XX)|800407|abcdef", "ENTRY": "Ventricular Systems, Cerebral", "MN": "A08.186.211.140", "FX": "Ventriculostomy", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE).", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002552"}, {"RECTYPE": "D", "MH": "Cerebroside-Sulfatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sulfatidate Sulfatase|T116|T126|NON|EQV|UNK (19XX)|750724|abbcdef", "ENTRY": "Sulfatase, Sulfatidate", "MN": "D08.811.277.352.827.070.250", "FX": "Leukodystrophy, Metachromatic", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "Cerebroside-3-sulfate 3-sulfohydrolase", "RN": "EC 3.1.6.8", "AN": "/defic: consider also LEUKODYSTROPHY, METACHROMATIC", "PI": "Sulfatases (1972-1974)", "MS": "An enzyme that catalyzes the hydrolysis of cerebroside 3-sulfate (sulfatide) to yield a cerebroside and inorganic sulfate. A marked deficiency of arylsulfatase A, which is considered the heat-labile component of cerebroside sulfatase, has been demonstrated in all forms of metachromatic leukodystrophy (LEUKODYSTROPHY, METACHROMATIC). EC 3.1.6.8.", "PM": "87; was see under SULFATASES 1976-86", "HN": "87(76); was see under SULFATASES 1976-86", "MR": "20030709", "DA": "19750725", "DC": "1", "DX": "19870101", "UI": "D002553"}, {"RECTYPE": "D", "MH": "Cerebrosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D10.570.877.360.612.200.250", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Neutral glycosphingolipids that contain a monosaccharide, normally glucose or galactose, in 1-ortho-beta-glycosidic linkage with the primary alcohol of an N-acyl sphingoid (ceramide). In plants the monosaccharide is normally glucose and the sphingoid usually phytosphingosine. In animals, the monosaccharide is usually galactose, though this may vary with the tissue and the sphingoid is usually sphingosine or dihydrosphingosine. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1st ed)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002554"}, {"RECTYPE": "D", "MH": "Cerebrospinal Fluid", "DE": "CSF", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Spinal Fluids, Cerebro", "MN": "A12.207.270.210", "FX": "Blood-Brain Barrier", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002555"}, {"RECTYPE": "D", "MH": "Cerebrospinal Fluid Proteins", "DE": "CSF PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fluid Proteins, Cerebrospinal", "MN": "D12.776.178", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "IM & coord with specific protein /csf (IM)", "MS": "Proteins in the cerebrospinal fluid, normally albumin and globulin present in the ratio of 8 to 1. Increases in protein levels are of diagnostic value in neurological diseases. (Brain and Bannister's Clinical Neurology, 7th ed, p221)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002556"}, {"RECTYPE": "D", "MH": "Cerebrospinal Fluid Shunts", "DE": "CSF SHUNTS", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Shunts, Cerebrospinal Fluid|T061|NON|EQV|UNK (19XX)|860101|SHUNTS CSF|abcdefv", "MN": "E04.525.170", "MH_TH": "NLM (1969)", "ST": "T061", "AN": "coordinate  with  destination of the shunt (NIM); VENTRICULOPERITONEAL SHUNT is available ", "PI": "Hydrocephalus/surgery (1966-1968)", "MS": "Tubes inserted to create communication between a cerebral ventricle and the internal jugular vein. Their emplacement permits draining of cerebrospinal fluid for relief of hydrocephalus or other condition leading to fluid accumulation in the ventricles.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002557"}, {"RECTYPE": "D", "MH": "Cerebrospinal Fluid Otorrhea", "DE": "CSF OTORRHEA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cerebrospinal Otorrhea|T047|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Post Traumatic Otorrhea, Cerebrospinal Fluid", "MN": "C26.915.300.225.500", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Discharge of cerebrospinal fluid through the external auditory meatus or through the eustachian tube into the nasopharynx. This is usually associated with CRANIOCEREBRAL TRAUMA (e.g., SKULL FRACTURE involving the TEMPORAL BONE;), NEUROSURGICAL PROCEDURES; or other conditions, but may rarely occur spontaneously. (From Am J Otol 1995 Nov;16(6):765-71)", "PM": "2000; see CEREBROSPINAL OTORRHEA 1988-1999; for CEREBROSPINAL FLUID OTORRHEA see CEREBROSPINAL OTORRHEA 1988-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002558"}, {"RECTYPE": "D", "MH": "Cerebrospinal Fluid Rhinorrhea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cerebrospinal Rhinorrhea|T047|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Rhinorrheas, Cerebrospinal Fluid", "MN": "C26.915.300.225.750", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Discharge of cerebrospinal fluid through the nose. Common etiologies include trauma, neoplasms, and prior surgery, although the condition may occur spontaneously. (Otolaryngol Head Neck Surg 1997 Apr;116(4):442-9)", "PM": "2000; see CEREBROSPINAL RHINORRHEA 1966-1999; for CEREBROSPINAL FLUID RHINORRHEA see CEREBROSPINAL RHINORRHEA 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002559"}, {"RECTYPE": "D", "MH": "Cerebrovascular Circulation", "DE": "CEREBROVASCULAR CIRC", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Regional Cerebral Blood Flow|T042|NON|NRW|NLM (2021)|191119|abcdef", "ENTRY": "Pressure, Cerebral Perfusion", "MN": "G09.330.100.159", "MH_TH": "NLM (1964)", "ST": "T042", "AN": "consider also BRAIN /blood supply", "MS": "The circulation of blood through the BLOOD VESSELS of the BRAIN.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D002560"}, {"RECTYPE": "D", "MH": "Cerebrovascular Disorders", "DE": "CEREBROVASCULAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vascular Diseases, Intracranial|T046|NON|EQV|NLM (2000)|991104|VASCULAR DIS INTRACRANIAL|abcdefv", "ENTRY": "Vascular Disorders, Intracranial", "MN": "C14.907.253", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "general or unspecified; prefer specifics", "MS": "A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.", "CATSH": "CAT LIST", "MR": "20150709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002561"}, {"RECTYPE": "D", "MH": "Ceremonial Behavior", "PRINT ENTRY": "Rituals|T054|NON|NRW|NLM (2003)|020424|abcdef", "ENTRY": "Ceremonial Behaviors", "MN": "I01.076.201.450.170", "FX": "Appetitive Behavior", "MH_TH": "NLM (1968)", "ST": "T054", "AN": "human & animal", "PI": "Sex Behavior (1966-1967)", "MS": "A series of actions, sometimes symbolic actions which may be associated with a behavior pattern, and are often indispensable to its performance.", "PM": "98; see CEREMONIAL 1968-97", "HN": "98(68)", "CATSH": "CAT LIST", "MR": "20030725", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002562"}, {"RECTYPE": "D", "MH": "Cerium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.249", "FX": "Cerium Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Cerium", "RN": "30K4522N6T", "RR": "7440-45-1 (Cerium)", "MS": "An element of the rare earth family of metals. It has the atomic symbol Ce, atomic number 58, and atomic weight 140.12. Cerium is a malleable metal used in industrial applications.", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002563"}, {"RECTYPE": "D", "MH": "Cerium Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Cerium", "MN": "D01.552.550.399.249.500", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable cerium atoms that have the same atomic number as the element cerium, but differ in atomic weight. Ce-136, 138, and 142 are stable cerium isotopes.", "MR": "20170424", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002564"}, {"RECTYPE": "D", "MH": "Cerium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Cerium", "MN": "D01.552.550.399.249.500.300", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1974)", "MS": "Unstable isotopes of cerium that decay or disintegrate emitting radiation. Ce atoms with atomic weights 132-135, 137, 139, and 141-148 are radioactive cerium isotopes.", "OL": "search CERIUM ISOTOPES 1966-74", "PM": "75", "HN": "75", "MR": "20170424", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D002565"}, {"RECTYPE": "D", "MH": "Ceroid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.767.300", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "a lipid pigment", "PI": "Pigments (1970-1974)", "MS": "A naturally occurring lipid pigment with histochemical characteristics similar to lipofuscin. It accumulates in various tissues in certain experimental and pathological conditions.", "PM": "91; was see under PIGMENTS 1975-90", "HN": "91(75); was see under PIGMENTS 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002566"}, {"RECTYPE": "D", "MH": "Certificate of Need", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Need Certification, Health Care|T064|NON|BRD|UNK (19XX)|790601|abcdef", "ENTRY": "Need Certificates", "MN": "N03.349.650.120", "MH_TH": "NLM (1977)", "ST": "T170", "AN": "regional or area needs, not personal or financial need; specify geog", "MS": "A certificate issued by a governmental body to an individual or organization proposing to construct or modify a health facility, or to offer a new or different service. The process of issuing the certificate is also included.", "PM": "91; was see under REGIONAL HEALTH PLANNING Aug 1977-90", "HN": "91(Aug 77); was see under REGIONAL HEALTH PLANNING 1977-90", "MR": "19991103", "DA": "19770512", "DC": "1", "DX": "19910101", "UI": "D002567"}, {"RECTYPE": "D", "MH": "Certification", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Levels, Certification", "MN": "N05.700.200.190", "FX": "Specialty Boards", "MH_TH": "NLM (1968)", "ST": "T064", "AN": "by the profession; certification by various boards can go here but consider also LICENSURE; coordinate IM with specialty or discipline (IM); specify geographic term if pertinent; ELIGIBILITY CERTIFICATION see ELIGIBILITY DETERMINATION is also available", "PI": "Accreditation (1966-1967)", "MS": "Compliance with a set of standards defined by non-governmental organizations. Certification is applied for by individuals on a voluntary basis and represents a professional status when achieved, e.g., certification for a medical specialty.", "PM": "68", "HN": "68", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002568"}, {"RECTYPE": "D", "MH": "Cerulenin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "2,3-Epoxy-4-oxo-7,10-dodecadienoylamide|T109|T121|T123|NON|EQV|UNK (19XX)|810108|abbbcdef", "MN": "D02.065.327", "PA": "Fatty Acid Synthesis Inhibitors", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, (2R-(2alpha,3alpha(4E,7E)))-", "RN": "17397-89-6", "AN": "do not confuse with CERULEIN see CERULETIDE", "PI": "Fatty Acids, Unsaturated (1974)", "MS": "An epoxydodecadienamide isolated from several species, including ACREMONIUM, Acrocylindrum, and Helicoceras. It inhibits the biosynthesis of several lipids by interfering with enzyme function.", "PM": "91; was see under ANTIBIOTICS, ANTIFUNGAL 1975-90", "HN": "91(75); was see under ANTIBIOTICS, ANTIFUNGAL 1975-90", "MR": "20130710", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002569"}, {"RECTYPE": "D", "MH": "Ceruloplasmin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ferroxidase|T116|T126|NON|EQV|NLM (1991)|900227|abbcdef", "ENTRY": "Oxidase, Ceruloplasmin", "MN": "D12.776.556.151", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Fe(II):oxygen oxidoreductase", "RN": "EC 1.16.3.1", "MS": "A multi-copper blood FERROXIDASE involved in iron and copper homeostasis and inflammation.", "MR": "20170208", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002570"}, {"RECTYPE": "D", "MH": "Cerumen", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Ear Wax|T031|NON|EQV|NLM (2002)|000927|abcdef", "ENTRY": "Wax, Ear", "MN": "A12.200.147", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "The yellow or brown waxy secretions produced by vestigial apocrine sweat glands in the external ear canal.", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002571"}, {"RECTYPE": "D", "MH": "Cervical Plexus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Plexus, Cervical", "MN": "A08.800.800.720.150", "FX": "Cervical Plexus Block", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A network of nerve fibers originating in the upper four CERVICAL SPINAL CORD segments. The cervical plexus distributes cutaneous nerves to parts of the neck, shoulders, and back of the head. It also distributes motor fibers to muscles of the cervical SPINAL COLUMN, infrahyoid muscles, and the DIAPHRAGM.", "MR": "20140606", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002572"}, {"RECTYPE": "D", "MH": "Cervical Rib Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Naffziger Syndrome|T047|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Syndromes, Naffziger's", "MN": "C16.131.621.174", "FX": "Cervical Rib", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "A condition associated with compression of the BRACHIAL PLEXUS; SUBCLAVIAN ARTERY; and SUBCLAVIAN VEIN at the thoracic outlet and caused by a complete or incomplete anomalous CERVICAL RIB or fascial band connecting the tip of a cervical rib with the first thoracic rib. Clinical manifestations may include pain in the neck and shoulder which radiates into the upper extremity, PARESIS or PARALYSIS of brachial plexus innervated muscles; sensory loss; PARESTHESIAS; ISCHEMIA; and EDEMA. (Adams et al., Principles of Neurology, 6th ed, p214)", "OL": "search THORACIC OUTLET SYNDROME 1966-74", "PM": "1991; was see under THORACIC OUTLET SYNDROME 1983-90; was see under SCALENUS ANTICUS SYNDROME 1963-82", "HN": "1991(1975); was see under THORACIC OUTLET SYNDROME 1983-90; was see under SCALENUS ANTICUS SYNDROME 1963-82", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002573"}, {"RECTYPE": "D", "MH": "Cervical Vertebrae", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cervical Spine|T023|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Vertebrae, Cervical", "MN": "A02.835.232.834.151", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The first seven VERTEBRAE of the SPINAL COLUMN, which correspond to the VERTEBRAE of the NECK.", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002574"}, {"RECTYPE": "D", "MH": "Uterine Cervicitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cervicitis|T047|NON|EQV|NLM (1963)|990101|abcdef", "ENTRY": "Uterine Cervicitides", "MN": "C12.100.250.852.593.150", "MH_TH": "NLM (2006)", "ST": "T047", "MS": "Inflammation of the UTERINE CERVIX.", "PM": "2006; see CERVICITIS 1963-2005", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D002575"}, {"RECTYPE": "D", "MH": "Uterine Cervical Diseases", "DE": "UTERINE CERVICAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cervix Diseases|T047|NON|EQV|NLM (1966)|990101|CERVIX DIS|abcdefv", "ENTRY": "Uterine Cervical Disease", "MN": "C12.100.250.852.593", "MH_TH": "NLM (2006)", "ST": "T047", "MS": "Pathological processes of the UTERINE CERVIX.", "PM": "2006; see CERVIX DISEASES 1966-2005", "HN": "2006 (1966)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002577"}, {"RECTYPE": "D", "MH": "Uterine Cervical Dysplasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neoplasia, Cervical Intraepithelial|T191|NON|EQV|NLM (1994)|930527|NEOPL CERVICAL INTRAEPITHELIAL|abcdefv", "ENTRY": "Neoplasms, Cervical Intraepithelial", "MN": "C12.100.250.852.593.074", "FX": "Uterine Cervical Neoplasms", "MH_TH": "NLM (2006)", "ST": "T191", "PI": "Cervix Neoplasms (1966-1976)", "MS": "Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE.", "PM": "2006; see CERVIX DYSPLASIA 1984-2005, see CERVIX NEOPLASMS 1977-1983, CERVICAL INTRAEPITHELIAL NEOPLASM was a heading 1994-2022", "HN": "2006; use CERVIX NEOPLASMS 1977-1983, CERVICAL INTRAEPITHELIAL NEOPLASM was a heading 1994-2022", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19771206", "DC": "1", "DX": "19840101", "UI": "D002578"}, {"RECTYPE": "D", "MH": "Uterine Cervical Erosion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cervix Erosion|T047|NON|EQV|NLM (1963)|990101|abcdef", "ENTRY": "Erosion, Uterine Cervix", "MN": "C12.100.250.852.593.112", "MH_TH": "NLM (2006)", "ST": "T047", "MS": "Loss or destruction of the epithelial lining of the UTERINE CERVIX.", "PM": "2006; see CERVIX EROSION 1963-2005", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D002579"}, {"RECTYPE": "D", "MH": "Uterine Cervical Incompetence", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cervix Incompetence|T047|NON|EQV|NLM (1973)|990101|abcdef", "ENTRY": "Incompetent Cervices", "MN": "C12.100.250.852.593.120", "MH_TH": "NLM (2006)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY", "PI": "Cervix Diseases (1966-1972)", "MS": "Incompetent UTERINE CERVIX is usually diagnosed in the second trimester of PREGNANCY. It is characterized by passive painless cervical dilation in the absence of UTERINE CONTRACTION; BLEEDING; INFECTION; and sometimes with the amniotic sac (AMNIOTIC MEMBRANE) bulging through the partially dilated cervix. Left untreated, this condition may lead to premature pregnancy loss, such as HABITUAL ABORTION.", "PM": "2006; see CERVIX INCOMPETENCE 1973-2005", "HN": "2006 (1973)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002581"}, {"RECTYPE": "D", "MH": "Cervix Mucus", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Palm-Leaf Reaction|T060|NON|REL|NLM (1998)|961010|abcdef", "ENTRY": "Tests, Fern", "MN": "A12.200.503.339", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "A slightly alkaline secretion of the endocervical glands. The consistency and amount are dependent on the physiological hormone changes in the menstrual cycle. It contains the glycoprotein mucin, amino acids, sugar, enzymes, and electrolytes, with a water content up to 90%. The mucus is a useful protection against the ascent of bacteria and sperm into the uterus. (From Dictionary of Obstetrics and Gynecology, 1988)", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002582"}, {"RECTYPE": "D", "MH": "Uterine Cervical Neoplasms", "DE": "UTERINE CERVICAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Uterine Cervical Neoplasm", "MN": "C12.900.418.875.850", "FX": "Uterine Cervical Dysplasia", "MH_TH": "NLM (2006)", "ST": "T191", "AN": "coordinate IM with histologic type of neoplasm (IM)", "MS": "Tumors or cancer of the UTERINE CERVIX.", "PM": "2006; see CERVIX NEOPLASMS (1963-2005)", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D002583"}, {"RECTYPE": "D", "MH": "Cervix Uteri", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Uterine Cervical Canal|T023|NON|EQV|NLM (2023)|210910|abcdef", "ENTRY": "Uterine Cervical Canals", "MN": "A05.360.319.679.256", "FX": "Colposcopy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal.", "OL": "use CERVIX UTERI to search CERVIX HYPERTROPHY 1966-96", "PM": "CERVIX HYPERTROPHY was heading 1963-96", "HN": "CERVIX HYPERTROPHY was heading 1963-96", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D002584"}, {"RECTYPE": "D", "MH": "Cesarean Section", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Delivery, Abdominal|T061|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Deliveries, Abdominal", "MN": "E04.520.252.500", "FX": "Vaginal Birth after Cesarean", "MH_TH": "NLM (1963)", "ST": "T061", "AN": "check the tags FEMALE & PREGNANCY; anesthesia in cesareans: coord IM with ANESTHESIA, OBSTETRICAL (IM)", "MS": "Extraction of the FETUS by means of abdominal HYSTEROTOMY.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002585"}, {"RECTYPE": "D", "MH": "Cesium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Caesium-133|T196|NON|EQV|NLM (2024)|221128|abcdef", "ENTRY": "Cesium 133", "MN": "D01.552.544.165", "FX": "Cesium Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Cesium", "RN": "1KSV9V4Y4I", "RR": "7440-46-2 (Cesium)", "MS": "A member of the alkali metals. It has an atomic symbol Cs, atomic number 55, and atomic weight 132.91. Cesium has many industrial applications, including the construction of atomic clocks based on its atomic vibrational frequency.", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002586"}, {"RECTYPE": "D", "MH": "Cesium Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Cesium", "MN": "D01.552.544.165.500", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable cesium atoms that have the same atomic number as the element cesium, but differ in atomic weight. Cs-133 is a naturally occurring isotope.", "MR": "20170424", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002587"}, {"RECTYPE": "D", "MH": "Cesium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Cesium", "MN": "D01.552.544.165.500.300", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1974)", "MS": "Unstable isotopes of cesium that decay or disintegrate emitting radiation. Cs atoms with atomic weights of 123, 125-132, and 134-145 are radioactive cesium isotopes.", "OL": "search CESIUM ISOTOPES 1966-74", "PM": "75", "HN": "75", "MR": "20170424", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D002588"}, {"RECTYPE": "D", "MH": "Cestoda", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Tapeworms|T204|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Tapeworm", "MN": "B01.050.500.500.736.215", "FX": "Anticestodal Agents", "MH_TH": "NLM (1965)", "ST": "T204", "RN": "txid6199", "RR": "txid70662", "AN": "general or unspecified; prefer specifics; infection equals CESTODE INFECTIONS; coordinate with specific helminth terms (ANTIGENS, HELMINTH etc.) if pertinent", "MS": "A subclass of segmented worms comprising the tapeworms.", "OL": "use CESTODA to search RAILLIETINA 1966-85", "PM": "65; was TAPEWORMS 1963-64; RAILLIETINA was see under CESTODA 1965-85, was see under TAPEWORMS 1963-64; SPIROMETRA was heading 1979-85, was indexed under CESTODA 1975-78", "HN": "65; was TAPEWORMS 1963-64; RAILLIETINA was see under CESTODA 1965-85, was see under TAPEWORMS 1963-64; SPIROMETRA was heading 1978-85", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002589"}, {"RECTYPE": "D", "MH": "Cestode Infections", "DE": "CESTODE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Tapeworm Infection|T047|NON|EQV|UNK (19XX)|740329|TAPEWORM INFECT|abcdefv", "ENTRY": "Tapeworm Infections", "MN": "C01.610.335.190", "FX": "Anticestodal Agents", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Infections with true tapeworms of the helminth subclass CESTODA.", "OL": "use CESTODE INFECTIONS to search DIPYLIDIASIS & RAILLIETINIASIS 1968-85 & CENURIASIS 1968-81", "PM": "65; was TAPEWORM INFECTION 1963-64; CENURIASIS was heading 1968-81; DIPYLIDIASIS & RAILLIETINIASIS were headings 1968-85", "HN": "65; was TAPEWORM INFECTION 1963-64; CENURIASIS was heading 1968-81; DIPYLIDIASIS & RAILLIETINIASIS were headings 1968-85", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002590"}, {"RECTYPE": "D", "MH": "Cetacea", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Cetaceas", "MN": "B01.050.150.900.649.313.875", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid9721", "MS": "An order of wholly aquatic MAMMALS occurring in all the OCEANS and adjoining seas of the world, as well as in certain river systems. They feed generally on FISHES, cephalopods, and crustaceans. Most are gregarious and most have a relatively long period of parental care and maturation. Included are DOLPHINS; PORPOISES; and WHALES. (From Walker's Mammals of the World, 5th ed, pp969-70)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002591"}, {"RECTYPE": "D", "MH": "Cetomacrogol", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polyethylene Glycol Cetyl Ether|T109|T121|NON|EQV|UNK (19XX)|800414|abbcdef", "ENTRY": "n Hexadecane Polyoxyethylene Glycol Monether", "MN": "J01.637.051.720.741.250", "PA": "Surface-Active Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Poly(oxy-1,2-ethanediyl), alpha-hexadecyl-omega-hydroxy-", "RN": "9004-95-9", "PI": "Polyethylene Glycols (1974)", "MS": "Non-ionic surfactant of the polyethylene glycol family. It is used as a solubilizer and emulsifying agent in foods, cosmetics, and pharmaceuticals, often as an ointment base, and also as a research tool.", "PM": "91; was see under POLYETHYLENE GLYCOLS 1975-90", "HN": "91(75); was see under POLYETHYLENE GLYCOLS 1975-90", "MR": "20060705", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002592"}, {"RECTYPE": "D", "MH": "Cetrimonium Compounds", "DE": "CETRIMONIUM CPDS", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Cetyltrimethylammonium Compounds|T109|T121|NON|EQV|UNK (19XX)|741111|CETYLTRIMETHYLAMMONIUM CPDS|abbcdefv", "ENTRY": "Compounds, Cetyltrimethylammonium", "MN": "D02.675.276.190", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Ammonium Compounds (1968-1974)", "MS": "Cetyltrimethylammonium compounds that have cationic detergent, antiseptic, and disinfectant activities. They are used in pharmaceuticals, foods, and cosmetics as preservatives; on skin, mucous membranes, etc., as antiseptics or cleansers, and also as emulsifiers. These compounds are toxic when used orally due to neuromuscular blockade.", "PM": "91; was see under AMMONIUM COMPOUNDS 1975-90", "HN": "91(75); was see under AMMONIUM COMPOUNDS 1975-90", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002593"}, {"RECTYPE": "D", "MH": "Cetylpyridinium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chloride, Cetylpyridinium", "MN": "D03.383.725.762.232", "PA": "Detergents", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "Pyridinium, 1-hexadecyl-", "RN": "CUB7JI0JV3", "RR": "D9OM4SK49P", "PI": "Surface-Active Agents (1966-1971)", "MS": "Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.", "PM": "91; was see under PYRIDINIUM COMPOUNDS 1972-90", "HN": "91(72); was see under PYRIDINIUM COMPOUNDS 1972-90", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002594"}, {"RECTYPE": "D", "MH": "Cevanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cevane Alkaloids|T109|NON|EQV|NLM (2001)|000525|abcdef", "ENTRY": "Alkaloids, Cevane", "MN": "D03.633.400.256", "MH_TH": "NLM (1969)", "ST": "T109", "RN": "0", "PI": "Veratrum (1966-1968)", "MS": "Structurally-related alkaloids that contain the cevane carbon backbone.", "PM": "69", "HN": "69", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D002595"}, {"RECTYPE": "D", "MH": "Chad", "AQ": "EH EP", "MN": "Z01.058.290.100.130", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in central Africa, east of NIGER, west of SUDAN and south of LIBYA. Its capital is N'Djamena.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D002596"}, {"RECTYPE": "D", "MH": "Chaetomium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Chaetomiums", "MN": "B01.300.107.800.150", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5149", "MS": "A genus of ascomycetous fungi of the family Chaetomiaceae, order SORDARIALES. Many members are cellulolytic and some mycotoxic. They occur naturally on paper and cotton fabric.", "PM": "91; see ASCOMYCETES 1975-90", "HN": "91(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D002597"}, {"RECTYPE": "D", "MH": "Chagas Cardiomyopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Trypanosomiasis, Cardiovascular|T047|NON|EQV|UNK (19XX)|800402|abcdef", "ENTRY": "Cardiovascular Trypanosomiasis", "MN": "C14.280.238.190", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "specific heart disease (1966-1980)", "MS": "A disease of the CARDIAC MUSCLE developed subsequent to the initial protozoan infection by TRYPANOSOMA CRUZI. After infection, less than 10% develop acute illness such as MYOCARDITIS (mostly in children). The disease then enters a latent phase without clinical symptoms until about 20 years later. Myocardial symptoms of advanced CHAGAS DISEASE include conduction defects (HEART BLOCK) and CARDIOMEGALY.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19800402", "DC": "1", "DX": "19810101", "UI": "D002598"}, {"RECTYPE": "D", "MH": "Chalcone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzylideneacetophenone|T109|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abcdeef", "ENTRY": "1,3 Diphenyl 2 Propen 1 One", "MN": "D03.633.100.150.266.450.221.500", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "2-Propen-1-one, 1,3-diphenyl-", "RN": "5S5A2Q39HX", "RR": "94-41-7 (Chalcone)", "AN": "do not confuse with CHALONES", "PI": "Propiophenones (1969-1974)", "MS": "An aromatic KETONE that forms the core molecule of CHALCONES.", "PM": "91; was see under PROPIOPHENONES 1975-90", "HN": "91(75); was see under PROPIOPHENONES 1975-90", "MR": "20161201", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002599"}, {"RECTYPE": "D", "MH": "Chancre", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C01.150.252.400.840.500.500", "MH_TH": "NLM (1975)", "ST": "T184", "AN": "primary lesion of syphilis: do not confuse with CHANCROID (caused by Haemophilus ducreyi)", "MS": "The primary sore of syphilis, a painless indurated, eroded papule, occurring at the site of entry of the infection.", "OL": "search SYPHILIS 1966-74", "PM": "91; was see under SYPHILIS 1975-90", "HN": "91(75); was see under SYPHILIS 1975-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002601"}, {"RECTYPE": "D", "MH": "Chancroid", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C12.100.937.281.201", "MH_TH": "POPLINE (1993)", "ST": "T047", "AN": "caused by Haemophilus ducreyi; do not confuse with CHANCRE, the primary lesion of syphilis", "MS": "Acute, localized autoinoculable infectious disease usually acquired through sexual contact. Caused by HAEMOPHILUS DUCREYI, it occurs endemically almost worldwide, especially in tropical and subtropical countries and more commonly in seaports and urban areas than in rural areas.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002602"}, {"RECTYPE": "D", "MH": "Channel Islands", "AQ": "EH EP", "PRINT ENTRY": "Sark|T083|NAM|NRW|NLM (1994)|920820|abcdef", "MN": "Z01.542.363.161", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "Channel refers to the English Channel", "MS": "A group of four British islands and several islets in the English Channel off the coast of France. They are known to have been occupied prehistorically. They were a part of Normandy in 933 but were united to the British crown at the time of the Norman Conquest in 1066. Guernsey and Jersey originated noted breeds of cattle. (From Webster's New Geographical Dictionary, 1988, p242)", "MR": "20160711", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D002603"}, {"RECTYPE": "D", "MH": "Chaplaincy Service, Hospital", "DE": "CHAPLAINCY SERV HOSP", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Hospital Chaplaincy Service|T093|NON|EQV|UNK (19XX)|770519|HOSP CHAPLAINCY SERV|abcdefv", "ENTRY": "Services, Hospital Chaplaincy", "MN": "N04.452.442.452.422.270", "MH_TH": "NLM (1977)", "ST": "T093", "AN": "IM; coord with specific religion (IM) if pertinent", "MS": "Hospital department which administers religious activities within the hospital, e.g., pastoral care, religious services.", "PM": "91; was see under HOSPITAL DEPARTMENTS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90", "MR": "20190709", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D002604"}, {"RECTYPE": "D", "MH": "Character", "ENTRY": "Characters", "MN": "F01.752.190", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "In current usage, approximately equivalent to personality. The sum of the relatively fixed personality traits and habitual modes of response of an individual.", "CATSH": "CAT LIST", "MR": "19890428", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002605"}, {"RECTYPE": "D", "MH": "Charcoal", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Activated Charcoal|T121|T196|NON|NRW|NLM (1994)|USP (19XX)|930324|abbcdeef", "ENTRY": "Charcoal, Activated", "MN": "D01.268.150.150", "PA": "Antidotes", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "16291-96-6", "RR": "64365-11-3 (activated)", "MS": "An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "1994; for NORIT see CARBON 1982-1993", "HN": "1994; for NORIT use CARBON 1982-1993", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D002606"}, {"RECTYPE": "D", "MH": "Charcot-Marie-Tooth Disease", "DE": "CHARCOT MARIE TOOTH DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Roussy-Levy Syndrome|T047|EPO|REL|NLM (1991)|OMIM (2013)|ORD (2010)|900112|abcdeeef", "ENTRY": "Syndrome, Roussy-Levy", "MN": "C16.320.400.375.200", "FX": "Myelin P0 Protein", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "A hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343)", "PM": "2000; see CHARCOT-MARIE DISEASE 1991-1999, see MUSCULAR ATROPHY, SPINAL 1988-1990, see MUSCULAR ATROPHY 1966-1987; for CHARCOT-MARIE-TOOTH DISEASE see CHARCOT-MARIE DISEASE 1991-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19991108", "DC": "1", "DX": "19910101", "UI": "D002607"}, {"RECTYPE": "D", "MH": "Charities", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "ENTRY": "Charity", "MN": "N03.540.125", "FX": "Uncompensated Care", "MH_TH": "NLM (1966)", "ST": "T095", "MS": "Social welfare organizations with programs designed to assist individuals in need.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002608"}, {"RECTYPE": "D", "MH": "Chediak-Higashi Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Chediak-Steinbrinck-Higashi Syndromes", "MN": "C20.673.795.375", "FX": "Aleutian Mink Disease", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Leukocytes (1966-1970)", "MS": "A form of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections. In many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions. The disease is transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the Aleutian mink, and albino Hereford cattle.", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D002609"}, {"RECTYPE": "D", "MH": "Cheek", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "Bucca|T029|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Cheeks", "MN": "A14.194", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "The part of the face that is below the eye and to the side of the nose and mouth.", "MR": "20150302", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002610"}, {"RECTYPE": "D", "MH": "Cheese", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Cheeses", "MN": "J02.500.350.300.444", "MH_TH": "NLM (1966)", "ST": "T168", "MS": "A nutritious food consisting primarily of the curd or the semisolid substance formed when milk coagulates.", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002611"}, {"RECTYPE": "D", "MH": "Acinonyx", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Cheetahs|T015|NON|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Cheetah", "MN": "B01.050.150.900.649.313.750.377.750.030", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid32535", "MS": "A genus of long-legged, swift-moving felines (FELIDAE) from Africa (and formerly Asia) about the size of a small leopard.", "PM": "2005; see CHEETAHS 1991-2004, see CARNIVORA 1975-1990", "HN": "2005 (1975)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D002612"}, {"RECTYPE": "D", "MH": "Cheilitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cheilitides", "MN": "C07.465.409.215", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "inflamm of the lips", "MS": "Inflammation of the lips. It is of various etiologies and degrees of pathology.", "CATSH": "CAT LIST", "MR": "19930526", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002613"}, {"RECTYPE": "D", "MH": "Chelating Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Metal Antagonists|T121|NON|BRD|NLM (1996)|950502|abcdef", "ENTRY": "Chelating Agents, Metal", "MN": "D27.720.832.500", "FX": "Iron Chelating Agents", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "MS": "Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS.", "PM": "HEAVY METAL DETOXICANTS was heading 1963-65", "HN": "HEAVY METAL DETOXICANTS was heading 1963-65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002614"}, {"RECTYPE": "D", "MH": "Chemexfoliation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Chemical Face Peeling|T061|NON|NRW|UNK (19XX)|760412|CHEM FACE PEELING|abcdefv", "ENTRY": "Chemexfoliations", "MN": "E04.617.275.200", "MH_TH": "NLM (1977)", "ST": "T061", "PI": "Surgery, Plastic (1966-1976)", "MS": "Application of a cauterant to the skin for the purpose of causing a superficial destruction of the epidermis and upper layers of the dermis. After healing, the treated area has new epithelium.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D002615"}, {"RECTYPE": "D", "MH": "Chemical Engineering", "DE": "CHEM ENGINEERING", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Engineering, Chemical|T090|NON|EQV|UNK (19XX)|860101|ENGINEERING CHEM|abcdefv", "MN": "J01.293.257", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "Application of principles and practices of engineering science to the transformation, design, and manufacture of substances on an industrial scale.", "PM": "66", "HN": "66", "MR": "20151130", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002616"}, {"RECTYPE": "D", "MH": "Chemical Industry", "DE": "CHEM INDUST", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Industries, Chemical", "MN": "J01.576.655.437", "MH_TH": "NLM (1966)", "ST": "T092", "MS": "The aggregate enterprise of manufacturing and technically producing chemicals. (From Random House Unabridged Dictionary, 2d ed)", "MR": "19950522", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002617"}, {"RECTYPE": "D", "MH": "Chemical Warfare", "DE": "CHEM WARFARE", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Warfares, Chemical", "MN": "I01.880.735.950.500.340", "FX": "Gas Poisoning", "MH_TH": "NLM (1966)", "ST": "T052", "MS": "Tactical warfare using incendiary mixtures, smokes, or irritant, burning, or asphyxiating gases.", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002618"}, {"RECTYPE": "D", "MH": "Chemical Warfare Agents", "DE": "CHEM WARFARE AGENTS", "AQ": "AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO", "ENTRY": "Warfare Agent, Chemical", "MN": "J01.637.870.900.200", "FX": "Tear Gases", "MH_TH": "NLM (1968)", "ST": "T131", "RN": "0", "PI": "Gases (1966-1967)", "MS": "Chemicals that are used to cause the disturbance, disease, or death of humans during WARFARE.", "PM": "68", "HN": "68", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002619"}, {"RECTYPE": "D", "MH": "Pharmacological and Toxicological Phenomena", "ENTRY": "Phenomenon, Toxicopharmacological", "MN": "G07.690", "FX": "Pharmacologic Actions", "MH_TH": "NLM (2016)", "ST": "T038", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Synthesis, metabolism, and poisoning associated with drugs, pharmaceuticals, and other active molecules. Toxicological phenomena also include the adverse effects of physical phenomena such as RADIATION and NOISE.", "PM": "2018; see PHARMACOLOGICAL AND TOXICOLOGICAL PHENOMENA AND PROCESSES 2016-2017; see PHARMACOLOGICAL PHENOMENA 2009-2015; see CHEMICAL AND PHARMACOLOGIC PHENOMENA 1998-2008", "HN": "2018 (1998)", "CATSH": "CAT LIST", "MR": "20170623", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D002620"}, {"RECTYPE": "D", "MH": "Chemistry", "DE": "CHEM", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.181", "FX": "Neurochemistry", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use CHEMICAL PHENOMENA or specifics treed under it for characteristics of chemicals and their reactions; the qualifier / chemistry is available for use with specific anatomical terms, lower organisms and chemicals", "MS": "A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002621"}, {"RECTYPE": "D", "MH": "Chemistry, Agricultural", "DE": "CHEM AGRICULTURAL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Agricultural Chemistry|T090|NON|EQV|UNK (19XX)|790329|AGRICULTURAL CHEM|abcdefv", "ENTRY": "Chemistries, Agricultural", "MN": "H01.181.216", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "MS": "The science of the chemical composition and reactions of chemicals involved in the production, protection and use of crops and livestock. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002622"}, {"RECTYPE": "D", "MH": "Chemistry Techniques, Analytical", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Analytical Chemistry Techniques|T059|NON|EQV|NLM (2010)|081118|abcdef", "ENTRY": "Techniques, Analytical Chemistry", "MN": "E05.196", "FX": "Autoanalysis", "MH_TH": "NLM (2010)", "ST": "T059", "AN": "general or unspecified; prefer specifics", "MS": "Methodologies used for the isolation, identification, detection, and quantitation of chemical substances.", "PM": "2010; see CHEMISTRY, ANALYTICAL 1963-2009", "HN": "2010 (1963)", "CATSH": "CAT LIST", "MR": "20091009", "DA": "19990101", "DC": "1", "DX": "20100101", "UI": "D002623"}, {"RECTYPE": "D", "MH": "Chemistry, Clinical", "DE": "CHEM CLIN", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Clinical Chemistry|T091|NON|EQV|NLM (1998)|970410|CLIN CHEM|abcdefv", "MN": "H01.181.341", "FX": "Clinical Chemistry Tests", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty; do not use as a coordinate", "MS": "The specialty of ANALYTIC CHEMISTRY applied to assays of physiologically important substances found in blood, urine, tissues, and other biological fluids for the purpose of aiding the physician in making a diagnosis or following therapy.", "PM": "67", "HN": "67(66)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002624"}, {"RECTYPE": "D", "MH": "Chemistry, Organic", "DE": "CHEM ORG", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Organic Chemistry|T090|NON|EQV|UNK (19XX)|860101|ORG CHEM|abcdefv", "MN": "H01.181.404", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use ORGANIC CHEMISTRY PHENOMENA or specifics treed under it for properties and reaction processes of organic compounds", "MS": "The study of the structure, preparation, properties, and reactions of carbon compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "66", "HN": "66", "MR": "20081130", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002625"}, {"RECTYPE": "D", "MH": "Chemistry, Pharmaceutical", "DE": "CHEM PHARM", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Medicinal Chemistry|T091|NON|EQV|NLM (2007)|051201|abcdef", "ENTRY": "Chemistry, Medicinal", "MN": "H01.181.466", "FX": "Technology, Pharmaceutical", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use for the specialty and as an NIM coordinate", "MS": "Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002626"}, {"RECTYPE": "D", "MH": "Chemistry, Physical", "DE": "CHEM PHYSICAL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Physical Chemistries", "MN": "H01.181.529", "MH_TH": "NLM (1965)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use PHYSICOCHEMICAL PHENOMENA or specifics treed under it for physical phenomena related to the structure and interactive processes of chemicals", "MS": "The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes.", "PM": "65", "HN": "65", "MR": "20090710", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002627"}, {"RECTYPE": "D", "MH": "Chemoreceptor Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Chemoreceptor Cell", "MN": "A11.671.650.915.500", "MH_TH": "NLM (2009)", "ST": "T025", "AN": "note category: do not confuse with chemoreceptor proteins", "PI": "Sensory Receptor Cells (1966-1967)", "MS": "Cells specialized to detect chemical substances and relay that information centrally in the nervous system. Chemoreceptor cells may monitor external stimuli, as in TASTE and OLFACTION, or internal stimuli, such as the concentrations of OXYGEN and CARBON DIOXIDE in the blood.", "PM": "2009; see CHEMORECEPTORS 1968-2008, see RECEPTORS, NEURAL 1963-1967", "HN": "2009 (1968)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002628"}, {"RECTYPE": "D", "MH": "Chemosterilants", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D27.888.723.141", "MH_TH": "POPLINE (1978)", "ST": "T131", "RN": "0", "MS": "Compounds that cause reproductive sterility in organisms. They are sometimes used to control pest populations by sterilizing males within the population.", "PM": "72", "HN": "72(66)", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002629"}, {"RECTYPE": "D", "MH": "Chemotactic Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Macrophage Chemotactic Factor|T129|NON|NRW|NLM (2021)|200203|abcdef", "ENTRY": "Factor, Macrophage Chemotactic", "MN": "D23.125", "FX": "Pheromones", "MH_TH": "NLM (1980)", "ST": "T129", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Chemotaxis, Leukocyte (1977-1979)", "MS": "Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult.", "PM": "1980; see CHEMOTACTIC FACTORS 1984-1990; for CHEMOTACTIC FACTORS, MACROPHAGE see CHEMOTACTIC FACTORS, MACROPHAGE 1980-2007", "HN": "1980", "MR": "20200527", "DA": "19790430", "DC": "1", "DX": "19800101", "UI": "D002630"}, {"RECTYPE": "D", "MH": "Chemotactic Factors, Eosinophil", "DE": "ECF A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Eosinophil Chemotaxins|T129|NON|EQV|UNK (19XX)|790430|abcdef", "ENTRY": "Factors, Eosinophil Chemotactic", "MN": "D23.125.320", "MH_TH": "NLM (1980)", "ST": "T129", "RN": "0", "PI": "Eosinophils (1966-1979)", "MS": "Cytotaxins liberated from normal or invading cells that specifically attract eosinophils; they may be complement fragments, lymphokines, neutrophil products, histamine or other; the best known is the tetrapeptide ECF-A, released mainly by mast cells.", "PM": "91; was see under CHEMOTACTIC FACTORS 1980-90", "HN": "91(80); was see under CHEMOTACTIC FACTORS 1980-90", "MR": "20050630", "DA": "19790430", "DC": "1", "DX": "19910101", "UI": "D002631"}, {"RECTYPE": "D", "MH": "Chemotaxis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Haptotaxis|T043|NON|NRW|NLM (2017)|160217|abcdef", "MN": "G11.427.410.568.850.500", "FX": "Chemotactic Factors", "MH_TH": "NLM (1965)", "ST": "T043", "MS": "The movement of cells or organisms toward or away from a substance in response to its concentration gradient.", "PM": "70", "HN": "70(65)", "CATSH": "CAT LIST", "MR": "20160616", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D002633"}, {"RECTYPE": "D", "MH": "Chemotaxis, Leukocyte", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Leukotaxis|T043|NON|EQV|UNK (19XX)|800402|abcdef", "ENTRY": "Leukocyte Chemotaxis", "MN": "G04.198.424.233", "MH_TH": "NLM (1977)", "ST": "T043", "AN": "coordinate IM with specific type of leukocyte (IM)", "PI": "Chemotaxis (1966-1976)", "MS": "The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20160217", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D002634"}, {"RECTYPE": "D", "MH": "Chenodeoxycholic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gallodesoxycholic Acid|T109|T121|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|770208|abbbcdeef", "ENTRY": "Chenodeoxycholate, Sodium", "MN": "D04.210.500.221.430.342.300", "PA": "Gastrointestinal Agents", "MH_TH": "INN (19XX)", "ST": "T123", "N1": "Cholan-24-oic acid, 3,7-dihydroxy-, (3alpha,5beta,7alpha)-", "RN": "0GEI24LG0J", "RR": "474-25-9 (Chenodeoxycholic Acid)", "PI": "Bile Acids and Salts (1966-1972)", "MS": "A bile acid, usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones.", "PM": "74", "HN": "74(73)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002635"}, {"RECTYPE": "D", "MH": "Cherubism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Familial Multilocular Cystic Disease of the Jaws|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef", "MN": "C16.320.170", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A fibro-osseous hereditary disease of the jaws. The swollen jaws and raised eyes give a cherubic appearance; multiple radiolucencies are evident upon radiographic examination.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002636"}, {"RECTYPE": "D", "MH": "Chest Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Texidor Twinge", "MN": "C23.888.592.612.233", "FX": "Angina Pectoris", "MH_TH": "NLM (1987)", "ST": "T184", "PI": "Thorax (1966-1986)", "MS": "Pressure, burning, or numbness in the chest.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19860326", "DC": "1", "DX": "19870101", "UI": "D002637"}, {"RECTYPE": "D", "MH": "Chewing Gum", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Gums, Chewing", "MN": "J02.500.140.200", "MH_TH": "NLM (1966)", "ST": "T167", "RN": "0", "AN": "as a confection or as vehicle for admin of med substances", "MS": "A preparation of chicle, sometimes mixed with other plastic substances, sweetened and flavored. It is masticated usually for pleasure as a candy substitute but it sometimes acts as a vehicle for the administration of medication.", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002638"}, {"RECTYPE": "D", "MH": "Cheyne-Stokes Respiration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Respiration, Cheyne-Stokes", "MN": "C23.888.852.227", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "An abnormal pattern of breathing characterized by alternating periods of apnea and deep, rapid breathing. The cycle begins with slow, shallow breaths that gradually increase in depth and rate and is then followed by a period of apnea. The period of apnea can last 5 to 30 seconds, then the cycle repeats every 45 seconds to 3 minutes.", "OL": "use RESPIRATION to search CHEYNE-STOKES RESPIRATION 1966-76", "PM": "91; was see under RESPIRATION DISORDERS 1977-90; was see under RESPIRATION 1966-76", "HN": "91(66); was see under RESPIRATION DISORDERS 1977-90; was see under RESPIRATION 1966-76", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002639"}, {"RECTYPE": "D", "MH": "Chiari-Frommel Syndrome", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Frommel's Disease|T047|EPO|EQV|UNK (19XX)|740329|FROMMELS DIS|abcdefv", "ENTRY": "Syndrome, Chiari-Frommel", "MN": "C17.800.090.937.439.500", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "A POSTPARTUM condition consists of persistent lactation (GALACTORRHEA) and AMENORRHEA in patients not BREAST FEEDING.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002640"}, {"RECTYPE": "D", "MH": "Chicago", "AQ": "EH EP", "MN": "Z01.433.305", "MH_TH": "NLM (1966)", "ST": "T083", "MS": "A city in Illinois.", "MR": "20160628", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D002641"}, {"RECTYPE": "D", "MH": "Chick Embryo", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Embryo, Chick|T018|NON|EQV|UNK (19XX)|771205|abcdef", "ENTRY": "Embryos, Chick", "MN": "A16.331.200", "MH_TH": "NLM (1964)", "ST": "T018", "MS": "The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching.", "PM": "64", "HN": "64", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D002642"}, {"RECTYPE": "D", "MH": "Chickenpox", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Varicella|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Chicken Pox|T047|NON|EQV|UNK (19XX)|880712|abcdef", "MN": "C01.925.256.466.930.250", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002644"}, {"RECTYPE": "D", "MH": "Chickens", "AQ": "AB AH BL CF CL GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Gallus gallus|T012|NON|EQV|NLM (2004)|021118|abcdef", "ENTRY": "Chicken", "MN": "B01.050.150.900.248.690.192", "EC": "embryology:Chick Embryo", "MH_TH": "NLM (1968)", "ST": "T012", "RN": "txid9031", "AN": "diseases: coord IM with POULTRY DISEASES (IM); canned chicken: coord IM with FOOD PRESERVATION", "PI": "Poultry (1966-1967)", "MS": "Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA.", "PM": "68", "HN": "68", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002645"}, {"RECTYPE": "D", "MH": "Chikungunya virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.578.875.054.198", "MH_TH": "NLM (1964)", "ST": "T005", "RN": "txid37124", "MS": "A species of ALPHAVIRUS causing an acute dengue-like fever.", "PM": "66", "HN": "66(64)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002646"}, {"RECTYPE": "D", "MH": "Chilblains", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Perniosis, Idiopathic", "MN": "C26.417.217", "MH_TH": "ORD (2010)", "ST": "T037", "MS": "Recurrent localized itching, swelling and painful erythema on the fingers, toes or ears, produced by exposure to cold.", "OL": "search FROSTBITE 1966-74", "PM": "91; was see under FROSTBITE 1975-90", "HN": "91(75); was see under FROSTBITE 1975-90", "CATSH": "CAT LIST", "MR": "20141202", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002647"}, {"RECTYPE": "D", "MH": "Child", "ENTRY": "Children|T100|NON|EQV|BIOETHICS (1989)|770317|abcdef", "MN": "M01.060.406", "FX": "Only Child", "EC": "psychology:Psychology, Child", "MH_TH": "NLM (1978)", "ST": "T100", "AN": "almost always check tag: NIM no qualifiers; see Manual Chapter 9", "MS": "A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002648"}, {"RECTYPE": "D", "MH": "Child Abuse", "AQ": "CL DI EC EH ES HI LJ MO PC PX RH SN TD TH", "PRINT ENTRY": "Physical Neglect, Childhood|T054|NON|REL|NLM (2024)|230424|abcdef", "ENTRY": "Physical Child Neglects", "MN": "I01.880.735.900.350.250", "FX": "Shaken Baby Syndrome", "MH_TH": "NLM (1965)", "ST": "T055", "AN": "check the tag CHILD or specific", "MS": "Abuse of children in a family, institutional, or other setting. (APA, Thesaurus of Psychological Index Terms, 1994)", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002649"}, {"RECTYPE": "D", "MH": "Child Abuse, Sexual", "AQ": "CL DI EC EH ES HI LJ MO PC PX RH SN TD TH", "PRINT ENTRY": "Sexual Abuse, Child|T054|T055|NON|EQV|UNK (19XX)|860327|abbcdef", "ENTRY": "Sexual Child Molestation", "MN": "I01.880.735.900.350.250.255", "MH_TH": "NLM (1987)", "ST": "T055", "AN": "check also tag CHILD or specific; for adult survivors of child sexual abuse, check both tags CHILD or specific + relevant adult age", "PI": "Sex Offenses (1968-1986)", "MS": "Sexual maltreatment of the child or minor.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19860325", "DC": "1", "DX": "19870101", "UI": "D002650"}, {"RECTYPE": "D", "MH": "Child Advocacy", "AQ": "CL EC ED ES HI IN LJ PX SN ST TD", "ENTRY": "Child Advocacies", "MN": "N03.706.437.300", "MH_TH": "NLM (1975)", "ST": "T090", "AN": "rights of children; check also tag CHILD or specific", "PI": "Child Welfare (1966-1974)", "MS": "Promotion and protection of the rights of children; frequently through a legal process.", "PM": "75", "HN": "75", "MR": "19890428", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D002651"}, {"RECTYPE": "D", "MH": "Child Behavior", "AQ": "CL DE EH ES PH PX RE", "PRINT ENTRY": "Behavior, Child|T055|NON|EQV|NLM (1994)|921120|abcdef", "MN": "F01.145.179", "MH_TH": "NLM (1968)", "ST": "T055", "AN": "check also tag CHILD or specific; INFANT BEHAVIOR is also available", "PI": "Child Psychology (1966-1967)", "MS": "Any observable response or action of a child from 24 months through 12 years of age. For neonates or children younger than 24 months, INFANT BEHAVIOR is available.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002652"}, {"RECTYPE": "D", "MH": "Child Behavior Disorders", "DE": "CHILD BEHAVIOR DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Childhood Behavior Disorders|T048|NON|EQV|NLM (2021)|200515|abcdef", "ENTRY": "Disorder, Childhood Behavior", "MN": "F03.625.141", "MH_TH": "NLM (1966)", "ST": "T048", "AN": "check the tag CHILD or specific", "MS": "Disturbances considered to be pathological based on age and stage appropriateness, e.g., conduct disturbances and anaclitic depression. This concept does not include psychoneuroses, psychoses, or personality disorders with fixed patterns.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002653"}, {"RECTYPE": "D", "MH": "Child Care", "AQ": "CL EC ES HI LJ MT OG PX SD SN ST TD", "PRINT ENTRY": "Puericulture|T056|T057|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Care, Child", "MN": "N02.421.088", "FX": "Infant Care", "MH_TH": "NLM (1978)", "ST": "T057", "AN": "check also tag CHILD or specific", "MS": "Care of CHILDREN in the home or in an institution.", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002654"}, {"RECTYPE": "D", "MH": "Child Custody", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Custody, Child|T078|NON|EQV|UNK (19XX)|870227|abcdef", "ENTRY": "Support, Child", "MN": "I01.880.787.293.370", "FX": "Child Advocacy", "MH_TH": "POPLINE (1987)", "ST": "T078", "AN": "check also tag CHILD or specific", "PI": "Child Welfare (1966-1987)", "MS": "The formally authorized guardianship or care of a CHILD.", "PM": "91; was see under CHILD WELFARE 1988-90", "HN": "91(88); was see under CHILD WELFARE 1988-90", "MR": "20150630", "DA": "19870227", "DC": "1", "DX": "19910101", "UI": "D002655"}, {"RECTYPE": "D", "MH": "Child Day Care Centers", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Day Care Centers for Children|T073|T092|NON|EQV|NLM (1995)|931122|abbcdef", "ENTRY": "Child Daycare Center", "MN": "N02.421.143.098", "FX": "Nurseries, Infant", "MH_TH": "NLM (1973)", "ST": "T092", "PI": "Child Welfare (1966-1972)", "MS": "Facilities which provide care for pre-school and school-age children.", "PM": "73", "HN": "73", "MR": "20190711", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002656"}, {"RECTYPE": "D", "MH": "Child Development", "AQ": "CL DE PH RE", "PRINT ENTRY": "Infant Development|T041|NON|NRW|NLM (1994)|930203|abcdef", "ENTRY": "Development, Infant", "MN": "G07.345.374.750", "FX": "Personality Development", "MH_TH": "NLM (1968)", "ST": "T041", "AN": "includes infant and child but not adolescents; add the appropriate age check tag", "PI": "Growth (1966-1967)", "MS": "The continuous sequential physiological and psychological maturing of an individual from birth up to but not including ADOLESCENCE.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002657"}, {"RECTYPE": "D", "MH": "Developmental Disabilities", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Disabilities, Developmental|T048|NON|EQV|NLM (1996)|950530|abcdef", "ENTRY": "Disability, Developmental", "MN": "F03.625.421", "MH_TH": "NLM (1968)", "ST": "T048", "PI": "Child Psychology (1966-1967)", "MS": "Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)", "PM": "96; was CHILD DEVELOPMENT DISORDERS 1981-95; was CHILD DEVELOPMENT DEVIATIONS 1968-80", "HN": "96; was CHILD DEVELOPMENT DISORDERS 1981-95; was CHILD DEVELOPMENT DEVIATIONS 1968-80", "CATSH": "CAT LIST", "MR": "20150706", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002658"}, {"RECTYPE": "D", "MH": "Child Development Disorders, Pervasive", "DE": "CHILD DEVELOPMENT DIS PERVASIVE", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Pervasive Development Disorders|T048|NON|BRD|NLM (1998)|970314|abcdef", "MN": "F03.625.164", "MH_TH": "NLM (1981)", "ST": "T048", "AN": "\"pervasive\" is a psychiatric diagnosis: follow text; check the tag CHILD or specific", "MS": "Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20150707", "DA": "19800521", "DC": "1", "DX": "19810101", "UI": "D002659"}, {"RECTYPE": "D", "MH": "Child Guidance", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Guidances, Child", "MN": "F04.408.192", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty; check also tag CHILD or specific", "MS": "The psychiatric, sociological and psychological study and treatment of the developing child with emphasis on preventive or prophylactic measures focused on the familial, educational and socio-environmental milieu of the child.", "CATSH": "CAT LIST", "MR": "19890428", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002660"}, {"RECTYPE": "D", "MH": "Child Guidance Clinics", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Guidance Clinics, Child", "MN": "N02.278.035.158.300", "MH_TH": "NLM (1975)", "ST": "T093", "AN": "check also tag CHILD or specific", "MS": "Facilities which administer the delivery of mental health counseling services to children.", "OL": "search COMMUNITY MENTAL HEALTH SERVICES 1967-74", "PM": "91; was see under COMMUNITY MENTAL HEALTH CENTERS 1979-90; was see under COMMUNITY MENTAL HEALTH SERVICES 1967-78", "HN": "91(75); was see under COMMUNITY MENTAL HEALTH CENTERS 1979-90; was see under COMMUNITY MENTAL HEALTH SERVICES 1967-78", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002661"}, {"RECTYPE": "D", "MH": "Child Health Services", "DE": "CHILD HEALTH SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Infant Health Services|T058|NON|NRW|UNK (19XX)|780508|INFANT HEALTH SERV|abcdefv", "ENTRY": "Service, Infant Health", "MN": "N02.421.143.130", "FX": "Child Welfare", "MH_TH": "NLM (1978)", "ST": "T058", "AN": "check also tag CHILD or specific", "PI": "Child Welfare (1966-1967)", "MS": "Organized services to provide health care for children.", "OL": "use CHILD HEALTH SERVICES to search INFANT HEALTH SERVICES 1968-78 & WELL CHILD CONFERENCE 1968-92", "PM": "68; WELL CHILD CONFERENCE was see under CHILD HEALTH SERVICES 1968-78, was see CHILD HEALTH SERVICES 1979-92", "HN": "68; INFANT HEALTH SERVICES was see under CHILD HEALTH SERVICES 1968-78; WELL CHILD CONFERENCE was see under CHILD HEALTH SERVICES 1968-78, was see CHILD HEALTH SERVICES 1979-92", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002662"}, {"RECTYPE": "D", "MH": "Child Language", "ENTRY": "Languages, Child", "MN": "F01.525.200.310.250", "MH_TH": "NLM (1975)", "ST": "T055", "AN": "check also tag CHILD or specific", "MS": "The language and sounds expressed by a child at a particular maturational stage in development.", "OL": "search LANGUAGE DEVELOPMENT 1968-74", "PM": "91; was see under LANGUAGE DEVELOPMENT 1975-90", "HN": "91(75); was see under LANGUAGE DEVELOPMENT 1975-90", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002663"}, {"RECTYPE": "D", "MH": "Child Nutritional Physiological Phenomena", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Nutrition Physiology, Child|T040|NON|EQV|NLM (2007)|051123|abcdef", "ENTRY": "Physiology, Child Nutritional", "MN": "G07.203.650.220", "FX": "Infant Nutritional Physiological Phenomena", "MH_TH": "NLM (2010)", "ST": "T040", "AN": "check also tag CHILD or specific", "PI": "Nutrition (1966)", "MS": "Nutritional physiology of children aged 2-12 years.", "PM": "2010; see CHILD NUTRITIONAL PHYSIOLOGY PHENOMENA 2009, see CHILD NUTRITION PHYSIOLOGY 2007-2008, see CHILD NUTRITION 1967-2006", "HN": "2010 (1967)", "CATSH": "CAT LIST", "MR": "20160928", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002664"}, {"RECTYPE": "D", "MH": "Child Psychiatry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychiatry, Child", "MN": "H02.403.690.130", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders in children.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002665"}, {"RECTYPE": "D", "MH": "Psychology, Child", "DE": "PSYCHOL CHILD", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Pediatric Psychology|T091|NON|EQV|UNK (19XX)|870325|PEDIATRIC PSYCHOL|abcdefv", "ENTRY": "Psychology, Pediatric|T091|NON|EQV|UNK (19XX)|880718|PSYCHOL PEDIATRIC|abcdefv", "MN": "F04.096.628.193", "FX": "Psychology, Developmental", "MH_TH": "UNK (19XX)", "ST": "T091", "AN": "use for the specialty and also for articles on the way a normal child thinks & acts", "MS": "Branch of psychology involving the study of normal and abnormal behavior of children.", "PM": "1966; see CHILD PSYCHOLOGY 1966-2014", "HN": "1966; use CHILD PSYCHOLOGY 1966-2014", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002666"}, {"RECTYPE": "D", "MH": "Child Reactive Disorders", "DE": "CHILD REACTIVE DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Reactive Disorder, Child", "MN": "F01.145.126.159", "MH_TH": "NLM (1975)", "ST": "T055", "AN": "child reaction to separation from parents: index under ANXIETY, SEPARATION; check also tag CHILD or specific", "MS": "Reactions to an event or set of events which are considered to be of pathological degree, that have not developed into a neurosis, psychosis, or personality disorder with fixed patterns.", "OL": "search CHILD BEHAVIOR DISORDERS 1968-74", "PM": "84; was see under CHILD BEHAVIOR DISORDERS 1968-83", "HN": "84(75); was see under CHILD BEHAVIOR DISORDERS 1968-83", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D002667"}, {"RECTYPE": "D", "MH": "Child Rearing", "AQ": "EH HI PX TD", "PRINT ENTRY": "Childrearing|T054|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Rearing, Child", "MN": "F01.318", "FX": "Parenting", "MH_TH": "POPLINE (1978)", "ST": "T054", "AN": "check also tag CHILD or specific; differentiate from PARENTING which emphasizes the role & responsibility of the parent while CHILD REARING emphasizes the upbringing: if in doubt use term of author", "MS": "The training or bringing-up of children by parents or parent-substitutes. It is used also for child rearing practices in different societies, at different economic levels, in different ethnic groups, etc. It differs from PARENTING in that in child rearing the emphasis is on the act of training or bringing up the child and the interaction between the parent and child, while parenting emphasizes the responsibility and qualities of exemplary behavior of the parent.", "PM": "68", "HN": "68(64)", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002668"}, {"RECTYPE": "D", "MH": "Child Welfare", "AQ": "CL EC EH ES HI LJ PX SN TD", "ENTRY": "Welfare, Child", "MN": "I01.880.787.293", "FX": "Foster Home Care", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "Organized efforts by communities or organizations to improve the health and well-being of the child.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002669"}, {"RECTYPE": "D", "MH": "Child, Abandoned", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Adolescents, Abandoned", "MN": "M01.097", "MH_TH": "NLM (1969)", "ST": "T099", "AN": "check also tag CHILD or specific", "PI": "Child (1966-1968)", "MS": "A child or adolescent who is deserted by parents or parent substitutes without regard for its future care.", "PM": "72", "HN": "72(69)", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002670"}, {"RECTYPE": "D", "MH": "Child, Exceptional", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Exceptional Child|T098|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Exceptional Children", "MN": "M01.102", "FX": "Mainstreaming, Education", "MH_TH": "NLM (1975)", "ST": "T098", "AN": "consider also CHILD, GIFTED & MENTALLY DISABLED PERSONS; check also tag CHILD or specific", "MS": "A child whose needs, abilities, or other characteristics vary so much from the average in mental, physical, or social areas that a greater than usual level of services is needed to facilitate the child's maximum potential development.", "OL": "search CHILD, GIFTED & MENTAL RETARDATION 1968-74 & MENTAL RETARDATION 1966-67", "PM": "75; was see under CHILD, GIFTED & MENTAL RETARDATION 1969-74; was see under MENTAL RETARDATION (but EXCEPTIONAL CHILD was see under CHILD, GIFTED) 1968; was see under MENTAL RETARDATION 1967; was see under MENTAL DEFICIENCY 1966", "HN": "75; was see under CHILD, GIFTED & MENTAL RETARDATION 1969-74; was see under MENTAL RETARDATION (but EXCEPTIONAL CHILD was see under CHILD, GIFTED) 1968; was see under MENTAL RETARDATION 1967; was see under MENTAL DEFICIENCY 1966", "CATSH": "CAT LIST", "MR": "20190711", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D002671"}, {"RECTYPE": "D", "MH": "Child, Gifted", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Gifted Child|T098|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Gifted Children", "MN": "M01.102.350", "MH_TH": "NLM (1966)", "ST": "T098", "AN": "check also tag CHILD or specific", "MS": "A child or adolescent who, when compared to others of the same age or experience, exhibits capability of high performance in intellectual, creative, or artistic areas, possesses an unusual capacity for leadership or excels in specific academic fields. (From PL 100-297, Sec. 4103, Definitions)", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002672"}, {"RECTYPE": "D", "MH": "Child, Hospitalized", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Hospitalized Child|T100|T101|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Hospitalized Children", "MN": "M01.643.259", "MH_TH": "NLM (1965)", "ST": "T101", "AN": "not for dis in child in hosp for diag or ther: use only for hospitalized child as a psychol, sociol or social entity; check also tag CHILD or specific", "MS": "Child hospitalized for short term care.", "PM": "67", "HN": "67(65)", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002673"}, {"RECTYPE": "D", "MH": "Child, Institutionalized", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Institutionalized Child|T101|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Institutionalized Children", "MN": "M01.643.364", "MH_TH": "NLM (1965)", "ST": "T101", "AN": "check also tag CHILD or specific", "MS": "A child who is receiving long-term in-patient services or who resides in an institutional setting.", "PM": "67", "HN": "67(65)", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002674"}, {"RECTYPE": "D", "MH": "Child, Preschool", "AQ": "CL ED HI LJ SN", "ENTRY": "Preschool Children", "MN": "M01.060.406.448", "MH_TH": "NLM (1966)", "ST": "T100", "AN": "almost always check tag: NIM no qualifiers; see Manual Chapter 9", "MS": "A child between the ages of 2 and 5.", "PM": "66", "HN": "66", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002675"}, {"RECTYPE": "D", "MH": "Child, Unwanted", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Unwanted Child", "MN": "M01.111", "MH_TH": "NLM (1978)", "ST": "T099", "AN": "check also tag CHILD or specific", "PI": "Pregnancy, Unwanted (1973-1977)", "MS": "The child who is not wanted by one or both parents.", "PM": "78", "HN": "78", "MR": "20020702", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D002676"}, {"RECTYPE": "D", "MH": "Chile", "AQ": "EH EP", "MN": "Z01.107.757.235", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in southern South America, bordering the South Pacific Ocean, between Argentina and Peru.", "MR": "20160531", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D002677"}, {"RECTYPE": "D", "MH": "Chimera", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Hybrid", "MN": "B05.200", "FX": "Mosaicism", "MH_TH": "NLM (1975)", "ST": "T001", "PI": "Mosaicism (1966-1977)", "MS": "An individual that contains cell populations derived from different zygotes.", "OL": "search MOSAICISM 1967-74", "PM": "78; was see under MOSAICISM 1967-77", "HN": "78(75); was see under MOSAICISM 1967-77", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D002678"}, {"RECTYPE": "D", "MH": "Pan troglodytes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Chimpanzee|T015|NON|EQV|UNK (19XX)|800512|abcdef", "ENTRY": "troglodytes, Chimpanzee", "MN": "B01.050.150.900.649.313.988.400.112.400.620", "MH_TH": "NLM (1972)", "ST": "T015", "RN": "txid9598", "AN": "diseases: coordinate with APE DISEASES + specific disease /vet ", "PI": "Pongidae (1966-1971)", "MS": "The common chimpanzee, a species of the genus Pan, family HOMINIDAE. It lives in Africa, primarily in the tropical rainforests. There are a number of recognized subspecies.", "PM": "1998; see CHIMPANZEE TROGLODYTES 1981-1997 & CHIMPANZEES 1972-1980", "HN": "1998 (1972)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002679"}, {"RECTYPE": "D", "MH": "Chin", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "Mental Region|T029|NON|EQV|NLM (2020)|190220|abcdef", "ENTRY": "Mentum|T029|NON|EQV|NLM (1991)|900410|abcdef", "MN": "A14.521.632.300", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "bone or site; usually NIM as site: submental (beneath the chin) refers to skin, fat & other tissue below the chin as in \"submental lipectomy for double chin\"; /growth: consider also MAXILLOFACIAL DEVELOPMENT", "MS": "The anatomical frontal portion of the mandible, also known as the mentum, that contains the line of fusion of the two separate halves of the mandible (symphysis menti). This line of fusion divides inferiorly to enclose a triangular area called the mental protuberance. On each side, inferior to the second premolar tooth, is the mental foramen for the passage of blood vessels and a nerve.", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002680"}, {"RECTYPE": "D", "MH": "China", "AQ": "EH EP", "PRINT ENTRY": "Sinkiang|T083|NAM|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Mainland China|T083|NAM|NRW|NLM (1976)|750101|abcdef", "MN": "Z01.252.474.164", "MH_TH": "NLM (1981)", "ST": "T083", "AN": "mainland China: do not confuse with TAIWAN, the Republic of China; in translations use spelling: People's Republic of China, not Peoples' nor Peoples", "MS": "A country spanning from central Asia to the Pacific Ocean.", "MR": "20210630", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D002681"}, {"RECTYPE": "D", "MH": "Chinchilla", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Chinchillas", "MN": "B01.050.150.900.649.313.992.328", "MH_TH": "NLM (1968)", "ST": "T015", "RN": "txid10151", "PI": "Rodentia (1966-1967)", "MS": "A genus of the family Chinchillidae which consists of three species: C. brevicaudata, C. lanigera, and C. villidera. They are used extensively in biomedical research.", "OL": "use CHINCHILLA to search CHINCHILLAS 1968-81", "PM": "82; was CHINCHILLAS 1968-81", "HN": "82; was CHINCHILLAS 1968-81", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002682"}, {"RECTYPE": "D", "MH": "Chironomidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Midges, Nonbiting|T204|NON|EQV|UNK (19XX)|800519|abcdef", "ENTRY": "Nonbiting Midges", "MN": "B01.050.500.131.617.720.500.500.750.712.500.750", "MH_TH": "NLM (1981)", "ST": "T204", "RN": "txid7149", "RR": "txid7150", "AN": "for killing Chironomidae with insecticides, see note at INSECTICIDES; gall midges: index NEMATOCERA", "PI": "Diptera (1975-1980)", "MS": "A family of nonbiting midges, in the order DIPTERA. Salivary glands of the genus Chironomus are used in studies of cellular genetics and biochemistry.", "PM": "91; see DIPTERA 1981-90", "HN": "91(81)", "MR": "20200813", "DA": "19800519", "DC": "1", "DX": "19910101", "UI": "D002683"}, {"RECTYPE": "D", "MH": "Chiropractic", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.110", "FX": "Manipulation, Orthopedic", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "the discipline only (education, history, etc); use MANIPULATION, CHIROPRACTIC for chiropractic procedures", "MS": "An occupational discipline founded by D.D. Palmer in the 1890's based on the relationship of the spine to health and disease.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002684"}, {"RECTYPE": "D", "MH": "Chiroptera", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rousettus|T015|NON|NRW|NLM (2001)|000321|abcdef", "ENTRY": "Horseshoe Bat", "MN": "B01.050.150.900.649.313.937", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid9397", "RR": "txid9406", "MS": "Order of mammals whose members are adapted for flight. It includes bats, flying foxes, and fruit bats.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002685"}, {"RECTYPE": "D", "MH": "Chitin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D09.698.211", "MH_TH": "NLM (1967)", "ST": "T123", "N1": "Chitin", "RN": "1398-61-4", "PI": "Polysaccharides (1966)", "MS": "A linear polysaccharide of beta-1->4 linked units of ACETYLGLUCOSAMINE. It is the second most abundant biopolymer on earth, found especially in INSECTS and FUNGI. When deacetylated it is called CHITOSAN.", "PM": "72", "HN": "72(67)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002686"}, {"RECTYPE": "D", "MH": "Chitin Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chitin-UDP Acetylglucosaminyltransferase|T116|T126|EQV|UNK (19XX)|741111|abbdef", "ENTRY": "trans N Acetylglucosaminosylase", "MN": "D08.811.913.400.450.460.200", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "UDP-N-acetyl-D-glucosamine:chitin 4-beta-N-acetylglucosaminyltransferase", "RN": "EC 2.4.1.16", "RR": "9030-18-6 (CAS RN)", "PI": "Uridine Diphosphate Sugars (1974)", "MS": "An enzyme that converts UDP glucosamine into chitin and UDP. EC 2.4.1.16.", "PM": "91; was see under GLUCOSYLTRANSFERASES 1979-90; was see under HEXOSYLTRANSFERASES 1975-78", "HN": "91(75); was see under GLUCOSYLTRANSFERASES 1979-90; was see under HEXOSYLTRANSFERASES 1975-78", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002687"}, {"RECTYPE": "D", "MH": "Chitinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chitinase|T116|T126|NON|EQV|NLM (1966)|990101|abbcdef", "ENTRY": "Endochitinase|T116|T126|NON|NRW|UNK (19XX)|820519|abbcdef", "MN": "D08.811.277.450.207", "MH_TH": "NLM (2017)", "ST": "T126", "N1": "Poly(1,4-(N-acetyl-beta-D-glucosaminide)) glycanohydrolase", "RN": "EC 3.2.1.14", "MS": "Glycoside hydrolases that break down glycosidic bonds in CHITIN. They are important for insect and worm morphogenesis and plant defense against pathogens. Human chitinases may play a role in the etiology of allergies and asthma.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002688"}, {"RECTYPE": "D", "MH": "Chlamydia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.190.190.190", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid810", "AN": "general or unspecified; prefer specifics; infection equals CHLAMYDIA INFECTIONS", "MS": "A genus of the family CHLAMYDIACEAE whose species cause a variety of diseases in vertebrates including humans, mice, and swine. Chlamydia species are gram-negative and produce glycogen. The type species is CHLAMYDIA TRACHOMATIS.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002689"}, {"RECTYPE": "D", "MH": "Chlamydia Infections", "DE": "CHLAMYDIA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Chlamydia", "MN": "C12.100.937.281.301", "MH_TH": "POPLINE (1986)", "ST": "T047", "PI": "Trachoma (1966)", "MS": "Infections with bacteria of the genus CHLAMYDIA.", "PM": "1967; for CHLAMYDIAL PNEUMONIA see PSITTACOSIS 2011", "HN": "1967; for CHLAMYDIAL PNEUMONIA use PSITTACOSIS 2011", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002690"}, {"RECTYPE": "D", "MH": "Chlamydophila psittaci", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Chlamydia psittaci|T007|NON|EQV|NLM (1975)|990101|abcdef", "MN": "B03.440.190.190.230.500", "MH_TH": "NLM (2001)", "ST": "T007", "RN": "txid83554", "PI": "Chlamydia (1966-1974)", "MS": "A genus of CHLAMYDOPHILA infecting primarily birds. It contains eight known serovars, some of which infect more than one type of host, including humans.", "PM": "2001; see CHLAMYDIA PSITTACI 1976-2000, see MIYAGAWANELLA 1963-75", "HN": "2001(1963)", "MR": "20200813", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D002691"}, {"RECTYPE": "D", "MH": "Chlamydia trachomatis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.190.190.190.750", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid813", "AN": "infection: coord IM with CHLAMYDIA INFECTIONS (IM) or index TRACHOMA; LYMPHOGRANULOMA VENEREUM; or CONJUNCTIVITIS, INCLUSION if specified in text", "PI": "Chlamydia (1966-1975)", "MS": "Type species of CHLAMYDIA causing a variety of ocular and urogenital diseases.", "OL": "use CHLAMYDIA TRACHOMATIS to search TRACHOMA VIRUS 1976-91; use CHLAMYDIA 1966-74", "PM": "76; TRACHOMA VIRUS was see CHLAMYDIA TRACHOMATIS 1976-91, was see CHLAMYDIA 1963-74", "HN": "76; TRACHOMA VIRUS was see CHLAMYDIA TRACHOMATIS 1976-91, was see CHLAMYDIA 1963-74", "MR": "20200813", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D002692"}, {"RECTYPE": "D", "MH": "Chlamydiaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.190.190", "MH_TH": "NLM (1964)", "ST": "T007", "RN": "txid809", "MS": "A family of gram-negative, coccoid microorganisms, in the order CHLAMYDIALES, pathogenic for vertebrates. Genera include CHLAMYDIA and CHLAMYDOPHILA.", "OL": "use CHLAMYDIACEAE to search BASOPHILIC VIRUSES 1975-91", "PM": "76; was see under RICKETTSIA 1975; BASOPHILIC VIRUSES was see CHLAMYDIACEAE 1975-91", "HN": "76(64); was see under RICKETTSIA 1975; BASOPHILIC VIRUSES was see CHLAMYDIACEAE 1975-91", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D002693"}, {"RECTYPE": "D", "MH": "Chlamydiaceae Infections", "DE": "CHLAMYDIACEAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Chlamydiaceae", "MN": "C01.150.252.400.210", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "rickettsial infect", "PI": "Rickettsial Infections (1966-1976)", "MS": "Infections with bacteria of the family CHLAMYDIACEAE.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D002694"}, {"RECTYPE": "D", "MH": "Chlamydiales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Waddliaceae|T007|NON|NRW|NLM (2001)|000606|abcdef", "ENTRY": "Microorganism Z|T007|NON|NRW|NLM (2001)|000623|abcdef", "MN": "B03.440.190", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid51291", "RR": "txid92714", "PI": "Micotatobiotes (1975)", "MS": "An order of obligately intracellular, gram-negative bacteria that have the chlamydia-like developmental cycle of replication. This is a two-stage cycle that includes a metabolically inactive infectious form, and a vegetative form that replicates by binary fission. Members of Chlamydiales are disseminated by aerosol or by contact. There are at least six recognized families: CHLAMYDIACEAE, Criblamydiaceae, Parachlamydiaceae, Rhabdochlamydia, Simkaniaceae, and Waddliaceae.", "PM": "1976", "HN": "1976", "MR": "20200813", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D002695"}, {"RECTYPE": "D", "MH": "Chlamydomonas", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Chlamydomona", "MN": "B01.875.150.385", "MH_TH": "NLM (1972)", "ST": "T002", "RN": "txid3052", "PI": "Algae, Green (1970-1971)", "MS": "A genus GREEN ALGAE in the order VOLVOCIDA. It consists of solitary biflagellated organisms common in fresh water and damp soil.", "PM": "74", "HN": "74(72)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002696"}, {"RECTYPE": "D", "MH": "Chloral Hydrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrate, Chloral", "MN": "D02.033.455.250.130", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,1-Ethanediol, 2,2,2-trichloro-", "RN": "418M5916WG", "RR": "302-17-0 (Chloral Hydrate)", "MS": "A hypnotic and sedative used in the treatment of INSOMNIA.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002697"}, {"RECTYPE": "D", "MH": "Chloralose", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glucochloral|T109|T121|NON|EQV|UNK (19XX)|770312|abbcdef", "ENTRY": "beta Chloralose", "MN": "D09.408.348.150", "PA": "Hypnotics and Sedatives", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "alpha-D-Glucofuranose, 1,2-O-(2,2,2-trichloroethylidene)-, (R)-", "RN": "238BZ29MUE", "RR": "15879-93-3 (Chloralose)", "MS": "A derivative of CHLORAL HYDRATE that was used as a sedative but has been replaced by safer and more effective drugs. Its most common use is as a general anesthetic in animal experiments.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002698"}, {"RECTYPE": "D", "MH": "Chlorambucil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NSC3088", "MN": "D02.455.526.728.650.156", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "USP (19XX)", "ST": "T131", "N1": "Benzenebutanoic acid, 4-(bis(2-chloroethyl)amino)-", "RN": "18D0SL7309", "RR": "305-03-3 (Chlorambucil)", "MS": "A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002699"}, {"RECTYPE": "D", "MH": "Chloramines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chloroamines|T109|NON|EQV|UNK (19XX)|831209|abcdef", "MN": "D02.092.348", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Inorganic derivatives of ammonia by substitution of one or more hydrogen atoms with chlorine atoms or organic compounds with the general formulas R2NCl and RNCl2 (where R is an organic group).", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002700"}, {"RECTYPE": "D", "MH": "Chloramphenicol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Levomycetin|T109|T121|TRD|NRW|UNK (19XX)|820421|abbcdef", "ENTRY": "Syntomycin|T109|T121|TRD|NRW|UNK (19XX)|871215|abbcdef", "MN": "D02.640.529.175", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Acetamide, 2,2-dichloro-N-(2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl)-, (R-(R*,R*))-", "RN": "66974FR9Q1", "RR": "56-75-7 (Chloramphenicol)", "AN": "an antibiotic", "MS": "An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002701"}, {"RECTYPE": "D", "MH": "Chloramphenicol Resistance", "AQ": "DE EH GE IM PH RE", "ENTRY": "Chloramphenicol Resistances", "MN": "G07.690.773.984.269.347.750", "MH_TH": "NLM (1988)", "ST": "T032", "PI": "Drug Resistance, Microbial (1966-1987)", "MS": "Nonsusceptibility of bacteria to the action of CHLORAMPHENICOL, a potent inhibitor of protein synthesis in the 50S ribosomal subunit where amino acids are added to nascent bacterial polypeptides.", "PM": "1988", "HN": "1988", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19870509", "DC": "1", "DX": "19880101", "UI": "D002702"}, {"RECTYPE": "D", "MH": "Chloranil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tetrachloro 1,4 benzoquinone", "MN": "D02.806.250.210", "PA": "Fungicides, Industrial", "MH_TH": "NLM (1976)", "ST": "T131", "N1": "2,5-Cyclohexadiene-1,4-dione, 2,3,5,6-tetrachloro-", "RN": "01W5X7N5XV", "RR": "118-75-2 (Chloranil)", "PI": "Quinones (1968-1975)", "MS": "A quinone fungicide used for treatment of seeds and foliage.", "PM": "91; was see under QUINONES 1976-90", "HN": "91(76); was see under QUINONES 1976-90", "MR": "20130708", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D002703"}, {"RECTYPE": "D", "MH": "Chlorates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chlorate|T197|NON|EQV|NLM (2021)|191118|abcdef", "MN": "D01.248.497.158.190", "MH_TH": "NLM (1971)", "ST": "T197", "RN": "0", "PI": "Chlorine (1966-1970)", "MS": "Inorganic salts of chloric acid that contain the ClO3- ion.", "PM": "73", "HN": "73(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002704"}, {"RECTYPE": "D", "MH": "Chlordan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "gamma Chlordane", "MN": "D02.455.526.439.180", "PA": "Insecticides", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Chlordane", "RN": "12789-03-6", "MS": "A highly poisonous organochlorine insecticide. The EPA has cancelled registrations of pesticides containing this compound with the exception of its use through subsurface ground insertion for termite control and the dipping of roots or tops of non-food plants. (From Merck Index, 11th ed)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002706"}, {"RECTYPE": "D", "MH": "Chlordiazepoxide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methaminodiazepoxide|T109|T121|NON|EQV|UNK (19XX)|761223|abbcdef", "ENTRY": "Perchlorate, Chlordiazepoxide", "MN": "D03.633.100.079.080.150", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl-, 4-oxide", "RN": "6RZ6XEZ3CR", "RR": "MFM6K1XWDK", "MS": "An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.", "MR": "20170117", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002707"}, {"RECTYPE": "D", "MH": "Chlorella", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Chlorellas", "MN": "B01.875.150.469", "MH_TH": "NLM (1972)", "ST": "T002", "RN": "txid3071", "PI": "Algae, Green (1970-1971)", "MS": "Nonmotile unicellular green algae potentially valuable as a source of high-grade protein and B-complex vitamins.", "PM": "74", "HN": "74(72)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002708"}, {"RECTYPE": "D", "MH": "Chlorfenvinphos", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Dermaton|T109|T121|T131|TRD|NRW|UNK (19XX)|810424|abbbcdef", "MN": "D02.705.400.120", "PA": "Insecticides", "MH_TH": "FDA SRS (2014)", "ST": "T131", "N1": "Phosphoric acid, 2-chloro-1-(2,4-dichlorophenyl)ethenyl diethyl ester", "RN": "F2G9XS1W91", "RR": "470-90-6 (Chlorfenvinphos)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Vinyl Compounds (1971-1974)", "MS": "An organophosphorus cholinesterase inhibitor that is used as an insecticide and an acaricide.", "PM": "91; was see under INSECTICIDES, ORGANOPHOSPHATE 1980-90", "HN": "91(80); was see under INSECTICIDES, ORGANOPHOSPHATE 1980-90", "MR": "20130708", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D002709"}, {"RECTYPE": "D", "MH": "Chlorhexidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MK412A", "MN": "D02.078.370.141.100", "PA": "Mouthwashes", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "2,4,11,13-Tetraazatetradecanediimidamide, N,N''-bis(4-chlorophenyl)-3,12-diimino-", "RN": "R4KO0DY52L", "RR": "E64XL9U38K", "PI": "Chlorobenzenes (1974)", "MS": "A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque.", "PM": "80; was see under BIGUANIDES 1975-79", "HN": "80(75); was see under BIGUANIDES 1975-79", "MR": "20160628", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D002710"}, {"RECTYPE": "D", "MH": "Chloride Peroxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chloroperoxidase|T116|T126|NON|EQV|UNK (19XX)|750630|abbcdef", "ENTRY": "Peroxidase, Chloride", "MN": "D08.811.682.732.360", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "Chloride:hydrogen-peroxide oxidoreductase", "RN": "EC 1.11.1.10", "PI": "Peroxidases (1973-1975)", "MS": "An enzyme that catalyzes the chlorination of a range of organic molecules, forming stable carbon-chloride bonds. EC 1.11.1.10.", "PM": "91; was see under PEROXIDASES 1976-90", "HN": "91(76); was see under PEROXIDASES 1976-90", "MR": "20030709", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D002711"}, {"RECTYPE": "D", "MH": "Chlorides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chloride|T197|NON|EQV|NLM (2021)|191125|abcdef", "ENTRY": "Level, Chloride Ion", "MN": "D01.248.497.158.215", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "only for inorganic cpds or chloride ion; /physiol permitted", "MS": "Inorganic compounds derived from hydrochloric acid that contain the Cl- ion.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002712"}, {"RECTYPE": "D", "MH": "Chlorine", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Gas, Cl2", "MN": "D01.362.225", "PA": "Chemical Warfare Agents", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Chlorine", "RN": "4R7X1O2820", "RR": "7782-50-5 (Chlorine)", "MS": "An element with atomic symbol Cl, atomic number 17, and atomic weight 35, and member of the halogen family.", "MR": "20180110", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002713"}, {"RECTYPE": "D", "MH": "Chlorisondamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dichloride, Chlorisondamine", "MN": "D03.633.100.513.249", "PA": "Nicotinic Antagonists", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "1H-Isoindolium, 4,5,6,7-tetrachloro-2,3-dihydro-2-methyl-2-(2-(trimethylammonio)ethyl)-, dichloride", "RN": "JD3M24F66I", "RR": "7B58W7756G", "MS": "A nicotinic antagonist used primarily as a ganglionic blocker in animal research. It has been used as an antihypertensive agent but has been supplanted by more specific drugs in most clinical applications.", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002714"}, {"RECTYPE": "D", "MH": "Chlormadinone Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-chloro-|T109|T121|T125|NON|EQV|NLM (2020)|190705|abbbcdef", "ENTRY": "NeoEunomin", "MN": "D04.210.500.883.294", "PA": "Contraceptives, Oral, Synthetic", "MH_TH": "USAN (1964)", "ST": "T125", "RN": "0SY050L61N", "RR": "SDS4N642GG", "MS": "An orally active synthetic progestational hormone used often in combinations as an oral contraceptive (CONTRACEPTIVES, ORAL).", "PM": "96; was CHLORMADINONE 1966-1995", "HN": "96; was CHLORMADINONE 1964-1995 (Prov 1964-65)", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002715"}, {"RECTYPE": "D", "MH": "Chlormequat", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chloride, Chlorocholine", "MN": "D02.675.276.207", "PA": "Plant Growth Regulators", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Ethanaminium, 2-chloro-N,N,N-trimethyl-", "RN": "8SUZ1123XX", "RR": "PPL2215L82", "PI": "Plant Growth Regulators (1966-1971)", "MS": "A plant growth regulator that is commonly used on ornamental plants.", "PM": "91; was see under AMMONIUM COMPOUNDS 1972-90", "HN": "91(72); was see under AMMONIUM COMPOUNDS 1972-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002716"}, {"RECTYPE": "D", "MH": "Chlormerodrin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chlormeroprin|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "3 Chloromercuri 2 methoxypropylurea", "MN": "D02.691.750.100.229", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Mercury, (3-((aminocarbonyl)amino)-2-methoxypropyl-C1,O3)chloro-", "RN": "99T5TWO621", "RR": "62-37-3 (Chlormerodrin)", "MS": "A mercurial compound that has been used as a diuretic but is now superseded by more potent and less toxic drugs. The radiolabeled form has been used as a diagnostic and research tool.", "PM": "66; was see under DIURETICS, MERCURIAL 1963-65", "HN": "66(64); was see under DIURETICS, MERCURIAL 1963-65", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002717"}, {"RECTYPE": "D", "MH": "Chlormethiazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Distraneurin|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef", "MN": "D03.383.129.708.180", "PA": "Neuroprotective Agents", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Thiazole, 5-(2-chloroethyl)-4-methyl-", "RN": "0C5DBZ19HV", "RR": "533-45-9 (Chlormethiazole)", "PI": "Thiazoles (1966-1967)", "MS": "A sedative and anticonvulsant often used in the treatment of alcohol withdrawal. Chlormethiazole has also been proposed as a neuroprotective agent. The mechanism of its therapeutic activity is not entirely clear, but it does potentiate GAMMA-AMINOBUTYRIC ACID receptors response and it may also affect glycine receptors.", "PM": "68; CHLORETHIAZOLE was see CHLORMETHAZOLE 1975-95", "HN": "68; CHLORETHIAZOLE was see CHLORMETHAZOLE 1975-95", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002719"}, {"RECTYPE": "D", "MH": "Chlormezanone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chlormethazanone|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef", "MN": "D03.383.855.150", "PA": "Muscle Relaxants, Central", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "4H-1,3-Thiazin-4-one, 2-(4-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide", "RN": "GP568V9G19", "RR": "80-77-3 (Chlormezanone)", "AN": "an anti-anxiety agent & central muscle relaxant", "MS": "A non-benzodiazepine that is used in the management of anxiety. It has been suggested for use in the treatment of muscle spasm.", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002720"}, {"RECTYPE": "D", "MH": "omega-Chloroacetophenone", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "alpha-Chloroacetophenone|T109|T131|NON|EQV|NLM (2001)|000531|abbcdef", "ENTRY": "omega Chloroacetophenone", "MN": "D02.522.120.575", "PA": "Tear Gases", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Ethanone, 2-chloro-1-phenyl-", "RN": "88B5039IQG", "RR": "88B5039IQG", "MS": "A potent eye, throat, and skin irritant. One of its uses is as a riot control agent.", "OL": "use OMEGA-CHLOROACETOPHENONE to search CHLOROACETOPHENONE 1966-90", "PM": "91; was CHLOROACETOPHENONE 1963-90", "HN": "91; was CHLOROACETOPHENONE 1963-90", "MR": "20160610", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002721"}, {"RECTYPE": "D", "MH": "Chlorobenzenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.526.439.202", "MH_TH": "NLM (1974)", "ST": "T131", "RN": "0", "MS": "Aromatic organic compounds with the chemical formula C6H5Cln.", "PM": "74", "HN": "74", "MR": "20161101", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002722"}, {"RECTYPE": "D", "MH": "Chlorobenzoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Chlorobenzoic", "MN": "D02.455.426.559.389.127.250", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Benzoates (1966-1974)", "MS": "Benzoic acid or benzoic acid esters substituted with one or more chlorine atoms.", "PM": "75", "HN": "75", "MR": "20120703", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D002723"}, {"RECTYPE": "D", "MH": "Chlorobutanol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trichlorbutanol|T109|T121|T130|NON|EQV|UNK (19XX)|770118|abbbcdef", "ENTRY": "Anhydrous Chlorobutanol", "MN": "D10.289.110.220", "PA": "Preservatives, Pharmaceutical", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "2-Propanol, 1,1,1-trichloro-2-methyl-", "RN": "HM4YQM8WRC", "RR": "57-15-8 (Chlorobutanol)", "MS": "A colorless to white crystalline compound with a camphoraceous odor and taste. It is a widely used preservative in various pharmaceutical solutions, especially injectables. Also, it is an active ingredient in certain oral sedatives and topical anesthetics.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002724"}, {"RECTYPE": "D", "MH": "Chloroform", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trichloromethane|T109|T130|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|801125|abbbcdeef", "MN": "D02.455.526.913.810", "PA": "Solvents", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Methane, trichloro-", "RN": "7V31YC746X", "RR": "67-66-3 (Chloroform)", "MS": "A commonly used laboratory solvent. It was previously used as an anesthetic, but was banned from use in the U.S. due to its suspected carcinogenicity.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002725"}, {"RECTYPE": "D", "MH": "Chlorogenic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Chlorogenic", "MN": "D02.241.223.268.220", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Cyclohexanecarboxylic acid, 3-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,4,5-trihydroxy-, (1S-(1alpha,3beta,4alpha,5alpha))-", "RN": "318ADP12RI", "RR": "327-97-9 (Chlorogenic Acid)", "MS": "A naturally occurring phenolic acid which is a carcinogenic inhibitor. It has also been shown to prevent paraquat-induced oxidative stress in rats. (From J Chromatogr A 1996;741(2):223-31; Biosci Biotechnol Biochem 1996;60(5):765-68).", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002726"}, {"RECTYPE": "D", "MH": "Proguanil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chloroguanide|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1966)|990101|abbcdeef", "ENTRY": "Hydrochloride, Proguanil", "MN": "D02.078.370.141.710", "PA": "Antimetabolites", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Imidodicarbonimidic diamide, N-(4-chlorophenyl)-N'-(1-methylethyl)-", "RN": "S61K3P7B2V", "RR": "R71Y86M0WT", "MS": "A biguanide compound which metabolizes in the body to form cycloguanil, an anti-malaria agent.", "PM": "2011; see CHLOROGUANIDE 1963-2011", "HN": "2011 (1963)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "20110101", "UI": "D002727"}, {"RECTYPE": "D", "MH": "Chlorohydrins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chlorhydrins|T109|NON|EQV|UNK (19XX)|741111|abcdef", "MN": "D02.033.260", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Alcohols (1966-1974)", "MS": "Any of the compounds derived from a group of glycols or polyhydroxy alcohols by chlorine substitution for part of the hydroxyl groups. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "PM": "75", "HN": "75", "MR": "19970620", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D002728"}, {"RECTYPE": "D", "MH": "Chloromercuribenzoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.691.750.740.644.261", "PA": "Sulfhydryl Reagents", "MH_TH": "NLM (1964)", "ST": "T130", "RN": "0", "AN": "P-CHLOROMERCURIBENZOIC ACID is available", "PI": "Benzoates (1966)", "MS": "Chloride and mercury-containing derivatives of benzoic acid.", "PM": "66", "HN": "66(64)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002729"}, {"RECTYPE": "D", "MH": "Chloromercurinitrophenols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.691.750.740.225", "PA": "Sulfhydryl Reagents", "MH_TH": "NLM (1977)", "ST": "T130", "RN": "0", "PI": "Organometallic Compounds (1968-1976)", "MS": "Mercuriphenols substituted with one or more chlorine atoms and one or more nitro groups. Some of these are sulfhydryl reagents which act as chromophoric probes in enzymes and other proteins.", "PM": "91; was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79", "HN": "91(77); was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79", "MR": "20110624", "DA": "19760419", "DC": "1", "DX": "19910101", "UI": "D002730"}, {"RECTYPE": "D", "MH": "4-Chloromercuribenzenesulfonate", "DS": "CHLOROMERCURIBENZENESULFONATE 04", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PCMBS|T109|T121|ABB|EQV|FDA SRS (2014)|UNK (19XX)|771005|abbcdeef", "ENTRY": "p Chloromercuriphenylsulphonate", "MN": "D02.886.645.600.080.050.100.100", "PA": "Sulfhydryl Reagents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Mercurate(1-), chloro(4-sulfonatophenyl)-, hydrogen", "RN": "5YIN07W42H", "RR": "554-77-8 (4-Chloromercuribenzenesulfonate)", "PI": "Sulfonic Acids (1966-1973)", "MS": "A cytotoxic sulfhydryl reagent that inhibits several subcellular metabolic systems and is used as a tool in cellular physiology.", "OL": "use 4-CHLOROMERCURIBENZENESULFONATE to search CHLOROMERCURIPHENYLSULFONATE & CHLOROMERCURIBENZENESULFONATE 1975-93", "PM": "94; was CHLOROMERCURIPHENYLSULFONATE (see under PHENYLMERCURY COMPOUNDS 1977-90, see under ORGANOMETALLIC COMPOUNDS 1975-76); CHLOROMERCURIBENZENESULFONATE was see CHLOROMERCURIPHENYLSULFONATE 1975-93", "HN": "94; was CHLOROMERCURIPHENYLSULFONATE (see under PHENYLMERCURY COMPOUNDS 1977-90, see under ORGANOMETALLIC COMPOUNDS 1975-76); CHLOROMERCURIBENZENESULFONATE was see CHLOROMERCURIPHENYLSULFONATE 1975-93", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002731"}, {"RECTYPE": "D", "MH": "Chlorophenols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxychlorobenzenes|T109|NON|EQV|UNK (19XX)|760516|abcdef", "MN": "D02.455.426.559.389.657.190", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "PI": "Phenols (1966-1976)", "MS": "Phenols substituted with one or more chlorine atoms in any position.", "PM": "77; PENTACHLOROPHENOL was see under PHENOLS 1971-76", "HN": "77", "MR": "20200527", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D002733"}, {"RECTYPE": "D", "MH": "Chlorophyll", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phyllobilins|T109|T123|NON|REL|NLM (2021)|191121|abbcdef", "ENTRY": "Chlorophyll 740|T109|T123|NON|NRW|UNK (19XX)|810918|abbcdef", "MN": "D04.345.783.374", "FX": "Photosynthesis", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Chlorophylls", "RN": "1406-65-1", "MS": "Porphyrin derivatives containing magnesium that act to convert light energy in photosynthetic organisms.", "MR": "20200221", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002734"}, {"RECTYPE": "D", "MH": "Chlorophyllides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chlorophyllide|T109|T123|NON|EQV|NLM (2021)|191120|abbcdef", "MN": "D04.345.783.374.180", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "products of chlorophil hydrolysis", "PI": "Chlorophyll (1972-1974)", "MS": "Products of the hydrolysis of chlorophylls in which the phytic acid side chain has been removed and the carboxylic acids saponified.", "PM": "91; was see under CHLOROPHYLL 1975-90", "HN": "91(75); was see under CHLOROPHYLL 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002735"}, {"RECTYPE": "D", "MH": "Chloroplasts", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Etioplast", "MN": "A11.284.430.214.190.875.700.140", "FX": "Photosynthesis", "MH_TH": "NLM (1964)", "ST": "T026", "MS": "Plant cell inclusion bodies that contain the photosynthetic pigment CHLOROPHYLL, which is associated with the membrane of THYLAKOIDS. Chloroplasts occur in cells of leaves and young stems of plants. They are also found in some forms of PHYTOPLANKTON such as HAPTOPHYTA; DINOFLAGELLATES; DIATOMS; and CRYPTOPHYTA.", "PM": "66", "HN": "66(64)", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002736"}, {"RECTYPE": "D", "MH": "Chloroprene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.326.271.665.146.280", "MH_TH": "NLM (1979)", "ST": "T131", "N1": "1,3-Butadiene, 2-chloro-", "RN": "126-99-8", "PI": "Neoprene (1975-1978)", "MS": "Toxic, possibly carcinogenic, monomer of neoprene, a synthetic rubber; causes damage to skin, lungs, CNS, kidneys, liver, blood cells and fetuses. Synonym: 2-chlorobutadiene.", "PM": "91; was see under BUTADIENES 1979-90", "HN": "91(79); was see under BUTADIENES 1979-90", "MR": "20060705", "DA": "19780501", "DC": "1", "DX": "19910101", "UI": "D002737"}, {"RECTYPE": "D", "MH": "Chloroquine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulphate, Chloroquine", "MN": "D03.633.100.810.050.180", "PA": "Antirheumatic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-", "RN": "886U3H6UFF", "RR": "OE48649K6N", "MS": "The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002738"}, {"RECTYPE": "D", "MH": "Chloroquinolinols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.810.350.625.250", "PA": "Amebicides", "MH_TH": "NLM (1965)", "ST": "T121", "RN": "0", "MS": "8-Hydroxyquinolinols chlorinated on the number 5 and/or 7 carbon atom(s). They are antibacterial, antiprotozoal, and antidiarrheal, especially in amebiasis, and have also been used as antiseborrheics. The compounds are mostly used topically, but have been used also as animal feed additives. They may cause optic and other neuropathies and are most frequently administered in combination with other agents.", "OL": "use HYDROXYQUINOLINES to search CHLOROQUINOLINOLS 1966-74 (as Prov)", "PM": "91; was see under HYDROXYQUINOLINES 1975-90", "HN": "91(65); was see under HYDROXYQUINOLINES 1965-90 (Prov 1965-74)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002739"}, {"RECTYPE": "D", "MH": "Chlorothiazide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.174.261", "PA": "Sodium Chloride Symporter Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide", "RN": "77W477J15H", "RR": "58-94-6 (Chlorothiazide)", "MS": "A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812)", "PM": "CHLORTHIZIDE was see CHLOROTHIAZIDE 1977-95; /adverse effects /poisoning /toxicity were CHLOROTHIAZIDE TOXICOLOGY 1963-65", "HN": "CHLORTHIZIDE was see CHLOROTHIAZIDE 1977-95; /adv eff-pois-tox was CHLOROTHIAZIDE TOXICOLOGY 1963-65", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D002740"}, {"RECTYPE": "D", "MH": "Chlorotrianisene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.150.700.100", "PA": "Estrogens, Non-Steroidal", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzene, 1,1',1''-(1-chloro-1-ethenyl-2-ylidene)tris(4-methoxy)-", "RN": "6V5034L121", "RR": "569-57-3 (Chlorotrianisene)", "MS": "A powerful synthetic, non-steroidal estrogen.", "OL": "use CHLOROTRIANISENE to search TRIANISOESTROL 1978-93", "PM": "65; TRIANISOESTROL was see CHLOROTRIANISENE 1978-93", "HN": "65(64); TRIANISOESTROL was see CHLOROTRIANISENE 1978-93", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002741"}, {"RECTYPE": "D", "MH": "Chlorphenamidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chlordimeform|T109|T121|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbbcdeef", "MN": "D02.078.200", "PA": "Uncoupling Agents", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Methanimidamide, N'-(4-chloro-2-methylphenyl)-N,N-dimethyl-", "RN": "GXA8FP6Y9C", "RR": "6164-98-3 (Chlorphenamidine)", "PI": "Toluene (1972-1974)", "MS": "An acaricide used against many organophosphate and carbamate resistant pests. It acts as an uncoupling agent and monoamine oxidase inhibitor.", "PM": "91; was see under AMIDINES 1975-90", "HN": "91(75); was see under AMIDINES 1975-90", "MR": "20180630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002742"}, {"RECTYPE": "D", "MH": "Chlorphenesin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.033.455.706.345", "PA": "Muscle Relaxants, Central", "MH_TH": "NLM (1964)", "ST": "T121", "N1": "1,2-Propanediol, 3-(4-chlorophenoxy)-", "RN": "I670DAL4SZ", "RR": "104-29-0 (Chlorphenesin)", "MS": "A centrally acting muscle relaxant. Its mode of action is unknown. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1203)", "PM": "74", "HN": "74(64)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002743"}, {"RECTYPE": "D", "MH": "Chlorpheniramine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chlorprophenpyridamine|T109|T121|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Tannate, Chlorpheniramine", "MN": "D03.383.725.620.150", "PA": "Histamine H1 Antagonists", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "2-Pyridinepropanamine, gamma-(4-chlorophenyl)-N,N-dimethyl-", "RN": "3U6IO1965U", "RR": "V1Q0O9OJ9Z", "AN": "a histamine H1 antag & antipruritic", "MS": "A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE.", "PM": "65", "HN": "65(63)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002744"}, {"RECTYPE": "D", "MH": "Chlorphentermine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Chlorphentermine", "MN": "D02.092.471.683.152.766.262", "PA": "Sympathomimetics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzeneethanamine, 4-chloro-alpha,alpha-dimethyl-", "RN": "NHW07912O7", "RR": "RL11HOJ7DM", "MS": "A sympathomimetic agent that was formerly used as an anorectic. It has properties similar to those of DEXTROAMPHETAMINE. It has been implicated in lipid storage disorders and pulmonary hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1223)", "PM": "91; see PHENTERMINE 1966-90", "HN": "91(66)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002745"}, {"RECTYPE": "D", "MH": "Chlorpromazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Chlorpromazine", "MN": "D03.633.300.783.198", "PA": "Dopamine Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-", "RN": "U42B7VYA4P", "RR": "9WP59609J6", "MS": "The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.", "PM": "/adverse effects /poisoning /toxicity were CHLORPROMAZINE TOXICOLOGY 1963-65", "HN": "/adv eff-pois-tox was CHLORPROMAZINE TOXICOLOGY 1963-65", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D002746"}, {"RECTYPE": "D", "MH": "Chlorpropamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Clorpropamid|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Meldian|T109|T121|TRD|NRW|UNK (19XX)|831020|abbcdef", "MN": "D02.886.590.795.283", "PA": "Hypoglycemic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-chloro-N-((propylamino)carbonyl)-", "RN": "WTM2C3IL2X", "RR": "94-20-2 (Chlorpropamide)", "MS": "A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002747"}, {"RECTYPE": "D", "MH": "Chlorpropham", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isopropyl N-(3-Chlorophenol)carbamate|T109|T131|NON|EQV|UNK (19XX)|811023|abbcdef", "MN": "D02.241.081.251.583.177", "PA": "Plant Growth Regulators", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Carbamic acid, (3-chlorophenyl)-, 1-methylethyl ester", "RN": "0HBU04R8B0", "RR": "101-21-3 (Chlorpropham)", "PI": "Herbicides (1966-1971)", "MS": "A carbamate that is used as an herbicide and as a plant growth regulator.", "PM": "91; was see under HERBICIDES, CARBAMATE 1972-90", "HN": "91(72); was see under HERBICIDES, CARBAMATE 1972-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002748"}, {"RECTYPE": "D", "MH": "Chlorprothixene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Taractan|T109|T121|TRD|NRW|UNK (19XX)|861120|abbcdef", "MN": "D03.633.300.953.704.250", "PA": "Dopamine Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1-Propanamine, 3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethyl-, (Z)-", "RN": "9S7OD60EWP", "RR": "113-59-7 (Chlorprothixene)", "MS": "A thioxanthine with effects similar to the phenothiazine antipsychotics.", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002749"}, {"RECTYPE": "D", "MH": "Chlorquinaldol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chlorchinaldol|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef", "ENTRY": "5,7 Dichloro 2 methyl 8 quinolinol", "MN": "D03.633.100.810.350.625.250.260", "PA": "Anti-Infective Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "8-Quinolinol, 5,7-dichloro-2-methyl-", "RN": "D6VHC87LLS", "RR": "72-80-0 (Chlorquinaldol)", "MS": "Local anti-infective agent used for skin, gastrointestinal, and vaginal infections with fungi, protozoa, and certain bacteria. In animals, it causes central nervous system damage and is not administered parenterally. It is also used as antiseptic, fungistat, or deodorant.", "PM": "91,63-82; was see under HYDROXYQUINOLINES 1983-90; was heading 1963-82", "HN": "91(83)63; was see under HYDROXYQUINOLINES 1983-90; was heading 1963-82", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D002750"}, {"RECTYPE": "D", "MH": "Chlortetracycline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Salt Chlortetracycline, Calcium", "MN": "D04.615.562.900.146", "PA": "Protein Synthesis Inhibitors", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-", "RN": "WCK1KIQ23Q", "RR": "O1GX33ON8R", "MS": "A TETRACYCLINE with a 7-chloro substitution.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002751"}, {"RECTYPE": "D", "MH": "Chlorthalidone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phthalamudine|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef", "ENTRY": "Thalitone|T109|T121|TRD|NRW|UNK (19XX)|861120|abbcdef", "MN": "D03.633.100.513.750.500", "PA": "Sodium Chloride Symporter Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)-", "RN": "Q0MQD1073Q", "RR": "77-36-1 (Chlorthalidone)", "MS": "A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic.", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002752"}, {"RECTYPE": "D", "MH": "Chlorzoxazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Parafon Forte DSC|T109|T121|TRD|NRW|US|041222|abbcdef", "MN": "D03.633.100.221.346", "PA": "Muscle Relaxants, Central", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2(3H)-Benzoxazolone, 5-chloro-", "RN": "H0DE420U8G", "RR": "95-25-0 (Chlorzoxazone)", "MS": "A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)", "PM": "91; was see under BENZOXAZOLES 1966-90", "HN": "91(66); was see under BENZOXAZOLES 1966-90", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002753"}, {"RECTYPE": "D", "MH": "Choanal Atresia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Atresia, Choanal|T019|NON|EQV|NLM (1995)|940106|abcdef", "ENTRY": "Choanal Atresias", "MN": "C16.131.740.271", "MH_TH": "NLM (1986)", "ST": "T019", "PI": "Nose/abnormalities (1966-1974)", "MS": "A congenital abnormality that is characterized by a blocked CHOANAE, the opening between the nose and the NASOPHARYNX. Blockage can be unilateral or bilateral; bony or membranous.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D002754"}, {"RECTYPE": "D", "MH": "Choice Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Choice Behaviors", "MN": "F02.463.785.373.346", "MH_TH": "NLM (1975)", "ST": "T055", "PI": "Decision Making (1974)", "MS": "The act of making a selection among two or more alternatives, usually after a period of deliberation.", "OL": "search DECISION MAKING 1974", "PM": "79; was see under DECISION MAKING 1974-78; CAREER CHOICE was see under DECISION MAKING 1975-80", "HN": "79(75); was see under DECISION MAKING 1974-78", "CATSH": "CAT LIST", "MR": "20160506", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D002755"}, {"RECTYPE": "D", "MH": "Cholagogues and Choleretics", "DE": "CHOLAGOGUES CHOLERETICS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Choleretics|T121|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Hydrocholeretics|T121|NON|NRW|UNK (19XX)|840216|abcdef", "MN": "D27.505.954.483.508", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic).", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002756"}, {"RECTYPE": "D", "MH": "Cholanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.221", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "do not confuse with CHOLENES", "PM": "68", "HN": "68", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002757"}, {"RECTYPE": "D", "MH": "Cholangiography", "DE": "CHOLANGIOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Cholangiographies", "MN": "E01.370.372.200", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "An imaging test of the BILIARY TRACT in which a contrast dye (RADIOPAQUE MEDIA) is injected into the BILE DUCT and x-ray pictures are taken.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002758"}, {"RECTYPE": "D", "MH": "Adenoma, Bile Duct", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Cholangioma|T191|NON|EQV|NLM (1994)|930329|abcdef", "ENTRY": "Cholangiomas", "MN": "C04.557.470.035.085", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with BILE DUCTS, INTRAHEPATIC + BILE DUCT NEOPLASMS ", "MS": "A benign tumor of the intrahepatic bile ducts.", "OL": "use ADENOMA, BILE DUCT to search CHOLANGIOMA 1966-93", "PM": "94; was CHOLANGIOMA 1963-93", "HN": "94; was CHOLANGIOMA 1963-93", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D002759"}, {"RECTYPE": "D", "MH": "Cholangiopancreatography, Endoscopic Retrograde", "DE": "CHOLANGIOPANCREATOGR ENDOSCOPIC RETROGRADE", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Endoscopic Retrograde Cholangiopancreatography|T060|NON|EQV|UNK (19XX)|800404|ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGR|abcdefv", "ENTRY": "Retrograde Cholangiopancreatographies, Endoscopic", "MN": "E04.502.250.250.160", "FX": "Sphincterotomy, Endoscopic", "MH_TH": "NLM (1981)", "ST": "T060", "AN": "/instrum is probably DUODENOSCOPES", "PI": "Pancreas (1966-1980)", "MS": "Fiberoptic endoscopy designed for duodenal observation and cannulation of VATER'S AMPULLA, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic (Vater) papillotomy (SPHINCTEROTOMY, ENDOSCOPIC) may be performed during this procedure.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19800404", "DC": "1", "DX": "19810101", "UI": "D002760"}, {"RECTYPE": "D", "MH": "Cholangitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cholangitides", "MN": "C06.130.120.200", "FX": "Cholecystitis", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002761"}, {"RECTYPE": "D", "MH": "Cholecalciferol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitamin D 3|T109|T127|NON|EQV|UNK (19XX)|741226|VITAMIN D A 03|abbcdefs", "ENTRY": "Vitamin D3|T109|T127|NON|EQV|FDA SRS (2014)|NLM (1990)|890413|abbcdeef", "MN": "D10.570.938.146", "PA": "Vitamins", "FX": "Receptors, Calcitriol", "MH_TH": "USP (19XX)", "ST": "T127", "N1": "9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)-", "RN": "1C6V77QF41", "RR": "67-97-0 (Cholecalciferol)", "AN": "deficiency: coordinate CHOLECALCIFEROL /defic (IM) with VITAMIN D DEFICIENCY (IM)", "MS": "Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24.", "OL": "use CHOLECALCIFEROL to search CHOLECALCIFEROLS 1975-93 & VITAMIN D 3 1966-74", "PM": "94, 67-74; was CHOLECALCIFEROLS 1975-93, was CHOLECALCIFEROL 1967-74, was VITAMIN D 3 1963-66", "HN": "94, 67-74; was CHOLECALCIFEROLS 1975-93, was CHOLECALCIFEROL 1967-74, was VITAMIN D 3 1963-66", "MR": "20180522", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002762"}, {"RECTYPE": "D", "MH": "Cholecystectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Cholecystectomies", "MN": "E04.210.120.172", "FX": "Postcholecystectomy Syndrome", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Surgical removal of the GALLBLADDER.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002763"}, {"RECTYPE": "D", "MH": "Cholecystitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gallbladder Inflammation|T047|NON|EQV|NLM (2004)|021220|GALLBLADDER INFLAMM|abcdefv", "ENTRY": "Inflammation, Gallbladder", "MN": "C06.130.564.263", "FX": "Cholangitis", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "note specifics; entry term EMPYEMA, GALLBLADDER: restrict to gallbladder; \"biliary empyema\": unless of gallbladder, index under EMPYEMA (IM) + BILIARY TRACT DISEASES (IM) or specific biliary precoord", "MS": "Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002764"}, {"RECTYPE": "D", "MH": "Cholecystography", "DE": "CHOLECYSTOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Cholecystographies", "MN": "E01.370.372.210", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Radiography of the gallbladder after ingestion of a contrast medium.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002765"}, {"RECTYPE": "D", "MH": "Cholecystokinin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pancreozymin|T116|T123|T125|NON|EQV|BAN (19XX)|760517|abbbcdef", "ENTRY": "Uropancreozymin|T116|T123|T125|NON|EQV|UNK (19XX)|820830|abbbcdef", "MN": "D12.644.120", "PA": "Cholagogues and Choleretics", "FX": "Receptors, Cholecystokinin", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "9011-97-6", "MS": "A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.", "OL": "use CHOLECYSTOKININ to search PANCREOZYMIN 1966-76 (as Prov 1966)", "PM": "PANCREOZYMIN was heading 1967-76", "HN": "PANCREOZYMIN was heading 1963-76 (Prov 1963-66), was see under GASTROINTESTINAL HORMONES 1963-66", "MR": "20150602", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D002766"}, {"RECTYPE": "D", "MH": "Cholecystostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Cholecystostomies", "MN": "E04.210.120.195", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Gallbladder/surgery (1966-1987)", "MS": "Establishment of an opening into the gallbladder either for drainage or surgical communication with another part of the digestive tract, usually the duodenum or jejunum.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19870320", "DC": "1", "DX": "19880101", "UI": "D002767"}, {"RECTYPE": "D", "MH": "Choledochostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Choledochojejunostomy|T061|NON|NRW|UNK (19XX)|870319|abcdef", "ENTRY": "Choledojejunostomy", "MN": "E04.210.120.200", "FX": "Postcholecystectomy Syndrome", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Jejunum/surgery (1966-1987)", "MS": "Surgical formation of an opening (stoma) into the COMMON BILE DUCT for drainage or for direct communication with a site in the small intestine, primarily the DUODENUM or JEJUNUM.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19870319", "DC": "1", "DX": "19880101", "UI": "D002768"}, {"RECTYPE": "D", "MH": "Cholelithiasis", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Gallstone Disease|T047|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Gallstone Diseases", "MN": "C06.130.409", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "CHOLECYSTOLITHIASIS and CHOLEDOCHOLITHIASIS are also available", "MS": "Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).", "OL": "to search for chem composition of biliary calculi, use CHOLELITHIASIS/anal 1987-90 & CHOLELITHIASIS/metab 1966-86", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002769"}, {"RECTYPE": "D", "MH": "Cholenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.221.263", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with CHOLANES or CHOLINE; includes choladienes, cholatrienes", "PI": "Cholanes (1968-1974)", "MS": "Unsaturated derivatives of cholane with methyl groups at C-10 and C-13 and a branched five-carbon chain at C-17. They must have at least one double bond in the ring system.", "OL": "search CHOLANES 1973-74", "PM": "75; was see under CHOLANES 1973-74", "HN": "75; was see under CHOLANES 1973-74", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D002770"}, {"RECTYPE": "D", "MH": "Cholera", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Vibrio cholerae Infections", "MN": "C01.150.252.400.959.347", "FX": "Cholera Morbus", "MH_TH": "POPLINE (1994)", "ST": "T047", "MS": "An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002771"}, {"RECTYPE": "D", "MH": "Cholera Toxin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Choleragenoid|T116|T129|NON|NRW|UNK (19XX)|770420|abbcdef", "ENTRY": "Toxin, Cholera", "MN": "D23.946.330.150", "PA": "Poisons", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "9012-63-9", "RR": "EC 2.4.2.31", "AN": "/antag permitted but consider also ANTITOXINS", "PI": "Toxins (1966-1967)", "MS": "An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy (H) or A subunit and the B protomer which consists of 5 light (L) or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO(ADP-RIBOSE) TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells.", "PM": "78", "HN": "78", "MR": "20210630", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D002772"}, {"RECTYPE": "D", "MH": "Cholestadienes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.247.222.222", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with CHOLESTADIENOLS", "PI": "Cholestenes (1973-1974)", "MS": "Cholene derivatives with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. They must have two double bonds in the ring system.", "OL": "search CHOLESTENES 1974", "PM": "75; was see under CHOLESTENES 1974", "HN": "75; was see under CHOLESTENES 1974", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D002774"}, {"RECTYPE": "D", "MH": "Cholestadienols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.247.222.222.347", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "do not confuse with CHOLESTADIENES", "MS": "Cholestadiene derivatives containing a hydroxy group anywhere in the molecule.", "PM": "74", "HN": "74", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002775"}, {"RECTYPE": "D", "MH": "Cholestanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.247", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "do not confuse with CHOLESTENES", "MS": "Derivatives of the saturated steroid cholestane with methyl groups at C-18 and C-19 and an iso-octyl side chain at C-17.", "PM": "68", "HN": "68", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002776"}, {"RECTYPE": "D", "MH": "Cholestanols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxycholestanes|T109|T123|NON|EQV|UNK (19XX)|770329|abbcdef", "ENTRY": "Alcohols, Bile", "MN": "D04.210.500.247.100", "MH_TH": "NLM (1978)", "ST": "T123", "RN": "0", "PI": "Sterols (1966-1977)", "MS": "Cholestanes substituted in any position with one or more hydroxy groups. They are found in feces and bile. In contrast to bile acids and salts, they are not reabsorbed.", "PM": "78", "HN": "78", "MR": "20200527", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D002777"}, {"RECTYPE": "D", "MH": "Cholestanones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.247.125", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with CHOLESTENONES; includes cholestanediones, cholestanetriones", "PI": "Cholestanes (1968-1974)", "MS": "CHOLESTANES substituted with any number of keto groups.", "PM": "91; was see under CHOLESTANES 1975-90", "HN": "91(75); was see under CHOLESTANES 1975-90", "MR": "20160528", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002778"}, {"RECTYPE": "D", "MH": "Cholestasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Biliary Stasis|T047|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Stasis, Biliary", "MN": "C06.130.120.135", "FX": "Jaundice, Obstructive", "MH_TH": "NLM (1972)", "ST": "T047", "MS": "Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).", "PM": "1972", "HN": "1972 (1969)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002779"}, {"RECTYPE": "D", "MH": "Cholestasis, Intrahepatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intrahepatic Cholestasis|T047|NON|EQV|NLM (2004)|021115|abcdef", "ENTRY": "Intrahepatic Cholestases", "MN": "C06.552.150", "FX": "Jaundice, Obstructive", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Liver (1966-1979)", "MS": "Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20050718", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D002780"}, {"RECTYPE": "D", "MH": "Cholesteatoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cholesteatomas", "MN": "C17.800.428.260", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with organ/disease (IM) but CHOLESTEATOMA, MIDDLE EAR is available", "MS": "A non-neoplastic mass of keratin-producing squamous EPITHELIUM, frequently occurring in the MENINGES; bones of the skull, and most commonly in the MIDDLE EAR and MASTOID region. Cholesteatoma can be congenital or acquired. Cholesteatoma is not a tumor nor is it associated with high CHOLESTEROL.", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002781"}, {"RECTYPE": "D", "MH": "Cholestenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.247.222", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "AN": "do not confuse with CHOLESTANES; includes cholestatrienes", "PI": "Cholestanes (1968-1972)", "MS": "Steroids with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. Members include compounds with any degree of unsaturation; however, CHOLESTADIENES is available for derivatives containing two double bonds.", "PM": "73", "HN": "73", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002782"}, {"RECTYPE": "D", "MH": "Cholestenones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.247.222.265", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with CHOLESTANONES; includes cholestenediones, cholestenetriones", "PI": "Cholestenes (1973-1974)", "MS": "CHOLESTENES with one or more double bonds and substituted by any number of keto groups.", "PM": "91; was see under CHOLESTENES 1975-90", "HN": "91(75); was see under CHOLESTENES 1975-90", "MR": "20160528", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002783"}, {"RECTYPE": "D", "MH": "Cholesterol", "AQ": "AA AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Epicholesterol|T109|T121|NON|REL|UNK (19XX)|841002|abbcdef", "MN": "D10.570.938.208", "FX": "Hypercholesterolemia", "EC": "antagonists & inhibitors:Anticholesteremic Agents", "MH_TH": "POPLINE (1978)", "ST": "T123", "N1": "Cholest-5-en-3-ol (3beta)-", "RN": "97C5T2UQ7J", "RR": "57-88-5 (Cholesterol)", "AN": "general or unspecified; prefer specifics; /blood: consider also HYPERCHOLESTEROLEMIA and specifics; cholesterol granuloma: index CHOLESTEROL and GRANULOMA, FOREIGN-BODY", "MS": "The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.", "OL": "use CHOLESTEROL to search BLOOD CHOLESTEROL 1966-67", "PM": "/blood was BLOOD CHOLESTEROL 1963-67", "HN": "/blood was BLOOD CHOLESTEROL 1963-67", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D002784"}, {"RECTYPE": "D", "MH": "Sterol O-Acyltransferase", "DS": "STEROL ACYLTRANSFERASE O", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cholesterol Acyltransferase|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef", "ENTRY": "Sterol O Acyltransferase", "MN": "D08.811.913.050.799", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "Acyl-CoA:cholesterol O-acyltransferase", "RN": "EC 2.3.1.26", "RR": "9027-63-8 (CAS RN)", "PI": "Coenzyme A (1973-1975)", "MS": "An enzyme that catalyzes the formation of cholesterol esters by the direct transfer of the fatty acid group from a fatty acyl CoA derivative. This enzyme has been found in the adrenal gland, gonads, liver, intestinal mucosa, and aorta of many mammalian species. EC 2.3.1.26.", "PM": "98; see CHOLESTEROL ACYLTRANSFERASE 1985-97; see ACYLTRANSFERASES 1976-84", "HN": "98(76)", "MR": "20030709", "DA": "19750725", "DC": "1", "DX": "19850101", "UI": "D002785"}, {"RECTYPE": "D", "MH": "Cholesterol Side-Chain Cleavage Enzyme", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochrome P-450(scc)|T116|T126|EQV|UNK (19XX)|870504|CYTOCHROME P 450 SCC|abbdefs", "ENTRY": "Cytochrome P 450 CYP11A1", "MN": "D12.776.422.220.453.915.212", "MH_TH": "UNK (19XX)", "ST": "T126", "N1": "Cholesterol,reduced-adrenal-ferredoxin:oxygen oxidoreductase (side-chain-cleaving)", "RN": "EC 1.14.15.6", "PI": "Oxidoreductases (1971-1974)", "MS": "A mitochondrial cytochrome P450 enzyme that catalyzes the side-chain cleavage of C27 cholesterol to C21 pregnenolone in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP11A1 gene, catalyzes the breakage between C20 and C22 which is the initial and rate-limiting step in the biosynthesis of various gonadal and adrenal steroid hormones.", "PM": "2003; see CHOLESTEROL MONOOXYGENASE 1997-2002, see CHOLESTEROL DESMOLASE 1988-1996, see OXIDOREDUCTASES 1975-1987", "HN": "2003 (1975)", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19880101", "UI": "D002786"}, {"RECTYPE": "D", "MH": "Sterol Esterase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cholesterol Esterase|T116|T126|NON|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "Steroid Esterase, Lipoidal", "MN": "D08.811.277.352.100.700", "FX": "Cholesterol Ester Storage Disease", "MH_TH": "NLM (2008)", "ST": "T126", "N1": "Steryl-ester acylhydrolase", "RN": "EC 3.1.1.13", "RR": "EC 3.1.1.13", "PI": "Esterases (1973-1974)", "MS": "An enzyme that catalyzes the hydrolysis of CHOLESTEROL ESTERS and some other sterol esters, to liberate cholesterol plus a fatty acid anion.", "PM": "2008; see CHLOLESTEROL ESTERASE 1991-2007, see CARBOXYLIC ESTER HYDROLASES 1976-1990, see ESTERASES 1975", "HN": "2008(1975)", "MR": "20070709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002787"}, {"RECTYPE": "D", "MH": "Cholesterol Esters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cholesteryl Ester|T109|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Esters, Cholesteryl", "MN": "D10.570.938.208.250", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "0", "PI": "Esters (1968-1977)", "MS": "Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis.", "PM": "78; was see under CHOLESTEROL 1976-77", "HN": "78(76); was see under CHOLESTEROL 1976-77", "MR": "20200527", "DA": "19750725", "DC": "1", "DX": "19780101", "UI": "D002788"}, {"RECTYPE": "D", "MH": "Cholesterol Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Cholesterol", "MN": "D08.811.682.047.436.350.150", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "Cholesterol:oxygen oxidoreductase", "RN": "EC 1.1.3.6", "PI": "Hydroxysteroid Dehydrogenases (1966-1977)", "MS": "An enzyme that catalyzes the oxidation of cholesterol in the presence of molecular oxygen to 4-cholesten-3-one and hydrogen peroxide. The enzyme is not specific for cholesterol, but will also oxidize other 3-hydroxysteroids. EC 1.1.3.6.", "PM": "91; was see under 3-HYDROXYSTEROID DEHYDROGENASES 1978-90", "HN": "91(78); was see under 3-HYDROXYSTEROID DEHYDROGENASES 1978-90", "MR": "20030709", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D002789"}, {"RECTYPE": "D", "MH": "Cholesterol 7-alpha-Hydroxylase", "DS": "CHOLESTEROL ALPHA HYDROXYLASE 07", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochrome P-450 CYP7|T116|T126|EQV|NLM (1997)|960310|CYTOCHROME P 450 CYP 007|abbdefs", "ENTRY": "Cytochrome P 450 CYP7", "MN": "D12.776.422.220.453.915.200", "MH_TH": "NLM (1997)", "ST": "T126", "N1": "Cholesterol,NADPH:oxygen oxidoreductase (7 alpha-hydroxylating)", "RN": "EC 1.14.14.23", "RR": "9037-53-0 (CAS RN)", "PI": "Steroid Hydroxylases (1974)", "MS": "A membrane-bound cytochrome P450 enzyme that catalyzes the 7-alpha-hydroxylation of CHOLESTEROL in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP7, converts cholesterol to 7-alpha-hydroxycholesterol which is the first and rate-limiting step in the synthesis of BILE ACIDS.", "PM": "2003; see CHOLESTEROL 7 ALPHA-MONOOXYGENASE 1997-2002, see CHOLESTEROL-7-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1975-1990", "HN": "2003 (1975)", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002790"}, {"RECTYPE": "D", "MH": "Cholesterol, Dietary", "AQ": "AA AD AE AG AI AN BL CF CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dietary Cholesterol|T109|NON|EQV|UNK (19XX)|740329|abcdef", "MN": "D10.570.938.208.222", "FX": "Hyperlipoproteinemia Type II", "EC": "chemistry:Cholesterol:chemistry", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "AN": "/adv eff: coord with disease /etiol, not /chem ind", "PI": "Dietary Fats (1966-1972)", "MS": "Cholesterol present in food, especially in animal products.", "PM": "73", "HN": "73", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002791"}, {"RECTYPE": "D", "MH": "Cholestyramine Resin", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Colestyramine|T109|T121|NON|EQV|INN (19XX)|761223|abbcdef", "ENTRY": "Resins, Cholestyramine", "MN": "J01.637.051.720.716.579.159", "PA": "Anticholesteremic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "11041-12-6", "MS": "A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium Cl(-) anion.", "PM": "2010; see CHOLESTYRAMINE RESIN 1966-2009;", "HN": "2010 (1964)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002792"}, {"RECTYPE": "D", "MH": "Cholic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cholalic Acids|T109|T121|T123|NON|EQV|UNK (19XX)|770209|abbbcdef", "ENTRY": "Acids, Cholic", "MN": "D04.210.500.221.430", "PA": "Gastrointestinal Agents", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "PI": "Bile Acids and Salts (1966-1972)", "MS": "The 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholanic acid family of bile acids in man, usually conjugated with glycine or taurine. They act as detergents to solubilize fats for intestinal absorption, are reabsorbed by the small intestine, and are used as cholagogues and choleretics.", "OL": "use CHOLIC ACIDS to search CHOLIC ACID 1973-74 (as Prov 1973); use BILE ACIDS AND SALTS 1966-72", "PM": "75; was CHOLIC ACID 1974, was CHOLIC ACID see under BILE ACIDS AND SALTS 1963-73", "HN": "75; was CHOLIC ACID 1973-74 (Prov 1973), was CHOLIC ACID see under BILE ACIDS AND SALTS 1963-73", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002793"}, {"RECTYPE": "D", "MH": "Choline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vidine|T109|T123|NON|NRW|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef", "ENTRY": "O-Sulfate, Choline", "MN": "D02.675.276.232", "PA": "Nootropic Agents", "EC": "deficiency:Choline Deficiency", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Ethanaminium, 2-hydroxy-N,N,N-trimethyl-", "RN": "N91BDP6H0X", "RR": "7THJ3EG9SY", "AN": "/biosyn /physiol permitted", "MS": "A basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism.", "MR": "20160520", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002794"}, {"RECTYPE": "D", "MH": "Choline O-Acetyltransferase", "DS": "CHOLINE ACETYLTRANSFERASE O", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Choline Acetyltransferase|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef", "ENTRY": "O-Acetyltransferase, Choline", "MN": "D08.811.913.050.134.180", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Acetyl-CoA:choline O-acetyltransferase", "RN": "EC 2.3.1.6", "RR": "9012-78-6 (CAS RN)", "PI": "Transferases (1966-1972)", "MS": "An enzyme that catalyzes the formation of acetylcholine from acetyl-CoA and choline. EC 2.3.1.6.", "PM": "98; see CHOLINE ACETYLTRANSFERASE 1978-97; see ACETYLTRANSFERASES 1975-77", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19780101", "UI": "D002795"}, {"RECTYPE": "D", "MH": "Choline Deficiency", "DE": "CHOLINE DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Deficiencies, Choline", "MN": "C18.654.521.500.133.699.160", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "A condition produced by a deficiency of CHOLINE in animals. Choline is known as a lipotropic agent because it has been shown to promote the transport of excess fat from the liver under certain conditions in laboratory animals. Combined deficiency of choline (included in the B vitamin complex) and all other methyl group donors causes liver cirrhosis in some animals. Unlike compounds normally considered as vitamins, choline does not serve as a cofactor in enzymatic reactions. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002796"}, {"RECTYPE": "D", "MH": "Choline Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ATP Choline Transphosphatase|T116|T126|EQV|UNK (19XX)|750630|abbdef", "ENTRY": "Transphosphatase, ATP Choline", "MN": "D08.811.913.696.620.155", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "ATP:choline phosphotransferase", "RN": "EC 2.7.1.32", "RR": "9026-67-9 (CAS RN)", "PI": "Phosphotransferases, ATP (1974-1975)", "MS": "An enzyme that is active in the first step of choline phosphoglyceride (lecithin) biosynthesis by catalyzing the phosphorylation of choline to phosphorylcholine in the presence of ATP. Ethanolamine and its methyl and ethyl derivatives can also act as acceptors. EC 2.7.1.32.", "PM": "91; was see under PHOSPHOTRANSFERASES, ATP 1976-90", "HN": "91(76); was see under PHOSPHOTRANSFERASES, ATP 1976-90", "MR": "20030709", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D002797"}, {"RECTYPE": "D", "MH": "Diacylglycerol Cholinephosphotransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphorylcholine-Glyceride Transferase|T116|T126|NON|EQV|UNK (19XX)|750206|abbcdef", "ENTRY": "Transferase, Phosphorylcholineglyceride", "MN": "D08.811.913.696.900.200", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "CDPcholine:1,2-diacylglycerol cholinephosphotransferase", "RN": "EC 2.7.8.2", "RR": "9026-13-5 (CAS RN)", "PI": "Phosphotransferases (1973-1974)", "MS": "An enzyme that catalyzes the synthesis of phosphatidylcholines from CDPcholine and 1,2-diacylglycerols. EC 2.7.8.2.", "PM": "1994; see CHOLINEPHOSPHOTRANSFERASE 1975-93; 1-ALKYL-2-ACETYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE was indexed under DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE 1994-1999; for PHOSPHORYLCHOLINE-GLYCERIDE TRANSFERASE see PHOSPHORYLCHOLINE GLYCERIDE TRANSFERASE 1976-1993", "HN": "1994(1975); use CHOLINEPHOSPHOTRANSFERASE 1975-93; for 1-ALKYL-2-ACETOGLYCEROL CHOLINEPHOSPHOTRANSFERASE use DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE (NM) 1987-1999; for PHOSPHORYLCHOLINE-GLYCERIDE TRANSFERASE use PHOSPHORYLCHOLINE GLYCERIDE TRANSFERASE 1976-1993", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002798"}, {"RECTYPE": "D", "MH": "Cholinergic Fibers", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Fibers, Cholinergic", "MN": "A11.671.501.234", "FX": "Cholinergic Neurons", "MH_TH": "NLM (1977)", "ST": "T026", "AN": "CHOLINERGIC NEURONS is also available", "PI": "Parasympathetic Nervous System (1966-1976)", "MS": "Nerve fibers liberating acetylcholine at the synapse after an impulse.", "PM": "77", "HN": "77", "MR": "20160415", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D002799"}, {"RECTYPE": "D", "MH": "Cholinesterase Inhibitors", "DE": "CHOLINESTERASE INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cholinesterase Inhibitor|T121|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Reversible Cholinesterase Inhibitors", "MN": "D27.505.696.577.120.300", "FX": "Insecticides", "MH_TH": "NLM (1965)", "ST": "T121", "RN": "0", "MS": "Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.", "OL": "use CHOLINESTERASE INHIBITORS to search CHOLINESTERASE INHIBITORS, IRREVERSIBLE & CHOLINESTERASE INHIBITORS, REVERSIBLE 1971-83 (as Prov 1971-74)", "PM": "65; CHOLINESTERASE INHIBITORS, IRREVERSIBLE & CHOLINESTERASE INHIBITORS, REVERSIBLE were see under CHOLINESTERASE INHIBITORS 1975-83; CHOLINESTERASE INHIBITORS, ORGANIC was see PHOSPHORUS POISONS, ORGANIC 1963-64 (PHOSPHORUS POISONS, ORGANIC deleted 1965)", "HN": "65; CHOLINESTERASE INHIBITORS, IRREVERSIBLE & CHOLINESTERASE INHIBITORS, REVERSIBLE were see under CHOLINESTERASE INHIBITORS 1975-83, were Prov 1971-74; CHOLINESTERASE INHIBITORS, ORGANIC was see PHOSPHORUS POISONS, ORGANIC 1963-64 (PHOSPHORUS POISONS, ORGANIC deleted 1965)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002800"}, {"RECTYPE": "D", "MH": "Cholinesterase Reactivators", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Organothiophosphate Insecticide Antagonists|T121|NON|NRW|NLM (1995)|940425|ORGANOTHIOPHOSPHATE INSECTICIDE ANTAG|abcdefv", "ENTRY": "Reactivators, Cholinesterase", "MN": "D27.505.696.577.120.400", "MH_TH": "NLM (1971)", "ST": "T121", "RN": "0", "AN": "note X refs", "PI": "Pyridinium Compounds (1968-1970)", "MS": "Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates.", "PM": "72", "HN": "72(71)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002801"}, {"RECTYPE": "D", "MH": "Cholinesterases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cholinesterase|T116|T126|NON|EQV|UNK (19XX)|760905|abbcdef", "MN": "D08.811.277.352.100.170", "EC": "antagonists & inhibitors:Cholinesterase Inhibitors", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Acylcholine acylhydrolase", "RN": "EC 3.1.1.8", "AN": "reactivation: index under CHOLINESTERASE REACTIVATORS", "OL": "use CHOLINESTERASES to search CHOLINESTERASE 1966-74", "PM": "75; was CHOLINESTERASE 1963-74", "HN": "75; was CHOLINESTERASE 1963-74", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D002802"}, {"RECTYPE": "D", "MH": "Chondro-4-Sulfatase", "DS": "CHONDROSULFATASE 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Chondro 4 Sulfatase", "MN": "D08.811.277.352.827.180.175.275", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine-4-sulfate 4-sulfohydrolase", "RN": "EC 3.1.6.9", "PI": "Sulfatases (1974-1975)", "MS": "An enzyme from the sulfuric ester hydrolase class that breaks down one of the products of the chondroitin lyase II reaction. EC 3.1.6.9.", "PM": "91; was see under SULFATASES 1976-90", "HN": "91(76); was see under SULFATASES 1976-90", "MR": "20030709", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D002803"}, {"RECTYPE": "D", "MH": "Chondroblastoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Chondroblastomas", "MN": "C04.557.450.565.250", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "benign or malignant; coordinate with BONE NEOPLASMS or precoordinated organ/neoplasm term ", "MS": "A usually benign tumor composed of cells which arise from chondroblasts or their precursors and which tend to differentiate into cartilage cells. It occurs primarily in the epiphyses of adolescents. It is relatively rare and represents less than 2% of all primary bone tumors. The peak incidence is in the second decade of life; it is about twice as common in males as in females. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1846)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002804"}, {"RECTYPE": "D", "MH": "Chondrocalcinosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pseudogout|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Chondrocalcinoses", "MN": "C05.550.354.125", "FX": "Gout", "MH_TH": "NLM (1972)", "ST": "T047", "AN": "note entry term: do not index CALCIUM PYROPHOSPHATE unless particularly discussed", "PI": "Joint Diseases (1966-1971)", "MS": "Presence of CALCIUM PYROPHOSPHATE in the connective tissues such as the cartilaginous structures of  joints. When accompanied by GOUT-like symptoms, it is referred to as pseudogout.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20160303", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002805"}, {"RECTYPE": "D", "MH": "Chondrodysplasia Punctata", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stippled Epiphyses|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "X Linked Dominant Chondrodysplasia Punctata", "MN": "C05.116.099.708.195", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "spell entry term name Hunermann with an umlaut in titles & translations; CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC is also available", "MS": "A heterogeneous group of bone dysplasias, the common character of which is stippling of the epiphyses in infancy. The group includes a severe autosomal recessive form (CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC), an autosomal dominant form (Conradi-Hunermann syndrome), and a milder X-linked form. Metabolic defects associated with impaired peroxisomes are present only in the rhizomelic form.", "PM": "1985; see CHONDRODYSTROPHIA CALCIFICANS CONGENITA 1967-1984", "HN": "1985(1964)", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002806"}, {"RECTYPE": "D", "MH": "Chondroitin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D09.698.373.200", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Chondroitin", "RN": "9007-27-6", "AN": "/biosyn /physiol permitted; CHONDROITIN SULFATE B see DERMATAN SULFATE is available", "MS": "A mucopolysaccharide constituent of chondrin. (Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002807"}, {"RECTYPE": "D", "MH": "Chondroitin Lyases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chondroitin Sulfate Lyase|T116|T126|NON|NRW|UNK (19XX)|750731|abbcdef", "ENTRY": "Sulfate Lyase, Chondroitin", "MN": "D08.811.520.241.700.350.500", "MH_TH": "NLM (1976)", "ST": "T126", "RN": "EC 4.2.2.-", "AN": "do not confuse with CHONDROITIN ABC LYASE", "PI": "Polysaccharide-Lyases (1975)", "MS": "Enzymes which catalyze the elimination of delta-4,5-D-glucuronate residues from polysaccharides containing 1,4-beta-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages thereby bringing about depolymerization. EC 4.2.2.4 acts on chondroitin sulfate A and C as well as on dermatan sulfate and slowly on hyaluronate. EC 4.2.2.5 acts on chondroitin sulfate A and C.", "PM": "91; was see under CHONDROITINASES 1976-90", "HN": "91(76); was see under CHONDROITINASES 1976-90", "MR": "20030709", "DA": "19750801", "DC": "1", "DX": "19910101", "UI": "D002808"}, {"RECTYPE": "D", "MH": "Chondroitin Sulfates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chondroitin Sulfate C|T109|T121|T123|NON|NRW|UNK (19XX)|750630|abbbcdef", "ENTRY": "Sulfates, Chondroitin", "MN": "D09.698.373.200.300", "MH_TH": "NLM (1976)", "ST": "T123", "N1": "Chondroitin, hydrogen sulfate", "RN": "9007-28-7", "RR": "9088-44-2 (unspecified sulfate, Fe(3+) salt)", "PI": "Sulfuric Acids (1971-1975)", "MS": "Derivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B (beta heparin; DERMATAN SULFATE) is a misnomer and this compound is not a true chondroitin sulfate.", "PM": "1991; see CHONDROITIN 1976-90; TRANSLAGEN was indexed under CHONDROITIN SULFATES, COLLAGEN & HEPARIN 1991-2000", "HN": "1991(1976); for TRANSLAGEN use CHONDROITIN SULFATE (NM) 1991-2000", "MR": "20040707", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D002809"}, {"RECTYPE": "D", "MH": "Chondroitinases and Chondroitin Lyases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chondroitinase|T116|T126|NON|NRW|NLM (2021)|200123|abbcdef", "ENTRY": "Depolymerase, Chondroitin-4-Sulfate", "MN": "D08.811.520.241.700.350", "MH_TH": "NLM (1976)", "ST": "T126", "RN": "EC 4.2.2.-", "AN": "CHONDROITIN LYASES is available", "PI": "Sulfatases (1970-1975)", "MS": "Enzymes which catalyze the elimination of glucuronate residues from chondroitin A, B, and C or which catalyze the hydrolysis of sulfate groups of the 2-acetamido-2-deoxy-D-galactose 6-sulfate units of chondroitin sulfate. EC 4.2.2.-.", "PM": "98; see CHONDROITINASES 1976-97", "HN": "98(76)", "MR": "20210630", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D002810"}, {"RECTYPE": "D", "MH": "Chondroitinsulfatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sulfohydrolase, Chondroitin", "MN": "D08.811.277.352.827.180.175", "MH_TH": "NLM (1976)", "ST": "T126", "RN": "EC 3.1.6.-", "PI": "Sulfatases (1970-1975)", "MS": "A group of enzymes that catalyze the hydrolysis of various sulfate bonds of chondroitin sulfate. EC 3.1.6.-.", "PM": "97; was CHONDROITINSULFATASE 1976-96 (see under CHONDROITINASES 1976-90)", "HN": "97; was CHONDROITINSULFATASE 1976-96 (see under CHONDROITINASES 1976-90)", "MR": "20030709", "DA": "19750801", "DC": "1", "DX": "19910101", "UI": "D002811"}, {"RECTYPE": "D", "MH": "Chondroma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Enchondroma|T191|NON|REL|NLM (1990)|890321|abcdef", "ENTRY": "Enchondromas", "MN": "C04.557.450.565.265", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "A benign neoplasm derived from mesodermal cells that form cartilage. It may remain within the substance of a cartilage or bone (true chondroma or enchondroma) or may develop on the surface of a cartilage (ecchondroma or ecchondrosis). (Dorland, 27th ed; Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002812"}, {"RECTYPE": "D", "MH": "Chondrosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Chondrosarcomas", "MN": "C04.557.450.795.300", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate with BONE NEOPLASMS or specific precoordinated bone/neoplasm term or specific bone + BONE NEOPLASMS ", "MS": "A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002813"}, {"RECTYPE": "D", "MH": "Chorda Tympani Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tympani Nerves, Chorda", "MN": "A08.800.800.120.250.120", "MH_TH": "NLM (1963)", "ST": "T023", "AN": "a branch of the facial (7th cranial) nerve; dis: coord IM with FACIAL NERVE DISEASES (IM); neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "A branch of the facial (7th cranial) nerve which passes through the middle ear and continues through the petrotympanic fissure. The chorda tympani nerve carries taste sensation from the anterior two-thirds of the tongue and conveys parasympathetic efferents to the salivary glands.", "PM": "65", "HN": "65(63)", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002814"}, {"RECTYPE": "D", "MH": "Chordae Tendineae", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tendineae, Chordae", "MN": "A07.541.510.240", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "for disease, coord IM with HEART VALVE DISEASES (IM); PAPILLARY MUSCLES is also available but read MeSH definition; false tendons: index PURKINJE FIBERS but see note there", "MS": "The tendinous cords that connect each cusp of the two atrioventricular HEART VALVES to appropriate PAPILLARY MUSCLES in the HEART VENTRICLES, preventing the valves from reversing themselves when the ventricles contract.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002815"}, {"RECTYPE": "D", "MH": "Chordata, Nonvertebrate", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Nonvertebrate Chordatas", "MN": "B01.050.500.272", "MH_TH": "NLM (1966)", "ST": "T008", "MS": "A portion of the animal phylum Chordata comprised of the subphyla CEPHALOCHORDATA; UROCHORDATA, and HYPEROTRETI, but not including the Vertebrata (VERTEBRATES). It includes nonvertebrate animals having a NOTOCHORD during some developmental stage.", "PM": "2000; see CHORDATA 1966-1999", "HN": "2000(1966)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D002816"}, {"RECTYPE": "D", "MH": "Chordoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Chordomas", "MN": "C04.557.465.220", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A malignant tumor arising from the embryonic remains of the notochord. It is also called chordocarcinoma, chordoepithelioma, and notochordoma. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002817"}, {"RECTYPE": "D", "MH": "Cordotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Chordotomy|T061|NON|EQV|UNK (19XX)|880519|abcdef", "ENTRY": "Cordotomies", "MN": "E04.525.210.210", "MH_TH": "NLM (1963)", "ST": "T061", "MS": "Any operation on the spinal cord. (Stedman, 26th ed)", "OL": "use CORDOTOMY to search CHORDOTOMY 1966-88", "PM": "89; was CHORDOTOMY 1966-88", "HN": "89; was CHORDOTOMY 1966-88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002818"}, {"RECTYPE": "D", "MH": "Chorea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Choreiform Movement|T184|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Syndromes, Choreatic", "MN": "C23.888.592.350.250", "MH_TH": "NLM (1963)", "ST": "T184", "MS": "Involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. Hypotonia and pendular reflexes are often associated. Conditions which feature recurrent or persistent episodes of chorea as a primary manifestation of disease are referred to as CHOREATIC DISORDERS. Chorea is also a frequent manifestation of BASAL GANGLIA DISEASES.", "PM": "1963; for CHOREATIC DISORDERS; CHOREA, BENIGN HERIDITARY; CHOREA, CHRONIC PROGRESSIVE; CHOREA, RHEUMATIC; CHOREA, SENILE; DYSKINESIAS, PAROXYSMAL; & HEREDITARY CHOREA use CHOREATIC DISORDERS 2000-2007", "HN": "1963; for CHOREATIC DISORDERS; CHOREA, BENIGN HERIDITARY; CHOREA, CHRONIC PROGRESSIVE; CHOREA, RHEUMATIC; CHOREA, SENILE; DYSKINESIAS, PAROXYSMAL; & HEREDITARY CHOREA use CHOREATIC DISORDERS 2000-2007", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D002819"}, {"RECTYPE": "D", "MH": "Hydatidiform Mole, Invasive", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Invasive Mole|T191|NON|EQV|NLM (1994)|930329|abcdef", "ENTRY": "Moles, Invasive Hydatidiform", "MN": "C12.050.703.720.949.416.875.500", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with UTERINE NEOPLASMS (IM); check the tags FEMALE & PREGNANCY", "MS": "A uterine tumor derived from persistent gestational TROPHOBLASTS, most likely after a molar pregnancy (HYDATIDIFORM MOLE). Invasive hyadatiform mole develops in about 15% of patients after evacuation of a complete mole and less frequently after other types of gestation. It may perforate the MYOMETRIUM and erode uterine vessels causing hemorrhage.", "OL": "use HYDATIDIFORM MOLE, INVASIVE to search CHORIOADENOMA 1966-93", "PM": "94; was CHORIOADENOMA 1963-93", "HN": "94; was CHORIOADENOMA 1963-93", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D002820"}, {"RECTYPE": "D", "MH": "Chorioamnionitis", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Funisitis|T047|NON|NRW|NLM (2006)|050225|abcdef", "ENTRY": "Funisitides", "MN": "C16.300.030", "MH_TH": "NLM (1985)", "ST": "T047", "PI": "Pregnancy Complications, Infectious (1966-1984)", "MS": "INFLAMMATION of the placental membranes (CHORION; AMNION) and connected tissues such as fetal BLOOD VESSELS and UMBILICAL CORD. It is often associated with intrauterine ascending infections during PREGNANCY.", "PM": "85", "HN": "85", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19840501", "DC": "1", "DX": "19850101", "UI": "D002821"}, {"RECTYPE": "D", "MH": "Choriocarcinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Choriocarcinomas", "MN": "C12.050.703.720.949.208", "FX": "Choriocarcinoma, Non-gestational", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with UTERINE NEOPLASMS (IM) + FEMALE + PREGNANCY", "MS": "A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL).", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002822"}, {"RECTYPE": "D", "MH": "Chorion", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Chorions", "MN": "A16.254.750.473", "FX": "Chorioallantoic Membrane", "MH_TH": "NLM (1975)", "ST": "T018", "PI": "Fetal Membranes (1966-1974)", "MS": "The outermost extra-embryonic membrane surrounding the developing embryo. In REPTILES and BIRDS, it adheres to the shell and allows exchange of gases between the egg and its environment. In MAMMALS, the chorion evolves into the fetal contribution of the PLACENTA.", "OL": "search FETAL MEMBRANES 1966-74", "PM": "78; was see under FETAL MEMBRANES 1963-77", "HN": "78(75); was see under FETAL MEMBRANES 1963-77", "MR": "20070711", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D002823"}, {"RECTYPE": "D", "MH": "Chorionic Villi", "AQ": "AB AH BS CH DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Placental Villi|T018|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Villus, Placental", "MN": "A16.710.189", "MH_TH": "NLM (1975)", "ST": "T018", "PI": "Placenta (1966-1974)", "MS": "Threadlike vascular projections of the chorion. Chorionic villi may be free or embedded within the DECIDUA forming the site for exchange of substances between fetal and maternal blood (PLACENTA).", "PM": "85; was see under PLACENTA 1975-84", "HN": "85(75); was see under PLACENTA 1975-84", "MR": "20170224", "DA": "19741111", "DC": "1", "DX": "19850101", "UI": "D002824"}, {"RECTYPE": "D", "MH": "Chorioretinitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Chorioretinitides", "MN": "C11.941.879.780.900.300.318", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "inflamm of choroid & retina", "MS": "Inflammation of the choroid in which the sensory retina becomes edematous and opaque. The inflammatory cells and exudate may burst through the sensory retina to cloud the vitreous body.", "CATSH": "CAT LIST", "MR": "19930526", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002825"}, {"RECTYPE": "D", "MH": "Chorismate Mutase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chorismate Pyruvatemutase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Pyruvatemutase, Chorismate", "MN": "D08.811.399.520.250", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Chorismate pyruvatemutase", "RN": "EC 5.4.99.5", "RR": "9068-30-8 (CAS RN)", "PI": "Vinyl Compounds (1972-1974)", "MS": "An isomerase that catalyzes the conversion of chorismic acid to prephenic acid. EC 5.4.99.5.", "PM": "91; was see under ISOMERASES 1975-90", "HN": "91(75); was see under ISOMERASES 1975-90", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002826"}, {"RECTYPE": "D", "MH": "Chorismic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Chorismic", "MN": "D02.455.426.392.368.367.379.374", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "1,5-Cyclohexadiene-1-carboxylic acid, 3-((1-carboxyethenyl)oxy)-4-hydroxy-, (3R-trans)-", "RN": "GI1BLY82Y1", "RR": "617-12-9 (Chorismic Acid)", "PI": "Vinyl Compounds (1972-1974)", "MS": "A cyclohexadiene carboxylic acid derived from SHIKIMIC ACID and a precursor for the biosynthesis of UBIQUINONE and the AROMATIC AMINO ACIDS.", "PM": "91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90", "HN": "91(75); was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002827"}, {"RECTYPE": "D", "MH": "Choristoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Heterotopic Tissue|T046|NON|EQV|UNK (19XX)|750116|abcdef", "ENTRY": "Tissues, Heterotopic", "MN": "C23.300.250", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "A mass of histologically normal tissue present in an abnormal location.", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002828"}, {"RECTYPE": "D", "MH": "Choroid", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sattler's Layer|T024|EPO|NRW|NLM (2020)|190215|abcdef", "ENTRY": "Choroids", "MN": "A09.371.894.223", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA.", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002829"}, {"RECTYPE": "D", "MH": "Choroid Neoplasms", "DE": "CHOROID NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasms, Choroidal", "MN": "C11.941.855.198", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "Tumors of the choroid; most common intraocular tumors are malignant melanomas of the choroid. These usually occur after puberty and increase in incidence with advancing age. Most malignant melanomas of the uveal tract develop from benign melanomas (nevi).", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002830"}, {"RECTYPE": "D", "MH": "Choroid Plexus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Plexus, Choroid", "MN": "A08.186.211.140.298", "FX": "Cerebral Ventriculography", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A villous structure of tangled masses of BLOOD VESSELS contained within the third, lateral, and fourth ventricles of the BRAIN. It regulates part of the production and composition of CEREBROSPINAL FLUID.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002831"}, {"RECTYPE": "D", "MH": "Choroid Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Choroid|T033|T046|NON|EQV|NLM (1990)|890315|abbcdef", "ENTRY": "Hemorrhage, Choroidal", "MN": "C23.550.414.756.300", "MH_TH": "NLM (1987)", "ST": "T046", "AN": "of the eye, not of the choroid plexus", "PI": "Hemorrhage (1966-1986)", "MS": "Hemorrhage from the vessels of the choroid.", "OL": "use CHOROID HEMORRHAGE to search CHOROIDAL HEMORRHAGE 1987-89", "PM": "91; was see under EYE HEMORRHAGE 1987-90; was CHOROIDAL HEMORRHAGE 1987-89", "HN": "91(87); was see under EYE HEMORRHAGE 1987-90; was CHOROIDAL HEMORRHAGE 1987-89", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19860408", "DC": "1", "DX": "19910101", "UI": "D002832"}, {"RECTYPE": "D", "MH": "Choroiditis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Choroiditides", "MN": "C11.941.879.780.900.300", "FX": "Chorioretinitis", "MH_TH": "NLM (1964)", "ST": "T184", "AN": "of the eye, not of the choroid plexus; consider also CHORIORETINITIS", "MS": "Inflammation of the choroid.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "19910620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002833"}, {"RECTYPE": "D", "MH": "Christian Science", "AQ": "HI PX", "ENTRY": "Scientists, Christian", "MN": "K01.844.188.431", "MH_TH": "BIOETHICS (1984)", "ST": "T078", "AN": "specify geographic location if pertinent", "MS": "A religion founded by Mary Baker Eddy in 1866 that was organized under the official name of the Church of Christ, Scientist. It includes the practice of spiritual healing.", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002834"}, {"RECTYPE": "D", "MH": "Christianity", "AQ": "HI PX", "PRINT ENTRY": "Stigmata|T067|NON|REL|NLM (1997)|951128|abcdef", "ENTRY": "Ethics, Christian", "MN": "K01.844.188", "MH_TH": "POPLINE (1983)", "ST": "T078", "AN": "specify geog if pertinent", "MS": "The religion stemming from the life, teachings, and death of Jesus Christ: the religion that believes in God as the Father Almighty who works redemptively through the Holy Spirit for men's salvation and that affirms Jesus Christ as Lord and Savior who proclaimed to man the gospel of salvation. (From Webster, 3d ed)", "HN": "1963", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D002835"}, {"RECTYPE": "D", "MH": "Hemophilia B", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Factor IX Deficiency|T047|NON|EQV|OMIM (2013)|ORD (2010)|UNK (19XX)|740701|FACTOR VIIII DEFICIENCY|FACTOR IX DEFIC|abcdeeefsv", "ENTRY": "Hemophilia Bs (M)", "MN": "C16.320.322.235", "FX": "Hemophilia A", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A deficiency of blood coagulation factor IX inherited as an X-linked disorder. (Also known as Christmas Disease, after the first patient studied in detail, not the holy day.) Historical and clinical features resemble those in classic hemophilia (HEMOPHILIA A), but patients present with fewer symptoms. Severity of bleeding is usually similar in members of a single family. Many patients are asymptomatic until the hemostatic system is stressed by surgery or trauma. Treatment is similar to that for hemophilia A. (From Cecil Textbook of Medicine, 19th ed, p1008)", "PM": "1999; see CHRISTMAS DISEASE 1966-1998; for HEMOPHILIA B see CHRISTMAS DISEASE 1974-1998; for Hemophilia B Leyden see FACTOR IX 1990-2012", "HN": "1999(1966)", "CATSH": "CAT LIST", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D002836"}, {"RECTYPE": "D", "MH": "Chromaffin Granules", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Granule, Chromaffin", "MN": "A11.284.430.214.190.875.190.190.207", "MH_TH": "NLM (1978)", "ST": "T026", "PI": "Cytoplasmic Granules (1966-1977)", "MS": "Organelles in CHROMAFFIN CELLS located in the adrenal glands and various other organs. These granules are the site of the synthesis, storage, metabolism, and secretion of EPINEPHRINE and NOREPINEPHRINE.", "PM": "91; was see under CHROMAFFIN SYSTEM 1978-90", "HN": "91(78); was see under CHROMAFFIN SYSTEM 1978-90", "MR": "20210305", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D002837"}, {"RECTYPE": "D", "MH": "Chromaffin System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Argentaffin System|T022|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Systems, Chromaffin", "MN": "A06.224", "MH_TH": "NLM (1966)", "ST": "T022", "AN": "/cytol: consider also specific CHROMAFFIN SYSTEM cell indentions", "MS": "The cells of the body which stain with chromium salts. They occur along the sympathetic nerves, in the adrenal gland, and in various other organs.", "MR": "19960614", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002838"}, {"RECTYPE": "D", "MH": "Chromans", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dihydrobenzopyrans|T109|NON|EQV|UNK (19XX)|741111|abcdef", "MN": "D03.633.100.150.240", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with CHROMONES", "PI": "Benzopyrans (1968-1974)", "MS": "Benzopyrans saturated in the 2 and 3 positions.", "PM": "91; was see under BENZOPYRANS 1975-90", "HN": "91(75); was see under BENZOPYRANS 1975-90", "MR": "20160528", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002839"}, {"RECTYPE": "D", "MH": "Chromates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chromate|T197|NON|EQV|NLM (2021)|191227|abcdef", "MN": "D01.248.497.158.235", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "MS": "Salts of chromic acid containing the CrO(2-)4 radical.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002840"}, {"RECTYPE": "D", "MH": "Chromatiaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Purple Sulfur Bacteria|T007|NON|EQV|NLM (2004)|021021|PURPLE SULFUR BACT|abcdefv", "MN": "B03.660.250.110", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid1046", "PI": "Bacteria (1966-1974)", "MS": "A family of phototrophic purple sulfur bacteria that deposit globules of elemental sulfur inside their cells. They are found in diverse aquatic environments.", "PM": "1976; see THIORHODACEAE 1975", "HN": "1976", "MR": "20200813", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D002841"}, {"RECTYPE": "D", "MH": "Chromatids", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Chromatid", "MN": "G05.360.160.175", "FX": "Sister Chromatid Exchange", "MH_TH": "NLM (1968)", "ST": "T026", "PI": "Chromosomes (1966-1967)", "MS": "Either of the two longitudinally adjacent threads formed when a eukaryotic chromosome replicates prior to mitosis. The chromatids are held together at the centromere. Sister chromatids are derived from the same chromosome. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)", "PM": "68", "HN": "68", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002842"}, {"RECTYPE": "D", "MH": "Chromatin", "AQ": "CH CL DE EN GE IM IP ME MI PA PH PS RE TR UL VI", "ENTRY": "Chromatins", "MN": "G05.360.160.180", "MH_TH": "NLM (1972)", "ST": "T116", "RN": "0", "PI": "Sex Chromatin (1966-1971)", "MS": "The material of CHROMOSOMES. It is a complex of DNA; HISTONES; and nonhistone proteins (CHROMOSOMAL PROTEINS, NON-HISTONE) found within the nucleus of a cell.", "PM": "72", "HN": "72", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002843"}, {"RECTYPE": "D", "MH": "Chromatium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.110.150", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1047", "AN": "in water", "MS": "A genus of gram-negative, ovoid to rod-shaped bacteria that is phototrophic. All species use ammonia as a nitrogen source. Some strains are found only in sulfide-containing freshwater habitats exposed to light while others may occur in marine, estuarine, and freshwater environments.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002844"}, {"RECTYPE": "D", "MH": "Chromatography", "DE": "CHROMATOGR", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Chromatographies", "MN": "E05.196.181", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "general or unspecified; prefer specifics; on Sephadex G equals GEL FILTRATION see CHROMATOGRAPHY, GEL; on DEAE Sephadex equals CHROMATOGRAPHY, ION EXCHANGE", "MS": "Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002845"}, {"RECTYPE": "D", "MH": "Chromatography, Affinity", "DE": "CHROMATOGR AFFINITY", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Immunochromatography|T059|T063|NON|NRW|NLM (2012)|101019|abbcdef", "ENTRY": "Bioaffinity Chromatography|T059|NON|EQV|NLM (2007)|060307|abcdef", "MN": "E05.196.181.400.170", "MH_TH": "NLM (1972)", "ST": "T059", "PI": "appropriate substances used for binding", "MS": "A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "74", "HN": "74(72)", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002846"}, {"RECTYPE": "D", "MH": "Chromatography, Agarose", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Chromatography, Sepharose|T059|T062|NON|EQV|NLM (1993)|910924|CHROMATOGR SEPHAROSE|abbcdefv", "ENTRY": "Sepharose Chromatographies", "MN": "E05.196.181.400.250.200", "MH_TH": "NLM (1975)", "ST": "T062", "MS": "A method of gel filtration chromatography using agarose, the non-ionic component of agar, for the separation of compounds with molecular weights up to several million.", "PM": "91; was see under CHROMATOGRAPHY, GEL 1975-90", "HN": "91(75); was see under CHROMATOGRAPHY, GEL 1975-90", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002847"}, {"RECTYPE": "D", "MH": "Chromatography, DEAE-Cellulose", "DE": "CHROMATOGR DEAE CELLULOSE", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "DEAE-Cellulose Chromatography|T059|EQV|UNK (19XX)|740329|DEAE CELLULOSE CHROMATOGR|abdefv", "ENTRY": "DEAE Cellulose Chromatography", "MN": "E05.196.181.400.383.349", "MH_TH": "NLM (1970)", "ST": "T059", "PI": "Chromatography (1966-1969)", "MS": "A type of ion exchange chromatography using diethylaminoethyl cellulose (DEAE-CELLULOSE) as a positively charged resin. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D002848"}, {"RECTYPE": "D", "MH": "Chromatography, Gas", "DE": "CHROMATOGR GAS", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Chromatography, Gas-Liquid|T059|NON|REL|UNK (19XX)|781219|CHROMATOGR GAS LIQUID|abcdefv", "ENTRY": "Gas-Liquid Chromatography", "MN": "E05.196.181.349", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "usually NIM", "MS": "Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002849"}, {"RECTYPE": "D", "MH": "Chromatography, Gel", "DE": "CHROMATOGR GEL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Gel Filtration Chromatography|T059|NON|EQV|NLM (2003)|011219|GEL FILTRATION CHROMATOGR|abcdefv", "ENTRY": "Size Exclusion Chromatography", "MN": "E05.196.181.400.250", "MH_TH": "NLM (1976)", "ST": "T059", "MS": "Chromatography on non-ionic gels without regard to the mechanism of solute discrimination.", "OL": "use CHROMATOGRAPHY, GEL to search GEL FILTRATION 1966-75 & CHROMATOGRAPHY, EXCLUSION 1973-75", "PM": "76; was GEL FILTRATION 1966-75; CHROMATOGRAPHY, GEL was see under GEL FILTRATION 1966-75; CHROMATOGRAPHY, EXCLUSION was see under CHROMATOGRAPHY, GEL 1976, was see under GEL FILTRATION 1973-75", "HN": "76; was GEL FILTRATION 1966-75; CHROMATOGRAPHY, GEL was see under GEL FILTRATION 1966-75; CHROMATOGRAPHY, EXCLUSION was see under CHROMATOGRAPHY, GEL 1976, was see under GEL FILTRATION 1973-75", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D002850"}, {"RECTYPE": "D", "MH": "Chromatography, High Pressure Liquid", "DE": "CHROMATOGR HIGH PRESSURE LIQUID", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Ultra Performance Liquid Chromatography|T059|NON|NRW|NLM (2024)|230427|abcdef", "ENTRY": "Liquid Chromatography, High-Performance", "MN": "E05.196.181.400.300", "MH_TH": "NLM (1976)", "ST": "T059", "AN": "usually NIM", "PI": "Chromatography (1966-1975)", "MS": "Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed.", "OL": "use CHROMATOGRAPHY, HIGH PRESSURE LIQUID to search CHROMATOGRAPHY, HIGH SPEED LIQUID 1976-80", "PM": "81; was CHROMATOGRAPHY, HIGH SPEED LIQUID 1976-80", "HN": "81; was CHROMATOGRAPHY, HIGH SPEED LIQUID 1976-80", "CATSH": "CAT LIST", "MR": "20230526", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D002851"}, {"RECTYPE": "D", "MH": "Chromatography, Ion Exchange", "DE": "CHROMATOGR ION EXCHANGE", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Ion-Exchange Chromatographies", "MN": "E05.196.181.400.383", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "usually NIM", "MS": "Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002852"}, {"RECTYPE": "D", "MH": "Chromatography, Liquid", "DE": "CHROMATOGR LIQUID", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Liquid Chromatography|T059|NON|EQV|NLM (1995)|931012|LIQUID CHROMATOGR|abcdefv", "MN": "E05.196.181.400", "MH_TH": "NLM (1976)", "ST": "T059", "AN": "usually NIM", "PI": "Chromatography (1966-1975)", "MS": "Chromatographic techniques in which the mobile phase is a liquid.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D002853"}, {"RECTYPE": "D", "MH": "Chromatography, Paper", "DE": "CHROMATOGR PAPER", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Paper Chromatographies", "MN": "E05.196.181.400.454", "MH_TH": "NLM (1966)", "ST": "T059", "MS": "An analytical technique for resolution of a chemical mixture into its component compounds. Compounds are separated on an adsorbent paper (stationary phase) by their varied degree of solubility/mobility in the eluting solvent (mobile phase).", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002854"}, {"RECTYPE": "D", "MH": "Chromatography, Thin Layer", "DE": "CHROMATOGR THIN LAYER", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Thin-Layer Chromatography", "MN": "E05.196.181.400.537", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "usually NIM", "MS": "Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002855"}, {"RECTYPE": "D", "MH": "Chromatophores", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Chromatophore", "MN": "A11.436.265", "FX": "Pigmentation", "MH_TH": "NLM (1966)", "ST": "T025", "AN": "do not confuse with chromophores (chemical groups imparting color to a cpd); BACTERIAL CHROMATOPHORES is available", "MS": "The large pigment cells of fish, amphibia, reptiles and many invertebrates which actively disperse and aggregate their pigment granules. These cells include MELANOPHORES, erythrophores, xanthophores, leucophores and iridiophores. (In algae, chromatophores refer to CHLOROPLASTS. In phototrophic bacteria chromatophores refer to membranous organelles (BACTERIAL CHROMATOPHORES).)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002856"}, {"RECTYPE": "D", "MH": "Chromium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.175", "PA": "Trace Elements", "FX": "Chromium Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Chromium", "RN": "0R0008Q3JB", "RR": "7440-47-3 (Chromium)", "MS": "A trace element that plays a role in glucose metabolism. It has the atomic symbol Cr, atomic number 24, and atomic weight 52. According to the Fourth Annual Report on Carcinogens (NTP85-002,1985), chromium and some of its compounds have been listed as known carcinogens.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002857"}, {"RECTYPE": "D", "MH": "Chromium Alloys", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Nickel-Chromium Alloys|T122|T197|NON|NRW|UNK (19XX)|810513|abbcdef", "ENTRY": "Nickel Chromium Alloys", "MN": "J01.637.051.339.208.224", "FX": "Dental Materials", "MH_TH": "NLM (1965)", "ST": "T197", "RN": "0", "MS": "Specific alloys not less than 85% chromium and nickel or cobalt, with traces of either nickel or cobalt, molybdenum, and other substances. They are used in partial dentures, orthopedic implants, etc.", "OL": "use CHROMIUM ALLOYS to search CHROMIUM-COBALT ALLOYS 1966-81 thru 1966", "PM": "82; was CHROMIUM-COBALT ALLOYS 1965-81", "HN": "82; was CHROMIUM-COBALT ALLOYS 1965-81", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002858"}, {"RECTYPE": "D", "MH": "Chromium Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Chromium", "MN": "D01.552.544.175.500", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable chromium atoms that have the same atomic number as the element chromium, but differ in atomic weight. Cr-50, 53, and 54 are stable chromium isotopes.", "MR": "20170424", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002859"}, {"RECTYPE": "D", "MH": "Chromium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Chromium", "MN": "D01.552.544.175.500.349", "MH_TH": "NLM (1974)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "MS": "Unstable isotopes of chromium that decay or disintegrate emitting radiation. Cr atoms with atomic weights of 46-49, 51, 55, and 56 are radioactive chromium isotopes.", "OL": "search CHROMIUM ISOTOPES 1966-73", "PM": "74", "HN": "74", "MR": "20170424", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002860"}, {"RECTYPE": "D", "MH": "Chromobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.525.100", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid535", "AN": "in soil & water", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria occurring in soil and water. Its organisms are generally nonpathogenic, but some species do cause infections of mammals, including humans.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002861"}, {"RECTYPE": "D", "MH": "Chromoblastomycosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Dermatitis Verrucosa|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Chromomycoses", "MN": "C17.800.838.208.241", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "fungus dis of skin; coord IM with causative agent (IM)", "MS": "Scaly papule or warty growth, caused by five fungi, that spreads as a result of satellite lesions affecting the foot or leg. The extremity may become swollen and, at its distal portion, covered with various nodular, tumorous, verrucous lesions that resemble cauliflower. In rare instances, the disease may begin on the hand or wrist and involve the entire upper extremity. (Arnold, Odom, and James, Andrew's Diseases of the Skin, 8th ed, p362)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002862"}, {"RECTYPE": "D", "MH": "Chromogenic Compounds", "DE": "CHROMOGENIC CPDS", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Chromogenic Substrates|T130|NON|NRW|UNK (19XX)|800402|abcdef", "ENTRY": "Substrates, Chromogenic", "MN": "D27.720.470.410.200", "MH_TH": "NLM (1981)", "ST": "T130", "RN": "0", "MS": "Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens (not to be confused with pigment-synthesizing bacteria also called chromogens).", "PM": "81", "HN": "81", "MR": "20200527", "DA": "19800402", "DC": "1", "DX": "19810101", "UI": "D002863"}, {"RECTYPE": "D", "MH": "Chromogranins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Secretogranins|T116|T123|NON|EQV|NLM (2007)|abbcde", "ENTRY": "Granins|T116|T123|NON|EQV|NLM (2007)|050607|abbcdef", "MN": "D12.776.811.185", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1966-1972)", "MS": "A group of acidic proteins that are major components of SECRETORY GRANULES in the endocrine and neuroendocrine cells. They play important roles in the aggregation, packaging, sorting, and processing of secretory protein prior to secretion. They are cleaved to release biologically active peptides. There are various types of granins, usually classified by their sources.", "PM": "1991; see NERVE TISSUE PROTEINS 1973-1990; SECRETOGRANINS was indexed under CHROMOGRANINS 1985-2006", "HN": "1991(1973)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002864"}, {"RECTYPE": "D", "MH": "Chromomycins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chromomycin|T109|T121|T130|NON|NRW|UNK (19XX)|800523|abbbcdef", "MN": "D09.408.210", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "NLM (1972)", "ST": "T130", "RN": "0", "AN": "antineoplastic antibiotics", "PI": "Antibiotics, Antineoplastic (1967-1971)", "MS": "A complex of several closely related glycosidic antibiotics from Streptomyces griseus. The major component, CHROMOMYCIN A3, is used as a fluorescent stain of DNA where it attaches and inhibits RNA synthesis. It is also used as an antineoplastic agent, especially for solid tumors.", "PM": "73", "HN": "73(72)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002865"}, {"RECTYPE": "D", "MH": "Chromonar", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbocromen|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|741111|abbcdeef", "ENTRY": "Hydrochloride, Chromonar", "MN": "D03.633.100.150.446.280", "PA": "Vasodilator Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Acetic acid, ((3-(2-(diethylamino)ethyl)-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy)-, ethyl ester", "RN": "R0C9NIE5JJ", "RR": "804-10-4 (Chromonar)", "PI": "Glycolates (1970-1974)", "MS": "A coronary vasodilator agent.", "PM": "91; was see under COUMARINS 1975-90", "HN": "91(75); was see under COUMARINS 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002866"}, {"RECTYPE": "D", "MH": "Chromones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chromone|T109|NON|EQV|NLM (2021)|200106|abcdef", "ENTRY": "1,4 Benzopyrones", "MN": "D03.633.100.150.266", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with CHROMANS", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002867"}, {"RECTYPE": "D", "MH": "Chromosomal Proteins, Non-Histone", "DS": "CHROMOSOMAL PROTEINS NONHISTONE", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Non-Histone Chromosomal Proteins|T116|T123|NON|EQV|UNK (19XX)|770912|NONHISTONE CHROMOSOMAL PROTEINS|abbcdefs", "ENTRY": "Proteins, Non-Histone Chromosomal", "MN": "D12.776.664.235", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "PI": "Nucleoproteins (1966-1976)", "MS": "Nucleoproteins, which in contrast to HISTONES, are acid insoluble. They are involved in chromosomal functions; e.g. they bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens.", "PM": "77", "HN": "77", "MR": "20050630", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D002868"}, {"RECTYPE": "D", "MH": "Chromosome Aberrations", "AQ": "CI CL DE EM RE SN VE", "PRINT ENTRY": "Cytogenetic Aberrations|T049|NON|EQV|NLM (2003)|020520|abcdef", "ENTRY": "Cytogenetic Abnormality", "MN": "G05.365.590.175", "FX": "Cytogenetic Analysis", "MH_TH": "ORD (2010)", "ST": "T049", "AN": "coordinate IM with specific numbered chromosome or sex chromosome (IM) but not with CHROMOSOMES, HUMAN", "PI": "Chromosome Abnormalities (1966-1967)", "MS": "Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS.", "PM": "1968; for CHROMOSOME ABNORMALITIES see CHROMOSOME ABNORMALITIES 1963-2001; for AUTOSOME ABNORMALITIES see CHROMOSOME ABNORMALITIES 1963-2001", "HN": "1968; for CHROMOSOME ABNORMALITIES use CHROMOSOME ABERRATIONS 1963-2001 or CHROMOSOME DISORDERS 1963-2001; for AUTOSOME ABNORMALITIES use CHROMOSOME ABERRATIONS 1963-2001 or CHROMOSOME DISORDERS 1963-2001", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002869"}, {"RECTYPE": "D", "MH": "Chromosome Banding", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Banding, Chromosome|T059|T063|NON|EQV|UNK (19XX)|780313|abbcdef", "ENTRY": "Chromosome Bandings", "MN": "E05.393.285.130", "MH_TH": "NLM (1979)", "ST": "T063", "PI": "specific dye (1966-1978)", "MS": "Staining of bands, or chromosome segments, allowing the precise identification of individual chromosomes or parts of chromosomes. Applications include the determination of chromosome rearrangements in malformation syndromes and cancer, the chemistry of chromosome segments, chromosome changes during evolution, and, in conjunction with cell hybridization studies, chromosome mapping.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19780313", "DC": "1", "DX": "19790101", "UI": "D002871"}, {"RECTYPE": "D", "MH": "Chromosome Deletion", "PRINT ENTRY": "Partial Monosomy|T049|NON|REL|UNK (19XX)|840405|abcdef", "ENTRY": "Partial Monosomies", "MN": "G05.700.131.500.500", "FX": "Gene Deletion", "MH_TH": "NLM (1975)", "ST": "T049", "AN": "coordinate IM with specific numbered chromosome or sex chromosome (IM) but not with CHROMOSOMES, HUMAN", "PI": "Chromosome Abnormalities (1966-1967)", "MS": "Actual loss of portion of a chromosome.", "PM": "78; was see under CHROMOSOME ABERRATIONS 1975-77", "HN": "78(75); was see under CHROMOSOME ABERRATIONS 1975-77", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D002872"}, {"RECTYPE": "D", "MH": "Chromosome Fragility", "AQ": "DE ES GE IM PH RE", "ENTRY": "Fragility, Chromosome", "MN": "G05.370.180.180", "FX": "Trinucleotide Repeat Expansion", "MH_TH": "NLM (1982)", "ST": "T049", "PI": "Chromosomes (1966-1967)", "MS": "Susceptibility of chromosomes to breakage leading to translocation; CHROMOSOME INVERSION; SEQUENCE DELETION; or other CHROMOSOME BREAKAGE related aberrations.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19810223", "DC": "1", "DX": "19820101", "UI": "D002873"}, {"RECTYPE": "D", "MH": "Chromosome Mapping", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Linkage Mapping|T059|T063|NON|EQV|NLM (1990)|890511|abbcdef", "ENTRY": "Mappings, Linkage", "MN": "E05.393.183", "FX": "Synteny", "MH_TH": "NLM (1965)", "ST": "T063", "MS": "Any method used for determining the location of and relative distances between genes on a chromosome.", "PM": "1967; for GENOME MAPPING see HUMAN GENOME PROJECT 1990-2001", "HN": "1967(1965); for GENOME MAPPING use HUMAN GENOME PROJECT 1990-2001", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D002874"}, {"RECTYPE": "D", "MH": "Chromosomes", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "ENTRY": "Chromosome", "MN": "G05.360.162", "FX": "Karyotyping", "EC": "abnormalities:Chromosome Aberrations", "MH_TH": "NLM (1966)", "ST": "T026", "AN": "general or unspecified; prefer specifics", "MS": "In a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002875"}, {"RECTYPE": "D", "MH": "Chromosomes, Bacterial", "DE": "CHROMOSOMES BACT", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "ENTRY": "Chromosome, Bacterial|T026|NON|EQV|NLM (1992)|901103|CHROMOSOME BACT|abcdefv", "MN": "G05.360.162.190", "MH_TH": "NLM (1968)", "ST": "T026", "AN": "coordinate with specific bacterium /genet ", "PI": "Chromosomes (1966-1967)", "MS": "Structures within the nucleus of bacterial cells consisting of or containing DNA, which carry genetic information essential to the cell.", "PM": "68", "HN": "68", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002876"}, {"RECTYPE": "D", "MH": "Chromosomes, Human", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "ENTRY": "Human Chromosomes", "MN": "G05.360.162.520.300", "MH_TH": "NLM (1978)", "ST": "T026", "AN": "general or unspecified; prefer specifics; do not coord with pre-coord chromosome terms, such as CHROMOSOME ABERRATIONS; CHROMOSOMAL PROTEINS, NON-HISTONE; etc.: check tag HUMANS will serve for these", "PI": "Chromosomes (1966-1977)", "MS": "Very long DNA molecules and associated proteins, HISTONES, and non-histone chromosomal proteins (CHROMOSOMAL PROTEINS, NON-HISTONE). Normally 46 chromosomes, including two sex chromosomes are found in the nucleus of human cells. They carry the hereditary information of the individual.", "PM": "78", "HN": "78", "MR": "20130709", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D002877"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 1", "DS": "CHROMOSOMES HUMAN PAIR 01", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 1|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 01|abcdefs", "MN": "G05.360.162.520.300.235.240", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 1-3 (1968-1986)", "MS": "A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002878"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 10", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 10|T026|NON|EQV|UNK (19XX)|860619|abcdef", "MN": "G05.360.162.520.300.325.350", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 6-12 (1968-1986)", "MS": "A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002879"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 11", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 11|T026|NON|EQV|UNK (19XX)|860619|abcdef", "MN": "G05.360.162.520.300.325.355", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 6-12 (1968-1986)", "MS": "A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002880"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 12", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 12|T026|NON|EQV|UNK (19XX)|860619|abcdef", "MN": "G05.360.162.520.300.325.360", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 6-12 (1968-1986)", "MS": "A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002881"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 13", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 13|T026|NON|EQV|UNK (19XX)|860619|abcdef", "MN": "G05.360.162.520.300.370.375", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 13-15 (1968-1986)", "MS": "A specific pair of GROUP D CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002882"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 14", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 14|T026|NON|EQV|UNK (19XX)|860619|abcdef", "MN": "G05.360.162.520.300.370.380", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 13-15 (1968-1986)", "MS": "A specific pair of GROUP D CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002883"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 15", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 15|T026|NON|EQV|UNK (19XX)|860619|abcdef", "MN": "G05.360.162.520.300.370.385", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 13-15 (1968-1986)", "MS": "A specific pair of GROUP D CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002884"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 16", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 16|T026|NON|EQV|UNK (19XX)|860619|abcdef", "MN": "G05.360.162.520.300.415.420", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 16-18 (1968-1986)", "MS": "A specific pair of GROUP E CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002885"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 17", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 17|T026|NON|EQV|UNK (19XX)|860619|abcdef", "MN": "G05.360.162.520.300.415.425", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 16-18 (1968-1986)", "MS": "A specific pair of GROUP E CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002886"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 18", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 18|T026|NON|EQV|UNK (19XX)|860619|abcdef", "MN": "G05.360.162.520.300.415.430", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 16-18 (1968-1986)", "MS": "A specific pair of GROUP E CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002887"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 19", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 19|T026|NON|EQV|UNK (19XX)|860619|abcdef", "MN": "G05.360.162.520.300.460.465", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 19-20 (1968-1986)", "MS": "A specific pair of GROUP F CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002888"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 2", "DS": "CHROMOSOMES HUMAN PAIR 02", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 2|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 02|abcdefs", "MN": "G05.360.162.520.300.235.245", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 1-3 (1968-1986)", "MS": "A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002889"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 20", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 20|T026|NON|EQV|UNK (19XX)|860619|abcdef", "MN": "G05.360.162.520.300.460.470", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 19-20 (1968-1986)", "MS": "A specific pair of GROUP F CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002890"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 21", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 21|T026|NON|EQV|UNK (19XX)|860619|abcdef", "MN": "G05.360.162.520.300.505.510", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 21-22 (1968-1986)", "MS": "A specific pair of GROUP G CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002891"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 22", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 22|T026|NON|EQV|UNK (19XX)|860619|abcdef", "MN": "G05.360.162.520.300.505.515", "FX": "Philadelphia Chromosome", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 21-22 (1968-1986)", "MS": "A specific pair of GROUP G CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002892"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 3", "DS": "CHROMOSOMES HUMAN PAIR 03", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 3|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 03|abcdefs", "MN": "G05.360.162.520.300.235.250", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 1-3 (1968-1986)", "MS": "A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002893"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 4", "DS": "CHROMOSOMES HUMAN PAIR 04", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 4|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 04|abcdefs", "MN": "G05.360.162.520.300.280.285", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 4-5 (1968-1986)", "MS": "A specific pair of GROUP B CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002894"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 5", "DS": "CHROMOSOMES HUMAN PAIR 05", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 5|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 05|abcdefs", "MN": "G05.360.162.520.300.280.290", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 4-5 (1968-1986)", "MS": "One of the two pairs of human chromosomes in the group B class (CHROMOSOMES, HUMAN, 4-5).", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002895"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 6", "DS": "CHROMOSOMES HUMAN PAIR 06", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 6|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 06|abcdefs", "MN": "G05.360.162.520.300.325.330", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 6-12 (1968-1986)", "MS": "A specific pair GROUP C CHROMSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002896"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 7", "DS": "CHROMOSOMES HUMAN PAIR 07", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 7|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 07|abcdefs", "MN": "G05.360.162.520.300.325.335", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 6-12 (1968-1986)", "MS": "A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002897"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 8", "DS": "CHROMOSOMES HUMAN PAIR 08", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 8|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 08|abcdefs", "MN": "G05.360.162.520.300.325.340", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 6-12 (1968-1986)", "MS": "A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002898"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Pair 9", "DS": "CHROMOSOMES HUMAN PAIR 09", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosome 9|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 09|abcdefs", "MN": "G05.360.162.520.300.325.345", "MH_TH": "NLM (1987)", "ST": "T026", "PI": "Chromosomes, Human, 6-12 (1968-1986)", "MS": "A specific pair of GROUP C CHROMSOMES of the human chromosome classification.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D002899"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, 1-3", "DS": "CHROMOSOMES HUMAN 01 03", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosomes A|T026|NON|EQV|UNK (19XX)|760512|abcdef", "ENTRY": "Group A Chromosome", "MN": "G05.360.162.520.300.235", "MH_TH": "NLM (1968)", "ST": "T026", "PI": "Chromosomes (1966-1967)", "MS": "The large, metacentric human chromosomes, called group A in the human chromosome classification. This group consists of chromosome pairs 1, 2, and 3.", "PM": "68", "HN": "68", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002900"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, 13-15", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Group D Chromosomes|T026|NON|EQV|NLM (2002)|010104|abcdef", "ENTRY": "Group D Chromosome", "MN": "G05.360.162.520.300.370", "MH_TH": "NLM (1968)", "ST": "T026", "PI": "Chromosomes (1966-1967)", "MS": "The medium-sized, acrocentric human chromosomes, called group D in the human chromosome classification. This group consists of chromosome pairs 13, 14, and 15.", "PM": "68", "HN": "68", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002901"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, 16-18", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Chromosomes E|T026|NON|EQV|UNK (19XX)|760512|abcdef", "ENTRY": "Group E Chromosome", "MN": "G05.360.162.520.300.415", "MH_TH": "NLM (1968)", "ST": "T026", "PI": "Chromosomes (1966-1967)", "MS": "The short, submetacentric human chromosomes, called group E in the human chromosome classification. This group consists of chromosome pairs 16, 17, and 18.", "PM": "68", "HN": "68", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002902"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, 19-20", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Group F Chromosomes|T026|NON|EQV|NLM (2002)|010104|abcdef", "ENTRY": "Group F Chromosome", "MN": "G05.360.162.520.300.460", "MH_TH": "NLM (1968)", "ST": "T026", "PI": "Chromosomes (1966-1967)", "MS": "The short, metacentric human chromosomes, called group F in the human chromosome classification. This group consists of chromosome pairs 19 and 20.", "PM": "68", "HN": "68", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002903"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, 21-22 and Y", "DE": "CHROMOSOMES HUMAN 21 22 Y", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Group G Chromosomes|T026|NON|EQV|NLM (2002)|010104|abcdef", "ENTRY": "Group G Chromosome", "MN": "G05.360.162.520.300.505", "MH_TH": "NLM (2002)", "ST": "T026", "PI": "Chromosomes (1966-1967)", "MS": "The short, acrocentric human chromosomes, called group G in the human chromosome classification. This group consists of chromosome pairs 21 and 22 and the Y chromosome.", "PM": "2001; see CHROMOSOMES, HUMAN, 21-22 1968-2001", "HN": "2001(1968)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002904"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, 4-5", "DS": "CHROMOSOMES HUMAN 04 05", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Group B Chromosomes|T026|NON|EQV|NLM (2002)|010104|abcdef", "ENTRY": "Group B Chromosome", "MN": "G05.360.162.520.300.280", "MH_TH": "NLM (1968)", "ST": "T026", "PI": "Chromosomes (1966-1967)", "MS": "The large, submetacentric human chromosomes, called group B in the human chromosome classification. This group consists of chromosome pairs 4 and 5.", "PM": "68", "HN": "68", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002905"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, 6-12 and X", "DE": "CHROMOSOMES HUMAN 6 12 X", "DS": "CHROMOSOMES HUMAN 06 12", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Group C Chromosomes|T026|NON|EQV|NLM (2002)|010104|abcdef", "ENTRY": "Group C Chromosome", "MN": "G05.360.162.520.300.325", "MH_TH": "NLM (2002)", "ST": "T026", "PI": "Chromosomes (1966-1967)", "MS": "The medium-sized, submetacentric human chromosomes, called group C in the human chromosome classification. This group consists of chromosome pairs 6, 7, 8, 9, 10, 11, and 12 and the X chromosome.", "PM": "2002; see CHROMOSOMES, HUMAN, 6-12 1968-2001", "HN": "2002(1968)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002906"}, {"RECTYPE": "D", "MH": "Chronaxy", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Chronaxie|T042|NON|EQV|NLM (1994)|930407|abcdef", "MN": "G11.561.175", "MH_TH": "NLM (1965)", "ST": "T042", "MS": "The shortest duration of an electrical stimulus where the threshold amplitude is twice the rheobase - the minimum required for eliciting an ACTION POTENTIAL at any time period. It is a measure of the excitability of nerve or muscle tissue, and is characteristic of types and/or condition of the nerve or muscle cells in the tissue.", "PM": "70", "HN": "70(65)", "CATSH": "CAT LIST", "MR": "20140616", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D002907"}, {"RECTYPE": "D", "MH": "Chronic Disease", "DE": "CHRONIC DIS", "AQ": "CL DT EC EH EP HI LJ MO NU PC PX RH TD TH VE", "PRINT ENTRY": "Chronic Illness|T047|NON|EQV|NLM (1992)|910429|abcdef", "ENTRY": "Illness, Chronic", "MN": "C23.550.291.500", "FX": "Persistent Infection", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "IM general only; usually NIM with specific disease IM", "MS": "Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).", "CATSH": "CAT LIST", "MR": "20210312", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002908"}, {"RECTYPE": "D", "MH": "Chronobiology Phenomena", "AQ": "DE GE IM PH RE", "ENTRY": "Phenomenon, Chronobiology", "MN": "G07.180", "FX": "Sleep Phase Chronotherapy", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "PI": "Periodicity (1966-1985)", "MS": "Biological systems as affected by time. Aging, biological rhythms, and cyclic phenomena are included. Statistical, computer-aided mathematical procedures are used to describe, in mathematical terminology, various biological functions over time.", "PM": "2009; see CHRONOBIOLOGY 1986-2008", "HN": "2009 (1986)", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19850619", "DC": "1", "DX": "19860101", "UI": "D002909"}, {"RECTYPE": "D", "MH": "Chronology as Topic", "ENTRY": "Chronology as Topics", "MN": "G01.910.200", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with TIME; TIME FACTORS or TIME PERCEPTION; do not confuse with the  Publication Type CHRONOLOGY", "MS": "Works about the temporal sequence of events.", "PM": "2008; see CHRONOLOGY 1963-2007", "HN": "2008(1963)", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D002910"}, {"RECTYPE": "D", "MH": "Chrysenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.723.180", "MH_TH": "NLM (1976)", "ST": "T109", "RN": "0", "AN": "hydrocarbons from coal tar", "PI": "Phenanthrenes (1969-1975)", "MS": "1,2-Benzphenanthrenes. POLYCYCLIC COMPOUNDS obtained from coal tar.", "PM": "91; was see under PHENANTHRENES 1976-90", "HN": "91(76); was see under PHENANTHRENES 1976-90", "MR": "20150623", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D002911"}, {"RECTYPE": "D", "MH": "Chrysosporium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Emmonsia|T004|NON|EQV|UNK (19XX)|850211|abcdef", "ENTRY": "Emmonsias", "MN": "B01.300.381.170", "FX": "Onygenales", "MH_TH": "NLM (1986)", "ST": "T004", "RN": "txid40411", "AN": "infection: coordinate IM with MYCOSES (IM) or specific mycosis (IM)", "PI": "Hyphomycetes (1966-1985)", "MS": "A mitosporic Onygenaceae fungal genus which causes adiaspiromycosis, a pulmonary mycosis of man and rodents. One of its teleomorphs is Ajellomyces.", "PM": "91; see HYPHOMYCETES 1986-90; for EMMONSIA see MONILIALES 1975-85", "HN": "91(86); for EMMONSIA use MITOSPORIC FUNGI 1975-85", "MR": "20200813", "DA": "19850211", "DC": "1", "DX": "19910101", "UI": "D002912"}, {"RECTYPE": "D", "MH": "Chyle", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Chyles", "MN": "A15.382.520.150.350", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "chyluria: index CHYLE (IM) + URINE (NIM)", "MS": "An opaque, milky-white fluid consisting mainly of emulsified fats that passes through the lacteals of the small intestines into the lymphatic system.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002913"}, {"RECTYPE": "D", "MH": "Chylomicrons", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chylomicron|T109|T116|T123|NON|EQV|NLM (2021)|191118|abbbcdef", "MN": "D12.776.521.242", "MH_TH": "NLM (1963)", "ST": "T123", "RN": "0", "MS": "A class of lipoproteins that carry dietary CHOLESTEROL and TRIGLYCERIDES from the SMALL INTESTINE to the tissues. Their density (0.93-1.006 g/ml) is the same as that of VERY-LOW-DENSITY LIPOPROTEINS.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002914"}, {"RECTYPE": "D", "MH": "Chylous Ascites", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Peritonitis, Chylous|T047|NON|NRW|NLM (1998)|960715|abcdef", "MN": "C06.844.200", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Presence of milky lymph (CHYLE) in the PERITONEAL CAVITY, with or without infection.", "PM": "2005; see CHYLOPERITONEUM 1966-2004", "HN": "2005 (1966)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D002915"}, {"RECTYPE": "D", "MH": "Chylothorax", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C08.528.142", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "chyle in thoracic cavity", "MS": "The presence of chyle in the thoracic cavity. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20021023", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002916"}, {"RECTYPE": "D", "MH": "Chymopapain", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Discase|T116|T126|TRD|NRW|UNK (19XX)|830330|abbcdef", "MN": "D08.811.277.656.300.200.160", "MH_TH": "USAN (1971)", "ST": "T126", "N1": "Chymopapain", "RN": "EC 3.4.22.6", "RR": "9001-09-6 (CAS RN)", "PI": "Papain (1973-1974)", "MS": "A cysteine endopeptidase isolated from papaya latex. Preferential cleavage at glutamic and aspartic acid residues. EC 3.4.22.6.", "PM": "86; was see under PEPTIDE PEPTIDOHYDROLASES 1975-85", "HN": "86(75); was see under PEPTIDE PEPTIDOHYDROLASES 1975-85", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D002917"}, {"RECTYPE": "D", "MH": "Chymotrypsin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Avazyme|T116|T121|T126|TRD|NRW|US|041222|abbbcdef", "MN": "D08.811.277.656.959.350.176", "MH_TH": "USP (19XX)", "ST": "T126", "N1": "Chymotrypsin", "RN": "EC 3.4.21.1", "RR": "9004-07-3 (CAS RN)", "AN": "/antag: consider also ALPHA 1-ANTICHYMOTRYPSIN", "MS": "A serine endopeptidase secreted by the pancreas as its zymogen, CHYMOTRYPSINOGEN and carried in the pancreatic juice to the duodenum where it is activated by TRYPSIN. It selectively cleaves aromatic amino acids on the carboxyl side.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002918"}, {"RECTYPE": "D", "MH": "Chymotrypsinogen", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta, Chymotrypsinogen", "MN": "D12.776.811.243.184", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "Chymotrypsinogen", "RN": "9035-75-0", "AN": "an enzyme precursor", "PI": "Enzyme Precursors (1966-1971)", "PM": "72", "HN": "72", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002919"}, {"RECTYPE": "D", "MH": "Cialit", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.221.370", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Mercurate(1-), (2,3-dihydro-2-thioxo-5-benzoxazolecarboxylato(2-)-S)ethyl-, sodium", "RN": "16509-11-8", "PI": "Sulfides (1972-1974)", "MS": "Tissue preservative.", "PM": "91; was see under ETHYLMERCURY COMPOUNDS 1980-90; was see under ETHYL MERCURY COMPOUNDS 1975-79", "HN": "91(75); was see under ETHYLMERCURY COMPOUNDS 1980-90; was see under ETHYL MERCURY COMPOUNDS 1975-79", "MR": "20160528", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D002920"}, {"RECTYPE": "D", "MH": "Cicatrix", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Scars|T020|T024|T033|NON|EQV|UNK (19XX)|740329|abbbcdef", "ENTRY": "Scarring|T042|NON|REL|NLM (2009)|071015|abcdef", "MN": "G16.762.891.249", "FX": "Keloid", "MH_TH": "NLM (1966)", "ST": "T033", "AN": "CICATRIX, HYPERTROPHIC is also available; do not confuse entry term SCARRING with scarification (scratching open the surface of the skin purposely for VACCINATION; BODY MODIFICATION, NON-THERAPEUTIC; etc.)", "MS": "The fibrous tissue that replaces normal tissue during the process of WOUND HEALING.", "CATSH": "CAT LIST", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002921"}, {"RECTYPE": "D", "MH": "Ciguatoxins", "AQ": "AA AD AE AG AI AN BL CF CH CL CS DF EC HI IM IP ME PD PK RE SD ST TO TU UR", "PRINT ENTRY": "Ciguatoxin|T123|T131|NON|EQV|NLM (1978)|990101|abbcdef", "MN": "D23.946.580.800.500", "PA": "Poisons", "EC": "poisoning:Ciguatera Poisoning", "MH_TH": "NLM (2003)", "ST": "T131", "RN": "11050-21-8", "AN": "/antag permitted but consider also ANTITOXINS; coordinate IM with source of ciguatoxin", "PI": "Toxins (1966-1973)", "MS": "Polycyclic ethers produced by Gambierdiscus (DINOFLAGELLATES) from gambiertoxins, which are ingested by fish which in turn may be ingested by humans who are susceptible to the CIGUATERA POISONING.", "PM": "2003; see CIGUATOXIN 1991-2002, see MARINE TOXINS 1978-1990", "HN": "1991(1978)", "MR": "20230607", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D002922"}, {"RECTYPE": "D", "MH": "Cilia", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Primary Cilium|T026|NON|NRW|NLM (2021)|191119|abcdef", "ENTRY": "Cilium, Primary", "MN": "A11.284.180.165", "FX": "Epithelium", "MH_TH": "NLM (1964)", "ST": "T026", "MS": "Populations of thin, motile processes found covering the surface of ciliates (CILIOPHORA) or the free surface of the cells making up ciliated EPITHELIUM. Each cilium arises from a basic granule in the superficial layer of CYTOPLASM. The movement of cilia propels ciliates through the liquid in which they live. The movement of cilia on a ciliated epithelium serves to propel a surface layer of mucus or fluid. (King & Stansfield, A Dictionary of Genetics, 4th ed)", "PM": "65", "HN": "65(64)", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002923"}, {"RECTYPE": "D", "MH": "Ciliary Body", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Corpus Ciliari", "MN": "A09.371.894.280", "FX": "Trabeculectomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A ring of tissue extending from the scleral spur to the ora serrata of the RETINA. It consists of the uveal portion and the epithelial portion. The ciliary muscle is in the uveal portion and the ciliary processes are in the epithelial portion.", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002924"}, {"RECTYPE": "D", "MH": "Ciliary Motility Disorders", "DE": "CILIARY MOTILITY DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Immotile Cilia Syndrome|T047|NON|NRW|GHR (2014)|ORD (2010)|UNK (19XX)|830311|abcdeeef", "ENTRY": "Immotile Cilia Syndromes", "MN": "C16.320.184.500", "MH_TH": "NLM (1984)", "ST": "T047", "PI": "Nasal Mucosa (1966-1983)", "MS": "Conditions caused by abnormal CILIA movement in the body, usually causing KARTAGENER SYNDROME, chronic respiratory disorders, chronic SINUSITIS, and chronic OTITIS. Abnormal ciliary beating is likely due to defects in any of the 200 plus ciliary proteins, such as missing motor enzyme DYNEIN arms.", "PM": "1984; for Ciliary Dyskinesia, Primary see Kartagener Syndrome 2014-2018", "HN": "1984; for Ciliary Dyskinesia, Primary use Kartagener Syndrome 2014-2018", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19830311", "DC": "1", "DX": "19840101", "UI": "D002925"}, {"RECTYPE": "D", "MH": "Cimetidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SKF92334", "MN": "D03.383.129.308.130", "PA": "Histamine H2 Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Guanidine, N-cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)-", "RN": "80061L1WGD", "RR": "WF10491673", "PI": "Imidazoles (1966-1977)", "MS": "A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.", "PM": "84; was see under GUANIDINES 1978-83", "HN": "84(78); was see under GUANIDINES 1978-83", "MR": "20160528", "DA": "19770422", "DC": "1", "DX": "19840101", "UI": "D002927"}, {"RECTYPE": "D", "MH": "Cinanserin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SQ16,167", "MN": "D02.241.223.200.200", "PA": "Serotonin Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Propenamide, N-(2-((3-(dimethylamino)propyl)thio)phenyl)-3-phenyl-", "RN": "KI6J9OY7A3", "RR": "F65Z32KI62", "PI": "Sulfides (1974)", "MS": "A serotonin antagonist with limited antihistaminic, anticholinergic, and immunosuppressive activity.", "PM": "91; was see under CINNAMATES 1975-90", "HN": "91(75); was see under CINNAMATES 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D002928"}, {"RECTYPE": "D", "MH": "Cinchona", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Peruvian Bark|T002|EPO|REL|NLM (2006)|050207|abcdef", "ENTRY": "Red Cinchonas", "MN": "B01.875.800.575.912.250.456.937.250", "FX": "Cinchona Alkaloids", "MH_TH": "NLM (1966)", "ST": "T002", "RN": "txid43462", "RR": "txid50278", "MS": "A genus of rubiaceous South American trees that yields the toxic CINCHONA ALKALOIDS from their bark; QUININE; QUINIDINE; chinconine, cinchonidine and others are used to treat MALARIA and CARDIAC ARRHYTHMIAS.", "HN": "was in Cat B & D 1963-76", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002929"}, {"RECTYPE": "D", "MH": "Cinchona Alkaloids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Alkaloids, Cinchona", "MN": "D03.132.206", "MH_TH": "NLM (1977)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Cinchona (1966-1976)", "MS": "Alkaloids extracted from various species of Cinchona.", "PM": "77", "HN": "77", "MR": "19920511", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D002930"}, {"RECTYPE": "D", "MH": "Cineangiography", "DE": "CINEANGIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Cineangiographies", "MN": "E01.370.370.050.190", "MH_TH": "NLM (1964)", "ST": "T060", "MS": "Motion pictures of the passage of contrast medium through blood vessels.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002932"}, {"RECTYPE": "D", "MH": "Cineradiography", "DE": "CINERADIOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Radiocinematography|T060|NON|EQV|UNK (19XX)|740329|RADIOCINEMATOGR|abcdefv", "ENTRY": "Radiocinematographies", "MN": "E01.370.350.700.225.469", "MH_TH": "NLM (1973)", "ST": "T060", "MS": "Motion picture study of successive images appearing on a fluoroscopic screen.", "OL": "use CINERADIOGRAPHY to search CINEFLUOROGRAPHY 1966-72", "PM": "73; was CINEFLUOROGRAPHY 1963-72", "HN": "73; was CINEFLUOROGRAPHY 1963-72", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002933"}, {"RECTYPE": "D", "MH": "Cinnamates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cinnamate|T109|NON|EQV|NLM (2021)|200227|abcdef", "MN": "D02.241.223.200", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of cinnamic acid (the structural formula: phenyl-HC=CH-COO-), including its salts and esters.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002934"}, {"RECTYPE": "D", "MH": "Cinnamomum zeylanicum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cinnamon|T168|NON|REL|NLM (1975)|990101|abcdef", "ENTRY": "Cinnamons", "MN": "B01.875.800.575.912.250.595.400.149.500", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid128608", "MS": "The tree which is known for its bark which is sold as cinnamon. The oil contains about 65-80% cinnamaldehyde and 10% EUGENOL and many TERPENES.", "PM": "2002; see CINNAMON 1991-2001, see CONDIMENTS 1975-1990;", "HN": "2002(1975)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002935"}, {"RECTYPE": "D", "MH": "Cinnarizine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Von Ct, Cinnarizin", "MN": "D03.383.606.290", "PA": "Histamine H1 Antagonists", "MH_TH": "USAN (1962)", "ST": "T121", "N1": "Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-", "RN": "3DI2E1X18L", "RR": "86349-62-4 (L-tartrate (1:1))", "PI": "Piperazines (1968-1974)", "MS": "A piperazine derivative having histamine H1-receptor and calcium-channel blocking activity with vasodilating and antiemetic properties but it induces PARKINSONIAN DISORDERS.", "PM": "86; see PIPERAZINES 1975-85", "HN": "86(75)", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D002936"}, {"RECTYPE": "D", "MH": "Cinoxacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Azolinic Acid|T109|T121|NON|EQV|UNK (19XX)|790301|abbcdef", "ENTRY": "Acid, Azolinic", "MN": "D03.633.300.160", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "(1,3)Dioxolo(4,5-g)cinnoline-3-carboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-", "RN": "LMK22VUH23", "RR": "28657-80-9 (Cinoxacin)", "PI": "Pyridazines (1966-1979)", "MS": "Synthetic antimicrobial related to OXOLINIC ACID and NALIDIXIC ACID and used in URINARY TRACT INFECTIONS.", "PM": "91; was see under PYRIDAZINES 1980-90", "HN": "91(80); was see under PYRIDAZINES 1980-90", "MR": "20160701", "DA": "19790301", "DC": "1", "DX": "19910101", "UI": "D002937"}, {"RECTYPE": "D", "MH": "Ciona intestinalis", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Yellow Sea Squirts", "MN": "B01.050.500.272.727.150.500", "MH_TH": "NLM (1975)", "ST": "T008", "RN": "txid7719", "RR": "txid1774208", "MS": "Vase or tube shaped TUNICATES with a cosmopolitan distribution.", "PM": "91; was see under UROCHORDATA 1975-90", "HN": "91(75); was see under UROCHORDATA 1975-90", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D002938"}, {"RECTYPE": "D", "MH": "Ciprofloxacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride Monohydrate, Ciprofloxacin", "MN": "D03.633.100.810.835.322.186", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-", "RN": "5E8K9I0O4U", "RR": "86393-32-0 (Ciprofloxacin Hydrochloride)", "PI": "Quinolines (1966-1986)", "MS": "A broad-spectrum antimicrobial carboxyfluoroquinoline.", "PM": "87", "HN": "87", "MR": "20160528", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D002939"}, {"RECTYPE": "D", "MH": "Circadian Rhythm", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Twenty-Four Hour Rhythm|T079|NON|EQV|UNK (19XX)|850619|abcdef", "ENTRY": "Twenty-Four Hour Rhythms", "MN": "G07.180.562.190", "FX": "Photoperiod", "MH_TH": "NLM (1964)", "ST": "T079", "MS": "The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli.", "PM": "66; DIURNAL RHYTHM was see under CIRCADIAN RHYTHM 1975-85", "HN": "66(64); DIURNAL RHYTHM was see under CIRCADIAN RHYTHM 1975-85 (Prov 1969-74)", "CATSH": "CAT LIST", "MR": "20160226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002940"}, {"RECTYPE": "D", "MH": "Circle of Willis", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Willis' Circle|T023|EPO|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Willis Circle", "MN": "A07.015.114.228.351", "MH_TH": "NLM (1965)", "ST": "T023", "MS": "A polygonal anastomosis at the base of the brain formed by the internal carotid (CAROTID ARTERY, INTERNAL), proximal parts of the anterior, middle, and posterior cerebral arteries (ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; POSTERIOR CEREBRAL ARTERY), the anterior communicating artery and the posterior communicating arteries.", "PM": "65", "HN": "65", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002941"}, {"RECTYPE": "D", "MH": "Circular Dichroism", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Circular Dichroism, Vibrational|T059|NON|NRW|NLM (2003)|010913|abcdef", "ENTRY": "Vibrational Circular Dichroism", "MN": "E05.196.867.151", "MH_TH": "NLM (1970)", "ST": "T070", "PI": "Spectrum Analysis (1966-1969)", "MS": "A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "91; was see under SPECTRUM ANALYSIS 1970-90", "HN": "91(70); was see under SPECTRUM ANALYSIS 1970-90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002942"}, {"RECTYPE": "D", "MH": "Circulatory and Respiratory Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Circulatory and Respiratory Physiology|T040|NON|EQV|NLM (1974)|990101|CIRC RESPIRATORY PHYSIOL|abcdefv", "ENTRY": "Physiology, Circulatory and Respiratory|T040|NON|EQV|NLM (1998)|970502|PHYSIOL CIRC RESPIRATORY|abcdefv", "MN": "G09", "RH": "G9 - PHYSIOLOGICAL PHENOMENA-CIRCULATORY AND RESPIRATORY", "MH_TH": "NLM (2009)", "ST": "T040", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "PI": "Respiration (1966-1997)", "MS": "Functional processes and properties characteristic of the BLOOD; CARDIOVASCULAR SYSTEM; and RESPIRATORY SYSTEM.", "PM": "2009; see CIRCULATORY AND RESPIRATORY PHYSIOLOGY 1998-2008", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D002943"}, {"RECTYPE": "D", "MH": "Circumcision, Male", "AQ": "AE CL EC ED EH ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Male Circumcisions", "MN": "E04.950.774.860.226", "FX": "Foreskin", "MH_TH": "NLM (2007)", "ST": "T061", "MS": "Excision of the prepuce of the penis (FORESKIN) or part of it.", "PM": "2007; see CIRCUMCISION 1966-2006", "HN": "2007(1966)", "CATSH": "CAT LIST", "MR": "20150901", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D002944"}, {"RECTYPE": "D", "MH": "Cisplatin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "cis-Dichlorodiammineplatinum(II)|T121|T197|NON|EQV|UNK (19XX)|770304|DICHLORODIAMMINEPLATINUM CIS 02|abbcdefs", "ENTRY": "cis Platinum", "MN": "D01.710.100", "PA": "Radiation-Sensitizing Agents", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Platinum, diamminedichloro-, (SP-4-2)-", "RN": "Q20Q21Q62J", "RR": "15663-27-1 (Cisplatin)", "PI": "Platinum (1966-1973)", "MS": "An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.", "OL": "use CISPLATIN to search PLATINUM DIAMMINODICHLORIDE 1974-80 & DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1974-83", "PM": "84; was see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1981-83; was PLATINUM DIAMMINODICHLORIDE see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1974-80; DIAMMONIUM CHLOROPLATINUM COMPOUNDS was heading 1974-83", "HN": "84(81); was see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1981-83; was PLATINUM DIAMMINODICHLORIDE see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1974-80; DIAMMONIUM CHLOROPLATINUM COMPOUNDS was heading 1974-83", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D002945"}, {"RECTYPE": "D", "MH": "Cisterna Magna", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Magna, Cisterna", "MN": "A08.186.566.166.686.351", "FX": "Ventriculostomy", "MH_TH": "NLM (1966)", "ST": "T030", "AN": "/surg: VENTRICULOCISTERNOSTOMY see VENTRICULOSTOMY is also available", "MS": "One of three principal openings in the SUBARACHNOID SPACE. They are also known as cerebellomedullary cistern, and collectively as cisterns.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002946"}, {"RECTYPE": "D", "MH": "Cities", "AQ": "CL EC EH EP HI LJ SN", "PRINT ENTRY": "Municipalities|T083|NON|BRD|NLM (1999)|980520|abcdef", "ENTRY": "Towns|T067|NON|REL|NLM (2019)|180525|abcdef", "MN": "Z01.433", "FX": "Urbanization", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "IM for cities as sociological or population entities; specific indentions are available (NIM only) for epidemiological or ethnological studies; URBANIZATION is available for the development from rural to urban society; URBAN POPULATION and URBAN HEALTH are also available ", "PI": "specific city (1966-1997)", "MS": "A large or important municipality of a country, usually a major metropolitan center.", "HN": "98; use explode 1967-97", "MR": "20180525", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D002947"}, {"RECTYPE": "D", "MH": "Citraconic Anhydrides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylmaleic Anhydrides|T109|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Anhydrides, Methylmaleic", "MN": "D03.383.312.250", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "RR": "616-02-4 (citraconic anhydride)", "PI": "Maleates (1972-1974)", "MS": "Methylmaleic anhydrides.", "OL": "use CITRACONIC ANHYDRIDES to search CITRACONIC ANHYDRIDE 1975-78", "PM": "91; was see under FURANS 1979-90; was CITRACONIC ANHYDRIDE see under FURANS 1977-78 & see under MALEATES 1975-76", "HN": "91(79); was see under FURANS 1979-90; was CITRACONIC ANHYDRIDE see under FURANS 1977-78 & see under MALEATES 1975-76", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002949"}, {"RECTYPE": "D", "MH": "Citrate (si)-Synthase", "DS": "CITRATE SYNTHASE SI", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Citrate Synthase|T116|T126|NON|EQV|NLM (1998)|961118|abbcdef", "ENTRY": "Synthase, Citrate", "MN": "D08.811.913.050.368", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Citrate oxaloacetate-lyase ((pro-3S)-CH2COO(-)--acetyl-CoA)", "RN": "EC 2.3.3.1", "MS": "Enzyme that catalyzes the first step of the tricarboxylic acid cycle (CITRIC ACID CYCLE). It catalyzes the reaction of oxaloacetate and acetyl CoA to form citrate and coenzyme A. This enzyme was formerly listed as EC 4.1.3.7.", "PM": "98; see CITRATE SYNTHASE 1991-97, see KETOACID-LYASES 1973-90", "HN": "98(73)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002950"}, {"RECTYPE": "D", "MH": "Citrates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D02.241.081.901.434", "FX": "Citric Acid Cycle", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "/metab: consider also CITRIC ACID CYCLE", "MS": "Derivatives of CITRIC ACID.", "PM": "RENACIDIN was see under PHARMACEUTIC AIDS 1964-80", "HN": "RENACIDIN was see under PHARMACEUTIC AIDS 1964-80 (Prov 1964-74)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D002951"}, {"RECTYPE": "D", "MH": "Citric Acid Cycle", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Tricarboxylic Acid Cycle|T044|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Tricarboxylic Acid Cycles", "MN": "G03.493.170", "MH_TH": "NLM (1966)", "ST": "T044", "MS": "A series of oxidative reactions in the breakdown of acetyl units derived from GLUCOSE; FATTY ACIDS; or AMINO ACIDS by means of tricarboxylic acid intermediates. The end products are CARBON DIOXIDE, water, and energy in the form of phosphate bonds.", "OL": "use CITRIC ACID CYCLE to search KREBS CYCLE 1966-84", "PM": "85; was KREBS CYCLE 1963-84", "HN": "85; was KREBS CYCLE 1963-84", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D002952"}, {"RECTYPE": "D", "MH": "Citrinin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.946.587.272", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1975)", "ST": "T195", "N1": "3H-2-Benzopyran-7-carboxylic acid, 4,6-dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-, (3R-trans)-", "RN": "3S697X6SNZ", "RR": "518-75-2 (Citrinin)", "PI": "Benzopyrans (1969-1974)", "MS": "Antibiotic and mycotoxin from Aspergillus niveus and Penicillium citrinum.", "PM": "91; was see under BENZOPYRANS 1975-90", "HN": "91(75); was see under BENZOPYRANS 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002953"}, {"RECTYPE": "D", "MH": "Citrobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.100", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid544", "AN": "in soil, water & sometimes intestine; infection: coordinate with ENTEROBACTERIACEAE INFECTIONS", "PI": "Escherichia (1966-1974)", "MS": "A genus of gram-negative, rod-shaped enterobacteria that can use citrate as the sole source of carbon.", "OL": "search ESCHERICHIA 1974", "PM": "79; was see under ENTEROBACTERIACEAE 1976-78; was see under ESCHERICHIA 1974-75", "HN": "79(75); was see under ENTEROBACTERIACEAE 1976-78; was see under ESCHERICHIA 1974-75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D002954"}, {"RECTYPE": "D", "MH": "Leucovorin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "N(5)-Formyltetrahydrofolate|T109|T127|NON|NRW|UNK (19XX)|750717|FORMYLTETRAHYDROFOLATE N 05|abbcdefs", "ENTRY": "Monosodium Salt Leucovorin", "MN": "D08.211.840.300.500", "PA": "Vitamin B Complex", "MH_TH": "NLM (1966)", "ST": "T127", "N1": "L-Glutamic acid, N-(4-(((2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-", "RN": "Q573I9DVLP", "RR": "RPR1R4C0P4", "AN": "deficiency: coordinate LEUCOVORIN /defic (IM) with FOLIC ACID DEFICIENCY (IM)", "MS": "The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS.", "OL": "use LEUCOVORIN to search CITROVORUM FACTOR 1966-89", "PM": "90; was CITROVORUM FACTOR 1964-89", "HN": "90; was CITROVORUM FACTOR 1964-89", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D002955"}, {"RECTYPE": "D", "MH": "Citrulline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.125.095.226", "MH_TH": "NLM (1964)", "ST": "T123", "N1": "L-Ornithine, N5-(aminocarbonyl)-", "RN": "29VT07BGDA", "RR": "372-75-8 (Citrulline)", "AN": "an amino acid", "PM": "65; was see under AMINO ACIDS 1963-64", "HN": "65(64); was see under AMINO ACIDS 1963-64", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002956"}, {"RECTYPE": "D", "MH": "Citrus", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Tangerine Tree|T002|NON|NRW|NLM (2003)|010928|abcdef", "ENTRY": "reticulata, Citrus", "MN": "B01.875.800.575.912.250.875.177", "MH_TH": "NLM (1966)", "ST": "T002", "RN": "txid2706", "RR": "txid85571", "AN": "juices: coordinate with FRUIT AND VEGETABLE JUICES; note entry term CITRUS BERGAMIA: the common name of Bergamot is also used for MONARDA", "MS": "A plant genus of the family RUTACEAE. They bear the familiar citrus fruits including oranges, grapefruit, lemons, and limes. There are many hybrids which makes the nomenclature confusing.", "PM": "was Citrus Fruits 1966-1997", "HN": "was Citrus Fruits 1966-1997", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002957"}, {"RECTYPE": "D", "MH": "City Planning", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Urban Planning|T064|NON|REL|UNK (19XX)|740329|abcdef", "ENTRY": "Urban Plannings", "MN": "I01.880.709.202", "MH_TH": "NLM (1966)", "ST": "T064", "AN": "IM", "MS": "Comprehensive planning for the physical development of the city.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002958"}, {"RECTYPE": "D", "MH": "Civil Defense", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Defenses, Civil", "MN": "I01.451.227", "FX": "United States Department of Homeland Security", "MH_TH": "NLM (1966)", "ST": "T064", "MS": "Preventive emergency measures and programs designed to protect the individual or community in times of hostile attack or natural disaster.", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002959"}, {"RECTYPE": "D", "MH": "Civil Disorders", "DE": "CIVIL DIS", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Disorders, Civil", "MN": "I01.880.735.140", "FX": "Dissent and Disputes", "MH_TH": "NLM (1968)", "ST": "T068", "AN": "specify geog if pertinent", "PI": "Emergency Service, Hospital (1966-1968)", "MS": "Deliberate and planned acts of unlawful behavior engaged in by aggrieved segments of the population in seeking social change.", "PM": "70", "HN": "70(69)", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D002960"}, {"RECTYPE": "D", "MH": "Civil Rights", "AQ": "CL EC ED ES HI IN LJ PX SN ST TD", "PRINT ENTRY": "Minority Rights|T078|NON|NRW|NLM (2020)|181218|abcdef", "ENTRY": "Voting Right", "MN": "N03.706.437.352", "MH_TH": "NLM (1968)", "ST": "T078", "AN": "specify geographic location if pertinent; consider also HUMAN RIGHTS & SOCIAL JUSTICE; PRIVACY ACT see PRIVACY is also available ", "PI": "Legislation (1966-1967)", "MS": "Legal guarantee protecting the individual from attack on personal liberties, right to fair trial, right to vote, and freedom from discrimination on the basis of race, color, religion, sex, age, disability, or national origin. (from http://www.usccr.gov/ accessed 1/31/2003)", "PM": "68; DUE PROCESS see JURISPRUDENCE 1977-97", "HN": "68", "MR": "20190307", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002961"}, {"RECTYPE": "D", "MH": "Civilization", "AQ": "HI", "ENTRY": "Civilizations", "MN": "I01.076.201.450.226", "MH_TH": "NLM (1966)", "ST": "T052", "AN": "specify geog if pertinent", "MS": "The distinctly human attributes and attainments of a particular society.", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002962"}, {"RECTYPE": "D", "MH": "Cladosporium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Cladosporiums", "MN": "B01.300.381.200", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5498", "AN": "infection: coord IM with probably MYCOSES or TINEA (IM)", "MS": "A mitosporic Loculoascomycetes fungal genus including some economically important plant parasites. Teleomorphs include Mycosphaerella and Venturia.", "PM": "91; was see under HYPHOMYCETES 1986-90; was see under MONILIALES 1975-85", "HN": "91(75); was see under HYPHOMYCETES 1986-90; was see under MONILIALES 1975-85", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D002963"}, {"RECTYPE": "D", "MH": "Classification", "DE": "CLASS", "AQ": "MT", "PRINT ENTRY": "Taxonomy|T090|NON|REL|NLM (1992)|910404|abcdef", "ENTRY": "Taxonomies", "MN": "L01.462.750.245.275", "FX": "Phylogeny", "MH_TH": "POPLINE (1986)", "ST": "T185", "AN": "general only; prefer /class", "MS": "The systematic arrangement of entities in any field into categories classes based on common characteristics such as properties, morphology, subject matter, etc.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002965"}, {"RECTYPE": "D", "MH": "Clathrin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.543.990.200", "MH_TH": "NLM (1984)", "ST": "T123", "RN": "0", "AN": "CLATHRIN ASSEMBLY PROTEINS see ADAPTOR PROTEINS, VESICULAR TRANSPORT is available", "PI": "Proteins (1966-1976)", "MS": "The main structural coat protein of COATED VESICLES which play a key role in the intracellular transport between membranous organelles. Each molecule of clathrin consists of three light chains (CLATHRIN LIGHT CHAINS) and three heavy chains (CLATHRIN HEAVY CHAINS) that form a structure called a triskelion. Clathrin also interacts with cytoskeletal proteins.", "PM": "84", "HN": "84", "MR": "20150623", "DA": "19830531", "DC": "1", "DX": "19840101", "UI": "D002966"}, {"RECTYPE": "D", "MH": "Claviceps", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Ergot Fungus|T004|NON|REL|UNK (19XX)|740329|abcdef", "ENTRY": "Fungus, Ergot", "MN": "B01.300.107.501.200", "MH_TH": "NLM (1974)", "ST": "T004", "RN": "txid5110", "RR": "txid5111", "MS": "A genus of ascomycetous fungi, family Clavicipitaceae, order Hypocreales, parasitic on various grasses (POACEAE). The sclerotia contain several toxic alkaloids. Claviceps purpurea on rye causes ERGOTISM.", "PM": "74; see ASCOMYCETES 1963-73", "HN": "74(63)", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002967"}, {"RECTYPE": "D", "MH": "Clavicle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Collar Bones", "MN": "A02.835.232.087.227", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A bone on the ventral side of the shoulder girdle, which in humans is commonly called the collar bone.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002968"}, {"RECTYPE": "D", "MH": "Clavulanic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Clavulanic", "MN": "D03.633.100.300.374", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1983)", "ST": "T195", "RN": "0", "AN": "/biosyn permitted if by living matter", "PI": "beta-Lactamases (1979-1982)", "MS": "Acids, salts, and derivatives of clavulanic acid (C8H9O5N). They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects.", "PM": "83", "HN": "83", "MR": "20160528", "DA": "19820505", "DC": "1", "DX": "19830101", "UI": "D002969"}, {"RECTYPE": "D", "MH": "Cleavage Stage, Ovum", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Segmentation Stage, Ovum|T018|NON|EQV|UNK (19XX)|790417|abcdef", "ENTRY": "Segmentation Stages, Ovum", "MN": "A16.166", "FX": "Cell Division", "MH_TH": "NLM (1980)", "ST": "T018", "PI": "Zygote (1975-1979)", "MS": "The earliest developmental stage of a fertilized ovum (ZYGOTE) during which there are several mitotic divisions within the ZONA PELLUCIDA. Each cleavage or segmentation yields two BLASTOMERES of about half size of the parent cell. This cleavage stage generally covers the period up to 16-cell MORULA.", "PM": "80", "HN": "80", "MR": "20070709", "DA": "19790417", "DC": "1", "DX": "19800101", "UI": "D002970"}, {"RECTYPE": "D", "MH": "Cleft Lip", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Harelip|T019|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Lips, Cleft", "MN": "C16.131.850.525.164", "MH_TH": "NLM (1965)", "ST": "T019", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; when with CLEFT PALATE, do not also use ABNORMALITIES, MULTIPLE", "MS": "Congenital defect in the upper lip where the maxillary prominence fails to merge with the merged medial nasal prominences. It is thought to be caused by faulty migration of the mesoderm in the head region.", "PM": "65; was HARELIP 1963-64", "HN": "65; was HARELIP 1963-64", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D002971"}, {"RECTYPE": "D", "MH": "Cleft Palate", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Palates, Cleft", "MN": "C16.131.850.525.185", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; when with CLEFT LIP, do not also use ABNORMALITIES, MULTIPLE", "MS": "Congenital fissure of the soft and/or hard palate, due to faulty fusion.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002972"}, {"RECTYPE": "D", "MH": "Cleidocranial Dysplasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dysostosis, Cleidocranial|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Syndrome, Scheuthauer-Marie-Sainton", "MN": "C16.131.621.207.207", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Autosomal dominant syndrome in which there is delayed closing of the CRANIAL FONTANELLES; complete or partial absence of the collarbones (CLAVICLES); wide PUBIC SYMPHYSIS; short middle phalanges of the fifth fingers; and dental and vertebral anomalies.", "OL": "use CLEIDOCRANIAL DYSPLASIA to search CLEIDOCRANIAL DYSOSTOSIS l966-84", "PM": "85; was CLEIDOCRANIAL DYSOSTOSIS 1963-84", "HN": "85; was CLEIDOCRANIAL DYSOSTOSIS 1963-84", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D002973"}, {"RECTYPE": "D", "MH": "Clemastine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mecloprodin|T109|T121|NON|EQV|UNK (19XX)|760430|abbcdef", "ENTRY": "HS592", "MN": "D03.383.773.165", "PA": "Histamine H1 Antagonists", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "Pyrrolidine, 2-(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methyl-, (R-(R*,R*))-", "RN": "95QN29S1ID", "RR": "19259EGQ3D", "PI": "Pyrrolidines (1966-1972)", "MS": "A histamine H1 antagonist used as the hydrogen fumarate in hay fever, rhinitis, allergic skin conditions, and pruritus. It causes drowsiness.", "OL": "use CLEMASTINE to search MECLASTINE 1973-78 (as Prov 1973-74)", "PM": "91; was see under PYRROLIDINES 1979-90; was MECLASTINE see under PYRROLIDINES 1975-78", "HN": "91(79); was see under PYRROLIDINES 1979-90; was MECLASTINE see under PYRROLIDINES 1973-78 (Prov 1973-74)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D002974"}, {"RECTYPE": "D", "MH": "Clenbuterol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NAB365", "MN": "D02.092.063.291.231", "PA": "Sympathomimetics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenemethanol, 4-amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)-", "RN": "XTZ6AXU7KN", "RR": "37148-27-9 (Clenbuterol)", "PI": "Ethanolamines (1973-1977)", "MS": "A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.", "PM": "91; was see under ETHANOLAMINES 1978-90", "HN": "91(78); was see under ETHANOLAMINES 1978-90", "MR": "20130708", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D002976"}, {"RECTYPE": "D", "MH": "Clergy", "AQ": "CL ED ES HI LJ PX SN", "ENTRY": "Rabbi", "MN": "M01.526.799.500", "MH_TH": "BIOETHICS (1989)", "ST": "T097", "AN": "specify religion if pertinent", "PI": "appropriate religion heading (1966-1968)", "MS": "Persons ordained for religious duties, who serve as leaders and perform religious services.", "PM": "73", "HN": "73(69)", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D002977"}, {"RECTYPE": "D", "MH": "Climacteric", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Change of Life|T040|T079|NON|EQV|NLM (1998)|961217|abbcdef", "ENTRY": "Life Changes", "MN": "G08.686.841.249", "MH_TH": "NLM (1966)", "ST": "T079", "AN": "female and male; consider also MENOPAUSE or ANDROPAUSE", "MS": "Physiologic period, characterized by endocrine, somatic, and psychic changes with the termination of ovarian function in the female. It may also accompany the normal diminution of sexual activity in the male.", "PM": "1966", "HN": "1966", "CATSH": "CAT LIST", "MR": "20160616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002979"}, {"RECTYPE": "D", "MH": "Climate", "ENTRY": "Climates", "MN": "N06.230.300.100.250", "FX": "Acclimatization", "MH_TH": "NLM (1986)", "ST": "T070", "AN": "general; note specifics", "MS": "The longterm manifestations of WEATHER. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002980"}, {"RECTYPE": "D", "MH": "Clindamycin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Monohydrate Clindamycin", "MN": "D09.408.471.500.125", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USAN (1968)", "ST": "T195", "N1": "L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, (2S-trans)-", "RN": "3U02EL437C", "RR": "T20OQ1YN1W", "PI": "Lincomycin (1966-1971)", "MS": "An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.", "PM": "74", "HN": "74(72)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002981"}, {"RECTYPE": "D", "MH": "Clinical Clerkship", "DE": "CLIN CLERKSHIP", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Clinical Apprenticeships", "MN": "I02.358.105", "MH_TH": "NLM (1983)", "ST": "T065", "PI": "Education, Medical, Undergraduate (1971-1982)", "MS": "Undergraduate education programs for second- , third- , and fourth-year students in health sciences in which the students receive clinical training and experience in teaching hospitals or affiliated health centers.", "PM": "91; was see under EDUCATION, MEDICAL, UNDERGRADUATE 1983-90", "HN": "91(83); was see under EDUCATION, MEDICAL, UNDERGRADUATE 1983-90", "MR": "20141016", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D002982"}, {"RECTYPE": "D", "MH": "Clinical Competence", "DE": "CLIN COMPETENCE", "AQ": "EC LJ SN ST", "PRINT ENTRY": "Competence, Clinical|T080|NON|EQV|UNK (19XX)|780509|COMPETENCE CLIN|abcdefv", "ENTRY": "Competencies, Clinical", "MN": "N05.715.175", "FX": "Culturally Competent Care", "MH_TH": "NLM (1975)", "ST": "T080", "AN": "competence in professional activities directly related to patient care: differentiate from PROFESSIONAL COMPETENCE which refers to competence not necessarily related to patient care", "PI": "Educational Measurement (1966-1974)", "MS": "The capability to perform acceptably those duties directly related to patient care.", "PM": "75", "HN": "75", "MR": "20150109", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D002983"}, {"RECTYPE": "D", "MH": "Clinical Laboratory Information Systems", "DE": "CLIN LABORATORY INFORMATION SYSTEMS", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Laboratory Information Systems|T170|NON|EQV|UNK (19XX)|860617|abcdef", "ENTRY": "Systems, Laboratory Information", "MN": "N04.452.515.080", "MH_TH": "NLM (1987)", "ST": "T170", "MS": "Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative and clinical activities associated with the provision and utilization of clinical laboratory services.", "PM": "91; was see under INFORMATION SYSTEMS 1987-90", "HN": "91(87); was see under INFORMATION SYSTEMS 1987-90", "MR": "20180629", "DA": "19860617", "DC": "1", "DX": "19910101", "UI": "D002984"}, {"RECTYPE": "D", "MH": "Clinical Protocols", "DE": "CLIN PROTOCOLS", "AQ": "CL ST", "PRINT ENTRY": "Treatment Protocols|T061|T062|NON|NRW|UNK (19XX)|870430|abbcdef", "ENTRY": "Treatment Protocol", "MN": "N05.715.360.330.125", "FX": "Practice Guidelines as Topic", "MH_TH": "NLM (1988)", "ST": "T062", "AN": "IM general only; ANTINEOPLASTIC PROTOCOLS and ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS are also available; do not confuse with CLINICAL TRIAL PROTOCOLS AS TOPIC or with the Publication Type CLINICAL TRIAL PROTOCOL ", "MS": "Precise and detailed plans for the study of a medical or biomedical problem and/or plans for a regimen of therapy.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20180626", "DA": "19870430", "DC": "1", "DX": "19880101", "UI": "D002985"}, {"RECTYPE": "D", "MH": "Clinical Trials as Topic", "AQ": "CL EC ES HI IS LJ MT OG PX SN ST", "ENTRY": "Clinical Trial as Topic|T062|NON|EQV|NLM (2008)|070625|abcdef", "MN": "N06.850.520.450.250.250", "FX": "Therapies, Investigational", "MH_TH": "NLM (2008)", "ST": "T062", "AN": "for general design, methodology, economics, etc. of clinical trials; a different heading CLINICAL TRIAL is used for reports of a specific clinical trial", "PI": "Drug Evaluation (1974-1979)", "MS": "Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.", "PM": "2008; see CLINICAL TRIALS 1980-2007", "HN": "2008(1965)", "CATSH": "CAT LIST", "MR": "20190429", "DA": "19790530", "DC": "1", "DX": "19800101", "UI": "D002986"}, {"RECTYPE": "D", "MH": "Clitoris", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A05.360.319.887.436", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "An erectile structure homologous with the penis, situated beneath the anterior labial commissure, partially hidden between the anterior ends of the labia minora.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D002987"}, {"RECTYPE": "D", "MH": "Cloaca", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cloacas", "MN": "A16.178", "MH_TH": "NLM (1968)", "ST": "T023", "PI": "Rectum (1966-1967)", "MS": "A dilated cavity extended caudally from the hindgut. In adult birds, reptiles, amphibians, and many fishes but few mammals, cloaca is a common chamber into which the digestive, urinary and reproductive tracts discharge their contents. In most mammals, cloaca gives rise to LARGE INTESTINE; URINARY BLADDER; and GENITALIA.", "PM": "68", "HN": "68", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002988"}, {"RECTYPE": "D", "MH": "Cloacin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Complex, Cloacin-Immunity Protein", "MN": "D12.776.097.151.190", "MH_TH": "NLM (1980)", "ST": "T123", "N1": "Cloacin DF 13", "RN": "37370-19-7", "PI": "Bacteriocins (1966-1979)", "MS": "A bacteriocin produced by a plasmid that can occur in several bacterial strains. It is a basic protein of molecular weight 56,000 and exists in a complex with its immunity protein which protects the host bacterium from its effects.", "PM": "91; was see under BACTERIOCINS 1980-90", "HN": "91(80); was see under BACTERIOCINS 1980-90", "MR": "20070709", "DA": "19790301", "DC": "1", "DX": "19910101", "UI": "D002989"}, {"RECTYPE": "D", "MH": "Clobetasol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Clobetasol 17 Propionate", "MN": "D04.210.500.908.093.250", "PA": "Glucocorticoids", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11,17-dihydroxy-16-methyl-, (11beta,16beta)-", "RN": "ADN79D536H", "RR": "779619577M", "PI": "Steroids, Chlorinated (1974-1975)", "MS": "A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression.", "PM": "1991, was indexed under BETAMETHASONE 1977-1990; CLOBETASOL PROPIONATE was indexed under COLBETASOL 1978-2006", "HN": "1991(1977); for CLOBETASOL PROPIONATE use COLBETASOL (NM) 1979", "MR": "20160528", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D002990"}, {"RECTYPE": "D", "MH": "Clofazimine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "G30,320", "MN": "D03.633.300.704.353", "PA": "Leprostatic Agents", "MH_TH": "USAN (1967)", "ST": "T130", "N1": "2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-", "RN": "D959AE5USF", "RR": "2030-63-9 (Clofazimine)", "MS": "A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619)", "PM": "74", "HN": "74", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D002991"}, {"RECTYPE": "D", "MH": "Clofenapate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methyl Clofenapate|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "ICI55695", "MN": "D02.455.426.559.389.657.654.305.374", "PA": "Hypolipidemic Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Propanoic acid, 2-((4'-chloro(1,1'-biphenyl)-4-yl)oxy)-2-methyl-, methyl ester", "RN": "21340-68-1", "PI": "Ethers (1972-1974)", "MS": "An oral hypolipemic agent primarily used in DOGS and RATS.", "PM": "91; was see under BUTYRATES 1975-90", "HN": "91(75); was see under BUTYRATES 1975-90", "MR": "20120703", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D002992"}, {"RECTYPE": "D", "MH": "Clofibrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chlorophenoxyisobutyrate, Ethyl", "MN": "D02.455.426.559.389.657.654.305.500.195", "PA": "Hypolipidemic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Propanoic acid, 2-(4-chlorophenoxy)-2-methyl-, ethyl ester", "RN": "HPN91K7FU3", "RR": "637-07-0 (Clofibrate)", "PI": "Propionates (1966-1968)", "MS": "A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986)", "PM": "72", "HN": "72(69)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D002994"}, {"RECTYPE": "D", "MH": "Clofibric Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Clofibrinic Acid|T109|T121|NON|EQV|UNK (19XX)|790221|abbcdef", "ENTRY": "NSC1149", "MN": "D02.455.426.559.389.657.654.305.500", "PA": "Hypolipidemic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Propanoic acid, 2-(4-chlorophenoxy)-2-methyl-", "RN": "53PF01Q249", "RR": "882-09-7 (Clofibric Acid)", "PI": "Clofibrate (1969-1974) /AA (1975-1979)", "MS": "An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.", "PM": "91; was see under CLOFIBRATE 1980-90", "HN": "91(80); was see under CLOFIBRATE 1980-90", "MR": "20130708", "DA": "19790221", "DC": "1", "DX": "19910101", "UI": "D002995"}, {"RECTYPE": "D", "MH": "Clomiphene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Clomifene|T109|T121|NON|EQV|INN (19XX)|UNK (19XX)|761230|abbcdeef", "ENTRY": "Hydrochloride, Clomiphene", "MN": "D02.455.426.559.389.150.700.125", "PA": "Selective Estrogen Receptor Modulators", "MH_TH": "POPLINE (1978)", "ST": "T121", "N1": "Ethanamine, 2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethyl-", "RN": "1HRS458QU2", "RR": "911-45-5 (Clomiphene)", "MS": "A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue. Note that ENCLOMIPHENE and ZUCLOMIPHENE are the (E) and (Z) isomers of Clomiphene respectively.", "PM": "68; CLOMIFENE was CLOMIFEN 1978-91", "HN": "68(64); CLOMIFENE was CLOMIFEN 1978-91", "MR": "20140615", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002996"}, {"RECTYPE": "D", "MH": "Clomipramine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chlorimipramine|T109|T121|NON|EQV|UNK (19XX)|790501|abbcdef", "ENTRY": "Monohydrochloride, Clomipramine", "MN": "D03.633.300.240.194", "PA": "Selective Serotonin Reuptake Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "5H-Dibenz(b,f)azepine-5-propanamine, 3-chloro-10,11-dihydro-N,N-dimethyl-", "RN": "NUV44L116D", "RR": "303-49-1 (Clomipramine)", "PI": "Dibenzazepines (1968-1974)", "MS": "A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.", "OL": "use CLOMIPRAMINE to search CHLORIMIPRAMINE 1975-79; use DIBENZAZEPINES 1968-74", "PM": "80; was CHLORIMIPRAMINE see under DIBENZAZEPINES 1968-79", "HN": "80(75); was CHLORIMIPRAMINE see under DIBENZAZEPINES 1968-79", "MR": "20220718", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D002997"}, {"RECTYPE": "D", "MH": "Clonazepam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Klonopin|T109|T121|TRD|REL|NLM (2021)|191015|abbcdef", "ENTRY": "Ro 54023", "MN": "D03.633.100.079.080.070.150", "PA": "GABA Modulators", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "5PE9FDE8GB", "RR": "1622-61-3 (Clonazepam)", "PI": "Nitro Compounds (1974)", "MS": "An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.", "PM": "87; was see under BENZODIAZEPINONES 1975-86", "HN": "87(75); was see under BENZODIAZEPINONES 1975-86", "MR": "20200206", "DA": "19741111", "DC": "1", "DX": "19870101", "UI": "D002998"}, {"RECTYPE": "D", "MH": "Clone Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Clones|T025|NON|EQV|NLM (1996)|950322|abcdef", "ENTRY": "Clone Cell", "MN": "A11.251.353", "MH_TH": "NLM (1964)", "ST": "T025", "AN": "differentiate from CLONING, MOLECULAR and CLONING, ORGANISM; \"clonal analysis\" probably goes here", "MS": "A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed)", "PM": "68", "HN": "68(64)", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D002999"}, {"RECTYPE": "D", "MH": "Clonidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ST155", "MN": "D03.383.129.308.436.500", "PA": "Sympatholytics", "MH_TH": "USAN (1984)", "ST": "T121", "N1": "1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-", "RN": "MN3L5RMN02", "RR": "W76I6XXF06", "PI": "Imidazoles (1966-1971)", "MS": "An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.", "PM": "73", "HN": "73(72)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003000"}, {"RECTYPE": "D", "MH": "Cloning, Molecular", "DE": "CLONING MOL", "AQ": "DE MT RE", "PRINT ENTRY": "Molecular Cloning|T059|T063|NON|EQV|UNK (19XX)|781221|MOL CLONING|abbcdefv", "MN": "E05.393.220", "FX": "Recombinant Fusion Proteins", "MH_TH": "NLM (1980)", "ST": "T063", "AN": "differentiate from CLONE CELLS and CLONING, ORGANISM; \"clonal analysis\": index under CLONE CELLS", "PI": "Plasmids (1975-1979)", "MS": "The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19781221", "DC": "1", "DX": "19800101", "UI": "D003001"}, {"RECTYPE": "D", "MH": "Clonixin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sch10304", "MN": "D03.383.725.547.375", "PA": "Anti-Inflammatory Agents, Non-Steroidal", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "3-Pyridinecarboxylic acid, 2-((3-chloro-2-methylphenyl)amino)-", "RN": "V7DXN0M42R", "RR": "17737-65-4 (Clonixin)", "PI": "Toluidines (1973-1974)", "MS": "Anti-inflammatory analgesic.", "PM": "91; was see under NICOTINIC ACIDS 1975-90", "HN": "91(75); was see under NICOTINIC ACIDS 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003002"}, {"RECTYPE": "D", "MH": "Clonorchiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Opisthorchis sinensis Infections", "MN": "C01.610.335.865.148", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Infection of the biliary passages with CLONORCHIS SINENSIS, also called Opisthorchis sinensis. It may lead to inflammation of the biliary tract, proliferation of biliary epithelium, progressive portal fibrosis, and sometimes bile duct carcinoma. Extension to the liver may lead to fatty changes and cirrhosis. (From Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003003"}, {"RECTYPE": "D", "MH": "Clonorchis sinensis", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Opisthorchis sinensis|T204|NON|EQV|UNK (19XX)|790417|abcdef", "ENTRY": "sinensis, Clonorchis", "MN": "B01.050.500.500.736.715.520.210", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid79923", "PI": "Opisthorchis (1966-1971)", "MS": "A species of trematode flukes of the family Opisthorchidae. Many authorities consider this genus belonging to Opisthorchis. It is common in China and other Asiatic countries. Snails and fish are the intermediate hosts.", "OL": "search OPISTHORCHIS 1966-71", "PM": "72; was see under OPISTHORCHIS 1963-71", "HN": "72; was see under OPISTHORCHIS 1963-71", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003004"}, {"RECTYPE": "D", "MH": "Clopamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Brinedine|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef", "MN": "D03.383.621.147", "PA": "Diuretics", "MH_TH": "USAN (1964)", "ST": "T121", "N1": "Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,6-dimethyl-1-piperidinyl)-, cis-", "RN": "17S83WON0I", "RR": "636-54-4 (Clopamide)", "MS": "A sulfamoylbenzamide piperidine. It is considered a thiazide-like diuretic.", "PM": "74", "HN": "74(64)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003005"}, {"RECTYPE": "D", "MH": "Clopenthixol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "alpha Clopenthixol", "MN": "D03.633.300.953.704.269", "PA": "Dopamine Antagonists", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "1-Piperazineethanol, 4-(3-(2-chloro-9H-thioxanthen-9-ylidene)propyl)-", "RN": "982-24-1", "RR": "53772-83-1 (Zuclopenthixol)", "MS": "A thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors.", "PM": "91; was see under THIOXANTHENES 1975-90; was see under TRANQUILIZING AGENTS 1967-74", "HN": "91(63); was see under THIOXANTHENES 1975-90; was see under TRANQUILIZING AGENTS 1967-74", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003006"}, {"RECTYPE": "D", "MH": "Clopidol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Meticlorpindol|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "3,5-Dichloro-2,6-dimethyl-4-pyridinol|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|810305|abbcdeef", "MN": "D03.383.725.180", "PA": "Coccidiostats", "MH_TH": "USAN (1968)", "ST": "T121", "N1": "4-Pyridinol, 3,5-dichloro-2,6-dimethyl-", "RN": "8J763HFF5N", "RR": "2971-90-6 (Clopidol)", "AN": "a coccidiostat", "PI": "Pyridines (1973-1974)", "MS": "A very effective anticoccidial agent used in poultry.", "PM": "91; was see under PYRIDINES 1975-90", "HN": "91(75); was see under PYRIDINES 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003007"}, {"RECTYPE": "D", "MH": "Cloprostenol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Cloprostenol", "MN": "D23.469.700.670.175", "PA": "Luteolytic Agents", "MH_TH": "NLM (1979)", "ST": "T121", "N1": "5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-(+-)-", "RN": "4208238832", "RR": "886SAV9675", "PI": "Prostaglandins F, Synthetic (1978)", "MS": "A synthetic prostaglandin F2alpha analog. The compound has luteolytic effects and is used for the synchronization of estrus in cattle.", "PM": "91; was see under PROSTAGLANDINS F, SYNTHETIC 1979-90", "HN": "91(79); was see under PROSTAGLANDINS F, SYNTHETIC 1979-90", "MR": "20150608", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D003008"}, {"RECTYPE": "D", "MH": "Clorazepate Dipotassium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dipotassium Chlorazepate|T109|T121|NON|EQV|INN (19XX)|741111|abbcdef", "ENTRY": "Tranxilium|T109|T121|TRD|NRW|UNK (19XX)|800731|abbcdef", "MN": "D03.633.100.079.080.180", "PA": "GABA Modulators", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (K(OH)) (1:1)", "RN": "63FN7G03XY", "RR": "MS63G8NQUI", "PI": "Carboxylic Acids (1971-1974)", "MS": "A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions.", "PM": "1991; was see under BENZODIAZEPINE TRANQUILIZERS 1975-1990", "HN": "1991 (1975); was see under BENZODIAZEPINE TRANQUILIZERS 1975-1990", "MR": "20180521", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003009"}, {"RECTYPE": "D", "MH": "Clorgyline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Clorgilin|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Clorgiline|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|940725|abbcdeef", "MN": "D02.092.831.180", "PA": "Monoamine Oxidase Inhibitors", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "2-Propyn-1-amine, N-(3-(2,4-dichlorophenoxy)propyl)-N-methyl-", "RN": "LYJ16FZU9Q", "RR": "17780-72-2 (Clorgyline)", "PI": "Propylamines (1970-1974)", "MS": "An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.", "PM": "91; was see under PROPYLAMINES 1975-90", "HN": "91(75); was see under PROPYLAMINES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003010"}, {"RECTYPE": "D", "MH": "Closing Volume", "AQ": "DE ES GE IM PH RE", "ENTRY": "Volumes, Closing", "MN": "G09.772.850.250", "MH_TH": "NLM (1978)", "ST": "T042", "AN": "NIM", "PI": "Respiratory Function Tests (1966-1974)", "MS": "The lung volume at which the dependent lung zones cease to ventilate presumably as a result of airway closure.", "PM": "91; was see under LUNG VOLUME MEASUREMENTS 1978-90", "HN": "91(78); was see under LUNG VOLUME MEASUREMENTS 1978-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D003011"}, {"RECTYPE": "D", "MH": "Microbial Collagenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Collagenase, Microbial|T116|T126|NON|EQV|NLM (1994)|921013|abbcdef", "ENTRY": "histolyticum, Collagenase Clostridium", "MN": "D08.811.277.656.675.374.205.500", "MH_TH": "NLM (1963)", "ST": "T126", "RN": "EC 3.4.24.3", "MS": "A metalloproteinase which degrades helical regions of native collagen to small fragments. Preferred cleavage is -Gly in the sequence -Pro-Xaa-Gly-Pro-. Six forms (or 2 classes) have been isolated from Clostridium histolyticum that are immunologically cross-reactive but possess different sequences and different specificities. Other variants have been isolated from Bacillus cereus, Empedobacter collagenolyticum, Pseudomonas marinoglutinosa, and species of Vibrio and Streptomyces. EC 3.4.24.3.", "OL": "use MICROBIAL COLLAGENASE to search CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1991-93 & CLOSTRIDIOPEPTIDASE A 1966-90", "PM": "94; was CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1991-93; was CLOSTRIDIOPEPTIDASE A 1963-90", "HN": "94; was CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1991-93; was CLOSTRIDIOPEPTIDASE A 1963-90", "MR": "20140612", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003012"}, {"RECTYPE": "D", "MH": "Clostridium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1485", "MS": "A genus of motile or nonmotile gram-positive bacteria of the family Clostridiaceae. Many species have been identified with some being pathogenic. They occur in water, soil, and in the intestinal tract of humans and lower animals.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003013"}, {"RECTYPE": "D", "MH": "Clostridium botulinum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.160", "FX": "Botulinum Toxins", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1491", "MS": "A species of anaerobic, gram-positive, rod-shaped bacteria in the family Clostridiaceae that produces proteins with characteristic neurotoxicity. It is the etiologic agent of BOTULISM in humans, wild fowl, HORSES; and CATTLE. Seven subtypes (sometimes called antigenic types, or strains) exist, each producing a different botulinum toxin (BOTULINUM TOXINS). The organism and its spores are widely distributed in nature.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003014"}, {"RECTYPE": "D", "MH": "Clostridium Infections", "DE": "CLOSTRIDIUM INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Clostridium sordellii Infections|T047|NON|NRW|NLM (2021)|200228|abcdef", "ENTRY": "Infection, Clostridium sordellii", "MN": "C01.150.252.410.222", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Clostridium (1966-1967)", "MS": "Infections with bacteria of the genus CLOSTRIDIUM and closely related CLOSTRIDIOIDES species.", "OL": "use CLOSTRIDIUM INFECTIONS /VE to search HEMOGLOBINURIA, BACILLARY 1968-81", "PM": "68; HEMOGLOBINURIA, BACILLARY was heading 1968-81", "HN": "68; HEMOGLOBINURIA, BACILLARY was heading 1968-81", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003015"}, {"RECTYPE": "D", "MH": "Clostridium perfringens", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Clostridium welchii|T007|NON|EQV|UNK (19XX)|740329|abcdef", "MN": "B03.510.415.400.200.575", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1502", "MS": "The most common etiologic agent of GAS GANGRENE. It is differentiable into several distinct types based on the distribution of twelve different toxins.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003016"}, {"RECTYPE": "D", "MH": "Clostridium tetani", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.725", "FX": "Tetanus Toxin", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1513", "MS": "The cause of TETANUS in humans and domestic animals. It is a common inhabitant of human and horse intestines as well as soil. Two components make up its potent exotoxin activity, a neurotoxin and a hemolytic toxin.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003017"}, {"RECTYPE": "D", "MH": "Clot Retraction", "AQ": "DE ES GE IM PH RE", "ENTRY": "Retractions, Clot", "MN": "G09.188.390.600.180", "MH_TH": "NLM (1964)", "ST": "T059", "MS": "Retraction of a clot resulting from contraction of PLATELET pseudopods attached to FIBRIN strands. The retraction is dependent on the contractile protein thrombosthenin. Clot retraction is used as a measure of platelet function.", "PM": "73", "HN": "73(64)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003018"}, {"RECTYPE": "D", "MH": "Clothing", "AQ": "AE EC HI PX SD SN ST", "ENTRY": "Uniforms, School", "MN": "J01.637.215", "FX": "Surgical Attire", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Fabric or other material used to cover the body.", "MR": "20190322", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003020"}, {"RECTYPE": "D", "MH": "Clotrimazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Mycelex|T109|T121|TRD|NRW|US|861120|abbcdef", "MN": "D03.383.129.308.175", "PA": "Antifungal Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Imidazole, 1-((2-chlorophenyl)diphenylmethyl)-", "RN": "G07GZ97H65", "RR": "23593-75-1 (Clotrimazole)", "PI": "Trityl Compounds (1974)", "MS": "An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal CELL MEMBRANES. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane.", "PM": "91; was see under IMIDAZOLES 1975-90", "HN": "91(75); was see under IMIDAZOLES 1975-90", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003022"}, {"RECTYPE": "D", "MH": "Cloxacillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sodium Cloxacillin|T109|T195|NON|NRW|UNK (19XX)|740329|abbcdef", "ENTRY": "Sodium, Cloxacillin", "MN": "D03.633.100.300.750.625.150", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1965)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-", "RN": "O6X5QGC2VB", "RR": "7081-44-9 (Cloxacillin Sodium)", "MS": "A semi-synthetic antibiotic that is a chlorinated derivative of OXACILLIN.", "PM": "67", "HN": "67(65)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D003023"}, {"RECTYPE": "D", "MH": "Clozapine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Leponex|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef", "MN": "D03.633.300.240.220", "PA": "Serotonin Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "5H-Dibenzo(b,e)(1,4)diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-", "RN": "J60AR2IKIC", "RR": "5786-21-0 (Clozapine)", "PI": "Piperazines (1971-1974)", "MS": "A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.", "PM": "91; was see under DIBENZAZEPINES 1975-90", "HN": "91(75); was see under DIBENZAZEPINES 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003024"}, {"RECTYPE": "D", "MH": "Clubfoot", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Talipes Equinovarus|T019|NON|EQV|OMIM (2013)|ORD (2010)|UNK (19XX)|870402|abcdeeef", "ENTRY": "Talipes Equinovarus, Congenital", "MN": "C16.131.621.585.512.500.681.063", "MH_TH": "ORD (2010)", "ST": "T019", "AN": "entry term EQUINOVARUS: do not confuse with EQUINUS DEFORMITY", "MS": "A deformed foot in which the foot is plantarflexed, inverted, and adducted.", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003025"}, {"RECTYPE": "D", "MH": "Clupeine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "MN": "D12.776.664.750.270", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Clupeine", "RN": "9007-31-2", "OL": "search PROTAMINES 1966-74", "PM": "91; was see under PROTAMINES 1975-90", "HN": "91(75); was see under PROTAMINES 1975-90", "MR": "19920511", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003026"}, {"RECTYPE": "D", "MH": "Cluster Headache", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuralgic Migraine|T047|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Syndromes, Cluster Headache", "MN": "C10.228.140.546.399.937.500", "MH_TH": "NLM (1978)", "ST": "T047", "PI": "Vascular Headache (1966-1977)", "MS": "A primary headache disorder that is characterized by severe, strictly unilateral PAIN which is orbital, supraorbital, temporal or in any combination of these sites, lasting 15-180 min. occurring 1 to 8 times a day. The attacks are associated with one or more of the following, all of which are ipsilateral: conjunctival injection, lacrimation, nasal congestion, rhinorrhea, facial SWEATING, eyelid EDEMA, and miosis. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)", "PM": "1991; see VASCULAR HEADACHE 1978-1990", "HN": "1991(1978)", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19770513", "DC": "1", "DX": "19910101", "UI": "D003027"}, {"RECTYPE": "D", "MH": "CME-Carbodiimide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Carbodiimide, CME", "MN": "D02.491.203.340", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "Morpholinium, 4-(2-((cyclohexylcarbonimidoyl)amino)ethyl)-4-methyl-, salt with 4-methylbenzenesulfonic acid (1:1)", "RN": "2491-17-0", "PI": "Tosyl Compounds (1974)", "PM": "91; was see under CARBODIIMIDES 1975-90", "HN": "91(75); was see under CARBODIIMIDES 1975-90", "MR": "20000622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003028"}, {"RECTYPE": "D", "MH": "Coagulants", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Coagulant|T121|NON|EQV|NLM (2021)|191118|abcdef", "MN": "D27.505.954.502.270", "FX": "Thrombin", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "consider also BLOOD COAGULATION /drug eff", "PI": "Hemostatics (1966-1974)", "MS": "Agents that cause clotting.", "OL": "search HEMOSTATICS 1966-74", "PM": "75; was see under HEMOSTATICS 1963-74", "HN": "75; was see under HEMOSTATICS 1963-74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D003029"}, {"RECTYPE": "D", "MH": "Coagulase", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Staphylococcal Clumping Factor|T116|T126|NON|NRW|UNK (19XX)|870409|abbcdef", "ENTRY": "Staphylococcus aureus strain 8325 4 of Coagulase", "MN": "D12.776.097.181", "PA": "Coagulants", "MH_TH": "NLM (1964)", "ST": "T126", "RN": "0", "RR": "130124-56-0 (Staphylococcus aureus strain 8325-4)", "AN": "do not routinely add when indexing coagulase negative organisms; index only when discussed", "MS": "Enzymes that cause coagulation in plasma by forming a complex with human PROTHROMBIN. Coagulases are produced by certain STAPHYLOCOCCUS and YERSINIA PESTIS. Staphylococci produce two types of coagulase: Staphylocoagulase, a free coagulase that produces true clotting of plasma, and Staphylococcal clumping factor, a bound coagulase in the cell wall that induces clumping of cells in the presence of fibrinogen.", "OL": "use HYDROLASES to search STAPHYLOCOAGULASE 1966-67", "PM": "66; was see under HYDROLASES 1963-65; STAPHYLOCOAGULASE was see under HYDROLASES 1963-67", "HN": "66(64); was see under HYDROLASES 1963-65; STAPHYLOCOAGULASE was see under HYDROLASES 1963-67", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003030"}, {"RECTYPE": "D", "MH": "Coal", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Soft Coals", "MN": "N06.230.132.258.108", "MH_TH": "NLM (1964)", "ST": "T167", "RN": "0", "AN": "/adv eff permitted but do not use for COAL MINING + PNEUMOCONIOSIS or ANTHRACOSILICOSIS unless particularly discussed as coal", "MS": "A natural fuel formed by partial decomposition of vegetable matter under certain environmental conditions.", "PM": "68", "HN": "68(64); was in Cat J only 1964-81", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003031"}, {"RECTYPE": "D", "MH": "Coal Mining", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Mining, Coal", "MN": "J01.576.655.875.500.500", "FX": "Silicosis", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "The practice of extracting COAL from the earth.", "MR": "20151130", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003032"}, {"RECTYPE": "D", "MH": "Coal Tar", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Tar, Coal", "MN": "D20.749.354", "PA": "Keratolytic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Tar, coal", "RN": "8007-45-2", "MS": "A by-product of the destructive distillation of coal used as a topical antieczematic. It is an antipruritic and keratoplastic agent used also in the treatment of psoriasis and other skin conditions. Occupational exposure to soots, tars, and certain mineral oils is known to be carcinogenic according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985) (Merck Index, 11th ed).", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003033"}, {"RECTYPE": "D", "MH": "Coated Pits, Cell-Membrane", "DE": "COATED PITS", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Cell-Membrane Coated Pits|T026|NON|EQV|UNK (19XX)|820422|abcdef", "ENTRY": "Pits, Cell-Membrane Coated", "MN": "A11.284.149.165.175", "FX": "Clathrin", "MH_TH": "NLM (1983)", "ST": "T026", "PI": "Endocytosis (1973-1982)", "MS": "Specialized regions of the cell membrane composed of pits coated with a bristle covering made of the protein CLATHRIN. These pits are the entry route for macromolecules bound by cell surface receptors. The pits are then internalized into the cytoplasm to form the COATED VESICLES.", "PM": "91; was see under RECEPTOSOMES 1983-90", "HN": "91(83); was see under RECEPTOSOMES 1983-90", "MR": "20000622", "DA": "19820422", "DC": "1", "DX": "19910101", "UI": "D003034"}, {"RECTYPE": "D", "MH": "Cobalt", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Cobalt 59", "MN": "D01.552.544.185", "PA": "Trace Elements", "FX": "Cobalt Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Cobalt", "RN": "3G0H8C9362", "RR": "7440-48-4 (Cobalt)", "MS": "A trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis.", "MR": "20170707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003035"}, {"RECTYPE": "D", "MH": "Cobalt Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Cobalt", "MN": "D01.552.544.185.500", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable cobalt atoms that have the same atomic number as the element cobalt, but differ in atomic weight. Co-59 is a stable cobalt isotope.", "MR": "20170424", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003036"}, {"RECTYPE": "D", "MH": "Cobalt Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Cobalt", "MN": "D01.552.544.185.500.354", "MH_TH": "NLM (1974)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "MS": "Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes.", "OL": "search COBALT ISOTOPES 1966-73", "PM": "74", "HN": "74", "MR": "20170424", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003037"}, {"RECTYPE": "D", "MH": "Cobamides", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitamin B 12 Coenzymes|T109|T121|T127|NON|EQV|UNK (19XX)|760526|VITAMIN B A 12 COENZYMES|abbbcdefs", "ENTRY": "Coenzymes, Vitamin B12", "MN": "D08.211.175", "PA": "Vitamin B Complex", "MH_TH": "NLM (1972)", "ST": "T127", "RN": "0", "AN": "deficiency: coordinate COBAMIDES /defic (IM) with VITAMIN B 12 DEFICIENCY (IM)", "PI": "Vitamin B 12 (1966-1971)", "PM": "74", "HN": "74(72)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003038"}, {"RECTYPE": "D", "MH": "Cobra Neurotoxin Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cobrotoxin|T131|NON|NRW|UNK (19XX)|770427|abcdef", "ENTRY": "Proteins, Cobra Neurotoxin", "MN": "D23.946.833.850.325.200", "PA": "Neurotoxins", "MH_TH": "NLM (2008)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTITOXINS", "PI": "Venoms (1966-1974)", "MS": "Toxins, contained in cobra (Naja) venom that block cholinergic receptors; two specific proteins have been described, the small (short, Type I) and the large (long, Type II) which also exist in other Elapid venoms.", "PM": "2008; see COBRA NEUROTOXINS 1991-2007, COBRA VENOMS 1978-1990", "HN": "2008(1991); use COBRA NEUROTOXINS 1991-2007, COBRA VENOMS 1978-1990", "MR": "20190701", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D003039"}, {"RECTYPE": "D", "MH": "Coca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Erythroxylon|T002|NON|EQV|UNK (19XX)|850430|abcdef", "ENTRY": "Erythroxylons", "MN": "B01.875.800.575.912.250.346.500", "MH_TH": "NLM (1966)", "ST": "T002", "RN": "txid13511", "AN": "do not confuse with cocoa see CACAO", "MS": "Any of several South American shrubs of the Erythroxylon genus (and family) that yield COCAINE; the leaves are chewed with alum for CNS stimulation.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003041"}, {"RECTYPE": "D", "MH": "Cocaine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Cocaine", "MN": "D03.605.869.388", "PA": "Vasoconstrictor Agents", "MH_TH": "USP (19XX)", "ST": "T131", "N1": "8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))-", "RN": "I5Y540LHVR", "RR": "XH8T8T6WZH", "MS": "An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.", "OL": "use COCAINE/analogs & derivatives to search COCAINE DERIVATIVES 1975-77; use TROPANES 1969-74", "PM": "COCAINE DERIVATIVES was see under COCAINE 1975-77; was see under TROPANES 1969-74", "HN": "COCAINE DERIVATIVES was see under COCAINE 1975-77; was see under TROPANES 1969-74", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D003042"}, {"RECTYPE": "D", "MH": "Cocarcinogenesis", "AQ": "CH CI CL DE GE IM ME PA RE UL", "ENTRY": "Cocarcinogeneses", "MN": "C23.550.727.098.750", "MH_TH": "NLM (1977)", "ST": "T191", "AN": "do not confuse with NEOPLASMS, MULTIPLE PRIMARY; Manual 24.4.1.14", "PI": "Neoplasms (1966-1976)", "MS": "The combination of two or more different factors in the production of cancer.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D003043"}, {"RECTYPE": "D", "MH": "Coccidia", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Coccidias", "MN": "B01.043.075.189", "FX": "Coccidiostats", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid5796", "PI": "Sporozoa (1966-1974)", "MS": "A subclass of protozoans commonly parasitic in the epithelial cells of the intestinal tract but also found in the liver and other organs. Its organisms are found in both vertebrates and higher invertebrates and comprise two orders: EIMERIIDA and EUCOCCIDIIDA.", "OL": "search SPOROZOA 1966-74", "PM": "79; was see under SPOROZOA 1963-78", "HN": "79(75); was see under SPOROZOA 1963-78", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D003044"}, {"RECTYPE": "D", "MH": "Coccidioides", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Coccidioides immitis|T004|NON|NRW|NLM (2003)|020529|abcdef", "MN": "B01.300.381.230", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid5500", "RR": "txid5501", "MS": "A mitosporic fungal genus which causes COCCIDIOIDOMYCOSIS.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003045"}, {"RECTYPE": "D", "MH": "Coccidioidin", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "MN": "D23.050.202.180", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "12622-73-0", "PI": "Coccidioides/IM (1973-1974)", "MS": "A sterile solution containing the by-products of growth products of COCCIDIOIDES IMMITIS, injected intracutaneously as a test for COCCIDIOIDOMYCOSIS.", "PM": "91; was see under ANTIGENS, FUNGAL 1975-90", "HN": "91(75); was see under ANTIGENS, FUNGAL 1975-90", "MR": "20220413", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003046"}, {"RECTYPE": "D", "MH": "Coccidioidomycosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Coccidioidomycosis Infection|T047|NON|EQV|NLM (2024)|230228|abcdef", "ENTRY": "Valley Fevers", "MN": "C01.150.703.203", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "fungus disease caused by COCCIDIOIDES, not COCCIDIA", "MS": "Infection with a fungus of the genus COCCIDIOIDES, endemic to the SOUTHWESTERN UNITED STATES. It is sometimes called valley fever but should not be confused with RIFT VALLEY FEVER. Infection is caused by inhalation of airborne, fungal particles known as arthroconidia, a form of FUNGAL SPORES. A primary form is an acute, benign, self-limited respiratory infection. A secondary form is a virulent, severe, chronic, progressive granulomatous disease with systemic involvement. It can be detected by use of COCCIDIOIDIN.", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003047"}, {"RECTYPE": "D", "MH": "Coccidiosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Besnoitiasis|T047|NON|NRW|NLM (1995)|940317|abcdef", "ENTRY": "Coccidioses", "MN": "C01.610.752.250", "FX": "Coccidiostats", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "protozoan infect caused by COCCIDIA, not COCCIDIOIDES; /drug ther: consider also COCCIDIOSTATS", "MS": "Protozoan infection found in animals and man. It is caused by several different genera of COCCIDIA.", "PM": "1995; for BESNOITIASIS see PROTOZOAN INFECTIONS 1985-1994, was heading 1968-1984; for EIMERIA INFECTIONS & ISOSPORA INFECTIONS see COCCIDIOSIS 1975-1991, see COCCIDIOSIS 1967-1974", "HN": "1995; for BESNOITIASIS use PROTOZOAN INFECTIONS 1985-1994, was heading 1968-1984; for EIMERIA INFECTIONS & ISOSPORA INFECTIONS use COCCIDIOSIS 1975-1991, use COCCIDIOSIS 1967-1974", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19950101", "UI": "D003048"}, {"RECTYPE": "D", "MH": "Coccidiostats", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Anticoccidial Agents|T121|NON|BRD|UNK (19XX)|741111|abcdef", "ENTRY": "Agents, Anticoccidial", "MN": "D27.505.954.122.250.100.170", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "consider also COCCIDIA /drug eff & COCCIDIOSIS /drug ther (& not COCCIDIOIDES & COCCIDIOIDOMYCOSIS)", "PI": "Antiprotozoal Agents (1969-1974)", "MS": "Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D003049"}, {"RECTYPE": "D", "MH": "Coccyx", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Caudal Vertebrae|T023|NON|REL|NLM (2021)|200221|abcdef", "ENTRY": "Vertebras, Caudal", "MN": "A02.835.232.834.229", "FX": "Tail", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "do not confuse with COCCYGEAL REGION", "MS": "The last bone in the VERTEBRAL COLUMN in tailless primates considered to be a vestigial tail-bone consisting of three to five fused VERTEBRAE.", "MR": "20200221", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003050"}, {"RECTYPE": "D", "MH": "Cochlea", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cochleas", "MN": "A09.246.300.246", "FX": "Otoacoustic Emissions, Spontaneous", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The part of the inner ear (LABYRINTH) that is concerned with hearing. It forms the anterior part of the labyrinth, as a snail-like structure that is situated almost horizontally anterior to the VESTIBULAR LABYRINTH.", "PM": "COCHLEAR DUCT was DUCTUS COCHLEARIS see under LABYRINTH 1963-78; BASILAR MEMBRANE was see under LABYRINTH 1960-89", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003051"}, {"RECTYPE": "D", "MH": "Cochlear Aqueduct", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Perilymphatic Duct|T023|NON|EQV|UNK (19XX)|780519|abcdef", "ENTRY": "Perilymphatic Ducts", "MN": "A09.246.300.246.280", "MH_TH": "NLM (1979)", "ST": "T023", "AN": "do not confuse with COCHLEAR DUCT", "PI": "Cochlea (1966-1978)", "MS": "A fine channel that passes through the TEMPORAL BONE near the SCALA TYMPANI (the basilar turn of the cochlea). The cochlear aqueduct connects the PERILYMPH-filled bony labyrinth to the SUBARACHNOID SPACE.", "PM": "91; was see under COCHLEA 1979-90", "HN": "91(79); was see under COCHLEA 1979-90", "MR": "20180702", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D003052"}, {"RECTYPE": "D", "MH": "Cochlear Duct", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Scala Media|T023|NON|EQV|UNK (19XX)|790519|abcdef", "ENTRY": "Scala Medias", "MN": "A09.246.300.246.292", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "do not confuse with COCHLEAR AQUEDUCT", "PI": "Labyrinth (1966-1978)", "MS": "A spiral tube that is firmly suspended in the bony shell-shaped part of the cochlea. This ENDOLYMPH-filled cochlear duct begins at the vestibule and makes 2.5 turns around a core of spongy bone (the modiolus) thus dividing the PERILYMPH-filled spiral canal into two channels, the SCALA VESTIBULI and the SCALA TYMPANI.", "OL": "use COCHLEAR DUCT to search DUCTUS COCHLEARIS 1975-78; use LABYRINTH 1966-74", "PM": "91; was see under COCHLEA 1979-90; was DUCTUS COCHLEARIS see under LABYRINTH 1963-78", "HN": "91(79); was see under COCHLEA 1979-90; was DUCTUS COCHLEARIS see under LABYRINTH 1963-78", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003053"}, {"RECTYPE": "D", "MH": "Cochlear Implants", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Implants, Cochlear|T074|NON|EQV|NLM (1998)|970509|abcdef", "ENTRY": "Prosthesis, Cochlear", "MN": "E07.814.458.150", "FX": "Cochlear Implantation", "MH_TH": "NLM (1980)", "ST": "T074", "AN": "subcutaneous electronic implants: do not confuse with French \"prothese auditive\" translated as \"hearing aid\" & indexed under HEARING AIDS", "PI": "Prosthesis (1966-1979)", "MS": "Electronic hearing devices typically used for patients with normal outer and middle ear function, but defective inner ear function. In the COCHLEA, the hair cells (HAIR CELLS, VESTIBULAR) may be absent or damaged but there are residual nerve fibers. The device electrically stimulates the COCHLEAR NERVE to create sound sensation.", "PM": "98; see COCHLEAR IMPLANT 1987-97, see AUDITORY PROSTHESIS 1980-86", "HN": "98(80)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19781221", "DC": "1", "DX": "19800101", "UI": "D003054"}, {"RECTYPE": "D", "MH": "Cochlear Microphonic Potentials", "AQ": "DE GE IM PH RE", "ENTRY": "Potentials, Cochlear Microphonic", "MN": "G11.561.200.500.370.223", "MH_TH": "NLM (1980)", "ST": "T042", "PI": "Evoked Potentials (1967-1979)", "MS": "The electric response of the cochlear hair cells to acoustic stimulation.", "PM": "91; was see under EVOKED POTENTIALS, AUDITORY 1980-90", "HN": "91(80); was see under EVOKED POTENTIALS, AUDITORY 1980-90", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19781214", "DC": "1", "DX": "19910101", "UI": "D003055"}, {"RECTYPE": "D", "MH": "Cochlear Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Auditory Nerve|T023|NON|EQV|UNK (19XX)|780622|abcdef", "ENTRY": "Nerves, Cochlear", "MN": "A08.800.800.120.910.120", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "dis: coord IM with VESTIBULOCOCHLEAR NERVE DISEASES (IM); neopl: coord IM with VESTIBULOCOCHLEAR NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "The cochlear part of the 8th cranial nerve (VESTIBULOCOCHLEAR NERVE). The cochlear nerve fibers originate from neurons of the SPIRAL GANGLION and project peripherally to cochlear hair cells and centrally to the cochlear nuclei (COCHLEAR NUCLEUS) of the BRAIN STEM. They mediate the sense of hearing.", "PM": "1963; for AUDITORY NERVE see ACOUSTIC NERVE 1979-1999; for ACOUSTIC NERVE see VESTIBULOCOCHLEAR NERVE 1963-1999", "HN": "1963; for AUDITORY NERVE use VESTIBULOCOCHLEAR NERVE 1979-1999; for ACOUSTIC NERVE use VESTIBULOCOCHLEAR NERVE 1963-1999", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D003056"}, {"RECTYPE": "D", "MH": "Cockayne Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Progeria-Like Syndrome|T047|NON|EQV|GHR (2014)|NLM (2000)|991103|abcdeef", "ENTRY": "Syndrome, Progeria-Like", "MN": "C18.452.284.250", "FX": "Intellectual Disability", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Photosensitivity Disorders (1966-1980)", "MS": "A syndrome characterized by multiple system abnormalities including DWARFISM; PHOTOSENSITIVITY DISORDERS; PREMATURE AGING; and HEARING LOSS. It is caused by mutations of a number of autosomal recessive genes encoding proteins that involve transcriptional-coupled DNA REPAIR processes. Cockayne syndrome is classified by the severity and age of onset. Type I (classical; CSA) is early childhood onset in the second year of life; type II (congenital; CSB) is early onset at birth with severe symptoms; type III (xeroderma pigmentosum; XP) is late childhood onset with mild symptoms.", "PM": "1991; see DWARFISM 1981-1990", "HN": "1991(1981); use DWARFISM 1981-1990", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19800509", "DC": "1", "DX": "19910101", "UI": "D003057"}, {"RECTYPE": "D", "MH": "Cockroaches", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Polyphagidae|T204|NON|NRW|NLM (1999)|971022|abcdef", "ENTRY": "Dictyopteras", "MN": "B01.050.500.131.617.140", "MH_TH": "NLM (1972)", "ST": "T204", "RR": "txid85823", "AN": "do not use /drug eff for insecticides: TN 111", "PI": "Insects (1966-1971)", "MS": "Insects of the order Dictyoptera comprising several families including Blaberidae, BLATTELLIDAE, Blattidae (containing the American cockroach PERIPLANETA americana), Cryptocercidae, and Polyphagidae.", "PM": "72; for DICTYOPTERA see ORTHOPTERA 1986-98, see DICTYOPTERA 1975-85", "HN": "72; for DICTYOPTERA use ORTHOPTERA 1975-98", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003058"}, {"RECTYPE": "D", "MH": "Cocos", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Coconut|T168|NON|NRW|NLM (1986)|990101|abcdef", "ENTRY": "nucifera, Cocos", "MN": "B01.875.800.575.912.250.093.211", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid13893", "RR": "txid13894", "MS": "A plant genus of the family ARECACEAE. It is a tropical palm tree that yields a large, edible hard-shelled fruit from which oil and fiber are also obtained.", "PM": "91,63-85; was see under NUTS 1986-90; was heading 1963-85", "HN": "91(86)63; was see under NUTS 1986-90; was heading 1963-85; was in Cat J only 1963-80", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003059"}, {"RECTYPE": "D", "MH": "Cod Liver Oil", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oil, Cod Liver", "MN": "D10.627.430.354", "PA": "Vitamins", "MH_TH": "NLM (1975)", "ST": "T127", "RN": "8001-69-2", "MS": "Oil obtained from fresh livers of the cod family, Gadidae. It is a source of VITAMIN A and VITAMIN D.", "OL": "search FISH OILS 1966-74", "PM": "91; was see under FISH OILS 1983-90; was see under FISH LIVER OILS 1963-82", "HN": "91(75); was see under FISH OILS 1983-90; was see under FISH LIVER OILS 1963-82", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003060"}, {"RECTYPE": "D", "MH": "Codeine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-|T109|T121|NON|EQV|NLM (2021)|200723|abbcdef", "ENTRY": "N Methylmorphine", "MN": "D04.615.723.795.576.149", "PA": "Narcotics", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "UX6OWY2V7J", "RR": "GSL05Y1MN6", "MS": "An opioid analgesic related to MORPHINE but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough.", "OL": "use CODEINE/analogs & derivatives to search CODEINE DERIVATIVES 1975-77; use MORPHINANS 1969-74", "PM": "CODEINE DERIVATIVES was see under CODEINE 1975-77, was see under MORPHINANS 1969-74", "HN": "CODEINE DERIVATIVES was see under CODEINE 1975-77, was see under MORPHINANS 1969-74", "MR": "20200723", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D003061"}, {"RECTYPE": "D", "MH": "Codon", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sense Codon|T114|T123|NON|NRW|NLM (2001)|000414|abbcdef", "ENTRY": "Sense Codons", "MN": "G05.360.340.024.340.137.190", "FX": "Reading Frames", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE).", "OL": "search RNA, MESSENGER 1974", "PM": "91; was see under RNA, MESSENGER 1975-90", "HN": "91(75); was see under RNA, MESSENGER 1975-90", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003062"}, {"RECTYPE": "D", "MH": "Cnidaria", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Cnidarias", "MN": "B01.050.500.308", "FX": "Cnidarian Venoms", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6073", "AN": "poisoning: coord with CNIDARIAN VENOMS if pertinent", "MS": "A phylum of radially symmetrical invertebrates characterized by possession of stinging cells called nematocysts. It includes the classes ANTHOZOA; CUBOZOA; HYDROZOA, and SCYPHOZOA. Members carry CNIDARIAN VENOMS.", "PM": "1995; see COELENTERATA 1963-1994", "HN": "1995 (1963)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19950101", "UI": "D003063"}, {"RECTYPE": "D", "MH": "Cnidarian Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sea Anemone Venoms|T123|T131|NON|NRW|UNK (19XX)|840524|abbcdef", "ENTRY": "Venoms, Sea Anemone", "MN": "D23.946.833.230", "PA": "Poisons", "FX": "Nematocyst", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTIVENINS; coordinate with specific Cnidaria source", "PI": "Venoms (1966-1977)", "MS": "Venoms from jellyfish; CORALS; SEA ANEMONES; etc. They contain hemo-, cardio-, dermo- , and neuro-toxic substances and probably ENZYMES. They include palytoxin, sarcophine, and anthopleurine.", "OL": "use CNIDARIAN VENOMS to search COELENTERATE VENOMS 1978-94", "PM": "95; was COELENTERATE VENOMS 1978-94", "HN": "95; was COELENTERATE VENOMS 1978-94", "MR": "20100625", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D003064"}, {"RECTYPE": "D", "MH": "Coenzyme A", "DS": "COENZYME A AA", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CoA|T114|T123|NON|EQV|UNK (19XX)|750208|abbcdef", "ENTRY": "CoASH|T114|T123|NRW|UNK (19XX)|810210|abbdef", "MN": "D13.695.827.068.382", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Coenzyme A", "RN": "SAA04E81UX", "RR": "85-61-0 (Coenzyme A)", "AN": "/biosyn /physiol permitted", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003065"}, {"RECTYPE": "D", "MH": "Coenzyme A Ligases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Coenzyme A Synthetases|T116|T126|NON|EQV|NLM (1998)|961106|abbcdef", "ENTRY": "Synthetases, Coenzyme A", "MN": "D08.811.464.267.500", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 6.2.1.-", "PI": "Ligases (1966-1972)", "MS": "Enzymes that catalyze the formation of acyl-CoA derivatives. EC 6.2.1.", "PM": "98; see COENZYME A SYNTHETASES 1973-97", "HN": "98(73)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003066"}, {"RECTYPE": "D", "MH": "Coenzymes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Enzyme Cofactor|T123|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Cofactor, Enzyme", "MN": "D08.211", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Small molecules that are required for the catalytic function of ENZYMES. Many VITAMINS are coenzymes.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003067"}, {"RECTYPE": "D", "MH": "Coercion", "MN": "I01.880.630.200", "FX": "Mandatory Programs", "MH_TH": "BIOETHICS (1989)", "ST": "T054", "MS": "The use of force or intimidation to obtain compliance.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D003068"}, {"RECTYPE": "D", "MH": "Coffee", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM LJ ME MI PH PO PS RE SD ST TO UL VI", "MN": "J02.200.325", "FX": "Coffea", "MH_TH": "NLM (1966)", "ST": "T168", "RN": "0", "AN": "for the plant use COFFEA", "MS": "A beverage made from ground COFFEA beans (SEEDS) infused in hot water. It generally contains CAFFEINE and THEOPHYLLINE unless it is decaffeinated.", "MR": "20230731", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003069"}, {"RECTYPE": "D", "MH": "Coformycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D13.570.800.410.200", "PA": "Immunosuppressive Agents", "MH_TH": "NLM (1979)", "ST": "T123", "N1": "Imidazo(4,5-d)(1,3)diazepin-8-ol, 3,4,7,8-tetrahydro-3-beta-D-ribofuranosyl-, (R)-", "RN": "11033-22-0", "AN": "an enzyme inhib & antineoplastic antibiotic", "PI": "Ribonucleosides (1971-1978)", "MS": "A ribonucleoside antibiotic synergist and adenosine deaminase inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis. It is proposed as an antineoplastic synergist and immunosuppressant.", "PM": "90; was see under RIBONUCLEOSIDES 1979-89", "HN": "90(79); was see under RIBONUCLEOSIDES 1979-89", "MR": "20160528", "DA": "19771208", "DC": "1", "DX": "19900101", "UI": "D003070"}, {"RECTYPE": "D", "MH": "Cognition", "AQ": "CL DE ES PH RE", "ENTRY": "Functions, Cognitive", "MN": "F02.463.188", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "Intellectual or mental process whereby an organism obtains knowledge.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003071"}, {"RECTYPE": "D", "MH": "Cognition Disorders", "DE": "COGNITION DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Overinclusion|T048|NON|NRW|NLM (1972)|970714|abcdef", "ENTRY": "Disorders, Cognition", "MN": "F03.615.250", "MH_TH": "OBSSR (2016)", "ST": "T048", "PI": "specific disorder", "MS": "Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D003072"}, {"RECTYPE": "D", "MH": "Cognitive Dissonance", "ENTRY": "Dissonances, Cognitive", "MN": "F02.463.188.305", "MH_TH": "NLM (1969)", "ST": "T041", "PI": "Motivation (1966-1968)", "MS": "Motivational state produced by inconsistencies between simultaneously held cognitions or between a cognition and behavior; e.g., smoking enjoyment and believing smoking is harmful are dissonant.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "19890428", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D003073"}, {"RECTYPE": "D", "MH": "Solitary Pulmonary Nodule", "DE": "SOLITARY PULM NODULE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Solitary Lung Nodule|T190|NON|EQV|NLM (2023)|210924|abcdef", "ENTRY": "Solitary Lung Nodules", "MN": "C08.381.884", "MH_TH": "NLM (1992)", "ST": "T190", "AN": "if neoplastic, coordinate with LUNG NEOPLASMS; if non-neoplastic, do not coordinate with LUNG DISEASES", "MS": "A single lung lesion that is characterized by a small round mass of tissue, usually less than 1 cm in diameter, and can be detected by chest radiography. A solitary pulmonary nodule can be associated with neoplasm, tuberculosis, cyst, or other anomalies in the lung, the CHEST WALL, or the PLEURA.", "PM": "2009; see COIN LESION, PULMONARY 1965-2008", "HN": "2009 (1965)", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003074"}, {"RECTYPE": "D", "MH": "Coitus", "AQ": "PH PX", "PRINT ENTRY": "Sexual Intercourse|T040|T055|NON|EQV|UNK (19XX)|880609|abbcdef", "ENTRY": "Intercourses, First", "MN": "G08.686.784.041", "MH_TH": "NLM (1963)", "ST": "T055", "MS": "The sexual union of a male and a female, a term used for human only.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003075"}, {"RECTYPE": "D", "MH": "Coitus Interruptus", "AQ": "PX", "ENTRY": "Interruptus, Coitus", "MN": "F01.145.802.188.300", "MH_TH": "NLM (1975)", "ST": "T061", "PI": "Contraception (1966-1974)", "MS": "A contraceptive method whereby coitus is purposely interrupted in order to prevent EJACULATION of SEMEN into the VAGINA.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D003076"}, {"RECTYPE": "D", "MH": "Coke", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Cokes", "MN": "N06.230.132.258.108.110", "MH_TH": "NLM (1975)", "ST": "T167", "RN": "0", "AN": "a coal residue used as fuel", "MS": "A residue of coal, left after dry (destructive) distillation, used as a fuel.", "OL": "search COAL 1968-74", "PM": "91; was see under COAL 1975-90; was in Cat J only 1975-81", "HN": "91(75); was see under COAL 1975-90; was in Cat J only 1975-81", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003077"}, {"RECTYPE": "D", "MH": "Colchicine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Colchicine, (R)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef", "MN": "D03.132.225", "PA": "Tubulin Modulators", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Acetamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)-", "RN": "SML2Y3J35T", "RR": "75520-89-7 ((R)-isomer)", "MS": "A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE).", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003078"}, {"RECTYPE": "D", "MH": "Colchicum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Meadow Saffron|T002|NON|NRW|NLM (2002)|010314|abcdef", "ENTRY": "autumnales, Colchicum", "MN": "B01.875.800.575.912.250.618.875.175.170", "FX": "Colchicine", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid13444", "RR": "txid45005", "AN": "COLCHICINE is also available", "MS": "A genus of poisonous, liliaceous plants. The roots (corms) of Colchicum autumnale, the fall crocus or meadow saffron, yield COLCHICINE, which is used as a biochemical tool and to treat gout. Other members of this genus yield saffron dye, flavoring agents, and aromatics.", "PM": "91,63-85; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85", "HN": "91(86)63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003079"}, {"RECTYPE": "D", "MH": "Cold Temperature", "AQ": "AE", "PRINT ENTRY": "Cold|T070|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Temperatures, Cold", "MN": "N06.230.300.100.725.710.300", "FX": "Shivering", "EC": "therapeutic use:Cryotherapy", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "cooling of organs during surg goes under HYPOTHERMIA, INDUCED", "CX": "consider also terms at CRYO-", "MS": "An absence of warmth or heat or a temperature notably below an accustomed norm.", "PM": "2009; see COLD 1963-2008", "HN": "2009 (1963)", "MR": "20150331", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D003080"}, {"RECTYPE": "D", "MH": "Cold Climate", "AQ": "AE", "PRINT ENTRY": "Polar Regions|T083|NON|NRW|UNK (19XX)|770509|abcdef", "ENTRY": "Regions, Polar", "MN": "N06.230.300.100.250.275", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "for Polar Region cold climate specify ARCTIC REGIONS or ANTARCTIC REGIONS; specify other geographical location for cold climate if pertinent", "MS": "A climate characterized by COLD TEMPERATURE for a majority of the time during the year.", "OL": "use COLD CLIMATE to search POLAR REGIONS 1966-77", "HN": "POLAR REGIONS was see under COLD CLIMATE 1963-77", "MR": "20090717", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D003081"}, {"RECTYPE": "D", "MH": "Colectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Resections, Large Bowel", "MN": "E04.210.219", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Surgical resection of a portion of or the entire colon.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20170421", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003082"}, {"RECTYPE": "D", "MH": "Colestipol", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "U26,597 A", "MN": "J01.637.051.720.200", "PA": "Sequestering Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Colestipol", "RN": "K50N755924", "RR": "X7D10K905G", "PI": "Polymers (1971-1974)", "MS": "Highly crosslinked and insoluble basic anion exchange resin used as anticholesteremic. It may also may reduce triglyceride levels.", "PM": "91; was see under POLYAMINES 1975-90", "HN": "91(75); was see under POLYAMINES 1975-90", "MR": "20130708", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D003084"}, {"RECTYPE": "D", "MH": "Colic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Abdominal Cramps|T184|NON|REL|POPLINE (1978)|781219|abcdef", "ENTRY": "Cramps, Abdominal", "MN": "C16.614.166", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A clinical syndrome with intermittent abdominal pain characterized by sudden onset and cessation that is commonly seen in infants. It is usually associated with obstruction of the INTESTINES; of the CYSTIC DUCT; or of the URINARY TRACT.", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003085"}, {"RECTYPE": "D", "MH": "Bacteriocin Plasmids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Colicin Factors|T114|T123|NON|NRW|NLM (1978)|990101|abbcdef", "ENTRY": "Plasmids, Colicin", "MN": "G05.360.600.080", "MH_TH": "NLM (2004)", "ST": "T123", "PI": "Plasmids (1975-1977)", "MS": "Plasmids encoding bacterial exotoxins (BACTERIOCINS).", "PM": "2004; see COLICIN FACTORS 1991-2003, see PLASMIDS 1978-1990", "HN": "2004(1978)", "MR": "20080708", "DA": "19770509", "DC": "1", "DX": "19910101", "UI": "D003086"}, {"RECTYPE": "D", "MH": "Colicins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Colicines|T116|T123|NON|EQV|UNK (19XX)|780501|abbcdef", "ENTRY": "E9, Colicin", "MN": "D12.776.097.200", "MH_TH": "NLM (1965)", "ST": "T123", "RN": "0", "MS": "Bacteriocins elaborated by strains of Escherichia coli and related species. They are proteins or protein-lipopolysaccharide complexes lethal to other strains of the same species.", "PM": "66", "HN": "66(65)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003087"}, {"RECTYPE": "D", "MH": "Colinus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Bobwhite|T012|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Bobwhites", "MN": "B01.050.150.900.248.350.650.300", "MH_TH": "NLM (1975)", "ST": "T012", "RN": "txid9013", "AN": "diseases: coord IM with BIRD DISEASES (IM)", "MS": "A genus of QUAIL, in the family Odontophoridae, comprised of at least four different species of bobwhites.", "PM": "91; was see under QUAIL 1975-90; BOBWHITE was BOB-WHITE 1975-94", "HN": "91(75); was see under QUAIL 1975-90; BOBWHITE was BOB-WHITE 1975-94", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003088"}, {"RECTYPE": "D", "MH": "Colipases", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Colipase B|T116|T126|NON|NRW|UNK (19XX)|811202|abbcdef", "MN": "D12.776.200", "MH_TH": "NLM (1976)", "ST": "T126", "RN": "0", "AN": "a protein: not an enzyme despite -ase; /biosyn /physiol permitted", "PI": "Proteins (1974-1975)", "MS": "Colipase I and II, consisting of 94-95 and 84-85 amino acid residues, respectively, have been isolated from porcine pancreas. Their role is to prevent the inhibitory effect of bile salts on the lipase-catalyzed intraduodenal hydrolysis of dietary long-chain triglycerides.", "PM": "91; was see under PROTEINS 1976-90", "HN": "91(76); was see under PROTEINS 1976-90", "MR": "20160628", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D003089"}, {"RECTYPE": "D", "MH": "Coliphages", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Escherichia coli Phages|T005|NON|EQV|UNK (19XX)|740320|E COLI PHAGES|abcdefv", "ENTRY": "Phages, Escherichia coli", "MN": "B04.123.205", "MH_TH": "NLM (1966)", "ST": "T005", "AN": "general or unspecified; prefer specifics", "MS": "Viruses whose host is Escherichia coli.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003090"}, {"RECTYPE": "D", "MH": "Colistin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polymyxin E|T116|T195|NON|EQV|UNK (19XX)|770330|abbcdef", "ENTRY": "Sulfate, Colistin", "MN": "D12.776.543.695.054.600.110", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "Colistin", "RN": "Z67X93HJG1", "RR": "WP15DXU577", "MS": "Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003091"}, {"RECTYPE": "D", "MH": "Colitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Colitides", "MN": "C06.405.469.158.188", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general; note specifics; ENTEROCOLITIS is also available", "MS": "Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003092"}, {"RECTYPE": "D", "MH": "Colitis, Ulcerative", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ulcerative Colitis|T047|NON|EQV|GHR (2014)|NLM (2004)|OMIM (2013)|021210|abcdeeef", "MN": "C06.405.469.432.249", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "usually chronic so do not coord with CHRONIC DISEASE", "MS": "Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003093"}, {"RECTYPE": "D", "MH": "Collagen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Collagen", "MN": "D12.776.860.300.250", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Collagens", "RN": "9007-34-5", "AN": "general or unspecified; prefer specifics; precusor equals PROCOLLAGEN; do not confuse entry term MICROFIBRIL COLLAGEN HEMOSTAT with FIBRILLAR COLLAGENS", "MS": "A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH).", "MR": "20050729", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003094"}, {"RECTYPE": "D", "MH": "Collagen Diseases", "DE": "COLLAGEN DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Collagen", "MN": "C17.300.200", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Historically, a heterogeneous group of acute and chronic diseases, including rheumatoid arthritis, systemic lupus erythematosus, progressive systemic sclerosis, dermatomyositis, etc. This classification was based on the notion that \"collagen\" was equivalent to \"connective tissue\", but with the present recognition of the different types of collagen and the aggregates derived from them as distinct entities, the term \"collagen diseases\" now pertains exclusively to those inherited conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly. (From Cecil Textbook of Medicine, 19th ed, p1494)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003095"}, {"RECTYPE": "D", "MH": "Collapse Therapy", "DE": "COLLAPSE THER", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Therapies, Collapse", "MN": "E04.928.600.220", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Surgical treatment of pulmonary tuberculosis whereby the lung is totally or partially, temporarily or permanently, immobilized. The procedure was based on the popular concept that collapsing the affected portion of a tuberculous lung allowed the infected area to rest and thereby recover. At the beginning of the 20th century artificially induced pneumothorax (PNEUMOTHORAX, ARTIFICIAL) was popular. Later a variety of other techniques was used to encourage collapse of the infected portion of the lung: unilateral phrenic nerve division, PNEUMONOLYSIS, pneumoperitoneum (PNEUMOPERITONEUM, ARTIFICIAL), and THORACOPLASTY. Collapse therapy has declined since the advent of antitubercular chemotherapy. (Stedman, 25th ed; from Sabiston Jr, Textbook of Surgery, 14th ed, p1733-4)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003096"}, {"RECTYPE": "D", "MH": "Collateral Circulation", "DE": "COLLATERAL CIRC", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Blood Circulation, Collateral|T039|NON|EQV|UNK (19XX)|740329|BLOOD CIRC COLLATERAL|abcdefv", "ENTRY": "Collateral Circulations, Blood", "MN": "G09.330.100.248", "FX": "Neovascularization, Physiologic", "MH_TH": "NLM (1964)", "ST": "T039", "AN": "a naturally occurring physiol phenomenon: not for restoration of funct by surg; not restricted to coronary vessels; do not confuse with NEOVASCULARIZATION, PHYSIOLOGIC: see MeSH scope notes", "MS": "Maintenance of blood flow to an organ despite obstruction of a principal vessel. Blood flow is maintained through small vessels.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003097"}, {"RECTYPE": "D", "MH": "Collective Bargaining", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Collective Bargainings", "MN": "N04.452.677.356", "MH_TH": "NLM (1971)", "ST": "T057", "PI": "Labor Unions (1966-1970)", "MS": "The process of negotiation between representatives of an employee organization, association or union, and representatives of the employer.", "PM": "71", "HN": "71", "MR": "19930916", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D003098"}, {"RECTYPE": "D", "MH": "College Admission Test", "AQ": "HI SN", "ENTRY": "Tests, College Admission", "MN": "I02.399.272", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "Test designed to identify students suitable for admission into a graduate or undergraduate curriculum.", "OL": "search EDUCATIONAL MEASUREMENT 1966-74", "PM": "91; was see under EDUCATIONAL MEASUREMENT 1975-90", "HN": "91(75); was see under EDUCATIONAL MEASUREMENT 1975-90", "MR": "19920507", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003099"}, {"RECTYPE": "D", "MH": "Colles' Fracture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fracture, Colles'", "MN": "C26.404.562.356", "MH_TH": "NLM (1975)", "ST": "T037", "MS": "Fracture of the lower end of the radius in which the lower fragment is displaced posteriorly.", "OL": "search RADIUS FRACTURES 1966-74", "PM": "91; was see under RADIUS FRACTURES 1975-90", "HN": "91(75); was see under RADIUS FRACTURES 1975-90", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003100"}, {"RECTYPE": "D", "MH": "Collodion", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Nitrocellulose|T109|T121|T122|NON|BRD|UNK (19XX)|840417|abbbcdef", "ENTRY": "Nitrate, Cellulose", "MN": "J01.637.051.720.099.500.439", "PA": "Tissue Adhesives", "MH_TH": "USP (19XX)", "ST": "T122", "N1": "Cellulose, nitrate", "RN": "9004-70-0", "AN": "do not index here for the dermatologic condition collodion membrane or collodion baby: consider ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL", "MS": "A nitrocellulose solution in ether and alcohol. Collodion has a wide range of uses in industry including applications in the manufacture of photographic film, in fibers, in lacquers, and in engraving and lithography. In medicine it is used as a drug solvent and a wound sealant.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003101"}, {"RECTYPE": "D", "MH": "Colloids", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Hydrocolloid", "MN": "D26.255.165", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "AN": "IM general only; NIM (no qualifiers) with specific drug IM", "MS": "Two-phase systems in which one is uniformly dispersed in another as particles small enough so they cannot be filtered or will not settle out. The dispersing or continuous phase or medium envelops the particles of the discontinuous phase. All three states of matter can form colloids among each other.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003102"}, {"RECTYPE": "D", "MH": "Coloboma", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Uveoretinal Colobomas", "MN": "C16.131.384.282", "MH_TH": "NLM (1965)", "ST": "T019", "AN": "coordinate with specific site in eye /abnorm", "MS": "Congenital anomaly in which some of the structures of the eye are absent due to incomplete fusion of the fetal intraocular fissure during gestation.", "PM": "73", "HN": "73(65)", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003103"}, {"RECTYPE": "D", "MH": "Colobus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Monkey, Colobus|T015|NON|EQV|UNK (19XX)|800507|abcdef", "ENTRY": "Colobus Monkeys", "MN": "B01.050.150.900.649.313.988.400.112.199.150.150", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9570", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "MS": "A genus of Old World monkeys, subfamily COLOBINAE, family CERCOPITHECIDAE, that inhabits the forests of Africa. It includes C. angolensis (Angolan colobus), C. guereza (Guereza or Eastern black-and-white colobus), C. polykomos (King colobus or Western black-and-white colobus), C. satanas (Black Colobus) and C. vellerosus.", "PM": "91; was see under CERCOPITHECIDAE 1981-90; was see under MONKEYS 1975-80", "HN": "91(75); was see under CERCOPITHECIDAE 1981-90; was see under MONKEYS 1975-80", "MR": "20210209", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003104"}, {"RECTYPE": "D", "MH": "Colombia", "AQ": "EH EP", "MN": "Z01.107.757.284", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the north Pacific Ocean, between Ecuador and Panama. The capital is Bogota.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D003105"}, {"RECTYPE": "D", "MH": "Colon", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Taenia Coli|T023|NON|NRW|NLM (1998)|960724|abcdef", "ENTRY": "Appendix, Omental", "MN": "A03.556.249.249.356", "FX": "Colostomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003106"}, {"RECTYPE": "D", "MH": "Colorectal Surgery", "DE": "COLORECTAL SURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX RH SN ST TD VE", "PRINT ENTRY": "Proctology|T091|NON|NRW|UNK (19XX)|790529|PROCTOL|abcdefv", "ENTRY": "Surgery, Colorectal|T091|NON|EQV|NLM (1998)|960925|SURG COLORECTAL|abcdefv", "MN": "H02.403.810.208", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "surgical specialty; do not confuse with COLON /surg & RECTUM /surg", "MS": "A surgical specialty concerned with the diagnosis and treatment of disorders and abnormalities of the COLON; RECTUM; and ANAL CANAL.", "OL": "use COLON AND RECTAL SURGERY (SPECIALTY) to search PROCTOLOGY 1966-79", "PM": "98; was COLON AND RECTAL SURGERY (SPECIALTY) 1980-97; was PROCTOLOGY 1963-79", "HN": "98; was COLON AND RECTAL SURGERY (SPECIALTY) 1980-97; was PROCTOLOGY 1963-79", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003107"}, {"RECTYPE": "D", "MH": "Colonic Diseases", "DE": "COLONIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Colonic", "MN": "C06.405.469.158", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003108"}, {"RECTYPE": "D", "MH": "Colonic Diseases, Functional", "DE": "COLONIC DIS FUNCTIONAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Functional Colonic Disease", "MN": "C06.405.469.158.272", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Chronic or recurrent colonic disorders without an identifiable structural or biochemical explanation. The widely recognized IRRITABLE BOWEL SYNDROME falls into this category.", "OL": "use COLONIC DISEASES, FUNCTIONAL to search COLITIS, MUCOUS 1966-78", "PM": "65; was COLITIS, MUCOUS 1963-64", "HN": "65; was COLITIS, MUCOUS 1963-64; COLITIS, MUCOUS was see under COLONIC DISEASES, FUNCTIONAL 1965-78", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003109"}, {"RECTYPE": "D", "MH": "Colonic Neoplasms", "DE": "COLONIC NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Colon Cancer|T191|NON|NRW|NLM (2000)|OMIM (2013)|991108|abcdeef", "ENTRY": "Neoplasms, Colon", "MN": "C06.405.469.491.307.180", "MH_TH": "NLM (1964)", "ST": "T191", "AN": "coordinate with histological type of neoplasm; note SIGMOID NEOPLASMS is available; familial: consider also ADENOMATOUS POLYPOSIS COLI & COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS", "MS": "Tumors or cancer of the COLON.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D003110"}, {"RECTYPE": "D", "MH": "Colonic Polyps", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Polyps, Colonic", "MN": "C23.300.825.411.235", "MH_TH": "NLM (1984)", "ST": "T190", "PI": "Intestinal Polyps (1968-1983)", "MS": "Discrete tissue masses that protrude into the lumen of the COLON. These POLYPS are connected to the wall of the colon either by a stalk, pedunculus, or by a broad base.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19830531", "DC": "1", "DX": "19840101", "UI": "D003111"}, {"RECTYPE": "D", "MH": "Colonic Pseudo-Obstruction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ogilvie Syndrome|T047|EPO|NRW|NLM (2004)|021219|abcdef", "ENTRY": "Syndrome, Ogilvie", "MN": "C06.405.469.531.492.500.217", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Intestinal Pseudo-Obstruction, Idiopathic (1981-1986)", "MS": "Functional obstruction of the COLON leading to MEGACOLON in the absence of obvious COLONIC DISEASES or mechanical obstruction. When this condition is acquired, acute, and coexisting with another medical condition (trauma, surgery, serious injuries or illness, or medication), it is called Ogilvie's syndrome.", "PM": "91; was see under INTESTINAL PSEUDO-OBSTRUCTION 1987-90", "HN": "91(87); was see under INTESTINAL PSEUDO-OBSTRUCTION 1987-90", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19860617", "DC": "1", "DX": "19910101", "UI": "D003112"}, {"RECTYPE": "D", "MH": "Colonoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Colonoscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES COLONOSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Colonoscopic", "MN": "E04.502.250.250.250.160", "FX": "Colonoscopes", "MH_TH": "NLM (1981)", "ST": "T061", "AN": "/ instrum permitted but consider also COLONOSCOPES", "PI": "Endoscopy (1966-1980)", "MS": "Endoscopic examination, therapy or surgery of the luminal surface of the colon.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19800404", "DC": "1", "DX": "19810101", "UI": "D003113"}, {"RECTYPE": "D", "MH": "Colony-Forming Units Assay", "DE": "CFU ASSAY", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Stem Cell Assay|T059|NON|EQV|UNK (19XX)|830404|abcdef", "ENTRY": "Colony Forming Units Assay", "MN": "E05.242.383", "MH_TH": "NLM (1979)", "ST": "T059", "PI": "Spleen (1966-1978)", "MS": "A cytologic technique for measuring the functional capacity of stem cells by assaying their activity.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19771123", "DC": "1", "DX": "19790101", "UI": "D003114"}, {"RECTYPE": "D", "MH": "Colony-Stimulating Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Macrophage-Granulocyte Inducer|T116|T123|NON|BRD|NLM (1991)|900308|abbcdef", "ENTRY": "Myeloid Cell Growth Inducer", "MN": "D23.529.374.410.240", "FX": "Receptors, Colony-Stimulating Factor", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "0", "PI": "Glycoproteins (1966-1975)", "MS": "Glycoproteins found in a subfraction of normal mammalian plasma and urine. They stimulate the proliferation of bone marrow cells in agar cultures and the formation of colonies of granulocytes and/or macrophages. The factors include INTERLEUKIN-3; (IL-3); GRANULOCYTE COLONY-STIMULATING FACTOR; (G-CSF); MACROPHAGE COLONY-STIMULATING FACTOR; (M-CSF); and GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; (GM-CSF).", "OL": "use COLONY-STIMULATING FACTORS to search COLONY-STIMULATING FACTOR 1976-89", "PM": "79; was COLONY STIMULATING FACTOR see under GLYCOPROTEINS 1976-78; was COLONY-STIMULATING FACTOR 1979-89", "HN": "79(76); was COLONY STIMULATING FACTOR see under GLYCOPROTEINS 1976-78; was COLONY-STIMULATING FACTOR 1979-89", "MR": "20230316", "DA": "19750718", "DC": "1", "DX": "19790101", "UI": "D003115"}, {"RECTYPE": "D", "MH": "Color", "AQ": "ST", "ENTRY": "Colors", "MN": "G01.590.540.199", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "NIM; differentiate from PIGMENTATION in that PIGMENTATION is related to PIGMENTS, BIOLOGICAL", "MS": "The visually perceived property of objects created by absorption or reflection of specific wavelengths of light.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003116"}, {"RECTYPE": "D", "MH": "Color Vision Defects", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Monochromatopsia|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Vision Deficiency, Color", "MN": "C23.888.592.763.941.256", "FX": "Retinal Diseases", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Defects of color vision are mainly hereditary traits but can be secondary to acquired or developmental abnormalities in the CONES (RETINA). Severity of hereditary defects of color vision depends on the degree of mutation of the ROD OPSINS genes (on X CHROMOSOME and CHROMOSOME 3) that code the photopigments for red, green and blue.", "OL": "use COLOR VISION DEFECTS to search COLOR BLINDNESS 1966-89", "PM": "90; was COLOR BLINDNESS 1963-89", "HN": "90; was COLOR BLINDNESS 1963-89", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D003117"}, {"RECTYPE": "D", "MH": "Color Perception", "AQ": "DE GE IM PH RE", "ENTRY": "Perceptions, Color", "MN": "F02.463.593.932.217", "FX": "Color Vision Defects", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "do not confuse with COLOR VISION", "MS": "Mental processing of chromatic signals (COLOR VISION) from the eye by the VISUAL CORTEX where they are converted into symbolic representations. Color perception involves numerous neurons, and is influenced not only by the distribution of wavelengths from the viewed object, but also by its background color and brightness contrast at its boundary.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003118"}, {"RECTYPE": "D", "MH": "Color Perception Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Color Perception", "MN": "E01.370.380.850.150", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Type of vision test used to determine COLOR VISION DEFECTS.", "CATSH": "CAT LIST", "MR": "20150522", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003119"}, {"RECTYPE": "D", "MH": "Colorado", "AQ": "EH EP", "MN": "Z01.107.567.875.760.210", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "State bounded on the north by Wyoming and Nebraska, on the east by Kansas and Nebraska, on the south by New Mexico and Oklahoma, and on the west by Utah.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D003120"}, {"RECTYPE": "D", "MH": "Colorado Tick Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Tick Fever, Colorado", "MN": "C01.925.782.791.482", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by a tick-transm reovirus", "MS": "A febrile illness characterized by chills, aches, vomiting, leukopenia, and sometimes encephalitis. It is caused by the COLORADO TICK FEVER VIRUS, a reovirus transmitted by the tick Dermacentor andersoni.", "OL": "use ARBOVIRUS INFECTIONS to search COLORADO TICK FEVER 1966-74 (as Prov)", "PM": "91; was see under REOVIRUS INFECTIONS 1977-90; was see under ARBOVIRUS INFECTIONS 1975-76", "HN": "91(66); was see under REOVIRUS INFECTIONS 1977-90; was see under ARBOVIRUS INFECTIONS 1966-76 (Prov 1966-74)", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003121"}, {"RECTYPE": "D", "MH": "Colorado tick fever virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.223.719.160.200", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid46839", "MS": "A species of COLTIVIRUS transmitted by the tick DERMACENTOR andersonii and causing fever, chills, aching head and limbs, and often vomiting. It occurs in the northwestern United States, except the Pacific Coast.", "PM": "91; was see under REOVIRIDAE 1981-90; was see under REOVIRUSES 1975-80", "HN": "91(75); was see under REOVIRIDAE 1981-90; was see under REOVIRUSES 1975-80", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D003122"}, {"RECTYPE": "D", "MH": "Colorectal Neoplasms, Hereditary Nonpolyposis", "DE": "COLORECTAL NEOPL HEREDITARY NONPOLYPOSIS", "AQ": "BL BS CF CH CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Lynch Syndrome|T191|EPO|NRW|GHR (2014)|NLM (1992)|910110|abcdeef", "ENTRY": "Syndrome, Lynch", "MN": "C18.452.284.255", "MH_TH": "NLM (1987)", "ST": "T191", "MS": "A group of autosomal-dominant inherited diseases in which COLON CANCER arises in discrete adenomas. Unlike FAMILIAL POLYPOSIS COLI with hundreds of polyps, hereditary nonpolyposis colorectal neoplasms occur much later, in the fourth and fifth decades. HNPCC has been associated with germline mutations in mismatch repair (MMR) genes. It has been subdivided into Lynch syndrome I or site-specific colonic cancer, and LYNCH SYNDROME II which includes extracolonic cancer.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20210305", "DA": "19860624", "DC": "1", "DX": "19870101", "UI": "D003123"}, {"RECTYPE": "D", "MH": "Colorimetry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "MN": "E05.196.922.250", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "an anal chem technique; NIM", "MS": "Any technique by which an unknown color is evaluated in terms of standard colors. The technique may be visual, photoelectric, or indirect by means of spectrophotometry. It is used in chemistry and physics. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003124"}, {"RECTYPE": "D", "MH": "Colostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Colostomies", "MN": "E04.579.338.225", "FX": "Surgical Stomas", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "artificial anus goes here; pathological artificial anus in historical literature is indexed under INTESTINAL FISTULA or its specifics", "MS": "The surgical construction of an opening between the colon and the surface of the body.", "PM": "ANUS, ARTIFICIAL was see COLOSTOMY 1975-97", "HN": "ANUS, ARTIFICIAL was see COLOSTOMY 1975-97", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D003125"}, {"RECTYPE": "D", "MH": "Colostrum", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Colostrums", "MN": "A12.200.194", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "check the tags FEMALE & PREGNANCY", "MS": "The thin, yellow, serous fluid secreted by the mammary glands during pregnancy and immediately postpartum before lactation begins. It consists of immunologically active substances, white blood cells, water, protein, fat, and carbohydrates.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003126"}, {"RECTYPE": "D", "MH": "Colposcopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Colposcopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES COLPOSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Colposcopic", "MN": "E04.950.300.210", "FX": "Colposcopes", "MH_TH": "NLM (1978)", "ST": "T061", "AN": "/ instrum permitted but consider also COLPOSCOPES", "MS": "The examination, therapy or surgery of the cervix and vagina by means of a specially designed endoscope introduced vaginally.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003127"}, {"RECTYPE": "D", "MH": "Coma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pseudocoma|T048|NON|REL|NLM (2000)|991108|abcdef", "ENTRY": "Pseudocomas", "MN": "C23.888.592.604.359.800.200", "FX": "Persistent Vegetative State", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "check MeSH for specific coma terms", "MS": "A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003128"}, {"RECTYPE": "D", "MH": "Comb and Wattles", "DE": "COMB WATTLES", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Wattles|T023|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Wattle", "MN": "A13.242", "MH_TH": "NLM (1968)", "ST": "T023", "PI": "Poultry (1966-1967)", "MS": "Fleshy and reddish outgrowth of skin tissue found on top of the head, attached to the sides of the head, and hanging from the mandible of birds such as turkeys and chickens.", "PM": "68", "HN": "68", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003129"}, {"RECTYPE": "D", "MH": "Combat Disorders", "DE": "COMBAT DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "War Neuroses|T048|NON|BRD|UNK (19XX)|800520|abcdef", "ENTRY": "Stress Disorders, Combat", "MN": "F03.950.750.249", "FX": "Stress Disorders, Post-Traumatic", "MH_TH": "NLM (1963)", "ST": "T048", "MS": "Neurotic reactions to unusual, severe, or overwhelming military stress.", "OL": "use COMBAT DISORDERS to search NEUROSES, WAR 1966-80", "PM": "91; was see under STRESS DISORDERS, POST-TRAUMATIC 1981-90; was NEUROSES, WAR 1963-80", "HN": "91(81); was see under STRESS DISORDERS, POST-TRAUMATIC 1981-90; was NEUROSES, WAR 1963-80", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D003130"}, {"RECTYPE": "D", "MH": "Combined Modality Therapy", "DE": "COMBINED MODALITY THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Therapy, Combined Modality|T061|NON|EQV|UNK (19XX)|830610|THER COMBINED MODALITY|abcdefv", "ENTRY": "Treatments, Multimodal", "MN": "E02.186", "FX": "Antineoplastic Combined Chemotherapy Protocols", "MH_TH": "NLM (1984)", "ST": "T061", "AN": "almost never IM; coordinate disease term with specific ther qualif (IM) + specific ther (IM or NIM): TN 6; for combined ther of drugs DRUG COMBINATIONS or DRUG THERAPY, COMBINATION is available, for combined anticancer ther ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS is available; CHEMOTHERAPY, ADJUVANT is also available; Manual 24.4.2.2+", "PI": "Drug Therapy, Combination (1974-1983)", "MS": "The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "20010803", "DA": "19830610", "DC": "1", "DX": "19840101", "UI": "D003131"}, {"RECTYPE": "D", "MH": "Commerce", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Business|T057|NON|BRD|POPLINE (1986)|740329|abcdef", "ENTRY": "Vendor", "MN": "J01.219", "FX": "Industry", "MH_TH": "NLM (1991)", "ST": "T057", "MS": "The interchange of goods or commodities, especially on a large scale, between different countries or between populations within the same country. It includes trade (the buying, selling, or exchanging of commodities, whether wholesale or retail) and business (the purchase and sale of goods to make a profit). (From Random House Unabridged Dictionary, 2d ed, p411, p2005 & p283)", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003132"}, {"RECTYPE": "D", "MH": "Commission on Professional and Hospital Activities", "DE": "CPHA", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Professional Activity Study|T170|NON|NRW|UNK (19XX)|770505|abcdef", "ENTRY": "Study, Professional Activity", "MN": "N05.700.175.500.200", "MH_TH": "NLM (1977)", "ST": "T093", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "MS": "The non-profit, non-governmental organization which collects, processes, and distributes data on hospital use. Two programs of the Commission are the Professional Activity Study and the Medical Audit Program.", "PM": "91; was see under MEDICAL AUDIT Aug 1977-90", "HN": "91(Aug 77); was see under MEDICAL AUDIT 1977-90", "MR": "20150605", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D003133"}, {"RECTYPE": "D", "MH": "Commitment of Mentally Ill", "AQ": "EC ES HI LJ SN ST TD", "ENTRY": "Mentally Ill Commitments", "MN": "N03.706.535.351.200", "FX": "Patient Advocacy", "MH_TH": "NLM (1975)", "ST": "T089", "AN": "do not coordinate with HOSPITALIZATION", "MS": "Legal process required for the institutionalization of a patient with severe mental problems.", "PM": "83; was see under FORENSIC PSYCHIATRY 1975-82", "HN": "83(75); was see under FORENSIC PSYCHIATRY 1975-82", "CATSH": "CAT LIST", "MR": "20181011", "DA": "19741111", "DC": "1", "DX": "19830101", "UI": "D003134"}, {"RECTYPE": "D", "MH": "Common Bile Duct", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Choledochus|T023|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Duct, Common Bile", "MN": "A03.159.183.079.300", "FX": "Choledochostomy", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at CHOLEDOCH-", "MS": "The largest bile duct. It is formed by the junction of the CYSTIC DUCT and the COMMON HEPATIC DUCT.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003135"}, {"RECTYPE": "D", "MH": "Common Bile Duct Diseases", "DE": "COMMON BILE DUCT DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C06.130.120.250", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Common Bile Duct (1966-1979)", "MS": "Diseases of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D003137"}, {"RECTYPE": "D", "MH": "Common Bile Duct Neoplasms", "DE": "COMMON BILE DUCT NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "MN": "C06.301.120.250.250", "MH_TH": "NLM (1980)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "PI": "Common Bile Duct (1966-1979)", "MS": "Tumor or cancer of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D003138"}, {"RECTYPE": "D", "MH": "Common Cold", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Coryza, Acute|T047|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Common Colds", "MN": "C08.730.162", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "often caused by a picornavirus; do not confuse CATARRH in animals with MALIGNANT CATARRH, a herpesvirus infection of cattle or with NASAL CATARRH see RHINITIS", "MS": "A catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. It generally involves a runny nose, nasal congestion, and sneezing.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003139"}, {"RECTYPE": "D", "MH": "Communicable Disease Control", "DE": "COMMUNICABLE DIS CONTROL", "AQ": "EC HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Flattening the Curve, Communicable Disease Control|T058|NON|NRW|NLM (2021)|200422|abcdef", "ENTRY": "Control, Parasite", "MN": "N06.850.780.200", "FX": "Infectious Disease Medicine", "MH_TH": "POPLINE (1978)", "ST": "T058", "AN": "general only: prefer specific disease with /prev; INFECTION CONTROL is also available", "MS": "Programs of surveillance designed to prevent the transmission of disease by any means from person to person or from animal to man.", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003140"}, {"RECTYPE": "D", "MH": "Communicable Diseases", "DE": "COMMUNICABLE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Infectious Diseases|T047|NON|EQV|UNK (19XX)|740329|INFECT DIS|abcdefv", "ENTRY": "Infectious Disease", "MN": "C23.550.291.531", "FX": "Disease Reservoirs", "EC": "prevention & control:Communicable Disease Control", "MH_TH": "POPLINE (1978)", "ST": "T047", "AN": "general or unspecified; prefer specific disease", "MS": "An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003141"}, {"RECTYPE": "D", "MH": "Communication", "AQ": "HI", "PRINT ENTRY": "Social Communication|T054|NON|NRW|NLM (2021)|200118|abcdef", "ENTRY": "Social Communications", "MN": "L01.143", "MH_TH": "POPLINE (1978)", "ST": "T054", "AN": "includes personal & technological communication; ANIMAL COMMUNICATION is also available", "MS": "The exchange or transmission of ideas, attitudes, or beliefs between individuals or groups.", "CATSH": "CAT LIST", "MR": "20210629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003142"}, {"RECTYPE": "D", "MH": "Communication Aids for Disabled", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Telecommunications Devices for the Deaf|T073|NON|NRW|NLM (2003)|020222|abcdef", "ENTRY": "Text Telephones", "MN": "E07.796.250", "FX": "Speech Recognition Software", "MH_TH": "NLM (1980)", "ST": "T073", "PI": "Nonverbal Communication (1970-1979)", "MS": "Equipment that provides mentally or physically disabled persons with a means of communication. The aids include display boards, typewriters, cathode ray tubes, computers, and speech synthesizers. The output of such aids includes written words, artificial speech, language signs, Morse code, and pictures.", "OL": "use COMMUNICATION AIDS FOR DISABLED to search COMMUNICATION AIDS FOR HANDICAPPED 1980-92", "PM": "93; was COMMUNICATION AIDS FOR HANDICAPPED 1980-92 (see under SELF-HELP DEVICES 1980-90)", "HN": "93; was COMMUNICATION AIDS FOR HANDICAPPED 1980-92 (see under SELF-HELP DEVICES 1980-90)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19790411", "DC": "1", "DX": "19910101", "UI": "D003143"}, {"RECTYPE": "D", "MH": "Communication Barriers", "ENTRY": "Language Barrier", "MN": "L01.143.230", "MH_TH": "NLM (1979)", "ST": "T078", "AN": "coordinate IM with specific \"barrier\" (language, cultural, etc.) if pertinent (IM)", "PI": "Communication (1966-1978)", "MS": "Those factors, such as language or sociocultural relationships, which interfere in the meaningful interpretation and transmission of ideas between individuals or groups.", "PM": "91; was see under COMMUNICATION 1979-90", "HN": "91(79); was see under COMMUNICATION 1979-90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19780504", "DC": "1", "DX": "19910101", "UI": "D003144"}, {"RECTYPE": "D", "MH": "Communication Methods, Total", "PRINT ENTRY": "Total Communication Methods|T054|NON|EQV|UNK (19XX)|781214|abcdef", "ENTRY": "Total Communication Method", "MN": "E02.831.200.221", "MH_TH": "NLM (1980)", "ST": "T054", "AN": "restrict to communication with hearing-impaired; coordinate with specific hearing disorder /rehabil", "PI": "Deafness (1966) /rehabilitation (1967-1979)", "MS": "Utilization of all available receptive and expressive modes for the purpose of achieving communication with the hearing impaired, such as gestures, postures, facial expression, types of voice, formal speech and non-speech systems, and simultaneous communication.", "PM": "91; was see under REHABILITATION 1980-90", "HN": "91(80); was see under REHABILITATION 1980-90", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19781214", "DC": "1", "DX": "19910101", "UI": "D003145"}, {"RECTYPE": "D", "MH": "Communications Media", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Media, Communications", "MN": "L01.462.500", "MH_TH": "NLM (1974)", "ST": "T170", "AN": "general or unspecified; prefer specifics", "PI": "specific medium (1966-1997)", "MS": "The means of interchanging or transmitting and receiving information. Historically the media were written: books, journals, newspapers, and other publications; in the modern age the media include, in addition, radio, television, computers, and information networks.", "PM": "98", "HN": "98; use explode 1975-97", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003146"}, {"RECTYPE": "D", "MH": "Communication Disorders", "DE": "COMMUNICATION DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Neurogenic Communication Disorder", "MN": "F03.625.374", "MH_TH": "NLM (1985)", "ST": "T048", "AN": "general or unspecified: prefer specifics", "PI": "Speech Disorders (1966-1984)", "MS": "Disorders of verbal and nonverbal communication caused by receptive or expressive LANGUAGE DISORDERS, cognitive dysfunction (e.g., MENTAL RETARDATION), psychiatric conditions, and HEARING DISORDERS.", "PM": "1998; see COMMUNICATIVE DISORDERS 1985-97", "HN": "1998(1985)", "CATSH": "CAT LIST", "MR": "20150706", "DA": "19840411", "DC": "1", "DX": "19850101", "UI": "D003147"}, {"RECTYPE": "D", "MH": "Communism", "AQ": "CL EC HI SN TD", "PRINT ENTRY": "Marxism|T078|NON|EQV|POPLINE (1981)|890216|abcdef", "MN": "I01.696.232", "MH_TH": "POPLINE (1978)", "ST": "T078", "AN": "specify geog if pertinent", "MS": "A totalitarian system of government in which a single authoritarian party controls state-owned means of production with the professed aim of establishing a classless society.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003148"}, {"RECTYPE": "D", "MH": "Community Dentistry", "DE": "COMMUNITY DENT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Dentistry, Community|T091|NON|EQV|NLM (1991)|900208|DENT COMMUNITY|abcdefv", "MN": "H02.163.876.770.357", "MH_TH": "NLM (1975)", "ST": "T091", "MS": "The practice of dentistry concerned with preventive as well as diagnostic and treatment programs in a circumscribed population.", "OL": "search PUBLIC HEALTH DENTISTRY 1971-74", "PM": "91; was see under PUBLIC HEALTH DENTISTRY 1975-90", "HN": "91(75); was see under PUBLIC HEALTH DENTISTRY 1975-90", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003149"}, {"RECTYPE": "D", "MH": "Community Health Workers", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Village Health Worker|T097|NON|NRW|UNK (19XX)|750619|abcdef", "ENTRY": "Workers, Village Health", "MN": "N02.360.067.080", "MH_TH": "NLM (2012)", "ST": "T097", "AN": "IM", "PI": "Community Mental Health Services (1967-1970)", "MS": "Persons trained to assist professional health personnel in communicating with residents in the community concerning needs and availability of health services.", "PM": "71", "HN": "71", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D003150"}, {"RECTYPE": "D", "MH": "Community Health Centers", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Neighborhood Health Centers|T073|T093|NON|NRW|UNK (19XX)|780517|abbcdef", "ENTRY": "Satellite Center", "MN": "N02.278.035.128", "MH_TH": "NLM (1975)", "ST": "T093", "AN": "IM", "PI": "Community Health Services (1966-1974)", "MS": "Facilities which administer the delivery of health care services to people living in a community or neighborhood.", "OL": "use COMMUNITY HEALTH CENTERS to search NEIGHBORHOOD HEALTH CENTERS 1975-78; use COMMUNITY HEALTH SERVICES 1968-74", "PM": "79; was NEIGHBORHOOD HEALTH CENTERS see under COMMUNITY HEALTH SERVICES 1968-78", "HN": "79; was NEIGHBORHOOD HEALTH CENTERS see under COMMUNITY HEALTH SERVICES 1968-78", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D003151"}, {"RECTYPE": "D", "MH": "Community Health Nursing", "DE": "COMMUNITY HEALTH NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Community Health|T058|T091|NON|EQV|UNK (19XX)|770421|NURS COMMUNITY HEALTH|abbcdefv", "MN": "N02.421.143.150", "MH_TH": "NLM (1975)", "ST": "T091", "AN": "do not confuse with PUBLIC HEALTH NURSING", "MS": "General and comprehensive nursing practice directed to individuals, families, or groups as it relates to and contributes to the health of a population or community. This is not an official program of a Public Health Department.", "PM": "77; was see under COMMUNITY HEALTH SERVICES 1975-76", "HN": "77(75); was see under COMMUNITY HEALTH SERVICES 1975-76", "MR": "20150629", "DA": "19741111", "DC": "1", "DX": "19770101", "UI": "D003152"}, {"RECTYPE": "D", "MH": "Community Health Services", "DE": "COMMUNITY HEALTH SERV", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Community Health Care|T058|NON|BRD|NLM (1998)|970507|abcdef", "ENTRY": "Service, Community Health", "MN": "N02.421.143", "FX": "Paramedicine", "MH_TH": "POPLINE (1978)", "ST": "T058", "MS": "Diagnostic, therapeutic and preventive health services provided for individuals in the community.", "PM": "67", "HN": "67(65)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D003153"}, {"RECTYPE": "D", "MH": "Community Medicine", "DE": "COMMUNITY MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Community|T091|NON|EQV|NLM (1991)|891129|MED COMMUNITY|abcdefv", "MN": "H02.403.220", "MH_TH": "NLM (1975)", "ST": "T091", "MS": "A branch of medicine concerned with the total health of the individual within the home environment and in the community, and with the application of comprehensive care to the prevention and treatment of illness in the entire community.", "OL": "search COMPREHENSIVE HEALTH CARE 1970-74", "PM": "77; was see under COMPREHENSIVE HEALTH CARE 1970-76", "HN": "77(75); was see under COMPREHENSIVE HEALTH CARE 1970-76", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D003154"}, {"RECTYPE": "D", "MH": "Community Mental Health Centers", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "CMHC|T073|T093|ABB|EQV|UNK (19XX)|850424|abbcdef", "MN": "N02.278.035.158", "MH_TH": "NLM (1979)", "ST": "T093", "PI": "Community Mental Health Services (1967-1978)", "MS": "Facilities which administer the delivery of psychologic and psychiatric services to people living in a neighborhood or community.", "OL": "search COMMUNITY MENTAL HEALTH SERVICES 1978", "PM": "79; was see COMMUNITY MENTAL HEALTH SERVICES 1978", "HN": "79; was see COMMUNITY MENTAL HEALTH SERVICES 1978", "MR": "19991103", "DA": "19780517", "DC": "1", "DX": "19790101", "UI": "D003155"}, {"RECTYPE": "D", "MH": "Community Mental Health Services", "DE": "COMMUNITY MENTAL HEALTH SERV", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Mental Health Services, Community|T058|NON|EQV|UNK (19XX)|780508|MENTAL HEALTH SERV COMMUNITY|abcdefv", "ENTRY": "Treatment, Assertive Community", "MN": "N02.421.461.232", "MH_TH": "NLM (1967)", "ST": "T058", "AN": "Public Laws 88-164 & 89-105", "PI": "Mental Health Services (1966)", "MS": "Diagnostic, therapeutic and preventive mental health services provided for individuals in the community.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D003156"}, {"RECTYPE": "D", "MH": "Community Pharmacy Services", "DE": "COMMUNITY PHARM SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Pharmacy Service, Community", "MN": "N02.421.668.274", "MH_TH": "NLM (1968)", "ST": "T058", "PI": "Pharmacy (1966-1967)", "MS": "Total pharmaceutical services provided to the public through community pharmacies.", "OL": "search COMMUNITY PHARMACIES under PHARMACIES 1968-78", "PM": "68; COMMUNITY PHARMACIES was see under PHARMACIES 1968-78", "HN": "68; COMMUNITY PHARMACIES was see under PHARMACIES 1968-78", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003157"}, {"RECTYPE": "D", "MH": "Community Psychiatry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Social Psychiatry|T091|NON|BRD|UNK (19XX)|740330|abcdef", "ENTRY": "Psychiatry, Social", "MN": "H02.403.690.150", "MH_TH": "NLM (1971)", "ST": "T091", "PI": "Psychiatry (1966-1970)", "MS": "Branch of psychiatry concerned with the provision and delivery of a coordinated program of mental health care to a specified population. The foci included in this concept are: all social, psychological and physical factors related to etiology, prevention, and maintaining positive mental health in the community.", "OL": "use COMMUNITY PSYCHIATRY to search PSYCHIATRY, COMMUNITY 1971-79 (as Prov 1971-72)", "PM": "80; was PSYCHIATRY, COMMUNITY 1973-79", "HN": "80; was PSYCHIATRY, COMMUNITY 1971-79 (Prov 1971-72)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003158"}, {"RECTYPE": "D", "MH": "Community-Institutional Relations", "DE": "COMMUNITY INSTITUTIONAL RELAT", "AQ": "EC LJ ST TD", "PRINT ENTRY": "Community Outreach|T057|NON|REL|NLM (1996)|950313|abcdef", "ENTRY": "Relations, Community-Institutional", "MN": "N04.452.822.210", "MH_TH": "NLM (1978)", "ST": "T054", "AN": "specify institution (IM) and geog if pertinent", "MS": "The interactions between members of a community and representatives of the institutions within that community.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20021023", "DA": "19770505", "DC": "1", "DX": "19780101", "UI": "D003159"}, {"RECTYPE": "D", "MH": "Comparative Study", "ENTRY": "Comparative Studies|T062|T170|NON|EQV|BIOETHICS (1995)|UNK (19XX)|781219|abbcdeef", "MN": "V03.250", "MH_TH": "NLM (1978)", "ST": "T170", "AN": "this heading is used as a Publication Type; do not use for comparison of subject & normal controls; differentiate from the specialties ANATOMY, COMPARATIVE; HISTOLOGY, COMPARATIVE; etc", "MS": "Comparison of outcomes, results, responses, etc for different techniques, therapeutic approaches or other inputs.", "HN": "1966", "MR": "20130709", "DA": "19990101", "DC": "2", "DX": "19660101", "UI": "D003160"}, {"RECTYPE": "D", "MH": "Compartment Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Compartment Syndrome", "MN": "C14.907.303", "FX": "Nerve Compression Syndromes", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Muscular Diseases (1966-1980)", "MS": "Conditions in which increased pressure within a limited space compromises the BLOOD CIRCULATION and function of tissue within that space. Some of the causes of increased pressure are TRAUMA, tight dressings, HEMORRHAGE, and exercise. Sequelae include nerve compression (NERVE COMPRESSION SYNDROMES); PARALYSIS; and ISCHEMIC CONTRACTURE. FASCIOTOMY is often used to decompress increased pressure and eliminate pain associated with compartment syndromes.", "PM": "1981", "HN": "1981", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19800514", "DC": "1", "DX": "19810101", "UI": "D003161"}, {"RECTYPE": "D", "MH": "Competency-Based Education", "DE": "COMPETENCY BASED EDUC", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Education, Competency-Based|T078|NON|EQV|UNK (19XX)|780508|EDUC COMPETENCY BASED|abcdefv", "ENTRY": "Educations, Competency-Based", "MN": "I02.158.210", "MH_TH": "NLM (1979)", "ST": "T078", "MS": "Educational programs designed to ensure that students attain prespecified levels of competence in a given field or training activity. Emphasis is on achievement or specified objectives.", "PM": "91; was see under CURRICULUM 1979-90", "HN": "91(79); was see under CURRICULUM 1979-90", "MR": "20180629", "DA": "19780508", "DC": "1", "DX": "19910101", "UI": "D003162"}, {"RECTYPE": "D", "MH": "Competitive Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Competitive Behaviors", "MN": "F01.145.813.105", "MH_TH": "NLM (1968)", "ST": "T054", "AN": "human & animal", "PI": "Motivation (1966-1967)", "MS": "The direct struggle between individuals for environmental necessities or for a common goal.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003163"}, {"RECTYPE": "D", "MH": "Competitive Bidding", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Request for Proposal|T170|NON|NRW|UNK (19XX)|850424|abcdef", "ENTRY": "Request for Proposals", "MN": "N03.219.463.100.110", "MH_TH": "NLM (1986)", "ST": "T057", "PI": "Financial Management (1978-1985)", "MS": "Pricing statements presented by more than one party for the purpose of securing a contract.", "PM": "91; was see under FINANCIAL MANAGEMENT 1986-90", "HN": "91(86); was see under FINANCIAL MANAGEMENT 1986-90", "MR": "19980610", "DA": "19850424", "DC": "1", "DX": "19910101", "UI": "D003164"}, {"RECTYPE": "D", "MH": "Complement System Proteins", "AQ": "AD AE AG AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Complement Proteins|T116|T129|NON|EQV|UNK (19XX)|870509|abbcdef", "ENTRY": "Proteins, Complement System", "MN": "D12.776.124.486.274", "PA": "Immunologic Factors", "FX": "Receptors, Complement", "EC": "antagonists & inhibitors:Complement Inactivator Proteins", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "9007-36-7", "AN": "general or unspecified; prefer specifics", "MS": "Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY).", "PM": "2006; see COMPLEMENT 1963-2005", "HN": "2006 (1963)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D003165"}, {"RECTYPE": "D", "MH": "Complement Activating Enzymes", "AQ": "AD AE AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Enzymes, Complement Activating", "MN": "D12.776.124.486.274.045", "PA": "Immunologic Factors", "MH_TH": "NLM (1978)", "ST": "T129", "RN": "EC 3.-", "PI": "specific complement (1975-1977)", "MS": "Enzymes that activate one or more COMPLEMENT PROTEINS in the complement system leading to the formation of the COMPLEMENT MEMBRANE ATTACK COMPLEX, an important response in host defense. They are enzymes in the various COMPLEMENT ACTIVATION pathways.", "PM": "78", "HN": "78", "MR": "20060705", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D003166"}, {"RECTYPE": "D", "MH": "Complement Activation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Complement Activations", "MN": "G12.274", "FX": "Complement Fixation Tests", "MH_TH": "NLM (1979)", "ST": "T044", "PI": "Complement Fixation Tests (1966-1978)", "MS": "The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19771202", "DC": "1", "DX": "19790101", "UI": "D003167"}, {"RECTYPE": "D", "MH": "Complement Fixation Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Conglutination Reaction|T059|NON|NRW|NLM (1997)|960412|abcdef", "ENTRY": "Tests, Complement Fixation", "MN": "E05.478.594.760.150", "MH_TH": "NLM (1966)", "ST": "T059", "MS": "Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1.", "PM": "CONGLUTINATION REACTION was heading 1975-96 (see under COMPLEMENT FIXATION TESTS 1975-90); COMPLEMENT ABSORPTION TEST, CONGLUTINATING was see CONGLUTINATION REACTION 1992-96", "HN": "CONGLUTINATION REACTION was heading 1975-96 (see under COMPLEMENT FIXATION TESTS 1975-90); COMPLEMENT ABSORPTION TEST, CONGLUTINATING was see CONGLUTINATION REACTION 1992-96", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D003168"}, {"RECTYPE": "D", "MH": "Complement Inactivator Proteins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Complement Inactivator", "MN": "D12.776.124.486.274.920", "PA": "Complement Inactivating Agents", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "AN": "do not confuse with COMPLEMENT INACTIVATING AGENTS", "PI": "specific complement/AI (1975-1977)", "MS": "Serum proteins that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. The complement system is tightly regulated by inactivators that accelerate the decay of intermediates and certain cell surface receptors.", "PM": "2006; see COMPLEMENT INACTIVATORS 1978-2005", "HN": "2006 (1978)", "MR": "20140617", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D003169"}, {"RECTYPE": "D", "MH": "Complement Pathway, Alternative", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Properdin Pathway|T044|NON|EQV|UNK (19XX)|771202|abcdef", "ENTRY": "Complement Activation Pathway, Alternative|T044|NON|EQV|NLM (2006)|041129|abcdef", "MN": "G12.274.695", "MH_TH": "NLM (1979)", "ST": "T044", "PI": "Complement Fixation Tests (1966-1978)", "MS": "Complement activation initiated by the interaction of microbial ANTIGENS with COMPLEMENT C3B. When COMPLEMENT FACTOR B binds to the membrane-bound C3b, COMPLEMENT FACTOR D cleaves it to form alternative C3 CONVERTASE (C3BBB) which, stabilized by COMPLEMENT FACTOR P, is able to cleave multiple COMPLEMENT C3 to form alternative C5 CONVERTASE (C3BBB3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX.", "PM": "91; was see under COMPLEMENT ACTIVATION 1979-90", "HN": "91(79); was see under COMPLEMENT ACTIVATION 1979-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19771202", "DC": "1", "DX": "19910101", "UI": "D003170"}, {"RECTYPE": "D", "MH": "Complement Pathway, Classical", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Classical Complement Pathway|T044|NON|EQV|UNK (19XX)|771202|abcdef", "ENTRY": "Complement Activation Pathway, Classical|T044|NON|EQV|NLM (2006)|041129|abcdef", "MN": "G12.274.698", "MH_TH": "NLM (1979)", "ST": "T044", "PI": "Complement Fixation Tests (1966-1978)", "MS": "Complement activation initiated by the binding of COMPLEMENT C1 to ANTIGEN-ANTIBODY COMPLEXES at the COMPLEMENT C1Q subunit. This leads to the sequential activation of COMPLEMENT C1R and COMPLEMENT C1S subunits. Activated C1s cleaves COMPLEMENT C4 and COMPLEMENT C2 forming the membrane-bound classical C3 CONVERTASE (C4B2A) and the subsequent C5 CONVERTASE (C4B2A3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX.", "PM": "91; was see under COMPLEMENT ACTIVATION 1979-90", "HN": "91(79); was see under COMPLEMENT ACTIVATION 1979-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19771202", "DC": "1", "DX": "19910101", "UI": "D003171"}, {"RECTYPE": "D", "MH": "Complement C1", "DS": "COMPLEMENT C 01", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 1, Complement", "MN": "D12.776.124.486.274.050", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "AN": "/antag permitted but consider also COMPLEMENT C1 INACTIVATOR PROTEINS", "PI": "Complement (1968-1974)", "MS": "The first complement component to act in the activation of CLASSICAL COMPLEMENT PATHWAY. It is a calcium-dependent trimolecular complex made up of three subcomponents: COMPLEMENT C1Q; COMPLEMENT C1R; and COMPLEMENT C1S at 1:2:2 ratios. When the intact C1 binds to at least two antibodies (involving C1q), C1r and C1s are sequentially activated, leading to subsequent steps in the cascade of COMPLEMENT ACTIVATION.", "PM": "2006; see COMPLEMENT 1 1978-2005, see COMPLEMENT 1975-1977", "HN": "2006 (1975)", "MR": "20130709", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D003172"}, {"RECTYPE": "D", "MH": "Complement C1s", "DS": "COMPLEMENT C 01 S", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Esterase, Complement 1", "MN": "D12.776.124.486.274.050.290", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "EC 3.4.21.42", "PI": "Esterases (1966-1977)", "MS": "A 77-kDa subcomponent of complement C1, encoded by gene C1S, is a SERINE PROTEASE existing as a proenzyme (homodimer) in the intact complement C1 complex. Upon the binding of COMPLEMENT C1Q to antibodies, the activated COMPLEMENT C1R cleaves C1s into two chains, A (heavy) and B (light, the serine protease), linked by disulfide bonds yielding the active C1s. The activated C1s, in turn, cleaves COMPLEMENT C2 and COMPLEMENT C4 to form C4b2a (CLASSICAL C3 CONVERTASE).", "PM": "2006; see COMPLEMENT 1S 1990-2005; for COMPLEMENT 1 ESTERASE see COMPLEMENT ACTIVATING ENZYMES 1978-1989", "HN": "2006 (1978)", "MR": "20060705", "DA": "19770516", "DC": "1", "DX": "19900101", "UI": "D003173"}, {"RECTYPE": "D", "MH": "Complement C1 Inactivator Proteins", "DE": "C1 INACT", "DS": "COMPLEMENT C 01 INACTIVATOR PROTEINS", "AQ": "AD AE AG AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Complement Component 1 Inactivator Proteins|T116|T129|NON|EQV|NLM (2006)|041215|abbcdef", "MN": "D12.776.872.140", "PA": "Complement Inactivating Agents", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "AN": "do not confuse with COMPLEMENT C1 INHIBITOR PROTEIN", "PI": "Glycoproteins (1966-1977)", "MS": "Serum proteins that inhibit, antagonize, or inactivate COMPLEMENT C1 or its subunits.", "PM": "2006; see COMPLEMENT 1 INACTIVATORS 1978-2005", "HN": "2006 (1978)", "MR": "20150622", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D003174"}, {"RECTYPE": "D", "MH": "Complement C2", "DS": "COMPLEMENT C 02", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 2, Complement", "MN": "D12.776.124.486.274.150", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Protein Binding (1966-1974)", "MS": "A component of the CLASSICAL COMPLEMENT PATHWAY. C2 is cleaved by activated COMPLEMENT C1S into COMPLEMENT C2B and COMPLEMENT C2A. C2a, the COOH-terminal fragment containing a SERINE PROTEASE, combines with COMPLEMENT C4B to form C4b2a (CLASSICAL PATHWAY C3 CONVERTASE) and subsequent C4b2a3b (CLASSICAL PATHWAY C5 CONVERTASE).", "PM": "2006; see COMPLEMENT 2 1978-2005, see COMPLEMENT 1975-1977", "HN": "2006 (1975)", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D003175"}, {"RECTYPE": "D", "MH": "Complement C3", "DS": "COMPLEMENT C 03", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pro Complement 3", "MN": "D12.776.124.486.274.250", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Phagocytosis (1966-1974)", "MS": "A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase.", "PM": "2006; see COMPLEMENT 3 1978-2005, see COMPLEMENT 1975-1977; COMPLEMENT C3 PRECURSOR was indexed under COMPLEMENT 3 1982-2005", "HN": "2006 (1975)", "MR": "20050711", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D003176"}, {"RECTYPE": "D", "MH": "Complement C3 Nephritic Factor", "DS": "COMPLEMENT C 03 NEPHRITIC FACTOR", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "C3NeF IgG Autoantibody|T116|T129|ABX|EQV|NLM (2023)|210924|abbcdef", "ENTRY": "IgG Autoantibody, C3NeF", "MN": "D12.776.377.715.548.114.323.300", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Complement 3 (1975-1977)", "MS": "An IgG autoantibody against the ALTERNATIVE PATHWAY C3 CONVERTASE, found in serum of patients with MESANGIOCAPILLARY GLOMERULONEPHRITIS. The binding of this autoantibody to C3bBb stabilizes the enzyme thus reduces the actions of C3b inactivators (COMPLEMENT FACTOR H; COMPLEMENT FACTOR I). This abnormally stabilized enzyme induces a continuous COMPLEMENT ACTIVATION and generation of C3b thereby promoting the assembly of MEMBRANE ATTACK COMPLEX and cytolysis.", "PM": "2006; see COMPLEMENT 3 NEPHRITIC FACTOR 1991-2005, see COMPLEMENT INACTIVATORS 1978-1990", "HN": "2006 (1978)", "MR": "20220413", "DA": "19770520", "DC": "1", "DX": "19910101", "UI": "D003178"}, {"RECTYPE": "D", "MH": "Complement C3b", "DS": "COMPLEMENT C 03 B", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 3b, Complement", "MN": "D12.776.124.486.274.250.260", "PA": "Immunologic Factors", "FX": "Receptors, Complement 3b", "MH_TH": "NLM (2006)", "ST": "T129", "N1": "Complement C3b", "RN": "80295-43-8", "AN": "/antag: consider COMPLEMENT C3B INACTIVATOR PROTEINS", "PI": "Complement 3 (1975-1977)", "MS": "The larger fragment generated from the cleavage of COMPLEMENT C3 by C3 CONVERTASE. It is a constituent of the ALTERNATIVE PATHWAY C3 CONVERTASE (C3bBb), and COMPLEMENT C5 CONVERTASES in both the classical (C4b2a3b) and the alternative (C3bBb3b) pathway. C3b participates in IMMUNE ADHERENCE REACTION and enhances PHAGOCYTOSIS. It can be inactivated (iC3b) or cleaved by various proteases to yield fragments such as COMPLEMENT C3C; COMPLEMENT C3D; C3e; C3f; and C3g.", "PM": "2006; see COMPLEMENT 3B 1978-2005", "HN": "2006 (1978)", "MR": "20130709", "DA": "19770517", "DC": "1", "DX": "19780101", "UI": "D003179"}, {"RECTYPE": "D", "MH": "Complement C3b Inactivator Proteins", "DS": "COMPLEMENT C 03 B INACTIVATOR PROTEINS", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Inhibitors, Complement 3b", "MN": "D12.776.124.486.274.920.325", "PA": "Complement Inactivating Agents", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Serum Globulins (1970-1977)", "MS": "Endogenous proteins that inhibit or inactivate COMPLEMENT C3B. They include COMPLEMENT FACTOR H and COMPLEMENT FACTOR I (C3b/C4b inactivator). They cleave or promote the cleavage of C3b into inactive fragments, and thus are important in the down-regulation of COMPLEMENT ACTIVATION and its cytolytic sequence.", "PM": "2006; see COMPLEMENT 3B INACTIVATORS 1978-2005", "HN": "2006 (1978)", "MR": "20050630", "DA": "19770517", "DC": "1", "DX": "19780101", "UI": "D003180"}, {"RECTYPE": "D", "MH": "Complement C4", "DS": "COMPLEMENT C 04", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pro complement 4", "MN": "D12.776.124.486.274.350", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Protein Binding (1966-1974)", "MS": "A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B.", "PM": "2006; see COMPLEMENT 4 1978-2005, see COMPLEMENT 1975-1977; COMPLEMENT C4, PRECURSOR was indexed under COMPLEMENT 4 1980-2005", "HN": "2006 (1975)", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D003181"}, {"RECTYPE": "D", "MH": "Complement C5", "DS": "COMPLEMENT C 05", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pro complement 5", "MN": "D12.776.124.486.274.450", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Histamine Liberation (1966-1974)", "MS": "C5 plays a central role in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C5 is cleaved by C5 CONVERTASE into COMPLEMENT C5A and COMPLEMENT C5B. The smaller fragment C5a is an ANAPHYLATOXIN and mediator of inflammatory process. The major fragment C5b binds to the membrane initiating the spontaneous assembly of the late complement components, C5-C9, into the MEMBRANE ATTACK COMPLEX.", "PM": "2006; see COMPLEMENT 5 1978-2005, see COMPLEMENT 1975-1977; COMPLEMENT C5, PRECURSOR was indexed under COMPLEMENT 5 1991-2005", "HN": "2006 (1975)", "MR": "20050711", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D003182"}, {"RECTYPE": "D", "MH": "Complement C6", "DS": "COMPLEMENT C 06", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 6, Complement", "MN": "D12.776.124.486.274.550", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Complement (1968-1974)", "MS": "A 105-kDa serum glycoprotein with significant homology to the other late complement components, C7-C9. It is a polypeptide chain cross-linked by 32 disulfide bonds. C6 is the next complement component to bind to the membrane-bound COMPLEMENT C5B in the assembly of MEMBRANE ATTACK COMPLEX. It is encoded by gene C6.", "PM": "2006; see COMPLEMENT 6 1978-2005, see COMPLEMENT 1975-1977", "HN": "2006 (1975)", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D003183"}, {"RECTYPE": "D", "MH": "Complement C7", "DS": "COMPLEMENT C 07", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 7, Complement", "MN": "D12.776.124.486.274.650", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Neutrophils (1966-1974)", "MS": "A 93-kDa serum glycoprotein encoded by C7 gene. It is a polypeptide chain with 28 disulfide bridges. In the formation of MEMBRANE ATTACK COMPLEX; C7 is the next component to bind the C5b-6 complex forming a trimolecular complex C5b-7 which is lipophilic, resembles an integral membrane protein, and serves as an anchor for the late complement components, C8 and C9.", "PM": "2006; see COMPLEMENT 7 1978-2005, see COMPLEMENT 1975-1977", "HN": "2006 (1975)", "MR": "20050719", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D003184"}, {"RECTYPE": "D", "MH": "Complement C8", "DS": "COMPLEMENT C 08", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 8, Complement", "MN": "D12.776.124.486.274.750", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Hemolysis (1966-1974)", "MS": "A 150-kDa serum glycoprotein composed of three subunits with each encoded by a different gene (C8A; C8B; and C8G). This heterotrimer contains a disulfide-linked C8alpha-C8gamma heterodimer and a noncovalently associated C8beta chain. C8 is the next component to bind the C5-7 complex forming C5b-8 that binds COMPLEMENT C9 and acts as a catalyst in the polymerization of C9.", "PM": "2006; see COMPLEMENT 8 1978-2005; see COMPLEMENT 1975-1977", "HN": "2006 (1975)", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D003185"}, {"RECTYPE": "D", "MH": "Complement C9", "DS": "COMPLEMENT C 09", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 9, Complement", "MN": "D12.776.124.486.274.850", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "specific cell", "MS": "A 63-kDa serum glycoprotein encoded by gene C9. Monomeric C9 (mC9) binds the C5b-8 complex to form C5b-9 which catalyzes the polymerization of C9 forming C5b-p9 (MEMBRANE ATTACK COMPLEX) and transmembrane channels leading to lysis of the target cell. Patients with C9 deficiency suffer from recurrent bacterial infections.", "PM": "2006; see COMPLEMENT 9 1978-2005, see COMPLEMENT 1975-1977", "HN": "2006 (1975)", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D003186"}, {"RECTYPE": "D", "MH": "Compliance", "AQ": "DE PH RE", "MN": "G01.374.590.210", "MH_TH": "NLM (1975)", "ST": "T081", "AN": "NIM; note category; LUNG COMPLIANCE is available; do not confuse with PATIENT COMPLIANCE", "MS": "Distensibility measure of a chamber such as the lungs (LUNG COMPLIANCE) or bladder. Compliance is expressed as a change in volume per unit change in pressure.", "OL": "use ELASTICITY to search COMPLIANCE 1968-74 (as Prov 1968-69)", "PM": "91; was see under ELASTICITY 1970-90", "HN": "91(68); was see under ELASTICITY 1968-90 (Prov 1968-69)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003187"}, {"RECTYPE": "D", "MH": "Composite Resins", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Composite Resin|T122|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Resins, Composite", "MN": "J01.637.051.720.716.822.308", "MH_TH": "NLM (1972)", "ST": "T122", "RN": "0", "PI": "Resins (1966-1971)", "MS": "Synthetic resins, containing an inert filler, that are widely used in dentistry.", "PM": "73", "HN": "73(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003188"}, {"RECTYPE": "D", "MH": "p-Methoxy-N-methylphenethylamine", "DS": "METHOXYMETHYLPHENETHYLAMINE P N", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "p Methoxy N methylphenethylamine", "MN": "D02.092.471.683.670", "MH_TH": "NLM (1998)", "ST": "T121", "N1": "Phenethylamine, p-methoxy-N-methyl-", "RN": "4091-50-3", "MS": "A potent mast cell degranulator. It is involved in histamine release.", "PM": "2001; see COMPOUND 48-80 1963-2000", "HN": "2001(1963)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003189"}, {"RECTYPE": "D", "MH": "Comprehensive Dental Care", "DE": "COMPREHENSIVE DENT CARE", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Dental Care, Comprehensive|T058|NON|EQV|NLM (1991)|900116|DENT CARE COMPREHENSIVE|abcdefv", "MN": "N04.590.233.250", "MH_TH": "NLM (1973)", "ST": "T058", "PI": "Comprehensive Health Care (1968-1971)", "MS": "Providing for the full range of dental health services for diagnosis, treatment, follow-up, and rehabilitation of patients.", "PM": "73", "HN": "73", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003190"}, {"RECTYPE": "D", "MH": "Comprehensive Health Care", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Healthcare, Comprehensive", "MN": "N04.590.233", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "IM", "PI": "specific service (1966-1967)", "MS": "Providing for the full range of personal health services for diagnosis, treatment, follow-up and rehabilitation of patients.", "PM": "68", "HN": "68", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003191"}, {"RECTYPE": "D", "MH": "Compulsive Behavior", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Behavior, Compulsive|T048|T055|NON|EQV|NLM (1992)|910426|abbcdef", "ENTRY": "Compulsive Behaviors", "MN": "F01.145.527.100", "FX": "Obsessive-Compulsive Disorder", "MH_TH": "NLM (1968)", "ST": "T055", "AN": "use Cat F3 qualif", "MS": "The behavior of performing an act persistently and repetitively without it leading to reward or pleasure. The act is usually a small, circumscribed behavior, almost ritualistic, yet not pathologically disturbing. Examples of compulsive behavior include twirling of hair, checking something constantly, not wanting pennies in change, straightening tilted pictures, etc.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003192"}, {"RECTYPE": "D", "MH": "Compulsive Personality Disorder", "DE": "COMPULSIVE PERSONALITY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Personality Disorder, Compulsive|T048|NON|EQV|UNK (19XX)|800520|PERSONALITY DIS COMPULSIVE|abcdefv", "ENTRY": "Personality, Obsessive-Compulsive", "MN": "F03.675.150", "MH_TH": "NLM (1975)", "ST": "T048", "AN": "OBSESSIVE-COMPULSIVE DISORDER is also available", "MS": "Disorder characterized by an emotionally constricted manner that is unduly conventional, serious, formal, and stingy, by preoccupation with trivial details, rules, order, organization, schedules, and lists, by stubborn insistence on having things one's own way without regard for the effects on others, by poor interpersonal relationships, and by indecisiveness due to fear of making mistakes.", "OL": "use COMPULSIVE PERSONALITY DISORDER to search OBSESSIVE-COMPULSIVE PERSONALITY 1975-80; use COMPULSIVE BEHAVIOR 1969-74", "PM": "91; was see under PERSONALITY DISORDERS 1981-90; was OBSESSIVE-COMPULSIVE PERSONALITY see under PERSONALITY DISORDERS 1975-80 & see under COMPULSIVE BEHAVIOR 1969-74", "HN": "91(81); was see under PERSONALITY DISORDERS 1981-90; was OBSESSIVE-COMPULSIVE PERSONALITY see under PERSONALITY DISORDERS 1975-80 & see under COMPULSIVE BEHAVIOR 1969-74", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003193"}, {"RECTYPE": "D", "MH": "Computer-Assisted Instruction", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "PRINT ENTRY": "Self-Instruction Programs, Computerized|T065|T066|NON|EQV|UNK (19XX)|820427|abbcdef", "ENTRY": "Self-Instruction Program, Computerized", "MN": "I02.903.771.500.208", "MH_TH": "NLM (1974)", "ST": "T066", "AN": "DIAGNOSIS, COMPUTER-ASSISTED is also available", "MS": "A self-learning technique, usually online, involving interaction of the student with programmed instructional materials.", "OL": "use COMPUTER-ASSISTED INSTRUCTION to search COMPUTER ASSISTED INSTRUCTION 1974-90", "PM": "91; was COMPUTER ASSISTED INSTRUCTION 1974-90", "HN": "91; was COMPUTER ASSISTED INSTRUCTION 1974-90", "MR": "20170116", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003194"}, {"RECTYPE": "D", "MH": "Computer Communication Networks", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Telecommunication Networks|T073|NON|REL|UNK (19XX)|860618|abcdef", "ENTRY": "Telecommunication Network", "MN": "L01.224.230.110", "MH_TH": "NLM (1987)", "ST": "T073", "MS": "A system containing any combination of computers, computer terminals, printers, audio or visual display devices, or telephones interconnected by telecommunications equipment or cables: used to transmit or receive information. (Random House Unabridged Dictionary, 2d ed)", "PM": "1991; see COMPUTER SYSTEMS 1987-1990", "HN": "1991(1987); use COMPUTER SYSTEMS 1987-1990", "MR": "20230226", "DA": "19860618", "DC": "1", "DX": "19910101", "UI": "D003195"}, {"RECTYPE": "D", "MH": "Computer Graphics", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "ENTRY": "Graphics, Computer", "MN": "L01.296.110", "MH_TH": "NLM (1987)", "ST": "T066", "MS": "The process of pictorial communication, between human and computers, in which the computer input and output have the form of charts, drawings, or other appropriate pictorial representation.", "PM": "87", "HN": "87", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D003196"}, {"RECTYPE": "D", "MH": "Computer Literacy", "AQ": "HI SN TD", "ENTRY": "Literacy, Computer", "MN": "L01.143.256", "FX": "Information Literacy", "MH_TH": "NLM (1987)", "ST": "T041", "MS": "Familiarity and comfort in using computers efficiently.", "PM": "87", "HN": "87", "MR": "20100625", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D003197"}, {"RECTYPE": "D", "MH": "Computer Simulation", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Models, Computer|T066|NON|EQV|UNK (19XX)|860618|abcdef", "ENTRY": "Simulations, Computer", "MN": "L01.224.160", "FX": "Models, Theoretical", "MH_TH": "NLM (1987)", "ST": "T066", "AN": "coordinate with specific models heading if pertinent", "MS": "Computer-based representation of physical systems and phenomena such as chemical processes.", "PM": "87", "HN": "87", "MR": "20210312", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D003198"}, {"RECTYPE": "D", "MH": "Computer Systems", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Real-Time Systems|T073|NON|NRW|UNK (19XX)|860619|abcdef", "ENTRY": "Time Systems, Real", "MN": "L01.224.230", "MH_TH": "NLM (1987)", "ST": "T073", "AN": "IM", "MS": "Systems composed of a computer or computers, peripheral equipment, such as disks, printers, and terminals, and telecommunications capabilities.", "PM": "87", "HN": "87", "MR": "20210630", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D003199"}, {"RECTYPE": "D", "MH": "Computer User Training", "AQ": "CL EC ES HI LJ MT SD SN ST TD", "ENTRY": "User Trainings, Computer", "MN": "I02.903.080", "MH_TH": "NLM (1987)", "ST": "T065", "MS": "Process of teaching a person to interact and communicate with a computer.", "PM": "87", "HN": "87", "MR": "19970620", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D003200"}, {"RECTYPE": "D", "MH": "Computers", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Hardware, Computer|T073|NON|REL|UNK (19XX)|860618|abcdef", "ENTRY": "Programmable Calculators", "MN": "L01.224.230.260", "FX": "Electronic Data Processing", "MH_TH": "NLM (1989)", "ST": "T073", "AN": "general or unspecified; prefer specifics", "MS": "Programmable electronic devices designed to accept data, perform prescribed mathematical and logical operations at high speed, and display the results of these operations.", "OL": "use COMPUTERS to search COMPUTERS, DIGITAL 1966-77 (as Prov 1964-65)", "PM": "66; COMPUTERS, DIGITAL was heading 1966-77", "HN": "66(64); COMPUTERS, DIGITAL was heading 1964-77 (Prov 1964-65)", "MR": "20180312", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003201"}, {"RECTYPE": "D", "MH": "Computers, Analog", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Computer, Analogue", "MN": "L01.224.230.260.230", "MH_TH": "NLM (1964)", "ST": "T073", "MS": "Computers in which quantities are represented by physical variables; problem parameters are translated into equivalent mechanical or electrical circuits as an analog for the physical phenomenon being investigated. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "66", "HN": "66(64)", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003202"}, {"RECTYPE": "D", "MH": "Computers, Hybrid", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Hybrid Computers", "MN": "L01.224.230.260.280", "MH_TH": "NLM (1964)", "ST": "T073", "MS": "Computers that combine the functions of analog and digital computers. (Sippl, Computer Dictionary, 4th ed)", "PM": "73", "HN": "73(64)", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003203"}, {"RECTYPE": "D", "MH": "Computers, Mainframe", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Mainframe Computers", "MN": "L01.224.230.260.308", "MH_TH": "NLM (1987)", "ST": "T073", "PI": "Computers (1966-1986)", "MS": "Large computers in both size and capacity.", "PM": "91; was see under COMPUTERS 1987-90", "HN": "91(87); was see under COMPUTERS 1987-90", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19910101", "UI": "D003204"}, {"RECTYPE": "D", "MH": "Computing Methodologies", "DE": "COMPUTING METHODOL", "PRINT ENTRY": "Methodologies, Computing|T170|NON|EQV|NLM (1997)|960311|METHODOL COMPUTING|abcdefv", "ENTRY": "Performance Computing, High", "MN": "L01.224", "MH_TH": "NLM (1987)", "ST": "T170", "MS": "Computer-assisted analysis and processing of problems in a particular area.", "PM": "97", "HN": "97; was NON MESH 1987-96", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19970101", "UI": "D003205"}, {"RECTYPE": "D", "MH": "Conalbumin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ovotransferrin|T116|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D12.776.556.579.750.124", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Conalbumin", "RN": "1391-06-6", "PI": "Egg Proteins (1973-1974)", "MS": "A glycoprotein albumin from hen's egg white with strong iron-binding affinity.", "PM": "91; was see under EGG PROTEINS 1975-90", "HN": "91(75); was see under EGG PROTEINS 1975-90", "MR": "20190708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003207"}, {"RECTYPE": "D", "MH": "Concanavalin A", "DE": "CON A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "MN": "D12.776.765.678.500", "PA": "Mitogens", "FX": "Receptors, Concanavalin A", "MH_TH": "NLM (1971)", "ST": "T123", "N1": "Concanavalin A", "RN": "11028-71-0", "PI": "Lectins (1966-1970)", "MS": "A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.", "PM": "74", "HN": "74(71)", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003208"}, {"RECTYPE": "D", "MH": "Concentration Camps", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Internment Camps|T073|NON|REL|NLM (2021)|191118|abcdef", "ENTRY": "Internment Camp", "MN": "J03.200", "MH_TH": "NLM (1975)", "ST": "T073", "AN": "specify geographic location if pertinent", "MS": "A place where large numbers of people, especially political prisoners or members of persecuted minorities, are deliberately imprisoned in a relatively small area with inadequate facilities, sometimes to provide forced labor or to await mass execution.", "OL": "search PRISONS 1966-74", "PM": "91; was see under PRISONS 1975-90", "HN": "91(75); was see under PRISONS 1975-90", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003209"}, {"RECTYPE": "D", "MH": "Concept Formation", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Conceptualization|T041|NON|EQV|OBSSR (2022)|200515|abcdef", "ENTRY": "Learning, Concept", "MN": "F02.463.785.233", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "A cognitive process involving the formation of ideas generalized from the knowledge of qualities, aspects, and relations of objects.", "CATSH": "CAT LIST", "MR": "20210706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003210"}, {"RECTYPE": "D", "MH": "Concurrent Review", "DE": "CONCURRENT REV", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Continued Stay Review|T058|NON|NRW|UNK (19XX)|770512|CONTINUED STAY REV|abcdefv", "ENTRY": "Reviews, Continued Stay", "MN": "N05.700.900.200", "MH_TH": "NLM (1977)", "ST": "T057", "PI": "Utilization Review (1968-Jul 1977)", "MS": "Review of the medical necessity of hospital or other health facility admissions, upon or within a short time following an admission, and periodic review of services provided during the course of treatment.", "PM": "91; was see under UTILIZATION REVIEW Aug 1977-90", "HN": "91(Aug 77); was see under UTILIZATION REVIEW 1977-90", "MR": "19940505", "DA": "19770512", "DC": "1", "DX": "19910101", "UI": "D003211"}, {"RECTYPE": "D", "MH": "Condiments", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Salad Dressing|T168|NON|NRW|NLM (2020)|190329|abcdef", "ENTRY": "Salad Dressings", "MN": "J02.500.250", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "SPICES & other condiments are also available", "MS": "Aromatic substances added to food before or after cooking to enhance its flavor. These are usually of vegetable origin.", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003212"}, {"RECTYPE": "D", "MH": "Conditioning, Psychological", "AQ": "CL DE ES PH RE", "ENTRY": "Theory, Social Learning", "MN": "F02.463.425.179", "MH_TH": "NLM (2020)", "ST": "T041", "AN": "human & animal", "MS": "Simple form of learning involving the formation, strengthening, or weakening of an association between a stimulus and a response.", "PM": "1965; was CONDITIONED LEARNING 1963-1964", "HN": "2020 (1965); was CONDITIONING (PSYCHOLOGY) 1965-2019; was CONDITIONED LEARNING 1963-1964", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003213"}, {"RECTYPE": "D", "MH": "Conditioning, Classical", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Reflex, Conditioned|T041|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Conditionings, Classical", "MN": "F02.463.425.179.308", "MH_TH": "NLM (1966)", "ST": "T041", "PI": "REFLEX, CONDITIONED", "MS": "Learning that takes place when a conditioned stimulus is paired with an unconditioned stimulus.", "OL": "use CONDITIONING, CLASSICAL to search REFLEX, CONDITIONED 1966-72", "PM": "73; was REFLEX, CONDITIONED 1963-72", "HN": "73(66); REFLEX, CONDITIONED was heading 1963-72", "CATSH": "CAT LIST", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003214"}, {"RECTYPE": "D", "MH": "Conditioning, Eyelid", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Eyelid Conditioning|T055|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Eyelid Conditionings", "MN": "F02.463.425.179.408", "MH_TH": "NLM (1969)", "ST": "T055", "PI": "Eyelids (1966-1968)", "MS": "Reflex closure of the eyelid occurring as a result of classical conditioning.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "19991213", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D003215"}, {"RECTYPE": "D", "MH": "Conditioning, Operant", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Instrumental Learning|T041|NON|EQV|UNK (19XX)|740329|INSTRUM LEARNING|abcdefv", "ENTRY": "Operant Conditionings", "MN": "F02.463.425.179.509", "FX": "Behavior Control", "MH_TH": "NLM (1965)", "ST": "T041", "AN": "human & animal", "MS": "Learning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced.", "PM": "68", "HN": "68(65)", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003216"}, {"RECTYPE": "D", "MH": "Conductometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Titration, Conductometric|T059|T062|NON|EQV|NLM (1993)|920414|abbcdef", "ENTRY": "Titrations, Conductometric", "MN": "E05.301.160", "MH_TH": "NLM (1968)", "ST": "T062", "AN": "a titrimetric & electrochem technique; NIM", "MS": "Determination of the quantity of a material present in a mixture by measurement of its effect on the electrical conductivity of the mixture. (Webster, 3d ed)", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003217"}, {"RECTYPE": "D", "MH": "Condylomata Acuminata", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Warts, Venereal|T047|NON|EQV|UNK (19XX)|880513|abcdef", "ENTRY": "Wart, Venereal", "MN": "C17.800.838.790.810.110", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "coordinate IM with precoordinated organ/disease term (IM) + specific virus (IM) if pertinent", "MS": "Sexually transmitted form of anogenital warty growth caused by the human papillomaviruses.", "PM": "72", "HN": "72(64)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003218"}, {"RECTYPE": "D", "MH": "Confidentiality", "AQ": "ES HI LJ PX ST TD", "PRINT ENTRY": "Privileged Communication|T170|NON|NRW|BIOETHICS (1974)|UNK (19XX)|790601|abcdeef", "ENTRY": "Privileged Communications", "MN": "N03.706.535.230", "FX": "Privacy", "MH_TH": "BIOETHICS (1974)", "ST": "T078", "AN": "secrecy goes here", "PI": "Jurisprudence (1966-1974)", "MS": "The privacy of information and its protection against unauthorized disclosure.", "OL": "use CONFIDENTIALITY to search PRIVILEGED COMMUNICATION 1975-79; use JURISPRUDENCE 1968-74", "PM": "80; was PRIVILEGED COMMUNICATION 1975-79; was PRIVILEGED COMMUNICATION see under JURISPRUDENCE 1968-74", "HN": "80; was PRIVILEGED COMMUNICATION 1975-79; was PRIVILEGED COMMUNICATION see under JURISPRUDENCE 1968-74", "CATSH": "CAT LIST", "MR": "20030725", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D003219"}, {"RECTYPE": "D", "MH": "Conflict, Psychological", "ENTRY": "Psychological Conflicts", "MN": "F01.658.209", "FX": "Dissent and Disputes", "MH_TH": "NLM (2020)", "ST": "T055", "AN": "human & animal; individual & group", "MS": "The internal individual struggle resulting from incompatible or opposing needs, drives, or external and internal demands. In group interactions, competitive or opposing action of incompatibles: antagonistic state or action (as of divergent ideas, interests, or persons). (from Merriam-Webster's Collegiate Dictionary, 10th ed)", "PM": "1965", "HN": "2020 (1965); was CONFLICT (PSYCHOLOGY) 1965-2019", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003220"}, {"RECTYPE": "D", "MH": "Confusion", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Confusional State|T048|T184|NON|EQV|NLM (2000)|991103|abbcdef", "ENTRY": "States, Confusional", "MN": "F01.700.250", "MH_TH": "NLM (1975)", "ST": "T184", "MS": "A mental state characterized by bewilderment, emotional disturbance, lack of clear thinking, and perceptual disorientation.", "OL": "search COGNITION DISORDERS 1969-74", "PM": "91; was see under COGNITION DISORDERS 1975-90", "HN": "91(75); was see under COGNITION DISORDERS 1975-90", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003221"}, {"RECTYPE": "D", "MH": "Congo", "AQ": "EH EP", "PRINT ENTRY": "Republic of the Congo|T083|NAM|EQV|NLM (2009)|080304|abcdef", "ENTRY": "Congo (Brazzaville)|T083|NAM|EQV|UNK (19XX)|750101|abcdef", "MN": "Z01.058.290.100.140", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "Republic of Congo (capital at Brazzaville); do not confuse with DEMOCRATIC REPUBLIC OF THE CONGO (capital at Kinshasa, formerly Leopoldville)", "MS": "A republic in central Africa lying between GABON and DEMOCRATIC REPUBLIC OF THE CONGO and south of Cameroon. Its capital is Brazzaville.", "MR": "20130709", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D003223"}, {"RECTYPE": "D", "MH": "Congo Red", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Red, Congo", "MN": "D04.615.638.555.300", "PA": "Coloring Agents", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "1-Naphthalenesulfonic acid, 3,3'-((1,1'-biphenyl)-4,4'-diylbis(azo))bis(4-amino)-, disodium salt", "RN": "3U05FHG59S", "RR": "573-58-0 (Congo Red)", "MS": "An acid dye used in testing for hydrochloric acid in gastric contents. It is also used histologically to test for AMYLOIDOSIS.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003224"}, {"RECTYPE": "D", "MH": "Hemorrhagic Fever Virus, Crimean-Congo", "DE": "CCHF VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hemorrhagic Fever Virus, Crimean|T005|EPO|EQV|UNK (19XX)|760515|abcdef", "ENTRY": "Hemorrhagic Fever Virus, Crimean Congo", "MN": "B04.820.480.750.565.400", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid1980519", "MS": "A species of NAIROVIRUS of the family BUNYAVIRIDAE. It is primarily transmitted by ticks and causes a severe, often fatal disease in humans.", "OL": "use HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO to search CONGO VIRUS 1975-91", "PM": "92; was CONGO VIRUS 1975-91 (see under BUNYAVIRIDAE 1981-90, see under ARBOVIRUSES 1975-80)", "HN": "92; was CONGO VIRUS 1975-91 (see under BUNYAVIRIDAE 1981-90, see under ARBOVIRUSES 1975-80)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D003225"}, {"RECTYPE": "D", "MH": "Congresses as Topic", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Conferences|T068|NON|BRD|UNK (19XX)|770519|abcdef", "ENTRY": "Topics, Congresses as", "MN": "N03.540.199", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "used for general articles about congresses, conferences, or meetings as a means of communication; do not add INTERNATIONAL COOPERATION for international congresses; do not confuse with Publication Type CONGRESS", "MS": "Works about conferences, conventions or formal meetings usually attended by delegates representing a special field of interest.", "PM": "2008; see CONGRESSES 1963-2007", "HN": "2008(1963)", "MR": "20180713", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D003226"}, {"RECTYPE": "D", "MH": "Conjugation, Genetic", "DE": "CONJUGATION GENET", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Bacterial Conjugation|T045|NON|NRW|UNK (19XX)|740329|BACT CONJUGATION|abcdefv", "ENTRY": "Genetic Conjugation|T045|NON|EQV|UNK (19XX)|740329|GENET CONJUGATION|abcdefv", "MN": "G05.728.200", "MH_TH": "NLM (1968)", "ST": "T045", "PI": "Genetics (1966-1967)", "MS": "A parasexual process in BACTERIA; ALGAE; FUNGI; and ciliate EUKARYOTA for achieving exchange of chromosome material during fusion of two cells. In bacteria, this is a uni-directional transfer of genetic material; in protozoa it is a bi-directional exchange. In algae and fungi, it is a form of sexual reproduction, with the union of male and female gametes.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003227"}, {"RECTYPE": "D", "MH": "Conjunctiva", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Tunica Conjunctiva|T023|NON|EQV|NLM (2020)|190121|abcdef", "ENTRY": "Conjunctivas", "MN": "A09.371.337.168", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The mucous membrane that covers the posterior surface of the eyelids and the anterior pericorneal surface of the eyeball.", "MR": "20190418", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003228"}, {"RECTYPE": "D", "MH": "Conjunctival Diseases", "DE": "CONJUNCTIVAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Conjunctival", "MN": "C11.187", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Eye Diseases (1966-1980)", "MS": "Diseases involving the CONJUNCTIVA.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20151008", "DA": "19800404", "DC": "1", "DX": "19810101", "UI": "D003229"}, {"RECTYPE": "D", "MH": "Conjunctival Neoplasms", "DE": "CONJUNCTIVAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasms, Conjunctival", "MN": "C11.319.217", "MH_TH": "NLM (1981)", "ST": "T191", "AN": "coordinate with histological type of neoplasm", "PI": "Eye Neoplasms (1966-1980)", "MS": "Tumors or cancer of the CONJUNCTIVA.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19800404", "DC": "1", "DX": "19810101", "UI": "D003230"}, {"RECTYPE": "D", "MH": "Conjunctivitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pink Eye|T047|T184|NON|EQV|NLM (2021)|200513|abbcdef", "ENTRY": "Pink Eyes", "MN": "C11.187.183", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "INFLAMMATION of the CONJUNCTIVA.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003231"}, {"RECTYPE": "D", "MH": "Conjunctivitis, Acute Hemorrhagic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Hemorrhagic Conjunctivitis, Acute", "MN": "C11.294.800.250.250", "MH_TH": "NLM (1986)", "ST": "T047", "AN": "coordinate  IM with  COXSACKIEVIRUS INFECTIONS (IM) if  pertinent", "PI": "Hemorrhage (1966-1985)", "MS": "A highly contagious disease characterized by subconjunctival hemorrhage, sudden swelling of the eyelids and congestion, redness, and pain in the eye. Epidemic conjunctivitis caused by Enterovirus 70 (EV-70) was first described in Africa in 1969. It is caused also by Coxsackievirus A24 variant (CA24v). Epidemics by this organism have appeared most frequently in Asia.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19850605", "DC": "1", "DX": "19860101", "UI": "D003232"}, {"RECTYPE": "D", "MH": "Conjunctivitis, Allergic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Keratoconjunctivitis, Vernal|T047|NON|BRD|UNK (19XX)|850606|abcdef", "ENTRY": "Vernal Keratoconjunctivitis", "MN": "C20.543.480.200", "MH_TH": "NLM (1986)", "ST": "T047", "AN": "coord IM with etiol of the allergy (IM) if specified", "PI": "Hypersensitivity (1966-1985)", "MS": "Conjunctivitis due to hypersensitivity to various allergens.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "19900529", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D003233"}, {"RECTYPE": "D", "MH": "Conjunctivitis, Bacterial", "DE": "CONJUNCTIVITIS BACT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Conjunctivitis, Purulent|T047|NON|EQV|NLM (1990)|890314|abcdef", "ENTRY": "Purulent Conjunctivitis", "MN": "C11.294.354.220", "MH_TH": "NLM (1986)", "ST": "T047", "AN": "coordinate with specific bacterial infection term ", "PI": "Conjunctivitis (1966-1985)", "MS": "Purulent infections of the conjunctiva by several species of gram-negative, gram-positive, or acid-fast organisms. Some of the more commonly found genera causing conjunctival infections are Haemophilus, Streptococcus, Neisseria, and Chlamydia.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19850605", "DC": "1", "DX": "19860101", "UI": "D003234"}, {"RECTYPE": "D", "MH": "Conjunctivitis, Inclusion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Blennorrhea, Inclusion|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Inclusion Conjunctivitis", "MN": "C11.294.354.220.250", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "caused by Chlamydia trachomatis", "MS": "An infection of the eyes characterized by the presence in conjunctival epithelial cells of inclusion bodies indistinguishable from those of trachoma. It is acquired by infants during birth and by adults from swimming pools. The etiological agent is CHLAMYDIA TRACHOMATIS whose natural habitat appears to be the genito-urinary tract. Inclusion conjunctivitis is a less severe disease than trachoma and usually clears up spontaneously.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D003235"}, {"RECTYPE": "D", "MH": "Conjunctivitis, Viral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Viral Conjunctivitis|T047|NON|EQV|UNK (19XX)|850605|abcdef", "ENTRY": "Viral Conjunctivitides", "MN": "C11.294.800.250", "MH_TH": "NLM (1986)", "ST": "T047", "AN": "coord IM with specific virus/infect heading (IM)", "PI": "Virus Diseases (1966-1985)", "MS": "Inflammation, often mild, of the conjunctiva caused by a variety of viral agents. Conjunctival involvement may be part of a systemic infection.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19850605", "DC": "1", "DX": "19860101", "UI": "D003236"}, {"RECTYPE": "D", "MH": "Connecticut", "AQ": "EH EP", "MN": "Z01.107.567.875.550.200", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Massachusetts, on the east by Rhode Island, on the south by Long Island Sound, and on the west by New York.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D003237"}, {"RECTYPE": "D", "MH": "Connective Tissue", "AQ": "AB AH BS CH DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tissues, Connective", "MN": "A10.165", "FX": "Collagen", "EC": "cytology:Connective Tissue Cells", "MH_TH": "NLM (1966)", "ST": "T024", "AN": "inflammation: consider CELLULITIS", "MS": "Tissue that supports and binds other tissues. It consists of CONNECTIVE TISSUE CELLS embedded in a large amount of EXTRACELLULAR MATRIX.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003238"}, {"RECTYPE": "D", "MH": "Connective Tissue Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Connective Tissue Cell", "MN": "A11.329", "MH_TH": "NLM (1965)", "ST": "T025", "PI": "Connective Tissue/cytology (1978-1997)", "MS": "A group of cells that includes FIBROBLASTS, cartilage cells, ADIPOCYTES, smooth muscle cells, and bone cells.", "PM": "1998, 1965-1977", "HN": "1998(1965)", "MR": "20210304", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003239"}, {"RECTYPE": "D", "MH": "Connective Tissue Diseases", "DE": "CONNECTIVE TISSUE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Connective Tissue", "MN": "C17.300", "FX": "Collagen Diseases", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "general or unspecified; prefer specifics; do not confuse with MIXED CONNECTIVE TISSUE DISEASE, a specific connective tissue disease entity", "PI": "Connective Tissue (1966-1979)", "MS": "A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "19920520", "DA": "19781221", "DC": "1", "DX": "19800101", "UI": "D003240"}, {"RECTYPE": "D", "MH": "Consanguinity", "PRINT ENTRY": "Inbreeding, Human|T045|NON|REL|NLM (1998)|960710|abcdef", "ENTRY": "Matings, Consanguinous", "MN": "G05.180", "MH_TH": "POPLINE (1988)", "ST": "T081", "AN": "human only: for animals use INBREEDING", "MS": "The magnitude of INBREEDING in humans.", "CATSH": "CAT LIST", "MR": "20170707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003241"}, {"RECTYPE": "D", "MH": "Conscience", "ENTRY": "Consciences", "MN": "K01.752.566.359", "MH_TH": "BIOETHICS (1989)", "ST": "T041", "MS": "The cognitive and affective processes which constitute an internalized moral governor over an individual's moral conduct.", "OL": "search MORALS 1966-74", "PM": "91; was see under MORALS 1975-90", "HN": "91(75); was see under MORALS 1975-90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003242"}, {"RECTYPE": "D", "MH": "Consciousness", "AQ": "CL DE ES PH RE", "ENTRY": "Consciousnesses", "MN": "F02.830.233", "FX": "Unconsciousness", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "Sense of awareness of self and of the environment.", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003243"}, {"RECTYPE": "D", "MH": "Consciousness Disorders", "DE": "CONSCIOUSNESS DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Semiconsciousness|T033|NON|NRW|NLM (2000)|991109|abcdef", "ENTRY": "Consciousness Disorder", "MN": "F03.615.300", "MH_TH": "NLM (1975)", "ST": "T048", "AN": "prefer specifics", "MS": "Organic mental disorders in which there is impairment of the ability to maintain awareness of self and environment and to respond to environmental stimuli. Dysfunction of the cerebral hemispheres or brain stem RETICULAR FORMATION may result in this condition.", "OL": "search COGNITION DISORDERS 1969-74", "PM": "91; was see under COGNITION DISORDERS 1975-90", "HN": "91(75); was see under COGNITION DISORDERS 1975-90", "CATSH": "CAT LIST", "MR": "20220531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003244"}, {"RECTYPE": "D", "MH": "Consensus Development Conferences as Topic", "PRINT ENTRY": "Consensus Workshops|T097|NON|NRW|UNK (19XX)|870512|CONSENS WORKSHOPS|abcdefv", "ENTRY": "Workshops, Consensus|T097|NON|NRW|NLM (1996)|950123|WORKSHOPS CONSENS|abcdefv", "MN": "N03.540.199.205", "FX": "Consensus", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "IM; for general design of consensus development conferences as a subject or means of scientific communication; specify geographic term only if pertinent; a different main heading CONSENSUS DEVELOPMENT CONFERENCE is used for original report of a specific consensus development conference", "MS": "Works that are about the concept of consensus development conferences, such as their general design or a means of scientific communication.", "PM": "2008; see CONSENSUS DEVELOPMENT CONFERENCES 1987-2007", "HN": "2008(1987)", "MR": "20220712", "DA": "19870512", "DC": "1", "DX": "19880101", "UI": "D003245"}, {"RECTYPE": "D", "MH": "Conservation of Energy Resources", "AQ": "EC HI LJ MT SN TD", "PRINT ENTRY": "Energy Resources Conservation|T078|NON|EQV|UNK (19XX)|790411|abcdef", "ENTRY": "Resources Conservations, Energy", "MN": "N06.230.080.078", "MH_TH": "NLM (1980)", "ST": "T078", "PI": "Conservation of Natural Resources (1977-1979)", "MS": "Planned management, use, and preservation of energy resources.", "PM": "91; was see under CONSERVATION OF NATURAL RESOURCES 1980-90", "HN": "91(80); was see under CONSERVATION OF NATURAL RESOURCES 1980-90", "MR": "20200708", "DA": "19790411", "DC": "1", "DX": "19910101", "UI": "D003246"}, {"RECTYPE": "D", "MH": "Conservation of Natural Resources", "AQ": "EC HI LJ MT SN TD", "ENTRY": "Conservation, Natural Resources", "MN": "N06.230.080", "FX": "Natural Resources", "MH_TH": "NLM (1977)", "ST": "T078", "MS": "The protection, preservation, restoration, and rational use of all resources in the total environment.", "PM": "1977", "HN": "1977", "MR": "20200709", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D003247"}, {"RECTYPE": "D", "MH": "Constipation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dyschezia|T184|NON|NRW|NLM (2004)|030102|abcdef", "MN": "C23.888.821.150", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003248"}, {"RECTYPE": "D", "MH": "Constitution and Bylaws", "DE": "CONSTITUTION BYLAWS", "PRINT ENTRY": "Bylaws|T089|NON|NRW|UNK (19XX)|770505|abcdef", "ENTRY": "Bylaws and Constitution", "MN": "N04.452.150", "MH_TH": "NLM (1977)", "ST": "T089", "AN": "coordinate with specific organization or society ", "MS": "The fundamental principles and laws adopted by an organization for the regulation and governing of its affairs.", "PM": "91; was see under ORGANIZATION AND ADMINISTRATION Aug 1977-90", "HN": "91(Aug 77); was see under ORGANIZATION AND ADMINISTRATION 1977-90", "MR": "19940317", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D003249"}, {"RECTYPE": "D", "MH": "Constriction", "PRINT ENTRY": "Clamping|T061|NON|NRW|NLM (1998)|961202|abcdef", "ENTRY": "Constrictions", "MN": "E05.225", "MH_TH": "NLM (1968)", "ST": "T061", "AN": "usually NIM", "MS": "The act of constricting.", "PM": "76; was see under PHYSIOLOGY 1975", "HN": "76(68); was in Cat C & E 1968-75 (Prov 1968-74), was see under PHYSIOLOGY 1975", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D003250"}, {"RECTYPE": "D", "MH": "Constriction, Pathologic", "DE": "CONSTRICTION PATHOL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stricture|T033|T046|NON|EQV|NLM (2009)|070917|abbcdef", "ENTRY": "Strictures", "MN": "C23.300.287", "FX": "Coronary Stenosis", "MH_TH": "NLM (1976)", "ST": "T046", "AN": "usually NIM", "PI": "Constriction (1968-1975)", "MS": "The condition of an anatomical structure's being constricted beyond normal dimensions.", "OL": "search CONSTRICTION 1968-75 (as Prov 1968-74, as Cat C & E heading 1968-75)", "PM": "76; was included in CONSTRICTION see under PHYSIOLOGY 1975", "HN": "76; was included in CONSTRICTION 1968-75 (Prov 1968-74, Cat C & E heading 1968-75)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D003251"}, {"RECTYPE": "D", "MH": "Construction Materials", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Materials, Construction", "MN": "J01.637.241", "FX": "Construction Industry", "MH_TH": "NLM (1972)", "ST": "T073", "MS": "Supplies used in building.", "PM": "74", "HN": "74(72)", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003252"}, {"RECTYPE": "D", "MH": "Consultants", "AQ": "CL HI LJ PX SN", "ENTRY": "Service, Advisory", "MN": "M01.120", "MH_TH": "NLM (1978)", "ST": "T097", "PI": "Referral and Consultation (1968-1977)", "MS": "Individuals referred to for expert or professional advice or services.", "PM": "78", "HN": "78", "MR": "19950522", "DA": "19770505", "DC": "1", "DX": "19780101", "UI": "D003253"}, {"RECTYPE": "D", "MH": "Consumer Advocacy", "AQ": "CL EC ED ES HI IN LJ PX SN ST TD", "PRINT ENTRY": "Public Advocacy|T057|T090|NON|BRD|NLM (1990)|890502|abbcdef", "ENTRY": "Public Advocacies", "MN": "N03.706.437.368", "MH_TH": "NLM (1982)", "ST": "T090", "PI": "Consumer Satisfaction (1968-1981)", "MS": "The promotion and support of consumers' rights and interests.", "PM": "82", "HN": "82", "MR": "19950523", "DA": "19810519", "DC": "1", "DX": "19820101", "UI": "D003254"}, {"RECTYPE": "D", "MH": "Consumer Organizations", "DE": "CONSUMER ORGAN", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Organization, Consumer", "MN": "N03.540.245", "MH_TH": "NLM (1968)", "ST": "T092", "AN": "IM; specify services, area of interest or geog if pertinent", "MS": "Organized groups of users of goods and services.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003255"}, {"RECTYPE": "D", "MH": "Community Participation", "AQ": "EC HI LJ MT PX SN TD", "PRINT ENTRY": "Consumer Participation|T078|NON|NRW|NLM (1966)|990101|abcdef", "ENTRY": "Participation, Public", "MN": "N03.540.245.360", "MH_TH": "POPLINE (1983)", "ST": "T052", "MS": "Involvement of members of the community in the affairs of that community.", "PM": "74", "HN": "74", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003256"}, {"RECTYPE": "D", "MH": "Consumer Product Safety", "AQ": "LJ ST", "PRINT ENTRY": "Safety, Consumer Product|T064|T080|NON|EQV|UNK (19XX)|810615|abbcdef", "ENTRY": "Product Safety, Consumer", "MN": "N06.850.210", "MH_TH": "NLM (1982)", "ST": "T080", "PI": "Accident Prevention (1966-1981)", "MS": "The sum total of measures taken and regulatory policies enacted to ensure the safe use of consumer products.", "PM": "82", "HN": "82", "MR": "20151124", "DA": "19810519", "DC": "1", "DX": "19820101", "UI": "D003257"}, {"RECTYPE": "D", "MH": "Consumer Behavior", "AQ": "EC SN", "PRINT ENTRY": "Consumer Satisfaction|T080|NON|NRW|NLM (1968)|990101|abcdef", "ENTRY": "Satisfaction, Consumer", "MN": "F01.145.236", "MH_TH": "NLM (2015)", "ST": "T055", "PI": "Attitude (1966-1967)", "MS": "Behavior associated with the procurement of goods, services, or experiences.", "PM": "68", "HN": "68", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003258"}, {"RECTYPE": "D", "MH": "Consummatory Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Consummatory Behaviors", "MN": "F01.145.113.252", "MH_TH": "NLM (1968)", "ST": "T054", "PI": "Behavior, Animal (1966-1967)", "MS": "An act which constitutes the termination of a given instinctive behavior pattern or sequence.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003259"}, {"RECTYPE": "D", "MH": "Contact Inhibition", "DE": "CONTACT INHIB", "AQ": "DE ES GE IM PH RE", "ENTRY": "Inhibitions, Contact", "MN": "G04.383", "MH_TH": "NLM (1968)", "ST": "T043", "PI": "Cytology (1966-1967)", "MS": "Arrest of cell locomotion or cell division when two cells come into contact.", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D003260"}, {"RECTYPE": "D", "MH": "Contact Lenses", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Lenses, Contact|T074|NON|EQV|UNK (19XX)|780123|abcdef", "ENTRY": "Lens, Contact", "MN": "E07.632.500.276", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "Lenses designed to be worn on the front surface of the eyeball. (UMDNS, 1999)", "CATSH": "CAT LIST", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003261"}, {"RECTYPE": "D", "MH": "Contact Lenses, Extended-Wear", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Lenses, Extended-Wear Contact", "MN": "E07.632.500.276.360.220", "MH_TH": "NLM (1984)", "ST": "T074", "PI": "Contact Lenses, Hydrophilic (1971-1983)", "MS": "Hydrophilic contact lenses worn for an extended period or permanently.", "PM": "89; was see under CONTACT LENSES, HYDROPHILIC 1984-88", "HN": "89(84); was see under CONTACT LENSES, HYDROPHILIC 1984-88", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19830209", "DC": "1", "DX": "19890101", "UI": "D003262"}, {"RECTYPE": "D", "MH": "Contact Lenses, Hydrophilic", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Soft Contact Lenses|T074|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Lenses, Soft Contact", "MN": "E07.632.500.276.360", "MH_TH": "NLM (1971)", "ST": "T074", "PI": "Contact Lenses (1966-1970)", "MS": "Soft, supple contact lenses made of plastic polymers which interact readily with water molecules. Many types are available, including continuous and extended-wear versions, which are gas-permeable and easily sterilized.", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003263"}, {"RECTYPE": "D", "MH": "Containment of Biohazards", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Biohazards Containment|T057|NON|EQV|UNK (19XX)|790309|abcdef", "ENTRY": "Containment, Physical", "MN": "N06.850.135.060.075.249", "FX": "Biosecurity", "MH_TH": "NLM (1980)", "ST": "T057", "AN": "do not use for radiation (= RADIATION PROTECTION)", "MS": "Physical and biological barriers to the spread of potentially hazardous biologically active agents such as bacteria, viruses, recombinant nucleotides, or contaminated bio-specimens.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20210706", "DA": "19790309", "DC": "1", "DX": "19800101", "UI": "D003264"}, {"RECTYPE": "D", "MH": "Contingent Negative Variation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Readiness Potential|T034|T042|NON|REL|NLM (1992)|901129|abbcdef", "ENTRY": "Variations, Contingent Negative", "MN": "G11.561.200.500.250", "MH_TH": "NLM (1971)", "ST": "T042", "AN": "refers to cortical electrical potentials", "PI": "Electrophysiology (1966-1970)", "MS": "A negative shift of the cortical electrical potentials that increases over time. It is associated with an anticipated response to an expected stimulus and is an electrical event indicative of a state of readiness or expectancy.", "PM": "91; was see under ELECTROPHYSIOLOGY 1971-90", "HN": "91(71); was see under ELECTROPHYSIOLOGY 1971-90", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003265"}, {"RECTYPE": "D", "MH": "Continuity of Patient Care", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Continuum of Care|T058|NON|EQV|NLM (1992)|910322|abcdef", "ENTRY": "Patient Care Continuity", "MN": "N04.590.233.727.210", "MH_TH": "NLM (1975)", "ST": "T058", "MS": "Health care provided on a continuing basis from the initial contact, following the patient through all phases of medical care.", "OL": "search COMPREHENSIVE HEALTH CARE 1968-74", "PM": "91; was see under PRIMARY HEALTH CARE 1979-90; was see under COMPREHENSIVE HEALTH CARE 1968-78", "HN": "91(75); was see under PRIMARY HEALTH CARE 1979-90; was see under COMPREHENSIVE HEALTH CARE 1968-78", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003266"}, {"RECTYPE": "D", "MH": "Contraception", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Birth Control|T061|NON|EQV|NLM (1963)|750716|abcdef", "ENTRY": "Male Contraceptions", "MN": "E02.875.194", "FX": "Population Control", "MH_TH": "NLM (1963)", "ST": "T061", "MS": "Prevention of CONCEPTION by blocking fertility temporarily, or permanently (STERILIZATION, REPRODUCTIVE). Common means of reversible contraception include NATURAL FAMILY PLANNING METHODS; CONTRACEPTIVE AGENTS; or CONTRACEPTIVE DEVICES.", "PM": "1963; for BIRTH CONTROL see FAMILY PLANNING 1968-1974, see BIRTH CONTROL 1963-1967", "HN": "1963; for BIRTH CONTROL use FAMILY PLANNING 1968-1974, use BIRTH CONTROL 1963-1967", "CATSH": "CAT LIST", "MR": "20050721", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D003267"}, {"RECTYPE": "D", "MH": "Contraception Behavior", "AQ": "EH HI PX SN TD", "ENTRY": "Contraceptive Behaviors", "MN": "G08.686.784.891.500", "MH_TH": "NLM (1975)", "ST": "T054", "PI": "Sex Behavior (1966-1974)", "MS": "Behavior patterns of those practicing CONTRACEPTION.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D003268"}, {"RECTYPE": "D", "MH": "Contraception, Immunologic", "DE": "CONTRACEPTION IMMUNOL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Immunocontraception|T061|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Immunological Contraceptive Technique", "MN": "E02.875.194.300", "FX": "Vaccines, Contraceptive", "MH_TH": "NLM (1975)", "ST": "T061", "MS": "Contraceptive methods based on immunological processes and techniques, such as the use of CONTRACEPTIVE VACCINES.", "PM": "91; was see under CONTRACEPTION 1975-90", "HN": "91(75); was see under CONTRACEPTION 1975-90", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003269"}, {"RECTYPE": "D", "MH": "Contraceptive Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Contraceptive|T121|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Effects, Contraceptive", "MN": "D27.505.954.705.360", "MH_TH": "NLM (1967)", "ST": "T121", "RN": "0", "PI": "Contraceptive Devices (1966)", "MS": "Chemical substances that prevent or reduce the probability of CONCEPTION.", "PM": "67", "HN": "67", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D003270"}, {"RECTYPE": "D", "MH": "Contraceptive Agents, Female", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Female Contraceptives", "MN": "D27.505.954.705.360.276", "FX": "Vaginal Creams, Foams, and Jellies", "MH_TH": "POPLINE (1978)", "ST": "T121", "RN": "0", "AN": "pregn despite use: see note on CONTRACEPTIVE AGENTS", "PI": "Contraceptive Agents (1967-1974)", "MS": "Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.", "PM": "75", "HN": "75", "MR": "20060710", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D003271"}, {"RECTYPE": "D", "MH": "Contraceptive Agents, Male", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Male Contraceptive|T121|NON|EQV|NLM (2022)|200930|abcdef", "ENTRY": "Male Contraceptives", "MN": "D27.505.954.705.360.443", "MH_TH": "POPLINE (1978)", "ST": "T121", "RN": "0", "AN": "pregn despite use: see note on CONTRACEPTIVE AGENTS", "PI": "Contraceptive Agents (1967-1974)", "MS": "Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading.", "PM": "75", "HN": "75", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D003272"}, {"RECTYPE": "D", "MH": "Contraceptive Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Devices, Contraceptive", "MN": "E07.190", "FX": "Device Removal", "MH_TH": "NLM (1967)", "ST": "T074", "MS": "Devices that diminish the likelihood of or prevent conception. (From Dorland, 28th ed)", "OL": "use CONTRACEPTIVE DEVICES to search CONTRACEPTIVES 1966", "PM": "67; was CONTRACEPTIVES 1963-66", "HN": "67; was CONTRACEPTIVES 1963-66", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D003273"}, {"RECTYPE": "D", "MH": "Contraceptive Devices, Female", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Vaginal Sponges", "MN": "E07.190.250", "MH_TH": "NLM (1975)", "ST": "T074", "PI": "Contraceptive Devices (1966-1974)", "MS": "Contraceptive devices used by females.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D003274"}, {"RECTYPE": "D", "MH": "Contraceptive Devices, Male", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Male Contraceptive Devices", "MN": "E07.190.270", "MH_TH": "NLM (1975)", "ST": "T074", "PI": "Contraceptive Devices (1966-1974)", "MS": "Contraceptive devices used by males.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D003275"}, {"RECTYPE": "D", "MH": "Contraceptives, Oral", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oral Contraceptive|T121|NON|EQV|NLM (2021)|200127|abcdef", "ENTRY": "Phasic Oral Contraceptives", "MN": "D27.505.954.705.360.276.210", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "pregn despite use: see note on CONTRACEPTIVE AGENTS", "MS": "Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003276"}, {"RECTYPE": "D", "MH": "Contraceptives, Oral, Combined", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Combined Oral Contraceptive|T121|NON|EQV|NLM (2021)|200203|abcdef", "ENTRY": "Oral Contraceptive, Combined", "MN": "D27.505.954.705.360.276.210.100", "MH_TH": "NLM (1976)", "ST": "T121", "RN": "0", "PI": "Drug Combinations (1972-1975)", "MS": "Fixed drug combinations administered orally for contraceptive purposes.", "PM": "86; was see under CONTRACEPTIVES, ORAL 1976-85", "HN": "86(76); was see under CONTRACEPTIVES, ORAL 1976-85", "MR": "20200527", "DA": "19750723", "DC": "1", "DX": "19860101", "UI": "D003277"}, {"RECTYPE": "D", "MH": "Contraceptives, Oral, Hormonal", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hormonal Oral Contraceptive Agent|T121|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Oral Contraceptive, Hormonal", "MN": "D27.505.954.705.360.360.500", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "pregn despite use: see note on CONTRACEPTIVE AGENTS", "MS": "Oral contraceptives which owe their effectiveness to hormonal preparations.", "PM": "1986; was see under CONTRACEPTIVES, ORAL 1975-1985", "HN": "1986 (1975); was see under CONTRACEPTIVES, ORAL 1975-1985", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D003278"}, {"RECTYPE": "D", "MH": "Contraceptives, Oral, Sequential", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sequential Oral Contraceptives", "MN": "D27.505.954.705.360.276.210.400", "MH_TH": "NLM (1976)", "ST": "T121", "RN": "0", "AN": "pregn despite use: see note on CONTRACEPTIVE AGENTS", "PI": "Contraceptives, Oral (1970-1975)", "MS": "Drugs administered orally and sequentially for contraceptive purposes.", "PM": "91; was see under CONTRACEPTIVES, ORAL 1976-90", "HN": "91(76); was see under CONTRACEPTIVES, ORAL 1976-90", "MR": "20050630", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D003279"}, {"RECTYPE": "D", "MH": "Contraceptives, Oral, Synthetic", "DE": "CONTRACEPTIVES ORAL SYN", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D27.505.954.705.360.276.210.443", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "pregn despite use: see note on CONTRACEPTIVE AGENTS", "MS": "Oral contraceptives which owe their effectiveness to synthetic preparations.", "PM": "86; was see under CONTRACEPTIVES, ORAL 1975-85", "HN": "86(75); was see under CONTRACEPTIVES, ORAL 1975-85", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D003280"}, {"RECTYPE": "D", "MH": "Contraceptives, Postcoital", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Postcoital Contraceptives|T121|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Postcoital Contraceptive Agents", "MN": "D27.505.954.705.360.276.310", "FX": "Contraception, Postcoital", "MH_TH": "NLM (1971)", "ST": "T121", "RN": "0", "PI": "Contraceptives, Oral (1966-1970)", "MS": "Contraceptive substances to be used after COITUS. These agents include high doses of estrogenic drugs; progesterone-receptor blockers; ANTIMETABOLITES; ALKALOIDS, and PROSTAGLANDINS.", "PM": "73", "HN": "73(71); MORNING AFTER PILL was see under CONTRACEPTIVES, POSTCOITAL 1973-83", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003281"}, {"RECTYPE": "D", "MH": "Contraceptives, Postcoital, Hormonal", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D27.505.954.705.360.360.750", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "pregn despite use: see note on CONTRACEPTIVE AGENTS", "MS": "Postcoital contraceptives which owe their effectiveness to hormonal preparations.", "PM": "1991; was see under CONTRACEPTIVES, POSTCOITAL 1975-1990", "HN": "1991(1975); was see under CONTRACEPTIVES, POSTCOITAL 1975-1990", "MR": "20190116", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003282"}, {"RECTYPE": "D", "MH": "Contraceptives, Postcoital, Synthetic", "DE": "CONTRACEPTIVES POSTCOITAL SYN", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Contraceptives, Synthetic Postcoital", "MN": "D27.505.954.705.360.276.310.360", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "pregn despite use: see note on CONTRACEPTIVE AGENTS", "MS": "Postcoital contraceptives which owe their effectiveness to synthetic preparations.", "PM": "91; was see under CONTRACEPTIVES, POSTCOITAL 1975-90", "HN": "91(75); was see under CONTRACEPTIVES, POSTCOITAL 1975-90", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003283"}, {"RECTYPE": "D", "MH": "Contract Services", "DE": "CONTRACT SERV", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Service, Contract", "MN": "N03.219.463.100", "FX": "Contracts", "MH_TH": "NLM (1978)", "ST": "T057", "PI": "Economics (1966-1977)", "MS": "Outside services provided to an institution under a formal financial agreement.", "PM": "91; was see under FINANCIAL MANAGEMENT 1978-90", "HN": "91(78); was see under FINANCIAL MANAGEMENT 1978-90", "MR": "20020703", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D003284"}, {"RECTYPE": "D", "MH": "Contractile Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Contractile Protein|T116|T123|NON|EQV|NLM (2022)|201015|abbcdef", "ENTRY": "Proteins, Contractile", "MN": "D12.776.210", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "proteins involved in contractile processes; if in muscle use MUSCLE PROTEINS or specifics but not also here; /biosyn /drug eff /physiol permitted", "PI": "specific protein (1966-1976)", "MS": "Proteins which participate in contractile processes. They include MUSCLE PROTEINS as well as those found in other cells and tissues. In the latter, these proteins participate in localized contractile events in the cytoplasm, in motile activity, and in cell aggregation phenomena.", "PM": "77", "HN": "77", "MR": "20210630", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D003285"}, {"RECTYPE": "D", "MH": "Contracture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Contractures", "MN": "C05.651.197", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "coordinate IM with specific muscle or other tissue or site (IM) but not with MUSCLES, skeletal; also available are DUPUYTREN'S CONTRACTURE; HIP CONTRACTURE; VOLKMANN CONTRACTURE & EQUINUS CONTRACTURE", "MS": "Prolonged shortening of the muscle or other soft tissue around a joint, preventing movement of the joint.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003286"}, {"RECTYPE": "D", "MH": "Contrast Media", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Radiopaque Media|T130|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Media, Radiopaque", "MN": "D27.720.259", "FX": "Extravasation of Diagnostic and Therapeutic Materials", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "AN": "/adv eff: consider also EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS", "MS": "Substances used to allow enhanced visualization of tissues.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003287"}, {"RECTYPE": "D", "MH": "Contusions", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bruise|T033|T037|NON|EQV|NLM (1999)|980109|abbcdef", "ENTRY": "Contusion", "MN": "C26.974.250", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "differentiate from ECCHYMOSIS: use term in the text", "MS": "Injuries resulting in hemorrhage, usually manifested in the skin.", "CATSH": "CAT LIST", "MR": "20160303", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003288"}, {"RECTYPE": "D", "MH": "Convalescence", "AQ": "EC PX", "ENTRY": "Convalescences", "MN": "C23.550.291.562", "FX": "Recovery of Function", "MH_TH": "NLM (1966)", "ST": "T079", "AN": "coord IM with specific dis (IM)", "MS": "The period of recovery following an illness.", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003289"}, {"RECTYPE": "D", "MH": "Convergence, Ocular", "AQ": "DE ES GE IM PH RE", "ENTRY": "Ocular Convergences", "MN": "G14.350.217", "MH_TH": "NLM (1985)", "ST": "T042", "PI": "Fixation, Ocular (1966-1984)", "MS": "The turning inward of the lines of sight toward each other.", "PM": "91; was see under EYE MOVEMENTS 1985-90", "HN": "91(85); was see under EYE MOVEMENTS 1985-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19840430", "DC": "1", "DX": "19910101", "UI": "D003290"}, {"RECTYPE": "D", "MH": "Conversion Disorder", "DE": "CONVERSION DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Hysteria, Conversion|T048|NON|EQV|UNK (19XX)|780428|abcdef", "ENTRY": "Neurosis, Conversion", "MN": "F03.875.300", "MH_TH": "NLM (1969)", "ST": "T048", "PI": "Hysteria (1966-1968)", "MS": "A disorder whose predominant feature is a loss or alteration in physical functioning that suggests a physical disorder but that is actually a direct expression of a psychological conflict or need.", "OL": "use CONVERSION DISORDER to search CONVERSION REACTION & HYSTERIA, CONVERSION 1969-80, GLOBUS HYSTERICUS 1974-80, & ASTASIA-ABASIA 1970-78", "PM": "81; was CONVERSION REACTION 1969-80", "HN": "81; was CONVERSION REACTION 1969-80; GLOBUS HYSTERICUS was see under CONVERSION REACTION 1974-80; ASTASIA-ABASIA was see under CONVERSION REACTION 1970-78; HYSTERIA, CONVERSION was see under CONVERSION REACTION 1969-78", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D003291"}, {"RECTYPE": "D", "MH": "Convulsants", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Convulsant|T121|T131|NON|EQV|NLM (2022)|200824|abbcdef", "ENTRY": "Effects, Convulsant", "MN": "D27.505.954.427.220.224", "FX": "Seizures", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "note entry term CONVULSANT EFFECT: use only for the convulsant effect of a chemical substance", "PI": "Central Nervous System Depressants (1966-1975)", "MS": "Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools.", "OL": "search ANALEPTICS 1966-74", "PM": "75; was see ANALEPTICS 1963-74", "HN": "75; was see ANALEPTICS 1963-74", "MR": "20210630", "DA": "19741127", "DC": "1", "DX": "19750901", "UI": "D003292"}, {"RECTYPE": "D", "MH": "Seizures, Febrile", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pyrexial Seizure|T184|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Seizures, Pyrexial", "MN": "C23.888.592.742.571", "MH_TH": "UNK (19XX)", "ST": "T184", "PI": "Convulsions (1966-1976)", "MS": "Seizures that occur during a febrile episode. It is a common condition, affecting 2-5% of children aged 3 months to five years. An autosomal dominant pattern of inheritance has been identified in some families. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy (i.e., a nonfebrile seizure disorder) following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. (From Menkes, Textbook of Child Neurology, 5th ed, p784)", "PM": "2000; see CONVULSIONS, FEBRILE 1982-1999, see CONVULSIONS 1977-1981; for SEIZURES, FEBRILE see CONVULSIONS, FEBRILE 1982-1999", "HN": "2000(1977)", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19760427", "DC": "1", "DX": "19820101", "UI": "D003294"}, {"RECTYPE": "D", "MH": "Convulsive Therapy", "DE": "CONVULSIVE THER", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Shock Therapy, Insulin|T061|NON|NRW|UNK (19XX)|800522|SHOCK THER INSULIN|abcdefv", "ENTRY": "Therapies, Shock", "MN": "F04.570.200", "FX": "Insulin Coma", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "do not confuse with CONVULSIONS /ther; do not confuse entry term SHOCK THERAPY with SHOCK /ther nor entry term INSULIN COMA THERAPY with INSULIN COMA", "MS": "Convulsions induced in order to treat MENTAL DISORDERS. It is used primarily in the treatment of severe affective disorders and SCHIZOPHRENIA.", "OL": "use CONVULSIVE THERAPY to search SHOCK THERAPY & SHOCK THERAPY, INSULIN 1966-80", "PM": "81; was SHOCK THERAPY 1963-80; SHOCK THERAPY, INSULIN was heading 1963-80", "HN": "81; was SHOCK THERAPY 1963-80; SHOCK THERAPY, INSULIN was heading 1963-80", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D003295"}, {"RECTYPE": "D", "MH": "Cooking", "AQ": "CL EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Cookery|T056|T057|NON|EQV|NLM (1966)|990101|abbcdef", "MN": "J01.576.423.200.200", "MH_TH": "NLM (2011)", "ST": "T057", "AN": "consider also HOT TEMPERATURE", "MS": "The art or practice of preparing food. It includes the preparation of special foods for diets in various diseases.", "PM": "2011; see COOKERY 2000-2010", "HN": "2011; use COOKERY 2000-2010", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "20110101", "UI": "D003296"}, {"RECTYPE": "D", "MH": "Cooking and Eating Utensils", "DE": "COOKING EATING UTENSILS", "AQ": "CL EC ES HI LJ SN ST", "PRINT ENTRY": "Eating Utensils|T073|NON|NRW|NLM (1991)|900222|abcdef", "ENTRY": "Utensils, Eating", "MN": "J01.637.370", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Tools used in COOKING or EATING such as cutlery, pots, pans, and dishes.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003297"}, {"RECTYPE": "D", "MH": "Coombs Test", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Coombs' Test|T059|EPO|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Tests, Indirect Antiglobulin", "MN": "E05.478.594.760.050.375.150", "MH_TH": "NLM (2013)", "ST": "T059", "AN": "for erythrocytes only: for lymphocytes consider HISTOCOMPATIBILITY TESTING or CYTOTOXICITY TESTS, IMMUNOLOGIC", "MS": "A test to detect non-agglutinating ANTIBODIES against ERYTHROCYTES by use of anti-antibodies (the Coombs' reagent.) The direct test is applied to freshly drawn blood to detect antibody bound to circulating red cells. The indirect test is applied to serum to detect the presence of antibodies that can bind to red blood cells.", "PM": "2013; see COOMBS' TEST 1966-2012", "HN": "2013 (1966)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "20130101", "UI": "D003298"}, {"RECTYPE": "D", "MH": "Cooperative Behavior", "PRINT ENTRY": "Compliant Behavior|T054|NON|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Cooperative Behaviors", "MN": "F01.145.813.115", "FX": "Community Networks", "MH_TH": "NLM (1971)", "ST": "T054", "PI": "Behavior, Animal (1966-1970)", "MS": "The interaction of two or more persons or organizations directed toward a common goal which is mutually beneficial. An act or instance of working or acting together for a common purpose or benefit, i.e., joint action. (From Random House Dictionary Unabridged, 2d ed)", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20210709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003299"}, {"RECTYPE": "D", "MH": "Copper", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Copper 63", "MN": "D01.552.544.195", "PA": "Trace Elements", "FX": "Copper Radioisotopes", "MH_TH": "POPLINE (1978)", "ST": "T196", "N1": "Copper", "RN": "789U1901C5", "RR": "7440-50-8 (Copper)", "MS": "A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003300"}, {"RECTYPE": "D", "MH": "Copper Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Copper", "MN": "D01.496.749.270", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1987)", "MS": "Unstable isotopes of copper that decay or disintegrate emitting radiation. Cu atoms with atomic weights 58-62, 64, and 66-68 are radioactive copper isotopes.", "PM": "88", "HN": "88", "MR": "20170703", "DA": "19870406", "DC": "1", "DX": "19880101", "UI": "D003301"}, {"RECTYPE": "D", "MH": "Coprinus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.179.100.200", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5345", "AN": "a basidiomycete", "MS": "A genus of black-spored basidiomycetous fungi of the family Coprinaceae, order Agaricales; some species are edible.", "PM": "91; was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85", "HN": "91(75); was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D003302"}, {"RECTYPE": "D", "MH": "Coprophagia", "AQ": "CL DE GE IM PH RE", "PRINT ENTRY": "Cecotrophy|T040|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Coprophagy|T040|NON|EQV|NLM (2014)|121217|abcdef", "MN": "F01.145.113.547.500", "MH_TH": "NLM (2014)", "ST": "T040", "AN": "animal only; HUMAN COPROPHAGIA is available for humans", "PI": "Feces (1966-1969)", "MS": "Eating of excrement by animal species.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D003303"}, {"RECTYPE": "D", "MH": "Coproporphyrinogen Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Coproporphyrinogenase|T116|T126|NON|EQV|UNK (19XX)|750715|abbcdef", "ENTRY": "Oxidases, Coproporphyrinogen III", "MN": "D08.811.682.660.250", "EC": "deficiency:Coproporphyria, Hereditary", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "Coproporphyrinogen:oxygen oxidoreductase (decarboxylating)", "RN": "EC 1.3.3.3", "PI": "Porphyrins (1972-1974)", "MS": "An enzyme that catalyzes the oxidative decarboxylation of coproporphyrinogen III to protoporphyrinogen IX by the conversion of two propionate groups to two vinyl groups. It is the sixth enzyme in the 8-enzyme biosynthetic pathway of HEME, and is encoded by CPO gene. Mutations of CPO gene result in HEREDITARY COPROPORPHYRIA.", "PM": "91; was see under OXIDOREDUCTASES 1976-90", "HN": "91(76); was see under OXIDOREDUCTASES 1976-90", "MR": "20080708", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D003304"}, {"RECTYPE": "D", "MH": "Coproporphyrinogens", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D04.345.783.500.700.250", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "0", "AN": "intermediates in heme biosyn", "PI": "Porphyrins (1971-1974)", "MS": "Porphyrinogens which are intermediates in the heme biosynthesis. They have four methyl and four propionic acid side chains attached to the pyrrole rings. Coproporphyrinogens I and III are formed in the presence of uroporphyrinogen decarboxylase from the corresponding uroporphyrinogen. They can yield coproporphyrins by autooxidation or protoporphyrin by oxidative decarboxylation.", "PM": "91; was see under PORPHYRINOGENS 1976-90", "HN": "91(76); was see under PORPHYRINOGENS 1976-90", "MR": "20160528", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D003305"}, {"RECTYPE": "D", "MH": "Coproporphyrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.767.727.250", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Porphyrins (1969-1974)", "MS": "Porphyrins with four methyl and four propionic acid side chains attached to the pyrrole rings. Elevated levels of Coproporphyrin III in the urine and feces are major findings in patients with HEREDITARY COPROPORPHYRIA.", "PM": "91; was see under PORPHYRINS 1975-90", "HN": "91(75); was see under PORPHYRINS 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003306"}, {"RECTYPE": "D", "MH": "Copulation", "AQ": "CL DE PH RE", "ENTRY": "Copulations", "MN": "F01.145.113.252.748.200", "MH_TH": "NLM (1975)", "ST": "T054", "AN": "animal only: for human, use COITUS", "PI": "Coitus (1966-1974)", "MS": "Sexual union of a male and a female in non-human species.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D003307"}, {"RECTYPE": "D", "MH": "Copying Processes", "AQ": "CL EC ES HI LJ MT SD SN ST TD", "PRINT ENTRY": "Photocopying|T066|NON|NRW|NLM (1997)|960311|abcdef", "ENTRY": "Processes, Duplicating", "MN": "L01.280", "MH_TH": "NLM (1966)", "ST": "T066", "MS": "Reproduction of data in a new location or other destination, leaving the source data unchanged, although the physical form of the result may differ from that of the source.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003308"}, {"RECTYPE": "D", "MH": "Copyright", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Copyrights", "MN": "N03.706.535.518.300", "MH_TH": "NLM (1966)", "ST": "T064", "AN": "specify geographic term if pertinent", "MS": "It is a form of protection provided by law. In the United States this protection is granted to authors of original works of authorship, including literary, dramatic, musical, artistic, and certain other intellectual works. This protection is available to both published and unpublished works. (from Circular of the United States Copyright Office, 6/30/2008)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003309"}, {"RECTYPE": "D", "MH": "Cor Triatriatum", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Triatrial Heart|T019|NON|EQV|ORD (2010)|UNK (19XX)|860623|abcdeef", "ENTRY": "Triatrial Hearts", "MN": "C16.131.240.400.200", "MH_TH": "ORD (2010)", "ST": "T019", "PI": "Heart Defects, Congenital (1966-1986)", "MS": "A malformation of the heart in which the embryonic common PULMONARY VEIN was not incorporated into the LEFT ATRIUM leaving behind a perforated fibromuscular membrane bisecting the left atrium, a three-atrium heart. The opening between the two left atrium sections determines the degree of obstruction to pulmonary venous return, pulmonary venous and pulmonary arterial hypertension.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19860623", "DC": "1", "DX": "19870101", "UI": "D003310"}, {"RECTYPE": "D", "MH": "Cord Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trehalose Dimycolates|T109|T121|T123|NON|EQV|UNK (19XX)|790530|abbbcdef", "ENTRY": "Trehalose 6,6' Dimycolate", "MN": "D23.946.123.208", "PA": "Adjuvants, Immunologic", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Trehalose (1973-1974)", "MS": "Toxic glycolipids composed of trehalose dimycolate derivatives. They are produced by MYCOBACTERIUM TUBERCULOSIS and other species of MYCOBACTERIUM. They induce cellular dysfunction in animals.", "OL": "use CORD FACTORS to search CORD FACTOR 1975-79", "PM": "91; was see under GLYCOLIPIDS 1980-90; was CORD FACTOR see under GLYCOLIPIDS 1975-79", "HN": "91(80); was see under GLYCOLIPIDS 1980-90; was CORD FACTOR see under GLYCOLIPIDS 1975-79", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003311"}, {"RECTYPE": "D", "MH": "Coriolis Force", "PRINT ENTRY": "Coriolis Stimulation|T070|NON|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Stimulation, Coriolis", "MN": "G01.482.311", "MH_TH": "NLM (1964)", "ST": "T070", "MS": "The apparent deflection (Coriolis acceleration) of a body in motion with respect to the earth, as seen by an observer on the earth, attributed to a fictitious force (Coriolis force) but actually caused by the rotation of the earth. In a medical context it refers to the physiological effects (nausea, vertigo, dizziness, etc.) felt by a person moving radially in a rotating system, as a rotating space station. (From Random House Unabridged Dictionary, 2d ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "OL": "use CORIOLIS FORCE to search CORIOLIS EFFECT 1966-69 (as Prov)", "PM": "70", "HN": "70; was CORIOLIS EFFECT 1964-69 (Prov)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D003312"}, {"RECTYPE": "D", "MH": "Zea mays", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Zea|T002|NON|BRD|UNK (19XX)|850503|abcdef", "ENTRY": "Corn, Indian", "MN": "B01.875.800.575.912.250.822.966", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4577", "RR": "txid4575", "AN": "restrict to American corn: for ancient & non-American use of the word \"corn\", index EDIBLE GRAIN", "MS": "A plant species of the family POACEAE. It is a tall grass grown for its EDIBLE GRAIN, corn, used as food and animal FODDER.", "PM": "2003; see CORN 1966-2002, see GRAIN 1963-1965", "HN": "2003(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003313"}, {"RECTYPE": "D", "MH": "Corn Oil", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Maize Oil|T109|T121|T123|T168|NON|EQV|UNK (19XX)|860603|abbbbcdef", "ENTRY": "Oils, Maize", "MN": "J02.500.375.400.250", "MH_TH": "NLM (1987)", "ST": "T168", "N1": "Corn oil", "RN": "8001-30-7", "PI": "Oils (1966-1986)", "MS": "Oil from ZEA MAYS or corn plant.", "PM": "91; was see under PLANT OILS 1987-90", "HN": "91(87); was see under PLANT OILS 1987-90", "MR": "20141014", "DA": "19860603", "DC": "1", "DX": "19910101", "UI": "D003314"}, {"RECTYPE": "D", "MH": "Cornea", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Corneas", "MN": "A09.371.060.217", "FX": "Photorefractive Keratectomy", "EC": "transplantation:Corneal Transplantation", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at KERAT-", "MS": "The transparent anterior portion of the fibrous coat of the eye consisting of five layers: stratified squamous CORNEAL EPITHELIUM; BOWMAN MEMBRANE; CORNEAL STROMA; DESCEMET MEMBRANE; and mesenchymal CORNEAL ENDOTHELIUM. It serves as the first refracting medium of the eye. It is structurally continuous with the SCLERA, avascular, receiving its nourishment by permeation through spaces between the lamellae, and is innervated by the ophthalmic division of the TRIGEMINAL NERVE via the ciliary nerves and those of the surrounding conjunctiva which together form plexuses. (Cline et al., Dictionary of Visual Science, 4th ed)", "PM": "/transplantation was CORNEAL TRANSPLANTATION 1963-65; was CORNEA/transplantation 1966-89", "HN": "/transplantation was CORNEAL TRANSPLANTATION 1963-65; was CORNEA/transplantation 1966-89", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003315"}, {"RECTYPE": "D", "MH": "Corneal Diseases", "DE": "CORNEAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Corneal", "MN": "C11.204", "MH_TH": "NLM (1976)", "ST": "T047", "PI": "specific corneal disease heading", "MS": "Diseases of the cornea.", "PM": "76", "HN": "76; was NON MESH before 1976", "CATSH": "CAT LIST", "MR": "19900529", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D003316"}, {"RECTYPE": "D", "MH": "Corneal Dystrophies, Hereditary", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stromal Dystrophies, Corneal|T047|NON|REL|NLM (1990)|890216|abcdef", "ENTRY": "Stromal Dystrophy, Corneal", "MN": "C16.320.290.162", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Bilateral hereditary disorders of the cornea, usually autosomal dominant, which may be present at birth but more frequently develop during adolescence and progress slowly throughout life. Central macular dystrophy is transmitted as an autosomal recessive defect.", "OL": "use CORNEAL DYSTROPHIES, HEREDITARY to search CORNEAL DYSTROPHIES 1966-89", "PM": "90; was CORNEAL DYSTROPHIES 1963-89", "HN": "90; was CORNEAL DYSTROPHIES 1963-89", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D003317"}, {"RECTYPE": "D", "MH": "Corneal Opacity", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Leukoma|T046|T184|NON|EQV|NLM (1990)|890217|abbcdef", "ENTRY": "Opacity, Corneal", "MN": "C11.204.299", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.", "PM": "ARCUS SENILIS was see under EYE DISEASES 1964-89", "HN": "ARCUS SENILIS was see under EYE DISEASES 1964-89", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D003318"}, {"RECTYPE": "D", "MH": "Corneal Stroma", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Stromas, Corneal", "MN": "A09.371.060.217.228", "MH_TH": "NLM (1983)", "ST": "T024", "PI": "Cornea (1966-1982)", "MS": "The lamellated connective tissue constituting the thickest layer of the cornea between the Bowman and Descemet membranes.", "PM": "91; was see under CORNEA 1983-90", "HN": "91(83); was see under CORNEA 1983-90", "MR": "19900413", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D003319"}, {"RECTYPE": "D", "MH": "Corneal Ulcer", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Keratitis, Ulcerative|T020|T047|NON|EQV|NLM (1990)|890217|abbcdef", "ENTRY": "Ulcerative Keratitis", "MN": "C11.294.177", "FX": "Canaliculitis", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "a form of keratitis", "MS": "Loss of epithelial tissue from the surface of the cornea due to progressive erosion and necrosis of the tissue; usually caused by bacterial, fungal, or viral infection.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003320"}, {"RECTYPE": "D", "MH": "Cornell Medical Index", "DE": "CORNELL MED INDEX", "MN": "E01.370.510.150", "MH_TH": "NLM (1975)", "ST": "T060", "MS": "Self-administered health questionnaire developed to obtain details of the medical history as an adjunct to the medical interview. It consists of 195 questions divided into eighteen sections; the first twelve deal with somatic complaints and the last six with mood and feeling patterns. The Index is used also as a personality inventory or in epidemiologic studies.", "PM": "91; was see under MEDICAL HISTORY TAKING 1975-90", "HN": "91(75); was see under MEDICAL HISTORY TAKING 1975-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19750204", "DC": "1", "DX": "19910101", "UI": "D003321"}, {"RECTYPE": "D", "MH": "Coronary Aneurysm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aneurysm, Coronary|T047|T190|NON|EQV|UNK (19XX)|860327|abbcdef", "ENTRY": "Coronary Aneurysms", "MN": "C14.907.585.250.250", "FX": "Heart Aneurysm", "MH_TH": "NLM (1987)", "ST": "T190", "PI": "Coronary Disease (1966-1986)", "MS": "Abnormal balloon- or sac-like dilatation in the wall of CORONARY VESSELS. Most coronary aneurysms are due to CORONARY ATHEROSCLEROSIS, and the rest are due to inflammatory diseases, such as KAWASAKI DISEASE.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19860327", "DC": "1", "DX": "19870101", "UI": "D003323"}, {"RECTYPE": "D", "MH": "Coronary Artery Disease", "DE": "CORONARY ARTERY DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Left Main Disease|T047|NON|NRW|NLM (2021)|191120|abcdef", "ENTRY": "Left Main Diseases", "MN": "C14.907.585.250.260", "FX": "Atherectomy, Coronary", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Coronary Disease (1966-1986)", "MS": "Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.", "PM": "2008; see CORONARY ARTERIOSCLEROSIS 1987-2007; for CORONARY ARTERIOSCLEROSIS see CORONARY DISEASE 1974-1986; for CORONARY ARTERY DISEASE see CORONARY DISEASE 1986-2001", "HN": "2008 (1987); for CORONARY ARTERIOSCLEROSIS use CORONARY DISEASE 1974-1986; for CORONARY ARTERY DISEASE use CORONARY DISEASE 1986-2001", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19860327", "DC": "1", "DX": "19870101", "UI": "D003324"}, {"RECTYPE": "D", "MH": "Coronary Care Units", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Units, Coronary Care", "MN": "N02.278.388.493.211", "MH_TH": "NLM (1970)", "ST": "T093", "PI": "Intensive Care Units (1966-1969)", "MS": "The hospital unit in which patients with acute cardiac disorders receive intensive care.", "PM": "72", "HN": "72(70)", "MR": "19920514", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003325"}, {"RECTYPE": "D", "MH": "Coronary Circulation", "DE": "CORONARY CIRC", "AQ": "DE ES GE IM PH RE", "ENTRY": "Circulation, Coronary|T042|NON|EQV|NLM (1994)|921001|CIRC CORONARY|abcdefv", "MN": "G09.330.100.324", "MH_TH": "NLM (1972)", "ST": "T042", "PI": "Coronary Vessels (1966-1971)", "MS": "The circulation of blood through the CORONARY VESSELS of the HEART.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003326"}, {"RECTYPE": "D", "MH": "Coronary Disease", "DE": "CORONARY DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Coronary Heart Disease|T047|NON|EQV|UNK (19XX)|860327|CORONARY HEART DIS|abcdefv", "ENTRY": "Heart Diseases, Coronary", "MN": "C14.907.585.250", "FX": "Myocardial Revascularization", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.", "CATSH": "CAT LIST", "MR": "20100628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003327"}, {"RECTYPE": "D", "MH": "Coronary Thrombosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombosis, Coronary|T047|NON|EQV|UNK (19XX)|860327|abcdef", "ENTRY": "Thromboses, Coronary", "MN": "C14.907.585.250.290", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "do not confuse \"mural thrombus\" with \"coronary thrombosis\": index under HEART DISEASES + THROMBOSIS", "PI": "Coronary Disease (1966-1986)", "MS": "Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.", "OL": "use CORONARY THROMBOSIS to search THROMBOSIS, CORONARY 1987-91; use CORONARY DISEASE 1974-86", "PM": "91; was see under CORONARY DISEASE 1987-90; was THROMBOSIS, CORONARY see CORONARY DISEASE 1974-86", "HN": "91(87); was see under CORONARY DISEASE 1987-90; was THROMBOSIS, CORONARY see CORONARY DISEASE 1974-86", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19860327", "DC": "1", "DX": "19910101", "UI": "D003328"}, {"RECTYPE": "D", "MH": "Coronary Vasospasm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Coronary Artery Vasospasm|T047|NON|EQV|UNK (19XX)|810519|abcdef", "ENTRY": "Vasospasm, Coronary Artery", "MN": "C14.907.585.250.295", "MH_TH": "NLM (1982)", "ST": "T047", "MS": "Spasm of the large- or medium-sized coronary arteries.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19810519", "DC": "1", "DX": "19820101", "UI": "D003329"}, {"RECTYPE": "D", "MH": "Coronary Vessel Anomalies", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Coronary Vessel Anomaly", "MN": "C16.131.240.400.210", "MH_TH": "NLM (1966)", "ST": "T019", "MS": "Malformations of CORONARY VESSELS, either arteries or veins. Included are anomalous origins of coronary arteries; ARTERIOVENOUS FISTULA; CORONARY ANEURYSM; MYOCARDIAL BRIDGING; and others.", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003330"}, {"RECTYPE": "D", "MH": "Coronary Vessels", "AQ": "AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sinus Node Artery|T023|NON|NRW|NLM (2006)|050112|abcdef", "ENTRY": "Vessels, Coronary", "MN": "A07.015.908.194", "FX": "Coronary Artery Bypass", "EC": "abnormalities:Coronary Vessel Anomalies", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "consider also CORONARY CIRCULATION; /surg: consider also CORONARY ARTERY BYPASS; use CORONARY ANGIOGRAPHY for radiography of coronary vessels using CONTRAST MEDIA", "MS": "The veins and arteries of the HEART.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003331"}, {"RECTYPE": "D", "MH": "Coronaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "White bream viruses", "MN": "B04.820.578.500.540", "MH_TH": "NLM (1974)", "ST": "T005", "RN": "txid11118", "RR": "txid694018", "MS": "Spherical RNA viruses, in the order NIDOVIRALES, infecting a wide range of animals including humans. Transmission is by fecal-oral and respiratory routes. Mechanical transmission is also common. There are two genera: CORONAVIRUS and TOROVIRUS.", "OL": "use CORONAVIRIDAE to search CORONAVIRUSES 1974-80", "PM": "81; was CORONAVIRUSES 1974-80", "HN": "81; was CORONAVIRUSES 1974-80", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003332"}, {"RECTYPE": "D", "MH": "Coronaviridae Infections", "DE": "CORONAVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Coronaviridae", "MN": "C01.925.782.600.550", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "caused by members of the Coronaviridae family: do not confuse with CORONAVIRUS INFECTIONS caused by members of the Coronavirus genus; GEN or unspecified; prefer specifics", "PI": "Virus Diseases (1968-1976)", "MS": "Virus diseases caused by CORONAVIRIDAE.", "OL": "use CORONAVIRIDAE INFECTIONS to search CORONAVIRUS INFECTIONS 1977-93", "PM": "94; was CORONAVIRUS INFECTIONS 1977-93", "HN": "94; was CORONAVIRUS INFECTIONS 1977-93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D003333"}, {"RECTYPE": "D", "MH": "Coroners and Medical Examiners", "DE": "CORONERS MED EXAMINERS", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Medical Examiners|T097|NON|NRW|UNK (19XX)|740329|MED EXAMINERS|abcdefv", "ENTRY": "Coroner", "MN": "N02.360.230", "MH_TH": "NLM (1966)", "ST": "T097", "MS": "Physicians appointed to investigate all cases of sudden or violent death.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003334"}, {"RECTYPE": "D", "MH": "Corpora Allata", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Corpus Cardiacum|T023|NON|NRW|UNK (19XX)|800407|abcdef", "ENTRY": "Allatum, Corpus", "MN": "A13.250", "MH_TH": "NLM (1977)", "ST": "T023", "PI": "Neurosecretory Systems (1970-1976)", "MS": "Paired or fused ganglion-like bodies in the head of insects. The bodies secrete hormones important in the regulation of metamorphosis and the development of some adult tissues.", "PM": "1977; for CORPUS CARDIACUM see NEUROSECRETORY SYSTEMS 1980-2014", "HN": "1977; for CORPUS CARDIACUM use NEUROSECRETORY SYSTEMS 1980-2014", "MR": "20140613", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D003335"}, {"RECTYPE": "D", "MH": "Tectum Mesencephali", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Tectal Plate|T023|NON|NRW|NLM (2024)|230423|abcdef", "ENTRY": "Tectum Mesencephalus", "MN": "A08.186.211.132.659.800", "MH_TH": "UNK (19XX)", "ST": "T023", "AN": "do not confuse with TEGMENTUM MESENCEPHALI", "MS": "The dorsal portion or roof of the midbrain which is composed of two pairs of bumps, the INFERIOR COLLICULI and the SUPERIOR COLLICULI. These four colliculi are also called the quadrigeminal bodies (TECTUM MESENCEPHALI). They are centers for sensorimotor integration.", "PM": "2008; see CORPORA QUADRIGEMIA 1963-2007", "HN": "2008 (1963)", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003336"}, {"RECTYPE": "D", "MH": "Corpus Callosum", "AQ": "AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Neocortical Commissures", "MN": "A08.186.211.200.885.800.750", "EC": "abnormalities:Agenesis of Corpus Callosum", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Broad plate of dense myelinated fibers that reciprocally interconnect regions of the cortex in all lobes with corresponding regions of the opposite hemisphere. The corpus callosum is located deep in the longitudinal fissure.", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003337"}, {"RECTYPE": "D", "MH": "Corpus Luteum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Lutea, Corpora", "MN": "A06.300.312.497.278", "FX": "Luteolytic Agents", "MH_TH": "NLM (1963)", "ST": "T024", "AN": "/cytol: consider also LUTEAL CELLS", "MS": "The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003338"}, {"RECTYPE": "D", "MH": "Corpus Luteum Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Luteum Hormones, Corpus", "MN": "D06.472.334.734", "MH_TH": "POPLINE (1984)", "ST": "T125", "RN": "0", "AN": "/biosyn /physiol permitted", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003339"}, {"RECTYPE": "D", "MH": "Corpus Luteum Maintenance", "AQ": "BL CF DE EH ES GE IM ME PH PX RE UR", "PRINT ENTRY": "Luteal Maintenance|T042|NON|EQV|UNK (19XX)|750712|abcdef", "ENTRY": "Luteum Maintenances, Corpus", "MN": "G08.686.784.769.520.500", "MH_TH": "NLM (1975)", "ST": "T042", "PI": "Corpus Luteum (1966-1974)", "MS": "Process of maintaining the functions of CORPORA LUTEA, specifically PROGESTERONE production which is regulated primarily by pituitary LUTEINIZING HORMONE in cycling females, and by PLACENTAL HORMONES in pregnant females. The ability to maintain luteal functions is important in PREGNANCY MAINTENANCE.", "PM": "76; was see under CORPUS LUTEUM 1975", "HN": "76(75); was see under CORPUS LUTEUM 1975", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19760101", "UI": "D003340"}, {"RECTYPE": "D", "MH": "Luteolysis", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Luteal Regression|T042|NON|EQV|UNK (19XX)|750712|abcdef", "ENTRY": "Regression, Luteal", "MN": "G08.686.784.690.380", "MH_TH": "NLM (2003)", "ST": "T042", "PI": "Corpus Luteum (1966-1974)", "MS": "Degradation of CORPUS LUTEUM. In the absence of pregnancy and diminishing trophic hormones, the corpus luteum undergoes luteolysis which is characterized by the involution and cessation of its endocrine function.", "PM": "2003; see CORPUS LUTEUM REGRESSION 1976-2002; see CORPUS LUTEUM 1975", "HN": "2003 (1976); use CORPUS LUTEUM 1975", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19760101", "UI": "D003341"}, {"RECTYPE": "D", "MH": "Corpus Striatum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Lentiform Nucleus|T023|NON|NRW|NLM (1993)|910917|abcdef", "ENTRY": "Striatum, Corpus", "MN": "A08.186.211.200.885.287.249.487", "FX": "Medium Spiny Neurons", "MH_TH": "NLM (1972)", "ST": "T023", "AN": "do not confuse with STRIATE CORTEX see VISUAL CORTEX or with VENTRAL STRIATUM", "PI": "Basal Ganglia (1966-1971)", "MS": "Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE.", "OL": "use CORPUS STRIATUM to search LENTICULAR NUCLEUS 1974-78; use BASAL GANGLIA 1966-73", "PM": "74; LENTICULAR NUCLEUS was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73", "HN": "74(72); LENTICULAR NUCLEUS was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003342"}, {"RECTYPE": "D", "MH": "Corrosion", "ENTRY": "Corrosions", "MN": "G02.165", "MH_TH": "NLM (1970)", "ST": "T070", "AN": "almost never IM", "PI": "Chemistry, Physical (1966-1969)", "MS": "The gradual destruction of a metal or alloy due to oxidation or action of a chemical agent. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "73", "HN": "73(70)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003343"}, {"RECTYPE": "D", "MH": "Cortical Synchronization", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Cortical Desynchronization|T034|T042|NON|NRW|UNK (19XX)|830617|abbcdef", "ENTRY": "Synchronizations, Cortical", "MN": "G07.265.256.249", "FX": "Evoked Potentials", "MH_TH": "NLM (1972)", "ST": "T060", "PI": "Electroencephalography (1966-1971)", "MS": "EEG phase synchronization of the cortical brain region (CEREBRAL CORTEX).", "OL": "use CORTICAL SYNCHRONIZATION to search CORTICAL DESYNCHRONIZATION 1972-83 (as Prov 1972-74)", "PM": "91; was see under ELECTROENCEPHALOGRAPHY 1975-90; CORTICAL DESYNCHRONIZATION was see under ELECTROENCEPHALOGRAPHY 1975-83", "HN": "91(72); was see under ELECTROENCEPHALOGRAPHY 1972-90 (Prov 1972-74); CORTICAL DESYNCHRONIZATION was see under ELECTROENCEPHALOGRAPHY 1972-83 (Prov 1972-74)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003344"}, {"RECTYPE": "D", "MH": "Corticosterone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D06.472.040.585.353.237", "PA": "Anti-Inflammatory Agents", "MH_TH": "NLM (1966)", "ST": "T125", "N1": "Pregn-4-ene-3,20-dione, 11,21-dihydroxy-, (11beta)-", "RN": "W980KJ009P", "RR": "50-22-6 (Corticosterone)", "AN": "/biosyn /physiol permitted", "MS": "An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003345"}, {"RECTYPE": "D", "MH": "Corticotropin-Releasing Hormone", "DE": "CRH", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Corticotropin-Releasing Hormone-41|T116|T123|T125|NON|EQV|NLM (1990)|890405|CORTICOTROPIN RELEASING HORMONE 041|abbbcdefs", "ENTRY": "Corticotropin Releasing Hormone 41", "MN": "D12.776.631.650.405.740.140", "PA": "Hormones", "FX": "Receptors, Corticotropin-Releasing Hormone", "MH_TH": "NLM (1968)", "ST": "T125", "RN": "9015-71-8", "PI": "Hypothalamo-Hypophyseal System/physiology (1966-1967)", "MS": "A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS.", "OL": "use CORTICOTROPIN-RELEASING HORMONE to search CORTICOTROPIN RELEASING HORMONE 1974-89 & CORTICOTROPIN RELEASING FACTOR 1968-73", "PM": "90; was CORTICOTROPIN RELEASING HORMONE 1974-89; was CORTICOTROPIN RELEASING FACTOR 1968-73", "HN": "90; was CORTICOTROPIN RELEASING HORMONE 1974-89; was CORTICOTROPIN RELEASING FACTOR 1968-73", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003346"}, {"RECTYPE": "D", "MH": "Cortisone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Cortone Acetate|T109|T121|TRD|NRW|NLM (1978)|180214|abbcdef", "MN": "D06.472.040.585.478.195", "PA": "Anti-Inflammatory Agents", "MH_TH": "INN (19XX)", "ST": "T125", "N1": "Pregn-4-ene-3,11,20-trione, 17,21-dihydroxy-", "RN": "V27W9254FZ", "RR": "883WKN7W8X", "MS": "A naturally occurring glucocorticoid that has been used in replacement therapy for ADRENAL INSUFFICIENCY and as an anti-inflammatory agent. Cortisone itself is inactive; it is converted in the liver to the active metabolite HYDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726)", "PM": "/adverse effects /poisoning /toxicity were CORTISONE TOXICOLOGY 1963-65; /therapeutic use was CORTISONE, THERAPEUTIC 1965", "HN": "/adv eff-pois-tox was CORTISONE TOXICOLOGY 1963-65; /ther use was CORTISONE, THERAPEUTIC 1965", "MR": "20180409", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D003348"}, {"RECTYPE": "D", "MH": "Cortisone Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "20-beta-Hydroxysteroid Dehydrogenase|T116|T126|NON|EQV|UNK (19XX)|770205|BETA HYDROXYSTEROID DEHYDROGENASE A 20|abbcdefs", "ENTRY": "Reductase, Cortisone", "MN": "D08.811.682.047.820.125.150", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "3 alpha(or 20 beta)-Hydroxysteroid:NAD+ oxidoreductase", "RN": "EC 1.1.1.53", "PI": "Hydroxysteroid Dehydrogenases (1972-1974)", "MS": "An enzyme that catalyzes the interconversion of a ketone and hydroxy group at C-20 of cortisone and other 17,20,21-trihydroxy steroids. EC 1.1.1.53.", "PM": "91; was see under 20-HYDROXYSTEROID DEHYDROGENASES 1975-90", "HN": "91(75); was see under 20-HYDROXYSTEROID DEHYDROGENASES 1975-90", "MR": "20130708", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D003349"}, {"RECTYPE": "D", "MH": "Cortodoxone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cortexolone|T109|T125|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Substance S, Reichstein's", "MN": "D06.472.040.585.478.225", "MH_TH": "USAN (19XX)", "ST": "T125", "N1": "Pregn-4-ene-3,20-dione, 17,21-dihydroxy-", "RN": "WDT5SLP0HQ", "RR": "152-58-9 (Cortodoxone)", "AN": "an anti-inflamm agent", "PI": "Pregnenediones (1974)", "MS": "17,21-Dihydroxypregn-4-ene-3,20-dione. A 17-hydroxycorticosteroid with glucocorticoid and anti-inflammatory activities.", "PM": "91; was see under 17-HYDROXYCORTICOSTEROIDS 1975-90", "HN": "91(75); was see under 17-HYDROXYCORTICOSTEROIDS 1975-90", "MR": "20160701", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003350"}, {"RECTYPE": "D", "MH": "Corynebacterium", "DE": "CORYNEBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.200", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1716", "MS": "A genus of asporogenous bacteria that is widely distributed in nature. Its organisms appear as straight to slightly curved rods and are known to be human and animal parasites and pathogens.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003352"}, {"RECTYPE": "D", "MH": "Corynebacterium diphtheriae", "DE": "CORYNEBACT DIPHTHERIAE", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.200.150", "FX": "Diphtheria Toxin", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1717", "AN": "infection in man: usually DIPHTHERIA, otherwise coordinate with CORYNEBACTERIUM INFECTIONS", "MS": "A species of gram-positive, asporogenous bacteria in which three cultural types are recognized. These types (gravis, intermedius, and mitis) were originally given in accordance with the clinical severity of the cases from which the different strains were most frequently isolated. This species is the causative agent of DIPHTHERIA.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003353"}, {"RECTYPE": "D", "MH": "Corynebacterium Infections", "DE": "CORYNEBACT INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Corynebacterium", "MN": "C01.150.252.410.040.246", "MH_TH": "NLM (1972)", "ST": "T047", "PI": "Corynebacterium (1966-1971)", "MS": "Infections with bacteria of the genus CORYNEBACTERIUM.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003354"}, {"RECTYPE": "D", "MH": "Corynebacterium pyogenes", "DE": "CORYNEBACT PYOGENES", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.200.625", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid1661", "AN": "infection: coordinate with CORYNEBACTERIUM INFECTIONS ", "PI": "Corynebacterium (1966-1971)", "MS": "A species of CORYNEBACTERIUM isolated from abscesses of warm-blooded animals.", "PM": "91; was see under CORYNEBACTERIUM 1972-90", "HN": "91(72); was see under CORYNEBACTERIUM 1972-90", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003355"}, {"RECTYPE": "D", "MH": "Cosmetic Techniques", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Cosmetic", "MN": "E02.218", "FX": "Dermatologic Surgical Procedures", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "general or unspecified; prefer specifics; usually surgical improvement of external parts of the body; coordinate with organ /surg or surgical procedure ", "PI": "Surgery, Plastic (1969-1997)", "MS": "Procedures for the improvement or enhancement of the appearance of the visible parts of the body.", "PM": "98", "HN": "98; use explode 1974-97", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003357"}, {"RECTYPE": "D", "MH": "Cosmetics", "AQ": "AD AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Personal Care Products|T073|NON|BRD|NLM (2020)|190329|abcdef", "ENTRY": "Products, Personal Care", "MN": "J01.516.213", "MH_TH": "NLM (1966)", "ST": "T073", "RN": "0", "AN": "general or unspecified: prefer specifics ", "MS": "Substances intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance without affecting the body's structure or functions. Included in this definition are skin creams, lotions, perfumes, lipsticks, fingernail polishes, eye and facial makeup preparations, permanent waves, hair colors, toothpastes, and deodorants, as well as any material intended for use as a component of a cosmetic product. (U.S. Food & Drug Administration Center for Food Safety & Applied Nutrition Office of Cosmetics Fact Sheet (web page) Feb 1995)", "MR": "20190507", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003358"}, {"RECTYPE": "D", "MH": "Cosmic Radiation", "DE": "COSMIC RAD", "AQ": "AE", "PRINT ENTRY": "HZE Particles|T070|NRW|NLM (1995)|940111|abdef", "ENTRY": "Radiations, Cosmic", "MN": "N06.230.300.100.300", "FX": "Solar Activity", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "entry term HZE PARTICLES stands for High atomic number (Z) Energy particles", "MS": "High-energy radiation or particles from extraterrestrial space that strike the earth, its atmosphere, or spacecraft and may create secondary radiation as a result of collisions with the atmosphere or spacecraft.", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003359"}, {"RECTYPE": "D", "MH": "Cosmids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cosmid|T114|T123|NON|EQV|NLM (2004)|030127|abbcdef", "MN": "G05.360.600.250", "FX": "Cloning, Molecular", "MH_TH": "NLM (1986)", "ST": "T123", "PI": "Plasmids (1978-1985)", "MS": "Plasmids containing at least one cos (cohesive-end site) of PHAGE LAMBDA. They are used as cloning vehicles.", "PM": "86", "HN": "86", "MR": "20080708", "DA": "19850225", "DC": "1", "DX": "19860101", "UI": "D003360"}, {"RECTYPE": "D", "MH": "Cost Allocation", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Cost Shifting|T057|NON|NRW|UNK (19XX)|840406|abcdef", "ENTRY": "Shiftings, Cost", "MN": "N03.219.151.080", "MH_TH": "NLM (1979)", "ST": "T057", "AN": "NIM", "PI": "Costs and Cost Analysis (1966-1978)", "MS": "The assignment, to each of several particular cost-centers, of an equitable proportion of the costs of activities that serve all of them. Cost-center usually refers to institutional departments or services.", "PM": "91; was see under COSTS AND COST ANALYSIS 1979-90", "HN": "91(79); was see under COSTS AND COST ANALYSIS 1979-90", "MR": "19930916", "DA": "19780508", "DC": "1", "DX": "19910101", "UI": "D003361"}, {"RECTYPE": "D", "MH": "Cost-Benefit Analysis", "DE": "COST BENEFIT ANAL", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Cost-Benefit Data|T081|NON|REL|NLM (1992)|910429|abcdef", "ENTRY": "Marginal Analyses", "MN": "N03.219.151.125", "MH_TH": "NLM (1976)", "ST": "T057", "PI": "Costs and Cost Analysis (1966-1975)", "MS": "A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes.", "PM": "76", "HN": "76", "MR": "20220523", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D003362"}, {"RECTYPE": "D", "MH": "Cost Control", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Cost Containment|T057|NON|EQV|UNK (19XX)|780508|abcdef", "ENTRY": "Cost Controls", "MN": "N03.219.151.160", "MH_TH": "NLM (1979)", "ST": "T057", "AN": "NIM", "PI": "Costs and Cost Analysis (1966-1978)", "MS": "The containment, regulation, or restraint of costs. Costs are said to be contained when the value of resources committed to an activity is not considered excessive. This determination is frequently subjective and dependent upon the specific geographic area of the activity being measured. (From Dictionary of Health Services Management, 2d ed)", "PM": "80; was see under COSTS AND COST ANALYSIS 1979", "HN": "80(79); was see under COSTS AND COST ANALYSIS 1979", "MR": "20040707", "DA": "19780508", "DC": "1", "DX": "19800101", "UI": "D003363"}, {"RECTYPE": "D", "MH": "Costa Rica", "AQ": "EH EP", "MN": "Z01.107.169.238", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in CENTRAL AMERICA, bordering both the Caribbean Sea and the North Pacific Ocean, between NICARAGUA and PANAMA.", "MR": "20151124", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D003364"}, {"RECTYPE": "D", "MH": "Costs and Cost Analysis", "DE": "COSTS COST ANAL", "AQ": "CL EC ES HI LJ MT SN ST TD", "ENTRY": "Measures, Cost", "MN": "N03.219.151", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "Absolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs.", "PM": "66", "HN": "66", "MR": "20180711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003365"}, {"RECTYPE": "D", "MH": "Cosyntropin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetracosactrin|T116|T121|T123|T125|NON|EQV|UNK (19XX)|741111|abbbbcdef", "ENTRY": "ACTH, Synthetic", "MN": "D12.776.631.650.405.935.531.500.200", "PA": "Hormones", "MH_TH": "NLM (1975)", "ST": "T125", "N1": "alpha1-24-Corticotropin", "RN": "16960-16-0", "PI": "Adrenocorticotropic Hormone (1971-1974)", "MS": "A synthetic peptide that is identical to the 24-amino acid segment at the N-terminal of ADRENOCORTICOTROPIC HORMONE. ACTH (1-24), a segment similar in all species, contains the biological activity that stimulates production of CORTICOSTEROIDS in the ADRENAL CORTEX.", "PM": "88; was see under ADRENOCORTICOTROPIC HORMONE 1987; was see under CORTICOTROPIN 1974-86", "HN": "88(75); was see under ADRENOCORTICOTROPIC HORMONE 1987; was see under CORTICOTROPIN 1974-86", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19880101", "UI": "D003366"}, {"RECTYPE": "D", "MH": "Cotinine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Scotine|T109|T121|NON|EQV|NLM (2002)|010103|abbcdef", "MN": "D03.383.773.812.180", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "2-Pyrrolidinone, 1-methyl-5-(3-pyridinyl)-, (S)-", "RN": "K5161X06LL", "RR": "486-56-6 (Cotinine)", "PI": "Pyrrolidinones (1969-1974)", "MS": "The N-glucuronide conjugate of cotinine is a major urinary metabolite of NICOTINE. It thus serves as a biomarker of exposure to tobacco SMOKING. It has CNS stimulating properties.", "PM": "91; was see under PYRROLIDINONES 1975-90", "HN": "91(75); was see under PYRROLIDINONES 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003367"}, {"RECTYPE": "D", "MH": "Gossypium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cotton Plant|T002|NON|EQV|NLM (2003)|011005|abcdef", "ENTRY": "Plants, Cotton", "MN": "B01.875.800.575.912.250.859.821.500.244", "FX": "Cotton Fiber", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid3633", "AN": "X ref COTTON PLANT; COTTON FIBER is also available for textile fiber", "MS": "A plant genus of the family MALVACEAE. It is the source of COTTON FIBER; COTTONSEED OIL, which is used for cooking, and GOSSYPOL. The economically important cotton crop is a major user of agricultural PESTICIDES.", "PM": "2003; see COTTON 1963-2002", "HN": "2003(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20030101", "UI": "D003368"}, {"RECTYPE": "D", "MH": "Cottonseed Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Cottonseed|T002|NON|REL|UNK (19XX)|860603|abcdef", "ENTRY": "Oils, Cottonseed", "MN": "J02.500.375.400.300", "FX": "Gossypol", "MH_TH": "NLM (1966)", "ST": "T168", "RN": "0", "MS": "Oil obtained from the seeds of Gossypium herbaceum L., the cotton plant. It is used in dietary products such as oleomargarine and many cooking oils. Cottonseed oil is commonly used in soaps and cosmetics.", "OL": "use COTTONSEED OIL to search COTTONSEED 1966-86", "PM": "87; was COTTONSEED 1963-86", "HN": "87; was COTTONSEED 1963-86", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D003369"}, {"RECTYPE": "D", "MH": "Coturnix", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Japanese Quail|T012|NON|NRW|UNK (19XX)|741111|abcdef", "ENTRY": "Quails, Japanese", "MN": "B01.050.150.900.248.350.650.350", "MH_TH": "NLM (1975)", "ST": "T012", "RN": "txid9090", "RR": "txid93934", "AN": "diseases: coord IM with BIRD DISEASES (IM)", "MS": "A genus of BIRDS in the family Phasianidae, order GALLIFORMES, containing the common European and other Old World QUAIL.", "PM": "91; was see under QUAIL 1975-90", "HN": "91(75); was see under QUAIL 1975-90", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003370"}, {"RECTYPE": "D", "MH": "Cough", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Coughs", "MN": "C23.888.852.293", "FX": "Expectorants", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "/drug ther: consider also ANTITUSSIVE AGENTS", "MS": "A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003371"}, {"RECTYPE": "D", "MH": "Coumaphos", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Coumafos|T109|T121|T131|NON|EQV|FDA SRS (2014)|INN (19XX)|940719|abbbcdeef", "MN": "D03.633.100.150.446.912.326", "PA": "Insecticides", "MH_TH": "FDA SRS (2014)", "ST": "T131", "N1": "Phosphorothioic acid, O-(3-chloro-4-methyl-2-oxo-2H-1-benzopyran-7-yl) O,O-diethyl ester", "RN": "L08SZ5Z5JC", "RR": "56-72-4 (Coumaphos)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Coumarins (1966-1971)", "MS": "A organothiophosphorus cholinesterase inhibitor that is used as an anthelmintic, insecticide, and as a nematocide.", "PM": "91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90", "HN": "91(72); was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003372"}, {"RECTYPE": "D", "MH": "Coumaric Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxycinnamic Acids|T109|T123|NON|EQV|UNK (19XX)|750617|abbcdef", "ENTRY": "Acids, Hydroxycinnamic", "MN": "D02.241.223.200.210", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "0", "PI": "Cinnamates (1969-1975)", "MS": "Hydroxycinnamic acid and its derivatives. Act as activators of the indoleacetic acid oxidizing system, thereby producing a decrease in the endogenous level of bound indoleacetic acid in plants.", "PM": "91; was see under CINNAMATES 1976-90", "HN": "91(76); was see under CINNAMATES 1976-90", "MR": "20200527", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D003373"}, {"RECTYPE": "D", "MH": "Coumarins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Coumarine|T109|T121|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Derivatives, Coumarin", "MN": "D03.633.100.150.446", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid.", "PM": "89; ESCULIN was see under BIOFLAVONOIDS 1966-88", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003374"}, {"RECTYPE": "D", "MH": "Coumestrol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.150.446.350", "PA": "Phytoestrogens", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-", "RN": "V7NW98OB34", "RR": "479-13-0 (Coumestrol)", "PI": "Coumarins (1972-1974)", "MS": "A daidzein derivative occurring naturally in forage crops which has some estrogenic activity.", "PM": "91; was see under COUMARINS 1975-90", "HN": "91(75); was see under COUMARINS 1975-90", "MR": "20160528", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003375"}, {"RECTYPE": "D", "MH": "Counseling", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "MN": "N02.421.461.363", "FX": "Vocational Guidance", "MH_TH": "POPLINE (1978)", "ST": "T061", "AN": "general; prefer specifics", "MS": "The giving of advice and assistance to individuals with educational or personal problems.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003376"}, {"RECTYPE": "D", "MH": "Countercurrent Distribution", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Countercurrent Chromatography|T059|NON|EQV|NLM (2002)|010220|COUNTERCURRENT CHROMATOGR|abcdefv", "ENTRY": "Distribution, Countercurrent", "MN": "E05.196.278", "MH_TH": "NLM (1964)", "ST": "T059", "AN": "NIM", "MS": "A method of separation of two or more substances by repeated distribution between two immiscible liquid phases that move past each other in opposite directions. It is a form of liquid-liquid chromatography. (Stedman, 25th ed)", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D003377"}, {"RECTYPE": "D", "MH": "Counterimmunoelectrophoresis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Immunoelectrophoresis, Crossover|T059|T060|NON|EQV|UNK (19XX)|750724|abbcdef", "ENTRY": "Crossover Immunoelectrophoresis", "MN": "E05.478.605.492.350.350.150", "MH_TH": "NLM (1976)", "ST": "T060", "AN": "NIM: do not confuse entry term IMMUNOELECTROPHORESIS, CROSSOVER with IMMUNOELECTROPHORESIS, CROSSED see IMMUNOELECTROPHORESIS, TWO-DIMENSIONAL", "PI": "Immunoelectrophoresis (1966-1975)", "MS": "Immunoelectrophoresis in which immunoprecipitation occurs when antigen at the cathode is caused to migrate in an electric field through a suitable medium of diffusion against a stream of antibody migrating from the anode as a result of endosmotic flow.", "PM": "91; was see under IMMUNOELECTROPHORESIS 1976-90", "HN": "91(76); was see under IMMUNOELECTROPHORESIS 1976-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D003378"}, {"RECTYPE": "D", "MH": "Countertransference", "ENTRY": "Countertransference, Psychology|T041|NON|EQV|NLM (2020)|180904|abcdef", "MN": "F04.754.720.864.363", "MH_TH": "UNK (19XX)", "ST": "T041", "PI": "Transference (Psychology) (1966-1967)", "MS": "Conscious or unconscious emotional reaction of the therapist to the patient which may interfere with treatment. (APA, Thesaurus of Psychological Index Terms, 8th ed.)", "PM": "1968", "HN": "2020 (1968); was COUNTERTRANSFERENCE (PSYCHOLOGY) 1968-2020", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003379"}, {"RECTYPE": "D", "MH": "Courtship", "AQ": "EH ES PX", "ENTRY": "Courtships", "MN": "F01.145.802.279", "FX": "Love", "MH_TH": "NLM (1966)", "ST": "T054", "AN": "human & animal", "MS": "Activities designed to attract the attention or favors of another.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003380"}, {"RECTYPE": "D", "MH": "Coxiella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.132.150", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid776", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "MS": "A genus of gram-negative, rod-shaped bacteria that is widely distributed in TICKS and various mammals throughout the world. Infection with this genus is particularly prevalent in CATTLE; SHEEP; and GOATS.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003381"}, {"RECTYPE": "D", "MH": "Coxsackievirus Infections", "DE": "COXSACKIEVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Coxsackievirus Infection", "MN": "C01.925.782.687.359.213", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A heterogeneous group of infections produced by coxsackieviruses, including HERPANGINA, aseptic meningitis (MENINGITIS, ASEPTIC), a common-cold-like syndrome, a non-paralytic poliomyelitis-like syndrome, epidemic pleurodynia (PLEURODYNIA, EPIDEMIC) and a serious MYOCARDITIS.", "OL": "use COXSACKIEVIRUS INFECTIONS to search COXSACKIE VIRUS INFECTIONS 1966-78", "PM": "79; was COXSACKIE VIRUS INFECTIONS 1963-78", "HN": "79; was COXSACKIE VIRUS INFECTIONS 1963-78", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D003384"}, {"RECTYPE": "D", "MH": "Brachyura", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Uca|T204|NON|NRW|NLM (2003)|011026|abcdef", "ENTRY": "maenas, Carcinus", "MN": "B01.050.500.131.365.190.110", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6752", "RR": "txid6763", "AN": "as animal & food; IM; as food, coord IM with SHELLFISH (IM)", "PI": "Crustacea (1966-1971)", "MS": "An infraorder of chiefly marine, largely carnivorous CRUSTACEA, in the order DECAPODA, including the genera Cancer, Uca, and Callinectes.", "PM": "2003; see CRABS 1972-2003", "HN": "2003 (1972)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003386"}, {"RECTYPE": "D", "MH": "Cracked Tooth Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Cracked Tooth", "MN": "C26.900.750.300", "MH_TH": "NLM (1975)", "ST": "T037", "AN": "incomplete tooth fracture causing sensitivity to heat, cold, sweet, sour, alcohol", "MS": "Incomplete fracture of any part of a tooth, characterized by pain during mastication and sensitivity to heat, cold, sweet or sour tastes, and alcohol; it is often undiagnosed because the tooth is usually X-ray negative and normal to pulp vitality tests.", "OL": "search TOOTH FRACTURES 1970-74", "PM": "91; was see under TOOTH FRACTURES 1975-90", "HN": "91(75); was see under TOOTH FRACTURES 1975-90", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003387"}, {"RECTYPE": "D", "MH": "Cranial Fossa, Posterior", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Clivus|T030|NON|NRW|NLM (1997)|951206|abcdef", "ENTRY": "Posterior Cranial Fossas", "MN": "A02.835.232.781.750.400", "MH_TH": "NLM (1964)", "ST": "T030", "AN": "NIM when merely locational; entry term CLIVUS: restrict to posterior cranial fossa; other clivus sites are indexed under specific cranial bone, as clivus ossis occipitalis goes under OCCIPITAL BONE; neopl: coord IM with SKULL BASE NEOPLASMS (IM)", "MS": "The infratentorial compartment that contains the CEREBELLUM and BRAIN STEM. It is formed by the posterior third of the superior surface of the body of the sphenoid (SPHENOID BONE), by the occipital, the petrous, and mastoid portions of the TEMPORAL BONE, and the posterior inferior angle of the PARIETAL BONE.", "PM": "91; was see under SKULL 1964-90", "HN": "91(64); was see under SKULL 1964-90", "MR": "20180614", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003388"}, {"RECTYPE": "D", "MH": "Cranial Nerve Diseases", "DE": "CRANIAL NERVE DIS", "DS": "CRANIAL NERVE Z DISEASES", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuropathies, Cranial|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Palsy, Cranial Nerve", "MN": "C10.292", "FX": "Neuroaspergillosis", "MH_TH": "NLM (1981)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "specific cranial nerve (1966-1980)", "MS": "Disorders of one or more of the twelve cranial nerves. With the exception of the optic and olfactory nerves, this includes disorders of the brain stem nuclei from which the cranial nerves originate or terminate.", "PM": "1981", "HN": "1981; was NON MESH before 1981", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D003389"}, {"RECTYPE": "D", "MH": "Cranial Nerve Neoplasms", "DE": "CRANIAL NERVE NEOPL", "DS": "CRANIAL NERVE Z NEOPLASMS", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cranial Neuroma, Benign|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neuromas, Benign Cranial", "MN": "C10.551.775.250", "MH_TH": "NLM (1978)", "ST": "T191", "AN": "coord IM with specific cranial nerve dis (IM) + histol type of neopl (IM)", "PI": "Peripheral Nerve Neoplasms (1966-1977)", "MS": "Benign and malignant neoplasms that arise from one or more of the twelve cranial nerves.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D003390"}, {"RECTYPE": "D", "MH": "Cranial Nerves", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nerves, Cranial", "MN": "A08.800.800.120", "EC": "injuries:Cranial Nerve Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Twelve pairs of nerves that carry general afferent, visceral afferent, special afferent, somatic efferent, and autonomic efferent fibers.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003391"}, {"RECTYPE": "D", "MH": "Cranial Sinuses", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Venous Sinuses, Cranial", "MN": "A07.015.908.224", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "do not confuse with CEREBRAL VEINS", "MS": "Large endothelium-lined venous channels situated between the two layers of DURA MATER, the endosteal and the meningeal layers. They are devoid of valves and are parts of the venous system of dura mater. Major cranial sinuses include a postero-superior group (such as superior sagittal, inferior sagittal, straight, transverse, and occipital) and an antero-inferior group (such as cavernous, petrosal, and basilar plexus).", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003392"}, {"RECTYPE": "D", "MH": "Cranial Sutures", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sutures, Cranial", "MN": "A02.835.232.781.200", "MH_TH": "NLM (1981)", "ST": "T030", "AN": "note category: a fibrous joint in bones of head; do not confuse with SUTURES (E7) or SUTURE TECHNIQUES (E4)", "PI": "specific skull bone (1966-1980)", "MS": "A type of fibrous joint between bones of the head.", "PM": "91; was see under SKULL 1981-90", "HN": "91(81); was see under SKULL 1981-90", "MR": "20180629", "DA": "19800404", "DC": "1", "DX": "19910101", "UI": "D003393"}, {"RECTYPE": "D", "MH": "Craniofacial Dysostosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dysostosis, Craniofacial|T019|T047|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Dysostoses, Craniofacial", "MN": "C16.131.621.207.231", "FX": "Receptor, Fibroblast Growth Factor, Type 2", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "\"craniofacial dysmorphism\" does not go here: index under FACIAL BONES / abnorm + SKULL / abnorm but not also ABNORMALITIES, MULTIPLE", "MS": "Autosomal dominant CRANIOSYNOSTOSIS with shallow ORBITS; EXOPHTHALMOS; and maxillary hypoplasia.", "CATSH": "CAT LIST", "MR": "20160119", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003394"}, {"RECTYPE": "D", "MH": "Craniology", "DE": "CRANIOL", "AQ": "HI", "MN": "I01.076.368.239", "FX": "Cephalometry", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "specialty; do not confuse with CRANIOMETRY see CEPHALOMETRY", "MS": "The scientific study of variations in size, shape, and proportion of the cranium.", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003395"}, {"RECTYPE": "D", "MH": "Craniopharyngioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Rathke Pouch Tumor|T019|T191|EPO|EQV|NLM (2000)|991108|abbcdef", "ENTRY": "Tumor, Rathke's Pouch", "MN": "C04.557.580.625.200", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with PITUITARY NEOPLASMS (IM)", "MS": "A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50)", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003397"}, {"RECTYPE": "D", "MH": "Craniosynostoses", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Oxycephaly|T019|T047|NON|NRW|OMIM (2013)|UNK (19XX)|780310|abbcdeef", "ENTRY": "Unilateral Coronal Synostoses", "MN": "C16.131.621.906.364", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Premature closure of one or more CRANIAL SUTURES. It often results in plagiocephaly. Craniosynostoses that involve multiple sutures are sometimes associated with congenital syndromes such as ACROCEPHALOSYNDACTYLIA; and CRANIOFACIAL DYSOSTOSIS.", "OL": "use CRANIOSYNOSTOSES to search OXYCEPHALY 1966-78", "PM": "OXYCEPHALY was see under CRANOPSYNOSTOSES 1963-78", "HN": "OXYCEPHALY was see under CRANIOSYNOSTOSES 1963-78", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D003398"}, {"RECTYPE": "D", "MH": "Craniotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Craniotomies", "MN": "E04.525.190", "MH_TH": "NLM (1964)", "ST": "T061", "AN": "consider also SKULL /surg", "MS": "Surgical incision into the cranium.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003399"}, {"RECTYPE": "D", "MH": "Astacoidea", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Procambarus|T204|NON|NRW|NLM (2003)|011022|abcdef", "ENTRY": "Crayfishs", "MN": "B01.050.500.131.365.190.070", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6724", "RR": "txid6726", "AN": "as animal & food; IM; as food, coord IM with SHELLFISH (IM)", "PI": "Crustacea (1966-1971)", "MS": "A superfamily of various freshwater CRUSTACEA, in the infraorder Astacidea, comprising the crayfish. Common genera include Astacus and Procambarus. Crayfish resemble lobsters, but are usually much smaller.", "PM": "2003; see CRAYFISH 1972-2002", "HN": "2003 (1972)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003400"}, {"RECTYPE": "D", "MH": "Creatine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.125.373", "MH_TH": "NLM (1968)", "ST": "T123", "N1": "Glycine, N-(aminoiminomethyl)-N-methyl-", "RN": "MU72812GK0", "RR": "57-00-1 (Creatine)", "AN": "do not confuse with CREATININE; CREATINE PHOSPHATE see PHOSPHOCREATINE", "MS": "An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine.", "OL": "use CREATINE to search CREATINE AND CREATININE 1966-67", "PM": "68; CREATINE AND CREATININE was heading 1963-67", "HN": "68; CREATINE AND CREATININE was heading 1963-67", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003401"}, {"RECTYPE": "D", "MH": "Creatine Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Creatine Phosphokinase|T116|T126|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Phosphotransferase, ATP Creatine", "MN": "D08.811.913.696.640.150", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "ATP:creatine N-phosphotransferase", "RN": "EC 2.7.3.2", "RR": "EC 2.7.3.2", "MS": "A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003402"}, {"RECTYPE": "D", "MH": "Creatinine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate Salt, Creatinine", "MN": "D03.383.129.308.207", "MH_TH": "NLM (1968)", "ST": "T123", "N1": "4H-Imidazol-4-one, 2-amino-1,5-dihydro-1-methyl-", "RN": "AYI8EX34EU", "RR": "60-27-5 (Creatinine)", "AN": "do not confuse with CREATINE", "OL": "search CREATINE AND CREATININE under CREATINE 1966-67", "PM": "68; CREATINE AND CREATININE was heading 1963-67", "HN": "68; CREATINE AND CREATININE was heading 1963-67", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003404"}, {"RECTYPE": "D", "MH": "Creativity", "PRINT ENTRY": "Originality|T041|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Thinking, Creative", "MN": "F02.463.785.302", "MH_TH": "NLM (2013)", "ST": "T041", "AN": "human & animal (especially primates)", "MS": "The ability to generate new ideas or images.", "PM": "2013; see CREATIVENESS 1966-2012", "HN": "2013 (1966)", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "20130101", "UI": "D003405"}, {"RECTYPE": "D", "MH": "Credentialing", "AQ": "CL EC ES HI LJ OG SN ST TD", "MN": "N05.700.200", "MH_TH": "NLM (1980)", "ST": "T064", "AN": "\"recognition of professional or technical competence\" through various measures: see MeSH definition", "MS": "The recognition of professional or technical competence through registration, certification, licensure, admission to association membership, the award of a diploma or degree, etc.", "PM": "80", "HN": "80; was NON MESH before 1980", "MR": "19930916", "DA": "19780508", "DC": "1", "DX": "19800101", "UI": "D003406"}, {"RECTYPE": "D", "MH": "Creosote", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Creosote, Beechwood", "MN": "D02.455.426.559.389.657.239.327", "MH_TH": "NLM (1975)", "ST": "T167", "N1": "Creosote, wood", "RN": "8021-39-4", "MS": "A greasy substance with a smoky odor and burned taste created by high temperature treatment of BEECH and other WOOD; COAL TAR; or resin of the CREOSOTE BUSH. It contains CRESOLS and POLYCYCLIC AROMATIC HYDROCARBONS which are CARCINOGENS. It has been widely used as wood preservative and in PESTICIDES and had former use medicinally in DISINFECTANTS; LAXATIVES; and DERMATOLOGIC AGENTS.", "OL": "search CRESOLS 1966-74", "PM": "91; was see under CRESOLS 1975-90", "HN": "91(75); was see under CRESOLS 1975-90", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003407"}, {"RECTYPE": "D", "MH": "Cresols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.657.239", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Any of three isomeric crystalline aromatic methylphenols, also known as hydroxytoluenes.", "MR": "20161101", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003408"}, {"RECTYPE": "D", "MH": "Congenital Hypothyroidism", "DE": "CONGEN HYPOTHYROIDISM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myxedema, Congenital|T047|NON|NRW|GHR (2014)|NLM (1998)|960801|MYXEDEMA CONGEN|abcdeefv", "ENTRY": "Hypothyroidism, Congenital", "MN": "C19.874.482.281", "FX": "Myxedema", "MH_TH": "NLM (2006)", "ST": "T047", "MS": "A condition in infancy or early childhood due to an in-utero deficiency of THYROID HORMONES that can be caused by genetic or environmental factors, such as thyroid dysgenesis or HYPOTHYROIDISM in infants of mothers treated with THIOURACIL during pregnancy. Endemic cretinism is the result of iodine deficiency. Clinical symptoms include severe MENTAL RETARDATION, impaired skeletal development, short stature, and MYXEDEMA.", "PM": "2006; see CRETINISM 1966-2005", "HN": "2006 (1966)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D003409"}, {"RECTYPE": "D", "MH": "Cri-du-Chat Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chromosome 5p- Syndrome|T019|T047|NON|EQV|GHR (2014)|NLM (2000)|ORD (2010)|991103|CHROMOSOME 05 P SYNDROME|abbcdeeefs", "ENTRY": "Syndromes, Crying Cat", "MN": "C16.320.180.190", "FX": "Intellectual Disability", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An infantile syndrome characterized by a cat-like cry, failure to thrive, microcephaly, MENTAL RETARDATION, spastic quadriparesis, micro- and retrognathia, glossoptosis, bilateral epicanthus, hypertelorism, and tiny external genitalia. It is caused by a deletion of the short arm of chromosome 5 (5p-).", "PM": "1977; see CRYING CAT SYNDROME 1964-1976", "HN": "1977; use CRYING CAT SYNDROME 1964-1976", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003410"}, {"RECTYPE": "D", "MH": "Arvicolinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Voles|T015|NON|NRW|UNK (19XX)|810514|abcdef", "ENTRY": "Vole", "MN": "B01.050.150.900.649.313.992.635.075", "MH_TH": "NLM (1991)", "ST": "T015", "RN": "txid39087", "RR": "txid85951", "AN": "for entry term MICE, RED-BACKED & other species commonly called \"mouse\" but taxonomically ARVICOLINAE, do not check tag MICE", "PI": "Rodentia (1966-1981)", "MS": "A subfamily of MURIDAE found nearly world-wide and consisting of about 20 genera. Voles, lemmings, and muskrats are members.", "PM": "2006; see MICROTINAE 1991-2005, see CRICETIDAE 1982-1990; for VOLES & MICROTUS see RODENTS 1975-1981", "HN": "2006 (1991); for VOLES & MICROTUS use RODENTS 1975-1981", "MR": "20200902", "DA": "19810514", "DC": "1", "DX": "19820101", "UI": "D003411"}, {"RECTYPE": "D", "MH": "Cricetulus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Hamsters, Grey|T015|NON|NRW|UNK (19XX)|810514|abcdef", "ENTRY": "Hamster, Grey", "MN": "B01.050.150.900.649.313.992.635.075.250.250", "MH_TH": "NLM (1978)", "ST": "T015", "RN": "txid10028", "AN": "do not confuse with CRICETUS see CRICETINAE or CRICETIDAE see ARVICOLINAE; NIM with no qualifiers when experimental animal", "PI": "Hamsters (1966-1977)", "MS": "A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research.", "PM": "91; was see under HAMSTERS 1978-90", "HN": "91(78); was see under HAMSTERS 1978-90", "MR": "20200902", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D003412"}, {"RECTYPE": "D", "MH": "Cricoid Cartilage", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cricoid Cartilages", "MN": "A04.329.591.211", "MH_TH": "NLM (1979)", "ST": "T023", "PI": "Laryngeal Cartilages (1966-1978)", "MS": "The small thick cartilage that forms the lower and posterior parts of the laryngeal wall.", "PM": "91; was see under LARYNGEAL CARTILAGES 1979-90", "HN": "91(79); was see under LARYNGEAL CARTILAGES 1979-90", "MR": "20050630", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D003413"}, {"RECTYPE": "D", "MH": "Crigler-Najjar Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Unconjugated Hyperbilirubinemia, Hereditary", "MN": "C18.452.648.300.281", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A familial form of congenital hyperbilirubinemia transmitted as an autosomal recessive trait. It is characterized by icterus and brain damage caused by a glucuronyl transferase deficiency in the liver and faulty bilirubin conjugation.", "OL": "use HYPERBILIRUBINEMIA, HEREDITARY to search CRIGLER-NAJJAR SYNDROME 1966-74", "PM": "91; was see under HYPERBILIRUBINEMIA, HEREDITARY 1975-90", "HN": "91(75); was see under HYPERBILIRUBINEMIA, HEREDITARY 1975-90", "CATSH": "CAT LIST", "MR": "20230426", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003414"}, {"RECTYPE": "D", "MH": "Crime", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Poaching|T068|NON|REL|NLM (2021)|200708|abcdef", "ENTRY": "Kidnappings", "MN": "I01.880.735.191", "MH_TH": "POPLINE (1978)", "ST": "T068", "AN": "specify geog if pertinent", "PI": "Criminology (1966-1967)", "MS": "A violation of the criminal law, i.e., a breach of the conduct code specifically sanctioned by the state, which through its administrative agencies prosecutes offenders and imposes and administers punishments. The concept includes unacceptable actions whether prosecuted or going unpunished.", "PM": "68", "HN": "68", "MR": "20200708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003415"}, {"RECTYPE": "D", "MH": "Criminal Law", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Criminal Justice|T078|NON|NRW|UNK (19XX)|770420|abcdef", "ENTRY": "Laws, Criminal", "MN": "I01.880.604.583.100", "FX": "Law Enforcement", "MH_TH": "BIOETHICS (1989)", "ST": "T089", "AN": "specify state or country", "PI": "Jurisprudence (1966-1977)", "MS": "A branch of law that defines criminal offenses, regulates the apprehension, charging and trial of suspected persons, and fixes the penalties and modes of treatment applicable to convicted offenders.", "PM": "91; was see under JURISPRUDENCE 1978-90", "HN": "91(78); was see under JURISPRUDENCE 1978-90", "MR": "20020703", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D003416"}, {"RECTYPE": "D", "MH": "Criminal Psychology", "DE": "CRIMINAL PSYCHOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Psychology, Criminal|T090|NON|EQV|UNK (19XX)|740329|PSYCHOL CRIMINAL|abcdefv", "MN": "F02.784.240", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "as SPEC, SPEC qualif; as psychol of the criminal mind, no qualif; consider also PRISONERS /psychol", "MS": "The branch of psychology which investigates the psychology of crime with particular reference to the personality factors of the criminal.", "CATSH": "CAT LIST", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003417"}, {"RECTYPE": "D", "MH": "Criminology", "DE": "CRIMINOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "I01.198", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "The study of crime and criminals with special reference to the personality factors and social conditions leading toward, or away from crime.", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003418"}, {"RECTYPE": "D", "MH": "Crisis Intervention", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Screening and Brief Intervention|T061|NON|REL|NLM (2021)|191129|abcdef", "ENTRY": "Treatment, Brief", "MN": "F04.754.252", "FX": "Hotlines", "MH_TH": "NLM (1970)", "ST": "T061", "AN": "a psychother technique", "PI": "Suicide/prevention & control (1966-1969)", "MS": "Brief therapeutic approach which is ameliorative rather than curative of acute psychiatric emergencies. Used in contexts such as emergency rooms of psychiatric or general hospitals, or in the home or place of crisis occurrence, this treatment approach focuses on interpersonal and intrapsychic factors and environmental modification. (APA Thesaurus of Psychological Index Terms, 7th ed)", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D003419"}, {"RECTYPE": "D", "MH": "Crisscross Heart", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hearts, Crisscross", "MN": "C16.131.240.400.220", "MH_TH": "NLM (1987)", "ST": "T019", "PI": "Heart Defects, Congenital (1966-1986)", "MS": "A developmental malformation of the heart characterized by a twisted but not defective atrioventicular connection. The abnormal rotation of the ventricular mass around its long axis results in the crossing of the inflow streams of the two ventricles. Other features include hypoplasia of the TRICUSPID VALVE and RIGHT VENTRICLE.", "PM": "91; was see under HEART DEFECTS, CONGENITAL 1987-90", "HN": "91(87); was see under HEART DEFECTS, CONGENITAL 1987-90", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19860623", "DC": "1", "DX": "19910101", "UI": "D003420"}, {"RECTYPE": "D", "MH": "Crithidia", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Crithidias", "MN": "B01.268.475.868.110", "MH_TH": "NLM (1979)", "ST": "T204", "RN": "txid5655", "AN": "infection: coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Trypanosoma (1966-1978)", "MS": "A genus of parasitic protozoans found in the digestive tract of invertebrates, especially insects. Organisms of this genus have an amastigote and choanomastigote stage in their life cycle.", "PM": "79", "HN": "79", "MR": "20200813", "DA": "19771205", "DC": "1", "DX": "19790101", "UI": "D003421"}, {"RECTYPE": "D", "MH": "Critical Care", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "PRINT ENTRY": "Intensive Care, Surgical|T058|NON|NRW|NLM (1992)|910503|INTENSIVE CARE SURG|abcdefv", "ENTRY": "Care, Surgical Intensive", "MN": "N02.421.585.190", "MH_TH": "NLM (1975)", "ST": "T058", "PI": "Nursing Care (1966-1974)", "MS": "Health care provided to a critically ill patient during a medical emergency or crisis.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D003422"}, {"RECTYPE": "D", "MH": "Critical Period, Psychological", "ENTRY": "Psychological Critical Period", "MN": "F02.463.425.209", "MH_TH": "NLM (2020)", "ST": "T079", "AN": "human & animal", "MS": "A specific stage in animal and human development during which certain types of behavior normally are shaped and molded for life.", "PM": "1968", "HN": "2020 (1968); was CRITICAL PERIOD (PSYCHOLOGY) 1968-2019", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003423"}, {"RECTYPE": "D", "MH": "Crohn Disease", "DE": "CROHN DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ileocolitis|T047|NON|NRW|GHR (2014)|UNK (19XX)|750116|abcdeef", "ENTRY": "Terminal Ileitis", "MN": "C06.405.469.432.500", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "coord IM with ILEITIS (IM) or COLITIS (IM) only if site is particularly discussed; usually chronic so do not coord with CHRONIC DISEASE", "MS": "A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.", "OL": "use CROHN DISEASE to search ENTERITIS, REGIONAL 1966-79", "PM": "80; was ENTERITIS, REGIONAL 1965-79, was ILEITIS, REGIONAL 1963-64", "HN": "80; was ENTERITIS, REGIONAL 1965-79, was ILEITIS, REGIONAL 1963-64", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003424"}, {"RECTYPE": "D", "MH": "Flurogestone Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Flurogestone|T109|T121|NON|BRD|UNK (19XX)|750101|abbcdef", "ENTRY": "beta-hydroxyprogesterone, 17 beta-Acetoxy-9-fluoro-11", "MN": "D04.210.500.908.550", "PA": "Progestins", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "Pregn-4-ene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-, (11beta)-", "RN": "X60881643X", "RR": "NT3ET34748", "MS": "A synthetic fluorinated steroid that is used as a progestational hormone.", "PM": "96; was CRONOLONE 1965-95 (see under PREGNENEDIONES 1965-90)", "HN": "96; was CRONOLONE 1965-95 (see under PREGNENEDIONES 1965-90)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003425"}, {"RECTYPE": "D", "MH": "Crop, Avian", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Avian Crop", "MN": "A13.265", "MH_TH": "NLM (1968)", "ST": "T023", "PI": "Birds (1966-1967)", "MS": "A thin-walled distention of the alimentary tract protruding just outside the body cavity in the distal end of the neck (esophagus), used for the temporary storage of food and water.", "PM": "68", "HN": "68", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003426"}, {"RECTYPE": "D", "MH": "Cross Circulation", "DE": "CROSS CIRC", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Cross Circulations", "MN": "E05.660.365", "MH_TH": "NLM (1975)", "ST": "T059", "MS": "The circulation in a portion of the body of one individual of blood supplied from another individual.", "OL": "search PARABIOSIS 1970-74", "PM": "91; was see under PARABIOSIS 1975-90; was in Cat G only 1975-78", "HN": "91(75); was see under PARABIOSIS 1975-90; was in Cat G only 1975-78", "CATSH": "CAT LIST", "MR": "19940603", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003427"}, {"RECTYPE": "D", "MH": "Cross Infection", "DE": "CROSS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Nosocomial Infections|T047|NON|NRW|UNK (19XX)|770107|NOSOCOMIAL INFECT|abcdefv", "ENTRY": "Nosocomial Infection", "MN": "C23.550.291.875.500", "FX": "Patient Isolators", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "note INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL and INFECTIOUS DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT are also available", "MS": "Any infection which a patient contracts in a health-care institution.", "OL": "use CROSS INFECTION to search HOSPITAL INFECTIONS 1966-78", "HN": "HOSPITAL INFECTIONS was see under CROSS INFECTION 1971-78, was see CROSS INFECTIONS 1963-70", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D003428"}, {"RECTYPE": "D", "MH": "Cross Reactions", "AQ": "DE ES GE IM PH RE", "ENTRY": "Reactions, Cross", "MN": "G12.122.281", "FX": "Immunity, Heterologous", "MH_TH": "NLM (1969)", "ST": "T044", "AN": "coordinate NIM with specific antigen or antibody (IM); do not confuse with CROSS PROTECTION", "PI": "Antigen-Antibody Reactions (1966-1968)", "MS": "Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003429"}, {"RECTYPE": "D", "MH": "Cross-Sectional Studies", "DS": "CROSS SECTIONAL STUDIES", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "PRINT ENTRY": "Prevalence Studies|T081|NON|NRW|NLM (1990)|890525|abcdef", "ENTRY": "Surveys, Cross-Sectional", "MN": "N06.850.520.450.500.875", "MH_TH": "NLM (1975)", "ST": "T062", "AN": "IM general only; coordinate NIM with specific disease (IM); specify geographic term if pertinent", "MS": "Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.", "OL": "use CROSS-SECTIONAL STUDIES to search PREVALENCE STUDIES 1989", "PM": "90; was see under EPIDEMIOLOGIC METHODS 1975-89; PREVALENCE STUDIES was heading 1989", "HN": "90(75); was see under EPIDEMIOLOGIC METHODS 1975-89; PREVALENCE STUDIES was heading 1989", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19741119", "DC": "1", "DX": "19900101", "UI": "D003430"}, {"RECTYPE": "D", "MH": "Cross-Cultural Comparison", "PRINT ENTRY": "Transcultural Studies|T062|NON|BRD|UNK (19XX)|790221|abcdef", "ENTRY": "Transcultural Study", "MN": "I01.880.853.100.257", "MH_TH": "POPLINE (1978)", "ST": "T062", "PI": "Sociology (1966-1967)", "MS": "Comparison of various psychological, sociological, or cultural factors in order to assess the similarities or diversities occurring in two or more different cultures or societies.", "PM": "68", "HN": "68", "MR": "19911105", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003431"}, {"RECTYPE": "D", "MH": "Cross-Linking Reagents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Crosslinking Reagent|T130|NON|EQV|NLM (2022)|201013|abcdef", "ENTRY": "Reagents, Crosslinking", "MN": "D27.720.470.410.210", "MH_TH": "NLM (1980)", "ST": "T130", "RN": "0", "PI": "Protein Binding (1966-1979)", "MS": "Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other.", "PM": "80", "HN": "80", "MR": "20210630", "DA": "19790301", "DC": "1", "DX": "19800101", "UI": "D003432"}, {"RECTYPE": "D", "MH": "Crosses, Genetic", "DE": "CROSSES GENET", "ENTRY": "Genetic Crosses|T059|T063|NON|EQV|UNK (19XX)|860101|GENET CROSSES|abbcdefv", "MN": "E05.393.281", "FX": "Transformation, Genetic", "MH_TH": "NLM (1968)", "ST": "T063", "AN": "do not confuse with CROSSING OVER, the interchange of genes between homologous chromosomes", "PI": "Genetics (1966-1967)", "MS": "Deliberate breeding of two different individuals that results in offspring that carry part of the genetic material of each parent. The parent organisms must be genetically compatible and may be from different varieties or closely related species.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003433"}, {"RECTYPE": "D", "MH": "Crossing Over, Genetic", "DE": "CROSSING OVER GENET", "AQ": "DE ES GE IM PH RE", "ENTRY": "Genetic Crossing-Over", "MN": "G05.728.615.200", "FX": "Sister Chromatid Exchange", "MH_TH": "NLM (2005)", "ST": "T045", "AN": "do not confuse with CROSSES, GENETIC, the result of breeding 2 varieties of the same species", "PI": "Genetics (1966-1967)", "MS": "The reciprocal exchange of segments at corresponding positions along pairs of homologous CHROMOSOMES by symmetrical breakage and crosswise rejoining forming cross-over sites (HOLLIDAY JUNCTIONS) that are resolved during CHROMOSOME SEGREGATION. Crossing-over typically occurs during MEIOSIS but it may also occur in the absence of meiosis, for example, with bacterial chromosomes, organelle chromosomes, or somatic cell nuclear chromosomes.", "PM": "2005; see CROSSING OVER (GENETICS) 1968-2004", "HN": "2005(1968)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003434"}, {"RECTYPE": "D", "MH": "Crotalid Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE TO TU UR", "PRINT ENTRY": "Rattlesnake Venoms|T123|T131|NON|NRW|UNK (19XX)|771005|abbcdef", "ENTRY": "Viper Venom, Pit", "MN": "D23.946.833.850.960.200", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "from pit vipers (rattlesnake, cottonmouth, etc.); /antag permitted but consider also ANTIVENINS; /enzymology permitted; TN 241: common & scientific names of various crotalids", "PI": "Venoms (1966-1974)", "MS": "Venoms from snakes of the subfamily Crotalinae or pit vipers, found mostly in the Americas. They include the rattlesnake, cottonmouth, fer-de-lance, bushmaster, and American copperhead. Their venoms contain nontoxic proteins, cardio-, hemo-, cyto-, and neurotoxins, and many enzymes, especially phospholipases A. Many of the toxins have been characterized.", "PM": "78", "HN": "78", "MR": "20230405", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D003435"}, {"RECTYPE": "D", "MH": "Croton Oil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oil, Croton", "MN": "D20.215.784.750.315", "PA": "Dermatologic Agents", "FX": "Phorbol Esters", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Oils, croton", "RN": "8001-28-3", "AN": "a dermatol agent & carcinogen", "MS": "Viscous, nauseating oil obtained from the shrub Croton tiglium (Euphorbaceae). It is a vesicant and skin irritant used as pharmacologic standard for skin inflammation and allergy and causes skin cancer. It was formerly used as an emetic and cathartic with frequent mortality.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003436"}, {"RECTYPE": "D", "MH": "Crotonates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Crotonic", "MN": "D10.251.400.143.687", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "PI": "Butyrates (1966-1972)", "MS": "Derivatives of BUTYRIC ACID that include a double bond between carbon 2 and 3 of the aliphatic structure. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the aminobutryrate structure.", "PM": "91; was see under FATTY ACIDS, MONOUNSATURATED 1973-90", "HN": "91(73); was see under FATTY ACIDS, MONOUNSATURATED 1973-90", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003437"}, {"RECTYPE": "D", "MH": "Crotoxin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Crotapotin|T126|T131|NON|NRW|UNK (19XX)|770426|abbcdef", "ENTRY": "Crotoxin B|T126|T131|NON|NRW|UNK (19XX)|831209|abbcdef", "MN": "D23.946.833.850.960.200.210", "MH_TH": "NLM (1978)", "ST": "T131", "N1": "Crotoxin", "RN": "9007-40-3", "AN": "from a So. Amer. rattlesnake; /antag permitted but consider also ANTIVENINS", "PI": "Venoms (1966-1974)", "MS": "A specific complex of toxic proteins from the venom of Crotalus durissus terrificus (South American rattlesnake). It can be separated into a phospholipase A and crotapotin fragment; the latter consists of three different amino acid chains, potentiates the enzyme, and is specifically neurotoxic.", "PM": "91; was see under CROTALID VENOMS 1978-90", "HN": "91(78); was see under CROTALID VENOMS 1978-90", "MR": "20050630", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D003439"}, {"RECTYPE": "D", "MH": "Croup", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Croup, Viral", "MN": "C09.400.535.365", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Inflammation involving the GLOTTIS or VOCAL CORDS and the subglottic larynx. Croup is characterized by a barking cough, HOARSENESS, and persistent inspiratory STRIDOR (a high-pitched breathing sound). It occurs chiefly in infants and children.", "OL": "search LARYNGITIS 1966-74", "PM": "91; was see under LARYNGITIS 1975-90", "HN": "91(75); was see under LARYNGITIS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003440"}, {"RECTYPE": "D", "MH": "Crowding", "AQ": "PX", "MN": "F01.145.875.281", "MH_TH": "NLM (1981)", "ST": "T054", "AN": "human & animal", "MS": "An excessive number of individuals, human or animal, in relation to available space.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003441"}, {"RECTYPE": "D", "MH": "Crowns", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Dental Crowns|T074|NON|EQV|UNK (19XX)|771201|DENT CROWNS|abcdefv", "ENTRY": "Crown", "MN": "E07.695.190.088", "FX": "Dental Porcelain", "MH_TH": "NLM (1965)", "ST": "T074", "MS": "A prosthetic restoration that reproduces the entire surface anatomy of the visible natural crown of a tooth. It may be partial (covering three or more surfaces of a tooth) or complete (covering all surfaces). It is made of gold or other metal, porcelain, or resin.", "PM": "65; CROWN AND BRIDGEWORK was heading 1963-64", "HN": "65; CROWN AND BRIDGEWORK was heading 1963-64", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003442"}, {"RECTYPE": "D", "MH": "Crush Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Crush", "MN": "C26.797.240", "FX": "Compartment Syndromes", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Severe systemic manifestation of trauma and ischemia involving soft tissues, principally skeletal muscle, due to prolonged severe crushing. It leads to increased permeability of the cell membrane and to the release of potassium, enzymes, and myoglobin from within cells. Ischemic renal dysfunction secondary to hypotension and diminished renal perfusion results in acute tubular necrosis and uremia.", "OL": "use KIDNEY FAILURE, ACUTE to search CRUSH SYNDROME 1966-74", "PM": "91; was see under SHOCK, TRAUMATIC 1979-90; was see under KIDNEY FAILURE, ACUTE 1967-78; was see under ACUTE KIDNEY FAILURE 1963-66", "HN": "91(75); was see under SHOCK, TRAUMATIC 1979-90; was see under KIDNEY FAILURE, ACUTE 1967-78; was see under ACUTE RENAL FAILURE 1963-66", "CATSH": "CAT LIST", "MR": "20160226", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003444"}, {"RECTYPE": "D", "MH": "Crustacea", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Ostracoda|T204|NON|NRW|NLM (2003)|011213|abcdef", "ENTRY": "Ostracodas", "MN": "B01.050.500.131.365", "FX": "Shellfish", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6657", "RR": "txid6670", "AN": "as animal and food; general or unspecified; prefer specifics; as food, coordinate with SHELLFISH ", "MS": "A large subphylum of mostly marine ARTHROPODS containing over 42,000 species. They include familiar arthropods such as lobsters (NEPHROPIDAE), crabs (BRACHYURA), shrimp (PENAEIDAE), and barnacles (THORACICA).", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003445"}, {"RECTYPE": "D", "MH": "Crutches", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "MN": "E07.858.442.281", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "Wooden or metal staffs designed to aid a person in walking. (UMDNS,1999)", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003446"}, {"RECTYPE": "D", "MH": "Crying", "AQ": "PH PX", "ENTRY": "Cryings", "MN": "F01.525.200.310.300", "MH_TH": "NLM (1970)", "ST": "T054", "PI": "Voice (1966-1969)", "MS": "To utter an inarticulate, characteristic sound in order to communicate or express a feeling, or desire for attention.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D003448"}, {"RECTYPE": "D", "MH": "Cryoglobulinemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cryoglobulinemias", "MN": "C20.683.780.250", "MH_TH": "NLM (1982)", "ST": "T047", "PI": "Paraproteinemias (1976-1981)", "MS": "A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas.", "PM": "85; was see under PARAPROTEINEMIAS 1982-84", "HN": "85(82); was see under PARAPROTEINEMIAS 1982-84", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19810519", "DC": "1", "DX": "19850101", "UI": "D003449"}, {"RECTYPE": "D", "MH": "Cryoglobulins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cryoprotein|T116|T129|NON|BRD|NLM (2021)|200210|abbcdef", "ENTRY": "Cryoproteins|T116|T129|NON|BRD|UNK (19XX)|810210|abbcdef", "MN": "D12.776.377.715.548.900.225", "PA": "Immunologic Factors", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "MS": "Abnormal immunoglobulins, especially IGG or IGM, that precipitate spontaneously when SERUM is cooled below 37 degrees Celsius. It is characteristic of CRYOGLOBULINEMIA.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003450"}, {"RECTYPE": "D", "MH": "Cryoprotective Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Cryoprotective Agent|T121|NON|EQV|NLM (2021)|200430|abcdef", "ENTRY": "Effects, Cryoprotective", "MN": "D27.720.799.180", "MH_TH": "NLM (1967)", "ST": "T121", "RN": "0", "AN": "note entry term CRYOPROTECTIVE EFFECT: use only for the cryoprotective effect of a chemical substance", "PI": "Freezing (1966)", "MS": "Substances that provide protection against the harmful effects of freezing temperatures.", "PM": "72", "HN": "72(67)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003451"}, {"RECTYPE": "D", "MH": "Cryosurgery", "DE": "CRYOSURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Cryoablation|T061|NON|EQV|NLM (1994)|921116|abcdef", "ENTRY": "Cryosurgeries", "MN": "E04.014.180", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "coordinate with organ or disease /surg; differentiate from HYPOTHERMIA, INDUCED for cooling of organs during surgery", "MS": "The use of freezing as a special surgical technique to destroy or excise tissue.", "OL": "use CRYOSURGERY to search CRYOGENIC SURGERY & CRYOTHERAPY 1966-83", "PM": "84; was CRYOGENIC SURGERY 1963-83; CRYOTHERAPY was heading 1967-83", "HN": "84; was CRYOGENIC SURGERY 1963-83; CRYOTHERAPY was heading 1964-83 (Prov 1964-66)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D003452"}, {"RECTYPE": "D", "MH": "Cryptococcosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Torulosis|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Toruloses", "MN": "C01.150.703.248", "FX": "Cryptococcus", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Fungal infection caused by genus CRYPTOCOCCUS.", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003453"}, {"RECTYPE": "D", "MH": "Cryptococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Torula|T004|NON|NRW|UNK (19XX)|740329|abcdef", "MN": "B01.300.930.316", "FX": "Cryptococcosis", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid5206", "RR": "txid430997", "MS": "A mitosporic Tremellales fungal genus whose species usually have a capsule and do not form pseudomycellium. Teleomorphs include Filobasidiella and Fidobasidium.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003454"}, {"RECTYPE": "D", "MH": "Cryptococcus neoformans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Torulopsis neoformans|T004|NON|EQV|NLM (2021)|200318|abcdef", "ENTRY": "Cryptococcus neoformans var. grubii|T004|NON|NRW|NLM (2010)|081120|abcdef", "MN": "B01.300.930.316.366", "MH_TH": "NLM (1972)", "ST": "T004", "RN": "txid5207", "RR": "txid178876", "AN": "infection: coordinate with CRYPTOCOCCOSIS ", "PI": "Cryptococcus (1966-1971)", "MS": "A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella neoformans.", "PM": "91; see CRYPTOCOCCUS 1972-90", "HN": "91(72)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003455"}, {"RECTYPE": "D", "MH": "Cryptorchidism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Testis, Undescended|T019|NON|EQV|NLM (1991)|900426|abcdef", "ENTRY": "Undescended Testes", "MN": "C19.391.829.258", "FX": "Gubernaculum", "MH_TH": "OMIM (2013)", "ST": "T019", "MS": "A developmental defect in which a TESTIS or both TESTES failed to descend from high in the ABDOMEN to the bottom of the SCROTUM. Testicular descent is essential to normal SPERMATOGENESIS which requires temperature lower than the BODY TEMPERATURE. Cryptorchidism can be subclassified by the location of the maldescended testis.", "OL": "95; use CRYPTORCHIDISM to search CRYPTORCHISM 1966-94", "PM": "95; was CRYPTORCHISM 1963-94", "HN": "95; was CRYPTORCHISM 1963-94", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19950101", "UI": "D003456"}, {"RECTYPE": "D", "MH": "Cryptosporidiosis", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "ENTRY": "Infection, Cryptosporidium", "MN": "C22.674.710.235", "MH_TH": "NLM (1985)", "ST": "T047", "PI": "Coccidiosis (1966-1984)", "MS": "Intestinal infection with organisms of the genus CRYPTOSPORIDIUM. It occurs in both animals and humans. Symptoms include severe DIARRHEA.", "PM": "1985", "HN": "1985", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19840406", "DC": "1", "DX": "19850101", "UI": "D003457"}, {"RECTYPE": "D", "MH": "Cryptosporidium", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Cryptosporidiums", "MN": "B01.043.075.189.250.150.160", "MH_TH": "NLM (1985)", "ST": "T204", "RN": "txid5806", "PI": "Coccidia (1975-1984)", "MS": "A genus of coccidian parasites of the family CRYPTOSPORIDIIDAE, found in the intestinal epithelium of many vertebrates including humans.", "PM": "1991; see COCCIDIA 1985-90", "HN": "1991(1985)", "MR": "20200813", "DA": "19840406", "DC": "1", "DX": "19910101", "UI": "D003458"}, {"RECTYPE": "D", "MH": "Crystallins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lens Proteins|T116|T123|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Proteins, Lens", "MN": "D12.776.306.366", "MH_TH": "NLM (1964)", "ST": "T123", "RN": "0", "MS": "A heterogeneous family of water-soluble structural proteins found in cells of the vertebrate lens. The presence of these proteins accounts for the transparency of the lens. The family is composed of four major groups, alpha, beta, gamma, and delta, and several minor groups, which are classed on the basis of size, charge, immunological properties, and vertebrate source. Alpha, beta, and delta crystallins occur in avian and reptilian lenses, while alpha, beta, and gamma crystallins occur in all other lenses.", "PM": "68", "HN": "68(64)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003459"}, {"RECTYPE": "D", "MH": "Crystallization", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Polymorphism, Crystallization|T104|NON|REL|NLM (2007)|060221|abcdef", "ENTRY": "Polymorphs, Crystalline", "MN": "G02.171", "MH_TH": "NLM (1964)", "ST": "T070", "AN": "do not confuse with genetic, protein and other polymorphs; NIM; coordinate NIM with substance being crystallized (IM or NIM)", "MS": "The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003460"}, {"RECTYPE": "D", "MH": "Crystallography", "DE": "CRYSTALLOGR", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Crystallographies", "MN": "H01.181.529.240", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "usually NIM", "MS": "The branch of science that deals with the geometric description of crystals and their internal arrangement. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003461"}, {"RECTYPE": "D", "MH": "Cuba", "AQ": "EH EP", "MN": "Z01.639.880.225", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island in the Greater Antilles in the West Indies", "MS": "An island in the Greater Antilles in the West Indies, south of Florida. With the adjacent islands it forms the Republic of Cuba. Its capital is Havana. It was discovered by Columbus on his first voyage in 1492 and conquered by Spain in 1511. It has a varied history under Spain, Great Britain, and the United States but has been independent since 1902. The name Cuba is said to be an Indian name of unknown origin but the language that gave the name is extinct, so the etymology is a conjecture. (From Webster's New Geographical Dictionary, 1988, p302 & Room, Brewer's Dictionary of Names, 1992, p132)", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D003462"}, {"RECTYPE": "D", "MH": "Cues", "ENTRY": "Cue", "MN": "F02.463.425.234", "MH_TH": "NLM (1964)", "ST": "T078", "MS": "Signals for an action; that specific portion of a perceptual field or pattern of stimuli to which a subject has learned to respond.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "19890428", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003463"}, {"RECTYPE": "D", "MH": "Culdoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Culdoscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES CULDOSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Culdoscopic", "MN": "E04.950.300.259", "FX": "Culdoscopes", "MH_TH": "BIOETHICS (1978)", "ST": "T060", "AN": "/ instrum permitted but consider also CULDOSCOPES", "MS": "Endoscopic examination, therapy or surgery of the female pelvic viscera by means of an endoscope introduced into the pelvic cavity through the posterior vaginal fornix.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003464"}, {"RECTYPE": "D", "MH": "Culex", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Culices", "MN": "B01.050.500.131.617.720.500.500.750.712.500.875.225", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid7174", "AN": "mosquito: do not confuse with CULICOIDES, gnat; do not use /drug eff for insecticides: TN 111; /microbiol /parasitol /virol permitted", "MS": "A genus of mosquitoes (CULICIDAE) commonly found in tropical regions. Species of this genus are vectors for ST. LOUIS ENCEPHALITIS as well as many other diseases of man and domestic and wild animals.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003465"}, {"RECTYPE": "D", "MH": "Cultural Characteristics", "AQ": "HI", "PRINT ENTRY": "Ethnic Boundary Maintenance|T102|NON|BRD|NLM (2020)|181218|abcdef", "ENTRY": "Maintenances, Ethnic Boundary", "MN": "I01.880.853.100.329", "FX": "Cross-Cultural Comparison", "MH_TH": "NLM (1975)", "ST": "T102", "AN": "not for microbial or tissue cultures", "MS": "Those aspects or characteristics which identify a culture.", "PM": "91; was see under CULTURE 1975-90", "HN": "91(75); was see under CULTURE 1975-90", "MR": "20190114", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003466"}, {"RECTYPE": "D", "MH": "Cultural Deprivation", "PRINT ENTRY": "Cultural Disadvantagement|T068|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Disadvantagements, Cultural", "MN": "I01.880.853.748.877.500", "MH_TH": "NLM (1968)", "ST": "T068", "MS": "The absence of certain expected and acceptable cultural phenomena in the environment which results in the failure of the individual to communicate and respond in the most appropriate manner within the context of society. Language acquisition and language use are commonly used in assessing this concept.", "PM": "68", "HN": "68", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003467"}, {"RECTYPE": "D", "MH": "Cultural Evolution", "AQ": "HI", "ENTRY": "Evolutions, Cultural", "MN": "I01.076.201.450.370", "MH_TH": "NLM (1978)", "ST": "T068", "MS": "The continuous developmental process of a culture from simple to complex forms and from homogeneous to heterogeneous qualities. It is the change of cultures over time. Research in cultural evolution tries to understand the causal relationships that shape and change human culture in both the long and the short term.", "PM": "91; was see under CULTURE 1978-90", "HN": "91(78); was see under CULTURE 1978-90", "MR": "20190114", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D003468"}, {"RECTYPE": "D", "MH": "Culture", "PRINT ENTRY": "Customs|T078|NON|NRW|NLM (1993)|911002|abcdef", "ENTRY": "Relativisms, Cultural", "MN": "I01.880.853.100", "FX": "Cross-Cultural Comparison", "MH_TH": "POPLINE (1978)", "ST": "T078", "AN": "note category: not for microbial or tissue cultures", "MS": "A collective expression for all behavior patterns acquired and socially transmitted through symbols. Culture includes customs, traditions, and language.", "MR": "20190114", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003469"}, {"RECTYPE": "D", "MH": "Culture Media", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO", "ENTRY": "Media, Culture", "MN": "E07.206", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "MS": "Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003470"}, {"RECTYPE": "D", "MH": "Cuprizone", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Biscyclohexanone Oxaldihydrazone|T109|T130|NON|EQV|UNK (19XX)|790606|abbcdef", "ENTRY": "Oxaldihydrazone, Biscyclohexanone", "MN": "D02.455.426.392.368.367.190", "PA": "Monoamine Oxidase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Ethanedioic acid, bis(cyclohexylidenehydrazide)", "RN": "5N16U7E0AO", "RR": "370-81-0 (Cuprizone)", "PI": "Hydrazones (1972-1974)", "MS": "Copper chelator that inhibits monoamine oxidase and causes liver and brain damage.", "PM": "91; was see under CYCLOHEXANES 1975-90", "HN": "91(75); was see under CYCLOHEXANES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003471"}, {"RECTYPE": "D", "MH": "Curare", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D20.215.784.500.200", "PA": "Nicotinic Antagonists", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "8063-06-7", "AN": "/analogs: consider also CURARE-LIKE AGENTS see NEUROMUSCULAR NONDEPOLARIZING AGENTS", "MS": "Plant extracts from several species, including genera STRYCHNOS and Chondodendron, which contain TETRAHYDROISOQUINOLINES that produce PARALYSIS of skeletal muscle. These extracts are toxic and must be used with the administration of artificial respiration.", "OL": "use CURARE to search CURARIFORM ANTAGONISTS 1966-69", "PM": "CURARIFORM ANTAGONISTS was heading 1963-69", "HN": "CURARIFORM ANTAGONISTS was heading 1963-69", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D003472"}, {"RECTYPE": "D", "MH": "Neuromuscular Nondepolarizing Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neuromuscular Blocking Agents, Competitive|T121|NON|EQV|NLM (1993)|920226|abcdef", "ENTRY": "Nondepolarizing Agents, Neuromuscular", "MN": "D27.505.696.663.700.710.575", "FX": "Nicotinic Antagonists", "MH_TH": "NLM (1970)", "ST": "T121", "RN": "0", "PI": "Muscles (1966-1969)", "MS": "Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants.", "OL": "use NEUROMUSCULAR NONDEPOLARIZING AGENTS to search MUSCLE RELAXANTS, POLARIZING 1989-94 & CURARE-LIKE AGENTS & PACHYCURARES 1970-92; search MUSCLE RELAXANTS under NEUROMUSCULAR NONDEPOLARIZING AGENTS, MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 & MUSCLES 1966-69; search CURARIFORM ANTAGONISTS under CURARE 1966-69", "PM": "93; was CURARE-LIKE AGENTS 1970-92; MUSCLE RELAXANTS, POLARIZING was see NEUROMUSCULAR NONDEPOLARIZING AGENTS 1989-94; NEUROMUSCULAR NONDEPOLARIZING AGENTS & PACHYCURARES were see CURARE-LIKE AGENTS 1970-92; CURARIFORM DRUGS was see MUSCLE RELAXANTS 1963-69; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69; CURARIFORM ANTAGONISTS was heading 1963-69", "HN": "93; was CURARE-LIKE AGENTS 1970-92; MUSCLE RELAXANTS, POLARIZING was see NEUROMUSCULAR NONDEPOLARIZING AGENTS 1989-94; NEUROMUSCULAR NONDEPOLARIZING AGENTS & PACHYCURARES were see CURARE-LIKE AGENTS 1975-92; CURARIFORM DRUGS was see under MUSCLE RELAXANTS 1963-69; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69; CURARIFORM ANTAGONISTS was heading 1963-69", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D003473"}, {"RECTYPE": "D", "MH": "Curcumin", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Turmeric Yellow|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Yellow, Turmeric", "MN": "D02.455.426.559.695.222", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "IT942ZTH98", "RR": "458-37-7 (Curcumin)", "AN": "entry term TURMERIC YELLOW: TUMERIC see CURCUMA is also available", "PI": "Catechols (1966-1974)", "MS": "A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes.", "PM": "91; was see under CATECHOLS 1975-90", "HN": "91(75); was see under CATECHOLS 1975-90", "MR": "20230531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003474"}, {"RECTYPE": "D", "MH": "Curettage", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Curettages", "MN": "E04.157", "FX": "Dilatation and Curettage", "MH_TH": "POPLINE (1978)", "ST": "T061", "AN": "note DILATATION AND CURETTAGE and SUBGINGIVAL CURETTAGE are also available", "MS": "A scraping, usually of the interior of a cavity or tract, for removal of new growth or other abnormal tissue, or to obtain material for tissue diagnosis. It is performed with a curet (curette), a spoon-shaped instrument designed for that purpose. (From Stedman, 25th ed & Dorland, 27th ed)", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "19950313", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003475"}, {"RECTYPE": "D", "MH": "Curium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.200", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Curium", "RN": "M5LL84MZ2W", "RR": "7440-51-9 (Curium)", "MS": "A radioactive actinide with atomic symbol Cm, and atomic number 96. Thirteen curium isotopes have been produced with mass numbers ranging from 238-250. Its valence can be +3 or +4. It is intensely radioactive and decays by alpha-emission.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003476"}, {"RECTYPE": "D", "MH": "Curriculum", "AQ": "SN ST TD", "ENTRY": "Short-Term Course", "MN": "I02.158", "MH_TH": "POPLINE (1978)", "ST": "T170", "MS": "A course of study offered by an educational institution.", "PM": "66", "HN": "66", "MR": "19920514", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003479"}, {"RECTYPE": "D", "MH": "Cushing Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Cushing's", "MN": "C19.053.800.367", "FX": "Pituitary ACTH Hypersecretion", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with CUSHING DISEASE see PITUITARY ACTH HYPERSECRETION", "MS": "A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.", "PM": "99; see CUSHING'S SYNDROME 1966-98", "HN": "99(66)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D003480"}, {"RECTYPE": "D", "MH": "Cuspid", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Canine Tooth|T023|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Tooth, Canine", "MN": "A14.549.167.860.200", "MH_TH": "NLM (1965)", "ST": "T023", "AN": "between the 2d incisor & premolars; NIM when merely locational", "MS": "The third tooth to the left and to the right of the midline of either jaw, situated between the second INCISOR and the premolar teeth (BICUSPID). (Jablonski, Dictionary of Dentistry, 1992, p817)", "PM": "65", "HN": "65", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003481"}, {"RECTYPE": "D", "MH": "Custodial Care", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "ENTRY": "Care, Custodial", "MN": "N02.421.585.215", "MH_TH": "NLM (1978)", "ST": "T058", "AN": "\"board, room & other personal assist serv\"", "MS": "Board, room, and other personal assistance services generally provided on a long term basis. It excludes regular medical care.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19770519", "DC": "1", "DX": "19780101", "UI": "D003482"}, {"RECTYPE": "D", "MH": "Cutis Laxa", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dermatomegaly|T047|NON|EQV|GHR (2014)|UNK (19XX)|750101|abcdeef", "ENTRY": "Dermatolyses", "MN": "C17.800.827.180", "FX": "Ehlers-Danlos Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with ANETODERMA; CUTIS LAXA is mostly a genetic disease: both are described as \"loose skin\"", "MS": "A group of connective tissue diseases in which skin hangs in loose pendulous folds. It is believed to be associated with decreased elastic tissue formation as well as an abnormality in elastin formation. Cutis laxa is usually a genetic disease, but acquired cases have been reported. (From Dorland, 27th ed)", "PM": "1968; sww DERMATOLYSIS 1963-1967", "HN": "1968; use DERMATOLYSIS 1963-1967", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003483"}, {"RECTYPE": "D", "MH": "Cyanamide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Citrated Calcium Cyanamide|T121|T197|NON|NRW|UNK (19XX)|780518|abbcdef", "ENTRY": "Cyanamide, Citrated Calcium", "MN": "D02.491.203.362", "MH_TH": "NLM (1979)", "ST": "T197", "N1": "Cyanamide", "RN": "420-04-2", "RR": "ZLR270912W", "PI": "Cyanides (1966-1978)", "MS": "A cyanide compound which has been used as a fertilizer, defoliant and in many manufacturing processes. It often occurs as the calcium salt, sometimes also referred to as cyanamide. The citrated calcium salt is used in the treatment of alcoholism.", "PM": "91; was see under CYANIDES 1979-90", "HN": "91(79); was see under CYANIDES 1979-90", "MR": "20160701", "DA": "19780518", "DC": "1", "DX": "19910101", "UI": "D003484"}, {"RECTYPE": "D", "MH": "Cyanates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyanate|T109|NON|EQV|NLM (2021)|200224|abcdef", "MN": "D02.262", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Organic salts of cyanic acid containing the -OCN radical.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003485"}, {"RECTYPE": "D", "MH": "Cyanides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isocyanides|T197|NON|REL|NLM (1993)|920204|abcdef", "MN": "D01.625.400.100", "FX": "Nitriles", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "inorganic salts having -CN radical: differentiate from NITRILES which are organic with -CN", "MS": "Inorganic salts of HYDROGEN CYANIDE containing the -CN radical. The concept also includes isocyanides. It is distinguished from NITRILES, which denotes organic compounds containing the -CN radical.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003486"}, {"RECTYPE": "D", "MH": "Cyanoacrylates", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Cyanoacrylate", "MN": "J01.637.051.919.367", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Tissue Adhesives (1966-1971)", "MS": "A group of compounds having the general formula CH2=C(CN)-COOR; it polymerizes on contact with moisture; used as tissue adhesive; higher homologs have hemostatic and antibacterial properties.", "PM": "72", "HN": "72", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003487"}, {"RECTYPE": "D", "MH": "Cyanogen Bromide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Bromide, Cyanogen", "MN": "D01.625.175", "MH_TH": "NLM (1971)", "ST": "T197", "N1": "Cyanogen bromide ((CN)Br)", "RN": "OS382OHJ8P", "RR": "506-68-3 (Cyanogen Bromide)", "AN": "useful reagent in molec biol", "PI": "Cyanides (1966-1970)", "MS": "Cyanogen bromide (CNBr). A compound used in molecular biology to digest some proteins and as a coupling reagent for phosphoroamidate or pyrophosphate internucleotide bonds in DNA duplexes.", "PM": "73", "HN": "73(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003488"}, {"RECTYPE": "D", "MH": "Cyanoketone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.054.079.429.320", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "Androst-5-ene-2-carbonitrile, 17-hydroxy-4,4,17-trimethyl-3-oxo-, (2alpha,17beta)-", "RN": "4248-66-2", "PI": "Nitriles (1974)", "MS": "2 alpha-Cyano-17 beta-hydroxy-4,4',17 alpha-trimethylandrost-5-ene-3-one. An androstenolone-nitrile compound with steroidogenesis-blocking activity.", "PM": "91; was see under ANDROSTENOLS 1975-90", "HN": "91(75); was see under ANDROSTENOLS 1975-90", "MR": "20160528", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003489"}, {"RECTYPE": "D", "MH": "Cyanosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cyanoses", "MN": "C23.888.248", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "do not use for cyanotic heart disease unless particularly discussed (=probably HEART DEFECTS, CONGENITAL)", "MS": "A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003490"}, {"RECTYPE": "D", "MH": "Cybernetics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Cybernetic", "MN": "L01.906.099", "FX": "Bionics", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "That branch of learning which brings together theories and studies on communication and control in living organisms and machines.", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003491"}, {"RECTYPE": "D", "MH": "Cycasin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylazoxymethanol beta-D-Glucoside|T109|T123|T131|NON|EQV|NLM (1991)|900305|abbbcdef", "ENTRY": "beta-D-Glucoside, Methylazoxymethanol", "MN": "D02.172.080.200", "PA": "Neurotoxins", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "beta-D-Glucopyranoside, (methyl-ONN-azoxy)methyl", "RN": "9H51HL0E1D", "RR": "14901-08-7 (Cycasin)", "PI": "Methylglycosides (1974)", "MS": "Carcinogenic and neurotoxic glycoside occurring in a number of plant species, including Cycas revoluta.", "PM": "91; was see under AZO COMPOUNDS 1975-90", "HN": "91(75); was see under AZO COMPOUNDS 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003492"}, {"RECTYPE": "D", "MH": "Cyclacillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ciclacillin|T109|T195|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|741111|abbcdeeef", "ENTRY": "Wy4508", "MN": "D03.633.100.300.750.249", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((1-aminocyclohexyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-", "RN": "72ZJ154X86", "RR": "3485-14-1 (Cyclacillin)", "PI": "Penicillins (1972-1974)", "MS": "A cyclohexylamido analog of PENICILLANIC ACID.", "PM": "91; was see under PENICILLINS 1975-90", "HN": "91(75); was see under PENICILLINS 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003493"}, {"RECTYPE": "D", "MH": "Cyclamates", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Cyclamic Acid|T109|NON|BRD|FDA SRS (2014)|NLM (1996)|USAN (19XX)|941205|abcdeeef", "ENTRY": "Cyclamate, Sodium", "MN": "D02.455.426.392.368.367.204", "PA": "Sweetening Agents", "MH_TH": "NLM (1970)", "ST": "T109", "RN": "0", "RR": "OK71859Z12", "PI": "Sweetening Agents (1966-1969)", "MS": "Salts and esters of cyclamic acid.", "OL": "search SWEETENING AGENTS 1966-69", "PM": "71; was CYCLAMATE see under SWEETENING AGENTS 1963-70; CYCLAMIC ACID was indexed under CYCLAMATES 1982-95", "HN": "71(70); was CYCLAMATE see under SWEETENING AGENTS 1963-70; was in Cat D & J 1973-82, was in Cat D only 1963-72; CYCLAMIC ACID was (NM) 1982-95", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D003494"}, {"RECTYPE": "D", "MH": "Cyclandelate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Cyclospasmol|T109|T121|TRD|NRW|UNK (19XX)|861120|abbcdef", "MN": "D02.241.511.536.180", "PA": "Vasodilator Agents", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Benzeneacetic acid, alpha-hydroxy-, 3,3,5-trimethylcyclohexyl ester", "RN": "4139O1OAY2", "RR": "456-59-7", "PI": "Mandelic Acids (1968-1974)", "MS": "A direct-acting SMOOTH MUSCLE relaxant used to dilate BLOOD VESSELS.", "PM": "91; was see under MANDELIC ACIDS 1975-90", "HN": "91(75); was see under MANDELIC ACIDS 1975-90", "MR": "20141014", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003495"}, {"RECTYPE": "D", "MH": "Cyclazocine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.605.168", "PA": "Narcotic Antagonists", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "2,6-Methano-3-benzazocin-8-ol, 3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-", "RN": "J5W1B1159C", "RR": "3572-80-3 (Cyclazocine)", "MS": "An analgesic with mixed narcotic agonist-antagonist properties.", "PM": "73", "HN": "73(64)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003496"}, {"RECTYPE": "D", "MH": "Cyclic N-Oxides", "DS": "CYCLIC OXIDES N", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Heterocyclic N-Oxides|T109|NON|EQV|UNK (19XX)|770520|HETEROCYCLIC OXIDES N|abcdefs", "ENTRY": "Oxides, Cyclic N", "MN": "D03.661.243", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PI": "Oxides (1966-1967)", "MS": "Heterocyclic compounds in which an oxygen is attached to a cyclic nitrogen.", "PM": "68", "HN": "68", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003497"}, {"RECTYPE": "D", "MH": "Cyclic P-Oxides", "DS": "CYCLIC OXIDES P", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Heterocyclic P-Oxides|T109|NON|EQV|UNK (19XX)|770520|HETEROCYCLIC OXIDES P|abcdefs", "ENTRY": "P-Oxides, Heterocyclic", "MN": "D03.661.368", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PI": "Oxides (1966-1967)", "PM": "68", "HN": "68", "MR": "19920511", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003498"}, {"RECTYPE": "D", "MH": "Cyclic S-Oxides", "DS": "CYCLIC OXIDES S", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Heterocyclic S-Oxides|T109|NON|EQV|UNK (19XX)|770520|HETEROCYCLIC OXIDES S|abcdefs", "ENTRY": "S-Oxides, Heterocyclic", "MN": "D03.661.493", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PI": "Oxides (1966-1967)", "PM": "68", "HN": "68", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003499"}, {"RECTYPE": "D", "MH": "Cyclization", "AQ": "DE GE IM PH RE", "ENTRY": "Cyclizations", "MN": "G03.208", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "almost never IM; enzymatic cyclization: coord NIM with specific enzyme (IM) + substrate (NIM)", "PI": "Chemistry, Organic (1966-1970)", "MS": "Changing an open-chain hydrocarbon to a closed ring. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003500"}, {"RECTYPE": "D", "MH": "Cyclizine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Cyclizine", "MN": "D03.383.606.320", "PA": "Histamine H1 Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Piperazine, 1-(diphenylmethyl)-4-methyl-", "RN": "QRW9FCR9P2", "RR": "W0O1NHP4WE", "MS": "A histamine H1 antagonist given by mouth or parenterally for the control of postoperative and drug-induced vomiting and in motion sickness. (From Martindale, The Extra Pharmacopoeia, 30th ed, p935)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003501"}, {"RECTYPE": "D", "MH": "Cyclobutanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.392.368.201", "FX": "Butanes", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "AN": "includes cyclobutenes", "PI": "Cycloparaffins (1966-1971)", "MS": "Four carbon cycloparaffin cyclobutane (the structural formula (CH2)4) and its derivatives.", "PM": "74", "HN": "74(72)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003503"}, {"RECTYPE": "D", "MH": "Ancitabine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclocytidine|T109|T121|NON|EQV|NLM (1996)|941021|abbcdef", "ENTRY": "U33624A", "MN": "D13.570.685.245.453.050", "PA": "Antimetabolites, Antineoplastic", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "6H-Furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, (2R-(2alpha,3beta,3abeta,9abeta))-", "RN": "DO2D32W0VC", "RR": "31698-14-3 (Ancitabine)", "PI": "Cytidine (1973)", "MS": "Congener of CYTARABINE that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action.", "PM": "96; was CYCLOCYTIDINE 1977-95 (see under CYTARABINE 1977-90)", "HN": "96; was CYCLOCYTIDINE 1977-95 (see under CYTARABINE 1977-90)", "MR": "20160527", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D003504"}, {"RECTYPE": "D", "MH": "Cyclodextrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclodextrin|T109|T123|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Derivatives, Cyclodextrin", "MN": "D09.698.365.855.400.375", "MH_TH": "NLM (1980)", "ST": "T123", "RN": "0", "AN": "note specifics", "PI": "Polysaccharides (1966-1974)", "MS": "A homologous group of cyclic GLUCANS consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances.", "PM": "91; was see under DEXTRINS 1980-90", "HN": "91(80); was see under DEXTRINS 1980-90", "MR": "20200527", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D003505"}, {"RECTYPE": "D", "MH": "Cyclofenil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "F6066", "MN": "D02.455.426.559.389.657.239.402", "PA": "Fertility Agents, Female", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Phenol, 4-((4-(acetyloxy)phenyl)cyclohexylidenemethyl)-, acetate", "RN": "J468V64WZ1", "RR": "2624-43-3 (Cyclofenil)", "PI": "Phenols (1969-1971)", "MS": "A gonadal stimulant and inducer of ovulation. It is used in the treatment of infertility and amenorrhea, but is thought to be less effective than CLOMIPHENE.", "PM": "91; was see under CRESOLS 1972-90", "HN": "91(72); was see under CRESOLS 1972-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003506"}, {"RECTYPE": "D", "MH": "Cycloheptanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.392.368.284", "FX": "Heptanes", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "includes cycloheptenes, cycloheptadienes, cycloheptatrienes", "MS": "Seven-carbon cycloparaffin cycloheptane (the structural formula (CH2)7) and its derivatives.", "PM": "68", "HN": "68", "MR": "20160121", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003508"}, {"RECTYPE": "D", "MH": "Cyclohexanecarboxylic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Cyclohexanecarboxylic", "MN": "D02.455.426.392.368.367.218", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Carboxylic acid derivatives of cyclohexane.", "PM": "68", "HN": "68", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003509"}, {"RECTYPE": "D", "MH": "Cyclohexanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.392.368.367", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Six-carbon alicyclic hydrocarbons.", "OL": "use CYCLOHEXANES to search CYCLOHEXANE 1966-74", "PM": "75; was CYCLOHEXANE 1963-74", "HN": "75; was CYCLOHEXANE 1963-74", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D003510"}, {"RECTYPE": "D", "MH": "Cyclohexanols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Cyclohexanol|T109|NON|NRW|FDA SRS (2014)|UNK (19XX)|760905|abcdeef", "MN": "D10.289.510.500", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "RR": "8E7S519M3P", "AN": "do not confuse with CYCLOHEXANONES", "PI": "Cyclohexanes (1966-1971)", "MS": "Monohydroxy derivatives of cyclohexanes that contain the general formula R-C6H11O. They have a camphorlike odor and are used in making soaps, insecticides, germicides, dry cleaning, and plasticizers.", "OL": "use CYCLOHEXANOLS to search CYCLOHEXANOL 1972-74 (as Prov 1972-73)", "PM": "75; was CYCLOHEXANOL 1974", "HN": "75; was CYCLOHEXANOL 1972-74 (Prov 1972-73)", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003511"}, {"RECTYPE": "D", "MH": "Cyclohexanones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.522.400", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with CYCLOHEXANOLS", "PI": "Ketones (1969-1974)", "MS": "Cyclohexane ring substituted by one or more ketones in any position.", "PM": "91; was see under CYCLOHEXANES 1975-90", "HN": "91(75); was see under CYCLOHEXANES 1975-90", "MR": "20040707", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D003512"}, {"RECTYPE": "D", "MH": "Cycloheximide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Cicloheximide|T109|T195|NON|EQV|FDA SRS (2014)|INN (19XX)|940727|abbcdeef", "MN": "D03.383.621.808.240", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USAN (1978)", "ST": "T195", "N1": "2,6-Piperidinedione, 4-(2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)-, (1S-(1alpha(S*),3alpha,5beta))-", "RN": "98600C0908", "RR": "66-81-9 (Cycloheximide)", "MS": "Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis.", "PM": "68", "HN": "68(66)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003513"}, {"RECTYPE": "D", "MH": "Cyclohexylamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Cyclohexylamine|T109|T130|NON|NRW|FDA SRS (2014)|UNK (19XX)|760905|abbcdeef", "MN": "D02.455.426.392.368.367.418", "MH_TH": "NLM (1971)", "ST": "T130", "RN": "0", "RR": "I6GH4W7AEG", "PI": "Cyclohexanes (1966-1970)", "MS": "A family of alicyclic hydrocarbons containing an amine group with the general formula R-C6H10NH2.", "OL": "use CYCLOHEXYLAMINES to search CYCLOHEXYLAMINE 1971-74 (as Prov 1971-72)", "PM": "75; was CYCLOHEXYLAMINE 1973-74", "HN": "75; was CYCLOHEXYLAMINE 1971-74 (Prov 1971-72)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003514"}, {"RECTYPE": "D", "MH": "Cycloleucine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "1-Aminocyclopentanecarboxylic Acid|T116|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|770520|AMINOCYCLOPENTANECARBOXYLIC ACID 01|abbcdeefs", "ENTRY": "Acid, Aminocyclopentanecarboxylic", "MN": "D12.125.072.170", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Cyclopentanecarboxylic acid, 1-amino-", "RN": "0TQU7668EI", "RR": "52-52-8 (Cycloleucine)", "PI": "Cyclopentanes (1970-1974)", "MS": "An amino acid formed by cyclization of leucine. It has cytostatic, immunosuppressive and antineoplastic activities.", "PM": "91; was see under AMINO ACIDS 1975-90", "HN": "91(75); was see under AMINO ACIDS 1975-90", "MR": "20160628", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D003515"}, {"RECTYPE": "D", "MH": "Cycloparaffins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cycloalkynes|T109|NON|NRW|NLM (2003)|020116|abcdef", "ENTRY": "Olefins, Cyclic", "MN": "D04.345.133", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Alicyclic hydrocarbons in which three or more of the carbon atoms in each molecule are united in a ring structure and each of the ring carbon atoms is joined to two hydrogen atoms or alkyl groups. The simplest members are cyclopropane (C3H6), cyclobutane (C4H8), cyclohexane (C6H12), and derivatives of these such as methylcyclohexane (C6H11CH3). (From Sax, et al., Hawley's Condensed Chemical Dictionary, 11th ed)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003516"}, {"RECTYPE": "D", "MH": "Cyclopentanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclopentenes|T109|NON|NRW|NLM (1998)|960819|abcdef", "ENTRY": "Cyclopentane|T109|NON|NRW|FDA SRS (2014)|UNK (19XX)|760905|abcdeef", "MN": "D02.455.426.392.368.450", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "RR": "T86PB90RNU", "MS": "A group of alicyclic hydrocarbons with the general formula R-C5H9.", "PM": "75; was CYCLOPENTANE 1966-74", "HN": "75; was CYCLOPENTANE 1966-74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003517"}, {"RECTYPE": "D", "MH": "Cyclopenthiazide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclomethiazide|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D03.633.100.174.285", "PA": "Sodium Chloride Symporter Inhibitors", "MH_TH": "USAN (1962)", "ST": "T121", "N1": "2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(cyclopentylmethyl)-3,4-dihydro-, 1,1-dioxide", "RN": "VX4S2N85F5", "RR": "742-20-1 (Cyclopenthiazide)", "PI": "Diuretics, Thiazide (1974)", "MS": "Thiazide diuretic also used as an antihypertensive agent.", "PM": "91; was see under DIURETICS, THIAZIDE 1975-90", "HN": "91(75); was see under DIURETICS, THIAZIDE 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003518"}, {"RECTYPE": "D", "MH": "Cyclopentolate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Cyclogyl|T109|T121|TRD|NRW|UNK (19XX)|861009|abbcdef", "MN": "D02.241.223.601.200", "PA": "Parasympatholytics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzeneacetic acid, alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester", "RN": "I76F4SHP7J", "RR": "512-15-2 (Cyclopentolate)", "PI": "Phenylacetates (1969-1974)", "MS": "A parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia.", "PM": "91; was see under PHENYLACETATES 1975-90", "HN": "91(75); was see under PHENYLACETATES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003519"}, {"RECTYPE": "D", "MH": "Cyclophosphamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NSC26271", "MN": "D02.705.672.500.243", "PA": "Myeloablative Agonists", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "8N3DW7272P", "RR": "6UXW23996M", "MS": "Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.", "MR": "20180521", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003520"}, {"RECTYPE": "D", "MH": "Cyclopropanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.392.368.533", "FX": "Propane", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "includes cyclopropenes", "MS": "Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.", "OL": "use CYCLOPROPANES to search CYCLOPROPANE 1966-74", "PM": "75; was CYCLOPROPANE 1963-74", "HN": "75; was CYCLOPROPANE 1963-74", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D003521"}, {"RECTYPE": "D", "MH": "Cycloserine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Seromycin|T116|T195|TRD|NRW|UNK (19XX)|861120|abbcdef", "MN": "D12.125.154.800.750", "PA": "Antimetabolites", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "3-Isoxazolidinone, 4-amino-, (R)-", "RN": "95IK5KI84Z", "RR": "68-41-7 (Cycloserine)", "MS": "Antibiotic substance produced by Streptomyces garyphalus.", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003523"}, {"RECTYPE": "D", "MH": "Cyclosporins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Cyclosporines|T116|T121|NON|EQV|NLM (1992)|901025|abbcdef", "MN": "D12.644.641.235", "PA": "Immunosuppressive Agents", "MH_TH": "NLM (1982)", "ST": "T121", "RN": "0", "AN": "do not confuse with CYCLOSPORINE, a specific drug", "PI": "Peptides, Cyclic (1971-1981)", "MS": "A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection.", "PM": "82", "HN": "82", "MR": "20140613", "DA": "19810514", "DC": "1", "DX": "19820101", "UI": "D003524"}, {"RECTYPE": "D", "MH": "Cyclosteroids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.294", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Steroid derivatives in which one or more bridges is formed between carbon atoms at any locant in any of the rings.", "PM": "68", "HN": "68", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003525"}, {"RECTYPE": "D", "MH": "Cyclothymic Disorder", "DE": "CYCLOTHYMIC DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Cyclothymic Personality|T048|NON|EQV|UNK (19XX)|800521|abcdef", "ENTRY": "Personality, Cyclothymic", "MN": "F03.600.500", "MH_TH": "NLM (1975)", "ST": "T048", "MS": "An affective disorder characterized by periods of depression and hypomania. These may be separated by periods of normal mood.", "OL": "use CYCLOTHYMIC DISORDER to search CYCLOTHYMIC PERSONALITY 1975-80; use PERSONALITY DISORDERS 1968-74", "PM": "91; was see under AFFECTIVE DISORDERS 1981-90; was CYCLOTHYMIC PERSONALITY see under PERSONALITY DISORDERS 1968-80", "HN": "91(81); was see under AFFECTIVE DISORDERS 1981-90; was CYCLOTHYMIC PERSONALITY see under PERSONALITY DISORDERS 1968-80", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003527"}, {"RECTYPE": "D", "MH": "Carcinoma, Adenoid Cystic", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cylindroma|T191|NON|EQV|NLM (1994)|ORD (2010)|930330|abcdeef", "ENTRY": "Cystic Carcinomas, Adenoid", "MN": "C04.557.470.200.025.220", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed)", "OL": "use CARCINOMA, ADENOID CYSTIC to search CYLINDROMA 1966-93", "PM": "94; was CYLINDROMA 1963-93", "HN": "94; was CYLINDROMA 1963-93", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D003528"}, {"RECTYPE": "D", "MH": "Cymarine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "k-Strophanthin-alpha|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|STROPHANTHIN K ALPHA|abbcdeefs", "ENTRY": "k Strophanthin alpha", "MN": "D09.408.180.810.250", "PA": "Cardiotonic Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Card-20(22)-enolide, 3-((2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3beta,5beta)-", "RN": "UK3LS8435E", "RR": "508-77-0 (Cymarine)", "PI": "Cardiac Glycosides (1974)", "MS": "A cardiotonic cardiac glycoside found in STROPHANTHUS. The aglycone is STROPHANTHIN.", "OL": "use CYMARINE to search TSIMARIN 1975-92", "PM": "91; was see under STROPHANTHINS 1975-90; TSIMARIN was see CYMARINE 1975-92", "HN": "91(75); was see under STROPHANTHINS 1975-90; TSIMARIN was see CYMARINE 1975-92", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003529"}, {"RECTYPE": "D", "MH": "Cyprinidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Tinca|T013|NON|NRW|NLM (2001)|991220|abcdef", "ENTRY": "tinca, Tinca", "MN": "B01.050.150.900.493.200.244", "MH_TH": "NLM (1968)", "ST": "T013", "RN": "txid7953", "RR": "txid8284", "AN": "general or unspecified; prefer specifics; note entry term MINNOWS: MUDMINNOWS see UMBRIDAE is also available", "PI": "Fishes (1966-1967)", "MS": "A family of freshwater fish comprising the minnows or CARPS.", "PM": "1968", "HN": "1968", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003530"}, {"RECTYPE": "D", "MH": "Cypriniformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Suckers (Fish)|T013|NON|NRW|UNK (19XX)|860415|SUCKERS|abcdefv", "ENTRY": "Sucker (Fish)", "MN": "B01.050.150.900.493.200", "MH_TH": "NLM (1987)", "ST": "T013", "RN": "txid7952", "RR": "txid7983", "AN": "do not confuse with CYPRINODONTIFORMES", "MS": "An order of fish with 26 families and over 3,000 species. This order includes the families CYPRINIDAE (minnows and CARPS), Cobitidae (loaches), and Catostomidae (suckers).", "PM": "1987; for CATOSTOMUS see CATASTOMUS 1987-2006", "HN": "1987", "MR": "20200813", "DA": "19860415", "DC": "1", "DX": "19870101", "UI": "D003531"}, {"RECTYPE": "D", "MH": "Cyprinodontiformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Xiphophorus|T013|NON|NRW|UNK (19XX)|860415|abcdef", "ENTRY": "Gambusias", "MN": "B01.050.150.900.493.850.280", "MH_TH": "NLM (1987)", "ST": "T013", "RN": "txid28738", "RR": "txid8082", "AN": "general or unspecified; prefer specifics; do not confuse with CYPRINIDAE or CYPRINIFORMES or CYPRINODON see KILLIFISHES", "PI": "Fishes (1966-1986)", "MS": "An order of fish with eight families and numerous species of both egg-laying and livebearing fish. Families include Cyprinodontidae (egg-laying KILLIFISHES;), FUNDULIDAEl; (topminnows), Goodeidae (Mexican livebearers), Jenynsiidae (jenynsiids), Poeciliidae (livebearers), Profundulidae (Middle American killifishes), Aplocheilidae, and Rivulidae (rivulines). In the family Poeciliidae, the guppy and molly belong to the genus POECILIA.", "PM": "1987; for MOSQUITO FISH see FISHES 1975-86", "HN": "1987(1975)", "MR": "20200902", "DA": "19860415", "DC": "1", "DX": "19870101", "UI": "D003532"}, {"RECTYPE": "D", "MH": "Cyproheptadine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Viternum|T109|T121|TRD|NRW|UNK (19XX)|820204|abbcdef", "MN": "D04.615.181.384.340", "PA": "Serotonin Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Piperidine, 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-", "RN": "2YHB6175DO", "RR": "129-03-3 (Cyproheptadine)", "AN": "a histamine H1 antag & serotonin antag", "MS": "A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003533"}, {"RECTYPE": "D", "MH": "Cyproterone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer|T109|T121|NRW|NLM (1999)|990913|abbdef", "MN": "D04.210.500.883.419", "PA": "Androgen Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "3'H-Cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 6-chloro-1,2-dihydro-17-hydroxy-, (1beta,2beta)-", "RN": "E61Q31EK2F", "RR": "34554-28-4 (1 alpha,2 alpha,9 beta,10 alpha-isomer)", "PI": "Androgens/antagonists & inhibitors (1968-1971)", "MS": "An anti-androgen that, in the form of its acetate (CYPROTERONE ACETATE), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females.", "PM": "74", "HN": "74(72)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003534"}, {"RECTYPE": "D", "MH": "Cyprus", "AQ": "EH EP", "MN": "Z01.639.640.300", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island republic in the eastern Mediterranean", "MS": "An island republic in the eastern Mediterranean Sea. Its capital is Nicosia. It was colonized by the Phoenicians and ancient Greeks and ruled successively by the Assyrian, Persian, Ptolemaic, Roman, and Byzantine Empires. It was under various countries from the 12th to the 20th century but became independent in 1960. The name comes from the Greek Kupros, probably representing the Sumerian kabar or gabar, copper, famous in historic times for its copper mines. The cypress tree is also named after the island. (From Webster's New Geographical Dictionary, 1988, p308 & Room, Brewer's Dictionary of Names, 1992, p134)", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D003535"}, {"RECTYPE": "D", "MH": "Cystadenocarcinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Cystadenocarcinomas", "MN": "C04.557.470.590.480", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term ", "MS": "A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003536"}, {"RECTYPE": "D", "MH": "Cystadenoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Cystadenomas", "MN": "C04.557.470.590.485", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003537"}, {"RECTYPE": "D", "MH": "Cystamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diaminodiethyldisulfide|T109|T121|NON|BRD|UNK (19XX)|750717|abbcdef", "ENTRY": "Sulfate, Cystamine", "MN": "D02.092.471.200", "PA": "Sulfhydryl Reagents", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Ethanamine, 2,2'-dithiobis-", "RN": "R110LV8L02", "RR": "I90T518457", "AN": "do not confuse with CYSTEAMINE nor Cystamin (a urinary antiseptic)", "MS": "A radiation-protective agent that interferes with sulfhydryl enzymes. It may also protect against carbon tetrachloride liver damage.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003538"}, {"RECTYPE": "D", "MH": "Cystaphos", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta Aminoethylthiophosphate, Sodium Salt", "MN": "D02.886.300.692.130", "PA": "Radiation-Protective Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Ethanethiol, 2-amino-, dihydrogen phosphate (ester), monosodium salt", "RN": "YC9U0409D3", "RR": "3724-89-8 (Cystaphos)", "PI": "Organothiophosphorus Compounds (1972-1974)", "MS": "Proposed as an adjuvant to cancer chemotherapy; may have radiation protective properties.", "PM": "91; was see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1975-90", "HN": "91(75); was see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003539"}, {"RECTYPE": "D", "MH": "Cystathionine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.125.166.175", "MH_TH": "NLM (1973)", "ST": "T123", "N1": "L-Homocysteine, S-(2-amino-2-carboxyethyl)-, (R)-", "RN": "375YFJ481O", "RR": "56-88-2 (Cystathionine)", "PI": "Amino Acids (1966-1970)", "MS": "Sulfur-containing amino acid formed as an intermediate in the conversion of METHIONINE to CYSTEINE.", "OL": "search AMINO ACIDS 1966-70", "PM": "73; was see under AMINO ACIDS 1963-72", "HN": "73(71); was see under AMINO ACIDS 1963-72", "MR": "20161129", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003540"}, {"RECTYPE": "D", "MH": "Cystathionine beta-Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Thionase|T116|T126|NON|EQV|UNK (19XX)|760518|abbcdef", "ENTRY": "beta-Synthase, Cystathionine", "MN": "D08.811.520.241.300.200", "FX": "Homocystinuria", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Serine hydro-lyase (adding homocysteine)", "RN": "EC 4.2.1.22", "RR": "9023-99-8 (CAS RN)", "AN": "/defic: consider also HOMOCYSTINURIA or HYPERHOMOCYSTEINEMIA", "PI": "Serine (1973-1974)", "MS": "A multifunctional pyridoxal phosphate enzyme. In the second stage of cysteine biosynthesis it catalyzes the reaction of homocysteine with serine to form cystathionine with the elimination of water. Deficiency of this enzyme leads to HYPERHOMOCYSTEINEMIA and HOMOCYSTINURIA. EC 4.2.1.22.", "PM": "1991; see HYDRO-LYASES 1975-1990", "HN": "1991(1975)", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003541"}, {"RECTYPE": "D", "MH": "Cystathionine gamma-Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gamma-Cystathionase|T116|T126|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "gamma-Lyase, Cystathionine", "MN": "D08.811.520.300.250", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Cystathionine cysteine-lyase (deaminating)", "RN": "EC 4.4.1.1", "RR": "9012-96-8 (CAS RN)", "AN": "/defic: consider also CYSTATHIONINE /urine (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM)", "PI": "Lyases (1973-1974)", "MS": "A multifunctional pyridoxal phosphate enzyme. In the final step in the biosynthesis of cysteine it catalyzes the cleavage of cystathionine to yield cysteine, ammonia, and 2-ketobutyrate. EC 4.4.1.1.", "PM": "91; was see under LYASES 1975-90", "HN": "91(75); was see under LYASES 1975-90", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003542"}, {"RECTYPE": "D", "MH": "Cysteamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mercaptamine|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|750717|abbcdeef", "ENTRY": "beta Mercaptoethylamine", "MN": "D02.886.489.472.369", "PA": "Cystine Depleting Agents", "MH_TH": "USAN (1990)", "ST": "T121", "N1": "Ethanethiol, 2-amino-", "RN": "5UX2SD1KE2", "RR": "QO84GZ3TST", "AN": "do not confuse with CYSTAMINE", "MS": "A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS.", "OL": "use MERCAPTOETHYLAMINES to search CYSTEINAMINE 1966", "PM": "CYSTEINAMINE was see under MERCAPTOETHYLAMINES 1963-66", "HN": "CYSTEINAMINE was see under MERCAPTOETHYLAMINES 1963-66", "MR": "20140612", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003543"}, {"RECTYPE": "D", "MH": "Cysteic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Sulfoalanine|T116|T123|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "beta Sulfoalanine", "MN": "D12.125.166.215", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Alanine, 3-sulfo-", "RN": "A3OGP4C37W", "RR": "13100-82-8 (Cysteic Acid)", "AN": "an amino acid", "PI": "Amino Acids, Sulfur (1974)", "MS": "Beta-Sulfoalanine. An amino acid with a C-terminal sulfonic acid group which has been isolated from human hair oxidized with permanganate. It occurs normally in the outer part of the sheep's fleece, where the wool is exposed to light and weather.", "PM": "91; was see under AMINO ACIDS, SULFUR 1975-90", "HN": "91(75); was see under AMINO ACIDS, SULFUR 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003544"}, {"RECTYPE": "D", "MH": "Cysteine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L Cysteine", "MN": "D12.125.166.230", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "L-Cysteine", "RN": "K848JZ4886", "RR": "ZT934N0X4W", "AN": "do not confuse with CYSTINE", "MS": "A thiol-containing non-essential amino acid that is oxidized to form CYSTINE.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003545"}, {"RECTYPE": "D", "MH": "Cysteine Endopeptidases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.656.300.200", "EC": "antagonists & inhibitors:Cysteine Proteinase Inhibitors", "MH_TH": "NLM (1990)", "ST": "T126", "RN": "EC 3.4.22.-", "AN": "do not confuse with CYSTEINE PROTEASES", "PI": "Peptide Peptidohydrolases (1966-1987)", "MS": "ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.", "PM": "2000; see CYSTEINE PROTEINASES 1988-1999; for CYSTEINE ENDOPEPTIDASES see CYSTEINE PROTEINASES 1990-1999", "HN": "2000(1988)", "MR": "20090706", "DA": "19870504", "DC": "1", "DX": "19880101", "UI": "D003546"}, {"RECTYPE": "D", "MH": "Cysteine Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "O-Acetylserine Sulfhydrylase|T116|T126|NON|EQV|UNK (19XX)|760518|ACETYLSERINE SULFHYDRYLASE O|abbcdefs", "ENTRY": "Sulfhydrylase, O-Acetylserine", "MN": "D08.811.913.225.224", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "O(3)-Acetyl-L-serine acetate-lyase (adding hydrogen sulfide)", "RN": "EC 2.5.1.47", "RR": "37290-89-4 (CAS RN)", "PI": "Serine (1966-1976)", "MS": "An enzyme that catalyzes the biosynthesis of cysteine in microorganisms and plants from O-acetyl-L-serine and hydrogen sulfide. This enzyme was formerly listed as EC 4.2.99.8.", "PM": "91; was see under LYASES 1977-90", "HN": "91(77); was see under LYASES 1977-90", "MR": "20130709", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D003547"}, {"RECTYPE": "D", "MH": "Cysteinyldopa", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "5 S Cysteinyldopa", "MN": "D12.125.166.230.330", "MH_TH": "NLM (1977)", "ST": "T123", "N1": "L-Tyrosine, 3-((2-amino-2-carboxyethyl)thio)-5-hydroxy-, (R)-", "RN": "19641-92-0", "AN": "/biosyn /physiol permitted", "PI": "Dopa (1966-1976)", "MS": "Found in large amounts in the plasma and urine of patients with malignant melanoma. It is therefore used in the diagnosis of melanoma and for the detection of postoperative metastases. Cysteinyldopa is believed to be formed by the rapid enzymatic hydrolysis of 5-S-glutathionedopa found in melanin-producing cells.", "PM": "91; was see under DOPA 1977-90", "HN": "91(77); was see under DOPA 1977-90", "MR": "20180630", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D003548"}, {"RECTYPE": "D", "MH": "Cystic Duct", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ducts, Cystic", "MN": "A03.159.183.079.450", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The duct that is connected to the GALLBLADDER and allows the emptying of bile into the COMMON BILE DUCT.", "MR": "20030725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003549"}, {"RECTYPE": "D", "MH": "Cystic Fibrosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mucoviscidosis|T047|NON|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|740329|abcdeeeef", "ENTRY": "Pancreas Fibrocystic Diseases", "MN": "C16.614.213", "FX": "Mice, Inbred CFTR", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a specific disease entity: do not use for fibrocystic states of various organs", "MS": "An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.", "OL": "use CYSTIC FIBROSIS to search PANCREATIC CYSTIC FIBROSIS 1966", "PM": "67; was PANCREATIC CYSTIC FIBROSIS 1963-66", "HN": "67; was PANCREATIC CYSTIC FIBROSIS 1963-66", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D003550"}, {"RECTYPE": "D", "MH": "Cysticercosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Taenia solium Cysticercosis|T047|NON|NRW|NLM (2021)|200506|abcdef", "ENTRY": "Taenia solium Cysticercoses", "MN": "C01.610.335.190.902.185", "FX": "Taenia", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent; NEUROCYSTICERCOSIS is also available.", "MS": "Infection with CYSTICERCUS, the larval form of the various tapeworms of the genus Taenia (usually T. solium in man). In humans they penetrate the intestinal wall and invade subcutaneous tissue, brain, eye, muscle, heart, liver, lung, and peritoneum. Brain involvement results in NEUROCYSTICERCOSIS.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003551"}, {"RECTYPE": "D", "MH": "Cysticercus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.736.215.895.286", "MH_TH": "NLM (1975)", "ST": "T204", "MS": "The larval form of various tapeworms of the genus Taenia.", "OL": "search TAENIA 1966-74", "PM": "91; was see under TAENIA 1975-90", "HN": "91(75); was see under TAENIA 1975-90", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003552"}, {"RECTYPE": "D", "MH": "Cystine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU", "ENTRY": "L Cystine", "MN": "D12.125.166.230.369", "EC": "urine:Cystinuria", "MH_TH": "USAN (1979)", "ST": "T123", "N1": "L-Cystine", "RN": "48TCX9A1VT", "RR": "56-89-3 (Cystine)", "AN": "do not confuse with CYSTEINE", "MS": "A covalently linked dimeric nonessential amino acid formed by the oxidation of CYSTEINE. Two molecules of cysteine are joined together by a disulfide bridge to form cystine.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003553"}, {"RECTYPE": "D", "MH": "Cystinosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Storage Diseases, Cystine", "MN": "C18.452.648.595.377", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A metabolic disease characterized by the defective transport of CYSTINE across the lysosomal membrane due to mutation of a membrane protein cystinosin. This results in cystine accumulation and crystallization in the cells causing widespread tissue damage. In the KIDNEY, nephropathic cystinosis is a common cause of RENAL FANCONI SYNDROME.", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003554"}, {"RECTYPE": "D", "MH": "Cystinuria", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cystinurias", "MN": "C16.320.831.885.250", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An inherited disorder due to defective reabsorption of CYSTINE and other BASIC AMINO ACIDS by the PROXIMAL RENAL TUBULES. This form of aminoaciduria is characterized by the abnormally high urinary levels of cystine; LYSINE; ARGININE; and ORNITHINE. Mutations involve the amino acid transport protein gene SLC3A1.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003555"}, {"RECTYPE": "D", "MH": "Cystitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cystitides", "MN": "C12.950.829.495", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003556"}, {"RECTYPE": "D", "MH": "Phyllodes Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cystosarcoma Phyllodes|T191|NON|EQV|NLM (1994)|930326|abcdef", "ENTRY": "Tumors, Phyllodes", "MN": "C04.557.450.795.650", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with probably BREAST NEOPLASMS (IM) or more rarely PROSTATIC NEOPLASMS (IM)", "MS": "A type of connective tissue neoplasm typically arising from intralobular stroma of the breast. It is characterized by the rapid enlargement of an asymmetric firm mobile mass. Histologically, its leaf-like stromal clefts are lined by EPITHELIAL CELLS. Rare phyllodes tumor of the prostate is also known.", "OL": "use PHYLLODES TUMOR to search CYSTOSARCOMA PHYLLODES 1966-93", "PM": "94; was CYSTOSARCOMA PHYLLODES 1963-93", "HN": "94; was CYSTOSARCOMA PHYLLODES 1963-93", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D003557"}, {"RECTYPE": "D", "MH": "Cystoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Cystoscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES CYSTOSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Cystoscopic", "MN": "E04.950.774.155", "FX": "Cystoscopes", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "/ instrum permitted but consider also CYSTOSCOPES", "MS": "Endoscopic examination, therapy or surgery of the urinary bladder.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003558"}, {"RECTYPE": "D", "MH": "Cystostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Vesicostomy|T061|NON|EQV|UNK (19XX)|870318|abcdef", "ENTRY": "Vesicostomies", "MN": "E04.950.774.852.240", "FX": "Cystotomy", "MH_TH": "NLM (1988)", "ST": "T061", "AN": "do not confuse with CYSTOTOMY", "PI": "Urinary Diversion (1966-1987)", "MS": "Surgical creation of an opening (stoma) in the URINARY BLADDER for drainage.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19870318", "DC": "1", "DX": "19880101", "UI": "D003559"}, {"RECTYPE": "D", "MH": "Cysts", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Cyst|T190|NON|EQV|NLM (2007)|060308|abcdef", "MN": "C23.300.306", "MH_TH": "NLM (1966)", "ST": "T190", "MS": "Any fluid-filled closed cavity or sac that is lined by an EPITHELIUM. Cysts can be of normal, abnormal, non-neoplastic, or neoplastic tissues.", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003560"}, {"RECTYPE": "D", "MH": "Cytarabine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cytosine Arabinoside|T114|T121|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "beta Ara C", "MN": "D13.570.685.245.453", "PA": "Immunosuppressive Agents", "FX": "Decitabine", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-", "RN": "04079A1RDZ", "RR": "69-74-9 (HCl)", "MS": "A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)", "PM": "1966", "HN": "1966", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003561"}, {"RECTYPE": "D", "MH": "Cytidine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cytosine Ribonucleoside|T114|T123|NON|EQV|NLM (1998)|970311|abbcdef", "ENTRY": "Riboside, Cytosine", "MN": "D13.570.800.286", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "Cytidine", "RN": "5CSZ8459RP", "RR": "65-46-3 (Cytidine)", "PI": "Nucleosides (1966-1971)", "MS": "A pyrimidine nucleoside that is composed of the base CYTOSINE linked to the five-carbon sugar D-RIBOSE.", "OL": "search NUCLEOSIDES 1966-71", "PM": "72; was see under NUCLEOSIDES 1963-71", "HN": "72; was see under NUCLEOSIDES 1963-71", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003562"}, {"RECTYPE": "D", "MH": "Cyclic CMP", "DE": "CYCL CMP", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cytidine Cyclic-3',5'-Monophosphate|T114|T123|NON|EQV|UNK (19XX)|790522|CYTIDINE CYCLIC MONOPHOSPHATE 03 05|abbcdefs", "ENTRY": "Monophosphate, Cytidine Cyclic", "MN": "D13.695.827.232.115", "MH_TH": "NLM (1980)", "ST": "T123", "N1": "Cytidine, cyclic 3',5'-(hydrogen phosphate)", "RN": "3616-08-8", "RR": "54925-33-6 (mono-Na salt)", "PI": "Nucleotides, Cyclic (1974-1979)", "MS": "A cyclic nucleotide formed from CYTIDINE TRIPHOSPHATE by the action of cytidylate cyclase. It is a potential cyclic nucleotide intracellular mediator of signal transductions.", "OL": "use CYCLIC CMP to search CYTIDINE CYCLIC MONOPHOSPHATE & CYTIDINE CYCLIC-2',3'-MONOPHOSPHATE 1980-93", "PM": "94; was CYTIDINE CYCLIC MONOPHOSPHATE 1980-93 (see under CYTOSINE NUCLEOTIDES 1980-90); CYCLIC CMP & CYTIDINE CYCLIC-2',3'-MONOPHOSPHATE were see CYTIDINE CYCLIC MONOPHOSPHATE 1980-93", "HN": "94; was CYTIDINE CYCLIC MONOPHOSPHATE 1980-93 (see under CYTOSINE NUCLEOTIDES 1980-90); CYCLIC CMP & CYTIDINE CYCLIC-2',3'-MONOPHOSPHATE were see CYTIDINE CYCLIC MONOPHOSPHATE 1980-93", "MR": "20160528", "DA": "19790221", "DC": "1", "DX": "19910101", "UI": "D003563"}, {"RECTYPE": "D", "MH": "Cytidine Deaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytidine Aminohydrolase|T116|T126|NON|EQV|UNK (19XX)|741024|abbcdef", "ENTRY": "Deaminase, Cytidine", "MN": "D08.811.277.151.486.250", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Cytidine aminohydrolase", "RN": "EC 3.5.4.5", "PI": "Cytidine (1973-1974)", "MS": "An enzyme that catalyzes the deamination of cytidine, forming uridine. EC 3.5.4.5.", "PM": "91; was see under NUCLEOSIDE DEAMINASES 1975-90", "HN": "91(75); was see under NUCLEOSIDE DEAMINASES 1975-90", "MR": "20030709", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D003564"}, {"RECTYPE": "D", "MH": "Cytidine Diphosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "CDP|T114|T123|ABB|EQV|UNK (19XX)|770420|abbcdef", "ENTRY": "Diphosphate, Cytidine", "MN": "D13.695.827.232.150", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Cytidine 5'-(trihydrogen diphosphate)", "RN": "63-38-7", "AN": "/biosyn /physiol permitted", "PI": "Cytosine Nucleotides (1966-1977)", "MS": "Cytidine 5'-(trihydrogen diphosphate). A cytosine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: CRPP; cytidine pyrophosphate.", "PM": "91; was see under CYTOSINE NUCLEOTIDES 1978-90", "HN": "91(78); was see under CYTOSINE NUCLEOTIDES 1978-90", "MR": "20160528", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D003565"}, {"RECTYPE": "D", "MH": "Cytidine Diphosphate Choline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Citicoline|T114|T123|NON|EQV|FDA SRS (2014)|INN (19XX)|UNK (19XX)|741111|abbcdeeef", "ENTRY": "Diphosphate Choline, Cytidine", "MN": "D13.695.827.232.150.180", "PA": "Nootropic Agents", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Cytidine 5'-(trihydrogen diphosphate), P'-(2-(trimethylammonio)ethyl) ester, inner salt", "RN": "536BQ2JVC7", "RR": "987-78-0 (Cytidine Diphosphate Choline)", "PI": "Cytosine Nucleotides (1969-1974)", "MS": "Donor of choline in biosynthesis of choline-containing phosphoglycerides.", "PM": "91; was see under CHOLINE 1975-90", "HN": "91(75); was see under CHOLINE 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003566"}, {"RECTYPE": "D", "MH": "Cytidine Diphosphate Diglycerides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cytidine Diphosphodiacylglycerols|T109|T114|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Diphosphodiacylglycerols, Cytidine", "MN": "D13.695.827.708.260", "MH_TH": "NLM (1975)", "ST": "T114", "RN": "0", "PI": "Phospholipids (1972-1974)", "MS": "The ester of diacylglycerol with the terminal phosphate of cytidine diphosphate. It serves as an intermediate in the biosynthesis of phosphatidylethanolamine and phosphatidylserine in bacteria.", "PM": "91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003567"}, {"RECTYPE": "D", "MH": "Cytidine Monophosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cytidylic Acid|T114|NON|EQV|UNK (19XX)|770401|abcdef", "ENTRY": "Monophosphate, Cytidine", "MN": "D13.695.827.232.370", "MH_TH": "NLM (1975)", "ST": "T114", "N1": "5'-Cytidylic acid", "RN": "F469818O25", "RR": "63-37-6 (Cytidine Monophosphate)", "AN": "/biosyn /physiol permitted", "PI": "Cytosine Nucleotides (1966-1974)", "MS": "Cytidine (dihydrogen phosphate). A cytosine nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position.", "OL": "to search CYTIDYLIC ACIDS use CYTIDINE MONOPHOSPHATE 1975-77 and CYTOSINE NUCLEOTIDES 1966-74", "PM": "91; was see under CYTOSINE NUCLEOTIDES 1978-90; was CYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77", "HN": "91(78); was see under CYTOSINE NUCLEOTIDES 1978-90; was CYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003568"}, {"RECTYPE": "D", "MH": "Cytidine Monophosphate N-Acetylneuraminic Acid", "DS": "CYTIDINE MONOPHOSPHATE ACETYLNEURAMINIC ACID N", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "D-glycero-beta-D-galacto-2-Nonulopyranosonic acid, 5-(acetylamino)-3,5-dideoxy-, 2-(hydrogen 5'-cytidylate)|T109|T114|T123|NON|EQV|NLM (2022)|210304|abbbcdef", "ENTRY": "CMP Sialic Acid", "MN": "D13.695.827.232.370.250", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "3063-71-6", "PI": "Neuraminic Acids (1974)", "MS": "A nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein.", "PM": "1991; see SIALIC ACIDS 1975-1990", "HN": "1991(1975); was see under SIALIC ACIDS 1975-1990", "MR": "20210628", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003569"}, {"RECTYPE": "D", "MH": "Cytidine Triphosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "CTP|T114|T123|ABB|EQV|UNK (19XX)|770420|abbcdef", "ENTRY": "Triphosphate, Cytidine", "MN": "D13.695.827.232.400", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Cytidine 5'-(tetrahydrogen triphosphate)", "RN": "65-47-4", "AN": "/biosyn /physiol permitted", "PI": "Cytosine Nucleotides (1966-1977)", "MS": "Cytidine 5'-(tetrahydrogen triphosphate). A cytosine nucleotide containing three phosphate groups esterified to the sugar moiety.", "PM": "91; was see under CYTOSINE NUCLEOTIDES 1978-90", "HN": "91(78); was see under CYTOSINE NUCLEOTIDES 1978-90", "MR": "20160528", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D003570"}, {"RECTYPE": "D", "MH": "Cytochalasin B", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phomin|T121|T123|NON|EQV|FDA SRS (2014)|NLM (2005)|040305|abbcdeef", "MN": "D23.946.587.370.370", "MH_TH": "NLM (1973)", "ST": "T123", "N1": "24-Oxa(14)cytochalasa-6(12),13,21-triene-1,23-dione, 7,20-dihydroxy-16-methyl-10-phenyl-, (7S,13E,16R,20R,21E)-", "RN": "3CHI920QS7", "RR": "14930-96-2 (Cytochalasin B)", "AN": "/antag permitted but consider also ANTITOXINS", "PI": "specific fungus", "MS": "A cytotoxic member of the CYTOCHALASINS.", "PM": "74", "HN": "74(73)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003571"}, {"RECTYPE": "D", "MH": "Cytochalasins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.946.587.370", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "AN": "/antag permitted but consider also ANTITOXINS", "PI": "specific fungus (1966-1972)", "MS": "11- to 14-membered macrocyclic lactones with a fused isoindolone. Members with INDOLES attached at the C10 position are called chaetoglobosins. They are produced by various fungi. Some members interact with ACTIN and inhibit CYTOKINESIS.", "PM": "74", "HN": "74(73)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003572"}, {"RECTYPE": "D", "MH": "Cytochrome b Group", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "b Group, Cytochrome", "MN": "D12.776.422.220.187", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "0", "AN": "/biosyn /physiol permitted; spell in titles & translations with lowercase b: cytochrome b; do not confuse with CYTOCHROMES B", "PI": "Cytochromes (1966-1982)", "MS": "Cytochromes (electron-transporting proteins) with protoheme (HEME B) as the prosthetic group.", "PM": "2004; see CYTOCHROME B 1983-2003", "HN": "2004(1983);", "MR": "20160628", "DA": "19820511", "DC": "1", "DX": "19830101", "UI": "D003573"}, {"RECTYPE": "D", "MH": "Cytochrome c Group", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Type c, Cytochromes", "MN": "D12.776.422.220.286", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "AN": "spell in titles & translations with lowercase c: cytochrome c; do not confuse with CYTOCHROMES C", "PI": "Cytochromes (1966-1972)", "MS": "A group of cytochromes with covalent thioether linkages between either or both of the vinyl side chains of protoheme and the protein. (Enzyme Nomenclature, 1992, p539)", "PM": "2004; see CYTOCHROME C 1973-2003", "HN": "2004(1973)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003574"}, {"RECTYPE": "D", "MH": "Cytochromes c1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochrome c1|T116|T123|NON|EQV|NLM (1975)|990101|CYTOCHROME C01|abbcdefs", "ENTRY": "Cytochrome c 1", "MN": "D12.776.422.220.286.200", "MH_TH": "NLM (2004)", "ST": "T123", "N1": "Cytochrome c1", "RN": "9035-42-1", "AN": "spell in titles & translations with lowercase c: cytochrome c1", "MS": "The 30-kDa membrane-bound c-type cytochrome protein of mitochondria that functions as an electron donor to CYTOCHROME C GROUP in the mitochondrial and bacterial RESPIRATORY CHAIN. (From Enzyme Nomenclature, 1992, p545)", "PM": "2004; see CYTOCHROME C1 1994-2003, see CYTOCHROME C-1 1991-1992, see CYTOCHROME C 1975-1990", "HN": "2004(1975)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003575"}, {"RECTYPE": "D", "MH": "Electron Transport Complex IV", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochrome-c Oxidase|T116|T126|NON|EQV|NLM (1966)|990101|abbcdef", "ENTRY": "p25 Presequence Peptide Cytochrome Oxidase", "MN": "D12.776.543.585.450.250.875.484", "FX": "Cytochrome-c Oxidase Deficiency", "EC": "deficiency:Cytochrome-c Oxidase Deficiency", "MH_TH": "NLM (2004)", "ST": "T126", "N1": "Ferricytochrome-c:oxygen oxidoreductase", "RN": "EC 1.9.3.1", "RR": "EC 1.9.3.1", "AN": "spell in titles & translations with lowercase c: cytochrome-c oxidase", "MS": "A multisubunit enzyme complex containing CYTOCHROME A GROUP; CYTOCHROME A3; two copper atoms; and 13 different protein subunits. It is the terminal oxidase complex of the RESPIRATORY CHAIN and collects electrons that are transferred from the reduced CYTOCHROME C GROUP and donates them to molecular OXYGEN, which is then reduced to water. The redox reaction is simultaneously coupled to the transport of PROTONS across the inner mitochondrial membrane.", "PM": "2004; see CYTOCHROME-C OXIDASE 1994-2003, see CYTOCHROME C OXIDASE 1992-1993, see CYTOCHROME OXIDASE 1963-1991; for CYTOCHROME C OXIDASE see CYTOCHROME OXIDASE 1984-1991; SIGNAL PEPTIDE P25-SUBUNIT IV CYTOCHROME OXIDASE was indexed under CYTOCHROME C OXIDASE 1988-2001; CYTOCHROME OXIDASE SUBUNIT III was indexed under CYTOCHROME C OXIDASE 1998-2001", "HN": "2004(1963); for SIGNAL PEPTIDE P25-SUBUNIT IV CYTOCHROME OXIDASE use CYTOCHROME C OXIDASE (NM) 1988-2001; for CYTOCHROME OXIDASE SUBUNIT III use CYTOCHROME C OXIDASE (NM) 1998-2001", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D003576"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 Enzyme System", "DS": "CYTOCHROME P 450 ENZYME SYSTEM", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "P450 Enzyme|T116|T126|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Superfamily, Cytochrome P450", "MN": "D12.776.422.220.453", "EC": "antagonists & inhibitors:Cytochrome P-450 Enzyme Inhibitors", "MH_TH": "NLM (2003)", "ST": "T126", "N1": "Cytochrome P 450", "RN": "9035-51-2", "AN": "general or unspecified; prefer specific cytochrome P-450's", "PI": "Cytochromes (1966-1972)", "MS": "A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism.", "PM": "73; CYTOCHROME P-450 OXYGENASE was indexed under CYTOCHROME P-450 & OXYGENASES 1977-96", "HN": "73; CYTOCHROME P-450 OXYGENASE was NM 1977-96", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003577"}, {"RECTYPE": "D", "MH": "Cytochrome-c Peroxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peroxidase, Cytochrome-c", "MN": "D08.811.682.732.380", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "Ferrocytochrome c:hydrogen-peroxide oxidoreductase", "RN": "EC 1.11.1.5", "RR": "9029-53-2 (CAS RN)", "AN": "spell in titles & translations with lowercase c: cytochrome-c peroxidase", "PI": "Peroxidases (1974-1975)", "MS": "A hemeprotein which catalyzes the oxidation of ferrocytochrome c to ferricytochrome c in the presence of hydrogen peroxide. EC 1.11.1.5.", "OL": "use CYTOCHROME-C PEROXIDASE to search CYTOCHROME PEROXIDASE & CYTOCHROME C PEROXIDASE 1976-93", "PM": "94; was CYTOCHROME PEROXIDASE 1976-93 (see under PEROXIDASES 1976-90); CYTOCHROME C PEROXIDASE was see CYTOCHROME PEROXIDASE 1976-93", "HN": "94; was CYTOCHROME PEROXIDASE 1976-93 (see under PEROXIDASES 1976-90); CYTOCHROME C PEROXIDASE was see CYTOCHROME PEROXIDASE 1976-93", "MR": "20030709", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D003578"}, {"RECTYPE": "D", "MH": "Cytochrome Reductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductases, Cytochrome", "MN": "D08.811.682.608.191", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 1.6.2.-", "PI": "Oxidoreductases (1966-1972)", "PM": "74", "HN": "74(73)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003579"}, {"RECTYPE": "D", "MH": "Cytochromes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cytochrome|T116|T123|NON|EQV|UNK (19XX)|870505|abbcdef", "MN": "D12.776.422.220", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specific cytochrome", "MS": "Hemeproteins whose characteristic mode of action involves transfer of reducing equivalents which are associated with a reversible change in oxidation state of the prosthetic group. Formally, this redox change involves a single-electron, reversible equilibrium between the Fe(II) and Fe(III) states of the central iron atom (From Enzyme Nomenclature, 1992, p539). The various cytochrome subclasses are organized by the type of HEME and by the wavelength range of their reduced alpha-absorption bands.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003580"}, {"RECTYPE": "D", "MH": "Cytodiagnosis", "DE": "CYTODIAG", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Cytodiagnoses|T059|T060|NON|EQV|NLM (1994)|920828|abbcdef", "MN": "E05.242.384", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "general or unspecified; prefer specifics", "MS": "Diagnosis of the type and, when feasible, the cause of a pathologic process by means of microscopic study of cells in an exudate or other form of body fluid. (Stedman, 26th ed)", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003581"}, {"RECTYPE": "D", "MH": "Cytogenetics", "DE": "CYTOGENET", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Cytogenetic", "MN": "H01.158.273.343.180", "FX": "Karyotyping", "MH_TH": "NLM (1967)", "ST": "T091", "AN": "specialty; avoid as coordinate; /methods: consider CYTOGENETIC ANALYSIS; CYTOGENETIC ABERRATIONS see CHROMOSOME ABERRATIONS is also available", "PI": "Genetics, Medical (1966)", "MS": "A subdiscipline of genetics which deals with the cytological and molecular analysis of the CHROMOSOMES, and location of the GENES on chromosomes, and the movements of chromosomes during the CELL CYCLE.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D003582"}, {"RECTYPE": "D", "MH": "Cytokinins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cytokinin|T123|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D03.633.100.759.138.525", "PA": "Plant Growth Regulators", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Plant Growth Regulators (1973-1974)", "MS": "Plant hormones that promote the separation of daughter cells after mitotic division of a parent cell. Frequently they are purine derivatives.", "PM": "91; was see under PLANT GROWTH REGULATORS 1975-90", "HN": "91(75); was see under PLANT GROWTH REGULATORS 1975-90", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003583"}, {"RECTYPE": "D", "MH": "Cytological Techniques", "DE": "CYTOL TECHNIQUES", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Technics, Cytologic", "MN": "E05.242", "FX": "Cytodiagnosis", "MH_TH": "NLM (1973)", "ST": "T059", "AN": "avoid: too general; usually NIM", "PI": "Cytology (1966-1972)", "MS": "Methods used to study CELLS.", "OL": "use CYTOLOGICAL TECHNIQUES to search CYTOLOGICAL TECHNICS 1973-90", "PM": "91; was CYTOLOGICAL TECHNICS 1973-90", "HN": "91; was CYTOLOGICAL TECHNICS 1973-90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003584"}, {"RECTYPE": "D", "MH": "Cell Biology", "AQ": "CL EC ED ES HI IS LJ OG SN ST TD", "ENTRY": "Cellular Biologies", "MN": "H01.158.273.160", "FX": "Cells", "EC": "methods:Cytological Techniques", "MH_TH": "NLM (2010)", "ST": "T091", "AN": "the discipline only (education, history, etc); entry term CYTOLOGY: for cytological structures use the qualifier /cytol with specific anatomical term or organism", "MS": "The study of the structure, behavior, growth, reproduction, and pathology of cells; and the function and chemistry of cellular components.", "PM": "2010; see CYTOLOGY 1984-2009", "HN": "2010 (1984)", "MR": "20220714", "DA": "19990101", "DC": "1", "DX": "20100101", "UI": "D003585"}, {"RECTYPE": "D", "MH": "Cytomegalovirus Infections", "DE": "CYTOMEGALOVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Severe Cytomegalovirus Infections|T047|NON|NRW|NLM (2023)|210831|abcdef", "ENTRY": "Perinatal Cytomegalovirus Infections", "MN": "C01.925.256.466.245", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "infection by MUROMEGALOVIRUS (MOUSE CYTOMEGALOVIRUS or RAT CYTOMEGALOVIRUS) does not go here: coordinate MUROMEGALOVIRUS with HERPESVIRIDAE INFECTIONS ", "MS": "Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.", "OL": "use CYTOMEGALOVIRUS INFECTIONS to search CYTOMEGALIC INCLUSION DISEASE 1966-93", "PM": "94; was CYTOMEGALIC INCLUSION DISEASE 1963-93; CYTOMEGALOVIRUS INFECTIONS was see CYTOMEGALIC INCLUSION DISEASE 1992-93", "HN": "94; was CYTOMEGALIC INCLUSION DISEASE 1963-93; CYTOMEGALOVIRUS INFECTIONS was see CYTOMEGALIC INCLUSION DISEASE 1992-93", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D003586"}, {"RECTYPE": "D", "MH": "Cytomegalovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Salivary Gland Viruses|T005|NON|EQV|UNK (19XX)|780130|abcdef", "ENTRY": "Viruses, Salivary Gland", "MN": "B04.280.382.150.150", "MH_TH": "NLM (1964)", "ST": "T005", "RN": "txid10358", "MS": "A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.", "OL": "use CYTOMEGALOVIRUS to search CYTOMEGALOVIRUSES 1966-93 & SALIVARY GLAND VIRUSES 1966-78.", "PM": "94; was CYTOMEGALOVIRUSES 1966-93; SALIVARY GLAND VIRUSES was see under CYTOMEGALOVIRUSES 1966-78", "HN": "94; was CYTOMEGALOVIRUSES 1966-93; SALIVARY GLAND VIRUSES was see under CYTOMEGALOVIRUSES 1966-78", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003587"}, {"RECTYPE": "D", "MH": "Cytopathogenic Effect, Viral", "DE": "CPE", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Cytopathic Effect, Viral|T049|NON|EQV|NLM (1990)|881208|CPE VIRAL|abcdefv", "ENTRY": "Viral Cytopathogenic Effects", "MN": "G06.920.190", "FX": "Viral Plaque Assay", "MH_TH": "NLM (1964)", "ST": "T049", "AN": "NIM; do not confuse with CELL TRANSFORMATION, VIRAL: see note there", "MS": "Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses.", "PM": "68", "HN": "68(64)", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003588"}, {"RECTYPE": "D", "MH": "Cytophaga", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.400.425.300.150", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid978", "AN": "infection: coord IM with CYTOPHAGACEAE INFECTIONS (IM)", "MS": "A genus of gram-negative gliding bacteria found in SOIL; HUMUS; and FRESHWATER and marine habitats.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003589"}, {"RECTYPE": "D", "MH": "Cytophotometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Microfluorometry|T059|NON|EQV|UNK (19XX)|850228|abcdef", "ENTRY": "Microfluorometries", "MN": "E05.242.386", "MH_TH": "NLM (1986)", "ST": "T059", "PI": "Photometry (1966-1985)", "MS": "A method for the study of certain organic compounds within cells, in situ, by measuring the light intensities of the selectively stained areas of cytoplasm. The compounds studied and their locations in the cells are made to fluoresce and are observed under a microscope.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19850228", "DC": "1", "DX": "19860101", "UI": "D003592"}, {"RECTYPE": "D", "MH": "Cytoplasm", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Protoplasm|T026|NON|BRD|NLM (1998)|960716|abcdef", "ENTRY": "Protoplasms", "MN": "A11.284.430.214", "MH_TH": "NLM (1964)", "ST": "T026", "MS": "The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990)", "PM": "65; PROTOPLASM was heading 1963-64", "HN": "65(64); PROTOPLASM was heading 1963-64", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003593"}, {"RECTYPE": "D", "MH": "Cytoplasmic Granules", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Granules, Cytoplasmic", "MN": "A11.284.430.214.190.875.190.190", "MH_TH": "NLM (1964)", "ST": "T026", "AN": "ZYMOGEN GRANULES see SECRETORY VESICLES is also available", "MS": "Condensed areas of cellular material that may be bounded by a membrane.", "PM": "65", "HN": "65(64)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003594"}, {"RECTYPE": "D", "MH": "Cytoplasmic Streaming", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Protoplasmic Streaming|T043|NON|BRD|NLM (1993)|911028|abcdef", "ENTRY": "Streamings, Protoplasmic", "MN": "G04.392", "MH_TH": "NLM (1967)", "ST": "T043", "AN": "permitted for micro-organisms also; do not confuse with CYTOKINESIS or CELL MOVEMENT", "PI": "Cytoplasm (1966)", "MS": "The movement of CYTOPLASM within a CELL. It serves as an internal transport system for moving essential substances throughout the cell, and in single-celled organisms, such as the AMOEBA, it is responsible for the movement (CELL MOVEMENT) of the entire cell.", "PM": "70", "HN": "70(67)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D003595"}, {"RECTYPE": "D", "MH": "Cytosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.383.742.698.421", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "2(1H)-Pyrimidinone, 4-amino-", "RN": "8J337D1HZY", "RR": "71-30-7 (Cytosine)", "AN": "/biosyn /physiol permitted", "MS": "A pyrimidine base that is a fundamental unit of nucleic acids.", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003596"}, {"RECTYPE": "D", "MH": "Cytosine Nucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cytidine Phosphates|T114|NON|EQV|UNK (19XX)|741105|abcdef", "ENTRY": "Phosphates, Cytidine", "MN": "D13.695.827.232", "MH_TH": "NLM (1966)", "ST": "T114", "RN": "0", "MS": "A group of pyrimidine NUCLEOTIDES which contain CYTOSINE.", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003597"}, {"RECTYPE": "D", "MH": "Cytoskeletal Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Cytoskeletal", "MN": "D12.776.220", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "AN": "/biosyn /drug eff /physiol permitted; do not use /analogs", "PI": "Proteins or specific proteins (1966-1984)", "MS": "Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible.", "PM": "85", "HN": "85", "MR": "20050630", "DA": "19840611", "DC": "1", "DX": "19850101", "UI": "D003598"}, {"RECTYPE": "D", "MH": "Cytoskeleton", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Microtrabecular Lattice|T026|NON|NRW|UNK (19XX)|850225|abcdef", "ENTRY": "Microtrabecular Lattices", "MN": "A11.284.430.214.190.750", "FX": "Cytoskeletal Proteins", "MH_TH": "NLM (1977)", "ST": "T026", "PI": "Organoids (1966-1976)", "MS": "The network of filaments, tubules, and interconnecting filamentous bridges which give shape, structure, and organization to the cytoplasm.", "OL": "use CYTOSKELETON to search CYTOPLASMIC FILAMENTS 1977-85", "PM": "86; was CYTOPLASMIC FILAMENTS 1980-85; was MICROFILAMENTS see under CYTOPLASM 1977-79", "HN": "86; was CYTOPLASMIC FILAMENTS 1980-85; was MICROFILAMENTS see under CYTOPLASM 1977-79", "MR": "20030709", "DA": "19760519", "DC": "1", "DX": "19800101", "UI": "D003599"}, {"RECTYPE": "D", "MH": "Cytosol", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cytosols", "MN": "A11.284.835.450.200", "MH_TH": "NLM (1973)", "ST": "T026", "PI": "Subcellular Fractions (1972)", "MS": "Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components.", "PM": "73", "HN": "73", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003600"}, {"RECTYPE": "D", "MH": "Cytotoxicity Tests, Immunologic", "DE": "CYTOTOX TESTS IMMUNOL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Microcytotoxicity Tests|T059|NON|NRW|NLM (1992)|900907|MICROCYTOTOX TESTS|abcdefv", "ENTRY": "Lymphocytotoxicity Tests, Antiglobulin Augmented", "MN": "E05.940.245", "MH_TH": "NLM (1971)", "ST": "T059", "AN": "note category: do not confuse with CYTOTOXICITY, IMMUNOLOGIC ", "PI": "specific immune factor (1966-1970)", "MS": "The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003601"}, {"RECTYPE": "D", "MH": "Cytotoxicity, Immunologic", "DE": "CYTOTOX IMMUNOL", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Tumoricidal Activity, Immunologic|T043|NON|NRW|NLM (1993)|911009|TUMORICICAL ACTIVITY IMMUNOL|abcdefv", "ENTRY": "Tumoricidal Activities, Immunologic|T043|NON|NRW|NLM (1994)|920825|TUMORICIDAL ACTIVITIES IMMUNOL|abcdefv", "MN": "G12.287", "FX": "T-Lymphocytes, Cytotoxic", "MH_TH": "NLM (1978)", "ST": "T043", "AN": "do not confuse with CYTOTOXICITY TESTS, IMMUNOLOGIC", "PI": "T Lymphocytes (1973-1979)", "MS": "The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid \"killer\" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19770301", "DC": "1", "DX": "19780101", "UI": "D003602"}, {"RECTYPE": "D", "MH": "Cytotoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cytotoxin|T123|T131|NON|EQV|NLM (2021)|200224|abbcdef", "ENTRY": "Agent, Cytotoxic", "MN": "D27.888.569.213", "FX": "Cytostatic Agents", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTITOXINS; coordinate with source of cytotoxin", "PI": "specific cell (1966-1977)", "MS": "Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS.", "PM": "78", "HN": "78", "MR": "20210630", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D003603"}, {"RECTYPE": "D", "MH": "Czechoslovakia", "AQ": "EH EP", "MN": "Z01.586.250", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "in translations of historical articles use spelling People's Republic, not Peoples' nor Peoples", "MS": "Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993.", "MR": "19930526", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D003604"}, {"RECTYPE": "D", "MH": "D-Amino-Acid Oxidase", "DS": "AMINO ACID OXIDASE D", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "dextro-Amino Acid Oxidase|T116|T126|NON|EQV|UNK (19XX)|760515|abbcdef", "ENTRY": "dextro Amino Acid Oxidase", "MN": "D08.811.682.664.500.125", "MH_TH": "NLM (1963)", "ST": "T126", "N1": "D-Amino-acid:oxygen oxidoreductase (deaminating)", "RN": "EC 1.4.3.3", "OL": "use D-AMINO-ACID OXIDASE to search D-AMINO ACID OXIDASE 1974-94 & D-AMINOACID OXIDASE 1966-73", "PM": "95; was D-AMINO ACID OXIDASE 1974-94, was D-AMINOACID OXIDASE 1966-73", "HN": "95; was D-AMINO ACID OXIDASE 1974-94, was D-AMINOACID OXIDASE 1963-73 (Prov 1963-65)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003605"}, {"RECTYPE": "D", "MH": "Dacarbazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DTIC|T109|T121|EQV|FDA SRS (2014)|NLM (2006)|741111|abbdeef", "ENTRY": "NSC45388", "MN": "D03.383.129.308.240", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-", "RN": "7GR28W0FJI", "RR": "4342-03-4 (Dacarbazine)", "PI": "Triazenes (1972-1974)", "MS": "An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564)", "PM": "80; see TRIAZENES 1975-79", "HN": "80(75)", "MR": "20160528", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D003606"}, {"RECTYPE": "D", "MH": "Dacryocystitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dacryoadenitis|T047|NON|REL|NLM (1995)|940113|abcdef", "ENTRY": "Dacryocystitides", "MN": "C11.496.221", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "inflamm of lacrimal sac", "MS": "Inflammation of the lacrimal sac. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19940125", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003607"}, {"RECTYPE": "D", "MH": "Dacryocystorhinostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Dacryocystostomy|T061|NON|NRW|UNK (19XX)|870318|abcdef", "ENTRY": "Dacryocystostomies", "MN": "E04.579.255", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Lacrimal Duct Obstruction/surgery (1966-1987)", "MS": "Surgical fistulization of the LACRIMAL SAC for external drainage of an obstructed nasolacrimal duct.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19870318", "DC": "1", "DX": "19880101", "UI": "D003608"}, {"RECTYPE": "D", "MH": "Dactinomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Meractinomycin|T116|T195|NON|EQV|FDA SRS (2014)|UNK (19XX)|770330|abbcdeef", "ENTRY": "LyovacCosmegen", "MN": "D12.644.641.252", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Actinomycin D", "RN": "1CC1JFE158", "RR": "50-76-0 (Dactinomycin)", "MS": "A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015)", "PM": "66; ACTINOMYCIN was heading 1963-95", "HN": "66; ACTINOMYCIN was heading 1963-95", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003609"}, {"RECTYPE": "D", "MH": "Dagestan", "AQ": "EH EP", "MN": "Z01.542.248.775.310", "MH_TH": "NLM (1975)", "ST": "T083", "MS": "One of the former Associated Soviet Socialist Republics, situated on the Caspian Sea in southwest Russia.", "HN": "75", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "19750101", "UI": "D003610"}, {"RECTYPE": "D", "MH": "Dairy Products", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Products, Dairy", "MN": "J02.500.350", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "general or unspecified; prefer specifics", "MS": "Raw and processed or manufactured milk and milk-derived products. These are usually from cows (bovine) but are also from goats, sheep, reindeer, and water buffalo.", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003611"}, {"RECTYPE": "D", "MH": "Dairying", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Industry, Dairy", "MN": "J01.040.246", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "Production, storage, and distribution of DAIRY PRODUCTS.", "MR": "20151130", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003612"}, {"RECTYPE": "D", "MH": "Danazol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Danazol Ratiopharm", "MN": "D04.210.500.745.432.235", "PA": "Estrogen Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol, (17alpha)-", "RN": "N29QWW3BUO", "RR": "17230-88-5 (Danazol)", "PI": "Pregnadienes (1973-1974)", "MS": "A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders.", "PM": "91; was see under PREGNADIENES 1975-90", "HN": "91(75); was see under PREGNADIENES 1975-90", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003613"}, {"RECTYPE": "D", "MH": "Dance Therapy", "DE": "DANCE THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapies, Dance", "MN": "F04.754.278", "MH_TH": "NLM (1980)", "ST": "T061", "PI": "Dancing (1966-1979)", "MS": "The use of dancing for therapeutic purposes.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D003614"}, {"RECTYPE": "D", "MH": "Dancing", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Hip Hop Dance", "MN": "I03.450.642.287", "MH_TH": "NLM (1966)", "ST": "T056", "MS": "Rhythmic and patterned body movements which are usually performed to music.", "MR": "20190322", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003615"}, {"RECTYPE": "D", "MH": "Dandy-Walker Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dandy-Walker Malformation|T047|EPO|EQV|GHR (2014)|NLM (2000)|OMIM (2013)|ORD (2010)|991104|abcdeeeef", "ENTRY": "Malformation, Dandy-Walker", "MN": "C16.131.666.205", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Hydrocephalus (1966-1969)", "MS": "A congenital abnormality of the central nervous system marked by failure of the midline structures of the cerebellum to develop, dilation of the fourth ventricle, and upward displacement of the transverse sinuses, tentorium, and torcula. Clinical features include occipital bossing, progressive head enlargement, bulging of anterior fontanelle, papilledema, ataxia, gait disturbances, nystagmus, and intellectual compromise. (From Menkes, Textbook of Child Neurology, 5th ed, pp294-5)", "PM": "1991; see HYDROCEPHALUS 1970-1990", "HN": "1991(1970)", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003616"}, {"RECTYPE": "D", "MH": "Dangerous Behavior", "PRINT ENTRY": "Behavior, Dangerous|T055|NON|EQV|UNK (19XX)|780112|abcdef", "ENTRY": "Hazardous Behaviors", "MN": "I01.880.735.223", "FX": "Risk-Taking", "MH_TH": "NLM (1978)", "ST": "T055", "AN": "human only", "PI": "Violence (1968-1977)", "MS": "Actions which have a high risk of being harmful or injurious to oneself or others.", "PM": "91; was see under VIOLENCE 1978-90", "HN": "91(78); was see under VIOLENCE 1978-90", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D003617"}, {"RECTYPE": "D", "MH": "Dansyl Compounds", "DE": "DANSYL CPDS", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Dimethylaminonaphthalenesulfonyl Compounds|T109|T130|NON|EQV|UNK (19XX)|770401|DIMETHYLAMINONAPHTHALENESULFONYL CPDS|abbcdefv", "ENTRY": "Compounds, Dimethylaminonaphthalenesulfonyl", "MN": "D04.615.638.204", "PA": "Indicators and Reagents", "MH_TH": "NLM (1972)", "ST": "T130", "RN": "0", "PI": "Sulfonic Acids (1966-1971)", "MS": "Compounds that contain a 1-dimethylaminonaphthalene-5-sulfonyl group.", "PM": "72", "HN": "72", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003619"}, {"RECTYPE": "D", "MH": "Dantrolene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Dantrolene", "MN": "D03.383.129.308.432.555.287", "PA": "Muscle Relaxants, Central", "MH_TH": "USAN (1966)", "ST": "T121", "N1": "2,4-Imidazolidinedione, 1-(((5-(4-nitrophenyl)-2-furanyl)methylene)amino)-", "RN": "F64QU97QCR", "RR": "7261-97-4 (Dantrolene)", "PI": "Hydantoins (1966-1974)", "MS": "Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.", "PM": "80; was see under HYDANTOINS 1975-79", "HN": "80(75); was see under HYDANTOINS 1975-79", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D003620"}, {"RECTYPE": "D", "MH": "Daphnia", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Daphnias", "MN": "B01.050.500.131.365.150.200", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid6668", "PI": "Crustacea (1966-1971)", "MS": "A diverse genus of minute freshwater CRUSTACEA, of the suborder CLADOCERA. They are a major food source for both young and adult freshwater fish.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003621"}, {"RECTYPE": "D", "MH": "Dapsone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfonyldianiline|T109|T121|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Sulfone, 4,4'-Diaminophenyl", "MN": "D02.886.590.263", "PA": "Leprostatic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "8W5C518302", "RR": "80-08-0 (Dapsone)", "MS": "A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003622"}, {"RECTYPE": "D", "MH": "Dark Adaptation", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Scotopic Adaptation|T042|NON|EQV|NLM (2001)|000516|abcdef", "ENTRY": "Adaptation, Scotopic", "MN": "G14.020.371", "MH_TH": "NLM (1968)", "ST": "T042", "PI": "Adaptation, Ocular (1966-1967)", "MS": "Adjustment of the eyes under conditions of low light. The sensitivity of the eye to light is increased during dark adaptation.", "PM": "72", "HN": "72(68)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003623"}, {"RECTYPE": "D", "MH": "Darkness", "AQ": "AE", "ENTRY": "Darknesses", "MN": "G01.590.540.233", "MH_TH": "NLM (1966)", "ST": "T070", "MS": "The absence of light.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003624"}, {"RECTYPE": "D", "MH": "Data Collection", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Methods, Data Collection", "MN": "N06.850.520.308", "FX": "Empirical Research", "MH_TH": "POPLINE (1978)", "ST": "T062", "MS": "Systematic gathering of data for a particular purpose from various sources, including questionnaires, interviews, observation, existing records, and electronic devices. The process is usually preliminary to statistical analysis of the data.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20180527", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D003625"}, {"RECTYPE": "D", "MH": "Data Display", "AQ": "AE CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Information Display|T066|T170|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Information Displays", "MN": "L01.296", "MH_TH": "NLM (1964)", "ST": "T170", "MS": "The visual representation of data via a manufactured system.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20180527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003626"}, {"RECTYPE": "D", "MH": "Data Interpretation, Statistical", "DE": "DATA INTERP", "PRINT ENTRY": "Data Analysis, Statistical|T081|NON|EQV|UNK (19XX)|870406|DATA ANAL STATIST|abcdefv", "ENTRY": "Statistical Data Interpretations", "MN": "N06.850.520.830.300", "MH_TH": "NLM (1988)", "ST": "T081", "AN": "usually NIM; do not use routinely for an author's interpretation of statistical findings: must be discussed substantively ", "MS": "Application of statistical procedures to analyze specific observed or assumed facts from a particular study.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19870406", "DC": "1", "DX": "19880101", "UI": "D003627"}, {"RECTYPE": "D", "MH": "Database Management Systems", "DE": "DBMS", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Database Management System", "MN": "N04.452.515.110", "MH_TH": "NLM (1987)", "ST": "T170", "MS": "Software designed to store, manipulate, manage, and control data for specific uses.", "PM": "91; was see under SOFTWARE 1987-90", "HN": "91(87); was see under SOFTWARE 1987-90", "MR": "20180527", "DA": "19860617", "DC": "1", "DX": "19910101", "UI": "D003628"}, {"RECTYPE": "D", "MH": "Modems", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "PRINT ENTRY": "Dataphones|T073|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Modem", "MN": "L01.462.500.847.698.500", "MH_TH": "NLM (1998)", "ST": "T073", "PI": "Computers (1966)", "MS": "Equipment that sends digital information over telephone lines. The term Modem is a short form of the phrase modulator-demodulator.", "PM": "2000; see DATAPHONE 1991-1999; see TELECOMMUNICATIONS 1998-1999; see TELEPHONE 1975-1990; see COMPUTERS 1967-1974", "HN": "2000(1967); use TELECOMMUNICATIONS 1998-1999", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003629"}, {"RECTYPE": "D", "MH": "Daunorubicin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rubomycin|T109|T121|NON|EQV|UNK (19XX)|800521|abbcdef", "ENTRY": "NSC82151", "MN": "D09.408.051.059.200", "PA": "Topoisomerase II Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-", "RN": "ZS7284E0ZP", "RR": "UD984I04LZ", "MS": "A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS.", "OL": "use DAUNORUBICIN to search DAUNOMYCIN 1966-79", "PM": "80; was DAUNOMYCIN 1966-79", "HN": "80; was DAUNOMYCIN 1964-79 (Prov 1964-65)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003630"}, {"RECTYPE": "D", "MH": "Day Care, Medical", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "PRINT ENTRY": "Hospitalization, Partial|T058|NON|EQV|NLM (1995)|940124|abcdef", "ENTRY": "Partial Hospitalization", "MN": "N02.421.585.246", "MH_TH": "NLM (2016)", "ST": "T058", "AN": "care to patients hospitalized only during day-time hours; for children in day-care schools use CHILD DAY CARE CENTERS or SCHOOLS, NURSERY", "PI": "Outpatient Clinics, Hospital (1966-1967)", "MS": "Institutional health care of patients during the day. The patients return home at night.", "PM": "2016; see DAY CARE 1968-2015", "HN": "2016 (1968)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003631"}, {"RECTYPE": "D", "MH": "Dichlorodiphenyldichloroethane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "TDE|T109|T131|ABB|EQV|UNK (19XX)|740329|abbcdef", "MN": "D02.455.526.439.294", "PA": "Insecticides", "MH_TH": "UNK (19XX)", "ST": "T131", "N1": "Benzene, 1,1'-(2,2-dichloroethylidene)bis(4-chloro-)", "RN": "V14159DF29", "RR": "72-54-8 (Dichlorodiphenyldichloroethane)", "AN": "do not confuse with o,p-DDD; for use as an insecticide, see note at INSECTICIDES", "MS": "An organochlorine insecticide that is slightly irritating to the skin. (From Merck Index, 11th ed, p482)", "PM": "2005; see DDD 1965-2004", "HN": "2005(1965)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003632"}, {"RECTYPE": "D", "MH": "Dichlorodiphenyl Dichloroethylene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DDX|T109|T131|ABB|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Dichloroethylene, Dichlorodiphenyl", "MN": "D02.455.526.439.292", "PA": "Insecticides", "MH_TH": "UNK (19XX)", "ST": "T131", "N1": "Benzene, 1,1'-(dichloroethenylidene)bis(4-chloro-)", "RN": "4M7FS82U08", "RR": "72-55-9 (Dichlorodiphenyl Dichloroethylene)", "PI": "Insecticides (1966-1972)", "MS": "An organochlorine pesticide, it is the ethylene metabolite of DDT.", "PM": "2005; see DDE 1973-2004, DDMU was indexed under DICHLORODIPHENYL DICHLOROEHTYLENE 2005-2013", "HN": "2005", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003633"}, {"RECTYPE": "D", "MH": "DDT", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TbisC ethane", "MN": "D02.455.526.439.255", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Benzene, 1,1'-(2,2,2-trichloroethylidene)bis(4-chloro)-", "RN": "CIW5S16655", "RR": "50-29-3 (DDT)", "MS": "A polychlorinated pesticide that is resistant to destruction by light and oxidation. Its unusual stability has resulted in difficulties in residue removal from water, soil, and foodstuffs. This substance may reasonably be anticipated to be a carcinogen: Fourth Annual Report on Carcinogens (NTP-85-002, 1985). (From Merck Index, 11th ed)", "PM": "1966; 1,1,1-TRICHLORO-2,2-BIS(P-CHLOROPHENYL)ETHANE was indexed under DDT 2008, & under CHLOROBENZENES 2007; CHLOROPHENOTHANE was indexed under DDT 2004-2013", "HN": "1966", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003634"}, {"RECTYPE": "D", "MH": "De Lange Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cornelia De Lange Syndrome|T047|EPO|EQV|GHR (2014)|NLM (2000)|991103|abcdeef", "ENTRY": "X-Linked CdLSs", "MN": "C16.320.180.210", "FX": "Intellectual Disability", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A syndrome characterized by growth retardation, severe MENTAL RETARDATION, short stature, a low-pitched growling cry, brachycephaly, low-set ears, webbed neck, carp mouth, depressed nasal bridge, bushy eyebrows meeting at the midline, hirsutism, and malformations of the hands. The condition may occur sporadically or be associated with an autosomal dominant pattern of inheritance or duplication of the long arm of chromosome 3. (Menkes, Textbook of Child Neurology, 5th ed, p231)", "PM": "2000; see DE LANGE'S SYNDROME 1966-1999", "HN": "2000(1964)", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003635"}, {"RECTYPE": "D", "MH": "DEAE-Cellulose", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diethylaminoethyl Cellulose|T109|T122|NON|EQV|NLM (2024)|220829|abbcdef", "ENTRY": "DEAE Cellulose", "MN": "D09.698.365.180.247", "MH_TH": "NLM (1975)", "ST": "T122", "N1": "Cellulose, 2-(diethylamino)ethyl ether", "RN": "9013-34-7", "MS": "Cellulose derivative used in chromatography, as ion-exchange material, and for various industrial applications.", "OL": "use CELLULOSE to search DEAE-CELLULOSE 1968-74 (as Prov 1968-69)", "PM": "91; was see under CELLULOSE/analogs & derivatives 1975-90; was see under CELLULOSE 1970-74", "HN": "91(75)(68-69); was see under CELLULOSE/analogs & derivatives 1975-90; was see under CELLULOSE 1968-74 (Prov 1968-69)", "MR": "20230609", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003636"}, {"RECTYPE": "D", "MH": "DEAE-Dextran", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sephadex, DEAE", "MN": "D09.698.365.272.250", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Dextran, 2-(diethylamino)ethyl ether", "RN": "9015-73-0", "PI": "Diethylamines (1974)", "MS": "Used as a support for ion-exchange chromatography.", "PM": "91; was see under DEXTRANS 1979-90; was see under DEXTRAN 1975-78", "HN": "91(75); was see under DEXTRANS 1979-90; was see under DEXTRAN 1975-78", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003637"}, {"RECTYPE": "D", "MH": "Deafness", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Prelingual Deafness|T047|NON|NRW|NLM (2008)|061106|abcdef", "ENTRY": "Permanents, Deafness", "MN": "C23.888.592.763.393.341.186", "FX": "Lipreading", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "differentiate from HEARING LOSS, BILATERAL; see various specific terms under HEARING LOSS", "MS": "A general term for the complete loss of the ability to hear from both ears.", "OL": "use DEAFNESS to search DEAF-MUTISM 1966-79", "PM": "DEAF-MUTISM was heading 1963-79", "HN": "DEAF-MUTISM was heading 1963-79", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D003638"}, {"RECTYPE": "D", "MH": "Hearing Loss, Sudden", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sudden Hearing Loss|T047|T184|NON|EQV|NLM (2020)|190501|abbcdef", "MN": "C23.888.592.763.393.341.900", "MH_TH": "NLM (2003)", "ST": "T184", "PI": "Deafness, Sudden (1979-2002)", "MS": "Sensorineural hearing loss which develops suddenly over a period of hours or a few days. It varies in severity from mild to total deafness. Sudden deafness can be due to head trauma, vascular diseases, infections, or can appear without obvious cause or warning.", "PM": "2003; see DEAFNESS, SUDDEN 1979-2002", "HN": "2003 (1979)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D003639"}, {"RECTYPE": "D", "MH": "Dealkylation", "AQ": "DE GE IM PH RE", "ENTRY": "Dealkylations", "MN": "G03.219", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "almost never IM; enzymatic dealkylation: coord NIM with specific enzyme (IM) + substrate (NIM)", "PI": "Alkylation (1966-1970)", "MS": "The removing of alkyl groups from a compound. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003640"}, {"RECTYPE": "D", "MH": "Deamination", "AQ": "DE GE IM PH RE", "ENTRY": "Deaminations", "MN": "G03.222", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "almost never IM; enzymatic deamination: coord NIM with specific enzyme (IM) + substrate (NIM)", "PI": "Chemistry, Organic (1966-1970)", "MS": "The removal of an amino group (NH2) from a chemical compound.", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003641"}, {"RECTYPE": "D", "MH": "Deanol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dimethylaminoethanol|T109|T121|NON|EQV|UNK (19XX)|741018|abbcdef", "ENTRY": "N,N Dimethyl 2 hydroxyethylamine", "MN": "D02.092.063.291.274", "PA": "Antidepressive Agents", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Ethanol, 2-(dimethylamino)-", "RN": "2N6K9DRA24", "RR": "108-01-0 (Deanol)", "MS": "An antidepressive agent that has also been used in the treatment of movement disorders. The mechanism of action is not well understood.", "PM": "91; was see under ETHANOLAMINES 1963-90", "HN": "91(63); was see under ETHANOLAMINES 1963-90", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003642"}, {"RECTYPE": "D", "MH": "Death", "PRINT ENTRY": "Near-Death Experience|T041|NON|REL|NLM (1996)|940922|abcdef", "ENTRY": "Death, Cardiac", "MN": "C23.550.260", "FX": "Thanatology", "MH_TH": "BIOETHICS (1974)", "ST": "T040", "AN": "IM; /mortal is available with Cat C, F, E; do not confuse with MORTALITY, a statist concept: DEATH is the biol or physiol, psychol concept; for theory, doctrine & philosophy of death THANATOLOGY is available; for death as a result of a dis or ther or diag procedure, FATAL OUTCOME is available: see note there", "CX": "consider also terms at THANATO-", "MS": "Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003643"}, {"RECTYPE": "D", "MH": "Death Certificates", "AQ": "HI LJ", "ENTRY": "Records, Death", "MN": "N06.850.520.308.940.350", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "IM", "MS": "Official records of individual deaths including the cause of death certified by a physician, and any other required identifying information.", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003644"}, {"RECTYPE": "D", "MH": "Death, Sudden", "AQ": "EH EP ET PA PC VE", "PRINT ENTRY": "Sudden Death|T033|T046|NON|EQV|NLM (2020)|190501|abbcdef", "MN": "C23.550.260.322", "FX": "Sudden Infant Death", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "DEATH, SUDDEN, CARDIAC is also available", "MS": "The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003645"}, {"RECTYPE": "D", "MH": "Debridement", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Debridements", "MN": "E04.176", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The removal of foreign material and devitalized or contaminated tissue from or adjacent to a traumatic or infected lesion until surrounding healthy tissue is exposed. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19950313", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003646"}, {"RECTYPE": "D", "MH": "Debrisoquin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tendor|T109|T121|TRD|NRW|UNK (19XX)|810604|abbcdef", "MN": "D03.633.100.531.205", "PA": "Sympatholytics", "MH_TH": "NLM (1973)", "ST": "T121", "N1": "2(1H)-Isoquinolinecarboximidamide, 3,4-dihydro-", "RN": "X31CDK040E", "RR": "1131-64-2 (Debrisoquin)", "PI": "Isoquinolines (1969-1972)", "MS": "An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.", "PM": "91; was see under ISOQUINOLINES 1973-90", "HN": "91(73); was see under ISOQUINOLINES 1973-90", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003647"}, {"RECTYPE": "D", "MH": "Decalcification Technique", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Techniques, Decalcification", "MN": "E05.200.750.288", "MH_TH": "NLM (1965)", "ST": "T059", "MS": "Removal of minerals from bones during bone examination.", "OL": "use DECALCIFICATION TECHNIQUE to search DECALCIFICATION TECHNIC 1966-90", "PM": "91; was DECALCIFICATION TECHNIC 1965-90", "HN": "91; was DECALCIFICATION TECHNIC 1965-90", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003648"}, {"RECTYPE": "D", "MH": "Decalcification, Pathologic", "DE": "DECALCIFICATION PATHOL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pathological Decalcification", "MN": "C18.452.174.289", "FX": "Tooth Demineralization", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "loss of calcium from bone & tooth but consider also TOOTH DEMINERALIZATION", "MS": "The loss of calcium salts from bones and teeth. Bacteria may be responsible for this occurrence in teeth. Old age may be a factor contributing to calcium loss, as is the presence of diseases such as rheumatoid arthritis.", "OL": "use CALCIUM METABOLISM DISORDERS to search DECALCIFICATION, PATHOLOGIC 1966-74", "PM": "91; was see under CALCIUM METABOLISM DISORDERS 1965-90", "HN": "91(65); was see under CALCIUM METABOLISM DISORDERS 1965-90", "CATSH": "CAT LIST", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003649"}, {"RECTYPE": "D", "MH": "Decamethonium Compounds", "DE": "DECAMETHONIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Decamethonium", "MN": "D02.675.276.558.372", "FX": "Neuromuscular Depolarizing Agents", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds that contain the decamethylenebis(trimethyl)ammonium radical. These compounds frequently act as neuromuscular depolarizing agents.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003650"}, {"RECTYPE": "D", "MH": "Decanoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D10.251.175.200", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Fatty Acids (1966-1974)", "MS": "Salts and esters of the 10-carbon monocarboxylic acid-decanoic acid.", "PM": "91; was see under DECANOIC ACIDS 1975-90", "HN": "91(75); was see under DECANOIC ACIDS 1975-90", "MR": "20030709", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D003651"}, {"RECTYPE": "D", "MH": "Decanoic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Capric Acids|T109|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Acids, Decanoic", "MN": "D10.251.175", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Fatty Acids (1966-1974)", "MS": "10-carbon saturated monocarboxylic acids.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D003652"}, {"RECTYPE": "D", "MH": "Decarboxylation", "AQ": "DE GE IM PH RE", "ENTRY": "Decarboxylations", "MN": "G03.225", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "almost never IM; enzymatic decarboxylation: coord NIM with CARBOXY-LYASES (IM) + substrate (NIM) or specific carboxy-lyase (IM)", "PI": "Chemistry, Organic (1966-1970)", "MS": "The removal of a carboxyl group, usually in the form of carbon dioxide, from a chemical compound.", "PM": "91; was see under CHEMISTRY, ORGANIC 1971-90", "HN": "91(71); was see under CHEMISTRY, ORGANIC 1971-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003653"}, {"RECTYPE": "D", "MH": "Deceleration", "AQ": "AE", "ENTRY": "Decelerations", "MN": "G01.482.107.373", "MH_TH": "NLM (1975)", "ST": "T070", "MS": "A decrease in the rate of speed.", "OL": "search ACCELERATION 1966-74", "PM": "91; was see under ACCELERATION 1975-90", "HN": "91(75); was see under ACCELERATION 1975-90", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003654"}, {"RECTYPE": "D", "MH": "Decerebrate State", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rigidity, Decorticate|T046|T184|NON|REL|NLM (2000)|991104|abbcdef", "ENTRY": "States, Decerebrate", "MN": "C23.888.592.298", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "\"brain-isolated\", \"enc\u00e9phale isol\u00e9\", \"pithed\", \"spinal\" as in \"spinal cat\", \"cerveau isol\u00e9\" go here", "MS": "A condition characterized by abnormal posturing of the limbs that is associated with injury to the brainstem. This may occur as a clinical manifestation or induced experimentally in animals. The extensor reflexes are exaggerated leading to rigid extension of the limbs accompanied by hyperreflexia and opisthotonus. This condition is usually caused by lesions which occur in the region of the brainstem that lies between the red nuclei and the vestibular nuclei. In contrast, decorticate rigidity is characterized by flexion of the elbows and wrists with extension of the legs and feet. The causative lesion for this condition is located above the red nuclei and usually consists of diffuse cerebral damage. (From Adams et al., Principles of Neurology, 6th ed, p358)", "CATSH": "CAT LIST", "MR": "20150112", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003655"}, {"RECTYPE": "D", "MH": "Decidua", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Deciduas", "MN": "A16.710.289", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The hormone-responsive glandular layer of ENDOMETRIUM that sloughs off at each menstrual flow (decidua menstrualis) or at the termination of pregnancy. During pregnancy, the thickest part of the decidua forms the maternal portion of the PLACENTA, thus named decidua placentalis. The thin portion of the decidua covering the rest of the embryo is the decidua capsularis.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003656"}, {"RECTYPE": "D", "MH": "Decision Making", "AQ": "DE ES PH RE", "PRINT ENTRY": "Credit Assignment|T041|NON|NRW|NLM (2023)|211228|abcdef", "ENTRY": "Credit Assignments", "MN": "F02.463.785.373", "FX": "Policy Making", "MH_TH": "POPLINE (1978)", "ST": "T041", "AN": "CLINICAL DECISION MAKING is also available", "MS": "The process of making a selective intellectual judgment when presented with several complex alternatives consisting of several variables, and usually defining a course of action or an idea.", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003657"}, {"RECTYPE": "D", "MH": "Decision Making, Computer-Assisted", "PRINT ENTRY": "Medical Decision Making, Computer-Assisted|T058|T066|NON|NRW|UNK (19XX)|860617|MED DECISION MAKING COMPUTER ASSISTED|abbcdefv", "ENTRY": "Medical Decision Making, Computer Assisted", "MN": "L01.313.500.750.100", "MH_TH": "NLM (1987)", "ST": "T041", "PI": "Decision Making (1966-1986)", "MS": "Use of an interactive computer system designed to assist the physician or other health professional in choosing between certain relationships or variables for the purpose of making a diagnostic or therapeutic decision.", "PM": "87", "HN": "87", "MR": "20150622", "DA": "19860617", "DC": "1", "DX": "19870101", "UI": "D003658"}, {"RECTYPE": "D", "MH": "Decision Making, Organizational", "DE": "DECISION MAKING ORGAN", "PRINT ENTRY": "Organizational Decision Making|T057|NON|EQV|UNK (19XX)|850523|ORGAN DECISION MAKING|abcdefv", "MN": "N04.452.190", "FX": "Policy Making", "MH_TH": "NLM (1986)", "ST": "T057", "PI": "Decision Making (1966-1985)", "MS": "The process by which decisions are made in an institution or other organization.", "PM": "86", "HN": "86", "MR": "19900802", "DA": "19850523", "DC": "1", "DX": "19860101", "UI": "D003659"}, {"RECTYPE": "D", "MH": "Decision Support Systems, Management", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "MN": "N04.452.515.135", "MH_TH": "NLM (1987)", "ST": "T170", "AN": "IM", "MS": "Computer-based systems that enable management to interrogate the computer on an ad hoc basis for various kinds of information in the organization, which predict the effect of potential decisions.", "PM": "91; was see under MANAGEMENT INFORMATION SYSTEMS 1987-90", "HN": "91(87); was see under MANAGEMENT INFORMATION SYSTEMS 1987-90", "MR": "20180527", "DA": "19860617", "DC": "1", "DX": "19910101", "UI": "D003660"}, {"RECTYPE": "D", "MH": "Decision Support Techniques", "PRINT ENTRY": "Models, Decision Support|T170|NON|NRW|NLM (1992)|910429|abcdef", "ENTRY": "Techniques, Decision Support", "MN": "L01.313.500.750.190", "FX": "Evidence-Based Medicine", "MH_TH": "NLM (1988)", "ST": "T170", "MS": "Mathematical or statistical procedures used as aids in making a decision. They are frequently used in medical decision-making.", "OL": "use DECISION SUPPORT TECHNIQUES to search DECISION SUPPORT TECHNICS 1988-90", "PM": "91; was DECISION SUPPORT TECHNICS 1988-90", "HN": "91; was DECISION SUPPORT TECHNICS 1988-90", "MR": "20190705", "DA": "19870406", "DC": "1", "DX": "19880101", "UI": "D003661"}, {"RECTYPE": "D", "MH": "Decision Theory", "ENTRY": "Theory, Decision", "MN": "G17.162", "FX": "Operations Research", "MH_TH": "NLM (1980)", "ST": "T170", "MS": "A theoretical technique utilizing a group of related constructs to describe or prescribe how individuals or groups of people choose a course of action when faced with several alternatives and a variable amount of knowledge about the determinants of the outcomes of those alternatives.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19790531", "DC": "1", "DX": "19800101", "UI": "D003662"}, {"RECTYPE": "D", "MH": "Decision Trees", "ENTRY": "Trees, Decision", "MN": "G17.162.500", "MH_TH": "NLM (1988)", "ST": "T170", "MS": "A graphic device used in decision analysis, series of decision options are represented as branches (hierarchical).", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19870406", "DC": "1", "DX": "19880101", "UI": "D003663"}, {"RECTYPE": "D", "MH": "Decompression", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "G01.374.715.250", "MH_TH": "NLM (1975)", "ST": "T067", "MS": "Decompression external to the body, most often the slow lessening of external pressure on the whole body (especially in caisson workers, deep sea divers, and persons who ascend to great heights) to prevent DECOMPRESSION SICKNESS. It includes also sudden accidental decompression, but not surgical (local) decompression or decompression applied through body openings.", "PM": "80; see PRESSURE 1975-79", "HN": "80(75)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D003664"}, {"RECTYPE": "D", "MH": "Decompression Sickness", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Caisson Disease|T047|NON|EQV|UNK (19XX)|740329|CAISSON DIS|abcdefv", "ENTRY": "Sickness, Decompression", "MN": "C26.120.248", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A condition occurring as a result of exposure to a rapid fall in ambient pressure. Gases, nitrogen in particular, come out of solution and form bubbles in body fluid and blood. These gas bubbles accumulate in joint spaces and the peripheral circulation impairing tissue oxygenation causing disorientation, severe pain, and potentially death.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003665"}, {"RECTYPE": "D", "MH": "Decontamination", "AQ": "EC ES HI IS LJ MT SN ST", "MN": "N06.850.780.325", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The removal of contaminating material, such as radioactive materials, biological materials, or CHEMICAL WARFARE AGENTS, from a person or object.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003666"}, {"RECTYPE": "D", "MH": "Decoquinate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ethyl-6-(Decycloxy)-7-ethoxy-4-hydroxy-3-quinolinecarboxylate|T109|T121|NON|EQV|UNK (19XX)|810108|abbcdef", "MN": "D03.633.100.810.350.250", "PA": "Coccidiostats", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3-Quinolinecarboxylic acid, 6-(decyloxy)-7-ethoxy-4-hydroxy-, ethyl ester", "RN": "534I52PVWH", "RR": "18507-89-6 (Decoquinate)", "PI": "Quinolines (1972-1974)", "MS": "A coccidiostat for poultry.", "PM": "91; was see under HYDROXYQUINOLINES 1975-90", "HN": "91(75); was see under HYDROXYQUINOLINES 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003667"}, {"RECTYPE": "D", "MH": "Pressure Ulcer", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pressure Sore|T047|NON|EQV|NLM (1992)|910131|abcdef", "ENTRY": "Ulcer, Pressure", "MN": "C17.800.893.665", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "pressure injury resulting from prolonged pressure on the skin and tissues is indexed here", "MS": "An ulceration caused by prolonged pressure on the SKIN and TISSUES when one stays in one position for a long period of time, such as lying in bed. The bony areas of the body are the most frequently affected sites which become ischemic (ISCHEMIA) under sustained and constant pressure.", "PM": "2006; see DECUBITUS ULCER 1963-2005", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D003668"}, {"RECTYPE": "D", "MH": "Deductibles and Coinsurance", "DE": "DEDUCTIBLES COINSURANCE", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Coinsurance|T058|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Deductibles|T081|NON|NRW|UNK (19XX)|790329|abcdef", "MN": "N03.219.521.576.090.300", "MH_TH": "NLM (1968)", "ST": "T078", "PI": "Insurance, Health (1966-1967)", "MS": "Cost-sharing mechanisms that provide for payment by the insured of some portion of covered expenses. Deductibles are the amounts paid by the insured under a health insurance contract before benefits become payable; coinsurance is the provision under which the insured pays part of the medical bill, usually according to a fixed percentage, when benefits become payable.", "PM": "68", "HN": "68", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003669"}, {"RECTYPE": "D", "MH": "Deer", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Deers", "MN": "B01.050.150.900.649.313.500.380.373", "MH_TH": "NLM (1968)", "ST": "T015", "RN": "txid9850", "AN": "includes elk, wapiti, moose, REINDEER & MUNTJACS", "PI": "Artiodactyla (1966-1967)", "MS": "The family Cervidae of 17 genera and 45 species occurring nearly throughout North America, South America, and Eurasia, on most associated continental islands, and in northern Africa. Wild populations of deer have been established through introduction by people in Cuba, New Guinea, Australia, New Zealand, and other places where the family does not naturally occur. They are slim, long-legged and best characterized by the presence of antlers. Their habitat is forests, swamps, brush country, deserts, and arctic tundra. They are usually good swimmers; some migrate seasonally. (Walker's Mammals of the World, 5th ed, p1362)", "PM": "68", "HN": "68", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003670"}, {"RECTYPE": "D", "MH": "DEET", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R209", "MN": "D02.455.426.559.389.127.085.230", "PA": "Insect Repellents", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "Benzamide, N,N-diethyl-3-methyl-", "RN": "134-62-3", "RR": "26906-15-0 (2,5-di-Me-analog)", "PI": "Insect Repellents (1966-1971)", "MS": "A compound used as a topical insect repellent that may cause irritation to eyes and mucous membranes, but not to the skin.", "PM": "91; was see under BENZAMIDES 1972-90", "HN": "91(72); was see under BENZAMIDES 1972-90", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003671"}, {"RECTYPE": "D", "MH": "Defecation", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Bowel Movement|T040|NON|EQV|NLM (2023)|220310|abcdef", "ENTRY": "Defecations", "MN": "G10.261.165", "FX": "Fecal Incontinence", "MH_TH": "NLM (1966)", "ST": "T040", "AN": "do not confuse with INTESTINAL ELIMINATION", "MS": "The normal process of elimination of fecal material from the RECTUM.", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003672"}, {"RECTYPE": "D", "MH": "Defective Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Incomplete Viruses|T005|NON|EQV|UNK (19XX)|741106|abcdef", "ENTRY": "Viruses, Incomplete", "MN": "B04.265", "MH_TH": "NLM (1967)", "ST": "T005", "PI": "specific virus (1966)", "MS": "Viruses which lack a complete genome so that they cannot completely replicate or cannot form a protein coat. Some are host-dependent defectives, meaning they can replicate only in cell systems which provide the particular genetic function which they lack. Others, called SATELLITE VIRUSES, are able to replicate only when their genetic defect is complemented by a helper virus.", "OL": "use DEFECTIVE VIRUSES to search DEFECTIVE VIRUS 1967-74 (as Prov 1967-72) & INCOMPLETE VIRUS 1975-93", "PM": "75; was DEFECTIVE VIRUS 1973-74; INCOMPLETE VIRUSES was INCOMPLETE VIRUS 1975-93", "HN": "75; was DEFECTIVE VIRUS 1967-74 (Prov 1967-72); INCOMPLETE VIRUSES was INCOMPLETE VIRUS 1975-93", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003673"}, {"RECTYPE": "D", "MH": "Defense Mechanisms", "ENTRY": "Mechanisms, Defense", "MN": "F01.393", "MH_TH": "NLM (1966)", "ST": "T055", "MS": "Unconscious process used by an individual or a group of individuals in order to cope with impulses, feelings or ideas which are not acceptable at their conscious level; various types include reaction formation, projection and self reversal.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003674"}, {"RECTYPE": "D", "MH": "Defensive Medicine", "DE": "DEFENSIVE MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Defensive Practice|T058|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Defensive Practices", "MN": "N03.706.535.606.300", "MH_TH": "NLM (1975)", "ST": "T058", "MS": "The alterations of modes of medical practice, induced by the threat of liability, for the principal purposes of forestalling lawsuits by patients as well as providing good legal defense in the event that such lawsuits are instituted.", "PM": "91; was see under MALPRACTICE 1975-90", "HN": "91(75); was see under MALPRACTICE 1975-90", "MR": "19900513", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003675"}, {"RECTYPE": "D", "MH": "Deferoxamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Desferrioxamine|T109|T123|T130|NON|EQV|BAN (19XX)|FDA SRS (2014)|740329|abbbcdeef", "ENTRY": "Methanesulfonate, Deferoxamine", "MN": "D02.241.511.372.265", "PA": "Siderophores", "MH_TH": "USAN (1964)", "ST": "T130", "N1": "Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy-", "RN": "J06Y7MXW4D", "RR": "V9TKO7EO6K", "MS": "Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.", "PM": "65", "HN": "65", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003676"}, {"RECTYPE": "D", "MH": "Deficiency Diseases", "DE": "DEFIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Deficiency", "MN": "C18.654.521.500", "MH_TH": "POPLINE (1978)", "ST": "T047", "AN": "general or unspecified; prefer /defic with specific Category D terms; do not confuse with NUTRITION DISORDERS: DEFICIENCY DISEASES results from deficient intake", "MS": "A condition produced by dietary or metabolic deficiency. The term includes all diseases caused by an insufficient supply of essential nutrients, i.e., protein (or amino acids), vitamins, and minerals. It also includes an inadequacy of calories. (From Dorland, 27th ed; Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003677"}, {"RECTYPE": "D", "MH": "Defoliants, Chemical", "DE": "DEFOLIANTS CHEM", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chemical Defoliants|T131|NON|EQV|UNK (19XX)|740329|CHEM DEFOLIANTS|abcdefv", "MN": "D27.888.723.366.181", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "MS": "Herbicides that remove leaves from trees and growing plants. They may be either organic or inorganic. Several of the more persistent types have been used in military operations and many are toxic. (From Hawley's Condensed Chemical Dictionary, 11th ed)", "OL": "search HERBICIDES 1969-74", "PM": "91; was see under HERBICIDES 1975-90", "HN": "91(75); was see under HERBICIDES 1975-90", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003678"}, {"RECTYPE": "D", "MH": "Deglutition", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Swallowing|T040|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Swallowings", "MN": "G10.261.178", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "The act of taking solids and liquids into the GASTROINTESTINAL TRACT through the mouth and throat.", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003679"}, {"RECTYPE": "D", "MH": "Deglutition Disorders", "DE": "DEGLUTITION DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Swallowing Disorders|T047|NON|EQV|NLM (2005)|040318|SWALLOWING DIS|abcdefv", "ENTRY": "Swallowing Disorder", "MN": "C09.775.174", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003680"}, {"RECTYPE": "D", "MH": "Dehydration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Water Stress|T047|NON|NRW|NLM (2003)|011129|abcdef", "ENTRY": "Stress, Water", "MN": "C23.550.274", "FX": "Thirst", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "differentiate from DESICCATION, a technique for removing moisture from matter; /ther: coord with ORAL REHYDRATION THERAPY see FLUID THERAPY if pertinent; do not use entry term WATER STRESS for water stress test: consider IMMERSION; permitted (NIM) with microorganisms, lower animals and plants", "MS": "The condition that results from excessive loss of water from a living organism.", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003681"}, {"RECTYPE": "D", "MH": "Dehydroascorbatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.352.100.220", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.1.1.-", "PI": "Ketones (1972-1974)", "MS": "Catalyzes the hydrolysis of the gamma lactone, dehydroascorbate, to diketogulonate.", "PM": "91; was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975", "HN": "91(75); was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975", "MR": "20030709", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D003682"}, {"RECTYPE": "D", "MH": "Dehydroascorbic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS DF EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Dehydroascorbic", "MN": "D09.811.100.260", "PA": "Vitamins", "MH_TH": "NLM (1975)", "ST": "T127", "N1": "L-threo-2,3-Hexodiulosonic acid, gamma-lactone", "RN": "Y2Z3ZTP9UM", "RR": "490-83-5 (Dehydroascorbic Acid)", "AN": "deficiency: coordinate DEHYDROASCORBIC ACID/defic (IM) with ASCORBIC ACID DEFICIENCY (IM)", "PI": "Ascorbic Acid (1969-1974)", "MS": "The reversibly oxidized form of ascorbic acid. It is the lactone of 2,3-DIKETOGULONIC ACID and has antiscorbutic activity in man on oral ingestion.", "PM": "91; was see under ASCORBIC ACID 1975-90", "HN": "91(75); was see under ASCORBIC ACID 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003683"}, {"RECTYPE": "D", "MH": "Dehydrocholesterols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "(Z)-3 beta-Hydroxycholesta-5,27(20)-diene|T109|NON|NRW|UNK (19XX)|810108|abcdef", "MN": "D10.570.938.208.320", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "AN": "do not confuse with DIHYDROCHOLESTEROL see CHOLESTANOL; 24-DEHYDROCHOLESTEROL see DESMOSTEROL is available", "PI": "Cholesterol (1966-1977)", "MS": "Cholesterol derivatives having an additional double bond in any position. The prevalent isomer 7-dehydrocholesterol is a precursor of cholesterol and of vitamin D3.", "OL": "use CHOLECALCIFEROLS to search DEHYDROCHOLESTEROL 1966", "PM": "91; was see under CHOLESTADIENOLS 1978-90; DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66", "HN": "91(78); was see under CHOLESTADIENOLS 1978-90; DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66", "MR": "20160705", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D003684"}, {"RECTYPE": "D", "MH": "Dehydrocholic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trioxocholate|T109|T121|T130|NON|NRW|UNK (19XX)|770208|abbbcdef", "ENTRY": "Dehydrocholate, Sodium", "MN": "D04.210.500.221.430.265", "PA": "Cholagogues and Choleretics", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "Cholan-24-oic acid, 3,7,12-trioxo-, (5beta)-", "RN": "NH5000009I", "RR": "W4193719XR", "MS": "A semisynthetic bile acid made from cholic acid. It is used as a cholagogue, hydrocholeretic, diuretic, and as a diagnostic aid.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003685"}, {"RECTYPE": "D", "MH": "Dehydroepiandrosterone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prasterone|T109|T125|NON|EQV|FDA SRS (2014)|INN (19XX)|NLM (1966)|990101|abbcdeeef", "ENTRY": "Prasterone, 3 alpha Isomer", "MN": "D06.472.334.851.968.952", "PA": "Adjuvants, Immunologic", "MH_TH": "NLM (1993)", "ST": "T125", "N1": "Androst-5-en-17-one, 3-hydroxy-, (3beta)-", "RN": "459AG36T1B", "RR": "53-43-0 (Dehydroepiandrosterone)", "MS": "A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.", "PM": "2004, 1963-1992; use PRASTERONE 1993-2003", "HN": "2004, 1963-1992", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D003687"}, {"RECTYPE": "D", "MH": "Deinstitutionalization", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Persons, Deinstitutionalized", "MN": "N02.421.585.415.280", "MH_TH": "NLM (1979)", "ST": "T058", "AN": "\"caring for individuals in the community, rather than in an institutional environment\"", "MS": "The practice of caring for individuals in the community, rather than in an institutional environment with resultant effects on the individual, the individual's family, the community, and the health care system.", "PM": "79", "HN": "79", "MR": "20150629", "DA": "19780508", "DC": "1", "DX": "19790101", "UI": "D003688"}, {"RECTYPE": "D", "MH": "Vestibular Nucleus, Lateral", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Lateral Vestibular Nucleus|T023|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Vestibularis Magnocellularis, Nucleus", "MN": "A09.923.375.800", "MH_TH": "NLM (2000)", "ST": "T023", "MS": "Vestibular nucleus lying immediately superior to the inferior vestibular nucleus and composed of large multipolar nerve cells. Its upper end becomes continuous with the superior vestibular nucleus.", "PM": "2000; see DEITER'S NUCLEUS 1991-1999, see VESTIBULAR NUCLEI 1967-90", "HN": "2000(1975); use VESTIBULAR NUCLEI 1967-1974", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003689"}, {"RECTYPE": "D", "MH": "Deja Vu", "AQ": "PX", "ENTRY": "Vu, Deja", "MN": "F02.463.425.540.203", "MH_TH": "NLM (1968)", "ST": "T041", "AN": "in translations use accents: d\u00e9j\u00e0 vu", "MS": "A subjective feeling that an experience which is occurring for the first time has been experienced before.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20150112", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003690"}, {"RECTYPE": "D", "MH": "Delaware", "AQ": "EH EP", "MN": "Z01.107.567.875.500.200", "MH_TH": "NLM (1998)", "ST": "T083", "MS": "State bounded on the north by Pennsylvania, on the west and south by Maryland, and on the east by Delaware Bay and the Atlantic Ocean.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D003691"}, {"RECTYPE": "D", "MH": "Delayed-Action Preparations", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Timed-Release Preparations|T121|NON|NRW|UNK (19XX)|760305|abcdef", "ENTRY": "Timed Release Preparations", "MN": "E02.319.300.253", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "IM general only; coord with specific drug", "MS": "Dosage forms of a drug that act over a period of time by controlled-release processes or technology.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003692"}, {"RECTYPE": "D", "MH": "Delirium", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Subacute Deliriums", "MN": "F03.615.350", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003693"}, {"RECTYPE": "D", "MH": "Delivery of Health Care", "AQ": "CL EC EH ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Health Care Systems|T058|NON|REL|UNK (19XX)|810226|abcdef", "ENTRY": "Systems, Healthcare", "MN": "N05.300", "FX": "Patient Acceptance of Health Care", "MH_TH": "NLM (1978)", "ST": "T058", "AN": "Public Law 91-515", "PI": "Personal Health Services (1968-1970)", "MS": "The concept concerned with all aspects of providing and distributing health services to a patient population.", "PM": "71; HEALTH CARE was heading 1997", "HN": "71", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D003695"}, {"RECTYPE": "D", "MH": "Delivery Rooms", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Birthing Centers, Hospital|T073|T093|NON|EQV|NLM (1990)|890411|BIRTHING CENTERS HOSP|abbcdefv", "ENTRY": "Hospital Birthing Center", "MN": "N02.278.388.150", "MH_TH": "NLM (1982)", "ST": "T093", "AN": "note X ref BIRTHING CENTERS, HOSPITAL: do not confuse with BIRTHING CENTERS, FREE-STANDING see BIRTHING CENTERS; check also tags PREGNANCY & INFANT, NEWBORN", "MS": "Hospital units equipped for childbirth.", "PM": "91; was see under OPERATING ROOMS 1982-90", "HN": "91(82); was see under OPERATING ROOMS 1982-90", "MR": "19960610", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D003696"}, {"RECTYPE": "D", "MH": "Delphi Technique", "PRINT ENTRY": "Delphi Method|T062|NON|EQV|NLM (2022)|210122|abcdef", "ENTRY": "Techniques, Delphi", "MN": "L01.906.197", "MH_TH": "NLM (1980)", "ST": "T062", "PI": "Questionnaires (1973-1979)", "MS": "An iterative questionnaire designed to measure consensus among individual responses. In the classic Delphi approach, there is no interaction between responder and interviewer.", "OL": "use DELPHI TECHNIQUE to search DELPHI TECHNIC 1980-90", "PM": "91; was DELPHI TECHNIC see under QUESTIONNAIRES 1980-90", "HN": "91(80); was DELPHI TECHNIC see under QUESTIONNAIRES 1980-90", "MR": "20210305", "DA": "19790531", "DC": "1", "DX": "19910101", "UI": "D003697"}, {"RECTYPE": "D", "MH": "Hepatitis Delta Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hepatitis D Virus|T005|NON|EQV|UNK (19XX)|850507|abcdef", "ENTRY": "Hepatitis Delta Viruses", "MN": "B04.820.480.875", "MH_TH": "NLM (1986)", "ST": "T005", "RN": "txid12475", "RR": "txid39759", "PI": "Hepatitis B Antigens (1977-1985)", "MS": "A defective virus, containing particles of RNA nucleoprotein in virion-like form, present in patients with acute hepatitis B and chronic hepatitis. It requires the presence of a hepadnavirus for full replication. This is the lone species in the genus Deltavirus.", "PM": "98; see DELTA AGENT 1986-97; for HEPATITIS DELTA VIRUS see DELTA AGENT 1997", "HN": "98(86)", "MR": "20200813", "DA": "19850507", "DC": "1", "DX": "19860101", "UI": "D003698"}, {"RECTYPE": "D", "MH": "Hepatitis D", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Labrea Disease|T047|NON|NRW|NLM (2008)|070221|abcdef", "ENTRY": "Superinfections, Delta", "MN": "C06.552.380.705.450", "MH_TH": "NLM (1986)", "ST": "T047", "AN": "HEPATITIS D, CHRONIC is also available; do not confuse entry term AMAZON BLACK FEVER with BLACKWATER FEVER or BLACK FEVER see LEISHMANIASIS, VISCERAL", "PI": "Hepatitis, Viral, Human (1977-1985)", "MS": "INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.", "PM": "98; see DELTA INFECTION 1986-97; for HEPATITIS D see DELTA INFECTION 1986-97", "HN": "98(86)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19850507", "DC": "1", "DX": "19860101", "UI": "D003699"}, {"RECTYPE": "D", "MH": "Delta Rhythm", "AQ": "DE GE IM PH RE", "ENTRY": "Rhythms, Delta", "MN": "G11.561.127.875", "MH_TH": "NLM (1975)", "ST": "T042", "MS": "Brain waves seen on EEG characterized by a high amplitude and a frequency of 4 Hz and below. They are considered the \"deep sleep waves\" observed during sleep in dreamless states, infancy, and in some brain disorders.", "PM": "91; was see under ELECTROENCEPHALOGRAPHY 1975-90", "HN": "91(75); was see under ELECTROENCEPHALOGRAPHY 1975-90", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D003700"}, {"RECTYPE": "D", "MH": "Delta Sleep-Inducing Peptide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DSIP|T116|T123|ABB|EQV|UNK (19XX)|860411|abbcdef", "ENTRY": "Trp Ala Gly Gly Asp Ala Ser Gly Glu", "MN": "D12.776.631.650.200", "PA": "Neurotransmitter Agents", "MH_TH": "NLM (1987)", "ST": "T123", "RN": "69431-45-4", "PI": "Peptides (1966-1972)", "MS": "A nonapeptide that is found in neurons, peripheral organs, and plasma. This neuropeptide induces mainly delta sleep in mammals. In addition to sleep, the peptide has been observed to affect electrophysiological activity, neurotransmitter levels in the brain, circadian and locomotor patterns, hormonal levels, psychological performance, and the activity of neuropharmacological drugs including their withdrawal.", "PM": "87", "HN": "87", "MR": "20151123", "DA": "19860411", "DC": "1", "DX": "19870101", "UI": "D003701"}, {"RECTYPE": "D", "MH": "Delusions", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Delusion", "MN": "F01.145.126.200", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "this is the French \"d\u00e9lire\"; do not confuse with ILLUSIONS", "MS": "A false belief regarding the self or persons or objects outside the self that persists despite the facts, and is not considered tenable by one's associates.", "CATSH": "CAT LIST", "MR": "20150112", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003702"}, {"RECTYPE": "D", "MH": "Demecolcine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Demecolcine, (+-)-Isomer|T109|T121|NRW|NLM (1999)|990913|abbdef", "MN": "D03.132.225.374", "PA": "Tubulin Modulators", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzo(a)heptalen-9(5H)-one, 6,7-dihydro-1,2,3,10-tetramethoxy-7-(methylamino)-, (S)-", "RN": "Z01IVE25KI", "RR": "477-30-5 (Demecolcine)", "AN": "/biosyn permitted if by plant", "PI": "Colchicine (1966-1971)", "MS": "An alkaloid isolated from Colchicum autumnale L. and used as an antineoplastic.", "PM": "73", "HN": "73(72)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003703"}, {"RECTYPE": "D", "MH": "Dementia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Senile Paranoid Dementia|T048|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Senile Paranoid Dementias", "MN": "F03.615.400", "FX": "Tauopathies", "MH_TH": "BIOETHICS (1989)", "ST": "T048", "MS": "An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.", "PM": "1981; see DEMENTIA, SENILE 1979-91; see PSYCHOSES, SENILE 1963-78; see PSYCHOSES, PRESENILE 1963-72; see PICK DISEASE OF BRAIN 1981-91; see PICK'S DISEASE OF BRAIN 1966-80; for DEMENTIA, PRESENILE see DEMENTIA 1967-97; for DEMENTIA, SENILE see DEMENTIA 1966-97", "HN": "1981(1963)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19800521", "DC": "1", "DX": "19810101", "UI": "D003704"}, {"RECTYPE": "D", "MH": "Demeclocycline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Demethylchlortetracycline|T109|T195|NON|EQV|FDA SRS (2014)|NLM (1992)|910430|abbcdeef", "ENTRY": "Monohydrochloride, Demeclocycline", "MN": "D04.615.562.900.185", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-", "RN": "5R5W9ICI6O", "RR": "96724-42-4 (Ca (1:1) salt)", "MS": "A TETRACYCLINE analog having a 7-chloro and a 6-methyl. Because it is excreted more slowly than tetracycline, it maintains effective blood levels for longer periods of time.", "OL": "use DEMECLOCYCLINE to search DEMETHYLCHLORTETRACYCLINE 1966-91", "PM": "92; was DEMETHYLCHLORTETRACYCLINE 1963-91; DEMECLOCYCLINE was see DEMETHYLCHLORTETRACYCLINE 1975-91", "HN": "92; was DEMETHYLCHLORTETRACYCLINE 1963-91; DEMECLOCYCLINE was see DEMETHYLCHLORTETRACYCLINE 1975-91", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D003707"}, {"RECTYPE": "D", "MH": "Nordazepam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nordiazepam|T109|T121|NON|EQV|NLM (1982)|900116|abbcdef", "ENTRY": "Ro 52180", "MN": "D03.633.100.079.080.070.216.500", "PA": "GABA Modulators", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl-", "RN": "67220MCM01", "RR": "1088-11-5 (Nordazepam)", "PI": "Diazepam (1973-1976)", "MS": "An intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam.", "OL": "use NORDAZEPAM to search DEMETHYLDIAZEPAM 1977-90", "PM": "91; was DEMETHYLDIAZEPAM see under DIAZEPAM 1977-90", "HN": "91(77); was DEMETHYLDIAZEPAM see under DIAZEPAM 1977-90", "MR": "20170524", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D003708"}, {"RECTYPE": "D", "MH": "Democracy", "ENTRY": "Democracies", "MN": "I01.696.374", "MH_TH": "POPLINE (1993)", "ST": "T078", "MS": "A system of government in which there is free and equal participation by the people in the political decision-making process.", "MR": "19940317", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003709"}, {"RECTYPE": "D", "MH": "Demography", "DE": "DEMOGR", "AQ": "CL EC ES HI LJ MT SD SN ST TD", "PRINT ENTRY": "Population Distribution|T081|NON|REL|UNK (19XX)|770317|abcdef", "ENTRY": "Technique, Brass", "MN": "N06.850.505.400", "MH_TH": "NLM (1978)", "ST": "T090", "AN": "the statistical study of population characteristics; do not confuse with the POPULATION itself", "MS": "Statistical interpretation and description of a population with reference to distribution, composition, or structure.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003710"}, {"RECTYPE": "D", "MH": "Demyelinating Diseases", "DE": "DEMYELINATING DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Demyelinations", "MN": "C10.314", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.", "OL": "use DEMYELINATING DISEASES to search DEMYELINATION 1966-78", "PM": "79; was DEMYELINATION 1963-78", "HN": "79; was DEMYELINATION 1963-78", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D003711"}, {"RECTYPE": "D", "MH": "Dendrites", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "ENTRY": "Dendrite", "MN": "A11.671.240", "MH_TH": "NLM (1964)", "ST": "T026", "AN": "do not confuse with DENDRITIC CELLS", "MS": "Extensions of the nerve cell body. They are short and branched and receive stimuli from other NEURONS.", "PM": "65", "HN": "65(64)", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003712"}, {"RECTYPE": "D", "MH": "Dendritic Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Veiled Cells|T025|NON|NRW|UNK (19XX)|860619|abcdef", "ENTRY": "Veiled Cell", "MN": "A15.382.670.260", "MH_TH": "NLM (1987)", "ST": "T025", "AN": "do not confuse with DENDRITES; DENDRITIC CELLS, FOLLICULAR is also available", "PI": "Skin (1966-1986)", "MS": "Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION).", "PM": "87", "HN": "87", "MR": "20180630", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D003713"}, {"RECTYPE": "D", "MH": "Denervation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Radiofrequency Neurotomies", "MN": "E04.525.210", "MH_TH": "NLM (1964)", "ST": "T061", "AN": "general or unspecified; prefer specifics; coordinate with specific nerve /surg or /physiol or specific organ /innerv but MUSCLE DENERVATION is also available for coordination with specific muscle; NIM when a study technique", "MS": "The resection or removal of the nerve to an organ or part.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20170707", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003714"}, {"RECTYPE": "D", "MH": "Dengue", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Dengue Fever|T047|NON|EQV|NLM (1997)|ORD (2010)|960503|abcdeef", "ENTRY": "Fever, Dengue", "MN": "C01.925.782.417.214", "MH_TH": "POPLINE (1994)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent; SEVERE DENGUE is also available", "MS": "An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003715"}, {"RECTYPE": "D", "MH": "Dengue Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Breakbone Fever Virus|T005|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Viruses, Dengue", "MN": "B04.820.578.344.350.270", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid12637", "MS": "A species of the genus FLAVIVIRUS which causes an acute febrile and sometimes hemorrhagic disease in man. Dengue is mosquito-borne and four serotypes are known.", "PM": "66; was see under ARBOVIRUS 1965, was see under ARBORVIRUSES 1963-64", "HN": "66; was see under ARBOVIRUS 1965, was see under ARBORVIRUSES 1963-64", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003716"}, {"RECTYPE": "D", "MH": "Denial, Psychological", "ENTRY": "Psychological Denial|T041|NON|EQV|NLM (2020)|180917|abcdef", "MN": "F01.393.200", "MH_TH": "NLM (2020)", "ST": "T041", "PI": "Defense Mechanisms (1966-1974)", "MS": "Refusal to admit the truth or reality of a situation or experience.", "PM": "1975", "HN": "2020 (1975); was DENIAL (PSYCHOLOGY) 1975-2019", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D003717"}, {"RECTYPE": "D", "MH": "Denmark", "AQ": "EH EP", "PRINT ENTRY": "Faeroe Islands|T083|NAM|NRW|POPLINE (1983)|750101|abcdef", "ENTRY": "Faroe Islands|T083|NAM|NRW|NLM (2015)|140506|abcdef", "MN": "Z01.542.816.124", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in northern Europe, bordering the Baltic Sea and the North Sea. The capital is Copenhagen.", "MR": "20161221", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D003718"}, {"RECTYPE": "D", "MH": "Dens in Dente", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "in Dentes, Dens", "MN": "C16.131.850.800.250", "MH_TH": "NLM (1975)", "ST": "T019", "AN": "a tooth abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Anomaly of the tooth, found chiefly in upper lateral incisors. It is characterized by invagination of the enamel at the incisal edge.", "OL": "search TOOTH ABNORMALITIES 1966-74", "PM": "91; was see under TOOTH ABNORMALITIES 1975-90", "HN": "91(75); was see under TOOTH ABNORMALITIES 1975-90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003719"}, {"RECTYPE": "D", "MH": "Densitometry", "AQ": "AE CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Densitometries", "MN": "E05.196.712.224", "MH_TH": "NLM (1964)", "ST": "T059", "AN": "TOMODENSITOMETRY see TOMOGRAPHY, X-RAY COMPUTED is also available", "MS": "The measurement of the density of a material by measuring the amount of light or radiation passing through (or absorbed by) the material.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D003720"}, {"RECTYPE": "D", "MH": "Dental Alloys", "DE": "DENT ALLOYS", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Dental Alloy|T122|T197|NON|EQV|NLM (1991)|900205|DENT ALLOY|abbcdefv", "MN": "J01.637.051.339.208", "MH_TH": "NLM (1973)", "ST": "T197", "RN": "0", "PI": "Dental Materials (1966-1972)", "MS": "A mixture of metallic elements or compounds with other metallic or metalloid elements in varying proportions for use in restorative or prosthetic dentistry.", "PM": "73", "HN": "73", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003722"}, {"RECTYPE": "D", "MH": "Dental Amalgam", "DE": "DENT AMALGAM", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Dental Amalgams|T122|T197|NON|EQV|NLM (1991)|900205|DENT AMALGAMS|abbcdefv", "MN": "J01.637.051.339.208.291", "MH_TH": "NLM (1965)", "ST": "T197", "N1": "Dental materials and fillings, amalgams", "RN": "8049-85-2", "MS": "An alloy used in restorative dentistry that contains mercury, silver, tin, copper, and possibly zinc.", "PM": "65", "HN": "65", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003723"}, {"RECTYPE": "D", "MH": "Dental Arch", "DE": "DENT ARCH", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Dental Arches|T023|NON|EQV|NLM (1991)|900116|DENT ARCHES|abcdefv", "MN": "A14.521.320", "FX": "Stomatognathic System", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The curve formed by the row of TEETH in their normal position in the JAW. The inferior dental arch is formed by the mandibular teeth, and the superior dental arch by the maxillary teeth.", "PM": "1966", "HN": "1966", "MR": "20180710", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003724"}, {"RECTYPE": "D", "MH": "Dental Articulators", "DE": "DENT ARTICULATORS", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Articulators|T074|NON|BRD|UNK (19XX)|760412|abcdef", "ENTRY": "Articulator", "MN": "E07.222.210", "MH_TH": "NLM (1977)", "ST": "T074", "PI": "Dental Equipment (1966-1976)", "MS": "Mechanical devices that simulate the temporomandibular joints and jaws to which maxillary and mandibular casts are attached. The entire assembly attempts to reproduce the movements of the mandible and the various tooth-to-tooth relationships that accompany those movements.", "OL": "use DENTAL EQUIPMENT to search ARTICULATORS, DENTAL 1969-74", "PM": "91; was see under DENTAL EQUIPMENT 1977-90; was ARTICULATORS, DENTAL see under DENTAL EQUIPMENT 1969-74", "HN": "91(77); was see under DENTAL EQUIPMENT 1977-90; was ARTICULATORS, DENTAL see under DENTAL EQUIPMENT 1969-74", "CATSH": "CAT LIST", "MR": "19920514", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D003725"}, {"RECTYPE": "D", "MH": "Dental Assistants", "DE": "DENT ASSISTANTS", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Nurses, Dental|T097|NON|EQV|NLM (1998)|961010|NURSES DENT|abcdefv", "ENTRY": "Nurse, Dental", "MN": "N02.360.330.245.250", "MH_TH": "NLM (1966)", "ST": "T097", "AN": "DENTAL AUXILIARIES is also available", "MS": "Individuals who assist the dentist or the dental hygienist.", "MR": "20230620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003726"}, {"RECTYPE": "D", "MH": "Dental Auxiliaries", "DE": "DENT AUXILIARIES", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Dental Auxiliary|T097|NON|EQV|NLM (1992)|910612|DENT AUXILIARY|abcdefv", "MN": "N02.360.330.245", "MH_TH": "NLM (1978)", "ST": "T097", "PI": "Dental Assistants (1966-1977)", "MS": "Personnel whose work is prescribed and supervised by the dentist and who provide dental related care.", "PM": "78", "HN": "78; was ALLIED DENTAL PERSONNEL (NON MESH) before 1978", "MR": "20230620", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D003727"}, {"RECTYPE": "D", "MH": "Dental Calculus", "DE": "DENT CALCULUS", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Tartar|T031|T046|NON|EQV|NLM (1998)|960716|abbcdef", "ENTRY": "Calculus, Dental|T031|T046|NON|EQV|NLM (1991)|900116|CALCULUS DENT|abbcdefv", "MN": "C23.300.175.350", "FX": "Dental Prophylaxis", "MH_TH": "NLM (1964)", "ST": "T046", "MS": "Abnormal concretion or calcified deposit that forms around the teeth or dental prostheses.", "PM": "64", "HN": "64; was in Cat C only 1964-74", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D003728"}, {"RECTYPE": "D", "MH": "Dental Care", "DE": "DENT CARE", "AQ": "AE CL EC ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Care, Dental|T061|NON|EQV|NLM (1991)|900116|CARE DENT|abcdefv", "MN": "N02.421.240.190", "FX": "Comprehensive Dental Care", "MH_TH": "NLM (1973)", "ST": "T061", "MS": "The total of dental diagnostic, preventive, and restorative services provided to meet the needs of a patient (from Illustrated Dictionary of Dentistry, 1982).", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003729"}, {"RECTYPE": "D", "MH": "Dental Care for Disabled", "DE": "DENT CARE DISABLED", "AQ": "AE CL EC ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Dentistry for Handicapped|T058|NON|BRD|UNK (19XX)|790425|DENT FOR HANDICAPPED|abcdefv", "ENTRY": "Handicapped, Dentistry for", "MN": "N02.421.240.190.230", "FX": "Dental Care for Chronically Ill", "MH_TH": "NLM (1980)", "ST": "T058", "AN": "= professional care by a professional", "PI": "specific mouth or tooth disease (1966-1979)", "OL": "93; use DENTAL CARE FOR DISABLED to search DENTAL CARE FOR HANDICAPPED 1980-92", "PM": "93; was DENTAL CARE FOR HANDICAPPED 1980-92", "HN": "93; was DENTAL CARE FOR HANDICAPPED 1980-92", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19790425", "DC": "1", "DX": "19800101", "UI": "D003730"}, {"RECTYPE": "D", "MH": "Dental Caries", "DE": "DENT CARIES", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dental White Spots|T047|NON|NRW|UNK (19XX)|860408|DENT WHITE SPOTS|abcdefv", "ENTRY": "Spots, Dental White", "MN": "C07.793.720.210", "FX": "Tooth Demineralization", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "DIET, CARIOGENIC, CARIOGENIC AGENTS, CARIOSTATIC AGENTS & DMF INDEX are also available", "MS": "Localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation. If left unchecked, the cavity may penetrate the enamel and dentin and reach the pulp.", "OL": "use DENTAL CARIES to search DENTAL CARIES CONTROL 1966", "PM": "DENTAL CARIES CONTROL was heading 1965-66", "HN": "DENTAL CARIES CONTROL was heading 1965-66", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D003731"}, {"RECTYPE": "D", "MH": "Dental Caries Activity Tests", "DE": "DENT CARIES ACTIVITY TESTS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E06.342.250", "MH_TH": "NLM (1970)", "ST": "T060", "PI": "Diagnosis, Oral (1966-1979)", "MS": "Diagnostic tests conducted in order to measure the increment of active DENTAL CARIES over a period of time.", "PM": "72", "HN": "72(70)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003732"}, {"RECTYPE": "D", "MH": "Dental Caries Susceptibility", "DE": "DENT CARIES SUSCEPTIBILITY", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Dental Caries Resistance|T032|NON|NRW|NLM (1998)|960718|DENT CARIES RESISTANCE|abcdefv", "ENTRY": "Susceptibility, Dental Caries|T032|NON|EQV|NLM (1991)|900116|SUSCEPTIBILITY DENT CARIES|abcdefv", "MN": "G10.549.140", "MH_TH": "NLM (1965)", "ST": "T032", "MS": "The predisposition to tooth decay (DENTAL CARIES).", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003733"}, {"RECTYPE": "D", "MH": "Dental Casting Investment", "DE": "DENT CASTING INVESTMENT", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Investments, Dental Casting|T122|NON|EQV|NLM (1991)|900205|INVESTMENTS DENT CASTING|abcdefv", "MN": "J01.637.051.339.250", "MH_TH": "NLM (1965)", "ST": "T122", "RN": "0", "MS": "Material from which the casting mold is made in the fabrication of gold or cobalt-chromium castings. (Boucher's Clinical Dental Terminology, 4th ed, p168)", "PM": "65", "HN": "65", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003734"}, {"RECTYPE": "D", "MH": "Dental Casting Technique", "DE": "DENT CASTING TECHNIQUE", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Dental Casting|T061|NON|EQV|NLM (1991)|900212|TECHNIQUES DENT CASTING|abcdefv", "MN": "E06.912.115", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "The process of producing a form or impression made of metal or plaster using a mold.", "OL": "use DENTAL CASTING TECHNIQUE to search DENTAL CASTING TECHNIC 1966-90", "PM": "91; was DENTAL CASTING TECHNIC 1965-90", "HN": "91; was DENTAL CASTING TECHNIC 1965-90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003735"}, {"RECTYPE": "D", "MH": "Dental Cavity Lining", "DE": "DENT CAVITY LINING", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Varnish, Cavity|T122|NON|NRW|UNK (19XX)|750206|abcdef", "ENTRY": "Varnishes, Cavity Lining", "MN": "E06.780.346.531", "FX": "Calcium Hydroxide", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "An inner coating, as of varnish or other protective substance, to cover the dental cavity wall. It is usually a resinous film-forming agent dissolved in a volatile solvent, or a suspension of calcium hydroxide in a solution of a synthetic resin. The lining seals the dentinal tubules and protects the pulp before a restoration is inserted. (Jablonski, Illustrated Dictionary of Dentistry, 1982)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20230705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003736"}, {"RECTYPE": "D", "MH": "Dental Cavity Preparation", "DE": "DENT CAVITY PREPARATION", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Preparations, Dental Cavity|T061|NON|EQV|NLM (1991)|900116|PREPARATIONS DENT CAVITY|abcdefv", "MN": "E06.931.325", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "restrict to fillings & inlays; for other prep procedures TOOTH PREPARATION, PROSTHODONTIC & ROOT CANAL PREPARATION are available", "MS": "An operation in which carious material is removed from teeth and biomechanically correct forms are established in the teeth to receive and retain restorations. A constant requirement is provision for prevention of failure of the restoration through recurrence of decay or inadequate resistance to applied stresses. (Boucher's Clinical Dental Terminology, 4th ed, p239-40)", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003737"}, {"RECTYPE": "D", "MH": "Dental Cements", "DE": "DENT CEMENTS", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Orthodontic Adhesives|T122|NON|EQV|NLM (2009)|071003|abcdef", "ENTRY": "Orthodontic Adhesive", "MN": "J01.637.051.339.291", "MH_TH": "NLM (1971)", "ST": "T122", "RN": "0", "PI": "Cementation (1966-1970)", "MS": "Substances used to bond COMPOSITE RESINS to DENTAL ENAMEL and DENTIN. These bonding or luting agents are used in restorative dentistry, ROOT CANAL THERAPY; PROSTHODONTICS; and ORTHODONTICS.", "PM": "72; was CEMENT, DENTAL see under DENTAL MATERIALS 1963-64", "HN": "72(71); was CEMENT, DENTAL see under DENTAL MATERIALS 1963-64", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003738"}, {"RECTYPE": "D", "MH": "Dental Cementum", "DE": "DENT CEMENTUM", "AQ": "AB AH BS CH CY DE DG EM EN IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cementum|T023|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Cementum, Dental|T023|NON|EQV|NLM (1991)|900126|CEMENTUM DENT|abcdefv", "MN": "A14.549.167.900.250", "FX": "Cementogenesis", "EC": "growth & development:Cementogenesis", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The bonelike rigid connective tissue covering the root of a tooth from the cementoenamel junction to the apex and lining the apex of the root canal, also assisting in tooth support by serving as attachment structures for the periodontal ligament. (Jablonski, Dictionary of Dentistry, 1992)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003739"}, {"RECTYPE": "D", "MH": "Dental Clinics", "DE": "DENT CLINICS", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Clinics, Dental|T073|T093|NON|EQV|UNK (19XX)|740329|CLINICS DENT|abbcdefv", "ENTRY": "Dental Clinic|T073|T093|NON|EQV|NLM (1991)|900116|DENT CLINIC|abbcdefv", "MN": "N02.278.192.250", "MH_TH": "NLM (1965)", "ST": "T093", "MS": "Facilities where dental care is provided to patients.", "PM": "65", "HN": "65", "MR": "19920514", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003740"}, {"RECTYPE": "D", "MH": "Dental Deposits", "DE": "DENT DEPOSITS", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Materia Alba|T020|NON|EQV|UNK (19XX)|860408|abcdef", "ENTRY": "Deposits, Dental|T020|NON|EQV|NLM (1991)|900116|DEPOSITS DENT|abcdefv", "MN": "C07.793.208", "FX": "Biofilms", "MH_TH": "NLM (1965)", "ST": "T020", "MS": "Accumulations of microflora that lead to pathological plaque and calculus which cause PERIODONTAL DISEASES. It can be considered a type of BIOFILMS. It is subtly distinguished from the protective DENTAL PELLICLE.", "OL": "use DENTAL DEPOSITS to search MATERIA ALBA 1966-86", "PM": "65; MATERIA ALBA was heading 1965-86", "HN": "65; was in Cat C only 1965-74; MATERIA ALBA was heading 1965-86", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003741"}, {"RECTYPE": "D", "MH": "Dental Devices, Home Care", "DE": "DENT DEVICES HOME CARE", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Dental Floss|T073|NON|NRW|NLM (1993)|911002|DENT FLOSS|abcdefv", "ENTRY": "Home Care Dental Devices|T073|NON|EQV|NLM (1992)|910305|HOME CARE DENT DEVICES|abcdefv", "MN": "E07.222.250", "FX": "Toothbrushing", "MH_TH": "NLM (1972)", "ST": "T073", "PI": "Oral Health (1966-1971)", "MS": "Devices used in the home by persons to maintain dental and periodontal health. The devices include toothbrushes, dental flosses, water irrigators, gingival stimulators, etc.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "19940420", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003742"}, {"RECTYPE": "D", "MH": "Dental Enamel", "DE": "DENT ENAMEL", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Enamel Cuticle|T024|NON|NRW|NLM (1997)|951205|abcdef", "ENTRY": "Enamels", "MN": "A14.549.167.900.255", "FX": "Amelogenesis", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "/embryol: consider also AMELOGENESIS", "MS": "A hard thin translucent layer of calcified substance which envelops and protects the dentin of the crown of the tooth. It is the hardest substance in the body and is almost entirely composed of calcium salts. Under the microscope, it is composed of thin rods (enamel prisms) held together by cementing substance, and surrounded by an enamel sheath. (From Jablonski, Dictionary of Dentistry, 1992, p286)", "OL": "use DENTAL ENAMEL to search NASMYTH'S MEMBRANE 1975-96", "PM": "ENAMEL CUTICLE was heading 1965-96; NASMYTH'S MEMBRANE was see ENAMEL CUTICLE 1975-96", "HN": "ENAMEL CUTICLE was heading 1965-96; NASMYTH'S MEMBRANE was see ENAMEL CUTICLE 1975-96", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D003743"}, {"RECTYPE": "D", "MH": "Dental Enamel Hypoplasia", "DE": "DENT ENAMEL HYPOPLASIA", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Enamel Hypoplasia|T019|T020|T047|NON|EQV|NLM (2009)|080325|abbbcdef", "ENTRY": "Hypoplasia, Enamel", "MN": "C16.131.850.800.295.625", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An acquired or hereditary condition due to deficiency in the formation of tooth enamel (AMELOGENESIS). It is usually characterized by defective, thin, or malformed DENTAL ENAMEL. Risk factors for enamel hypoplasia include gene mutations, nutritional deficiencies, diseases, and environmental factors.", "PM": "66; was ENAMEL HYPOPLASIA 1965", "HN": "66; was ENAMEL HYPOPLASIA 1965", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003744"}, {"RECTYPE": "D", "MH": "Dental Enamel Permeability", "DE": "DENT ENAMEL PERMEABILITY", "AQ": "DE ES GE IM PH RE", "ENTRY": "Permeability, Dental Enamel|T042|NON|EQV|NLM (1991)|900117|PERMEABILITY DENT ENAMEL|abcdefv", "MN": "G10.549.845.292", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "coordinate with substance /pharmacokin  ", "MS": "The property of dental enamel to permit passage of light, heat, gases, liquids, metabolites, mineral ions and other substances. It does not include the penetration of the dental enamel by microorganisms.", "OL": "search TOOTH PERMEABILITY 1966-74", "PM": "91; was see under TOOTH PERMEABILITY 1975-90", "HN": "91(75); was see under TOOTH PERMEABILITY 1975-90", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003745"}, {"RECTYPE": "D", "MH": "Dental Enamel Proteins", "DE": "DENT ENAMEL PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Dental Enamel|T116|T123|NON|EQV|NLM (1991)|900117|PROTEINS DENT ENAMEL|abbcdefv", "MN": "D12.776.231", "MH_TH": "NLM (1965)", "ST": "T123", "RN": "0", "AN": "coord IM with specific protein (IM)", "MS": "The proteins that are part of the dental enamel matrix.", "PM": "65", "HN": "65", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003746"}, {"RECTYPE": "D", "MH": "Dental Enamel Solubility", "DE": "DENT ENAMEL SOLUBILITY", "AQ": "DE GE IM PH RE", "ENTRY": "Solubility, Dental Enamel|T081|NON|EQV|NLM (1991)|900117|SOLUBILITY DENT ENAMEL|abcdefv", "MN": "G10.549.181", "MH_TH": "NLM (1965)", "ST": "T081", "MS": "The susceptibility of the DENTAL ENAMEL to dissolution.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003747"}, {"RECTYPE": "D", "MH": "Dental Equipment", "DE": "DENT EQUIPMENT", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Equipments, Dental", "MN": "E07.222", "MH_TH": "NLM (1965)", "ST": "T074", "AN": "for the dental professional, not the patient; differentiate from DENTAL INSTRUMENTS on basis of size (instruments are holdable in the hand)", "MS": "The nonexpendable items used by the dentist or dental staff in the performance of professional duties. (From Boucher's Clinical Dental Terminology, 4th ed, p106)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003748"}, {"RECTYPE": "D", "MH": "Dental Facilities", "DE": "DENT FACILITIES", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Facility, Dental|T073|T093|NON|EQV|NLM (1991)|900125|FACILITY DENT|abbcdefv", "MN": "N02.278.192", "MH_TH": "NLM (1972)", "ST": "T093", "PI": "Health Facilities (1968-1971)", "MS": "Use for material on dental facilities in general or for which there is no specific heading.", "PM": "72", "HN": "72", "MR": "19920514", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003749"}, {"RECTYPE": "D", "MH": "Dental Fissures", "DE": "DENT FISSURES", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fissures, Dental|T020|NON|EQV|UNK (19XX)|860406|FISSURES DENT|abcdefv", "ENTRY": "Fissure, Dental|T020|NON|EQV|UNK (19XX)|860408|FISSURE DENT|abcdefv", "MN": "C07.793.700.255", "FX": "Pit and Fissure Sealants", "MH_TH": "NLM (1987)", "ST": "T020", "PI": "Dental Caries (1966-1986)", "MS": "Naturally occurring deep grooves or clefts in the surface of teeth equivalent to class 1 cavities in Black's classification of dental caries.", "PM": "91; was see under DENTAL CARIES 1987-90", "HN": "91(87); was see under DENTAL CARIES 1987-90", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19860408", "DC": "1", "DX": "19910101", "UI": "D003750"}, {"RECTYPE": "D", "MH": "Dental Fistula", "DE": "DENT FISTULA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gingival Fistula|T046|T190|NON|EQV|NLM (1995)|930901|abbcdef", "ENTRY": "Gingival Fistulas", "MN": "C23.300.575.500.275", "MH_TH": "NLM (1970)", "ST": "T190", "PI": "Periapical Abscess (1966-1969)", "MS": "An abnormal passage in the oral cavity on the gingiva.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D003751"}, {"RECTYPE": "D", "MH": "Dental Health Services", "DE": "DENT HEALTH SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Service, Dental Health", "MN": "N02.421.240", "MH_TH": "NLM (1978)", "ST": "T058", "PI": "Dental Service, Hospital (1966-1977)", "MS": "Services designed to promote, maintain, or restore dental health.", "PM": "78", "HN": "78", "MR": "20150629", "DA": "19770519", "DC": "1", "DX": "19780101", "UI": "D003752"}, {"RECTYPE": "D", "MH": "Dental Health Surveys", "DE": "DENT HEALTH SURVEYS", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Surveys, Dental Health|T062|NON|EQV|NLM (1991)|900212|SURVEYS DENT HEALTH|abcdefv", "MN": "N06.890.160", "MH_TH": "NLM (1969)", "ST": "T062", "AN": "specify geographic term if pertinent", "PI": "Health Surveys (1966-1971)", "MS": "A systematic collection of factual data pertaining to dental or oral health and disease in a human population within a given geographic area.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003753"}, {"RECTYPE": "D", "MH": "Dental High-Speed Equipment", "DE": "DENT HIGH SPEED EQUIPMENT", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "High-Speed Equipments, Dental", "MN": "E07.222.376", "MH_TH": "NLM (1965)", "ST": "T074", "AN": "restrict to dental high-speed equipment: do not confuse with DENTAL INSTRUMENTS", "MS": "Tools used in dentistry that operate at high rotation speeds.", "OL": "use DENTAL HIGH-SPEED EQUIPMENT to search DENTAL HIGH SPEED EQUIPMENT 1966-90", "PM": "65; was DENTAL HIGH SPEED EQUIPMENT 1965-90", "HN": "65; was DENTAL HIGH SPEED EQUIPMENT 1965-90", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003754"}, {"RECTYPE": "D", "MH": "Dental High-Speed Technique", "DE": "DENT HIGH SPEED TECHNIQUE", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, High Speed Dental", "MN": "E06.216", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Dental methods involving the use of DENTAL HIGH-SPEED EQUIPMENT.", "OL": "use DENTAL HIGH-SPEED TECHNIQUE to search DENTAL HIGH SPEED TECHNIC 1966-90", "PM": "91; was DENTAL HIGH SPEED TECHNIC 1965-90", "HN": "91; was DENTAL HIGH SPEED TECHNIC 1965-90", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003755"}, {"RECTYPE": "D", "MH": "Dental Hygienists", "DE": "DENT HYGIENISTS", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Hygienists, Dental|T097|NON|EQV|NLM (1991)|900125|HYGIENISTS DENT|abcdefv", "MN": "N02.360.330.245.376", "MH_TH": "NLM (1965)", "ST": "T097", "AN": "trained in accredited schools and licensed to practice DENTAL PROPHYLAXIS (see note there) under a licensed dentist", "MS": "Persons trained in an accredited school or dental college and licensed by the state in which they reside to provide dental prophylaxis under the direction of a licensed dentist.", "PM": "65", "HN": "65", "MR": "20230620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003756"}, {"RECTYPE": "D", "MH": "Dental Implantation", "DE": "DENT IMPLANTATION", "AQ": "AE CL EC ED ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Dental Prosthesis Implantation|T061|NON|EQV|NLM (1998)|970227|DENT PROSTHESIS IMPLANTATION|abcdefv", "ENTRY": "Therapy, Dental Implant", "MN": "E06.780.314", "FX": "Dental Implants", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "general or unspecified; prefer specifics;  the procedure: do not confuse with DENTAL IMPLANTS, the implant itself; differentiate from TOOTH REPLANTATION (reinsertion of a tooth lost by trauma or deliberate extraction)", "MS": "The grafting or inserting of a prosthetic device of alloplastic material into the oral tissue beneath the mucosal or periosteal layer or within the bone. Its purpose is to provide support and retention to a partial or complete denture.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003757"}, {"RECTYPE": "D", "MH": "Dental Implantation, Endosseous", "DE": "DENT IMPLANT ENDOSS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Osseointegrated Dental Implantation|T061|NON|NRW|NLM (1991)|900427|OSSEOINTEGRATED DENT IMPLANT|abcdefv", "ENTRY": "Implantation, Osseointegrated Dental|T061|NON|NRW|NLM (1991)|900411|IMPLANT OSSEOINTEGRATED DENT|abcdefv", "MN": "E06.780.314.310", "MH_TH": "NLM (1977)", "ST": "T061", "AN": "DENTAL IMPLANTATION, ENDOSSEOUS, ENDODONTIC is also available", "PI": "Dental Implantation (1966-1976)", "MS": "Insertion of an implant into the bone of the mandible or maxilla. The implant has an exposed head which protrudes through the mucosa and is a prosthodontic abutment.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D003758"}, {"RECTYPE": "D", "MH": "Dental Implantation, Endosseous, Endodontic", "DE": "DENT IMPLANT ENDOSS ENDO", "AQ": "AE CL EC ED ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Endosseous Implantation, Endodontic|T061|NON|EQV|UNK (19XX)|760430|abcdef", "ENTRY": "Stabilization, Endodontic", "MN": "E06.780.314.310.360", "MH_TH": "NLM (1971)", "ST": "T061", "PI": "Root Canal Therapy (1966-1970)", "MS": "Insertion of a tapered rod through the root canal into the periapical osseous structure to lengthen the existing root and provide individual tooth stabilization.", "OL": "use DENTAL IMPLANTATION, ENDOSSEOUS, ENDODONTIC to search ENDODONTIC ENDOSSEOUS IMPLANTATION 1971-76", "PM": "77; was ENDODONTIC ENDOSSEOUS IMPLANTATION 1971-76", "HN": "77; was ENDODONTIC ENDOSSEOUS IMPLANTATION 1971-76", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003759"}, {"RECTYPE": "D", "MH": "Dental Impression Materials", "DE": "DENT IMPRESSION MATERIALS", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Materials, Dental Impression|T122|NON|EQV|NLM (1991)|900125|MATERIALS DENT IMPRESSION|abcdefv", "MN": "J01.637.051.339.334", "FX": "Silicone Elastomers", "MH_TH": "NLM (1965)", "ST": "T122", "RN": "0", "AN": "coordinate with specific material if pertinent", "MS": "Substances used to create an impression, or negative reproduction, of the teeth and dental arches. These materials include dental plasters and cements, metallic oxide pastes, silicone base materials, or elastomeric materials.", "PM": "65", "HN": "65", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003760"}, {"RECTYPE": "D", "MH": "Dental Impression Technique", "DE": "DENT IMPRESSION TECHNIQUE", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Dental Impression|T061|NON|EQV|NLM (1991)|900212|TECHNIQUES DENT IMPRESSION|abcdefv", "MN": "E06.912.130", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Procedure of producing an imprint or negative likeness of the teeth and/or edentulous areas. Impressions are made in plastic material which becomes hardened or set while in contact with the tissue. They are later filled with plaster of Paris or artificial stone to produce a facsimile of the oral structures present. Impressions may be made of a full complement of teeth, of areas where some teeth have been removed, or in a mouth from which all teeth have been extracted. (Illustrated Dictionary of Dentistry, 1982)", "OL": "use DENTAL IMPRESSION TECHNIQUE to search DENTAL IMPRESSION TECHNIC 1966-90", "PM": "91; was DENTAL IMPRESSION TECHNIC 1965-90", "HN": "91; was DENTAL IMPRESSION TECHNIC 1965-90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003761"}, {"RECTYPE": "D", "MH": "Dental Instruments", "DE": "DENT INSTRUM", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Instruments, Dental", "MN": "E07.222.501", "MH_TH": "NLM (1965)", "ST": "T074", "AN": "differentiate from DENTAL EQUIPMENT on the basis of size (instruments are entirely holdable in the hand); reamers & broaches: index under ROOT CANAL PREPARATION /instrum", "MS": "Hand-held tools or implements especially used by dental professionals for the performance of clinical tasks.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003762"}, {"RECTYPE": "D", "MH": "Dental Leakage", "DE": "DENT LEAKAGE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Leakages, Dental|T046|NON|EQV|NLM (1991)|900125|LEAKAGES DENT|abcdefv", "MN": "C07.793.221", "MH_TH": "NLM (1984)", "ST": "T046", "PI": "Dental Restoration, Permanent (1966-1983)", "MS": "The seepage of fluids, debris, and micro-organisms between the walls of a prepared dental cavity and the restoration.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "19900529", "DA": "19830311", "DC": "1", "DX": "19840101", "UI": "D003763"}, {"RECTYPE": "D", "MH": "Dental Materials", "DE": "DENT MATERIALS", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Materials, Dental|T122|NON|EQV|NLM (1991)|900125|MATERIALS DENT|abcdefv", "MN": "J01.637.051.339", "FX": "Inlays", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "MS": "Materials used in the production of dental bases, restorations, impressions, prostheses, etc.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003764"}, {"RECTYPE": "D", "MH": "Models, Dental", "DE": "MODELS DENT", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Dental Models|T074|NON|EQV|NLM (1965)|990101|DENT MODELS|abcdefv", "ENTRY": "Model, Dental|T074|NON|EQV|NLM (1991)|900125|MODEL DENT|abcdefv", "MN": "L01.462.500.820.090.545.129.450", "MH_TH": "NLM (1991)", "ST": "T074", "MS": "Presentation devices used for patient education and technique training in dentistry.", "PM": "2022; see DENTAL MODELS 1965-2021", "HN": "2022 (1965)", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003765"}, {"RECTYPE": "D", "MH": "Dental Occlusion", "DE": "DENT OCCLUSION", "PRINT ENTRY": "Occlusal Plane|T042|NON|NRW|NLM (1998)|960716|abcdef", "ENTRY": "Planes, Occlusal", "MN": "G10.549.208", "FX": "Malocclusion", "MH_TH": "NLM (1965)", "ST": "T042", "AN": "MALOCCLUSION & its specifics are also available", "MS": "The relationship of all the components of the masticatory system in normal function. It has special reference to the position and contact of the maxillary and mandibular teeth for the highest efficiency during the excursive movements of the jaw that are essential for mastication. (From Jablonski, Dictionary of Dentistry, 1992, p556, p472)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003766"}, {"RECTYPE": "D", "MH": "Dental Occlusion, Balanced", "DE": "DENT OCCLUSION BALANCED", "AQ": "ST", "ENTRY": "Occlusions, Balanced Dental", "MN": "E06.276.293", "FX": "Occlusal Adjustment", "MH_TH": "NLM (1965)", "ST": "T033", "MS": "Dental occlusion in which the occlusal contact of the teeth on the working side of the jaw is accompanied by the harmonious contact of the teeth on the opposite (balancing) side. (From Jablonski, Dictionary of Dentistry, 1992, p556)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19960613", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003767"}, {"RECTYPE": "D", "MH": "Dental Occlusion, Centric", "DE": "DENT OCCLUSION CENTRIC", "AQ": "ST", "ENTRY": "Occlusion, Centric Dental|T201|NON|EQV|NLM (1991)|900126|OCCLUSION CENTRIC DENT|abcdefv", "MN": "E06.276.459", "MH_TH": "NLM (1965)", "ST": "T201", "MS": "Contact between opposing teeth during a person's habitual bite.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003768"}, {"RECTYPE": "D", "MH": "Dental Occlusion, Traumatic", "DE": "DENT OCCLUSION TRAUMATIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Traumatic Dental Occlusions", "MN": "C07.793.494.293", "MH_TH": "NLM (1965)", "ST": "T037", "MS": "An occlusion resulting in overstrain and injury to teeth, periodontal tissue, or other oral structures.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19900529", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003769"}, {"RECTYPE": "D", "MH": "Dental Offices", "DE": "DENT OFFICES", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Offices, Dental|T073|NON|EQV|NLM (1991)|900125|OFFICES DENT|abcdefv", "MN": "N02.278.192.377", "MH_TH": "NLM (1970)", "ST": "T073", "PI": "Health Facilities (1968-1969)", "MS": "The room or rooms in which the dentist and dental staff provide care. Offices include all rooms in the dentist's office suite.", "OL": "use DENTAL OFFICES to search DENTAL OFFICE 1970-71 (as Prov)", "PM": "72", "HN": "72; was DENTAL OFFICE 1970-71 (Prov)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003770"}, {"RECTYPE": "D", "MH": "Dental Papilla", "DE": "DENT PAPILLA", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Papillae, Dental|T023|NON|EQV|NLM (1991)|900208|PAPILLAE DENT|abcdefv", "MN": "A14.549.167.900.720.250", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "do not confuse with INTERDENTAL PAPILLA ", "MS": "Mesodermal tissue enclosed in the invaginated portion of the epithelial enamel organ and giving rise to the dentin and pulp.", "OL": "search TOOTH GERM 1966-74", "PM": "91; was see under TOOTH GERM 1975-90", "HN": "91(75); was see under TOOTH GERM 1975-90", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003771"}, {"RECTYPE": "D", "MH": "Dental Pins", "DE": "DENT PINS", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Dental Pegs|T074|NON|EQV|NLM (1998)|961108|DENT PEGS|abcdefv", "ENTRY": "Pins, Dental|T074|NON|EQV|NLM (1991)|900208|PINS DENT|abcdefv", "MN": "E06.292", "MH_TH": "NLM (1970)", "ST": "T074", "PI": "Inlays (1966-1969)", "MS": "Small cylindrical pieces of metal used to enhance retention.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D003772"}, {"RECTYPE": "D", "MH": "Dental Plaque", "DE": "DENT PLAQUE", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Plaque, Dental|T047|NON|EQV|NLM (1991)|900208|PLAQUE DENT|abcdefv", "MN": "C07.793.208.377", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "A film that attaches to teeth, often causing DENTAL CARIES and GINGIVITIS. It is composed of MUCINS, secreted from salivary glands, and microorganisms.", "PM": "65", "HN": "65(64); was in Cat C only 1964-74", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003773"}, {"RECTYPE": "D", "MH": "Dental Plaque Index", "DE": "DENT PLAQUE INDEX", "ENTRY": "Indices, Dental Plaque|T081|NON|EQV|NLM (1991)|900125|INDICES DENT PLAQUE|abcdefv", "MN": "N06.890.160.090", "MH_TH": "NLM (1983)", "ST": "T081", "PI": "Periodontal Index (1966-1982)", "MS": "An index which scores the degree of dental plaque accumulation.", "PM": "91; was see under DENTAL HEALTH SURVEYS 1983-90", "HN": "91(83); was see under DENTAL HEALTH SURVEYS 1983-90", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19820422", "DC": "1", "DX": "19910101", "UI": "D003774"}, {"RECTYPE": "D", "MH": "Dental Polishing", "DE": "DENT POLISHING", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Dental Finishing|T061|NON|BRD|UNK (19XX)|830421|DENT FINISHING|abcdefv", "ENTRY": "Polishing, Dental|T061|NON|EQV|NLM (1991)|900129|POLISHING DENT|abcdefv", "MN": "E06.298", "MH_TH": "NLM (1984)", "ST": "T061", "AN": "restrict to polishing of dentures, amalgams & resins; tooth polishing: index under DENTAL PROPHYLAXIS or DENTAL SCALING or TOOTHBRUSHING", "PI": "Surface Properties (1968-1983)", "MS": "Creation of a smooth and glossy surface finish on a denture or amalgam.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19830421", "DC": "1", "DX": "19840101", "UI": "D003775"}, {"RECTYPE": "D", "MH": "Dental Porcelain", "DE": "DENT PORCELAIN", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Porcelain|T122|T197|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Porcelains, Dental", "MN": "J01.637.153.377", "MH_TH": "NLM (1965)", "ST": "T197", "N1": "Dental materials and fillings, porcelain", "RN": "12001-21-7", "MS": "A type of porcelain used in dental restorations, either jacket crowns or inlays, artificial teeth, or metal-ceramic crowns. It is essentially a mixture of particles of feldspar and quartz, the feldspar melting first and providing a glass matrix for the quartz. Dental porcelain is produced by mixing ceramic powder (a mixture of quartz, kaolin, pigments, opacifiers, a suitable flux, and other substances) with distilled water. (From Jablonski's Dictionary of Dentistry, 1992)", "PM": "65", "HN": "65", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003776"}, {"RECTYPE": "D", "MH": "Dental Prophylaxis", "DE": "DENT PROPHYLAXIS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Prophylaxis, Dental|T061|NON|EQV|NLM (1991)|900129|PROPHYLAXIS DENT|abcdefv", "MN": "E06.761.227", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Treatment for the prevention of periodontal diseases or other dental diseases by the cleaning of the teeth in the dental office using the procedures of DENTAL SCALING and DENTAL POLISHING. The treatment may include plaque detection, removal of supra- and subgingival plaque and calculus, application of caries-preventing agents, checking of restorations and prostheses and correcting overhanging margins and proximal contours of restorations, and checking for signs of food impaction.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19920514", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003777"}, {"RECTYPE": "D", "MH": "Dentures", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Denture", "MN": "E07.695.190.200", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "An appliance used as an artificial or prosthetic replacement for missing teeth and adjacent tissues. It does not include CROWNS; DENTAL ABUTMENTS; nor TOOTH, ARTIFICIAL.", "PM": "91; was DENTAL PROSTHESIS 1963-90; DENTURES was see DENTAL PROSTHESIS 1984-90", "HN": "91; was DENTAL PROSTHESIS 1963-90; DENTURES was see DENTAL PROSTHESIS 1984-90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003778"}, {"RECTYPE": "D", "MH": "Denture Design", "AQ": "AE CL EC ES HI IS MT NU PX SN ST TD VE", "ENTRY": "Designs, Denture", "MN": "E06.912.250", "MH_TH": "NLM (1970)", "ST": "T058", "AN": "coord IM with specific denture (IM or NIM)", "PI": "Mandibular Prosthesis (1967-1969)", "MS": "The plan, delineation, and location of actual structural elements of dentures. The design can relate to retainers, stress-breakers, occlusal rests, flanges, framework, lingual or palatal bars, reciprocal arms, etc.", "PM": "91; was DENTAL PROSTHESIS DESIGN 1970-90", "HN": "91; was DENTAL PROSTHESIS DESIGN 1970-90", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D003779"}, {"RECTYPE": "D", "MH": "Denture Repair", "AQ": "AE CL EC ES HI IS MT NU PX SN ST TD VE", "ENTRY": "Repairs, Denture", "MN": "E06.912.285", "MH_TH": "NLM (1972)", "ST": "T058", "AN": "coord IM with specific denture (IM or NIM)", "PI": "Dental Prosthesis (1966-1971)", "MS": "The process of reuniting or replacing broken or worn parts of a denture.", "PM": "91; was DENTAL PROSTHESIS REPAIR 1974-90", "HN": "91; was DENTAL PROSTHESIS REPAIR 1972-90 (Prov 1972-73)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003780"}, {"RECTYPE": "D", "MH": "Denture Retention", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Denture Stability|T080|NON|NRW|UNK (19XX)|770325|abcdef", "ENTRY": "Stability, Denture", "MN": "E06.780.346.760.550", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "coord IM with specific denture (IM or NIM); for denture fixative & adhesives, coord IM with ADHESIVES (IM)", "MS": "The retention of a denture in place by design, device, or adhesion.", "OL": "use DENTURE RETENTION to search DENTURE STABILITY 1966-77", "PM": "91; was DENTAL PROSTHESIS RETENTION 1985-90, was DENTURE RETENTION 1965-84; DENTURE RETENTION was see DENTAL PROSTHESIS RETENTION 1985-90; DENTURE STABILITY was heading 1965-77", "HN": "91; was DENTAL PROSTHESIS RETENTION 1985-90, was DENTURE RETENTION 1965-84; DENTURE RETENTION was see DENTAL PROSTHESIS RETENTION 1985-90; DENTURE STABILITY was heading 1965-77", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003781"}, {"RECTYPE": "D", "MH": "Dental Pulp", "DE": "DENT PULP", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE TR UL VI", "ENTRY": "Pulps, Dental|T023|NON|EQV|NLM (1991)|900125|PULPS DENT|abcdefv", "MN": "A14.549.167.900.260", "FX": "Pulpotomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A richly vascularized and innervated connective tissue of mesodermal origin, contained in the central cavity of a tooth and delimited by the dentin, and having formative, nutritive, sensory, and protective functions. (Jablonski, Dictionary of Dentistry, 1992)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003782"}, {"RECTYPE": "D", "MH": "Dental Pulp Calcification", "DE": "DENT PULP CALCIFICATION", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Denticle|T031|NON|REL|UNK (19XX)|740329|abcdef", "ENTRY": "Stones, Pulp", "MN": "C07.793.237.252", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "CALCINOSIS of the DENTAL PULP or ROOT CANAL.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003784"}, {"RECTYPE": "D", "MH": "Dental Pulp Capping", "DE": "DENT PULP CAPPING", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Pulp Capping|T061|NON|EQV|UNK (19XX)|760422|abcdef", "ENTRY": "Pulp Cappings, Dental", "MN": "E06.397.370", "FX": "Calcium Hydroxide", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Application of a protective agent to an exposed pulp (direct capping) or the remaining thin layer of dentin over a nearly exposed pulp (indirect capping) in order to allow the pulp to recover and maintain its normal vitality and function.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003785"}, {"RECTYPE": "D", "MH": "Dental Pulp Cavity", "DE": "DENT PULP CAVITY", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Root Canal|T030|NON|NRW|UNK (19XX)|771011|abcdef", "ENTRY": "Root Canals", "MN": "A14.549.167.900.265", "MH_TH": "NLM (1965)", "ST": "T030", "MS": "The space in a tooth bounded by the dentin and containing the dental pulp. The portion of the cavity within the crown of the tooth is the pulp chamber; the portion within the root is the pulp canal or root canal.", "PM": "65", "HN": "65", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003786"}, {"RECTYPE": "D", "MH": "Dental Pulp Devitalization", "DE": "DENT PULP DEVITALIZATION", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Pulp Devitalization, Dental|T061|NON|EQV|NLM (1991)|900126|PULP DEVITALIZATION DENT|abcdefv", "MN": "E06.397.778.377", "MH_TH": "NLM (1970)", "ST": "T061", "AN": "a root canal proced: do not confuse with TOOTH, DEVITALIZED see TOOTH, NONVITAL", "PI": "Dental Pulp (1966-1969)", "MS": "The destruction of the vitality of the pulp of the tooth. (From Jablonski, Dictionary of Dentistry, 1992, p243)", "OL": "search DENTAL PULP MUMMIFICATION under DENTAL PULP 1966-69", "PM": "70; DENTAL PULP MUMMIFICATION was heading 1965-69", "HN": "70; DENTAL PULP MUMMIFICATION was heading 1965-69", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D003787"}, {"RECTYPE": "D", "MH": "Dental Pulp Diseases", "DE": "DENT PULP DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pulp Diseases, Dental|T047|NON|EQV|NLM (1991)|900126|abcdef", "MN": "C07.793.237", "FX": "Periapical Diseases", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Endodontic diseases of the DENTAL PULP inside the tooth, which is distinguished from PERIAPICAL DISEASES of the tissue surrounding the root.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003788"}, {"RECTYPE": "D", "MH": "Dental Pulp Exposure", "DE": "DENT PULP EXPOSURE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pulp Exposure, Dental|T047|NON|EQV|NLM (1991)|900126|PULP EXPOSURE DENT|abcdefv", "MN": "C07.793.237.283", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "The result of pathological changes in the hard tissue of a tooth caused by carious lesions, mechanical factors, or trauma, which render the pulp susceptible to bacterial invasion from the external environment.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19930527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003789"}, {"RECTYPE": "D", "MH": "Dental Pulp Necrosis", "DE": "DENT PULP NECROSIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulp Necrosis|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Pulp Necroses, Dental", "MN": "C23.550.717.182", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Death of pulp tissue with or without bacterial invasion. When the necrosis is due to ischemia with superimposed bacterial infection, it is referred to as pulp gangrene. When the necrosis is non-bacterial in origin, it is called pulp mummification.", "PM": "97; was DENTAL PULP GANGRENE 1965-96; DENTAL PULP AUTOLYSIS was heading 1965-96", "HN": "97; was DENTAL PULP GANGRENE 1965-96; DENTAL PULP AUTOLYSIS was heading 1965-96", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003790"}, {"RECTYPE": "D", "MH": "Dental Pulp Test", "DE": "DENT PULP TEST", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Thermal Pulp Test|T060|NON|NRW|NLM (2023)|220520|abcdef", "ENTRY": "Thermal Pulp Tests", "MN": "E06.342.377", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "A diagnostic aid used in evaluating the physical health of teeth. It involves using a tool that transmits hot or cold temperatures, or electric currents to a tooth's surface. The sensitivity to hot or cold or to the currents on a tooth can determine if there are problems with that tooth.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003791"}, {"RECTYPE": "D", "MH": "Dental Records", "DE": "DENT RECORDS", "AQ": "CL EC LJ SN ST", "ENTRY": "Records, Dental|T073|T170|NON|EQV|NLM (1991)|900126|RECORDS DENT|abbcdefv", "MN": "N06.850.520.308.940.375", "MH_TH": "NLM (1967)", "ST": "T170", "PI": "Medical Records (1966)", "MS": "Data collected during dental examination for the purpose of study, diagnosis, or treatment planning.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D003792"}, {"RECTYPE": "D", "MH": "Dental Restoration, Permanent", "DE": "DENT RESTORATION PERMANENT", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Dental Fillings, Permanent|T122|NON|NRW|UNK (19XX)|780921|DENT FILLINGS PERMANENT|abcdefv", "ENTRY": "Restorations, Permanent Dental|T122|NON|EQV|NLM (1991)|900130|RESTORATIONS PERMANENT DENT|abcdefv", "MN": "E07.695.190.190", "FX": "Dental Materials", "MH_TH": "NLM (1965)", "ST": "T122", "AN": "dental restoration unspecified probably goes here", "MS": "A restoration designed to remain in service for not less than 20 to 30 years, usually made of gold casting, cohesive gold, or amalgam. (Jablonski, Dictionary of Dentistry, 1992)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20230705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003793"}, {"RECTYPE": "D", "MH": "Dental Restoration, Temporary", "DE": "DENT RESTORATION TEMPORARY", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Dental Prosthesis, Temporary|T122|NON|REL|NLM (2000)|991104|abcdef", "ENTRY": "Temporary Dental Prosthesis", "MN": "E07.695.190.192", "FX": "Dental Materials", "MH_TH": "NLM (1965)", "ST": "T122", "AN": "dent restoration unspecified probably goes under DENTAL RESTORATION, PERMANENT", "MS": "A prosthesis or restoration placed for a limited period, from several days to several months, which is designed to seal the tooth and maintain its position until a permanent restoration (DENTAL RESTORATION, PERMANENT) will replace it. (From Jablonski, Dictionary of Dentistry, 1992)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20230705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003794"}, {"RECTYPE": "D", "MH": "Dental Sac", "DE": "DENT SAC", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Dental Follicle|T023|NON|EQV|UNK (19XX)|780119|DENT FOLLICLE|abcdefv", "ENTRY": "Sacs, Dental|T023|NON|EQV|NLM (1991)|900129|SACS DENT|abcdefv", "MN": "A14.549.167.900.720.255", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "Dense fibrous layer formed from mesodermal tissue that surrounds the epithelial enamel organ. The cells eventually migrate to the external surface of the newly formed root dentin and give rise to the cementoblasts that deposit cementum on the developing root, fibroblasts of the developing periodontal ligament, and osteoblasts of the developing alveolar bone.", "OL": "search TOOTH GERM 1966-74", "PM": "91; was see under TOOTH GERM 1975-90", "HN": "91(75); was see under TOOTH GERM 1975-90", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003795"}, {"RECTYPE": "D", "MH": "Dental Service, Hospital", "DE": "DENT SERV HOSP", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Hospital Dental Service|T093|NON|EQV|UNK (19XX)|770519|HOSP DENT SERV|abcdefv", "ENTRY": "Services, Hospital Dental", "MN": "N04.452.442.452.422.298", "MH_TH": "NLM (1966)", "ST": "T093", "MS": "Hospital department providing dental care.", "OL": "use DENTAL SERVICE, HOSPITAL to search HOSPITAL DENTAL SERVICE 1966-77", "PM": "78; was HOSPITAL DENTAL SERVICE 1963-77", "HN": "78; was HOSPITAL DENTAL SERVICE 1963-77", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D003796"}, {"RECTYPE": "D", "MH": "Dental Staff", "DE": "DENT STAFF", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Dental Receptionists|T097|NON|NRW|UNK (19XX)|771011|DENT RECEPTIONISTS|abcdefv", "ENTRY": "Staffs, Dental|T097|NON|EQV|NLM (1991)|900126|STAFFS DENT|abcdefv", "MN": "N02.360.330", "MH_TH": "NLM (1973)", "ST": "T097", "MS": "Personnel who provide dental service to patients in an organized facility, institution or agency. This includes those who work in DENTAL FACILITIES but do not provide direct dental care.", "PM": "73", "HN": "73", "MR": "20230620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003797"}, {"RECTYPE": "D", "MH": "Dental Staff, Hospital", "DE": "DENT STAFF HOSP", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Hospital Dental Staff|T097|NON|EQV|UNK (19XX)|770519|HOSP DENT STAFF|abcdefv", "ENTRY": "Staffs, Hospital Dental|T097|NON|EQV|NLM (1991)|900126|STAFFS HOSP DENT|abcdefv", "MN": "N02.360.740.322", "MH_TH": "NLM (1971)", "ST": "T097", "MS": "Dental personnel practicing in hospitals.", "OL": "use DENTAL STAFF, HOSPITAL to search HOSPITAL DENTAL STAFF 1971-77", "PM": "78; was HOSPITAL DENTAL STAFF 1971-77", "HN": "78; was HOSPITAL DENTAL STAFF 1971-77", "MR": "20230620", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003798"}, {"RECTYPE": "D", "MH": "Dental Stress Analysis", "DE": "DENT STRESS ANAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Dental Stress Analyses", "MN": "E06.308", "MH_TH": "NLM (1968)", "ST": "T060", "AN": "coordinate with specific dental feature; COMPRESSIVE STRENGTH & TENSILE STRENGTH are available for these aspects of characterization", "PI": "Dental Occlusion (1966-1969)", "MS": "The description and measurement of the various factors that produce physical stress upon dental restorations, prostheses, or appliances, materials associated with them, or the natural oral structures.", "PM": "72", "HN": "72(68)", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003799"}, {"RECTYPE": "D", "MH": "Dental Technicians", "DE": "DENT TECHNICIANS", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Technicians, Dental|T097|NON|EQV|NLM (1991)|900126|TECHNICIANS DENT|abcdefv", "MN": "N02.360.330.245.503", "MH_TH": "NLM (1965)", "ST": "T097", "MS": "Individuals responsible for fabrication of dental appliances.", "PM": "65", "HN": "65", "MR": "20230620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003800"}, {"RECTYPE": "D", "MH": "Dental Veneers", "DE": "DENT VENEERS", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Dental Laminates|T061|NON|EQV|NLM (1997)|960423|DENT LAMINATES|abcdefv", "ENTRY": "Veneers, Dental|T061|NON|EQV|NLM (1991)|900126|VENEERS DENT|abcdefv", "MN": "E07.695.190.196", "MH_TH": "NLM (1984)", "ST": "T061", "AN": "coordinate IM with specific material (IM) if pertinent", "PI": "Dental Prosthesis Design (1970-1983)", "MS": "The use of a layer of tooth-colored material, usually porcelain or acrylic resin, applied to the surface of natural teeth, crowns, or pontics by fusion, cementation, or mechanical retention.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19830209", "DC": "1", "DX": "19840101", "UI": "D003801"}, {"RECTYPE": "D", "MH": "Dentifrices", "AQ": "AD AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polishes, Dental|T122|NON|NRW|UNK (19XX)|770429|POLISHES DENT|abcdefv", "ENTRY": "Dentifrice", "MN": "J01.637.051.376", "FX": "Mouthwashes", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "MS": "Any preparations used for cleansing teeth; they usually contain an abrasive, detergent, binder and flavoring agent and may exist in the form of liquid, paste or powder; may also contain medicaments and caries preventives.", "MR": "20190501", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003802"}, {"RECTYPE": "D", "MH": "Dentigerous Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Dentigerous Cysts", "MN": "C07.320.450.670.275", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "non-neoplastic; coordinate with precoordinated organ/disease term ", "MS": "Most common follicular odontogenic cyst. Occurs in relation to a partially erupted or unerupted tooth with at least the crown of the tooth to which the cyst is attached protruding into the cystic cavity. May give rise to an ameloblastoma and, in rare instances, undergo malignant transformation.", "CATSH": "CAT LIST", "MR": "19900605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003803"}, {"RECTYPE": "D", "MH": "Dentin", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Dentine|T023|NON|EQV|NLM (1997)|950906|abcdef", "ENTRY": "Dentins", "MN": "A14.549.167.900.280", "FX": "Odontoblasts", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The hard portion of the tooth surrounding the pulp, covered by enamel on the crown and cementum on the root, which is harder and denser than bone but softer than enamel, and is thus readily abraded when left unprotected. (From Jablonski, Dictionary of Dentistry, 1992)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003804"}, {"RECTYPE": "D", "MH": "Dentin Dysplasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dysplasias, Dentin", "MN": "C16.131.850.800.260", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "a tooth abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "An apparently hereditary disorder of dentin formation, marked by a normal appearance of coronal dentin associated with pulpal obliteration, faulty root formation, and a tendency for peripheral lesions without obvious cause. (From Dorland, 27th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003805"}, {"RECTYPE": "D", "MH": "Dentin Permeability", "AQ": "DE ES GE IM PH RE", "ENTRY": "Permeability, Dentin", "MN": "G10.549.845.461", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "IM; coord with permeating substance (IM) if relevant", "MS": "The property of dentin that permits passage of light, heat, cold, and chemical substances. It does not include penetration by microorganisms.", "OL": "search TOOTH PERMEABILITY 1966-74", "PM": "91; was see under TOOTH PERMEABILITY 1975-90", "HN": "91(75); was see under TOOTH PERMEABILITY 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003806"}, {"RECTYPE": "D", "MH": "Dentin Sensitivity", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dentin Hypersensitivity|T047|NON|EQV|NLM (1998)|960730|abcdef", "ENTRY": "Tooth Sensitivities", "MN": "C07.793.266", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Pain associated with exposed DENTIN surfaces of the teeth.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003807"}, {"RECTYPE": "D", "MH": "Dentin Solubility", "AQ": "DE GE IM PH RE", "ENTRY": "Solubility, Dentin", "MN": "G10.549.245", "MH_TH": "NLM (1965)", "ST": "T081", "MS": "The susceptibility of the DENTIN to dissolution.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003808"}, {"RECTYPE": "D", "MH": "Dentin, Secondary", "DE": "DENTIN SECOND", "AQ": "AB AH BS CH CI CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Secondary Dentins", "MN": "C07.793.237.378", "MH_TH": "NLM (1965)", "ST": "T023", "MS": "Dentin formed by normal pulp after completion of root end formation.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003809"}, {"RECTYPE": "D", "MH": "Dentinogenesis", "AQ": "DE GE IM PH RE", "ENTRY": "Dentinogeneses", "MN": "G07.345.500.325.377.186", "MH_TH": "NLM (1965)", "ST": "T042", "MS": "The formation of dentin. Dentin first appears in the layer between the ameloblasts and odontoblasts and becomes calcified immediately. Formation progresses from the tip of the papilla over its slope to form a calcified cap becoming thicker by the apposition of new layers pulpward. A layer of uncalcified dentin intervenes between the calcified tissue and the odontoblast and its processes. (From Jablonski, Dictionary of Dentistry, 1992)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003810"}, {"RECTYPE": "D", "MH": "Dentinogenesis Imperfecta", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hereditary Opalescent Dentin|T019|T047|NON|NRW|GHR (2014)|UNK (19XX)|740329|abbcdeef", "ENTRY": "Teeth, Capdepont", "MN": "C16.131.850.800.270", "FX": "Osteogenesis Imperfecta", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An autosomal dominant disorder of tooth development characterized by opalescent dentin resulting in discoloration of the teeth. The dentin develops poorly with low mineral content while the pulp canal is obliterated.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003811"}, {"RECTYPE": "D", "MH": "Dentist-Patient Relations", "DE": "DENTIST PATIENT RELAT", "AQ": "ES", "ENTRY": "Relationships, Dentist-Patient", "MN": "N05.300.660.325", "MH_TH": "NLM (1965)", "ST": "T054", "MS": "The psychological relations between the dentist and patient.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003812"}, {"RECTYPE": "D", "MH": "Dentistry", "AQ": "CL MT OG SN ST TD VE", "MN": "H02.163", "RH": "E6 - PROCEDURES AND TECHNIQUES-DENTAL", "FX": "Oral Medicine", "EC": "legislation & jurisprudence:Legislation, Dental", "MH_TH": "BIOETHICS (1989)", "ST": "T091", "MS": "The profession concerned with the teeth, oral cavity, and associated structures, and the diagnosis and treatment of their diseases including prevention and the restoration of defective and missing tissue.", "PM": "AVIATION DENTISTRY was heading 1965-79", "HN": "AVIATION DENTISTRY was heading 1965-79", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D003813"}, {"RECTYPE": "D", "MH": "Dentistry, Operative", "DE": "DENT OPERATIVE", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Operative Dentistry|T091|NON|EQV|NLM (1991)|900208|OPERATIVE DENT|abcdefv", "MN": "H02.163.180", "MH_TH": "NLM (1965)", "ST": "T091", "AN": "clinical dentistry concerned with restoration of tooth function (filling, inlay, etc.); do not confuse with SURGERY, ORAL the dental specialty concerned with  diagnosis and surgical therapy of diseases, injuries or defects of soft tissues of mouth or jaws", "MS": "That phase of clinical dentistry concerned with the restoration of parts of existing teeth that are defective through disease, trauma, or abnormal development, to the state of normal function, health, and esthetics, including preventive, diagnostic, biological, mechanical, and therapeutic techniques, as well as material and instrument science and application. (Jablonski's Dictionary of Dentistry, 2d ed, p237)", "PM": "65", "HN": "65; was in Cat E only 1972-79", "CATSH": "CAT LIST", "MR": "20230705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003814"}, {"RECTYPE": "D", "MH": "Dentists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Restorative Dentists", "MN": "N02.360.330.330", "MH_TH": "NLM (1965)", "ST": "T097", "MS": "Individuals licensed to practice DENTISTRY.", "PM": "65", "HN": "65", "MR": "20230620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003815"}, {"RECTYPE": "D", "MH": "Dentists, Women", "AQ": "CL EC ES HI LJ OG PX SD SN ST TD", "ENTRY": "Women Dentists", "MN": "N02.360.330.330.310", "EC": "education:Education, Dental", "MH_TH": "NLM (1965)", "ST": "T097", "MS": "Female dentists.", "PM": "65", "HN": "65", "MR": "20230620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003816"}, {"RECTYPE": "D", "MH": "Dentition", "ENTRY": "Dentitions", "MN": "A14.549.167", "FX": "Tooth", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "general or unspecified; prefer DENTITION, PRIMARY; DENTITION, PERMANENT; or DENTITION, MIXED; differentiate from TOOTH", "MS": "The teeth collectively in the dental arch. Dentition ordinarily refers to the natural teeth in position in their alveoli. Dentition referring to the deciduous teeth is DENTITION, PRIMARY; to the permanent teeth, DENTITION, PERMANENT. (From Jablonski, Dictionary of Dentistry, 1992)", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003817"}, {"RECTYPE": "D", "MH": "Dentition, Mixed", "PRINT ENTRY": "Dentition, Transitional|T023|NON|EQV|NLM (1997)|951006|abcdef", "ENTRY": "Transitional Dentitions", "MN": "A14.549.167.229", "FX": "Serial Extraction", "MH_TH": "NLM (1971)", "ST": "T023", "PI": "Dentition (1966-1970)", "MS": "The complement of teeth in the jaws after the eruption of some of the permanent teeth but before all the deciduous teeth are absent. (Boucher's Clinical Dental Terminology, 4th ed)", "PM": "73", "HN": "73(71)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003818"}, {"RECTYPE": "D", "MH": "Denture Bases", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Denture Base", "MN": "E07.695.190.200.200", "MH_TH": "NLM (1965)", "ST": "T074", "AN": "coordinate IM with specific denture term (IM or NIM)", "MS": "The part of a denture that overlies the soft tissue and supports the supplied teeth and is supported in turn by abutment teeth or the residual alveolar ridge. It is usually made of resins or metal or their combination.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003819"}, {"RECTYPE": "D", "MH": "Denture Cleansers", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Cleansers, Denture|T122|NON|EQV|UNK (19XX)|771208|abcdef", "ENTRY": "Denture Cleanser", "MN": "J01.637.051.376.262", "MH_TH": "NLM (1979)", "ST": "T122", "RN": "0", "PI": "Oral Hygiene (1973-1978)", "MS": "Substances used to clean dentures; they are usually alkaline peroxides or hypochlorites, may contain enzymes and release oxygen. Use also for sonic action cleaners.", "PM": "91; was see under DENTIFRICES 1979-90", "HN": "91(79); was see under DENTIFRICES 1979-90", "MR": "20060705", "DA": "19771208", "DC": "1", "DX": "19910101", "UI": "D003820"}, {"RECTYPE": "D", "MH": "Denture Identification Marking", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Markings, Denture Identification", "MN": "E06.912.275", "MH_TH": "NLM (1984)", "ST": "T170", "AN": "marking of dentures or dent prostheses", "PI": "Forensic Dentistry (1966-1983)", "MS": "Any system of defining ownership of dentures or dental prostheses.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19830421", "DC": "1", "DX": "19840101", "UI": "D003821"}, {"RECTYPE": "D", "MH": "Denture Liners", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Cushion Liners|T074|NON|EQV|NLM (1991)|900510|abcdef", "ENTRY": "Liners, Denture", "MN": "E07.695.190.200.210", "FX": "Silicone Elastomers", "MH_TH": "NLM (1965)", "ST": "T074", "AN": "coordinate IM with specific denture term (IM or NIM)", "MS": "Material applied to the tissue side of a denture to provide a soft lining to the parts of a denture coming in contact with soft tissue. It cushions contact of the denture with the tissues.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003822"}, {"RECTYPE": "D", "MH": "Denture Rebasing", "AQ": "AE CL EC ES HI IS MT NU PX SN ST TD VE", "PRINT ENTRY": "Denture Relining|T061|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Relinings, Denture", "MN": "E06.912.280", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "coord IM with specific denture term (IM or NIM)", "MS": "The process of refitting a denture by replacing the denture base material without changing the occlusal relations of the teeth. Rebasing may include adding to the denture base to compensate for resorptive changes to subjacent structures.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003823"}, {"RECTYPE": "D", "MH": "Denture, Complete", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Dentures, Complete", "MN": "E07.695.190.200.205", "MH_TH": "NLM (1965)", "ST": "T074", "MS": "A denture replacing all natural teeth and associated structures in both the maxilla and mandible.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003824"}, {"RECTYPE": "D", "MH": "Denture, Complete, Immediate", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "MN": "E07.695.190.200.205.205", "MH_TH": "NLM (1965)", "ST": "T074", "MS": "A complete denture constructed for replacement of natural teeth immediately after their removal. It does not fit the mouth perfectly and is intended only for functional and cosmetic purposes during the healing process after total extraction. It is to be replaced by the fitted permanent denture.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003825"}, {"RECTYPE": "D", "MH": "Denture, Complete, Lower", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "MN": "E07.695.190.200.205.210", "MH_TH": "NLM (1965)", "ST": "T074", "MS": "A complete denture replacing all the natural mandibular teeth and associated structures. It is completely supported by the oral tissue and underlying mandibular bone.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003826"}, {"RECTYPE": "D", "MH": "Denture, Complete, Upper", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "MN": "E07.695.190.200.205.215", "MH_TH": "NLM (1965)", "ST": "T074", "MS": "A complete denture replacing all the natural maxillary teeth and associated maxillary structures. It is completely supported by the oral tissue and underlying maxillary bone.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003827"}, {"RECTYPE": "D", "MH": "Denture, Overlay", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Overdenture|T074|NON|EQV|NLM (1993)|920502|abcdef", "ENTRY": "Overlay Dentures", "MN": "E07.695.190.200.215", "MH_TH": "NLM (1974)", "ST": "T074", "AN": "coordinate IM with specific denture term (IM or NIM)", "MS": "Removable prosthesis constructed over natural teeth or implanted studs.", "OL": "use DENTURE, OVERLAY to search TELESCOPIC PROSTHESIS 1974-92", "PM": "74; TELESCOPIC PROSTHESIS was see DENTURE, OVERLAY 1974-92", "HN": "74; TELESCOPIC PROSTHESIS was see DENTURE, OVERLAY 1974-92", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003828"}, {"RECTYPE": "D", "MH": "Denture, Partial", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Dental Bridgework|T074|NON|EQV|UNK (19XX)|780921|DENT BRIDGEWORK|abcdefv", "ENTRY": "Partial Dentures", "MN": "E07.695.190.200.220", "MH_TH": "NLM (1965)", "ST": "T074", "MS": "A denture replacing one or more (but not all) natural teeth. It is supported and retained by underlying tissue and some or all of the remaining teeth.", "PM": "65; CROWN AND BRIDGEWORK was heading 1963-64", "HN": "65; CROWN AND BRIDGEWORK was heading 1963-64", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003829"}, {"RECTYPE": "D", "MH": "Denture, Partial, Fixed", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Pontic|T074|NON|NRW|NLM (1998)|960715|abcdef", "ENTRY": "Pontics", "MN": "E07.695.190.200.220.220", "MH_TH": "NLM (1965)", "ST": "T074", "MS": "A partial denture attached to prepared natural teeth, roots, or implants by cementation.", "PM": "65; CROWN AND BRIDGEWORK was heading 1963-64", "HN": "65; CROWN AND BRIDGEWORK was heading 1963-64", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003830"}, {"RECTYPE": "D", "MH": "Denture, Partial, Immediate", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "MN": "E07.695.190.200.220.225", "MH_TH": "NLM (1965)", "ST": "T074", "MS": "A partial denture constructed before the teeth it replaces are removed. It is then inserted immediately after the removal of the natural teeth for functional and cosmetic reasons during the healing process. It is to be replaced later by the fitted partial denture.", "PM": "65; CROWN AND BRIDGEWORK was heading 1963-64", "HN": "65; CROWN AND BRIDGEWORK was heading 1963-64", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003831"}, {"RECTYPE": "D", "MH": "Denture, Partial, Removable", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Removable Partial Dentures", "MN": "E07.695.190.200.220.230", "MH_TH": "NLM (1965)", "ST": "T074", "MS": "A partial denture designed and constructed to be removed readily from the mouth.", "PM": "65; CROWN AND BRIDGEWORK was heading 1963-64", "HN": "65; CROWN AND BRIDGEWORK was heading 1963-64", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003832"}, {"RECTYPE": "D", "MH": "Denture, Partial, Temporary", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Dental Prosthesis, Interim|T074|NON|REL|NLM (1997)|960329|DENT PROSTHESIS INTERIM|abcdefv", "ENTRY": "Prosthesis, Interim Dental", "MN": "E07.695.190.200.220.235", "MH_TH": "NLM (1965)", "ST": "T074", "MS": "A partial denture intended for short-term use in a temporary or emergency situation.", "PM": "65; CROWN AND BRIDGEWORK was heading 1963-64", "HN": "65; CROWN AND BRIDGEWORK was heading 1963-64", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003833"}, {"RECTYPE": "D", "MH": "Denture Precision Attachment", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Slotted Attachment, Dental|T074|NON|EQV|NLM (1991)|900510|SLOTTED ATTACHMENT DENT|abcdefv", "ENTRY": "Precision Attachments, Denture", "MN": "E07.695.190.200.220.245", "MH_TH": "NLM (1970)", "ST": "T074", "AN": "restrict to partial dentures", "PI": "Denture, Partial, Removable (1966-1969)", "MS": "A precision device used for attaching a fixed or removable partial denture to the crown of an abutment tooth or a restoration. One type is the intracoronal attachment and the other type is the extracoronal attachment. It consists of a female portion within the coronal portion of the crown of an abutment and a fitted male portion attached to the denture proper. (Jablonski, Dictionary of Dentistry, 1992, p85; from Boucher's Clinical Dental Terminology, 4th ed, p264)", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D003834"}, {"RECTYPE": "D", "MH": "Denturists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Denturism|T090|NON|REL|NLM (2009)|070927|abcdef", "ENTRY": "Denturist", "MN": "N02.360.330.245.751", "MH_TH": "NLM (1980)", "ST": "T097", "PI": "Dental Technicians (1966-1978)", "MS": "Individuals who fabricate and fit DENTURES without the supervision of DENTISTS. (from Stedman's Medical Dictionary, 27th ed) They may or may not have formal education in health sciences, but are well versed in the art of constructing dentures.", "OL": "search DENTAL AUXILIARIES 1979", "PM": "91; was see under DENTAL AUXILIARIES 1980-90; was see DENTAL AUXILIARIES 1979", "HN": "91(80); was see under DENTAL AUXILIARIES 1980-90; was see DENTAL AUXILIARIES 1979", "MR": "20230620", "DA": "19790309", "DC": "1", "DX": "19910101", "UI": "D003835"}, {"RECTYPE": "D", "MH": "Deodorants", "AQ": "AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO TU", "ENTRY": "Deodorant", "MN": "D27.720.269.385", "MH_TH": "NLM (1966)", "ST": "T120", "RN": "0", "MS": "Agents that remove, correct, repress, or mask undesirable ODORANTS. In personal hygiene, deodorants often contain astringent preparations that reduce SWEATING, referred to as ANTIPERSPIRANTS. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20190501", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003836"}, {"RECTYPE": "D", "MH": "Deoxy Sugars", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Deoxy Sugar|T109|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Sugars, Deoxy", "MN": "D09.254", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Sugars that in which one or more hydroxyl groups of the pyranose or furanose ring is substituted by hydrogen.", "PM": "74; DEOXYGLUCOSE was see under GLUCOSE 1973-74, was see under HEXOSES 1967-72", "HN": "74", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003837"}, {"RECTYPE": "D", "MH": "Deoxyadenine Nucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Deoxyadenosine Phosphates|T114|NON|EQV|UNK (19XX)|770422|abcdef", "ENTRY": "Phosphates, Deoxyadenosine", "MN": "D13.695.667.138.410", "MH_TH": "NLM (1978)", "ST": "T114", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Deoxyribonucleotides (1973-1977)", "MS": "Adenine nucleotides which contain deoxyribose as the sugar moiety.", "PM": "78", "HN": "78", "MR": "20160528", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D003838"}, {"RECTYPE": "D", "MH": "Deoxyadenosines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adenine Deoxyribonucleosides|T114|NON|EQV|NLM (1990)|890119|abcdef", "ENTRY": "Derivatives, Deoxyadenosine", "MN": "D13.570.583.138.325", "MH_TH": "NLM (1971)", "ST": "T114", "RN": "0", "PI": "Adenosine (1966-1970)", "MS": "Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule.", "OL": "use DEOXYADENOSINES to search DEOXYADENOSINE 1971-89(Prov 1971-72)", "PM": "90; was DEOXYADENOSINE 1973-89", "HN": "90; was DEOXYADENOSINE 1971-89 (Prov 1971-72)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003839"}, {"RECTYPE": "D", "MH": "Deoxycholic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Kybella|T109|T121|TRD|REL|NLM (2021)|191004|abbcdef", "ENTRY": "Deoxycholic Acid, 5alpha Isomer", "MN": "D04.210.500.221.430.342", "PA": "Cholagogues and Choleretics", "MH_TH": "NLM (1973)", "ST": "T123", "N1": "Cholan-24-oic acid, 3,12-dihydroxy-, (3alpha,5beta,12alpha)-", "RN": "005990WHZZ", "RR": "83-44-3 (Deoxycholic Acid)", "PI": "Bile Acids and Salts (1966-1972)", "MS": "A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent.", "PM": "74", "HN": "74(73)", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003840"}, {"RECTYPE": "D", "MH": "Deoxycytidine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Deoxyriboside, Cytosine", "MN": "D13.570.685.245.500", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Cytidine, 2'-deoxy-", "RN": "0W860991D6", "RR": "951-77-9 (Deoxycytidine)", "PI": "Nucleosides (1966-1972)", "MS": "A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE.", "PM": "75", "HN": "75(73)", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D003841"}, {"RECTYPE": "D", "MH": "Deoxycytidine Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kinase, Deoxycytidine", "MN": "D08.811.913.696.620.175", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "NTP:deoxycytidine 5'-phosphotransferase", "RN": "EC 2.7.1.74", "RR": "9039-45-6 (CAS RN)", "PI": "Phosphotransferases (1966-1978)", "MS": "An enzyme that catalyzes reversibly the phosphorylation of deoxycytidine with the formation of a nucleoside diphosphate and deoxycytidine monophosphate. Cytosine arabinoside can also act as an acceptor. All natural nucleoside triphosphates, except deoxycytidine triphosphate, can act as donors. The enzyme is induced by some viruses, particularly the herpes simplex virus (HERPESVIRUS HOMINIS). EC 2.7.1.74.", "PM": "91; was see under PHOSPHOTRANSFERASES, ATP 1979-90", "HN": "91(79); was see under PHOSPHOTRANSFERASES, ATP 1979-90", "MR": "20030709", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D003842"}, {"RECTYPE": "D", "MH": "Deoxycytidine Monophosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Deoxycytidylic Acid|T114|NON|EQV|UNK (19XX)|770426|abcdef", "ENTRY": "Monophosphate, Deoxycytidine", "MN": "D13.695.740.246.425.300", "MH_TH": "NLM (1975)", "ST": "T114", "N1": "5'-Cytidylic acid, 2'-deoxy-", "RN": "1032-65-1", "AN": "/biosyn /physiol permitted", "PI": "Cytosine Nucleotides (1966-1974)", "MS": "Deoxycytidine (dihydrogen phosphate). A deoxycytosine nucleotide containing one phosphate group esterified to the deoxyribose moiety in the 2'-,3'- or 5- positions.", "OL": "to search DEOXYCYTIDYLIC ACIDS use DEOXYCYTIDINE MONOPHOSPHATE 1975-77 & CYTOSINE NUCLEOTIDES 1966-74", "PM": "91; was see under DEOXYCYTOSINE NUCLEOTIDES 1978-90; was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77", "HN": "91(78); was see under DEOXYCYTOSINE NUCLEOTIDES 1978-90; was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003843"}, {"RECTYPE": "D", "MH": "DCMP Deaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Deoxycytidylate Deaminase|T116|T126|NON|EQV|NLM (1997)|951213|abbcdef", "ENTRY": "Monophosphate Deaminase, Deoxycytidine", "MN": "D08.811.277.151.653.200", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "dCMP aminohydrolase", "RN": "EC 3.5.4.12", "PI": "Nucleotide Deaminases (1975)", "MS": "An enzyme that catalyzes the hydrolytic deamination of deoxycytidylic acid to deoxyuridylic acid and ammonia. It plays an important role in the regulation of the pool of deoxynucleotides in higher organisms. The enzyme also acts on some 5-substituted deoxycytidylic acids. EC 3.5.4.12.", "PM": "97; was DEOXYCYTIDYLATE DEAMINASE 1976-96 (see under NUCLEOTIDE DEAMINASES 1976-90); DCMP DEAMINASE was see DEOXYCYTIDYLATE DEAMINASE 1976-96", "HN": "97; was DEOXYCYTIDYLATE DEAMINASE 1976-96 (see under NUCLEOTIDE DEAMINASES 1976-90); DCMP DEAMINASE was see DEOXYCYTIDYLATE DEAMINASE 1976-96", "MR": "20030709", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D003844"}, {"RECTYPE": "D", "MH": "Deoxycytosine Nucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Deoxycytidine Phosphates|T114|NON|EQV|UNK (19XX)|770422|abcdef", "ENTRY": "Phosphates, Deoxycytidine", "MN": "D13.695.740.246.425", "MH_TH": "NLM (1978)", "ST": "T114", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Deoxyribonucleotides (1973-1977)", "MS": "Cytosine nucleotides which contain deoxyribose as the sugar moiety.", "PM": "78; DEOXYCYTIDINE MONOPHOSPHATE was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77", "HN": "78", "MR": "20160528", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D003845"}, {"RECTYPE": "D", "MH": "Deoxyepinephrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methyldopamine|T109|T121|NON|EQV|UNK (19XX)|741127|abbcdef", "ENTRY": "Epinine|T109|T121|TRD|NRW|UNK (19XX)|801204|abbcdef", "MN": "D02.455.426.559.389.657.166.175.461.200", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "1,2-Benzenediol, 4-(2-(methylamino)ethyl)-", "RN": "R7339QLN1C", "RR": "501-15-5 (Deoxyepinephrine)", "PI": "Methane (1973-1974)", "MS": "Sympathomimetic, vasoconstrictor agent.", "PM": "91; was see under DOPAMINE 1975-90", "HN": "91(75); was see under DOPAMINE 1975-90", "MR": "20180630", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D003846"}, {"RECTYPE": "D", "MH": "Deoxyglucose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "2 Desoxy D glucose", "MN": "D09.254.229", "PA": "Antiviral Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "D-arabino-Hexose, 2-deoxy-", "RN": "9G2MP84A8W", "RR": "154-17-6 (Deoxyglucose)", "MS": "2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity.", "OL": "use GLUCOSE to search DEOXYGLUCOSE 1973-74 & use HEXOSES 1967-72", "PM": "91; was see under DEOXY SUGARS 1975-90; was see under GLUCOSE 1973-74; was see under HEXOSES 1967-72", "HN": "91(75); was see under DEOXY SUGARS 1975-90; was see under GLUCOSE 1973-74; was see under HEXOSES 1967-72", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003847"}, {"RECTYPE": "D", "MH": "Deoxyguanine Nucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Deoxyguanosine Phosphates|T114|NON|EQV|UNK (19XX)|770422|abcdef", "ENTRY": "Phosphates, Deoxyguanosine", "MN": "D13.695.667.454.200", "MH_TH": "NLM (1978)", "ST": "T114", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Guanine Nucleotides (1966-1977)", "MS": "Guanine nucleotides which contain deoxyribose as the sugar moiety.", "PM": "78", "HN": "78", "MR": "20160528", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D003848"}, {"RECTYPE": "D", "MH": "Deoxyguanosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D13.570.583.454.240", "MH_TH": "NLM (1978)", "ST": "T114", "N1": "Guanosine, 2'-deoxy-", "RN": "G9481N71RO", "RR": "961-07-9 (Deoxyguanosine)", "AN": "/biosyn /physiol permitted", "PI": "Guanosine (1972-1977)", "MS": "A nucleoside consisting of the base guanine and the sugar deoxyribose.", "PM": "78", "HN": "78", "MR": "20160528", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D003849"}, {"RECTYPE": "D", "MH": "Deoxyribonuclease I", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Streptodornase|T116|T126|NON|REL|NLM (1994)|921006|abbcdef", "ENTRY": "T7 Endonuclease I", "MN": "D08.811.277.352.335.350.250", "MH_TH": "NLM (1985)", "ST": "T126", "RN": "EC 3.1.21.1", "AN": "do not confuse entry term STREPTODORNASE with STREPTODORNASE AND STREPTOKINASE", "PI": "Endonucleases (1973-1982)", "MS": "An enzyme capable of hydrolyzing highly polymerized DNA by splitting phosphodiester linkages, preferentially adjacent to a pyrimidine nucleotide. This catalyzes endonucleolytic cleavage of DNA yielding 5'-phosphodi- and oligonucleotide end-products. The enzyme has a preference for double-stranded DNA.", "OL": "use DEOXYRIBONUCLEASES to search STREPTODORNASE 1966-93", "PM": "85; STREPTORDORNASE was see DEOXYRIBONUCLEASES 1966-93", "HN": "85; STREPTODORNASE was see DEOXYRIBONUCLEASES 1966-93", "MR": "20030709", "DA": "19840524", "DC": "1", "DX": "19850101", "UI": "D003850"}, {"RECTYPE": "D", "MH": "Deoxyribonucleases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleases, DNA|T116|T126|EQV|UNK (19XX)|820518|abbdef", "ENTRY": "DNase, Alkaline", "MN": "D08.811.277.352.335", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.1.-", "AN": "differentiate STREPTODORNASE referred to here and STREPTODORNASE AND STREPTOKINASE (see note there)", "MS": "Enzymes which catalyze the hydrolases of ester bonds within DNA. EC 3.1.-.", "OL": "use DEOXYRIBONUCLEASES to search DEOXYRIBONUCLEASE 1966-83", "PM": "83; was DEOXYRIBONUCLEASE 1966-82, was DESOXYRIBONUCLEASE 1963-65", "HN": "83; was DEOXYRIBONUCLEASE 1966-82, was DESOXYRIBONUCLEASE 1963-65", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003851"}, {"RECTYPE": "D", "MH": "Deoxyribonucleoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.664.275", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "0", "PI": "specific DNA (1966-1975)", "MS": "Proteins conjugated with deoxyribonucleic acids (DNA) or specific DNA.", "PM": "84; was see under NUCLEOPROTEINS 1976-83", "HN": "84(76); was see under NUCLEOPROTEINS 1976-83", "MR": "20050630", "DA": "19750725", "DC": "1", "DX": "19840101", "UI": "D003852"}, {"RECTYPE": "D", "MH": "Deoxyribonucleosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D13.570.230", "MH_TH": "NLM (1973)", "ST": "T114", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "specific nucleoside (1966-1972)", "MS": "A purine or pyrimidine base bonded to DEOXYRIBOSE.", "OL": "use DEOXYRIBONUCLEOSIDES to search RIBONUCLEOSIDES, DEOXY 1971-72 (as Prov)", "PM": "73", "HN": "73; was RIBONUCLEOSIDES, DEOXY 1971-72 (Prov)", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003853"}, {"RECTYPE": "D", "MH": "Deoxyribonucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Deoxyribonucleotide|T114|NON|EQV|NLM (2021)|200506|abcdef", "MN": "D13.695.201", "MH_TH": "NLM (1973)", "ST": "T114", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "specific nucleotide (1966-1972)", "MS": "A purine or pyrimidine base bonded to a DEOXYRIBOSE containing a bond to a phosphate group.", "OL": "use DEOXYRIBONUCLEOTIDES to search RIBONUCLEOTIDES, DEOXY 1971-72 (as Prov)", "PM": "73", "HN": "73; was RIBONUCLEOTIDES, DEOXY 1971-72 (Prov)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003854"}, {"RECTYPE": "D", "MH": "Deoxyribose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "2 Deoxyribose", "MN": "D09.254.330", "MH_TH": "NLM (1974)", "ST": "T123", "N1": "D-erythro-Pentose, 2-deoxy-", "RN": "533-67-5", "PM": "74", "HN": "74", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003855"}, {"RECTYPE": "D", "MH": "Deoxyuracil Nucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Deoxyuridine Phosphates|T114|NON|EQV|UNK (19XX)|770517|abcdef", "ENTRY": "Phosphates, Deoxyuridine", "MN": "D13.695.740.850.210", "MH_TH": "NLM (1978)", "ST": "T114", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Uracil Nucleotides (1966-1977)", "MS": "Uracil nucleotides which contain deoxyribose as the sugar moiety.", "PM": "78; FLUORODEOXYURIDYLATE was see under URACIL NUCLEOTIDES 1975-77", "HN": "78", "MR": "20160528", "DA": "19770517", "DC": "1", "DX": "19780101", "UI": "D003856"}, {"RECTYPE": "D", "MH": "Deoxyuridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "(beta 1-(2-Deoxyribopyranosyl))thymidine|T114|T123|NON|EQV|UNK (19XX)|840920|abbcdef", "MN": "D13.570.685.852.300", "PA": "Antimetabolites", "MH_TH": "NLM (1964)", "ST": "T123", "N1": "Uridine, 2'-deoxy-", "RN": "W78I7AY22C", "RR": "951-78-0 (Deoxyuridine)", "AN": "an antimetabolite", "MS": "2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies.", "PM": "66", "HN": "66(64)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003857"}, {"RECTYPE": "D", "MH": "Dependency, Psychological", "ENTRY": "Dependence, Psychological", "MN": "F01.752.330", "MH_TH": "NLM (2020)", "ST": "T041", "MS": "The tendency of an individual or individuals to rely on others for advice, guidance, or support.", "PM": "1991; see PERSONALITY 1975-1990", "HN": "2020 (1990); was DEPENDENCY (PSYCHOLOGY) 1975-2019; use PERSONALITY 1975-1990", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003858"}, {"RECTYPE": "D", "MH": "Dependent Personality Disorder", "DE": "DEPENDENT PERSONALITY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Personality Disorder, Dependent|T048|NON|EQV|UNK (19XX)|800521|PERSONALITY DIS DEPENDENT|abcdefv", "ENTRY": "Personality, Passive-Dependent", "MN": "F03.675.200", "MH_TH": "NLM (1974)", "ST": "T048", "MS": "A personality disorder characterized by a pervasive and excessive need to be taken care of that leads to submissive and clinging behavior and fears of separation, beginning by early adulthood and present in a variety of contexts. (From DSM-IV, 1994)", "OL": "use DEPENDENT PERSONALITY DISORDER to search PASSIVE-DEPENDENT PERSONALITY 1975-80", "PM": "91; was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-DEPENDENT PERSONALITY see under PERSONALITY DISORDERS 1975-80", "HN": "91(81); was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-DEPENDENT PERSONALITY see under PERSONALITY DISORDERS 1975-80", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003859"}, {"RECTYPE": "D", "MH": "Depersonalization", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Derealization|T048|T184|NON|REL|NLM (1998)|970311|abbcdef", "ENTRY": "Disorders, Depersonalization", "MN": "F01.145.126.300", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "State in which an individual perceives or experiences a sensation of unreality concerning the self or the environment; it is seen in disorders such as schizophrenia, affection disorders, organic mental disorders, and personality disorders. (APA, Thesaurus of Psychological Index Terms, 8th ed.)", "PM": "98; see DEPERSONALIZATION DISORDER 1963-80; see DEPERSONALIZATION 1963-80", "HN": "98(63)", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003861"}, {"RECTYPE": "D", "MH": "Depreciation", "AQ": "LJ TD", "ENTRY": "Depreciations", "MN": "N03.219.463.030.120", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "NIM", "MS": "Decline in value of capital assets of a permanent or fixed nature over time with use.", "PM": "91; was see under ACCOUNTING 1978-90", "HN": "91(78); was see under ACCOUNTING 1978-90", "MR": "19920514", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D003862"}, {"RECTYPE": "D", "MH": "Depression", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Depressive Symptoms|T048|T184|NON|NRW|UNK (19XX)|800521|abbcdef", "ENTRY": "Symptom, Depressive", "MN": "F01.470.282", "FX": "Antidepressive Agents", "MH_TH": "NLM (1966)", "ST": "T048", "AN": "human & animal; /drug ther: consider also ANTIDEPRESSIVE AGENTS; do not confuse this or X ref (depression of \"moderate intensity\") with DEPRESSIVE DISORDER (\"prominent & relatively persistent\" depression): psychiatrists differentiate on basis of degree", "MS": "Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003863"}, {"RECTYPE": "D", "MH": "Depression, Chemical", "DE": "DEPRESSION CHEM", "ENTRY": "Depressions, Chemical", "MN": "G07.690.773.750", "MH_TH": "NLM (1968)", "ST": "T048", "AN": "NIM", "MS": "The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003864"}, {"RECTYPE": "D", "MH": "Depressive Disorder, Major", "DE": "DEPRESSIVE DIS MAJOR", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Psychosis, Involutional|T048|NON|REL|UNK (19XX)|800521|abcdef", "ENTRY": "Psychoses, Involutional", "MN": "F03.600.300.375", "MH_TH": "NLM (1998)", "ST": "T048", "MS": "Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or  recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)", "OL": "use DEPRESSION, INVOLUTIONAL to search PSYCHOSES, INVOLUTIONAL & MELANCHOLIA, INVOLUTIONAL 1966-80", "PM": "81; was PSYCHOSES, INVOLUTIONAL 1963-80", "HN": "81; was PSYCHOSES, INVOLUTIONAL 1963-80; MELANCHOLIA, INVOLUTIONAL was see under PSYCHOSES, INVOLUTIONAL 1963-78", "CATSH": "CAT LIST", "MR": "20190322", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D003865"}, {"RECTYPE": "D", "MH": "Depressive Disorder", "DE": "DEPRESSIVE DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Unipolar Depression|T048|NON|NRW|OMIM (2013)|UNK (19XX)|820527|abcdeef", "ENTRY": "Unipolar Depressions", "MN": "F03.600.300", "MH_TH": "NLM (1981)", "ST": "T048", "PI": "Depression (1966-1980)", "MS": "An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.", "OL": "use ADJUSTMENT DISORDERS to search DEPRESSIVE NEUROSES 1969-80", "PM": "81; DEPRESSION, NEUROTIC was DEPRESSIVE NEUROSES see DEPRESSION, REACTIVE 1979-80, see under DEPRESSION, REACTIVE 1969-78", "HN": "81; DEPRESSION, NEUROTIC was DEPRESSIVE NEUROSES see DEPRESSION, REACTIVE 1979-80, see under DEPRESSION, REACTIVE 1969-78", "CATSH": "CAT LIST", "MR": "20150708", "DA": "19800521", "DC": "1", "DX": "19810101", "UI": "D003866"}, {"RECTYPE": "D", "MH": "Depth Perception", "AQ": "CL DE ES GE PH RE", "PRINT ENTRY": "Stereoscopic Vision|T041|NON|EQV|UNK (19XX)|880602|abcdef", "ENTRY": "Visions, Stereoscopic", "MN": "F02.463.593.778.255", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "disord of depth perception: coord IM with PERCEPTUAL DISORDERS (IM)", "MS": "Perception of three-dimensionality.", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003867"}, {"RECTYPE": "D", "MH": "Dequalinium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Gurgell\u00f6sung Ratiopharm", "MN": "D03.633.100.810.824.200", "PA": "Anti-Infective Agents, Local", "MH_TH": "NLM (1976)", "ST": "T121", "N1": "1,1'-(1,10-Decanediyl)bis(4-amino-2-methylquinolinium)", "RN": "E7QC7V26B8", "RR": "XYS8INN1I6", "PI": "Quinolinium Compounds (1970-1975)", "MS": "A topical bacteriostat that is available as various salts. It is used in wound dressings and mouth infections and may also have antifungal action, but may cause skin ulceration.", "PM": "1991; see QUINOLINIUM COMPOUNDS 1976-90; for DECHALINIUM & DEQUALONUM see DEQUALINIUM 1976-1993; DYNEXAN-MHP was indexed under DEQUALINIUM, POLYETHYLENES & SESQUITERPENES 1977-2000 and under POLYMERS & QUINOLINIUM COMPOUNDS 1974-1976", "HN": "1991(1976); see QUINOLINIUM COMPOUNDS 1976-1990; for DECHALINIUM & DEQUALONUM see DEQUALINIUM 1976-1993", "MR": "20170524", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D003868"}, {"RECTYPE": "D", "MH": "Dermabrasion", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Dermabrasions", "MN": "E04.617.275.250", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The mechanical planing of the SKIN with sand paper, emery paper, or wire brushes, to promote reepithelialization and smoothing of skin disfigured by ACNE scars or dermal NEVI.", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003869"}, {"RECTYPE": "D", "MH": "Dermacentor", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Rocky Mountain Wood Tick|T204|EPO|NRW|NLM (2024)|230411|abcdef", "MN": "B01.050.500.131.166.132.832.400.200", "MH_TH": "NLM (1973)", "ST": "T204", "RN": "txid34619", "RR": "txid34620", "AN": "infestation: coord IM with TICK INFESTATIONS (IM)", "PI": "Ticks (1966-1972)", "MS": "A widely distributed genus of TICKS, in the family IXODIDAE, including a number that infest humans and other mammals. Several are vectors of diseases such as TULAREMIA; ROCKY MOUNTAIN SPOTTED FEVER; COLORADO TICK FEVER; and ANAPLASMOSIS.", "PM": "91; was see under TICKS 1973-90", "HN": "91(73); was see under TICKS 1973-90", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003870"}, {"RECTYPE": "D", "MH": "Dermatan Sulfate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Heparin|T109|T123|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "beta Heparin", "MN": "D09.698.373.200.380", "PA": "Anticoagulants", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Dermatan, 4-(hydrogen sulfate)", "RN": "24967-94-0", "MS": "A naturally occurring glycosaminoglycan found mostly in the skin and in connective tissue. It differs from CHONDROITIN SULFATE A (see CHONDROITIN SULFATES) by containing IDURONIC ACID in place of glucuronic acid, its epimer, at carbon atom 5. (from Merck, 12th ed)", "PM": "91; see CHONDROITIN 1975-90", "HN": "91(75)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003871"}, {"RECTYPE": "D", "MH": "Dermatitis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dermatitides", "MN": "C17.800.174", "MH_TH": "POPLINE (1984)", "ST": "T047", "MS": "Any inflammation of the skin.", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003872"}, {"RECTYPE": "D", "MH": "Dermatitis, Exfoliative", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Erythroderma|T184|NON|EQV|NLM (1993)|920402|abcdef", "ENTRY": "Generalised, Dermatitis Exfoliative", "MN": "C17.800.815.318", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder (e.g., atopic dermatitis, psoriasis, etc.), or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. (From Dorland, 27th ed)", "OL": "use DERMATITIS, EXFOLIATIVE to search DERMATITIS EXFOLIATIVA & ERYTHRODERMA 1966-92", "PM": "93; was DERMATITIS EXFOLIATIVA 1963-92; ERYTHRODERMA was heading 1963-92", "HN": "93; was DERMATITIS EXFOLIATIVA 1963-92; ERYTHRODERMA was heading 1963-92", "CATSH": "CAT LIST", "MR": "20190618", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D003873"}, {"RECTYPE": "D", "MH": "Dermatitis Herpetiformis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Duhring's Disease|T047|EPO|EQV|UNK (19XX)|740329|DUHRINGS DIS|abcdefv", "ENTRY": "Duhrings Disease", "MN": "C20.111.318", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a bullous skin dis: nothing to do with herpes", "MS": "Rare, chronic, papulo-vesicular disease characterized by an intensely pruritic eruption consisting of various combinations of symmetrical, erythematous, papular, vesicular, or bullous lesions. The disease is strongly associated with the presence of HLA-B8 and HLA-DR3 antigens. A variety of different autoantibodies has been detected in small numbers in patients with dermatitis herpetiformis.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003874"}, {"RECTYPE": "D", "MH": "Drug Eruptions", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dermatitis, Adverse Drug Reaction|T047|NON|EQV|NLM (1993)|920402|abcdef", "ENTRY": "Reactions, Morbilliform Drug", "MN": "C25.100.468.380", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions.", "OL": "use DRUG ERUPTIONS to search DERMATITIS MEDICAMENTOSA 1966-92", "PM": "93; was DERMATITIS MEDICAMENTOSA 1963-92; DRUG ERUPTIONS was see DERMATITIS MEDICAMENTOSA 1975-92, was see under DERMATITIS MEDICAMENTOSA 1971-74", "HN": "93; was DERMATITIS MEDICAMENTOSA 1963-92; DRUG ERUPTIONS was see DERMATITIS MEDICAMENTOSA 1975-92, was see under DERMATITIS MEDICAMENTOSA 1971-74", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D003875"}, {"RECTYPE": "D", "MH": "Dermatitis, Atopic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neurodermatitis, Disseminated|T047|NON|EQV|UNK (19XX)|770202|abcdef", "ENTRY": "Infantile Eczema", "MN": "C20.543.480.343", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "a type of immediate hypersensitivity", "MS": "A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003876"}, {"RECTYPE": "D", "MH": "Dermatitis, Contact", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sensitivity, Contact|T033|T047|NON|EQV|UNK (19XX)|810515|abbcdef", "ENTRY": "Sensitivities, Contact", "MN": "C17.800.815.255", "FX": "Dermatitis, Occupational", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "unspecified as allergic or non-allergic but DERMATITIS, ALLERGIC CONTACT is available", "MS": "A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003877"}, {"RECTYPE": "D", "MH": "Dermatoglyphics", "AQ": "CL HI", "PRINT ENTRY": "Plantar Prints|T073|NON|NRW|UNK (19XX)|780227|abcdef", "ENTRY": "Prints, Plantar", "MN": "N04.452.910.099.500", "MH_TH": "NLM (1966)", "ST": "T059", "MS": "The study of the patterns of ridges of the skin of the fingers, palms, toes, and soles.", "OL": "use DERMATOGLYPHICS to search FINGERPRINTS & PLANTAR PRINTS 1966-78", "PM": "66; FINGERPRINTS was see under DERMATOGLYPHICS 1966-78, was heading 1963-65; PLANTAR PRINTS was see under DERMATOGLYPHICS 1966-78", "HN": "66; FINGERPRINTS was see under DERMATOGLYPHICS 1966-78, was heading 1963-65; PLANTAR PRINTS was see under DERMATOGLYPHICS 1966-78", "CATSH": "CAT LIST", "MR": "20200623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003878"}, {"RECTYPE": "D", "MH": "Dermatologic Agents", "DE": "DERMATOL AGENTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dermatological Agent", "MN": "D27.505.954.444", "FX": "Anti-Infective Agents, Local", "MH_TH": "NLM (1967)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Drugs used to treat or prevent skin disorders or for the routine care of skin.", "PM": "67", "HN": "67", "MR": "20050815", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D003879"}, {"RECTYPE": "D", "MH": "Dermatology", "DE": "DERMATOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.225", "FX": "Skin Diseases", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "A medical specialty concerned with the skin, its structure, functions, diseases, and treatment.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003880"}, {"RECTYPE": "D", "MH": "Dermatomycoses", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Skin Diseases, Fungal|T047|NON|EQV|UNK (19XX)|810223|SKIN DIS FUNGAL|abcdefv", "ENTRY": "Fungal Skin Diseases|T047|NON|EQV|NLM (1993)|920403|FUNGAL SKIN DIS|abcdefv", "MN": "C17.800.838.208", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "fungus dis of skin; coord IM with specific fungus or fungal dis (IM)", "MS": "Superficial infections of the skin or its appendages by any of various fungi.", "OL": "use DERMATOMYCOSES to search DERMATOMYCOSIS 1966-76", "PM": "77; was DERMATOMYCOSIS 1963-76", "HN": "77; was DERMATOMYCOSIS 1963-76", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D003881"}, {"RECTYPE": "D", "MH": "Dermatomyositis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polymyositis-Dermatomyositis|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Polymyositis Dermatomyositis", "MN": "C17.800.185", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with PARANEOPLASTIC SYNDROMES if pertinent", "MS": "A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003882"}, {"RECTYPE": "D", "MH": "Arthrodermataceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Keratinomyces|T004|NON|NRW|NLM (2009)|071019|abcdef", "ENTRY": "Nannizzias", "MN": "B01.300.107.650.080", "FX": "Trichophyton", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid34384", "RR": "txid63399", "MS": "A family of ascomycetous fungi, order Onygenales, characterized by smooth ascospores. Genera in the family include Arthroderma, Keratinomyces, and Ctenomyces. Several well-known anamorphic forms are parasitic upon the skin.", "PM": "99; see DERMATOPHYTES 1963-98; for ARTHRODERMA see ASCOMYCOTA 1975-98; for NANNIZZIA see MICROSPORUM 1975-98", "HN": "99; for ARTHRODERMA use ASCOMYCOTA 1975-98; for NANNIZZIA use MICROSPORUM 1975-98", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D003883"}, {"RECTYPE": "D", "MH": "Dermoid Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Dermoid|T191|NON|EQV|UNK (19XX)|800509|abcdef", "ENTRY": "Dermoids", "MN": "C04.557.465.910.250", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "neoplastic; coord IM with precoord organ/neopl term (IM)", "MS": "A tumor consisting of displaced ectodermal structures along the lines of embryonic fusion, the wall being formed of epithelium-lined connective tissue, including skin appendages, and containing keratin, sebum, and hair. (Stedman, 25th ed)", "OL": "use DERMOID CYST to search DERMOID 1968-80", "PM": "DERMOID was heading 1968-80", "HN": "DERMOID was heading 1968-80", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D003884"}, {"RECTYPE": "D", "MH": "Dermotoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Epidermotoxins|T131|NON|REL|UNK (19XX)|770420|abcdef", "MN": "D27.888.569.242", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "PI": "specific skin heading (1966-1977)", "MS": "Specific substances elaborated by plants, microorganisms or animals that cause damage to the skin; they may be proteins or other specific factors or substances; constituents of spider, jellyfish or other venoms cause dermonecrosis and certain bacteria synthesize dermolytic agents.", "PM": "78", "HN": "78", "MR": "20050630", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D003885"}, {"RECTYPE": "D", "MH": "Descemet Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Lamina Elastica Posterior|T023|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Posteriors, Lamina Elastica", "MN": "A10.615.179.437", "MH_TH": "NLM (2006)", "ST": "T023", "MS": "A layer of the cornea. It is the basal lamina of the CORNEAL ENDOTHELIUM (from which it is secreted) separating it from the CORNEAL STROMA. It is a homogeneous structure composed of fine collagenous filaments, and slowly increases in thickness with age.", "PM": "2006; see DESCEMENT'S MEMBRANE 1964-2005", "HN": "2006 (1964)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003886"}, {"RECTYPE": "D", "MH": "Desensitization, Psychologic", "DE": "DESENSITIZATION PSYCHOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Desensitizations (Psychology)", "MN": "F04.754.137.506", "MH_TH": "NLM (1975)", "ST": "T061", "MS": "A behavior therapy technique in which deep muscle relaxation is used to inhibit the effects of graded anxiety-evoking stimuli.", "OL": "use DESENSITIZATION, PSYCHOLOGIC to search DESENSITIZATION (PSYCHOLOGY) 1975-94; use BEHAVIOR THERAPY 1969-74", "PM": "95; was DESENSITIZATION (PSYCHOLOGY) 1975-94 (see under BEHAVIOR THERAPY 1975-90)", "HN": "95; was DESENSITIZATION (PSYCHOLOGY) 1975-94 (see under BEHAVIOR THERAPY 1975-90)", "CATSH": "CAT LIST", "MR": "19950531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003887"}, {"RECTYPE": "D", "MH": "Desensitization, Immunologic", "DE": "DESENSITIZATION IMMUNOL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Venom Immunotherapy|T061|NON|REL|NLM (2021)|200131|abcdef", "ENTRY": "Venom Immunotherapies", "MN": "E05.478.610.310", "FX": "Allergoids", "MH_TH": "NLM (1963)", "ST": "T061", "MS": "Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity.", "OL": "use DESENSITIZATION, IMMUNOLOGIC to search DESENSITIZATION 1966-79", "PM": "80; was DESENSITIZATION 1965-79", "HN": "80; was DESENSITIZATION 1963-79 (Prov 1963-64)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003888"}, {"RECTYPE": "D", "MH": "Desert Climate", "AQ": "AE", "ENTRY": "Desert Climates", "MN": "N06.230.300.100.250.325", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "specify geog if pertinent", "MS": "A type of climate characterized by insufficient moisture to support appreciable plant life. It is a climate of extreme aridity, usually of extreme heat, and of negligible rainfall. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003889"}, {"RECTYPE": "D", "MH": "Desiccation", "AQ": "IS MT", "ENTRY": "Dessication|T070|NON|EQV|UNK (19XX)|830505|abcdef", "MN": "G02.176", "FX": "Freeze Drying", "MH_TH": "NLM (1977)", "ST": "T070", "AN": "note category; differentiate from DEHYDRATION, a disease state", "MS": "Removal of moisture from a substance (chemical, food, tissue, etc.).", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D003890"}, {"RECTYPE": "D", "MH": "Desipramine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Desmethylimipramine|T109|T121|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Ratio Desipramine", "MN": "D03.633.300.240.281", "PA": "Enzyme Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N-methyl-", "RN": "TG537D343B", "RR": "58-28-6 (HCl)", "MS": "A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.", "PM": "65", "HN": "65(63)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003891"}, {"RECTYPE": "D", "MH": "Deslanoside", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Desacetyllanatoside C|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Lanatoside, Desacetyl", "MN": "D09.408.180.261.657.200", "PA": "Enzyme Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Card-20(22)-enolide, 3-((O-beta-D-glucopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-", "RN": "YGY317RK75", "RR": "17598-65-1 (Deslanoside)", "PI": "Lanatosides (1969-1974)", "MS": "Deacetyllanatoside C. A cardiotonic glycoside from the leaves of Digitalis lanata.", "PM": "91; was see under LANATOSIDES 1975-90", "HN": "91(75); was see under LANATOSIDES 1975-90", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003892"}, {"RECTYPE": "D", "MH": "Desmin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Skeletin|T116|T123|NON|EQV|UNK (19XX)|840406|abbcdef", "MN": "D12.776.220.475.200", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "AN": "an intermediate filament protein; /biosyn /physiol permitted", "PI": "Muscle Proteins (1966-1982)", "MS": "An intermediate filament protein found predominantly in smooth, skeletal, and cardiac muscle cells. Localized at the Z line. MW 50,000 to 55,000 is species dependent.", "PM": "85", "HN": "85", "MR": "20040707", "DA": "19840406", "DC": "1", "DX": "19850101", "UI": "D003893"}, {"RECTYPE": "D", "MH": "Deamino Arginine Vasopressin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vasopressin, Deamino Arginine|T116|T121|NON|EQV|UNK (19XX)|771212|abbcdef", "ENTRY": "Vasopressin, 1-Desamino-8-arginine", "MN": "D12.776.631.650.937.100.250", "PA": "Hemostatics", "MH_TH": "UNK (19XX)", "ST": "T121", "N1": "Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-", "RN": "ENR1LLB0FP", "RR": "XB13HYU18U", "PI": "Vasopressins (1966-1974)", "MS": "A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.", "OL": "use DESMOPRESSIN to search DEAMINO ARGININE VASOPRESSIN 1975-78", "PM": "86; was see under ARGIPRESSIN 1979-85; was DEAMINO ARGININE VASOPRESSIN see under VASOPRESSIN 1975-78", "HN": "86(79); was see under ARGIPRESSIN 1979-85; was DEAMINO ARGININE VASOPRESSIN see under VASOPRESSIN 1975-78", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D003894"}, {"RECTYPE": "D", "MH": "Desmosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "4-(4-Amino-4-Carboxybutyl)-1-(5-Amino-5-Carboxypentyl)-3,5-bis(3-Amino-3-Carboxypropyl)pyridinium|T116|T123|NON|EQV|NLM (2009)|071022|abbcdef", "MN": "D12.125.072.200", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Pyridinium, 4-(4-amino-4-carboxybutyl)-1-(5-amino-5-carboxypentyl)-3,5-bis(3-amino-3-carboxypropyl)-", "RN": "11003-57-9", "PI": "Pyridinium Compounds (1970-1974)", "MS": "A rare amino acid found in elastin, formed by condensation of four molecules of lysine into a pyridinium ring.", "PM": "91; was see under AMINO ACIDS 1975-90", "HN": "91(75); was see under AMINO ACIDS 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003895"}, {"RECTYPE": "D", "MH": "Desmosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Desmosome", "MN": "A11.284.149.165.420.297", "MH_TH": "NLM (1972)", "ST": "T030", "PI": "Cell Membrane (1966-1971)", "MS": "A type of junction that attaches one cell to its neighbor. One of a number of differentiated regions which occur, for example, where the cytoplasmic membranes of adjacent epithelial cells are closely apposed. It consists of a circular region of each membrane together with associated intracellular microfilaments and an intercellular material which may include, for example, mucopolysaccharides. (From Glick, Glossary of Biochemistry and Molecular Biology, 1990; Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)", "PM": "72", "HN": "72", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003896"}, {"RECTYPE": "D", "MH": "Desmosterol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "24-Dehydrocholesterol|T109|T123|NON|EQV|UNK (19XX)|770205|DEHYDROCHOLESTEROL 24|abbcdefs", "ENTRY": "24 Dehydrocholesterol", "MN": "D10.570.938.208.320.297", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "Cholesta-5,24-dien-3-ol, (3beta)-", "RN": "313-04-2", "PI": "Sterols (1966-1971)", "MS": "An intermediate in the synthesis of cholesterol.", "OL": "search DEHYDROCHOLESTEROL under CHOLECALCIFEROLS 1966", "PM": "74; DEHYDROCHOLESTEROL was see under VITAMIN D3 1963-66", "HN": "74(72); DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003897"}, {"RECTYPE": "D", "MH": "Desonide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prednacinolone|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Trid\u00e9sonit|T109|T121|TRD|NRW|FR|040827|abbcdef", "MN": "D04.210.500.745.432.769.325", "PA": "Anti-Inflammatory Agents", "MH_TH": "USAN (1970)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-", "RN": "J280872D1O", "RR": "638-94-8 (Desonide)", "PI": "Pregnadienetriols (1974)", "MS": "A nonfluorinated corticosteroid anti-inflammatory agent used topically for DERMATOSES.", "PM": "91; was see under PREGNADIENETRIOLS 1975-90; PREDNACINOLONE was PREDNACINOLON 1975-94; HYDROXYPREDNISOLONACETONIDE was see DESONIDE 1975-95", "HN": "91(75); was see under PREGNADIENETRIOLS 1975-90; PREDNACINOLONE was PREDNACINOLON 1975-94; HYDROXYPREDNISOLONACETONIDE was see DESONIDE 1975-95", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003898"}, {"RECTYPE": "D", "MH": "Desoximetasone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Desoxymethasone|T109|T121|NON|EQV|UNK (19XX)|771208|abbcdef", "ENTRY": "A41304", "MN": "D04.210.500.908.238.250", "PA": "Glucocorticoids", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, (11beta,16alpha)-", "RN": "4E07GXB7AU", "RR": "382-67-2 (Desoximetasone)", "PI": "Steroids, Fluorinated (1974)", "MS": "A topical anti-inflammatory glucocorticoid used in DERMATOSES, skin allergies, PSORIASIS, etc.", "PM": "91; was see under DEXAMETHASONE 1979-90", "HN": "91(79); was see under DEXAMETHASONE 1979-90", "MR": "20170524", "DA": "19771208", "DC": "1", "DX": "19910101", "UI": "D003899"}, {"RECTYPE": "D", "MH": "Desoxycorticosterone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Desoxycortone|T109|T125|NON|EQV|FDA SRS (2014)|INN (19XX)|UNK (19XX)|740329|abbcdeeef", "ENTRY": "21 Hydroxyprogesterone", "MN": "D06.472.040.585.611", "PA": "Mineralocorticoids", "MH_TH": "NLM (1966)", "ST": "T125", "N1": "Pregn-4-ene-3,20-dione, 21-hydroxy-", "RN": "40GP35YQ49", "RR": "64-85-7 (Desoxycorticosterone)", "MS": "A steroid metabolite that is the 11-deoxy derivative of CORTICOSTERONE and the 21-hydroxy derivative of PROGESTERONE", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003900"}, {"RECTYPE": "D", "MH": "Desulfovibrio", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.900.350", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid872", "AN": "infection: coordinate with DESULFOVIBRIONACEAE INFECTIONS", "MS": "A genus of gram-negative, anaerobic, rod-shaped bacteria capable of reducing sulfur compounds to hydrogen sulfide. Organisms are isolated from anaerobic mud of fresh and salt water, animal intestines, manure, and feces.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003901"}, {"RECTYPE": "D", "MH": "Detergents", "AQ": "AD AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Cleansing Agents|T121|NON|BRD|UNK (19XX)|800411|abcdef", "ENTRY": "Synthetic Detergents", "MN": "J01.516.381", "MH_TH": "NLM (1963)", "ST": "T120", "RN": "0", "MS": "Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties.", "PM": "91; was see under SURFACE-ACTIVE AGENTS 1981-90; was heading 1963-80", "HN": "91(81)63; was see under SURFACE-ACTIVE AGENTS 1981-90; was heading 1963-80", "MR": "20190507", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D003902"}, {"RECTYPE": "D", "MH": "Deuterium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "PRINT ENTRY": "Deuterons|T196|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Hydrogen 2", "MN": "D01.496.289", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Deuterium", "RN": "AR09D82C7G", "RR": "7782-39-0 (Deuterium)", "AN": "heavy hydrogen; HEAVY WATER see DEUTERIUM OXIDE is also available", "MS": "The stable isotope of hydrogen. It has one neutron and one proton in the nucleus.", "MR": "20170414", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003903"}, {"RECTYPE": "D", "MH": "Mitosporic Fungi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Hyphomycetes|T004|NON|NRW|NLM (1999)|980116|abcdef", "ENTRY": "imperfectus, Fungi", "MN": "B01.300.381", "MH_TH": "NLM (1971)", "ST": "T004", "AN": "general or unspecified; prefer specifics; infection equals MYCOSES or specific mycosis ", "PI": "Fungi (1966-1972)", "MS": "A large and heterogenous group of fungi whose common characteristic is the absence of a sexual state. Many of the pathogenic fungi in humans belong to this group.", "PM": "99; see DEUTEROMYCETES 1973-98; for HYPHOMYCETES see HYPHOMYCETES 1986-98, see MONILIALES 1963-85; for MADURELLA & GLIOCLADIUM see HYPHOMYCETES 1986-98", "HN": "99(73)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003904"}, {"RECTYPE": "D", "MH": "Deuteroporphyrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Deuteroporphyrin, Cobalt", "MN": "D23.767.727.280", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "pigments", "PI": "Porphyrins (1970-1974)", "MS": "Porphyrins with four methyl and two propionic acid side chains attached to the pyrrole rings.", "PM": "91; was see under PORPHYRINS 1975-90", "HN": "91(75); was see under PORPHYRINS 1975-90", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003905"}, {"RECTYPE": "D", "MH": "Developing Countries", "AQ": "CL EC HI SN", "PRINT ENTRY": "Under-Developed Countries|T080|NON|EQV|NLM (1996)|950314|abcdef", "ENTRY": "Under-Developed Nation", "MN": "I01.615.500.300", "MH_TH": "NLM (1978)", "ST": "T080", "AN": "do not confuse with DEVELOPED COUNTRIES; IM; specify country or countries if relevant", "PI": "specific country (1966-1970)", "MS": "Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures.", "PM": "71", "HN": "71", "MR": "20220719", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D003906"}, {"RECTYPE": "D", "MH": "Dexamethasone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hexadecadrol|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740329|abbcdeef", "ENTRY": "Decaject L.A.", "MN": "D04.210.500.908.238", "PA": "Glucocorticoids", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11beta,16alpha)-", "RN": "7S5I7G3JQL", "RR": "50-02-2 (Dexamethasone)", "MS": "An anti-inflammatory 9-fluoro-glucocorticoid.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003907"}, {"RECTYPE": "D", "MH": "Dexamethasone Isonicotinate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isonicotinate, Dexamethasone", "MN": "D04.210.500.908.238.300", "PA": "Glucocorticoids", "MH_TH": "NLM (1976)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-((4-pyridinylcarbonyl)oxy)-, (11beta,16alpha)-", "RN": "8LGC0BOA71", "RR": "2265-64-7 (Dexamethasone Isonicotinate)", "PI": "Isonicotinic Acids (1972-1975)", "MS": "An anti-inflammatory, anti-allergic glucocorticoid that can be administered orally, by inhalation, locally, and parenterally. It may cause water and salt retention.", "PM": "91; was see under DEXAMETHASONE 1976-90", "HN": "91(76); was see under DEXAMETHASONE 1976-90", "MR": "20160528", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D003908"}, {"RECTYPE": "D", "MH": "Dexetimide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dexbenzetimide|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "dextro Benzetimide", "MN": "D03.383.621.808.250", "PA": "Parasympatholytics", "MH_TH": "USAN (1971)", "ST": "T121", "N1": "(3,4'-Bipiperidine)-2,6-dione, 3-phenyl-1'-(phenylmethyl)-, (S)-", "RN": "43477QYX3D", "RR": "B987T0L5FX", "AN": "an antiparkinson agent", "PI": "Piperidones (1972-1974)", "MS": "A muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the (-)-enantimorph of dexetimide.", "PM": "91; was see under PIPERIDINES 1975-90", "HN": "91(75); was see under PIPERIDINES 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003909"}, {"RECTYPE": "D", "MH": "Dextranase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glucanase 447 G", "MN": "D08.811.277.450.283", "MH_TH": "NLM (1971)", "ST": "T126", "N1": "1,6-alpha-D-Glucan 6-glucanohydrolase", "RN": "EC 3.2.1.11", "PI": "Glycoside Hydrolases (1966-1970)", "MS": "Enzyme that hydrolyzes DEXTRAN to OLIGOSACCHARIDES.", "PM": "73", "HN": "73(71)", "MR": "20161026", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003910"}, {"RECTYPE": "D", "MH": "Dextrans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Dextran T 500", "MN": "D09.698.365.272", "PA": "Plasma Substitutes", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "RR": "K3R6ZDH4DU", "MS": "A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes.", "OL": "use DEXTRANS to search DEXTRAN 1966-78", "PM": "79; was DEXTRAN 1963-78", "HN": "79; was DEXTRAN 1963-78", "MR": "20160610", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D003911"}, {"RECTYPE": "D", "MH": "Dextrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dextrin", "MN": "D09.698.365.855.400", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "A group of low-molecular-weight carbohydrates produced by the hydrolysis of STARCH or GLYCOGEN. They are mixtures of polymers of D-glucose units linked by alpha-(1->4) or alpha-(1->6) glycosidic bonds.", "PM": "1991; see STARCH 1979-1990; see POLYSACCHARIDES 1963-78", "HN": "1991(1975); use STARCH 1979-1990; use POLYSACCHARIDES 1963-1978", "MR": "20180409", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003912"}, {"RECTYPE": "D", "MH": "Dextroamphetamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "d-Amphetamine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|760515|AMPHETAMINE A D|abbcdeefs", "ENTRY": "dextro Amphetamine", "MN": "D02.092.471.683.152.110.200", "PA": "Dopamine Uptake Inhibitors", "MH_TH": "USAN (1964)", "ST": "T121", "N1": "Benzeneethanamine, alpha-methyl-, (S)-", "RN": "TZ47U051FI", "RR": "JJ768O327N", "MS": "The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.", "OL": "use DEXTROAMPHETAMINE to search DEXTRO AMPHETAMINE 1966-76", "PM": "77; was DEXTRO AMPHETAMINE 1963-76", "HN": "77; was DEXTRO AMPHETAMINE 1963-76", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D003913"}, {"RECTYPE": "D", "MH": "Dextrocardia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dextrocardias", "MN": "C16.131.810.250", "MH_TH": "NLM (1984)", "ST": "T019", "MS": "A congenital defect in which the heart is located on the right side of the THORAX instead of on the left side (levocardia, the normal position). When dextrocardia is accompanied with inverted HEART ATRIA, a right-sided STOMACH, and a left-sided LIVER, the combination is called dextrocardia with SITUS INVERSUS. Dextrocardia may adversely affect other thoracic organs.", "PM": "91; was see under HEART DEFECTS, CONGENITAL 1984-90; was heading 1963-83", "HN": "91(84)63; was see under HEART DEFECTS, CONGENITAL 1984-90; was heading 1963-83", "CATSH": "CAT LIST", "MR": "20090710", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003914"}, {"RECTYPE": "D", "MH": "Dextromethorphan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "d-Methorphan|T109|T121|NON|EQV|UNK (19XX)|760515|METHORPHAN D|abbcdefs", "ENTRY": "Hydrochloride, Dextromethorphan", "MN": "D04.615.723.795.200", "PA": "Excitatory Amino Acid Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Morphinan, 3-methoxy-17-methyl-, (9alpha,13alpha,14alpha)-", "RN": "7355X3ROTS", "RR": "9D2RTI9KYH", "PI": "Morphinans (1969-1971)", "MS": "Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (RECEPTORS, N-METHYL-D-ASPARTATE) and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity.", "PM": "91; was see under LEVORPHANOL 1972-90", "HN": "91(72); was see under LEVORPHANOL 1972-90", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003915"}, {"RECTYPE": "D", "MH": "Dextromoramide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrrolamidol|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|770330|abbcdeef", "ENTRY": "Tartrate, Dextromoramide", "MN": "D03.383.533.640.250", "PA": "Narcotics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pyrrolidine, 1-(3-methyl-4-(4-morpholinyl)-1-oxo-2,2-diphenylbutyl)-, (S)-", "RN": "9S4S6CIY83", "RR": "J778U505W5", "AN": "an opioid analgesic", "MS": "An opioid analgesic structurally related to METHADONE and used in the treatment of severe pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1070)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003916"}, {"RECTYPE": "D", "MH": "Dextrorphan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "(+-)-17-Methylmorphinan-3-ol|T109|T121|NON|EQV|UNK (19XX)|830831|abbcdef", "MN": "D04.615.723.795.235", "PA": "Neuroprotective Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Morphinan-3-ol, 17-methyl-, (9alpha,13alpha,14alpha)-", "RN": "04B7QNO9WS", "RR": "125-73-5 (Dextrorphan)", "PI": "Morphinans (1969-1974)", "MS": "Dextro form of levorphanol. It acts as a noncompetitive NMDA receptor antagonist, among other effects, and has been proposed as a neuroprotective agent. It is also a metabolite of DEXTROMETHORPHAN.", "OL": "use DEXTRORPHAN to search DEXTRODROMORAN & D-DROMORAN 1977-94 & DESTRORPHANOLUM 1975-94", "PM": "91; was see under MORPHINANS 1975-90; DEXTRODROMORAN & D-DROMORAN were see DEXTRORPHAN 1977-94; DESTRORPHANOLUM was see DEXTRORPHAN 1975-94", "HN": "91(75); was see under MORPHINANS 1975-90; DEXTRODROMORAN & D-DROMORAN were see DEXTRORPHAN 1977-94; DESTRORPHANOLUM was see DEXTRORPHAN 1975-94", "MR": "20160529", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D003917"}, {"RECTYPE": "D", "MH": "Dextrothyroxine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dextrothyroxine Sodium|T116|T121|NON|NRW|FDA SRS (2014)|INN (19XX)|USAN (1962)|900320|abbcdeeef", "ENTRY": "D Thyroxine", "MN": "D12.125.072.050.342", "MH_TH": "FDA SRS (2014)", "ST": "T125", "N1": "D-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-", "RN": "4W9K63FION", "RR": "7054-08-2 (Dextrothyroxine Sodium)", "MS": "The dextrorotary isomer of the synthetic THYROXINE.", "PM": "65", "HN": "65", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003918"}, {"RECTYPE": "D", "MH": "Diabetes Insipidus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C19.700.159", "FX": "Diabetes Mellitus", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003919"}, {"RECTYPE": "D", "MH": "Diabetes Mellitus", "AQ": "BL CF CI CL CN DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C19.246", "FX": "Scleredema Adultorum", "EC": "complications:Diabetes Complications", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.", "CATSH": "CAT LIST", "MR": "20170717", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003920"}, {"RECTYPE": "D", "MH": "Diabetes Mellitus, Experimental", "DE": "DIABETES MELLITUS EXPER", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Streptozotocin Diabetes|T050|NON|NRW|UNK (19XX)|770505|abcdef", "ENTRY": "Streptozocin Diabete", "MN": "E05.598.500.374", "FX": "Mice, Inbred NOD", "MH_TH": "NLM (1978)", "ST": "T050", "AN": "index alloxan or streptozocin diabetes as DIABETES MELLITUS, EXPERIMENTAL (IM) + ALLOXAN or STREPTOZOCIN (NIM) only if the chem are particularly discussed; probably in animal so do not use /vet but don't forget check tag ANIMALS", "PI": "Diabetes Mellitus (1966-1977)", "MS": "Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY.", "OL": "use DIABETES MELLITUS, EXPERIMENTAL to search ALLOXAN DIABETES 1966-77", "PM": "78; ALLOXAN DIABETES was heading 1963-77", "HN": "78; ALLOXAN DIABETES was heading 1963-77", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19770505", "DC": "1", "DX": "19780101", "UI": "D003921"}, {"RECTYPE": "D", "MH": "Diabetes Mellitus, Type 1", "DS": "DIABETES MELLITUS TYPE 01", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "IDDM|T047|ABB|EQV|UNK (19XX)|830405|abcdef", "ENTRY": "Sudden-Onset Diabetes Mellitus", "MN": "C20.111.327", "FX": "Mice, Inbred NOD", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "MICE, INBRED NOD are a common model for this disease", "MS": "A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.", "PM": "2005; see DIABETES MELLITUS, TYPE I 2004, see DIABETES MELLITUS, INSULIN-DEPENDENT 1984-2003, see DIABETES MELLITUS, JUVENILE 1966-1983", "HN": "2005 (1984)", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D003922"}, {"RECTYPE": "D", "MH": "Diabetes Mellitus, Lipoatrophic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lipoatrophic Diabetes Mellitus", "MN": "C19.246.300.500", "MH_TH": "NLM (1979)", "ST": "T047", "PI": "Lipodystrophy (1966-1978)", "MS": "A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and LIPODYSTROPHY. The latter may be generalized, partial, acquired, or congenital (LIPODYSTROPHY, CONGENITAL GENERALIZED).", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D003923"}, {"RECTYPE": "D", "MH": "Diabetes Mellitus, Type 2", "DS": "DIABETES MELLITUS TYPE 02", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "NIDDM|T047|ABB|EQV|OMIM (2013)|UNK (19XX)|830405|abcdeef", "ENTRY": "Stable Diabetes Mellitus", "MN": "C19.246.300", "FX": "Rats, Inbred OLETF", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Diabetes Mellitus (1966-1983)", "MS": "A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.", "PM": "2005; see DIABETES MELLITUS, TYPE I 2004, see DIABETES MELLITUS, NON-INSULIN-DEPENDENT 1984-2003", "HN": "2005 (1984)", "CATSH": "CAT LIST", "MR": "20170717", "DA": "19830405", "DC": "1", "DX": "19840101", "UI": "D003924"}, {"RECTYPE": "D", "MH": "Diabetic Angiopathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Microangiopathy, Diabetic|T047|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Vascular Diseases, Diabetic", "MN": "C19.246.099.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific vascular dis (IM) + specific type of diabetes", "MS": "VASCULAR DISEASES that are associated with DIABETES MELLITUS.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003925"}, {"RECTYPE": "D", "MH": "Diabetic Coma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diabetic Comas", "MN": "C19.246.099.750", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific type of diabetes mellitus (IM) if pertinent", "MS": "A state of unconsciousness as a complication of diabetes mellitus. It occurs in cases of extreme HYPERGLYCEMIA or extreme HYPOGLYCEMIA as a complication of INSULIN therapy.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003926"}, {"RECTYPE": "D", "MH": "Diet, Diabetic", "AQ": "AE CL EC EH HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Diabetic Diet|T061|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Diets, Diabetic", "MN": "G07.203.650.240.240", "MH_TH": "NLM (1993)", "ST": "T061", "AN": "a specific dietary regimen for diabetics: not all diet therapy of diabetes is DIABETIC DIET; when specified by author as a diabetic diet, coordinate with DIABETES MELLITUS / diet ther (IM) or specific type of diabetes / diet ther (IM) + specific dietary element / ther use (IM)", "MS": "A course of food intake prescribed for patients, that limits the amount of foods with a high GLYCEMIC INDEX.", "PM": "2016; see DIABETIC DIET 1966-2015", "HN": "2016 (1966)", "CATSH": "CAT LIST", "MR": "20150706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003927"}, {"RECTYPE": "D", "MH": "Diabetic Nephropathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Glomerulosclerosis, Diabetic|T047|NON|NRW|UNK (19XX)|760508|abcdef", "ENTRY": "Syndrome, Kimmelstiel-Wilson", "MN": "C19.246.099.875", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "coordinate with specific kidney disease; do not confuse with DIABETES INSIPIDUS, NEPHROGENIC, a form of diabetes insipidus ", "MS": "KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.", "OL": "use DIABETIC NEPHROPATHIES to search KIMMELSTIEL-WILSON SYNDROME 1966-76", "PM": "65; KIMMELSTIEL-WILSON SYNDROME was heading 1963-76", "HN": "65(64); KIMMELSTIEL-WILSON SYNDROME was heading 1963-76", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003928"}, {"RECTYPE": "D", "MH": "Diabetic Neuropathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuralgia, Diabetic|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Simplices, Diabetic Mononeuropathy", "MN": "C19.246.099.937", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific neurol dis (IM) but do not coord with PERIPHERAL NERVOUS SYSTEM DISEASES for \"diabetic peripheral neuropathy\"", "MS": "Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003929"}, {"RECTYPE": "D", "MH": "Diabetic Retinopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Retinopathy, Diabetic", "MN": "C19.246.099.500.382", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific type of diabetes mellitus (IM) if pertinent", "MS": "Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003930"}, {"RECTYPE": "D", "MH": "Diacetyl", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dimethylglyoxal|T109|T123|NON|EQV|UNK (19XX)|741024|abbcdef", "ENTRY": "2,3 Butanedione", "MN": "D02.522.296.400", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "2,3-Butanedione", "RN": "K324J5K4HM", "RR": "431-03-8 (Diacetyl)", "MS": "Carrier of aroma of butter, vinegar, coffee, and other foods.", "PM": "91; was see under BUTANONES 1975-90", "HN": "91(75); was see under BUTANONES 1975-90", "MR": "20130708", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D003931"}, {"RECTYPE": "D", "MH": "Heroin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diamorphine|T109|T121|T131|NON|EQV|BAN (19XX)|FDA SRS (2014)|760317|abbbcdeef", "ENTRY": "Min I Jet Morphine Sulphate", "MN": "D04.615.723.795.576.445", "PA": "Narcotics", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester)", "RN": "70D95007SX", "RR": "8H672SHT8E", "MS": "A narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed)", "PM": "99; see DIACETYLMORPHINE 1978-98; for HEROIN see DIACETYLMORPHINE 1963-98", "HN": "99(63)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D003932"}, {"RECTYPE": "D", "MH": "Diagnosis", "DE": "DIAG", "PRINT ENTRY": "Diagnoses and Examination|T060|NON|BRD|NLM (2022)|200831|abcdef", "ENTRY": "Postmortem Diagnoses", "MN": "E01", "RH": "E1 - PROCEDURES AND TECHNIQUES-DIAGNOSTIC", "EC": "methods:Diagnostic Techniques and Procedures", "MH_TH": "BIOETHICS (1974)", "ST": "T060", "AN": "general only; prefer /diag with disease term; in Chinese traditional medicine, index bianzheng shizhi (differentiation of signs & symptoms) under DIAGNOSIS, DIFFERENTIAL (IM) + MEDICINE, CHINESE TRADITIONAL (IM)", "MS": "The determination of the nature of a disease or condition, or the distinguishing of one disease or condition from another. Assessment may be made through physical examination, laboratory tests, or the likes. Computerized programs may be used to enhance the decision-making process.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003933"}, {"RECTYPE": "D", "MH": "Diagnostic Techniques, Cardiovascular", "DE": "DIAG TECHNIQUES CARDIOVASC", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Cardiovascular Diagnostic|T060|NON|EQV|NLM (1998)|960909|TECHNIQUES CARDIOVASC DIAG|abcdefv", "MN": "E01.370.370", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "general or unspecified; prefer specifics", "PI": "specific technique (1966-1997)", "MS": "Methods and procedures for the diagnosis of diseases or dysfunction of the cardiovascular system or its organs or demonstration of their physiological processes.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003935"}, {"RECTYPE": "D", "MH": "Diagnosis, Computer-Assisted", "DE": "DIAG COMPUTER ASSISTED", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Computer-Assisted Diagnosis|T060|NON|EQV|UNK (19XX)|860617|COMPUTER ASSISTED DIAG|abcdefv", "ENTRY": "Diagnosis, Computer Assisted", "MN": "L01.313.500.750.100.158", "MH_TH": "NLM (1969)", "ST": "T060", "PI": "Computers (1966-1968)", "MS": "Application of computer programs designed to assist the physician in solving a diagnostic problem.", "OL": "use DIAGNOSIS, COMPUTER-ASSISTED to search DIAGNOSIS, COMPUTER ASSISTED l969-90 (as Prov 1969-72)", "PM": "91; was DIAGNOSIS, COMPUTER ASSISTED 1973-90", "HN": "91(69); was DIAGNOSIS, COMPUTER ASSISTED 1969-90 (Prov 1969-72)", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003936"}, {"RECTYPE": "D", "MH": "Diagnosis, Differential", "DE": "DIAG DIFFER", "ENTRY": "Differential Diagnosis|T060|NON|EQV|UNK (19XX)|850807|DIFFER DIAG|abcdefv", "MN": "E01.171", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "NIM; correct NIM coord for \"mimicking\", \"simulating\"; Manual 26.13+; in Chinese traditional med index bianzheng shizhi (\"differentiation of symptoms & signs\") under DIAGNOSIS, DIFFERENTIAL (IM) + MEDICINE, CHINESE TRADITIONAL (IM); DF: DIAG DIFFER", "MS": "Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures.", "CATSH": "CAT LIST", "MR": "19940523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003937"}, {"RECTYPE": "D", "MH": "Diagnostic Techniques, Digestive System", "DE": "DIAG TECHNIQUES DIGESTIVE SYSTEM", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Digestive System Diagnostic|T060|NON|EQV|NLM (1998)|960909|TECHNIQUES DIGESTIVE SYSTEM DIAG|abcdefv", "MN": "E01.370.372", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "general or unspecified; prefer specifics", "PI": "specific technique (1966-1997)", "MS": "Methods and procedures for the diagnosis of diseases or dysfunction of the digestive system or its organs or demonstration of their physiological processes.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003938"}, {"RECTYPE": "D", "MH": "Diagnostic Techniques, Otological", "DE": "DIAG TECHNIQUES OTOL", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Otologic Diagnostic", "MN": "E01.370.382", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "general or unspecified; prefer specifics", "PI": "specific technique (1966-1997)", "MS": "Methods and procedures for the diagnosis of diseases of the ear or of hearing disorders or demonstration of hearing acuity or loss.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003939"}, {"RECTYPE": "D", "MH": "Diagnostic Techniques, Endocrine", "DE": "DIAG TECHNIQUES ENDOCRINE", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Endocrine Diagnostic|T060|NON|EQV|NLM (1998)|970211|TECHNIQUES ENDOCRINE DIAG|abcdefv", "MN": "E01.370.374", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "general or unspecified; prefer specifics", "PI": "specific technique (1966-1997)", "MS": "Methods and procedures for the diagnosis of diseases or dysfunction of the endocrine glands or demonstration of their physiological processes.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003940"}, {"RECTYPE": "D", "MH": "Diagnostic Techniques, Ophthalmological", "DE": "DIAG TECHNIQUES OPHTHALMOL", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Ophthalmologic Diagnostic", "MN": "E01.370.380", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "general or unspecified; prefer specifics", "PI": "specific technique (1966-1997)", "MS": "Methods and procedures for the diagnosis of diseases of the eye or of vision disorders.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003941"}, {"RECTYPE": "D", "MH": "Diagnostic Techniques, Neurological", "DE": "DIAG TECHNIQUES NEUROL", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Neurologic Diagnostic", "MN": "E01.370.376", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "general or unspecified; prefer specifics; NEUROLOGIC EXAMINATION is also available", "PI": "specific technique (1966-1997)", "MS": "Methods and procedures for the diagnosis of diseases of the nervous system, central and peripheral, or demonstration of neurologic function or dysfunction.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003943"}, {"RECTYPE": "D", "MH": "Diagnostic Techniques, Obstetrical and Gynecological", "DE": "DIAG TECHNIQUES OB GYN", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Obstetrical and Gynecological Diagnostic|T060|NON|EQV|NLM (1998)|961101|TECHNIQUES OBSTET GYNECOL DIAG|abcdefv", "MN": "E01.370.378", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "avoid: too inclusive; prefer specifics; check the tag FEMALE & check the tags FEMALE & PREGNANCY when applicable; DF: DIAG TECHNIQUES OB GYN", "PI": "specific technique (1966-1997)", "MS": "Methods and procedures for the diagnosis of conditions related to pregnancy, labor, and the puerperium and of diseases of the female genitalia. It includes also demonstration of genital and pregnancy physiology.", "OL": "emphasis here is on technique; consider also GENITAL DISEASES, FEMALE /DI or /DI with specific gynecol dis & PREGNANCY COMPLICATIONS /DI & /DI with specific pregn compl", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003944"}, {"RECTYPE": "D", "MH": "Diagnosis, Oral", "DE": "DIAG ORAL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Oral Examination|T060|NON|REL|NLM (1997)|951023|ORAL EXAM|abcdefv", "ENTRY": "Oral Examinations", "MN": "E06.342", "FX": "Radiography, Dental", "MH_TH": "NLM (1965)", "ST": "T060", "AN": "general or unspecified; prefer /diag with specific mouth or tooth disease", "MS": "Examination of the mouth and teeth toward the identification and diagnosis of intraoral disease or manifestation of non-oral conditions.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003945"}, {"RECTYPE": "D", "MH": "Diagnostic Techniques, Radioisotope", "DE": "DIAG TECHNIQUES RADIOISOTOPE", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Radioisotope Diagnostic|T060|NON|EQV|NLM (1998)|970312|TECHNIQUES RADIOISOTOPE DIAG|abcdefv", "MN": "E01.370.384", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "general only; prefer specifics", "MS": "Any diagnostic evaluation using radioactive (unstable) isotopes. This diagnosis includes many nuclear medicine procedures as well as radioimmunoassay tests.", "PM": "98; see DIAGNOSIS, RADIOISOTOPE 1988-97", "HN": "98(88); was DIAGNOSIS, RADIOISOTOPE (NON MESH) 1974-87", "CATSH": "CAT LIST", "MR": "20160317", "DA": "19990101", "DC": "1", "DX": "19880101", "UI": "D003947"}, {"RECTYPE": "D", "MH": "Diagnostic Techniques, Respiratory System", "DE": "DIAG TECHNIQUES RESPIRATORY SYSTEM", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Respiratory System Diagnostic|T060|NON|EQV|NLM (1998)|960910|TECHNIQUES RESPIRATORY SYSTEM DIAG|abcdefv", "MN": "E01.370.386", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "general or unspecified; prefer specifics", "PI": "specific technique (1966-1997)", "MS": "Methods and procedures for the diagnosis of diseases of the respiratory tract or its organs. It includes RESPIRATORY FUNCTION TESTS.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003948"}, {"RECTYPE": "D", "MH": "Diagnostic Techniques, Surgical", "DE": "DIAG TECHNIQUES SURG", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Surgical Diagnostic|T060|NON|EQV|NLM (1998)|970303|TECHNIQUES SURG DIAG|abcdefv", "MN": "E01.370.388", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "general or unspecified; prefer specifics", "MS": "Methods and procedures for the diagnosis of disease or dysfunction by examination of the pathological site or operative field during surgical intervention.", "PM": "98; see DIAGNOSIS, SURGICAL 1966-97", "HN": "98(66)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003949"}, {"RECTYPE": "D", "MH": "Diagnostic Techniques, Urological", "DE": "DIAG TECHNIQUES UROL", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Urologic Diagnostic Techniques", "MN": "E01.370.390", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "general or unspecified; prefer specifics", "PI": "specific technique (1966-1997)", "MS": "Methods and procedures for the diagnosis of diseases or dysfunction of the urinary tract or its organs or demonstration of its physiological processes.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D003950"}, {"RECTYPE": "D", "MH": "Diagnostic Errors", "AQ": "AE CL EC ES HI LJ MO NU PC PX SN TD VE", "PRINT ENTRY": "Diagnostic Blind Spots|T080|NON|REL|NLM (2021)|200313|abcdef", "ENTRY": "Misdiagnoses", "MN": "N02.421.450.280", "MH_TH": "NLM (1970)", "ST": "T080", "AN": "coordinate with specific disease /diag & specific diagnostic procedure; do not confuse with DIAGNOSIS, DIFFERENTIAL; DELAYED DIAGNOSIS is also available", "PI": "Diagnosis (1966-1969)", "MS": "Incorrect or incomplete diagnoses following clinical or technical diagnostic procedures.", "PM": "73", "HN": "73(70)", "CATSH": "CAT LIST", "MR": "20200618", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D003951"}, {"RECTYPE": "D", "MH": "Diagnostic Imaging", "DE": "DIAG IMAGE", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Medical Imaging|T060|NON|BRD|UNK (19XX)|870316|MED IMAGING|abcdefv", "MN": "E01.370.350", "FX": "Phantoms, Imaging", "MH_TH": "NLM (1988)", "ST": "T060", "AN": "general only; prefer /diag image with anatomical term or disease term and coordinate with specific imaging technique if pertinent", "PI": "specific radiographic technique (1966-1987)", "MS": "Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20160425", "DA": "19870316", "DC": "1", "DX": "19880101", "UI": "D003952"}, {"RECTYPE": "D", "MH": "Diagnosis-Related Groups", "DE": "DIAG RELAT GROUPS", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Diagnosis-Related Group|T170|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Related Groups, Diagnosis", "MN": "N03.219.521.710.305.200.080", "MH_TH": "NLM (1986)", "ST": "T170", "PI": "Costs and Cost Analysis (1966-1985)", "MS": "A system for classifying patient care by relating common characteristics such as diagnosis, treatment, and age to an expected consumption of hospital resources and length of stay. Its purpose is to provide a framework for specifying case mix and to reduce hospital costs and reimbursements and it forms the cornerstone of the prospective payment system.", "OL": "use DIAGNOSIS-RELATED GROUPS to search DIAGNOSTIC RELATED GROUPS 1986-91 & CASE MIX 1982-85", "PM": "92; was DIAGNOSTIC RELATED GROUPS 1986-91; was CASE MIX see under COSTS AND COST ANALYSIS 1982-85; DIAGNOSTIC RELATED GROUPS was see CASE MIX 1982-85", "HN": "92; was DIAGNOSTIC RELATED GROUPS 1986-91; was CASE MIX see under COSTS AND COST ANALYSIS 1982-85; DIAGNOSTIC RELATED GROUPS was see CASE MIX 1982-85", "MR": "20200527", "DA": "19850520", "DC": "1", "DX": "19860101", "UI": "D003953"}, {"RECTYPE": "D", "MH": "Diagnostic Services", "DE": "DIAG SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Service, Diagnostic", "MN": "N02.421.726.233", "MH_TH": "NLM (1968)", "ST": "T058", "PI": "Physical Examination (1966-1967)", "MS": "Organized services for the purpose of providing diagnosis to promote and maintain health.", "PM": "68", "HN": "68", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003954"}, {"RECTYPE": "D", "MH": "Diagnostic Tests, Routine", "DE": "DIAG TESTS ROUTINE", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Routine Diagnostic Tests|T060|NON|EQV|UNK (19XX)|810515|ROUTINE DIAG TESTS|abcdefv", "ENTRY": "Tests, Routine Admission", "MN": "E01.370.395", "FX": "Reagent Kits, Diagnostic", "MH_TH": "NLM (1982)", "ST": "T060", "AN": "do not confuse with PHYSICAL EXAMINATION or MASS SCREENING", "MS": "Diagnostic procedures, such as laboratory tests and x-rays, routinely performed on all individuals or specified categories of individuals in a specified situation, e.g., patients being admitted to the hospital. These include routine tests administered to neonates.", "PM": "1982; PHYSICAL EXAMINATION, PREADMISSION was see under PHYSICAL EXAMINATION Aug 1977-1981", "HN": "1982; for PHYSICAL EXAMINATION, PREADMISSION use PHYSICAL EXAMINATION 1977-1981", "CATSH": "CAT LIST", "MR": "20210304", "DA": "19810515", "DC": "1", "DX": "19820101", "UI": "D003955"}, {"RECTYPE": "D", "MH": "Dialysis", "AQ": "AE CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Dialyses", "MN": "G02.186", "MH_TH": "NLM (1966)", "ST": "T070", "MS": "A process of selective diffusion through a membrane. It is usually used to separate low-molecular-weight solutes which diffuse through the membrane from the colloidal and high-molecular-weight solutes which do not. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003956"}, {"RECTYPE": "D", "MH": "Diamfenetide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diamphenethide|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|780201|abbcdeef", "ENTRY": "Di-(2-(4-acetamidophenoxy)ethyl) Ether|T109|T121|NON|EQV|UNK (19XX)|800917|abbcdef", "MN": "D02.092.146.113.092.250", "PA": "Antiplatyhelmintic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Acetamide, N,N'-(oxybis(2,1-ethanediyloxy-4,1-phenylene))bis-", "RN": "U4TFJ7GB6T", "RR": "36141-82-9 (Diamfenetide)", "PI": "Phenyl Ethers (1974)", "MS": "Anthelmintic. It has been shown to be useful in fasciola infections in sheep.", "OL": "use DIAMFENETIDE to search DIAMPHENETHIDE 1975-78", "PM": "91; was see under ACETANILIDES 1979-90; was DIAMPHENETHIDE see under ACETANILIDE 1975-78", "HN": "91(79); was see under ACETANILIDES 1979-90; was DIAMPHENETHIDE see under ACETANILIDE 1975-78", "MR": "20151123", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D003957"}, {"RECTYPE": "D", "MH": "Diamide", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Bisdimethylamide, Diazodicarboxylic Acid", "MN": "D02.172.300", "PA": "Sulfhydryl Reagents", "MH_TH": "NLM (1977)", "ST": "T130", "N1": "Diazenedicarboxamide, tetramethyl-", "RN": "10465-78-8", "PI": "Formamides (1966-1976)", "MS": "A sulfhydryl reagent which oxidizes sulfhydryl groups to the disulfide form. It is a radiation-sensitizing agent of anoxic bacterial and mammalian cells.", "PM": "91; was see under AZO COMPOUNDS 1977-90", "HN": "91(77); was see under AZO COMPOUNDS 1977-90", "MR": "20000621", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D003958"}, {"RECTYPE": "D", "MH": "Diamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diamine|T109|NON|EQV|NLM (2021)|200210|abcdef", "MN": "D02.092.782.258", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Organic chemicals which have two amino groups in an aliphatic chain.", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003959"}, {"RECTYPE": "D", "MH": "Diaminopimelic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Diaminopimelic", "MN": "D12.125.095.390", "MH_TH": "NLM (1975)", "ST": "T116", "N1": "Heptanedioic acid, 2,6-diamino-", "RN": "583-93-7", "PI": "Pimelic Acids (1972-1974)", "MS": "A diamino derivative of heptanedioic acid with amino groups at C-2 and C-6 and the general formula (COOH)CH(NH2)CH2CH2CH2CH(NH2)(COOH).", "PM": "91; was see under AMINO ACIDS, DIAMINO 1980-90; was see under PIMELIC ACIDS 1975-79", "HN": "91(75); was see under AMINO ACIDS, DIAMINO 1980-90; was see under PIMELIC ACIDS 1975-79", "MR": "20151008", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003960"}, {"RECTYPE": "D", "MH": "Dianhydrogalactitol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diepoxygalactitol|T109|T121|NON|EQV|UNK (19XX)|780207|abbcdef", "ENTRY": "NSC132313", "MN": "D09.853.400.350", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "NLM (1979)", "ST": "T121", "N1": "Galactitol, 1,2:5,6-dianhydro-", "RN": "4S465RYF7M", "RR": "23261-20-3 (Dianhydrogalactitol)", "PI": "Ethers, Cyclic (1966-1978)", "MS": "One of the cytotoxic dihalohexitols that alkylates and cross-links DNA via an epoxide group during all phases of the cell cycle, resulting in a disruption of DNA function and cell cycle arrest. It has antineoplastic activity and also causes bone marrow toxicity.", "PM": "91; was see under SUGAR ALCOHOLS 1979-90", "HN": "91(79); was see under SUGAR ALCOHOLS 1979-90", "MR": "20180702", "DA": "19780207", "DC": "1", "DX": "19910101", "UI": "D003961"}, {"RECTYPE": "D", "MH": "Dianisidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Dianisidine", "MN": "D02.455.426.559.389.185.220", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "(1,1'-Biphenyl)-4,4'-diamine, 3,3'-dimethoxy-", "RN": "MJY508JZXV", "RR": "56436-30-7 (sulfate)", "PI": "Biphenyl Compounds (1969-1974)", "MS": "Highly toxic compound which can cause skin irritation and sensitization. It is used in manufacture of azo dyes.", "PM": "91; was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76; 3,3'-DIMETHOXYBENZIDINE was indexed under DIANISIDINE 1982-96", "HN": "91(75); was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76; 3,3'-DIMETHOXYBENZIDINE was (NM) 1982-96", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003962"}, {"RECTYPE": "D", "MH": "Diaper Rash", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Rashes, Diaper", "MN": "C17.800.815.255.400.250", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "an irritant dermatitis", "MS": "A type of irritant dermatitis localized to the area in contact with a diaper and occurring most often as a reaction to prolonged contact with urine, feces, or retained soap or detergent.", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003963"}, {"RECTYPE": "D", "MH": "Diaphragm", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Respiratory Diaphragms", "MN": "A02.633.567.900.300", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "IM when organ of respiration; NIM in studies on muscle tissue; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent", "MS": "The musculofibrous partition that separates the THORACIC CAVITY from the ABDOMINAL CAVITY. Contraction of the diaphragm increases the volume of the thoracic cavity aiding INHALATION.", "MR": "20210706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003964"}, {"RECTYPE": "D", "MH": "Diaphragmatic Eventration", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Eventration, Diaphragmatic", "MN": "C16.131.314.244", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A congenital abnormality characterized by the elevation of the DIAPHRAGM dome. It is the result of a thinned diaphragmatic muscle and injured PHRENIC NERVE, allowing the intra-abdominal viscera to push the diaphragm upward against the LUNG.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003965"}, {"RECTYPE": "D", "MH": "Camurati-Engelmann Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Engelmann's Disease|T019|EPO|EQV|GHR (2014)|UNK (19XX)|741111|ENGELMANNS DIS|abcdeefv", "ENTRY": "Hyperostosis, Diaphyseal", "MN": "C16.320.144", "MH_TH": "UNK (19XX)", "ST": "T019", "MS": "An autosomal dominant form of dysplasia that is characterized by progressive thickening of diaphyseal cortex of long bones. Mutations in the gene that encodes TRANSFORMING GROWTH FACTOR BETA1 are one cause of this disorder.", "PM": "2007; see OSTEOCHONDRODYSPLASIAS 1985-1990, see BONE DISEASES, DEVELOPMENTAL 1975-1984", "HN": "2007(1975)", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003966"}, {"RECTYPE": "D", "MH": "Diarrhea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diarrheas", "MN": "C23.888.821.214", "FX": "Rehydration Solutions", "MH_TH": "NLM (1963)", "ST": "T184", "MS": "An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003967"}, {"RECTYPE": "D", "MH": "Diarrhea, Infantile", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Infantile Diarrheas", "MN": "C23.888.821.214.500", "MH_TH": "NLM (1963)", "ST": "T184", "AN": "human only; don't forget infant check tags as pertinent", "MS": "DIARRHEA occurring in infants from newborn to 24-months old.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003968"}, {"RECTYPE": "D", "MH": "Vipoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Watery Diarrhea with Hypokalemic Alkalosis|T047|NON|REL|UNK (19XX)|810519|abcdef", "ENTRY": "WDHA Syndromes", "MN": "C19.344.421.500.750", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coord IM with PANCREATIC NEOPLASMS (IM)", "PI": "Vasoactive Intestinal Peptide (1977-1981)", "MS": "A tumor that secretes VASOACTIVE INTESTINAL PEPTIDE, a neuropeptide that causes VASODILATION; relaxation of smooth muscles; watery DIARRHEA; HYPOKALEMIA; and HYPOCHLORHYDRIA. Vipomas, derived from the pancreatic ISLET CELLS, generally are malignant and can secrete other hormones. In most cases, Vipomas are located in the PANCREAS but can be found in extrapancreatic sites.", "OL": "use VIPOMA to search DIARRHEOGENIC TUMOR 1982-93", "PM": "94; was DIARRHEOGENIC TUMOR 1982-93 (see under ISLET CELL TUMOR 1982-90); VIPOMA was see DIARRHEOGENIC TUMOR 1982-93", "HN": "94; was DIARRHEOGENIC TUMOR 1982-93 (see under ISLET CELL TUMOR 1982-90); VIPOMA was see DIARRHEOGENIC TUMOR 1982-93", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19810519", "DC": "1", "DX": "19910101", "UI": "D003969"}, {"RECTYPE": "D", "MH": "Diastema", "AQ": "EM EP ET PA PC PP SU TH", "ENTRY": "Diastemas", "MN": "C16.131.850.800.320", "FX": "Labial Frenum", "MH_TH": "NLM (1967)", "ST": "T047", "PI": "Dentition (1966)", "MS": "An abnormal opening or fissure between two adjacent teeth.", "PM": "72", "HN": "72(67)", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D003970"}, {"RECTYPE": "D", "MH": "Diastole", "AQ": "DE ES GE IM PH RE", "ENTRY": "Diastoles", "MN": "G11.427.494.570.295", "MH_TH": "NLM (1979)", "ST": "T079", "AN": "DIASTOLIC PRESSURE see BLOOD PRESSURE & do not add DIASTOLE (NIM) unless particularly discussed", "PI": "Heart Ventricle (1966-1978)", "MS": "Post-systolic relaxation of the HEART, especially the HEART VENTRICLES.", "PM": "91; was see under MYOCARDIAL CONTRACTION 1979-90", "HN": "91(79); was see under MYOCARDIAL CONTRACTION 1979-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19771206", "DC": "1", "DX": "19910101", "UI": "D003971"}, {"RECTYPE": "D", "MH": "Diathermy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Diathermies", "MN": "E02.565.280", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The induction of local hyperthermia by either short radio waves or high-frequency sound waves.", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003972"}, {"RECTYPE": "D", "MH": "Diatrizoate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amidotrezoate|T109|T130|NON|NRW|UNK (19XX)|770111|abbcdef", "ENTRY": "Diatrizoate, Sodium-Magnesium", "MN": "D02.455.426.559.389.127.375.880.270", "PA": "Contrast Media", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "117-96-4", "RR": "V5403H8VG7", "MS": "A commonly used x-ray contrast medium. As DIATRIZOATE MEGLUMINE and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography.", "PM": "2019; DIATRIZOIC ACID was indexed under DIATRIZOATE 2013-2018; under MESYLATES 1980-2012; and under IODINE 1978-1979", "HN": "2019 (1978)", "MR": "20180521", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003973"}, {"RECTYPE": "D", "MH": "Diatrizoate Meglumine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylglucamine Diatrizoate|T109|T121|T130|NON|EQV|UNK (19XX)|810514|abbbcdef", "ENTRY": "Renografin M76", "MN": "D09.853.813.550.500", "PA": "Contrast Media", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "D-Glucitol, 1-deoxy-1-(methylamino)-, 3,5-bis(acetylamino)-2,4,6-triiodobenzoate (salt)", "RN": "3X9MR4N98U", "RR": "131-49-7", "PI": "Sorbitol (1972-1974)", "MS": "A versatile contrast medium used for DIAGNOSTIC X-RAY RADIOLOGY.", "OL": "use DIATRIZOATE MEGLUMINE to search MEGLUMINE DIATRIZOATE 1975-81", "PM": "87; was see under DIATRIZOATE 1982-86; was MEGLUMINE DIATRIZOATE see under DIATRIZOATE 1975-81", "HN": "87(82); was see under DIATRIZOATE 1982-86; was MEGLUMINE DIATRIZOATE see under DIATRIZOATE 1975-81", "MR": "20150527", "DA": "19741111", "DC": "1", "DX": "19870101", "UI": "D003974"}, {"RECTYPE": "D", "MH": "Diazepam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Valium|T109|T121|TRD|NRW|UNK (19XX)|810728|abbcdef", "MN": "D03.633.100.079.080.070.216", "PA": "Muscle Relaxants, Central", "FX": "Receptors, GABA-A", "MH_TH": "USP (1963)", "ST": "T121", "N1": "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-", "RN": "Q3JTX2Q7TU", "RR": "439-14-5 (Diazepam)", "MS": "A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.", "PM": "65", "HN": "65(63)", "MR": "20160529", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D003975"}, {"RECTYPE": "D", "MH": "Diazinon", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Neotsidol|T109|T131|TRD|NRW|NLM (1998)|961115|abbcdef", "MN": "D02.886.300.692.200", "PA": "Insecticides", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Phosphorothioic acid, O,O-diethyl O-(6-methyl-2-(1-methylethyl)-4-pyrimidinyl) ester", "RN": "YUS1M1Q929", "RR": "333-41-5 (Diazinon)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Pyrimidines (1973-1974)", "MS": "A cholinesterase inhibitor that is used as an organothiophosphorus insecticide.", "PM": "91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-90", "HN": "91(75); was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D003976"}, {"RECTYPE": "D", "MH": "Diazomethane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Diazirine|T109|T130|NON|EQV|UNK (19XX)|820204|abbcdef", "MN": "D02.172.383.383", "MH_TH": "NLM (1967)", "ST": "T130", "N1": "Methane, diazo-", "RN": "60A625P70P", "RR": "334-88-3 (Diazomethane)", "PI": "Methane (1966)", "MS": "A diazonium compound with the formula CH2N2.", "PM": "68", "HN": "68(67)", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003978"}, {"RECTYPE": "D", "MH": "Diazonium Compounds", "DE": "DIAZONIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Diazonium", "MN": "D02.172.383", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Azo compounds consisting of an aryl or alkyl group that is joined through two nitrogen atoms to an anion (R-N2+X-).", "PM": "68", "HN": "68", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003979"}, {"RECTYPE": "D", "MH": "Diazooxonorleucine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "6 Diazo 5 oxo L norleucine", "MN": "D12.125.213.568.175", "PA": "Antimetabolites, Antineoplastic", "MH_TH": "NLM (1965)", "ST": "T121", "N1": "Norleucine, 6-diazo-5-oxo-", "RN": "03J0H273KZ", "RR": "764-17-0 (Diazooxonorleucine)", "MS": "An amino acid that inhibits phosphate-activated glutaminase and interferes with glutamine metabolism. It is an antineoplastic antibiotic produced by an unidentified species of Streptomyces from Peruvian soil. (From Merck Index, 11th ed)", "PM": "91; was see under AZO COMPOUNDS 1965-90", "HN": "91(65); was see under AZO COMPOUNDS 1965-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003980"}, {"RECTYPE": "D", "MH": "Diazoxide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Proglycem|T109|T121|TRD|NRW|UNK (19XX)|861024|abbcdef", "MN": "D03.633.100.174.300", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1,2,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide", "RN": "O5CB12L4FN", "RR": "364-98-7 (Diazoxide)", "MS": "A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.", "PM": "67", "HN": "67(63)", "MR": "20160529", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D003981"}, {"RECTYPE": "D", "MH": "Dibekacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dideoxykanamycin B|T109|T195|NON|EQV|UNK (19XX)|840501|abbcdef", "ENTRY": "Sulphate, Dibekacin", "MN": "D09.408.051.476.200", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4))-2-deoxy-", "RN": "45ZFO9E525", "RR": "A0869I992Z", "PI": "Kanamycin (1973-1974)", "MS": "Analog of KANAMYCIN with antitubercular as well as broad-spectrum antimicrobial properties.", "OL": "use DIBEKACIN to search DIDEOXYKANAMYCIN B 1975-84", "PM": "91; was see under KANAMYCIN 1985-90; was DIDEOXYKANAMYCIN B see under KANAMYCIN 1975-84", "HN": "91(85); was see under KANAMYCIN 1985-90; was DIDEOXYKANAMYCIN B see under KANAMYCIN 1975-84", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003982"}, {"RECTYPE": "D", "MH": "Dibenzylchlorethamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dibenamine|T109|T121|TRD|NRW|NLM (1963)|990101|abbcdef", "ENTRY": "Chlorethylamine, Dibenzyl", "MN": "D02.092.471.245", "PA": "Sympatholytics", "MH_TH": "NLM (2005)", "ST": "T121", "N1": "Benzenemethanamine, N-(2-chloroethyl)-N-(phenylmethyl)-", "RN": "43EXU2S56H", "RR": "51-50-3 (Dibenzylchlorethamine)", "MS": "An alpha adrenergic antagonist.", "PM": "2005; see SYMPATHOLYTICS 1963-1965, see DIBENAMINE 1966-2004", "HN": "2005(1963)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003983"}, {"RECTYPE": "D", "MH": "Dibenzazepines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.240", "FX": "Benzazepines", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Compounds with two BENZENE rings fused to AZEPINES.", "PM": "68", "HN": "68", "MR": "20160529", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003984"}, {"RECTYPE": "D", "MH": "Dibenzocycloheptenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.181.384", "MH_TH": "NLM (1968)", "ST": "T121", "RN": "0", "MS": "A family of tricyclic hydrocarbons whose members include many of the commonly used tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC).", "PM": "68", "HN": "68", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003986"}, {"RECTYPE": "D", "MH": "Dibenzothiazepines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.276", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PM": "68", "HN": "68", "MR": "20160529", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003987"}, {"RECTYPE": "D", "MH": "Dibenzothiepins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.311", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PM": "68", "HN": "68", "MR": "20160529", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003988"}, {"RECTYPE": "D", "MH": "Dibenzoxazepines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.347", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PM": "68", "HN": "68", "MR": "20160529", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003989"}, {"RECTYPE": "D", "MH": "Dibenzoxepins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.382", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PM": "68", "HN": "68", "MR": "20160529", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003990"}, {"RECTYPE": "D", "MH": "Dibromothymoquinone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "2,5 Dibromo 3 methyl 6 isopropyl p benzoquinone", "MN": "D02.806.250.280", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "2,5-Cyclohexadiene-1,4-dione, 2,5-dibromo-3-methyl-6-(1-methylethyl)-", "RN": "29096-93-3", "PI": "Quinones (1973-1974)", "MS": "At low concentrations, this compound inhibits reduction of conventional hydrophilic electron acceptors, probably acting as a plastoquinone antagonist. At higher concentrations, it acts as an electron acceptor, intercepting electrons either before or at the site of its inhibitory activity.", "PM": "91; was see under QUINONES 1975-90", "HN": "91(75); was see under QUINONES 1975-90", "MR": "20000622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003991"}, {"RECTYPE": "D", "MH": "Dibucaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cinchocaine|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|770330|abbcdeeef", "ENTRY": "Sovcaine|T109|T121|TRD|NRW|UNK (19XX)|861203|abbcdef", "MN": "D03.633.100.810.125", "PA": "Anesthetics, Local", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4-Quinolinecarboxamide, 2-butoxy-N-(2-(diethylamino)ethyl)-", "RN": "L6JW2TJG99", "RR": "85-79-0 (Dibucaine)", "MS": "A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1006)", "MR": "20160529", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D003992"}, {"RECTYPE": "D", "MH": "Dibutyl Phthalate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Butyl Phthalate|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|760412|abbcdeef", "ENTRY": "Phthalate, Dibutyl", "MN": "D02.241.223.805.225", "PA": "Plasticizers", "MH_TH": "NLM (1977)", "ST": "T121", "N1": "1,2-Benzenedicarboxylic acid, dibutyl ester", "RN": "2286E5R2KE", "RR": "84-74-2 (Dibutyl Phthalate)", "PI": "Phthalic Acids (1969-1976)", "MS": "A plasticizer used in most plastics and found in water, air, soil, plants and animals. It may have some adverse effects with long-term exposure.", "PM": "91; was see under PHTHALIC ACIDS 1977-90", "HN": "91(77); was see under PHTHALIC ACIDS 1977-90", "MR": "20130708", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D003993"}, {"RECTYPE": "D", "MH": "Bucladesine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dibutyryl Cyclic AMP|T114|T121|NON|EQV|NLM (1994)|921218|DIBU CYCL AMP|abbcdefv", "ENTRY": "Sodium Salt Bucladesine", "MN": "D13.695.827.068.395.250", "MH_TH": "NLM (1974)", "ST": "T121", "N1": "Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate", "RN": "63X7MBT2LQ", "RR": "362-74-3 (Bucladesine)", "MS": "A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed)", "OL": "use BUCLADESINE to search DIBUTYRYL CYCLIC AMP 1974-93", "PM": "94; was DIBUTYRYL CYCLIC AMP 1974-93", "HN": "94; was DIBUTYRYL CYCLIC AMP 1974-93", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D003994"}, {"RECTYPE": "D", "MH": "Dibutyryl Cyclic GMP", "DE": "DIBU CYCL GMP", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dibutyryl Guanosine-3',5'-Monophosphate|T114|NON|EQV|UNK (19XX)|770520|DIBUTYRYL GUANOSINE MONOPHOSPHATE 03 05|abcdefs", "ENTRY": "Guanosine-3',5'-Monophosphate, Dibutyryl", "MN": "D13.695.827.426.160.325", "MH_TH": "NLM (1978)", "ST": "T114", "N1": "Guanosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate", "RN": "32266-35-6", "PI": "Guanosine Cyclic Monophosphate (1971-1977)", "MS": "N-(1-Oxobutyl)-cyclic 3',5'-(hydrogen phosphate)-2'-butanoate guanosine. A derivative of cyclic GMP. It has a higher resistance to extracellular and intracellular phosphodiesterase than cyclic GMP.", "PM": "91; was see under GUANOSINE CYCLIC MONOPHOSPHATE 1980-90; was see under GUANOSINE CYCLIC-3',5'-MONOPHOSPHATE 1978-79", "HN": "91(78); was see under GUANOSINE CYCLIC MONOPHOSPHATE 1980-90; was see under GUANOSINE CYCLIC-3',5'-MONOPHOSPHATE 1978-79", "MR": "20160529", "DA": "19770520", "DC": "1", "DX": "19910101", "UI": "D003995"}, {"RECTYPE": "D", "MH": "Dicamba", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.657.410.595.202", "PA": "Herbicides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Benzoic acid, 3,6-dichloro-2-methoxy-", "RN": "SJG3M6RY6H", "RR": "1918-00-9 (Dicamba)", "PI": "Herbicides (1966-1971)", "MS": "A chlorinated organic herbicide.", "PM": "91; was see under BENZOATES 1972-90", "HN": "91(72); was see under BENZOATES 1972-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D003996"}, {"RECTYPE": "D", "MH": "Dicarbethoxydihydrocollidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diethoxycarbonyldihydrocollidine|T109|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "3,5-Diethoxycarbonyl-1,4-Dihydro-2,4,6-Trimethylpyridine|T109|NON|EQV|UNK (19XX)|820331|abcdef", "MN": "D03.383.725.203.200", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,4,6-trimethyl-, diethyl ester", "RN": "632-93-9", "PI": "Pyridines (1972-1974)", "MS": "1,4-Dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylic acid diethyl ester.", "PM": "91; was see under DIHYDROPYRIDINES 1975-90", "HN": "91(75); was see under DIHYDROPYRIDINES 1975-90", "MR": "20160529", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D003997"}, {"RECTYPE": "D", "MH": "Dicarboxylic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Dicarboxylic", "MN": "D02.241.081.337", "MH_TH": "NLM (1965)", "ST": "T109", "RN": "0", "MS": "Acyclic acids that contain two carboxyl groups and have the formula HO2C-R-CO2H, where R may be an aromatic or aliphatic group.", "PM": "68", "HN": "68(65)", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D003998"}, {"RECTYPE": "D", "MH": "Dichloroacetic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sodium Dichloroacetate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|USAN (19XX)|801205|abbcdeeef", "ENTRY": "Dichloroacetate, Sodium", "MN": "D02.455.526.439.196.500", "EC": "analogs & derivatives:Chloroacetates", "MH_TH": "UNK (19XX)", "ST": "T121", "RN": "9LSH52S3LQ", "RR": "79-43-6 (Dichloroacetic Acid)", "PI": "Acetic Acids (1968-1977)", "MS": "A derivative of ACETIC ACID that contains two CHLORINE atoms attached to its methyl group.", "PM": "1991; see ACETIC ACIDS 1978-1990, see DICHLOROACETATE 1991-2012", "HN": "2013(1978); use ACETIC ACIDS 1978-1990", "MR": "20130708", "DA": "19770520", "DC": "1", "DX": "19910101", "UI": "D003999"}, {"RECTYPE": "D", "MH": "Dichloroethylenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vinylidene Chlorides|T109|T131|NON|EQV|UNK (19XX)|750715|abbcdef", "ENTRY": "Chlorides, Vinylidene", "MN": "D02.455.526.439.350", "MH_TH": "NLM (1976)", "ST": "T131", "RN": "0", "AN": "do not confuse with ETHYLENE DICHLORIDES", "PI": "Hydrocarbons, Chlorinated (1974-1975)", "MS": "Toxic chlorinated unsaturated hydrocarbons. Include both the 1,1- and 1,2-dichloro isomers. Both isomers are toxic, but 1,1-dichloroethylene is the more potent CNS depressant and hepatotoxin. It is used in the manufacture of thermoplastic polymers.", "PM": "91; was see under HYDROCARBONS, CHLORINATED 1976-90", "HN": "91(76); was see under HYDROCARBONS, CHLORINATED 1976-90", "MR": "20000622", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D004000"}, {"RECTYPE": "D", "MH": "Clodronic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dichloromethylene Diphosphonate|T109|T121|NON|EQV|NLM (1993)|920310|abbcdef", "ENTRY": "Sodium, Clodronate", "MN": "D02.705.429.500.200", "PA": "Bone Density Conservation Agents", "MH_TH": "USAN (1977)", "ST": "T121", "N1": "Phosphonic acid, (dichloromethylene)bis-", "RN": "0813BZ6866", "RR": "N030400H8J", "PI": "Phosphonic Acids (1966-1976)", "MS": "A diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification.", "OL": "use CLODRONIC ACID to search DICHLOROMETHYLENE DIPHOSPHONATE 1977-92", "PM": "93; was DICHLOROMETHYLENE DIPHOSPHONATE 1977-92 (see under DIPHOSPHONATES 1977-90)", "HN": "93; was DICHLOROMETHYLENE DIPHOSPHONATE 1977-92 (see under DIPHOSPHONATES 1977-90)", "MR": "20130708", "DA": "19760419", "DC": "1", "DX": "19910101", "UI": "D004002"}, {"RECTYPE": "D", "MH": "Dichlorophen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Panacide|T109|T121|TRD|REL|UNK (19XX)|801120|abbcdef", "MN": "D02.455.426.559.389.657.190.270", "PA": "Antiprotozoal Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Phenol, 2,2'-methylenebis(4-chloro)-", "RN": "T1J0JOU64O", "RR": "97-23-4 (Dichlorophen)", "PI": "Phenols (1966-1974)", "MS": "Nontoxic laxative vermicide effective for taenia infestation. It tends to produce colic and nausea. It is also used as a veterinary fungicide, anthelmintic, and antiprotozoan. (From Merck, 11th ed.)", "PM": "75", "HN": "75", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D004003"}, {"RECTYPE": "D", "MH": "Dichlororibofuranosylbenzimidazole", "DE": "DCRFB", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dichlorobenzimidazole Riboside|T114|T121|NON|EQV|UNK (19XX)|780308|abbcdef", "ENTRY": "Riboside, Dichlorobenzimidazole", "MN": "D13.570.800.330", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "NLM (1979)", "ST": "T121", "N1": "1H-Benzimidazole, 5,6-dichloro-1-beta-D-ribofuranosyl-", "RN": "53-85-0", "PI": "Ribonucleosides (1971-1978)", "MS": "An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.", "PM": "91; was see under RIBONUCLEOSIDES 1979-90", "HN": "91(79); was see under RIBONUCLEOSIDES 1979-90", "MR": "19980610", "DA": "19780308", "DC": "1", "DX": "19910101", "UI": "D004004"}, {"RECTYPE": "D", "MH": "Dichlorphenamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diclofenamid|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Glauconide|T109|T121|TRD|NRW|ES|041213|abbcdef", "MN": "D02.886.590.700.410", "PA": "Carbonic Anhydrase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,3-Benzenedisulfonamide, 4,5-dichloro-", "RN": "VVJ6673MHY", "RR": "120-97-8 (Dichlorphenamide)", "MS": "A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004005"}, {"RECTYPE": "D", "MH": "Dichlorvos", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "PRINT ENTRY": "DDVP|T109|T131|ABB|EQV|FDA SRS (2014)|UNK (19XX)|740329|abbcdeef", "ENTRY": "Phosphoric acid 2,2 dichloroethenyl dimethyl ester", "MN": "D02.705.400.130", "PA": "Insecticides", "MH_TH": "USAN (1972)", "ST": "T131", "N1": "Phosphoric acid, 2,2-dichloroethenyl dimethyl ester", "RN": "7U370BPS14", "RR": "62-73-7 (Dichlorvos)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Organophosphorus Compounds (1966-1970)", "MS": "An organophosphorus insecticide that inhibits ACETYLCHOLINESTERASE.", "PM": "73", "HN": "73(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004006"}, {"RECTYPE": "D", "MH": "Dichotic Listening Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Dichotic Listening", "MN": "E01.370.382.375.200", "MH_TH": "NLM (1980)", "ST": "T060", "AN": "dichotic refers to the \"competing message technique\"", "PI": "Perception (1966)", "MS": "Tests for central hearing disorders based on the competing message technique (binaural separation).", "PM": "91; was see under HEARING TESTS 1980-90", "HN": "91(80); was see under HEARING TESTS 1980-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19781214", "DC": "1", "DX": "19910101", "UI": "D004007"}, {"RECTYPE": "D", "MH": "Diclofenac", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diclophenac|T109|T121|NON|EQV|UNK (19XX)|760412|abbcdef", "ENTRY": "SR38", "MN": "D02.241.223.601.210", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-", "RN": "144O8QL0L1", "RR": "QTG126297Q", "PI": "Phenylacetates (1973-1976)", "MS": "A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.", "PM": "1986; see PHENYLACETATES 1977-1985; for DICLOFENAC SODIUM see 2000-2001", "HN": "1986(1977)", "MR": "20130708", "DA": "19760413", "DC": "1", "DX": "19860101", "UI": "D004008"}, {"RECTYPE": "D", "MH": "Dicloxacillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dichloroxacillin|T109|T195|NON|EQV|UNK (19XX)|840213|abbcdef", "ENTRY": "Sodium, Dicloxacillin", "MN": "D03.633.100.300.750.625.150.205", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1965)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-", "RN": "COF19H7WBK", "RR": "4HZT2V9KX0", "MS": "One of the PENICILLINS which is resistant to PENICILLINASE.", "PM": "73", "HN": "73(66)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004009"}, {"RECTYPE": "D", "MH": "Dicofol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Kelthane|T109|T131|TRD|NRW|UNK (19XX)|800825|abbcdef", "MN": "D02.455.526.439.202.190", "PA": "Insecticides", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Benzenemethanol, 4-chloro-alpha-(4-chlorophenyl)-alpha-(trichloromethyl)-", "RN": "W4WMM0WS91", "RR": "115-32-2 (Dicofol)", "PI": "Insecticides, Organochlorine (1973-1974)", "MS": "An organochlorine insecticide.", "PM": "91; was see under INSECTICIDES, ORGANOCHLORINE 1975-90", "HN": "91(75); was see under INSECTICIDES, ORGANOCHLORINE 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004010"}, {"RECTYPE": "D", "MH": "Dicrocoeliasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Dicrocoeliases", "MN": "C01.610.335.865.224", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "trematode infect", "PI": "Trematode Infections (1966-1967)", "MS": "Infection with flukes of the genus Dicrocoelium.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004011"}, {"RECTYPE": "D", "MH": "Dicrocoeliidae", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.736.715.300", "MH_TH": "NLM (1982)", "ST": "T204", "RN": "txid73421", "AN": "a family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Trematoda (1966-1997)", "MS": "A family of flattened, translucent flukes (TREMATODA) occurring in the gut, gallbladder, bile ducts, liver or pancreatic ducts of amphibians, reptiles, birds, and mammals. (Noble et al., Parasitology: the Biology of Animal Parasites, 6th ed, p188)", "PM": "98", "HN": "98; use explode 1982-97", "MR": "20200813", "DA": "19810515", "DC": "1", "DX": "19980101", "UI": "D004012"}, {"RECTYPE": "D", "MH": "Dicrocoelium", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "lanceolatums, Dicrocoelium", "MN": "B01.050.500.500.736.715.300.308", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid57077", "RR": "txid57078", "MS": "A genus of trematode liver flukes of the family Dicrocoeliidae which includes the species dendriticum and hospes. It occurs in the biliary passages or liver of many vertebrates including man. The intermediate hosts are mainly mollusks but occasionally ants.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004013"}, {"RECTYPE": "D", "MH": "Dictionaries as Topic", "ENTRY": "Glossaries as Topics", "MN": "L01.462.500.682.192.836.285", "FX": "Terminology as Topic", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with Publication Type DICTIONARY", "MS": "Works about reference books containing words and their meaning.", "PM": "2008; see DICTIONARIES 1963-2007", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D004014"}, {"RECTYPE": "D", "MH": "Dictionaries, Chemical as Topic", "MN": "L01.462.500.682.192.836.285.206", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "do not confuse with the Publication Type DICTIONARY, CHEMICAL ", "MS": "Works about sources listing chemicals and their characteristics.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004015"}, {"RECTYPE": "D", "MH": "Dictionaries, Classical as Topic", "MN": "L01.462.500.682.192.836.285.277", "MH_TH": "NLM (2018)", "ST": "T170", "AN": "do not confuse with the Publication Type DICTIONARY, CLASSICAL", "MS": "Works about or subject matter related to reference works on the Greco-Roman world.", "PM": "2018; See DICTIONARIES, CLASSICAL 1966-2017", "HN": "2018(1966)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004016"}, {"RECTYPE": "D", "MH": "Dictionaries, Dental as Topic", "MN": "L01.462.500.682.192.836.285.348", "MH_TH": "NLM (2018)", "ST": "T170", "AN": "do not confuse with the Publication Type DICTIONARY, DENTAL", "MS": "Works about or subject matter related to reference works listing and describing concepts related to oral medicine and dentistry.", "PM": "2018; See DICTIONARIES, DENTAL 1966-2017", "HN": "2018(1966)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004017"}, {"RECTYPE": "D", "MH": "Dictionaries, Medical as Topic", "MN": "L01.462.500.682.192.836.842.385", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "do not confuse with the Publication Type DICTIONARY, MEDICAL", "MS": "Works about or subject matter related to reference works listing and describing concepts related to medicine.", "PM": "2018; See DICTIONARIES, MEDICAL 1966-2017", "HN": "2018(1966)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004018"}, {"RECTYPE": "D", "MH": "Dictionaries, Pharmaceutic as Topic", "ENTRY": "Pharmacy Dictionary|T073|T170|NON|EQV|NLM (1994)|930122|abbcdef", "MN": "L01.462.500.682.192.836.285.490", "MH_TH": "NLM (2018)", "ST": "T170", "AN": "do not confuse with the Publication Type DICTIONARY, PHARMACEUTIC", "MS": "Works about specialized reference lists and descriptions of drugs and related concepts.", "PM": "2018; See DICTIONARIES, PHARMACEUTIC 1966-2017", "HN": "2018(1966)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004019"}, {"RECTYPE": "D", "MH": "Dictionary, Polyglot", "PRINT ENTRY": "Dictionaries, Polyglot|T073|T170|NON|EQV|NLM (2020)|190701|abbcdef", "MN": "V02.310.475", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Polyglot Dictionaries as a subject are indexed under the main heading DICTIONARIES AS TOPIC.  INDEXER: Do not use  ", "MS": "Reference list of definitions of words repeated in several languages.", "HN": "2018(1966)", "MR": "20190705", "DA": "19990101", "DC": "2", "DX": "19660101", "UI": "D004020"}, {"RECTYPE": "D", "MH": "Dictyocaulus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.294.400.968.746.300", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid29171", "MS": "Nematodes parasitic in the bronchi of herbivorous animals.", "PM": "91; was see under TRICHOSTRONGYLOIDEA 1986-90; was see under METASTRONGYLOIDEA 1975-85", "HN": "91(75); was see under TRICHOSTRONGYLOIDEA 1986-90; was see under METASTRONGYLOIDEA 1975-85", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004021"}, {"RECTYPE": "D", "MH": "Dictyocaulus Infections", "DE": "DICTYOCAULUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Dictyocauliasis|T047|NON|EQV|UNK (19XX)|810518|abcdef", "ENTRY": "Infection, Dictyocaulus", "MN": "C22.674.377.315", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "nematode infect; usually animal; check tag ANIMALS", "PI": "Nematode Infections (1966-1967)", "MS": "Infection with nematodes of the genus DICTYOCAULUS. In deer, cattle, sheep, and horses the bronchi are the site of infestation.", "OL": "use DICTYOCAULUS INFECTIONS to search DICTYOCAULUS INFECTION 1982-92 & DICTYOCAULIASIS 1968-81", "PM": "93; was DICTYOCAULUS INFECTION 1982-92; was DICTYOCAULIASIS 1968-81", "HN": "93; was DICTYOCAULUS INFECTION 1982-92; was DICTYOCAULIASIS 1968-81", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004022"}, {"RECTYPE": "D", "MH": "Dictyostelium", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Dictyostelium discoideum|T204|NON|NRW|NLM (1992)|910214|abcdef", "ENTRY": "discoideum, Dictyostelium", "MN": "B01.046.550.200.300", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid5782", "RR": "txid44689", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Myxomycetes (1966-1974)", "MS": "A genus of protozoa, formerly also considered a fungus. Its natural habitat is decaying forest leaves, where it feeds on bacteria. D. discoideum is the best-known species and is widely used in biomedical research.", "PM": "79; see MYXOMYCETES 1975-78", "HN": "79(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19790101", "UI": "D004023"}, {"RECTYPE": "D", "MH": "Dicyclohexylcarbodiimide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DCCD|T109|T130|ABB|EQV|NLM (1997)|950713|abbcdef", "MN": "D02.491.203.385", "MH_TH": "NLM (1973)", "ST": "T130", "N1": "Cyclohexanamine, N,N'-methanetetraylbis-", "RN": "538-75-0", "MS": "A carbodiimide that is used as a chemical intermediate and coupling agent in peptide synthesis. (From Hawley's Condensed Chemical Dictionary, 12th ed)", "PM": "91; was see under CARBODIIMIDES 1973-90", "HN": "91(73); was see under CARBODIIMIDES 1973-90", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004024"}, {"RECTYPE": "D", "MH": "Dicyclomine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dicycloverin|T109|T121|NON|EQV|INN (19XX)|UNK (19XX)|750630|abbcdeef", "ENTRY": "OR Tyl", "MN": "D02.455.426.392.368.367.440", "PA": "Parasympatholytics", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "(1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(diethylamino)ethyl ester", "RN": "4KV4X8IF6V", "RR": "CQ903KQA31", "PI": "Diethylamines (1974-1975)", "MS": "A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms.", "PM": "91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1976-90", "HN": "91(76); was see under CYCLOHEXANECARBOXYLIC ACIDS 1976-90", "MR": "20160705", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D004025"}, {"RECTYPE": "D", "MH": "Dieldrin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Alvit55", "MN": "D02.455.526.439.371", "MH_TH": "INN (19XX)", "ST": "T131", "N1": "2,7:3,6-Dimethanonaphth(2,3-b)oxirene, 3,4,5,6,9,9-hexachloro-1a,2,2a,3,6,6a,7,7a-octahydro-, (1aalpha,2beta,2aalpha,3beta,6beta,6aalpha,7beta,7aalpha)-", "RN": "I0246D2ZS0", "RR": "60-57-1 (Dieldrin)", "MS": "An organochlorine insecticide whose use has been cancelled or suspended in the United States. It has been used to control locusts, tropical disease vectors, in termite control by direct soil injection, and non-food seed and plant treatment. (From HSDB)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004026"}, {"RECTYPE": "D", "MH": "Diencephalon", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Interbrains", "MN": "A08.186.211.200.317", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The paired caudal parts of the PROSENCEPHALON from which the THALAMUS; HYPOTHALAMUS; EPITHALAMUS; and SUBTHALAMUS are derived.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004027"}, {"RECTYPE": "D", "MH": "Dienestrol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Synestrol|T109|T121|TRD|NRW|UNK (19XX)|830915|abbcdef", "MN": "D02.455.426.559.389.657.290", "PA": "Estrogens, Non-Steroidal", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Phenol, 4,4'-(1,2-diethylidene-1,2-ethanediyl)bis-", "RN": "RRW32X4U1F", "RR": "84-17-3 (Dienestrol)", "PI": "Phenols (1969-1974)", "MS": "A synthetic, non-steroidal estrogen structurally related to stilbestrol. It is used, usually as the cream, in the treatment of menopausal and postmenopausal symptoms.", "PM": "91; was see under PHENOLS 1975-90", "HN": "91(75); was see under PHENOLS 1975-90", "MR": "20190705", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004028"}, {"RECTYPE": "D", "MH": "Dientamoeba", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Dientamoebas", "MN": "B01.630.800.180", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid43351", "MS": "A genus of minute EUKARYOTES that are characterized by the preponderance of binucleate over uninucleate forms, the presence of several distinct granules in the karyosome, and the lack of a cystic stage. It is parasitic in the large intestine of humans and certain monkeys.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004029"}, {"RECTYPE": "D", "MH": "Dientamoebiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Dientamoeba fragilis", "MN": "C06.405.469.452.275", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Gastrointestinal infection with organisms of the genus DIENTAMOEBA.", "OL": "use AMEBIASIS to search DIENTAMOEBIASIS 1967-74", "PM": "91; was see under PROTOZOAN INFECTIONS 1990; was see under AMEBIASIS 1967-89", "HN": "91(75); was see under PROTOZOAN INFECTIONS 1990; was see under AMEBIASIS 1967-89", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004030"}, {"RECTYPE": "D", "MH": "Diestrus", "AQ": "BL CF DE GE IM ME PH RE UR", "MN": "G08.686.195.374", "MH_TH": "NLM (1975)", "ST": "T079", "AN": "non-primate mammals only", "MS": "A phase of the ESTROUS CYCLES that follows METESTRUS. Diestrus is a period of sexual quiescence separating phases of ESTRUS in polyestrous animals.", "PM": "91; was see under ESTRUS 1975-90", "HN": "91(75); was see under ESTRUS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004031"}, {"RECTYPE": "D", "MH": "Diet", "AQ": "AE CL EC EH ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Diets", "MN": "G07.203.650.240", "FX": "Cooking", "EC": "therapeutic use:Diet Therapy", "MH_TH": "NLM (1993)", "ST": "T078", "AN": "general or unspecified; prefer specific diets; DIET THERAPY and specifics are also available; /trends: do not confuse with DIET FADS; in veterinary journals consider also ANIMAL FEED; SILAGE; etc.", "MS": "Regular course of eating and drinking adopted by a person or animal.", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004032"}, {"RECTYPE": "D", "MH": "Diet Fads", "AQ": "AE EH HI PX", "PRINT ENTRY": "Food Fads|T061|NON|BRD|UNK (19XX)|740329|abcdef", "ENTRY": "Food Fad", "MN": "I03.287", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Diets which become fashionable, but which are not necessarily nutritious.(Lehninger 1982, page 484)", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004033"}, {"RECTYPE": "D", "MH": "Diet Surveys", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Surveys, Diet", "MN": "N06.850.520.308.980.469.350", "MH_TH": "NLM (1975)", "ST": "T058", "MS": "Systematic collections of factual data pertaining to the diet of a human population within a given geographic area.", "OL": "use NUTRITION SURVEYS to search DIET SURVEYS 1966-74", "PM": "91; was see under NUTRITION SURVEYS 1975-90", "HN": "91(75); was see under NUTRITION SURVEYS 1975-90", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004034"}, {"RECTYPE": "D", "MH": "Diet Therapy", "DE": "DIET THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Restrictive Diet Therapy|T061|NON|NRW|NLM (2020)|190611|abcdef", "ENTRY": "Therapy, Restrictive Diet", "MN": "E02.642.249", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general only: prefer /diet ther with disease term", "MS": "Adjusting the quantity and quality of food intake to improve health status of an individual. This term does not include the methods of food intake (NUTRITIONAL SUPPORT).", "PM": "1966; for DIETARY MODIFICATION see FOOD HABITS 1992-2016", "HN": "1966; for DIETARY MODIFICATION use FOOD HABITS 1992-2016", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004035"}, {"RECTYPE": "D", "MH": "Diet, Atherogenic", "AQ": "AE CL EC EH ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Diets, Atherogenic", "MN": "G07.203.650.240.242", "FX": "Cholesterol, Dietary", "MH_TH": "NLM (1967)", "ST": "T080", "PI": "Diet (1966)", "MS": "A diet that contributes to the development and acceleration of ATHEROGENESIS.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004036"}, {"RECTYPE": "D", "MH": "Diet, Cariogenic", "AQ": "AE CL EC EH ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Diets, Cariogenic", "MN": "G07.203.650.240.255", "FX": "Cariogenic Agents", "MH_TH": "NLM (1972)", "ST": "T080", "PI": "Diet (1966-1971)", "MS": "A consistent pattern of food and drink consumption that contributes to the development and advancement of DENTAL CARIES.", "PM": "73", "HN": "73(72)", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004037"}, {"RECTYPE": "D", "MH": "Diet, Reducing", "AQ": "AE CL EC EH ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Weight Reduction Diets", "MN": "G07.203.650.240.285", "FX": "Weight Reduction Programs", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "coordinate IM with specific disease / diet ther (IM) if pertinent", "MS": "A diet designed to cause an individual to lose weight.", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004038"}, {"RECTYPE": "D", "MH": "Diet, Sodium-Restricted", "AQ": "AE CL EC EH HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Diet, Low-Sodium|T061|NON|EQV|NLM (1995)|930915|abcdef", "ENTRY": "Sodium-Restricted Diets", "MN": "G07.203.650.240.290", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "coord IM with specific dis /diet ther (IM)", "MS": "A diet which contains very little sodium chloride. It is prescribed by some for hypertension and for edematous states. (Dorland, 27th ed)", "OL": "use DIET, SODIUM-RESTRICTED to search DIET, SALT-FREE 1966-79", "PM": "80; was DIET, SALT-FREE 1963-79", "HN": "80; was DIET, SALT-FREE 1963-79", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D004039"}, {"RECTYPE": "D", "MH": "Dietary Carbohydrates", "AQ": "AD AE AG AI AN BL CF CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbohydrates, Dietary|T109|T168|NON|EQV|NLM (1997)|960417|abbcdef", "ENTRY": "Dietary Carbohydrate", "MN": "J02.500.362", "FX": "Diet, Carbohydrate Loading", "EC": "deficiency:Carbohydrates:deficiency", "MH_TH": "NLM (1964)", "ST": "T168", "RN": "0", "AN": "/adv eff: coordinate with disease /etiol, not /chem ind; /ther use: coordinate with specific disease /diet ther", "MS": "Carbohydrates present in food comprising digestible sugars and starches and indigestible cellulose and other dietary fibers. The former are the major source of energy. The sugars are in beet and cane sugar, fruits, honey, sweet corn, corn syrup, milk and milk products, etc.; the starches are in cereal grains, legumes (FABACEAE), tubers, etc. (From Claudio & Lagua, Nutrition and Diet Therapy Dictionary, 3d ed, p32, p277)", "PM": "64", "HN": "64", "MR": "20160502", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D004040"}, {"RECTYPE": "D", "MH": "Dietary Fats", "AQ": "AD AE AG AI AN BL CF CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fats, Dietary|T109|T168|NON|EQV|NLM (1997)|960417|abbcdef", "ENTRY": "Fat, Dietary", "MN": "J02.500.375", "EC": "deficiency:Lipids:deficiency", "MH_TH": "NLM (1964)", "ST": "T168", "RN": "0", "AN": "/adv eff: coordinate with disease /etiol, not /chem ind; /ther use: coordinate with specific disease /diet ther", "MS": "Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados.", "PM": "64", "HN": "64", "MR": "20141218", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D004041"}, {"RECTYPE": "D", "MH": "Dietary Fats, Unsaturated", "AQ": "AD AE AG AI AN BL CF CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Unsaturated Dietary Fats|T109|T168|NON|EQV|UNK (19XX)|860603|abbcdef", "ENTRY": "Unsaturated Dietary Fat", "MN": "J02.500.375.400", "EC": "chemistry:Fats, Unsaturated:chemistry", "MH_TH": "NLM (1987)", "ST": "T168", "RN": "0", "AN": "/adv eff: coord with disease /etiol, not /chem /ind; /ther use: coord with specific disease /diet ther", "PI": "Oils (1966-1986)", "MS": "Unsaturated fats or oils used in foods or as a food.", "PM": "87", "HN": "87", "MR": "20141014", "DA": "19860603", "DC": "1", "DX": "19870101", "UI": "D004042"}, {"RECTYPE": "D", "MH": "Dietary Fiber", "AQ": "AD AE AN CL DF EC HI ME MI PD PO PS RE SD SN ST TO TU VI", "PRINT ENTRY": "Roughage|T168|NON|REL|UNK (19XX)|760427|abcdef", "ENTRY": "Wheat Brans", "MN": "J02.500.400", "MH_TH": "NLM (1977)", "ST": "T168", "RN": "0", "AN": "\u200c/\u200cadv \u200ceff: coordinate with disease  /etiol, not  \u200c/\u200cchem\u200c ind;  \u200c/\u200cther \u200cuse: coordinate with specific disease \u200c/\u200cdiet \u200cther; low- or high-fiber diet: use /admin", "MS": "The remnants of plant cell walls that are resistant to digestion by the alimentary enzymes of man. It comprises various polysaccharides and lignins.", "PM": "82; was see under CELLULOSE 1977-81", "HN": "82(77); was see under CELLULOSE 1977-81", "MR": "20170501", "DA": "19760427", "DC": "1", "DX": "19820101", "UI": "D004043"}, {"RECTYPE": "D", "MH": "Dietary Proteins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Proteins, Dietary|T116|NON|EQV|NLM (1997)|960417|abcdef", "ENTRY": "Protein, Dietary", "MN": "J02.500.428", "FX": "Protein Deficiency", "EC": "deficiency:Protein Deficiency", "MH_TH": "NLM (1966)", "ST": "T116", "RN": "0", "AN": "general or unspecified; prefer specifics; \u200c/\u200cadv \u200ceff: coordinate with disease /etiol, not \u200c/\u200cchem\u200c ind;  \u200c/\u200cther \u200cuse: coordinate with disease  \u200c/\u200cdiet \u200cther", "MS": "Proteins obtained from foods. They are the main source of the ESSENTIAL AMINO ACIDS.", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004044"}, {"RECTYPE": "D", "MH": "Dietary Services", "DE": "DIETARY SERV", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Service, Dietary", "MN": "N02.421.242", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "emphasis on nutrition: differentiate from FOOD SERVICES, mere preparation and distribution of \"ready-to-eat food\"", "PI": "Food Service, Hospital (1966-1967)", "MS": "Services provided by dietitians or nutritionists to meet the nutritional needs of individuals, including consultation with other professional personnel.", "PM": "68", "HN": "68", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004045"}, {"RECTYPE": "D", "MH": "Dietetics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.533.290", "FX": "Food Service, Hospital", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "The application of nutritional principles to regulation of the diet and feeding persons or groups of persons.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004046"}, {"RECTYPE": "D", "MH": "Diethyl Pyrocarbonate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Pyrocarbonic Acid Diethyl Ester|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741024|abbcdeef", "ENTRY": "Pyrocarbonate, Diethyl", "MN": "D02.241.081.420.750.250", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Dicarbonic acid, diethyl ester", "RN": "LMR3LZG146", "RR": "1609-47-8 (Diethyl Pyrocarbonate)", "PI": "Formic Acids (1974)", "MS": "Preservative for wines, soft drinks, and fruit juices and a gentle esterifying agent.", "PM": "91; was see under FORMATES 1975-90", "HN": "91(75); was see under FORMATES 1975-90", "MR": "20130708", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D004047"}, {"RECTYPE": "D", "MH": "Diethylamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.092.471.302", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Diethylamine with the formula CH3CH2NHCH2CH3 and its derivatives.", "PM": "74", "HN": "74", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004048"}, {"RECTYPE": "D", "MH": "Diethylcarbamazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbamazine|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef", "ENTRY": "Monohydrochloride, Diethylcarbamazine", "MN": "D03.383.606.380", "PA": "Lipoxygenase Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Piperazinecarboxamide, N,N-diethyl-4-methyl-", "RN": "V867Q8X3ZD", "RR": "OS1Z389K8S", "AN": "do not confuse entry term CARBAMAZINE with CARBAMAZEPINE", "MS": "An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004049"}, {"RECTYPE": "D", "MH": "Ditiocarb", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Diethyldithiocarbamate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1994)|921203|abbcdeef", "ENTRY": "Zinc Salt Ditiocarb", "MN": "D02.886.706.200", "PA": "Chelating Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Carbamodithioic acid, diethyl-", "RN": "99Z2744345", "RR": "A5304YEB5E", "PI": "Thiocarbamates (1969-1974)", "MS": "A chelating agent that has been used to mobilize toxic metals from the tissues of humans and experimental animals. It is the main metabolite of DISULFIRAM.", "OL": "use DITIOCARB to search DIETHYLDITHIOCARBAMATE 1973-93", "PM": "94; was DIETHYLDITHIOCARBAMATE 1973-93 (see under THIOCARBAMATES 1973-86); DITIOCARB was see DIETHYLDITHIOCARBAMATE 1992-93", "HN": "94; was DIETHYLDITHIOCARBAMATE 1973-93 (see under THIOCARBAMATES 1973-86); DITIOCARB was see DIETHYLDITHIOCARBAMATE 1992-93", "MR": "20150527", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D004050"}, {"RECTYPE": "D", "MH": "Diethylhexyl Phthalate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dioctyl Phthalate|T109|T122|NON|EQV|UNK (19XX)|741127|abbcdef", "ENTRY": "Phthalate, Dioctyl", "MN": "D02.241.223.805.250", "PA": "Plasticizers", "MH_TH": "NLM (1975)", "ST": "T122", "N1": "1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester", "RN": "C42K0PH13C", "RR": "117-81-7 (Diethylhexyl Phthalate)", "PI": "Phthalic Acids (1969-1974)", "MS": "An ester of phthalic acid. It appears as a light-colored, odorless liquid and is used as a plasticizer for many resins and elastomers.", "PM": "91; was see under PHTHALIC ACIDS 1975-90", "HN": "91(75); was see under PHTHALIC ACIDS 1975-90", "MR": "20170224", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D004051"}, {"RECTYPE": "D", "MH": "Diethylnitrosamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrosodiethylamine|T109|T131|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "N Nitrosodiethylamine", "MN": "D02.654.442.200", "PA": "Alkylating Agents", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Ethanamine, N-ethyl-N-nitroso-", "RN": "3IQ78TTX1A", "RR": "55-18-5 (Diethylnitrosamine)", "PI": "Nitrosamines (1969-1974)", "MS": "A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.", "PM": "86; was see under NITROSAMINES 1975-85", "HN": "86(75); was see under NITROSAMINES 1975-85", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19860101", "UI": "D004052"}, {"RECTYPE": "D", "MH": "Diethylpropion", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amfepramon|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef", "ENTRY": "Norex, Ifa", "MN": "D02.092.471.308", "PA": "Appetite Depressants", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "1-Propanone, 2-(diethylamino)-1-phenyl-", "RN": "Q94YYU22B8", "RR": "90-84-6 (Diethylpropion)", "MS": "A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p2290)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004053"}, {"RECTYPE": "D", "MH": "Diethylstilbestrol", "DE": "DES", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Stilbestrol|T109|NRW|FDA SRS (2014)|NLM (19XX)|740329|abdeef", "ENTRY": "Estrogen, Stilbene", "MN": "D02.455.426.559.389.150.700.725.500", "PA": "Estrogens, Non-Steroidal", "MH_TH": "USP (19XX)", "ST": "T131", "N1": "Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, (E)-", "RN": "731DCA35BT", "RR": "6898-97-1 (cpd w/o stereochem designation)", "MS": "A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004054"}, {"RECTYPE": "D", "MH": "Differential Thermal Analysis", "DE": "DIFFER THERMAL ANAL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Thermal Analyses, Differential", "MN": "E05.196.370", "MH_TH": "NLM (1977)", "ST": "T059", "AN": "NIM", "PI": "Thermodynamics (1966-1976)", "MS": "Technique by which phase transitions of chemical reactions can be followed by observation of the heat absorbed or liberated.", "PM": "91; was see under CHEMISTRY, ANALYTICAL 1977-90", "HN": "91(77); was see under CHEMISTRY, ANALYTICAL 1977-90", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D004055"}, {"RECTYPE": "D", "MH": "Differential Threshold", "DE": "DIFFER THRESHOLD", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Weber-Fechner Law|T081|T170|EPO|NRW|UNK (19XX)|740329|abbcdef", "ENTRY": "Weber Fechner Law", "MN": "F02.463.593.710.370", "MH_TH": "NLM (1972)", "ST": "T081", "AN": "NIM", "PI": "Psychophysics (1970-1971)", "MS": "The smallest difference which can be discriminated between two stimuli or one which is barely above the threshold.", "PM": "74", "HN": "74(72)", "CATSH": "CAT LIST", "MR": "20230615", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004056"}, {"RECTYPE": "D", "MH": "Hyperostosis, Diffuse Idiopathic Skeletal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vertebral Ankylosing Hyperostosis|T047|NON|EQV|UNK (19XX)|840406|abcdef", "ENTRY": "Vertebral Ankylosing Hyperostoses", "MN": "C05.116.900.815.651", "MH_TH": "NLM (1985)", "ST": "T047", "PI": "Spondylitis, Ankylosing (1966-1984)", "MS": "A disease of elderly men characterized by large osteophytes that bridge vertebrae and ossification of ligaments and tendon insertions.", "OL": "use HYPEROSTOSIS, DIFFUSE IDIOPATHIC SKELETAL to search DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS 1985-89", "PM": "91; was see under SPINAL OSTEOPHYTOSIS 1990; was DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS see under SPINAL OSTEOPHYTOSIS 1985-89", "HN": "91(90); was see under SPINAL OSTEOPHYTOSIS 1990; was DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS see under SPINAL OSTEOPHYTOSIS 1985-89", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19840406", "DC": "1", "DX": "19910101", "UI": "D004057"}, {"RECTYPE": "D", "MH": "Diffusion", "AQ": "DE RE", "ENTRY": "Diffusions", "MN": "G02.196", "MH_TH": "NLM (1968)", "ST": "T070", "PI": "Chemistry, Physical (1966-1967)", "MS": "The tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space. Diffusion, especially FACILITATED DIFFUSION, is a major mechanism of BIOLOGICAL TRANSPORT.", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D004058"}, {"RECTYPE": "D", "MH": "Diffusion of Innovation", "PRINT ENTRY": "Innovation Diffusion|T078|NON|EQV|UNK (19XX)|790531|abcdef", "ENTRY": "Diffusion, Innovation", "MN": "L01.143.320", "FX": "Information Dissemination", "MH_TH": "NLM (1980)", "ST": "T078", "MS": "The broad dissemination of new ideas, procedures, techniques, materials, and devices and the degree to which these are accepted and used.", "PM": "91; was see under COMMUNICATION 1980-90", "HN": "91(80); was see under COMMUNICATION 1980-90", "MR": "20180227", "DA": "19790531", "DC": "1", "DX": "19910101", "UI": "D004059"}, {"RECTYPE": "D", "MH": "Diflucortolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro 107614", "MN": "D04.210.500.908.405.250", "PA": "Glucocorticoids", "MH_TH": "USAN (1967)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16-methyl-, (6alpha,11beta,16alpha)-", "RN": "K253365DXI", "RR": "2607-06-9 (Diflucortolone)", "PI": "Pregnanes (1968-1972)", "MS": "A topical glucocorticoid used in various DERMATOSES. It is absorbed through the skin, bound to plasma albumin, and may cause adrenal suppression. It is also administered as the valerate.", "PM": "91; was see under FLUOCORTOLONE 1980-90", "HN": "91(80); was see under FLUOCORTOLONE 1980-90", "MR": "20160531", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D004060"}, {"RECTYPE": "D", "MH": "Diflunisal", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NuDiflunisal", "MN": "D02.455.426.559.389.657.410.595.303", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "(1,1'-Biphenyl)-3-carboxylic acid, 2',4'-difluoro-4-hydroxy-", "RN": "7C546U4DEN", "RR": "22494-42-4 (Diflunisal)", "PI": "Salicylic Acids (1966-1979)", "MS": "A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN.", "PM": "90; was see under SALICYLIC ACIDS 1980-89", "HN": "90(80); was see under SALICYLIC ACIDS 1980-89", "MR": "20160705", "DA": "19790530", "DC": "1", "DX": "19900101", "UI": "D004061"}, {"RECTYPE": "D", "MH": "DiGeorge Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Velocardiofacial Syndrome|T047|NON|NRW|GHR (2014)|NLM (2006)|OMIM (2013)|ORD (2010)|041019|abcdeeeef", "ENTRY": "Velo Cardio Facial Syndrome", "MN": "C19.642.482.500.500", "FX": "Claudin-5", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Thymus Gland (1966-1976)", "MS": "Congenital syndrome characterized by a wide spectrum of characteristics including the absence of the THYMUS and PARATHYROID GLANDS resulting in T-cell immunodeficiency, HYPOCALCEMIA, defects in the outflow tract of the heart, and craniofacial anomalies.", "PM": "91; was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1977-90", "HN": "91(77); was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1977-90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D004062"}, {"RECTYPE": "D", "MH": "Digestion", "AQ": "DE EH GE IM PH RE", "MN": "G10.261.190", "MH_TH": "NLM (1966)", "ST": "T042", "MS": "The process of breakdown of food for metabolism and use by the body.", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004063"}, {"RECTYPE": "D", "MH": "Digestive System", "AQ": "AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PP PS RE UL VI", "ENTRY": "Alimentary System|T022|NON|EQV|NLM (2003)|010921|abcdef", "MN": "A03", "RH": "A3 - ANATOMY-DIGESTIVE SYSTEM", "EC": "surgery:Digestive System Surgical Procedures", "MH_TH": "NLM (1972)", "ST": "T022", "PI": "Gastrointestinal System (1966-1971)", "MS": "A group of organs stretching from the MOUTH to the ANUS, serving to breakdown foods, assimilate nutrients, and eliminate waste. In humans, the digestive system includes the GASTROINTESTINAL TRACT and the accessory glands (LIVER; BILIARY TRACT; PANCREAS).", "PM": "1972; see GASTROINTESTINAL SYSTEM 1963-1971", "HN": "1972", "MR": "20080710", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D004064"}, {"RECTYPE": "D", "MH": "Digestive System Abnormalities", "DE": "DIGESTIVE SYSTEM ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Digestive System Abnormality", "MN": "C16.131.314", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics or specific organ /abnorm", "PI": "Digestive System/abnormalities (1968-1997)", "MS": "Congenital structural abnormalities of the DIGESTIVE SYSTEM.", "PM": "98", "HN": "98; use explode 1971-97", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004065"}, {"RECTYPE": "D", "MH": "Digestive System Diseases", "DE": "DIGESTIVE SYSTEM DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hepatobiliary Disorders|T047|NON|NRW|NLM (2020)|190506|abcdef", "ENTRY": "System Disorders, Digestive", "MN": "C06", "RH": "C6 - DISEASES-DIGESTIVE", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "general or unspecified; prefer specifics; refers to all organs of digestive tract: do not confuse with GASTROINTESTINAL DISEASES;  /diag: consider also DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM ", "PI": "Gastrointestinal Diseases (1966-1979)", "MS": "Diseases in any part of the GASTROINTESTINAL TRACT or the accessory organs (LIVER; BILIARY TRACT; PANCREAS).", "PM": "1980", "HN": "1980", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D004066"}, {"RECTYPE": "D", "MH": "Digestive System Neoplasms", "DE": "DIGESTIVE SYSTEM NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Digestive System Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Digestive System", "MN": "C06.301", "MH_TH": "NLM (1980)", "ST": "T191", "AN": "general or unspecified; prefer specifics; refers to all organs and accessory organs (biliary, liver, and pancreas) of the DIGESTIVE TRACT: do not confuse with GASTROINTESTINAL NEOPLASMS (eosphagus, stomach and intestines only); coordinate with histological type of neoplasm ", "PI": "Gastrointestinal Neoplasms (1966-1979)", "MS": "Tumors or cancer of the DIGESTIVE SYSTEM.", "PM": "80", "HN": "80; was NON MESH before 1980", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D004067"}, {"RECTYPE": "D", "MH": "Digestive System Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Digestive System Processes|T042|NON|NRW|NLM (2007)|050920|abcdef", "ENTRY": "Processes, Digestive System", "MN": "G10.261", "MH_TH": "NLM (2009)", "ST": "T042", "AN": "general or unspecified; prefer specifics", "PI": "Digestive System/physiology (1970-1997)", "MS": "Properties and processes of the DIGESTIVE SYSTEM as a whole or of any of its parts.", "PM": "2009; see DIGESTIVE PHYSIOLOGY 1998-2008", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004068"}, {"RECTYPE": "D", "MH": "Digitalis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Foxglove|T002|NON|EQV|UNK (19XX)|850430|abcdef", "ENTRY": "Grecian Foxgloves", "MN": "B01.875.800.575.912.250.583.700.265", "MH_TH": "NLM (1966)", "ST": "T002", "RN": "txid4163", "RR": "txid49450", "AN": "the plant, not the drug which is probably DIGITALIS GLYCOSIDES or specifics", "MS": "A genus of toxic herbaceous Eurasian plants of the Plantaginaceae which yield cardiotonic DIGITALIS GLYCOSIDES. The most useful species are Digitalis lanata and D. purpurea.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004070"}, {"RECTYPE": "D", "MH": "Digitalis Glycosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Glycosides, Digitalis", "MN": "D09.408.180.261", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "cardiotonics; the pharmacological principle in the plant Digitalis", "MS": "Glycosides from plants of the genus DIGITALIS. Some of these are useful as cardiotonic and anti-arrhythmia agents. Included also are semi-synthetic derivatives of the naturally occurring glycosides. The term has sometimes been used more broadly to include all CARDIAC GLYCOSIDES, but here is restricted to those related to Digitalis.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004071"}, {"RECTYPE": "D", "MH": "Digitonin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Digitin|T109|T130|NON|EQV|UNK (19XX)|771213|abbcdef", "MN": "D09.408.180.261.236", "PA": "Indicators and Reagents", "MH_TH": "NLM (1973)", "ST": "T130", "N1": "beta-D-Galactopyranoside, (2alpha,3beta,5alpha,15beta,25R)-2,15-dihydroxyspirostan-3-yl) O-beta-D-glucopyranosyl-(1-3)-O-beta-D-galactopyranosyl-(1-2)-O-(beta-D-xylopyranosyl-(1-3))-O-beta-D-glucopyranosyl-(1-4", "RN": "KOO5CM684H", "RR": "11024-24-1 (Digitonin)", "PI": "Indicators and Reagents (1966-1972)", "MS": "A glycoside obtained from Digitalis purpurea; the aglycone is digitogenin which is bound to five sugars. Digitonin solubilizes lipids, especially in membranes and is used as a tool in cellular biochemistry, and reagent for precipitating cholesterol. It has no cardiac effects.", "PM": "79; was see under DIGITALIS GLYCOSIDES 1975-78", "HN": "79(73); was see under DIGITALIS GLYCOSIDES 1975-78", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D004072"}, {"RECTYPE": "D", "MH": "Digitoxigenin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Uzarigenin|T109|T121|NON|NRW|UNK (19XX)|830901|abbcdef", "MN": "D04.210.500.155.580.130.625.350", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Card-20(22)-enolide, 3,14-dihydroxy-, (3beta,5beta)-", "RN": "143-62-4", "AN": "a Digitalis glycoside; do not confuse with DIGOXIGENIN", "PI": "Cardanolides (1968-1974)", "MS": "3 beta,14-Dihydroxy-5 beta-card-20(22)enolide. A cardenolide which is the aglycon of digitoxin. Synonyms: Cerberigenin; Echujetin; Evonogenin; Thevetigenin.", "OL": "search CARDANOLIDES 1968-74", "PM": "77; was see under CARDANOLIDES 1968-76", "HN": "77(75); was see under CARDANOLIDES 1968-76", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D004073"}, {"RECTYPE": "D", "MH": "Digitoxin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nativelle, Digitaline", "MN": "D09.408.180.261.336", "PA": "Enzyme Inhibitors", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-14-hydroxy-, (3beta,5beta)-", "RN": "E90NZP2L9U", "RR": "71-63-6 (Digitoxin)", "AN": "a Digitalis glycoside; do not confuse with DIGOXIN", "MS": "A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004074"}, {"RECTYPE": "D", "MH": "Diglycerides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diacylglycerols|T109|NON|EQV|UNK (19XX)|771128|abcdef", "MN": "D10.351.303", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "Glycerides composed of two fatty acids esterified to the trihydric alcohol GLYCEROL.  There are two possible forms that exist:  1,2-diacylglycerols and 1,3-diacylglycerols.", "OL": "search GLYCERIDES 1968-74", "PM": "91; was see under GLYCERIDES 1975-90", "HN": "91(75); was see under GLYCERIDES 1975-90", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004075"}, {"RECTYPE": "D", "MH": "Digoxigenin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lanadigenin|T109|T121|T123|NON|EQV|UNK (19XX)|760414|abbbcdef", "MN": "D04.210.500.155.580.130.688.350", "MH_TH": "NLM (1977)", "ST": "T123", "N1": "Card-20(22)-enolide, 3,12,14-trihydroxy-, (3beta,5beta,12beta)-", "RN": "NQ1SX9LNAU", "RR": "1672-46-4 (Digoxigenin)", "AN": "a Digitalis glycoside; do not confuse with DIGITOXIGENIN; /biosyn permitted if by plant", "PI": "Digoxin/AA (1975-1976)", "MS": "3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide. A cardenolide which is the aglycon of digoxin. Can be obtained by hydrolysis of digoxin or from Digitalis orientalis L. and Digitalis lanata Ehrh.", "PM": "91; was see under DIGOXIN 1977-90", "HN": "91(77); was see under DIGOXIN 1977-90", "MR": "20160531", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D004076"}, {"RECTYPE": "D", "MH": "Digoxin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nativelle, Hemigoxine", "MN": "D09.408.180.261.436", "PA": "Enzyme Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-", "RN": "73K4184T59", "RR": "20830-75-5 (Digoxin)", "AN": "do not confuse with DIGITOXIN", "MS": "A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004077"}, {"RECTYPE": "D", "MH": "Dihydralazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Dihydralazine", "MN": "D03.383.710.605.500.250", "PA": "Antihypertensive Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1,4-Phthalazinedione, 2,3-dihydro-, dihydrazone", "RN": "PCU411F5L6", "RR": "484-23-1 (Dihydralazine)", "AN": "an antihypertensive", "PI": "Pyridazines (1968-1975)", "MS": "1,4-Dihydrazinophthalazine. An antihypertensive agent with actions and uses similar to those of HYDRALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p354)", "PM": "91; was see under HYDRALAZINE 1976-90", "HN": "91(76); was see under HYDRALAZINE 1976-90", "MR": "20170524", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D004078"}, {"RECTYPE": "D", "MH": "Dihydro-beta-Erythroidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta Erythroidine, Dihydro", "MN": "D03.633.400.380", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "16(15H)-Oxaerythrinan-15-one, 1,6-didehydro-14,17-dihydro-3-methoxy-, (3beta)-", "RN": "23255-54-1", "PI": "Indoles (1969-1974)", "MS": "Dihydro analog of beta-erythroidine, which is isolated from the seeds and other plant parts of Erythrina sp. Leguminosae. It is an alkaloid with curarimimetic properties.", "PM": "91; was see under ALKALOIDS 1975-90", "HN": "91(75); was see under ALKALOIDS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004079"}, {"RECTYPE": "D", "MH": "Dihydroorotase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dihydro-Orotate Amidohydrolase|T116|T126|NON|EQV|UNK (19XX)|760426|abbcdef", "ENTRY": "Dihydro Orotate Amidohydrolase", "MN": "D08.811.277.087.280", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "(S)-Dihydroorotate amidohydrolase", "RN": "EC 3.5.2.3", "PI": "Orotic Acid (1966-1976)", "MS": "An enzyme that, in the course of pyrimidine biosynthesis, catalyzes ring closure by removal of water from N-carbamoylaspartate to yield dihydro-orotic acid. EC 3.5.2.3.", "OL": "use DIHYDROOROTASE to search DIHYDRO-OROTASE 1977-94", "PM": "95; was DIHYDRO-OROTASE 1977-94 (see under AMIDOHYDROLASES 1977-90)", "HN": "95; was DIHYDRO-OROTASE 1977-94 (see under AMIDOHYDROLASES 1977-90)", "MR": "20030709", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D004080"}, {"RECTYPE": "D", "MH": "Dihydroorotate Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Dihydroorotate", "MN": "D08.811.682.660.300", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "(S)-Dihydroorotate:oxygen oxidoreductase", "RN": "EC 1.3.98.1", "PI": "Oxidoreductases (1966-1976)", "MS": "An enzyme that in the course of pyrimidine biosynthesis, catalyzes the oxidation of dihydro-orotic acid to orotic acid utilizing oxygen as the electron acceptor. This enzyme is a flavoprotein which contains both FLAVIN-ADENINE DINUCLEOTIDE and FLAVIN MONONUCLEOTIDE as well as iron-sulfur centers. EC 1.3.3.1.", "OL": "use DIHYDROOROTATE OXIDASE to search DIHYDRO-OROTATE OXIDASE, DIHYDRO-OROTATE DEHYDROGENASE & OROTATE REDUCTASE 1977-93", "PM": "94; was DIHYDRO-OROTATE OXIDASE 1977-93 (see under OXIDOREDUCTASES 1977-90); DIHYDRO-OROTATE DEHYDROGENASE & OROTATE REDUCTASE were see DIHYDRO-OROTATE OXIDASE 1977-93", "HN": "94; was DIHYDRO-OROTATE OXIDASE 1977-93 (see under OXIDOREDUCTASES 1977-90); DIHYDRO-OROTATE DEHYDROGENASE & OROTATE REDUCTASE were see DIHYDRO-OROTATE OXIDASE 1977-93", "MR": "20120703", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D004081"}, {"RECTYPE": "D", "MH": "Dihydroalprenolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "1-((Methylethyl)amino)-3-(2-propylphenoxy)-2-propanol|T109|T121|NON|EQV|NLM (1995)|940321|abbcdef", "MN": "D02.092.063.624.698.055.200", "PA": "Sympatholytics", "MH_TH": "NLM (1980)", "ST": "T121", "N1": "2-Propanol, 1-((1-methylethyl)amino)-3-(2-propylphenoxy)-", "RN": "60106-89-0", "PI": "Sympatholytics (1966-1971)", "MS": "Hydrogenated alprenolol derivative where the extra hydrogens are often tritiated. This radiolabeled form of ALPRENOLOL, a beta-adrenergic blocker, is used to label the beta-adrenergic receptor for isolation and study.", "PM": "91; was see under ALPRENOLOL 1980-90", "HN": "91(80); was see under ALPRENOLOL 1980-90", "MR": "20130708", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D004082"}, {"RECTYPE": "D", "MH": "Cholestanol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Cholestanol|T109|T123|NON|EQV|UNK (19XX)|770204|abbcdef", "ENTRY": "beta-ol, 5 beta-Cholestan-3", "MN": "D10.570.938.208.160", "MH_TH": "NLM (1964)", "ST": "T123", "N1": "Cholestan-3-ol, (3beta,5alpha)-", "RN": "8M308U816E", "RR": "80-97-7 (Cholestanol)", "AN": "do not confuse with CHOLESTANOLS; do not confuse x-ref DIHYDROCHOLESTEROL with DEHYDROCHOLESTEROLS", "MS": "A cholesterol derivative found in human feces, gallstones, eggs, and other biological matter.", "OL": "use CHOLESTANOL to search DIHYDROCHOLESTEROL 1975-90; use CHOLESTEROL 1973-74; use CHOLESTANES 1969-72; use STEROLS 1966-68 (as prov)", "PM": "91; was DIHYDROCHOLESTEROL see under CHOLESTEROL/analogs & derivatives 1975-90, see under CHOLESTEROL 1973-74, see under CHOLESTANES 1969-72", "HN": "91(64); was DIHYDROCHOLESTEROL see under CHOLESTEROL/analogs & derivatives 1975-90, see under CHOLESTEROL 1973-74, see under CHOLESTANES 1969-72, & see under STEROLS 1964-68 (Prov)", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004083"}, {"RECTYPE": "D", "MH": "Dihydroergotamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Von Ct, Ergotam", "MN": "D03.633.400.562.300", "PA": "Vasoconstrictor Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha,10alpha)-", "RN": "436O5HM03C", "RR": "81AXN7R2QT", "PI": "Ergotamine (1966-1974)", "MS": "A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS.", "OL": "search ERGOTAMINE 1966-74", "PM": "78; was see under ERGOTAMINE 1963-77", "HN": "78(75); was see under ERGOTAMINE 1963-77", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D004087"}, {"RECTYPE": "D", "MH": "Dihydroergotoxine", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ergot Alkaloids, Hydrogenated|T109|T121|NON|BRD|NLM (1992)|910314|abbcdef", "ENTRY": "Hydrogenated Ergot Alkaloids", "MN": "D03.633.400.562.400", "PA": "Dopamine Agonists", "FX": "Dihydroergocryptine", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Ergotoxine, dihydro-", "RN": "11032-41-0", "PI": "Ergot Mesylates (1973-1974)", "MS": "A mixture of three different hydrogenated derivatives of ERGOTAMINE: DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and DIHYDROERGOCRYPTINE. Dihydroergotoxine has been proposed to be a neuroprotective agent and a nootropic agent. The mechanism of its therapeutic actions is not clear, but it can act as an alpha-adrenergic antagonist and a dopamine agonist. The methanesulfonate salts of this mixture of alkaloids are called ERGOLOID MESYLATES.", "PM": "1977; see ERGOT ALKALOIDS HYDROGENATED 1975-1976; for ERGOT ALKALOIDS, HYDROGENATED see ERGOLOID MESYLATES 1992-2001", "HN": "1977(1975); for ERGOT ALKALOIDS, HYDROGENATED use ERGOLOID MESYLATES 1992-2001", "MR": "20160531", "DA": "19741127", "DC": "1", "DX": "19770101", "UI": "D004088"}, {"RECTYPE": "D", "MH": "Dihydromorphine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Paramorphan|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|771209|abbcdeef", "ENTRY": "Paramorfan|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|771209|abbcdeef", "MN": "D04.615.723.795.576.350", "PA": "Narcotics", "MH_TH": "NLM (1979)", "ST": "T121", "N1": "Morphinan-3,6-diol, 4,5-epoxy-17-methyl-, (5alpha,6alpha)-", "RN": "C3S5FRP6JW", "RR": "509-60-4 (Dihydromorphine)", "AN": "do not confuse with DIHYDROMORPHINONE see HYDROMORPHONE, also a narcotic analgesic", "PI": "Morphine Derivatives (1969-1978)", "MS": "A semisynthetic analgesic used in the study of narcotic receptors.", "PM": "91; was see under MORPHINE DERIVATIVES 1979-90", "HN": "91(79); was see under MORPHINE DERIVATIVES 1979-90", "MR": "20160531", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D004090"}, {"RECTYPE": "D", "MH": "Hydromorphone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydromorphon|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Palladone|T109|T121|TRD|NRW|NLM (2006)|041115|abbcdef", "MN": "D04.615.723.795.576.450", "PA": "Narcotics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Morphinan-6-one, 4,5-epoxy-3-hydroxy-17-methyl-, (5alpha)-", "RN": "Q812464R06", "RR": "L960UP2KRW", "AN": "do not confuse with entry term DIHYDROMORPHINONE with DIHYDROMORPHINE", "MS": "An opioid analgesic made from MORPHINE and used mainly as an analgesic. It has a shorter duration of action than morphine.", "OL": "use HYDROMORPHONE/analogs & derivatives to search DIHYDROMORPHINONE DERIVATIVES 1975-77; use MORPHINANS 1969-74", "PM": "96; was DIHYDROMORPHINONE 1963-95; DIHYDROMORPHINONE DERIVATIVES was see under DIHYDROMORPHINONE 1975-77, was see under MORPHINANS 1969-74", "HN": "96; was DIHYDROMORPHINONE 1963-95; DIHYDROMORPHINONE DERIVATIVES was see under DIHYDROMORPHINONE 1975-77, was see under MORPHINANS 1969-74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D004091"}, {"RECTYPE": "D", "MH": "20-alpha-Dihydroprogesterone", "DS": "ALPHA DIHYDROPROGESTERONE 20", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dihydroprogesterone|T109|T125|NON|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "Pregn 4 en 3 one, 20 alpha hydroxy", "MN": "D06.472.334.851.687.750.074", "PA": "Progestins", "MH_TH": "NLM (2004)", "ST": "T125", "N1": "Pregn-4-en-3-one, 20-hydroxy-, (20S)-", "RN": "145-14-2", "PI": "Progesterone (1974)", "MS": "A biologically active 20-alpha-reduced metabolite of PROGESTERONE. It is converted from progesterone to 20-alpha-hydroxypregn-4-en-3-one by the 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE in the CORPUS LUTEUM and the PLACENTA.", "PM": "2004; see DIHYDROPROGESTERONE 1991-2003, see PROGESTERONE 1975-1990", "HN": "2004 (1975)", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004092"}, {"RECTYPE": "D", "MH": "Dihydropteridine Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase, Dihydropteridine", "MN": "D08.811.682.662.582.361", "EC": "deficiency:Phenylketonurias", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "NAD(P)H:6,7-dihydropteridine oxidoreductase", "RN": "EC 1.5.1.34", "PI": "Pteridines (1973-1974)", "MS": "An enzyme that catalyzes the reduction of 6,7-dihydropteridine to 5,6,7,8-tetrahydropteridine in the presence of NADP+. Defects in the enzyme are a cause of PHENYLKETONURIA II. Formerly listed as EC 1.6.99.7.", "PM": "91; was see under NADH, NADPH OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under NADH, NADPH OXIDOREDUCTASES 1975-90", "MR": "20150622", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D004093"}, {"RECTYPE": "D", "MH": "Dihydropteroate Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dihydropteroate Synthetase|T116|T126|NON|EQV|UNK (19XX)|741024|abbcdef", "ENTRY": "Synthetase, Dihydropteroate", "MN": "D08.811.913.225.300", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine-diphosphate:4-aminobenzoate 2-amino-4-hydroxydihydropteridine-6-methenyltransferase", "RN": "EC 2.5.1.15", "RR": "9055-61-2 (CAS RN)", "PI": "Pteridines (1969-1974)", "MS": "An enzyme that catalyzes the formation of dihydropteroate from p-aminobenzoic acid and dihydropteridine-hydroxymethyl-pyrophosphate. EC 2.5.1.15.", "PM": "91; was see under TRANSFERASES 1975-90", "HN": "91(75); was see under TRANSFERASES 1975-90", "MR": "20030709", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D004094"}, {"RECTYPE": "D", "MH": "Dihydropyridines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.725.203", "MH_TH": "NLM (1988)", "ST": "T109", "RN": "0", "PI": "Pyridines (1966-1987)", "MS": "Pyridine moieties which are partially saturated by the addition of two hydrogen atoms in any position.", "PM": "88", "HN": "88", "MR": "20160531", "DA": "19870331", "DC": "1", "DX": "19880101", "UI": "D004095"}, {"RECTYPE": "D", "MH": "Dihydrostreptomycin Sulfate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dihydrostreptomycin|T109|T195|NON|BRD|BAN (19XX)|FDA SRS (2014)|INN (19XX)|NLM (1996)|940720|abbcdeeeef", "ENTRY": "Sulfate, Dihydrostreptomycin", "MN": "D09.408.051.885.387", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "D-Streptamine, O-2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl-(1-2)-O-5-deoxy- 3-C-(hydroxymethyl)-alpha-L-lyxofuranosyl-(1-4)-N,N'-bis(aminoiminomethyl)-, sulfate (2:3) (salt)", "RN": "T7D4876IUE", "RR": "P2I6R8W6UA", "MS": "A semi-synthetic aminoglycoside antibiotic that is used in the treatment of TUBERCULOSIS.", "PM": "96; was DIHYDROSTREPTOMYCIN 1963-95", "HN": "96; was DIHYDROSTREPTOMYCIN 1963-95", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D004096"}, {"RECTYPE": "D", "MH": "Dihydrotachysterol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "AT10", "MN": "D10.570.938.439.750", "PA": "Vitamins", "MH_TH": "USP (19XX)", "ST": "T127", "N1": "9,10-Secoergosta-5,7,22-trien-3-ol, (3beta,5E,7E,10alpha,22E)-", "RN": "R5LM3H112R", "RR": "67-96-9 (Dihydrotachysterol)", "MS": "A VITAMIN D that can be regarded as a reduction product of vitamin D2.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004097"}, {"RECTYPE": "D", "MH": "Dihydroxyacetone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "1,3 Dihydroxy 2 Propanone", "MN": "D09.947.875.894.200", "MH_TH": "USP (19XX)", "ST": "T122", "N1": "2-Propanone, 1,3-dihydroxy-", "RN": "O10DDW6JOO", "RR": "96-26-4 (Dihydroxyacetone)", "PI": "Trioses (1969-1974)", "MS": "A ketotriose compound. Its addition to blood preservation solutions results in better maintenance of 2,3-diphosphoglycerate levels during storage. It is readily phosphorylated to dihydroxyacetone phosphate by triokinase in erythrocytes. In combination with naphthoquinones it acts as a sunscreening agent.", "PM": "91; was see under TRIOSES 1975-90", "HN": "91(75); was see under TRIOSES 1975-90", "MR": "20170410", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004098"}, {"RECTYPE": "D", "MH": "Dihydroxyacetone Phosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Phosphate, Dihydroxyacetone", "MN": "D09.894.150", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "2-Propanone, 1-hydroxy-3-(phosphonooxy)-", "RN": "57-04-5", "AN": "/biosyn /physiol permitted", "PI": "Trioses (1972-1974)", "MS": "An important intermediate in lipid biosynthesis and in glycolysis.", "PM": "91; was see under TRIOSES 1975-90", "HN": "91(75); was see under TRIOSES 1975-90", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004099"}, {"RECTYPE": "D", "MH": "Dihydroxycholecalciferols", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dihydroxyvitamins D|T109|T127|NON|EQV|UNK (19XX)|760520|abbcdef", "MN": "D10.570.938.146.478.387", "PA": "Vitamins", "MH_TH": "NLM (1975)", "ST": "T127", "RN": "0", "AN": "deficiency: coordinate DIHYDROXYCHOLECALCIFEROLS /defic (IM) with VITAMIN D DEFICIENCY (IM)", "MS": "Cholecalciferols substituted with two hydroxy groups in any position.", "PM": "83; was see under HYDROXYCHOLECALCIFEROLS 1975-82", "HN": "83(73); was see under HYDROXYCHOLECALCIFEROLS 1975-82", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19830101", "UI": "D004100"}, {"RECTYPE": "D", "MH": "Dihydroxydihydrobenzopyrenes", "DE": "DDBPS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dihydrodiolbenzopyrenes|T109|T131|NON|EQV|UNK (19XX)|860409|abbcdef", "ENTRY": "Diols, Dihydrobenzopyrene", "MN": "D04.615.799.306.400", "MH_TH": "NLM (1987)", "ST": "T131", "RN": "0", "PI": "Benzopyrenes (1966-1986)", "MS": "Benzopyrenes saturated in any two adjacent positions and substituted with two hydroxyl groups in any position. The majority of these compounds have carcinogenic or mutagenic activity.", "PM": "87", "HN": "87", "MR": "20060705", "DA": "19860409", "DC": "1", "DX": "19870101", "UI": "D004101"}, {"RECTYPE": "D", "MH": "Dihydroxytryptamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.473.914.201", "MH_TH": "NLM (1978)", "ST": "T121", "RN": "0", "PI": "Tryptamines (1966-1977)", "MS": "Tryptamine substituted with two hydroxyl groups in any position. Some are cytotoxic serotonin analogs that are preferentially taken up by serotonergic neurons and then destroy those neurons.", "PM": "78", "HN": "78", "MR": "20160531", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D004102"}, {"RECTYPE": "D", "MH": "Iodoquinol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diodoxyquinoline|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef", "ENTRY": "EnteroDiyod", "MN": "D03.633.100.810.350.625.420", "PA": "Amebicides", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "8-Quinolinol, 5,7-diiodo-", "RN": "63W7IE88K8", "RR": "83-73-8 (Iodoquinol)", "MS": "One of the halogenated 8-quinolinols widely used as an intestinal antiseptic, especially as an antiamebic agent. It is also used topically in other infections and may cause CNS and eye damage. It is known by very many similar trade names world-wide.", "OL": "use IODOQUINOL to search DIIODOHYDROXYQUIN 1966-90", "PM": "91; was DIIODOHYDROXYQUIN 1963-91 (see under HYDROXYQUINOLINES 1983-90)", "HN": "91(83)63; was DIIODOHYDROXYQUIN 1963-91 (see under HYDROXYQUINOLINES 1983-90)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D004103"}, {"RECTYPE": "D", "MH": "Diiodothyronines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.125.072.050.767.741.180", "MH_TH": "NLM (1979)", "ST": "T125", "RN": "0", "PI": "Thyronines (1966-1978)", "MS": "These metabolites of THYROXINE are formed by the deiodination of T3 or reverse T3.", "PM": "91; was see under THYRONINES 1979-90", "HN": "91(79); was see under THYRONINES 1979-90", "MR": "20050630", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D004104"}, {"RECTYPE": "D", "MH": "Diiodotyrosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Iodogorgoic Acid|T116|T123|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "Acid, Iodogorgoic", "MN": "D12.125.072.050.875.262", "FX": "Receptors, Thyroid Hormone", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Tyrosine, 3,5-diiodo-", "RN": "6L57Q44ZWW", "RR": "66-02-4 (Diiodotyrosine)", "MS": "A product from the iodination of MONOIODOTYROSINE. In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones (THYROXINE and TRIIODOTHYRONINE).", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004105"}, {"RECTYPE": "D", "MH": "Dilatation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Dilations", "MN": "E05.284", "MH_TH": "NLM (1968)", "ST": "T061", "MS": "The act of dilating.", "PM": "76; was see under PATHOLOGY 1975", "HN": "76(68); was in Cat C & E 1968-75 (Prov 1968-74); was see under PATHOLOGY 1975", "CATSH": "CAT LIST", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D004106"}, {"RECTYPE": "D", "MH": "Dilatation and Curettage", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Dilatation & Curettage|T061|NON|EQV|UNK (19XX)|790329|abcdef", "MN": "E04.950.300.299", "MH_TH": "NLM (1975)", "ST": "T061", "PI": "Curettage (1966-1974)", "MS": "Dilatation of the cervix uteri followed by a scraping of the endometrium with a curette.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20190429", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D004107"}, {"RECTYPE": "D", "MH": "Dilatation, Pathologic", "DE": "DILATATION PATHOL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ectasia|T046|NON|EQV|NLM (1999)|980128|abcdef", "ENTRY": "Pathological Dilatations", "MN": "C23.300.325", "MH_TH": "NLM (1976)", "ST": "T046", "AN": "usually NIM", "PI": "Dilatation (1968-1975)", "MS": "The condition of an anatomical structure's being dilated beyond normal dimensions.", "OL": "search DILATATION 1968-75 (as Prov 1968-74, as Cat C & E heading 1968-75)", "PM": "76; was included in DILATATION see under PATHOLOGY 1975", "HN": "76; was included in DILATATION 1968-75 (Prov 1968-74, Cat C & E heading 1968-75)", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D004108"}, {"RECTYPE": "D", "MH": "Dilazep", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trimethoxybenzoate, Biopropazepan", "MN": "D03.383.066.200", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzoic acid, 3,4,5-trimethoxy-, (tetrahydro-1H-1,4-diazepine-1,4(5H)-diyl)di-3,1-propanediyl ester", "RN": "F8KLC2BD5Z", "RR": "35898-87-4 (Dilazep)", "PI": "Benzoates (1972-1974)", "MS": "Coronary vasodilator with some antiarrhythmic activity.", "PM": "91; was see under AZEPINES 1975-90", "HN": "91(75); was see under AZEPINES 1975-90", "MR": "20160628", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D004109"}, {"RECTYPE": "D", "MH": "Diltiazem", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CRD401", "MN": "D03.633.100.079.150", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-cis)-", "RN": "EE92BBP03H", "RR": "OLH94387TE", "PI": "Dimethylamines (1973-1974)", "MS": "A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions.", "OL": "use DILTIAZEM to search CRD 401 1975-78", "PM": "87; was see under BENZAZEPINES 1979-86; was CRD 401 see under BENZAZEPINES 1975-78", "HN": "87(79); was see under BENZAZEPINES 1979-86; was CRD 401 see under BENZAZEPINES 1975-78", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D004110"}, {"RECTYPE": "D", "MH": "Dimenhydrinate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diphenhydramine Theoclate|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef", "ENTRY": "Vertigo Vomex", "MN": "D26.310.368", "PA": "Histamine H1 Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Purine-2,6-dione, 8-chloro-3,7-dihydro-1,3-dimethyl-, compd. with 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1)", "RN": "JB937PER5C", "RR": "523-87-5 (Dimenhydrinate)", "MS": "A drug combination that contains diphenhydramine and theophylline. It is used for treating VERTIGO, MOTION SICKNESS, and NAUSEA associated with PREGNANCY.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004111"}, {"RECTYPE": "D", "MH": "Dimercaprol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "in Oil, BAL", "MN": "D02.886.489.180", "PA": "Chelating Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1-Propanol, 2,3-dimercapto-", "RN": "0CPP32S55X", "RR": "59-52-9 (Dimercaprol)", "MS": "An anti-gas warfare agent that is effective against Lewisite (dichloro(2-chlorovinyl)arsine) and formerly known as British Anti-Lewisite or BAL. It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004112"}, {"RECTYPE": "D", "MH": "Succimer", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Dimercaptosuccinic Acid|T109|T123|NON|NRW|NLM (1994)|920812|abbcdef", "ENTRY": "meso Dimercaptosuccinic Acid", "MN": "D02.886.489.750", "PA": "Chelating Agents", "MH_TH": "USAN (1978)", "ST": "T130", "N1": "Butanedioic acid, 2,3-dimercapto-, (R*,S*)-", "RN": "DX1U2629QE", "RR": "96861-19-7 (cpd w/o isomeric designation, tin salt)", "PI": "Sulfhydryl Compounds (1966-1978)", "MS": "A mercaptodicarboxylic acid used as an antidote to heavy metal poisoning because it forms strong chelates with them.", "OL": "use SUCCIMER to search DIMERCAPTOSUCCINIC ACID 1979-93", "PM": "94; was DIMERCAPTOSUCCINIC ACID 1979-93 (see under SULFHYDRYL COMPOUNDS 1979-90); SUCCIMER was see DIMERCAPTOSUCCINIC ACID 1979-93", "HN": "94; was DIMERCAPTOSUCCINIC ACID 1979-93 (see under SULFHYDRYL COMPOUNDS 1979-90); SUCCIMER was see DIMERCAPTOSUCCINIC ACID 1979-93", "MR": "20160705", "DA": "19780207", "DC": "1", "DX": "19910101", "UI": "D004113"}, {"RECTYPE": "D", "MH": "Dimethadione", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dimethyloxazolidinedione|T109|T121|NON|EQV|UNK (19XX)|810728|abbcdef", "MN": "D03.383.129.462.175", "PA": "Anticonvulsants", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "2,4-Oxazolidinedione, 5,5-dimethyl-", "RN": "ALU9NPM703", "RR": "695-53-4 (Dimethadione)", "PI": "Oxazoles (1970-1974)", "MS": "An anticonvulsant that is the active metabolite of TRIMETHADIONE.", "PM": "91; was see under OXAZOLES 1975-90", "HN": "91(75); was see under OXAZOLES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004114"}, {"RECTYPE": "D", "MH": "Dimethindene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dimethpyrindene|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740329|abbcdeef", "ENTRY": "Maleate, Dimethindene", "MN": "D04.615.486.250", "PA": "Histamine H1 Antagonists", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "1H-Indene-2-ethanamine, N,N-dimethyl-3-(1-(2-pyridinyl)ethyl)-", "RN": "661FH77Z3P", "RR": "6LL60J9E0O", "MS": "A histamine H1 antagonist. It is used in hypersensitivity reactions, in rhinitis, for pruritus, and in some common cold remedies.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004115"}, {"RECTYPE": "D", "MH": "Dimethisterone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Androst-4-en-3-one, 17-hydroxy-6-methyl-17-(1-propynyl)-, (6alpha,17beta)-|T109|T121|T125|NON|EQV|NLM (2020)|190625|abbbcdef", "ENTRY": "Dimethisterone Monohydrate|T109|T121|T125|NRW|NLM (1999)|990913|abbbdef", "MN": "D04.210.500.745.745.279", "PA": "Contraceptives, Oral, Synthetic", "MH_TH": "USAN (1965)", "ST": "T125", "RN": "K4MZ02M175", "RR": "79-64-1 (Dimethisterone)", "MS": "A synthetic progestational hormone without significant estrogenic or androgenic properties. It was formerly used as the progestational component in SEQUENTIAL ORAL CONTRACEPTIVE AGENTS .", "PM": "73", "HN": "73(65)", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004116"}, {"RECTYPE": "D", "MH": "Dimethoate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "PRINT ENTRY": "Phosphamide|T109|T121|T131|NON|EQV|UNK (19XX)|740329|abbbcdef", "ENTRY": "Bi58", "MN": "D02.886.300.692.220", "PA": "Insecticides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Phosphorodithioic acid, O,O-dimethyl S-(2-(methylamino)-2-oxoethyl) ester", "RN": "W6U08B045O", "RR": "60-51-5 (Dimethoate)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides (1966-1971)", "MS": "An organothiophosphorus cholinesterase inhibitor that is used as a systemic and contact insecticide.", "PM": "74", "HN": "74(72)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004117"}, {"RECTYPE": "D", "MH": "Dimethoxyphenylethylamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.092.471.683.386", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "A derivative of phenethylamine containing two substituent methoxy groups in the phenyl ring.", "OL": "search PHENETHYLAMINES 1968-74", "PM": "91; was see under PHENETHYLAMINES 1975-90", "HN": "91(75); was see under PHENETHYLAMINES 1975-90", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004118"}, {"RECTYPE": "D", "MH": "Dimethyl Adipimidate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dimethyl Adipinamidate|T109|T130|NON|EQV|UNK (19XX)|770420|abbcdef", "ENTRY": "Adipinamidate, Dimethyl", "MN": "D02.478.400.175", "PA": "Indicators and Reagents", "MH_TH": "NLM (1978)", "ST": "T130", "N1": "Hexanediimidic acid, dimethyl ester", "RN": "13139-70-3", "PI": "Imides (1966-1977)", "MS": "Bifunctional cross-linking agent that links covalently free amino groups of proteins or polypeptides, including those in cell membranes. It is used as reagent or fixative in immunohistochemistry and is a proposed antisickling agent.", "PM": "91; was see under IMIDOESTERS 1980-90; was see under IMIDES 1978-79", "HN": "91(78); was see under IMIDOESTERS 1980-90; was see under IMIDES 1978-79", "MR": "20000621", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D004119"}, {"RECTYPE": "D", "MH": "Dimethyl Suberimidate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bismethyl Suberimidate|T109|T130|NON|EQV|UNK (19XX)|790221|abbcdef", "ENTRY": "Suberimidate, Dimethyl", "MN": "D02.478.400.200", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Octanediimidic acid, dimethyl ester", "RN": "29878-26-0", "PI": "Imides (1973-1974)", "MS": "The methyl imidoester of suberic acid used to produce cross links in proteins. Each end of the imidoester will react with an amino group in the protein molecule to form an amidine.", "PM": "91; was see under IMIDOESTERS 1980-90; was see under IMIDES 1975-79", "HN": "91(75); was see under IMIDOESTERS 1980-90; was see under IMIDES 1975-79", "MR": "19980610", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004120"}, {"RECTYPE": "D", "MH": "Dimethyl Sulfoxide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DMSO|T109|T121|ABB|EQV|FDA SRS (2014)|UNK (19XX)|750116|abbcdeef", "ENTRY": "Sulphoxide, Dimethyl", "MN": "D02.886.640.150", "PA": "Solvents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Methane, sulfinylbis-", "RN": "YOW8V9698H", "RR": "67-68-5 (Dimethyl Sulfoxide)", "MS": "A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.", "PM": "65", "HN": "65(64)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004121"}, {"RECTYPE": "D", "MH": "Dimethylallyltranstransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Prenyltransferase|T116|T126|NON|EQV|UNK (19XX)|780518|abbcdef", "ENTRY": "Synthetase, Nerylpyrophosphate", "MN": "D08.811.913.225.400", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "Dimethylallyl-diphosphate:isopentenyl-diphosphate dimethylallyl (trans) transferase", "RN": "EC 2.5.1.1", "RR": "9032-79-5 (CAS RN)", "PI": "Transferases (1966-1978)", "MS": "An enzyme that, in the pathway of cholesterol biosynthesis, catalyzes the condensation of isopentenyl pyrophosphate and dimethylallylpyrophosphate to yield pyrophosphate and geranylpyrophosphate. The enzyme then catalyzes the condensation of the latter compound with another molecule of isopentenyl pyrophosphate to yield pyrophosphate and farnesylpyrophosphate. EC 2.5.1.1.", "PM": "97; was DIMETHYLALLYLTRANSFERASE 1979-96 (see under TRANSFERASES 1979-90)", "HN": "97; was DIMETHYLALLYLTRANSFERASE 1979-96 (see under TRANSFERASES 1979-90)", "MR": "20140613", "DA": "19780518", "DC": "1", "DX": "19910101", "UI": "D004122"}, {"RECTYPE": "D", "MH": "Dimethylamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.092.668.387", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "METHYLAMINES (1972-1973)", "MS": "Derivatives of dimethylamine (the structural formula CH3NHCH3).", "PM": "74", "HN": "74(72)", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004123"}, {"RECTYPE": "D", "MH": "p-Dimethylaminoazobenzene", "DS": "DIMETHYLAMINOAZOBENZENE A", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Dimethylaminoazobenzene|T109|T131|NON|BRD|NLM (1992)|901101|abbcdef", "ENTRY": "p Dimethylaminoazobenzene", "MN": "D02.092.146.325", "PA": "Coloring Agents", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Benzenamine, N,N-dimethyl-4-(phenylazo)-", "RN": "A49L8E13FD", "RR": "60-11-7 (p-Dimethylaminoazobenzene)", "MS": "A reagent used mainly to induce experimental liver cancer. According to the Fourth Annual Report on Carcinogens (NTP 85-002, p. 89) published in 1985, this compound \"may reasonably be anticipated to be a carcinogen.\" (Merck, 11th ed)", "OL": "use P-DIMETHYLAMINOAZOBENZENE to search DIMETHYLAMINOAZOBENZENE 1966-91", "PM": "92; was DIMETHYLAMINOAZOBENZENE 1963-91", "HN": "92; was DIMETHYLAMINOAZOBENZENE 1963-91", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D004124"}, {"RECTYPE": "D", "MH": "Dimethyldithiocarbamate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.886.706.175", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Thiocarbamates (1966-1974)", "MS": "A chemical that acts as a dopamine beta-hydroxylase inhibitor. Its salts are agricultural fungicides. It is inferior to diethyldithiocarbamate as a chelating agent.", "PM": "91; was see under THIOCARBAMATES 1975-90", "HN": "91(75); was see under THIOCARBAMATES 1975-90", "MR": "19930604", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004125"}, {"RECTYPE": "D", "MH": "Dimethylformamide", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "N,N Dimethylformamide", "MN": "D02.241.081.420.500.387", "MH_TH": "NLM (1963)", "ST": "T130", "N1": "Formamide, N,N-dimethyl-", "RN": "8696NH0Y2X", "RR": "68-12-2 (Dimethylformamide)", "MS": "A formamide in which the amino hydrogens are replaced by methyl groups.", "PM": "1966; N,N-DIMETHYLFORMAMIDE was indexed under FORMAMIDES 2006-2012", "HN": "1966(1963)", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004126"}, {"RECTYPE": "D", "MH": "Dimethylhydrazines", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dimethylhydrazine|T109|T131|NON|EQV|NLM (2021)|191120|abbcdef", "MN": "D02.442.600.400", "PA": "Carcinogens", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "PI": "Hydrazines (1968-1974)", "MS": "Hydrazines substituted with two methyl groups in any position.", "OL": "use DIMETHYLHYDRAZINES to search 1,2 DIMETHYLHYDRAZINE 1975-77", "PM": "91; was see under METHYLHYDRAZINES 1978-90; was 1,2 DIMETHYLHYDRAZINE see under HYDRAZINES 1975-77", "HN": "91(78); was see under METHYLHYDRAZINES 1978-90; was 1,2 DIMETHYLHYDRAZINE see under HYDRAZINES 1975-77", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004127"}, {"RECTYPE": "D", "MH": "Dimethylnitrosamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrosodimethylamine|T109|T131|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Nitrosodimethylamine, NDMA", "MN": "D02.654.442.225", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Methanamine, N-methyl-N-nitroso-", "RN": "M43H21IO8R", "RR": "62-75-9 (Dimethylnitrosamine)", "PI": "Nitrosamines (1966-1974)", "MS": "A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. It causes serious liver damage and is a hepatocarcinogen in rodents.", "PM": "1980; see NITROSAMINES 1975-1979; N-NITROSODIMETHYLAMINE was indexed under NITROSAMINES 2003-2008", "HN": "1980(1975)", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D004128"}, {"RECTYPE": "D", "MH": "Dimethylpolysiloxanes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polydimethylsiloxanes|T109|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Dimethylsiloxane", "MN": "J01.637.051.720.900.850.150", "MH_TH": "POPLINE (1984)", "ST": "T109", "RN": "0", "PI": "Silicones (1972-1974)", "MS": "Silicone polymers which consist of silicon atoms substituted with methyl groups and linked by oxygen atoms. They comprise a series of biocompatible materials used as liquids, gels or solids; as film for artificial membranes, gels for implants, and liquids for drug vehicles; and as antifoaming agents.", "PM": "91; was see under SILICONES 1975-90", "HN": "91(75); was see under SILICONES 1975-90", "MR": "20190627", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004129"}, {"RECTYPE": "D", "MH": "N,N-Dimethyltryptamine", "DS": "DIMETHYLTRYPTAMINE N N", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dimethyltryptamine|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|880523|abbcdeef", "ENTRY": "N,N Dimethyltryptamine", "MN": "D03.633.100.473.914.237", "PA": "Serotonin Receptor Agonists", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "1H-Indole-3-ethanamine, N,N-dimethyl-", "RN": "WUB601BHAA", "RR": "61-50-7 (N,N-Dimethyltryptamine)", "MS": "An N-methylated indoleamine derivative and serotonergic hallucinogen which occurs naturally and ubiquitously in several plant species including Psychotria veridis. It also occurs in trace amounts in mammalian brain, blood, and urine, and is known to act as an agonist or antagonist of certain SEROTONIN RECEPTORS.", "OL": "use N,N-DIMETHYLTRYPTAMINE to search DIMETHYLTRYPTAMINE 1973-88 (as Prov 1973-74)", "PM": "91; was see under TRYPTAMINES 1989-90; was DIMETHYLTRYPTAMINE 1975-88", "HN": "91(89); was see under TRYPTAMINES 1989-90; was DIMETHYLTRYPTAMINE 1973-88 (Prov 1973-74)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004130"}, {"RECTYPE": "D", "MH": "Dimetridazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Emtryl|T109|T121|TRD|NRW|IE|810210|abbcdef", "MN": "D03.383.129.308.658.200", "PA": "Antiprotozoal Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1H-Imidazole, 1,2-dimethyl-5-nitro-", "RN": "K59P7XNB8X", "RR": "551-92-8 (Dimetridazole)", "PI": "Nitroimidazoles (1974)", "MS": "A compound used to treat histomoniasis in poultry.", "PM": "91; was see under NITROIMIDAZOLES 1975-90", "HN": "91(75); was see under NITROIMIDAZOLES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004131"}, {"RECTYPE": "D", "MH": "Diflubenzuron", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TH6040", "MN": "D06.472.445.573.666.170", "MH_TH": "NLM (1977)", "ST": "T121", "N1": "Benzamide, N-(((4-chlorophenyl)amino)carbonyl)-2,6-difluoro-", "RN": "J76U6ZSI8D", "RR": "35367-38-5 (Diflubenzuron)", "PI": "Phenylurea Compounds (1974-1976)", "MS": "An insect growth regulator which interferes with the formation of the insect cuticle. It is effective in the control of mosquitoes and flies.", "OL": "use DIFLUBENZURON to search DIMILIN 1977-90", "PM": "91; was DIMILIN see under JUVENILE HORMONES 1977-90", "HN": "91(77); was DIMILIN see under JUVENILE HORMONES 1977-90", "MR": "20200527", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D004132"}, {"RECTYPE": "D", "MH": "Diminazene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "4,4' Diazoaminobenzamidine", "MN": "D02.925.240", "PA": "Trypanocidal Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenecarboximidamide, 4,4'-(1-triazene-1,3-diyl)bis-", "RN": "Y5G36EEA5Z", "RR": "536-71-0 (Diminazene)", "PI": "Triazenes (1974)", "MS": "An effective trypanocidal agent.", "PM": "91; was see under AMIDINES 1975-90", "HN": "91(75); was see under AMIDINES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004133"}, {"RECTYPE": "D", "MH": "Dimyristoylphosphatidylcholine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dimyristoyllecithin|T109|T130|NON|EQV|UNK (19XX)|830317|abbcdef", "ENTRY": "1,2 Ditetradecyl glycero 3 phosphocholine", "MN": "D10.570.755.375.760.400.800.200", "PA": "Indicators and Reagents", "MH_TH": "NLM (1984)", "ST": "T130", "N1": "3,5,9-Trioxa-4-phosphatricosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-((1-oxotetradecyl)oxy)-, inner salt, 4-oxide", "RN": "U86ZGC74V5", "RR": "13699-48-4 (Dimyristoylphosphatidylcholine)", "PI": "Phosphatidylcholines (1980-1983)", "MS": "A synthetic phospholipid used in liposomes and lipid bilayers for the study of biological membranes.", "PM": "84", "HN": "84", "MR": "20130708", "DA": "19830317", "DC": "1", "DX": "19840101", "UI": "D004134"}, {"RECTYPE": "D", "MH": "Dinitolmide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methyldinitrobenzamide|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Zoalene|T109|T121|TRD|NRW|UNK (19XX)|861007|abbcdef", "MN": "D02.455.426.559.389.127.085.240", "PA": "Coccidiostats", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzamide, 2-methyl-3,5-dinitro-", "RN": "AOX68RY4TV", "RR": "148-01-6 (Dinitolmide)", "PI": "Nitrobenzenes (1974)", "MS": "A coccidiostat for poultry.", "PM": "91; was see under BENZAMIDES 1975-90", "HN": "91(75); was see under BENZAMIDES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004135"}, {"RECTYPE": "D", "MH": "Dinitrobenzenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dinitrotoluene|T109|NON|NRW|NLM (2021)|191119|abcdef", "ENTRY": "Compound, Dinitrophenyl", "MN": "D02.640.529.240", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "AN": "includes ortho-, meta- & para-dinitrobenzenes", "PI": "Nitrobenzenes (1966-1976)", "MS": "Benzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions.", "PM": "91; was see under NITROBENZENES 1977-90", "HN": "91(77); was see under NITROBENZENES 1977-90", "MR": "20200527", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D004136"}, {"RECTYPE": "D", "MH": "Dinitrochlorobenzene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DNCB|T109|T130|ABB|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "2,4 Dinitrochlorobenzene", "MN": "D23.050.550.480.350", "PA": "Irritants", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "0", "RR": "GE3IBT7BMN", "PI": "Nitrobenzenes (1971-1974)", "MS": "A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.", "PM": "87; was see under NITROBENZENES 1975-86", "HN": "87(75); was see under NITROBENZENES 1975-86", "MR": "20210707", "DA": "19741111", "DC": "1", "DX": "19870101", "UI": "D004137"}, {"RECTYPE": "D", "MH": "Dinitrocresols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.640.280", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Cresols (1966-1971)", "MS": "Derivatives of CRESOLS containing two nitro groups.", "PM": "91; was see under CRESOLS 1972-90", "HN": "91(72); was see under CRESOLS 1972-90", "MR": "20161026", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004138"}, {"RECTYPE": "D", "MH": "Dinitrofluorobenzene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluorodinitrobenzene|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|750127|abbcdeef", "ENTRY": "1 Fluoro 2,4 dinitrobenzene", "MN": "D02.640.529.240.280", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Benzene, 1-fluoro-2,4-dinitro-", "RN": "D241E059U6", "RR": "70-34-8 (Dinitrofluorobenzene)", "PI": "Nitrobenzenes (1969-1974)", "MS": "Irritants and reagents for labeling terminal amino acid groups.", "PM": "91; was see under NITROBENZENES 1975-90", "HN": "91(75); was see under NITROBENZENES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004139"}, {"RECTYPE": "D", "MH": "Dinitrophenols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.640.743.304", "PA": "Uncoupling Agents", "MH_TH": "NLM (1963)", "ST": "T109", "RN": "0", "AN": "uncoupling agents & indust fungicides", "MS": "Organic compounds that contain two nitro groups attached to a phenol.", "PM": "64", "HN": "64(63)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D004140"}, {"RECTYPE": "D", "MH": "Dinoflagellida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Pyrrophyta|T204|NON|NRW|NLM (2024)|220923|abcdef", "ENTRY": "Dinoflagellates|T204|NON|EQV|UNK (19XX)|850520|abcdef", "MN": "B01.043.214", "FX": "Saxitoxin", "MH_TH": "NLM (1975)", "ST": "T204", "RR": "txid373098", "AN": "infection: coordinate with PROTOZOAN INFECTIONS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent ", "PI": "Mastigophora (1966-1974)", "MS": "Flagellate EUKARYOTES, found mainly in the oceans. They are characterized by the presence of transverse and longitudinal flagella which propel the organisms in a rotating manner through the water. Dinoflagellida were formerly members of the class Phytomastigophorea under the old five kingdom paradigm.", "PM": "1986; see DINOFLAGELLATES 1979-1985, see MASTIGOPHORA 1969-1978; GONYAULAX, GYMNODINIUM & PERIDINIUM were see RED TIDE 1979-1985", "HN": "1986 (1969); use DINOFLAGELLATES 1979-1985; GONYAULAX, GYMNODINIUM & PERIDINIUM were see RED TIDE 1979-1985", "MR": "20230414", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D004141"}, {"RECTYPE": "D", "MH": "Dioctyl Sulfosuccinic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Docusate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1996)|941116|abbcdeef", "ENTRY": "Sulfosuccinates, Dioctyl", "MN": "D02.241.081.337.759.249", "PA": "Surface-Active Agents", "MH_TH": "NLM (1978)", "ST": "T121", "RN": "10041-19-7", "RR": "M7P27195AG", "PI": "Surface-Active Agents (1966-1977)", "MS": "All-purpose surfactant, wetting agent, and solubilizer used in the drug, cosmetics, and food industries. It has also been used in laxatives and as cerumenolytics. It is usually administered as either the calcium, potassium, or sodium salt.", "PM": "96; was DIOCTYL SULFOSUCCINATES 1978-95 (see under SUCCINATES 1978-90); DIOCTYL SULFOSUCCINIC ACID was indexed under DIOCTYL SULFOSUCCINATES 1978-95; ALCOHOLS, OCTYL 1973-78; ALKYL SULFONATES 1974-76; & SUCCINATES 1968-78; DIETHYLHEXYL SODIUM SULFOSUCCINATE was indexed under SUCCINATES 2002-2013", "HN": "96; was DIOCTYL SULFOSUCCINATES 1978-95 (see under SUCCINATES 1978-90); DIOCTYL SULFOSUCCINIC ACID was NM 1968-95", "MR": "20130708", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D004143"}, {"RECTYPE": "D", "MH": "Diosgenin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.247.515.500", "MH_TH": "NLM (1979)", "ST": "T123", "N1": "Spirost-5-en-3-ol, (3beta,25R)-", "RN": "K49P2K8WLX", "RR": "512-04-9 (Diosgenin)", "PI": "Spirostans (1968-1978)", "MS": "A spirostan found in DIOSCOREA and other plants. The 25S isomer is called yamogenin. Solasodine is a natural derivative formed by replacing the spiro-ring with a nitrogen, which can rearrange to SOLANINE.", "PM": "91; was see under SAPOGENINS 1979-90", "HN": "91(79); was see under SAPOGENINS 1979-90", "MR": "20160531", "DA": "19771216", "DC": "1", "DX": "19910101", "UI": "D004144"}, {"RECTYPE": "D", "MH": "Diosmin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Buchu Resin|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Resin, Buchu", "MN": "D03.633.100.150.266.450.260.222", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-", "RN": "7QM776WJ5N", "RR": "520-27-4 (Diosmin)", "PI": "Bioflavonoids (1973-1974)", "MS": "A bioflavonoid that strengthens vascular walls.", "PM": "91; was see under BIOFLAVONOIDS 1975-90", "HN": "91(75); was see under BIOFLAVONOIDS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004145"}, {"RECTYPE": "D", "MH": "Dioxanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.188", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "MS": "Compounds that contain the structure 1,4-dioxane.", "OL": "use DIOXINS to search DIOXANES 1966-74", "PM": "91,63-67; was see under DIOXINS 1968-90; was heading 1963-67", "HN": "91(75)63-67; was see under DIOXINS 1968-90; was heading 1963-67", "MR": "20160608", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004146"}, {"RECTYPE": "D", "MH": "Dioxins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dioxin|T109|NON|EQV|NLM (2021)|191129|abcdef", "MN": "D03.383.231", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "A family of compounds that contain the 1,4-dioxin structure. Many specific dioxin derivatives are listed as CARCINOGENS; TERATOGENS; or MUTAGENS.", "PM": "68; DIOXANES was heading 1963-67", "HN": "68", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004147"}, {"RECTYPE": "D", "MH": "Dioxolanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.246.238", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "OL": "search DIOXOLES 1968-74", "PM": "91; was see under DIOXOLES 1975-90", "HN": "91(75); was see under DIOXOLES 1975-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004148"}, {"RECTYPE": "D", "MH": "Dioxoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.246", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PI": "Heterocyclic Compounds (1966-1967)", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004149"}, {"RECTYPE": "D", "MH": "Dipeptidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.656.350.297", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.4.13.-", "MS": "EXOPEPTIDASES that specifically act on dipeptides. EC 3.4.13.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004150"}, {"RECTYPE": "D", "MH": "Dipeptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dipeptide|T116|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D12.644.456.345", "MH_TH": "NLM (1966)", "ST": "T116", "RN": "0", "MS": "Peptides composed of two amino acid units.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004151"}, {"RECTYPE": "D", "MH": "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tripeptidyl-Peptidase|T116|T126|NON|NRW|NLM (2021)|191120|abbcdef", "ENTRY": "Tripeptidyl-Peptidases and Dipeptidyl-Peptidases", "MN": "D08.811.277.656.350.350", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.4.14.-", "PI": "Peptide Peptidohydrolases (1966-1979)", "MS": "A subclass of exopeptidases that includes enzymes which cleave either two or three AMINO ACIDS from the end of a peptide chain.", "PM": "2010; see DIPEPTIDYL PEPTIDASES 1986-2009, see PEPTIDE PEPTIDOHYDROLASES 1980-1985", "HN": "2010(1980)", "MR": "20200527", "DA": "19790523", "DC": "1", "DX": "19860101", "UI": "D004152"}, {"RECTYPE": "D", "MH": "Dipetalonema", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Dipetalonemas", "MN": "B01.050.500.500.294.400.937.463.208", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid114233", "MS": "A filarial nematode parasite of mammalian blood with the vector being a tick or small fly.", "OL": "use DIPETALONEMA to search ACANTHOCHEILONEMA 1966-85", "PM": "86; was ACANTHOCHEILONEMA 1963-85", "HN": "86; was ACANTHOCHEILONEMA 1963-85", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D004153"}, {"RECTYPE": "D", "MH": "Dipetalonema Infections", "DE": "DIPETALONEMA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Dipetalonema", "MN": "C01.610.335.508.700.750.361.275", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Infections with nematodes of the genus DIPETALONEMA.", "OL": "use DIPETALONEMA INFECTIONS to search ACANTHOCHEILONEMIASIS 1975-85 & NEMATODE INFECTIONS 1967-74", "PM": "91; was see under FILARIASIS 1986-90; was ACANTHOCHEILONEMIASIS see under FILARIASIS 1975-85 & see under NEMATODE INFECTIONS 1967-74", "HN": "91(86); was see under FILARIASIS 1986-90; was ACANTHOCHEILONEMIASIS see under FILARIASIS 1975-85 & see under NEMATODE INFECTIONS 1967-74", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004154"}, {"RECTYPE": "D", "MH": "Diphenhydramine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diphenylhydramin|T109|T121|NON|EQV|UNK (19XX)|760430|abbcdef", "ENTRY": "Hydrochloride, Diphenhydramine", "MN": "D02.455.426.559.389.115.250", "PA": "Hypnotics and Sedatives", "MH_TH": "JAN (19XX)", "ST": "T121", "N1": "Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-", "RN": "8GTS82S83M", "RR": "TC2D6JAD40", "MS": "A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.", "MR": "20150618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004155"}, {"RECTYPE": "D", "MH": "Catechol Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Diphenol Oxidases|T116|T126|NON|EQV|NLM (1992)|910314|abbcdef", "ENTRY": "Oxidases, Diphenol", "MN": "D08.811.682.690.708.125", "MH_TH": "NLM (1968)", "ST": "T126", "N1": "1,2-Benzenediol:oxygen oxidoreductase", "RN": "EC 1.10.3.1", "PI": "Tyrosine Decarboxylase (1966-1967)", "MS": "An enzyme of the oxidoreductase class that catalyzes the reaction between catechol and oxygen to yield benzoquinone and water. It is a complex of copper-containing proteins that acts also on a variety of substituted catechols. EC 1.10.3.1.", "OL": "use CATECHOL OXIDASE to search DIPHENOL OXIDASES 1968-91", "PM": "92; was DIPHENOL OXIDASES 1968-91", "HN": "92; was DIPHENOL OXIDASES 1968-91", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004156"}, {"RECTYPE": "D", "MH": "Diphenoxylate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Diphenoxylate", "MN": "D03.383.621.349.300", "PA": "Antidiarrheals", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "4-Piperidinecarboxylic acid, 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-, ethyl ester", "RN": "73312P173G", "RR": "W24OD7YW48", "PI": "Nitriles (1974)", "MS": "A MEPERIDINE congener used as an antidiarrheal, usually in combination with ATROPINE. At high doses, it acts like morphine. Its unesterified metabolite difenoxin has similar properties and is used similarly. It has little or no analgesic activity.", "PM": "91; was see under ISONIPECOTIC ACIDS 1975-90", "HN": "91(75); was see under ISONIPECOTIC ACIDS 1975-90", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004157"}, {"RECTYPE": "D", "MH": "Diphenylacetic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Diphenylacetic", "MN": "D02.241.223.601.238", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Monocarboxylic acid derivatives of acetic acids, where the methyl hydrogens have been replaced by two phenyl groups.", "PM": "68", "HN": "68", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004158"}, {"RECTYPE": "D", "MH": "Diphenylamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.092.146.350", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Benzenamine, N-phenyl-", "RN": "9N3CBB0BIQ", "RR": "122-39-4 (Diphenylamine)", "PI": "Aniline Compounds (1969-1974)", "MS": "In humans it may be irritating to mucous membranes. Methemoglobinemia has been produced experimentally. In veterinary use, it is one of active ingredients in topical agents for prevention and treatment of screwworm infestation. An indicator in tests for nitrate poisoning.", "PM": "91; was see under ANILINE COMPOUNDS 1975-90", "HN": "91(75); was see under ANILINE COMPOUNDS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004159"}, {"RECTYPE": "D", "MH": "Diphenylcarbazide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "1,5-Diphenylcarbazide|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|741114|DIPHENYLCARBAZIDE 01 05|abbcdeefs", "ENTRY": "S Diphenylcarbazide", "MN": "D02.845.250", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Carbonic dihydrazide, 2,2'-diphenyl-", "RN": "1W1XPA8N0P", "RR": "140-22-7 (Diphenylcarbazide)", "PI": "Semicarbazides (1972-1974)", "MS": "Used as an indicator in titrating iron and for the colorimetric determination of chromium and the detection of cadmium, mercury, magnesium, aldehydes, and emetine.", "PM": "91; was see under SEMICARBAZIDES 1975-90", "HN": "91(75); was see under SEMICARBAZIDES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004160"}, {"RECTYPE": "D", "MH": "Diphenylhexatriene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "1,6 Diphenylhexatriene", "MN": "D02.455.326.271.665.250", "PA": "Fluorescent Dyes", "MH_TH": "NLM (1980)", "ST": "T130", "N1": "Benzene, 1,1'-(1,3,5-hexatriene-1,6-diyl)bis-", "RN": "1720-32-7", "PI": "Spectrometry, Fluorescence (1974-1979)", "MS": "A fluorescent compound that emits light only in specific configurations in certain lipid media. It is used as a tool in the study of membrane lipids.", "PM": "91; was see under POLYENES 1980-90", "HN": "91(80); was see under POLYENES 1980-90", "MR": "20000622", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D004161"}, {"RECTYPE": "D", "MH": "Diphosphoglyceric Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bisphosphoglycerates|T109|NON|EQV|UNK (19XX)|780510|abcdef", "ENTRY": "Acids, Diphosphoglyceric", "MN": "D09.811.366.388", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "PI": "Organophosphorus Compounds (1971-1972)", "MS": "Glyceric acids where two of the hydroxyl groups have been replaced by phosphates.", "PM": "74", "HN": "74(73)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004163"}, {"RECTYPE": "D", "MH": "Diphosphonates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bisphosphonates|T109|NON|EQV|NLM (1990)|890517|abcdef", "MN": "D02.705.429.500", "PA": "Bone Density Conservation Agents", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "PI": "Phosphonic Acids (1966-1976)", "MS": "Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents.", "PM": "77", "HN": "77", "MR": "20200527", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D004164"}, {"RECTYPE": "D", "MH": "Diphtheria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Corynebacterium diphtheriae", "MN": "C01.150.252.410.040.246.388", "MH_TH": "POPLINE (1994)", "ST": "T047", "AN": "caused by Corynebacterium diphtheriae", "MS": "A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004165"}, {"RECTYPE": "D", "MH": "Diphtheria Antitoxin", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Antitoxin, Diphtheria", "MN": "D20.215.401.601.388", "PA": "Immunologic Factors", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "MS": "An antitoxin produced against the toxin of CORYNEBACTERIUM DIPHTHERIAE that is used for the treatment of DIPHTHERIA.", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004166"}, {"RECTYPE": "D", "MH": "Diphtheria Toxin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Corynebacterium Diphtheriae Toxin|T123|T131|NON|EQV|UNK (19XX)|850617|CORYNEBACT DIPHTHERIAE TOXIN|abbcdefv", "ENTRY": "Toxin, Corynebacterium Diphtheriae|T123|T131|NON|EQV|NLM (1992)|901105|TOXIN CORYNEBACT DIPHTHERIAE|abbcdefv", "MN": "D23.946.123.305", "PA": "Poisons", "FX": "Diphtheria Toxoid", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also DIPHTHERIA ANTITOXIN", "MS": "An ADP-ribosylating polypeptide produced by CORYNEBACTERIUM DIPHTHERIAE that causes the signs and symptoms of DIPHTHERIA. It can be broken into two unequal domains: the smaller, catalytic A domain is the lethal moiety and contains MONO(ADP-RIBOSE) TRANSFERASES which transfers ADP RIBOSE to PEPTIDE ELONGATION FACTOR 2 thereby inhibiting protein synthesis; and the larger B domain that is needed for entry into cells.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004167"}, {"RECTYPE": "D", "MH": "Diphtheria Toxoid", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diphtheria Vaccine|T121|T129|NON|EQV|UNK (19XX)|790606|abbcdef", "ENTRY": "Vaccine, Diphtheria", "MN": "D20.215.894.691.263", "FX": "Diphtheria-Tetanus-Pertussis Vaccine", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "MS": "The formaldehyde-inactivated toxin of Corynebacterium diphtheriae. It is generally used in mixtures with TETANUS TOXOID and PERTUSSIS VACCINE; (DTP); or with tetanus toxoid alone (DT for pediatric use and Td, which contains 5- to 10-fold less diphtheria toxoid, for other use). Diphtheria toxoid is used for the prevention of diphtheria; DIPHTHERIA ANTITOXIN is for treatment.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004168"}, {"RECTYPE": "D", "MH": "Diphyllobothriasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Diphyllobothrium", "MN": "C01.610.335.190.304", "FX": "Sparganosis", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "tapeworm infect; consider also SPARGANOSIS (infection at larval stage)", "PI": "Cestode Infections (1966-1967)", "MS": "Infection with tapeworms of the genus Diphyllobothrium.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004169"}, {"RECTYPE": "D", "MH": "Diphyllobothrium", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Diphyllobothriums", "MN": "B01.050.500.500.736.215.228", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid28844", "MS": "A genus of tapeworm containing several species which occurs in the intestine of fish, birds, and mammals including man. Infection in humans is usually by eating uncooked fish. The larval stage is known as SPARGANUM.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004170"}, {"RECTYPE": "D", "MH": "Diploidy", "ENTRY": "Diploids", "MN": "G05.700.264", "MH_TH": "NLM (1968)", "ST": "T032", "PI": "Chromosomes (1966-1967)", "MS": "The chromosomal constitution of cells, in which each type of CHROMOSOME is represented twice. Symbol: 2N or 2X.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004171"}, {"RECTYPE": "D", "MH": "Diplopia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polyopsia|T184|NON|REL|NLM (2000)|991103|abcdef", "ENTRY": "Vision, Double", "MN": "C23.888.592.763.941.339", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A visual symptom in which a single object is perceived by the visual cortex as two objects rather than one. Disorders associated with this condition include REFRACTIVE ERRORS; STRABISMUS; OCULOMOTOR NERVE DISEASES; TROCHLEAR NERVE DISEASES; ABDUCENS NERVE DISEASES; and diseases of the BRAIN STEM and OCCIPITAL LOBE.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004172"}, {"RECTYPE": "D", "MH": "Dipodomys", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rats, Kangaroo|T015|NON|EQV|UNK (19XX)|810514|abcdef", "ENTRY": "Rat, Kangaroo", "MN": "B01.050.150.900.649.313.992.510", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid10016", "AN": "do not confuse entry term KANGAROO RATS with RAT KANGAROO see POTOROIDAE", "MS": "A genus of the family Heteromyidae which contains 22 species. Their physiology is adapted for the conservation of water, and they seldom drink water. They are found in arid or desert habitats and travel by hopping on their hind limbs.", "OL": "use DIPODOMYS to search KANGAROO RATS 1975-81", "PM": "91; was see under RODENTIA 1982-90; was KANGAROO RATS see under RODENTS 1975-81", "HN": "91(82); was see under RODENTIA 1982-90; was KANGAROO RATS see under RODENTS 1975-81", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004173"}, {"RECTYPE": "D", "MH": "Diprenorphine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Diprenorphine", "MN": "D04.615.723.795.250", "PA": "Narcotic Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-, (5alpha,7alpha)-", "RN": "1F0L5N25ZZ", "RR": "WBS7IEP4SN", "PI": "Morphinans (1973-1975)", "MS": "A narcotic antagonist similar in action to NALOXONE. It is used to remobilize animals after ETORPHINE neuroleptanalgesia and is considered a specific antagonist to etorphine.", "PM": "91; was see under MORPHINANS 1976-90", "HN": "91(76); was see under MORPHINANS 1976-90", "MR": "20160531", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D004174"}, {"RECTYPE": "D", "MH": "Diptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Flies, True|T204|NON|EQV|UNK (19XX)|800519|abcdef", "ENTRY": "True Fly", "MN": "B01.050.500.131.617.720.500.500.750", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid7147", "MS": "An order of the class Insecta. Wings, when present, number two and distinguish Diptera from other so-called flies, while the halteres, or reduced hindwings, separate Diptera from other insects with one pair of wings. The order includes the families Calliphoridae, Oestridae, Phoridae, SARCOPHAGIDAE, Scatophagidae, Sciaridae, SIMULIIDAE, Tabanidae, Therevidae, Trypetidae, CERATOPOGONIDAE; CHIRONOMIDAE; CULICIDAE; DROSOPHILIDAE; GLOSSINIDAE; MUSCIDAE; TEPHRITIDAE; and PSYCHODIDAE. The larval form of Diptera species are called maggots (see LARVA).", "PM": "81, 63-74; FLIES was heading 1975-80; was see under DIPTERA 1963-74; MIDGES (either MIDGES, BITING see CERATOPOGONIDAE or MIDGES, NONBITING see CHIRONOMIDAE as of 1981) was see under DIPTERA 1975-80; CERATOPOGONIDAE was see CULICOIDES 1975-80; CULICOIDES (see CERATOPOGONIDAE as of 1981) was heading 1963-80; was see under INSECTS 1980-2017", "HN": "81, 63-74; FLIES was heading 1975-80; was see under DIPTERA 1963-74; was see under INSECTS 1974-2017", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004175"}, {"RECTYPE": "D", "MH": "Dipyridamole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Novo Dipiradol", "MN": "D03.383.742.175", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Ethanol, 2,2',2'',2'''-((4,8-di-1-piperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis-", "RN": "64ALC7F90C", "RR": "58-32-2 (Dipyridamole)", "MS": "A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)", "PM": "66; was PERSANTIN 1963-65", "HN": "66; was PERSANTIN 1963-65", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004176"}, {"RECTYPE": "D", "MH": "Dipyrone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Noramidopyrine Methanesulfonate|T109|T121|NON|REL|UNK (19XX)|741111|abbcdef", "ENTRY": "Sulpyrine|T109|T121|TRD|NRW|UNK (19XX)|830330|abbcdef", "MN": "D03.383.129.539.850.077.150", "PA": "Anti-Inflammatory Agents, Non-Steroidal", "MH_TH": "USAN (1962)", "ST": "T121", "N1": "Methanesulfonic acid, 1-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)-", "RN": "6429L0L52Y", "RR": "VSU62Z74ON", "AN": "do not confuse with DIPYRINE see AMINOPYRINE", "PI": "Methanesulfonates (1974)", "MS": "A drug that has analgesic, anti-inflammatory, and antipyretic properties. It is the sodium sulfonate of AMINOPYRINE.", "PM": "1991; DIPYRONE was indexed under AMINOPYRINE 1975-1990", "HN": "1991 (1975)", "MR": "20180521", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004177"}, {"RECTYPE": "D", "MH": "Diquat", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dibromide, Diquat", "MN": "D03.383.725.762.352", "PA": "Herbicides", "MH_TH": "NLM (1971)", "ST": "T131", "N1": "Dipyrido(1,2-a:2',1'-c)pyrazinediium, 6,7-dihydro-", "RN": "A9A615U4MP", "RR": "6BDV3T272W", "AN": "an herbicide", "PI": "Pyridinium Compounds (1968-1970)", "MS": "A contact herbicide used also to produce desiccation and defoliation. (From Merck Index, 11th ed)", "PM": "91; was see under PYRIDINIUM COMPOUNDS 1971-90", "HN": "91(71); was see under PYRIDINIUM COMPOUNDS 1971-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004178"}, {"RECTYPE": "D", "MH": "Cobra Cardiotoxin Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Direct Lytic Factors|T116|T131|NON|EQV|NLM (1978)|990101|abbcdef", "ENTRY": "Toxin Gamma, Cobra", "MN": "D23.946.833.850.325.180", "MH_TH": "NLM (2008)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTIVENINS", "PI": "Venoms (1966-1974)", "MS": "Most abundant proteins in COBRA venom; basic polypeptides of 57 to 62 amino acids with four disulfide bonds and a molecular weight of less than 7000; causes skeletal and cardiac muscle contraction, interferes with neuromuscular and ganglionic transmission, depolarizes nerve, muscle and blood cell membranes, thus causing hemolysis.", "PM": "2008; see DIRECT LYTIC FACTORS 1991-2008,` see COBRA VENOMS 1978-1990", "HN": "2008(1978)", "MR": "20170117", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D004179"}, {"RECTYPE": "D", "MH": "Direct Service Costs", "DE": "DIRECT SERV COSTS", "AQ": "CL ES HI LJ SN ST TD", "PRINT ENTRY": "Costs, Direct Service|T081|NON|EQV|UNK (19XX)|790530|COSTS DIRECT SERV|abcdefv", "ENTRY": "Service Cost, Direct", "MN": "N05.300.375.250", "MH_TH": "NLM (1975)", "ST": "T081", "MS": "Costs which are directly identifiable with a particular service.", "OL": "search COSTS AND COST ANALYSIS 1968-74", "PM": "91; was see under COSTS AND COST ANALYSIS 1975-90", "HN": "91(75); was see under COSTS AND COST ANALYSIS 1975-90", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004180"}, {"RECTYPE": "D", "MH": "Directories as Topic", "ENTRY": "Directories as Topics", "MN": "L01.462.500.682.192.836.339", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with the Publication Type DIRECTORY", "MS": "Works about lists of persons or organizations, systematically arranged, usually in alphabetic or classed order, giving address, affiliations, etc., for individuals, and giving address, officers, functions, and similar data for organizations.", "PM": "1966", "HN": "1966", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004181"}, {"RECTYPE": "D", "MH": "Dirofilaria", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Dirofilarias", "MN": "B01.050.500.500.294.400.937.463.230", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid6286", "MS": "A genus of filarial nematodes. Various immature species have been found to infect the eyes or subcutaneous tissue in humans.", "OL": "search FILARIOIDEA 1966-74", "PM": "91; was see under FILARIOIDEA 1975-90", "HN": "91(75); was see under FILARIOIDEA 1975-90", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004182"}, {"RECTYPE": "D", "MH": "Dirofilaria immitis", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Dog Heartworm|T204|NON|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "immitis, Dirofilaria", "MN": "B01.050.500.500.294.400.937.463.230.300", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid6287", "MS": "A filarial parasite primarily of dogs but occurring also in foxes, wolves, and humans. The parasite is transmitted by mosquitoes.", "PM": "91; was see under FILARIOIDEA 1975-90", "HN": "91(75); was see under FILARIOIDEA 1975-90", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004183"}, {"RECTYPE": "D", "MH": "Dirofilariasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Heartworm Disease|T047|NON|EQV|UNK (19XX)|740329|HEARTWORM DIS|abcdefv", "ENTRY": "Disease, Heartworm", "MN": "C22.674.377.320", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "usually in animals, espec dogs; coord IM with precoord animal/dis term (IM) + specific animal (NIM); check also tag ANIMALS; drug ther: consider FILARICIDES", "PI": "Filariasis (1966-1967)", "MS": "Infection with nematodes of the genus DIROFILARIA, usually in animals, especially dogs, but occasionally in man.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004184"}, {"RECTYPE": "D", "MH": "Disability Evaluation", "ENTRY": "Evaluations, Disability", "MN": "E01.370.400", "FX": "Veterans Disability Claims", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Determination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen's compensation benefits.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004185"}, {"RECTYPE": "D", "MH": "Disaccharidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Disaccharidase|T116|T126|NON|EQV|NLM (2022)|200831|abbcdef", "MN": "D08.811.277.450.329", "MH_TH": "NLM (1974)", "ST": "T126", "RN": "EC 3.2.1.-", "MS": "Enzymes belonging to the class of GLYCOSIDE HYDROLASES which break down DISACCHARIDES into simpler sugars, MONOSACCHARIDES.", "PM": "74", "HN": "74", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004186"}, {"RECTYPE": "D", "MH": "Disaccharides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Disaccharide|T109|NON|EQV|NLM (2021)|200123|abcdef", "MN": "D09.947.750", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified only; prefer specifics", "MS": "Oligosaccharides containing two monosaccharide units linked by a glycosidic bond.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004187"}, {"RECTYPE": "D", "MH": "Disarticulation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Disarticulations", "MN": "E04.555.080.250", "MH_TH": "NLM (1972)", "ST": "T061", "PI": "Amputation (1966-1971)", "MS": "AMPUTATION, SURGICAL or separation at a joint. (Dorland, 28th ed)", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20220715", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D004188"}, {"RECTYPE": "D", "MH": "Disaster Planning", "AQ": "EC HI LJ MT OG SN ST TD", "PRINT ENTRY": "Emergency Preparedness|T064|NON|REL|NLM (2008)|070707|abcdef", "ENTRY": "Relief Planning, Disaster", "MN": "N06.230.100.035", "FX": "Civil Defense", "MH_TH": "NLM (1978)", "ST": "T064", "AN": "specify disaster (IM) if pertinent; specify geog if pertinent", "PI": "Disasters (1966-1977)", "MS": "Procedures outlined for the care of casualties and the maintenance of services in disasters.", "PM": "1978; for EMERGENCY PREPAREDNESS see CIVIL DEFENSE 2008-2023", "HN": "1978; for EMERGENCY PREPAREDNESS use CIVIL DEFENSE 2008-2023", "MR": "20230316", "DA": "19770505", "DC": "1", "DX": "19780101", "UI": "D004189"}, {"RECTYPE": "D", "MH": "Disasters", "AQ": "CL EC HI PC SN", "MN": "N06.230.100", "FX": "Relief Work", "MH_TH": "NLM (2008)", "ST": "T067", "AN": "coordinate with specific event causing the disaster; specify geographic location", "MS": "Calamities producing great damage, loss of life, and distress. They include results of natural phenomena and man-made phenomena. Normal conditions of existence are disrupted and the level of impact exceeds the capacity of the hazard-affected community.", "PM": "1972; for NATURAL DISASTERS see NATURAL DISASTERS 1991-2008, see DISASTERS 1972-1990; for FLOODS see DISASTERS 1963-1981", "MR": "20180601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004190"}, {"RECTYPE": "D", "MH": "Behavioral Disciplines and Activities", "DE": "BEHAVIORAL DISCIPLINES", "MN": "F04", "RH": "F4 - BEHAVIORAL DISCIPLINES AND ACTIVITIES", "MH_TH": "NLM (1974)", "ST": "T091", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "The specialties in psychiatry and psychology, their diagnostic techniques and tests, their therapeutic methods, and psychiatric and psychological services.", "PM": "98", "HN": "98; use explode", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004191"}, {"RECTYPE": "D", "MH": "Discrimination, Psychological", "AQ": "CL DE ES PH RE", "ENTRY": "Psychological Discrimination|T041|NON|EQV|NLM (2020)|180917|abcdef", "MN": "F02.463.593.257", "MH_TH": "NLM (2020)", "ST": "T041", "AN": "do not confuse with SOCIAL DISCRIMINATION and specifics", "MS": "Differential response to different stimuli.", "PM": "1978; was DISCRIMINATION 1966-1977", "HN": "2020 (1966); was DISCRIMINATION (PSYCHOLOGY) 1978-2019; was DISCRIMINATION 1966-1977", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004192"}, {"RECTYPE": "D", "MH": "Discrimination Learning", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Discriminative Learning|T041|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Learning, Discriminative", "MN": "F02.463.425.280", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "Learning that is manifested in the ability to respond differentially to various stimuli.", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004193"}, {"RECTYPE": "D", "MH": "Disease", "DE": "DIS", "AQ": "CL EC EH ET GE HI PX", "ENTRY": "Diseases", "MN": "C23.550.288", "EC": "veterinary:Animal Diseases", "MH_TH": "POPLINE (1978)", "ST": "T047", "AN": "general only as a physiological, pathological, philosophical concept, opposite \"health\"; Manual 23.5+; / econ permitted but consider also economic aspects of disease as ECONOMICS, MEDICAL; / psychol permitted but consider also psychogenic origin of disease as PSYCHOPHYSIOLOGIC DISORDERS", "MS": "A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004194"}, {"RECTYPE": "D", "MH": "Disease Models, Animal", "DE": "DIS MODELS ANIMAL", "ENTRY": "Disease Model, Animal", "MN": "E05.599.395.080", "FX": "Animals, Laboratory", "MH_TH": "NLM (1970)", "ST": "T050", "AN": "not a routine coordinate with experimental animal diseases: index only when the text indicates a disease model; when the model is the point of the article, coordinate IM with the specific disease (IM) + specific animal (IM) if pertinent", "PI": "Models, Biological (1968-1969)", "MS": "Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D004195"}, {"RECTYPE": "D", "MH": "Disease Outbreaks", "DE": "DIS OUTBREAKS", "AQ": "CL EC ES HI LJ PC SN VE", "PRINT ENTRY": "Outbreaks|T067|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Outbreaks, Infectious Disease", "MN": "N06.850.290", "FX": "Communicable Diseases", "MH_TH": "NLM (1968)", "ST": "T067", "AN": "coordinate IM with specific disease / epidemiol (IM) & specify geographic location if pertinent; differentiate from EPIDEMICS, follow terminology in text", "MS": "Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS.", "PM": "68", "HN": "68(66)", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004196"}, {"RECTYPE": "D", "MH": "Disease Reservoirs", "DE": "DIS RESERVOIRS", "AQ": "CL MI PS SN VE VI", "PRINT ENTRY": "Reservoirs of Infection|T078|NON|NRW|NLM (2021)|200410|abcdef", "ENTRY": "Reservoirs, Human Disease", "MN": "N06.850.520.203.250", "FX": "Zoonoses", "MH_TH": "NLM (1965)", "ST": "T078", "AN": "differentiate from DISEASE VECTORS: reservoirs can be animate or inanimate (like swamps, housedust, etc.)", "MS": "Animate or inanimate sources which normally harbor disease-causing organisms and thus serve as potential sources of disease outbreaks. Reservoirs are distinguished from vectors (DISEASE VECTORS) and carriers, which are agents of disease transmission rather than continuing sources of potential disease outbreaks. Humans may serve both as disease reservoirs and carriers.", "PM": "67", "HN": "67(65)", "MR": "20200617", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004197"}, {"RECTYPE": "D", "MH": "Disease Susceptibility", "DE": "DIS SUSCEPTIBILITY", "AQ": "BL CF CI CL CN CO DG DH DI EC EH EM EN EP ET HI IM ME MI MO NU PA PP PS PX SU TH UR VE VI", "PRINT ENTRY": "Diathesis|T032|T080|NON|EQV|UNK (19XX)|800519|abbcdef", "ENTRY": "Susceptibilities, Disease", "MN": "G07.100.250", "EC": "genetics:Genetic Predisposition to Disease", "MH_TH": "NLM (1966)", "ST": "T080", "AN": "IM GEN only", "MS": "A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases.", "OL": "use DISEASE SUSCEPTIBILITY to search DIATHESIS 1966-80", "PM": "81; was DIATHESIS 1963-80", "HN": "81; was DIATHESIS 1963-80", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D004198"}, {"RECTYPE": "D", "MH": "Disease Vectors", "DE": "DIS VECTORS", "AQ": "CL", "ENTRY": "Vectors, Infectious Disease", "MN": "N06.850.520.203.375", "FX": "Disease Reservoirs", "MH_TH": "NLM (1965)", "ST": "T008", "MS": "Invertebrates or non-human vertebrates which transmit infective organisms from one host to another.", "PM": "67", "HN": "67(65)", "MR": "20200612", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004199"}, {"RECTYPE": "D", "MH": "Diseases in Twins", "DE": "DIS IN TWINS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "in Twins, Diseases", "MN": "C23.550.291.750", "FX": "Twins", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "human only", "MS": "Disorders affecting TWINS, one or both, at any age.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004200"}, {"RECTYPE": "D", "MH": "Disinfectants", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Disinfectant|T120|NON|EQV|NLM (2021)|191219|abcdef", "ENTRY": "Biocides|T120|NON|NRW|NLM (2007)|051123|abcdef", "MN": "D27.720.274", "MH_TH": "NLM (1967)", "ST": "T120", "RN": "0", "AN": "do not confuse with ANTISEPTICS which are used against organisms in man & animal", "PI": "Anti-Infective Agents, Local (1966)", "MS": "Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley's Condensed Chemical Dictionary, 11th ed)", "OL": "search ANTI-INFECTIVE AGENTS, LOCAL 1966", "PM": "67; was see ANTISEPTICS 1963-66", "HN": "67; was see ANTISEPTICS 1963-66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004202"}, {"RECTYPE": "D", "MH": "Disinfection", "DE": "DISINFECT", "AQ": "CL EC ES HI IS LJ MT OG SN ST TD", "MN": "N06.850.780.200.450.850.375", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "differentiate from STERILIZATION: DISINFECTION renders matter free of pathogens, STERILIZATION destroys all microbes; if in doubt, use the word of the text; disinfection of needles using household bleach Clorox, as by intravenous drug users, is indexed under DISINFECTION + NEEDLES + SODIUM HYPOCHLORITE", "MS": "Rendering pathogens harmless through the use of heat, antiseptics, antibacterial agents, etc.", "OL": "use STERILIZATION to search DISINFECTION 1966-74", "PM": "91,63-66; was see under STERILIZATION 1967-90; was heading 1963-66", "HN": "91(75)63-66; was see under STERILIZATION 1967-90; was heading 1963-66", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004203"}, {"RECTYPE": "D", "MH": "Joint Dislocations", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Subluxations, Joint", "MN": "C26.289", "MH_TH": "NLM (2017)", "ST": "T037", "AN": "luxation & subluxation go here; coordinate with specific  joint", "MS": "Displacement of bones from their normal positions at a joint.", "PM": "2017; see DISLOCATIONS 1966-2016", "HN": "2017(1966)", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004204"}, {"RECTYPE": "D", "MH": "Cromolyn Sodium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sodium Cromoglycate|T109|T121|NON|EQV|UNK (19XX)|760520|abbcdef", "ENTRY": "FPL670", "MN": "D03.633.100.150.266.300", "PA": "Anti-Asthmatic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4H-1-Benzopyran-2-carboxylic acid, 5,5'-((2-hydroxy-1,3-propanediyl)bis(oxy))bis(4-oxo-, disodium salt)", "RN": "Q2WXR1I0PK", "RR": "Y0TK0FS77W", "PI": "Chromones (1966-1970)", "MS": "A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.", "OL": "use CROMOLYN SODIUM to search DISODIUM CROMOGLYCATE 1971-91 (as Prov 1971-72)", "PM": "92; was DISODIUM CROMOGLYCATE 1973-91; CROMOLYN SODIUM was see DISODIUM CROMOGLYCATE 1973-91", "HN": "92; was DISODIUM CROMOGLYCATE 1971-91 (Prov 1971-72); CROMOLYN SODIUM was see DISODIUM CROMOGLYCATE 1973-91", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004205"}, {"RECTYPE": "D", "MH": "Disopyramide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SC13957", "MN": "D03.383.725.227", "PA": "Voltage-Gated Sodium Channel Blockers", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-", "RN": "GFO928U8MQ", "RR": "N6BOM1935W", "PI": "Pyridines (1966-1971)", "MS": "A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.", "PM": "84; was see under PYRIDINES 1975-83", "HN": "84(72); was see under PYRIDINES 1972-83 (Prov 1972-74)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D004206"}, {"RECTYPE": "D", "MH": "Dispensatories as Topic", "AQ": "HI ST", "ENTRY": "Dispensatories as Topics", "MN": "L01.462.500.682.192.836.390", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "do not confuse with the Publication Type DISPENSATORY", "MS": "Works about systematic description of the drugs and preparations used generally or in a specific setting.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004207"}, {"RECTYPE": "D", "MH": "Displacement, Psychological", "ENTRY": "Psychological Displacement|T041|NON|EQV|NLM (2020)|181004|abcdef", "MN": "F01.393.246", "MH_TH": "NLM (2020)", "ST": "T041", "PI": "Psychoanalytic Interpretation (1966-1967)", "MS": "The process by which an emotional or behavioral response that is appropriate for one situation appears in another situation for which it is inappropriate.", "PM": "1968", "HN": "2020 (1968); was DISPLACEMENT (PSYCHOLOGY) 1968-2019", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004208"}, {"RECTYPE": "D", "MH": "Disposable Equipment", "AQ": "CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Equipment, Disposable|T073|NON|EQV|NLM (1994)|921119|abcdef", "MN": "E07.252", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Apparatus, devices, or supplies intended for one-time or temporary use.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20170531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004209"}, {"RECTYPE": "D", "MH": "Dissection", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Dissections", "MN": "E05.200.998.221", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "NECK DISSECTION is also available", "MS": "The separation and isolation of tissues for surgical purposes, or for the analysis or study of their structures.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004210"}, {"RECTYPE": "D", "MH": "Disseminated Intravascular Coagulation", "DE": "DISSEM INTRAVASC COAG", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Consumption Coagulopathy|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Intravascular Disseminated Coagulations", "MN": "C15.378.925.220", "FX": "Purpura Fulminans", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "do not confuse with ERYTHROCYTE AGGREGATION, INTRAVASCULAR", "PI": "Blood Coagulation Disorders (1966-1969)", "MS": "A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.", "PM": "72", "HN": "72(70)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D004211"}, {"RECTYPE": "D", "MH": "Academic Dissertations as Topic", "AQ": "HI ST", "PRINT ENTRY": "Theses as Topic|T170|NON|BRD|NLM (2008)|070621|abcdef", "ENTRY": "Theses as Topics", "MN": "L01.462.500.682.389", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with Publication Type ACADEMIC DISSERTATION", "MS": "Works about substantial papers written by candidates for an academic degree under the individual direction of a professor or papers written by undergraduates desirous of achieving honors or distinction.", "PM": "2018; see DISSERTATIONS, ACADEMIC 1963-2007", "HN": "2018(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D004212"}, {"RECTYPE": "D", "MH": "Dissociative Disorders", "DE": "DISSOCIATIVE DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Hysteria, Dissociative|T048|NON|REL|UNK (19XX)|800521|abcdef", "ENTRY": "Reactions, Dissociative", "MN": "F03.300", "MH_TH": "NLM (1968)", "ST": "T048", "AN": "use Cat F3 qualif", "MS": "Sudden temporary alterations in the normally integrative functions of consciousness.", "OL": "use DISSOCIATIVE DISORDERS to search DISSOCIATIVE REACTION 1969-80, FUGUE 1966-78, & DISSOCIATION 1969-78", "PM": "81; was DISSOCIATIVE REACTION 1968-80; FUGUE was heading 1963-67", "HN": "81; was DISSOCIATIVE REACTION 1968-80; DISSOCIATION was see under DISSOCIATIVE REACTION 1969-78; FUGUE was see under DISSOCIATIVE REACTION 1968-78, was heading 1963-67", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004213"}, {"RECTYPE": "D", "MH": "Distamycins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D12.644.140", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "NLM (1975)", "ST": "T195", "RN": "0", "PI": "Pyrroles (1970-1974)", "MS": "Oligopeptide antibiotics from Streptomyces distallicus. Their binding to DNA inhibits synthesis of nucleic acids.", "PM": "91; was see under PYRROLES 1975-90", "HN": "91(75); was see under PYRROLES 1975-90", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004214"}, {"RECTYPE": "D", "MH": "Distance Perception", "AQ": "CL DE ES GE PH RE", "PRINT ENTRY": "Distance Discrimination|T041|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Perception, Distance", "MN": "F02.463.593.778.255.390", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "The act of knowing or the recognition of a distance by recollective thought, or by means of a sensory process which is under the influence of a set of prior experiences.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004215"}, {"RECTYPE": "D", "MH": "Distemper", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Distemper, Canine|T047|NON|NRW|NLM (1994)|930524|abcdef", "ENTRY": "Distempers, Canine", "MN": "C22.268.265", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A name for several highly contagious viral diseases of animals, especially canine distemper. In dogs, it is caused by the canine distemper virus (DISTEMPER VIRUS, CANINE). It is characterized by a diphasic fever, leukopenia, gastrointestinal and respiratory inflammation and sometimes, neurologic complications. In cats it is known as FELINE PANLEUKOPENIA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004216"}, {"RECTYPE": "D", "MH": "Distemper Virus, Canine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Distemper Viruses, Canine", "MN": "B04.820.480.937.600.650.500.280", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid11232", "AN": "infection: coordinate with DISTEMPER; DISTEMPER VIRUS, PHOCINE is also available ", "MS": "A species of MORBILLIVIRUS causing distemper in dogs, wolves, foxes, raccoons, and ferrets. Pinnipeds have also been known to contract Canine distemper virus from contact with domestic dogs.", "PM": "66; was DISTEMPER VIRUS 1963-65", "HN": "66; was DISTEMPER VIRUS 1963-65", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004217"}, {"RECTYPE": "D", "MH": "District of Columbia", "AQ": "EH EP", "PRINT ENTRY": "Washington, D.C.|T083|EQV|NLM (1990)|890201|abdef", "ENTRY": "Washington, DC|T083|EQV|NLM (1990)|890201|abdef", "MN": "Z01.433.429", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "= the Federal district; city is Washington, D.C.", "MS": "A federal area located between Maryland and Virginia on the Potomac river; it is coextensive with Washington, D.C., which is the capital of the United States.", "MR": "19970620", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D004219"}, {"RECTYPE": "D", "MH": "Disulfides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Disulfide|T104|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D02.886.520.150", "MH_TH": "NLM (1971)", "ST": "T104", "RN": "0", "PI": "Sulfides (1966-1970)", "MS": "Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties.", "PM": "73", "HN": "73(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004220"}, {"RECTYPE": "D", "MH": "Disulfiram", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetraethylthiuram Disulfide|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740329|abbcdeef", "ENTRY": "Disulfide, Tetraethylthiuram", "MN": "D02.886.706.200.200", "PA": "Alcohol Deterrents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Thioperoxydicarbonic diamide (((H2N)C(S))2S2), tetraethyl-", "RN": "TR3MLJ1UAI", "RR": "97-77-8 (Disulfiram)", "MS": "A carbamate derivative used as an alcohol deterrent. It is a relatively nontoxic substance when administered alone, but markedly alters the intermediary metabolism of alcohol. When alcohol is ingested after administration of disulfiram, blood acetaldehyde concentrations are increased, followed by flushing, systemic vasodilation, respiratory difficulties, nausea, hypotension, and other symptoms (acetaldehyde syndrome). It acts by inhibiting aldehyde dehydrogenase.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004221"}, {"RECTYPE": "D", "MH": "Disulfoton", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Di Syston", "MN": "D02.886.300.692.230", "PA": "Insecticides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Phosphorodithioic acid, O,O-diethyl S-(2-(ethylthio)ethyl) ester", "RN": "3CY5EKL6MT", "RR": "298-04-4 (Disulfoton)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides (1966-1971)", "MS": "An organothiophosphate insecticide.", "PM": "91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90", "HN": "91(72); was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004222"}, {"RECTYPE": "D", "MH": "Diterpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Norditerpenoid|T109|NON|NRW|NLM (2021)|191120|abcdef", "ENTRY": "Labdane Diterpenes", "MN": "D02.455.849.291", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate.", "PM": "74; PHYTOL was see under TERPENES 1968-74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004224"}, {"RECTYPE": "D", "MH": "Dithiazanine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Iodide, Dithiazanine", "MN": "D03.633.100.185.222", "PA": "Fluorescent Dyes", "MH_TH": "FDA SRS (2014)", "ST": "T130", "N1": "Benzothiazolium, 3-ethyl-2-(5-(3-ethyl-2(3H)-benzothiazolylidene)-1,3-pentadienyl)-", "RN": "5L7E7IY5EH", "RR": "8OEC3RA07X", "AN": "an antinematodal agent", "MS": "3-Ethyl-2-(5-(3-ethyl-2-benzothiazolinylidene)-1,3- pentadienyl)benzothiazolium. A benzothiazole that was formerly used as an antinematodal agent and is currently used as a fluorescent dye.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004225"}, {"RECTYPE": "D", "MH": "Dithioerythritol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dithioerythreitol|T109|T130|NON|EQV|NLM (1992)|910114|abbcdef", "MN": "D09.853.175", "PA": "Sulfhydryl Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "2,3-Butanediol, 1,4-dimercapto-, (R*,S*)-", "RN": "6892-68-8", "MS": "A compound that, along with its isomer, Cleland's reagent (DITHIOTHREITOL), is used for the protection of sulfhydryl groups against oxidation to disulfides and for the reduction of disulfides to sulfhydryl groups.", "OL": "search DITHIOTHREITOL 1972-74", "PM": "91; was see under DITHIOTHREITOL 1975-90", "HN": "91(75); was see under DITHIOTHREITOL 1975-90", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004226"}, {"RECTYPE": "D", "MH": "Dithionite", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dithionite, Sodium", "MN": "D01.875.750.200", "MH_TH": "NLM (1975)", "ST": "T196", "N1": "Dithionite", "RN": "14844-07-6", "RR": "2K5B8F6ES1", "MS": "Dithionite. The dithionous acid ion and its salts.", "OL": "search SULFITES 1973-74", "PM": "91; was see under SULFITES 1975-90", "HN": "91(75); was see under SULFITES 1975-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004227"}, {"RECTYPE": "D", "MH": "Dithionitrobenzoic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ellman's Reagent|T109|T130|EPO|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Reagent, Ellman's", "MN": "D02.455.426.559.389.127.650.300", "PA": "Sulfhydryl Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Benzoic acid, 3,3'-dithiobis(6-nitro)-", "RN": "9BZQ3U62JX", "RR": "69-78-3 (Dithionitrobenzoic Acid)", "PI": "Nitro Compounds (1972-1974)", "MS": "A standard reagent for the determination of reactive sulfhydryl groups by absorbance measurements. It is used primarily for the determination of sulfhydryl and disulfide groups in proteins. The color produced is due to the formation of a thio anion, 3-carboxyl-4-nitrothiophenolate.", "PM": "91; was see under NITROBENZOATES 1975-90", "HN": "91(75); was see under NITROBENZOATES 1975-90", "MR": "20130708", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D004228"}, {"RECTYPE": "D", "MH": "Dithiothreitol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Reagent, Cleland's", "MN": "D09.853.196", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "2,3-Butanediol, 1,4-dimercapto-, (R*,R*)-", "RN": "T8ID5YZU6Y", "RR": "3483-12-3 (Dithiothreitol)", "PI": "Tetroses (1966-1971)", "MS": "A reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH (thiol) groups and for reducing disulphides to dithiols.", "PM": "72", "HN": "72", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D004229"}, {"RECTYPE": "D", "MH": "Dithizone", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Diphenylthiocarbazone|T109|T121|T130|NON|EQV|UNK (19XX)|790606|abbbcdef", "ENTRY": "Dithizon|T109|T121|T130|NON|EQV|UNK (19XX)|790607|abbbcdef", "MN": "D02.442.726.200", "PA": "Chelating Agents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Diazenecarbothioic acid, phenyl-, 2-phenylhydrazide", "RN": "60-10-6", "MS": "Chelating agent used for heavy metal poisoning and assay. It causes diabetes.", "OL": "search INDICATORS AND REAGENTS 1966-74", "PM": "91; was see under AZO COMPOUNDS 1975-90; was see under INDICATORS AND REAGENTS 1963-74", "HN": "91(75); was see under AZO COMPOUNDS 1975-90; was see under INDICATORS AND REAGENTS 1963-74", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004230"}, {"RECTYPE": "D", "MH": "Diuresis", "AQ": "DE GE IM PH RE", "ENTRY": "Diureses", "MN": "G08.852.179", "FX": "Osmolar Concentration", "MH_TH": "NLM (1966)", "ST": "T042", "MS": "An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004231"}, {"RECTYPE": "D", "MH": "Diuretics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Diuretic", "MN": "D27.505.696.560.500", "FX": "Carbonic Anhydrase Inhibitors", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "note entry term DIURETIC EFFECT: use only for the diuretic effect of a chemical substance", "MS": "Agents that promote the excretion of urine through their effects on kidney function.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004232"}, {"RECTYPE": "D", "MH": "Diuretics, Osmotic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Osmotic Diuretics|T121|NON|EQV|UNK (19XX)|760305|abcdef", "ENTRY": "Diuretic, Osmotic", "MN": "D27.505.696.560.500.453", "MH_TH": "NLM (1974)", "ST": "T121", "RN": "0", "MS": "Compounds that increase urine volume by increasing the amount of osmotically active solute in the urine. Osmotic diuretics also increase the osmolarity of plasma.", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004234"}, {"RECTYPE": "D", "MH": "Diuron", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DCMU|T109|T131|ABB|EQV|UNK (19XX)|760317|abbcdef", "ENTRY": "3-(3,4-Dichlorophenyl)-1,1-dimethylurea|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|810427|abbcdeef", "MN": "D02.455.426.559.389.703.397", "PA": "Herbicides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Urea, N'-(3,4-dichlorophenyl)-N,N-dimethyl-", "RN": "9I3SDS92WY", "RR": "330-54-1 (Diuron)", "PI": "Urea (1966-1971)", "MS": "A pre-emergent herbicide.", "PM": "74", "HN": "74(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004237"}, {"RECTYPE": "D", "MH": "Diverticulitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diverticulitides", "MN": "C06.405.205.282.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with precoordinated organ/disease terms (IM) or specific diverticulum (IM)", "MS": "Inflammation of a DIVERTICULUM or diverticula.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004238"}, {"RECTYPE": "D", "MH": "Diverticulitis, Colonic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Colonic Diverticulitis|T047|NON|EQV|NLM (2004)|021224|abcdef", "MN": "C06.405.469.158.587.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with DIVERTICULOSIS, COLONIC", "MS": "Inflammation of the COLONIC DIVERTICULA, generally with abscess formation and subsequent perforation.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004239"}, {"RECTYPE": "D", "MH": "Diverticulum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Diverticulosis|T047|NON|REL|NLM (1992)|901231|abcdef", "ENTRY": "Diverticula|T190|NON|EQV|NLM (1992)|901231|abcdef", "MN": "C23.300.415", "FX": "Diverticular Diseases", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "coordinate IM with precoordinated organ/disease term (IM) but note specifics are available", "MS": "A pouch or sac developed from a tubular or saccular organ, such as the GASTROINTESTINAL TRACT.", "OL": "use DIVERTICULUM to search DIVERTICULOSIS 1966-91", "PM": "92; was DIVERTICULOSIS 1963-91", "HN": "92; was DIVERTICULOSIS 1963-91", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D004240"}, {"RECTYPE": "D", "MH": "Diverticulum, Colon", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Colonic Diverticulum|T190|NON|EQV|NLM (2001)|000324|abcdef", "ENTRY": "Diverticulum, Colonic", "MN": "C23.300.415.500", "MH_TH": "NLM (2001)", "ST": "T190", "MS": "A pouch or sac opening from the COLON.", "PM": "2001; see DIVERTICULOSIS, COLONIC 1963-2000", "HN": "2001(1963)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "20010101", "UI": "D004241"}, {"RECTYPE": "D", "MH": "Diving", "AQ": "AE CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Divings", "MN": "N06.230.150.150", "FX": "Inert Gas Narcosis", "MH_TH": "NLM (1966)", "ST": "T056", "AN": "human & animal; /adv eff permitted for hazards of diving as a Cat G3 concept, /inj permitted for diving as a sport in Cat I: coord IM with specific inj (IM); /physiol permitted; includes scuba & bell diving", "MS": "An activity in which the organism plunges into water. It includes scuba and bell diving. Diving as natural behavior of animals goes here, as well as diving in decompression experiments with humans or animals.", "HN": "was in Cat G only 1975-80; was in Cat E only 1968-74; was in Cat E & J 1963-67", "MR": "20170414", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D004242"}, {"RECTYPE": "D", "MH": "Divorce", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Separations", "MN": "N01.824.308.500.300", "MH_TH": "POPLINE (1978)", "ST": "T068", "MS": "Legal dissolution of an officially recognized marriage relationship.", "CATSH": "CAT LIST", "MR": "19930605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004243"}, {"RECTYPE": "D", "MH": "Dizziness", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Orthostasis|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Light Headedness", "MN": "C23.888.592.763.237", "FX": "Vertigo", "MH_TH": "POPLINE (1978)", "ST": "T184", "AN": "differentiate from VERTIGO, illusion of revolution in space, but use word of text", "PI": "Vertigo (1966-1978)", "MS": "An imprecise term which may refer to a sense of spatial disorientation, motion of the environment, or lightheadedness.", "PM": "1979", "HN": "1979", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19780517", "DC": "1", "DX": "19790101", "UI": "D004244"}, {"RECTYPE": "D", "MH": "DMF Index", "PRINT ENTRY": "Decayed, Missing, and Filled Teeth|T020|NON|BRD|UNK (19XX)|740329|DECAYED MISSING FILLED TEETH|abcdefv", "ENTRY": "Indices, DMF", "MN": "N06.890.160.100", "MH_TH": "NLM (1966)", "ST": "T081", "MS": "\"Decayed, missing and filled teeth,\" a routinely used statistical concept in dentistry.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004245"}, {"RECTYPE": "D", "MH": "Dimethylphenylpiperazinium Iodide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DMPP|T109|T121|ACR|EQV|NLM (1972)|990101|abbcdef", "ENTRY": "Iodide, Dimethylphenylpiperazinium", "MN": "D03.383.606.390", "PA": "Nicotinic Agonists", "MH_TH": "NLM (2001)", "ST": "T121", "N1": "Piperazinium, 1,1-dimethyl-4-phenyl-, iodide", "RN": "54-77-3", "PI": "Piperazines (1966-1971)", "MS": "A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.", "PM": "2001; see DMPP 1991-2000 & PIPERAZINES 1972-1990", "HN": "2001(1972);", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004246"}, {"RECTYPE": "D", "MH": "DNA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Deoxyribonucleic Acid|T114|T123|NON|EQV|UNK (19XX)|740329|abbcdef", "ENTRY": "ds DNA", "MN": "D13.444.308", "FX": "Repetitive Sequences, Nucleic Acid", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Deoxyribonucleic acids", "RN": "9007-49-2", "MS": "A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004247"}, {"RECTYPE": "D", "MH": "DNA (Cytosine-5-)-Methyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA Cytosine-5-Methylase|T116|T126|EQV|UNK (19XX)|880517|DNA CYTOSINE METHYLASE 05|abbdefs", "ENTRY": "DNA Cytosine 5 Methylase", "MN": "D08.811.913.555.500.350.100.500", "MH_TH": "NLM (2018)", "ST": "T126", "N1": "S-Adenosyl-L-methionine:DNA (cytosine-5-)-methyltransferase", "RN": "EC 2.1.1.37", "PI": "Methyltransferases (1973-1974)", "MS": "Enzymes that catalyzes the transfer of a methyl group from S-ADENOSYLMETHIONINE to the 5-position of CYTOSINE residues in DNA.", "PM": "2018; see DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1986-2017;  see METHYLTRANSFERASES 1975-1985", "HN": "2018 (1975); use METHYLTRANSFERASES 1975-1985", "MR": "20170629", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D004248"}, {"RECTYPE": "D", "MH": "DNA Damage", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Stress, Genotoxic|T049|NON|NRW|NLM (2004)|030124|abcdef", "ENTRY": "DNA Injuries", "MN": "G05.200", "FX": "Mutation", "MH_TH": "NLM (1987)", "ST": "T049", "AN": "do not use /drug eff & /rad eff for DNA damage induced by drugs or radiation; do not confuse with DNA FRAGMENTATION: see note there", "PI": "DNA Replication (1968-1986)", "MS": "Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20230526", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D004249"}, {"RECTYPE": "D", "MH": "DNA Topoisomerases, Type II", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA Topoisomerase II|T116|T126|EQV|UNK (19XX)|850605|abbdef", "ENTRY": "beta, Topoisomerase II", "MN": "D08.811.399.403.741", "EC": "antagonists & inhibitors:Topoisomerase II Inhibitors", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 5.99.1.3", "PI": "DNA, Superhelical (1978-1979)", "MS": "DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex.", "PM": "2018; see DNA TOPOISOMERASE (ATP-HYDROLYSING) 1994-2001, see DNA GYRASE 1980-1993; DNA TOPOISOMERASE II ALPHA was indexed under ANTIGENS, NEOPLASM; DNA TOPOSIOMERASES, TYPE II, and DNA-BINDING PROTEINS 2002-2017; and under DNA TOPOISOMERASE (ATP-HYDROLYSING) 1992-2001; DNA TOPOISOMERASE II BETA was indexed under DNA TOPOISOMERASES, TYPE II and DNA-BINDING PROTEINS 2002-2017", "HN": "2018(2002); use DNA GYRASE 1980-1993", "MR": "20170703", "DA": "19790523", "DC": "1", "DX": "19800101", "UI": "D004250"}, {"RECTYPE": "D", "MH": "DNA Transposable Elements", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Transposable Elements|T114|T123|NON|EQV|NLM (1979)|980420|abbcdef", "ENTRY": "Transposons, DNA", "MN": "G05.360.340.024.425.200", "FX": "Retroelements", "MH_TH": "NLM (1980)", "ST": "T123", "RN": "0", "AN": "do not use for retrotransposable elements (RETROELEMENTS)", "PI": "Recombination, Genetic (1968-1979)", "MS": "Discrete segments of DNA which can excise and reintegrate to another site in the genome. Most are inactive, i.e., have not been found to exist outside the integrated state. DNA transposable elements include bacterial IS (insertion sequence) elements, Tn elements, the maize controlling elements Ac and Ds, Drosophila P, gypsy, and pogo elements, the human Tigger elements and the Tc and mariner elements which are found throughout the animal kingdom.", "PM": "99; see DNA INSERTION ELEMENTS 1980-98; for INSERTION SEQUENCE ELEMENTS see INSERTION SEQUENCE ELEMENTS 1980", "HN": "99(80)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19781221", "DC": "1", "DX": "19800101", "UI": "D004251"}, {"RECTYPE": "D", "MH": "DNA Mutational Analysis", "DE": "DNA MUTATIONAL ANAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Mutational Analysis, DNA|T059|T063|EQV|UNK (19XX)|870509|MUTATIONAL ANAL DNA|abbdefv", "ENTRY": "Mutational Analyses, DNA", "MN": "E05.393.760.700.300", "FX": "Polymorphism, Single-Stranded Conformational", "MH_TH": "NLM (1988)", "ST": "T063", "AN": "IM GEN only; coord NIM with specific DNA &/or specific protein (IM)", "PI": "Mutation (1966-1987)", "MS": "Biochemical identification of mutational changes in a nucleotide sequence.", "PM": "91; was see under BASE SEQUENCE 1988-90", "HN": "91(88); was see under BASE SEQUENCE 1988-90", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19870509", "DC": "1", "DX": "19910101", "UI": "D004252"}, {"RECTYPE": "D", "MH": "DNA Nucleotidylexotransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Terminal Deoxyribonucleotidyltransferase|T116|T126|NON|EQV|UNK (19XX)|780516|abbcdef", "ENTRY": "Transferase, Terminal Deoxyribonucleotidyl", "MN": "D08.811.913.696.445.308.325", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "Nucleoside-triphosphate:DNA deoxynucleotidylexotransferase", "RN": "EC 2.7.7.31", "RR": "9027-67-2 (CAS RN)", "PI": "Transferases (1966-1967)", "MS": "A non-template-directed DNA polymerase normally found in vertebrate thymus and bone marrow. It catalyzes the elongation of oligo- or polydeoxynucleotide chains and is widely used as a tool in the differential diagnosis of acute leukemias in man. EC 2.7.7.31.", "PM": "89; was see under DNA NUCLEOTIDYLTRANSFERASES 1979-88", "HN": "89(79); was see under DNA NUCLEOTIDYLTRANSFERASES 1979-88", "MR": "20030709", "DA": "19780516", "DC": "1", "DX": "19890101", "UI": "D004253"}, {"RECTYPE": "D", "MH": "DNA Nucleotidyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nucleotidyltransferases, DNA", "MN": "D08.811.913.696.445.308", "MH_TH": "NLM (1968)", "ST": "T126", "RN": "EC 2.7.7.-", "PI": "Nucleotidyltransferases (1966-1967)", "MS": "Enzymes that catalyze the incorporation of deoxyribonucleotides into a chain of DNA. EC 2.7.7.-.", "OL": "use DNA NUCLEOTIDYLTRANSFERASES to search DNA NUCLEOTIDYLTRANSFERASE 1968-72", "PM": "73; was DNA NUCLEOTIDYLTRANSFERASE 1968-72", "HN": "73; was DNA NUCLEOTIDYLTRANSFERASE 1968-72", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004254"}, {"RECTYPE": "D", "MH": "Deoxyribodipyrimidine Photo-Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Photoreactivation Enzyme|T116|T126|NON|EQV|NLM (2024)|230306|abbcdef", "ENTRY": "Photoreactivating Enzyme, DNA", "MN": "D08.811.520.224.187", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Deoxyribocyclobutadipyrimidine pyrimidine-lyase", "RN": "EC 4.1.99.3", "PI": "Photochemistry (1972-1974)", "MS": "An enzyme that catalyzes the reactivation by light of UV-irradiated DNA. It breaks two carbon-carbon bonds in PYRIMIDINE DIMERS in DNA.", "PM": "97; was DNA PHOTOLYASE 1975-96 (see under LYASES 1975-90); DEOXYRIBODIPYRIMIDINE PHOTOLYASE was see DNA PHOTOLYASE 1975-96", "HN": "97; was DNA PHOTOLYASE 1975-96 (see under LYASES 1975-90); DEOXYRIBODIPYRIMIDINE PHOTOLYASE was see DNA PHOTOLYASE 1975-96", "MR": "20230526", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004255"}, {"RECTYPE": "D", "MH": "DNA Polymerase I", "DS": "DNA POLYMERASE 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Klenow Fragment|T116|T126|EPO|EQV|NLM (1991)|900320|abbcdef", "ENTRY": "Polymerase alpha, DNA", "MN": "D08.811.913.696.445.308.300.225", "MH_TH": "NLM (1977)", "ST": "T126", "RN": "EC 2.7.7.7", "PI": "DNA Nucleotidyltransferases (1968-1976)", "MS": "A DNA-dependent DNA polymerase characterized in prokaryotes and may be present in higher organisms. It has both 3'-5' and 5'-3' exonuclease activity, but cannot use native double-stranded DNA as template-primer. It is not inhibited by sulfhydryl reagents and is active in both DNA synthesis and repair.", "PM": "84; see DNA POLYMERASES 1977-83; for DNA POLYMERASE ALPHA see DNA POLYMERASE II 1982-97", "HN": "84(77); for DNA POLYMERASE ALPHA use DNA POLYMERASE II 1982-97", "MR": "20200622", "DA": "19760421", "DC": "1", "DX": "19840101", "UI": "D004256"}, {"RECTYPE": "D", "MH": "DNA Polymerase II", "DS": "DNA POLYMERASE 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA-Dependent DNA Polymerase II|T116|T126|EQV|UNK (19XX)|760420|DNA DEPENDENT DNA POLYMERASE 02|abbdefs", "ENTRY": "DNA Dependent DNA Polymerase II", "MN": "D08.811.913.696.445.308.300.230", "MH_TH": "NLM (1977)", "ST": "T126", "RN": "EC 2.7.7.7", "PI": "DNA Nucleotidyltransferases (1968-1976)", "MS": "A DNA-dependent DNA polymerase characterized in E. coli and other lower organisms. It may be present in higher organisms and has an intrinsic molecular activity only 5% of that of DNA Polymerase I. This polymerase has 3'-5' exonuclease activity, is effective only on duplex DNA with gaps or single-strand ends of less than 100 nucleotides as template, and is inhibited by sulfhydryl reagents.", "PM": "84; see DNA POLYMERASES 1977-83; DNA POLYMERASE EPSILON was indexed under DNA POLYMERASES 1994-97", "HN": "84(77); for DNA POLYMERASE EPSILON use DNA POLYMERASE II (NM) 1994-97", "MR": "20200622", "DA": "19760421", "DC": "1", "DX": "19840101", "UI": "D004257"}, {"RECTYPE": "D", "MH": "DNA Polymerase III", "DS": "DNA POLYMERASE 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA-Dependent DNA Polymerase III|T116|T126|EQV|UNK (19XX)|760420|DNA DEPENDENT DNA POLYMERASE 03|abbdefs", "ENTRY": "Polymerase delta, DNA", "MN": "D08.811.913.696.445.308.300.235", "MH_TH": "NLM (1977)", "ST": "T126", "RN": "EC 2.7.7.7", "PI": "DNA Nucleotidyltransferases (1968-1976)", "MS": "A DNA-dependent DNA polymerase characterized in E. coli and other lower organisms but may be present in higher organisms. Use also for a more complex form of DNA polymerase III designated as DNA polymerase III* or pol III* which is 15 times more active biologically than DNA polymerase I in the synthesis of DNA. This polymerase has both 3'-5' and 5'-3' exonuclease activities, is inhibited by sulfhydryl reagents, and has the same template-primer dependence as pol II.", "PM": "91; see DNA POLYMERASES 1977-90, DNA POLYMERASE DELTA was indexed under DNA POLYMERASES 1980-97", "HN": "91(77); for DNA POLYMERASE DELTA use DNA POLYMERASE III (NM) 1980-97", "MR": "20200622", "DA": "19760421", "DC": "1", "DX": "19910101", "UI": "D004258"}, {"RECTYPE": "D", "MH": "DNA-Directed DNA Polymerase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA-Dependent DNA Polymerases|T116|T126|EQV|UNK (19XX)|760416|abbdef", "ENTRY": "Polymerases, DNA-Dependent DNA", "MN": "D08.811.913.696.445.308.300", "EC": "antagonists & inhibitors:Nucleic Acid Synthesis Inhibitors", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "Deoxynucleoside-triphosphate:DNA deoxynucleotidyltransferase (DNA-directed)", "RN": "EC 2.7.7.7", "RR": "9012-90-2 (CAS RN)", "AN": "general; prefer specifics", "PI": "DNA Nucleotidyltransferases (1968-1976)", "MS": "DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair.", "PM": "98; see DNA POLYMERASES 1977-97, for DNA POLYMERASE see DNA NUCLEOTIDYLTRANSFERASES 1973-76, see DNA NUCLEOTIDYLTRANSFERASE 1968-72", "HN": "98(68); for DNA POLYMERASE use DNA NUCLEOTIDYLTRANSFERASES 1968-76", "MR": "20200527", "DA": "19760419", "DC": "1", "DX": "19770101", "UI": "D004259"}, {"RECTYPE": "D", "MH": "DNA Repair", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "DNA Damage Response|T045|NON|BRD|NLM (2024)|230303|abcdef", "MN": "G05.219", "FX": "DNA Repair Enzymes", "MH_TH": "NLM (1971)", "ST": "T045", "AN": "coord IM with specific DNA (IM)", "PI": "DNA/biosynthesis (1966-1970)", "MS": "The removal of DNA LESIONS and/or restoration of intact DNA strands without  BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones.", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20230526", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004260"}, {"RECTYPE": "D", "MH": "DNA Replication", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Autonomous Replication|T045|NON|NRW|UNK (19XX)|870509|abcdef", "ENTRY": "Replications, DNA", "MN": "G05.226", "FX": "Virus Replication", "MH_TH": "NLM (1968)", "ST": "T045", "AN": "coord IM with specific DNA (IM); coord IM with VIRUS REPLICATION (IM) for DNA replic in viruses; consider also DNA /biosyn", "PI": "DNA/biosynthesis (1966-1967)", "MS": "The process by which a DNA molecule is duplicated.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004261"}, {"RECTYPE": "D", "MH": "DNA Restriction Enzymes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Restriction Endonucleases|T116|T126|NON|EQV|UNK (19XX)|780518|abbcdef", "ENTRY": "Restriction Enzymes, DNA", "MN": "D08.811.277.352.355.325.300", "FX": "Restriction Mapping", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.1.21.-", "AN": "DNA restriction enzyme used as a DNA marker: coord probably NIM with GENETIC MARKER (IM)", "PI": "Endonucleases (1974)", "MS": "Enzymes that are part of the restriction-modification systems. They catalyze the endonucleolytic cleavage of DNA sequences which lack the species-specific methylation pattern in the host cell's DNA. Cleavage yields random or specific double-stranded fragments with terminal 5'-phosphates. The function of restriction enzymes is to destroy any foreign DNA that invades the host cell. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. They are also used as tools for the systematic dissection and mapping of chromosomes, in the determination of base sequences of DNAs, and have made it possible to splice and recombine genes from one organism into the genome of another. EC 3.21.1.", "OL": "use DNA RESTRICTION ENZYMES to search DNA RESTRICTION ENZYME l975-89", "PM": "79; was DNA RESTRICTION ENZYME 1978, was DNA RESTRICTION ENZYME see under ENDONUCLEASES 1975-77", "HN": "79; was DNA RESTRICTION ENZYME 1978, was DNA RESTRICTION ENZYME see under ENDONUCLEASES 1975-77", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19780101", "UI": "D004262"}, {"RECTYPE": "D", "MH": "DNA Tumor Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, DNA Tumor", "MN": "B04.613.204", "MH_TH": "NLM (1978)", "ST": "T005", "AN": "general or unspecified; prefer specifics; infection: coordinate with TUMOR VIRUS INFECTIONS ", "PI": "Oncogenic Viruses (1966-1977)", "MS": "DNA viruses producing malignant tumors. Of the six major groupings of DNA viruses four contain members which are actually or potentially oncogenic: the Adenoviridae, the Herpesviridae, the Papovaviridae, and the Poxviridae.", "PM": "78", "HN": "78", "MR": "20200902", "DA": "19770513", "DC": "1", "DX": "19780101", "UI": "D004263"}, {"RECTYPE": "D", "MH": "DNA Topoisomerases, Type I", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Topoisomerase IIIbeta|T116|T126|NON|NRW|NLM (2020)|190517|abbcdef", "ENTRY": "beta, Topoisomerase III", "MN": "D12.776.660.720.375", "EC": "antagonists & inhibitors:Topoisomerase I Inhibitors", "MH_TH": "NLM (2002)", "ST": "T126", "N1": "DNA topoisomerase", "RN": "EC 5.99.1.2", "RR": "143180-75-0 (CAS RN)", "AN": "do not confuse entry term DNA UNTWISTING PROTEIN with DNA UNWINDING PROTEINS see DNA HELICASES; coordinate with BACTERIAL PROTEINS or ARCHAEAL PROTEINS if pertinent", "PI": "specific protein (1966-1977)", "MS": "DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix.", "PM": "2002; see DNA TOPOISOMERASE 1994-2001, see DNA UNTWISTING PROTEINS 1978-1993; for DNA NICKING-CLOSING PROTEIN see DNA NICKING-CLOSING PROTEINS 1978-1993; for DNA RELAXING ENZYME see DNA RELAXING ENZYMES 1978-1993; for DNA UNTWISTING ENZYME see DNA UNTWISTING ENZYMES 1978-1993", "HN": "2002", "MR": "20190708", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D004264"}, {"RECTYPE": "D", "MH": "DNA Helicases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA Unwinding Proteins|T116|T126|ACX|EQV|NLM (1994)|921013|abbcdef", "ENTRY": "Unwinding Proteins, DNA", "MN": "D08.811.399.340", "MH_TH": "NLM (1978)", "ST": "T126", "RN": "EC 3.6.4.-", "RR": "EC 3.6.4.12", "AN": "do not confuse entry term DNA UNWINDING PROTEINS with DNA UNTWISTING PROTEINS", "PI": "specific protein (1966-1977)", "MS": "Proteins that catalyze the unwinding of duplex DNA during replication by binding cooperatively to single-stranded regions of DNA or to short regions of duplex DNA that are undergoing transient opening. In addition, DNA helicases are DNA-dependent ATPases that harness the free energy of ATP hydrolysis to translocate DNA strands.", "PM": "1994; see DNA UNWINDING PROTEINS 1978-1993; for DNA HELICASE A, DNA HELICASE E, DNA HELICASE II were indexed under ADENOSINE TRIPHOSPHATASES & DNA HELICASES 1980-2006; DNA HELICASE III was indexed under DNA HELICASES 1981-2006 & under DNA GYRASE 1980-1981, & under DNA, SUPERHELICAL 1979-1980", "HN": "1994", "MR": "20210630", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D004265"}, {"RECTYPE": "D", "MH": "DNA Virus Infections", "DE": "DNA VIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Virus Infections, DNA", "MN": "C01.925.256", "MH_TH": "NLM (1974)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Virus Diseases (1966-1997)", "MS": "Diseases caused by DNA VIRUSES.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004266"}, {"RECTYPE": "D", "MH": "DNA Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, DNA", "MN": "B04.280", "FX": "DNA, Viral", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid2080735", "MS": "Viruses whose nucleic acid is DNA.", "PM": "66", "HN": "66", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004267"}, {"RECTYPE": "D", "MH": "DNA-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Single-Stranded DNA Binding Proteins|T116|T123|NRW|UNK (19XX)|830317|abbdef", "ENTRY": "Single Stranded DNA Binding Proteins", "MN": "D12.776.260", "FX": "Zinc Fingers", "MH_TH": "NLM (1984)", "ST": "T123", "RN": "0", "PI": "DNA Unwinding Proteins (1981-1983)", "MS": "Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases.", "OL": "use DNA UNWINDING PROTEINS to search DNA HELIX DESTABILIZING PROTEINS 1980-83", "PM": "84; DNA HELIX DESTABILIZING PROTEINS was see DNA UNWINDING PROTEINS 1980-83", "HN": "84; DNA HELIX DESTABILIZING PROTEINS was see DNA UNWINDING PROTEINS 1980-83", "MR": "20200527", "DA": "19830317", "DC": "1", "DX": "19840101", "UI": "D004268"}, {"RECTYPE": "D", "MH": "DNA, Bacterial", "DE": "DNA BACT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Bacterial DNA|T114|EQV|NLM (1991)|891228|BACT DNA|abdefv", "MN": "D13.444.308.212", "MH_TH": "NLM (1966)", "ST": "T114", "RN": "0", "AN": "IM; coord with specific bacterium (IM); /drug eff /ultrastruct permitted", "MS": "Deoxyribonucleic acid that makes up the genetic material of bacteria.", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004269"}, {"RECTYPE": "D", "MH": "DNA, Circular", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DNAs, Circular", "MN": "G05.360.580.156", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "AN": "IM; /drug eff /ultrastruct permitted", "PI": "DNA (1966-1972)", "MS": "Any of the covalently closed DNA molecules found in bacteria, many viruses, mitochondria, plastids, and plasmids. Small, polydisperse circular DNA's have also been observed in a number of eukaryotic organisms and are suggested to have homology with chromosomal DNA and the capacity to be inserted into, and excised from, chromosomal DNA. It is a fragment of DNA formed by a process of looping out and deletion, containing a constant region of the mu heavy chain and the 3'-part of the mu switch region. Circular DNA is a normal product of rearrangement among gene segments encoding the variable regions of immunoglobulin light and heavy chains, as well as the T-cell receptor. (Riger et al., Glossary of Genetics, 5th ed & Segen, Dictionary of Modern Medicine, 1992)", "PM": "74", "HN": "74(73)", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004270"}, {"RECTYPE": "D", "MH": "DNA, Fungal", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fungal DNA|T114|EQV|NLM (1991)|891228|abdef", "MN": "D13.444.308.300", "MH_TH": "NLM (1980)", "ST": "T114", "RN": "0", "AN": "IM; coord with specific fungus (IM); /drug eff /ultrastruct permitted", "PI": "DNA (1966-1979)", "MS": "Deoxyribonucleic acid that makes up the genetic material of fungi.", "PM": "80", "HN": "80", "MR": "19950608", "DA": "19790523", "DC": "1", "DX": "19800101", "UI": "D004271"}, {"RECTYPE": "D", "MH": "DNA, Mitochondrial", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "mtDNA|T114|T123|ABB|EQV|NLM (1995)|931012|abbcdef", "MN": "D13.444.308.283.225", "FX": "Genes, Mitochondrial", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "PI": "Mitochondria (1966-1972)", "MS": "Double-stranded DNA of MITOCHONDRIA. In eukaryotes, the mitochondrial GENOME is circular and codes for ribosomal RNAs, transfer RNAs, and about 10 proteins.", "PM": "74", "HN": "74(73)", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004272"}, {"RECTYPE": "D", "MH": "DNA, Neoplasm", "DE": "DNA NEOPL", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neoplasm DNA|T114|EQV|NLM (1991)|891228|abdef", "MN": "D13.444.308.425", "MH_TH": "NLM (1966)", "ST": "T114", "RN": "0", "AN": "coordinate with required neoplasm terms", "MS": "DNA present in neoplastic tissue.", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004273"}, {"RECTYPE": "D", "MH": "DNA, Recombinant", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD TO TU UL UR", "PRINT ENTRY": "Spliced Gene|T028|NON|BRD|NLM (2022)|201006|abcdef", "ENTRY": "Spliced Genes", "MN": "D13.444.308.460", "FX": "Genetic Vectors", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "IM; /drug eff /ultrastruct permitted; formed by in vitro joining of DNA from 2 different species: do not confuse with RECOMBINATION, GENETIC (within same species); for guidelines for preventing hazards of recombinant DNA research, coord IM with CONTAINMENT OF BIOHAZARDS (IM) if by MeSH definition (procedures, facilities, programs, equipmt, etc.); for ethical, moral or religious aspects of DNA research: coord with specific ethical, moral or religious aspect (IM); for legal aspects, coord with LEGISLATION AS TOPIC (IM), not LEGISLATION, DRUG nor LEGISLATION, MEDICAL", "PI": "Recombination, Genetic (1968-1976)", "MS": "Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected.", "PM": "77", "HN": "77", "MR": "20210630", "DA": "19770422", "DC": "1", "DX": "19770101", "UI": "D004274"}, {"RECTYPE": "D", "MH": "DNA, Ribosomal", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ribosomal DNA|T114|T123|EQV|UNK (19XX)|840524|abbdef", "ENTRY": "rDNA|T114|T123|ABB|EQV|UNK (19XX)|841126|abbcdef", "MN": "D13.444.308.475", "FX": "Transcription, Genetic", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "AN": "DNA, RIBOSOMAL SPACER is also available", "PI": "Ribosomes (1966-1984)", "MS": "DNA sequences encoding RIBOSOMAL RNA and the segments of DNA separating the individual ribosomal RNA genes, referred to as RIBOSOMAL SPACER DNA.", "PM": "85", "HN": "85", "MR": "20050728", "DA": "19840524", "DC": "1", "DX": "19850101", "UI": "D004275"}, {"RECTYPE": "D", "MH": "DNA, Satellite", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Satellite DNA|T114|T123|EQV|UNK (19XX)|741111|abbdef", "ENTRY": "Satellite I DNAs", "MN": "G05.360.340.024.850.150", "FX": "Centromere", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "DNA (1966-1974)", "MS": "Highly repetitive DNA sequences found in HETEROCHROMATIN, mainly near centromeres. They are composed of simple sequences (very short) (see MINISATELLITE REPEATS) repeated in tandem many times to form large blocks of sequence. Additionally, following the accumulation of mutations, these blocks of repeats have been repeated in tandem themselves. The degree of repetition is on the order of 1000 to 10 million at each locus. Loci are few, usually one or two per chromosome. They were called satellites since in density gradients, they often sediment as distinct, satellite bands separate from the bulk of genomic DNA owing to a distinct BASE COMPOSITION.", "PM": "80; was see under DNA 1975-79", "HN": "80(75); was see under DNA 1975-79", "MR": "20080708", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D004276"}, {"RECTYPE": "D", "MH": "DNA, Single-Stranded", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Single-Stranded DNA|T114|EQV|NLM (1991)|900102|abdef", "ENTRY": "Single Stranded DNA", "MN": "G05.360.580.437", "MH_TH": "NLM (1972)", "ST": "T114", "RN": "0", "AN": "IM; /drug eff /ultrastruct permitted", "PI": "DNA, Viral (1966-1971)", "MS": "A single chain of deoxyribonucleotides that occurs in some bacteria and viruses. It usually exists as a covalently closed circle.", "PM": "74", "HN": "74(72)", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004277"}, {"RECTYPE": "D", "MH": "DNA, Superhelical", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA, Supertwisted|T114|EQV|UNK (19XX)|770517|abdef", "ENTRY": "Supertwisted DNA", "MN": "G05.360.580.156.250", "MH_TH": "NLM (1978)", "ST": "T114", "RN": "0", "AN": "IM; /drug eff /ultrastruct permitted", "PI": "DNA, Circular (1973-1977)", "MS": "Circular duplex DNA isolated from viruses, bacteria and mitochondria in supercoiled or supertwisted form. This superhelical DNA is endowed with free energy. During transcription, the magnitude of RNA initiation is proportional to the DNA superhelicity.", "PM": "78", "HN": "78", "MR": "20150622", "DA": "19770517", "DC": "1", "DX": "19780101", "UI": "D004278"}, {"RECTYPE": "D", "MH": "DNA, Viral", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Viral DNA|T114|EQV|NLM (1991)|900102|abdef", "MN": "D13.444.308.568", "MH_TH": "NLM (1966)", "ST": "T114", "RN": "0", "AN": "IM; coord with specific virus (IM); /drug eff /ultrastruct permitted", "MS": "Deoxyribonucleic acid that makes up the genetic material of viruses.", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004279"}, {"RECTYPE": "D", "MH": "Dobutamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tartrate, Dobutamine", "MN": "D02.455.426.559.389.657.166.175.220", "PA": "Sympathomimetics", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, (+-)-", "RN": "3S12J47372", "RR": "CP0YC140T9", "PI": "Phenols (1974-1975)", "MS": "A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY.", "PM": "86; was see under CATECHOLAMINES 1976-85", "HN": "86(76); was see under CATECHOLAMINES 1976-85", "MR": "20180630", "DA": "19750718", "DC": "1", "DX": "19860101", "UI": "D004280"}, {"RECTYPE": "D", "MH": "Docosahexaenoic Acids", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Docosahexenoic Acids|T109|T123|NON|EQV|UNK (19XX)|870331|abbcdef", "ENTRY": "Acids, Docosahexenoic", "MN": "D10.627.430.450.375", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "25167-62-8", "RR": "91403-70-2", "PI": "Fatty Acids, Unsaturated (1973-1987)", "MS": "C22-unsaturated fatty acids found predominantly in FISH OILS.", "PM": "88", "HN": "88", "MR": "20200409", "DA": "19870331", "DC": "1", "DX": "19880101", "UI": "D004281"}, {"RECTYPE": "D", "MH": "Documentation", "AQ": "CL EC ES HI MT SN ST TD", "ENTRY": "Documentations", "MN": "L01.462.750.245", "FX": "Records", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "med docum: do not coord with MEDICINE", "MS": "Systematic organization, storage, retrieval, and dissemination of specialized information, especially of a scientific or technical nature (From ALA Glossary of Library and Information Science, 1983). It often involves authenticating or validating information.", "PM": "66; was see under BIBLIOGRAPHY 1963-65", "HN": "66; was see under BIBLIOGRAPHY 1963-65", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004282"}, {"RECTYPE": "D", "MH": "Dog Diseases", "DE": "DOG DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Dog Disease", "MN": "C22.268", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "IM GEN or unspecified; coord IM with specific dis /vet (IM) or specific dog dis (IM); for abnormalities or injuries, index under DOGS /abnorm or DOGS /inj; don't forget also DOGS (NIM) & check tag ANIMALS; DF: DOG DIS", "MS": "Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used.", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004283"}, {"RECTYPE": "D", "MH": "Dogfish", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Squalidae|T013|NON|EQV|NLM (2005)|040218|abcdef", "ENTRY": "Dogfishes|T013|NON|EQV|NLM (1992)|900911|abcdef", "MN": "B01.050.150.900.493.370.853.392", "MH_TH": "NLM (1975)", "ST": "T013", "RN": "txid30511", "MS": "Sharks of the family Squalidae, also called dogfish sharks. They comprise at least eight genera and 44 species. Their LIVER is valued for its oil and its flesh is often made into fertilizer.", "OL": "search SHARKS 1966-74", "PM": "91; was see under SHARKS 1975-90", "HN": "91(75); was see under SHARKS 1975-90", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004284"}, {"RECTYPE": "D", "MH": "Dogs", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Canis familiaris|T015|NON|EQV|NLM (1998)|961025|abcdef", "ENTRY": "Dog", "MN": "B01.050.150.900.649.313.750.250.216.200", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid9615", "AN": "check tag: no qualif; TN 3: spelling of breeds", "CX": "consider also terms at CANINE", "MS": "The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004285"}, {"RECTYPE": "D", "MH": "Dolichols", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Eicosamethyl Octacontanonadecasen-1-ol|T109|NON|NRW|NLM (2021)|191127|abcdef", "ENTRY": "Octacontanonadecasen-1-ol, Eicosamethyl", "MN": "D10.289.230", "MH_TH": "NLM (2020)", "ST": "T123", "RN": "0", "PI": "Fatty Alcohols (1974)", "MS": "A class of polyprenols which contain approximately 20 isoprene residues. Although considered ISOPRENOIDS, they terminate with an alpha-saturated isoprenoid group at the hydroxy end of the molecule.", "PM": "2020; see DOLICHOL 1989-2019; see DITERPENES 1975-1988", "HN": "2020(1975)", "MR": "20200228", "DA": "19741119", "DC": "1", "DX": "19890101", "UI": "D004286"}, {"RECTYPE": "D", "MH": "Dolichol Monophosphate Mannose", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mannosyl Phosphoryl Dolichol|T109|T123|NON|EQV|UNK (19XX)|770516|abbcdef", "ENTRY": "Phosphoryl Dolichol, Mannosyl", "MN": "D10.390.700.700.250", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "beta-D-Mannopyranose, 1-ester with dolichol dihydrogen phosphate", "RN": "55598-56-6", "PI": "Hexosephosphates (1966-1977)", "MS": "A lipophilic glycosyl carrier of the monosaccharide mannose in the biosynthesis of oligosaccharide phospholipids and glycoproteins.", "PM": "91; was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90", "HN": "91(78); was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90", "MR": "20040707", "DA": "19770516", "DC": "1", "DX": "19910101", "UI": "D004287"}, {"RECTYPE": "D", "MH": "Dolichol Phosphates", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Phosphates, Dolichol", "MN": "D10.289.230.250", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Organophosphorus Compounds (1971-1977)", "MS": "Phosphoric acid esters of dolichol.", "PM": "91; was see under POLYISOPRENYL PHOSPHATES 1978-90", "HN": "91(78); was see under POLYISOPRENYL PHOSPHATES 1978-90", "MR": "20190705", "DA": "19770516", "DC": "1", "DX": "19910101", "UI": "D004288"}, {"RECTYPE": "D", "MH": "Dolphins", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "White-Beaked Dolphins|T015|NON|NRW|NLM (1998)|961010|abcdef", "ENTRY": "White-Beaked Dolphin", "MN": "B01.050.150.900.649.313.875.267", "MH_TH": "NLM (1968)", "ST": "T015", "RR": "txid9726", "AN": "do not confuse with DOLPHIN FISH see PERCIFORMES; note \"whale\" entry terms: these are common misnomers and are taxonomically DOLPHINS not WHALES", "PI": "Cetacea (1966-1967)", "MS": "Mammals of the families Delphinidae (ocean dolphins), Iniidae, Lipotidae, Pontoporiidae, and Platanistidae (all river dolphins). Among the most well-known species are the BOTTLE-NOSED DOLPHIN and the KILLER WHALE (a dolphin). The common name dolphin is applied to small cetaceans having a beaklike snout and a slender, streamlined body, whereas PORPOISES are small cetaceans with a blunt snout and rather stocky body. (From Walker's Mammals of the World, 5th ed, pp978-9)", "PM": "1968", "HN": "1968", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004289"}, {"RECTYPE": "D", "MH": "DOM 2,5-Dimethoxy-4-Methylamphetamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2,5-Dimethoxy-4-Methylamphetamine (DOM)|T109|T121|NON|EQV|NLM (2024)|230303|abbcdef", "ENTRY": "DOM 2,5 Dimethoxy 4 Methylamphetamine", "MN": "D02.092.471.683.152.391", "PA": "Serotonin Receptor Agonists", "MH_TH": "NLM (2024)", "ST": "T121", "N1": "Benzeneethanamine, 2,5-dimethoxy-alpha,4-dimethyl-", "RN": "15588-95-1", "RR": "50505-89-0 ((S)-isomer, HCl)", "MS": "A psychedelic phenyl isopropylamine derivative, commonly called DOM, whose mood-altering effects and mechanism of action may be similar to those of LSD.", "PM": "2024; see 2,5-Dimethoxy-4-Methylamphetamine 2000-2023", "HN": "2024; was 2,5-Dimethoxy-4-Methylamphetamine 2000-2023", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004290"}, {"RECTYPE": "D", "MH": "Dominance-Subordination", "ENTRY": "Dominance-Subordinations", "MN": "F01.145.813.650.400", "MH_TH": "NLM (1975)", "ST": "T054", "AN": "human & animal", "MS": "Relationship between individuals when one individual threatens or becomes aggressive and the other individual remains passive or attempts to escape.", "OL": "search SOCIAL DOMINANCE 1968-74", "PM": "91; was see under SOCIAL DOMINANCE 1969-90; was see under DOMINANCE, SOCIAL 1968", "HN": "91(75); was see under SOCIAL DOMINANCE 1969-90; was see under DOMINANCE, SOCIAL 1968", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004291"}, {"RECTYPE": "D", "MH": "Dominance, Cerebral", "AQ": "DE GE PH RE", "PRINT ENTRY": "Cerebral Dominance|T042|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Specialization, Hemispheric", "MN": "G11.561.225", "FX": "Aphasia", "MH_TH": "NLM (1967)", "ST": "T042", "MS": "Dominance of one cerebral hemisphere over the other in cerebral functions.", "PM": "1967", "HN": "1967(1965)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004292"}, {"RECTYPE": "D", "MH": "Dominican Republic", "AQ": "EH EP", "MN": "Z01.639.880.300", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "A republic in the Greater Antilles in the West Indies. Its capital is Santo Domingo. With Haiti, it forms the island of Hispaniola - the Dominican Republic occupying the eastern two thirds, and Haiti, the western third. It was created in 1844 after a revolt against the rule of President Boyer over the entire island of Hispaniola, itself visited by Columbus in 1492 and settled the next year. Except for a brief period of annexation to Spain (1861-65), it has been independent, though closely associated with the United States. Its name comes from the Spanish Santo Domingo, Holy Sunday, with reference to its discovery on a Sunday. (From Webster's New Geographical Dictionary, 1988, p338, 506 & Room, Brewer's Dictionary of Names, 1992, p151)", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D004293"}, {"RECTYPE": "D", "MH": "Domperidone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Stada, Domperidon", "MN": "D03.633.100.103.370", "PA": "Dopamine Antagonists", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "2H-Benzimidazol-2-one, 5-chloro-1-(1-(3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl)-4-piperidinyl)-1,3-dihydro-", "RN": "5587267Z69", "RR": "99497-03-7 (maleate)", "PI": "Piperidines (1977-1981)", "MS": "A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.", "PM": "82", "HN": "82", "MR": "20170524", "DA": "19810513", "DC": "1", "DX": "19820101", "UI": "D004294"}, {"RECTYPE": "D", "MH": "Dihydroxyphenylalanine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dopa|T116|T121|ACR|EQV|NLM (1966)|990101|abbcdef", "ENTRY": "beta Hydroxytyrosine", "MN": "D12.125.072.050.875.130", "PA": "Dopamine Agents", "FX": "Dopamine", "MH_TH": "UNK (19XX)", "ST": "T121", "N1": "DL-Tyrosine, 3-hydroxy-", "RN": "63-84-3", "RR": "37466-26-5 (HCl (2:1))", "AN": "check text to see if LEVODOPA; (L-DOPA); is not meant instead", "MS": "A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.", "PM": "2002; see DOPA 1966-2001", "HN": "2002(1966); for BETA-HYDROXYTYROSINE use DIHYDOXYPHENYLALANINE (NM) 1989-1991", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D004295"}, {"RECTYPE": "D", "MH": "Dopa Decarboxylase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Decarboxylase, Dopa", "MN": "D08.811.520.224.125.100.500", "PA": "Antiparkinson Agents", "EC": "antagonists & inhibitors:Aromatic Amino Acid Decarboxylase Inhibitors", "MH_TH": "NLM (1980)", "ST": "T126", "RN": "EC 4.1.1.-", "MS": "One of the AROMATIC-L-AMINO-ACID DECARBOXYLASES, this enzyme is responsible for the conversion of DOPA to DOPAMINE. It is of clinical importance in the treatment of Parkinson's disease.", "PM": "91,63-79; was see under AROMATIC AMINO ACID DECARBOXYLASES 1980-90; was heading 1963-79", "HN": "91(80)63; was see under AROMATIC AMINO ACID DECARBOXYLASES 1980-90; was heading 1963-79", "MR": "20140610", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004296"}, {"RECTYPE": "D", "MH": "Dopamine", "AQ": "AA AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxytyramine|T109|T121|T123|NON|EQV|UNK (19XX)|740329|abbbcdef", "ENTRY": "Hydrochloride, Dopamine", "MN": "D02.455.426.559.389.657.166.175.342", "PA": "Sympathomimetics", "FX": "Receptors, Dopamine", "EC": "antagonists & inhibitors:Dopamine Antagonists", "MH_TH": "INN (19XX)", "ST": "T123", "N1": "1,2-Benzenediol, 4-(2-aminoethyl)-", "RN": "VTD58H1Z2X", "RR": "7L3E358N9L", "MS": "One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.", "MR": "20180529", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004298"}, {"RECTYPE": "D", "MH": "Dopamine beta-Hydroxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta-Monooxygenase, Dopamine", "MN": "D08.811.682.690.708.292", "MH_TH": "NLM (1971)", "ST": "T126", "N1": "3,4-Dihydroxyphenethylamine, ascorbate:oxygen oxidoreductase (beta-hydroxylating)", "RN": "EC 1.14.17.1", "PI": "Hydroxylases (1966-1970)", "PM": "73", "HN": "73(71)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004299"}, {"RECTYPE": "D", "MH": "Doping in Sports", "AQ": "CL EC EH ES HI LJ MT PC PX SN TD", "PRINT ENTRY": "Blood Doping|T052|NON|NRW|NLM (1991)|900326|abcdef", "ENTRY": "in Sports, Doping", "MN": "I01.880.735.265", "FX": "Performance-Enhancing Substances", "MH_TH": "NLM (1978)", "ST": "T052", "AN": "human & animal", "MS": "Illegitimate use of substances for a desired effect in competitive sports. It includes humans and animals.", "PM": "78", "HN": "78", "MR": "20100625", "DA": "19770513", "DC": "1", "DX": "19780101", "UI": "D004300"}, {"RECTYPE": "D", "MH": "Doppler Effect", "DE": "DOPPLER EFF", "PRINT ENTRY": "Doppler Shift|T070|EPO|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "Shift, Doppler", "MN": "G01.226", "MH_TH": "NLM (1975)", "ST": "T070", "MS": "Changes in the observed frequency of waves (as sound, light, or radio waves) due to the relative motion of source and observer. The effect was named for the 19th century Austrian physicist Johann Christian Doppler.", "PM": "91; was see under PHYSICS 1975-90", "HN": "91(75); was see under PHYSICS 1975-90", "MR": "20160322", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004301"}, {"RECTYPE": "D", "MH": "Dorsomedial Hypothalamic Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hypothalamic Nucleus, Dorsomedial|T023|NON|EQV|UNK (19XX)|820428|abcdef", "ENTRY": "Nucleus, Dorsomedial Hypothalamic", "MN": "A08.186.211.200.317.357.352.270", "MH_TH": "NLM (1983)", "ST": "T023", "PI": "Hypothalamus (1966-1982)", "MS": "An aggregation of cells in the middle hypothalamus dorsal to the ventromedial nucleus and bordering the THIRD VENTRICLE.", "PM": "91; was see under HYPOTHALAMUS, MIDDLE 1983-90", "HN": "91(83); was see under HYPOTHALAMUS, MIDDLE 1983-90", "MR": "20180630", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D004302"}, {"RECTYPE": "D", "MH": "Dosage Compensation, Genetic", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Dosage Compensation (Genetics)|T045|NON|EQV|NLM (1982)|990101|DOSAGE COMPENSATION GENET|abcdefv", "ENTRY": "X Chromosome Hypertranscription", "MN": "G05.308.203.249", "MH_TH": "NLM (2006)", "ST": "T045", "AN": "do not confuse with GENE DOSAGE", "PI": "X Chromosome (1978-1981)", "MS": "Genetic mechanisms that allow GENES to be expressed at a similar level irrespective of their GENE DOSAGE. This term is usually used in discussing genes that lie on the SEX CHROMOSOMES. Because the sex chromosomes are only partially homologous, there is a different copy number, i.e., dosage, of these genes in males vs. females. In DROSOPHILA, dosage compensation is accomplished by hypertranscription of genes located on the X CHROMOSOME. In mammals, dosage compensation of X chromosome genes is accomplished by random X CHROMOSOME INACTIVATION of one of the two X chromosomes in the female.", "PM": "2006; see DOSAGE COMPENSATION (GENETICS) 1982-2005", "HN": "2006 (1982)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19810223", "DC": "1", "DX": "19820101", "UI": "D004303"}, {"RECTYPE": "D", "MH": "Dosage Forms", "AQ": "ST", "ENTRY": "Forms, Dosage", "MN": "E05.916.250", "FX": "Drug Delivery Systems", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "AN": "general only: prefer specifics", "MS": "Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect.", "CATSH": "CAT LIST", "MR": "20140617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004304"}, {"RECTYPE": "D", "MH": "Dose-Response Relationship, Drug", "DE": "DOSE RESPONSE RELAT DRUG", "ENTRY": "Relationships, Drug Dose-Response", "MN": "G07.690.936.500", "MH_TH": "NLM (1973)", "ST": "T081", "AN": "IM general only; coordinate NIM with specific drug", "MS": "The relationship between the dose of an administered drug and the response of the organism to the drug.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004305"}, {"RECTYPE": "D", "MH": "Dose-Response Relationship, Immunologic", "DE": "DOSE RESPONSE RELAT IMMUNOL", "ENTRY": "Relationships, Immunologic Dose-Response", "MN": "G12.300", "MH_TH": "NLM (1977)", "ST": "T081", "AN": "IM general only; coordinate NIM with specific immunologic concept", "MS": "A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D004306"}, {"RECTYPE": "D", "MH": "Dose-Response Relationship, Radiation", "DE": "DOSE RESPONSE RELAT RAD", "ENTRY": "Relationships, Radiation Dose-Response", "MN": "N06.850.810.250.180", "MH_TH": "NLM (1973)", "ST": "T081", "AN": "IM general only; coordinate NIM with specific type of radiation", "PI": "Radiotherapy Dosage (1966-1972)", "MS": "The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation.", "PM": "73", "HN": "73", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004307"}, {"RECTYPE": "D", "MH": "Dothiepin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dosulepin|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|771213|abbcdeef", "ENTRY": "Hydrochloride, Dothiepin", "MN": "D03.633.300.311.250", "PA": "Antidepressive Agents, Tricyclic", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "1-Propanamine, 3-dibenzo(b,e)thiepin-11(6H)-ylidene-N,N-dimethyl-", "RN": "W13O82Z7HL", "RR": "897-15-4 (HCl)", "PI": "Dibenzothiepins (1968-1974)", "MS": "A tricyclic antidepressant with some tranquilizing action.", "OL": "use DOTHIEPIN to search PROTHIADENE 1975-94; use DIBENZOTHIEPINS 1968-74", "PM": "91; was see under DIBENZOTHIEPINS 1979-90; was PROTHIADENE see under DIBENZOTHIEPINS 1968-78; PROTHIADENE was see DOTHIEPIN 1979-94", "HN": "91(79); was see under DIBENZOTHIEPINS 1979-90; was PROTHIADENE see under DIBENZOTHIEPINS 1968-78; PROTHIADENE was see DOTHIEPIN 1979-94", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004308"}, {"RECTYPE": "D", "MH": "Double Bind Interaction", "PRINT ENTRY": "Double Bind Theory|T170|NON|REL|NLM (2000)|991103|abcdef", "ENTRY": "Theory, Double Bind", "MN": "F01.829.131", "MH_TH": "NLM (1972)", "ST": "T054", "PI": "Psychological Theory (1966-1971)", "MS": "Simultaneous communication of conflicting messages in which the response to either message evokes rejection or disapproval. (APA, Thesaurus of Psychological Index Terms, 8th ed.)", "PM": "2000; see DOUBLE BIND THEORY 1991-1999; see PSYCHOLOGICAL THEORY 1972-1990", "HN": "2000(1972)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004309"}, {"RECTYPE": "D", "MH": "Double Outlet Right Ventricle", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Taussig-Bing Anomaly|T019|EPO|NRW|UNK (19XX)|860624|abcdef", "ENTRY": "Ventricle, Double-Outlet Right", "MN": "C16.131.240.400.915.300", "MH_TH": "NLM (1987)", "ST": "T019", "PI": "Transposition of Great Vessels (1966-1986)", "MS": "Incomplete transposition of the great vessels in which both the AORTA and the PULMONARY ARTERY arise from the RIGHT VENTRICLE. The only outlet of the LEFT VENTRICLE is a large ventricular septal defect (VENTRICULAR SEPTAL DEFECTS or VSD). The various subtypes are classified by the location of the septal defect, such as subaortic, subpulmonary, or noncommitted.", "OL": "search TRANSPOSITION OF GREAT VESSELS 1984-86", "PM": "87; was see TRANSPOSITION OF GREAT VESSELS 1984-86", "HN": "87; was see TRANSPOSITION OF GREAT VESSELS 1984-86", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19860624", "DC": "1", "DX": "19870101", "UI": "D004310"}, {"RECTYPE": "D", "MH": "Double-Blind Method", "PRINT ENTRY": "Double-Masked Study|T062|NON|EQV|NLM (1995)|940124|abcdef", "ENTRY": "Study, Double-Masked", "MN": "N06.850.520.445.300", "MH_TH": "NLM (1977)", "ST": "T062", "AN": "IM GEN only; coord NIM with specific disease (IM); when pertinent add CLINICAL TRIAL (PT) or RANDOMIZED CONTROLLED TRIAL (PT); do not index also under PLACEBOS unless particularly discussed", "MS": "A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.", "PM": "90; was see under RESEARCH DESIGN 1977-89", "HN": "90(Aug 77); was in Cat E & H Aug 77-79; was see under RESEARCH DESIGN 1977-89", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19770512", "DC": "1", "DX": "19900101", "UI": "D004311"}, {"RECTYPE": "D", "MH": "Douglas' Pouch", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "Cul-de-Sac, Douglas'|T030|EPO|EQV|NLM (1992)|901003|abcdef", "ENTRY": "Pouch, Rectouterine", "MN": "A01.923.047.025.600.225", "FX": "Culdoscopy", "MH_TH": "NLM (1966)", "ST": "T030", "AN": "diseases: coordinate with PERITONEAL DISEASES", "MS": "A sac or recess formed by a fold of the peritoneum.", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004312"}, {"RECTYPE": "D", "MH": "Dourine", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Dourines", "MN": "C22.674.710.367", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "coordinate  IM with HORSE DISEASES (IM) + HORSES (NIM); if in donkeys, coordinate IM with DONKEYS (IM); check tag ANIMALS", "MS": "A disease of horses and donkeys caused by Trypanosoma equiperdum. The disease occurs in Africa, the Americas, and Asia.", "OL": "search TRYPANOSOMIASIS 1968-74", "PM": "91; was see under TRYPANOSOMIASIS 1975-90", "HN": "91(75); was see under TRYPANOSOMIASIS 1975-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004313"}, {"RECTYPE": "D", "MH": "Down Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Trisomy 21|T019|NON|EQV|GHR (2014)|NLM (1992)|OMIM (2013)|901207|abcdeeef", "ENTRY": "Syndrome, Down's", "MN": "C16.320.180.260", "MH_TH": "OMIM (2013)", "ST": "T019", "MS": "A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213)", "OL": "use DOWN SYNDROME to search DOWN'S SYNDROME 1975-92 & MONGOLISM 1966-74", "PM": "93; was DOWN'S SYNDROME 1975-92 & 1963-64; was MONGOLISM 1965-74", "HN": "93; was DOWN'S SYNDROME 1975-92 & 1963-64; was MONGOLISM 1965-74", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D004314"}, {"RECTYPE": "D", "MH": "Doxapram", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Doxapram", "MN": "D03.383.773.812.226", "PA": "Respiratory System Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-", "RN": "94F3830Q73", "RR": "P5RU6UOQ5Y", "MS": "A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)", "PM": "73", "HN": "73(65)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004315"}, {"RECTYPE": "D", "MH": "Doxepin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Novo Doxepin", "MN": "D03.633.300.382.393", "PA": "Histamine Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)-ylidene-N,N-dimethyl-", "RN": "1668-19-5", "RR": "5ASJ6HUZ7D", "MS": "A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.", "PM": "74", "HN": "74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004316"}, {"RECTYPE": "D", "MH": "Doxorubicin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adriamycin|T109|T121|TRD|NRW|UNK (1978)|770412|abbcdef", "ENTRY": "Urokit Doxo cell", "MN": "D09.408.051.059.200.175", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USAN (1973)", "ST": "T121", "N1": "5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-", "RN": "80168379AG", "RR": "82F2G7BL4E", "PI": "Antibiotics, Antineoplastic (1967-1972)", "MS": "Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.", "PM": "78; see ADRIAMYCIN 1973-77", "HN": "78(73)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004317"}, {"RECTYPE": "D", "MH": "Doxycycline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vibra Tabs", "MN": "D04.615.562.900.200", "PA": "Antimalarials", "MH_TH": "USP (19XX)", "ST": "T195", "RN": "N12000U13O", "RR": "N12000U13O", "PI": "Oxytetracycline (1966-1970)", "MS": "A synthetic tetracycline derivative with similar antimicrobial activity.", "OL": "use DOXYCYCLINE (NM) to search HYDRAMYCIN 1991-92", "PM": "73; HYDRAMYCIN was indexed under ANTHRAQUINONES 1991-92", "HN": "73; HYDRAMYCIN was NM 1991-92", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004318"}, {"RECTYPE": "D", "MH": "Doxylamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.725.259", "PA": "Histamine H1 Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Ethanamine, N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)-", "RN": "95QB77JKPL", "RR": "469-21-6 (Doxylamine)", "PI": "Pyridines (1972)", "MS": "Histamine H1 antagonist with pronounced sedative properties. It is used in allergies and as an antitussive, antiemetic, and hypnotic. Doxylamine has also been administered in veterinary applications and was formerly used in PARKINSONISM.", "PM": "91; was see under PYRIDINES 1972-90", "HN": "91(72); was see under PYRIDINES 1972-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004319"}, {"RECTYPE": "D", "MH": "Dracunculiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Guinea Worm Infection|T047|EPO|EQV|ORD (2010)|UNK (19XX)|750101|GUINEA WORM INFECT|abcdeefv", "ENTRY": "Worm Disease, Guinea", "MN": "C01.610.335.508.700.750.299", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "MS": "Infection with nematodes of the genus Dracunculus. One or more worms may be seen at a time, with the legs and feet being the most commonly infected areas. Symptoms include pruritus, nausea, vomiting, diarrhea, or asthmatic attacks.", "OL": "use DRACUNCULIASIS to search DRACUNCULOSIS 1966-92", "PM": "93; was DRACUNCULOSIS 1963-92", "HN": "93; was DRACUNCULOSIS 1963-92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D004320"}, {"RECTYPE": "D", "MH": "Dracunculus Nematode", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Medina Worm|T204|NON|NRW|UNK (19XX)|850319|abcdef", "ENTRY": "medinenses, Dracunculus", "MN": "B01.050.500.500.294.400.937.225.250.250", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid318478", "RR": "txid318479", "MS": "A genus of nematode parasites which inhabit the body cavity, serous membranes, and connective tissues of vertebrates. The parasitic species in humans is Dracunculus medinensis.", "PM": "2003; see DRACUNCULUS 1963-2002; for DRACUNCULUS MEDINENSIS see DRACUNCULUS 1963-1985; for GUINEA WORM see DRACUNCULUS MEDINENSIS 1979-1985, see DRACUNCULUS 1968-1978; for MEDINA WORM see DRACUNCULUS MEDINENSIS 1979-1985", "HN": "2003(1963)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "20030101", "UI": "D004321"}, {"RECTYPE": "D", "MH": "Drainage", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E04.237", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "DRAINAGE, SUCTION see SUCTION is also available", "MS": "The removal of fluids or discharges from the body, such as from a wound, sore, or cavity.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004322"}, {"RECTYPE": "D", "MH": "Drainage, Sanitary", "AQ": "CL EC ES HI LJ MT SN ST", "ENTRY": "Sanitary Drainages", "MN": "N06.850.780.200.800.800.350", "MH_TH": "NLM (1975)", "ST": "T073", "PI": "Sanitary Engineering (1966-1974)", "MS": "A system of artificial or natural drains, generally used for the disposal of liquid wastes.", "OL": "search SANITARY ENGINEERING 1966-74", "PM": "75; was see under SANITARY ENGINEERING 1963-74", "HN": "75; was see under SANITARY ENGINEERING 1963-74", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D004323"}, {"RECTYPE": "D", "MH": "Drama", "AQ": "HI", "ENTRY": "Dramas", "MN": "K01.517.333", "MH_TH": "NLM (1975)", "ST": "T170", "AN": "coord IM with LITERATURE, MEDIEVAL (IM) or LITERATURE, MODERN (IM); docudrama as a stage presentation goes here", "MS": "A composition in prose or verse presenting in dialogue or pantomime a story involving various characters, usually intended to be acted on a stage and to be regarded as a form of entertainment. (From Random House Unabridged Dictionary, 2d ed)", "OL": "search LITERATURE 1966-74", "PM": "91; was see under LITERATURE 1975-90", "HN": "91(75); was see under LITERATURE 1975-90", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004324"}, {"RECTYPE": "D", "MH": "Dreams", "AQ": "CL DE ES PH PX RE", "PRINT ENTRY": "Nightmares|T041|NON|REL|UNK (19XX)|770422|abcdef", "ENTRY": "Nightmare", "MN": "F02.830.855.268", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "consider also PAVOR NOCTURNUS (see NIGHT TERRORS)", "MS": "A series of thoughts, images, or emotions occurring during sleep which are dissociated from the usual stream of consciousness of the waking state.", "CATSH": "CAT LIST", "MR": "19920514", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004325"}, {"RECTYPE": "D", "MH": "Drinking", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Water Intake|T040|NON|NRW|NLM (1993)|911106|abcdef", "ENTRY": "Drinkings", "MN": "G10.261.330.249", "FX": "Alcohol Drinking", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "The consumption of liquids.", "PM": "70", "HN": "70(66)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D004326"}, {"RECTYPE": "D", "MH": "Drinking Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Drinking Behaviors", "MN": "F01.145.317", "MH_TH": "NLM (1969)", "ST": "T055", "PI": "Thirst (1966-1968)", "MS": "Behaviors associated with the ingesting of water and other liquids; includes rhythmic patterns of drinking (time intervals - onset and duration), frequency and satiety.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D004327"}, {"RECTYPE": "D", "MH": "Drive", "ENTRY": "Drives", "MN": "F01.658.293", "FX": "Motivation", "MH_TH": "NLM (1965)", "ST": "T041", "AN": "human & animal", "MS": "A state of internal activity of an organism that is a necessary condition before a given stimulus will elicit a class of responses; e.g., a certain level of hunger (drive) must be present before food will elicit an eating response.", "PM": "69; was see under MOTIVATION 1963-68", "HN": "69(65); was see under MOTIVATION 1963-68", "CATSH": "CAT LIST", "MR": "19910620", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D004328"}, {"RECTYPE": "D", "MH": "Droperidol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dehydrobenzperidol|T109|T121|TRD|NRW|MX|NL|740329|abbcdeef", "ENTRY": "Inapsine|T109|T121|TRD|NRW|US|861024|abbcdef", "MN": "D03.633.100.103.393", "PA": "Dopamine D2 Receptor Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-Benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-", "RN": "O9U0F09D5X", "RR": "548-73-2 (Droperidol)", "MS": "A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593)", "PM": "74", "HN": "74(73)", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004329"}, {"RECTYPE": "D", "MH": "Drosophila", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Fruit Fly, Drosophila|T204|NON|EQV|NLM (2003)|011030|abcdef", "ENTRY": "Fruit Flies, Drosophila", "MN": "B01.050.500.131.617.720.500.500.750.310.250", "FX": "Drosophila Proteins", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid7215", "MS": "A genus of small, two-winged flies containing approximately 900 described species. These organisms are the most extensively studied of all genera from the standpoint of genetics and cytology.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004330"}, {"RECTYPE": "D", "MH": "Drosophila melanogaster", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "melanogaster, Drosophila", "MN": "B01.050.500.131.617.720.500.500.750.310.250.500", "FX": "Drosophila Proteins", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid7227", "AN": "NIM with no qualifiers when an experimental animal", "PI": "Drosophila (1966-1971)", "MS": "A species of fruit fly frequently used in genetics because of the large size of its chromosomes.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D004331"}, {"RECTYPE": "D", "MH": "Drowning", "AQ": "BL CF CL DG DI EC EH EM EN EP ET GE HI ME MI MO NU PA PC PP PS PX SU UR VE", "ENTRY": "Drownings", "MN": "N06.850.135.696", "FX": "Resuscitation", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Death that occurs as a result of anoxia or heart arrest, associated with immersion in liquid.", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004332"}, {"RECTYPE": "D", "MH": "Drug Administration Routes", "DE": "DRUG ADMIN ROUTES", "AQ": "VE", "ENTRY": "Routes, Drug Administration", "MN": "E02.319.267", "FX": "Dosage Forms", "MH_TH": "NLM (1987)", "ST": "T169", "AN": "general or unspecified; prefer specifics; NIM", "MS": "The various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed into the blood and delivered to the target tissue.", "PM": "87", "HN": "87; was DRUG ADMINISTRATION (NON MESH) before 1987", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D004333"}, {"RECTYPE": "D", "MH": "Drug Administration Schedule", "DE": "DRUG ADMIN SCHEDULE", "AQ": "VE", "PRINT ENTRY": "Administration Schedule, Drug|T079|NON|EQV|UNK (19XX)|750116|ADMIN SCHEDULE DRUG|abcdefv", "ENTRY": "Schedules, Drug Administration", "MN": "E02.319.283", "FX": "Chronotherapy", "MH_TH": "NLM (1975)", "ST": "T079", "PI": "specific drug/administration & dosage (1966-1974)", "MS": "Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D004334"}, {"RECTYPE": "D", "MH": "Drug and Narcotic Control", "DE": "DRUG NARCOTIC CONTROL", "AQ": "EC HI LJ MT OG SN TD", "PRINT ENTRY": "Pharmaceutical Policy|T064|NON|NRW|NLM (1999)|980114|PHARM POLICY|abcdefv", "ENTRY": "Regulations, Drug", "MN": "N04.452.706.310", "FX": "Substance-Related Disorders", "MH_TH": "NLM (1968)", "ST": "T064", "AN": "Public Law 91-513; includes international agreement; specify country or state", "MS": "Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (DRUG APPROVAL), and marketing of drugs.", "OL": "use LEGISLATION, DRUG to search DRUG REGULATIONS 1990-92 & DRUG RECALL 1985-92; use DRUG AND NARCOTIC CONTROL to search NARCOTIC TRADE 1966-67", "PM": "68; DRUG REGULATIONS was see LEGISLATION, DRUG 1990-92; DRUG RECALL was see LEGISLATION, DRUG 1985-92; NARCOTIC TRADE was heading 1963-67", "HN": "68; DRUG REGULATIONS was see LEGISLATION, DRUG 1990-92; DRUG RECALL was see LEGISLATION, DRUG 1985-92; NARCOTIC TRADE was heading 1963-67", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004335"}, {"RECTYPE": "D", "MH": "Drug Antagonism", "DE": "DRUG ANTAG", "ENTRY": "Drug Antagonisms", "MN": "G07.690.773.968.310", "FX": "Narcotic Antagonists", "MH_TH": "NLM (1966)", "ST": "T044", "AN": "general only; prefer specific drug with /antag", "MS": "Phenomena and pharmaceutics of compounds that inhibit the function of agonists (DRUG AGONISM) and inverse agonists (DRUG INVERSE AGONISM) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy.", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004336"}, {"RECTYPE": "D", "MH": "Drug Carriers", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Drug Carrier", "MN": "E02.319.300.380", "FX": "Magnetic Iron Oxide Nanoparticles", "MH_TH": "NLM (1988)", "ST": "T122", "RN": "0", "AN": "coord with specific drug", "PI": "Drugs (1966-1987)", "MS": "Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.", "PM": "88", "HN": "88", "MR": "20200617", "DA": "19870504", "DC": "1", "DX": "19880101", "UI": "D004337"}, {"RECTYPE": "D", "MH": "Drug Combinations", "PRINT ENTRY": "Drug Combination|T121|NON|EQV|NLM (2021)|191126|abcdef", "ENTRY": "Combinations, Drug", "MN": "D26.310", "FX": "Polypharmacy", "MH_TH": "NLM (1971)", "ST": "T121", "RN": "0", "PI": "Dosage Forms (1966-1970)", "MS": "Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.", "PM": "73", "HN": "73(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004338"}, {"RECTYPE": "D", "MH": "Drug Compounding", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Drug Preparation|T058|NON|EQV|NLM (1998)|961206|abcdef", "ENTRY": "Preparation, Drug", "MN": "E05.916.270", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "do not confuse with DRUG PRESCRIPTIONS (prescribing is by the MD, compounding by the pharmacist or drug company)", "MS": "The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814).", "PM": "2017; for DRUG FORMULATION see CHEMISTRY, PHARMACEUTICAL 1998-2016", "HN": "2017; for DRUG FORMULATION use CHEMISTRY, PHARMACEUTICAL 1998-2016", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004339"}, {"RECTYPE": "D", "MH": "Drug Contamination", "AQ": "EC LJ PC SN", "PRINT ENTRY": "Drug Impurity|T068|NON|NRW|NLM (2003)|011022|abcdef", "ENTRY": "Physical Drug Contaminations", "MN": "N06.850.360", "MH_TH": "NLM (1974)", "ST": "T068", "AN": "can be used for contamination of any Category D term", "MS": "The presence of organisms, or any foreign material that makes a drug preparation impure.", "OL": "use DRUG CONTAMINATION to search DRUG ADULTERATION 1966-76", "PM": "74; DRUG ADULTERATION was heading 1963-76", "HN": "74; DRUG ADULTERATION was heading 1963-76", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004340"}, {"RECTYPE": "D", "MH": "Drug Evaluation", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Evaluation Studies, Drug|T062|T064|NON|EQV|NLM (1993)|920313|abbcdef", "ENTRY": "Study, Drug Evaluation", "MN": "E05.337.425", "FX": "Clinical Trials as Topic", "MH_TH": "NLM (1974)", "ST": "T064", "AN": "general: more likely CLINICAL TRIAL and its indentations or CLINICAL TRIALS AS TOPIC and its indentations; differentiate from DRUG EVALUATION, PRECLINICAL which is used for studies in experimental animals or in vitro", "MS": "Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.", "PM": "74", "HN": "74; was in Cat E & G 1974-79", "CATSH": "CAT LIST", "MR": "20171208", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004341"}, {"RECTYPE": "D", "MH": "Drug Hypersensitivity", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypersensitivity, Drug|T037|T047|NON|EQV|NLM (1993)|920203|abbcdef", "ENTRY": "Hypersensitivities, Drug", "MN": "C25.100.468", "FX": "Drug Hypersensitivity Syndrome", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "use in conventional sense and not for allergy to every category D term; allergy to non-drug chemical substance=substance /ad eff + HYPERSENSITIVITY or its specifics /etiol", "MS": "Immunologically mediated adverse reactions to medicinal substances used legally or illegally.", "PM": "66; was DRUG ALLERGY 1963-65", "HN": "66; was DRUG ALLERGY 1963-65", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004342"}, {"RECTYPE": "D", "MH": "Drug Implants", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Pellets, Drug|T122|NON|NRW|UNK (19XX)|840223|abcdef", "ENTRY": "Pellet, Drug", "MN": "D26.255.210.315", "FX": "Infusion Pumps, Implantable", "MH_TH": "NLM (1975)", "ST": "T122", "RN": "0", "PI": "Delayed-Action Preparations (1966-1974)", "MS": "Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug.", "PM": "75", "HN": "75", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D004343"}, {"RECTYPE": "D", "MH": "Drug Incompatibility", "ENTRY": "Incompatibility, Drug", "MN": "E05.916.290", "MH_TH": "NLM (1965)", "ST": "T080", "AN": "\"one drug is not of suitable composition to be combined or mixed with another\": do not confuse with DRUG INTERACTIONS, \"the action of one drug on the metab, effect or tox of another\"; IM when general; NIM when with specific drug", "MS": "The quality of not being miscible with another given substance without a chemical change. One drug is not of suitable composition to be combined or mixed with another agent or substance. The incompatibility usually results in an undesirable reaction, including chemical alteration or destruction. (Dorland, 27th ed; Stedman, 25th ed)", "PM": "73", "HN": "73(65)", "CATSH": "CAT LIST", "MR": "19920508", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004344"}, {"RECTYPE": "D", "MH": "Drug Industry", "DE": "DRUG INDUST", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Pharmaceutical Industries", "MN": "J01.576.655.750", "FX": "Technology, Pharmaceutical", "MH_TH": "BIOETHICS (1978)", "ST": "T093", "AN": "/instrum /methods: consider probably better TECHNOLOGY, PHARMACEUTICAL", "MS": "That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004345"}, {"RECTYPE": "D", "MH": "Drug Information Services", "DE": "DRUG INFORMATION SERV", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Service, Drug Information", "MN": "N02.421.668.320", "MH_TH": "NLM (1977)", "ST": "T058", "PI": "Information Services (1966-1976)", "MS": "Services providing pharmaceutic and therapeutic drug information and consultation.", "PM": "81; was see under INFORMATION SERVICES 1977-80", "HN": "81(77); was see under INFORMATION SERVICES 1977-80", "MR": "20170703", "DA": "19760519", "DC": "1", "DX": "19810101", "UI": "D004346"}, {"RECTYPE": "D", "MH": "Drug Interactions", "AQ": "EH GE IM PH RE", "ENTRY": "Interactions, Drug", "MN": "G07.690.773.968", "FX": "Drug-Related Side Effects and Adverse Reactions", "MH_TH": "POPLINE (1988)", "ST": "T044", "AN": "IM general only; coordinate NIM with specific drug (IM);  do not confuse with DRUG INCOMPATIBILITY", "PI": "Drug Synergism (1966-1971)", "MS": "The action of a drug that may affect the activity, metabolism, or toxicity of another drug.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D004347"}, {"RECTYPE": "D", "MH": "Drug Labeling", "AQ": "CL EC ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Product Labeling, Drug|T058|NON|EQV|UNK (19XX)|780428|abcdef", "ENTRY": "Warnings, Boxed", "MN": "J01.576.761.300.400", "FX": "Off-Label Use", "MH_TH": "NLM (1968)", "ST": "T058", "PI": "Medication Errors (1966-1967)", "MS": "Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20150109", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004348"}, {"RECTYPE": "D", "MH": "Drug Packaging", "AQ": "CL EC ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Packaging, Drug|T058|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Packagings, Drug", "MN": "J01.576.761.300", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "includes containers, packaging methods, packaging materials; IM; DRUG LABELING is also available", "PI": "Pharmacy (1966-1967)", "MS": "Containers, packaging, and packaging materials for drugs and BIOLOGICAL PRODUCTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available.", "OL": "use DRUG PACKAGING to search DRUG CONTAINERS AND CLOSURES 1968-77", "PM": "78; was DRUG CONTAINERS AND CLOSURES 1968-77", "HN": "78; was DRUG CONTAINERS AND CLOSURES 1968-77", "CATSH": "CAT LIST", "MR": "20130710", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004349"}, {"RECTYPE": "D", "MH": "Drug Residues", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO", "ENTRY": "Residues, Drug", "MN": "N06.850.460.200.250", "FX": "Pesticide Residues", "MH_TH": "NLM (1988)", "ST": "T121", "PI": "Drugs (1966-1987)", "MS": "Drugs and their metabolites which are found in the edible tissues and milk of animals after their medication with specific drugs. This term can also apply to drugs found in adipose tissue of humans after drug treatment.", "PM": "88", "HN": "88", "MR": "20080708", "DA": "19870504", "DC": "1", "DX": "19880101", "UI": "D004350"}, {"RECTYPE": "D", "MH": "Drug Resistance", "AQ": "DE GE IM PH RE", "ENTRY": "Resistance, Drug", "MN": "G07.690.773.984", "FX": "Pharmacogenetics", "MH_TH": "NLM (1972)", "ST": "T032", "AN": "general or unspecified; prefer specifics; differentiate from DRUG TOLERANCE; resistance of parasites including protozoa goes here", "MS": "Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration.", "PM": "1972", "HN": "1972", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D004351"}, {"RECTYPE": "D", "MH": "Drug Resistance, Microbial", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Antimicrobial Resistance, Drug|T032|NON|NRW|NLM (2024)|230509|abcdef", "ENTRY": "Resistances, Drug Antimicrobial", "MN": "G07.690.773.984.269", "FX": "Tuberculosis, Multidrug-Resistant", "MH_TH": "NLM (1966)", "ST": "T032", "AN": "general or unspecified; prefer specifics; not for protozoa: index DRUG RESISTANCE", "MS": "The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).", "PM": "1963; for ANTIBIOTIC RESISTANCE see DRUG RESISTANCE 2002-2007", "HN": "1963; for ANTIBIOTIC RESISTANCE use DRUG RESISTANCE 2002-2007", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D004352"}, {"RECTYPE": "D", "MH": "Drug Evaluation, Preclinical", "DE": "DRUG EVALUATION PRECLIN", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Evaluation Studies, Drug, Pre-Clinical|T062|NON|EQV|UNK (19XX)|810415|EVALUATION STUDIES PRE CLIN|abcdefv", "ENTRY": "Screenings, Drug", "MN": "E05.337.550", "FX": "Toxicity Tests", "MH_TH": "UNK (19XX)", "ST": "T062", "AN": "IM when general; NIM with specific drug; used for studies in experimental animals or in vitro;` do not confuse entry term DRUG SCREENING for screening for substance abuse (= SUBSTANCE ABUSE DETECTION)", "MS": "Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications.", "PM": "74", "HN": "74; was in Cat E & G 1974-79", "CATSH": "CAT LIST", "MR": "20171208", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004353"}, {"RECTYPE": "D", "MH": "Drug Screening Assays, Antitumor", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Dye Exclusion Assays, Antitumor|T059|NON|NRW|UNK (19XX)|870508|abcdef", "ENTRY": "Tumor Specific Drug Screening Tests", "MN": "E05.337.550.200", "MH_TH": "NLM (1988)", "ST": "T059", "AN": "IM when general; NIM when with specific antineoplastic agent (IM)", "PI": "Tumor Stem Cell Assay (1984-1987)", "MS": "Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19870508", "DC": "1", "DX": "19880101", "UI": "D004354"}, {"RECTYPE": "D", "MH": "Drug Stability", "ENTRY": "Shelf Lives, Drugs", "MN": "E05.916.330", "MH_TH": "NLM (1965)", "ST": "T080", "AN": "IM general only; coordinate NIM with specific drug; ENZYME STABILITY is also available", "MS": "The chemical and physical integrity of a pharmaceutical product.", "PM": "68", "HN": "68(65)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004355"}, {"RECTYPE": "D", "MH": "Drug Storage", "AQ": "EC HI LJ MT SN ST", "ENTRY": "Storages, Drug", "MN": "E05.916.350", "MH_TH": "NLM (1968)", "ST": "T067", "AN": "IM general only; coordinate NIM with specific drug", "PI": "Pharmacy Service, Hospital (1966-1967)", "MS": "The process of keeping pharmaceutical products in an appropriate location.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004356"}, {"RECTYPE": "D", "MH": "Drug Synergism", "PRINT ENTRY": "Drug Potentiation|T044|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Synergisms, Drug", "MN": "G07.690.773.968.477", "FX": "Pesticide Synergists", "MH_TH": "NLM (1965)", "ST": "T044", "AN": "IM when general; NIM when with specific drugs (IM)", "MS": "The action of a drug in promoting or enhancing the effectiveness of another drug.", "PM": "66", "HN": "66(65)", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004357"}, {"RECTYPE": "D", "MH": "Drug Therapy", "DE": "DRUG THER", "AQ": "CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Pharmacotherapy|T061|NON|EQV|UNK (19XX)|740329|PHARMACOTHER|abcdefv", "ENTRY": "Therapies, Drug", "MN": "E02.319", "FX": "Pharmacologic Actions", "EC": "adverse effects:Drug-Related Side Effects and Adverse Reactions", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004358"}, {"RECTYPE": "D", "MH": "Drug Therapy, Combination", "DE": "DRUG THER COMBINATION", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Polychemotherapy|T061|NON|NRW|UNK (19XX)|810515|POLYCHEMOTHER|abcdefv", "ENTRY": "Therapies, Combination Drug", "MN": "E02.319.310", "FX": "Drug Synergism", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "IM when general; NIM when with specific drugs; differentiate from DRUG COMBINATIONS which is single preparation of multiple drugs; note entry term POLYCHEMOTHERAPY: do not confuse with POLYPHARMACY which is available for the use of multiple drugs administered to the same patient", "MS": "Therapy with two or more separate preparations given for a combined effect.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004359"}, {"RECTYPE": "D", "MH": "Drug Therapy, Computer-Assisted", "DE": "DRUG THER COMPUTER ASSISTED", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Protocol Drug Therapy, Computer-Assisted|T061|T062|NON|NRW|UNK (19XX)|860617|PROTOCOL DRUG THER COMPUTER ASSISTED|abbcdefv", "ENTRY": "Therapy, Computer Assisted Drug", "MN": "L01.313.500.750.100.710.180", "FX": "Medical Order Entry Systems", "MH_TH": "NLM (1987)", "ST": "T062", "MS": "Adjunctive computer programs in providing drug treatment to patients.", "PM": "91; was see under THERAPY, COMPUTER-ASSISTED 1987-90", "HN": "91(87); was see under THERAPY, COMPUTER-ASSISTED 1987-90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19860617", "DC": "1", "DX": "19910101", "UI": "D004360"}, {"RECTYPE": "D", "MH": "Drug Tolerance", "AQ": "EH GE IM PH RE", "ENTRY": "Tolerances, Drug", "MN": "G07.690.773.992", "MH_TH": "NLM (1966)", "ST": "T032", "MS": "Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL.", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004361"}, {"RECTYPE": "D", "MH": "Drug Utilization", "DE": "DRUG UTIL", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Utilizations, Drug", "MN": "N04.452.706.477", "MH_TH": "NLM (1968)", "ST": "T081", "PI": "specific drug class (1966-1972)", "MS": "The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles.", "PM": "73", "HN": "73(68)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004363"}, {"RECTYPE": "D", "MH": "Pharmaceutical Preparations", "DE": "PHARM PREPARATIONS", "AQ": "AD AN BL CF CH CL CS EC HI IP ME RE SD ST UR", "PRINT ENTRY": "Pharmaceutical Product|T121|NON|EQV|NLM (2021)|191125|abcdef", "ENTRY": "Products, Pharmaceutical", "MN": "D26", "RH": "D26 - PHARMACEUTICAL PREPARATIONS", "FX": "Receptors, Drug", "EC": "toxicity:Drug-Related Side Effects and Adverse Reactions", "MH_TH": "NLM (1998)", "ST": "T121", "RN": "0", "AN": "general or unspecified only; prefer specific drugs; drug names: use NOMENCLATURE; policy: Manual chapter 25", "MS": "Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.", "PM": "98; see DRUGS 1963-97", "HN": "98(63)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004364"}, {"RECTYPE": "D", "MH": "Drugs, Chinese Herbal", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Plant Extracts, Chinese|T121|T123|NON|BRD|UNK (19XX)|870325|abbcdef", "ENTRY": "Herbal Drugs, Chinese", "MN": "D26.335", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "AN": "drugs used in MEDICINE, CHINESE TRADITIONAL or MEDICINE, KAMPO not synthetic drugs manufactured in China; Chinese names of these drugs not capitalized in titles or translations; TN J: indexing instructions", "PI": "Plants, Medicinal (1966-1987)", "MS": "Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China.", "PM": "88", "HN": "88", "MR": "20060705", "DA": "19870325", "DC": "1", "DX": "19880101", "UI": "D004365"}, {"RECTYPE": "D", "MH": "Nonprescription Drugs", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Patent Medicines|T121|NON|EQV|UNK (19XX)|750101|PATENT MED|abcdefv", "ENTRY": "Over the Counter Drugs", "MN": "D26.530", "MH_TH": "NLM (2009)", "ST": "T121", "RN": "0", "AN": "entry term OVER-THE-COUNTER DRUGS: BEHIND-THE-COUNTER DRUGS is also available", "PI": "Drugs (1966-1972)", "MS": "Medicines that can be sold legally without a DRUG PRESCRIPTION.", "PM": "2009; see DRUGS, NON-PRESCRIPTION 1973-2008", "HN": "2009(1973)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004366"}, {"RECTYPE": "D", "MH": "Dry Ice", "AQ": "AE TU", "PRINT ENTRY": "Carbon Dioxide Snow|T197|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Snow, Carbon Dioxide", "MN": "D01.650.550.200.250", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "note X ref; a refrigerant", "MS": "A solid form of carbon dioxide used as a refrigerant.", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004367"}, {"RECTYPE": "D", "MH": "Dry Socket", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Periostitis, Alveolar|T047|NON|EQV|NLM (1998)|960718|abcdef", "ENTRY": "Sockets, Dry", "MN": "C07.465.227", "FX": "Tooth Extraction", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "note category: after surg or traumatic tooth extraction", "MS": "A condition sometimes occurring after tooth extraction, particularly after traumatic extraction, resulting in a dry appearance of the exposed bone in the socket, due to disintegration or loss of the blood clot. It is basically a focal osteomyelitis without suppuration and is accompanied by severe pain (alveolalgia) and foul odor. (Dorland, 28th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004368"}, {"RECTYPE": "D", "MH": "Pentetic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Penthanil|T109|T121|T130|NON|EQV|UNK (19XX)|770330|abbbcdef", "ENTRY": "Zinc DTPA", "MN": "D02.241.081.018.639", "PA": "Iron Chelating Agents", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "Glycine, N,N-bis(2-(bis(carboxymethyl)amino)ethyl)-", "RN": "7A314HQM0I", "RR": "NXU65IC8PG", "MS": "An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.", "PM": "1999; see DTPA 1966-1998; for PENTETIC ACID see DTPA 1966-1998; CALCIUM TRISODIUM PENTETATE was indexed under ORGANOMETALLIC COMPOUNDS and GLYCINE 1998-2005", "HN": "1999 (1966)", "MR": "20180301", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004369"}, {"RECTYPE": "D", "MH": "Duane Retraction Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ocular Retraction Syndrome|T047|NON|EQV|GHR (2014)|NLM (2000)|991108|abcdeef", "ENTRY": "Syndrome, Okihiro", "MN": "C16.320.290.235", "FX": "Ophthalmoplegia", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "A syndrome characterized by marked limitation of abduction of the eye, variable limitation of adduction and retraction of the globe, and narrowing of the palpebral fissure on attempted adduction. The condition is caused by aberrant innervation of the lateral rectus by fibers of the OCULOMOTOR NERVE.", "PM": "2000; see DUANE'S SYNDROME 1991-1999, see OPHTHALMOPLEGIA 1979-1990, see OCULOMOTOR PARALYSIS 1966-1978", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004370"}, {"RECTYPE": "D", "MH": "Hepatitis Virus, Duck", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Duck Hepatitis Virus|T005|NON|EQV|NLM (1990)|890224|abcdef", "ENTRY": "Duck Hepatitis Viruses", "MN": "B04.820.578.750.284.645", "MH_TH": "NLM (1975)", "ST": "T005", "RR": "txid691956", "AN": "infection: coordinate with PICORNAVIRIDAE INFECTIONS /vet + HEPATITIS, VIRAL, ANIMAL; do not confuse with HEPATITIS B VIRUS, DUCK ", "MS": "Unassigned species, in the family PICORNAVIRIDAE, causing high mortality in ducklings 3 days to 3 weeks old.", "OL": "use HEPATITIS VIRUS, DUCK to search DUCK HEPATITIS VIRUS 1975-89", "PM": "91; was see under ENTEROVIRUSES 1990; was DUCK HEPATITIS VIRUS 1975-89", "HN": "91(90); was see under ENTEROVIRUSES 1990; was DUCK HEPATITIS VIRUS 1975-89", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004371"}, {"RECTYPE": "D", "MH": "Ducks", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Duck", "MN": "B01.050.150.900.248.690.345", "MH_TH": "NLM (1968)", "ST": "T012", "RN": "txid2068716", "AN": "diseases in domestic ducks: coordinate with POULTRY DISEASES; diseases in wild ducks: coordinate with BIRD DISEASES", "PI": "Poultry (1966-1967)", "MS": "A water bird in the order Anseriformes (subfamily Anatinae (true ducks)) with a broad blunt bill, short legs, webbed feet, and a waddling gait.", "PM": "68", "HN": "68", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004372"}, {"RECTYPE": "D", "MH": "Ductus Arteriosus", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Arteriosus, Ductus", "MN": "A16.378.303.395", "MH_TH": "NLM (1966)", "ST": "T018", "AN": "normal; abnormal is probably DUCTUS ARTERIOSUS, PATENT", "MS": "A fetal blood vessel connecting the pulmonary artery with the descending aorta.", "MR": "19920514", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004373"}, {"RECTYPE": "D", "MH": "Ductus Arteriosus, Patent", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Patent Ductus Arteriosus Familial|T019|NON|NRW|NLM (2011)|ORD (2010)|100420|abcdeef", "ENTRY": "Patent Ductus Arteriosus|T019|NON|EQV|OMIM (2013)|111115|abcdef", "MN": "C16.131.240.400.340", "FX": "Persistent Fetal Circulation Syndrome", "MH_TH": "ORD (2010)", "ST": "T019", "MS": "A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004374"}, {"RECTYPE": "D", "MH": "Duffy Blood-Group System", "AQ": "AD AE AN BI BL CF CH CL EC GE HI IM IP ME PD PH PO TO TU UL UR", "ENTRY": "System, Duffy Blood-Group", "MN": "D23.050.705.230.301", "MH_TH": "NLM (1976)", "ST": "T022", "RN": "0", "AN": "IM; coord with disease /blood (IM), not /immunol nor /genet; TN 230", "PI": "Blood Groups (1966-1975)", "MS": "A blood group consisting mainly of the antigens Fy(a) and Fy(b), determined by allelic genes, the frequency of which varies profoundly in different human groups; amorphic genes are common.", "PM": "91; was see under BLOOD GROUPS 1976-90", "HN": "91(76); was see under BLOOD GROUPS 1976-90", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D004375"}, {"RECTYPE": "D", "MH": "Galactitol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Dulcitol|T109|T123|TRD|NRW|NLM (1998)|970429|abbcdef", "MN": "D09.853.400", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "Galactitol", "RN": "113ZQ1Y7DD", "RR": "608-66-2 (Galactitol)", "PI": "Hexoses (1966-1971)", "MS": "A naturally occurring product of plants obtained following reduction of GALACTOSE. It appears as a white crystalline powder with a slight sweet taste. It may form in excess in the lens of the eye in GALACTOSEMIAS, a deficiency of GALACTOKINASE.", "PM": "98; see DULCITOL 1991-97, see SUGAR ALCOHOLS 1972-90; for GALACTITOL see DULCITOL 1978-97", "HN": "98(72)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004376"}, {"RECTYPE": "D", "MH": "Dumping Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Dumping", "MN": "C23.550.767.812.500", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Gastrointestinal symptoms resulting from an absent or nonfunctioning pylorus.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004377"}, {"RECTYPE": "D", "MH": "Duodenal Diseases", "DE": "DUODENAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Duodenal Disease", "MN": "C06.405.469.275", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; inflammatory disease equals DUODENITIS", "MS": "Pathological conditions in the DUODENUM region of the small intestine (INTESTINE, SMALL).", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004378"}, {"RECTYPE": "D", "MH": "Duodenal Neoplasms", "DE": "DUODENAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasms, Duodenal", "MN": "C06.405.469.491.445", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the DUODENUM.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004379"}, {"RECTYPE": "D", "MH": "Duodenal Obstruction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Obstructions, Duodenal", "MN": "C06.405.469.531.311", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Hindrance of the passage of luminal contents in the DUODENUM. Duodenal obstruction can be partial or complete, and caused by intrinsic or extrinsic factors. Simple obstruction is associated with diminished or stopped flow of luminal contents. Strangulating obstruction is associated with impaired blood flow to the duodenum in addition to obstructed flow of luminal contents.", "CATSH": "CAT LIST", "MR": "20040719", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004380"}, {"RECTYPE": "D", "MH": "Duodenal Ulcer", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Curling's Ulcer|T047|EPO|NRW|NLM (1997)|960412|abcdef", "ENTRY": "Ulcers, Duodenal", "MN": "C06.405.748.586.349", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A PEPTIC ULCER located in the DUODENUM.", "PM": "CURLING'S ULCER was heading 1975-96 (see under DUODENAL ULCER 1975-90)", "HN": "CURLING'S ULCER was heading 1975-96 (see under DUODENAL ULCER 1975-90)", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D004381"}, {"RECTYPE": "D", "MH": "Duodenitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Duodenitis, Erosive", "MN": "C06.405.469.326.750", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Enteritis (1966-1979)", "MS": "Inflammation of the DUODENUM section of the small intestine (INTESTINE, SMALL). Erosive duodenitis may cause bleeding in the UPPER GI TRACT and PEPTIC ULCER.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D004382"}, {"RECTYPE": "D", "MH": "Duodenogastric Reflux", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Duodenal Reflux|T047|NON|EQV|NLM (1998)|960716|abcdef", "ENTRY": "Reflux, Duodenogastric", "MN": "C06.405.748.240", "MH_TH": "NLM (1984)", "ST": "T047", "PI": "Stomach Diseases(1966-1983)", "MS": "Retrograde flow of duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the STOMACH.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19830311", "DC": "1", "DX": "19840101", "UI": "D004383"}, {"RECTYPE": "D", "MH": "Duodenoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Duodenoscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES DUODENOSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Duodenoscopic", "MN": "E04.502.250.250.250.200", "FX": "Duodenoscopes", "MH_TH": "NLM (1981)", "ST": "T061", "AN": "/ instrum permitted but consider also DUODENOSCOPES", "PI": "Endoscopy (1966-1980)", "MS": "Endoscopic examination, therapy or surgery of the luminal surface of the duodenum.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19800404", "DC": "1", "DX": "19810101", "UI": "D004384"}, {"RECTYPE": "D", "MH": "Duodenostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Duodenostomies", "MN": "E04.579.338.303", "FX": "Surgical Stomas", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Duodenum/surgery (1966-1987)", "MS": "Surgical formation of an opening into the DUODENUM.", "PM": "91; was see under ENTEROSTOMY 1988-90", "HN": "91(88); was see under ENTEROSTOMY 1988-90", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19870319", "DC": "1", "DX": "19910101", "UI": "D004385"}, {"RECTYPE": "D", "MH": "Duodenum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Duodenums", "MN": "A03.556.875.249", "FX": "Duodenostomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers.", "PM": "DUODENAL INTUBATION was heading 1963-65", "HN": "DUODENAL INTUBATION was heading 1963-65", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D004386"}, {"RECTYPE": "D", "MH": "Dupuytren Contracture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dupuytren's Contracture|T047|EPO|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Palmar Fibromatosis", "MN": "C17.300.270", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "A fibromatosis of the palmar fascia characterized by thickening and contracture of the fibrous bands on the palmar surfaces of the hand and fingers. It arises most commonly in men between the ages of 30 and 50.", "PM": "2010; see DUPUYTREN'S CONTRACTURE 1963-2009", "HN": "2010(1963)", "CATSH": "CAT LIST", "MR": "20160303", "DA": "19990101", "DC": "1", "DX": "20100101", "UI": "D004387"}, {"RECTYPE": "D", "MH": "Dura Mater", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tentorium Cerebelli|T023|NON|NRW|NLM (2015)|140515|abcdef", "MN": "A08.186.566.395", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The outermost of the three MENINGES, a fibrous membrane of connective tissue that covers the brain and the spinal cord.", "PM": "2015; for FALX CEREBRI and TENTORIUM CEREBELLI see SPINAL CORD 2015-2019", "HN": "2015; for FALX CEREBRI and TENTORIUM CEREBELLI use SPINAL CORD 2015-2019", "MR": "20190408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004388"}, {"RECTYPE": "D", "MH": "Durable Medical Equipment", "DE": "DURABLE MED EQUIPMENT", "AQ": "CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Equipment, Medical, Durable|T074|NON|EQV|UNK (19XX)|870502|EQUIPMENT MED DURABLE|abcdefv", "ENTRY": "Medical Equipment, Durable|T074|NON|EQV|NLM (1991)|891129|MED EQUIPMENT DURABLE|abcdefv", "MN": "E07.278", "MH_TH": "NLM (1988)", "ST": "T074", "MS": "Devices which are very resistant to wear and may be used over a long period of time. They include items such as wheelchairs, hospital beds, artificial limbs, etc.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20170601", "DA": "19870502", "DC": "1", "DX": "19880101", "UI": "D004389"}, {"RECTYPE": "D", "MH": "Chlorpyrifos", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Lorsban|T109|T131|TRD|NRW|NLM (1998)|961122|abbcdef", "MN": "D02.886.300.692.100", "PA": "Insecticides", "MH_TH": "FDA SRS (2014)", "ST": "T131", "N1": "Phosphorothioic acid, O,O-diethyl O-(3,5,6-trichloro-2-pyridinyl) ester", "RN": "JCS58I644W", "RR": "2921-88-2 (Chlorpyrifos)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides (1966-1970)", "MS": "An organothiophosphate cholinesterase inhibitor that is used as an insecticide and as an acaricide.", "PM": "96; was DURSBAN 1971-95 (Prov 1971-74); CHLORPYRIFOS was see DURSBAN 1971-95", "HN": "96; was DURSBAN 1971-95 (Prov 1971-74); CHLORPYRIFOS was see DURSBAN 1971-95", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004390"}, {"RECTYPE": "D", "MH": "Dust", "AQ": "AN IM PC", "PRINT ENTRY": "House Dust|T167|NON|NRW|NLM (2003)|020412|abcdef", "ENTRY": "Dust, House", "MN": "D20.633.222", "FX": "Pyroglyphidae", "MH_TH": "NLM (1966)", "ST": "T167", "RN": "0", "AN": "coord with specific substance yielding dust: GOLD + DUST; COAL + DUST; do not index here for specific dusts in pneumoconiosis: see note under PNEUMOCONIOSIS", "MS": "Earth or other matter in fine, dry particles. (Random House Unabridged Dictionary, 2d ed)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004391"}, {"RECTYPE": "D", "MH": "Dwarfism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nanism|T047|NON|EQV|UNK (19XX)|740329|abcdef", "MN": "C19.297", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004392"}, {"RECTYPE": "D", "MH": "Dwarfism, Pituitary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pituitary Dwarf|T101|NON|REL|NLM (2000)|991103|abcdef", "ENTRY": "Pituitary Nanism", "MN": "C19.700.482.311", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A form of dwarfism caused by complete or partial GROWTH HORMONE deficiency, resulting from either the lack of GROWTH HORMONE-RELEASING FACTOR from the HYPOTHALAMUS or from the mutations in the growth hormone gene (GH1) in the PITUITARY GLAND. It is also known as Type I pituitary dwarfism. Human hypophysial dwarf is caused by a deficiency of HUMAN GROWTH HORMONE during development.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004393"}, {"RECTYPE": "D", "MH": "Dydrogesterone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isopregnenone|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "6 Dehydro 9 beta 10 alpha progesterone", "MN": "D04.210.500.745.432.296", "PA": "Progestins", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-4,6-diene-3,20-dione, (9beta,10alpha)-", "RN": "90I02KLE8K", "RR": "152-62-5 (Dydrogesterone)", "MS": "A synthetic progestational hormone with no androgenic or estrogenic properties. Unlike many other progestational compounds, dydrogesterone produces no increase in temperature and does not inhibit OVULATION.", "PM": "65", "HN": "65(63)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004394"}, {"RECTYPE": "D", "MH": "Dye Dilution Technique", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Dye Dilution", "MN": "E05.484.250", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Method for assessing flow through a system by injection of a known quantity of dye into the system and monitoring its concentration over time at a specific point in the system. (From Dorland, 28th ed)", "OL": "use DYE DILUTION TECHNIQUE to search DYE DILUTION TECHNIC 1966-90", "PM": "91; was DYE DILUTION TECHNIC 1963-90", "HN": "91; was DYE DILUTION TECHNIC 1963-90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004395"}, {"RECTYPE": "D", "MH": "Coloring Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tissue Stains|T130|NON|NRW|NLM (1996)|950531|abcdef", "ENTRY": "Stains, Tissue", "MN": "D27.720.233", "FX": "Water Decolorization", "MH_TH": "NLM (2006)", "ST": "T130", "RN": "0", "AN": "differentiate from PIGMENTS, BIOLOGICAL", "MS": "Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS.", "PM": "2006; see DYES 1963-2005; for STAINS see STAINS AND STAINING 1991-1995", "HN": "2006(1963); for STAINS use STAINS AND STAINING 1991-1995", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D004396"}, {"RECTYPE": "D", "MH": "Fonofos", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Stauffer N2790", "MN": "D02.886.300.846.249", "PA": "Insecticides", "MH_TH": "NLM (1973)", "ST": "T131", "N1": "Phosphonodithioic acid, ethyl-, O-ethyl S-phenyl ester", "RN": "P4VT8081QO", "RR": "944-22-9 (Fonofos)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "MS": "An organothiophosphorus cholinesterase inhibitor that is used as an insecticide.", "PM": "96; was DYFONATE 1973-95 (see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1973-90)", "HN": "96; was DYFONATE 1973-95 (see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1973-90)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004397"}, {"RECTYPE": "D", "MH": "Dyneins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dynein Light Intermediate Chain|T116|T123|NON|NRW|NLM (2021)|191121|abbcdef", "ENTRY": "Light Chains, Dynein", "MN": "D12.776.220.600.200", "MH_TH": "NLM (2010)", "ST": "T126", "N1": "Dynein ATP phosphohydrolase (tubulin-translocating)", "RN": "EC 3.6.4.2", "RR": "EC 3.6.4.2", "PI": "Proteins (1966-1976)", "MS": "A family of multi-subunit cytoskeletal motor proteins that use the energy of ATP hydrolysis, generated by a ring of AAA ATPASES in the dynein heavy chain, to power a variety of cellular functions. Dyneins fall into two major classes based upon structural and functional criteria.", "PM": "2010; see DYNEIN ATPASE 1993-2009, see DYNEIN 1977-1992", "HN": "2010(1993)", "MR": "20210630", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D004398"}, {"RECTYPE": "D", "MH": "Dynorphins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Dynorphin A (1-17)|T116|T123|NON|NRW|NLM (1990)|890609|DYNORPHIN A 1 17|abbcdefv", "MN": "D12.776.631.650.575.180", "PA": "Neurotransmitter Agents", "FX": "Receptors, Opioid, kappa", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "74913-18-1", "PI": "Peptides (1966-Jul 1977)", "MS": "A class of opioid peptides including dynorphin A, dynorphin B, and smaller fragments of these peptides. Dynorphins prefer kappa-opioid receptors (RECEPTORS, OPIOID, KAPPA) and have been shown to play a role as central nervous system transmitters.", "OL": "use DYNORPHINS to search DYNORPHIN 1985-94", "PM": "95; was DYNORPHIN 1985-94", "HN": "95; was DYNORPHIN 1985-94", "MR": "20151123", "DA": "19840525", "DC": "1", "DX": "19850101", "UI": "D004399"}, {"RECTYPE": "D", "MH": "Dyphylline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diprophylline|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|UNK (19XX)|790530|abbcdeeef", "ENTRY": "Neothylline|T109|T121|TRD|NRW|US|041008|abbcdef", "MN": "D03.633.100.759.758.824.751.250", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Purine-2,6-dione, 7-(2,3-dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-", "RN": "263T0E9RR9", "RR": "479-18-5 (Dyphylline)", "PI": "Theophylline (1966-1974) /analogs & derivatives (1975-1979)", "MS": "A THEOPHYLLINE derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis.", "PM": "91; was see under THEOPHYLLINE 1980-90", "HN": "91(80); was see under THEOPHYLLINE 1980-90", "MR": "20170524", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D004400"}, {"RECTYPE": "D", "MH": "Dysarthria", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Scanning Speech|T047|NON|NRW|NLM (2022)|210218|abcdef", "ENTRY": "Speechs, Scanning", "MN": "C23.888.592.604.150.500.800.150.200", "MH_TH": "NLM (1979)", "ST": "T047", "PI": "Speech Disorders (1966-1978)", "MS": "Disorders of speech articulation caused by imperfect coordination of pharynx, larynx, tongue, or face muscles. This may result from CRANIAL NERVE DISEASES; NEUROMUSCULAR DISEASES; CEREBELLAR DISEASES; BASAL GANGLIA DISEASES; BRAIN STEM diseases; or diseases of the corticobulbar tracts (see PYRAMIDAL TRACTS). The cortical language centers are intact in this condition. (From Adams et al., Principles of Neurology, 6th ed, p489)", "PM": "1991; see SPEECH DISORDERS 1963-1990", "HN": "1991(1975); use SPEECH DISORDERS 1963-1990", "CATSH": "CAT LIST", "MR": "20210702", "DA": "19780517", "DC": "1", "DX": "19910101", "UI": "D004401"}, {"RECTYPE": "D", "MH": "Dysautonomia, Familial", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Riley-Day Syndrome|T019|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|740329|abbcdeeeef", "ENTRY": "Riley Day Syndrome", "MN": "C16.320.400.415.309", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "PRIMARY DYSAUTONOMIAS is also available", "MS": "An autosomal disorder of the peripheral and autonomic nervous systems limited to individuals of Ashkenazic Jewish descent. Clinical manifestations are present at birth and include diminished lacrimation, defective thermoregulation, orthostatic hypotension (HYPOTENSION, ORTHOSTATIC), fixed pupils, excessive SWEATING, loss of pain and temperature sensation, and absent reflexes. Pathologic features include reduced numbers of small diameter peripheral nerve fibers and autonomic ganglion neurons. (From Adams et al., Principles of Neurology, 6th ed, p1348; Nat Genet 1993;4(2):160-4)", "PM": "1981; see AUTONOMIC DYSFUNCTION 1963-1980", "HN": "1981; uss AUTONOMIC DYSFUNCTION 1963-1980", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D004402"}, {"RECTYPE": "D", "MH": "Dysentery", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Infectious Diarrheal Diseases", "MN": "C06.405.469.300", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Acute inflammation of the intestine associated with infectious DIARRHEA of various etiologies, generally acquired by eating contaminated food containing TOXINS, BIOLOGICAL derived from BACTERIA or other microorganisms. Dysentery is characterized initially by watery FECES then by bloody mucoid stools. It is often associated with ABDOMINAL PAIN; FEVER; and DEHYDRATION.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004403"}, {"RECTYPE": "D", "MH": "Dysentery, Amebic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Intestinal Amebiasis|T047|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Intestinal Entamoebiasis", "MN": "C06.405.469.452.396", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "DYSENTERY caused by intestinal amebic infection, chiefly with ENTAMOEBA HISTOLYTICA. This condition may be associated with amebic infection of the LIVER and other distant sites.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004404"}, {"RECTYPE": "D", "MH": "Dysentery, Bacillary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Shigellosis|T047|NON|NRW|NLM (2004)|030314|abcdef", "ENTRY": "Shigella sonnei Dysentery", "MN": "C06.405.469.300.479", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific organism (IM) if pertinent", "MS": "DYSENTERY caused by gram-negative rod-shaped enteric bacteria (ENTEROBACTERIACEAE), most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE (severest); Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI (mildest).", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004405"}, {"RECTYPE": "D", "MH": "Dysgammaglobulinemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dysgammaglobulinemias", "MN": "C20.673.430", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "coord IM with specific immunoglobulin /defic (IM) but note IGA DEFICIENCY and IGG DEFICIENCY are available; AGAMMAGLOBULINEMIA is also available", "PI": "Immunologic Deficiency Syndromes (1968-1974)", "MS": "An immunologic deficiency state characterized by selective deficiencies of one or more, but not all, classes of immunoglobulins.", "OL": "search IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-74", "PM": "78; was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77", "HN": "78(75); was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D004406"}, {"RECTYPE": "D", "MH": "Dysgerminoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Disgerminoma|T191|NON|EQV|UNK (19XX)|780523|abcdef", "ENTRY": "Dysgerminomas", "MN": "C04.557.465.330.300", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with probably OVARIAN NEOPLASMS ", "MS": "A malignant ovarian neoplasm, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. It is the counterpart of the classical seminoma of the testis, to which it is both grossly and histologically identical. Dysgerminomas comprise 16% of all germ cell tumors but are rare before the age of 10, although nearly 50% occur before the age of 20. They are generally considered of low-grade malignancy but may spread if the tumor extends through its capsule and involves lymph nodes or blood vessels. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1646)", "OL": "use DYSGERMINOMA to search DISGERMINOMA 1966-78", "PM": "79; was DISGERMINOMA 1963-78", "HN": "79; was DISGERMINOMA 1963-78", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D004407"}, {"RECTYPE": "D", "MH": "Dysgeusia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Taste, Distorted|T184|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Parageusias", "MN": "C23.888.592.763.861.479", "MH_TH": "NLM (1975)", "ST": "T184", "AN": "do not confuse with AGEUSIA, loss of sense of taste", "MS": "A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.", "PM": "1991; see TASTE DISORDERS 1975-1990", "HN": "1991(1975)", "CATSH": "CAT LIST", "MR": "20180521", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004408"}, {"RECTYPE": "D", "MH": "Dyskinesia, Drug-Induced", "DE": "DYSKINESIA DRUG IND", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dyskinesia, Medication-Induced|T047|NON|NRW|NLM (2000)|991109|DYSKINESIA MEDICATION IND|abcdefv", "ENTRY": "Medication-Induced Dyskinesias", "MN": "C25.723.705.200", "FX": "Akathisia, Drug-Induced", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "do not confuse with AKATHISIA, DRUG-INDUCED", "PI": "Movement Disorders (1966-1976)", "MS": "Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D004409"}, {"RECTYPE": "D", "MH": "Dyslexia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Reading Disorder, Developmental|T048|NON|NRW|NLM (2000)|991103|READING DIS DEVELOPMENTAL|abcdefv", "ENTRY": "Word Blindnesses", "MN": "F03.625.562.700.500", "FX": "Learning Disabilities", "MH_TH": "NLM (1963)", "ST": "T048", "AN": "dyslexia caused by a brain lesion is DYSLEXIA, ACQUIRED; note x-ref: ALEXIA, PURE is also available", "MS": "A cognitive disorder characterized by an impaired ability to comprehend written and printed words or phrases despite intact vision. This condition may be developmental or acquired. Developmental dyslexia is marked by reading achievement that falls substantially below that expected given the individual's chronological age, measured intelligence, and age-appropriate education. The disturbance in reading significantly interferes with academic achievement or with activities of daily living that require reading skills. (From DSM-IV)", "PM": "1966; see READING 1963-1965; for ALEXIA see DYSLEXIA, ACQUIRED 1977-1999", "HN": "1966(1963); for ALEXIA use DYSLEXIA, ACQUIRED 1977-1999", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004410"}, {"RECTYPE": "D", "MH": "Dyslexia, Acquired", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Word Blindness, Acquired|T048|T184|NON|EQV|NLM (2000)|991104|abbcdef", "ENTRY": "Word Blindnesses, Acquired", "MN": "F03.625.562.700.500.500", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A receptive visual aphasia characterized by the loss of a previously possessed ability to comprehend the meaning or significance of handwritten words, despite intact vision. This condition may be associated with posterior cerebral artery infarction (INFARCTION, POSTERIOR CEREBRAL ARTERY) and other BRAIN DISEASES.", "PM": "1977; see ALEXIA 1963-1976", "HN": "1977(1963)", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D004411"}, {"RECTYPE": "D", "MH": "Dysmenorrhea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pain, Menstrual|T033|T046|NON|EQV|NLM (2000)|991104|abbcdef", "ENTRY": "Pains, Menstrual", "MN": "C23.888.592.612.944.500", "MH_TH": "POPLINE (1978)", "ST": "T046", "MS": "Painful menstruation.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004412"}, {"RECTYPE": "D", "MH": "Dysostoses", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dysostosis|T047|NON|EQV|NLM (1994)|930527|abcdef", "MN": "C05.116.099.370", "MH_TH": "NLM (1985)", "ST": "T047", "AN": "defective bone formation", "PI": "Bone Diseases, Developmental (1970-1984)", "MS": "Defective bone formation involving individual bones, singly or in combination.", "PM": "85", "HN": "85", "CATSH": "CAT LIST", "MR": "19930527", "DA": "19840405", "DC": "1", "DX": "19850101", "UI": "D004413"}, {"RECTYPE": "D", "MH": "Dyspareunia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "MN": "F03.835.199", "FX": "Vulvar Vestibulitis", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Recurrent genital pain occurring during, before, or after SEXUAL INTERCOURSE in either the male or the female.", "PM": "67", "HN": "67(63)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004414"}, {"RECTYPE": "D", "MH": "Dyspepsia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Indigestion|T184|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Indigestions", "MN": "C23.888.821.236", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Impaired digestion, especially after eating.", "CATSH": "CAT LIST", "MR": "19991104", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004415"}, {"RECTYPE": "D", "MH": "Dysplastic Nevus Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nevus, Dysplastic|T191|NON|NRW|NLM (1994)|930401|abcdef", "ENTRY": "Syndrome, Dysplastic Nevus", "MN": "C16.320.700.305", "MH_TH": "NLM (1987)", "ST": "T191", "PI": "Nevus, Pigmented (1966-1986)", "MS": "Clinically atypical nevi (usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders) with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. (Stedman, 25th ed)", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D004416"}, {"RECTYPE": "D", "MH": "Dyspnea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Trepopnea|T184|NON|NRW|NLM (2023)|210826|abcdef", "ENTRY": "Dyspneas, Rest", "MN": "C23.888.852.371", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "do not confuse with APNEA or other respiration disorders", "MS": "Difficult or labored breathing.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004417"}, {"RECTYPE": "D", "MH": "Dyspnea, Paroxysmal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paroxysmal Nocturnal Dyspnea|T046|T184|NON|NRW|NLM (2023)|210826|abbcdef", "ENTRY": "Paroxysmal Dyspnea", "MN": "C23.888.852.371.396", "MH_TH": "NLM (2000)", "ST": "T184", "MS": "A disorder characterized by sudden attacks of respiratory distress in at rest patients with HEART FAILURE and PULMONARY EDEMA. It usually occurs at night after several hours of sleep in a reclining position. Patients awaken with a feeling of suffocation, coughing, a cold sweat, and TACHYCARDIA. When there is significant WHEEZING, it is called CARDIAC ASTHMA.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004418"}, {"RECTYPE": "D", "MH": "Dysprosium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.374", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Dysprosium", "RN": "1D4N45714Q", "RR": "7429-91-6 (Dysprosium)", "MS": "An element of the rare earth family that has the atomic symbol Dy, atomic number 66, and atomic weight 162.50. Dysprosium is a silvery metal used primarily in the form of various salts.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004419"}, {"RECTYPE": "D", "MH": "Dystocia", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dystocias", "MN": "C12.050.703.420.288", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Slow or difficult OBSTETRIC LABOR or CHILDBIRTH.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004420"}, {"RECTYPE": "D", "MH": "Dystonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Muscle Dystonia|T184|NON|EQV|UNK (19XX)|810519|abcdef", "ENTRY": "Paroxysmal Dystonia", "MN": "C23.888.592.350.300", "FX": "Torsion Abnormality", "MH_TH": "NLM (1979)", "ST": "T184", "AN": "do not confuse with MUSCLE HYPERTONIA or MUSCLE HYPOTONIA; DYSTONIC DISORDERS is available", "PI": "Muscle Tonus (1970-1978)", "MS": "An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)", "PM": "1982; see MUSCLE DYSTONIA 1979-1981", "HN": "1982", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19780517", "DC": "1", "DX": "19790101", "UI": "D004421"}, {"RECTYPE": "D", "MH": "Dystonia Musculorum Deformans", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Torsion Dystonia|T047|NON|EQV|UNK (19XX)|840605|abcdef", "ENTRY": "Torsion Spasm, Progressive", "MN": "C16.320.400.330", "FX": "Dystonia", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A condition characterized by focal DYSTONIA that progresses to involuntary spasmodic contractions of the muscles of the legs, trunk, arms, and face. The hands are often spared, however, sustained axial and limb contractions may lead to a state where the body is grossly contorted. Onset is usually in the first or second decade. Familial patterns of inheritance, primarily autosomal dominant with incomplete penetrance, have been identified. (Adams et al., Principles of Neurology, 6th ed, p1078)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004422"}, {"RECTYPE": "D", "MH": "Ear", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "Vestibulocochlear System|T023|NON|EQV|NLM (2006)|041124|abcdef", "ENTRY": "System, Vestibulocochlear", "MN": "A09.246", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "general only or unspecified; prefer EAR, EXTERNAL or EAR, MIDDLE or EAR, INNER; /abnorm permitted but note EAR DEFORMITIES, ACQUIRED; /surg: consider also OTOLOGIC SURGICAL PROCEDURES; ear acupuncture or otopuncture or auriculoacupuncture (acupunct ther with ear as pressure point): index under ACUPUNCTURE THERAPY (IM) + EAR, EXTERNAL (IM)", "CX": "consider also terms at OTI- and OTO-", "MS": "The hearing and equilibrium system of the body. It consists of three parts: the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR. Sound waves are transmitted through this organ where vibration is transduced to nerve signals that pass through the ACOUSTIC NERVE to the CENTRAL NERVOUS SYSTEM. The inner ear also contains the vestibular organ that maintains equilibrium by transducing signals to the VESTIBULAR NERVE.", "OL": "use EAR /AB & EAR, EXTERNAL /AB & EAR DEFORMITIES, ACQUIRED to search EAR, EXTERNAL, DEFORMITY 1966-70; in searching non-acquired ear abnormalities consider EAR DEFORMITIES, ACQUIRED 1966-74", "PM": "EAR, EXTERNAL, DEFORMITY was heading 1966-70", "HN": "EAR, EXTERNAL, DEFORMITY was heading 1966-70", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D004423"}, {"RECTYPE": "D", "MH": "Ear Canal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Auditory Canal, External|T023|NON|EQV|UNK (19XX)|781214|abcdef", "ENTRY": "External Ear Canals", "MN": "A09.246.272.396", "FX": "Cerumen", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The narrow passage way that conducts the sound collected by the EAR AURICLE to the TYMPANIC MEMBRANE.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004424"}, {"RECTYPE": "D", "MH": "Ear Cartilage", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "External Ear Cartilages", "MN": "A09.246.272.549", "MH_TH": "NLM (2008)", "ST": "T024", "PI": "Ear, External (1966-1978)", "MS": "Cartilage of the EAR AURICLE and the EXTERNAL EAR CANAL.", "PM": "2008; see EAR CARTILAGES 1991-2007, see EAR, EXTERNAL 1979-1990", "HN": "2008 (1979)", "MR": "20070710", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D004425"}, {"RECTYPE": "D", "MH": "Ear Deformities, Acquired", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ear Deformity, Acquired", "MN": "C09.218.271", "MH_TH": "NLM (1971)", "ST": "T020", "MS": "Distortion or disfigurement of the ear caused by disease or injury after birth.", "OL": "use EAR /AB & EAR, EXTERNAL /AB & EAR DEFORMITIES, ACQUIRED to search EAR, EXTERNAL, DEFORMITY 1966-70", "PM": "71; was EAR, EXTERNAL, DEFORMITY 1963-70", "HN": "71; was EAR, EXTERNAL, DEFORMITY 1963-70", "CATSH": "CAT LIST", "MR": "19900604", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D004426"}, {"RECTYPE": "D", "MH": "Ear Diseases", "DE": "EAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Otologic Diseases|T047|NON|EQV|NLM (2008)|070110|OTOLOGIC DIS|abcdefv", "ENTRY": "Otological Disease", "MN": "C09.218", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes of the ear, the hearing, and the equilibrium system of the body.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004427"}, {"RECTYPE": "D", "MH": "Ear Neoplasms", "DE": "EAR NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Ear Cancer|T191|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Neoplasm, Ear", "MN": "C09.647.312", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with specific ear term (IM) + histological type of neoplasm (IM)", "MS": "Tumors or cancer of any part of the hearing and equilibrium system of the body (the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR).", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004428"}, {"RECTYPE": "D", "MH": "Ear Ossicles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Auditory Ossicles|T023|NON|EQV|UNK (19XX)|781214|abcdef", "ENTRY": "Ossicles, Ear", "MN": "A09.246.397.247", "FX": "Stapes Surgery", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A mobile chain of three small bones (INCUS; MALLEUS; STAPES) in the TYMPANIC CAVITY between the TYMPANIC MEMBRANE and the oval window on the wall of INNER EAR. Sound waves are converted to vibration by the tympanic membrane then transmitted via these ear ossicles to the inner ear.", "MR": "20070711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004429"}, {"RECTYPE": "D", "MH": "Ear Protective Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Hearing Protective Devices|T074|NON|NRW|UNK (19XX)|741205|abcdef", "ENTRY": "Protective Devices, Hearing", "MN": "J01.637.708.560.250", "MH_TH": "NLM (1975)", "ST": "T074", "MS": "Personal devices for protection of the ears from loud or high intensity noise, water, or cold. These include earmuffs and earplugs.", "PM": "91; see PROTECTIVE DEVICES 1975-90", "HN": "91(75)", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004430"}, {"RECTYPE": "D", "MH": "Ear, External", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Outer Ears", "MN": "A09.246.272", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The outer part of the hearing system of the body. It includes the shell-like EAR AURICLE which collects sound, and the EXTERNAL EAR CANAL, the TYMPANIC MEMBRANE, and the EXTERNAL EAR CARTILAGES.", "OL": "use EAR /AB & EAR, EXTERNAL /AB & EAR DEFORMITIES, ACQUIRED to search EAR, EXTERNAL, DEFORMITY 1966-70; in searching non-acquired ear abnormalities consider EAR DEFORMITIES, ACQUIRED 1966-74", "PM": "EAR, EXTERNAL, DEFORMITY was heading 1966-70", "HN": "EAR, EXTERNAL, DEFORMITY was heading 1966-70", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D004431"}, {"RECTYPE": "D", "MH": "Ear, Middle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Tympanum|T030|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Tympanums", "MN": "A09.246.397", "FX": "Tympanoplasty", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The space and structures directly internal to the TYMPANIC MEMBRANE and external to the inner ear (LABYRINTH). Its major components include the AUDITORY OSSICLES and the EUSTACHIAN TUBE that connects the cavity of middle ear (tympanic cavity) to the upper part of the throat.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004432"}, {"RECTYPE": "D", "MH": "Earache", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Otalgia|T184|NON|EQV|UNK (19XX)|820426|abcdef", "ENTRY": "Otalgias", "MN": "C23.888.592.612.302", "MH_TH": "NLM (1983)", "ST": "T184", "PI": "Pain (1966-1982)", "MS": "Pain in the ear.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19820426", "DC": "1", "DX": "19830101", "UI": "D004433"}, {"RECTYPE": "D", "MH": "Early Ambulation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Early Mobilization|T061|NON|BRD|UNK (19XX)|750617|abcdef", "ENTRY": "Mobilization, Early", "MN": "E02.831.335", "MH_TH": "NLM (1976)", "ST": "T061", "AN": "for patient recovery not child development", "PI": "specific heading/rehabilitation (1966-1975)", "MS": "Procedure to accelerate the ability of a patient to walk or move about by reducing the time to AMBULATION. It is characterized by a shorter period of hospitalization or recumbency than is normally practiced.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D004434"}, {"RECTYPE": "D", "MH": "Eating", "AQ": "DE EH GE IM PH PX RE", "PRINT ENTRY": "Nutritional Intake|T040|NON|REL|NLM (2021)|191122|abcdef", "ENTRY": "Nutritional Intakes", "MN": "G10.261.330", "MH_TH": "NLM (1966)", "ST": "T040", "AN": "the act of eating: do not confuse with FOOD (the substance eaten) or EATING BEHAVIOR (the manner of eating)", "MS": "The consumption of edible substances.", "PM": "73", "HN": "73(66)", "CATSH": "CAT LIST", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004435"}, {"RECTYPE": "D", "MH": "Ebstein Anomaly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Malformation, Ebstein's", "MN": "C16.131.240.400.395", "MH_TH": "ORD (2010)", "ST": "T019", "MS": "A congenital heart defect characterized by downward or apical displacement of the TRICUSPID VALVE, usually with the septal and posterior leaflets being attached to the wall of the RIGHT VENTRICLE. It is characterized by a huge RIGHT ATRIUM and a small and less effective right ventricle.", "PM": "2008; see EBSTEIN'S ANOMALY 1963-2007", "HN": "2008 (1963)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D004437"}, {"RECTYPE": "D", "MH": "Ecchymosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ecchymoses", "MN": "C23.888.885.312", "MH_TH": "NLM (1964)", "ST": "T046", "AN": "differentiate from CONTUSIONS: use term in the text", "MS": "Extravasation of blood into the skin, resulting in a nonelevated, rounded or irregular, blue or purplish patch, larger than a petechia.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D004438"}, {"RECTYPE": "D", "MH": "Eccrine Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Glands, Eccrine", "MN": "A17.815.830.480", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "SWEAT and SWEATING are also available", "MS": "Simple sweat glands that secrete sweat directly onto the SKIN.", "OL": "search SWEAT GLANDS 1971-74", "PM": "91; was see under SWEAT GLANDS 1975-90", "HN": "91(75); was see under SWEAT GLANDS 1975-90", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004439"}, {"RECTYPE": "D", "MH": "Ecdysone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Molting Hormone|T109|T125|NON|EQV|UNK (19XX)|740329|abbcdef", "MN": "D06.472.445.573.271.500", "MH_TH": "NLM (1964)", "ST": "T125", "N1": "Cholest-7-en-6-one, 2,3,14,22,25-pentahydroxy-, (2beta,3beta,5beta,22R)-", "RN": "3604-87-3", "AN": "do not confuse with ECDYSTERONE", "MS": "A steroid hormone that regulates the processes of MOLTING or ecdysis in insects.", "PM": "1967", "HN": "1967(1964)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004440"}, {"RECTYPE": "D", "MH": "Ecdysterone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "20-Hydroxyecdysone|T109|T125|NON|EQV|UNK (19XX)|780518|HYDROXYECDYSONE 20|abbcdefs", "ENTRY": "Beta Ecdysone", "MN": "D06.472.445.573.271.750", "MH_TH": "NLM (1975)", "ST": "T125", "N1": "Cholest-7-en-6-one, 2,3,14,20,22,25-hexahydroxy-, (2beta,3beta,5beta,22R)-", "RN": "5289-74-7", "AN": "do not confuse with ECDYSONE", "PI": "Invertebrate Hormones (1967-1974)", "MS": "A steroid hormone that regulates the processes of MOLTING or ecdysis in insects. Ecdysterone is the 20-hydroxylated ECDYSONE.", "PM": "1977; see CHOLESTENES 1975-1977, see INVERTEBRATE HORMONES 1972-1974, see CHOLESTANES 1969-1971", "HN": "1977 (1969)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D004441"}, {"RECTYPE": "D", "MH": "Tachyglossidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Zaglossus|T015|NON|NRW|NLM (2021)|200511|abcdef", "ENTRY": "Spiny Ant-Eaters", "MN": "B01.050.150.900.649.627.300", "MH_TH": "NLM (2021)", "ST": "T015", "RN": "txid9259", "RR": "txid9260", "AN": "do not confuse entry term SPINY ANTEATER with ANTEATERS see VERMILINGUA", "MS": "An oviparous burrowing mammal of the order Monotremata native to AUSTRALIA, TASMANIA, and NEW GUINEA. It has hair mingled with spines on the upper part of the body and is adapted for feeding on ants.", "PM": "2022; see MONOTREMATA 1975-1990 and ECHIDNA 1991-2021", "HN": "2022(1975)", "MR": "20220714", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004442"}, {"RECTYPE": "D", "MH": "Echinococcosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Hydatidosis|T047|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Infections, Echinococcus Granulosus", "MN": "C01.610.335.190.396", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An infection caused by the infestation of the larval form of tapeworms of the genus Echinococcus. The liver, lungs, and kidney are the most common areas of infestation.", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004443"}, {"RECTYPE": "D", "MH": "Echinococcosis, Hepatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Hydatidosis, Hepatic|T047|NON|EQV|UNK (19XX)|770212|abcdef", "ENTRY": "Hydatid Cysts, Hepatic", "MN": "C06.552.664.272", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "MS": "Liver disease caused by infections with parasitic tapeworms of the genus ECHINOCOCCUS, such as Echinococcus granulosus or Echinococcus multilocularis. Ingested Echinococcus ova burrow into the intestinal mucosa. The larval migration to the liver via the PORTAL VEIN leads to watery vesicles (HYDATID CYST).", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004444"}, {"RECTYPE": "D", "MH": "Echinococcosis, Pulmonary", "DE": "ECHINOCOCCOSIS PULM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Hydatidosis, Pulmonary|T020|T047|NON|EQV|UNK (19XX)|770212|HYDATIDOSIS PULM|abbcdefv", "ENTRY": "Pulmonary Hydatidosis|T020|T047|NON|EQV|NLM (1992)|900925|PULM HYDATIDOSIS|abbcdefv", "MN": "C08.730.450.314", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "MS": "Helminth infection of the lung caused by Echinococcus granulosus or Echinococcus multilocularis.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004445"}, {"RECTYPE": "D", "MH": "Echinococcus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.736.215.327", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6209", "MS": "A genus of very small TAPEWORMS, in the family Taeniidae. The adult form is found in various CARNIVORA but not humans. The larval form is seen in humans under certain epidemiologic circumstances.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004446"}, {"RECTYPE": "D", "MH": "Echinodermata", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Echinodermatas", "MN": "B01.050.500.408", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid7586", "AN": "includes SEA URCHINS; STARFISH; sea lilies, SEA CUCUMBERS & brittle stars; /microbiol /parasitol /virol permitted", "MS": "A phylum of the most familiar marine invertebrates. Its class Stelleroidea contains two subclasses, the Asteroidea (the STARFISH or sea stars) and the Ophiuroidea (the brittle stars, also called basket stars and serpent stars). There are 1500 described species of STARFISH found throughout the world. The second class, Echinoidea, contains about 950 species of SEA URCHINS, heart urchins, and sand dollars. A third class, Holothuroidea, comprises about 900 echinoderms known as SEA CUCUMBERS. Echinoderms are used extensively in biological research. (From Barnes, Invertebrate Zoology, 5th ed, pp773-826)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004447"}, {"RECTYPE": "D", "MH": "Echinomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Quinomycin A|T116|T195|NON|EQV|UNK (19XX)|750630|abbcdef", "ENTRY": "NSC526417", "MN": "D12.644.641.297.250", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "NLM (1976)", "ST": "T195", "N1": "Quinomycin A", "RN": "512-64-1", "PI": "Quinoxalines (1972-1975)", "MS": "A cytotoxic polypeptide quinoxaline antibiotic isolated from Streptomyces echinatus that binds to DNA and inhibits RNA synthesis.", "PM": "91; was see under QUINOXALINES 1976-90", "HN": "91(76); was see under QUINOXALINES 1976-90", "MR": "20230226", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D004448"}, {"RECTYPE": "D", "MH": "Echinostoma", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "ilocanums, Euparyphium", "MN": "B01.050.500.500.736.715.360.310", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid27847", "MS": "A genus of intestinal flukes of the family Echinostomatidae which consists of many species. They occur in man and other vertebrates. The intermediate hosts are frequently mollusks.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004449"}, {"RECTYPE": "D", "MH": "Echinostomatidae", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.736.715.360", "MH_TH": "NLM (1982)", "ST": "T204", "RN": "txid99737", "AN": "a family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Trematoda (1966-1997)", "MS": "A family of flukes (TREMATODA) characterized by a collar of spines at their anterior end. The body is elongated and is covered with spines, and the two suckers are usually close together. (Noble et al., Parasitology: the Biology of Animal Parasites, 6th ed, p183)", "PM": "98", "HN": "98; use explode 1982-97", "MR": "20200813", "DA": "19810515", "DC": "1", "DX": "19980101", "UI": "D004450"}, {"RECTYPE": "D", "MH": "Echinostomiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Echinostomiases", "MN": "C01.610.335.865.282", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Infection by flukes of the genus Echinostoma.", "OL": "search TREMATODE INFECTIONS 1967-74", "PM": "91; was see under TREMATODE INFECTIONS 1975-90", "HN": "91(75); was see under TREMATODE INFECTIONS 1975-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004451"}, {"RECTYPE": "D", "MH": "Echocardiography", "DE": "ECHOCARDIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Transthoracic Echocardiography|T060|NON|EQV|NLM (1999)|980223|TRANSTHORACIC ECHOCARDIOG|abcdefv", "ENTRY": "Two Dimensional Echocardiography", "MN": "E01.370.370.380.220", "MH_TH": "NLM (1967)", "ST": "T060", "AN": "coordinate with specific heart disease /diag image; note entry term ECHOCARDIOGRAPHY, TRANSTHORACIC; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL is also available", "PI": "Ultrasonics (1966)", "MS": "Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic.", "PM": "73", "HN": "73(67)", "CATSH": "CAT LIST", "MR": "20160317", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004452"}, {"RECTYPE": "D", "MH": "Echoencephalography", "DE": "ECHOENCEPHALOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Echoencephalographies", "MN": "E05.629.937.260", "MH_TH": "NLM (1964)", "ST": "T060", "MS": "Use of reflected ultrasound in the diagnosis of intracranial pathologic processes.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004453"}, {"RECTYPE": "D", "MH": "Echolalia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Speech, Echo", "MN": "C23.888.592.604.150.500.800.300", "MH_TH": "NLM (1964)", "ST": "T184", "MS": "Involuntary (\"parrot-like\"), meaningless repetition of a recently heard word, phrase, or song. This condition may be associated with transcortical APHASIA; SCHIZOPHRENIA; or other disorders. (From Adams et al., Principles of Neurology, 6th ed, p485)", "PM": "1969", "HN": "1969(1964)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D004454"}, {"RECTYPE": "D", "MH": "Echolocation", "AQ": "CL DE ES PH RE", "ENTRY": "Echolocations", "MN": "F01.145.113.055.400", "MH_TH": "NLM (1972)", "ST": "T055", "AN": "animal only; for human consider SOUND LOCALIZATION", "PI": "Orientation (1966-1971)", "MS": "An auditory orientation mechanism involving the emission of high frequency sounds which are reflected back to the emitter (animal).", "PM": "91; was see under ORIENTATION 1972-90", "HN": "91(72); was see under ORIENTATION 1972-90", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004455"}, {"RECTYPE": "D", "MH": "Echothiophate Iodide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ecothiopate Iodide|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|NLM (1992)|901102|abbcdeeeef", "ENTRY": "Iodide, Phospholine", "MN": "D02.886.300.692.240", "PA": "Parasympathomimetics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Ethanaminium, 2-((diethoxyphosphinyl)thio)-N,N,N-trimethyl-, iodide", "RN": "BA9QH3P00T", "RR": "513-10-0 (Echothiophate Iodide)", "MS": "A potent, long-acting cholinesterase inhibitor used as a miotic in the treatment of glaucoma.", "OL": "use ECHOTHIOPHATE IODIDE to search PHOSPHOLINE IODIDE 1975-91", "PM": "65; PHOSPHOLINE IODIDE was see ECHOTHIOPHATE IODIDE 1975-91", "HN": "65; PHOSPHOLINE IODIDE was see ECHOTHIOPHATE IODIDE 1975-91", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004456"}, {"RECTYPE": "D", "MH": "Echovirus Infections", "DE": "ECHOVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Echovirus", "MN": "C01.925.782.687.359.347", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "coordinate with specific Echovirus if pertinent", "PI": "Enterovirus Infections (1966-1967)", "MS": "Infectious disease processes, including meningitis, diarrhea, and respiratory disorders, caused by echoviruses.", "OL": "use ECHOVIRUS INFECTIONS to search ECHO VIRUS INFECTIONS 1968-77", "PM": "78; was ECHO VIRUS INFECTIONS 1968-77", "HN": "78; was ECHO VIRUS INFECTIONS 1968-77", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004457"}, {"RECTYPE": "D", "MH": "Echovirus 6, Human", "DS": "ECHOVIRUS A 006 HUMAN", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human echovirus 6|T005|NON|EQV|NLM (2002)|010426|HUMAN ECHOVIRUS 006|abcdefs", "ENTRY": "Virus, Burgess", "MN": "B04.820.578.750.284.182.225", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid12062", "AN": "do not confuse with ECHOVIRUS 9; infection: coord IM with ECHOVIRUS INFECTIONS (IM)", "MS": "A species of ENTEROVIRUS that has caused outbreaks of aseptic meningitis in children and adults.", "PM": "2002; see ECHOVIRUS 6 1991-2001, see ECHOVIRUSES 1975-1990", "HN": "2002 (1975)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004458"}, {"RECTYPE": "D", "MH": "Echovirus 9", "DS": "ECHOVIRUS A 009", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human echovirus 9|T005|NON|EQV|NLM (2002)|010426|HUMAN ECHOVIRUS 009|abcdefs", "ENTRY": "Echo Virus 9|T005|NON|EQV|NLM (1991)|900330|abcdef", "MN": "B04.820.578.750.284.182.250", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid12060", "AN": "infection: coordinate with ECHOVIRUS INFECTIONS", "MS": "A species of ENTEROVIRUS associated with outbreaks of aseptic meningitis (MENINGITIS, ASEPTIC).", "PM": "2002; see ECHOVIRUS 9 1991-2001, see ECHOVIRUSES 1975-1990", "HN": "1991 (1975)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004459"}, {"RECTYPE": "D", "MH": "Eclampsia", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Eclampsias", "MN": "C12.050.703.395.124", "FX": "Seizures", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Onset of HYPERREFLEXIA; SEIZURES; or COMA in a previously diagnosed pre-eclamptic patient (PRE-ECLAMPSIA).", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004461"}, {"RECTYPE": "D", "MH": "Ecology", "DE": "ECOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Bionomics|T090|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Ecologies", "MN": "H01.277.249", "FX": "Environmental Health", "MH_TH": "POPLINE (1978)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use ECOLOGICAL AND ENVIRONMENTAL PHENOMENA or specifics treed under it for characteristics and processes of ecological and environmental systems", "MS": "The branch of science concerned with the interrelationship of organisms and their ENVIRONMENT, especially as manifested by natural cycles and rhythms, community development and structure, interactions between different kinds of organisms, geographic distributions, and population alterations. (Webster's, 3d ed)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004463"}, {"RECTYPE": "D", "MH": "Econazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nitrate, Econazole", "MN": "D03.383.129.308.250", "PA": "Antifungal Agents", "MH_TH": "USAN (1972)", "ST": "T121", "N1": "1H-Imidazole, 1-(2-((4-chlorophenyl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-", "RN": "6Z1Y2V4A7M", "RR": "H438WYN10E", "PI": "Imidazoles (1974-1976)", "MS": "An imidazole derivative that is commonly used as a topical antifungal agent.", "PM": "91; was see under IMIDAZOLES 1977-90", "HN": "91(77); was see under IMIDAZOLES 1977-90", "MR": "20160531", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D004464"}, {"RECTYPE": "D", "MH": "Economic Competition", "DE": "ECON COMPETITION", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Competition, Economic|T057|NON|EQV|UNK (19XX)|810226|COMPETITION ECON|abcdefv", "ENTRY": "Economic Competitions", "MN": "N03.219.188", "FX": "Antitrust Laws", "MH_TH": "NLM (1982)", "ST": "T057", "AN": "unfair competition goes here but consider also ANTITRUST LAWS", "MS": "The effort of two or more parties to secure the business of a third party by offering, usually under fair or equitable rules of business practice, the most favorable terms.", "PM": "91; was see under ECONOMICS 1982-90", "HN": "91(82); was see under ECONOMICS 1982-90", "MR": "19930916", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D004465"}, {"RECTYPE": "D", "MH": "Economics", "DE": "ECON", "AQ": "HI LJ SN TD", "PRINT ENTRY": "Consumer Price Index|T081|NON|NRW|UNK (19XX)|770421|abcdef", "ENTRY": "Utility Theories", "MN": "N03.219", "FX": "Socioeconomic Factors", "MH_TH": "NLM (1978)", "ST": "T090", "AN": "general or unspecified only: prefer /econ; note ECONOMIC FACTORS and SOCIOECONOMIC FACTORS are available", "MS": "The science of utilization, distribution, and consumption of services and materials.", "MR": "20200618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004467"}, {"RECTYPE": "D", "MH": "Economics, Dental", "DE": "ECON DENT", "AQ": "CL ES HI LJ OG SN ST TD", "PRINT ENTRY": "Dental Economics|T090|NON|EQV|NLM (1991)|900202|DENT ECON|abcdefv", "MN": "N03.219.224", "FX": "Office Management", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "general or unspecified; prefer specifics: prefer /econ with specific dental subject", "MS": "Economic aspects of the dental profession and dental care.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004468"}, {"RECTYPE": "D", "MH": "Economics, Hospital", "DE": "ECON HOSP", "AQ": "CL ES HI LJ OG SN ST TD", "PRINT ENTRY": "Hospital Economics|T090|NON|EQV|UNK (19XX)|770524|HOSP ECON|abcdefv", "ENTRY": "Hospital Economic", "MN": "N03.219.262", "FX": "Purchasing, Hospital", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "general or unspecified; prefer /econ with specific hospital subject", "MS": "Economic aspects related to the management and operation of a hospital.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004469"}, {"RECTYPE": "D", "MH": "Economics, Medical", "DE": "ECON MED", "AQ": "CL ES HI LJ OG SN ST TD", "PRINT ENTRY": "Medical Economics|T090|NON|EQV|NLM (1991)|900130|MED ECON|abcdefv", "MN": "N03.219.300", "FX": "Office Management", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "general or unspecified; prefer /econ with specific subject", "MS": "Economic aspects of the field of medicine, the medical profession, and health care. It includes the economic and financial impact of disease in general on the patient, the physician, society, or government.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004470"}, {"RECTYPE": "D", "MH": "Economics, Nursing", "DE": "ECON NURS", "AQ": "CL ES HI LJ OG SN ST TD", "PRINT ENTRY": "Nursing Economics|T090|NON|EQV|NLM (1991)|900202|NURS ECON|abcdefv", "ENTRY": "Nursing Economic", "MN": "N03.219.338", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "general or unspecified; prefer specifics: prefer /econ with specific nursing subject", "MS": "Economic aspects of the nursing profession.", "PM": "66", "HN": "66", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004471"}, {"RECTYPE": "D", "MH": "Health Care Economics and Organizations", "DE": "HEALTH CARE ECON ORGAN", "PRINT ENTRY": "Healthcare Economics|T057|NON|NRW|NLM (2021)|191122|abcdef", "ENTRY": "Healthcare Economic", "MN": "N03", "RH": "N3 - HEALTH CARE ECONOMICS AND ORGANIZATIONS", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "The economic aspects of health care, its planning, and delivery. It includes government agencies and organizations in the private sector.", "PM": "98", "HN": "98; use explode", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004472"}, {"RECTYPE": "D", "MH": "Ecthyma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.838.765.210", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "Strep infect", "MS": "An ulcerative pyoderma usually caused by group A beta-hemolytic streptococcal infection at the site of minor trauma. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004473"}, {"RECTYPE": "D", "MH": "Ecthyma, Contagious", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Dermatitis, Contagious Pustular|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Virus Infections, Orf", "MN": "C22.836.259", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "caused by a poxvirus; usually animal; check tag ANIMALS; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES", "PI": "Sheep Diseases (1966-1969)", "MS": "An infectious dermatitis of sheep and goats, affecting primarily the muzzle and lips. It is caused by a poxvirus and may be transmitted to man.", "OL": "search POXVIRUS INFECTIONS 1966-69", "PM": "70; was ECTHYMA CONTAGIOSUM see under POXVIRUS INFECTIONS 1963-69", "HN": "70; was ECTHYMA CONTAGIOSUM see under POXVIRUS INFECTIONS 1963-69", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D004474"}, {"RECTYPE": "D", "MH": "Ectoderm", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Apical Ectodermal Ridge|T018|NON|REL|NLM (2024)|230423|abcdef", "ENTRY": "Ectoderms", "MN": "A16.504.273", "MH_TH": "NLM (1966)", "ST": "T018", "MS": "The outer of the three germ layers of an embryo.", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004475"}, {"RECTYPE": "D", "MH": "Ectodermal Dysplasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hidrotic Ectodermal Dysplasia|T019|T047|NON|NRW|NLM (1993)|ORD (2010)|920407|abbcdeef", "ENTRY": "Syndrome, Clouston's", "MN": "C17.800.827.250", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "A group of hereditary disorders involving tissues and structures derived from the embryonic ectoderm. They are characterized by the presence of abnormalities at birth and involvement of both the epidermis and skin appendages. They are generally nonprogressive and diffuse. Various forms exist, including anhidrotic and hidrotic dysplasias, FOCAL DERMAL HYPOPLASIA, and aplasia cutis congenita.", "PM": "1965; ECTODERMAL DEFECT, CONGENITAL was heading 1963-1986", "HN": "1965", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004476"}, {"RECTYPE": "D", "MH": "Ectogenesis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Ectogeneses", "MN": "G07.345.500.325.089", "FX": "Fertilization in Vitro", "MH_TH": "NLM (1975)", "ST": "T040", "PI": "Embryo (1966-1974)", "MS": "Embryonic and fetal development that takes place in an artificial environment in vitro.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D004477"}, {"RECTYPE": "D", "MH": "Ectoparasitic Infestations", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infestations, Ectoparasitic", "MN": "C01.610.858.211", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "general only: prefer specifics; coordinate IM with ectoparasite (IM); refers to ectoparasite on or within the skin so do not coordinate with SKIN DISEASES, PARASITIC", "PI": "specific parasite", "MS": "Infestations by PARASITES which live on, or burrow into, the surface of their host's EPIDERMIS. Most ectoparasites are ARTHROPODS.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004478"}, {"RECTYPE": "D", "MH": "Ectopia Lentis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lentis, Ectopia", "MN": "C16.131.384.405", "MH_TH": "NLM (1978)", "ST": "T019", "AN": "congen lens dislocation; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Lens, Crystalline (1966-1977)", "MS": "Congenital displacement of the lens resulting from defective zonule formation.", "PM": "91", "HN": "91(78)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D004479"}, {"RECTYPE": "D", "MH": "Ectromelia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sirenomelia|T019|NON|REL|ORD (2010)|UNK (19XX)|780130|abcdeef", "ENTRY": "Syndrome, Mermaid", "MN": "C16.131.621.585.350", "MH_TH": "NLM (1963)", "ST": "T019", "MS": "Gross hypo- or aplasia of one or more long bones of one or more limbs. The concept includes amelia, hemimelia, phocomelia, and sirenomelia.", "OL": "use ECTROMELIA to search PHOCOMELIA 1966-78 & SIRENOMELIA 1967-78", "PM": "1967; PHOCOMELIA was heading 1963-66", "HN": "1967(1963); PHOCOMELIA was see under ECTROMELIA 1967-78, was heading 1963-66; SIRENOMELIA was see under ECTROMELIA 1967-78", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004480"}, {"RECTYPE": "D", "MH": "Ectromelia virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Poxvirus muris|T005|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Mousepox viruses", "MN": "B04.280.650.160.650.200", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid12643", "MS": "A species of ORTHOPOXVIRUS infecting mice and causing a disease that involves internal organs and produces characteristic skin lesions.", "PM": "66; MOUSEPOX VIRUS was MOUSE POX VIRUS 1975-93", "HN": "66; MOUSEPOX VIRUS was MOUSE POX VIRUS 1975-93", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004481"}, {"RECTYPE": "D", "MH": "Ectromelia, Infectious", "DE": "ECTROMELIA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Mousepox|T047|NON|EQV|NLM (1990)|890113|abcdef", "ENTRY": "Mouse Pox|T047|NON|EQV|NLM (1990)|890113|abcdef", "MN": "C22.795.239", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "caused by a poxvirus; don't forget also MICE (NIM) & check tag ANIMALS", "MS": "A viral infection of mice, causing edema and necrosis followed by limb loss.", "OL": "search POXVIRUS INFECTIONS 1967-74", "PM": "90; was see under POXVIRUS INFECTIONS 1975-89", "HN": "90(75); was see under POXVIRUS INFECTIONS 1975-89", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D004482"}, {"RECTYPE": "D", "MH": "Ectropion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ectropions", "MN": "C11.338.362", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "eversion of eyelid: do not confuse with ENTROPION, inversion", "MS": "The turning outward (eversion) of the edge of the eyelid, resulting in the exposure of the palpebral conjunctiva. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004483"}, {"RECTYPE": "D", "MH": "Ecuador", "AQ": "EH EP", "PRINT ENTRY": "Galapagos Islands|T083|NAM|NRW|UNK (19XX)|750101|abcdef", "MN": "Z01.107.757.362", "MH_TH": "NLM (1977)", "ST": "T083", "MS": "A country in western South America, bordering the Pacific Ocean at the equator, between Colombia and Peru.", "MR": "20160531", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D004484"}, {"RECTYPE": "D", "MH": "Eczema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dermatitis, Eczematous|T047|NON|EQV|NLM (1993)|920402|abcdef", "ENTRY": "Eczematous Dermatitis", "MN": "C17.800.815.620", "MH_TH": "POPLINE (1978)", "ST": "T047", "AN": "an indistinct concept: check text for more specific skin dis; if more specific term is not in text, do not make a diagnosis: index here", "MS": "A dermatitis characterized by a spongiotic tissue reaction pattern occurring as a reaction to many endogenous and exogenous agents.", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004485"}, {"RECTYPE": "D", "MH": "Edeine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D12.644.146", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "NLM (1975)", "ST": "T195", "N1": "Edeine", "RN": "11006-90-9", "PI": "Polyamines (1973-1974)", "MS": "Basic peptide antibiotic from Bacillus brevis. It exhibits broad-spectrum antibacterial activity and inhibits bacterial DNA synthesis.", "PM": "91; was see under ANTIBIOTICS 1975-90", "HN": "91(75); was see under ANTIBIOTICS 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004486"}, {"RECTYPE": "D", "MH": "Edema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hydrops|T184|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Anasarca|T184|NON|NRW|NLM (2012)|101004|abcdef", "MN": "C23.888.277", "FX": "Pulmonary Edema", "MH_TH": "NLM (1963)", "ST": "T184", "MS": "Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004487"}, {"RECTYPE": "D", "MH": "Edema Disease of Swine", "DE": "EDEMA DIS SWINE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Swine Edema Diseases", "MN": "C22.905.260", "MH_TH": "NLM (1971)", "ST": "T047", "AN": "don't forget also SWINE (NIM) & check tag ANIMALS", "PI": "Swine Diseases (1966-1970)", "MS": "An acute disease of young pigs that is usually associated with weaning. It is characterized clinically by paresis and subcutaneous edema.", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D004488"}, {"RECTYPE": "D", "MH": "Edema, Cardiac", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Edemas, Cardiac", "MN": "C23.888.277.197", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Abnormal fluid retention by the body due to impaired cardiac function or heart failure. It is usually characterized by increase in venous and capillary pressure, and swollen legs when standing. It is different from the generalized edema caused by renal dysfunction (NEPHROTIC SYNDROME).", "OL": "search HEART FAILURE, CONGESTIVE 1966-74", "PM": "91; was see under HEART FAILURE, CONGESTIVE 1975-90", "HN": "91(75); was see under HEART FAILURE, CONGESTIVE 1975-90", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004489"}, {"RECTYPE": "D", "MH": "Xenarthra", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Edentata|T015|NON|REL|NLM (1998)|961010|abcdef", "MN": "B01.050.150.900.649.313.999", "MH_TH": "NLM (1966)", "ST": "T015", "MS": "A superorder of New World mammals characterized by the absence of incisors and canines from among their teeth, and comprising the ARMADILLOS and the SLOTHS. The superorder is distinguished from all others by what are known as xenarthrous vertebrae (xenos, strange; arthron, joint): there are secondary, and sometimes even more, articulations between the vertebrae of the lumbar series. The superorder in part was formerly called Edentata. (From Random House Unabridged Dictionary, 2d ed; Walker's Mammals of the World, 5th ed, vol. I, p515)", "PM": "2022; see EDENTATA 1963-1997; XENARTHRA 1998-2019; and CINGULATA 2020-2021", "HN": "2022(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004490"}, {"RECTYPE": "D", "MH": "Edrophonium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Edrophonium Chloride|T109|T121|NON|NRW|BAN (1996)|FDA SRS (2014)|INN (1996)|USP (19XX)|820518|abbcdeeeef", "ENTRY": "Chloride, Edrophonium", "MN": "D02.675.276.352", "PA": "Cholinesterase Inhibitors", "MH_TH": "NLM (1964)", "ST": "T121", "N1": "Benzenaminium, N-ethyl-3-hydroxy-N,N-dimethyl-", "RN": "70FP3JLY7N", "RR": "QO611KSM5P", "MS": "A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.", "OL": "search CURARIFORM ANTAGONISTS 1966-69; use EDROPHONIUM to search EDROPHONIUM CHLORIDE 1966-82 (as Prov 1966-71)", "PM": "83; was see under CURARIFORM ANTAGONISTS 1963-69; EDROPHONIUM CHLORIDE was heading 1972-82", "HN": "83; was see under CURARIFORM ANTAGONISTS 1963-69; EDROPHONIUM CHLORIDE was heading 1964-82 (Prov 1964-71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D004491"}, {"RECTYPE": "D", "MH": "Edetic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetracemate|T109|T121|T130|NON|NRW|UNK (19XX)|770330|abbbcdef", "ENTRY": "Versenate, Calcium Disodium", "MN": "D02.241.081.018.253", "PA": "Food Additives", "MH_TH": "INN (19XX)", "ST": "T130", "N1": "Glycine, N,N'-1,2-ethanediylbis(N-(carboxymethyl))-", "RN": "9G34HU7RV0", "RR": "NDT563S5VZ", "MS": "A chelating agent that sequesters a variety of polyvalent cations such as CALCIUM. It is used in pharmaceutical manufacturing and as a food additive.", "PM": "92; see EDTA 1966-91, see EDATHAMIL 1963-65", "HN": "92(63)", "MR": "20140616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004492"}, {"RECTYPE": "D", "MH": "Education", "DE": "EDUC", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Training Programs|T061|T065|NON|NRW|NLM (1978)|890502|abbcdef", "ENTRY": "Workshop", "MN": "I02", "RH": "I2 - EDUCATION", "FX": "Training Support", "MH_TH": "NLM (1978)", "ST": "T065", "AN": "general only; prefer /educ: Manual 19.7+, 19.8.28; policy: Manual 30.7+", "MS": "Acquisition of knowledge as a result of instruction in a formal course of study.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004493"}, {"RECTYPE": "D", "MH": "Education Department, Hospital", "DE": "EDUC DEP", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Hospital Education Department|T093|NON|EQV|UNK (19XX)|810226|HOSP EDUC DEP|abcdefv", "ENTRY": "Hospital Education Departments", "MN": "N04.452.442.452.422.310", "MH_TH": "NLM (1982)", "ST": "T093", "MS": "Hospital department responsible for administering educational and training activities pertaining to health for patients and staff.", "PM": "91; was see under HOSPITAL DEPARTMENTS 1982-90", "HN": "91(82); was see under HOSPITAL DEPARTMENTS 1982-90", "MR": "20190709", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D004494"}, {"RECTYPE": "D", "MH": "Education of Intellectually Disabled", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Education of Mentally Retarded|T065|NON|EQV|NLM (1967)|990101|EDUC MENTALLY RETARDED|abcdefv", "ENTRY": "Mentally Defective Education", "MN": "I02.233.213.400", "MH_TH": "NLM (2012)", "ST": "T065", "MS": "The teaching or training of those individuals with subnormal intellectual functioning.", "OL": "use EDUCATION OF MENTALLY RETARDED to search EDUCATION OF MENTALLY DEFECTIVE 1966", "PM": "67; was EDUCATION OF MENTALLY DEFECTIVE 1963-66", "HN": "67; was EDUCATION OF MENTALLY DEFECTIVE 1963-66", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004495"}, {"RECTYPE": "D", "MH": "Education, Continuing", "DE": "EDUC CONTINUING", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Lifelong Learning|T065|NON|EQV|NLM (2022)|210126|abcdef", "ENTRY": "Life-Long Learnings", "MN": "I02.358.212", "MH_TH": "NLM (1966)", "ST": "T065", "AN": "formal or informal courses to advance or update knowledge: differentiate from EDUCATION, GRADUATE: formal prep for specialty training or advanced study leading to official certification or degree; includes refresher courses", "MS": "Educational programs designed to inform individuals of recent advances in their particular field of interest. They do not lead to any formal advanced standing.", "PM": "66", "HN": "66", "MR": "20210706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004496"}, {"RECTYPE": "D", "MH": "Education, Dental", "DE": "EDUC DENT", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Dental Education|T065|NON|EQV|NLM (1990)|890502|DENT EDUC|abcdefv", "MN": "I02.358.274", "MH_TH": "NLM (1966)", "ST": "T065", "MS": "Use for articles concerning dental education in general.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004497"}, {"RECTYPE": "D", "MH": "Education, Dental, Continuing", "DE": "EDUC DENT CONTINUING", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Dental Education, Continuing|T065|NON|EQV|NLM (1990)|890502|DENT EDUC CONTINUING|abcdefv", "ENTRY": "Educations, Continuing Dental", "MN": "I02.358.274.316", "MH_TH": "NLM (1966)", "ST": "T065", "AN": "differentiate from EDUCATION, DENTAL, GRADUATE: see note on EDUCATION, CONTINUING", "MS": "Educational programs designed to inform dentists of recent advances in their fields.", "OL": "use EDUCATION, DENTAL, CONTINUING & EDUCATION, DENTAL, GRADUATE to search EDUCATION, DENTAL, POSTGRADUATE 1966-74", "PM": "66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING & EDUCATION, DENTAL, GRADUATE 1966-74, was heading 1965", "HN": "66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING & EDUCATION, DENTAL, GRADUATE 1966-74, was heading 1965", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004498"}, {"RECTYPE": "D", "MH": "Education, Dental, Graduate", "DE": "EDUC DENT GRAD", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Dental Education, Graduate|T065|NON|EQV|NLM (1990)|890502|DENT EDUC GRAD|abcdefv", "ENTRY": "Graduate Dental Education|T065|NON|EQV|UNK (19XX)|880804|GRAD DENT EDUC|abcdefv", "MN": "I02.358.337.249", "MH_TH": "NLM (1966)", "ST": "T065", "AN": "differentiate from EDUCATION, DENTAL, CONTINUING: see note on EDUCATION, CONTINUING", "MS": "Educational programs for dental graduates entering a specialty. They include formal specialty training as well as academic work in the clinical and basic dental sciences, and may lead to board certification or an advanced dental degree.", "OL": "use EDUCATION, DENTAL, GRADUATE & EDUCATION, DENTAL, CONTINUING to search EDUCATION, DENTAL, POSTGRADUATE 1966-74", "PM": "66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING & EDUCATION, DENTAL, GRADUATE 1966-74; was heading 1965", "HN": "66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING & EDUCATION, DENTAL, GRADUATE 1966-74; was heading 1965", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004499"}, {"RECTYPE": "D", "MH": "Education, Graduate", "DE": "EDUC GRAD", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Graduate Educations", "MN": "I02.358.337", "MH_TH": "NLM (1967)", "ST": "T065", "AN": "differentiate from EDUCATION, CONTINUING: see note on EDUCATION, CONTINUING", "PI": "Education (1966)", "MS": "Studies beyond the bachelor's degree at an institution having graduate programs for the purpose of preparing for entrance into a specific field, and obtaining a higher degree.", "PM": "70", "HN": "70(67)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D004500"}, {"RECTYPE": "D", "MH": "Education, Medical", "DE": "EDUC MED", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Medical Education|T065|NON|EQV|BIOETHICS (1974)|NLM (1990)|890502|MED EDUC|abcdeefv", "MN": "I02.358.399", "MH_TH": "NLM (1966)", "ST": "T065", "MS": "Use for general articles concerning medical education.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004501"}, {"RECTYPE": "D", "MH": "Education, Medical, Continuing", "DE": "EDUC MED CONTINUING", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Medical Education, Continuing|T065|NON|EQV|NLM (1990)|890502|MED EDUC CONTINUING|abcdefv", "ENTRY": "Education, Continuing Medical|T065|NON|EQV|NLM (1991)|891129|EDUC CONTINUING MED|abcdefv", "MN": "I02.358.399.250", "MH_TH": "NLM (1966)", "ST": "T065", "AN": "differentiate from EDUCATION, MEDICAL, GRADUATE: see note on EDUCATION, CONTINUING", "MS": "Educational programs designed to inform physicians of recent advances in their field.", "OL": "use EDUCATION, MEDICAL, CONTINUING & EDUCATION, MEDICAL, GRADUATE to search EDUCATION, MEDICAL, POSTGRADUATE 1966-74", "PM": "66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING & EDUCATION, MEDICAL, GRADUATE 1966-74, was heading 1963-65", "HN": "66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING & EDUCATION, MEDICAL, GRADUATE 1966-74, was heading 1963-65", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004502"}, {"RECTYPE": "D", "MH": "Education, Medical, Graduate", "DE": "EDUC MED GRAD", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Medical Education, Graduate|T065|NON|EQV|NLM (1991)|900202|MED EDUC GRAD|abcdefv", "ENTRY": "Graduate Medical Education|T065|NON|EQV|UNK (19XX)|880804|GRAD MED EDUC|abcdefv", "MN": "I02.358.399.350", "MH_TH": "NLM (1966)", "ST": "T065", "AN": "differentiate from EDUCATION, MEDICAL, CONTINUING: see note on EDUCATION, CONTINUING; Manual 34.22 GRAD", "MS": "Educational programs for medical graduates entering a specialty. They include formal specialty training as well as academic work in the clinical and basic medical sciences, and may lead to board certification or an advanced medical degree.", "OL": "use EDUCATION, MEDICAL, GRADUATE & EDUCATION, MEDICAL, CONTINUING to search EDUCATION, MEDICAL, POSTGRADUATE 1966-74", "PM": "66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING & EDUCATION, MEDICAL, GRADUATE 1966-74; was heading 1963-65", "HN": "66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING & EDUCATION, MEDICAL, GRADUATE 1966-74; was heading 1963-65", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004503"}, {"RECTYPE": "D", "MH": "Education, Medical, Undergraduate", "DE": "EDUC MED UNDERGRAD", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Medical Education, Undergraduate|T065|NON|EQV|NLM (1991)|900202|MED EDUC UNDERGRAD|abcdefv", "ENTRY": "Undergraduate Medical Education|T065|NON|EQV|UNK (19XX)|880804|UNDERGRAD MED EDUC|abcdefv", "MN": "I02.358.399.450", "MH_TH": "NLM (1971)", "ST": "T065", "PI": "Education, Medical (1966-1970)", "MS": "The period of medical education in a medical school. In the United States it follows the baccalaureate degree and precedes the granting of the M.D.", "PM": "73", "HN": "73(71)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004504"}, {"RECTYPE": "D", "MH": "Education, Nonprofessional", "DE": "EDUC NONPROFESSIONAL", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Parenting Education|T065|NON|NRW|NLM (1993)|940315|PARENTING EDUC|abcdefv", "MN": "I02.233", "MH_TH": "NLM (1966)", "ST": "T065", "AN": "general or unspecified; prefer specifics; note entry term PARENTING EDUCATION: coordinate IM with PARENTING (IM)", "MS": "Education and training outside that for the professions.", "PM": "1998; for PARENTING EDUCATION see EDUCATION 1993-2013", "HN": "1998; for PARENTING EDUCATION use EDUCATION 1993-2013", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004505"}, {"RECTYPE": "D", "MH": "Education, Nursing", "DE": "EDUC NURS", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Nursing Education|T065|NON|EQV|BIOETHICS (1974)|NLM (1991)|900202|NURS EDUC|abcdeefv", "ENTRY": "Nursing Educations", "MN": "I02.358.462", "MH_TH": "NLM (1966)", "ST": "T065", "AN": "general or unspecified; prefer specifics", "MS": "Use for general articles concerning nursing education.", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004506"}, {"RECTYPE": "D", "MH": "Education, Nursing, Associate", "DE": "EDUC NURS ASSOCIATE", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Nursing Education, Associate|T065|NON|EQV|NLM (1991)|900202|NURS EDUC ASSOCIATE|abcdefv", "ENTRY": "Nursing Educations, Associate", "MN": "I02.358.462.233", "MH_TH": "NLM (1971)", "ST": "T065", "MS": "A two-year program in nursing education in a community or junior college leading to an A.D. (Associate Degree). Graduates of this program are eligible for state examination for licensure as RN (Registered Nurse).", "OL": "search EDUCATION, NURSING, DEGREE PROGRAMS under EDUCATION, NURSING, BACCALAUREATE 1967-70", "PM": "71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70", "HN": "71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D004507"}, {"RECTYPE": "D", "MH": "Education, Nursing, Baccalaureate", "DE": "EDUC NURS BACCALAUREATE", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Nursing Education, Baccalaureate|T065|NON|EQV|NLM (1991)|900202|NURS EDUC BACCALAUREATE|abcdefv", "ENTRY": "Nursing Educations, Baccalaureate", "MN": "I02.358.462.316", "MH_TH": "NLM (1971)", "ST": "T065", "MS": "A four-year program in nursing education in a college or university leading to a B.S.N. (Bachelor of Science in Nursing). Graduates are eligible for state examination for licensure as RN (Registered Nurse).", "OL": "use EDUCATION, NURSING, BACCALAUREATE to search EDUCATION, NURSING, DEGREE PROGRAMS 1967-70", "PM": "71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70", "HN": "71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D004508"}, {"RECTYPE": "D", "MH": "Education, Nursing, Continuing", "DE": "EDUC NURS CONTINUING", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Post-Registration Nursing Education|T065|NON|EQV|NLM (1998)|961022|POSTREGISTRATION NURSING EDUCATION|POST REGISTRATION NURS EDUC|abcdefsv", "ENTRY": "Post Registration Nursing Education", "MN": "I02.358.462.399", "FX": "Specialties, Nursing", "MH_TH": "NLM (1966)", "ST": "T065", "AN": "differentiate from EDUCATION, NURSING, GRADUATE: see note on EDUCATION, CONTINUING; special courses, workshops, etc.", "MS": "Educational programs designed to inform nurses of recent advances in their fields.", "PM": "66", "HN": "66", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004509"}, {"RECTYPE": "D", "MH": "Education, Nursing, Diploma Programs", "DE": "EDUC NURS DIPLOMA PROGRAMS", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Nursing Education, Diploma Programs|T065|NON|EQV|NLM (1991)|900202|NURS EDUC DIPLOMA PROGRAMS|abcdefv", "ENTRY": "Programs, Nursing Diploma", "MN": "I02.358.462.482", "MH_TH": "NLM (1967)", "ST": "T065", "AN": "2-3-yr program in hosp school of nurs", "PI": "Education, Nursing (1966)", "MS": "Programs usually offered in hospital schools of nursing leading to a registered nurse diploma (RN). Graduates are eligible for state examination for licensure as RN (Registered Nurse).", "PM": "67", "HN": "67", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004510"}, {"RECTYPE": "D", "MH": "Education, Nursing, Graduate", "DE": "EDUC NURS GRAD", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Postgraduate Nursing Education|T065|NON|EQV|NLM (1998)|961022|POSTGRAD NURS EDUC|abcdefv", "ENTRY": "Education, Postgraduate Nursing", "MN": "I02.358.462.565", "MH_TH": "NLM (1966)", "ST": "T065", "AN": "differentiate from EDUCATION, NURSING, CONTINUING: see note on EDUCATION, CONTINUING; leads to MS or PhD", "MS": "Those educational activities engaged in by holders of a bachelor's degree in nursing, which are primarily designed to prepare them for entrance into a specific field of nursing, and may lead to board certification or a more advanced degree.", "PM": "66", "HN": "66", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004511"}, {"RECTYPE": "D", "MH": "Education, Pharmacy", "DE": "EDUC PHARM", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Pharmacy Education|T065|NON|EQV|NLM (1991)|900202|PHARM EDUC|abcdefv", "ENTRY": "Pharmaceutical Education", "MN": "I02.358.525", "MH_TH": "NLM (1966)", "ST": "T065", "MS": "Formal instruction, learning, or training in the preparation, dispensing, and proper utilization of drugs in the field of medicine.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004512"}, {"RECTYPE": "D", "MH": "Education, Pharmacy, Continuing", "DE": "EDUC PHARM CONTINUING", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Pharmacy Education, Continuing|T065|NON|EQV|NLM (1991)|900205|PHARM EDUC CONTINUING|abcdefv", "ENTRY": "Education, Continuing Pharmaceutical", "MN": "I02.358.525.317", "MH_TH": "NLM (1968)", "ST": "T065", "AN": "differentiate from EDUCATION, PHARMACY, GRADUATE: see note on EDUCATION, CONTINUING", "PI": "Education, Pharmacy (1966-1967)", "MS": "Educational programs designed to inform graduate pharmacists of recent advances in their particular field.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004513"}, {"RECTYPE": "D", "MH": "Education, Pharmacy, Graduate", "DE": "EDUC PHARM GRAD", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Pharmacy Education, Graduate|T065|NON|EQV|NLM (1990)|890502|PHARM EDUC GRAD|abcdefv", "ENTRY": "Graduate Pharmaceutical Education", "MN": "I02.358.525.483", "MH_TH": "NLM (1968)", "ST": "T065", "AN": "differentiate from EDUCATION, PHARMACY, CONTINUING: see note on EDUCATION, CONTINUING", "PI": "Education, Pharmacy (1966-1967)", "MS": "Educational programs for pharmacists who have a bachelor's degree or a Doctor of Pharmacy degree entering a specific field of pharmacy. They may lead to an advanced degree.", "PM": "68", "HN": "68", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004514"}, {"RECTYPE": "D", "MH": "Education, Predental", "DE": "EDUC PREDENT", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Predental Education|T065|NON|EQV|NLM (1991)|900202|PREDENT EDUC|abcdefv", "ENTRY": "Predental Educations", "MN": "I02.275", "MH_TH": "NLM (1966)", "ST": "T065", "MS": "Preparatory education meeting the requirements for admission to dental school.", "PM": "66", "HN": "66", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004515"}, {"RECTYPE": "D", "MH": "Education, Premedical", "DE": "EDUC PREMED", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Premedical Education|T065|NON|EQV|NLM (1991)|891201|PREMED EDUC|abcdefv", "ENTRY": "Propedeutics, Medical", "MN": "I02.316", "MH_TH": "NLM (1966)", "ST": "T065", "MS": "Introductory courses leading to an advance study in medicine.", "PM": "66", "HN": "66", "MR": "20170208", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004516"}, {"RECTYPE": "D", "MH": "Education, Professional", "DE": "EDUC PROFESSIONAL", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Professional Education|T065|NON|EQV|NLM (1998)|970107|PROFESSIONAL EDUC|abcdefv", "MN": "I02.358", "MH_TH": "NLM (1974)", "ST": "T065", "AN": "general or unspecified; prefer specifics", "MS": "Formal education and training in preparation for the practice of a profession.", "PM": "98", "HN": "98; use explode 1975-97", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004517"}, {"RECTYPE": "D", "MH": "Education, Professional, Retraining", "DE": "EDUC PROFESSIONAL RETRAINING", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Retraining, Professional|T065|NON|EQV|UNK (19XX)|780508|abcdef", "ENTRY": "Retrainings, Professional", "MN": "I02.358.212.590", "MH_TH": "NLM (1979)", "ST": "T065", "AN": "coord NIM with specific type (medical, dental, etc.) of continuing educ (IM)", "MS": "Educational programs for individuals who have been inactive in their profession, or who wish to regain unused skills.", "PM": "91; was see under EDUCATION, CONTINUING 1979-90", "HN": "91(79); was see under EDUCATION, CONTINUING 1979-90", "MR": "19991103", "DA": "19780508", "DC": "1", "DX": "19910101", "UI": "D004518"}, {"RECTYPE": "D", "MH": "Education, Special", "DE": "EDUC SPECIAL", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Special Educations", "MN": "I02.233.213", "MH_TH": "NLM (1966)", "ST": "T065", "AN": "IM", "MS": "Education of the individual who markedly deviates intellectually, physically, socially, or emotionally from those considered to be normal, thus requiring special instruction.", "PM": "68", "HN": "68(66)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004519"}, {"RECTYPE": "D", "MH": "Education, Veterinary", "DE": "EDUC VET", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Veterinary Education|T065|NON|EQV|NLM (1990)|890502|VET EDUC|abcdefv", "ENTRY": "Veterinary Educations", "MN": "I02.358.588", "MH_TH": "NLM (1974)", "ST": "T065", "MS": "Use for general articles concerning veterinary medical education.", "PM": "74", "HN": "74", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004520"}, {"RECTYPE": "D", "MH": "Educational Measurement", "DE": "EDUC MEASUREMENT", "AQ": "EC HI MT SN ST", "PRINT ENTRY": "Graduate Records Examination|T065|NON|NRW|UNK (19XX)|820429|GRAD RECORDS EXAM|abcdefv", "ENTRY": "Measurements, Educational", "MN": "I02.399", "FX": "Aptitude Tests", "MH_TH": "NLM (1966)", "ST": "T065", "MS": "The assessing of academic or educational achievement. It includes all aspects of testing and test construction.", "OL": "use EDUCATIONAL MEASUREMENT to search GRADUATE RECORDS EXAMINATION 1966-82", "PM": "66; GRADUATE RECORDS EXAMINATION was see under EDUCATIONAL MEASUREMENT 1966-82", "HN": "66; GRADUATE RECORDS EXAMINATION was see under EDUCATIONAL MEASUREMENT 1966-82", "MR": "19940125", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004521"}, {"RECTYPE": "D", "MH": "Educational Status", "DE": "EDUC STATUS", "PRINT ENTRY": "Paternal Educational Level|T080|NON|NRW|NLM (2023)|211028|abcdef", "ENTRY": "Status, Paternal Educational", "MN": "N01.824.196", "MH_TH": "NLM (1978)", "ST": "T080", "PI": "Students (1966-1967)", "MS": "Educational attainment or level of education of an individual.", "PM": "68", "HN": "68", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004522"}, {"RECTYPE": "D", "MH": "Eels", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Anguilliformes|T013|NON|EQV|NLM (2002)|001005|abcdef", "ENTRY": "Eel", "MN": "B01.050.150.900.493.338", "MH_TH": "NLM (1966)", "ST": "T013", "RN": "txid7933", "AN": "EELS, SWAMP see SMEGMAMORPHA and EEL, ELECTRIC see ELECTROPHORUS are also available", "MS": "Common name for an order (Anguilliformes) of voracious, elongate, snakelike teleost fishes.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004524"}, {"RECTYPE": "D", "MH": "Efferent Pathways", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Motor Pathways|T023|NON|NRW|NLM (2003)|020107|abcdef", "ENTRY": "Pathways, Efferent", "MN": "A08.612.380", "MH_TH": "NLM (1976)", "ST": "T023", "AN": "coord NIM with origin (IM) + termination (IM)", "PI": "specific central nervous system heading", "MS": "Nerve structures through which impulses are conducted from a nerve center toward a peripheral site. Such impulses are conducted via efferent neurons (NEURONS, EFFERENT), such as MOTOR NEURONS, autonomic neurons, and hypophyseal neurons.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20050721", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D004525"}, {"RECTYPE": "D", "MH": "Efficiency", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Productivity|T081|NON|NRW|NLM (2018)|750101|abcdef", "MN": "N04.452.209", "MH_TH": "NLM (1994)", "ST": "T081", "AN": "note category: do not confuse with PHYSICAL FITNESS nor with metabolic efficiency; EFFICIENCY, ORGANIZATIONAL is available", "MS": "Ratio of output to effort and or resources, or the ratio of effort and or resources produced to energy expended.", "HN": "was in Cat F only 1963-81; was in Cat F & N 1982-91", "CATSH": "CAT LIST", "MR": "20170708", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D004526"}, {"RECTYPE": "D", "MH": "Egg Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Yolk Proteins|T116|T123|NON|NRW|UNK (19XX)|880606|abbcdef", "ENTRY": "Yolk Proteins, Egg", "MN": "D12.776.290", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Proteins (1966-1972)", "MS": "Proteins which are found in eggs (OVA) from any species.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004527"}, {"RECTYPE": "D", "MH": "Egg Shell", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Shells, Egg", "MN": "A13.316", "MH_TH": "NLM (1974)", "ST": "T018", "AN": "IM avian only; NIM reptilian; do not use for lower animals; ANIMAL SHELLS is also available", "MS": "A hard or leathery calciferous exterior covering of an egg.", "PM": "74", "HN": "74", "MR": "20160226", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004528"}, {"RECTYPE": "D", "MH": "Egg White", "AQ": "AE AN CH CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Egg Whites", "MN": "J02.500.470.700", "FX": "Ovalbumin", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "white of egg as food or as distinct from EGG YOLK, or egg white from dietary, food technol or econ viewpoint; differentiate from OVALBUMIN, the chemical albumin in egg white; egg-white edema: coord EDEMA (IM) + OVALBUMIN (NIM if indexed at all)", "MS": "The white of an egg, especially a chicken's egg, used in cooking. It contains albumin. (Random House Unabridged Dictionary, 2d ed)", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004529"}, {"RECTYPE": "D", "MH": "Egg Yolk", "AQ": "AE CH CL CY DE EN IM ME MI PA PH PO PS RE TO TR UL VI", "ENTRY": "Yolks, Egg", "MN": "J02.500.470.800", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "for both ovum nutrient & dietary portion of eggs", "MS": "Cytoplasm stored in an egg that contains nutritional reserves for the developing embryo. It is rich in polysaccharides, lipids, and proteins.", "HN": "was in Cat J only 1963-76", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D004530"}, {"RECTYPE": "D", "MH": "Eggs", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "MN": "J02.500.470", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "differentiate from OVUM; eggs as food (chicken, duck, quail, etc. eggs); fish roe & reptile eggs as food go here but if physiol or anat, use OVUM; /adv eff consider also EGG HYPERSENSITIVITY", "MS": "Animal reproductive bodies, or the contents thereof, used as food. The concept is differentiated from OVUM, the anatomic or physiologic entity.", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004531"}, {"RECTYPE": "D", "MH": "Ego", "PRINT ENTRY": "Self|T078|NON|BRD|UNK (19XX)|750101|abcdef", "ENTRY": "Egos", "MN": "F02.739.794.206", "FX": "Self Psychology", "MH_TH": "NLM (1968)", "ST": "T078", "AN": "EGOCENTRISM is also available", "PI": "Psychoanalytic Theory (1966-1967)", "MS": "The conscious portion of the personality structure which serves to mediate between the demands of the primitive instinctual drives, (the id), of internalized parental and social prohibitions or the conscience, (the superego), and of reality.", "OL": "use EGO to search SELF 1969-75 & SELF CONCEPT 1966-68", "PM": "68; SELF was heading 1965-68, was see under PERSONALITY 1963-64", "HN": "68; SELF was heading 1965-68, was see under PERSONALITY 1963-64", "CATSH": "CAT LIST", "MR": "19960613", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004532"}, {"RECTYPE": "D", "MH": "Egtazic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethylene Glycol Tetraacetic Acid|T109|T130|NON|EQV|UNK (19XX)|750208|abbcdef", "ENTRY": "Magnesium EGTA", "MN": "D02.241.081.018.269", "PA": "Calcium Chelating Agents", "MH_TH": "USAN (1983)", "ST": "T130", "N1": "6,9-Dioxa-3,12-diazatetradecanedioic acid, 3,12-bis(carboxymethyl)-", "RN": "526U7A2651", "RR": "67-42-5 (Egtazic Acid)", "PI": "Glycols (1969-1974)", "MS": "A chelating agent relatively more specific for calcium and less toxic than EDETIC ACID.", "OL": "use EGTAZIC ACID to search EGTA 1975-91", "PM": "92; was EGTA 1975-91 (see under ETHYLENE GLYCOLS 1975-86)", "HN": "92; was EGTA 1975-91 (see under ETHYLENE GLYCOLS 1975-86)", "MR": "20140617", "DA": "19741111", "DC": "1", "DX": "19870101", "UI": "D004533"}, {"RECTYPE": "D", "MH": "Egypt", "AQ": "EH EP", "PRINT ENTRY": "United Arab Republic|T083|NAM|BRD|NLM (1976)|750101|abcdef", "MN": "Z01.058.266.317", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "ANCIENT EGYPT is also available", "MS": "A country in northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip, and the Red Sea north of Sudan, and includes the Asian Sinai Peninsula Its capital is Cairo.", "MR": "20210630", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D004534"}, {"RECTYPE": "D", "MH": "Ehlers-Danlos Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cutis Elastica|T047|NON|EQV|NLM (1993)|920330|abcdef", "ENTRY": "Syndrome, Ehlers-Danlos", "MN": "C17.800.827.260", "FX": "Reticulin", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004535"}, {"RECTYPE": "D", "MH": "Ehrlichia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Ehrlichia ewingii|T007|NON|NRW|NLM (2003)|020529|abcdef", "MN": "B03.660.050.783.500.287", "MH_TH": "NLM (1973)", "ST": "T007", "RN": "txid943", "RR": "txid947", "MS": "Small, often pleomorphic, coccoid to ellipsoidal organisms occurring intracytoplasmically in circulating LYMPHOCYTES. They are the etiologic agents of tick-borne diseases of humans; DOGS; CATTLE; SHEEP; GOATS; and HORSES.", "PM": "91,63-65; was see under RICKETTSIACEAE 1975-90; was heading 1963-65", "HN": "91(73)63-65; was see under RICKETTSIACEAE 1973-90 (Prov 1973-75); was heading 1963-65", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004536"}, {"RECTYPE": "D", "MH": "Eicosanoic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Arachidic Acids|T109|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Acids, Eicosanoic", "MN": "D10.251.220", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "fatty acids", "PI": "Fatty Acids, Nonesterified (1968-1974)", "MS": "20-carbon saturated monocarboxylic acids.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D004537"}, {"RECTYPE": "D", "MH": "Eidetic Imagery", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Memory, Photographic|T041|NON|EQV|UNK (19XX)|780503|MEMORY PHOTOGR|abcdefv", "ENTRY": "Photographic Memories", "MN": "F02.463.593.292", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "a form of perception", "MS": "A visual image which is recalled in accurate detail. It is a sort of projection of an image on a mental screen.", "OL": "use EIDETIC IMAGERY to search PHOTOGRAPHIC MEMORY 1969-78", "HN": "PHOTOGRAPHIC MEMORY was see under EIDETIC IMAGERY 1969-78", "CATSH": "CAT LIST", "MR": "19940421", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D004538"}, {"RECTYPE": "D", "MH": "Eimeria", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Eimerias", "MN": "B01.043.075.189.250.250.250", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5800", "AN": "infection: coordinate IM with COCCIDIOSIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A genus of protozoan parasites of the subclass COCCIDIA. Various species are parasitic in the epithelial cells of the liver and intestines of man and other animals.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004539"}, {"RECTYPE": "D", "MH": "Einsteinium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.244", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Einsteinium", "RN": "WV8XL34X3O", "RR": "7429-92-7 (Einsteinium)", "MS": "A man-made radioactive actinide with atomic symbol Es, and atomic number 99. Its known isotopes range in mass number from 240-258. Its valence can be +2 or +3. Einsteinium was originally discovered in the debris from a thermonuclear explosion in 1952.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004540"}, {"RECTYPE": "D", "MH": "Eisenmenger Complex", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Eisenmenger Syndrome|T019|EPO|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Syndrome, Eisenmenger's", "MN": "C16.131.240.400.450", "MH_TH": "NLM (1966)", "ST": "T019", "MS": "A condition associated with VENTRICULAR SEPTAL DEFECT and other congenital heart defects that allow the mixing of pulmonary and systemic circulation, increase blood flow into the lung, and subsequent responses to low oxygen in blood. This complex is characterized by progressive PULMONARY HYPERTENSION; HYPERTROPHY of the RIGHT VENTRICLE; CYANOSIS; and ERYTHROCYTOSIS.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004541"}, {"RECTYPE": "D", "MH": "Ejaculation", "AQ": "DE GE IM PH RE", "ENTRY": "Ejaculations", "MN": "G08.686.784.084", "FX": "Premature Ejaculation", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "The emission of SEMEN to the exterior, resulting from the contraction of muscles surrounding the male internal urogenital ducts.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004542"}, {"RECTYPE": "D", "MH": "Ejaculatory Ducts", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ejaculatory Duct", "MN": "A05.360.444.251", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Paired ducts in the human male through which semen is ejaculated into the urethra.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004543"}, {"RECTYPE": "D", "MH": "El Salvador", "AQ": "EH EP", "MN": "Z01.107.169.339", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "A country in Central America, bordering the north Pacific Ocean, between Guatemala and Honduras. The capital is San Salvador.", "MR": "20180629", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D004544"}, {"RECTYPE": "D", "MH": "Elapid Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE TO TU UR", "PRINT ENTRY": "Naja Venoms|T123|T131|NON|NRW|UNK (19XX)|770421|abbcdef", "ENTRY": "Venoms, Sea Snake", "MN": "D23.946.833.850.325", "FX": "Elapidae", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTIVENINS", "PI": "Venoms (1966-1974)", "MS": "Venoms from snakes of the family Elapidae, including cobras, kraits, mambas, coral, tiger, and Australian snakes. The venoms contain polypeptide toxins of various kinds, cytolytic, hemolytic, and neurotoxic factors, but fewer enzymes than viper or crotalid venoms. Many of the toxins have been characterized.", "PM": "78", "HN": "78", "MR": "20200527", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D004546"}, {"RECTYPE": "D", "MH": "Elastic Tissue", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Elastic Fibers|T024|NON|NRW|NLM (2006)|050214|abcdef", "ENTRY": "Tissues, Elastic", "MN": "A10.165.400", "MH_TH": "NLM (1966)", "ST": "T024", "AN": "ELASTIC CARTILAGE is also available", "MS": "Connective tissue comprised chiefly of elastic fibers. Elastic fibers have two components: ELASTIN and MICROFIBRILS.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004547"}, {"RECTYPE": "D", "MH": "Elasticity", "AQ": "DE PH RE", "MN": "G01.374.590", "FX": "Elastic Modulus", "MH_TH": "NLM (1964)", "ST": "T070", "AN": "of inanimate or living structures", "MS": "Resistance and recovery from distortion of shape.", "PM": "67", "HN": "67(64)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004548"}, {"RECTYPE": "D", "MH": "Elastin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "kappa Elastin", "MN": "D12.776.860.300.350", "FX": "Williams Syndrome", "MH_TH": "NLM (1963)", "ST": "T024", "N1": "Elastins", "RN": "9007-58-3", "AN": "/biosyn /physiol permitted", "PM": "66", "HN": "66(63)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004549"}, {"RECTYPE": "D", "MH": "Elbow", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "MN": "A01.378.800.420", "EC": "injuries:Elbow Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "use for primates only; use FORELIMB for non-primate vertebrates; differentiate from ELBOW JOINT", "MS": "Region of the body immediately surrounding and including the ELBOW JOINT.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004550"}, {"RECTYPE": "D", "MH": "Elbow Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Joints, Elbow", "MN": "A02.835.583.290", "FX": "Olecranon Process", "EC": "injuries:Elbow Injuries", "MH_TH": "NLM (1965)", "ST": "T030", "AN": "primates only; differentiate from ELBOW; Manual 21.58: use FORELIMB (probably IM) + JOINTS (NIM) for non-primate vertebrates", "MS": "A hinge joint connecting the FOREARM to the ARM.", "PM": "65", "HN": "65", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004551"}, {"RECTYPE": "D", "MH": "Elder Abuse", "AQ": "CL DI EC EH ES HI LJ MO PC PX RH SN TD TH", "PRINT ENTRY": "Senior Neglect|T054|T055|NON|REL|NLM (2024)|230526|abbcdef", "ENTRY": "Senior Neglects", "MN": "I01.880.735.900.350.390", "MH_TH": "NLM (1984)", "ST": "T055", "PI": "Violence (1968-1983)", "MS": "Emotional, nutritional, financial, or physical maltreatment, exploitation, or abandonment of the older person generally by family members or by institutional personnel.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19830606", "DC": "1", "DX": "19840101", "UI": "D004552"}, {"RECTYPE": "D", "MH": "Electric Conductivity", "AQ": "AE CL HI TU", "ENTRY": "Conductivity, Electrical", "MN": "G01.358.500.249.277", "MH_TH": "NLM (1968)", "ST": "T081", "PI": "Electrophysiology (1966-1967)", "MS": "The ability of a substrate to allow the passage of ELECTRONS.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004553"}, {"RECTYPE": "D", "MH": "Electric Countershock", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Electroversion, Cardiac|T061|NON|EQV|IOM (1990)|890414|abcdef", "ENTRY": "Therapies, Electroversion", "MN": "E02.331.350", "FX": "Defibrillators", "MH_TH": "NLM (1963)", "ST": "T061", "AN": "/instrum: consider also DEFIBRILLATORS or DEFIBRILLATORS, IMPLANTABLE", "MS": "An electrical current applied to the HEART to terminate a CARDIAC ARRHYTHMIA.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004554"}, {"RECTYPE": "D", "MH": "Electric Fish", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Mormyridae|T013|NON|NRW|NLM (2002)|001010|abcdef", "ENTRY": "Mormyrids", "MN": "B01.050.150.900.493.378", "MH_TH": "NLM (1987)", "ST": "T013", "RR": "txid31092", "AN": "do not confuse with EEL, ELECTRIC see ELECTROPHORUS", "MS": "Fishes which generate an electric discharge. The voltage of the discharge varies from weak to strong in various groups of fish. The ELECTRIC ORGAN and electroplax are of prime interest in this group. They occur in more than one family.", "PM": "87", "HN": "87", "MR": "20200902", "DA": "19860415", "DC": "1", "DX": "19870101", "UI": "D004555"}, {"RECTYPE": "D", "MH": "Electric Injuries", "DE": "ELECTRIC INJ", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Electrocution, Accidental|T037|NON|NRW|UNK (19XX)|880408|abcdef", "ENTRY": "Injury, Electric", "MN": "C26.324", "MH_TH": "NLM (1973)", "ST": "T037", "AN": "consider also BURNS, ELECTRIC; accidental shock by electricity is ELECTRIC INJURIES, not ELECTROSHOCK (for exper shock by electricity usually in psychol lit)", "MS": "Injuries caused by electric currents. The concept excludes electric burns (BURNS, ELECTRIC), but includes accidental electrocution and electric shock.", "OL": "use ELECTRIC INJURIES to search ELECTRIC INJURY 1966-72", "PM": "73; was ELECTRIC INJURY 1963-72", "HN": "73; was ELECTRIC INJURY 1963-72", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004556"}, {"RECTYPE": "D", "MH": "Electric Organ", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Organs, Electric", "MN": "A13.332", "MH_TH": "NLM (1963)", "ST": "T032", "AN": "animal only; IM", "MS": "In about 250 species of electric fishes, modified muscle fibers forming disklike multinucleate plates arranged in stacks like batteries in series and embedded in a gelatinous matrix. A large torpedo ray may have half a million plates. Muscles in different parts of the body may be modified, i.e., the trunk and tail in the electric eel, the hyobranchial apparatus in the electric ray, and extrinsic eye muscles in the stargazers. Powerful electric organs emit pulses in brief bursts several times a second. They serve to stun prey and ward off predators. A large torpedo ray can produce of shock of more than 200 volts, capable of stunning a human. (Storer et al., General Zoology, 6th ed, p672)", "PM": "68", "HN": "68(63)", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004557"}, {"RECTYPE": "D", "MH": "Electric Stimulation", "AQ": "AE IS MT", "PRINT ENTRY": "Stimulation, Electric|T059|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Stimulations, Electrical", "MN": "E05.723.402", "FX": "Electroshock", "MH_TH": "NLM (1964)", "ST": "T059", "MS": "Use of electric potential or currents to elicit biological responses.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004558"}, {"RECTYPE": "D", "MH": "Electric Wiring", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Wiring, Electrical", "MN": "E07.305.245", "MH_TH": "NLM (1977)", "ST": "T073", "MS": "An arrangement of wires distributing electricity.", "PM": "91; was see under ELECTRICITY Aug 1977-90", "HN": "91(Aug 77); was see under ELECTRICITY 1977-90", "MR": "20080708", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D004559"}, {"RECTYPE": "D", "MH": "Electricity", "AQ": "AE HI", "MN": "G01.358.500.249", "FX": "Lightning", "EC": "therapeutic use:Electric Stimulation Therapy", "MH_TH": "NLM (1966)", "ST": "T070", "MS": "The physical effects involving the presence of electric charges at rest and in motion.", "HN": "was in Cat H only 1963-81", "MR": "20150331", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D004560"}, {"RECTYPE": "D", "MH": "Transcutaneous Electric Nerve Stimulation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Transdermal Electrostimulation|T061|NON|EQV|UNK (19XX)|830613|abcdef", "ENTRY": "Transcutaneous Electrical Stimulation", "MN": "E03.091.823", "FX": "Transcranial Direct Current Stimulation", "MH_TH": "NLM (1984)", "ST": "T061", "AN": "do not confuse with ELECTRONARCOSIS", "PI": "Electric Stimulation Therapy (1966-1983)", "MS": "The use of specifically placed small electrodes to deliver electrical impulses across the SKIN to relieve PAIN. It is used less frequently to produce ANESTHESIA.", "PM": "1990; was ELECTROANALGESIA see under ELECTROTHERAPY l984-1989", "HN": "1990; use ELECTROTHERAPY 1984-1989", "CATSH": "CAT LIST", "MR": "20210304", "DA": "19830613", "DC": "1", "DX": "19900101", "UI": "D004561"}, {"RECTYPE": "D", "MH": "Electrocardiography", "DE": "ELECTROCARDIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "EKG|T060|ABB|EQV|UNK (19XX)|880607|abcdef", "ENTRY": "Electrocardiography, 12-Lead", "MN": "E01.370.405.240", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY.", "CATSH": "CAT LIST", "MR": "20230615", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004562"}, {"RECTYPE": "D", "MH": "Electrochemistry", "DE": "ELECTROCHEM", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Electrochemistries", "MN": "H01.181.529.307", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "NIM with no qualif; when IM, SPEC qualif", "MS": "The study of chemical changes resulting from electrical action and electrical activity resulting from chemical changes.", "PM": "66", "HN": "66", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004563"}, {"RECTYPE": "D", "MH": "Electrocoagulation", "DE": "ELECTROCOAG", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Thermocoagulation|T061|NON|EQV|UNK (19XX)|880412|THERMOCOAG|abcdefv", "ENTRY": "Fulguration, Endocavitary", "MN": "E04.014.170.402", "MH_TH": "POPLINE (1978)", "ST": "T061", "AN": "coordinate with organ or disease /surg", "MS": "Procedures using an electrically heated wire or scalpel to treat hemorrhage (e.g., bleeding ulcers) and to ablate tumors, mucosal lesions, and refractory arrhythmias. It is different from ELECTROSURGERY which is used more for cutting tissue than destroying and in which the patient is part of the electric circuit.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004564"}, {"RECTYPE": "D", "MH": "Electroconvulsive Therapy", "DE": "ELECTROCONVULSIVE THER", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Shock Therapy, Electric|T061|NON|EQV|BIOETHICS (1989)|800509|SHOCK THER ELECTRIC|abcdefv", "ENTRY": "Therapy, Electroshock", "MN": "F04.669.224.300", "MH_TH": "BIOETHICS (1989)", "ST": "T061", "AN": "a psychotherapy technique: do not confuse with ELECTROCONVULSIVE SHOCK, an experimental tool", "MS": "Electrically induced CONVULSIONS primarily used in the treatment of severe AFFECTIVE DISORDERS and SCHIZOPHRENIA.", "OL": "use ELECTROCONVULSIVE THERAPY to search SHOCK THERAPY, ELECTRIC 1966-80 & ELECTROCONVULSIVE SHOCK 1966-67", "PM": "81; was SHOCK THERAPY, ELECTRIC 1963-80; ELECTROCONVULSIVE SHOCK was heading 1966-67", "HN": "81; was SHOCK THERAPY, ELECTRIC 1963-80; ELECTROCONVULSIVE SHOCK was heading 1966-67", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D004565"}, {"RECTYPE": "D", "MH": "Electrodes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Cathode Materials|T073|NON|REL|NLM (2021)|191122|abcdef", "ENTRY": "Material, Cathode", "MN": "E07.305.250", "MH_TH": "NLM (1968)", "ST": "T073", "AN": "NIM", "PI": "Equipment and Supplies (1966-1967)", "MS": "Electric conductors through which electric currents enter or leave a medium, whether it be an electrolytic solution, solid, molten mass, gas, or vacuum.", "PM": "72", "HN": "72(68)", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D004566"}, {"RECTYPE": "D", "MH": "Electrodes, Implanted", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Stimulation Electrodes, Implanted", "MN": "E07.695.202", "MH_TH": "NLM (1971)", "ST": "T073", "PI": "Electrodes (1968-1970)", "MS": "Surgically placed electric conductors through which ELECTRIC STIMULATION is delivered to or electrical activity is recorded from a specific point inside the body.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004567"}, {"RECTYPE": "D", "MH": "Electrodiagnosis", "DE": "ELECTRODIAG", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Electrodiagnoses", "MN": "E01.370.405", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Diagnosis of disease states by recording the spontaneous electrical activity of tissues or organs or by the response to stimulation of electrically excitable tissue.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004568"}, {"RECTYPE": "D", "MH": "Electroencephalography", "DE": "ELECTROENCEPHALOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "EEG|T060|ABB|EQV|UNK (19XX)|880607|abcdef", "ENTRY": "Electroencephalograms", "MN": "E01.370.405.245", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004569"}, {"RECTYPE": "D", "MH": "Electrogalvanism, Intraoral", "PRINT ENTRY": "Galvanism, Oral|T061|NON|EQV|UNK (19XX)|840406|abcdef", "ENTRY": "Oral Galvanisms", "MN": "E06.377", "MH_TH": "NLM (1972)", "ST": "T061", "MS": "Chemical reaction that occurs when saliva comes into contact with the metals in dental fillings. This reaction can send electric currents through the brain causing negative symptoms.", "OL": "use ELECTROGALVANISM, INTRAORAL to search ELECTROGALVANISM 1966-71", "PM": "72; was ELECTROGALVANISM 1965-71", "HN": "72; was ELECTROGALVANISM 1965-71", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D004570"}, {"RECTYPE": "D", "MH": "Electrokymography", "DE": "ELECTROKYMOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Roentgenkymography|T060|NON|EQV|UNK (19XX)|740330|ROENTGENKYMOGR|abcdefv", "ENTRY": "Roentgenkymographies", "MN": "E01.370.475.200", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Radiographic technique combining a photoelectric recording system with fluoroscopy. It is used especially with electrocardiography to study heart motion.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004571"}, {"RECTYPE": "D", "MH": "Electrolysis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Electrolyses", "MN": "E05.301.250", "MH_TH": "NLM (1966)", "ST": "T067", "MS": "Destruction by passage of a galvanic electric current, as in disintegration of a chemical compound in solution.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004572"}, {"RECTYPE": "D", "MH": "Electrolytes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Electrolyte|T197|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D01.248", "FX": "Water-Electrolyte Imbalance", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics; /ther use: consider also ORAL REHYDRATION THERAPY see FLUID THERAPY", "MS": "Substances that dissociate into two or more ions, to some extent, in water. Solutions of electrolytes thus conduct an electric current and can be decomposed by it (ELECTROLYSIS). (Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004573"}, {"RECTYPE": "D", "MH": "Electromagnetic Fields", "AQ": "AE", "ENTRY": "Fields, Electromagnetic", "MN": "G01.358.750.500", "EC": "therapeutic use:Magnetic Field Therapy", "MH_TH": "NLM (1975)", "ST": "T070", "MS": "Fields representing the joint interplay of electric and magnetic forces.", "PM": "91; was see under ELECTROMAGNETICS 1975-90", "HN": "91(75); was see under ELECTROMAGNETICS 1975-90", "MR": "20110624", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004574"}, {"RECTYPE": "D", "MH": "Electromyography", "DE": "ELECTROMYOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Surface Electromyographies", "MN": "E01.370.530.255", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Recording of the changes in electric potential of muscle by means of surface or needle electrodes.", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004576"}, {"RECTYPE": "D", "MH": "Electron Probe Microanalysis", "DE": "ELECTRON PROBE MICROANAL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "X-Ray Microanalysis, Electron Probe|T059|NON|EQV|UNK (19XX)|800512|X RAY MICROANAL ELECTRON PROBE|abcdefv", "ENTRY": "X Ray Microanalysis, Electron Probe", "MN": "E05.799.830.360", "FX": "Nuclear Microscopy", "MH_TH": "NLM (1967)", "ST": "T059", "PI": "Spectrum Analysis (1966)", "MS": "Identification and measurement of ELEMENTS and their location based on the fact that X-RAYS emitted by an element excited by an electron beam have a wavelength characteristic of that element and an intensity related to its concentration. It is performed with an electron microscope fitted with an x-ray spectrometer, in scanning or transmission mode.", "PM": "70", "HN": "70(67)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D004577"}, {"RECTYPE": "D", "MH": "Electron Spin Resonance Spectroscopy", "AQ": "AE CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Paramagnetic Resonance|T059|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Resonance, Paramagnetic", "MN": "E05.196.867.519.274", "FX": "Spin Trapping", "MH_TH": "NLM (1964)", "ST": "T059", "AN": "usually NIM", "MS": "A technique applicable to the wide variety of substances which exhibit paramagnetism because of the magnetic moments of unpaired electrons. The spectra are useful for detection and identification, for determination of electron structure, for study of interactions between molecules, and for measurement of nuclear spins and moments. (From McGraw-Hill Encyclopedia of Science and Technology, 7th edition) Electron nuclear double resonance (ENDOR) spectroscopy is a variant of the technique which can give enhanced resolution. Electron spin resonance analysis can now be used in vivo, including imaging applications such as MAGNETIC RESONANCE IMAGING.", "OL": "use ELECTRON SPIN RESONANCE SPECTROSCOPY to search ELECTRON SPIN RESONANCE 1966-93", "PM": "94; was ELECTRON SPIN RESONANCE 1966-93", "HN": "94; was ELECTRON SPIN RESONANCE 1966-93 (Prov 1964-66)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004578"}, {"RECTYPE": "D", "MH": "Electron Transport", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Respiratory Chain|T044|NON|REL|NLM (1993)|911106|abcdef", "ENTRY": "Transport, Electron", "MN": "G03.493.350", "MH_TH": "NLM (1964)", "ST": "T044", "MS": "The process by which ELECTRONS are transported from a reduced substrate to molecular OXYGEN. (From Bennington, Saunders Dictionary and Encyclopedia of Laboratory Medicine and Technology, 1984, p270)", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004579"}, {"RECTYPE": "D", "MH": "Electronarcosis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Electrosleep|T061|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Electronarcoses", "MN": "E03.340", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "do not confuse with ELECTROANALGESIA ", "MS": "Profound stupor produced by passing an electric current through the brain.", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004580"}, {"RECTYPE": "D", "MH": "Electronics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Electronic", "MN": "H01.671.293", "FX": "Electrical Equipment and Supplies", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "The study, control, and application of the conduction of ELECTRICITY through gases or vacuum, or through semiconducting or conducting materials. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004581"}, {"RECTYPE": "D", "MH": "Electronics, Medical", "DE": "ELECTRONICS MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medical Electronics|T091|NON|EQV|NLM (1991)|891129|MED ELECTRONICS|abcdefv", "MN": "H01.671.293.319", "MH_TH": "NLM (1968)", "ST": "T091", "AN": "use for the discipline (education, history, etc) only", "PI": "Electronics (1966-1967)", "MS": "The research and development of ELECTRICAL EQUIPMENT AND SUPPLIES for such medical applications as diagnosis, therapy, research, anesthesia control, cardiac control, and surgery. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "68", "HN": "68", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004582"}, {"RECTYPE": "D", "MH": "Electrons", "AQ": "AE CL HI TU", "PRINT ENTRY": "Positrons|T081|NON|REL|UNK (19XX)|840302|abcdef", "ENTRY": "Positron", "MN": "G01.358.500.750", "FX": "Beta Particles", "MH_TH": "NLM (1966)", "ST": "T081", "AN": "elementary particles; IM", "MS": "Stable elementary particles having the smallest known negative charge, present in all elements; also called negatrons. Positively charged electrons are called positrons. The numbers, energies and arrangement of electrons around atomic nuclei determine the chemical identities of elements. Beams of electrons are called CATHODE RAYS.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004583"}, {"RECTYPE": "D", "MH": "Electronystagmography", "DE": "ELECTRONYSTAGMOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Electronystagmographies", "MN": "E01.370.405.312.280", "MH_TH": "NLM (1975)", "ST": "T060", "PI": "Electrooculography (1973-1974)", "MS": "Recording of nystagmus based on changes in the electrical field surrounding the eye produced by the difference in potential between the cornea and the retina.", "OL": "search ELECTROOCULOGRAPHY 1973-74", "PM": "79; was see under ELECTROOCULOGRAPHY 1973-78", "HN": "79(75); was see under ELECTROOCULOGRAPHY 1973-78", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D004584"}, {"RECTYPE": "D", "MH": "Electrooculography", "DE": "ELECTROOCULOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "EOG|T060|ABB|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Electrooculogram", "MN": "E01.370.405.312.285", "MH_TH": "NLM (1964)", "ST": "T060", "MS": "Recording of the average amplitude of the resting potential arising between the cornea and the retina in light and dark adaptation as the eyes turn a standard distance to the right and the left. The increase in potential with light adaptation is used to evaluate the condition of the retinal pigment epithelium.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004585"}, {"RECTYPE": "D", "MH": "Electrophoresis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Electrophoreses", "MN": "E05.301.300", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "general or unspecified; prefer specifics", "MS": "An electrochemical process in which macromolecules or colloidal particles with a net electric charge migrate in a solution under the influence of an electric current.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004586"}, {"RECTYPE": "D", "MH": "Electrophoresis, Agar Gel", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Electrophoresis, Agarose Gel|T059|NON|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "Gel Electrophoresis, Agarose", "MN": "E05.301.300.100", "MH_TH": "NLM (1975)", "ST": "T059", "AN": "NIM", "MS": "Electrophoresis in which agar or agarose gel is used as the diffusion medium.", "PM": "91; was see under ELECTROPHORESIS 1975-90", "HN": "91(75); was see under ELECTROPHORESIS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004587"}, {"RECTYPE": "D", "MH": "Electrophoresis, Cellulose Acetate", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Electrophoreses, Cellulose Acetate", "MN": "E05.301.300.200", "MH_TH": "NLM (1975)", "ST": "T059", "AN": "NIM", "MS": "Electrophoresis in which cellulose acetate is the diffusion medium.", "PM": "91; was see under ELECTROPHORESIS 1975-90", "HN": "91(75); was see under ELECTROPHORESIS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004588"}, {"RECTYPE": "D", "MH": "Electrophoresis, Disc", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Disk Electrophoresis", "MN": "E05.301.300.319.403", "MH_TH": "NLM (1970)", "ST": "T059", "AN": "disc stands for \"discontinous\"; NIM", "PI": "Electrophoresis (1966)", "MS": "Electrophoresis in which discontinuities in both the voltage and pH gradients are introduced by using buffers of different composition and pH in the different parts of the gel column. The term 'disc' was originally used as an abbreviation for 'discontinuous' referring to the buffers employed, and does not have anything to do with the shape of the separated zones.", "OL": "use ELECTROPHORESIS, DISC to search ELECTROPHORESIS, DISK 1967-73 (as Prov 1967-69)", "PM": "91,74-84; was see under ELECTROPHORESIS, POLYACRYLAMIDE GEL 1985-91; was heading 1974-84; was ELECTROPHORESIS, DISK 1970-73", "HN": "91(85)74(67); was see under ELECTROPHORESIS, POLYACRYLAMIDE GEL 1985-91; was heading 1974-84; was ELECTROPHORESIS, DISK 1967-73 (Prov 1967-69)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D004589"}, {"RECTYPE": "D", "MH": "Electrophoresis, Paper", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Paper Electrophoresis", "MN": "E05.301.300.236", "MH_TH": "NLM (1973)", "ST": "T059", "AN": "NIM", "PI": "Electrophoresis (1966-1970)", "MS": "Electrophoresis in which paper is used as the diffusion medium. This technique is confined almost entirely to separations of small molecules such as amino acids, peptides, and nucleotides, and relatively high voltages are nearly always used.", "PM": "91,73-86; was see under ELECTROPHORESIS 1987-90; was heading 1973-86", "HN": "91(87)73(71); was see under ELECTROPHORESIS 1987-90; was heading 1971-86 (Prov 1971-73)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004590"}, {"RECTYPE": "D", "MH": "Electrophoresis, Polyacrylamide Gel", "DE": "E PAG", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Sodium Dodecyl Sulfate-PAGE|T059|T062|NON|NRW|NLM (1999)|980401|abbcdef", "ENTRY": "Sodium Dodecyl Sulfate-PAGEs", "MN": "E05.301.300.319", "MH_TH": "NLM (1973)", "ST": "T062", "PI": "Electrophoresis, Disc (1967-1972)", "MS": "Electrophoresis in which a polyacrylamide gel is used as the diffusion medium.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004591"}, {"RECTYPE": "D", "MH": "Electrophoresis, Starch Gel", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Starch Gel Electrophoresis", "MN": "E05.301.300.402", "MH_TH": "NLM (1973)", "ST": "T059", "AN": "NIM", "PI": "Electrophoresis (1966-1969)", "MS": "Electrophoresis in which a starch gel (a mixture of amylose and amylopectin) is used as the diffusion medium.", "PM": "91,73-86; was see under ELECTROPHORESIS 1987-90; was heading 1973-86", "HN": "91(87)73(72); was see under ELECTROPHORESIS 1987-90; was heading 1972-86 (Prov 1972)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004592"}, {"RECTYPE": "D", "MH": "Electrophorus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Electric Eel|T013|NON|NRW|NLM (2002)|000814|abcdef", "ENTRY": "Electrophorus electricus|T013|NON|NRW|NLM (2002)|000814|abcdef", "MN": "B01.050.150.900.493.378.430.250", "MH_TH": "NLM (1974)", "ST": "T013", "RN": "txid8004", "RR": "txid8005", "AN": "do not confuse entry term EEL, ELECTRIC with ELECTRIC FISH", "MS": "A genus of fish, in the family GYMNOTIFORMES, capable of producing an electric shock that immobilizes fish and other prey. The species Electrophorus electricus is also known as the electric eel, though it is not a true eel.", "PM": "1974", "HN": "1974", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004593"}, {"RECTYPE": "D", "MH": "Electrophysiology", "DE": "ELECTROPHYSIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.158.782.236", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use ELECTROPHYSIOLOGICAL PHENOMENA or specifics treed under it for electrical properties and processes of organisms; methods: consider ELECTRODIAGNOSIS or specfics treed under it; DF: ELECTROPHYSIOL", "MS": "The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.", "CATSH": "CAT LIST", "MR": "20140617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004594"}, {"RECTYPE": "D", "MH": "Electroplating", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Metal Plating|T070|NON|EQV|UNK (19XX)|840529|abcdef", "ENTRY": "Plating, Metal", "MN": "E05.301.250.348", "MH_TH": "NLM (1985)", "ST": "T070", "PI": "Metallurgy (1966-1984)", "MS": "Coating with a metal or alloy by electrolysis.", "PM": "91; was see under ELECTROLYSIS 1985-90", "HN": "91(85); was see under ELECTROLYSIS 1985-90", "MR": "20080708", "DA": "19840529", "DC": "1", "DX": "19910101", "UI": "D004595"}, {"RECTYPE": "D", "MH": "Electroretinography", "DE": "ELECTRORETINOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Electroretinographies", "MN": "E01.370.405.270", "FX": "Retina", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Recording of electric potentials in the retina after stimulation by light.", "CATSH": "CAT LIST", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004596"}, {"RECTYPE": "D", "MH": "Electroshock", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Electroconvulsive Shock|T062|NON|EQV|NLM (1998)|960726|abcdef", "ENTRY": "Shocks, Electroconvulsive", "MN": "F04.669.224", "MH_TH": "NLM (1964)", "ST": "T062", "MS": "Induction of a stress reaction in experimental subjects by means of an electrical shock; applies to either convulsive or non-convulsive states.", "OL": "search ELECTROCONVULSIVE SHOCK under SHOCK THERAPY, ELECTRIC 1966-67", "PM": "68; ELECTROCONVULSIVE SHOCK was heading 1966-67", "HN": "68(64); ELECTROCONVULSIVE SHOCK was heading 1966-67", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004597"}, {"RECTYPE": "D", "MH": "Electrosurgery", "DE": "ELECTROSURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Electrosurgeries", "MN": "E04.262", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Division of tissues by a high-frequency current applied locally with a metal instrument or needle. (Stedman, 25th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19950313", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004598"}, {"RECTYPE": "D", "MH": "Electric Stimulation Therapy", "DE": "ELECTRIC STIMULATION THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Electrotherapy|T061|NON|EQV|NLM (1990)|890206|ELECTROTHER|abcdefv", "ENTRY": "Therapy, Electrical Stimulation", "MN": "E02.831.535.468", "FX": "Magnetic Field Therapy", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Application of electric current in treatment without the generation of perceptible heat. It includes electric stimulation of nerves or muscles, passage of current into the body, or use of interrupted current of low intensity to raise the detection threshold of the skin to pain.", "OL": "use ELECTRIC STIMULATION THERAPY to search ELECTROTHERAPY 1966-89", "PM": "90; was ELECTROTHERAPY 1966-89", "HN": "90; was ELECTROTHERAPY 1966-89", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D004599"}, {"RECTYPE": "D", "MH": "Eledoisin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.946.833.590.325", "PA": "Neurotransmitter Agents", "MH_TH": "NLM (1963)", "ST": "T131", "RN": "69-25-0", "MS": "A peptide extracted from the posterior salivary glands of certain small octopi (Eledone spp., Mollusca), or obtained by synthesis. Its actions resemble those of SUBSTANCE P; it is a potent vasodilator and increases capillary permeability. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1364)", "PM": "65", "HN": "65(63)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004600"}, {"RECTYPE": "D", "MH": "Elementary Particles", "AQ": "AE CL HI TU", "PRINT ENTRY": "Fundamental Particles|T081|NON|EQV|UNK (19XX)|840223|abcdef", "ENTRY": "Particles, Fundamental", "MN": "G01.249", "MH_TH": "NLM (1971)", "ST": "T081", "AN": "IM; includes nucleons, quarks, gluons, neutrinos, strange particles, antiparticles", "PI": "Nuclear Physics (1966-1970)", "MS": "Individual components of atoms, usually subatomic; subnuclear particles are usually detected only when the atomic nucleus decays and then only transiently, as most of them are unstable, often yielding pure energy without substance, i.e., radiation.", "OL": "use ELEMENTARY PARTICLES to search BARYONS 1975-84", "PM": "75; BARYONS was heading 1975-84", "HN": "75(71); BARYONS was heading 1975-84", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D004601"}, {"RECTYPE": "D", "MH": "Elements", "PRINT ENTRY": "Element|T196|NON|EQV|NLM (2021)|191118|abcdef", "MN": "D01.268", "FX": "Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Substances that comprise all matter. Each element is made up of atoms that are identical in number of electrons and protons and in nuclear charge but may differ in mass or number of neutrons.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004602"}, {"RECTYPE": "D", "MH": "Elements, Radioactive", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "PRINT ENTRY": "Radioactive Elements|T196|NON|EQV|NLM (1998)|961217|abcdef", "MN": "D01.496.749.305", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Unstable elements with atomic numbers greater than 83 that exist in nature solely as radioisotopes.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004603"}, {"RECTYPE": "D", "MH": "Elephantiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "foots, Mossy", "MN": "C15.604.496.320", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "ELEPHANTIASIS, FILARIAL is also available", "MS": "Hypertrophy and thickening of tissues from causes other than filarial infection, the latter being described as ELEPHANTIASIS, FILARIAL.", "OL": "search FILARIASIS & LYMPHEDEMA 1966-74", "PM": "91; was see under LYMPHEDEMA 1975-90; was see FILARIASIS & LYMPHEDEMA 1963-74", "HN": "91(75); was see under LYMPHEDEMA 1975-90; was see FILARIASIS & LYMPHEDEMA 1963-74", "CATSH": "CAT LIST", "MR": "20121204", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004604"}, {"RECTYPE": "D", "MH": "Elephantiasis, Filarial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Wuchereria bancrofti Infection|T047|NON|NRW|NLM (2024)|230601|abcdef", "ENTRY": "Wuchereria bancrofti Infections", "MN": "C15.604.496.490", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent; coordinate with BRUGIA MALAYI or WUCHERERIA BANCROFTI if pertinent", "PI": "Filariasis (1966-1986)", "MS": "Parasitic infestation of the human lymphatic system by WUCHERERIA BANCROFTI or BRUGIA MALAYI. It is also called lymphatic filariasis.", "PM": "91; was see under FILARIASIS 1988-90; was see under LYMPHEDEMA 1987", "HN": "91(87); was see under FILARIASIS 1988-90; was see under LYMPHEDEMA 1987", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19860327", "DC": "1", "DX": "19910101", "UI": "D004605"}, {"RECTYPE": "D", "MH": "Elephants", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Elephants, Asiatic", "MN": "B01.050.150.900.649.313.250.500.249", "MH_TH": "NLM (1966)", "ST": "T015", "RR": "txid9784", "MS": "Large mammals in the family Elephantidae, with columnar limbs, bulky bodies, and elongated snouts. They are the only surviving members of the PROBOSCIDEA MAMMALS.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004606"}, {"RECTYPE": "D", "MH": "Elevators and Escalators", "DE": "ELEVATORS ESCALATORS", "AQ": "CL EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Escalators|T073|NON|NRW|UNK (19XX)|770505|abcdef", "ENTRY": "Escalators and Elevators", "MN": "J01.086.339.115", "MH_TH": "NLM (1977)", "ST": "T073", "MS": "Mechanical ascending and descending devices which convey objects and/or people.", "PM": "91; was see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-90", "HN": "91(Aug 77); was see under FACILITY DESIGN AND CONSTRUCTION 1977-90", "MR": "19920515", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D004607"}, {"RECTYPE": "D", "MH": "Eligibility Determination", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Eligibility Determinations", "MN": "N04.452.264", "FX": "Disability Evaluation", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "note entry term ELIGIBILITY CERTIFICATION: CERTIFICATION is also available", "PI": "Patients (1966-1967)", "MS": "Criteria to determine eligibility of patients for medical care programs and services.", "PM": "68", "HN": "68", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004608"}, {"RECTYPE": "D", "MH": "Eliminative Behavior, Animal", "AQ": "CL DE ES PH RE", "ENTRY": "Eliminative Behaviors, Animal", "MN": "F01.145.113.367", "MH_TH": "NLM (1975)", "ST": "T055", "AN": "elimination of urine or feces", "MS": "Behavior associated with the elimination of feces and urine from the body.", "OL": "use ELIMINATIVE BEHAVIOR, ANIMAL to search ELIMINATIVE BEHAVIOR 1975-78; use BEHAVIOR, ANIMAL 1968-74", "PM": "91; was see under BEHAVIOR, ANIMAL 1979-90; was ELIMINATIVE BEHAVIOR see under BEHAVIOR, ANIMAL 1968-78", "HN": "91(79); was see under BEHAVIOR, ANIMAL 1979-90; was ELIMINATIVE BEHAVIOR see under BEHAVIOR, ANIMAL 1968-78", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004609"}, {"RECTYPE": "D", "MH": "Ellagic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzoaric Acid|T109|T121|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Acid, Ellagic", "MN": "D03.633.100.150.500", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "(1)Benzopyrano(5,4,3-cde)(1)benzopyran-5,10-dione, 2,3,7,8-tetrahydroxy-", "RN": "19YRN3ZS9P", "RR": "476-66-4 (Ellagic Acid)", "PI": "Benzopyrans (1969-1974)", "MS": "A fused four ring compound occurring free or combined in galls. Isolated from the kino of Eucalyptus maculata Hook and E. Hemipholia F. Muell. Activates Factor XII of the blood clotting system which also causes kinin release; used in research and as a dye.", "PM": "91; was see under BENZOPYRANS 1975-90", "HN": "91(75); was see under BENZOPYRANS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004610"}, {"RECTYPE": "D", "MH": "Ellipticines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.633.300.148.249", "PA": "Immunosuppressive Agents", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Pyridines (1972-1974)", "MS": "Pyrido-CARBAZOLES originally discovered in the bark of OCHROSIA ELLIPTICA. They inhibit DNA and RNA synthesis and have immunosuppressive properties.", "PM": "91; was see under ALKALOIDS 1975-90", "HN": "91(75); was see under ALKALOIDS 1975-90", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004611"}, {"RECTYPE": "D", "MH": "Elliptocytosis, Hereditary", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ovalocytosis, Hereditary|T047|NON|EQV|UNK (19XX)|810520|abcdef", "ENTRY": "Ovalocytoses, Hereditary", "MN": "C16.320.070.365", "FX": "Anemia, Sideroblastic", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "a congen hemolytic anemia; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "An intrinsic defect of erythrocytes inherited as an autosomal dominant trait. The erythrocytes assume an oval or elliptical shape.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004612"}, {"RECTYPE": "D", "MH": "Ellis-Van Creveld Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chondroectodermal Dysplasia|T047|NON|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|740330|abcdeeeef", "ENTRY": "Syndrome, Ellis-Van Creveld", "MN": "C17.800.827.250.398", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Dwarfism occurring in association with defective development of skin, hair, and teeth, polydactyly, and defect of the cardiac septum. (Dorland, 27th ed)", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004613"}, {"RECTYPE": "D", "MH": "Emaciation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Emaciations", "MN": "C23.888.144.828.500", "FX": "Wasting Syndrome", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Clinical manifestation of excessive LEANNESS usually caused by disease or a lack of nutrition (MALNUTRITION).", "CATSH": "CAT LIST", "MR": "20220520", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004614"}, {"RECTYPE": "D", "MH": "Embalming", "AQ": "EC ES HI LJ MT SN ST", "ENTRY": "Embalmings", "MN": "I01.076.201.450.550.250", "FX": "Mummies", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "Process of preserving a dead body to protect it from decay.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004615"}, {"RECTYPE": "D", "MH": "Emblems and Insignia", "DE": "EMBLEMS INSIGNIA", "AQ": "CL HI LJ", "PRINT ENTRY": "Insignia|T073|NON|NRW|UNK (19XX)|770512|abcdef", "ENTRY": "Banners and Flags", "MN": "K01.400.255", "FX": "Genealogy and Heraldry", "MH_TH": "NLM (1978)", "ST": "T073", "MS": "Figures or symbols identifying or representing organizations or societies.", "PM": "78; CADUCEUS was see under HISTORY OF MEDICINE 1975-77; INSIGNIA AND DECORATIONS was heading 1963-65", "HN": "78; CADUCEUS was see under HISTORY OF MEDICINE 1975-77, was Prov 1966-74; INSIGNIA AND DECORATIONS was heading 1963-65", "MR": "20190507", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D004616"}, {"RECTYPE": "D", "MH": "Embolism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Embolus|T020|NON|REL|NLM (1993)|911024|abcdef", "ENTRY": "Embolisms", "MN": "C14.907.355.350", "FX": "Embolectomy", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "general; prefer specifics; coordinate with specific blood vessel", "MS": "Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004617"}, {"RECTYPE": "D", "MH": "Embolism, Air", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Embolism, Gas|T037|T047|NON|EQV|UNK (19XX)|850311|abbcdef", "ENTRY": "Gas Embolisms", "MN": "C14.907.355.350.254", "FX": "Decompression Sickness", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Blocking of a blood vessel by air bubbles that enter the circulatory system, usually after TRAUMA; surgical procedures, or changes in atmospheric pressure.", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004618"}, {"RECTYPE": "D", "MH": "Embolism, Amniotic Fluid", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Embolisms, Amniotic Fluid", "MN": "C14.907.355.350.354", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Blocking of maternal circulation by AMNIOTIC FLUID that is forced into uterine VEINS by strong UTERINE CONTRACTION near the end of pregnancy. It is characterized by the sudden onset of severe respiratory distress and HYPOTENSION that can lead to maternal DEATH.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004619"}, {"RECTYPE": "D", "MH": "Embolism, Fat", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fat Embolisms", "MN": "C14.907.355.350.454", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with EMBOLISM, CHOLESTEROL", "MS": "Blocking of a blood vessel by fat deposits in the circulation. It is often seen after fractures of large bones or after administration of CORTICOSTEROIDS.", "CATSH": "CAT LIST", "MR": "20160226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004620"}, {"RECTYPE": "D", "MH": "Embolization, Therapeutic", "DE": "EMBOLIZATION THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Embolotherapy|T061|NON|EQV|NLM (1998)|970408|abcdef", "ENTRY": "Therapeutic Embolizations", "MN": "E02.926.500", "MH_TH": "NLM (1976)", "ST": "T061", "AN": "coord IM with disease /ther (IM), not /surg", "PI": "specific heading/therapy (1966-1975)", "MS": "A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D004621"}, {"RECTYPE": "D", "MH": "Embryo, Mammalian", "AQ": "AB AH BS CH CY DE DG EM EN IM IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Embryonic Structures, Mammalian|T018|NON|REL|NLM (2010)|090218|abcdef", "ENTRY": "Structures, Mammalian Embryonic", "MN": "A16.254", "FX": "Gestational Age", "EC": "transplantation:Embryo Transfer", "MH_TH": "NLM (2008)", "ST": "T018", "AN": "human: 0-2 months; use for mammalian embryo as an entity or as tissue; use the qualifier / embryol with an organ for embryologic aspects of that organ; embryonic tissue or cells in tissue & cell cultures: coordinate EMBRYO, MAMMALIAN + tissues or cell without qualifiers (not with / embryol) + culture term, all probably NIM; EMBRYO, NONMAMMALIAN is also available", "MS": "The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS.", "PM": "2008; see EMBRYO 1963-2007", "HN": "2008 (1963)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D004622"}, {"RECTYPE": "D", "MH": "Embryo Transfer", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tubal Embryo Transfer|T061|NON|NRW|NLM (1993)|920320|abcdef", "ENTRY": "Transfers, Embryo", "MN": "E05.820.800.500", "MH_TH": "NLM (1980)", "ST": "T062", "PI": "Embryo/transplantation (1966-1979)", "MS": "The transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO.", "PM": "1980", "HN": "1980", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19790525", "DC": "1", "DX": "19800101", "UI": "D004624"}, {"RECTYPE": "D", "MH": "Embryo, Nonmammalian", "AQ": "AB AH BS CH CY DE DG EM EN IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Embryonic Structures, Nonmammalian|T018|NON|REL|NLM (2010)|090218|abcdef", "ENTRY": "Structures, Nonmammalian Embryonic", "MN": "A16.331", "EC": "growth & development:Embryonic Development", "MH_TH": "NLM (1975)", "ST": "T018", "PI": "Embryo (1966-1974)", "MS": "The developmental entity of a fertilized egg (ZYGOTE) in animal species other than MAMMALS. For chickens, use CHICK EMBRYO.", "PM": "1975", "HN": "1975", "MR": "20090706", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D004625"}, {"RECTYPE": "D", "MH": "Embryology", "DE": "EMBRYOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Embryologies", "MN": "H01.158.273.200.350", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "the discipline (education, history, etc) only; the qualifier/ embryol is available for use with specific anatomical terms, organisms, or diseases", "MS": "The study of the development of an organism during the embryonic and fetal stages of life.", "MR": "20081208", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004626"}, {"RECTYPE": "D", "MH": "Embryonic Induction", "DE": "EMBRYONIC IND", "AQ": "DE GE IM PH RE", "ENTRY": "Inductions, Embryonic", "MN": "G08.686.784.170.104.750", "FX": "Organizers, Embryonic", "MH_TH": "NLM (1975)", "ST": "T043", "MS": "The complex processes of initiating CELL DIFFERENTIATION in the embryo. The precise regulation by cell interactions leads to diversity of cell types and specific pattern of organization (EMBRYOGENESIS).", "PM": "91; was see under CELL DIFFERENTIATION 1975-90", "HN": "91(75); was see under CELL DIFFERENTIATION 1975-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004627"}, {"RECTYPE": "D", "MH": "Embryonic Structures", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Presumptive Structures|T018|NON|REL|NLM (2024)|230419|abcdef", "ENTRY": "Structure, Presumptive", "MN": "A16", "RH": "A16 - ANATOMY-EMBRYONIC STRUCTURES", "MH_TH": "NLM (1998)", "ST": "T018", "AN": "INDEXER: Do not use", "PI": "specific organism/embryology (1975-1997)", "MS": "The anatomical parts that make up an organism in the early stages of development.", "PM": "1998; for EMBRYO see EMBRYO 1963-2007", "HN": "1998; for EMBRYO use EMBRYO, MAMMALIAN 1963-2007", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004628"}, {"RECTYPE": "D", "MH": "Emepronium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Emepronium Bromide|T109|T121|NON|NRW|BAN (19XX)|FDA SRS (2014)|INN (19XX)|741111|abbcdeeef", "ENTRY": "Bromide, Emepronium", "MN": "D02.675.276.370", "PA": "Urological Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Benzenepropanaminium, N-ethyl-N,N,alpha-trimethyl-gamma-phenyl-", "RN": "04QQ8SWA4U", "RR": "WZM699L2TL", "PI": "Benzene Derivatives (1974)", "MS": "A muscarinic antagonist used mainly in the treatment of urinary syndromes. It is incompletely absorbed from the gastrointestinal tract and does not cross the blood-brain barrier.", "PM": "91; was see under AMMONIUM COMPOUNDS 1975-90", "HN": "91(75); was see under AMMONIUM COMPOUNDS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004629"}, {"RECTYPE": "D", "MH": "Emergencies", "AQ": "CL EC EP HI NU PX VE", "ENTRY": "Emergency", "MN": "N06.850.376", "FX": "Hotlines", "MH_TH": "NLM (1966)", "ST": "T067", "AN": "EMERGENCY MEDICINE is the corresponding specialty; emergencies in specific diseases: coordinate NIM with specific disease (IM); \"drug emergencies\": coordinate NIM with specific drug or chemical with probably /pois (IM)", "MS": "Situations or conditions requiring immediate intervention to avoid serious adverse results.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004630"}, {"RECTYPE": "D", "MH": "Emergency Medical Service Communication Systems", "DE": "EMSCS", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "EMS Communication Systems|T073|T170|EQV|UNK (19XX)|790531|abbdef", "ENTRY": "Systems, EMS Communication", "MN": "N02.421.297.058", "MH_TH": "NLM (1980)", "ST": "T170", "AN": "commun between hosp & ambulance, 911 systems, emerg calling systems, etc.: do not confuse with EMERGENCY CARE INFORMATION SYSTEMS see INFORMATION SYSTEMS", "PI": "specific telecommunication (1966-1979)", "MS": "The use of communication systems, such as telecommunication, to transmit emergency information to appropriate providers of health services.", "PM": "91; was see under EMERGENCY MEDICAL SERVICES 1980-90", "HN": "91(80); was see under EMERGENCY MEDICAL SERVICES 1980-90", "MR": "20190524", "DA": "19790531", "DC": "1", "DX": "19910101", "UI": "D004631"}, {"RECTYPE": "D", "MH": "Emergency Medical Services", "DE": "EMERGENCY MED SERV", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Prehospital Emergency Care|T058|NON|NRW|UNK (19XX)|860325|PREHOSP EMERGENCY CARE|abcdefv", "ENTRY": "Services, Medical Emergency", "MN": "N02.421.297", "FX": "First Aid", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "Public Law 93-154", "PI": "First Aid (1966-1967)", "MS": "Services specifically designed, staffed, and equipped for the emergency care of patients.", "OL": "use EMERGENCY MEDICAL SERVICES to search EMERGENCY HEALTH SERVICES 1968-79", "PM": "80; was EMERGENCY HEALTH SERVICES 1968-79", "HN": "80; was EMERGENCY HEALTH SERVICES 1968-79", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004632"}, {"RECTYPE": "D", "MH": "Emergency Medical Tags", "DE": "EMERGENCY MED TAGS", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Tags, Emergency Medical|T074|NON|EQV|NLM (1991)|891129|TAGS EMERGENCY MED|abcdefv", "MN": "E07.315", "MH_TH": "NLM (1969)", "ST": "T074", "PI": "Equipment and Supplies (1966-1968)", "MS": "A bracelet or necklace worn by an individual that alerts emergency personnel of medical information for that individual which could affect their condition or treatment.", "PM": "91; was see under EQUIPMENT AND SUPPLIES 1969-90", "HN": "91(69); was see under EQUIPMENT AND SUPPLIES 1969-90", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004633"}, {"RECTYPE": "D", "MH": "Emergency Medical Technicians", "DE": "EMERGENCY MED TECHNICIANS", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Advanced Emergency Medical Technicians|T097|NON|NRW|NLM (2023)|220426|abcdef", "ENTRY": "Technicians, Emergency Medicine", "MN": "N02.360.067.150", "FX": "Paramedics", "MH_TH": "NLM (1979)", "ST": "T097", "PI": "Allied Health Personnel (1971-1978)", "MS": "Allied health personnel trained to provide basic emergency care and life support under the supervision of physicians and/or nurses. These services may be carried out at the site of the emergency, in the ambulance, or in a health care institution.", "PM": "1991; was see under ALLIED HEALTH PERSONNEL 1979-1990", "HN": "1991(1979); was see under ALLIED HEALTH PERSONNEL 1979-1990", "MR": "20220712", "DA": "19780508", "DC": "1", "DX": "19910101", "UI": "D004634"}, {"RECTYPE": "D", "MH": "Emergency Medicine", "DE": "EMERGENCY MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Emergency|T091|NON|EQV|NLM (1991)|891129|MED EMERGENCY|abcdefv", "MN": "H02.403.250", "FX": "Paramedicine", "MH_TH": "NLM (1977)", "ST": "T091", "AN": "specialty; differentiate from EMERGENCIES, the patient", "MS": "The branch of medicine concerned with the evaluation and initial treatment of urgent and emergent medical problems, such as those caused by accidents, trauma, sudden illness, poisoning, or disasters. Emergency medical care can be provided at the hospital or at sites outside the medical facility.", "PM": "77", "HN": "77", "MR": "20220712", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D004635"}, {"RECTYPE": "D", "MH": "Emergency Service, Hospital", "DE": "EMERGENCY SERV HOSP", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Hospital Emergency Services Utilization|T093|NON|NRW|NLM (2024)|230220|abcdef", "ENTRY": "Wards, Emergency", "MN": "N04.452.442.452.422.336", "FX": "Emergency Responders", "MH_TH": "NLM (1966)", "ST": "T093", "MS": "Hospital department responsible for the administration and provision of immediate medical or surgical care to the emergency patient.", "OL": "use EMERGENCY SERVICE, HOSPITAL to search HOSPITAL EMERGENCY SERVICE 1966-77", "PM": "78; was HOSPITAL EMERGENCY SERVICE 1963-77", "HN": "78; was HOSPITAL EMERGENCY SERVICE 1963-77", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D004636"}, {"RECTYPE": "D", "MH": "Emergency Services, Psychiatric", "DE": "EMERGENCY SERV PSYCHIATRIC", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Service, Psychiatric Emergency", "MN": "N02.421.297.200", "FX": "Hotlines", "MH_TH": "NLM (1976)", "ST": "T061", "PI": "Emergency Medical Services (1968-1975)", "MS": "Organized services to provide immediate psychiatric care to patients with acute psychological disturbances.", "PM": "90; was see under EMERGENCY MEDICAL SERVICES 1976-89", "HN": "90(76); was see under EMERGENCY MEDICAL SERVICES 1976-89", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19771207", "DC": "1", "DX": "19900101", "UI": "D004637"}, {"RECTYPE": "D", "MH": "Emergency Treatment", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Treatments, Emergency", "MN": "E02.365", "FX": "Emergencies", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "general or unspecified; prefer specifics; coordinate with medical condition with appropriate qualifiers ", "PI": "Emergencies (1966-1997)", "MS": "First aid or other immediate intervention for accidents or medical conditions requiring immediate care and treatment before definitive medical and surgical management can be procured.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004638"}, {"RECTYPE": "D", "MH": "Emetics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Emetic Drug|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Effects, Emetic", "MN": "D27.505.954.483.560", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "note entry term EMETIC EFFECT: use only for the emetic effect of a chemical substance", "MS": "Agents that cause vomiting. They may act directly on the gastrointestinal tract, bringing about emesis through local irritant effects, or indirectly, through their effects on the chemoreceptor trigger zone in the postremal area near the medulla.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004639"}, {"RECTYPE": "D", "MH": "Emetine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylcephaeline|T109|T121|NON|EQV|UNK (19XX)|770304|abbcdef", "ENTRY": "Hydrochloride, Emetine", "MN": "D03.633.100.531.321", "PA": "Protein Synthesis Inhibitors", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Emetan, 6',7',10,11-tetramethoxy-", "RN": "X8D5EPO80M", "RR": "U52OG12P96", "MS": "The principal alkaloid of ipecac, from the ground roots of Uragoga (or Cephaelis) ipecacuanha or U. acuminata, of the Rubiaceae. It is used as an amebicide in many different preparations and may cause serious cardiac, hepatic, or renal damage and violent diarrhea and vomiting. Emetine inhibits protein synthesis in EUKARYOTIC CELLS but not PROKARYOTIC CELLS.", "MR": "20171208", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004640"}, {"RECTYPE": "D", "MH": "Emigration and Immigration", "DE": "EMIGRATION IMMIGRATION", "AQ": "CL HI LJ SN TD", "PRINT ENTRY": "Labor Migration|T055|NON|NRW|NLM (1990)|890227|abcdef", "ENTRY": "Turnaround Migrations", "MN": "N06.850.505.400.700.525.500", "FX": "Transients and Migrants", "MH_TH": "NLM (1966)", "ST": "T052", "AN": "humans only; EMIGRANTS AND IMMIGRANTS is also available", "MS": "The process of leaving one's country to establish residence in a foreign country.", "PM": "1963; for LABOR MIGRATION see TRANSIENTS AND MIGRANTS 1990-2007", "HN": "1963; for LABOR MIGRATION use TRANSIENTS AND MIGRANTS 1990-2007", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D004641"}, {"RECTYPE": "D", "MH": "Emodin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rheum Emodin|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|790606|abbcdeef", "ENTRY": "Emodin, Rheum", "MN": "D04.615.125.380.625.353", "PA": "Protein Kinase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "9,10-Anthracenedione, 1,3,8-trihydroxy-6-methyl-", "RN": "KA46RNI6HN", "RR": "8024-48-4", "AN": "emodin from aloe goes here not under SCR term aloe emodin ", "MS": "Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as a laxative, but is now used mainly as a tool in toxicity studies.", "PM": "1991; EMODIN was indexed under ANTHRAQUINONES 1975-1990 and under CATHARTICS 1963-1974; for CASANTHRANOL was indexed under CATHARTICS 1975-1990 and see CASCARA 1991-2019", "HN": "1991(1975)", "MR": "20230607", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004642"}, {"RECTYPE": "D", "MH": "Emollients", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Emollient|T121|T122|NON|EQV|NLM (2021)|191115|abbcdef", "MN": "D27.505.954.444.200", "MH_TH": "NLM (1975)", "ST": "T122", "RN": "0", "MS": "Oleagenous substances used topically to soothe, soften or protect skin or mucous membranes. They are used also as vehicles for other dermatologic agents.", "OL": "search DERMATOLOGIC AGENTS 1967-74", "PM": "91; was see under DERMATOLOGIC AGENTS 1975-90", "HN": "91(75); was see under DERMATOLOGIC AGENTS 1975-90", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004643"}, {"RECTYPE": "D", "MH": "Emotions", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Feelings|T041|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Regrets", "MN": "F01.470", "FX": "Affective Symptoms", "MH_TH": "POPLINE (1986)", "ST": "T041", "AN": "human & animal", "MS": "Those affective states which can be experienced and have arousing and motivational properties.", "CATSH": "CAT LIST", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004644"}, {"RECTYPE": "D", "MH": "Empathy", "AQ": "CL DE ES GE PH RE", "PRINT ENTRY": "Caring|T054|T055|NON|BRD|BIOETHICS (1992)|NLM (1994)|930310|abbcdeef", "ENTRY": "Compassion|T054|NON|NRW|BIOETHICS (1994)|931129|abcdef", "MN": "F01.752.543.500.500", "MH_TH": "NLM (1971)", "ST": "T055", "PI": "Emotions (1966-1970)", "MS": "An individual's objective and insightful awareness of the feelings and behavior of another person. It should be distinguished from sympathy, which is usually nonobjective and noncritical. It includes caring, which is the demonstration of an awareness of and a concern for the good of others. (From Bioethics Thesaurus, 1992)", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D004645"}, {"RECTYPE": "D", "MH": "Emphysema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.550.325", "FX": "Pulmonary Emphysema", "MH_TH": "POPLINE (1978)", "ST": "T046", "AN": "also available are PULMONARY EMPHYSEMA; SUBCUTANEOUS EMPHYSEMA and PNEUMOMEDIASTINUM see MEDIASTINAL EMPHYSEMA", "MS": "A pathological accumulation of air in tissues or organs.", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004646"}, {"RECTYPE": "D", "MH": "Employee Discipline", "AQ": "CL EC ES HI LJ MT SN ST TD", "PRINT ENTRY": "Personnel Discipline|T057|NON|EQV|UNK (19XX)|810226|abcdef", "ENTRY": "Personnel Disciplines", "MN": "N04.452.677.358", "MH_TH": "NLM (1982)", "ST": "T057", "AN": "med or non-med personnel", "PI": "Personnel Management (1966-1981)", "MS": "Regulations or conditions imposed on employees by management in order to correct or prevent behaviors which are counterproductive to the organization.", "PM": "91; was see under PERSONNEL MANAGEMENT 1982-90", "HN": "91(82); was see under PERSONNEL MANAGEMENT 1982-90", "MR": "19940505", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D004647"}, {"RECTYPE": "D", "MH": "Employee Grievances", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Grievances, Employee|T057|NON|EQV|UNK (19XX)|780508|abcdef", "ENTRY": "Grievance, Employee", "MN": "N04.452.677.362", "MH_TH": "NLM (1977)", "ST": "T057", "AN": "med or non-med personnel", "MS": "Formal procedures whereby the employee expresses any dissatisfaction or feeling of injustice regarding the work situation.", "PM": "91; was see under PERSONNEL MANAGEMENT Aug 1977-90", "HN": "91(Aug 77); was see under PERSONNEL MANAGEMENT 1977-90", "MR": "19940505", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D004648"}, {"RECTYPE": "D", "MH": "Employee Incentive Plans", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Incentive Plans, Employee|T078|NON|EQV|UNK (19XX)|780508|abcdef", "ENTRY": "Plans, Employee Incentive", "MN": "N04.452.677.368", "MH_TH": "NLM (1979)", "ST": "T078", "AN": "med or non-med personnel", "MS": "Programs designed by management to motivate employees to work more efficiently with increased productivity, and greater employee satisfaction.", "PM": "91; was see under PERSONNEL MANAGEMENT 1979-90", "HN": "91(79); was see under PERSONNEL MANAGEMENT 1979-90", "MR": "19940505", "DA": "19780508", "DC": "1", "DX": "19910101", "UI": "D004649"}, {"RECTYPE": "D", "MH": "Employee Performance Appraisal", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Performance Appraisal, Employee|T078|NON|EQV|UNK (19XX)|780508|abcdef", "ENTRY": "Performance Evaluations, Nurses", "MN": "N04.452.677.370", "MH_TH": "NLM (1977)", "ST": "T078", "AN": "med or non-med personnel", "MS": "The assessment of the functioning of an employee in relation to work.", "PM": "91; was see under PERSONNEL MANAGEMENT Aug 1977-90", "HN": "91(Aug 77); was see under PERSONNEL MANAGEMENT 1977-90", "MR": "19991103", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D004650"}, {"RECTYPE": "D", "MH": "Employment", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "PRINT ENTRY": "Employment Termination|T068|NON|NRW|UNK (19XX)|770421|abcdef", "ENTRY": "Termination, Employment", "MN": "N01.824.245", "FX": "Unemployment", "MH_TH": "POPLINE (1987)", "ST": "T080", "AN": "for pay: differentiate from WORK ", "PI": "Work (1966-1969)", "MS": "The state of being engaged in an activity or service for wages or salary.", "PM": "70", "HN": "70", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D004651"}, {"RECTYPE": "D", "MH": "Empty Sella Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Empty Sella Syndrome, Secondary|T047|NON|NRW|NLM (2000)|991103|EMPTY SELLA SYNDROME SECOND|abcdefv", "ENTRY": "Sella Turcicas, Empty", "MN": "C19.700.320", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Sella Turcica (1966-1977)", "MS": "A condition when the SELLA TURCICA is not filled with pituitary tissue. The pituitary gland is either compressed, atrophied, or removed. There are two types: (1) primary empty sella is due a defect in the sella diaphragm leading to arachnoid herniation into the sellar space; (2) secondary empty sella is associated with the removal or treatment of PITUITARY NEOPLASMS.", "PM": "1978", "HN": "1978", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D004652"}, {"RECTYPE": "D", "MH": "Empyema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C23.550.470.756.305", "FX": "Abscess", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "general or unspecified; prefer specifics but empyema unspecified may be EMPYEMA, PLEURAL: check text; coordinate with precoordinated organ/disease term", "MS": "Presence of pus in a hollow organ or body cavity.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004653"}, {"RECTYPE": "D", "MH": "Empyema, Tuberculous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Empyema, Pleural, Tuberculous|T047|NON|EQV|NLM (1998)|960807|abcdef", "ENTRY": "Tuberculous Empyemas", "MN": "C23.550.470.756.305.250.320", "MH_TH": "NLM (1984)", "ST": "T047", "AN": "pleural empyema caused by M. tuberc", "MS": "Empyema due to MYCOBACTERIUM TUBERCULOSIS.", "PM": "91,63-83; was see under TUBERCULOSIS, PLEURAL 1984-90; was heading 1963-83", "HN": "91(84)63; was see under TUBERCULOSIS, PLEURAL 1984-90; was heading 1963-83", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004654"}, {"RECTYPE": "D", "MH": "Emulsions", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Emulsion|T104|NON|EQV|NLM (2021)|191113|abcdef", "MN": "D26.255.165.260", "FX": "Micelles", "MH_TH": "NLM (1966)", "ST": "T104", "RN": "0", "AN": "IM general only; coordinate NIM with specific drug; FAT EMULSIONS, INTRAVENOUS is also available ", "MS": "Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES.", "MR": "20200409", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004655"}, {"RECTYPE": "D", "MH": "Enalapril", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Enalapril Maleate|T116|T121|NON|NRW|FDA SRS (2015)|INN (19XX)|JAN (19XX)|USAN (1981)|850425|abbcdeeeef", "ENTRY": "Maleate, Enalapril", "MN": "D12.644.456.345.360", "PA": "Antihypertensive Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "L-Proline, 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-, (S)-", "RN": "69PN84IO1A", "RR": "9O25354EPJ", "PI": "Kininase II/antagonists & inhibitors (1974-1985)", "MS": "An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE.", "PM": "86", "HN": "86", "MR": "20141014", "DA": "19850425", "DC": "1", "DX": "19860101", "UI": "D004656"}, {"RECTYPE": "D", "MH": "Enamel Organ", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Organs, Enamel", "MN": "A14.549.167.900.720.265", "MH_TH": "NLM (1975)", "ST": "T024", "MS": "Epithelial cells surrounding the dental papilla and differentiated into three layers: the inner enamel epithelium, consisting of ameloblasts which eventually form the enamel, and the enamel pulp and external enamel epithelium, both of which atrophy and disappear before and upon eruption of the tooth, respectively.", "OL": "search TOOTH GERM 1966-74", "PM": "91; was see under TOOTH GERM 1975-90", "HN": "91(75); was see under TOOTH GERM 1975-90", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004658"}, {"RECTYPE": "D", "MH": "Enbucrilate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Butylcyanoacrylate|T109|T121|T122|NON|BRD|UNK (19XX)|790503|abbbcdef", "ENTRY": "Polyisobutylcyanoacrylates", "MN": "J01.637.051.919.367.341", "MH_TH": "NLM (1975)", "ST": "T122", "N1": "2-Propenoic acid, 2-cyano-, butyl ester", "RN": "F8CEP82QNP", "RR": "6606-65-1 (Enbucrilate)", "PI": "Tissue Adhesives (1966-1971)", "MS": "A tissue adhesive that is applied as a monomer to moist tissue and polymerizes to form a bond. It is slowly biodegradable and used in all kinds of surgery, including dental.", "PM": "1986; was ENBUCRYLATE 1980-1985; HISTOACRYL N-BLAU was indexed under ENBUCRILATE 1980-2008; N-BUTYL-CYANOACRYLATE was indexed under CYANOACRYLATES 2008; HISTOACRYL N-BLAU was indexed under ENBUCRILATE 1980-2006;  POLYISOBUTYL CYANOACRYLATE was indexed under CYANOACRYLATES 2009-2018", "HN": "1986; was ENBUCRYLATE 1980-1985", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D004659"}, {"RECTYPE": "D", "MH": "Encephalitis", "DE": "ENCEPH", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rasmussen Syndrome|T047|EPO|NRW|NLM (2000)|OMIM (2013)|ORD (2010)|991105|abcdeeef", "ENTRY": "Brain Inflammations", "MN": "C10.586.250", "FX": "Encephalomyelitis", "MH_TH": "POPLINE (1994)", "ST": "T047", "AN": "general, note specifics particularly INFECTIOUS ENCEPHALITIS  and ENCEPHALITIS, VIRAL", "MS": "Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004660"}, {"RECTYPE": "D", "MH": "Encephalitis Virus, Eastern Equine", "DE": "ENCEPH VIRUS EASTERN EQUINE", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Encephalomyelitis Virus, Eastern Equine|T005|NON|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "EEE Viruses", "MN": "B04.820.578.875.054.320", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid11021", "AN": "infection: coordinate with ENCEPHALOMYELITIS, EQUINE but see note there", "MS": "A species of ALPHAVIRUS causing encephalomyelitis in Equidae and humans. The virus ranges along the Atlantic seaboard of the United States and Canada and as far south as the Caribbean, Mexico, and parts of Central and South America. Infections in horses show a mortality of up to 90 percent and in humans as high as 80 percent in epidemics.", "PM": "91; was see under ALPHAVIRUSES 1981-90; was see under ENCEPHALITIS VIRUSES 1975-80", "HN": "91(75); was see under ALPHAVIRUSES 1981-90; was see under ENCEPHALITIS VIRUSES 1975-80", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004663"}, {"RECTYPE": "D", "MH": "Encephalitis Virus, Japanese", "DE": "ENCEPH VIRUS JAPANESE", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Virus, Japanese Encephalitis|T005|EPO|EQV|NLM (1992)|901128|VIRUS JAPANESE ENCEPH|abcdefv", "MN": "B04.820.578.344.350.300.227", "MH_TH": "NLM (1971)", "ST": "T005", "RN": "txid11072", "PI": "Encephalitis Viruses (1966-1970)", "MS": "A species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE), which is the etiological agent of Japanese encephalitis found in Asia, southeast Asia, and the Indian subcontinent.", "PM": "73", "HN": "73(71)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004664"}, {"RECTYPE": "D", "MH": "Encephalitis Virus, St. Louis", "DE": "ENCEPH VIRUS ST LOUIS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Saint Louis Encephalitis Virus|T005|NON|EQV|NLM (2003)|020628|SAINT LOUIS ENCEPH VIRUS|abcdefv", "ENTRY": "Viruses, St. Louis Encephalitis|T005|EPO|EQV|NLM (1992)|901128|VIRUSES ST LOUIS ENCEPH|abcdefv", "MN": "B04.820.578.344.350.300.330", "MH_TH": "NLM (1971)", "ST": "T005", "RN": "txid11080", "PI": "Encephalitis Viruses (1966-1970)", "MS": "A species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE), which is the etiologic agent of ST. LOUIS ENCEPHALITIS in the United States, the Caribbean, and Central and South America.", "PM": "91; was see under FLAVIVIRUSES 1981-90; was see under ENCEPHALITIS VIRUSES 1975-80", "HN": "91(71); was see under FLAVIVIRUSES 1981-90; was see under ENCEPHALITIS VIRUSES 1975-80", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004665"}, {"RECTYPE": "D", "MH": "Encephalitis Virus, Venezuelan Equine", "DE": "ENCEPH VIRUS VENEZ EQUINE", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Encephalomyelitis Virus, Venezuelan Equine|T005|EPO|EQV|UNK (19XX)|860617|ENCEPHALOMYELITIS VIRUS VENEZ EQUINE|abcdefv", "ENTRY": "Viruses, Venezuelan Equine Encephalitis|T005|EPO|EQV|NLM (1992)|901128|VIRUSES VENEZ EQUINE ENCEPH|abcdefv", "MN": "B04.820.578.875.054.340", "MH_TH": "NLM (1971)", "ST": "T005", "RN": "txid11036", "PI": "Encephalitis Viruses (1966-1970)", "MS": "A species of ALPHAVIRUS that is the etiologic agent of encephalomyelitis in humans and equines. It is seen most commonly in parts of Central and South America.", "PM": "73", "HN": "73(71)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004666"}, {"RECTYPE": "D", "MH": "Encephalitis Virus, Western Equine", "DE": "ENCEPH VIRUS WESTERN EQUINE", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Western equine encephalitis virus|T005|NON|EQV|NLM (1992)|901128|WESTERN EQUINE ENCEPH VIRUS|abcdefv", "ENTRY": "WEE Viruses", "MN": "B04.820.578.875.054.360", "MH_TH": "NLM (1971)", "ST": "T005", "RN": "txid11039", "AN": "infection: coord IM with ENCEPHALOMYELITIS, EQUINE (IM) but see note there", "PI": "Encephalitis Viruses (1966-1970)", "MS": "A species of ALPHAVIRUS that is the etiologic agent of encephalomyelitis in humans and equines in the United States, southern Canada, and parts of South America.", "PM": "73", "HN": "73(71)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004667"}, {"RECTYPE": "D", "MH": "Encephalitis Viruses", "DE": "ENCEPH VIRUSES", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, Encephalitis|T005|NON|EQV|NLM (1992)|901128|VIRUSES ENCEPH|abcdefv", "MN": "B04.820.230", "MH_TH": "NLM (1966)", "ST": "T005", "MS": "A collection of single-stranded RNA viruses scattered across the Bunyaviridae, Flaviviridae, and Togaviridae families whose common property is the ability to induce encephalitic conditions in infected hosts.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004668"}, {"RECTYPE": "D", "MH": "Encephalitis Viruses, Tick-Borne", "DE": "ENCEPH VIRUSES TICK BORNE", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Powassan virus|T005|EPO|NRW|NLM (1994)|930127|abcdef", "ENTRY": "Tick Borne Encephalitis Viruses", "MN": "B04.820.578.344.350.350", "MH_TH": "NLM (1965)", "ST": "T005", "RN": "txid11084", "RR": "txid33743", "MS": "A subgroup of the genus FLAVIVIRUS that causes encephalitis and hemorrhagic fevers and is found in eastern and western Europe and the former Soviet Union. It is transmitted by TICKS and there is an associated milk-borne transmission from viremic cattle, goats, and sheep.", "PM": "1966; for LANGAT VIRUS see LANGAT VIRUS 1991-1993, see FLAVIVIRUSES 1981-1990, see ARBOVIRUSES 1975-1980; for LOUPING ILL VIRUS see LOUPING ILL VIRUS 1991-1993, see ENCEPHALITIS VIRUSES, TICK-BORNE 1967-1990, see ARBOVIRUS 1965-1966, see ARBOVIRUSES 1963-1964; for POWASSAN VIRUS see POWASSAN VIRUS 1991-1993, see ENCEPHALITIS VIRUSES, TICK-BORNE 1975-1990; for KYASANUR FOREST DISEASE VIRUS see FLAVIVIRUSES 1986-1993, see FLAVIVIRUSES 1981-1985, see ARBOVIRUSES 1975-80", "HN": "1966 (1965)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004669"}, {"RECTYPE": "D", "MH": "Encephalitis, California", "DE": "ENCEPH CALIFORNIA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Tahyna Virus Infection|T047|EPO|NRW|NLM (2024)|230601|abcdef", "ENTRY": "Virus Infection, Tahyna", "MN": "C10.586.250.520.750.300.200", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "for La Crosse virus encephalitis, coordinate with LA CROSSE VIRUS", "MS": "A viral infection of the brain caused by serotypes of California encephalitis virus (ENCEPHALITIS VIRUS, CALIFORNIA) transmitted to humans by the mosquito AEDES triseriatus. The majority of cases are caused by the LA CROSSE VIRUS. This condition is endemic to the midwestern United States and primarily affects children between 5-10 years of age. Clinical manifestations include FEVER; VOMITING; HEADACHE; and abdominal pain followed by SEIZURES, altered mentation, and focal neurologic deficits. (From Joynt, Clinical Neurology, 1996, Ch26, p13)", "PM": "1991; see ENCEPHALITIS, EPIDEMIC 1975-1990", "HN": "1991 (1975)", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004670"}, {"RECTYPE": "D", "MH": "Encephalitis, Arbovirus", "DE": "ENCEPH ARBOVIRUS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Murray Valley Encephalitis|T047|EPO|NRW|NLM (2024)|230601|abcdef", "ENTRY": "Viral Encephalitis, Arthropod Borne", "MN": "C10.586.250.520.750.300", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "general or unspecified; prefer specifics; despite entry term  ENCEPHALITIS, EPIDEMIC not for an \"epidemic of encephalitis\" ", "MS": "Infections of the brain caused by arthropod-borne viruses (i.e., arboviruses) primarily from the families TOGAVIRIDAE; FLAVIVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; and RHABDOVIRIDAE. Life cycles of these viruses are characterized by ZOONOSES, with birds and lower mammals serving as intermediate hosts. The virus is transmitted to humans by the bite of mosquitoes (CULICIDAE) or TICKS. Clinical manifestations include fever, headache, alterations of mentation, focal neurologic deficits, and COMA. (From Clin Microbiol Rev 1994 Jan;7(1):89-116; Walton, Brain's Diseases of the Nervous System, 10th ed, p321)", "PM": "2000; see ENCEPHALITIS, EPIDEMIC 1966-1999", "HN": "2000", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D004671"}, {"RECTYPE": "D", "MH": "Encephalitis, Japanese", "DE": "ENCEPH JAPANESE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Japanese Encephalitis|T047|EPO|EQV|NLM (1994)|ORD (2010)|930506|JAPANESE ENCEPH|abcdeefv", "ENTRY": "Viral Encephalitis, Japanese B|T047|NON|EQV|NLM (2000)|991103|VIRAL ENCEPH JAPANESE B|abcdefv", "MN": "C10.586.250.520.750.300.400", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "for encephalitis caused by Japanese B encephalitis virus only not ENCEPHALITIS VIRUSES, JAPANESE: see annotation there", "MS": "A mosquito-borne encephalitis caused by the Japanese B encephalitis virus (ENCEPHALITIS VIRUS, JAPANESE) occurring throughout Eastern Asia and Australia. The majority of infections occur in children and are subclinical or have features limited to transient fever and gastrointestinal symptoms. Inflammation of the brain, spinal cord, and meninges may occur and lead to transient or permanent neurologic deficits (including a POLIOMYELITIS-like presentation); SEIZURES; COMA; and death. (From Adams et al., Principles of Neurology, 6th ed, p751; Lancet 1998 Apr 11;351(9109):1094-7)", "OL": "use ENCEPHALITIS, JAPANESE to search ENCEPHALITIS, JAPANESE B 1966-93", "PM": "94; was ENCEPHALITIS, JAPANESE B 1963-93", "HN": "94; was ENCEPHALITIS, JAPANESE B 1963-93", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D004672"}, {"RECTYPE": "D", "MH": "Encephalomyelitis, Acute Disseminated", "DE": "ENCEPH ACUTE DISSEM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vaccination Encephalitis|T047|NON|NRW|UNK (19XX)|740330|VACCINATION ENCEPH|abcdefv", "ENTRY": "Post-Vaccinal Encephalomyelitides", "MN": "C23.550.291.500.829.188", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "when post-vaccinal (note X ref) coord IM with vaccine source if pertinent (IM or NIM); for post-vaccinal or postinfectious inflammation of the spinal cord only, use MYELITIS, TRANSVERSE", "MS": "An acute or subacute inflammatory process of the CENTRAL NERVOUS SYSTEM characterized histologically by multiple foci of perivascular demyelination. Symptom onset usually occurs several days after an acute viral infection or immunization, but it may coincide with the onset of infection or rarely no antecedent event can be identified. Clinical manifestations include CONFUSION, somnolence, FEVER, nuchal rigidity, and involuntary movements. The illness may progress to COMA and eventually be fatal. (Adams et al., Principles of Neurology, 6th ed, p921)", "PM": "1995; was ENCEPHALITIS, POST-VACCINAL 1963-94", "HN": "1995; was ENCEPHALITIS, POST-VACCINAL 1963-94", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19950101", "UI": "D004673"}, {"RECTYPE": "D", "MH": "Encephalitis, St. Louis", "DE": "ENCEPH ST LOUIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "St. Louis Viral Encephalitis|T047|EPO|EQV|NLM (2000)|991103|ST LOUIS VIRAL ENCEPH|abcdefv", "ENTRY": "St. Louis Meningoencephalitides", "MN": "C10.586.250.520.750.300.550", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A viral encephalitis caused by the St. Louis encephalitis virus (ENCEPHALITIS VIRUS, ST. LOUIS), a FLAVIVIRUS. It is transmitted to humans and other vertebrates primarily by mosquitoes of the genus CULEX. The primary animal vectors are wild birds and the disorder is endemic to the midwestern and southeastern United States. Infections may be limited to an influenza-like illness or present as an ASEPTIC MENINGITIS or ENCEPHALITIS. Clinical manifestations of the encephalitic presentation may include SEIZURES, lethargy, MYOCLONUS, focal neurologic signs, COMA, and DEATH. (From Adams et al., Principles of Neurology, 6th ed, p750)", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004674"}, {"RECTYPE": "D", "MH": "Encephalitis, Tick-Borne", "DE": "ENCEPH TICK BORNE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Powassan Encephalitis|T047|NON|NRW|NLM (2000)|991108|POWASSAN ENCEPH|abcdefv", "ENTRY": "Virus Diseases, Powassan", "MN": "C10.586.250.520.750.300.775", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Encephalitis caused by neurotropic viruses that are transmitted via the bite of TICKS. In Europe, the diseases are caused by ENCEPHALITIS VIRUSES, TICK-BORNE, which give rise to Russian spring-summer encephalitis, central European encephalitis, louping ill encephalitis, and related disorders. Powassan encephalitis occurs in North America and Russia and is caused by the Powassan virus. ASEPTIC MENINGITIS and rarely encephalitis may complicate COLORADO TICK FEVER which is endemic to mountainous regions of the western United States. (From Joynt, Clinical Neurology, 1996, Ch26, pp14-5)", "PM": "1968; for ENCEPHALITIS, CENTRAL EUROPEAN see ENCEPHALITIS, TICK-BORNE 1963-1999", "HN": "1968(1966)", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004675"}, {"RECTYPE": "D", "MH": "Myelin Basic Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Golli MBP2 Protein", "MN": "D12.776.631.580.510", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1966-1972)", "MS": "An abundant cytosolic protein that plays a critical role in the structure of multilamellar myelin. Myelin basic protein binds to the cytosolic sides of myelin cell membranes and causes a tight adhesion between opposing cell membranes.", "PM": "2013; see MYELIN BASIC PROTEINS 1996-2012; see ENCEPHALITOGENIC BASIC PROTEINS 1974-1995", "HN": "2013(1996)", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004676"}, {"RECTYPE": "D", "MH": "Encephalocele", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Occipital Encephalocele|T190|NON|NRW|NLM (2000)|991103|OCCIPITAL ENCEPH|abcdefv", "ENTRY": "Tonsillar Herniations", "MN": "C23.300.707.186", "MH_TH": "ORD (2010)", "ST": "T190", "AN": "meningoencephalocele: coordinate IM with MENINGOCELE (IM)", "MS": "Brain tissue herniation through a congenital or acquired defect in the skull. The majority of congenital encephaloceles occur in the occipital or frontal regions. Clinical features include a protuberant mass that may be pulsatile. The quantity and location of protruding neural tissue determines the type and degree of neurologic deficit. Visual defects, psychomotor developmental delay, and persistent motor deficits frequently occur.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004677"}, {"RECTYPE": "D", "MH": "Encephalomalacia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Encephalomalacia, Multicystic|T047|NON|NRW|NLM (2000)|991108|ENCEPH MULTICYSTIC|abcdefv", "ENTRY": "Multicystic Encephalomalacias", "MN": "C10.228.140.461", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "Softening or loss of brain tissue following CEREBRAL INFARCTION; cerebral ischemia (see BRAIN ISCHEMIA), infection, CRANIOCEREBRAL TRAUMA, or other injury. The term is often used during gross pathologic inspection to describe blurred cortical margins and decreased consistency of brain tissue following infarction. Multicystic encephalomalacia refers to the formation of multiple cystic cavities of various sizes in the cerebral cortex of neonates and infants following injury, most notably perinatal hypoxia-ischemic events. (From Davis et al., Textbook of Neuropathology, 2nd ed, p665; J Neuropathol Exp Neurol, 1995 Mar;54(2):268-75)", "PM": "1966", "HN": "1966(1964)", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004678"}, {"RECTYPE": "D", "MH": "Encephalomyelitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myeloencephalitis|T047|NON|EQV|NLM (2000)|991103|MYELOENCEPH|abcdefv", "ENTRY": "Myeloencephalitides", "MN": "C10.586.500", "FX": "Encephalitis", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate IM with specific organism/infection term (IM) or other cause (IM)", "MS": "A general term indicating inflammation of the BRAIN and SPINAL CORD, often used to indicate an infectious process, but also applicable to a variety of autoimmune and toxic-metabolic conditions. There is significant overlap regarding the usage of this term and ENCEPHALITIS in the literature.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004679"}, {"RECTYPE": "D", "MH": "Maus Elberfeld virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Murine Encephalomyelitis Virus|T005|NON|EQV|NLM (1994)|921118|MURINE ENCEPH VIRUS|abcdefv", "ENTRY": "Encephalomyelitis Virus, Mouse", "MN": "B04.820.578.750.170.200.480", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid12468", "AN": "do not confuse entry term MURINE ENCEPHALOMYELITIS VIRUS with THEILER'S MURINE ENCEPHALOMYELITIS VIRUS; infection: coord IM with CARDIOVIRUS INFECTIONS (IM)", "MS": "A strain of ENCEPHALOMYOCARDITIS VIRUS, a species of CARDIOVIRUS, usually causing an inapparent intestinal infection in mice. A small number of mice may show signs of flaccid paralysis.", "PM": "2002; see ENCEPHALOMYELITIS VIRUS, MURINE 1991-2001, see ENTEROVIRUSES 1975-1990, see ENTEROVIRUS 1967-1974, see POLIOVIRUS 1963-1966; for MOUSE ELBERFELD VIRUS see ENCEPHALOMYOCARDITIS VIRUS 1997-2001", "HN": "2002 (1963); for MOUSE ELBERFELD VIRUS use ENCEPHALOMYOCARDITIS VIRUS 1997-2001", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004680"}, {"RECTYPE": "D", "MH": "Encephalomyelitis, Autoimmune, Experimental", "DE": "ENCEPH AUTOIMMUNE EXPER", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Encephalomyelitis, Experimental Autoimmune|T050|NON|EQV|NLM (1996)|940902|ENCEPH EXPER AUTOIMMUNE|abcdefv", "ENTRY": "Experimental Encephalomyelitis, Autoimmune", "MN": "E05.598.500.500.500", "MH_TH": "NLM (1996)", "ST": "T050", "AN": "coordinate with specific demyelinating disease if pertinent", "MS": "An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5)", "PM": "2005; see ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE 2000-2004, see ENCEPHALOMYELITIS, ALLERGIC 1964-1999", "HN": "2005 (1964)", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004681"}, {"RECTYPE": "D", "MH": "Encephalomyelitis, Enzootic Porcine", "DE": "ENCEPH ENZOOTIC PORCINE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Teschen Disease|T047|EPO|NRW|UNK (19XX)|760430|TESCHEN DIS|abcdefv", "ENTRY": "Porcine Encephalomyelitis, Enzootic", "MN": "C22.905.323", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "caused by an enterovirus; don't forget also SWINE (NIM) & check tag ANIMALS", "PI": "Swine Diseases (1966-1969)", "MS": "A picornavirus infection producing symptoms similar to poliomyelitis in pigs.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D004682"}, {"RECTYPE": "D", "MH": "Encephalomyelitis, Equine", "DE": "ENCEPH EQUINE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Equine Encephalomyelitis Virus Infections|T047|NON|EQV|NLM (2000)|991103|EQUINE ENCEPH VIRUS INFECT|abcdefv", "ENTRY": "Equine Encephalomyelitis", "MN": "C10.586.500.406", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "human & animal; if in horses, coord with HORSE DISEASES (IM) + HORSES (NIM) & use /vet", "MS": "A group of ALPHAVIRUS INFECTIONS which affect horses and man, transmitted via the bites of mosquitoes. Disorders in this category are endemic to regions of South America and North America. In humans, clinical manifestations vary with the type of infection, and range from a mild influenza-like syndrome to a fulminant encephalitis. (From Joynt, Clinical Neurology, 1996, Ch26, pp8-10)", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004683"}, {"RECTYPE": "D", "MH": "Leukoencephalitis, Acute Hemorrhagic", "DE": "LEUKOENCEPH ACUTE HEMORRHAGIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Necrotizing Hemorrhagic Encephalomyelitis|T047|NON|REL|NLM (1995)|940210|NECROTIZING HEMORRHAGIC ENCEPH|abcdefv", "ENTRY": "Syndrome, Hurst", "MN": "C20.111.258.250.350.500", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Encephalomyelitis (1966-1971)", "MS": "A fulminant and often fatal demyelinating disease of the brain which primarily affects young adults and children. Clinical features include the rapid onset of weakness, SEIZURES, and COMA. It may follow a viral illness or MYCOPLASMA PNEUMONIAE infections but in most instances there is no precipitating event. Pathologic examination reveals marked perivascular demyelination and necrosis of white matter with microhemorrhages. (Adams et al., Principles of Neurology, 6th ed, pp924-5)", "PM": "1997; was ENCEPHALOMYELITIS, NECROTIZING HEMORRHAGIC 1991-1996 (see under ENCEPHALOMYELITIS 1972-1990); HURST DISEASE was HURST'S DISEASE 1997", "HN": "1997; was ENCEPHALOMYELITIS, NECROTIZING HEMORRHAGIC 1991-1996 (see under ENCEPHALOMYELITIS 1972-1990); HURST DISEASE was HURST'S DISEASE 1997", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004684"}, {"RECTYPE": "D", "MH": "Encephalomyelitis, Venezuelan Equine", "DE": "ENCEPH VENEZUELAN EQUINE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Encephalitis, Venezuelan Equine|T047|EPO|EQV|UNK (19XX)|750619|abcdef", "ENTRY": "Venezuelan Equine Encephalomyelitis", "MN": "C10.586.500.406.225", "MH_TH": "NLM (1976)", "ST": "T047", "AN": "human & animal; if in horses, coord with HORSE DISEASES (IM) + HORSES (NIM) & use /vet", "PI": "Encephalomyelitis, Equine (1966-1975)", "MS": "A form of arboviral encephalitis endemic to Central America and the northern latitudes of South America. The causative organism (ENCEPHALITIS VIRUS, VENEZUELAN EQUINE) is transmitted to humans and horses via the bite of several mosquito species. Human viral infection may be asymptomatic or remain restricted to a mild influenza-like illness. Encephalitis, usually not severe, occurs in a small percentage of cases and may rarely feature SEIZURES and COMA. (From Joynt, Clinical Neurology, 1996, Ch26, pp9-10)", "PM": "1991; was see under ENCEPHALOMYELITIS, EQUINE 1976-1990", "HN": "1991(1976); was see under ENCEPHALOMYELITIS, EQUINE 1976-1990", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D004685"}, {"RECTYPE": "D", "MH": "Encephalomyocarditis virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "EMCV|T005|ABB|EQV|NLM (1997)|951002|abcdef", "MN": "B04.820.578.750.170.200", "MH_TH": "NLM (1963)", "ST": "T005", "RN": "txid12104", "AN": "infection: coordinate with CARDIOVIRUS INFECTIONS", "MS": "The type species of CARDIOVIRUS causing encephalomyelitis and myocarditis in rodents, pigs, and monkeys. Infection in man has been reported with CNS involvement but without myocarditis.", "OL": "use ENCEPHALOMYOCARDITIS VIRUS to search ENCEPHALOMYOCARDITIS VIRUSES 1966-93", "PM": "94; was ENCEPHALOMYOCARDITIS VIRUSES 1965-93", "HN": "94; was ENCEPHALOMYOCARDITIS VIRUSES 1965-93", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004686"}, {"RECTYPE": "D", "MH": "Enchondromatosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ollier's Disease|T019|T047|EPO|EQV|UNK (19XX)|840406|OLLIERS DIS|abbcdefv", "ENTRY": "Syndrome, Maffucci", "MN": "C05.116.099.708.338", "MH_TH": "NLM (1985)", "ST": "T047", "MS": "Benign growths of cartilage in the metaphyses of several bones.", "OL": "to search OLLIER'S DISEASE use OSTEOCHONDRODYSPLASIAS 1966-84", "PM": "91; was see under OSTEOCHONDRODYSPLASIAS 1985-90; OLLIER'S DISEASE was see DYSCHONDROPLASIA 1963-84", "HN": "91(85); was see under OSTEOCHONDRODYSPLASIAS 1985-90; OLLIER'S DISEASE was see DYSCHONDROPLASIA 1963-84", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19840406", "DC": "1", "DX": "19910101", "UI": "D004687"}, {"RECTYPE": "D", "MH": "Encopresis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "MN": "F03.388.300", "MH_TH": "NLM (1963)", "ST": "T184", "AN": "of psychological origin: differentiate from FECAL INCONTINENCE, of organic origin", "MS": "Incontinence of feces not due to organic defect or illness.", "PM": "69", "HN": "69(63)", "CATSH": "CAT LIST", "MR": "20150706", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D004688"}, {"RECTYPE": "D", "MH": "Encyclopedias as Topic", "ENTRY": "Encyclopedias as Topics", "MN": "L01.462.500.682.192.836.456", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with Publication Type ENCYCLOPEDIA", "MS": "Discussion of works containing information articles on subjects in various fields of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)", "PM": "2008; ENCYCLOPEDIAS 1963-2007", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D004690"}, {"RECTYPE": "D", "MH": "Endarterectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Thromboendarterectomy|T061|NON|BRD|NLM (1993)|911029|abcdef", "ENTRY": "Thromboendarterectomies", "MN": "E04.100.814.456", "FX": "Atherectomy", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Surgical excision, performed under general anesthesia, of the atheromatous tunica intima of an artery. When reconstruction of an artery is performed as an endovascular procedure through a catheter, it is called ATHERECTOMY.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004691"}, {"RECTYPE": "D", "MH": "Endarteritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Endarteritides", "MN": "C14.907.940.090.340", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the inner endothelial lining (TUNICA INTIMA) of an artery.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004692"}, {"RECTYPE": "D", "MH": "Glucan Endo-1,3-beta-D-Glucosidase", "DS": "GLUCAN ENDO BETA D GLUCOSIDASE 01 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Oligo-1,3-Glucosidase|T116|T126|NON|EQV|UNK (19XX)|770323|OLIGOGLUCOSIDASE 01 03|abbcdefs", "ENTRY": "Oligo 1,3 Glucosidase", "MN": "D08.811.277.450.420.200.600", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "1,3-beta-D-Glucan glucanohydrolase", "RN": "EC 3.2.1.39", "PI": "Polysaccharides (1969-1974)", "MS": "An endocellulase with specificity for the hydrolysis of 1,3-beta-D-glucosidic linkages in 1,3-beta-D-glucans including laminarin, paramylon, and pachyman.", "PM": "97; was ENDO-1,3-BETA-GLUCANASE 1975-96 (see under GLYCOSIDE HYDROLASES 1975-90)", "HN": "97; was ENDO-1,3-BETA-GLUCANASE 1975-96 (see under GLYCOSIDE HYDROLASES 1975-90)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004693"}, {"RECTYPE": "D", "MH": "Endocardial Cushion Defects", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Persistent Common Atrioventricular Canal|T019|NON|NRW|UNK (19XX)|820423|abcdef", "ENTRY": "Defects, Endocardial Cushion", "MN": "C16.131.240.400.560.350", "MH_TH": "NLM (1983)", "ST": "T019", "PI": "Heart Defects, Congenital (1966-1982)", "MS": "A spectrum of septal defects involving the ATRIAL SEPTUM; VENTRICULAR SEPTUM; and the atrioventricular valves (TRICUSPID VALVE; BICUSPID VALVE). These defects are due to incomplete growth and fusion of the ENDOCARDIAL CUSHIONS which are important in the formation of two atrioventricular canals, site of future atrioventricular valves.", "PM": "91; was see under HEART SEPTAL DEFECTS 1983-90", "HN": "91(83); was see under HEART SEPTAL DEFECTS 1983-90", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19820423", "DC": "1", "DX": "19910101", "UI": "D004694"}, {"RECTYPE": "D", "MH": "Endocardial Fibroelastosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fibroelastosis, Endocardial", "MN": "C14.280.238.281", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "A condition characterized by the thickening of ENDOCARDIUM due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function (CARDIOMYOPATHY, RESTRICTIVE). It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies (HEART DEFECTS CONGENITAL;) INFECTION; or gene mutation. Defects in the tafazzin protein, encoded by TAZ gene, result in a form of autosomal dominant familial endocardial fibroelastosis.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004695"}, {"RECTYPE": "D", "MH": "Endocarditis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Infective Endocarditides", "MN": "C14.280.282", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "rheumatic endocarditis: index under RHEUMATIC HEART DISEASE (IM) + ENDOCARDITIS (IM)", "MS": "Inflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, endocarditis can damage heart valves and become life-threatening.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004696"}, {"RECTYPE": "D", "MH": "Endocarditis, Bacterial", "DE": "ENDOCARDITIS BACT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Endocarditides, Bacterial|T047|NON|EQV|NLM (1992)|901103|ENDOCARDITIDES BACT|abcdefv", "MN": "C14.280.282.407", "FX": "Aneurysm, Infected", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with specific bacterium /infections heading (IM) if pertinent", "MS": "Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004697"}, {"RECTYPE": "D", "MH": "Endocarditis, Subacute Bacterial", "DE": "ENDOCARDITIS SUBACUTE BACT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Endocarditis Lenta|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Subacute Bacterial Endocarditis|T047|NON|EQV|NLM (1992)|901105|SUBACUTE BACT ENDOCARDITIS|abcdefv", "MN": "C14.280.282.407.407", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with specific bacterium /infections heading (IM)", "MS": "ENDOCARDIUM infection that is usually caused by STREPTOCOCCUS. Subacute infective endocarditis evolves over weeks and months with modest toxicity and rare metastatic infection.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004698"}, {"RECTYPE": "D", "MH": "Endocardium", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Endocardiums", "MN": "A07.541.207", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "The innermost layer of the heart, comprised of endothelial cells.", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004699"}, {"RECTYPE": "D", "MH": "Endocrine System Diseases", "DE": "ENDOCRINE SYSTEM DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Endocrine Diseases|T047|NON|EQV|NLM (1965)|990101|ENDOCRINE DIS|abcdefv", "ENTRY": "System Diseases, Endocrine", "MN": "C19", "RH": "C19 - DISEASES-ENDOCRINE", "FX": "Endocrinology", "MH_TH": "NLM (2005)", "ST": "T047", "AN": "general; prefer specific disease: Manual 23.25.3; /diag: consider also DIAGNOSTIC TECHNIQUES, ENDOCRINE", "MS": "Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES.", "PM": "2005; see ENDOCRINE DISEASES 1965-2004", "HN": "2005 (1965)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004700"}, {"RECTYPE": "D", "MH": "Endocrine Gland Neoplasms", "DE": "ENDOCRINE GLAND NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Endocrine Gland Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Endocrine Gland", "MN": "C19.344", "MH_TH": "NLM (1971)", "ST": "T191", "AN": "general; prefer specifics; coordinate IM with histological type of neoplasm (IM)", "PI": "Endocrine Diseases (1966-1991)", "MS": "Tumors or cancer of the ENDOCRINE GLANDS.", "PM": "92", "HN": "92; was ENDOCRINE GLAND NEOPLASMS (NON MESH) 1971-91", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D004701"}, {"RECTYPE": "D", "MH": "Endocrine Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Gland, Endocrine", "MN": "A06.300", "FX": "Hormones", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "general; prefer specifics, / surg: consider also ENDOCRINE SURGICAL PROCEDURES; endocrine deficiency: probably specific ENDOCRINE SYSTEM DISEASE: Manual 23.25.3", "MS": "Ductless glands that secrete HORMONES directly into the BLOOD CIRCULATION. These hormones influence the METABOLISM and other functions of cells in the body.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004702"}, {"RECTYPE": "D", "MH": "Endocrine System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Systems, Endocrine", "MN": "A06", "RH": "A6 - ANATOMY-ENDOCRINE SYSTEM", "MH_TH": "NLM (1966)", "ST": "T022", "AN": "avoid: too general; prefer ENDOCRINE GLANDS; CHROMAFFIN SYSTEM; or NEUROSECRETORY SYSTEMS & their specifics", "PI": "Endocrine Glands (1966-1997)", "MS": "The system of glands that release their secretions (hormones) directly into the circulatory system. In addition to the ENDOCRINE GLANDS, included are the CHROMAFFIN SYSTEM and the NEUROSECRETORY SYSTEMS.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "20050713", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004703"}, {"RECTYPE": "D", "MH": "Endocrinology", "DE": "ENDOCRINOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Metabolism and Endocrinology Specialty|T091|NON|BRD|NLM (2012)|110218|abcdef", "MN": "H02.403.429.323", "FX": "Endocrine System Diseases", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "A subspecialty of internal medicine concerned with the metabolism, physiology, and disorders of the ENDOCRINE SYSTEM.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004704"}, {"RECTYPE": "D", "MH": "Endocytosis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Endocytoses", "MN": "G04.417", "FX": "Endosomes", "MH_TH": "NLM (1973)", "ST": "T043", "PI": "Cells/physiology (1966-1972)", "MS": "Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis.", "PM": "76; was see under PHAGOCYTOSIS 1975", "HN": "76(73); was see under PHAGOCYTOSIS 1975", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D004705"}, {"RECTYPE": "D", "MH": "Endodeoxyribonucleases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.352.355.325", "MH_TH": "NLM (1983)", "ST": "T126", "RN": "EC 3.1.-", "PI": "Phosphatases (1966-1972)", "MS": "A group of enzymes catalyzing the endonucleolytic cleavage of DNA. They include members of EC 3.1.21.-, EC 3.1.22.-, EC 3.1.23.- (DNA RESTRICTION ENZYMES), EC 3.1.24.- (DNA RESTRICTION ENZYMES), and EC 3.1.25.-.", "PM": "83", "HN": "83", "MR": "20030709", "DA": "19820430", "DC": "1", "DX": "19830101", "UI": "D004706"}, {"RECTYPE": "D", "MH": "Endoderm", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Definitive Endoderm|T018|NON|REL|NLM (2024)|230423|abcdef", "ENTRY": "Endoderms", "MN": "A16.504.407", "MH_TH": "NLM (1966)", "ST": "T018", "MS": "The inner of the three germ layers of an embryo.", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004707"}, {"RECTYPE": "D", "MH": "Endodontics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Endodontology|T091|NON|BRD|NLM (2017)|160408|abcdef", "MN": "H02.163.876.213", "FX": "Dental Pulp Test", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use for the specialty only", "MS": "A dental specialty concerned with the maintenance of the dental pulp in a state of health and the treatment of the pulp cavity (pulp chamber and pulp canal).", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004708"}, {"RECTYPE": "D", "MH": "Endolimax", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Endolimaxs", "MN": "B01.046.500.100.700.325", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid110787", "AN": "infection: coordinate IM with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A genus of ameboid protozoa found in the intestines of vertebrates and invertebrates.", "OL": "search SARCODINA 1966-74", "PM": "91; was see under AMOEBA 1977-90; was see under SARCODINA 1963-76", "HN": "91(75); was see under AMOEBA 1977-90; was see under SARCODINA 1963-76", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004709"}, {"RECTYPE": "D", "MH": "Endolymph", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Endolymphs", "MN": "A12.207.270.517.324", "MH_TH": "NLM (1975)", "ST": "T031", "MS": "The lymph fluid found in the membranous labyrinth of the ear. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "OL": "search LABYRINTHINE FLUIDS 1966-74", "PM": "91; was see under LABYRINTHINE FLUIDS 1975-90", "HN": "91(75); was see under LABYRINTHINE FLUIDS 1975-90", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004710"}, {"RECTYPE": "D", "MH": "Endolymphatic Duct", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Endolymphatic Ducts", "MN": "A09.923.500.957.360", "MH_TH": "NLM (1979)", "ST": "T023", "PI": "Labyrinthine Fluids (1966-1974)", "MS": "The part of the membranous labyrinth that traverses the bony vestibular aqueduct and emerges through the bone of posterior cranial fossa (CRANIAL FOSSA, POSTERIOR) where it expands into a blind pouch called the endolymphatic sac.", "PM": "91; was see under VESTIBULE 1990; was see under LABYRINTH 1979-89", "HN": "91(79); was see under VESTIBULE 1990; was see under LABYRINTH 1979-89", "MR": "20210630", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D004711"}, {"RECTYPE": "D", "MH": "Endolymphatic Sac", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sacs, Endolymphatic", "MN": "A09.923.500.957.360.701", "MH_TH": "NLM (1979)", "ST": "T023", "PI": "Labyrinthine Fluids (1966-1974)", "MS": "The blind pouch at the end of the endolymphatic duct. It is a storage reservoir for excess ENDOLYMPH, formed by the blood vessels in the membranous labyrinth.", "PM": "91; was see under VESTIBULE 1990; was see under LABYRINTH 1979-89", "HN": "91(79); was see under VESTIBULE 1990; was see under LABYRINTH 1979-89", "MR": "20210630", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D004712"}, {"RECTYPE": "D", "MH": "Endolymphatic Shunt", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Shunts, Endolymphatic", "MN": "E04.580.450.230", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Meniere's Disease/surgery (1966-1987)", "MS": "Surgical fistulization of the membranous labyrinth of the inner ear with mastoid, subarachnoid or cochlear shunt. This procedure is used in the treatment of MENIERE DISEASE.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19870318", "DC": "1", "DX": "19880101", "UI": "D004713"}, {"RECTYPE": "D", "MH": "Endometrial Hyperplasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Simple Endometrial Hyperplasias", "MN": "C12.100.250.852.228", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex (adenomatous without atypia), and atypical hyperplasia representing also the ascending risk of becoming malignant.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004714"}, {"RECTYPE": "D", "MH": "Endometriosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Endometrioma|T047|NON|REL|NLM (2003)|011210|abcdef", "ENTRY": "Endometrioses", "MN": "C12.100.250.163", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004715"}, {"RECTYPE": "D", "MH": "Endometritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Endomyometritis|T047|NON|REL|NLM (2003)|011017|abcdef", "MN": "C12.100.250.852.299", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Inflammation of the ENDOMETRIUM, usually caused by intrauterine infections. Endometritis is the most common cause of postpartum fever.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004716"}, {"RECTYPE": "D", "MH": "Endometrium", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Endometria|T023|NON|EQV|NLM (1992)|911107|abcdef", "MN": "A05.360.319.679.490", "MH_TH": "NLM (1963)", "ST": "T023", "MS": "The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.", "MR": "20070711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004717"}, {"RECTYPE": "D", "MH": "Saccharomycetales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Yeast, Budding|T004|NON|EQV|NLM (1999)|971107|abcdef", "ENTRY": "Yeasts, Budding", "MN": "B01.300.107.795", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid4892", "MS": "An order of fungi in the phylum Ascomycota that multiply by budding. They include the telomorphic ascomycetous yeasts which are found in a very wide range of habitats.", "PM": "1999; see ENDOMYCETALES 1986-1998, see ASCOMYCETES 1963-1985; for ENDOMYCOPSIS see ASCOMYCETES 1975-1985", "HN": "1999 (1963)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D004718"}, {"RECTYPE": "D", "MH": "Endomyocardial Fibrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fibrosis, Endomyocardial", "MN": "C14.280.238.406", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004719"}, {"RECTYPE": "D", "MH": "Endonucleases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endonuclease|T116|T126|NON|EQV|NLM (2021)|191227|abbcdef", "MN": "D08.811.277.352.355", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 3.1.-", "PI": "Phosphatases (1966-1972)", "MS": "Enzymes that catalyze the hydrolysis of the internal bonds and thereby the formation of polynucleotides or oligonucleotides from ribo- or deoxyribonucleotide chains. EC 3.1.-.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004720"}, {"RECTYPE": "D", "MH": "Endoplasmic Reticulum", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Ergastoplasm|T026|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Reticulum, Endoplasmic", "MN": "A11.284.430.214.190.875.248", "MH_TH": "NLM (1964)", "ST": "T026", "MS": "A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed)", "PM": "65", "HN": "65", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004721"}, {"RECTYPE": "D", "MH": "Endoribonucleases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endoribonuclease|T116|T126|NON|EQV|NLM (2021)|200117|abbcdef", "MN": "D08.811.277.352.700.350", "MH_TH": "NLM (1983)", "ST": "T126", "RN": "EC 3.1.-", "PI": "Ribonucleases (1966-1982)", "MS": "A family of enzymes that catalyze the endonucleolytic cleavage of RNA. It includes EC 3.1.26.-, EC 3.1.27.-, EC 3.1.30.-, and EC 3.1.31.-.", "PM": "83", "HN": "83", "MR": "20200527", "DA": "19820429", "DC": "1", "DX": "19830101", "UI": "D004722"}, {"RECTYPE": "D", "MH": "Endorphins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Endorphin|T116|T123|NON|EQV|UNK (19XX)|870511|abbcdef", "MN": "D12.776.631.650.575.241", "PA": "Neurotransmitter Agents", "FX": "Receptors, Opioid", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "PI": "Peptides (1966-Jul 1977)", "MS": "One of the three major groups of endogenous opioid peptides. They are large peptides derived from the PRO-OPIOMELANOCORTIN precursor. The known members of this group are alpha-, beta-, and gamma-endorphin. The term endorphin is also sometimes used to refer to all opioid peptides, but the narrower sense is used here; OPIOID PEPTIDES is used for the broader group.", "PM": "78; was indexed under PEPTIDES Aug-Dec 1977", "HN": "78(Aug 77); was see under PEPTIDES Aug-Dec 1977", "MR": "20151123", "DA": "19770516", "DC": "1", "DX": "19780101", "UI": "D004723"}, {"RECTYPE": "D", "MH": "Endoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Endoscopic|T060|T061|NON|NRW|NLM (1996)|990101|SURG PROCEDURES ENDOSCOPIC|abbcdefv", "ENTRY": "Procedures, Endoscopic Surgical", "MN": "E04.502.250", "FX": "Endoscopes", "MH_TH": "NLM (1978)", "ST": "T061", "AN": "general or unspecified; prefer specifics; / instrum permitted but consider also ENDOSCOPES", "MS": "Procedures of applying ENDOSCOPES for disease diagnosis and treatment. Endoscopy involves passing an optical instrument through a small incision in the skin i.e., percutaneous; or through a natural orifice and along natural body pathways such as the digestive tract; and/or through an incision in the wall of a tubular structure or organ, i.e. transluminal, to examine or perform surgery on the interior parts of the body.", "PM": "1963; for SURGICAL PROCEDURES, ENDOSCOPIC and ENDOSCOPIC SURGICAL PROCEDURES see SURGICAL PROCEDURES, ENDOSCOPIC 1998-1999, see SURGERY, ENDOSCOPIC 1996-1997", "HN": "1963", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004724"}, {"RECTYPE": "D", "MH": "Endospore-Forming Bacteria", "DE": "ENDOSPORE FORMING BACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Endospore Forming Bacteria|T007|NON|EQV|UNK (19XX)|780228|abcdef", "MN": "B03.300", "MH_TH": "NLM (1976)", "ST": "T007", "AN": "general or unspecified; prefer specific families & genera", "PI": "Spores, Bacterial (1976-1997)", "MS": "A group of rods or cocci whose taxonomic affinities are uncertain. They form endospores, thick-walled bodies formed within the vegetative cells of certain bacteria, able to withstand adverse environmental conditions for prolonged periods.", "PM": "98", "HN": "98; use explode 1976-97", "MR": "20200902", "DA": "19750725", "DC": "1", "DX": "19980101", "UI": "D004725"}, {"RECTYPE": "D", "MH": "Endosulfan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta Endosulfan", "MN": "D03.633.100.197.408", "PA": "Insecticides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "6,9-Methano-2,4,3-benzodioxathiepin, 6,7,8,9,10,10-hexachloro-1,5,5a,6,9,9a-hexahydro-, 3-oxide", "RN": "OKA6A6ZD4K", "RR": "TT768EVS2A", "PI": "Insecticides (1966-1972)", "MS": "A polychlorinated compound used for controlling a variety of insects. It is practically water-insoluble, but readily adheres to clay particles and persists in soil and water for several years. Its mode of action involves repetitive nerve-discharges positively correlated to increase in temperature. This compound is extremely toxic to most fish. (From Comp Biochem Physiol (C) 1993 Jul;105(3):347-61)", "PM": "74", "HN": "74(72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004726"}, {"RECTYPE": "D", "MH": "Endothelium", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Endotheliums", "MN": "A10.272.491", "MH_TH": "NLM (1973)", "ST": "T024", "AN": "general or unspecified; prefer specifics; usually NIM with specific organ IM", "PI": "Epithelium (1966-1972)", "MS": "A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body.", "PM": "74", "HN": "74(73)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004727"}, {"RECTYPE": "D", "MH": "Endothelium, Corneal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Epithelium, Anterior Chamber|T024|NON|NRW|NLM (1991)|900308|abcdef", "ENTRY": "Anterior Chamber Endothelium", "MN": "A10.272.491.318", "MH_TH": "NLM (1988)", "ST": "T024", "AN": "do not confuse with EPITHELIUM, CORNEAL; do not confuse entry term ANTERIOR CHAMBER EPITHELIUM with ANTERIOR CORNEAL EPITHELIUM see EPITHELIUM, CORNEAL", "PI": "Epithelium (1966-1987)", "MS": "Single layer of large flattened cells covering the surface of the cornea.", "PM": "88", "HN": "88", "MR": "19970620", "DA": "19870508", "DC": "1", "DX": "19880101", "UI": "D004728"}, {"RECTYPE": "D", "MH": "Endothelium, Lymphatic", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Lymphatic Endothelium|T024|NON|EQV|UNK (19XX)|870508|abcdef", "ENTRY": "Lymphatic Endotheliums", "MN": "A15.382.520.301.500", "MH_TH": "NLM (1988)", "ST": "T024", "PI": "Lymphatic System or specific (1966-1987)", "MS": "Unbroken cellular lining (intima) of the lymph vessels (e.g., the high endothelial lymphatic venules). It is more permeable than vascular endothelium, lacking selective absorption and functioning mainly to remove plasma proteins that have filtered through the capillaries into the tissue spaces.", "PM": "91; was see under ENDOTHELIUM 1988-90", "HN": "91(88); was see under ENDOTHELIUM 1988-90", "MR": "20030709", "DA": "19870508", "DC": "1", "DX": "19910101", "UI": "D004729"}, {"RECTYPE": "D", "MH": "Endothelium, Vascular", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Vascular Endothelium|T024|NON|EQV|UNK (19XX)|870508|abcdef", "ENTRY": "Vascular Endotheliums", "MN": "A10.272.491.355", "MH_TH": "NLM (1988)", "ST": "T024", "PI": "Endothelium (1973-1987)", "MS": "Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components.", "PM": "88", "HN": "88", "MR": "20180630", "DA": "19870508", "DC": "1", "DX": "19880101", "UI": "D004730"}, {"RECTYPE": "D", "MH": "Endotoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Endotoxin|T131|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D23.946.123.329", "FX": "Limulus Test", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "antag permitted but consider also ANTITOXINS; coordinate IM with specific bacterium (IM with no qualifiers); for interaction of endotoxins with SUPERANTIGENS", "MS": "Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004731"}, {"RECTYPE": "D", "MH": "Endrin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hexadrin|T109|T131|TRD|NRW|UNK (19XX)|810427|abbcdef", "MN": "D02.455.526.439.416", "PA": "Insecticides", "MH_TH": "NLM (1971)", "ST": "T131", "N1": "2,7:3,6-Dimethanonaphth(2,3-b)oxirene, 3,4,5,6,9,9-hexachloro-1a,2,2a,3,6,6a,7,7a-octahydro-, (1aalpha,2beta,2abeta,3alpha,6alpha,6abeta,7beta,7aalpha)-", "RN": "OB9NVE7YCL", "RR": "72-20-8 (Endrin)", "PI": "Insecticides (1966-1972)", "MS": "An organochlorine compound that was formerly used as an insecticide. Its manufacture and use has been discontinued in the United States. (From Merck Index, 11th ed)", "PM": "74", "HN": "74(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004732"}, {"RECTYPE": "D", "MH": "Enema", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Enematas", "MN": "E02.319.347", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "barium enema: coordinate with BARIUM SULFATE, not BARIUM", "MS": "Insertion of a solution or compound through the RECTUM with the purpose of cleansing the COLON or for diagnostic procedures.", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004733"}, {"RECTYPE": "D", "MH": "Energy Metabolism", "DE": "ENERGY METAB", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Energy Expenditure|T039|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Metabolisms, Energy", "MN": "G03.295", "MH_TH": "NLM (1974)", "ST": "T039", "MS": "The chemical reactions involved in the production and utilization of various forms of energy in cells.", "PM": "74,63-65", "HN": "74,63-65", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004734"}, {"RECTYPE": "D", "MH": "Energy Transfer", "AQ": "DE GE IM PH RE", "ENTRY": "Transfer, Energy", "MN": "G02.216", "MH_TH": "NLM (1965)", "ST": "T044", "MS": "The transfer of energy of a given form among different scales of motion. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed). It includes the transfer of kinetic energy and the transfer of chemical energy. The transfer of chemical energy from one molecule to another depends on proximity of molecules so it is often used as in techniques to measure distance such as the use of FORSTER RESONANCE ENERGY TRANSFER.", "PM": "68", "HN": "68(65)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004735"}, {"RECTYPE": "D", "MH": "Energy-Generating Resources", "AQ": "CL EC ES HI LJ SN ST", "ENTRY": "Secondary Energy Resource", "MN": "N06.230.132", "FX": "Power Plants", "MH_TH": "NLM (1982)", "ST": "T169", "MS": "Materials or phenomena which can provide energy directly or via conversion.", "PM": "82", "HN": "82", "MR": "20110624", "DA": "19810519", "DC": "1", "DX": "19820101", "UI": "D004736"}, {"RECTYPE": "D", "MH": "Enflurane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Etran|T109|T121|TRD|NRW|UNK (19XX)|870812|abbcdef", "MN": "D02.355.601.400", "PA": "Anesthetics, Inhalation", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Ethane, 2-chloro-1-(difluoromethoxy)-1,1,2-trifluoro-", "RN": "91I69L5AY5", "RR": "13838-16-9 (Enflurane)", "PI": "Methyl Ethers (1973-1974)", "MS": "An extremely stable inhalation anesthetic that allows rapid adjustments of anesthesia depth with little change in pulse or respiratory rate.", "PM": "80; was see under METHYL ETHERS 1975-79", "HN": "80(75); was see under METHYL ETHERS 1975-79", "MR": "20160705", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D004737"}, {"RECTYPE": "D", "MH": "Engineering", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Engineerings", "MN": "J01.293", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "The practical application of physical, mechanical, and mathematical principles. (Stedman, 25th ed)", "MR": "19950523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004738"}, {"RECTYPE": "D", "MH": "England", "AQ": "EH EP", "MN": "Z01.542.363.300", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "LONDON is also available", "MS": "A part of Great Britain within the United Kingdom.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D004739"}, {"RECTYPE": "D", "MH": "English Abstract", "MN": "V01.260", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "for English Abstracts of foreign articles only; do not confuse with author abstracts; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Identifier for English language abstracts provided with non-English language works.", "HN": "1969", "MR": "20171211", "DA": "19990101", "DC": "2", "DX": "19690101", "UI": "D004740"}, {"RECTYPE": "D", "MH": "Engraving and Engravings", "DE": "ENGRAVING ENGRAVINGS", "AQ": "CL HI", "ENTRY": "Engravings and Engraving", "MN": "K01.093.346", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Creating marks on a hard surface by incising with a sharp tool. Resulting images are created for their own sake or for printing processes that involve this technique. (Getty ATT).", "MR": "20180124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004741"}, {"RECTYPE": "D", "MH": "Enhancer Elements, Genetic", "AQ": "DE GE IM PH RE", "ENTRY": "Sequences, Enhancer", "MN": "G05.360.340.024.340.137.750.249", "MH_TH": "NLM (2009)", "ST": "T123", "PI": "Transcription, Genetic (1973-1984)", "MS": "Cis-acting DNA sequences which can increase transcription of genes. Enhancers can usually function in either orientation and at various distances from a promoter.", "PM": "2009; see ENHANCER ELEMENTS (GENETICS) 1988-2008, see GENES, REGULATOR 1985-1987", "HN": "2009 (1985)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19840405", "DC": "1", "DX": "19880101", "UI": "D004742"}, {"RECTYPE": "D", "MH": "Enkephalin, Leucine", "DE": "ENKEPHALIN LEU", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Leucine Enkephalin|T116|T123|NON|EQV|UNK (19XX)|820504|abbcdef", "ENTRY": "Leu Enkephalin", "MN": "D12.776.631.650.575.281.231", "PA": "Neurotransmitter Agents", "MH_TH": "NLM (1983)", "ST": "T123", "N1": "Tyr-Gly-Gly-Phe-Leu", "RN": "58822-25-6", "PI": "Peptides (1966-Jul 1977)", "MS": "One of the endogenous pentapeptides with morphine-like activity. It differs from MET-ENKEPHALIN in the LEUCINE at position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN.", "PM": "83", "HN": "83", "MR": "20151123", "DA": "19820504", "DC": "1", "DX": "19830101", "UI": "D004743"}, {"RECTYPE": "D", "MH": "Enkephalin, Methionine", "DE": "ENKEPHALIN MET", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methionine Enkephalin|T116|T123|NON|EQV|UNK (19XX)|820504|abbcdef", "ENTRY": "Met Enkephalin", "MN": "D12.776.631.650.575.281.381", "PA": "Neurotransmitter Agents", "MH_TH": "NLM (1983)", "ST": "T123", "N1": "Tyr-Gly-Gly-Phe-Met", "RN": "58569-55-4", "PI": "Peptides (1966-Jul 1977)", "MS": "One of the endogenous pentapeptides with morphine-like activity. It differs from LEU-ENKEPHALIN by the amino acid METHIONINE in position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN.", "PM": "83", "HN": "83", "MR": "20151123", "DA": "19820504", "DC": "1", "DX": "19830101", "UI": "D004744"}, {"RECTYPE": "D", "MH": "Enkephalins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Enkephalin|T116|T123|NON|EQV|UNK (19XX)|870504|abbcdef", "MN": "D12.776.631.650.575.281", "PA": "Neurotransmitter Agents", "FX": "Receptors, Opioid", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Oligopeptides (1973-Jul 1977)", "MS": "One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla.", "PM": "83; was see under ENDORPHINS Aug 1977-82", "HN": "83(Aug 77); was see under ENDORPHINS Aug 1977-82", "MR": "20151123", "DA": "19770516", "DC": "1", "DX": "19830101", "UI": "D004745"}, {"RECTYPE": "D", "MH": "Enoyl-CoA Hydratase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Hydroxyacyl Dehydratases|T116|T126|NON|EQV|UNK (19XX)|770520|abbcdef", "ENTRY": "trans 2 Enoyl Coenzyme A Hydratase", "MN": "D08.811.520.241.300.250", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "(3S)-3-Hydroxyacyl-CoA hydro-lyase", "RN": "EC 4.2.1.17", "RR": "9027-13-8 (CAS RN)", "PI": "Hydro-Lyases (1966-1977)", "MS": "An enzyme that catalyzes reversibly the hydration of unsaturated fatty acyl-CoA to yield beta-hydroxyacyl-CoA. It plays a role in the oxidation of fatty acids and in mitochondrial fatty acid synthesis, has broad specificity, and is most active with crotonyl-CoA. EC 4.2.1.17.", "PM": "97; was ENOYL COA HYDRATASES 1978-96 (see under HYDRO-LYASES 1978-90)", "HN": "97; was ENOYL COA HYDRATASES 1978-96 (see under HYDRO-LYASES 1978-90)", "MR": "20160628", "DA": "19770520", "DC": "1", "DX": "19910101", "UI": "D004746"}, {"RECTYPE": "D", "MH": "Entamoeba", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Entamoebas", "MN": "B01.046.500.100.700.335", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5758", "MS": "A genus of ameboid protozoa characterized by the presence of beaded chromatin on the inner surface of the nuclear membrane. Its organisms are parasitic in invertebrates and vertebrates, including humans.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004747"}, {"RECTYPE": "D", "MH": "Entamoeba histolytica", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Endamoeba histolytica|T204|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "histolytica, Endamoeba", "MN": "B01.046.500.100.700.335.330", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5759", "AN": "infection: coordinate with ENTAMOEBIASIS and, if pertinent, coordinate with  DYSENTERY, AMEBIC or LIVER ABSCESS, AMEBIC; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A species of parasitic protozoa causing ENTAMOEBIASIS and amebic dysentery (DYSENTERY, AMEBIC). Characteristics include a single nucleus containing a small central karyosome and peripheral chromatin that is finely and regularly beaded.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004748"}, {"RECTYPE": "D", "MH": "Entamoebiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Entamoeba histolytica", "MN": "C01.610.752.049.407", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "amebic infect", "MS": "Infection with amoebae of the genus ENTAMOEBA. Infection with E. histolytica causes DYSENTERY, AMEBIC and LIVER ABSCESS, AMEBIC.", "OL": "search AMEBIASIS 1966-74", "PM": "91; was see under AMEBIASIS 1975-90", "HN": "91(75); was see under AMEBIASIS 1975-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004749"}, {"RECTYPE": "D", "MH": "Enteral Nutrition", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tube Feeding|T061|NON|NRW|UNK (19XX)|790530|abcdef", "ENTRY": "Tubes, Gastric Feeding", "MN": "E02.642.500.360", "FX": "Intubation, Gastrointestinal", "MH_TH": "IOM (1990)", "ST": "T061", "AN": "coordinate with disease /ther, not disease /diet ther; do not confuse with PARENTERAL NUTRITION or PARENTERAL NUTRITION, TOTAL", "MS": "Nutritional support given via the alimentary canal or any route connected to the gastrointestinal system (i.e., the enteral route). This includes oral feeding, sip feeding, and tube feeding using nasogastric, gastrostomy, and jejunostomy tubes.", "OL": "use ENTERAL NUTRITION to search ENTERAL FEEDING 1980-91 & TUBE FEEDING 1966-79", "PM": "92; was ENTERAL FEEDING 1980-91, was TUBE FEEDING 1966-79; ENTERAL NUTRITION was see ENTERAL FEEDING 1990-91", "HN": "92; was ENTERAL FEEDING 1980-91, was TUBE FEEDING 1964-79 (Prov 1964-65); ENTERAL NUTRITION was see ENTERAL FEEDING 1990-91", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004750"}, {"RECTYPE": "D", "MH": "Enteritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Enteritides", "MN": "C06.405.469.326", "FX": "Ileitis", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "general or unspecified; prefer specifics; jejunitis: index JEJUNAL DISEASES and ENTERITIS ", "MS": "Inflammation of any segment of the SMALL INTESTINE.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004751"}, {"RECTYPE": "D", "MH": "Coronavirus, Turkey", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Transmissible Enteritis Virus of Turkeys|T005|NON|EQV|UNK (19XX)|741211|TRANSM ENTERITIS VIRUS OF TURKEYS|abcdefv", "ENTRY": "Turkey Enteritis Viruses", "MN": "B04.820.578.500.540.150.400.500", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid11152", "MS": "A species of CORONAVIRUS causing enteritis in turkeys and pullets.", "OL": "use CORONAVIRUS, TURKEY to search ENTERITIS VIRUS, TURKEY 1975-93", "PM": "94; was ENTERITIS VIRUS, TURKEY 1991-93 (see under CORONAVIRIDAE 1981-90, see under REOVIRUSES 1975-80)", "HN": "94; was ENTERITIS VIRUS, TURKEY 1975-93 (see under CORONAVIRIDAE 1981-90, see under REOVIRUSES 1975-80)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004752"}, {"RECTYPE": "D", "MH": "Enteritis, Transmissible, of Turkeys", "DE": "ENTERITIS TRANSM TURKEYS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Transmissible Enteritis of Turkeys|T047|NON|EQV|UNK (19XX)|750722|TRANSM ENTERITIS TURKEYS|abcdefv", "MN": "C22.131.728.250", "FX": "Poult Enteritis Mortality Syndrome", "MH_TH": "NLM (1976)", "ST": "T047", "AN": "don't forget TURKEYS (NIM); POULT ENTERITIS MORTALITY SYNDROME is also available", "PI": "Poultry Diseases (1966-1975)", "MS": "An acute, highly contagious virus disease of turkeys characterized by chilling, anorexia, decreased water intake, diarrhea, dehydration and weight loss. The infectious agent is a CORONAVIRUS.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D004753"}, {"RECTYPE": "D", "MH": "Enterobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.170", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid547", "AN": "infection: coordinate with ENTEROBACTERIACEAE INFECTIONS ", "MS": "Gram-negative gas-producing rods found in feces of humans and other animals, sewage, soil, water, and dairy products.", "OL": "use ENTEROBACTER to search AEROBACTER 1966-77", "PM": "91; was see under ENTEROBACTERIACEAE 1978-90; was AEROBACTER see under ENTEROBACTERIACEAE 1976-77; was AEROBACTER 1963-75", "HN": "91(78); was see under ENTEROBACTERIACEAE 1978-90; was AEROBACTER see under ENTEROBACTERIACEAE 1976-77; was AEROBACTER 1963-75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004754"}, {"RECTYPE": "D", "MH": "Enterobacteriaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Sodalis|T007|NON|NRW|NLM (2007)|060119|abcdef", "MN": "B03.660.250.150", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid543", "RR": "txid84565", "MS": "A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004755"}, {"RECTYPE": "D", "MH": "Enterobacteriaceae Infections", "DE": "ENTEROBACTERIACEAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Enterobacterial Infections|T047|NON|EQV|NLM (1998)|960716|ENTEROBACT INFECT|abcdefv", "ENTRY": "Infections, Cronobacter", "MN": "C01.150.252.400.310", "MH_TH": "NLM (1968)", "ST": "T047", "PI": "Enterobacteriaceae (1966-1967)", "MS": "Infections with bacteria of the family ENTEROBACTERIACEAE.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004756"}, {"RECTYPE": "D", "MH": "Enterobius", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Threadworms|T204|NON|EQV|UNK (19XX)|780310|abcdef", "ENTRY": "vermicularis, Oxyuris", "MN": "B01.050.500.500.294.400.750.500.308", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid51027", "RR": "txid51028", "MS": "A genus of intestinal nematode worms which includes the pinworm or threadworm Enterobius vermicularis.", "OL": "use ENTEROBIUS to search OXYURIS VERMICULARIS 1966-78", "PM": "OXYURIS VERMICULARIS was see under ENTEROBIUS 1963-78", "HN": "OXYURIS VERMICULARIS was see under ENTEROBIUS 1963-78", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D004757"}, {"RECTYPE": "D", "MH": "Enterobactin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Enterochelin|T116|NON|EQV|NLM (1993)|920313|abcdef", "MN": "D12.644.641.352", "PA": "Siderophores", "MH_TH": "NLM (1975)", "ST": "T116", "N1": "Benzamide, N,N',N''-(2,6,10-trioxo-1,5,9-trioxacyclododecane-3,7,11-triyl)tris(2,3-dihydroxy-, (3S-(3R*,7R*,11R*)))-", "RN": "28384-96-5", "PI": "Serine (1971-1974)", "MS": "An iron-binding cyclic trimer of 2,3-dihydroxy-N-benzoyl-L-serine. It is produced by E COLI and other enteric bacteria.", "OL": "use ENTEROBACTIN to search ENTEROCHELIN 1975-92", "PM": "91; was ENTEROCHELIN 1975-92; ENTEROCHELIN was see under SERINE 1975-92; ENTEROBACTIN was see ENTEROCHELIN 1975-92", "HN": "93(75); was ENTEROCHELIN 1975-92; ENTEROCHELIN was see under SERINE 1975-90; ENTEROBACTIN was see ENTEROCHELIN 1975-92", "MR": "20150622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004758"}, {"RECTYPE": "D", "MH": "Enterochromaffin Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Argentaffin Cells|T025|NON|EQV|UNK (19XX)|770111|abcdef", "ENTRY": "Serotonin-Containing Enterochromaffin Cell", "MN": "A15.382.250", "FX": "Enterochromaffin-like Cells", "MH_TH": "NLM (1975)", "ST": "T025", "MS": "A subtype of enteroendocrine cells found in the gastrointestinal MUCOSA, particularly in the glands of PYLORIC ANTRUM; DUODENUM; and ILEUM. These cells secrete mainly SEROTONIN and some neuropeptides. Their secretory granules stain readily with silver (argentaffin stain).", "OL": "search CHROMAFFIN SYSTEM 1968-74", "PM": "91; was see under CHROMAFFIN SYSTEM 1975-90", "HN": "91(75); was see under CHROMAFFIN SYSTEM 1975-90", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004759"}, {"RECTYPE": "D", "MH": "Enterocolitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Enterocolitides", "MN": "C06.405.469.363", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "note specifics", "PI": "Enteritis (1966-1984)", "MS": "Inflammation of the MUCOSA of both the SMALL INTESTINE and the LARGE INTESTINE. Etiology includes ISCHEMIA, infections, allergic, and immune responses.", "PM": "85", "HN": "85", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19840406", "DC": "1", "DX": "19850101", "UI": "D004760"}, {"RECTYPE": "D", "MH": "Enterocolitis, Pseudomembranous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Enteritis, Pseudomembranous|T047|NON|NRW|NLM (1991)|900113|abcdef", "ENTRY": "Colitis, Antibiotic-Associated", "MN": "C06.405.469.363.800", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific Clostridium species (IM)", "MS": "An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.", "OL": "use ENTEROCOLITIS, PSEUDOMEMBRANOUS to search ENTEROCOLITIS, ACUTE 1966-84", "PM": "85; was ENTEROCOLITIS, ACUTE 1963-84", "HN": "85; was ENTEROCOLITIS, ACUTE 1963-84", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D004761"}, {"RECTYPE": "D", "MH": "Glucagon-Like Peptides", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gut Glucagon|T116|T123|NON|NRW|UNK (19XX)|771209|abbcdef", "ENTRY": "Polypeptide, Glucagon-Like", "MN": "D06.472.317.680.500", "FX": "Gastrointestinal Agents", "MH_TH": "NLM (2006)", "ST": "T125", "RN": "62340-29-8", "PI": "Peptides (1966-1978)", "MS": "Peptides derived from proglucagon which is also the precursor of pancreatic GLUCAGON. Despite expression of proglucagon in multiple tissues, the major production site of glucagon-like peptides (GLPs) is the INTESTINAL L CELLS. GLPs include glucagon-like peptide 1, glucagon-like peptide 2, and the various truncated forms.", "PM": "2007; see ENTEROGLUCAGONS 2006, see ENTEROGLUCAGON 1991-2005, see GASTROINTESTINAL HORMONES 1979-1990", "HN": "2007 (1979)", "MR": "20200527", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D004763"}, {"RECTYPE": "D", "MH": "Enterohepatic Circulation", "DE": "ENTEROHEPATIC CIRC", "AQ": "DE ES GE IM PH RE", "ENTRY": "Enterohepatic Circulations", "MN": "G03.312", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "a metab concept, not a hemodynamic circ concept; bile-to-intestines-to-portal circ-to-liver-to-bile", "PI": "Liver Circulation (1966-1974)", "MS": "Recycling through liver by excretion in bile, reabsorption from intestines (INTESTINAL REABSORPTION) into portal circulation, passage back into liver, and re-excretion in bile.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D004764"}, {"RECTYPE": "D", "MH": "Enteropeptidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Enterokinase|T116|T126|NON|EQV|UNK (19XX)|800801|abbcdef", "MN": "D08.811.277.656.959.350.284", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 3.4.21.9", "MS": "A specialized proteolytic enzyme secreted by intestinal cells. It converts TRYPSINOGEN into its active form TRYPSIN by removing the N-terminal peptide. EC 3.4.21.9.", "PM": "91; was see under SERINE PROTEINASES 1973-90", "HN": "91(73); was see under SERINE ENDOPEPTIDASES 1973-90", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004765"}, {"RECTYPE": "D", "MH": "Enterostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Enterostomies", "MN": "E04.579.338", "MH_TH": "NLM (1988)", "ST": "T061", "AN": "general or unspecified only; prefer specifics ", "PI": "Ileostomy (1966-1987)", "MS": "Creation of an artificial external opening or fistula in the intestines.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19870318", "DC": "1", "DX": "19880101", "UI": "D004766"}, {"RECTYPE": "D", "MH": "Enterotoxemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Enterotoxemias", "MN": "C22.313", "MH_TH": "NLM (1969)", "ST": "T047", "AN": "Clostridium infect; animal only; check tag ANIMALS; coord IM with precoord animal/dis term (IM) + animal (NIM) or with animal (IM) in absence of precoord", "PI": "Clostridium Infections/veterinary (1966-1968)", "MS": "Disease caused by the liberation of exotoxins of CLOSTRIDIUM PERFRINGENS in the intestines of sheep, goats, cattle, foals, and piglets. Type B enterotoxemia in lambs is lamb dysentery; type C enterotoxemia in mature sheep produces \"struck\", and in calves, lambs and piglets it produces hemorrhagic enterotoxemia; type D enterotoxemia in sheep and goats is pulpy-kidney disease or overeating disease.", "PM": "91; was see under CLOSTRIDIUM INFECTIONS 1969-90", "HN": "91(69); was see under CLOSTRIDIUM INFECTIONS 1969-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004767"}, {"RECTYPE": "D", "MH": "Enterotoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Staphylococcal Enterotoxin|T131|NON|NRW|NLM (2021)|200317|abcdef", "ENTRY": "Enterotoxins, Staphylococcal", "MN": "D23.946.330", "FX": "Staphylococcal Food Poisoning", "MH_TH": "NLM (1964)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTITOXINS; coordinate with specific microorganism", "MS": "Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria.", "OL": "use ENTEROTOXINS to search ENTEROTOXIN 1966-67 (as Prov)", "PM": "68", "HN": "68; was ENTEROTOXIN 1964-67 (Prov)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004768"}, {"RECTYPE": "D", "MH": "Enterovirus Infections", "DE": "ENTEROVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Enterovirus", "MN": "C01.925.782.687.359", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases caused by ENTEROVIRUS.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004769"}, {"RECTYPE": "D", "MH": "Enterovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Coxsackieviruses|T005|NON|NRW|NLM (1966)|990101|abcdef", "MN": "B04.820.578.750.284", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid12059", "MS": "A genus of the family PICORNAVIRIDAE whose members preferentially inhabit the intestinal tract of a variety of hosts. The genus contains many species. Newly described members of human enteroviruses are assigned continuous numbers with the species designated \"human enterovirus\".", "OL": "use ENTEROVIRUS to search ENTEROVIRUSES 1975-93", "PM": "94,63-74; was ENTEROVIRUSES 1975-93", "HN": "94,63-74; was ENTEROVIRUSES 1975-93", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D004770"}, {"RECTYPE": "D", "MH": "Enteroviruses, Porcine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Porcine Enteroviruses|T005|NON|EQV|UNK (19XX)|741211|abcdef", "ENTRY": "Porcine Enterovirus", "MN": "B04.820.578.750.284.600", "MH_TH": "NLM (1975)", "ST": "T005", "RR": "txid686984", "AN": "infection: coordinate IM with ENTEROVIRUS INFECTIONS (IM)", "MS": "Species of ENTEROVIRUS causing mild to severe neurological diseases among pigs especially in Eastern Europe. Mild strains are also present in Canada, U.S., and Australia. Specific species include Porcine enterovirus A and Porcine enterovirus B.", "PM": "91; was see under ENTEROVIRUSES 1975-90", "HN": "91(75); was see under ENTEROVIRUSES 1975-90", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004771"}, {"RECTYPE": "D", "MH": "Entomology", "DE": "ENTOMOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.158.273.943.409", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "A discipline or occupation concerned with the study of INSECTS, including the biology and the control of insects.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004772"}, {"RECTYPE": "D", "MH": "Entomophthora", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Entomophthoras", "MN": "B01.300.300.300.300", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid34484", "AN": "infection: coord IM with ZYGOMYCOSIS (IM)", "MS": "A genus of fungi in the family Entomophthoraceae, order Entomorphthorales. They are primarily parasites of insects and spiders, but have been found to cause mycotic infections of the nose in man and horses.", "PM": "91; see ZYGOMYCOTINA 1986-90, see ZYGOMYCETES 1979-85, see PHYCOMYCETES 1975-78", "HN": "91(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004773"}, {"RECTYPE": "D", "MH": "Entropion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Entropions", "MN": "C11.338.443", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "inversion of eyelid: do not confuse with ECTROPION, eversion", "MS": "The turning inward (inversion) of the edge of the eyelid, with the tarsal cartilage turned inward toward the eyeball. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004774"}, {"RECTYPE": "D", "MH": "Enuresis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "F03.388.400", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general; prefer specifics", "MS": "Involuntary discharge of URINE after expected age of completed development of urinary control. This can happen during the daytime (DIURNAL ENURESIS) while one is awake or during sleep (NOCTURNAL ENURESIS). Enuresis can be in children or in adults (as persistent primary enuresis and secondary adult-onset enuresis).", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004775"}, {"RECTYPE": "D", "MH": "Enviomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tuberactinomycin N|T116|T195|NON|EQV|FDA SRS (2014)|UNK (19XX)|800523|abbcdeef", "ENTRY": "Tuberactinomycin-N|T116|T195|NON|EQV|UNK (19XX)|780126|abbcdef", "MN": "D12.644.641.875.250", "PA": "Antibiotics, Antitubercular", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "Viomycin, 1-((3R,4R)-4-hydroxy-3,6-diaminohexanoic acid)-6-(L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine)-, (R)-", "RN": "XU299C23A2", "RR": "33103-22-9 (Enviomycin)", "PI": "Peptides (1966-1974)", "MS": "Cyclic basic peptide related to VIOMYCIN. It is isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin.", "OL": "use ENVIOMYCIN to search TUBERACTINOMYCIN-N 1975-80", "PM": "91; was see under VIOMYCINS 1981-90; was TUBERACTINOMYCIN-N see under ANTIBIOTICS, ANTITUBERCULAR 1975-80", "HN": "91(81); was see under VIOMYCINS 1981-90; was TUBERACTINOMYCIN-N see under ANTIBIOTICS, ANTITUBERCULAR 1975-80", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004776"}, {"RECTYPE": "D", "MH": "Environment", "DE": "ENVIR", "ENTRY": "Environments", "MN": "N06.230", "FX": "Social Environment", "EC": "microbiology:Environmental Microbiology", "MH_TH": "NLM (1986)", "ST": "T082", "MS": "The external elements and conditions which surround, influence, and affect the life and development of an organism or population.", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004777"}, {"RECTYPE": "D", "MH": "Environment and Public Health", "DE": "ENVIR PUBLIC HEALTH", "AQ": "AE AN CL EC ES HI LJ MT PC SN ST", "MN": "N06", "RH": "N6 - ENVIRONMENT AND PUBLIC HEALTH", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Natural and man-made environments and their impact on public health.", "PM": "1998", "HN": "1998; use explode 1970-1997", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004778"}, {"RECTYPE": "D", "MH": "Environment Design", "DE": "ENVIR DESIGN", "AQ": "EC LJ SN ST TD", "ENTRY": "Healthy Place", "MN": "N06.230.145", "MH_TH": "NLM (1972)", "ST": "T078", "PI": "Environment (1966-1971)", "MS": "The structuring of the environment to permit or promote specific patterns of behavior.", "PM": "74", "HN": "74(72)", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004779"}, {"RECTYPE": "D", "MH": "Environment, Controlled", "DE": "ENVIR CONTROLLED", "PRINT ENTRY": "Laminar Air-Flow Areas|T068|NON|NRW|UNK (19XX)|820426|abcdef", "ENTRY": "Room, Clean", "MN": "N06.230.150", "FX": "Patient Isolators", "MH_TH": "NLM (1973)", "ST": "T068", "PI": "Environment (1966-1972)", "MS": "A state in which the environs of hospitals, laboratories, domestic and animal housing, work places, spacecraft, and other surroundings are under technological control with regard to air conditioning, heating, lighting, humidity, ventilation, and other ambient features. The concept includes control of atmospheric composition. (From Jane's Aerospace Dictionary, 3d ed)", "PM": "73", "HN": "73", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004780"}, {"RECTYPE": "D", "MH": "Environmental Exposure", "DE": "ENVIR EXPOSURE", "AQ": "AE AN CL EC ES HI LJ PC SN ST", "ENTRY": "Exposures, Environmental", "MN": "N06.850.460.350", "FX": "Persian Gulf Syndrome", "MH_TH": "NLM (1967)", "ST": "T037", "AN": "coordinate with specific substance ", "MS": "The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals.", "PM": "74", "HN": "74(67)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004781"}, {"RECTYPE": "D", "MH": "Environmental Health", "DE": "ENVIR HEALTH", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sciences, Environmental Health", "MN": "H02.229", "FX": "Environment", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "index geographic term if pertinent", "MS": "The science of controlling or modifying those conditions, influences, or forces surrounding man which relate to promoting, establishing, and maintaining health.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004782"}, {"RECTYPE": "D", "MH": "Environmental Microbiology", "DE": "ENVIR MICROBIOL", "AQ": "ST", "ENTRY": "Microbiology, Environmental|T067|NON|EQV|UNK (19XX)|840620|MICROBIOL ENVIR|abcdefv", "MN": "N06.850.425", "MH_TH": "NLM (1985)", "ST": "T067", "AN": "general or unspecified; prefer specifics", "MS": "The study of microorganisms living in a variety of environments (air, soil, water, etc.) and their pathogenic relationship to other organisms including man.", "PM": "85", "HN": "85; was NON MESH before 1985", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D004783"}, {"RECTYPE": "D", "MH": "Environmental Monitoring", "DE": "ENVIR MONITORING", "AQ": "EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Monitoring, Environmental|T057|NON|EQV|UNK (19XX)|850618|MONITORING ENVIR|abcdefv", "ENTRY": "Surveillance, Environmental", "MN": "N06.850.780.375", "FX": "Ecological Parameter Monitoring", "MH_TH": "NLM (1986)", "ST": "T057", "AN": "do not confuse with EPIDEMIOLOGICAL MONITORING", "PI": "Environmental Exposure (1967-1985)", "MS": "The monitoring of the level of toxins, chemical pollutants, microbial contaminants, or other harmful substances in the environment (soil, air, and water), workplace, or in the bodies of people and animals present in that environment.", "PM": "86", "HN": "86", "MR": "20190530", "DA": "19850618", "DC": "1", "DX": "19860101", "UI": "D004784"}, {"RECTYPE": "D", "MH": "Environmental Pollutants", "DE": "ENVIR POLLUTANTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pollutant|T131|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Pollutant, Environmental", "MN": "D27.888.284", "FX": "Environmental Pollution", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "specify pollutant if pertinent (IM or NIM); in addition to AIR POLLUTANTS; RADIOACTIVE POLLUTANTS; SOIL POLLUTANTS & WATER POLLUTANTS & their specifics, CARCINOGENS, ENVIRONMENTAL is also available; DF: ENVIR POLLUTANTS", "PI": "Environmental Pollution (1971-1974)", "MS": "Substances or energies, for example heat or light, which when introduced into the air, water, or land threaten life or health of individuals or ECOSYSTEMS.", "PM": "75", "HN": "75", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D004785"}, {"RECTYPE": "D", "MH": "Toxic Actions", "AQ": "AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO UR", "PRINT ENTRY": "Toxic Action|T131|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Actions, Toxic", "MN": "D27.888", "MH_TH": "NLM (2004)", "ST": "T131", "RN": "0", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "A broad category of chemical actions with harmful or deadly effect on living organisms.", "PM": "2004; see ENVIRONMENTAL POLLUTANTS, NOXAE, AND PESTICIDES 1998-2003", "HN": "2004(1998)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004786"}, {"RECTYPE": "D", "MH": "Environmental Pollution", "DE": "ENVIR POLLUTION", "AQ": "AE AN EC ES HI LJ PC SN", "ENTRY": "Pollution, Soil", "MN": "N06.850.460", "FX": "Environmental Pollutants", "MH_TH": "NLM (1986)", "ST": "T069", "AN": "coordinate IM with source of pollution (IM); specify geographic location if pertinent", "PI": "Environment (1966-1970)", "MS": "Contamination of the air, bodies of water, or land with substances that are harmful to human health and the environment.", "PM": "74", "HN": "74(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004787"}, {"RECTYPE": "D", "MH": "Enzyme Activation", "AQ": "DE GE IM PH RE", "ENTRY": "Enzyme Activations", "MN": "G03.328", "MH_TH": "NLM (1969)", "ST": "T044", "AN": "IM for general only; NIM with specific enzyme (IM); \"enzyme reactivation\": coord IM with specific enzyme /metab (IM) + ENZYME REACTIVATORS (IM) if discussed (see note there)", "MS": "Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme.", "PM": "76; was see under BIOCHEMISTRY 1975", "HN": "76(69); was see under BIOCHEMISTRY 1975", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D004789"}, {"RECTYPE": "D", "MH": "Enzyme Induction", "DE": "ENZYME IND", "AQ": "DE ES GE IM PH RE", "ENTRY": "Induction, Enzyme", "MN": "G05.308.320.200", "MH_TH": "NLM (1966)", "ST": "T045", "AN": "IM for general only; NIM with specific enzyme /biosyn (IM)", "MS": "An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis.", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004790"}, {"RECTYPE": "D", "MH": "Enzyme Inhibitors", "DE": "ENZYME INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Enzyme Inhibitor|T121|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Inhibitors, Enzyme", "MN": "D27.505.519.389", "MH_TH": "POPLINE (1978)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Enzymes/antagonists & inhibitors (1968-1974)", "MS": "Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.", "PM": "1975, 1964-1967", "HN": "1975(1964)", "MR": "20210304", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D004791"}, {"RECTYPE": "D", "MH": "Enzyme Precursors", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Zymogens|T116|T123|NON|EQV|UNK (19XX)|860414|abbcdef", "ENTRY": "Precursors, Enzyme", "MN": "D12.776.811.243", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "IM; coord with specific enzyme (IM); zymogen granules: index under ZYMOGEN GRANULES see SECRETORY VESICLES (IM) + ENZYME PRECURSORS (IM) + specific enzyme (IM)", "MS": "Physiologically inactive substances that can be converted to active enzymes.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004792"}, {"RECTYPE": "D", "MH": "Enzyme Reactivators", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Reactivators, Enzyme", "MN": "D27.505.519.405", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "coord IM with specific enzyme (IM) but CHOLINESTERASE REACTIVATORS is available for reactivators of CHOLINESTERASES & ACETYLCHOLINESTERASE (see note there)", "PI": "Enzymes (1966-1974)", "MS": "Compounds which restore enzymatic activity by removing an inhibitory group bound to the reactive site of the enzyme.", "PM": "75", "HN": "75", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D004793"}, {"RECTYPE": "D", "MH": "Enzyme Repression", "AQ": "DE ES GE IM PH RE", "ENTRY": "Repression, Enzyme", "MN": "G05.308.320.300", "MH_TH": "NLM (1964)", "ST": "T045", "AN": "IM for general only; NIM with specific enzyme /biosyn (IM)", "MS": "The interference in synthesis of an enzyme due to the elevated level of an effector substance, usually a metabolite, whose presence would cause depression of the gene responsible for enzyme synthesis.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004794"}, {"RECTYPE": "D", "MH": "Enzyme Stability", "AQ": "DE ES GE IM PH RE", "ENTRY": "Stability, Enzyme", "MN": "G02.111.700.500", "MH_TH": "NLM (1987)", "ST": "T080", "AN": "IM for general only; NIM with specific enzyme (IM)", "PI": "Temperature (1966-1986)", "MS": "The extent to which an enzyme retains its structural conformation or its activity when subjected to storage, isolation, and purification or various other physical or chemical manipulations, including proteolytic enzymes and heat.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19860325", "DC": "1", "DX": "19870101", "UI": "D004795"}, {"RECTYPE": "D", "MH": "Clinical Enzyme Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Enzyme Tests, Clinical|T059|NON|EQV|NLM (2008)|070604|abcdef", "ENTRY": "Tests, Clinical Enzyme", "MN": "E05.200.124.200", "MH_TH": "NLM (2008)", "ST": "T059", "AN": "coordinate with specific enzyme with pertinent qualifiers + disease /diag, not disease /enzymol", "MS": "Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status.", "PM": "2008; see ENZYME TESTS 1963-2007", "HN": "2008 (1963)", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D004796"}, {"RECTYPE": "D", "MH": "Enzyme-Linked Immunosorbent Assay", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "ELISA|T059|ABB|EQV|UNK (19XX)|800625|abcdef", "ENTRY": "Immunosorbent Assays, Enzyme-Linked", "MN": "E05.601.470.380.360", "MH_TH": "NLM (1977)", "ST": "T059", "AN": "NIM; IMMUNOSORBENTS is also available", "PI": "Serodiagnosis (1966-1976)", "MS": "An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.", "PM": "86; was see under IMMUNOENZYME TECHNIQUES 1977-85", "HN": "86(77); was see under IMMUNOENZYME TECHNIQUES 1977-85", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19760419", "DC": "1", "DX": "19860101", "UI": "D004797"}, {"RECTYPE": "D", "MH": "Enzymes", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO UL UR", "PRINT ENTRY": "Enzyme|T109|T126|NON|EQV|NLM (2021)|191113|abbcdef", "ENTRY": "Biocatalysts|T109|T126|NON|EQV|NLM (2009)|071024|abbcdef", "MN": "D08.811", "FX": "Substrate Specificity", "EC": "therapeutic use:Enzyme Therapy", "MH_TH": "POPLINE (1978)", "ST": "T126", "RN": "0", "AN": "general only: avoid; prefer specific enzyme or / enzymol: Manual 19.7+, 19.8.30; policy: Manual 25.18+; SUBSTRATE SPECIFICITY, restricted to enzymes, is available; ENZYME TESTS, CLINICAL is available for measuring the level of a specific enzyme in the diagnosis of a disease; ENZYME ACTIVATION; ENZYME REPRESSION; ENZYME STABILITY are also available; ENZYME INDUCTION: coordinate with specific enzyme / biosyn", "MS": "Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004798"}, {"RECTYPE": "D", "MH": "Enzymes, Immobilized", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Immobilized Enzymes|T116|T126|T130|NON|EQV|UNK (19XX)|760512|abbbcdef", "ENTRY": "Immobilized Enzyme", "MN": "D12.776.463.500", "FX": "Enzyme Stability", "MH_TH": "NLM (1977)", "ST": "T130", "RN": "0", "PI": "specific enzyme(1966-1976)", "MS": "Enzymes which are immobilized on or in a variety of water-soluble or water-insoluble matrices with little or no loss of their catalytic activity. Since they can be reused continuously, immobilized enzymes have found wide application in the industrial, medical and research fields.", "PM": "77", "HN": "77", "MR": "20080708", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D004800"}, {"RECTYPE": "D", "MH": "Eosine Yellowish-(YS)", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tetrabromofluorescein|T109|T130|NON|EQV|UNK (19XX)|780207|abbcdef", "ENTRY": "Eosine Yellowish-(YS), Potassium, Sodium Salt|T109|T130|NON|NRW|NLM (1999)|990913|abbcdef", "MN": "D04.711.347.325", "PA": "Fluorescent Dyes", "MH_TH": "NLM (1979)", "ST": "T130", "N1": "Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 2',4',5',7'-tetrabromo-3',6'-dihydroxy-, disodium salt", "RN": "TDQ283MPCW", "RR": "56897-54-2 (di-K-salt)", "PI": "Staining (1966-1978)", "MS": "A versatile red dye used in cosmetics, pharmaceuticals, textiles, etc., and as tissue stain, vital stain, and counterstain with HEMATOXYLIN. It is also used in special culture media.", "PM": "1994; was EOSIN 1979-1993; C.I. ACID RED 87 was indexed under FLUORESCEINS 2009-2010", "HN": "1994; was EOSIN 1979-1993", "MR": "20160531", "DA": "19780207", "DC": "1", "DX": "19790101", "UI": "D004801"}, {"RECTYPE": "D", "MH": "Eosinophilia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypereosinophilia|T047|NON|NRW|NLM (2023)|210901|abcdef", "ENTRY": "Tropical Eosinophilias", "MN": "C15.378.553.231", "FX": "Angiolymphoid Hyperplasia with Eosinophilia", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "general or unspecified; prefer specifics; for eosinophilic states (as eosinophilic gastritis, eosinophilic meningitis) coordinate IM with disease (IM); /chem ind: consider also EOSINOPHILIA-MYALGIA SYNDROME; HYPEREOSINOPHILIC SYNDROME is also available", "MS": "Abnormal increase of EOSINOPHILS in the blood, tissues or organs.", "PM": "1963; for EOSINOPHILIA, TROPICAL see PULMONARY EOSINOPHILIA 1982-2008", "HN": "1963; for EOSINOPHILIA, TROPICAL use PULMONARY EOSINOPHILIA 1982-2008", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D004802"}, {"RECTYPE": "D", "MH": "Eosinophilic Granuloma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Granuloma, Eosinophilic|T046|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Granulomas, Eosinophilic", "MN": "C23.550.382.250", "MH_TH": "ORD (2010)", "ST": "T046", "MS": "The most benign and common form of Langerhans-cell histiocytosis which involves localized nodular lesions predominantly of the bones but also of the gastric mucosa, small intestine, lungs, or skin, with infiltration by EOSINOPHILS.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004803"}, {"RECTYPE": "D", "MH": "Eosinophils", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Eosinophil", "MN": "A15.382.490.315.251", "MH_TH": "NLM (1966)", "ST": "T025", "MS": "Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004804"}, {"RECTYPE": "D", "MH": "Ependyma", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ependymas", "MN": "A10.755.260", "FX": "Ependymoglial Cells", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "A thin membrane that lines the CEREBRAL VENTRICLES and the central canal of the SPINAL CORD.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004805"}, {"RECTYPE": "D", "MH": "Ependymoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Ependymoma, Papillary|T191|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Papillary Ependymomas", "MN": "C04.557.580.625.600.380.290", "FX": "Ependymoglial Cells", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with precoordinated central nervous system/neoplasm term (IM) + site (IM); MIXED OLIGODENDROGLIOMA-EPENDYMOMA see OLIGODENDROGLIOMA is also available", "MS": "Glioma derived from EPENDYMOGLIAL CELLS that tend to present as malignant intracranial tumors in children and as benign intraspinal neoplasms in adults. It may arise from any level of the ventricular system or central canal of the spinal cord. Intracranial ependymomas most frequently originate in the FOURTH VENTRICLE and histologically are densely cellular tumors which may contain ependymal tubules and perivascular pseudorosettes. Spinal ependymomas are usually benign papillary or myxopapillary tumors. (From DeVita et al., Principles and Practice of Oncology, 5th ed, p2018; Escourolle et al., Manual of Basic Neuropathology, 2nd ed, pp28-9)", "PM": "1963; for EPENDYMOMA, MYXOPAPILLARY see GLIOMA 1994-1999", "HN": "1963; for EPENDYMOMA, MYXOPAPILLARY use GLIOMA 1994-1999", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D004806"}, {"RECTYPE": "D", "MH": "Ephedrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Ephedrine", "MN": "D02.092.471.683.430", "PA": "Vasoconstrictor Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "(1R,2S)-2-methylamino-1-phenyl-propan-1-ol", "RN": "GN83C131XS", "RR": "U6X61U5ZEG", "MS": "A phenethylamine found in EPHEDRA SINICA. PSEUDOEPHEDRINE is an isomer. It is an alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine. It has been used for asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004809"}, {"RECTYPE": "D", "MH": "Ephemeral Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Three-Day Sickness|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Three Day Sickness", "MN": "C22.196.274", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "caused by an Ephemerovirus; animal only; check tag ANIMALS; don't forget also CATTLE (NIM) but do not index under CATTLE DISEASES", "PI": "Cattle Diseases (1966-1969)", "MS": "An Ephemerovirus infection of cattle caused by bovine ephemeral fever virus (EPHEMERAL FEVER VIRUS, BOVINE). It is characterized by respiratory symptoms, increased oropharyngeal secretions and lacrimation, joint pains, tremor, and stiffness.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D004810"}, {"RECTYPE": "D", "MH": "Epichlorohydrin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Epichlorohydrin, (S)-Isomer|T109|T131|NON|NRW|NLM (1999)|990913|abbcdef", "MN": "D02.355.291.411.400", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Oxirane, (chloromethyl)-", "RN": "08OOR508C0", "RR": "67843-74-7 ((S)-isomer)", "PI": "Propane (1973-1974)", "MS": "A chlorinated epoxy compound used as an industrial solvent. It is a strong skin irritant and carcinogen.", "PM": "91; was see under CHLOROHYDRINS 1975-90", "HN": "91(75); was see under CHLOROHYDRINS 1975-90", "MR": "20130708", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D004811"}, {"RECTYPE": "D", "MH": "Epidemiologic Methods", "DE": "EPIDEMIOL METHODS", "AQ": "VE", "ENTRY": "Methods, Epidemiological", "MN": "N06.850.520", "MH_TH": "POPLINE (1978)", "ST": "T062", "AN": "IM general only; coordinate NIM with disease / epidemiol (IM); specify geographic term if pertinent", "MS": "Research techniques that focus on study designs and data gathering methods in human and animal populations.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004812"}, {"RECTYPE": "D", "MH": "Epidemiology", "DE": "EPIDEMIOL", "AQ": "CL EC ED ES HI IS LJ OG SN ST TD", "PRINT ENTRY": "Social Epidemiology|T091|NON|NRW|NLM (2021)|200115|abcdef", "ENTRY": "Social Epidemiologies", "MN": "H02.403.720.500", "EC": "methods:Epidemiologic Methods", "MH_TH": "POPLINE (1994)", "ST": "T091", "AN": "specialty only; prefer /\u200cepidemiol with diseases; do not confuse with TOPOGRAPHY, MEDICAL: epidemiology  emphasizes disease outbreaks & disease-related conditions, topography emphasizes geography-related events", "MS": "Field concerned with the determination of causes, incidence, and characteristic behavior of disease outbreaks affecting human populations. It includes the interrelationships of host, agent, and environment as related to the distribution and control of disease.", "MR": "20200514", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004813"}, {"RECTYPE": "D", "MH": "Epidermal Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Sebaceous Cyst|T020|NON|EQV|UNK (19XX)|830615|abcdef", "ENTRY": "Sebaceous Cysts", "MN": "C04.182.254", "MH_TH": "NLM (1965)", "ST": "T020", "AN": "non-neoplastic; coordinate with organ/diseases term", "MS": "Intradermal or subcutaneous saclike structure, the wall of which is stratified epithelium containing keratohyalin granules.", "OL": "use EPIDERMAL CYST to search SEBACEOUS CYST 1966-83", "PM": "72; SEBACEOUS CYST was heading 1963-83", "HN": "72(65); SEBACEOUS CYST was heading 1963-83", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D004814"}, {"RECTYPE": "D", "MH": "Epidermal Growth Factor", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Urogastrone|T116|T121|T125|NON|EQV|UNK (19XX)|810512|abbbcdef", "ENTRY": "beta Urogastrone", "MN": "D23.529.382.500", "FX": "Gastrointestinal Agents", "MH_TH": "UNK (19XX)", "ST": "T125", "N1": "Epidermal growth factor", "RN": "62229-50-9", "PI": "Peptides (1966-1976)", "MS": "A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form.", "PM": "2000; see EPIDERMAL GROWTH FACTOR-UROGASTRONE 1982-1999, see PEPTIDES 1977-1981; for UROGASTRONE see GASTROINTESTINAL HORMONES 1963-1981", "HN": "2000(1982); use PEPTIDES 1977-1981; for UROGASTRONE use GASTROINTESTINAL HORMONES 1963-1981", "MR": "20180702", "DA": "19760416", "DC": "1", "DX": "19820101", "UI": "D004815"}, {"RECTYPE": "D", "MH": "Epidermis", "AQ": "AB AH CH DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A17.815.250", "EC": "cytology:Epidermal Cells", "MH_TH": "NLM (1978)", "ST": "T024", "PI": "Skin (1966-1977)", "MS": "The external, nonvascular layer of the skin. It is made up, from within outward, of five layers of EPITHELIUM: (1) basal layer (stratum basale epidermidis); (2) spinous layer (stratum spinosum epidermidis); (3) granular layer (stratum granulosum epidermidis); (4) clear layer (stratum lucidum epidermidis); and (5) horny layer (stratum corneum epidermidis).", "PM": "78", "HN": "78", "MR": "20180702", "DA": "19770301", "DC": "1", "DX": "19780101", "UI": "D004817"}, {"RECTYPE": "D", "MH": "Epidermitis, Exudative, of Swine", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Greasy Pig Disease|T047|NON|EQV|UNK (19XX)|740330|GREASY PIG DIS|abcdefv", "ENTRY": "Swine Exudative Dermatitis", "MN": "C22.905.382", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "don't forget also SWINE (NIM) & check tag ANIMALS", "PI": "Swine Diseases (1966-1969)", "MS": "An acute generalized dermatitis of pigs which occurs from 5 to 35 days of age, characterized by sudden onset, with morbidity of 10 to 90% and mortality of 5 to 90%. The lesions are caused by Staphylococcus hyos but the bacterial agent is unable to penetrate the intact skin. Abrasions on the feet and legs or lacerations on the body frequently precede infection. In acute cases, a vesicular-type virus may be the predisposing factor. The causative organism is inhibited by most antibiotics. (Merck Veterinary Manual, 5th ed)", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D004818"}, {"RECTYPE": "D", "MH": "Epidermodysplasia Verruciformis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Lewandowsky-Lutz Disease|T191|EPO|EQV|UNK (19XX)|860401|LEWANDOWSKY LUTZ DIS|abcdefv", "ENTRY": "Lutz Lewandowsky Disease", "MN": "C17.800.838.790.810.260", "MH_TH": "OMIM (2013)", "ST": "T191", "AN": "a non-neoplastic tumor virus infect", "PI": "Warts (1966-1986)", "MS": "An autosomal recessive trait with impaired cell-mediated immunity. About 15 human papillomaviruses are implicated in associated infection, four of which lead to skin neoplasms. The disease begins in childhood with red papules and later spreads over the body as gray or yellow scales.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19860401", "DC": "1", "DX": "19870101", "UI": "D004819"}, {"RECTYPE": "D", "MH": "Epidermolysis Bullosa", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Acantholysis Bullosa|T019|T047|NON|EQV|UNK (19XX)|780316|abbcdef", "MN": "C17.800.865.410", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Group of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties.", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004820"}, {"RECTYPE": "D", "MH": "Epidermophyton", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Epidermophytons", "MN": "B01.300.381.340", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid34390", "MS": "A fungal genus which grows in the epidermis and is the cause of TINEA.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004821"}, {"RECTYPE": "D", "MH": "Epididymis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A05.360.444.371", "MH_TH": "NLM (1963)", "ST": "T023", "MS": "The convoluted cordlike structure attached to the posterior of the TESTIS. Epididymis consists of the head (caput), the body (corpus), and the tail (cauda). A network of ducts leaving the testis joins into a common epididymal tubule proper which provides the transport, storage, and maturation of SPERMATOZOA.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004822"}, {"RECTYPE": "D", "MH": "Epididymitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Epididymitides", "MN": "C12.200.294.199", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Inflammation of the EPIDIDYMIS. Its clinical features include enlarged epididymis, a swollen SCROTUM; PAIN; PYURIA; and FEVER. It is usually related to infections in the URINARY TRACT, which likely spread to the EPIDIDYMIS through either the VAS DEFERENS or the lymphatics of the SPERMATIC CORD.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004823"}, {"RECTYPE": "D", "MH": "Epidural Space", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Spaces, Epidural", "MN": "A02.835.232.834.803.350", "MH_TH": "NLM (1979)", "ST": "T030", "AN": "NIM: usually locational so few qualif apply", "PI": "Spinal Cord (1966-1978)", "MS": "Space between the dura mater and the walls of the vertebral canal.", "PM": "91; was see under SPINAL CANAL 1979-90", "HN": "91(79); was see under SPINAL CANAL 1979-90", "MR": "20180629", "DA": "19780522", "DC": "1", "DX": "19910101", "UI": "D004824"}, {"RECTYPE": "D", "MH": "Epiglottis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Epiglottic Cartilages", "MN": "A04.329.591.411", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A thin leaf-shaped cartilage that is covered with LARYNGEAL MUCOSA and situated posterior to the root of the tongue and HYOID BONE. During swallowing, the epiglottis folds back over the larynx inlet thus prevents foods from entering the airway.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004825"}, {"RECTYPE": "D", "MH": "Epiglottitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Epiglottitides", "MN": "C08.730.798.200", "MH_TH": "NLM (1984)", "ST": "T047", "AN": "inflamm of epiglottis", "PI": "Laryngitis (1966-1983)", "MS": "Inflammation of the EPIGLOTTIS.", "PM": "91; was see under LARYNGITIS 1984-90", "HN": "91(84); was see under LARYNGITIS 1984-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19830531", "DC": "1", "DX": "19910101", "UI": "D004826"}, {"RECTYPE": "D", "MH": "Epilepsy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Seizure Disorder|T047|NON|EQV|NLM (2000)|991108|SEIZURE DIS|abcdefv", "ENTRY": "Seizure Disorders", "MN": "C10.228.140.490", "FX": "Seizures", "MH_TH": "BIOETHICS (1991)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004827"}, {"RECTYPE": "D", "MH": "Epilepsies, Partial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Simple Partial Seizures|T047|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Uncinate Seizure", "MN": "C10.228.140.490.360", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Jacksonian Seizure (1966-1976)", "MS": "Conditions characterized by recurrent paroxysmal neuronal discharges which arise from a focal region of the brain. Partial seizures are divided into simple and complex, depending on whether consciousness is unaltered (simple partial seizure) or disturbed (complex partial seizure). Both types may feature a wide variety of motor, sensory, and autonomic symptoms. Partial seizures may be classified by associated clinical features or anatomic location of the seizure focus. A secondary generalized seizure refers to a partial seizure that spreads to involve the brain diffusely. (From Adams et al., Principles of Neurology, 6th ed, pp317)", "PM": "2000; see EPILEPSY, PARTIAL 1966-1999, see EPILEPSY, FOCAL 1977-1991; for PANAYIOTOPOULOS SYNDROME see MYOCLONIC EPILEPSY, JUVENILE 2018; for EPILEPSY, ABDOMINAL see EPILEPSY, TEMPORAL LOBE, 1975-1999; for EPILEPSY, PARTIAL see EPILEPSY, FOCAL 1977-1991; for EPILEPSY, FOCAL see JACKSONIAN SEIZURE 1970-1976; for JACKSONIAN SEIZURE see JACKSONIAN SEIZURE 1963-1991", "HN": "2000 (1966); for PANAYIOTOPOULOS SYNDROME use MYOCLONIC EPILEPSY, JUVENILE 2018; for EPILEPSY, ABDOMINAL use EPILEPSY, TEMPORAL LOBE 1975-1999", "CATSH": "CAT LIST", "MR": "20180406", "DA": "19760505", "DC": "1", "DX": "19770101", "UI": "D004828"}, {"RECTYPE": "D", "MH": "Epilepsy, Generalized", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Seizure Disorder, Generalized|T047|NON|EQV|NLM (2000)|991109|SEIZURE DIS GENERALIZED|abcdefv", "ENTRY": "Tonic Epilepsy", "MN": "C10.228.140.490.375", "MH_TH": "NLM (1977)", "ST": "T047", "PI": "Epilepsy (1966-1991)", "MS": "Recurrent conditions characterized by epileptic seizures which arise diffusely and simultaneously from both hemispheres of the brain. Classification is generally based upon motor manifestations of the seizure (e.g., convulsive, nonconvulsive, akinetic, atonic, etc.) or etiology (e.g., idiopathic, cryptogenic, and symptomatic). (From Mayo Clin Proc, 1996 Apr;71(4):405-14)", "PM": "1992", "HN": "1992; was EPILEPSY, GENERALIZED (NON MESH) 1977-1991", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19760427", "DC": "1", "DX": "19920101", "UI": "D004829"}, {"RECTYPE": "D", "MH": "Epilepsy, Tonic-Clonic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Seizure Disorder, Tonic Clonic|T047|NON|EQV|NLM (2000)|991103|SEIZURE DIS TONIC CLONIC|abcdefv", "ENTRY": "Tonic-Clonic Seizure Syndromes", "MN": "C10.228.140.490.375.290", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with EPILEPSY, TONIC see EPILEPSY, GENERALIZED", "MS": "A generalized seizure disorder characterized by recurrent major motor seizures. The initial brief tonic phase is marked by trunk flexion followed by diffuse extension of the trunk and extremities. The clonic phase features rhythmic flexor contractions of the trunk and limbs, pupillary dilation, elevations of blood pressure and pulse, urinary incontinence, and tongue biting. This is followed by a profound state of depressed consciousness (post-ictal state) which gradually improves over minutes to hours. The disorder may be cryptogenic, familial, or symptomatic (caused by an identified disease process). (From Adams et al., Principles of Neurology, 6th ed, p329)", "PM": "1992; see EPILEPSY, GRAND MAL 1963-1991", "HN": "1992(1963)", "CATSH": "CAT LIST", "MR": "20050730", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D004830"}, {"RECTYPE": "D", "MH": "Epilepsies, Myoclonic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Symptomatic Myoclonic Epilepsy|T047|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Symptomatic Myoclonic Epilepsies", "MN": "C10.228.140.490.493.063", "FX": "NAV1.1 Voltage-Gated Sodium Channel", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Myoclonus (1966-1976)", "MS": "A clinically diverse group of epilepsy syndromes characterized either by myoclonic seizures or by myoclonus in association with other seizure types. Myoclonic epilepsy syndromes are divided into three subtypes based on etiology: familial, cryptogenic, and symptomatic.", "PM": "2000; see EPILEPSY, MYOCLONIC 1992-1999; see EPILEPSY, MYOCLONUS 1977-1991", "HN": "2000(1992) was EPILEPSY, MYOCLONUS 1977-1991", "CATSH": "CAT LIST", "MR": "20180309", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D004831"}, {"RECTYPE": "D", "MH": "Epilepsy, Absence", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pyknolepsy|T047|NON|NRW|UNK (19XX)|760430|abcdef", "ENTRY": "Seizure Disorders, Absence", "MN": "C10.228.140.490.493.125", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "note entry term PETIT MAL EPILEPSY: do not confuse with PETIT MAL STATUS see STATUS EPILEPTICUS", "MS": "A seizure disorder usually occurring in childhood characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736)", "PM": "1992; was EPILEPSY, PETIT MAL 1963-1991", "HN": "1992; was EPILEPSY, PETIT MAL 1963-1991", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D004832"}, {"RECTYPE": "D", "MH": "Epilepsy, Temporal Lobe", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Epilepsy, Benign Psychomotor, Childhood|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Uncinate Epilepsy", "MN": "C10.228.140.490.493.375", "FX": "Anterior Temporal Lobectomy", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "A localization-related (focal) form of epilepsy characterized by recurrent seizures that arise from foci within the TEMPORAL LOBE, most commonly from its mesial aspect. A wide variety of psychic phenomena may be associated, including illusions, hallucinations, dyscognitive states, and affective experiences. The majority of complex partial seizures (see EPILEPSY, COMPLEX PARTIAL) originate from the temporal lobes. Temporal lobe seizures may be classified by etiology as cryptogenic, familial, or symptomatic. (From Adams et al., Principles of Neurology, 6th ed, p321).", "PM": "1964", "HN": "1964", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D004833"}, {"RECTYPE": "D", "MH": "Epilepsy, Post-Traumatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Seizure Disorder, Post-Traumatic|T037|NON|EQV|NLM (2000)|991105|SEIZURE DIS POST TRAUMATIC|abcdefv", "ENTRY": "Traumatic Epilepsy", "MN": "C26.915.300.200.475", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "coord IM with specific type of epilepsy (IM or NIM)", "MS": "Recurrent seizures causally related to CRANIOCEREBRAL TRAUMA. Seizure onset may be immediate but is typically delayed for several days after the injury and may not occur for up to two years. The majority of seizures have a focal onset that correlates clinically with the site of brain injury. Cerebral cortex injuries caused by a penetrating foreign object (CRANIOCEREBRAL TRAUMA, PENETRATING) are more likely than closed head injuries (HEAD INJURIES, CLOSED) to be associated with epilepsy. Concussive convulsions are nonepileptic phenomena that occur immediately after head injury and are characterized by tonic and clonic movements. (From Rev Neurol 1998 Feb;26(150):256-261; Sports Med 1998 Feb;25(2):131-6)", "PM": "1992; was EPILEPSY, TRAUMATIC 1963-1991", "HN": "1992; was EPILEPSY, TRAUMATIC 1963-1991", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D004834"}, {"RECTYPE": "D", "MH": "Epimestrol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Stimuvol|T109|T121|TRD|NRW|UNK (19XX)|861009|abbcdef", "MN": "D04.210.500.365.415.200", "PA": "Estrogens", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "Estra-1,3,5(10)-triene-16,17-diol, 3-methoxy-, (16alpha,17alpha)-", "RN": "7IVE3SDZ38", "RR": "7004-98-0 (Epimestrol)", "PI": "Methyl Ethers (1972-1974)", "MS": "A synthetic steroid with estrogenic activity.", "PM": "91; was see under ESTRENES 1975-90", "HN": "91(75); was see under ESTRENES 1975-90", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004836"}, {"RECTYPE": "D", "MH": "Epinephrine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adrenaline|T109|T121|T125|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|740330|abbbcdeeef", "ENTRY": "Acetate, Epinephrine", "MN": "D02.455.426.559.389.657.166.175.461", "PA": "Vasoconstrictor Agents", "FX": "Receptors, Adrenergic", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (R)-", "RN": "YKH834O4BH", "RR": "WBB047OO38", "MS": "The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS.", "MR": "20180529", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004837"}, {"RECTYPE": "D", "MH": "Epiphyses", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Epiphysis|T023|NON|EQV|NLM (1995)|931122|abcdef", "MN": "A02.835.232.251", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "IM GEN or unspecified; NIM with specific long bone IM; DIAPHYSES (shaft of long bones) is also available", "MS": "The head of a long bone that is separated from the shaft by the epiphyseal plate until bone growth stops. At that time, the plate disappears and the head and shaft are united.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004838"}, {"RECTYPE": "D", "MH": "Epiphyses, Slipped", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Epiphysiolysis|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Slipped Epiphyses", "MN": "C05.116.425", "MH_TH": "NLM (1967)", "ST": "T047", "PI": "Epiphyses (1966)", "MS": "A complete or partial separation of the EPIPHYSES from the DIAPHYSES.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004839"}, {"RECTYPE": "D", "MH": "Epirizole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methopyrimazole|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|750630|abbcdeef", "MN": "D03.383.742.200", "PA": "Anti-Inflammatory Agents, Non-Steroidal", "MH_TH": "USAN (1977)", "ST": "T121", "N1": "Pyrimidine, 4-methoxy-2-(5-methoxy-3-methyl-1H-pyrazol-1-yl)-6-methyl-", "RN": "3B46O2FH8I", "RR": "18694-40-1 (Epirizole)", "AN": "a non-steroidal anti-inflamm agent", "PI": "Pyrimidines (1972-1975)", "MS": "4-Methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine. A pyrimidinyl pyrazole with antipyretic, analgesic, and anti-inflammatory activity.", "PM": "91; was see under PYRAZOLES 1976-90", "HN": "91(76); was see under PYRAZOLES 1976-90", "MR": "20160531", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D004840"}, {"RECTYPE": "D", "MH": "Episiotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Episiotomies", "MN": "E04.520.252.750", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "An incision of the posterior vaginal wall and a portion of the pudenda which enlarges the vaginal introitus to facilitate delivery and prevent lacerations.", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004841"}, {"RECTYPE": "D", "MH": "Epispadias", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Epispadia", "MN": "C16.131.939.374", "MH_TH": "NLM (1966)", "ST": "T019", "MS": "A birth defect due to malformation of the URETHRA in which the urethral opening is above its normal location. In the male, the malformed urethra generally opens on the top or the side of the PENIS, but the urethra can also be open the entire length of the penis. In the female, the malformed urethral opening is often between the CLITORIS and the labia, or in the ABDOMEN.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004842"}, {"RECTYPE": "D", "MH": "Epistasis, Genetic", "DE": "EPISTASIS GENET", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Genes, Hypostatic|T028|NON|NRW|UNK (19XX)|780127|abcdef", "ENTRY": "Non-Allelic Gene Interaction", "MN": "G05.308.207", "FX": "Multifactorial Inheritance", "MH_TH": "NLM (1979)", "ST": "T045", "PI": "Phenotype (1968-1978)", "MS": "A form of gene interaction whereby the expression of one gene interferes with or masks the expression of a different gene or genes. Genes whose expression interferes with or masks the effects of other genes are said to be epistatic to the effected genes. Genes whose expression is affected (blocked or masked) are hypostatic to the interfering genes.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19780127", "DC": "1", "DX": "19790101", "UI": "D004843"}, {"RECTYPE": "D", "MH": "Epistaxis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nosebleed|T046|T184|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Nose Bleeds", "MN": "C23.888.852.040", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Bleeding from the nose.", "CATSH": "CAT LIST", "MR": "20161101", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004844"}, {"RECTYPE": "D", "MH": "Epitestosterone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "17 alpha Testosterone", "MN": "D06.472.334.851.968.984.500", "MH_TH": "NLM (1975)", "ST": "T125", "N1": "Androst-4-en-3-one, 17-hydroxy-, (17alpha)-", "RN": "481-30-1", "PI": "Testosterone (1969-1974)", "MS": "The 17-alpha isomer of TESTOSTERONE, derived from PREGNENOLONE via the delta5-steroid pathway, and via 5-androstene-3-beta,17-alpha-diol. Epitestosterone acts as an antiandrogen in various target tissues. The ratio between testosterone/epitestosterone is used to monitor anabolic drug abuse.", "PM": "91; was see under TESTOSTERONE 1975-90", "HN": "91(75); was see under TESTOSTERONE 1975-90", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004845"}, {"RECTYPE": "D", "MH": "Epithelial Attachment", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Junctional Epithelium|T024|NON|EQV|NLM (1994)|920810|abcdef", "ENTRY": "Epithelial Attachments", "MN": "A14.549.167.646.374", "MH_TH": "NLM (1975)", "ST": "T024", "AN": "do not confuse with \"periodontal attachment\" as in PERIODONTAL ATTACHMENT LOSS", "MS": "A wedge-shaped collar of epithelial cells which form the attachment of the gingiva to the tooth surface at the base of the gingival crevice.", "OL": "search PERIODONTIUM 1969-74", "PM": "91; was see under PERIODONTIUM 1975-90", "HN": "91(75); was see under PERIODONTIUM 1975-90", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004846"}, {"RECTYPE": "D", "MH": "Epithelial Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Transitional Epithelial Cell", "MN": "A11.436", "MH_TH": "NLM (1965)", "ST": "T025", "AN": "coordinate with specific tissue type if pertinent; do not confuse with EPITHELIOID CELLS (type of macrophage)", "PI": "Epithelium/cytology (1978-1997)", "MS": "Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells.", "PM": "1998, 1972-1977", "HN": "1998(1965)", "MR": "20210304", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D004847"}, {"RECTYPE": "D", "MH": "Epithelium", "AQ": "AB AH BS CH DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Mesothelium|T024|NON|NRW|NLM (1992)|900904|abcdef", "ENTRY": "Tissues, Mesothelial", "MN": "A10.272", "EC": "cytology:Epithelial Cells", "MH_TH": "NLM (1966)", "ST": "T024", "AN": "usually NIM with specific organ IM", "MS": "The layers of EPITHELIAL CELLS which cover the inner and outer surfaces of the cutaneous, mucus, and serous tissues and glands of the body.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004848"}, {"RECTYPE": "D", "MH": "Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester", "DS": "PHENYLPHOSPHONOTHIOIC ACID ETHYL NITROPHENYL ESTER 02 02 04", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "EPN300", "MN": "D02.886.300.846.750", "PA": "Insecticides", "MH_TH": "NLM (2001)", "ST": "T131", "N1": "Phosphonothioic acid, phenyl-, O-ethyl O-(4-nitrophenyl) ester", "RN": "2104-64-5", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides (1966-1971)", "MS": "An organothiophosphorus cholinesterase inhibitor that is used as an insecticide and as a acaricide.", "PM": "2001; see EPN 1991-2000 & INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-1990", "HN": "2001(1972);", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004849"}, {"RECTYPE": "D", "MH": "Eponyms", "ENTRY": "Eponym", "MN": "L01.559.598.400.556.536", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "IM; no qualif", "MS": "Names based on or derived from the name of a person or a place.", "MR": "20171211", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004850"}, {"RECTYPE": "D", "MH": "Epoxide Hydrolases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Epoxide Hydrolase|T116|T126|NON|EQV|NLM (2021)|200123|abbcdef", "ENTRY": "Hydrolases, Epoxide", "MN": "D08.811.277.340", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Epoxide hydrolase", "RN": "EC 3.3.2.-", "RR": "EC 3.3.2.9", "PI": "Hydro-Lyases (1966-1974)", "MS": "Enzymes that catalyze reversibly the formation of an epoxide or arene oxide from a glycol or aromatic diol, respectively.", "OL": "use EPOXIDE HYDROLASES to search EPOXIDE HYDRATASES 1975-80", "PM": "81; was EPOXIDE HYDRATASES 1975-80 (see under HYDRO-LYASES 1975-77)", "HN": "81; was EPOXIDE HYDRATASES 1975-80 (see under HYDRO-LYASES 1975-77)", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D004851"}, {"RECTYPE": "D", "MH": "Epoxy Compounds", "DE": "EPOXY CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Epoxy Compound|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Compounds, Epoxy", "MN": "D02.355.291.411", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "Organic compounds that include a cyclic ether with three ring atoms in their structure. They are commonly used as precursors for POLYMERS such as EPOXY RESINS.", "OL": "search ETHERS, CYCLIC 1966-74", "PM": "91; was see under ETHERS, CYCLIC 1975-90", "HN": "91(75); was see under ETHERS, CYCLIC 1975-90", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004852"}, {"RECTYPE": "D", "MH": "Epoxy Resins", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Epoxy Resin|T109|T122|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Resins, Epoxy", "MN": "J01.637.051.720.716.822.461", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "MS": "Polymeric resins derived from OXIRANES and characterized by strength and thermosetting properties. Epoxy resins are often used as dental materials.", "PM": "68", "HN": "68(66)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004853"}, {"RECTYPE": "D", "MH": "Herpesvirus 4, Human", "DE": "HHV 4", "DS": "HERPESVIRUS HUMAN 04", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Infectious Mononucleosis Virus|T005|NON|EQV|UNK (19XX)|750101|INFECT MONONUCLEOSIS VIRUS|abcdefv", "ENTRY": "Mononucleosis Viruses, Infectious", "MN": "B04.613.204.500.500.400", "FX": "Fatigue Syndrome, Chronic", "MH_TH": "NLM (1969)", "ST": "T005", "RN": "txid10376", "PI": "specific disease/microbiology (1966-1968)", "MS": "The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies.", "OL": "use HERPESVIRUS 4, HUMAN to search EPSTEIN-BARR VIRUS 1978-93 & BURKITT'S LYMPHOMA VIRUS 1969-77 (as Prov 1969-72)", "PM": "94; was EPSTEIN-BARR VIRUS 1978-93; was BURKITT'S LYMPHOMA VIRUS 1973-77", "HN": "94; was EPSTEIN-BARR VIRUS 1978-93; was BURKITT'S LYMPHOMA VIRUS 1969-77 (Prov 1969-72)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004854"}, {"RECTYPE": "D", "MH": "Equilenin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D06.472.334.851.437.249", "MH_TH": "NLM (1975)", "ST": "T125", "N1": "Estra-1,3,5,7,9-pentaen-17-one, 3-hydroxy-", "RN": "W8FTJ17C4J", "RR": "517-09-9 (Equilenin)", "AN": "do not confuse with EQUILIN", "PI": "Hydroxysteroids (1974)", "MS": "An estrogenic steroid produced by HORSES. It has a total of five double bonds in the A- and B-ring. High concentration of equilenin is found in the URINE of pregnant mares.", "PM": "91; was see under 17-KETOSTEROIDS 1975-90", "HN": "91(75); was see under 17-KETOSTEROIDS 1975-90", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004855"}, {"RECTYPE": "D", "MH": "Postural Balance", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Posture Equilibrium|T040|NON|EQV|NLM (2020)|190124|abcdef", "ENTRY": "Posture Equilibriums", "MN": "G11.561.790.541.595", "MH_TH": "NLM (2004)", "ST": "T040", "AN": "disorders of equilibrium: coordinate with SENSATION DISORDERS", "MS": "A POSTURE in which an ideal body mass distribution is achieved. Postural balance provides the body carriage stability and conditions for normal functions in stationary position or in movement, such as sitting, standing, or walking.", "PM": "2009; see MUSCULOSKELETAL EQUILIBRIUM 2004-2008, see EQUILIBRIUM 1963-2003", "HN": "2009(1963)", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D004856"}, {"RECTYPE": "D", "MH": "Equilin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D06.472.334.851.437.374", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Estra-1,3,5(10),7-tetraen-17-one, 3-hydroxy-", "RN": "08O86EX0J4", "RR": "474-86-2 (Equilin)", "AN": "do not confuse with EQUILENIN", "PI": "Hydroxysteroids (1974)", "MS": "An estrogenic steroid produced by HORSES. It has a total of four double bonds in the A- and B-ring. High concentration of euilin is found in the URINE of pregnant mares.", "PM": "91; was see under 17-KETOSTEROIDS 1975-90", "HN": "91(75); was see under 17-KETOSTEROIDS 1975-90", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004857"}, {"RECTYPE": "D", "MH": "Herpesvirus 3, Equid", "DS": "HERPESVIRUS EQUID 03", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Equine coital exanthema virus|T005|NON|EQV|NLM (1994)|930302|abcdef", "ENTRY": "Herpesvirus 3, Equine", "MN": "B04.280.382.100.900.435", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid80341", "AN": "infection: coordinate with HERPESVIRIDAE INFECTIONS", "MS": "A species of VARICELLOVIRUS causing coital exanthema in horses.", "OL": "use HERPESVIRUS 3, EQUID to search EQUINE COITAL EXANTHEMA VIRUS 1975-93", "PM": "94; was EQUINE COITAL EXANTHEMA VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80)", "HN": "94; was EQUINE COITAL EXANTHEMA VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004858"}, {"RECTYPE": "D", "MH": "Equine Infectious Anemia", "DE": "EQUINE INFECT ANEMIA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Swamp Fever|T047|NON|EQV|ORD (2010)|UNK (19XX)|740330|abcdeef", "ENTRY": "Swamp Fevers", "MN": "C22.488.304", "MH_TH": "NLM (1970)", "ST": "T047", "PI": "Virus Diseases (1966-1969)", "MS": "Viral disease of horses caused by the equine infectious anemia virus (EIAV; INFECTIOUS ANEMIA VIRUS, EQUINE). It is characterized by intermittent fever, weakness, and anemia. Chronic infection consists of acute episodes with remissions.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D004859"}, {"RECTYPE": "D", "MH": "Infectious Anemia Virus, Equine", "DE": "INFECT ANEMIA VIRUS EQUINE", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Swamp Fever Virus|T005|NON|EQV|UNK (19XX)|770426|abcdef", "ENTRY": "Swamp Fever Viruses", "MN": "B04.820.650.589.520.400", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid11665", "MS": "A species of LENTIVIRUS, subgenus equine lentiviruses (LENTIVIRUSES, EQUINE), causing acute and chronic infection in horses. It is transmitted mechanically by biting flies, mosquitoes, and midges, and iatrogenically through unsterilized equipment. Chronic infection often consists of acute episodes with remissions.", "OL": "use INFECTIOUS ANEMIA VIRUS, EQUINE to search EQUINE INFECTIOUS ANEMIA VIRUS 1966-93", "PM": "94; was EQUINE INFECTIOUS ANEMIA VIRUS 1963-93", "HN": "94; was EQUINE INFECTIOUS ANEMIA VIRUS 1963-93", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D004860"}, {"RECTYPE": "D", "MH": "Herpesvirus 1, Equid", "DS": "HERPESVIRUS EQUID 01", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Equine abortion Virus|T005|NON|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "Herpesvirus 1, Equine", "MN": "B04.280.382.100.900.430", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid10326", "AN": "infection: coord IM with HERPESVIRIDAE INFECTIONS (IM)", "MS": "A species of VARICELLOVIRUS causing abortion and respiratory disease in horses.", "OL": "use HERPESVIRUS 1, EQUID to search EQUINE RHINOPNEUMONITIS VIRUS 1975-93", "PM": "94; was EQUINE RHINOPNEUMONITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80)", "HN": "94; was EQUINE RHINOPNEUMONITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D004861"}, {"RECTYPE": "D", "MH": "Equinus Deformity", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Talipes Equinus|T019|NON|EQV|NLM (2003)|020206|abcdef", "ENTRY": "Equinus Deformities", "MN": "C16.131.621.585.512.500.681.125", "MH_TH": "NLM (1988)", "ST": "T019", "AN": "do not confuse with EQUINOVARUS see CLUBFOOT", "MS": "Plantar declination of the foot.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19870402", "DC": "1", "DX": "19880101", "UI": "D004863"}, {"RECTYPE": "D", "MH": "Equipment and Supplies", "DE": "EQUIPMENT SUPPLIES", "AQ": "AE CL EC ES HI MI PS SD SN ST VE VI", "PRINT ENTRY": "Medical Devices|T074|NON|NRW|BIOETHICS (1975)|770414|MED DEVICES|abcdefv", "ENTRY": "Supplies and Equipment", "MN": "E07", "RH": "E7 - EQUIPMENT AND SUPPLIES", "FX": "Catalogs, Commercial as Topic", "MH_TH": "POPLINE (1978)", "ST": "T073", "AN": "general or unspecified; prefer /instrum", "MS": "Expendable and nonexpendable equipment, supplies, apparatus, and instruments that are used in diagnostic, surgical, therapeutic, scientific, and experimental procedures.", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004864"}, {"RECTYPE": "D", "MH": "Equipment and Supplies, Hospital", "DE": "EQUIPMENT SUPPLIES HOSP", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Hospital Equipment and Supplies|T073|NON|EQV|UNK (19XX)|770519|HOSP EQUIPMENT SUPPLIES|abcdefv", "ENTRY": "Hospital Supply", "MN": "E07.325", "EC": "organization & administration:Materials Management, Hospital", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "covers wide range from furnaces to surgical dressings", "MS": "Any materials used in providing care specifically in the hospital.", "OL": "use EQUIPMENT AND SUPPLIES, HOSPITAL to search HOSPITAL EQUIPMENT AND SUPPLIES 1966-77", "PM": "78; was HOSPITAL EQUIPMENT AND SUPPLIES 1963-77", "HN": "78; was HOSPITAL EQUIPMENT AND SUPPLIES 1963-77", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D004865"}, {"RECTYPE": "D", "MH": "Equipment Contamination", "AQ": "EC LJ PC SN", "ENTRY": "Equipment Contaminations", "MN": "N06.850.540", "FX": "Fomites", "MH_TH": "NLM (1985)", "ST": "T067", "MS": "The presence of an infectious agent on instruments, prostheses, or other inanimate articles.", "PM": "85", "HN": "85", "MR": "20080708", "DA": "19840406", "DC": "1", "DX": "19850101", "UI": "D004866"}, {"RECTYPE": "D", "MH": "Equipment Design", "AQ": "AE CL EC ES HI IS MO MT PX SN ST TD VE", "PRINT ENTRY": "Medical Device Design|T057|NON|NRW|UNK (19XX)|810515|MED DEVICE DESIGN|abcdefv", "ENTRY": "Equipment Designs", "MN": "E05.320", "FX": "Prosthesis Design", "MH_TH": "NLM (1982)", "ST": "T057", "AN": "coordinate with specific equipment or specific technique /instrum", "MS": "Methods and patterns of fabricating machines and related hardware.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19810515", "DC": "1", "DX": "19820101", "UI": "D004867"}, {"RECTYPE": "D", "MH": "Equipment Failure", "AQ": "EC SN VE", "PRINT ENTRY": "Misuse, Equipment|T052|NON|BRD|UNK (19XX)|810515|abcdef", "ENTRY": "Misuses, Equipment", "MN": "E05.325", "MH_TH": "NLM (1982)", "ST": "T066", "AN": "coordinate with specific equipment or specific technique / instrum", "MS": "Failure of equipment to perform to standard. The failure may be due to defects or improper use.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19810515", "DC": "1", "DX": "19820101", "UI": "D004868"}, {"RECTYPE": "D", "MH": "Equipment Safety", "AQ": "CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Safety, Equipment|T080|NON|EQV|UNK (19XX)|810515|abcdef", "ENTRY": "Safety, Device", "MN": "E05.330", "MH_TH": "NLM (1982)", "ST": "T080", "AN": "coordinate with specific equipment or specific technique /instrum", "MS": "Freedom of equipment from actual or potential hazards.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20170601", "DA": "19810515", "DC": "1", "DX": "19820101", "UI": "D004869"}, {"RECTYPE": "D", "MH": "Erabutoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.644.173", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "59536-69-5", "AN": "toxins from venom of a sea snake; /antag permitted but consider also ANTIVENINS", "MS": "Toxins isolated from the venom of Laticauda semifasciata, a sea snake (Hydrophid); immunogenic, basic polypeptides of 62 amino acids, folded by four disulfide bonds, block neuromuscular end-plates irreversibly, thus causing paralysis and severe muscle damage; they are similar to Elapid neurotoxins.", "PM": "91; was see under HYDROPHID VENOMS 1978-90; was see under SNAKE VENOMS 1975-77", "HN": "91(73); was see under HYDROPHID VENOMS 1978-90; was see under SNAKE VENOMS 1975-77", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004870"}, {"RECTYPE": "D", "MH": "Erbium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.437", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Erbium", "RN": "77B218D3YE", "RR": "7440-52-0 (Erbium)", "MS": "Erbium. An element of the rare earth family of metals. It has the atomic symbol Er, atomic number 68, and atomic weight 167.26.", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004871"}, {"RECTYPE": "D", "MH": "Ergocalciferols", "AQ": "AD AE AG AI AN BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitamin D 2|T109|T121|T127|NON|NRW|UNK (19XX)|740330|VITAMIN D A 02|abbbcdefs", "ENTRY": "D2, Vitamin", "MN": "D10.570.938.439", "PA": "Vitamins", "MH_TH": "NLM (1967)", "ST": "T127", "RN": "0", "RR": "VS041H42XC", "AN": "deficiency: coordinate ERGOCALCIFEROLS /defic (IM) with VITAMIN D DEFICIENCY (IM)", "MS": "Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24.", "OL": "use ERGOCALCIFEROLS to search ERGOCALCIFEROL 1967-89; VITAMIN D 2 1966", "PM": "90; was ERGOCALCIFEROL 1967-89; was VITAMIN D 2 1963-66", "HN": "90; was ERGOCALCIFEROL 1967-89; was VITAMIN D 2 1963-66", "MR": "20180522", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004872"}, {"RECTYPE": "D", "MH": "Ergolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ergoline|T109|NON|NRW|NLM (2002)|001215|abcdef", "MN": "D03.633.400.439", "MH_TH": "NLM (1969)", "ST": "T109", "RN": "0", "RR": "478-88-6", "PI": "Methysergide (1966-1968)", "MS": "A series of structurally-related alkaloids that contain the ergoline backbone structure.", "PM": "69", "HN": "69", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D004873"}, {"RECTYPE": "D", "MH": "Ergonovine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ergonovine Maleate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2002)|USP (19XX)|abbcdeee", "ENTRY": "Ergotrate|T109|T121|TRD|NRW|US|abbcde", "MN": "D03.633.400.439.262", "PA": "Oxytocics", "MH_TH": "NLM (1965)", "ST": "T121", "N1": "Ergoline-8-carboxamide, 9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methyl-, (8beta(S))-", "RN": "WH41D8433D", "RR": "YMH3D0ZJWV", "MS": "An ergot alkaloid (ERGOT ALKALOIDS) with uterine and VASCULAR SMOOTH MUSCLE contractile properties.", "PM": "1965; see ERGOLINES 1969-1974; ERGONIVINE MALEATE was indexed under ERGONOVINE 1979-2001", "HN": "1965; for ERGONOVINE MALEATE use ERGONOVINE (NM) 1979-2001", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004874"}, {"RECTYPE": "D", "MH": "Ergosterol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pro Vitamin D2", "MN": "D04.210.500.247.222.537", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "Ergosta-5,7,22-trien-3-ol, (3beta,22E)-", "RN": "Z30RAY509F", "RR": "57-87-4 (Ergosterol)", "PI": "Vitamin D (1967-1971)", "MS": "A steroid occurring in FUNGI. Irradiation with ULTRAVIOLET RAYS results in formation of ERGOCALCIFEROL (vitamin D2).", "OL": "search VITAMIN D 1967-71 & ERGOCALCIFEROL 1966", "PM": "74; was see under VITAMIN D 1967-73, was see under VITAMIN D 2 1963-66", "HN": "74(72); was see under VITAMIN D 1967-73, was see under VITAMIN D 2 1963-66", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004875"}, {"RECTYPE": "D", "MH": "Ergot Alkaloids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK RE SD ST TO TU UR", "ENTRY": "Alkaloids, Ergot", "MN": "D03.132.327", "EC": "poisoning:Ergotism", "MH_TH": "POPLINE (1978)", "ST": "T123", "RN": "0", "MS": "Alkaloids originally isolated from the ergot fungus Claviceps purpurea (Hypocreaceae). They include compounds that are structurally related to ergoline (ERGOLINES) and ergotamine (ERGOTAMINES). Many of the ergot alkaloids act as alpha-adrenergic antagonists.", "MR": "20050713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004876"}, {"RECTYPE": "D", "MH": "Ergoloid Mesylates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dihydroergotoxine Mesylate|T109|T121|NON|EQV|NLM (1992)|910314|abbcdef", "ENTRY": "Monomethanesulfonate, Dihydroergotoxine", "MN": "D03.633.400.562.400.500", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "8067-24-1", "MS": "A mixture of the mesylates (methane sulfonates) of DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and the alpha- and beta-isomers of DIHYDROERGOCRYPTINE. The substance produces a generalized peripheral vasodilation and a fall in arterial pressure and has been used to treat symptoms of mild to moderate impairment of mental function in the elderly.", "OL": "use ERGOLOID MESYLATES to search ERGOT ALKALOIDS, HYDROGENATED 1966-91; use DIHYDROERGOTOXINE to search ERGOLOID MESYLATE 1984-91; use DIHYDROERGOTOXINE to search HYDERGINE 1977-91, use ERGOLOID MESYLATES 1966-76", "PM": "92; was ERGOT ALKALOIDS, HYDROGENATED 1963-91; ERGOLOID MESYLATE was see DIHYDROERGOTOXINE 1984-91; HYDERGINE was see DIHYDROERGOTOXINE 1977-91, see under ERGOT ALKALOIDS, HYDROGENATED 1963-76", "HN": "92; was ERGOT ALKALOIDS, HYDROGENATED 1963-91; ERGOLOID MESYLATE was see DIHYDROERGOTOXINE 1984-91; HYDERGINE was see DIHYDROERGOTOXINE 1977-91, see under ERGOT ALKALOIDS, HYDROGENATED 1963-76", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D004877"}, {"RECTYPE": "D", "MH": "Ergotamine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ergotamine Tartrate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1992)|USP (19XX)|910114|abbcdeeef", "ENTRY": "Tartrate, Ergotamine", "MN": "D03.633.400.562.500", "PA": "Vasoconstrictor Agents", "EC": "analogs & derivatives:Ergotamines", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-", "RN": "PR834Q503T", "RR": "MRU5XH3B48", "MS": "A vasoconstrictor found in ergot of Central Europe. It is a serotonin agonist that has been used as an oxytocic agent and in the treatment of MIGRAINE DISORDERS.", "OL": "use ERGOTAMINE (NM) to search ERGOTAMINE TARTRATE (NM) 1980-91", "PM": "ERGOTAMINE TARTRATE was indexed under ERGOTAMINE DERIVATIVES 1977-91 & under ERGOTAMINE 1975-76", "HN": "ERGOTAMINE TARTRATE was ERGOTAMINE TARTRATE (NM) 1975-91", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D004878"}, {"RECTYPE": "D", "MH": "Ergotamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.400.562", "MH_TH": "NLM (2002)", "ST": "T109", "RN": "0", "PI": "Ergotamine (1966-1974)", "MS": "A series of structurally-related alkaloids containing the ergotaman backbone structure.", "PM": "2001; see ERGOTAMINE DERIVATIVES 1978-2001, see ERGOTAMINE 1975-1977, see ERGOLINES 1969-1974", "HN": "2001(1969)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D004879"}, {"RECTYPE": "D", "MH": "Ergothioneine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thioneine|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbcdeef", "ENTRY": "2 Thiol L histidine betaine", "MN": "D12.125.072.329.269", "PA": "Antioxidants", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "1H-Imidazole-4-ethanaminium, alpha-carboxy-2,3-dihydro-N,N,N-trimethyl-2-thioxo-, inner salt, (S)-", "RN": "BDZ3DQM98W", "RR": "497-30-3 (Ergothioneine)", "MS": "A naturally occurring metabolite of HISTIDINE that has antioxidant properties.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004880"}, {"RECTYPE": "D", "MH": "Ergotism", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "St. Anthonys Fire|T037|EPO|EQV|NLM (2003)|020628|abcdef", "ENTRY": "St. Anthony Fire", "MN": "C25.723.680.262", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Poisoning caused by ingesting ergotized grain or by the misdirected or excessive use of ergot as a medicine.", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004881"}, {"RECTYPE": "D", "MH": "Erotica", "AQ": "HI LJ PX", "PRINT ENTRY": "Pornography|T170|NON|NRW|UNK (19XX)|740330|PORNOGR|abcdefv", "ENTRY": "Eroticism|T055|NON|REL|POPLINE (1993)|940315|abcdef", "MN": "L01.462.500.682.441", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "only /hist /legis /psychol", "MS": "Literary or artistic items having an erotic theme. It refers especially to books treating sexual love in a sensuous or voluptuous manner. (Webster, 3d ed)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004882"}, {"RECTYPE": "D", "MH": "Erucic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Docosenoic Acids|T109|T123|NON|EQV|UNK (19XX)|741125|abbcdef", "ENTRY": "Acids, Erucic", "MN": "D10.251.355.325.300", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Fatty Acids, Unsaturated (1973-1974)", "MS": "cis-13-Docosenoic Acids. 22-Carbon monounsaturated, monocarboxylic acids.", "PM": "91; was see under FATTY ACIDS, MONOUNSATURATED 1988-90; was see under FATTY ACIDS, UNSATURATED 1975-87", "HN": "91(75); was see under FATTY ACIDS, MONOUNSATURATED 1988-90; was see under FATTY ACIDS, UNSATURATED 1975-87", "MR": "20030709", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D004883"}, {"RECTYPE": "D", "MH": "Eructation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Belching|T184|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Eructations", "MN": "C23.888.821.297", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "The ejection of gas or air through the mouth from the stomach.", "CATSH": "CAT LIST", "MR": "19991124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004884"}, {"RECTYPE": "D", "MH": "Erwinia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.175", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid551", "AN": "in plants; rarely infects humans but if so, coordinate with ENTEROBACTERIACEAE INFECTIONS", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms are associated with plants as pathogens, saprophytes, or as constituents of the epiphytic flora.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004885"}, {"RECTYPE": "D", "MH": "Erysipelas", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C17.800.838.765.260", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "Strep skin dis; do not confuse with ERYSIPELOID, caused by Erysipelothrix; do not confuse with SWINE ERYSIPELAS, also an Erysipelothrix infection", "MS": "An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004886"}, {"RECTYPE": "D", "MH": "Erysipeloid", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Erysipeloids", "MN": "C01.150.252.410.334.329", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by the bacterium Erysipelothrix; do not confuse with ERYSIPELAS, caused by a Streptococcus", "MS": "An infection caused by Erysipelothrix rhusiopathiae that is almost wholly restricted to persons who in their occupation handle infected fish, shellfish, poultry, or meat. Three forms of this condition exist: a mild localized form manifested by local swelling and redness of the skin; a diffuse form that might present with fever; and a rare systemic form associated with endocarditis.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004887"}, {"RECTYPE": "D", "MH": "Erysipelothrix", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Erysipelothrix rhusiopathiae|T007|NON|NRW|NLM (2005)|040213|abcdef", "MN": "B03.510.460.400.410.350", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1647", "RR": "txid1648", "MS": "A genus of gram-positive, facultatively anaerobic, rod-shaped bacteria that has a tendency to form long filaments. Its organisms are widely distributed in nature and are found in MAMMALS; BIRDS; and FISHES. Erysipelothrix may appear gram-negative because they decolorize easily.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004888"}, {"RECTYPE": "D", "MH": "Erysipelothrix Infections", "DE": "ERYSIPELOTHRIX INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Infection, Erysipelothrix", "MN": "C22.331", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "gram-pos bact infect; usually animal; check tag ANIMALS", "PI": "Erysipeloid (1966-1967)", "MS": "Infections with bacteria of the genus ERYSIPELOTHRIX.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004889"}, {"RECTYPE": "D", "MH": "Erythema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Erythemas", "MN": "C23.888.885.328", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "general or unspecified; prefer specifics; do not confuse with ERYTHRODERMA see DERMATITIS, EXFOLIATIVE; prickly heat: index MILIARIA", "MS": "Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004890"}, {"RECTYPE": "D", "MH": "Erythema Induratum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Tuberculosis Cutis Indurativa|T047|NON|EQV|NLM (1992)|910418|abcdef", "ENTRY": "Disease, Bazin's", "MN": "C17.800.838.765.820.320", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "a form of cutaneous tuberc", "MS": "A type of panniculitis characterized histologically by the presence of granulomas, vasculitis, and necrosis. It is traditionally considered to be the tuberculous counterpart of nodular vasculitis, but is now known to occur without tuberculous precedent. It is seen most commonly in adolescent and menopausal women, is initiated or exacerbated by cold weather, and typically presents as one or more recurrent erythrocyanotic nodules or plaques on the calves. The nodules may progress to form indurations, ulcerations, and scars.", "OL": "search TUBERCULOSIS, CUTANEOUS 1966-74", "PM": "91; was see under TUBERCULOSIS, CUTANEOUS 1975-90", "HN": "91(75); was see under TUBERCULOSIS, CUTANEOUS 1975-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004891"}, {"RECTYPE": "D", "MH": "Erythema Multiforme", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.865.475", "FX": "Stevens-Johnson Syndrome", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic \"bull's-eye\" lesions usually occurring on the dorsal aspect of the hands and forearms.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004892"}, {"RECTYPE": "D", "MH": "Erythema Nodosum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C25.100.468.380.375", "MH_TH": "POPLINE (1978)", "ST": "T047", "MS": "An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy.", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004893"}, {"RECTYPE": "D", "MH": "Erythrasma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C17.800.838.765.320", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "bact skin dis caused by Corynebacterium minutissimum", "MS": "A chronic bacterial infection of major folds of the skin, caused by Corynebacterium minutissimum.", "OL": "search NOCARDIA INFECTIONS 1966-74", "PM": "91; was see under CORYNEBACTERIUM INFECTIONS 1977-90; was see under NOCARDIA INFECTIONS 1963-76", "HN": "91(75); was see under CORYNEBACTERIUM INFECTIONS 1977-90; was see under NOCARDIA INFECTIONS 1963-76", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004894"}, {"RECTYPE": "D", "MH": "Erythrina", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Trees, Indian Coral", "MN": "B01.875.800.575.912.250.401.200", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid3841", "RR": "txid49817", "MS": "A genus of leguminous shrubs or trees, mainly tropical, yielding useful compounds such as ALKALOIDS and  PLANT LECTINS.", "PM": "91; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85", "HN": "91(86)63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004895"}, {"RECTYPE": "D", "MH": "Erythritol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.853.329", "PA": "Vasodilator Agents", "MH_TH": "NLM (1965)", "ST": "T123", "N1": "1,2,3,4-Butanetetrol, (R*,S*)-", "RN": "RA96B954X6", "RR": "149-32-6 (Erythritol)", "MS": "A four-carbon sugar that is found in algae, fungi, and lichens. It is twice as sweet as sucrose and can be used as a coronary vasodilator.", "PM": "73", "HN": "73(65)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004896"}, {"RECTYPE": "D", "MH": "Erythrityl Tetranitrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tetranitrate, Erythrityl", "MN": "D09.853.329.225", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,2,3,4-Butanetetrol, tetranitrate, (R*,S*)-", "RN": "35X333P19D", "RR": "7297-25-8 (Erythrityl Tetranitrate)", "MS": "A vasodilator with general properties similar to NITROGLYCERIN. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1020)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004897"}, {"RECTYPE": "D", "MH": "Erythroblastosis, Fetal", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemolytic Disease of Newborn|T047|NON|EQV|UNK (19XX)|740330|HEMOLYTIC DIS NEWBORN|abcdefv", "ENTRY": "Newborn Hemolytic Diseases", "MN": "C20.306", "FX": "Jaundice, Neonatal", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "erythroblastosis, non-fetal may be ERYTHREMIC MYELOSIS but be careful; do not confuse with VITAMIN K DEFICIENCY BLEEDING", "MS": "A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004899"}, {"RECTYPE": "D", "MH": "Erythroblasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Pronormoblasts|T025|NON|NRW|NLM (1990)|890207|abcdef", "ENTRY": "Pronormoblast", "MN": "A15.378.316.378.590.837.250.200", "MH_TH": "NLM (1975)", "ST": "T025", "PI": "Erythrocytes (1966-1974)", "MS": "Immature, nucleated ERYTHROCYTES occupying the stage of ERYTHROPOIESIS that follows formation of ERYTHROID PRECURSOR CELLS and precedes formation of RETICULOCYTES. The normal series is called normoblasts. Cells called MEGALOBLASTS are a pathologic series of erythroblasts.", "PM": "84; was see under ERYTHROCYTES 1975-83", "HN": "84(75); was see under ERYTHROCYTES 1975-83", "MR": "20080709", "DA": "19741111", "DC": "1", "DX": "19840101", "UI": "D004900"}, {"RECTYPE": "D", "MH": "Erythrocebus patas", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Red Monkey|T015|NON|EQV|NLM (1992)|901128|abcdef", "ENTRY": "Red Monkeys", "MN": "B01.050.150.900.649.313.988.400.112.199.120.260.260", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9538", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "MS": "A species of the genus ERYTHROCEBUS, subfamily CERCOPITHECINAE, family CERCOPITHECIDAE. It inhabits the flat open arid country of Africa. It is also known as the patas monkey or the red monkey.", "OL": "use ERYTHROCEBUS PATAS to search PATAS MONKEYS 1975-80", "PM": "91; was see under CERCOPITHECIDAE 1981-90; was PATAS MONKEYS see under MONKEYS 1975-80", "HN": "91(81); was see under CERCOPITHECIDAE 1981-90; was PATAS MONKEYS see under MONKEYS 1975-80", "MR": "20200813", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004901"}, {"RECTYPE": "D", "MH": "Erythrocruorins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.422.316.762.260", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "PI": "Hemeproteins (1973-1976)", "MS": "High molecular weight (1,500,000 to 3,000,000) hemoglobins found in the plasma of many polychete and oligochete annelid worms, crustaceans, insects, and mollusks. They bind one mole of oxygen per heme and function as oxygen carriers.", "PM": "1991; see HEMOGLOBINS 1977-1990", "HN": "1991 (1977); use HEMOGLOBINS 1977-1990", "MR": "20170703", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D004902"}, {"RECTYPE": "D", "MH": "Erythrocyte Aggregation", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Erythrocyte Aggregation, Intravascular|T043|NON|NRW|NLM (1964)|990101|ERYTHROCYTE AGGREGATION INTRAVASC|abcdefv", "ENTRY": "Rouleaux Formations, Erythrocyte", "MN": "G09.188.370.187", "FX": "Hemorheology", "MH_TH": "NLM (1976)", "ST": "T059", "AN": "coordinate with disease /blood, not disease /physiopathol", "PI": "Erythrocytes (1966-1975)", "MS": "The formation of clumps of RED BLOOD CELLS under low or non-flow conditions, resulting from the attraction forces between the red blood cells. The cells adhere to each other in rouleaux aggregates. Slight mechanical force, such as occurs in the circulation, is enough to disperse these aggregates. Stronger or weaker than normal aggregation may result from a variety of effects in the ERYTHROCYTE MEMBRANE or in BLOOD PLASMA. The degree of aggregation is affected by ERYTHROCYTE DEFORMABILITY, erythrocyte membrane sialylation, masking of negative surface charge by plasma proteins, etc. BLOOD VISCOSITY and the ERYTHROCYTE SEDIMENTATION RATE are affected by the amount of erythrocyte aggregation and are parameters used to measure the aggregation.", "PM": "1976; for ERYTHROCYTE AGGREGATION, INTRAVASCULAR see ERYTHROCYTE AGGREGATION, INTRAVASCULAR 1964-2003; for INTRAVASCULAR AGGLUTINATION see ERYTHROCYTE AGGREGATION, INTRAVASCULAR 1976-2003", "HN": "1976", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D004903"}, {"RECTYPE": "D", "MH": "Erythrocyte Aging", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Erythrocyte Survival|T081|NON|REL|NLM (1992)|910514|abcdef", "ENTRY": "Survival, Erythrocyte", "MN": "G09.188.230", "MH_TH": "NLM (1965)", "ST": "T043", "AN": "coord with disease /blood, not /physiopathol", "MS": "The senescence of RED BLOOD CELLS. Lacking the organelles that make protein synthesis possible, the mature erythrocyte is incapable of self-repair, reproduction, and carrying out certain functions performed by other cells. This limits the average life span of an erythrocyte to 120 days.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004905"}, {"RECTYPE": "D", "MH": "Erythrocyte Count", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Red Blood Cell Count|T034|T081|NON|EQV|NLM (1993)|911008|abbcdef", "ENTRY": "Erythrocyte Numbers", "MN": "G09.188.105.330", "MH_TH": "NLM (1966)", "ST": "T081", "AN": "usually NIM; coord with disease /blood, not /physiopathol", "MS": "The number of RED BLOOD CELLS per unit volume in a sample of venous BLOOD.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004906"}, {"RECTYPE": "D", "MH": "Erythrocyte Deformability", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Erythrocyte Filterability|T043|NON|EQV|UNK (19XX)|840530|abcdef", "ENTRY": "Filterability, Erythrocyte", "MN": "G09.188.370.249", "FX": "Hemorheology", "MH_TH": "NLM (1985)", "ST": "T043", "AN": "note category: do not confuse with ERYTHROCYTES, ABNORMAL: deformability is a normal desirable characteristic of erythrocytes; coord with disease /blood, not /physiopathol", "PI": "Erythrocytes, Abnormal (1968-1984)", "MS": "Ability of ERYTHROCYTES to change shape as they pass through narrow spaces, such as the microvasculature.", "PM": "85", "HN": "85", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19840530", "DC": "1", "DX": "19850101", "UI": "D004907"}, {"RECTYPE": "D", "MH": "Erythrocyte Inclusions", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Howell-Jolly Bodies|T020|EPO|NRW|UNK (19XX)|750304|abcdef", "ENTRY": "Inclusions, Erythrocyte", "MN": "A15.145.229.334.330.340", "MH_TH": "NLM (1975)", "ST": "T026", "MS": "Pathologic inclusions occurring in erythrocytes.", "OL": "search ERYTHROCYTES, ABNORMAL 1968-74", "PM": "91; was see under ERYTHROCYTES, ABNORMAL 1975-90", "HN": "91(75); was see under ERYTHROCYTES, ABNORMAL 1975-90", "MR": "20000622", "DA": "19750204", "DC": "1", "DX": "19910101", "UI": "D004908"}, {"RECTYPE": "D", "MH": "Erythrocyte Indices", "AQ": "DE GE IM PH RE VE", "PRINT ENTRY": "Red Cell Indices|T034|NON|EQV|UNK (19XX)|781219|abcdef", "ENTRY": "Volumes, Mean Corpuscular", "MN": "G09.188.260", "MH_TH": "NLM (1980)", "ST": "T034", "AN": "coordinate with disease /blood, not /physiopathol", "PI": "Hemoglobins (1966-1979)", "MS": "ERYTHROCYTE size and HEMOGLOBIN content or concentration, usually derived from ERYTHROCYTE COUNT; BLOOD hemoglobin concentration; and HEMATOCRIT. The indices include the mean corpuscular volume (MCV), the mean corpuscular hemoglobin (MCH), and the mean corpuscular hemoglobin concentration (MCHC).", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19781219", "DC": "1", "DX": "19800101", "UI": "D004909"}, {"RECTYPE": "D", "MH": "Erythrocyte Membrane", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Red Cell Ghost|T026|NON|NRW|UNK (19XX)|760512|abcdef", "ENTRY": "Red Cell Ghosts", "MN": "A15.145.229.334.270", "MH_TH": "NLM (1977)", "ST": "T026", "PI": "Erythrocytes (1966-1976)", "MS": "The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS.", "PM": "84; was see under ERYTHROCYTES 1977-83", "HN": "84(77); was see under ERYTHROCYTES 1977-83", "MR": "20210510", "DA": "19760519", "DC": "1", "DX": "19840101", "UI": "D004910"}, {"RECTYPE": "D", "MH": "Erythrocyte Volume", "AQ": "DE ES GE IM PH RE VE", "PRINT ENTRY": "Red Cell Mass|T034|NON|NRW|UNK (19XX)|770426|abcdef", "ENTRY": "Volumes, Erythrocyte", "MN": "G09.330.380.092.370", "FX": "Hematocrit", "MH_TH": "NLM (1978)", "ST": "T034", "AN": "restrict to total amount of circulating erythrocytes: do not use for size of individual erythrocytes (use ERYTHROCYTES / cytol + CELL SIZE); ERYTHROCYTE VOLUME, PACKED & ERYTHROCYTE INDICES are also available; coordinate with disease /physiopathol, not / blood", "PI": "Erythrocytes (1966-1977)", "MS": "Volume of circulating ERYTHROCYTES . It is usually measured by RADIOISOTOPE DILUTION TECHNIQUE.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20150625", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D004911"}, {"RECTYPE": "D", "MH": "Erythrocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Red Blood Cells|T025|NON|EQV|NLM (1993)|911008|abcdef", "ENTRY": "Red Blood Corpuscle", "MN": "A15.145.229.334", "EC": "transplantation:Erythrocyte Transfusion", "MH_TH": "NLM (1966)", "ST": "T025", "AN": "vertebrates only; for invertebrates index under HEMOCYTES; /cytol: consider also ERYTHROCYTE INDICES; do not equate /pathol with ERYTHROCYTES, ABNORMAL; erythrocyte antibodies: index BLOOD GROUP ANTIGENS /immunol + ISOANTIBODIES & do not index under ERYTHROCYTES", "MS": "Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN.", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004912"}, {"RECTYPE": "D", "MH": "Erythrocytes, Abnormal", "DE": "ERYTHROCYTES ABNORM", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Erythrocyte, Abnormal", "MN": "A15.145.229.334.330", "MH_TH": "NLM (1968)", "ST": "T034", "AN": "abnormal size & shape; do not equate with ERYTHROCYTES / pathol; do not confuse with ERYTHROCYTE DEFORMABILITY, a normal characteristic of erythrocytes; coordinate with disease / blood, not / compl", "PI": "Erythrocytes (1966-1967)", "MS": "Oxygen-carrying RED BLOOD CELLS in mammalian blood that are abnormal in structure or function.", "PM": "68", "HN": "68", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004913"}, {"RECTYPE": "D", "MH": "Leukemia, Erythroblastic, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myeloid Leukemia, Acute, M6|T191|NON|EQV|UNK (19XX)|880609|MYELOID LEUKEMIA ACUTE M 06|abcdefs", "ENTRY": "Myelosis, Erythremic", "MN": "C15.378.508.539.275.325", "MH_TH": "NLM (1968)", "ST": "T191", "AN": "Friend erythroleukemia cells: coordinate with FRIEND MURINE LEUKEMIA VIRUS + TUMOR CELLS, CULTURED ", "PI": "Erythremic Myelosis (1966-1967)", "MS": "A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.", "OL": "use LEUKEMIA, ERYTHROBLASTIC, ACUTE to search ERYTHROLEUKEMIA 1973-88 (as Prov 1968-72) & ERYTHREMIC MYELOSIS 1966-83", "PM": "89; ERYTHROLEUKEMIA was heading 1973-88; ERYTHREMIC MYELOSIS was heading 1963-83", "HN": "89; ERYTHROLEUKEMIA was heading 1973-88 (Prov 1968-72); ERYTHREMIC MYELOSIS was heading 1963-83", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004915"}, {"RECTYPE": "D", "MH": "Erythromelalgia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Erythermalgia|T047|NON|EQV|GHR (2014)|UNK (19XX)|840213|abcdeef", "ENTRY": "Primary Erythermalgias", "MN": "C14.907.617.500", "FX": "NAV1.7 Voltage-Gated Sodium Channel", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A peripheral arterial disease that is characterized by the triad of ERYTHEMA, burning PAIN, and increased SKIN TEMPERATURE of the extremities (or red, painful extremities). Erythromelalgia may be classified as primary or idiopathic, familial or non-familial. Secondary erythromelalgia is associated with other diseases, the most common being MYELOPROLIFERATIVE DISORDERS.", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004916"}, {"RECTYPE": "D", "MH": "Erythromycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TStat", "MN": "D02.540.576.500.992", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T195", "RN": "63937KV33D", "RR": "I8T8KU14X7", "MS": "A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004917"}, {"RECTYPE": "D", "MH": "Erythromycin Estolate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Erythromycin Propionate Lauryl Sulfate|T109|T195|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Estolate, Erythromycin", "MN": "D02.540.576.500.992.250", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Erythromycin, 2'-propanoate, dodecyl sulfate (salt)", "RN": "XRJ2P631HP", "RR": "3521-62-8 (Erythromycin Estolate)", "PI": "Sodium Dodecyl Sulfate (1974)", "MS": "A macrolide antibiotic, produced by Streptomyces erythreus. It is the lauryl sulfate salt of the propionic ester of erythromycin. This erythromycin salt acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.", "PM": "91; was see under ERYTHROMYCIN 1975-90", "HN": "91(75); was see under ERYTHROMYCIN 1975-90", "MR": "20150622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004918"}, {"RECTYPE": "D", "MH": "Erythroplasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Erythroplasias", "MN": "C04.834.288", "MH_TH": "NLM (1966)", "ST": "T049", "AN": "precancerous dis of the mucous membranes", "MS": "A condition of the mucous membrane characterized by erythematous papular lesions.", "CATSH": "CAT LIST", "MR": "20170707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004919"}, {"RECTYPE": "D", "MH": "Erythropoiesis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Erythropoieses", "MN": "G09.188.343.414", "MH_TH": "NLM (1966)", "ST": "T042", "MS": "The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004920"}, {"RECTYPE": "D", "MH": "Erythropoietin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.529.374.410.240.150", "FX": "Receptors, Erythropoietin", "MH_TH": "NLM (1966)", "ST": "T125", "N1": "Erythropoietin", "RN": "11096-26-7", "MS": "Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004921"}, {"RECTYPE": "D", "MH": "Erythrosine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "FD & C Red No. 3|T109|T130|NON|EQV|NLM (2003)|011212|abbcdef", "ENTRY": "FDC Red No. 3|T109|T130|NON|EQV|NLM (2003)|011212|abbcdef", "MN": "D04.711.347.350", "PA": "Fluorescent Dyes", "MH_TH": "NLM (1979)", "ST": "T130", "N1": "Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 3',6'-dihydroxy-2',4',5',7'-tetraiodo-, disodium salt", "RN": "PN2ZH5LOQY", "RR": "16423-68-0 (Erythrosine)", "AN": "do not confuse with Erythrocin, a brand of ERYTHROMYCIN", "PI": "Fluoresceins (1966-1978)", "MS": "A tetraiodofluorescein used as a red coloring in some foods (cherries, fish), as a disclosure of DENTAL PLAQUE, and as a stain of some cell types. It has structural similarity to THYROXINE.", "PM": "91; was see under FLUORESCEINS 1979-90", "HN": "91(79); was see under FLUORESCEINS 1979-90", "MR": "20160531", "DA": "19780207", "DC": "1", "DX": "19910101", "UI": "D004923"}, {"RECTYPE": "D", "MH": "Escape Reaction", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Flight Reaction|T055|NON|EQV|UNK (19XX)|780426|abcdef", "ENTRY": "Reactions, Flight", "MN": "G11.427.410.568.850.688", "MH_TH": "NLM (1968)", "ST": "T055", "AN": "human & animal", "PI": "Fear (1966-1967)", "MS": "Innate response elicited by sensory stimuli associated with a threatening situation, or actual confrontation with an enemy.", "OL": "use ESCAPE REACTION to search FLIGHT REACTION 1968-78", "PM": "68", "HN": "68; FLIGHT REACTION was see under ESCAPE REACTION 1968-78", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004924"}, {"RECTYPE": "D", "MH": "Escherichia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.180", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid561", "AN": "infection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms occur in the lower part of the intestine of warm-blooded animals. The species are either nonpathogenic or opportunistic pathogens.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004925"}, {"RECTYPE": "D", "MH": "Escherichia coli", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Enterococcus coli|T007|NON|EQV|NLM (2021)|190919|abcdef", "ENTRY": "Enteroinvasive Escherichia coli|T007|NON|NRW|NLM (2008)|061115|abcdef", "MN": "B03.660.250.150.180.100", "FX": "Escherichia coli Proteins", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid562", "MS": "A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.", "OL": "use SHIGELLA to search ALKALESCENS-DISPAR GROUP 1974; use ENTEROBACTERIACEAE 1966-73", "PM": "ALKALESCENS-DISPAR GROUP was heading 1975-96 (see under ESCHERICHIA 1975-90); was see under SHIGELLA 1974; was see under ENTEROBACTERIACEAE 1968-73", "HN": "ALKALESCENS-DISPAR GROUP was heading 1975-96 (see under ESCHERICHIA 1975-90); was see under SHIGELLA 1974; was see under ENTEROBACTERIACEAE 1963-73 (Prov 1963-67)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D004926"}, {"RECTYPE": "D", "MH": "Escherichia coli Infections", "DE": "ESCHERICHIA COLI INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Escherichia coli", "MN": "C01.150.252.400.310.330", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific strain (IM) if pertinent", "MS": "Infections with bacteria of the species ESCHERICHIA COLI.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004927"}, {"RECTYPE": "D", "MH": "Escin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aescin|T109|T121|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "opinobiomo", "MN": "D09.408.782.250", "PA": "Cardiovascular Agents", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "6805-41-0", "RR": "QYK0D6H79O", "PI": "Saponins (1971-1975)", "MS": "Pentacyclic triterpene saponins, biosynthesized from protoaescigenin and barringtogenol, occurring in the seeds of AESCULUS. It inhibits edema formation and decreases vascular fragility.", "PM": "91; was see under SAPONINS 1975-90", "HN": "91(75); was see under SAPONINS 1975-90", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004928"}, {"RECTYPE": "D", "MH": "Esculin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Venoplant|T109|T121|T123|T130|NON|EQV|UNK (19XX)|861113|abbbbcdef", "MN": "D09.408.348.250", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "2H-1-Benzopyran-2-one, 6-(beta-D-glucopyranosyloxy)-7-hydroxy-", "RN": "1Y1L18LQAF", "RR": "531-75-9 (Esculin)", "MS": "A derivative of COUMARIN with molecular formula C15H16O9.", "OL": "search BIOFLAVONOIDS 1966-74", "PM": "91; was see under COUMARINS 1989-90; was see under BIOFLAVONOIDS 1966-88", "HN": "91(75); was see under COUMARINS 1989-90; was see under BIOFLAVONOIDS 1966-88", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004929"}, {"RECTYPE": "D", "MH": "Inuit", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Kalaallits|T098|NON|NRW|NLM (2004)|030617|abcdef", "ENTRY": "Kalaallit", "MN": "M01.686.477.250.600.375.500", "MH_TH": "NLM (2023)", "ST": "T098", "AN": "specify geographic location if pertinent", "MS": "Inuktitut-speakers generally associated with the northern polar region.", "PM": "2023; see ESKIMOS 1965-2003, INUITS 2004-2022", "HN": "2023; use ESKIMOS 1965-2003, INUITS 2004-2022", "MR": "20221101", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004930"}, {"RECTYPE": "D", "MH": "Esophageal Achalasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Megaesophagus|T047|NON|REL|UNK (19XX)|840606|abcdef", "ENTRY": "Esophageal Achalasias", "MN": "C06.405.117.119.500.432", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER (near the CARDIA) fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus (megaesophagus).", "PM": "1985; for ACHALASIA OF ESOPHAGUS see CARDIOSPASM 1974-1984; for ACHALASIA see CARDIOSPASM 1963-1973; CARDIOSPASM was heading 1963-1984", "HN": "1985; for ACHALASIA OF ESOPHAGUS use CARDIOSPASM 1974-1984; for ACHALASIA use CARDIOSPASM 1963-1973; CARDIOSPASM was heading 1963-1984", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D004931"}, {"RECTYPE": "D", "MH": "Esophageal and Gastric Varices", "DE": "ESOPHAGEAL GASTRIC VARICES", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gastric Varices|T020|T047|NON|NRW|UNK (19XX)|840531|abbcdef", "ENTRY": "Varix, Gastric", "MN": "C06.552.494.414", "MH_TH": "NLM (1966)", "ST": "T020", "AN": "do not specify esophageal or gastric aspect unless particularly discussed; hemorrhaging esophageal or gastric varices: coordinate with HEMORRHAGE, GASTROINTESTINAL", "MS": "Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL).", "OL": "use ESOPHAGEAL AND GASTRIC VARICES to search ESOPHAGEAL VARICES 1966-84", "PM": "85; was ESOPHAGEAL VARICES 1963-84", "HN": "85; was ESOPHAGEAL VARICES 1963-84", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D004932"}, {"RECTYPE": "D", "MH": "Esophageal Atresia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Atresia, Esophageal|T019|T047|NON|EQV|NLM (1995)|940106|abbcdef", "ENTRY": "Esophageal Atresias", "MN": "C16.131.314.330", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Congenital abnormality characterized by the lack of full development of the ESOPHAGUS that commonly occurs with TRACHEOESOPHAGEAL FISTULA. Symptoms include excessive SALIVATION; GAGGING; CYANOSIS; and DYSPNEA.", "PM": "70", "HN": "70(66)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D004933"}, {"RECTYPE": "D", "MH": "Esophageal Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Esophageal Cysts", "MN": "C06.405.117.316", "MH_TH": "NLM (1966)", "ST": "T019", "AN": "non-neoplastic", "MS": "Any fluid-filled closed cavity or sac (CYSTS) that is lined by an EPITHELIUM and found in the ESOPHAGUS region.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004934"}, {"RECTYPE": "D", "MH": "Esophageal Diseases", "DE": "ESOPHAGEAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Esophageal Disease", "MN": "C06.405.117", "FX": "Esophageal Atresia", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes in the ESOPHAGUS.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004935"}, {"RECTYPE": "D", "MH": "Diverticulum, Esophageal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Esophageal Diverticulum|T190|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Esophageal Diverticula|T190|NON|EQV|NLM (2004)|030507|abcdef", "MN": "C23.300.415.625", "FX": "Diverticulosis, Esophageal", "MH_TH": "NLM (2001)", "ST": "T190", "AN": "inflamm divertic or diverticulitis: coord IM with DIVERTICULITIS (IM)", "MS": "Saccular protrusion beyond the wall of the ESOPHAGUS.", "OL": "use ESOPHAGEAL DIVERTICULUM to search ESOPHAGEAL DIVERTICULA 1966-91", "PM": "92; was ESOPHAGEAL DIVERTICULA 1963-91", "HN": "92; was ESOPHAGEAL DIVERTICULA 1963-91", "CATSH": "CAT LIST", "MR": "20170707", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D004936"}, {"RECTYPE": "D", "MH": "Esophageal Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fistulas, Esophageal", "MN": "C23.300.575.185.250", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "fistula policy: Manual 23.19+; ESOPHAGOTRACHEAL FISTULA see TRACHEOESOPHAGEAL FISTULA is also available", "MS": "Abnormal passage communicating with the ESOPHAGUS. The most common type is TRACHEOESOPHAGEAL FISTULA between the esophagus and the TRACHEA.", "CATSH": "CAT LIST", "MR": "20050802", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004937"}, {"RECTYPE": "D", "MH": "Esophageal Neoplasms", "DE": "ESOPHAGEAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Esophageal Cancer|T191|NON|NRW|NLM (2000)|OMIM (2013)|991105|abcdeef", "ENTRY": "Neoplasms, Esophagus", "MN": "C06.405.249.205", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the ESOPHAGUS.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004938"}, {"RECTYPE": "D", "MH": "Esophageal Perforation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Perforations, Esophageal", "MN": "C26.348", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "esophageal rupture does not go here: index ESOPHAGUS /inj (IM) + RUPTURE (NIM) or ESOPHAGEAL DISEASES (IM) + RUPTURE, SPONTANEOUS (NIM)", "MS": "An opening or hole in the ESOPHAGUS that is caused by TRAUMA, injury, or pathological process.", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004939"}, {"RECTYPE": "D", "MH": "Esophageal Stenosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Esophageal Stricture|T047|NON|REL|NLM (1993)|911106|abcdef", "ENTRY": "Stricture, Esophageal", "MN": "C06.405.117.544", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caustic stenosis is indexed ESOPHAGEAL STENOSIS /chem ind + BURNS, CHEMICAL", "MS": "A stricture of the ESOPHAGUS. Most are acquired but can be congenital.", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004940"}, {"RECTYPE": "D", "MH": "Esophagitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Esophagitides", "MN": "C06.405.205.663", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "ESOPHAGITIS, PEPTIC is also available", "MS": "INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004941"}, {"RECTYPE": "D", "MH": "Esophagitis, Peptic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Esophagitis, Reflux|T047|NON|EQV|UNK (19XX)|771123|abcdef", "ENTRY": "Reflux Esophagitis", "MN": "C06.405.748.586.524", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "INFLAMMATION of the ESOPHAGUS that is caused by the reflux of GASTRIC JUICE with contents of the STOMACH and DUODENUM.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004942"}, {"RECTYPE": "D", "MH": "Esophagogastric Junction", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Gastroesophageal Junction|T030|NON|EQV|NLM (2005)|040601|abcdef", "ENTRY": "Junctions, Gastroesophageal", "MN": "A03.556.875.875.330", "MH_TH": "NLM (1964)", "ST": "T030", "AN": "diseases: coordinate IM with ESOPHAGEAL DISEASES (IM) or specific esophageal disease (IM); neoplasms: coordinate IM with STOMACH NEOPLASMS (IM) or ESOPHAGEAL NEOPLASMS (IM) depending on text", "MS": "The area covering the terminal portion of ESOPHAGUS and the beginning of STOMACH at the cardiac orifice.", "PM": "66", "HN": "66(64)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004943"}, {"RECTYPE": "D", "MH": "Esophagoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Esophagoplasties", "MN": "E04.210.355", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "A plastic operation on the esophagus. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004944"}, {"RECTYPE": "D", "MH": "Esophagoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Esophagoscopic|T060|T061|NON|NRW|NLM (2000)|991104|SURG PROCEDURES ESOPHAGOSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Esophagoscopic", "MN": "E04.502.250.250.250.260", "FX": "Esophagoscopes", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "/ instrum permitted but consider also ESOPHAGOSCOPES", "MS": "Endoscopic examination, therapy or surgery of the esophagus.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004945"}, {"RECTYPE": "D", "MH": "Esophagostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Cervical Esophagostomy|T061|NON|NRW|UNK (19XX)|870319|abcdef", "ENTRY": "Esophagostomy, Cervical", "MN": "E04.579.358", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Esophagus/surgery (1966-1987)", "MS": "Surgical formation of an external opening (stoma) into the esophagus.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19870319", "DC": "1", "DX": "19880101", "UI": "D004946"}, {"RECTYPE": "D", "MH": "Esophagus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A03.556.875.500", "FX": "Esophagostomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The muscular membranous segment between the PHARYNX and the STOMACH in the UPPER GASTROINTESTINAL TRACT.", "MR": "20050713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004947"}, {"RECTYPE": "D", "MH": "Esotropia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Strabismus, Internal|T047|NON|EQV|NLM (2002)|000928|abcdef", "ENTRY": "Secondary Esotropias", "MN": "C11.590.810.400", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "do not confuse with EXOTROPIA, eye turning outward", "PI": "Strabismus (1966-1979)", "MS": "A form of ocular misalignment characterized by an excessive convergence of the visual axes, resulting in a \"cross-eye\" appearance. An example of this condition occurs when paralysis of the lateral rectus muscle causes an abnormal inward deviation of one eye on attempted gaze.", "OL": "use STRABISMUS to search ESOTROPIA 1975-89", "PM": "90; was see under STRABISMUS 1980-89; was see STRABISMUS 1975-79", "HN": "90(80); was see under STRABISMUS 1980-89; was see STRABISMUS 1975-79", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19790522", "DC": "1", "DX": "19900101", "UI": "D004948"}, {"RECTYPE": "D", "MH": "Estazolam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tasedan|T109|T121|TRD|NRW|MX|041210|abbcdef", "MN": "D03.633.100.079.080.250", "PA": "GABA Modulators", "MH_TH": "USAN (1990)", "ST": "T121", "N1": "4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-phenyl-", "RN": "36S3EQV54C", "RR": "29975-16-4 (Estazolam)", "PI": "Triazoles (1972-1974)", "MS": "A benzodiazepine with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than DIAZEPAM or NITRAZEPAM.", "OL": "use ESTAZOLAM to search D 40TA 1975-79", "PM": "91; was see under BENZODIAZEPINE TRANQUILIZERS 1980-90; was D 40TA see under BENZODIAZEPINE TRANQUILIZERS 1975-79", "HN": "91(80); was see under BENZODIAZEPINE TRANQUILIZERS 1980-90; was D 40TA see under BENZODIAZEPINE TRANQUILIZERS 1975-79", "MR": "20170524", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D004949"}, {"RECTYPE": "D", "MH": "Esterases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Esterase|T116|T126|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D08.811.277.352", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.1.-", "MS": "Any member of the class of enzymes that catalyze the cleavage of an ester bond and result in the addition of water to the resulting molecules.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004950"}, {"RECTYPE": "D", "MH": "Esterification", "AQ": "DE GE IM PH RE", "ENTRY": "Esterifications", "MN": "G03.344", "MH_TH": "NLM (1976)", "ST": "T070", "AN": "almost never IM", "PI": "Esters (1968-1975)", "MS": "The process of converting an acid into an alkyl or aryl derivative. Most frequently the process consists of the reaction of an acid with an alcohol in the presence of a trace of mineral acid as catalyst or the reaction of an acyl chloride with an alcohol. Esterification can also be accomplished by enzymatic processes.", "PM": "91; was see under CHEMISTRY, ORGANIC 1976-90", "HN": "91(76); was see under CHEMISTRY, ORGANIC 1976-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D004951"}, {"RECTYPE": "D", "MH": "Esters", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ester|T109|NON|EQV|NLM (2021)|191230|abcdef", "MN": "D02.241.400", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PI": "specific alcohol (1968-1990)", "MS": "Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an \u2013O-alkyl or another organic group. They can be represented by the structure formula RCOOR\u2019 and are usually formed by the reaction between an acid and an alcohol with elimination of water.", "PM": "91; was see under CARBOXYLIC ACIDS 1968-90", "HN": "91(68); was see under CARBOXYLIC ACIDS 1968-90", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004952"}, {"RECTYPE": "D", "MH": "Estetrol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "15 alpha Hydroxyestriol", "MN": "D06.472.334.851.437.750.320", "MH_TH": "NLM (1975)", "ST": "T125", "N1": "Estra-1,3,5(10)-triene-3,15,16,17-tetrol, (15alpha,16alpha,17beta)-", "RN": "ENB39R14VF", "RR": "15183-37-6 (Estetrol)", "PI": "Estriol (1973-1974)", "MS": "A metabolite of ESTRIOL with a 15-alpha-hydroxyl group. Estetrol can be converted from estriol sulfate or DEHYDROEPIANDROSTERONE SULFATE by the fetal-placental unit.", "PM": "91; was see under ESTRIOL 1975-90", "HN": "91(75); was see under ESTRIOL 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004953"}, {"RECTYPE": "D", "MH": "Esthetics", "AQ": "CL ED HI PX", "PRINT ENTRY": "Aesthetics|T090|NON|EQV|NLM (2000)|991103|abcdef", "MN": "K01.752.210", "MH_TH": "NLM (1967)", "ST": "T090", "MS": "The branch of philosophy dealing with the nature of the beautiful. It includes beauty, esthetic experience, esthetic judgment, esthetic aspects of medicine, etc.", "OL": "use ESTHETICS to search BEAUTY 1966", "PM": "67; was BEAUTY 1963-66", "HN": "67; was BEAUTY 1963-66", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D004954"}, {"RECTYPE": "D", "MH": "Esthetics, Dental", "DE": "ESTHETICS DENT", "AQ": "CL EC HI PX SN", "PRINT ENTRY": "Cosmetic Dentistry|T080|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Dentistry, Cosmetic", "MN": "E06.420", "MH_TH": "NLM (1965)", "ST": "T080", "MS": "Skills, techniques, standards, and principles used to improve the art and symmetry of the teeth and face to improve the appearance as well as the function of the teeth, mouth, and face. (From Boucher's Clinical Dental Terminology, 4th ed, p108)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D004955"}, {"RECTYPE": "D", "MH": "Estivation", "AQ": "DE GE IM PH RE", "ENTRY": "Aestivation|T040|NON|EQV|NLM (2018)|170131|abcdef", "MN": "G16.012.500.535.889.249", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "In certain living species, a period of dormancy during the summer months marked by decreased metabolism.", "PM": "91; was see under ADAPTATION, PHYSIOLOGICAL 1966-90", "HN": "91(66); was see under ADAPTATION, PHYSIOLOGICAL 1966-90", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004956"}, {"RECTYPE": "D", "MH": "Estonia", "AQ": "EH EP", "MN": "Z01.542.248.136.360", "MH_TH": "NLM (1993)", "ST": "T083", "MS": "A country in Eastern Europe, bordering the Baltic Sea and Gulf of Finland, between Latvia and Russia. The capital is Tallinn.", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D004957"}, {"RECTYPE": "D", "MH": "Estradiol", "AQ": "AA AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oestradiol|T109|T121|T125|NON|EQV|BAN (19XX)|FDA SRS (2014)|NLM (1999)|971222|abbbcdeeef", "ENTRY": "Progynon Depot", "MN": "D06.472.334.851.437.500", "PA": "Estrogens", "FX": "Receptors, Estradiol", "EC": "antagonists & inhibitors:Estrogen Antagonists", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Estra-1,3,5(10)-triene-3,17-diol (17beta)-", "RN": "4TI98Z838E", "RR": "OKG364O896", "AN": "for /antag also consider: ESTROGEN RECEPTOR MODULATORS; ESTROGEN RECEPTOR ANTAGONISTS; and AROMATASE INHIBITORS.", "MS": "The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.", "PM": "1963; OVOCYCLIN was indexed under ESTRADIOL/analogs & derivatives 1980-1998; /therapeutic use was ESTRADIOL, THERAPEUTIC 1965", "HN": "1963; for OVOCYCLIN use ESTRADIOL DIPROPIONATE (NM) 1980-1998; /therapeutic use was ESTRADIOL, THERAPEUTIC 1965", "MR": "20180409", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004958"}, {"RECTYPE": "D", "MH": "Estradiol Dehydrogenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Estradiol 17 beta Dehydrogenase", "MN": "D08.811.682.047.436.375.280", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Estradiol-17 beta:NAD(P)+ 17-oxidoreductase", "RN": "EC 1.1.1.62", "PI": "Hydroxysteroid Dehydrogenases (1973-1974)", "MS": "Enzymes that catalyze the oxidation of estradiol at the 17-hydroxyl group in the presence of NAD+ or NADP+ to yield estrone and NADH or NADPH. The 17-hydroxyl group can be in the alpha- or beta-configuration. EC 1.1.1.62", "OL": "use ESTRADIOL DEHYDROGENASES to search ESTRADIOL DEHYDROGENASE 1975-77", "PM": "91; was see under 17-HYDROXYSTEROID DEHYDROGENASES 1978-90; was ESTRADIOL DEHYDROGENASE see under HYDROXYSTEROID DEHYDROGENASES 1975-77", "HN": "91(78); was see under 17-HYDROXYSTEROID DEHYDROGENASES 1978-90; was ESTRADIOL DEHYDROGENASE see under HYDROXYSTEROID DEHYDROGENASES 1975-77", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004960"}, {"RECTYPE": "D", "MH": "Estramustine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Estramustinphosphate|T109|T121|NON|NRW|UNK (19XX)|790503|abbcdef", "ENTRY": "Phosphate, Estramustin", "MN": "D04.210.500.365.415.248.320", "PA": "Antineoplastic Agents, Hormonal", "MH_TH": "USAN (1978)", "ST": "T121", "N1": "Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 3-(bis(2-chloroethyl)carbamate)", "RN": "35LT29625A", "RR": "75F375MT2N", "PI": "Organophosphorus Compounds (1973-1974)", "MS": "A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties.", "OL": "use ESTRAMUSTINE to search ESTRAMUSTINPHOSPHATE 1975-79", "PM": "91; was see under NITROGEN MUSTARD COMPOUNDS 1980-90; was ESTRAMUSTINPHOSPHATE see under NITROGEN MUSTARD COMPOUNDS 1975-79", "HN": "91(80); was see under NITROGEN MUSTARD COMPOUNDS 1980-90; was ESTRAMUSTINPHOSPHATE see under NITROGEN MUSTARD COMPOUNDS 1975-79", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004961"}, {"RECTYPE": "D", "MH": "Estranes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "19-Norandrostanes|T109|NON|EQV|UNK (19XX)|750101|NORANDROSTANES 19|abcdefs", "ENTRY": "19 Norandrostanes", "MN": "D04.210.500.365", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "do not confuse with ESTRENES", "MS": "A group of compounds forming the nucleus of the estrogenic steroid family.", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004962"}, {"RECTYPE": "D", "MH": "Estrenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "19-Norandrostenes|T109|NON|EQV|UNK (19XX)|750101|NORANDROSTENES 19|abcdefs", "ENTRY": "19 Norandrostenes", "MN": "D04.210.500.365.415", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with ESTRANES", "PI": "Estranes (1968-1974)", "MS": "Unsaturated derivatives of the ESTRANES with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17. They must contain one or more double bonds.", "OL": "search ESTRANES 1973-74", "PM": "75; was see under ESTRANES 1973-74", "HN": "75; was see under ESTRANES 1973-74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D004963"}, {"RECTYPE": "D", "MH": "Estriol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "16beta Hydroxy Estradiol", "MN": "D06.472.334.851.437.750", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Estra-1,3,5(10)-triene-3,16,17-triol, (16alpha,17beta)-", "RN": "FB33469R8E", "RR": "8XZ32LI44K", "MS": "A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, a large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004964"}, {"RECTYPE": "D", "MH": "Estrogen Antagonists", "DE": "ESTROGEN ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Antagonists, Estrogen", "MN": "D27.505.696.399.450.327", "FX": "Estrogens", "MH_TH": "NLM (1978)", "ST": "T121", "RN": "0", "AN": "do not confuse with ANTIESTROGENS see ESTROGEN RECEPTOR MODULATORS", "PI": "specific estrogen (1966-1977)", "MS": "Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.", "PM": "78", "HN": "78", "MR": "20140612", "DA": "19991108", "DC": "1", "DX": "19780101", "UI": "D004965"}, {"RECTYPE": "D", "MH": "Estrogens, Conjugated (USP)", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Progen|T109|T121|T125|NON|NRW|NLM (2021)|191120|abbbcdef", "ENTRY": "Oestro Feminal", "MN": "D06.472.334.851.437.988", "PA": "Estrogens", "MH_TH": "NLM (2004)", "ST": "T125", "RN": "0", "AN": "do not confuse with ESTRADIOL CONGENERS", "MS": "A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate.", "PM": "2004; see ESTROGENS, CONJUGATED 1994-2003, see ESTROGENIC SUBSTANCES, CONJUGATED 1973-1993; CENESTIN was indexed under ESTROGENS, CONJUGATED 1999-2002; PRESOMEN was indexed under ESTROGENIC SUBSTANCES, CONJUGATED 1987-1998; for PREMARIN see PREMARIN 1991-1993, see ESTROGENIC SUBSTANCES, CONJUGATED 1975-1990", "HN": "2004 (1973); for CENESTIN use ESTROGENS, CONJUGATED (NM) 1999-2002", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D004966"}, {"RECTYPE": "D", "MH": "Estrogens", "AQ": "AA AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Receptor Agonists, Estrogen", "MN": "D27.505.696.399.472.277", "FX": "Receptors, Estrogen", "EC": "antagonists & inhibitors:Estrogen Antagonists", "MH_TH": "NLM (1963)", "ST": "T125", "RN": "0", "MS": "Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.", "PM": "1963; /therapeutic use was ESTROGENS, THERAPEUTIC 1965", "HN": "1963; /therapeutic use was ESTROGENS, THERAPEUTIC 1965", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004967"}, {"RECTYPE": "D", "MH": "Estrogens, Non-Steroidal", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nonsteroidal Estrogens", "MN": "D27.505.696.399.472.277.540", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Estrogens (1966-1974)", "MS": "Non-steroidal compounds with estrogenic activity.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D004968"}, {"RECTYPE": "D", "MH": "Estrone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Folliculin (Hormone)|T109|T121|T125|TRD|NRW|NLM (2022)|210518|abbbcdef", "ENTRY": "Wehgen|T109|T121|T125|TRD|NRW|US|041215|abbbcdef", "MN": "D06.472.334.851.437.996", "PA": "Estrogens", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Estra-1,3,5(10)-trien-17-one, 3-hydroxy-", "RN": "2DI9HA706A", "RR": "53-16-7 (Estrone)", "MS": "An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004970"}, {"RECTYPE": "D", "MH": "Estrus", "AQ": "BL CF DE GE IM ME PH RE UR", "MN": "G08.686.195.500", "MH_TH": "NLM (1966)", "ST": "T040", "AN": "non-primate mammals only", "MS": "The period in the ESTROUS CYCLE associated with maximum sexual receptivity and fertility in non-primate female mammals.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004971"}, {"RECTYPE": "D", "MH": "Estrus Detection", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD", "ENTRY": "Estrus Detections", "MN": "E05.820.150.360", "MH_TH": "NLM (1975)", "ST": "T059", "AN": "animal only", "MS": "Methods for recognizing the state of ESTRUS.", "PM": "91; was see under BREEDING 1975-90", "HN": "91(75); was see under BREEDING 1975-90", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004972"}, {"RECTYPE": "D", "MH": "Estrus Synchronization", "AQ": "BL CF DE GE IM ME MT PH RE UR", "ENTRY": "Synchronizations, Estrus", "MN": "G08.686.195.500.500", "MH_TH": "NLM (1975)", "ST": "T067", "AN": "non-primate mammals only", "PI": "Estrus (1966-1974)", "MS": "Occurrence or induction of ESTRUS in all of the females in a group at the same time, applies only to non-primate mammals with ESTROUS CYCLE.", "PM": "76; was see under ESTRUS 1975", "HN": "76(75); was see under ESTRUS 1975", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741111", "DC": "1", "DX": "19760101", "UI": "D004973"}, {"RECTYPE": "D", "MH": "Etazolate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SQ20009", "MN": "D03.383.725.547.400", "PA": "Phosphodiesterase Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1H-Pyrazolo(3,4-b)pyridine-5-carboxylic acid, 1-ethyl-4-((1-methylethylidene)hydrazino)-, ethyl ester", "RN": "I89Y79062L", "RR": "7YO3254Y6B", "PI": "Pyridines (1973-1974)", "MS": "A potent phosphodiesterase inhibitor proposed as an antipsychotic agent.", "OL": "use ETAZOLATE to search SQ 20009 1976-79", "PM": "91; was see under NICOTINIC ACIDS 1980-90; was SQ 20009 see under NICOTINIC ACIDS 1976-79", "HN": "91(80); was see under NICOTINIC ACIDS 1980-90; was SQ 20009 see under NICOTINIC ACIDS 1976-79", "MR": "20160531", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D004974"}, {"RECTYPE": "D", "MH": "Ethacridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrate, Ethacridine", "MN": "D03.633.300.046.250.450", "PA": "Anti-Infective Agents, Local", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "3,9-Acridinediamine, 7-ethoxy-", "RN": "WIX85M1A6R", "RR": "V5IL571C1T", "PI": "Lactates (1968-1974)", "MS": "A topically applied anti-infective agent.", "PM": "91; was see under ACRIDINES 1975-90", "HN": "91(75); was see under ACRIDINES 1975-90", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004975"}, {"RECTYPE": "D", "MH": "Ethacrynic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Ethacrynate", "MN": "D02.241.511.316.682.200", "PA": "Enzyme Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Acetic acid, (2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy)-", "RN": "M5DP350VZV", "RR": "K41MYV7MPM", "MS": "A compound that inhibits symport of sodium, potassium, and chloride primarily in the ascending limb of Henle, but also in the proximal and distal tubules. This pharmacological action results in excretion of these ions, increased urinary output, and reduction in extracellular fluid. This compound has been classified as a loop or high ceiling diuretic.", "PM": "66", "HN": "66(63)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004976"}, {"RECTYPE": "D", "MH": "Ethambutol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Llorente, Etambutol", "MN": "D02.092.782.258.368.265", "PA": "Antitubercular Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Butanol, 2,2'-(1,2-ethanediyldiimino)bis-, (S-(R*,R*))-", "RN": "8G167061QZ", "RR": "QE4VW5FO07", "MS": "An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863)", "PM": "68", "HN": "68(63)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004977"}, {"RECTYPE": "D", "MH": "Ethamoxytriphetol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MER25", "MN": "D02.033.375.270", "PA": "Estrogen Antagonists", "MH_TH": "POPLINE (1978)", "ST": "T121", "N1": "Benzeneethanol, alpha-(4-(2-(diethylamino)ethoxy)phenyl)-4-methoxy-alpha-phenyl-", "RN": "67-98-1", "PI": "Phenyl Ethers (1974)", "MS": "A non-steroidal estrogen antagonist.", "PM": "91; was see under ALCOHOL, ETHYL 1975-90", "HN": "91(75); was see under ALCOHOL, ETHYL 1975-90", "MR": "20000622", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D004978"}, {"RECTYPE": "D", "MH": "Ethamsylate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclonamine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Hemo 141|T109|T121|TRD|NRW|ES|041215|abbcdef", "MN": "D02.886.645.600.080.050.100.300", "PA": "Hemostatics", "MH_TH": "USAN (1964)", "ST": "T121", "N1": "Benzenesulfonic acid, 2,5-dihydroxy-, compd. with N-ethylethanamine (1:1)", "RN": "24YL531VOH", "RR": "2624-44-4 (Ethamsylate)", "PI": "Hydroquinones (1974)", "MS": "Benzenesulfonate derivative used as a systemic hemostatic.", "PM": "91; was see under BENZENESULFONATES 1975-90", "HN": "91(75); was see under BENZENESULFONATES 1975-90", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004979"}, {"RECTYPE": "D", "MH": "Ethane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.326.146.379", "MH_TH": "NLM (1973)", "ST": "T131", "N1": "Ethane", "RN": "L99N5N533T", "RR": "74-84-0 (Ethane)", "PI": "Alkanes (1966-1972)", "MS": "A two carbon alkane with the formula H3C-CH3.", "PM": "73", "HN": "73", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004980"}, {"RECTYPE": "D", "MH": "Ethanolamine Ammonia-Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ethanolamine Deaminase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Ethanolamine Ammonia Lyase", "MN": "D08.811.520.232.400.350", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Ethanolamine ammonia-lyase", "RN": "EC 4.3.1.7", "RR": "9054-69-7 (CAS RN)", "PI": "Ethanolamines (1973-1974)", "MS": "An enzyme that catalyzes the deamination of ethanolamine to acetaldehyde. EC 4.3.1.7.", "PM": "91; was see under AMMONIA-LYASES 1975-90", "HN": "91(75); was see under AMMONIA-LYASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004981"}, {"RECTYPE": "D", "MH": "Ethanolaminephosphotransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "sn 1,2 Diacylglycerol Ethanolaminephosphotransferase", "MN": "D08.811.913.696.900.250", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "CDPethanolamine:1,2-diacylglycerol ethanolaminephosphotransferase", "RN": "EC 2.7.8.1", "RR": "9026-19-1 (CAS RN)", "PI": "Phosphotransferases (1966-1978)", "MS": "An enzyme that catalyzes reversibly the transfer of phosphoethanolamine from CDP-ethanolamine to diacylglycerol to yield phosphatidylethanolamine (cephalin) and CMP. The enzyme is found in the endoplasmic reticulum. EC 2.7.8.1.", "PM": "91; was see under PHOSPHOTRANSFERASES 1979-90", "HN": "91(79); was see under PHOSPHOTRANSFERASES 1979-90", "MR": "20030709", "DA": "19780308", "DC": "1", "DX": "19910101", "UI": "D004982"}, {"RECTYPE": "D", "MH": "Ethanolamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aminoethanols|T109|NON|EQV|UNK (19XX)|760317|abcdef", "MN": "D02.092.063.291", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "AN": "ETHANOLAMINE is also available", "PI": "Amino Alcohols (1966-1972)", "MS": "AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives.", "PM": "73", "HN": "73", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004983"}, {"RECTYPE": "D", "MH": "Ethchlorvynol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethchlorvinol|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef", "ENTRY": "Placidyl|T109|T121|TRD|NRW|UNK (19XX)|811218|abbcdef", "MN": "D02.033.260.335", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1-Penten-4-yn-3-ol, 1-chloro-3-ethyl-", "RN": "6EIM3851UZ", "RR": "113-18-8 (Ethchlorvynol)", "MS": "A sedative and hypnotic that has been used in the short-term management of INSOMNIA. Its use has been superseded by other drugs.", "PM": "66", "HN": "66(63)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004984"}, {"RECTYPE": "D", "MH": "Ethenoadenosine Triphosphate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "epsilon ATP", "MN": "D13.695.827.068.236.250", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "0", "AN": "\"a fluorescent analog of ATP\"", "PI": "Imidazoles (1972-1974)", "MS": "1,N-6-Ethenoadenosine triphosphate. A fluorescent analog of adenosine triphosphate.", "PM": "91; was see under ADENOSINE TRIPHOSPHATE 1975-90", "HN": "91(75); was see under ADENOSINE TRIPHOSPHATE 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D004985"}, {"RECTYPE": "D", "MH": "Ether", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethyl Ether|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|820505|abbcdeef", "ENTRY": "Ether, Diethyl", "MN": "D02.355.417.332", "PA": "Solvents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Ethane, 1,1'-oxybis-", "RN": "0F5N573A2Y", "RR": "60-29-7 (Ether, Ethyl)", "MS": "A mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes.", "PM": "2014: see ETHER, ETHYL 1991-2013, see ETHYL ETHERS 1974-1990, see ETHYL ETHER 1963-1973", "HN": "2014(1963)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D004986"}, {"RECTYPE": "D", "MH": "Ethers", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.355", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with ETHER", "MS": "Organic compounds having two alkyl or aryl groups bonded to an oxygen atom, as in the formula R1\u2013O\u2013R2.", "PM": "ETHOGLUCID was see under ALKYLATING AGENTS 1967-74", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004987"}, {"RECTYPE": "D", "MH": "Ethers, Cyclic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclic Ether|T109|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Ether, Cyclic", "MN": "D04.345.241", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds of the general formula R-O-R arranged in a ring or crown formation.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004988"}, {"RECTYPE": "D", "MH": "Ethics", "AQ": "CL HI", "ENTRY": "Policy, Moral", "MN": "N05.350", "MH_TH": "NLM (2002)", "ST": "T078", "MS": "The philosophy or code pertaining to what is ideal in human character and conduct. Also, the field of study dealing with the principles of morality.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004989"}, {"RECTYPE": "D", "MH": "Ethics, Dental", "DE": "ETHICS DENT", "AQ": "ED HI", "ENTRY": "Ethic, Dental", "MN": "N05.350.340.162.249", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "specify geographic term if pertinent", "MS": "The principles of proper professional conduct concerning the rights and duties of the dentist, relations with patients and fellow practitioners, as well as actions of the dentist in patient care and interpersonal relations with patient families. (From Stedman, 25th ed)", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004990"}, {"RECTYPE": "D", "MH": "Ethics, Institutional", "AQ": "ED HI", "PRINT ENTRY": "Organizational Ethics|T078|NON|REL|NLM (2003)|020227|abcdef", "ENTRY": "Organizational Ethic", "MN": "N05.350.325", "FX": "Ethics, Business", "MH_TH": "BIOETHICS (1989)", "ST": "T078", "AN": "coord IM with type of institution (IM); specify geog if pertinent", "MS": "The moral and ethical obligations or responsibilities of institutions.", "PM": "91; was see under ETHICS Aug 1977-90", "HN": "91(Aug 77); was see under ETHICS 1977-90", "MR": "20150622", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D004991"}, {"RECTYPE": "D", "MH": "Ethics, Medical", "DE": "ETHICS MED", "AQ": "ED HI", "ENTRY": "Medical Ethics|T078|NON|EQV|BIOETHICS (1974)|770317|MED ETHICS|abcdefv", "MN": "N05.350.340.162.500", "FX": "Bioethics", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "restrict to ethics in relation to the physician; BIOETHICS and BIOETHICAL ISSUES are also available", "MS": "The principles of professional conduct concerning the rights and duties of the physician, relations with patients and fellow practitioners, as well as actions of the physician in patient care and interpersonal relations with patient families.", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004992"}, {"RECTYPE": "D", "MH": "Ethics, Nursing", "DE": "ETHICS NURS", "AQ": "ED HI", "PRINT ENTRY": "Nursing Ethics|T078|NON|EQV|BIOETHICS (1974)|780928|NURS ETHICS|abcdefv", "ENTRY": "Nursing Ethic", "MN": "N05.350.340.162.750", "MH_TH": "NLM (1966)", "ST": "T078", "MS": "The principles of proper professional conduct concerning the rights and duties of nurses themselves, their patients, and their fellow practitioners, as well as their actions in the care of patients and in relations with their families.", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004993"}, {"RECTYPE": "D", "MH": "Ethics, Pharmacy", "DE": "ETHICS PHARM", "AQ": "ED HI", "ENTRY": "Pharmacy Ethic", "MN": "N05.350.340.162.875", "MH_TH": "NLM (1968)", "ST": "T078", "MS": "The principles of proper professional conduct concerning the rights and duties of the pharmacist, relations with patients and fellow practitioners, as well as actions of the pharmacist in health care and interpersonal relations with patient families. (From Stedman, 25th ed)", "OL": "use ETHICS, PHARMACY to search ETHICS, PHARMACEUTICAL 1966-67", "PM": "68; was ETHICS, PHARMACEUTICAL 1963-67", "HN": "68; was ETHICS, PHARMACEUTICAL 1963-67", "MR": "20170711", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004994"}, {"RECTYPE": "D", "MH": "Ethics, Professional", "AQ": "ED HI", "ENTRY": "Professional Ethic", "MN": "N05.350.340", "FX": "Professional Misconduct", "MH_TH": "NLM (1968)", "ST": "T078", "AN": "specify geog if pertinent", "PI": "Ethics (1966-1967)", "MS": "The principles of proper conduct concerning the rights and duties of the professional, relations with patients or consumers and fellow practitioners, as well as actions of the professional and interpersonal relations with patient or consumer families. (From Stedman, 25th ed)", "PM": "68", "HN": "68", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D004995"}, {"RECTYPE": "D", "MH": "Ethidium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethidium Bromide|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|741220|abbcdeef", "ENTRY": "Bromide, Homidium", "MN": "D03.633.300.633.416", "PA": "Trypanocidal Agents", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "Phenanthridinium, 3,8-diamino-5-ethyl-6-phenyl-", "RN": "EN464416SI", "RR": "3546-21-2 (Ethidium)", "PI": "appropriate enzyme/AI (1968-1971)", "MS": "A trypanocidal agent and possible antiviral agent that is widely used in experimental cell biology and biochemistry. Ethidium has several experimentally useful properties including binding to nucleic acids, noncompetitive inhibition of nicotinic acetylcholine receptors, and fluorescence among others. It is most commonly used as the bromide.", "PM": "74", "HN": "74(72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D004996"}, {"RECTYPE": "D", "MH": "Ethinyl Estradiol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethynyl Estradiol|T109|T121|T125|NON|EQV|UNK (19XX)|740330|abbbcdef", "ENTRY": "Jenapharm, Ethinylestradiol", "MN": "D06.472.334.851.437.968.500", "PA": "Estrogens", "MH_TH": "USP (19XX)", "ST": "T125", "RN": "423D2T571U", "RR": "99946-33-5 ((8 alpha)-isomer)", "MS": "A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D004997"}, {"RECTYPE": "D", "MH": "Ethiodized Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "UltraFluid, Lipiodol", "MN": "D20.215.784.750.550.300", "PA": "Contrast Media", "MH_TH": "NLM (1964)", "ST": "T130", "N1": "Ethiodized Oil", "RN": "8008-53-5", "RR": "87435-86-7 (ethyl ester of iodinated fatty acid of poppy seed oil)", "MS": "Ethyl ester of iodinated fatty acid of poppyseed oil. It contains 37% organically bound iodine and has been used as a diagnostic aid (radiopaque medium) and as an antineoplastic agent when part of the iodine is 131-I. (From Merck Index, 11th ed)", "PM": "2011; see ETHIODIZED OILS 1978-1993, see ETHIODOL 1973-1977; for ETHIODOL see ETHIODIZED OILS 1978-1993; ETHIODIZED POPPY SEED OIL was indexed under ETHIODIZED OILS 1991-1993; for LIPIODOL and LIPIODOL ULTRAFLUID see IODIZED OIL 1993-2010", "HN": "1994; ETHIODIZED POPPY SEED OIL was (NM) 1991-1993; for LIPIDOL and LIPIODOL ULTRAFLUID use IODIZED OIL 1993-2010", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D004998"}, {"RECTYPE": "D", "MH": "Amifostine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Gammaphos|T121|TRD|NRW|FDA SRS (2014)|UNK (19XX)|840608|abcdeef", "ENTRY": "YM08310", "MN": "D02.886.300.692.050", "PA": "Radiation-Protective Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Ethanethiol, 2-((3-aminopropyl)amino)-, dihydrogen phosphate (ester)", "RN": "M487QF2F4V", "RR": "L693H6MM64", "PI": "Organothiophosphorus Compounds (1972-1976)", "MS": "A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.", "OL": "use AMIFOSTINE to search ETHIOFOS 1985-93 & WR 2721 1977-84", "PM": "1994; was ETHIOFOS 1985-1993 (see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1985-1990); was WR 2721 see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1977-1984", "HN": "1994; was ETHIOFOS 1985-1993 (see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1985-1990); was WR 2721 see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1977-1984", "MR": "20180530", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D004999"}, {"RECTYPE": "D", "MH": "Ethionamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethioniamide|T109|T121|NON|EQV|UNK (19XX)|770422|abbcdef", "ENTRY": "Trecator SC", "MN": "D03.383.725.394.220", "PA": "Fatty Acid Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4-Pyridinecarbothioamide, 2-ethyl-", "RN": "OAY8ORS3CQ", "RR": "536-33-4 (Ethionamide)", "MS": "A second-line antitubercular agent that inhibits mycolic acid synthesis.", "PM": "64; was ETHIONIAMIDE 1963", "HN": "64; was ETHIONIAMIDE 1963", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D005000"}, {"RECTYPE": "D", "MH": "Ethionine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.125.166.388", "PA": "Antimetabolites", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "L-Homocysteine, S-ethyl-", "RN": "WX1BN24WZT", "RR": "13073-35-3 (Ethionine)", "AN": "a carcinogen & antimetabolite; /biosyn /defic /physiol permitted", "MS": "2-Amino-4-(ethylthio)butyric acid. An antimetabolite and methionine antagonist that interferes with amino acid incorporation into proteins and with cellular ATP utilization. It also produces liver neoplasms.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005001"}, {"RECTYPE": "D", "MH": "Ethiopia", "AQ": "EH EP", "PRINT ENTRY": "Federal Democratic Republic of Ethiopia|T083|NAM|EQV|NLM (2009)|080304|abcdef", "MN": "Z01.058.290.120.310", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "An independent state in eastern Africa. Ethiopia is located in the Horn of Africa and is bordered on the north and northeast by Eritrea, on the east by Djibouti and Somalia, on the south by Kenya, and on the west and southwest by Sudan. Its capital is Addis Ababa.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005002"}, {"RECTYPE": "D", "MH": "Ethisterone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pregneninolone|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbcdeef", "ENTRY": "17 alpha Ethynyltestosterone", "MN": "D04.210.500.745.745.379", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pregn-4-en-20-yn-3-one, 17-hydroxy-, (17alpha)-", "RN": "P201BVY1MJ", "RR": "434-03-7 (Ethisterone)", "MS": "17 alpha-Hydroxypregn-4-en-20-yn-3-one. A synthetic steroid hormone with progestational effects.", "PM": "65", "HN": "65", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005003"}, {"RECTYPE": "D", "MH": "Ethmoid Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cribriform Plate|T023|NON|NRW|UNK (19XX)|780522|abcdef", "ENTRY": "Plates, Cribriform", "MN": "A02.835.232.781.292", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "fractures: coordinate ETHMOID BONE /inj (IM) + SKULL FRACTURES (IM); neoplasms: coordinate IM with SKULL NEOPLASMS (IM)", "MS": "A light and spongy (pneumatized) bone that lies between the orbital part of FRONTAL BONE and the anterior of SPHENOID BONE. Ethmoid bone separates the ORBIT from the ETHMOID SINUS. It consists of a horizontal plate, a perpendicular plate, and two lateral labyrinths.", "OL": "use ETHMOID BONE to search CRIBRIFORM PLATE 1966-78", "HN": "CRIBRIFORM PLATE was see under ETHMOID BONE 1963-78", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D005004"}, {"RECTYPE": "D", "MH": "Ethmoid Sinus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Sphenoethmoidal Air Cell|T030|NON|REL|NLM (2024)|230209|abcdef", "ENTRY": "Sphenoethmoidal Air Cells", "MN": "A04.531.621.267", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "The numerous (6-12) small thin-walled spaces or air cells in the ETHMOID BONE located between the eyes. These air cells form an ethmoidal labyrinth.", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005005"}, {"RECTYPE": "D", "MH": "Ethnicity", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Nationality|T102|NON|REL|POPLINE (1987)|740330|abcdef", "ENTRY": "Nationalities", "MN": "N01.224.317", "MH_TH": "NLM (2019)", "ST": "T102", "AN": "do not confuse ethnicity with RACIAL GROUPS", "PI": "Ethnology (1966-1967)", "MS": "A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships.", "PM": "2022; see ETHNOLOGY 1966-1967, see ETHNIC GROUPS 1968-2021", "HN": "2022(1968)", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005006"}, {"RECTYPE": "D", "MH": "Ethnology", "DE": "ETHNOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Society, Primitive", "MN": "I01.076.201.450.457", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "do not confuse with ETHOLOGY, the study of animal behavior; prefer /ethnol", "MS": "The comparative and theoretical study of culture, often synonymous with cultural anthropology.", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005007"}, {"RECTYPE": "D", "MH": "Ethnopsychology", "DE": "ETHNOPSYCHOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychology, Transcultural", "MN": "F04.096.628.317", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "Comparative PSYCHOLOGY of different ethnic and cultural groups.", "CATSH": "CAT LIST", "MR": "20210712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005008"}, {"RECTYPE": "D", "MH": "Ethoglucid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Etoglucid|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|800404|abbcdeef", "MN": "D02.355.354", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Oxirane, 2,2'-(2,5,8,11-tetraoxadodecane-1,12-diyl)bis-", "RN": "4F9KUA0T4D", "RR": "1954-28-5 (Ethoglucid)", "MS": "Alkylating antineoplastic agent used especially in bladder neoplasms. It is toxic to hair follicles, gastro-intestinal tract, and vasculature.", "PM": "91; was see under ETHERS 1975-90; was see under ALKYLATING AGENTS 1967-74", "HN": "91(65); was see under ETHERS 1975-90; was see under ALKYLATING AGENTS 1967-74", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005009"}, {"RECTYPE": "D", "MH": "Ethology", "DE": "ETHOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "F04.096.208", "FX": "Behavior, Animal", "MH_TH": "NLM (1969)", "ST": "T090", "AN": "do not confuse with ETHNOLOGY", "PI": "Behavior, Animal (1966-1968)", "MS": "The discipline pertaining to the study of animal behavior.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D005010"}, {"RECTYPE": "D", "MH": "Ethopabate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.127.020.937.645", "PA": "Coccidiostats", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzoic acid, 4-(acetylamino)-2-ethoxy-, methyl ester", "RN": "F4X3L6068O", "RR": "59-06-3 (Ethopabate)", "PI": "Benzoates (1966-1975)", "MS": "An inhibitor of folate metabolism. It is used as a coccidiostat in poultry.", "PM": "91; was see under AMINOBENZOIC ACIDS 1977-90", "HN": "91(77); was see under AMINOBENZOIC ACIDS 1977-90", "MR": "20130708", "DA": "19760503", "DC": "1", "DX": "19910101", "UI": "D005011"}, {"RECTYPE": "D", "MH": "Ethosuximide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethosuccimid|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Faes, Etosuximida", "MN": "D03.383.773.812.852.333", "PA": "Anticonvulsants", "FX": "Succinates", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,5-Pyrrolidinedione, 3-ethyl-3-methyl-", "RN": "5SEH9X1D1D", "RR": "77-67-8 (Ethosuximide)", "MS": "An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.", "PM": "65", "HN": "65(63)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005013"}, {"RECTYPE": "D", "MH": "Ethoxyquin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Santoquin|T109|T121|T130|TRD|NRW|UNK (19XX)|810318|abbbcdef", "MN": "D03.633.100.810.200", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Quinoline, 6-ethoxy-1,2-dihydro-2,2,4-trimethyl-", "RN": "9T1410R4OR", "RR": "91-53-2 (Ethoxyquin)", "PI": "Quinolines (1970-1974)", "MS": "Antioxidant; also a post-harvest dip to prevent scald on apples and pears.", "PM": "1991; 6-ETHOXY-2,2,4-TRIMETHYL-1,2-DIHYDROQUINOLINE was indexed under ETHOXYQUIN 2008, & under QUINOLINES 1997-2007", "HN": "1991(1975)", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005015"}, {"RECTYPE": "D", "MH": "Ethoxzolamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethoxyzolamide|T109|T121|NON|EQV|UNK (19XX)|790606|abbcdef", "ENTRY": "Ethoxazolamide|T109|T121|NON|EQV|NLM (1998)|970226|abbcdef", "MN": "D03.633.100.185.416", "PA": "Diuretics", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "2-Benzothiazolesulfonamide, 6-ethoxy-", "RN": "Z52H4811WX", "RR": "452-35-7 (Ethoxzolamide)", "PI": "Thiazoles (1966-1974)", "MS": "A carbonic anhydrase inhibitor used as diuretic and in glaucoma. It may cause hypokalemia.", "OL": "search CARBONIC ANHYDRASE INHIBITORS 1966-74", "PM": "91; was see under THIAZOLES 1975-90; was see under CARBONIC ANHYDRASE INHIBITORS 1965-74", "HN": "91(75); was see under THIAZOLES 1975-90; was see under CARBONIC ANHYDRASE INHIBITORS 1965-74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005016"}, {"RECTYPE": "D", "MH": "Ethyl Biscoumacetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethyldicoumarol|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef", "ENTRY": "Biscoumacetate, Ethyl", "MN": "D03.633.100.150.446.520.451", "PA": "Anticoagulants", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2H-1-Benzopyran-3-acetic acid, 4-hydroxy-alpha-(4-hydroxy-2-oxo-2H-1-benzopyran-3-yl)-2-oxo-, ethyl ester", "RN": "08KL644731", "RR": "548-00-5 (Ethyl Biscoumacetate)", "MS": "A coumarin that is used as an anticoagulant. It has actions similar to those of WARFARIN. (From Martindale, The Extra Pharmacopoeia, 30th ed, p226)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005017"}, {"RECTYPE": "D", "MH": "Ethyl Chloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chloroethane|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1996)|940727|abbcdeef", "ENTRY": "Gebauers Ethyl Chloride", "MN": "D02.455.526.439.447", "PA": "Anesthetics, Local", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Ethane, chloro-", "RN": "46U771ERWK", "RR": "75-00-3 (Ethyl Chloride)", "MS": "A gas that condenses under slight pressure. Because of its low boiling point ethyl chloride sprayed on skin produces an intense cold by evaporation. Cold blocks nerve conduction. Ethyl chloride has been used in surgery but is primarily used to relieve local pain in sports medicine.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005018"}, {"RECTYPE": "D", "MH": "Ethyl Ethers", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethoxy Compounds|T109|NON|BRD|UNK (19XX)|770401|ETHOXY CPDS|abcdefv", "ENTRY": "Ethers, Ethyl", "MN": "D02.355.417", "MH_TH": "NLM (1965)", "ST": "T109", "RN": "0", "AN": "do not confuse with ETHER", "MS": "Organic compounds having ethyl groups bound to an oxygen atom.", "OL": "use ETHYL ETHERS to search ETHYL ETHER 1966-73", "PM": "74; was ETHYL ETHER 1965-73", "HN": "74; was ETHYL ETHER 1965-73", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005019"}, {"RECTYPE": "D", "MH": "Ethyl Methanesulfonate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethylmethane Sulfonate|T109|T121|T131|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Sulfonate, Ethylmethane", "MN": "D02.886.645.600.055.050.510.300", "PA": "Mutagens", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Methanesulfonic acid, ethyl ester", "RN": "9H154DI0UP", "RR": "62-50-0 (Ethyl Methanesulfonate)", "PI": "Sulfonic Acids (1966-1973)", "MS": "An antineoplastic agent with alkylating properties. It also acts as a mutagen by damaging DNA and is used experimentally for that effect.", "OL": "use ETHYL METHANESULFONATE to search ETHYLMESYLATE & MESILATE, ETHYL 1981-93 and ETHYL MESILATE 1980-93", "PM": "80; was see under METHANESULFONATES 1975-79; ETHYLMESYLATE & MESILATE, ETHYL were see ETHYL METHANESULFONATE 1981-93; ETHYL MESILATE was see ETHYL METHANESULFONATE 1980-93", "HN": "80(75); was see under METHANESULFONATES 1975-79; ETHYLMESYLATE & MESILATE, ETHYL were see ETHYL METHANESULFONATE 1981-93; ETHYL MESILATE was see ETHYL METHANESULFONATE 1980-93", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19800101", "UI": "D005020"}, {"RECTYPE": "D", "MH": "Ethylamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.092.471", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of ethylamine (the structural formula CH3CH2NH2).", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005021"}, {"RECTYPE": "D", "MH": "Ethyldimethylaminopropyl Carbodiimide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "EDAP Carbodiimide", "MN": "D02.491.203.425", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-", "RN": "RJ5OZG6I4A", "RR": "1892-57-5 (Ethyldimethylaminopropyl Carbodiimide)", "PI": "Dimethylamines (1973-1974)", "MS": "Carbodiimide cross-linking reagent.", "PM": "91; was see under CARBODIIMIDES 1975-90", "HN": "91(75); was see under CARBODIIMIDES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005022"}, {"RECTYPE": "D", "MH": "Ethylene Chlorohydrin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2-Chloroethyl Alcohol|T109|T131|NON|EQV|UNK (19XX)|741111|CHLOROETHYL ALCOHOL 02|abbcdefs", "ENTRY": "Chlorohydrin, Ethylene", "MN": "D02.033.375.310", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Ethanol, 2-chloro-", "RN": "753N66IHAN", "RR": "107-07-3 (Ethylene Chlorohydrin)", "PI": "Chlorine (1971-1974)", "MS": "Used as a solvent, in the manufacture of insecticides, and for treating sweet potatoes before planting. May cause nausea, vomiting, pains in head and chest, stupefaction. Irritates mucous membranes and causes kidney and liver degeneration.", "PM": "91; was see under CHLOROHYDRINS 1975-90", "HN": "91(75); was see under CHLOROHYDRINS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005023"}, {"RECTYPE": "D", "MH": "Ethylene Dichlorides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dichloroethanes|T109|T130|T131|NON|EQV|UNK (19XX)|750725|abbbcdef", "ENTRY": "Dichlorides, Ethylene", "MN": "D02.455.526.439.458", "MH_TH": "NLM (1976)", "ST": "T131", "RN": "0", "AN": "do not confuse with DICHLOROETHYLENES", "PI": "Ethane (1974) /AA (1975)", "MS": "Toxic, chlorinated, saturated hydrocarbons. Include both the 1,1- and 1,2-dichloro isomers. The latter is considerably more toxic. It has a sweet taste, ethereal odor and has been used as a fumigant and intoxicant among sniffers. Has many household and industrial uses.", "PM": "91; was see under HYDROCARBONS, CHLORINATED 1976-90", "HN": "91(76); was see under HYDROCARBONS, CHLORINATED 1976-90", "MR": "20000622", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D005025"}, {"RECTYPE": "D", "MH": "Ethylene Glycols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethanediols|T109|NON|EQV|UNK (19XX)|741220|abcdef", "ENTRY": "Glycols, Ethylene", "MN": "D02.033.455.250", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "ETHYLENE GLYCOL is also available", "PI": "Glycols (1966-1974)", "MS": "An ethylene compound with two hydroxy groups (-OH) located on adjacent carbons. They are viscous and colorless liquids. Some are used as anesthetics or hypnotics. However, the class is best known for their use as a coolant or antifreeze.", "OL": "search GLYCOLS 1966-74", "PM": "75; was ETHYLENE GLYCOL see under GLYCOLS 1963-74", "HN": "75; was ETHYLENE GLYCOL see under GLYCOLS 1963-74", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D005026"}, {"RECTYPE": "D", "MH": "Ethylene Oxide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxide, Ethylene", "MN": "D02.355.291.411.417", "PA": "Disinfectants", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Oxirane", "RN": "JJH7GNN18P", "RR": "75-21-8 (Ethylene Oxide)", "MS": "A colorless and flammable gas at room temperature and pressure. Ethylene oxide is a bactericidal, fungicidal, and sporicidal disinfectant. It is effective against most micro-organisms, including viruses. It is used as a fumigant for foodstuffs and textiles and as an agent for the gaseous sterilization of heat-labile pharmaceutical and surgical materials. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p794)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005027"}, {"RECTYPE": "D", "MH": "Ethylenebis(dithiocarbamates)", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.886.706.250", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "AN": "an antifungal", "PI": "Thiocarbamates (1966-1976)", "MS": "A class of thiocarbamate derivatives whose salts possess fungicidal activity.", "PM": "91; was see under THIOCARBAMATES 1977-90", "HN": "91(77); was see under THIOCARBAMATES 1977-90", "MR": "19930604", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D005028"}, {"RECTYPE": "D", "MH": "Ethylenediamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.092.782.258.368", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of ethylenediamine (the structural formula NH2CH2CH2NH2).", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005029"}, {"RECTYPE": "D", "MH": "Ethylenes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.326.271.367", "FX": "Polyethylenes", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of ethylene, a simple organic gas of biological origin with many industrial and biological use.", "OL": "use ETHYLENES to search ETHYLENE 1966-74", "PM": "75; was ETHYLENE 1963-74", "HN": "75; was ETHYLENE 1963-74", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D005030"}, {"RECTYPE": "D", "MH": "Ethylenethiourea", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Imidazolidinethione|T109|T131|NON|EQV|UNK (19XX)|760414|abbcdef", "ENTRY": "2 Mercaptoimidazoline", "MN": "D03.383.129.308.432.500", "MH_TH": "NLM (1977)", "ST": "T131", "N1": "2-Imidazolidinethione", "RN": "24FOJ4N18S", "RR": "96-45-7 (Ethylenethiourea)", "PI": "Thiourea (1966-1976)", "MS": "A degradation product of ethylenebis(dithiocarbamate) fungicides. It has been found to be carcinogenic and to cause THYROID hyperplasia.", "PM": "1991; IMIDAZOLIDINE-2-THIONE was indexed under IMIDAZOLIDINES and THIOUREA 2008-2013", "HN": "1991(1977)", "MR": "20200527", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D005031"}, {"RECTYPE": "D", "MH": "Ethylestrenol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Maxibolin|T109|T121|TRD|NRW|UNK (19XX)|861029|abbcdef", "MN": "D04.210.500.668.651.693.223", "PA": "Anabolic Agents", "MH_TH": "USAN (1962)", "ST": "T121", "N1": "19-Norpregn-4-en-17-ol, (17alpha)-", "RN": "ADC79EK5Q8", "RR": "965-90-2 (Ethylestrenol)", "MS": "An anabolic steroid with some progestational activity and little androgenic effect.", "PM": "65", "HN": "65", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005032"}, {"RECTYPE": "D", "MH": "Ethylmaleimide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "N Ethylmaleimide", "MN": "D03.383.129.578.399.418", "PA": "Sulfhydryl Reagents", "MH_TH": "NLM (1964)", "ST": "T130", "N1": "1H-Pyrrole-2,5-dione, 1-ethyl-", "RN": "O3C74ACM9V", "RR": "128-53-0 (Ethylmaleimide)", "MS": "A sulfhydryl reagent that is widely used in experimental biochemical studies.", "PM": "66", "HN": "66(64)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005033"}, {"RECTYPE": "D", "MH": "Ethylmercuric Chloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethylmercury Chloride|T109|T131|NON|EQV|FDA SRS (2014)|NLM (1991)|900513|abbcdeef", "ENTRY": "Chloride, Ethylmercury", "MN": "D02.691.750.100.347.417", "PA": "Fungicides, Industrial", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Mercury, chloroethyl-", "RN": "M04218TP6P", "RR": "107-27-7 (Ethylmercuric Chloride)", "PI": "Organometallic Compounds (1968-1971)", "MS": "A highly toxic compound used as a fungicide for treating seeds.", "OL": "use ETHYLMERCURIC CHLORIDE to search ETHYLMERCURY CHLORIDE 1980-90 & ETHYL MERCURY CHLORIDE 1972-79 (as Prov 1972-74)", "PM": "91; was ETHYLMERCURY CHLORIDE see under ETHYLMERCURY COMPOUNDS 1980-90; was ETHYL MERCURY CHLORIDE see under ETHYL MERCURY COMPOUNDS 1975-79", "HN": "91(80); was ETHYLMERCURY CHLORIDE see under ETHYLMERCURY COMPOUNDS 1980-90; was ETHYL MERCURY CHLORIDE see under ETHYL MERCURY COMPOUNDS 1972-79 (Prov 1972-74)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005034"}, {"RECTYPE": "D", "MH": "Ethylmercury Compounds", "DE": "ETHYLMERCURY CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethylmercurials|T109|NON|EQV|UNK (19XX)|760416|abcdef", "ENTRY": "Mercury Compounds, Ethyl", "MN": "D02.691.750.100.347", "PA": "Fungicides, Industrial", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Organometallic Compounds (1968-1971)", "MS": "Organic mercury compounds in which the mercury is attached to an ethyl group.", "OL": "use ETHYLMERCURY COMPOUNDS to search ETHYL MERCURY COMPOUNDS 1972-79 (as Prov 1972-73)", "PM": "80; was ETHYL MERCURY COMPOUNDS 1974-79", "HN": "80; was ETHYL MERCURY COMPOUNDS 1972-79 (Prov 1972-73)", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005035"}, {"RECTYPE": "D", "MH": "Ethylmorphine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethomorphine|T109|T121|NON|EQV|UNK (19XX)|770509|abbcdef", "ENTRY": "Trachyl|T109|T121|TRD|NRW|FR|041215|abbcdef", "MN": "D04.615.723.795.576.430", "PA": "Narcotics", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-ethoxy-17-methyl-, (5alpha,6alpha)-", "RN": "RWO67D87EU", "RR": "76-58-4 (Ethylmorphine)", "PI": "Morphine Derivatives (1975-1977)", "MS": "A narcotic analgesic and antitussive. It is metabolized in the liver by ETHYLMORPHINE-N-DEMETHYLASE and used as an indicator of liver function.", "OL": "use ETHYLMORPHINE to search CODETHYLINE 1978-94", "PM": "91; was see under MORPHINE DERIVATIVES 1978-90; CODETHYLINE was see ETHYLMORPHINE 1978-94", "HN": "91(78); was see under MORPHINE DERIVATIVES 1978-90; CODETHYLINE was see ETHYLMORPHINE 1978-94", "MR": "20170524", "DA": "19770509", "DC": "1", "DX": "19910101", "UI": "D005036"}, {"RECTYPE": "D", "MH": "Ethylmorphine-N-Demethylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "N Demethylase, Ethylmorphine", "MN": "D08.811.682.662.582.400", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.5.3.-", "PI": "Oxidoreductases, N-Demethylating (1973-1974)", "MS": "A drug-metabolizing enzyme of the hepatic microsomal oxidase system which catalyzes the oxidation of the N-methyl group of ethylmorphine with the formation of formaldehyde.", "PM": "91; was see under OXIDOREDUCTASES, N-DEMETHYLATING 1975-90", "HN": "91(75); was see under OXIDOREDUCTASES, N-DEMETHYLATING 1975-90", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D005037"}, {"RECTYPE": "D", "MH": "Ethylnitrosourea", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Nitrosoethylurea|T109|T131|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "N Ethyl N nitrosourea", "MN": "D02.654.692.300", "PA": "Alkylating Agents", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Urea, N-ethyl-N-nitroso-", "RN": "P8M1T4190R", "RR": "759-73-9 (Ethylnitrosourea)", "PI": "Nitrosourea Compounds (1973-1974)", "MS": "A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.", "PM": "86; was see under NITROSOUREA COMPOUNDS 1975-85", "HN": "86(75); was see under NITROSOUREA COMPOUNDS 1975-85", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19860101", "UI": "D005038"}, {"RECTYPE": "D", "MH": "Etilefrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethylphenylephrine|T109|T121|NON|EQV|NLM (1995)|940424|abbcdef", "ENTRY": "Pivalate Hydrochloride, Etilefrine", "MN": "D02.092.063.291.617.300", "PA": "Vasoconstrictor Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenemethanol, alpha-((ethylamino)methyl)-3-hydroxy-", "RN": "ZB6F8MY53V", "RR": "ZBI6Q5FH3S", "PI": "Phenylephrine/analogs & derivatives (1975)", "MS": "A phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.", "OL": "use ETILEFRINE to search ETHYLPHENYLEPHRINE, ETHYLNORMETAOXEDRIN, & ETILEFRIN 1976-94", "PM": "95; was ETHYLPHENYLEPHRINE 1976-94 (see under PHENYLEPHRINE 1976-90); ETHYLNORMETAOXEDRIN & ETILEFRIN were see ETHYLPHENYLEPHRINE 1976-94", "HN": "95; was ETHYLPHENYLEPHRINE 1976-94 (see under PHENYLEPHRINE 1976-90); ETHYLNORMETAOXEDRIN & ETILEFRIN were see ETHYLPHENYLEPHRINE 1976-94", "MR": "20160705", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D005039"}, {"RECTYPE": "D", "MH": "Ethynodiol Diacetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "19-Norpregn-4-en-20-yne-3,17-diol, diacetate, (3beta,17alpha)-|T109|T121|T125|NON|EQV|NLM (2020)|190708|abbbcdef", "ENTRY": "Femulen|T109|T121|TRD|NRW|UNK (19XX)|820830|abbcdef", "MN": "D04.210.500.668.651.693.279", "PA": "Contraceptives, Oral, Synthetic", "MH_TH": "USP (19XX)", "ST": "T125", "RN": "62H10A1236", "RR": "6785-71-3 ((17 alpha)-isomer)", "MS": "A synthetic progestational hormone used alone or in combination with estrogens as an oral contraceptive (CONTRACEPTIVES, ORAL).", "PM": "68", "HN": "68(64)", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005040"}, {"RECTYPE": "D", "MH": "Etidocaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "W19053", "MN": "D02.092.146.113.092.325", "PA": "Anesthetics, Local", "MH_TH": "USAN (1973)", "ST": "T121", "N1": "Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (+-)-", "RN": "I6CQM0F31V", "RR": "36637-18-0 (Etidocaine)", "PI": "Propylamines (1973-1975)", "MS": "A local anesthetic with rapid onset and long action, similar to BUPIVACAINE.", "PM": "91; was see under ACETANILIDES 1976-90", "HN": "91(76); was see under ACETANILIDES 1976-90", "MR": "20151123", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D005041"}, {"RECTYPE": "D", "MH": "Etimizol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethymisole|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Ethymizol|T109|T121|NON|EQV|UNK (19XX)|871215|abbcdef", "MN": "D03.383.129.308.260", "PA": "Nootropic Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "1H-Imidazole-4,5-dicarboxamide, 1-ethyl-N,N'-dimethyl-", "RN": "NG2MF3646P", "RR": "64-99-3 (Etimizol)", "PI": "Imidazoles (1972-1974)", "MS": "A xanthine-related, putative nootropic drug.", "PM": "91; was see under IMIDAZOLES 1975-90", "HN": "91(75); was see under IMIDAZOLES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005042"}, {"RECTYPE": "D", "MH": "Etiocholanolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "5 beta Androsterone", "MN": "D06.472.334.851.968.968", "MH_TH": "NLM (1963)", "ST": "T125", "N1": "Androstan-17-one, 3-hydroxy-, (3alpha,5beta)-", "RN": "97CGB1M48I", "RR": "53-42-9 (Etiocholanolone)", "MS": "The 5-beta-reduced isomer of ANDROSTERONE. Etiocholanolone is a major metabolite of TESTOSTERONE and ANDROSTENEDIONE in many mammalian species including humans. It is excreted in the URINE.", "PM": "65", "HN": "65(63)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005043"}, {"RECTYPE": "D", "MH": "Etioporphyrins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.767.727.340", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "pigments", "PI": "Porphyrins (1966-1974)", "MS": "Porphyrins with four methyl and four ethyl side chains attached to the pyrrole rings.", "PM": "91; was see under PORPHYRINS 1975-90", "HN": "91(75); was see under PORPHYRINS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005044"}, {"RECTYPE": "D", "MH": "Etomidate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R26490", "MN": "D03.383.129.308.265", "PA": "Hypnotics and Sedatives", "MH_TH": "USAN (1975)", "ST": "T121", "N1": "1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (R)-", "RN": "Z22628B598", "RR": "33125-97-2 (Etomidate)", "PI": "Imidazoles (1969-1976)", "MS": "Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic.", "PM": "86; was see under IMIDAZOLES 1977-85", "HN": "86(77); was see under IMIDAZOLES 1977-85", "MR": "20160531", "DA": "19760413", "DC": "1", "DX": "19860101", "UI": "D005045"}, {"RECTYPE": "D", "MH": "Etoposide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Demethyl Epipodophyllotoxin Ethylidine Glucoside|T109|T121|NON|EQV|UNK (19XX)|750716|abbcdef", "ENTRY": "alpha-D-Glucopyranosyl Isomer Etoposide", "MN": "D09.408.348.275", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 9-((4,6-O-ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-", "RN": "6PLQ3CP4P3", "RR": "96554-41-5 ((5a alpha,9 alpha)-isomer)", "PI": "Podophyllotoxin (1973-1974)/analogs & derivatives (1975)", "MS": "A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.", "OL": "use ETOPOSIDE to search VP 16-213 1976-80", "PM": "87; was see under PODOPHYLLOTOXIN 1981-86; was VP 16-213 see under PODOPHYLLOTOXIN 1976-80", "HN": "87(81); was see under PODOPHYLLOTOXIN 1981-86; was VP 16-213 see under PODOPHYLLOTOXIN 1976-80", "MR": "20180301", "DA": "19750725", "DC": "1", "DX": "19870101", "UI": "D005047"}, {"RECTYPE": "D", "MH": "Etorphine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "M99|T109|T121|LAB|NRW|UNK (19XX)|750708|abbcdef", "MN": "D04.615.723.795.270", "PA": "Narcotics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "6,14-Ethenomorphinan-7-methanol, 4,5-epoxy-3-hydroxy-6-methoxy-alpha,17-dimethyl-alpha-propyl-, (5alpha,7alpha(R))-", "RN": "42M2Y6NU9O", "RR": "14521-96-1 (Etorphine)", "PI": "Morphinans (1969-1974)", "MS": "A narcotic analgesic morphinan used as a sedative in veterinary practice.", "PM": "91; was see under MORPHINANS 1975-90", "HN": "91(75); was see under MORPHINANS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005048"}, {"RECTYPE": "D", "MH": "Etretinate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro109359", "MN": "D23.767.261.700.250", "PA": "Keratolytic Agents", "MH_TH": "USAN (1979)", "ST": "T121", "N1": "2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, ethyl ester, (all-E)-", "RN": "65M2UDR9AG", "RR": "54350-48-0 (Etretinate)", "PI": "Vitamin A (1966-1974)", "MS": "An oral retinoid used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic.", "OL": "use ETRETINATE to search RO 10-9359 1980-83", "PM": "1984; was RO 10-9359 see under TRETINOIN 1980-1983", "HN": "1984(1980); was RO 10-9359 see under TRETINOIN 1980-1983", "MR": "20190701", "DA": "19790525", "DC": "1", "DX": "19840101", "UI": "D005050"}, {"RECTYPE": "D", "MH": "Eubacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Butyribacterium|T007|NON|REL|UNK (19XX)|750716|abcdef", "MN": "B03.510.460.400.400.250", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1730", "AN": "for genus Eubacterium only: not for EUBACTERIA the domain (see BACTERIA); infection: coordinate IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM)", "MS": "A genus of gram-positive, rod-shaped bacteria found in cavities of man and animals, animal and plant products, infections of soft tissue, and soil. Some species may be pathogenic. No endospores are produced. The genus Eubacterium should not be confused with EUBACTERIA, one of the three domains of life.", "OL": "use EUBACTERIUM to search BUTYRIBACTERIUM 1966-75", "PM": "76; was BUTYRIBACTERIUM 1963-75", "HN": "76; was BUTYRIBACTERIUM 1963-75", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D005051"}, {"RECTYPE": "D", "MH": "Eucalyptus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Trees, Blue Gum", "MN": "B01.875.800.575.912.250.773.366", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid3932", "RR": "txid34317", "MS": "A genus of trees of the Myrtaceae family, native to Australia, that yields gums, oils, and resins which are used as flavoring agents, astringents, and aromatics.", "PM": "91,63-85; was see under TREES 1986-90; was heading 1963-85", "HN": "91(86)63; was see under TREES 1986-90; was heading 1963-86", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005052"}, {"RECTYPE": "D", "MH": "Eugenics", "AQ": "HI LJ MT SN TD", "ENTRY": "Eugenics, Positive", "MN": "K01.400.307", "FX": "Genetic Counseling", "MH_TH": "POPLINE (1978)", "ST": "T078", "MS": "The attempt to improve the PHENOTYPES of future generations of the human population by fostering the reproduction of those with favorable phenotypes and GENOTYPES and hampering or preventing BREEDING by those with \"undesirable\" phenotypes and genotypes. The concept is largely discredited. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005053"}, {"RECTYPE": "D", "MH": "Eugenol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenol, 2-methoxy-4-(2-propenyl)-|T109|T121|T122|NON|EQV|NLM (2022)|210628|abbbcdef", "MN": "D02.455.426.559.389.012.250", "PA": "Solvents", "FX": "Zinc Oxide-Eugenol Cement", "MH_TH": "USP (19XX)", "ST": "T122", "RN": "3T8H1794QW", "RR": "97-53-0 (Eugenol)", "MS": "A cinnamate derivative of the shikimate pathway found in CLOVE OIL and other PLANTS.", "MR": "20210628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005054"}, {"RECTYPE": "D", "MH": "Euglena", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Euglenas", "MN": "B01.268.250.320", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid3038", "AN": "infection; coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A genus of EUKARYOTES, in the phylum EUGLENIDA, found mostly in stagnant water. Characteristics include a pellicle usually marked by spiral or longitudinal striations.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005055"}, {"RECTYPE": "D", "MH": "Euglena gracilis", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "gracilis, Euglena", "MN": "B01.268.250.320.418", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid3039", "AN": "infection; coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Euglena (1966-1971)", "MS": "A species of fresh-water, flagellated EUKARYOTES in the phylum EUGLENIDA.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D005056"}, {"RECTYPE": "D", "MH": "Eukaryotic Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Eukaryotic Cell", "MN": "A11.450", "MH_TH": "NLM (1978)", "ST": "T025", "AN": "do not confuse with EUKARYOTA", "PI": "appropriate cell, organism, subcellular fraction, or process", "MS": "Cells of the higher organisms, containing a true nucleus bounded by a nuclear membrane.", "PM": "91; was see under CELLS 1978-90", "HN": "91(78); was see under CELLS 1978-90", "MR": "20090706", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D005057"}, {"RECTYPE": "D", "MH": "Eunuchism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypogonadism, Male|T047|NON|NRW|OMIM (2013)|111115|abcdef", "MN": "C19.391.482.293", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not routinely interpret hypogonadism in males as EUNUCHISM: use terminology of the author; check tags HUMANS and MALE", "MS": "The state of being a eunuch, a male without TESTES or whose testes failed to develop. It is characterized by the lack of mature male GERM CELLS and TESTICULAR HORMONES.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005058"}, {"RECTYPE": "D", "MH": "Euphoria", "AQ": "CL DE ES PH RE", "ENTRY": "Euphorias", "MN": "F01.470.323", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "An exaggerated feeling of physical and emotional well-being not consonant with apparent stimuli or events; usually of psychologic origin, but also seen in organic brain disease and toxic states.", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005059"}, {"RECTYPE": "D", "MH": "Europe", "AQ": "EH EP", "ENTRY": "Western Europe|T083|NAM|NRW|POPLINE (1978)|790927|abcdef", "MN": "Z01.542", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "each European country is available as a heading", "MS": "The continent north of AFRICA, west of ASIA and east of the ATLANTIC OCEAN.", "MR": "20151124", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005060"}, {"RECTYPE": "D", "MH": "Europe, Eastern", "AQ": "EH EP", "ENTRY": "Eastern Europe|T083|NAM|EQV|POPLINE (1978)|781226|abcdef", "MN": "Z01.542.248", "MH_TH": "NLM (1966)", "ST": "T083", "MS": "The region of Europe generally from the area of the Baltic Sea to the Ural Mountains of Russia.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005061"}, {"RECTYPE": "D", "MH": "European Union", "AQ": "EC HI OG SN", "PRINT ENTRY": "European Economic Community|T092|NON|NRW|NLM (1998)|970130|EUROPEAN ECON COMMUNITY|abcdefv", "ENTRY": "Union, European", "MN": "I01.615.500.475", "MH_TH": "NLM (1976)", "ST": "T092", "AN": "name specific European country if pertinent; CATALOGER: Use NAF entry", "PI": "International Cooperation (1966-1975)", "MS": "An economic union with the principal objectives of free movement of goods, capital, and labor. The constituent countries are Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, and Sweden. (https://europa.eu/european-union/about-eu/countries accessed 12/31/2020)", "PM": "98; see EUROPEAN ECONOMIC COMMUNITY 1976-97", "HN": "98(76)", "MR": "20210706", "DA": "19750718", "DC": "1", "DX": "19760101", "UI": "D005062"}, {"RECTYPE": "D", "MH": "Europium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.468", "PA": "Luminescent Agents", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "444W947O8O", "RR": "7440-53-1 (Europium)", "MS": "An element of the rare earth family of metals. It has the atomic symbol Eu, atomic number 63, and atomic weight 152. Europium is used in the form of its salts as coatings for cathode ray tubes and in the form of its organic derivatives as shift reagents in NMR spectroscopy.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005063"}, {"RECTYPE": "D", "MH": "Eustachian Tube", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Auditory Tube|T023|NON|EQV|UNK (19XX)|850507|abcdef", "ENTRY": "Tubes, Pharyngotympanic", "MN": "A09.246.397.369", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "\"eustachian\" is not capitalized in titles or translations", "MS": "A narrow passageway that connects the upper part of the throat to the TYMPANIC CAVITY.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005064"}, {"RECTYPE": "D", "MH": "Euthanasia", "AQ": "CL ES HI LJ PX SN TD", "PRINT ENTRY": "Mercy Killing|T052|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Mercy Killings", "MN": "N02.421.585.905.199", "FX": "Suicide, Assisted", "MH_TH": "POPLINE (1986)", "ST": "T052", "AN": "HUMAN only; EUTHANASIA, ANIMAL is available for animals; EUTHANASIA, ACTIVE and EUTHANASIA, PASSIVE are also available", "MS": "The act or practice of killing or allowing death from natural causes, for reasons of mercy, i.e., in order to release a person from incurable disease, intolerable suffering, or undignified death. (from Beauchamp and Walters, Contemporary Issues in Bioethics, 5th ed)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005065"}, {"RECTYPE": "D", "MH": "Euthanasia, Passive", "AQ": "CL ES HI LJ PX SN TD", "PRINT ENTRY": "Allowing to Die|T052|NON|EQV|BIOETHICS (1989)|770420|abcdef", "ENTRY": "Passive Euthanasia|T052|NON|EQV|BIOETHICS (1989)|900803|abcdef", "MN": "N02.421.585.952.500", "FX": "Withholding Treatment", "MH_TH": "NLM (1978)", "ST": "T052", "AN": "human only; differentiate entry term ALLOWING TO DIE from RIGHT TO DIE", "PI": "Euthanasia (1966-1977)", "MS": "Failing to prevent death from natural causes, for reasons of mercy by the withdrawal or withholding of life-prolonging treatment.", "PM": "90; was see under EUTHANASIA 1978-89", "HN": "90(78); was see under EUTHANASIA 1978-89", "MR": "20200409", "DA": "19770422", "DC": "1", "DX": "19900101", "UI": "D005066"}, {"RECTYPE": "D", "MH": "Euthyroid Sick Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Low T3 Syndrome|T047|NRW|UNK (19XX)|860418|abdef", "ENTRY": "Syndromes, Non-Thyroidal Illness", "MN": "C19.874.255", "FX": "Thyroid Hormone Resistance Syndrome", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "differentiate from THYROID HORMONE RESISTANCE SYNDROME where no other disease is present", "MS": "Conditions of abnormal THYROID HORMONES release in patients with apparently normal THYROID GLAND during severe systemic illness, physical TRAUMA, and psychiatric disturbances. It can be caused by the loss of endogenous hypothalamic input or by exogenous drug effects. The most common abnormality results in low T3 THYROID HORMONE with progressive decrease in THYROXINE; (T4) and TSH. Elevated T4 with normal T3 may be seen in diseases in which THYROXINE-BINDING GLOBULIN synthesis and release are increased.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20050802", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D005067"}, {"RECTYPE": "D", "MH": "Eutrophication", "AQ": "DE ES PH RE", "PRINT ENTRY": "Algal Bloom|T067|NON|NRW|UNK (19XX)|750617|abcdef", "ENTRY": "Eutrophications", "MN": "G16.500.285", "FX": "Water Pollution, Chemical", "MH_TH": "NLM (1976)", "ST": "T067", "AN": "entry term ALGAL BLOOM: HARMFUL ALGAL BLOOM is also available", "PI": "Water Pollution, Chemical (1975)", "MS": "The enrichment of a terrestrial or aquatic ECOSYSTEM by the addition of nutrients, especially nitrogen and phosphorus, that results in a superabundant growth of plants, ALGAE, or other primary producers. It can be a natural process or result from human activity such as agriculture runoff or sewage pollution. In aquatic ecosystems, an increase in the algae population is termed an algal bloom.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D005068"}, {"RECTYPE": "D", "MH": "Evaluation Studies as Topic", "ENTRY": "Use Effectiveness", "MN": "N05.715.360.335", "FX": "Program Evaluation", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with the Publication Type EVALUATION STUDY", "MS": "Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies.", "PM": "2008; see EVALUATION STUDIES 1974-2007", "HN": "2008(1966)", "CATSH": "CAT LIST", "MR": "20190710", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005069"}, {"RECTYPE": "D", "MH": "Evans Blue", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Evan Blue", "MN": "D04.615.638.555.400", "PA": "Coloring Agents", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "1,3-Naphthalenedisulfonic acid, 6,6'-((3,3'-dimethyl(1,1'-biphenyl)-4,4'-diyl)bis(azo))bis(4-amino-5-hydroxy)-, tetrasodium salt", "RN": "45PG892GO1", "RR": "314-13-6 (Evans Blue)", "PI": "Naphthalenesulfonates (1974-1975)", "MS": "An azo dye used in blood volume and cardiac output measurement by the dye dilution method. It is very soluble, strongly bound to plasma albumin, and disappears very slowly.", "OL": "use EVANS BLUE to search AZOVAN BLUE, AZOVANUM CAERULEUM, DIAZOBLEU, & T-1824 1976-93", "PM": "91; was see under AZO COMPOUNDS 1976-90; AZOVAN BLUE, AZOVANUM CAERULEUM, DIAZOBLEU & T-1824 were see EVANS BLUE 1976-93", "HN": "91(76); was see under AZO COMPOUNDS 1976-90; AZOVAN BLUE, AZOVANUM CAERULEUM, DIAZOBLEU & T-1824 were see EVANS BLUE 1976-93", "MR": "20130708", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D005070"}, {"RECTYPE": "D", "MH": "Evoked Potentials", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "P50 Evoked Potential|T042|NON|NRW|NLM (2021)|191115|abcdef", "ENTRY": "Waves, P50", "MN": "G11.561.200.500", "FX": "Electroencephalography Phase Synchronization", "MH_TH": "NLM (1967)", "ST": "T060", "AN": "general or unspecified; prefer specifics", "PI": "Electrophysiology (1966)", "MS": "Electrical responses recorded from nerve, muscle, SENSORY RECEPTOR, or area of the CENTRAL NERVOUS SYSTEM following stimulation. They range from less than a microvolt to several microvolts. The evoked potential can be auditory (EVOKED POTENTIALS, AUDITORY), somatosensory (EVOKED POTENTIALS, SOMATOSENSORY), visual (EVOKED POTENTIALS, VISUAL), or motor (EVOKED POTENTIALS, MOTOR), or other modalities that have been reported.", "PM": "68", "HN": "68(67)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005071"}, {"RECTYPE": "D", "MH": "Evoked Potentials, Auditory", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Auditory Evoked Response|T042|T060|NON|EQV|NLM (1991)|891117|abbcdef", "ENTRY": "Potentials, Auditory Evoked", "MN": "G11.561.200.500.370", "MH_TH": "NLM (1980)", "ST": "T060", "AN": "IM", "PI": "Sound (1966-1971)", "MS": "The electric response evoked in the CEREBRAL CORTEX by ACOUSTIC STIMULATION or stimulation of the AUDITORY PATHWAYS.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19781214", "DC": "1", "DX": "19800101", "UI": "D005072"}, {"RECTYPE": "D", "MH": "Evoked Potentials, Somatosensory", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Somatosensory Evoked Potentials|T042|T060|NON|EQV|UNK (19XX)|810520|abbcdef", "ENTRY": "Somatosensory Evoked Potential", "MN": "G11.561.200.500.400", "MH_TH": "NLM (1982)", "ST": "T060", "AN": "IM", "PI": "Somatosensory Cortex (1971-1981)", "MS": "The electric response evoked in the CEREBRAL CORTEX by stimulation along AFFERENT PATHWAYS from PERIPHERAL NERVES to CEREBRUM.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19810520", "DC": "1", "DX": "19820101", "UI": "D005073"}, {"RECTYPE": "D", "MH": "Evoked Potentials, Visual", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Visual Evoked Response|T042|T060|NON|EQV|UNK (19XX)|810224|abbcdef", "ENTRY": "Visual Evoked Responses", "MN": "G14.330", "MH_TH": "NLM (1982)", "ST": "T060", "AN": "IM", "PI": "Visual Perception (1966-1981)", "MS": "The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19810224", "DC": "1", "DX": "19820101", "UI": "D005074"}, {"RECTYPE": "D", "MH": "Biological Evolution", "ENTRY": "Evolution, Biological", "MN": "G16.075", "FX": "Sociobiology", "MH_TH": "NLM (2011)", "ST": "T045", "AN": "Man in the evolutionary process is HOMINIDAE; evolution at the molecular level of DNA sequence is EVOLUTION, MOLECULAR", "MS": "The process of cumulative change over successive generations through which organisms acquire their distinguishing morphological and physiological characteristics.", "PM": "2011; see EVOLUTION 1989-2010", "HN": "2011 (1989)", "CATSH": "CAT LIST", "MR": "20200618", "DA": "19990101", "DC": "1", "DX": "20110101", "UI": "D005075"}, {"RECTYPE": "D", "MH": "Exanthema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Skin Rash|T047|T184|NON|EQV|NLM (1998)|961029|abbcdef", "ENTRY": "Rash, Skin", "MN": "C17.800.257", "FX": "Wissler's Syndrome", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "a skin eruption usually chem- or viral-induced; EXANTHEMA SUBITUM is also available", "MS": "Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005076"}, {"RECTYPE": "D", "MH": "Exanthema Subitum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Sixth Disease|T047|NON|EQV|NLM (1993)|920430|SIXTH DIS|abcdefv", "ENTRY": "Disease, Sixth", "MN": "C17.800.838.790.290", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "acute short-lived viral dis of inf & young child caused by human herpesvirus 6", "MS": "An acute, short-lived, viral disease of infants and young children characterized by a high fever at onset that drops to normal after 3-4 days and the concomitant appearance of a macular or maculopapular rash that appears first on the trunk and then spreads to other areas. It is the sixth of the classical exanthematous diseases and is caused by HHV-6; (HERPESVIRUS 6, HUMAN). (From Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005077"}, {"RECTYPE": "D", "MH": "Exchange Transfusion, Whole Blood", "DE": "EXCHANGE TRANSFUSION", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "MN": "E02.095.135.469", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "do not confuse with PLASMA EXCHANGE (removal & replacement of plasma); differentiate from BLOOD TRANSFUSION, AUTOLOGOUS; /adv eff: coordinate with TRANSFUSION REACTION if pertinent ", "MS": "Repetitive withdrawal of small amounts of blood and replacement with donor blood until a large proportion of the blood volume has been exchanged. Used in treatment of fetal erythroblastosis, hepatic coma, sickle cell anemia, disseminated intravascular coagulation, septicemia, burns, thrombotic thrombopenic purpura, and fulminant malaria.", "OL": "use EXCHANGE TRANSFUSION, WHOLE BLOOD to search EXCHANGE TRANSFUSION 1966-80", "PM": "81; was EXCHANGE TRANSFUSION 1963-80", "HN": "81; was EXCHANGE TRANSFUSION 1963-80", "CATSH": "CAT LIST", "MR": "19921228", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D005078"}, {"RECTYPE": "D", "MH": "Excipients", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Suspending Agents|T120|NON|REL|UNK (19XX)|820429|abcdef", "ENTRY": "Agents, Suspending", "MN": "D27.720.744.770.419", "MH_TH": "NLM (1975)", "ST": "T120", "RN": "0", "PI": "Vehicles (1966-1974)", "MS": "Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc.", "OL": "search PHARMACEUTIC AIDS 1968-74", "PM": "80; was see under VEHICLES 1975-79, was see under PHARMACEUTIC AIDS 1968-74", "HN": "80(75); was see under VEHICLES 1975-79, was see under PHARMACEUTIC AIDS 1968-74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D005079"}, {"RECTYPE": "D", "MH": "Exercise Test", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Treadmill Test|T060|NON|NRW|NLM (1992)|900919|abcdef", "ENTRY": "Treadmill Tests", "MN": "E05.333.250", "FX": "Physical Fitness", "MH_TH": "NLM (1963)", "ST": "T060", "AN": "for \"exercise electrocardiogram\" or \"stress electrocardiogram\" coordinate with ELECTROCARDIOGRAPHY or specifics", "MS": "Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used.", "HN": "1966 (1963)", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005080"}, {"RECTYPE": "D", "MH": "Exercise Therapy", "DE": "EXERCISE THER", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Therapies, Exercise", "MN": "E02.831.535.483", "FX": "Sports", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "EXERCISE is also available", "MS": "A regimen or plan of physical activities designed and prescribed for specific therapeutic goals. Its purpose is to restore normal musculoskeletal function or to reduce pain caused by diseases or injuries.", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005081"}, {"RECTYPE": "D", "MH": "Physical Exertion", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Physical Effort|T040|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Physical Exertions", "MN": "G11.427.683", "FX": "Work", "MH_TH": "NLM (2009)", "ST": "T040", "AN": "do not confuse with EXERCISE", "MS": "Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included.", "PM": "2009; see EXERTION 1963-2008", "HN": "2009 (1963)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D005082"}, {"RECTYPE": "D", "MH": "Exfoliatins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Exfoliative Toxins|T116|T131|NON|BRD|UNK (19XX)|770421|abbcdef", "ENTRY": "Toxins, Exfoliative", "MN": "D23.946.350.500", "PA": "Dermotoxins", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTITOXINS", "PI": "Toxins (1966-1976)", "MS": "Protein exotoxins from Staphylococcus aureus, phage type II, which cause epidermal necrolysis. They are proteins with a molecular weight of 26,000 to 32,000. They cause a condition variously called scaled skin, Lyell or Ritter syndrome, epidermal exfoliative disease, toxic epidermal necrolysis, etc.", "PM": "91; was see under BACTERIAL TOXINS 1978-90", "HN": "91(78); was see under BACTERIAL TOXINS 1978-90", "MR": "20180629", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D005083"}, {"RECTYPE": "D", "MH": "Exhibitionism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Exhibitionisms", "MN": "F03.657.300", "MH_TH": "NLM (1975)", "ST": "T048", "MS": "A disorder in which fantasies about or the act of exposing the genitals to an unsuspecting stranger produces sexual excitement with no attempt at further sexual activity with the stranger.", "OL": "search PARAPHILIAS 1968-74", "PM": "91; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80", "HN": "91(75); was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005084"}, {"RECTYPE": "D", "MH": "Exhibitions as Topic", "PRINT ENTRY": "Exhibits as Topic|T052|NON|EQV|NLM (2008)|070625|abcdef", "ENTRY": "Topics, Exhibitions as", "MN": "L01.462.500.820.090.269", "MH_TH": "NLM (2020)", "ST": "T052", "AN": "do not confuse with the Publication Type EXHIBITION", "MS": "Works about discussions, descriptions or catalogs of public displays or items representative of a given subject.", "PM": "2008; see EXHIBITS 1963-2007", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D005085"}, {"RECTYPE": "D", "MH": "Existentialism", "AQ": "HI PX", "PRINT ENTRY": "Existential Psychology|T091|NON|NRW|UNK (19XX)|780426|EXISTENTIAL PSYCHOL|abcdefv", "ENTRY": "Psychology, Existential|T091|NON|NRW|UNK (19XX)|780426|PSYCHOL EXISTENTIAL|abcdefv", "MN": "K01.752.304", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "Philosophy based on the analysis of the individual's existence in the world which holds that human existence cannot be completely described in scientific terms. Existentialism also stresses the freedom and responsibility of the individual as well as the uniqueness of religious and ethical experiences and the analysis of subjective phenomena such as anxiety, guilt, and suffering. (APA, Thesaurus of Psychological Index Terms, 8th ed.)", "OL": "use EXISTENTIALISM to search EXISTENTIAL PSYCHOLOGY 1974-78", "HN": "EXISTENTIAL PSYCHOLOGY was see under EXISTENTIALISM 1974-78", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D005086"}, {"RECTYPE": "D", "MH": "Glucan 1,4-alpha-Glucosidase", "DS": "GLUCAN ALPHA GLUCOSIDASE 01 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gamma-Amylase|T116|T126|NON|EQV|UNK (19XX)|770331|abbcdef", "ENTRY": "gamma Amylase", "MN": "D08.811.277.450.420.375", "FX": "Glycogen Storage Disease Type II", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "1,4-alpha-D-Glucan glucohydrolase", "RN": "EC 3.2.1.3", "PI": "Glucosidases (1966-1977)", "MS": "An enzyme that catalyzes the hydrolysis of terminal 1,4-linked alpha-D-glucose residues successively from non-reducing ends of polysaccharide chains with the release of beta-glucose. It is also able to hydrolyze 1,6-alpha-glucosidic bonds when the next bond in sequence is 1,4.", "OL": "use GLUCAN 1,4-ALPHA-GLUCOSIDASE to search EXO-1,4-ALPHA-GLUCOSIDASE 1978-90", "PM": "91; was EXO-1,4-ALPHA-GLUCOSIDASE 1978-90; was EXO-1,4-ALPHA-GLUCOSIDASE see under GLUCOSIDASES 1978-88", "HN": "91(78); was EXO-1,4-ALPHA-GLUCOSIDASE 1978-90; was EXO-1,4-ALPHA-GLUCOSIDASE see under GLUCOSIDASES 1978-88", "MR": "20090706", "DA": "19770415", "DC": "1", "DX": "19890101", "UI": "D005087"}, {"RECTYPE": "D", "MH": "Exocrine Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Glands, Exocrine", "MN": "A10.336", "MH_TH": "NLM (1967)", "ST": "T024", "AN": "general: prefer specifics", "PI": "specific animal (1966)", "MS": "Glands of external secretion that release its secretions to the body's cavities, organs, or surface, through a duct.", "PM": "70", "HN": "70(67)", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005088"}, {"RECTYPE": "D", "MH": "Exocytosis", "AQ": "DE ES GE IM PH RE", "MN": "G04.468", "MH_TH": "NLM (1973)", "ST": "T043", "PI": "Cells/SE (1966-1972)", "MS": "Cellular release of material within membrane-limited vesicles by fusion of the vesicles with the CELL MEMBRANE.", "PM": "76; was see under CELLS 1975", "HN": "76(73); was see under CELLS 1975", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D005089"}, {"RECTYPE": "D", "MH": "Exodeoxyribonucleases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Exonucleases, DNA", "MN": "D08.811.277.352.365.290", "MH_TH": "NLM (1983)", "ST": "T126", "RN": "EC 3.1.-", "PI": "Phosphatases (1966-1972)", "MS": "A family of enzymes that catalyze the exonucleolytic cleavage of DNA. It includes members of the class EC 3.1.11 that produce 5'-phosphomonoesters as cleavage products.", "PM": "83", "HN": "83", "MR": "20030709", "DA": "19820430", "DC": "1", "DX": "19830101", "UI": "D005090"}, {"RECTYPE": "D", "MH": "Exons", "AQ": "DE GE IM PH RE", "ENTRY": "Mini-Exons", "MN": "G05.360.340.024.340.137.232", "FX": "Exome", "MH_TH": "NLM (1987)", "ST": "T123", "PI": "Genes, Structural (1977-1986)", "MS": "The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.", "OL": "search BASE SEQUENCE 1980-86", "PM": "87; was see BASE SEQUENCE 1980-86", "HN": "87; was see BASE SEQUENCE 1980-86", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D005091"}, {"RECTYPE": "D", "MH": "Exonucleases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Exonuclease|T116|T126|NON|EQV|NLM (2021)|200106|abbcdef", "ENTRY": "5' 3' Exonucleases", "MN": "D08.811.277.352.365", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 3.1.-", "RR": "EC 3.1.-", "PI": "Phosphatases (1966-1972)", "MS": "Enzymes that catalyze the release of mononucleotides by the hydrolysis of the terminal bond of deoxyribonucleotide or ribonucleotide chains.", "PM": "1973; 3'-5'-EXONUCLEASE use EXODEOXYRIBONUCLEASE V & 5'-3'-EXONUCLEASE were indexed under EXODEORIBONUCLEASES 1992-2003", "HN": "1973; for 3'-5'-EXONUCLEASE use EXODEOXYRIBONUCLEASE V & 5'-3'-EXONUCLEASE (NM) 1992-2003", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005092"}, {"RECTYPE": "D", "MH": "Exophiala", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Wangiella|T004|NON|EQV|UNK (19XX)|850212|abcdef", "ENTRY": "Exophiala jeanselmei|T004|NON|NRW|NLM (1999)|980420|abcdef", "MN": "B01.300.381.355", "MH_TH": "NLM (1986)", "ST": "T004", "RN": "txid5583", "RR": "txid91943", "AN": "infection: in general coordinate with PHAEOHYPHOMYCOSIS but consider also CHROMOBLASTOMYCOSIS; infection caused by Exophiala jeanselmei: consider MYCETOMA ", "PI": "Hyphomycetes (1966-1985)", "MS": "A normally saprophytic mitosporic Chaetothyriales fungal genus. Infections in humans include PHAEOHYPHOMYCOSIS; and PERITONITIS. Exophiala jeanselmei (previously Phialophora jeanselmei) is an etiological agent of MYCETOMA.", "PM": "91; see HYPHOMYCETES 1986-90", "HN": "91(86)", "MR": "20210630", "DA": "19850212", "DC": "1", "DX": "19910101", "UI": "D005093"}, {"RECTYPE": "D", "MH": "Exophthalmos", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Proptosis|T047|NON|EQV|NLM (1990)|890322|abcdef", "ENTRY": "Proptoses", "MN": "C11.675.349", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "protrusion of eye: do not confuse with ENOPHTHALMOS, recession", "MS": "Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye.", "CATSH": "CAT LIST", "MR": "19930527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005094"}, {"RECTYPE": "D", "MH": "Exoribonucleases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Exoribonuclease|T116|T126|NON|EQV|NLM (2021)|191118|abbcdef", "MN": "D08.811.277.352.700.375", "MH_TH": "NLM (1983)", "ST": "T126", "RN": "EC 3.1.-", "PI": "Ribonucleases (1966-1982)", "MS": "A family of enzymes that catalyze the exonucleolytic cleavage of RNA. It includes EC 3.1.13.-, EC 3.1.14.-, EC 3.1.15.-, and EC 3.1.16.-. EC 3.1.-", "PM": "83", "HN": "83", "MR": "20200527", "DA": "19820430", "DC": "1", "DX": "19830101", "UI": "D005095"}, {"RECTYPE": "D", "MH": "Exostoses", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Exostosis|T046|NON|EQV|NLM (1990)|890306|abcdef", "MN": "C05.116.540.310", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "cartilaginous & osteocartilaginous exostoses: index under OSTEOCHONDROMA; EXOSTOSES, MULTIPLE HEREDITARY is also available", "MS": "Benign hypertrophy that projects outward from the surface of bone, often containing a cartilaginous component.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005096"}, {"RECTYPE": "D", "MH": "Exostoses, Multiple Hereditary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Osteochondromas, Multiple|T019|T191|NON|EQV|NLM (1990)|890511|abbcdef", "ENTRY": "Osteochondroma, Multiple", "MN": "C16.320.700.330", "MH_TH": "NLM (1968)", "ST": "T191", "PI": "Exostoses (1966-1967)", "MS": "Hereditary disorder transmitted by an autosomal dominant gene and characterized by multiple exostoses (multiple osteochondromas) near the ends of long bones. The genetic abnormality results in a defect in the osteoclastic activity at the metaphyseal ends of the bone during the remodeling process in childhood or early adolescence. The metaphyses develop benign, bony outgrowths often capped by cartilage. A small number undergo neoplastic transformation.", "OL": "use EXOSTOSES, MULTIPLE HEREDITARY to search EXOSTOSES, MULTIPLE 1968-89", "PM": "90; was EXOSTOSES, MULTIPLE 1968-89", "HN": "90; was EXOSTOSES, MULTIPLE 1968-89", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005097"}, {"RECTYPE": "D", "MH": "Exotoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Exotoxin|T131|NON|EQV|NLM (1991)|891024|abcdef", "MN": "D23.946.350", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "bacterial or fungal toxins; /antag permitted but consider also ANTITOXINS: coord IM with source of exotoxin (IM or NIM)", "PI": "Toxins (1966-1977)", "MS": "Toxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment.", "PM": "78", "HN": "78", "MR": "20050630", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D005098"}, {"RECTYPE": "D", "MH": "Exotropia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Strabismus, Divergent|T047|NON|EQV|UNK (19XX)|820428|abcdef", "ENTRY": "Exotropia, Secondary", "MN": "C11.590.810.440", "MH_TH": "NLM (1983)", "ST": "T047", "AN": "do not confuse with ESOTROPIA, eye turning inward", "PI": "Strabismus (1966-1982)", "MS": "A form of ocular misalignment where the visual axes diverge inappropriately. For example, medial rectus muscle weakness may produce this condition as the affected eye will deviate laterally upon attempted forward gaze. An exotropia occurs due to the relatively unopposed force exerted on the eye by the lateral rectus muscle, which pulls the eye in an outward direction.", "PM": "90; was see under STRABISMUS 1983-89", "HN": "90(83); was see under STRABISMUS 1983-89", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19820428", "DC": "1", "DX": "19900101", "UI": "D005099"}, {"RECTYPE": "D", "MH": "Expectorants", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Mucolytic Agents|T121|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Agents, Mucolytic", "MN": "D27.505.954.796.250", "FX": "Antitussive Agents", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005100"}, {"RECTYPE": "D", "MH": "Expeditions", "AQ": "CL EC ES HI LJ PX SN ST TD", "ENTRY": "Expedition", "MN": "I03.883.532", "MH_TH": "NLM (1966)", "ST": "T052", "AN": "IM; coord with type of exped & geog destination (IM)", "MS": "Usually refers to planned scientific data-gathering excursions.", "MR": "20180525", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005101"}, {"RECTYPE": "D", "MH": "Health Expenditures", "AQ": "CL ES HI LJ SN ST TD", "PRINT ENTRY": "Out-of-Pocket Payment|T081|NON|NRW|NLM (2021)|191119|abcdef", "ENTRY": "Spending, Out-of-Pocket", "MN": "N05.300.385", "FX": "Health Care Costs", "MH_TH": "NLM (1968)", "ST": "T081", "AN": "amount spent for health care: do not confuse with HEALTH CARE COSTS (actual costs of providing care) or with FEES AND CHARGES (amount charged regardless of cost)", "PI": "Economics, Medical (1966-1967)", "MS": "The amounts spent by individuals, groups, nations, or private or public organizations for total health care and/or its various components. These amounts may or may not be equivalent to the actual costs (HEALTH CARE COSTS) and may or may not be shared among the patient, insurers, and/or employers.", "OL": "use HEALTH EXPENDITURES to search EXPENDITURES, HEALTH 1968-91", "PM": "92; was EXPENDITURES, HEALTH 1968-91", "HN": "92; was EXPENDITURES, HEALTH 1968-91", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005102"}, {"RECTYPE": "D", "MH": "Expert Systems", "AQ": "IS", "ENTRY": "Systems, Expert", "MN": "L01.224.050.375.190", "MH_TH": "NLM (1987)", "ST": "T170", "AN": "IM; restrict to field of computer programs & artificial intelligence", "MS": "Computer programs based on knowledge developed from consultation with experts on a problem, and the processing and/or formalizing of this knowledge using these programs in such a manner that the problems may be solved.", "PM": "87", "HN": "87", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D005103"}, {"RECTYPE": "D", "MH": "Expert Testimony", "AQ": "EC ES LJ MT SN ST TD", "PRINT ENTRY": "Expert Witness|T097|NON|REL|NLM (1999)|980414|abcdef", "ENTRY": "Witnesses, Expert", "MN": "N03.706.535.253", "MH_TH": "BIOETHICS (1989)", "ST": "T057", "MS": "Presentation of pertinent data by one with special skill or knowledge representing mastery of a particular subject.", "PM": "66", "HN": "66", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005104"}, {"RECTYPE": "D", "MH": "Expiratory Reserve Volume", "AQ": "DE ES GE IM PH RE", "ENTRY": "Volumes, Expiratory Reserve", "MN": "G09.772.850.970.360", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "NIM; in texts as ERV", "MS": "The extra volume of air that can be expired with maximum effort beyond the level reached at the end of a normal, quiet expiration. Common abbreviation is ERV.", "PM": "91; was see under LUNG VOLUME MEASUREMENTS 1975-90", "HN": "91(75); was see under LUNG VOLUME MEASUREMENTS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D005105"}, {"RECTYPE": "D", "MH": "Exploratory Behavior", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Novelty-Seeking Behavior|T055|NON|NRW|UNK (19XX)|800514|abcdef", "ENTRY": "Novelty-Seeking Behaviors", "MN": "F01.658.370", "MH_TH": "NLM (1968)", "ST": "T055", "AN": "human & animal", "MS": "The tendency to explore or investigate a novel environment. It is considered a motivation not clearly distinguishable from curiosity.", "OL": "use EXPLORATORY BEHAVIOR to search BEHAVIOR, EXPLORATORY 1966-67 & CURIOSITY 1969-78", "PM": "68; was BEHAVIOR, EXPLORATORY 1965-67", "HN": "68; was BEHAVIOR, EXPLORATORY 1965-67; CURIOSITY was see under EXPLORATORY BEHAVIOR 1969-78", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005106"}, {"RECTYPE": "D", "MH": "Explosions", "AQ": "CL EC HI LJ PC SN", "ENTRY": "Explosion", "MN": "N06.230.208", "FX": "Blast Injuries", "MH_TH": "NLM (1966)", "ST": "T067", "MS": "Sudden, violent, and often destructive expansion of gases which propagates energy outward, such as a shock wave, ejecting fragments and debris at high velocities.", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005107"}, {"RECTYPE": "D", "MH": "Extinction, Psychological", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Psychological Extinction|T041|NON|EQV|NLM (2007)|051229|abcdef", "ENTRY": "Psychological Extinctions", "MN": "F02.463.425.770.232", "MH_TH": "NLM (2007)", "ST": "T041", "MS": "The procedure of presenting the conditioned stimulus without REINFORCEMENT to an organism previously conditioned. It refers also to the diminution of a conditioned response resulting from this procedure.", "PM": "2007; see EXTINCTION (PSYCHOLOGY) 1965-2006, see EXTINCTION LEARNING 1963-1964", "HN": "2007 (1963)", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005108"}, {"RECTYPE": "D", "MH": "Extracellular Matrix", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Matrix, Extracellular|T024|NON|EQV|UNK (19XX)|830531|abcdef", "ENTRY": "Matrices, Extracellular", "MN": "A11.284.295.310", "MH_TH": "NLM (1984)", "ST": "T024", "PI": "Extracellular Space (1966-1983)", "MS": "A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere.", "PM": "84", "HN": "84", "MR": "20210510", "DA": "19830531", "DC": "1", "DX": "19840101", "UI": "D005109"}, {"RECTYPE": "D", "MH": "Extracellular Space", "AQ": "CH DE DG EN GE IM ME MI PH PS RE VI", "PRINT ENTRY": "Intercellular Space|T030|NON|EQV|UNK (19XX)|830531|abcdef", "ENTRY": "Spaces, Intercellular", "MN": "A11.284.295", "MH_TH": "NLM (1964)", "ST": "T030", "MS": "Interstitial space between cells, occupied by INTERSTITIAL FLUID as well as amorphous and fibrous substances. For organisms with a CELL WALL, the extracellular space includes everything outside of the CELL MEMBRANE including the PERIPLASM and the cell wall.", "PM": "1966", "HN": "1966(1964)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005110"}, {"RECTYPE": "D", "MH": "Extrachromosomal Inheritance", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Extranuclear Inheritance|T045|NON|NRW|NLM (2001)|000411|abcdef", "ENTRY": "Inheritance, Extranuclear", "MN": "G05.420.275", "FX": "DNA, Mitochondrial", "MH_TH": "NLM (1968)", "ST": "T045", "PI": "Genetics (1966-1967)", "MS": "Vertical transmission of hereditary characters by DNA from cytoplasmic organelles such as MITOCHONDRIA; CHLOROPLASTS; and PLASTIDS, or from PLASMIDS or viral episomal DNA.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005111"}, {"RECTYPE": "D", "MH": "Extracorporeal Circulation", "DE": "EXTRACORPOREAL CIRC", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Extracorporeal Circulations", "MN": "E04.292", "MH_TH": "NLM (1967)", "ST": "T061", "AN": "general or unspecified; prefer specifics; do not confuse with ASSISTED CIRCULATION", "PI": "Heart-Lung Machine (1966)", "MS": "Diversion of blood flow through a circuit located outside the body but continuous with the bodily circulation.", "OL": "search HEART, MECHANICAL 1966", "PM": "67; was see under HEART, MECHANICAL 1963-66", "HN": "67; was see under HEART, MECHANICAL 1963-66", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D005112"}, {"RECTYPE": "D", "MH": "Extraction, Obstetrical", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Obstetrical Extractions", "MN": "E04.520.252.875", "FX": "Obstetrical Forceps", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Extraction of the fetus by means of obstetrical instruments.", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005113"}, {"RECTYPE": "D", "MH": "Extramarital Relations", "DE": "EXTRAMARITAL RELAT", "AQ": "EH ES HI LJ PX", "PRINT ENTRY": "Adultery|T055|NON|EQV|NLM (1994)|930322|abcdef", "ENTRY": "Sex Behavior, Extramarital", "MN": "F01.145.802.295", "MH_TH": "NLM (1975)", "ST": "T055", "MS": "Voluntary SEXUAL INTERCOURSE between a married person and someone other than the SPOUSE.", "PM": "91; was see under SEX BEHAVIOR 1975-90", "HN": "91(75); was see under SEX BEHAVIOR 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D005114"}, {"RECTYPE": "D", "MH": "Extraoral Traction Appliances", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Headgear, Orthodontic|T074|NON|NRW|UNK (19XX)|760412|abcdef", "ENTRY": "Traction Appliances, Extraoral", "MN": "E06.658.453.578.360", "MH_TH": "NLM (1977)", "ST": "T074", "PI": "Orthodontic Appliances, Removable (1971-1976)", "MS": "Extraoral devices for applying force to the dentition in order to avoid some of the problems in anchorage control met with in intermaxillary traction and to apply force in directions not otherwise possible.", "PM": "91; was see under ORTHODONTIC APPLIANCES, REMOVABLE 1977-90", "HN": "91(77); was see under ORTHODONTIC APPLIANCES, REMOVABLE 1977-90", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D005115"}, {"RECTYPE": "D", "MH": "Extrapyramidal Tracts", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Tract, Extrapyramidal", "MN": "A08.612.380.239", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Uncrossed tracts of motor nerves from the brain to the anterior horns of the spinal cord, involved in reflexes, locomotion, complex movements, and postural control.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005116"}, {"RECTYPE": "D", "MH": "Cardiac Complexes, Premature", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Premature Cardiac Complexes|T047|NON|EQV|NLM (1996)|940718|abcdef", "ENTRY": "Premature Cardiac Complices", "MN": "C23.550.073.325", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A group of cardiac arrhythmias in which the cardiac contractions are not initiated at the SINOATRIAL NODE. They include both atrial and ventricular premature beats, and are also known as extra or ectopic heartbeats. Their frequency is increased in heart diseases.", "PM": "96; was EXTRASYSTOLE 1963-95; PREMATURE BEATS was PREMATURE BEAT 1985-95", "HN": "96; was EXTRASYSTOLE 1963-95; PREMATURE BEATS was PREMATURE BEAT 1985-95", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D005117"}, {"RECTYPE": "D", "MH": "Extraterrestrial Environment", "DE": "EXTRATERRESTRIAL ENVIR", "AQ": "CH", "PRINT ENTRY": "Space (Astronomy)|T070|NON|REL|NLM (1996)|950127|SPACE|abcdefv", "ENTRY": "Spaces (Astronomy)", "MN": "G16.500.275.240", "FX": "Solar System", "MH_TH": "NLM (1966)", "ST": "T070", "MS": "The environment outside the earth or its atmosphere. The environment may refer to a closed cabin (such as a space shuttle or space station) or to space itself, the moon, or other planets.", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005118"}, {"RECTYPE": "D", "MH": "Extravasation of Diagnostic and Therapeutic Materials", "DE": "EXTRAVASATION", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Extravasation of Contrast Media|T037|T046|NON|NRW|UNK (19XX)|840608|EXTRAVASATION CONTRAST MEDIA|abbcdefv", "ENTRY": "Contrast Media Extravasation", "MN": "C26.371", "MH_TH": "NLM (1981)", "ST": "T046", "PI": "specific organ or disease/radiography (1967-1980)", "MS": "The escape of diagnostic or therapeutic material from the vessel into which it is introduced into the surrounding tissue or body cavity.", "OL": "use EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS to search EXTRAVASATION OF CONTRAST MEDIA 1981-84", "PM": "85; was EXTRAVASATION OF CONTRAST MEDIA 1981-84", "HN": "85; was EXTRAVASATION OF CONTRAST MEDIA 1981-84", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19800402", "DC": "1", "DX": "19810101", "UI": "D005119"}, {"RECTYPE": "D", "MH": "Extraversion, Psychological", "PRINT ENTRY": "Extroversion, Psychology|T041|NON|EQV|NLM (2020)|190117|abcdef", "ENTRY": "Psychology Extroversion", "MN": "F02.739.794.253", "MH_TH": "NLM (2020)", "ST": "T041", "PI": "Psychoanalytic Theory (1966-1967)", "MS": "A state in which attention is largely directed outward from the self.", "PM": "2020; was EXTRAVERSION (PSYCHOLOGY) 1978-2019; was EXTROVERSION (PSYCHOLOGY) 1968-1977", "HN": "2020 (1968); was EXTRAVERSION (PSYCHOLOGY) 1978-2019; was EXTROVERSION (PSYCHOLOGY) 1968-197", "CATSH": "CAT LIST", "MR": "20190117", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005120"}, {"RECTYPE": "D", "MH": "Extremities", "AQ": "AH BS DG EM GD IN IR MI PA PH PP PS RE SU TR VI", "PRINT ENTRY": "Limbs|T029|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Limb", "MN": "A01.378", "EC": "abnormalities:Limb Deformities, Congenital", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "The farthest or outermost projections of the body, such as the HAND and FOOT.", "MR": "20150615", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005121"}, {"RECTYPE": "D", "MH": "Exudates and Transudates", "DE": "EXUDATES TRANSUDATES", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Transudates|T031|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Transudate", "MN": "A12.383", "FX": "Seroma", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005122"}, {"RECTYPE": "D", "MH": "Eye", "AQ": "AH BS CH CY DE DG EM EN GD IM IR ME MI PA PP PS RE TR UL VI", "ENTRY": "Eyes", "MN": "A09.371", "FX": "Vision, Ocular", "EC": "surgery:Ophthalmologic Surgical Procedures", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at OCUL-, OPHTHALM-, OPT-, and VIS-", "MS": "The organ of sight constituting a pair of globular organs made up of a three-layered roughly spherical structure specialized for receiving and responding to light.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005123"}, {"RECTYPE": "D", "MH": "Eye Abnormalities", "DE": "EYE ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Eye Abnormality", "MN": "C16.131.384", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; these are structural abnorm: EYE DISEASES, HEREDITARY is also available", "PI": "specific eye heading/abnormalities (1977-1989)", "MS": "Congenital absence of or defects in structures of the eye; may also be hereditary.", "PM": "90", "HN": "90; was NON MESH 1977-89", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D005124"}, {"RECTYPE": "D", "MH": "Eye Banks", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Eye Bank", "MN": "N02.278.065.900.400", "MH_TH": "NLM (1975)", "ST": "T093", "MS": "Centers for storing various parts of the eye for future use.", "OL": "search TISSUE BANKS 1966-74", "PM": "91; was see under TISSUE BANKS 1975-90", "HN": "91(75); was see under TISSUE BANKS 1975-90", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005125"}, {"RECTYPE": "D", "MH": "Eye Burns", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Eye Burn", "MN": "C26.915.300.425.250.250", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Injury to any part of the eye by extreme heat, chemical agents, or ultraviolet radiation.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005126"}, {"RECTYPE": "D", "MH": "Eye Color", "AQ": "DE ES GE IM PH RE", "ENTRY": "Eye Colors", "MN": "G16.690.360", "MH_TH": "NLM (1976)", "ST": "T032", "AN": "= color of iris, not the color of the eye as in disease", "PI": "Pigmentation (1966-1975)", "MS": "Color of the iris.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D005127"}, {"RECTYPE": "D", "MH": "Eye Diseases", "DE": "EYE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Eye Disorders|T047|NON|EQV|NLM (2020)|190501|abcdef", "ENTRY": "Eye Disorder", "MN": "C11", "RH": "C11 - DISEASES-OCULAR", "FX": "Eye Manifestations", "MH_TH": "BIOETHICS (1989)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate IM with specific part of eye (IM); /diag: consider also DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL", "MS": "Diseases affecting the eye.", "PM": "65; was see under OPHTHALMOLOGY 1963-64", "HN": "65; was see under OPHTHALMOLOGY 1963-64", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005128"}, {"RECTYPE": "D", "MH": "Eye Foreign Bodies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Foreign Objects, Eye", "MN": "C26.915.300.425.250.260", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Inanimate objects that become enclosed in the eye.", "CATSH": "CAT LIST", "MR": "20150325", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005129"}, {"RECTYPE": "D", "MH": "Eye Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Eye|T046|T184|NON|EQV|NLM (1990)|890314|abbcdef", "ENTRY": "Eye Hemorrhages", "MN": "C23.888.307.500", "MH_TH": "NLM (1987)", "ST": "T184", "AN": "general or unspecified; prefer specifics; hemorrhage of eye tissue: do not confuse with RETROBULBAR HEMORRHAGE, hemorrhage within the orbital cavity behind the eyeball; CHOROIDAL HEMORRHAGE; HYPHEMA; RETINAL HEMORRHAGE; and VITREOUS HEMORRHAGE are also available", "PI": "Hemorrhage (1966-1986)", "MS": "Intraocular hemorrhage from the vessels of various tissues of the eye.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19860408", "DC": "1", "DX": "19870101", "UI": "D005130"}, {"RECTYPE": "D", "MH": "Eye Injuries", "DE": "EYE INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injury, Eye", "MN": "C26.915.300.425.250", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "general or unspecified; consider also /inj with specific parts of eye; EYE INJURIES, PENETRATING & EYE BURNS are also available", "MS": "Damage or trauma inflicted to the eye by external means. The concept includes both surface injuries and intraocular injuries.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005131"}, {"RECTYPE": "D", "MH": "Eye Manifestations", "ENTRY": "Manifestations, Eye", "MN": "C23.888.307", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "not used for indexing since 1989; prior to 1989 used for eye manifest of non-eye diseases", "MS": "Ocular disorders attendant upon non-ocular disease or injury.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005132"}, {"RECTYPE": "D", "MH": "Eye Movements", "AQ": "DE ES GE IM PH RE", "ENTRY": "Movements, Eye", "MN": "G14.350", "FX": "Sleep, REM", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "EYE MOVEMENT MEASUREMENTS is also available", "MS": "Voluntary or reflex-controlled movements of the eye.", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005133"}, {"RECTYPE": "D", "MH": "Eye Neoplasms", "DE": "EYE NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Eye Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Eye", "MN": "C11.319", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with specific site in eye (IM) + histol type of neopl (IM)", "MS": "Tumors or cancer of the EYE.", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005134"}, {"RECTYPE": "D", "MH": "Eye Protective Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Sun Glasses, Nonprescription|T073|NON|NRW|NLM (1998)|961010|abcdef", "ENTRY": "Protective Devices, Eye", "MN": "J01.637.708.560.500", "MH_TH": "NLM (1975)", "ST": "T073", "AN": "for physical protection: do not confuse with EYEGLASSES which is for improvement of vision", "MS": "Personal devices for protection of the eyes from impact, flying objects, glare, liquids, or injurious radiation.", "PM": "91; see PROTECTIVE DEVICES 1975-90", "HN": "91(75)", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D005135"}, {"RECTYPE": "D", "MH": "Eye Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Eye", "MN": "D12.776.306", "MH_TH": "NLM (1966)", "ST": "T116", "RN": "0", "AN": "IM; coord with specific protein (IM) & specific part of eye (IM); /biosyn /drug eff /physiol permitted", "MS": "PROTEINS derived from TISSUES of the EYE.", "MR": "20170712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005136"}, {"RECTYPE": "D", "MH": "Eye, Artificial", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Ocular Prosthesis|T074|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Prosthesis, Ocular", "MN": "E07.695.225", "FX": "Orbital Implants", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "A ready-made or custom-made prosthesis of glass or plastic shaped and colored to resemble the anterior portion of a normal eye and used for cosmetic reasons. It is attached to the anterior portion of an orbital implant (ORBITAL IMPLANTS) which is placed in the socket of an enucleated or eviscerated eye. (From Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005137"}, {"RECTYPE": "D", "MH": "Eyebrows", "AQ": "AB AH CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE TR UL VI", "ENTRY": "Eyebrow", "MN": "A17.360.296", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "Curved rows of HAIR located on the upper edges of the eye sockets.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005138"}, {"RECTYPE": "D", "MH": "Eyeglasses", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Sun Glasses, Prescription|T074|NON|NRW|NLM (1998)|961010|abcdef", "ENTRY": "Prescription Sun Glasses", "MN": "E07.632.500.300", "MH_TH": "NLM (1966)", "ST": "T074", "AN": "prescription lenses to aid vision: do not confuse with EYE PROTECTIVE DEVICES", "MS": "A pair of ophthalmic lenses in a frame or mounting which is supported by the nose and ears. The purpose is to aid or improve vision. It does not include goggles or nonprescription sun glasses for which EYE PROTECTIVE DEVICES is available.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005139"}, {"RECTYPE": "D", "MH": "Eyelashes", "AQ": "AB AH CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE TR UL VI", "MN": "A17.360.421", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "The hairs which project from the edges of the EYELIDS.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005140"}, {"RECTYPE": "D", "MH": "Eyelid Diseases", "DE": "EYELID DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Eyelid Disease", "MN": "C11.338", "MH_TH": "NLM (1970)", "ST": "T047", "PI": "Skin Diseases (1966-1969)", "MS": "Diseases involving the EYELIDS.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005141"}, {"RECTYPE": "D", "MH": "Eyelid Neoplasms", "DE": "EYELID NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasms, Eyelid", "MN": "C11.338.526", "MH_TH": "NLM (1970)", "ST": "T191", "AN": "coordinate with histological type of neoplasm", "PI": "Skin Neoplasms (1966-1969)", "MS": "Tumors of cancer of the EYELIDS.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005142"}, {"RECTYPE": "D", "MH": "Eyelids", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Eyelid", "MN": "A09.371.337", "FX": "Nictitating Membrane", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at BLEPHAR-", "MS": "Each of the upper and lower folds of SKIN which cover the EYE when closed.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005143"}, {"RECTYPE": "D", "MH": "F Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sex Factor, Bacterial|T114|T123|NON|EQV|UNK (19XX)|830224|SEX FACTOR BACT|abbcdefv", "ENTRY": "Transfer Factors, Resistance", "MN": "G05.360.600.300", "FX": "Pili, Sex", "MH_TH": "NLM (1975)", "ST": "T123", "PI": "Genetics (1966-1967)", "MS": "A plasmid whose presence in the cell, either extrachromosomal or integrated into the BACTERIAL CHROMOSOME, determines the \"sex\" of the bacterium, host chromosome mobilization, transfer via conjugation (CONJUGATION, GENETIC) of genetic material, and the formation of SEX PILI.", "OL": "use F FACTOR to search SEX FACTORS, BACTERIAL 1978-83", "PM": "78; was see under CONJUGATION, GENETIC 1975-77; SEX FACTOR, BACTERIAL was SEX FACTORS, BACTERIAL see under PLASMIDS 1978-83", "HN": "78(75); was see under CONJUGATION, GENETIC 1975-77; SEX FACTOR, BACTERIAL was SEX FACTORS, BACTERIAL see under PLASMIDS 1978-83", "MR": "20160628", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D005144"}, {"RECTYPE": "D", "MH": "Face", "AQ": "AB AH BS DG EM IR MI PA PH PP PS RE SU VI", "ENTRY": "Faces", "MN": "A01.456.505", "EC": "transplantation:Facial Transplantation", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "The anterior portion of the head that includes the skin, muscles, and structures of the forehead, eyes, nose, mouth, cheeks, and jaw.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005145"}, {"RECTYPE": "D", "MH": "Facial Asymmetry", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Facial Asymmetries", "MN": "C23.300.505", "FX": "Facies", "MH_TH": "OMIM (2013)", "ST": "T190", "AN": "if congen use /congen; do not confuse with FACIAL HEMIATROPHY; since asymmetry is lateral, long face syndrome does not go here: index under FACIAL BONES /abnorm (IM) + MALOCCLUSION or specific type (IM) + SYNDROME (NIM)", "PI": "Face (1966-1976)", "MS": "Congenital or acquired asymmetry of the face.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D005146"}, {"RECTYPE": "D", "MH": "Facial Bones", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Facial Bone", "MN": "A02.835.232.781.324", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "consider specifics; do not confuse with FACE (locational & soft tissue) or its specifics; /abnorm: consider also CRANIOFACIAL ABNORMALITIES; fractures: coord FACIAL BONES /inj (IM) + SKULL FRACTURES (IM); neopl: coord IM + SKULL NEOPLASMS; craniofacial dysmorphism: index under CRANIOFACIAL ABNORMALITIES; craniofacial dysplasia or craniofacial fibrous dysplasia: index under FACIAL BONES (IM) + SKULL (IM) + FIBROUS DYSPLASIA, POLYOSTOTIC (IM)", "MS": "The facial skeleton, consisting of bones situated between the cranial base and the mandibular region. While some consider the facial bones to comprise the hyoid (HYOID BONE), palatine (HARD PALATE), and zygomatic (ZYGOMA) bones, MANDIBLE, and MAXILLA, others include also the lacrimal and nasal bones, inferior nasal concha, and vomer but exclude the hyoid bone. (Jablonski, Dictionary of Dentistry, 1992, p113)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005147"}, {"RECTYPE": "D", "MH": "Facial Dermatoses", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nodular Elastoidosis|T047|NON|NRW|NLM (1997)|960412|abcdef", "ENTRY": "Syndrome, Favre-Racouchot", "MN": "C17.800.271", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "consider synonym for dermatitis of face & do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH; does not include neoplasms of face (= FACIAL NEOPLASMS)", "MS": "Skin diseases involving the FACE.", "PM": "FAVRE-RACOUCHOT SYNDROME was heading 1964-96 (see under SKIN DISEASES 1964-90); NODULAR ELASTOIDOSIS was see FAVRE-RACOUCHOT SYNDROME 1992-96", "HN": "FAVRE-RACOUCHOT SYNDROME was heading 1964-96 (see under SKIN DISEASES 1964-90); NODULAR ELASTOIDOSIS was see FAVRE-RACOUCHOT SYNDROME 1992-96", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D005148"}, {"RECTYPE": "D", "MH": "Facial Expression", "PRINT ENTRY": "Face Expression|T033|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Facial Expressions", "MN": "F01.145.209.530.385", "MH_TH": "NLM (1966)", "ST": "T033", "AN": "human & animal; a psychological response: do not confuse with FACIES, the physical appearance characteristic of various diseases", "MS": "Observable changes of expression in the face in response to emotional stimuli.", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005149"}, {"RECTYPE": "D", "MH": "Facial Hemiatrophy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Romberg Disease|T047|EPO|EQV|UNK (19XX)|740330|ROMBERG DIS|abcdefv", "ENTRY": "Syndrome, Parry-Romberg", "MN": "C10.292.319.375", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with FACIAL ASYMMETRY; note HEMIFACIAL MICROSOMIA see FACIAL ASYMMETRY", "MS": "A syndrome characterized by slowly progressive unilateral atrophy of facial subcutaneous fat, muscle tissue, skin, cartilage, and bone. The condition typically progresses over a period of 2-10 years and then stabilizes.", "PM": "for ROMBERG DISEASE see ROMBERG'S DISEASE 1963-97", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005150"}, {"RECTYPE": "D", "MH": "Facial Injuries", "DE": "FACIAL INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injury, Facial", "MN": "C26.915.300.425", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "general or unspecified for soft tissue or bony portions of face; consider also  /inj with FACIAL BONES or specific facial bones ", "MS": "General or unspecified injuries to the soft tissue or bony portions of the face.", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005151"}, {"RECTYPE": "D", "MH": "Facial Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Mimetic Muscles|T023|NON|NRW|UNK (19XX)|750116|abcdef", "ENTRY": "Muscles, Mimetic", "MN": "A14.363", "FX": "Myofunctional Therapy", "MH_TH": "NLM (1965)", "ST": "T023", "AN": "/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent", "MS": "Muscles of facial expression or mimetic muscles that include the numerous muscles supplied by the facial nerve that are attached to and move the skin of the face. (From Stedman, 25th ed)", "PM": "65", "HN": "65", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005152"}, {"RECTYPE": "D", "MH": "Facial Neoplasms", "DE": "FACIAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasms, Facial", "MN": "C04.588.443.392", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "not for facial bone neoplasms (= FACIAL BONES  + SKULL NEOPLASMS); coordinate with site + histological type of neoplasm", "MS": "New abnormal growth of tissue in the FACE.", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005153"}, {"RECTYPE": "D", "MH": "Facial Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Seventh Cranial Nerve|T023|NON|EQV|NLM (1998)|960731|abcdef", "ENTRY": "Wrisberg Nervus Intermedius", "MN": "A08.800.800.120.250", "FX": "Facial Nucleus", "EC": "injuries:Facial Nerve Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The 7th cranial nerve. The facial nerve has two parts, the larger motor root which may be called the facial nerve proper, and the smaller intermediate or sensory root. Together they provide efferent innervation to the muscles of facial expression and to the lacrimal and SALIVARY GLANDS, and convey afferent information for TASTE from the anterior two-thirds of the TONGUE and for TOUCH from the EXTERNAL EAR.", "MR": "20190521", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005154"}, {"RECTYPE": "D", "MH": "Facial Nerve Diseases", "DE": "FACIAL NERVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Geniculate Ganglionitis|T047|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Neuropathy, Familial Facial", "MN": "C10.292.319", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Peripheral Nerve Diseases (1966-1980)", "MS": "Diseases of the facial nerve or nuclei. Pontine disorders may affect the facial nuclei or nerve fascicle. The nerve may be involved intracranially, along its course through the petrous portion of the temporal bone, or along its extracranial course. Clinical manifestations include facial muscle weakness, loss of taste from the anterior tongue, hyperacusis, and decreased lacrimation.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19800404", "DC": "1", "DX": "19810101", "UI": "D005155"}, {"RECTYPE": "D", "MH": "Facial Neuralgia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sphenopalatine Neuralgia|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Syndromes, Myofacial Pain", "MN": "C10.292.319.625", "FX": "Facial Pain", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Neuralgic syndromes which feature chronic or recurrent FACIAL PAIN as the primary manifestation of disease. Disorders of the trigeminal and facial nerves are frequently associated with these conditions.", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005156"}, {"RECTYPE": "D", "MH": "Facial Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pain, Facial|T184|NON|EQV|UNK (19XX)|850507|abcdef", "ENTRY": "Pain, Orofacial", "MN": "C23.888.592.612.330", "FX": "Trigeminal Neuralgia", "MH_TH": "NLM (1986)", "ST": "T184", "PI": "Trigeminal Neuralgia (1966-1985)", "MS": "Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.", "PM": "1986", "HN": "1986", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19850507", "DC": "1", "DX": "19860101", "UI": "D005157"}, {"RECTYPE": "D", "MH": "Facial Paralysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemifacial Paralysis|T184|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Peripheral Facial Paralysis", "MN": "C23.888.592.636.214", "FX": "Mobius Syndrome", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Severe or complete loss of facial muscle motor function. This condition may result from central or peripheral lesions. Damage to CNS motor pathways from the cerebral cortex to the facial nuclei in the pons leads to facial weakness that generally spares the forehead muscles. FACIAL NERVE DISEASES generally results in generalized hemifacial weakness. NEUROMUSCULAR JUNCTION DISEASES and MUSCULAR DISEASES may also cause facial paralysis or paresis.", "CATSH": "CAT LIST", "MR": "19991105", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005158"}, {"RECTYPE": "D", "MH": "Health Care Facilities, Manpower, and Services", "ENTRY": "Healthcare Facilities, Manpower, and Services|T078|NON|EQV|NLM (1998)|970110|abcdef", "MN": "N02", "RH": "N2 - HEALTH CARE FACILITIES, MANPOWER, AND SERVICES", "MH_TH": "NLM (1974)", "ST": "T078", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "The services provided in the delivery of health care, associated facilities in health care, and attendant manpower required or available.", "PM": "98", "HN": "98; use explode", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D005159"}, {"RECTYPE": "D", "MH": "Facility Design and Construction", "DE": "FACILITY DESIGN CONSTRUCTION", "AQ": "CL EC ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Facility Construction|T057|NON|NRW|NLM (1991)|900222|abcdef", "ENTRY": "Facility Designs", "MN": "N02.278.200", "FX": "Construction Industry", "MH_TH": "NLM (1967)", "ST": "T057", "AN": "HOSPITAL DESIGN AND CONSTRUCTION is also available ", "PI": "Architecture (1966)", "MS": "Architecture, exterior and interior design, and construction of facilities other than hospitals, e.g., dental schools, medical schools, ambulatory care clinics, and specified units of health care facilities. The concept also includes architecture, design, and construction of specialized contained, controlled, or closed research environments including those of space labs and stations.", "PM": "73", "HN": "73(67)", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005160"}, {"RECTYPE": "D", "MH": "Facility Regulation and Control", "DE": "FACILITY REG CONTROL", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Regulations, Facility", "MN": "N05.700.300", "MH_TH": "NLM (1978)", "ST": "T064", "MS": "Formal voluntary or governmental procedures and standards required of hospitals and health or other facilities to improve operating efficiency, and for the protection of the consumer.", "PM": "78", "HN": "78", "MR": "19991105", "DA": "19770505", "DC": "1", "DX": "19780101", "UI": "D005161"}, {"RECTYPE": "D", "MH": "Factitious Disorders", "DE": "FACTITIOUS DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Pseudopsychosis|T048|NON|NRW|UNK (19XX)|800521|abcdef", "ENTRY": "Syndrome, Ganser", "MN": "F03.875.375", "MH_TH": "NLM (1981)", "ST": "T048", "AN": "differentiate from SOMATOFORM DISORDERS: factitious are phys or psychol sympt under voluntary control, somatoform are phys sympt linked to psychol factors but not under voluntary control", "MS": "Disorders characterized by physical or psychological symptoms that are not real, genuine, or natural.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19800521", "DC": "1", "DX": "19810101", "UI": "D005162"}, {"RECTYPE": "D", "MH": "Factor Analysis, Statistical", "DE": "FACTOR ANAL STATIST", "ENTRY": "Statistical Factor Analyses", "MN": "N06.850.520.830.400", "MH_TH": "NLM (1966)", "ST": "T081", "AN": "usually NIM", "MS": "A set of statistical methods for analyzing the correlations among several variables in order to estimate the number of fundamental dimensions that underlie the observed data and to describe and measure those dimensions. It is used frequently in the development of scoring systems for rating scales and questionnaires.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005163"}, {"RECTYPE": "D", "MH": "Factor IX", "DS": "FACTOR VIIII", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Plasma Thromboplastin Component|T116|T121|T123|NON|EQV|UNK (19XX)|750101|abbbcdef", "ENTRY": "Factor IX, Coagulation", "MN": "D23.119.375", "FX": "Coagulants", "EC": "deficiency:Hemophilia B", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Blood-coagulation factor IX", "RN": "9001-28-9", "MS": "Storage-stable blood coagulation factor acting in the intrinsic pathway of blood coagulation. Its activated form, IXa, forms a complex with factor VIII and calcium on platelet factor 3 to activate factor X to Xa. Deficiency of factor IX results in HEMOPHILIA B (Christmas Disease).", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005164"}, {"RECTYPE": "D", "MH": "Factor V", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proaccelerin|T116|T123|NON|EQV|UNK (19XX)|750101|abbcdef", "ENTRY": "Factor V, Coagulation", "MN": "D23.119.300", "FX": "Coagulants", "EC": "deficiency:Factor V Deficiency", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Blood-coagulation factor V", "RN": "9001-24-5", "MS": "Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor V accomplishes this by forming a complex with factor Xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor V leads to Owren's disease.", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005165"}, {"RECTYPE": "D", "MH": "Factor V Deficiency", "DE": "FACTOR V DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Parahemophilia|T047|NON|EQV|NLM (1999)|OMIM (2013)|980313|abcdeef", "ENTRY": "Parahemophilias", "MN": "C16.320.099.300", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "a blood coag disord", "MS": "A deficiency of blood coagulation factor V (known as proaccelerin or accelerator globulin or labile factor) leading to a rare hemorrhagic tendency known as Owren's disease or parahemophilia. It varies greatly in severity. Factor V deficiency is an autosomal recessive trait. (Dorland, 27th ed)", "OL": "use HYPOPROTHROMBINEMIAS to search FACTOR V DEFICIENCY 1966-72", "PM": "73; was see under HYPOPROTHROMBINEMIAS 1963-72", "HN": "73(64); was see under HYPOPROTHROMBINEMIAS 1963-72", "CATSH": "CAT LIST", "MR": "20170502", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005166"}, {"RECTYPE": "D", "MH": "Factor VII", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stable Factor|T116|T123|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Factor VII, Coagulation", "MN": "D23.119.325", "FX": "Coagulants", "EC": "deficiency:Factor VII Deficiency", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Blood-coagulation factor VII", "RN": "9001-25-6", "MS": "Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor VIIa in the extrinsic pathway of blood coagulation. The activated form then catalyzes the activation of factor X to factor Xa.", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005167"}, {"RECTYPE": "D", "MH": "Factor VII Deficiency", "DE": "FACTOR VII DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypoproconvertinemia|T047|NON|EQV|UNK (19XX)|840214|abcdef", "ENTRY": "Hypoproconvertinemias", "MN": "C16.320.099.310", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An autosomal recessive characteristic or a coagulation disorder acquired in association with VITAMIN K DEFICIENCY. FACTOR VII is a Vitamin K dependent glycoprotein essential to the extrinsic pathway of coagulation.", "OL": "use FACTOR VII DEFICIENCY to search HYPOPROCONVERTINEMIA 1966-84", "PM": "85; was HYPOPROCONVERTINEMIA 1963-84", "HN": "85; was HYPOPROCONVERTINEMIA 1963-84", "CATSH": "CAT LIST", "MR": "20170502", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D005168"}, {"RECTYPE": "D", "MH": "Factor VIII", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thromboplastinogen|T116|T121|T129|NON|EQV|UNK (19XX)|740330|abbbcdef", "ENTRY": "HyattC", "MN": "D23.119.350", "PA": "Coagulants", "EC": "deficiency:Hemophilia A", "MH_TH": "NLM (1966)", "ST": "T129", "N1": "Blood-coagulation factor VIII, complex", "RN": "9001-27-8", "MS": "Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin.", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005169"}, {"RECTYPE": "D", "MH": "Factor X", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stuart-Prower Factor|T116|T123|EPO|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Factor X, Coagulation", "MN": "D23.119.400", "FX": "Coagulants", "EC": "deficiency:Factor X Deficiency", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Blood-coagulation factor X", "RN": "9001-29-0", "AN": "a blood coag factor", "MS": "Storage-stable glycoprotein blood coagulation factor that can be activated to factor Xa by both the intrinsic and extrinsic pathways. A deficiency of factor X, sometimes called Stuart-Prower factor deficiency, may lead to a systemic coagulation disorder.", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005170"}, {"RECTYPE": "D", "MH": "Factor X Deficiency", "DE": "FACTOR X DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ten Deficiencies, Factor", "MN": "C16.320.099.320", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "a blood coag disord", "MS": "Blood coagulation disorder usually inherited as an autosomal recessive trait, though it can be acquired. It is characterized by defective activity in both the intrinsic and extrinsic pathways, impaired thromboplastin time, and impaired prothrombin consumption.", "OL": "search HYPOPROTHROMBINEMIAS 1966-74", "PM": "91; was see under HYPOPROTHROMBINEMIAS 1975-90", "HN": "91(75); was see under HYPOPROTHROMBINEMIAS 1975-90", "CATSH": "CAT LIST", "MR": "20170502", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005171"}, {"RECTYPE": "D", "MH": "Factor XI", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Plasma Thromboplastin Antecedent|T116|T123|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Thromboplastin Antecedent, Plasma", "MN": "D23.119.425", "FX": "Coagulants", "EC": "deficiency:Factor XI Deficiency", "MH_TH": "NLM (1964)", "ST": "T123", "N1": "Blood-coagulation factor XI", "RN": "9013-55-2", "AN": "a blood coag factor", "MS": "Stable blood coagulation factor involved in the intrinsic pathway. The activated form XIa activates factor IX to IXa. Deficiency of factor XI is often called hemophilia C.", "PM": "68", "HN": "68(64)", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005172"}, {"RECTYPE": "D", "MH": "Factor XI Deficiency", "DE": "FACTOR XI DEFIC", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rosenthal Syndrome|T047|NON|EQV|NLM (1999)|OMIM (2013)|ORD (2010)|980316|abcdeeef", "ENTRY": "Syndrome, Rosenthal's", "MN": "C16.320.099.325", "FX": "Factor XI", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a blood coag disord", "MS": "A hereditary deficiency of blood coagulation factor XI (also known as plasma thromboplastin antecedent or PTA or antihemophilic factor C) resulting in a systemic blood-clotting defect called hemophilia C or Rosenthal's syndrome, that may resemble classical hemophilia.", "PM": "1973", "HN": "1973(1966)", "CATSH": "CAT LIST", "MR": "20170502", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005173"}, {"RECTYPE": "D", "MH": "Factor XII", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hageman Factor|T116|T123|EPO|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Factor Twelve|T116|T123|NON|EQV|NLM (2018)|170104|abbcdef", "MN": "D23.119.450", "FX": "Hereditary Angioedema Type III", "EC": "deficiency:Factor XII Deficiency", "MH_TH": "NLM (1964)", "ST": "T123", "N1": "Blood-coagulation factor XII", "RN": "9001-30-3", "MS": "Stable blood coagulation factor activated by contact with the subendothelial surface of an injured vessel. Along with prekallikrein, it serves as the contact factor that initiates the intrinsic pathway of blood coagulation. Kallikrein activates factor XII to XIIa. Deficiency of factor XII, also called the Hageman trait, leads to increased incidence of thromboembolic disease. Mutations in the gene for factor XII that appear to increase factor XII amidolytic activity are associated with HEREDITARY ANGIOEDEMA TYPE III.", "PM": "66", "HN": "66(64)", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005174"}, {"RECTYPE": "D", "MH": "Factor XII Deficiency", "DE": "FACTOR XII DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hageman Trait|T047|EPO|EQV|UNK (19XX)|770426|abcdef", "ENTRY": "Factor XII Deficiencies", "MN": "C16.320.099.330", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a blood coag disord", "PI": "Factor XII (1966-1977)", "MS": "An absence or reduced level of blood coagulation factor XII. It normally occurs in the absence of patient or family history of hemorrhagic disorders and is marked by prolonged clotting time.", "PM": "1978", "HN": "1978", "CATSH": "CAT LIST", "MR": "20170502", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D005175"}, {"RECTYPE": "D", "MH": "Factor XIII", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Laki-Lorand Factor|T116|T123|EPO|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "XIII, Coagulation Factor", "MN": "D23.119.475", "FX": "Coagulants", "EC": "deficiency:Factor XIII Deficiency", "MH_TH": "NLM (1964)", "ST": "T123", "N1": "Blood-coagulation factor XIII", "RN": "9013-56-3", "AN": "activated form use FACTOR XIIIA", "MS": "A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade.", "PM": "1970; for FACTOR XIII TRANSAMIDASE use PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE (1990-2001)", "HN": "1970(1964); for FACTOR XIII TRANSAMIDASE see TRANSGLUTAMINASES (1990-2001)", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005176"}, {"RECTYPE": "D", "MH": "Factor XIII Deficiency", "DE": "FACTOR XIII DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Factor XIII Deficiencies", "MN": "C16.320.099.335", "FX": "Factor XIIIa", "MH_TH": "NLM (1973)", "ST": "T047", "PI": "Hemorrhagic Diathesis (1966-1972)", "MS": "A deficiency of blood coagulation FACTOR XIII or fibrin stabilizing factor (FSF) that prevents blood clot formation and results in a clinical hemorrhagic diathesis.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20170502", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005177"}, {"RECTYPE": "D", "MH": "Faculty", "AQ": "CL ED HI LJ OG PX SN ST", "ENTRY": "University Professors", "MN": "M01.526.702.250", "MH_TH": "POPLINE (1978)", "ST": "T097", "AN": "not for Facult\u00e9 de M\u00e9decine nor Facultad de Medicina (= SCHOOLS, MEDICAL)", "PI": "Teaching (1966-1967)", "MS": "TEACHING and administrative staff having academic rank in a post-secondary educational institution.", "OL": "use FACULTY to search FACULTY, PHARMACY 1968-85", "PM": "68; FACULTY, PHARMACY was heading 1968-85", "HN": "68; FACULTY, PHARMACY was heading 1968-85", "MR": "20160928", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005178"}, {"RECTYPE": "D", "MH": "Faculty, Dental", "DE": "FACULTY DENT", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Faculties, Dental|T097|NON|EQV|NLM (1991)|900105|FACULTIES DENT|abcdefv", "MN": "N02.360.360", "MH_TH": "NLM (1966)", "ST": "T097", "MS": "The teaching staff and members of the administrative staff having academic rank in a dental school.", "PM": "66", "HN": "66", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005179"}, {"RECTYPE": "D", "MH": "Faculty, Medical", "DE": "FACULTY MED", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Medical Faculty|T097|NON|EQV|NLM (1991)|891129|MED FACULTY|abcdefv", "MN": "N02.360.375", "MH_TH": "NLM (1966)", "ST": "T097", "MS": "Teaching and administrative staff having academic rank in a medical school.", "PM": "66", "HN": "66", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005180"}, {"RECTYPE": "D", "MH": "Faculty, Nursing", "DE": "FACULTY NURS", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Nursing Faculty|T097|NON|EQV|NLM (1990)|890502|NURS FACULTY|abcdefv", "ENTRY": "Nursing Faculties|T097|NON|EQV|NLM (1991)|900105|NURS FACULTIES|abcdefv", "MN": "N02.360.390", "MH_TH": "NLM (1966)", "ST": "T097", "MS": "The teaching staff and members of the administrative staff having academic rank in a nursing school.", "PM": "66", "HN": "66", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005181"}, {"RECTYPE": "D", "MH": "Flavin-Adenine Dinucleotide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "FAD|T114|T123|ACR|EQV|NLM (1966)|990101|abbcdef", "ENTRY": "Flavin Adenine Dinucleotide", "MN": "D23.767.405.650.249", "MH_TH": "UNK (19XX)", "ST": "T123", "N1": "Riboflavin 5'-(trihydrogen diphosphate), P'-5'-ester with adenosine", "RN": "146-14-5", "MS": "A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972)", "PM": "2002; see FAD 1963-2001; for FLAVIN-ADENINE DINUCLEOTIDE see FAD 1963-2001", "HN": "2002(1963)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D005182"}, {"RECTYPE": "D", "MH": "Failure to Thrive", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thrive, Failure to", "MN": "C23.888.338", "MH_TH": "NLM (1984)", "ST": "T047", "AN": "permitted with all age groups", "PI": "Growth Disorders (1969-1983)", "MS": "A condition of substandard growth or diminished capacity to maintain normal function.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19830224", "DC": "1", "DX": "19840101", "UI": "D005183"}, {"RECTYPE": "D", "MH": "Fallopian Tube Diseases", "DE": "FALLOPIAN TUBE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tubal Obstructions", "MN": "C12.100.250.056.390", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Fallopian Tubes (1966-1979)", "MS": "Diseases involving the FALLOPIAN TUBES including neoplasms (FALLOPIAN TUBE NEOPLASMS); SALPINGITIS; tubo-ovarian abscess; and blockage.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19790530", "DC": "1", "DX": "19800101", "UI": "D005184"}, {"RECTYPE": "D", "MH": "Fallopian Tube Neoplasms", "DE": "FALLOPIAN TUBE NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasms, Fallopian Tube", "MN": "C12.900.418.365", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with histologic type of neoplasm (IM)", "MS": "Benign or malignant neoplasms of the FALLOPIAN TUBES. They are uncommon. If they develop, they may be located in the wall or within the lumen as a growth attached to the wall by a stalk.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005185"}, {"RECTYPE": "D", "MH": "Fallopian Tube Patency Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Fallopian Tube Patency Test|T060|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Patency Tests, Fallopian Tube|T060|NON|EQV|NLM (1998)|970303|abcdef", "MN": "E05.820.390", "MH_TH": "NLM (1975)", "ST": "T060", "AN": "NIM", "PI": "Infertility, Female/DI (1966-1974)", "MS": "Methods for assessing the patency of the fallopian tubes.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D005186"}, {"RECTYPE": "D", "MH": "Fallopian Tubes", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Uterine Salpinx|T023|NON|EQV|NLM (2021)|191008|abcdef", "ENTRY": "Uterine Tube", "MN": "A13.706.500", "FX": "Sterilization, Tubal", "MH_TH": "NLM (1963)", "ST": "T023", "MS": "A pair of highly specialized canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM transport from the ovaries and they are the site of the ovum's final maturation and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005187"}, {"RECTYPE": "D", "MH": "False Negative Reactions", "ENTRY": "Reactions, False Negative", "MN": "E01.354.340", "MH_TH": "POPLINE (1990)", "ST": "T034", "AN": "usually NIM", "PI": "Diagnosis (1966-1969)", "MS": "Negative test results in subjects who possess the attribute for which the test is conducted. The labeling of diseased persons as healthy when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed)", "PM": "73", "HN": "73(70)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005188"}, {"RECTYPE": "D", "MH": "False Positive Reactions", "ENTRY": "Reactions, False Positive", "MN": "E01.354.506", "MH_TH": "POPLINE (1990)", "ST": "T034", "AN": "usually NIM", "PI": "specific test (1966-1967)", "MS": "Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed)", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005189"}, {"RECTYPE": "D", "MH": "Family", "AQ": "EH HI PX", "PRINT ENTRY": "Family Members|T099|NON|REL|BIOETHICS (1989)|770330|abcdef", "ENTRY": "Research, Family", "MN": "I01.880.853.150", "FX": "Consanguinity", "MH_TH": "NLM (1966)", "ST": "T099", "AN": "entry term FAMILY LIFE CYCLES refers to stages through which the family evolves (e.g., marriage, childbearing & death): do not confuse with LIFE CHANGE EVENTS", "MS": "A social group consisting of parents or parent substitutes and children.", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005190"}, {"RECTYPE": "D", "MH": "Family Characteristics", "AQ": "EH HI", "PRINT ENTRY": "Family Size|T081|T102|NON|NRW|NLM (1978)|781226|abbcdef", "ENTRY": "Survey, Family Life", "MN": "N06.850.505.400.400", "FX": "Social Determinants of Health", "MH_TH": "NLM (1978)", "ST": "T102", "PI": "Family (1966-1967)", "MS": "Size and composition of the family.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005191"}, {"RECTYPE": "D", "MH": "Family Health", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "ENTRY": "Health, Family", "MN": "N01.400.300", "MH_TH": "NLM (1979)", "ST": "T078", "AN": "health status of family as a unit & impact on individual members; /ethnol permitted", "PI": "Health (1966-1978)", "MS": "The health status of the family as a unit including the impact of the health of one member of the family on the family as a unit and on individual family members; also, the impact of family organization or disorganization on the health status of its members.", "PM": "91; was see under FAMILY 1979-90", "HN": "91(79); was see under FAMILY 1979-90", "MR": "20180629", "DA": "19780508", "DC": "1", "DX": "19910101", "UI": "D005192"}, {"RECTYPE": "D", "MH": "Family Planning Services", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Family Planning|T058|NON|EQV|BIOETHICS (1974)|NLM (1968)|990101|abcdeef", "ENTRY": "Services, Family Planning", "MN": "N02.421.800.249", "FX": "Contraception", "MH_TH": "NLM (2004)", "ST": "T058", "AN": "/legis: consider also FAMILY PLANNING POLICY", "MS": "Health care programs or services designed to assist individuals in the planning of family size. Various methods of CONTRACEPTION can be used to control the number and timing of childbirths.", "PM": "2004; see FAMILY PLANNING 1968-2003; for FAMILY PLANNING PROGRAMS see HEALTH PLANNING 1980-2003", "HN": "2004 (1968); for FAMILY PLANNING PROGRAMS use HEALTH PLANNING 1980-2003", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005193"}, {"RECTYPE": "D", "MH": "Family Practice", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Practices, Family", "MN": "H02.403.340.500", "FX": "Physicians, Family", "MH_TH": "BIOETHICS (1990)", "ST": "T091", "MS": "A medical specialty concerned with the provision of continuing, comprehensive primary health care for the entire family.", "PM": "78; was indexed under GENERAL PRACTICE 1969-77; GENERAL PRACTICE was heading 1963-77", "HN": "78; was see under GENERAL PRACTICE 1975-77, was see GENERAL PRACTICE 1969-74; GENERAL PRACTICE was heading 1963-77", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D005194"}, {"RECTYPE": "D", "MH": "Family Relations", "DE": "FAMILY RELAT", "AQ": "EH LJ PX", "PRINT ENTRY": "Family Relationship|T054|NON|EQV|NLM (1989)|961003|abcdef", "ENTRY": "Relationships, Family", "MN": "I01.880.853.150.439", "MH_TH": "NLM (1978)", "ST": "T054", "AN": "general or unspecified; prefer specifics", "PI": "Family (1966-1997)", "MS": "Behavioral, psychological, and social relations among various members of the nuclear family and the extended family.", "PM": "98; for FAMILY RELATIONSHIP see FAMILY 1978-97", "HN": "98; use explode 1978-97; for FAMILY RELATIONSHIP use FAMILY 1978-97", "CATSH": "CAT LIST", "MR": "20180227", "DA": "19770505", "DC": "1", "DX": "19980101", "UI": "D005195"}, {"RECTYPE": "D", "MH": "Family Therapy", "DE": "FAMILY THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapies, Family", "MN": "F04.754.864.581.273", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "A form of group psychotherapy. It involves treatment of more than one member of the family simultaneously in the same session.", "PM": "68", "HN": "68(65)", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005196"}, {"RECTYPE": "D", "MH": "Famous Persons", "ENTRY": "Persons, Famous", "MN": "M01.228", "MH_TH": "BIOETHICS (1989)", "ST": "T098", "MS": "Individuals widely known or recognized.", "MR": "20180308", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005197"}, {"RECTYPE": "D", "MH": "Fanconi Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Renal Fanconi Syndrome|T047|EPO|NRW|NLM (2007)|OMIM (2013)|ORD (2010)|051005|abcdeeef", "ENTRY": "Syndromes, Fanconi-Bickel", "MN": "C16.320.831.450", "FX": "Glucose Transporter Type 2", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "do not confuse with other diseases with \"FANCONI\" as part of the name", "MS": "A hereditary or acquired form of generalized dysfunction of the PROXIMAL KIDNEY TUBULE without primary involvement of the KIDNEY GLOMERULUS. It is usually characterized by the tubular wasting of nutrients and salts (GLUCOSE; AMINO ACIDS; PHOSPHATES; and BICARBONATES) resulting in HYPOKALEMIA; ACIDOSIS; HYPERCALCIURIA; and PROTEINURIA.", "PM": "1965; LIGNAC-FANCONI SYNDROME was LIGNAC-FANCONI DISEASE see METABOLIC DISEASES 1963-1964", "HN": "1965; LIGNAC-FANCONI SYNDROME was LIGNAC-FANCONI DISEASE use METABOLIC DISEASES 1963-1964", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005198"}, {"RECTYPE": "D", "MH": "Fanconi Anemia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anemia, Fanconi|T047|EPO|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Fanconi Anemias", "MN": "C18.452.284.280", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "do not confuse with FANCONI SYNDROME, a dysfunction of proximal renal tubules", "MS": "Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004)", "PM": "2002; see FANCONI'S ANEMIA 1991-2001; was see under ANEMIA, APLASTIC 1975-1990", "HN": "2002(1975); was see under ANEMIA, APLASTIC 1975-1990", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D005199"}, {"RECTYPE": "D", "MH": "FANFT", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "N-4-(5-Nitro-2-furyl)-2-thiazolylformamide|T109|T121|T131|NON|EQV|UNK (19XX)|831014|abbbcdef", "MN": "D03.383.312.649.290", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Formamide, N-(4-(5-nitro-2-furanyl)-2-thiazolyl)-", "RN": "7N99PZG62O", "RR": "24554-26-5 (FANFT)", "PI": "Thiazoles (1970-1974)", "MS": "A potent nitrofuran derivative tumor initiator. It causes bladder tumors in all animals studied and is mutagenic to many bacteria.", "PM": "91; was see under THIAZOLES 1975-90", "HN": "91(75); was see under THIAZOLES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005200"}, {"RECTYPE": "D", "MH": "Fantasy", "PRINT ENTRY": "Day Dreams|T041|NON|NRW|UNK (19XX)|780426|abcdef", "ENTRY": "Fantasies", "MN": "F02.463.188.634.507", "MH_TH": "NLM (1968)", "ST": "T041", "PI": "Imagination (1966-1967)", "MS": "An imagined sequence of events or mental images, e.g., daydreams.", "OL": "use FANTASY to search DAY DREAMS 1968-78", "PM": "68", "HN": "68; DAY DREAMS was see under FANTASY 1968-78", "CATSH": "CAT LIST", "MR": "19910611", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005201"}, {"RECTYPE": "D", "MH": "Asia, Eastern", "AQ": "EH EP", "PRINT ENTRY": "Far East|T083|NAM|EQV|NLM (1963)|990101|abcdef", "ENTRY": "Eastern Asia|T083|NAM|EQV|POPLINE (1983)|911109|abcdef", "MN": "Z01.252.474", "MH_TH": "NLM (2023)", "ST": "T083", "AN": "a geog area of east & southeast Asia; prefer specific countries", "MS": "A geographic area of east and southeast Asia encompassing CHINA; HONG KONG; JAPAN; KOREA; MACAO; MONGOLIA; and TAIWAN.", "HN": "2023(1967)", "MR": "20220708", "DA": "19750619", "DC": "4", "DX": "19630101", "UI": "D005202"}, {"RECTYPE": "D", "MH": "Farmer's Lung", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mushroom Worker's Lung|T047|NON|NRW|NLM (2009)|070918|abcdef", "ENTRY": "Mushroom Workers Lung", "MN": "C24.080.365", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "A form of alveolitis or pneumonitis due to an acquired hypersensitivity to inhaled antigens associated with farm environment. Antigens in the farm dust are commonly from bacteria actinomycetes (SACCHAROPOLYSPORA and THERMOACTINOMYCES), fungi, and animal proteins in the soil, straw, crops, pelts, serum, and excreta.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005203"}, {"RECTYPE": "D", "MH": "Farnesol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D10.289.400", "MH_TH": "NLM (1965)", "ST": "T121", "N1": "2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-", "RN": "4602-84-0", "MS": "A colorless liquid extracted from oils of plants such as citronella, neroli, cyclamen, and tuberose. It is an intermediate step in the biological synthesis of cholesterol from mevalonic acid in vertebrates. It has a delicate odor and is used in perfumery. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "OL": "use FARNESOL to search FARNESYL COMPOUNDS 1966-67 (as Prov)", "PM": "68", "HN": "68; was FARNESYL COMPOUNDS 1965-67 (Prov)", "MR": "20040727", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005204"}, {"RECTYPE": "D", "MH": "Fascia", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE TR UL VI", "MN": "A10.165.425", "FX": "Fasciotomy", "EC": "surgery:Fasciotomy", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "Layers of connective tissue of variable thickness. The superficial fascia is found immediately below the skin; the deep fascia invests MUSCLES, nerves, and other organs.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005205"}, {"RECTYPE": "D", "MH": "Fascia Lata", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Latas, Fascia", "MN": "A10.165.425.500", "MH_TH": "NLM (1972)", "ST": "T024", "PI": "Thigh (1966-1971)", "MS": "CONNECTIVE TISSUE of the anterior compartment of the THIGH that has its origins on the anterior aspect of the iliac crest and anterior superior iliac spine, and its insertion point on the iliotibial tract. It plays a role in medial rotation of the THIGH, steadying the trunk, and in KNEE extension.", "PM": "91; was see under FASCIA 1972-90", "HN": "91(72); was see under FASCIA 1972-90", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005206"}, {"RECTYPE": "D", "MH": "Fasciculation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tongue Fasciculations", "MN": "C23.888.592.608.250", "MH_TH": "NLM (1979)", "ST": "T184", "AN": "note category: do not confuse with AXON FASCICULATION", "MS": "Involuntary contraction of the muscle fibers innervated by a motor unit. Fasciculations may be visualized as a muscle twitch or dimpling under the skin, but usually do not generate sufficient force to move a limb. They may represent a benign condition or occur as a manifestation of MOTOR NEURON DISEASE or PERIPHERAL NERVOUS SYSTEM DISEASES. (Adams et al., Principles of Neurology, 6th ed, p1294)", "PM": "1987; see NEUROLOGIC MANIFESTATIONS 1982-86, see MOVEMENT DISORDERS 1979-81", "HN": "1987(1979)", "CATSH": "CAT LIST", "MR": "20160616", "DA": "19780522", "DC": "1", "DX": "19870101", "UI": "D005207"}, {"RECTYPE": "D", "MH": "Fasciitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fascitides", "MN": "C05.321", "MH_TH": "NLM (1981)", "ST": "T184", "AN": "see MeSH definition for major types; eosinophilic fasciitis: coord IM with EOSINOPHILIA (IM); FASCIITIS, NECROTIZING is available", "PI": "Necrosis (1966-1980)", "MS": "Inflammation of the fascia. There are three major types: 1, Eosinophilic fasciitis, an inflammatory reaction with eosinophilia, producing hard thickened skin with an orange-peel configuration suggestive of scleroderma and considered by some a variant of scleroderma; 2, Necrotizing fasciitis (FASCIITIS, NECROTIZING), a serious fulminating infection (usually by a beta hemolytic streptococcus) causing extensive necrosis of superficial fascia; 3, Nodular/Pseudosarcomatous /Proliferative fasciitis, characterized by a rapid growth of fibroblasts with mononuclear inflammatory cells and proliferating capillaries in soft tissue, often the forearm; it is not malignant but is sometimes mistaken for fibrosarcoma.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19800409", "DC": "1", "DX": "19810101", "UI": "D005208"}, {"RECTYPE": "D", "MH": "Fasciola", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Fasciolas", "MN": "B01.050.500.500.736.715.408.380", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6191", "MS": "A genus of trematode liver flukes of the family Fasciolidae. Two species of this genus are F. hepatica and F. gigantica. The parasites are found in the liver and gallbladder and associated ducts in mammals and occasionally man. F. gigantica occurs rarely in man.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005209"}, {"RECTYPE": "D", "MH": "Fasciola hepatica", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Liver Fluke|T204|NON|EQV|NLM (1991)|900330|abcdef", "ENTRY": "hepatica, Fasciola", "MN": "B01.050.500.500.736.715.408.380.420", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6192", "MS": "A species of helminth commonly called the sheep liver fluke. It occurs in the biliary passages, liver, and gallbladder during various stages of development. Snails and aquatic vegetation are the intermediate hosts. Occasionally seen in man, it is most common in sheep and cattle.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005210"}, {"RECTYPE": "D", "MH": "Fascioliasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Fasciola", "MN": "C06.552.664.424", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent; do not confuse with FASCIOLOIDIASIS (caused by Fascioloides) or FASCIOLOPSIASIS (caused by Fasciolopsis)", "MS": "Liver disease caused by infections with parasitic flukes of the genus FASCIOLA, such as FASCIOLA HEPATICA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005211"}, {"RECTYPE": "D", "MH": "Fasciolidae", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Fasciolopsis|T204|NON|NRW|UNK (19XX)|810515|abcdef", "ENTRY": "Fasciolopses", "MN": "B01.050.500.500.736.715.408", "MH_TH": "NLM (1982)", "ST": "T204", "RN": "txid27843", "RR": "txid394414", "AN": "a family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM) but note specific FASCIOL- disease terms; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Trematoda (1966-1981)", "MS": "A family of flukes of the class Trematoda occurring primarily in the liver of animals and man. There are six genera: Fasciola, Fasciolopsis, Fascioloides, Tenuifasciola, Parafasciolopsis, and Protofasciola. The adult form of Fasciolopsis occurs in the intestines of pigs and man.", "OL": "use FASCIOLIDAE to search FASCIOLOPSIS 1966-80", "PM": "82; FASCIOLOPSIS was heading 1963-81", "HN": "82; FASCIOLOPSIS was heading 1963-81", "MR": "20200813", "DA": "19810515", "DC": "1", "DX": "19820101", "UI": "D005212"}, {"RECTYPE": "D", "MH": "Fascioloidiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Fascioloidiases", "MN": "C22.674.377.444", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "trematode infect; usually animal; check tag ANIMALS; caused by FASCIOLOIDES; do not confuse with FASCIOLIASIS (caused by FASCIOLA) or FASCIOLOPSIASIS (caused by FASCIOLOPSIS)", "PI": "Trematode Infections (1966-1967)", "MS": "Infection of cattle and other herbivores with the giant liver fluke Fascioloides magna. It is characterized by extensive destruction of the liver parenchyma.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005213"}, {"RECTYPE": "D", "MH": "Fast Neutrons", "AQ": "AE CL HI TU", "ENTRY": "Neutrons, Fast", "MN": "G01.249.660.250.368", "MH_TH": "NLM (1971)", "ST": "T081", "AN": "elementary particles; IM", "PI": "Neutrons (1966-1970)", "MS": "Neutrons, the energy of which exceeds some arbitrary level, usually around one million electron volts.", "PM": "91; was see under NEUTRONS 1971-90", "HN": "91(71); was see under NEUTRONS 1971-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005214"}, {"RECTYPE": "D", "MH": "Fasting", "AQ": "AE BL CF ME PH PX UR", "ENTRY": "Strikes, Hunger", "MN": "G07.203.650.353.400", "FX": "Starvation", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "human & animal; differs from STARVATION in matter of degree; FOOD DEPRIVATION is also available", "MS": "Abstaining from FOOD.", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005215"}, {"RECTYPE": "D", "MH": "Fat Body", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Insect Fat Body|T023|NON|NRW|NLM (2022)|210621|abcdef", "ENTRY": "Insect Fat Bodies", "MN": "A13.365", "MH_TH": "NLM (1980)", "ST": "T023", "AN": "in AMPHIBIANS & insects", "PI": "Adipose Tissue (1966-1979)", "MS": "A nutritional reservoir of fatty tissue found mainly in INSECTS and AMPHIBIANS.", "PM": "1989; was see under ADIPOSE TISSUE 1980-1988", "HN": "89(80); was see under ADIPOSE TISSUE 1980-88", "MR": "20210628", "DA": "19790524", "DC": "1", "DX": "19890101", "UI": "D005216"}, {"RECTYPE": "D", "MH": "Fat Emulsions, Intravenous", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Lipid Emulsions, Intravenous|T109|T121|NON|EQV|UNK (19XX)|771209|abbcdef", "ENTRY": "Lipid Emulsion, Intravenous", "MN": "D27.720.752.733.500", "MH_TH": "NLM (1979)", "ST": "T121", "RN": "0", "AN": "coordinate with disease /ther", "PI": "Oils (1966-1978)", "MS": "Emulsions of fats or lipids used primarily in parenteral feeding.", "PM": "79", "HN": "79", "MR": "20200527", "DA": "19771209", "DC": "1", "DX": "19790101", "UI": "D005217"}, {"RECTYPE": "D", "MH": "Fat Necrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Steatonecrosis|T033|T046|NON|EQV|UNK (19XX)|760426|abbcdef", "ENTRY": "Steatonecroses", "MN": "C23.550.717.365", "MH_TH": "NLM (1977)", "ST": "T046", "PI": "Necrosis (1966-1976)", "MS": "A condition in which the death of adipose tissue results in neutral fats being split into fatty acids and glycerol.", "PM": "91; was see under NECROSIS 1977-90", "HN": "91(77); was see under NECROSIS 1977-90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D005218"}, {"RECTYPE": "D", "MH": "Father-Child Relations", "DE": "FATHER CHILD RELAT", "AQ": "EH", "ENTRY": "Relationships, Father-Child", "MN": "F01.829.263.370.290.110", "MH_TH": "NLM (1968)", "ST": "T054", "AN": "human only", "PI": "Parent-Child Relations (1966-1967)", "MS": "Interaction between the father and the child.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005219"}, {"RECTYPE": "D", "MH": "Fathers", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Father", "MN": "M01.620.390", "MH_TH": "POPLINE (1981)", "ST": "T099", "AN": "human & animal; /psychol: consider also FATHER-CHILD RELATIONS", "PI": "Paternal Behavior (1969-1977)", "MS": "Male parents, human or animal.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D005220"}, {"RECTYPE": "D", "MH": "Fatigue", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lassitude|T184|NON|REL|UNK (19XX)|770127|abcdef", "MN": "C23.888.369", "FX": "Asthenia", "MH_TH": "POPLINE (1978)", "ST": "T184", "MS": "The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005221"}, {"RECTYPE": "D", "MH": "Mental Fatigue", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Mental Fog|T041|T184|NON|EQV|NLM (2023)|210930|abbcdef", "ENTRY": "Weariness, Cognitive", "MN": "F01.145.126.937", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A condition of low alertness or cognitive impairment, usually associated with prolonged mental activities or stress.", "OL": "use MENTAL FATIGUE to search FATIGUE, MENTAL 1966-94", "PM": "95; was FATIGUE, MENTAL 1963-94", "HN": "95; was FATIGUE, MENTAL 1963-94", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19950101", "UI": "D005222"}, {"RECTYPE": "D", "MH": "Fats", "AQ": "AD AE AG AI AN CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU", "MN": "D10.212", "MH_TH": "POPLINE (1993)", "ST": "T109", "RN": "0", "AN": "differentiate from LIPIDS; DIETARY FATS and BODY FAT see ADIPOSE TISSUE are also available", "MS": "The glyceryl esters of a fatty acid, or of a mixture of fatty acids. They are generally odorless, colorless, and tasteless if pure, but they may be flavored according to origin. Fats are insoluble in water, soluble in most organic solvents. They occur in animal and vegetable tissue and are generally obtained by boiling or by extraction under pressure. They are important in the diet (DIETARY FATS) as a source of energy. (Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "/metabolism was FAT METABOLISM see under LIPID METABOLISM 1963-65", "HN": "/metabolism was FAT METABOLISM see under LIPID METABOLISM 1963-65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D005223"}, {"RECTYPE": "D", "MH": "Fats, Unsaturated", "AQ": "AD AE AG AI AN CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Unsaturated Oils|T109|NON|NRW|UNK (19XX)|860603|abcdef", "ENTRY": "Fat, Unsaturated", "MN": "D10.212.507", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Fats containing one or more double bonds, as from oleic acid, an unsaturated fatty acid.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005224"}, {"RECTYPE": "D", "MH": "Fatty Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Saturated Fatty Acid|T109|NON|NRW|NLM (2021)|191115|abcdef", "ENTRY": "Saturated Fatty Acids", "MN": "D10.251", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "/metabolism was FATTY ACID METABOLISM 1965; SODIUM MORRHUATE was see under SCLEROSING SOLUTIONS 1963-74", "HN": "/metabolism was FATTY ACID METABOLISM 1965", "MR": "20200114", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D005227"}, {"RECTYPE": "D", "MH": "Fatty Acids, Essential", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Essential Fatty Acids", "MN": "D10.251.355.310", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specific groups or specific acid", "MS": "Long chain organic acid molecules that must be obtained from the diet. Examples are LINOLEIC ACIDS and LINOLENIC ACIDS.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005228"}, {"RECTYPE": "D", "MH": "Fatty Acids, Monounsaturated", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Monounsaturated Fatty Acid|T109|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Monounsaturated Fatty Acids", "MN": "D10.251.355.325", "MH_TH": "NLM (1988)", "ST": "T109", "RN": "0", "PI": "Fatty Acids, Unsaturated (1973-1987)", "MS": "Fatty acids which are unsaturated in only one position.", "OL": "use FATTY ACIDS, MONOUNSATURATED to search MONOUNSATURATED FATTY ACIDS 1988-93", "PM": "88; MONOUNSATURATED FATTY ACIDS was see FATTY ACIDS, MONOUNSATURATED 1988-93", "HN": "88; MONOUNSATURATED FATTY ACIDS was see FATTY ACIDS, MONOUNSATURATED 1988-93", "MR": "20200527", "DA": "19870331", "DC": "1", "DX": "19880101", "UI": "D005229"}, {"RECTYPE": "D", "MH": "Fatty Acids, Nonesterified", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "NEFA|T109|ABB|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Nonesterified Fatty Acids", "MN": "D10.251.310", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form.", "PM": "68", "HN": "68(66)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005230"}, {"RECTYPE": "D", "MH": "Fatty Acids, Unsaturated", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Unsaturated Fatty Acid|T109|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Unsaturated Fatty Acids", "MN": "D10.251.355", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specific groups or specific acid", "PI": "Fatty Acids, Essential (1966-1972)", "MS": "FATTY ACIDS in which the carbon chain contains one or more double or triple carbon-carbon bonds.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005231"}, {"RECTYPE": "D", "MH": "Fatty Acids, Volatile", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Volatile Fatty Acid|T109|T123|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Volatile Fatty Acids", "MN": "D10.251.400", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specific groups or specific acid", "PI": "Fatty Acids (1966-1972)", "MS": "Short-chain fatty acids of up to six carbon atoms in length. They are the major end products of microbial fermentation in the ruminant digestive tract and have also been implicated in the causation of neurological diseases in humans.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005232"}, {"RECTYPE": "D", "MH": "Fatty Alcohols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fatty Alcohol|T109|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Alcohols, Fatty", "MN": "D10.289", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Alcohols (1966-1971)", "MS": "Usually high-molecular-weight, straight-chain primary alcohols, but can also range from as few as 4 carbons, derived from natural fats and oils, including lauryl, stearyl, oleyl, and linoleyl alcohols. They are used in pharmaceuticals, cosmetics, detergents, plastics, and lube oils and in textile manufacture. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "PM": "72; SODIUM TETRADECYL SULFATE was SODIUM TETRADECYL SULFATES see under SCLEROSING SOLUTIONS 1963-74", "HN": "72", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D005233"}, {"RECTYPE": "D", "MH": "Fatty Liver", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Visceral Steatoses", "MN": "C06.552.241", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005234"}, {"RECTYPE": "D", "MH": "Fatty Liver, Alcoholic", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Alcoholic Fatty Liver|T047|NON|EQV|UNK (19XX)|770418|abcdef", "ENTRY": "Alcoholic Steatohepatitis|T047|NON|NRW|NLM (2010)|090310|abcdef", "MN": "C25.775.100.087.645.390", "MH_TH": "NLM (1978)", "ST": "T047", "PI": "Fatty Liver (1966-1977)", "MS": "Lipid infiltration of the hepatic parenchymal cells that is due to ALCOHOL ABUSE. The fatty changes in the alcoholic fatty liver may be reversible, depending on the amounts of TRIGLYCERIDES accumulated.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D005235"}, {"RECTYPE": "D", "MH": "Favism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Favisms", "MN": "C25.723.756.375", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a hemolytic anemia caused by fava bean or its pollen", "MS": "Hemolytic anemia due to the ingestion of fava beans or after inhalation of pollen from the Vicia fava plant by persons with glucose-6-phosphate dehydrogenase deficient erythrocytes.", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005236"}, {"RECTYPE": "D", "MH": "Fear", "AQ": "CL DE ES PH PX RE", "PRINT ENTRY": "Threat Sensitivity|T041|NON|NRW|NLM (2024)|230420|abcdef", "ENTRY": "Threat Sensitivities", "MN": "F01.470.361", "FX": "Phobic Disorders", "MH_TH": "POPLINE (1993)", "ST": "T041", "AN": "human & animal", "MS": "The affective response to an actual current external danger which subsides with the elimination of the threatening condition.", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005239"}, {"RECTYPE": "D", "MH": "Feasibility Studies", "ENTRY": "Study, Feasibility", "MN": "N06.850.520.450.550", "MH_TH": "NLM (1980)", "ST": "T170", "AN": "IM general only; coordinate NIM with specific subject (IM)", "MS": "Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19790531", "DC": "1", "DX": "19800101", "UI": "D005240"}, {"RECTYPE": "D", "MH": "Feathers", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Feather", "MN": "A13.370", "MH_TH": "NLM (1963)", "ST": "T023", "MS": "Flat keratinous structures found on the skin surface of birds. Feathers are made partly of a hollow shaft fringed with barbs. They constitute the plumage.", "PM": "66", "HN": "66(63)", "MR": "20170711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005241"}, {"RECTYPE": "D", "MH": "Fecal Incontinence", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Soilings, Fecal", "MN": "C06.405.469.860.300", "FX": "Encopresis", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "of organic origin: differentiate from ENCOPRESIS, of psychological origin", "MS": "Failure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus.", "PM": "70", "HN": "70(66)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005242"}, {"RECTYPE": "D", "MH": "Feces", "AQ": "CH CY EN MI PS VI", "MN": "A12.459", "FX": "Melena", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "/parasitol: often coord with PARASITE EGG COUNT; consider also DEFECATION; CONSTIPATION; DIARRHEA; FECAL IMPACTION & FECAL INCONTINENCE; fecalith: index FECAL IMPACTION; fecal blood: index under OCCULT BLOOD & not also here", "MS": "Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.", "MR": "20030725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005243"}, {"RECTYPE": "D", "MH": "Fecal Impaction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fecalith|T031|NON|REL|NLM (1998)|960723|abcdef", "ENTRY": "Impaction, Fecal", "MN": "C06.405.469.531.424", "MH_TH": "NLM (2004)", "ST": "T201", "MS": "Formation of a firm impassable mass of stool in the RECTUM or distal COLON.", "PM": "2004; see FECES, IMPACTED 1964-2003", "HN": "2004 (1964)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D005244"}, {"RECTYPE": "D", "MH": "Fee Schedules", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Schedules, Fee", "MN": "N04.452.313", "FX": "Fees and Charges", "MH_TH": "NLM (1968)", "ST": "T081", "PI": "Economics (1966-1967)", "MS": "A listing of established professional service charges, for specified dental and medical procedures.", "PM": "68", "HN": "68", "MR": "19940505", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005245"}, {"RECTYPE": "D", "MH": "Feedback", "AQ": "DE RE", "ENTRY": "Feedbacks", "MN": "L01.906.394.211", "FX": "Knowledge of Results, Psychological", "MH_TH": "NLM (1978)", "ST": "T067", "AN": "general; prefer specifics", "MS": "A mechanism of communication within a system in that the input signal generates an output response which returns to influence the continued activity or productivity of that system.", "PM": "1965", "HN": "1965", "CATSH": "CAT LIST", "MR": "20190711", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005246"}, {"RECTYPE": "D", "MH": "Feeding Behavior", "AQ": "CL DE EH ES PH PX RE", "PRINT ENTRY": "Food Habits|T055|NON|NRW|NLM (1969)|OBSSR (2021)|990101|abcdeef", "ENTRY": "Restrictions, Faith-based Dietary", "MN": "G07.203.650.353", "MH_TH": "OBSSR (2021)", "ST": "T055", "PI": "Nutrition (1966-1968)", "MS": "Behavioral responses or sequences associated with eating including modes of feeding, rhythmic patterns of eating, and time intervals.", "PM": "1969; for FOOD HABITS see FOOD HABITS 1969-2016", "HN": "1969", "CATSH": "CAT LIST", "MR": "20230219", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D005247"}, {"RECTYPE": "D", "MH": "Feeding Methods", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Methods, Feeding", "MN": "E02.421", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "human and animal; general or unspecified; prefer specifics", "MS": "Methods of giving food to humans or animals.", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D005248"}, {"RECTYPE": "D", "MH": "Fees and Charges", "DE": "FEES CHARGES", "AQ": "CL ES HI LJ SN ST TD", "PRINT ENTRY": "Charges|T081|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Fee", "MN": "N03.219.442", "FX": "Rate Setting and Review", "MH_TH": "NLM (1968)", "ST": "T081", "PI": "Economics (1966-1967)", "MS": "Amounts charged to the patient as payer for health care services.", "PM": "68", "HN": "68", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005249"}, {"RECTYPE": "D", "MH": "Fees, Dental", "DE": "FEES DENT", "AQ": "CL ES HI LJ SN ST TD", "ENTRY": "Fee, Dental|T081|NON|EQV|NLM (1991)|900105|FEE DENT|abcdefv", "MN": "N03.219.442.301", "MH_TH": "NLM (1968)", "ST": "T081", "PI": "Economics, Dental (1966-1967)", "MS": "Amounts charged to the patient as payer for dental services.", "PM": "68", "HN": "68", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005250"}, {"RECTYPE": "D", "MH": "Fees, Medical", "DE": "FEES MED", "AQ": "CL ES HI LJ SN ST TD", "ENTRY": "Medical Fees|T081|NON|EQV|BIOETHICS (1974)|770317|MED FEES|abcdefv", "MN": "N03.219.442.426", "FX": "Relative Value Scales", "MH_TH": "NLM (1968)", "ST": "T081", "PI": "Economics, Medical (1966-1967)", "MS": "Amounts charged to the patient as payer for medical services.", "PM": "68", "HN": "68", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005251"}, {"RECTYPE": "D", "MH": "Fees, Pharmaceutical", "DE": "FEES PHARM", "AQ": "CL ES HI LJ SN ST TD", "ENTRY": "Pharmacy Fees", "MN": "N03.219.442.551", "MH_TH": "NLM (1968)", "ST": "T081", "AN": "costs to the patient or third-party payer: do not confuse with DRUG COSTS which are costs to a health facility or organization", "PI": "Prescriptions (1966-1967)", "MS": "Amounts charged to the patient or third-party payer for medication. It includes the pharmacist's professional fee and cost of ingredients, containers, etc.", "PM": "68", "HN": "68", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005252"}, {"RECTYPE": "D", "MH": "Sarcoma Viruses, Feline", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Snyder-Theilen feline sarcoma virus|T005|EPO|NRW|NLM (2002)|010503|abcdef", "ENTRY": "Snyder Theilen feline sarcoma virus", "MN": "B04.820.650.375.800", "MH_TH": "NLM (2002)", "ST": "T005", "AN": "infection: coordinate IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM); add SARCOMA, EXPERIMENTAL (IM), SARCOMA (IM), or FIBROSARCOMA (IM) if pertinent; DF: FESV", "PI": "Vertebrate Viruses, Unclassified (1970-1974)", "MS": "Species of GAMMARETROVIRUS isolated from fibrosarcoma in cats. The viruses are actually recombinant feline leukemia viruses (FeLV) where part of the genome has been replaced by cellular oncogenes. It is unique to individuals and not transmitted naturally to other cats. FeSVs are replication defective and require FeLV to reproduce.", "PM": "2002; see SARCOMA VIRUS, FELINE 1994-2001, see FELINE FIBROSARCOMA VIRUS 1991-1993, see RETROVIRIDAE 1981-1990, see LEUKOVIRUSES 1978-1980, see LEUKEMOGENIC VIRUSES 1975-1977", "HN": "2002 (1975)", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D005253"}, {"RECTYPE": "D", "MH": "Feline Panleukopenia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Show Fever|T047|NON|EQV|NLM (1998)|970106|abcdef", "ENTRY": "Show Fevers", "MN": "C22.180.460", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "don't forget also CATS (NIM) & check tag ANIMALS", "PI": "Virus Diseases (1966-1969)", "MS": "A highly contagious DNA virus infection of the cat family, characterized by fever, enteritis and bone marrow changes. It is also called feline ataxia, feline agranulocytosis, feline infectious enteritis, cat fever, cat plague, and show fever. It is caused by FELINE PANLEUKOPENIA VIRUS or the closely related MINK ENTERITIS VIRUS or CANINE PARVOVIRUS.", "PM": "97; was FELINE INFECTIOUS ENTERITIS 1970-96", "HN": "97; was FELINE INFECTIOUS ENTERITIS 1970-96", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005254"}, {"RECTYPE": "D", "MH": "Leukemia Virus, Feline", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Feline Lymphoma Virus|T005|NON|EQV|UNK (19XX)|741127|abcdef", "ENTRY": "Lymphoma Viruses, Feline", "MN": "B04.820.650.375.500", "FX": "Sarcoma Viruses, Feline", "MH_TH": "NLM (1973)", "ST": "T005", "RN": "txid11768", "AN": "infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) or if so specified by author index instead under LEUKEMIA, FELINE (IM but see note there) or FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME (IM but see note there)", "PI": "Retroviridae (1966-1972)", "MS": "A species of GAMMARETROVIRUS causing leukemia, lymphosarcoma, immune deficiency, or other degenerative diseases in cats. Several cellular oncogenes confer on FeLV the ability to induce sarcomas (see also SARCOMA VIRUSES, FELINE).", "OL": "use LEUKEMIA VIRUS, FELINE to search FELINE LEUKEMIA VIRUS 1973-93", "PM": "94; was FELINE LEUKEMIA VIRUS 1973-93", "HN": "94; was FELINE LEUKEMIA VIRUS 1973-93", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005256"}, {"RECTYPE": "D", "MH": "Fellowships and Scholarships", "DE": "FELLOWSHIPS SCHOLARSHIPS", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Scholarships|T078|NON|NRW|UNK (19XX)|780508|abcdef", "ENTRY": "Scholarships and Fellowships", "MN": "N03.219.483.838.276", "MH_TH": "NLM (1975)", "ST": "T065", "AN": "specify agency if possible", "PI": "Training Support (1966-1974)", "MS": "Stipends or grants-in-aid granted by foundations or institutions to individuals for study.", "OL": "to search SCHOLARSHIPS & FELLOWSHIPS use FELLOWSHIPS AND SCHOLARSHIPS 1975-78 & TRAINING SUPPORT 1966-74", "PM": "79; was SCHOLARSHIPS AND FELLOWSHIPS 1963-65; FELLOWSHIPS & SCHOLARSHIPS were see under TRAINING SUPPORT 1966-78", "HN": "79; was SCHOLARSHIPS AND FELLOWSHIPS 1963-65; FELLOWSHIPS & SCHOLARSHIPS were see under TRAINING SUPPORT 1966-78", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D005257"}, {"RECTYPE": "D", "MH": "Felty Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Felty's Syndrome|T047|EPO|EQV|NLM (1966)|ORD (2010)|990101|abcdeef", "ENTRY": "Syndrome, Felty's", "MN": "C20.111.199.389", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "a type of rheum arthritis", "MS": "A rare complication of rheumatoid arthritis with autoimmune NEUTROPENIA; and SPLENOMEGALY.", "PM": "2013; see Reproductive Medicine 1995-2011", "HN": "2013(1966)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "20130101", "UI": "D005258"}, {"RECTYPE": "D", "MH": "Felypressin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vasopressin, Phenylalanyl-Lysyl|T116|T121|NON|EQV|UNK (19XX)|820429|abbcdef", "ENTRY": "Vasopressin, Phenylalanyl Lysyl", "MN": "D12.776.631.650.937.400.350", "PA": "Vasoconstrictor Agents", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "Vasopressin, 2-L-phenylalanine-8-L-lysine-", "RN": "56-59-7", "MS": "A synthetic analog of LYPRESSIN with a PHENYLALANINE substitution at residue 2. Felypressin is a vasoconstrictor with reduced antidiuretic activity.", "OL": "use FELYPRESSIN to search PHELYPRESSIN 1966-78", "PM": "91; was see under LYPRESSIN 1979-90; was PHELYPRESSIN see under VASOPRESSIN 1975-78", "HN": "91(79); was see under LYPRESSIN 1979-90; was PHELYPRESSIN see under VASOPRESSIN 1965-78 (Prov 1965-74)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005259"}, {"RECTYPE": "D", "MH": "Female", "ENTRY": "Females|T032|NON|EQV|BIOETHICS (1974)|770317|abcdef", "MH_TH": "NLM (1966)", "ST": "T032", "AN": "check tag only for female organs, diseases, physiologic processes, genetics, etc.; do not confuse with WOMEN as a social, cultural, political, economic force; CATALOGER: Do not use", "HN": "1966; for FEMALES use WOMEN 1978-2005", "MR": "20150610", "DA": "19990101", "DC": "3", "DX": "19660101", "UI": "D005260"}, {"RECTYPE": "D", "MH": "Female Urogenital Diseases and Pregnancy Complications", "DE": "FEMALE UROGENITAL DIS PREGNANCY COMPL", "MN": "C12.050", "RH": "C13 - DISEASES-FEMALE UROGENITAL AND PREGNANCY COMPLICATIONS", "MH_TH": "NLM (2007)", "ST": "T047", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Pathological processes of the female URINARY TRACT, the reproductive system (GENITALIA, FEMALE), and disorders related to PREGNANCY.", "PM": "2007; see FEMALE GENITAL DISEASES AND PREGNANCY COMPLICATIONS 1998-2006", "HN": "2007 (1998)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D005261"}, {"RECTYPE": "D", "MH": "Feminization", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Feminizations", "MN": "C23.888.378", "MH_TH": "NLM (1967)", "ST": "T047", "AN": "check the tag MALE", "PI": "Sex Characteristics (1966)", "MS": "Development of female secondary SEX CHARACTERISTICS in the MALE. It is due to the effects of estrogenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs.", "PM": "72", "HN": "72(67)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D005262"}, {"RECTYPE": "D", "MH": "Femoral Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Common Femoral Artery|T023|NON|NRW|NLM (2020)|190424|abcdef", "ENTRY": "Femoral Artery, Common", "MN": "A07.015.114.351", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The main artery of the thigh, a continuation of the external iliac artery.", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005263"}, {"RECTYPE": "D", "MH": "Femoral Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fractures, Femoral", "MN": "C26.558.276", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "of femoral shaft only; see X refs & note at HIP FRACTURES", "MS": "Fractures of the femur.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005264"}, {"RECTYPE": "D", "MH": "Femoral Neck Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Femur Neck Fracture", "MN": "C26.558.276.425.500", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Fractures of the short, constricted portion of the thigh bone between the femur head and the trochanters. It excludes intertrochanteric fractures which are HIP FRACTURES.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005265"}, {"RECTYPE": "D", "MH": "Femoral Neoplasms", "DE": "FEMORAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasms, Femoral", "MN": "C05.116.231.343", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with FEMUR HEAD or FEMUR NECK + histological type of neoplasm", "MS": "New abnormal growth of tissue in the FEMUR.", "CATSH": "CAT LIST", "MR": "20151209", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005266"}, {"RECTYPE": "D", "MH": "Femoral Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nerves, Femoral", "MN": "A08.800.800.720.450.250", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A nerve originating in the lumbar spinal cord (usually L2 to L4) and traveling through the lumbar plexus to provide motor innervation to extensors of the thigh and sensory innervation to parts of the thigh, lower leg, and foot, and to the hip and knee joints.", "MR": "19991105", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005267"}, {"RECTYPE": "D", "MH": "Femoral Vein", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Femoral", "MN": "A07.015.908.314", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005268"}, {"RECTYPE": "D", "MH": "Femur", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Trochanter|T023|NON|REL|NLM (1993)|911002|abcdef", "ENTRY": "Trochanters, Lesser", "MN": "A02.835.232.043.150", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "fractures: FEMORAL FRACTURES & FEMORAL NECK FRACTURES are available but see note under HIP FRACTURES", "MS": "The longest and largest bone of the skeleton, it is situated between the hip and the knee.", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005269"}, {"RECTYPE": "D", "MH": "Femur Head", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Femoral Head|T023|NON|EQV|NLM (2021)|200220|abcdef", "ENTRY": "Head, Femur", "MN": "A02.835.232.043.150.343", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The hemispheric articular surface at the upper extremity of the thigh bone. (Stedman, 26th ed)", "MR": "20200221", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005270"}, {"RECTYPE": "D", "MH": "Femur Head Necrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Necrosis, Avascular, of Femur Head|T046|NON|NRW|NLM (1998)|960807|abcdef", "ENTRY": "Necrosis, Femur Head", "MN": "C23.550.717.732.368", "MH_TH": "NLM (1973)", "ST": "T047", "PI": "Necrosis (1966-1972)", "MS": "Aseptic or avascular necrosis of the femoral head. The major types are idiopathic (primary), as a complication of fractures or dislocations, and LEGG-CALVE-PERTHES DISEASE.", "PM": "73; LEGG-PERTHES DISEASE was see under OSTEOCHONDRITIS 1963-78", "HN": "73", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005271"}, {"RECTYPE": "D", "MH": "Femur Neck", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Femoral Neck|T029|NON|EQV|NLM (2008)|061114|abcdef", "ENTRY": "Neck, Femur", "MN": "A02.835.232.043.150.510", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "The constricted portion of the thigh bone between the femur head and the trochanters.", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005272"}, {"RECTYPE": "D", "MH": "Fenbendazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phenbendasol|T109|T121|NON|EQV|NLM (1996)|950403|abbcdef", "MN": "D03.633.100.103.450", "PA": "Antinematodal Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Carbamic acid, (5-(phenylthio)-1H-benzimidazol-2-yl)-, methyl ester", "RN": "621BVT9M36", "RR": "43210-67-9 (Fenbendazole)", "PI": "Sulfides (1974)", "MS": "Antinematodal benzimidazole used in veterinary medicine.", "PM": "91; was see under BENZIMIDAZOLES 1977-90", "HN": "91(77); was see under BENZIMIDAZOLES 1977-90", "MR": "20160531", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D005273"}, {"RECTYPE": "D", "MH": "Fendiline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Fendiline", "MN": "D02.092.471.683.450", "PA": "Calcium Channel Blockers", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenepropanamine, gamma-phenyl-N-(1-phenylethyl)-", "RN": "S253D559A8", "RR": "HEM3Z10IIK", "PI": "Phenethylamines (1966-1979)", "MS": "Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.", "PM": "91; was see under PHENETHYLAMINES 1980-90", "HN": "91(80); was see under PHENETHYLAMINES 1980-90", "MR": "20160705", "DA": "19790301", "DC": "1", "DX": "19910101", "UI": "D005275"}, {"RECTYPE": "D", "MH": "Fenestration, Labyrinth", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Labyrinth Fenestrations", "MN": "E04.580.450.277", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The surgical creation of a new opening in the labyrinth of the ear for the restoration of hearing in cases of OTOSCLEROSIS. (Dorland, 27th ed)", "OL": "use FENESTRATION, LABYRINTH to search FENESTRATION 1966-96", "PM": "97; was FENESTRATION 1963-96", "HN": "97; was FENESTRATION 1966-96", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19970101", "UI": "D005276"}, {"RECTYPE": "D", "MH": "Fenfluramine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fintepla|T109|T121|TRD|NRW|NLM (2021)|200629|abbcdef", "ENTRY": "Hydrochloride, Fenfluramine", "MN": "D02.092.471.683.467", "PA": "Serotonin Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-", "RN": "2DS058H2CF", "RR": "5220-89-3 ((+-)-isomer)", "MS": "A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release.", "PM": "72", "HN": "72(66)", "MR": "20220718", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D005277"}, {"RECTYPE": "D", "MH": "Fenitrothion", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Sumithione|T109|T131|TRD|NRW|UNK (19XX)|850103|abbcdef", "MN": "D02.886.300.692.300", "PA": "Insecticides", "MH_TH": "FDA SRS (2014)", "ST": "T131", "N1": "Phosphorothioic acid, O,O-dimethyl O-(3-methyl-4-nitrophenyl) ester", "RN": "W8M4X3Y7ZY", "RR": "122-14-5 (Fenitrothion)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides (1966-1971)", "MS": "An organothiophosphate cholinesterase inhibitor that is used as an insecticide.", "PM": "74", "HN": "74(72)", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005278"}, {"RECTYPE": "D", "MH": "Fenoprofen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nalgesic|T109|T121|TRD|NRW|UNK (19XX)|800731|abbcdef", "MN": "D02.241.223.701.350", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USAN (1971)", "ST": "T121", "N1": "Benzeneacetic acid, alpha-methyl-3-phenoxy-, (+-)-", "RN": "RA33EAC7KY", "RR": "34597-40-5 (Ca salt, anhydrous)", "PI": "Propionates (1972-1974)", "MS": "A propionic acid derivative that is used as a non-steroidal anti-inflammatory agent.", "PM": "1991; FENOPROFEN was indexed under PHENYLPROPIONATES 1975-1990", "HN": "1991 (1975)", "MR": "20180410", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D005279"}, {"RECTYPE": "D", "MH": "Fenoterol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "p Hydroxyphenylorciprenaline", "MN": "D02.455.426.559.389.657.166.175.660.300", "PA": "Tocolytic Agents", "MH_TH": "USAN (1971)", "ST": "T121", "N1": "1,3-Benzenediol, 5-(1-hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)-", "RN": "22M9P70OQ9", "RR": "RLI45Z99RB", "PI": "Phenols (1973-1974)", "MS": "A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.", "PM": "1986; FENOTEROL was indexed under ETHANOLAMINES 1975-1985", "HN": "1986 (1975)", "MR": "20180529", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D005280"}, {"RECTYPE": "D", "MH": "Fentanyl", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phentanyl|T109|T121|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "R4263", "MN": "D03.383.621.265", "PA": "Narcotics", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)-", "RN": "UF599785JZ", "RR": "MUN5LYG46H", "MS": "A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)", "PM": "66", "HN": "66", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005283"}, {"RECTYPE": "D", "MH": "Fenthion", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "PRINT ENTRY": "Mercaptophos|T109|T131|TRD|NRW|UNK (19XX)|740330|abbcdef", "ENTRY": "Lebaycid|T109|T131|TRD|NRW|UNK (19XX)|801120|abbcdef", "MN": "D02.886.300.692.320", "PA": "Insecticides", "MH_TH": "FDA SRS (2014)", "ST": "T131", "N1": "Phosphorothioic acid, O,O-dimethyl O-(3-methyl-4-(methylthio)phenyl) ester", "RN": "BL0L45OVKT", "RR": "55-38-9 (Fenthion)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides (1966-1971)", "MS": "Potent cholinesterase inhibitor used as an insecticide and acaricide.", "PM": "74", "HN": "74(72)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005284"}, {"RECTYPE": "D", "MH": "Fermentation", "AQ": "DE GE IM PH RE", "ENTRY": "Fermentations", "MN": "G03.191.249", "FX": "Bioreactors", "MH_TH": "NLM (1966)", "ST": "T044", "MS": "Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID.", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005285"}, {"RECTYPE": "D", "MH": "Fermium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.266", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Fermium", "RN": "Q70I3KBF4W", "RR": "7440-72-4 (Fermium)", "MS": "A man-made radioactive actinide with atomic symbol Fm, and atomic number 100. Its known isotopes range from 244-254 and 256-258. Its valence can be +2 or +3. Like einsteinium, it was discovered in 1952 in the debris from a thermonuclear explosion.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005286"}, {"RECTYPE": "D", "MH": "Ferredoxin-NADP Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Iron-Sulfur Protein Reductase|T116|T126|NON|EQV|NLM (1990)|890118|abbcdef", "ENTRY": "Reductase, NADPH-Ferredoxin", "MN": "D08.811.682.667.076", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Ferredoxin:NADP+ oxidoreductase", "RN": "EC 1.18.1.2", "PI": "NADH, NADPH Oxidoreductases (1974)", "MS": "An enzyme that catalyzes the oxidation and reduction of FERREDOXIN or ADRENODOXIN in the presence of NADP. EC 1.18.1.2 was formerly listed as EC 1.6.7.1 and EC 1.6.99.4.", "PM": "91; was see under NADH, NADPH OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under NADH, NADPH OXIDOREDUCTASES 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005287"}, {"RECTYPE": "D", "MH": "Ferredoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ferredoxin III|T116|T123|NON|NRW|NLM (1998)|961120|abbcdef", "MN": "D12.776.765.319", "MH_TH": "NLM (1964)", "ST": "T123", "RN": "0", "AN": "bact & plant proteins; /drug eff /ultrastruct permitted", "MS": "Iron-containing proteins that transfer electrons, usually at a low potential, to flavoproteins; the iron is not present as in heme. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "PM": "66", "HN": "66(64)", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005288"}, {"RECTYPE": "D", "MH": "Ferrets", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Mustela putorius furo|T015|NON|NRW|NLM (1998)|961028|abcdef", "ENTRY": "Polecats, European", "MN": "B01.050.150.900.649.313.750.250.575.350", "MH_TH": "NLM (1975)", "ST": "T015", "RR": "txid9669", "MS": "Semidomesticated variety of European polecat much used for hunting RODENTS and/or RABBITS and as a laboratory animal. It is in the subfamily Mustelinae, family MUSTELIDAE.", "PM": "91; was see under CARNIVORA 1975-90", "HN": "91(75); was see under CARNIVORA 1975-90", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D005289"}, {"RECTYPE": "D", "MH": "Ferric Compounds", "DE": "FERRIC CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Ferric", "MN": "D01.490.100", "PA": "Hematinics", "FX": "Iron", "MH_TH": "NLM (1975)", "ST": "T104", "RN": "0", "PI": "Iron (1966-1974)", "MS": "Inorganic or organic compounds containing trivalent iron.", "OL": "use IRON to search FERRIC AND FERROUS COMPOUNDS 1966-74", "PM": "87; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74", "HN": "87(75); was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74", "MR": "20190617", "DA": "19750204", "DC": "1", "DX": "19870101", "UI": "D005290"}, {"RECTYPE": "D", "MH": "Ferrichrome", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D12.644.641.380", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Ferrichrome", "RN": "15630-64-5", "PI": "Peptides, Cyclic (1973-1974)", "MS": "A cyclic peptide consisting of three residues of delta-N-hydroxy-delta-N-acetylornithine. It acts as an iron transport agent in Ustilago sphaerogena.", "PM": "91; was see under HYDROXAMIC ACIDS 1975-90", "HN": "91(75); was see under HYDROXAMIC ACIDS 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005291"}, {"RECTYPE": "D", "MH": "Ferricyanides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D01.625.400.100.325", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "do not confuse with FERROCYANIDES", "MS": "Inorganic salts of the hypothetical acid, H3Fe(CN)6.", "PM": "66", "HN": "66", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005292"}, {"RECTYPE": "D", "MH": "Ferritins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Isoferritin, Basic|T116|NON|NRW|NLM (2007)|abcde", "MN": "D12.776.556.579.249", "MH_TH": "NLM (2007)", "ST": "T123", "N1": "Ferritins", "RN": "9007-73-2", "MS": "Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types.", "PM": "2007; see FERRITIN 1966-2006; ISOFERRITIN was indexed under FERRITIN 1972-2006", "HN": "2007 (1966); for ISOFERRITIN use FERRITIN (NM) 1972-2006", "MR": "20060707", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D005293"}, {"RECTYPE": "D", "MH": "Ferrochelatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Porphyrin-Metal Chelatase|T116|T126|NON|EQV|UNK (19XX)|760426|abbcdef", "ENTRY": "Synthetase, Heme", "MN": "D12.776.575.562", "EC": "deficiency:Protoporphyria, Erythropoietic", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "Protoheme ferro-lyase", "RN": "EC 4.99.1.1", "RR": "EC 4.99.1.1", "PI": "Protoporphyrins (1975-1976)", "MS": "A mitochondrial enzyme found in a wide variety of cells and tissues. It is the final enzyme in the 8-enzyme biosynthetic pathway of HEME. Ferrochelatase catalyzes ferrous insertion into protoporphyrin IX to form protoheme or heme. Deficiency in this enzyme results in ERYTHROPOIETIC PROTOPORPHYRIA.", "PM": "1991; see LYASES 1977-1990", "HN": "1991(1977); use LYASES 1977-1990", "MR": "20110624", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D005294"}, {"RECTYPE": "D", "MH": "Ferrocyanides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D01.625.400.100.350", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "do not confuse with FERRICYANIDES", "MS": "Inorganic salts of the hypothetical acid ferrocyanic acid (H4Fe(CN)6).", "PM": "66", "HN": "66", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005295"}, {"RECTYPE": "D", "MH": "Ferrous Compounds", "DE": "FERROUS CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Ferrous", "MN": "D01.490.200", "FX": "Iron", "MH_TH": "NLM (1975)", "ST": "T104", "RN": "0", "PI": "Iron (1966-1974)", "MS": "Inorganic or organic compounds that contain divalent iron.", "OL": "use IRON to search FERRIC AND FERROUS COMPOUNDS 1966-74", "PM": "87; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1964-74", "HN": "87(75); was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74", "MR": "20190617", "DA": "19750204", "DC": "1", "DX": "19870101", "UI": "D005296"}, {"RECTYPE": "D", "MH": "Ferrozine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Monosodium Salt Ferrozine", "MN": "D03.383.931.320", "PA": "Iron Chelating Agents", "MH_TH": "NLM (1976)", "ST": "T130", "N1": "Benzenesulfonic acid, 4,4'-(3-(2-pyridinyl)-1,2,4-triazine-5,6-diyl)bis-, disodium salt", "RN": "28048-33-1", "RR": "69898-45-9 (mono-Na salt)", "PI": "Triazines (1972-1975)", "MS": "A ferroin compound that forms a stable magenta-colored solution with the ferrous ion. The complex has an absorption peak at 562 nm and is used as a reagent and indicator for iron.", "PM": "91; was see under TRIAZINES 1976-90", "HN": "91(76); was see under TRIAZINES 1976-90", "MR": "20160531", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D005297"}, {"RECTYPE": "D", "MH": "Fertility", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Fecundity|T032|NON|EQV|POPLINE (1978)|740330|abcdef", "ENTRY": "World Fertility Surveys", "MN": "G08.686.210", "FX": "Infertility", "MH_TH": "POPLINE (1978)", "ST": "T032", "AN": "IM for human, other mammals, birds & fish, NIM for animals lower than fish, plants & micro-organisms; /drug eff: consider also FERTILITY AGENTS", "MS": "The capacity to conceive or to induce conception. It may refer to either the male or female.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005298"}, {"RECTYPE": "D", "MH": "Fertility Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Infertility Agents|T121|NON|EQV|NLM (1996)|941026|abcdef", "ENTRY": "Effects, Infertility", "MN": "D27.505.954.705.552", "MH_TH": "POPLINE (1984)", "ST": "T121", "RN": "0", "AN": "note entry term FERTILITY EFFECT: use only for the fertility effect of a chemical substance", "PI": "Ovulation/drug effects (1966-1972)", "MS": "Drugs used to increase fertility or to treat infertility.", "PM": "73", "HN": "73", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005299"}, {"RECTYPE": "D", "MH": "Fertility Agents, Female", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Infertility Agents, Female|T121|NON|EQV|NLM (1996)|941026|abcdef", "ENTRY": "Female Infertility Drugs", "MN": "D27.505.954.705.552.344", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Fertility Agents (1973-1974)", "MS": "Compounds which increase the capacity to conceive in females.", "OL": "use FERTILITY AGENTS, FEMALE to search FERTILITY AGENTS, FEMALE, HORMONAL & FERTILITY AGENTS, FEMALE, SYNTHETIC 1975-91", "PM": "75; FERTILITY AGENTS, FEMALE, HORMONAL & FERTILITY AGENTS, FEMALE, SYNTHETIC were headings 1991, were see under FERTILITY AGENTS, FEMALE 1975-90", "HN": "75; FERTILITY AGENTS, FEMALE, HORMONAL & FERTILITY AGENTS, FEMALE, SYNTHETIC were headings 1975-91 (see under FERTILITY AGENTS, FEMALE 1975-90)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D005300"}, {"RECTYPE": "D", "MH": "Fertility Agents, Male", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fertility Agents, Male, Synthetic|T121|NON|NRW|NLM (1992)|910401|FERTILITY AGENTS MALE SYN|abcdefv", "ENTRY": "Male Fertility Agents", "MN": "D27.505.954.705.552.510", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Fertility Agents (1973-1974)", "MS": "Compounds which increase the capacity of the male to induce conception.", "OL": "use FERTILITY AGENTS, MALE to search FERTILITY AGENTS, MALE, HORMONAL & FERTILITY AGENTS, MALE, SYNTHETIC 1975-91", "PM": "75; FERTILITY AGENTS, MALE, HORMONAL & FERTILITY AGENTS, MALE, SYNTHETIC were headings 1991, were see under FERTILITY AGENTS, MALE 1975-90", "HN": "75; FERTILITY AGENTS, MALE, HORMONAL & FERTILITY AGENTS, MALE, SYNTHETIC were headings 1975-91 (see under FERTILITY AGENTS, MALE 1975-90)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D005303"}, {"RECTYPE": "D", "MH": "Fertilization", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Fertilization, Polyspermic|T070|NON|NRW|UNK (19XX)|840612|abcdef", "ENTRY": "Polyspermic Fertilizations", "MN": "G08.686.784.277", "FX": "Posthumous Conception", "MH_TH": "NLM (1963)", "ST": "T040", "AN": "physiol fertilization only: FERTILIZATION IN VITRO (Cat E2 and E5) is also available", "MS": "The fusion of a spermatozoon (SPERMATOZOA) with an OVUM thus resulting in the formation of a ZYGOTE.", "OL": "use FERTILIZATION to search FERTILIZATION, DELAYED & FERTILIZATION, POLYSPERMIC 1975-84", "HN": "FERTILIZATION, DELAYED & FERTILIZATION, POLYSPERMIC were see under FERTILIZATION 1975-84", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D005306"}, {"RECTYPE": "D", "MH": "Fertilization in Vitro", "AQ": "AE CL DE EC ES HI IS LJ MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Test-Tube Fertilization|T061|T062|NON|EQV|NLM (1980)|790427|abbcdef", "ENTRY": "Test-Tube Fertilizations", "MN": "E05.820.800.750", "FX": "Ovarian Hyperstimulation Syndrome", "MH_TH": "NLM (1979)", "ST": "T062", "AN": "do not check the tags IN VITRO; PREGNANCY; or FEMALE", "PI": "Fertilization (1966-1979)", "MS": "An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro.", "OL": "use FERTILIZATION IN VITRO to search TEST TUBE BABIES Apr 1979, use ECTOGENESIS 1978-Mar 79", "PM": "Apr 79; TEST-TUBE FERTILIZATION was TEST TUBE BABIES see FERTILIZATION IN VITRO Apr-Dec 1979, was TEST TUBE BABIES see ECTOGENESIS 1978-Mar 79", "HN": "79; TEST-TUBE FERTILIZATION was TEST TUBE BABIES see FERTILIZATION IN VITRO Apr-Dec 1979, was TEST TUBE BABIES see ECTOGENESIS 1978-Mar 79", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19781122", "DC": "1", "DX": "19790101", "UI": "D005307"}, {"RECTYPE": "D", "MH": "Fertilizers", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Fertilizer|T073|T131|NON|EQV|NLM (2021)|191129|abbcdef", "MN": "D27.720.031.400", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "MS": "Substances or mixtures that are added to the soil to supply nutrients or to make available nutrients already present in the soil, in order to increase plant growth and productivity.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005308"}, {"RECTYPE": "D", "MH": "Ferula", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Asafoetida|T002|T168|NON|NRW|UNK (19XX)|850514|abbcdef", "ENTRY": "hermonis, Ferula", "MN": "B01.875.800.575.912.250.075.300", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid52470", "RR": "txid662815", "MS": "A plant genus of the family APIACEAE. It contains pungent oils and resins. It is used to flavor curries, as a carminative, and as cat and dog repellent. The occasionally used common name of 'giant fennel' should not be confused with true fennel (FOENICULUM).", "PM": "91,63-85; was see under PLANTS, TOXIC 1986-90; was heading 1963-85", "HN": "91(86)63; was see under PLANTS, TOXIC 1986-90; was heading 1963-85", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005309"}, {"RECTYPE": "D", "MH": "Fetal Hypoxia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fetal Anoxia|T047|NON|REL|NLM (1975)|990101|abcdef", "ENTRY": "Hypoxia, Fetal", "MN": "C23.888.852.079.594", "FX": "Asphyxia Neonatorum", "MH_TH": "NLM (2006)", "ST": "T047", "AN": "do not confuse with ASPHYXIA NEONATORUM", "PI": "Fetal Diseases (1966-1974)", "MS": "Deficient oxygenation of FETAL BLOOD.", "PM": "2006; see FETAL ANOXIA 1975-2005", "HN": "2006 (1975)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D005311"}, {"RECTYPE": "D", "MH": "Fetal Blood", "AQ": "CH CY DE DG EN IM ME MI PH PS RE TR VI", "PRINT ENTRY": "Umbilical Cord Blood|T024|NON|NRW|UNK (19XX)|741111|abcdef", "ENTRY": "Umbilical Cord Bloods", "MN": "A16.378.200", "MH_TH": "NLM (1975)", "ST": "T024", "AN": "/transpl: consider also CORD BLOOD STEM CELL TRANSPLANTATION", "PI": "Umbilical Cord (1966-1974)", "MS": "Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery.", "PM": "75", "HN": "75", "MR": "20180629", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D005312"}, {"RECTYPE": "D", "MH": "Fetal Death", "AQ": "ET PC", "PRINT ENTRY": "Fetal Mummification|T046|NON|REL|NLM (2010)|090323|abcdef", "ENTRY": "Mummification, Fetal", "MN": "C23.550.260.585", "FX": "Pregnancy Outcome", "MH_TH": "NLM (1963)", "ST": "T046", "AN": "use PERINATAL DEATH for death of a fetus of gestational age 28 weeks or more; do not confuse with FETAL MORTALITY, a statistical concept", "MS": "Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005313"}, {"RECTYPE": "D", "MH": "Embryonic and Fetal Development", "DE": "EMBRYONIC FETAL DEVELOPMENT", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Embryo and Fetal Development|T039|NON|EQV|NLM (2003)|020104|EMBRYO FETAL DEVELOPMENT|abcdefv", "ENTRY": "Programming, Prenatal", "MN": "G08.686.784.170", "FX": "Developmental Biology", "MH_TH": "NLM (2005)", "ST": "T039", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "PI": "specific organ/embryology (1966-1994)", "MS": "Morphological and physiological development of EMBRYOS or FETUSES.", "PM": "2005; see EMBRYO AND FETAL DEVELOPMENT 2003-2004, see FETAL DEVELOPMENT 1985-2002", "HN": "2005 (1985)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19840611", "DC": "1", "DX": "19850101", "UI": "D005314"}, {"RECTYPE": "D", "MH": "Fetal Diseases", "DE": "FETAL DIS", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Embryopathies|T047|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Fetal Disease", "MN": "C16.300", "FX": "Congenital Abnormalities", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES.", "OL": "search PRENATAL INFLUENCES under PREGNANCY 1966-72", "PM": "PRENATAL INFLUENCES was heading 1963-72", "HN": "PRENATAL INFLUENCES was heading 1963-72", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D005315"}, {"RECTYPE": "D", "MH": "Fetal Distress", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nonreassuring Fetal Status|T184|NON|EQV|NLM (2006)|050419|abcdef", "ENTRY": "Fetal Status, Nonreassuring", "MN": "C23.888.380", "MH_TH": "NLM (1975)", "ST": "T184", "AN": "do not confuse with RESPIRATORY DISTRESS SYNDROME, NEWBORN (postnatal)", "PI": "Fetal Diseases (1966-1974)", "MS": "A nonreassuring fetal status (NRFS) indicating that the FETUS is compromised (American College of Obstetricians and Gynecologists 1988). It can be identified by sub-optimal values in FETAL HEART RATE; oxygenation of FETAL BLOOD; and other parameters.", "PM": "1975", "HN": "1975", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D005316"}, {"RECTYPE": "D", "MH": "Fetal Growth Retardation", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intrauterine Growth Retardation|T184|NON|EQV|UNK (19XX)|770208|abcdef", "ENTRY": "Intrauterine Growth Restriction|T184|NON|EQV|NLM (2018)|170123|abcdef", "MN": "C23.550.393.450", "FX": "Infant, Small for Gestational Age", "MH_TH": "NLM (1978)", "ST": "T184", "PI": "Growth Disorders (1972-1977)", "MS": "Failure of a FETUS to attain expected GROWTH.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19770302", "DC": "1", "DX": "19780101", "UI": "D005317"}, {"RECTYPE": "D", "MH": "Fetal Heart", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Hearts, Fetal", "MN": "A16.378.303", "MH_TH": "NLM (1966)", "ST": "T018", "MS": "The heart of the fetus of any viviparous animal. It refers to the heart in the postembryonic period and is differentiated from the embryonic heart (HEART/embryology) only on the basis of time.", "MR": "20050715", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005318"}, {"RECTYPE": "D", "MH": "Fetal Hemoglobin", "DE": "HBF", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hemoglobin F|T116|T123|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Hemoglobin, Fetal", "MN": "D12.776.422.316.762.320", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Hemoglobin F", "RN": "9034-63-3", "MS": "The major component of hemoglobin in the fetus. This HEMOGLOBIN has two alpha and two gamma polypeptide subunits in comparison to normal adult hemoglobin, which has two alpha and two beta polypeptide subunits. Fetal hemoglobin concentrations can be elevated (usually above 0.5%) in children and adults affected by LEUKEMIA and several types of ANEMIA.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005319"}, {"RECTYPE": "D", "MH": "Fetal Macrosomia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Macrosomia, Fetal|T033|NON|EQV|UNK (19XX)|860618|abcdef", "ENTRY": "Macrosomias, Fetal", "MN": "C23.888.144.186.500", "FX": "Sotos Syndrome", "MH_TH": "NLM (1987)", "ST": "T033", "AN": "do not confuse with INFANT, POSTMATURE ", "PI": "Pregnancy in Diabetes (1966-1986)", "MS": "A condition of fetal overgrowth defined as BIRTH WEIGHT greater than 4,000 grams, regardless of gestational age. It is commonly seen in GESTATIONAL DIABETES; PROLONGED PREGNANCY; and pregnancies complicated by pre-existing diabetes mellitus.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D005320"}, {"RECTYPE": "D", "MH": "Extraembryonic Membranes", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Fetal Membranes|T017|NON|REL|NLM (1963)|990101|abcdef", "ENTRY": "Membranes, Fetal", "MN": "A16.254.750", "MH_TH": "NLM (2006)", "ST": "T018", "MS": "The thin layers of tissue that surround the developing embryo. There are four extra-embryonic membranes commonly found in VERTEBRATES, such as REPTILES; BIRDS; and MAMMALS. They are the YOLK SAC, the ALLANTOIS, the AMNION, and the CHORION. These membranes provide protection and means to transport nutrients and wastes.", "MR": "20070711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005321"}, {"RECTYPE": "D", "MH": "Fetal Membranes, Premature Rupture", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Premature Rupture of Membrane (Pregnancy)|T047|NON|EQV|NLM (2006)|050505|abcdef", "ENTRY": "PROM, Preterm (Pregnancy)", "MN": "C12.050.703.420.339", "MH_TH": "NLM (1975)", "ST": "T047", "PI": "Fetal Membranes (1966-1974)", "MS": "Spontaneous tearing of the membranes surrounding the FETUS any time before the onset of OBSTETRIC LABOR. Preterm PROM is membrane rupture before 37 weeks of GESTATION.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D005322"}, {"RECTYPE": "D", "MH": "Fetal Monitoring", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Monitoring, Fetal|T060|NON|EQV|UNK (19XX)|770426|abcdef", "ENTRY": "Monitorings, Fetal", "MN": "E01.370.520.230", "FX": "Signal Processing, Computer-Assisted", "MH_TH": "NLM (1978)", "ST": "T060", "AN": "during LABOR, OBSTETRIC or during prenatal maternal surg", "PI": "Monitoring, Physiologic (1966-1977)", "MS": "Physiologic or biochemical monitoring of the fetus. It is usually done during LABOR, OBSTETRIC and may be performed in conjunction with the monitoring of uterine activity. It may also be performed prenatally as when the mother is undergoing surgery.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D005323"}, {"RECTYPE": "D", "MH": "Fetal Movement", "AQ": "DE GE IM PH RE", "ENTRY": "Fetal Movements", "MN": "G08.686.784.170.157.374", "MH_TH": "NLM (1985)", "ST": "T040", "PI": "Movement (1966-1984)", "MS": "Physical activity of the FETUS in utero. Gross or fine fetal body movement can be monitored by the mother, PALPATION, or ULTRASONOGRAPHY.", "PM": "85", "HN": "85", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19840406", "DC": "1", "DX": "19850101", "UI": "D005324"}, {"RECTYPE": "D", "MH": "Fetal Organ Maturity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Fetal Maturity, Functional|T032|NON|EQV|UNK (19XX)|800513|abcdef", "ENTRY": "Organ Maturity, Fetal", "MN": "G08.686.784.170.157.750", "MH_TH": "NLM (1981)", "ST": "T032", "AN": "coordinate with organ/embryol", "PI": "Respiratory Distress Syndrome (1966-1980)", "MS": "Functional competence of specific organs or body systems of the FETUS in utero.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19800513", "DC": "1", "DX": "19810101", "UI": "D005325"}, {"RECTYPE": "D", "MH": "Fetal Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Fetal", "MN": "D12.776.320", "MH_TH": "NLM (1970)", "ST": "T123", "RN": "0", "PI": "Serum Globulins (1966-1969)", "MS": "Proteins that are preferentially expressed or upregulated during FETAL DEVELOPMENT.", "PM": "1984; see FETAL GLOBULINS 1970-1983; for FETOPROTEIN see ALPHA-FETOPROTEINS 1988-2011", "HN": "1984(1970); for FETOPROTEIN use ALPHA-FETOPROTEINS 1988-2011", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005326"}, {"RECTYPE": "D", "MH": "Fetal Resorption", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Resorptions, Fetal", "MN": "C23.550.260.585.260", "FX": "Embryo Loss", "MH_TH": "NLM (1976)", "ST": "T047", "PI": "Fetal Death (1966-1975)", "MS": "The disintegration and assimilation of the dead FETUS in the UTERUS at any stage after the completion of organogenesis which, in humans, is after the 9th week of GESTATION. It does not include embryo resorption (see EMBRYO LOSS).", "PM": "91; was see under FETAL DEATH 1976-90", "HN": "91(76); was see under FETAL DEATH 1976-90", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D005327"}, {"RECTYPE": "D", "MH": "Fetal Viability", "AQ": "DE GE IM PH RE", "ENTRY": "Viability, Fetal", "MN": "G08.686.220", "FX": "Fetal Death", "MH_TH": "NLM (1978)", "ST": "T032", "PI": "Fetus (1966-1977)", "MS": "The potential of the FETUS to survive outside the UTERUS after birth, natural or induced. Fetal viability depends largely on the FETAL ORGAN MATURITY, and environmental conditions.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D005328"}, {"RECTYPE": "D", "MH": "Fetishism, Psychiatric", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Fetishism (Psychiatric)|T048|NON|EQV|NLM (1975)|990101|FETISHISM|abcdefv", "ENTRY": "Psychiatric Fetishism", "MN": "F03.657.350", "MH_TH": "NLM (2020)", "ST": "T048", "AN": "belief in religious or magic fetishes goes under RELIGION; SUPERSTITION & its indentions, ANTHROPOLOGY, CULTURAL or other pertinent term", "MS": "A condition in which inanimate objects are utilized as a preferred or exclusive method of stimulating erotic arousal.", "PM": "2020; was FETISHISM (PSYCHIATRIC) 1991-2019; see PARAPHILIAS 1981-1990; see SEX DEVIATION 1968-1980", "HN": "2020 (1975); was FETISHISM (PSYCHIATRIC) 1991-2019; was indexed under PARAPHILIAS 1981-1990; was indexed under SEX DEVIATION 1975-1980; use SEX DEVIATION 1968-1974", "CATSH": "CAT LIST", "MR": "20190117", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005329"}, {"RECTYPE": "D", "MH": "Fetofetal Transfusion", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Twin-to-Twin Transfusion|T019|NON|EQV|NLM (2023)|210830|abcdef", "ENTRY": "Twin-to-Twin Transfusions", "MN": "C16.614.053.344", "MH_TH": "NLM (1968)", "ST": "T019", "AN": "do not coordinate with DISEASES IN TWINS; note category: do not confuse with other \"transfusion\" concepts in MeSH", "PI": "Infant, Newborn, Diseases (1966-1967)", "MS": "Passage of blood from one fetus to another via an arteriovenous communication or other shunt, in a monozygotic twin pregnancy. It results in anemia in one twin and polycythemia in the other. (Lee et al., Wintrobe's Clinical Hematology, 9th ed, p737-8)", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005330"}, {"RECTYPE": "D", "MH": "Fetomaternal Transfusion", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Fetomaternal|T047|NON|EQV|UNK (19XX)|870402|abcdef", "ENTRY": "Transfusions, Fetomaternal", "MN": "C16.614.053.511", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Transplacental passage of fetal blood into the circulation of the maternal organism. (Dorland, 27th ed)", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005331"}, {"RECTYPE": "D", "MH": "Fetoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Fetoscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES FETOSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Fetoscopic", "MN": "E04.520.280", "FX": "Fetoscopes", "MH_TH": "NLM (1977)", "ST": "T061", "AN": "/ instrum permitted but consider also FETOSCOPES", "PI": "Prenatal Diagnosis (1973-1976)", "MS": "Endoscopic examination, therapy or surgery of the fetus and amniotic cavity through abdominal or uterine entry.", "PM": "1991; see PRENATAL DIAGNOSIS 1977-1990; for AMNIOSCOPY see AMNIOSCOPY 1971-1999", "HN": "1991(1971)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D005332"}, {"RECTYPE": "D", "MH": "Fetus", "AQ": "AB AH BS CH CY DE DG EM EN IM IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Fetal Structures|T018|NON|REL|NLM (1998)|970224|abcdef", "ENTRY": "Tissues, Fetal", "MN": "A16.378", "FX": "Maternal-Fetal Exchange", "EC": "transplantation:Fetal Tissue Transplantation", "MH_TH": "NLM (1963)", "ST": "T018", "MS": "The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN.", "PM": "1972", "HN": "1972 (1963)", "MR": "20160809", "DA": "19780619", "DC": "1", "DX": "19660101", "UI": "D005333"}, {"RECTYPE": "D", "MH": "Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pyrexia|T184|NON|EQV|UNK (19XX)|840530|abcdef", "ENTRY": "Pyrexias", "MN": "C23.888.119.344", "FX": "Pyrogens", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "An abnormal elevation of body temperature, usually as a result of a pathologic process.", "CATSH": "CAT LIST", "MR": "20200317", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005334"}, {"RECTYPE": "D", "MH": "Fever of Unknown Origin", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Unknown Origin Fevers", "MN": "C23.888.119.344.345", "MH_TH": "NLM (1971)", "ST": "T184", "AN": "referred to as FUO; for ultimate determ of cause or origin coord FEVER OF UNKNOWN ORIGIN /etiol (IM) (not /diag) + disease /compl (IM) (not /diag)", "PI": "Fever (1966-1970)", "MS": "Fever in which the etiology cannot be ascertained.", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005335"}, {"RECTYPE": "D", "MH": "Fiber Optic Technology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Technology, Fiber Optic", "MN": "H01.671.617.249", "FX": "Optical Fibers", "MH_TH": "NLM (2009)", "ST": "T090", "PI": "Optics (1966-1969)", "MS": "The technology of transmitting light over long distances through strands of glass or other transparent material.", "PM": "2009; see FIBER OPTICS 1970-2008", "HN": "2009 (1970)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005336"}, {"RECTYPE": "D", "MH": "Fibrin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antithrombin I|T120|NON|REL|NLM (1999)|971224|abcdef", "MN": "D12.776.124.270", "MH_TH": "INN (19XX)", "ST": "T123", "N1": "Fibrins", "RN": "9001-31-4", "MS": "A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot.", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005337"}, {"RECTYPE": "D", "MH": "Fibrin Fibrinogen Degradation Products", "DE": "FFDP", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fibrin Fibrinogen Split Products|T116|T123|NON|EQV|UNK (19XX)|750722|abbcdef", "ENTRY": "Product, Fibrin Degradation", "MN": "D12.776.811.300.290", "PA": "Anticoagulants", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "0", "AN": "in texts as FDP", "PI": "Fibrinogen/metabolism (1970-1975)", "MS": "Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis.", "PM": "76", "HN": "76", "MR": "20200527", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D005338"}, {"RECTYPE": "D", "MH": "Fibrin Foam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Foam, Fibrin", "MN": "D12.776.124.270.302", "PA": "Tissue Adhesives", "MH_TH": "NLM (1963)", "ST": "T122", "RN": "0", "AN": "a hemostatic", "PI": "Hemostatics (1966-1972)", "MS": "A dry artificial sterile sponge of fibrin prepared by clotting with thrombin a foam or solution of fibrinogen. It is used in conjunction with thrombin as a hemostatic in surgery at sites where bleeding cannot be controlled by more common methods. (From Martindale, The Extra Pharmacopoeia, 30th ed, p648)", "OL": "use FIBRIN FOAM to search FIBRIN FILM AND FOAM 1966-72 (as Prov)", "PM": "73; was FIBRIN FILM AND FOAM see under HEMOSTATICS 1963-72", "HN": "73; was FIBRIN FILM AND FOAM 1963-72 (Prov) see under HEMOSTATICS", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005339"}, {"RECTYPE": "D", "MH": "Fibrinogen", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Factor I|T116|T123|NON|EQV|UNK (19XX)|750101|abbcdef", "ENTRY": "gamma Fibrinogen", "MN": "D23.119.490", "FX": "Hemostatics", "EC": "deficiency:Afibrinogenemia", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Fibrinogens", "RN": "9001-32-5", "AN": "a blood coag factor: do not confuse entry term FACTOR I with COMPLEMENT FACTOR I", "MS": "Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products.", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005340"}, {"RECTYPE": "D", "MH": "Fibrinolysin", "AQ": "AD AE AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Plasmin|T116|T121|T126|NON|EQV|BAN (19XX)|990101|abbbcdef", "ENTRY": "Glu Plasmin", "MN": "D08.811.277.656.959.350.330", "PA": "Fibrinolytic Agents", "MH_TH": "NLM (1993)", "ST": "T126", "RN": "EC 3.4.21.7", "MS": "A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins.", "PM": "2010, 1963-1992; see PLASMIN 1993-2009; for PLASMIN see FIBRINOLYSIN 1963-92", "HN": "2010, 1963-1992;", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "20100101", "UI": "D005341"}, {"RECTYPE": "D", "MH": "Fibrinolysis", "AQ": "DE GE IM PH RE", "ENTRY": "Fibrinolyses", "MN": "G09.188.390.150.390", "FX": "Fibrin Clot Lysis Time", "MH_TH": "NLM (1978)", "ST": "T042", "MS": "The natural enzymatic dissolution of FIBRIN.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005342"}, {"RECTYPE": "D", "MH": "Fibrinolytic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thrombolytic Drug|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Drugs, Antithrombic", "MN": "D27.505.954.502.427", "EC": "antagonists & inhibitors:Antifibrinolytic Agents", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.", "PM": "66", "HN": "66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005343"}, {"RECTYPE": "D", "MH": "Fibrinopeptide A", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Fibrinopeptides A|T116|T123|NON|EQV|NLM (1998)|961025|abbcdef", "MN": "D23.119.500", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "25422-31-5", "PI": "Peptides (1968-1975)", "MS": "Two small peptide chains removed from the N-terminal segment of the alpha chains of fibrinogen by the action of thrombin during the blood coagulation process. Each peptide chain contains 18 amino acid residues. In vivo, fibrinopeptide A is used as a marker to determine the rate of conversion of fibrinogen to fibrin by thrombin.", "PM": "98; see FIBRINOPEPTIDES A 1991-97; see FIBRINOGEN 1976-90", "HN": "98(76)", "MR": "20160628", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D005344"}, {"RECTYPE": "D", "MH": "Fibrinopeptide B", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Fibrinopeptides B|T116|T123|NON|EQV|NLM (1998)|961025|abbcdef", "MN": "D23.119.510", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "36204-23-6", "PI": "Peptides (1968-1975)", "MS": "Two small peptide chains removed from the N-terminal segment of the beta chains of fibrinogen by the action of thrombin. Each peptide chain contains 20 amino acid residues. The removal of fibrinopeptides B is not required for coagulation.", "PM": "98; see FIBRINOPEPTIDES B 1991-97; see FIBRINOGEN 1976-90", "HN": "98(76)", "MR": "20160628", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D005345"}, {"RECTYPE": "D", "MH": "Fibroblast Growth Factors", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Growth Factors, Fibroblast", "MN": "D23.529.624", "FX": "Receptors, Fibroblast Growth Factor", "MH_TH": "NLM (2002)", "ST": "T123", "N1": "Fibroblast growth factor", "RN": "62031-54-3", "PI": "Pituitary Hormones (1974-1983)", "MS": "A family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family.", "PM": "2001; see FIBROBLAST GROWTH FACTOR 1984-2001", "HN": "2001(1984)", "MR": "20060705", "DA": "19830531", "DC": "1", "DX": "19840101", "UI": "D005346"}, {"RECTYPE": "D", "MH": "Fibroblasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Fibroblast", "MN": "A11.329.228", "MH_TH": "NLM (1964)", "ST": "T025", "MS": "Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules.", "PM": "65", "HN": "65(64)", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005347"}, {"RECTYPE": "D", "MH": "Fibrocystic Breast Disease", "DE": "FIBROCYSTIC BREAST DIS", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Mammary Dysplasia|T047|NON|EQV|UNK (19XX)|781220|abcdef", "ENTRY": "Microglandular Adenoses", "MN": "C17.800.090.750", "FX": "Breast Cyst", "MH_TH": "NLM (2005)", "ST": "T047", "AN": "commonly chronic so do not coordinate with CHRONIC DISEASE; breast cyst fluid in fibrocystic breast disease: coordinate IM with CYST FLUID (NIM); BREAST CYST is also available", "PI": "Breast Diseases (1966-1979)", "MS": "A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.", "PM": "2005; see FIBROCYSTIC DISEASE OF BREAST 1984-2004, see BREAST DISEASES 1980-1983", "HN": "2005 (1980)", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19781220", "DC": "1", "DX": "19840101", "UI": "D005348"}, {"RECTYPE": "D", "MH": "Fibroins", "AQ": "AD AE AG AI AN BI BL CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Spidroin|T116|NON|NRW|NLM (2021)|200317|abcdef", "ENTRY": "Spider Fibroins", "MN": "D12.776.093.750.500", "MH_TH": "NLM (2005)", "ST": "T123", "N1": "Fibroins", "RN": "9007-76-5", "MS": "Fibrous proteins secreted by INSECTS and SPIDERS. Generally, the term refers to silkworm fibroin secreted by the silk gland cells of SILKWORMS, Bombyx mori. Spider fibroins are called spidroins or dragline silk fibroins.", "PM": "2005; see FIBROIN 1966-2004", "HN": "2005 (1966)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D005349"}, {"RECTYPE": "D", "MH": "Fibroma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Myxofibroma|T191|NON|REL|NLM (1994)|930326|abcdef", "ENTRY": "Myxofibromas", "MN": "C04.557.450.565.590.340", "FX": "Tuberous Sclerosis", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "A benign tumor of fibrous or fully developed connective tissue.", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005350"}, {"RECTYPE": "D", "MH": "Fibromatosis, Gingival", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gingival Fibromatosis|T019|NON|EQV|NLM (1997)|950906|abcdef", "ENTRY": "Gingival Fibromatoses", "MN": "C16.131.850.525.304", "MH_TH": "NLM (1965)", "ST": "T019", "AN": "non-neoplastic; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Generalized or localized diffuse fibrous overgrowth of the gingival tissue, usually transmitted as an autosomal dominant trait, but some cases are idiopathic and others produced by drugs. The enlarged gingiva is pink, firm, and has a leather-like consistency with a minutely pebbled surface and in severe cases the teeth are almost completely covered and the enlargement projects into the oral vestibule. (Dorland, 28th ed)", "PM": "97; was FIBROMATOSIS GINGIVAE 1965-96", "HN": "97; was FIBROMATOSIS GINGIVAE 1965-96", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005351"}, {"RECTYPE": "D", "MH": "Fibromuscular Dysplasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fibromuscular Dysplasias", "MN": "C14.907.137.372", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a disease of the musculature of arterial walls; do not confuse with the various MUSCULAR DISEASES in Category C5; coordinate IM with specific artery or pre-coordinated arterial disease (IM)", "PI": "Vascular Diseases (1966-1977)", "MS": "An idiopathic, segmental, nonatheromatous disease of the musculature of arterial walls, leading to STENOSIS of small and medium-sized arteries. There is true proliferation of SMOOTH MUSCLE CELLS and fibrous tissue. Fibromuscular dysplasia lesions are smooth stenosis and occur most often in the renal and carotid arteries. They may also occur in other peripheral arteries of the extremity.", "PM": "91; was see under ARTERIAL OCCLUSIVE DISEASES 1978-90", "HN": "91(78); was see under ARTERIAL OCCLUSIVE DISEASES 1978-90", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D005352"}, {"RECTYPE": "D", "MH": "Fibronectins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "LETS Proteins|T116|T123|EQV|UNK (19XX)|790221|abbdef", "ENTRY": "alpha 2 Surface Binding Glycoprotein", "MN": "D12.776.860.300.450", "FX": "Receptors, Fibronectin", "MH_TH": "NLM (1980)", "ST": "T123", "RN": "0", "AN": "extracellular matrix proteins; /biosyn /physiol permitted", "PI": "Membrane Proteins (1977-1979)", "MS": "Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins.", "PM": "80", "HN": "80", "MR": "20230316", "DA": "19790221", "DC": "1", "DX": "19800101", "UI": "D005353"}, {"RECTYPE": "D", "MH": "Fibrosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Fibrosarcomas", "MN": "C04.557.450.795.350", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005354"}, {"RECTYPE": "D", "MH": "Fibrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cirrhosis|T047|NON|NRW|UNK (19XX)|860325|abcdef", "ENTRY": "Fibroses", "MN": "C23.550.355", "MH_TH": "NLM (1987)", "ST": "T046", "AN": "NIM only as pathol process with no qualif: coord with Cat A term /pathol (IM); several specific fibrosis terms are also available", "PI": "specific organ/pathology (1966-1986)", "MS": "Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19860325", "DC": "1", "DX": "19870101", "UI": "D005355"}, {"RECTYPE": "D", "MH": "Fibromyalgia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rheumatism, Muscular|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Syndromes, Fibromyositis-Fibromyalgia", "MN": "C10.668.491.425", "FX": "Fatigue Syndrome, Chronic", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)", "OL": "use FIBROMYALGIA to search FIBROSITIS 1966-88", "PM": "89; was FIBROSITIS 1963-88", "HN": "89; was FIBROSITIS 1963-88", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19890101", "UI": "D005356"}, {"RECTYPE": "D", "MH": "Fibrous Dysplasia of Bone", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Osteitis Fibrosa Disseminata|T047|NON|EQV|GHR (2014)|UNK (19XX)|740330|abcdeef", "ENTRY": "Jaffe Lichtenstein Disease", "MN": "C05.116.099.708.375", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "PERIAPICAL FIBROUS DYSPLASIA see CEMENTOMA is also available ", "MS": "A disease of bone marked by thinning of the cortex by fibrous tissue containing bony spicules, producing pain, disability, and gradually increasing deformity. Only one bone may be involved (FIBROUS DYSPLASIA, MONOSTOTIC) or several (FIBROUS DYSPLASIA, POLYOSTOTIC).", "OL": "use FIBROUS DYSPLASIA OF BONE to search FIBROUS DYSPLASIA 1966 (as Prov); search ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE under OSTEITIS FIBROSA CYSTICA 1966", "PM": "67; ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66", "HN": "67; was FIBROUS DYSPLASIA 1963-66 (Prov); ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66", "CATSH": "CAT LIST", "MR": "20180308", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D005357"}, {"RECTYPE": "D", "MH": "Fibrous Dysplasia, Monostotic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Monostotic Fibrous Dysplasias", "MN": "C05.116.099.708.375.372", "MH_TH": "NLM (1975)", "ST": "T019", "AN": "Jaffe-Lichtenstein usually goes here but check text for possible \"polyostotic\"", "MS": "FIBROUS DYSPLASIA OF BONE involving only one bone.", "OL": "use FIBROUS DYSPLASIA OF BONE to search FIBROUS DYSPLASIA, MONOSTOTIC 1967-74; search ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE under OSTEITIS FIBROSA CYSTICA 1966", "PM": "91; was see under FIBROUS DYSPLASIA OF BONE 1967-90; ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66", "HN": "91(75); was see under FIBROUS DYSPLASIA OF BONE 1967-90; ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005358"}, {"RECTYPE": "D", "MH": "Fibrous Dysplasia, Polyostotic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "McCune-Albright Syndrome|T047|EPO|NRW|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|780612|abcdeeeef", "ENTRY": "Syndrome, McCune-Albright", "MN": "C05.116.099.708.375.381", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "sometimes Jaffe-Lichtenstein (usually monostotic) goes here: check text; craniofacial fibrous dysplasia: coord IM with FACIAL BONES (IM) + SKULL (IM)", "MS": "FIBROUS DYSPLASIA OF BONE affecting several bones. When melanotic pigmentation (CAFE-AU-LAIT SPOTS) and multiple endocrine hyperfunction are additionally associated it is referred to as Albright syndrome.", "OL": "use FIBROUS DYSPLASIA OF BONE to search FIBROUS DYSPLASIA, POLYOSTOTIC 1967-74; search ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE under OSTEITIS FIBROSA CYSTICA 1966", "PM": "91; was see under FIBROUS DYSPLASIA OF BONE 1967-90; ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66", "HN": "91(75); was see under FIBROUS DYSPLASIA OF BONE 1967-90; ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005359"}, {"RECTYPE": "D", "MH": "Fibula", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Fibulas", "MN": "A02.835.232.043.650.321", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The bone of the lower leg lateral to and smaller than the tibia. In proportion to its length, it is the most slender of the long bones.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005360"}, {"RECTYPE": "D", "MH": "Ficain", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ficin|T116|T126|NON|EQV|NLM (1975)|990101|abbcdef", "MN": "D08.811.277.656.300.200.350", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.4.22.3", "PI": "Peptide Peptidohydrolases (1971-1974)", "MS": "A sulfhydryl proteinase with cysteine at the active site from ficus latex. Preferential cleavage is at tyrosine and phenylalanine residues. EC 3.4.22.3.", "PM": "2000; see FICIN 1990-1999; see CYSTEINE PROTEINASES 1975-1990", "HN": "2000(1990)", "MR": "20090706", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005361"}, {"RECTYPE": "D", "MH": "Ficoll", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "MN": "D09.698.330", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "alpha-D-Glucopyranoside, beta-D-fructofuranosyl, homopolymer", "RN": "25702-74-3", "PI": "Sucrose (1971-1974)", "MS": "A sucrose polymer of high molecular weight.", "PM": "90; was see under POLYSACCHARIDES 1975-89", "HN": "90(75); was see under POLYSACCHARIDES 1975-89", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19900101", "UI": "D005362"}, {"RECTYPE": "D", "MH": "Ficusin", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Psoralen|T109|T121|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbbcdeef", "ENTRY": "Psoralene|T109|T121|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "MN": "D03.633.300.770.200", "PA": "Photosensitizing Agents", "EC": "analogs & derivatives:Furocoumarins", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "7H-Furo(3,2-g)(1)benzopyran-7-one", "RN": "KTZ7ZCN2EX", "RR": "66-97-7 (Ficusin)", "AN": "do not confuse entry term PSORALEN, this specific drug, with PSORALENS;", "PI": "Furans (1966-1974)", "MS": "A naturally occurring furocoumarin, found in PSORALEA. After photoactivation with UV radiation, it binds DNA via single and double-stranded cross-linking.", "PM": "91; was see under PSORALENS 1979-90; was see under COUMARINS 1975-78", "HN": "91(75); was see under PSORALENS 1979-90; was see under COUMARINS 1975-78", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005363"}, {"RECTYPE": "D", "MH": "Field Dependence-Independence", "ENTRY": "Field Dependence-Independences", "MN": "F02.463.593.343", "MH_TH": "NLM (1972)", "ST": "T041", "PI": "Visual Perception (1966-1971)", "MS": "The ability to respond to segments of the perceptual experience rather than to the whole.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D005364"}, {"RECTYPE": "D", "MH": "FIGLU Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Formiminoglutamic Acid Test|T059|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Tests, Formiminoglutamic Acid", "MN": "E05.200.625.300", "MH_TH": "NLM (1964)", "ST": "T059", "MS": "A urine test for formiminoglutamic acid, an intermediate metabolite in L-histidine catabolism in the conversion of L-histidine to L-glutamic acid. It may be an indicator of vitamin B12 or folic acid deficiency or liver disease.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005365"}, {"RECTYPE": "D", "MH": "Figural Aftereffect", "DE": "FIGURAL AFTEREFF", "AQ": "CL DE ES GE PH RE", "ENTRY": "Figural Aftereffects", "MN": "G14.360", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "usually involves displacement of afterimage of geometric pattern in shape & space: differentiate from AFTERIMAGE; while both are in the field of perception, AFTERIMAGE is likely to be in ophthalmol jrnls, FIGURAL AFTEREFFECT, in psychol jrnls", "MS": "A perceptual phenomenon used by Gestalt psychologists to demonstrate that events in one part of the perceptual field may affect perception in another part.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005366"}, {"RECTYPE": "D", "MH": "Fiji", "AQ": "EH EP", "MN": "Z01.639.760.590.373", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island group in Melanesia", "MS": "A republic consisting of an island group in Melanesia, in the southwest Pacific Ocean. Its capital is Suva. It was discovered by Abel Tasman in 1643 and was visited by Captain Cook in 1774. It was used by escaped convicts from Australia as early as 1804. It was annexed by Great Britain in 1874 but achieved independence in 1970. The name Fiji is of uncertain origin. In its present form it may represent that of Viti, the main island in the group. (From Webster's New Geographical Dictionary, 1988, p396 & Room, Brewer's Dictionary of Names, 1992, p186)", "HN": "75", "MR": "20120703", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D005367"}, {"RECTYPE": "D", "MH": "Filariasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Filarioidea Infections|T047|NON|EQV|UNK (19XX)|740330|FILARIOIDEA INFECT|abcdefv", "ENTRY": "Infection, Filarioidea", "MN": "C01.610.335.508.700.750.361", "MH_TH": "POPLINE (1994)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Infections with nematodes of the superfamily FILARIOIDEA. The presence of living worms in the body is mainly asymptomatic but the death of adult worms leads to granulomatous inflammation and permanent fibrosis. Organisms of the genus Elaeophora infect wild elk and domestic sheep causing ischemic necrosis of the brain, blindness, and dermatosis of the face.", "OL": "use FILARIASIS to search ELAEOPHORIASIS 1975-92", "PM": "ELAEOPHORIASIS was heading 1975-92 (see under FILARIASIS 1975-90)", "HN": "ELAEOPHORIASIS was heading 1975-92 (see under FILARIASIS 1975-90)", "CATSH": "CAT LIST", "MR": "20200629", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D005368"}, {"RECTYPE": "D", "MH": "Filaricides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D27.505.954.122.250.075.080.275", "MH_TH": "NLM (1973)", "ST": "T121", "RN": "0", "AN": "consider also FILARIOIDEA /drug eff & FILARIASIS /drug ther or pertinent specifics", "MS": "Pharmacological agents destructive to nematodes in the superfamily Filarioidea.", "PM": "91; was see under ANTHELMINTICS 1973-90", "HN": "91(73); was see under ANTHELMINTICS 1973-90", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005369"}, {"RECTYPE": "D", "MH": "Filarioidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Litomosoides|T204|NON|NRW|NLM (1993)|911107|abcdef", "ENTRY": "Litomosoide", "MN": "B01.050.500.500.294.400.937.463", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6295", "RR": "txid6298", "MS": "A superfamily of nematodes of the order SPIRURIDA. Members possess a filiform body and a mouth surrounded by papillae.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005370"}, {"RECTYPE": "D", "MH": "Filing", "AQ": "CL EC ES HI MT SN ST TD", "ENTRY": "Filings", "MN": "L01.462.750.245.390", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "IM", "MS": "Collections of related records treated as a unit; ordering of such files.", "OL": "use FILING to search FILES AND FILING 1966-84", "PM": "85; was FILES AND FILING 1963-84", "HN": "85; was FILES AND FILING 1963-84", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D005371"}, {"RECTYPE": "D", "MH": "Filipin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Filipin III|T109|T195|NON|EQV|FDA SRS (2014)|NLM (1990)|890510|abbcdeef", "ENTRY": "U5956", "MN": "D02.540.576.500.996", "PA": "Antiviral Agents", "MH_TH": "USAN (1968)", "ST": "T195", "RN": "87Z59R7D14", "RR": "480-49-9 (Filipin)", "PI": "Polyenes (1966-1974)", "MS": "A complex of polyene antibiotics obtained from Streptomyces filipinensis. Filipin III alters membrane function by interfering with membrane sterols, inhibits mitochondrial respiration, and is proposed as an antifungal agent. Filipins I, II, and IV are less important.", "PM": "91; was see under ANTIBIOTICS, ANTIFUNGAL 1990-90; was see under POLYENES 1975-89", "HN": "91(75); was see under ANTIBIOTICS, ANTIFUNGAL 1990-90; was see under POLYENES 1975-89", "MR": "20150622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005372"}, {"RECTYPE": "D", "MH": "Film Dosimetry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Film Badge Dosimetry|T059|NON|EQV|UNK (19XX)|780428|abcdef", "ENTRY": "Film Dosimetries", "MN": "N06.850.810.370.310", "MH_TH": "NLM (1971)", "ST": "T059", "PI": "Radiation Monitoring (1966-1970)", "MS": "Use of a device (film badge) for measuring exposure of individuals to radiation. It is usually made of metal, plastic, or paper and loaded with one or more pieces of x-ray film.", "OL": "use FILM DOSIMETRY to search FILM BADGE 1971-78 (as Prov 1971-73)", "PM": "79; was FILM BADGE 1974-78", "HN": "79; was FILM BADGE 1971-78 (Prov 1971-73)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005373"}, {"RECTYPE": "D", "MH": "Filtration", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Filtrations", "MN": "G02.263", "MH_TH": "NLM (1970)", "ST": "T059", "AN": "includes filtration of fluids, gases & radiations; not for electrical or electronic filtering; filters: index FILTRATION / instrum but note MICROPORE FILTERS and AIR FILTERS are available", "MS": "A process of separating particulate matter from a fluid, such as air or a liquid, by passing the fluid carrier through a medium that will not pass the particulates. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "OL": "use FILTRATION to search FILTERS 1966-74", "PM": "70; FILTERS was see under FILTRATION 1970-74, was heading 1963-69", "HN": "70; FILTERS was see under FILTRATION 1970-74, was heading 1963-69", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D005374"}, {"RECTYPE": "D", "MH": "Financial Audit", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Financial Audits", "MN": "N03.219.463.030.160", "MH_TH": "NLM (1978)", "ST": "T081", "MS": "An examination, review and verification of all financial accounts.", "PM": "91; was see under ACCOUNTING 1978-90", "HN": "91(78); was see under ACCOUNTING 1978-90", "MR": "20150616", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D005375"}, {"RECTYPE": "D", "MH": "Financial Management", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Endowments|T081|NON|NRW|UNK (19XX)|770509|abcdef", "ENTRY": "Management, Financial", "MN": "N03.219.463", "FX": "Income", "MH_TH": "NLM (1978)", "ST": "T057", "MS": "The obtaining and management of funds for institutional needs and responsibility for fiscal affairs.", "PM": "78", "HN": "78", "MR": "19930916", "DA": "19770505", "DC": "1", "DX": "19780101", "UI": "D005376"}, {"RECTYPE": "D", "MH": "Financial Management, Hospital", "DE": "FINANCIAL MANAGEMENT HOSP", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Hospital Financial Managements|T058|NON|EQV|UNK (1997)|950926|HOSP FINANCIAL MANAGEMENTS|abcdefv", "ENTRY": "Managements, Hospital Financial|T058|NON|EQV|NLM (1997)|950926|MANAGEMENTS HOSP FINANCIAL|abcdefv", "MN": "N04.452.442.452.180", "MH_TH": "NLM (1982)", "ST": "T058", "PI": "Financial Management (1978-1981)", "MS": "The obtaining and management of funds for hospital needs and responsibility for fiscal affairs.", "PM": "91; was see under FINANCIAL MANAGEMENT 1982-90", "HN": "91(82); was see under FINANCIAL MANAGEMENT 1982-90", "MR": "20190709", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D005377"}, {"RECTYPE": "D", "MH": "Financial Support", "AQ": "ES", "ENTRY": "Supports, Financial", "MN": "N03.219.483", "FX": "Gift Giving", "MH_TH": "BIOETHICS (1974)", "ST": "T078", "PI": "specific forms of support (1975-1995)", "MS": "The provision of monetary resources including money or capital and credit; obtaining or furnishing money or capital for a purchase or enterprise and the funds so obtained. (From Random House Unabridged Dictionary, 2d ed.)", "PM": "96", "HN": "96; was NON MESH 1975-95", "MR": "20021031", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D005378"}, {"RECTYPE": "D", "MH": "Financing, Construction", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Construction Loans|T081|NON|NRW|UNK (19XX)|770505|abcdef", "ENTRY": "Loans, Construction", "MN": "N03.219.463.300", "MH_TH": "NLM (1978)", "ST": "T078", "PI": "Financing, Government (1968-1977)", "MS": "Funding resources and procedures for capital improvement or the construction of facilities.", "PM": "91; was see under FINANCIAL MANAGEMENT 1978-90", "HN": "91(78); was see under FINANCIAL MANAGEMENT 1978-90", "MR": "19930916", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D005379"}, {"RECTYPE": "D", "MH": "Financing, Government", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Subsidies, Government|T081|NON|NRW|UNK (19XX)|790601|abcdef", "ENTRY": "Subsidy, Government", "MN": "N03.219.521.346", "MH_TH": "POPLINE (1978)", "ST": "T064", "AN": "specify geographic term for the government; CATALOGER: Coordinate with specific NAF entry if applicable", "PI": "Social Welfare (1966-1967)", "MS": "Federal, state, or local government organized methods of financial assistance.", "PM": "68", "HN": "68; FEDERAL AID see FINANCIAL SUPPORT 1994-2000", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005380"}, {"RECTYPE": "D", "MH": "Financing, Organized", "DE": "FINANCING ORGAN", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Grant", "MN": "N03.219.521", "MH_TH": "NLM (1968)", "ST": "T078", "AN": "IM", "PI": "Insurance (1966-1967)", "MS": "All organized methods of funding.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005381"}, {"RECTYPE": "D", "MH": "Financing, Personal", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Personal Expenditures|T081|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Personal Financing", "MN": "N03.219.559", "MH_TH": "NLM (1968)", "ST": "T052", "AN": "restricted to a person's payment of health care expenditures: read MeSH definition; not for the personal finances of physicans & other health care professionals: index under PHYSICIANS; DENTISTS; NURSES; PHARMACISTS; etc., for personal non-professional expenses or under PRACTICE MANAGEMENT, MEDICAL; PRACTICE MANAGEMENT, DENTAL & similar headings for finances assoc with professional practice", "PI": "Economics (1966-1967)", "MS": "Payment by individuals or their family for health care services which are not covered by a third-party payer, either insurance or medical assistance.", "PM": "68", "HN": "68", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005382"}, {"RECTYPE": "D", "MH": "Finger Injuries", "DE": "FINGER INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injury, Finger", "MN": "C26.448.429", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "consider also THUMB /inj", "MS": "General or unspecified injuries involving the fingers.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005383"}, {"RECTYPE": "D", "MH": "Finger Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Interphalangeal Joint of Hand|T030|NON|EQV|NLM (2006)|041220|abcdef", "ENTRY": "Joints, Finger", "MN": "A02.835.583.405.350", "EC": "injuries:Finger Injuries", "MH_TH": "NLM (1965)", "ST": "T030", "AN": "primates only: TN 117; TN 238: differentiation from FINGERS & indexing instructions", "MS": "The articulation between the head of one phalanx and the base of the one distal to it, in each finger.", "PM": "65", "HN": "65", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005384"}, {"RECTYPE": "D", "MH": "Fingers", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU TR VI", "ENTRY": "Finger", "MN": "A01.378.800.667.430", "EC": "injuries:Finger Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "use for primates only; use TOES (IM) + FORELIMB (NIM) for non-primate vertebrates; differentiate from FINGER JOINT; NIM when merely locational", "MS": "Four or five slender jointed digits in humans and primates, attached to each HAND.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005385"}, {"RECTYPE": "D", "MH": "Fingersucking", "AQ": "AE PX TH", "PRINT ENTRY": "Thumbsucking|T048|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Sucking, Thumb", "MN": "F01.145.466.263", "MH_TH": "NLM (1966)", "ST": "T055", "MS": "Sucking of the finger. This is one of the most common manipulations of the body found in young children.", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005386"}, {"RECTYPE": "D", "MH": "Finland", "AQ": "EH EP", "ENTRY": "\u00c5land Islands|T083|NON|NRW|NLM (2015)|140506|abcdef", "MN": "Z01.542.816.186", "MH_TH": "NLM (1979)", "ST": "T083", "MS": "A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005387"}, {"RECTYPE": "D", "MH": "Fire Extinguishing Systems", "AQ": "CL HI LJ SN ST", "ENTRY": "Systems, Fire Extinguishing", "MN": "N06.230.216.500", "MH_TH": "NLM (1977)", "ST": "T073", "PI": "Fires (1966-Jul 1977)", "MS": "Automatic or hand operated equipment used to control and extinguish fires.", "PM": "91; was see under FIRES Aug 1977-90", "HN": "91(Aug 77); was see under FIRES 1977-90", "MR": "20080708", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D005388"}, {"RECTYPE": "D", "MH": "Firearms", "AQ": "CL EC ES HI LJ SN ST", "PRINT ENTRY": "Shotguns|T073|NON|NRW|UNK (19XX)|860418|abcdef", "MN": "J01.637.870.350", "FX": "Wounds, Gunshot", "MH_TH": "NLM (1987)", "ST": "T073", "AN": "ballistics goes here only if pertinent to nature of firearm; wound ballistics goes under BALLISTICS, WOUND see WOUNDS, GUNSHOT & FORENSIC MEDICINE if pertinent", "MS": "Small-arms weapons, including handguns, pistols, revolvers, rifles, shotguns, etc.", "PM": "87", "HN": "87", "MR": "20180629", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D005389"}, {"RECTYPE": "D", "MH": "Fires", "AQ": "EC HI LJ PC SN", "ENTRY": "Fire", "MN": "N06.230.216", "FX": "Smoke Inhalation Injury", "MH_TH": "NLM (1966)", "ST": "T067", "MS": "Combustion or burning in which substances combine chemically with oxygen typically giving out bright light, heat, and smoke.", "MR": "20170711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005390"}, {"RECTYPE": "D", "MH": "Firesetting Behavior", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Pyromania|T048|T055|NON|EQV|UNK (19XX)|750630|abbcdef", "ENTRY": "Pyromanias", "MN": "F03.250.300", "MH_TH": "NLM (1976)", "ST": "T055", "PI": "Fires (1966-1975)", "MS": "A compulsion to set fires.", "PM": "91; was see under IMPULSE CONTROL DISORDERS 1981-90; was see under COMPULSIVE BEHAVIOR 1976-80", "HN": "91(76); was see under IMPULSE CONTROL DISORDERS 1981-90; was see under COMPULSIVE BEHAVIOR 1976-80", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D005391"}, {"RECTYPE": "D", "MH": "First Aid", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "First Aids", "MN": "E02.365.305", "FX": "Wounds and Injuries", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Emergency care or treatment given to a person who suddenly becomes ill or injured before full medical services become available.", "CATSH": "CAT LIST", "MR": "20150706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005392"}, {"RECTYPE": "D", "MH": "Fish Diseases", "DE": "FISH DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Fish Disease", "MN": "C22.362", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "IM GEN or unspecified; coord IM with specific dis /vet (IM) & specific fish (IM); for abnormalities or injuries, index under FISHES /abnorm or FISHES /inj; don't forget also FISHES (NIM) & check tag ANIMALS; DF: FISH DIS", "PI": "Fishes (1966-1969)", "MS": "Diseases of freshwater, marine, hatchery or aquarium fish. This term includes diseases of both teleosts (true fish) and elasmobranchs (sharks, rays and skates).", "PM": "72", "HN": "72(70)", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D005393"}, {"RECTYPE": "D", "MH": "Fish Flour", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Flours, Fish", "MN": "J02.500.600.875.400.400", "MH_TH": "NLM (1975)", "ST": "T168", "AN": "not for \"fish meal\", which is indexed under FISH PRODUCTS", "MS": "A flour made of pulverized, dried fish or fish parts.", "OL": "search FISH PRODUCTS 1968-74", "PM": "91; was see under FISH PRODUCTS 1975-90", "HN": "91(75); was see under FISH PRODUCTS 1975-90", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005394"}, {"RECTYPE": "D", "MH": "Fish Oils", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME MI PD PK PO PS RE SD ST TO TU UR VI", "PRINT ENTRY": "Fish Liver Oils|T109|T123|NON|NRW|UNK (19XX)|820518|abbcdef", "ENTRY": "Oils, Fish Liver", "MN": "D10.627.430", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "coordinate with specific fish", "MS": "Oils high in unsaturated fats extracted from the bodies of fish or fish parts, especially the LIVER. Those from the liver are usually high in VITAMIN A. The oils are used as DIETARY SUPPLEMENTS. They are also used in soaps and detergents and as protective coatings.", "OL": "use FISH OILS to search FISH LIVER OILS 1966-82", "PM": "83; was FISH LIVER OILS 1963-82", "HN": "83; was FISH LIVER OILS 1963-82", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19830101", "UI": "D005395"}, {"RECTYPE": "D", "MH": "Fish Products", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Products, Fish", "MN": "J02.500.600.875.400", "MH_TH": "NLM (1968)", "ST": "T168", "AN": "\"food products manufactured from fish (e.g., FISH FLOUR, fish meal)\" but for canned fish coord FISHES (IM) or specific fish (IM) + FOOD PRESERVATION (IM); coord IM with fish source (NIM)", "PI": "Fishes (1966-1967)", "MS": "Food products manufactured from fish (e.g., FISH FLOUR, fish meal).", "PM": "68", "HN": "68", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005396"}, {"RECTYPE": "D", "MH": "Fish Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Venoms, Fish", "MN": "D23.946.833.370", "PA": "Poisons", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTIVENINS", "PI": "Venoms (1966-1977)", "MS": "Venoms produced by FISHES, including SHARKS and sting rays, usually delivered by spines. They contain various substances, including very labile toxins that affect the HEART specifically and all MUSCLES generally.", "PM": "78", "HN": "78", "MR": "20050630", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D005397"}, {"RECTYPE": "D", "MH": "Fisheries", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Hatchery, Fish", "MN": "J03.540.280", "MH_TH": "NLM (1966)", "ST": "T072", "AN": "specify geographic location if pertinent", "MS": "Places for cultivation and harvesting of fish, particularly in sea waters. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "MR": "20160613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005398"}, {"RECTYPE": "D", "MH": "Fishes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.493", "MH_TH": "NLM (1968)", "ST": "T013", "AN": "general or unspecified; prefer specifics; canned fish: coordinate with FOOD, PRESERVED", "MS": "A group of cold-blooded, aquatic vertebrates having gills, fins, a cartilaginous or bony endoskeleton, and elongated bodies covered with scales.", "PM": "1968; see FISH 1963-1967", "HN": "1968 (1963)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005399"}, {"RECTYPE": "D", "MH": "Fishes, Poisonous", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Poisonous Fishes", "MN": "B01.050.150.900.493.392", "FX": "Tetrodotoxin", "MH_TH": "NLM (1968)", "ST": "T013", "PI": "Fishes (1966-1967)", "MS": "Fishes that produce FISH VENOMS, as well as members of the TETRAODONTIFORMES order, which produce TETRODOTOXIN.", "PM": "68", "HN": "68", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005400"}, {"RECTYPE": "D", "MH": "Fissure in Ano", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anal Ulcer|T020|T033|NON|REL|NLM (1993)|911107|abbcdef", "ENTRY": "Ulcers, Anal", "MN": "C06.405.469.860.101.430", "MH_TH": "NLM (1966)", "ST": "T033", "AN": "do not confuse entry term ANAL FISSURE with ANAL FISTULA see RECTAL FISTULA", "MS": "A painful linear tear at the margin of the anus. It appears as a crack or slit in the mucous membrane of the anus and is very painful and difficult to heal.", "CATSH": "CAT LIST", "MR": "20200303", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005401"}, {"RECTYPE": "D", "MH": "Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fistulas", "MN": "C23.300.575", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "general or unspecified; prefer specifics; coordinate with organ or precoordinated organ/disease term; anal fistula or fistula in ano: index RECTAL FISTULA, not FISSURE IN ANO; artificial fistula: Manual 23.14; ECK FISTULA see PORTACAVAL SHUNT, SURGICAL is also available", "MS": "Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.", "CATSH": "CAT LIST", "MR": "19991109", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005402"}, {"RECTYPE": "D", "MH": "Fixation, Ocular", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Ocular Fixation|T042|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Ocular Focusing", "MN": "G14.350.253", "MH_TH": "NLM (1964)", "ST": "T042", "MS": "Positioning and accommodation of eyes that allows the image to be brought into place on the FOVEA CENTRALIS of each eye.", "PM": "68", "HN": "68(64)", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005403"}, {"RECTYPE": "D", "MH": "Fixatives", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO", "PRINT ENTRY": "Fixative|T130|NON|EQV|NLM (2021)|200319|abcdef", "ENTRY": "Agents, Pickling", "MN": "D27.720.355", "MH_TH": "NLM (1977)", "ST": "T130", "RN": "0", "AN": "not restricted to use with histological techniques: may be used with microbiological techniques ", "PI": "Histological Techniques (1966-1976)", "MS": "Agents employed in the preparation of histologic or pathologic specimens for the purpose of maintaining the existing form and structure of all of the constituent elements. Great numbers of different agents are used; some are also decalcifying and hardening agents. They must quickly kill and coagulate living tissue.", "OL": "search HISTOLOGICAL TECHNIQUES 1974", "PM": "77; was see under HISTOLOGICAL TECHNIQUES 1974", "HN": "77; was see under HISTOLOGICAL TECHNIQUES 1974", "MR": "20200527", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D005404"}, {"RECTYPE": "D", "MH": "D-Ala(2),MePhe(4),Met(0)-ol-enkephalin", "DS": "ALA MEPHE MET OL ENKEPHALIN D 02 04 00", "AQ": "AA AD AE AG AI AN BL CF CH CL CS DE DF EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DAMME|T116|T121|ABB|EQV|UNK (19XX)|830615|abbcdef", "ENTRY": "Tyr Ala Gly MePhe Met OH", "MN": "D12.776.631.650.575.281.381.500", "PA": "Analgesics", "MH_TH": "UNK (19XX)", "ST": "T121", "RN": "64854-64-4", "PI": "Enkephalins (1978-1982)", "MS": "A stable synthetic analog of methionine enkephalin (ENKEPHALIN, METHIONINE). Actions are similar to those of methionine enkephalin. Its effects can be reversed by narcotic antagonists such as naloxone.", "PM": "84", "HN": "84", "MR": "20151123", "DA": "19830615", "DC": "1", "DX": "19840101", "UI": "D005405"}, {"RECTYPE": "D", "MH": "Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide", "DS": "BISMETHYL HOMOPIPERAZINYLTHIOCARBONYL DISULFIDE 04 01", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "FLA 63|T109|T121|LAB|NRW|NLM (1975)|990101|abbcdef", "MN": "D03.383.129.308.090", "MH_TH": "UNK (19XX)", "ST": "T121", "N1": "1H-1,4-Diazepine, 1,1'-(dithiodicarbonothioyl)bis(hexahydro-4-methyl)", "RN": "26087-98-9", "PI": "Imidazoles (1972-1990)", "MS": "An inhibitor of the last step of noradrenaline biosynthesis.", "PM": "2002; see FLA 63 1991-2001 & IMIDAZOLES 1975-1990", "HN": "2002(1975); use IMIDAZOLES 1975-1990", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005406"}, {"RECTYPE": "D", "MH": "Flagella", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Flagellum|T026|NON|EQV|NLM (1995)|940513|abcdef", "MN": "A11.284.180.290", "MH_TH": "NLM (1964)", "ST": "T026", "MS": "A whiplike motility appendage present on the surface cells. Prokaryote flagella are composed of a protein called FLAGELLIN. Bacteria can have a single flagellum, a tuft at one pole, or multiple flagella covering the entire surface. In eukaryotes, flagella are threadlike protoplasmic extensions used to propel flagellates and sperm. Flagella have the same basic structure as CILIA but are longer in proportion to the cell bearing them and present in much smaller numbers. (From King & Stansfield, A Dictionary of Genetics, 4th ed)", "PM": "65", "HN": "65(64)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005407"}, {"RECTYPE": "D", "MH": "Flagellin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "MN": "D12.776.097.380", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Flagellins", "RN": "12777-81-0", "AN": "a bact protein", "PI": "Bacterial Proteins (1972-1974)", "MS": "A protein with a molecular weight of 40,000 isolated from bacterial flagella. At appropriate pH and salt concentration, three flagellin monomers can spontaneously reaggregate to form structures which appear identical to intact flagella.", "PM": "91; was see under BACTERIAL PROTEINS 1975-90", "HN": "91(75); was see under BACTERIAL PROTEINS 1975-90", "MR": "19950519", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005408"}, {"RECTYPE": "D", "MH": "Flail Chest", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stove-in Chest|T047|NON|EQV|UNK (19XX)|781221|abcdef", "ENTRY": "Stove in Chest", "MN": "C26.891.315", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Thoracic Injuries (1966-1979)", "MS": "A complication of multiple RIB FRACTURES; RIB and STERNUM fractures, or thoracic surgery. A portion of the THORACIC WALL becomes isolated from the RIB CAGE and exhibits paradoxical respiration.", "PM": "91; was see under THORACIC INJURIES 1980-90", "HN": "91(80); was see under THORACIC INJURIES 1980-90", "CATSH": "CAT LIST", "MR": "20160303", "DA": "19781221", "DC": "1", "DX": "19910101", "UI": "D005409"}, {"RECTYPE": "D", "MH": "Flame Ionization", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Ionizations, Flame", "MN": "E05.196.181.349.390", "MH_TH": "NLM (1975)", "ST": "T059", "AN": "a type of gas chromatogr; NIM", "MS": "Pyrolysis of organic compounds at the temperature of a hydrogen-air flame to produce ionic intermediates which can be collected and the resulting ion current measured by gas chromatography.", "PM": "91; was see under CHROMATOGRAPHY, GAS 1975-90", "HN": "91(75); was see under CHROMATOGRAPHY, GAS 1975-90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D005410"}, {"RECTYPE": "D", "MH": "Flame Retardants", "AQ": "AD AE AN CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Flame Retardant|T120|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Retardants, Flame", "MN": "D27.720.361", "MH_TH": "NLM (1978)", "ST": "T120", "RN": "0", "PI": "specific substance (1966-1977)", "MS": "Materials applied to fabrics, bedding, furniture, plastics, etc. to retard their burning; many may leach out and cause allergies or other harm.", "PM": "78", "HN": "78; was in Cat D & J 1978-82", "MR": "20200527", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D005411"}, {"RECTYPE": "D", "MH": "Flatfishes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Turbot|T013|NON|NRW|UNK (19XX)|860415|abcdef", "ENTRY": "Turbots", "MN": "B01.050.150.900.493.418", "MH_TH": "NLM (1987)", "ST": "T013", "RN": "txid8252", "RR": "txid52904", "AN": "sole may be SOLEA see FLATFISHES or FLOUNDER (Pleuronectidae); check text", "PI": "Fishes (1966-1986)", "MS": "Common name for the order Pleuronectiformes. A very distinctive group in that during development they become asymmetrical, i.e., one eye migrates to lie adjacent to the other. They swim on the eyeless side. FLOUNDER, sole, and turbot, along with several others, are included in this order.", "PM": "1987", "HN": "1987", "MR": "20200813", "DA": "19860415", "DC": "1", "DX": "19870101", "UI": "D005412"}, {"RECTYPE": "D", "MH": "Flatfoot", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pes Planus|T190|NON|EQV|UNK (19XX)|870402|abcdef", "ENTRY": "Valgus, Talipes", "MN": "C16.131.621.585.512.500.681.250", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "congenital or acquired", "MS": "Anomaly in which one or more of the arches of the feet are flat.", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005413"}, {"RECTYPE": "D", "MH": "Flatulence", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Flatus|T184|NON|EQV|UNK (19XX)|880412|abcdef", "MN": "C23.888.821.360", "FX": "Antifoaming Agents", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "/drug ther: consider also ANTIFOAMING AGENTS; see note on \"intestinal gases\" under GASES", "MS": "Production or presence of gas in the gastrointestinal tract which may be expelled through the anus.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005414"}, {"RECTYPE": "D", "MH": "Flavins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.767.405", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with FLAVONES", "MS": "Derivatives of the dimethylisoalloxazine (7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione) skeleton. Flavin derivatives serve an electron transfer function as ENZYME COFACTORS in FLAVOPROTEINS.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005415"}, {"RECTYPE": "D", "MH": "Flavivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Group B Arboviruses", "MN": "B04.820.578.344.350", "MH_TH": "NLM (1981)", "ST": "T005", "RN": "txid11051", "PI": "Arboviruses (1966-1980)", "MS": "A genus of FLAVIVIRIDAE containing several subgroups and many species. Most are arboviruses transmitted by mosquitoes or ticks. The type species is YELLOW FEVER VIRUS.", "OL": "use FLAVIVIRUS to search FLAVIVIRUSES & ARBOVIRUSES GROUP B 1981-93; use ARBOVIRUSES 1978-80", "PM": "94; was FLAVIVIRUSES 1981-93, was see ARBOVIRUSES 1978-80; ARBOVIRUS GROUP B was ARBOVIRUSES GROUP B see FLAVIVIRUSES 1981-93", "HN": "94; was FLAVIVIRUSES 1981-93, was see ARBOVIRUSES 1978-80; ARBOVIRUS GROUP B was ARBOVIRUSES GROUP B see FLAVIVIRUSES 1981-93", "MR": "20200813", "DA": "19800514", "DC": "1", "DX": "19810101", "UI": "D005416"}, {"RECTYPE": "D", "MH": "Flavobacterium", "DE": "FLAVOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.400.425.310.250", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid237", "AN": "infection: coord IM with FLAVOBACTERIACEAE INFECTIONS (IM)", "MS": "A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in SOIL and WATER. Its organisms are also found in raw meats, MILK and other FOOD, hospital environments, and human clinical specimens. Some species are pathogenic in humans.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005417"}, {"RECTYPE": "D", "MH": "Flavodoxin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "MN": "D12.776.331.400", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "a bact protein", "PI": "Flavoproteins (1970-1976)", "MS": "A low-molecular-weight (16,000) iron-free flavoprotein containing one molecule of flavin mononucleotide (FMN) and isolated from bacteria grown on an iron-deficient medium. It can replace ferredoxin in all the electron-transfer functions in which the latter is known to serve in bacterial cells.", "PM": "91; was see under FLAVOPROTEINS 1977-90", "HN": "91(77); was see under FLAVOPROTEINS 1977-90", "MR": "19920519", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D005418"}, {"RECTYPE": "D", "MH": "Flavonoids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Flavonoid|T109|NON|EQV|NLM (2021)|191113|abcdef", "ENTRY": "2 Phenyl Chromenes", "MN": "D03.633.100.150.266.450", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "AN": "do not confuse with FLAVINS, pigments", "MS": "A group of phenyl benzopyrans named for having structures like FLAVONES.", "PM": "2004; see FLAVONES 1963-2003; for BIOFLAVONOIDS see BIOFLAVONOIDS 1963-2003; QUERCETIN was under BIOFLAVONOIDS 1963-1974", "HN": "2004(1963)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D005419"}, {"RECTYPE": "D", "MH": "Flavoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Flavoprotein|T116|T123|NON|EQV|NLM (1991)|891012|abbcdef", "MN": "D12.776.331", "MH_TH": "NLM (1971)", "ST": "T123", "RN": "0", "PI": "Proteins (1966-1970)", "PM": "73", "HN": "73(71)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005420"}, {"RECTYPE": "D", "MH": "Flavoring Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME MI PD PK PO PS RE SD ST TO TU VI", "ENTRY": "Flavoring Agent", "MN": "J02.500.514.500.400", "MH_TH": "NLM (1966)", "ST": "T120", "RN": "0", "AN": "coordinate with specific substance if pertinent", "MS": "Substances added to foods and medicine to improve the taste.", "OL": "use FLAVORING AGENTS to search VANILLIN 1966-83", "PM": "VANILLIN was see FLAVORING AGENTS 1983, was heading 1963-82", "HN": "VANILLIN was see FLAVORING AGENTS 1983, was heading 1963-82", "MR": "20170622", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D005421"}, {"RECTYPE": "D", "MH": "Flavoxate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Flavoxate", "MN": "D03.633.100.150.266.450.260.444", "PA": "Urological Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester", "RN": "3E74Y80MEY", "RR": "9C05J6089W", "PI": "Piperidines (1972-1976)", "MS": "A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist.", "PM": "91; was see under FLAVONES 1977-90", "HN": "91(77); was see under FLAVONES 1977-90", "MR": "20170524", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D005422"}, {"RECTYPE": "D", "MH": "Siphonaptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Fleas|T204|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Flea", "MN": "B01.050.500.131.617.720.500.500.968", "MH_TH": "UNK (19XX)", "ST": "T204", "RN": "txid7509", "MS": "An order of parasitic, blood-sucking, wingless INSECTS with the common name of fleas.", "PM": "2011; see FLEAS 1980-2010, see SIPHONAPTERA 1975-1979, see FLEAS 1963-1974", "HN": "2011(1963)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "20110101", "UI": "D005423"}, {"RECTYPE": "D", "MH": "Flecainide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Flecainide Acetate|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1977)|USP (19XX)|910422|abbcdeeef", "ENTRY": "Flecainid Isis", "MN": "D03.383.621.270", "PA": "Voltage-Gated Sodium Channel Blockers", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-", "RN": "K94FTS1806", "RR": "M8U465Q1WQ", "PI": "Piperidines (1966-1986)", "MS": "A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.", "PM": "1992; wsee FLECAINIDE ACETATE 1991; see FLECAINIDE 1987-1990", "HN": "1992; use FLECAINIDE ACETATE 1991; use FLECAINIDE 1987-1990", "MR": "20180301", "DA": "19860602", "DC": "1", "DX": "19870101", "UI": "D005424"}, {"RECTYPE": "D", "MH": "Flicker Fusion", "AQ": "DE ES GE IM PH RE", "ENTRY": "Fusions, Flicker", "MN": "G14.370", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "also called flicker fusion frequency (FFF)", "MS": "The point or frequency at which all flicker of an intermittent light stimulus disappears.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005425"}, {"RECTYPE": "D", "MH": "Flight, Animal", "AQ": "DE PH RE", "ENTRY": "Flights, Animal", "MN": "G11.427.410.698.416", "MH_TH": "NLM (1972)", "ST": "T040", "AN": "do not confuse with FLIGHT REACTION see ESCAPE REACTION", "PI": "specific animal", "MS": "The use of wings or wing-like appendages to remain aloft and move through the air.", "PM": "74", "HN": "74(72)", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005426"}, {"RECTYPE": "D", "MH": "Flocculation", "AQ": "DE RE", "ENTRY": "Flocculations", "MN": "G02.159.347", "MH_TH": "NLM (1972)", "ST": "T070", "AN": "NIM", "PI": "Precipitation (1966-1971)", "MS": "The aggregation of suspended solids into larger clumps.", "PM": "91; was see under PRECIPITATION 1972-90", "HN": "91(72); was see under PRECIPITATION 1972-90", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005427"}, {"RECTYPE": "D", "MH": "Flocculation Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Flocculation", "MN": "E05.478.605.492.300", "MH_TH": "NLM (1973)", "ST": "T059", "PI": "Serodiagnosis (1966-1972)", "MS": "Precipitin tests which occur over a narrow range of antigen-antibody ratio, due chiefly to peculiarities of the antibody (precipitin). (From Stedman, 26th ed)", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005428"}, {"RECTYPE": "D", "MH": "Floors and Floorcoverings", "DE": "FLOORS FLOORCOVERINGS", "AQ": "CL EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Floorcoverings|T073|NON|NRW|NLM (1991)|900222|abcdef", "ENTRY": "Floorcoverings and Floors", "MN": "J01.086.339.140", "MH_TH": "NLM (1977)", "ST": "T073", "AN": "for houses, commercial establishments, hospitals, institutions, etc.", "MS": "The surface of a structure upon which one stands or walks.", "PM": "91; was see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-90", "HN": "91(Aug 77); was see under FACILITY DESIGN AND CONSTRUCTION 1977-90", "MR": "19920515", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D005430"}, {"RECTYPE": "D", "MH": "Florida", "AQ": "EH EP", "MN": "Z01.107.567.875.750.350", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on east by the Atlantic Ocean, on the south by the Gulf of Mexico, on the west by Alabama and on the north by Alabama and Georgia.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005431"}, {"RECTYPE": "D", "MH": "Flounder", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Pseudopleuronectes|T013|NON|NRW|UNK (19XX)|860415|abcdef", "ENTRY": "Flounders", "MN": "B01.050.150.900.493.418.438", "MH_TH": "NLM (1987)", "ST": "T013", "RR": "txid8264", "AN": "sole may be FLOUNDER (Pleuronectidae) or SOLEA see FLATFISHES", "PI": "Fishes (1966-1986)", "MS": "Common name for two families of FLATFISHES belonging to the order Pleuronectiformes: left-eye flounders (Bothidae) and right-eye flounders (Pleuronectidae). The latter is more commonly used in research.", "PM": "91; was see under FLATFISHES 1987-90", "HN": "91(87); was see under FLATFISHES 1987-90", "MR": "20200902", "DA": "19860415", "DC": "1", "DX": "19910101", "UI": "D005432"}, {"RECTYPE": "D", "MH": "Flour", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Wheat Meal|T168|NON|NRW|NLM (2023)|220112|abcdef", "ENTRY": "Wheat Meals", "MN": "J02.500.484", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "FISH FLOUR is available ", "MS": "A powdery meal obtained from ground up starchy foodstuff, such as seeds of WHEAT; RICE and other EDIBLE GRAIN; LEGUMES; and NUTS; or ground up PLANT TUBERS.", "MR": "20220406", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005433"}, {"RECTYPE": "D", "MH": "Flow Cytometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Microfluorometry, Flow|T059|NON|EQV|UNK (19XX)|810224|abcdef", "ENTRY": "Sortings, Fluorescence-Activated Cell", "MN": "E05.242.386.350", "MH_TH": "NLM (1982)", "ST": "T059", "AN": "flow cell sorting & FLUORESCENCE-ACTIVATED CELL SORTING: coord with CELL SEPARATION", "MS": "Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake.", "OL": "use FLUOROIMMUNOASSAY to search FLOW MICROFLUORIMETRY 1989-90", "PM": "82; FLOW MICROFLUORIMETRY was see FLUOROIMMUNOASSAY 1989-90", "HN": "82; FLOW MICROFLUORIMETRY was see FLUOROIMMUNOASSAY 1989-90", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19810224", "DC": "1", "DX": "19820101", "UI": "D005434"}, {"RECTYPE": "D", "MH": "Floxacillin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluorochloroxacillin|T109|T195|NON|EQV|UNK (19XX)|840213|abbcdef", "MN": "D03.633.100.300.750.625.150.250", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1972)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-", "RN": "43B2M34G2V", "RR": "5250-39-5 (Floxacillin)", "PI": "Cloxacillin (1974)", "MS": "Antibiotic analog of CLOXACILLIN.", "PM": "91; was see under CLOXACILLIN 1975-90", "HN": "91(75); was see under CLOXACILLIN 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005436"}, {"RECTYPE": "D", "MH": "Flucytosine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "5-Fluorocytosine|T114|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741127|FLUOROCYTOSINE 05|abbcdeefs", "ENTRY": "Ancotil|T114|T121|TRD|NRW|AU|DE|FR|IE|NL|UK|041227|abbcdeeeeeef", "MN": "D03.383.742.698.421.431", "PA": "Antimetabolites", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2(1H)-Pyrimidinone, 4-amino-5-fluoro-", "RN": "D83282DT06", "RR": "2022-85-7 (Flucytosine)", "PI": "Cytosine (1966-1971)", "MS": "A fluorinated cytosine analog that is used as an antifungal agent.", "PM": "87; was see under CYTOSINE 1972-86", "HN": "87(72); was see under CYTOSINE 1972-86", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D005437"}, {"RECTYPE": "D", "MH": "Fludrocortisone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "9-Fluorocortisol|T109|T121|NON|EQV|UNK (19XX)|780518|FLUOROCORTISOL 09|abbcdefs", "ENTRY": "Merck, Astonin", "MN": "D04.210.500.745.745.654.600.500", "PA": "Anti-Inflammatory Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pregn-4-ene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-, (11beta)-", "RN": "U0476M545B", "RR": "127-31-1 (Fludrocortisone)", "MS": "A synthetic mineralocorticoid with anti-inflammatory activity.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005438"}, {"RECTYPE": "D", "MH": "Flufenamic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Flufenamic", "MN": "D02.455.426.559.389.127.020.906.750.249", "PA": "Anti-Inflammatory Agents", "MH_TH": "USAN (1962)", "ST": "T121", "N1": "Benzoic acid, 2-((3-(trifluoromethyl)phenyl)amino)-", "RN": "60GCX7Y6BH", "RR": "530-78-9 (Flufenamic Acid)", "MS": "An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)", "PM": "73", "HN": "73(65)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005439"}, {"RECTYPE": "D", "MH": "Fluid Therapy", "DE": "FLUID THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Rehydration, Oral|T061|NON|NRW|UNK (19XX)|860408|abcdef", "ENTRY": "Therapies, Oral Rehydration", "MN": "E02.319.360", "FX": "Rehydration Solutions", "MH_TH": "NLM (1979)", "ST": "T061", "AN": "coordinate with disease /ther, not disease /diet ther; do not specify route of administration unless particularly significant ", "PI": "Water-Electrolyte Balance (1966-1978)", "MS": "Therapy whose basic objective is to restore the volume and composition of the body fluids to normal with respect to WATER-ELECTROLYTE BALANCE. Fluids may be administered intravenously, orally, by intermittent gavage, or by HYPODERMOCLYSIS.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19771128", "DC": "1", "DX": "19790101", "UI": "D005440"}, {"RECTYPE": "D", "MH": "Fluids and Secretions", "DE": "FLUIDS SECRETIONS", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Secretions and Fluids", "MN": "A12", "RH": "A12 - ANATOMY-FLUIDS AND SECRETIONS", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "PI": "specific secretion (1966-1997)", "MS": "Liquid substances produced by living organisms to fulfill specific functions or excreted as waste.", "PM": "98", "HN": "98; use explode", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D005441"}, {"RECTYPE": "D", "MH": "Flumazenil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Flumazepil|T109|T121|NON|EQV|NLM (1991)|900221|abbcdef", "ENTRY": "Ro 151788", "MN": "D03.633.100.079.080.070.305", "PA": "GABA Modulators", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4H-Imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester", "RN": "40P7XK9392", "RR": "78755-81-4 (Flumazenil)", "PI": "Benzodiazepinones (1974-1986)", "MS": "A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.", "OL": "use FLUMAZENIL to search FLUMAZEPIL 1987-90", "PM": "91; was FLUMAZEPIL 1987-90", "HN": "91; was FLUMAZEPIL 1987-90", "MR": "20170117", "DA": "19860409", "DC": "1", "DX": "19870101", "UI": "D005442"}, {"RECTYPE": "D", "MH": "Flumethasone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluorodexamethasone|T109|T121|NON|EQV|UNK (19XX)|750101|abbcdef", "MN": "D04.210.500.908.359", "PA": "Glucocorticoids", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,17,21-trihydroxy-16-methyl-, (6alpha,11beta,16alpha)-", "RN": "LR3CD8SX89", "RR": "2135-17-3 (Flumethasone)", "MS": "An anti-inflammatory glucocorticoid used in veterinary practice.", "PM": "72", "HN": "72(66)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D005443"}, {"RECTYPE": "D", "MH": "Flunarizine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R14950", "MN": "D03.383.606.450", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Piperazine, 1-(bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)-, (E)-", "RN": "R7PLA2DM0J", "RR": "C11102TO53", "PI": "Piperazines (1966-1974)", "MS": "Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.", "PM": "87", "HN": "87", "MR": "20160531", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D005444"}, {"RECTYPE": "D", "MH": "Flunitrazepam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rohypnol|T109|T121|TRD|NRW|DE|FDA SRS (2014)|FR|IE|MX|NL|NLM (1997)|UK|960619|abbcdeeeeeeeef", "ENTRY": "Von Ct, Flunizep", "MN": "D03.633.100.079.080.070.320", "PA": "GABA Modulators", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "2H-1,4-Benzodiazepin-2-one, 5-(2-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-", "RN": "620X0222FQ", "RR": "1622-62-4 (Flunitrazepam)", "AN": "colloquially called \"rophies\" and \"roofies\" from entry term ROHYPNOL", "PI": "Nitro Compounds (1974)", "MS": "A benzodiazepine with pharmacologic actions similar to those of DIAZEPAM that can cause ANTEROGRADE AMNESIA. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug.", "PM": "84; was see under BENZODIAZEPINE TRANQUILIZERS 1975-83", "HN": "84(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-83", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D005445"}, {"RECTYPE": "D", "MH": "Fluocinolone Acetonide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluortriamcinolone Acetonide|T109|T121|NON|EQV|UNK (19XX)|770202|abbcdef", "ENTRY": "Synalar HP", "MN": "D04.210.500.908.394", "PA": "Glucocorticoids", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)-", "RN": "0CD5FD6S2M", "RR": "67-73-2 (Fluocinolone Acetonide)", "MS": "A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732)", "PM": "65", "HN": "65(63)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005446"}, {"RECTYPE": "D", "MH": "Fluocinonide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluocinolide|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Fluocinolone Acetonide 21 Acetate", "MN": "D04.210.500.908.394.300", "PA": "Glucocorticoids", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)-", "RN": "2W4A77YPAN", "RR": "356-12-7 (Fluocinonide)", "PI": "Fluocinolone Acetonide (1972-1974)", "MS": "A topical glucocorticoid used in the treatment of ECZEMA.", "PM": "91; was see under FLUOCINOLONE ACETONIDE 1975-90", "HN": "91(75); was see under FLUOCINOLONE ACETONIDE 1975-90", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D005447"}, {"RECTYPE": "D", "MH": "Fluocortolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluocortolone Pivalate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|790530|abbcdeef", "ENTRY": "Pivalate, Fluocortolone", "MN": "D04.210.500.908.405", "PA": "Glucocorticoids", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 6-fluoro-11,21-dihydroxy-16-methyl-, (6alpha,11beta,16alpha)-", "RN": "65VXC1MH0J", "RR": "9J8AL6K50Q", "PI": "Steroids, Fluorinated (1974)", "MS": "A glucocorticoid with anti-inflammatory activity used topically for various skin disorders.", "OL": "use FLUOCORTOLONE to search FLUORMETHYLDEHYDROCORTICOSTERONE 1975-94", "PM": "80; was see under PREGNADIENEDIOLS 1975-79; FLUORMETHYLDEHYDROCORTICOSTERONE was see FLUOCORTOLONE 1975-94", "HN": "80(75); was see under PREGNADIENEDIOLS 1975-79; FLUORMETHYLDEHYDROCORTICOSTERONE was see FLUOCORTOLONE 1975-94", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D005448"}, {"RECTYPE": "D", "MH": "Fluorenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.389", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "do not confuse with FLUORINE", "MS": "A family of diphenylenemethane derivatives.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005449"}, {"RECTYPE": "D", "MH": "Fluorescamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Fluram|T109|T130|TRD|NRW|UNK (19XX)|870810|abbcdef", "MN": "D04.711.345", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Spiro(furan-2(3H),1'(3'H)-isobenzofuran)-3,3'-dione, 4-phenyl-", "RN": "38183-12-9", "PI": "Spiro Compounds (1973-1974)", "MS": "A nonfluorescent reagent for the detection of primary amines, peptides and proteins. The reaction products are highly fluorescent.", "PM": "91; was see under SPIRO COMPOUNDS 1975-90", "HN": "91(75); was see under SPIRO COMPOUNDS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005450"}, {"RECTYPE": "D", "MH": "Fluorescein Angiography", "DE": "FLUORESCEIN ANGIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Fundus Fluorescence Photography|T060|NON|NRW|UNK (19XX)|780227|FUNDUS FLUORESCENCE PHOTOGR|abcdefv", "ENTRY": "Photography, Fundus Fluorescence|T060|NON|NRW|NLM (1995)|931013|PHOTOGR FUNDUS FLUORESCENCE|abcdefv", "MN": "E01.370.380.250", "MH_TH": "NLM (1973)", "ST": "T060", "AN": "coordinate with disease /diag", "PI": "Photography (1966-1972)", "MS": "Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature.", "OL": "use FLUORESCEIN ANGIOGRAPHY to search FLUORESCENCE ANGIOGRAPHY & FUNDUS FLUORESCENCE ANGIOGRAPHY 1973-78", "PM": "79; was FLUORESCENCE ANGIOGRAPHY 1973-78", "HN": "79; was FLUORESCENCE ANGIOGRAPHY 1973-78; FUNDUS FLUORESCENCE PHOTOGRAPHY was see under FLUORESCENCE ANGIOGRAPHY 1973-78", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005451"}, {"RECTYPE": "D", "MH": "Fluoresceins", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tetraiodofluorescein|T109|T130|NON|NRW|UNK (19XX)|780207|abbcdef", "MN": "D04.711.347", "PA": "Fluorescent Dyes", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "RR": "15905-32-5", "MS": "A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.", "MR": "20220714", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005452"}, {"RECTYPE": "D", "MH": "Fluorescence", "MN": "G01.590.540.665.500", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "usually NIM", "MS": "The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005453"}, {"RECTYPE": "D", "MH": "Fluorescence Polarization", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Polarization, Fluorescence|T059|NON|EQV|NLM (1992)|910425|abcdef", "ENTRY": "Polarizations, Fluorescence", "MN": "E05.196.712.516.600.390", "MH_TH": "NLM (1979)", "ST": "T059", "AN": "determ of polarization of fluorescent light: do not confuse with FLUORESCENCE POLARIZATION IMMUNOASSAY, its application to hapten-antibody reaction; NIM", "PI": "Spectrometry, Fluorescence (1972-1978)", "MS": "Measurement of the polarization of fluorescent light from solutions or microscopic specimens. It is used to provide information concerning molecular size, shape, and conformation, molecular anisotropy, electronic energy transfer, molecular interaction, including dye and coenzyme binding, and the antigen-antibody reaction.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19780428", "DC": "1", "DX": "19790101", "UI": "D005454"}, {"RECTYPE": "D", "MH": "Fluorescent Antibody Technique", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Immunofluorescence Technique|T059|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Tracings, Fluorescent Protein", "MN": "E05.478.583.375", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "general or unspecified; prefer specifics", "MS": "Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy.", "OL": "use FLUORESCENT ANTIBODY TECHNIQUE to search FLUORESCENT ANTIBODY TECHNIC 1966-90", "PM": "91; was FLUORESCENT ANTIBODY TECHNIC 1963-90", "HN": "91; was FLUORESCENT ANTIBODY TECHNIC 1963-90", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005455"}, {"RECTYPE": "D", "MH": "Fluorescent Dyes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Fluorogenic Substrates|T130|NON|NRW|NLM (2021)|191206|abcdef", "ENTRY": "Substrates, Fluorogenic", "MN": "D27.720.470.410.505.500", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "MS": "Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags.", "MR": "20200409", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005456"}, {"RECTYPE": "D", "MH": "Fluoridation", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Fluoridation, Water", "MN": "N06.890.235", "MH_TH": "BIOETHICS (1989)", "ST": "T061", "AN": " \u200c/\u200cadv \u200ceff permitted but more likely is FLUORIDES \u200c/\u200cadv \u200ceff or specific fluoride term /adv eff; coordinate with substance  fluoridated", "MS": "Practice of adding fluoride to water, and other food or beverages, for the purpose of preventing DENTAL CARIES.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005457"}, {"RECTYPE": "D", "MH": "Fluoride Poisoning", "DE": "FLUORIDE POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Poisonings, Fluoride", "MN": "C25.723.380", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "coordinate with specific fluoride compound /pois if pertinent", "MS": "Poisoning that results from chronic or acute ingestion, injection, inhalation, or skin absorption of FLUORIDE compounds.", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005458"}, {"RECTYPE": "D", "MH": "Fluorides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Fluoride|T197|NON|EQV|FDA SRS (2014)|NLM (1994)|930601|abcdeef", "MN": "D01.303.350.300", "PA": "Cariostatic Agents", "FX": "Fluorosis, Dental", "EC": "poisoning:Fluoride Poisoning", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "Q80VPU408O", "AN": "only for inorganic cpds or fluoride ion; /admin: consider also FLUORIDES, TOPICAL", "MS": "Inorganic salts of hydrofluoric acid, HF, in which the fluorine atom is in the -1 oxidation state. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Sodium and stannous salts are commonly used in dentifrices.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005459"}, {"RECTYPE": "D", "MH": "Fluorides, Topical", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Fluoride Varnishes|T122|T197|NON|NRW|IOM (1990)|890512|abbcdef", "ENTRY": "Varnishes, Fluoride", "MN": "J01.637.051.223.432", "PA": "Cariostatic Agents", "MH_TH": "NLM (1965)", "ST": "T197", "RN": "0", "AN": "fluoride-containing toothpastes: index TOOTHPASTES (IM) + FLUORIDES (IM), not here; fluoride-containing mouthwashes: index MOUTHWASHES (IM) + FLUORIDES (IM), not here", "MS": "Fluorides, usually in pastes or gels, used for topical application to reduce the incidence of DENTAL CARIES.", "PM": "65", "HN": "65", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005460"}, {"RECTYPE": "D", "MH": "Fluorine", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Fluorine 19", "MN": "D01.268.380.300", "FX": "Fluorine Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Fluorine", "RN": "284SYP0193", "RR": "7782-41-4 (Fluorine)", "AN": "if discussed as a trace element, coordinate with TRACE ELEMENTS", "MS": "A nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as fluoride (FLUORIDES) to prevent dental caries.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005461"}, {"RECTYPE": "D", "MH": "Fluorine Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Fluorine", "MN": "D01.496.749.340", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1987)", "MS": "Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes.", "PM": "88", "HN": "88", "MR": "20170703", "DA": "19870406", "DC": "1", "DX": "19880101", "UI": "D005462"}, {"RECTYPE": "D", "MH": "Fluoroacetates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.526.510.286", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "MS": "Derivatives of acetic acid with one or more fluorines attached. They are almost odorless, difficult to detect chemically, and very stable. The acid itself, as well as the derivatives that are broken down in the body to the acid, are highly toxic substances, behaving as convulsant poisons with a delayed action. (From Miall's Dictionary of Chemistry, 5th ed)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005463"}, {"RECTYPE": "D", "MH": "Fluorobenzenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluorobenzene|T109|NON|EQV|NLM (2021)|191120|abcdef", "MN": "D02.455.526.510.432", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Derivatives of BENZENE that contain FLUORINE.", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005464"}, {"RECTYPE": "D", "MH": "Fluorocarbon Polymers", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Fluoropolymers|T109|NON|EQV|NLM (2023)|211123|abcdef", "ENTRY": "Resins, Fluorocarbon", "MN": "J01.637.051.720.395", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "PM": "66", "HN": "66", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005465"}, {"RECTYPE": "D", "MH": "Fluorocarbons", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyfluorocarbons|T109|NON|EQV|NLM (2023)|211124|abcdef", "ENTRY": "Telomer Alcohols, Polyfluorinated", "MN": "D02.455.526.510.435", "FX": "Blood Substitutes", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with HYDROCARBONS, FLUORINATED or CHLOROFLUOROCARBONS or TELOMERE", "PI": "Hydrocarbons, Fluorinated (1974-1976)", "MS": "Liquid perfluorinated carbon compounds which may or may not contain a hetero atom such as nitrogen, oxygen or sulfur, but do not contain another halogen or hydrogen atom. This concept includes fluorocarbon emulsions, and fluorocarbon blood substitutes. Perfluorinated and related polyfluorinated chemicals are referred to as PFAS and are defined as chemicals with at least two adjacent carbon atoms, where one carbon is fully fluorinated and the other is at least partially fluorinated.", "PM": "77; was see under FLUOROCARBON POLYMERS 1975-76; PERFLUOROBUTYL TETRAHYDROFURAN was see under FURANS 1975-77", "HN": "77(75); was see under FLUOROCARBON POLYMERS 1975-76", "MR": "20220708", "DA": "19741119", "DC": "1", "DX": "19770101", "UI": "D005466"}, {"RECTYPE": "D", "MH": "Floxuridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluorodeoxyuridine|T114|T121|NON|EQV|FDA SRS (2014)|NLM (1993)|920227|abbcdeef", "ENTRY": "5 Fluorodeoxyuridine", "MN": "D13.570.685.852.300.350", "PA": "Antimetabolites, Antineoplastic", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Uridine, 2'-deoxy-5-fluoro-", "RN": "039LU44I5M", "RR": "50-91-9 (Floxuridine)", "AN": "an antiviral & antineoplastic antimetabolite", "MS": "An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.", "OL": "use FLOXURIDINE to search FLUORODEOXYURIDINE 1966-92", "PM": "93; was FLUORODEOXYURIDINE 1963-92; FLOXURIDINE was see FLUORODEOXYURIDINE 1976-92", "HN": "93; was FLUORODEOXYURIDINE 1963-92; FLOXURIDINE was see FLUORODEOXYURIDINE 1976-92", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D005467"}, {"RECTYPE": "D", "MH": "Fluorodeoxyuridylate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "5 Fluoro 2' Deoxyuridine 5' Monophosphate", "MN": "D13.695.740.850.210.200", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "5'-Uridylic acid, 2'-deoxy-5-fluoro-", "RN": "134-46-3", "PI": "Uracil Nucleotides (1972-1974)", "MS": "5-Fluoro-2'-deoxyuridylate. An inhibitor of thymidylate synthetase. Formed from 5-fluorouracil or 5-fluorodeoxyuridine.", "PM": "91; was see under DEOXYURACIL NUCLEOTIDES 1978-90; was see under URACIL NUCLEOTIDES 1975-77", "HN": "91(75); was see under DEOXYURACIL NUCLEOTIDES 1978-90; was see under URACIL NUCLEOTIDES 1975-77", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005468"}, {"RECTYPE": "D", "MH": "Fluorometholone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "PMS Fluorometholone", "MN": "D04.210.500.908.431", "PA": "Glucocorticoids", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-", "RN": "SV0CSG527L", "RR": "426-13-1 (Fluorometholone)", "MS": "A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005469"}, {"RECTYPE": "D", "MH": "Fluorometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Fluorimetry|T059|NON|EQV|NLM (1993)|911118|abcdef", "ENTRY": "Analysis, Fluorometric", "MN": "E05.196.712.516.600", "MH_TH": "NLM (1964)", "ST": "T059", "MS": "An analytical method for detecting and measuring FLUORESCENCE in compounds or targets such as cells, proteins, or nucleotides, or targets previously labeled with FLUORESCENCE AGENTS.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005470"}, {"RECTYPE": "D", "MH": "Fluoroscopy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Fluoroscopies", "MN": "E01.370.350.700.225", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "usually NIM", "MS": "Production of an image when x-rays strike a fluorescent screen.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005471"}, {"RECTYPE": "D", "MH": "Fluorouracil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Haemato FU", "MN": "D03.383.742.698.875.404", "PA": "Immunosuppressive Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4(1H,3H)-Pyrimidinedione, 5-fluoro-", "RN": "U3P01618RT", "RR": "68021-61-4 (mono-K salt)", "MS": "A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005472"}, {"RECTYPE": "D", "MH": "Fluoxetine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Lilly110140", "MN": "D02.092.831.280", "PA": "Selective Serotonin Reuptake Inhibitors", "MH_TH": "USAN (1975)", "ST": "T121", "N1": "Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-", "RN": "01K63SUP8D", "RR": "I9W7N6B1KJ", "PI": "Propylamines (1966-1978)", "MS": "The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.", "OL": "use FLUOXETINE to search FLUOXETIN 1979-89", "PM": "90; was FLUOXETIN see under PROPYLAMINES 1979-88; was FLUOXETIN 1989", "HN": "90(79); was FLUOXETIN see under PROPYLAMINES 1979-88; was FLUOXETIN 1989", "MR": "20220718", "DA": "19771209", "DC": "1", "DX": "19890101", "UI": "D005473"}, {"RECTYPE": "D", "MH": "Fluoxymesterone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluoximesteron|T109|T121|NON|EQV|UNK (19XX)|770111|abbcdef", "ENTRY": "Android F", "MN": "D04.210.500.908.466", "PA": "Anabolic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Androst-4-en-3-one, 9-fluoro-11,17-dihydroxy-17-methyl-, (11beta,17beta)-", "RN": "9JU12S4YFY", "RR": "76-43-7 (Fluoxymesterone)", "MS": "An anabolic steroid that has been used in the treatment of male HYPOGONADISM, delayed puberty in males, and in the treatment of breast neoplasms in women.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005474"}, {"RECTYPE": "D", "MH": "Flupenthixol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "cis-Flupenthixol|T109|T121|NON|EQV|UNK (19XX)|840305|abbcdef", "MN": "D03.633.300.953.704.360", "PA": "Dopamine Antagonists", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-9H-thioxanthen-9-ylidene)propyl)-", "RN": "FA0UYH6QUO", "RR": "2709-56-0 (Flupenthixol)", "PI": "Thioxanthenes (1974)", "MS": "A thioxanthene neuroleptic that, unlike CHLORPROMAZINE, is claimed to have CNS-activating properties. It is used in the treatment of psychoses although not in excited or manic patients. (From Martindale, The Extra Pharmacopoeia, 30th ed, p595)", "PM": "91; was see under THIOXANTHENES 1975-90", "HN": "91(75); was see under THIOXANTHENES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005475"}, {"RECTYPE": "D", "MH": "Fluphenazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Flufenazin|T109|T121|NON|EQV|UNK (19XX)|770111|abbcdef", "ENTRY": "Hydrochloride, Fluphenazine", "MN": "D03.633.300.783.326", "PA": "Dopamine Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-", "RN": "S79426A41Z", "RR": "ZOU145W1XL", "MS": "A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE.", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005476"}, {"RECTYPE": "D", "MH": "Fluprednisolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.908.502", "PA": "Glucocorticoids", "MH_TH": "USAN (1962)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 6-fluoro-11,17,21-trihydroxy-, (6alpha,11beta)-", "RN": "9H05937G3X", "RR": "53-34-9 (Fluprednisolone)", "MS": "A synthetic glucocorticoid with anti-inflammatory properties.", "PM": "65", "HN": "65", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005477"}, {"RECTYPE": "D", "MH": "Flurandrenolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Flurandrenolide|T109|T121|NON|EQV|FDA SRS (2014)|USAN (1969)|USP (19XX)|761230|abbcdeeef", "ENTRY": "Haelan|T109|T121|TRD|NRW|UK|041227|abbcdef", "MN": "D04.210.500.908.537", "PA": "Glucocorticoids", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Pregn-4-ene-3,20-dione, 6-fluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)-", "RN": "8EUL29XUQT", "RR": "1524-88-5 (Flurandrenolone)", "MS": "A corticosteroid used topically in the treatment of various skin disorders. It is usually employed as a cream or an ointment, and is also used as a polyethylene tape with an adhesive. (From Martindale, The Extra Pharmacopoeia, 30th ed, p733)", "OL": "use FLURANDRENOLONE to search FLUDROXYCORTID 1977-94", "PM": "65; FLUDROXYCORTID was see FLURANDRENOLONE 1977-94", "HN": "65(63); FLUDROXYCORTID was see FLURANDRENOLONE 1977-94", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005478"}, {"RECTYPE": "D", "MH": "Flurazepam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Flurazepam", "MN": "D03.633.100.079.080.070.348", "PA": "Hypnotics and Sedatives", "MH_TH": "JAN (19XX)", "ST": "T121", "N1": "2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-", "RN": "IHP475989U", "RR": "7C4JH842IJ", "PI": "Hypnotics and Sedatives (1967-1974)", "MS": "A benzodiazepine derivative used mainly as a hypnotic.", "PM": "80; was see under BENZODIAZEPINE TRANQUILIZERS 1975-79", "HN": "80(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-79", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D005479"}, {"RECTYPE": "D", "MH": "Flurbiprofen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ratio Flurbiprofen", "MN": "D02.455.426.559.389.185.350", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "(1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-", "RN": "5GRO578KLP", "RR": "Z5B97MU9K4", "PI": "Propionates (1973-1975)", "MS": "An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.", "PM": "1990; see PROPIONATES 1976-1989", "HN": "1990 (1976)", "MR": "20180410", "DA": "19750725", "DC": "1", "DX": "19900101", "UI": "D005480"}, {"RECTYPE": "D", "MH": "Flurothyl", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Indoklon|T109|T121|TRD|NRW|UNK (19XX)|811023|abbcdef", "MN": "D02.455.526.510.576", "PA": "Convulsants", "MH_TH": "USAN (1962)", "ST": "T121", "N1": "Ethane, 1,1'-oxybis(2,2,2-trifluoro)-", "RN": "9Z467FG2YK", "RR": "333-36-8 (Flurothyl)", "PI": "Ethers (1966-1972)", "MS": "A convulsant primarily used in experimental animals. It was formerly used to induce convulsions as a alternative to electroshock therapy.", "PM": "73", "HN": "73", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005481"}, {"RECTYPE": "D", "MH": "Flushing", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Flushings", "MN": "C23.888.885.344", "FX": "Blushing", "MH_TH": "NLM (1984)", "ST": "T184", "AN": "do not confuse with BLUSHING or HOT FLASHES", "MS": "A transient reddening of the face that may be due to fever, certain drugs, exertion, or stress.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19830531", "DC": "1", "DX": "19840101", "UI": "D005483"}, {"RECTYPE": "D", "MH": "Fluspirilene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Spirodiflamine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Beta, Fluspirilen", "MN": "D04.711.350", "PA": "Dopamine Antagonists", "MH_TH": "USAN (1970)", "ST": "T121", "N1": "1,3,8-Triazaspiro(4.5)decan-4-one, 8-(4,4-bis(4-fluorophenyl)butyl)-1-phenyl-", "RN": "C5QA4GLR9M", "RR": "1841-19-6 (Fluspirilene)", "PI": "Spiro Compounds (1969-1974)", "MS": "A long-acting injectable antipsychotic agent used for chronic schizophrenia.", "PM": "91; was see under SPIRO COMPOUNDS 1975-90", "HN": "91(75); was see under SPIRO COMPOUNDS 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005484"}, {"RECTYPE": "D", "MH": "Flutamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Niftolid|T109|T121|NON|EQV|NLM (1991)|900307|abbcdef", "ENTRY": "SCH13521", "MN": "D02.092.146.113.420", "PA": "Antineoplastic Agents, Hormonal", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Propanamide, 2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-", "RN": "76W6J0943E", "RR": "13311-84-7 (Flutamide)", "PI": "Nitro Compounds (1973-1974)", "MS": "An antiandrogen with about the same potency as cyproterone in rodent and canine species.", "PM": "91; was see under ANILIDES 1975-90", "HN": "91(75); was see under ANILIDES 1975-90", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005485"}, {"RECTYPE": "D", "MH": "Flavin Mononucleotide", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "FMN|T114|T121|T123|ACR|EQV|NLM (1966)|990101|abbbcdef", "ENTRY": "Riboflavin Phosphate, Sodium", "MN": "D23.767.405.650.500", "PA": "Vitamin B Complex", "MH_TH": "UNK (19XX)", "ST": "T123", "N1": "Riboflavin 5'-(dihydrogen phosphate)", "RN": "7N464URE7E", "RR": "6184-17-4 (mono-Na salt, di-H2O)", "MS": "A coenzyme for a number of oxidative enzymes including NADH DEHYDROGENASE. It is the principal form in which RIBOFLAVIN is found in cells and tissues.", "PM": "1996; see FMN 1966-2002", "HN": "1966(2003);", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005486"}, {"RECTYPE": "D", "MH": "Foam Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Foam Cell", "MN": "A15.382.680.397.368", "MH_TH": "NLM (1977)", "ST": "T025", "PI": "Macrophages (1966-1976)", "MS": "Lipid-laden macrophages originating from monocytes or from smooth muscle cells.", "PM": "91; was see under MACROPHAGES 1977-90", "HN": "91(77); was see under MACROPHAGES 1977-90", "MR": "20180630", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D005487"}, {"RECTYPE": "D", "MH": "Focal Dermal Hypoplasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Goltz Syndrome|T019|T047|EPO|EQV|GHR (2014)|NLM (1993)|OMIM (2013)|ORD (2010)|920407|abbcdeeeef", "ENTRY": "Syndrome, Goltz-Gorlin", "MN": "C17.800.827.250.424", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse entry term GOLTZ-GORLIN SYNDROME with GORLIN-GOLTZ SYNDROME see BASAL CELL NEVUS SYNDROME", "PI": "Skin Diseases (1966-1984)", "MS": "A genetic skin disease characterized by hypoplasia of the dermis, herniations of fat, and hand anomalies. It is found exclusively in females and transmitted as an X-linked dominant trait.", "OL": "use FOCAL DERMAL HYPOPLASIA to search GOLTZ-GORLIN SYNDROME 1985-92", "PM": "91; was see under ECTODERMAL DYSPLASIA 1987-90, was see under ECTODERMAL DEFECT, CONGENITAL 1985-86; GOLTZ-GORLIN SYNDROME was see FOCAL DERMAL HYPOPLASIA 1985-92", "HN": "91(85); was see under ECTODERMAL DYSPLASIA 1987-90, was see under ECTODERMAL DEFECT, CONGENITAL 1985-86; GOLTZ-GORLIN SYNDROME was see FOCAL DERMAL HYPOPLASIA 1985-92", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19840405", "DC": "1", "DX": "19910101", "UI": "D005489"}, {"RECTYPE": "D", "MH": "Focal Infection", "DE": "FOCAL INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Focal", "MN": "C01.392", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with precoordinated organ/disease site of infection (IM) + specific infection (IM)", "MS": "An infection at a specific location that may spread to another region of the body.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005490"}, {"RECTYPE": "D", "MH": "Focal Infection, Dental", "DE": "FOCAL INFECT DENT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Dental Focal Infection|T046|NON|EQV|UNK (19XX)|740330|DENT FOCAL INFECT|abcdefv", "ENTRY": "Infections, Dental Focal|T046|NON|EQV|NLM (1991)|900126|INFECT DENT FOCAL|abcdefv", "MN": "C07.793.348", "MH_TH": "NLM (1964)", "ST": "T046", "AN": "coordinate with precoordinated organ/disease site of infection + name of infection ", "MS": "Secondary or systemic infections due to dissemination throughout the body of microorganisms whose primary focus of infection lies in the periodontal tissues.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D005491"}, {"RECTYPE": "D", "MH": "Folic Acid", "AQ": "AA AD AE AG AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitamin M|T109|T127|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbcdeef", "ENTRY": "B9, Vitamin", "MN": "D03.633.100.733.631.400", "PA": "Vitamin B Complex", "EC": "deficiency:Folic Acid Deficiency", "MH_TH": "USP (19XX)", "ST": "T127", "N1": "L-Glutamic acid, N-(4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-", "RN": "935E97BOY8", "RR": "9P9W8GGU78", "MS": "A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.", "OL": "use FOLIC ACID/AA to search HOMOFOLIC ACID 1975-84", "PM": "HOMOFOLIC ACID was heading 1975-84", "HN": "HOMOFOLIC ACID was heading 1975-84", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D005492"}, {"RECTYPE": "D", "MH": "Folic Acid Antagonists", "DE": "FOLIC ACID ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Folic Acid Antagonist|T121|NON|EQV|NLM (2022)|201007|abcdef", "ENTRY": "Reductase Inhibitors, Dihydrofolate", "MN": "D27.505.519.389.350", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005493"}, {"RECTYPE": "D", "MH": "Folic Acid Deficiency", "DE": "FOLIC ACID DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Folic Acid Deficiencies", "MN": "C18.654.521.500.133.699.308", "FX": "FIGLU Test", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "A nutritional condition produced by a deficiency of FOLIC ACID in the diet. Many plant and animal tissues contain folic acid, abundant in green leafy vegetables, yeast, liver, and mushrooms but destroyed by long-term cooking. Alcohol interferes with its intermediate metabolism and absorption. Folic acid deficiency may develop in long-term anticonvulsant therapy or with use of oral contraceptives. This deficiency causes anemia, macrocytic anemia, and megaloblastic anemia. It is indistinguishable from vitamin B 12 deficiency in peripheral blood and bone marrow findings, but the neurologic lesions seen in B 12 deficiency do not occur. (Merck Manual, 16th ed)", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005494"}, {"RECTYPE": "D", "MH": "Folklore", "AQ": "HI PX", "PRINT ENTRY": "Folktale|T078|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Folktales", "MN": "K01.517.455", "MH_TH": "NLM (1978)", "ST": "T078", "MS": "The common orally transmitted traditions, folktales, festivals, songs, superstitions, and stories of all peoples.", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005495"}, {"RECTYPE": "D", "MH": "Follicular Atresia", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Atresia, Follicular|T042|NON|EQV|UNK (19XX)|840531|abcdef", "ENTRY": "Follicular Atresias", "MN": "G08.686.290", "MH_TH": "NLM (1985)", "ST": "T042", "PI": "Ovulation (1966-1984)", "MS": "The degeneration and resorption of an OVARIAN FOLLICLE before it reaches maturity and ruptures.", "PM": "91; was see under FOLLICULAR PHASE 1985-90", "HN": "91(85); was see under FOLLICULAR PHASE 1985-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19840531", "DC": "1", "DX": "19910101", "UI": "D005496"}, {"RECTYPE": "D", "MH": "Follicular Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Follicular Cysts", "MN": "C04.182.300", "MH_TH": "NLM (1987)", "ST": "T020", "AN": "non-neoplastic", "MS": "Cyst due to the occlusion of the duct of a follicle or small gland.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "19920520", "DA": "19860623", "DC": "1", "DX": "19870101", "UI": "D005497"}, {"RECTYPE": "D", "MH": "Follicular Phase", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Preovulatory Phase|T079|NON|EQV|UNK (19XX)|840531|abcdef", "ENTRY": "Proliferative Phase, Menstrual", "MN": "G08.686.605.310", "MH_TH": "NLM (1975)", "ST": "T079", "MS": "The period of the MENSTRUAL CYCLE representing follicular growth, increase in ovarian estrogen (ESTROGENS) production, and epithelial proliferation of the ENDOMETRIUM. Follicular phase begins with the onset of MENSTRUATION and ends with OVULATION.", "PM": "1985; was MENSTRUATION, FOLLICULAR PHASE see under MENSTRUATION 1975-1984; for MENSTRUAL PROLIFERATIVE PHASE see MENSTRUAL CYCLE 1985-2002", "HN": "1985(1975); was MENSTRUATION, FOLLICULAR PHASE see under MENSTRUATION 1975-1984; for MENSTRUAL PROLIFERATIVE PHASE use MENSTRUAL CYCLE 1985-2002", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741111", "DC": "1", "DX": "19850101", "UI": "D005498"}, {"RECTYPE": "D", "MH": "Folliculitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sycosis|T047|NON|REL|UNK (19XX)|770425|abcdef", "ENTRY": "Sycoses", "MN": "C17.800.329.500", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "inflammation of hair follicles", "MS": "Inflammation of follicles, primarily hair follicles.", "OL": "use FOLLICULITIS to search SYCOSIS 1966-77", "PM": "SYCOSIS was heading 1963-77", "HN": "SYCOSIS was heading 1963-77", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D005499"}, {"RECTYPE": "D", "MH": "Follow-Up Studies", "ENTRY": "Study, Followup", "MN": "N06.850.520.450.500.750.350", "MH_TH": "POPLINE (1978)", "ST": "T062", "AN": "IM general only; coordinate NIM with specific disease (IM); add geographic term if pertinent", "MS": "Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D005500"}, {"RECTYPE": "D", "MH": "Food", "AQ": "AE CL EC HI RE SN ST TO VI", "ENTRY": "Foods", "MN": "J02.500", "FX": "Plants, Edible", "EC": "supply & distribution:Food Supply", "MH_TH": "BIOETHICS (1989)", "ST": "T168", "MS": "Substances taken in by the body to provide nourishment.", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005502"}, {"RECTYPE": "D", "MH": "Food Additives", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Food Additive", "MN": "J02.500.514.500", "FX": "Pharmaceutic Aids", "MH_TH": "NLM (1966)", "ST": "T168", "RN": "0", "MS": "Substances used in the processing or storage of foods or animal feed including ANTIOXIDANTS; FOOD PRESERVATIVES; FOOD COLORING AGENTS; FLAVORING AGENTS; ANTI-INFECTIVE AGENTS; EXCIPIENTS and other similarly used substances. Many of the same substances are used as PHARMACEUTIC AIDS.", "MR": "20170622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005503"}, {"RECTYPE": "D", "MH": "Food Analysis", "DE": "FOOD ANAL", "AQ": "CL EC ES HI IS LJ MT SN ST", "ENTRY": "Food Analyses", "MN": "J01.576.423.850.100", "FX": "Food Quality", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "general only; prefer /anal with specific food item", "MS": "Measurement and evaluation of the components of substances to be taken as FOOD.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005504"}, {"RECTYPE": "D", "MH": "Food Coloring Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Food Colorants|T120|NON|EQV|NLM (1996)|941020|abcdef", "ENTRY": "Colorants, Food", "MN": "D27.720.372.300.355", "MH_TH": "NLM (1975)", "ST": "T120", "RN": "0", "PI": "Food Additives (1966-1974)", "MS": "Natural or synthetic dyes used as coloring agents in processed foods.", "PM": "75", "HN": "75", "MR": "20170628", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D005505"}, {"RECTYPE": "D", "MH": "Food Contamination", "AQ": "AN EC LJ PC SN", "PRINT ENTRY": "Food Adulteration|T068|NON|NRW|UNK (19XX)|770428|abcdef", "ENTRY": "Food Contaminations", "MN": "N06.850.601.500.249", "MH_TH": "NLM (1966)", "ST": "T067", "AN": "coordinate with specific food item; contamination by dirt, dust, chemicals & toxic substances, organisms; contamination by microbes: consider FOOD MICROBIOLOGY + specific microbe + specific food item /microbiol; contamination by parasites: consider FOOD PARASITOLOGY + specific parasite + specific food item /parasitol", "MS": "The presence in food of harmful, unpalatable, or otherwise objectionable foreign substances, e.g. chemicals, microorganisms or diluents, before, during, or after processing or storage.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005506"}, {"RECTYPE": "D", "MH": "Food Contamination, Radioactive", "AQ": "AN EC LJ PC SN", "ENTRY": "Radioactive Food Contamination", "MN": "N06.850.810.125", "MH_TH": "NLM (1966)", "ST": "T069", "AN": "do not confuse with FOOD IRRADIATION: food preservation by irradiation", "MS": "Exposure of FOOD to radioactive substances, distinguishable from FOOD IRRADIATION, a food preservation technique.", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005507"}, {"RECTYPE": "D", "MH": "Food Deprivation", "AQ": "PH", "ENTRY": "Food Deprivations", "MN": "F01.658.433", "FX": "Starvation", "MH_TH": "NLM (1969)", "ST": "T037", "AN": "human & animal; /physiol permitted for physiol & metab eff", "PI": "Motivation (1966-1968)", "MS": "The withholding of food in a structured experimental situation.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "19910620", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D005508"}, {"RECTYPE": "D", "MH": "Food Dispensers, Automatic", "AQ": "CL EC ES HI IS LJ SN ST", "PRINT ENTRY": "Vending Machines, Food|T073|NON|NRW|UNK (19XX)|770505|abcdef", "ENTRY": "Vending Machine, Food", "MN": "J01.576.423.200.350", "MH_TH": "NLM (1977)", "ST": "T073", "MS": "Mechanical food dispensing machines.", "PM": "91; was see under FOOD SERVICES 1977-90", "HN": "91(Aug 77); was see under FOOD SERVICES 1977-90", "MR": "20180629", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D005509"}, {"RECTYPE": "D", "MH": "Food Handling", "AQ": "CL EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Food Processing|T057|NON|NRW|UNK (19XX)|770428|abcdef", "ENTRY": "Processing, Food", "MN": "J01.576.423.200", "FX": "Maillard Reaction", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "Any aspect of the operations in the preparation, processing, transport, storage, packaging, wrapping, exposure for sale, service, or delivery of food.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005511"}, {"RECTYPE": "D", "MH": "Food Hypersensitivity", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypersensitivity, Food|T047|NON|EQV|NLM (1993)|920203|abcdef", "ENTRY": "Hypersensitivities, Food", "MN": "C20.543.480.370", "FX": "Foodborne Diseases", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with specific food /adv eff ", "MS": "Gastrointestinal disturbances, skin eruptions, or shock due to allergic reactions to allergens in food.", "PM": "66; was FOOD ALLERGY 1963-65", "HN": "66; was FOOD ALLERGY 1963-65", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005512"}, {"RECTYPE": "D", "MH": "Food Inspection", "AQ": "EC HI IS LJ MT SN ST TD", "ENTRY": "Inspections, Food", "MN": "N06.850.780.200.800.325", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "Examination of foods to assure wholesome and clean products free from unsafe microbes or chemical contamination, natural or added deleterious substances, and decomposition during production, processing, packaging, etc.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005513"}, {"RECTYPE": "D", "MH": "Food Irradiation", "DE": "FOOD IRRAD", "AQ": "AE CL EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Food, Irradiated|T168|NON|NRW|UNK (19XX)|810519|abcdef", "ENTRY": "Irradiations, Food", "MN": "J01.576.423.850.700.700.500", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "do not confuse with FOOD CONTAMINATION, RADIOACTIVE", "MS": "Treatment of food with RADIATION.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005514"}, {"RECTYPE": "D", "MH": "Food Labeling", "AQ": "CL EC ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Product Labeling, Food|T068|NON|EQV|UNK (19XX)|780428|abcdef", "ENTRY": "Labelling, Food", "MN": "J01.576.761.400.450", "FX": "Food Quality", "MH_TH": "NLM (1974)", "ST": "T068", "MS": "Use of written, printed, or graphic materials upon or accompanying a food or its container or wrapper. The concept includes ingredients, NUTRITIONAL VALUE, directions, warnings, and other relevant information.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005515"}, {"RECTYPE": "D", "MH": "Food Microbiology", "DE": "FOOD MICROBIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Microbiology, Food|T067|NON|EQV|UNK (19XX)|860101|MICROBIOL FOOD|abcdefv", "MN": "N06.850.601.500.249.300", "MH_TH": "NLM (1966)", "ST": "T067", "AN": "coordinate with specific food / microbiol or / virol and specific microbe; FOOD PARASITOLOGY is also available", "MS": "The presence of bacteria, viruses, and fungi in food and food products. This term is not restricted to pathogenic organisms: the presence of various non-pathogenic bacteria and fungi in cheeses and wines, for example, is included in this concept.", "PM": "1966", "HN": "1966", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005516"}, {"RECTYPE": "D", "MH": "Foodborne Diseases", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Foodborne Illness|T047|NON|EQV|NLM (2021)|200319|abcdef", "ENTRY": "Illnesses, Foodborne", "MN": "C25.723.415", "FX": "Food Hypersensitivity", "MH_TH": "NLM (2010)", "ST": "T047", "AN": "coordinate with specific food item / pois; note several specific precoordinated food poisoning terms are also available", "MS": "Acute illnesses, usually affecting the GASTROINTESTINAL TRACT, brought on by consuming contaminated food or beverages. Most of these diseases are infectious, caused by a variety of bacteria, viruses, or parasites that can be foodborne. Sometimes the diseases are caused by harmful toxins from the microbes or other chemicals present in the food. Especially in the latter case, the condition is often called food poisoning.", "PM": "2010; see FOOD POISONING 1963-2009", "HN": "2010 (1963)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20100101", "UI": "D005517"}, {"RECTYPE": "D", "MH": "Food Preferences", "AQ": "CL DE EH ES PH PX RE", "PRINT ENTRY": "Food Selection|T055|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Selections, Food", "MN": "G07.203.650.353.516", "MH_TH": "NLM (1969)", "ST": "T080", "AN": "human & animal", "PI": "Food (1966-1968)", "MS": "The selection of one food over another.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20150708", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D005518"}, {"RECTYPE": "D", "MH": "Food Preservation", "AQ": "CL EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Preservation, Food|T057|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "J01.576.423.850.700", "FX": "Maillard Reaction", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "FOOD, PRESERVED and FOOD PRESERVATIVES is also available", "MS": "Procedures or techniques used to keep food from spoiling.", "MR": "20110701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005519"}, {"RECTYPE": "D", "MH": "Food Preservatives", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Preservatives, Food", "MN": "J02.500.514.500.700", "FX": "Antioxidants", "MH_TH": "NLM (1975)", "ST": "T120", "RN": "0", "AN": "FOOD, PRESERVED and FOOD PRESERVATION are also available", "PI": "Food Additives (1966-1974)", "MS": "Substances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods.", "PM": "75", "HN": "75", "MR": "20170628", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D005520"}, {"RECTYPE": "D", "MH": "Food Service, Hospital", "DE": "FOOD SERV HOSP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Food Service|T058|NON|EQV|UNK (19XX)|770519|HOSP FOOD SERVICE|abcdefv", "ENTRY": "Services, Hospital Food", "MN": "N04.452.442.452.422.374", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "Hospital department that manages and supervises the dietary program in accordance with the patients' requirements.", "OL": "use FOOD SERVICE, HOSPITAL to search HOSPITAL FOOD SERVICE 1966-77", "PM": "78; was HOSPITAL FOOD SERVICE 1963-77", "HN": "78; was HOSPITAL FOOD SERVICE 1963-77", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D005521"}, {"RECTYPE": "D", "MH": "Food Services", "DE": "FOOD SERV", "AQ": "CL EC ES HI IS LJ OG SN ST TD", "PRINT ENTRY": "Meals on Wheels|T095|T168|NON|NRW|UNK (19XX)|810519|abbcdef", "ENTRY": "Service, Food", "MN": "J01.576.423.500", "MH_TH": "NLM (1976)", "ST": "T057", "AN": "do not confuse with DIETARY SERVICES where nutrition is emphasized; do not confuse with FOOD ASSISTANCE", "MS": "Functions, equipment, and facilities concerned with the preparation and distribution of ready-to-eat food.", "PM": "76", "HN": "76; was FOOD SERVICE (NON MESH) before 1976", "MR": "20180629", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D005522"}, {"RECTYPE": "D", "MH": "Food Supply", "AQ": "CL EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Food Supply Chain|T080|NON|EQV|NLM (2021)|200415|abcdef", "ENTRY": "Supply, Food", "MN": "J01.576.423.750", "FX": "Food Storage", "MH_TH": "NLM (1978)", "ST": "T080", "AN": "specify geographic location if pertinent", "MS": "The production and movement of food items from point of origin to use or consumption.", "MR": "20200708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005523"}, {"RECTYPE": "D", "MH": "Food Technology", "DE": "FOOD TECHNOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Technology, Food|T090|NON|EQV|UNK (19XX)|750711|TECHNOL FOOD|abcdefv", "ENTRY": "Sciences, Food", "MN": "J01.576.423.850", "FX": "Nutritional Sciences", "MH_TH": "NLM (1976)", "ST": "T090", "AN": "usually in reference to the food industry and food manufacture or preparation on a large scale; covers aroma, flavor, color, texture, temperature, preparability, cookability, packaging, etc.", "MS": "The application of knowledge to the food industry.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20060705", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D005524"}, {"RECTYPE": "D", "MH": "Food-Processing Industry", "DE": "FOOD PROCESSING INDUST", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Industry, Food Processing", "MN": "J01.576.423.200.400", "MH_TH": "NLM (1966)", "ST": "T092", "MS": "The productive enterprises concerned with food processing.", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005525"}, {"RECTYPE": "D", "MH": "Food, Formulated", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Dietary Formulations|T168|NON|NRW|UNK (19XX)|790530|abcdef", "ENTRY": "Formulations, Dietary", "MN": "J02.500.525.350", "FX": "Parenteral Nutrition Solutions", "MH_TH": "NLM (1972)", "ST": "T168", "AN": "INFANT FORMULA and INFANT FOOD are also available; do not confuse with FOOD, FORTIFIED which emphasizes addition of essential nutrients", "PI": "specific food (1966-1971)", "MS": "Food and dietary formulations including elemental (chemically defined formula) diets, synthetic and semisynthetic diets, space diets, weight-reduction formulas, tube-feeding diets, complete liquid diets, and supplemental liquid and solid diets.", "OL": "use FOOD, FORMULATED to search FOOD, ARTIFICIAL & FOODS, ARTIFICIAL 1972-79 (as Prov 1972-74)", "PM": "80; was FOOD, ARTIFICIAL 1979; was FOOD, ARTIFICIAL see under FOOD 1975-78", "HN": "80; was FOOD, ARTIFICIAL 1979; was FOOD, ARTIFICIAL see under FOOD 1973-78 (Prov 1973-74); was FOODS, ARTIFICIAL 1972 (Prov)", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D005526"}, {"RECTYPE": "D", "MH": "Food, Fortified", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Food, Supplemented|T168|NON|EQV|NLM (1998)|960916|abcdef", "ENTRY": "Supplemented Foods", "MN": "J02.500.515", "FX": "Biofortification", "MH_TH": "NLM (1970)", "ST": "T168", "AN": "coordinate IM with added nutrient if relevant (IM); do not confuse with FOOD, FORMULATED or DIETARY SUPPLEMENTS", "PI": "Food (1966-1969)", "MS": "Any food that has been supplemented with essential NUTRIENTS either in quantities that are greater than those normally present, or which are not found in the food typically. Fortified food also includes food enriched by adding various nutrients to compensate for those removed by refinement or processing. (Modified from Segen, Dictionary of Modern Medicine, 1992).", "PM": "1973; for FOOD, SUPPLEMENTED see DIETARY SUPPLEMENTS 1998-2014", "HN": "1970; for FOOD, SUPPLEMENTED use DIETARY SUPPLEMENTS 1998-2014", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005527"}, {"RECTYPE": "D", "MH": "Foot", "AQ": "AH BS DG EM GD IR MI PA PH PP PS RE SU TR VI", "ENTRY": "Feet|T029|NON|EQV|UNK (19XX)|881119|abcdef", "MN": "A01.378.610.250", "FX": "Foot Bones", "EC": "injuries:Foot Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "The distal extremity of the leg in vertebrates, consisting of the tarsus (ANKLE); METATARSUS; phalanges; and the soft tissues surrounding these bones.", "MR": "20090731", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005528"}, {"RECTYPE": "D", "MH": "Foot Bones", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Bones of Foot|T023|NON|EQV|NLM (1998)|970311|abcdef", "ENTRY": "Foot Bone", "MN": "A02.835.232.043.300", "FX": "Foot", "MH_TH": "NLM (1988)", "ST": "T023", "AN": "general or unspecified; prefer specifics; permitted with all vertebrates; Manual 21.58", "PI": "specific bones of foot (1966-1997)", "MS": "The TARSAL BONES; METATARSAL BONES; and PHALANGES OF TOES. The tarsal bones consists of seven bones: CALCANEUS; TALUS; cuboid; navicular; internal; middle; and external cuneiform bones. The five metatarsal bones are numbered one through five, running medial to lateral. There are 14 phalanges in each foot, the great toe has two while the other toes have three each.", "PM": "98", "HN": "98; use explode 1988-97", "MR": "20180629", "DA": "19870402", "DC": "1", "DX": "19980101", "UI": "D005529"}, {"RECTYPE": "D", "MH": "Foot Deformities", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Metatarsal Deformity|T190|NON|NRW|UNK (19XX)|870402|abcdef", "ENTRY": "Metatarsal Deformities", "MN": "C05.330", "EC": "congenital:Foot Deformities, Congenital", "MH_TH": "NLM (1988)", "ST": "T190", "AN": "general or unspecified; prefer specifics", "PI": "Foot/abnormalities (1966-1987)", "MS": "Alterations or deviations from normal shape or size which result in a disfigurement of the foot.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19870402", "DC": "1", "DX": "19880101", "UI": "D005530"}, {"RECTYPE": "D", "MH": "Foot Deformities, Acquired", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Foot Deformity, Acquired", "MN": "C05.330.488", "MH_TH": "NLM (1971)", "ST": "T020", "AN": "deformity of bone, joint, muscle, etc.", "PI": "Foot Diseases (1966-1970)", "MS": "Distortion or disfigurement of the foot, or a part of the foot, acquired through disease or injury after birth.", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "19920520", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D005531"}, {"RECTYPE": "D", "MH": "Foot Deformities, Congenital", "DE": "FOOT DEFORMITIES CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Foot Deformity, Congenital|T019|T047|NON|EQV|NLM (1994)|921209|FOOT DEFORMITY CONGEN|abbcdefv", "MN": "C16.131.621.585.512.500", "MH_TH": "NLM (1988)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Alterations or deviations from normal shape or size which result in a disfigurement of the foot occurring at or before birth.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19870402", "DC": "1", "DX": "19880101", "UI": "D005532"}, {"RECTYPE": "D", "MH": "Foot Dermatoses", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dermatosis, Foot", "MN": "C17.800.321.125", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; use as coordinate with specific diseases of the foot; not as coordinate for neoplasms of the foot (use neoplasm terms + FOOT DISEASES); consider synonym for dermatitis of foot and do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH", "MS": "Skin diseases of the foot, general or unspecified.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005533"}, {"RECTYPE": "D", "MH": "Foot Diseases", "DE": "FOOT DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Foot Disease", "MN": "C17.800.321", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Anatomical and functional disorders affecting the foot.", "CATSH": "CAT LIST", "MR": "20160426", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005534"}, {"RECTYPE": "D", "MH": "Foot Rot", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Rots, Foot", "MN": "C22.394", "FX": "Fusobacterium necrophorum", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "coordinate with appropriate infection term + precoordinated animal/disease term if pertinent ", "PI": "Swine Diseases (1966-1969)", "MS": "A disease of the horny parts and of the adjacent soft structures of the feet of cattle, swine, and sheep. It is usually caused by Corynebacterium pyogenes or Bacteroides nodosus (see DICHELOBACTER NODOSUS). It is also known as interdigital necrobacillosis. (From Black's Veterinary Dictionary, 18th ed)", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005535"}, {"RECTYPE": "D", "MH": "Foot-and-Mouth Disease", "DE": "FOOT MOUTH DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Foot-and-Mouth Diseases", "MN": "C22.380", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with HAND, FOOT AND MOUTH DISEASE; check tag ANIMALS", "MS": "A highly infectious disease caused by FOOT AND MOUTH DISEASE VIRUS that affects mammals of the ARTIODACTYLA order (CATTLE; SHEEP; GOATS; and PIGS) and is characterized by high fever followed by the appearance of blisters inside the mouth and on the feet.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005536"}, {"RECTYPE": "D", "MH": "Aphthovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Equine rhinovirus 1|T005|NON|NRW|NLM (2002)|010423|abcdef", "ENTRY": "Aphthoviruses", "MN": "B04.820.578.750.070", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid12109", "RR": "txid47000", "AN": "infection: coord IM with PICORNAVIRIDAE INFECTIONS (IM)", "MS": "A genus of the family PICORNAVIRIDAE infecting mainly cloven-hoofed animals. They cause vesicular lesions and upper respiratory tract infections. FOOT AND MOUTH DISEASE VIRUS is the type species.", "PM": "1994; see FOOT-AND-MOUTH DISEASE VIRUS 1963-1993", "HN": "1994 (1963)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D005537"}, {"RECTYPE": "D", "MH": "Football", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Football, American|T056|NON|EQV|NLM (2022)|210118|abcdef", "MN": "I03.450.642.845.300", "MH_TH": "NLM (1976)", "ST": "T056", "AN": "inj: coordinate with specific injury", "PI": "Sports (1966-1975)", "MS": "A competitive team sport played on a rectangular field.This is the American version of the game. It does not include non-North American football (= SOCCER).", "PM": "76", "HN": "76", "MR": "20210706", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D005538"}, {"RECTYPE": "D", "MH": "Foramen Magnum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Magnums, Foramen", "MN": "A02.835.232.781.572.434", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "The large hole at the base of the skull through which the SPINAL CORD passes.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005539"}, {"RECTYPE": "D", "MH": "Forced Expiratory Flow Rates", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Expiratory Forced Flow Rates|T034|T042|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Flow Rates, Forced Expiratory|T034|T042|NON|EQV|NLM (1990)|890314|abbcdef", "MN": "G09.772.650.300", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "general or unspecified; prefer specifics; do not confuse with FORCED EXPIRATORY VOLUME", "PI": "Spirometry (1966-1974)", "MS": "The rate of airflow measured during a FORCED VITAL CAPACITY determination.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D005540"}, {"RECTYPE": "D", "MH": "Forced Expiratory Volume", "DE": "FEV", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Vital Capacity, Timed|T034|T042|NON|EQV|UNK (19XX)|760424|VITAL CAPAC TIMED|abbcdefv", "ENTRY": "Volumes, Forced Expiratory", "MN": "G09.772.650.430", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "usually NIM; do not confuse with FORCED EXPIRATORY FLOW RATES", "PI": "Vital Capacity (1969-1974)", "MS": "Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D005541"}, {"RECTYPE": "D", "MH": "Forearm", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "ENTRY": "Forearms", "MN": "A01.378.800.585", "EC": "injuries:Forearm Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "use for primates only; use FORELIMB for non-primate vertebrates & EXTREMITIES for invertebrates; for bones use RADIUS or ULNA; NIM when merely locational", "MS": "Part of the upper extremity in humans and primates extending from the ELBOW to the WRIST.", "MR": "20160610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005542"}, {"RECTYPE": "D", "MH": "Forearm Injuries", "DE": "FOREARM INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injury, Forearm", "MN": "C26.088.268", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "general or unspecified; prefer specifics for soft tissue and bones; consider also /inj with specific bones and also specific fracture terms; available also are HAND INJURIES; FINGER INJURIES; and WRIST INJURIES", "MS": "Injuries to the part of the upper limb of the body between the wrist and elbow.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005543"}, {"RECTYPE": "D", "MH": "Forecasting", "AQ": "MT", "PRINT ENTRY": "Projections and Predictions|T170|NON|EQV|NLM (1990)|890502|PROJECTIONS PREDICTIONS|abcdefv", "ENTRY": "Predictions and Projections", "MN": "I01.320", "MH_TH": "NLM (1971)", "ST": "T170", "AN": "IM general only; consider also as IM coord with specific subject /trends (IM) if future is particularly significant: Manual 19.8.76, 35.2.9", "MS": "The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology.", "OL": "use FORECASTING to search FUTUROLOGY 1971-79", "PM": "80; was FUTUROLOGY 1971-79", "HN": "80; was FUTUROLOGY 1971-79", "MR": "20150625", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D005544"}, {"RECTYPE": "D", "MH": "Forefoot, Human", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "Human Forefoot|T029|NON|EQV|UNK (19XX)|870402|abcdef", "MN": "A01.378.610.250.300", "MH_TH": "NLM (1988)", "ST": "T029", "AN": "do not confuse with FORELIMB for non-primate vertebrates", "MS": "The forepart of the foot including the metatarsals and the TOES.", "PM": "88", "HN": "88", "MR": "20020703", "DA": "19870402", "DC": "1", "DX": "19880101", "UI": "D005545"}, {"RECTYPE": "D", "MH": "Forehead", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Foreheads", "MN": "A01.456.505.580", "MH_TH": "NLM (1977)", "ST": "T029", "AN": "NIM as locational", "PI": "Face (1966-1976)", "MS": "The part of the face above the eyes.", "PM": "77", "HN": "77", "MR": "19920515", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D005546"}, {"RECTYPE": "D", "MH": "Foreign Bodies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Textilomas", "MN": "C26.392", "MH_TH": "NLM (1966)", "ST": "T072", "AN": "coordinate IM with organ (IM), not organ/disease; EYE FOREIGN BODIES is also available", "MS": "Inanimate objects that become enclosed in the body.", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005547"}, {"RECTYPE": "D", "MH": "Foreign-Body Migration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Migrations, Foreign-Body", "MN": "C26.392.500", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "note category", "MS": "Migration of a foreign body from its original location to some other location in the body.", "OL": "use FOREIGN-BODY MIGRATION to search FOREIGN BODY MIGRATION 1975-90", "PM": "91; was FOREIGN BODY MIGRATION see under FOREIGN BODIES 1975-90", "HN": "91(75); was FOREIGN BODY MIGRATION see under FOREIGN BODIES 1975-90", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D005548"}, {"RECTYPE": "D", "MH": "Foreign-Body Reaction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Reaction, Foreign-Body", "MN": "C26.392.560", "MH_TH": "NLM (1972)", "ST": "T046", "AN": "note category: in presence of a dis, use /etiol, not /compl", "PI": "Foreign Bodies (1966-1971)", "MS": "Chronic inflammation and granuloma formation around irritating foreign bodies.", "OL": "use FOREIGN-BODY REACTION to search FOREIGN BODY REACTION 1972-90 (as Prov 1972-73)", "PM": "91; was FOREIGN BODY REACTION 1974-90", "HN": "91(72); was FOREIGN BODY REACTION 1972-90 (Prov 1972-73)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005549"}, {"RECTYPE": "D", "MH": "Foreign Medical Graduates", "DE": "FOREIGN MED GRAD", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Medical Graduates, Foreign|T097|NON|EQV|NLM (1991)|891129|MED GRAD FOREIGN|abcdefv", "MN": "N02.360.810.390", "MH_TH": "NLM (1968)", "ST": "T097", "PI": "Physicians (1966-1967)", "MS": "Physicians who hold degrees from medical schools in countries other than the ones in which they practice.", "PM": "70", "HN": "70(68)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005550"}, {"RECTYPE": "D", "MH": "Foreign Professional Personnel", "AQ": "CL ED HI LJ PX SD SN ST", "ENTRY": "Professional Personnel, Foreign", "MN": "M01.526.407", "MH_TH": "NLM (1971)", "ST": "T097", "AN": "specify geog", "PI": "Health Manpower (1968-1970)", "MS": "Persons who have acquired academic or specialized training in countries other than that in which they are working. The concept excludes physicians for which FOREIGN MEDICAL GRADUATES is the likely heading.", "PM": "71", "HN": "71", "MR": "20180629", "DA": "19780329", "DC": "1", "DX": "19710101", "UI": "D005551"}, {"RECTYPE": "D", "MH": "Forelimb", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Forelimbs", "MN": "A13.395", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "non-primate vertebrates only: for human use ARM; for invertebrates use EXTREMITIES; TN 75: animal extremities; TN 117: table of animal extremities", "PI": "Extremities (1966-1967)", "MS": "A front limb of a quadruped. (The Random House College Dictionary, 1980)", "PM": "68", "HN": "68", "MR": "20040713", "DA": "19780329", "DC": "1", "DX": "19680101", "UI": "D005552"}, {"RECTYPE": "D", "MH": "Forensic Dentistry", "DE": "FORENSIC DENT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Dentistry, Forensic|T091|NON|EQV|NLM (1991)|900126|DENT FORENSIC|abcdefv", "MN": "I01.198.780.875", "MH_TH": "NLM (1965)", "ST": "T091", "AN": "see note on FORENSIC MEDICINE; for human identif by teeth: coord FORENSIC DENTISTRY (IM) and specific dent heading (IM)", "MS": "The application of dental knowledge to questions of law.", "OL": "use FORENSIC DENTISTRY & FORENSIC MEDICINE to search CRIMINAL INVESTIGATION 1966-74", "PM": "65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74; was heading 1963-64", "HN": "65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74; was heading 1963-64", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005553"}, {"RECTYPE": "D", "MH": "Forensic Medicine", "DE": "FORENSIC MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Legal Medicine|T091|NON|BRD|UNK (19XX)|760430|LEGAL MED|abcdefv", "ENTRY": "Medicine, Legal|T091|NON|BRD|NLM (1991)|891129|MED LEGAL|abcdefv", "MN": "I01.198.780.937", "FX": "Law Enforcement", "MH_TH": "BIOETHICS (1991)", "ST": "T091", "AN": "for crime or identification: differentiate from JURISPRUDENCE, usually civil suits; for human identification of skeletal remains HUMAN IDENTIFICATION see FORENSIC ANTHROPOLOGY is available; for human identification by teeth see FORENSIC DENTISTRY; note other specific forensic terms are also available", "MS": "The application of medical knowledge to questions of law.", "OL": "use FORENSIC MEDICINE & FORENSIC DENTISTRY to search CRIMINAL INVESTIGATION 1966-74", "PM": "65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74; was heading 1963-64", "HN": "65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74; was heading 1963-64", "MR": "20190507", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005554"}, {"RECTYPE": "D", "MH": "Forensic Psychiatry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Jurisprudence, Psychiatric|T091|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Psychiatry, Forensic", "MN": "N03.706.535.351", "MH_TH": "BIOETHICS (1991)", "ST": "T091", "MS": "Psychiatry in its legal aspects. This includes criminology, penology, commitment of mentally ill, the psychiatrist's role in compensation cases, the problems of releasing information to the court, and of expert testimony.", "OL": "use FORENSIC PSYCHIATRY to search JURISPRUDENCE, PSYCHIATRIC 1967-68; use FORENSIC DENTISTRY & FORENSIC MEDICINE to search CRIMINAL INVESTIGATION 1966-74", "PM": "69; was JURISPRUDENCE, PSYCHIATRIC 1967-68; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74, was heading 1963-64", "HN": "69; was JURISPRUDENCE, PSYCHIATRIC 1967-68; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74, was heading 1963-64", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D005555"}, {"RECTYPE": "D", "MH": "Form Perception", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Contour Perception|T041|NON|REL|UNK (19XX)|780426|abcdef", "ENTRY": "Perceptions, Form", "MN": "F02.463.593.778.435", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "The sensory discrimination of a pattern, shape, or outline.", "OL": "use FORM PERCEPTION to search CONTOUR PERCEPTION 1970-78", "HN": "CONTOUR PERCEPTION was see under FORM PERCEPTION 1970-78", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D005556"}, {"RECTYPE": "D", "MH": "Formaldehyde", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxomethane|T109|T131|NON|EQV|NLM (1999)|980220|abbcdef", "MN": "D02.047.407", "PA": "Fixatives", "MH_TH": "USP (19XX)", "ST": "T131", "N1": "Formaldehyde", "RN": "1HG84L3525", "RR": "50-00-0 (Formaldehyde)", "MS": "A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005557"}, {"RECTYPE": "D", "MH": "Arylformamidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Formamidase, Kynurenine", "MN": "D08.811.277.087.100", "MH_TH": "NLM (1964)", "ST": "T126", "N1": "Aryl-formylamine amidohydrolase", "RN": "EC 3.5.1.9", "RR": "9013-59-6 (CAS RN)", "MS": "An enzyme that catalyzes the conversion of N-formyl-L-kynurenine and water to formate and L-kynurenine. It also acts on other aromatic formylamines. (Enzyme Nomenclature, 1992) EC 3.5.1.9.", "OL": "use ARYLFORMAMIDASE to search FORMAMIDASE 1966-95", "PM": "96; was FORMAMIDASE 1964-95 (see under AMIDOHYDROLASES 1964-90)", "HN": "96; was FORMAMIDASE 1964-95 (see under AMIDOHYDROLASES 1964-90)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005558"}, {"RECTYPE": "D", "MH": "Formamides", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D02.241.081.420.500", "MH_TH": "NLM (1964)", "ST": "T109", "RN": "0", "MS": "A group of amides with the general formula of R-CONH2.", "OL": "use FORMAMIDES to search FORMAMIDE 1966-74 (as Prov 1966-72)", "PM": "75; was FORMAMIDE 1973-74", "HN": "75; was FORMAMIDE 1964-74 (Prov 1964-72)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005559"}, {"RECTYPE": "D", "MH": "Formate Dehydrogenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Formate Hydrogenlyases|T116|T126|NON|EQV|UNK (19XX)|790523|abbcdef", "ENTRY": "NAD Formate Dehydrogenase", "MN": "D08.811.682.657.180", "MH_TH": "NLM (1980)", "ST": "T126", "N1": "Formate:NAD+ oxidoreductase", "RN": "EC 1.17.1.9", "PI": "Oxidoreductases (1966-1972)", "MS": "Flavoproteins that catalyze reversibly the reduction of carbon dioxide to formate. Many compounds can act as acceptors, but the only physiologically active acceptor is NAD. The enzymes are active in the fermentation of sugars and other compounds to carbon dioxide and are the key enzymes in obtaining energy when bacteria are grown on formate as the main carbon source. They have been purified from bovine blood. EC 1.2.1.2.", "PM": "91; was see under ALDEHYDE OXIDOREDUCTASES 1980-90", "HN": "91(80); was see under ALDEHYDE OXIDOREDUCTASES 1980-90", "MR": "20200527", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D005560"}, {"RECTYPE": "D", "MH": "Formates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Formic", "MN": "D02.241.081.420", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of formic acids. Included under this heading are a broad variety of acid forms, salts, esters, and amides that are formed with a single carbon carboxy group.", "PM": "1966; for FORMIC ACIDS see FORMIC ACIDS 1968-2012", "HN": "1966", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005561"}, {"RECTYPE": "D", "MH": "Formazans", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Formazan|T109|T130|NON|EQV|NLM (2021)|191119|abbcdef", "MN": "D02.172.600", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "0", "PI": "Formic Acids (1972-1974)", "MS": "Colored azo compounds formed by the reduction of tetrazolium salts. Employing this reaction, oxidoreductase activity can be determined quantitatively in tissue sections by allowing the enzymes to act on their specific substrates in the presence of tetrazolium salts.", "PM": "91; was see under AZO COMPOUNDS 1975-90", "HN": "91(75); was see under AZO COMPOUNDS 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005562"}, {"RECTYPE": "D", "MH": "Formic Acid Esters", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Esters, Formic Acid", "MN": "D02.241.081.420.750", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "ESTER derivatives of formic acid with the formula H-COO-R.", "OL": "search FORMIC ACIDS 1968-74", "PM": "91; was see under FORMIC ACIDS 1975-90", "HN": "91(75); was see under FORMIC ACIDS 1975-90", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005563"}, {"RECTYPE": "D", "MH": "Formiminoglutamic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "FIGLU|T109|T123|ABB|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Acid, Formiminoglutamic", "MN": "D02.241.081.337.351.300", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "L-Glutamic acid, N-(iminomethyl)-", "RN": "816-90-0", "PI": "Glutarates (1970-1974)", "MS": "Measurement of this acid in the urine after oral administration of histidine provides the basis for the diagnostic test of folic acid deficiency and of megaloblastic anemia of pregnancy.", "PM": "91; was see under GLUTARATES 1975-90", "HN": "91(75); was see under GLUTARATES 1975-90", "MR": "20000621", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005565"}, {"RECTYPE": "D", "MH": "Formocresols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.657.239.611", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Formaldehyde (1966-1971)", "MS": "Compounds consisting of formaldehyde, cresol, GLYCERIN, and water. They are  used in the PULPOTOMY of PRIMARY TEETH and as ROOT CANAL IRRIGANTS.", "PM": "73", "HN": "73(72)", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005566"}, {"RECTYPE": "D", "MH": "Forms and Records Control", "DE": "FORMS RECORDS CONTROL", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Records Control|T058|NON|NRW|UNK (19XX)|770505|abcdef", "ENTRY": "Records Controls", "MN": "N04.452.758.708.200.400", "FX": "Medical Records Systems, Computerized", "MH_TH": "NLM (1977)", "ST": "T057", "AN": "coordinate NIM with specific records heading (e.g., MEDICAL RECORDS; NURSING RECORDS) (IM)", "MS": "A management function in which standards and guidelines are developed for the development, maintenance, and handling of forms and records.", "PM": "91; was see under OFFICE MANAGEMENT Aug 1977-90", "HN": "91(Aug 77); was see under OFFICE MANAGEMENT 1977-90", "MR": "20100625", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D005568"}, {"RECTYPE": "D", "MH": "Formularies as Topic", "AQ": "CL HI ST", "MN": "L01.462.500.682.192.836.535", "FX": "Pharmacopoeias as Topic", "MH_TH": "NLM (2009)", "ST": "T170", "AN": "general or unspecified; prefer specifics; do not confuse with PHARMACOPOEIAS AS TOPIC; NATIONAL FORMULARY see PHARMACOPOEIAS AS TOPIC is also available; do not confuse with the Publication Type FORMULARY", "MS": "Works about lists of drugs or collections of recipes, formulas, and prescriptions for the compounding of medicinal preparations. Formularies differ from PHARMACOPEIA in that they are less complete, lacking full descriptions of the drugs, their formulations, analytic composition, chemical properties, etc. In hospitals, formularies list all drugs commonly stocked in the hospital pharmacy.", "HN": "2009(1966)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005569"}, {"RECTYPE": "D", "MH": "Formularies, Dental as Topic", "AQ": "CL HI ST", "MN": "L01.462.500.682.192.836.535.310", "MH_TH": "NLM (2018)", "ST": "T170", "AN": "do not confuse with the Publication Type FORMULARY, DENTAL", "MS": "Works about reference lists of descriptions and uses of drugs related to oral medicine and dentistry.", "PM": "2018; See FORMULARIES, DENTAL 1966-2017", "HN": "2018(1966)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005570"}, {"RECTYPE": "D", "MH": "Formularies, Homeopathic as Topic", "AQ": "CL HI ST", "ENTRY": "Homeopathic Formularies as Topic|T073|T170|NON|EQV|NLM (2019)|180618|abbcdef", "MN": "L01.462.500.682.192.836.535.435", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "do not confuse with the Publication Type FORMULARY, HOMEOPATHIC", "MS": "Works about formularies concerned with HOMEOPATHIC REMEDIES.", "PM": "2019; see FORMULARIES, HOMEOPATHIC 1966-2018", "HN": "2019(1966); was FORMULARIES, HOMEOPATHIC 1966-2018", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005571"}, {"RECTYPE": "D", "MH": "Formularies, Hospital as Topic", "AQ": "CL HI ST", "ENTRY": "Hospital Formularies as Topic|T170|NON|EQV|NLM (2019)|180618|abcdef", "MN": "L01.462.500.682.192.836.535.561", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "do not confuse with the Publication Type FORMULARY, HOSPITAL", "PI": "Formularies (1966-1967)", "MS": "Works about formularies concerned with PHARMACEUTICAL PREPARATIONS prescribed in hospitals.", "PM": "2019; see FORMULARIES, HOSPITAL (1968-2018)", "HN": "2019(1968)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005572"}, {"RECTYPE": "D", "MH": "Formycins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D13.570.800.410", "PA": "Antibiotics, Antineoplastic", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "antineoplastic antibiotics", "PI": "Ribonucleotides (1973-1974)", "MS": "Pyrazolopyrimidine ribonucleosides isolated from Nocardia interforma. They are antineoplastic antibiotics with cytostatic properties.", "PM": "91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90", "HN": "91(75); was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005573"}, {"RECTYPE": "D", "MH": "Formate-Tetrahydrofolate Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tetrahydrofolate Formylase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Synthetase, Formyltetrahydrofolate", "MN": "D08.811.464.259.550", "FX": "Methylenetetrahydrofolate Dehydrogenase (NADP)", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Formate:tetrahydrofolate ligase (ADP-forming)", "RN": "EC 6.3.4.3", "RR": "9023-66-9 (CAS RN)", "PI": "Tetrahydrofolates (1972-1974)", "MS": "A carbon-nitrogen ligase that catalyzes the formation of 10-formyltetrahydrofolate from formate and tetrahydrofolate in the presence of ATP. In higher eukaryotes the enzyme also contains METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP+) and METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE activity.", "PM": "98; see FORMYLTETRAHYDROFOLATE SYNTHETASE 1991-97; see LIGASES 1975-90", "HN": "98(75)", "MR": "20090710", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005574"}, {"RECTYPE": "D", "MH": "Formyltetrahydrofolates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "N(10)-Formyltetrahydrofolate|T109|T123|NON|NRW|NLM (1990)|890525|FORMYLTETRAHYDROFOLATE N 10|abbcdefs", "MN": "D08.211.840.300", "PA": "Vitamin B Complex", "MH_TH": "NLM (1976)", "ST": "T127", "RN": "0", "AN": "deficiency: coordinate FORMYLTETRAHYDROFOLATES /defic (IM) with FOLIC ACID DEFICIENCY (IM)", "PI": "Citrovorum Factor (1966-1975)", "MS": "Tetrahydrofolates which are substituted by a formyl group at either the nitrogen atom in the 5 position or the nitrogen atom in the 10 position. N(5)-Formyltetrahydrofolate is leucovorin (citrovorum factor) while N(10)-formyltetrahydrofolate is an active coenzyme which functions as a carrier of the formyl group in a number of enzymatic reactions.", "PM": "1991; FORMYLTETRAHYDROFOLATES was indexed under TETRAHYDROFOLATES 1976-1990", "HN": "1991 (1976)", "MR": "20180227", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D005575"}, {"RECTYPE": "D", "MH": "Colforsin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Forskolin|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1986)|990101|abbcdeef", "ENTRY": "NKH477|T109|T121|NON|NRW|NLM (1992)|abbcde", "MN": "D02.455.849.291.300", "PA": "Vasodilator Agents", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1H-Naphtho(2,1-b)pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-", "RN": "1F7A44V6OU", "RR": "66428-89-5 (Forskolin)", "PI": "Terpenes (1966-1973)", "MS": "Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant COLEUS FORSKOHLII. Has antihypertensive, positive inotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland.", "PM": "2014; see FORSKOLIN 1986-2013", "HN": "2014(1986)", "MR": "20150617", "DA": "19850308", "DC": "1", "DX": "19860101", "UI": "D005576"}, {"RECTYPE": "D", "MH": "Forssman Antigen", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Antigen, Forssman", "MN": "D23.050.244.436", "MH_TH": "NLM (1973)", "ST": "T129", "N1": "Antigens, Forssman", "RN": "9013-60-9", "MS": "A glycolipid, cross-species antigen that induces production of antisheep hemolysin. It is present on the tissue cells of many species but absent in humans. It is found in many infectious agents.", "OL": "use HAPTENS to search FORSSMAN ANTIGEN 1966-72 (as Prov 1966)", "PM": "91,73-81; was see under ANTIGENS, HETEROPHILE 1983-90; was heading 1973-81; was see under HAPTENS 1965, 1967-72", "HN": "91(82)73(66 only); was see under ANTIGENS, HETEROPHILE 1983-90; was heading 1973-81; was see under HAPTENS 1965-72 (Prov 1966)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005577"}, {"RECTYPE": "D", "MH": "Fosfomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphonomycin|T109|T195|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Tromethamine, Fosfomycin", "MN": "D02.705.429.625", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1970)", "ST": "T195", "N1": "Phosphonic acid, (3-methyloxiranyl)-, (2R-cis)-", "RN": "2N81MY12TE", "RR": "7FXW6U30GY", "PI": "Organophosphorus Compounds (1973-1974)", "MS": "An antibiotic produced by Streptomyces fradiae.", "PM": "1986; see ANTIBIOTICS 1975-1985; FOSFOMYCIN TROMETHAMINE was indexed under FOSFOMYCIN 1993-2008", "HN": "1986(1975); use ANTIBIOTICS 1975-1985", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D005578"}, {"RECTYPE": "D", "MH": "Fossil Fuels", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Fuels, Fossil", "MN": "N06.230.132.258", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Any combustible hydrocarbon deposit formed from the remains of prehistoric organisms. Examples are petroleum, coal, and natural gas.", "OL": "use FOSSIL FUELS to search FUELS 1966-81 (as Prov 1966-67)", "PM": "82; was FUELS 1968-81", "HN": "82; was FUELS (Cat J heading only) 1966-81 (Prov 1966-67)", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005579"}, {"RECTYPE": "D", "MH": "Fossils", "AQ": "AH DG HI LJ MI PA PS UL VI", "ENTRY": "Fossil", "MN": "I01.076.368.584.311", "MH_TH": "NLM (1975)", "ST": "T167", "MS": "Remains, impressions, or traces of animals or plants of past geological times which have been preserved in the earth's crust.", "OL": "search PALEONTOLOGY 1966-74", "PM": "91; was see under PALEONTOLOGY 1975-90", "HN": "91(75); was see under PALEONTOLOGY 1975-90", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005580"}, {"RECTYPE": "D", "MH": "Foster Home Care", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "PRINT ENTRY": "Kinship Care|T056|NON|REL|NLM (2008)|070707|abcdef", "ENTRY": "Foster Care, Adult", "MN": "N02.421.585.352", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "Families who care for neglected children or patients unable to care for themselves.", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005581"}, {"RECTYPE": "D", "MH": "Foundations", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Foundation", "MN": "N03.540.630.180", "MH_TH": "POPLINE (1978)", "ST": "T092", "MS": "Organizations established by endowments with provision for future maintenance.", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005582"}, {"RECTYPE": "D", "MH": "Fourier Analysis", "DE": "FOURIER ANAL", "PRINT ENTRY": "Fourier Transform|T081|EPO|REL|NLM (1996)|950221|abcdef", "ENTRY": "Transform, Fourier", "MN": "L01.224.800.625", "FX": "Wavelet Analysis", "MH_TH": "NLM (1973)", "ST": "T062", "MS": "Analysis based on the mathematical function first formulated by Jean-Baptiste-Joseph Fourier in 1807. The function, known as the Fourier transform, describes the sinusoidal pattern of any fluctuating pattern in the physical world in terms of its amplitude and its phase. It has broad applications in biomedicine, e.g., analysis of the x-ray crystallography data pivotal in identifying the double helical nature of DNA and in analysis of other molecules, including viruses, and the modified back-projection algorithm universally used in computerized tomography imaging, etc. (From Segen, The Dictionary of Modern Medicine, 1992)", "PM": "73", "HN": "73", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005583"}, {"RECTYPE": "D", "MH": "Fovea Centralis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A09.371.729.522.436", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "a pit in the macula lutea of the retina", "MS": "An area approximately 1.5 millimeters in diameter within the macula lutea where the retina thins out greatly because of the oblique shifting of all layers except the pigment epithelium layer. It includes the sloping walls of the fovea (clivus) and contains a few rods in its periphery. In its center (foveola) are the cones most adapted to yield high visual acuity, each cone being connected to only one ganglion cell. (Cline et al., Dictionary of Visual Science, 4th ed)", "OL": "search MACULA LUTEA 1968-74", "PM": "91; was see under MACULA LUTEA 1975-90", "HN": "91(75); was see under MACULA LUTEA 1975-90", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005584"}, {"RECTYPE": "D", "MH": "Influenza in Birds", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Influenza, Avian|T047|NON|EQV|NLM (2005)|040211|abcdef", "ENTRY": "Plague, Fowl", "MN": "C22.131.450", "MH_TH": "NLM (2006)", "ST": "T047", "AN": "coordinate IM with specific virus subtype (IM) if pertinent; don't forget also BIRDS or POULTRY (NIM) & check tag ANIMALS", "PI": "Poultry Diseases (1966-1969)", "MS": "Infection of domestic and wild fowl and other BIRDS with INFLUENZA A VIRUS. Avian influenza usually does not sicken birds, but can be highly pathogenic and fatal in domestic POULTRY.", "PM": "2006; see INFLUENZA, AVIAN 2005, see FOWL PLAGUE 1970-2004, see MYXOVIRUS INFECTIONS 1963-1969", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005585"}, {"RECTYPE": "D", "MH": "Fowlpox", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Variola Avium|T047|NON|EQV|NLM (1990)|890616|abcdef", "ENTRY": "Pox, Fowl", "MN": "C22.131.321", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "caused by a poxvirus; don't forget also BIRDS or POULTRY (NIM) & check tag ANIMALS", "PI": "Poxvirus Infections (1966-1969)", "MS": "A poxvirus infection of poultry and other birds characterized by the formation of wart-like nodules on the skin and diphtheritic necrotic masses (cankers) in the upper digestive and respiratory tracts.", "OL": "use FOWLPOX to search BIRD POX & FOWL POX 1970-93", "PM": "94; was FOWL POX 1970-93; BIRDPOX was BIRD POX see FOWL POX 1970-93", "HN": "94; was FOWL POX 1970-93; BIRDPOX was BIRD POX see FOWL POX 1970-93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005586"}, {"RECTYPE": "D", "MH": "Fowlpox virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Fowlpox viruses", "MN": "B04.280.650.160.100.300", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid10261", "MS": "The type species of the genus AVIPOXVIRUS. It is the etiologic agent of FOWLPOX.", "OL": "use FOWLPOX VIRUS to search FOWL POX VIRUS 1975-93", "PM": "94; was FOWL POX VIRUS 1975-93 (see under POXVIRIDAE 1981-89, see under POXVIRUSES 1975-80)", "HN": "94; was FOWL POX VIRUS 1975-93 (see under POXVIRIDAE 1981-89, see under POXVIRUSES 1975-80)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19900101", "UI": "D005587"}, {"RECTYPE": "D", "MH": "Fox-Fordyce Disease", "DE": "FOX FORDYCE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Miliaria, Apocrine|T047|NON|EQV|NLM (1993)|ORD (2010)|920407|abcdeef", "ENTRY": "Syndrome, Fox-Fordyce", "MN": "C17.800.946.492.285", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "pruritic apocrine dis in women", "MS": "Chronic pruritic disease, usually in women, characterized by small follicular papular eruptions in APOCRINE GLANDS areas. It is caused by obstruction and rupture of intraepidermal apocrine ducts.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005588"}, {"RECTYPE": "D", "MH": "Foxes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Vulpes vulpes|T015|NON|NRW|NLM (2021)|191129|abcdef", "ENTRY": "Fox, Red", "MN": "B01.050.150.900.649.313.750.250.216.250", "MH_TH": "NLM (1968)", "ST": "T015", "RR": "txid9627", "PI": "Carnivora (1966-1967)", "MS": "Any of several carnivores in the family CANIDAE, that possess erect ears and long bushy tails and are smaller than WOLVES. They are classified in several genera and found on all continents except Antarctica.", "PM": "68", "HN": "68", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005589"}, {"RECTYPE": "D", "MH": "Fractional Precipitation", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Precipitations, Fractional", "MN": "E05.196.150.519", "MH_TH": "NLM (1975)", "ST": "T062", "MS": "A method which uses specific precipitation reactions to separate or collect substances from a solution.", "OL": "search PRECIPITATION 1966-74", "PM": "91; was see under PRECIPITATION 1975-90", "HN": "91(75); was see under PRECIPITATION 1975-90", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005590"}, {"RECTYPE": "D", "MH": "Chemical Fractionation", "AQ": "IS MT", "PRINT ENTRY": "Fractionation, Chemical|T059|NON|EQV|NLM (2003)|011219|abcdef", "ENTRY": "Fractionations, Chemical", "MN": "E05.196.155", "MH_TH": "NLM (2003)", "ST": "T059", "AN": "DOSE FRACTIONATION, RADIATION; CELL FRACTIONATION and FRACTIONATION, FIELD FLOW are also available", "MS": "Separation of a mixture in successive stages, each stage removing from the mixture some proportion of one of the substances, for example by differential solubility in water-solvent mixtures. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "2003; see FRACTIONATION 1991-2002; see CHEMISTRY, ANALYTICAL 1967-1990", "HN": "2003(1964)", "CATSH": "CAT LIST", "MR": "20180713", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005591"}, {"RECTYPE": "D", "MH": "Fracture Fixation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Skeletal Fixation|T061|NON|EQV|NLM (1991)|900502|abcdef", "ENTRY": "Skeletal Fixations", "MN": "E04.555.300", "FX": "Orthopedic Fixation Devices", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "osteosynthesis in fracture surgery goes under FRACTURE FIXATION, INTERNAL or FRACTURE FIXATION, INTRAMEDULLARY", "MS": "The use of metallic devices inserted into or through bone to hold a fracture in a set position and alignment while it heals.", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005592"}, {"RECTYPE": "D", "MH": "Fracture Fixation, Internal", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Osteosynthesis, Fracture|T061|NON|EQV|UNK (19XX)|790315|OSTEOSYN FRACTURE|abcdefv", "ENTRY": "Osteosyntheses, Fracture", "MN": "E04.555.300.300", "FX": "Internal Fixators", "MH_TH": "NLM (1969)", "ST": "T061", "PI": "Fracture Fixation (1966-1969)", "MS": "The use of internal devices (metal plates, nails, rods, etc.) to hold the position of a fracture in proper alignment.", "PM": "72", "HN": "72(70)", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D005593"}, {"RECTYPE": "D", "MH": "Fracture Fixation, Intramedullary", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Osteosynthesis, Fracture, Intramedullary|T061|NON|EQV|UNK (19XX)|790315|OSTEOSYN FRACTURE INTRAMEDULLARY|abcdefv", "ENTRY": "Nailings, Intramedullary", "MN": "E04.555.300.300.300", "FX": "Internal Fixators", "MH_TH": "NLM (1970)", "ST": "T061", "PI": "specific fracture/surgery (1966-1969)", "MS": "The use of nails that are inserted into bone cavities in order to keep fractured bones together.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005594"}, {"RECTYPE": "D", "MH": "Fractures, Closed", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fractures, Occult|T037|NON|NRW|NLM (1998)|970115|abcdef", "ENTRY": "Occult Fractures", "MN": "C26.404.124", "FX": "Closed Fracture Reduction", "MH_TH": "NLM (1973)", "ST": "T037", "MS": "Fractures in which the break in bone is not accompanied by an external wound.", "PM": "86; was see under FRACTURES 1975-85", "HN": "86(73); was see under FRACTURES 1975-85, was Prov 1973-74", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D005596"}, {"RECTYPE": "D", "MH": "Fractures, Open", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fractures, Compound|T037|NON|EQV|UNK (19XX)|770127|abcdef", "ENTRY": "Open Fractures", "MN": "C26.404.311", "FX": "Open Fracture Reduction", "MH_TH": "NLM (1973)", "ST": "T037", "AN": "coordinate with specific bone /inj or precoordinated Bone/Fracture term", "PI": "Fractures (1966-1972)", "MS": "Fractures in which there is an external wound communicating with the break of the bone.", "PM": "78", "HN": "78(73)", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D005597"}, {"RECTYPE": "D", "MH": "Fractures, Spontaneous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fractures, Pathological|T047|NON|EQV|NLM (1993)|911107|FRACTURES PATHOL|abcdefv", "ENTRY": "Spontaneous Fractures", "MN": "C26.404.374", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "fract not caused by trauma; IM; coord with specific organ /inj or organ/fract term (IM)", "MS": "Fractures occurring as a result of disease of a bone or from some undiscoverable cause, and not due to trauma. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005598"}, {"RECTYPE": "D", "MH": "Fractures, Ununited", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ununited Fractures", "MN": "C26.404.468", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "do not confuse with FRACTURES, MALUNITED; coordinate with specific bone /inj or precoordinated bone/fracture term", "MS": "A fracture in which union fails to occur, the ends of the bone becoming rounded and eburnated, and a false joint occurs. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20160613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005599"}, {"RECTYPE": "D", "MH": "Fragile X Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Martin-Bell Syndrome|T019|EPO|EQV|GHR (2014)|NLM (2000)|OMIM (2013)|ORD (2010)|991103|abcdeeeef", "ENTRY": "X Linked Mental Retardation and Macroorchidism", "MN": "C16.320.400.525.500", "FX": "Trinucleotide Repeat Expansion", "MH_TH": "ORD (2010)", "ST": "T019", "PI": "X Chromosome (1978-1982)", "MS": "A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226)", "PM": "91; was see under SEX CHROMOSOME ABNORMALITIES 1983-90", "HN": "91(83); was see under SEX CHROMOSOME ABNORMALITIES 1983-90", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19820422", "DC": "1", "DX": "19910101", "UI": "D005600"}, {"RECTYPE": "D", "MH": "Framycetin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neomycin B|T109|T195|NON|EQV|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef", "ENTRY": "Sulfate, Neomycin B", "MN": "D09.408.051.623.300", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-", "RN": "4BOC774388", "RR": "Y3720KZ4TQ", "MS": "A component of NEOMYCIN that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. (From Merck Index, 11th ed)", "PM": "68", "HN": "68(63)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005601"}, {"RECTYPE": "D", "MH": "France", "AQ": "EH EP", "PRINT ENTRY": "Saint Pierre and Miquelon|T083|NAM|NRW|POPLINE (1993)|920903|abcdef", "ENTRY": "St. Pierre and Miquelon|T083|NAM|NRW|NLM (1996)|950110|abcdef", "MN": "Z01.542.286", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "PARIS is also available", "MS": "A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris.", "HN": "1978; for SAINT PIERRE AND MIQUELON use CANADA 1996-1999", "MR": "19991108", "DA": "19990101", "DC": "4", "DX": "19780101", "UI": "D005602"}, {"RECTYPE": "D", "MH": "Francisella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Francisellaceae|T007|NON|BRD|NLM (2004)|030108|abcdef", "MN": "B03.660.250.200", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid262", "RR": "txid34064", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Pasteurella (1966-1975)", "MS": "The lone genus of bacteria in the family Francisellaceae, frequently found in natural waters. It can be parasitic in humans, other MAMMALS; BIRDS; and ARTHROPODS.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D005603"}, {"RECTYPE": "D", "MH": "Francisella tularensis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pasteurella tularensis|T007|NON|EQV|UNK (19XX)|750711|abcdef", "MN": "B03.660.250.200.750", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid263", "MS": "The etiologic agent of TULAREMIA in man and other warm-blooded animals.", "OL": "use FRANCISELLA TULARENSIS to search PASTEURELLA TULARENSIS 1966-75", "PM": "76; was PASTEURELLA TULARENSIS 1963-75", "HN": "76; was PASTEURELLA TULARENSIS 1963-75", "MR": "20200128", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D005604"}, {"RECTYPE": "D", "MH": "Francium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.277", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Francium", "RN": "15TEQ7D2QF", "RR": "7440-73-5 (Francium)", "MS": "A radioactive alkali metal with the atomic symbol Fr, and atomic number 87. The mass numbers of known isotopes are 204-213, 217-224. Its valence is +1.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005605"}, {"RECTYPE": "D", "MH": "Fraud", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Kickbacks|T054|NON|REL|NLM (1994)|920812|abcdef", "ENTRY": "Kickback", "MN": "I01.198.240.300", "FX": "Quackery", "MH_TH": "BIOETHICS (1989)", "ST": "T054", "AN": "for drug counterfeiting, coordinate with COUNTERFEIT DRUGS; FRAUD, SCIENTIFIC see SCIENTIFIC MISCONDUCT is also available", "MS": "Exploitation through misrepresentation of the facts or concealment of the purposes of the exploiter.", "OL": "use CRIME to search KICKBACKS 1992-93", "PM": "1977; see CRIME 1977-1990; for KICKBACKS see CRIME 1992-1993; for DRUG COUNTERFEITING see COUNTERFEIT DRUGS 2011-2018", "HN": "1977; use CRIME 1977-1990; for KICKBACKS use CRIME 1992-1993; for DRUG COUNTERFEITING use COUNTERFEIT DRUGS 2011-2018", "MR": "20180702", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D005607"}, {"RECTYPE": "D", "MH": "Free Association", "DE": "FREE ASSOC", "PRINT ENTRY": "Association, Free|T041|T061|NON|EQV|UNK (19XX)|740330|ASSOC FREE|abbcdefv", "ENTRY": "Free Associations", "MN": "F04.754.709.437", "MH_TH": "NLM (1969)", "ST": "T061", "PI": "Association (1966-1968)", "MS": "Spontaneous verbalization of whatever comes to mind.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "19940512", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D005608"}, {"RECTYPE": "D", "MH": "Free Radicals", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Free Radical|T104|T123|NON|EQV|NLM (2021)|191129|abbcdef", "MN": "D02.389", "FX": "Spin Trapping", "MH_TH": "NLM (1967)", "ST": "T123", "RN": "0", "AN": "IM GEN only; usually NIM with coord IM", "PI": "Electron Spin Resonance (1966)", "MS": "Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated.", "PM": "76", "HN": "76(67)", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D005609"}, {"RECTYPE": "D", "MH": "Freedom", "PRINT ENTRY": "Liberty|T078|NON|EQV|NLM (2002)|010612|abcdef", "ENTRY": "Freedoms", "MN": "N03.706.437.380", "MH_TH": "BIOETHICS (1974)", "ST": "T078", "PI": "Philosophy (1966-1977)", "MS": "The rights of individuals to act and make decisions without external constraints.", "PM": "91; was see under HUMAN RIGHTS 1978-90", "HN": "91(78); was see under HUMAN RIGHTS 1978-90", "MR": "20191118", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D005610"}, {"RECTYPE": "D", "MH": "Freemartinism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "MN": "C22.196.339", "FX": "Chimera", "MH_TH": "NLM (1970)", "ST": "T047", "PI": "Infertility, Female (1966-1969)", "MS": "A condition occurring in the female offspring of dizygotic twins (TWIN, DIZYGOTIC) in a mixed-sex pregnancy, usually in CATTLE. Freemartinism can occur in other mammals. When placental fusion between the male and the female FETUSES permits the exchange of fetal cells and fetal hormones, TESTICULAR HORMONES from the male fetus can androgenize the female fetus producing a sterile XX/XY chimeric \"female\"(CHIMERISM).", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005611"}, {"RECTYPE": "D", "MH": "Freeze Drying", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Lyophilization|T059|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Lyophilizations", "MN": "E05.760.156.260", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "NIM", "MS": "Method of tissue preparation in which the tissue specimen is frozen and then dehydrated at low temperature in a high vacuum. This method is also used for dehydrating pharmaceutical and food products.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005612"}, {"RECTYPE": "D", "MH": "Freeze Etching", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Etching, Freeze", "MN": "E05.200.750.600.620.260.400", "MH_TH": "NLM (1969)", "ST": "T062", "AN": "do not confuse with FREEZE FRACTURING (wherein a cryoprotectant is used)", "PI": "Microscopy, Electron (1966-1968)", "MS": "A replica technique in which cells are frozen to a very low temperature and cracked with a knife blade to expose the interior surfaces of the cells or cell membranes. The cracked cell surfaces are then freeze-dried to expose their constituents. The surfaces are now ready for shadowing to be viewed using an electron microscope. This method differs from freeze-fracturing in that no cryoprotectant is used and, thus, allows for the sublimation of water during the freeze-drying process to etch the surfaces.", "PM": "73", "HN": "73(69)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005613"}, {"RECTYPE": "D", "MH": "Freeze Fracturing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Freeze Fracturings", "MN": "E05.200.750.600.620.260", "MH_TH": "NLM (1975)", "ST": "T059", "AN": "do not confuse with FREEZE ETCHING (wherein no cryoprotectant is used)", "PI": "Freeze Etching (1969-1974)", "MS": "Preparation for electron microscopy of minute replicas of exposed surfaces of the cell which have been ruptured in the frozen state. The specimen is frozen, then cleaved under high vacuum at the same temperature. The exposed surface is shadowed with carbon and platinum and coated with carbon to obtain a carbon replica.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D005614"}, {"RECTYPE": "D", "MH": "Freezing", "AQ": "AE", "ENTRY": "Melting|T070|NON|REL|NLM (2009)|080603|abcdef", "MN": "G02.734.466", "FX": "Refrigeration", "MH_TH": "NLM (19XX)", "ST": "T070", "MS": "Liquids transforming into solids by the removal of heat.", "PM": "67", "HN": "67(64)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D005615"}, {"RECTYPE": "D", "MH": "French Guiana", "AQ": "EH EP", "MN": "Z01.107.757.435", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "A French overseas department on the northeast coast of South America. Its capital is Cayenne. It was first settled by the French in 1604. Early development was hindered because of the presence of a penal colony. The name of the country and the capital are variants of Guyana, possibly from the native Indian Guarani guai (born) + ana (kin), implying a united and interrelated race of people. (From Webster's New Geographical Dictionary, 1988, p418 & Room, Brewer's Dictionary of Names, 1992, p195)", "MR": "19950217", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005616"}, {"RECTYPE": "D", "MH": "Chlorofluorocarbons, Methane", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluorocarbon Propellants|T109|NON|EQV|UNK (19XX)|760520|abcdef", "ENTRY": "Propellants, Fluorocarbon", "MN": "D02.455.526.510.140.300", "MH_TH": "NLM (2001)", "ST": "T109", "RN": "0", "AN": "do not confuse entry terms FLUOROCARBON AEROSOLS or FLUOROCARBON PROPELLANTS with FLUOROCARBONS", "MS": "A group of methane-based halogenated hydrocarbons containing one or more fluorine and chlorine atoms.", "PM": "2001; see FREONS 1977-2000, see HYDROCARBONS, HALOGENATED 1973-1976", "HN": "2001(1973)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D005617"}, {"RECTYPE": "D", "MH": "Fresh Water", "AQ": "AN CH MI PS VI", "ENTRY": "Waters, Fresh", "MN": "N06.230.232", "FX": "Drinking Water", "MH_TH": "NLM (1972)", "ST": "T167", "PI": "Water (1966-1971)", "MS": "Water containing no significant amounts of salts, such as water from RIVERS and LAKES.", "PM": "91; was see under WATER 1972-90", "HN": "91(72); was see under WATER 1972-90", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005618"}, {"RECTYPE": "D", "MH": "Freudian Theory", "AQ": "HI", "ENTRY": "Theory, Freudian", "MN": "F02.739.794.297", "MH_TH": "NLM (1975)", "ST": "T170", "AN": "IM", "MS": "Philosophic formulations which are basic to psychoanalysis. Some of the conceptual theories developed were of the libido, repression, regression, transference, id, ego, superego, Oedipus Complex, etc.", "OL": "search PSYCHOANALYTIC THEORY 1969-74", "PM": "91; was see under PSYCHOANALYTIC THEORY 1975-90", "HN": "91(75); was see under PSYCHOANALYTIC THEORY 1975-90", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005619"}, {"RECTYPE": "D", "MH": "Freund's Adjuvant", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Freunds Adjuvant", "MN": "D20.475", "PA": "Adjuvants, Immunologic", "MH_TH": "NLM (1963)", "ST": "T129", "RN": "9007-81-2", "MS": "An antigen solution emulsified in mineral oil. The complete form is made up of killed, dried mycobacteria, usually M. tuberculosis, suspended in the oil phase. It is effective in stimulating cell-mediated immunity (IMMUNITY, CELLULAR) and potentiates the production of certain IMMUNOGLOBULINS in some animals. The incomplete form does not contain mycobacteria.", "PM": "64", "HN": "64(63)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D005620"}, {"RECTYPE": "D", "MH": "Friedreich Ataxia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sclerosis, Hereditary Spinal|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Spinocerebellar Ataxia, Friedreich", "MN": "C18.452.660.300", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An autosomal recessive disease, usually of childhood onset, characterized pathologically by degeneration of the spinocerebellar tracts, posterior columns, and to a lesser extent the corticospinal tracts. Clinical manifestations include GAIT ATAXIA, pes cavus, speech impairment, lateral curvature of spine, rhythmic head tremor, kyphoscoliosis, congestive heart failure (secondary to a cardiomyopathy), and lower extremity weakness. Most forms of this condition are associated with a mutation in a gene on chromosome 9, at band q13, which codes for the mitochondrial protein frataxin. (From Adams et al., Principles of Neurology, 6th ed, p1081; N Engl J Med 1996 Oct 17;335(16):1169-75) The severity of Friedreich ataxia associated with expansion of GAA repeats in the first intron of the frataxin gene correlates with the number of trinucleotide repeats. (From Durr et al, N Engl J Med 1996 Oct 17;335(16):1169-75)", "PM": "2000; see FRIEDREICH'S ATAXIA 1966-1999; for FRIEDREICH'S DISEASE see MYOCLONUS 1997-1999", "HN": "2000(1966); for FRIEDREICH'S DISEASE use MYOCLONUS 1997-1999", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D005621"}, {"RECTYPE": "D", "MH": "Friend murine leukemia virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Rowson-Parr Virus|T005|EPO|EQV|UNK (19XX)|741127|abcdef", "ENTRY": "Virus, Rowson-Parr", "MN": "B04.820.650.375.525.225", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11795", "AN": "infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + LEUKEMIA, EXPERIMENTAL (IM) or LEUKEMIA (IM); Friend erythroleukemia cells: coord IM with LEUKEMIA, ERYTHROBLASTIC, ACUTE + TUMOR CELLS, CULTURED", "MS": "A strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) producing leukemia of the reticulum-cell type with massive infiltration of liver, spleen, and bone marrow. It infects DBA/2 and Swiss mice.", "PM": "2002; see FRIEND VIRUS 1966-2001", "HN": "2002 (1966)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005622"}, {"RECTYPE": "D", "MH": "Frontal Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Frontal Bones", "MN": "A02.835.232.781.375", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "fractures: coordinate FRONTAL BONE /inj (IM) + SKULL FRACTURES (IM); neoplasms: coordinate IM with SKULL NEOPLASMS (IM)", "MS": "The bone that forms the frontal aspect of the skull. Its flat part forms the forehead, articulating inferiorly with the NASAL BONE and the CHEEK BONE on each side of the face.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005624"}, {"RECTYPE": "D", "MH": "Frontal Lobe", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Brodmann's Area 8|T023|EPO|NRW|NLM (2022)|201007|abcdef", "ENTRY": "Supplementary Eye Fields", "MN": "A08.186.211.200.885.287.500.270", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "diseases: coordinate with BRAIN DISEASES; neoplasms: coordinate with BRAIN NEOPLASMS + histological type of neoplasm ", "MS": "The part of the cerebral hemisphere anterior to the central sulcus, and anterior and superior to the lateral sulcus.", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005625"}, {"RECTYPE": "D", "MH": "Frontal Sinus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Frontal Sinus Ostium|T030|NON|REL|NLM (2024)|230209|abcdef", "ENTRY": "Sinus, Frontal", "MN": "A04.531.621.387", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "One of the paired, but seldom symmetrical, air spaces located between the inner and outer compact layers of the FRONTAL BONE in the forehead.", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005626"}, {"RECTYPE": "D", "MH": "Frostbite", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Frostbites", "MN": "C26.417", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Damage to tissues as the result of low environmental temperatures.", "CATSH": "CAT LIST", "MR": "20141202", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005627"}, {"RECTYPE": "D", "MH": "Frozen Foods", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Food, Frozen|T168|NON|EQV|UNK (19XX)|810519|abcdef", "ENTRY": "Frozen Food", "MN": "J02.500.521.500", "MH_TH": "NLM (1975)", "ST": "T168", "MS": "Foods that are preserved by lowering their storage temperature below the freezing point.", "OL": "use FOOD PRESERVATION to search FROZEN FOODS 1966-74", "PM": "91; was see under FOOD PRESERVATION 1968-90", "HN": "91(64); was see under FOOD PRESERVATION 1964-90 (Prov 1964-67)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005628"}, {"RECTYPE": "D", "MH": "Frozen Sections", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Sections, Frozen", "MN": "E05.200.750.600.530.160.260", "MH_TH": "NLM (1975)", "ST": "T024", "MS": "Thinly cut sections of frozen tissue specimens prepared with a cryostat or freezing microtome.", "OL": "search MICROTOMY 1966-74", "PM": "91; was see under MICROTOMY 1975-90", "HN": "91(75); was see under MICROTOMY 1975-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005629"}, {"RECTYPE": "D", "MH": "Fructans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Levans|T109|NON|EQV|UNK (19XX)|771216|abcdef", "MN": "D09.698.350", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "polysaccharides", "PI": "Polysaccharides (1973-1974)", "MS": "Polysaccharides composed of D-fructose units.", "PM": "91; was see under POLYSACCHARIDES 1975-90", "HN": "91(75); was see under POLYSACCHARIDES 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005630"}, {"RECTYPE": "D", "MH": "Fructokinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ketohexokinases|T116|T126|NON|EQV|UNK (19XX)|780518|abbcdef", "MN": "D08.811.913.696.620.225", "MH_TH": "NLM (1979)", "ST": "T126", "RN": "EC 2.7.1.-", "PI": "Phosphotransferases, ATP (1974-1978)", "MS": "A class of enzymes that catalyzes the phosphorylation of fructose in the presence of ATP. EC 2.7.1.-.", "PM": "91; was see under PHOSPHOTRANSFERASES, ATP 1979-90", "HN": "91(79); was see under PHOSPHOTRANSFERASES, ATP 1979-90", "MR": "20030709", "DA": "19780518", "DC": "1", "DX": "19910101", "UI": "D005631"}, {"RECTYPE": "D", "MH": "Fructose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Levulose|T109|T121|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Levulosa, Fleboplast", "MN": "D09.947.875.465.354", "PA": "Sweetening Agents", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Fructose", "RN": "30237-26-4", "MS": "A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding.", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005632"}, {"RECTYPE": "D", "MH": "Fructose Intolerance", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Intolerances, Fructose", "MN": "C18.452.648.202.251.271", "FX": "Fructose-Bisphosphate Aldolase", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "an inborn error of fructose metab; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "An autosomal recessive fructose metabolism disorder due to deficient fructose-1-phosphate aldolase (EC 2.1.2.13) activity, resulting in accumulation of fructose-1-phosphate. The accumulated fructose-1-phosphate inhibits glycogenolysis and gluconeogenesis, causing severe hypoglycemia following ingestion of fructose. Prolonged fructose ingestion in infants leads ultimately to hepatic failure and death. Patients develop a strong distaste for sweet food, and avoid a chronic course of the disease by remaining on a fructose- and sucrose-free diet.", "PM": "1991; see FRUCTOSE METABOLISM, INBORN ERRORS 1989-1990; see CARBOHYDRATE METABOLISM, INBORN ERRORS 1967-1988", "HN": "1991(1975); use FRUCTOSE METABOLISM, INBORN ERRORS 1989-1990; use CARBOHYDRATE METABOLISM, INBORN ERRORS 1964-1988", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005633"}, {"RECTYPE": "D", "MH": "Fructose-Bisphosphate Aldolase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fructosediphosphate Aldolase|T116|T126|NON|EQV|NLM (1998)|961115|abbcdef", "ENTRY": "Fructose Bisphosphate Aldolase", "MN": "D08.811.520.224.062.400", "FX": "Fructose Intolerance", "MH_TH": "NLM (1973)", "ST": "T126", "N1": "D-Fructose-1,6-biphosphate D-glyceraldehyde-3-phosphate-lyase", "RN": "EC 4.1.2.13", "RR": "9024-52-6 (CAS RN)", "AN": "/defic: consider also FRUCTOSE INTOLERANCE", "MS": "An enzyme of the lyase class that catalyzes the cleavage of fructose 1,6-biphosphate to form dihydroxyacetone phosphate and glyceraldehyde 3-phosphate. The enzyme also acts on (3S,4R)-ketose 1-phosphates. The yeast and bacterial enzymes are zinc proteins. (Enzyme Nomenclature, 1992) E.C. 4.1.2.13.", "PM": "98; see FRUCTOSEDIPHOSPHATE ALDOLASE 1974-97, see ALDOLASE 1963-73", "HN": "98(63)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005634"}, {"RECTYPE": "D", "MH": "Fructosediphosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D09.894.417.592.300", "MH_TH": "NLM (1978)", "ST": "T123", "RN": "0", "PI": "Hexosediphosphates (1973-1977)", "MS": "Diphosphoric acid esters of fructose. The fructose-1,6- diphosphate isomer is most prevalent. It is an important intermediate in the glycolysis process.", "PM": "91; was see under HEXOSEDIPHOSPHATES 1978-90", "HN": "91(78); was see under HEXOSEDIPHOSPHATES 1978-90", "MR": "20040707", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D005635"}, {"RECTYPE": "D", "MH": "Fructosephosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D09.894.417.313", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "Hexosephosphates (1966-1970)", "PM": "73", "HN": "73(71)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005636"}, {"RECTYPE": "D", "MH": "Fructuronate Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mannonate Oxidoreductase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Reductase, Fructuronate", "MN": "D08.811.682.047.150.225", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "D-Mannonate:NAD+ 5-oxidoreductase", "RN": "EC 1.1.1.57", "PI": "Uronic Acids (1974)", "MS": "An enzyme that catalyzes the reversible oxidation of mannonate to fructuronate in the presence of NAD. Also reduces D-tagaturonate to D-altronate. EC 1.1.1.57.", "PM": "91; was see under CARBOHYDRATE DEHYDROGENASES 1978-90; was see under ALCOHOL OXIDOREDUCTASES 1975-77", "HN": "91(75); was see under CARBOHYDRATE DEHYDROGENASES 1978-90; was see under ALCOHOL OXIDOREDUCTASES 1975-77", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005637"}, {"RECTYPE": "D", "MH": "Fruit", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Plant Capsule|T002|NON|NRW|NLM (2003)|011211|abcdef", "ENTRY": "Pods, Legume", "MN": "J02.500.562", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "coordinate with specific plant if pertinent; therapeutic use of fruit: index FRUIT + specific plant  if pertinent + disease /diet ther; PHYTOTHERAPY is also available", "MS": "The fleshy or dry ripened ovary of a plant, enclosing the seed or seeds.", "PM": "66", "HN": "66", "MR": "20160517", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005638"}, {"RECTYPE": "D", "MH": "Frustration", "ENTRY": "Frustrations", "MN": "F01.470.405", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "human & animal", "MS": "The motivational and/or affective state resulting from being blocked, thwarted, disappointed or defeated.", "CATSH": "CAT LIST", "MR": "19890428", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005639"}, {"RECTYPE": "D", "MH": "Follicle Stimulating Hormone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "FSH (Follicle Stimulating Hormone)|T116|T125|NON|EQV|NLM (2003)|020314|abbcdef", "ENTRY": "Follitropin|T116|T125|NON|EQV|UNK (19XX)|810108|abbcdef", "MN": "D12.644.548.691.525.343.288", "PA": "Hormones", "FX": "Receptors, FSH", "MH_TH": "NLM (1993)", "ST": "T125", "N1": "Follicle-stimulating hormone", "RN": "9002-68-0", "AN": "for alpha subunit, coord with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT is also available; FOLLICLE STIMULATING HORMONE, HUMAN is also available", "MS": "A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.", "PM": "2002; see FSH 1963-2001; for FOLLICLE STIMULATING HORMONE see FSH 1963-2001", "HN": "2002(1963)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D005640"}, {"RECTYPE": "D", "MH": "Tegafur", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "FT 207", "MN": "D03.383.742.698.875.404.850", "PA": "Antimetabolites, Antineoplastic", "MH_TH": "USAN (1979)", "ST": "T121", "N1": "2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-", "RN": "1548R74NSZ", "RR": "17902-23-7 (Tegafur)", "PI": "Furans (1972-1976)", "MS": "Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms.", "OL": "use TEGAFUR to search FTORAFUR 1977-91", "PM": "91; was FTORAFUR 1986-90 & FTORAFUR see under FLUOROURACIL 1977-85", "HN": "91(77); was FTORAFUR 1986-90 & FTORAFUR see under FLUOROURACIL 1977-85", "MR": "20170524", "DA": "19760416", "DC": "1", "DX": "19860101", "UI": "D005641"}, {"RECTYPE": "D", "MH": "Fuchs' Endothelial Dystrophy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fuch Endothelial Dystrophy", "MN": "C16.320.290.162.410", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a corneal dystrophy", "MS": "Disorder caused by loss of endothelium of the central cornea. It is characterized by hyaline endothelial outgrowths on Descemet's membrane, epithelial blisters, reduced vision, and pain.", "PM": "91; was see under CORNEAL DYSTROPHIES, HEREDITARY 1990; was see under CORNEAL DYSTROPHIES 1975-89", "HN": "91(75); was see under CORNEAL DYSTROPHIES, HEREDITARY 1990; was see under CORNEAL DYSTROPHIES 1975-89", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005642"}, {"RECTYPE": "D", "MH": "Fucose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Deoxygalactose|T109|T123|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "alpha Fucose", "MN": "D09.254.488", "MH_TH": "NLM (1963)", "ST": "T123", "RN": "28RYY2IV3F", "RR": "3713-31-3", "MS": "A six-member ring deoxysugar with the chemical formula C6H12O5. It lacks a hydroxyl group on the carbon at position 6 of the molecule.", "PM": "66", "HN": "66(63)", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005643"}, {"RECTYPE": "D", "MH": "alpha-L-Fucosidase", "DS": "ALPHA FUCOSIDASE L", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fucosidase|T116|T126|NON|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "alpha L Fucosidase", "MN": "D08.811.277.450.050", "FX": "Fucosidosis", "MH_TH": "UNK (19XX)", "ST": "T126", "N1": "alpha-L-Fucoside fucohydrolase", "RN": "EC 3.2.1.51", "AN": "/defic: consider also FUCOSIDOSIS", "PI": "Glycoside Hydrolases (1966-1974)", "MS": "An enzyme that catalyzes the hydrolysis of an alpha L-fucoside to yield an alcohol and L-fucose. Deficiency of this enzyme can cause FUCOSIDOSIS. EC 3.2.1.51.", "PM": "1978; see DISACCHARIDASES 1975-1977, see FUCOSIDASE 1975-1999", "HN": "1978(1975)", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19780101", "UI": "D005644"}, {"RECTYPE": "D", "MH": "Fucosidosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fucosidase Deficiency Disease|T047|NON|EQV|GHR (2014)|NLM (2000)|991103|FUCOSIDASE DEFIC DIS|abcdeefv", "ENTRY": "alpha-L-Fucosidase Deficiency Diseases", "MN": "C18.452.648.595.554.295", "FX": "alpha-L-Fucosidase", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Fucosidase (1975-1984)", "MS": "An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS; GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)", "PM": "1985", "HN": "1985", "CATSH": "CAT LIST", "MR": "20160628", "DA": "19840529", "DC": "1", "DX": "19850101", "UI": "D005645"}, {"RECTYPE": "D", "MH": "Fucosyl Galactose alpha-N-Acetylgalactosaminyltransferase", "DE": "FUG TRANSFERASE", "DS": "FUCOSYL GALACTOSE ALPHA ACETYLGALACTOSAMINYLTRANSFERASE N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fucosyl Galactose Acetylgalactosaminyltransferase|T116|T126|NON|EQV|NLM (1992)|901220|abbcdef", "ENTRY": "alpha-N-Acetylgalactosaminyltransferase, Fucosyl Galactose", "MN": "D08.811.913.400.100.200.300", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "UDP-N-acetyl-D-galactosamine:alpha-L-fucosyl-(1,2)-D-galactose 3-N-acetyl-D-galactosaminyltransferase", "RN": "EC 2.4.1.40", "RR": "9067-69-0 (CAS RN)", "PI": "Oligosaccharides (1970-1974)", "MS": "An enzyme that catalyzes the transfer of acetylgalactosamine from UDP N-acetylgalactosamine to various 2-fucosylgalactosides as acceptors. EC 2.4.1.40.", "OL": "use FUCOSYL GALACTOSE ALPHA-N-ACETYLGALACTOSAMINYLTRANSFERASE to search FUCOSYL GALACTOSE ACETYLGALACTOSAMINYLTRANSFERASE 1975-91", "PM": "92; was FUCOSYL GALACTOSE ACETYLGALACTOSAMINYLTRANSFERASE 1975-91 (see under GALACTOSYLTRANSFERASES 1979-90, see under HEXOSYLTRANSFERASES 1975-78)", "HN": "92(75); was FUCOSYL GALACTOSE ACETYLGALACTOSAMINYLTRANSFERASE 1975-91 (see under GALACTOSYLTRANSFERASES 1979-90, see under HEXOSYLTRANSFERASES 1975-78)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005646"}, {"RECTYPE": "D", "MH": "Fucosyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fucosyltransferase|T116|T126|NON|EQV|NLM (2021)|191115|abbcdef", "MN": "D08.811.913.400.450.300", "MH_TH": "NLM (1979)", "ST": "T126", "RN": "EC 2.4.1.-", "RR": "56626-18-7 (CAS RN)", "PI": "Transferases (1966-1971)", "MS": "Enzymes catalyzing the transfer of fucose from a nucleoside diphosphate fucose to an acceptor molecule which is frequently another carbohydrate, a glycoprotein, or a glycolipid molecule. Elevated activity of some fucosyltransferases in human serum may serve as an indicator of malignancy. The class includes EC 2.4.1.65; EC 2.4.1.68; EC 2.4.1.69; EC 2.4.1.89.", "PM": "91; was see under HEXOSYLTRANSFERASES 1979-90", "HN": "91(79); was see under HEXOSYLTRANSFERASES 1979-90", "MR": "20200527", "DA": "19780309", "DC": "1", "DX": "19910101", "UI": "D005647"}, {"RECTYPE": "D", "MH": "Fuel Oils", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Oils, Fuel", "MN": "N06.230.132.258.630.500", "MH_TH": "NLM (1975)", "ST": "T073", "RN": "0", "MS": "Complex petroleum hydrocarbons consisting mainly of residues from crude oil distillation. These liquid products include heating oils, stove oils, and furnace oils and are burned to generate energy.", "OL": "use PETROLEUM to search FOSSIL FUELS 1968-74", "PM": "91; was see under PETROLEUM 1975-90; was in Cat J only 1975-81", "HN": "91(75); was see under PETROLEUM 1975-90; was in Cat J only 1975-81", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005648"}, {"RECTYPE": "D", "MH": "Fumarate Hydratase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fumarase|T116|T126|NON|EQV|UNK (19XX)|770408|abbcdef", "ENTRY": "Hydratase, Fumarate", "MN": "D08.811.520.241.300.300", "MH_TH": "NLM (1973)", "ST": "T126", "N1": "(S)-Malate hydro-lyase", "RN": "EC 4.2.1.2", "RR": "9032-88-6 (CAS RN)", "PI": "Hydro-Lyases (1966-1972)", "MS": "An enzyme that catalyzes the reversible hydration of fumaric acid to yield L-malic acid. It is one of the citric acid cycle enzymes. EC 4.2.1.2.", "PM": "78; was see under HYDRO-LYASES 1975-77", "HN": "78(73); was see under HYDRO-LYASES 1975-77", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D005649"}, {"RECTYPE": "D", "MH": "Fumarates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fumaric Acid Esters|T109|NON|NRW|NLM (2008)|060629|abcdef", "ENTRY": "Esters, Fumaric Acid", "MN": "D02.241.081.337.302", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "for esters add ESTERS (NIM)", "MS": "Compounds based on fumaric acid.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005650"}, {"RECTYPE": "D", "MH": "Fumigation", "AQ": "AE EC ES HI LJ MT SN ST", "ENTRY": "Fumigations", "MN": "N06.850.780.200.300", "MH_TH": "NLM (1966)", "ST": "T068", "MS": "The application of smoke, vapor, or gas for the purpose of disinfecting or destroying pests or microorganisms.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005651"}, {"RECTYPE": "D", "MH": "Functional Residual Capacity", "DE": "FRC", "AQ": "DE ES GE IM PH RE", "ENTRY": "Residual Capacity, Functional", "MN": "G09.772.850.390", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "usually NIM", "MS": "The volume of air remaining in the LUNGS at the end of a normal, quiet expiration. It is the sum of the RESIDUAL VOLUME and the EXPIRATORY RESERVE VOLUME. Common abbreviation is FRC.", "PM": "91; was see under LUNG VOLUME MEASUREMENTS 1975-90", "HN": "91(75); was see under LUNG VOLUME MEASUREMENTS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D005652"}, {"RECTYPE": "D", "MH": "Fund Raising", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Philanthropic Funds|T095|NON|REL|UNK (19XX)|810226|abcdef", "ENTRY": "Philanthropic Fund", "MN": "N03.219.463.360", "FX": "Gift Giving", "MH_TH": "NLM (1978)", "ST": "T052", "MS": "Usually organized community efforts to raise money to promote financial programs of institutions. The funds may include individual gifts.", "PM": "91; was see under FINANCIAL MANAGEMENT 1978-90", "HN": "91(78); was see under FINANCIAL MANAGEMENT 1978-90", "MR": "20180629", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D005653"}, {"RECTYPE": "D", "MH": "Fundus Oculi", "AQ": "DE RE", "PRINT ENTRY": "Ocular Fundus|T029|NON|EQV|NLM (2023)|220112|abcdef", "ENTRY": "Fundus, Ocular", "MN": "A09.371.729.313", "FX": "Ophthalmoscopy", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "what is seen through an ophthalmoscope: do not confuse with RETINA & RETINAL VESSELS, the correct terms with subheadings, not FUNDUS OCULI; early coord for fundus fluorescent angiography: see hist notes under FLUORESCEIN ANGIOGRAPHY", "MS": "The concave interior of the eye, consisting of the retina, the choroid, the sclera, the optic disk, and blood vessels, seen by means of the ophthalmoscope. (Cline et al., Dictionary of Visual Science, 4th ed)", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005654"}, {"RECTYPE": "D", "MH": "Funeral Rites", "AQ": "CL HI PX", "PRINT ENTRY": "Mortuary Customs|T054|NON|BRD|UNK (19XX)|820503|abcdef", "ENTRY": "Rites, Funeral", "MN": "I01.076.201.450.550", "MH_TH": "NLM (1975)", "ST": "T054", "AN": "specify geographic term if pertinent", "MS": "Those customs and ceremonies pertaining to the dead.", "OL": "use FUNERAL RITES to search MORTUARY CUSTOMS 1966-82", "PM": "83; was see under MORTUARY CUSTOMS 1963-82; MORTUARY CUSTOMS was heading 1963-82", "HN": "83(75); was see under MORTUARY CUSTOMS 1963-82; MORTUARY CUSTOMS was heading 1963-82", "MR": "20170308", "DA": "19990101", "DC": "1", "DX": "19830101", "UI": "D005655"}, {"RECTYPE": "D", "MH": "Fungal Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Yeast Proteins|T116|T123|NON|NRW|NLM (2002)|010425|abbcdef", "ENTRY": "Proteins, Fungal", "MN": "D12.776.354", "FX": "Yeasts", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "AN": "/drug eff /ultrastruct permitted; /physiol permitted for function within the fungus; coord IM with specific protein (IM) + specific fungus (IM)", "PI": "Proteins (1966-1972)", "MS": "Proteins found in any species of fungus.", "PM": "73", "HN": "73", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005656"}, {"RECTYPE": "D", "MH": "Fungal Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Fungal", "MN": "D20.215.894.354", "MH_TH": "NLM (1965)", "ST": "T129", "RN": "0", "AN": "coord IM with specific fungus /immunol (IM)", "MS": "Suspensions of attenuated or killed fungi administered for the prevention or treatment of infectious fungal disease.", "PM": "65", "HN": "65", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005657"}, {"RECTYPE": "D", "MH": "Fungi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Molds|T004|NON|NRW|NLM (2005)|031030|abcdef", "ENTRY": "Mold", "MN": "B01.300", "FX": "Fungicides, Industrial", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid4751", "AN": "general or unspecified; prefer specifics; fungal diseases equals MYCOSES, fungal diseases of skin equals DERMATOMYCOSES", "CX": "consider also terms at MYCO-", "MS": "A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005658"}, {"RECTYPE": "D", "MH": "Fungicides, Industrial", "DE": "FUNGICIDES INDUST", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Industrial Fungicides|T121|T131|NON|EQV|NLM (1996)|950309|INDUST FUNGICIDES|abbcdefv", "MN": "D27.888.723.288", "MH_TH": "NLM (1972)", "ST": "T131", "RN": "0", "PI": "Antifungal Agents (1966-1971)", "MS": "Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc.", "OL": "search FUNGICIDES under ANTIFUNGAL AGENTS 1966-71", "PM": "72; FUNGICIDES was included in ANTIFUNGAL AGENTS 1967-71, was heading 1963-66", "HN": "72; FUNGICIDES was included in ANTIFUNGAL AGENTS 1967-71, was heading 1963-66", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D005659"}, {"RECTYPE": "D", "MH": "Funnel Chest", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pectus Excavatum|T019|NON|EQV|OMIM (2013)|UNK (19XX)|790417|abcdeef", "ENTRY": "Funnel Chests", "MN": "C16.131.621.386", "MH_TH": "OMIM (2013)", "ST": "T019", "AN": "a sternum abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "A developmental anomaly in which the lower sternum is posteriorly dislocated and concavely deformed, resulting in a funnel-shaped thorax.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005660"}, {"RECTYPE": "D", "MH": "Furagin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Solafur|T109|T121|TRD|NRW|UNK (19XX)|850528|abbcdef", "MN": "D03.383.312.649.308", "PA": "Anti-Infective Agents, Urinary", "MH_TH": "NLM (1978)", "ST": "T121", "N1": "2,4-Imidazolidinedione, 1-((3-(5-nitro-2-furanyl)-2-propenylidene)amino)-", "RN": "K2R4N34Y9I", "RR": "1672-88-4 (Furagin)", "PI": "Nitrofurans (1966-1977)", "MS": "Nitrofuran derivative anti-infective agent used for urinary tract infections.", "PM": "91; was see under NITROFURANS 1978-90", "HN": "91(78); was see under NITROFURANS 1978-90", "MR": "20160531", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D005661"}, {"RECTYPE": "D", "MH": "Furaldehyde", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Furfural|T109|T123|T130|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbbbcdeef", "MN": "D03.383.312.355", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "2-Furancarboxaldehyde", "RN": "DJ1HGI319P", "RR": "98-01-1 (Furaldehyde)", "MS": "A heterocyclic compound consisting of a furan where the hydrogen at position 2 is substituted by a formyl group.", "MR": "20160426", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005662"}, {"RECTYPE": "D", "MH": "Furans", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetrahydrofurans|T109|NON|NRW|NLM (2003)|020214|abcdef", "MN": "D03.383.312", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005663"}, {"RECTYPE": "D", "MH": "Furazolidone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nifurazolidone|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef", "ENTRY": "Furoxone|T109|T121|TRD|NRW|UNK (19XX)|830330|abbcdef", "MN": "D03.383.312.649.313", "PA": "Monoamine Oxidase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2-Oxazolidinone, 3-(((5-nitro-2-furanyl)methylene)amino)-", "RN": "5J9CPU3RE0", "RR": "67-45-8 (Furazolidone)", "MS": "A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005664"}, {"RECTYPE": "D", "MH": "Furosemide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fursemide|T109|T121|NON|EQV|UNK (19XX)|760306|abbcdef", "ENTRY": "Lasix|T109|T121|TRD|NRW|UNK (19XX)|800801|abbcdef", "MN": "D02.886.590.700.725.300", "PA": "Sodium Potassium Chloride Symporter Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)-", "RN": "7LXU5N7ZO5", "RR": "54-31-9 (Furosemide)", "MS": "A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.", "OL": "use FUROSEMIDE to search FRUSEMID 1977-91", "PM": "67; FRUSEMIDE was FRUSEMID see FUROSEMIDE 1977-91", "HN": "67(65); FRUSEMIDE was FRUSEMID see FUROSEMIDE 1977-91", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D005665"}, {"RECTYPE": "D", "MH": "Fursultiamin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiamine Tetrahydrofurfuryl Disulfide|T109|T121|NON|EQV|UNK (19XX)|780208|TTFD|abbcdefv", "ENTRY": "Monohydrochloride, Fursultiamin", "MN": "D03.383.742.795.300", "PA": "Vitamin B Complex", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Formamide, N-((4-amino-2-methyl-5-pyrimidinyl)methyl)-N-(4-hydroxy-1-methyl-2-(((tetrahydro-2-furanyl)methyl)dithio)-1-butenyl)-", "RN": "05J61265PX", "RR": "804-30-8 (Fursultiamin)", "PI": "Pyrimidines (1973-1974)", "MS": "Compound used for therapy of thiamine deficiency. It has also been suggested for several non-deficiency disorders but has not yet proven useful.", "OL": "use FURSULTIAMIN to search THIAMINE TETRAHYDROFURFURYL DISULFIDE 1975-78", "PM": "91; was see under PYRIMIDINES 1979-90; was THIAMINE TETRAHYDROFURFURYL DISULFIDE see under PYRIMIDINES 1975-78", "HN": "91(79); was see under PYRIMIDINES 1979-90; was THIAMINE TETRAHYDROFURFURYL DISULFIDE see under PYRIMIDINES 1975-78", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005666"}, {"RECTYPE": "D", "MH": "Furunculosis", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Boils|T184|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Furuncles|T184|NON|REL|NLM (1993)|920421|abcdef", "MN": "C22.362.224", "FX": "Carbuncle", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A persistent skin infection marked by the presence of furuncles, often chronic and recurrent. In humans, the causative agent is various species of STAPHYLOCOCCUS. In salmonid fish (SALMONIDS), the pathogen is AEROMONAS SALMONICIDA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005667"}, {"RECTYPE": "D", "MH": "Furylfuramide", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "AF2", "MN": "D03.383.312.649.330", "PA": "Mutagens", "MH_TH": "NLM (1978)", "ST": "T131", "N1": "2-Furanacetamide, alpha-((5-nitro-2-furanyl)methylene)-", "RN": "054NR2135Y", "RR": "3688-53-7 (Furylfuramide)", "PI": "Nitrofurans (1966-1977)", "MS": "Used formerly as antimicrobial food additive. It causes mutations in many cell cultures and may be carcinogenic.", "PM": "91; was see under NITROFURANS 1978-90", "HN": "91(78); was see under NITROFURANS 1978-90", "MR": "20160531", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D005668"}, {"RECTYPE": "D", "MH": "Fusaric Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Fusarate, Calcium", "MN": "D03.383.725.705.200", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "2-Pyridinecarboxylic acid, 5-butyl-", "RN": "JWJ963070N", "RR": "536-69-6 (Fusaric Acid)", "AN": "/biosyn permitted if by organism", "PI": "Picolinic Acids (1969-1974)", "MS": "A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.", "PM": "91; was see under PICOLINIC ACIDS 1975-90", "HN": "91(75); was see under PICOLINIC ACIDS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005669"}, {"RECTYPE": "D", "MH": "Fusarium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Fusariums", "MN": "B01.300.381.366", "FX": "Gibberella", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid5506", "MS": "A mitosporic Hypocreales fungal genus, various species of which are important parasitic pathogens of plants and a variety of vertebrates. Teleomorphs include GIBBERELLA.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005670"}, {"RECTYPE": "D", "MH": "Fused Teeth", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tooth, Double", "MN": "C16.131.850.800.370", "MH_TH": "NLM (1975)", "ST": "T019", "MS": "Two teeth united during development by the union of their tooth germs; the teeth may be joined by the enamel of their crowns, by their root dentin, or by both.", "OL": "search TOOTH ABNORMALITIES 1966-74", "PM": "91; was see under TOOTH ABNORMALITIES 1975-90", "HN": "91(75); was see under TOOTH ABNORMALITIES 1975-90", "CATSH": "CAT LIST", "MR": "20151130", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005671"}, {"RECTYPE": "D", "MH": "Fusidic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Fusidate", "MN": "D10.570.938.515", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USAN (1967)", "ST": "T195", "N1": "29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, (3alpha,4alpha,8alpha,9beta,11alpha,13alpha,14beta,16beta,17Z)-", "RN": "59XE10C19C", "RR": "J7P3696BCQ", "MS": "An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis.", "PM": "65; FUSIDIN was see FUSIDIC ACID 1965-95", "HN": "65; FUSIDIN was see FUSIDIC ACID 1965-95", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005672"}, {"RECTYPE": "D", "MH": "Fusobacterium", "DE": "FUSOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Sphaerophorus|T007|NON|EQV|UNK (19XX)|760526|abcdef", "MN": "B03.440.425.410.420", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid848", "MS": "A genus of gram-negative, anaerobic, rod-shaped bacteria found in cavities of humans and other animals. No endospores are formed. Some species are pathogenic and occur in various purulent or gangrenous infections.", "OL": "use FUSOBACTERIUM to search SPHAEROPHORUS 1966-76", "PM": "SPHAEROPHORUS was heading 1963-76 (see under BACTEROIDACEAE 1976)", "HN": "SPHAEROPHORUS was heading 1963-76 (see under BACTEROIDACEAE 1976)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D005673"}, {"RECTYPE": "D", "MH": "Fusobacterium Infections", "DE": "FUSOBACT INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Sphaerophorus Infections|T047|NON|EQV|UNK (19XX)|760414|SPHAEROPHORUS INFECT|abcdefv", "ENTRY": "Sphaerophorus Infection", "MN": "C01.150.252.400.388.350", "MH_TH": "NLM (1977)", "ST": "T047", "PI": "Fusobacterium (1966-1967)", "MS": "Infections with bacteria of the genus FUSOBACTERIUM.", "OL": "use FUSOBACTERIUM INFECTIONS to search SPHAEROPHORUS INFECTIONS 1968-76", "PM": "77; was SPHAEROPHORUS INFECTIONS 1968-76", "HN": "77; was SPHAEROPHORUS INFECTIONS 1968-76", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D005674"}, {"RECTYPE": "D", "MH": "Fusobacterium necrophorum", "DE": "FUSOBACT NECROPHORUM", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Sphaerophorus necrophorus|T007|NON|EQV|UNK (19XX)|750711|abcdef", "MN": "B03.440.425.410.420.400", "FX": "Foot Rot", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid859", "AN": "infection: coord IM with FUSOBACTERIUM INFECTIONS (IM)", "PI": "Fusobacterium (1966-1974)", "MS": "A species of gram-negative, non-spore-forming bacteria isolated from the natural cavities of man and other animals and from necrotic lesions, abscesses, and blood.", "OL": "use FUSOBACTERIUM NECROPHORUM to search SPHAEROPHORUS NECROPHORUS 1975", "PM": "76; was SPHAEROPHORUS NECROPHORUS see under SPHAEROPHORUS 1975", "HN": "76; was SPHAEROPHORUS NECROPHORUS see under SPHAEROPHORUS 1975", "MR": "20200813", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D005675"}, {"RECTYPE": "D", "MH": "Gravity Suits", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Pressure Suits|T073|NON|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "Trousers, Military Antishock", "MN": "E07.440", "FX": "Intermittent Pneumatic Compression Devices", "MH_TH": "UNK (19XX)", "ST": "T073", "AN": "MAST suit (Military or Medical Anti-Shock Trousers) goes here (do not add MILITARY MEDICINE); SPACE SUITS is also available", "PI": "Protective Clothing (1970-1974)", "MS": "Double-layered inflatable suits which, when inflated, exert pressure on the lower part of the wearer's body. The suits are used to improve or stabilize the circulatory state, i.e., to prevent hypotension, control hemorrhage, and regulate blood pressure. The suits are also used by pilots under positive acceleration.", "PM": "76; was see under CLOTHING 1975", "HN": "76(75); was see under CLOTHING 1975", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19741212", "DC": "1", "DX": "19760101", "UI": "D005676"}, {"RECTYPE": "D", "MH": "G(M1) Ganglioside", "DE": "GM1 GANGLIOSIDE", "DS": "GM GANGLIOSIDE 01", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Monosialosyl Tetraglycosyl Ceramide|T109|T123|NON|EQV|UNK (19XX)|760512|MONOSIALOSYLTETRAGLYCOSYLCERAMIDE|abbcdefs", "ENTRY": "Tetraglycosyl Ceramide, Monosialosyl", "MN": "D10.570.877.360.025.475.390", "MH_TH": "NLM (1977)", "ST": "T123", "N1": "Ganglioside GM1", "RN": "37758-47-7", "PI": "Gangliosides (1966-1976)", "MS": "A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis.", "PM": "86; was see under GANGLIOSIDES 1977-85", "HN": "86(77); was see under GANGLIOSIDES 1977-85", "MR": "20190322", "DA": "19760519", "DC": "1", "DX": "19860101", "UI": "D005677"}, {"RECTYPE": "D", "MH": "G(M2) Ganglioside", "DE": "GM2 GANGLIOSIDE", "DS": "GM GANGLIOSIDE 02", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tay-Sachs Disease Ganglioside|T109|T123|EPO|EQV|UNK (19XX)|760520|TAY SACHS DIS GANGLIOSIDE|abbcdefv", "ENTRY": "Tay Sachs Disease Ganglioside", "MN": "D10.570.877.360.025.475.400", "FX": "Tay-Sachs Disease", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Ganglioside GM2", "RN": "19600-01-2", "PI": "Gangliosides (1974)", "MS": "A glycosphingolipid that accumulates due to a deficiency of hexosaminidase A or B (BETA-N-ACETYLHEXOSAMINIDASES), or GM2 activator protein, resulting in GANGLIOSIDOSES, heredity metabolic disorders that include TAY-SACHS DISEASE and SANDHOFF DISEASE.", "PM": "91; was see under GANGLIOSIDES 1975-90", "HN": "91(75); was see under GANGLIOSIDES 1975-90", "MR": "20190322", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005678"}, {"RECTYPE": "D", "MH": "G(M3) Ganglioside", "DS": "GM GANGLIOSIDE 03", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sialyllactosylceramide|T109|T123|NON|EQV|UNK (19XX)|760512|abbcdef", "ENTRY": "Lactosylceramide, Sialyl", "MN": "D10.570.877.360.025.475.510", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "G(M3) gangliosidosis: coord NIM with GANGLIOSIDOSIS (IM)", "PI": "Gangliosides (1966-1976)", "MS": "A ganglioside present in abnormally large amounts in the brain and liver due to a deficient biosynthetic enzyme, G(M3):UDP-N-acetylgalactosaminyltransferase. Deficiency of this enzyme prevents the formation of G(M2) ganglioside from G(M3) ganglioside and is the cause of an anabolic sphingolipidosis.", "PM": "91; was see under GANGLIOSIDES 1977-90", "HN": "91(77); was see under GANGLIOSIDES 1977-90", "MR": "20040707", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D005679"}, {"RECTYPE": "D", "MH": "gamma-Aminobutyric Acid", "AQ": "AA AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "GABA|T116|T123|ACR|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "gamma Aminobutyric Acid, Monosodium Salt", "MN": "D12.125.190.350", "PA": "GABA Agents", "FX": "Receptors, GABA", "EC": "antagonists & inhibitors:GABA Antagonists", "MH_TH": "UNK (19XX)", "ST": "T123", "N1": "Butanoic acid, 4-amino-", "RN": "56-12-2", "RR": "92138-11-9 (Zn salt (2:1))", "PI": "Aminobutyric Acids (1966-1974)", "MS": "The most common inhibitory neurotransmitter in the central nervous system.", "PM": "2001; see GABA 1979-2001, see AMINOBUTYRIC ACIDS 1975-1978, see AMINOBUTYRIC ACID 1963-1974", "HN": "2001(1975); use AMINOBUTYRIC ACIDS 1966-1974", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D005680"}, {"RECTYPE": "D", "MH": "Gabon", "AQ": "EH EP", "PRINT ENTRY": "Gabonese Republic|T083|NAM|EQV|NLM (2009)|080304|abcdef", "MN": "Z01.058.290.100.380", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in west equatorial Africa, south of CAMEROON and west of the CONGO. Its capital is Libreville.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005681"}, {"RECTYPE": "D", "MH": "Gadolinium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.484", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Gadolinium", "RN": "AU0V1LM3JT", "RR": "7440-54-2 (Gadolinium)", "MS": "An element of the rare earth family of metals. It has the atomic symbol Gd, atomic number 64, and atomic weight 157.25. Its oxide is used in the control rods of some nuclear reactors.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005682"}, {"RECTYPE": "D", "MH": "Gagging", "AQ": "DE PC PH RE", "PRINT ENTRY": "Reflex, Pharyngeal|T042|T184|NON|EQV|UNK (19XX)|750708|abbcdef", "ENTRY": "Pharyngeal Reflex|T042|T184|NON|EQV|NLM (2015)|140116|abbcdef", "MN": "G11.561.731.251", "MH_TH": "NLM (1971)", "ST": "T184", "PI": "Reflex (1966-1970)", "MS": "Contraction of the muscle of the PHARYNX caused by stimulation of sensory receptors on the SOFT PALATE, by psychic stimuli, or systemically by drugs.", "PM": "91; was see under REFLEX 1971-90", "HN": "91(71); was see under REFLEX 1971-90", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005683"}, {"RECTYPE": "D", "MH": "Gait", "AQ": "DE GE IM PH RE", "ENTRY": "Gaits", "MN": "G11.427.410.568.900.750", "MH_TH": "NLM (1966)", "ST": "T040", "AN": "differentiate from LOCOMOTION & WALKING", "MS": "Manner or style of walking.", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005684"}, {"RECTYPE": "D", "MH": "Galactans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polygalactoses|T109|NON|EQV|UNK (19XX)|771215|abcdef", "MN": "D09.698.360", "FX": "Galactose", "MH_TH": "NLM (1979)", "ST": "T109", "RN": "0", "AN": "polysaccharides", "PI": "Polysaccharides (1966-1978)", "MS": "Polysaccharides composed of repeating galactose units. They can consist of branched or unbranched chains in any linkages.", "PM": "79", "HN": "79", "MR": "20200527", "DA": "19771215", "DC": "1", "DX": "19790101", "UI": "D005685"}, {"RECTYPE": "D", "MH": "Galactokinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.913.696.620.240", "FX": "Galactosemias", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "ATP:D-galactose 1-phosphotransferase", "RN": "EC 2.7.1.6", "RR": "9030-53-9 (CAS RN)", "AN": "/defic: consider also GALACTOSEMIAS", "PI": "Phosphotransferases, ATP (1974-1978)", "MS": "An enzyme that catalyzes reversibly the formation of galactose 1-phosphate and ADP from ATP and D-galactose. Galactosamine can also act as the acceptor. A deficiency of this enzyme results in GALACTOSEMIA. EC 2.7.1.6.", "PM": "79", "HN": "79", "MR": "20030709", "DA": "19771215", "DC": "1", "DX": "19790101", "UI": "D005686"}, {"RECTYPE": "D", "MH": "Galactorrhea", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Galactorrheas", "MN": "C17.800.090.937.439", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "usually check tags PREGNANCY & FEMALE", "MS": "Excessive or inappropriate LACTATION in females or males, and not necessarily related to PREGNANCY. Galactorrhea can occur either unilaterally or bilaterally, and be profuse or sparse. Its most common cause is HYPERPROLACTINEMIA.", "OL": "search LACTATION DISORDERS 1966-74", "PM": "91; was see under LACTATION DISORDERS 1975-90", "HN": "91(75); was see under LACTATION DISORDERS 1975-90", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005687"}, {"RECTYPE": "D", "MH": "Galactosamine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.067.342.356", "MH_TH": "NLM (1971)", "ST": "T123", "N1": "D-Galactose, 2-amino-2-deoxy-", "RN": "7535-00-4", "PI": "Hexosamines (1966-1970)", "PM": "73", "HN": "73(71)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005688"}, {"RECTYPE": "D", "MH": "Galactose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "D Galactose", "MN": "D09.947.875.359.377", "FX": "Galactosemias", "MH_TH": "USAN (19XX)", "ST": "T130", "N1": "Galactose", "RN": "X2RN3Q8DNE", "RR": "26566-61-0 (Galactose)", "AN": "/blood: consider also GALACTOSEMIAS", "MS": "An aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. Deficiency of galactosyl-1-phosphate uridyltransferase (GALACTOSE-1-PHOSPHATE URIDYL-TRANSFERASE DEFICIENCY DISEASE) causes an error in galactose metabolism called GALACTOSEMIA, resulting in elevations of galactose in the blood.", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005690"}, {"RECTYPE": "D", "MH": "Galactose Dehydrogenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Galactose Oxidoreductases|T116|T126|NON|EQV|UNK (19XX)|770517|abbcdef", "ENTRY": "Oxidoreductases, Galactose", "MN": "D08.811.682.047.150.250", "MH_TH": "NLM (1978)", "ST": "T126", "RN": "EC 1.1.1.-", "PI": "Alcohol Oxidoreductases (1966-1977)", "MS": "D-Galactose:NAD(P)+ 1-oxidoreductases. Catalyzes the oxidation of D-galactose in the presence of NAD+ or NADP+ to D-galactono-gamma-lactone and NADH or NADPH. Includes EC 1.1.1.48 and EC 1.1.1.120.", "PM": "91; was see under CARBOHYDRATE DEHYDROGENASES 1978-90", "HN": "91(78); was see under CARBOHYDRATE DEHYDROGENASES 1978-90", "MR": "20060705", "DA": "19770517", "DC": "1", "DX": "19910101", "UI": "D005691"}, {"RECTYPE": "D", "MH": "Galactose Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Galactose", "MN": "D08.811.682.047.210", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "D-Galactose:oxygen 6-oxidoreductase", "RN": "EC 1.1.3.9", "PI": "Galactose (1966-1974)", "MS": "An enzyme that oxidizes galactose in the presence of molecular oxygen to D-galacto-hexodialdose. It is a copper protein. EC 1.1.3.9.", "PM": "78; was see under ALCOHOL OXIDOREDUCTASES 1975-77", "HN": "78(75); was see under ALCOHOL OXIDOREDUCTASES 1975-77", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19780101", "UI": "D005692"}, {"RECTYPE": "D", "MH": "Galactosemias", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "UDPglucose 4-Epimerase Deficiency Disease|T047|NON|NRW|GHR (2014)|NLM (2000)|991108|UDPGLUCOSE EPIMERASE 04 DEFICIENCY DISEASE|UDPGLUCOSE 4 EPIMERASE DEFIC DIS|abcdeefsv", "ENTRY": "Uridylyltransferase Deficiency, Galactose-1-Phosphate", "MN": "C18.452.648.202.355", "FX": "UTP-Hexose-1-Phosphate Uridylyltransferase", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A group of inherited enzyme deficiencies which feature elevations of GALACTOSE in the blood. This condition may be associated with deficiencies of GALACTOKINASE; UDPGLUCOSE-HEXOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; or UDPGLUCOSE 4-EPIMERASE. The classic form is caused by UDPglucose-Hexose-1-Phosphate Uridylyltransferase deficiency, and presents in infancy with FAILURE TO THRIVE; VOMITING; and INTRACRANIAL HYPERTENSION. Affected individuals also may develop MENTAL RETARDATION; JAUNDICE; hepatosplenomegaly; ovarian failure (PRIMARY OVARIAN INSUFFICIENCY); and cataracts. (From Menkes, Textbook of Child Neurology, 5th ed, pp61-3)", "PM": "2000; see GALACTOSEMIA 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D005693"}, {"RECTYPE": "D", "MH": "UTP-Hexose-1-Phosphate Uridylyltransferase", "DS": "UTP HEXOSE PHOSPHATE URIDYLYLTRANSFERASE 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "UDP Galactose Pyrophosphorylase|T116|T126|EQV|UNK (19XX)|750208|abbdef", "ENTRY": "Uridylyltransferase, UTP-Hexose-1-Phosphate", "MN": "D08.811.913.696.445.900", "FX": "Galactosemias", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "UTP:alpha-D-hexose-1-phosphate uridylyltransferase", "RN": "EC 2.7.7.10", "RR": "9016-11-9 (CAS RN)", "AN": "/defic: consider also GALACTOSEMIAS", "PI": "Uracil Nucleotides (1974)", "MS": "An enzyme that catalyzes the synthesis of UDPgalactose from UTP and galactose-1-phosphate. It is present in low levels in fetal and infant liver, but increases with age, thereby enabling galactosemic infants who survive to develop the capacity to metabolize galactose. EC 2.7.7.10.", "PM": "98; see GALACTOSEPHOSPHATE URIDYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005694"}, {"RECTYPE": "D", "MH": "Galactosephosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D09.894.417.370", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Hexosephosphates (1966-1977)", "MS": "Phosphoric acid esters of galactose.", "PM": "91; was see under HEXOSEPHOSPHATES 1978-90", "HN": "91(78); was see under HEXOSEPHOSPHATES 1978-90", "MR": "20040707", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D005695"}, {"RECTYPE": "D", "MH": "Galactosidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Galactosidase|T116|T126|NON|EQV|UNK (19XX)|760905|abbcdef", "MN": "D08.811.277.450.410", "FX": "Gangliosidoses", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.2.1.-", "AN": "note ALPHA- & BETA-GALACTOSIDASES are also available", "MS": "A family of galactoside hydrolases that hydrolyze compounds with an O-galactosyl linkage. EC 3.2.1.-.", "OL": "use GALACTOSIDASES to search GALACTOSIDASE 1966-74", "PM": "75; was GALACTOSIDASE 1963-74", "HN": "75; was GALACTOSIDASE 1963-74", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D005696"}, {"RECTYPE": "D", "MH": "Galactosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D09.408.320", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Glycosides (1966-1974)", "MS": "Glycosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of galactose with an alcohol to form an acetal. They include both alpha- and beta-galactosides.", "PM": "91; was see under GLYCOSIDES 1975-90", "HN": "91(75); was see under GLYCOSIDES 1975-90", "MR": "20040707", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D005697"}, {"RECTYPE": "D", "MH": "Galactosylceramidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Galactocerebrosidase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "beta-Galactosidase, Galactosylcerebroside", "MN": "D08.811.277.450.410.120", "FX": "Leukodystrophy, Globoid Cell", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "D-Galactosyl-N-acylsphingosine galactohydrolase", "RN": "EC 3.2.1.46", "AN": "/defic: consider also LEUKODYSTROPHY, GLOBOID CELL", "PI": "Glycoside Hydrolases (1972-1974)", "MS": "An enzyme that hydrolyzes galactose from ceramide monohexosides. Deficiency of this enzyme may cause globoid cell leukodystrophy (LEUKODYSTROPHY, GLOBOID CELL). EC 3.2.1.46.", "PM": "91; was see under GALACTOSIDASES 1975-90", "HN": "91(75); was see under GALACTOSIDASES 1975-90", "MR": "20120703", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005698"}, {"RECTYPE": "D", "MH": "Galactosylceramides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Galactosylceramide|T109|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Ceramides, Galactosyl", "MN": "D10.570.877.360.612.200.250.450", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "PI": "Glycosphingolipids (1975-1978)", "MS": "Cerebrosides which contain as their polar head group a galactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in beta-galactosidase, is the cause of galactosylceramide lipidosis or globoid cell leukodystrophy.", "PM": "91; was see under CEREBROSIDES 1979-90", "HN": "91(79); was see under CEREBROSIDES 1979-90", "MR": "20200527", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D005699"}, {"RECTYPE": "D", "MH": "Galactosyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Galactosyltransferase|T116|T126|NON|EQV|NLM (2021)|191118|abbcdef", "MN": "D08.811.913.400.450.400", "MH_TH": "NLM (1976)", "ST": "T126", "RN": "EC 2.4.1.-", "PI": "Hexosyltransferases (1972-1975)", "MS": "Enzymes that catalyze the transfer of galactose from a nucleoside diphosphate galactose to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.", "HN": "76", "MR": "20200527", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D005700"}, {"RECTYPE": "D", "MH": "Galago", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Bush Babies|T015|NON|EQV|UNK (19XX)|800509|abcdef", "ENTRY": "Bush Baby", "MN": "B01.050.150.900.649.313.988.700.277.500", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9462", "PI": "Anthropoidea (1966-1974)", "MS": "A genus of the family Lorisidae having four species which inhabit the forests and bush regions of Africa south of the Sahara and some nearby islands. The four species are G. alleni, G. crassicaudatus, G. demidovii, and G. senegalensis. There is another genus, Euoticus, containing two species which some authors have included in the Galago genus.", "OL": "use GALAGO to search GALAGOS 1975-80", "PM": "81; was GALAGOS 1978-80, was GALAGOS see under MONKEYS 1975-77", "HN": "81; was GALAGOS 1978-80, was GALAGOS see under MONKEYS 1975-77", "MR": "20200813", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D005701"}, {"RECTYPE": "D", "MH": "Galantamine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Reminyl|T109|T121|TRD|NRW|NLM (2002)|010314|abbcdef", "ENTRY": "Razadyne|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2010)|090623|abbcdeef", "MN": "D03.633.100.079.525", "PA": "Parasympathomimetics", "MH_TH": "USAN (2000)", "ST": "T121", "N1": "6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-", "RN": "0D3Q044KCA", "RR": "MJ4PTD2VVW", "MS": "A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders.", "PM": "2004; see GALANTHAMINE 1999-2003;RAZADYNE was indexed under GALANTAMINE 2006-2009", "HN": "2004(1999)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D005702"}, {"RECTYPE": "D", "MH": "Gallamine Triethiodide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gallamonium Iodide|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef", "ENTRY": "Triethyl Iodide, Gallamine", "MN": "D02.675.276.400", "PA": "Nicotinic Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Ethanaminium, 2,2',2''-(1,2,3-benzenetriyltris(oxy))tris(N,N,N-triethyl)-, triiodide", "RN": "Q3254X40X2", "RR": "65-29-2 (Gallamine Triethiodide)", "MS": "A synthetic nondepolarizing blocking drug. The actions of gallamine triethiodide are similar to those of TUBOCURARINE, but this agent blocks the cardiac vagus and may cause sinus tachycardia and, occasionally, hypertension and increased cardiac output. It should be used cautiously in patients at risk from increased heart rate but may be preferred for patients with bradycardia. (From AMA Drug Evaluations Annual, 1992, p198)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005703"}, {"RECTYPE": "D", "MH": "Gallbladder", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Gallbladders", "MN": "A03.159.439", "FX": "Cholecystostomy", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at CHOLECYST-", "MS": "A storage reservoir for BILE secretion. Gallbladder allows the delivery of bile acids at a high concentration and in a controlled manner, via the CYSTIC DUCT to the DUODENUM, for degradation of dietary lipid.", "MR": "20160809", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005704"}, {"RECTYPE": "D", "MH": "Gallbladder Diseases", "DE": "GALLBLADDER DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Gallbladder Disease", "MN": "C06.130.564", "MH_TH": "NLM (1978)", "ST": "T047", "MS": "Diseases of the GALLBLADDER. They generally involve the impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, neoplasms, or other diseases.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005705"}, {"RECTYPE": "D", "MH": "Gallbladder Neoplasms", "DE": "GALLBLADDER NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Gallbladder Cancer|T191|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Neoplasm, Gallbladder", "MN": "C06.301.120.401", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the gallbladder.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005706"}, {"RECTYPE": "D", "MH": "Gallic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Gallic", "MN": "D02.455.426.559.389.657.410.200", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "Benzoic acid, 3,4,5-trihydroxy-", "RN": "632XD903SP", "RR": "149-91-7 (Gallic Acid)", "MS": "A colorless or slightly yellow crystalline compound obtained from nutgalls. It is used in photography, pharmaceuticals, and as an analytical reagent.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005707"}, {"RECTYPE": "D", "MH": "Gallium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.289", "FX": "Gallium Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Gallium", "RN": "CH46OC8YV4", "RR": "7440-55-3 (Gallium)", "MS": "A rare, metallic element designated by the symbol, Ga, atomic number 31, and atomic weight 69.72.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005708"}, {"RECTYPE": "D", "MH": "Gallium Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Gallium", "MN": "D01.552.544.289.500", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "PI": "Radioisotopes (1966-1973)", "MS": "Stable gallium atoms that have the same atomic number as the element gallium, but differ in atomic weight. Ga-71 is a stable gallium isotope.", "PM": "75", "HN": "75", "MR": "20170425", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D005709"}, {"RECTYPE": "D", "MH": "Gallium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Gallium", "MN": "D01.552.544.289.500.400", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1974)", "MS": "Unstable isotopes of gallium that decay or disintegrate emitting radiation. Ga atoms with atomic weights 63-68, 70 and 72-76 are radioactive gallium isotopes.", "PM": "75", "HN": "75", "MR": "20170425", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D005710"}, {"RECTYPE": "D", "MH": "Gallopamil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methoxyverapamil|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1980)|900307|abbcdeef", "ENTRY": "Hydrochloride, Gallopamil", "MN": "D02.092.471.683.953.395", "PA": "Calcium Channel Blockers", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4,5-trimethoxy-alpha-(1-methylethyl)-", "RN": "39WPC8JHR8", "RR": "VT4VR32A0T", "PI": "Iproveratril (1973-1974)", "MS": "Coronary vasodilator that is an analog of iproveratril (VERAPAMIL) with one more methoxy group on the benzene ring.", "OL": "use GALLOPAMIL to search D 600 1975-83", "PM": "87; was see under VERAPAMIL 1984-86; was D 600 see under IPROVERATRIL 1975-83", "HN": "87(84); was see under VERAPAMIL 1984-86; was D 600 see under IPROVERATRIL 1975-83", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D005711"}, {"RECTYPE": "D", "MH": "Galvanic Skin Response", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Skin Electric Conductance|T042|NON|EQV|UNK (19XX)|810515|abcdef", "ENTRY": "Skin Responses, Galvanic", "MN": "G13.750.415", "MH_TH": "NLM (1966)", "ST": "T042", "MS": "A change in electrical resistance of the skin, occurring in emotion and in certain other conditions.", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005712"}, {"RECTYPE": "D", "MH": "Gambia", "AQ": "EH EP", "ENTRY": "Republic of the Gambia|T083|NAM|EQV|NLM (2009)|080327|abcdef", "MN": "Z01.058.290.190.300", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in western Africa, constituting an enclave within SENEGAL extending on both sides of the Gambia River. Its capital is Banjul, formerly Bathurst.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005714"}, {"RECTYPE": "D", "MH": "Gambling", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Pathological Gambling|T048|NON|REL|NLM (1998)|970319|PATHOL GAMBLING|abcdefv", "ENTRY": "Pathological Gamblings", "MN": "F03.250.400", "MH_TH": "NLM (1968)", "ST": "T055", "MS": "An activity distinguished primarily by an element of risk in trying to obtain a desired goal, e.g., playing a game of chance for money.", "PM": "91; was see under RISK-TAKING 1979-90; was heading 1968-78", "HN": "91(79)68; was see under RISK-TAKING 1979-90; was heading 1968-78", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005715"}, {"RECTYPE": "D", "MH": "Game Theory", "ENTRY": "Theory, Game", "MN": "G17.388", "FX": "Operations Research", "MH_TH": "NLM (1969)", "ST": "T170", "PI": "Operations Research (1966-1968)", "MS": "Theoretical construct used in applied mathematics to analyze certain situations in which there is an interplay between parties that may have similar, opposed, or mixed interests. In a typical game, decision-making \"players,\" who each have their own goals, try to gain advantage over the other parties by anticipating each other's decisions; the game is finally resolved as a consequence of the players' decisions.", "PM": "1969", "HN": "1969", "CATSH": "CAT LIST", "MR": "20150901", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D005716"}, {"RECTYPE": "D", "MH": "Games, Experimental", "DE": "GAMES EXPER", "ENTRY": "Game, Experimental|T073|T170|NON|EQV|NLM (1992)|901128|GAME EXPER|abbcdefv", "MN": "E05.385", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "Games designed to provide information on hypotheses, policies, procedures, or strategies.", "OL": "search GAME THEORY 1969-74", "PM": "91; was see under GAME THEORY 1975-90", "HN": "91(75); was see under GAME THEORY 1975-90", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005717"}, {"RECTYPE": "D", "MH": "Gametogenesis", "AQ": "DE GE IM PH RE", "ENTRY": "Gametogeneses", "MN": "G08.686.784.310", "MH_TH": "NLM (1985)", "ST": "T042", "AN": "GAMETOGENESIS, PLANT is also available", "MS": "The process of germ cell development from the primordial GERM CELLS to the mature haploid GAMETES: ova in the female (OOGENESIS) or sperm in the male (SPERMATOGENESIS).", "PM": "1985", "HN": "1985", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19840525", "DC": "1", "DX": "19850101", "UI": "D005718"}, {"RECTYPE": "D", "MH": "gamma-Globulins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "gamma Globulins", "MN": "D12.776.377.715.548.397", "PA": "Immunologic Factors", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Serum globulins that migrate to the gamma region (most positively charged) upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline.", "PM": "1996; see GAMMA GLOBULINS 1975-1995, see GAMMA GLOBULIN 1963-1974; /deficiency see GAMMA GLOBULIN DEFICIENCY see AGAMMAGLOBULINEMIA 1963-1967", "HN": "1996 (1963)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D005719"}, {"RECTYPE": "D", "MH": "Gamma Rays", "AQ": "AE CL HI TU", "PRINT ENTRY": "Gamma Wave|T070|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "X-Ray, Nuclear", "MN": "G01.750.750.400", "MH_TH": "NLM (1975)", "ST": "T070", "MS": "Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source.", "OL": "search RADIATION 1966-74", "PM": "91; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1963-75", "HN": "91(75); was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1963-75", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005720"}, {"RECTYPE": "D", "MH": "Glutamate-Cysteine Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gamma-Glutamyl-Cysteine Synthetase|T116|T126|NON|EQV|NLM (1998)|961106|abbcdef", "ENTRY": "gamma Glutamyl Cysteine Synthetase", "MN": "D08.811.464.259.850.400", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "L-Glutamate:L-cysteine gamma-ligase (ADP-forming)", "RN": "EC 6.3.2.2", "RR": "9023-64-7 (CAS RN)", "PI": "Peptide Synthetases (1973-1976)", "MS": "One of the enzymes active in the gamma-glutamyl cycle. It catalyzes the synthesis of gamma-glutamylcysteine from glutamate and cysteine in the presence of ATP with the formation of ADP and orthophosphate. EC 6.3.2.2.", "PM": "98; see GAMMA-GLUTAMYL-CYSTEINE SYNTHETASE 1991-97; see PEPTIDE SYNTHETASES 1977-90", "HN": "98(77)", "MR": "20030709", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D005721"}, {"RECTYPE": "D", "MH": "gamma-Glutamylcyclotransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "gamma Glutamylcyclotransferase", "MN": "D08.811.913.050.200.400", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "(5-L-Glutamyl)-L-amino-acid 5-glutamyltransferase (cyclizing)", "RN": "EC 4.3.2.9", "RR": "9045-44-7 (CAS RN)", "AN": "do not confuse with GAMMA-GLUTAMYLTRANSFERASE", "PI": "Pyrrolidonecarboxylic Acid (1972-1974)", "MS": "An enzyme that catalyzes the synthesis of pyroglutamate from a gamma-glutamyl-amino acid, also releasing the free amino acid. The enzyme acts on derivatives of glutamate, 2-aminobutyrate, alanine and glycine. The enzyme has been proposed to have a role in a gamma-glutamyl cycle for amino acid transport into cells in the intestines. EC 2.3.2.4.", "PM": "91; was see under ACYLTRANSFERASES 1975-90", "HN": "91(75); was see under ACYLTRANSFERASES 1975-90", "MR": "20190322", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005722"}, {"RECTYPE": "D", "MH": "gamma-Glutamyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gammaglutamyltransferase|T116|T126|NON|EQV|NLM (2002)|010123|abbcdef", "ENTRY": "gamma Glutamyltransferase", "MN": "D08.811.913.050.200.500", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "(5-L-Glutamyl)-peptide:amino-acid 5-glutamyltransferase", "RN": "EC 2.3.2.2", "RR": "9046-27-9 (CAS RN)", "AN": "do not confuse with PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASES or GLUTAMINYL-PEPTIDE GAMMA-GLUTAMYLTRANSFERASES see TRANSGLUTAMINASES which crosslinks proteins nor with GAMMA-GLUTAMYLCYCLOTRANSFERASE", "PI": "Acyltransferases (1966-1971)", "MS": "An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid.", "OL": "use GAMMA-GLUTAMYLTRANSFERASE to search GLUTAMYL TRANSPEPTIDASE 1972-83", "PM": "84; was GLUTAMYL TRANSPEPTIDASE 1972-83", "HN": "84; was GLUTAMYL TRANSPEPTIDASE 1972-83", "MR": "20050802", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005723"}, {"RECTYPE": "D", "MH": "Ganglia", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "MN": "A08.340", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "general or unspecified; prefer specifics; wrist ganglion is indexed under WRIST and SYNOVIAL CYST", "MS": "Clusters of multipolar neurons surrounded by a capsule of loosely organized CONNECTIVE TISSUE located outside the CENTRAL NERVOUS SYSTEM.", "MR": "20021024", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005724"}, {"RECTYPE": "D", "MH": "Ganglia, Autonomic", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Autonomic Ganglia|T023|NON|EQV|NLM (1991)|900108|abcdef", "ENTRY": "Autonomic Ganglion", "MN": "A08.800.050.300", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Clusters of neurons and their processes in the autonomic nervous system. In the autonomic ganglia, the preganglionic fibers from the central nervous system synapse onto the neurons whose axons are the postganglionic fibers innervating target organs. The ganglia also contain intrinsic neurons and supporting cells and preganglionic fibers passing through to other ganglia.", "MR": "19940411", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005725"}, {"RECTYPE": "D", "MH": "Ganglia, Parasympathetic", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Parasympathetic Ganglia|T023|NON|EQV|UNK (19XX)|790522|abcdef", "ENTRY": "Submandibular Ganglias", "MN": "A08.800.050.600.300", "MH_TH": "NLM (1980)", "ST": "T023", "PI": "Parasympathetic Nervous System (1966-1979)", "MS": "Ganglia of the parasympathetic nervous system, including the ciliary, pterygopalatine, submandibular, and otic ganglia in the cranial region and intrinsic (terminal) ganglia associated with target organs in the thorax and abdomen.", "PM": "80", "HN": "80", "MR": "20140613", "DA": "19790522", "DC": "1", "DX": "19800101", "UI": "D005726"}, {"RECTYPE": "D", "MH": "Ganglia, Spinal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Spinal Ganglia|T023|NON|EQV|NLM (1991)|900108|abcdef", "ENTRY": "Spinal Ganglion", "MN": "A08.800.800.720.725.350", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "sensory ganglia on spinal nerve roots", "MS": "Sensory ganglia located on the dorsal spinal roots within the vertebral column. The spinal ganglion cells are pseudounipolar. The single primary branch bifurcates sending a peripheral process to carry sensory information from the periphery and a central branch which relays that information to the spinal cord or brain.", "MR": "19940603", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005727"}, {"RECTYPE": "D", "MH": "Ganglia, Sympathetic", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sympathetic Ganglia|T023|NON|EQV|UNK (19XX)|790522|abcdef", "ENTRY": "Sympathetic Ganglion", "MN": "A08.800.050.800.300", "FX": "Ganglionectomy", "MH_TH": "NLM (1980)", "ST": "T023", "PI": "Sympathetic Nervous System (1966-1979)", "MS": "Ganglia of the sympathetic nervous system including the paravertebral and the prevertebral ganglia. Among these are the sympathetic chain ganglia, the superior, middle, and inferior cervical ganglia, and the aorticorenal, celiac, and stellate ganglia.", "OL": "use GANGLIA, AUTONOMIC to search SYMPATHETIC GANGLIA 1966-79; use CELIAC PLEXUS to search CELIAC GANGLIA 1966-79", "PM": "80; SYMPATHETIC GANGLIA was see GANGLIA, AUTONOMIC 1975-79, was see under GANGLIA, AUTONOMIC 1963-74; CELIAC GANGLIA was see CELIAC PLEXUS 1975-79, was see under CELIAC PLEXUS 1963-74", "HN": "80; SYMPATHETIC GANGLIA was see GANGLIA, AUTONOMIC 1975-79, was see under GANGLIA, AUTONOMIC 1963-74; CELIAC GANGLIA was see CELIAC PLEXUS 1975-79, was see under CELIAC PLEXUS 1963-74", "MR": "19940615", "DA": "19790522", "DC": "1", "DX": "19800101", "UI": "D005728"}, {"RECTYPE": "D", "MH": "Ganglioneuroma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Gangliocytoma|T191|NON|EQV|NLM (1994)|930326|abcdef", "ENTRY": "Ganglioneuromas", "MN": "C04.557.580.625.600.355", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with precoord organ/neopl term (IM)", "MS": "A benign neoplasm that usually arises from the sympathetic trunk in the mediastinum. Histologic features include spindle cell proliferation (resembling a neurofibroma) and the presence of large ganglion cells. The tumor may present clinically with HORNER SYNDROME or diarrhea due to ectopic production of vasoactive intestinal peptide. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p966)", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005729"}, {"RECTYPE": "D", "MH": "Ganglionic Blockers", "DE": "GANGLIONIC BLOCK", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ganglioplegic Agents|T121|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Blockers, Ganglionic", "MN": "D27.505.696.663.050.340", "FX": "Receptors, Nicotinic", "MH_TH": "NLM (1970)", "ST": "T121", "RN": "0", "MS": "Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery.", "OL": "use GANGLIONIC BLOCKERS to search GANGLIONIC BLOCKADERS 1970-94 & GANGLIONIC-BLOCKING AGENTS 1966-69", "PM": "95; was GANGLIONIC BLOCKADERS 1970-94; was GANGLIONIC-BLOCKING AGENTS 1963-69", "HN": "95; was GANGLIONIC BLOCKADERS 1970-94; was GANGLIONIC-BLOCKING AGENTS 1963-69", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005730"}, {"RECTYPE": "D", "MH": "Ganglionic Stimulants", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Stimulants, Ganglionic", "MN": "D27.505.696.663.050.400", "FX": "Receptors, Nicotinic", "MH_TH": "NLM (1971)", "ST": "T121", "RN": "0", "PI": "Autonomic Agents (1966-1970)", "MS": "Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects on postganglionic neurons are not included here nor are the nonspecific cholinergic agonists.", "PM": "72", "HN": "72(71)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D005731"}, {"RECTYPE": "D", "MH": "Gangliosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sialoglycosphingolipids|T109|T123|NON|EQV|NLM (1999)|980306|abbcdef", "MN": "D10.570.877.360.025.475", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005732"}, {"RECTYPE": "D", "MH": "Gangliosidoses", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Storage Disorders, Ganglioside", "MN": "C18.452.648.595.554.825.300", "FX": "Mucolipidoses", "MH_TH": "NLM (1976)", "ST": "T047", "AN": "coordinate IM with specific ganglioside (IM) but GANGLIOSIDOSIS, GM1 and GANGLIOSIDOSES, GM2 are available", "PI": "Lipoidosis (1966-1975)", "MS": "A group of autosomal recessive lysosomal storage disorders marked by the accumulation of GANGLIOSIDES. They are caused by impaired enzymes or defective cofactors required for normal ganglioside degradation in the LYSOSOMES. Gangliosidoses are classified by the specific ganglioside accumulated in the defective degradation pathway.", "PM": "1992; see GANGLIOSIDOSIS 1976-91", "HN": "1992(1976)", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D005733"}, {"RECTYPE": "D", "MH": "Gangrene", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Gangrenes", "MN": "C23.550.717.427", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "IM for general or for gangrene process; coord NIM with tissue/pathol (IM)", "MS": "Death and putrefaction of tissue usually due to a loss of blood supply.", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005734"}, {"RECTYPE": "D", "MH": "Garbage", "ENTRY": "Garbages", "MN": "N06.850.860.510.900.600.400", "MH_TH": "NLM (1975)", "ST": "T069", "MS": "Discarded animal and vegetable matter from a kitchen or the refuse from food preparation. (From Random House College Dictionary, 1982)", "OL": "search REFUSE DISPOSAL 1966-74", "PM": "91; was see under REFUSE DISPOSAL 1975-90", "HN": "91(75); was see under REFUSE DISPOSAL 1975-90", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005735"}, {"RECTYPE": "D", "MH": "Gardner Syndrome", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Syndromes, Gardner's", "MN": "C16.320.700.100.393", "FX": "Genes, APC", "MH_TH": "ORD (2010)", "ST": "T191", "PI": "Neoplasms, Multiple Primary (1966-1980)", "MS": "A variant of ADENOMATOUS POLYPOSIS COLI caused by mutation in the APC gene (GENES, APC) on CHROMOSOME 5. It is characterized by not only the presence of multiple colonic polyposis but also extracolonic ADENOMATOUS POLYPS in the UPPER GASTROINTESTINAL TRACT; the EYE; the SKIN; the SKULL; and the FACIAL BONES; as well as malignancy in organs other than the GI tract.", "PM": "1981", "HN": "1981", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19800404", "DC": "1", "DX": "19810101", "UI": "D005736"}, {"RECTYPE": "D", "MH": "Garlic", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Allium sativum|T002|T168|NON|EQV|UNK (19XX)|850430|abbcdef", "MN": "B01.875.800.575.912.250.618.100.050.060.300", "MH_TH": "NLM (1966)", "ST": "T168", "RN": "txid4682", "MS": "A species of Allium used as a spice (SPICES) and traditional remedy. It contains alliin lyase and alliin, which is converted by alliin lyase to allicin, the pungent ingredient responsible for the aroma of fresh cut garlic.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005737"}, {"RECTYPE": "D", "MH": "Gas Gangrene", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Gas Gangrenes", "MN": "C01.150.252.410.222.440", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "usually caused by Clostridium perfringens but all C. perfringens infections need not be gas gangrene", "MS": "A severe condition resulting from bacteria invading healthy muscle from adjacent traumatized muscle or soft tissue. The infection originates in a wound contaminated with bacteria of the genus CLOSTRIDIUM. C. perfringens accounts for the majority of cases (over eighty percent), while C. noyvi, C. septicum, and C. histolyticum cause most of the other cases.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005738"}, {"RECTYPE": "D", "MH": "Gas Poisoning", "DE": "GAS POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Poisonings, Gas", "MN": "C25.723.455", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "coordinate with  specific gas /pois if pertinent", "MS": "Poisoning that results from exposure to gases such as CARBON MONOXIDE; NOBLE GASES; OXYGEN; or NATURAL GAS.", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005739"}, {"RECTYPE": "D", "MH": "Gases", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "MN": "D01.362", "EC": "poisoning:Gas Poisoning", "MH_TH": "NLM (1966)", "ST": "T104", "RN": "0", "MS": "The vapor state of matter; nonelastic fluids in which the molecules are in free movement and their mean positions far apart. Gases tend to expand indefinitely, to diffuse and mix readily with other gases, to have definite relations of volume, temperature, and pressure, and to condense or liquefy at low temperatures or under sufficient pressure. (Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20140627", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005740"}, {"RECTYPE": "D", "MH": "Noble Gases", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rare Gases|T196|NON|EQV|UNK (19XX)|750711|abcdef", "ENTRY": "Inert Gases", "MN": "D01.362.641", "MH_TH": "NLM (1976)", "ST": "T196", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Gases (1966-1975)", "MS": "Elements that constitute group 18 (formerly the zero group) of the periodic table. They are gases that generally do not react chemically.", "OL": "use NOBLE GASES to search GASES, RARE 1976-93", "PM": "94; was GASES, RARE 1976-93", "HN": "94; was GASES, RARE 1976-93; was RARE GASES (NON MESH) 1971-76", "MR": "20010725", "DA": "19750725", "DC": "1", "DX": "19770101", "UI": "D005741"}, {"RECTYPE": "D", "MH": "Gasoline", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Gasolines", "MN": "N06.230.132.258.630.540", "PA": "Carcinogens, Environmental", "MH_TH": "NLM (1975)", "ST": "T073", "RN": "0", "MS": "Volative flammable fuel (liquid hydrocarbons) derived from crude petroleum by processes such as distillation reforming, polymerization, etc.", "OL": "use PETROLEUM to search GASOLINE 1966-74", "PM": "91; was see under PETROLEUM 1975-90; was in Cat J only 1975-81", "HN": "91(75); was see under PETROLEUM 1975-90; was in Cat J only 1975-81", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005742"}, {"RECTYPE": "D", "MH": "Gastrectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Gastrectomies", "MN": "E04.210.419", "FX": "Postgastrectomy Syndromes", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Excision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005743"}, {"RECTYPE": "D", "MH": "Gastric Acid", "AQ": "CH EN ME PH", "PRINT ENTRY": "Hydrochloric Acid, Gastric|T123|T197|NON|EQV|UNK (19XX)|800512|abbcdef", "ENTRY": "Hydrochloric Acids, Gastric", "MN": "A12.200.307.603", "FX": "Achlorhydria", "EC": "analysis:Gastric Acidity Determination", "MH_TH": "NLM (1981)", "ST": "T197", "PI": "Gastric Juice (1966-1980)", "MS": "Hydrochloric acid present in GASTRIC JUICE.", "OL": "use GASTRIC JUICE to search HYDROCHLORIC ACID, GASTRIC 1969-80", "PM": "81; HYDROCHLORIC ACID, GASTRIC was see GASTRIC JUICE 1969-80", "HN": "81; HYDROCHLORIC ACID, GASTRIC was see GASTRIC JUICE 1969-80", "MR": "20180629", "DA": "19800512", "DC": "1", "DX": "19810101", "UI": "D005744"}, {"RECTYPE": "D", "MH": "Gastric Acidity Determination", "AQ": "IS VE", "ENTRY": "Gastric Acidity Determinations", "MN": "E05.200.124.300", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "NIM", "MS": "Gastric analysis for determination of free acid or total acid.", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005745"}, {"RECTYPE": "D", "MH": "Gastric Emptying", "AQ": "DE ES GE IM PH RE", "ENTRY": "Gastric Emptyings", "MN": "G10.261.360.400", "MH_TH": "NLM (1978)", "ST": "T042", "PI": "Stomach (1966-1977)", "MS": "The evacuation of food from the stomach into the duodenum.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D005746"}, {"RECTYPE": "D", "MH": "Gastric Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fistula, Stomach", "MN": "C23.300.575.185.375", "FX": "Gastrostomy", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "fistula policy: Manual 23.19+", "MS": "Abnormal passage communicating with the STOMACH.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005747"}, {"RECTYPE": "D", "MH": "Gastric Fundus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Fundus, Gastric", "MN": "A03.556.875.875.419", "FX": "Fundoplication", "MH_TH": "NLM (1981)", "ST": "T023", "AN": "NIM when merely locational; neopl of gastric fundus: coord NIM with STOMACH NEOPLASMS (IM) + histol type of neopl (IM)", "PI": "Stomach (1966-1980)", "MS": "The superior portion of the body of the stomach above the level of the cardiac notch.", "PM": "81", "HN": "81", "MR": "20030709", "DA": "19800404", "DC": "1", "DX": "19810101", "UI": "D005748"}, {"RECTYPE": "D", "MH": "Gastric Inhibitory Polypeptide", "DE": "GIP", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glucose-Dependent Insulinotropic Peptide|T116|T121|T125|NON|EQV|UNK (19XX)|850228|abbbcdef", "ENTRY": "Polypeptide, Gastric-Inhibitory", "MN": "D12.776.631.650.300", "PA": "Incretins", "MH_TH": "NLM (1977)", "ST": "T125", "RN": "59392-49-3", "PI": "Peptides (1974-1976)", "MS": "A gastrointestinal peptide hormone of about 43-amino acids. It is found to be a potent stimulator of INSULIN secretion and a relatively poor inhibitor of GASTRIC ACID secretion.", "PM": "86; was see under GASTROINTESTINAL HORMONES 1977-85", "HN": "86(77); was see under GASTROINTESTINAL HORMONES 1977-85", "MR": "20151123", "DA": "19760413", "DC": "1", "DX": "19860101", "UI": "D005749"}, {"RECTYPE": "D", "MH": "Gastric Juice", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Juices, Gastric", "MN": "A12.200.307", "FX": "Pepsinogens", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "The liquid secretion of the stomach mucosa consisting of hydrochloric acid (GASTRIC ACID); PEPSINOGENS; INTRINSIC FACTOR; GASTRIN; MUCUS; and the bicarbonate ion (BICARBONATES). (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p651)", "MR": "20190307", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005750"}, {"RECTYPE": "D", "MH": "Gastric Lavage", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Lavage, Gastric|T061|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Lavages, Gastric", "MN": "E05.927.441", "MH_TH": "NLM (1963)", "ST": "T061", "MS": "Medical procedure involving the emptying of contents in the stomach through the use of a tube inserted through the nose or mouth. It is performed to remove poisons or relieve pressure due to intestinal blockages or during surgery.", "PM": "66", "HN": "66(63)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005751"}, {"RECTYPE": "D", "MH": "Gastric Mucins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gastric Mucin|T116|T123|NON|EQV|NLM (1966)|990101|abbcdef", "ENTRY": "Mucins, Gastric", "MN": "D12.776.395.560.631.100", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "Mucins that are found on the surface of the gastric epithelium. They play a role in protecting the epithelial layer from mechanical and chemical damage.", "PM": "2009; see GASTRIC MUCIN 1966-2008", "HN": "2009", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D005752"}, {"RECTYPE": "D", "MH": "Gastric Mucosa", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Pyloric Glands|T023|NON|NRW|NLM (1998)|970206|abcdef", "ENTRY": "Pyloric Gland", "MN": "A10.615.550.291", "MH_TH": "NLM (1964)", "ST": "T024", "MS": "Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones.", "OL": "use GASTRIC MUCOSA to search GASTRIC MUCOSA PROLAPSE 1966-96", "PM": "64; GASTRIC MUCOSA PROLAPSE was heading 1963-96", "HN": "64; GASTRIC MUCOSA PROLAPSE was heading 1963-96", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D005753"}, {"RECTYPE": "D", "MH": "Gastrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Gastrin|T116|T125|NON|NRW|UNK (19XX)|770520|abbcdef", "MN": "D12.776.631.650.320", "PA": "Hormones", "FX": "Gastrointestinal Agents", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters.", "OL": "use GASTRINS to search GASTRIN 1966-77", "PM": "78; was GASTRIN 1963-77", "HN": "78; was GASTRIN 1963-77", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D005755"}, {"RECTYPE": "D", "MH": "Gastritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Gastritides", "MN": "C06.405.748.398", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005756"}, {"RECTYPE": "D", "MH": "Gastritis, Atrophic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Gastritides, Atrophic", "MN": "C06.405.748.398.394", "MH_TH": "NLM (1981)", "ST": "T047", "AN": "a chronic dis: do not coord with CHRONIC DISEASE", "PI": "Gastritis (1966-1980)", "MS": "GASTRITIS with atrophy of the GASTRIC MUCOSA, the GASTRIC PARIETAL CELLS, and the mucosal glands leading to ACHLORHYDRIA. Atrophic gastritis usually progresses from chronic gastritis.", "PM": "91; was see under GASTRITIS 1981-90", "HN": "91(81); was see under GASTRITIS 1981-90", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19800404", "DC": "1", "DX": "19910101", "UI": "D005757"}, {"RECTYPE": "D", "MH": "Gastritis, Hypertrophic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Menetrier Disease|T047|EPO|EQV|OMIM (2013)|ORD (2010)|UNK (19XX)|800404|MENETRIER DIS|abcdeeefv", "ENTRY": "Menetriers Disease", "MN": "C06.405.748.398.410", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Hypertrophy (1966-1980)", "MS": "GASTRITIS with HYPERTROPHY of the GASTRIC MUCOSA. It is characterized by giant gastric folds, diminished acid secretion, excessive MUCUS secretion, and HYPOPROTEINEMIA. Symptoms include VOMITING; DIARRHEA; and WEIGHT LOSS.", "PM": "91; was see under GASTRITIS 1981-90", "HN": "91(81); was see under GASTRITIS 1981-90", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19800404", "DC": "1", "DX": "19910101", "UI": "D005758"}, {"RECTYPE": "D", "MH": "Gastroenteritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Gastroenteritides", "MN": "C06.405.205", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "INFLAMMATION of any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Causes of gastroenteritis are many including genetic, infection, HYPERSENSITIVITY, drug effects, and CANCER.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005759"}, {"RECTYPE": "D", "MH": "Transmissible gastroenteritis virus", "DE": "TRANSM GASTROENTERITIS VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Transmissible Gastroenteritis Virus, Swine|T005|NON|EQV|NLM (1994)|921116|TRANSM GASTROENTERITIS VIRUS SWINE|abcdefv", "ENTRY": "TGE Viruses", "MN": "B04.820.578.500.540.150.075.500.500", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11149", "MS": "A species of CORONAVIRUS causing a fatal disease to pigs under 3 weeks old.", "PM": "2002; see GASTROENTERITIS VIRUS, PORCINE TRANSMISSIBLE 1994-2001, see GASTROENTERITIS VIRUS OF SWINE 1991-1993, see CORONAVIRIDAE 1981-1990, see CORONAVIRUSES 1975-1980; for TRANSMISSIBLE GASTROENTERITIS VIRUS, SWINE see GASTROENTERITIS VIRUS OF SWINE 1976-1993", "HN": "2002 (1975)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D005760"}, {"RECTYPE": "D", "MH": "Gastroenteritis, Transmissible, of Swine", "DE": "GASTROENTERITIS TRANSM SWINE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Transmissible Gastroenteritis of Swine|T047|NON|EQV|UNK (19XX)|740330|TRANSM GASTROENTERITIS SWINE|abcdefv", "ENTRY": "Transmissible Porcine Gastroenteritis", "MN": "C22.905.469", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "a specific disease caused by a coronavirus", "PI": "Swine Diseases (1966-1969)", "MS": "A condition of chronic gastroenteritis in adult pigs and fatal gastroenteritis in piglets caused by a CORONAVIRUS.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20190529", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005761"}, {"RECTYPE": "D", "MH": "Gastroenterology", "DE": "GASTROENTEROL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Hepatology|T091|NON|REL|NLM (1992)|910110|HEPATOL|abcdefv", "MN": "H02.403.429.405", "FX": "Gastrointestinal Diseases", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "A subspecialty of internal medicine concerned with the study of the physiology and diseases of the digestive system and related structures (esophagus, liver, gallbladder, and pancreas).", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005762"}, {"RECTYPE": "D", "MH": "Gastroenterostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Procedure, Billroth II", "MN": "E04.210.457", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "restrict to specific internal surg procedure; do not confuse with GASTROSTOMY & ENTEROSTOMY (both artif external openings) or specifics (e.g. DUODENOSTOMY; ILEOSTOMY, etc.)", "MS": "A variety of surgical reconstructive procedures devised to restore gastrointestinal continuity, The two major classes of reconstruction are the Billroth I (gastroduodenostomy) and Billroth II (gastrojejunostomy) procedures.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005763"}, {"RECTYPE": "D", "MH": "Gastroesophageal Reflux", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gastro-Esophageal Reflux Disease|T047|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Reflux, Gastro-oesophageal", "MN": "C06.405.117.119.500.484", "FX": "Heartburn", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "note ESOPHAGITIS, REFLUX see ESOPHAGITIS, PEPTIC is available", "MS": "Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER.", "OL": "use GASTROESOPHAGEAL REFLUX to search ESOPHAGEAL REFLUX 1966-83", "PM": "84; was ESOPHAGEAL REFLUX 1966-83", "HN": "84; was ESOPHAGEAL REFLUX 1964-83 (Prov 1964-65)", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005764"}, {"RECTYPE": "D", "MH": "Gastrointestinal Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Digestants|T121|NON|REL|UNK (19XX)|860604|abcdef", "ENTRY": "Drugs, Gastrointestinal", "MN": "D27.505.954.483", "MH_TH": "NLM (1967)", "ST": "T121", "RN": "0", "MS": "Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.", "OL": "use GASTROINTESTINAL AGENTS to search DIGESTANTS 1967-86", "PM": "67; DIGESTANTS was heading 1967-86", "HN": "67; DIGESTANTS was heading 1967-86", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D005765"}, {"RECTYPE": "D", "MH": "Gastrointestinal Contents", "AQ": "CH DE DG EN MI PS RE UL VI", "PRINT ENTRY": "Stomach Contents|T031|NON|NRW|UNK (19XX)|840620|abcdef", "ENTRY": "Stomach Content", "MN": "A12.519", "FX": "Feces", "MH_TH": "NLM (1999)", "ST": "T031", "AN": "coordinate with specific part of digestive tract if discussed", "MS": "The contents included in all or any segment of the GASTROINTESTINAL TRACT.", "PM": "2004; see DIGESTIVE TRACT CONTENTS 1999-2003; see GASTROINTESTINAL CONTENTS 1985-1998", "HN": "2004 (1985)", "MR": "20160601", "DA": "19840502", "DC": "1", "DX": "19850101", "UI": "D005766"}, {"RECTYPE": "D", "MH": "Gastrointestinal Diseases", "DE": "GASTROINTESTINAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gastrointestinal Disorders|T047|NON|EQV|NLM (2020)|190501|abcdef", "ENTRY": "Gastrointestinal Disorder, Functional", "MN": "C06.405", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.", "PM": "1965", "HN": "1965", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005767"}, {"RECTYPE": "D", "MH": "Gastrointestinal Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Intestinal Hormones|T125|NON|NRW|UNK (19XX)|780501|abcdef", "ENTRY": "Hormones, Intestinal", "MN": "D06.472.317", "FX": "Receptors, Gastrointestinal Hormone", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "0", "MS": "HORMONES secreted by the gastrointestinal mucosa that affect the timing or the quality of secretion of digestive enzymes, and regulate the motor activity of the digestive system organs.", "PM": "GASTRONE was see under MUCOPOLYSACCHARIDES 1964-76", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005768"}, {"RECTYPE": "D", "MH": "Gastrointestinal Motility", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Intestinal Motility|T042|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Motility, Intestinal", "MN": "G10.261.360", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "do not coordinate with STOMACH or INTESTINES, but coordinate with specific intestine / physiol if pertinent (IM); GASTRIC EMPTYING is available", "MS": "The motor activity of the GASTROINTESTINAL TRACT.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005769"}, {"RECTYPE": "D", "MH": "Gastrointestinal Neoplasms", "DE": "GASTROINTESTINAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Gastrointestinal Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Gastrointestinal", "MN": "C06.405.249", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "general or unspecified; prefer specifics; coordinate with histological type of neoplasm", "MS": "Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.", "CATSH": "CAT LIST", "MR": "20050701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005770"}, {"RECTYPE": "D", "MH": "Gastrointestinal Transit", "DE": "GI TRANSIT", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "GI Transit|T042|T060|ABX|EQV|NLM (2020)|190228|abbcdef", "ENTRY": "Transits, Gastrointestinal", "MN": "G10.261.360.525", "MH_TH": "NLM (1988)", "ST": "T060", "AN": "transit time also goes here", "PI": "Gastrointestinal System (1966-1987)", "MS": "Passage of food (sometimes in the form of a test meal) through the gastrointestinal tract as measured in minutes or hours. The rate of passage through the intestine is an indicator of small bowel function.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20190429", "DA": "19870313", "DC": "1", "DX": "19880101", "UI": "D005772"}, {"RECTYPE": "D", "MH": "Gastroscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Gastroscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES GASTROSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Gastroscopic", "MN": "E04.502.250.250.250.320", "FX": "Gastroscopes", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "/ instrum permitted but consider also GASTROSCOPES", "MS": "Endoscopic examination, therapy or surgery of the interior of the stomach.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005773"}, {"RECTYPE": "D", "MH": "Gastrostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Gastrostomies", "MN": "E04.579.408", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Creation of an artificial external opening into the stomach for nutritional support or gastrointestinal compression.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D005774"}, {"RECTYPE": "D", "MH": "Gastrula", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Primitive Gut|T018|NON|NRW|UNK (19XX)|790417|abcdef", "ENTRY": "Primitive Guts", "MN": "A16.441", "MH_TH": "NLM (1980)", "ST": "T018", "PI": "specific organism/EM (1966-1979)", "MS": "The developmental stage that follows BLASTULA or BLASTOCYST. It is characterized by the morphogenetic cell movements including invagination, ingression, and involution. Gastrulation begins with the formation of the PRIMITIVE STREAK, and ends with the formation of three GERM LAYERS, the body plan of the mature organism.", "PM": "80", "HN": "80", "MR": "20150424", "DA": "19790417", "DC": "1", "DX": "19800101", "UI": "D005775"}, {"RECTYPE": "D", "MH": "Gaucher Disease", "DE": "GAUCHER DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuronopathic Gaucher Disease|T047|EPO|NRW|NLM (2000)|991103|NEURONOPATHIC GAUCHER DIS|abcdefv", "ENTRY": "thesaurismosis, Kerasin", "MN": "C18.452.648.595.554.825.400", "FX": "Glucosylceramidase", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (GLUCOSYLCERAMIDASE) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the MONONUCLEAR PHAGOCYTE SYSTEM. The characteristic Gaucher cells, glycosphingolipid-filled HISTIOCYTES, displace normal cells in BONE MARROW and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement.", "PM": "2000; see GAUCHER'S DISEASE 1966-1999; for GAUCHER DISEASE see GAUCHER'S DISEASE 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D005776"}, {"RECTYPE": "D", "MH": "Geese", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Gooses", "MN": "B01.050.150.900.248.690.492", "MH_TH": "NLM (1968)", "ST": "T012", "AN": "diseases in domestic geese: coordinate with POULTRY DISEASES; diseases in wild geese: coordinate with BIRD DISEASES", "PI": "Poultry (1966-1967)", "MS": "Any of various large waterfowl in the order Anseriformes, especially those of the genera Anser (gray geese) and Branta (black geese). They are larger than ducks but smaller than swans, prefer FRESH WATER, and occur primarily in the northern hemisphere.", "PM": "68", "HN": "68", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005777"}, {"RECTYPE": "D", "MH": "Gefarnate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Geranyl Farnesylacetate|T109|T121|NON|EQV|UNK (19XX)|770418|abbcdef", "ENTRY": "Farnesylacetate, Geranyl", "MN": "D10.251.355.350", "PA": "Anti-Ulcer Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "4,8,12-Tetradecatrienoic acid, 5,9,13-trimethyl-, 3,7-dimethyl-2,6-octadienyl ester, (E,E,E)-", "RN": "1ISE2Y6ULA", "RR": "51-77-4 (Gefarnate)", "PI": "Terpenes (1969-1977)", "MS": "A water insoluble terpene fatty acid used in the treatment of gastrointestinal ulcers; it facilitates the healing and function of mucosal tissue.", "PM": "91; was see under TERPENES 1978-90", "HN": "91(78); was see under TERPENES 1978-90", "MR": "20130708", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D005778"}, {"RECTYPE": "D", "MH": "Immunodiffusion", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Gel Diffusion Tests|T059|NON|EQV|NLM (1992)|901025|abcdef", "ENTRY": "Tests, Gel Diffusion", "MN": "E05.478.605.492.350", "MH_TH": "NLM (1963)", "ST": "T059", "AN": "NIM", "MS": "Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction.", "OL": "use IMMUNODIFFUSION to search GEL DIFFUSION TESTS 1966-91", "PM": "92; was GEL DIFFUSION TESTS 1966-91; was see GEL DIFFUSION TESTS 1975-91; was see under PRECIPITIN TESTS 1963-65", "HN": "92(63); was GEL DIFFUSION TESTS 1966-91; was see GEL DIFFUSION TESTS 1975-91; was see under PRECIPITIN TESTS 1963-65", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005779"}, {"RECTYPE": "D", "MH": "Gelatin", "AQ": "AD AE AG AI AN BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Gelafusal|T116|NON|NRW|UNK (19XX)|861110|abcdef", "MN": "D12.776.860.476", "MH_TH": "NLM (1966)", "ST": "T168", "N1": "Gelatins", "RN": "9000-70-8", "MS": "A product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories.", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005780"}, {"RECTYPE": "D", "MH": "Gelatin Sponge, Absorbable", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Sponges, Absorbable Gelatin", "MN": "E07.858.740.300", "PA": "Hemostatics", "MH_TH": "USP (19XX)", "ST": "T074", "MS": "Sterile, gelatin-base surgical sponge applied topically as an adjunct to hemostasis when the control of bleeding by conventional procedures is ineffective to reduce capillary ooze or is impractical. (From AMA Drug Evaluations Annual, 1994, p797)", "OL": "use GELATIN SPONGE, ABSORBABLE to search GELFOAM 1966-77 (as Prov 1966-72)", "PM": "78; was GELFOAM 1973-77, was GELFOAM see under HEMOSTATICS 1963-72", "HN": "78; was GELFOAM 1964-77 (Prov 1964-72), was GELFOAM see under HEMOSTATICS 1963-72", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005781"}, {"RECTYPE": "D", "MH": "Gels", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D26.255.165.320", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "AN": "IM for general only, qualif permitted; NIM (no qualif) with specific drug IM (with qualif)", "MS": "Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005782"}, {"RECTYPE": "D", "MH": "Gender Identity", "ENTRY": "Identity, Gender", "MN": "F02.739.794.793.200", "FX": "Transgender Persons", "MH_TH": "NLM (1976)", "ST": "T055", "AN": "psychological; do not confuse with SEX CHARACTERISTICS (physiological); do not confuse with SEXUAL ORIENTATION see SEX BEHAVIOR: gender identity is knowing that one is male or female; sexual orientation is preferring heterosexual or homosexual behavior", "PI": "Sex (1968-1975)", "MS": "A person's concept of self as being male and masculine or female and feminine, or ambivalent, based in part on physical characteristics, parental responses, and psychological and social pressures. It is the internal experience of gender role.", "PM": "1991; see IDENTIFICATION (PSYCHOLOGY) 1976-1990; for GENDER see SEX 1991-2003", "HN": "1991(1975); for GENDER use SEX 1991-2003", "CATSH": "CAT LIST", "MR": "20200618", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D005783"}, {"RECTYPE": "D", "MH": "Gene Amplification", "AQ": "DE ES GE IM PH RE", "ENTRY": "Amplification, Gene", "MN": "G05.558.315", "FX": "Gene Dosage", "EC": "methods:Nucleic Acid Amplification Techniques", "MH_TH": "NLM (1980)", "ST": "T045", "AN": "for physiol process only; for technique use NUCLEIC ACID AMPLIFICATION TECHNIQUES or specifics", "PI": "Plasmids (1975-1979)", "MS": "A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19790417", "DC": "1", "DX": "19800101", "UI": "D005784"}, {"RECTYPE": "D", "MH": "Gene Conversion", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Polaron|T114|NON|REL|UNK (19XX)|790523|abcdef", "ENTRY": "Recombinations, Polar", "MN": "G05.728.615.475", "MH_TH": "NLM (1980)", "ST": "T045", "PI": "Recombination, Genetic (1968-1979)", "MS": "The asymmetrical segregation of genes during replication which leads to the production of non-reciprocal recombinant strands and the apparent conversion of one allele into another. Thus, e.g., the meiotic products of an Aa individual may be AAAa or aaaA instead of AAaa, i.e., the A allele has been converted into the a allele or vice versa.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19790523", "DC": "1", "DX": "19800101", "UI": "D005785"}, {"RECTYPE": "D", "MH": "Gene Expression Regulation", "DE": "GENE EXPRESSION REG", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Regulation of Gene Expression|T045|NON|EQV|UNK (19XX)|800402|REG GENE EXPRESSION|abcdefv", "ENTRY": "Regulation, Gene Expression|T045|NON|EQV|NLM (1992)|901015|abcdef", "MN": "G05.308", "FX": "Transcription Factors", "MH_TH": "NLM (1981)", "ST": "T045", "AN": "general or unspecified; prefer specifics", "PI": "Translation, Genetic (1973-1980)", "MS": "Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19800402", "DC": "1", "DX": "19810101", "UI": "D005786"}, {"RECTYPE": "D", "MH": "Gene Frequency", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Genetic Equilibrium|T078|NON|REL|NLM (1998)|961010|GENET EQUILIBRIUM|abcdefv", "ENTRY": "Gene Frequencies", "MN": "G05.330", "MH_TH": "NLM (1968)", "ST": "T081", "PI": "Genetics, Population (1966-1967)", "MS": "The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION.", "PM": "1968; for GENETIC EQUILIBRIUM see GENETICS, POPULATION 1998-2002", "HN": "1968; for GENETIC EQUILIBRIUM use GENETICS, POPULATION 1998-2002", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005787"}, {"RECTYPE": "D", "MH": "Gene Pool", "ENTRY": "Pools, Gene", "MN": "G05.342", "FX": "Founder Effect", "MH_TH": "BIOETHICS (1989)", "ST": "T078", "AN": "not for micro-organisms", "PI": "Genetics, Population (1966-1977)", "MS": "The total genetic information possessed by the reproductive members of a POPULATION of sexually reproducing organisms.", "PM": "91; was see under GENETICS, POPULATION 1978-90", "HN": "91(78); was see under GENETICS, POPULATION 1978-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19770302", "DC": "1", "DX": "19910101", "UI": "D005788"}, {"RECTYPE": "D", "MH": "Genealogy and Heraldry", "DE": "GENEALOGY HERALDRY", "PRINT ENTRY": "Heraldry|T170|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Heraldry and Geneology", "MN": "K01.400.359", "FX": "Emblems and Insignia", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "do not confuse with GENEALOGICAL TREE see PEDIGREE", "MS": "Descent of a person, family, or group from an ancestor and coats of arms and other armorial bearings associated with an ancestor.", "MR": "20180206", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005789"}, {"RECTYPE": "D", "MH": "General Adaptation Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, General Adaptation", "MN": "I01.880.735.784.350", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "The sum of all nonspecific systemic reactions of the body to long-continued exposure to systemic stress.", "OL": "search STRESS & ADAPTATION, PHYSIOLOGICAL 1966-74", "PM": "91; was see under STRESS 1975-90; was see under STRESS & ADAPTATION, PHYSIOLOGICAL 1963-74", "HN": "91(75); was see under STRESS 1975-90; was see under STRESS & ADAPTATION, PHYSIOLOGICAL 1963-74", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005790"}, {"RECTYPE": "D", "MH": "Patient Care", "AQ": "AE CL EC ES HI IS MO MT PX SN ST TD VE", "ENTRY": "cares, Informal", "MN": "N02.421.585", "EC": "nursing:Nursing Care", "MH_TH": "BIOETHICS (1991)", "ST": "T058", "AN": "general or unspecified; prefer specifics; not a synonym for NURSING CARE: nursing care is only one type of patient care", "PI": "Patient Care Planning (1993-1997)", "MS": "The services rendered by members of the health profession and non-professionals under their supervision.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D005791"}, {"RECTYPE": "D", "MH": "General Practice, Dental", "DE": "GENERAL PRACTICE DENT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Practices, Dental General|T091|NON|EQV|NLM (1991)|900126|PRACTICES DENT GENERAL|abcdefv", "MN": "H02.163.342", "MH_TH": "NLM (1967)", "ST": "T091", "PI": "Family Practice (1966)", "MS": "Nonspecialized dental practice which is concerned with providing primary and continuing dental care.", "PM": "67", "HN": "67", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D005792"}, {"RECTYPE": "D", "MH": "Generalization, Psychological", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Generalization, Psychology|T041|NON|EQV|NLM (2020)|190118|abcdef", "ENTRY": "Psychology Generalizations", "MN": "F02.463.425.357", "MH_TH": "NLM (2020)", "ST": "T041", "MS": "The phenomenon of an organism's responding to all situations similar to one in which it has been conditioned.", "PM": "2020; was GENERALIZATION (PSYCHOLOGY) 1965-2019; was GENERALIZATION LEARNING 1963-1964", "HN": "2020 (1965); was GENERALIZATION (PSYCHOLOGY) 1965-2019; was GENERALIZATION LEARNING 1963-1964", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005793"}, {"RECTYPE": "D", "MH": "Generalization, Response", "AQ": "CL DE ES PH RE", "ENTRY": "Response Generalizations", "MN": "F02.463.425.357.359", "MH_TH": "NLM (1965)", "ST": "T041", "MS": "The principle that after an organism learns to respond in a particular manner to a stimulus, that stimulus is effective in eliciting similar responses.", "PM": "69", "HN": "69(65)", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D005794"}, {"RECTYPE": "D", "MH": "Generalization, Stimulus", "AQ": "CL DE ES PH RE", "ENTRY": "Stimulus Generalizations", "MN": "F02.463.425.357.526", "MH_TH": "NLM (1965)", "ST": "T041", "MS": "The tendency to react to stimuli that are different from, but somewhat similar to, the stimulus used as a conditioned stimulus.", "PM": "69", "HN": "69(65)", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D005795"}, {"RECTYPE": "D", "MH": "Genes", "AQ": "DE GE IM PH RE", "ENTRY": "Materials, Genetic", "MN": "G05.360.340.024.340", "FX": "Genomic Library", "MH_TH": "NLM (1965)", "ST": "T028", "MS": "A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.", "PM": "1965; see CHROMOSOMES 1963-1964; for CISTRON see GENES, STRUCTURAL 1980-2005", "HN": "1965; (1963); for CISTRON use GENES, STRUCTURAL 1980-2005", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005796"}, {"RECTYPE": "D", "MH": "Genes, araC", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "araC Genes|T028|EQV|UNK (19XX)|870509|abdef", "ENTRY": "araC Gene", "MN": "G05.360.340.024.340.425.412", "MH_TH": "NLM (1988)", "ST": "T028", "AN": "araC stands for \"arabinose C\" where C is 3d of a sequence araA, araB, etc.", "PI": "Operon (1971-1987)", "MS": "Regulatory genes which encode a cyclic AMP receptor protein required for L-arabinose utilization in E. coli. It is an example of positive control or regulation of gene expression in the bacterial operon.", "PM": "91; was see under GENES, REGULATOR 1988-90", "HN": "91(88); was see under GENES, REGULATOR 1988-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19870509", "DC": "1", "DX": "19910101", "UI": "D005797"}, {"RECTYPE": "D", "MH": "Genes, Bacterial", "DE": "GENES BACT", "AQ": "DE ES GE IM PH RE", "ENTRY": "Gene, Bacterial|T028|NON|EQV|NLM (1992)|901105|GENE BACT|abcdefv", "MN": "G05.360.340.358.207.249", "FX": "Genome, Bacterial", "MH_TH": "NLM (1982)", "ST": "T028", "AN": "coordinate with specific bacterium /genet ", "PI": "specific bacterium/GE (1978-1981)", "MS": "The functional hereditary units of BACTERIA.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19810223", "DC": "1", "DX": "19820101", "UI": "D005798"}, {"RECTYPE": "D", "MH": "Genes, Dominant", "AQ": "DE ES GE IM PH RE", "ENTRY": "Genetic Condition, Dominant", "MN": "G05.420.320", "MH_TH": "NLM (1968)", "ST": "T028", "PI": "Genes (1966-1967)", "MS": "Genes that influence the PHENOTYPE both in the homozygous and the heterozygous state.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005799"}, {"RECTYPE": "D", "MH": "Genes, Fungal", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Fungal Genes|T028|NON|EQV|NLM (1992)|901113|abcdef", "ENTRY": "Gene, Fungal", "MN": "G05.360.340.358.365.500", "MH_TH": "NLM (1984)", "ST": "T028", "AN": "coordinate with specific fungus /genet", "PI": "specific fungus/genetics (1978-1979)", "MS": "The functional hereditary units of FUNGI.", "PM": "1984", "HN": "1984", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19830224", "DC": "1", "DX": "19840101", "UI": "D005800"}, {"RECTYPE": "D", "MH": "Genes, Homeobox", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Homeotic Genes|T028|NON|EQV|UNK (19XX)|860618|abcdef", "ENTRY": "Sequences, Homeobox", "MN": "G05.360.340.024.340.230.500", "FX": "Homeodomain Proteins", "MH_TH": "NLM (1987)", "ST": "T028", "PI": "Morphogenesis (1983-1986)", "MS": "Genes that encode highly conserved TRANSCRIPTION FACTORS that control positional identity of cells (BODY PATTERNING) and MORPHOGENESIS throughout development. Their sequences contain a 180 nucleotide sequence designated the homeobox, so called because mutations of these genes often results in homeotic transformations, in which one body structure replaces another. The proteins encoded by homeobox genes are called HOMEODOMAIN PROTEINS.", "OL": "use GENES, HOMEOBOX to search GENES, HOMEO BOX 1987-94", "PM": "95; was GENES, HOMEO BOX 1987-94", "HN": "95; was GENES, HOMEO BOX 1987-94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D005801"}, {"RECTYPE": "D", "MH": "Genes, MHC Class II", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "MHC Class II Genes|T028|EQV|NLM (1992)|910325|abdef", "ENTRY": "Gene, Class II", "MN": "G12.500.500.600", "FX": "Histocompatibility Antigens Class II", "MH_TH": "NLM (1978)", "ST": "T028", "PI": "Genes, Structural (1968-1977)", "MS": "Genetic loci in the vertebrate major histocompatibility complex that encode polymorphic products which control the immune response to specific antigens. The genes are found in the HLA-D region in humans and include H-2M, I-A, and I-E loci in mice.", "PM": "1992; see GENES, IMMUNE RESPONSE 1978-1991", "HN": "1992 (1978); use GENES, IMMUNE RESPONSE 1978-1991", "CATSH": "CAT LIST", "MR": "20180619", "DA": "19770504", "DC": "1", "DX": "19780101", "UI": "D005802"}, {"RECTYPE": "D", "MH": "Genes, Immunoglobulin", "DE": "GENES IG", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Immunoglobulin Genes|T028|NON|EQV|NLM (1992)|910521|abcdef", "ENTRY": "Immunoglobulin Gene", "MN": "G12.500.299", "FX": "Immunoglobulins", "MH_TH": "NLM (1988)", "ST": "T028", "PI": "specific immunoglobulin chain or region (1975-1987)", "MS": "Genes encoding the different subunits of the IMMUNOGLOBULINS, for example the IMMUNOGLOBULIN LIGHT CHAIN GENES and the IMMUNOGLOBULIN HEAVY CHAIN GENES. The heavy and light immunoglobulin genes are present as gene segments in the germline cells. The completed genes are created when the segments are shuffled and assembled (B-LYMPHOCYTE GENE REARRANGEMENT) during B-LYMPHOCYTE maturation. The gene segments of the human light and heavy chain germline genes are symbolized V (variable), J (joining) and C (constant). The heavy chain germline genes have an additional segment D (diversity).", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19870511", "DC": "1", "DX": "19880101", "UI": "D005803"}, {"RECTYPE": "D", "MH": "Genes, Lethal", "AQ": "DE GE IM PH RE", "ENTRY": "Lethal Genes", "MN": "G05.360.340.024.340.350", "FX": "Synthetic Lethal Mutations", "MH_TH": "NLM (1968)", "ST": "T028", "PI": "Genes (1966-1967)", "MS": "Genes whose loss of function or gain of function MUTATION leads to the death of the carrier prior to maturity. They may be essential genes (GENES, ESSENTIAL) required for viability, or genes which cause a block of function of an essential gene at a time when the essential gene function is required for viability.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005804"}, {"RECTYPE": "D", "MH": "Genes, MHC Class I", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "MHC Class I Genes|T028|EQV|UNK (19XX)|870511|abdef", "ENTRY": "H 2 Class I Genes", "MN": "G12.500.500.595", "FX": "Histocompatibility Antigens Class I", "MH_TH": "NLM (1988)", "ST": "T028", "PI": "Major Histocompatibility Complex (1980-1987)", "MS": "Genetic loci in the vertebrate major histocompatibility complex which encode polymorphic characteristics not related to immune responsiveness or complement activity, e.g., B loci (chicken), DLA (dog), GPLA (guinea pig), H-2 (mouse), RT-1 (rat), HLA-A, -B, and -C class I genes of man.", "HN": "1988", "CATSH": "CAT LIST", "MR": "20180201", "DA": "19870511", "DC": "1", "DX": "19880101", "UI": "D005805"}, {"RECTYPE": "D", "MH": "Genes, Overlapping", "AQ": "DE ES GE IM PH RE", "ENTRY": "Overlapping Gene", "MN": "G05.360.340.024.340.385", "MH_TH": "NLM (1988)", "ST": "T028", "PI": "specific microbial gene heading (1978-1987)", "MS": "Genes whose nucleotide sequences overlap to some degree. The overlapped sequences may involve structural or regulatory genes of eukaryotic or prokaryotic cells.", "PM": "91; was see under GENES 1988-90", "HN": "91(88); was see under GENES 1988-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19870508", "DC": "1", "DX": "19910101", "UI": "D005807"}, {"RECTYPE": "D", "MH": "Genes, Recessive", "AQ": "DE ES GE IM PH RE", "ENTRY": "Recessive Genetic Condition", "MN": "G05.420.325", "MH_TH": "NLM (1968)", "ST": "T028", "PI": "Genes (1966-1967)", "MS": "Genes that influence the PHENOTYPE only in the homozygous state.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005808"}, {"RECTYPE": "D", "MH": "Genes, Regulator", "DE": "GENES REG", "AQ": "DE GE IM PH RE", "ENTRY": "Regulatory Gene", "MN": "G05.360.340.024.340.425", "FX": "Transcriptional Activation", "MH_TH": "NLM (1968)", "ST": "T028", "AN": "regulatory proteins go under TRANSCRIPTION FACTORS or REPRESSOR PROTEINS or TRANS-ACTIVATORS", "PI": "Genes (1966-1967)", "MS": "Genes which regulate or circumscribe the activity of other genes; specifically, genes which code for PROTEINS or RNAs which have GENE EXPRESSION REGULATION functions.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005809"}, {"RECTYPE": "D", "MH": "Multigene Family", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Genes, Reiterated|T028|NON|NRW|NLM (1997)|960412|abcdef", "ENTRY": "Reiterated Genes", "MN": "G05.360.340.024.340.645", "FX": "Repetitive Sequences, Nucleic Acid", "MH_TH": "NLM (1987)", "ST": "T028", "PI": "Genes, Viral (1978-1986)", "MS": "A set of genes descended by duplication and variation from some ancestral gene. Such genes may be clustered together on the same chromosome or dispersed on different chromosomes. Examples of multigene families include those that encode the hemoglobins, immunoglobulins, histocompatibility antigens, actins, tubulins, keratins, collagens, heat shock proteins, salivary glue proteins, chorion proteins, cuticle proteins, yolk proteins, and phaseolins, as well as histones, ribosomal RNA, and transfer RNA genes. The latter three are examples of reiterated genes, where hundreds of identical genes are present in a tandem array. (King & Stanfield, A Dictionary of Genetics, 4th ed)", "PM": "97; was GENES, REITERATED 1987-96; MULTIGENE FAMILY was see GENES, REITERATED 1987-96", "HN": "97; was GENES, REITERATED 1987-96; MULTIGENE FAMILY was see GENES, REITERATED 1987-96", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D005810"}, {"RECTYPE": "D", "MH": "Genes, Switch", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Switching Complex|T028|NON|BRD|UNK (19XX)|870511|abcdef", "ENTRY": "Switch Gene", "MN": "G05.360.340.024.340.425.420", "MH_TH": "NLM (1988)", "ST": "T028", "PI": "Genes, Structural (1977-1987)", "MS": "Genes that cause the epigenotype (i.e., the interrelated developmental pathways through which the adult organism is realized) to switch to an alternate cell lineage-related pathway. Switch complexes control the expression of normal functional development as well as oncogenic transformation.", "PM": "91; was see under GENES, REGULATOR 1988-90", "HN": "91(88); was see under GENES, REGULATOR 1988-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19870511", "DC": "1", "DX": "19910101", "UI": "D005812"}, {"RECTYPE": "D", "MH": "Genes, Synthetic", "DE": "GENES SYN", "AQ": "DE ES GE IM PH RE", "ENTRY": "Synthetic Gene", "MN": "G05.360.340.024.340.465", "MH_TH": "NLM (1980)", "ST": "T028", "PI": "Oligodeoxyribonucleotides/chemical synthesis (1976-1979)", "MS": "Biologically functional sequences of DNA chemically synthesized in vitro.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19790523", "DC": "1", "DX": "19800101", "UI": "D005813"}, {"RECTYPE": "D", "MH": "Genes, Viral", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Viral Genes|T028|NON|EQV|UNK (19XX)|770504|abcdef", "ENTRY": "Viral Gene", "MN": "G05.360.340.358.840.500", "FX": "Viral Proteins", "MH_TH": "NLM (1978)", "ST": "T028", "AN": "coordinate IM with specific virus /genet (IM)", "PI": "RNA, Viral (1966-1977)", "MS": "The functional hereditary units of VIRUSES.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19770504", "DC": "1", "DX": "19780101", "UI": "D005814"}, {"RECTYPE": "D", "MH": "Genetic Code", "DE": "GENET CODE", "AQ": "DE ES GE IM PH RE", "ENTRY": "Genetic Codes", "MN": "G05.360.335", "FX": "Protein Biosynthesis", "MH_TH": "NLM (1964)", "ST": "T085", "MS": "The meaning ascribed to the BASE SEQUENCE with respect to how it is translated into AMINO ACID SEQUENCE. The start, stop, and order of amino acids of a protein is specified by consecutive triplets of nucleotides called codons (CODON).", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005815"}, {"RECTYPE": "D", "MH": "Genetic Complementation Test", "DE": "GENET COMPLEMENTATION TEST", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Trans Test|T059|T063|NON|EQV|NLM (1991)|891220|abbcdef", "ENTRY": "Trans Tests", "MN": "E05.393.281.526", "MH_TH": "NLM (1968)", "ST": "T063", "PI": "Genetics (1966-1967)", "MS": "A test used to determine whether or not complementation (compensation in the form of dominance) will occur in a cell with a given mutant phenotype when another mutant genome, encoding the same mutant phenotype, is introduced into that cell.", "OL": "use GENETIC COMPLEMENTATION TEST to search ALLELISM TEST 1968-90", "PM": "68; ALLELISM TEST was heading 1968-90", "HN": "68; ALLELISM TEST was heading 1968-90", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005816"}, {"RECTYPE": "D", "MH": "Genetic Counseling", "DE": "GENET COUNSELING", "AQ": "CL EC ES HI LJ MT OG PX SD SN ST TD", "ENTRY": "Prenatal Genetic Counseling|T061|T091|NON|NRW|NLM (2004)|021120|PRENATAL GENET COUNSELING|abbcdefv", "MN": "N02.421.308.400", "FX": "Preconception Care", "MH_TH": "NLM (1973)", "ST": "T091", "PI": "Eugenics (1966-1972)", "MS": "An educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005817"}, {"RECTYPE": "D", "MH": "Genetic Engineering", "DE": "GENET ENGINEERING", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Genetic Intervention|T063|NON|EQV|BIOETHICS (1989)|880531|GENET INTERVENTION|abcdefv", "ENTRY": "Interventions, Genetic", "MN": "E05.393.420", "FX": "Protein Engineering", "MH_TH": "NLM (1973)", "ST": "T063", "PI": "Genetics, Medical (1966-1972)", "MS": "Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc.", "OL": "use GENETIC ENGINEERING to search GENETIC INTERVENTION 1973-88", "PM": "89; was GENETIC INTERVENTION 1973-88; was in Cat E & G 1973-79", "HN": "89; was GENETIC INTERVENTION 1973-88; was in Cat E & G 1973-79", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005818"}, {"RECTYPE": "D", "MH": "Genetic Markers", "DE": "GENET MARKERS", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Markers, Genetic|T034|T184|NON|EQV|UNK (19XX)|790524|MARKERS GENET|abbcdefv", "ENTRY": "Markers, Chromosome", "MN": "G05.695.450", "FX": "Chromosome Mapping", "MH_TH": "NLM (1980)", "ST": "T184", "RN": "0", "AN": "usually NIM; IM GEN only; coord with specific genetic feature (IM) if pertinent", "PI": "Recombination, Genetic (1968-1979)", "MS": "A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event.", "OL": "use GENETIC MARKERS to search GENETIC MARKER 1980-88", "PM": "89; was GENETIC MARKER 1980-88", "HN": "89; was GENETIC MARKER 1980-88", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19790524", "DC": "1", "DX": "19800101", "UI": "D005819"}, {"RECTYPE": "D", "MH": "Genetic Testing", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "PRINT ENTRY": "Genetic Predisposition Testing|T060|T061|NON|NRW|NLM (1999)|970804|GENET PREDISPOSITION TESTING|abbcdefv", "ENTRY": "Testing, Predictive Genetic", "MN": "N02.421.726.233.221", "FX": "Prenatal Diagnosis", "MH_TH": "NLM (2010)", "ST": "T060", "AN": "human and animal; for phenotype or genotype", "PI": "Mass Screening (1968-1977)", "MS": "Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing.", "PM": "2010; see GENETIC SCREENING 1978-2009", "HN": "2010 (1978)", "CATSH": "CAT LIST", "MR": "20170717", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D005820"}, {"RECTYPE": "D", "MH": "Genetic Techniques", "DE": "GENET TECHNIQUES", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Genetic|T058|T062|NON|EQV|NLM (1991)|900110|TECHNIQUES GENET|abbcdefv", "MN": "E05.393", "FX": "Chromosomes, Artificial, Yeast", "MH_TH": "NLM (1973)", "ST": "T062", "MS": "Chromosomal, biochemical, intracellular, and other methods used in the study of genetics.", "OL": "use GENETIC TECHNIQUES to search GENETIC TECHNICS 1973-90", "PM": "91; was GENETIC TECHNICS 1973-90", "HN": "91; was GENETIC TECHNICS 1973-90", "CATSH": "CAT LIST", "MR": "20010814", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005821"}, {"RECTYPE": "D", "MH": "Genetic Vectors", "DE": "GENET VECTORS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vectors, Genetic|T005|T114|NON|EQV|UNK (19XX)|791119|VECTORS GENET|abbcdefv", "ENTRY": "Vectors, Shuttle", "MN": "G05.360.337", "FX": "Viruses", "MH_TH": "NLM (1980)", "ST": "T114", "AN": "coord with specific bacterium, virus, phage or plasmid", "PI": "Plasmids (1975-1979)", "MS": "DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition.", "PM": "80", "HN": "80", "MR": "20080708", "DA": "19781221", "DC": "1", "DX": "19800101", "UI": "D005822"}, {"RECTYPE": "D", "MH": "Genetics", "DE": "GENET", "AQ": "CL EC ED ES HI IS LJ OG SN ST TD", "MN": "H01.158.273.343", "FX": "Histocompatibility Testing", "EC": "methods:Genetic Techniques", "MH_TH": "POPLINE (1978)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use GENETIC PHENOMENA or specifics treed under it for genetic processes and properties of organisms, or the qualifier / genet with specific anatomical terms, organisms, diseases, etc.", "MS": "The branch of science concerned with the means and consequences of transmission and generation of the components of biological inheritance. (Stedman, 26th ed)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005823"}, {"RECTYPE": "D", "MH": "Genetics, Behavioral", "DE": "GENET BEHAVIORAL", "AQ": "CL DE EC ED ES HI IS LJ MT OG RE SN ST TD", "PRINT ENTRY": "Psychogenetics|T091|NON|REL|UNK (19XX)|740330|PSYCHOGENET|abcdefv", "ENTRY": "Behavioral Genetics|T091|NON|EQV|BIOETHICS (1989)|770317|BEHAVIORAL GENET|abcdefv", "MN": "H01.158.273.343.290", "FX": "Sociobiology", "MH_TH": "NLM (1968)", "ST": "T091", "AN": "specialty or general; prefer specifics", "PI": "Genetics (1966-1967)", "MS": "The experimental study of the relationship between the genotype of an organism and its behavior. The scope includes the effects of genes on simple sensory processes to complex organization of the nervous system.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005824"}, {"RECTYPE": "D", "MH": "Genetics, Medical", "DE": "GENET MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medical Genetics|T091|NON|EQV|UNK (19XX)|860101|MED GENET|abcdefv", "MN": "H02.403.350", "FX": "Molecular Medicine", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use for the discipline only; restrict to the subfield of human genetics dealing with genetic or hereditary disorders", "MS": "A subdiscipline of human genetics which entails the reliable prediction of certain human disorders as a function of the lineage and/or genetic makeup of an individual or of any two parents or potential parents.", "OL": "use GENETICS, MEDICAL to search GENETICS, HUMAN 1966-79", "PM": "80; was GENETICS, HUMAN 1963-79", "HN": "80; was GENETICS, HUMAN 1963-79", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D005826"}, {"RECTYPE": "D", "MH": "Genetics, Microbial", "DE": "GENET MICROBIAL", "AQ": "CL DE EC ED ES HI IM IS LJ MT OG RE SN ST TD", "ENTRY": "Microbial Genetic", "MN": "H01.158.273.540.367", "FX": "Genome, Microbial", "MH_TH": "NLM (1968)", "ST": "T091", "AN": "specialty; general and unspecified only: prefer /genet with specific microbes", "PI": "Genetics (1966-1967)", "MS": "A subdiscipline of genetics which deals with the genetic mechanisms and processes of microorganisms.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005827"}, {"RECTYPE": "D", "MH": "Genetics, Population", "DE": "GENET POPULATION", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Population Genetics|T090|NON|EQV|UNK (19XX)|860101|POPULATION GENET|abcdefv", "MN": "H01.158.273.343.335", "FX": "Population Dynamics", "MH_TH": "POPLINE (1978)", "ST": "T090", "AN": "general or unspecified; prefer specifics treed under GENETIC PHENOMENA; human and animal; specify geographic location", "MS": "The discipline studying genetic composition of populations and effects of factors such as GENETIC SELECTION, population size, MUTATION, migration, and GENETIC DRIFT on the frequencies of various GENOTYPES and PHENOTYPES using a variety of GENETIC TECHNIQUES.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005828"}, {"RECTYPE": "D", "MH": "Geniculate Bodies", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Metathalamus|T023|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Nucleus, Medial Geniculate", "MN": "A08.186.211.200.317.826.701.444", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Part of the DIENCEPHALON inferior to the caudal end of the dorsal THALAMUS. Includes the lateral geniculate body which relays visual impulses from the OPTIC TRACT to the calcarine cortex, and the medial geniculate body which relays auditory impulses from the lateral lemniscus to the AUDITORY CORTEX.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005829"}, {"RECTYPE": "D", "MH": "Geniculate Ganglion", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Superficial Petrosal Nerve|T023|NON|NRW|NLM (2020)|190220|abcdef", "ENTRY": "Superficial Petrosal Nerves", "MN": "A08.800.800.120.250.280", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "neoplasms: coordinate with CRANIAL NERVE NEOPLASMS + histological type of neoplasm", "MS": "The sensory ganglion of the facial (7th cranial) nerve. The geniculate ganglion cells send central processes to the brain stem and peripheral processes to the taste buds in the anterior tongue, the soft palate, and the skin of the external auditory meatus and the mastoid process.", "OL": "search FACIAL NERVE 1966-74", "PM": "91; was see under FACIAL NERVE 1975-90", "HN": "91(75); was see under FACIAL NERVE 1975-90", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005830"}, {"RECTYPE": "D", "MH": "Genital Diseases, Female", "DE": "GENITAL DIS FEMALE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gynecologic Diseases|T047|NON|EQV|UNK (19XX)|780512|GYNECOL DIS|abcdefv", "ENTRY": "Gynecologic Disease", "MN": "C12.100.250", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "human & animal; general: prefer specifics", "MS": "Pathological processes involving the female reproductive tract (GENITALIA, FEMALE).", "OL": "use GENITAL DISEASES, FEMALE to search GYNECOLOGIC DISEASES 1966-78", "PM": "79; was GYNECOLOGIC DISEASES 1965-78", "HN": "79; was GYNECOLOGIC DISEASES 1965-78", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005831"}, {"RECTYPE": "D", "MH": "Genital Diseases, Male", "DE": "GENITAL DIS MALE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Male Genital Diseases|T047|NON|EQV|NLM (2007)|050919|MALE GENITAL DIS|abcdefv", "ENTRY": "Male Genital Disease", "MN": "C12.200.294", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "human & animal; general: prefer specifics", "MS": "Pathological processes involving the male reproductive tract (GENITALIA, MALE).", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005832"}, {"RECTYPE": "D", "MH": "Genital Neoplasms, Female", "DE": "GENITAL NEOPL FEMALE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Gynecologic Neoplasms|T191|NON|EQV|UNK (19XX)|780512|GYNECOL NEOPL|abcdefv", "ENTRY": "Neoplasm, Gynecologic", "MN": "C12.900.418", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "human & animal; general or unspecified only: prefer specifics; coordinate IM with histological type of neoplasm (IM); /vet: consider also VENEREAL TUMORS, VETERINARY", "MS": "Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).", "OL": "use GENITAL NEOPLASMS, FEMALE to search GYNECOLOGIC NEOPLASMS 1966-78", "PM": "79; was GYNECOLOGIC NEOPLASMS 1963-78", "HN": "79; was GYNECOLOGIC NEOPLASMS 1963-78", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D005833"}, {"RECTYPE": "D", "MH": "Genital Neoplasms, Male", "DE": "GENITAL NEOPL MALE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Male Genital Neoplasms|T191|NON|EQV|NLM (1993)|920504|MALE GENITAL NEOPL|abcdefv", "ENTRY": "Neoplasm, Male Genital", "MN": "C12.900.619", "MH_TH": "NLM (1978)", "ST": "T191", "AN": "human & animal; general or unspecified only: prefer specifics; coordinate IM with histological type of neoplasm (IM); /vet: consider also VENEREAL TUMORS, VETERINARY", "PI": "Urogenital Neoplasms (1966-1977)", "MS": "Tumor or cancer of the MALE GENITALIA.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19770329", "DC": "1", "DX": "19780101", "UI": "D005834"}, {"RECTYPE": "D", "MH": "Genitalia", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sex Organs, Accessory|T023|NON|NRW|NLM (1998)|960712|abcdef", "ENTRY": "Systems, Reproductive", "MN": "A05.360", "MH_TH": "NLM (1984)", "ST": "T023", "AN": "general; prefer GENITALIA, FEMALE or GENITALIA, MALE or their specifics", "MS": "The external and internal organs involved in the functions of REPRODUCTION.", "MR": "20170612", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005835"}, {"RECTYPE": "D", "MH": "Genitalia, Female", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sex Organs, Accessory, Female|T023|NON|NRW|NLM (1998)|960715|abcdef", "ENTRY": "Reproductive Systems, Female", "MN": "A05.360.319", "FX": "Hysterosalpingography", "MH_TH": "NLM (1963)", "ST": "T023", "MS": "The female reproductive organs. The external organs include the VULVA; BARTHOLIN'S GLANDS; and CLITORIS. The internal organs include the VAGINA; UTERUS; OVARY; and FALLOPIAN TUBES.", "MR": "20180301", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005836"}, {"RECTYPE": "D", "MH": "Genitalia, Male", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sex Organs, Accessory, Male|T023|NON|NRW|NLM (1998)|960712|abcdef", "ENTRY": "Reproductive Systems, Male", "MN": "A05.360.444", "MH_TH": "NLM (1963)", "ST": "T023", "MS": "The male reproductive organs. They are divided into the external organs (PENIS; SCROTUM; and URETHRA) and the internal organs (TESTIS; EPIDIDYMIS; VAS DEFERENS; SEMINAL VESICLES; EJACULATORY DUCTS; PROSTATE; and BULBOURETHRAL GLANDS).", "MR": "20180227", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005837"}, {"RECTYPE": "D", "MH": "Genotype", "ENTRY": "Genotypes", "MN": "G05.380", "FX": "Genotyping Techniques", "MH_TH": "NLM (1968)", "ST": "T032", "PI": "Genetics (1966-1967)", "MS": "The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005838"}, {"RECTYPE": "D", "MH": "Gentamicins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gentamycin|T109|T195|NON|NRW|BAN (19XX)|770412|abbcdef", "ENTRY": "Sulfate, Gentamicin", "MN": "D09.408.051.374", "PA": "Protein Synthesis Inhibitors", "MH_TH": "NLM (1963)", "ST": "T195", "RN": "0", "RR": "T6Z9V48IKG", "MS": "A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.", "OL": "use GENTAMICINS to search GENTAMICIN 1966-77", "PM": "78; was GENTAMICIN 1966-77", "HN": "78; was GENTAMICIN 1963-77 (Prov 1963-65)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005839"}, {"RECTYPE": "D", "MH": "Gentian Violet", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylrosaniline Chloride|T109|T121|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbbcdeef", "ENTRY": "Violet, Methyl", "MN": "D02.092.146.400", "PA": "Anti-Infective Agents, Local", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "Methanaminium, N-(4-(bis(4-(dimethylamino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-methyl-, chloride", "RN": "J4Z741D6O5", "RR": "548-62-9 (Gentian Violet)", "MS": "A dye that is a mixture of violet rosanilinis with antibacterial, antifungal, and anthelmintic properties.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005840"}, {"RECTYPE": "D", "MH": "Gentisates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2,5-Dihydroxybenzoic Acids|T109|NON|EQV|NLM (1999)|980409|DIHYDROXYBENZOIC ACIDS 02 05|abcdefs", "ENTRY": "Acids, 2,5-Dihydroxybenzoic", "MN": "D02.455.426.559.389.657.410.595.405", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Salts and esters of gentisic acid.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005841"}, {"RECTYPE": "D", "MH": "Geographic Locations", "DE": "GEOGR LOCATIONS", "AQ": "EH EP", "PRINT ENTRY": "Geographic Location|T083|NON|EQV|NLM (2021)|191118|abcdef", "MN": "Z01", "RH": "Z1 - GEOGRAPHIC LOCATIONS", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "used for searching; do not confuse with GEOGRAPHY; INDEXER: Do not use; CATALOGER: Do not use", "PI": "specific geographic location (1966-1997)", "MS": "The continents and countries situated on those continents; the UNITED STATES and each of the constituent states arranged by region; CANADA and each of its provinces; AUSTRALIA and each of its states; the major bodies of water and major islands on both hemispheres; and selected major cities.", "HN": "98; use explode 1967-97", "MR": "20200527", "DA": "19990101", "DC": "4", "DX": "19980101", "UI": "D005842"}, {"RECTYPE": "D", "MH": "Geography", "DE": "GEOGR", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Human Geography|T090|NON|NRW|NLM (1983)|861231|HUMAN GEOGR|abcdefv", "MN": "H01.277.500", "FX": "Topography, Medical", "MH_TH": "NLM (1981)", "ST": "T090", "AN": "IM as the discipline (education, history, etc); NIM with no qualifiers as a coordinate; do not use for epidemiologic aspects of disease, index disease /epidemiol + geographic location term", "MS": "The science dealing with the earth and its life, especially the description of land, sea, and air and the distribution of plant and animal life, including humanity and human industries with reference to the mutual relations of these elements. (From Webster, 3d ed)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005843"}, {"RECTYPE": "D", "MH": "Geology", "DE": "GEOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.277.562", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use GEOLOGICAL PHENOMENA or specifics treed under it for structures and properties of the inanimate matter of Earth and other celestial bodies and processes affecting them", "MS": "The science of the earth and other celestial bodies and their history as recorded in the rocks. It includes the study of geologic processes of an area such as rock formations, weathering and erosion, and sedimentation. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005844"}, {"RECTYPE": "D", "MH": "Georgia", "AQ": "EH EP", "MN": "Z01.107.567.875.750.370", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "U.S. only; do not confuse with GEORGIA (REPUBLIC)", "MS": "A state located in the southeastern United States, The capital is Atlanta.", "MR": "20161221", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005845"}, {"RECTYPE": "D", "MH": "Georgia (Republic)", "AQ": "EH EP", "PRINT ENTRY": "Georgian S.S.R.|T083|NAM|EQV|NLM (1993)|920422|abcdef", "ENTRY": "Republic of Georgia|T083|NON|EQV|NLM (2013)|111124|abcdef", "MN": "Z01.586.950.420", "MH_TH": "NLM (1966)", "ST": "T083", "MS": "A country in southwestern Asia, bordering the Black Sea, between Turkey and Russia. The capital is Tbilisi.", "OL": "use GEORGIA (REPUBLIC) to search GEORGIAN S.S.R. 1982-92, GEORGIAN SSR 1967-81 & GEORGIA SSR 1966", "HN": "93; was GEORGIAN S.S.R. 1982-92; was GEORGIAN SSR 1967-81; was GEORGIA SSR 1963-66", "MR": "20170717", "DA": "19990101", "DC": "4", "DX": "19930101", "UI": "D005846"}, {"RECTYPE": "D", "MH": "Geotrichosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Geotrichoses", "MN": "C01.150.703.392", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "fungus dis", "MS": "Infection due to the fungus Geotrichum.", "PM": "91; was see under MYCOSES 1966-90", "HN": "91(66); was see under MYCOSES 1966-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005847"}, {"RECTYPE": "D", "MH": "Geotrichum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Geotrichums", "MN": "B01.300.381.380", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid43987", "MS": "A mitosporic Saccharomycetales fungal genus, various species of which have been isolated from pulmonary lesions. Teleomorphs include Dipodascus and Galactomyces.", "PM": "91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85", "HN": "91(75)", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005848"}, {"RECTYPE": "D", "MH": "Gerbillinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rats, Sand|T015|NON|NRW|NLM (1991)|900305|abcdef", "ENTRY": "Sand Rats", "MN": "B01.050.150.900.649.313.992.635.300", "MH_TH": "NLM (1968)", "ST": "T015", "RN": "txid10045", "RR": "txid48138", "AN": "NIM when experimental animal", "PI": "Rodentia (1966-1967)", "MS": "A subfamily of the Muridae consisting of several genera including Gerbillus, Rhombomys, Tatera, Meriones, and Psammomys.", "OL": "use GERBILLINAE to search GERBILS 1968-81; use MICROTINAE to search PSAMMOMYS 1982-90", "PM": "82; was GERBILS 1968-81; PSAMMOMYS was see CRICETIDAE 1982-90", "HN": "82; was GERBILS 1968-81; PSAMMOMYS was see CRICETIDAE 1982-90", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005849"}, {"RECTYPE": "D", "MH": "Geriatric Dentistry", "DE": "GERIATRIC DENT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Dentistry, Geriatric|T091|NON|EQV|NLM (1991)|900503|DENT GERIATRIC|abcdefv", "MN": "H02.163.394", "FX": "Dental Care for Aged", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "The branch of dentistry concerned with the dental problems of older people.", "PM": "66", "HN": "66", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005850"}, {"RECTYPE": "D", "MH": "Geriatric Nursing", "DE": "GERIATRIC NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursings, Geriatric", "MN": "N02.421.533.245", "MH_TH": "NLM (1967)", "ST": "T091", "PI": "Nursing Care (1966)", "MS": "Nursing care of the aged patient given in the home, the hospital, or special institutions such as nursing homes, psychiatric institutions, etc.", "PM": "67", "HN": "67", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D005851"}, {"RECTYPE": "D", "MH": "Geriatric Psychiatry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Psychogeriatrics|T091|NON|EQV|UNK (19XX)|760512|abcdef", "MN": "H02.403.690.260", "MH_TH": "NLM (1975)", "ST": "T091", "PI": "Psychiatry (1966-1974)", "MS": "A subspecialty of psychiatry concerned with the mental health of the aged.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D005852"}, {"RECTYPE": "D", "MH": "Geriatrics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Gerontology|T090|NON|BRD|UNK (19XX)|750101|GERONTOL|abcdefv", "MN": "H02.403.355", "FX": "Aged", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty; when permitted for \"geriatric diseases\": Manual 28.9.1", "MS": "The branch of medicine concerned with the physiological and pathological aspects of the aged, including the clinical problems of senescence and senility.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005853"}, {"RECTYPE": "D", "MH": "Germ Cells", "AQ": "CH CL CY DE EN GD IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Germ-Line Cells|T025|NON|EQV|UNK (19XX)|870511|abcdef", "ENTRY": "Germ-Line Cell", "MN": "A11.497", "MH_TH": "NLM (1978)", "ST": "T025", "AN": "general; prefer OVUM or SPERMATOZOA; GERM CELLS, PLANT is also available", "MS": "The reproductive cells in multicellular organisms at various stages during GAMETOGENESIS.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005854"}, {"RECTYPE": "D", "MH": "Germ Layers", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Layers, Germ", "MN": "A16.504", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "The three primary germinal layers (ECTODERM; ENDODERM; and MESODERM) developed during GASTRULATION that provide tissues and body plan of a mature organism. They derive from two early layers, hypoblast and epiblast.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005855"}, {"RECTYPE": "D", "MH": "Germ-Free Life", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Gnotobiotics|T090|NON|BRD|UNK (19XX)|740330|abcdef", "ENTRY": "Life, Germfree", "MN": "G06.320", "FX": "Axenic Culture", "MH_TH": "NLM (1966)", "ST": "T068", "AN": "IM", "MS": "Animals not contaminated by or associated with any foreign organisms.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005856"}, {"RECTYPE": "D", "MH": "Germanium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.305", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Germanium", "RN": "00072J7XWS", "RR": "7440-56-4 (Germanium)", "MS": "A rare metal element with a blue-gray appearance and atomic symbol Ge, atomic number 32, and atomic weight 72.63.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005857"}, {"RECTYPE": "D", "MH": "Germany", "AQ": "EH EP", "MN": "Z01.542.315", "MH_TH": "NLM (1991)", "ST": "T083", "AN": "for Germany before 23 May 1949 & after 3 Oct 1990; for historical articles before & after 1949; BERLIN is also available", "MS": "A country in central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. The capital is Berlin.", "MR": "20161221", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005858"}, {"RECTYPE": "D", "MH": "Germany, East", "AQ": "EH EP", "PRINT ENTRY": "Germany, Democratic Republic of|T083|NAM|EQV|NLM (1994)|920908|abcdef", "MN": "Z01.586.338", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "for East Germany 7 Oct 1949-3 Oct 1990; BERLIN is also available; in German texts as DDR (Deutsche Demokratische Republik)", "MS": "The former German Democratic Republic which was reunified with the former Federal Republic of Germany in 1990.", "MR": "20161221", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005859"}, {"RECTYPE": "D", "MH": "Germany, West", "AQ": "EH EP", "PRINT ENTRY": "Germany, Federal Republic of|T083|NAM|EQV|POPLINE (1978)|920908|abcdef", "MN": "Z01.586.350", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "for West Germany 23 May 1949-3 Oct 1990; BERLIN is also available; in German texts as BRD (Bundesrepublik Deutschland)", "MS": "The former Federal Republic of Germany which was reunified with the former German Democratic Republic in 1990.", "MR": "20161221", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005860"}, {"RECTYPE": "D", "MH": "Germine Acetates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Germine-3-monoacetate|T109|T121|T123|NON|NRW|UNK (19XX)|741111|GERMINEMONOACETATE 3|abbbcdefs", "ENTRY": "Germine 3 monoacetate", "MN": "D03.633.400.256.310", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Veratrum (1972-1974)", "MS": "Germine derivatives acetylated on any one or more of the hydroxy groups. These compounds are present in many polyester alkaloids which occur in Veratrum and Zygadenus species. They are used as antihypertensive agents, and in some cases, exhibit curare-like activity.", "PM": "91; was see under CEVANES 1975-90", "HN": "91(75); was see under CEVANES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005861"}, {"RECTYPE": "D", "MH": "Gerstmann Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Finger-Agnosia-Left-Right-Confusion-Acalculia-Agraphia|T047|NON|EQV|NLM (2000)|991105|abcdef", "ENTRY": "de Gerstmann, Syndrome", "MN": "F01.700.750.100.300", "FX": "Dyscalculia", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with GERSTMANN-STRAUSSLER SYNDROME, a prion disease", "MS": "A disorder of cognition characterized by the tetrad of finger agnosia, dysgraphia, DYSCALCULIA, and right-left disorientation. The syndrome may be developmental or acquired. Acquired Gerstmann syndrome is associated with lesions in the dominant (usually left) PARIETAL LOBE which involve the angular gyrus or subjacent white matter. (From Adams et al., Principles of Neurology, 6th ed, p457)", "PM": "2000; see Gerstmann's Syndrome 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D005862"}, {"RECTYPE": "D", "MH": "Gestalt Theory", "AQ": "HI", "ENTRY": "Theory, Gestalt", "MN": "F02.739.527", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "A system which emphasizes that experience and behavior contain basic patterns and relationships which cannot be reduced to simpler components; that is, the whole is greater than the sum of its parts.", "OL": "search PSYCHOLOGICAL THEORY 1969-74", "PM": "91; was see under PSYCHOLOGICAL THEORY 1975-90", "HN": "91(75); was see under PSYCHOLOGICAL THEORY 1975-90", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005863"}, {"RECTYPE": "D", "MH": "Gestalt Therapy", "DE": "GESTALT THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapy, Gestalt|T061|NON|EQV|UNK (19XX)|860101|THER GESTALT|abcdefv", "MN": "F04.754.360", "MH_TH": "NLM (1975)", "ST": "T061", "MS": "A form of psychotherapy with emphasis on the interplay of organism and environment. Basic to this therapy is the development of awareness and maturity, as well as self-confidence.", "PM": "91; was see under PSYCHOTHERAPY 1973-90", "HN": "91(73); was see under PSYCHOTHERAPY 1973-90", "CATSH": "CAT LIST", "MR": "19950531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005864"}, {"RECTYPE": "D", "MH": "Gestational Age", "PRINT ENTRY": "Fetal Maturity, Chronologic|T032|NON|REL|UNK (19XX)|800513|FETAL MATURITY CHRONOL|abcdefv", "ENTRY": "Gestational Ages", "MN": "G08.686.320", "FX": "Term Birth", "MH_TH": "NLM (1970)", "ST": "T040", "AN": "mammalian only; for fetus not mother", "PI": "Infant, Premature (1966-1967)", "MS": "The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination.", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20220408", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D005865"}, {"RECTYPE": "D", "MH": "Gestonorone Caproate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hexanoate, Gestronol", "MN": "D04.210.500.745.745.654.527", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "19-Norpregn-4-ene-3,20-dione, 17-((1-oxohexyl)oxy)-", "RN": "U38E620NS6", "RR": "H4G605B7VP", "PI": "Pregnanes (1971)", "MS": "A long-acting potent progestogen structurally related to PROGESTERONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1185)", "PM": "73", "HN": "73(72)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005866"}, {"RECTYPE": "D", "MH": "Gestrinone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-|T109|T121|T125|NON|EQV|NLM (2020)|190705|abbbcdef", "ENTRY": "R 2323", "MN": "D04.210.500.668.651.568.620.400", "PA": "Progestins", "MH_TH": "USAN (1978)", "ST": "T125", "N1": "18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-", "RN": "1421533RCM", "RR": "83648-01-5 (cpd w/o stereochem designation)", "PI": "Norgestrienone/analogs & derivatives (1975-1978)", "MS": "A non-estrogenic contraceptive which is a weak progestin with strong anti-progesterone properties. It is effective if used once a week orally or can also be used in intravaginal devices.", "OL": "use GESTRINONE to search R 2323 1979-87", "PM": "91; was see under NORPREGNATRIENES 1988-90; was R 2323 see under NORPREGNATRIENES 1979-87", "HN": "91(88); was see under NORPREGNATRIENES 1988-90; was R 2323 see under NORPREGNATRIENES 1979-87", "MR": "20190705", "DA": "19771215", "DC": "1", "DX": "19910101", "UI": "D005867"}, {"RECTYPE": "D", "MH": "Gestures", "ENTRY": "Gesture", "MN": "F01.145.209.530.538.445", "MH_TH": "NLM (1975)", "ST": "T054", "MS": "Movement of a part of the body for the purpose of communication.", "OL": "search KINESICS 1968-74 & COMMUNICATION 1966-67", "PM": "91; was see under KINESICS 1968-90; was see under COMMUNICATION 1963-67", "HN": "91(75); was see under KINESICS 1968-90; was see under COMMUNICATION 1963-67", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005868"}, {"RECTYPE": "D", "MH": "Ghana", "AQ": "EH EP", "PRINT ENTRY": "Gold Coast|T083|NAM|EQV|NLM (1998)|960816|abcdef", "ENTRY": "Republic of Ghana|T083|NAM|EQV|NLM (2009)|080327|abcdef", "MN": "Z01.058.290.190.320", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in western Africa, south of BURKINA FASO and west of TOGO. Its capital is Accra.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005869"}, {"RECTYPE": "D", "MH": "Giant Cell Tumors", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Giant Cell", "MN": "C04.557.450.565.380", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "benign or malignant; coordinate with precoordinated organ/neoplasm term but GIANT CELL TUMOR OF BONE is available", "MS": "Tumors of bone tissue or synovial or other soft tissue characterized by the presence of giant cells. The most common are giant cell tumor of tendon sheath and GIANT CELL TUMOR OF BONE.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005870"}, {"RECTYPE": "D", "MH": "Castleman Disease", "DE": "CASTLEMAN DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lymph Node Hyperplasia, Giant|T047|NON|EQV|UNK (19XX)|860624|abcdef", "ENTRY": "Tumor, Castleman's", "MN": "C20.683.515.250", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Lymph Nodes (1966-1986)", "MS": "Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A.", "PM": "2018; see Giant Lymph Node Hyperplasia (1987-2017)", "HN": "2018(1987)", "CATSH": "CAT LIST", "MR": "20170707", "DA": "19860624", "DC": "1", "DX": "19870101", "UI": "D005871"}, {"RECTYPE": "D", "MH": "Giardia", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Lamblia|T204|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Lamblias", "MN": "B01.237.385", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5740", "MS": "A genus of flagellate intestinal EUKARYOTES parasitic in various vertebrates, including humans. Characteristics include the presence of four pairs of flagella arising from a complicated system of axonemes and cysts that are ellipsoidal to ovoidal in shape.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005872"}, {"RECTYPE": "D", "MH": "Giardiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Lambliasis|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Lambliases", "MN": "C06.405.469.452.481", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An infection of the SMALL INTESTINE caused by the flagellated protozoan GIARDIA. It is spread via contaminated food and water and by direct person-to-person contact.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005873"}, {"RECTYPE": "D", "MH": "Gibberella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gibberellas", "MN": "B01.300.107.501.400", "FX": "Fusarium", "MH_TH": "NLM (1975)", "ST": "T004", "AN": "an ascomycete yielding gibberellin & gibberellic acid", "MS": "A genus of ascomycetous fungi of the family Hypocreaceae, order Hypocreales including several pathogens of grains and cereals. It is also the source of plant growth regulators such as gibberellin and gibberellic acid.", "PM": "91; see HYPOCREALES 1975-90", "HN": "91(75)", "MR": "20200902", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005874"}, {"RECTYPE": "D", "MH": "Gibberellins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gibberellin|T109|T123|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D02.455.849.291.350.500", "PA": "Plant Growth Regulators", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "A class of plant growth hormone isolated from cultures of GIBBERELLA FUJIKUROI, a fungus causing Bakanae disease in rice. There are many different members of the family as well as mixtures of multiple members; all are diterpenoid acids based on the gibberellane skeleton.", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005875"}, {"RECTYPE": "D", "MH": "Gibraltar", "AQ": "EH EP", "MN": "Z01.542.335", "MH_TH": "NLM (1983)", "ST": "T083", "MS": "An overseas territory of the United Kingdom in southwestern Europe, bordering the Strait of Gibraltar.", "MR": "20161222", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D005876"}, {"RECTYPE": "D", "MH": "Gigantism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Gigantism, Pituitary", "MN": "C19.700.355.528", "FX": "Sotos Syndrome", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "The condition of accelerated and excessive GROWTH in children or adolescents who are exposed to excess HUMAN GROWTH HORMONE before the closure of EPIPHYSES. It is usually caused by somatotroph hyperplasia or a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. These patients are of abnormally tall stature, more than 3 standard deviations above normal mean height for age.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005877"}, {"RECTYPE": "D", "MH": "Gilbert Disease", "DE": "GILBERT DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Gilbert's", "MN": "C18.452.648.300.528", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "A benign familial disorder, transmitted as an autosomal dominant trait. It is characterized by low-grade chronic hyperbilirubinemia with considerable daily fluctuations of the bilirubin level.", "PM": "2000; see GILBERT'S DISEASE 1991-1999, see HYPERBILIRUBINEMIA, HEREDITARY 1975-90", "HN": "2000(1975)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005878"}, {"RECTYPE": "D", "MH": "Tourette Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tic Disorder, Combined Vocal and Multiple Motor|T048|NON|EQV|NLM (2000)|991103|TIC DIS COMBINED VOCAL MULTIPLE MOTOR|abcdefv", "ENTRY": "Tourettes Syndrome", "MN": "F03.625.992.850", "FX": "Tics", "MH_TH": "OMIM (2013)", "ST": "T048", "MS": "A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79)", "PM": "1989; see GILLES DE LA TOURETTE'S DISEASE 1966-88", "HN": "1989(1966)", "CATSH": "CAT LIST", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005879"}, {"RECTYPE": "D", "MH": "Gills", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Gill", "MN": "A13.421", "MH_TH": "NLM (1968)", "ST": "T023", "PI": "Fishes (1966-1967)", "MS": "Paired respiratory organs of fishes and some amphibians that are analogous to lungs. They are richly supplied with blood vessels by which oxygen and carbon dioxide are exchanged directly with the environment.", "PM": "68", "HN": "68", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005880"}, {"RECTYPE": "D", "MH": "Gingiva", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Interdental Papilla|T023|NON|NRW|NLM (1997)|960530|INTERDENT PAPILLA|abcdefv", "ENTRY": "Gum", "MN": "A14.549.167.646.480", "FX": "Gingivoplasty", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Oral tissue surrounding and attached to TEETH.", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005881"}, {"RECTYPE": "D", "MH": "Gingival Diseases", "DE": "GINGIVAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gingivosis|T047|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Gingivoses", "MN": "C07.465.714.258", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Diseases involving the GINGIVA.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20151009", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005882"}, {"RECTYPE": "D", "MH": "Gingival Crevicular Fluid", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Gingival Exudate|T031|NON|EQV|NLM (1991)|900418|abcdef", "ENTRY": "Gingival Exudates", "MN": "A12.383.500", "MH_TH": "NLM (1972)", "ST": "T031", "AN": "note X ref; crevicular refers to the gingival crevice", "PI": "Gingiva (1966-1972)", "MS": "A fluid occurring in minute amounts in the gingival crevice, believed by some authorities to be an inflammatory exudate and by others to cleanse material from the crevice, containing sticky plasma proteins which improve adhesions of the epithelial attachment, have antimicrobial properties, and exert antibody activity. (From Jablonski, Illustrated Dictionary of Dentistry, 1982)", "OL": "use GINGIVAL CREVICULAR FLUID to search GINGIVAL EXUDATE 1972-90 (as Prov 1972-74)", "PM": "91; was GINGIVAL EXUDATE see under GINGIVITIS 1975-90; was in Cat A & C 1972-83, was in Cat C 1984-95", "HN": "91(72); was GINGIVAL EXUDATE see under GINGIVITIS 1972-90 (Prov 1972-74); was in Cat A & C 1972-83, was in Cat C 1984-95", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005883"}, {"RECTYPE": "D", "MH": "Gingival Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Gingival|T033|T046|NON|EQV|UNK (19XX)|770202|abbcdef", "ENTRY": "Gingival Hemorrhages", "MN": "C23.550.414.922.500", "MH_TH": "NLM (1975)", "ST": "T046", "AN": "do not confuse with BLEEDING ON PROBING, GINGIVAL see PERIODONTAL INDEX", "MS": "The flowing of blood from the marginal gingival area, particularly the sulcus, seen in such conditions as GINGIVITIS, marginal PERIODONTITIS, injury, and ASCORBIC ACID DEFICIENCY.", "OL": "use ORAL HEMORRHAGE to search GINVIVAL HEMORRHAGE 1967-74", "PM": "91; was see under ORAL HEMORRHAGE 1990; was see under HEMORRHAGE, ORAL 1967-89", "HN": "91(75); was see under ORAL HEMORRHAGE 1990; was see under HEMORRHAGE, ORAL 1967-89", "CATSH": "CAT LIST", "MR": "20050722", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005884"}, {"RECTYPE": "D", "MH": "Gingival Hyperplasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperplasias, Gingival", "MN": "C07.465.714.258.428.250", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "differentiate from GINGIVAL HYPERTROPHY", "MS": "Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells. (From Jablonski's Dictionary of Dentistry, 1992, p400)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005885"}, {"RECTYPE": "D", "MH": "Gingival Hypertrophy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypertrophy, Gingival", "MN": "C07.465.714.258.428.260", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "differentiate from GINGIVAL HYPERPLASIA", "MS": "Abnormal enlargement or overgrowth of the gingivae brought about by enlargement of existing cells.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005886"}, {"RECTYPE": "D", "MH": "Gingival Neoplasms", "DE": "GINGIVAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Epulis, Congenital|T191|NON|NRW|NLM (1997)|960328|EPULIS CONGEN|abcdefv", "ENTRY": "Neoplasm, Gingival", "MN": "C07.465.714.258.409", "MH_TH": "NLM (1971)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM); note entry term EPULIS, CONGENITAL: do not confuse with EPULIS see GINGIVAL DISEASES; index EPULIS, CONGENITAL under GINGIVAL NEOPLASMS /congen", "PI": "Mouth Neoplasms (1966-1970)", "MS": "New abnormal growth of tissue in the GINGIVA.", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005887"}, {"RECTYPE": "D", "MH": "Gingival Pocket", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pocket, Gingival|T020|NON|EQV|UNK (19XX)|780228|abcdef", "ENTRY": "Pockets, Gingival", "MN": "C07.465.714.258.480.360", "FX": "Periodontal Pocket", "MH_TH": "NLM (1975)", "ST": "T020", "AN": "do not confuse with PERIODONTAL POCKET: read MeSH definition", "PI": "Periodontitis (1968-1974)", "MS": "An abnormal extension of a gingival sulcus not accompanied by the apical migration of the epithelial attachment.", "OL": "search PERIODONTITIS 1968-74", "PM": "91; was see under GINGIVITIS 1979-90; was see under PERIODONTITIS 1968-78", "HN": "91(75); was see under GINGIVITIS 1979-90; was see under PERIODONTITIS 1968-78", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005888"}, {"RECTYPE": "D", "MH": "Gingival Recession", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gingival Atrophy|T047|NON|NRW|NLM (2009)|070920|abcdef", "ENTRY": "Recessions, Gingival", "MN": "C07.465.714.354.625", "MH_TH": "NLM (1985)", "ST": "T047", "PI": "Gingival Diseases (1966-1984)", "MS": "Exposure of the root surface when the edge of the gum (GINGIVA) moves apically away from the crown of the tooth. This is common with advancing age, vigorous tooth brushing, diseases, or tissue loss of the gingiva, the PERIODONTAL LIGAMENT and the supporting bone (ALVEOLAR PROCESS).", "PM": "91; was see under GINGIVAL DISEASES 1985-90", "HN": "91(85); was see under GINGIVAL DISEASES 1985-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19840501", "DC": "1", "DX": "19910101", "UI": "D005889"}, {"RECTYPE": "D", "MH": "Gingivectomy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Gingivectomies", "MN": "E06.721.321", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Surgical excision of the gingiva at the level of its attachment, thus creating new marginal gingiva. This procedure is used to eliminate gingival or periodontal pockets or to provide an approach for extensive surgical interventions, and to gain access necessary to remove calculus within the pocket. (Dorland, 28th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005890"}, {"RECTYPE": "D", "MH": "Gingivitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Gingivitides", "MN": "C07.465.714.258.480", "FX": "Pericoronitis", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Inflammation of gum tissue (GINGIVA) without loss of connective tissue.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005891"}, {"RECTYPE": "D", "MH": "Gingivitis, Necrotizing Ulcerative", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vincent Infection|T047|EPO|EQV|NLM (2004)|030317|abcdef", "ENTRY": "Vincent's Stomatitis|T047|EPO|EQV|NLM (2012)|ORD (2010)|101210|abcdeef", "MN": "C07.465.714.258.480.446", "MH_TH": "NLM (1973)", "ST": "T047", "MS": "An acute or chronic GINGIVITIS characterized by redness and swelling, NECROSIS extending from the interdental papillae along the gingival margins, PAIN; HEMORRHAGE, necrotic odor, and often a pseudomembrane. The condition may extend to the ORAL MUCOSA; TONGUE; PALATE; or PHARYNX. The etiology is somewhat unclear, but may involve a complex of FUSOBACTERIUM NUCLEATUM along with spirochetes BORRELIA or TREPONEMA.", "OL": "use GINGIVITIS, NECROTIZING ULCERATIVE to search VINCENT'S INFECTION 1966-72", "PM": "73; was VINCENT'S INFECTION 1963-72", "HN": "73; was VINCENT'S INFECTIONS 1963-72", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005892"}, {"RECTYPE": "D", "MH": "Gingivoplasty", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Gingivoplasties", "MN": "E06.721.384", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Surgical reshaping of the gingivae and papillae for correction of deformities (particularly enlargements) and to provide the gingivae with a normal and functional form, the incision creating an external bevel. (Dorland, 28th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005893"}, {"RECTYPE": "D", "MH": "Panax", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Panax ginseng|T002|NON|NRW|NLM (2002)|010523|abcdef", "ENTRY": "Shinsengs", "MN": "B01.875.800.575.912.250.087.500", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid4053", "RR": "txid4054", "AN": "do not confuse entry term GINSENG with SIBERIAN GINSENG see Eleutherococcus", "MS": "An araliaceous genus of plants that contains a number of pharmacologically active agents used as stimulants, sedatives, and tonics, especially in traditional medicine. Sometimes confused with Siberian ginseng (ELEUTHEROCOCCUS).", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005894"}, {"RECTYPE": "D", "MH": "Gizzard, Avian", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Gizzard|T023|NON|EQV|NLM (1968)|990101|abcdef", "ENTRY": "Gizzards, Avian", "MN": "A13.853.355", "FX": "Gizzard, Non-avian", "MH_TH": "NLM (2017)", "ST": "T023", "AN": "diseases: coordinate IM with STOMACH DISEASES /vet (IM); neoplasms: coordinate IM with STOMACH NEOPLASMS /vet (IM) + histological type of neoplasm /vet (IM)", "PI": "Stomach (1966-1967)", "MS": "The posterior portion of the avian stomach located between the PROVENTRICULUS and INTESTINE. It consists of a thick muscular wall and small stones (gastroliths) that function to mechanically grind SEEDS and other ingested objects.", "PM": "2017; see GIZZARD 1968-2016", "HN": "2017(1968)", "MR": "20170117", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005895"}, {"RECTYPE": "D", "MH": "Glanders", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "MN": "C22.488.409", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A contagious disease of horses that can be transmitted to humans. It is caused by BURKHOLDERIA MALLEI and characterized by ulceration of the respiratory mucosa and an eruption of nodules on the skin.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005896"}, {"RECTYPE": "D", "MH": "Glafenine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycerylaminophenaquine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Glafenin|T109|T121|NON|EQV|UNK (19XX)|771125|abbcdef", "MN": "D02.455.426.559.389.127.020.906.875", "PA": "Analgesics, Non-Narcotic", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzoic acid, 2-((7-chloro-4-quinolinyl)amino)-, 2,3-dihydroxypropyl ester", "RN": "46HL4I09AH", "RR": "3820-67-5 (Glafenine)", "PI": "Quinolines (1972-1974)", "MS": "An anthranilic acid derivative with analgesic properties used for the relief of all types of pain.", "OL": "use GLAFENINE to search GLAPHENINE 1975-94", "PM": "95; was GLAPHENINE 1975-94 (see under ANTHRANILIC ACIDS 1975-90); GLAFENINE was see GLAPHENINE 1978-94", "HN": "95; was GLAPHENINE 1975-94 (see under ANTHRANILIC ACIDS 1975-90); GLAFENINE was see GLAPHENINE 1978-94", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005897"}, {"RECTYPE": "D", "MH": "Glass", "AQ": "AN CH HI RE ST", "MN": "J01.637.437", "MH_TH": "NLM (1966)", "ST": "T197", "MS": "Hard, amorphous, brittle, inorganic, usually transparent, polymerous silicate of basic oxides, usually potassium or sodium. It is used in the form of hard sheets, vessels, tubing, fibers, ceramics, beads, etc.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005898"}, {"RECTYPE": "D", "MH": "Glass Ionomer Cements", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polyalkenoate Cements|T122|NON|EQV|NLM (1997)|951127|abcdef", "ENTRY": "Polyalkenoate Cement, Glass", "MN": "J01.637.051.339.291.402", "MH_TH": "NLM (1980)", "ST": "T122", "RN": "0", "PI": "Dental Cements (1972-1979)", "MS": "A polymer obtained by reacting polyacrylic acid with a special anion-leachable glass (alumino-silicate). The resulting cement is more durable and tougher than others in that the materials comprising the polymer backbone do not leach out.", "OL": "use GLASS IONOMER CEMENTS to search ASPA CEMENT & SILICOPOLYACRYLATE CEMENT 1980-96", "PM": "91; was see under DENTAL CEMENTS 1980-90; ASPA CEMENT & SILICOPOLYACRYLATE CEMENT were see GLASS IONOMER CEMENTS 1980-96", "HN": "91(80); was see under DENTAL CEMENTS 1980-90; ASPA CEMENT & SILICOPOLYACRYLATE CEMENT were see GLASS IONOMER CEMENTS 1980-96", "MR": "20200527", "DA": "19790430", "DC": "1", "DX": "19910101", "UI": "D005899"}, {"RECTYPE": "D", "MH": "Glaucarubin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Kirondrin|T109|T121|NON|EQV|UNK (19XX)|800401|abbcdef", "MN": "D03.383.663.387", "PA": "Antineoplastic Agents, Phytogenic", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Picras-3-en-16-one, 11,20-epoxy-1,2,11,12-tetrahydroxy-15-(2-hydroxy-2-methyl-1-oxobutoxy)-, (1beta,2alpha,11beta,12alpha,15beta(S))-", "RN": "EH6H7VS52J", "RR": "1448-23-3 (Glaucarubin)", "MS": "(1 beta,2 alpha,11 beta,12 alpha,15 beta(S))-11,20-Epoxy-1,2,11,12-tetrahydroxy-15-(2-hydroxy-2-methyl-1-oxobutoxy)picras-3-en-16-one. A quassinoid (Simaroubolide) from Simaruba glauca, a tropical shrub. It has been used as an antiamebic agent and is found to be cytotoxic. It may be of use in cancer chemotherapy.", "PM": "91; was see under PHENANTHRENES 1981-90; was see under PYRANS 1975-80", "HN": "91(66); was see under PHENANTHRENES 1981-90; was see under PYRANS 1975-80", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005900"}, {"RECTYPE": "D", "MH": "Glaucoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Glaucomas", "MN": "C11.525.381", "FX": "Trabeculectomy", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "differentiate from OCULAR HYPERTENSION; / surg: consider FILTERING SURGERY or SCLEROSTOMY or TRABECULECTOMY", "MS": "An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005901"}, {"RECTYPE": "D", "MH": "Glaucoma, Open-Angle", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Open-Angle Glaucoma|T047|NON|EQV|NLM (1990)|890316|abcdef", "ENTRY": "Simplices, Glaucoma", "MN": "C11.525.381.407", "FX": "Iridocorneal Endothelial Syndrome", "MH_TH": "NLM (1982)", "ST": "T047", "AN": "do not confuse with GLAUCOMA, CLOSED-ANGLE see GLAUCOMA, ANGLE-CLOSURE", "PI": "Glaucoma (1966-1981)", "MS": "Glaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris.", "PM": "1982; GLAUCOMA, PRIMARY OPEN ANGLE was indexed under GLAUCOMA, OPEN ANGLE 2013-2017", "HN": "1982", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19810224", "DC": "1", "DX": "19820101", "UI": "D005902"}, {"RECTYPE": "D", "MH": "Gliadin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Gliadin", "MN": "D12.776.765.725.500.500.400", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Gliadins", "RN": "9007-90-3", "AN": "from gluten", "PI": "Plant Proteins (1973-1974)", "MS": "Simple protein, one of the prolamines, derived from the gluten of wheat, rye, etc. May be separated into 4 discrete electrophoretic fractions. It is the toxic factor associated with CELIAC DISEASE.", "PM": "91; was see under PLANT PROTEINS 1975-90", "HN": "91(75); was see under PLANT PROTEINS 1975-90", "MR": "20180630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005903"}, {"RECTYPE": "D", "MH": "Glial Fibrillary Acidic Protein", "DE": "GFAP", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glial Intermediate Filament Protein|T116|T123|NON|EQV|UNK (19XX)|840416|abbcdef", "ENTRY": "GFA Protein", "MN": "D12.776.220.475.400", "FX": "Alexander Disease", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1966-1984)", "MS": "An intermediate filament protein found only in glial cells or cells of glial origin. MW 51,000.", "OL": "use INTERMEDIATE FILAMENT PROTEINS to search GLIAL INTERMEDIATE FILAMENT PROTEINS 1983-84; use GLIAL FIBRILLARY ACIDIC PROTEIN (NM) to search GFA-PROTEIN 1980-93", "PM": "85; was GLIAL INTERMEDIATE FILAMENT PROTEINS see INTERMEDIATE FILAMENT PROTEINS 1983-84; GFA-PROTEIN was indexed under NERVE TISSUE PROTEINS 1980-93", "HN": "85; was GLIAL INTERMEDIATE FILAMENT PROTEINS see INTERMEDIATE FILAMENT PROTEINS 1983-84; GFA-PROTEIN was (NM) 1980-93", "MR": "20100625", "DA": "19840416", "DC": "1", "DX": "19850101", "UI": "D005904"}, {"RECTYPE": "D", "MH": "Glyburide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glibenclamide|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|740330|abbcdeeef", "ENTRY": "HB420", "MN": "D02.886.590.795.575", "PA": "Hypoglycemic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzamide, 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-", "RN": "SX6K58TVWC", "RR": "10238-21-8 (Glyburide)", "PI": "Hypoglycemic Agents (1966-1970)", "MS": "An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide", "OL": "use GLYBURIDE to search GLIBENCLAMIDE 1971-91 (as Prov 1971-72)", "PM": "92; was GLIBENCLAMIDE 1973-91; GLYBURIDE was see GLIBENCLAMIDE 1973-91", "HN": "92; was GLIBENCLAMIDE 1971-91 (Prov 1971-72); GLYBURIDE was see GLIBENCLAMIDE 1973-91", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005905"}, {"RECTYPE": "D", "MH": "Gliclazide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "S852", "MN": "D02.886.590.795.475", "PA": "Hypoglycemic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, N-(((hexahydrocyclopenta(c)pyrrol-2(1H)-yl)amino)carbonyl)-4-methyl-", "RN": "G4PX8C4HKV", "RR": "21187-98-4 (Gliclazide)", "PI": "Sulfonylurea Compounds (1972-1974)", "MS": "An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.", "PM": "91; was see under SULFONYLUREA COMPOUNDS 1975-90", "HN": "91(75); was see under SULFONYLUREA COMPOUNDS 1975-90", "MR": "20230608", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D005907"}, {"RECTYPE": "D", "MH": "Glioblastoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Glioblastoma Multiforme|T191|NON|NRW|NLM (1994)|OMIM (2013)|930331|abcdeef", "ENTRY": "Grade IV Astrocytomas", "MN": "C04.557.580.625.600.380.080.335", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with probably precoord CNS/neopl term + site (IM); for GLIOBLASTOMA WITH SARCOMATOUS COMPONENT see GLIOSARCOMA; for GLIOBLASTOMA, RETINAL see RETINOBLASTOMA", "MS": "A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.", "OL": "use GLIOBLASTOMA to search GLIOBLASTOMA MULTIFORME 1966-93; search GLIOBLASTOMA under GLIOMA 1980-93", "PM": "94; was GLIOBLASTOMA MULTIFORME 1963-93; GLIOBLASTOMA was see ASTROCYTOMA 1993", "HN": "94; was GLIOBLASTOMA MULTIFORME 1963-93; GLIOBLASTOMA was see ASTROCYTOMA 1993", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D005909"}, {"RECTYPE": "D", "MH": "Glioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Glial Cell Tumors|T191|NON|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Tumors, Glial Cell", "MN": "C04.557.580.625.600.380", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with precoord CNS/neopl term + site (IM); GLIOMA, SUBEPENDYMAL is available; for sarcomatous GLIOMA use GLIOSARCOMA; for GLIOMA, RETINAL see RETINOBLASTOMA", "MS": "Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)", "CATSH": "CAT LIST", "MR": "20050713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005910"}, {"RECTYPE": "D", "MH": "Gliosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Glial Scar|T033|NON|REL|NLM (2021)|OBSSR (2021)|191122|abcdeef", "ENTRY": "Scar, Glial", "MN": "C23.550.369", "MH_TH": "NLM (1969)", "ST": "T046", "PI": "appropriate heading/PA (1966-1968)", "MS": "The production of a dense fibrous network of neuroglia; includes astrocytosis, which is a proliferation of astrocytes in the area of a degenerative lesion.", "PM": "74", "HN": "74(69)", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D005911"}, {"RECTYPE": "D", "MH": "Gliotoxin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Gliotoxins|T121|T131|NON|EQV|NLM (1996)|950310|abbcdef", "MN": "D23.946.587.401", "PA": "Immunosuppressive Agents", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "10H-3,10a-Epidithiopyrazino(1,2-a)indole-1,4-dione, 2,3,5a,6-tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-", "RN": "67-99-2", "AN": "/antag permitted but consider also ANTITOXINS;/biosyn permitted if by fungus", "PI": "Piperazines (1972-1974)", "MS": "A fungal toxin produced by various species of Trichoderma, Gladiocladium fimbriatum, Aspergillus fumigatus, and Penicillium. It is used as an immunosuppressive agent.", "PM": "96; was GLIOTOXINS 1981-95 (see under MYCOTOXINS 1981-90); was GLIOTOXIN see under ANTIBIOTICS 1975-80", "HN": "96; was GLIOTOXINS 1981-95 (see under MYCOTOXINS 1981-90); was GLIOTOXIN see under ANTIBIOTICS 1975-80", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005912"}, {"RECTYPE": "D", "MH": "Glipizide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glypidizine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "K4024", "MN": "D02.886.590.795.500", "PA": "Hypoglycemic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pyrazinecarboxamide, N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-", "RN": "X7WDT95N5C", "RR": "29094-61-9 (Glipizide)", "PI": "Sulfonylurea Compounds (1971-1974)", "MS": "An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.", "PM": "91; was see under SULFONYLUREA COMPOUNDS 1975-90", "HN": "91(75); was see under SULFONYLUREA COMPOUNDS 1975-90", "MR": "20170224", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D005913"}, {"RECTYPE": "D", "MH": "Globins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Globin|T116|T123|NON|EQV|NLM (1965)|990101|abbcdef", "MN": "D12.776.422.316", "MH_TH": "NLM (2001)", "ST": "T123", "N1": "Globins", "RN": "9004-22-2", "MS": "A superfamily of proteins containing the globin fold which is composed of 6-8 alpha helices arranged in a characterstic HEME enclosing structure.", "PM": "2001; see GLOBIN 1972-2000", "HN": "2001, 1965-1971(1972)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D005914"}, {"RECTYPE": "D", "MH": "Globosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lacto-N-tetraosylceramide|T109|T123|NON|NRW|UNK (19XX)|780516|LACTOTETRAOSYLCERAMIDE N|abbcdefs", "ENTRY": "Lacto N tetraosylceramide", "MN": "D10.570.877.360.612.200.425", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Glycosphingolipids (1975-1978)", "MS": "Glycosphingolipids containing N-acetylglucosamine (paragloboside) or N-acetylgalactosamine (globoside). Globoside is the P antigen on erythrocytes and paragloboside is an intermediate in the biosynthesis of erythrocyte blood group ABH and P 1 glycosphingolipid antigens. The accumulation of globoside in tissue, due to a defect in hexosaminidases A and B, is the cause of Sandhoff disease.", "PM": "91; was see under GLYCOSPHINGOLIPIDS 1979-90", "HN": "91(79); was see under GLYCOSPHINGOLIPIDS 1979-90", "MR": "20060705", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D005915"}, {"RECTYPE": "D", "MH": "Globulins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Globulin|T116|T123|NON|EQV|NLM (2021)|191118|abbcdef", "MN": "D12.776.377", "EC": "blood:Serum Globulins", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics; permeability globulins: index under SERUM GLOBULINS; EUGLOBULINS, and PSEUDOGLOBULINS are entry terms to SERUM GLOBULINS; do not confuse with GLOBULINS, IMMUNE see IMMUNOGLOBULINS ", "MS": "A group of proteins that are salt-soluble and form a large fraction of BLOOD PROTEINS. There are three types of globulins, ALPHA-GLOBULINS, BETA-GLOBULINS, and GAMMA-GLOBULINS, which are distinguished from one another by their degree of electrophoretic mobility.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005916"}, {"RECTYPE": "D", "MH": "Globus Pallidus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Paleostriatum|T023|NON|BRD|NLM (1993)|910917|abcdef", "ENTRY": "Pallidums", "MN": "A08.186.211.200.885.287.249.487.397", "FX": "Entopeduncular Nucleus", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The representation of the phylogenetically oldest part of the corpus striatum called the paleostriatum. It forms the smaller, more medial part of the lentiform nucleus.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005917"}, {"RECTYPE": "D", "MH": "Glomus Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Glomangioma|T191|NON|REL|NLM (1994)|ORD (2010)|930329|abcdeef", "ENTRY": "Tumors, Glomus", "MN": "C04.557.645.350", "FX": "Paraganglioma, Extra-Adrenal", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coord IM with precoord organ/neopl term (IM)", "MS": "A blue-red, extremely painful vascular neoplasm involving a glomeriform arteriovenous anastomosis (glomus body), which may be found anywhere in the skin, most often in the distal portion of the fingers and toes, especially beneath the nail. It is composed of specialized pericytes (sometimes termed glomus cells), usually in single encapsulated nodular masses which may be several millimeters in diameter (From Stedman, 27th ed). CHEMODECTOMA, a tumor of NEURAL CREST origin, is also sometimes called a glomus tumor.", "OL": "use GLOMUS TUMOR to search GLOMANGIOMA 1966-93", "PM": "94; was GLOMANGIOMA 1963-93", "HN": "94; was GLOMANGIOMA 1963-93", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D005918"}, {"RECTYPE": "D", "MH": "Glomerular Filtration Rate", "AQ": "DE GE IM PH RE VE", "ENTRY": "Rates, Glomerular Filtration", "MN": "G08.852.357", "MH_TH": "NLM (1965)", "ST": "T060", "MS": "The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance.", "PM": "66", "HN": "66(65)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005919"}, {"RECTYPE": "D", "MH": "Glomerular Mesangium", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Mesangium, Glomerular|T024|NON|EQV|UNK (19XX)|830606|abcdef", "ENTRY": "Mesangiums, Glomerular", "MN": "A05.810.453.736.520.620.500", "MH_TH": "NLM (1984)", "ST": "T024", "PI": "Kidney Glomerulus (1966-1983)", "MS": "The thin membranous structure supporting the adjoining glomerular capillaries. It is composed of GLOMERULAR MESANGIAL CELLS and their EXTRACELLULAR MATRIX.", "PM": "84", "HN": "84", "MR": "20060705", "DA": "19830606", "DC": "1", "DX": "19840101", "UI": "D005920"}, {"RECTYPE": "D", "MH": "Glomerulonephritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bright Disease|T047|EPO|BRD|UNK (19XX)|780316|BRIGHT DIS|abcdefv", "ENTRY": "Scarring, Kidney", "MN": "C12.950.419.570.363", "FX": "Kidney Failure, Chronic", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.", "OL": "search BRIGHT DISEASE under NEPHRITIS 1966-78", "PM": "BRIGHT DISEASE was BRIGHT'S DISEASE see NEPHRITIS 1963-78", "HN": "BRIGHT DISEASE was BRIGHT'S DISEASE see NEPHRITIS 1963-78", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D005921"}, {"RECTYPE": "D", "MH": "Glomerulonephritis, IGA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nephropathy, IGA|T047|EQV|UNK (19XX)|840412|abdef", "ENTRY": "Nephropathy, Immunoglobulin A", "MN": "C20.111.525", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse entry term BERGER'S DISEASE with BUERGER'S DISEASE see THROMBOANGIITIS OBLITERANS", "PI": "IGA/immunology (1973-1984)", "MS": "A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE.", "PM": "85", "HN": "85", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19840412", "DC": "1", "DX": "19850101", "UI": "D005922"}, {"RECTYPE": "D", "MH": "Glomerulosclerosis, Focal Segmental", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyalinosis, Segmental Glomerular|T047|NON|REL|NLM (2007)|051026|abcdef", "ENTRY": "Segmental Hyalinosis", "MN": "C12.950.419.570.363.640", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Kidney Glomerulus (1966-1976)", "MS": "A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.", "PM": "2007; see GLOMERULOSCLEROSIS, FOCAL 1991-2006, GLOMERULONEPHRITIS 1977-1990", "HN": "2007 (1977)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D005923"}, {"RECTYPE": "D", "MH": "Glomus Jugulare", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Jugulare, Glomus", "MN": "A11.671.650.915.500.600.350", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "a nonchromaffin paraganglion", "MS": "A nonchromaffin paraganglion located in the wall of the jugular bulb. The most common tumors of the middle ear arise from this tissue. (Lockard, Desk Reference for Neuroscience, 1992, p114)", "OL": "search PARAGANGLIA, NONCHROMAFFIN 1966-74", "PM": "91; was see under PARAGANGLIA, NONCHROMAFFIN 1975-90", "HN": "91(75); was see under PARAGANGLIA, NONCHROMAFFIN 1975-90", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005924"}, {"RECTYPE": "D", "MH": "Glomus Jugulare Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumor, Glomus Jugulare", "MN": "C04.557.580.625.650.700.705.340", "MH_TH": "NLM (1975)", "ST": "T191", "AN": "organ/neoplasm & histological coordinates not necessary", "MS": "A paraganglioma involving the glomus jugulare, a microscopic collection of chemoreceptor tissue in the adventitia of the bulb of the jugular vein. It may cause paralysis of the vocal cords, attacks of dizziness, blackouts, and nystagmus. It is not resectable but radiation therapy is effective. It regresses slowly, but permanent control is regularly achieved. (From Dorland, 27th ed; Stedman, 25th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1603-4)", "PM": "1991(1975); see PARAGANGLIOMA, NONCHROMAFFIN 1975-1990; for PARAGANGLIOMAS 1 see PARAGANGLIOMA 2013-2022", "HN": "1991(1975); use PARAGANGLIOMA, NONCHROMAFFIN 1975-1990; for PARAGANGLIOMAS 1 use PARAGANGLIOMA 2013-2022", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005925"}, {"RECTYPE": "D", "MH": "Glossalgia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Glossopyrosis|T184|NON|NRW|NLM (1998)|961008|abcdef", "ENTRY": "Glossopyroses", "MN": "C23.888.592.612.414", "MH_TH": "NLM (1965)", "ST": "T184", "MS": "Painful sensations in the tongue, including a sensation of burning.", "OL": "use GLOSSALGIA to search GLOSSODYNIA 1966-68", "PM": "65", "HN": "65; GLOSSODYNIA was see under GLOSSALGIA 1965-68", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005926"}, {"RECTYPE": "D", "MH": "Glossectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Glossectomies", "MN": "E06.645.380", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Partial or total surgical excision of the tongue. (Dorland, 28th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005927"}, {"RECTYPE": "D", "MH": "Glossitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Glossitides", "MN": "C07.465.910.363", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "inflamm of the tongue", "MS": "Inflammation of the tongue.", "CATSH": "CAT LIST", "MR": "19930528", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005928"}, {"RECTYPE": "D", "MH": "Glossitis, Benign Migratory", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tongue, Geographic|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Migratory Glossitis, Benign", "MN": "C07.465.910.363.447", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An idiopathic disorder of the tongue characterized by the loss of filiform papillae leaving reddened areas of circinate macules bound by a white band. The lesions heal, then others erupt.", "PM": "2017; ERYTHEMA MIGRANS, LINGUAL was indexed under GLOSSITIS, BENIGN MIGRATORY 2011-2016", "HN": "2017 (1965)", "CATSH": "CAT LIST", "MR": "20180614", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005929"}, {"RECTYPE": "D", "MH": "Glossopharyngeal Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Ninth Cranial Nerve|T023|NON|EQV|NLM (1998)|960731|abcdef", "ENTRY": "Ninth Cranial Nerves", "MN": "A08.800.800.120.290", "EC": "injuries:Glossopharyngeal Nerve Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The 9th cranial nerve. The glossopharyngeal nerve is a mixed motor and sensory nerve; it conveys somatic and autonomic efferents as well as general, special, and visceral afferents. Among the connections are motor fibers to the stylopharyngeus muscle, parasympathetic fibers to the parotid glands, general and taste afferents from the posterior third of the tongue, the nasopharynx, and the palate, and afferents from baroreceptors and CHEMORECEPTOR CELLS of the carotid sinus.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005930"}, {"RECTYPE": "D", "MH": "Glottis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Rima Glottidi", "MN": "A04.329.364", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The vocal apparatus of the larynx, situated in the middle section of the larynx. Glottis consists of the VOCAL FOLDS and an opening (rima glottidis) between the folds.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005931"}, {"RECTYPE": "D", "MH": "Gloves, Surgical", "DE": "GLOVES SURG", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Surgical Gloves|T073|NON|EQV|NLM (1994)|920911|SURG GLOVES|abcdefv", "ENTRY": "Surgical Glove", "MN": "J01.637.708.560.875.400.400", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Gloves, usually rubber, worn by surgeons, examining physicians, dentists, and other health personnel for the mutual protection of personnel and patient.", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005932"}, {"RECTYPE": "D", "MH": "Glucagon", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Hyperglycemic Glycogenolytic Factor", "MN": "D12.644.548.586.730.500", "PA": "Hormones", "FX": "Receptors, Glucagon", "MH_TH": "USP (19XX)", "ST": "T125", "RN": "9007-92-5", "AN": "do not confuse with GLUCAGON-LIKE PEPTIDES secreted by the intestine", "MS": "A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D005934"}, {"RECTYPE": "D", "MH": "Glucagonoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "alpha-Cell Tumor|T191|NON|EQV|UNK (19XX)|810520|abcdef", "ENTRY": "alpha-Cell Tumors", "MN": "C19.344.421.500.249", "FX": "Necrolytic Migratory Erythema", "MH_TH": "NLM (1982)", "ST": "T191", "AN": "coordinate IM with PANCREATIC NEOPLASMS (IM); for glucagonoma syndrome, coordinate also with NECROLYTIC MIGRATORY ERYTHEMA", "PI": "Islet Cell Tumor (1966-1981)", "MS": "An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA.", "OL": "search ISLET CELL TUMOR 1981", "PM": "91; was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1981", "HN": "91(82); was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1981", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19810520", "DC": "1", "DX": "19910101", "UI": "D005935"}, {"RECTYPE": "D", "MH": "Glucans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polyglucoses|T109|NON|EQV|UNK (19XX)|771215|abcdef", "ENTRY": "Polymer, Glucose", "MN": "D09.698.365", "MH_TH": "NLM (1979)", "ST": "T109", "RN": "0", "PI": "Polysaccharides (1966-1978)", "MS": "Polysaccharides composed of repeating glucose units. They can consist of branched or unbranched chains in any linkages.", "PM": "79", "HN": "79", "MR": "20200527", "DA": "19771215", "DC": "1", "DX": "19790101", "UI": "D005936"}, {"RECTYPE": "D", "MH": "Glucaric Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetrahydroxyadipic Acid|T109|NON|EQV|UNK (19XX)|750715|abcdef", "ENTRY": "Tetrahydrate, Calcium Saccharate", "MN": "D09.811.295", "MH_TH": "NLM (1976)", "ST": "T109", "N1": "Glucaric acid", "RN": "QLZ991V4A2", "RR": "SST07NLK7J", "PI": "Sugar Acids (1974)", "MS": "A sugar acid derived from D-glucose in which both the aldehydic carbon atom and the carbon atom bearing the primary hydroxyl group are oxidized to carboxylic acid groups.", "PM": "91; was see under SUGAR ACIDS 1976-90", "HN": "91(76); was see under SUGAR ACIDS 1976-90", "MR": "20130708", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D005937"}, {"RECTYPE": "D", "MH": "Glucocorticoids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Glucorticoid", "MN": "D27.505.696.399.472.488", "FX": "Receptors, Glucocorticoid", "MH_TH": "NLM (1967)", "ST": "T125", "RN": "0", "AN": "note entry term GLUCOCORTICOID EFFECT: use only for the glucocorticoid effect of a chemical substance", "PI": "Adrenal Cortex Hormones (1966)", "MS": "A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.", "PM": "67", "HN": "67", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D005938"}, {"RECTYPE": "D", "MH": "Glucokinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.913.696.620.250", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "ATP:D-glucose 6-phosphotransferase", "RN": "EC 2.7.1.2", "RR": "9001-36-9 (CAS RN)", "MS": "A group of enzymes that catalyzes the conversion of ATP and D-glucose to ADP and D-glucose 6-phosphate. They are found in invertebrates and microorganisms, and are highly specific for glucose. (Enzyme Nomenclature, 1992) EC 2.7.1.2.", "PM": "65; was see under HEXOKINASE 1963-64", "HN": "65; was see under HEXOKINASE 1963-64", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005941"}, {"RECTYPE": "D", "MH": "Gluconates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Gluconate, Copper", "MN": "D09.811.308", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "RR": "RV823G6G67", "AN": "do not confuse with GLUCURONATES", "MS": "Derivatives of gluconic acid (the structural formula HOCH2(CHOH)4COOH), including its salts and esters.", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005942"}, {"RECTYPE": "D", "MH": "Gluconeogenesis", "AQ": "DE ES GE IM PH RE", "MN": "G03.191.500", "MH_TH": "NLM (1965)", "ST": "T044", "MS": "Biosynthesis of GLUCOSE from nonhexose or non-carbohydrate precursors, such as LACTATE; PYRUVATE; ALANINE; and GLYCEROL.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D005943"}, {"RECTYPE": "D", "MH": "Glucosamine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Glucosamine", "MN": "D09.067.342.531", "MH_TH": "USAN (19XX)", "ST": "T109", "N1": "D-Glucose, 2-amino-2-deoxy-", "RN": "N08U5BOQ1K", "RR": "3416-24-8 (Glucosamine)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005944"}, {"RECTYPE": "D", "MH": "Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)", "DS": "GLUTAMINE FRUCTOSE PHOSPHATE TRANSAMINASE ISOMERIZING 06", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hexosephosphate Aminotransferase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Ketol-Isomerase, 2-Amino-2-Deoxy-D-Glucose-6-Phosphate", "MN": "D08.811.913.477.700.500", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Glutamine:D-fructose-6-phosphate aminotransferase (hexose-isomerizing)", "RN": "EC 2.6.1.16", "RR": "9030-45-9 (CAS RN)", "PI": "Glutamine (1970-1974)", "MS": "An enzyme that catalyzes the synthesis of fructose-6-phosphate plus GLUTAMINE from GLUTAMATE plus glucosamine-6-phosphate.", "PM": "98; see GLUCOSAMINEPHOSPHATE ISOMERASE (GLUTAMINE-FORMING) 1991-97; see AMINOTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20080708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005945"}, {"RECTYPE": "D", "MH": "Glucose", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU", "PRINT ENTRY": "Dextrose|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|USP (19XX)|740330|abbcdeeef", "ENTRY": "Monohydrate, Glucose", "MN": "D09.947.875.359.448", "PA": "Sweetening Agents", "FX": "Hypoglycemia", "EC": "urine:Glycosuria", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "D-Glucose", "RN": "IY9XDZ35W2", "RR": "LX22YL083G", "MS": "A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.", "OL": "use GLUCOSE to search GLUCOSE INJECTION 1966", "PM": "/metabolism was GLUCOSE METABOLISM 1965; GLUCOSE INJECTION was heading 1963-66", "HN": "/metabolism was GLUCOSE METABOLISM 1965; GLUCOSE INJECTION was heading 1963-66", "MR": "20230526", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D005947"}, {"RECTYPE": "D", "MH": "Glucose Dehydrogenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glucose Oxidoreductases|T116|T126|NON|EQV|UNK (19XX)|770517|abbcdef", "ENTRY": "Oxidoreductases, Glucose", "MN": "D08.811.682.047.150.270", "MH_TH": "NLM (1978)", "ST": "T126", "RN": "EC 1.1.1.-", "PI": "Alcohol Oxidoreductases (1966-1977)", "MS": "D-Glucose:1-oxidoreductases. Catalyzes the oxidation of D-glucose to D-glucono-gamma-lactone and reduced acceptor. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.47; EC 1.1.1.118; EC 1.1.1.119 and EC 1.1.99.10.", "PM": "91; was see under CARBOHYDRATE DEHYDROGENASES 1978-90", "HN": "91(78); was see under CARBOHYDRATE DEHYDROGENASES 1978-90", "MR": "20060705", "DA": "19770517", "DC": "1", "DX": "19910101", "UI": "D005948"}, {"RECTYPE": "D", "MH": "Glucose Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Glucose", "MN": "D08.811.682.047.239", "MH_TH": "NLM (1964)", "ST": "T126", "N1": "beta-D-Glucose:oxygen 1-oxidoreductase", "RN": "EC 1.1.3.4", "MS": "An enzyme of the oxidoreductase class that catalyzes the conversion of beta-D-glucose and oxygen to D-glucono-1,5-lactone and peroxide. It is a flavoprotein, highly specific for beta-D-glucose. The enzyme is produced by Penicillium notatum and other fungi and has antibacterial activity in the presence of glucose and oxygen. It is used to estimate glucose concentration in blood or urine samples through the formation of colored dyes by the hydrogen peroxide produced in the reaction. (From Enzyme Nomenclature, 1992) EC 1.1.3.4.", "PM": "64", "HN": "64", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D005949"}, {"RECTYPE": "D", "MH": "Glucose Solution, Hypertonic", "DE": "GLUCOSE SOL HYPERTONIC", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Hypertonic Solution, Glucose|T109|T121|NON|EQV|NLM (1990)|881206|HYPERTONIC SOL GLUCOSE|abbcdefv", "ENTRY": "Solutions, Hypertonic Glucose", "MN": "D26.776.314.420", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Hypertonic Solutions (1969-1974)", "MS": "Solution that is usually 10 percent glucose but may be higher. An isotonic solution of glucose is 5 percent.", "PM": "90; was see under GLUCOSE 1975-89", "HN": "90(75); was see under GLUCOSE 1975-89", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19900101", "UI": "D005950"}, {"RECTYPE": "D", "MH": "Glucose Tolerance Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Glucose Tolerance, Oral", "MN": "E05.200.124.100.355", "MH_TH": "NLM (1963)", "ST": "T060", "AN": "NIM", "MS": "A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg).", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005951"}, {"RECTYPE": "D", "MH": "Glucose-6-Phosphatase", "DS": "GLUCOSE PHOSPHATASE A 06", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glucosephosphatase|T116|T126|NON|BRD|NLM (1994)|921116|abbcdef", "ENTRY": "Glucose 6 Phosphatase", "MN": "D08.811.277.352.650.225", "EC": "deficiency:Glycogen Storage Disease Type I", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "D-Glucose-6-phosphate phosphohydrolase", "RN": "EC 3.1.3.9", "RR": "9001-39-2 (CAS RN)", "MS": "An enzyme that catalyzes the conversion of D-glucose 6-phosphate and water to D-glucose and orthophosphate. EC 3.1.3.9.", "OL": "use GLUCOSE-6-PHOSPHATASE to search GLUCOSEPHOSPHATASE 1966-93", "PM": "94; was GLUCOSEPHOSPHATASE 1965-93; was GLUCOSE PHOSPHATASES 1964", "HN": "94; was GLUCOSEPHOSPHATASE 1965-93; was GLUCOSE PHOSPHATASES 1964", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005952"}, {"RECTYPE": "D", "MH": "Glycogen Storage Disease Type I", "DE": "GLYCOGEN STORAGE DIS I", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "von Gierke Disease|T047|EPO|EQV|GHR (2014)|NLM (2009)|ORD (2010)|070823|abcdeeef", "ENTRY": "von Gierkes Disease", "MN": "C18.452.648.202.449.448", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.", "PM": "1989; see GLUCOSEPHOSPHATASE DEFICIENCY 1964-1988; for VON GIERKE'S DISEASE see GLYCOGENOSIS 1963-64", "HN": "1989; use GLUCOSEPHOSPHATASE DEFICIENCY 1964-1988; for VON GIERKE'S DISEASE use GLYCOGENOSIS 1963-1964", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005953"}, {"RECTYPE": "D", "MH": "Glucosephosphate Dehydrogenase", "DE": "GPD", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glucose-6-Phosphate Dehydrogenase|T116|T126|NON|EQV|NLM (1988)|881129|GLUCOSE PHOSPHATE DEHYDROGENASE 06|abbcdefs", "ENTRY": "Glucose 6 Phosphate Dehydrogenase", "MN": "D08.811.682.047.150.300", "EC": "deficiency:Glucosephosphate Dehydrogenase Deficiency", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "D-Glucose-6-phosphate:NADP+ 1-oxidoreductase", "RN": "EC 1.1.1.49", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005954"}, {"RECTYPE": "D", "MH": "Glucosephosphate Dehydrogenase Deficiency", "DE": "GPD DEFIC", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Glucose-6-Phosphate Dehydrogenase Deficiencies", "MN": "C18.452.648.202.402", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D005955"}, {"RECTYPE": "D", "MH": "Glucose-6-Phosphate Isomerase", "DS": "GLUCOSE PHOSPHATE ISOMERASE 06", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphohexose Isomerase|T116|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Tumor Cell Autocrine Motility Factor", "MN": "D08.811.399.475.200.350", "EC": "deficiency:Anemia, Hemolytic, Congenital Nonspherocytic", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "D-Glucose-6-phosphate ketol-isomerase", "RN": "EC 5.3.1.9", "RR": "EC 5.3.1.9", "MS": "An aldose-ketose isomerase that catalyzes the reversible interconversion of glucose 6-phosphate and fructose 6-phosphate. In prokaryotic and eukaryotic organisms it plays an essential role in glycolytic and gluconeogenic pathways. In mammalian systems the enzyme is found in the cytoplasm and as a secreted protein. This secreted form of glucose-6-phosphate isomerase has been referred to as autocrine motility factor or neuroleukin, and acts as a cytokine which binds to the AUTOCRINE MOTILITY FACTOR RECEPTOR. Deficiency of the enzyme in humans is an autosomal recessive trait, which results in CONGENITAL NONSPHEROCYTIC HEMOLYTIC ANEMIA.", "PM": "1998; see GLUCOSEPHOSPHATE ISOMERASE 1965-1997; for AUTOCRINE MOTILITY FACTOR see AUTOCRINE MOTILITY FACTOR 1992-2011; for NEUROLEUKIN see NEUROLEUKIN 1990-2011", "HN": "1998(1965)", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005956"}, {"RECTYPE": "D", "MH": "UTP-Glucose-1-Phosphate Uridylyltransferase", "DS": "UTP GLUCOSE PHOSPHATE URIDYLYLTRANSFERASE 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "UDP Glucose Pyrophosphorylase|T116|T126|EQV|UNK (19XX)|750208|abbdef", "ENTRY": "Uridylyltransferase, UTP-Glucose-1-Phosphate", "MN": "D08.811.913.696.445.875", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "UTP:alpha-D-glucose-1-phosphate uridylyltransferase", "RN": "EC 2.7.7.9", "RR": "9026-22-6 (CAS RN)", "PI": "Uridine Diphosphate Sugars (1973-1974)", "MS": "An enzyme that catalyzes the formation of UDPglucose from UTP plus glucose 1-phosphate. EC 2.7.7.9.", "PM": "98; see GLUCOSEPHOSPHATE URIDYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005957"}, {"RECTYPE": "D", "MH": "Glucosephosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.894.417.448", "MH_TH": "NLM (1971)", "ST": "T123", "RN": "0", "PI": "Hexosephosphates (1966-1971)", "PM": "73", "HN": "73(71)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005958"}, {"RECTYPE": "D", "MH": "Glucosidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glucosidase|T116|T126|NON|EQV|UNK (19XX)|760905|abbcdef", "MN": "D08.811.277.450.420", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.2.1.-", "MS": "Enzymes that hydrolyze O-glucosyl-compounds. (Enzyme Nomenclature, 1992) EC 3.2.1.-.", "OL": "use GLUCOSIDASES to search GLUCOSIDASE 1966-74", "PM": "75; was GLUCOSIDASE 1963-74", "HN": "75; was GLUCOSIDASE 1963-74", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D005959"}, {"RECTYPE": "D", "MH": "Glucosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glucoside|T109|NON|EQV|NLM (2021)|191121|abcdef", "MN": "D09.408.348", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with GLYCOSIDES", "MS": "A GLYCOSIDE that is derived from GLUCOSE.", "OL": "search GLYCOSIDES 1966-74", "PM": "91; was see under GLYCOSIDES 1975-90", "HN": "91(75); was see under GLYCOSIDES 1975-90", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005960"}, {"RECTYPE": "D", "MH": "Glucosinolates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glucosinolate|T109|T123|NON|EQV|NLM (2021)|191219|abbcdef", "MN": "D09.408.903.703.350", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "PI": "Thioglycosides (1974)", "MS": "Substituted thioglucosides. They are found in rapeseed (Brassica campestris) products and related cruciferae. They are metabolized to a variety of toxic products which are most likely the cause of hepatocytic necrosis in animals and humans.", "PM": "91; was see under THIOGLYCOSIDES 1979-90", "HN": "91(79); was see under THIOGLYCOSIDES 1979-90", "MR": "20200527", "DA": "19780518", "DC": "1", "DX": "19910101", "UI": "D005961"}, {"RECTYPE": "D", "MH": "Glucosylceramidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glucocerebrosidase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "beta-Glucosidase, Glucosylceramide", "MN": "D08.811.277.450.420.412", "FX": "Gaucher Disease", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "D-Glucosyl-N-acylsphingosine glucosylhydrolase", "RN": "EC 3.2.1.45", "AN": "/defic: consider also GAUCHER DISEASE", "PI": "Glycoside Hydrolases (1970-1974)", "MS": "A glycosidase that hydrolyzes a glucosylceramide to yield free ceramide plus glucose. Deficiency of this enzyme leads to abnormally high concentrations of glucosylceramide in the brain in GAUCHER DISEASE. EC 3.2.1.45.", "PM": "91; was see under GLUCOSIDASES 1975-90", "HN": "91(75); was see under GLUCOSIDASES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005962"}, {"RECTYPE": "D", "MH": "Glucosylceramides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glucosylceramide|T109|T123|NON|EQV|NLM (2021)|191227|abbcdef", "ENTRY": "Ceramides, Glucosyl", "MN": "D10.570.877.360.612.200.250.490", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "PI": "Glycosphingolipids (1975-1978)", "MS": "Cerebrosides which contain as their polar head group a glucose moiety bound in glycosidic linkage to the hydroxyl group of ceramides. Their accumulation in tissue, due to a defect in beta-glucosidase, is the cause of Gaucher's disease.", "PM": "91; was see under CEREBROSIDES 1979-90", "HN": "91(79); was see under CEREBROSIDES 1979-90", "MR": "20200527", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D005963"}, {"RECTYPE": "D", "MH": "Glucosyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glucosyltransferase|T116|T126|NON|EQV|NLM (2021)|191115|abbcdef", "MN": "D08.811.913.400.450.460", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 2.4.1.-", "MS": "Enzymes that catalyze the transfer of glucose from a nucleoside diphosphate glucose to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005964"}, {"RECTYPE": "D", "MH": "Glucuronates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glucosiduronates|T109|T123|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Acids, Glucuronic", "MN": "D09.811.922.162", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "do not confuse with GLUCONATES", "MS": "Derivatives of GLUCURONIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the 6-carboxy glucose structure.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005965"}, {"RECTYPE": "D", "MH": "Glucuronidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Glucuronidase", "MN": "D08.811.277.450.426", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "beta-D-Glucuronoside glucuronosohydrolase", "RN": "EC 3.2.1.31", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005966"}, {"RECTYPE": "D", "MH": "Glue Proteins, Drosophila", "DE": "DME GLUE PROTEINS", "AQ": "AD AE AG AI AN BI BL CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Drosophila Glue Proteins|T116|T123|NON|EQV|UNK (19XX)|870505|abbcdef", "ENTRY": "Proteins, Drosophila Glue", "MN": "D12.776.850.400", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "Salivary Proteins (1977-1987)", "MS": "Glycosylated proteins which are part of the salivary glue that Drosophila larvae secrete as a means of fixing themselves to an external substrate for the duration of the pre-pupal and pupal period.", "PM": "91; was see under SALIVARY PROTEINS 1988-90", "HN": "91(88); was see under SALIVARY PROTEINS 1988-90", "MR": "20150618", "DA": "19870505", "DC": "1", "DX": "19910101", "UI": "D005967"}, {"RECTYPE": "D", "MH": "Glutamate Decarboxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glutamate Carboxy-Lyase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Glutamate Carboxy Lyase", "MN": "D08.811.520.224.125.250", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Glutamate-1-carboxy-lyase", "RN": "EC 4.1.1.15", "PI": "Glutamates (1973-1974)", "MS": "A pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GAMMA-AMINOBUTYRIC ACID levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate, and L-aspartate. EC 4.1.1.15.", "PM": "84; was see under CARBOXY-LYASES 1975-83", "HN": "84(75); was see under CARBOXY-LYASES 1975-83", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D005968"}, {"RECTYPE": "D", "MH": "Glutamate Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, Glutamate", "MN": "D08.811.682.664.500.398", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "L-Glutamate:NAD+ oxidoreductase (deaminating)", "RN": "EC 1.4.1.2", "RR": "9001-46-1 (CAS RN)", "MS": "An enzyme that catalyzes the conversion of L-glutamate and water to 2-oxoglutarate and NH3 in the presence of NAD+. (From Enzyme Nomenclature, 1992) EC 1.4.1.2.", "PM": "65", "HN": "65", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005969"}, {"RECTYPE": "D", "MH": "Glutamate Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ketoglutarate Glutamine Amidotransferase|T116|T126|NON|EQV|UNK (19XX)|750206|abbcdef", "ENTRY": "Synthase, Glutamate", "MN": "D08.811.913.477.700.470", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Glutamate:NADP+ oxidoreductase (transaminating)", "RN": "EC 1.4.1.13", "PI": "NADP (1974)", "MS": "An enzyme that catalyzes the formation of 2 molecules of glutamate from glutamine plus alpha-ketoglutarate in the presence of NADPH. EC 1.4.1.13.", "PM": "91; was see under AMINOTRANSFERASES 1975-90", "HN": "91(75); was see under AMINOTRANSFERASES 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005970"}, {"RECTYPE": "D", "MH": "Glutamates", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Glutaminic Acids|T116|NON|REL|UNK (19XX)|800730|abcdef", "MN": "D12.125.119.409", "FX": "Receptors, Glutamate", "EC": "antagonists & inhibitors:Excitatory Amino Acid Antagonists", "MH_TH": "NLM (1966)", "ST": "T116", "RN": "0", "MS": "Derivatives of GLUTAMIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the 2-aminopentanedioic acid structure.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005971"}, {"RECTYPE": "D", "MH": "Glutaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphate Activated Glutaminase", "MN": "D08.811.277.087.483", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "L-Glutamine amidohydrolase", "RN": "EC 3.5.1.2", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005972"}, {"RECTYPE": "D", "MH": "Glutamine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L Glutamine", "MN": "D12.125.154.424", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "Glutamine", "RN": "0RH81L854J", "RR": "6899-04-3 (without isomeric designation)", "AN": "/biosyn /physiol permitted", "MS": "A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005973"}, {"RECTYPE": "D", "MH": "Glutamate-Ammonia Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glutamine Synthetase|T116|T126|NON|EQV|NLM (1995)|931118|abbcdef", "ENTRY": "Synthetase, Glutamine", "MN": "D08.811.464.259.200.600", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "L-Glutamate:ammonia ligase (ADP-forming)", "RN": "EC 6.3.1.2", "RR": "9023-70-5 (CAS RN)", "PI": "Ligases (1966-1971)", "MS": "An enzyme that catalyzes the conversion of ATP, L-glutamate, and NH3 to ADP, orthophosphate, and L-glutamine. It also acts more slowly on 4-methylene-L-glutamate. (From Enzyme Nomenclature, 1992) EC 6.3.1.2.", "OL": "use GLUTAMATE-AMMONIA LIGASE to search GLUTAMINE SYNTHETASE 1972-94", "PM": "95; was GLUTAMINE SYNTHETASE 1972-94", "HN": "95; was GLUTAMINE SYNTHETASE 1972-94", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D005974"}, {"RECTYPE": "D", "MH": "Glutamate-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glutamyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961105|abbdef", "ENTRY": "Synthetase, Glutamyl-tRNA", "MN": "D08.811.464.263.200.250", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Glutamate:tRNA(Glu) ligase (AMP-forming)", "RN": "EC 6.1.1.17", "PI": "Glutamates (1972-1974)", "MS": "An enzyme that activates glutamic acid with its specific transfer RNA. EC 6.1.1.17.", "PM": "98; see GLUTAMYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005975"}, {"RECTYPE": "D", "MH": "Glutaral", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glutaraldehyde|T109|T130|NON|EQV|FDA SRS (2014)|NLM (1992)|910405|abbcdeef", "ENTRY": "Sporicidin|T109|T130|TRD|NRW|UNK (19XX)|831209|abbcdef", "MN": "D02.047.532", "PA": "Fixatives", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "Pentanedial", "RN": "T3C89M417N", "RR": "111-30-8 (Glutaral)", "MS": "One of the protein CROSS-LINKING REAGENTS that is used as a disinfectant for sterilization of heat-sensitive equipment and as a laboratory reagent, especially as a fixative.", "OL": "use GLUTARAL to search GLUTARALDEHYDE 1973-91", "PM": "92; was GLUTARALDEHYDE 1973-91 (see under ALDEHYDES 1973-90)", "HN": "92; was GLUTARALDEHYDE 1973-91 (see under ALDEHYDES 1973-90)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D005976"}, {"RECTYPE": "D", "MH": "Glutarates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glutarate|T109|NON|EQV|NLM (2021)|200225|abcdef", "MN": "D02.241.081.337.351", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of glutaric acid (the structural formula (COO-)2C3H6), including its salts and esters.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005977"}, {"RECTYPE": "D", "MH": "Glutathione", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "gamma L Glutamyl L Cysteinylglycine", "MN": "D12.644.456.448", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)-", "RN": "GAN16C9B8O", "RR": "70-18-8 (Glutathione)", "MS": "A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005978"}, {"RECTYPE": "D", "MH": "Glutathione Peroxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytosolic Glutathione Peroxidase|T116|T126|NON|EQV|NLM (2020)|190502|abbcdef", "ENTRY": "Peroxidase, Selenoglutathione", "MN": "D12.776.864.050", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Glutathione:hydrogen-peroxide oxidoreductase", "RN": "EC 1.11.1.9", "PI": "Peroxidases (1968-1974)", "MS": "An enzyme catalyzing the oxidation of 2 moles of GLUTATHIONE in the presence of HYDROGEN PEROXIDE to yield oxidized glutathione and water.", "PM": "84; was see under PEROXIDASES 1975-83", "HN": "84(75); was see under PEROXIDASES 1975-83", "MR": "20220712", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D005979"}, {"RECTYPE": "D", "MH": "Glutathione Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase, Glutathione-Disulfide", "MN": "D08.811.682.667.092", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "NADPH:oxidized-glutathione oxidoreductase", "RN": "EC 1.8.1.7", "MS": "Catalyzes the oxidation of GLUTATHIONE to GLUTATHIONE DISULFIDE in the presence of NADP+. Deficiency in the enzyme is associated with HEMOLYTIC ANEMIA. Formerly listed as EC 1.6.4.2.", "PM": "65", "HN": "65", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005980"}, {"RECTYPE": "D", "MH": "Glutathione Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glutathione Synthetase|T116|T126|NON|EQV|NLM (1998)|961106|abbcdef", "ENTRY": "Synthetase, Glutathione", "MN": "D08.811.464.259.850.500", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "gamma-L-Glutamyl-L-cysteine:glycine ligase (ADP-forming)", "RN": "EC 6.3.2.3", "RR": "9023-62-5 (CAS RN)", "PI": "Peptide Synthetases (1973-1976)", "MS": "One of the enzymes active in the gamma-glutamyl cycle. It catalyzes the synthesis of glutathione from gamma-glutamylcysteine and glycine in the presence of ATP with the formation of ADP and orthophosphate. EC 6.3.2.3.", "PM": "98; see GLUTATHIONE SYNTHETASE 1991-97; see PEPTIDE SYNTHETASES 1977-90", "HN": "98(77)", "MR": "20030709", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D005981"}, {"RECTYPE": "D", "MH": "Glutathione Transferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "S-Hydroxyalkyl Glutathione Lyase|T116|T126|NON|EQV|UNK (19XX)|760626|HYDROXYALKYL GLUTATHIONE LYASE S|abbcdefs", "ENTRY": "Transferases, Glutathione", "MN": "D08.811.913.225.500", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "RX:glutathione R-transferase", "RN": "EC 2.5.1.18", "RR": "50812-37-8 (CAS RN)", "PI": "Transferases (1970-1976)", "MS": "A transferase that catalyzes the addition of aliphatic, aromatic, or heterocyclic FREE RADICALS as well as EPOXIDES and arene oxides to GLUTATHIONE. Addition takes place at the SULFUR. It also catalyzes the reduction of polyol nitrate by glutathione to polyol and nitrite.", "PM": "1977; see CARRIER PROTEINS & TRANSFERASES 1975-1976", "HN": "1977; use CARRIER PROTEINS & TRANSFERASES 1975-1976", "MR": "20050630", "DA": "19760419", "DC": "1", "DX": "19770101", "UI": "D005982"}, {"RECTYPE": "D", "MH": "Glutens", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gluten Protein|T116|T123|NON|EQV|NLM (2021)|200522|abbcdef", "ENTRY": "Protein, Gluten", "MN": "D12.776.765.725.500.500", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "8002-80-0", "MS": "Prolamins in the endosperm of SEEDS from the Triticeae tribe which includes species of WHEAT; BARLEY; and RYE.", "PM": "2009; see GLUTEN 1963-2008", "HN": "2009 (1963)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D005983"}, {"RECTYPE": "D", "MH": "Glutethimide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Noxiron|T109|T121|TRD|NRW|UNK (19XX)|831209|abbcdef", "MN": "D03.383.621.808.425", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,6-Piperidinedione, 3-ethyl-3-phenyl-", "RN": "C8I4BVN78E", "RR": "77-21-4 (Glutethimide)", "MS": "A hypnotic and sedative. Its use has been largely superseded by other drugs.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005984"}, {"RECTYPE": "D", "MH": "Glyceraldehyde", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D09.947.875.894.449", "MH_TH": "NLM (1966)", "ST": "T109", "N1": "Propanal, 2,3-dihydroxy-", "RN": "367-47-5", "MS": "An aldotriose containing the propionaldehyde structure with hydroxy groups at the 2- and 3-positions. It is involved in the formation of ADVANCED GLYCOSYLATION END PRODUCTS.", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005985"}, {"RECTYPE": "D", "MH": "Glyceraldehyde 3-Phosphate", "DS": "GLYCERALDEHYDEPHOSPHATE A 03", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "3-Phosphoglyceraldehyde|T109|T123|NON|EQV|UNK (19XX)|790221|PHOSPHOGLYCERALDEHYDE A 03|abbcdefs", "ENTRY": "Glyceraldehyde 3 Phosphate", "MN": "D02.047.587.450", "MH_TH": "NLM (1980)", "ST": "T123", "N1": "Propanal, 2-hydroxy-3-(phosphonooxy)-", "RN": "142-10-9", "AN": "/physiol permitted", "PI": "Glyceraldehyde (1966-1974) /AA (1975-1979)", "MS": "An aldotriose which is an important intermediate in glycolysis and in tryptophan biosynthesis.", "PM": "91; was see under GLYCERALDEHYDE 1980-90", "HN": "91(80); was see under GLYCERALDEHYDE 1980-90", "MR": "20170410", "DA": "19790221", "DC": "1", "DX": "19910101", "UI": "D005986"}, {"RECTYPE": "D", "MH": "Glyceraldehyde-3-Phosphate Dehydrogenases", "DS": "GLYCERALDEHYDEPHOSPHATE DES 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Triosephosphate Dehydrogenase|T116|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Glyceraldehyde 3 Phosphate Dehydrogenase", "MN": "D08.811.682.657.163.750", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "D-Glyceraldehyde-3-phosphate:NADP+ oxidoreductase", "RN": "EC 1.2.1.-", "AN": "general or unspecified; prefer specifics", "MS": "Enzymes that catalyze the dehydrogenation of GLYCERALDEHYDE 3-PHOSPHATE. Several types of glyceraldehyde-3-phosphate-dehydrogenase exist including phosphorylating and non-phosphorylating varieties and ones that transfer hydrogen to NADP and ones that transfer hydrogen to NAD.", "PM": "1999; see GLYCERALDEHYDEPHOSPHATE DEHYDROGENASE 1965-1998", "HN": "1999(1965)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005987"}, {"RECTYPE": "D", "MH": "Glyceric Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Glyceric", "MN": "D09.811.366", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Three-carbon SUGAR ACIDS with the formula HOCH2(CHOH)COOH.", "PM": "68", "HN": "68", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D005988"}, {"RECTYPE": "D", "MH": "Glycerides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Acylglycerols|T109|NON|EQV|NLM (2006)|040923|abcdef", "MN": "D10.351", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "GLYCEROL esterified with FATTY ACIDS.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005989"}, {"RECTYPE": "D", "MH": "Glycerol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycerin|T109|T121|T123|NON|EQV|FDA SRS (2014)|NLM (1998)|USP (19XX)|970429|abbbcdeeef", "ENTRY": "Glycerine|T109|T121|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|841002|abbbcdeef", "MN": "D09.853.875.500", "PA": "Solvents", "MH_TH": "INN (19XX)", "ST": "T123", "RN": "PDC6A3C0OX", "RR": "56-81-5 (Glycerol)", "MS": "A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, or sweetening agent.", "PM": "98; see GLYCERIN 1963-97; for GLYCEROL see GLYCERIN 1976-97", "HN": "98", "MR": "20200723", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D005990"}, {"RECTYPE": "D", "MH": "Glycerol Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glycerokinase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Kinase, Glycerol", "MN": "D08.811.913.696.620.275", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "ATP:glycerol 3-phosphotransferase", "RN": "EC 2.7.1.30", "RR": "9030-66-4 (CAS RN)", "PI": "Phosphotransferases, ATP (1974)", "MS": "An enzyme that catalyzes the formation of glycerol 3-phosphate from ATP and glycerol. Dihydroxyacetone and L-glyceraldehyde can also act as acceptors; UTP and, in the case of the yeast enzyme, ITP and GTP can act as donors. It provides a way for glycerol derived from fats or glycerides to enter the glycolytic pathway. EC 2.7.1.30.", "PM": "91; was see under PHOSPHOTRANSFERASES, ATP 1975-90", "HN": "91(75); was see under PHOSPHOTRANSFERASES, ATP 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005991"}, {"RECTYPE": "D", "MH": "Glycerol-3-Phosphate O-Acyltransferase", "DS": "GLYCEROL PHOSPHATE ACYLTRANSFERASE O 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stearyl-CoA Glycerophosphate Transstearylase|T116|T126|EQV|UNK (19XX)|741111|abbdef", "ENTRY": "Transstearylase, Stearyl-CoA Glycerophosphate", "MN": "D08.811.913.050.425", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Acyl-CoA:sn-glycerol-3-phosphate 1-O-acyltransferase", "RN": "EC 2.3.1.15", "RR": "9029-96-3 (CAS RN)", "PI": "Glycerophosphates (1972-1974)", "MS": "An enzyme that transfers acyl groups from acyl-CoA to glycerol-3-phosphate to form monoglyceride phosphates. It acts only with CoA derivatives of fatty acids of chain length above C-10. Also forms diglyceride phosphates. EC 2.3.1.15.", "PM": "98; see GLYCEROLPHOSPHATE ACYLTRANSFERASE 1991-97; see ACYLTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D005992"}, {"RECTYPE": "D", "MH": "Glycerolphosphate Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Glycerophosphate", "MN": "D08.811.682.047.150.700.400", "MH_TH": "NLM (1965)", "ST": "T126", "RN": "EC 1.1.-", "PM": "65", "HN": "65", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D005993"}, {"RECTYPE": "D", "MH": "Glycerophosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycerophosphate|T109|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Glycerophosphate, Calcium", "MN": "D10.570.755.375", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Any salt or ester of glycerophosphoric acid.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005994"}, {"RECTYPE": "D", "MH": "Glyceryl Ethers", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycerol Ethers|T109|NON|EQV|UNK (19XX)|870323|abcdef", "ENTRY": "Glyceryl Ethers, Alkyl", "MN": "D02.355.460", "MH_TH": "NLM (1988)", "ST": "T109", "RN": "0", "PI": "Glycerin/analogs & derivatives (1975-1987)", "MS": "Compounds in which one or more of the three hydroxyl groups of glycerol are in ethereal linkage with a saturated or unsaturated aliphatic alcohol; one or two of the hydroxyl groups of glycerol may be esterified. These compounds have been found in various animal tissue.", "PM": "88", "HN": "88", "MR": "20170410", "DA": "19870323", "DC": "1", "DX": "19880101", "UI": "D005995"}, {"RECTYPE": "D", "MH": "Nitroglycerin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glyceryl Trinitrate|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1992)|910115|abbcdeef", "ENTRY": "Trinitrate, Glyceryl", "MN": "D02.640.636", "PA": "Vasodilator Agents", "FX": "Nitro Compounds", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,2,3-Propanetriol, trinitrate", "RN": "G59M7S0WS3", "RR": "55-63-0 (Nitroglycerin)", "MS": "A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.", "OL": "use NITROGLYCERIN to search GLYCERYL TRINITRATE 1966-91", "PM": "92; was GLYCERYL TRINITRATE 1963-91; NITROGLYCERIN was see GLYCERYL TRINITRATE 1963-91", "HN": "92; was GLYCERYL TRINITRATE 1963-91; NITROGLYCERIN was see GLYCERYL TRINITRATE 1963-91", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D005996"}, {"RECTYPE": "D", "MH": "Glycerylphosphorylcholine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Choline Glycerophosphate|T109|T123|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "L alpha Glycerylphosphorylcholine", "MN": "D10.570.755.375.760.400.800.806.500", "MH_TH": "NLM (1964)", "ST": "T123", "N1": "Ethanaminium, 2-(((2,3-dihydroxypropoxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, inner salt", "RN": "60M22SGW66", "RR": "563-24-6 (Glycerylphosphorylcholine)", "MS": "A component of PHOSPHATIDYLCHOLINES or LECITHINS, in which the two hydroxy groups of GLYCEROL are esterified with fatty acids. (From Stedman, 26th ed)", "PM": "73", "HN": "73(64)", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D005997"}, {"RECTYPE": "D", "MH": "Glycine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycine, Monopotassium Salt|T116|NON|NRW|NLM (2020)|190501|abcdef", "ENTRY": "Salt Glycine, Monosodium", "MN": "D12.125.481", "PA": "Glycine Agents", "FX": "Receptors, Glycine", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "2-aminoacetic acid", "RN": "TE7660XO1C", "RR": "F6B979BV8Z", "MS": "A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D005998"}, {"RECTYPE": "D", "MH": "Glycochenodeoxycholic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycochenodeoxycholate|T109|T116|T121|NON|NRW|UNK (19XX)|770224|abbbcdef", "ENTRY": "Chenodeoxycholate, Glycine", "MN": "D12.125.481.700.249.420.400", "PA": "Detergents", "MH_TH": "NLM (1978)", "ST": "T121", "N1": "Glycine, N-((3alpha,5beta,7alpha)-3,7-dihydroxy-24-oxocholan-24-yl)-", "RN": "640-79-9", "AN": "a bile acid; /biosyn /physiol permitted", "PI": "Glycocholic Acid (1973-1977)", "MS": "A bile salt formed in the liver from chenodeoxycholate and glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic.", "PM": "91; was see under CHENODEOXYCHOLIC ACID 1978-90", "HN": "91(78); was see under CHENODEOXYCHOLIC ACID 1978-90", "MR": "20160531", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D005999"}, {"RECTYPE": "D", "MH": "Glycocholic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycocholate|T109|T121|T123|NON|NRW|UNK (19XX)|770208|abbbcdef", "ENTRY": "Glycocholic Acid, Sodium Salt|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2004)|030219|abbcdeef", "MN": "D12.125.481.700.249", "PA": "Detergents", "MH_TH": "NLM (1973)", "ST": "T123", "N1": "Glycine, N-((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)-", "RN": "G59NX3I3RT", "RR": "V06CXA1W3K", "MS": "The glycine conjugate of CHOLIC ACID. It acts as a detergent to solubilize fats for absorption and is itself absorbed.", "PM": "78", "HN": "78(73)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D006000"}, {"RECTYPE": "D", "MH": "Glycoconjugates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycoconjugate|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D09.400", "MH_TH": "NLM (1988)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics ", "PI": "Peptidoglycan (1971-1987)", "MS": "Carbohydrates covalently linked to a nonsugar moiety (lipids or proteins). The major glycoconjugates are glycoproteins, glycopeptides, peptidoglycans, glycolipids, and lipopolysaccharides. (From Biochemical Nomenclature and Related Documents, 2d ed; From Principles of Biochemistry, 2d ed)", "PM": "88", "HN": "88", "MR": "20200527", "DA": "19870323", "DC": "1", "DX": "19880101", "UI": "D006001"}, {"RECTYPE": "D", "MH": "Glycodeoxycholic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycodeoxycholate|T109|T121|T123|NON|NRW|UNK (19XX)|770225|abbbcdef", "ENTRY": "Deoxycholate, Glycine", "MN": "D12.125.481.700.249.420", "PA": "Detergents", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Glycine, N-((3alpha,5beta,12alpha)-3,12-dihydroxy-24-oxocholan-24-yl)-", "RN": "360-65-6", "AN": "a bile acid; /biosyn /physiol permitted", "PI": "Glycocholic Acid (1973-1977)", "MS": "A bile salt formed in the liver by conjugation of deoxycholate with glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and choleretic.", "PM": "91; was see under DEOXYCHOLIC ACID 1978-90", "HN": "91(78); was see under DEOXYCHOLIC ACID 1978-90", "MR": "20160531", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D006002"}, {"RECTYPE": "D", "MH": "Glycogen", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D09.698.365.388", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Glycogen", "RN": "9005-79-2", "AN": "/metab consider also GLYCOGENOLYSIS or GLYCOGEN STORAGE DISEASE and specifics", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006003"}, {"RECTYPE": "D", "MH": "Glycogen Debranching Enzyme System", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transfer-Glucosidase|T116|T126|NON|EQV|UNK (19XX)|750630|abbcdef", "ENTRY": "Transfer Glucosidase", "MN": "D08.811.913.400.450.460.350", "FX": "Glycogen Storage Disease Type III", "MH_TH": "NLM (1976)", "ST": "T126", "RN": "0", "AN": "/defic: consider also GLYCOGEN STORAGE DISEASE TYPE III", "PI": "Glycogen (1973-1975)", "MS": "1,4-alpha-D-Glucan-1,4-alpha-D-glucan 4-alpha-D-glucosyltransferase/dextrin 6 alpha-D-glucanohydrolase. An enzyme system having both 4-alpha-glucanotransferase (EC 2.4.1.25) and amylo-1,6-glucosidase (EC 3.2.1.33) activities. As a transferase it transfers a segment of a 1,4-alpha-D-glucan to a new 4-position in an acceptor, which may be glucose or another 1,4-alpha-D-glucan. As a glucosidase it catalyzes the endohydrolysis of 1,6-alpha-D-glucoside linkages at points of branching in chains of 1,4-linked alpha-D-glucose residues. Amylo-1,6-glucosidase activity is deficient in glycogen storage disease type III.", "OL": "use GLYCOGEN DEBRANCHING ENZYME SYSTEM to search GLYCOGEN DEBRANCHING ENZYME 1976-88", "PM": "89; was GLYCOGEN DEBRANCHING ENZYME see under GLUCOSYLTRANSFERASES 1976-88", "HN": "89(76); was GLYCOGEN DEBRANCHING ENZYME see under GLUCOSYLTRANSFERASES 1976-88", "MR": "20030709", "DA": "19750721", "DC": "1", "DX": "19890101", "UI": "D006004"}, {"RECTYPE": "D", "MH": "Phosphorylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphorylase|T116|T126|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "alpha-Glucan Phosphorylases|T116|T126|NON|EQV|UNK (19XX)|810713|abbcdef", "MN": "D08.811.913.400.450.460.400", "MH_TH": "NLM (1971)", "ST": "T126", "N1": "1,4-alpha-D-Glucan:orthophosphate alpha-D-glucosyltransferase", "RN": "EC 2.4.1.-", "RR": "9035-74-9 (CAS RN)", "AN": "general or unspecified; prefer specifics", "PI": "Glucosyltransferases (1966-1970)", "MS": "A class of glucosyltransferases that catalyzes the degradation of storage polysaccharides, such as glucose polymers, by phosphorolysis in animals (GLYCOGEN PHOSPHORYLASE) and in plants (STARCH PHOSPHORYLASE).", "PM": "98; see GLYCOGEN PHOSPHORYLASE 1971-97", "HN": "98(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006005"}, {"RECTYPE": "D", "MH": "Glycogen Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glycogen Synthetase|T116|T126|NON|EQV|NLM (1992)|901231|abbcdef", "ENTRY": "UDP Glucose Glycogen Glucosyl Transferase", "MN": "D08.811.913.400.450.460.375", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "UDPglucose:glycogen 4-alpha-D-glucosyltransferase", "RN": "EC 2.4.1.11", "PI": "Glucosyltransferases (1966-1971)", "MS": "An enzyme that catalyzes the transfer of D-glucose from UDPglucose into 1,4-alpha-D-glucosyl chains. EC 2.4.1.11.", "OL": "use GLYCOGEN SYNTHASE to search GLYCOGEN SYNTHETASE 1972-91 (as Prov 1972-73)", "PM": "92; was GLYCOGEN SYNTHETASE 1974-91; GLYCOGEN SYNTHASE was see GLYCOGEN SYNTHETASE 1975-91", "HN": "92; was GLYCOGEN SYNTHETASE 1972-91 (Prov 1972-73); GLYCOGEN SYNTHASE was see GLYCOGEN SYNTHETASE 1975-91", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006006"}, {"RECTYPE": "D", "MH": "Glycogen-Synthase-D Phosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glycogen Synthetase Phosphatase|T116|T126|NON|EQV|NLM (1992)|910403|abbcdef", "ENTRY": "Synthetase Phosphatase, Glycogen", "MN": "D12.776.476.559.300", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "(UDPglucose:glycogen 4-alpha-D-glucosyltransferase-D) phosphohydrolase", "RN": "EC 3.1.3.42", "PI": "Glycogen Synthetase (1973-1974)", "MS": "An enzyme that catalyzes the conversion of phosphorylated, inactive glycogen synthase D to active dephosphoglycogen synthase I. EC 3.1.3.42.", "OL": "use GLYCOGEN-SYNTHASE-D PHOSPHATASE to search GLYCOGEN SYNTHETASE PHOSPHATASE 1975-91", "PM": "92; was GLYCOGEN SYNTHETASE PHOSPHATASE 1975-91 (see under PHOSPHOPROTEIN PHOSPHATASES 1979-90, see under PHOSPHOMONOESTERASES 1975-78)", "HN": "92; was GLYCOGEN SYNTHETASE PHOSPHATASE 1975-91 (see under PHOSPHOPROTEIN PHOSPHATASES 1979-90, see under PHOSPHOMONOESTERASES 1975-78)", "MR": "20210521", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006007"}, {"RECTYPE": "D", "MH": "Glycogen Storage Disease", "DE": "GLYCOGEN STORAGE DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Glycogenosis|T047|NON|EQV|UNK (19XX)|880531|abcdef", "ENTRY": "Storage Diseases, Glycogen", "MN": "C18.452.648.202.449", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "an inborn error of carbohydrate metab; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.", "OL": "use GLYCOGEN STORAGE DISEASE to search GLYCOGENOSIS 1966-88", "PM": "89; was GLYCOGENOSIS 1963-88", "HN": "89; was GLYCOGENOSIS 1963-88", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19890101", "UI": "D006008"}, {"RECTYPE": "D", "MH": "Glycogen Storage Disease Type II", "DE": "GLYCOGEN STORAGE DIS II", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pompe Disease|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|840615|POMPE DIS|abcdeeeefv", "ENTRY": "Type IIs, Glycogenosis", "MN": "C18.452.648.595.554.340", "FX": "Glucan 1,4-alpha-Glucosidase", "MH_TH": "NLM (1975)", "ST": "T047", "PI": "Heart Diseases (1966-1974)", "MS": "An autosomal recessively inherited glycogen storage disease caused by GLUCAN 1,4-ALPHA-GLUCOSIDASE deficiency. Large amounts of GLYCOGEN accumulate in the LYSOSOMES of skeletal muscle (MUSCLE, SKELETAL); HEART; LIVER; SPINAL CORD; and BRAIN. Three forms have been described: infantile, childhood, and adult. The infantile form is fatal in infancy and presents with hypotonia and a hypertrophic cardiomyopathy (CARDIOMYOPATHY, HYPERTROPHIC). The childhood form usually presents in the second year of life with proximal weakness and respiratory symptoms. The adult form consists of a slowly progressive proximal myopathy. (From Muscle Nerve 1995;3:S61-9; Menkes, Textbook of Child Neurology, 5th ed, pp73-4)", "PM": "1989; see GLYCOGENOSIS 1975-88", "HN": "1989(1975); use GLYCOGENOSIS 1975-1988", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19741212", "DC": "1", "DX": "19890101", "UI": "D006009"}, {"RECTYPE": "D", "MH": "Glycogen Storage Disease Type III", "DE": "GLYCOGEN STORAGE DIS III", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Limit Dextrinosis|T047|NON|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|741211|abcdeeeef", "ENTRY": "Limit Dextrinoses", "MN": "C18.452.648.202.449.520", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Liver Diseases (1966-1974)", "MS": "An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system). The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups Type IIIa and Type IIIb being the most prevalent.", "PM": "1991; see GLYCOGEN STORAGE DISEASE 1989-1990; for GLYCOGENOSIS 3 see GLYCOGENOSIS 1975-1988", "HN": "1991(1989); use GLYCOGEN STORAGE DISEASE 1989-1990; for GLYCOGENOSIS 3 use GLYCOGENOSIS 1975-1988", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D006010"}, {"RECTYPE": "D", "MH": "Glycogen Storage Disease Type IV", "DE": "GLYCOGEN STORAGE DIS IV", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Glycogenosis 4|T047|NON|EQV|ORD (2010)|UNK (19XX)|880531|GLYCOGENOSIS 04|abcdeefs", "ENTRY": "Type IV Glycogenoses", "MN": "C18.452.648.202.449.540", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "do not confuse with ANDERSEN SYNDROME, a potassium-sensitive familial periodic paralysis", "PI": "Liver Diseases (1966-1974)", "MS": "An autosomal recessive metabolic disorder due to a deficiency in expression of glycogen branching enzyme 1 (alpha-1,4-glucan-6-alpha-glucosyltransferase), resulting in an accumulation of abnormal GLYCOGEN with long outer branches. Clinical features are MUSCLE HYPOTONIA and CIRRHOSIS. Death from liver disease usually occurs before age 2.", "PM": "1991; see GLYCOGEN STORAGE DISEASE 1989-1990; for GLYCOGENOSIS 4 see GLYCOGENOSIS 1975-1988", "HN": "1991(1989); use GLYCOGEN STORAGE DISEASE 1989-1990; for GLYCOGENOSIS 4 use GLYCOGENOSIS 1975-1988", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D006011"}, {"RECTYPE": "D", "MH": "Glycogen Storage Disease Type V", "DE": "GLYCOGEN STORAGE DIS V", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "McArdle's Disease|T047|EPO|EQV|GHR (2014)|UNK (19XX)|741211|MCARDLES DIS|abcdeefv", "ENTRY": "deficiency, Myophosphorylase", "MN": "C18.452.648.202.449.560", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Muscular Diseases (1966-1974)", "MS": "Glycogenosis due to muscle phosphorylase deficiency. Characterized by painful cramps following sustained exercise.", "PM": "1989; for GLYCOGENOSIS 5 see GLYCOGENOSIS 1975-1988", "HN": "1989(1975); for GLYCOGENOSIS 5 use GLYCOGENOSIS 1975-1988", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19741212", "DC": "1", "DX": "19890101", "UI": "D006012"}, {"RECTYPE": "D", "MH": "Glycogen Storage Disease Type VI", "DE": "GLYCOGEN STORAGE DIS VI", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hers Disease|T047|EPO|EQV|GHR (2014)|NLM (2002)|010208|HERS DIS|abcdeefv", "ENTRY": "Type VI, Glycogenosis", "MN": "C18.452.648.202.449.580", "FX": "Glycogen Phosphorylase, Liver Form", "MH_TH": "NLM (1975)", "ST": "T047", "PI": "Liver Diseases (1966-1974)", "MS": "A hepatic GLYCOGEN STORAGE DISEASE in which there is an apparent deficiency of hepatic phosphorylase (GLYCOGEN PHOSPHORYLASE, LIVER FORM) activity.", "OL": "use GLYCOGEN STORAGE DISEASE TYPE VI to search GLYCOGENOSIS 6 1975-88", "PM": "91; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 6 see under GLYCOGENOSIS 1975-88", "HN": "91(89); was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 6 see under GLYCOGENOSIS 1975-88", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D006013"}, {"RECTYPE": "D", "MH": "Glycogen Storage Disease Type VII", "DE": "GLYCOGEN STORAGE DIS VII", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tarui Disease|T047|EPO|EQV|OMIM (2013)|UNK (19XX)|880531|TARUI DIS|abcdeefv", "ENTRY": "Taruis Disease", "MN": "C18.452.648.202.449.600", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Glycogenosis (1966-1974)", "MS": "An autosomal recessive glycogen storage disease in which there is deficient expression of 6-phosphofructose 1-kinase in muscle (PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE) resulting in abnormal deposition of glycogen in muscle tissue. These patients have severe congenital muscular dystrophy and are exercise intolerant.", "OL": "use GLYCOGEN STORAGE DISEASE TYPE VII to search GLYCOGENOSIS 7 1975-88", "PM": "91; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 7 see under GLYCOGENOSIS 1975-88", "HN": "91(89); was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 7 see under GLYCOGENOSIS 1975-88", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D006014"}, {"RECTYPE": "D", "MH": "Glycogen Storage Disease Type VIII", "DE": "GLYCOGEN STORAGE DIS VIII", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Glycogenosis 8|T047|NON|EQV|UNK (19XX)|880531|GLYCOGENOSIS 08|abcdefs", "MN": "C18.452.648.202.449.620", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Glycogenosis (1966-1974)", "MS": "An x-linked recessive hepatic glycogen storage disease resulting from lack of expression of phosphorylase-b-kinase activity. Symptoms are relatively mild; hepatomegaly, increased liver glycogen, and decreased leukocyte phosphorylase are present. Liver shrinkage occurs in response to glucagon.", "OL": "use GLYCOGEN STORAGE DISEASE TYPE VIII to search GLYCOGENOSIS 8 1975-88", "PM": "91; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 8 see under GLYCOGENOSIS 1975-88", "HN": "91(89); was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 8 see under GLYCOGENOSIS 1975-88", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D006015"}, {"RECTYPE": "D", "MH": "Glycolates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ethers, Hydroxyacetate", "MN": "D02.241.511.316", "FX": "Polyglycolic Acid", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of ACETIC ACID which contain an hydroxy group attached to the methyl carbon.", "PM": "1966", "HN": "1966", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006016"}, {"RECTYPE": "D", "MH": "Glycolipids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycolipid|T109|T123|NON|EQV|NLM (2021)|191129|abbcdef", "MN": "D10.390", "MH_TH": "NLM (1963)", "ST": "T123", "RN": "0", "MS": "Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage)", "PM": "66; was see under LIPIDS 1963-65", "HN": "66(63); was see under LIPIDS 1963-65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006017"}, {"RECTYPE": "D", "MH": "Glycols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.033.455", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A generic grouping for dihydric alcohols with the hydroxy groups (-OH) located on different carbon atoms. They are viscous liquids with high boiling points for their molecular weights.", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006018"}, {"RECTYPE": "D", "MH": "Glycolysis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Pathways, Embden-Meyerhof", "MN": "G03.493.360", "MH_TH": "NLM (1964)", "ST": "T044", "MS": "A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006019"}, {"RECTYPE": "D", "MH": "Glycopeptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycopeptide|T116|NON|EQV|NLM (2021)|191219|abcdef", "MN": "D12.644.233", "MH_TH": "NLM (1971)", "ST": "T116", "RN": "0", "PI": "specific polysaccharide (1966-1970)", "MS": "Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight.", "PM": "73", "HN": "73(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006020"}, {"RECTYPE": "D", "MH": "Glycophorins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Red Blood Cell Membrane Sialoglycoprotein|T116|T123|NON|EQV|UNK (19XX)|760505|abbcdef", "ENTRY": "beta Sialoglycoprotein", "MN": "D12.776.395.700.350", "MH_TH": "NLM (2020)", "ST": "T123", "RN": "0", "PI": "Sialic Acids (1975-1976)", "MS": "The major sialoglycoprotein of human erythrocyte membranes. It consists of at least two sialoglycopeptides and is composed of 60% carbohydrate including sialic acid and 40% protein. It is involved in a number of different biological activities including the binding of MN blood groups, influenza viruses, kidney bean phytohemagglutinin, and wheat germ agglutinin.", "PM": "91; was see under SIALOGLYCOPROTEINS 1977-90", "HN": "91(77); was see under SIALOGLYCOPROTEINS 1977-90", "MR": "20230316", "DA": "19760505", "DC": "1", "DX": "19910101", "UI": "D006021"}, {"RECTYPE": "D", "MH": "beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase", "DS": "BETA ACETYLGLUCOSAMINYLGLYCOPEPTIDE BETA", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thyroid Galactosyltransferase|T116|T126|NON|NRW|UNK (19XX)|750731|abbcdef", "ENTRY": "beta-Galactosyltransferase, Glycoprotein", "MN": "D08.811.913.400.450.400.450", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "UDPgalactose:N-acetyl-beta-D-glucosaminylglycopeptide beta-1,4-galactosyltransferase", "RN": "EC 2.4.1.38", "RR": "37237-43-7 (CAS RN)", "PI": "Hexosyltransferases (1973-1975)", "MS": "An enzyme that catalyzes the transfer of galactose from UDP-galactose to a specific glycoprotein receptor, 2-acetamido-2-deoxy-D-glucosyl-glycopeptide, during glycopeptide synthesis. EC 2.4.1.38.", "PM": "98; see GLYCOPROTEIN 4-BETA-GALACTOSYLTRANSFERASE 1992-97; see GLYCOPROTEIN BETA-GALACTOSYLTRANSFERASE 1991; see GALACTOSYLTRANSFERASES 1976-90", "HN": "98(76)", "MR": "20030709", "DA": "19750801", "DC": "1", "DX": "19910101", "UI": "D006022"}, {"RECTYPE": "D", "MH": "Glycoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "O-Glycosylated Proteins|T109|NON|BRD|NLM (2023)|220406|abcdef", "ENTRY": "Proteins, O-Glycosylated", "MN": "D12.776.395", "FX": "Glycosylation", "MH_TH": "NLM (1966)", "ST": "T116", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins.", "PM": "THROMBOPOIETIN was see under BLOOD PLATELETS 1975", "MR": "20220407", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006023"}, {"RECTYPE": "D", "MH": "Glycopyrrolate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycopyrronium|T109|NON|REL|NLM (2021)|200312|abcdef", "ENTRY": "Bromide, Glycopyrronium", "MN": "D03.383.773.342", "PA": "Muscarinic Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "V92SO9WP2I", "RR": "A14FB57V1D", "MS": "A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics.", "PM": "91; was see under PYRROLIDINES 1964-90", "HN": "91(64); was see under PYRROLIDINES 1964-90", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006024"}, {"RECTYPE": "D", "MH": "Glycosaminoglycans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mucopolysaccharides|T109|T123|NON|EQV|NLM (1993)|920415|abbcdef", "MN": "D09.698.373", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "polysaccharides; note X ref", "PI": "Mucopolysaccharides (1966-1974)", "MS": "Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE).", "OL": "use GLYCOSAMINOGLYCANS to search MUCOPOLYSACCHARIDES 1966-92", "PM": "77; was see under MUCOPOLYSACCHARIDES 1969-76; MUCOPOLYSACCHARIDES was heading 1963-92", "HN": "77(75); was see under MUCOPOLYSACCHARIDES 1969-76; MUCOPOLYSACCHARIDES was heading 1963-92", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D006025"}, {"RECTYPE": "D", "MH": "Glycoside Hydrolases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glycoside Hydrolase|T116|T126|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Hydrolases, Glycoside", "MN": "D08.811.277.450", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.2.1.-", "MS": "Any member of the class of enzymes that catalyze the cleavage of the glycosidic linkage of glycosides and the addition of water to the resulting molecules.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006026"}, {"RECTYPE": "D", "MH": "Glycosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycoside|T109|NON|EQV|NLM (2021)|200106|abcdef", "MN": "D09.408", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general; do not confuse with GLUCOSIDES; glucides is a European term for CARBOHYDRATES ", "MS": "Any compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. They are named specifically for the sugar contained, such as glucoside (glucose), pentoside (pentose), fructoside (fructose), etc. Upon hydrolysis, a sugar and nonsugar component (aglycone) are formed. (From Dorland, 28th ed; From Miall's Dictionary of Chemistry, 5th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006027"}, {"RECTYPE": "D", "MH": "Glycosphingolipids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sphingoglycolipids|T109|NON|EQV|UNK (19XX)|760317|abcdef", "MN": "D10.570.877.360", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Sphingolipids (1972-1974)", "MS": "Lipids containing at least one monosaccharide residue and either a sphingoid or a ceramide (CERAMIDES). They are subdivided into NEUTRAL GLYCOSPHINGOLIPIDS comprising monoglycosyl- and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides; and ACIDIC GLYCOSPHINGOLIPIDS which comprises sialosylglycosylsphingolipids (GANGLIOSIDES); SULFOGLYCOSPHINGOLIPIDS (formerly known as sulfatides), glycuronoglycosphingolipids, and phospho- and phosphonoglycosphingolipids. (From IUPAC's webpage)", "PM": "75", "HN": "75", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D006028"}, {"RECTYPE": "D", "MH": "Glycosuria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C18.452.394.937", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "The appearance of an abnormally large amount of GLUCOSE in the urine, such as more than 500 mg/day in adults. It can be due to HYPERGLYCEMIA or genetic defects in renal reabsorption (RENAL GLYCOSURIA).", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006029"}, {"RECTYPE": "D", "MH": "Glycosuria, Renal", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Renal Glycosuria|T047|NON|EQV|NLM (2007)|051107|abcdef", "MN": "C18.452.394.937.450", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "An autosomal inherited disorder due to defective reabsorption of GLUCOSE by the PROXIMAL RENAL TUBULES. The urinary loss of glucose can reach beyond 50 g/day. It is attributed to the mutations in the SODIUM-GLUCOSE TRANSPORTER 2 encoded by the SLC5A2 gene.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006030"}, {"RECTYPE": "D", "MH": "Glycosylation", "AQ": "DE RE", "PRINT ENTRY": "Protein Glycosylation|T070|NON|NRW|NLM (1997)|950801|abcdef", "ENTRY": "Glycosylation, Protein", "MN": "G03.191.812", "FX": "Protein Processing, Post-Translational", "MH_TH": "NLM (1987)", "ST": "T070", "AN": "almost never IM", "PI": "Protein Processing, Post-Translational (1983-1986)", "MS": "The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION).", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20220407", "DA": "19860624", "DC": "1", "DX": "19870101", "UI": "D006031"}, {"RECTYPE": "D", "MH": "Glycine-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glycyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961105|abbdef", "ENTRY": "Synthetase, Glycyl-tRNA", "MN": "D08.811.464.263.200.350", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Glycine:tRNA(Gly) ligase (AMP-forming)", "RN": "EC 6.1.1.14", "PI": "Glycine (1972-1974)", "MS": "An enzyme that activates glycine with its specific transfer RNA. EC 6.1.1.14.", "PM": "98; see GLYCYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006032"}, {"RECTYPE": "D", "MH": "Glycylglycine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "N Glycylglycine", "MN": "D12.644.456.345.575", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Glycine, N-glycyl-", "RN": "10525P22U0", "RR": "556-50-3 (Glycylglycine)", "AN": "/biosyn /drug eff /physiol permitted", "MS": "The simplest of all peptides. It functions as a gamma-glutamyl acceptor.", "OL": "search DIPEPTIDES 1968-74", "PM": "91; was see under DIPEPTIDES 1975-90", "HN": "91(75); was see under DIPEPTIDES 1975-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006033"}, {"RECTYPE": "D", "MH": "Glycyrrhetinic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uralenic Acid|T109|T121|NON|EQV|UNK (19XX)|760429|abbcdef", "ENTRY": "Acid, Uralenic", "MN": "D02.455.849.919.530.444", "PA": "Anti-Inflammatory Agents", "MH_TH": "NLM (1977)", "ST": "T121", "N1": "Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3beta,20beta)-", "RN": "P540XA09DR", "RR": "471-53-4 (Glycyrrhetinic Acid)", "PI": "Triterpenes (1974-1976)", "MS": "An oleanolic acid from GLYCYRRHIZA that has some antiallergic, antibacterial, and antiviral properties. It is used topically for allergic or infectious skin inflammation and orally for its aldosterone effects in electrolyte regulation.", "OL": "use GLYCYRRHETINIC ACID to search ENOXOLONE 1977-78", "PM": "79; was ENOXOLONE see under TRITERPENES 1977-78; CARBENOXOLONE was see under TRITERPENES 1975-78", "HN": "79; was ENOXOLONE see under TRITERPENES 1977-78", "MR": "20160705", "DA": "19760503", "DC": "1", "DX": "19790101", "UI": "D006034"}, {"RECTYPE": "D", "MH": "Glycyrrhiza", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Licorice|T002|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Liquorices", "MN": "B01.875.800.575.912.250.401.300", "MH_TH": "NLM (1966)", "ST": "T002", "RN": "txid46347", "RR": "txid49827", "MS": "A genus of leguminous herbs or shrubs whose roots yield GLYCYRRHETINIC ACID and its derivative, CARBENOXOLONE.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006035"}, {"RECTYPE": "D", "MH": "Glyoxal", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ethanedione|T109|NON|EQV|UNK (19XX)|810318|abcdef", "MN": "D02.047.644", "MH_TH": "NLM (1973)", "ST": "T109", "N1": "Ethanedial", "RN": "50NP6JJ975", "RR": "107-22-2 (Glyoxal)", "MS": "A 2-carbon aldehyde with carbonyl groups on both carbons.", "PM": "91; was see under ALDEHYDES 1973-90", "HN": "91(73); was see under ALDEHYDES 1973-90", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006037"}, {"RECTYPE": "D", "MH": "Glyoxylates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.152.367", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of glyoxylic acid (the structural formula C2H2O3), including its salts and esters.", "PM": "66", "HN": "66", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006038"}, {"RECTYPE": "D", "MH": "Gnathostoma", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Gnathostomas", "MN": "B01.050.500.500.294.400.937.700.722.375", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid61463", "MS": "A genus of parasitic nematodes that occurs in mammals including man. Infection in humans is either by larvae penetrating the skin or by ingestion of uncooked fish.", "OL": "search SPIRUROIDEA 1966-74", "PM": "91; was see under THELAZIOIDEA 1986-90; was see under SPIRUROIDEA 1963-85", "HN": "91(75); was see under THELAZIOIDEA 1986-90; was see under SPIRUROIDEA 1963-85", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006039"}, {"RECTYPE": "D", "MH": "Goals", "ENTRY": "Goal", "MN": "F01.658.500", "FX": "Intention", "MH_TH": "POPLINE (1978)", "ST": "T170", "PI": "Motivation (1966-1974)", "MS": "The end-result or objective, which may be specified or required in advance.", "OL": "use GOALS to search GOAL 1975-78; use MOTIVATION 1969-74", "PM": "79; was GOAL see under MOTIVATION 1969-78", "HN": "79; was GOAL see under MOTIVATION 1969-78", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D006040"}, {"RECTYPE": "D", "MH": "Goats", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Capra|T015|NON|EQV|NLM (2005)|040308|abcdef", "ENTRY": "Goat", "MN": "B01.050.150.900.649.313.500.380.513", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid9925", "MS": "Any of numerous agile, hollow-horned RUMINANTS of the genus Capra, in the family Bovidae, closely related to the SHEEP.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006041"}, {"RECTYPE": "D", "MH": "Goiter", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Goiters", "MN": "C19.874.283", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "note specific goiter terms", "MS": "Enlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function (euthyroidism), thyroid deficiency (HYPOTHYROIDISM), or hormone overproduction (HYPERTHYROIDISM). Goiter may be congenital or acquired, sporadic or endemic (GOITER, ENDEMIC).", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006042"}, {"RECTYPE": "D", "MH": "Goiter, Endemic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Goiters, Endemic", "MN": "C19.874.283.300", "MH_TH": "NLM (1969)", "ST": "T047", "PI": "Goiter (1966-1968)", "MS": "A form of IODINE deficiency disorders characterized by an enlargement of the THYROID GLAND in a significantly large fraction of a POPULATION GROUP. Endemic goiter is common in mountainous and iodine-deficient areas of the world where the DIET contains insufficient amount of iodine.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006043"}, {"RECTYPE": "D", "MH": "Goiter, Nodular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Nodular Goiters", "MN": "C19.874.283.501", "MH_TH": "NLM (1971)", "ST": "T047", "PI": "Goiter (1966-1971)", "MS": "An enlarged THYROID GLAND containing multiple nodules (THYROID NODULE), usually resulting from recurrent thyroid HYPERPLASIA and involution over many years to produce the irregular enlargement. Multinodular goiters may be nontoxic or may induce THYROTOXICOSIS.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006044"}, {"RECTYPE": "D", "MH": "Goiter, Substernal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Goiter, Intrathoracic|T047|NON|BRD|UNK (19XX)|840214|abcdef", "ENTRY": "Substernal Goiters", "MN": "C19.874.283.601", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An enlarged THYROID GLAND with at least 50% of the gland situated behind the STERNUM. It is an unusual presentation of an intrathoracic goiter. Substernal goiters frequently cause compression on the TRACHEA leading to deviation, narrowing, and respiratory symptoms.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006045"}, {"RECTYPE": "D", "MH": "Gold", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.322", "FX": "Organogold Compounds", "MH_TH": "POPLINE (1978)", "ST": "T196", "N1": "Gold", "RN": "7440-57-5", "MS": "A yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. Many of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006046"}, {"RECTYPE": "D", "MH": "Gold Alloys", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Gold Alloy|T122|T197|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Alloys, Gold", "MN": "J01.637.051.339.208.534", "MH_TH": "NLM (1965)", "ST": "T197", "RN": "0", "MS": "Alloys that contain a high percentage of gold. They are used in restorative or prosthetic dentistry.", "PM": "65", "HN": "65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006047"}, {"RECTYPE": "D", "MH": "Gold Colloid, Radioactive", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioactive Gold Colloid", "MN": "D01.552.544.322.500.550.400", "PA": "Radiopharmaceuticals", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "MS": "A suspension of radioactive gold particles emitting negative beta particles and gamma irradiation. It was formerly used for liver scans and irradiation treatment of some metastatic malignancies.", "MR": "20170414", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006048"}, {"RECTYPE": "D", "MH": "Gold Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Gold", "MN": "D01.552.544.322.500", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable gold atoms that have the same atomic number as the element gold, but differ in atomic weight. Au-197 is a stable isotope.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006049"}, {"RECTYPE": "D", "MH": "Gold Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Gold", "MN": "D01.552.544.322.500.550", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1974)", "MS": "Unstable isotopes of gold that decay or disintegrate emitting radiation. Au 185-196, 198-201, and 203 are radioactive gold isotopes.", "OL": "search GOLD ISOTOPES 1966-74", "PM": "75", "HN": "75", "MR": "20170425", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D006050"}, {"RECTYPE": "D", "MH": "Aurothioglucose", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gold Thioglucose|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1991)|900517|abbcdeef", "ENTRY": "beta-D Isomer Aurothioglucose", "MN": "D02.691.675.249", "PA": "Antirheumatic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Gold, (1-thio-D-glucopyranosato-O2,S1)-", "RN": "2P2V9Q0E78", "RR": "82475-04-5 (beta-D, Na salt)", "PI": "Gold (1966-1972)", "MS": "A thioglucose derivative used as an antirheumatic and experimentally to produce obesity in animals.", "OL": "use AUROTHIOGLUCOSE to search GOLD THIOGLUCOSE 1979-90; use GOLD to search AUROTHIOGLUCOSE 1973-74 (as Prov)", "PM": "91; was GOLD THIOGLUCOSE see under GOLD 1979-90; was AUROTHIOGLUCOSE see under GOLD 1975-78", "HN": "91(79); was GOLD THIOGLUCOSE see under GOLD 1979-90; was AUROTHIOGLUCOSE see under GOLD 1973-78 (Prov 1973-74)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006051"}, {"RECTYPE": "D", "MH": "Gold Sodium Thiomalate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sodium Gold Thiomalate|T109|T121|NON|EQV|NLM (1992)|910408|abbcdef", "ENTRY": "Thiomalatoaurate, Sodium", "MN": "D02.886.489.891.451", "PA": "Antirheumatic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Butanedioic acid, mercapto-, monogold(1+) sodium salt", "RN": "12244-57-4", "RR": "74916-57-7 (monogold(1+) di-Na salt)", "PI": "Gold (1966-1972)", "MS": "A variable mixture of the mono- and disodium salts of gold thiomalic acid used mainly for its anti-inflammatory action in the treatment of rheumatoid arthritis. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis.", "OL": "use GOLD SODIUM THIOMALATE to search GOLD THIOMALATE 1973-91 (as Prov 1973)", "PM": "92; was GOLD THIOMALATE 1974-91", "HN": "92; was GOLD THIOMALATE 1973-91 (Prov 1973)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006052"}, {"RECTYPE": "D", "MH": "Goldenhar Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Oculoauriculovertebral Syndrome|T019|T047|NON|EQV|UNK (19XX)|790519|abbcdef", "ENTRY": "Oral-Mandibular-Auricular Syndromes", "MN": "C16.131.621.207.231.576.410", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Mandibulofacial Dysostosis (1966-1978)", "MS": "Mandibulofacial dysostosis with congenital eyelid dermoids.", "PM": "91; was see under MANDIBULOFACIAL DYSOSTOSIS 1979-90", "HN": "91(79); was see under MANDIBULOFACIAL DYSOSTOSIS 1979-90", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D006053"}, {"RECTYPE": "D", "MH": "Goldfish", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Carassius auratus|T013|NON|EQV|UNK (19XX)|860415|abcdef", "MN": "B01.050.150.900.493.200.244.248.480", "MH_TH": "NLM (1975)", "ST": "T013", "RN": "txid7957", "MS": "Common name for Carassius auratus, a type of carp (CARPS).", "OL": "search CYPRINIDAE 1968-74", "PM": "91; was see under CYPRINIDAE 1975-90", "HN": "91(75); was see under CYPRINIDAE 1975-90", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006054"}, {"RECTYPE": "D", "MH": "Golf", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Golfs", "MN": "I03.450.642.845.400", "MH_TH": "NLM (1976)", "ST": "T056", "AN": "/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1", "PI": "Sports (1966-1975)", "MS": "A game whose object is to sink a ball into each of 9 or 18 successive holes on a golf course using as few strokes as possible.", "PM": "90; was see under SPORTS 1976-89", "HN": "90(76); was see under SPORTS 1976-89", "MR": "19960610", "DA": "19750725", "DC": "1", "DX": "19900101", "UI": "D006055"}, {"RECTYPE": "D", "MH": "Golgi Apparatus", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Complex, Golgi", "MN": "A11.284.430.214.190.875.336", "MH_TH": "NLM (1966)", "ST": "T026", "MS": "A stack of flattened vesicles that functions in posttranslational processing and sorting of proteins, receiving them from the rough ENDOPLASMIC RETICULUM and directing them to secretory vesicles, LYSOSOMES, or the CELL MEMBRANE. The movement of proteins takes place by transfer vesicles that bud off from the rough endoplasmic reticulum or Golgi apparatus and fuse with the Golgi, lysosomes or cell membrane. (From Glick, Glossary of Biochemistry and Molecular Biology, 1990)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006056"}, {"RECTYPE": "D", "MH": "Golgi-Mazzoni Corpuscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Golgi Mazzoni Corpuscles", "MN": "A11.671.650.915.750.300", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "Thin capsules enveloping end nerve fibrils in the subcutaneous tissue of fingers.", "OL": "search MECHANORECEPTORS 1972-74 & NERVE ENDINGS 1966-71", "PM": "91; was see under MECHANORECEPTORS 1972-90; was see under NERVE ENDINGS 1963-71", "HN": "91(75); was see under MECHANORECEPTORS 1972-90; was see under NERVE ENDINGS 1963-71", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006057"}, {"RECTYPE": "D", "MH": "Gonadal Disorders", "DE": "GONADAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Gonadal Disorder", "MN": "C19.391", "MH_TH": "NLM (1974)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Pathological processes of the OVARIES or the TESTES.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006058"}, {"RECTYPE": "D", "MH": "Gonadal Dysgenesis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dysgenesis, Gonadal", "MN": "C19.391.119.309", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Turner Syndrome (1967-1979)", "MS": "A number of syndromes with defective gonadal developments such as streak GONADS and dysgenetic testes or ovaries. The spectrum of gonadal and sexual abnormalities is reflected in their varied sex chromosome (SEX CHROMOSOMES) constitution as shown by the karyotypes of 45,X monosomy (TURNER SYNDROME); 46,XX (GONADAL DYSGENESIS, 46XX); 46,XY (GONADAL DYSGENESIS, 46,XY); and sex chromosome MOSAICISM; (GONADAL DYSGENESIS, MIXED). Their phenotypes range from female, through ambiguous, to male. This concept includes gonadal agenesis.", "OL": "use TURNER'S SYNDROME to search GONADAL DYSGENESIS 1967-79", "PM": "80; was see TURNER'S SYNDROME 1967-79", "HN": "80; was see TURNER'S SYNDROME 1967-79", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19781221", "DC": "1", "DX": "19800101", "UI": "D006059"}, {"RECTYPE": "D", "MH": "Gonadal Dysgenesis, Mixed", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mixed Gonadal Dysgenesis|T019|T047|NON|EQV|UNK (19XX)|781221|abbcdef", "MN": "C19.391.119.795.249", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Turner's Syndrome (1967-1979)", "MS": "A type of defective gonadal development in patients with a wide spectrum of chromosomal mosaic variants. Their karyotypes are of partial sex chromosome monosomy resulting from an absence or an abnormal second sex chromosome (X or Y). Karyotypes include 45,X/46,XX; 45,X/46,XX/47,XXX; 46,XXp-; 45,X/46,XY; 45,X/47,XYY; 46,XYpi; etc. The spectrum of phenotypes may range from phenotypic female to phenotypic male including variations in gonads and internal and external genitalia, depending on the ratio in each gonad of 45,X primordial germ cells to those with normal 46,XX or 46,XY constitution.", "PM": "91; was see under GONADAL DYSGENESIS 1980-90", "HN": "91(80); was see under GONADAL DYSGENESIS 1980-90", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19781221", "DC": "1", "DX": "19910101", "UI": "D006060"}, {"RECTYPE": "D", "MH": "Gonadal Dysgenesis, 46,XY", "DS": "GONADAL DYSGENESIS AAAA", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Swyer Syndrome|T019|T047|EPO|NRW|GHR (2014)|UNK (19XX)|781221|abbcdeef", "ENTRY": "Syndrome, Swyer", "MN": "C19.391.119.309.388", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Turner's Syndrome (1967-1979)", "MS": "Defects in the SEX DETERMINATION PROCESS in 46, XY individuals that result in abnormal gonadal development and deficiencies in TESTOSTERONE and subsequently ANTIMULLERIAN HORMONE or other factors required for normal male sex development. This leads to the development of female phenotypes (male to female sex reversal), normal to tall stature, and bilateral streak or dysgenic gonads which are susceptible to GONADAL TISSUE NEOPLASMS. An XY gonadal dysgenesis is associated with structural abnormalities on the Y CHROMOSOME, a mutation in the GENE, SRY, or a mutation in other autosomal genes that are involved in sex determination.", "PM": "91; was see under GONADAL DYSGENESIS 1980-90", "HN": "91(80); was see under GONADAL DYSGENESIS 1980-90", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19781221", "DC": "1", "DX": "19910101", "UI": "D006061"}, {"RECTYPE": "D", "MH": "Gonadotropins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Gonadotropin|T116|T121|T125|NON|EQV|UNK (19XX)|870504|abbbcdef", "MN": "D06.472.699.322", "FX": "Receptors, Gonadotropin", "MH_TH": "NLM (1964)", "ST": "T125", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Hormones that stimulate gonadal functions such as GAMETOGENESIS and sex steroid hormone production in the OVARY and the TESTIS. Major gonadotropins are glycoproteins produced primarily by the adenohypophysis (GONADOTROPINS, PITUITARY) and the placenta (CHORIONIC GONADOTROPIN). In some species, pituitary PROLACTIN and PLACENTAL LACTOGEN exert some luteotropic activities.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006062"}, {"RECTYPE": "D", "MH": "Chorionic Gonadotropin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "HCG (Human Chorionic Gonadotropin)|T116|T121|T125|ACX|NRW|NLM (2003)|020315|HCG|abbbcdefs", "ENTRY": "Gonadotropin, Human Chorionic", "MN": "D12.776.780.400", "PA": "Reproductive Control Agents", "FX": "Receptors, Gonadotropin", "MH_TH": "UNK (19XX)", "ST": "T125", "RN": "0", "AN": "for alpha subunit, coordinate with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN is also available", "MS": "A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN).", "PM": "2003; see GONADOTROPINS, CHORIONIC 1964-2002", "HN": "2003(1964)", "MR": "20210304", "DA": "19990101", "DC": "1", "DX": "20030101", "UI": "D006063"}, {"RECTYPE": "D", "MH": "Gonadotropins, Equine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pregnant Mare Serum Gonadotropins|T116|T121|T125|NON|NRW|NLM (2003)|020315|abbbcdef", "ENTRY": "Gonadotropins, PMS", "MN": "D12.776.780.451", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "0", "MS": "Gonadotropins secreted by the pituitary or the placenta in horses. This term generally refers to the gonadotropins found in the pregnant mare serum, a rich source of equine CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE; and FOLLICLE STIMULATING HORMONE. Unlike that in humans, the equine LUTEINIZING HORMONE, BETA SUBUNIT is identical to the equine choronic gonadotropin, beta. Equine gonadotropins prepared from pregnant mare serum are used in reproductive studies.", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006064"}, {"RECTYPE": "D", "MH": "Gonadotropins, Pituitary", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Pituitary Gonadotropins", "MN": "D12.644.548.691.525.343", "PA": "Fertility Agents, Male", "FX": "Receptors, Gonadotropin", "MH_TH": "NLM (1964)", "ST": "T125", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Hormones secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR) that stimulate gonadal functions in both males and females. They include FOLLICLE STIMULATING HORMONE that stimulates germ cell maturation (OOGENESIS; SPERMATOGENESIS), and LUTEINIZING HORMONE that stimulates the production of sex steroids (ESTROGENS; PROGESTERONE; ANDROGENS).", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006065"}, {"RECTYPE": "D", "MH": "Gonads", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Gonad", "MN": "A06.300.312", "FX": "Castration", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The gamete-producing glands, OVARY or TESTIS.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006066"}, {"RECTYPE": "D", "MH": "Gonanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.451", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "includes gonenes, gonadienes, gonatrienes", "MS": "Steroids containing the fundamental tetracyclic unit with no methyl groups at C-10 and C-13 and with no side chain at C-17. The concept includes both saturated and unsaturated derivatives.", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006067"}, {"RECTYPE": "D", "MH": "Gonioscopy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Gonioscopies", "MN": "E01.370.380.300", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Examination of the angle of the anterior chamber of the eye with a specialized optical instrument (gonioscope) or a contact prism lens.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006068"}, {"RECTYPE": "D", "MH": "Gonorrhea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Neisseria gonorrhoeae Infection|T047|NON|EQV|NLM (2018)|161004|abcdef", "MN": "C12.100.937.281.401", "MH_TH": "POPLINE (1986)", "ST": "T047", "AN": "caused by Neisseria gonorrhoeae", "MS": "Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006069"}, {"RECTYPE": "D", "MH": "Gorilla gorilla", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "gorillas, Gorilla", "MN": "B01.050.150.900.649.313.988.400.112.400.375", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9593", "AN": "diseases: coordinate with APE DISEASES + specific disease /vet ", "PI": "Pongidae (1966-1974)", "MS": "This single species of Gorilla, which is a member of the HOMINIDAE family, is the largest and most powerful of the PRIMATES. It is distributed in isolated scattered populations throughout forests of equatorial Africa.", "OL": "use GORILLA GORILLA to search GORILLAS 1975-80", "PM": "81; was GORILLAS 1975-80", "HN": "81; was GORILLAS 1975-80", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D006071"}, {"RECTYPE": "D", "MH": "Gossypol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium Salt, Gossypol", "MN": "D02.455.849.765.444", "PA": "Contraceptive Agents, Male", "FX": "Cottonseed Oil", "MH_TH": "POPLINE (1986)", "ST": "T131", "N1": "(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-", "RN": "KAV15B369O", "RR": "90141-22-3 ((-)-isomer)", "MS": "A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006072"}, {"RECTYPE": "D", "MH": "Gout", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Gouts", "MN": "C18.452.648.798.368", "FX": "Hypoxanthine Phosphoribosyltransferase", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi.", "CATSH": "CAT LIST", "MR": "20160303", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006073"}, {"RECTYPE": "D", "MH": "Gout Suppressants", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antihyperuricemic|T121|NON|NRW|NLM (2022)|200727|abcdef", "ENTRY": "Suppressants, Gout", "MN": "D27.505.954.329.337", "FX": "Gout", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Uricosuric Agents (1966-1974)", "MS": "Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.", "PM": "75", "HN": "75", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D006074"}, {"RECTYPE": "D", "MH": "Governing Board", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Board, Governing|T098|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Governing Boards", "MN": "N04.452.394", "MH_TH": "NLM (1968)", "ST": "T098", "AN": "coord NIM with society, hosp or other organiz (IM)", "PI": "Public Health Administration (1966-1967)", "MS": "The group in which legal authority is vested for the control of health-related institutions and organizations.", "PM": "68", "HN": "68", "MR": "19940505", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006075"}, {"RECTYPE": "D", "MH": "Government", "AQ": "HI", "ENTRY": "Governments", "MN": "N03.540.348", "MH_TH": "NLM (2000)", "ST": "T092", "AN": "specify country or state", "MS": "The complex of political institutions, laws, and customs through which the function of governing is carried out in a specific political unit.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006076"}, {"RECTYPE": "D", "MH": "Government Agencies", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Government Agency", "MN": "N03.540.400", "MH_TH": "NLM (1978)", "ST": "T092", "AN": "specify country or state; CATALOGER: Coordinate with specific NAF entry if applicable", "PI": "Government (1966-1967)", "MS": "Administrative units of government responsible for policy making and management of governmental activities.", "PM": "68", "HN": "68", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006077"}, {"RECTYPE": "D", "MH": "Government Programs", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Government-Sponsored Programs|T064|NON|NRW|NLM (1998)|961015|abcdef", "ENTRY": "Programs, Government-Sponsored", "MN": "I01.451", "FX": "National Health Programs", "MH_TH": "POPLINE (1979)", "ST": "T064", "AN": "general or unspecified; prefer specifics; coordinate with endeavor sponsored; specify geographic location", "PI": "Government (1967-1997)", "MS": "Programs and activities sponsored or administered by local, state, or national governments.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006078"}, {"RECTYPE": "D", "MH": "Government Publications as Topic", "PRINT ENTRY": "Government Documents as Topic|T073|T170|NON|NRW|NLM (2020)|190517|abbcdef", "MN": "L01.462.500.682.492", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with Publication Type GOVERNMENT PUBLICATION", "MS": "Works about publications issued by local, regional, or national governments or by their agencies or subdivisions.", "PM": "2008; GOVERNMENT PUBLICATIONS 1963-2007", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D006079"}, {"RECTYPE": "D", "MH": "Ovarian Follicle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Graafian Follicle|T023|NON|NRW|NLM (1999)|980204|abcdef", "ENTRY": "Graafian Follicles", "MN": "A06.300.312.497.535", "FX": "Theca Cells", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "/cytol: consider also THECA CELLS; GRANULOSA CELLS; for follicular development use /physiol, not /growth", "MS": "An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment (FOLLICULAR FLUID). The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS.", "PM": "99; see GRAAFIAN FOLLICLE 1966-98", "HN": "99", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D006080"}, {"RECTYPE": "D", "MH": "Graft Enhancement, Immunologic", "DE": "GRAFT ENHANCEMENT IMMUNOL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Immunologic Enhancement of Grafts|T061|NON|EQV|UNK (19XX)|790529|IMMUNOL ENHANCEMENT GRAFTS|abcdefv", "ENTRY": "Immunological Graft Enhancements", "MN": "E05.478.610.500", "MH_TH": "NLM (1980)", "ST": "T061", "PI": "Transplantation, Homologous (1966-1979)", "MS": "The induction of prolonged survival and growth of allografts of either tumors or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunized donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D006082"}, {"RECTYPE": "D", "MH": "Graft Occlusion, Vascular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vascular Graft Restenosis|T033|T046|NON|EQV|NLM (1999)|980305|abbcdef", "ENTRY": "Restenosis, Vascular Graft", "MN": "C23.550.767.400", "FX": "Vascular Patency", "MH_TH": "NLM (1985)", "ST": "T046", "MS": "Obstruction of flow in biological or prosthetic vascular grafts.", "PM": "85", "HN": "85", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19840529", "DC": "1", "DX": "19850101", "UI": "D006083"}, {"RECTYPE": "D", "MH": "Graft Rejection", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Transplant Rejection|T042|NON|EQV|NLM (1995)|930916|TRANSPL REJECTION|abcdefv", "ENTRY": "Transplantation Rejections", "MN": "G12.875.545.328", "FX": "Delayed Graft Function", "MH_TH": "NLM (1971)", "ST": "T042", "AN": "may be used with transplanted neoplasms", "PI": "Transplantation Immunology (1966-1970)", "MS": "An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006084"}, {"RECTYPE": "D", "MH": "Graft Survival", "AQ": "DE GE IM PH RE", "ENTRY": "Survivals, Graft", "MN": "G12.875.545.340", "FX": "Transplantation Tolerance", "MH_TH": "NLM (1977)", "ST": "T042", "AN": "may be used with transplanted neoplasms", "PI": "Transplantation Immunology (1966-1972)", "MS": "The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D006085"}, {"RECTYPE": "D", "MH": "Graft vs Host Disease", "DE": "GRAFT VS HOST DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Runt Disease|T047|NON|EQV|UNK (19XX)|740330|RUNT DIS|abcdefv", "ENTRY": "Graft-vs-Host Diseases", "MN": "C20.452", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "do not confuse with GRAFT VS HOST REACTION ", "MS": "The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.", "OL": "use GRAFT VS HOST DISEASE to search HOMOLOGOUS WASTING DISEASE 1966-83 (as Prov 1966)", "PM": "84; was HOMOLOGOUS WASTING DISEASE 1967-83", "HN": "84; was HOMOLOGOUS WASTING DISEASE 1964-83 (Prov 1964-66)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006086"}, {"RECTYPE": "D", "MH": "Graft vs Host Reaction", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Human Leukocyte Antigen Sensitization|T046|NON|NRW|NLM (2023)|220325|abcdef", "ENTRY": "Sensitization, HLA", "MN": "G12.875.402", "FX": "Graft vs Host Disease", "MH_TH": "NLM (1970)", "ST": "T046", "AN": "do not confuse with HOST VS GRAFT REACTION nor with GRAFT VS HOST DISEASE", "PI": "Transplantation Immunology (1966-1969)", "MS": "An immunological attack mounted by a graft against the host because of HISTOINCOMPATIBILITY when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D006087"}, {"RECTYPE": "D", "MH": "Gram-Negative Aerobic Bacteria", "DE": "GRAM NEG AEROBIC BACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Achromobacteriaceae|T007|NON|REL|UNK (1992)|910415|abcdef", "ENTRY": "Gram Negative Aerobic Bacteria|T007|NON|EQV|NLM (1992)|901105|abcdef", "MN": "B03.440.400", "MH_TH": "NLM (1976)", "ST": "T007", "RR": "txid44937", "AN": "general or unspecified; prefer specifics; do not use as a routine coordinate for a gram-negative aerobic bacterium; infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS ", "PI": "Bacteria (1966-1975)", "MS": "A large group of aerobic bacteria which show up as pink (negative) when treated by the gram-staining method. This is because the cell walls of gram-negative bacteria are low in peptidoglycan and thus have low affinity for violet stain and high affinity for the pink dye safranine.", "OL": "use GRAM-NEGATIVE AEROBIC BACTERIA to search ACHROMATIACEAE 1975-96; ACHROMATIUM, LEPTOTHRIX, & SPHAEROTILUS 1966-96, & ACHROMOBACTERIACEAE 1975-91", "PM": "76; ACHROMATIACEAE was heading 1975-96; ACHROMATIUM, LEPTOTHRIX, & SPHAEROTILUS were headings 1963-96; ACHROMOBACTERIACEAE was heading 1975-91 (see under GRAM-NEGATIVE AEROBIC BACTERIA 1976-90)", "HN": "76; ACHROMATIACEAE was heading 1975-96; ACHROMATIUM, LEPTOTHRIX, & SPHAEROTILUS were headings 1963-96; ACHROMOBACTERIACEAE was heading 1975-91 (was see under GRAM-NEGATIVE AEROBIC BACTERIA 1976-90)", "MR": "20200902", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D006088"}, {"RECTYPE": "D", "MH": "Gram-Negative Anaerobic Bacteria", "DE": "GRAM NEG ANAEROBIC BACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Negative Anaerobic Bacteria|T007|EPO|EQV|NLM (1992)|901105|abcdef", "MN": "B03.440.425", "MH_TH": "NLM (1976)", "ST": "T007", "AN": "general or unspecified; prefer specifics; do not use as a routine coordinate for a gram-negative anaerobic bacterium; infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS ", "PI": "Bacteria (1966-1975)", "MS": "A large group of anaerobic bacteria which show up as pink (negative) when treated by the Gram-staining method.", "PM": "76", "HN": "76", "MR": "20200902", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D006089"}, {"RECTYPE": "D", "MH": "Gram-Negative Bacteria", "DE": "GRAM NEG BACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Negative Bacteria|T007|EPO|EQV|NLM (1992)|901105|abcdef", "MN": "B03.440", "MH_TH": "NLM (1984)", "ST": "T007", "AN": "general or unspecified; prefer specifics; do not use as a routine coordinate for a gram-negative bacterium; infection equals GRAM-NEGATIVE BACTERIAL INFECTIONS", "PI": "Bacteria (1966-1983)", "MS": "Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method.", "PM": "1984, 1973-1975", "HN": "1984(1973)", "MR": "20210304", "DA": "19830603", "DC": "1", "DX": "19840101", "UI": "D006090"}, {"RECTYPE": "D", "MH": "Gram-Negative Chemolithotrophic Bacteria", "DE": "GRAM NEG CHEMOLITHOTROPHIC BACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Thiobacteriaceae|T007|NON|REL|UNK (1992)|910326|abcdef", "ENTRY": "Gram Negative Chemolithotrophic Bacteria|T007|NON|EQV|UNK (19XX)|771207|abcdef", "MN": "B03.440.400.450", "MH_TH": "NLM (1976)", "ST": "T007", "AN": "general or unspecified; prefer specifics; do not use as a routine coordinate for a gram-negative chemolithotrophic bacterium; infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS", "PI": "Schizomycetes (1973-1974)", "MS": "A large group of bacteria including those which oxidize ammonia or nitrite, metabolize sulfur and sulfur compounds, or deposit iron and/or manganese oxides.", "OL": "use GRAM-NEGATIVE CHEMOLITHOTROPHIC BACTERIA to search THIOBACTERIACEAE 1975-91", "PM": "76; THIOBACTERIACEAE was heading 1975-91 (see under GRAM-NEGATIVE CHEMOLITHOTROPHIC BACTERIA 1976-90)", "HN": "76; THIOBACTERIACEAE was heading 1975-91 (see under GRAM-NEGATIVE CHEMOLITHOTROPHIC BACTERIA 1976-90)", "MR": "20200902", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D006091"}, {"RECTYPE": "D", "MH": "Gram-Negative Facultatively Anaerobic Rods", "DE": "GRAM NEG FACULTATIVELY ANAEROBIC RODS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Negative Facultatively Anaerobic Rods|T007|NON|EQV|UNK (19XX)|780228|abcdef", "MN": "B03.440.450", "MH_TH": "NLM (1976)", "ST": "T007", "AN": "general or unspecified; prefer specifics; infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS ", "PI": "Gram-Negative Bacteria (1973-1975)", "MS": "A large group of facultatively anaerobic, rod-shaped bacteria that show up as pink (negative) when treated by the gram-staining method.", "PM": "92", "HN": "92; was GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS (NON MESH) 1976-91", "MR": "20200902", "DA": "19750725", "DC": "1", "DX": "19920101", "UI": "D006092"}, {"RECTYPE": "D", "MH": "Gram-Positive Asporogenous Rods", "DE": "GRAM POS ASPOROGENOUS RODS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Gram-Positive Non-Spore-Forming Rods|T007|NON|EQV|NLM (1990)|890111|GRAM POS NON SPORE FORMING RODS|abcdefv", "ENTRY": "Gram Positive Non Spore Forming Rods|T007|NON|EQV|NLM (1990)|890111|abcdef", "MN": "B03.510.460.400", "MH_TH": "NLM (1976)", "ST": "T007", "AN": "general or unspecified; prefer specifics; do not use as a routine coordinate for a gram-positive asporogenous rod; infection: coordinate with GRAM-POSITIVE BACTERIAL INFECTIONS", "MS": "A gram-positive, non-spore-forming group of bacteria comprising organisms that have morphological and physiological characteristics in common.", "OL": "indexed under BACTERIA 1976-83", "PM": "90", "HN": "90; was NON MESH before 1990", "MR": "20200902", "DA": "19750725", "DC": "1", "DX": "19900101", "UI": "D006093"}, {"RECTYPE": "D", "MH": "Gram-Positive Bacteria", "DE": "GRAM POS BACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Positive Bacteria|T007|NON|EQV|NLM (1990)|890703|abcdef", "MN": "B03.510", "MH_TH": "NLM (1984)", "ST": "T007", "AN": "general or unspecified; prefer specifics; do not use as a routine coordinate for a gram-positive bacterium; infection equals GRAM-POSITIVE BACTERIAL INFECTIONS", "PI": "Bacteria (1966-1983)", "MS": "Bacteria which retain the crystal violet stain when treated by Gram's method.", "PM": "1984,1973-1975", "HN": "1984(1973)", "MR": "20210304", "DA": "19830603", "DC": "1", "DX": "19840101", "UI": "D006094"}, {"RECTYPE": "D", "MH": "Gram-Positive Cocci", "DE": "GRAM POS COCCI", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Positive Cocci|T007|NON|EQV|UNK (19XX)|780228|abcdef", "MN": "B03.510.400", "MH_TH": "NLM (1976)", "ST": "T007", "AN": "gram-positive bacteria; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM)", "PI": "Gram-Positive Bacteria (1973-1991)", "MS": "Coccus-shaped bacteria that retain the crystal violet stain when treated by Gram's method.", "PM": "92", "HN": "92; was GRAM-POSITIVE COCCI (NON MESH) 1976-91", "MR": "20200902", "DA": "19750725", "DC": "1", "DX": "19920101", "UI": "D006095"}, {"RECTYPE": "D", "MH": "Gramicidin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Gramicidin, Linear", "MN": "D12.776.543.695.221", "PA": "Anti-Infective Agents, Local", "MH_TH": "USP (19XX)", "ST": "T195", "RN": "1405-97-6", "RR": "WHM29QA23F", "MS": "A group of peptide antibiotics from BACILLUS brevis. Gramicidin C or S is a cyclic, ten-amino acid polypeptide and gramicidins A, B, D are linear. Gramicidin is one of the two principal components of TYROTHRICIN.", "OL": "search TYROTHRICIN 1966-73", "PM": "96; was GRAMICIDINS 1963-95 (see under TYROTHRICIN 1963-73)", "HN": "96; was GRAMICIDINS 1963-95 (see under TYROTHRICIN 1963-73)", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006096"}, {"RECTYPE": "D", "MH": "Granulation Tissue", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tissues, Granulation", "MN": "A10.165.450", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "A vascular connective tissue formed on the surface of a healing wound, ulcer, or inflamed tissue. It consists of new capillaries and an infiltrate containing lymphoid cells, macrophages, and plasma cells.", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006097"}, {"RECTYPE": "D", "MH": "Granulocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Granulocyte", "MN": "A15.382.490.315", "MH_TH": "NLM (1975)", "ST": "T025", "PI": "Leukocytes (1966-1974)", "MS": "Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS.", "OL": "search LEUKOCYTES 1968-74", "PM": "79; was see under LEUKOCYTES 1968-78", "HN": "79(75); was see under LEUKOCYTES 1968-78", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D006098"}, {"RECTYPE": "D", "MH": "Granuloma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Granulomas|T046|NON|EQV|POPLINE (1978)|911109|abcdef", "MN": "C23.550.382", "FX": "Tuberculoma", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "general or unspecified; prefer specifics; coordinate with organ/disease; malignant of nose equals GRANULOMA, LETHAL MIDLINE; central giant cell granuloma equals GRANULOMA, GIANT CELL; granulomatous disease or granulomatous disease of childhood equals GRANULOMATOUS DISEASE, CHRONIC; cholesterol granuloma equals GRANULOMA, FOREIGN BODY and CHOLESTEROL; talc granuloma equals GRANULOMA, FOREIGN BODY /etiol (not/chem ind) and TALC /adv eff; xanthogranuloma equals XANTHOMATOSIS and GRANULOMA but XANTHOGRANULOMA, JUVENILE is available", "MS": "A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006099"}, {"RECTYPE": "D", "MH": "Granuloma Inguinale", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Granuloma Venereum|T047|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "C17.800.838.765.360", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "non-neoplastic; gram-neg bact infect; sexually transmitted", "MS": "Anogenital ulcers caused by Calymmatobacterium granulomatis as distinguished from lymphogranuloma inguinale (see LYMPHOGRANULOMA VENEREUM) caused by CHLAMYDIA TRACHOMATIS. Diagnosis is made by demonstration of typical intracellular Donovan bodies in crushed-tissue smears.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006100"}, {"RECTYPE": "D", "MH": "Granuloma, Giant Cell", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Granuloma, Giant Cell Reparative|T047|NON|NRW|NLM (1993)|911106|abcdef", "ENTRY": "Granulomas, Giant Cell", "MN": "C23.550.382.468", "MH_TH": "NLM (1965)", "ST": "T046", "AN": "do not confuse with GIANT CELL TUMORS, benign or malignant neopl; coord IM with organ/dis (IM), not organ/neopl; peripheral or epulis involves gingiva, central refers to jaw", "MS": "A non-neoplastic inflammatory lesion, usually of the jaw or gingiva, containing large, multinucleated cells. It includes reparative giant cell granuloma. Peripheral giant cell granuloma refers to the gingiva (giant cell epulis); central refers to the jaw.", "OL": "use GRANULOMA, GIANT CELL to search GRANULOMA, REPARATIVE GIANT CELL 1966-73", "PM": "74; was GRANULOMA, REPARATIVE GIANT CELL 1965-73", "HN": "74; was GRANULOMA, REPARATIVE GIANT CELL 1965-73", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006101"}, {"RECTYPE": "D", "MH": "Granuloma, Laryngeal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Laryngeal Granuloma|T046|NON|EQV|UNK (19XX)|790519|abcdef", "ENTRY": "Larynx Granulomas", "MN": "C23.550.382.968.500", "MH_TH": "NLM (1979)", "ST": "T046", "AN": "non-neoplastic", "MS": "A tumor-like nodule or mass of inflammatory granulation tissue projecting into the lumen of the LARYNX.", "PM": "91; was see under LARYNGEAL DISEASES 1979-90", "HN": "91(79); was see under LARYNGEAL DISEASES 1979-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D006102"}, {"RECTYPE": "D", "MH": "Granuloma, Lethal Midline", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polymorphic Reticulosis|T047|NON|NRW|NLM (2009)|ORD (2010)|071219|abcdeef", "ENTRY": "Reticulosis, Polymorphic", "MN": "C09.603.393", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "A condition that is characterized by inflammation, ulceration, and perforation of the nose and the PALATE with progressive destruction of midline facial structures. This syndrome can be manifested in several diseases including the nasal type of EXTRANODAL NK-T-CELL LYMPHOMA and GRANULOMATOSIS WITH POLYANGIITIS.", "PM": "65; GRANULOMA GANGRAENESCENS & LETHAL MIDLINE GRANULOMA were see under WEGENER'S GRANULOMATOSIS 1963-64", "HN": "65; GRANULOMA GANGRAENESCENS & LETHAL MIDLINE GRANULOMA were see under WEGENER'S GRANULOMATOSIS 1963-64", "CATSH": "CAT LIST", "MR": "20140627", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006103"}, {"RECTYPE": "D", "MH": "Granuloma, Plasma Cell", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pseudotumor, Inflammatory|T047|NON|REL|NLM (1992)|901231|PSEUDOTUMOR INFLAMM|abcdefv", "ENTRY": "Pseudotumors, Inflammatory", "MN": "C23.550.382.875", "MH_TH": "NLM (1984)", "ST": "T046", "AN": "non-neoplastic; coordinate with organ/disease, not organ/neoplasm", "PI": "Plasma Cells (1966-1983)", "MS": "A slow-growing benign pseudotumor in which plasma cells greatly outnumber the inflammatory cells.", "OL": "use FIBROMA to search PSEUDOTUMOR, INFLAMMATORY 1990-91", "PM": "91; was see under GRANULOMA 1984-90; PSEUDOTUMOR, INFLAMMATORY was see FIBROMA 1990-1991", "HN": "91(84); was see under GRANULOMA 1984-90; PSEUDOTUMOR, INFLAMMATORY was see FIBROMA 1990-91", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19830531", "DC": "1", "DX": "19910101", "UI": "D006104"}, {"RECTYPE": "D", "MH": "Granulomatous Disease, Chronic", "DE": "GRANULOMATOUS DIS CHRONIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "X Linked Chronic Granulomatous Disease", "MN": "C23.550.291.500.423", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "also called granulomatous disease of childhood", "PI": "Phagocytosis (1966-1971)", "MS": "A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.", "OL": "search PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-74", "PM": "78; was see under PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-77", "HN": "78(75); was see under PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-77", "CATSH": "CAT LIST", "MR": "20210312", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D006105"}, {"RECTYPE": "D", "MH": "Granulosa Cell Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Granulosa Cell", "MN": "C19.391.630.705.398", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with probably OVARIAN NEOPLASMS (IM); do not confuse with GRANULAR CELL TUMOR, a myoblastoma", "MS": "A neoplasm composed entirely of GRANULOSA CELLS, occurring mostly in the OVARY. In the adult form, it may contain some THECA CELLS. This tumor often produces ESTRADIOL and INHIBIN. The excess estrogen exposure can lead to other malignancies in women and PRECOCIOUS PUBERTY in girls. In rare cases, granulosa cell tumors have been identified in the TESTES.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006106"}, {"RECTYPE": "D", "MH": "Granulosa Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Granulosa Cell", "MN": "A11.436.329", "MH_TH": "NLM (1975)", "ST": "T025", "MS": "Supporting cells for the developing female gamete in the OVARY. They are derived from the coelomic epithelial cells of the gonadal ridge. Granulosa cells form a single layer around the OOCYTE in the primordial ovarian follicle and advance to form a multilayered cumulus oophorus surrounding the OVUM in the Graafian follicle. The major functions of granulosa cells include the production of steroids and LH receptors (RECEPTORS, LH).", "PM": "78; was see under GRAAFIAN FOLLICLE 1975-77", "HN": "78(75); was see under GRAAFIAN FOLLICLE 1975-77", "MR": "20180630", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D006107"}, {"RECTYPE": "D", "MH": "Graphite", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Graphene|T196|NON|NRW|NLM (2011)|100407|abcdef", "MN": "D01.578.300", "MH_TH": "NLM (1975)", "ST": "T196", "N1": "Graphite", "RN": "7782-42-5", "MS": "An allotropic form of carbon that is used in pencils, as a lubricant, and in matches and explosives. It is obtained by mining and its dust can cause lung irritation.", "OL": "search CARBON 1966-74", "PM": "91; was see under CARBON 1975-90", "HN": "91(75); was see under CARBON 1975-90", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006108"}, {"RECTYPE": "D", "MH": "Poaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Imperata|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Imperata cylindrica|T002|NON|NRW|NLM (2016)|150327|abcdef", "MN": "B01.875.800.575.912.250.822", "FX": "Pollen", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid4479", "RR": "txid80369", "MS": "A large family of narrow-leaved herbaceous grasses of the order Cyperales, subclass Commelinidae, class Liliopsida (monocotyledons). Food grains (EDIBLE GRAIN) come from members of this family. RHINITIS, ALLERGIC, SEASONAL can be induced by POLLEN of many of the grasses.", "PM": "2002; see GRASSES 1963-2001; for GRAMINEAE see GRAMINEA 1986-1997", "HN": "2002(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D006109"}, {"RECTYPE": "D", "MH": "Grasshoppers", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Romaleidae|T204|NON|NRW|NLM (1999)|970822|abcdef", "ENTRY": "Locust", "MN": "B01.050.500.131.617.678.369", "MH_TH": "NLM (1972)", "ST": "T204", "RR": "txid7002", "AN": "do not use /drug eff for insecticides: TN 111", "PI": "Insects (1966-1971)", "MS": "Plant-eating orthopterans having hindlegs adapted for jumping. There are two main families: Acrididae and Romaleidae. Some of the more common genera are: Melanoplus, the most common grasshopper; Conocephalus, the eastern meadow grasshopper; and Pterophylla, the true katydid.", "OL": "use GRASSHOPPERS to search LOCUSTS 1972-77", "HN": "72; LOCUSTS was see under GRASSHOPPERS 1972-77", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006110"}, {"RECTYPE": "D", "MH": "Graves Disease", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Graves' Disease|T047|EPO|EQV|NLM (1966)|990101|GRAVES DIS|abcdefv", "ENTRY": "Goiters, Exophthalmic", "MN": "C20.111.555", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "GRAVES OPHTHALMOPATHY is also available", "MS": "A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).", "PM": "2006; see GRAVES' DISEASE 1987-2005, see GOITER, EXOPHTHALMIC 1963-1986", "HN": "2006 (1987); use GOITER, EXOPHTHALMIC 1963-1986", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D006111"}, {"RECTYPE": "D", "MH": "Gravitation", "PRINT ENTRY": "Gravity|T070|NON|REL|NLM (1995)|940405|abcdef", "ENTRY": "Gravities", "MN": "G01.060.350", "FX": "Gravitropism", "MH_TH": "NLM (1966)", "ST": "T070", "MS": "Acceleration produced by the mutual attraction of two masses, and of magnitude inversely proportional to the square of the distance between the two centers of mass. It is also the force imparted by the earth, moon, or a planet to an object near its surface. (From NASA Thesaurus, 1988)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006112"}, {"RECTYPE": "D", "MH": "United Kingdom", "AQ": "EH EP", "PRINT ENTRY": "Isle of Man|T083|NAM|NRW|NLM (1983)|920908|abcdef", "MN": "Z01.542.363", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "Country in northwestern Europe including Great Britain and the northern one-sixth of the island of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London.", "MR": "20181012", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D006113"}, {"RECTYPE": "D", "MH": "Great Lakes Region", "AQ": "EH EP", "MN": "Z01.107.567.875.350", "MH_TH": "NLM (1975)", "ST": "T083", "AN": "index specific states as needed but use GREAT LAKES REGION when text uses the term & when the region is the intent of the author; CATALOGER: Use for 4 or more states", "MS": "The geographic area of the Great Lakes in general and when the specific state or states are not indicated. It usually includes Illinois, Indiana, Michigan, Minnesota, New York, Ohio, Pennsylvania, and Wisconsin.", "HN": "75", "MR": "20150605", "DA": "19990101", "DC": "4", "DX": "19750101", "UI": "D006114"}, {"RECTYPE": "D", "MH": "Greece", "AQ": "EH EP", "PRINT ENTRY": "Macedonia (Greece)|T083|NAM|NRW|NLM (1994)|930309|abcdef", "MN": "Z01.542.383", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "ancient or modern Greece; do not confuse with GREEK WORLD, the culture and civilization; do not confuse entry term MACEDONIA (GREECE) with MACEDONIA (REPUBLIC)", "MS": "A country in southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. The capital is Athens.", "MR": "20170708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D006115"}, {"RECTYPE": "D", "MH": "Greenland", "AQ": "EH EP", "PRINT ENTRY": "Kalaallit Nunaat|T083|NAM|EQV|NLM (2000)|991103|abcdef", "MN": "Z01.639.400", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "An island in Northern North America, between the Arctic Ocean and the North Atlantic Ocean, northeast of Canada.", "MR": "20160627", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D006116"}, {"RECTYPE": "D", "MH": "Grief", "PRINT ENTRY": "Mourning|T041|NON|NRW|UNK (19XX)|870314|abcdef", "ENTRY": "Mournings", "MN": "F01.470.142.110", "MH_TH": "NLM (1968)", "ST": "T041", "AN": "human & animal", "MS": "Normal, appropriate sorrowful response to an immediate cause. It is self-limiting and gradually subsides within a reasonable time.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19910611", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006117"}, {"RECTYPE": "D", "MH": "Griseofulvin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "GrisPEG", "MN": "D03.633.100.127.275", "PA": "Antifungal Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Spiro(benzofuran-2(3H),1'-(2)cyclohexene)-3,4'-dione, 7-chloro-2',4,6-trimethoxy-6'-methyl-, (1'S-trans)-", "RN": "32HRV3E3D5", "RR": "126-07-8 (Griseofulvin)", "MS": "An antifungal agent used in the treatment of TINEA infections.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006118"}, {"RECTYPE": "D", "MH": "Groin", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Groins", "MN": "A01.923.047.365", "MH_TH": "NLM (1981)", "ST": "T029", "AN": "external only: do not confuse with INGUINAL CANAL, internal only; NIM when merely locational", "PI": "Inguinal Canal (1966-1980)", "MS": "The external junctural region between the lower part of the abdomen and the thigh.", "PM": "81", "HN": "81", "MR": "20110624", "DA": "19800402", "DC": "1", "DX": "19810101", "UI": "D006119"}, {"RECTYPE": "D", "MH": "Grooming", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Preening|T055|NON|NRW|UNK (1990)|900514|abcdef", "ENTRY": "Preenings", "MN": "F01.145.113.111.453", "MH_TH": "NLM (1968)", "ST": "T055", "AN": "animal only; for personal grooming of humans use HYGIENE", "PI": "Behavior, Animal (1966-1967)", "MS": "An animal's cleaning and caring for the body surface. This includes preening, the cleaning and oiling of feathers with the bill or of hair with the tongue.", "OL": "use GROOMING to search PREENING 1975-90", "PM": "68; PREENING was see under GROOMING 1975-90", "HN": "68; PREENING was see under GROOMING 1975-90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006120"}, {"RECTYPE": "D", "MH": "Group Practice", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Practices, Group", "MN": "N04.452.758.244", "MH_TH": "NLM (1966)", "ST": "T093", "AN": "coord IM with med or other specialty (IM); do not confuse with PARTNERSHIP PRACTICE but do not interpret: use word of text", "MS": "Any group of three or more full-time physicians organized in a legally recognized entity for the provision of health care services, sharing space, equipment, personnel and records for both patient care and business management, and who have a predetermined arrangement for the distribution of income.", "MR": "19940505", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006123"}, {"RECTYPE": "D", "MH": "Group Practice, Dental", "DE": "GROUP PRACTICE DENT", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Practices, Dental Group|T058|NON|EQV|NLM (1991)|900126|PRACTICES DENT GROUP|abcdefv", "MN": "N04.452.758.244.369", "MH_TH": "NLM (1967)", "ST": "T058", "AN": "coord IM with specific dent specialty (IM); do not confuse with PARTNERSHIP PRACTICE, DENTAL but do not interpret: use word of text; DF: GROUP PRACTICE DENT", "PI": "Group Practice (1966)", "MS": "Any group of three or more full-time dentists, organized in a legally recognized entity for the provision of dental care, sharing space, equipment, personnel and records for both patient care and business management, and who have a predetermined arrangement for the distribution of income.", "PM": "67", "HN": "67", "MR": "19940505", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006124"}, {"RECTYPE": "D", "MH": "Group Practice, Prepaid", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Prepaid Group Practice|T058|NON|EQV|UNK (19XX)|790601|abcdef", "ENTRY": "Prepaid Group Practices", "MN": "N04.452.758.244.400", "MH_TH": "NLM (1980)", "ST": "T058", "AN": "coord IM with med or other specialty (IM)", "PI": "Insurance, Health (1966-1979)", "MS": "An organized group of three or more full-time physicians rendering services for a fixed prepayment.", "PM": "91; was see under GROUP PRACTICE 1980-90", "HN": "91(80); was see under GROUP PRACTICE 1980-90", "MR": "19940505", "DA": "19790601", "DC": "1", "DX": "19910101", "UI": "D006125"}, {"RECTYPE": "D", "MH": "Group Processes", "ENTRY": "Thinking, Group", "MN": "F01.829.316", "FX": "Social Change", "MH_TH": "NLM (1984)", "ST": "T054", "AN": "differentiate from MASS BEHAVIOR", "MS": "The procedures through which a group approaches, attacks, and solves a common problem.", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006126"}, {"RECTYPE": "D", "MH": "Group Structure", "ENTRY": "Structures, Group", "MN": "F01.829.316.274", "MH_TH": "NLM (1968)", "ST": "T102", "PI": "Group Processes (1966-1967)", "MS": "The informal or formal organization of a group of people based on a network of personal relationships which is influenced by the size and composition, etc., of the group.", "PM": "69", "HN": "69(68)", "CATSH": "CAT LIST", "MR": "19890428", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D006127"}, {"RECTYPE": "D", "MH": "Growth", "AQ": "DE GE IM PH RE", "MN": "G07.345.249", "FX": "Personality Development", "MH_TH": "NLM (1963)", "ST": "T040", "AN": "General only; prefer /growth with specific organ or organism: Manual 19.7+, 19.8.35", "MS": "Gradual increase in the number, the size, and the complexity of cells of an individual. Growth generally results in increase in ORGAN WEIGHT; BODY WEIGHT; and BODY HEIGHT.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006128"}, {"RECTYPE": "D", "MH": "Growth Disorders", "DE": "GROWTH DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stuntings", "MN": "C23.550.393", "FX": "Gigantism", "MH_TH": "BIOETHICS (1989)", "ST": "T046", "AN": "do not confuse with NUTRITION DISORDERS (disorders of assimilating & utilizing nutrients)", "PI": "Growth (1966-1968)", "MS": "Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "20190322", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006130"}, {"RECTYPE": "D", "MH": "Growth Inhibitors", "DE": "GROWTH INHIB", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Growth Inhibitor|T121|T123|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Inhibitors, Growth", "MN": "D27.505.696.377.450", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "MS": "Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= PLANT GROWTH REGULATORS).", "OL": "use GROWTH INHIBITORS to search CHALONES 1969-92 (as Prov 1969-71)", "PM": "1979", "HN": "1979", "MR": "20200527", "DA": "19780213", "DC": "1", "DX": "19790101", "UI": "D006131"}, {"RECTYPE": "D", "MH": "Growth Plate", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Epiphyseal Plate|T024|NON|EQV|UNK (19XX)|830209|abcdef", "ENTRY": "Plates, Growth", "MN": "A02.835.232.251.352", "FX": "Bone Development", "EC": "injuries:Salter-Harris Fractures", "MH_TH": "NLM (1984)", "ST": "T024", "PI": "Epiphyses (1966-1983)", "MS": "The area between the EPIPHYSIS and the DIAPHYSIS within which bone growth occurs.", "PM": "84", "HN": "84", "MR": "20180629", "DA": "19830209", "DC": "1", "DX": "19840101", "UI": "D006132"}, {"RECTYPE": "D", "MH": "Growth Substances", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mitogens, Endogenous|T039|T123|NON|NRW|UNK (19XX)|850606|abbcdef", "ENTRY": "Endogenous Mitogens", "MN": "D27.505.696.377", "FX": "Receptors, Growth Factor", "EC": "antagonists & inhibitors:Growth Inhibitors", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "general or unspecified: prefer specifics", "MS": "Signal molecules that are involved in the control of cell growth and differentiation.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006133"}, {"RECTYPE": "D", "MH": "Gryllidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Crickets|T204|NON|EQV|UNK (19XX)|850315|abcdef", "ENTRY": "Cricket", "MN": "B01.050.500.131.617.678.410", "MH_TH": "NLM (1986)", "ST": "T204", "RN": "txid6995", "AN": "/microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111", "PI": "Orthoptera (1975-1985)", "MS": "The family Gryllidae consists of the common house cricket, Acheta domesticus, which is used in neurological and physiological studies. Other genera include Gryllotalpa (mole cricket); Gryllus (field cricket); and Oecanthus (tree cricket).", "PM": "91; was see under ORTHOPTERA 1986-90", "HN": "91(86); was see under ORTHOPTERA 1986-90", "MR": "20200813", "DA": "19850315", "DC": "1", "DX": "19910101", "UI": "D006135"}, {"RECTYPE": "D", "MH": "GTP Cyclohydrolase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "GTP Ring-Opening Enzyme|T126|EQV|UNK (19XX)|741111|abdef", "ENTRY": "Synthetase, 7,8-Dihydroneopterintriphosphate", "MN": "D08.811.277.151.300", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "GTP 7,8-8,9-dihydrolase", "RN": "EC 3.5.4.16", "PI": "Guanosine Triphosphate (1974)", "MS": "(GTP cyclohydrolase I) or GTP 7,8-8,9-dihydrolase (pyrophosphate-forming) (GTP cyclohydrolase II). An enzyme group that hydrolyzes the imidazole ring of GTP, releasing carbon-8 as formate. Two C-N bonds are hydrolyzed and the pentase unit is isomerized. This is the first step in the synthesis of folic acid from GTP. EC 3.5.4.16 (GTP cyclohydrolase I) and EC 3.5.4.25 (GTP cyclohydrolase II).", "PM": "91; was see under AMINOHYDROLASES 1975-90", "HN": "91(75); was see under AMINOHYDROLASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006136"}, {"RECTYPE": "D", "MH": "Guaiac", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D20.215.721.500.490", "PA": "Indicators and Reagents", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "Guaiacum (resin)", "RN": "9000-29-7", "MS": "Resin from wood of certain species of GUAIACUM. It is used as clinical reagent for occult blood.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006138"}, {"RECTYPE": "D", "MH": "Guaiacol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Catechol, Methyl", "MN": "D02.455.426.559.389.657.654.453", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Phenol, 2-methoxy-", "RN": "6JKA7MAH9C", "RR": "90-05-1 (Guaiacol)", "MS": "An agent thought to have disinfectant properties and used as an expectorant. (From Martindale, The Extra Pharmacopoeia, 30th ed, p747)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006139"}, {"RECTYPE": "D", "MH": "Guaifenesin", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Guaiphenesin|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|770330|abbcdeef", "ENTRY": "ScottTussin", "MN": "D02.455.426.559.389.657.654.453.400", "PA": "Expectorants", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,2-Propanediol, 3-(2-methoxyphenoxy)-", "RN": "495W7451VQ", "RR": "93-14-1 (Guaifenesin)", "MS": "An expectorant that also has some muscle relaxing action. It is used in many cough preparations.", "PM": "2004; see GUAIACOL GLYCERYL ETHER 1966-2003", "HN": "2004(1966)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D006140"}, {"RECTYPE": "D", "MH": "Guam", "AQ": "EH EP", "MN": "Z01.639.760.680.435", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island in Micronesia", "MS": "An island in Micronesia, east of the Philippines, the largest and southernmost of the Marianas. Its capital is Agana. It was discovered by Magellan in 1521 and occupied by Spain in 1565. They ceded it to the United States in 1898. It is an unincorporated territory of the United States, administered by the Department of the Interior since 1950. The derivation of the name Guam is in dispute. (From Webster's New Geographical Dictionary, 1988, p471)", "HN": "75", "MR": "20120703", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D006141"}, {"RECTYPE": "D", "MH": "Guanabenz", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Wyeth Ayerst of Guanabenz Acetate", "MN": "D02.078.370.435", "PA": "Antihypertensive Agents", "MH_TH": "USAN (1971)", "ST": "T121", "N1": "Hydrazinecarboximidamide, 2-((2,6-dichlorophenyl)methylene)-", "RN": "GGD30112WC", "RR": "5051-62-7 (Guanabenz)", "PI": "Imines (1973-1974)", "MS": "An alpha-2 selective adrenergic agonist used as an antihypertensive agent.", "PM": "91; was see under GUANIDINES 1975-90", "HN": "91(75); was see under GUANIDINES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006143"}, {"RECTYPE": "D", "MH": "Guanazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.799.500", "PA": "Antineoplastic Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "1H-1,2,4-Triazole-3,5-diamine", "RN": "I01TWM5267", "RR": "1455-77-2 (Guanazole)", "PI": "Triazoles (1972-1974)", "MS": "A cytostatic triazole derivative which is not to be confused with guanazolo, the generic name for 8-azaguanine.", "PM": "91; was see under TRIAZOLES 1975-90", "HN": "91(75); was see under TRIAZOLES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006144"}, {"RECTYPE": "D", "MH": "Guanethidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Guanethidine", "MN": "D02.078.370.460", "PA": "Sympatholytics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Guanidine, (2-(hexahydro-1(2H)-azocinyl)ethyl)-", "RN": "ZTI6C33Q2Q", "RR": "8AQ60474G9", "MS": "An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006145"}, {"RECTYPE": "D", "MH": "Guanidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.078.370", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with GUANINE", "MS": "A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.", "MR": "19930603", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006146"}, {"RECTYPE": "D", "MH": "Guanine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.633.100.759.758.399.454", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "6H-Purin-6-one, 2-amino-1,7-dihydro-", "RN": "5Z93L87A1R", "RR": "73-40-5 (Guanine)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006147"}, {"RECTYPE": "D", "MH": "Guanine Deaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Guanine Aminohydrolase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Deaminase, Guanine", "MN": "D08.811.277.151.350", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Guanine aminohydrolase", "RN": "EC 3.5.4.3", "PI": "Guanine (1973-1974)", "MS": "An enzyme that catalyzes the deamination of guanine to form xanthine. EC 3.5.4.3.", "PM": "91; was see under AMINOHYDROLASES 1975-90", "HN": "91(75); was see under AMINOHYDROLASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006148"}, {"RECTYPE": "D", "MH": "Guanine Nucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Guanosine Phosphates|T114|NON|EQV|UNK (19XX)|741105|abcdef", "ENTRY": "Phosphates, Guanosine", "MN": "D13.695.827.426", "MH_TH": "NLM (1966)", "ST": "T114", "RN": "0", "AN": "/biosyn /physiol permitted", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006150"}, {"RECTYPE": "D", "MH": "Guanosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D13.570.800.453", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "Guanosine", "RN": "12133JR80S", "RR": "118-00-3 (Guanosine)", "PI": "Nucleosides (1966-1971)", "MS": "A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed)", "OL": "search NUCLEOSIDES 1966-71", "PM": "72; was see under NUCLEOSIDES 1963-71", "HN": "72; was see under NUCLEOSIDES 1963-71", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006151"}, {"RECTYPE": "D", "MH": "Cyclic GMP", "DE": "CYCL GMP", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Guanosine Cyclic 3',5'-Monophosphate|T114|T123|NON|EQV|UNK (19XX)|790522|GUANOSINE CYCLIC MONOPHOSPHATE 03 05|abbcdefs", "ENTRY": "Monophosphate, Guanosine Cyclic", "MN": "D13.695.827.426.160", "MH_TH": "NLM (1971)", "ST": "T123", "N1": "Guanosine, cyclic 3',5'-(hydrogen phosphate)", "RN": "H2D2X058MU", "RR": "7665-99-8 (Cyclic GMP)", "PI": "Guanine Nucleotides (1966-1971)", "MS": "Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed)", "OL": "use CYCLIC GMP to search GUANOSINE CYCLIC MONOPHOSPHATE & GUANOSINE CYCLIC 2',3'-MONOPHOSPHATE 1980-93 & GUANOSINE CYCLIC-3',5'-MONOPHOSPHATE 1971-79 (as Prov 1971)", "PM": "94; was GUANOSINE CYCLIC MONOPHOSPHATE 1980-93, was GUANOSINE CYCLIC-3',5'-MONOPHOSPHATE 1978-79, was GUANOSINE CYCLIC 3',5' MONOPHOSPHATE 1972-77; CYCLIC GMP was see GUANOSINE CYCLIC MONOPHOSPHATE 1975-93; GUANOSINE CYCLIC 2',3'-MONOPHOSPHATE was see GUANOSINE CYCLIC MONOPHOSPHATE 1980-93", "HN": "94; was GUANOSINE CYCLIC MONOPHOSPHATE 1980-93, was GUANOSINE CYCLIC-3',5'-MONOPHOSPHATE 1978-79, was GUANOSINE CYCLIC 3',5' MONOPHOSPHATE 1971-77 (Prov 1971); CYCLIC GMP was see GUANOSINE CYCLIC MONOPHOSPHATE 1975-93; GUANOSINE CYCLIC 2',3'-MONOPHOSPHATE was see GUANOSINE CYCLIC MONOPHOSPHATE 1980-93", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006152"}, {"RECTYPE": "D", "MH": "Guanosine Diphosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "GDP|T114|T123|ABB|EQV|UNK (19XX)|770420|abbcdef", "ENTRY": "Guanosine 5' Trihydrogen Diphosphate", "MN": "D13.695.827.426.340", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Guanosine 5'-(trihydrogen diphosphate)", "RN": "146-91-8", "AN": "/biosyn /physiol permitted", "PI": "Guanine Nucleotides (1966-1977)", "MS": "A guanine nucleotide containing two phosphate groups esterified to the sugar moiety.", "PM": "91; was see under GUANINE NUCLEOTIDES 1978-90", "HN": "91(78); was see under GUANINE NUCLEOTIDES 1978-90", "MR": "20160531", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D006153"}, {"RECTYPE": "D", "MH": "Guanosine Diphosphate Fucose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Guanosine Diphosphofucose|T109|T114|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Fucose, Guanosine Diphosphate", "MN": "D13.695.827.708.400.410", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Guanosine 5'-(trihydrogen diphosphate), P'-(6-deoxy-beta-L-galactopyranosyl) ester", "RN": "15839-70-0", "AN": "/biosyn /physiol permitted", "PI": "Nucleoside Diphosphate Sugars (1973-1974)", "MS": "A nucleoside diphosphate sugar formed from GDPmannose, which provides fucose for lipopolysaccharides of bacterial cell walls, and for blood group substances and other glycoproteins.", "PM": "91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006154"}, {"RECTYPE": "D", "MH": "Guanosine Diphosphate Mannose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Guanosine Pyrophosphate Mannose|T109|T114|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Pyrophosphate Mannose, Guanosine", "MN": "D13.695.827.708.400.500", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Guanosine 5'-(trihydrogen diphosphate), mono-alpha-D-mannopyranosyl ester", "RN": "3123-67-9", "AN": "/biosyn /physiol permitted", "PI": "Nucleoside Diphosphate Sugars (1973-1974)", "MS": "A nucleoside diphosphate sugar which can be converted to the deoxy sugar GDPfucose, which provides fucose for lipopolysaccharides of bacterial cell walls. Also acts as mannose donor for glycolipid synthesis.", "PM": "91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006155"}, {"RECTYPE": "D", "MH": "Guanosine Diphosphate Sugars", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "GDP Sugars|T109|T114|EQV|UNK (19XX)|760507|abbdef", "ENTRY": "Sugars, Guanosine Diphosphate", "MN": "D13.695.827.708.400", "MH_TH": "NLM (1975)", "ST": "T114", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Nucleoside Diphosphate Sugars (1973-1974)", "MS": "Esters formed between the aldehydic carbon of sugars and the terminal phosphate of guanosine diphosphate.", "PM": "91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006156"}, {"RECTYPE": "D", "MH": "Guanosine Monophosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Guanosine 5'-Monophosphate|T114|NON|EQV|NLM (1994)|921026|GUANOSINE MONOPHOSPHATE 05|abcdefs", "ENTRY": "Monophosphate, Guanosine", "MN": "D13.695.827.426.400", "MH_TH": "NLM (1994)", "ST": "T114", "N1": "5'-Guanylic acid", "RN": "85-32-5", "PI": "Guanine Nucleotides (1966-1974)", "MS": "A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature.", "OL": "use 5'-GUANYLIC ACID to search GUANOSINE MONOPHOSPHATE & GUANYLIC ACID 1978-93; use GUANINE NUCLEOTIDES 1966-77", "PM": "2012; see 5'-Guanylic Acid 1994-2012", "HN": "2012 (1994)", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006157"}, {"RECTYPE": "D", "MH": "Guanosine Pentaphosphate", "DE": "PPPGPP", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ppprGpp|T114|T123|ABB|EQV|NLM (2021)|200124|abbcdef", "ENTRY": "pppGpp, Alarmone", "MN": "D13.695.827.426.440", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Guanosine 5'-(tetrahydrogen triphosphate), 3'-(trihydrogen diphosphate)", "RN": "38918-96-6", "PI": "Guanine Nucleotides (1966-1977)", "MS": "Guanosine 5'-triphosphate 2'(3')-diphosphate. A guanine nucleotide containing five phosphate groups. Three phosphate groups are esterified to the sugar moiety in the 5' position and the other two in the 2' or 3' position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis.", "PM": "91; was see under GUANINE NUCLEOTIDES 1978-90", "HN": "91(78); was see under GUANINE NUCLEOTIDES 1978-90", "MR": "20200228", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D006158"}, {"RECTYPE": "D", "MH": "Guanosine Tetraphosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ppGpp|T114|T123|NON|EQV|NLM (2021)|200124|abbcdef", "ENTRY": "ppGpp, Alarmone", "MN": "D13.695.827.426.480", "MH_TH": "NLM (1978)", "ST": "T123", "RN": "33503-72-9", "PI": "Guanine Nucleotides (1966-1977)", "MS": "Guanosine 5'-diphosphate 2'(3')-diphosphate. A guanine nucleotide containing four phosphate groups. Two phosphate groups are esterified to the sugar moiety in the 5' position and the other two in the 2' or 3' position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis. Synonym: magic spot I.", "PM": "91; was see under GUANINE NUCLEOTIDES 1978-90", "HN": "91(78); was see under GUANINE NUCLEOTIDES 1978-90", "MR": "20200228", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D006159"}, {"RECTYPE": "D", "MH": "Guanosine Triphosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "GTP|T114|T123|ABB|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "Triphosphate, Guanosine", "MN": "D13.695.827.426.504", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "Guanosine 5'-(tetrahydrogen triphosphate)", "RN": "86-01-1", "AN": "/biosyn /physiol permitted", "PI": "Guanine Nucleotides (1966-1971)", "MS": "Guanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety.", "PM": "72", "HN": "72", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006160"}, {"RECTYPE": "D", "MH": "Guanylate Cyclase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Guanyl Cyclase|T116|T126|NON|EQV|NLM (1995)|940302|abbcdef", "ENTRY": "Cyclase, Inosinate", "MN": "D12.776.476.350", "MH_TH": "NLM (1973)", "ST": "T126", "N1": "GTP pyrophosphate-lyase (cyclizing)", "RN": "EC 4.6.1.2", "RR": "9054-75-5 (CAS RN)", "PI": "Nucleotidyltransferases (1966-1972)", "MS": "An enzyme that catalyzes the conversion of GTP to 3',5'-cyclic GMP and pyrophosphate. It also acts on ITP and dGTP. (From Enzyme Nomenclature, 1992) EC 4.6.1.2.", "OL": "use GUANYLATE CYCLASE to search GUANYL CYCLASE 1973-94", "PM": "94; was GUANYL CYCLASE 1973-94", "HN": "94; was GUANYL CYCLASE 1973-94", "MR": "20210521", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006162"}, {"RECTYPE": "D", "MH": "Ribonuclease T1", "DS": "RIBONUCLEASE T 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ribonuclease N1|T116|T126|NON|EQV|UNK (19XX)|741111|RIBONUCLEASE N 01|abbcdefs", "ENTRY": "Ribonuclease, Aspergillus oryzae", "MN": "D08.811.277.352.700.350.725", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Ribonucleate 3'-guanylo-oligonucleotidohydrolase", "RN": "EC 3.1.27.3", "PI": "Ribonucleases (1974)", "MS": "An enzyme catalyzing the endonucleolytic cleavage of RNA at the 3'-position of a guanylate residue. EC 3.1.27.3.", "OL": "use RIBONUCLEASE T1 to search GUANYLORIBONUCLEASE 1975-91", "PM": "92; was GUANYLORIBONUCLEASE 1975-91 (see under ENDORIBONUCLEASES 1984-90 & see under RIBONUCLEASES 1975-83)", "HN": "92; was GUANYLORIBONUCLEASE 1975-91 (was see under ENDORIBONUCLEASES 1984-90 & see under RIBONUCLEASES 1975-83)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006163"}, {"RECTYPE": "D", "MH": "Guanylthiourea", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gutimine|T109|T121|NON|EQV|UNK (19XX)|780207|abbcdef", "ENTRY": "Gutimin|T109|T121|NON|EQV|UNK (19XX)|780207|abbcdef", "MN": "D02.886.904.365", "MH_TH": "NLM (1979)", "ST": "T121", "N1": "Thiourea, (aminoiminomethyl)-", "RN": "LF1NJY8ID8", "RR": "2114-02-5 (Guanylthiourea)", "PI": "Thiourea (1966-1978)", "MS": "May protect against hypoxic damage; proposed for treatment of shock due to trauma or blood loss; also stimulates paretic gastrointestinal system.", "PM": "91; was see under THIOUREA 1979-90", "HN": "91(79); was see under THIOUREA 1979-90", "MR": "20200527", "DA": "19780207", "DC": "1", "DX": "19910101", "UI": "D006164"}, {"RECTYPE": "D", "MH": "Guanylyl Imidodiphosphate", "DE": "GPPNHP", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "GMP-PNP|T114|T123|ABB|EQV|NLM (1999)|980224|abbcdef", "ENTRY": "Imidodiphosphate, Guanylyl", "MN": "D13.695.827.426.504.400", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "5'-Guanylic acid, monoanhydride with imidodiphosphoric acid", "RN": "34273-04-6", "PI": "Guanosine Triphosphate (1972-1977)", "MS": "A non-hydrolyzable analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It binds tightly to G-protein in the presence of Mg2+. The nucleotide is a potent stimulator of ADENYLYL CYCLASES.", "PM": "91; was see under GUANOSINE TRIPHOSPHATE 1978-90", "HN": "91(78); was see under GUANOSINE TRIPHOSPHATE 1978-90", "MR": "20160531", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D006165"}, {"RECTYPE": "D", "MH": "Guatemala", "AQ": "EH EP", "MN": "Z01.107.169.454", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in CENTRAL AMERICA bordering the North Pacific Ocean, between EL SALVADOR and MEXICO, and bordering the Gulf of Honduras (Caribbean Sea) between HONDURAS and BELIZE.", "MR": "20151124", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D006166"}, {"RECTYPE": "D", "MH": "Guilt", "ENTRY": "Guilts", "MN": "F01.470.483", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "Subjective feeling of having committed an error, offense or sin; unpleasant feeling of self-criticism. These result from acts, impulses, or thoughts contrary to one's personal conscience.", "CATSH": "CAT LIST", "MR": "19890428", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006167"}, {"RECTYPE": "D", "MH": "Guinea Pigs", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Cavia|T015|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Pigs, Guinea", "MN": "B01.050.150.900.649.313.992.550", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid10140", "RR": "txid10141", "AN": "check tag: no qualif", "MS": "A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006168"}, {"RECTYPE": "D", "MH": "Guinea-Bissau", "AQ": "EH EP", "PRINT ENTRY": "Portuguese Guinea|T083|NAM|EQV|NLM (1992)|901203|abcdef", "ENTRY": "Republic of Guinea-Bissau|T083|NON|EQV|NLM (2009)|080327|abcdef", "MN": "Z01.058.290.190.380", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "do not confuse entry term PORTUGUESE GUINEA (its former name) with GUINEA (formerly French Guinea) or EQUATORIAL GUINEA (formerly Spanish Guinea)", "MS": "A republic in western Africa, south of SENEGAL and west of GUINEA. Its capital is Bissau.", "HN": "80", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19800101", "UI": "D006169"}, {"RECTYPE": "D", "MH": "Gum Arabic", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Gum Acacia|T121|NON|EQV|UNK (19XX)|790430|abcdef", "ENTRY": "Gum, Acacia", "MN": "D20.215.721.249.500", "MH_TH": "NLM (1980)", "ST": "T121", "N1": "Gum arabic", "RN": "9000-01-5", "PI": "Polysaccharides (1966-1979)", "MS": "Powdered exudate from various Acacia species, especially A. senegal (Leguminosae). It forms mucilage or syrup in water. Gum arabic is used as a suspending agent, excipient, and emulsifier in foods and pharmaceuticals.", "PM": "91; was see under POLYSACCHARIDES 1980-90", "HN": "91(80); was see under POLYSACCHARIDES 1980-90", "MR": "20060705", "DA": "19790430", "DC": "1", "DX": "19910101", "UI": "D006170"}, {"RECTYPE": "D", "MH": "Gutta-Percha", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Thermafil|T122|T123|TRD|NRW|NLM (1992)|191204|abbcdef", "ENTRY": "Gutta Percha", "MN": "J01.637.051.339.859.495", "MH_TH": "NLM (1965)", "ST": "T123", "N1": "Gutta-percha", "RN": "9000-32-2", "MS": "Coagulated exudate isolated from several species of the tropical tree Palaquium (Sapotaceae). It is the trans-isomer of natural rubber and is used as a filling and impression material in dentistry and orthopedics and as an insulator in electronics. It has also been used as a rubber substitute.", "PM": "65", "HN": "65", "MR": "20191204", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006171"}, {"RECTYPE": "D", "MH": "Guyana", "AQ": "EH EP", "PRINT ENTRY": "Guiana, British|T083|NAM|EQV|NLM (1996)|950217|abcdef", "MN": "Z01.107.757.488", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "do not confuse with GUINEA in Africa", "MS": "A republic in the north of South America, east of VENEZUELA and west of SURINAME. Its capital is Georgetown.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D006172"}, {"RECTYPE": "D", "MH": "Gymnastics", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Calisthenics|T056|NON|NRW|UNK (19XX)|820429|abcdef", "MN": "I03.450.642.845.417", "MH_TH": "NLM (1966)", "ST": "T056", "AN": "\"corrective gymnastics\" is probably EXERCISE THERAPY", "MS": "A system of exercise using the weight of the body and specific apparatus to promote strength and grace of carriage.", "OL": "use GYMNASTICS to search CALISTHENICS 1966-82", "HN": "CALISTHENICS was see under GYMNASTICS 1963-82", "MR": "20160614", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006173"}, {"RECTYPE": "D", "MH": "Gynatresia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Asherman Syndrome|T047|EPO|NRW|NLM (1998)|ORD (2010)|960926|abcdeef", "ENTRY": "Synechiae, Uterine", "MN": "C12.100.250.320", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Absence of a normal opening in the lumen of the female genital tract, from the FALLOPIAN TUBES to the VAGINA. This anomaly may be congenital or acquired due to injuries, diseases, or TISSUE ADHESIONS.", "PM": "98", "HN": "98; use explode 1979-97", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19771123", "DC": "1", "DX": "19980101", "UI": "D006175"}, {"RECTYPE": "D", "MH": "Gynecology", "DE": "GYNECOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.810.310", "FX": "Reproductive Medicine", "MH_TH": "POPLINE (1994)", "ST": "T091", "AN": "specialty; corresponding organ term is GENITALIA, FEMALE", "MS": "A medical-surgical specialty concerned with the physiology and disorders primarily of the female genital tract, as well as female endocrinology and reproductive physiology.", "MR": "20210312", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006176"}, {"RECTYPE": "D", "MH": "Gynecomastia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Gynecomastia, Newborn", "MN": "C17.800.090.875", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "check tags HUMANS & MALE", "MS": "Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males.", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006177"}, {"RECTYPE": "D", "MH": "Roma", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Gypsies|T098|NON|EQV|NLM (1979)|990101|abcdef", "ENTRY": "Gypsy", "MN": "M01.270.984", "MH_TH": "NLM (2016)", "ST": "T098", "AN": "use this spelling in translations; specify geographic term", "PI": "Ethnology (1966-1967)", "MS": "Ethnic group originating in India and entering Europe in the 14th or 15th century.", "PM": "2016; see GYPSIES 1991-2015, see ETHNIC GROUPS 1979-90", "HN": "2016(1979); use GYPSIES 1991-2015, use ETHNIC GROUPS 1979-1990", "MR": "20210630", "DA": "19780428", "DC": "1", "DX": "19910101", "UI": "D006178"}, {"RECTYPE": "D", "MH": "Gyrus Cinguli", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Retrosplenial Cortex|T023|NON|NRW|NLM (2021)|200506|abcdef", "ENTRY": "Superior Mesial Region", "MN": "A08.186.211.200.885.287.500.382.500", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "One of the convolutions on the medial surface of the CEREBRAL HEMISPHERES. It surrounds the rostral part of the brain and CORPUS CALLOSUM and forms part of the LIMBIC SYSTEM.", "MR": "20230824", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006179"}, {"RECTYPE": "D", "MH": "Proton-Translocating ATPases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proton-Translocating ATPase Complexes|T116|T126|ACX|EQV|NLM (2002)|001016|abbcdef", "ENTRY": "Triphosphatase Complex, Adenosine", "MN": "D12.776.543.585.450.250.875.500", "MH_TH": "NLM (2002)", "ST": "T126", "N1": "ATP phosphohydrolase (H+-transporting)", "RN": "EC 3.6.3.14", "RR": "EC 3.6.3.6 (acyl-phosphate-linked)", "AN": "general or unspecified; prefer specifics; do not confuse with H(+)-K(+)-TRANSPORTING ATPASE see H(+)-K(+)-EXCHANGING ATPASE", "PI": "Adenosine Triphosphatase (1966-1982)", "MS": "Multisubunit enzymes that reversibly synthesize ADENOSINE TRIPHOSPHATE. They are coupled to the transport of protons across a membrane.", "PM": "2002; see H(+)-TRANSPORTING ATP SYNTHASE 1993-2001, H(+)-TRANSPORTING ATPASE 1984-92, ADENOSINE TRIPHOSPHATASE F1 1983; for ATPASE, F0 see ATPASE F(0) 1984-1992; for ATPASE, F1 see ATPASE F1 1983-1992; for F1F0 ATPASE COMPLEX see H(+)-TRANSPORTING ATP SYNTHASE 1984-1993; F(1)F(0) ATPASE was indexed under ADENOSINE TRIPHOSPHATASE 1979-1985 & H(+)-TRANSPORTING ATP SYNTHASE 1986-1993", "HN": "2002(1983); for F(1)F(0)-ATPASE use PROTON-TRANSLOCATING ATPASES (NM)", "MR": "20130709", "DA": "19820511", "DC": "1", "DX": "19830101", "UI": "D006180"}, {"RECTYPE": "D", "MH": "H-Reflex", "DS": "H REFLEX", "AQ": "DE ES GE IM PH RE", "ENTRY": "Reflex, H", "MN": "G11.561.731.643.474", "MH_TH": "NLM (1975)", "ST": "T042", "MS": "A monosynaptic reflex elicited by stimulating a nerve, particularly the tibial nerve, with an electric shock.", "OL": "search REFLEX, MONOSYNAPTIC 1970-74", "PM": "91; was see under REFLEX, MONOSYNAPTIC 1975-90", "HN": "91(75); was see under REFLEX, MONOSYNAPTIC 1975-90", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006181"}, {"RECTYPE": "D", "MH": "H-Y Antigen", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "HY Antigen|T129|NON|EQV|UNK (19XX)|780703|abcdef", "ENTRY": "H Y Antigen", "MN": "D23.050.705.552.600.400", "MH_TH": "NLM (1979)", "ST": "T129", "RN": "0", "AN": "mammals only", "PI": "Histocompatibility Antigens (1973-1978)", "MS": "A sex-specific cell surface antigen produced by the sex-determining gene of the Y chromosome in mammals. It causes syngeneic grafts from males to females to be rejected and interacts with somatic elements of the embryologic undifferentiated gonad to produce testicular organogenesis.", "PM": "79", "HN": "79", "MR": "20050630", "DA": "19780317", "DC": "1", "DX": "19790101", "UI": "D006182"}, {"RECTYPE": "D", "MH": "H-2 Antigens", "DS": "H A 02 ANTIGENS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "H 2 Antigens", "MN": "D23.050.705.552.410.199", "MH_TH": "NLM (1978)", "ST": "T129", "RN": "0", "AN": "mouse only", "PI": "Transplantation Immunology (1966-1969)", "MS": "The major group of transplantation antigens in the mouse.", "PM": "78", "HN": "78", "MR": "20110624", "DA": "19770329", "DC": "1", "DX": "19780101", "UI": "D006183"}, {"RECTYPE": "D", "MH": "Habits", "PRINT ENTRY": "Habit Disturbances|T048|T055|NON|NRW|UNK (19XX)|800521|abbcdef", "ENTRY": "Habit Disturbance", "MN": "F01.145.466", "MH_TH": "NLM (1969)", "ST": "T055", "MS": "Acquired or learned responses which are regularly manifested.", "OL": "use HABITS to search HABIT 1966-68", "PM": "69; was HABIT 1963-68", "HN": "69; was HABIT 1963-68", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D006184"}, {"RECTYPE": "D", "MH": "Habituation, Psychophysiologic", "DE": "HABITUATION PSYCHOPHYSIOL", "AQ": "CL DE ES GE PH RE", "ENTRY": "Habituations (Psychophysiology)", "MN": "G11.561.312", "MH_TH": "UNK (19XX)", "ST": "T041", "PI": "Learning (1966-1967)", "MS": "The disappearance of responsiveness to a repeated stimulation. It does not include drug habituation.", "PM": "2007; see HABITUATION (PSYCHOPHYSIOLOGY) 1970-2006", "HN": "2007 (1968)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D006185"}, {"RECTYPE": "D", "MH": "Haemonchiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Haemonchiases", "MN": "C01.610.335.508.700.775.825.400", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "nematode infect", "MS": "Infection with nematodes of the genus HAEMONCHUS, characterized by digestive abnormalities and anemia similar to that from hookworm infestation.", "OL": "search TRICHOSTRONGYLOIDIASIS 1968-74", "PM": "91; was see under TRICHOSTRONGYLOIDIASIS 1975-90", "HN": "91(75); was see under TRICHOSTRONGYLOIDIASIS 1975-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006188"}, {"RECTYPE": "D", "MH": "Haemonchus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Hemonchus|T204|NON|EQV|NLM (2010)|080918|abcdef", "MN": "B01.050.500.500.294.400.968.746.410", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid6288", "MS": "A genus of parasitic nematode worms which infest the duodenum and stomach of domestic and wild herbivores, which ingest it with the grasses (POACEAE) they eat. Infestation of man is accidental.", "OL": "search TRICHOSTRONGYLOIDEA 1966-74", "PM": "91; was see under TRICHOSTRONGYLOIDEA 1975-90", "HN": "91(75); was see under TRICHOSTRONGYLOIDEA 1975-90", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006189"}, {"RECTYPE": "D", "MH": "Haemophilus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Hemophilus|T007|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "B03.660.250.550.290", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid724", "MS": "A genus of PASTEURELLACEAE that consists of several species occurring in animals and humans. Its organisms are described as gram-negative, facultatively anaerobic, coccobacillus or rod-shaped, and nonmotile.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006190"}, {"RECTYPE": "D", "MH": "Haemophilus ducreyi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Hemophilus ducreyi|T007|NON|EQV|NLM (1992)|910327|abcdef", "MN": "B03.660.250.550.290.125", "FX": "Chancroid", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid730", "MS": "A species of HAEMOPHILUS that appears to be the pathogen or causative agent of the sexually transmitted disease, CHANCROID.", "MR": "20200128", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006191"}, {"RECTYPE": "D", "MH": "Haemophilus Infections", "DE": "HAEMOPHILUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Hemophilus Infections|T047|NON|EQV|UNK (19XX)|870507|HEMOPHILUS INFECT|abcdefv", "ENTRY": "Infection, Hib", "MN": "C01.150.252.400.700.433", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "check text for species & index by instructions on species; MENINGITIS, HAEMOPHILUS is also available ", "PI": "Haemophilus (1966-1967)", "MS": "Infections with bacteria of the genus HAEMOPHILUS.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006192"}, {"RECTYPE": "D", "MH": "Haemophilus influenzae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mycobacterium influenzae|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.550.290.330", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid727", "MS": "A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII.", "MR": "20200128", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006193"}, {"RECTYPE": "D", "MH": "Gardnerella vaginalis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Haemophilus vaginalis|T007|NON|EQV|UNK (19XX)|991012|abcdef", "ENTRY": "Hemophilus vaginalis|T007|NON|EQV|UNK (19XX)|870507|abcdef", "MN": "B03.510.024.400.800", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid2702", "AN": "infection: coordinate with GRAM-POSITIVE BACTERIAL INFECTIONS and also with VAGINOSIS, BACTERIAL if pertinent ", "MS": "A species in the genus GARDNERELLA previously classified as Haemophilus vaginalis. This bacterium, also isolated from the female genital tract of healthy women, is implicated in the cause of bacterial vaginosis (VAGINOSIS, BACTERIAL).", "OL": "use GARDNERELLA VAGINALIS to search HAEMOPHILUS VAGINALIS 1975-89 & CORYNEBACTERIUM VAGINALE 1983-91", "PM": "90; was HAEMOPHILUS VAGINALIS see under HAEMOPHILUS 1975-89; CORYNEBACTERIUM VAGINALE was see GARDNERELLA VAGINALIS 1983-91", "HN": "90(75); was HAEMOPHILUS VAGINALIS see under HAEMOPHILUS 1975-89; CORYNEBACTERIUM VAGINALE was see GARDNERELLA VAGINALIS 1983-91", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19900101", "UI": "D006194"}, {"RECTYPE": "D", "MH": "Hafnium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.337", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Hafnium", "RN": "X71938L1DO", "RR": "7440-58-6 (Hafnium)", "MS": "A metal element of atomic number 72 and atomic weight 178.49, symbol Hf.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006195"}, {"RECTYPE": "D", "MH": "Hagfishes", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Myxiniforme", "MN": "B01.050.500.272.400.380", "MH_TH": "NLM (2002)", "ST": "T204", "RN": "txid7762", "RR": "txid7761", "MS": "Common name for a family of eel-shaped jawless fishes (Myxinidae), the only family in the order MYXINIFORMES. They are not true vertebrates.", "PM": "2002; see HAGFISH 1991-2001, see CYCLOSTOMES 1975-1990", "HN": "2002 (1975)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006196"}, {"RECTYPE": "D", "MH": "Hair", "AQ": "AB AH CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE TR UL VI", "PRINT ENTRY": "Lanugo|T017|NON|NRW|UNK (19XX)|771205|abcdef", "ENTRY": "Hairs, Fetal", "MN": "A17.360", "FX": "Hair Analysis", "MH_TH": "NLM (1966)", "ST": "T017", "MS": "A filament-like structure consisting of a shaft which projects to the surface of the SKIN from a root which is softer than the shaft and lodges in the cavity of a HAIR FOLLICLE. It is found on most surfaces of the body.", "OL": "use HAIR to search LANUGO 1966-78", "HN": "LANUGO was see under HAIR 1963-78", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006197"}, {"RECTYPE": "D", "MH": "Hair Cells, Auditory", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Hair Cells, Cochlear", "MN": "A11.671.650.915.750.600.350", "FX": "Stereocilia", "MH_TH": "NLM (2008)", "ST": "T025", "PI": "Organ of Corti (1966-1976)", "MS": "Sensory cells in the organ of Corti, characterized by their apical stereocilia (hair-like projections). The inner and outer hair cells, as defined by their proximity to the core of spongy bone (the modiolus), change morphologically along the COCHLEA. Towards the cochlear apex, the length of hair cell bodies and their apical STEREOCILIA increase, allowing differential responses to various frequencies of sound.", "PM": "2008; see HAIR CELLS 1980-2007, see MECHANORECEPTORS 1977-1979", "HN": "2008 (1977)", "MR": "20180702", "DA": "19760427", "DC": "1", "DX": "19800101", "UI": "D006198"}, {"RECTYPE": "D", "MH": "Hair Cells, Auditory, Inner", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Inner Hair Cell", "MN": "A11.671.650.915.750.600.350.350", "FX": "Stereocilia", "MH_TH": "NLM (2008)", "ST": "T025", "PI": "Organ of Corti (1966-1976)", "MS": "Auditory sensory cells of organ of Corti, usually placed in one row medially to the core of spongy bone (the modiolus). Inner hair cells are in fewer numbers than the OUTER AUDITORY HAIR CELLS, and their STEREOCILIA are approximately twice as thick as those of the outer hair cells.", "PM": "2008; see HAIR CELLS 1980-2007", "HN": "2008 (1980)", "MR": "20180702", "DA": "19781221", "DC": "1", "DX": "19910101", "UI": "D006199"}, {"RECTYPE": "D", "MH": "Hair Color", "AQ": "DE ES GE IM PH RE", "ENTRY": "Hair Colors", "MN": "G16.690.490", "MH_TH": "NLM (1976)", "ST": "T032", "AN": "natural color of human hair or animal fur; do not use for color of hair after dyeing", "PI": "Pigments (1966-1975)", "MS": "Color of hair or fur.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D006200"}, {"RECTYPE": "D", "MH": "Hair Diseases", "DE": "HAIR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hair Disease", "MN": "C17.800.329", "MH_TH": "POPLINE (1984)", "ST": "T047", "AN": "general or unspecified; prefer specifics; diseases of hair follicles: coordinate with HAIR FOLLICLES ", "PI": "Skin Appendage Diseases (1968-1979)", "MS": "Diseases affecting the orderly growth and persistence of hair.", "OL": "use HAIR DISEASES to search HAIR FOLLICLE DISEASES 1993-95", "PM": "80; HAIR FOLLICLE DISEASES was see HAIR DISEASES 1993-95", "HN": "80; was HAIR FOLLICLE DISEASES (NON MESH) before 1980; HAIR FOLLICLE DISEASES was see HAIR DISEASES 1993-95", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D006201"}, {"RECTYPE": "D", "MH": "Hair Dyes", "AQ": "AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO", "PRINT ENTRY": "Hair Dye|T120|NON|EQV|NLM (2021)|200204|abcdef", "ENTRY": "Hair Coloring Agents", "MN": "D27.720.269.430.430", "MH_TH": "NLM (1979)", "ST": "T120", "RN": "0", "PI": "Hair Color (1976-1978)", "MS": "Dyes used as cosmetics to change hair color either permanently or temporarily.", "PM": "91; was see under HAIR PREPARATIONS 1980-90; was see under COSMETICS 1979", "HN": "91(79); was see under HAIR PREPARATIONS 1980-90; was see under COSMETICS 1979", "MR": "20200527", "DA": "19780501", "DC": "1", "DX": "19910101", "UI": "D006202"}, {"RECTYPE": "D", "MH": "Hair Preparations", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Hair Preparation|T073|T120|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Preparations, Hair", "MN": "D27.720.269.430", "MH_TH": "NLM (1980)", "ST": "T120", "RN": "0", "AN": "HAIR DYES and HAIR BLEACHING AGENTS are also available", "PI": "Hair (1966-1979)", "MS": "Hair grooming, cleansing and modifying products meant for topical application to hair, usually human. They include sprays, bleaches, dyes, conditioners, rinses, shampoos, nutrient lotions, etc.", "PM": "80", "HN": "80", "MR": "20200527", "DA": "19790530", "DC": "1", "DX": "19800101", "UI": "D006203"}, {"RECTYPE": "D", "MH": "Hair Removal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Epilation|T061|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Removals, Hair", "MN": "E02.218.372", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Methods used to remove unwanted facial and body hair.", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006204"}, {"RECTYPE": "D", "MH": "Haiti", "AQ": "EH EP", "MN": "Z01.639.880.425", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "A republic in the Greater Antilles in the West Indies. Its capital is Port-au-Prince. With the Dominican Republic it forms the island of Hispaniola - Haiti occupying the western third and the Dominican Republic, the eastern two thirds. Haiti belonged to France from 1697 until its rule was challenged by slave insurrections from 1791. It became a republic in 1820. It was virtually an American protectorate from 1915 to 1934. It adopted its present constitution in 1964 and amended it in 1971. The name may represent either of two Caribbean words, haiti, mountain land, or jhaiti, nest. (From Webster's New Geographical Dictionary, 1988, p481 & Room, Brewer's Dictionary of Names, 1992, p225)", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D006205"}, {"RECTYPE": "D", "MH": "Halcinonide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SQ18,566", "MN": "D04.210.500.745.745.654.570", "PA": "Anti-Inflammatory Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregn-4-ene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-", "RN": "SI86V6QNEG", "RR": "3093-35-4 (Halcinonide)", "PI": "Pregnenediones (1974-1978)", "MS": "A glucocorticoid used topically in the treatment of DERMATITIS; ECZEMA; or PSORIASIS. It may cause skin irritation.", "PM": "91; was see under PREGNENEDIONES 1979-90", "HN": "91(79); was see under PREGNENEDIONES 1979-90", "MR": "20170524", "DA": "19780207", "DC": "1", "DX": "19910101", "UI": "D006206"}, {"RECTYPE": "D", "MH": "Half-Life", "ENTRY": "Halflifes", "MN": "G01.910.405", "MH_TH": "NLM (1971)", "ST": "T079", "AN": "usually NIM", "PI": "specific radioisotope, substance, or cell", "MS": "The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity.", "PM": "74", "HN": "74(71)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006207"}, {"RECTYPE": "D", "MH": "Halfway Houses", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Houses, Halfway", "MN": "J03.775.450", "MH_TH": "NLM (1965)", "ST": "T093", "MS": "Specialized residences for persons who do not require full hospitalization, and are not well enough to function completely within the community without professional supervision, protection and support.", "PM": "67", "HN": "67(65)", "MR": "20160616", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006208"}, {"RECTYPE": "D", "MH": "Halitosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Halitoses", "MN": "C23.888.821.475", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "An offensive, foul breath odor resulting from a variety of causes such as poor oral hygiene, dental or oral infections, or the ingestion of certain foods.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006209"}, {"RECTYPE": "D", "MH": "Hallermann's Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hallermann-Streiff Syndrome|T019|EPO|EQV|NLM (1995)|OMIM (2013)|ORD (2010)|940516|abcdeeef", "ENTRY": "Syndromes, Francois Dyscephalic", "MN": "C16.131.621.207.231.427", "MH_TH": "NLM (1965)", "ST": "T019", "AN": "a form of craniofacial dysostosis with other abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "An oculomandibulofacial syndrome principally characterized by dyscephaly (usually brachycephaly), parrot nose, mandibular hypoplasia, proportionate nanism, hypotrichosis, bilateral congenital cataracts, and microphthalmia. (Dorland, 27th ed)", "PM": "91; was see under CRANIOFACIAL DYSOSTOSIS 1985-90; was see under MANDIBULOFACIAL DYSOSTOSIS 1965-84", "HN": "91(65); was see under CRANIOFACIAL DYSOSTOSIS 1985-90; was see under MANDIBULOFACIAL DYSOSTOSIS 1965-84", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006210"}, {"RECTYPE": "D", "MH": "Pantothenate Kinase-Associated Neurodegeneration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pigmentary Pallidal Degeneration|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Pantothenate Kinase Associated Neurodegeneration", "MN": "C16.320.400.650", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A rare autosomal recessive degenerative disorder which usually presents in late childhood or adolescence. Clinical manifestations include progressive MUSCLE SPASTICITY; hyperreflexia; MUSCLE RIGIDITY; DYSTONIA; DYSARTHRIA; and intellectual deterioration which progresses to severe dementia over several years. (From Adams et al., Principles of Neurology, 6th ed, p972; Davis & Robertson, Textbook of Neuropathology, 2nd ed, pp972-929)", "PM": "2008; see HALLERVORDEN-SPATZ SYNDROME 1991-2007, see BASAL GANGLIA DISEASES 1979-1990, see BRAIN DISEASES 1975-1978", "HN": "2008 (1965)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006211"}, {"RECTYPE": "D", "MH": "Hallucinations", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Visual Hallucinations", "MN": "F01.700.750.300", "FX": "Hallucinogens", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "/chem ind: consider also HALLUCINOGENS", "MS": "Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006212"}, {"RECTYPE": "D", "MH": "Hallucinogens", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Psychotomimetic Agents|T121|T131|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Substances, Hallucinogenic", "MN": "D27.505.954.427.700.372", "FX": "Hallucinations", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "MS": "Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006213"}, {"RECTYPE": "D", "MH": "Hallux", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU TR VI", "ENTRY": "Toes, Great", "MN": "A01.378.610.250.300.792.380", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "primates only", "MS": "The innermost digit of the foot in PRIMATES.", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006214"}, {"RECTYPE": "D", "MH": "Hallux Valgus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hallux Abductovalgus|T190|NON|EQV|UNK (19XX)|870402|abcdef", "MN": "C05.330.610", "FX": "Bunion, Tailor's", "MH_TH": "NLM (1963)", "ST": "T190", "AN": "note BUNION is also available", "MS": "Lateral displacement of the great toe (HALLUX), producing deformity of the first METATARSOPHALANGEAL JOINT with callous, bursa, or BUNION formation over the bony prominence.", "PM": "1967", "HN": "1967(1963)", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006215"}, {"RECTYPE": "D", "MH": "Halobacteriaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.400.400", "FX": "Salt Tolerance", "MH_TH": "NLM (1976)", "ST": "T194", "RN": "txid2236", "PI": "Pseudomonadaceae (1975)", "MS": "A family of extremely halophilic archaea found in environments with high salt concentrations, such as salt lakes, evaporated brines, or salted fish. Halobacteriaceae are either obligate aerobes or facultative anaerobes and are divided into at least twenty-six genera including: HALOARCULA; HALOBACTERIUM; HALOCOCCUS; HALOFERAX; HALORUBRUM; NATRONOBACTERIUM; and NATRONOCOCCUS.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D006216"}, {"RECTYPE": "D", "MH": "Halobacterium", "DE": "HALOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.400.400.410", "MH_TH": "NLM (1966)", "ST": "T194", "RN": "txid2239", "MS": "A genus of HALOBACTERIACEAE whose growth requires a high concentration of salt. Binary fission is by constriction.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006217"}, {"RECTYPE": "D", "MH": "Halofenate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MK185", "MN": "D02.241.511.316.455", "PA": "Uricosuric Agents", "MH_TH": "USAN (1971)", "ST": "T121", "N1": "Benzeneacetic acid, 4-chloro-alpha-(3-(trifluoromethyl)phenoxy)-, 2-(acetylamino)ethyl ester", "RN": "K9TZK4MNO6", "RR": "26718-25-2 (Halofenate)", "PI": "Glycolates (1966-1972)", "MS": "An antihyperlipoproteinemic agent and uricosuric agent.", "PM": "91; was see under GLYCOLATES 1973-90", "HN": "91(73); was see under GLYCOLATES 1973-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006218"}, {"RECTYPE": "D", "MH": "Halogens", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Halogen|T196|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Elements, Group 17", "MN": "D01.268.380", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "A family of nonmetallic, generally electronegative, elements that form group 17 (formerly group VIIa) of the periodic table.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006219"}, {"RECTYPE": "D", "MH": "Haloperidol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Haldol|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef", "MN": "D02.522.352.506", "PA": "Dopamine Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-", "RN": "J6292F8L3D", "RR": "52-86-8 (Haloperidol)", "MS": "A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006220"}, {"RECTYPE": "D", "MH": "Halothane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Narcotan|T109|T121|TRD|NRW|UNK (19XX)|830223|abbcdef", "MN": "D02.455.526.340", "PA": "Anesthetics, Inhalation", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Ethane, 2-bromo-2-chloro-1,1,1-trifluoro-", "RN": "UQT9G45D1P", "RR": "151-67-7 (Halothane)", "MS": "A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178)", "OL": "use HALOTHANE to search BROMCHLORTRIFLUORETHANE 1978-94", "PM": "BROMCHLORTRIFLUORETHANE was see HALOTHANE 1978-94", "HN": "BROMCHLORTRIFLUORETHANE was see HALOTHANE 1978-94", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D006221"}, {"RECTYPE": "D", "MH": "Hamartoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Hamartomas", "MN": "C04.445", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "non-neoplastic; coord IM with precoord organ/diseases term (IM)", "MS": "A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006222"}, {"RECTYPE": "D", "MH": "Hamartoma Syndrome, Multiple", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "PTEN Hamartoma Tumor Syndrome|T191|ACX|REL|NLM (2008)|060711|abcdef", "ENTRY": "Ruvalcaba Myhre Smith Syndrome", "MN": "C16.320.700.435", "MH_TH": "NLM (1987)", "ST": "T191", "PI": "Neoplasms, Multiple Primary (1966-1986)", "MS": "A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Facial trichilemmomas and papillomatous papules of the oral mucosa are the most characteristic lesions. Individuals with this syndrome have a high risk of BREAST CANCER; THYROID CANCER; and ENDOMETRIAL CANCER. This syndrome is associated with mutations in the gene for PTEN PHOSPHATASE.", "PM": "91; was see under NEOPLASMS, MULTIPLE PRIMARY 1987-90", "HN": "91(87); was see under NEOPLASMS, MULTIPLE PRIMARY 1987-90", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19860623", "DC": "1", "DX": "19910101", "UI": "D006223"}, {"RECTYPE": "D", "MH": "Cricetinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Hamsters|T015|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Hamster", "MN": "B01.050.150.900.649.313.992.635.075.250", "MH_TH": "UNK (19XX)", "ST": "T015", "RN": "txid10026", "RR": "txid10033", "AN": "check tag: NIM no qualifiers for HAMSTERS or any CRICETINAE", "MS": "A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS.", "PM": "2006; for CRICETUS see HAMSTERS 1966-1981", "HN": "2006 (1963)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D006224"}, {"RECTYPE": "D", "MH": "Hand", "AQ": "AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "ENTRY": "Hands", "MN": "A01.378.800.667", "EC": "transplantation:Hand Transplantation", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The distal part of the arm beyond the wrist in humans and primates, that includes the palm, fingers, and thumb.", "OL": "use HAND /AB & HAND DEFORMITIES, ACQUIRED to search HAND DEFORMITY 1966-70; in searching non-acquired hand abnormalities consider HAND DEFORMITIES, ACQUIRED 1966-72", "PM": "HAND DEFORMITIES was heading 1966-70", "HN": "HAND DEFORMITIES was heading 1966-70", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006225"}, {"RECTYPE": "D", "MH": "Hand Deformities", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hand Deformity", "MN": "C05.390", "EC": "congenital:Hand Deformities, Congenital", "MH_TH": "NLM (1988)", "ST": "T190", "AN": "general or unspecified; prefer specifics", "MS": "Alterations or deviations from normal shape or size which result in a disfigurement of the hand.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19870430", "DC": "1", "DX": "19880101", "UI": "D006226"}, {"RECTYPE": "D", "MH": "Hand Deformities, Acquired", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hand Deformity, Acquired", "MN": "C05.390.110", "MH_TH": "NLM (1971)", "ST": "T020", "AN": "deformity of bone, joint, muscle, etc.", "MS": "Deformities of the hand, or a part of the hand, acquired after birth as the result of injury or disease.", "OL": "use HAND /AB & HAND DEFORMITIES, ACQUIRED to search HAND DEFORMITIES 1966-70", "PM": "71; was HAND DEFORMITIES 1963-70", "HN": "71; was HAND DEFORMITIES 1963-70", "CATSH": "CAT LIST", "MR": "19920520", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D006227"}, {"RECTYPE": "D", "MH": "Hand Deformities, Congenital", "DE": "HAND DEFORMITIES CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hand Deformity, Congenital|T019|NON|EQV|UNK (19XX)|870430|HAND DEFORMITY CONGEN|abcdefv", "MN": "C16.131.621.585.988.500", "MH_TH": "NLM (1988)", "ST": "T019", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Alterations or deviations from normal shape or size which result in a disfigurement of the hand occurring at or before birth.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19870430", "DC": "1", "DX": "19880101", "UI": "D006228"}, {"RECTYPE": "D", "MH": "Hand Dermatoses", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dermatosis, Hand", "MN": "C17.800.338", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with specific skin diseases if pertinent; does not include neoplasms of the hand: index neoplasm terms + HAND", "MS": "Skin diseases involving the HANDS.", "CATSH": "CAT LIST", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006229"}, {"RECTYPE": "D", "MH": "Hand Injuries", "DE": "HAND INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injury, Hand", "MN": "C26.448", "FX": "Wrist Injuries", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "consider also METACARPUS /inj; FINGER INJURIES is also available", "MS": "General or unspecified injuries to the hand.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006230"}, {"RECTYPE": "D", "MH": "Hand, Foot and Mouth Disease", "DE": "HAND FOOT MOUTH DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Hand, Foot, and Mouth Disease|T047|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Hand, Foot, Mouth Disease|T047|NON|EQV|NLM (1990)|891011|abcdef", "MN": "C01.925.782.687.359.213.331", "FX": "Hand-Foot Syndrome", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "do not confuse with FOOT-AND-MOUTH DISEASE or with HAND-FOOT SYNDROME", "MS": "A mild, highly infectious viral disease of children, characterized by vesicular lesions in the mouth and on the hands and feet. It is caused by coxsackieviruses A.", "OL": "search COXSACKIEVIRUS INFECTIONS 1970-74", "PM": "91; was see under COXSACKIEVIRUS INFECTIONS 1979-90; was see under COXSACKIE VIRUS INFECTIONS 1970-78", "HN": "91(75); was see under COXSACKIEVIRUS INFECTIONS 1979-90; was see under COXSACKIE VIRUS INFECTIONS 1970-78", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19780222", "DC": "1", "DX": "19910101", "UI": "D006232"}, {"RECTYPE": "D", "MH": "Disabled Persons", "DE": "DISABLED", "AQ": "CL ED HI LJ PX RH SN", "PRINT ENTRY": "Physically Handicapped|T101|NON|NRW|BIOETHICS (1974)|770317|abcdef", "ENTRY": "Persons, Disabled", "MN": "M01.150", "FX": "Self-Help Devices", "MH_TH": "BIOETHICS (1994)", "ST": "T101", "MS": "Persons with physical or mental disabilities that affect or limit their activities of daily living and that may require special accommodations.", "PM": "98; see DISABLED 1993-97; see HANDICAPPED 1963-92", "HN": "98(63)", "MR": "20190711", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006233"}, {"RECTYPE": "D", "MH": "Handling, Psychological", "PRINT ENTRY": "Handling, Psychology|T053|NON|EQV|NLM (2020)|190118|abcdef", "ENTRY": "Psychology Handling", "MN": "F01.658.556", "MH_TH": "NLM (2020)", "ST": "T053", "AN": "human & animal", "MS": "Physical manipulation of animals and humans to induce a behavioral or other psychological reaction. In experimental psychology, the animal is handled to induce a stress situation or to study the effects of \"gentling\" or \"mothering\".", "PM": "2020; was HANDLING (PSYCHOLOGY) 1964-2019", "HN": "2020 (1965); was HANDLING (PSYCHOLOGY) 1964-2019", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006234"}, {"RECTYPE": "D", "MH": "Hand Disinfection", "DE": "HAND DISINFECT", "AQ": "EC IS MT ST TD", "PRINT ENTRY": "Handwashing|T055|NON|NRW|NLM (1982)|990101|abcdef", "ENTRY": "Washings, Hand", "MN": "N06.850.670.150.500", "FX": "Hand Sanitizers", "MH_TH": "UNK (19XX)", "ST": "T058", "PI": "Sterilization (1966-1974)", "MS": "The act of cleansing the hands with water or other liquid, with or without the inclusion of soap or other detergent, for the purpose of destroying infectious microorganisms.", "PM": "2013; see HANDWASHING 1982-2012", "HN": "2013 (1982)", "MR": "20151124", "DA": "19810302", "DC": "1", "DX": "19820101", "UI": "D006235"}, {"RECTYPE": "D", "MH": "Handwriting", "MN": "L01.559.423.906.539", "FX": "Agraphia", "MH_TH": "NLM (1966)", "ST": "T052", "MS": "Manual writing with a pen or pencil.", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006236"}, {"RECTYPE": "D", "MH": "Haploidy", "ENTRY": "Haploids", "MN": "G05.700.456", "MH_TH": "NLM (1968)", "ST": "T081", "PI": "Chromosomes (1966-1967)", "MS": "The chromosomal constitution of cells, in which each type of CHROMOSOME is represented once. Symbol: N.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006238"}, {"RECTYPE": "D", "MH": "Haplotypes", "AQ": "DE GE IM PH RE", "ENTRY": "Haplotype", "MN": "G05.380.360", "FX": "HapMap Project", "MH_TH": "NLM (1987)", "ST": "T032", "AN": "for \"haplotype-tagging SNPs\" coordinate with POLYMORPHISM, SINGLE NUCLEOTIDE", "PI": "specific histocompatibility antigen (1975-1986)", "MS": "The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D006239"}, {"RECTYPE": "D", "MH": "Happiness", "PRINT ENTRY": "Joy|T041|NON|EQV|NLM (2021)|200515|abcdef", "ENTRY": "Happinesses", "MN": "F01.470.516", "MH_TH": "NLM (1970)", "ST": "T041", "PI": "Emotions (1966-1969)", "MS": "Highly pleasant emotion characterized by outward manifestations of gratification.", "PM": "74", "HN": "74(70)", "CATSH": "CAT LIST", "MR": "20200617", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006240"}, {"RECTYPE": "D", "MH": "Haptens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Hapten|T129|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Contact Sensitizing Agents", "MN": "D23.050.550.480", "MH_TH": "NLM (1964)", "ST": "T129", "RN": "0", "MS": "Small antigenic determinants capable of eliciting an immune response only when coupled to a carrier. Haptens bind to antibodies but by themselves cannot elicit an antibody response.", "PM": "65", "HN": "65(64)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006241"}, {"RECTYPE": "D", "MH": "Haptoglobins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Haptoglobin|T116|T123|NON|EQV|UNK (19XX)|870511|abbcdef", "MN": "D12.776.395.560.373", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "alpha-globulins; acute phase proteins", "MS": "Plasma glycoproteins that form a stable complex with hemoglobin to aid the recycling of heme iron. They are encoded in man by a gene on the short arm of chromosome 16.", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006242"}, {"RECTYPE": "D", "MH": "Harderian Gland", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Gland, Harderian", "MN": "A13.445", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "animal only; accessory lacrimal gland", "MS": "A sebaceous gland that, in some animals, acts as an accessory to the lacrimal gland. The harderian gland excretes fluid that facilitates movement of the third eyelid.", "OL": "search LACRIMAL APPARATUS 1969-74", "PM": "91; was see under LACRIMAL APPARATUS 1975-90", "HN": "91(75); was see under LACRIMAL APPARATUS 1975-90", "MR": "19940416", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006243"}, {"RECTYPE": "D", "MH": "Hardness", "AQ": "DE PH RE", "ENTRY": "Hardnesses", "MN": "G01.374.647", "FX": "Hardness Tests", "MH_TH": "NLM (1965)", "ST": "T080", "MS": "The mechanical property of material that determines its resistance to force. HARDNESS TESTS measure this property.", "PM": "65", "HN": "65", "MR": "20200721", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006244"}, {"RECTYPE": "D", "MH": "Hardness Tests", "AQ": "IS MT ST", "ENTRY": "Tests, Hardness", "MN": "E05.570.500.500", "FX": "Hardness", "MH_TH": "NLM (1964)", "ST": "T059", "MS": "A test to determine the relative HARDNESS of a metal, mineral, or other material according to one of several scales, such as Brinell, Mohs, Rockwell, Vickers, or Shore. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed).", "PM": "72", "HN": "72(64)", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006245"}, {"RECTYPE": "D", "MH": "Harmaline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Harmidine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D03.633.300.154.333", "PA": "Monoamine Oxidase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "CN58I4TOET", "RR": "304-21-2 (Harmaline)", "AN": "do not confuse with HARMINE", "PI": "Pyridines (1972-1974)", "MS": "A beta-carboline alkaloid isolated from seeds of PEGANUM.", "PM": "91; was see under ALKALOIDS 1975-90", "HN": "91(75); was see under ALKALOIDS 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006246"}, {"RECTYPE": "D", "MH": "Harmine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Yageine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "MN": "D03.633.300.154.344", "PA": "Monoamine Oxidase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "4FHH5G48T7", "RR": "442-51-3 (Harmine)", "AN": "do not confuse with HARMIDINE or HARMALINE", "PI": "Pyridines (1969-1974)", "MS": "Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is one of the active ingredients of hallucinogenic drinks made in the western Amazon region from related plants. It has no therapeutic use, but (as banisterine) was hailed as a cure for postencephalitic PARKINSON DISEASE in the 1920's.", "PM": "91; was see under ALKALOIDS 1975-90", "HN": "91(75); was see under ALKALOIDS 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006247"}, {"RECTYPE": "D", "MH": "Harringtonines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cephalotaxus Alkaloids|T109|T121|NON|EQV|UNK (19XX)|770317|abbcdef", "ENTRY": "Alkaloids, Cephalotaxus", "MN": "D03.633.400.624", "PA": "Antineoplastic Agents, Phytogenic", "MH_TH": "NLM (1977)", "ST": "T121", "RN": "0", "PI": "Dioxoles (1972-1976)", "MS": "Tetracyclic spiro-BENZAZEPINES isolated from the seeds of CEPHALOTAXUS. They are esters of the alkaloid cephalotaxine and may be effective as antineoplastic agents.", "PM": "91; was see under ALKALOIDS 1977-90", "HN": "91(77); was see under ALKALOIDS 1977-90", "MR": "20160531", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D006248"}, {"RECTYPE": "D", "MH": "Hartmannella", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Hartmannellas", "MN": "B01.046.500.100.700.430", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid5777", "AN": "infection: coordinate with AMEBIASIS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent ", "PI": "Sarcodina (1966-1971)", "MS": "A genus of free-living amoebae found in fresh water. The cysts usually pass harmlessly through the intestinal tract of man and may thus be found in feces. Occasionally, these organisms cause respiratory tract infections or generalized fatal meningoencephalitis.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006249"}, {"RECTYPE": "D", "MH": "Hartnup Disease", "DE": "HARTNUP DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Transport Disorder, Neutral Amino Acid|T047|NON|EQV|NLM (2000)|991103|TRANSPORT DIS NEUTRAL AA|abcdefv", "ENTRY": "Transport Disorder, Neutral Amino Acids|T047|NON|EQV|NLM (2000)|991103|TRANSPORT DIS NEUTRAL AMINO ACIDS|abcdefv", "MN": "C18.452.648.189.355", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An autosomal recessive disorder due to defective absorption of NEUTRAL AMINO ACIDS by both the intestine and the PROXIMAL RENAL TUBULES. The abnormal urinary loss of TRYPTOPHAN, a precursor of NIACIN, leads to a NICOTINAMIDE deficiency, PELLAGRA-like light-sensitive rash, CEREBELLAR ATAXIA, emotional instability, and aminoaciduria. Mutations involve the neurotransmitter transporter gene SLC6A19.", "PM": "1965", "HN": "1965", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006250"}, {"RECTYPE": "D", "MH": "Harvey murine sarcoma virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Harvey Sarcoma Virus|T005|EPO|EQV|NLM (1984)|990101|abcdef", "ENTRY": "Virus, Harvey Sarcoma", "MN": "B04.820.650.375.860.400", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11807", "AN": "infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + SARCOMA, EXPERIMENTAL (IM)", "PI": "Mouse Tumor Viruses (1966-1979)", "MS": "A replication-defective mouse sarcoma virus (SARCOMA VIRUSES, MURINE) first described by J.J. Harvey in 1964.", "PM": "2002; see HARVEY SARCOMA VIRUS 1991-2001, see MOUSE SARCOMA VIRUSES 1984-1990", "HN": "2002 (1984)", "MR": "20200813", "DA": "19830311", "DC": "1", "DX": "19910101", "UI": "D006251"}, {"RECTYPE": "D", "MH": "Hate", "ENTRY": "Hates", "MN": "F01.470.548", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "An enduring attitude or sentiment toward persons or objects manifested by anger, aversion and desire for the misfortune of others.", "CATSH": "CAT LIST", "MR": "19890428", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006252"}, {"RECTYPE": "D", "MH": "Haversian System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Osteon|T024|NON|EQV|NLM (1996)|940727|abcdef", "ENTRY": "Volkmann Canal", "MN": "A10.165.265.521.500", "MH_TH": "NLM (1964)", "ST": "T024", "MS": "A circular structural unit of bone tissue. It consists of a central hole, the Haversian canal through which blood vessels run, surrounded by concentric rings, called lamellae.", "PM": "73", "HN": "73(64)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006253"}, {"RECTYPE": "D", "MH": "Hawaii", "AQ": "EH EP", "ENTRY": "Midway Islands|T083|NAM|REL|POPLINE (1978)|911112|abcdef", "MN": "Z01.639.760.815.482", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island group in Polynesia; Hawaii is also the name of the largest island in the group", "MS": "A group of islands in Polynesia, in the north central Pacific Ocean, comprising eight major and 114 minor islands, largely volcanic and coral. Its capital is Honolulu. It was first reached by Polynesians about 500 A.D. It was discovered and named the Sandwich Islands in 1778 by Captain Cook. The islands were united under the rule of King Kamehameha 1795-1819 and requested annexation to the United States in 1893 when a provisional government was set up. Hawaii was established as a territory in 1900 and admitted as a state in 1959. The name is from the Polynesian Owhyhii, place of the gods, with reference to the two volcanoes Mauna Kea and Mauna Loa, regarded as the abode of the gods. (From Webster's New Geographical Dictionary, 1988, p493 & Room, Brewer's Dictionary of Names, 1992, p2330)", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D006254"}, {"RECTYPE": "D", "MH": "Rhinitis, Allergic, Seasonal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Seasonal Allergic Rhinitis|T047|T184|NON|EQV|NLM (2006)|050420|abbcdef", "ENTRY": "Seasonal Allergic Rhinitides", "MN": "C20.543.480.680.443.750", "MH_TH": "UNK (19XX)", "ST": "T184", "AN": "do not confuse with RHINITIS, ALLERGIC, NONSEASONAL", "MS": "Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS.", "PM": "2006; see HAY FEVER 1963-2005", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006255"}, {"RECTYPE": "D", "MH": "Hazardous Waste", "AQ": "AE AN CL EC ES HI LJ PC SN", "ENTRY": "Wastes, Hazardous", "MN": "N06.850.460.710.380", "MH_TH": "NLM (1988)", "ST": "T131", "RN": "0", "AN": "HAZARDOUS SUBSTANCES is also available", "PI": "Waste Products (1976-1987)", "MS": "Waste products which threaten life, health, or the environment when improperly treated, stored, transported, disposed of, or otherwise managed.", "PM": "88", "HN": "88", "MR": "20130708", "DA": "19870504", "DC": "1", "DX": "19880101", "UI": "D006256"}, {"RECTYPE": "D", "MH": "Head", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "ENTRY": "Heads", "MN": "A01.456", "FX": "Skull", "EC": "injuries:Craniocerebral Trauma", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "The upper part of the human body, or the front or upper part of the body of an animal, typically separated from the rest of the body by a neck, and containing the brain, mouth, and sense organs.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006257"}, {"RECTYPE": "D", "MH": "Head and Neck Neoplasms", "DE": "HEAD NECK NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Upper Aerodigestive Tract Neoplasms|T191|NON|NRW|NLM (2001)|000303|UPPER AERODIGESTIVE TRACT NEOPL|abcdefv", "ENTRY": "Neoplasms, UADT", "MN": "C04.588.443", "MH_TH": "NLM (1976)", "ST": "T191", "AN": "soft tissue neoplasms only; general or unspecified; prefer specifics; coordinate with histological type of neoplasm", "MS": "Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)", "OL": "use HEAD AND NECK NEOPLASMS to search NECK NEOPLASMS 1966-75", "PM": "76; NECK NEOPLASMS was heading 1963-75", "HN": "76; NECK NEOPLASMS was heading 1963-75", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D006258"}, {"RECTYPE": "D", "MH": "Craniocerebral Trauma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Temporal Region Trauma|T037|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Traumas, Temporal Region", "MN": "C26.915.300", "FX": "Optic Nerve Injuries", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "general or unspecified; do not consider a substitute for /inj with various bones or other portions of the head; do not confuse with BRAIN INJURIES", "MS": "Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.", "PM": "2000; see HEAD INJURIES 1966-1999; for CRANIOCEREBRAL INJURIES see BRAIN INJURIES 1998-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20150702", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D006259"}, {"RECTYPE": "D", "MH": "Head Protective Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Helmets|T073|NON|NRW|UNK (19XX)|741205|abcdef", "ENTRY": "Protective Devices, Head", "MN": "J01.637.708.560.750", "MH_TH": "NLM (1975)", "ST": "T073", "MS": "Personal devices for protection of heads from impact, penetration from falling and flying objects, and from limited electric shock and burn.", "PM": "91; see PROTECTIVE DEVICES 1975-90", "HN": "91(75)", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D006260"}, {"RECTYPE": "D", "MH": "Headache", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemicrania|T184|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Vertex Headaches", "MN": "C23.888.592.612.441", "FX": "Headache Disorders", "MH_TH": "NLM (1963)", "ST": "T184", "AN": "HEADACHE DISORDERS and specifics are also available but do not diagnose: use word of text", "MS": "The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.", "PM": "2006 (1963); for HEMICRANIA see MIGRAINE 1963-2005", "HN": "2006 (1963); for HEMICRANIA use MIGRAINE 1963-2005", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D006261"}, {"RECTYPE": "D", "MH": "Health", "AQ": "CL EC EH ES HI LJ SN ST TD", "PRINT ENTRY": "Individual Health|T078|NON|NRW|NLM (2023)|211028|abcdef", "ENTRY": "Normalities", "MN": "N01.400", "EC": "education:Health Education", "MH_TH": "POPLINE (1978)", "ST": "T078", "MS": "The state of the organism when it functions optimally without evidence of disease.", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006262"}, {"RECTYPE": "D", "MH": "Health Benefit Plans, Employee", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Employee Health Benefit Plans|T058|NON|EQV|NLM (1993)|910923|abcdef", "MN": "N04.452.677.800.325", "MH_TH": "NLM (1975)", "ST": "T058", "AN": "specify geog if possible", "MS": "Health insurance plans for employees, and generally including their dependents, usually on a cost-sharing basis with the employer paying a percentage of the premium.", "OL": "search INSURANCE, HEALTH 1968-74", "PM": "91; was see under INSURANCE, HEALTH 1975-90", "HN": "91(75); was see under INSURANCE, HEALTH 1975-90", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006264"}, {"RECTYPE": "D", "MH": "Health Care Coalitions", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Business Coalitions (Health Care)|T093|NON|NRW|UNK (19XX)|850523|BUSINESS COALITIONS|abcdefv", "ENTRY": "Healthcare Coalition", "MN": "N03.540.452.188", "MH_TH": "NLM (1986)", "ST": "T093", "PI": "Health Planning Organizations (1980-1985)", "MS": "Voluntary groups of people representing diverse interests in the community such as hospitals, businesses, physicians, and insurers, with the principal objective to improve health care cost effectiveness.", "OL": "search HEALTH PLANNING ORGANIZATIONS 1984-85", "PM": "91; was see under HEALTH PLANNING ORGANIZATIONS 1986-90; was see HEALTH PLANNING ORGANIZATIONS 1984-85", "HN": "91(86); was see under HEALTH PLANNING ORGANIZATIONS 1986-90; was see HEALTH PLANNING ORGANIZATIONS 1984-85", "MR": "19991103", "DA": "19850523", "DC": "1", "DX": "19910101", "UI": "D006265"}, {"RECTYPE": "D", "MH": "Health Education", "DE": "HEALTH EDUC", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Education, Health|T065|T091|NON|EQV|UNK (19XX)|790601|EDUC HEALTH|abbcdefv", "ENTRY": "Health Education, Community|T058|T065|NON|NRW|UNK (19XX)|790531|HEALTH EDUC COMMUNITY|abbcdefv", "MN": "N02.421.726.407", "FX": "Health Promotion", "MH_TH": "BIOETHICS (1989)", "ST": "T091", "MS": "Education that increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis.", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006266"}, {"RECTYPE": "D", "MH": "Health Education, Dental", "DE": "HEALTH EDUC DENT", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Education, Dental Health|T058|T065|NON|EQV|NLM (1990)|890501|EDUC DENT HEALTH|abbcdefv", "MN": "N06.890.410", "MH_TH": "NLM (1965)", "ST": "T065", "MS": "Education which increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of dental health on a personal or community basis.", "PM": "65", "HN": "65", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006267"}, {"RECTYPE": "D", "MH": "Health Facilities", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Health Facility", "MN": "N02.278", "EC": "organization & administration:Health Facility Administration", "MH_TH": "BIOETHICS (1989)", "ST": "T093", "AN": "IM", "PI": "specific facility (1966-1967)", "MS": "Institutions which provide medical or health-related services.", "PM": "1968", "HN": "1968", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006268"}, {"RECTYPE": "D", "MH": "Health Facilities, Proprietary", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Proprietary Health Facility", "MN": "N02.278.215", "MH_TH": "NLM (1977)", "ST": "T073", "AN": "\"operated by private groups or corporations for a profit\"", "MS": "Health care institutions operated by private groups or corporations for a profit.", "PM": "91; was see under HEALTH FACILITIES Aug 1977-90", "HN": "91(Aug 77); was see under HEALTH FACILITIES 1977-90", "MR": "20180629", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D006269"}, {"RECTYPE": "D", "MH": "Health Facility Administrators", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Health Facility Administrator", "MN": "N02.360.430", "MH_TH": "NLM (1978)", "ST": "T097", "MS": "Managerial personnel responsible for implementing policy and directing the activities of health care facilities such as nursing homes.", "PM": "78", "HN": "78", "MR": "20180629", "DA": "19770505", "DC": "1", "DX": "19780101", "UI": "D006270"}, {"RECTYPE": "D", "MH": "Health Facility Closure", "AQ": "EC HI LJ MT SN ST TD", "PRINT ENTRY": "Hospital Closures|T058|NON|NRW|NLM (1997)|951004|HOSP CLOSURES|abcdefv", "ENTRY": "Health Facility Closures|T057|NON|EQV|NLM (1997)|951004|abcdef", "MN": "N05.300.430.390", "MH_TH": "NLM (1977)", "ST": "T057", "PI": "Hospital Administration (1966-Jul 1977)", "MS": "The closing of any health facility, e.g., health centers, residential facilities, and hospitals.", "OL": "use HEALTH FACILITY CLOSURE to search HOSPITAL CLOSURE Aug 1977-82", "PM": "91; was see under HEALTH FACILITIES 1983-90; was HOSPITAL CLOSURE see under HOSPITAL ADMINISTRATION Aug 1977-82", "HN": "91(83); was see under HEALTH FACILITIES 1983-90; was HOSPITAL CLOSURE see under HOSPITAL ADMINISTRATION Aug 1977-82", "MR": "19970620", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D006271"}, {"RECTYPE": "D", "MH": "Health Facility Environment", "DE": "HEALTH FACILITY ENVIR", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Health Facility Environments", "MN": "N05.300.430.400", "MH_TH": "NLM (1980)", "ST": "T068", "MS": "Physical surroundings or conditions of a hospital or other health facility and influence of these factors on patients and staff.", "PM": "91; was see under HEALTH FACILITIES 1980-90", "HN": "91(80); was see under HEALTH FACILITIES 1980-90", "MR": "19950519", "DA": "19790529", "DC": "1", "DX": "19910101", "UI": "D006272"}, {"RECTYPE": "D", "MH": "Health Facility Merger", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Merger, Health Facility|T058|NON|EQV|UNK (19XX)|810226|abcdef", "ENTRY": "Mergers, Hospital", "MN": "N02.278.235", "MH_TH": "NLM (1977)", "ST": "T058", "MS": "The combining of administrative and organizational resources of two or more health care facilities.", "PM": "91; was see under HEALTH FACILITIES Aug 1977-90", "HN": "91(Aug 77); was see under HEALTH FACILITIES 1977-90", "MR": "19920515", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D006273"}, {"RECTYPE": "D", "MH": "Health Facility Moving", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Moving, Health Facility|T058|NON|EQV|UNK (19XX)|810226|abcdef", "ENTRY": "Facility Moving, Health", "MN": "N02.278.255", "MH_TH": "NLM (1977)", "ST": "T058", "MS": "The relocation of health care institutions or units thereof. The concept includes equipment relocation.", "PM": "91; was see under HEALTH FACILITIES Aug 1977-90", "HN": "91(Aug 77); was see under HEALTH FACILITIES 1977-90", "MR": "19970620", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D006274"}, {"RECTYPE": "D", "MH": "Health Facility Planning", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Planning, Health Facility|T058|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Plannings, Health Facility", "MN": "N03.349.650.250", "FX": "Facility Design and Construction", "MH_TH": "POPLINE (1978)", "ST": "T058", "AN": "differentiate from FACILITY DESIGN AND CONSTRUCTION", "PI": "Hospital Design and Construction (1966-1967)", "MS": "Areawide planning for health care institutions on the basis of projected consumer need.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006275"}, {"RECTYPE": "D", "MH": "Health Facility Size", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Hospital Size|T081|NON|NRW|NLM (1994)|921029|HOSP SIZE|abcdefv", "ENTRY": "Sizes, Hospital", "MN": "N05.300.430.410", "MH_TH": "NLM (1968)", "ST": "T081", "AN": "note X ref", "PI": "Hospitals (1966-1967)", "MS": "The physical space or dimensions of a facility. Size may be indicated by bed capacity.", "PM": "68", "HN": "68", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006276"}, {"RECTYPE": "D", "MH": "Health Fairs", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Health Fair", "MN": "N02.421.726.407.478", "MH_TH": "NLM (1983)", "ST": "T065", "PI": "Health Education (1966-1982)", "MS": "Community health education events focused on prevention of disease and promotion of health through audiovisual exhibits.", "PM": "91; was see under HEALTH EDUCATION 1983-90", "HN": "91(83); was see under HEALTH EDUCATION 1983-90", "MR": "20150626", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D006277"}, {"RECTYPE": "D", "MH": "Medicare", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Insurance, Health, for Aged and Disabled|T058|T089|NON|BRD|UNK (19XX)|740330|INSURANCE HEALTH AGED DISABLED|abbcdefv", "ENTRY": "Health Insurance for Aged, Title 18|T089|NON|EQV|UNK (19XX)|780508|HEALTH INSURANCE AGED TITLE 18|abcdefv", "MN": "N03.706.615.696", "FX": "Insurance, Medigap", "MH_TH": "NLM (1966)", "ST": "T089", "AN": "U.S. only: for Canada & Australia index under NATIONAL HEALTH PROGRAMS + country; specify geog; Public Law 89-97", "MS": "Federal program, created by Public Law 89-97, Title XVIII-Health Insurance for the Aged, a 1965 amendment to the Social Security Act, that provides health insurance benefits to persons over the age of 65 and others eligible for Social Security benefits. It consists of two separate but coordinated programs: hospital insurance (MEDICARE PART A) and supplementary medical insurance (MEDICARE PART B). (Hospital Administration Terminology, AHA, 2d ed and A Discursive Dictionary of Health Care, US House of Representatives, 1976)", "OL": "use MEDICARE to search HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90; HEALTH INSURANCE FOR AGED, TITLE l8 1966-78 (as Prov 1966)", "PM": "91; was HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, was HEALTH INSURANCE FOR AGED, TITLE 18 1966-78 (PROV 1966); MEDICARE was see HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, & HEALTH INSURANCE FOR AGED, TITLE 18 1975-78", "HN": "91; was HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, was HEALTH INSURANCE FOR AGED, TITLE 18 1966-78 (PROV 1966); MEDICARE was see HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, & HEALTH INSURANCE FOR AGED, TITLE 18 1975-78 1966-78 (Prov 1966)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006278"}, {"RECTYPE": "D", "MH": "Health Maintenance Organizations", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Prepaid Group Health Organizations|T093|NON|EQV|UNK (19XX)|790601|PREPAID GROUP HEALTH ORGAN|abcdefv", "ENTRY": "Organization, Health Maintenance", "MN": "N04.590.374.410.400", "MH_TH": "BIOETHICS (1989)", "ST": "T093", "PI": "Insurance, Health (1966-1970)", "MS": "Organized systems for providing comprehensive prepaid health care that have five basic attributes: (1) provide care in a defined geographic area; (2) provide or ensure delivery of an agreed-upon set of basic and supplemental health maintenance and treatment services; (3) provide care to a voluntarily enrolled group of persons; (4) require their enrollees to use the services of designated providers; and (5) receive reimbursement through a predetermined, fixed, periodic prepayment made by the enrollee without regard to the degree of services provided. (From Facts on File Dictionary of Health Care Management, 1988)", "PM": "74", "HN": "74(71)", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006279"}, {"RECTYPE": "D", "MH": "Health Workforce", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Health Occupations Manpower|T081|NON|EQV|UNK (19XX)|770524|HEALTH OCCUP MAN|abcdefv", "ENTRY": "Workforce, Health", "MN": "N05.300.420.400", "FX": "Medicine", "EC": "education:Health Occupations:education", "MH_TH": "NLM (2013)", "ST": "T081", "AN": "do not confuse with HEALTH PERSONNEL, the persons in the field of health care & delivery; coordinate with specific health discipline, occupation or program if pertinent", "PI": "Health Occupations (1966-1967)", "MS": "The availability of HEALTH PERSONNEL. It includes the demand and recruitment of both professional and allied health personnel, their present and future supply and distribution, and their assignment and utilization.", "PM": "2019; see Health Manpower 1968-2018", "HN": "2019(1968)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006280"}, {"RECTYPE": "D", "MH": "Health Occupations", "DE": "HEALTH OCCUP", "AQ": "CL EC ED ES HI LJ SN ST TD", "PRINT ENTRY": "Health Professions|T091|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Professions, Health", "MN": "H02", "RH": "H2 - HEALTH OCCUPATIONS", "MH_TH": "NLM (1968)", "ST": "T091", "AN": "do not confuse with OCCUPATIONAL HEALTH; ALLIED HEALTH OCCUPATIONS is also available; for health aides consider  HEALTH WORKFORCE or ALLIED HEALTH PERSONNEL or specifics", "MS": "Professions or other business activities directed to the cure and prevention of disease. For occupations of medical personnel who are not physicians but who are working in the fields of medical technology, physical therapy, etc., ALLIED HEALTH OCCUPATIONS is available.", "OL": "use HEALTH OCCUPATIONS to search HEALTH PROFESSIONS 1966-67", "PM": "68; was HEALTH PROFESSIONS 1963-67", "HN": "68; was HEALTH PROFESSIONS 1963-67", "MR": "20180713", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006281"}, {"RECTYPE": "D", "MH": "Health Personnel", "AQ": "CL EC ED ES HI LJ OG PX SN ST TD", "PRINT ENTRY": "Health Care Providers|T097|NON|EQV|NLM (1992)|910422|abcdef", "ENTRY": "Provider, Healthcare", "MN": "N02.360", "MH_TH": "POPLINE (1978)", "ST": "T097", "AN": "persons working in the field of health: do not confuse with HEALTH WORKFORCE, the availability of HEALTH PERSONNEL", "PI": "Health Manpower (1966-1991)", "MS": "Men and women working in the provision of health services, whether as individual practitioners or employees of health institutions and programs, whether or not professionally trained, and whether or not subject to public regulation. (From A Discursive Dictionary of Health Care, 1976)", "PM": "1992; was see HEALTH MANPOWER 1989-91", "HN": "1992; was NON MESH 1966-91; was see HEALTH MANPOWER 1989-91", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D006282"}, {"RECTYPE": "D", "MH": "Health Physics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Radiologic Physics|T091|NON|EQV|UNK (19XX)|740330|RADIOL PHYSICS|abcdefv", "ENTRY": "Physics, Health", "MN": "H02.229.333", "FX": "Radiometry", "MH_TH": "NLM (1967)", "ST": "T091", "PI": "Radiation Protection (1966)", "MS": "The science concerned with problems of radiation protection relevant to reducing or preventing radiation exposure, and the effects of ionizing radiation on humans and their environment.", "PM": "73", "HN": "73(67)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006283"}, {"RECTYPE": "D", "MH": "Health Plan Implementation", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Plan Implementations, Health", "MN": "N03.349.300", "MH_TH": "NLM (1980)", "ST": "T058", "AN": "specify geog", "PI": "Health Planning (1968-1979)", "MS": "Those actions designed to carry out recommendations pertaining to health plans or programs.", "PM": "91; was see under HEALTH PLANNING 1980-90", "HN": "91(80); was see under HEALTH PLANNING 1980-90", "MR": "19991103", "DA": "19790601", "DC": "1", "DX": "19910101", "UI": "D006284"}, {"RECTYPE": "D", "MH": "Health Planning", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "State Health Planning, United States|T058|T064|NON|NRW|UNK (19XX)|780508|abbcdef", "ENTRY": "Public Law 93 641", "MN": "N03.706.615.302", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "specify geog & add UNITED STATES (NIM) for X ref STATE HEALTH PLANNING, UNITED STATES", "PI": "Social Welfare (1966-1967)", "MS": "Planning for needed health and/or welfare services and facilities.", "OL": "use HEALTH PLANNING to search HEALTH AND WELFARE PLANNING 1968-78", "PM": "79; was HEALTH AND WELFARE PLANNING 1968-78; NATIONAL HEALTH PLANNING AND RESOURCES DEVELOPMENT ACT OF 1974 was heading 1982-95; HEALTH PLANNING AND RESOURCES DEVELOPMENT AMENDMENTS OF 1979, PL96-79; HEALTH PLANNING ACT 93-641; PUBLIC LAW 93-641; & PL93-641 were see NATIONAL HEALTH PLANNING AND RESOURCES DEVELOPMENT ACT OF 1974 1982-95", "HN": "79; was HEALTH AND WELFARE PLANNING 1968-78; NATIONAL HEALTH PLANNING AND RESOURCES DEVELOPMENT ACT OF 1974 was heading 1982-95; HEALTH PLANNING AND RESOURCES DEVELOPMENT AMENDMENTS OF 1979, PL96-79; HEALTH PLANNING ACT 93-641; PUBLIC LAW 93-641; & PL93-641 were see NATIONAL HEALTH PLANNING AND RESOURCES DEVELOPMENT ACT OF 1974 1982-95", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006285"}, {"RECTYPE": "D", "MH": "Health Planning Councils", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Statewide Health Coordinating Councils|T097|NON|NRW|UNK (19XX)|790601|abcdef", "ENTRY": "Planning Councils, Health", "MN": "N03.540.452.210", "MH_TH": "NLM (1980)", "ST": "T097", "AN": "Public Law 93-641; specify geog", "PI": "Health Planning (1968-1979)", "MS": "Organized groups serving in advisory capacities related to health planning activities.", "PM": "91; was see under HEALTH PLANNING ORGANIZATIONS 1980-90", "HN": "91(80); was see under HEALTH PLANNING ORGANIZATIONS 1980-90", "MR": "19991103", "DA": "19790601", "DC": "1", "DX": "19910101", "UI": "D006286"}, {"RECTYPE": "D", "MH": "Health Planning Guidelines", "PRINT ENTRY": "Guidelines for Health Planning|T078|T089|NON|EQV|UNK (19XX)|790601|abbcdef", "ENTRY": "Recommendation, Health Planning", "MN": "N03.349.315", "MH_TH": "NLM (1980)", "ST": "T089", "AN": "do not confuse with PRACTICE GUIDELINES AS TOPIC", "PI": "Health Planning (1968-1979)", "MS": "Recommendations for directing health planning functions and policies. These may be mandated by PL93-641 and issued by the Department of Health and Human Services for use by state and local planning agencies.", "PM": "1991; see HEALTH PLANNING 1980-1990", "HN": "1991(1980); use HEALTH PLANNING 1980-1990", "MR": "20100625", "DA": "19790601", "DC": "1", "DX": "19910101", "UI": "D006287"}, {"RECTYPE": "D", "MH": "Health Planning Organizations", "DE": "HEALTH PLANNING ORGAN", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Centers for Health Planning|T093|NON|EQV|UNK (19XX)|790531|abcdef", "ENTRY": "Planning Organization, Health", "MN": "N03.540.452", "MH_TH": "NLM (1980)", "ST": "T093", "AN": "specify geog", "MS": "Organizations involved in all aspects of health planning activities.", "PM": "80", "HN": "80", "MR": "19991103", "DA": "19790531", "DC": "1", "DX": "19800101", "UI": "D006288"}, {"RECTYPE": "D", "MH": "Health Planning Support", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Subsidies, Health Planning|T058|NON|NRW|UNK (19XX)|790601|abcdef", "ENTRY": "Supports, Health Planning", "MN": "N03.219.483.408", "MH_TH": "NLM (1980)", "ST": "T058", "AN": "IM", "PI": "Health Planning (1968-1979)", "MS": "Financial resources provided for activities related to health planning and development.", "PM": "80", "HN": "80", "MR": "19991103", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D006289"}, {"RECTYPE": "D", "MH": "Health Planning Technical Assistance", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Technical Assistance for Health Planning|T058|NON|EQV|UNK (19XX)|790601|abcdef", "MN": "N03.349.325", "MH_TH": "NLM (1980)", "ST": "T058", "MS": "The provision of expert assistance in developing health planning programs, plans as technical materials, etc., as requested by Health Systems Agencies or other health planning organizations.", "PM": "91; was see under HEALTH PLANNING 1980-90", "HN": "91(80); was see under HEALTH PLANNING 1980-90", "MR": "19930916", "DA": "19790601", "DC": "1", "DX": "19910101", "UI": "D006290"}, {"RECTYPE": "D", "MH": "Health Policy", "AQ": "EC HI LJ TD", "PRINT ENTRY": "National Health Policy|T170|NON|NRW|UNK (19XX)|790601|abcdef", "ENTRY": "Policy, Healthcare", "MN": "N03.623.500.608.428", "MH_TH": "NLM (1980)", "ST": "T089", "AN": "specify state or country or other body if pertinent; SOCIAL DETERMINANTS OF HEALTH is available", "PI": "Public Policy (1978-1979)", "MS": "Decisions, usually developed by government policymakers, for determining present and future objectives pertaining to the health care system.", "PM": "80", "HN": "80", "MR": "20220713", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D006291"}, {"RECTYPE": "D", "MH": "Health Priorities", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Priorities, Health|T080|NON|EQV|UNK (19XX)|790601|abcdef", "ENTRY": "Priority, Health", "MN": "N05.300.400", "MH_TH": "NLM (1980)", "ST": "T080", "MS": "Preferentially rated health-related activities or functions to be used in establishing health planning goals. This may refer specifically to PL93-641.", "PM": "91; was see under HEALTH PLANNING 1980-90", "HN": "91(80); was see under HEALTH PLANNING 1980-90", "MR": "19930916", "DA": "19790601", "DC": "1", "DX": "19910101", "UI": "D006292"}, {"RECTYPE": "D", "MH": "Health Promotion", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Wellness Programs|T058|T065|NON|NRW|UNK (19XX)|820426|abbcdef", "ENTRY": "Wellness Program", "MN": "N02.421.726.407.579", "FX": "Health Behavior", "MH_TH": "NLM (1980)", "ST": "T065", "AN": "IM", "MS": "Encouraging consumer behaviors most likely to optimize health potentials (physical and psychosocial) through health information, preventive programs, and access to medical care.", "PM": "80", "HN": "80", "MR": "20170711", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D006293"}, {"RECTYPE": "D", "MH": "Health Resorts", "AQ": "CL EC HI LJ SN ST", "ENTRY": "Resorts, Health", "MN": "N02.278.330", "FX": "Sports and Recreational Facilities", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "sanatoria & sanitaria (often used interchangeably) can go here but consider also HOSPITALS, SPECIAL", "MS": "Destinations frequented as vacation or recreational retreats, equipped with specialized amenities, treatments and facilities, for the promotion of general well-being and health.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006294"}, {"RECTYPE": "D", "MH": "Health Resources", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Resources, Health", "MN": "N05.300.420", "FX": "Health Care Rationing", "MH_TH": "NLM (1978)", "ST": "T078", "AN": "specify geog", "MS": "Available manpower, facilities, revenue, equipment, and supplies to produce requisite health care and services.", "PM": "78", "HN": "78", "MR": "19991103", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D006295"}, {"RECTYPE": "D", "MH": "Health Services", "DE": "HEALTH SERV", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Health Service", "MN": "N02.421", "EC": "organization & administration:Health Services Administration", "MH_TH": "POPLINE (1978)", "ST": "T058", "AN": "general or unspecified; prefer specifics", "MS": "Services for the diagnosis and treatment of disease and the maintenance of health.", "PM": "1974", "HN": "1974", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006296"}, {"RECTYPE": "D", "MH": "Health Services Accessibility", "DE": "HEALTH SERV ACCESS", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Medication Access|T080|NON|REL|NLM (2021)|OBSSR (2021)|200221|abcdeef", "ENTRY": "Treatment, Access to", "MN": "N05.300.430", "MH_TH": "NLM (1978)", "ST": "T080", "AN": "coordinate with SOCIAL DETERMINANTS OF HEALTH; specify geographic location if pertinent ", "PI": "Health Services (1974-1977)", "MS": "The degree to which individuals are inhibited or facilitated in their ability to gain entry to and to receive care and services from the health care system. Factors influencing this ability include geographic, architectural, transportational, and financial considerations, among others.", "PM": "78", "HN": "78", "MR": "20220713", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D006297"}, {"RECTYPE": "D", "MH": "Health Services Administration", "DE": "HEALTH SERV ADMIN", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Administration, Health Services|T058|NON|EQV|NLM (1998)|970109|ADMIN HEALTH SERV|abcdefv", "MN": "N04", "RH": "N4 - HEALTH CARE-HEALTH SERVICES ADMINISTRATION", "MH_TH": "POPLINE (1978)", "ST": "T058", "AN": "general or unspecified; prefer specific health service with /organ ", "PI": "Public Health Administration (1969-1997)", "MS": "The organization and administration of health services dedicated to the delivery of health care.", "PM": "1998", "HN": "1998; use explode 1970-97", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006298"}, {"RECTYPE": "D", "MH": "Health Services for the Aged", "DE": "HEALTH SERV AGED", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Health Systems for the Aged|T058|NON|REL|NLM (2024)|220831|abcdef", "ENTRY": "Systems, Geriatric Health", "MN": "N02.421.320", "MH_TH": "NLM (1980)", "ST": "T058", "AN": "coord IM with specific serv (IM or NIM) if pertinent; check also tag AGED", "PI": "specific health service (1966-1979)", "MS": "Services for the diagnosis and treatment of diseases in the AGED and the maintenance of health in the ELDERLY.", "PM": "80", "HN": "80", "MR": "20221215", "DA": "19781222", "DC": "1", "DX": "19800101", "UI": "D006299"}, {"RECTYPE": "D", "MH": "Health Services Misuse", "DE": "HEALTH SERV MISUSE", "AQ": "EC LJ PC SN TD", "PRINT ENTRY": "Misuse of Health Services|T055|NON|EQV|UNK (19XX)|770512|MISUSE OF HEALTH SERV|abcdefv", "ENTRY": "Underutilizations, Health Services", "MN": "N05.300.150.395", "FX": "Munchausen Syndrome", "MH_TH": "NLM (1977)", "ST": "T055", "MS": "Excessive, under or unnecessary utilization of health services by patients or physicians.", "PM": "91; was see under HEALTH SERVICES Aug 1977-90", "HN": "91(Aug 77); was see under HEALTH SERVICES 1977-90", "MR": "20150626", "DA": "19770512", "DC": "1", "DX": "19910101", "UI": "D006300"}, {"RECTYPE": "D", "MH": "Health Services Needs and Demand", "DE": "HEALTH SERV NEEDS DEMAND", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Target Populations", "MN": "N05.300.450", "MH_TH": "NLM (1977)", "ST": "T080", "AN": "specify geographic location", "MS": "Health services required by a population or community as well as the health services that the population or community is able and willing to pay for.", "PM": "91; was see under HEALTH SERVICES RESEARCH 1980-90; was see under HEALTH PLANNING 1979; was see under HEALTH AND WELFARE PLANNING Aug 1977-78", "HN": "91(Aug 77); was see under HEALTH SERVICES RESEARCH 1980-90; was see under HEALTH PLANNING 1979; was see under HEALTH AND WELFARE PLANNING 1977-78", "MR": "19991103", "DA": "19770512", "DC": "1", "DX": "19910101", "UI": "D006301"}, {"RECTYPE": "D", "MH": "Health Services Research", "DE": "HEALTH SERV RESEARCH", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Research, Health Services|T058|T062|NON|EQV|UNK (19XX)|790601|RESEARCH HEALTH SERV|abbcdefv", "ENTRY": "Research, Healthcare", "MN": "N05.425", "MH_TH": "NLM (1980)", "ST": "T062", "PI": "Research (1966-1979)", "MS": "The integration of epidemiologic, sociological, economic, and other analytic sciences in the study of health services. Health services research is usually concerned with relationships between need, demand, supply, use, and outcome of health services. The aim of the research is evaluation, particularly in terms of structure, process, output, and outcome. (From Last, Dictionary of Epidemiology, 2d ed)", "PM": "80", "HN": "80", "MR": "20180629", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D006302"}, {"RECTYPE": "D", "MH": "Health Services, Indigenous", "DE": "HEALTH SERV INDIGENOUS", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Services, Health Indigenous", "MN": "N02.421.330", "MH_TH": "NLM (1977)", "ST": "T058", "AN": "\"health care provided to specific cultural or tribal peoples which incorporates local customs, beliefs & taboos\"; specify ethnic group (IM) + geog", "MS": "Health care provided to specific cultural or tribal peoples which incorporates local customs, beliefs, and taboos.", "PM": "81; was see under HEALTH SERVICES 1977-80", "HN": "81(Aug 77); was see under HEALTH SERVICES Aug 1977-80", "MR": "20190524", "DA": "19770512", "DC": "1", "DX": "19810101", "UI": "D006303"}, {"RECTYPE": "D", "MH": "Health Status", "PRINT ENTRY": "Overall Health Status|T080|NON|REL|NLM (2023)|211028|abcdef", "ENTRY": "Status, Overall Health", "MN": "N06.850.505.400.425", "MH_TH": "NLM (1980)", "ST": "T080", "PI": "Health Surveys (1966-1979)", "MS": "The level of health of the individual, group, or population as subjectively assessed by the individual or by more objective measures.", "PM": "90; was see under HEALTH 1980-89", "HN": "90(80); was see under HEALTH 1980-89", "MR": "20220413", "DA": "19790601", "DC": "1", "DX": "19900101", "UI": "D006304"}, {"RECTYPE": "D", "MH": "Health Status Indicators", "PRINT ENTRY": "Health Status Index|T081|T170|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Risk Appraisals, Health", "MN": "N06.850.520.308.980.438.475", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "The measurement of the health status for a given population using a variety of indices, including morbidity, mortality, and available health resources.", "PM": "90; was see under HEALTH SURVEYS 1975-89", "HN": "90(75); was see under HEALTH SURVEYS 1975-89", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19741111", "DC": "1", "DX": "19900101", "UI": "D006305"}, {"RECTYPE": "D", "MH": "Health Surveys", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Surveys, Health", "MN": "N06.850.520.308.980.438", "MH_TH": "NLM (1978)", "ST": "T062", "AN": "do not confuse with HEALTH CARE SURVEYS: health surveys are on health statistics, health care surveys are on health services provided; specify geographic term if pertinent", "MS": "A systematic collection of factual data pertaining to health and disease in a human population within a given geographic area.", "OL": "use HEALTH SURVEYS to search SANITARY SURVEYS 1966", "PM": "SANITARY SURVEYS was heading 1963-66", "HN": "SANITARY SURVEYS was heading 1963-66", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006306"}, {"RECTYPE": "D", "MH": "Health Systems Agencies", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Comprehensive Health Planning Agencies|T093|NON|NRW|UNK (19XX)|770505|abcdef", "ENTRY": "Systems Agency, Health", "MN": "N03.540.452.508.440", "MH_TH": "NLM (1978)", "ST": "T093", "AN": "Public Law 93-641; specify geog & add UNITED STATES also", "PI": "Health Planning (1968-1977)", "MS": "Health planning and resources development agencies which function in each health service area of the United States (PL 93-641).", "PM": "78", "HN": "78", "MR": "19991103", "DA": "19770505", "DC": "1", "DX": "19780101", "UI": "D006307"}, {"RECTYPE": "D", "MH": "Health Systems Plans", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Comprehensive Health Plans, Local|T058|T170|NON|NRW|UNK (19XX)|790601|abbcdef", "ENTRY": "Plans, Health Systems", "MN": "N03.349.650.270", "MH_TH": "NLM (1980)", "ST": "T170", "AN": "Public Law 93-641; specify geog & add UNITED STATES also", "MS": "Statements of goals for the delivery of health services pertaining to the Health Systems Agency service area, established under PL 93-641, and consistent with national guidelines for health planning.", "PM": "91; was see under REGIONAL HEALTH PLANNING 1981-90; was see under STATE HEALTH PLANS 1980", "HN": "91(80); was see under REGIONAL HEALTH PLANNING 1981-90; was see under STATE HEALTH PLANS 1980", "MR": "19991103", "DA": "19790601", "DC": "1", "DX": "19910101", "UI": "D006308"}, {"RECTYPE": "D", "MH": "Hearing", "AQ": "DE GE IM PH RE", "ENTRY": "Audition|T042|NON|EQV|NLM (2009)|080306|abcdef", "MN": "G11.561.790.263", "FX": "Bone Conduction", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "differentiate from AUDITORY PERCEPTION: auditory perception takes place in the brain, hearing takes place in the ear; PSYCHOACOUSTICS is also available; AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION is available", "CX": "consider also terms at ACOUSTIC and AUDIO-", "MS": "The ability or act of sensing and transducing ACOUSTIC STIMULATION to the CENTRAL NERVOUS SYSTEM. It is also called audition.", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006309"}, {"RECTYPE": "D", "MH": "Hearing Aids", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Ear Molds, Hearing Aid|T074|NON|NRW|NLM (2023)|220311|abcdef", "ENTRY": "Hearing Aid", "MN": "E07.814.458", "MH_TH": "NLM (1966)", "ST": "T074", "AN": "\"hearing aid\" is correct translation for \"proth\u00e8se auditive\", not \"auditory prosthesis\" unless you mean COCHLEAR IMPLANT", "MS": "Wearable sound-amplifying devices that are intended to compensate for impaired hearing. These generic devices include air-conduction hearing aids and bone-conduction hearing aids. (UMDNS, 1999)", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006310"}, {"RECTYPE": "D", "MH": "Hearing Disorders", "DE": "HEARING DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH UR VE VI", "ENTRY": "Hearing, Distorted", "MN": "C23.888.592.763.393", "FX": "Persons With Hearing Impairments", "EC": "rehabilitation:Correction of Hearing Impairment", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Conditions that impair the transmission of auditory impulses and information from the level of the ear to the temporal cortices, including the sensorineural pathways.", "CATSH": "CAT LIST", "MR": "20130710", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006311"}, {"RECTYPE": "D", "MH": "Hearing Loss, Bilateral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Deafness Bilateral|T047|NON|NRW|NLM (2020)|190501|abcdef", "ENTRY": "Loss, Bilateral Hearing", "MN": "C23.888.592.763.393.341.374", "FX": "Deafness", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "differentiate from DEAFNESS, total hearing loss in both ears", "PI": "Deafness (1966-1978)", "MS": "Partial hearing loss in both ears.", "PM": "91; was see under HEARING LOSS, PARTIAL 1979-90", "HN": "91(79); was see under HEARING LOSS, PARTIAL 1979-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19780522", "DC": "1", "DX": "19910101", "UI": "D006312"}, {"RECTYPE": "D", "MH": "Hearing Loss, Central", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Deafness, Cortical|T047|NON|NRW|NLM (2000)|991103|abcdef", "MN": "C23.888.592.763.393.341.887.432", "FX": "Vestibulocochlear Nerve Diseases", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "coordinate with VESTIBULOCOCHLEAR NERVE DISEASES for hearing loss due to cochlear nerve disease ", "PI": "Deafness (1966-1978)", "MS": "Hearing loss due to disease of the AUDITORY PATHWAYS (in the CENTRAL NERVOUS SYSTEM) which originate in the COCHLEAR NUCLEI of the PONS and then ascend bilaterally to the MIDBRAIN, the THALAMUS, and then the AUDITORY CORTEX in the TEMPORAL LOBE. Bilateral lesions of the auditory pathways are usually required to cause central hearing loss. Cortical deafness refers to loss of hearing due to bilateral auditory cortex lesions. Unilateral BRAIN STEM lesions involving the cochlear nuclei may result in unilateral hearing loss.", "PM": "91; was see under HEARING LOSS, SENSORINEURAL 1979-90", "HN": "91(79); was see under HEARING LOSS, SENSORINEURAL 1979-90", "CATSH": "CAT LIST", "MR": "20200303", "DA": "19780522", "DC": "1", "DX": "19910101", "UI": "D006313"}, {"RECTYPE": "D", "MH": "Hearing Loss, Conductive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Conductive Hearing Loss|T047|T184|NON|EQV|NLM (2005)|031106|abbcdef", "MN": "C23.888.592.763.393.341.562", "MH_TH": "NLM (1979)", "ST": "T184", "AN": "HEARING LOSS, MIXED CONDUCTIVE-SENSORINEURAL is also available.", "PI": "Deafness (1966-1978)", "MS": "Hearing loss due to interference with the mechanical reception or amplification of sound to the COCHLEA. The interference is in the outer or middle ear involving the EAR CANAL; TYMPANIC MEMBRANE; or EAR OSSICLES.", "PM": "91; was see under HEARING LOSS, PARTIAL 1979-90", "HN": "91(79); was see under HEARING LOSS, PARTIAL 1979-90", "CATSH": "CAT LIST", "MR": "20050713", "DA": "19780522", "DC": "1", "DX": "19910101", "UI": "D006314"}, {"RECTYPE": "D", "MH": "Hearing Loss, Functional", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hearing Loss, Nonorganic|T048|T184|NON|EQV|UNK (19XX)|780522|abbcdef", "ENTRY": "Psychogenic Hearing Loss", "MN": "F01.145.126.875", "MH_TH": "NLM (1979)", "ST": "T184", "PI": "Deafness (1966-1978)", "MS": "Hearing loss without a physical basis. Often observed in patients with psychological or behavioral disorders.", "PM": "91; was see under HEARING LOSS, PARTIAL 1979-90", "HN": "91(79); was see under HEARING LOSS, PARTIAL 1979-90", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19780522", "DC": "1", "DX": "19910101", "UI": "D006315"}, {"RECTYPE": "D", "MH": "Hearing Loss, High-Frequency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "High-Frequency Hearing Loss", "MN": "C23.888.592.763.393.341.812", "MH_TH": "NLM (1979)", "ST": "T047", "PI": "Deafness (1966-1978)", "MS": "Hearing loss in frequencies above 1000 hertz.", "PM": "91; was see under HEARING LOSS, PARTIAL 1979-90", "HN": "91(79); was see under HEARING LOSS, PARTIAL 1979-90", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19780522", "DC": "1", "DX": "19910101", "UI": "D006316"}, {"RECTYPE": "D", "MH": "Hearing Loss, Noise-Induced", "DE": "HEARING LOSS NOISE IND", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Acoustic Trauma|T037|T184|NON|NRW|UNK (19XX)|780522|abbcdef", "ENTRY": "Noise-Induced Hearing Loss", "MN": "C23.888.592.763.393.341.887.460", "MH_TH": "NLM (1966)", "ST": "T184", "PI": "Noise (1966-1978)", "MS": "Hearing loss due to exposure to explosive loud noise or chronic exposure to sound level greater than 85 dB. The hearing loss is often in the frequency range 4000-6000 hertz.", "OL": "use HEARING LOSS, NOISE-INDUCED to search ACOUSTIC TRAUMA 1966-78", "PM": "79; was ACOUSTIC TRAUMA 1963-78", "HN": "79; was ACOUSTIC TRAUMA 1963-78", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D006317"}, {"RECTYPE": "D", "MH": "Hearing Loss, Sensorineural", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sensoryneural Deafness|T047|NON|EQV|NLM (2022)|210318|abcdef", "ENTRY": "Sensoryneural Deafnesses", "MN": "C23.888.592.763.393.341.887", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "HEARING LOSS, MIXED CONDUCTIVE-SENSORINEURAL is also available", "PI": "Deafness (1966-1978)", "MS": "Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D006319"}, {"RECTYPE": "D", "MH": "Hearing Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Speech in Noise Hearing Test|T060|NON|NRW|NLM (2022)|210223|abcdef", "ENTRY": "Tests, Hearing", "MN": "E01.370.382.375", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Part of an ear examination that measures the ability of sound to reach the brain.", "CATSH": "CAT LIST", "MR": "20230326", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006320"}, {"RECTYPE": "D", "MH": "Heart", "AQ": "AH DE DG EM GD IR MI PH PP PS RE VI", "ENTRY": "Hearts|T023|NON|EQV|BIOETHICS (1989)|770317|abcdef", "MN": "A07.541", "FX": "Myocardium", "EC": "ultrastructure:Myocardium:ultrastructure", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "heart as pump, not tissue (MYOCARDIUM);  mural thrombosis: index HEART DISEASE  + THROMBOSIS", "CX": "consider also terms at CARDI- and MYOCARDI-", "MS": "The hollow, muscular organ that maintains the circulation of the blood.", "MR": "20160809", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006321"}, {"RECTYPE": "D", "MH": "Heart Aneurysm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Heart Aneurysms", "MN": "C14.907.055.608", "FX": "Coronary Aneurysm", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "myocardium only: CORONARY ANEURYSM is also available", "MS": "A localized bulging or dilatation in the muscle wall of a heart (MYOCARDIUM), usually in the LEFT VENTRICLE. Blood-filled aneurysms are dangerous because they may burst. Fibrous aneurysms interfere with the heart function through the loss of contractility. True aneurysm is bound by the vessel wall or cardiac wall. False aneurysms are HEMATOMA caused by myocardial rupture.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006322"}, {"RECTYPE": "D", "MH": "Heart Arrest", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cardiopulmonary Arrest|T033|T046|NON|BRD|UNK (19XX)|770427|abbcdef", "ENTRY": "Asystoles", "MN": "C14.280.383", "FX": "Heart Arrest, Induced", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "do not confuse with CARDIAC ARREST, SUDDEN see DEATH, SUDDEN, CARDIAC", "MS": "Cessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart arrest can be reversed in most cases to normal cardiac rhythm and effective circulation.", "OL": "use HEART ARREST to search ASYSTOLE 1969-74", "PM": "ASYSTOLE was see under ARRHYTHMIA 1969-90", "HN": "ASYSTOLE was see under ARRHYTHMIA 1969-90", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006323"}, {"RECTYPE": "D", "MH": "Heart Arrest, Induced", "DE": "HEART ARREST IND", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Cardioplegia|T061|NON|EQV|UNK (19XX)|810513|abcdef", "ENTRY": "Cardioplegias", "MN": "E04.928.220.360", "FX": "Cardioplegic Solutions", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "note category: a technique, not a disease; do not coordinate with HYPOTHERMIA, INDUCED unless this is particularly discussed", "MS": "A procedure to stop the contraction of MYOCARDIUM during HEART SURGERY. It is usually achieved with the use of chemicals (CARDIOPLEGIC SOLUTIONS) or cold temperature (such as chilled perfusate).", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006324"}, {"RECTYPE": "D", "MH": "Heart Atria", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PP PS RE SU TR UL VI", "PRINT ENTRY": "Heart Atrium|T023|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Atrium, Right", "MN": "A07.541.358", "FX": "Atrial Function", "EC": "physiology:Atrial Function", "MH_TH": "NLM (2004)", "ST": "T023", "AN": "NIM: Manual 21.51", "MS": "The chambers of the heart, to which the BLOOD returns from the circulation.", "PM": "2004; see HEART ATRIUM 1966-2003", "HN": "2004(1966)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006325"}, {"RECTYPE": "D", "MH": "Heart Auscultation", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Heart Auscultations", "MN": "E01.370.600.060.400", "FX": "Phonocardiography", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "/instrum: STETHOSCOPES is also available", "MS": "Act of listening for sounds within the heart.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006326"}, {"RECTYPE": "D", "MH": "Heart Block", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Auriculo-Ventricular Dissociation|T047|NON|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Heart Blocks", "MN": "C23.550.073.425", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Impaired conduction of cardiac impulse that can occur anywhere along the conduction pathway, such as between the SINOATRIAL NODE and the right atrium (SA block) or between atria and ventricles (AV block). Heart blocks can be classified by the duration, frequency, or completeness of conduction block. Reversibility depends on the degree of structural or functional defects.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006327"}, {"RECTYPE": "D", "MH": "Cardiac Catheterization", "DE": "CARDIAC CATH", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Heart Catheterization|T060|NON|EQV|NLM (1966)|990101|HEART CATH|abcdefv", "ENTRY": "Heart Catheterizations", "MN": "E05.157.250", "FX": "Pulmonary Wedge Pressure", "MH_TH": "UNK (19XX)", "ST": "T060", "MS": "Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures.", "PM": "2013; see HEART CATHETERIZATION 1966-2012", "HN": "2013 (1966)", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "20130101", "UI": "D006328"}, {"RECTYPE": "D", "MH": "Heart Conduction System", "AQ": "AB AH CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Systems, Heart Conduction", "MN": "A07.541.409", "FX": "Arrhythmias, Cardiac", "MH_TH": "NLM (1966)", "ST": "T022", "MS": "An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart.", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006329"}, {"RECTYPE": "D", "MH": "Heart Defects, Congenital", "DE": "HEART DEFECTS CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Heart Abnormalities|T019|T047|NON|EQV|UNK (19XX)|740330|HEART ABNORM|abbcdefv", "ENTRY": "Malformation Of Hearts", "MN": "C16.131.240.400", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general only; do not use as coordinate for specific term /abnorm; cyanotic defects probably go here but do not also index under CYANOSIS unless especially discussed", "MS": "Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006330"}, {"RECTYPE": "D", "MH": "Heart Diseases", "DE": "HEART DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Heart Disorders|T047|NON|EQV|NLM (2020)|190501|abcdef", "ENTRY": "Heart Disorder", "MN": "C14.280", "FX": "Neurocirculatory Asthenia", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Pathological conditions involving the HEART including its structural and functional abnormalities.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006331"}, {"RECTYPE": "D", "MH": "Cardiomegaly", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Heart Hypertrophy|T033|T046|NON|NRW|NLM (1966)|990101|abbcdef", "ENTRY": "Hypertrophy, Heart", "MN": "C23.300.775.250", "MH_TH": "NLM (1990)", "ST": "T046", "AN": "general or unspecified; prefer HYPERTROPHY, LEFT VENTRICULAR or HYPERTROPHY, RIGHT VENTRICULAR; note entry term CARDIAC HYPERTROPHY: do not confuse with CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMEGALY, EXERCISE-INDUCED is also available", "MS": "Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.", "PM": "2000; see HEART HYPERTROPHY 1993-1999; see HEART ENLARGEMENT 1963-1992", "HN": "2000(1963)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D006332"}, {"RECTYPE": "D", "MH": "Heart Failure", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Heart Decompensation|T047|NON|REL|NLM (1998)|960715|abcdef", "ENTRY": "Right Sided Heart Failure", "MN": "C14.280.434", "MH_TH": "NLM (2008)", "ST": "T047", "AN": "\"scompenso di cuore\" is \"heart decompensation\" in Italian; do not confuse with CARDIOMYOPATHY, CONGESTIVE", "MS": "A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.", "PM": "2008; see HEART FAILURE, CONGESTIVE 1966-2007", "HN": "2008 (1966)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D006333"}, {"RECTYPE": "D", "MH": "Heart Function Tests", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Tests, Heart Function", "MN": "E01.370.370.380", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Examinations used to diagnose and treat heart conditions.", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006334"}, {"RECTYPE": "D", "MH": "Heart Injuries", "DE": "HEART INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Heart Rupture, Traumatic|T037|NON|NRW|UNK (19XX)|770428|abcdef", "ENTRY": "Traumatic Heart Ruptures", "MN": "C26.891.375", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "coordinate with specific part of heart /inj", "MS": "General or unspecified injuries to the heart.", "CATSH": "CAT LIST", "MR": "20160706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006335"}, {"RECTYPE": "D", "MH": "Heart Massage", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Massages, Heart", "MN": "E04.928.220.380", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Rhythmic compression of the heart by pressure applied manually over the sternum (closed heart massage) or directly to the heart through an opening in the chest wall (open heart massage). It is done to reinstate and maintain circulation. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006336"}, {"RECTYPE": "D", "MH": "Heart Murmurs", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Murmurs, Innocent", "MN": "C23.888.447", "FX": "Phonocardiography", "MH_TH": "NLM (1975)", "ST": "T184", "AN": "do not confuse with HEART SOUNDS, a physiological concept", "MS": "Heart sounds caused by vibrations resulting from the flow of blood through the heart. Heart murmurs can be examined by HEART AUSCULTATION, and analyzed by their intensity (6 grades), duration, timing (systolic, diastolic, or continuous), location, transmission, and quality (musical, vibratory, blowing, etc).", "OL": "search HEART AUSCULTATION 1972-74", "PM": "91; was see under HEART AUSCULTATION in Cat E 1972-90", "HN": "91(75); was see under HEART AUSCULTATION in Cat E 1972-90", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006337"}, {"RECTYPE": "D", "MH": "Heart Neoplasms", "DE": "HEART NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Myocardial (Rhabdomyomas and Fibromas)", "MN": "C14.280.459", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with specific site in heart (NIM) + histological type of neoplasm (IM)", "MS": "Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006338"}, {"RECTYPE": "D", "MH": "Heart Rate", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Pulse Rate|T033|T040|NON|REL|NLM (2004)|030513|abbcdef", "ENTRY": "Rate, Pulse", "MN": "G09.330.380.500", "FX": "Pulse", "MH_TH": "NLM (1964)", "ST": "T033", "MS": "The number of times the HEART VENTRICLES contract per unit of time, usually per minute.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006339"}, {"RECTYPE": "D", "MH": "Heart Rate, Fetal", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Fetal Heart Rate|T032|T033|NON|EQV|UNK (19XX)|860418|abbcdef", "ENTRY": "Rates, Fetal Heart", "MN": "G09.330.380.500.430", "MH_TH": "NLM (1987)", "ST": "T033", "AN": "mammals only", "PI": "Heart Rate (1966-1986)", "MS": "The heart rate of the FETUS. The normal range at term is between 120 and 160 beats per minute.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D006340"}, {"RECTYPE": "D", "MH": "Heart Rupture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cardiac Rupture|T047|NON|EQV|UNK (19XX)|770427|abcdef", "ENTRY": "Heart Ruptures", "MN": "C14.280.470", "MH_TH": "NLM (1978)", "ST": "T047", "AN": "do not confuse with HEART RUPTURE, TRAUMATIC see HEART INJURIES; coordinate IM with specific part (IM) if pertinent but VENTRICULAR SEPTAL RUPTURE is available", "PI": "Rupture, Spontaneous (1966-1977)", "MS": "Disease-related laceration or tearing of tissues of the heart, including the free-wall MYOCARDIUM; HEART SEPTUM; PAPILLARY MUSCLES; CHORDAE TENDINEAE; and any of the HEART VALVES. Pathological rupture usually results from myocardial infarction (HEART RUPTURE, POST-INFARCTION).", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D006341"}, {"RECTYPE": "D", "MH": "Heart Rupture, Post-Infarction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Post-Infarction Heart Rupture|T047|NON|EQV|UNK (19XX)|860624|POSTINFARCTION HEART RUPTURE|abcdefs", "ENTRY": "Ruptures, Post-Infarction Heart", "MN": "C14.280.470.475", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "do not coordinate with MYOCARDIAL INFARCTION unless specifically discussed", "PI": "Myocardial Infarction (1979-1986)", "MS": "Laceration or tearing of cardiac tissues appearing after MYOCARDIAL INFARCTION.", "PM": "91; was see under HEART RUPTURE 1987-90", "HN": "91(87); was see under HEART RUPTURE 1987-90", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19860624", "DC": "1", "DX": "19910101", "UI": "D006342"}, {"RECTYPE": "D", "MH": "Heart Septal Defects", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Heart Septal Defect|T019|T047|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Septal Defects, Heart", "MN": "C16.131.240.400.560", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Abnormalities in any part of the HEART SEPTUM resulting in abnormal communication between the left and the right chambers of the heart. The abnormal blood flow inside the heart may be caused by defects in the ATRIAL SEPTUM, the VENTRICULAR SEPTUM, or both.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D006343"}, {"RECTYPE": "D", "MH": "Heart Septal Defects, Atrial", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Persistent Ostium Primum|T019|NON|NRW|UNK (19XX)|820423|abcdef", "ENTRY": "Septal Defect, Atrial", "MN": "C16.131.240.400.560.375", "MH_TH": "NLM (1964)", "ST": "T019", "MS": "Developmental abnormalities in any portion of the ATRIAL SEPTUM resulting in abnormal communications between the two upper chambers of the heart. Classification of atrial septal defects is based on location of the communication and types of incomplete fusion of atrial septa with the ENDOCARDIAL CUSHIONS in the fetal heart. They include ostium primum, ostium secundum, sinus venosus, and coronary sinus defects.", "PM": "1964; ATRIAL SEPTAL DEFECT OSTIUM PRIMUM was indexed under HEART SEPTAL DEFECTS, ATRIAL 2011-2017", "HN": "1964; ATRIAL SEPTAL DEFECT OSTIUM PRIMUM was indexed under HEART SEPTAL DEFECTS, ATRIAL 2011-2017", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D006344"}, {"RECTYPE": "D", "MH": "Heart Septal Defects, Ventricular", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ventricular Septal Defects|T019|T047|NON|EQV|NLM (1995)|940111|abbcdef", "ENTRY": "Septal Defects, Ventricular", "MN": "C16.131.240.400.560.540", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D006345"}, {"RECTYPE": "D", "MH": "Heart Septum", "AQ": "AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Septum, Heart", "MN": "A07.541.459", "EC": "abnormalities:Heart Septal Defects", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "heart septal disease: coordinate IM with CARDIOMYOPATHIES (IM)", "MS": "This structure includes the thin muscular atrial septum between the two HEART ATRIA, and the thick muscular ventricular septum between the two HEART VENTRICLES.", "PM": "HEART SEPTUM, ATRIAL & HEART SEPTUM, VENTRICULAR were headings 1963", "HN": "HEART SEPTUM, ATRIAL & HEART SEPTUM, VENTRICULAR were headings 1963", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006346"}, {"RECTYPE": "D", "MH": "Heart Sounds", "AQ": "DE ES GE IM PH RE", "ENTRY": "Sounds, Heart", "MN": "G09.330.380.510", "FX": "Phonocardiography", "MH_TH": "NLM (1975)", "ST": "T033", "AN": "note category: do not confuse with HEART MURMURS, a disease concept", "MS": "The sounds heard over the cardiac region produced by the functioning of the heart. There are four distinct sounds: the first occurs at the beginning of SYSTOLE and is heard as a \"lubb\" sound; the second is produced by the closing of the AORTIC VALVE and PULMONARY VALVE and is heard as a \"dupp\" sound; the third is produced by vibrations of the ventricular walls when suddenly distended by the rush of blood from the HEART ATRIA; and the fourth is produced by atrial contraction and ventricular filling.", "OL": "search HEART AUSCULTATION 1966-74", "PM": "91; was see under HEART AUSCULTATION 1963-90; was in Cat E 1963-90", "HN": "91(75); was see under HEART AUSCULTATION 1963-90; was in Cat E 1963-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006347"}, {"RECTYPE": "D", "MH": "Cardiac Surgical Procedures", "DE": "CARDIAC SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Heart|T061|NON|EQV|NLM (1998)|970210|SURG PROCEDURES HEART|abcdefv", "MN": "E04.928.220", "FX": "Thoracic Surgery", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general only; prefer specifics; do not use for surgery of specific parts of heart (equals specific heart term /surg) or specific heart disease (equals disease /surg)", "MS": "Surgery performed on the heart.", "PM": "98; was HEART SURGERY 1963-97", "HN": "98; was HEART SURGERY 1963-97", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006348"}, {"RECTYPE": "D", "MH": "Heart Valve Diseases", "DE": "HEART VALVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Valvular Heart Diseases|T047|NON|EQV|NLM (2002)|001011|abcdef", "ENTRY": "Valvular Heart Disease", "MN": "C14.280.484", "MH_TH": "NLM (1967)", "ST": "T047", "AN": "coordinate with specific valve but note specifics", "PI": "Heart Diseases (1966)", "MS": "Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).", "OL": "use HEART VALVE DISEASES to search AORTIC VALVE DISEASES 1966", "PM": "67; AORTIC VALVE DISEASES was heading 1963-66", "HN": "67; AORTIC VALVE DISEASES was heading 1963-66", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006349"}, {"RECTYPE": "D", "MH": "Heart Valve Prosthesis", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Prosthesis, Heart Valve|T074|NON|EQV|NLM (2002)|001019|abcdef", "ENTRY": "Valve Prosthesis, Heart", "MN": "E07.695.310", "FX": "Heart Valve Prosthesis Implantation", "MH_TH": "NLM (1965)", "ST": "T074", "AN": "coord IM with specific valve (IM); for bioprostheses coord IM with BIOPROSTHESIS (IM) & do not specify source of biol material unless especially discussed", "MS": "A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20050730", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006350"}, {"RECTYPE": "D", "MH": "Heart Valves", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Valves, Heart", "MN": "A07.541.510", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "general or unspecified; prefer specifics", "MS": "Flaps of tissue that prevent regurgitation of BLOOD from the HEART VENTRICLES to the HEART ATRIA or from the PULMONARY ARTERIES or AORTA to the ventricles.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006351"}, {"RECTYPE": "D", "MH": "Heart Ventricles", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PP PS RE SU TR UL VI", "ENTRY": "Ventricles, Right", "MN": "A07.541.560", "FX": "Ventricular Pressure", "EC": "physiology:Ventricular Function", "MH_TH": "NLM (2004)", "ST": "T023", "MS": "The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation.", "PM": "2004; see HEART VENTRICLE 1966-2003", "HN": "2004(1966)", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006352"}, {"RECTYPE": "D", "MH": "Heart-Assist Devices", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Ventricle-Assist Device|T074|NON|NRW|UNK (19XX)|850607|abcdef", "ENTRY": "Ventricular Assist Devices", "MN": "E07.858.082.374.300", "MH_TH": "NLM (1986)", "ST": "T074", "PI": "Pacemaker, Artificial (1966-1985)", "MS": "Small pumps, often implantable, designed for temporarily assisting the heart, usually the LEFT VENTRICLE, to pump blood. They consist of a pumping chamber and a power source, which may be partially or totally external to the body and activated by electromagnetic motors.", "PM": "90; was see under ASSISTED CIRCULATION 1986-89", "HN": "90(86); was see under ASSISTED CIRCULATION 1986-89", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19850607", "DC": "1", "DX": "19900101", "UI": "D006353"}, {"RECTYPE": "D", "MH": "Heart, Artificial", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Artificial Heart|T074|NON|EQV|NLM (1998)|970515|abcdef", "ENTRY": "Hearts, Artificial", "MN": "E07.858.082.374", "MH_TH": "NLM (1967)", "ST": "T074", "AN": "pump replacing whole or part of heart: do not confuse with HEART-LUNG MACHINE (external to heart); /psychol permitted", "PI": "Heart-Lung Machine (1966)", "MS": "A pumping mechanism that duplicates the output, rate, and blood pressure of the natural heart. It may replace the function of the entire heart or a portion of it, and may be an intracorporeal, extracorporeal, or paracorporeal heart. (Dorland, 28th ed)", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006354"}, {"RECTYPE": "D", "MH": "Heart-Lung Machine", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Machines, Heart-Lung", "MN": "E07.858.082.458", "FX": "Oxygenators", "MH_TH": "NLM (1966)", "ST": "T074", "AN": "external: do not confuse with HEART, ARTIFICIAL (pump replacing whole or part of heart)", "MS": "Apparatus that provides mechanical circulatory support during open-heart surgery, by passing the heart to facilitate surgery on the organ. The basic function of the machine is to oxygenate the body's venous supply of blood and then pump it back into the arterial system. The machine also provides intracardiac suction, filtration, and temperature control. Some of the more important components of these machines include pumps, oxygenators, temperature regulators, and filters. (UMDNS, 1999)", "PM": "98; see HEART, MECHANICAL 1963-97, for HEART-LUNG MACHINE see HEART, MECHANICAL 1967-97", "HN": "98(63)", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006355"}, {"RECTYPE": "D", "MH": "Heartburn", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pyrosis|T046|T184|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Pyroses", "MN": "C23.888.821.525", "FX": "Gastroesophageal Reflux", "MH_TH": "NLM (1964)", "ST": "T184", "MS": "Substernal pain or burning sensation, usually associated with regurgitation of gastric juice into the esophagus.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D006356"}, {"RECTYPE": "D", "MH": "Heartwater Disease", "DE": "HEARTWATER DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Disease, Heartwater", "MN": "C22.434", "MH_TH": "NLM (1970)", "ST": "T047", "PI": "Rickettsial Infections (1966-1969)", "MS": "A tick-borne septicemic disease of domestic and wild ruminants caused by EHRLICHIA RUMINANTIUM.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D006357"}, {"RECTYPE": "D", "MH": "Hot Temperature", "AQ": "AE TU", "PRINT ENTRY": "Heat|T070|NON|REL|NLM (1966)|990101|abcdef", "ENTRY": "Temperatures, Hot", "MN": "N06.230.300.100.725.710.380", "FX": "Tropical Climate", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "differentiate from HEATING (the environment); /ther use: consider also HYPERTHERMIA, INDUCED; HOT TEMPERATURE /adv eff: consider also HEAT STRESS DISORDERS & its specifics", "CX": "consider also terms at THERM-", "MS": "Presence of warmth or heat or a temperature notably higher than an accustomed norm.", "PM": "2009; see HEAT 1963-2008", "HN": "2009 (1963)", "MR": "20150331", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D006358"}, {"RECTYPE": "D", "MH": "Heat Exhaustion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Heat Prostration|T037|NON|EQV|NLM (1996)|940815|abcdef", "ENTRY": "Prostration, Heat", "MN": "C26.522.250", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "near normal body temperature: do not confuse with HEAT STROKE where body temp is dangerously high; SUNSTROKE is also available", "MS": "A clinical syndrome caused by heat stress, such as over-exertion in a hot environment or excessive exposure to sun. It is characterized by SWEATING, water (volume) depletion, salt depletion, cool clammy skin, NAUSEA, and HEADACHE.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006359"}, {"RECTYPE": "D", "MH": "Heat-Shock Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stress Proteins|T116|T123|NON|EQV|UNK (19XX)|830616|abbcdef", "ENTRY": "Protein, Stress", "MN": "D12.776.580.216", "FX": "Heat-Shock Response", "MH_TH": "NLM (1984)", "ST": "T123", "RN": "0", "PI": "Proteins (1966-1983)", "MS": "Proteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions.", "PM": "84", "HN": "84", "MR": "20200527", "DA": "19830616", "DC": "1", "DX": "19840101", "UI": "D006360"}, {"RECTYPE": "D", "MH": "Heating", "AQ": "AE EC ES HI IS LJ MT SN ST TD", "MN": "N06.230.150.300", "MH_TH": "NLM (1966)", "ST": "T069", "AN": "the environment: differentiate from HEAT, the principle of physics; /adv eff permitted but do not confuse with HEAT /adv eff", "MS": "The application of heat to raise the temperature of the environment, ambient or local, or the systems for accomplishing this effect. It is distinguished from HEAT, the physical property and principle of physics.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006361"}, {"RECTYPE": "D", "MH": "Heavy Chain Disease", "DE": "HEAVY CHAIN DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "mu-Chain Disease|T047|NON|NRW|NLM (1995)|930902|abcdef", "ENTRY": "mu-Chain Diseases", "MN": "C20.683.780.490", "FX": "Immunoglobulin Heavy Chains", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "A disorder of immunoglobulin synthesis in which large quantities of abnormal heavy chains are excreted in the urine. The amino acid sequences of the N-(amino-) terminal regions of these chains are normal, but they have a deletion extending from part of the variable domain through the first domain of the constant region, so that they cannot form cross-links to the light chains. The defect arises through faulty coupling of the variable (V) and constant (C) region genes.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20050701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006362"}, {"RECTYPE": "D", "MH": "Hebrides", "AQ": "EH EP", "MN": "Z01.542.363.766.500", "MH_TH": "NLM (1966)", "ST": "T083", "MS": "A group of islands in the Atlantic Ocean west of Scotland, comprising the Outer Hebrides and the Inner Hebrides.", "MR": "20160711", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D006363"}, {"RECTYPE": "D", "MH": "Hedgehogs", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Erinaceidae|T015|NON|EQV|NLM (2003)|020426|abcdef", "ENTRY": "Hedgehog", "MN": "B01.050.150.900.649.313.961.376", "MH_TH": "NLM (1972)", "ST": "T015", "RN": "txid9363", "PI": "Insectivora (1966-1971)", "MS": "The family Erinaceidae, in the order EULIPOTYPHLA. Most are true hedgehogs possessing a coat of spines and a very short tail. Those members of the family found in Southeast Asia (moonrats or gymnures) have normal body hair and a long tail.", "PM": "72", "HN": "72", "MR": "20210712", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006364"}, {"RECTYPE": "D", "MH": "Heel", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Sinus Tarsus", "MN": "A01.378.610.250.510", "FX": "Talus", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "primates only", "MS": "The back (or posterior) of the foot in PRIMATES, found behind the ankle and distal to the toes.", "MR": "20160226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006365"}, {"RECTYPE": "D", "MH": "Heinz Bodies", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Bodies, Heinz", "MN": "A15.145.229.334.330.340.335", "MH_TH": "NLM (1963)", "ST": "T026", "MS": "Abnormal intracellular inclusions, composed of denatured hemoglobin, found on the membrane of red blood cells. They are seen in thalassemias, enzymopathies, hemoglobinopathies, and after splenectomy.", "PM": "68", "HN": "68(63)", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006366"}, {"RECTYPE": "D", "MH": "HeLa Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "HeLa Cell", "MN": "A11.436.340", "MH_TH": "NLM (2011)", "ST": "T025", "AN": "almost always NIM with no subheadings; check HUMAN; do not routinely add UTERINE CERVICAL NEOPLASMS", "MS": "The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays.", "PM": "2011; see Hela Cells 1968-2011", "HN": "2011 (1965)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006367"}, {"RECTYPE": "D", "MH": "Helianthus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sunflower|T002|NON|NRW|UNK (19XX)|850430|abcdef", "ENTRY": "Sunflowers", "MN": "B01.875.800.575.912.250.100.400", "MH_TH": "NLM (1966)", "ST": "T002", "RN": "txid4231", "RR": "txid4233", "AN": "for sunflower seeds coordinate with SEEDS; do not confuse entry term JERUSALEM ARTICHOKE with ARTICHOKE see CYNARA SCOLYMUS", "MS": "A genus herbs of the Asteraceae family. The SEEDS yield oil and are used as food and animal feed; the roots of Helianthus tuberosum (Jerusalem artichoke) are edible.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006368"}, {"RECTYPE": "D", "MH": "Heligmosomatoidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Heligmosomatoideas", "MN": "B01.050.500.500.294.400.968.400", "MH_TH": "NLM (1986)", "ST": "T204", "RN": "txid2572560", "AN": "infection: coordinate with STRONGYLIDA INFECTIONS; coordinate with specific helminth terms (ANTIGENS, HELMINTH, etc.) if pertinent ", "MS": "A superfamily of parasitic nematodes which were formerly considered a part of TRICHOSTRONGYLOIDEA. It includes the following genera: Heligmosomum, NEMATOSPIROIDES, and NIPPOSTRONGYLUS. The hosts are rodents.", "PM": "86", "HN": "86", "MR": "20200813", "DA": "19850311", "DC": "1", "DX": "19860101", "UI": "D006369"}, {"RECTYPE": "D", "MH": "Heliotherapy", "DE": "HELIOTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E02.774.430", "MH_TH": "NLM (1975)", "ST": "T061", "MS": "The treatment of disease by exposing the body to SUNLIGHT, a therapeutic use of SUNBATHING.", "OL": "use SUNLIGHT to search HELIOTHERAPY 1966-74", "PM": "91; was see under PHOTOTHERAPY 1986-90; was see under PHYSICAL THERAPY 1975-85; was see under SUNLIGHT 1966-74", "HN": "91(75); was see under PHOTOTHERAPY 1986-90; was see under PHYSICAL THERAPY 1975-85; was see under SUNLIGHT 1963-74", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006370"}, {"RECTYPE": "D", "MH": "Helium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Helium 4", "MN": "D01.362.641.352", "MH_TH": "USP (19XX)", "ST": "T196", "N1": "Helium", "RN": "206GF3GB41", "RR": "7440-59-7 (Helium)", "MS": "A noble gas with the atomic symbol He, atomic number 2, and atomic weight 4.003. It is a colorless, odorless, tasteless gas that is not combustible and does not support combustion. It was first detected in the sun and is now obtained from natural gas. Medically it is used as a diluent for other gases, being especially useful with oxygen in the treatment of certain cases of respiratory obstruction, and as a vehicle for general anesthetics.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006371"}, {"RECTYPE": "D", "MH": "Helix, Snails", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Helix (Snails)|T204|NON|EQV|NLM (1975)|990101|HELIX A|HELIX|abcdefsv", "ENTRY": "Snails Helix", "MN": "B01.050.500.644.400.750.450", "MH_TH": "NLM (2020)", "ST": "T204", "RN": "txid6534", "PI": "Snails (1966-1974)", "MS": "A genus of chiefly Eurasian and African land snails including the principal edible snails as well as several pests of cultivated plants.", "PM": "2020; was HELIX (SNAILS) 1978-2019; was indexed under SNAILS 1975-1977", "HN": "2020 (1975); was HELIX (SNAILS) 1978-2019; was indexed under SNAILS 1975-1977", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19780101", "UI": "D006372"}, {"RECTYPE": "D", "MH": "Helminthiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Nematomorpha Infections|T047|NON|NRW|NLM (1992)|910328|NEMATOMORPHA INFECT|abcdefv", "ENTRY": "Nematomorpha Infection", "MN": "C01.610.335", "FX": "Anthelmintics", "EC": "veterinary:Helminthiasis, Animal", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with NEGLECTED DISEASES if pertinent; infections in the intestines: coordinate IM with INTESTINAL DISEASES, PARASITIC (IM)", "MS": "Infestation with parasitic worms of the helminth class.", "OL": "use HELMINTHIASIS to search NEMATOMORPHA INFECTIONS 1975-91", "PM": "NEMATOMORPHA INFECTIONS was heading 1991, see under HELMINTHIASIS 1975-90", "HN": "NEMATOMORPHA INFECTIONS was heading 1975-91 (see under HELMINTHIASIS 1975-90)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006373"}, {"RECTYPE": "D", "MH": "Helminthiasis, Animal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Helminthiases, Animal", "MN": "C22.674.377", "MH_TH": "NLM (1974)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Helminthiasis/veterinary (1966-1997)", "MS": "Infestation of animals with parasitic worms of the helminth class. The infestation may be experimental or veterinary.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006374"}, {"RECTYPE": "D", "MH": "Helminthosporium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Helminthosporiums", "MN": "B01.300.381.420", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid58127", "MS": "A mitosporic fungal genus including both saprophytes and plant parasites.", "PM": "91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85", "HN": "91(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D006375"}, {"RECTYPE": "D", "MH": "Helminths", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Worms, Parasitic|T204|NON|EQV|NLM (1998)|970203|abcdef", "ENTRY": "Worm, Parasitic", "MN": "B01.050.500.500", "MH_TH": "NLM (1966)", "ST": "T204", "RR": "txid42814", "AN": "general or unspecified; prefer specifics; infection equals HELMINTHIASIS; coordinate with specific precoordinated helminth terms (e.g., ANTIGENS, HELMINTH) if pertinent", "MS": "Commonly known as parasitic worms, this group includes the ACANTHOCEPHALA; NEMATODA; and PLATYHELMINTHS. Some authors consider certain species of LEECHES that can become temporarily parasitic as helminths.", "OL": "use HELMINTHS to search ASCHELMINTHES 1976-85", "PM": "ASCHELMINTHES was heading 1976-85", "HN": "ASCHELMINTHES was heading 1976-85", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006376"}, {"RECTYPE": "D", "MH": "T-Lymphocytes, Helper-Inducer", "DS": "LYMPHOCYTES J HELPER INDUCER", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "T-Lymphocytes, Inducer|T025|EQV|UNK (19XX)|840417|LYMPHOCYTES J INDUCER|abdefs", "ENTRY": "T-Lymphocyte, Inducer", "MN": "A15.382.490.555.567.569.500.400", "FX": "Lymphocyte Cooperation", "MH_TH": "NLM (1983)", "ST": "T025", "AN": "subpopulations: coordinate IM with T-LYMPHOCYTE SUBSETS (IM)", "PI": "T-Lymphocytes (1973-1982)", "MS": "Subpopulation of CD4+ lymphocytes that cooperate with other lymphocytes (either T or B) to initiate a variety of immune functions. For example, helper-inducer T-cells cooperate with B-cells to produce antibodies to thymus-dependent antigens and with other subpopulations of T-cells to initiate a variety of cell-mediated immune functions.", "OL": "use T-LYMPHOCYTES, HELPER-INDUCER to search HELPER CELLS 1983-92; use T-LYMPHOCYTES 1979-82 & LYMPHOCYTE COOPERATION 1978", "PM": "93; was HELPER CELLS 1983-92; was see T-LYMPHOCYTES 1979-82; was see LYMPHOCYTE COOPERATION 1978", "HN": "93; was HELPER CELLS 1983-92; was see T-LYMPHOCYTES 1979-82; was see LYMPHOCYTE COOPERATION 1978", "MR": "20200527", "DA": "19820429", "DC": "1", "DX": "19830101", "UI": "D006377"}, {"RECTYPE": "D", "MH": "Helper Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, Helper", "MN": "B04.423", "FX": "Satellite Viruses", "MH_TH": "NLM (1967)", "ST": "T005", "AN": "enable defective viruses to replicate or to form a protein coat; coord IM with specific virus (IM)", "PI": "specific virus (1966)", "MS": "Viruses which enable defective viruses to replicate or to form a protein coat by complementing the missing gene function of the defective (satellite) virus. Helper and satellite may be of the same or different genus.", "OL": "use HELPER VIRUSES to search HELPER VIRUS 1967-74 (as Prov 1967-72)", "PM": "75; was HELPER VIRUS 1973-74", "HN": "75; was HELPER VIRUS 1967-74 (Prov 1967-72)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006378"}, {"RECTYPE": "D", "MH": "Helping Behavior", "ENTRY": "Helping Behaviors", "MN": "F01.145.813.225", "MH_TH": "NLM (1975)", "ST": "T054", "PI": "specific interpersonal relations heading", "MS": "Behaviors associated with the giving of assistance or aid to individuals.", "PM": "79; was see under SOCIAL BEHAVIOR 1975-78", "HN": "79(75); was see under SOCIAL BEHAVIOR 1975-78", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19741119", "DC": "1", "DX": "19790101", "UI": "D006379"}, {"RECTYPE": "D", "MH": "Helplessness, Learned", "PRINT ENTRY": "Learned Helplessness|T041|NON|EQV|UNK (19XX)|820428|abcdef", "MN": "F02.463.425.420", "MH_TH": "NLM (1983)", "ST": "T041", "MS": "Learned expectation that one's responses are independent of reward and, hence, do not predict or control the occurrence of rewards. Learned helplessness derives from a history, experimentally induced or naturally occurring, of having received punishment/aversive stimulation regardless of responses made. Such circumstances result in an impaired ability to learn. Used for human or animal populations. (APA, Thesaurus of Psychological Index Terms, 1994)", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19820428", "DC": "1", "DX": "19830101", "UI": "D006380"}, {"RECTYPE": "D", "MH": "Helsinki Declaration", "AQ": "HI", "PRINT ENTRY": "Declaration of Helsinki|T089|NON|EQV|NLM (2003)|020314|abcdef", "ENTRY": "Helsinki Declarations", "MN": "N05.350.670.500", "FX": "Human Experimentation", "MH_TH": "NLM (1975)", "ST": "T089", "MS": "An international agreement of the World Medical Association which offers guidelines for conducting experiments using human subjects. It was adopted in 1962 and revised by the 18th World Medical Assembly at Helsinki, Finland in 1964. Subsequent revisions were made in 1975, 1983, 1989, and 1996. (From Encyclopedia of Bioethics, rev ed, 1995)", "OL": "search ETHICS, MEDICAL 1969-74", "PM": "91; was see under ETHICS, MEDICAL 1975-90", "HN": "91(75); was see under ETHICS, MEDICAL 1975-90", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006381"}, {"RECTYPE": "D", "MH": "Hemadsorption", "AQ": "DE ES GE IM PH RE", "ENTRY": "Hemadsorptions", "MN": "G06.365", "MH_TH": "NLM (1970)", "ST": "T043", "AN": "do not confuse with HEMOSORPTION see HEMOPERFUSION", "PI": "Hemagglutination (1966-1969)", "MS": "A phenomenon manifested by an agent or substance adhering to or being adsorbed on the surface of a red blood cell, as tuberculin can be adsorbed on red blood cells under certain conditions. (Stedman, 25th ed)", "PM": "72", "HN": "72(70)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006382"}, {"RECTYPE": "D", "MH": "Hemadsorption Inhibition Tests", "DE": "HEMADSORPTION INHIB TESTS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Hemadsorption Inhibition", "MN": "E05.478.594.760.360", "MH_TH": "NLM (1963)", "ST": "T059", "AN": "NIM", "MS": "Serological tests that measure anti-hemadsorption agents such as antiviral ANTIBODIES that block VIRAL HEMAGGLUNININS from adhering to the surface of red blood cells.", "PM": "73", "HN": "73(63)", "CATSH": "CAT LIST", "MR": "20150522", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006383"}, {"RECTYPE": "D", "MH": "Hemagglutination", "AQ": "DE GE IM PH RE", "ENTRY": "Hemagglutinations", "MN": "G12.122.100.200", "FX": "Hemagglutination Tests", "MH_TH": "NLM (1966)", "ST": "T044", "MS": "The aggregation of ERYTHROCYTES by AGGLUTININS, including antibodies, lectins, and viral proteins (HEMAGGLUTINATION, VIRAL).", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006384"}, {"RECTYPE": "D", "MH": "Hemagglutination Inhibition Tests", "DE": "HEMAGGLUTINATION INHIB TESTS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Hemagglutination Inhibition", "MN": "E05.478.594.760.370", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "NIM", "MS": "Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006385"}, {"RECTYPE": "D", "MH": "Hemagglutination Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Hemagglutination", "MN": "E05.478.594.760.050.375", "FX": "Hemagglutination, Viral", "MH_TH": "NLM (1966)", "ST": "T059", "MS": "Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed)", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006386"}, {"RECTYPE": "D", "MH": "Hemagglutination, Viral", "AQ": "DE GE IM PH RE", "ENTRY": "Viral Hemagglutinations", "MN": "G06.920.370", "FX": "Hemagglutination Tests", "MH_TH": "NLM (1970)", "ST": "T070", "PI": "Hemagglutination (1966-1969)", "MS": "Agglutination of ERYTHROCYTES by a virus.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D006387"}, {"RECTYPE": "D", "MH": "Hemagglutinins", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Isohemagglutinins|T129|NON|NRW|UNK (19XX)|880518|abcdef", "ENTRY": "Hemagglutinin|T123|T129|NON|EQV|NLM (1988)|870509|abbcdef", "MN": "D27.505.954.502.270.232.500", "MH_TH": "NLM (1975)", "ST": "T129", "RN": "0", "AN": "restrict to erythrocytes: leukoagglutinins are indexed under AGGLUTININS (IM) + LEUKOCYTES or specific with /immunol (IM)", "PI": "Antibodies (1966-1974)", "MS": "Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc.", "OL": "search ANTIBODIES 1966-74", "PM": "81; was see under AGGLUTININS 1975-80, was indexed under ANTIBODIES 1963-74.", "HN": "81(75); was see under AGGLUTININS 1975-80, was see under ANTIBODIES 1968-74, was see ANTIBODIES 1963-67", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D006388"}, {"RECTYPE": "D", "MH": "Hemagglutinins, Viral", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Hemagglutinin, Viral", "MN": "D23.050.327.461", "MH_TH": "NLM (1967)", "ST": "T129", "RN": "0", "PI": "Antigens (1966)", "MS": "Specific hemagglutinin subtypes encoded by VIRUSES.", "PM": "72; was see under ANTIGENS 1968-71", "HN": "72(67); was see under ANTIGENS 1968-71", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006389"}, {"RECTYPE": "D", "MH": "Hemangioendothelioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Vascular Endotheliomas", "MN": "C04.557.645.375.370", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "MS": "A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy (between benign hemangiomas and conventional angiosarcomas). They affect men and women about equally and rarely develop in childhood. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1866)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006390"}, {"RECTYPE": "D", "MH": "Hemangioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Hemangioma, Intramuscular|T191|NON|NRW|NLM (1994)|930326|abcdef", "ENTRY": "Intramuscular Hemangiomas", "MN": "C04.557.645.375", "FX": "Pulmonary Sclerosing Hemangioma", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with pre-coordinated organ/neoplasm term (IM); note specific hemangioma terms are also available", "MS": "A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006391"}, {"RECTYPE": "D", "MH": "Hemangioma, Cavernous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Angioma, Cavernous|T191|NON|BRD|NLM (1998)|960730|abcdef", "ENTRY": "Strawberry Hemangioma", "MN": "C15.378.463.515.385", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with pre-coordinated organ/neoplasm term (IM)", "MS": "A vascular anomaly that is a collection of tortuous BLOOD VESSELS and connective tissue. This tumor-like mass with the large vascular space is filled with blood and usually appears as a strawberry-like lesion in the subcutaneous areas of the face, extremities, or other regions of the body including the central nervous system.", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006392"}, {"RECTYPE": "D", "MH": "Hemangiopericytoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Hemangiopericytomas", "MN": "C04.557.645.380", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "benign or malignant; coordinate with precoordinated organ/neoplasm term", "MS": "A tumor composed of spindle cells with a rich vascular network, which apparently arises from pericytes, cells of smooth muscle origin that lie around small vessels. Benign and malignant hemangiopericytomas exist, and the rarity of these lesions has led to considerable confusion in distinguishing between benign and malignant variants. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1364)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006393"}, {"RECTYPE": "D", "MH": "Hemangiosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Angiosarcoma|T191|NON|EQV|UNK (19XX)|850325|abcdef", "ENTRY": "Hemangiosarcomas", "MN": "C04.557.645.390", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)", "OL": "use HEMANGIOSARCOMA to search ANGIOSARCOMA 1966-85", "PM": "86; was ANGIOSARCOMA 1963-85", "HN": "86; was ANGIOSARCOMA 1963-85", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D006394"}, {"RECTYPE": "D", "MH": "Hemarthrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hemarthroses", "MN": "C23.550.414.794", "MH_TH": "NLM (1964)", "ST": "T046", "MS": "Bleeding into the joints. It may arise from trauma or spontaneously in patients with hemophilia.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006395"}, {"RECTYPE": "D", "MH": "Hematemesis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hematemeses", "MN": "C23.888.821.937.019", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Vomiting of blood that is either fresh bright red, or older \"coffee-ground\" in character. It generally indicates bleeding of the UPPER GASTROINTESTINAL TRACT.", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006396"}, {"RECTYPE": "D", "MH": "Hematinics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hematopoietic Agents|T121|NON|EQV|UNK (19XX)|741226|abcdef", "ENTRY": "Stimulating Agent, Erythropoiesis", "MN": "D27.505.954.502.543", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Anemia/drug therapy (1966-1974)", "MS": "Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias.", "PM": "75", "HN": "75", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D006397"}, {"RECTYPE": "D", "MH": "Hematocele", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Testicular Hematoceles", "MN": "C23.550.414.817", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Hemorrhage into a canal or cavity of the body, such as the space covered by the serous membrane (tunica vaginalis) around the TESTIS leading to testicular hematocele or scrotal hematocele.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006398"}, {"RECTYPE": "D", "MH": "Hematocolpos", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C12.100.250.894.300", "MH_TH": "NLM (1979)", "ST": "T184", "PI": "Vaginal Diseases (1966-1978)", "MS": "A blood-filled VAGINA that is obstructed.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19771125", "DC": "1", "DX": "19790101", "UI": "D006399"}, {"RECTYPE": "D", "MH": "Hematocrit", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Packed Red-Cell Volume|T034|NON|EQV|NLM (1990)|890314|abcdef", "ENTRY": "Volumes, Packed Red-Cell", "MN": "G09.188.370.374", "MH_TH": "POPLINE (1978)", "ST": "T034", "AN": "usually NIM", "MS": "The volume of packed RED BLOOD CELLS in a blood specimen. The volume is measured by centrifugation in a tube with graduated markings, or with automated blood cell counters. It is an indicator of erythrocyte status in disease. For example, ANEMIA shows a low value; POLYCYTHEMIA, a high value.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006400"}, {"RECTYPE": "D", "MH": "Hematologic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Agents, Hematological", "MN": "D27.505.954.502", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Drugs that act on blood and blood-forming organs and those that affect the hemostatic system.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006401"}, {"RECTYPE": "D", "MH": "Hematologic Diseases", "DE": "HEMATOL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Blood Diseases|T047|NON|EQV|UNK (19XX)|740330|BLOOD DIS|abcdefv", "ENTRY": "Hematological Disease", "MN": "C15.378", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Disorders of the blood and blood forming tissues.", "PM": "65; was BLOOD DISEASES see under HEMATOLOGY 1963-64", "HN": "65; was BLOOD DISEASES see under HEMATOLOGY 1963-64", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006402"}, {"RECTYPE": "D", "MH": "Hematologic Tests", "DE": "HEMATOL TESTS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Blood Tests|T059|NON|EQV|UNK (19XX)|860604|abcdef", "ENTRY": "Tests, Hematological", "MN": "E05.200.625", "MH_TH": "POPLINE (1984)", "ST": "T059", "AN": "general; prefer specifics; does not include BLOOD CHEMICAL ANALYSIS or SEROLOGIC TESTS", "PI": "Hematology (1966-1977)", "MS": "Tests used in the analysis of the hemic system.", "PM": "78", "HN": "78; was NON MESH before 1978", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D006403"}, {"RECTYPE": "D", "MH": "Hematology", "DE": "HEMATOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.429.445", "FX": "Hematologic Diseases", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "A subspecialty of internal medicine concerned with morphology, physiology, and pathology of the blood and blood-forming tissues.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006405"}, {"RECTYPE": "D", "MH": "Hematoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hematomas", "MN": "C23.550.414.838", "MH_TH": "NLM (1963)", "ST": "T046", "AN": "not a neoplasm: coordinate with organ/disease or organ/hemorrhage term (IM)", "MS": "A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006406"}, {"RECTYPE": "D", "MH": "Hematoma, Epidural, Cranial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Cranial Epidural|T020|T037|NON|EQV|NLM (2005)|031028|abbcdef", "ENTRY": "Intracranial Epidural Hematomas", "MN": "C26.915.300.490.400", "MH_TH": "NLM (2005)", "ST": "T037", "MS": "Accumulation of blood in the EPIDURAL SPACE between the SKULL and the DURA MATER, often as a result of bleeding from the MENINGEAL ARTERIES associated with a temporal or parietal bone fracture. Epidural hematoma tends to expand rapidly, compressing the dura and underlying brain. Clinical features may include HEADACHE; VOMITING; HEMIPARESIS; and impaired mental function.", "PM": "2005; see HEMATOMA, EPIDURAL 1966-2004", "HN": "2005 (1966)", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D006407"}, {"RECTYPE": "D", "MH": "Hematoma, Subdural", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subdural Hematoma|T020|T037|NON|EQV|NLM (2000)|991103|abbcdef", "ENTRY": "Traumatic Subdural Hematomas", "MN": "C26.915.300.490.450", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Accumulation of blood in the SUBDURAL SPACE between the DURA MATER and the arachnoidal layer of the MENINGES. This condition primarily occurs over the surface of a CEREBRAL HEMISPHERE, but may develop in the spinal canal (HEMATOMA, SUBDURAL, SPINAL). Subdural hematoma can be classified as the acute or the chronic form, with immediate or delayed symptom onset, respectively. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006408"}, {"RECTYPE": "D", "MH": "Hematometra", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hematometras", "MN": "C12.100.250.852.495", "MH_TH": "NLM (1975)", "ST": "T184", "AN": "do not confuse with UTERINE HEMORRHAGE", "PI": "Uterine Diseases (1966-1974)", "MS": "Blood-filled UTERUS.", "PM": "79; was see under UTERINE DISEASES 1975-78", "HN": "79(75); was see under UTERINE DISEASES 1975-78", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19741119", "DC": "1", "DX": "19790101", "UI": "D006409"}, {"RECTYPE": "D", "MH": "Hematopoiesis", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Hematopoiesis, Medullary|T042|NON|NRW|NLM (1998)|970213|abcdef", "ENTRY": "Medullary Hematopoiesis", "MN": "G09.188.343", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "general or unspecified; prefer specifics", "MS": "The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY).", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006410"}, {"RECTYPE": "D", "MH": "Hematopoiesis, Extramedullary", "AQ": "DE ES GE IM PH RE", "ENTRY": "Hematopoieses, Extramedullary", "MN": "G09.188.343.463", "MH_TH": "NLM (1987)", "ST": "T042", "AN": "for splenic, hepatic or lymphatic hematopoiesis do not coord with SPLEEN /physiol, LIVER /physiol or LYMPH NODES /physiol unless particularly discussed & then probably NIM", "PI": "Hematopoietic Stem Cells (1971-1986)", "MS": "The formation and development of blood cells outside the BONE MARROW, as in the SPLEEN; LIVER; or LYMPH NODES.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D006411"}, {"RECTYPE": "D", "MH": "Hematopoietic Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Stem Cells, Hematopoietic|T025|NON|EQV|UNK (19XX)|830224|abcdef", "ENTRY": "Units, Hematopoietic Colony-Forming", "MN": "A15.378.316.378", "FX": "Colony-Forming Units Assay", "EC": "transplantation:Hematopoietic Stem Cell Transplantation", "MH_TH": "NLM (1971)", "ST": "T025", "PI": "Bone Marrow/cytology (1966-1970)", "MS": "Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood.", "PM": "72", "HN": "72(71)", "MR": "20181102", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006412"}, {"RECTYPE": "D", "MH": "Hematopoietic System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "System, Hematopoietic", "MN": "A15.378", "MH_TH": "NLM (1966)", "ST": "T022", "AN": "/physiol: consider also HEMATOPOIESIS", "MS": "The blood-making organs and tissues, principally the bone marrow and lymph nodes.", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006413"}, {"RECTYPE": "D", "MH": "Hematoporphyrin Photoradiation", "DE": "HEMATOPORPHYRIN PHOTORAD", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Photoradiation, Hematoporphyrin|T061|NON|EQV|UNK (19XX)|850607|PHOTORAD HEMATOPORPHYRIN|abcdefv", "ENTRY": "Hematoporphyrin Photochemotherapy|T061|NON|EQV|NLM (1992)|910514|HEMATOPORPHYRIN PHOTOCHEMOTHER|abcdefv", "MN": "E02.774.722.435", "MH_TH": "NLM (1986)", "ST": "T061", "AN": "IM; coord with disease /drug ther (IM), not /radiother", "PI": "Phototherapy (1981-1985)", "MS": "Photochemotherapy using visible light, usually red, topically or delivered locally by fiberoptic probe to tissues sensitized with hematoporphyrins.", "PM": "91; was see under PHOTOCHEMOTHERAPY 1986-90", "HN": "91(86); was see under PHOTOCHEMOTHERAPY 1986-90", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19850607", "DC": "1", "DX": "19910101", "UI": "D006414"}, {"RECTYPE": "D", "MH": "Hematoporphyrins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hemedonin|T109|T121|T123|NON|NRW|UNK (19XX)|871208|abbbcdef", "MN": "D23.767.727.462", "PA": "Photosensitizing Agents", "MH_TH": "NLM (1965)", "ST": "T123", "RN": "0", "RR": "HBT6M5H379", "MS": "Iron-free derivatives of heme with 4 methyl groups, 2 hydroxyethyl groups and 2 propionic acid groups attached to the pyrrole rings. Some of these PHOTOSENSITIZING AGENTS are used in the PHOTOTHERAPY of malignant NEOPLASMS.", "OL": "use HEMATOPORPHYRINS to search HEMATOPORPHYRIN 1966-79 (as Prov 1966-73)", "PM": "80; was HEMATOPORPHYRIN 1974-79", "HN": "80; was HEMATOPORPHYRIN 1965-79 (Prov 1965-73)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006415"}, {"RECTYPE": "D", "MH": "Hematoxylin", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Hydroxybrazilin|T109|T130|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Hydroxybrasilin|T109|T130|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D03.633.100.150.600", "PA": "Coloring Agents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Benz(b)indeno(1,2-d)pyran-3,4,6a,9,10(6H)-pentol, 7,11b-dihydro-, cis-(+)-", "RN": "YKM8PY2Z55", "RR": "517-28-2 (Hematoxylin)", "PI": "Indenes (1973-1974)", "MS": "A dye obtained from the heartwood of logwood (Haematoxylon campechianum Linn., Leguminosae) used as a stain in microscopy and in the manufacture of ink.", "PM": "91; was see under BENZOPYRANS 1975-90", "HN": "91(75); was see under BENZOPYRANS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006416"}, {"RECTYPE": "D", "MH": "Hematuria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hematurias", "MN": "C23.550.414.849", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Presence of blood in the urine.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006417"}, {"RECTYPE": "D", "MH": "Heme", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Protoheme|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|760416|abbcdeef", "ENTRY": "Protoheme IX|T109|T123|NON|EQV|FDA SRS (2014)|NLM (1998)|961112|abbcdeef", "MN": "D23.767.727.640.587", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Ferrate(2-), (7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-N21,N22,N23,N24)-, dihydrogen, (SP-4-2)-", "RN": "42VZT0U6YR", "RR": "14875-96-8 (Heme)", "MS": "The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006418"}, {"RECTYPE": "D", "MH": "Heme Oxygenase (Decyclizing)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Haem Oxygenase|T116|T126|NON|EQV|UNK (19XX)|790221|abbcdef", "ENTRY": "Oxygenase, Heme", "MN": "D08.811.682.690.708.410", "MH_TH": "NLM (1980)", "ST": "T126", "N1": "Heme,hydrogen-donor:oxygen oxidoreductase (alpha-methene-oxidizing, hydroxylating)", "RN": "EC 1.14.14.18", "PI": "Oxygenases (1966-1979)", "MS": "A mixed function oxidase enzyme which during hemoglobin catabolism catalyzes the degradation of heme to ferrous iron, carbon monoxide and biliverdin in the presence of molecular oxygen and reduced NADPH. The enzyme is induced by metals, particularly cobalt.", "PM": "98; was HEME OXYGENASE 1980-97 (see under HYDROXYLASES 1980-90)", "HN": "98; was HEME OXYGENASE 1980-97 (see under HYDROXYLASES 1980-90)", "MR": "20160601", "DA": "19790221", "DC": "1", "DX": "19910101", "UI": "D006419"}, {"RECTYPE": "D", "MH": "Hemeproteins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hemeprotein|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Proteins, Heme", "MN": "D12.776.422", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "PI": "Proteins (1966-1972)", "MS": "Proteins that contain an iron-porphyrin, or heme, prosthetic group resembling that of hemoglobin. (From Lehninger, Principles of Biochemistry, 1982, p480)", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006420"}, {"RECTYPE": "D", "MH": "Hemerythrin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.556.579.374.187", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Metalloproteins (1973-1974)", "MS": "A non-heme iron protein consisting of eight apparently identical subunits each containing 2 iron atoms. It binds one molecule of oxygen per pair of iron atoms and functions as a respiratory protein.", "PM": "91; was see under METALLOPROTEINS 1975-90", "HN": "91(75); was see under METALLOPROTEINS 1975-90", "MR": "20020703", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006422"}, {"RECTYPE": "D", "MH": "Hemianopsia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Quadrantanopsia|T033|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Quadrantanopsias", "MN": "C23.888.592.763.941.512", "MH_TH": "NLM (1966)", "ST": "T033", "MS": "Partial or complete loss of vision in one half of the visual field(s) of one or both eyes. Subtypes include altitudinal hemianopsia, characterized by a visual defect above or below the horizontal meridian of the visual field. Homonymous hemianopsia refers to a visual defect that affects both eyes equally, and occurs either to the left or right of the midline of the visual field. Binasal hemianopsia consists of loss of vision in the nasal hemifields of both eyes. Bitemporal hemianopsia is the bilateral loss of vision in the temporal fields. Quadrantanopsia refers to loss of vision in one quarter of the visual field in one or both eyes.", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006423"}, {"RECTYPE": "D", "MH": "Hemic and Immune Systems", "DE": "HEMIC IMMUNE SYSTEMS", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "System, Hemic", "MN": "A15", "RH": "A15 - ANATOMY-HEMIC AND IMMUNE SYSTEMS", "MH_TH": "NLM (1985)", "ST": "T022", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "PI": "Immune System (1966-1997)", "MS": "Organs involved in the production of BLOOD, including the cellular and the molecular components essential in providing defense against foreign organisms or substances.", "PM": "1998; for HEMIC SYSTEM see BLOOD 1995-2003", "HN": "1998; use explode", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006424"}, {"RECTYPE": "D", "MH": "Hemic and Lymphatic Diseases", "DE": "HEMIC LYMPHATIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Blood and Lymphatic System Disorders|T047|NON|EQV|NLM (2020)|190507|abcdef", "MN": "C15", "RH": "C15 - DISEASES-HEMIC AND LYMPHATIC", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Hematologic diseases and diseases of the lymphatic system collectively. Hemic diseases include disorders involving the formed elements (e.g., ERYTHROCYTE AGGREGATION, INTRAVASCULAR) and chemical components (e.g., BLOOD PROTEIN DISORDERS); lymphatic diseases include disorders relating to lymph, lymph nodes, and lymphocytes.", "PM": "98", "HN": "98; use explode 1971-97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006425"}, {"RECTYPE": "D", "MH": "Hemicholinium 3", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hemicholinium|T109|T121|NON|EQV|UNK (19XX)|781215|abbcdef", "MN": "D02.675.276.435", "PA": "Neurotransmitter Uptake Inhibitors", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "Morpholinium, 2,2'-(1,1'-biphenyl)-4,4'-diylbis(2-hydroxy-4,4-dimethyl)-, dibromide", "RN": "312-45-8", "PI": "Morpholines (1966-1971)", "MS": "A potent inhibitor of the high affinity uptake system for CHOLINE. It has less effect on the low affinity uptake system. Since choline is one of the components of ACETYLCHOLINE, treatment with hemicholinium can deplete acetylcholine from cholinergic terminals. Hemicholinium 3 is commonly used as a research tool in animal and in vitro experiments.", "PM": "72", "HN": "72", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006426"}, {"RECTYPE": "D", "MH": "Hemin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hematin|T109|T123|NON|REL|UNK (19XX)|760416|abbcdef", "ENTRY": "Hematin D-575, Alkaline", "MN": "D23.767.727.640.587.462", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Ferrate(2-), chloro(7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-N21,N22,N23,N24)-, dihydrogen, (SP-5-13)-", "RN": "743LRP9S7N", "RR": "16009-13-5 (Hemin)", "AN": "a porphyrin", "MS": "Chloro(7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-N(21),N(22),N(23),N(24)) ferrate(2-) dihydrogen.", "OL": "search HEME 1968-74", "PM": "91; was see under HEME 1975-90", "HN": "91(75); was see under HEME 1975-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006427"}, {"RECTYPE": "D", "MH": "Hemipelvectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Hemipelvectomies", "MN": "E04.555.080.380", "MH_TH": "NLM (1975)", "ST": "T061", "MS": "AMPUTATION, SURGICAL of a lower limb through the sacroiliac joint.", "PM": "91; was see under AMPUTATION 1975-90", "HN": "91(75); was see under AMPUTATION 1975-90", "CATSH": "CAT LIST", "MR": "20220715", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D006428"}, {"RECTYPE": "D", "MH": "Hemiplegia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Monoplegia|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Transient Hemiplegias", "MN": "C23.888.592.636.312", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Severe or complete loss of motor function on one side of the body. This condition is usually caused by BRAIN DISEASES that are localized to the cerebral hemisphere opposite to the side of weakness. Less frequently, BRAIN STEM lesions; cervical SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; and other conditions may manifest as hemiplegia. The term hemiparesis (see PARESIS) refers to mild to moderate weakness involving one side of the body.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006429"}, {"RECTYPE": "D", "MH": "Hemiptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Whiteflies|T204|NON|NRW|NLM (1999)|970818|abcdef", "ENTRY": "Whitefly", "MN": "B01.050.500.131.617.412", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid7524", "RR": "txid7036", "AN": "for killing Hemiptera with insecticides, see note at INSECTICIDES", "PI": "Insects (1966-1974)", "MS": "A large order of insects characterized by having the mouth parts adapted to piercing or sucking. It is comprised of four suborders: HETEROPTERA, Auchenorrhyncha, Sternorrhyncha, and Coleorrhyncha.", "PM": "75", "HN": "75", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D006430"}, {"RECTYPE": "D", "MH": "Hemobilia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Biliary Tract|T033|T046|NON|EQV|UNK (19XX)|790529|abbcdef", "ENTRY": "Hemobilias", "MN": "C23.550.414.864", "MH_TH": "NLM (1980)", "ST": "T046", "PI": "Liver/injuries (1966-1979)", "MS": "Hemorrhage in or through the BILIARY TRACT due to trauma, inflammation, CHOLELITHIASIS, vascular disease, or neoplasms.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D006431"}, {"RECTYPE": "D", "MH": "Hemochromatosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Diabetes, Bronze|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Von Recklenhausen-Applebaum Diseases", "MN": "C18.452.648.618.337", "FX": "Hepcidins", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "accumulation of hemosiderin in tissue", "MS": "A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006432"}, {"RECTYPE": "D", "MH": "Hemocyanins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hemocyanin|T116|T123|NON|EQV|NLM (1964)|990101|abbcdef", "ENTRY": "alpha Hemocyanins", "MN": "D23.767.482", "MH_TH": "NLM (2018)", "ST": "T123", "N1": "Hemocyanins", "RN": "9013-72-3", "MS": "Metalloproteins that function as oxygen transport proteins in the HEMOLYMPH of MOLLUSKS and ARTHROPODS. They are characterized by two copper atoms, coordinated with HISTIDINE residues, that reversibly bind a single oxygen molecule; they do not contain HEME groups.", "PM": "2018; see HEMOCYANIN 1964-2017", "HN": "2018 (1964)", "MR": "20170629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006433"}, {"RECTYPE": "D", "MH": "Hemocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Hemocyte", "MN": "A15.145.229.480", "MH_TH": "NLM (1977)", "ST": "T025", "AN": "check tag ANIMALS", "PI": "Hemolymph (1966-1976)", "MS": "Any blood or formed element especially in invertebrates.", "PM": "91; was see under BLOOD CELLS 1977-90", "HN": "91(77); was see under BLOOD CELLS 1977-90", "MR": "20030730", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D006434"}, {"RECTYPE": "D", "MH": "Renal Dialysis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Hemodialysis|T061|NON|NRW|BIOETHICS (1974)|NLM (1967)|990101|abcdeef", "ENTRY": "Renal Dialyses", "MN": "E02.912.800", "FX": "Kidneys, Artificial", "MH_TH": "UNK (19XX)", "ST": "T061", "AN": "/instrum permitted but consider also KIDNEYS, ARTIFICIAL", "PI": "Kidney, Artificial (1966)", "MS": "Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.", "PM": "2001; see HEMODIALYSIS 1967-2000", "HN": "2001(1967)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006435"}, {"RECTYPE": "D", "MH": "Hemodialysis Units, Hospital", "DE": "HEMODIALYSIS UNITS HOSP", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Renal Dialysis Units, Hospital|T073|T093|NON|EQV|UNK (19XX)|810226|RENAL DIALYSIS UNITS HOSP|abbcdefv", "ENTRY": "Units, Hospital Hemodialysis", "MN": "N02.278.388.200", "MH_TH": "NLM (1982)", "ST": "T093", "PI": "Hospital Units (1974-1981)", "MS": "Hospital units in which care is provided the hemodialysis patient. This includes hemodialysis centers in hospitals.", "PM": "91; was see under HOSPITAL UNITS 1982-90", "HN": "91(82); was see under HOSPITAL UNITS 1982-90", "MR": "19960610", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D006436"}, {"RECTYPE": "D", "MH": "Hemodialysis, Home", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Renal Dialysis, Home|T061|NON|EQV|UNK (19XX)|770322|abcdef", "ENTRY": "Renal Dialyses, Home", "MN": "N02.421.143.524.337", "MH_TH": "NLM (1973)", "ST": "T061", "AN": "/instrum permitted if not KIDNEYS, ARTIFICIAL", "PI": "Peritoneal Dialysis (1966-1972)", "MS": "Long-term maintenance hemodialysis in the home.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006437"}, {"RECTYPE": "D", "MH": "Hemodilution", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Hemodilutions", "MN": "E02.514", "MH_TH": "NLM (1979)", "ST": "T061", "PI": "Plasma Substitutes (1966-1978)", "MS": "Reduction of blood viscosity usually by the addition of cell free solutions. Used clinically (1) in states of impaired microcirculation, (2) for replacement of intraoperative blood loss without homologous blood transfusion, and (3) in cardiopulmonary bypass and hypothermia.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20030722", "DA": "19780126", "DC": "1", "DX": "19790101", "UI": "D006438"}, {"RECTYPE": "D", "MH": "Hemodynamics", "AQ": "DE ES GE IM PH RE", "ENTRY": "Hemodynamic", "MN": "G09.330.380", "MH_TH": "NLM (2008)", "ST": "T042", "MS": "The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM.", "PM": "2008, 1966-2003; see HEMODYNAMIC PROCESSES 2004-2007", "HN": "2008, 1966-2003 (1964)", "CATSH": "was", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006439"}, {"RECTYPE": "D", "MH": "Hemofiltration", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Venovenous Hemofiltration|T061|NON|NRW|UNK (19XX)|870508|abcdef", "ENTRY": "Venovenous Hemofiltrations", "MN": "E04.292.471", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Ultrafiltration (1973-1987)", "MS": "Extracorporeal ULTRAFILTRATION technique without HEMODIALYSIS for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19870508", "DC": "1", "DX": "19880101", "UI": "D006440"}, {"RECTYPE": "D", "MH": "Hemoglobin A", "DE": "HBA", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.422.316.762.380", "MH_TH": "NLM (1977)", "ST": "T123", "N1": "Hemoglobin A", "RN": "9034-51-9", "AN": "/urine: coordinate with HEMOGLOBINURIA ", "PI": "Hemoglobins (1966-1976)", "MS": "Normal adult human hemoglobin. The globin moiety consists of two alpha and two beta chains.", "PM": "79; was see under HEMOGLOBINS 1977-78", "HN": "79(77); was see under HEMOGLOBINS 1977-78", "MR": "20190524", "DA": "19760427", "DC": "1", "DX": "19790101", "UI": "D006441"}, {"RECTYPE": "D", "MH": "Glycated Hemoglobin", "AQ": "AA AD AE AG AI AN CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hemoglobin A, Glycosylated|T116|T123|NON|NRW|NLM (1982)|990101|HBA GLYCOSYLATED|abbcdefv", "ENTRY": "Hemoglobins, Glycated", "MN": "D23.946.381.625.500.250", "MH_TH": "NLM (2021)", "ST": "T123", "RN": "0", "AN": "urine: coordinate with HEMOGLOBINURIA", "PI": "Hemoglobins (1966-1976)", "MS": "Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN (occurring as a minor fraction of the hemoglobin of ERYTHROCYTES.) It generally refers to glycated HEMOGLOBIN A. Hemoglobin A1c (Hb A1c) is hemoglobin A with GLYCATION on a terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes.", "PM": "2018; see HEMOGLOBIN A, GLYCOSYLATED 1982-2017", "HN": "2018 (1982)", "MR": "20230316", "DA": "19810512", "DC": "1", "DX": "19820101", "UI": "D006442"}, {"RECTYPE": "D", "MH": "Hemoglobin A2", "DE": "HBA2", "DS": "HEMOGLOBIN AA 02", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "A2, Hemoglobin", "MN": "D12.776.422.316.762.380.450", "MH_TH": "NLM (1979)", "ST": "T123", "N1": "Hemoglobin A2", "RN": "9034-53-1", "AN": "/urine: coordinate with HEMOGLOBINURIA ", "PI": "Hemoglobins (1966-1976)", "MS": "An adult hemoglobin component normally present in hemolysates from human erythrocytes in concentrations of about 3%. The hemoglobin is composed of two alpha chains and two delta chains. The percentage of HbA2 varies in some hematologic disorders, but is about double in beta-thalassemia.", "PM": "91; was see under HEMOGLOBIN A 1979-90", "HN": "91(79); was see under HEMOGLOBIN A 1979-90", "MR": "20080708", "DA": "19780518", "DC": "1", "DX": "19910101", "UI": "D006443"}, {"RECTYPE": "D", "MH": "Hemoglobin C", "DE": "HBC", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.422.316.762.426.338", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Hemoglobin C", "RN": "9008-00-8", "AN": "/urine: coordinate with HEMOGLOBINURIA", "MS": "A commonly occurring abnormal hemoglobin in which lysine replaces a glutamic acid residue at the sixth position of the beta chains. It results in reduced plasticity of erythrocytes.", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006444"}, {"RECTYPE": "D", "MH": "Hemoglobin C Disease", "DE": "HEMOGLOBIN C DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hemoglobin-C Diseases", "MN": "C16.320.365.463", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a congen hemolytic anemia; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; do not confuse with HEMOGLOBIN SC DISEASE", "MS": "A disease characterized by compensated hemolysis with a normal hemoglobin level or a mild to moderate anemia. There may be intermittent abdominal discomfort, splenomegaly, and slight jaundice.", "PM": "1972", "HN": "1972(1966)", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006445"}, {"RECTYPE": "D", "MH": "Hemoglobin E", "DE": "HBE", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.422.316.762.426.375", "MH_TH": "NLM (1977)", "ST": "T123", "N1": "Hemoglobin E", "RN": "9034-61-1", "AN": "/urine: coordinate with HEMOGLOBINURIA ", "PI": "Hemoglobins, Abnormal (1966-1976)", "MS": "An abnormal hemoglobin that results from the substitution of lysine for glutamic acid at position 26 of the beta chain. It is most frequently observed in southeast Asian populations.", "PM": "91; was see under HEMOGLOBINS, ABNORMAL 1977-90", "HN": "91(77); was see under HEMOGLOBINS, ABNORMAL 1977-90", "MR": "20160628", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D006446"}, {"RECTYPE": "D", "MH": "Hemoglobin H", "DE": "HBH", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.422.316.762.426.463", "FX": "alpha-Thalassemia", "MH_TH": "NLM (1973)", "ST": "T123", "N1": "Hemoglobin H", "RN": "9034-79-1", "AN": "/urine: coordinate with HEMOGLOBINURIA ", "MS": "An abnormal hemoglobin composed of four beta chains. It is caused by the reduced synthesis of the alpha chain. This abnormality results in ALPHA-THALASSEMIA.", "PM": "91; was see under HEMOGLOBINS, ABNORMAL 1973-90", "HN": "91(73); was see under HEMOGLOBINS, ABNORMAL 1973-90", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006447"}, {"RECTYPE": "D", "MH": "Hemoglobin J", "DE": "HBJ", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.422.316.762.426.480", "MH_TH": "NLM (1977)", "ST": "T123", "N1": "Hemoglobin J", "RN": "58128-48-6", "AN": "/urine: coordinate with HEMOGLOBINURIA ", "PI": "Hemoglobins, Abnormal (1966-1976)", "MS": "A group of abnormal hemoglobins with similar electrophoretic characteristics. They have faster electrophoretic mobility and different amino acid substitutions in either the alpha or beta chains than normal adult hemoglobin. Some of the variants produce hematologic abnormalities, others result in no clinical disorders.", "PM": "91; was see under HEMOGLOBINS, ABNORMAL 1977-90", "HN": "91(77); was see under HEMOGLOBINS, ABNORMAL 1977-90", "MR": "20160628", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D006448"}, {"RECTYPE": "D", "MH": "Hemoglobin M", "DE": "HBM", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.422.316.762.426.510", "MH_TH": "NLM (1977)", "ST": "T123", "N1": "Hemoglobin M", "RN": "9083-28-7", "AN": "/urine: coordinate with HEMOGLOBINURIA ", "PI": "Hemoglobins, Abnormal (1966-1976)", "MS": "A group of abnormal hemoglobins in which amino acid substitutions take place in either the alpha or beta chains but near the heme iron. This results in facilitated oxidation of the hemoglobin to yield excess methemoglobin which leads to cyanosis.", "PM": "91; was see under HEMOGLOBINS, ABNORMAL 1977-90", "HN": "91(77); was see under HEMOGLOBINS, ABNORMAL 1977-90", "MR": "20160628", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D006449"}, {"RECTYPE": "D", "MH": "Hemoglobin SC Disease", "DE": "HEMOGLOBIN SC DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sickle Cell Hemoglobin C Disease|T047|NON|EQV|UNK (19XX)|830503|SICKLE CELL HEMOGLOBIN C DIS|abcdefv", "ENTRY": "SC Diseases, Hemoglobin", "MN": "C16.320.365.155.440", "MH_TH": "NLM (1984)", "ST": "T047", "AN": "a sickle cell anemia; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; do not confuse with HEMOGLOBIN C DISEASE", "PI": "Hemoglobin C Disease (1966-1983)", "MS": "One of the sickle cell disorders characterized by the presence of both hemoglobin S and hemoglobin C. It is similar to, but less severe than sickle cell anemia.", "PM": "91; was see under ANEMIA, SICKLE CELL 1984-90", "HN": "91(84); was see under ANEMIA, SICKLE CELL 1984-90", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19830503", "DC": "1", "DX": "19910101", "UI": "D006450"}, {"RECTYPE": "D", "MH": "Hemoglobin, Sickle", "DE": "HBS", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hemoglobin S|T116|T123|EQV|UNK (19XX)|751231|abbdef", "ENTRY": "Sickle Hemoglobin, Deoxygenated", "MN": "D12.776.422.316.762.426.588", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "PI": "Hemoglobins, Abnormal (1966-1972)", "MS": "An abnormal hemoglobin resulting from the substitution of valine for glutamic acid at position 6 of the beta chain of the globin moiety. The heterozygous state results in sickle cell trait, the homozygous in sickle cell anemia.", "OL": "use HEMOGLOBIN, SICKLE to search HEMOGLOBIN S 1973-74 (as Prov)", "PM": "77", "HN": "77(75); was HEMOGLOBIN S 1973-74 (Prov)", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D006451"}, {"RECTYPE": "D", "MH": "Hemoglobinometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Hemoglobinometries", "MN": "E05.200.625.410", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "NIM; do not equate with HEMOGLOBINS /anal; note ERYTHROCYTE HEMOGLOBIN, MEAN CELL see ERYTHROCYTE INDICES is available", "MS": "Measurement of hemoglobin concentration in blood.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006452"}, {"RECTYPE": "D", "MH": "Hemoglobinopathies", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hemoglobinopathy", "MN": "C16.320.365", "FX": "Hemoglobins, Abnormal", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "do not confuse with HEMOGLOBINS, ABNORMAL (D12): use term in the text; coord IM with specific abnormal hemoglobin (IM) but HEMOGLOBIN C DISEASE; THALASSEMIA (hemoglobin H disease) & ANEMIA, SICKLE CELL (hemoglobin S disease) are available", "MS": "A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006453"}, {"RECTYPE": "D", "MH": "Hemoglobins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "ENTRY": "Hemoglobin, Ferrous", "MN": "D12.776.422.316.762", "FX": "Iron Chelating Agents", "EC": "urine:Hemoglobinuria", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements.", "OL": "use HEMOGLOBINS to search HEMOGLOBIN 1966-74", "PM": "75; was HEMOGLOBIN 1963-74", "HN": "75; was HEMOGLOBIN 1963-74", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D006454"}, {"RECTYPE": "D", "MH": "Hemoglobins, Abnormal", "DE": "HEMOGLOBINS ABNORM", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Abnormal Hemoglobins|T116|T123|NON|EQV|UNK (19XX)|860101|ABNORM HEMOGLOBINS|abbcdefv", "MN": "D12.776.422.316.762.426", "FX": "Hemoglobinopathies", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "/urine: coord IM with HEMOGLOBINURIA (IM); do not confuse with HEMOGLOBINOPATHIES: use term in the text", "MS": "Hemoglobins characterized by structural alterations within the molecule. The alteration can be either absence, addition or substitution of one or more amino acids in the globin part of the molecule at selected positions in the polypeptide chains.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006455"}, {"RECTYPE": "D", "MH": "Hemoglobinuria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.942.750.634", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "HEMOGLOBINURIA, PAROXYSMAL is also available: see note there", "MS": "The presence of free HEMOGLOBIN in the URINE, indicating hemolysis of ERYTHROCYTES within the vascular system. After saturating the hemoglobin-binding proteins (HAPTOGLOBINS), free hemoglobin begins to appear in the urine.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006456"}, {"RECTYPE": "D", "MH": "Hemoglobinuria, Paroxysmal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paroxysmal Nocturnal Hemoglobinuria|T047|NON|NRW|GHR (2014)|NLM (2007)|OMIM (2013)|ORD (2010)|060224|abcdeeeef", "ENTRY": "Syndrome, Marchiafava-Micheli", "MN": "C15.378.190.625.460", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins.", "OL": "use HEMOGLOBINURIA, PAROXYSMAL to search MARCHIAFAVA-MICHELI SYNDROME 1966-77", "PM": "78; was MARCHIAFAVA-MICHELI SYNDROME 1963-77", "HN": "78; was MARCHIAFAVA-MICHELI SYNDROME 1963-77", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D006457"}, {"RECTYPE": "D", "MH": "Hemolymph", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Hemolymphs", "MN": "A13.453", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "The blood/lymphlike nutrient fluid of some invertebrates.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006458"}, {"RECTYPE": "D", "MH": "Hemolysin Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hly Factors|T114|T123|NON|EQV|UNK (19XX)|770509|abbcdef", "ENTRY": "Factors, Hly", "MN": "G05.360.600.430", "MH_TH": "NLM (1978)", "ST": "T123", "PI": "Plasmids (1966-1977)", "MS": "Plasmids controlling the synthesis of hemolysin by bacteria.", "PM": "91; was see under PLASMIDS 1978-90", "HN": "91(78); was see under PLASMIDS 1978-90", "MR": "20080708", "DA": "19770509", "DC": "1", "DX": "19910101", "UI": "D006459"}, {"RECTYPE": "D", "MH": "Hemolysin Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hemolysins|T123|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Proteins, Hemolysin", "MN": "D12.776.543.695.444", "PA": "Hemolytic Agents", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "Proteins from BACTERIA and FUNGI that are soluble enough to be secreted to target ERYTHROCYTES and insert into the membrane to form beta-barrel pores. Biosynthesis may be regulated by HEMOLYSIN FACTORS.", "PM": "2007; see HEMOLYSINS (1963-2006)", "HN": "2007(1963)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D006460"}, {"RECTYPE": "D", "MH": "Hemolysis", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Haemolysis|T049|NON|EQV|NLM (2020)|190501|abcdef", "ENTRY": "Intravascular Hemolyses", "MN": "G12.122.545", "FX": "Osmotic Fragility", "MH_TH": "NLM (1966)", "ST": "T049", "MS": "The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006461"}, {"RECTYPE": "D", "MH": "Hemolytic Plaque Technique", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Jerne's Plaque Technique|T059|EPO|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Techniques, Hemolytic Plaque", "MN": "E05.478.594.375", "MH_TH": "NLM (1969)", "ST": "T059", "AN": "hemolysis in gel goes here", "PI": "Antibody Formation (1966-1968)", "MS": "A method to identify and enumerate cells that are synthesizing ANTIBODIES against ANTIGENS or HAPTENS conjugated to sheep RED BLOOD CELLS. The sheep red blood cells surrounding cells secreting antibody are lysed by added COMPLEMENT producing a clear zone of HEMOLYSIS. (From Illustrated Dictionary of Immunology, 3rd ed)", "OL": "use HEMOLYTIC PLAQUE TECHNIQUE to search HEMOLYTIC PLAQUE TECHNIC 1969-90", "PM": "91; was HEMOLYTIC PLAQUE TECHNIC 1973-90", "HN": "91(69); was HEMOLYTIC PLAQUE TECHNIC 1969-90 (Prov 1969-72)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006462"}, {"RECTYPE": "D", "MH": "Hemolytic-Uremic Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gasser's Syndrome|T047|EPO|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Syndrome, Hemolytic-Uremic", "MN": "C15.378.243.937.925.500", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Uremia (1966-1971)", "MS": "A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE.", "PM": "74", "HN": "74(72)", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006463"}, {"RECTYPE": "D", "MH": "Hemoperfusion", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Hemosorption|T061|NON|EQV|UNK (19XX)|820420|abcdef", "ENTRY": "Hemosorptions", "MN": "E04.292.510", "MH_TH": "NLM (1978)", "ST": "T061", "AN": "do not confuse with RENAL DIALYSIS or PERFUSION; HEMOFILTRATION is available", "PI": "Perfusion (1966-1977)", "MS": "Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose).", "HN": "78", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D006464"}, {"RECTYPE": "D", "MH": "Hemoperitoneum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hemoperitoneums", "MN": "C23.550.414.888", "MH_TH": "NLM (1966)", "ST": "T033", "MS": "Accumulations of blood in the PERITONEAL CAVITY due to internal HEMORRHAGE.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006465"}, {"RECTYPE": "D", "MH": "Hemopexin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.395.401", "MH_TH": "NLM (1971)", "ST": "T123", "N1": "Hemopexins", "RN": "9013-71-2", "AN": "a beta-globulin", "PI": "Heme (1966-1970)", "PM": "74", "HN": "74(71)", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006466"}, {"RECTYPE": "D", "MH": "Hemophilia A", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemophilia|T047|NON|EQV|BIOETHICS (1974)|GHR (2014)|NLM (1999)|980316|abcdeeef", "ENTRY": "Hemophilias, Classic", "MN": "C16.320.099.500", "FX": "Hemophilia B", "MH_TH": "NLM (1974)", "ST": "T047", "MS": "The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.", "PM": "99; see HEMOPHILIA 1966-98; for HEMOPHILIA A see HEMOPHILIA 1993-98", "HN": "99(66)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D006467"}, {"RECTYPE": "D", "MH": "Hemopneumothorax", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.550.414.904.500", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Collection of air and blood in the pleural cavity.", "CATSH": "CAT LIST", "MR": "20021023", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006468"}, {"RECTYPE": "D", "MH": "Hemoptysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hemoptyses", "MN": "C23.888.852.430", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Expectoration or spitting of blood originating from any part of the RESPIRATORY TRACT, usually from hemorrhage in the lung parenchyma (PULMONARY ALVEOLI) and the BRONCHIAL ARTERIES.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006469"}, {"RECTYPE": "D", "MH": "Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bleeding|T033|T046|NON|EQV|NLM (1990)|890330|abbcdef", "ENTRY": "Hemorrhages", "MN": "C23.550.414", "FX": "Phlebotomy", "MH_TH": "POPLINE (1978)", "ST": "T046", "AN": "general or unspecified; prefer specifics; coordinate with organ/disease term, not organ /blood supply; consider also terms for presence of blood within cavities, as HEMOTHORAX; HEMATOCOLPOS; etc.", "MS": "Bleeding or escape of blood from a vessel.", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006470"}, {"RECTYPE": "D", "MH": "Gastrointestinal Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Gastrointestinal|T033|T046|NON|EQV|NLM (1990)|890314|abbcdef", "ENTRY": "Hematochezias", "MN": "C23.550.414.788", "FX": "Hemostasis, Endoscopic", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.", "OL": "use GASTROINTESTINAL HEMORRHAGE to search HEMORRHAGE, GASTROINTESTINAL 1966-89", "PM": "90; was HEMORRHAGE, GASTROINTESTINAL 1966-89", "HN": "90; was HEMORRHAGE, GASTROINTESTINAL 1966-89", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D006471"}, {"RECTYPE": "D", "MH": "Oral Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Oral|T033|T046|NON|EQV|NLM (1990)|890314|abbcdef", "ENTRY": "Oral Hemorrhages", "MN": "C23.888.619.500", "MH_TH": "NLM (1967)", "ST": "T046", "AN": "not hemorrh from the mouth but hemorrh of oral tissue; do not confuse with BLEEDING ON PROBING, GINGIVAL see PERIODONTAL INDEX", "PI": "Hemorrhage (1966)", "MS": "Bleeding from the blood vessels of the mouth, which may occur as a result of injuries to the mouth, accidents in oral surgery, or diseases of the gums.", "OL": "use ORAL HEMORRHAGE to search HEMORRHAGE, ORAL 1967-89", "PM": "90; was HEMORRHAGE, ORAL 1967-89", "HN": "90; was HEMORRHAGE, ORAL 1967-89", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006472"}, {"RECTYPE": "D", "MH": "Postpartum Hemorrhage", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Postpartum|T046|NON|EQV|NLM (1990)|890314|abcdef", "ENTRY": "Postpartum Hemorrhage, Immediate", "MN": "C23.550.414.993.850", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "check the tags FEMALE & PREGNANCY", "MS": "Excess blood loss from uterine bleeding associated with OBSTETRIC LABOR or CHILDBIRTH. It is defined as blood loss greater than 500 ml or of the amount that adversely affects the maternal physiology, such as BLOOD PRESSURE and HEMATOCRIT. Postpartum hemorrhage is divided into two categories, immediate (within first 24 hours after birth) or delayed (after 24 hours postpartum).", "OL": "use POSTPARTUM HEMORRHAGE to search HEMORRHAGE, POSTPARTUM 1966-89", "PM": "90; was HEMORRHAGE, POSTPARTUM 1963-89", "HN": "90; was HEMORRHAGE, POSTPARTUM 1963-89", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D006473"}, {"RECTYPE": "D", "MH": "Hemorrhagic Disorders", "DE": "HEMORRHAGIC DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhagic Diathesis|T047|NON|EQV|NLM (1999)|980421|abcdef", "ENTRY": "Hemorrhagic Disorder", "MN": "C15.378.463", "FX": "Hemostatic Disorders", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "\"predisposition to abnormal hemostasis\"; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Spontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms (BLOOD COAGULATION DISORDERS) or another abnormality causing a structural flaw in the blood vessels (HEMOSTATIC DISORDERS).", "PM": "99; see HEMORRHAGIC DIATHESIS 1963-98", "HN": "99(63)", "CATSH": "CAT LIST", "MR": "20070711", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D006474"}, {"RECTYPE": "D", "MH": "Vitamin K Deficiency Bleeding", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhagic Disease of Newborn|T047|NON|REL|NLM (1966)|990101|HEMORRHAGIC DIS NEWBORN|abcdefv", "ENTRY": "Newborn Hemorrhagic Diseases", "MN": "C18.654.521.500.133.912.360", "MH_TH": "NLM (2010)", "ST": "T047", "AN": "do not confuse with HEMOLYTIC DISEASE OF NEWBORN see ERYTHROBLASTOSIS, FETAL", "MS": "Hemorrhage caused by vitamin K deficiency.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006475"}, {"RECTYPE": "D", "MH": "Orthohantavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hantavirus|T005|NON|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Orthohantaviruses", "MN": "B04.820.480.750.440", "MH_TH": "NLM (2023)", "ST": "T005", "RN": "txid1980442", "RR": "txid1980467", "MS": "A genus of the family BUNYAVIRIDAE causing HANTAVIRUS INFECTIONS, first identified during the Korean war. Infection is found primarily in rodents and humans. Transmission does not appear to involve arthropods. HANTAAN VIRUS is the type species.", "OL": "use HANTAVIRUS to search HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1977-91 & EPIDEMIC HEMORRHAGIC FEVER VIRUS 1975-76; use ARBOVIRUSES 1966-74", "PM": "2023; was HANTAVIRUS 1992-2022; HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1977-1991 (see RNA VIRUSES 1978-1986, see ARBOVIRUSES 1977); was EPIDEMIC HEMORRHAGIC FEVER VIRUS see ARBOVIRUSES 1975-1976, see ARBOVIRUS 1965-1974, see ARBORVIRUSES 1963-1964", "HN": "2023(1992); use RNA VIRUSES 1978-1986; use ARBOVIRUSES 1965-1977", "MR": "20230426", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D006476"}, {"RECTYPE": "D", "MH": "Arenaviruses, New World", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Tacaribe virus|T005|NON|NRW|NLM (2023)|220601|abcdef", "ENTRY": "viruses, Tacaribe", "MN": "B04.820.480.500.070.095", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid208897", "RR": "txid499556", "AN": "infection: coordinate with probably HEMORRHAGIC FEVER, AMERICAN; otherwise coordinate with ARENAVIRIDAE INFECTIONS ", "PI": "Arboviruses (1966-1974)", "MS": "One of two groups of viruses in the ARENAVIRUS genus and considered part of the New World complex. It includes JUNIN VIRUS; PICHINDE VIRUS; Amapari virus, and Machupo virus among others. They are the cause of human hemorrhagic fevers mostly in Central and South America.", "PM": "2002; see TACARIBE COMPLEX VIRUSES 1994-2001, see HEMORRHAGIC FEVER VIRUSES, AMERICAN 1991-1993, see ARENAVIRIDAE 1981-1990, see ARENAVIRUSES 1978-1980, see RNA VIRUSES 1977, see ARBOVIRUSES 1975-1976, see ARBOVIRUS 1973-1974", "HN": "2002 (1973)", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006477"}, {"RECTYPE": "D", "MH": "Hemorrhagic Fever, American", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Sabia virus Infection|T047|NON|NRW|NLM (2024)|220909|abcdef", "ENTRY": "Sabia virus Infections", "MN": "C01.925.782.417.400", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "caused by ARENAVIRUSES, NEW WORLD", "PI": "Hemorrhagic Fevers, Viral (1966-1976)", "MS": "Diseases caused by American hemorrhagic fever viruses (ARENAVIRUSES, NEW WORLD).", "OL": "use HEMORRHAGIC FEVER, AMERICAN to search HEMORRHAGIC FEVER, ARGENTINIAN & HEMORRHAGIC FEVER, BOLIVIAN 1975-77; search HEMORRHAGIC FEVERS, VIRAL 1966-76", "PM": "77; HEMORRHAGIC FEVER, ARGENTINIAN & HEMORRHAGIC FEVER, BOLIVIAN were see under EPIDEMIC HEMORRHAGIC FEVER 1975-76; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76", "HN": "77; HEMORRHAGIC FEVER, ARGENTINIAN & HEMORRHAGIC FEVER, BOLIVIAN were see under EPIDEMIC HEMORRHAGIC FEVER 1975-76; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19760505", "DC": "1", "DX": "19770101", "UI": "D006478"}, {"RECTYPE": "D", "MH": "Hemorrhagic Fever, Crimean", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Congo Virus Infection|T047|EPO|EQV|UNK (19XX)|760426|CONGO VIRUS INFECT|abcdefv", "ENTRY": "Hemorrhagic Fever, Crimean-Congo", "MN": "C01.925.782.417.412", "MH_TH": "NLM (1977)", "ST": "T047", "PI": "Hemorrhagic Fevers, Viral (1966-1976)", "MS": "A severe, often fatal disease in humans caused by the Crimean-Congo hemorrhagic fever virus (HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO).", "OL": "search HEMORRHAGIC FEVERS, VIRAL 1966-76", "PM": "78; was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76", "HN": "78(77); was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19760427", "DC": "1", "DX": "19780101", "UI": "D006479"}, {"RECTYPE": "D", "MH": "Hemorrhagic Fever with Renal Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Nephropathia Epidemica|T047|NON|NRW|NLM (1995)|OMIM (2013)|ORD (2010)|940304|abcdeeef", "ENTRY": "Nephroso-Nephritis, Hemorrhagic", "MN": "C01.925.782.417.300", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Hemorrhagic Fevers, Viral (1966-1976)", "MS": "An acute febrile disease occurring predominately in Asia. It is characterized by fever, prostration, vomiting, hemorrhagic phenonema, shock, and renal failure. It is caused by any one of several closely related species of the genus ORTHOHANTAVIRUS. The most severe form is caused by HANTAAN VIRUS whose natural host is the rodent Apodemus agrarius. Milder forms are caused by SEOUL VIRUS and transmitted by the rodents Rattus rattus and R. norvegicus, and the PUUMALA VIRUS with transmission by Clethrionomys galreolus.", "PM": "1995; see HEMORRHAGIC FEVER, EPIDEMIC 1977-1994, see HEMORRHAGIC FEVERS, VIRAL 1966-1976; for NEUROPATHIA EPIDEMICA see HANTAVIRUS INFECTIONS 1994-2001; for EPIDEMIC HEMORRHAGIC FEVER see EPIDEMIC HEMORRHAGIC FEVER 1963-1976", "HN": "1995 (1977); for NEUROPATHIA EPIDEMICA use HANTAVIRUS INFECTIONS 1994-2001", "CATSH": "CAT LIST", "MR": "20220715", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D006480"}, {"RECTYPE": "D", "MH": "Hemorrhagic Fever, Omsk", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Omsk Hemorrhagic Fever", "MN": "C01.925.782.417.435", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "caused by a flavivirus", "PI": "Hemorrhagic Fevers, Viral (1966-1976)", "MS": "Infection with the Omsk hemorrhagic fever virus, a Flavivirus.", "OL": "search HEMORRHAGIC FEVERS, VIRAL 1966-76", "PM": "78; was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76", "HN": "78(77); was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19760427", "DC": "1", "DX": "19780101", "UI": "D006481"}, {"RECTYPE": "D", "MH": "Hemorrhagic Fevers, Viral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Viral Hemorrhagic Fevers", "MN": "C01.925.782.417", "MH_TH": "NLM (1978)", "ST": "T047", "AN": "general or unspecified; prefer specifics; if renal involvement, disease is probably HEMORRHAGIC FEVER WITH RENAL SYNDROME", "PI": "specific hemorrhagic fever (1977)", "MS": "A group of viral diseases of diverse etiology but having many similar clinical characteristics; increased capillary permeability, leukopenia, and thrombocytopenia are common to all. Hemorrhagic fevers are characterized by sudden onset, fever, headache, generalized myalgia, backache, conjunctivitis, and severe prostration, followed by various hemorrhagic symptoms. Hemorrhagic fever with kidney involvement is HEMORRHAGIC FEVER WITH RENAL SYNDROME.", "OL": "use HEMORRHAGIC FEVERS, VIRAL to search EPIDEMIC HEMORRHAGIC FEVER 1966-76; search specifics 1977", "PM": "78; was EPIDEMIC HEMORRHAGIC FEVER 1963-76; several specifics became headings & x-refs as of 1977", "HN": "78; was EPIDEMIC HEMORRHAGIC FEVER 1963-76; several specifics became headings & x-refs as of 1977", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19770513", "DC": "1", "DX": "19780101", "UI": "D006482"}, {"RECTYPE": "D", "MH": "Hemorrhagic Septicemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Septicemia, Hemorrhagic|T047|NON|EQV|NLM (1992)|910412|abcdef", "ENTRY": "Hemorrhagic Septicaemia|T047|NON|EQV|NLM (2003)|010921|abcdef", "MN": "C23.550.470.790.500.100.375", "FX": "Hemorrhagic Septicemia, Viral", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "coord (IM) with PASTEURELLA MULTOCIDA (IM) or specific organism /infection term (IM) if pertinent", "MS": "Any of several bacterial diseases, usually caused by PASTEURELLA MULTOCIDA, marked by the presence of hemorrhagic areas in the subcutaneous tissues, serous membranes, muscles, lymph glands, and throughout the internal organs. The diseases primarily affect animals and rarely humans.", "PM": "2003, 1975-1991; see HEMORRHAGIC BACTEREMIA 1992-2002, see HEMORRHAGIC SEPTICEMIA 1990-1991, see PASTEURELLA INFECTIONS 1975-1990", "HN": "2003, 1975-1991", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006483"}, {"RECTYPE": "D", "MH": "Hemorrhoids", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hemorrhoid", "MN": "C14.907.449", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "/surg : consider also HEMORRHOIDECTOMY", "MS": "Swollen veins in the lower part of the RECTUM or ANUS. Hemorrhoids can be inside the anus (internal), under the skin around the anus (external), or protruding from inside to outside of the anus. People with hemorrhoids may or may not exhibit symptoms which include bleeding, itching, and pain.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006484"}, {"RECTYPE": "D", "MH": "Hemosiderin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.556.526", "FX": "Siderosis", "MH_TH": "NLM (1963)", "ST": "T123", "N1": "Hemosiderins", "RN": "9011-92-1", "AN": "a metalloprotein", "PM": "66", "HN": "66(63)", "MR": "19920519", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006485"}, {"RECTYPE": "D", "MH": "Hemosiderosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hemosideroses", "MN": "C18.452.565.500.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a form of tissue iron accumulation in total body iron overload", "MS": "Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the MONONUCLEAR PHAGOCYTE SYSTEM, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006486"}, {"RECTYPE": "D", "MH": "Hemostasis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Hemostases", "MN": "G09.188.390", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "note Cat G, a physiol process; differentiate from HEMOSTATIC TECHNIQUES and specifics, Cat E; coord HEMOSTASIS in diseases with disease /blood, not /physiopathol", "MS": "The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION.", "HN": "was in Cat E only 1963-75", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006487"}, {"RECTYPE": "D", "MH": "Hemostasis, Surgical", "DE": "HEMOSTASIS SURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Hemostases", "MN": "E04.350", "MH_TH": "NLM (1976)", "ST": "T061", "PI": "Hemostasis (1966-1975)", "MS": "Control of bleeding during or after surgery.", "OL": "search HEMOSTASIS 1966-75 (as Cat E heading)", "PM": "76; was indexed under HEMOSTASIS 1963-75", "HN": "76; was indexed under HEMOSTASIS 1963-75 (Cat E heading)", "CATSH": "CAT LIST", "MR": "19910515", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D006488"}, {"RECTYPE": "D", "MH": "Hemostatic Techniques", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Hemostatic", "MN": "E02.520", "FX": "Vascular Closure Devices", "MH_TH": "NLM (1976)", "ST": "T061", "AN": "differentiate from HEMOSTASIS, a physiologic process ", "PI": "Hemostasis (1966-1975)", "MS": "Techniques for controlling bleeding.", "OL": "use HEMOSTATIC TECHNIQUES to search HEMOSTATIC TECHNICS 1976-90; search HEMOSTASIS 1966-75 (as Cat E heading)", "PM": "91; was HEMOSTATIC TECHNICS 1976-90; was indexed under HEMOSTASIS 1963-75", "HN": "91; was HEMOSTATIC TECHNICS 1976-90; was indexed under HEMOSTASIS 1963-75 (Cat E heading)", "CATSH": "CAT LIST", "MR": "20140606", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D006489"}, {"RECTYPE": "D", "MH": "Hemostatics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hemostatic|T121|NON|EQV|NLM (2021)|200106|abcdef", "ENTRY": "Antihemorrhagics|T121|NON|NRW|IOM (1990)|890512|abcdef", "MN": "D27.505.954.502.270.463", "FX": "Vasoconstrictor Agents", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006490"}, {"RECTYPE": "D", "MH": "Hemothorax", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.550.414.904", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Hemorrhage within the pleural cavity.", "CATSH": "CAT LIST", "MR": "20021023", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006491"}, {"RECTYPE": "D", "MH": "Hempa", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hexametapol|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Triamide, Hexamethylphosphoric", "MN": "D02.705.672.249", "PA": "Chemosterilants", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Phosphoric triamide, hexamethyl-", "RN": "M42TU5843Z", "RR": "680-31-9 (Hempa)", "AN": "= HExaMethylPhosphorAmide", "PI": "Organophosphorus Compounds (1972-1974)", "MS": "A chemosterilant agent that is anticipated to be a carcinogen.", "PM": "91; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90", "HN": "91(75); was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006492"}, {"RECTYPE": "D", "MH": "Heparin", "AQ": "AA AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-Heparin|T109|T121|T123|NON|NRW|UNK (19XX)|800523|abbbcdef", "ENTRY": "alpha Heparin", "MN": "D09.698.373.400", "PA": "Fibrinolytic Agents", "EC": "antagonists & inhibitors:Heparin Antagonists", "MH_TH": "BAN (19XX)", "ST": "T123", "RN": "9005-49-6", "MS": "A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.", "PM": "/therapeutic use was HEPARIN, THERAPEUTIC 1965", "HN": "/therapeutic use was HEPARIN, THERAPEUTIC 1965", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006493"}, {"RECTYPE": "D", "MH": "Heparin Antagonists", "DE": "HEPARIN ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Antagonists, Heparin", "MN": "D27.505.954.502.270.546", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Coagulant substances inhibiting the anticoagulant action of heparin.", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006494"}, {"RECTYPE": "D", "MH": "Heparin, Low-Molecular-Weight", "DE": "HEPARIN LMW", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Low-Molecular-Weight Heparin|T109|T121|NON|EQV|UNK (19XX)|870325|LMW HEPARIN|abbcdefv", "ENTRY": "Heparin, Low Molecular Weight", "MN": "D09.698.373.400.300", "PA": "Fibrinolytic Agents", "MH_TH": "NLM (1988)", "ST": "T121", "RN": "0", "PI": "Heparin (1966-1987)", "MS": "Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.", "OL": "use HEPARIN, LOW-MOLECULAR-WEIGHT to search ENOXAPARIN 1990-93 & HEPARIN, LOW MOLECULAR WEIGHT 1988-93", "PM": "94; was ENOXAPARIN 1992-93, was HEPARIN, LOW MOLECULAR WEIGHT 1988-91; HEPARIN, LOW MOLECULAR WEIGHT was see ENOXAPARIN 1992-93; LOW-MOLECULAR-WEIGHT HEPARIN was LOW MOLECULAR WEIGHT HEPARIN 1988-93", "HN": "94; was ENOXAPARIN 1992-93, was HEPARIN, LOW MOLECULAR WEIGHT 1988-91; HEPARIN, LOW MOLECULAR WEIGHT was see ENOXAPARIN 1992-93; LOW-MOLECULAR-WEIGHT HEPARIN was LOW MOLECULAR WEIGHT HEPARIN 1988-93", "MR": "20040707", "DA": "19870325", "DC": "1", "DX": "19880101", "UI": "D006495"}, {"RECTYPE": "D", "MH": "Heparinoids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Heparinoid|T109|T121|NON|EQV|NLM (1996)|950531|abbcdef", "MN": "D09.698.373.400.320", "PA": "Anticoagulants", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Heparin derivatives. The term has also been used more loosely to include naturally occurring and synthetic highly-sulphated polysaccharides of similar structure. Heparinoid preparations have been used for a wide range of applications including as anticoagulants and anti-inflammatories and they have been claimed to have hypolipidemic properties. (From Martindale, The Extra Pharmacopoeia, 30th, p232)", "PM": "96; was HEPARANOID 1963-95", "HN": "96; was HEPARANOID 1963-95", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D006496"}, {"RECTYPE": "D", "MH": "Heparitin Sulfate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heparan Sulfate|T109|T123|NON|EQV|UNK (19XX)|750717|abbcdef", "ENTRY": "Sulfate, Heparitin", "MN": "D09.698.373.425", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "Heparitin, sulfate", "RN": "9050-30-0", "AN": "do not confuse entry term HEPARAN SULFATE with HEPARAN SULFATE PROTEOGLYCANS", "PI": "Mucopolysaccharides (1966-1971)", "MS": "A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS.", "PM": "91; was see under MUCOPOLYSACCHARIDES 1972-90", "HN": "91(72); was see under MUCOPOLYSACCHARIDES 1972-90", "MR": "20060707", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006497"}, {"RECTYPE": "D", "MH": "Hepatectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Hepatectomies", "MN": "E04.210.556", "FX": "Liver Regeneration", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Excision of all or part of the liver. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006498"}, {"RECTYPE": "D", "MH": "Hepatic Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Hepatic Arteries", "MN": "A07.015.114.407", "FX": "Liver Circulation", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006499"}, {"RECTYPE": "D", "MH": "Hepatic Duct, Common", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Common Hepatic Duct|T023|NON|EQV|UNK (19XX)|790427|abcdef", "ENTRY": "Hepatic Ducts, Common", "MN": "A03.159.183.079.600", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "an external bile duct formed by junction of right & left hepatic ducts; diseases: coord IM with BILE DUCT DISEASES (IM); neopl: coord IM with BILE DUCT NEOPLASMS (IM); inflammation: coord IM with CHOLANGITIS (IM); obstruct: coord IM with CHOLESTASIS, EXTRAHEPATIC (IM); calculi: coord (IM) with CHOLELITHIASIS (IM)", "MS": "Predominantly extrahepatic bile duct which is formed by the junction of the right and left hepatic ducts, which are predominantly intrahepatic, and, in turn, joins the cystic duct to form the common bile duct.", "OL": "use HEPATIC DUCT, COMMON to search HEPATIC DUCT 1966-79", "PM": "80; was HEPATIC DUCT 1963-79", "HN": "80; was HEPATIC DUCT 1963-79", "MR": "20030725", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D006500"}, {"RECTYPE": "D", "MH": "Hepatic Encephalopathy", "DE": "HEPATIC ENCEPH", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Portosystemic Encephalopathy|T047|NON|EQV|NLM (1990)|890413|PORTOSYSTEMIC ENCEPH|abcdefv", "ENTRY": "Stupors, Hepatic", "MN": "C18.452.132.360", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)", "PM": "1984; see HEPATIC COMA 1975-83; HEPATIC COMA was heading 1963-83", "HN": "1984; use HEPATIC COMA 1975-83", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D006501"}, {"RECTYPE": "D", "MH": "Budd-Chiari Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hepatic Venous Outflow Obstruction|T047|NON|EQV|NLM (2008)|060816|abcdef", "ENTRY": "Vein Thrombosis, Hepatic", "MN": "C14.907.355.830.925.275", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "do not confuse with ARNOLD-CHIARI SYNDROME", "MS": "A condition in which the hepatic venous outflow is obstructed anywhere from the small HEPATIC VEINS to the junction of the INFERIOR VENA CAVA and the RIGHT ATRIUM. Usually the blockage is extrahepatic and caused by blood clots (THROMBUS) or fibrous webs. Parenchymal FIBROSIS is uncommon.", "PM": "2008; use HEPATIC VEIN THROMBOSIS 1966-2007", "HN": "2008 (1966)", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D006502"}, {"RECTYPE": "D", "MH": "Hepatic Veins", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Hepatic", "MN": "A07.015.908.380", "FX": "Liver Circulation", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Veins which drain the liver.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006503"}, {"RECTYPE": "D", "MH": "Hepatic Veno-Occlusive Disease", "DE": "HVOD", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Veno-Occlusive Disease, Hepatic|T047|NON|EQV|NLM (1994)|921016|VENO OCCLUSIVE DIS HEPATIC|abcdefv", "ENTRY": "Veno Occlusive Disease, Hepatic", "MN": "C14.907.460", "FX": "Budd-Chiari Syndrome", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Liver/blood supply (1966-1986)", "MS": "Liver disease that is caused by injuries to the ENDOTHELIAL CELLS of the vessels and subendothelial EDEMA, but not by THROMBOSIS. Extracellular matrix, rich in FIBRONECTINS, is usually deposited around the HEPATIC VEINS leading to venous outflow occlusion and sinusoidal obstruction.", "OL": "use HEPATIC VENO-OCCLUSIVE DISEASE to search VENO-OCCLUSIVE DISEASE OF LIVER 1987-93", "PM": "87; VENO-OCCLUSIVE DISEASE OF LIVER was see HEPATIC VENO-OCCLUSIVE DISEASE 1987-93", "HN": "87; VENO-OCCLUSIVE DISEASE OF LIVER was see HEPATIC VENO-OCCLUSIVE DISEASE 1987-93", "CATSH": "CAT LIST", "MR": "20070711", "DA": "19860624", "DC": "1", "DX": "19870101", "UI": "D006504"}, {"RECTYPE": "D", "MH": "Hepatitis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "ENTRY": "Hepatitides", "MN": "C06.552.380", "EC": "veterinary:Hepatitis, Animal", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "general or unspecified; prefer specifics; probably non-viral; viral hepatitis equals HEPATITIS, VIRAL, HUMAN or HEPATITIS, VIRAL, ANIMAL or their specifics; /chem ind equals CHEMICAL AND DRUG INDUCED LIVER INJURY", "MS": "INFLAMMATION of the LIVER.", "CATSH": "CAT LIST", "MR": "20160712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006505"}, {"RECTYPE": "D", "MH": "Hepatitis A", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Hepatitis, Infectious|T047|NON|EQV|UNK (19XX)|760508|HEPATITIS INFECT|abcdefv", "ENTRY": "Infectious Hepatitides", "MN": "C06.552.380.705.422", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.", "OL": "use HEPATITIS A to search HEPATITIS, INFECTIOUS 1966-76", "PM": "77; was HEPATITIS, INFECTIOUS 1963-76", "HN": "77; was HEPATITIS, INFECTIOUS 1963-76", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D006506"}, {"RECTYPE": "D", "MH": "Hepatovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hepatitis Virus, Infectious|T005|NON|EQV|UNK (19XX)|760522|HEPATITIS VIRUS INFECT|abcdefv", "ENTRY": "Infectious Hepatitis Viruses", "MN": "B04.820.578.750.400", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid12091", "MS": "A genus of PICORNAVIRIDAE causing infectious hepatitis naturally in humans and experimentally in other primates. It is transmitted through fecal contamination of food or water. HEPATITIS A VIRUS is the type species.", "OL": "use HEPATOVIRUS to search HEPATITIS A VIRUS 1977-93 & HEPATITIS VIRUS, INFECTIOUS 1966-76", "PM": "94; was HEPATITIS A VIRUS 1977-93; was HEPATITIS VIRUS, INFECTIOUS 1966-76", "HN": "94; was HEPATITIS A VIRUS 1977-93; was HEPATITIS VIRUS, INFECTIOUS 1966-76", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006507"}, {"RECTYPE": "D", "MH": "Hepatitis Antibodies", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Antibodies, Hepatitis|T116|T129|NON|EQV|UNK (19XX)|840620|abbcdef", "MN": "D12.776.377.715.548.114.254.450", "PA": "Immunologic Factors", "MH_TH": "NLM (1985)", "ST": "T129", "RN": "0", "AN": "coordinate IM with specific hepatitis virus /immunol (IM); do not coord with ANTIBODY FORMATION for /biosyn", "PI": "Antibodies, Viral (1973-1984)", "MS": "Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis.", "PM": "85", "HN": "85", "MR": "20050630", "DA": "19840501", "DC": "1", "DX": "19850101", "UI": "D006508"}, {"RECTYPE": "D", "MH": "Hepatitis B", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Hepatitis B Virus Infection|T047|NON|EQV|NLM (2018)|160930|abcdef", "MN": "C06.552.380.705.437", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.", "OL": "use HEPATITIS B to search HEPATITIS, HOMOLOGOUS SERUM 1966-76", "PM": "77; was HEPATITIS, HOMOLOGOUS SERUM 1963-76", "HN": "77; was HEPATITIS, HOMOLOGOUS SERUM 1963-76", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D006509"}, {"RECTYPE": "D", "MH": "Hepatitis B Antibodies", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Anti-Hepatitis B Antigens|T129|NON|EQV|UNK (19XX)|770526|ANTIHEPATITIS B ANTIGENS|abcdefs", "ENTRY": "HBAg, Anti", "MN": "D12.776.377.715.548.114.254.450.504", "PA": "Immunologic Factors", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "PI": "Immune Sera (1966-1972)", "MS": "Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the \"e\" antigens.", "OL": "use HEPATITIS B ANTIBODIES to search ANTI-AUSTRALIA ANTIGEN 1973-77 (as Prov 1973-74)", "PM": "84; was see under ANTIBODIES, VIRAL 1978-83, was ANTI-AUSTRALIA ANTIGEN see under ANTIBODIES, VIRAL 1975-77", "HN": "84(78); was see under ANTIBODIES, VIRAL 1978-83; was ANTI-AUSTRALIA ANTIGEN see under ANTIBODIES, VIRAL 1975-77, was ANTI-AUSTRALIA ANTIGEN 1973-74 (Prov)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D006510"}, {"RECTYPE": "D", "MH": "Hepatitis B Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Hepatitis B Antigen|T129|NON|EQV|NLM (2022)|200928|abcdef", "ENTRY": "B Antigens, Hepatitis", "MN": "D23.050.327.495.500", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "PI": "Hepatitis B Virus (1966-1972)", "MS": "Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS.", "PM": "77; HEPATITIS B ANTIGEN was see AUSTRALIA ANTIGEN 1974-76", "HN": "77; HEPATITIS B ANTIGEN was see AUSTRALIA ANTIGEN 1974-76", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006511"}, {"RECTYPE": "D", "MH": "Hepatitis B Core Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "HBcAg|T129|ABB|EQV|UNK (19XX)|761222|abcdef", "ENTRY": "Hepatitis B Core Antigen|T129|NON|EQV|UNK (19XX)|840501|abcdef", "MN": "D23.050.327.495.500.450", "MH_TH": "NLM (1977)", "ST": "T129", "RN": "0", "PI": "Hepatitis B Virus (1970-1972)", "MS": "The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion.", "OL": "use HEPATITIS B CORE ANTIGENS to search HEPATITIS B CORE ANTIGEN 1977-84", "PM": "85; was HEPATITIS B CORE ANTIGEN 1977-84", "HN": "85; was HEPATITIS B CORE ANTIGEN 1977-84", "MR": "20220413", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D006512"}, {"RECTYPE": "D", "MH": "Hepatitis B e Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "e Antigens|T129|NON|EQV|UNK (19XX)|800513|abcdef", "ENTRY": "Be Antigens, Hepatitis", "MN": "D23.050.327.495.500.469", "MH_TH": "NLM (1981)", "ST": "T129", "RN": "0", "PI": "Hepatitis B Virus (1966-1972)", "MS": "A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G.", "PM": "87; was see under HEPATITIS B ANTIGENS 1981-86", "HN": "87(81); was see under HEPATITIS B ANTIGENS 1981-86", "MR": "20220413", "DA": "19800513", "DC": "1", "DX": "19870101", "UI": "D006513"}, {"RECTYPE": "D", "MH": "Hepatitis B Surface Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "HBsAg|T129|ABB|EQV|UNK (19XX)|761222|abcdef", "ENTRY": "Antigen, Australia", "MN": "D23.050.327.495.500.475", "MH_TH": "NLM (1977)", "ST": "T129", "RN": "0", "PI": "Hepatitis B Virus (1970-1972)", "MS": "Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.", "OL": "use HEPATITIS B SURFACE ANTIGENS to search HEPATITIS B SURFACE ANTIGEN 1977-80; to search AUSTRALIA ANTIGEN use HEPATITIS B ANTIGENS 1973-77 & HEPATITIS VIRUS, HOMOLOGOUS SERUM 1971-72", "PM": "81; was HEPATITIS B SURFACE ANTIGEN 1977-80; AUSTRALIA ANTIGEN was see HEPATITIS B ANTIGENS 1977, was heading 1973-76, was see HEPATITIS VIRUS, HOMOLOGOUS SERUM 1971-72; HEPATITIS ASSOCIATED ANTIGEN was see AUSTRALIA ANTIGEN 1973-75, was see under HEPATITIS VIRUS, HOMOLOGOUS SERUM 1970-72", "HN": "81; was HEPATITIS B SURFACE ANTIGEN 1977-80; AUSTRALIA ANTIGEN was see HEPATITIS B ANTIGENS 1977, was heading 1973-76, was see HEPATITIS VIRUS, HOMOLOGOUS SERUM 1971-72; HEPATITIS ASSOCIATED ANTIGEN was see AUSTRALIA ANTIGEN 1973-75, was see under HEPATITIS VIRUS, HOMOLOGOUS SERUM 1970-72", "MR": "20220413", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D006514"}, {"RECTYPE": "D", "MH": "Hepatitis B virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hepatitis Virus, Homologous Serum|T005|NON|EQV|UNK (19XX)|760522|HEPATITIS VIRUS HOMOL SERUM|abcdefv", "ENTRY": "viruses, Hepatitis B", "MN": "B04.450.390.650.425", "FX": "Hepatitis B Surface Antigens", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid10407", "MS": "The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum.", "OL": "use HEPATITIS B VIRUS to search HEPATITIS VIRUS, HOMOLOGOUS SERUM 1966-76; use HEPATITIS B VIRUS to search DANE PARTICLE 1981 & use HEPATITIS B ANTIGENS 1977-80", "PM": "77; was HEPATITIS VIRUS, HOMOLOGOUS SERUM 1966-76; DANE PARTICLE was see HEPATITIS B ANTIGENS 1977-80", "HN": "77; was HEPATITIS VIRUS, HOMOLOGOUS SERUM 1966-76; DANE PARTICLE was see HEPATITIS B ANTIGENS 1977-80", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006515"}, {"RECTYPE": "D", "MH": "Adenoviruses, Canine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hepatitis Virus, Infectious Canine|T005|NON|EQV|NLM (1994)|921106|HEPATITIS VIRUS INFECT CANINE|abcdefv", "ENTRY": "Viruses, Canine Hepatitis", "MN": "B04.450.100", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid10537", "AN": "infection: coord IM with ADENOVIRIDAE INFECTIONS (IM) or HEPATITIS, INFECTIOUS CANINE (IM) if pertinent", "MS": "Species of the genus MASTADENOVIRUS that causes fever, edema, vomiting, and diarrhea in dogs and encephalitis in foxes. Epizootics have also been caused in bears, wolves, coyotes, and skunks. The official species name is Canine adenovirus and it contains two serotypes.", "OL": "use ADENOVIRUSES, CANINE to search HEPATITIS VIRUS, INFECTIOUS CANINE 1966-93", "PM": "94; was HEPATITIS VIRUS, INFECTIOUS CANINE 1966-93", "HN": "94; was HEPATITIS VIRUS, INFECTIOUS CANINE 1966-93", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006516"}, {"RECTYPE": "D", "MH": "Murine hepatitis virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Murine Gastroenteritis Virus|T005|NON|EQV|NLM (1994)|921113|abcdef", "ENTRY": "Murine hepatitis viruses", "MN": "B04.820.578.500.540.150.113.875", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11138", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS and also coordinate with HEPATITIS, VIRAL, ANIMAL if pertinent", "MS": "A species of the CORONAVIRUS genus causing hepatitis in mice. Four strains have been identified as MHV 1, MHV 2, MHV 3, and MHV 4 (also known as MHV-JHM, which is neurotropic and causes disseminated encephalomyelitis with demyelination as well as focal liver necrosis).", "PM": "2002; see GASTROENTERITIS VIRUS, MURINE 1994-2001, see HEPATITIS VIRUS, MOUSE 1966-1993", "HN": "2002 (1966)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006517"}, {"RECTYPE": "D", "MH": "Hepatitis Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hepatitis Virus, Marmoset|T005|NON|NRW|UNK (19XX)|850705|abcdef", "ENTRY": "Viruses, Marmoset Hepatitis", "MN": "B04.450", "MH_TH": "NLM (1966)", "ST": "T005", "AN": "general or unspecified; prefer specifics; infection equals HEPATITIS, VIRAL, HUMAN or HEPATITIS, VIRAL, ANIMAL or their specifics", "MS": "Any of the viruses that cause inflammation of the liver. They include both DNA and RNA viruses as well viruses from humans and animals.", "OL": "use HEPATITIS VIRUSES to search HEPATITIS VIRUS, MARMOSET 1975-85", "PM": "HEPATITIS VIRUS, MARMOSET was see under HEPATITIS VIRUSES 1975-85", "HN": "HEPATITIS VIRUS, MARMOSET was see under HEPATITIS VIRUSES 1975-85", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D006518"}, {"RECTYPE": "D", "MH": "Hepatitis, Alcoholic", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hepatitis, Alcoholic, Chronic|T047|NON|NRW|NLM (1998)|970131|abcdef", "ENTRY": "Chronic Alcoholic Hepatitides", "MN": "C25.775.100.087.645.490", "MH_TH": "NLM (1978)", "ST": "T047", "PI": "Hepatitis, Toxic (1966-1977)", "MS": "INFLAMMATION of the LIVER due to ALCOHOL ABUSE. It is characterized by NECROSIS of HEPATOCYTES, infiltration by NEUTROPHILS, and deposit of MALLORY BODIES. Depending on its severity, the inflammatory lesion may be reversible or progress to LIVER CIRRHOSIS.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D006519"}, {"RECTYPE": "D", "MH": "Hepatitis, Animal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Hepatitides, Animal", "MN": "C22.467", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "Experimental or veterinary; general or unspecified only; for specific experimental hepatitis, index the specific hepatitis term + ANIMALS check tag; for specific veterinary hepatitis, index the specific hepatitis term /vet + pre-coordinated animal disease term + ANIMALS check tag and do not coordinate with HEPATITIS, ANIMAL", "MS": "INFLAMMATION of the LIVER in non-human animals.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006520"}, {"RECTYPE": "D", "MH": "Hepatitis, Chronic", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hepatitis, Chronic, Cryptogenic|T047|NON|NRW|NLM (1998)|961104|abcdef", "ENTRY": "Hepatitis, Cryptogenic Chronic", "MN": "C23.550.291.500.477", "EC": "chemically induced:Chemical and Drug Induced Liver Injury, Chronic", "MH_TH": "NLM (1983)", "ST": "T047", "AN": "general or unspecified; prefer specifics; chronic alcoholic hepatitis equals HEPATITIS, ALCOHOLIC", "PI": "Hepatitis B (1966-1982)", "MS": "INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.", "PM": "98; was HEPATITIS, CHRONIC ACTIVE 1983-97", "HN": "98; was HEPATITIS, CHRONIC ACTIVE 1983-97", "CATSH": "CAT LIST", "MR": "20210312", "DA": "19820427", "DC": "1", "DX": "19830101", "UI": "D006521"}, {"RECTYPE": "D", "MH": "Hepatitis, Infectious Canine", "DE": "HEPATITIS INFECT CANINE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Infectious Hepatitis, Canine", "MN": "C22.467.435.442", "MH_TH": "NLM (1971)", "ST": "T047", "AN": "check the tags DOGS and ANIMALS or index other animal term if appropriate", "PI": "Hepatitis, Animal (1966-1970)", "MS": "A contagious disease caused by canine adenovirus (ADENOVIRUSES, CANINE) infecting the LIVER, the EYE, the KIDNEY, and other organs in dogs, other canids, and bears. Symptoms include FEVER; EDEMA; VOMITING; and DIARRHEA.", "OL": "use HEPATITIS, INFECTIOUS CANINE to search HEPATITIS, CANINE INFECTIOUS 1971-81", "PM": "82; was HEPATITIS, CANINE INFECTIOUS 1971-81", "HN": "82; was HEPATITIS, CANINE INFECTIOUS 1971-81", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D006522"}, {"RECTYPE": "D", "MH": "Hepatitis, Viral, Animal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Viral Hepatitides, Animal", "MN": "C22.467.435", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "not restricted to hepatitis caused by hepatitis viruses: use also for hepatitis caused by other viruses; exper or vet but do not use /vet; don't forget to check tag ANIMALS", "PI": "Hepatitis, Animal (1966-1976)", "MS": "INFLAMMATION of the LIVER in animals due to viral infection.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D006524"}, {"RECTYPE": "D", "MH": "Hepatitis, Viral, Human", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "ENTRY": "Viral Hepatitides, Human", "MN": "C06.552.380.705", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "coordinate IM with pre-coordinated virus disease term (IM) but note specific viral hepatitis terms", "PI": "Hepatitis A (1966-1976)", "MS": "INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D).", "OL": "use HEPATITIS C to search HEPATITIS, VIRAL, NON-A, NON-B 1980-93", "PM": "77; HEPATITIS, VIRAL, NON-A, NON-B was heading 1980-91 (see under HEPATITIS, VIRAL, HUMAN 1980-90), was see HEPATITIS C 1992-93", "HN": "77; HEPATITIS, VIRAL, NON-A, NON-B was heading 1980-91 (see under HEPATITIS, VIRAL, HUMAN 1980-90), was see HEPATITIS C 1992-93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D006525"}, {"RECTYPE": "D", "MH": "Hepatitis C", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Parenterally-Transmitted Non-A, Non-B Hepatitis|T047|NON|EQV|NLM (1992)|910116|PT NANBH|abcdefv", "ENTRY": "Parenterally Transmitted Non A, Non B Hepatitis", "MN": "C06.552.380.705.440", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Hepatitis, Viral, Human (1977-1979)", "MS": "INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.", "OL": "use HEPATITIS C to search HEPATITIS, VIRAL, NON-A, NON-B 1980-91", "PM": "92; was HEPATITIS, VIRAL, NON-A, NON-B 1980-91 (see under HEPATITIS, VIRAL, HUMAN 1980-90); HEPATITIS C was see HEPATITIS, VIRAL, NON-A, NON-B 1985-91", "HN": "92; was HEPATITIS, VIRAL, NON-A, NON-B 1980-91 (see under HEPATITIS, VIRAL, HUMAN 1980-90); HEPATITIS C was see HEPATITIS, VIRAL, NON-A, NON-B 1985-91", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D006526"}, {"RECTYPE": "D", "MH": "Hepatolenticular Degeneration", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wilson Disease|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|840615|WILSON DIS|abcdeeeefv", "ENTRY": "Wilsons Disease", "MN": "C18.452.648.618.403", "FX": "Copper-Transporting ATPases", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "lenticular refers to the lenticular nucleus in the brain", "MS": "A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.", "PM": "1964; see HEPATO-LENTICULAR DEGENERATION 1963", "HN": "1964(1963)", "CATSH": "CAT LIST", "MR": "20190711", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D006527"}, {"RECTYPE": "D", "MH": "Carcinoma, Hepatocellular", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Hepatoma|T191|NON|EQV|NLM (1994)|OMIM (2013)|ORD (2010)|930330|abcdeeef", "ENTRY": "Liver Cell Carcinomas", "MN": "C06.552.697.160", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "human and vet only: note entry term HEPATOMA: also available is HEPATOMA, EXPERIMENTAL see LIVER NEOPLASMS, EXPERIMENTAL for exper anim; coord IM with LIVER NEOPLASMS (IM)", "MS": "A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.", "OL": "use CARCINOMA, HEPATOCELLULAR to search HEPATOMA 1966-93", "PM": "94; was HEPATOMA 1963-93; CARCINOMA, HEPATOCELLULAR was see HEPATOMA 1991-93", "HN": "94; was HEPATOMA 1963-93; CARCINOMA, HEPATOCELLULAR was see HEPATOMA 1991-93", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D006528"}, {"RECTYPE": "D", "MH": "Hepatomegaly", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Enlarged Liver|T033|T046|NON|EQV|NLM (2000)|991103|abbcdef", "ENTRY": "Liver, Enlarged", "MN": "C23.300.775.525", "MH_TH": "NLM (1963)", "ST": "T046", "MS": "Enlargement of the liver.", "PM": "66", "HN": "66(63)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006529"}, {"RECTYPE": "D", "MH": "Hepatorenal Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Hepatorenal", "MN": "C12.950.419.291", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Syndrome (1972-1986)", "MS": "Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention.", "PM": "91; was see under KIDNEY DISEASES 1987-90", "HN": "91(87); was see under KIDNEY DISEASES 1987-90", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19860404", "DC": "1", "DX": "19910101", "UI": "D006530"}, {"RECTYPE": "D", "MH": "HEPES", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "N-2-Hydroxyethylpiperazine-N'-2'-ethanesulfonic Acid|T109|T130|NON|EQV|UNK (19XX)|741111|HYDROXYETHYLPIPERAZINE ETHANESULFONIC ACID N N 02 02|abbcdefs", "ENTRY": "Salt, HEPES Monosodium", "MN": "D03.383.606.500", "PA": "Buffers", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "1-Piperazineethanesulfonic acid, 4-(2-hydroxyethyl)-", "RN": "RWW266YE9I", "RR": "75277-39-3 (mono-Na salt)", "PI": "Piperazines (1970-1974)", "MS": "A dipolar ionic buffer.", "PM": "91; was see under PIPERAZINES 1975-90", "HN": "91(75); was see under PIPERAZINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006531"}, {"RECTYPE": "D", "MH": "Heptachlor", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.526.439.516", "PA": "Soil Pollutants", "MH_TH": "NLM (1971)", "ST": "T131", "N1": "4,7-Methano-1H-indene, 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-", "RN": "7GLS9ACN3L", "RR": "76-44-8 (Heptachlor)", "PI": "Insecticides (1966-1970)", "MS": "A man-made compound previously used to control termites and other insects. Even though production of heptachlor was phased out of use in the United States during the late 1980's it remains in soil and hazardous waste sites. It is clearly toxic to animals and humans but, the International Agency for Research on Cancer (IARC) has determined that heptachlor is not classifiable as to its carcinogenicity to humans. (From ATSDR Public Heath Statement, April 1989)", "PM": "73", "HN": "73(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006533"}, {"RECTYPE": "D", "MH": "Heptachlor Epoxide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Epoxide, Heptachlor", "MN": "D02.455.526.439.516.350", "PA": "Insecticides", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "2,5-Methano-2H-indeno(1,2-b)oxirene, 2,3,4,5,6,7,7-heptachloro-1a,1b,5,5a,6,6a-hexahydro-, (1aalpha,1bbeta,2alpha,5alpha,5abeta,6beta,6aalpha)-", "RN": "1024-57-3", "MS": "An oxidation product of HEPTACHLOR formed by many plants and animals, including humans, after exposure to HEPTACHLOR. It has been shown to remain in soil treated with HEPTACHLOR for over fifteen years and is toxic to animals and humans. (From ATSDR Public Heath Statement, April 1989)", "OL": "search HEPTACHLOR 1973-74", "PM": "91; was see under HEPTACHLOR 1975-90", "HN": "91(75); was see under HEPTACHLOR 1975-90", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006534"}, {"RECTYPE": "D", "MH": "Heptaminol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Heptaminol Hydrochloride|T109|T121|NRW|FDA SRS (2014)|NLM (1999)|990913|abbdeef", "MN": "D02.092.063.350", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Heptanol, 6-amino-2-methyl-", "RN": "3DQS188SY5", "RR": "XB3RM40HIR", "PI": "Amino Alcohols (1969-1975)", "MS": "An amino alcohol that has been used as a myocardial stimulant and vasodilator and to relieve bronchospasm. Its most common therapeutic use is in orthostatic hypotension. The mechanism of heptaminol's therapeutic actions is not well understood although it has been suggested to affect catecholamine release or calcium metabolism.", "PM": "91; was see under AMINO ALCOHOLS 1976-90", "HN": "91(76); was see under AMINO ALCOHOLS 1976-90", "MR": "20160701", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D006535"}, {"RECTYPE": "D", "MH": "Heptanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isoheptanes|T109|NON|NRW|UNK (19XX)|770520|abcdef", "MN": "D02.455.326.146.485", "FX": "Cycloheptanes", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "AN": "CYCLOHEPTANES is also available", "PI": "Hydrocarbons (1966-1977)", "MS": "Seven-carbon alkanes with the formula C7H16.", "PM": "78", "HN": "78", "MR": "20200527", "DA": "19770520", "DC": "1", "DX": "19780101", "UI": "D006536"}, {"RECTYPE": "D", "MH": "Heptanoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Enanthates|T109|NON|EQV|UNK (19XX)|741111|abcdef", "MN": "D10.251.450.400", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Fatty Acids (1969-1974)", "MS": "Salts and esters of the 7-carbon saturated monocarboxylic acid heptanoic acid.", "PM": "91; was see under HEPTANOIC ACIDS 1975-90", "HN": "91(75); was see under HEPTANOIC ACIDS 1975-90", "MR": "20030709", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D006537"}, {"RECTYPE": "D", "MH": "Heptanoic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Heptanoic", "MN": "D10.251.450", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Fatty Acids (1966-1974)", "MS": "7-carbon saturated monocarboxylic acids.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D006538"}, {"RECTYPE": "D", "MH": "Heptoses", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.947.875.286", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006539"}, {"RECTYPE": "D", "MH": "Herbicides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Herbicide|T131|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Algicides|T131|NON|BRD|NLM (2018)|170206|abcdef", "MN": "D27.888.723.366", "FX": "Weed Control", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "HERBICIDE RESISTANCE is available", "MS": "Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006540"}, {"RECTYPE": "D", "MH": "Hernia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT TH UR VE VI", "PRINT ENTRY": "Enterocele|T047|T190|NON|NRW|UNK (19XX)|750101|abbcdef", "ENTRY": "Hernias", "MN": "C23.300.707", "FX": "Trusses", "EC": "surgery:Herniorrhaphy", "MH_TH": "NLM (1963)", "ST": "T190", "AN": "general or unspecified; prefer specifics; coordinate with specific organ/disease; /surg: consider HERNIORRHAPHY", "MS": "Protrusion of tissue, structure, or part of an organ through the bone, muscular tissue, or the membrane by which it is normally contained. Hernia may involve tissues such as the ABDOMINAL WALL or the respiratory DIAPHRAGM. Hernias may be internal, external, congenital, or acquired.", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006547"}, {"RECTYPE": "D", "MH": "Hernia, Diaphragmatic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Diaphragmatic Hernia|T047|T190|NON|EQV|UNK (19XX)|790530|abbcdef", "ENTRY": "Hernias, Diaphragmatic", "MN": "C23.300.707.960.500", "EC": "congenital:Hernias, Diaphragmatic, Congenital", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "HERNIA, DIAPHRAGMATIC, TRAUMATIC is also available", "MS": "Protrusion of abdominal structures into the THORAX as a result of congenital or traumatic defects in the respiratory DIAPHRAGM.", "OL": "use HERNIA, DIAPHRAGMATIC to search DIAPHRAGMATIC HERNIA 1966-79", "PM": "80; was DIAPHRAGMATIC HERNIA 1963-79", "HN": "80; was DIAPHRAGMATIC HERNIA 1963-79", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006548"}, {"RECTYPE": "D", "MH": "Hernia, Diaphragmatic, Traumatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Diaphragmatic Hernia, Traumatic|T037|T190|NON|EQV|UNK (19XX)|790530|abbcdef", "ENTRY": "Traumatic Diaphragmatic Hernias", "MN": "C26.017.258", "MH_TH": "NLM (1966)", "ST": "T190", "MS": "The type of DIAPHRAGMATIC HERNIA caused by TRAUMA or injury, usually to the ABDOMEN.", "OL": "use HERNIA, DIAPHRAGMATIC, TRAUMATIC to search DIAPHRAGMATIC HERNIA, TRAUMATIC 1966-79", "PM": "80; was DIAPHRAGMATIC HERNIA, TRAUMATIC 1963-79", "HN": "80; was DIAPHRAGMATIC HERNIA, TRAUMATIC 1963-79", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D006549"}, {"RECTYPE": "D", "MH": "Hernia, Femoral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Femoral Hernia|T020|T047|NON|EQV|UNK (19XX)|790530|abbcdef", "ENTRY": "Hernias, Femoral", "MN": "C23.300.707.374.750", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A groin hernia occurring inferior to the inguinal ligament and medial to the FEMORAL VEIN and FEMORAL ARTERY. The femoral hernia sac has a small neck but may enlarge considerably when it enters the subcutaneous tissue of the thigh. It is caused by defects in the ABDOMINAL WALL.", "OL": "use HERNIA, FEMORAL to search FEMORAL HERNIA 1966-79", "PM": "80; was FEMORAL HERNIA 1963-79", "HN": "80; was FEMORAL HERNIA 1963-79", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D006550"}, {"RECTYPE": "D", "MH": "Hernia, Hiatal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hiatal Hernia|T047|T190|NON|EQV|OMIM (2013)|UNK (19XX)|790530|abbcdeef", "ENTRY": "Sliding Hiatal Hernias", "MN": "C23.300.707.960.500.467", "MH_TH": "NLM (1975)", "ST": "T190", "MS": "STOMACH herniation located at or near the diaphragmatic opening for the ESOPHAGUS, the esophageal hiatus.", "OL": "use HERNIA, HIATAL to search HIATAL HERNIA 1975-79; use HERNIA, DIAPHRAGMATIC 1966-74", "PM": "91; was see under HERNIA, DIAPHRAGMATIC 1980-90; was HIATAL HERNIA see under DIAPHRAGMATIC HERNIA 1963-79", "HN": "91(80); was see under HERNIA, DIAPHRAGMATIC 1980-90; was HIATAL HERNIA see under DIAPHRAGMATIC HERNIA 1963-79", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006551"}, {"RECTYPE": "D", "MH": "Hernia, Inguinal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Inguinal Hernia|T047|T190|NON|EQV|UNK (19XX)|790530|abbcdef", "ENTRY": "Inguinal Hernias, Indirect", "MN": "C23.300.707.374.875", "MH_TH": "NLM (1966)", "ST": "T190", "MS": "An abdominal hernia with an external bulge in the GROIN region. It can be classified by the location of herniation. Indirect inguinal hernias occur through the internal inguinal ring. Direct inguinal hernias occur through defects in the ABDOMINAL WALL (transversalis fascia) in Hesselbach's triangle. The former type is commonly seen in children and young adults; the latter in adults.", "OL": "use HERNIA, INGUINAL to search INGUINAL HERNIA 1966-79", "PM": "80; was INGUINAL HERNIA 1963-79", "HN": "80; was INGUINAL HERNIA 1963-79", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D006552"}, {"RECTYPE": "D", "MH": "Hernia, Obturator", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Obturator Hernia|T020|NON|EQV|UNK (19XX)|790522|abcdef", "ENTRY": "Obturator Hernias", "MN": "C23.300.707.937", "MH_TH": "NLM (1975)", "ST": "T020", "MS": "A pelvic hernia through the obturator foramen, a large aperture in the hip bone normally covered by a membrane. Obturator hernia can lead to intestinal incarceration and INTESTINAL OBSTRUCTION.", "OL": "use HERNIA, OBTURATOR to search OBTURATOR HERNIA 1975-79", "PM": "91; was see under HERNIA 1980-90; was OBTURATOR HERNIA see under HERNIA 1975-79", "HN": "91(80); was see under HERNIA 1980-90; was OBTURATOR HERNIA see under HERNIA 1975-79", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006553"}, {"RECTYPE": "D", "MH": "Hernia, Umbilical", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Umbilical Hernia|T047|T190|NON|EQV|UNK (19XX)|790530|abbcdef", "ENTRY": "Umbilical Hernias", "MN": "C23.300.707.374.937.500", "FX": "Beckwith-Wiedemann Syndrome", "MH_TH": "NLM (1966)", "ST": "T190", "MS": "A HERNIA due to an imperfect closure or weakness of the umbilical ring. It appears as a skin-covered protrusion at the UMBILICUS during crying, coughing, or straining. The hernia generally consists of OMENTUM or SMALL INTESTINE. The vast majority of umbilical hernias are congenital but can be acquired due to severe abdominal distention.", "OL": "use HERNIA, UMBILICAL to search UMBILICAL HERNIA 1966-79", "PM": "80; was UMBILICAL HERNIA 1963-79", "HN": "80; was UMBILICAL HERNIA 1963-79", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D006554"}, {"RECTYPE": "D", "MH": "Hernia, Ventral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ventral Hernia|T047|T190|NON|EQV|UNK (19XX)|790530|abbcdef", "ENTRY": "Ventral Hernias", "MN": "C23.300.707.374.937", "MH_TH": "NLM (1966)", "ST": "T190", "MS": "A hernia caused by weakness of the anterior ABDOMINAL WALL due to midline defects, previous incisions, or increased intra-abdominal pressure. Ventral hernias include UMBILICAL HERNIA, incisional, epigastric, and spigelian hernias.", "OL": "use HERNIA, VENTRAL to search VENTRAL HERNIA 1966-79", "PM": "80; was VENTRAL HERNIA 1963-79", "HN": "80; was VENTRAL HERNIA 1963-79", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D006555"}, {"RECTYPE": "D", "MH": "Heroin Dependence", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Heroin Addiction|T048|NON|EQV|NLM (1998)|960816|abcdef", "ENTRY": "Smoking, Heroin", "MN": "F03.900.647.500.300", "FX": "Smoking, Non-Tobacco Products", "MH_TH": "NLM (1973)", "ST": "T048", "PI": "Substance Dependence (1966-1972)", "MS": "Strong dependence or addiction, both physiological and emotional, upon HEROIN.", "OL": "use HEROIN DEPENDENCE to search HEROIN ADDICTION 1973-80 (as Prov 1973)", "PM": "81; was HEROIN ADDICTION 1974-80", "HN": "81; was HEROIN ADDICTION 1973-80 (Prov 1973)", "CATSH": "CAT LIST", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006556"}, {"RECTYPE": "D", "MH": "Herpangina", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Herpanginas", "MN": "C01.925.782.687.359.347.500", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Acute types of coxsackievirus infections or ECHOVIRUS INFECTIONS that usually affect children during the summer and are characterized by vesiculoulcerative lesions on the MUCOUS MEMBRANES of the THROAT; DYSPHAGIA; VOMITING, and FEVER.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006557"}, {"RECTYPE": "D", "MH": "Herpes Genitalis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Herpes Simplex, Genital|T047|NON|EQV|UNK (19XX)|810302|abcdef", "ENTRY": "Herpes, Genital", "MN": "C12.200.294.329", "MH_TH": "NLM (1982)", "ST": "T047", "PI": "Herpes Simplex (1966-1981)", "MS": "Infection of the genitals (GENITALIA) with HERPES SIMPLEX VIRUS in either the males or the females.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19810302", "DC": "1", "DX": "19820101", "UI": "D006558"}, {"RECTYPE": "D", "MH": "Pemphigoid Gestationis", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pemphigoids, Gestational", "MN": "C17.800.865.700", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "check the tags FEMALE and probably PREGNANCY", "PI": "Dermatitis Herpetiformis (1966-1975)", "MS": "An itching, autoimmune, bullous SKIN disease that occurs during the last two trimesters of PREGNANCY and PUERPERIUM. It also affects non-pregnant females with tissue of PLACENTA origin, such as CHORIOCARCINOMA; or HYDATIDIFORM MOLE. It exhibits antigenic and clinical similarity to bullous pemphigoid (PEMPHIGOID, BULLOUS). This disease does not involve herpes viruses (old name, herpes gestationis).", "PM": "2006; see HERPES GESTATIONIS 1991-2005, see SKIN DISEASES, VESICULOBULLOUS 1976-1990", "HN": "2006 (1976)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19750730", "DC": "1", "DX": "19910101", "UI": "D006559"}, {"RECTYPE": "D", "MH": "Herpes Labialis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Herpes Simplex, Labial|T047|NON|EQV|UNK (19XX)|781215|abcdef", "ENTRY": "Sores, Cold", "MN": "C17.800.838.790.320.320", "FX": "Stomatitis, Herpetic", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "herpes simplex of the lips & nares; STOMATITIS, HERPETIC (oral cavity) is also available", "MS": "Herpes simplex, caused by type 1 virus, primarily spread by oral secretions and usually occurring as a concomitant of fever. It may also develop in the absence of fever or prior illness. It commonly involves the facial region, especially the lips and the nares. (Dorland, 27th ed.)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006560"}, {"RECTYPE": "D", "MH": "Herpes Simplex", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Herpes Simplex Virus Infection|T047|NON|EQV|NLM (2018)|160930|abcdef", "MN": "C17.800.838.790.320", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "note Cat C; caused by Simplexvirus (also called Herpes simplex virus & Herpesvirus hominis)", "MS": "A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006561"}, {"RECTYPE": "D", "MH": "Herpes Zoster", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Zoster|T047|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "C01.925.256.466.930.750", "FX": "Neuralgia, Postherpetic", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006562"}, {"RECTYPE": "D", "MH": "Herpes Zoster Ophthalmicus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Herpes Zoster, Ocular|T047|NON|EQV|NLM (1990)|890316|abcdef", "ENTRY": "Ocular Herpes Zoster", "MN": "C11.294.800.450", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by human herpesvirus 3 (OCULAR HERPES ZOSTER VIRUS see HERPESVIRUS 3, HUMAN)", "MS": "Virus infection of the Gasserian ganglion and its nerve branches characterized by pain and vesicular eruptions with much swelling. Ocular involvement is usually heralded by a vesicle on the tip of the nose. This area is innervated by the nasociliary nerve.", "OL": "use HERPES ZOSTER OPHTHALMICUS to search HERPES ZOSTER, OCULAR 1966-89", "PM": "90; was HERPES ZOSTER, OCULAR 1963-89", "HN": "90; was HERPES ZOSTER, OCULAR 1963-89", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D006563"}, {"RECTYPE": "D", "MH": "Herpesviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Thymic Group Viruses|T005|NON|NRW|NLM (1992)|900925|abcdef", "ENTRY": "Thymic Viruses, Mouse", "MN": "B04.280.382", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid10292", "RR": "txid2419785", "MS": "A family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. Subfamilies, based on biological characteristics, include: ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; and GAMMAHERPESVIRINAE.", "OL": "use HERPESVIRIDAE to search HERPESVIRUSES 1975-80 & HERPESVIRUS 1966-74; use MOUSE LEUKEMIA VIRUSES to search THYMIC GROUP VIRUSES 1975-91", "PM": "81; was HERPESVIRUSES 1975-80, was HERPESVIRUS 1963-74; THYMIC GROUP VIRUSES was see MOUSE LEUKEMIA VIRUSES 1975-91", "HN": "81; was HERPESVIRUSES 1975-80, was HERPESVIRUS 1963-74; THYMIC GROUP VIRUSES was see MOUSE LEUKEMIA VIRUSES 1975-91", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D006564"}, {"RECTYPE": "D", "MH": "Herpesviridae Infections", "DE": "HERPESVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Herpesvirus Infections|T047|NON|EQV|NLM (1994)|930525|HERPESVIRUS INFECT|abcdefv", "ENTRY": "Infections, B Virus", "MN": "C01.925.256.466", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Virus diseases caused by the HERPESVIRIDAE.", "OL": "use HERPESVIRIDAE INFECTIONS to search HERPESVIRUS INFECTIONS 1966-93", "PM": "94; was HERPESVIRUS INFECTIONS 1963-93", "HN": "94; was HERPESVIRUS INFECTIONS 1963-93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D006566"}, {"RECTYPE": "D", "MH": "Herpesvirus 2, Saimiriine", "DS": "HERPESVIRUS SAIMIRIINE 002", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Herpesvirus 2, Saimirine|T005|NON|EQV|NLM (1975)|990101|HERPESVIRUS SAIMIRINE 02|abcdefs", "ENTRY": "Saimirus, Herpesvirus", "MN": "B04.613.204.500.700.400", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid10381", "AN": "do not confuse with HERPESVIRUS 1, SAIMIRIINE see SIMPLEXVIRUS; infection: coord IM with HERPESVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "PI": "Herpesviridae (1966-1974)", "MS": "The type species of RHADINOVIRUS, in the subfamily GAMMAHERPESVIRINAE, isolated from squirrel monkeys. It produces malignant lymphomas (LYMPHOMA, MALIGNANT) in inoculated marmosets or owl monkeys.", "PM": "2002; see HERPESVIRUS SAIMIRINE 1994-2001, see HERPESVIRUS SAIMIRI 1980-1993, see HERPESVIRUSES 1975-1979", "HN": "2002 (1975)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19800101", "UI": "D006567"}, {"RECTYPE": "D", "MH": "Herpesvirus 1, Cercopithecine", "DS": "HERPESVIRUS CERCOPITHECINE 01", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Simian Herpesvirus|T005|NON|EQV|NLM (1994)|930302|abcdef", "ENTRY": "alphaherpesvirus 1, Macacine", "MN": "B04.280.382.100.750.350", "MH_TH": "NLM (1971)", "ST": "T005", "RN": "txid10325", "AN": "infection: coordinate with HERPESVIRIDAE INFECTIONS", "PI": "Herpesviridae (1966-1970)", "MS": "A species of SIMPLEXVIRUS that causes vesicular lesions of the mouth in monkeys. When the virus is transmitted to man it causes an acute encephalitis or encephalomyelitis, which is nearly always fatal.", "OL": "use HERPESVIRUS 1, CERCOPITHECINE to search HERPESVIRUS SIMIAE 1991-93 & HERPESVIRUS SIMIAN B 1971-93 (as Prov 1971-74)", "PM": "94; was HERPESVIRUS SIMIAE 1991-93; was HERPESVIRUS SIMIAN B see under HERPESVIRIDAE 1981-90 & see under HERPESVIRUSES 1975-80; HERPESVIRUS SIMIAN B was see HERPESVIRUS SIMIAE 1991-93", "HN": "94; was HERPESVIRUS SIMIAE 1991-93; was HERPESVIRUS SIMIAN B see under HERPESVIRIDAE 1981-90 & see under HERPESVIRUSES 1971-80 (Prov 1971-74); HERPESVIRUS SIMIAN B was see HERPESVIRUS SIMIAE 1991-93", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006568"}, {"RECTYPE": "D", "MH": "Hesperidin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hesperidin 2S|T109|T123|NON|EQV|NLM (2020)|190611|abbcdef", "ENTRY": "Hesperetin 7 Rutinoside", "MN": "D09.408.386", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "E750O06Y6O", "RR": "520-26-3 (Hesperidin)", "MS": "A flavanone glycoside found in CITRUS fruit peels.", "PM": "1991; see BIOFLAVONOIDS 1975-1990, HESPERETIN 7-RHAMNOGLUCOSIDE was indexed under HESPERIDIN and GLUCOSIDES 2006-2013", "HN": "1991(1975)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006569"}, {"RECTYPE": "D", "MH": "Heterochromatin", "AQ": "CH CL DE EN GE IM IP ME MI PA PH PS RE TR UL VI", "ENTRY": "Heterochromatins", "MN": "G05.360.160.180.383", "MH_TH": "NLM (1968)", "ST": "T123", "RN": "0", "PI": "Chromosomes (1966-1967)", "MS": "The portion of chromosome material that remains condensed and is transcriptionally inactive during INTERPHASE.", "PM": "72", "HN": "72(68)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006570"}, {"RECTYPE": "D", "MH": "Heterocyclic Compounds", "DE": "HETEROCYCLIC CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Heterocyclic Compound|T109|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Compounds, Heterocyclic", "MN": "D03", "RH": "D3 - HETEROCYCLIC COMPOUNDS", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specific groups or specific compound", "MS": "Cyclic compounds that include atoms other than carbon in their ring structure.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006571"}, {"RECTYPE": "D", "MH": "Heterocyclic Compounds, Bridged-Ring", "DE": "HETEROCYCLIC CPDS BRIDGED RING", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Heterocyclic Compounds, Bridged Ring", "MN": "D03.605", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A class of organic compounds which contain two rings that share a pair of bridgehead carbon atoms.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006572"}, {"RECTYPE": "D", "MH": "Heterocyclic Compounds, 1-Ring", "DE": "HETEROCYCLIC CPDS 1 RING", "DS": "HETEROCYCLIC COMPOUNDS A 1 RING", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Heterocyclic Cpds, 1 Ring", "MN": "D03.383", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics; used for mapping supplementary chemicals", "MS": "Organic compounds that contain a ring structure made up of carbon and one or more additional elements such as nitrogen and oxygen.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006573"}, {"RECTYPE": "D", "MH": "Heterocyclic Compounds, 2-Ring", "DE": "HETEROCYCLIC CPDS 2 RING", "DS": "HETEROCYCLIC COMPOUNDS A 2 RING", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Heterocyclic Compounds, 2 Ring", "MN": "D03.633.100", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A class of heterocyclic compounds that include a two-ring fused structure. Both aromatic and non-aromatic ring structures are included in this category.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006574"}, {"RECTYPE": "D", "MH": "Heterocyclic Compounds, 3-Ring", "DE": "HETEROCYCLIC CPDS 3 RING", "DS": "HETEROCYCLIC COMPOUNDS A 3 RING", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Heterocyclic Compounds, 3 Ring", "MN": "D03.633.300", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A class of heterocyclic compounds that include a three-ring fused structure. Both aromatic or non-aromatic ring structures are included in this category.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "20160608", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006575"}, {"RECTYPE": "D", "MH": "Heterocyclic Compounds, 4 or More Rings", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Heterocyclic Compounds with 4 or More Rings|T109|NON|EQV|NLM (1966)|990101|HETEROCYCLIC COMPOUNDS A 4 OR MORE RINGS|HETEROCYCLIC CPDS WITH 4 OR MORE RINGS|abcdefsv", "ENTRY": "Heterocyclic Compounds, 5 Ring", "MN": "D03.633.400", "MH_TH": "NLM (2017)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A class of heterocyclic compounds that include four or more fused rings. Both aromatic or non-aromatic ring structures are included in this category.", "PM": "2017: see HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS 1998-2016", "HN": "2017(1998)", "MR": "20160608", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006576"}, {"RECTYPE": "D", "MH": "Heterocyclic Oxides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxides, Heterocyclic", "MN": "D03.661", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Oxides (1966-1974)", "MS": "Oxides of a ring compound having atoms other than carbon in its ring.", "PM": "75", "HN": "75", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D006577"}, {"RECTYPE": "D", "MH": "Heterophyidae", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Metagonimus|T204|NON|NRW|UNK (19XX)|810515|abcdef", "ENTRY": "Fluke, Yokogawa's", "MN": "B01.050.500.500.736.715.465", "MH_TH": "NLM (1982)", "ST": "T204", "RN": "txid84526", "RR": "txid84529", "AN": "a family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Trematoda (1966-1981)", "MS": "A family of intestinal flukes of the class Trematoda which occurs in animals and man. Some of the genera are Heterophyes, Metagonimus, Cryptocotyle, Stellantchasmus, and Euryhelmis.", "OL": "use HETEROPHYIDAE to search HETEROPHYES 1975-81 & METAGONIMUS 1966-81; use TREMATODA to search HETEROPHYES 1966-74", "PM": "82; HETEROPHYES was see under TREMATODA 1963-81; METAGONIMUS was heading 1963-81", "HN": "82; HETEROPHYES was see under TREMATODA 1963-81; METAGONIMUS was heading 1963-81", "MR": "20200813", "DA": "19810515", "DC": "1", "DX": "19820101", "UI": "D006578"}, {"RECTYPE": "D", "MH": "Heterozygote", "PRINT ENTRY": "Genetic Carriers|T001|NON|BRD|UNK (19XX)|790522|GENET CARRIERS|abcdefv", "ENTRY": "Heterozygotes", "MN": "G05.380.383", "FX": "Genetic Carrier Screening", "MH_TH": "NLM (1968)", "ST": "T001", "PI": "Genetics (1966-1967)", "MS": "An individual having different alleles at one or more loci regarding a specific character.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20170717", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006579"}, {"RECTYPE": "D", "MH": "Genetic Carrier Screening", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "PRINT ENTRY": "Heterozygote Detection|T059|T063|NON|EQV|NLM (1979)|990101|abbcdef", "ENTRY": "Screenings, Genetic Carrier", "MN": "N02.421.726.233.221.250", "MH_TH": "NLM (2018)", "ST": "T063", "PI": "Heterozygote (1968-1978)", "MS": "Identification of individuals who are heterozygous at a GENETIC LOCUS for a recessive PHENOTYPE.", "PM": "2018; see HETEROZYGOTE DETECTION 1979-2017", "HN": "2018 (1979)", "CATSH": "CAT LIST", "MR": "20170623", "DA": "19771123", "DC": "1", "DX": "19790101", "UI": "D006580"}, {"RECTYPE": "D", "MH": "Hexachlorobenzene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "HCB|T109|T131|ABB|EQV|UNK (19XX)|741111|abbcdef", "MN": "D02.455.526.439.202.400", "PA": "Fungicides, Industrial", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Benzene, hexachloro-", "RN": "4Z87H0LKUY", "RR": "118-74-1 (Hexachlorobenzene)", "AN": "do not confuse with BENZENE HEXACHLORIDE see HEXACHLOROCYCLOHEXANE", "PI": "Chlorobenzenes (1974)", "MS": "An agricultural fungicide and seed treatment agent.", "PM": "91; was see under CHLOROBENZENES 1975-90", "HN": "91(75); was see under CHLOROBENZENES 1975-90", "MR": "20180713", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D006581"}, {"RECTYPE": "D", "MH": "Hexachlorophene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hexachlorophane|T109|T121|NON|EQV|BAN (19XX)|800801|abbcdef", "MN": "D02.455.426.559.389.657.190.350", "PA": "Anti-Infective Agents, Local", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Phenol, 2,2'-methylenebis(3,4,6-trichloro)-", "RN": "IWW5FV6NK2", "RR": "70-30-4", "MS": "A chlorinated bisphenol antiseptic with a bacteriostatic action against Gram-positive organisms, but much less effective against Gram-negative organisms. It is mainly used in soaps and creams and is an ingredient of various preparations used for skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p797)", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006582"}, {"RECTYPE": "D", "MH": "Hexadimethrine Bromide", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Hexadimethrine|T109|T121|NON|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "Bromide, Hexadimethrine", "MN": "J01.637.051.720.470", "PA": "Heparin Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1,6-Hexanediamine, N,N,N',N'-tetramethyl-, polymer with 1,3-dibromopropane", "RN": "4C905MSK4W", "RR": "9011-04-5 (Hexadimethrine Bromide)", "PI": "Polymers (1972-1974)", "MS": "A synthetic polymer which agglutinates red blood cells. It is used as a heparin antagonist.", "PM": "2014; see HEXADIMETHRINE 1975-2013", "HN": "2014(1975)", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006583"}, {"RECTYPE": "D", "MH": "Hexamethonium Compounds", "DE": "HEXAMETHONIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Hexamethonium", "MN": "D02.675.276.558.592", "PA": "Ganglionic Blockers", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds containing the hexamethylenebis(trimethylammonium) cation. Members of this group frequently act as antihypertensive agents and selective ganglionic blocking agents.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006584"}, {"RECTYPE": "D", "MH": "Altretamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hexamethylmelamine|T109|T121|NON|EQV|NLM (1992)|910115|abbcdef", "ENTRY": "Hexinawas|T109|T121|TRD|NRW|ES|020723|abbcdef", "MN": "D03.383.931.135", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-", "RN": "Q8BIH59O7H", "RR": "645-05-6 (Altretamine)", "PI": "Triazines (1970-1974)", "MS": "A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.", "OL": "use ALTRETAMINE to search HEXAMETHYLMELAMINE 1975-91", "PM": "92; was HEXAMETHYLMELAMINE 1975-91 (see under TRIAZINES 1975-90)", "HN": "92; was HEXAMETHYLMELAMINE 1975-91 (see under TRIAZINES 1975-90)", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006585"}, {"RECTYPE": "D", "MH": "Hexanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isohexanes|T109|NON|NRW|UNK (19XX)|770520|abcdef", "MN": "D02.455.326.146.500", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Hydrocarbons (1966-1977)", "MS": "Six-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives. Various polyneuropathies are caused by hexane poisoning.", "PM": "78", "HN": "78", "MR": "20200527", "DA": "19770520", "DC": "1", "DX": "19780101", "UI": "D006586"}, {"RECTYPE": "D", "MH": "Hexanones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethyl Propyl Ketones|T109|NON|NRW|UNK (19XX)|741111|abcdef", "ENTRY": "Propyl Ketones, Ethyl", "MN": "D02.522.520", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Ketones (1966-1974)", "MS": "6-carbon straight-chain or branched ketones.", "PM": "91; was see under KETONES 1975-90", "HN": "91(75); was see under KETONES 1975-90", "MR": "19920519", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D006588"}, {"RECTYPE": "D", "MH": "Hexestrol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dihydrodiethylstilbestrol|T109|T121|NON|EQV|UNK (19XX)|750101|abbcdef", "ENTRY": "Hexestrol, (S-(R*,R*))-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef", "MN": "D02.455.426.559.389.150.700.725.750", "PA": "Estrogens, Non-Steroidal", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Phenol, 4,4'-(1,2-diethyl-1,2-ethanediyl)bis-", "RN": "10BI795R7D", "RR": "84-16-2 ((R*,S*)-isomer)", "MS": "A synthetic estrogen that has been used as a hormonal antineoplastic agent.", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006589"}, {"RECTYPE": "D", "MH": "Hexetidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Steri-sol|T109|T121|TRD|NRW|CA|111212|abbcdef", "MN": "D03.383.742.279", "PA": "Antifungal Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "5-Pyrimidinamine, 1,3-bis(2-ethylhexyl)hexahydro-5-methyl-", "RN": "852A84Y8LS", "RR": "141-94-6 (Hexetidine)", "MS": "A bactericidal and fungicidal antiseptic. It is used as a 0.1% mouthwash for local infections and oral hygiene. (From Martindale, The Extra Pharmacopoeia, 30th ed, p797)", "PM": "1973", "HN": "1973(1966)", "MR": "20210628", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006590"}, {"RECTYPE": "D", "MH": "Hexobarbital", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hexobarbital, Sodium", "MN": "D03.383.742.698.253.317", "PA": "Hypnotics and Sedatives", "MH_TH": "JAN (19XX)", "ST": "T121", "N1": "2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohexen-1-yl)-1,5-dimethyl-", "RN": "AL8Z8K3P6S", "RR": "56-29-1 (Hexobarbital)", "MS": "A barbiturate that is effective as a hypnotic and sedative.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006591"}, {"RECTYPE": "D", "MH": "Hexobendine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ustimon|T109|T121|TRD|NRW|UNK (19XX)|800825|abbcdef", "MN": "D02.455.426.559.389.657.654.638.500", "PA": "Vasodilator Agents", "MH_TH": "USAN (1972)", "ST": "T121", "N1": "Benzoic acid, 3,4,5-trimethoxy-, 1,2-ethanediylbis((methylimino)-3,1-propanediyl) ester", "RN": "B6X4SYR93B", "RR": "54-03-5 (Hexobendine)", "PI": "Ethylenediamines (1971-1974)", "MS": "A potent vasoactive agent that dilates cerebral and coronary arteries, but slightly constricts femoral arteries, without any effects on heart rate, blood pressure or cardiac output.", "PM": "91; was see under BENZOATES 1975-90", "HN": "91(75); was see under BENZOATES 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D006592"}, {"RECTYPE": "D", "MH": "Hexokinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hexokinase II|T116|T126|NON|NRW|UNK (19XX)|810608|abbcdef", "MN": "D08.811.913.696.620.300", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "ATP:D-hexose 6-phosphotransferase", "RN": "EC 2.7.1.1", "RR": "9001-51-8 (CAS RN)", "MS": "An enzyme that catalyzes the conversion of ATP and a D-hexose to ADP and a D-hexose 6-phosphate. D-Glucose, D-mannose, D-fructose, sorbitol, and D-glucosamine can act as acceptors; ITP and dATP can act as donors. The liver isoenzyme has sometimes been called glucokinase. (From Enzyme Nomenclature, 1992) EC 2.7.1.1.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006593"}, {"RECTYPE": "D", "MH": "Hexoprenaline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Hexoprenaline", "MN": "D02.092.471.683.530", "PA": "Tocolytic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1,2-Benzenediol, 4,4'-(1,6-hexanediylbis(imino(1-hydroxy-2,1-ethanediyl)))bis-", "RN": "G9L6B3W684", "RR": "U851S9102C", "PI": "Phenethylamines (1972-1974)", "MS": "Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.", "PM": "91; was see under PHENETHYLAMINES 1975-90", "HN": "91(75); was see under PHENETHYLAMINES 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D006594"}, {"RECTYPE": "D", "MH": "Hexosamines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hexosamine|T109|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D09.067.342", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "AMINO SUGARS created by adding an amine group to a hexose sugar.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006595"}, {"RECTYPE": "D", "MH": "Hexosaminidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hexosaminidase|T116|T126|NON|EQV|UNK (19XX)|860602|abbcdef", "ENTRY": "Glucosaminidases|T116|T126|NON|NRW|NLM (2005)|040319|abbcdef", "MN": "D08.811.277.450.483", "FX": "Gangliosidoses", "MH_TH": "NLM (1971)", "ST": "T126", "RN": "EC 3.2.1.-", "PI": "Glycoside Hydrolases (1966-1970)", "MS": "Enzymes that catalyze the hydrolysis of N-acylhexosamine residues in N-acylhexosamides. Hexosaminidases also act on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES.", "PM": "1973; for GALACTOSAMINIDASE see GALACTOAMINIDASE 1973-2004; for GLUCOSAMINIDASE see GLUCOSAMINIDASE 1973-2004; for HEXOAMINIDASE see BETA-N-ACETYLHEXOSAMINIDASE 1987-2004", "HN": "1973(1971); for HEXOAMINIDASE use BETA-N-ACETYLHEXOSAMINIDASE 1987-2004", "MR": "20150708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006596"}, {"RECTYPE": "D", "MH": "Fructose-Bisphosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hexosediphosphatase|T116|T126|NON|EQV|UNK (19XX)|880525|abbcdef", "ENTRY": "Fructose Bisphosphatase", "MN": "D08.811.277.352.650.200", "EC": "deficiency:Fructose-1,6-Diphosphatase Deficiency", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "D-Fructose-1,6-bisphosphate 1-phosphohydrolase", "RN": "EC 3.1.3.11", "MS": "An enzyme that catalyzes the conversion of D-fructose 1,6-bisphosphate and water to D-fructose 6-phosphate and orthophosphate. EC 3.1.3.11.", "OL": "use FRUCTOSE-BISPHOSPHATASE to search FRUCTOSE-1,6-DIPHOSPHATASE 1989-93 & HEXOSEDIPHOSPHATASE 1966-88", "PM": "94; was FRUCTOSE-1,6-DIPHOSPHATASE 1989-93; was HEXOSEDIPHOSPHATASE 1965-88", "HN": "94; was FRUCTOSE-1,6-DIPHOSPHATASE 1989-93; was HEXOSEDIPHOSPHATASE 1965-88", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006597"}, {"RECTYPE": "D", "MH": "Hexosediphosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.894.417.592", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "PI": "Hexosephosphates (1966-1972)", "PM": "73", "HN": "73", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006598"}, {"RECTYPE": "D", "MH": "UDPglucose-Hexose-1-Phosphate Uridylyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Uridyl Transferase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Uridylyltransferase, UDPglucose-Hexose-1-Phosphate", "MN": "D08.811.913.696.445.850", "FX": "Galactosemias", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "UDPglucose:alpha-D-galactose-1-phosphate uridylyltransferase", "RN": "EC 2.7.7.12", "RR": "9026-21-5 (CAS RN)", "AN": "/defic: consider GALACTOSEMIAS", "PI": "Uridine Diphosphate Sugars (1970-1974)", "MS": "An enzyme that catalyzes the transfer of UMP from UDPglucose to galactose 1-phosphate, forming UDPgalactose and glucose 1-phosphate. Deficiency in this enzyme is the major cause of GALACTOSEMIA. EC 2.7.7.12.", "PM": "98; see HEXOSEPHOSPHATE URIDYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20180701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006599"}, {"RECTYPE": "D", "MH": "Hexosephosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.894.417", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006600"}, {"RECTYPE": "D", "MH": "Hexoses", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hexose|T109|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D09.947.875.359", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "MONOSACCHARIDES whose molecules contain six carbon atoms, such as GLUCOSE and FRUCTOSE. They generally have the chemical formula C6H12O6.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006601"}, {"RECTYPE": "D", "MH": "Hexosyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.913.400.450", "MH_TH": "NLM (1972)", "ST": "T126", "RN": "EC 2.4.1.-", "PI": "Transferases (1966-1971)", "MS": "Enzymes that catalyze the transfer of hexose groups. EC 2.4.1.-.", "PM": "72", "HN": "72", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006602"}, {"RECTYPE": "D", "MH": "Hexuronic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hexouronic Acids|T109|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Acids, Hexuronic", "MN": "D09.811.922.400", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Uronic Acids (1971-1974)", "MS": "Term used to designate tetrahydroxy aldehydic acids obtained by oxidation of hexose sugars, i.e. glucuronic acid, galacturonic acid, etc. Historically, the name hexuronic acid was originally given to ascorbic acid.", "PM": "91; was see under URONIC ACIDS 1975-90", "HN": "91(75); was see under URONIC ACIDS 1975-90", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006603"}, {"RECTYPE": "D", "MH": "Hexylresorcinol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "4 Hexylresorcinol", "MN": "D02.455.426.559.389.657.852.467", "PA": "Anthelmintics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,3-Benzenediol, 4-hexyl-", "RN": "R9QTB5E82N", "RR": "136-77-6 (Hexylresorcinol)", "MS": "A substituted dihydroxybenzene used topically as an antiseptic for the treatment of minor skin infections.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006604"}, {"RECTYPE": "D", "MH": "Hibernation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Hibernation, Artificial|T040|NON|NRW|UNK (19XX)|830617|abcdef", "ENTRY": "Induced Hibernations", "MN": "G16.012.500.535.889.500", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "The dormant state in which some warm-blooded animal species pass the winter. It is characterized by narcosis and by sharp reduction in body temperature and metabolic activity and by a depression of vital signs.", "PM": "1963; for HIBERNATION, ARTIFICIAL see HYPOTHERMIA, INDUCED 1983-2008", "HN": "1963; for HIBERNATION, ARTIFICIAL use HYPOTHERMIA, INDUCED 1983-2008", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D006605"}, {"RECTYPE": "D", "MH": "Hiccup", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hiccups", "MN": "C23.888.821.578", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A spasm of the diaphragm that causes a sudden inhalation followed by rapid closure of the glottis which produces a sound.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006606"}, {"RECTYPE": "D", "MH": "Adenoma, Sweat Gland", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Syringadenoma|T191|NON|EQV|UNK (19XX)|840214|abcdef", "ENTRY": "Syringadenomas", "MN": "C04.557.470.550.175", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with SWEAT GLAND NEOPLASMS (IM)", "MS": "A benign neoplasm derived from epithelial cells of sweat glands. (Stedman, 25th ed)", "PM": "1994; see HIDRADENOMA 1963-1993", "HN": "1994 (1963)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D006607"}, {"RECTYPE": "D", "MH": "Hierarchy, Social", "AQ": "HI", "ENTRY": "Social Hierarchy", "MN": "I01.880.853.200", "MH_TH": "NLM (1975)", "ST": "T080", "AN": "human & animal", "MS": "Social rank-order established by certain behavioral patterns.", "OL": "search SOCIAL DOMINANCE 1968-74", "PM": "91; was see under SOCIAL DOMINANCE 1969-90; was see under DOMINANCE, SOCIAL 1968", "HN": "91(75); was see under SOCIAL DOMINANCE 1969-90; was see under DOMINANCE, SOCIAL 1968", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006608"}, {"RECTYPE": "D", "MH": "High Mobility Group Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HMG Proteins|T116|T123|ACX|EQV|UNK (19XX)|840530|abbcdef", "ENTRY": "High Mobility Group Chromosomal Proteins|T116|T123|NON|EQV|UNK (19XX)|840530|abbcdef", "MN": "D12.776.664.235.400", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics; HMG-BOX DOMAINS is also available", "PI": "Nucleoproteins (1966-1981)", "MS": "A family of low-molecular weight, non-histone proteins found in chromatin.", "PM": "85", "HN": "85", "MR": "20050630", "DA": "19840530", "DC": "1", "DX": "19850101", "UI": "D006609"}, {"RECTYPE": "D", "MH": "High Pressure Neurological Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "High Pressure Nervous Syndrome|T047|NON|EQV|NLM (1986)|990101|abcdef", "ENTRY": "HPNSs", "MN": "C24.410", "FX": "Diving", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "in divers; do not confuse with INERT GAS NARCOSIS", "PI": "Syndrome (1972-1985)", "MS": "A syndrome related to increased atmospheric pressure and characterized by tremors, nausea, dizziness, decreased motor and mental performance, and SEIZURES. This condition may occur in those who dive deeply (c. 1000 ft) usually while breathing a mixture of oxygen and helium. The condition is associated with a neuroexcitatory effect of helium.", "PM": "2000; see HIGH PRESSURE NERVOUS SYNDROME 1991-1999; see CENTRAL NERVOUS SYSTEM DISEASES 1986-1990", "HN": "2000(1986)", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19850509", "DC": "1", "DX": "19910101", "UI": "D006610"}, {"RECTYPE": "D", "MH": "High-Frequency Jet Ventilation", "DE": "HFJV", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ventilation, High Frequency Jet|T061|NON|EQV|UNK (19XX)|870430|abcdef", "ENTRY": "Ventilations, High-Frequency Jet", "MN": "E02.880.820.508.510", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Respiration, Artificial (1966-1987)", "MS": "Respiratory support system used primarily with rates of about 100 to 200/min with volumes of from about one to three times predicted anatomic dead space. Used to treat respiratory failure and maintain ventilation under severe circumstances.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19870430", "DC": "1", "DX": "19880101", "UI": "D006611"}, {"RECTYPE": "D", "MH": "High-Frequency Ventilation", "DE": "HFV", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ventilation, High-Frequency|T061|NON|EQV|UNK (19XX)|870430|abcdef", "ENTRY": "Ventilations, High-Frequency Oscillation", "MN": "E02.880.820.508", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Respiration, Artificial (1966-1987)", "MS": "Ventilatory support system using frequencies from 60-900 cycles/min or more. Three types of systems have been distinguished on the basis of rates, volumes, and the system used. They are high frequency positive-pressure ventilation (HFPPV); HIGH-FREQUENCY JET VENTILATION; (HFJV); and high-frequency oscillation (HFO).", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19870430", "DC": "1", "DX": "19880101", "UI": "D006612"}, {"RECTYPE": "D", "MH": "Higher Nervous Activity", "AQ": "DE ES GE IM PH RE", "ENTRY": "Nervous Activity, Higher", "MN": "G11.561.398", "MH_TH": "NLM (1964)", "ST": "T042", "AN": "this expression is found intact as \"vysshaia nervnaia deiatel'nost\" in Russian neurophysiol literature", "MS": "A term used in Eastern European research literature on brain and behavior physiology for cortical functions. It refers to the highest level of integrative function of the brain, centered in the CEREBRAL CORTEX, regulating language, thought, and behavior via sensory, motor, and cognitive processes.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006613"}, {"RECTYPE": "D", "MH": "Hindlimb", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Hindlimbs", "MN": "A13.473", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "non-primate vertebrates only; for primates use LEG", "PI": "Leg (1966-1967)", "MS": "Either of two extremities of four-footed non-primate land animals. It usually consists of a FEMUR; TIBIA; and FIBULA; tarsals; METATARSALS; and TOES. (From Storer et al., General Zoology, 6th ed, p73)", "PM": "1968", "HN": "1968", "MR": "20050713", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006614"}, {"RECTYPE": "D", "MH": "Hip", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "Coxa|T029|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Hips", "MN": "A01.378.610.400", "EC": "injuries:Hip Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "CX": "consider also terms at COX-", "MS": "The projecting part on each side of the body, formed by the side of the pelvis and the top portion of the femur.", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006615"}, {"RECTYPE": "D", "MH": "Hip Contracture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hip Contractures", "MN": "C05.651.197.468", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Permanent fixation of the hip in primary positions, with limited passive or active motion at the hip joint. Locomotion is difficult and pain is sometimes present when the hip is in motion. It may be caused by trauma, infection, or poliomyelitis. (From Current Medical Information & Technology, 5th ed)", "CATSH": "CAT LIST", "MR": "19940524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006616"}, {"RECTYPE": "D", "MH": "Hip Dislocation", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hip Dysplasias", "MN": "C26.531.500", "EC": "congenital:Hip Dislocation, Congenital", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "note entry term HIP DYSPLASIA: HIP DYSPLASIA, CANINE is also available", "MS": "Displacement of the femur bone from its normal position at the HIP JOINT.", "CATSH": "CAT LIST", "MR": "20200221", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006617"}, {"RECTYPE": "D", "MH": "Hip Dislocation, Congenital", "DE": "HIP DISLOCATION CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hip Dysplasia, Congenital|T019|T047|NON|EQV|UNK (19XX)|740330|HIP DYSPLASIA CONGEN|abbcdefv", "ENTRY": "Hip Dysplasias, Congenital", "MN": "C16.131.621.449", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Congenital dislocation of the hip generally includes subluxation of the femoral head, acetabular dysplasia, and complete dislocation of the femoral head from the true acetabulum. This condition occurs in approximately 1 in 1000 live births and is more common in females than in males.", "CATSH": "CAT LIST", "MR": "20200303", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006618"}, {"RECTYPE": "D", "MH": "Hip Dysplasia, Canine", "AQ": "BL CF CI CL CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Canine Hip Dysplasia|T019|T047|NON|EQV|NLM (1995)|940119|abbcdef", "ENTRY": "Dysplasia, Canine Hip", "MN": "C22.268.485", "MH_TH": "NLM (1976)", "ST": "T047", "AN": "congen hip disloc in dogs; don't forget check tags ANIMALS & DOGS (NIM)", "PI": "Hip Dislocation, Congenital/veterinary (1966-1975)", "MS": "A hereditary disease of the hip joints in dogs. Signs of the disease may be evident any time after 4 weeks of age.", "PM": "91; was see under HIP DISLOCATION, CONGENITAL 1976-90", "HN": "91(76); was see under HIP DISLOCATION, CONGENITAL 1976-90", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D006619"}, {"RECTYPE": "D", "MH": "Hip Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Trochlear Fractures, Femur|T037|NON|NRW|NLM (2023)|210929|abcdef", "ENTRY": "Trochlear Fractures, Femoral", "MN": "C26.558.276.425", "MH_TH": "NLM (1978)", "ST": "T037", "PI": "Fractures (1966-1977)", "MS": "Fractures of the FEMUR HEAD; the FEMUR NECK; (FEMORAL NECK FRACTURES); the trochanters; or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region (FEMORAL FRACTURES).", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19770504", "DC": "1", "DX": "19780101", "UI": "D006620"}, {"RECTYPE": "D", "MH": "Hip Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Joints, Hip", "MN": "A02.835.583.411", "EC": "injuries:Hip Injuries", "MH_TH": "NLM (1965)", "ST": "T030", "AN": "injury is probably HIP DISLOCATION or HIP FRACTURES, otherwise coordinate IM with HIP INJURIES (IM); differentiate from HIP", "MS": "The joint that is formed by the articulation of the head of FEMUR and the ACETABULUM of the PELVIS.", "PM": "65", "HN": "65", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006621"}, {"RECTYPE": "D", "MH": "Hip Prosthesis", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Femoral Head Prosthesis|T074|NON|NRW|UNK (19XX)|781219|abcdef", "ENTRY": "Prosthesis, Hip", "MN": "E07.695.400.400", "FX": "Arthroplasty, Replacement, Hip", "MH_TH": "NLM (1980)", "ST": "T074", "PI": "Prosthesis (1966-1970)", "MS": "Replacement for a hip joint.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19781219", "DC": "1", "DX": "19800101", "UI": "D006622"}, {"RECTYPE": "D", "MH": "von Hippel-Lindau Disease", "DE": "VON HIPPEL LINDAU DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lindau Disease|T047|EPO|EQV|NLM (2000)|991108|LINDAU DIS|abcdefv", "ENTRY": "von Hippel Lindau Syndrome", "MN": "C16.320.184.750", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.", "PM": "2008; see HIPPEL-LINDAU DISEASE 1991-2007; see ANGIOMATOSIS 1975-1990", "HN": "2008 (1975)", "CATSH": "CAT LIST", "MR": "20171214", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006623"}, {"RECTYPE": "D", "MH": "Hippocampus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Subiculum|T023|NON|NRW|NLM (1996)|941028|abcdef", "ENTRY": "Subiculums", "MN": "A08.186.211.200.885.287.500.345", "FX": "Perforant Pathway", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation.", "PM": "2015; see under HIPPOCAMPUS1966-2014", "HN": "2015(1966)", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006624"}, {"RECTYPE": "D", "MH": "Hippocratic Oath", "ENTRY": "Oath, Hippocratic", "MN": "N05.350.340.162.500.500", "MH_TH": "NLM (1966)", "ST": "T089", "AN": "capitalize Hippocratic in titles & translations", "MS": "An oath, attributed to Hippocrates, that serves as an ethical guide for the medical profession.", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006625"}, {"RECTYPE": "D", "MH": "Hippurates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.127.085.460", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Salts and esters of hippuric acid.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006626"}, {"RECTYPE": "D", "MH": "Hirschsprung Disease", "DE": "HIRSCHSPRUNG DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Megacolon, Congenital|T019|NON|EQV|UNK (19XX)|820427|MEGACOLON CONGEN|abcdefv", "ENTRY": "Rectosigmoid Colon Aganglionosis", "MN": "C16.131.314.439", "MH_TH": "OMIM (2013)", "ST": "T019", "PI": "Megacolon (1966-1982)", "MS": "Congenital MEGACOLON resulting from the absence of ganglion cells (aganglionosis) in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.", "OL": "search MEGACOLON 1966-82", "PM": "83; was HIRSCHSPRUNG'S DISEASE see MEGACOLON 1963-82", "HN": "83; was HIRSCHSPRUNG'S DISEASE see MEGACOLON 1963-82", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19820427", "DC": "1", "DX": "19830101", "UI": "D006627"}, {"RECTYPE": "D", "MH": "Hirsutism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.971.468", "FX": "Hypertrichosis", "MH_TH": "NLM (1963)", "ST": "T184", "MS": "A condition observed in WOMEN and CHILDREN when there is excess coarse body hair of an adult male distribution pattern, such as facial and chest areas. It is the result of elevated ANDROGENS from the OVARIES, the ADRENAL GLANDS, or exogenous sources. The concept does not include HYPERTRICHOSIS, which is an androgen-independent excessive hair growth.", "PM": "66; was see under HYPERTRICHOSIS 1963-65", "HN": "66(64); was see under HYPERTRICHOSIS 1963-65", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006628"}, {"RECTYPE": "D", "MH": "Hirudins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO UL UR", "PRINT ENTRY": "Hirudin|T116|T121|T123|NON|NRW|NLM (1966)|990101|abbbcdef", "MN": "D12.776.872.060.875", "PA": "Fibrinolytic Agents", "EC": "therapeutic use:Hirudin Therapy", "MH_TH": "NLM (2005)", "ST": "T121", "RN": "0", "RR": "8001-27-2", "MS": "Single-chain polypeptides of about 65 amino acids (7 kDa) from LEECHES that have a neutral hydrophobic N terminus, an acidic hydrophilic C terminus, and a compact, hydrophobic core region. Recombinant hirudins lack tyr-63 sulfation and are referred to as 'desulfato-hirudins'. They form a stable non-covalent complex with ALPHA-THROMBIN, thereby abolishing its ability to cleave FIBRINOGEN.", "PM": "2005; see HIRUDIN 1963-2004", "HN": "2005(1963)", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D006629"}, {"RECTYPE": "D", "MH": "Hispanic or Latino", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Spanish Americans|T098|NON|REL|UNK (19XX)|770225|abcdef", "ENTRY": "US Latin Americans", "MN": "M01.686.477.625.188.441", "MH_TH": "OMB (2023)", "ST": "T098", "PI": "specific state (1966-1977)", "MS": "A person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the-classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.", "PM": "2022; see HISPANIC AMERICANS 1978-2021", "HN": "2022(1978)", "MR": "20220714", "DA": "19770301", "DC": "1", "DX": "19780101", "UI": "D006630"}, {"RECTYPE": "D", "MH": "Amine Oxidase (Copper-Containing)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Histaminase|T116|T126|NON|EQV|NLM (1992)|910226|abbcdef", "ENTRY": "Semicarbazide Sensitive Amine Oxidase", "MN": "D08.811.682.664.249", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Amine:oxygen oxidoreductase (deaminating)(copper-containing)", "RN": "EC 1.4.3.21", "RR": "EC 1.4.3.22", "MS": "A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide.", "OL": "use AMINE OXIDASE (COPPER-CONTAINING) to search HISTAMINASE 1966-91; use AMINE OXIDASE (NM) to search COPPER AMINE OXIDASE 1978-91", "PM": "92; was HISTAMINASE 1963-91; COPPER AMINE OXIDASE was indexed under AMINE OXIDOREDUCTASES 1978-91", "HN": "92; was HISTAMINASE 1963-91; COPPER AMINE OXIDASE was SY to AMINE OXIDASE (NM) 1978-91", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D006631"}, {"RECTYPE": "D", "MH": "Histamine", "AQ": "AA AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Peremin|T109|T121|TRD|REL|NLM (1990)|890607|abbcdef", "MN": "D23.469.050.300", "PA": "Histamine Agonists", "FX": "Receptors, Histamine", "EC": "antagonists & inhibitors:Histamine Antagonists", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "1H-Imidazole-4-ethanamine", "RN": "820484N8I3", "RR": "51-45-6 (Histamine)", "MS": "An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.", "OL": "search HISTAMINE /antagonists & inhibitors under HISTAMINE H1 RECEPTOR BLOCKADERS 1966-76", "PM": "/antagonists & inhibitors was ANTIHISTAMINICS 1963-76", "HN": "/antagonists & inhibitors was ANTIHISTAMINICS 1963-76", "MR": "20180613", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006632"}, {"RECTYPE": "D", "MH": "Histamine Antagonists", "DE": "HISTAMINE ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Histamine Antagonist|T121|NON|EQV|NLM (2021)|191227|abcdef", "ENTRY": "Antagonists, Histamine", "MN": "D27.505.696.577.375.425", "MH_TH": "NLM (1977)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; do not confuse with HISTAMINE AGONISTS", "PI": "Histamine H1 Receptor Blockaders (1966-1976)", "MS": "Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.", "PM": "1977; see ANTIHISTAMINICS 1963-1976, for ANTIHISTAMINES see HISTAMINE H1 ANTAGONISTS 1997-2008", "HN": "1977; for ANTIHISTAMINES use HISTAMINE H1 ANTAGONISTS 1997-2008", "MR": "20200527", "DA": "19760505", "DC": "1", "DX": "19770101", "UI": "D006633"}, {"RECTYPE": "D", "MH": "Histamine H1 Antagonists", "DE": "HISTAMINE H1 ANTAG", "DS": "HISTAMINE ANTAGONISTS H 001", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Histamine H1 Receptor Blockaders|T121|NON|EQV|NLM (1995)|940128|HISTAMINE RECEPTOR BLOCKADERS H1|HISTAMINE H1 RECEPT BLOCK|abcdefsv", "ENTRY": "Sedating Antihistamines", "MN": "D27.505.696.577.375.425.400", "FX": "Hypersensitivity, Immediate", "MH_TH": "NLM (1977)", "ST": "T121", "RN": "0", "AN": "HISTAMINE H1 ANTAGONISTS, NON-SEDATING is also available", "MS": "Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.", "OL": "use HISTAMINE H1 ANTAGONISTS to search HISTAMINE H1 RECEPTOR BLOCKADERS 1977-94 and ANTIHISTAMINICS 1966-76", "PM": "95; was HISTAMINE H1 RECEPTOR BLOCKADERS 1977-94; was ANTIHISTAMINICS 1963-76; ANTIHISTAMINICS, CLASSICAL was ANTIHISTAMINICS see HISTAMINE H1 RECEPTOR BLOCKADERS 1977-90", "HN": "95; was HISTAMINE H1 RECEPTOR BLOCKADERS 1977-94; was ANTIHISTAMINICS 1963-76; ANTIHISTAMINICS, CLASSICAL was ANTIHISTAMINICS see HISTAMINE H1 RECEPTOR BLOCKADERS 1977-90", "MR": "20210630", "DA": "19760505", "DC": "1", "DX": "19770101", "UI": "D006634"}, {"RECTYPE": "D", "MH": "Histamine H2 Antagonists", "DE": "HISTAMINE H2 ANTAG", "DS": "HISTAMINE ANTAGONISTS H 002", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Histamine H2 Receptor Blockaders|T121|NON|EQV|NLM (1995)|940128|HISTAMINE RECEPTOR BLOCKADERS H2|HISTAMINE H2 RECEPT BLOCK|abcdefsv", "ENTRY": "Receptor Blockader, H2", "MN": "D27.505.696.577.375.425.425", "FX": "Anti-Ulcer Agents", "MH_TH": "NLM (1977)", "ST": "T121", "RN": "0", "MS": "Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood.", "OL": "use HISTAMINE H2 ANTAGONISTS to search HISTAMINE H2 RECEPTOR BLOCKADERS 1977-94", "PM": "95; was HISTAMINE H2 RECEPTOR BLOCKADERS 1977-94", "HN": "95; was HISTAMINE H2 RECEPTOR BLOCKADERS 1977-94", "MR": "20200527", "DA": "19760505", "DC": "1", "DX": "19770101", "UI": "D006635"}, {"RECTYPE": "D", "MH": "Histamine Release", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Histamine Liberation|T043|NON|EQV|NLM (1996)|940909|abcdef", "ENTRY": "Histamine Releases", "MN": "G12.350", "FX": "p-Methoxy-N-methylphenethylamine", "MH_TH": "NLM (1966)", "ST": "T043", "MS": "The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects.", "PM": "96; was HISTAMINE LIBERATION 1963-95", "HN": "96; was HISTAMINE LIBERATION 1963-95", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D006636"}, {"RECTYPE": "D", "MH": "Histamine N-Methyltransferase", "DS": "HISTAMINE METHYLTRANSFERASE N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Histamine Methyltransferase|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef", "ENTRY": "N-Methyltransferase, Histamine", "MN": "D08.811.913.555.500.500", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "S-Adenosyl-L-methionine:histamine N-tele-methyltransferase", "RN": "EC 2.1.1.8", "RR": "9029-80-5 (CAS RN)", "PI": "Methyltransferases (1973-1974)", "MS": "An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to histamine, forming N-methylhistamine, the major metabolite of histamine in man. EC 2.1.1.8.", "PM": "98; see HISTAMINE METHYLTRANSFERASE 1991-97; see METHYLTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006637"}, {"RECTYPE": "D", "MH": "Histidine Ammonia-Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Histidase|T116|T126|NON|EQV|NLM (1998)|961115|abbcdef", "ENTRY": "alpha-Deaminase, Histidine", "MN": "D08.811.520.232.400.500", "MH_TH": "NLM (1973)", "ST": "T126", "N1": "L-Histidine ammonia-lyase", "RN": "EC 4.3.1.3", "RR": "9013-75-6 (CAS RN)", "AN": "/defic: consider also histidinemia (AMINO ACID METABOLISM, INBORN ERRORS)", "MS": "An enzyme that catalyzes the first step of histidine catabolism, forming UROCANIC ACID and AMMONIA from HISTIDINE. Deficiency of this enzyme is associated with elevated levels of serum histidine and is called histidinemia (AMINO ACID METABOLISM, INBORN ERRORS).", "PM": "98; see HISTIDASE 1991-97, see AMMONIA-LYASES 1973-90", "HN": "98(73)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006638"}, {"RECTYPE": "D", "MH": "Histidine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L-isomer Histidine", "MN": "D12.125.142.308", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "L-Histidine", "RN": "4QD397987E", "RR": "71-00-1 (Histidine)", "AN": "/biosyn /defic /physiol permitted", "MS": "An essential amino acid that is required for the production of HISTAMINE.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006639"}, {"RECTYPE": "D", "MH": "Histidine Decarboxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Histidine Carboxy-Lyase|T116|T126|NON|EQV|UNK (19XX)|760317|abbcdef", "ENTRY": "Histidine Carboxy Lyase", "MN": "D08.811.520.224.125.300", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Histidine carboxy-lyase", "RN": "EC 4.1.1.22", "RR": "9024-61-7 (CAS RN)", "PI": "Histidine (1973-1974)", "MS": "An enzyme that catalyzes the decarboxylation of histidine to histamine and carbon dioxide. It requires pyridoxal phosphate in animal tissues, but not in microorganisms. EC 4.1.1.22.", "PM": "91; was see under CARBOXY-LYASES 1975-90", "HN": "91(75); was see under CARBOXY-LYASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006640"}, {"RECTYPE": "D", "MH": "Histidinol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Histidol|T109|T121|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "MN": "D03.383.129.308.385", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "1H-Imidazole-4-propanol, beta-amino-", "RN": "501-28-0", "PI": "Imidazoles (1972-1974)", "MS": "The penultimate step in the pathway of histidine biosynthesis. Oxidation of the alcohol group on the side chain gives the acid group forming histidine. Histidinol has also been used as an inhibitor of protein synthesis.", "PM": "91; was see under IMIDAZOLES 1975-90", "HN": "91(75); was see under IMIDAZOLES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006641"}, {"RECTYPE": "D", "MH": "Histidinol-Phosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Histidinol Phosphate Phosphatase|T116|T126|NON|EQV|UNK (19XX)|800328|abbcdef", "ENTRY": "Histidinolphosphatase|T116|T126|NON|EQV|NLM (1994)|921006|abbcdef", "MN": "D08.811.277.352.650.300", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Histidinol-phosphate phosphohydrolase", "RN": "EC 3.1.3.15", "RR": "9025-79-0 (CAS RN)", "PI": "Phosphatases (1973-1974)", "MS": "An enzyme that catalyzes the hydrolysis of histidinol-phosphate to histidinol. One of the regulatory enzymes in histidine biosynthesis. EC 3.1.3.15.", "OL": "use HISTIDINOL-PHOSPHATASE to search HISTIDINOLPHOSPHATASE 1975-93", "PM": "94; was HISTIDINOLPHOSPHATASE 1975-93 (see under PHOSPHOMONOESTERASES 1975-90)", "HN": "94; was HISTIDINOLPHOSPHATASE 1975-93 (see under PHOSPHOMONOESTERASES 1975-90)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006642"}, {"RECTYPE": "D", "MH": "Histidine-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Histidyl T RNA Synthetase|T116|T126|T129|EQV|NLM (1998)|961105|abbbdef", "ENTRY": "Synthetase, Histidyl-tRNA", "MN": "D08.811.464.263.200.400", "MH_TH": "NLM (1975)", "ST": "T129", "N1": "L-Histidine:tRNA(His) ligase (AMP-forming)", "RN": "EC 6.1.1.21", "PI": "Histidine (1972-1974)", "MS": "An enzyme that activates histidine with its specific transfer RNA. EC 6.1.1.21.", "PM": "98; see HISTIDYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASE 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006643"}, {"RECTYPE": "D", "MH": "Histiocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Histiocyte", "MN": "A15.382.680.397.385", "MH_TH": "NLM (1964)", "ST": "T025", "MS": "Macrophages found in the TISSUES, as opposed to those found in the blood (MONOCYTES) or serous cavities (SEROUS MEMBRANE).", "PM": "65", "HN": "65(64)", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006644"}, {"RECTYPE": "D", "MH": "Histiocytosis, Langerhans-Cell", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Langerhans-Cell Histiocytosis|T047|EPO|EQV|NLM (2009)|ORD (2010)|070918|abcdeef", "ENTRY": "Type 2 Histiocytoses", "MN": "C15.604.250.400", "MH_TH": "NLM (1976)", "ST": "T047", "PI": "Reticuloendotheliosis (1966-1974)", "MS": "A group of disorders resulting from the abnormal proliferation of and tissue infiltration by LANGERHANS CELLS which can be detected by their characteristic Birbeck granules (X bodies), or by monoclonal antibody staining for their surface CD1 ANTIGENS. Langerhans-cell granulomatosis can involve a single organ, or can be a systemic disorder.", "OL": "use HISTIOCYTOSIS, LANGERHANS-CELL to search HISTIOCYTOSIS X 1975-89; use RETICULOENDOTHELIOSIS 1966-74", "PM": "90; was see under RETICULOENDOTHELIOSIS 1965-75; was HISTIOCYTOSIS X 1975-89", "HN": "90(75); was see under RETICULOENDOTHELIOSIS 1966-75; was HISTIOCYTOSIS X 1975-89", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D006646"}, {"RECTYPE": "D", "MH": "Histocompatibility", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Tissue Compatibility|T080|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Tissue Compatibilities", "MN": "G12.875.519", "MH_TH": "NLM (1968)", "ST": "T080", "PI": "Transplantation Immunology (1966-1967)", "MS": "The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts.", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D006648"}, {"RECTYPE": "D", "MH": "Histocompatibility Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Transplantation Antigens|T129|NON|EQV|UNK (19XX)|870509|TRANSPL ANTIGENS|abcdefv", "ENTRY": "Antigens, SD", "MN": "D23.050.705.552", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "AN": "general or unspecified; prefer specifics but for humans, use HLA ANTIGENS; /genet permitted but consider also MAJOR HISTOCOMPATIBILITY COMPLEX", "PI": "Transplantation Immunology (1966-1969)", "MS": "A group of antigens that includes both the major and minor histocompatibility antigens. The former are genetically determined by the major histocompatibility complex. They determine tissue type for transplantation and cause allograft rejections. The latter are systems of allelic alloantigens that can cause weak transplant rejection.", "PM": "73", "HN": "73", "MR": "20050718", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006649"}, {"RECTYPE": "D", "MH": "Histocompatibility Testing", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tissue Typing|T059|NON|EQV|UNK (19XX)|741127|abcdef", "ENTRY": "Typings, Tissue", "MN": "E05.478.594.385", "MH_TH": "NLM (1968)", "ST": "T059", "AN": "human or animal; do not confuse with HEMOCOMPATIBILITY TESTING see MATERIALS TESTING", "PI": "Transplantation Immunology (1966-1967)", "MS": "Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed)", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D006650"}, {"RECTYPE": "D", "MH": "Histocytochemistry", "DE": "HISTOCYTOCHEM", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Cytochemistry|T091|NON|NRW|UNK (19XX)|740330|CYTOCHEM|abcdefv", "MN": "H01.181.122.573", "MH_TH": "NLM (1967)", "ST": "T090", "AN": "histocytochemistry of disease is disease / metab; Manual 26.11.3+", "MS": "Study of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods.", "OL": "use HISTOCYTOCHEMISTRY to search CYTOCHEMISTRY & HISTOCHEMISTRY 1966", "PM": "67; CYTOCHEMISTRY was heading 1966; HISTOCHEMISTRY was heading 1964-66", "HN": "67; CYTOCHEMISTRY was heading 1966; HISTOCHEMISTRY was heading 1964-66", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006651"}, {"RECTYPE": "D", "MH": "Histological Techniques", "DE": "HISTOL TECHNIQUES", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Techniques, Histological", "MN": "E05.200.750", "MH_TH": "NLM (1966)", "ST": "T059", "MS": "Methods of preparing tissue for examination and study of the origin, structure, function, or pathology.", "OL": "use HISTOLOGICAL TECHNIQUES to search HISTOLOGICAL TECHNICS 1966-90", "PM": "91; was HISTOLOGICAL TECHNICS 1963-90", "HN": "91; was HISTOLOGICAL TECHNICS 1963-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006652"}, {"RECTYPE": "D", "MH": "Histology", "DE": "HISTOL", "AQ": "CL EC ED ES HI IS LJ OG SN ST TD", "MN": "H01.158.100.656", "EC": "methods:Histological Techniques", "MH_TH": "POPLINE (1978)", "ST": "T091", "AN": "the discipline only (education, history, etc); for histological structures, use the qualifier /anat with specific anatomical term or organism", "MS": "The study of the structure of various TISSUES of organisms on a microscopic level.", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006653"}, {"RECTYPE": "D", "MH": "Histology, Comparative", "DE": "HISTOL COMPARATIVE", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Comparative Histology|T091|NON|EQV|NLM (1992)|900927|COMPARATIVE HISTOL|abcdefv", "MN": "H01.158.100.656.469", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "the discipline (education, history, etc) only; for comparative histological studies, use the qualifier/ anat with specific anatomical term or organism + the Publication Type COMPARATIVE STUDY", "MS": "The study of the similarities and differences in the structures of homologous tissues across various species.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006654"}, {"RECTYPE": "D", "MH": "Histone Deacetylases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Deacetylases, Histone", "MN": "D08.811.277.087.520", "EC": "antagonists & inhibitors:Histone Deacetylase Inhibitors", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 3.5.1.98", "RR": "EC 3.5.1.98", "PI": "Histones (1971-1974)", "MS": "Deacetylases that remove N-acetyl groups from amino side chains of the amino acids of HISTONES. The enzyme family can be divided into at least three structurally-defined subclasses. Class I and class II deacetylases utilize a zinc-dependent mechanism. The sirtuin histone deacetylases belong to class III and are NAD-dependent enzymes.", "PM": "2003; see HISTONE DEACETYLASE 1991-2002; see AMIDOHYDROLASES 1975-1990", "HN": "2003; use AMIDOHYDROLASES 1975-1990", "MR": "20090706", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006655"}, {"RECTYPE": "D", "MH": "Protamine Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Histone Kinase|T116|T126|NON|EQV|NLM (1994)|921015|abbcdef", "ENTRY": "Kinase, Protamine", "MN": "D12.776.476.563.150.575", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "ATP:protamine O-phosphotransferase", "RN": "EC 2.7.11.1", "RR": "37278-10-7 (CAS RN)", "PI": "Protein Kinases (1974)", "MS": "An aspect of protein kinase (EC 2.7.1.37) in which serine residues in protamines and histones are phosphorylated in the presence of ATP.", "OL": "use PROTAMINE KINASE to search HISTONE KINASE 1975-93; use PROTAMINE KINASE (NM) to search PROTAMINE KINASE 1982-93", "PM": "94; was HISTONE KINASE 1975-93 (see under PROTEIN KINASES 1980-90, see under PROTEIN KINASE 1975-79); PROTAMINE KINASE was indexed under PROTEIN KINASES 1982-93", "HN": "94; was HISTONE KINASE 1975-93 (see under PROTEIN KINASES 1980-90, see under PROTEIN KINASE 1975-79); PROTAMINE KINASE was (NM) 1982-93", "MR": "20210521", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006656"}, {"RECTYPE": "D", "MH": "Histones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Histone H7|T116|T123|NON|NRW|UNK (19XX)|810625|abbcdef", "MN": "D12.776.664.469", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "H1, H2a, H2b, H3, etc. go here", "MS": "Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006657"}, {"RECTYPE": "D", "MH": "Histoplasma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Histoplasma capsulatum|T004|NON|NRW|NLM (2003)|020605|abcdef", "ENTRY": "Histoplasmas", "MN": "B01.300.381.440", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid5036", "RR": "txid5037", "MS": "A mitosporic Onygenales fungal genus causing HISTOPLASMOSIS in humans and animals. Its single species is Histoplasma capsulatum which has two varieties: H. capsulatum var. capsulatum and H. capsulatum var. duboisii. Its teleomorph is AJELLOMYCES capsulatus.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006658"}, {"RECTYPE": "D", "MH": "Histoplasmin", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "MN": "D23.050.202.386", "MH_TH": "NLM (1986)", "ST": "T129", "N1": "Histoplasmin", "RN": "9008-05-3", "PM": "91; was see under ANTIGENS, FUNGAL 1986-90; was heading 1963-85", "HN": "91(86)63; was see under ANTIGENS, FUNGAL 1986-90; was heading 1963-85", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006659"}, {"RECTYPE": "D", "MH": "Histoplasmosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pulmonary Histoplasmosis|T047|NON|NRW|NLM (2023)|210831|abcdef", "ENTRY": "Infection, Histoplasma duboisii", "MN": "C01.150.703.450", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Infection resulting from exposure to the fungus HISTOPLASMA.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006660"}, {"RECTYPE": "D", "MH": "Historiography", "DE": "HISTORIOGR", "ENTRY": "Historiographies", "MN": "K01.400.441", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "The writing of history; the principles, theory, and history of historical writing; the product of historical writing. (Webster, 3d ed)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006663"}, {"RECTYPE": "D", "MH": "History", "DE": "HIST", "ENTRY": "Histories", "MN": "K01.400", "MH_TH": "POPLINE (1978)", "ST": "T090", "AN": "IM for the discipline or general articles on history; prefer /hist with specific subjects", "MS": "Record and study of past events.", "MR": "20171211", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006664"}, {"RECTYPE": "D", "MH": "History of Dentistry", "DE": "HIST DENT", "ENTRY": "Dentistry Histories", "MN": "K01.400.450", "MH_TH": "NLM (1965)", "ST": "T090", "AN": "general; prefer /hist with specific dentistry term & do not coordinate here or with DENTISTRY", "MS": "Study of past events and development in the field of DENTISTRY.", "PM": "65", "HN": "65", "MR": "20180620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006665"}, {"RECTYPE": "D", "MH": "History of Medicine", "DE": "HIST MED", "ENTRY": "Medicines, History", "MN": "K01.400.552", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "general; prefer /hist with specific medical concept and do not coordinate here; Manual 18.14+; 32.4-.6; Avicenna (Ibn Sina): see note under MEDICINE, ARABIC; DF: HIST MED", "MS": "Study of past events and development in the field of Medicine.", "MR": "20180122", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006666"}, {"RECTYPE": "D", "MH": "History of Nursing", "DE": "HIST NURS", "ENTRY": "Nursing History", "MN": "K01.400.608", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "general; prefer /hist with specific nursing term and do not coordinate here or with NURSING", "MS": "Study of past events and development in the field of Nursing.", "PM": "66", "HN": "66", "MR": "20180122", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006676"}, {"RECTYPE": "D", "MH": "Histrionic Personality Disorder", "DE": "HISTRIONIC PERSONALITY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Personality, Hysterical|T048|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Personality Disorders, Histrionic", "MN": "F03.675.400", "MH_TH": "NLM (1969)", "ST": "T048", "PI": "Hysteria (1966-1968)", "MS": "A personality disorder characterized by overly reactive and intensely expressed or overly dramatic behavior, proneness to exaggeration, emotional excitability, and disturbances in interpersonal relationships.", "OL": "use HISTRIONIC PERSONALITY DISORDER to search HYSTERICAL PERSONALITY 1969-80", "PM": "81; was HYSTERICAL PERSONALITY 1969-80", "HN": "81; was HYSTERICAL PERSONALITY 1969-80", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D006677"}, {"RECTYPE": "D", "MH": "HIV", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Lymphadenopathy-Associated Virus|T005|NON|EQV|UNK (19XX)|860617|abcdef", "ENTRY": "Viruses, Lymphadenopathy-Associated", "MN": "B04.820.650.589.650.350", "FX": "Reverse Transcriptase Inhibitors", "MH_TH": "NLM (1987)", "ST": "T005", "RN": "txid12721", "PI": "Human T-Cell Leukemia Virus (1984-1986)", "MS": "Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.", "PM": "1988; see HTLV-III 1987; for AIDS VIRUS see HIV-1 1990-2004; for HUMAN T-CELL LEUKEMIA VIRUS TYPE III see HIV 1987-1991", "HN": "1988; use HTLV-III 1987; for AIDS VIRUS use HIV-1 1990-2004; for HUMAN T-CELL LEUKEMIA VIRUS TYPE III see HIV 1987-1991", "MR": "20200813", "DA": "19860617", "DC": "1", "DX": "19870101", "UI": "D006678"}, {"RECTYPE": "D", "MH": "HIV Seropositivity", "DE": "HIV SEROPOS", "AQ": "BL CF CL CN CO DG DI DT EC EH EN EP GE HI IM ME MI MO NU PA PP PS PX RH TH TM UR VE VI", "PRINT ENTRY": "HTLV-III Seropositivity|T034|EQV|UNK (19XX)|870928|HTLV WIII SEROPOSITIVITY|HTLV III SEROPOS|abdefsv", "ENTRY": "Seropositivity, HTLV-III", "MN": "C20.673.480.500", "FX": "HIV Seroprevalence", "MH_TH": "BIOETHICS (1989)", "ST": "T034", "AN": "note category; HIV SERONEGATIVITY (Cat G) is also available; /diag /immunol permitted but use caution; coord IM with HIV-1 /immunol (IM) or HIV-2 /immunol (IM); do not confuse with HIV SEROPREVALENCE, an epidemiol concept; DF: HIV SEROPOS", "PI": "Human T-Cell Leukemia Virus (1984-1986)", "MS": "Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).", "PM": "88; ANTI-HIV POSITIVITY was ANTI-HIV POSITIVE 1988-93; HIV ANTIBODY POSITIVITY was HIV ANTIBODY POSITIVE 1988-93", "HN": "88; ANTI-HIV POSITIVITY was ANTI-HIV POSITIVE 1988-93; HIV ANTIBODY POSITIVITY was HIV ANTIBODY POSITIVE 1988-93", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19870928", "DC": "1", "DX": "19880101", "UI": "D006679"}, {"RECTYPE": "D", "MH": "HLA Antigens", "DE": "HLA", "DS": "HLA A 00 ANTIGENS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Leukocyte Antigens|T116|T129|NON|EQV|UNK (19XX)|880606|abbcdef", "ENTRY": "Leukocyte Antigens, Human", "MN": "D23.050.705.552.450", "MH_TH": "NLM (1978)", "ST": "T129", "RN": "0", "AN": "human only, standing for Human Leukocyte Antigen; general or unspecified; prefer specifics; HLA goes here", "PI": "Histocompatibility Antigens (1973-1974)", "MS": "Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases.", "OL": "use HLA ANTIGENS to search HL-A ANTIGENS 1978-81 and HL-A 1975-77; use HISTOCOMPATIBILITY ANTIGENS to search HL-A 1974", "PM": "82; was HL-A ANTIGENS 1978-81; was HL-A see under HISTOCOMPATIBILITY ANTIGENS 1974-77", "HN": "82; was HL-A ANTIGENS 1978-81; was HL-A see under HISTOCOMPATIBILITY ANTIGENS 1974-77", "MR": "20200527", "DA": "19770329", "DC": "1", "DX": "19780101", "UI": "D006680"}, {"RECTYPE": "D", "MH": "HLA-D Antigens", "DS": "HLA D 00 ANTIGENS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immune-Response Antigens, Human|T116|T129|NON|EQV|UNK (19XX)|860625|abbcdef", "ENTRY": "Immune Response Antigens, Human", "MN": "D23.050.705.552.450.400", "MH_TH": "NLM (1987)", "ST": "T129", "RN": "0", "AN": "general; prefer specifics", "PI": "Antigens, Immune Response (1981-1986)", "MS": "Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology.", "OL": "search HISTOCOMPATIBILITY ANTIGENS CLASS II 1981-86", "PM": "87; was see ANTIGENS, IMMUNE RESPONSE 1981-86", "HN": "87; was see ANTIGENS, IMMUNE RESPONSE 1981-86", "MR": "20230316", "DA": "19860625", "DC": "1", "DX": "19870101", "UI": "D006681"}, {"RECTYPE": "D", "MH": "HLA-DP Antigens", "DE": "HLA DP", "DS": "HLA DP 00 ANTIGENS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "HLA-SB Antigens|T116|T129|EQV|UNK (19XX)|860625|abbdef", "ENTRY": "HLA SB Antigens", "MN": "D23.050.705.552.450.400.420", "MH_TH": "NLM (1987)", "ST": "T129", "RN": "0", "PI": "Antigens, Immune Response (1981-1986)", "MS": "A group of the D-related HLA antigens (human) found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases.", "PM": "89; was see under HLA-D ANTIGENS 1987-88", "HN": "89(87); was see under HLA-D ANTIGENS 1987-88", "MR": "20230316", "DA": "19860625", "DC": "1", "DX": "19890101", "UI": "D006682"}, {"RECTYPE": "D", "MH": "HLA-DQ Antigens", "DE": "HLA DQ", "DS": "HLA DQ 00 ANTIGENS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "HLA-MB Antigens|T116|T129|EQV|UNK (19XX)|860625|abbdef", "ENTRY": "HLA MB Antigens", "MN": "D23.050.705.552.450.400.430", "MH_TH": "NLM (1987)", "ST": "T129", "RN": "0", "PI": "Antigens, Immune Response (1981-1986)", "MS": "A group of the D-related HLA antigens found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases.", "PM": "89; was see under HLA-D ANTIGENS 1987-88", "HN": "89(87); was see under HLA-ANTIGENS 1987-88", "MR": "20230316", "DA": "19860625", "DC": "1", "DX": "19890101", "UI": "D006683"}, {"RECTYPE": "D", "MH": "HLA-DR Antigens", "DE": "HLA DR", "DS": "HLA DR 00 ANTIGENS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA DR Antigens", "MN": "D23.050.705.552.450.400.440", "MH_TH": "NLM (1987)", "ST": "T129", "RN": "0", "AN": "general; prefer specifics", "PI": "Antigens, Immune Response (1981-1986)", "MS": "A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS.", "PM": "89; was see under HLA-D ANTIGENS 1987-88", "HN": "89(87); was see under HLA-D ANTIGENS 1987-88", "MR": "20230316", "DA": "19860625", "DC": "1", "DX": "19890101", "UI": "D006684"}, {"RECTYPE": "D", "MH": "Hoarseness", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neurogenic Hoarsenesses", "MN": "C23.888.852.490", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "for other qualities of voice VOICE QUALITY & VOICE DISORDERS are available", "MS": "An unnaturally deep or rough quality of voice.", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006685"}, {"RECTYPE": "D", "MH": "Hobbies", "AQ": "CL EC ES HI PX SN TD", "ENTRY": "Hobby", "MN": "I03.450.642.469", "MH_TH": "NLM (1966)", "ST": "T056", "AN": "IM; coord with person pursuing the hobby (IM)", "MS": "Leisure activities engaged in for pleasure.", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006686"}, {"RECTYPE": "D", "MH": "Hockey", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Ice Hockey|T056|NON|NRW|UNK (19XX)|780524|abcdef", "ENTRY": "Ice Hockeys", "MN": "I03.450.642.845.475", "MH_TH": "NLM (1976)", "ST": "T056", "AN": "/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1", "PI": "Sports (1966-1975)", "MS": "A game in which two parties of players provided with curved or hooked sticks seek to drive a ball or puck through opposite goals. This applies to either ice hockey or field hockey.", "PM": "90; was see under SPORTS 1976-89", "HN": "90(76); was see under SPORTS 1976-89", "MR": "19960610", "DA": "19750725", "DC": "1", "DX": "19900101", "UI": "D006688"}, {"RECTYPE": "D", "MH": "Hodgkin Disease", "DE": "HODGKIN DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lymphogranuloma, Malignant|T191|NON|EQV|UNK (19XX)|780523|abcdef", "ENTRY": "Nodular Lymphocyte Predominant Hodgkin's Lymphoma", "MN": "C20.683.515.761.355", "FX": "Reed-Sternberg Cells", "MH_TH": "ORD (2010)", "ST": "T191", "MS": "A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.", "PM": "98; see HODGKIN'S DISEASE 1966-97", "HN": "98(66)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006689"}, {"RECTYPE": "D", "MH": "Bisbenzimidazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bisbenzimide|T109|T121|T130|NON|NRW|UNK (19XX)|810424|abbbcdef", "ENTRY": "NSC322921", "MN": "D03.633.100.103.145", "PA": "Fluorescent Dyes", "MH_TH": "NLM (2009)", "ST": "T121", "N1": "4-(5-(5-(4-Methylpiperazin-1-yl)benzimidazol-2- yl)benzimidazol-2-yl)phenol", "RN": "LHQ7J5KV9B", "RR": "23491-45-4", "PI": "Piperazines (1971-1975)", "MS": "A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.", "PM": "2008; see BISBENZIMIDE 1991-2008, see BENZIMIDAZOLES 1977-1990", "HN": "2008(1977)", "MR": "20160527", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D006690"}, {"RECTYPE": "D", "MH": "Classical Swine Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Swine Fever, Classical|T047|NON|EQV|NLM (2002)|010420|abcdef", "ENTRY": "Cholera, Hog", "MN": "C22.905.170", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "do not confuse entry term SWINE FEVER with AFRICAN SWINE FEVER; don't forget also SWINE (NIM)", "MS": "An acute, highly contagious disease affecting swine of all ages and caused by the CLASSICAL SWINE FEVER VIRUS. It has a sudden onset with high morbidity and mortality.", "PM": "2002; see HOG CHOLERA 1963-2001", "HN": "2002 (1963)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D006691"}, {"RECTYPE": "D", "MH": "Classical Swine Fever Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Swine Fever Virus, Classical|T005|NON|EQV|NLM (2002)|010420|abcdef", "ENTRY": "Cholera Virus, Hog", "MN": "B04.820.578.344.700.125", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11096", "PI": "RNA Viruses (1966-1978)", "MS": "A species of the PESTIVIRUS genus causing exceedingly contagious and fatal hemorrhagic disease of swine.", "PM": "2002; see HOG CHOLERA VIRUS 1979-2001", "HN": "2002 (1979)", "MR": "20200813", "DA": "19771205", "DC": "1", "DX": "19790101", "UI": "D006692"}, {"RECTYPE": "D", "MH": "Holidays", "AQ": "CL HI PX SN", "PRINT ENTRY": "Festivals|T052|NON|NRW|UNK (19XX)|820429|abcdef", "ENTRY": "Holiday", "MN": "I03.450.345", "MH_TH": "NLM (1966)", "ST": "T052", "MS": "Days commemorating events. Holidays also include vacation periods.", "OL": "use HOLIDAYS to search FESTIVALS 1966-82", "HN": "FESTIVALS was see under HOLIDAYS 1963-82", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006693"}, {"RECTYPE": "D", "MH": "Holistic Health", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "PRINT ENTRY": "Wholistic Health|T078|NON|EQV|NLM (2002)|010316|abcdef", "ENTRY": "Wholistic Therapy", "MN": "N01.400.350", "FX": "Integrative Medicine", "MH_TH": "NLM (1980)", "ST": "T078", "AN": "coordinate with specific complementary therapy if pertinent", "MS": "Health as viewed from the perspective that humans function as complete, integrated units rather than as aggregates of separate parts.", "PM": "80", "HN": "80", "MR": "20230615", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D006694"}, {"RECTYPE": "D", "MH": "Holmium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.492", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Holmium", "RN": "W1XX32SQN1", "RR": "7440-60-0 (Holmium)", "MS": "An element of the rare earth family of metals. It has the atomic symbol Ho, atomic number 67, and atomic weight 164.93.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006695"}, {"RECTYPE": "D", "MH": "Holography", "DE": "HOLOGR", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD VE", "MN": "E01.370.350.600.300", "MH_TH": "NLM (1969)", "ST": "T060", "PI": "Photography (1966-1968)", "MS": "The recording of images in three-dimensional form on a photographic film by exposing it to a laser beam reflected from the object under study.", "PM": "74", "HN": "74(69)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006696"}, {"RECTYPE": "D", "MH": "Holothurin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.946.580.450", "PA": "Poisons", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "11029-72-4", "AN": "/antag permitted but consider also ANTITOXINS", "PI": "Toxins (1970-1974)", "MS": "A highly toxic saponin occurring in HOLOTHUROIDEA. This marine toxin is an anionic surfactant, hemolyzing ERYTHROCYTES.", "PM": "91; was see under SAPONINS 1975-90", "HN": "91(75); was see under SAPONINS 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006697"}, {"RECTYPE": "D", "MH": "Holtzman Inkblot Test", "AQ": "HI SN ST", "ENTRY": "Test, Holtzman Inkblot", "MN": "F04.711.647.622.341.387", "MH_TH": "NLM (1971)", "ST": "T170", "PI": "Ink Blot Tests (1966-1970)", "MS": "Personality evaluation based on the scoring of several variables as a result of the subject's responses in perceiving 47 inkblot plates.", "OL": "search INK BLOT TESTS 1969-70", "PM": "91; was see under INK BLOT TESTS 1971-90", "HN": "91(71); was see under INK BLOT TESTS 1971-90", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006698"}, {"RECTYPE": "D", "MH": "Home Care Services", "DE": "HOME CARE SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Home Health Care|T058|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Service, Home Care", "MN": "N02.421.539.089", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "coordinate with specific home care ", "MS": "Community health and NURSING SERVICES providing coordinated multiple services to the patient at the patient's homes. These home-care services are provided by a visiting nurse, home health agencies, HOSPITALS, or organized community groups using professional staff for care delivery. It differs from HOME NURSING which is provided by non-professionals.", "OL": "use HOME CARE SERVICES to search HOME CARE SERVICE 1966", "PM": "67; was HOME CARE SERVICE 1966", "HN": "67; was HOME CARE SERVICE 1966", "MR": "20210512", "DA": "19771207", "DC": "1", "DX": "19660101", "UI": "D006699"}, {"RECTYPE": "D", "MH": "Home Childbirth", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Childbirth at Home|T061|NON|EQV|UNK (19XX)|820505|abcdef", "ENTRY": "Home Births", "MN": "G08.686.784.769.490.062.500", "MH_TH": "NLM (1983)", "ST": "T061", "AN": "check the tags FEMALE and PREGNANCY", "PI": "Delivery (1966-1982)", "MS": "Childbirth taking place in the home.", "PM": "91; was see under DELIVERY 1983-90", "HN": "91(83); was see under DELIVERY 1983-90", "CATSH": "CAT LIST", "MR": "20180227", "DA": "19820505", "DC": "1", "DX": "19910101", "UI": "D006700"}, {"RECTYPE": "D", "MH": "Home Nursing", "DE": "HOME NURS", "AQ": "CL EC ED ES HI LJ MT OG PX SN ST TD", "PRINT ENTRY": "Nursing, Home|T058|NON|EQV|UNK (19XX)|740330|NURS HOME|abcdefv", "ENTRY": "Nonprofessional Home Care", "MN": "N02.421.533.320", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "by non-professionals only (family, friends, etc.): do not confuse with HOME CARE SERVICES (by professional: visiting nurse, public health nurse, etc.)", "MS": "Nursing care given to an individual in the home. The care may be provided by a family member or a friend. Home nursing as care by a non-professional is differentiated from HOME CARE SERVICES provided by professionals: visiting nurse, home health agencies, hospital, or other organized community group.", "PM": "66; was NURSING, HOME 1963-65", "HN": "66; was NURSING, HOME 1963-65", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006701"}, {"RECTYPE": "D", "MH": "Homing Behavior", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Home Range|T082|NON|REL|NLM (1998)|970528|abcdef", "ENTRY": "Ranges, Home", "MN": "F01.145.113.646", "FX": "Animal Migration", "MH_TH": "NLM (1968)", "ST": "T053", "PI": "Behavior, Animal (1966-1967)", "MS": "Instinctual patterns of activity related to a specific area including ability of certain animals to return to a given place when displaced from it, often over great distances using navigational clues such as those used in migration (ANIMAL MIGRATION).", "PM": "98; see HOME RANGE 1968-97", "HN": "98;(68)", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006702"}, {"RECTYPE": "D", "MH": "Ill-Housed Persons", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Unhoused Persons|T098|NON|EQV|NLM (2023)|220311|abcdef", "ENTRY": "Unhoused Person", "MN": "M01.325", "MH_TH": "NLM (2023)", "ST": "T098", "AN": "not for nomads; for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "PI": "Transients and Migrants (1966-1985)", "MS": "Persons without adequate housing or without permanent residence. The concept excludes nomadic peoples.", "PM": "2023; see HOMELESS PERSONS 1986-2022", "HN": "2023 (1996)", "MR": "20220715", "DA": "19850320", "DC": "1", "DX": "19860101", "UI": "D006703"}, {"RECTYPE": "D", "MH": "Homemaker Services", "DE": "HOMEMAKER SERV", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Service, Homemaker", "MN": "N02.421.143.524.595", "MH_TH": "NLM (1973)", "ST": "T058", "PI": "Home Care Services (1966-1972)", "MS": "Non-medical support services, such as food preparation and bathing, given by trained personnel to disabled, sick or convalescent individuals in their home.", "PM": "91; was see under HOME CARE SERVICES 1973-90", "HN": "91(73); was see under HOME CARE SERVICES 1973-90", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006704"}, {"RECTYPE": "D", "MH": "Homeopathy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Homoeopathy|T058|NON|EQV|NLM (2002)|010313|abcdef", "MN": "E02.190.388", "FX": "Pharmacopoeias, Homeopathic as Topic", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "A system of therapeutics founded by Samuel Hahnemann (1755-1843), based on the Law of Similars where \"like cures like\". Diseases are treated by highly diluted substances that cause, in healthy persons, symptoms like those of the disease to be treated.", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006705"}, {"RECTYPE": "D", "MH": "Homeostasis", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Autoregulation|T040|NON|EQV|UNK (19XX)|750101|abcdef", "MN": "G07.410", "FX": "Neuroimmunomodulation", "MH_TH": "NLM (1984)", "ST": "T040", "MS": "The processes whereby the internal environment of an organism tends to remain balanced and stable.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006706"}, {"RECTYPE": "D", "MH": "Homes for the Aged", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Senior Housing|T073|T093|NON|EQV|NLM (2023)|211128|abbcdef", "ENTRY": "Old Age Home", "MN": "N02.278.825.462", "FX": "Housing for the Elderly", "MH_TH": "NLM (1968)", "ST": "T093", "AN": "nursing homes for the aged: coord IM with NURSING HOMES (IM); check also tag AGED", "MS": "Geriatric long-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required.", "OL": "use HOMES FOR THE AGED to search OLD AGE HOMES 1966-67", "PM": "68; was OLD AGE HOMES 1963-67", "HN": "68; was OLD AGE HOMES 1963-67", "MR": "20211202", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006707"}, {"RECTYPE": "D", "MH": "Homicide", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Murder|T054|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Wrongful Deaths", "MN": "I01.880.735.344", "MH_TH": "POPLINE (1978)", "ST": "T054", "MS": "The killing of one person by another.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006708"}, {"RECTYPE": "D", "MH": "Homoarginine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.125.095.104.400", "MH_TH": "NLM (1975)", "ST": "T116", "N1": "L-Lysine, N(6)-(aminoiminomethyl)-", "RN": "156-86-5", "PI": "Guanidines (1972-1974)", "PM": "91; was see under ARGININE 1975-90", "HN": "91(75); was see under ARGININE 1975-90", "MR": "20010725", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006709"}, {"RECTYPE": "D", "MH": "Homocysteine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2-amino-4-mercaptobutyric acid|T116|T123|NON|EQV|NLM (2002)|010208|AMINOMERCAPTOBUTYRIC ACID 0204|abbcdefs", "ENTRY": "L-Isomer Homocysteine", "MN": "D12.125.166.498", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Homocysteine", "RN": "0LVT1QZ0BA", "RR": "6027-13-0 (L-isomer)", "AN": "do not confuse with HOMOCYSTINE", "MS": "A thiol-containing amino acid formed by a demethylation of METHIONINE.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006710"}, {"RECTYPE": "D", "MH": "Homocystine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.125.166.554", "MH_TH": "NLM (1967)", "ST": "T123", "N1": "Butanoic acid, 4,4'-dithiobis(2-amino)-", "RN": "462-10-2", "AN": "/urine: consider also HOMOCYSTINURIA; do not confuse with HOMOCYSTEINE", "PI": "Aminobutyric Acids (1966)", "PM": "73", "HN": "73(67)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006711"}, {"RECTYPE": "D", "MH": "Homocystinuria", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cystathionine beta-Synthase Deficiency Disease|T047|NON|NRW|NLM (2000)|ORD (2010)|991103|CYSTATHIONINE BETA SYNTHASE DEFIC DIS|abcdeefv", "ENTRY": "Deficiency, CBS", "MN": "C18.452.648.189.365", "FX": "Cystathionine beta-Synthase", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Mental Retardation (1966)", "MS": "Autosomal recessive inborn error of methionine metabolism usually caused by a deficiency of CYSTATHIONINE BETA-SYNTHASE and associated with elevations of homocysteine in plasma and urine. Clinical features include a tall slender habitus, SCOLIOSIS, arachnodactyly, MUSCLE WEAKNESS, genu varus, thin blond hair, malar flush, lens dislocations, an increased incidence of MENTAL RETARDATION, and a tendency to develop fibrosis of arteries, frequently complicated by CEREBROVASCULAR ACCIDENTS and MYOCARDIAL INFARCTION. (From Adams et al., Principles of Neurology, 6th ed, p979)", "PM": "1969", "HN": "1969(1967)", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D006712"}, {"RECTYPE": "D", "MH": "Homogentisic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Homogentisic", "MN": "D02.241.223.601.421", "MH_TH": "NLM (1971)", "ST": "T123", "N1": "Benzeneacetic acid, 2,5-dihydroxy-", "RN": "NP8UE6VF08", "RR": "451-13-8 (Homogentisic Acid)", "PI": "Phenylacetates (1966-1970)", "MS": "Dihydroxyphenylacetic acid with hydroxyls at the 2 and 5 positions of the phenyl ring.", "PM": "73", "HN": "73(71)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006713"}, {"RECTYPE": "D", "MH": "Homoserine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L isomer of Homoserine", "MN": "D12.125.526", "MH_TH": "NLM (1971)", "ST": "T123", "N1": "Homoserine", "RN": "6KA95X0IVO", "RR": "672-15-1 (L-isomer)", "AN": "an amino acid", "PI": "Hydroxybutyrates (1966-1970)", "PM": "73", "HN": "73(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006714"}, {"RECTYPE": "D", "MH": "Homoserine Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, Homoserine", "MN": "D08.811.682.047.820.300", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Homoserine:NAD(P)+ oxidoreductase", "RN": "EC 1.1.1.3", "PI": "Homoserine (1973-1974)", "MS": "An enzyme that catalyzes the reduction of aspartic beta-semialdehyde to homoserine, which is the branch point in biosynthesis of methionine, lysine, threonine and leucine from aspartic acid. EC 1.1.1.3.", "PM": "91; was see under ALCOHOL OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under ALCOHOL OXIDOREDUCTASES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006715"}, {"RECTYPE": "D", "MH": "Homosexuality", "AQ": "CL DE EH ES HI PH PX RE SN", "PRINT ENTRY": "Homosexuality, Ego-Dystonic|T048|NON|NRW|NLM (1981)|970714|abcdef", "ENTRY": "Homosexuality, Ego Dystonic", "MN": "G08.686.867.500", "FX": "Sexual and Gender Minorities", "MH_TH": "NLM (1963)", "ST": "T054", "AN": "general; prefer HOMOSEXUALITY, MALE or HOMOSEXUALITY, FEMALE", "PI": "Homosexuality (1966-2012)", "MS": "The sexual attraction or relationship between members of the same SEX.", "CATSH": "CAT LIST", "MR": "20170118", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006716"}, {"RECTYPE": "D", "MH": "Homosteroids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.496", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Steroids whose structure has been expanded by the addition of one or more carbon atoms to the ring skeleton in any of the four rings.", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006718"}, {"RECTYPE": "D", "MH": "Homovanillic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Homovanillic", "MN": "D02.241.223.601.521", "MH_TH": "NLM (1973)", "ST": "T123", "N1": "Benzeneacetic acid, 4-hydroxy-3-methoxy-", "RN": "X77S6GMS36", "RR": "306-08-1 (Homovanillic Acid)", "MS": "A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.", "PM": "86; was see under PHENYLACETATES 1975-85", "HN": "86(73); was see under PHENYLACETATES 1975-85, was Prov 1973-74", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D006719"}, {"RECTYPE": "D", "MH": "Homozygote", "ENTRY": "Homozygotes", "MN": "G05.380.554", "MH_TH": "NLM (1968)", "ST": "T001", "PI": "Genetics (1966-1967)", "MS": "An individual in which both alleles at a given locus are identical.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006720"}, {"RECTYPE": "D", "MH": "Honduras", "AQ": "EH EP", "MN": "Z01.107.169.534", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in CENTRAL AMERICA, bordering the Caribbean Sea, between GUATEMALA and NICARAGUA and bordering the Gulf of Fonseca (North Pacific Ocean), between EL SALVADOR and NICARAGUA.", "MR": "20151124", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D006721"}, {"RECTYPE": "D", "MH": "Honey", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Honeys", "MN": "J02.500.581", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "for medical use, coordinate with APITHERAPY", "MS": "A sweet viscous liquid food, produced in the honey sacs of various bees from nectar collected from flowers. The nectar is ripened into honey by inversion of its sucrose sugar into fructose and glucose. It is somewhat acidic and has mild antiseptic properties, being sometimes used in the treatment of burns and lacerations.", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006722"}, {"RECTYPE": "D", "MH": "Hong Kong", "AQ": "EH EP", "PRINT ENTRY": "New Territories|T083|NAM|NRW|NLM (1998)|970225|abcdef", "ENTRY": "Hongkong|T083|NAM|EQV|UNK (19XX)|781214|abcdef", "MN": "Z01.252.474.164.450", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "The former British crown colony located off the southeast coast of China, comprised of Hong Kong Island, Kowloon Peninsula, and New Territories. The three sites were ceded to the British by the Chinese respectively in 1841, 1860, and 1898. Hong Kong reverted to China in July 1997. The name represents the Cantonese pronunciation of the Chinese xianggang, fragrant port, from xiang, perfume and gang, port or harbor, with reference to its currents sweetened by fresh water from a river west of it.", "MR": "19970620", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D006723"}, {"RECTYPE": "D", "MH": "Hoof and Claw", "DE": "HOOF CLAW", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Claw|T023|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Hoofs", "MN": "A13.491", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "for cat & dog claws (nails): not for chicken claws (whole foot); diseases: coordinate IM with FOOT DISEASES / vet (IM)", "PI": "specific animal", "MS": "Highly keratinized processes that are sharp and curved, or flat with pointed margins. They are found especially at the end of the limbs in certain animals.", "PM": "68", "HN": "68", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006724"}, {"RECTYPE": "D", "MH": "Hookworm Infections", "DE": "HOOKWORM INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Bunostomiasis|T047|NON|NRW|NLM (1993)|911115|abcdef", "ENTRY": "Infection, Hookworm", "MN": "C01.610.335.508.700.775.455", "MH_TH": "NLM (1973)", "ST": "T047", "AN": "general or unspecified; prefer specifics; New World hookworm infection equals NECATORIASIS, Old World hookworm infection equals ANCYLOSTOMIASIS", "MS": "Infection of humans or animals with hookworms other than those caused by the genus Ancylostoma or Necator, for which the specific terms ANCYLOSTOMIASIS and NECATORIASIS are available.", "OL": "use HOOKWORM INFECTIONS to search HOOKWORM INFECTION 1966-72 & BUNOSTOMIASIS 1968-92", "PM": "73; was HOOKWORM INFECTION 1963-72; BUNOSTOMIASIS was heading 1968-92", "HN": "73; was HOOKWORM INFECTION 1963-72; BUNOSTOMIASIS was heading 1968-92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006725"}, {"RECTYPE": "D", "MH": "Hordeolum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Stye|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Styes", "MN": "C11.338.648", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Purulent infection of one of the sebaceous glands of Zeis along the eyelid margin (external) or of the meibomian gland on the conjunctival side of the eyelid (internal).", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006726"}, {"RECTYPE": "D", "MH": "Hormone Antagonists", "DE": "HORMONE ANTAG", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Antagonists, Hormone", "MN": "D27.505.696.399.450", "MH_TH": "POPLINE (1978)", "ST": "T121", "RN": "0", "PI": "Hormones/antagonists & inhibitors (1968-1974)", "MS": "Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D006727"}, {"RECTYPE": "D", "MH": "Hormones", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Receptor Agonists, Hormone", "MN": "D27.505.696.399.472", "FX": "Receptors, Cytoplasmic and Nuclear", "EC": "antagonists & inhibitors:Hormone Antagonists", "MH_TH": "POPLINE (1978)", "ST": "T125", "RN": "0", "AN": "general; prefer specifics; for hormone receptors, see note at RECEPTORS, CELL SURFACE", "MS": "Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.", "MR": "20140617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006728"}, {"RECTYPE": "D", "MH": "Hormones, Ectopic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ectopic Hormone|T125|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Hormone, Ectopic", "MN": "D23.101.140.375", "FX": "Paraneoplastic Endocrine Syndromes", "MH_TH": "NLM (1968)", "ST": "T125", "RN": "0", "AN": "coordinate  IM with specific hormone (IM) + ectopic site (IM) or neoplasm term (IM) if applicable", "MS": "Hormones released from neoplasms or from other cells that are not the usual sources of hormones.", "PM": "68", "HN": "68", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006729"}, {"RECTYPE": "D", "MH": "Hormones, Hormone Substitutes, and Hormone Antagonists", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hormones, Substitutes, Antagonists|T121|NON|EQV|NLM (1998)|961220|abcdef", "MN": "D27.505.696.399", "RH": "D6 - HORMONES, HORMONE SUBSTITUTES, AND HORMONE ANTAGONISTS", "FX": "Endocrine Disruptors", "MH_TH": "NLM (1974)", "ST": "T121", "RN": "0", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "A collective grouping for both naturally occurring and synthetic hormones, substitutes, and antagonists.", "PM": "98", "HN": "98; use explode", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006730"}, {"RECTYPE": "D", "MH": "Horner Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Oculosympathetic Syndrome|T047|NON|EQV|NLM (2000)|991105|abcdef", "ENTRY": "Syndromes, Oculosympathetic", "MN": "C23.888.592.708.362.500", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "A syndrome associated with defective sympathetic innervation to one side of the face, including the eye. Clinical features include MIOSIS; mild BLEPHAROPTOSIS; and hemifacial ANHIDROSIS (decreased sweating)(see HYPOHIDROSIS). Lesions of the BRAIN STEM; cervical SPINAL CORD; first thoracic nerve root; apex of the LUNG; CAROTID ARTERY; CAVERNOUS SINUS; and apex of the ORBIT may cause this condition. (From Miller et al., Clinical Neuro-Ophthalmology, 4th ed, pp500-11)", "PM": "2000; see HORNER'S SYNDROME 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D006732"}, {"RECTYPE": "D", "MH": "Horns", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Horn", "MN": "A13.507", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "animal only: not for cutaneous horn (= SKIN DISEASES or SKIN ABNORMALITIES); horn cancer: coordinate IM with NEOPLASMS /vet (IM) + histological type of neoplasm /vet (IM)", "PI": "specific animal (1966-1967)", "MS": "Either of the pair of hard processes, including ANTLERS, that consist of a BONE core surrounded by a middle KERATIN layer which is in turn covered by EPIDERMIS. They grow from the upper portion of the head of many RUMINANTS.", "PM": "68", "HN": "68", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006733"}, {"RECTYPE": "D", "MH": "Horse Diseases", "DE": "HORSE DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Horse Disease", "MN": "C22.488", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "IM GEN or unspecified; coord IM with specific dis /vet (IM) or specific horse dis (IM); for abnormalities or injuries index under HORSES /abnorm or HORSES /inj; don't forget also HORSES (NIM) & check tag ANIMALS; DF: HORSE DIS", "MS": "Diseases of domestic and wild horses of the species Equus caballus.", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006734"}, {"RECTYPE": "D", "MH": "Horseradish Peroxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peroxidase, Horseradish", "MN": "D08.811.682.732.512", "MH_TH": "NLM (1976)", "ST": "T130", "RN": "EC 1.11.1.-", "AN": "NIM", "PI": "Plants (1972-1975)", "MS": "An enzyme isolated from horseradish which is able to act as an antigen. It is frequently used as a histochemical tracer for light and electron microscopy. Its antigenicity has permitted its use as a combined antigen and marker in experimental immunology.", "PM": "91; was see under PEROXIDASES 1976-90", "HN": "91(76); was see under PEROXIDASES 1976-90", "MR": "20030709", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D006735"}, {"RECTYPE": "D", "MH": "Horses", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Horses, Domestic", "MN": "B01.050.150.900.649.313.984.235.472", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid9796", "RR": "txid9798", "AN": "see X refs at EQUIDAE", "CX": "consider also terms at EQUINE", "MS": "Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006736"}, {"RECTYPE": "D", "MH": "Horseshoe Crabs", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Xiphosura|T204|NON|EQV|UNK (19XX)|770411|abcdef", "ENTRY": "Xiphosuras", "MN": "B01.050.500.131.450", "FX": "Limulus Test", "MH_TH": "NLM (1977)", "ST": "T204", "RN": "txid6845", "RR": "txid6851", "PI": "Crustacea (1966-1976)", "MS": "An arthropod subclass (Xiphosura) comprising the North American (Limulus) and Asiatic (Tachypleus) genera of horseshoe crabs.", "OL": "use HORSESHOE CRABS to search LIMULUS 1977", "PM": "78; was LIMULUS see under ARTHROPODS 1977", "HN": "78; was LIMULUS see under ARTHROPODS 1977", "MR": "20200813", "DA": "19760416", "DC": "1", "DX": "19780101", "UI": "D006737"}, {"RECTYPE": "D", "MH": "Hospices", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Hospice", "MN": "N02.421.143.550", "MH_TH": "BIOETHICS (1989)", "ST": "T093", "AN": "\"palliative & supportive care to the dying patient & his family\"; specify geog", "PI": "Hospitals, Special (1968-Jul 1977)", "MS": "Facilities or services which are especially devoted to providing palliative and supportive care to the patient with a terminal illness and to the patient's family.", "PM": "80; was see under HOSPITALS, SPECIAL 1978-79", "HN": "80(Aug 77); was see under HOSPITALS, SPECIAL Aug 77-79", "MR": "20150629", "DA": "19770512", "DC": "1", "DX": "19800101", "UI": "D006738"}, {"RECTYPE": "D", "MH": "Hospital Administration", "DE": "HOSP ADMIN", "AQ": "CL EC ED ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Organization and Administration, Hospital|T058|NON|BRD|NLM (1992)|910610|ORGAN ADMIN HOSP|abcdefv", "ENTRY": "Administration, Hospital|T058|NON|EQV|UNK (19XX)|770524|ADMIN HOSP|abcdefv", "MN": "N04.452.442.452", "FX": "Professional Staff Committees", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "Management of the internal organization of the hospital.", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006739"}, {"RECTYPE": "D", "MH": "Hospital Administrators", "DE": "HOSP ADMINISTRATORS", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Hospital Administrator|T097|NON|EQV|NLM (1992)|910612|HOSP ADMINISTRATOR|abcdefv", "MN": "N02.360.740.380", "MH_TH": "NLM (1978)", "ST": "T097", "PI": "Hospital Administration (1966-1977)", "MS": "Managerial personnel responsible for implementing policy and directing the activities of hospitals.", "PM": "90; was see under HEALTH FACILITY ADMINISTRATORS 1978-89", "HN": "90(78); was see under HEALTH FACILITY ADMINISTRATORS 1978-89", "MR": "20180629", "DA": "19770505", "DC": "1", "DX": "19900101", "UI": "D006740"}, {"RECTYPE": "D", "MH": "Hospital Auxiliaries", "DE": "HOSP AUXILIARIES", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Hospital Auxiliary|T091|NON|EQV|NLM (1992)|910612|HOSP AUXILIARY|abcdefv", "MN": "N03.540.630.630", "FX": "Hospital Volunteers", "MH_TH": "NLM (1977)", "ST": "T091", "AN": "organizations: do not confuse with HOSPITAL VOLUNTEERS, people", "MS": "Volunteer organizations whose members perform work for the hospital without compensation.", "PM": "91; was see under HOSPITAL VOLUNTEERS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL VOLUNTEERS 1977-90", "MR": "20180629", "DA": "19770505", "DC": "1", "DX": "19910101", "UI": "D006741"}, {"RECTYPE": "D", "MH": "Hospital Bed Capacity", "DE": "HOSP BED CAPAC", "AQ": "EC SN ST", "PRINT ENTRY": "Bed Size, Hospital|T081|NON|EQV|NLM (1992)|910501|BED SIZE HOSP|abcdefv", "ENTRY": "Hospital Bed Capacities", "MN": "N02.278.306.472", "FX": "Bed Occupancy", "MH_TH": "NLM (1975)", "ST": "T081", "AN": "general or unspecified; prefer specific capacity; specify geographic location; do not confuse with BED OCCUPANCY which is for actual number of beds occupied", "PI": "Health Facility Size (1968-1974)", "MS": "The number of beds which a hospital has been designed and constructed to contain. It may also refer to the number of beds set up and staffed for use.", "OL": "search HEALTH FACILITY SIZE 1968-74", "PM": "78; was see under HEALTH FACILITY SIZE 1968-77", "HN": "78(75); was see under HEALTH FACILITY SIZE 1968-77", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D006742"}, {"RECTYPE": "D", "MH": "Hospital Bed Capacity, under 100", "DE": "HOSP BED CAPAC UNDER 100", "DS": "HOSPITAL BED CAPACITY A", "AQ": "EC SN ST", "MN": "N02.278.306.472.080", "MH_TH": "NLM (1980)", "ST": "T081", "AN": "usually NIM", "PI": "Hospital Bed Capacity, 100 to 299 (1978-1979)", "MS": "The number of beds under 100 which a hospital has been designed and constructed to contain. It may also refer to the number of beds set up and staffed for use.", "PM": "91; was see under HOSPITAL BED CAPACITY 1980-90", "HN": "91(80); was see under HOSPITAL BED CAPACITY 1980-90", "MR": "20180313", "DA": "19790411", "DC": "1", "DX": "19910101", "UI": "D006743"}, {"RECTYPE": "D", "MH": "Hospital Bed Capacity, 100 to 299", "DE": "HOSP BED CAPAC 100", "DS": "HOSPITAL BED CAPACITY B", "AQ": "EC SN ST", "MN": "N02.278.306.472.120", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "specify geographic location if pertinent", "PI": "Hospital Bed Capacity (1975-1977)", "OL": "use HOSPITAL BED CAPACITY, 100 TO 299 to search HOSPITAL BED CAPACITY, UNDER 200 1978-79", "PM": "91; was see under HOSPITAL BED CAPACITY 1980-90; was HOSPITAL BED CAPACITY, UNDER 200 see under HOSPITAL BED CAPACITY 1978-79", "HN": "91(80); was see under HOSPITAL BED CAPACITY 1980-90; was HOSPITAL BED CAPACITY, UNDER 200 see under HOSPITAL BED CAPACITY 1978-79", "MR": "19991103", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D006744"}, {"RECTYPE": "D", "MH": "Hospital Bed Capacity, 300 to 499", "DE": "HOSP BED CAPAC 300", "DS": "HOSPITAL BED CAPACITY C", "AQ": "EC SN ST", "MN": "N02.278.306.472.180", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "usually NIM", "PI": "Hospital Bed Capacity (1975-1977)", "MS": "The number of beds from 300 to 499 which a hospital has been designed and constructed to contain. It may also refer to the number of beds set up and staffed for use.", "OL": "use HOSPITAL BED CAPACITY, 300 TO 499 to search HOSPITAL BED CAPACITY, 200 TO 499 1978-79", "PM": "91; was see under HOSPITAL BED CAPACITY 1980-90; was HOSPITAL BED CAPACITY, 200 TO 499 see under HOSPITAL BED CAPACITY 1978-79", "HN": "91(80); was see under HOSPITAL BED CAPACITY 1980-90; was HOSPITAL BED CAPACITY, 200 TO 499 see under HOSPITAL BED CAPACITY 1978-79", "MR": "20180313", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D006745"}, {"RECTYPE": "D", "MH": "Hospital Bed Capacity, 500 and over", "DE": "HOSP BED CAPAC 500", "DS": "HOSPITAL BED CAPACITY D", "AQ": "EC SN ST", "ENTRY": "Hospital Bed Capacity 500 Over|T081|NON|EQV|UNK (19XX)|790405|HOSP BED CAPAC 500 OVER|abcdefv", "MN": "N02.278.306.472.300", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "usually NIM", "PI": "Hospital Bed Capacity (1975-1977)", "MS": "The number of beds 500 or more which a hospital has been designed and constructed to contain. It may also refer to the number of beds set up and staffed for use.", "PM": "91; was see under HOSPITAL BED CAPACITY 1978-90", "HN": "91(78); was see under HOSPITAL BED CAPACITY 1978-90", "MR": "20180313", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D006746"}, {"RECTYPE": "D", "MH": "Hospital Communication Systems", "DE": "HOSP COMMUNICATION SYSTEMS", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Systems, Hospital Communication", "MN": "N04.452.442.452.322", "MH_TH": "NLM (1964)", "ST": "T170", "AN": "communication with staff or patients", "MS": "The transmission of messages to staff and patients within a hospital.", "PM": "73", "HN": "73(64)", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006747"}, {"RECTYPE": "D", "MH": "Hospital Departments", "DE": "HOSP DEP", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Hospital Department", "MN": "N04.452.442.452.422", "MH_TH": "NLM (1968)", "ST": "T093", "AN": "general or unspecified; prefer specifics; for those not precoordinated, coordinate with specialty or service ", "PI": "Hospital Administration (1966-1967)", "MS": "Major administrative divisions of the hospital.", "PM": "68", "HN": "68", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006748"}, {"RECTYPE": "D", "MH": "Hospital Design and Construction", "DE": "HOSP DESIGN CONSTRUCTION", "AQ": "CL EC ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Hospital Renovations|T057|NON|NRW|UNK (1997)|950926|HOSP RENOVATIONS|abcdefv", "ENTRY": "Renovations, Hospital", "MN": "N02.278.200.403", "MH_TH": "NLM (1968)", "ST": "T057", "AN": "differentiate from HOSPITAL PLANNING (develop of plans at a community, state, regional or natl level): HOSPITAL DESIGN AND CONSTRUCTION refers to architecture & decor", "MS": "The architecture, functional design, and construction of hospitals.", "OL": "use HOSPITAL DESIGN AND CONSTRUCTION to search HOSPITAL PLANNING AND CONSTRUCTION 1966-67", "PM": "68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67", "HN": "68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006749"}, {"RECTYPE": "D", "MH": "Hospital Distribution Systems", "DE": "HOSP DISTRIBUTION SYSTEMS", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Systems, Hospital Distribution", "MN": "N04.452.442.452.450", "MH_TH": "NLM (1975)", "ST": "T170", "AN": "within a hosp or between hosps", "MS": "Systems for delivering hospital supplies, food, laundry, etc., to patient care areas.", "PM": "91; was see under HOSPITAL ADMINISTRATION 1975-90", "HN": "91(75); was see under HOSPITAL ADMINISTRATION 1975-90", "MR": "20190709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D006750"}, {"RECTYPE": "D", "MH": "Hospital Information Systems", "DE": "HOSP INFORMATION SYSTEMS", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Multi-Hospital Information Systems|T073|T170|NON|NRW|UNK (19XX)|860617|MULTIHOSPITAL INFORMATION SYSTEMS|abbcdefs", "ENTRY": "Multihospital Information System", "MN": "N04.452.515.360", "MH_TH": "NLM (1987)", "ST": "T170", "MS": "Integrated, computer-assisted systems designed to store, manipulate, and retrieve information concerned with the administrative and clinical aspects of providing medical services within the hospital.", "PM": "87", "HN": "87", "MR": "20190709", "DA": "19860617", "DC": "1", "DX": "19870101", "UI": "D006751"}, {"RECTYPE": "D", "MH": "Hospital Planning", "DE": "HOSP PLANNING", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Regional Hospital Plannings|T058|NON|NRW|UNK (1997)|950926|REGIONAL HOSP PLANNINGS|abcdefv", "ENTRY": "Planning, Regional Hospital", "MN": "N03.349.650.250.200", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "differentiate from HOSPITAL DESIGN AND CONSTRUCTION (architecture & decor): HOSPITAL PLANNING is for develop of plans at a community, state, regional or natl level", "PI": "Hospital Design and Construction (1966-1967)", "MS": "Areawide planning for hospitals or planning of a particular hospital unit on the basis of projected consumer need. This does not include hospital design and construction or architectural plans.", "OL": "search HOSPITAL PLANNING AND CONSTRUCTION under HOSPITAL DESIGN AND CONSTRUCTION 1966-67", "PM": "68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67", "HN": "68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006752"}, {"RECTYPE": "D", "MH": "Hospital Records", "DE": "HOSP RECORDS", "AQ": "CL EC LJ SN ST", "ENTRY": "Record, Hospital", "MN": "N06.850.520.308.940.425", "FX": "Forms and Records Control", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "Compilations of data on hospital activities and programs; excludes patient medical records.", "OL": "use MEDICAL RECORDS to search HOSPITAL RECORDS 1966-74", "PM": "89; was see under RECORDS 1979-88; was see under MEDICAL RECORDS 1963-78", "HN": "89(75); was see under RECORDS 1979-88; was see under MEDICAL RECORDS 1963-78", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19890101", "UI": "D006753"}, {"RECTYPE": "D", "MH": "Hospital Restructuring", "DE": "HOSP RESTRUCTURING", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Hospital Reorganization|T058|NON|EQV|UNK (19XX)|830610|HOSP REORGAN|abcdefv", "ENTRY": "Restructurings, Hospital", "MN": "N04.452.442.452.550", "MH_TH": "NLM (1984)", "ST": "T058", "AN": "restruct the corporate struct", "PI": "Hospital Administration (1966-1983)", "MS": "Reorganization of the hospital corporate structure.", "PM": "91; was see under HOSPITAL ADMINISTRATION 1984-90", "HN": "91(84); was see under HOSPITAL ADMINISTRATION 1984-90", "MR": "20190709", "DA": "19830610", "DC": "1", "DX": "19910101", "UI": "D006754"}, {"RECTYPE": "D", "MH": "Hospital Shared Services", "DE": "HOSP SHARED SERV", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Shared Service, Hospital", "MN": "N04.452.540.308", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "sharing between or among hosp", "PI": "specific department", "MS": "Cooperation among hospitals for the purpose of sharing various departmental services, e.g., pharmacy, laundry, data processing, etc.", "PM": "72", "HN": "72(68)", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006755"}, {"RECTYPE": "D", "MH": "Hospital Shops", "DE": "HOSP SHOPS", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Hospital Gift Shops|T093|NON|NRW|UNK (19XX)|770511|HOSP GIFT SHOPS|abcdefv", "ENTRY": "Shops, Hospital Gift|T093|NON|NRW|NLM (1995)|940527|SHOPS HOSP GIFT|abcdefv", "MN": "N04.452.442.452.585", "MH_TH": "NLM (1977)", "ST": "T093", "AN": "for purchases by visitors, patients or staff", "MS": "Stores located in hospitals selling merchandise or services for the convenience of patients, staff, and visitors.", "PM": "91; was see under HOSPITAL ADMINISTRATION Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL ADMINISTRATION 1977-90", "MR": "20190709", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D006756"}, {"RECTYPE": "D", "MH": "Hospital Units", "DE": "HOSP UNITS", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Units, Hospital", "MN": "N02.278.388", "MH_TH": "NLM (1974)", "ST": "T093", "AN": "special care wards go here or specific unit; consider also PATIENTS' ROOMS & see X refs there", "MS": "Those areas of the hospital organization not considered departments which provide specialized patient care. They include various hospital special care wards.", "OL": "use HOSPITAL UNITS to search WARDS, HOSPITAL 1974-78", "PM": "74", "HN": "74; WARDS, HOSPITAL was see under HOSPITAL UNITS 1974-78", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006757"}, {"RECTYPE": "D", "MH": "Hospital Volunteers", "DE": "HOSP VOLUNTEERS", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Volunteers, Hospital|T097|NON|EQV|NLM (1992)|910612|VOLUNTEERS HOSP|abcdefv", "MN": "N02.360.740.400", "MH_TH": "NLM (1965)", "ST": "T097", "AN": "do not confuse with HOSPITAL AUXILIARIES, volunteer organizations", "MS": "Individuals who donate their services to the hospital.", "PM": "66", "HN": "66(65)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006758"}, {"RECTYPE": "D", "MH": "Hospital-Physician Joint Ventures", "DE": "HOSP PHYSICIAN JOINT VENTURES", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Physician-Hospital Organizations|T093|NON|NRW|NLM (1996)|950314|PHYSICIAN HOSP ORGAN|abcdefv", "ENTRY": "Ventures, Joint", "MN": "N04.452.442.452.550.380", "MH_TH": "NLM (1986)", "ST": "T058", "PI": "Medical Staff, Hospital (1978-1985)", "MS": "A formal financial agreement made between one or more physicians and a hospital to provide ambulatory alternative services to those patients who do not require hospitalization.", "PM": "91; was see under HOSPITAL ADMINISTRATION 1986-90", "HN": "91(86); was see under HOSPITAL ADMINISTRATION 1986-90", "MR": "20190709", "DA": "19850523", "DC": "1", "DX": "19910101", "UI": "D006759"}, {"RECTYPE": "D", "MH": "Hospitalization", "AQ": "EC LJ SN TD", "ENTRY": "Hospitalizations", "MN": "N02.421.585.400", "FX": "Patient Discharge", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "being in a hosp or being placed in a hosp: do not confuse with PATIENT ADMISSION or PATIENT READMISSION", "MS": "The confinement of a patient in a hospital.", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006760"}, {"RECTYPE": "D", "MH": "Hospitals", "DE": "HOSP", "AQ": "CL ES HI SD SN ST TD", "ENTRY": "Hospital", "MN": "N02.278.421", "FX": "Hospital Administration", "EC": "organization & administration:Hospital Administration", "MH_TH": "POPLINE (1978)", "ST": "T093", "MS": "Institutions with an organized medical staff which provide medical care to patients.", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006761"}, {"RECTYPE": "D", "MH": "Hospitals, Animal", "DE": "HOSP ANIMAL", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Veterinary Hospitals|T073|T093|NON|EQV|NLM (1993)|911003|VET HOSP|abbcdefv", "ENTRY": "Veterinary Hospital", "MN": "N06.230.150.360.250.200", "FX": "Practice Management, Veterinary", "MH_TH": "NLM (1974)", "ST": "T093", "AN": "specify geographic location", "MS": "Facility for in-house medical care of animals.", "PM": "74", "HN": "74", "MR": "20171211", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006762"}, {"RECTYPE": "D", "MH": "Hospitals, Chronic Disease", "DE": "HOSP CHRONIC DIS", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Tuberculosis Sanitorias", "MN": "N02.278.421.556.200", "MH_TH": "NLM (1977)", "ST": "T093", "AN": "coordinate IM with hospital ownership term (e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) if pertinent; entry term HOSPITALS, TUBERCULOSIS: coordinate with TUBERCULOSIS; specify geographic location if pertinent", "PI": "Hospitals, Special (1968-1977)", "MS": "Hospitals which provide care to patients with long-term illnesses.", "PM": "91; was see under HOSPITALS, SPECIAL 1977-90", "HN": "91(77); was see under HOSPITALS, SPECIAL 1977-90", "MR": "20130709", "DA": "19760505", "DC": "1", "DX": "19910101", "UI": "D006763"}, {"RECTYPE": "D", "MH": "Hospitals, Community", "DE": "HOSP COMMUNITY", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Hospital, Community", "MN": "N02.278.421.306", "MH_TH": "NLM (1973)", "ST": "T093", "AN": "coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog", "PI": "Hospitals (1966-1972)", "MS": "Institutions with permanent facilities and organized medical staff which provide the full range of hospital services primarily to a neighborhood area.", "PM": "73", "HN": "73", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006764"}, {"RECTYPE": "D", "MH": "Hospitals, Convalescent", "DE": "HOSP CONVALESCENT", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Hospital, Convalescent", "MN": "N02.278.421.556.294", "MH_TH": "NLM (1966)", "ST": "T093", "AN": "coord IM with special hosp or med specialty (IM or NIM) or with hosp ownership term (e.g., HOSPITALS, COUNTY) (IM or NIM) if pertinent; specify geog", "MS": "Hospitals which provide care to the patient for the period following an acute illness until health is restored.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006765"}, {"RECTYPE": "D", "MH": "Hospitals, County", "DE": "HOSP COUNTY", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Hospital, County", "MN": "N02.278.421.510.100", "MH_TH": "NLM (1978)", "ST": "T093", "AN": "coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog", "MS": "Hospitals controlled by the county government.", "PM": "91; was see under HOSPITALS, PUBLIC 1978-90", "HN": "91(78); was see under HOSPITALS, PUBLIC 1978-90", "MR": "19991103", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D006766"}, {"RECTYPE": "D", "MH": "Hospitals, District", "DE": "HOSP DISTRICT", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Hospital, District", "MN": "N02.278.421.510.140", "MH_TH": "NLM (1978)", "ST": "T093", "AN": "coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog", "MS": "Government-controlled hospitals which represent the major health facility for a designated geographic area.", "PM": "91; was see under HOSPITALS, PUBLIC 1978-90", "HN": "91(78); was see under HOSPITALS, PUBLIC 1978-90", "MR": "19991103", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D006767"}, {"RECTYPE": "D", "MH": "Hospitals, Federal", "DE": "HOSP FEDERAL", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Hospital, Federal", "MN": "N02.278.421.510.180", "MH_TH": "NLM (1978)", "ST": "T093", "AN": "US only; add UNITED STATES + state for location if pertinent", "MS": "Hospitals controlled by agencies and departments of the U.S. federal government.", "PM": "91; was see under HOSPITALS, PUBLIC 1978-90", "HN": "91(78); was see under HOSPITALS, PUBLIC 1978-90", "MR": "19920515", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D006768"}, {"RECTYPE": "D", "MH": "Hospitals, General", "DE": "HOSP GENERAL", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Hospital, General", "MN": "N02.278.421.389", "MH_TH": "NLM (1968)", "ST": "T093", "AN": "coord IM with hosp ownership term (e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) if pertinent; specify geog", "PI": "Hospitals (1966-1967)", "MS": "Large hospitals with a resident medical staff which provides continuous care to maternity, surgical and medical patients.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006769"}, {"RECTYPE": "D", "MH": "Hospitals, Group Practice", "DE": "HOSP GROUP PRACTICE", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Practice Hospitals, Group", "MN": "N02.278.421.395", "MH_TH": "NLM (1977)", "ST": "T093", "AN": "coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog", "PI": "Hospitals (1966-Jul 1977)", "MS": "Hospitals organized and controlled by a group of physicians who practice together and provide each other with mutual support.", "PM": "91; was see under HOSPITALS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITALS 1977-90", "MR": "19991103", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D006770"}, {"RECTYPE": "D", "MH": "Hospitals, Maternity", "DE": "HOSP MATERNITY", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Maternity Hospital", "MN": "N02.278.421.556.366", "MH_TH": "NLM (1975)", "ST": "T093", "AN": "coord IM with hosp ownership term (e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) if pertinent; specify geog; check also tags FEMALE & PREGNANCY", "MS": "Special hospitals which provide care to women during pregnancy and parturition.", "OL": "search HOSPITALS, SPECIAL 1968-74", "PM": "91; was see under HOSPITALS, SPECIAL 1975-90", "HN": "91(75); was see under HOSPITALS, SPECIAL 1975-90", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006771"}, {"RECTYPE": "D", "MH": "Hospitals, Military", "DE": "HOSP MILITARY", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospitals, Navy|T073|T093|NON|NRW|UNK (19XX)|770511|HOSP NAVY|abbcdefv", "ENTRY": "Navy Hospital", "MN": "N02.278.421.510.180.250", "MH_TH": "NLM (1978)", "ST": "T093", "AN": "add country of ownership and specify geographic location, if different; for U.S hospitals located within the U.S., index UNITED STATES for ownership plus the state for location if pertinent", "MS": "Hospitals which provide care for the military personnel and usually for their dependents.", "PM": "91; was see under HOSPITALS, PUBLIC 1978-90", "HN": "91(78); was see under HOSPITALS, PUBLIC 1978-90", "MR": "20160608", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D006772"}, {"RECTYPE": "D", "MH": "Hospitals, Municipal", "DE": "HOSP MUNICIPAL", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospitals, City, Public-Owned|T073|T093|NON|EQV|UNK (19XX)|850424|HOSP CITY PUBLIC OWNED|abbcdefv", "ENTRY": "Municipal Hospital", "MN": "N02.278.421.660.400", "MH_TH": "NLM (1978)", "ST": "T093", "AN": "coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify city if in MeSH or state, province or country if city is not in MeSH", "MS": "Hospitals controlled by the city government.", "PM": "91; was see under HOSPITALS, PUBLIC 1978-90", "HN": "91(78); was see under HOSPITALS, PUBLIC 1978-90", "MR": "19920515", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D006773"}, {"RECTYPE": "D", "MH": "Hospitals, Osteopathic", "DE": "HOSP OSTEOPATHIC", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Osteopathic Hospital", "MN": "N02.278.421.556.386", "MH_TH": "NLM (1982)", "ST": "T093", "AN": "coord IM with hosp ownership term (e.g., HOSPITALS, PROPRIETARY) (IM or NIM) if pertinent; specify geog", "PI": "Osteopathic Medicine (1966-1981)", "MS": "Hospitals providing care utilizing the generally accepted medical and surgical methods but with emphasis on the osteopathic system of therapy.", "PM": "91; was see under HOSPITALS, SPECIAL 1982-90", "HN": "91(82); was see under HOSPITALS, SPECIAL 1982-90", "MR": "19991103", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D006774"}, {"RECTYPE": "D", "MH": "Hospitals, Packaged", "DE": "HOSP PACKAGED", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Packaged Hospital", "MN": "E07.325.473", "MH_TH": "NLM (1967)", "ST": "T093", "AN": "packaged for long-term storage toward an emergency; specify geog", "PI": "Hospitals (1966)", "MS": "Hospital equipment and supplies, packaged for long-term storage, sufficient to set up a general hospital in an emergency situation. They are also called Packaged Disaster Hospitals and formerly Civil Defense Emergency Hospitals.", "PM": "91; was see under HOSPITALS 1967-90", "HN": "91(67); was see under HOSPITALS 1967-90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006775"}, {"RECTYPE": "D", "MH": "Hospitals, Pediatric", "DE": "HOSP PEDIATRIC", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Pediatric Hospital", "MN": "N02.278.421.556.437", "MH_TH": "NLM (1975)", "ST": "T093", "AN": "coord IM with hosp ownership term (e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) if pertinent; check also tag CHILD or specific; specify geog", "MS": "Special hospitals which provide care for ill children.", "OL": "search HOSPITALS, SPECIAL 1968-74", "PM": "91; was see under HOSPITALS, SPECIAL 1975-90", "HN": "91(75); was see under HOSPITALS, SPECIAL 1975-90", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006776"}, {"RECTYPE": "D", "MH": "Hospitals, Proprietary", "DE": "HOSP PROPRIETARY", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospitals, Private, for-Profit|T073|T093|NON|EQV|UNK (19XX)|780504|HOSP PRIVATE FOR PROFIT|abbcdefv", "ENTRY": "Proprietary Hospital", "MN": "N02.278.421.481.500", "MH_TH": "NLM (1975)", "ST": "T093", "AN": "privately organized & controlled hosp operated for profit; coord NIM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE) or med specialty (IM or NIM) if pertinent; specify geog", "MS": "Hospitals owned and operated by a corporation or an individual that operate on a for-profit basis, also referred to as investor-owned hospitals.", "PM": "91; was see under HOSPITALS 1975-90", "HN": "91(75); was see under HOSPITALS 1975-90", "MR": "19991103", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D006777"}, {"RECTYPE": "D", "MH": "Hospitals, Psychiatric", "DE": "HOSP PSYCHIATRIC", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Mental Hospitals|T073|T093|NON|EQV|UNK (19XX)|740330|MENTAL HOSP|abbcdefv", "ENTRY": "Psychiatric Hospital", "MN": "N02.278.421.556.508", "MH_TH": "NLM (1966)", "ST": "T093", "AN": "coord IM with hosp ownership term (e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) if pertinent; specify geog", "MS": "Special hospitals which provide care to the mentally ill patient.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006778"}, {"RECTYPE": "D", "MH": "Hospitals, Public", "DE": "HOSP PUBLIC", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Public Hospital", "MN": "N02.278.421.510", "MH_TH": "NLM (1978)", "ST": "T093", "AN": "government-owned; coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog", "MS": "Hospitals controlled by various types of government, i.e., city, county, district, state or federal.", "PM": "78", "HN": "78", "MR": "20000622", "DA": "19770511", "DC": "1", "DX": "19780101", "UI": "D006779"}, {"RECTYPE": "D", "MH": "Hospitals, Rural", "DE": "HOSP RURAL", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Rural Hospitals|T093|NON|EQV|UNK (19XX)|850523|RURAL HOSP|abcdefv", "ENTRY": "Rural Hospital", "MN": "N02.278.421.518", "MH_TH": "NLM (1986)", "ST": "T093", "AN": "coord IM with special hosp or med specialty (IM or NIM) if pertinent; specify geog", "PI": "Rural Population (1968-1985)", "MS": "Hospitals located in a rural area.", "PM": "91; was see under HOSPITALS 1986-90", "HN": "91(86); was see under HOSPITALS 1986-90", "MR": "19991103", "DA": "19850523", "DC": "1", "DX": "19910101", "UI": "D006780"}, {"RECTYPE": "D", "MH": "Hospitals, Satellite", "DE": "HOSP SATELLITE", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospitals, Branch|T093|NON|EQV|UNK (19XX)|770511|HOSP BRANCH|abcdefv", "ENTRY": "Satellite Hospital", "MN": "N02.278.421.530", "MH_TH": "NLM (1977)", "ST": "T093", "AN": "extensions of a main hosp & admin by it; coord IM with hosp ownership term (e.g., HOSPITALS, FEDERAL; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) or specialty hosp or med specialty (IM or NIM) if relevant; specify geog", "MS": "Those hospitals which are extensions of a main hospital and are wholly or partly administered by that hospital.", "PM": "91; was see under HOSPITALS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITALS 1977-90", "MR": "19991103", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D006781"}, {"RECTYPE": "D", "MH": "Hospitals, Special", "DE": "HOSP SPECIAL", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Special Hospitals", "MN": "N02.278.421.556", "FX": "Tertiary Care Centers", "EC": "veterinary:Hospitals, Animal", "MH_TH": "NLM (1968)", "ST": "T093", "AN": "coordinate IM with medical specialty & hospital ownership term (e.g., HOSPITALS, COUNTY) (IM or NIM) if pertinent; specify geographic location if pertinent; sanatoria & sanitaria (often used interchangeably) can go here but consider also HEALTH RESORTS; note SANITARIA, TUBERCULOSIS see HOSPITALS, CHRONIC DISEASE is available", "PI": "Hospitals (1966-1967)", "MS": "Hospitals which provide care for a single category of illness with facilities and staff directed toward a specific service.", "PM": "68", "HN": "68", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006782"}, {"RECTYPE": "D", "MH": "Hospitals, State", "DE": "HOSP STATE", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "State Hospital", "MN": "N02.278.421.510.300", "MH_TH": "NLM (1978)", "ST": "T093", "AN": "coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify state if US, province if Canada, or other country", "MS": "Hospitals controlled by agencies and departments of the state government.", "PM": "91; was see under HOSPITALS, PUBLIC 1978-90", "HN": "91(78); was see under HOSPITALS, PUBLIC 1978-90", "MR": "19960610", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D006783"}, {"RECTYPE": "D", "MH": "Hospitals, Teaching", "DE": "HOSP TEACHING", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Teaching Hospitals", "MN": "N02.278.421.639", "MH_TH": "NLM (1968)", "ST": "T093", "AN": "coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog; consider also INTERNSHIP AND RESIDENCY", "PI": "Hospitals (1966-1967)", "MS": "Hospitals engaged in educational and research programs, as well as providing medical care to the patients.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006784"}, {"RECTYPE": "D", "MH": "Hospitals, University", "DE": "HOSP UNIV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "University Hospitals|T073|T093|NON|EQV|UNK (19XX)|770928|UNIV HOSP|abbcdefv", "MN": "N02.278.421.639.725", "MH_TH": "NLM (1975)", "ST": "T093", "AN": "coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog; DF: HOSP UNIV", "MS": "Hospitals maintained by a university for the teaching of medical students, postgraduate training programs, and clinical research.", "OL": "use HOSPITALS, UNIVERSITY to search UNIVERSITY HOSPITALS 1975-77; use HOSPITALS, TEACHING 1968-74", "PM": "91; was see under HOSPITALS, TEACHING 1978-90; was UNIVERSITY HOSPITALS see under HOSPITALS, TEACHING 1968-77", "HN": "91(78); was see under HOSPITALS, TEACHING 1978-90; was UNIVERSITY HOSPITALS see under HOSPITALS, TEACHING 1968-77", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006785"}, {"RECTYPE": "D", "MH": "Hospitals, Urban", "DE": "HOSP URBAN", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Urban Hospitals|T093|NON|EQV|UNK (19XX)|850523|URBAN HOSP|abcdefv", "ENTRY": "Urban Hospital", "MN": "N02.278.421.660", "MH_TH": "NLM (1986)", "ST": "T093", "AN": "coord IM with special hosp or med specialty (IM or NIM) if pertinent; specify geog", "PI": "Urban Population (1968-1985)", "MS": "Hospitals located in metropolitan areas.", "PM": "91; was see under HOSPITALS 1986-90", "HN": "91(86); was see under HOSPITALS 1986-90", "MR": "19991108", "DA": "19850523", "DC": "1", "DX": "19910101", "UI": "D006786"}, {"RECTYPE": "D", "MH": "Hospitals, Veterans", "DE": "HOSP VETERANS", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Veterans Hospitals|T073|T093|NON|EQV|UNK (19XX)|800513|VETERANS HOSP|abbcdefv", "ENTRY": "Veterans Hospital", "MN": "N02.278.421.510.180.400", "MH_TH": "NLM (1966)", "ST": "T093", "AN": "coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, PSYCHIATRIC; etc.) or med specialty (IM or NIM) if pertinent; specify geog", "MS": "Hospitals providing medical care to veterans of wars.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006787"}, {"RECTYPE": "D", "MH": "Hospitals, Voluntary", "DE": "HOSP VOLUNTARY", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospitals, Private, Not-for-Profit|T093|NON|EQV|NLM (1991)|900430|HOSP PRIVATE NOT FOR PROFIT|abcdefv", "ENTRY": "Voluntary Hospital", "MN": "N02.278.421.481.800", "MH_TH": "NLM (1979)", "ST": "T093", "AN": "coord NIM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE) or med specialty (IM or NIM) if pertinent; specify geog", "MS": "Private, not-for-profit hospitals that are autonomous, self-established, and self-supported.", "PM": "91; was see under HOSPITALS 1979-90", "HN": "91(79); was see under HOSPITALS 1979-90", "MR": "19991103", "DA": "19780504", "DC": "1", "DX": "19910101", "UI": "D006788"}, {"RECTYPE": "D", "MH": "Host vs Graft Reaction", "AQ": "DE GE IM PH RE", "MN": "G12.875.545", "MH_TH": "NLM (1977)", "ST": "T046", "AN": "do not confuse with GRAFT VS HOST REACTION (Cat G) nor GRAFT VS HOST DISEASE (Cat C)", "PI": "Transplantation Immunology (1966-1972)", "MS": "The immune responses of a host to a graft. A specific response is GRAFT REJECTION.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D006789"}, {"RECTYPE": "D", "MH": "Host-Parasite Interactions", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Parasite-Host Relations|T070|NON|EQV|UNK (19XX)|781221|PARASITE HOST RELAT|abcdefv", "ENTRY": "Relationships, Host-Parasite", "MN": "G16.527.200.400", "MH_TH": "NLM (2008)", "ST": "T070", "AN": "coordinate with host /parasitol + parasite /physiol or other more specific qualifier; HOST-PATHOGEN INTERACTIONS is also available", "PI": "specific host, organ, disease/parasitology (1975-1979)", "MS": "The relationship between an invertebrate and another organism (the host), one of which lives at the expense of the other. Traditionally excluded from definition of parasites are pathogenic BACTERIA; FUNGI; VIRUSES; and PLANTS; though they may live parasitically.", "PM": "2008; see HOST-PARASITE RELATIONS 1980-2007", "HN": "2008 (1980)", "CATSH": "CAT LIST", "MR": "20171214", "DA": "19781221", "DC": "1", "DX": "19800101", "UI": "D006790"}, {"RECTYPE": "D", "MH": "Hostility", "ENTRY": "Hostilities", "MN": "F01.470.596", "MH_TH": "NLM (1968)", "ST": "T041", "PI": "Hate (1966-1967)", "MS": "Tendency to feel anger toward and to seek to inflict harm upon a person or group.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19890428", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006791"}, {"RECTYPE": "D", "MH": "House Calls", "AQ": "EC SN TD", "ENTRY": "Visits, Home", "MN": "N04.452.758.307", "MH_TH": "NLM (1968)", "ST": "T058", "MS": "Visits to the patient's home by professional personnel for the purpose of diagnosis and/or treatment.", "PM": "68", "HN": "68", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006792"}, {"RECTYPE": "D", "MH": "Houseflies", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Musca domestica|T204|NON|EQV|UNK (19XX)|800519|abcdef", "ENTRY": "domesticas, Musca", "MN": "B01.050.500.131.617.720.500.500.750.642.470", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid7370", "AN": "/microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111; note entry term MUSCA DOMESTICA but other Musca species and genera of family Muscidae go under MUSCIDAE", "MS": "Flies of the species Musca domestica (family MUSCIDAE), which infest human habitations throughout the world and often act as carriers of pathogenic organisms.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006793"}, {"RECTYPE": "D", "MH": "Household Articles", "AQ": "CL EC ES HI IS LJ SN ST", "PRINT ENTRY": "Household Equipment|T073|NON|BRD|UNK (19XX)|750711|abcdef", "ENTRY": "Household Article", "MN": "J01.494", "MH_TH": "NLM (1976)", "ST": "T073", "AN": "various household items & appliances; do not confuse with HOUSEHOLD PRODUCTS (substances & material used in \"housekeeping or personal routine\"); BEDDING AND LINENS & COOKING AND EATING UTENSILS are also available; does not include furniture (FURNITURE see INTERIOR DESIGN AND FURNISHINGS) or furnishings (INTERIOR FURNISHINGS see INTERIOR DESIGN AND FURNISHINGS)", "MS": "Various material objects and items in the home. It includes temporary or permanent machinery and appliances. It does not include furniture or interior furnishings (FURNITURE see INTERIOR DESIGN AND FURNISHINGS; INTERIOR FURNISHINGS see INTERIOR DESIGN AND FURNISHINGS).", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20180629", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D006794"}, {"RECTYPE": "D", "MH": "Household Products", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Household Supplies|T073|NON|EQV|UNK (19XX)|750619|abcdef", "ENTRY": "Supplies, Household", "MN": "J01.516", "MH_TH": "NLM (1975)", "ST": "T073", "AN": "these are consumable (like housecleaning products): differentiate from HOUSEHOLD ARTICLES, more or less permanent (like rugs)", "MS": "Substances or materials used in the course of HOUSEHOLD WORK or personal routine.", "PM": "75", "HN": "75", "MR": "20210712", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D006795"}, {"RECTYPE": "D", "MH": "Household Work", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Housekeeping|T057|NON|EQV|NLM (1973)|990101|abcdef", "ENTRY": "Works, Household", "MN": "N02.508", "MH_TH": "NLM (2022)", "ST": "T057", "AN": "not restricted to domestic housekeeping; HOUSEKEEPING, HOSPITAL is also available", "MS": "Household work including physical, emotional, and spiritual integrating household work with care work whether on a paid or unpaid basis.", "PM": "73", "HN": "73", "MR": "20210706", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006796"}, {"RECTYPE": "D", "MH": "Housekeeping, Hospital", "DE": "HOUSEKEEPING HOSP", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Hospital Housekeeping|T058|NON|EQV|UNK (19XX)|770519|HOSP HOUSEKEEPING|abcdefv", "ENTRY": "Housekeepings, Hospital", "MN": "N04.452.442.452.422.412", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "Hospital department which manages and provides the required housekeeping functions in all areas of the hospital.", "OL": "use HOUSEKEEPING, HOSPITAL to search HOSPITAL HOUSEKEEPING 1966-77", "PM": "78; was HOSPITAL HOUSEKEEPING 1963-77", "HN": "78; was HOSPITAL HOUSEKEEPING 1963-77", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D006797"}, {"RECTYPE": "D", "MH": "Housing", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Patient-Family Lodging|T073|NON|NRW|UNK (19XX)|820426|abcdef", "ENTRY": "Patient-Family Lodgings", "MN": "N06.850.505.400.800.400", "FX": "Housing Quality", "MH_TH": "POPLINE (1978)", "ST": "T073", "AN": "for persons; for animals use HOUSING, ANIMAL", "MS": "Living facilities for humans.", "MR": "20210705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006798"}, {"RECTYPE": "D", "MH": "Housing, Animal", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Animal Housing", "MN": "N06.230.150.360.250", "MH_TH": "NLM (1972)", "ST": "T073", "PI": "Housing (1966-1971)", "MS": "The physical environment in which animals are maintained.", "PM": "72", "HN": "72", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006799"}, {"RECTYPE": "D", "MH": "Deltaretrovirus Infections", "DE": "DELTARETROVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "HTLV-BLV Infections|T047|ACX|EQV|NLM (1987)|990101|HTLV BLV INFECT|abcdefv", "ENTRY": "Infections, Deltaretrovirus", "MN": "C20.673.483", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "general or unspecified; prefer specifics; do not confuse entry term BLV INFECTIONS with ENZOOTIC BOVINE LEUKOSIS ", "PI": "Retrovirus Infections (1981-1986)", "MS": "Infections caused by the HTLV or BLV deltaretroviruses. They include human T-cell leukemia-lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED).", "PM": "2002; see HTLV-BLV INFECTIONS 1995-2001, see HTLV INFECTIONS 1987-1994", "HN": "2002 (1987)", "CATSH": "CAT LIST", "MR": "20190529", "DA": "19860617", "DC": "1", "DX": "19870101", "UI": "D006800"}, {"RECTYPE": "D", "MH": "Humans", "PRINT ENTRY": "Man (Taxonomy)|T016|T098|NON|EQV|NLM (1998)|960724|MAN|abbcdefs", "ENTRY": "Modern Man", "MN": "B01.050.150.900.649.313.988.400.112.400.400", "FX": "Human Development", "MH_TH": "NLM (2005)", "ST": "T098", "RN": "txid9606", "AN": "NIM as check tag only; ; Homo species other than Homo sapiens are indexed HOMO see HOMINIDAE, but note NEANDERTHALS is  available  ", "MS": "Members of the species Homo sapiens.", "PM": "2005; for HOMO SAPIENS see HOMINIDAE 1989-2004; for MAN (TAXONOMY) see HOMINIDAE 1998-2004", "HN": "2005 (1966); was check tag only (not a descriptor) 1966-2004; for HOMO SAPIENS use HOMINIDAE 1989-2004; for MAN (TAXONOMY) use HOMINIDAE 1998-2004", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D006801"}, {"RECTYPE": "D", "MH": "Human Activities", "AQ": "CL EC ED ES HI IN LJ PX SN ST TD", "ENTRY": "Human Activity", "MN": "I03", "RH": "I3 - HUMAN ACTIVITIES", "MH_TH": "NLM (1974)", "ST": "T052", "AN": "general or unspecified; prefer specifics", "MS": "Activities performed by humans.", "PM": "98", "HN": "98; use explode 1975-97", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006802"}, {"RECTYPE": "D", "MH": "Human Development", "AQ": "CL DE PH RE", "ENTRY": "Development, Human", "MN": "G07.345.374", "FX": "Psychology, Developmental", "MH_TH": "NLM (1978)", "ST": "T041", "MS": "Continuous sequential changes which occur in the physiological and psychological functions during the life-time of an individual.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D006803"}, {"RECTYPE": "D", "MH": "Ergonomics", "AQ": "CL EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Human Engineering|T090|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Visual Ergonomic", "MN": "J01.293.556", "FX": "Psychology, Industrial", "MH_TH": "NLM (2018)", "ST": "T090", "AN": "index \"medical ergonomics\" here but do not coordinate with MEDICINE", "MS": "The science of designing, building or equipping mechanical devices or artificial environments to the anthropometric, physiological, or psychological requirements of the people who will use them.", "OL": "2018; see HUMAN ENGINEERING 1966-2017; use HUMAN ENGINEERING to search ENGINEERING PSYCHOLOGY 1969-78", "PM": "2018; use HUMAN ENGINEERING 1966-2017; use HUMAN ENGINEERING to search ENGINEERING PSYCHOLOGY 1969-78", "HN": "2018; use HUMAN ENGINEERING 1966-2017; use HUMAN ENGINEERING to search ENGINEERING PSYCHOLOGY 1969-78", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006804"}, {"RECTYPE": "D", "MH": "Human Experimentation", "AQ": "ES HI LJ SN ST", "ENTRY": "Experimentation, Human", "MN": "H01.770.644.145.365", "FX": "Research Subjects", "MH_TH": "BIOETHICS (1989)", "ST": "T062", "AN": "IM for moral, legal, ethical, sociologic, religious aspect of experiments on humans; coordinate IM with aspect (IM); do not routinely add for research involving human disease, therapy or physiology", "MS": "The use of humans as investigational subjects.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006805"}, {"RECTYPE": "D", "MH": "Human Rights", "AQ": "CL ES HI LJ MT SN ST TD", "PRINT ENTRY": "Rights of Indigenous Peoples|T064|NON|NRW|NLM (2020)|181218|abcdef", "ENTRY": "Rights, Linguistic", "MN": "N03.706.437", "FX": "Women's Rights", "MH_TH": "BIOETHICS (1974)", "ST": "T064", "PI": "Civil Rights (1968-1972)", "MS": "The right of the individual to cultural, social, economic, and educational opportunities as provided by society, e.g., right to work, right to education, and right to social security.", "PM": "73", "HN": "73", "MR": "20200618", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006806"}, {"RECTYPE": "D", "MH": "Humanism", "AQ": "HI", "MN": "N05.350.835", "MH_TH": "BIOETHICS (1989)", "ST": "T078", "PI": "Philosophy, Medical (1966-1977)", "MS": "An ethical system which emphasizes human values and the personal worth of each individual, as well as concern for the dignity and freedom of humankind.", "PM": "78", "HN": "78", "MR": "20150622", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D006808"}, {"RECTYPE": "D", "MH": "Humanities", "AQ": "CL ED ES HI PX SN TD", "MN": "K01", "RH": "K1 - HUMANITIES-ART, HISTORY, PHILOSOPHY AND RELIGIONS", "MH_TH": "BIOETHICS (1989)", "ST": "T090", "MS": "Fields of inquiry in human constructs and concerns as opposed to natural processes and social relations. These are traditionally the study of literature, philosophy, and religion.", "MR": "20171211", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006809"}, {"RECTYPE": "D", "MH": "Humeral Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Humerus Fractures|T037|NON|EQV|NLM (2023)|210929|abcdef", "ENTRY": "Humerus Fracture", "MN": "C26.404.500", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "HUMERAL FRACTURES, PROXIMAL see SHOULDER FRACTURES is also available and includes fractures of the HUMERAL HEAD, neck & tuberosities", "MS": "Fractures of the HUMERUS.", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006810"}, {"RECTYPE": "D", "MH": "Humerus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Humeri|T023|NON|EQV|NLM (2023)|210929|abcdef", "ENTRY": "Tubercles, Greater", "MN": "A02.835.232.087.090.400", "FX": "Olecranon Process", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Bone in humans and primates extending from the SHOULDER JOINT to the ELBOW JOINT.", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006811"}, {"RECTYPE": "D", "MH": "Humic Substances", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Humic Substance|T123|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Substances, Humic", "MN": "D20.721.500", "PA": "Chelating Agents", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "RR": "1415-93-6", "MS": "Organic matter in a state of advanced decay, after passing through the stages of COMPOST and PEAT and before becoming lignite (COAL). It is composed of a heterogenous mixture of compounds including phenolic radicals and acids that polymerize and are not easily separated nor analyzed. (E.A. Ghabbour & G. Davies, eds. Humic Substances, 2001).", "PM": "2005; see HUMIC ACIDS 1963-2004", "HN": "2005(1963)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D006812"}, {"RECTYPE": "D", "MH": "Humidity", "AQ": "AE PC ST", "ENTRY": "Humidities", "MN": "N06.230.300.100.725.310", "MH_TH": "NLM (1966)", "ST": "T070", "MS": "A measure of the amount of WATER VAPOR in the air.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006813"}, {"RECTYPE": "D", "MH": "Hungary", "AQ": "EH EP", "MN": "Z01.542.248.495", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in Europe, northwest of Romania, south of Slovakia, and east of Austria. The capital is Budapest.", "MR": "20161222", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D006814"}, {"RECTYPE": "D", "MH": "Hunger", "AQ": "CL DE EH PH RE", "MN": "G10.261.390", "MH_TH": "NLM (1966)", "ST": "T039", "MS": "The desire for FOOD generated by a sensation arising from the lack of food in the STOMACH.", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006815"}, {"RECTYPE": "D", "MH": "Huntington Disease", "DE": "HUNTINGTON DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Juvenile Huntington Disease|T047|EPO|NRW|NLM (2000)|991103|JUVENILE HUNTINGTON DIS|abcdefv", "ENTRY": "Late Onset Huntington Disease", "MN": "F03.615.400.390", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)", "PM": "2000; see HUNTINGTON'S DISEASE 1993-1999; for HUNTINGTON DISEASE see HUNTINGTON'S DISEASE 1993-1999, see HUNTINGTON CHOREA 1977-1992, see CHOREA, HEREDITARY 1963-1976", "HN": "2000(1963)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D006816"}, {"RECTYPE": "D", "MH": "Hyalin", "AQ": "CH CY DE DG EN IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Hyalin Substance|T031|NON|EQV|NLM (1996)|940906|abcdef", "ENTRY": "Substance, Hyaline", "MN": "A12.580", "MH_TH": "NLM (1965)", "ST": "T031", "MS": "A clear, homogenous, structureless, eosinophilic substance occurring in pathological degeneration of tissues.", "PM": "96; was HYALIN SUBSTANCE 1965-95", "HN": "96; was HYALIN SUBSTANCE 1965-95", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006818"}, {"RECTYPE": "D", "MH": "Hyaline Membrane Disease", "DE": "HYALINE MEMBRANE DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyaline Membrane Diseases", "MN": "C16.614.521.563.475", "FX": "Hyaline Fibromatosis Syndrome", "MH_TH": "ORD (2010)", "ST": "T019", "AN": "do not confuse with INFANTILE SYSTEMIC HYALINOSIS see HYALINE FIBROMATOSIS SYNDROME", "MS": "A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).", "CATSH": "CAT LIST", "MR": "20230727", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006819"}, {"RECTYPE": "D", "MH": "Hyaluronic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Vitrax, Amo", "MN": "D09.698.373.475", "PA": "Viscosupplements", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Hyaluronic acid", "RN": "9004-61-9", "RR": "9067-32-7", "MS": "A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA.", "PM": "2002; for BIOLON see POLYMETHYL METHACRYLATE 1977-2001", "HN": "2002; for BIOLON use POLYMETHYL METHACRYLATE 1977-2001", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D006820"}, {"RECTYPE": "D", "MH": "Hyaluronoglucosaminidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hyaluronidase|T116|T121|T126|NON|EQV|NLM (1998)|961212|abbbcdef", "ENTRY": "Permeability Factor, Duran-Reynals", "MN": "D08.811.520.241.700.675", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Hyaluronate 4-glycanohydrolase", "RN": "EC 3.2.1.35", "MS": "An enzyme that catalyzes the random hydrolysis of 1,4-linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate. (From Enzyme Nomenclature, 1992) There has been use as ANTINEOPLASTIC AGENTS to limit NEOPLASM METASTASIS.", "PM": "98; see HYALURONIDASE 1963-97", "HN": "98(63)", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006821"}, {"RECTYPE": "D", "MH": "Hybrid Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Somatic Cell Hybrids|T025|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Somatic Cell Hybrid", "MN": "A11.251.600", "MH_TH": "NLM (1972)", "ST": "T025", "AN": "not for micro-organisms", "PI": "Tissue Culture (1966-1971)", "MS": "Any cell, other than a ZYGOTE, that contains elements (such as NUCLEI and CYTOPLASM) from two or more different cells, usually produced by artificial CELL FUSION.", "PM": "72", "HN": "72", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006822"}, {"RECTYPE": "D", "MH": "Hybrid Vigor", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Heterosis|T081|NON|EQV|NLM (1993)|911030|abcdef", "ENTRY": "Vigor, Hybrid", "MN": "G05.400", "FX": "Hybridization, Genetic", "MH_TH": "NLM (1968)", "ST": "T081", "PI": "Hybridization (1966-1967)", "MS": "The adaptive superiority of the heterozygous GENOTYPE with respect to one or more characters in comparison with the corresponding HOMOZYGOTE.", "PM": "91; was see under HYBRIDIZATION 1968-90", "HN": "91(68); was see under HYBRIDIZATION 1968-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006823"}, {"RECTYPE": "D", "MH": "Hybridization, Genetic", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Crossbreeding|T045|NON|EQV|NLM (2003)|020614|abcdef", "ENTRY": "Intraspecies Hybridizations", "MN": "G05.090.390", "FX": "Hybrid Vigor", "MH_TH": "NLM (2003)", "ST": "T045", "AN": "NUCLEIC ACID HYBRIDIZATION is also available", "MS": "The genetic process of crossbreeding between genetically dissimilar parents to produce a hybrid.", "PM": "2003; HYBRIDIZATION was heading 1966-2002", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006824"}, {"RECTYPE": "D", "MH": "Hybridomas", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Hybridoma|T025|NON|EQV|UNK (19XX)|810608|abcdef", "MN": "A11.251.600.485", "FX": "Antibodies, Monoclonal", "MH_TH": "NLM (1982)", "ST": "T025", "AN": "note category: not a tumor ", "PI": "Hybrid Cells (1975-1981)", "MS": "Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell.", "PM": "82", "HN": "82", "MR": "20100625", "DA": "19810520", "DC": "1", "DX": "19820101", "UI": "D006825"}, {"RECTYPE": "D", "MH": "Hycanthone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.953.704.450", "PA": "Schistosomicides", "MH_TH": "USAN (1966)", "ST": "T121", "N1": "9H-Thioxanthen-9-one, 1-((2-(diethylamino)ethyl)amino)-4-(hydroxymethyl)-", "RN": "2BXX5EVN2A", "RR": "3105-97-3 (Hycanthone)", "PI": "Thioxanthenes (1974)", "MS": "Potentially toxic, but effective antischistosomal agent, it is a metabolite of LUCANTHONE.", "PM": "91; was see under THIOXANTHENES 1975-90", "HN": "91(75); was see under THIOXANTHENES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006826"}, {"RECTYPE": "D", "MH": "Hydantoins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydantoin|T109|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Imidazolidine 2,4 Diones", "MN": "D03.383.129.308.432.555", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds based on imidazolidine dione. Some derivatives are ANTICONVULSANTS.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006827"}, {"RECTYPE": "D", "MH": "Hydatidiform Mole", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pregnancy, Molar|T191|NON|EQV|NLM (1998)|960730|PREGN MOLAR|abcdefv", "ENTRY": "Pregnancies, Molar", "MN": "C12.050.703.720.949.416.875", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "do not confuse with HYDATID CYST see ECHINOCOCCOSIS or specifics; coord IM with UTERINE NEOPLASMS (IM); check the tags FEMALE and PREGNANCY", "MS": "Trophoblastic hyperplasia associated with normal gestation, or molar pregnancy. It is characterized by the swelling of the CHORIONIC VILLI and elevated human CHORIONIC GONADOTROPIN. Hydatidiform moles or molar pregnancy may be categorized as complete or partial based on their gross morphology, histopathology, and karyotype.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006828"}, {"RECTYPE": "D", "MH": "Hydra", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Hydras", "MN": "B01.050.500.308.485.400", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid6083", "PI": "Coelenterata (1966-1971)", "MS": "A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006829"}, {"RECTYPE": "D", "MH": "Hydralazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydrallazin|T109|T121|NON|EQV|UNK (19XX)|770111|abbcdef", "ENTRY": "mono-Hydrochloride, Hydralazine", "MN": "D03.383.710.605.500", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1(2H)-Phthalazinone, hydrazone", "RN": "26NAK24LS8", "RR": "FD171B778Y", "MS": "A direct-acting vasodilator that is used as an antihypertensive agent.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006830"}, {"RECTYPE": "D", "MH": "Polyhydramnios", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hydramnios|T046|NON|EQV|NLM (1991)|891221|abcdef", "MN": "C12.050.703.610", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "A condition of abnormally high AMNIOTIC FLUID volume, such as greater than 2,000 ml in the LAST TRIMESTER and usually diagnosed by ultrasonographic criteria (AMNIOTIC FLUID INDEX). It is associated with maternal DIABETES MELLITUS; MULTIPLE PREGNANCY; CHROMOSOMAL DISORDERS; and congenital abnormalities.", "OL": "use POLYHYDRAMNIOS to search HYDRAMNIOS 1966-90", "PM": "91; was HYDRAMNIOS 1963-90", "HN": "91; was HYDRAMNIOS 1963-90", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006831"}, {"RECTYPE": "D", "MH": "Hydranencephaly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemihydranencephaly|T019|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Hydranencephalies", "MN": "C16.131.666.450", "MH_TH": "NLM (1964)", "ST": "T019", "MS": "A congenital condition where the greater portions of the cerebral hemispheres and CORPUS STRIATUM are replaced by CSF and glial tissue. The meninges and the skull are well formed, which is consistent with earlier normal embryogenesis of the telencephalon. Bilateral occlusions of the internal carotid arteries in utero is a potential mechanism. Clinical features include intact brainstem reflexes without evidence of higher cortical activity. (Menkes, Textbook of Child Neurology, 5th ed, p307)", "PM": "91; was see under ANENCEPHALY 1979-90; was see under ANENCEPHALUS 1967-78", "HN": "91(64); was see under ANENCEPHALY 1979-90; was see under ANENCEPHALUS 1967-78", "CATSH": "CAT LIST", "MR": "20050730", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006832"}, {"RECTYPE": "D", "MH": "Hydrarthrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hydrarthroses", "MN": "C05.550.509", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "fluid in a joint cavity", "MS": "Accumulation of watery fluid in the cavity of a joint. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006833"}, {"RECTYPE": "D", "MH": "Hydrazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydrazide|T109|NON|NRW|NLM (2022)|210518|abcdef", "MN": "D02.442", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with HYDRAZONES", "MS": "Substituted derivatives of hydrazine (formula H2N-NH2).", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006834"}, {"RECTYPE": "D", "MH": "Hydrazones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydrazone|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D02.442.288", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "AN": "do not confuse with HYDRAZINES", "PI": "specific hydrazine (1966-1971)", "MS": "Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "74", "HN": "74(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006835"}, {"RECTYPE": "D", "MH": "Hydro-Lyases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hydro-Lyase|T116|T126|NON|EQV|NLM (2021)|200211|abbcdef", "ENTRY": "Lyases, Hydro", "MN": "D08.811.520.241.300", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 4.2.1.-", "AN": "do not confuse with HYDROLASES", "MS": "Enzymes that catalyze the breakage of a carbon-oxygen bond leading to unsaturated products via the removal of water. EC 4.2.1.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006836"}, {"RECTYPE": "D", "MH": "Hydroa Vacciniforme", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.865.575", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a vesiculobullous skin dis on sun-exposed skin", "MS": "A vesicular and bullous eruption having a tendency to recur in summer during childhood and commonly appearing on sun-exposed skin. The lesions are surrounded by an erythematous zone and resemble a vaccination. (From Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006837"}, {"RECTYPE": "D", "MH": "Hydrocarbons", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Unsaturated Hydrocarbons|T109|NON|NRW|NLM (2020)|190124|abcdef", "ENTRY": "Hydrocarbons, Unsaturated", "MN": "D02.455", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specific hydrocarbon groups or specific hydrocarbons; POLYCYCLIC HYDROCARBONS see HYDROCARBONS, CYCLIC is also available", "MS": "Organic compounds that primarily contain carbon and hydrogen atoms with the carbon atoms forming a linear or circular structure.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006838"}, {"RECTYPE": "D", "MH": "Hydrocarbons, Acyclic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acyclic Hydrocarbons|T109|NON|EQV|NLM (1998)|970314|abcdef", "MN": "D02.455.326", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics; used for mapping supplementary chemicals; do not confuse with HYDROCARBONS, ALICYCLIC", "MS": "Organic compounds composed exclusively of carbon and hydrogen where no carbon atoms join to form a ring structure.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006839"}, {"RECTYPE": "D", "MH": "Hydrocarbons, Alicyclic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alicyclic Hydrocarbons|T109|NON|EQV|NLM (1998)|970314|abcdef", "MN": "D02.455.426.392", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics; used for mapping supplementary chemicals; do not confuse with HYDROCARBONS, ACYCLIC", "MS": "Organic compounds composed exclusively of carbon and hydrogen. Three or more carbon atoms are arranged in a cyclic structure and they possess aliphatic properties.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006840"}, {"RECTYPE": "D", "MH": "Hydrocarbons, Aromatic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aromatic Hydrocarbons|T109|NON|EQV|NLM (1998)|970314|abcdef", "ENTRY": "Hydrocarbon, Aromatic", "MN": "D02.455.426.559", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Organic compounds containing carbon and hydrogen in the form of an unsaturated, usually hexagonal ring structure. The compounds can be single ring, or double, triple, or multiple fused rings.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006841"}, {"RECTYPE": "D", "MH": "Hydrocarbons, Brominated", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Brominated Hydrocarbons|T109|NON|EQV|UNK (19XX)|760317|abcdef", "MN": "D02.455.526.368", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Hydrocarbon compounds with one or more HYDROGEN atoms substituted with BROMINE.", "PM": "74", "HN": "74", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006842"}, {"RECTYPE": "D", "MH": "Hydrocarbons, Chlorinated", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Organochlorine Compound|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Organic Chlorine Compounds", "MN": "D02.455.526.439", "FX": "Chlorine Compounds", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "general; prefer specifics", "MS": "Hydrocarbon compounds with one or more of the hydrogens replaced by CHLORINE.", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006843"}, {"RECTYPE": "D", "MH": "Hydrocarbons, Cyclic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polycyclic Hydrocarbons|T109|NON|NRW|NLM (1974)|990101|abcdef", "MN": "D02.455.426", "FX": "Polycyclic Compounds", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics; do not confuse with HYDROCARBONS, ACYCLIC", "MS": "Organic compounds composed exclusively of carbon and hydrogen forming a closed ring that may be either alicyclic or aromatic.", "PM": "1998; for HYDROCARBONS, POLYCYCLIC see POLYCYCLIC COMPOUNDS 1978-2017", "HN": "1998; for HYDROCARBONS, POLYCYCLIC use POLYCYCLIC COMPOUNDS 1978-2017", "MR": "20160609", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D006844"}, {"RECTYPE": "D", "MH": "Hydrocarbons, Fluorinated", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluorinated Hydrocarbons|T109|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "D02.455.526.510", "FX": "Fluorocarbon Polymers", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "do not confuse with FLUOROCARBONS nor with CHLOROFLUOROCARBONS", "MS": "Inert liquid or gaseous halocarbon compounds in which FLUORINE replaces some or all HYDROGEN atoms.", "PM": "74", "HN": "74", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006845"}, {"RECTYPE": "D", "MH": "Hydrocarbons, Halogenated", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Halogenated Hydrocarbons|T109|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "D02.455.526", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general; note specific halogenated hydrocarbon groups are available", "MS": "Hydrocarbon compounds with one or more HYDROGEN atoms substituted with HALOGENS.", "PM": "66", "HN": "66", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006846"}, {"RECTYPE": "D", "MH": "Hydrocarbons, Iodinated", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Iodinated Hydrocarbons|T109|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "D02.455.526.581", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Hydrocarbon compounds with one or more HYDROGEN atoms substituted with IODINE.", "PM": "74", "HN": "74", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006847"}, {"RECTYPE": "D", "MH": "Testicular Hydrocele", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vaginal Hydroceles", "MN": "C12.200.294.882", "MH_TH": "NLM (2007)", "ST": "T047", "AN": "\"vaginal hydrocele\" is of the tunica vaginalis of the testis, not of the vagina; in females, hydrocele of Nuck's canal is a watery dilatation of the processus vaginalis peritonei: index under PERITONEAL DISEASES", "MS": "Accumulation of serous fluid between the layers of membrane (tunica vaginalis) covering the TESTIS in the SCROTUM.", "PM": "2007; see HYDROCELE 1966-2006", "HN": "2007; use HYDROCELE 1966-2006", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D006848"}, {"RECTYPE": "D", "MH": "Hydrocephalus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Post-Traumatic Hydrocephalus|T047|NON|NRW|NLM (2000)|991103|POSTTRAUMATIC HYDROCEPHALUS|abcdefs", "ENTRY": "Ventriculomegaly, Fetal Cerebral", "MN": "C10.228.140.602", "FX": "Megalencephaly", "MH_TH": "ORD (2010)", "ST": "T190", "MS": "Excessive accumulation of cerebrospinal fluid within the cranium which may be associated with dilation of cerebral ventricles, INTRACRANIAL HYPERTENSION; HEADACHE; lethargy; URINARY INCONTINENCE; and ATAXIA.", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006849"}, {"RECTYPE": "D", "MH": "Hydrocephalus, Normal Pressure", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Normal Pressure Hydrocephalus|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Syndromes, Hakim's", "MN": "C10.228.140.602.750", "MH_TH": "NLM (1971)", "ST": "T047", "PI": "Hydrocephalus (1966-1970)", "MS": "A form of compensated hydrocephalus characterized clinically by a slowly progressive gait disorder (see GAIT DISORDERS, NEUROLOGIC), progressive intellectual decline, and URINARY INCONTINENCE. Spinal fluid pressure tends to be in the high normal range. This condition may result from processes which interfere with the absorption of CSF including SUBARACHNOID HEMORRHAGE, chronic MENINGITIS, and other conditions. (From Adams et al., Principles of Neurology, 6th ed, pp631-3)", "PM": "1991; see HYDROCEPHALUS 1971-90", "HN": "1991(1971)", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006850"}, {"RECTYPE": "D", "MH": "Hydrochloric Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydrogen Chloride|T130|T197|NON|EQV|FDA SRS (2014)|UNK (19XX)|750101|abbcdeef", "ENTRY": "Chloride, Hydrogen", "MN": "D01.210.450", "FX": "Gastric Acid", "MH_TH": "NLM (1966)", "ST": "T197", "N1": "Hydrochloric acid", "RN": "QTT17582CB", "RR": "7647-01-0 (Hydrochloric Acid)", "MS": "A strong corrosive acid that is commonly used as a laboratory reagent. It is formed by dissolving hydrogen chloride in water. GASTRIC ACID is the hydrochloric acid component of GASTRIC JUICE.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006851"}, {"RECTYPE": "D", "MH": "Hydrochlorothiazide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sectrazide|T109|T121|TRD|NRW|UNK (19XX)|831020|abbcdef", "MN": "D03.633.100.174.261.476", "PA": "Sodium Chloride Symporter Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide", "RN": "0J48LPH2TH", "RR": "58-93-5 (Hydrochlorothiazide)", "MS": "A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006852"}, {"RECTYPE": "D", "MH": "Hydrocodone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydrocon|T109|T121|TRD|NRW|UNK (19XX)|750630|abbcdef", "ENTRY": "Robidone|T109|T121|TRD|NRW|US|030613|abbcdef", "MN": "D04.615.723.795.576.149.287", "PA": "Narcotics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Morphinan-6-one, 4,5-epoxy-3-methoxy-17-methyl-, (5alpha)-", "RN": "6YKS4Y3WQ7", "RR": "NO70W886KK", "AN": "do not confuse HYDROCODONE x refs with OXYCODONE x refs", "PI": "Morphinans (1970-1974)", "MS": "Narcotic analgesic related to CODEINE, but more potent and more addicting by weight. It is used also as cough suppressant.", "PM": "91; was see under CODEINE 1976-90", "HN": "91(76); was see under CODEINE 1976-90", "MR": "20170524", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D006853"}, {"RECTYPE": "D", "MH": "Hydrocortisone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-|T109|T121|T125|NON|EQV|NLM (2022)|210629|abbbcdef", "ENTRY": "11 Epicortisol", "MN": "D06.472.040.585.478.392", "PA": "Anti-Inflammatory Agents", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-", "RN": "WI4X0X7BPJ", "RR": "60103-17-5 (cpd w/o stereochem designation)", "MS": "The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.", "PM": "/adverse effects /poisoning /toxicity were HYDROCORTISONE TOXICOLOGY 1963-65", "HN": "/adv eff-pois-tox was HYDROCORTISONE TOXICOLOGY 1963-65", "MR": "20210629", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006854"}, {"RECTYPE": "D", "MH": "Hydrogen Cyanide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydrocyanic Acid|T131|T197|NON|EQV|FDA SRS (2014)|NLM (1994)|921216|abbcdeef", "ENTRY": "Cyanide, Hydrogen", "MN": "D01.625.400", "PA": "Chemical Warfare Agents", "MH_TH": "NLM (1966)", "ST": "T197", "N1": "Hydrocyanic acid", "RN": "2WTB3V159F", "RR": "74-90-8 (Hydrogen Cyanide)", "MS": "Hydrogen cyanide (HCN); A toxic liquid or colorless gas. It is found in the smoke of various tobacco products and released by combustion of nitrogen-containing organic materials.", "OL": "use HYDROGEN CYANIDE to search HYDROCYANIC ACID 1978-93", "PM": "94; was HYDROCYANIC ACID 1963-93; HYDROGEN CYANIDE was see HYDROCYANIC ACID 1978-93", "HN": "94; was HYDROCYANIC ACID 1963-93; HYDROGEN CYANIDE was see HYDROCYANIC ACID 1978-93", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D006856"}, {"RECTYPE": "D", "MH": "Hydroflumethiazide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trifluoromethylhydrothiazide|T109|T121|NON|EQV|UNK (19XX)|740330|abbcdef", "MN": "D03.633.100.174.475", "PA": "Sodium Chloride Symporter Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide", "RN": "501CFL162R", "RR": "135-09-1 (Hydroflumethiazide)", "MS": "A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p822)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006857"}, {"RECTYPE": "D", "MH": "Hydrofluoric Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydrogen Fluoride|T131|T197|NON|EQV|FDA SRS (2014)|UNK (19XX)|760523|abbcdeef", "ENTRY": "Fluoride, Hydrogen", "MN": "D01.303.350", "MH_TH": "NLM (1972)", "ST": "T197", "N1": "Hydrofluoric acid", "RN": "RGL5YE86CZ", "RR": "7664-39-3 (Hydrofluoric Acid)", "PI": "Fluorides (1966-1971)", "MS": "Hydrofluoric acid. A solution of hydrogen fluoride in water. It is a colorless fuming liquid which can cause painful burns.", "PM": "77", "HN": "77(72)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D006858"}, {"RECTYPE": "D", "MH": "Hydrogen", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Protium|T196|NON|EQV|NLM (2020)|190226|abcdef", "ENTRY": "Hydrogen-1|T196|NON|EQV|NLM (2018)|170411|abcdef", "MN": "D01.362.340", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "7YNJ3PO35Z", "RR": "1333-74-0 (Hydrogen)", "MS": "The first chemical element in the periodic table with atomic symbol H, and atomic number 1. Protium (atomic weight 1) is by far the most common hydrogen isotope. Hydrogen also exists as the stable isotope DEUTERIUM (atomic weight 2) and the radioactive isotope TRITIUM (atomic weight 3). Hydrogen forms into a diatomic molecule at room temperature and appears as a highly flammable colorless and odorless gas.", "MR": "20190405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006859"}, {"RECTYPE": "D", "MH": "Hydrogen Bonding", "AQ": "DE RE", "PRINT ENTRY": "Hydrogen Bonds|T070|NON|REL|NLM (2020)|190409|abcdef", "ENTRY": "Hydrogen Bond", "MN": "G02.282", "MH_TH": "NLM (1975)", "ST": "T070", "AN": "usually NIM", "MS": "A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds.", "PM": "91; was see under CHEMISTRY, PHYSICAL 1975-90", "HN": "91(75); was see under CHEMISTRY, PHYSICAL 1975-90", "MR": "20190521", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D006860"}, {"RECTYPE": "D", "MH": "Hydrogen Peroxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Peroxide, Hydrogen", "MN": "D02.389.593.374.424", "PA": "Oxidants", "EC": "analogs & derivatives:Peroxides", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Hydrogen peroxide (H2O2)", "RN": "BBX060AN9V", "RR": "7722-84-1 (Hydrogen Peroxide)", "MS": "A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials.", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006861"}, {"RECTYPE": "D", "MH": "Hydrogen Sulfide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfide, Hydrogen", "MN": "D01.875.350", "PA": "Gasotransmitters", "MH_TH": "NLM (1971)", "ST": "T197", "N1": "Hydrogen sulfide (H2S)", "RN": "YY9FVM7NSN", "RR": "7783-06-4 (Hydrogen Sulfide)", "PI": "Sulfides (1966-1970)", "MS": "A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)", "PM": "73", "HN": "73(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006862"}, {"RECTYPE": "D", "MH": "Hydrogen-Ion Concentration", "AQ": "DE RE", "PRINT ENTRY": "pH|T081|EQV|UNK (19XX)|880602|abdef", "ENTRY": "Hydrogen-Ion Concentrations", "MN": "G02.300", "FX": "Buffers", "MH_TH": "NLM (1966)", "ST": "T081", "AN": "usually NIM", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006863"}, {"RECTYPE": "D", "MH": "Hydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hydrogenase, H2-Oxidizing", "MN": "D08.811.682.400", "MH_TH": "NLM (1985)", "ST": "T126", "N1": "Ferredoxin:H+ oxidoreductase", "RN": "EC 1.12.7.2", "PI": "Oxidoreductases (1966-1984)", "MS": "An enzyme found in bacteria. It catalyzes the reduction of FERREDOXIN and other substances in the presence of molecular hydrogen and is involved in the electron transport of bacterial photosynthesis.", "PM": "85", "HN": "85", "MR": "20090706", "DA": "19840525", "DC": "1", "DX": "19850101", "UI": "D006864"}, {"RECTYPE": "D", "MH": "Hydrogenation", "AQ": "DE RE", "ENTRY": "Hydrogenations", "MN": "G03.409", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "almost never IM; enzymatic hydrogenation: coord NIM with specific enzyme (IM) + substrate (NIM)", "PI": "Hydrogen (1966-1970)", "MS": "Addition of hydrogen to a compound, especially to an unsaturated fat or fatty acid. (From Stedman, 26th ed)", "PM": "91; was see under CHEMISTRY, ORGANIC 1971-90", "HN": "91(71); was see under CHEMISTRY, ORGANIC 1971-90", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006865"}, {"RECTYPE": "D", "MH": "Hydrolases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hydrolase|T116|T126|NON|EQV|NLM (2021)|191227|abbcdef", "MN": "D08.811.277", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.-", "AN": "do not confuse with HYDRO-LYASES", "MS": "Any member of the class of enzymes that catalyze the cleavage of the substrate and the addition of water to the resulting molecules, e.g., ESTERASES, glycosidases (GLYCOSIDE HYDROLASES), lipases, NUCLEOTIDASES, peptidases (PEPTIDE HYDROLASES), and phosphatases (PHOSPHORIC MONOESTER HYDROLASES). EC 3.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006867"}, {"RECTYPE": "D", "MH": "Hydrolysis", "AQ": "DE RE", "MN": "G02.380", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "almost never IM", "PI": "Chemistry, Physical (1966-1970)", "MS": "The process of cleaving a chemical compound by the addition of a molecule of water.", "PM": "91; was see under CHEMISTRY, PHYSICAL 1971-90", "HN": "91(71); was see under CHEMISTRY, PHYSICAL 1971-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006868"}, {"RECTYPE": "D", "MH": "Hydronephrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hydronephroses", "MN": "C12.950.419.307", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Abnormal enlargement or swelling of a KIDNEY due to dilation of the KIDNEY CALICES and the KIDNEY PELVIS. It is often associated with obstruction of the URETER or chronic kidney diseases that prevents normal drainage of urine into the URINARY BLADDER.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006869"}, {"RECTYPE": "D", "MH": "Hydrophthalmos", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Buphthalmos|T019|T047|NON|EQV|NLM (1990)|OMIM (2013)|890314|abbcdeef", "MN": "C16.614.438", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a type of open-angle glaucoma; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Congenital open-angle glaucoma that results from dysgenesis of the angle structures accompanied by increased intraocular pressure and enlargement of the eye. Treatment is both medical and surgical.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006871"}, {"RECTYPE": "D", "MH": "Hydropneumothorax", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C08.528.434", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "pneumothorax with fluid in pleural cavity", "MS": "A collection of fluid and gas within the pleural cavity. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930809", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006872"}, {"RECTYPE": "D", "MH": "Hydroquinones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "para-Dihydroxybenzenes|T109|NON|EQV|UNK (19XX)|770520|abcdef", "ENTRY": "para Dihydroxybenzenes", "MN": "D02.455.426.559.389.657.393", "MH_TH": "NLM (1963)", "ST": "T109", "RN": "0", "MS": "Derivatives of hydroquinone (1,4-dihydrobenzene) made by reduction of BENZOQUINONES.", "PM": "66; was see under PHENOLS 1963-65", "HN": "66(63); was see under PHENOLS 1963-65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006873"}, {"RECTYPE": "D", "MH": "Hydrostatic Pressure", "AQ": "AE", "ENTRY": "Pressures, Hydrostatic", "MN": "G01.374.715.352", "MH_TH": "NLM (1973)", "ST": "T070", "AN": "NIM", "PI": "Pressure (1966-1972)", "MS": "The pressure due to the weight of fluid.", "PM": "91; was see under PRESSURE 1973-90", "HN": "91(73); was see under PRESSURE 1973-90", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006874"}, {"RECTYPE": "D", "MH": "Hydrotherapy", "DE": "HYDROTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Whirlpool Baths|T056|T061|NON|NRW|UNK (19XX)|850228|abbcdef", "ENTRY": "Whirlpool Bath", "MN": "E02.831.535.492", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "external with natural water only, with emphasis on water temperature & motion of water ;do not confuse with BALNEOLOGY (see note there); if in doubt, use word of text", "MS": "External application of water for therapeutic purposes, such as whirlpool baths or water shiatsu.", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006875"}, {"RECTYPE": "D", "MH": "Hydrothorax", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C08.528.476", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "fluid in pleural cavity", "MS": "A collection of watery fluid in the pleural cavity. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930809", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006876"}, {"RECTYPE": "D", "MH": "Hydroxamic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Hydroxamic", "MN": "D02.241.511.372", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A class of weak acids with the general formula R-CONHOH.", "OL": "use HYDROXAMIC ACIDS to search HYDROXAMIC ACID 1966-74", "PM": "75; was HYDROXAMIC ACID 1963-74", "HN": "75; was HYDROXAMIC ACID 1963-74", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D006877"}, {"RECTYPE": "D", "MH": "Hydroxides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D01.248.497.158.459", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Inorganic compounds that contain the OH- group.", "MR": "20150625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006878"}, {"RECTYPE": "D", "MH": "Hydroxocobalamin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxycobalamin|T109|T121|T127|NON|EQV|UNK (19XX)|790221|abbbcdef", "ENTRY": "Hydroxo-Cobalamin|T109|T121|T127|NON|EQV|NLM (2006)|050304|abbbcdef", "MN": "D04.345.783.437.777.560", "PA": "Vitamin B Complex", "MH_TH": "USP (19XX)", "ST": "T127", "N1": "Cobinamide, hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole", "RN": "Q40X8H422O", "RR": "13422-51-0 (Hydroxocobalamin)", "MS": "Injectable form of VITAMIN B 12 that has been used therapeutically to treat VITAMIN B 12 DEFICIENCY.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006879"}, {"RECTYPE": "D", "MH": "Hydroxy Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxy Acid|T109|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Acids, Hydroxy", "MN": "D02.241.511", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Fatty Acids (1966-1974)", "MS": "Organic compounds containing both the hydroxyl and carboxyl radicals.", "PM": "75", "HN": "75", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D006880"}, {"RECTYPE": "D", "MH": "Hydroxyacetylaminofluorene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxyfluorenylacetamide|T109|T131|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "N Hydroxy 2 acetamidofluorene", "MN": "D04.615.389.050.400", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Acetamide, N-9H-fluoren-2-yl-N-hydroxy-", "RN": "53-95-2", "PI": "Hydroxamic Acids (1966-1974)", "MS": "A N-hydroxylated derivative of 2-ACETYLAMINOFLUORENE that has demonstrated carcinogenic action.", "PM": "91; was see under 2-ACETYLAMINOFLUORENE 1980-90; was see under FLUORENES 1975-79", "HN": "91(75); was see under 2-ACETYLAMINOFLUORENE 1980-90; was see under FLUORENES 1975-79", "MR": "20120703", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D006881"}, {"RECTYPE": "D", "MH": "Hydroxyapatites", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Derivatives, Hydroxyapatite", "MN": "D01.695.625.675.650.075.025.300", "MH_TH": "NLM (1964)", "ST": "T197", "RN": "0", "AN": "in phosphorite deposits & biol tissue", "MS": "A group of compounds with the general formula M10(PO4)6(OH)2, where M is barium, strontium, or calcium. The compounds are the principal mineral in phosphorite deposits, biological tissue, human bones, and teeth. They are also used as an anticaking agent and polymer catalysts. (Grant & Hackh's Chemical Dictionary, 5th ed)", "OL": "use HYDROXYAPATITES to search HYDROXYAPATITE 1964-74 (as Prov 1966)", "PM": "75; was HYDROXYAPATITE 1967-74", "HN": "75; was HYDROXYAPATITE 1964-74 (Prov 1964-66)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006882"}, {"RECTYPE": "D", "MH": "Hydroxybutyrate Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, Hydroxybutyrate", "MN": "D08.811.682.047.820.350", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "(R)-3-Hydroxybutanoate:NAD+ oxidoreductase", "RN": "EC 1.1.1.30", "PM": "65", "HN": "65", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006884"}, {"RECTYPE": "D", "MH": "Hydroxybutyrates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid Derivatives, Hydroxybutyric", "MN": "D10.251.400.143.781", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Salts and esters of hydroxybutyric acid.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006885"}, {"RECTYPE": "D", "MH": "Hydroxychloroquine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxychloroquine|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef", "ENTRY": "Plaquenil|T109|T121|TRD|NRW|UNK (19XX)|810625|abbcdef", "MN": "D03.633.100.810.050.180.350", "PA": "Enzyme Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "ethanol, 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethylamino)-", "RN": "4QWG6N8QKH", "RR": "8Q2869CNVH", "MS": "A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006886"}, {"RECTYPE": "D", "MH": "Hydroxycholecalciferols", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxyvitamins D|T109|T127|NON|EQV|UNK (19XX)|760520|abbcdef", "ENTRY": "Hydroxycholecalciferol|T109|T127|NON|EQV|UNK (19XX)|760905|abbcdef", "MN": "D10.570.938.146.478", "PA": "Vitamins", "MH_TH": "NLM (1972)", "ST": "T127", "RN": "0", "AN": "deficiency: coordinate HYDROXYCHOLECALCIFEROLS /defic (IM) with VITAMIN D DEFICIENCY (IM)", "MS": "Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3.", "OL": "use HYDROXYCHOLECALCIFEROLS to search HYDROXYCHOLECALCIFEROL 1972-74 (as Prov 1972)", "PM": "75; was HYDROXYCHOLECALCIFEROL 1973-74", "HN": "75; was HYDROXYCHOLECALCIFEROL 1972-74 (Prov 1972)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006887"}, {"RECTYPE": "D", "MH": "Hydroxycholesterols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D10.570.938.208.825.500", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Cholesterol (1966-1977)", "MS": "Cholesterol which is substituted by a hydroxy group in any position.", "OL": "use HYDROXYCHOLESTEROLS to search HYDROXYCHOLESTEROL 1975-77; use CHOLESTEROL 1973-74", "PM": "78; was HYDROXYCHOLESTEROL see under CHOLESTEROL 1973-77", "HN": "78; was HYDROXYCHOLESTEROL see under CHOLESTEROL 1973-77", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D006888"}, {"RECTYPE": "D", "MH": "Hydroxycorticosteroids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D06.472.040.585", "MH_TH": "NLM (1972)", "ST": "T125", "RN": "0", "PI": "Mineralocorticoids (1967-1971)", "MS": "A group of corticosteroids carrying hydroxy groups, usually in the 11- or 17-positions. They comprise the bulk of the corticosteroids used systemically. As they are relatively insoluble in water, salts of various esterified forms are often used for injections or solutions.", "PM": "73", "HN": "73(72)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006889"}, {"RECTYPE": "D", "MH": "Hydroxydopamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydroxydopamine|T109|NON|NRW|UNK (19XX)|810512|abcdef", "MN": "D02.455.426.559.389.657.166.175.342.478", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "PI": "Phenethylamines (1966-1972)", "MS": "Dopamines with a hydroxy group substituted in one or more positions.", "OL": "use HYDROXYDOPAMINES to search HYDROXYDOPAMINE 1973-81", "PM": "82; was HYDROXYDOPAMINE 1973-81", "HN": "82; was HYDROXYDOPAMINE 1973-81", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006892"}, {"RECTYPE": "D", "MH": "Hydroxyeicosatetraenoic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "HETE|T109|T123|ABB|EQV|NLM (1990)|890327|abbcdef", "ENTRY": "Acids, Hydroxyeicosatetraenoic", "MN": "D10.251.355.310.166.550", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "PI": "Fatty Acids, Essential (1966)", "MS": "Eicosatetraenoic acids substituted in any position by one or more hydroxy groups. They are important intermediates in a series of biosynthetic processes leading from arachidonic acid to a number of biologically active compounds such as prostaglandins, thromboxanes, and leukotrienes.", "PM": "85", "HN": "85", "MR": "20150622", "DA": "19840530", "DC": "1", "DX": "19850101", "UI": "D006893"}, {"RECTYPE": "D", "MH": "Hydroxyestrones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D06.472.334.851.437.984.350", "MH_TH": "NLM (1977)", "ST": "T121", "RN": "0", "PI": "Hydroxysteroids (1972-1975)", "MS": "Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.", "PM": "91; was see under ESTRONE 1977-90", "HN": "91(77); was see under ESTRONE 1977-90", "MR": "20160531", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D006894"}, {"RECTYPE": "D", "MH": "Hydroxyethyl Starch Derivatives", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hetastarch|T109|T121|NON|NRW|BAN (19XX)|FDA SRS (2014)|JAN (19XX)|USAN (1972)|990101|abbcdeeeef", "ENTRY": "Starches, Hydroxyethylated", "MN": "D09.698.365.855.500", "PA": "Plasma Substitutes", "MH_TH": "NLM (2014)", "ST": "T109", "RN": "0", "RR": "MOQ3RNM0SV", "PI": "Starch (1971-1974)", "MS": "Starches that have been chemically modified so that a percentage of OH groups are substituted with 2-hydroxyethyl ether groups.", "PM": "2014; see HYDROXYETHYL STARCH 1975-2013; see HETASTARCH 1996-2013", "HN": "2014(1975); was HYDROXYETHYL STARCH 1975-2013; was HETASTARCH 1996-2013", "MR": "20170410", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006895"}, {"RECTYPE": "D", "MH": "Hydroxyethylrutoside", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "beta Hydroxyethylrutoside", "MN": "D03.633.100.150.266.450.284.888.500", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Rutin (1972-1974)", "MS": "Monohydroxyethyl derivative of rutin. Peripheral circulation stimulant used in treatment of venous disorders.", "PM": "91; was see under RUTIN 1975-90", "HN": "91(75); was see under RUTIN 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006896"}, {"RECTYPE": "D", "MH": "Hydroxyindoleacetic Acid", "DE": "HIAA", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Hydroxyindoleacetic", "MN": "D03.633.100.473.404.478", "MH_TH": "NLM (1964)", "ST": "T123", "N1": "1H-Indole-3-acetic acid, 5-hydroxy-", "RN": "54-16-0", "PM": "66", "HN": "66(64)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006897"}, {"RECTYPE": "D", "MH": "Hydroxylamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.092.570", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "HYDROXYLAMINE is also available", "MS": "Organic compounds that contain the (-NH2OH) radical.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006898"}, {"RECTYPE": "D", "MH": "Mixed Function Oxygenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Monooxygenases|T116|T126|NON|EQV|NLM (2003)|020312|abbcdef", "ENTRY": "Oxygenases, Mixed Function", "MN": "D08.811.682.690.708", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 1.-", "AN": "do not confuse with HYDRO-LYASES", "MS": "Widely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate (COENZYMES) required in the mixed-function oxidation.", "PM": "2003 (1966)", "HN": "2003 (1966)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20030101", "UI": "D006899"}, {"RECTYPE": "D", "MH": "Hydroxylation", "AQ": "DE GE IM PH RE", "ENTRY": "Hydroxylations", "MN": "G03.425", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "almost never IM; enzymatic hydroxylation: coord NIM with MIXED FUNCTION OXYGENASES (IM) + substrate (NIM) or specific hydroxylase (IM)", "PI": "Chemistry, Organic (1966-1970)", "MS": "Placing of a hydroxyl group on a compound in a position where one did not exist before. (Stedman, 26th ed)", "PM": "91; was see under CHEMISTRY, ORGANIC 1971-90", "HN": "91(71); was see under CHEMISTRY, ORGANIC 1971-90", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006900"}, {"RECTYPE": "D", "MH": "Hydroxylysine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Lysine, 5 Hydroxy", "MN": "D12.125.095.647.478", "MH_TH": "NLM (1971)", "ST": "T123", "N1": "Lysine, hydroxy-", "RN": "2GQB349IUB", "RR": "28902-93-4 (Hydroxylysine)", "PI": "Lysine (1966-1970)", "MS": "A hydroxylated derivative of the amino acid LYSINE that is present in certain collagens.", "HN": "1973 (1971)", "MR": "20180301", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D006901"}, {"RECTYPE": "D", "MH": "Hydroxymercuribenzoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.691.750.740.644.450", "PA": "Sulfhydryl Reagents", "MH_TH": "NLM (1972)", "ST": "T130", "RN": "0", "PI": "Organometallic Compounds (1968-1971)", "MS": "Hydroxylated benzoic acid derivatives that contain mercury. Some of these are used as sulfhydryl reagents in biochemical studies.", "PM": "72", "HN": "72", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006902"}, {"RECTYPE": "D", "MH": "Hydroxymethylglutaryl CoA Reductases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HMG CoA Reductases|T116|T126|EQV|UNK (19XX)|870323|abbdef", "ENTRY": "Reductase, 3-Hydroxy-3-methylglutaryl CoA", "MN": "D08.811.682.047.820.150.415", "FX": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", "EC": "antagonists & inhibitors:Hydroxymethylglutaryl-CoA Reductase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.1.1.-", "PI": "Mevalonic Acid (1966-1974)", "MS": "Enzymes that catalyze the reversible reduction of alpha-carboxyl group of 3-hydroxy-3-methylglutaryl-coenzyme A to yield MEVALONIC ACID.", "PM": "78; was see under ALCOHOL OXIDOREDUCTASES 1975-77", "HN": "78(75); was see under ALCOHOL OXIDOREDUCTASES 1975-77", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D006903"}, {"RECTYPE": "D", "MH": "Hydroxymethylglutaryl-CoA Synthase", "DE": "HMG COA SYNTHASE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HMG CoA Synthase|T116|T126|ABX|EQV|NLM (2020)|190228|abbcdef", "ENTRY": "synthase, HMG-CoA", "MN": "D08.811.913.050.612", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "(S)-3-Hydroxy-3-methylglutaryl-CoA acetoacetyl-CoA-lyase (CoA-acetylating)", "RN": "EC 2.3.3.10", "RR": "9027-44-5 (CAS RN)", "PI": "Ketoacid-Lyases (1973-1974)", "MS": "An enzyme that catalyzes the synthesis of hydroxymethylglutaryl-CoA from acetyl-CoA and acetoacetyl-CoA. This is a key enzyme in steroid biosynthesis. This enzyme was formerly listed as EC 4.1.3.5.", "PM": "1991; HMG-COA SYNTHASE was indexed under HYDROXYMETHYLGLUTARYL-COA SYNTHASE 2005-2008, & under COENZYME A LIGASES 2001-2005", "HN": "1991(1975);", "MR": "20190429", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006904"}, {"RECTYPE": "D", "MH": "Hydroxyphenylazouracil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "6-(4-Hydroxyphenylazo)uracil|T114|T121|NON|EQV|UNK (19XX)|820519|abbcdef", "MN": "D03.383.742.698.875.480", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "29050-86-0", "PI": "Uracil (1972-1974)", "MS": "Inhibitor of DNA replication in gram-positive bacteria.", "PM": "91; was see under URACIL 1975-90", "HN": "91(75); was see under URACIL 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006906"}, {"RECTYPE": "D", "MH": "17-alpha-Hydroxypregnenolone", "DS": "ALPHA HYDROXYPREGNENOLONE 17", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "17alpha Hydroxypregnenolone", "MN": "D06.472.334.851.687.500.500", "MH_TH": "NLM (2004)", "ST": "T123", "N1": "Pregn-5-en-20-one, 3,17-dihydroxy-, (3beta)-", "RN": "387-79-1", "RR": "33999-97-2 ((3beta,13alpha,17alpha)-isomer)", "MS": "A 21-carbon steroid that is converted from PREGNENOLONE by STEROID 17-ALPHA-HYDROXYLASE. It is an intermediate in the delta-5 pathway of biosynthesis of GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS.", "PM": "2004; see HYDROXYPREGNENOLONE 1972-2003; 17-HYDROXYPREGNENOLONE was indexed under HYDROXYPREGNENOLONE (NM) 1981-2003", "HN": "2004 (1964); for 17-HYDROXYPREGNENOLONE use HYDROXYPREGNENOLONE (NM) 1981-2003", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006907"}, {"RECTYPE": "D", "MH": "Hydroxyprogesterones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D06.472.334.851.687.750.478", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "0", "MS": "Metabolites or derivatives of PROGESTERONE with hydroxyl group substitution at various sites.", "OL": "use HYDROXYPROGESTERONES to search HYDROXYPROGESTERONE 1966-77", "PM": "78; was HYDROXYPROGESTERONE 1963-77", "HN": "78; was HYDROXYPROGESTERONE 1963-77", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D006908"}, {"RECTYPE": "D", "MH": "Hydroxyproline", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Oxyproline|T116|T123|NON|EQV|UNK (19XX)|770426|abbcdef", "ENTRY": "cis 4 Hydroxyproline", "MN": "D12.125.072.401.623.478", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "L-Proline, 4-hydroxy-, trans-", "RN": "RMB44WO89X", "RR": "51-35-4 (Hydroxyproline)", "MS": "A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006909"}, {"RECTYPE": "D", "MH": "Hydroxypropiophenone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.522.818.561", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "1-Propanone, 1-phenyl-, monohydroxy deriv.", "RN": "1321-48-8", "MR": "19920519", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006910"}, {"RECTYPE": "D", "MH": "Hydroxyprostaglandin Dehydrogenases", "DE": "HYDROXYPG DEHYDROGENASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenases, Hydroxyprostaglandin", "MN": "D08.811.682.047.820.375", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.1.1.-", "PI": "Prostaglandins (1966-1974)", "MS": "Catalyzes reversibly the oxidation of hydroxyl groups of prostaglandins.", "PM": "78; was see under ALCOHOL OXIDOREDUCTASES 1975-77", "HN": "78(75); was see under ALCOHOL OXIDOREDUCTASES 1975-77", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19780101", "UI": "D006911"}, {"RECTYPE": "D", "MH": "Hydroxyquinolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Quinolinols|T109|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Chiniofon|T109|NON|REL|FDA SRS (2014)|INN (19XX)|UNK (19XX)|820505|abcdeeef", "MN": "D03.633.100.810.350", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "RR": "98F8Y85B6W", "PI": "Quinolines (1966-1974)", "MS": "The 8-hydroxy derivatives inhibit various enzymes and their halogenated derivatives, though neurotoxic, are used as topical anti-infective agents, among other uses.", "OL": "use HYDROXYQUINOLINES to search CHINIOFON 1966-82", "PM": "CHINIOFON, DIIODOHYDROXYQUIN, IODOCHLORHYDROXYQUIN & CHLORQUINALDOL were headings 1963-82", "HN": "CHINIOFON was heading 1963-82", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D006912"}, {"RECTYPE": "D", "MH": "Hydroxysteroid Dehydrogenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hydroxysteroid Dehydrogenase|T116|T126|NON|EQV|NLM (2021)|200225|abbcdef", "ENTRY": "Dehydrogenases, Hydroxysteroid", "MN": "D08.811.682.047.436", "MH_TH": "NLM (1965)", "ST": "T126", "RN": "EC 1.1.-", "MS": "Enzymes of the oxidoreductase class that catalyze the dehydrogenation of hydroxysteroids. (From Enzyme Nomenclature, 1992) EC 1.1.-.", "OL": "use HYDROXYSTEROID DEHYDROGENASES to search HYDROXYSTEROID DEHYDROGENASE 1966-73", "PM": "74; was HYDROXYSTEROID DEHYDROGENASE 1965-73", "HN": "74; was HYDROXYSTEROID DEHYDROGENASE 1965-73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006913"}, {"RECTYPE": "D", "MH": "Hydroxysteroids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.528", "FX": "Hydroxycorticosteroids", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "MS": "Steroids in which one or more hydroxy groups have been substituted for hydrogen atoms either within the ring skeleton or on any of the side chains.", "PM": "74", "HN": "74(72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D006914"}, {"RECTYPE": "D", "MH": "Hydroxytestosterones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.054.079.429.824.375", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "PI": "Testosterone (1972-1976)", "MS": "17 beta-Hydroxy-4-androsten-3-ones. Testosterone derivatives formed by the substitution of one or more hydroxyl groups in any position.", "PM": "91; was see under TESTOSTERONE 1977-90", "HN": "91(77); was see under TESTOSTERONE 1977-90", "MR": "20160531", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D006915"}, {"RECTYPE": "D", "MH": "5-Hydroxytryptophan", "DS": "HYDROXYTRYPTOPHAN 05", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "5-HTP|T116|T121|T123|ABB|EQV|UNK (19XX)|760317|HTP 05|abbbcdefs", "ENTRY": "Tryptophan, 5 Hydroxy", "MN": "D12.125.072.050.850.479", "PA": "Antidepressive Agents, Second-Generation", "MH_TH": "NLM (1963)", "ST": "T123", "N1": "2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid", "RN": "C1LJO185Q9", "RR": "56-69-9 (5-Hydroxytryptophan)", "MS": "The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.", "OL": "use 5-HYDROXYTRYPTOPHAN to search HYDROXYTRYPTOPHAN 1966-89", "PM": "90; was HYDROXYTRYPTOPHAN 1965-89", "HN": "90; was HYDROXYTRYPTOPHAN 1963-89 (Prov 1963-65)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006916"}, {"RECTYPE": "D", "MH": "Hydroxytryptophol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.473.385", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "1H-Indole-3-ethanol, 5-hydroxy-", "RN": "154-02-9", "PI": "Indoles (1970-1974)", "MS": "5-Hydroxy-indole-3-ethanol.", "PM": "91; was see under INDOLES 1975-90", "HN": "91(75); was see under INDOLES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006917"}, {"RECTYPE": "D", "MH": "Hydroxyurea", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxycarbamid|T109|T121|NON|EQV|INN (19XX)|761230|abbcdef", "ENTRY": "Oncocarbide|T109|T121|TRD|NRW|UNK (19XX)|840207|abbcdef", "MN": "D02.065.950.395", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Urea, hydroxy-", "RN": "X6Q56QN5QC", "RR": "127-07-1 (Hydroxyurea)", "PI": "Urea (1966)", "MS": "An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.", "PM": "68", "HN": "68(67)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006918"}, {"RECTYPE": "D", "MH": "Hydroxyzine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pamoate, Hydroxyzine", "MN": "D03.383.606.515", "PA": "Histamine H1 Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-", "RN": "30S50YM8OG", "RR": "M20215MUFR", "MS": "A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006919"}, {"RECTYPE": "D", "MH": "Hygiene", "AQ": "EC ED HI LJ ST", "MN": "N06.850.670", "MH_TH": "POPLINE (1983)", "ST": "T091", "MS": "The science dealing with the establishment and maintenance of health in the individual and the group. It includes the conditions and practices conducive to health. (Webster, 3d ed)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006920"}, {"RECTYPE": "D", "MH": "Hygromycin B", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D09.408.051.420", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "D-Streptamine, O-6-amino-6-deoxy-L-glycero-D-galacto-heptopyranosylidene-(1-2-3)-O-beta-D-talopyranosyl-(1-5)-2-deoxy-N3-methyl-", "RN": "3XQ2233B0B", "RR": "31282-04-9 (Hygromycin B)", "PI": "Antibiotics (1970-1974)", "MS": "Aminoglycoside produced by Streptomyces hygroscopicus. It is used as an anthelmintic against swine infections by large roundworms, nodular worms, and whipworms.", "PM": "91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90", "HN": "91(75); was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90", "MR": "20160628", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006921"}, {"RECTYPE": "D", "MH": "Hylobates", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Gibbons|T015|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Gibbon", "MN": "B01.050.150.900.649.313.988.400.112.420.390", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9578", "AN": "NIM when experimental animal; diseases: coordinate with specific disease /vet ", "MS": "A genus of the family HYLOBATIDAE consisting of nine species. The members of this genus inhabit rain forests in southeast Asia. They are arboreal and differ from other anthropoids in the great length of their arms and very slender bodies and limbs. Their major means of locomotion is by swinging from branch to branch by their arms. Hylobates means dweller in the trees.", "OL": "use HYLOBATES to search GIBBONS 1975-80", "PM": "91; was see under PONGIDAE 1981-90; was GIBBONS see under APES 1975-80", "HN": "91(81); was see under PONGIDAE 1981-90; was GIBBONS see under APES 1975-80", "MR": "20200813", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D006922"}, {"RECTYPE": "D", "MH": "Hymecromone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Resocyanine|T109|T121|T130|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "7 Hydroxy 4 methyl coumarin", "MN": "D03.633.100.150.446.912.531", "PA": "Indicators and Reagents", "MH_TH": "USAN (1978)", "ST": "T130", "N1": "2H-1-Benzopyran-2-one, 7-hydroxy-4-methyl-", "RN": "3T5NG4Q468", "RR": "90-33-5 (Hymecromone)", "PI": "Coumarins (1969-1974)", "MS": "A coumarin derivative possessing properties as a spasmolytic, choleretic and light-protective agent. It is also used in ANALYTICAL CHEMISTRY TECHNIQUES for the determination of NITRIC ACID.", "PM": "91; was see under UMBELLIFERONES 1977-90; was see under COUMARINS 1975-76", "HN": "91(75); was see under UMBELLIFERONES 1977-90; was see under COUMARINS 1975-76", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006923"}, {"RECTYPE": "D", "MH": "Hymen", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A10.615.550.368", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A thin fold of MUCOUS MEMBRANE situated at the orifice of the vagina.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006924"}, {"RECTYPE": "D", "MH": "Hymenolepiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Hymenolepis", "MN": "C01.610.335.190.519", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "tapeworm infect", "PI": "Cestode Infections (1966-1967)", "MS": "Infection with tapeworms of the genus Hymenolepis.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006925"}, {"RECTYPE": "D", "MH": "Hymenolepis", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Hymenolepi", "MN": "B01.050.500.500.736.215.454", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid6215", "PI": "Cestoda (1966-1974)", "MS": "A genus of small tapeworms of birds and mammals.", "OL": "search CESTODA 1966-74", "PM": "79; was see under CESTODA 1965-78, was see under TAPEWORMS 1963-64", "HN": "79(75); was see under CESTODA 1965-78, was see under TAPEWORMS 1963-64", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D006926"}, {"RECTYPE": "D", "MH": "Hymenoptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.720.500.500.875", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid7399", "PI": "specific insect", "MS": "An extensive order of highly specialized insects including bees, wasps, and ants.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D006927"}, {"RECTYPE": "D", "MH": "Hyoid Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Lingual Bone|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Lingual Bones", "MN": "A02.835.232.409", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A mobile U-shaped bone that lies in the anterior part of the neck at the level of the third CERVICAL VERTEBRAE. The hyoid bone is suspended from the processes of the TEMPORAL BONES by ligaments, and is firmly bound to the THYROID CARTILAGE by muscles.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006928"}, {"RECTYPE": "D", "MH": "Hyperaldosteronism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aldosteronism|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Syndrome, Conn's", "MN": "C19.053.800.604", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with HYPOALDOSTERONISM; do not confuse entry term CONN SYNDROME with CONN DISEASE see ADRENOCORTICAL ADENOMA", "MS": "A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006929"}, {"RECTYPE": "D", "MH": "Hyperalgesia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperalgia, Secondary|T184|NON|NRW|NLM (2021)|200612|abcdef", "ENTRY": "Thermal Hyperalgesia", "MN": "C23.888.592.763.770.400", "FX": "Pain", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "coordinate with TOUCH or HOT TEMPERATURE if pertinent", "MS": "An increased sensation of pain or discomfort produced by minimally noxious stimuli due to damage to soft tissue containing NOCICEPTORS or injury to a peripheral nerve.", "PM": "1991; see HYPERESTHESIA 1975-90", "HN": "1991(1975)", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006930"}, {"RECTYPE": "D", "MH": "Hyperbaric Oxygenation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Oxygenation, Hyperbaric|T061|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Therapy, Hyperbaric Oxygen", "MN": "E02.880.690.490", "MH_TH": "NLM (1964)", "ST": "T061", "AN": "coord IM with disease /ther (IM), not /drug ther", "MS": "The therapeutic intermittent administration of oxygen in a chamber at greater than sea-level atmospheric pressures (three atmospheres). It is considered effective treatment for air and gas embolisms, smoke inhalation, acute carbon monoxide poisoning, caisson disease, clostridial gangrene, etc. (From Segen, Dictionary of Modern Medicine, 1992). The list of treatment modalities includes stroke.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006931"}, {"RECTYPE": "D", "MH": "Hyperbilirubinemia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bilirubinemia|T046|NON|EQV|NLM (1990)|890330|abcdef", "ENTRY": "Hyperbilirubinemias", "MN": "C23.550.429", "EC": "congenital:Hyperbilirubinemia, Hereditary", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "A condition characterized by an abnormal increase of BILIRUBIN in the blood, which may result in JAUNDICE. Bilirubin, a breakdown product of HEME, is normally excreted in the BILE or further catabolized before excretion in the urine.", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006932"}, {"RECTYPE": "D", "MH": "Hyperbilirubinemia, Hereditary", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rotor Syndrome|T047|NON|NRW|NLM (1998)|ORD (2010)|960723|abcdeef", "ENTRY": "Syndrome, Rotor", "MN": "C18.452.648.300", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Inborn errors of bilirubin metabolism resulting in excessive amounts of bilirubin in the circulating blood, either because of increased bilirubin production or because of delayed clearance of bilirubin from the blood.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006933"}, {"RECTYPE": "D", "MH": "Hypercalcemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Milk-Alkali Syndrome|T047|NON|REL|UNK (19XX)|830504|abcdef", "ENTRY": "Syndrome, Milk-Alkali", "MN": "C18.452.950.340", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "high blood calcium levels; do not confuse with HYPOCALCEMIA; X ref is also called Burnett's syndrome or milk-drinker's syndrome", "MS": "Abnormally high level of calcium in the blood.", "OL": "use HYPERCALCEMIA to search MILK-ALKALI SYNDROME 1966-77", "PM": "MILK-ALKALI SYNDROME was see under CALCINOSIS 1975-77", "HN": "MILK-ALKALI SYNDROME was see under HYPERCALCEMIA 1978-83, was see under CALCINOSIS 1975-77", "CATSH": "CAT LIST", "MR": "19940923", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D006934"}, {"RECTYPE": "D", "MH": "Hypercapnia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.852.544", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "CARBON DIOXIDE/blood is also available", "MS": "A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D006935"}, {"RECTYPE": "D", "MH": "Hypercementosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypercementoses", "MN": "C07.793.422", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "excessive develop of secondary cementum on tooth surface", "MS": "A regressive change of teeth characterized by excessive development of secondary cementum on the tooth surface. It may occur on any part of the root, but the apical two-thirds are most commonly affected. (Dorland, 27th ed)", "OL": "search TOOTH DISEASES 1969-74", "PM": "91; was see under TOOTH DISEASES 1975-90", "HN": "91(75); was see under TOOTH DISEASES 1975-90", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006936"}, {"RECTYPE": "D", "MH": "Hypercholesterolemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypercholesteremia|T047|NON|EQV|UNK (19XX)|790425|abcdef", "ENTRY": "Levels, High Cholesterol", "MN": "C18.452.584.500.500.396", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.", "OL": "use HYPERCHOLESTEROLEMIA to search HYPERCHOLESTEREMIA 1966-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA/genetics 1966-79", "PM": "80; was HYPERCHOLESTEREMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it)", "HN": "80; was HYPERCHOLESTEREMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it)", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D006937"}, {"RECTYPE": "D", "MH": "Hyperlipoproteinemia Type II", "DS": "HYPERLIPOPROTEINEMIA TYPE 02", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypercholesterolemia, Familial|T047|NON|EQV|NLM (1980)|990101|abcdef", "ENTRY": "Xanthomatosis, Familial Hypercholesterolemic", "MN": "C18.452.648.398.481", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Hyperlipidemia/familial & genetic (1966-1979)", "MS": "A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).", "PM": "2007; see HYPERCHOLESTEROLEMIA, FAMILIAL 1980-2007", "HN": "2007 (1980)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19790423", "DC": "1", "DX": "19800101", "UI": "D006938"}, {"RECTYPE": "D", "MH": "Hyperemesis Gravidarum", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pernicious Vomiting of Pregnancy|T184|NON|EQV|NLM (2004)|021001|abcdef", "ENTRY": "Pregnancy Pernicious Vomiting", "MN": "C23.888.821.937.049.500", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "check tags FEMALE & PREGNANCY", "MS": "Intractable VOMITING that develops in early PREGNANCY and persists. This can lead to DEHYDRATION and WEIGHT LOSS.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006939"}, {"RECTYPE": "D", "MH": "Hyperemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Reactive Hyperemias", "MN": "C14.907.474", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "The presence of an increased amount of blood in a body part or an organ leading to congestion or engorgement of blood vessels. Hyperemia can be due to increase of blood flow into the area (active or arterial), or due to obstruction of outflow of blood from the area (passive or venous).", "PM": "1966; for VENOUS ENGORGEMENT see VEINS 1978-2006", "HN": "1966; for VENOUS ENGORGEMENT use VEINS 1978-2006", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006940"}, {"RECTYPE": "D", "MH": "Hyperesthesia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperesthesia, Thermal|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Thermal Hyperesthesias", "MN": "C23.888.592.763.770.450", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "do not confuse with HYPESTHESIA, diminished sensitivity; coord with TOUCH or HOT TEMPERATURE if pertinent", "MS": "Increased sensitivity to cutaneous stimulation due to a diminished threshold or an increased response to stimuli.", "CATSH": "CAT LIST", "MR": "20080710", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006941"}, {"RECTYPE": "D", "MH": "Hypergammaglobulinemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperimmunoglobulinemia|T034|T047|NON|EQV|NLM (2007)|050810|abbcdef", "ENTRY": "Hyperimmunoglobulinemias", "MN": "C23.888.512", "MH_TH": "NLM (1969)", "ST": "T047", "AN": "coord IM with specific immunoglobulin (IM)", "PI": "Blood Protein Disorders (1966-1968)", "MS": "An excess of GAMMA-GLOBULINS in the serum due to chronic infections or PARAPROTEINEMIAS.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D006942"}, {"RECTYPE": "D", "MH": "Hyperglycemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Postprandial Hyperglycemia|T047|NON|NRW|NLM (2009)|080128|abcdef", "ENTRY": "Postprandial Hyperglycemias", "MN": "C18.452.394.952", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with HYPOGLYCEMIA; HYPERGLYCEMIC MICE see MICE, OBESE is available: do not add HYPERGLYCEMIA or OBESITY unless disease is particularly discussed; Somogyi effect or rebound hyperglycemia: index HYPERGLYCEMIA / chem ind + DIABETES MELLITUS / drug ther + INSULIN / adv eff; \"induced hyperglycemia\" in disease states or physiologic studies: index BLOOD GLUCOSE, not HYPERGLYCEMIA", "MS": "Abnormally high BLOOD GLUCOSE level.", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006943"}, {"RECTYPE": "D", "MH": "Hyperglycemic Hyperosmolar Nonketotic Coma", "DE": "HHNK", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Coma, Hyperglycemic Hyperosmolar Nonketotic|T047|NON|EQV|UNK (19XX)|760426|abcdef", "ENTRY": "Syndromes, Hyperosmolar Hyperglycemic", "MN": "C19.246.099.750.490", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "do not confuse with HYPERGLYCINEMIA, NONKETOTIC", "PI": "Osmolar Concentration (1970-1976)", "MS": "A serious complication of TYPE 2 DIABETES MELLITUS. It is characterized by extreme HYPERGLYCEMIA; DEHYDRATION; serum hyperosmolarity; and depressed consciousness leading to COMA in the absence of KETOSIS and ACIDOSIS.", "PM": "91; was see under DIABETIC COMA 1977-90", "HN": "91(77); was see under DIABETIC COMA 1977-90", "CATSH": "CAT LIST", "MR": "20150109", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D006944"}, {"RECTYPE": "D", "MH": "Hyperhidrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperidrosis|T033|T047|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abbcdeef", "MN": "C17.800.946.350", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "excessive sweating; do not confuse with HYPOHIDROSIS, reduced sweating", "PI": "Sweating (1966-1975)", "MS": "Excessive sweating. In the localized type, the most frequent sites are the palms, soles, axillae, inguinal folds, and the perineal area. Its chief cause is thought to be emotional. Generalized hyperhidrosis may be induced by a hot, humid environment, by fever, or by vigorous exercise.", "OL": "search SWEATING 1966-75", "PM": "76; was see under SWEATING 1963-75", "HN": "76; was see under SWEATING 1963-75", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D006945"}, {"RECTYPE": "D", "MH": "Hyperinsulinism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperinsulinism, Exogenous", "MN": "C18.452.394.968", "FX": "Insulin", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.", "PM": "1963; for HYPERINSULINEMIA see HYPERINSULINEMIA 1997-2003", "HN": "1963", "CATSH": "CAT LIST", "MR": "20040728", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D006946"}, {"RECTYPE": "D", "MH": "Hyperkalemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperpotassemia|T033|T046|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Hyperpotassemias", "MN": "C18.452.950.396", "FX": "Paralysis, Hyperkalemic Periodic", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "high blood potassium levels; do not confuse with HYPOKALEMIA", "MS": "Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006947"}, {"RECTYPE": "D", "MH": "Hyperkinesis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperactivity, Motor|T184|NON|EQV|UNK (19XX)|781219|abcdef", "ENTRY": "Movements, Hyperkinetic", "MN": "C23.888.592.350.350", "MH_TH": "BIOETHICS (1989)", "ST": "T184", "AN": "human & animal; MOTOR ACTIVITY is also available: see note there; do not confuse with MYOKYMIA or ISAACS SYNDROME", "PI": "Movement Disorders (1966-1967)", "MS": "Excessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders.", "OL": "use MOVEMENT DISORDERS to search HYPERKINESIA 1966-68", "PM": "69; was HYPERKINESIA see under MOVEMENT DISORDERS 1963-68", "HN": "69; was HYPERKINESIA see under MOVEMENT DISORDERS 1963-68", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D006948"}, {"RECTYPE": "D", "MH": "Hyperlipidemias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperlipemia|T047|NON|EQV|UNK (19XX)|790425|abcdef", "ENTRY": "Lipidemias", "MN": "C18.452.584.500.500", "MH_TH": "NLM (2007)", "ST": "T047", "AN": "general; prefer specifics", "MS": "Conditions with excess LIPIDS in the blood.", "OL": "use HYPERLIPIDEMIA to search HYPERLIPEMIA 1966-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA/genetics 1966-79", "PM": "80; was HYPERLIPEMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79; HYPERCHOLESTEREMIA, ESSENTIAL FAMILIAL was see under HYPERLIPEMIA, ESSENTIAL FAMILIAL 1963-74; HYPERLIPOPROTEINEMIA, FAMILIAL was see HYPERLIPEMIA, ESSENTIAL FAMILIAL 1974-79", "HN": "80; was HYPERLIPEMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79; HYPERCHOLESTEREMIA, ESSENTIAL FAMILIAL was see under HYPERLIPEMIA, ESSENTIAL FAMILIAL 1963-74; HYPERLIPOPROTEINEMIA, FAMILIAL was see HYPERLIPEMIA, ESSENTIAL FAMILIAL 1974-79", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D006949"}, {"RECTYPE": "D", "MH": "Hyperlipidemia, Familial Combined", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperlipidemia, Multiple Lipoprotein-Type|T047|NON|EQV|UNK (19XX)|790423|abcdef", "ENTRY": "Multiple Lipoprotein-Type Hyperlipidemias", "MN": "C18.452.648.398.450", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma CHOLESTEROL and/or TRIGLYCERIDES. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (UPSTREAM STIMULATORY FACTORS) on CHROMOSOME 1.", "OL": "search HYPERLIPOPROTEINEMIA under HYPERLIPIDEMIA 1975-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA/genetics 1966-79", "PM": "80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it)", "HN": "80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19790423", "DC": "1", "DX": "19800101", "UI": "D006950"}, {"RECTYPE": "D", "MH": "Hyperlipoproteinemias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperlipoproteinemia|T047|NON|EQV|NLM (1980)|990101|abcdef", "MN": "C18.452.584.500.500.644", "FX": "Lipoproteins", "MH_TH": "NLM (2007)", "ST": "T047", "AN": "do not confuse with HYPOLIPOPROTEINEMIA; general or unspecified: specific Types I-V are available", "PI": "Hyperlipidemia (1966-1979)", "MS": "Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.", "PM": "2007; see HYPERLIPOPROTEINEMIA 1980-2006, see HYPERLIPEMIA 1975-1979", "HN": "2007 (1980); use HYPERLIPEMIA 1975-1979", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19790423", "DC": "1", "DX": "19800101", "UI": "D006951"}, {"RECTYPE": "D", "MH": "Hyperlipoproteinemia Type III", "DS": "HYPERLIPOPROTEINEMIA TYPE 03", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dysbetalipoproteinemia, Familial|T047|NON|EQV|NLM (2007)|050718|abcdef", "ENTRY": "Type III Hyperlipoproteinemias", "MN": "C18.452.648.398.483", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Hyperlipidemia/familial & genetic (1966-1979)", "MS": "An autosomal recessively inherited disorder characterized by the accumulation of intermediate-density lipoprotein (IDL or broad-beta-lipoprotein). IDL has a CHOLESTEROL to TRIGLYCERIDES ratio greater than that of VERY-LOW-DENSITY LIPOPROTEINS. This disorder is due to mutation of APOLIPOPROTEINS E, a receptor-binding component of VLDL and CHYLOMICRONS, resulting in their reduced clearance and high plasma levels of both cholesterol and triglycerides.", "PM": "1980; for AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA see HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA 2022", "HN": "1980; for AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA use HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA 2022", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19790423", "DC": "1", "DX": "19800101", "UI": "D006952"}, {"RECTYPE": "D", "MH": "Hyperlipoproteinemia Type IV", "DS": "HYPERLIPOPROTEINEMIA TYPE 04", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypertriglyceridemia, Familial|T047|NON|EQV|OMIM (2013)|UNK (19XX)|790423|abcdeef", "ENTRY": "Type IV, Hyperlipoproteinemia", "MN": "C18.452.648.398.487", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Hyperlipidemia (1966-1979)", "MS": "A hypertriglyceridemia disorder, often with autosomal dominant inheritance. It is characterized by the persistent elevations of plasma TRIGLYCERIDES, endogenously synthesized and contained predominantly in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). In contrast, the plasma CHOLESTEROL and PHOSPHOLIPIDS usually remain within normal limits.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19790423", "DC": "1", "DX": "19800101", "UI": "D006953"}, {"RECTYPE": "D", "MH": "Hyperlipoproteinemia Type V", "DS": "HYPERLIPOPROTEINEMIA TYPE 05", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Type V Hyperlipoproteinemias", "MN": "C18.452.648.398.493", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Hyperlipidemia (1966-1979)", "MS": "A severe type of hyperlipidemia, sometimes familial, that is characterized by the elevation of both plasma CHYLOMICRONS and TRIGLYCERIDES contained in VERY-LOW-DENSITY LIPOPROTEINS. Type V hyperlipoproteinemia is often associated with DIABETES MELLITUS and is not caused by reduced LIPOPROTEIN LIPASE activity as in HYPERLIPOPROTEINEMIA TYPE I .", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19790423", "DC": "1", "DX": "19800101", "UI": "D006954"}, {"RECTYPE": "D", "MH": "Hypernatremia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypernatremias", "MN": "C18.452.950.452", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "high blood sodium levels; do not confuse with HYPONATREMIA", "MS": "Excessive amount of sodium in the blood. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006955"}, {"RECTYPE": "D", "MH": "Hyperopia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypermetropia|T047|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "C11.744.479", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "refractive error; note X ref", "MS": "A refractive error in which rays of light entering the eye parallel to the optic axis are brought to a focus behind the retina, as a result of the eyeball being too short from front to back. It is also called farsightedness because the near point is more distant than it is in emmetropia with an equal amplitude of accommodation. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006956"}, {"RECTYPE": "D", "MH": "Hyperostosis Frontalis Interna", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Morgagni-Stewart-Morel Syndrome|T047|EPO|REL|OMIM (2013)|ORD (2010)|UNK (19XX)|840406|abcdeeef", "ENTRY": "Syndrome, Morgagni-Stewart-Morel", "MN": "C05.116.540.420", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "frontalis refers to frontal bone of skull", "MS": "Thickening of the inner table of the frontal bone, which may be associated with hypertrichosis and obesity. It most commonly affects women near menopause.", "OL": "use HYPEROSTOSIS FRONTALIS INTERNA to search LEONTIASIS OSSIUM 1966-84", "PM": "LEONTIASIS OSSIUM was heading 1963-84", "HN": "LEONTIASIS OSSIUM was heading 1963-84", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006957"}, {"RECTYPE": "D", "MH": "Hyperostosis, Cortical, Congenital", "DE": "HYPEROSTOSIS CORTICAL CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Infantile Cortical Hyperostosis|T047|NON|EQV|OMIM (2013)|ORD (2010)|UNK (19XX)|740330|abcdeeef", "ENTRY": "Syndrome, Caffey-De Toni-Silvermann", "MN": "C16.614.465", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "cortical refers to cortex of bone; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "A disease of young infants characterized by soft tissue swellings over the affected bones, fever, and irritability, and marked by periods of remission and exacerbation. (Dorland, 27th ed)", "OL": "use HYPEROSTOSIS, CORTICAL, CONGENITAL to search HYPEROSTOSIS, CORTICAL CONGENITAL 1966-90", "PM": "91; was HYPEROSTOSIS, CORTICAL CONGENITAL 1964-90", "HN": "91; was HYPEROSTOSIS, CORTICAL CONGENITAL 1964-90", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D006958"}, {"RECTYPE": "D", "MH": "Hyperoxaluria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Oxaluria|T047|NON|EQV|UNK (19XX)|860418|abcdef", "ENTRY": "Oxalosis|T047|NON|REL|GHR (2014)|130418|abcdef", "MN": "C12.950.419.313", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "HYPEROXALURIA, PRIMARY is also available", "PI": "Oxalates/urine (1966-1986)", "MS": "Excretion of an excessive amount of OXALATES in the urine.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D006959"}, {"RECTYPE": "D", "MH": "Hyperoxaluria, Primary", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Oxaluria, Primary|T047|NON|EQV|GHR (2014)|UNK (19XX)|860418|abcdeef", "ENTRY": "Primary Oxalurias", "MN": "C18.452.648.202.460", "MH_TH": "NLM (1987)", "ST": "T047", "MS": "A genetic disorder characterized by excretion of large amounts of OXALATES in urine; NEPHROLITHIASIS; NEPHROCALCINOSIS; early onset of RENAL FAILURE; and often a generalized deposit of CALCIUM OXALATE. There are subtypes classified by the enzyme defects in glyoxylate metabolism.", "PM": "91; was see under HYPEROXALURIA 1987-90", "HN": "91(87); was see under HYPEROXALURIA 1987-90", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19860418", "DC": "1", "DX": "19910101", "UI": "D006960"}, {"RECTYPE": "D", "MH": "Hyperparathyroidism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C19.642.355", "FX": "Osteitis Fibrosa Cystica", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006961"}, {"RECTYPE": "D", "MH": "Hyperparathyroidism, Secondary", "DE": "HYPERPARATHYROIDISM SECOND", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Secondary Hyperparathyroidisms", "MN": "C19.642.355.480", "MH_TH": "NLM (1970)", "ST": "T047", "PI": "Hyperparathyroidism (1966-1969)", "MS": "Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D006962"}, {"RECTYPE": "D", "MH": "Hyperphagia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Overeating|T184|NON|EQV|UNK (19XX)|800521|abcdef", "ENTRY": "Polyphagias", "MN": "C23.888.821.645", "FX": "Overnutrition", "MH_TH": "NLM (1981)", "ST": "T184", "PI": "Feeding Behavior (1969-1980)", "MS": "Ingestion of a greater than optimal quantity of food.", "PM": "89; was see under APPETITE DISORDERS 1981-88", "HN": "89(81); was see under APPETITE DISORDERS 1981-88", "CATSH": "CAT LIST", "MR": "20140606", "DA": "19800521", "DC": "1", "DX": "19890101", "UI": "D006963"}, {"RECTYPE": "D", "MH": "Hyperpituitarism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thyroid Stimulating Hormone, Inappropriate Secretion|T047|NON|NRW|NLM (2000)|991103|THYROID STIMULATING HORMONE INAPPROPRIATE SECRET|abcdefv", "ENTRY": "TSH Hypersecretion, Pituitary", "MN": "C19.700.355", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "coordinate with specific hormone if pertinent", "MS": "Disease of the glandular, anterior portion of the pituitary (PITUITARY GLAND, ANTERIOR) resulting in hypersecretion of ADENOHYPOPHYSEAL HORMONES such as GROWTH HORMONE; PROLACTIN; THYROTROPIN; LUTEINIZING HORMONE; FOLLICLE STIMULATING HORMONE ; and ADRENOCORTICOTROPIC HORMONE. Hyperpituitarism usually is caused by a functional ADENOMA.", "PM": "1967", "HN": "1967(1965)", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006964"}, {"RECTYPE": "D", "MH": "Hyperplasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperplasias", "MN": "C23.550.444", "FX": "Precancerous Conditions", "MH_TH": "NLM (1965)", "ST": "T046", "MS": "An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.", "PM": "1965", "HN": "1965", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006965"}, {"RECTYPE": "D", "MH": "Hyperprolactinemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Prolactin, Inappropriate Secretion|T047|NON|EQV|NLM (2000)|991103|PROLACTIN INAPPROPRIATE SECRET|abcdefv", "ENTRY": "Syndrome, Prolactin Hypersecretion", "MN": "C19.700.355.600", "MH_TH": "NLM (1986)", "ST": "T047", "PI": "Prolactin/blood (1966-1985)", "MS": "Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)", "PM": "1986", "HN": "1986", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19850311", "DC": "1", "DX": "19860101", "UI": "D006966"}, {"RECTYPE": "D", "MH": "Hypersensitivity", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Allergy|T033|T046|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Reactions, Allergic", "MN": "C20.543", "FX": "Multiple Chemical Sensitivity", "EC": "chemically induced:Drug Hypersensitivity", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.", "PM": "66; was ALLERGY 1963-65", "HN": "66; was ALLERGY 1963-65", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006967"}, {"RECTYPE": "D", "MH": "Hypersensitivity, Delayed", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Type IV Hypersensitivity|T046|NON|EQV|NLM (1993)|920203|abcdef", "ENTRY": "Type IV Hypersensitivities", "MN": "C20.543.418", "FX": "Encephalomyelitis, Acute Disseminated", "MH_TH": "NLM (1965)", "ST": "T046", "AN": "use qualif with caution; /chem ind: coordinate with DRUG HYPERSENSITIVITY or specifics ", "MS": "An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS.", "PM": "66", "HN": "66(65)", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006968"}, {"RECTYPE": "D", "MH": "Hypersensitivity, Immediate", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Type I Hypersensitivity|T046|NON|EQV|NLM (1993)|920203|abcdef", "ENTRY": "Type I Hypersensitivities", "MN": "C20.543.480", "FX": "Latex Hypersensitivity", "MH_TH": "NLM (1965)", "ST": "T046", "AN": "/chem ind: coord with DRUG HYPERSENSITIVITY or specifics", "MS": "Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability.", "PM": "66", "HN": "66(65)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006969"}, {"RECTYPE": "D", "MH": "Disorders of Excessive Somnolence", "DE": "DIS EXCESSIVE SOMNOLENCE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Secondary Hypersomnia Disorders|T047|NON|NRW|NLM (2021)|191219|abcdef", "ENTRY": "Somnolence, Daytime", "MN": "F03.870.400.800.200", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320)", "PM": "2000; see HYPERSOMNIA 1991-1999, see SLEEP DISORDERS 1975-1990", "HN": "2000(1975)", "CATSH": "CAT LIST", "MR": "20200221", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D006970"}, {"RECTYPE": "D", "MH": "Hypersplenism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anemia, Splenic|T047|NON|REL|UNK (19XX)|830503|abcdef", "ENTRY": "Splenic Anemias", "MN": "C15.604.744.293", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "increase in splenic hemolytic function: do not confuse with SPLENOMEGALY, increase in spleen size", "MS": "Condition characterized by splenomegaly, some reduction in the number of circulating blood cells in the presence of a normal or hyperactive bone marrow, and the potential for reversal by splenectomy.", "OL": "use HYPERSPLENISM to search ANEMIA, SPLENIC 1966-83", "PM": "ANEMIA, SPLENIC was heading 1963-81", "HN": "66; ANEMIA, SPLENIC was heading 1963-83, was see under HYPERSPLENISM 1982-83", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006971"}, {"RECTYPE": "D", "MH": "Hypertelorism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypertelorisms", "MN": "C16.131.621.207.231.480", "MH_TH": "OMIM (2013)", "ST": "T019", "AN": "a form of craniofacial dysostosis; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Abnormal increase in the interorbital distance due to overdevelopment of the lesser wings of the sphenoid.", "OL": "search CRANIOFACIAL DYSOSTOSIS 1966-74", "PM": "91; was see under BONE DISEASES, DEVELOPMENTAL 1985-90; was see under CRANIOFACIAL DYSOSTOSIS 1963-84", "HN": "91(75); was see under BONE DISEASES, DEVELOPMENTAL 1985-90; was see under CRANIOFACIAL DYSOSTOSIS 1963-84", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D006972"}, {"RECTYPE": "D", "MH": "Hypertension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Blood Pressure, High|T047|T184|NON|EQV|BIOETHICS (1989)|740330|abbcdef", "ENTRY": "High Blood Pressures", "MN": "C14.907.489", "FX": "Vascular Resistance", "MH_TH": "NLM (1963)", "ST": "T184", "AN": "not for intracranial or intraocular pressure; relation to BLOOD PRESSURE: Manual 23.27; Goldblatt kidney is HYPERTENSION, GOLDBLATT see HYPERTENSION, RENOVASCULAR; hypertension with kidney disease is probably HYPERTENSION, RENAL, not HYPERTENSION; venous hypertension: index under VENOUS PRESSURE (IM) & do not coordinate with HYPERTENSION; PREHYPERTENSION is also available", "MS": "Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006973"}, {"RECTYPE": "D", "MH": "Hypertension, Malignant", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Malignant Hypertension|T047|NON|EQV|NLM (2005)|040206|abcdef", "MN": "C14.907.489.330", "FX": "Hypertensive Encephalopathy", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "malignant does not refer to neoplasm: refers to severe hypertension with papilledema & arterial necrosis", "MS": "A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006974"}, {"RECTYPE": "D", "MH": "Hypertension, Portal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cruveilhier-Baumgarten Syndrome|T047|EPO|REL|NLM (1997)|960412|abcdef", "ENTRY": "Syndrome, Cruveilhier-Baumgarten", "MN": "C06.552.494", "FX": "Portasystemic Shunt, Surgical", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.", "OL": "use LIVER CIRRHOSIS to search CRUVEILHIER-BAUMGARTEN SYNDROME 1966-74", "PM": "CRUVEILHIER-BAUMGARTEN SYNDROME was heading 1975-96 (see under HYPERTENSION, PORTAL 1979-90, see under LIVER CIRRHOSIS 1975-78); was see under LIVER CIRRHOSIS 1963-74", "HN": "CRUVEILHIER-BAUMGARTEN SYNDROME was heading 1975-96 (see under HYPERTENSION, PORTAL 1979-90, see under LIVER CIRRHOSIS 1975-78); was see under LIVER CIRRHOSIS 1963-74", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006975"}, {"RECTYPE": "D", "MH": "Hypertension, Pulmonary", "DE": "HYPERTENSION PULM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulmonary Hypertension|T047|T184|NON|EQV|NLM (1992)|900925|PULM HYPERTENSION|abbcdefv", "MN": "C14.907.489.556", "FX": "Pulmonary Heart Disease", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006976"}, {"RECTYPE": "D", "MH": "Hypertension, Renal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Renal Hypertensions", "MN": "C14.907.489.631", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific kidney dis (IM) if pertinent; Goldblatt hypertension or Goldblatt kidney is HYPERTENSION, GOLDBLATT see HYPERTENSION, RENOVASCULAR", "MS": "Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006977"}, {"RECTYPE": "D", "MH": "Hypertension, Renovascular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypertension, Goldblatt|T047|EPO|NRW|UNK (19XX)|840214|abcdef", "ENTRY": "Syndrome, Goldblatt", "MN": "C14.907.489.631.485", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "do not routinely index also under RENAL ARTERY or RENAL ARTERY OBSTRUCTION", "PI": "Hypertension, Renal (1966-1978)", "MS": "Hypertension due to RENAL ARTERY OBSTRUCTION or compression.", "PM": "84; was see under HYPERTENSION, RENAL 1979-83", "HN": "84(79); was see under HYPERTENSION, RENAL 1979-83", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19771206", "DC": "1", "DX": "19840101", "UI": "D006978"}, {"RECTYPE": "D", "MH": "Hyperthermia, Induced", "DE": "HYPERTHERMIA IND", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Thermotherapy|T061|NON|EQV|UNK (19XX)|830617|THERMOTHER|abcdefv", "ENTRY": "Local Hyperthermia", "MN": "E02.565", "FX": "Hyperthermia", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs.", "OL": "use HYPERTHERMIA, INDUCED to search FEVER THERAPY 1966-83", "PM": "84; was FEVER THERAPY 1963-83", "HN": "84; was FEVER THERAPY 1963-83", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D006979"}, {"RECTYPE": "D", "MH": "Hyperthyroidism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperthyroids", "MN": "C19.874.397", "FX": "Long-Acting Thyroid Stimulator", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE.", "CATSH": "CAT LIST", "MR": "20160606", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006980"}, {"RECTYPE": "D", "MH": "Hyperthyroxinemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperthyroxinemias", "MN": "C19.874.410", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Thyroxine/blood (1966-1986)", "MS": "Abnormally elevated THYROXINE level in the BLOOD.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19860326", "DC": "1", "DX": "19870101", "UI": "D006981"}, {"RECTYPE": "D", "MH": "Hypertonic Solutions", "DE": "HYPERTONIC SOL", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Hypertonic Solution|T121|NON|EQV|NLM (2022)|200928|abcdef", "ENTRY": "Solutions, Hypertonic", "MN": "D26.776.314", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; no qualifers when NIM coorddinate", "MS": "Solutions that have a greater osmotic pressure than a reference solution such as blood, plasma, or interstitial fluid.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006982"}, {"RECTYPE": "D", "MH": "Hypertrichosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypertrichoses", "MN": "C17.800.329.875", "FX": "Hirsutism", "MH_TH": "NLM (1963)", "ST": "T184", "MS": "Excessive hair growth at inappropriate locations, such as on the extremities, the head, and the back. It is caused by genetic or acquired factors, and is an androgen-independent process. This concept does not include HIRSUTISM which is an androgen-dependent excess hair growth in WOMEN and CHILDREN.", "CATSH": "CAT LIST", "MR": "20040728", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006983"}, {"RECTYPE": "D", "MH": "Hypertrophy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypertrophies", "MN": "C23.300.775", "FX": "Cell Enlargement", "MH_TH": "NLM (1965)", "ST": "T190", "AN": "NIM; general or unspecified: many precoordinated organ/hypertrophy terms are available; do not confuse with HYPERPLASIA; coord with organ /pathol (IM)", "MS": "General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).", "PM": "65; HYPERTROPHY AND HYPERPLASIA was heading 1963-64", "HN": "65; HYPERTROPHY AND HYPERPLASIA was heading 1963-64", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006984"}, {"RECTYPE": "D", "MH": "Hyperventilation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperventilations", "MN": "C23.888.852.591", "FX": "Hypocapnia", "MH_TH": "NLM (1964)", "ST": "T184", "AN": "respiratory, not environmental; hyperventilation syndrome: coord IM with /psychol + emotional aspect (IM or NIM)", "MS": "A pulmonary ventilation rate faster than is metabolically necessary for the exchange of gases. It is the result of an increased frequency of breathing, an increased tidal volume, or a combination of both. It causes an excess intake of oxygen and the blowing off of carbon dioxide.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D006985"}, {"RECTYPE": "D", "MH": "Hypervitaminosis A", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C18.654.301", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Vitamin A (1966-1986)", "MS": "A symptom complex resulting from ingesting excessive amounts of VITAMIN A.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D006986"}, {"RECTYPE": "D", "MH": "Hypesthesia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Numbness|T184|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Thermal Hypesthesias", "MN": "C23.888.592.763.770.500", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "do not confuse with HYPERESTHESIA, increased sensitivity; coord with TOUCH or HOT TEMPERATURE if pertinent", "MS": "Absent or reduced sensitivity to cutaneous stimulation.", "CATSH": "CAT LIST", "MR": "20080710", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006987"}, {"RECTYPE": "D", "MH": "Hyphema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyphemas", "MN": "C23.550.414.756.550", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Bleeding in the anterior chamber of the eye.", "OL": "use HYPHEMA to search HYPHEMIA 1966", "PM": "67; was HYPHEMIA 1966", "HN": "67; was HYPHEMIA 1966", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D006988"}, {"RECTYPE": "D", "MH": "Hypnosis", "AQ": "ES HI IS MT SN", "PRINT ENTRY": "Self-Hypnosis|T061|NON|REL|NLM (2024)|230202|abcdef", "ENTRY": "Self Hypnosis", "MN": "F04.754.424", "MH_TH": "BIOETHICS (1989)", "ST": "T061", "AN": "human only; for animals use ANIMAL HYPNOSIS see IMMOBILITY RESPONSE, TONIC", "MS": "A state of increased receptivity to suggestion and direction, initially induced by the influence of another person or oneself.", "OL": "use HYPNOSIS to search MESMERISM 1966-78", "HN": "MESMERISM was see under HYPNOSIS 1963-78", "CATSH": "CAT LIST", "MR": "20230414", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006990"}, {"RECTYPE": "D", "MH": "Hypnosis, Anesthetic", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Hypnoses, Anesthetic", "MN": "E03.155.675", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Procedure in which an individual is induced into a trance-like state to relieve pain. This procedure is frequently performed with local but not general ANESTHESIA.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006991"}, {"RECTYPE": "D", "MH": "Hypnosis, Dental", "DE": "HYPNOSIS DENT", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Hypnoses, Dental", "MN": "E06.045.481", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Process in which a patient is induced into a trance-like state in order to relieve anxiety during a dental procedure.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D006992"}, {"RECTYPE": "D", "MH": "Hypnotics and Sedatives", "DE": "HYPNOTICS SEDATIVES", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sedatives|T121|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Hypnotic and Sedative", "MN": "D27.505.954.427.210.350", "FX": "Tranquilizing Agents", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "note entry terms HYPNOTIC EFFECT and SEDATIVE EFFECT: use only for the hypnotic or sedative effect of a chemical substance", "MS": "Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006993"}, {"RECTYPE": "D", "MH": "Hypoaldosteronism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Type IV Renal Tubular Acidosis|T047|NON|NRW|NLM (1998)|970616|abcdef", "ENTRY": "Hyporeninemic Hypoaldosteronism|T047|NON|NRW|NLM (2007)|051101|abcdef", "MN": "C19.053.500.480", "MH_TH": "NLM (1988)", "ST": "T047", "AN": "do not confuse with HYPERALDOSTERONISM or PSEUDOHYPOALDOSTERONISM", "PI": "Aldosterone (1966-1987)", "MS": "A congenital or acquired condition of insufficient production of ALDOSTERONE by the ADRENAL CORTEX leading to diminished aldosterone-mediated synthesis of Na(+)-K(+)-EXCHANGING ATPASE in renal tubular cells. Clinical symptoms include HYPERKALEMIA, sodium-wasting, HYPOTENSION, and sometimes metabolic ACIDOSIS.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19870313", "DC": "1", "DX": "19880101", "UI": "D006994"}, {"RECTYPE": "D", "MH": "Hypobetalipoproteinemias", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypo beta Lipoproteinemias", "MN": "C18.452.648.398.500.440", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Lipoproteins, LDL (1972-1977)", "MS": "Conditions with abnormally low levels of BETA-LIPOPROTEINS (low density lipoproteins or LDL) in the blood. It is defined as LDL values equal to or less than the 5th percentile for the population. They include the autosomal dominant form involving mutation of the APOLIPOPROTEINS B gene, and the autosomal recessive form involving mutation of the microsomal triglyceride transfer protein. All are characterized by low LDL and dietary fat malabsorption.", "PM": "2007; see HYPOBETALIPOPROTEINEMIA 1991-2006, see HYPOLIPOPROTEINEMIA 1980-1990, see HYPOLIPOPROTEINEMIAS 1978-1979", "HN": "2007 (1978)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19770429", "DC": "1", "DX": "19910101", "UI": "D006995"}, {"RECTYPE": "D", "MH": "Hypocalcemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypocalcemias", "MN": "C18.452.950.509", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "low blood calcium levels; do not confuse with HYPERCALCEMIA", "MS": "Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D006996"}, {"RECTYPE": "D", "MH": "Hypochlorous Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hypochlorite|T196|NON|NRW|FDA SRS (2014)|NLM (1994)|930106|abcdeef", "ENTRY": "Hypochlorous Acids|T197|NON|BRD|NLM (1994)|921211|abcdef", "MN": "D01.650.550.400", "PA": "Oxidants", "MH_TH": "NLM (1975)", "ST": "T197", "N1": "Hypochlorous acid", "RN": "712K4CDC10", "RR": "T5UM7HB19N", "PI": "Sodium Hypochlorite (1966-1974)", "MS": "An oxyacid of chlorine (HClO) containing monovalent chlorine that acts as an oxidizing or reducing agent.", "OL": "use HYPOCHLOROUS ACID to search HYPOCHLOROUS ACIDS 1975-93", "PM": "94; was HYPOCHLOROUS ACIDS 1975-93 (see under ACIDS 1975-76); HYPOCHLOROUS ACID was indexed under HYPOCHLOROUS ACIDS 1982-93", "HN": "94; was HYPOCHLOROUS ACIDS 1975-93 (see under ACIDS 1975-76); HYPOCHLOROUS ACID was (NM) 1982-93", "MR": "20230226", "DA": "19741119", "DC": "1", "DX": "19770101", "UI": "D006997"}, {"RECTYPE": "D", "MH": "Hypochondriasis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Neurosis, Hypochondriacal|T048|NON|EQV|UNK (19XX)|800520|abcdef", "ENTRY": "Hypochondriacal Neurosis", "MN": "F03.875.450", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "Preoccupation with the fear of having, or the idea that one has, a serious disease based on the person's misinterpretation of bodily symptoms. (APA, DSM-IV)", "OL": "use HYPOCHONDRIASIS to search HYPOCHONDRIACAL NEUROSES 1969-80", "HN": "NEUROSIS, HYPOCHONDRIACAL was HYPOCHONDRIACAL NEUROSES see HYPOCHONDRIASIS 1979-80, was HYPOCHONDRIACAL NEUROSES see under HYPOCHONDRIASIS 1969-78", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D006998"}, {"RECTYPE": "D", "MH": "Hypocreales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Hypocreale", "MN": "B01.300.107.501", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5125", "PI": "Ascomycetes (1966-1974)", "MS": "An order of fungi in the phylum ASCOMYCOTA that includes a number of species which are parasitic on higher plants, insects, or fungi. Other species are saprotrophic.", "PM": "75; see ASCOMYCETES 1963-74", "HN": "75(63)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D006999"}, {"RECTYPE": "D", "MH": "Hypodermyiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Hypodermyiases", "MN": "C01.610.858.211.503.398", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "Hypoderma is indexed under DIPTERA", "PI": "Myiasis (1966-1967)", "MS": "Infestation with larvae of the genus Hypoderma, the warble fly.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007000"}, {"RECTYPE": "D", "MH": "Hypogastric Plexus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Pelvic Plexus|T023|NON|NRW|NLM (1994)|921005|abcdef", "ENTRY": "Plexus, Pelvic", "MN": "A08.800.800.060.400", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "a network of autonomic nerve fibers in the pelvic region", "MS": "A complex network of nerve fibers in the pelvic region. The hypogastric plexus distributes sympathetic fibers from the lumbar paravertebral ganglia and the aortic plexus, parasympathetic fibers from the pelvic nerve, and visceral afferents. The bilateral pelvic plexus is in its lateral extent.", "MR": "19930618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007001"}, {"RECTYPE": "D", "MH": "Hypoglossal Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Twelfth Cranial Nerve|T023|NON|EQV|NLM (1998)|960731|abcdef", "ENTRY": "XIIs, Nerve", "MN": "A08.800.800.120.330", "EC": "injuries:Hypoglossal Nerve Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The 12th cranial nerve. The hypoglossal nerve originates in the hypoglossal nucleus of the medulla and supplies motor innervation to all of the muscles of the tongue except the palatoglossus (which is supplied by the vagus). This nerve also contains proprioceptive afferents from the tongue muscles.", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007002"}, {"RECTYPE": "D", "MH": "Hypoglycemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypoglycemia, Reactive", "MN": "C18.452.394.984", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "for hypoglycemic effects caused by plants or extracts use HYPOGLYCEMIC AGENTS", "MS": "A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007003"}, {"RECTYPE": "D", "MH": "Hypoglycemic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hypoglycemic Drug|T121|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Effects, Hypoglycemic", "MN": "D27.505.696.422", "MH_TH": "NLM (1976)", "ST": "T121", "RN": "0", "AN": "note entry term HYPOGLYCEMIC EFFECT: use only for the hypoglycemic effect of a chemical substance", "MS": "Substances which lower blood glucose levels.", "OL": "use HYPOGLYCEMIC AGENTS to search ANTIDIABETICS 1966-75", "PM": "76; was see under ANTIDIABETICS 1968-74; ANTIDIABETICS was heading 1963-75", "HN": "76; was NON MESH 1975, was see under ANTIDIABETICS 1968-74; ANTIDIABETICS was heading 1963-75", "MR": "20200527", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D007004"}, {"RECTYPE": "D", "MH": "Hypoglycins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.946.412", "PA": "Poisons", "MH_TH": "NLM (1977)", "ST": "T131", "RN": "0", "AN": "Jamaican vomiting sickness : coordinate HYPOGLYCINS /pois (IM) with PLANT POISONING (IM)", "PI": "Cyclopropanes (1970-1976)", "MS": "Methylene cyclopropyl alanine and congeners isolated from the unripe edible fruit of the AKEE plant (BLIGHIA SAPIDA). Hypoglycin B is the gamma-glutamyl congener of hypoglycin A. They are very toxic and teratogenic, causing a syndrome called Jamaican vomiting sickness that includes a fall in blood glucose due to the interference of FATTY ACIDS and LEUCINE metabolism which leads to VOMITING, liver damage, CONVULSIONS and DEATH.", "PM": "91; was see under CYCLOPROPANES 1977-90", "HN": "91(77); was see under CYCLOPROPANES 1977-90", "MR": "20050630", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D007005"}, {"RECTYPE": "D", "MH": "Hypogonadism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypogonadism, Hypogonadotropic", "MN": "C19.391.482", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "for male or female; do not routinely interpret hypogonadism in male as EUNUCHISM: use terminology of author", "MS": "Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism).", "PM": "1966", "HN": "1966", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007006"}, {"RECTYPE": "D", "MH": "Hypohidrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anhidrosis|T047|NON|REL|OMIM (2013)|UNK (19XX)|750724|abcdeef", "MN": "C17.800.946.370", "MH_TH": "NLM (1976)", "ST": "T047", "AN": "diminished sweating; do not confuse with HYPERHIDROSIS, excessive sweating", "PI": "Sweating (1966-1974)", "MS": "Abnormally diminished or absent perspiration. Both generalized and segmented (reduced or absent sweating in circumscribed locations) forms of the disease are usually associated with other underlying conditions.", "OL": "use HYPOHIDROSIS to search ANHIDROSIS 1975", "PM": "76; was ANHIDROSIS 1975", "HN": "76; was ANHIDROSIS 1975", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D007007"}, {"RECTYPE": "D", "MH": "Hypokalemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypopotassemia|T033|T047|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Hypopotassemias", "MN": "C18.452.950.565", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "low blood potassium levels; do not confuse with HYPERKALEMIA", "MS": "Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007008"}, {"RECTYPE": "D", "MH": "Hypolipoproteinemias", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypoprebetalipoproteinemia|T047|NON|NRW|NLM (2007)|050719|abcdef", "MN": "C18.452.648.398.500", "FX": "Lipoproteins", "MH_TH": "NLM (2007)", "ST": "T047", "AN": "do not confuse with HYPERLIPOPROTEINEMIA; hypoprebetalipoproteinemia: coordinate IM with LIPOPROTEINS, VLDL /blood (IM); HYPOALPHALIPOPROTEINEMIA; HYPOBETALIPOPROTEINEMIA; & ABETALIPOPROTEINEMIA are also available", "PI": "Lipoproteins, HDL (1972-1977)", "MS": "Conditions with abnormally low levels of LIPOPROTEINS in the blood. This may involve any of the lipoprotein subclasses, including ALPHA-LIPOPROTEINS (high-density lipoproteins); BETA-LIPOPROTEINS (low-density lipoproteins); and PREBETA-LIPOPROTEINS (very-low-density lipoproteins).", "PM": "2007; see HYPOLIPOPROTEINEMIA 1980-2006, see HYPOLIPOPROTEINEMIAS 1978-1979", "HN": "2007 (1978)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D007009"}, {"RECTYPE": "D", "MH": "Hyponatremia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyponatremias", "MN": "C18.452.950.620", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "low blood sodium levels; do not confuse with HYPERNATREMIA", "MS": "Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007010"}, {"RECTYPE": "D", "MH": "Hypoparathyroidism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypoparathyroidism, Idiopathic", "MN": "C19.642.482", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.", "CATSH": "CAT LIST", "MR": "20090731", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007011"}, {"RECTYPE": "D", "MH": "Hypopharyngeal Neoplasms", "DE": "HYPOPHARYNGEAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Hypopharyngeal Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Hypopharyngeal", "MN": "C09.775.549.485", "MH_TH": "NLM (1985)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "PI": "Pharyngeal Neoplasms (1966-1984)", "MS": "Tumors or cancer of the HYPOPHARYNX.", "PM": "91; was see under PHARYNGEAL NEOPLASMS 1985-90", "HN": "91(85); was see under PHARYNGEAL NEOPLASMS 1985-90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19840529", "DC": "1", "DX": "19910101", "UI": "D007012"}, {"RECTYPE": "D", "MH": "Hypopharynx", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Laryngopharynx|T023|NON|EQV|NLM (1988)|881130|abcdef", "ENTRY": "Laryngopharynxes|T023|NON|EQV|NLM (1990)|890306|abcdef", "MN": "A14.724.490", "MH_TH": "NLM (1979)", "ST": "T023", "AN": "inflammation: coordinate IM with PHARYNGITIS (IM)", "PI": "Pharynx (1966-1978)", "MS": "The bottom portion of the pharynx situated below the OROPHARYNX and posterior to the LARYNX. The hypopharynx communicates with the larynx through the laryngeal inlet, and is also called laryngopharynx.", "PM": "79", "HN": "79", "MR": "20080708", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D007013"}, {"RECTYPE": "D", "MH": "Hypophosphatasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypophosphatasias", "MN": "C18.452.648.618.482", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "defic of blood phosphatases; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "A genetic metabolic disorder resulting from serum and bone alkaline phosphatase deficiency leading to hypercalcemia, ethanolamine phosphatemia, and ethanolamine phosphaturia. Clinical manifestations include severe skeletal defects resembling vitamin D-resistant rickets, failure of the calvarium to calcify, dyspnea, cyanosis, vomiting, constipation, renal calcinosis, failure to thrive, disorders of movement, beading of the costochondral junction, and rachitic bone changes. (From Dorland, 27th ed)", "PM": "72", "HN": "72(66)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D007014"}, {"RECTYPE": "D", "MH": "Hypophosphatemia, Familial", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypophosphatemias, Familial", "MN": "C18.452.750.400.500", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "An inherited condition of abnormally low serum levels of PHOSPHATES (below 1 mg/liter) which can occur in a number of genetic diseases with defective reabsorption of inorganic phosphorus by the PROXIMAL RENAL TUBULES. This leads to phosphaturia, HYPOPHOSPHATEMIA, and disturbances of cellular and organ functions such as those in X-LINKED HYPOPHOSPHATEMIC RICKETS; OSTEOMALACIA; and FANCONI SYNDROME.", "PM": "1965", "HN": "1965", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007015"}, {"RECTYPE": "D", "MH": "Hypophysectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Hypophysectomies", "MN": "E04.525.400", "FX": "Pituitary Irradiation", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Surgical removal or destruction of the hypophysis, or pituitary gland. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007016"}, {"RECTYPE": "D", "MH": "Hypophysectomy, Chemical", "DE": "HYPOPHYSECTOMY CHEM", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Hypophysectomies, Chemical", "MN": "E04.270.532.490", "MH_TH": "NLM (1982)", "ST": "T061", "AN": "coord IM with disease /ther (IM), not /surg; usually performed with ethyl alcohol so do not index under ETHANOL unless particularly discussed", "PI": "Pituitary Gland/drug effects (1977-1981)", "MS": "Total or subtotal destruction of the pituitary gland by chemical injection. It is usually achieved by injection of ethyl alcohol via trans-sphenoidal cannulation under stereotaxic control. It is usually performed for the treatment of intractable pain.", "PM": "91; was see under HYPOPHYSECTOMY 1982-90", "HN": "91(82); was see under HYPOPHYSECTOMY 1982-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19810224", "DC": "1", "DX": "19910101", "UI": "D007017"}, {"RECTYPE": "D", "MH": "Hypopituitarism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Simmonds Disease|T047|EPO|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Syndrome, Sheehan's", "MN": "C19.700.482", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions.", "PM": "1963; for SIMMONDS' DISEASE & SHEEHAN'S SYNDROME see SIMMONDS' DISEASE 1963-1967", "HN": "1963; for SIMMONDS' DISEASE & SHEEHAN'S SYNDROME use SIMMONDS' DISEASE 1963-1967", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D007018"}, {"RECTYPE": "D", "MH": "Hypoproteinemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypoproteinemias", "MN": "C15.378.147.607", "FX": "Protein-Losing Enteropathies", "MH_TH": "NLM (1963)", "ST": "T184", "MS": "A condition in which total serum protein level is below the normal range. Hypoproteinemia can be caused by protein malabsorption in the gastrointestinal tract, EDEMA, or PROTEINURIA.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007019"}, {"RECTYPE": "D", "MH": "Hypoprothrombinemias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Prothrombin Deficiency|T047|NON|EQV|GHR (2014)|NLM (1999)|980316|PROTHROMBIN DEFIC|abcdeefv", "ENTRY": "Prothrombin Deficiencies", "MN": "C16.320.099.550", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Absence or reduced levels of PROTHROMBIN in the blood.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007020"}, {"RECTYPE": "D", "MH": "Hypospadias", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypospadia", "MN": "C16.131.939.516", "MH_TH": "NLM (1966)", "ST": "T019", "MS": "A birth defect due to malformation of the URETHRA in which the urethral opening is below its normal location. In the male, the malformed urethra generally opens on the ventral surface of the PENIS or on the PERINEUM. In the female, the malformed urethral opening is in the VAGINA.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007021"}, {"RECTYPE": "D", "MH": "Hypotension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Blood Pressure, Low|T033|T046|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Vascular Hypotension|T033|T046|NON|EQV|NLM (2008)|070109|abbcdef", "MN": "C14.907.514", "FX": "Syncope, Vasovagal", "MH_TH": "NLM (1963)", "ST": "T046", "AN": "only blood pressure; INTRACRANIAL HYPOTENSION and OCULAR HYPOTENSION are also available; relation to BLOOD PRESSURE: Manual 23.27+", "MS": "Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007022"}, {"RECTYPE": "D", "MH": "Hypotension, Controlled", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Induced Hypotension|T061|NON|EQV|NLM (2016)|150223|abcdef", "MN": "E03.545", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "note category: a technique", "MS": "Procedure in which arterial blood pressure is intentionally reduced in order to control blood loss during surgery. This procedure is performed either pharmacologically or by pre-surgical removal of blood.", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007023"}, {"RECTYPE": "D", "MH": "Hypotension, Orthostatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypotension, Postural|T033|NON|EQV|NLM (1993)|911107|abcdef", "ENTRY": "Postural Hypotension", "MN": "C14.907.514.482", "FX": "Posture", "MH_TH": "ORD (2010)", "ST": "T033", "MS": "A significant drop in BLOOD PRESSURE after assuming a standing position. Orthostatic hypotension is a finding, and defined as a 20-mm Hg decrease in systolic pressure or a 10-mm Hg decrease in diastolic pressure 3 minutes after the person has risen from supine to standing. Symptoms generally include DIZZINESS, blurred vision, and SYNCOPE.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007024"}, {"RECTYPE": "D", "MH": "Anterior Hypothalamic Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hypothalamic Area, Anterior|T023|NON|EQV|NLM (1983)|990101|abcdef", "ENTRY": "Nucleus, Anterior Hypothalamic", "MN": "A08.186.211.200.317.357.342.063", "MH_TH": "UNK (19XX)", "ST": "T023", "AN": "diseases: coordinate IM with HYPOTHALAMIC DISEASES (IM)", "PI": "Hypothalamus, Anterior (1975-1982)", "MS": "Loose heterogeneous collection of cells in the anterior hypothalamus, continuous rostrally with the medial and lateral PREOPTIC AREAS and caudally with the TUBER CINEREUM.", "PM": "2000; see HYPOTHALAMIC AREA, ANTERIOR 1983-1999; for ANTERIOR HYPOTHALAMIC NUCLEUS see HYPOTHALAMIC AREA, ANTERIOR 1983-1999", "HN": "2000(1983)", "MR": "20180630", "DA": "19820428", "DC": "1", "DX": "19830101", "UI": "D007025"}, {"RECTYPE": "D", "MH": "Hypothalamic Area, Lateral", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Tuberomammillary Nucleus|T023|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Tuberal Nucleus, Lateral", "MN": "A08.186.211.200.317.357.300", "MH_TH": "NLM (1983)", "ST": "T023", "AN": "diseases: coordinate IM with HYPOTHALAMIC DISEASES (IM)", "PI": "Hypothalamus (1966-1982)", "MS": "Area in the hypothalamus bounded medially by the mammillothalamic tract and the anterior column of the FORNIX (BRAIN). The medial edge of the INTERNAL CAPSULE and the subthalamic region form its lateral boundary. It contains the lateral hypothalamic nucleus, tuberomammillary nucleus, lateral tuberal nuclei, and fibers of the MEDIAL FOREBRAIN BUNDLE.", "PM": "83", "HN": "83", "MR": "20180630", "DA": "19820428", "DC": "1", "DX": "19830101", "UI": "D007026"}, {"RECTYPE": "D", "MH": "Hypothalamic Diseases", "DE": "HYPOTHALAMIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pituitary Diencephalic Syndrome|T047|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Syndromes, Pituitary Diencephalic", "MN": "C10.228.140.617", "MH_TH": "NLM (1981)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with specific part of hypothalamus ", "PI": "Hypothalamus (1966-1980)", "MS": "Neoplastic, inflammatory, infectious, and other diseases of the hypothalamus. Clinical manifestations include appetite disorders; AUTONOMIC NERVOUS SYSTEM DISEASES; SLEEP DISORDERS; behavioral symptoms related to dysfunction of the LIMBIC SYSTEM; and neuroendocrine disorders.", "PM": "1981; FROEHLICH'S SYNDROME was heading 1963-1984", "HN": "1981", "CATSH": "CAT LIST", "MR": "19991203", "DA": "19800404", "DC": "1", "DX": "19810101", "UI": "D007027"}, {"RECTYPE": "D", "MH": "Hypothalamic Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Pituitary-Regulating Peptides, Hypothalamic", "MN": "D12.776.631.650.405", "FX": "Pituitary Hormones, Posterior", "MH_TH": "NLM (1979)", "ST": "T125", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "specific hormone (1966-1978)", "MS": "Peptide hormones produced by NEURONS of various regions in the HYPOTHALAMUS. They are released into the pituitary portal circulation to stimulate or inhibit PITUITARY GLAND functions. VASOPRESSIN and OXYTOCIN, though produced in the hypothalamus, are not included here for they are transported down the AXONS to the POSTERIOR LOBE OF PITUITARY before being released into the portal circulation.", "PM": "79", "HN": "79", "MR": "20151123", "DA": "19780516", "DC": "1", "DX": "19790101", "UI": "D007028"}, {"RECTYPE": "D", "MH": "Hypothalamic Neoplasms", "DE": "HYPOTHALAMIC NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Hypothalamic-Pituitary Neoplasms|T191|NON|BRD|NLM (2000)|991103|HYPOTHALAMIC PITUITARY NEOPL|abcdefv", "ENTRY": "Tumors, Hypothalamic", "MN": "C10.551.240.250.700.500", "MH_TH": "NLM (1981)", "ST": "T191", "AN": "coord IM with site in hypothalamus (IM) + histol type of neopl (IM)", "PI": "Hypothalamus (1966-1980)", "MS": "Benign and malignant tumors of the HYPOTHALAMUS. Pilocytic astrocytomas and hamartomas are relatively frequent histologic types. Neoplasms of the hypothalamus frequently originate from adjacent structures, including the OPTIC CHIASM, optic nerve (see OPTIC NERVE NEOPLASMS), and pituitary gland (see PITUITARY NEOPLASMS). Relatively frequent clinical manifestations include visual loss, developmental delay, macrocephaly, and precocious puberty. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2051)", "PM": "1981", "HN": "1981", "CATSH": "CAT LIST", "MR": "20040728", "DA": "19800404", "DC": "1", "DX": "19810101", "UI": "D007029"}, {"RECTYPE": "D", "MH": "Hypothalamo-Hypophyseal System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hypothalamo-Pituitary-Adrenal Axis|T022|NON|REL|NLM (2020)|190214|abcdef", "ENTRY": "Portal System, Hypophyseal", "MN": "A08.713.357", "FX": "Pituitary Hormone-Releasing Hormones", "MH_TH": "NLM (1965)", "ST": "T022", "AN": "emphasis is on interrelation between hypothalamus & pituitary: do not use as a substitute for HYPOTHALAMUS & PITUITARY GLAND as entities; diseases: coordinate with HYPOTHALAMIC DISEASES ", "MS": "A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS.", "PM": "65", "HN": "65", "MR": "20190415", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007030"}, {"RECTYPE": "D", "MH": "Hypothalamus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Lamina Terminalis|T023|NON|NRW|NLM (2001)|991216|abcdef", "ENTRY": "Preoptico-Hypothalamic Areas", "MN": "A08.186.211.200.317.357", "MH_TH": "POPLINE (1978)", "ST": "T023", "AN": "general or unspecified; prefer specific structures & areas in the hypothalamus; HYPOTHALAMO-HYPOPHYSEAL SYSTEM is available for the hypothalamus-pituitary relationship", "MS": "Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007031"}, {"RECTYPE": "D", "MH": "Hypothalamus, Anterior", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hypothalamus, Supraoptic|T023|NON|NRW|UNK (19XX)|820428|abcdef", "ENTRY": "Supraoptic Hypothalamus", "MN": "A08.186.211.200.317.357.342", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "diseases: coordinate IM with HYPOTHALAMIC DISEASES (IM); do not confuse with ANTERIOR HYPOTHALAMIC NUCLEUS", "MS": "The front portion of the HYPOTHALAMUS separated into the preoptic region and the supraoptic region. The preoptic region is made up of the periventricular GRAY MATTER of the rostral portion of the THIRD VENTRICLE and contains the preoptic ventricular nucleus and the medial preoptic nucleus. The supraoptic region contains the PARAVENTRICULAR HYPOTHALAMIC NUCLEUS, the SUPRAOPTIC NUCLEUS, the ANTERIOR HYPOTHALAMIC NUCLEUS, and the SUPRACHIASMATIC NUCLEUS.", "PM": "83; was see under HYPOTHALAMUS 1975-82", "HN": "83(75); was see under HYPOTHALAMUS 1975-82", "MR": "20180630", "DA": "19741111", "DC": "1", "DX": "19830101", "UI": "D007032"}, {"RECTYPE": "D", "MH": "Hypothalamus, Middle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Intermediate Hypothalamic Region|T023|NON|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Regions, Intermediate Hypothalamic", "MN": "A08.186.211.200.317.357.352", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "diseases: coordinate IM with HYPOTHALAMIC DISEASES (IM); HYPOTHALAMIC AREA, LATERAL is also available", "MS": "Middle portion of the hypothalamus containing the arcuate, dorsomedial, ventromedial nuclei, the TUBER CINEREUM and the PITUITARY GLAND.", "OL": "use HYPOTHALAMUS, MIDDLE to search HYPOTHALAMUS, MEDIAL 1975-82", "PM": "83; was HYPOTHALAMUS, MEDIAL see under HYPOTHALAMUS 1975-82", "HN": "83; was HYPOTHALAMUS, MEDIAL see under HYPOTHALAMUS 1975-82", "MR": "20180630", "DA": "19741111", "DC": "1", "DX": "19830101", "UI": "D007033"}, {"RECTYPE": "D", "MH": "Hypothalamus, Posterior", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Posterior Hypothalamic Region|T023|NON|EQV|NLM (2000)|991105|abcdef", "ENTRY": "Supramammillary Commissures", "MN": "A08.186.211.200.317.357.362", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "diseases: coordinate IM with HYPOTHALAMIC DISEASES (IM)", "MS": "The part of the hypothalamus posterior to the middle region consisting of several nuclei including the medial maxillary nucleus, lateral mammillary nucleus, and posterior hypothalamic nucleus (posterior hypothalamic area). The posterior hypothalamic area is concerned with control of sympathetic responses and is sensitive to conditions of decreasing temperature and controls the mechanisms for the conservation and increased production of heat.", "PM": "91; was see under HYPOTHALAMUS 1975-90", "HN": "91(75); was see under HYPOTHALAMUS 1975-90", "MR": "20180630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D007034"}, {"RECTYPE": "D", "MH": "Hypothermia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypothermias, Accidental", "MN": "C23.888.119.565", "FX": "Rewarming", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "do not confuse with HYPOTHERMIA, INDUCED for cooling of organs during surgery or for therapy; relation to BODY TEMPERATURE: see Manual 23.27+", "MS": "Lower than normal body temperature, especially in warm-blooded animals.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007035"}, {"RECTYPE": "D", "MH": "Hypothermia, Induced", "DE": "HYPOTHERMIA IND", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Targeted Temperature Managements", "MN": "E02.258.750", "FX": "Rewarming", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Abnormally low BODY TEMPERATURE that is intentionally induced in warm-blooded animals by artificial means. In humans, mild or moderate hypothermia has been used to reduce tissue damages, particularly after cardiac or spinal cord injuries and during subsequent surgeries.", "OL": "use HYPOTHERMIA, INDUCED to search ANESTHESIA, REFRIGERATION & HIBERNATION, ARTIFICIAL 1966-83; use HYPOTHERMIA, INDUCED + STOMACH (NIM) to search GASTRIC HYPOTHERMIA 1966-83", "PM": "ANESTHESIA, REFRIGERATION & HIBERNATION, ARTIFICIAL were headings 1963-83; GASTRIC HYPOTHERMIA was heading 1966-83", "HN": "ANESTHESIA, REFRIGERATION & HIBERNATION, ARTIFICIAL were headings 1963-83; GASTRIC HYPOTHERMIA was heading 1964-83 (Prov 1964-65)", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007036"}, {"RECTYPE": "D", "MH": "Hypothyroidism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thyroid-Stimulating Hormone Deficiencies", "MN": "C19.874.482", "FX": "Myxedema", "EC": "congenital:Congenital Hypothyroidism", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.", "CATSH": "CAT LIST", "MR": "20170118", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007037"}, {"RECTYPE": "D", "MH": "Hypotonic Solutions", "DE": "HYPOTONIC SOL", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Solutions, Hypotonic", "MN": "D26.776.399", "MH_TH": "NLM (1965)", "ST": "T121", "RN": "0", "MS": "Solutions that have a lesser osmotic pressure than a reference solution such as blood, plasma, or interstitial fluid.", "PM": "66", "HN": "66(65)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007038"}, {"RECTYPE": "D", "MH": "Hypotrichosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypotrichoses", "MN": "C17.800.329.937", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "less than normal amt of hair; do not confuse with HYPERTRICHOSIS, localized or generalized excess hair", "MS": "Presence of less than the normal amount of hair. (Dorland, 27th ed)", "OL": "search ALOPECIA 1966-74", "PM": "91; was see under ALOPECIA 1975-90", "HN": "91(75); was see under ALOPECIA 1975-90", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007039"}, {"RECTYPE": "D", "MH": "Hypoventilation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypoventilations", "MN": "C23.888.852.638", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "respiratory, not environmental", "MS": "A reduction in the amount of air entering the pulmonary alveoli.", "PM": "70", "HN": "70(66)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D007040"}, {"RECTYPE": "D", "MH": "Hypoxanthine Phosphoribosyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "IMP Pyrophosphorylase|T116|T126|EQV|UNK (19XX)|741111|abbdef", "ENTRY": "Pyrophosphorylase, IMP", "MN": "D08.811.913.400.725.450", "FX": "Lesch-Nyhan Syndrome", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "IMP:pyrophosphate phospho-D-ribosyltransferase", "RN": "EC 2.4.2.8", "RR": "9016-12-0 (CAS RN)", "AN": "/defic: consider also LESCH-NYHAN SYNDROME or GOUT", "PI": "Pentosyltransferases (1972-1974)", "MS": "An enzyme that catalyzes the conversion of 5-phosphoribosyl-1-pyrophosphate and hypoxanthine, guanine, or MERCAPTOPURINE to the corresponding 5'-mononucleotides and pyrophosphate. The enzyme is important in purine biosynthesis as well as central nervous system functions. Complete lack of enzyme activity is associated with the LESCH-NYHAN SYNDROME, while partial deficiency results in overproduction of uric acid. EC 2.4.2.8.", "OL": "use HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE (NM) to search GUANINE PHOSPHORIBOSYLTRANSFERASE (NM) 1980-91", "PM": "75; GUANINE PHOSPHORIBOSYLTRANSFERASE was indexed under PENTOSYLTRANSFERASES 1978-91", "HN": "75; GUANINE PHOSPHORIBOSYLTRANSFERASE was GUANINE PHOSPHORIBOSYLTRANSFERASE (NM) 1978-91", "MR": "20190524", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D007041"}, {"RECTYPE": "D", "MH": "Hypoxanthines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.633.100.759.758.399", "MH_TH": "NLM (1964)", "ST": "T109", "RN": "0", "MS": "Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.", "PM": "66", "HN": "66(64)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007042"}, {"RECTYPE": "D", "MH": "Hyraxes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Hyrax|T015|NON|EQV|NLM (1990)|890711|abcdef", "MN": "B01.050.150.900.649.313.250.250", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9811", "MS": "Any of certain small hoofed mammals of the order Hyracoidea native to Africa and southwestern Asia.", "PM": "91; was see under MAMMALS 1975-90", "HN": "91(75); was see under MAMMALS 1975-90", "MR": "20210630", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D007043"}, {"RECTYPE": "D", "MH": "Hysterectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Hysterectomies", "MN": "E04.950.300.399", "MH_TH": "POPLINE (1978)", "ST": "T061", "AN": "abdominal: do not coordinate with ABDOMEN", "MS": "Excision of the uterus.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007044"}, {"RECTYPE": "D", "MH": "Hysterectomy, Vaginal", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Colpohysterectomy|T061|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Vaginal Hysterectomy", "MN": "E04.950.300.399.380", "MH_TH": "NLM (1975)", "ST": "T061", "MS": "Removal of the uterus through the vagina.", "PM": "91; was see under HYSTERECTOMY 1975-90", "HN": "91(75); was see under HYSTERECTOMY 1975-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007045"}, {"RECTYPE": "D", "MH": "Hysteria", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Neuroses, Hysterical", "MN": "F03.675.400.500", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Historical term for a chronic, but fluctuating, disorder beginning in early life and characterized by recurrent and multiple somatic complaints not apparently due to physical illness. This diagnosis is not used in contemporary practice.", "OL": "use HYSTERIA to search HYSTERICAL NEUROSES 1969-78", "HN": "HYSTERICAL NEUROSES was see under HYSTERIA 1969-78", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007046"}, {"RECTYPE": "D", "MH": "Hysterosalpingography", "DE": "HYSTEROSALPINGOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Salpingography|T060|NON|NRW|UNK (19XX)|740330|SALPINGOGR|abcdefv", "ENTRY": "Salpingographies", "MN": "E01.370.378.325", "MH_TH": "POPLINE (1978)", "ST": "T060", "MS": "Radiography of the uterus and fallopian tubes after the injection of a contrast medium.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007047"}, {"RECTYPE": "D", "MH": "I Blood-Group System", "AQ": "AD AE AN BI BL CF CH CL EC GE HI IM IP ME PD PH PO TO TU UL UR", "ENTRY": "Systems, I Blood-Group", "MN": "D23.050.705.230.501", "MH_TH": "NLM (1976)", "ST": "T022", "RN": "0", "AN": "IM; coord with disease /blood (IM), not /immunol nor /genet; TN 230", "PI": "Blood Groups (1966-1975)", "MS": "A blood group related both to the ABO and P systems that includes several different antigens found in most people on erythrocytes, in milk, and in saliva. The antibodies react only at low temperatures.", "PM": "91; was see under BLOOD GROUPS 1976-90", "HN": "91(76); was see under BLOOD GROUPS 1976-90", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D007048"}, {"RECTYPE": "D", "MH": "Iatrogenic Disease", "DE": "IATROGENIC DIS", "AQ": "EC EH EP PC VE", "ENTRY": "Iatrogenic Diseases", "MN": "C23.550.291.875", "FX": "Medical Errors", "MH_TH": "BIOETHICS (1979)", "ST": "T047", "AN": "IM general only; coordinate NIM with specific iatrogenic disease (IM); article must discuss disease as iatrogenic: do not routinely use for  adverse effects of drugs or procedures", "MS": "Any adverse condition in a patient occurring as the result of treatment by a physician, surgeon, or other health professional, especially infections acquired by a patient during the course of treatment.", "CATSH": "CAT LIST", "MR": "20150701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007049"}, {"RECTYPE": "D", "MH": "Ibogaine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "12-Methoxyibogamine|T109|T121|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|750630|METHOXYIBOGAMINE 12|abbbcdeefs", "ENTRY": "NIH10567", "MN": "D03.633.100.496.500.500.681.444", "PA": "Hallucinogens", "MH_TH": "NLM (1976)", "ST": "T123", "N1": "Ibogamine, 12-methoxy-", "RN": "3S814I130U", "RR": "83-74-9 (Ibogaine)", "PI": "Indoles (1972-1975)", "MS": "One of several indole alkaloids extracted from Tabernanthe iboga, Baill. It has a complex pharmacological profile, and interacts with multiple systems of neurotransmission. Ibogaine has psychoactive properties and appears to modulate tolerance to opiates.", "PM": "91; was see under ALKALOIDS 1976-90", "HN": "91(76); was see under ALKALOIDS 1976-90", "MR": "20200527", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D007050"}, {"RECTYPE": "D", "MH": "Ibotenic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Ibotenic", "MN": "D23.946.587.475", "PA": "Excitatory Amino Acid Agonists", "MH_TH": "NLM (1976)", "ST": "T130", "N1": "5-Isoxazoleacetic acid, alpha-amino-2,3-dihydro-3-oxo-", "RN": "2552-55-8", "PI": "Oxazoles (1973-1975)", "MS": "A neurotoxic isoxazole (similar to KAINIC ACID and MUSCIMOL) found in AMANITA mushrooms. It causes motor depression, ataxia, and changes in mood, perceptions and feelings, and is a potent excitatory amino acid agonist.", "PM": "91; was see under OXAZOLES 1976-90", "HN": "91(76); was see under OXAZOLES 1976-90", "MR": "20160531", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D007051"}, {"RECTYPE": "D", "MH": "Ibuprofen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzeneacetic Acid, alpha-methyl-4-(2-methylpropyl)- trimethylsilyl ester|T109|T121|NON|EQV|NLM (2023)|211210|abbcdef", "ENTRY": "Trauma Dolgit Gel", "MN": "D02.241.223.701.430", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "WK2XYI10QM", "RR": "79261-49-7 (K salt)", "PI": "Propionates (1972-1974)", "MS": "A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties", "PM": "1978; see PHENYLPROPIONATES 1975-1977", "HN": "1978 (1975)", "MR": "20220714", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D007052"}, {"RECTYPE": "D", "MH": "Ice", "AQ": "AE AN ST", "MN": "N06.230.291", "FX": "Water", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "MS": "The solid substance formed by the FREEZING of water.", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007053"}, {"RECTYPE": "D", "MH": "Ice Cream", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Ice Creams", "MN": "J02.500.350.400", "MH_TH": "NLM (1966)", "ST": "T168", "MS": "A frozen dairy food made from cream or butterfat, milk, sugar, and flavorings. Frozen custard and French-type ice creams also contain eggs.", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007054"}, {"RECTYPE": "D", "MH": "Iceland", "AQ": "EH EP", "MN": "Z01.639.490", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in northern Europe, an island between the Greenland Sea and the North Atlantic Ocean, northwest of the United Kingdom. The capital is Reykjavik.", "MR": "20161222", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007055"}, {"RECTYPE": "D", "MH": "Ichthyosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Xeroderma|T047|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Xerodermas", "MN": "C17.800.804.512", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "general or unspecified; prefer specifics; unspecified dryness of skin is indexed under SKIN DISEASES, not here", "MS": "Any of several generalized skin disorders characterized by dryness, roughness, and scaliness, due to hypertrophy of the stratum corneum epidermis. Most are genetic, but some are acquired, developing in association with other systemic disease or genetic syndrome.", "OL": "use ICHTHYOSIS & SKIN DISEASES, VESCICULOBULLOUS to search ERYTHRODERMA ICHTHYOSIFORME 1975-78; use ICHTHYOSIS 1966-74", "PM": "ERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78", "HN": "ERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007057"}, {"RECTYPE": "D", "MH": "Ictaluridae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Ictalurus|T013|NON|NRW|UNK (19XX)|860415|abcdef", "ENTRY": "Catfishes, Bullhead", "MN": "B01.050.150.900.493.080.148", "MH_TH": "NLM (1987)", "ST": "T013", "RN": "txid7996", "RR": "txid7998", "PI": "Fishes (1966-1986)", "MS": "A family of North American freshwater CATFISHES. It consists of four genera (Ameiurus, Ictalurus, Noturus, Pylodictis,) comprising several species, two of which are eyeless.", "PM": "91; was see under CATFISH 1987-90", "HN": "91(87); was see under CATFISH 1987-90", "MR": "20200813", "DA": "19860415", "DC": "1", "DX": "19910101", "UI": "D007059"}, {"RECTYPE": "D", "MH": "Id", "ENTRY": "Ids", "MN": "F02.739.794.371", "MH_TH": "NLM (1968)", "ST": "T078", "PI": "Psychoanalytic Theory (1966-1967)", "MS": "The part of the personality structure which harbors the unconscious instinctive desires and strivings of the individual.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19900831", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007060"}, {"RECTYPE": "D", "MH": "Idaho", "AQ": "EH EP", "MN": "Z01.107.567.875.560.380", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Canada, on the east by Montana and Wyoming, on the south by Nevada and Utah, and on the west by Oregon and Washington.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007061"}, {"RECTYPE": "D", "MH": "Identification, Psychological", "PRINT ENTRY": "Identification, Psychology|T041|NON|EQV|NLM (2020)|190118|abcdef", "ENTRY": "Psychology Identifications", "MN": "F01.752.747.385", "MH_TH": "NLM (2020)", "ST": "T041", "PI": "Personality (1966-1967)", "MS": "A process by which an individual unconsciously endeavors to pattern himself after another. This process is also important in the development of the personality, particularly the superego or conscience, which is modeled largely on the behavior of adult significant others.", "PM": "2020; was IDENTIFICATION (PSYCHOLOGY) 1968-2019; see DEFENSE MECHANISMS 1963-1967", "HN": "2020 (1968); was IDENTIFICATION (PSYCHOLOGY) 1968-2019; use DEFENSE MECHANISMS 1963-1967", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007062"}, {"RECTYPE": "D", "MH": "Identity Crisis", "ENTRY": "Identity Crises", "MN": "F01.752.747.423", "MH_TH": "NLM (1971)", "ST": "T041", "PI": "Self Concept (1966-1970)", "MS": "Chaotic concept of self wherein one's role in life appears to be an insoluble dilemma often expressed by isolation, withdrawal, rebellion and extremism.", "PM": "1973", "HN": "1973(1971)", "CATSH": "CAT LIST", "MR": "19991216", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007063"}, {"RECTYPE": "D", "MH": "L-Iditol 2-Dehydrogenase", "DS": "IDITOL DEHYDROGENASE L 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sorbitol Dehydrogenase|T116|T126|NON|EQV|UNK (19XX)|760426|abbcdef", "ENTRY": "L Iditol 2 Dehydrogenase", "MN": "D08.811.682.047.150.700.475", "MH_TH": "NLM (2000)", "ST": "T126", "N1": "L-Iditol:NAD+ 2-oxidoreductase", "RN": "EC 1.1.1.14", "PI": "Alcohol Oxidoreductases (1966-1976)", "MS": "An alcohol oxidoreductase which catalyzes the oxidation of L-iditol to L-sorbose in the presence of NAD. It also acts on D-glucitol to form D-fructose. It also acts on other closely related sugar alcohols to form the corresponding sugar. EC 1.1.1.14", "PM": "2000; see IDITOL DEHYDROGENASE 1991-1999, see SUGAR ALCOHOL DEHYDROGENASES 1978-90, see ALCOHOL OXIDOREDUCTASES 1977", "HN": "2000(1997)", "MR": "20030709", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D007064"}, {"RECTYPE": "D", "MH": "Idoxuridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Iododeoxyuridine|T114|T121|NON|EQV|UNK (19XX)|750127|abbcdef", "ENTRY": "OftanIDU", "MN": "D13.570.685.852.300.400", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Uridine, 2'-deoxy-5-iodo-", "RN": "LGP81V5245", "RR": "90640-08-7 (radical ion (+1))", "PI": "Deoxyuridine (1966-1991)", "MS": "An analog of DEOXYURIDINE that inhibits viral DNA synthesis. The drug is used as an antiviral agent.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007065"}, {"RECTYPE": "D", "MH": "Iduronate Sulfatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sulfoiduronate Sulfatase|T116|T126|NON|EQV|UNK (19XX)|750722|abbcdef", "ENTRY": "Sulfohydrolase, Iduronatesulfate", "MN": "D08.811.277.352.827.500", "FX": "Mucopolysaccharidosis II", "EC": "deficiency:Mucopolysaccharidosis II", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "L-Iduronate-2-sulfate 2-sulfohydrolase", "RN": "EC 3.1.6.13", "PI": "Uronic Acids (1972-1975)", "MS": "An enzyme that specifically cleaves the ester sulfate of iduronic acid. Its deficiency has been demonstrated in Hunter's syndrome, which is characterized by an excess of dermatan sulfate and heparan sulfate. EC 3.1.6.13.", "PM": "91; was see under SULFATASES 1976-90", "HN": "91(76); was see under SULFATASES 1976-90", "MR": "20090706", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D007066"}, {"RECTYPE": "D", "MH": "Iduronic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Iduronic", "MN": "D09.811.922.400.500", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Iduronic acid", "RN": "3402-98-0", "PI": "Uronic Acids (1971-1974)", "MS": "Component of dermatan sulfate. Differs in configuration from glucuronic acid only at the C-5 position.", "PM": "91; was see under URONIC ACIDS 1975-90", "HN": "91(75); was see under URONIC ACIDS 1975-90", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007067"}, {"RECTYPE": "D", "MH": "Iduronidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha L Iduronidase", "MN": "D08.811.277.450.560", "FX": "Mucopolysaccharidosis I", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Glycosaminoglycan alpha-L-iduronohydrolase", "RN": "EC 3.2.1.76", "AN": "/defic: consider also MUCOPOLYSACCHARIDOSIS I", "PI": "Uronic Acids (1972-1974)", "MS": "An enzyme that hydrolyzes iduronosidic linkages in desulfated dermatan. Deficiency of this enzyme produces Hurler's syndrome. EC 3.2.1.76.", "PM": "91; was see under GLYCOSIDE HYDROLASES 1975-90", "HN": "91(75); was see under GLYCOSIDE HYDROLASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007068"}, {"RECTYPE": "D", "MH": "Ifosfamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isophosphamide|T109|T121|NON|EQV|UNK (19XX)|770520|abbcdef", "ENTRY": "NSC109724", "MN": "D03.383.533.500", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide", "RN": "UM20QQM95Y", "RR": "3778-73-2 (Ifosfamide)", "PI": "Oxazines (1972-1974)", "MS": "Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent.", "PM": "86; was see under CYCLOPHOSPHAMIDE 1975-85", "HN": "86(75); was see under CYCLOPHOSPHAMIDE 1975-85", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D007069"}, {"RECTYPE": "D", "MH": "Immunoglobulin A", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "IgA Antibody|T116|T129|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Antibody, IgA", "MN": "D12.776.377.715.548.114.619.026", "PA": "Immunologic Factors", "FX": "Immunoglobulin J-Chains", "EC": "deficiency:IgA Deficiency", "MH_TH": "NLM (2002)", "ST": "T129", "RN": "0", "AN": "gammopathy: coordinate IMMUNOGLOBULIN A  with PARAPROTEINEMIAS but consider also HYPERGAMMAGLOBULINEMIA, follow text; salivary immunoglobulin A: index IGA, SECRETORY + SALIVA /immunol; immunoglobulin A in tears: index IGA, SECRETORY + TEARS /immunol ", "PI": "Immunoglobulins (1970)", "MS": "Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions.", "PM": "2002; see IgA 1973-2001", "HN": "2002(1971)", "MR": "20200514", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007070"}, {"RECTYPE": "D", "MH": "Immunoglobulin A, Secretory", "DE": "IMMUNOGLOBULIN A SECRET", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Secretory IgA|T116|T129|EQV|UNK (19XX)|750630|SECRET IGA|abbdefv", "ENTRY": "IgA, Colostral", "MN": "D12.776.377.715.548.114.619.026.030", "PA": "Immunologic Factors", "MH_TH": "NLM (2002)", "ST": "T129", "RN": "0", "PI": "Immunoglobulin Fragments (1973-1975)", "MS": "The principle immunoglobulin in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. The complete molecule (around 400 kD) is composed of two four-chain units of IMMUNOGLOBULIN A, one SECRETORY COMPONENT and one J chain (IMMUNOGLOBULIN J-CHAINS).", "PM": "2002; see IgA, Secretory 1984-2001, see IGA 1976-1983", "HN": "2002(1976)", "MR": "20050701", "DA": "19750723", "DC": "1", "DX": "19840101", "UI": "D007071"}, {"RECTYPE": "D", "MH": "Immunoglobulin D", "AQ": "AD AE AN BI BL CF CH CL DE DF EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "IgD|T116|T129|ACX|EQV|NLM (1971)|990101|abbcdef", "ENTRY": "IgD2|T116|T129|NON|NRW|UNK (19XX)|810625|abbcdef", "MN": "D12.776.377.715.548.114.619.251", "PA": "Immunologic Factors", "MH_TH": "NLM (2002)", "ST": "T129", "RN": "0", "PI": "Immunoglobulins (1970)", "MS": "An immunoglobulin which accounts for less than 1% of plasma immunoglobulin. It is found on the membrane of many circulating B LYMPHOCYTES.", "PM": "2002; see IgD 1973-2001", "HN": "2002(1971)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007072"}, {"RECTYPE": "D", "MH": "Immunoglobulin E", "AQ": "AD AE AN BI BL CF CH CL DE DF EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "IgE|T116|T129|ACX|EQV|NLM (1971)|990101|abbcdef", "MN": "D12.776.377.715.548.114.619.312", "PA": "Immunologic Factors", "FX": "Receptors, IgE", "MH_TH": "NLM (2002)", "ST": "T129", "N1": "Immunoglobulins, E", "RN": "37341-29-0", "PI": "Immunoglobulins (1970)", "MS": "An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE).", "PM": "2002; see IgE 1973-2001", "HN": "2002(1971)", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007073"}, {"RECTYPE": "D", "MH": "Immunoglobulin G", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "IgG Antibody|T116|T129|ABX|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "GT, Immunoglobulin", "MN": "D12.776.377.715.548.114.619.393", "PA": "Immunologic Factors", "FX": "Receptors, IgG", "EC": "deficiency:IgG Deficiency", "MH_TH": "NLM (2002)", "ST": "T129", "RN": "0", "AN": "gammopathy: coordinate IMMUNOGLOBULIN G with PARAPROTEINEMIAS but consider also HYPERGAMMAGLOBULINEMIA, follow text ", "PI": "Immunoglobulins (1970)", "MS": "The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.", "PM": "2002; see IgG 1973-2001; for GAMMA GLOBULIN, 7S see GAMMA GLOBULIN, 7S 1965-1981", "HN": "2002(1971)", "MR": "20200514", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007074"}, {"RECTYPE": "D", "MH": "Immunoglobulin M", "AQ": "AD AE AN BI BL CF CH CL DE DF EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "IgM Antibody|T116|T129|ABX|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Antibody, IgM", "MN": "D12.776.377.715.548.114.619.574", "PA": "Immunologic Factors", "FX": "Immunoglobulin J-Chains", "MH_TH": "NLM (2002)", "ST": "T129", "RN": "0", "PI": "Immunoglobulins (1970)", "MS": "A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin.", "PM": "2002; see IgM 1973-2001; for GAMMA GLOBULIN, 19S see GAMMA GLOBULIN, 19S 1965-1981", "HN": "2002(1973)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007075"}, {"RECTYPE": "D", "MH": "Iguanas", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Iguana", "MN": "B01.050.150.900.833.393.500", "MH_TH": "NLM (1975)", "ST": "T014", "MS": "Large herbivorous tropical American lizards.", "PM": "91; was see under LIZARDS 1975-90", "HN": "91(75); was see under LIZARDS 1975-90", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D007076"}, {"RECTYPE": "D", "MH": "Ileal Diseases", "DE": "ILEAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ileal Disease", "MN": "C06.405.469.420", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "specific intestinal disease", "MS": "Pathological development in the ILEUM including the ILEOCECAL VALVE.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19790427", "DC": "1", "DX": "19800101", "UI": "D007077"}, {"RECTYPE": "D", "MH": "Ileal Neoplasms", "DE": "ILEAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasms, Ileal", "MN": "C06.405.469.491.501", "MH_TH": "NLM (1980)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "PI": "Intestinal Neoplasms (1966-1979)", "MS": "Tumors or cancer in the ILEUM region of the small intestine (INTESTINE, SMALL).", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19790425", "DC": "1", "DX": "19800101", "UI": "D007078"}, {"RECTYPE": "D", "MH": "Ileitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C06.405.469.420.520", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Inflammation of any segment of the ILEUM and the ILEOCECAL VALVE.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007079"}, {"RECTYPE": "D", "MH": "Ileocecal Valve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Valves, Ileocecal", "MN": "A03.556.249.124.400", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "diseases: coord IM with ILEAL DISEASES (IM); neopl: coord IM with ILEAL NEOPLASMS (IM); ileocecal intussusception or invagination: index under ILEOCECAL VALVE (IM) + INTUSSUSCEPTION (IM) + ILEAL DISEASES (IM) but not also CECAL DISEASES", "MS": "The valve, at the junction of the CECUM with the COLON, that guards the opening where the ILEUM enters the LARGE INTESTINE.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007080"}, {"RECTYPE": "D", "MH": "Ileostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Tube Ileostomy|T061|NON|NRW|UNK (19XX)|870325|abcdef", "ENTRY": "Tube Ileostomies", "MN": "E04.579.338.508", "FX": "Surgical Stomas", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "restrict to ileal stoma on abdominal wall: do not confuse with JEJUNOILEAL BYPASS", "MS": "Surgical creation of an external opening into the ILEUM for fecal diversion or drainage. This replacement for the RECTUM is usually created in patients with severe INFLAMMATORY BOWEL DISEASES. Loop (continent) or tube (incontinent) procedures are most often employed.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007081"}, {"RECTYPE": "D", "MH": "Ileum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A03.556.249.124", "FX": "Ileostomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007082"}, {"RECTYPE": "D", "MH": "Iliac Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Iliac Arteries", "MN": "A07.015.114.444", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Either of two large arteries originating from the abdominal aorta; they supply blood to the pelvis, abdominal wall and legs.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007083"}, {"RECTYPE": "D", "MH": "Iliac Vein", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Iliac", "MN": "A07.015.908.427", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A vein on either side of the body which is formed by the union of the external and internal iliac veins and passes upward to join with its fellow of the opposite side to form the inferior vena cava.", "MR": "20180621", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007084"}, {"RECTYPE": "D", "MH": "Ilium", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Iliums", "MN": "A02.835.232.043.825.434", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "part of the hip; do not confuse with ILEUM, part of the small intestine", "MS": "The largest of three bones that make up each half of the pelvic girdle.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007085"}, {"RECTYPE": "D", "MH": "Illegitimacy", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Unmarried Mother", "MN": "I01.880.853.150.465", "MH_TH": "POPLINE (1978)", "ST": "T033", "AN": "the child or the unwed parents; if with ref to parents, coord IM with PARENTS (IM)", "MS": "The state of birth outside of wedlock. It may refer to the offspring or the parents.", "MR": "19931201", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007086"}, {"RECTYPE": "D", "MH": "Illinois", "AQ": "EH EP", "MN": "Z01.107.567.875.510.350", "MH_TH": "NLM (1998)", "ST": "T083", "AN": "CHICAGO is also available", "MS": "State bounded on the north by Wisconsin, on the east by Lake Michigan, Indiana, and Kentucky, on the west by Missouri and Iowa, and on the south by Kentucky.", "MR": "20160608", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007087"}, {"RECTYPE": "D", "MH": "Illusions", "AQ": "CL DE ET GE HI PH PX RE", "PRINT ENTRY": "Autokinetic Effect|T041|NON|NRW|NLM (1997)|960411|AUTOKINETIC EFF|abcdefv", "ENTRY": "Visual Illusions", "MN": "F02.463.593.446", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "do not confuse with DELUSIONS", "MS": "The misinterpretation of a real external, sensory experience.", "PM": "1963; for AUTOKINETIC EFFECT see AUTOKINETIC EFFECT 1991-1996, see ILLUSIONS 1968-1990", "HN": "1963", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D007088"}, {"RECTYPE": "D", "MH": "Image Enhancement", "AQ": "IS MT ST", "ENTRY": "Quality Enhancements, Image", "MN": "L01.224.308.380", "FX": "Subtraction Technique", "MH_TH": "NLM (1971)", "ST": "T066", "AN": "RADIOGRAPHIC IMAGE ENHANCEMENT is also available", "PI": "Technology, Radiologic (1966-1970)", "MS": "Improvement of the quality of a picture by various techniques, including computer processing, digital filtering, echocardiographic techniques, light and ultrastructural MICROSCOPY, fluorescence spectrometry and microscopy, scintigraphy, and in vitro image processing at the molecular level.", "PM": "73", "HN": "73(72)", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007089"}, {"RECTYPE": "D", "MH": "Image Interpretation, Computer-Assisted", "DE": "IMAGE INTERP", "AQ": "IS MT SN ST", "ENTRY": "Interpretations, Computer-Assisted Image", "MN": "L01.313.500.750.100.158.600", "MH_TH": "NLM (1987)", "ST": "T062", "MS": "Methods developed to aid in the interpretation of ultrasound, radiographic images, etc., for diagnosis of disease.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19860617", "DC": "1", "DX": "19870101", "UI": "D007090"}, {"RECTYPE": "D", "MH": "Image Processing, Computer-Assisted", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "PRINT ENTRY": "Medical Image Processing|T066|NON|NRW|NLM (2021)|200116|abcdef", "ENTRY": "Reconstructions, Image", "MN": "L01.224.308", "FX": "Multimodal Imaging", "MH_TH": "NLM (1987)", "ST": "T066", "AN": "image analysis for diagnostic purposes is IMAGE INTERPRETATION, COMPUTER-ASSISTED or specifics", "MS": "A technique of inputting two-dimensional or three-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer.", "PM": "87", "HN": "87", "MR": "20200721", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D007091"}, {"RECTYPE": "D", "MH": "Imagination", "AQ": "CL DE ES PH RE", "ENTRY": "Imaginations", "MN": "F02.463.188.634", "FX": "Imagery, Psychotherapy", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "A new pattern of perceptual or ideational material derived from past experience.", "CATSH": "CAT LIST", "MR": "20190711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007092"}, {"RECTYPE": "D", "MH": "Imidazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.308", "FX": "Benzimidazoles", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).", "PM": "NAPHAZOLINE was see under VASOCONSTRICTOR AGENTS, NASAL 1967-74, was see under SYMPATHOMIMETICS 1963-66", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007093"}, {"RECTYPE": "D", "MH": "Imides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Imide|T109|NON|EQV|NLM (2021)|191118|abcdef", "MN": "D02.478", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with IMINES or AMIDES", "MS": "Organic compounds containing two acyl groups bound to NITROGEN.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007094"}, {"RECTYPE": "D", "MH": "Imidocarb", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Imidocarb", "MN": "D02.455.426.559.389.703.202.400", "PA": "Antiprotozoal Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Urea, N,N'-bis(3-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-", "RN": "8USS3K0VDH", "RR": "KCC1V76AH8", "PI": "Urea (1966-1973)", "MS": "One of ANTIPROTOZOAL AGENTS used especially against BABESIA in livestock. Toxicity has been reported.", "PM": "91; was see under CARBANILIDES 1975-90", "HN": "91(75); was see under CARBANILIDES 1975-90", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D007095"}, {"RECTYPE": "D", "MH": "Imidoesters", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Imidates|T109|NON|REL|UNK (19XX)|790221|abcdef", "MN": "D02.478.400", "PA": "Indicators and Reagents", "MH_TH": "NLM (1980)", "ST": "T130", "RN": "0", "PI": "Imides (1966-1979)", "MS": "Esters of the hypothetical imidic acids. They react with amines or amino acids to form amidines and are therefore used to modify protein structures and as cross-linking agents.", "PM": "80; DIMETHYL ADIPIMIDATE was see under IMIDES 1978-79; DIMETHYL SUBERIMIDATE was see under IMIDES 1975-79", "HN": "80", "MR": "19950608", "DA": "19790221", "DC": "1", "DX": "19800101", "UI": "D007096"}, {"RECTYPE": "D", "MH": "Imines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Imine|T109|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D02.491", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with IMIDES or AMINES", "MS": "Organic compounds containing a carbon-nitrogen double bond where a NITROGEN atom can be attached to HYDROGEN or an alkyl or aryl group.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007097"}, {"RECTYPE": "D", "MH": "Imino Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amino Acids, Secondary|T116|NON|EQV|UNK (19XX)|741127|AA SECOND|abcdefv", "ENTRY": "Acids, Imino", "MN": "D12.125.072.401", "MH_TH": "NLM (1974)", "ST": "T116", "RN": "0", "AN": "do not confuse with AMINO ACIDS", "MS": "Carboxylic acids that contain an imino group (C=NH).", "PM": "74", "HN": "74", "MR": "20151201", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007098"}, {"RECTYPE": "D", "MH": "Imipramine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Imizin|T109|T121|TRD|NRW|UNK (19XX)|761230|abbcdef", "ENTRY": "Tofranil|T109|T121|TRD|NRW|UNK (19XX)|870114|abbcdef", "MN": "D03.633.300.240.485", "PA": "Antidepressive Agents, Tricyclic", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-", "RN": "OGG85SX4E4", "RR": "MC34P30298", "MS": "The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007099"}, {"RECTYPE": "D", "MH": "Imitative Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Imitative Behaviors", "MN": "F01.145.510", "MH_TH": "NLM (1968)", "ST": "T054", "AN": "human & animal", "PI": "Behavior, Animal (1966-1967)", "MS": "The mimicking of the behavior of one individual by another.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007100"}, {"RECTYPE": "D", "MH": "Immersion", "AQ": "AE PP", "PRINT ENTRY": "Submersion|T037|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Submersions", "MN": "E05.466", "FX": "Drowning", "MH_TH": "NLM (1967)", "ST": "T061", "PI": "Diving (1966)", "MS": "The placing of a body or a part thereof into a liquid.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "19920514", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007101"}, {"RECTYPE": "D", "MH": "Immersion Foot", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Trench Foot|T037|NON|NRW|NLM (1995)|940222|abcdef", "ENTRY": "Foot, Trench", "MN": "C17.800.321.500", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "A condition of the feet produced by prolonged exposure of the feet to water. Exposure for 48 hours or more to warm water causes tropical immersion foot or warm-water immersion foot common in Vietnam where troops were exposed to prolonged or repeated wading in paddy fields or streams. Trench foot results from prolonged exposure to cold, without actual freezing. It was common in trench warfare during World War I, when soldiers stood, sometimes for hours, in trenches with a few inches of cold water in them. (Andrews' Diseases of the Skin, 8th ed, p27)", "OL": "use IMMERSION FOOT to search TRENCH FOOT 1966-94", "PM": "TRENCH FOOT was heading 1963-94", "HN": "TRENCH FOOT was heading 1963-94", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007102"}, {"RECTYPE": "D", "MH": "Immobilization", "AQ": "AE ES IS LJ MT PH PX SN ST VE", "PRINT ENTRY": "Hypokinesia, Experimental|T050|NON|NRW|NLM (2000)|991104|HYPOKINESIA EXPER|abcdefv", "ENTRY": "Hypokinesias, Experimental", "MN": "E05.472", "FX": "Orthopedic Fixation Devices", "MH_TH": "NLM (1964)", "ST": "T061", "MS": "The restriction of the MOVEMENT of whole or part of the body by physical means (RESTRAINT, PHYSICAL) or chemically by ANALGESIA, or the use of TRANQUILIZING AGENTS or NEUROMUSCULAR NONDEPOLARIZING AGENTS. It includes experimental protocols used to evaluate the physiologic effects of immobility.", "PM": "1967; for HYPOKINESIA, EXPERIMENTAL see HYPOKINESIA 2000-2004", "HN": "1967(1964); for HYPOKINESIA, EXPERIMENTAL use HYPOKINESIA 2000-2004", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007103"}, {"RECTYPE": "D", "MH": "Immune Adherence Reaction", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Reactions, Immune Adherence", "MN": "E05.478.594.400", "MH_TH": "NLM (1971)", "ST": "T059", "PI": "Antigen-Antibody Reactions (1966-1970)", "MS": "A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007104"}, {"RECTYPE": "D", "MH": "Immune Complex Diseases", "DE": "IMMUNE COMPLEX DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Type III Hypersensitivity|T047|NON|EQV|NLM (1993)|920203|abcdef", "ENTRY": "Type III Hypersensitivities", "MN": "C20.543.520", "MH_TH": "NLM (1972)", "ST": "T047", "PI": "Immunologic Diseases (1971)", "MS": "Group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. Besides SERUM SICKNESS and the ARTHUS REACTION, evidence supports a pathogenic role for immune complexes in many other IMMUNE SYSTEM DISEASES including GLOMERULONEPHRITIS, systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC) and POLYARTERITIS NODOSA.", "OL": "use IMMUNE COMPLEX DISEASES to search IMMUNE COMPLEX DISEASE 1972-92 (as Prov 1972-73)", "PM": "93; was IMMUNE COMPLEX DISEASE 1974-92", "HN": "93; was IMMUNE COMPLEX DISEASE 1972-92 (Prov 1972-73)", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007105"}, {"RECTYPE": "D", "MH": "Immune Sera", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO UL UR", "PRINT ENTRY": "Antisera|T031|T129|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Serums, Immune", "MN": "D20.215.401", "PA": "Immunologic Factors", "FX": "Immunization, Passive", "EC": "therapeutic use:Immunization, Passive", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "MS": "Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen.", "OL": "use IMMUNE SERA to search IMMUNE SERUMS 1966-79", "PM": "80; was IMMUNE SERUMS 1963-79; IMMUNE SERUM GLOBULIN was heading 1965", "HN": "80; was IMMUNE SERUMS 1963-79; IMMUNE SERUM GLOBULIN was heading 1965", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D007106"}, {"RECTYPE": "D", "MH": "Immune System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Systems, Immune", "MN": "A15.382", "MH_TH": "NLM (1985)", "ST": "T022", "AN": "general or unspecified; prefer specifics; /physiol: consider also IMMUNITY and its indentions", "PI": "T Lymphocytes (1973-1984)", "MS": "The body's defense mechanism against foreign organisms or substances and deviant native cells. It includes the humoral immune response and the cell-mediated response and consists of a complex of interrelated cellular, molecular, and genetic components.", "PM": "1985", "HN": "1985", "MR": "20180228", "DA": "19840530", "DC": "1", "DX": "19850101", "UI": "D007107"}, {"RECTYPE": "D", "MH": "Immune Tolerance", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Immunosuppression (Physiology)|T040|NON|REL|UNK (19XX)|790522|IMMUNOSUPPRESSION PHYSIOL|abcdefv", "ENTRY": "Tolerance, Immune", "MN": "G12.535.425", "FX": "Immunosuppression Therapy", "MH_TH": "NLM (1964)", "ST": "T040", "AN": "do not confuse X ref IMMUNOSUPPRESSION (PHYSIOLOGY) with the Cat E immunol technique IMMUNOSUPPRESSION: Manual 28.21.1", "MS": "The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20210713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007108"}, {"RECTYPE": "D", "MH": "Immunity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Immune Response|T039|NON|EQV|NLM (2021)|200113|abcdef", "ENTRY": "Response, Immune", "MN": "G12.450", "FX": "Tumor Escape", "MH_TH": "NLM (1978)", "ST": "T039", "AN": "general or unspecified; prefer specifics", "MS": "Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances.", "PM": "RADIATION IMMUNOLOGY was heading 1964-66", "HN": "RADIATION IMMUNOLOGY was heading 1964-66", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007109"}, {"RECTYPE": "D", "MH": "Immunity, Active", "AQ": "DE GE IM PH RE", "ENTRY": "Responses, Active Immune", "MN": "G12.450.050.370", "FX": "Immunotherapy", "MH_TH": "NLM (1984)", "ST": "T042", "AN": "coordinate with specific disease / immunol", "MS": "Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007110"}, {"RECTYPE": "D", "MH": "Immunity, Cellular", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Cell-Mediated Immunity|T040|NON|EQV|NLM (1990)|890201|abcdef", "ENTRY": "Response, Cellular Immune", "MN": "G12.450.050.400", "FX": "Hypersensitivity, Delayed", "MH_TH": "NLM (1984)", "ST": "T040", "AN": "coordinate with specific disease / immunol", "PI": "Immunity (1966-1969)", "MS": "Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role.", "PM": "72", "HN": "72(70)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D007111"}, {"RECTYPE": "D", "MH": "Immunity, Maternally-Acquired", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Neonatal Immunity, Maternally-Acquired|T040|NON|NRW|UNK (19XX)|820430|abcdef", "ENTRY": "Neonatal Immunity, Maternally Acquired", "MN": "G12.450.570", "FX": "Immunization, Passive", "MH_TH": "NLM (1965)", "ST": "T040", "AN": "do not add MATERNAL-FETAL EXCHANGE; note category: do not confuse with IMMUNIZATION, PASSIVE ", "MS": "Resistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk.", "OL": "use IMMUNITY, MATERNALLY-ACQUIRED to search IMMUNITY, PASSIVE 1966-82 (as Prov 1966)", "PM": "83; was IMMUNITY, PASSIVE 1967-82", "HN": "83; was IMMUNITY, PASSIVE 1966-82 (Prov 1966)", "CATSH": "CAT LIST", "MR": "20200317", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007112"}, {"RECTYPE": "D", "MH": "Immunity, Innate", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Resistance, Natural|T032|NON|REL|UNK (19XX)|770127|abcdef", "ENTRY": "Non-Specific Immunity", "MN": "G12.450.564", "FX": "Inflammation", "MH_TH": "NLM (2003)", "ST": "T032", "AN": "coordinate with specific disease /immunol", "PI": "specific term/immunology (1966-1977)", "MS": "The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS.", "PM": "2009; see IMMUNITY, NATURAL 1978-2008", "HN": "2009(1978)", "CATSH": "CAT LIST", "MR": "20190408", "DA": "19770301", "DC": "1", "DX": "19780101", "UI": "D007113"}, {"RECTYPE": "D", "MH": "Immunization", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Variolation|T061|NON|REL|NLM (2006)|050411|abcdef", "ENTRY": "Variolations", "MN": "N06.850.780.680.310", "MH_TH": "BIOETHICS (1989)", "ST": "T061", "MS": "Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow).", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007114"}, {"RECTYPE": "D", "MH": "Immunization Schedule", "ENTRY": "Schedules, Immunization", "MN": "E05.478.550.545", "MH_TH": "NLM (1966)", "ST": "T079", "MS": "Schedule giving optimum times usually for primary and/or secondary immunization.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007115"}, {"RECTYPE": "D", "MH": "Immunization, Passive", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Serotherapy|T061|NON|NRW|UNK (19XX)|820430|SEROTHER|abcdefv", "ENTRY": "Transfer, Passive Antibody", "MN": "E05.478.550.520", "MH_TH": "NLM (1970)", "ST": "T061", "PI": "Immunity, Maternally-Acquired (1966-1969)", "MS": "Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER).", "OL": "use IMMUNIZATION, PASSIVE to search PASSIVE TRANSFER 1970-79 (Prov 1970-72), IMMUNOTHERAPY, PASSIVE 1983-90, IMMUNE SERUM GLOBULIN THERAPY 1983-91, & SEROTHERAPY 1966-82; use IMMUNOTHERAPY, ADOPTIVE to search IMMUNOTHERAPY, PASSIVE 1991-96", "PM": "80; was PASSIVE TRANSFER 1973-79; IMMUNOTHERAPY, PASSIVE was see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90; IMMUNE SERUM GLOBULIN THERAPY was see IMMUNIZATION, PASSIVE 1983-91; SEROTHERAPY was heading 1963-82", "HN": "80; was PASSIVE TRANSFER 1970-79 (Prov 1970-72); IMMUNOTHERAPY, PASSIVE was see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90; IMMUNE SERUM GLOBULIN THERAPY was see IMMUNIZATION, PASSIVE 1983-91; SEROTHERAPY was heading 1963-82", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007116"}, {"RECTYPE": "D", "MH": "Immunization, Secondary", "DE": "IMMUNIZATION SECOND", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Revaccination|T061|NON|REL|NLM (2010)|081202|abcdef", "ENTRY": "Secondary Immunizations", "MN": "E05.478.550.550", "MH_TH": "NLM (1971)", "ST": "T061", "PI": "Immunization (1966-1970)", "MS": "Any immunization following a primary immunization and involving exposure to the same or a closely related antigen.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007117"}, {"RECTYPE": "D", "MH": "Immunoassay", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Immunochromatographic Assays", "MN": "E05.601.470", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "general or unspecified; prefer specifics; usually NIM ", "MS": "A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance.", "PM": "1967; for IMMUNOCHROMATOGRAPHIC ASSAY see IMMUNOCHROMATOGRAPHY 2012-2018", "HN": "1967 (1966);  for IMMUNOCHROMATOGRAPHIC ASSAY use CHROMATOGRAPHY, AFFINITY 2012-2018", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007118"}, {"RECTYPE": "D", "MH": "Immunoblastic Lymphadenopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lymphadenopathy, Immunoblastic|T047|NON|EQV|UNK (19XX)|780519|abcdef", "ENTRY": "Lymphadenopathy, Angioimmunoblastic", "MN": "C20.683.515.501", "MH_TH": "NLM (1979)", "ST": "T047", "MS": "A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D007119"}, {"RECTYPE": "D", "MH": "Immunochemistry", "DE": "IMMUNOCHEM", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.044.500", "FX": "Immunologic Techniques", "MH_TH": "NLM (1964)", "ST": "T091", "AN": "IM as the discipline (education, history, etc) only; NIM with no qualifiers as a coordinate", "MS": "Field of chemistry that pertains to immunological phenomena and the study of chemical reactions related to antigen stimulation of tissues. It includes physicochemical interactions between antigens and antibodies.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007120"}, {"RECTYPE": "D", "MH": "Immunocompetence", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Immunologic Competence|T043|NON|EQV|UNK (19XX)|790523|IMMUNOL COMPETENCE|abcdefv", "ENTRY": "Competence, Immunological", "MN": "G12.460", "MH_TH": "NLM (1980)", "ST": "T043", "PI": "T Lymphocytes (1973-1979)", "MS": "The ability of lymphoid cells to mount a humoral or cellular immune response when challenged by antigen.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19790523", "DC": "1", "DX": "19800101", "UI": "D007121"}, {"RECTYPE": "D", "MH": "Immunoelectrophoresis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "MN": "E05.478.605.492.350.350", "FX": "Blood Protein Electrophoresis", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "general or unspecified; prefer specifics", "MS": "A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007122"}, {"RECTYPE": "D", "MH": "Immunoelectrophoresis, Two-Dimensional", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Immunoelectrophoresis, Crossed|T059|NON|EQV|UNK (19XX)|750724|abcdef", "ENTRY": "Two-Dimensional Immunoelectrophoresis", "MN": "E05.478.605.492.350.350.350", "MH_TH": "NLM (1976)", "ST": "T059", "AN": "usually NIM; do not confuse entry term IMMUNOELECTROPHORESIS, CROSSED with IMMUNOELECTROPHORESIS, CROSSOVER see COUNTERIMMUNOELECTROPHORESIS", "PI": "Immunoelectrophoresis (1966-1975)", "MS": "Immunoelectrophoresis in which a second electrophoretic transport is performed on the initially separated antigen fragments into an antibody-containing medium in a direction perpendicular to the first electrophoresis.", "PM": "91; was see under IMMUNOELECTROPHORESIS 1976-90", "HN": "91(76); was see under IMMUNOELECTROPHORESIS 1976-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D007123"}, {"RECTYPE": "D", "MH": "Immunoenzyme Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Peroxidase-Labeled Antibody Technique|T059|NON|NRW|UNK (19XX)|760518|abcdef", "ENTRY": "Techniques, Peroxidase-Labeled Antibody", "MN": "E05.601.470.350", "MH_TH": "NLM (1977)", "ST": "T059", "AN": "coord with specific enzyme with no qualif (NIM) but do not bother to add PEROXIDASES or specific; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE is available", "PI": "Peroxidases (1966-1976)", "MS": "Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.", "OL": "use IMMUNOENZYME TECHNIQUES to search IMMUNOENZYME TECHNICS 1977-90", "PM": "91; was IMMUNOENZYME TECHNICS 1977-90", "HN": "91; was IMMUNOENZYME TECHNICS 1977-90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D007124"}, {"RECTYPE": "D", "MH": "Immunogenetics", "DE": "IMMUNOGENET", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Immunogenetic", "MN": "H01.158.273.343.420", "MH_TH": "NLM (1971)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use IMMUNOGENETIC PHENOMENA for genetic phenomena related to the immune system", "PI": "Genetics (1966-1970)", "MS": "A subdiscipline of genetics which deals with the genetic basis of the immune response (IMMUNITY).", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20081130", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D007125"}, {"RECTYPE": "D", "MH": "Immunoglobulin Allotypes", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Antibodies, Allotypic|T129|NON|EQV|UNK (19XX)|780127|abcdef", "ENTRY": "Immunoglobulin Allotype", "MN": "G12.500.400", "PA": "Immunologic Factors", "FX": "Genes, Immunoglobulin", "MH_TH": "NLM (1975)", "ST": "T129", "RN": "0", "AN": "Am allotype: coordinate with IMMUNOGLOBULIN A ", "PI": "Isoantibodies (1966-1974)", "MS": "Allelic variants of the immunoglobulin light chains (IMMUNOGLOBULIN LIGHT CHAINS) or heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) encoded by ALLELES of IMMUNOGLOBULIN GENES.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D007126"}, {"RECTYPE": "D", "MH": "Immunoglobulin Constant Regions", "DE": "IG CONSTANT REGIONS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunoglobulin Constant Region|T116|T129|NON|EQV|NLM (1979)|990101|IG CONSTANT REGION|abbcdefv", "ENTRY": "Regions, Ig Constant", "MN": "D12.776.377.715.548.538", "PA": "Immunologic Factors", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "specific immunoglobulin fragment (1973-1978)", "MS": "The domains of the immunoglobulin molecules that are invariable in their amino acid sequence within any class or subclass of immunoglobulin. They confer biological as well as structural functions to immunoglobulins. One each on both the light chains and the heavy chains comprises the C-terminus half of the IMMUNOGLOBULIN FAB FRAGMENT and two or three of them make up the rest of the heavy chains (all of the IMMUNOGLOBULIN FC FRAGMENT)", "OL": "use IMMUNOGLOBULIN CONSTANT REGION to search CONSTANT REGION, IG 1979-91", "PM": "2006; see IMMUNOGLOBULIN CONSTANT REGION 1988-2005, see IMMUNOGLOBULINS 1979-1987; for CONSTANT REGION IG see IMMUNOGLOBULIN CONSTANT REGION 1979-1991", "HN": "2006 (1979)", "MR": "20190705", "DA": "19780317", "DC": "1", "DX": "19880101", "UI": "D007127"}, {"RECTYPE": "D", "MH": "Immunoglobulin Fragments", "DE": "IG FRAGMENTS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunoglobulin Fragment|T116|T129|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Fragments, Immunoglobulin", "MN": "D12.776.377.715.548.680", "PA": "Immunologic Factors", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "PI": "Immunoglobulins (1970-1972)", "MS": "Partial immunoglobulin molecules resulting from selective cleavage by proteolytic enzymes or generated through PROTEIN ENGINEERING techniques.", "PM": "73; IMMUNOGLOBULINS, FC & IMMUNOGLOBULINS, FD were headings 1973-83", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007128"}, {"RECTYPE": "D", "MH": "Immunoglobulin Gm Allotypes", "DE": "IG GM ALLOTYPES", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Ig Gm Allotypes|T129|NON|EQV|NLM (2020)|190301|abcdef", "ENTRY": "Immunoglobulin Gm Allotype", "MN": "G12.500.400.586", "PA": "Immunologic Factors", "FX": "Genes, Immunoglobulin", "MH_TH": "NLM (1987)", "ST": "T129", "RN": "0", "PI": "Immunoglobulin Allotypes (1975-1986)", "MS": "Allelic variants of the gamma-immunoglobulin heavy chain (IMMUNOGLOBULIN GAMMA-CHAINS) encoded by ALLELES of IMMUNOGLOBULIN HEAVY CHAIN GENES.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D007129"}, {"RECTYPE": "D", "MH": "Immunoglobulin Idiotypes", "DE": "IG IDIOTYPES", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Ig Idiotypes|T116|T129|NON|EQV|NLM (2020)|190301|abbcdef", "ENTRY": "Immunoglobulin Idiotype", "MN": "G12.500.450", "PA": "Immunologic Factors", "MH_TH": "NLM (1979)", "ST": "T129", "RN": "0", "PI": "Binding Sites, Antibody (1973-1978)", "MS": "Unique genetically-controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19780127", "DC": "1", "DX": "19790101", "UI": "D007130"}, {"RECTYPE": "D", "MH": "Immunoglobulin Km Allotypes", "DE": "IG KM ALLOTYPES", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Inv Allotypes|T129|NON|EQV|UNK (19XX)|860619|abcdef", "ENTRY": "Km Allotypes, Immunoglobulin", "MN": "G12.500.400.587", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "Allelic variants of the kappa light chains (IMMUNOGLOBULIN KAPPA-CHAINS) encoded by ALLELES of IMMUNOGLOBULIN LIGHT CHAIN GENES.", "PM": "2006; see IMMUNOGLOBULIN INV ALLOTYPES 1987-2005", "HN": "2006 (1987)", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D007131"}, {"RECTYPE": "D", "MH": "Immunoglobulin Isotypes", "DE": "IG ISOTYPES", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunoglobulin Isotype|T116|T129|NON|EQV|NLM (2022)|201019|abbcdef", "ENTRY": "Isotypes, Immunoglobulin", "MN": "D12.776.377.715.548.114.619", "PA": "Immunologic Factors", "MH_TH": "NLM (1987)", "ST": "T129", "RN": "0", "PI": "Immunoglobulins(1972-1986)", "MS": "The classes of immunoglobulins found in any species of animal. In man there are nine classes that migrate in five different groups in electrophoresis; they each consist of two light and two heavy protein chains, and each group has distinguishing structural and functional properties.", "PM": "87", "HN": "87", "MR": "20210630", "DA": "19860623", "DC": "1", "DX": "19870101", "UI": "D007132"}, {"RECTYPE": "D", "MH": "Immunoglobulin Joining Region", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Joining Region, Ig|T129|NON|EQV|UNK (19XX)|870511|JOINING REGION IG|abcdefv", "ENTRY": "Joining Region, Immunoglobulin", "MN": "D12.776.377.715.548.797.590", "PA": "Immunologic Factors", "FX": "Genes, Immunoglobulin", "MH_TH": "NLM (1988)", "ST": "T129", "RN": "0", "PI": "Immunoglobulins, Heavy Chain (1977-1987)", "MS": "A segment of the immunoglobulin heavy chains, encoded by the IMMUNOGLOBULIN HEAVY CHAIN GENES in the J segment where, during the maturation of B-LYMPHOCYTES; the gene segment for the variable region upstream is joined to a constant region gene segment downstream. The exact position of joining of the two gene segments is variable and contributes to ANTIBODY DIVERSITY. It is distinguished from the IMMUNOGLOBULIN J CHAINS; a separate polypeptide that serves as a linkage piece in polymeric IGA or IGM.", "PM": "88", "HN": "88", "MR": "20100625", "DA": "19870511", "DC": "1", "DX": "19880101", "UI": "D007133"}, {"RECTYPE": "D", "MH": "Immunoglobulin Switch Region", "DE": "IG SWITCH REGION", "AQ": "DE ES GE IM IP PH RE", "PRINT ENTRY": "Switch Region, Immunoglobulin|T114|T123|NON|EQV|UNK (19XX)|870511|SWITCH REGION IG|abbcdefv", "ENTRY": "Switch Sequences, Ig", "MN": "G05.360.340.024.340.335.300.500", "FX": "Immunoglobulin Class Switching", "MH_TH": "NLM (1988)", "ST": "T123", "PI": "Immunoglobulin Variable Region (1977-1987)", "MS": "A site located in the INTRONS at the 5' end of each constant region segment of a immunoglobulin heavy-chain gene where recombination (or rearrangement) occur during IMMUNOGLOBULIN CLASS SWITCHING. Ig switch regions are found on genes encoding all five classes (IMMUNOGLOBULIN ISOTYPES) of IMMUNOGLOBULIN HEAVY CHAINS.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19870511", "DC": "1", "DX": "19880101", "UI": "D007134"}, {"RECTYPE": "D", "MH": "Immunoglobulin Variable Region", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Variable Region, Immunoglobulin|T116|T129|NON|EQV|NLM (2001)|000327|abbcdef", "ENTRY": "Variable Regions, Immunoglobulin", "MN": "G02.111.570.060.425", "PA": "Immunologic Factors", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (1977)", "ST": "T129", "RN": "0", "PI": "Immunoglobulins, Fab (1973-1976)", "MS": "That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions.", "PM": "84; was see under BINDING SITES, ANTIBODY 1977-83", "HN": "84(77); was see under BINDING SITES, ANTIBODY 1977-83", "MR": "20151120", "DA": "19760416", "DC": "1", "DX": "19840101", "UI": "D007135"}, {"RECTYPE": "D", "MH": "Immunoglobulins", "AQ": "AD AE AN BI BL CF CH CL DE DF EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immune Globulins|T116|T121|T129|NON|EQV|NLM (1994)|930212|abbbcdef", "ENTRY": "Globulin, Immune", "MN": "D12.776.377.715.548", "PA": "Immunologic Factors", "FX": "Paraproteinemias", "MH_TH": "NLM (1970)", "ST": "T129", "RN": "0", "PI": "Gamma Globulins (1966-1969)", "MS": "Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses.", "OL": "use IMMUNOGLOBULINS, INTRAVENOUS to search GLOBULINS, IMMUNE& IMMUNE GLOBULINS 1992-93", "PM": "72; IMMUNE SERUM GLOBULIN was heading 1965; GLOBULINS, IMMUNE & IMMUNE GLOBULINS were see IMMUNOGLOBULINS, INTRAVENOUS 1992-93", "HN": "72(70); IMMUNE SERUM GLOBULIN was heading 1965; GLOBULINS, IMMUNE & IMMUNE GLOBULINS were see IMMUNOGLOBULINS, INTRAVENOUS 1992-93", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D007136"}, {"RECTYPE": "D", "MH": "Immunoglobulin alpha-Chains", "DE": "IG ALPHA CHAINS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunoglobulins, alpha-Chain|T116|T129|NON|EQV|NLM (1976)|990101|IG ALPHA CHAIN|abbcdefv", "ENTRY": "alpha-Chains, Immunoglobulin", "MN": "D12.776.377.715.548.705.500.350", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "AN": "gammopathy: coordinate IMMUNOGLOBULIN ALPHA-CHAINS (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA (IM) or ALPHA-CHAIN DISEASE (IM), follow text; DF: IG ALPHA CHAIN", "PI": "Immunoglobulins, Heavy Chain (1975)", "MS": "The class of heavy chains found in IMMUNOGLOBULIN A. They have a molecular weight of approximately 58 kDa and contain about 470 amino acid residues arranged in four domains and an oligosaccharide component bound covalently to their Fc fragment constant region.", "PM": "2006; see IMMUNOGLOBULINS, ALPHA-CHAIN 1992-2005, see IMMUNOGLOBULINS, ALPHA CHAIN 1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1990", "HN": "2006 (1976)", "MR": "20190705", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D007137"}, {"RECTYPE": "D", "MH": "Immunoglobulin delta-Chains", "DE": "IG DELTA CHAINS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunoglobulins, delta-Chain|T116|T129|NON|EQV|NLM (1976)|990101|IG DELTA CHAIN|abbcdefv", "ENTRY": "delta-Chains, Immunoglobulin", "MN": "D12.776.377.715.548.705.500.360", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "AN": "gammopathy: coordinate IMMUNOGLOBULIN DELTA-CHAINS (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA (IM) or HEAVY CHAIN DISEASE (IM), follow text; DF: IG DELTA CHAIN", "PI": "Immunoglobulins, Heavy Chain (1975)", "MS": "The class of heavy chains found in IMMUNOGLOBULIN D. They have a molecular weight of approximately 64 kDa and they contain about 500 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the Fc fragment constant region.", "PM": "2006; see IMMUNOGLOBULINS, DELTA-CHAIN 1992-2005, see IMMUNOGLOBULINS, DELTA CHAIN 1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1990", "HN": "2006 (1976)", "MR": "20190705", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D007138"}, {"RECTYPE": "D", "MH": "Immunoglobulin epsilon-Chains", "DE": "IG EPSILON CHAINS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunoglobulins, epsilon-Chain|T116|T129|NON|EQV|NLM (1976)|990101|IG EPSILON CHAIN|abbcdefv", "ENTRY": "epsilon-Chains, Immunoglobulin", "MN": "D12.776.377.715.548.705.500.370", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "AN": "gammopathy: coordinate IMMUNOGLOBULIN EPSILON-CHAINS (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA (IM) or HEAVY CHAIN DISEASE (IM), follow text; DF: IG EPSILON CHAIN", "PI": "Immunoglobulins, Heavy Chain (1975)", "MS": "The class of heavy chains found in IMMUNOGLOBULIN E. They have a molecular weight of approximately 72 kDa and they contain about 550 amino acid residues arranged in five domains and about three times more carbohydrate than the heavy chains of IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; and IMMUNOGLOBULIN G.", "PM": "2006; see IMMUNOGLOBULINS, EPSILON-CHAIN 1992-2005, see IMMUNOGLOBULINS, EPSILON CHAIN 1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1990", "HN": "2006 (1976)", "MR": "20190705", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D007139"}, {"RECTYPE": "D", "MH": "Immunoglobulin Fab Fragments", "DE": "IG FAB FRAGMENTS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunoglobulins, Fab Fragment|T116|T129|NON|EQV|NLM (2006)|050323|abbcdef", "ENTRY": "Immunoglobulin Fragments, Fab", "MN": "D12.776.377.715.548.680.650", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Immunoglobulins (1970-1972)", "MS": "Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN.", "PM": "2006; was IMMUNOGLOBULINS, FAB 1973-2005", "HN": "2006 (1973)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007140"}, {"RECTYPE": "D", "MH": "Immunoglobulin Fc Fragments", "DE": "IG FC FRAGMENTS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Ig Fc Fragments|T116|T129|ABX|EQV|NLM (2020)|190625|abbcdef", "ENTRY": "Immunoglobulin, Fc", "MN": "D12.776.377.715.548.680.660", "PA": "Immunologic Factors", "FX": "Receptors, Fc", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Immunoglobulins (1970-1972)", "MS": "Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin (COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport). This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN.", "PM": "2006; see IMMUNOGLOBULINS, FC 1987-2005, see IMMUNOGLOBULIN FRAGMENTS 1984-1986, see IMMUNOGLOBULINS, FC 1973-1983", "HN": "2006 (1973)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007141"}, {"RECTYPE": "D", "MH": "Immunoglobulin gamma-Chains", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunoglobulins, gamma-Chain|T116|T129|NON|EQV|NLM (1976)|990101|IG GAMMA CHAIN|abbcdefv", "ENTRY": "gamma-Chains, Immunoglobulin", "MN": "D12.776.377.715.548.705.500.380", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "AN": "gammopathy: coordinate IMMUNOGLOBULIN GAMMA-CHAINS (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA (IM) or HEAVY CHAIN DISEASE (IM), follow text; DF: IG GAMMA CHAIN", "PI": "Immunoglobulins, Heavy Chain (1975)", "MS": "Heavy chains of IMMUNOGLOBULIN G having a molecular weight of approximately 51 kDa. They contain about 450 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the Fc fragment constant region. The gamma heavy chain subclasses (for example, gamma 1, gamma 2a, and gamma 2b) of the IMMUNOGLOBULIN G isotype subclasses (IgG1, IgG2A, and IgG2B) resemble each other more closely than the heavy chains of the other IMMUNOGLOBULIN ISOTYPES.", "PM": "2006; see IMMUNOGLOBULINS, GAMMA-CHAIN 1992-2005, see IMMUNOGLOBULINS, GAMMA CHAIN 1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1990", "HN": "2006 (1976)", "MR": "20050715", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D007142"}, {"RECTYPE": "D", "MH": "Immunoglobulin Heavy Chains", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunoglobulins, Heavy-Chain|T116|T129|NON|EQV|NLM (1975)|990101|IG HEAVY CHAIN|abbcdefv", "ENTRY": "Immunoglobulins, Heavy Chain", "MN": "D12.776.377.715.548.705.500", "PA": "Immunologic Factors", "FX": "Heavy Chain Disease", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "AN": "gammopathy: coordinate IMMUNOGLOBULIN HEAVY CHAINS (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA (IM) or HEAVY CHAIN DISEASE (IM), follow text", "PI": "Immunoglobulin Fragments (1973-1974)", "MS": "The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa.", "PM": "2006; see IMMUNOGLOBULINS, HEAVY-CHAIN 1992-2005, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1991, see IMMUNOGLOBULIN FRAGMENTS 1973-1975", "HN": "2006 (1973)", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D007143"}, {"RECTYPE": "D", "MH": "Immunoglobulin J-Chains", "DE": "IG J CHAINS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "J-Chains, Immunoglobulin|T116|T129|NON|EQV|NLM (2006)|050617|abbcdef", "ENTRY": "Polypeptide, Immunoglobulin J", "MN": "D12.776.377.715.548.705.625", "PA": "Immunologic Factors", "FX": "Immunoglobulin M", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A 15 kDa \"joining\" peptide that forms one of the linkages between monomers of IMMUNOGLOBULIN A or IMMUNOGLOBULIN M in the formation of polymeric immunoglobulins. There is one J chain per one IgA dimer or one IgM pentamer. It is also involved in binding the polymeric immunoglobulins to POLYMERIC IMMUNOGLOBULIN RECEPTOR which is necessary for their transcytosis to the lumen. It is distinguished from the IMMUNOGLOBULIN JOINING REGION which is part of the IMMUNOGLOBULIN VARIABLE REGION of the immunoglobulin light and heavy chains.", "PM": "2006; see IMMUNOGLOBULINS, J-CHAIN 1992-2005, see IMMUNOGLOBULINS, J CHAIN 1974-1991", "HN": "2006 (1974)", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007144"}, {"RECTYPE": "D", "MH": "Immunoglobulin kappa-Chains", "DE": "IG KAPPA CHAINS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "kappa-Immunoglobulin Light Chains|T116|T129|NON|EQV|NLM (2006)|050324|KAPPA IG LIGHT CHAINS|abbcdefv", "ENTRY": "kappa-Chains, Immunoglobulin", "MN": "D12.776.377.715.548.705.750.530", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "AN": "gammopathy: coordinate IMMUNOGLOBULIN KAPPA-CHAINS with PARAPROTEINEMIAS but consider also HYPERGAMMAGLOBULINEMIA, follow text", "PI": "Immunoglobulins (1972)", "MS": "One of the types of light chains of the immunoglobulins with a molecular weight of approximately 22 kDa.", "PM": "2006; see IMMUNOGLOBULINS, KAPPA-CHAIN 1992-2005, see IMMUNOGLOBULINS, KAPPA CHAIN 1986-1991, see IMMUNOGLOBULINS, LIGHT CHAIN 1975-1985, see IMMUNOGLOBULIN FRAGMENTS 1973-1974", "HN": "2006 (1973)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D007145"}, {"RECTYPE": "D", "MH": "Immunoglobulin lambda-Chains", "DE": "IG LAMBDA CHAINS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunoglobulins, lambda-Chain|T116|T129|NON|EQV|NLM (1975)|990101|IG LAMBDA CHAIN|abbcdefv", "ENTRY": "lambda-Chains, Immunoglobulin", "MN": "D12.776.377.715.548.705.750.550", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "AN": "gammopathy: coordinate IMMUNOGLOBULIN LAMBDA-CHAINS (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA (IM), follow text", "PI": "Immunoglobulins (1972)", "MS": "One of the types of light chain subunits of the immunoglobulins with a molecular weight of approximately 22 kDa.", "PM": "2006; see IMMUNOGLOBULINS, LAMBDA-CHAIN 1992-2005, see IMMUNOGLOBULINS, LAMBDA CHAIN 1986-1991, see IMMUNOGLOBULINS, LIGHT CHAIN 1975-1985, see IMMUNOGLOBULIN FRAGMENTS 1973-1974", "HN": "2006 (1973)", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D007146"}, {"RECTYPE": "D", "MH": "Immunoglobulin Light Chains", "DE": "IG LIGHT CHAINS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunoglobulins, Light-Chain|T116|T129|NON|EQV|NLM (1976)|990101|IG LIGHT CHAIN|abbcdefv", "ENTRY": "Light-Chain, Immunoglobulin", "MN": "D12.776.377.715.548.705.750", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "AN": "gammopathy: coordinate IMMUNOGLOBULIN LIGHT CHAINS (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA (IM), follow text", "PI": "Immunoglobulin Fragments (1973-1975)", "MS": "Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) make one immunoglobulin molecule.", "PM": "2006; see IMMUNOGLOBULINS, LIGHT-CHAIN 1992-2005, see IMMUNOGLOBULINS, LIGHT CHAIN 1976-1991", "HN": "2006 (1976)", "MR": "20190702", "DA": "19750718", "DC": "1", "DX": "19760101", "UI": "D007147"}, {"RECTYPE": "D", "MH": "Immunoglobulin mu-Chains", "DE": "IG MU CHAINS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunoglobulins, mu-Chain|T116|T129|NON|EQV|NLM (1976)|990101|IG MU CHAIN|abbcdefv", "ENTRY": "mu-Chains, Immunoglobulin", "MN": "D12.776.377.715.548.705.500.500", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "AN": "gammopathy: coordinate IMMUNOGLOBULIN MU-CHAINS (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA (IM) or HEAVY CHAIN DISEASE (IM), follow text; for immunoglobulin C mu (IG C mu) coordinate with IMMUNOGLOBULIN CONSTANT REGION", "PI": "Immunoglobulins, Heavy Chain (1975)", "MS": "The class of heavy chains found in IMMUNOGLOBULIN M. They have a molecular weight of approximately 72 kDa and they contain about 57 amino acid residues arranged in five domains and have more oligosaccharide branches and a higher carbohydrate content than the heavy chains of IMMUNOGLOBULIN G.", "PM": "2006; see IMMUNOGLOBULINS, MU-CHAIN 1992-2005, see IMMUNOGLOBULINS, MU CHAIN 1987-1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1986", "HN": "2006 (1976)", "MR": "20190702", "DA": "19750723", "DC": "1", "DX": "19870101", "UI": "D007148"}, {"RECTYPE": "D", "MH": "Immunohistochemistry", "DE": "IMMUNOHISTOCHEM", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Immunolabeling Techniques|T059|NON|BRD|UNK (19XX)|870508|abcdef", "ENTRY": "Techniques, Immunolabeling", "MN": "H01.181.122.605.512", "MH_TH": "NLM (1988)", "ST": "T059", "AN": "general or unspecified; prefer specifics; avoid as a coordinate; immunohistochemistry of disease is disease /diag or /metab", "PI": "Immunoenzyme Techniques (1977-1987)", "MS": "Histochemical localization of immunoreactive substances using labeled antibodies as reagents.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19870508", "DC": "1", "DX": "19880101", "UI": "D007150"}, {"RECTYPE": "D", "MH": "Immunologic Capping", "DE": "IMMUNOL CAPPING", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Capping, Immunologic|T043|NON|EQV|UNK (19XX)|770510|CAPPING IMMUNOL|abcdefv", "ENTRY": "Capping, Immunological", "MN": "G12.122.612", "FX": "Receptors, Antigen, B-Cell", "MH_TH": "NLM (1978)", "ST": "T043", "AN": "may appear in the literature as \"capping of lymphocytes\" or \"leukocyte capping\"; do not confuse with RECEPTOR CAPPING", "PI": "Lymphocytes (1966-1977)", "MS": "An energy dependent process following the crosslinking of B CELL ANTIGEN RECEPTORS by multivalent ligands (bivalent anti-antibodies, LECTINS or ANTIGENS), on the B-cell surface. The crosslinked ligand-antigen receptor complexes collect in patches which flow to and aggregate at one pole of the cell to form a large mass - the cap. The caps may then be endocytosed or shed into the environment.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19770510", "DC": "1", "DX": "19780101", "UI": "D007152"}, {"RECTYPE": "D", "MH": "Immunologic Deficiency Syndromes", "DE": "IMMUNOL DEFIC SYNDROMES", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Antibody Deficiency Syndrome|T047|NON|NRW|UNK (19XX)|770516|ANTIBODY DEFIC SYNDROME|abcdefv", "ENTRY": "Syndromes, Immunological Deficiency", "MN": "C20.673", "FX": "Immunocompromised Host", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "general or unspecified; prefer specifics; for deficiency of specific immunoprotein index the immunoprotein with /defic", "PI": "Immunity (1966-1967)", "MS": "Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.", "OL": "use IMMUNOLOGIC DEFICIENCY SYNDROMES to search ANTIBODY DEFICIENCY SYNDROME 1970-77", "PM": "70", "HN": "70(68); ANTIBODY DEFICIENCY SYNDROME was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D007153"}, {"RECTYPE": "D", "MH": "Immune System Diseases", "DE": "IMMUNE SYSTEM DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Immunologic Diseases|T047|NON|EQV|NLM (1971)|990101|IMMUNOL DIS|abcdefv", "ENTRY": "Immunological Disease", "MN": "C20", "RH": "C20 - DISEASES-IMMUNE", "FX": "Blood Protein Disorders", "MH_TH": "NLM (2005)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Allergy and Immunology (1966-1970)", "MS": "Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.", "PM": "2005; see IMMUNOLOGIC DISEASES 1971-2004", "HN": "2005 (1971)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D007154"}, {"RECTYPE": "D", "MH": "Immunologic Factors", "DE": "IMMUNOL FACTORS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Immunomodulators|T129|NON|REL|UNK (19XX)|781215|IMMUNOMOD|abcdefv", "ENTRY": "Response Modifier, Biological", "MN": "D27.505.696.477", "MH_TH": "NLM (1974)", "ST": "T129", "RN": "0", "MS": "Biologically active substances whose activities affect or play a role in the functioning of the immune system.", "PM": "1998; for IMMUNOMODULATORS see ADJUVANTS, IMMUNOLOGIC 1980-2004", "HN": "1998; for IMMUNOMODULATORS use ADJUVANTS, IMMUNOLOGIC 1980-2004", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D007155"}, {"RECTYPE": "D", "MH": "Immunologic Memory", "DE": "IMMUNOL MEMORY", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Immune Memory|T042|NON|EQV|NLM (2023)|220324|abcdef", "ENTRY": "Memory, Immunological", "MN": "G12.450.050.500", "MH_TH": "NLM (1971)", "ST": "T042", "PI": "Antibody Formation (1966-1970)", "MS": "The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007156"}, {"RECTYPE": "D", "MH": "Immunologic Surveillance", "DE": "IMMUNOL SURVEILLANCE", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Surveillance, Immunologic|T040|NON|EQV|UNK (19XX)|790523|SURVEILLANCE IMMUNOL|abcdefv", "ENTRY": "Surveillances, Immunological", "MN": "G12.525", "MH_TH": "NLM (1980)", "ST": "T040", "AN": "a function of T-lymphocytes: nothing to do with epidemiol surveillance", "PI": "specific cell, organ, neoplasm/TR", "MS": "The theory that T-cells monitor cell surfaces and detect structural changes in the plasma membrane and/or surface antigens of virally or neoplastically transformed cells.", "PM": "91; was see under IMMUNITY, CELLULAR 1980-90", "HN": "91(80); was see under IMMUNITY, CELLULAR 1980-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D007157"}, {"RECTYPE": "D", "MH": "Immunologic Techniques", "DE": "IMMUNOL TECHNIQUES", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Techniques, Immunological", "MN": "E05.478", "FX": "Immunotherapy", "MH_TH": "NLM (1973)", "ST": "T059", "AN": "general or unspecified; prefer specifics; do not confuse with IMMUNOLOGIC TESTS (equals immunol techniques applied to diagnosis)", "MS": "Techniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies.", "OL": "use IMMUNOLOGIC TECHNIQUES to search IMMUNOLOGIC TECHNICS 1973-90 and ANTIBODY DISSOCIATION 1971-82 (as prov 1971-72)", "PM": "91; was IMMUNOLOGIC TECHNICS 1973-90; ANTIBODY DISSOCIATION was heading 1973-82", "HN": "91; was IMMUNOLOGIC TECHNICS 1973-90; ANTIBODY DISSOCIATION was heading 1971-82 (Prov 1971-72)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007158"}, {"RECTYPE": "D", "MH": "Immunologic Tests", "DE": "IMMUNOL TESTS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Immunodiagnosis|T059|NON|BRD|UNK (19XX)|860401|IMMUNODIAG|abcdefv", "ENTRY": "Tests, Immunological", "MN": "E05.478.594", "MH_TH": "NLM (1987)", "ST": "T060", "AN": "general; prefer specifics; do not confuse with IMMUNOLOGIC TECHNIQUES", "PI": "specific technique or test (1973-1986)", "MS": "Immunologic techniques involved in diagnosis.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19860401", "DC": "1", "DX": "19870101", "UI": "D007159"}, {"RECTYPE": "D", "MH": "Immunoproliferative Disorders", "DE": "IMMUNOPROLIFERATIVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Immunoproliferative Disorder", "MN": "C20.683", "MH_TH": "NLM (1986)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Disorders characterized by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "19900817", "DA": "19850225", "DC": "1", "DX": "19860101", "UI": "D007160"}, {"RECTYPE": "D", "MH": "Immunoproliferative Small Intestinal Disease", "DE": "IMMUNOPROLIFERATIVE SMALL INTESTINAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "alpha-Chain Disease|T191|EQV|UNK (19XX)|860624|ALPHA CHAIN DIS|abdefv", "ENTRY": "alpha-Chain Diseases", "MN": "C20.683.780.490.512", "MH_TH": "NLM (1987)", "ST": "T191", "PI": "Lymphoma (1966-1986)", "MS": "A condition that is caused by HYPERPLASIA of LYMPHOCYTES in the small intestine (INTESTINE, SMALL) and the mesenteric LYMPH NODES. These lymphocytes produce an anomalous alpha heavy chain protein. Generally, these IPSID patients have either concurrent LYMPHOMA or develop lymphoma within a few years. The disease was first described in the Mediterranean region and is characterized by malabsorption; WEIGHT LOSS; DIARRHEA; and STEATORRHEA.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19860624", "DC": "1", "DX": "19870101", "UI": "D007161"}, {"RECTYPE": "D", "MH": "Immunoproteins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.124.486", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Blood proteins whose activities affect or play a role in the functioning of the immune system.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D007162"}, {"RECTYPE": "D", "MH": "Immunosorbent Techniques", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "PRINT ENTRY": "Immunoadsorbent Techniques|T059|NON|EQV|UNK (19XX)|760416|abcdef", "ENTRY": "Techniques, Immunosorbent", "MN": "E05.601.470.380", "MH_TH": "NLM (1977)", "ST": "T059", "PI": "specific antigen/isolation & purification (1969-1976)", "MS": "Techniques for removal by adsorption and subsequent elution of a specific antibody or antigen using an immunosorbent containing the homologous antigen or antibody.", "OL": "use IMMUNOSORBENT TECHNIQUES to search IMMUNOSORBENT TECHNICS 1977-90", "PM": "91; was IMMUNOSORBENT TECHNICS 1977-90", "HN": "91; was IMMUNOSORBENT TECHNICS 1977-90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D007163"}, {"RECTYPE": "D", "MH": "Immunosorbents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Immunosorbent|T130|NON|EQV|NLM (2021)|200526|abcdef", "MN": "D27.720.877.501", "FX": "Enzyme-Linked Immunosorbent Assay", "MH_TH": "NLM (1977)", "ST": "T130", "RN": "0", "PI": "Antigen-Antibody Reactions (1966-1976)", "MS": "An insoluble support for an ANTIGEN or ANTIBODIES that is used in AFFINITY CHROMATOGRAPHY to adsorb the homologous antibody or antigen from a mixture. Many different substances are used, among them SEPHAROSE; GLUTARALDEHYDE; copolymers of ANHYDRIDES; polyacrylamides, etc.", "PM": "91; was see under ANTIGEN-ANTIBODY COMPLEX 1977-90", "HN": "91(77); was see under ANTIGEN-ANTIBODY COMPLEX 1977-90", "MR": "20200527", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D007164"}, {"RECTYPE": "D", "MH": "Immunosuppression Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Immunosuppressive Therapy|T061|NON|EQV|NLM (2022)|210330|abcdef", "ENTRY": "Therapy, Immunosuppressive", "MN": "E05.478.610", "FX": "Immunocompromised Host", "MH_TH": "NLM (2022)", "ST": "T061", "AN": "note category: do not confuse with IMMUNOSUPPRESSION (PHYSIOLOGY) see IMMUNE TOLERANCE", "PI": "Immunosuppressive Agents (1966-1970)", "MS": "Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.", "PM": "2022; see IMMUNOSUPPRESSION 1971-2021", "HN": "2022 (1971)", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D007165"}, {"RECTYPE": "D", "MH": "Immunosuppressive Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Immunosuppressive Agent|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Agents, Immunosuppressive", "MN": "D27.505.696.477.656", "FX": "Antirheumatic Agents", "MH_TH": "NLM (1964)", "ST": "T121", "RN": "0", "MS": "Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.", "PM": "66", "HN": "66(64)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007166"}, {"RECTYPE": "D", "MH": "Immunotherapy", "DE": "IMMUNOTHER", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Immunotherapies", "MN": "E02.095.465.425", "MH_TH": "NLM (1973)", "ST": "T061", "AN": "coordinate with disease /ther ", "PI": "specific disease/therapy (1966-1972)", "MS": "Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.", "OL": "use IMMUNOTHERAPY to search VACCINE THERAPY 1966-72", "PM": "73; VACCINE THERAPY was heading 1963-82", "HN": "73; VACCINE THERAPY was heading 1963-82", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007167"}, {"RECTYPE": "D", "MH": "IMP Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Inosinic Acid Dehydrogenase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Inosine 5 Monophosphate Dehydrogenase", "MN": "D08.811.682.047.820.450", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "IMP:NAD+ oxidoreductase", "RN": "EC 1.1.1.205", "PI": "Ketone Oxidoreductases (1974)", "MS": "An enzyme that catalyzes the dehydrogenation of inosine 5'-phosphate to xanthosine 5'-phosphate in the presence of NAD. EC 1.1.1.205.", "PM": "91; was see under KETONE OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under KETONE OXIDOREDUCTASES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007168"}, {"RECTYPE": "D", "MH": "Impetigo", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Impetigo Contagiosa|T047|NON|REL|NLM (1993)|920421|abcdef", "ENTRY": "Impetigos", "MN": "C17.800.838.765.770.360", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a staph or strep infect of the skin", "MS": "A common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose.", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007169"}, {"RECTYPE": "D", "MH": "Implosive Therapy", "DE": "IMPLOSIVE THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Flooding, Imaginal|T061|NON|EQV|NLM (2009)|080807|abcdef", "ENTRY": "Therapy, Flooding", "MN": "F04.754.137.506.325", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "a psychotherapy technique", "MS": "A method for extinguishing anxiety by a saturation exposure to the feared stimulus situation or its substitute.", "PM": "91; was see under BEHAVIOR THERAPY 1975-90", "HN": "91(75); was see under BEHAVIOR THERAPY 1975-90", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D007171"}, {"RECTYPE": "D", "MH": "Erectile Dysfunction", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Impotence|T047|NON|EQV|NLM (1963)|990101|abcdef", "ENTRY": "Sexual Impotence, Male", "MN": "F03.835.400", "MH_TH": "NLM (1995)", "ST": "T047", "MS": "The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.", "PM": "2008; see IMPOTENCE 1963-2007", "HN": "2008 (1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D007172"}, {"RECTYPE": "D", "MH": "Imprinting, Psychological", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Imprinting, Psychology|T041|NON|EQV|NLM (2020)|190118|abcdef", "ENTRY": "Psychology Imprintings", "MN": "F02.463.425.448", "MH_TH": "NLM (2020)", "ST": "T041", "AN": "human & animal", "MS": "A particular kind of learning characterized by occurrence in very early life, rapidity of acquisition, and relative insusceptibility to forgetting or extinction. Imprinted behavior includes most (or all) behavior commonly called instinctive, but imprinting is used purely descriptively.", "PM": "2020; was IMPRINTING (PSYCHOLOGY) 1964-2019", "HN": "2020 (1965); was IMPRINTING (PSYCHOLOGY) 1964-2019", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007173"}, {"RECTYPE": "D", "MH": "Disruptive, Impulse Control, and Conduct Disorders", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Kleptomania|T048|NON|NRW|UNK (19XX)|800520|abcdef", "ENTRY": "Intermittent Explosive Disorders", "MN": "F03.250", "FX": "Substance-Related Disorders", "MH_TH": "NLM (2016)", "ST": "T048", "MS": "Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.", "PM": "2016; for KLEPTOMANIA see NEUROSES, OBSESSIVE-COMPULSIVE 1963-80", "HN": "2016 (1980)", "CATSH": "CAT LIST", "MR": "20171208", "DA": "19800520", "DC": "1", "DX": "19810101", "UI": "D007174"}, {"RECTYPE": "D", "MH": "Impulsive Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Impulsivities", "MN": "F01.145.527", "FX": "Delay Discounting", "MH_TH": "NLM (1968)", "ST": "T055", "PI": "Behavior (1966-1967)", "MS": "An act performed without delay, reflection, voluntary direction or obvious control in response to a stimulus.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20140616", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007175"}, {"RECTYPE": "D", "MH": "Inappropriate ADH Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Schwartz-Bartter Syndrome|T047|EPO|EQV|UNK (19XX)|771206|abcdef", "ENTRY": "Syndrome, Schwartz-Bartter", "MN": "C19.700.490", "MH_TH": "NLM (1979)", "ST": "T047", "PI": "Vasopressins (1966-1978)", "MS": "A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.", "PM": "1979", "HN": "1979", "CATSH": "CAT LIST", "MR": "20050708", "DA": "19771206", "DC": "1", "DX": "19790101", "UI": "D007177"}, {"RECTYPE": "D", "MH": "Inbreeding", "AQ": "EC HI LJ MT SN ST", "PRINT ENTRY": "Sib Mating|T040|NON|NRW|NLM (1998)|960710|abcdef", "ENTRY": "Sib Matings", "MN": "G05.090.403", "FX": "Consanguinity", "MH_TH": "NLM (1968)", "ST": "T040", "AN": "animals or plants only: for humans use CONSANGUINITY; restrict to inbreeding as a genetic concept or a technique: not a routine term for inbred animals (= ANIMALS, INBRED STRAINS or specifics)", "PI": "Genetics, Population (1966-1967)", "MS": "The mating of plants or non-human animals which are closely related genetically.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20180525", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007178"}, {"RECTYPE": "D", "MH": "Incest", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "MN": "I01.880.735.442", "MH_TH": "POPLINE (1993)", "ST": "T048", "AN": "/ethnol /psychol permitted", "PI": "Paraphilias (1966)", "MS": "Sexual intercourse between persons so closely related that they are forbidden by law to marry.", "PM": "67", "HN": "67", "MR": "19940317", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007179"}, {"RECTYPE": "D", "MH": "Incisor", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Incisors", "MN": "A14.549.167.860.425", "MH_TH": "NLM (1965)", "ST": "T023", "AN": "one of the 8 front teeth; NIM when merely locational; \"incisive papilla\", a projection on the palate posterior to the central incisors: index under PALATE & do not add INCISOR", "MS": "Any of the eight frontal teeth (four maxillary and four mandibular) having a sharp incisal edge for cutting food and a single root, which occurs in man both as a deciduous and a permanent tooth. (Jablonski, Dictionary of Dentistry, 1992, p820)", "PM": "65", "HN": "65", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007180"}, {"RECTYPE": "D", "MH": "Inclusion Bodies, Viral", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Viral Inclusion Bodies|T026|NON|EQV|NLM (1994)|930222|abcdef", "ENTRY": "Viral Inclusion Body", "MN": "G06.920.400", "MH_TH": "NLM (1966)", "ST": "T026", "MS": "An area showing altered staining behavior in the nucleus or cytoplasm of a virus-infected cell. Some inclusion bodies represent \"virus factories\" in which viral nucleic acid or protein is being synthesized; others are merely artifacts of fixation and staining. One example, Negri bodies, are found in the cytoplasm or processes of nerve cells in animals that have died from rabies.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007181"}, {"RECTYPE": "D", "MH": "Income", "AQ": "CL HI SN TD", "ENTRY": "Programs, Income Generation", "MN": "N01.824.417", "FX": "Salaries and Fringe Benefits", "MH_TH": "POPLINE (1978)", "ST": "T081", "PI": "Social Conditions (1966-1967)", "MS": "Revenues or receipts accruing from business enterprise, labor, or invested capital.", "PM": "68", "HN": "68", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007182"}, {"RECTYPE": "D", "MH": "Income Tax", "AQ": "CL EC HI LJ SN TD", "ENTRY": "Taxes, Income", "MN": "N03.219.900.250", "MH_TH": "NLM (1966)", "ST": "T064", "AN": "IM; specify geog", "MS": "Tax on the net income of an individual, organization, or business.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007183"}, {"RECTYPE": "D", "MH": "Incontinentia Pigmenti", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bloch-Sulzberger Syndrome|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|860403|abcdeeeef", "ENTRY": "Syndrome, Bloch-Sulzberger", "MN": "C17.800.827.420", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "multiple skin & other abnorm; do not confuse with INCONTINENTIA PIGMENTI ACHROMIANS see PIGMENTATION DISORDERS", "PI": "Pigmentation Disorders (1966-1986)", "MS": "A genodermatosis occurring mostly in females and characterized by skin changes in three phases - vesiculobullous, verrucous papillomatous, and macular melanodermic. Hyperpigmentation is bizarre and irregular. Sixty percent of patients have abnormalities of eyes, teeth, central nervous system, and skin appendages.", "PM": "91; was see under PIGMENTATION DISORDERS 1987-90", "HN": "91(87); was see under PIGMENTATION DISORDERS 1987-90", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19860403", "DC": "1", "DX": "19910101", "UI": "D007184"}, {"RECTYPE": "D", "MH": "Incubators", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Incubator", "MN": "E07.461", "FX": "Life Support Systems", "MH_TH": "NLM (1973)", "ST": "T074", "AN": "for eggs, microbial cultures, cell cultures, etc.; INCUBATORS, INFANT is also available", "MS": "Insulated enclosures in which temperature, humidity, and other environmental conditions can be regulated at levels optimal for growth, hatching, reproduction, or metabolic reactions.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007185"}, {"RECTYPE": "D", "MH": "Incubators, Infant", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Radiant Warmers, Infant|T074|NON|REL|IOM (1990)|890417|abcdef", "ENTRY": "Warmers, Infant Radiant", "MN": "E07.461.487", "MH_TH": "NLM (1974)", "ST": "T074", "MS": "Electrically powered devices that are intended to assist in the maintenance of the thermal balance of infants, principally by controlling the air temperature and humidity in an enclosure. (from UMDNS, 1999)", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "19991109", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007186"}, {"RECTYPE": "D", "MH": "Incunabula as Topic", "AQ": "EC HI", "MN": "L01.462.500.682.192.515", "MH_TH": "NLM (2010)", "ST": "T170", "AN": "do not confuse with the Publication Type INCUNABULA", "MS": "Works about books printed before the year before 1501.", "PM": "2010; see INCUNABULA 1966-2009", "HN": "2010(1966)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20100101", "UI": "D007187"}, {"RECTYPE": "D", "MH": "Incus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A09.246.397.247.362", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "One of three ossicles of the middle ear. It conducts sound vibrations from the MALLEUS to the STAPES.", "OL": "search EAR OSSICLES 1966-74", "PM": "91; was see under EAR OSSICLES 1975-90", "HN": "91(75); was see under EAR OSSICLES 1975-90", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007188"}, {"RECTYPE": "D", "MH": "Indans", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Indanones|T109|NON|NRW|NLM (2004)|030404|abcdef", "MN": "D04.615.486.487", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "Aryl CYCLOPENTANES that are a reduced (protonated) form of INDENES.", "OL": "search INDENES 1966-74", "PM": "91,63-67; was see under INDENES 1975-90; was heading 1963-67", "HN": "91(75)63-67; was see under INDENES 1975-90; was heading 1963-67", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007189"}, {"RECTYPE": "D", "MH": "Indapamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Metindamide|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "SE1520", "MN": "D03.633.100.473.391", "PA": "Sodium Chloride Symporter Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)-", "RN": "F089I0511L", "RR": "26807-65-8 (Indapamide)", "PI": "Indoles (1974)", "MS": "A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.", "PM": "91; was see under DIURETICS, SULFAMYL 1975-90", "HN": "91(75); was see under DIURETICS, SULFAMYL 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007190"}, {"RECTYPE": "D", "MH": "Indazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Indazole|T109|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D03.633.100.449", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "Pyrazoles (1966-1970)", "MS": "A group of heterocyclic aromatic organic compounds consisting of the fusion of BENZENE and PYRAZOLES.", "PM": "91; was see under PYRAZOLES 1971-90", "HN": "91(71); was see under PYRAZOLES 1971-90", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007191"}, {"RECTYPE": "D", "MH": "Indenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.486", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "aromatic hydrocarbons", "MS": "A family of fused-ring hydrocarbons isolated from coal tar that act as intermediates in various chemical reactions and are used in the production of coumarone-indene resins.", "PM": "68", "HN": "68", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007192"}, {"RECTYPE": "D", "MH": "Independent Practice Associations", "DE": "INDEPENDENT PRACTICE ASSOC", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Individual Practice Associations|T093|NON|EQV|UNK (19XX)|880519|INDIVIDUAL PRACTICE ASSOC|abcdefv", "ENTRY": "Practice Associations, Individual", "MN": "N04.590.374.410.450", "MH_TH": "NLM (1988)", "ST": "T093", "MS": "A partnership, corporation, association, or other legal entity that enters into an arrangement for the provision of services with persons who are licensed to practice medicine, osteopathy, and dentistry, and with other care personnel. Under an IPA arrangement, licensed professional persons provide services through the entity in accordance with a mutually accepted compensation arrangement, while retaining their private practices. Services under the IPA are marketed through a prepaid health plan. (From Facts on File Dictionary of Health Care Management, 1988)", "OL": "use INDEPENDENT PRACTICE ASSOCIATIONS to search INDEPENDENT PRACTICE ASSOCIATION 1988-91", "PM": "92; was INDEPENDENT PRACTICE ASSOCIATION 1988-91 (see under PRIVATE PRACTICE 1988-90)", "HN": "92; was INDEPENDENT PRACTICE ASSOCIATION 1988-91 (see under PRIVATE PRACTICE 1988-90)", "MR": "19940512", "DA": "19870502", "DC": "1", "DX": "19910101", "UI": "D007193"}, {"RECTYPE": "D", "MH": "India", "AQ": "EH EP", "ENTRY": "Republic of India|T083|NON|EQV|NLM (2018)|161222|abcdef", "MN": "Z01.252.245.782.875", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "Indians are of CAUCASOID RACE unless otherwise specified", "MS": "A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi.", "MR": "20220708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007194"}, {"RECTYPE": "D", "MH": "Indian Ocean Islands", "AQ": "EH EP", "PRINT ENTRY": "Pemba|T083|NAM|NRW|NLM (1994)|920910|abcdef", "ENTRY": "Cocos (Keeling) Islands|T083|NAM|NRW|POPLINE (1983)|861231|abcdef", "MN": "Z01.639.520", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "in addition to indentions here, includes Maldives, Pemba & Cocos (Keeling) Islands", "MS": "Numerous islands in the Indian Ocean situated east of Madagascar, north to the Arabian Sea and east to Sri Lanka. Included are COMOROS (republic), MADAGASCAR (republic), Maldives (republic), MAURITIUS (parliamentary democracy), Pemba (administered by Tanzania), REUNION (a department of France), and SEYCHELLES (republic).", "MR": "20220708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007195"}, {"RECTYPE": "D", "MH": "Indiana", "AQ": "EH EP", "MN": "Z01.107.567.875.510.360", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Lake Michigan and Michigan, on the east by Ohio, on the south by Kentucky, and on the west by Illinois.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007196"}, {"RECTYPE": "D", "MH": "Indians, Central American", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Indigenous Central Americans|T098|NON|EQV|NLM (2024)|221109|abcdef", "ENTRY": "Indigenous Central American", "MN": "M01.686.477.250.575", "MH_TH": "NLM (1978)", "ST": "T098", "PI": "Indians, South American (1966-1977)", "MS": "Members of indigenous Central American populations with pre-colonial contact origins.", "PM": "78", "HN": "78", "MR": "20230226", "DA": "19770513", "DC": "1", "DX": "19780101", "UI": "D007197"}, {"RECTYPE": "D", "MH": "Indians, North American", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Indigenous North Americans|T098|NON|EQV|NLM (2024)|221109|abcdef", "ENTRY": "North American, Indigenous", "MN": "M01.686.477.250.600", "FX": "United States Indian Health Service", "MH_TH": "POPLINE (1978)", "ST": "T098", "AN": "specify geographic location if possible", "MS": "Members of indigenous North American populations with pre-colonial contact origins.", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007198"}, {"RECTYPE": "D", "MH": "Indians, South American", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Indigenous South Americans|T098|NON|EQV|NLM (2024)|221103|abcdef", "ENTRY": "South Americans, Indigenous", "MN": "M01.686.685.500", "MH_TH": "NLM (1978)", "ST": "T098", "AN": "specify geog if possible; in titles capitalize both Native and American", "MS": "Members of indigenous South American populations with pre-colonial contact origins.", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007199"}, {"RECTYPE": "D", "MH": "Indican", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Indoxyl", "MN": "D03.633.100.473.393", "FX": "Hartnup Disease", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "1H-Indol-3-ol, hydrogen sulfate (ester)", "RN": "N187WK1Y1J", "RR": "79395-72-5 (mono-Na salt)", "AN": "do not confuse with indican, a glycoside from plants yielding indigo (index under GLYCOSIDES)", "MS": "A substance occurring in the urine of mammals and also in blood plasma as the normal metabolite of tryptophan. An increased urinary excretion of indican is seen in Hartnup disease from the bacterial degradation of unabsorbed tryptophan.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007200"}, {"RECTYPE": "D", "MH": "Indicator Dilution Techniques", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "PRINT ENTRY": "Dilution Techniques|T059|NON|BRD|UNK (19XX)|740330|abcdef", "ENTRY": "Techniques, Indicator Dilution", "MN": "E05.484", "MH_TH": "NLM (1967)", "ST": "T059", "AN": "usually NIM; DYE DILUTION TECHNIQUE and RADIOISOTOPE DILUTION TECHNIQUE are also available", "PI": "Dye Dilution Technique (1966)", "MS": "Methods for assessing flow through a system by injection of a known quantity of an indicator, such as a dye, radionuclide, or chilled liquid, into the system and monitoring its concentration over time at a specific point in the system. (From Dorland, 28th ed)", "OL": "use INDICATOR DILUTION TECHNIQUES to search INDICATOR DILUTION TECHNICS 1967-90", "PM": "91; was INDICATOR DILUTION TECHNICS 1967-90", "HN": "91; was INDICATOR DILUTION TECHNICS 1967-90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007201"}, {"RECTYPE": "D", "MH": "Indicators and Reagents", "DE": "INDICATORS REAGENTS", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Reagents|T130|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Reagents and Indicators|T130|NON|EQV|UNK (19XX)|790329|REAGENTS INDICATORS|abcdefv", "MN": "D27.720.470.410", "FX": "Reagent Kits, Diagnostic", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "AN": "coordinate NIM with specific substance (IM or NIM);  REAGENT KITS, DIAGNOSTIC & REAGENT STRIPS are also available", "MS": "Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007202"}, {"RECTYPE": "D", "MH": "Indigo Carmine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Soluble Indigo Blue|T109|T130|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Indigo Blue, Soluble", "MN": "D03.633.100.473.396", "PA": "Coloring Agents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "1H-Indole-5-sulfonic acid, 2-(1,3-dihydro-3-oxo-5-sulfo-2H-indol-2-ylidene)-2,3-dihydro-3-oxo-, disodium salt", "RN": "D3741U8K7L", "RR": "X7OI7JF73P", "PI": "Sulfonic Acids (1969-1974)", "MS": "Indolesulfonic acid used as a dye in renal function testing for the detection of nitrates and chlorates, and in the testing of milk.", "PM": "2010-2012; INDIGO was indexed under INDOLES 1980-2013; see INDIGOTINDISULFONATE SODIUM 2002-2011, see INDIGO CARMINE 1976-2001; see INDOLES 1975-1990", "HN": "2012 (1975)", "MR": "20180301", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007203"}, {"RECTYPE": "D", "MH": "Indium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.381", "FX": "Indium Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Indium", "RN": "045A6V3VFX", "RR": "7440-74-6 (Indium)", "MS": "A metallic element, atomic number 49, atomic weight 114.818, symbol In. It is named from its blue line in the spectrum.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007204"}, {"RECTYPE": "D", "MH": "Indium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Indium", "MN": "D01.496.749.460", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1987)", "MS": "Unstable isotopes of indium that decay or disintegrate emitting radiation. In atoms with atomic weights 106-112, 113m, 114, and 116-124 are radioactive indium isotopes.", "PM": "88", "HN": "88", "MR": "20170703", "DA": "19870406", "DC": "1", "DX": "19880101", "UI": "D007205"}, {"RECTYPE": "D", "MH": "Individuality", "PRINT ENTRY": "Individual Differences|T041|T080|NON|EQV|UNK (19XX)|750101|abbcdef", "ENTRY": "Individual Difference", "MN": "F01.752.488", "MH_TH": "NLM (1975)", "ST": "T080", "AN": "do not confuse with PERSONHOOD", "PI": "Personality (1966-1974)", "MS": "Those psychological characteristics which differentiate individuals from one another.", "OL": "search PERSONALITY 1966-74", "PM": "75; was see under PERSONALITY 1963-74", "HN": "75; was see under PERSONALITY 1963-74", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D007206"}, {"RECTYPE": "D", "MH": "Individuation", "ENTRY": "Individuations", "MN": "F01.752.747.466", "MH_TH": "NLM (1975)", "ST": "T041", "MS": "A process of differentiation having for its goal the development of the individual personality.", "OL": "search PERSONALITY DISORDERS 1970-74", "PM": "91; was see under PERSONALITY DEVELOPMENT 1975-90", "HN": "91(75); was see under PERSONALITY DEVELOPMENT 1975-90", "CATSH": "CAT LIST", "MR": "19900413", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007207"}, {"RECTYPE": "D", "MH": "Indocyanine Green", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Green, Indocyanine", "MN": "D03.633.100.473.400", "PA": "Coloring Agents", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "1H-Benz(e)indolium, 2-(7-(1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benz(e)indol-2-ylidene)-1,3,5-heptatrienyl)-1,1-dimethyl-3-(4-sulfobutyl)-, inner salt, sodium salt", "RN": "IX6J1063HV", "RR": "3599-32-4 (Indocyanine Green)", "MS": "A tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output.", "PM": "68", "HN": "68(63)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007208"}, {"RECTYPE": "D", "MH": "Indole-3-Glycerol-Phosphate Synthase", "DS": "INDOLE GLYCEROL PHOSPHATE SYNTHASE 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthase, Indole-3-Glycerol-Phosphate", "MN": "D08.811.520.224.125.350", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose-5-phosphate carboxy-lyase (cyclizing)", "RN": "EC 4.1.1.48", "RR": "9031-60-1 (CAS RN)", "PI": "Pentosephosphates (1970-1974)", "MS": "An enzyme in the tryptophan biosynthetic pathway. EC 4.1.1.48.", "PM": "91; was see under CARBOXY-LYASES 1975-90", "HN": "91(75); was see under CARBOXY-LYASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007209"}, {"RECTYPE": "D", "MH": "Indoleacetic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Indolylacetic", "MN": "D03.633.100.473.404", "PA": "Plant Growth Regulators", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Acetic acid derivatives of the heterocyclic compound indole. (Merck Index, 11th ed)", "OL": "use INDOLEACETIC ACIDS to search INDOLEACETIC ACID 1966-74", "PM": "75; was INDOLEACETIC ACID 1963-74", "HN": "75; was INDOLEACETIC ACID 1963-74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D007210"}, {"RECTYPE": "D", "MH": "Indoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.473", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007211"}, {"RECTYPE": "D", "MH": "Indolizines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.496", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "PM": "66", "HN": "66", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007212"}, {"RECTYPE": "D", "MH": "Indomethacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Osmosin|T109|T121|TRD|NRW|UNK (19XX)|830914|abbcdef", "MN": "D03.633.100.473.420", "PA": "Tocolytic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-", "RN": "XXE1CET956", "RR": "88170-06-3 (Ca salt)", "MS": "A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.", "PM": "1966", "HN": "1966 (1964)", "MR": "20180410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007213"}, {"RECTYPE": "D", "MH": "Indonesia", "AQ": "EH EP", "PRINT ENTRY": "West Irian|T083|NAM|NRW|UNK (19XX)|810227|abcdef", "ENTRY": "Malay Archipelago|T083|NAM|BRD|NLM (1992)|180312|abcdef", "MN": "Z01.639.580", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "A republic stretching from the Indian Ocean east to New Guinea, comprising six main islands: Java, Sumatra, Bali, Kalimantan (the Indonesian portion of the island of Borneo), Sulawesi (formerly known as the Celebes) and Irian Jaya (the western part of New Guinea). Its capital is Djakarta. The ethnic groups living there are largely Chinese, Arab, Eurasian, Indian, and Pakistani; 85% of the peoples are of the Islamic faith.", "OL": "use INDONESIA to search TIMOR 1966-94", "HN": "TIMOR was heading 1963-94", "MR": "20220818", "DA": "19990101", "DC": "4", "DX": "19630101", "UI": "D007214"}, {"RECTYPE": "D", "MH": "Indophenol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.657.446", "MH_TH": "NLM (1966)", "ST": "T109", "N1": "2,5-Cyclohexadien-1-one, 4-((4-hydroxyphenyl)imino)-", "RN": "500-85-6", "MS": "A deep blue dye (with the formula OC6H4NC6H4OH) used to detect AMMONIA in a common test called the Berthelot's reaction and to detect PARACETAMOL by spectrophotometry.", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007215"}, {"RECTYPE": "D", "MH": "Indoprofen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dexindoprofen|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|861009|abbcdeef", "MN": "D03.633.100.513.374", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "Benzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-alpha-methyl-", "RN": "CPE46ZU14N", "RR": "31842-01-0 (Indoprofen)", "PI": "Propionates (1966-1973)", "MS": "A drug that has analgesic and anti-inflammatory properties. Following reports of adverse reactions including reports of carcinogenicity in animal studies it was withdrawn from the market worldwide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p21)", "PM": "91; was see under PHENYLPROPIONATES 1979-90", "HN": "91(79); was see under PHENYLPROPIONATES 1979-90", "MR": "20160531", "DA": "19780320", "DC": "1", "DX": "19910101", "UI": "D007216"}, {"RECTYPE": "D", "MH": "Indoramin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Wy21901", "MN": "D03.633.100.473.432", "PA": "Antihypertensive Agents", "MH_TH": "USAN (1971)", "ST": "T121", "N1": "Benzamide, N-(1-(2-(1H-indol-3-yl)ethyl)-4-piperidinyl)-", "RN": "0Z802HMY7H", "RR": "26844-12-2 (Indoramin)", "PI": "Piperidines (1971-1974)", "MS": "An alpha-1 adrenergic antagonist that is commonly used as an antihypertensive agent.", "PM": "91; was see under INDOLES 1975-90", "HN": "91(75); was see under INDOLES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007217"}, {"RECTYPE": "D", "MH": "Industrial Microbiology", "DE": "INDUST MICROBIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Microbiology, Industrial|T090|NON|EQV|UNK (19XX)|860327|MICROBIOL INDUST|abcdefv", "MN": "J01.897.120.460", "FX": "Genetic Engineering", "MH_TH": "NLM (1987)", "ST": "T090", "MS": "The study, utilization, and manipulation of those microorganisms capable of economically producing desirable substances or changes in substances, and the control of undesirable microorganisms.", "PM": "87", "HN": "87", "MR": "20100625", "DA": "19860327", "DC": "1", "DX": "19870101", "UI": "D007218"}, {"RECTYPE": "D", "MH": "Industrial Oils", "DE": "INDUST OILS", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Polishes|T073|NON|NRW|UNK (19XX)|860620|abcdef", "ENTRY": "Oils, Commercial", "MN": "J01.637.450", "MH_TH": "NLM (1987)", "ST": "T167", "AN": "coordinate with specific oil if pertinent", "PI": "Oils (1966-1986)", "MS": "Oils which are used in industrial or commercial applications.", "OL": "use INDUSTRIAL OILS to search POLISHES 1987; use OILS to search POLISHES 1966-86 (as Prov 1966-74)", "PM": "87; POLISHES was see OILS 1978-86; was see under OILS 1975-77", "HN": "87; POLISHES was see OILS 1978-86; was see under OILS 1966-77 (Prov 1966-74)", "MR": "19970620", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D007219"}, {"RECTYPE": "D", "MH": "Industrial Waste", "DE": "INDUST WASTE", "AQ": "AE AN EC ES LJ PC SN", "ENTRY": "Wastes, Industrial", "MN": "N06.850.460.710.420", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "specify geog if pertinent", "MS": "Worthless, damaged, defective, superfluous or effluent material from industrial operations.", "PM": "66", "HN": "66", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007220"}, {"RECTYPE": "D", "MH": "Industry", "DE": "INDUST", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Tertiary Sectors", "MN": "J01.576", "FX": "Workplace", "MH_TH": "NLM (1978)", "ST": "T057", "MS": "Any enterprise centered on the processing, assembly, production, or marketing of a line of products, services, commodities, or merchandise, in a particular field often named after its principal product. Examples include the automobile, fishing, music, publishing, insurance, and textile industries.", "PM": "73", "HN": "73", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007221"}, {"RECTYPE": "D", "MH": "Inert Gas Narcosis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nitrogen Narcosis|T037|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Nitrogen Narcoses", "MN": "C25.723.455.571", "MH_TH": "NLM (1968)", "ST": "T037", "AN": "IM; specify gas (IM)", "PI": "specific gas (1966-1967)", "MS": "Progressive mental disturbances and unconsciousness due to breathing mixtures of oxygen and inert gases (argon, helium, xenon, krypton, and atmospheric nitrogen) at high pressure.", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D007222"}, {"RECTYPE": "D", "MH": "Infant", "ENTRY": "Infants|T100|NON|EQV|NLM (1996)|950327|abcdef", "MN": "M01.060.703", "EC": "psychology:Psychology, Child", "MH_TH": "NLM (1966)", "ST": "T100", "AN": "almost always check tag: NIM no qualifiers; see Manual Chapter 9", "MS": "A child between 1 and 23 months of age.", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007223"}, {"RECTYPE": "D", "MH": "Infant Care", "AQ": "CL EC ES HI IS LJ MT OG PX SD SN ST TD", "MN": "N02.421.088.120", "FX": "Intensive Care, Neonatal", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "humans only; check the tags HUMAN and INFANT or INFANT, NEWBORN", "MS": "Care of infants in the home or institution.", "OL": "use INFANT CARE to search DIAPERS 1989-91", "PM": "DIAPERS was see INFANT CARE 1989-91", "HN": "DIAPERS was see INFANT CARE 1989-91", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007224"}, {"RECTYPE": "D", "MH": "Infant Food", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Food, Infant|T168|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Infant Foods", "MN": "J02.500.525.500", "FX": "Infant Formula", "MH_TH": "NLM (1970)", "ST": "T168", "PI": "Infant Nutrition (1966-1969)", "MS": "Food processed and manufactured for the nutritional health of children in their first year of life.", "OL": "use INFANT FOOD to search INFANT FOODS 1970-72 (as Prov)", "PM": "73", "HN": "73; was INFANT FOODS 1970-72 (Prov)", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007225"}, {"RECTYPE": "D", "MH": "Infant Mortality", "DE": "INFANT MORTAL", "AQ": "EH HI TD", "PRINT ENTRY": "Neonatal Mortality|T081|NON|REL|NLM (1990)|890508|NEONATAL MORTAL|abcdefv", "ENTRY": "Postneonatal Mortalities", "MN": "N06.850.520.308.985.550.475", "FX": "Infant Death", "MH_TH": "NLM (1963)", "ST": "T081", "AN": "a statistical concept & not a substitute for / mortal with INFANT, NEWBORN, DISEASES or with specific diseases in infants; do not confuse with INFANT DEATH;  add geographic term if pertinent; PERINATAL MORTALITY is also available", "MS": "Postnatal deaths from BIRTH to 365 days after birth in a given population. Postneonatal mortality represents deaths between 28 days and 365 days after birth (as defined by National Center for Health Statistics). Neonatal mortality represents deaths from birth to 27 days after birth.", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007226"}, {"RECTYPE": "D", "MH": "Infant Nutritional Physiological Phenomena", "AQ": "DE EC EH GE HI IM LJ PH RE ST", "PRINT ENTRY": "Nutrition Physiology, Infant|T040|NON|EQV|NLM (2007)|051123|abcdef", "ENTRY": "Supplementary Feedings", "MN": "G07.203.650.220.500", "FX": "Milk, Human", "MH_TH": "NLM (2009)", "ST": "T040", "AN": "check the tag INFANT", "MS": "Nutritional physiology of children from birth to 2 years of age.", "PM": "2009; see INFANT NUTRITION PHYSIOLOGY 2007-2008, see INFANT NUTRITION 1963-2006", "HN": "2009 (1963)", "CATSH": "CAT LIST", "MR": "20160928", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D007227"}, {"RECTYPE": "D", "MH": "Infant Nutrition Disorders", "DE": "INFANT NUTRITION DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nutrition Disorders, Infant|T047|NON|EQV|UNK (19XX)|880602|NUTRITION DIS INFANT|abcdefv", "ENTRY": "Overnutrition, Infant", "MN": "C18.654.422", "FX": "Child Nutrition Disorders", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "general or unspecified; prefer specific disease with infant check tag", "MS": "Disorders caused by nutritional imbalance, either overnutrition or undernutrition, occurring in infants ages 1 month to 24 months.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007228"}, {"RECTYPE": "D", "MH": "Infant Welfare", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Well-Being, Newborn Infant", "MN": "I01.880.787.539", "FX": "Infant Health", "MH_TH": "NLM (1975)", "ST": "T058", "AN": "check the tag INFANT or INFANT, NEWBORN", "MS": "Organized efforts by communities or organizations to improve the health and well-being of infants.", "OL": "search CHILD WELFARE 1966-74", "PM": "91; was see under CHILD WELFARE 1975-90", "HN": "91(75); was see under CHILD WELFARE 1975-90", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007229"}, {"RECTYPE": "D", "MH": "Infant, Low Birth Weight", "DE": "INFANT LBW", "AQ": "BL CF GD IM ME PH PX UR", "ENTRY": "Low-Birth-Weight Infants", "MN": "M01.060.703.520.460", "MH_TH": "NLM (1977)", "ST": "T101", "AN": "check tag INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT is also available", "PI": "Infant, Premature (1966-1976)", "MS": "An infant having a birth weight of 2500 gm. (5.5 lb.) or less but INFANT, VERY LOW BIRTH WEIGHT is available for infants having a birth weight of 1500 grams (3.3 lb.) or less.", "PM": "77", "HN": "77", "MR": "20020702", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D007230"}, {"RECTYPE": "D", "MH": "Infant, Newborn", "AQ": "BL CF GD IM ME PH PX UR", "PRINT ENTRY": "Neonate|T100|NON|EQV|NLM (1990)|890216|abcdef", "ENTRY": "Newborn Infants", "MN": "M01.060.703.520", "FX": "Animals, Newborn", "MH_TH": "NLM (1966)", "ST": "T100", "AN": "usually check tag: NIM no qualifiers; IM when a healthy neonate is the point of the article; see Manual Chapter 9", "MS": "An infant during the first 28 days after birth.", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007231"}, {"RECTYPE": "D", "MH": "Infant, Newborn, Diseases", "DE": "INFANT NEWBORN DIS", "AQ": "BL CF CI CL DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neonatal Disease", "MN": "C16.614", "FX": "Congenital Abnormalities", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general only; for specific disease in newborn infant index specific disease + check tag INFANT, NEWBORN", "MS": "Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.", "CATSH": "CAT LIST", "MR": "20160226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007232"}, {"RECTYPE": "D", "MH": "Infant, Postmature", "AQ": "BL CF GD IM ME PH PX UR", "ENTRY": "Postmature Infants", "MN": "M01.060.703.520.500", "MH_TH": "NLM (1975)", "ST": "T100", "AN": "check the tag INFANT, NEWBORN; do not confuse with FETAL MACROSOMIA or INFANT, LARGE FOR GESTATIONAL AGE ", "MS": "An infant born at or after 42 weeks of gestation.", "PM": "91; was see under INFANT, NEWBORN 1975-90", "HN": "91(75); was see under INFANT, NEWBORN 1975-90", "MR": "20220711", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D007233"}, {"RECTYPE": "D", "MH": "Infant, Premature", "AQ": "BL CF GD IM ME PH PX UR", "ENTRY": "Preterm Infant", "MN": "M01.060.703.520.520", "FX": "Premature Birth", "MH_TH": "NLM (1963)", "ST": "T100", "AN": "check the tag INFANT, NEWBORN", "MS": "A human infant born before 37 weeks of GESTATION.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007234"}, {"RECTYPE": "D", "MH": "Infant, Premature, Diseases", "DE": "INFANT PREMATURE DIS", "AQ": "BL CF CI CL DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C16.614.521", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "add INFANT, PREMATURE", "MS": "Diseases that occur in PREMATURE INFANTS.", "CATSH": "CAT LIST", "MR": "20151216", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007235"}, {"RECTYPE": "D", "MH": "Infant, Small for Gestational Age", "DE": "INFANT SGA", "AQ": "BL CF GD IM ME PH PX UR", "MN": "M01.060.703.520.460.560", "MH_TH": "NLM (1977)", "ST": "T100", "AN": "check the tag INFANT, NEWBORN", "PI": "Infant, Premature (1966-1976)", "MS": "An infant having a birth weight lower than expected for its gestational age.", "PM": "78; was see under INFANT, LOW BIRTH WEIGHT 1977", "HN": "78(77); was see under INFANT, LOW BIRTH WEIGHT 1977", "MR": "20020703", "DA": "19760505", "DC": "1", "DX": "19780101", "UI": "D007236"}, {"RECTYPE": "D", "MH": "Infanticide", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Neonaticide|T054|NON|NRW|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Neonaticides", "MN": "I01.198.240.470.572", "MH_TH": "POPLINE (1978)", "ST": "T054", "MS": "The killing of infants at birth or soon after.", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007237"}, {"RECTYPE": "D", "MH": "Infarction", "DE": "INFARCT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Infarct|T047|NON|EQV|NLM (2020)|190301|abcdef", "ENTRY": "Infarcts", "MN": "C23.550.717.489", "FX": "Splenic Infarction", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate IM with organ /blood supply (IM): Manual 23.14.2", "MS": "Formation of an infarct, which is NECROSIS in tissue due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS.", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007238"}, {"RECTYPE": "D", "MH": "Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Infections and Infestations|T047|NON|EQV|NLM (2020)|190703|abcdef", "ENTRY": "Infestations and Infections", "MN": "C01", "FX": "Anti-Infective Agents", "EC": "prevention & control:Infection Control", "MH_TH": "NLM (2020)", "ST": "T047", "MS": "Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases.", "OL": "use INFECTION CONTROL to search INFECTION/prevention & control 1966-91", "PM": "2020; see Infection 1963-2019; /prevention & control was INFECTION/prevention & control 1966-91", "HN": "2020; was Infection 1963-2019; /prevention & control was INFECTION/prevention & control 1966-91", "CATSH": "CAT LIST", "MR": "20191015", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007239"}, {"RECTYPE": "D", "MH": "Equartevirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Infectious Arteritis Virus, Equine|T005|NON|NRW|NLM (1994)|921217|INFECT ARTERITIS VIRUS EQUINE|abcdefv", "ENTRY": "Equine Arteritis Viruses", "MN": "B04.820.578.500.080.500.100", "MH_TH": "NLM (2019)", "ST": "T005", "RN": "txid2003400", "RR": "txid2499610", "MS": "A genus of the family ARTERIVIRIDAE.", "OL": "use ARTERITIS VIRUS, EQUINE to search INFECTIOUS ARTERITIS VIRUS, EQUINE 1981-93 & INFECTIOUS ARTERITIS VIRUS OF HORSES 1975-80", "PM": "2019; see ARTERITIS VIRUS, EQUINE 1994-2018; INFECTIOUS ARTERITIS VIRUS, EQUINE 1981-1993 (see under RNA VIRUSES 1981-1990); for INFECTIOUS ARTERITIS VIRUS OF HORSES see under RNA VIRUSES 1975-1980", "HN": "2019(1975); for INFECTIOUS ARTERITIS VIRUS, EQUINE use RNA VIRUSES 1981-1990; for INFECTIOUS ARTERITIS VIRUS OF HORSES use RNA VIRUSES 1975-1980", "MR": "20230405", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D007240"}, {"RECTYPE": "D", "MH": "Infectious Bovine Rhinotracheitis", "DE": "INFECT BOVINE RHINOTRACHEITIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Rhinotracheitis, Infectious Bovine", "MN": "C22.196.429", "MH_TH": "NLM (1973)", "ST": "T047", "AN": "check the tags ANIMALS and CATTLE", "PI": "Infectious Bovine Rhinotracheitis Virus (1966-1972)", "MS": "A herpesvirus infection of CATTLE characterized by INFLAMMATION and NECROSIS of the mucous membranes of the upper RESPIRATORY TRACT.", "PM": "78; was see under CATTLE DISEASES 1975-77", "HN": "78(73); was see under CATTLE DISEASES 1975-77", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D007241"}, {"RECTYPE": "D", "MH": "Herpesvirus 1, Bovine", "DS": "HERPESVIRUS BOVINE 01", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Infectious Pustular Vulvovaginitis Virus|T005|NON|EQV|UNK (19XX)|741127|INFECT PUSTULAR VULVOVAGINITIS VIRUS|abcdefv", "ENTRY": "Viruses, IBR-IPV", "MN": "B04.280.382.100.900.400", "MH_TH": "NLM (1964)", "ST": "T005", "RN": "txid10320", "AN": "infection: coord IM with HERPESVIRIDAE INFECTIONS (IM) but consider also INFECTIOUS BOVINE RHINOTRACHEITIS", "MS": "A species of VARICELLOVIRUS that causes INFECTIOUS BOVINE RHINOTRACHEITIS and other associated syndromes in CATTLE.", "OL": "use HERPESVIRUS 1, BOVINE to search INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS 1966-93", "PM": "94; was INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS 1966-93", "HN": "94; was INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS 1966-93", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007242"}, {"RECTYPE": "D", "MH": "Infectious bursal disease virus", "DE": "INFECT BURSAL DIS VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Infectious Bursal Agent|T005|NON|EQV|NLM (1994)|930107|INFECT BURSAL AGENT|abcdefv", "ENTRY": "Nephrosis Viruses, Avian", "MN": "B04.820.223.500.060.400", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid10995", "AN": "infection: coordinate with BIRNAVIRIDAE INFECTIONS", "MS": "A species of AVIBIRNAVIRUS causing severe inflammation of the bursa of Fabricius in chickens and other fowl. Transmission is thought to be through contaminated feed or water. Vaccines have been used with varying degrees of success.", "OL": "use INFECTIOUS BURSAL DISEASE VIRUS to search INFECTIOUS BURSAL AGENT 1975-93", "PM": "94; was INFECTIOUS BURSAL AGENT 1975-93 (see under REOVIRIDAE 1981-90, see under REOVIRUSES 1975-80)", "HN": "94; was INFECTIOUS BURSAL AGENT 1975-93 (see under REOVIRIDAE 1981-90, see under REOVIRUSES 1975-80)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D007243"}, {"RECTYPE": "D", "MH": "Infectious Mononucleosis", "DE": "INFECT MONONUCLEOSIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Glandular Fever|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Fever, Glandular", "MN": "C20.683.515.515", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "if not caused by Epstein-Barr Virus (HERPESVIRUS 4, HUMAN) coord IM with specific infection (IM)", "MS": "A common, acute infection usually caused by the Epstein-Barr virus (HERPESVIRUS 4, HUMAN). There is an increase in mononuclear white blood cells and other atypical lymphocytes, generalized lymphadenopathy, splenomegaly, and occasionally hepatomegaly with hepatitis.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007244"}, {"RECTYPE": "D", "MH": "Inferior Colliculi", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Colliculus, Inferior|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Inferiors, Colliculus", "MN": "A08.186.211.132.659.800.407", "MH_TH": "NLM (2008)", "ST": "T023", "PI": "Corpora Quadrigemina (1966-1970)", "MS": "The posterior pair of the quadrigeminal bodies which contain centers for auditory function.", "PM": "2008; see INFERIOR COLLICULUS 1971-2007", "HN": "2008; use INFERIOR COLLICULUS 1971-2007", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D007245"}, {"RECTYPE": "D", "MH": "Infertility", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sterility|T046|NON|NRW|UNK (19XX)|820503|abcdef", "ENTRY": "Subfertility|T047|NON|NRW|NLM (2012)|100908|abcdef", "MN": "C12.100.750", "MH_TH": "NLM (1983)", "ST": "T046", "AN": "general or unspecified as male or female; prefer the specifics; PLANT INFERTILITY is available", "MS": "A reduced or absent capacity to reproduce.", "OL": "use INFERTILITY to search STERILITY 1966-82", "PM": "83; was STERILITY 1963-82", "HN": "83; was STERILITY 1963-82", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19830101", "UI": "D007246"}, {"RECTYPE": "D", "MH": "Infertility, Female", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sterility, Female|T033|T046|NON|NRW|UNK (19XX)|820503|abbcdef", "ENTRY": "Sub Fertility, Female", "MN": "C12.100.750.350", "MH_TH": "POPLINE (1978)", "ST": "T046", "AN": "/chem ind permitted but not for testing of contraceptives", "MS": "Diminished or absent ability of a female to achieve conception.", "OL": "use INFERTILITY, FEMALE to search STERILITY, FEMALE 1966-82", "PM": "83; was STERILITY, FEMALE 1963-82", "HN": "83; was STERILITY, FEMALE 1963-82", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19830101", "UI": "D007247"}, {"RECTYPE": "D", "MH": "Infertility, Male", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sterility, Male|T033|T046|NON|NRW|UNK (19XX)|820503|abbcdef", "ENTRY": "Sub Fertility, Male", "MN": "C12.200.294.430", "FX": "Sperm Injections, Intracytoplasmic", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "/chem ind permitted but not for testing of contraceptives", "MS": "The inability of the male to effect FERTILIZATION of an OVUM after a specified period of unprotected intercourse. Male sterility is permanent infertility.", "OL": "use INFERTILITY, MALE to search STERILITY, MALE 1966-82", "PM": "83; was STERILITY, MALE 1963-82", "HN": "83; was STERILITY, MALE 1963-82", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19830101", "UI": "D007248"}, {"RECTYPE": "D", "MH": "Inflammation", "DE": "INFLAMM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Innate Inflammatory Response|T033|NON|REL|NLM (2020)|190408|abcdef", "ENTRY": "Innate Inflammatory Responses", "MN": "C23.550.470", "FX": "Immunity, Innate", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.", "CATSH": "CAT LIST", "MR": "20190408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007249"}, {"RECTYPE": "D", "MH": "Inflation, Economic", "DE": "INFLATION ECON", "AQ": "CL ES HI LJ SN TD", "PRINT ENTRY": "Economic Inflation|T081|NON|EQV|UNK (19XX)|790601|ECON INFLATION|abcdefv", "ENTRY": "Inflation|T081|NON|EQV|POPLINE (1986)|850805|abcdef", "MN": "N03.219.680", "MH_TH": "NLM (1980)", "ST": "T081", "AN": "specify geog if pertinent", "MS": "An increase in the volume of money and credit relative to available goods resulting in a substantial and continuing rise in the general price level.", "PM": "91; was see under ECONOMICS 1980-90", "HN": "91(80); was see under ECONOMICS 1980-90", "MR": "20180629", "DA": "19790601", "DC": "1", "DX": "19910101", "UI": "D007250"}, {"RECTYPE": "D", "MH": "Influenza, Human", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Influenza in Humans|T047|NON|EQV|NLM (2006)|051109|abcdef", "ENTRY": "Influenzas, Human", "MN": "C08.730.310", "FX": "Influenza Pandemic, 1918-1919", "MH_TH": "NLM (2006)", "ST": "T047", "AN": "coordinate IM with specific influenza virus (IM) if pertinent; note specific subtypes of INFLUENZA A VIRUS are available", "MS": "An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.", "PM": "2006; see INFLUENZA 1963-2005", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D007251"}, {"RECTYPE": "D", "MH": "Influenza Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Universal Influenza Vaccine|T121|T129|NON|NRW|NLM (2021)|191118|abbcdef", "ENTRY": "Virus Vaccine, Influenza", "MN": "D20.215.894.899.302", "MH_TH": "NLM (2005)", "ST": "T129", "RN": "0", "AN": "coordinate with specific influenza virus or virus subtype /immunol; not for Haemophilus influenzae vaccines (= HAEMOPHILUS VACCINES)", "MS": "Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains.", "PM": "2005; see INFLUENZA VACCINE 1963-2004; TRIVALENT LIVE INFLUENZA VACCINE was indexed under INFLUENZA VACCINES 2003-2004", "HN": "2005 (1963)", "MR": "20230727", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D007252"}, {"RECTYPE": "D", "MH": "Information Centers", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Information Center", "MN": "L01.462.625", "MH_TH": "POPLINE (1978)", "ST": "T092", "AN": "medical information centers: do not coordinate with MEDICINE", "PI": "Information Services (1966-1975)", "MS": "Facilities for collecting and organizing information. They may be specialized by subject field, type of source material, persons served, location, or type of services.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20220712", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D007253"}, {"RECTYPE": "D", "MH": "Information Science", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sciences, Information", "MN": "L01", "RH": "L1 - INFORMATION SCIENCES-COMMUNICATION TECHNIQUES AND SERVICES", "MH_TH": "NLM (1974)", "ST": "T090", "PI": "Information Systems (1966-1992)", "MS": "The field of knowledge, theory, and technology dealing with the collection of facts and figures, and the processes and methods involved in their manipulation, storage, dissemination, publication, and retrieval. It includes the fields of COMMUNICATION; PUBLISHING; LIBRARY SCIENCE; and informatics.", "PM": "93", "HN": "93; was INFORMATION SCIENCE (NON MESH) 1974-92", "MR": "20050712", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D007254"}, {"RECTYPE": "D", "MH": "Information Services", "DE": "INFORMATION SERV", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Specialists, Information", "MN": "L01.462.750", "FX": "Libraries", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "medical information services: do not coordinate with MEDICINE; DRUG INFORMATION SERVICES is available", "MS": "Organized services to provide information on any questions an individual might have using databases and other sources. (From Random House Unabridged Dictionary, 2d ed)", "PM": "66", "HN": "66", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007255"}, {"RECTYPE": "D", "MH": "Information Systems", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Perinatal Information System|T066|NON|NRW|NLM (2020)|190422|abcdef", "ENTRY": "Systems, Information Retrieval", "MN": "L01.313.500.750.300", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "for automated systems do not coord with AUTOMATIC DATA PROCESSING; for medical information systems do not coord with MEDICINE", "MS": "Integrated set of files, procedures, and equipment for the storage, manipulation, and retrieval of information.", "OL": "use INFORMATION SYSTEMS to search INFORMATION RETRIEVAL SYSTEMS 1966-81; use EMERGENCY MEDICAL SERVICE COMMUNICATION SYSTEMS to search EMERGENCY CARE INFORMATION SYSTEMS 1987-91", "PM": "82; was INFORMATION RETRIEVAL SYSTEMS 1966-81; EMERGENCY CARE INFORMATION SYSTEMS was see EMERGENCY MEDICAL SERVICE COMMUNICATION SYSTEMS 1987-91", "HN": "82; was INFORMATION RETRIEVAL SYSTEMS 1966-81; EMERGENCY CARE INFORMATION SYSTEMS was see EMERGENCY MEDICAL SERVICE COMMUNICATION SYSTEMS 1987-91", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007256"}, {"RECTYPE": "D", "MH": "Information Theory", "AQ": "HI", "ENTRY": "Theory, Information", "MN": "L01.488", "FX": "Operations Research", "MH_TH": "NLM (1964)", "ST": "T170", "MS": "An interdisciplinary study dealing with the transmission of messages or signals, or the communication of information. Information theory does not directly deal with meaning or content, but with physical representations that have meaning or content. It overlaps considerably with communication theory and CYBERNETICS.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007257"}, {"RECTYPE": "D", "MH": "Informed Consent", "AQ": "ES HI LJ PX SN ST", "ENTRY": "Consent, Informed", "MN": "N03.706.535.489", "FX": "Treatment Refusal", "MH_TH": "BIOETHICS (1974)", "ST": "T078", "AN": "competency to consent: coordinate IM with MENTAL COMPETENCY (IM)", "PI": "Physician-Patient Relations (1966-1970)", "MS": "Voluntary authorization, by a patient or research subject, with full comprehension of the risks involved, for diagnostic or investigative procedures, and for medical and surgical treatment.", "PM": "73", "HN": "73(71)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007258"}, {"RECTYPE": "D", "MH": "Infrared Rays", "AQ": "AE CL HI TU", "PRINT ENTRY": "Heat Waves|T070|NON|EQV|UNK (19XX)|800520|abcdef", "ENTRY": "Waves, Heat", "MN": "N06.230.300.100.725.525.400", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "non-ionizing; radiation policy: Manual 28.11+; black light goes here or under ULTRAVIOLET RAYS depending on text but unspecified index under ULTRAVIOLET RAYS", "MS": "That portion of the electromagnetic spectrum usually sensed as heat. Infrared wavelengths are longer than those of visible light, extending into the microwave frequencies. They are used therapeutically as heat, and also to warm food in restaurants.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007259"}, {"RECTYPE": "D", "MH": "Infusion Pumps", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Pumps, Infusion|T074|NON|EQV|UNK (19XX)|860604|abcdef", "ENTRY": "Systems, Drug Infusion", "MN": "E07.858.082.505", "MH_TH": "NLM (1987)", "ST": "T074", "AN": "/psychol permitted; coord IM with drug /admin (IM); INFUSION PUMPS, IMPLANTABLE is also available", "PI": "Perfusion, Regional (1978-1986)", "MS": "Fluid propulsion systems driven mechanically, electrically, or osmotically that are used to inject (or infuse) over time agents into a patient or experimental animal; used routinely in hospitals to maintain a patent intravenous line, to administer antineoplastic agents and other drugs in thromboembolism, heart disease, diabetes mellitus (INSULIN INFUSION SYSTEMS is also available), and other disorders.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19860604", "DC": "1", "DX": "19870101", "UI": "D007260"}, {"RECTYPE": "D", "MH": "Infusions, Intra-Arterial", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Infusions, Regional Arterial|T061|NON|NRW|UNK (19XX)|770418|abcdef", "ENTRY": "Regional Arterial Infusions", "MN": "E02.319.267.510.520", "MH_TH": "NLM (1978)", "ST": "T061", "AN": "do not confuse with CHEMOTHERAPY, CANCER, REGIONAL PERFUSION which is also used in cancer therapy or with INJECTIONS, INTRA-ARTERIAL", "PI": "Isolation Perfusion (1966-1977)", "MS": "Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D007261"}, {"RECTYPE": "D", "MH": "Infusions, Intravenous", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Intravenous Infusions|T061|NON|EQV|UNK (19XX)|860619|abcdef", "ENTRY": "Intravenous Infusion", "MN": "E02.319.267.510.590", "FX": "Immunoglobulins, Intravenous", "MH_TH": "NLM (1987)", "ST": "T061", "AN": "usually NIM; do not confuse with INJECTIONS, INTRAVENOUS", "PI": "Infusions, Parenteral (1966-1986)", "MS": "The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it.", "OL": "search INFUSIONS, PARENTERAL 1975-86", "PM": "87; was see INFUSIONS, PARENTERAL 1975-86", "HN": "87; was see INFUSIONS, PARENTERAL 1975-86", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D007262"}, {"RECTYPE": "D", "MH": "Infusions, Parenteral", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Peritoneal Infusions|T061|NON|NRW|UNK (19XX)|860619|abcdef", "ENTRY": "Peritoneal Infusion", "MN": "E02.319.267.510", "FX": "Home Infusion Therapy", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007263"}, {"RECTYPE": "D", "MH": "Inguinal Canal", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Rings, Inguinal", "MN": "A01.923.047.412", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "internal canal only: do not confuse with GROIN, external only", "MS": "The tunnel in the lower anterior ABDOMINAL WALL through which the SPERMATIC CORD, in the male; ROUND LIGAMENT, in the female; nerves; and vessels pass. Its internal end is at the deep inguinal ring and its external end is at the superficial inguinal ring.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007264"}, {"RECTYPE": "D", "MH": "Inhibins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Testicular Inhibins", "MN": "D12.776.395.439", "MH_TH": "NLM (2002)", "ST": "T125", "N1": "Inhibin", "RN": "57285-09-3", "AN": "/biosyn /physiol permitted", "PI": "Testicular Hormones (1975-1982)", "MS": "Glycoproteins that inhibit pituitary FOLLICLE STIMULATING HORMONE secretion. Inhibins are secreted by the Sertoli cells of the testes, the granulosa cells of the ovarian follicles, the placenta, and other tissues. Inhibins and ACTIVINS are modulators of FOLLICLE STIMULATING HORMONE secretions; both groups belong to the TGF-beta superfamily, as the TRANSFORMING GROWTH FACTOR BETA. Inhibins consist of a disulfide-linked heterodimer with a unique alpha linked to either a beta A or a beta B subunit to form inhibin A or inhibin B, respectively", "PM": "2002; see INHIBIN 1983-2001", "HN": "2002; (1983)", "MR": "20230316", "DA": "19820511", "DC": "1", "DX": "19830101", "UI": "D007265"}, {"RECTYPE": "D", "MH": "Inhibition, Psychological", "PRINT ENTRY": "Psychological Inhibition|T041|NON|EQV|NLM (2020)|190118|abcdef", "ENTRY": "Psychology Inhibitions", "MN": "F02.739.794.405", "MH_TH": "NLM (2020)", "ST": "T041", "AN": "human & animal", "PI": "Psychoanalytic Theory (1966-1970)", "MS": "The interference with or prevention of a behavioral or verbal response even though the stimulus for that response is present; in psychoanalysis the unconscious restraining of an instinctual process.", "PM": "2020; was INHIBITION (PSYCHOLOGY) 1971-2019", "HN": "2020 (1971); was INHIBITION (PSYCHOLOGY) 1971-2019", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D007266"}, {"RECTYPE": "D", "MH": "Injections", "DE": "INJECT", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Injection", "MN": "E02.319.267.530", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "Introduction of substances into the body using a needle and syringe.", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007267"}, {"RECTYPE": "D", "MH": "Injections, Epidural", "DE": "INJECT EPIDURAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Peridural Injections|T061|NON|EQV|UNK (19XX)|860604|PERIDURAL INJECT|abcdefv", "ENTRY": "Peridural Injection", "MN": "E02.319.267.530.580.300", "FX": "Anesthesia, Epidural", "MH_TH": "NLM (1987)", "ST": "T061", "AN": "usually NIM", "PI": "Injections (1966-1986)", "MS": "The injection of drugs, most often analgesics, into the spinal canal without puncturing the dura mater.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19860604", "DC": "1", "DX": "19870101", "UI": "D007268"}, {"RECTYPE": "D", "MH": "Injections, Intra-Arterial", "DE": "INJECT INTRA ARTERIAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Intraarterial Injection", "MN": "E02.319.267.530.370", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "do not confuse with INFUSIONS, INTRA-ARTERIAL", "MS": "Delivery of drugs into an artery.", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007269"}, {"RECTYPE": "D", "MH": "Injections, Intra-Articular", "DE": "INJECT INTRA ARTICULAR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Intraarticular Injection|T061|NON|EQV|NLM (2022)|201019|abcdef", "ENTRY": "Intra-Articular Injection", "MN": "E02.319.267.530.380", "MH_TH": "NLM (1964)", "ST": "T061", "AN": "usually NIM", "MS": "Methods of delivering drugs into a joint space.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007270"}, {"RECTYPE": "D", "MH": "Injections, Intradermal", "DE": "INJECT INTRADERMAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Intradermal Injection", "MN": "E02.319.267.530.620.410", "MH_TH": "NLM (1964)", "ST": "T061", "AN": "usually NIM", "MS": "The forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer.", "PM": "91,66-86; was see under INJECTIONS, SUBCUTANEOUS 1987-90; was heading 1966-86", "HN": "91(87)66(64); was see under INJECTIONS, SUBCUTANEOUS 1987-90; was heading 1966-86; was Prov 1964-65", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007271"}, {"RECTYPE": "D", "MH": "Injections, Intralymphatic", "DE": "INJECT INTRALYMPHATIC", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Injections, Endolymphatic|T061|NON|EQV|NLM (1998)|961213|INJECT ENDOLYMPHATIC|abcdefv", "ENTRY": "Intralymphatic Injection", "MN": "E02.319.267.530.440", "MH_TH": "NLM (1964)", "ST": "T061", "AN": "usually NIM; entry term INJECTIONS, ENDOLYMPHATIC is seen mostly in foreign literature: nothing to do with ENDOLYMPH ", "MS": "Injections into the lymph nodes or the lymphatic system.", "PM": "73", "HN": "73(64)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007272"}, {"RECTYPE": "D", "MH": "Injections, Intramuscular", "DE": "INJECT INTRAMUSCULAR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Intramuscular Injection", "MN": "E02.319.267.530.460", "FX": "Intramuscular Absorption", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "usually NIM", "MS": "Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it.", "CATSH": "CAT LIST", "MR": "20140606", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007273"}, {"RECTYPE": "D", "MH": "Injections, Intraperitoneal", "DE": "INJECT INTRAPERITONEAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Intraperitoneal Injection", "MN": "E02.319.267.530.490", "MH_TH": "NLM (1964)", "ST": "T061", "AN": "usually NIM", "MS": "Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007274"}, {"RECTYPE": "D", "MH": "Injections, Intravenous", "DE": "INJECT INTRAVENOUS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Intravenous Injection", "MN": "E02.319.267.530.540", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "usually NIM; do not confuse with INFUSIONS, INTRAVENOUS ", "MS": "Injections made into a vein for therapeutic or experimental purposes.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007275"}, {"RECTYPE": "D", "MH": "Injections, Intraventricular", "DE": "INJECT INTRAVENTRICULAR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Intraventricular Injection", "MN": "E02.319.267.530.550", "FX": "Cerebral Ventricles", "MH_TH": "NLM (1976)", "ST": "T061", "AN": "brain, not heart; usually NIM", "PI": "Injections (1966-1975)", "MS": "Injections into the cerebral ventricles.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19750718", "DC": "1", "DX": "19760101", "UI": "D007276"}, {"RECTYPE": "D", "MH": "Injections, Jet", "DE": "INJECT JET", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Jet Injection", "MN": "E02.319.267.530.620.570", "MH_TH": "NLM (1972)", "ST": "T061", "AN": "usually NIM", "PI": "Injections (1966-1971)", "MS": "The injection of solutions into the skin by compressed air devices so that only the solution pierces the skin.", "PM": "73", "HN": "73(72)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007277"}, {"RECTYPE": "D", "MH": "Injections, Spinal", "DE": "INJECT SPINAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Intrathecal Injections|T061|NON|NRW|UNK (19XX)|860620|INTRATHECAL INJECT|abcdefv", "ENTRY": "Spinal Injection", "MN": "E02.319.267.530.580", "FX": "Anesthesia, Spinal", "MH_TH": "NLM (1963)", "ST": "T061", "AN": "do not confuse with INFUSIONS, SPINAL", "MS": "Introduction of therapeutic agents into the spinal region using a needle and syringe.", "OL": "use INJECTIONS, SPINAL to search INJECTIONS, INTRATHECAL 1966-86", "PM": "87; was INJECTIONS, INTRATHECAL 1966-86", "HN": "87; was INJECTIONS, INTRATHECAL 1963-86 (Prov 1963-65)", "CATSH": "CAT LIST", "MR": "20150522", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007278"}, {"RECTYPE": "D", "MH": "Injections, Subcutaneous", "DE": "INJECT SUBCUTANEOUS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Subcutaneous Injection", "MN": "E02.319.267.530.620", "FX": "Subcutaneous Absorption", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "usually NIM", "MS": "Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin.", "PM": "INJECTIONS, INTRADERMAL was heading 1966-86", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007279"}, {"RECTYPE": "D", "MH": "Disorders of Environmental Origin", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C21", "RH": "C21 - DISORDERS OF ENVIRONMENTAL ORIGIN", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Disorders caused by external forces rather than by physiologic dysfunction or by pathogens.", "PM": "2000; see INJURIES, POISONINGS, AND OCCUPATIONAL DISEASES 1974-1999", "HN": "2000(1997); use explode 1970-97", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D007280"}, {"RECTYPE": "D", "MH": "Ink", "ENTRY": "Inks", "MN": "J01.637.500", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Pigmented or colored fluid used for writing, staining, painting, drawing, printing, or copying images.", "MR": "20151130", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007281"}, {"RECTYPE": "D", "MH": "Ink Blot Tests", "AQ": "HI SN ST", "ENTRY": "Tests, Ink Blot", "MN": "F04.711.647.622.341", "MH_TH": "NLM (1964)", "ST": "T170", "MS": "Projective tests utilizing ink blots to which a subject responds. They are used in personality diagnosis.", "PM": "68", "HN": "68(64)", "CATSH": "CAT LIST", "MR": "19920514", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007282"}, {"RECTYPE": "D", "MH": "Inlay Casting Wax", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Wax, Inlay Casting", "MN": "J01.637.051.339.334.574", "MH_TH": "NLM (1965)", "ST": "T122", "N1": "Inlay casting wax", "RN": "8024-51-9", "MS": "A mixture of several dental waxes, usually containing paraffin wax, ceresin, beeswax, resins, and other natural and synthetic waxes. It is used for making patterns to determine the shape of the metallic framework and other parts of removable partial dentures. (From Jablonski's Dictionary of Dentistry, 1992, p868)", "PM": "65", "HN": "65", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007283"}, {"RECTYPE": "D", "MH": "Inlays", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Onlays|T074|NON|EQV|NLM (1993)|911118|abcdef", "ENTRY": "Onlay", "MN": "E07.695.190.190.350", "MH_TH": "NLM (1966)", "ST": "T074", "AN": "coordinate IM with specific tooth (IM) if pertinent + specific material (IM)", "MS": "Restorations of metal, porcelain, or plastic made to fit a cavity preparation, then cemented into the tooth. Onlays are restorations which fit into cavity preparations and overlay the occlusal surface of a tooth or teeth. Onlays are retained by frictional or mechanical factors.", "OL": "use DENTURE, OVERLAY to search DENTAL ONLAYS & ONLAYS 1991-92; use INLAYS to search ONLAYS 1984-90", "PM": "63; DENTAL ONLAYS & ONLAYS were see DENTURE, OVERLAY 1991-92; ONLAYS was see INLAYS 1984-90", "HN": "63; DENTAL ONLAYS & ONLAYS were see DENTURE, OVERLAY 1991-92; ONLAYS was see INLAYS 1984-90", "CATSH": "CAT LIST", "MR": "20230705", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D007284"}, {"RECTYPE": "D", "MH": "Inorganic Chemicals", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chemicals, Inorganic", "MN": "D01", "RH": "D1 - INORGANIC CHEMICALS", "MH_TH": "NLM (1974)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specific groups or specific chemicals", "MS": "A broad class of substances encompassing all those that do not include carbon and its derivatives as their principal elements. However, carbides, carbonates, cyanides, cyanates, and carbon disulfide are included in this class.", "PM": "98", "HN": "98; use explode 1975-97", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D007287"}, {"RECTYPE": "D", "MH": "Inosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D13.570.800.573", "MH_TH": "NLM (1971)", "ST": "T123", "N1": "Inosine", "RN": "5A614L51CT", "RR": "58-63-9 (Inosine)", "PI": "Nucleosides (1966-1970)", "MS": "A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)", "OL": "search NUCLEOSIDES 1966-70", "PM": "73; was see under NUCLEOSIDES 1963-71", "HN": "73(71); was see under NUCLEOSIDES 1963-71", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007288"}, {"RECTYPE": "D", "MH": "Cyclic IMP", "DE": "CYCL IMP", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Inosine Cyclic 3',5'-Monophosphate|T114|T123|NON|EQV|UNK (19XX)|850612|INOSINE CYCLIC MONOPHOSPHATE 03 05|abbcdefs", "ENTRY": "Inosine Cyclic 3',5' Monophosphate", "MN": "D13.695.827.519.300", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Inosine, cyclic 3',5'-(hydrogen phosphate)", "RN": "3545-76-4", "PI": "Nucleotides, Cyclic (1974)", "MS": "Inosine cyclic 3',5'-(hydrogen phosphate). An inosine nucleotide which acts as a mild inhibitor of the hydrolysis of cyclic AMP and cyclic GMP and as an inhibitor of cat heart cyclic AMP phosphodiesterase.", "OL": "use CYCLIC IMP to search INOSINE CYCLIC MONOPHOSPHATE 1980-93 & INOSINE CYCLIC-3',5'-MONOPHOSPHATE 1975-79", "PM": "94; was INOSINE CYCLIC MONOPHOSPHATE 1980-93 (see under INOSINE NUCLEOTIDES 1980-90), was INOSINE CYCLIC-3',5'-MONOPHOSPHATE see under INOSINE NUCLEOTIDES 1975-79; CYCLIC IMP was see INOSINE CYCLIC MONOPHOSPHATE 1975-93; INOSINE CYCLIC 2',3'-MONOPHOSPHATE was see INOSINE CYCLIC MONOPHOSPHATE 1980-93", "HN": "94; was INOSINE CYCLIC MONOPHOSPHATE 1980-93 (see under INOSINE NUCLEOTIDES 1980-90), was INOSINE CYCLIC-3',5'-MONOPHOSPHATE see under INOSINE NUCLEOTIDES 1975-79; CYCLIC IMP was see INOSINE CYCLIC MONOPHOSPHATE 1975-93; INOSINE CYCLIC 2',3'-MONOPHOSPHATE was see INOSINE CYCLIC MONOPHOSPHATE 1980-93", "MR": "20160528", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007289"}, {"RECTYPE": "D", "MH": "Inosine Diphosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "IDP|T114|T121|T123|ABB|EQV|UNK (19XX)|770420|abbbcdef", "ENTRY": "Pyrophosphate, Inosine", "MN": "D13.695.827.519.400", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Inosine 5'-(trihydrogen diphosphate)", "RN": "86-04-4", "PI": "Inosine Nucleotides (1971-1977)", "MS": "An inosine nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety.", "PM": "91; was see under INOSINE NUCLEOTIDES 1978-90", "HN": "91(78); was see under INOSINE NUCLEOTIDES 1978-90", "MR": "20160531", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D007290"}, {"RECTYPE": "D", "MH": "Inosine Monophosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ribosylhypoxanthine Monophosphate|T114|T123|NON|EQV|UNK (19XX)|770401|abbcdef", "ENTRY": "Monophosphate, Ribosylhypoxanthine", "MN": "D13.695.827.519.500", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "5'-Inosinic acid", "RN": "131-99-7", "RR": "TAO7US05G5", "AN": "/biosyn /physiol permitted", "PI": "Inosine Nucleotides (1971-1974)", "MS": "Inosine 5'-Monophosphate. A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety.", "OL": "to search INOSINIC ACIDS use INOSINE MONOPHOSPHATE 1975-77 & INOSINE NUCLEOTIDES 1974", "PM": "91; was see under INOSINE NUCLEOTIDES 1978-90; was INOSINIC ACIDS see under INOSINE NUCLEOTIDES 1974-77", "HN": "91(78); was see under INOSINE NUCLEOTIDES 1978-90; was INOSINIC ACIDS see under INOSINE NUCLEOTIDES 1974-77", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007291"}, {"RECTYPE": "D", "MH": "Inosine Nucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Inosine Phosphates|T114|NON|EQV|UNK (19XX)|741030|abcdef", "ENTRY": "Phosphates, Inosine", "MN": "D13.695.827.519", "MH_TH": "NLM (1971)", "ST": "T114", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Nucleotides (1966-1970)", "PM": "73", "HN": "73(71)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007292"}, {"RECTYPE": "D", "MH": "Inosine Triphosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ITP|T114|T123|NON|EQV|UNK (19XX)|770420|abbcdef", "ENTRY": "Triphosphate, Inosine", "MN": "D13.695.827.519.800", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Inosine 5'-(tetrahydrogen triphosphate)", "RN": "132-06-9", "AN": "/biosyn /physiol permitted", "PI": "Inosine Nucleotides (1971-1977)", "MS": "Inosine 5'-(tetrahydrogen triphosphate). An inosine nucleotide containing three phosphate groups esterified to the sugar moiety. Synonym: IRPPP.", "PM": "91; was see under INOSINE NUCLEOTIDES 1978-90", "HN": "91(78); was see under INOSINE NUCLEOTIDES 1978-90", "MR": "20160531", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D007293"}, {"RECTYPE": "D", "MH": "Inositol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Myoinositol|T109|T127|NON|EQV|UNK (19XX)|760317|abbcdef", "ENTRY": "Chiro Inositol", "MN": "D09.853.519", "PA": "Vitamin B Complex", "MH_TH": "NLM (1966)", "ST": "T127", "RN": "4L6452S749", "RR": "6917-35-7 (Inositol)", "MS": "An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007294"}, {"RECTYPE": "D", "MH": "Inositol Phosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Inositol Phosphate|T109|NON|EQV|NLM (2021)|200113|abcdef", "ENTRY": "Phosphates, Inositol", "MN": "D09.894.480", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Sugar Phosphates (1974-1977)", "MS": "Phosphoric acid esters of inositol. They include mono- and polyphosphoric acid esters, with the exception of inositol hexaphosphate which is PHYTIC ACID.", "PM": "90; was see under SUGAR PHOSPHATES 1978-89", "HN": "90(78); was see under SUGAR PHOSPHATES 1978-89", "MR": "20200527", "DA": "19770415", "DC": "1", "DX": "19900101", "UI": "D007295"}, {"RECTYPE": "D", "MH": "Myo-Inositol-1-Phosphate Synthase", "DS": "MYO INOSITOL PHOSPHATE SYNTHASE 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Inositol-1-Phosphate Synthase|T116|T126|NON|EQV|NLM (1998)|961108|INOSITOL PHOSPHATE SYNTHASE 01|abbcdefs", "ENTRY": "Synthase, Myo-Inositol-1-Phosphate", "MN": "D08.811.399.430.500", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "1L-myo-Inositol-1-phosphate lyase (isomerizing)", "RN": "EC 5.5.1.4", "RR": "9032-95-5 (CAS RN)", "PI": "Inositol (1973-1974)", "MS": "An enzyme that catalyzes the formation of myo-inositol-1-phosphate from glucose-6-phosphate in the presence of NAD. EC 5.5.1.4.", "PM": "98; see INOSITOL-1-PHOSPHATE SYNTHASE 1991-97, see CARBOHYDRATE ISOMERASES 1975-90; for MYO-INOSITOL-1-PHOSPHATE SYNTHASE see INOSITOL-1-PHOSPHATE SYNTHASE 1975-97", "HN": "98(75)", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007296"}, {"RECTYPE": "D", "MH": "Inpatients", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Inpatient", "MN": "M01.643.470", "MH_TH": "NLM (1980)", "ST": "T101", "AN": "inpatients as people or as a social, sociol, psychol, etc., group; do not confuse with HOSPITALIZATION", "PI": "Patients (1966-1979)", "MS": "Persons admitted to health facilities which provide board and room, for the purpose of observation, care, diagnosis or treatment.", "PM": "91; was see under PATIENTS 1980-90", "HN": "91(80); was see under PATIENTS 1980-90", "MR": "19920514", "DA": "19781222", "DC": "1", "DX": "19910101", "UI": "D007297"}, {"RECTYPE": "D", "MH": "Insanity Defense", "AQ": "CL HI SN", "PRINT ENTRY": "McNaughton Rule|T078|EPO|REL|UNK (19XX)|840413|abcdef", "ENTRY": "Rule, McNaughton", "MN": "N03.706.535.351.528", "FX": "Mental Competency", "MH_TH": "NLM (1975)", "ST": "T078", "MS": "A legal concept that an accused is not criminally responsible if, at the time of committing the act, the person was laboring under such a defect of reason from disease of the mind as not to know the nature and quality of the act done or if the act was known, to not have known that what was done was wrong. (From Black's Law Dictionary, 6th ed)", "OL": "use FORENSIC PSYCHIATRY to search MCNAUGHTON RULE 1969-84; use JURISPRUDENCE, PSYCHIATRIC to search MCNAUGHTON RULE 1968", "PM": "91; was see under FORENSIC PSYCHIATRY 1985-90; was MCNAUGHTON RULE see under FORENSIC PSYCHIATRY 1969-84; was MCNAUGHTON RULE see under JURISPRUDENCE, PSYCHIATRIC 1968", "HN": "91(85); was see under FORENSIC PSYCHIATRY 1985-90; was MCNAUGHTON RULE see under FORENSIC PSYCHIATRY 1969-84; was MCNAUGHTON RULE see under JURISPRUDENCE, PSYCHIATRIC 1968", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007298"}, {"RECTYPE": "D", "MH": "Insect Bites and Stings", "DE": "INSECT BITES STINGS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stings, Insect", "MN": "C26.176.143", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Bites and stings inflicted by insects.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007299"}, {"RECTYPE": "D", "MH": "Insect Control", "AQ": "EC ES HI IS LJ MT OG SN ST TD", "ENTRY": "Control, Insect", "MN": "N06.850.780.200.650.425", "FX": "Pest Control, Biological", "MH_TH": "NLM (1966)", "ST": "T068", "AN": "for sterilization of insects, coord specific insect (IM) + PEST CONTROL, BIOLOGICAL (IM) but not also STERILIZATION, REPRODUCTIVE (see note there) & not also INSECT CONTROL", "MS": "The reduction or regulation of the population of noxious, destructive, or dangerous insects through chemical, biological, or other means.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007300"}, {"RECTYPE": "D", "MH": "Insect Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Insect Hormone|T125|NON|EQV|NLM (2022)|201019|abcdef", "ENTRY": "Hormones, Insect", "MN": "D06.472.445.573", "MH_TH": "NLM (1975)", "ST": "T125", "RN": "0", "AN": "coord IM with specific insect (IM)", "PI": "Invertebrate Hormones (1967-1974)", "MS": "Hormones secreted by insects. They influence their growth and development. Also synthetic substances that act like insect hormones.", "OL": "search INVERTEBRATE HORMONES 1967-74", "PM": "77; was see under INVERTEBRATE HORMONES 1967-76", "HN": "77(75); was see under INVERTEBRATE HORMONES 1967-76", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D007301"}, {"RECTYPE": "D", "MH": "Insect Repellents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Insect Repellent|T131|NON|EQV|NLM (2021)|200227|abcdef", "ENTRY": "Repellents, Insect", "MN": "D27.888.723.441", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "specify insect if pertinent", "MS": "Substances causing insects to turn away from them or reject them as food.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007302"}, {"RECTYPE": "D", "MH": "Insect Vectors", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Vectors, Insect", "MN": "N06.850.520.203.375.100.500", "MH_TH": "NLM (1966)", "ST": "T204", "AN": "coord IM with specific insect (IM); specify both infecting organism & vector if pertinent; in the trypanosome-tsetse fly-cow relationship, the fly (not the cow) is the insect vector", "MS": "Insects that transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.", "MR": "20200612", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007303"}, {"RECTYPE": "D", "MH": "Insect Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, Insect", "MN": "B04.525", "MH_TH": "NLM (1966)", "ST": "T005", "AN": "IM; coord with specific insect /virol (IM)", "MS": "Viruses infecting insects, the largest family being BACULOVIRIDAE.", "OL": "use INSECT VIRUSES to search POLYHEDROSIS VIRUSES 1973-90 (as Prov 1973-74)", "PM": "63; POLYHEDROSIS VIRUSES was heading 1978-90; was see under INSECT VIRUSES 1975-77", "HN": "63; POLYHEDROSIS VIRUSES was heading 1978-90; was see under INSECT VIRUSES 1973-77 (Prov 1973-74)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D007304"}, {"RECTYPE": "D", "MH": "Insecticide Resistance", "AQ": "DE EH GE IM PH RE", "ENTRY": "Resistances, Insecticide", "MN": "G07.690.773.984.491", "MH_TH": "NLM (1964)", "ST": "T032", "AN": "IM when general; NIM when with specific insecticide (IM) & specific insect (IM)", "MS": "The development by insects of resistance to insecticides.", "OL": "use INSECTICIDE RESISTANCE to search INSECTICIDES RESISTANCE 1966 (as Prov)", "PM": "67", "HN": "67; was INSECTICIDES RESISTANCE 1964-66 (Prov)", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007305"}, {"RECTYPE": "D", "MH": "Insecticides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Insecticide|T131|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D27.888.723.491", "FX": "Cholinesterase Inhibitors", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect.", "MS": "Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007306"}, {"RECTYPE": "D", "MH": "Eulipotyphla", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Soricomorpha|T015|NON|EQV|NLM (2022)|210316|abcdef", "MN": "B01.050.150.900.649.313.961", "MH_TH": "NLM (2022)", "ST": "T015", "RN": "txid9362", "MS": "An order of insect eating MAMMALS including MOLES; SHREWS; HEDGEHOGS.", "PM": "2022; see Insectivora 2010-2021", "HN": "2022(2010)", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007312"}, {"RECTYPE": "D", "MH": "Insecta", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Insects|T204|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Insect", "MN": "B01.050.500.131.617", "MH_TH": "NLM (2012)", "ST": "T204", "RN": "txid50557", "AN": "general or unspecified; prefer specifics; for killing insects with insecticides, see note at INSECTICIDES", "MS": "Members of the phylum ARTHROPODA composed or organisms characterized by division into three parts: head, thorax, and abdomen. They are the dominant group of animals on earth with several hundred thousand different kinds. Three orders, HEMIPTERA; DIPTERA; and SIPHONAPTERA; are of medical interest in that they cause disease in humans and animals. (From Borror et al., An Introduction to the Study of Insects, 4th ed, p1).", "PM": "2018; see INSECTS 1966-2017", "HN": "2018(1966)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007313"}, {"RECTYPE": "D", "MH": "Insemination", "AQ": "DE ES GE IM PH RE", "ENTRY": "Inseminations", "MN": "G08.686.784.363", "MH_TH": "NLM (1966)", "ST": "T042", "MS": "The deposit of SEMEN or SPERMATOZOA into the VAGINA to facilitate FERTILIZATION.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007314"}, {"RECTYPE": "D", "MH": "Insemination, Artificial", "AQ": "AE CL EC ES GE HI IM IS LJ MO MT NU PH PX SN ST TD VE", "PRINT ENTRY": "Artificial Insemination|T061|NON|EQV|BIOETHICS (1989)|NLM (1980)|781226|abcdeef", "ENTRY": "Inseminations, Artificial", "MN": "G08.686.784.363.492", "FX": "Sperm Banks", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "MS": "Artificial introduction of SEMEN or SPERMATOZOA into the VAGINA to facilitate FERTILIZATION.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007315"}, {"RECTYPE": "D", "MH": "Insemination, Artificial, Heterologous", "DE": "INSEMINATION ARTIFICIAL HETEROL", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Insemination, Artificial, Human Donor|T061|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Insemination, Donor Artificial", "MN": "G08.686.784.363.492.500", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "human only: semen other than husband's", "MS": "Human artificial insemination in which the semen used is that of a man other than the woman's husband.", "PM": "91; was see under INSEMINATION, ARTIFICIAL 1975-90", "HN": "91(75); was see under INSEMINATION, ARTIFICIAL 1975-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007316"}, {"RECTYPE": "D", "MH": "Insemination, Artificial, Homologous", "DE": "INSEMINATION ARTIFICIAL HOMOL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Insemination, Artificial, Husband|T061|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Insemination, Husband Artificial", "MN": "G08.686.784.363.492.750", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "human only", "MS": "Human artificial insemination in which the husband's semen is used.", "PM": "91; was see under INSEMINATION, ARTIFICIAL 1975-90", "HN": "91(75); was see under INSEMINATION, ARTIFICIAL 1975-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007317"}, {"RECTYPE": "D", "MH": "Inservice Training", "DE": "INSERV TRAINING", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Orientation Programs, Employee|T065|NON|NRW|UNK (19XX)|810302|abcdef", "ENTRY": "Training, On-the-Job", "MN": "I02.574", "MH_TH": "NLM (1967)", "ST": "T065", "PI": "Education, Continuing (1966)", "MS": "On the job training programs for personnel carried out within an institution or agency. It includes orientation programs.", "PM": "70", "HN": "70(67)", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D007318"}, {"RECTYPE": "D", "MH": "Sleep Initiation and Maintenance Disorders", "DE": "SLEEP INITIATION MAINTENANCE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sleeplessness|T184|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Sleep Initiation Dysfunctions", "MN": "F03.870.400.800.800", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "do not confuse with SLEEP DEPRIVATION, being deprived of sleep or prevented from sleeping; usually chronic so do not coord with CHRONIC DISEASE", "MS": "Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.", "PM": "2000; see INSOMNIA 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20000621", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D007319"}, {"RECTYPE": "D", "MH": "Inspiratory Capacity", "DE": "INSPIRATORY CAPAC", "AQ": "DE ES GE IM PH RE", "ENTRY": "Inspiratory Capacities", "MN": "G09.772.850.970.500", "MH_TH": "NLM (1975)", "ST": "T042", "MS": "The maximum volume of air that can be inspired after reaching the end of a normal, quiet expiration. It is the sum of the TIDAL VOLUME and the INSPIRATORY RESERVE VOLUME. Common abbreviation is IC.", "PM": "91; was see under LUNG VOLUME MEASUREMENTS 1975-90", "HN": "91(75); was see under LUNG VOLUME MEASUREMENTS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D007320"}, {"RECTYPE": "D", "MH": "Inspiratory Reserve Volume", "AQ": "DE ES GE IM PH RE", "ENTRY": "Volumes, Inspiratory Reserve", "MN": "G09.772.850.970.500.375", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "NIM; in texts as IRV", "MS": "The extra volume of air that can be inspired with maximal effort after reaching the end of a normal, quiet inspiration. Common abbreviation is IRV.", "PM": "91; was see under LUNG VOLUME MEASUREMENTS 1975-90", "HN": "91(75); was see under LUNG VOLUME MEASUREMENTS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D007321"}, {"RECTYPE": "D", "MH": "Instillation, Drug", "PRINT ENTRY": "Drug Instillation|T061|NON|EQV|UNK (19XX)|860619|abcdef", "ENTRY": "Instillations, Drug", "MN": "E02.319.267.641", "MH_TH": "NLM (1987)", "ST": "T061", "AN": "usually NIM ", "MS": "The administration of therapeutic agents drop by drop, as eye drops, ear drops, or nose drops. It is also administered into a body space or cavity through a catheter. It differs from THERAPEUTIC IRRIGATION in that the irrigate is removed within minutes, but the instillate is left in place.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20110701", "DA": "19860619", "DC": "1", "DX": "19870101", "UI": "D007322"}, {"RECTYPE": "D", "MH": "Instinct", "PRINT ENTRY": "Innate Behavior|T055|NON|EQV|UNK (19XX)|780428|abcdef", "ENTRY": "Patterns, Fixed Action", "MN": "F01.658.642", "FX": "Libido", "MH_TH": "NLM (1966)", "ST": "T055", "AN": "human & animal", "MS": "Stereotyped patterns of response, characteristic of a given species, that have been phylogenetically adapted to a specific type of situation.", "OL": "to search FIXED ACTION PATTERN use INSTINCT 1975-78 & BEHAVIOR, ANIMAL 1968-74; use INSTINCT to search INNATE BEHAVIOR 1968-78", "PM": "FIXED ACTION PATTERN was see under BEHAVIOR, ANIMAL 1968-78", "HN": "FIXED ACTION PATTERN was see under BEHAVIOR, ANIMAL 1968-78; INNATE BEHAVIOR was see under INSTINCT 1968-78", "CATSH": "CAT LIST", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007323"}, {"RECTYPE": "D", "MH": "Institutional Management Teams", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Management Teams, Institutional|T097|NON|EQV|UNK (19XX)|820428|abcdef", "ENTRY": "Teams, Institutional Management", "MN": "N04.452.460", "MH_TH": "NLM (1983)", "ST": "T097", "AN": "IM; toward integration of various institutional functions: do not confuse with PATIENT CARE TEAM (directed to personal care)", "MS": "Administrator-selected management groups who are responsible for making decisions pertaining to the provision of integrated direction for various institutional functions.", "PM": "91; was see under ORGANIZATION AND ADMINISTRATION 1983-90", "HN": "91(83); was see under ORGANIZATION AND ADMINISTRATION 1983-90", "MR": "19940505", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D007324"}, {"RECTYPE": "D", "MH": "Institutional Practice", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Practices, Institutional", "MN": "N04.452.758.367", "MH_TH": "NLM (1968)", "ST": "T058", "PI": "Medical Staff, Hospital (1966-1967)", "MS": "Professional practice as an employee or contractee of a health care institution.", "PM": "68", "HN": "68", "MR": "19940505", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007325"}, {"RECTYPE": "D", "MH": "Institutionalization", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Persons, Institutionalized", "MN": "N02.421.585.415", "FX": "Hospitalization", "MH_TH": "NLM (1979)", "ST": "T058", "AN": "coord IM with type of institution (IM) if pertinent; institutionalization of mentally ill: consider also COMMITMENT OF MENTALLY ILL", "MS": "The caring for individuals in institutions and their adaptation to routines characteristic of the institutional environment, and/or their loss of adaptation to life outside the institution.", "PM": "79", "HN": "79", "MR": "20150629", "DA": "19780516", "DC": "1", "DX": "19790101", "UI": "D007326"}, {"RECTYPE": "D", "MH": "Insufflation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Insufflations", "MN": "E02.583", "MH_TH": "POPLINE (1978)", "ST": "T061", "MS": "The act of blowing a powder, vapor, or gas into any body cavity for experimental, diagnostic, or therapeutic purposes.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19860620", "DC": "1", "DX": "19870101", "UI": "D007327"}, {"RECTYPE": "D", "MH": "Insulin", "AQ": "AA AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Regular Insulin", "MN": "D12.644.548.586.200.500.625", "PA": "Hypoglycemic Agents", "FX": "Receptor, Insulin", "EC": "antagonists & inhibitors:Insulin Antagonists", "MH_TH": "USP (19XX)", "ST": "T125", "RN": "0", "MS": "A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007328"}, {"RECTYPE": "D", "MH": "Insulin Antagonists", "DE": "INSULIN ANTAG", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Antagonists, Insulin", "MN": "D27.505.696.399.450.420", "MH_TH": "NLM (1978)", "ST": "T121", "RN": "0", "PI": "Insulin (1966-1977)", "MS": "Compounds which inhibit or antagonize the biosynthesis or action of insulin.", "PM": "78", "HN": "78", "MR": "20030709", "DA": "19770517", "DC": "1", "DX": "19780101", "UI": "D007329"}, {"RECTYPE": "D", "MH": "Insulin Antibodies", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Antibodies, Insulin", "MN": "D12.776.377.715.548.114.656", "PA": "Immunologic Factors", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "MS": "Antibodies specific to INSULIN.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007330"}, {"RECTYPE": "D", "MH": "Insulin Coma", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Shock, Insulin", "MN": "C18.452.394.984.492", "FX": "Convulsive Therapy", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "Severe HYPOGLYCEMIA induced by a large dose of exogenous INSULIN resulting in a COMA or profound state of unconsciousness from which the individual cannot be aroused.", "PM": "91; was see under HYPOGLYCEMIA 1964-90", "HN": "91(64); was see under HYPOGLYCEMIA 1964-90", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007331"}, {"RECTYPE": "D", "MH": "Insulin Infusion Systems", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "beta Cell, Artificial|T074|NON|NRW|UNK (19XX)|810226|abcdef", "ENTRY": "beta Cells, Artificial", "MN": "E07.858.082.505.508", "MH_TH": "NLM (1982)", "ST": "T074", "PI": "Pancreas (1973-1981)", "MS": "Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19810226", "DC": "1", "DX": "19820101", "UI": "D007332"}, {"RECTYPE": "D", "MH": "Insulin Resistance", "AQ": "EH GE IM PH RE", "ENTRY": "Sensitivity, Insulin", "MN": "G07.690.773.984.617", "MH_TH": "NLM (1964)", "ST": "T046", "AN": "INSULIN RESISTANCE SYNDROME X see METABOLIC SYNDROME is available", "MS": "Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20170713", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007333"}, {"RECTYPE": "D", "MH": "Insulin-Like Growth Factor I", "DS": "INSULIN LIKE GROWTH FACTOR 00 01", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Somatomedin C|T116|T123|NON|EQV|UNK (19XX)|850425|abbcdef", "ENTRY": "Insulin Like Somatomedin Peptide I", "MN": "D12.776.124.862.400", "FX": "Receptor, IGF Type 1", "MH_TH": "NLM (1986)", "ST": "T123", "N1": "Insulin-like growth factor I", "RN": "67763-96-6", "PI": "Sulfation Factor (1971-1972)", "MS": "A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor.", "PM": "91; was see under SOMATOMEDINS 1986-90", "HN": "91(86); was see under SOMATOMEDINS 1986-90", "MR": "20230517", "DA": "19850425", "DC": "1", "DX": "19910101", "UI": "D007334"}, {"RECTYPE": "D", "MH": "Insulin-Like Growth Factor II", "DS": "INSULIN LIKE GROWTH FACTOR 00 02", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Somatomedin MSA|T116|T123|EQV|UNK (19XX)|850425|abbdef", "ENTRY": "Multiplication Stimulating Factor", "MN": "D12.776.124.862.425", "FX": "Receptor, IGF Type 2", "MH_TH": "NLM (1986)", "ST": "T123", "N1": "Insulin-like growth factor II", "RN": "67763-97-7", "RR": "9038-70-4 (somatomedin)", "PI": "Sulfation Factor (1971-1972)", "MS": "A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults.", "PM": "1991; see SOMATOMEDINS 1986-1990; SOMATOMEDIN A was indexed under INSULIN-LIKE GROWTH FACTOR II 1980-2004", "HN": "1991(1986)", "MR": "20230517", "DA": "19850425", "DC": "1", "DX": "19910101", "UI": "D007335"}, {"RECTYPE": "D", "MH": "Insulin, Isophane", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Insulin, NPH|T116|T121|T125|ACX|EQV|UNK (19XX)|800801|abbbcdef", "ENTRY": "Zinc Insulin, Protamine", "MN": "D12.644.548.586.200.300.200", "PA": "Hypoglycemic Agents", "EC": "antagonists & inhibitors:Insulin Antagonists", "MH_TH": "NLM (1966)", "ST": "T125", "N1": "Insulin Isophane", "RN": "53027-39-7", "MS": "An intermediate-acting INSULIN preparation with onset time of 2 hours and duration of 24 hours. It is produced by crystallizing ZINC-insulin-PROTAMINES at neutral pH 7. Thus it is called neutral protamine Hagedorn for inventor Hans Christian Hagedorn.", "PM": "2009; see INSULIN, NPH 2009-2011; see INSULIN, ISOPHANE 1963-2008; for INSULIN, PROTAMINE ZINC see INSULIN, LONG-ACTING 1966-2011", "HN": "2009 (1963); for INSULIN, PROTAMINE ZINC use INSULIN, LONG-ACTING 1966-2011", "MR": "20150526", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D007336"}, {"RECTYPE": "D", "MH": "Insulysin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Insulinase|T116|T126|NON|EQV|NLM (1997)|960208|abbcdef", "ENTRY": "Proteinase, Insulin", "MN": "D08.811.277.656.675.374.300", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.4.24.56", "MS": "An enzyme the catalyzes the degradation of insulin, glucagon and other polypeptides. It is inhibited by bacitracin, chelating agents EDTA and 1,10-phenanthroline, and by thiol-blocking reagents such as N-ethylmaleimide, but not phosphoramidon. (Eur J Biochem 1994;223:1-5) EC 3.4.24.56.", "OL": "search ENDOPEPTIDASES 1966-74", "PM": "97; was INSULINASE 1963-96 (see under PEPTIDE HYDROLASES 1975-90, see under PEPTIDE PEPTIDOHYDROLASES 1963-74)", "HN": "97; was INSULINASE 1963-96 (see under PEPTIDE HYDROLASES 1975-90, see under ENDOPEPTIDASES 1963-74)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007339"}, {"RECTYPE": "D", "MH": "Insulinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "beta-Cell Tumor|T191|NON|EQV|UNK (19XX)|810520|abcdef", "ENTRY": "beta-Cell Tumors", "MN": "C19.344.421.249.500", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coord IM with PANCREATIC NEOPLASMS (IM)", "PI": "Islet Cell Tumor (1966-1981)", "MS": "A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.", "OL": "search ISLET CELL TUMOR 1979-81", "PM": "91; was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1979-81", "HN": "91(82); was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1979-81", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19810520", "DC": "1", "DX": "19910101", "UI": "D007340"}, {"RECTYPE": "D", "MH": "Insurance", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Premiums, Insurance", "MN": "N03.219.521.576", "MH_TH": "BIOETHICS (1977)", "ST": "T078", "AN": "coordinate with geographic term if pertinent", "MS": "Coverage by contract whereby one part indemnifies or guarantees another against loss by a specified contingency.", "MR": "20140616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007341"}, {"RECTYPE": "D", "MH": "Insurance Benefits", "AQ": "CL EC ES HI LJ MT SN ST TD", "PRINT ENTRY": "Health Benefits|T081|NON|NRW|NLM (1992)|910503|abcdef", "ENTRY": "Insurance Benefit", "MN": "N03.219.521.576.130", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "coordinate IM with specific type of insurance (IM) + geographic term if pertinent", "PI": "Insurance (1966-1977)", "MS": "Payments or services provided under stated circumstances under the terms of an insurance policy. In prepayment programs, benefits are the services the programs will provide at defined locations and to the extent needed.", "PM": "78", "HN": "78", "MR": "20180629", "DA": "19770511", "DC": "1", "DX": "19780101", "UI": "D007342"}, {"RECTYPE": "D", "MH": "Insurance Carriers", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Insurers|T092|NON|EQV|UNK (19XX)|770512|abcdef", "ENTRY": "Providers, Insurance", "MN": "N03.219.521.576.160", "MH_TH": "NLM (1977)", "ST": "T092", "AN": "specify geog if possible", "MS": "Organizations which assume the financial responsibility for the risks of policyholders.", "PM": "91; was see under INSURANCE Aug 1977-90", "HN": "91(Aug 77); was see under INSURANCE 1977-90", "MR": "20200618", "DA": "19770512", "DC": "1", "DX": "19910101", "UI": "D007343"}, {"RECTYPE": "D", "MH": "Insurance Claim Reporting", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Reporting, Insurance Claim", "MN": "N03.219.521.576.210", "MH_TH": "NLM (1977)", "ST": "T058", "MS": "The design, completion, and filing of forms with the insurer.", "PM": "91; was see under INSURANCE Aug 1977-90", "HN": "91(Aug 77); was see under INSURANCE 1977-90", "MR": "20180629", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D007344"}, {"RECTYPE": "D", "MH": "Insurance Claim Review", "DE": "INSURANCE CLAIM REV", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Insurance Claims Processing|T058|NON|BRD|NLM (1992)|910503|abcdef", "ENTRY": "Reviews, Insurance Claim", "MN": "N03.219.521.576.215", "MH_TH": "NLM (1986)", "ST": "T058", "PI": "Utilization Review (1968-1985)", "MS": "Review of claims by insurance companies to determine liability and amount of payment for various services. The review may also include determination of eligibility of the claimant or beneficiary or of the provider of the benefit; determination that the benefit is covered or not payable under another policy; or determination that the service was necessary and of reasonable cost and quality.", "PM": "91; was see under INSURANCE, HEALTH 1986-90", "HN": "91(86); was see under INSURANCE, HEALTH 1986-90", "MR": "20171213", "DA": "19850424", "DC": "1", "DX": "19910101", "UI": "D007345"}, {"RECTYPE": "D", "MH": "Insurance, Accident", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Accident Insurance|T058|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Insurances, Accident", "MN": "N03.219.521.576.343.409", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "specify geog if possible", "MS": "Insurance providing coverage for physical injury suffered as a result of unavoidable circumstances.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007346"}, {"RECTYPE": "D", "MH": "Insurance, Dental", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Prepaid Dental Care|T058|NON|NRW|NLM (1991)|780509|abcdef", "ENTRY": "Dental Care, Prepaid", "MN": "N03.219.521.576.343.450", "MH_TH": "NLM (1991)", "ST": "T058", "AN": "specify geog if possible", "MS": "Insurance providing coverage for dental care.", "HN": "DENTAL CARE PLANS was see under INSURANCE, DENTAL 1963-78; PREPAID DENTAL CARE was see under INSURANCE, DENTAL 1969-78", "MR": "20180525", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007347"}, {"RECTYPE": "D", "MH": "Insurance, Health", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Health Insurance, Voluntary|T058|NON|NRW|UNK (19XX)|770421|abcdef", "ENTRY": "Voluntary Health Insurance", "MN": "N03.219.521.576.343", "FX": "Practice Patterns, Physicians'", "MH_TH": "POPLINE (1987)", "ST": "T058", "AN": "specify geographic term if possible; CHAMPUS: index under HEALTH BENEFIT PLANS, EMPLOYEE", "MS": "Insurance providing coverage of medical, surgical, or hospital care in general or for which there is no specific heading.", "MR": "20210706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007348"}, {"RECTYPE": "D", "MH": "Insurance, Health, Reimbursement", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Third-Party Payments|T058|T081|NON|EQV|UNK (19XX)|810302|abbcdef", "ENTRY": "Third-Party Payment", "MN": "N03.219.521.710", "MH_TH": "NLM (1977)", "ST": "T081", "AN": "specify geog if possible", "MS": "Payment by a third-party payer in a sum equal to the amount expended by a health care provider or facility for health services rendered to an insured or program beneficiary. (From Facts on File Dictionary of Health Care Management, 1988)", "PM": "1982; was indexed under INSURANCE, HEALTH Aug 1977-1981", "HN": "1982; use INSURANCE, HEALTH  1977- 1982", "MR": "20210304", "DA": "19770511", "DC": "1", "DX": "19820101", "UI": "D007349"}, {"RECTYPE": "D", "MH": "Insurance, Hospitalization", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Hospitalization Insurance|T058|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Hospitalization, Group", "MN": "N03.219.521.576.343.492", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "specify geog if possible", "MS": "Health insurance providing benefits to cover or partly cover hospital expenses.", "OL": "use INSURANCE, HOSPITALIZATION to search GROUP HOSPITALIZATION 1975-91", "PM": "GROUP HOSPITALIZATION was heading 1991, was see under INSURANCE, HOSPITALIZATION 1975-90", "HN": "GROUP HOSPITALIZATION was heading 1975-91 (see under INSURANCE, HOSPITALIZATION 1975-90)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007350"}, {"RECTYPE": "D", "MH": "Insurance, Liability", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "No-Fault Insurance|T080|NON|NRW|UNK (19XX)|770421|abcdef", "ENTRY": "No Fault Insurance", "MN": "N03.219.521.576.443", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "add geographic term if pertinent", "MS": "Insurance against loss resulting from liability for injury or damage to the persons or property of others.", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007351"}, {"RECTYPE": "D", "MH": "Insurance, Life", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Life Insurances", "MN": "N03.219.521.576.543", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "specify geog if possible", "MS": "Insurance providing for payment of a stipulated sum to a designated beneficiary upon death of the insured.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007352"}, {"RECTYPE": "D", "MH": "Insurance, Long-Term Care", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Long-Term Care Insurance|T058|NON|EQV|UNK (19XX)|860530|abcdef", "ENTRY": "Long Term Care Insurance", "MN": "N03.219.521.576.343.508", "MH_TH": "NLM (1987)", "ST": "T058", "AN": "specify geog if possible", "PI": "Long-Term Care (1968-1986)", "MS": "Health insurance to provide full or partial coverage for long-term home care services or for long-term nursing care provided in a residential facility such as a nursing home.", "OL": "use INSURANCE, LONG-TERM CARE to search INSURANCE, LONG TERM CARE 1987-91", "PM": "92; was INSURANCE, LONG TERM CARE 1987-91", "HN": "92; was INSURANCE, LONG TERM CARE 1987-91", "MR": "19991103", "DA": "19860530", "DC": "1", "DX": "19870101", "UI": "D007353"}, {"RECTYPE": "D", "MH": "Insurance, Major Medical", "DE": "INSURANCE MAJOR MED", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Insurance, Health, Catastrophic|T058|NON|NRW|UNK (19XX)|770421|abcdef", "ENTRY": "Insurances, Comprehensive Health", "MN": "N03.219.521.576.343.533", "FX": "Catastrophic Illness", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "specify geog if possible", "PI": "Insurance, Health (1966-1967)", "MS": "Insurance providing a broad range of medical services and supplies, when prescribed by a physician, whether or not the patient is hospitalized. It frequently is an extension of a basic policy and benefits will not begin until the basic policy is exhausted.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007354"}, {"RECTYPE": "D", "MH": "Insurance, Nursing Services", "DE": "INSURANCE NURS SERV", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Services Insurances, Nursing", "MN": "N03.219.521.576.343.545", "MH_TH": "NLM (1984)", "ST": "T058", "AN": "specify geog if possible", "MS": "Insurance providing benefits for the costs of care provided by nurses, especially nurse practitioners and nurse clinicians.", "PM": "91; was see under INSURANCE, HEALTH 1984-90", "HN": "91(84); was see under INSURANCE, HEALTH 1984-90", "MR": "19991103", "DA": "19830606", "DC": "1", "DX": "19910101", "UI": "D007355"}, {"RECTYPE": "D", "MH": "Insurance, Pharmaceutical Services", "DE": "INSURANCE PHARM SERV", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Prescription Insurance|T093|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Plans, Drug Benefit", "MN": "N03.219.521.576.343.575", "MH_TH": "NLM (1968)", "ST": "T093", "AN": "specify geog if possible", "PI": "Prescriptions (1966-1967)", "MS": "Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products.", "PM": "68", "HN": "68", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007356"}, {"RECTYPE": "D", "MH": "Insurance, Physician Services", "DE": "INSURANCE PHYSICIAN SERV", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Services, Insurance Physician", "MN": "N03.219.521.576.343.616", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "specify geog if possible", "PI": "Insurance, Health (1966-1967)", "MS": "Insurance providing benefits for the costs of care by a physician which can be comprehensive or limited to surgical expenses or for care provided only in the hospital. It is frequently called \"regular medical expense\" or \"surgical expense\".", "PM": "68", "HN": "68", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007357"}, {"RECTYPE": "D", "MH": "Insurance, Psychiatric", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Psychiatric Insurances", "MN": "N03.219.521.576.343.658", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "specify geog if possible", "PI": "Insurance, Health (1966-1967)", "MS": "Insurance providing benefits to cover part or all of the psychiatric care.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007358"}, {"RECTYPE": "D", "MH": "Insurance, Surgical", "DE": "INSURANCE SURG", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Surgical Insurances", "MN": "N03.219.521.576.343.700", "MH_TH": "NLM (1975)", "ST": "T058", "MS": "A specific type of health insurance which provides surgeons' fees for specified amounts according to the type of surgery listed in the policy.", "OL": "search INSURANCE, HEALTH 1966-74", "PM": "91; was see under INSURANCE, HEALTH 1975-90", "HN": "91(75); was see under INSURANCE, HEALTH 1975-90", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007359"}, {"RECTYPE": "D", "MH": "Intelligence", "AQ": "CL DE GE PH RE", "MN": "F01.752.543", "MH_TH": "POPLINE (1978)", "ST": "T041", "AN": "/genet permitted", "MS": "The ability to learn and to deal with new situations and to deal effectively with tasks involving abstractions.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007360"}, {"RECTYPE": "D", "MH": "Intelligence Tests", "AQ": "HI SN ST", "PRINT ENTRY": "Raven's Progressive Matrices|T060|EPO|NRW|NLM (2023)|211028|abcdef", "ENTRY": "Test, Raven", "MN": "F04.711.141.493", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Standardized tests that measure the present general ability or aptitude for intellectual performance.", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007361"}, {"RECTYPE": "D", "MH": "Intensive Care Units", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "ICU Intensive Care Units|T073|T093|NON|EQV|NLM (2021)|200422|abbcdef", "ENTRY": "Unit, Intensive Care", "MN": "N02.278.388.493", "MH_TH": "BIOETHICS (1974)", "ST": "T093", "MS": "Hospital units providing continuous surveillance and care to acutely ill patients.", "PM": "66", "HN": "66(63)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007362"}, {"RECTYPE": "D", "MH": "Intensive Care Units, Neonatal", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Newborn Intensive Care Units|T073|T093|NON|EQV|UNK (19XX)|810226|abbcdef", "ENTRY": "Newborn ICUs", "MN": "N02.278.388.493.390.380", "MH_TH": "NLM (1982)", "ST": "T093", "AN": "check also tags HUMANS & INFANT, NEWBORN", "PI": "Intensive Care Units (1966-1981)", "MS": "Hospital units providing continuing surveillance and care to acutely ill newborn infants.", "PM": "82", "HN": "82", "MR": "20200527", "DA": "19810226", "DC": "1", "DX": "19820101", "UI": "D007363"}, {"RECTYPE": "D", "MH": "Intercalating Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Intercalators|T130|NON|EQV|NLM (1998)|961122|abcdef", "ENTRY": "Ligands, Intercalating", "MN": "D27.720.470.410.360", "MH_TH": "NLM (1980)", "ST": "T130", "RN": "0", "PI": "specific DNA (1966-1979)", "MS": "Agents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning. They are used in the study of DNA.", "PM": "80", "HN": "80", "MR": "20200527", "DA": "19790501", "DC": "1", "DX": "19800101", "UI": "D007364"}, {"RECTYPE": "D", "MH": "Intercellular Junctions", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Cell Junctions|T030|NON|EQV|NLM (1995)|940513|abcdef", "ENTRY": "Junctions, Intercellular", "MN": "A11.284.149.165.420", "MH_TH": "NLM (1970)", "ST": "T030", "PI": "Cell Membrane (1966-1969)", "MS": "Direct contact of a cell with a neighboring cell. Most such junctions are too small to be resolved by light microscopy, but they can be visualized by conventional or freeze-fracture electron microscopy, both of which show that the interacting CELL MEMBRANE and often the underlying CYTOPLASM and the intervening EXTRACELLULAR SPACE are highly specialized in these regions. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p792)", "PM": "72", "HN": "72(70)", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D007365"}, {"RECTYPE": "D", "MH": "Intercostal Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Muscles, Intercostal", "MN": "A02.633.567.900.500", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent", "MS": "Respiratory muscles that arise from the lower border of one rib and insert into the upper border of the adjoining rib, and contract during inspiration or respiration. (From Stedman, 25th ed)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007366"}, {"RECTYPE": "D", "MH": "Intercostal Nerves", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nerves, Intercostal", "MN": "A08.800.800.720.800.350", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES (IM); neopl: coord IM with PERIPHERAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "The ventral rami of the thoracic nerves from segments T1 through T11. The intercostal nerves supply motor and sensory innervation to the thorax and abdomen. The skin and muscles supplied by a given pair are called, respectively, a dermatome and a myotome.", "OL": "search THORACIC NERVES 1966-74", "PM": "91; was see under THORACIC NERVES 1975-90", "HN": "91(75); was see under THORACIC NERVES 1975-90", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007367"}, {"RECTYPE": "D", "MH": "Interferometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Interferometries", "MN": "E05.490", "MH_TH": "NLM (1977)", "ST": "T059", "AN": "NIM; coord with LIGHT (NIM) or SOUND (NIM) if specified", "PI": "Optics (1966-1976)", "MS": "Measurement of distances or movements by means of the phenomena caused by the interference of two rays of light (optical interferometry) or of sound (acoustic interferometry).", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "19920514", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D007368"}, {"RECTYPE": "D", "MH": "Interferon Inducers", "DE": "INTERFERON IND", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inducers, Interferon", "MN": "D27.505.696.477.828", "FX": "Antiviral Agents", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "PI": "Interferons/biosynthesis (1966-1972)", "MS": "Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons.", "PM": "73", "HN": "73", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007369"}, {"RECTYPE": "D", "MH": "Interferon Type I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Interferons, Type I", "MN": "D23.529.374.440.890", "PA": "Antiviral Agents", "MH_TH": "NLM (1983)", "ST": "T129", "RN": "0", "PI": "Interferons (1966-1982)", "MS": "Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA).", "PM": "83", "HN": "83", "MR": "20150622", "DA": "19820519", "DC": "1", "DX": "19830101", "UI": "D007370"}, {"RECTYPE": "D", "MH": "Interferon-gamma", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gamma-Interferon|T116|T121|T129|NON|EQV|NLM (1992)|910319|abbbcdef", "ENTRY": "Interferon, Type II", "MN": "D23.529.374.480.615.350", "PA": "Antiviral Agents", "FX": "Interferon-gamma Release Tests", "MH_TH": "NLM (1991)", "ST": "T129", "N1": "Interferon gamma (human lymphocyte protein moiety reduced)", "RN": "82115-62-6", "PI": "Interferons (1966-1982)", "MS": "The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES.", "PM": "2009; see INTERFERON TYPE II 1984-2008, see INTERFERON, GAMMA 1983-1990", "HN": "2009(1983); INTERFERON-GAMMA was INTERFERON, GAMMA 1983-1990", "MR": "20150622", "DA": "19820519", "DC": "1", "DX": "19830101", "UI": "D007371"}, {"RECTYPE": "D", "MH": "Interferons", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Interferon|T116|T121|T129|NON|EQV|UNK (19XX)|820504|abbbcdef", "MN": "D23.529.374.440", "PA": "Antiviral Agents", "FX": "Receptors, Interferon", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "9008-11-1", "MS": "Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions.", "OL": "use INTERFERONS to search INTERFERON 1966-82", "PM": "83; was INTERFERON 1963-82", "HN": "83; was INTERFERON 1963-82", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19830101", "UI": "D007372"}, {"RECTYPE": "D", "MH": "Interinstitutional Relations", "DE": "INTERINSTITUTIONAL RELAT", "PRINT ENTRY": "Interagency Relations|T054|NON|BRD|UNK (19XX)|790601|INTERAGENCY RELAT|abcdefv", "ENTRY": "Relations, Interinstitutional", "MN": "N04.452.822.400", "MH_TH": "NLM (1980)", "ST": "T054", "MS": "The interactions between representatives of institutions, agencies, or organizations.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D007373"}, {"RECTYPE": "D", "MH": "Interior Design and Furnishings", "DE": "INTERIOR DESIGN FURNISHINGS", "AQ": "CL EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Interior Furnishings|T073|NON|NRW|NLM (1991)|900222|abcdef", "ENTRY": "Interior Furnishing", "MN": "J01.086.339.290", "MH_TH": "NLM (1977)", "ST": "T073", "AN": "for houses, commerc estab, hosp, institutions, etc.", "MS": "The planning of the furnishings and decorations of an architectural interior.", "PM": "91; was see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-90", "HN": "91(Aug 77); was see under FACILITY DESIGN AND CONSTRUCTION 1977-90", "MR": "19930602", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D007374"}, {"RECTYPE": "D", "MH": "Interleukin-1", "DS": "INTERLEUKIN 001", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lymphocyte-Activating Factor|T116|T129|NON|EQV|UNK (19XX)|820429|abbcdef", "ENTRY": "Lymphocyte Activating Factor", "MN": "D23.529.374.500.400", "FX": "Receptors, Interleukin-1", "MH_TH": "NLM (1983)", "ST": "T129", "RN": "0", "PI": "Toxins (1966-1973)", "MS": "A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation.", "PM": "1990; see INTERLEUKIN 1 1983-1989", "HN": "1990(1983)", "MR": "20150415", "DA": "19820429", "DC": "1", "DX": "19830101", "UI": "D007375"}, {"RECTYPE": "D", "MH": "Interleukin-2", "DS": "INTERLEUKIN 002", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "TCGF|T116|T129|ABB|EQV|UNK (19XX)|820430|abbcdef", "ENTRY": "T Cell Stimulating Factor", "MN": "D23.529.374.480.372", "PA": "Antineoplastic Agents", "FX": "Receptors, Interleukin-2", "MH_TH": "NLM (1978)", "ST": "T129", "RN": "0", "PI": "Mitogens (1973-1977)", "MS": "A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes.", "PM": "1990; see INTERLEUKIN 2 1987-1989, see MITOGENIC FACTORS, LYMPHOCYTE 1983-1986, see LYMPHOKINES 1978-1982; RU 49637 was indexed under INTERLEUKIN-2 1993-2006", "HN": "1990(1978)", "MR": "20150415", "DA": "19770301", "DC": "1", "DX": "19830101", "UI": "D007376"}, {"RECTYPE": "D", "MH": "Interleukin-3", "DS": "INTERLEUKIN 003", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "P-Cell Stimulating Factor|T116|T129|EQV|UNK (19XX)|860620|abbdef", "ENTRY": "P Cell Stimulating Factor", "MN": "D23.529.374.465.169", "FX": "Receptors, Interleukin-3", "MH_TH": "NLM (1987)", "ST": "T129", "RN": "0", "PI": "Lymphokines (1974-1986)", "MS": "A multilineage cell growth factor secreted by LYMPHOCYTES; EPITHELIAL CELLS; and ASTROCYTES which stimulates clonal proliferation and differentiation of various types of blood and tissue cells.", "PM": "1987; see INTERLEUKIN 3 1987-1989; for HEMATOPOIETIN-2 see HEMATOPOIETIC CELL GROWTH FACTORS 1990-2006", "HN": "1987; for HEMATOPOIETIN-2 use HEMATOPOIETIC CELL GROWTH FACTORS 1990-2006", "MR": "20230316", "DA": "19860408", "DC": "1", "DX": "19870101", "UI": "D007377"}, {"RECTYPE": "D", "MH": "Interleukins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Interleukin|T116|T129|NON|EQV|NLM (1988)|870509|abbcdef", "MN": "D23.529.374.465", "MH_TH": "NLM (1988)", "ST": "T129", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli.", "PM": "1988; for MITOGENIC FACTORS, LYMPHOCYTE see INTERLEUKIN-2 1990-2001, INTERLEUKIN 2 1987-1989, LYMPHOKINES 1978-1982", "HN": "1988; for MITOGENIC FACTORS, LYMPHOCYTE use INTERLEUKIN-2 1983-2001, LYMPHOKINES 1978-1982", "MR": "20130709", "DA": "19870509", "DC": "1", "DX": "19880101", "UI": "D007378"}, {"RECTYPE": "D", "MH": "Interlibrary Loans", "AQ": "CL EC ES HI IS LJ MT OG SD SN ST TD", "ENTRY": "Loans, Interlibrary", "MN": "L01.583.464.493", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "Copies or original works acquired from cooperating institutions on request.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007379"}, {"RECTYPE": "D", "MH": "Intermediate Care Facilities", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Intermediate Care Facility", "MN": "N02.278.825.610.480", "MH_TH": "NLM (1979)", "ST": "T093", "PI": "Nursing Homes (1966-1978)", "MS": "Institutions which provide health-related care and services to individuals who do not require the degree of care which hospitals or skilled nursing facilities provide, but because of their physical or mental condition require care and services above the level of room and board.", "PM": "91; was see under NURSING HOMES 1979-90", "HN": "91(79); was see under NURSING HOMES 1979-90", "MR": "20160623", "DA": "19780508", "DC": "1", "DX": "19910101", "UI": "D007380"}, {"RECTYPE": "D", "MH": "Intermediate Filament Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fibroblast Intermediate Filament Proteins|T116|T123|NON|EQV|UNK (19XX)|820511|abbcdef", "ENTRY": "Proteins, Intermediate Filament", "MN": "D12.776.220.475", "MH_TH": "NLM (1983)", "ST": "T123", "RN": "0", "AN": "/biosyn /drug eff /physiol permitted", "PI": "Proteins (1966-1982)", "MS": "Filaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein.", "PM": "83", "HN": "83", "MR": "20050630", "DA": "19820511", "DC": "1", "DX": "19830101", "UI": "D007381"}, {"RECTYPE": "D", "MH": "Intermediate Filaments", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Tonofilaments|T026|NON|REL|UNK (19XX)|850225|abcdef", "ENTRY": "Tonofilament", "MN": "A11.284.430.214.190.750.410", "MH_TH": "NLM (1986)", "ST": "T026", "PI": "Cytoskeleton (1977-1985)", "MS": "Cytoplasmic filaments intermediate in diameter (about 10 nanometers) between the microfilaments and the microtubules. They may be composed of any of a number of different proteins and form a ring around the cell nucleus.", "OL": "search CYTOSKELETON 1980-85", "PM": "91; was see under CYTOSKELETON 1986-90; was see CYTOPLASMIC FILAMENTS 1980-85", "HN": "91(86); was see under CYTOSKELETON 1986-90; was see CYTOPLASMIC FILAMENTS 1980-85", "MR": "20140613", "DA": "19850225", "DC": "1", "DX": "19910101", "UI": "D007382"}, {"RECTYPE": "D", "MH": "Intermittent Claudication", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Claudication, Intermittent", "MN": "C23.888.531", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A symptom complex characterized by pain and weakness in SKELETAL MUSCLE group associated with exercise, such as leg pain and weakness brought on by walking. Such muscle limpness disappears after a brief rest and is often relates to arterial STENOSIS; muscle ISCHEMIA; and accumulation of LACTATE.", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007383"}, {"RECTYPE": "D", "MH": "Intermittent Positive-Pressure Breathing", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Inspiratory Positive-Pressure Breathing|T061|NON|EQV|UNK (19XX)|780313|abcdef", "ENTRY": "Positive-Pressure Breathing, Intermittent", "MN": "E02.880.820.790.520", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "do not confuse with INTERMITTENT POSITIVE-PRESSURE VENTILATION: IPPB is spontaneous, IPPV is on a ventilator ", "MS": "Application of positive pressure to the inspiratory phase of spontaneous respiration.", "OL": "use INTERMITTENT POSITIVE-PRESSURE BREATHING to search INTERMITTENT POSITIVE PRESSURE BREATHING 1979-90 & INTERMITTENT POSITIVE PRESSURE BREATHING (IPPB) 1975-78; use POSITIVE PRESSURE RESPIRATION 1969-74", "PM": "91; was INTERMITTENT POSITIVE PRESSURE BREATHING see under POSITIVE PRESSURE RESPIRATION 1979-90; was INTERMITTENT POSITIVE PRESSURE BREATHING (IPPB) see under POSITIVE PRESSURE RESPIRATION 1969-78", "HN": "91(79); was INTERMITTENT POSITIVE PRESSURE BREATHING see under POSITIVE PRESSURE RESPIRATION 1979-90; was INTERMITTENT POSITIVE PRESSURE BREATHING (IPPB) see under POSITIVE PRESSURE RESPIRATION 1969-78", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007384"}, {"RECTYPE": "D", "MH": "Intermittent Positive-Pressure Ventilation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ventilation, Intermittent Positive-Pressure|T061|NON|EQV|UNK (19XX)|780313|abcdef", "ENTRY": "Ventilation, Intermittent Positive Pressure", "MN": "E02.880.820.790.550", "MH_TH": "NLM (1979)", "ST": "T061", "AN": "do not confuse with INTERMITTENT POSITIVE-PRESSURE BREATHING: IPPV is on a ventilator, IPPB is spontaneous; in the literature BIPAP (BIPHASIC INTERMITTENT POSITIVE AIRWAY PRESSURE) goes here and BiPAP (BIPHASIC CONTINUOUS POSITIVE AIRWAY PRESSURE) goes under CONTINUOUS POSITIVE AIRWAY PRESSURE", "PI": "Positive Pressure Respiration (1966-1978)", "MS": "Application of positive pressure to the inspiratory phase when the patient has an artificial airway in place and is connected to a ventilator.", "OL": "use INTERMITTENT POSITIVE-PRESSURE VENTILATION to search INTERMITTENT POSITIVE PRESSURE VENTILATION 1979-90", "PM": "91; was INTERMITTENT POSITIVE PRESSURE VENTILATION see under POSITIVE PRESSURE RESPIRATION 1979-90", "HN": "91(79); was INTERMITTENT POSITIVE PRESSURE VENTILATION see under POSITIVE PRESSURE RESPIRATION 1979-90", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19780313", "DC": "1", "DX": "19910101", "UI": "D007385"}, {"RECTYPE": "D", "MH": "Internal Mammary-Coronary Artery Anastomosis", "DE": "IMA ANASTOMOSIS", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Coronary Internal Mammary Artery Anastomosis", "MN": "E04.928.220.520.220.380", "MH_TH": "NLM (1975)", "ST": "T061", "MS": "Direct myocardial revascularization in which the internal mammary artery is anastomosed to the right coronary artery, circumflex artery, or anterior descending coronary artery. The internal mammary artery is the most frequent choice, especially for a single graft, for coronary artery bypass surgery.", "PM": "88; was see under MYOCARDIAL REVASCULARIZATION 1975-87", "HN": "88(75); was see under MYOCARDIAL REVASCULARIZATION 1975-87", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19741212", "DC": "1", "DX": "19880101", "UI": "D007387"}, {"RECTYPE": "D", "MH": "Internal Medicine", "DE": "INTERNAL MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "General Internal Medicine|T091|NON|EQV|NLM (2022)|210122|abcdef", "ENTRY": "Medicine, General Internal", "MN": "H02.403.429", "MH_TH": "BIOETHICS (1991)", "ST": "T091", "AN": "specialty", "MS": "A medical specialty concerned with the diagnosis and treatment of diseases of the internal organ systems of adults.", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007388"}, {"RECTYPE": "D", "MH": "Internal-External Control", "PRINT ENTRY": "Locus of Control|T078|NON|BRD|UNK (19XX)|800507|abcdef", "ENTRY": "Internal-External Controls", "MN": "F01.829.379", "MH_TH": "NLM (1972)", "ST": "T078", "PI": "Social Control, Informal (1968-1971)", "MS": "Personality construct referring to an individual's perception of the locus of events as determined internally by his or her own behavior versus fate, luck, or external forces. (ERIC Thesaurus, 1996).", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D007389"}, {"RECTYPE": "D", "MH": "International Agencies", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "International Agency", "MN": "N03.540.514", "MH_TH": "POPLINE (1978)", "ST": "T092", "AN": "specify geog", "MS": "International organizations which provide health-related or other cooperative services.", "MR": "20140616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007390"}, {"RECTYPE": "D", "MH": "International Cooperation", "AQ": "HI LJ", "PRINT ENTRY": "Foreign Aid|T064|NON|NRW|POPLINE (1978)|890502|abcdef", "ENTRY": "Treaty", "MN": "I01.615.500", "FX": "Congresses as Topic", "MH_TH": "POPLINE (1978)", "ST": "T064", "AN": "specify geog for cooperating nations; do not index here for \"international congresses\": CONGRESS is adequate", "MS": "The interaction of persons or groups of persons representing various nations in the pursuit of a common goal or interest.", "MR": "20180713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007391"}, {"RECTYPE": "D", "MH": "International Council of Nurses", "AQ": "EC HI OG", "ENTRY": "Nurses International Councils", "MN": "N03.540.828.672.463", "MH_TH": "NLM (1980)", "ST": "T094", "AN": "CATALOGER: Use NAF entry", "PI": "Societies, Nursing (1966-1979)", "MS": "An international professional organization composed of one association per country for the purpose of improving and developing nursing's contribution to the promotion of health and care of the sick.", "PM": "91; was see under SOCIETIES, NURSING 1980-90", "HN": "91(80); was see under SOCIETIES, NURSING 1980-90", "MR": "20150605", "DA": "19790411", "DC": "1", "DX": "19910101", "UI": "D007392"}, {"RECTYPE": "D", "MH": "International Educational Exchange", "DE": "INTERNATIONAL EDUC EXCHANGE", "AQ": "EC HI SN TD", "PRINT ENTRY": "Educational Exchange, International|T052|NON|EQV|NLM (1990)|890502|EDUC EXCHANGE INTERNATIONAL|abcdefv", "ENTRY": "International Educational Exchanges", "MN": "I02.581", "FX": "Foreign Medical Graduates", "MH_TH": "NLM (1968)", "ST": "T052", "AN": "specify geog if pertinent", "PI": "International Cooperation (1966-1967)", "MS": "The exchange of students or professional personnel between countries done under the auspices of an organization for the purpose of further education.", "PM": "70", "HN": "70(68)", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D007393"}, {"RECTYPE": "D", "MH": "International System of Units", "AQ": "CL HI IS ST", "PRINT ENTRY": "Systeme International d'Unites|T081|NON|EQV|NLM (1992)|901010|abcdef", "ENTRY": "Units, SI", "MN": "E05.978.507", "MH_TH": "NLM (1979)", "ST": "T081", "AN": "in titles use diacritics: Syst\u00e8me International d'Unites; CATALOGER: Use NAF entry", "PI": "Weights and Measures (1966-1978)", "MS": "A system of physical units in which the fundamental quantities are length, time, mass, electric current, temperature, luminous intensity, and amount of substance, and the corresponding units are the meter, second, kilogram, ampere, kelvin, candela, and mole. The system has been given official status and recommended for universal use by the General Conference on Weights and Measures.", "PM": "91; was see under WEIGHTS AND MEASURES 1979-90", "HN": "91(79); was see under WEIGHTS AND MEASURES 1979-90", "MR": "20150605", "DA": "19780324", "DC": "1", "DX": "19910101", "UI": "D007394"}, {"RECTYPE": "D", "MH": "Interneurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Intercalated Neurons|T025|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Neurons, Intercalated", "MN": "A11.671.358", "MH_TH": "NLM (1968)", "ST": "T025", "PI": "Neurons (1966-1967)", "MS": "Most generally any NEURONS which are not motor or sensory. Interneurons may also refer to neurons whose AXONS remain within a particular brain region in contrast to projection neurons, which have axons projecting to other brain regions.", "PM": "68", "HN": "68", "MR": "20150709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007395"}, {"RECTYPE": "D", "MH": "Internship and Residency", "DE": "INTERNSHIP RESIDENCY", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Residency, Medical|T065|NON|NRW|UNK (19XX)|740330|RESIDENCY MED|abcdefv", "ENTRY": "Staff, House", "MN": "I02.358.399.350.750", "MH_TH": "BIOETHICS (1980)", "ST": "T065", "AN": "medical & dental only", "MS": "Programs of EDUCATION, MEDICAL, GRADUATE training to meet the requirements established by accrediting authorities.", "MR": "20181011", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007396"}, {"RECTYPE": "D", "MH": "Internship, Nonmedical", "DE": "INTERNSHIP NONMED", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Residency, Nonmedical|T065|NON|EQV|UNK (19XX)|770513|RESIDENCY NONMED|abcdefv", "ENTRY": "Residency, Non Medical", "MN": "I02.358.750", "MH_TH": "NLM (1978)", "ST": "T065", "MS": "Advanced programs of training to meet certain professional requirements in fields other than medicine or dentistry, e.g., pharmacology, nutrition, nursing, etc.", "PM": "78", "HN": "78", "MR": "19960610", "DA": "19770513", "DC": "1", "DX": "19780101", "UI": "D007397"}, {"RECTYPE": "D", "MH": "Interpersonal Relations", "DE": "INTERPERSONAL RELAT", "AQ": "HI", "PRINT ENTRY": "Social Relationships|T054|NON|EQV|NLM (2021)|200116|abcdef", "ENTRY": "Social Relationship", "MN": "F01.829.401", "FX": "Friends", "MH_TH": "NLM (2000)", "ST": "T054", "MS": "The reciprocal interaction of two or more persons.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D007398"}, {"RECTYPE": "D", "MH": "Interphase", "AQ": "DE ES GE IM PH RE", "ENTRY": "Interphases", "MN": "G04.144.500", "MH_TH": "NLM (1978)", "ST": "T079", "AN": "specific phases are available; coordinate with specific cell /cytol; permitted with micro-organisms", "PI": "Mitosis (1968-1977)", "MS": "The interval between two successive CELL DIVISIONS during which the CHROMOSOMES are not individually distinguishable. It is composed of the G phases (G1 PHASE; G0 PHASE; G2 PHASE) and S PHASE (when DNA replication occurs).", "PM": "81; was see under CELL CYCLE 1978-80", "HN": "81(78); was see under CELL CYCLE 1978-80", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19770510", "DC": "1", "DX": "19810101", "UI": "D007399"}, {"RECTYPE": "D", "MH": "Interprofessional Relations", "DE": "INTERPROFESSIONAL RELAT", "AQ": "ES", "ENTRY": "Relations, Interprofessional", "MN": "F01.829.401.205", "FX": "Interdisciplinary Communication", "MH_TH": "BIOETHICS (1991)", "ST": "T054", "AN": "coord IM with med or other spec (IM) if pertinent; INTERDISCIPLINARY COMMUNICATION is also available", "MS": "The reciprocal interaction of two or more professional individuals.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20021031", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007400"}, {"RECTYPE": "D", "MH": "Interrenal Gland", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Interrenal Glands", "MN": "A13.530", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "also called interrenal body; in fish", "MS": "Structures in fishes homologous to the cortical tissue of the mammalian adrenal gland; they are in close proximity to or imbedded in the kidney.", "PM": "89; was see under ADRENAL GLANDS 1969-88", "HN": "89(75); was see under ADRENAL GLANDS 1969-88", "MR": "19880611", "DA": "19990101", "DC": "1", "DX": "19890101", "UI": "D007401"}, {"RECTYPE": "D", "MH": "Intertrigo", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.815.650", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a dermatitis of skin folds", "MS": "A superficial dermatitis occurring on skin surfaces in contact with each other, such as the axillae, neck creases, intergluteal fold, between the toes, etc. Obesity is a predisposing factor. The condition is caused by moisture and friction and is characterized by erythema, maceration, burning, and exudation.", "CATSH": "CAT LIST", "MR": "19920520", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007402"}, {"RECTYPE": "D", "MH": "Intervertebral Disc", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Intervertebral Disk|T023|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Intervertebral Disks", "MN": "A10.165.382.350.050", "FX": "Diskectomy", "MH_TH": "NLM (2012)", "ST": "T023", "MS": "Any of the 23 plates of fibrocartilage found between the bodies of adjacent VERTEBRAE.", "PM": "2012; see INTERVERTEBRAL DISK 1963-2011", "HN": "2012 (1963)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "20120101", "UI": "D007403"}, {"RECTYPE": "D", "MH": "Intervertebral Disc Chemolysis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Nucleolysis, Intervertebral Disk|T061|NON|EQV|UNK (19XX)|860620|abcdef", "ENTRY": "Nucleolyses, Intervertebral Disk", "MN": "E02.718.500", "FX": "Chymopapain", "MH_TH": "NLM (2012)", "ST": "T061", "AN": "coordinate IM with specific substance /ther use (usually CHYMOPAPAIN) if particularly discussed", "PI": "Intervertebral Disk Displacement (1966-1986)", "MS": "The dissolving of the NUCLEUS PULPOSUS, the semi-gelatinous tissue of a displaced INTERVERTEBRAL DISC. It is usually achieved by the direct injection of a proteolytic enzyme, especially CHYMOPAPAIN, into the herniated disc.", "PM": "2012; see INTERVERTEBRAL DISK CHEMOLYSIS 1987-2011", "HN": "2012 (1987)", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19860620", "DC": "1", "DX": "19870101", "UI": "D007404"}, {"RECTYPE": "D", "MH": "Intervertebral Disc Displacement", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Slipped Disk|T047|NON|EQV|NLM (1990)|890520|abcdef", "ENTRY": "Slipped Disks", "MN": "C23.300.707.952", "FX": "Sciatica", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "An INTERVERTEBRAL DISC in which the NUCLEUS PULPOSUS has protruded through surrounding ANNULUS FIBROSUS. This occurs most frequently in the lower lumbar region.", "CATSH": "CAT LIST", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007405"}, {"RECTYPE": "D", "MH": "Interview, Psychological", "DE": "INTERVIEW PSYCHOL", "AQ": "MT ST", "ENTRY": "Psychologic Interviews", "MN": "F04.669.599", "MH_TH": "NLM (1965)", "ST": "T060", "MS": "A directed conversation aimed at eliciting information for psychiatric diagnosis, evaluation, treatment planning, etc. The interview may be conducted by a social worker or psychologist.", "PM": "68", "HN": "68(65)", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007406"}, {"RECTYPE": "D", "MH": "Interviews as Topic", "AQ": "MT SN ST", "ENTRY": "Telephone Interviews", "MN": "N06.850.520.308.420", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "for articles on how to conduct interviews, their value, behavior of participants, etc.: do not confuse with the Publication Type INTERVIEW", "MS": "Works about conversations with an individual or individuals held in order to obtain information about their background and other personal biographical data, their attitudes and opinions, etc. It includes works about school admission or job interviews.", "PM": "2008; see INTERVIEWS 1980-2007", "HN": "2008(1980)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19790530", "DC": "1", "DX": "19800101", "UI": "D007407"}, {"RECTYPE": "D", "MH": "Intestinal Absorption", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Absorption, Intestinal|T042|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "G10.261.353.500", "FX": "Malabsorption Syndromes", "MH_TH": "NLM (1965)", "ST": "T042", "MS": "Uptake of substances through the lining of the INTESTINES.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007408"}, {"RECTYPE": "D", "MH": "Intestinal Atresia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Atresia, Intestinal|T019|T047|NON|EQV|NLM (1995)|940106|abbcdef", "ENTRY": "Intestinal Atresias, Congenital", "MN": "C16.131.314.466", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific intestine /abnorm except for duodenum: index duodenal atresia as DUODENAL OBSTRUCTION /congen (IM) + INTESTINAL ATRESIA (IM)", "MS": "Congenital obliteration of the lumen of the intestine, with the ILEUM involved in 50% of the cases and the JEJUNUM and DUODENUM following in frequency. It is the most frequent cause of INTESTINAL OBSTRUCTION in NEWBORNS. (From Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007409"}, {"RECTYPE": "D", "MH": "Intestinal Diseases", "DE": "INTESTINAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Intestinal Disease", "MN": "C06.405.469", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; inflammatory disease equals GASTROENTERITIS or specifics; gas cysts equals PNEUMATOSIS CYSTOIDES INTESTINALIS", "MS": "Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.", "OL": "search INTESTINAL MICROORGANISMS under INTESTINES 1966-67", "PM": "INTESTINAL MICROORGANISMS was heading 1963-67; general or unspecified inflammatory disease is indexed here, was indexed under INTESTINAL DISEASES or ENTERITIS 1963-79", "HN": "INTESTINAL MICROORGANISMS was heading 1963-67; general or unspecified inflamm dis was indexed under ENTERITIS or INTESTINAL DISEASES 1966-79", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D007410"}, {"RECTYPE": "D", "MH": "Intestinal Diseases, Parasitic", "DE": "INTESTINAL DIS PARASITIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Parasitic Intestinal Diseases|T047|NON|EQV|NLM (1995)|940105|PARASITIC INTESTINAL DIS|abcdefv", "ENTRY": "Parasitic Intestinal Disease", "MN": "C06.405.469.452", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specific indentations; otherwise coordinate with specific parasitic disease and specific precoordinated intestinal disease ", "MS": "Infections of the INTESTINES with PARASITES, commonly involving PARASITIC WORMS. Infections with roundworms (NEMATODE INFECTIONS) and tapeworms (CESTODE INFECTIONS) are also known as HELMINTHIASIS.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007411"}, {"RECTYPE": "D", "MH": "Intestinal Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fistula, Intestinal", "MN": "C23.300.575.185.550", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "fistula policy: Manual 23.19+; RECTAL FISTULA & RECTOVAGINAL FISTULA are also available; pathological artificial anus in historical literature is indexed here or under its specifics; surgically created artificial anus is indexed under COLOSTOMY", "MS": "An abnormal anatomical passage between the INTESTINE, and another segment of the intestine or other organs. External intestinal fistula is connected to the SKIN (enterocutaneous fistula). Internal intestinal fistula can be connected to a number of organs, such as STOMACH (gastrocolic fistula), the BILIARY TRACT (cholecystoduodenal fistula), or the URINARY BLADDER of the URINARY TRACT (colovesical fistula). Risk factors include inflammatory processes, cancer, radiation treatment, and surgical misadventures (MEDICAL ERRORS).", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007412"}, {"RECTYPE": "D", "MH": "Intestinal Mucosa", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Intestinal Epithelium|T024|NON|NRW|NLM (1996)|941017|abcdef", "ENTRY": "Mucosa, Intestinal", "MN": "A10.615.550.444", "FX": "Intestinal Secretions", "MH_TH": "NLM (1965)", "ST": "T024", "AN": "/cytol: consider also specific cell types available in MeSH; for entry term INTESTINAL EPITHELIUM, do not routinely coordinate with EPITHELIUM unless it is specifically discussed", "MS": "Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI.", "PM": "67", "HN": "67(65)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007413"}, {"RECTYPE": "D", "MH": "Intestinal Neoplasms", "DE": "INTESTINAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Intestinal Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasms, Intestines", "MN": "C06.405.469.491", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "general or unspecified; prefer specific precoordinated neoplasm terms; coordinate with histological type of neoplasm ", "MS": "Tumors or cancer of the INTESTINES.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007414"}, {"RECTYPE": "D", "MH": "Intestinal Obstruction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Obstruction, Intestinal", "MN": "C06.405.469.531", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific precoord intestinal dis (IM); INTESTINAL PSEUDO-OBSTRUCTION is also available", "MS": "Any impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL.", "CATSH": "CAT LIST", "MR": "20050701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007415"}, {"RECTYPE": "D", "MH": "Intestinal Perforation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Perforations, Intestinal", "MN": "C06.405.469.557", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by dis or inj; coord IM with specific intestine (IM) or specific precoord intestinal dis (IM); intestinal rupture does not go here: index with INTESTINES /inj or specific intestine /inj (IM) + RUPTURE (NIM) or specific intestine (IM) or specific precoord intestinal dis (IM) + RUPTURE, SPONTANEOUS (NIM)", "MS": "Opening or penetration through the wall of the INTESTINES.", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007416"}, {"RECTYPE": "D", "MH": "Intestinal Polyps", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Polyps, Intestinal", "MN": "C23.300.825.411", "MH_TH": "NLM (1968)", "ST": "T190", "AN": "INTESTINAL POLYPOSIS is also available", "PI": "Polyps (1966-1967)", "MS": "Discrete abnormal tissue masses that protrude into the lumen of the INTESTINE. A polyp is attached to the intestinal wall either by a stalk, pedunculus, or by a broad base.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19771206", "DC": "1", "DX": "19680101", "UI": "D007417"}, {"RECTYPE": "D", "MH": "Intestinal Pseudo-Obstruction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Visceral Myopathy|T047|NON|BRD|UNK (19XX)|860617|abcdef", "ENTRY": "Visceral Myopathies", "MN": "C06.405.469.531.492.500", "MH_TH": "NLM (1981)", "ST": "T047", "AN": "coordinate with specific precoordinated intestinal disease; INTESTINAL OBSTRUCTION and ILEUS are also available", "PI": "Intestinal Obstruction (1966-1980)", "MS": "A type of ILEUS, a functional not mechanical obstruction of the INTESTINES. This syndrome is caused by a large number of disorders involving the smooth muscles (MUSCLE, SMOOTH) or the NERVOUS SYSTEM.", "OL": "use INTESTINAL PSEUDO-OBSTRUCTION to search INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC 1981-86 & PARALYTIC ILEUS 1971-86 (as Prov 1971-74)", "PM": "87; was INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC see under INTESTINAL OBSTRUCTION 1981-86; PARALYTIC ILEUS was see under INTESTINAL OBSTRUCTION 1975-86", "HN": "87; was INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC see under INTESTINAL OBSTRUCTION 1981-86; PARALYTIC ILEUS was see under INTESTINAL OBSTRUCTION 1975-86, was Prov 1971-74", "CATSH": "CAT LIST", "MR": "20230426", "DA": "19800407", "DC": "1", "DX": "19870101", "UI": "D007418"}, {"RECTYPE": "D", "MH": "Intestinal Secretions", "DE": "INTESTINAL SECRET", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Secretions, Intestinal", "MN": "A12.200.390", "FX": "Gastrointestinal Hormones", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "Fluids originating from the epithelial lining of the intestines, adjoining exocrine glands and from organs such as the liver, which empty into the cavity of the intestines.", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007419"}, {"RECTYPE": "D", "MH": "Intestine, Large", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Large Intestine|T023|NON|EQV|NLM (2004)|021218|abcdef", "MN": "A03.556.249.249", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "general or unspecified; prefer specifics; inflammation: coordinate with GASTROENTERITIS ", "MS": "A segment of the LOWER GASTROINTESTINAL TRACT that includes the CECUM; the COLON; and the RECTUM.", "OL": "search INTESTINAL MICROORGANISMS under INTESTINES 1966-67", "PM": "INTESTINAL MICROORGANISMS was heading 1963-67", "HN": "INTESTINAL MICROORGANISMS was heading 1963-67", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007420"}, {"RECTYPE": "D", "MH": "Intestine, Small", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Small Intestines", "MN": "A03.556.124.684", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "general or unspecified; prefer specifics; inflammation equals ENTERITIS but ENTEROCOLITIS; DUODENITIS; and ILEITIS are available", "MS": "The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM.", "OL": "search INTESTINAL MICROORGANISMS under INTESTINES 1966-67", "PM": "INTESTINAL MICROORGANISMS was heading 1963-67", "HN": "INTESTINAL MICROORGANISMS was heading 1963-67", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007421"}, {"RECTYPE": "D", "MH": "Intestines", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Intestine", "MN": "A03.556.124", "FX": "Gastroenterostomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.", "PM": "/microbiology was INTESTINAL MICROORGANISMS 1963-67", "HN": "/microbiology was INTESTINAL MICROORGANISMS 1963-67", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007422"}, {"RECTYPE": "D", "MH": "Intra-Aortic Balloon Pumping", "DE": "IABP", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Pumping, Intra-Aortic Balloon|T061|NON|EQV|UNK (19XX)|850611|PUMPING INTRA AORTIC BALLOON|abcdefv", "ENTRY": "Pumping, Intraaortic Balloon", "MN": "E04.050.215.400", "MH_TH": "NLM (1977)", "ST": "T061", "PI": "Assisted Circulation (1967-1976)", "MS": "Counterpulsation in which a pumping unit synchronized with the patient's electrocardiogram rapidly fills a balloon in the aorta with helium or carbon dioxide in early diastole and evacuates the balloon at the onset of systole. As the balloon inflates, it raises aortic diastolic pressure, and as it deflates, it lowers aortic systolic pressure. The result is a decrease in left ventricular work and increased myocardial and peripheral perfusion.", "PM": "86; was see under ASSISTED CIRCULATION 1977-85", "HN": "86(77); was see under ASSISTED CIRCULATION 1977-85", "CATSH": "CAT LIST", "MR": "19940125", "DA": "19760413", "DC": "1", "DX": "19860101", "UI": "D007423"}, {"RECTYPE": "D", "MH": "Intracellular Fluid", "AQ": "CH DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Intracellular Fluids", "MN": "A12.207.515", "MH_TH": "NLM (1975)", "ST": "T031", "AN": "do not confuse with INTERSTITIAL FLUID see EXTRACELLULAR FLUID", "MS": "The fluid inside CELLS.", "OL": "search BODY FLUIDS 1966-74", "PM": "91; was see under BODY FLUIDS 1975-90", "HN": "91(75); was see under BODY FLUIDS 1975-90", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007424"}, {"RECTYPE": "D", "MH": "Intracellular Membranes", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Membranes, Intracellular|T026|NON|EQV|UNK (19XX)|780519|abcdef", "ENTRY": "Membrane, Intracellular", "MN": "A11.284.835.514", "FX": "Vesicular Transport Proteins", "MH_TH": "NLM (1979)", "ST": "T026", "PI": "Membranes (1966-1978)", "MS": "Thin structures that encapsulate subcellular structures or ORGANELLES in EUKARYOTIC CELLS. They include a variety of membranes associated with the CELL NUCLEUS; the MITOCHONDRIA; the GOLGI APPARATUS; the ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES.", "PM": "79", "HN": "79", "MR": "20050721", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D007425"}, {"RECTYPE": "D", "MH": "Genes, Intracisternal A-Particle", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Intracisternal A-Particle Genes|T028|NON|EQV|NLM (1992)|910109|abcdef", "ENTRY": "Intracisternal A-Particle Gene", "MN": "G05.360.340.358.840.500.360", "MH_TH": "NLM (1986)", "ST": "T028", "PI": "Retroviridae (1980-1985)", "MS": "Genes of IAP elements (a family of retrovirus-like genetic elements) which code for virus-like particles (IAPs) found regularly in rodent early embryos. (\"Intracisternal\" refers to the cisternae of the endoplasmic reticulum.) Under certain circumstances, such as DNA hypomethylation they are transcribed. Their transcripts are found in a variety of neoplasms, including plasmacytomas, neuroblastoma, rhabdomyosarcomas, teratocarcinomas, and colon carcinomas.", "OL": "use GENES, INTRACISTERNAL A-PARTICLE to search INTRACISTERNAL A-PARTICLE GENES 1986-91", "PM": "92; was INTRACISTERNAL A-PARTICLE GENES 1986-91 (see under PROTO-ONCOGENES 1986-90)", "HN": "92; was INTRACISTERNAL A-PARTICLE GENES 1986-91 (see under PROTO-ONCOGENES 1986-90)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19850311", "DC": "1", "DX": "19910101", "UI": "D007426"}, {"RECTYPE": "D", "MH": "Intracranial Pressure", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Subarachnoid Pressure|T042|NON|EQV|UNK (19XX)|880412|abcdef", "ENTRY": "Subarachnoid Pressures", "MN": "G11.561.170.505", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "INTRACRANIAL HYPOTENSION & INTRACRANIAL HYPERTENSION are also available", "MS": "Pressure within the cranial cavity. It is influenced by brain mass, the circulatory system, CSF dynamics, and skull rigidity.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007427"}, {"RECTYPE": "D", "MH": "Intradermal Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Prausnitz-Kustner Test|T060|EPO|NRW|UNK (19XX)|790530|abcdef", "ENTRY": "Tests, Passive Transfer", "MN": "E05.478.594.890.300", "MH_TH": "NLM (1975)", "ST": "T060", "AN": "NIM", "MS": "Skin tests in which the sensitizer is injected.", "OL": "search SKIN TESTS 1966-74", "PM": "91; was see under SKIN TESTS 1975-90", "HN": "91(75); was see under SKIN TESTS 1975-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007428"}, {"RECTYPE": "D", "MH": "Intraocular Pressure", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Ocular Tension|T042|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Tensions, Ocular", "MN": "G14.440", "FX": "Tonometry, Ocular", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "OCULAR HYPERTENSION & OCULAR HYPOTENSION are also available", "MS": "The pressure of the fluids in the eye.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007429"}, {"RECTYPE": "D", "MH": "Intraoperative Care", "DE": "INTRAOP CARE", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Care, Intraoperative", "MN": "N02.421.585.722.400", "MH_TH": "NLM (1980)", "ST": "T058", "MS": "Patient care procedures performed during the operation that are ancillary to the actual surgery. It includes monitoring, fluid therapy, medication, transfusion, anesthesia, radiography, and laboratory tests.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20190226", "DA": "19790312", "DC": "1", "DX": "19800101", "UI": "D007430"}, {"RECTYPE": "D", "MH": "Intraoperative Complications", "DE": "INTRAOP COMPL", "AQ": "BL CF CI CL DG DH DI DT EC EN EP ET IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Surgical Injuries|T037|T046|NON|REL|NLM (1996)|950103|SURG INJ|abbcdefv", "ENTRY": "Surgical Injury", "MN": "C23.550.505", "MH_TH": "NLM (1980)", "ST": "T046", "AN": "few qualif apply; IM; coord with Cat E4 term (IM) if pertinent with or without /adv eff depending on its relation to the intraop compl: for policy apply principles of POSTOPERATIVE COMPLICATIONS, Manual 23.18+; for iatrogenic compl (as entry term SURGICAL INJURIES) or other: TN 179", "MS": "Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19790312", "DC": "1", "DX": "19800101", "UI": "D007431"}, {"RECTYPE": "D", "MH": "Intraoperative Period", "DE": "INTRAOP PERIOD", "ENTRY": "Periods, Intraoperative", "MN": "N02.421.585.753.374", "MH_TH": "NLM (1980)", "ST": "T079", "AN": "usually NIM", "MS": "The period during a surgical operation.", "PM": "91; was see under SURGERY, OPERATIVE 1980-90", "HN": "91(80); was see under SURGERY, OPERATIVE 1980-90", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19790312", "DC": "1", "DX": "19910101", "UI": "D007432"}, {"RECTYPE": "D", "MH": "Intrauterine Device Expulsion", "AQ": "AE DE ET RE TD", "ENTRY": "Intrauterine Device Expulsions", "MN": "E05.325.578.500", "MH_TH": "NLM (1975)", "ST": "T067", "PI": "Intrauterine Devices (1967-1974)", "MS": "Spontaneous loss of INTRAUTERINE DEVICES from the UTERUS.", "PM": "78; was see under INTRAUTERINE DEVICES 1975-77", "HN": "78(75); was see under INTRAUTERINE DEVICES 1975-77", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19741119", "DC": "1", "DX": "19780101", "UI": "D007433"}, {"RECTYPE": "D", "MH": "Intrauterine Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Contraceptive Devices, Intrauterine|T074|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Unmedicated IUD", "MN": "E07.190.250.510", "MH_TH": "NLM (1967)", "ST": "T074", "PI": "Contraceptive Devices (1966)", "MS": "Contraceptive devices placed high in the uterine fundus.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007434"}, {"RECTYPE": "D", "MH": "Intrauterine Devices, Copper", "DE": "IUD COPPER", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Intrauterine Device, Copper", "MN": "E07.190.250.510.520.300", "MH_TH": "NLM (1978)", "ST": "T074", "AN": "pregn despite use: see note under INTRAUTERINE DEVICES", "PI": "Intrauterine Devices, Medicated (1975-1977)", "MS": "Intrauterine contraceptive devices that depend on the release of metallic copper.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D007435"}, {"RECTYPE": "D", "MH": "Intrauterine Devices, Medicated", "DE": "IUD MEDICATED", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Progesterone-Releasing Intrauterine Devices", "MN": "E07.190.250.510.520", "MH_TH": "NLM (1975)", "ST": "T074", "AN": "\"IUDs that release contraceptive agents\"; coord IM with specific contraceptive agent (IM); pregn despite use: see note on INTRAUTERINE DEVICES", "PI": "Intrauterine Devices (1967-1974)", "MS": "Intrauterine devices that release contraceptive agents.", "PM": "79; was see under INTRAUTERINE DEVICES 1975-78", "HN": "79(75); was see under INTRAUTERINE DEVICES 1975-78", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19741119", "DC": "1", "DX": "19790101", "UI": "D007436"}, {"RECTYPE": "D", "MH": "Intrinsic Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Factor, Intrinsic", "MN": "D12.776.395.560.494", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "9008-12-2", "MS": "A glycoprotein secreted by the cells of the GASTRIC GLANDS that is required for the absorption of VITAMIN B 12 (cyanocobalamin). Deficiency of intrinsic factor leads to VITAMIN B 12 DEFICIENCY and ANEMIA, PERNICIOUS.", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007437"}, {"RECTYPE": "D", "MH": "Introns", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Intervening Sequences|T114|T123|NON|EQV|UNK (19XX)|860618|INTERVENING SEQ|abbcdefv", "ENTRY": "Sequence, Intervening", "MN": "G05.360.340.024.340.137.515", "MH_TH": "NLM (1987)", "ST": "T123", "PI": "Genes, Structural (1977-1986)", "MS": "Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes.", "OL": "use BASE SEQUENCE to search INTRONS & INTERVENING SEQUENCES 1981-86", "PM": "87; INTERVENING SEQUENCES & INTRONS were see BASE SEQUENCE 1981-86", "HN": "87; INTERVENING SEQUENCES & INTRONS were see BASE SEQUENCE 1981-86", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D007438"}, {"RECTYPE": "D", "MH": "Introversion, Psychological", "PRINT ENTRY": "Introversion, Psychology|T041|NON|EQV|NLM (2020)|190118|abcdef", "ENTRY": "Psychology Introversion", "MN": "F02.739.794.438", "MH_TH": "NLM (2020)", "ST": "T041", "PI": "Personality (1966-1967)", "MS": "A state in which attention is largely directed inward upon one's self.", "PM": "2020; was INTROVERSION (PSYCHOLOGY) 1968-2019", "HN": "2020 (1968); was INTROVERSION (PSYCHOLOGY) 1968-2019", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007439"}, {"RECTYPE": "D", "MH": "Intubation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Intubations", "MN": "E05.497", "FX": "Chest Tubes", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Introduction of a tube into a hollow organ to restore or maintain patency if obstructed. It is differentiated from CATHETERIZATION in that the insertion of a catheter is usually performed for the introducing or withdrawing of fluids from the body.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007440"}, {"RECTYPE": "D", "MH": "Intubation, Gastrointestinal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Intubation, Nasogastric|T061|NON|NRW|NLM (1993)|911003|abcdef", "ENTRY": "Nasogastric Intubations", "MN": "E05.497.412", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "for intubation in disease, coordinate with disease /ther, not /surg; esophageal intubation & esophageal obturator airway do not go here: see note on INTUBATION", "MS": "The insertion of a tube into the stomach, intestines, or other portion of the gastrointestinal tract to allow for the passage of food products, etc.", "PM": "66; DUODENAL INTUBATION was heading 1963-65", "HN": "66; DUODENAL INTUBATION was heading 1963-65", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007441"}, {"RECTYPE": "D", "MH": "Intubation, Intratracheal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Intubation, Endotracheal|T061|NON|EQV|UNK (19XX)|870323|abcdef", "ENTRY": "Intubations, Intratracheal", "MN": "E05.497.578", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "for intubation in disease, coordinate with disease / ther, not / surg", "MS": "A procedure involving placement of a tube into the trachea through the mouth or nose in order to provide a patient with oxygen and anesthesia.", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007442"}, {"RECTYPE": "D", "MH": "Intussusception", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Invagination, Intestinal|T020|T047|NON|EQV|NLM (1998)|960730|abbcdef", "ENTRY": "Invaginations, Intestinal", "MN": "C06.405.469.531.577", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "A form of intestinal obstruction caused by the PROLAPSE of a part of the intestine into the adjoining intestinal lumen. There are four types: colic, involving segments of the LARGE INTESTINE; enteric, involving only the SMALL INTESTINE; ileocecal, in which the ILEOCECAL VALVE prolapses into the CECUM, drawing the ILEUM along with it; and ileocolic, in which the ileum prolapses through the ileocecal valve into the COLON.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007443"}, {"RECTYPE": "D", "MH": "Inulin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D09.698.365.855.750", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "Inulin", "RN": "9005-80-5", "AN": "do not confuse with INSULIN", "MS": "A starch found in the tubers and roots of many plants. Since it is hydrolyzable to FRUCTOSE, it is classified as a fructosan. It has been used in physiologic investigation for determination of the rate of glomerular function.", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007444"}, {"RECTYPE": "D", "MH": "Inventories, Hospital", "DE": "INVENTORIES HOSP", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Hospital Inventories|T081|NON|EQV|NLM (1995)|940527|HOSP INVENTORIES|abcdefv", "ENTRY": "Inventory, Hospital|T081|NON|EQV|NLM (1995)|940527|INVENTORY HOSP|abcdefv", "MN": "N04.452.442.452.650.300", "MH_TH": "NLM (1978)", "ST": "T081", "MS": "Materials and equipment in stock; includes drugs in pharmacies, blood in blood banks, etc.", "PM": "91; was see under MATERIALS MANAGEMENT, HOSPITAL 1978-90", "HN": "91(78); was see under MATERIALS MANAGEMENT, HOSPITAL 1978-90", "MR": "20190709", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D007445"}, {"RECTYPE": "D", "MH": "Chromosome Inversion", "AQ": "CI CL DE EM GE RE SN VE", "PRINT ENTRY": "Inversion, Chromosome|T049|NON|EQV|NLM (2005)|040318|abcdef", "ENTRY": "Inversions, Chromosome", "MN": "G05.558.805.500", "MH_TH": "NLM (2005)", "ST": "T049", "PI": "Chromosome Abnormalities (1966-1967)", "MS": "An aberration in which a chromosomal segment is deleted and reinserted in the same place but turned 180 degrees from its original orientation, so that the gene sequence for the segment is reversed with respect to that of the rest of the chromosome.", "PM": "2005; see INVERSION, CHROMOSOME 2005-2009, see INVERSION (GENETICS) 1978-2004, see CHROMOSOME ABERRATIONS 1969-1977", "HN": "2010 (1969)", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D007446"}, {"RECTYPE": "D", "MH": "Invertebrate Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hormones, Invertebrate|T125|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "D06.472.445", "MH_TH": "NLM (1967)", "ST": "T125", "RN": "0", "AN": "coord IM with specific invertebrate (IM)", "PI": "Insects (1966)", "MS": "Hormones produced by invertebrates, usually insects, mollusks, annelids, and helminths.", "PM": "67", "HN": "67", "MR": "19950317", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007447"}, {"RECTYPE": "D", "MH": "Invertebrates", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Mesozoa|T204|NON|NRW|UNK (19XX)|850322|abcdef", "ENTRY": "Mesozoas", "MN": "B01.050.500", "MH_TH": "NLM (1966)", "ST": "T204", "RR": "txid7568", "AN": "general; prefer specific classes, orders, families, & genera", "MS": "Animals that have no spinal column.", "OL": "pre-explosion - INVERTEBRATES (PX)", "PM": "BRACHIOPODA was heading 1963-85; MESOZOA was heading 1977-85", "HN": "BRACHIOPODA was heading 1963-85; MESOZOA was heading 1977-85", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007448"}, {"RECTYPE": "D", "MH": "Investments", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Investment", "MN": "N03.219.702", "MH_TH": "POPLINE (1986)", "ST": "T073", "MS": "Use for articles on the investing of funds for income or profit.", "PM": "68", "HN": "68(64)", "MR": "19930916", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007449"}, {"RECTYPE": "D", "MH": "Iodamide", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Uromiro|T109|T130|TRD|NRW|UNK (19XX)|810318|abbcdef", "MN": "D02.455.426.559.389.127.375.880.375", "PA": "Contrast Media", "MH_TH": "USAN (1968)", "ST": "T130", "N1": "Benzoic acid, 3-(acetylamino)-5-((acetylamino)methyl)-2,4,6-triiodo-", "RN": "4RII332O0R", "RR": "CRK52426X3", "PI": "Iodobenzoates (1974)", "MS": "An ionic monomeric contrast medium. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)", "PM": "91; was see under IODOBENZOATES 1975-90", "HN": "91(75); was see under IODOBENZOATES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007451"}, {"RECTYPE": "D", "MH": "Iodates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Iodate|T197|NON|EQV|NLM (2021)|200210|abcdef", "MN": "D01.475.400", "MH_TH": "NLM (1971)", "ST": "T197", "RN": "0", "AN": "salts of iodic acid", "PI": "Iodine (1966-1970)", "MS": "Inorganic salts of iodic acid (HIO3).", "PM": "91; was see under IODINE 1971-90", "HN": "91(71); was see under IODINE 1971-90", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007452"}, {"RECTYPE": "D", "MH": "Iodide Peroxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thyroxine 5'-Monodeiodinase|T116|T126|NON|REL|UNK (19XX)|880602|THYROXINE MONODEIODINASE 05|abbcdefs", "ENTRY": "Triiodothyronine 5'-Deiodinase, Reverse", "MN": "D08.811.682.732.525", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "Iodide:hydrogen-peroxide oxidoreductase", "RN": "EC 1.11.1.8", "AN": "/defic: consider also MONOIODOTYROSINE /metab (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) + CONGENITAL HYPOTHYROIDISM", "PI": "Peroxidases (1973-1975)", "MS": "A hemeprotein that catalyzes the oxidation of the iodide radical to iodine with the subsequent iodination of many organic compounds, particularly proteins. EC 1.11.1.8.", "PM": "86; was see under PEROXIDASES 1976-85", "HN": "86(76); was see under PEROXIDASES 1976-85", "MR": "20050701", "DA": "19750718", "DC": "1", "DX": "19860101", "UI": "D007453"}, {"RECTYPE": "D", "MH": "Iodides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Iodide|T197|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D01.475.410", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "inorganic cpds or iodide ion only", "MS": "Inorganic binary compounds of iodine or the I- ion.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007454"}, {"RECTYPE": "D", "MH": "Iodine", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Iodine 127", "MN": "D01.268.380.400", "PA": "Trace Elements", "FX": "Iodine Radioisotopes", "MH_TH": "USP (19XX)", "ST": "T196", "N1": "Iodine", "RN": "9679TC07X4", "RR": "7553-56-2 (Iodine)", "MS": "A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007455"}, {"RECTYPE": "D", "MH": "Iodine Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Iodine", "MN": "D01.496.448", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable iodine atoms that have the same atomic number as the element iodine, but differ in atomic weight. I-127 is the only naturally occurring stable iodine isotope.", "OL": "search IODINE ISOTOPES, DIAGNOSTIC under IODINE RADIOISOTOPES /DU 1966-76", "PM": "/diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65", "HN": "/diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D007456"}, {"RECTYPE": "D", "MH": "Iodine Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Iodine", "MN": "D01.496.749.474", "MH_TH": "NLM (1974)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "MS": "Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes.", "OL": "search IODINE ISOTOPES 1966-73; search IODINE ISOTOPES, DIAGNOSTIC under IODINE RADIOISOTOPES /DU 1966-76", "PM": "74; /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65", "HN": "74; /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007457"}, {"RECTYPE": "D", "MH": "Iodipamide", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Adipiodon|T109|T130|NON|EQV|UNK (19XX)|760324|abbcdef", "ENTRY": "Endographin|T109|T130|TRD|NRW|UNK (19XX)|810210|abbcdef", "MN": "D02.455.426.559.389.127.375.880.380", "PA": "Contrast Media", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "Benzoic acid, 3,3'-((1,6-dioxo-1,6-hexanediyl)diimino)bis(2,4,6-triiodo)-", "RN": "TKQ858A3VW", "RR": "606-17-7 (Iodipamide)", "MS": "A water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007458"}, {"RECTYPE": "D", "MH": "Iodized Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Oil, Iodized|T109|T130|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Oils, Iodized", "MN": "D20.215.784.750.550", "PA": "Contrast Media", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "Fats and Glyceridic oils, vegetable, iodinated", "RN": "8001-40-9", "MS": "A preparation of oil that contains covalently bound IODINE. It is commonly used as a RADIOCONTRAST AGENT and as a suspension medium for CHEMOTHERAPEUTIC AGENTS.", "OL": "use IODIZED OIL to search IODIZED OILS 1966-93 & LIPIODOL 1975-93; use IODIZED OIL (NM) to search IODOLIPOL 1980-93", "PM": "94; was IODIZED OILS 1963-93; OIL, IODIZED was OILS, IODIZED 1963-93; LIPIODOL was heading 1975-93 (see under IODIZED OILS 1975-90); IODOLIPOL was indexed under IODIZED OILS 1967-93", "HN": "94; was IODIZED OILS 1963-93; OIL, IODIZED was OILS, IODIZED 1963-93; LIPIODOL was heading 1975-93 (see under IODIZED OILS 1975-90); IODOLIPOL was (NM) 1967-93", "MR": "20140617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007459"}, {"RECTYPE": "D", "MH": "Iodoacetamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.526.581.247.249", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Acetamide, 2-iodo-", "RN": "ZRH8M27S79", "RR": "144-48-9 (Iodoacetamide)", "PI": "Iodoacetates (1969-1974)", "MS": "An alkylating sulfhydryl reagent. Its actions are similar to those of iodoacetate.", "PM": "91; was see under IODOACETATES 1975-90", "HN": "91(75); was see under IODOACETATES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007460"}, {"RECTYPE": "D", "MH": "Iodoacetates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Iodoacetic", "MN": "D02.455.526.581.247", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Iodinated derivatives of acetic acid. Iodoacetates are commonly used as alkylating sulfhydryl reagents and enzyme inhibitors in biochemical research.", "PM": "63; SODIUM IODOACETATE was indexed under IODOACETATES 1988-98; IODOACETATE was indexed under IODOACETATES 1980-98", "HN": "63; for SODIUM IODOACETATE use IODOACETATES (NM) 1988-98; for IODOACETATE use IODOACETATES (NM) 1980-98", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D007461"}, {"RECTYPE": "D", "MH": "Iodobenzenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.526.581.496", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Benzene Derivatives (1968-1971)", "MS": "Any derivative of BENZENE that contains IODINE.", "PM": "73", "HN": "73(72)", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007462"}, {"RECTYPE": "D", "MH": "Iodobenzoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Iodobenzoic", "MN": "D02.455.426.559.389.127.375", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Benzoates (1966-1971)", "MS": "Benzoic acid esters or salts substituted with one or more iodine atoms.", "PM": "74", "HN": "74(72)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007463"}, {"RECTYPE": "D", "MH": "Clioquinol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Iodochloroxyquinoline|T109|T121|NON|EQV|UNK (19XX)|770317|abbcdef", "ENTRY": "EnteroVioform", "MN": "D03.633.100.810.350.625.400", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "8-Quinolinol, 5-chloro-7-iodo-", "RN": "7BHQ856EJ5", "RR": "130-26-7 (Clioquinol)", "MS": "A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.", "OL": "use CLIOQUINOL to search IODOCHLORHYDROXYQUIN 1966-92", "PM": "93; was IODOCHLORHYDROXYQUIN 1963-92 (see under HYDROXYQUINOLINES 1983-90); CLIOQUINOL was see IODOCHLORHYDROXYQUIN 1976-92", "HN": "93; was IODOCHLORHYDROXYQUIN 1963-92 (see under HYDROXYQUINOLINES 1983-90); CLIOQUINOL was see IODOCHLORHYDROXYQUIN 1976-92", "MR": "20160528", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D007464"}, {"RECTYPE": "D", "MH": "Iodohippuric Acid", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sodium Iodohippurate|T109|T130|NRW|UNK (19XX)|740330|abbdef", "ENTRY": "ortho Iodohippurate", "MN": "D02.455.426.559.389.127.085.460.500", "PA": "Contrast Media", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "Glycine, N-(2-iodobenzoyl)-", "RN": "147-58-0", "RR": "UVJ3W62NGI", "AN": "for radiolabeled cpd coord IM with IODINE RADIOISOTOPES (NIM)", "MS": "An iodine-containing compound used in pyelography as a radiopaque medium. If labeled with radioiodine, it can be used for studies of renal function.", "OL": "use IODOHIPPURIC ACID to search RADIO-HIPPURAN & HIPPURAN 1966-77", "PM": "66; HIPPURAN was see under IODOHIPPURIC ACID 1975-77, was see under IODOHIPPURIC ACID 1966-74, was see under CONTRAST MEDIA 1963-65", "HN": "66; RADIO-HIPPURAN was see under IUDOHIPPURIC ACID 1966-77; HIPPURAN was see IODOHIPPURIC ACID 1975-77, was see under IODOHIPPURIC ACID 1966-74, was see under CONTRAST MEDIA 1963-65", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007465"}, {"RECTYPE": "D", "MH": "Iodophors", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Iodine, Tamed", "MN": "D01.475.557", "PA": "Surface-Active Agents", "FX": "Anti-Infective Agents, Local", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Iodine (1971-1974)", "MS": "Complexes of iodine and non-ionic SURFACE-ACTIVE AGENTS acting as carrier and solubilizing agent for the iodine in water. Iodophors usually enhance bactericidal activity of iodine, reduce vapor pressure and odor, minimize staining, and allow wide dilution with water. (From Merck Index, 11th ed)", "PM": "91; was see under IODINE 1975-90", "HN": "91(75); was see under IODINE 1975-90", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007466"}, {"RECTYPE": "D", "MH": "Iodoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Iodopeptides|T116|NON|NRW|UNK (19XX)|810427|abcdef", "MN": "D12.776.486", "FX": "Serum Albumin, Radio-Iodinated", "MH_TH": "NLM (1968)", "ST": "T116", "RN": "0", "PI": "Proteins (1966-1967)", "PM": "72", "HN": "72(68)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D007467"}, {"RECTYPE": "D", "MH": "Iodopyracet", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Diodone|T109|T130|NON|EQV|FDA SRS (2014)|INN (19XX)|741223|abbcdeef", "ENTRY": "Kardiotrast|T109|T130|NON|EQV|NLM (1990)|890607|abbcdef", "MN": "D03.383.725.791.496.371", "PA": "Contrast Media", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "1(4H)-Pyridineacetic acid, 3,5-diiodo-4-oxo-, compd. with 2,2'-iminobis(ethanol) (1:1)", "RN": "ZTK4026YJ5", "RR": "300-37-8 (Iodopyracet)", "MS": "An ionic monomeric contrast medium that was formerly used for a variety of diagnostic procedures. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007468"}, {"RECTYPE": "D", "MH": "Iodopyridones", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D03.383.725.791.496", "MH_TH": "NLM (1968)", "ST": "T130", "RN": "0", "PI": "Contrast Media (1966-1967)", "MS": "Iodinated pyridine derivatives that are often used as contrast media.", "PM": "68; PROPYLIODONE was see under CONTRAST MEDIA 1963-74", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007469"}, {"RECTYPE": "D", "MH": "Monoiodotyrosine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Iodotyrosine|T116|T123|NON|EQV|NLM (1968)|990101|abbcdef", "MN": "D12.125.072.050.875.496", "MH_TH": "UNK (19XX)", "ST": "T123", "N1": "L-Tyrosine, iodo-", "RN": "FRQ98U4U27", "RR": "29592-76-5 (Monoiodotyrosine)", "PI": "Tyrosine (1966-1967)", "MS": "A product from the iodination of tyrosine. In the biosynthesis of thyroid hormones (THYROXINE and TRIIODOTHYRONINE), tyrosine is first iodized to monoiodotyrosine.", "PM": "72", "HN": "72(68)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D007470"}, {"RECTYPE": "D", "MH": "Ioglycamic Acid", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Ioglycamide|T109|T130|NON|REL|UNK (19XX)|741111|abbcdef", "ENTRY": "Acid, Ioglycamic", "MN": "D02.455.426.559.389.127.375.880.390", "PA": "Contrast Media", "MH_TH": "USAN (1964)", "ST": "T130", "N1": "Benzoic acid, 3,3'-(oxybis((1-oxo-2,1-ethanediyl)imino))bis(2,4,6-triiodo)-", "RN": "ET36GPP4T7", "RR": "2618-25-9 (Ioglycamic Acid)", "AN": "D25-26 qualif", "PI": "Iodobenzoates (1974)", "MS": "A radiopaque medium. It is a mixture of its meglumine and sodium salts and is used to visualize the biliary tract.", "PM": "91; was see under IODOBENZOATES 1975-90", "HN": "91(75); was see under IODOBENZOATES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007471"}, {"RECTYPE": "D", "MH": "Iohexol", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Omnipaque|T109|T130|TRD|NRW|UNK (19XX)|860603|abbcdef", "MN": "D02.455.426.559.389.127.375.880.400", "PA": "Contrast Media", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "1,3-Benzenedicarboxamide, 5-(acetyl(2,3-dihydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-", "RN": "4419T9MX03", "RR": "66108-95-0 (Iohexol)", "PI": "Triiodobenzoic Acids (1972-1986)", "MS": "An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.", "PM": "87", "HN": "87", "MR": "20130708", "DA": "19860603", "DC": "1", "DX": "19870101", "UI": "D007472"}, {"RECTYPE": "D", "MH": "Ion Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Membrane Channels|T116|T123|NON|EQV|UNK (19XX)|780519|abbcdef", "ENTRY": "Channels, Membrane", "MN": "D12.776.543.585.400", "FX": "Ion Pumps", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics; coordinate IM with specific ion / metab (IM)", "PI": "Membrane Potentials (1967-1978)", "MS": "Gated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS.", "PM": "79", "HN": "79", "MR": "20160701", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D007473"}, {"RECTYPE": "D", "MH": "Ion Exchange", "ENTRY": "Exchange, Ion", "MN": "G02.437", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "usually NIM; do not confuse with ION TRANSPORT", "MS": "Reversible chemical reaction between a solid, often one of the ION EXCHANGE RESINS, and a fluid whereby ions may be exchanged from one substance to another. This technique is used in water purification, in research, and in industry.", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007474"}, {"RECTYPE": "D", "MH": "Ion Exchange Resins", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Ion Exchange Resin|T122|T130|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Resins, Ion Exchange", "MN": "D27.720.470.420", "FX": "Chromatography, Ion Exchange", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "MS": "High molecular weight, insoluble polymers which contain functional groups that are capable of undergoing exchange reactions (ION EXCHANGE) with either cations or anions.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007475"}, {"RECTYPE": "D", "MH": "Ionophores", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ionophore|T121|NON|EQV|NLM (2021)|200210|abcdef", "MN": "D27.720.395", "FX": "Cell Membrane Permeability", "MH_TH": "NLM (1976)", "ST": "T121", "RN": "0", "PI": "Uncoupling Agents (1972-1975)", "MS": "Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes.", "PM": "76", "HN": "76", "MR": "20200527", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D007476"}, {"RECTYPE": "D", "MH": "Ions", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D01.248.497", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "AN": "general or unspecified; prefer specifics; ionization chamber: index under RADIOMETRY /instrum", "MS": "An atom or group of atoms that have a positive or negative electric charge due to a gain (negative charge) or loss (positive charge) of one or more electrons. Atoms with a positive charge are known as CATIONS; those with a negative charge are ANIONS.", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007477"}, {"RECTYPE": "D", "MH": "Iontophoresis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Iontophoreses", "MN": "E05.301.300.575", "MH_TH": "NLM (1966)", "ST": "T062", "MS": "Therapeutic introduction of ions of soluble salts into tissues by means of electric current. In medical literature it is commonly used to indicate the process of increasing the penetration of drugs into surface tissues by the application of electric current. It has nothing to do with ION EXCHANGE; AIR IONIZATION nor PHONOPHORESIS, none of which requires current.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007478"}, {"RECTYPE": "D", "MH": "Iopamidol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "B15000", "MN": "D02.455.426.559.389.127.375.880.410", "PA": "Contrast Media", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "1,3-Benzenedicarboxamide, N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-((2-hydroxy-1-oxopropyl)amino)-2,4,6-triiodo-", "RN": "JR13W81H44", "RR": "88375-91-1 ((R)-isomer)", "PI": "Iothalamic Acid/analogs & derivatives (1975-1986)", "MS": "A non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures.", "PM": "87", "HN": "87", "MR": "20130708", "DA": "19860602", "DC": "1", "DX": "19870101", "UI": "D007479"}, {"RECTYPE": "D", "MH": "Iopanoic Acid", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Iodopanoic Acid|T109|T130|NON|EQV|UNK (19XX)|770317|abbcdef", "ENTRY": "Acid, Iopanoic", "MN": "D02.455.526.581.496.385", "PA": "Contrast Media", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "Benzenepropanoic acid, 3-amino-alpha-ethyl-2,4,6-triiodo-", "RN": "FE9794P71J", "RR": "96-83-3 (Iopanoic Acid)", "MS": "Radiopaque medium used as diagnostic aid.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007480"}, {"RECTYPE": "D", "MH": "Iophendylate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Pantopaque|T109|T130|TRD|NRW|UNK (19XX)|810318|abbcdef", "MN": "D02.455.526.581.496.400", "PA": "Contrast Media", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "Benzenedecanoic acid, 4-iodo-iota-methyl-, ethyl ester", "RN": "99-79-6", "RR": "V4XU46CRKN", "PI": "Iodobenzenes (1973-1974)", "MS": "An inert iodine-containing agent which is opaque to X-RAYS. It is used mainly for BRAIN and SPINAL CORD visualization.", "PM": "91; was see under IODOBENZENES 1975-90", "HN": "91(75); was see under IODOBENZENES 1975-90", "MR": "20150527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007481"}, {"RECTYPE": "D", "MH": "Iothalamate Meglumine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Meglumine Iothalamate|T109|T130|NON|EQV|BAN (19XX)|810514|abbcdef", "ENTRY": "Methylglucamine, Iothalamic Acid", "MN": "D09.853.813.550.600", "PA": "Contrast Media", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "D-Glucitol, 1-deoxy-1-(methylamino)-, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate (salt)", "RN": "XUW72GOP7W", "RR": "13087-53-1 (Iothalamate Meglumine)", "PI": "Sorbitol (1966-1977)", "MS": "A radiopaque medium used for urography, angiography, venography, and myelography. It is highly viscous and binds to plasma proteins.", "OL": "use IOTHALAMATE MEGLUMINE to search MEGLUMINE IOTHALAMATE 1975-81", "PM": "82; was MEGLUMINE IOTHALAMATE 1978-81, was MEGLUMINE IOTHALAMATE see under IOTHALAMIC ACID 1975-77", "HN": "82; was MEGLUMINE IOTHALAMATE 1978-81, was MEGLUMINE IOTHALAMATE see under IOTHALAMIC ACID 1975-77", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19780101", "UI": "D007482"}, {"RECTYPE": "D", "MH": "Iothalamic Acid", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Methalamic Acid|T109|T130|NON|EQV|UNK (19XX)|770317|abbcdef", "ENTRY": "Iothalamate, Sodium", "MN": "D02.455.426.559.389.127.375.880.430", "PA": "Contrast Media", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)-", "RN": "16CHD79MIX", "RR": "KDN276D83N", "MS": "A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts.", "PM": "66", "HN": "66(63)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007483"}, {"RECTYPE": "D", "MH": "Iowa", "AQ": "EH EP", "MN": "Z01.107.567.875.510.370", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Minnesota, on the east by Wisconsin and Illinois, on the south by Missouri, and on the west by Nebraska and South Dakota.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007484"}, {"RECTYPE": "D", "MH": "Ioxaglic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ioxaglate Sodium|T109|T130|NON|NRW|FDA SRS (2014)|USAN (1982)|860616|abbcdeef", "ENTRY": "Meglumine, Ioxaglate", "MN": "D02.455.426.559.389.127.375.880.450", "PA": "Contrast Media", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "Benzoic acid, 3-((((3-(acetylmethylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoyl)amino)acetyl)amino)-5-(((2-hydroxyethyl)amino)carbonyl)-2,4,6-triiodo-", "RN": "Z40X7EI2AF", "RR": "HQ43CN02U9", "PI": "Triiodobenzoic Acids (1972-1986)", "MS": "A low-osmolar, ionic contrast medium used in various radiographic procedures.", "PM": "87; IOXAGLATE MEGLUMINE was IOXAGLATE, MEGLUMINE 1987-93; IOXAGLATE SODIUM was IOXAGLATE, SODIUM 1987-93", "HN": "87; IOXAGLATE MEGLUMINE was IOXAGLATE, MEGLUMINE 1987-93; IOXAGLATE SODIUM was IOXAGLATE, SODIUM 1987-93", "MR": "20160610", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D007485"}, {"RECTYPE": "D", "MH": "Ipecac", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Syrup of Ipecac|T109|T121|NON|EQV|NLM (1999)|971218|abbcdef", "ENTRY": "Ipecac Syrup", "MN": "D20.215.784.500.450", "PA": "Emetics", "FX": "Emetine", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Ipecac", "RN": "8012-96-2", "MS": "A syrup made from the dried rhizomes of two different species, CEPHAELIS ipecacuanha and C. acuminata. They contain EMETINE, cephaeline, psychotrine and other ISOQUINOLINES. Ipecac syrup is used widely as an emetic acting both locally on the gastric mucosa and centrally on the chemoreceptor trigger zone.", "PM": "99; see IPECAC (SYRUP) 1995-98; see IPECAC 1963-94", "HN": "99(63)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D007486"}, {"RECTYPE": "D", "MH": "Ipodate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sodium Ipodate|T109|T130|NON|NRW|BAN (19XX)|FDA SRS (2014)|INN (19XX)|770317|abbcdeeef", "ENTRY": "Solu Biloptin", "MN": "D02.455.526.581.496.450", "PA": "Contrast Media", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "F604ZKI910", "RR": "F316LLW9WW", "MS": "Ionic monomeric contrast media. Usually the sodium or calcium salts are used for examination of the gall bladder and biliary tract. (From Martindale, The Extra Pharmacopoeia, 30th ed, p704)", "MR": "20180521", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007487"}, {"RECTYPE": "D", "MH": "Iprindole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.473.469", "PA": "Antidepressive Agents, Tricyclic", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "5H-Cyclooct(b)indole-5-propanamine, 6,7,8,9,10,11-hexahydro-N,N-dimethyl-", "RN": "69U0IKR8FP", "RR": "5560-72-5 (Iprindole)", "PI": "Indoles (1966-1971)", "MS": "A tricyclic antidepressant that has actions and uses similar to those of AMITRIPTYLINE, but has only weak antimuscarinic and sedative effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p257)", "PM": "91; was see under INDOLES 1972-90", "HN": "91(72); was see under INDOLES 1972-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007488"}, {"RECTYPE": "D", "MH": "Iproniazid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Iprazid|T109|T121|NON|EQV|UNK (19XX)|830223|abbcdef", "MN": "D03.383.725.394.414", "PA": "Monoamine Oxidase Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "4-Pyridinecarboxylic acid, 2-(1-methylethyl)hydrazide", "RN": "D892HFI3XA", "RR": "54-92-2 (Iproniazid)", "MS": "An irreversible inhibitor of monoamine oxidase types A and B that is used as an antidepressive agent. It has also been used as an antitubercular agent, but its use is limited by its toxicity.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007490"}, {"RECTYPE": "D", "MH": "Ipronidazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.308.658.400", "PA": "Antiprotozoal Agents", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "1H-Imidazole, 1-methyl-2-(1-methylethyl)-5-nitro-", "RN": "045BU63E23", "RR": "14885-29-1 (Ipronidazole)", "PI": "Nitroimidazoles (1974)", "MS": "An antihistomonal agent with low toxicity. It also promotes growth and feed utilization in poultry.", "PM": "91; was see under NITROIMIDAZOLES 1975-90", "HN": "91(75); was see under NITROIMIDAZOLES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007491"}, {"RECTYPE": "D", "MH": "Iran", "AQ": "EH EP", "ENTRY": "Islamic Republic of Iran|T083|NON|EQV|NLM (2018)|171204|abcdef", "MN": "Z01.252.245.500.350", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. The capital is Tehran.", "MR": "20171204", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007492"}, {"RECTYPE": "D", "MH": "Iraq", "AQ": "EH EP", "ENTRY": "Republic of Iraq|T083|NON|EQV|NLM (2018)|161222|abcdef", "MN": "Z01.252.245.500.360", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country bordering the Persian Gulf, between Iran and Kuwait. The capital is Baghdad.", "MR": "20161222", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007493"}, {"RECTYPE": "D", "MH": "Ireland", "AQ": "EH EP", "PRINT ENTRY": "Irish Free State|T083|NAM|EQV|NLM (1994)|920911|abcdef", "MN": "Z01.639.587", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "differentiate from NORTHERN IRELAND", "MS": "A country in western Europe, occupying five-sixths of the island of Ireland in the North Atlantic Ocean, west of Great Britain. The capital is Dublin.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007494"}, {"RECTYPE": "D", "MH": "Iridium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.401", "FX": "Iridium Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Iridium", "RN": "44448S9773", "RR": "7439-88-5 (Iridium)", "MS": "A metallic element with the atomic symbol Ir, atomic number 77, and atomic weight 192.22.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007495"}, {"RECTYPE": "D", "MH": "Iridium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Iridium", "MN": "D01.496.749.500", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1987)", "MS": "Unstable isotopes of iridium that decay or disintegrate emitting radiation. Ir atoms with atomic weights 182-190, 192, and 194-198 are radioactive iridium isotopes.", "PM": "88", "HN": "88", "MR": "20170707", "DA": "19870408", "DC": "1", "DX": "19880101", "UI": "D007496"}, {"RECTYPE": "D", "MH": "Iridoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Megalocytivirus|T005|NON|NRW|NLM (2007)|050825|abcdef", "ENTRY": "Viruses, Goldfish", "MN": "B04.280.410", "MH_TH": "NLM (1978)", "ST": "T005", "RN": "txid10486", "RR": "txid308906", "AN": "infection in insects: coordinate IM with specific insect /virol (IM); infection in vertebrates: coordinate IM with DNA VIRUS INFECTIONS (IM)", "PI": "Insect Viruses (1966-1977)", "MS": "A family of large icosahedral DNA viruses infecting insects and poikilothermic vertebrates. Genera include IRIDOVIRUS; RANAVIRUS; Chloriridovirus; Megalocytivirus; and Lymphocystivirus.", "PM": "1981; see IRIDOVIRUSES 1978-80; for GOLDFISH VIRUSES see GOLDFISH VIRUS 1-LIKE VIRUSES 1997-2001, see IRIDOVIRIDAE 1994-96, see IRIDOVIRUSES 1978-80", "HN": "1981 (1978)", "MR": "20200902", "DA": "19770504", "DC": "1", "DX": "19780101", "UI": "D007497"}, {"RECTYPE": "D", "MH": "Iris", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A09.371.894.513", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The most anterior portion of the uveal layer, separating the anterior chamber from the posterior. It consists of two layers - the stroma and the pigmented epithelium. Color of the iris depends on the amount of melanin in the stroma on reflection from the pigmented epithelium.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007498"}, {"RECTYPE": "D", "MH": "Iris Diseases", "DE": "IRIS DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Iris Disease", "MN": "C11.941.375", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Uveal Diseases (1966-1980)", "MS": "Diseases, dysfunctions, or disorders of or located in the iris.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19800407", "DC": "1", "DX": "19810101", "UI": "D007499"}, {"RECTYPE": "D", "MH": "Iritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Iritides", "MN": "C11.941.879.780.880.448", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a type of anterior uveitis", "MS": "Inflammation of the iris characterized by circumcorneal injection, aqueous flare, keratotic precipitates, and constricted and sluggish pupil along with discoloration of the iris.", "CATSH": "CAT LIST", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007500"}, {"RECTYPE": "D", "MH": "Iron", "AQ": "AD AE AG AN BL CF CH CL EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Iron 56", "MN": "D01.552.544.412", "PA": "Trace Elements", "FX": "Transferrin", "EC": "deficiency:Iron Deficiencies", "MH_TH": "NLM (1978)", "ST": "T196", "N1": "Iron", "RN": "E1UOL152H7", "RR": "7439-89-6 (Iron)", "MS": "A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN.", "PM": "/metabolism was IRON METABOLISM 1963-65", "HN": "/metabolism was IRON METABOLISM 1963-65", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007501"}, {"RECTYPE": "D", "MH": "Iron Chelating Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Iron Chelates|T121|T130|NON|EQV|NLM (1998)|970320|abbcdef", "ENTRY": "Chelating Agents, Iron", "MN": "D27.720.832.500.410", "FX": "Siderophores", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "MS": "Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems.", "PM": "98; see IRON CHELATES 1963-97", "HN": "98(63)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D007502"}, {"RECTYPE": "D", "MH": "Iron Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Iron", "MN": "D01.552.544.412.500", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable iron atoms that have the same atomic number as the element iron, but differ in atomic weight. Fe-54, 57, and 58 are stable iron isotopes.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007503"}, {"RECTYPE": "D", "MH": "Iron Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Iron", "MN": "D01.552.544.412.500.498", "MH_TH": "NLM (1974)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "MS": "Unstable isotopes of iron that decay or disintegrate emitting radiation. Fe atoms with atomic weights 52, 53, 55, and 59-61 are radioactive iron isotopes.", "OL": "search IRON ISOTOPES 1966-73", "PM": "74", "HN": "74", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007504"}, {"RECTYPE": "D", "MH": "Iron-Dextran Complex", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dextran-Iron Complex|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Iron Dextran Complex", "MN": "D09.698.365.272.400", "PA": "Hematinics", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "9004-66-4", "MS": "A complex of ferric oxyhydroxide with dextrans of 5000 to 7000 daltons in a viscous solution containing 50 mg/ml of iron. It is supplied as a parenteral preparation and is used as a hematinic. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1292)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007505"}, {"RECTYPE": "D", "MH": "Iron-Sulfur Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Iron-Sulfur Protein|T116|T123|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Sulfur Proteins, Iron", "MN": "D12.776.556.579.374.375", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Sulfur (1973-1976)", "MS": "A group of proteins possessing only the iron-sulfur complex as the prosthetic group. These proteins participate in all major pathways of electron transport: photosynthesis, respiration, hydroxylation and bacterial hydrogen and nitrogen fixation.", "PM": "91; was see under METALLOPROTEINS 1977-90", "HN": "91(77); was see under METALLOPROTEINS 1977-90", "MR": "20200527", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D007506"}, {"RECTYPE": "D", "MH": "Therapeutic Irrigation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Lavage|T061|NON|NRW|UNK (19XX)|741126|abcdef", "ENTRY": "Therapeutic Irrigations", "MN": "E05.927", "MH_TH": "NLM (2011)", "ST": "T061", "AN": "IM only as general procedure; NIM for irrigation of specific organ or site; entry term LAVAGE: note several precoordinated lavage terms are also available.", "MS": "The washing of a body cavity or surface by flowing water or solution for therapy or diagnosis.", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007507"}, {"RECTYPE": "D", "MH": "Irritable Mood", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Mood, Irritable|T055|NON|EQV|UNK (19XX)|840411|abcdef", "ENTRY": "Moods, Irritable", "MN": "F01.470.047.110", "MH_TH": "NLM (1985)", "ST": "T055", "MS": "Abnormal or excessive excitability with easily triggered anger, annoyance, or impatience.", "PM": "91; was see under AFFECT 1988-90; was see under EMOTIONS 1985-87", "HN": "91(85); was see under AFFECT 1988-90; was see under EMOTIONS 1985-87", "CATSH": "CAT LIST", "MR": "19920514", "DA": "19840411", "DC": "1", "DX": "19910101", "UI": "D007508"}, {"RECTYPE": "D", "MH": "Irritants", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vesicants|T131|NON|NRW|UNK (19XX)|790430|abcdef", "MN": "D27.888.569.300", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "MS": "Drugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants.", "OL": "use IRRITANTS to search RUBEFACIENTS & VESICANTS 1966-79", "HN": "RUBEFACIENTS & VESICANTS were see under IRRITANTS 1963-79", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007509"}, {"RECTYPE": "D", "MH": "Isatin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "2,3 Dioxoindoline", "MN": "D03.633.100.473.525", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "1H-Indole-2,3-dione", "RN": "82X95S7M06", "RR": "91-56-5 (Isatin)", "AN": "do not confuse with isatan", "MS": "An indole-dione that is obtained by oxidation of indigo blue. It is a MONOAMINE OXIDASE INHIBITOR and high levels have been found in urine of PARKINSONISM patients.", "OL": "search INDOLES 1966-74", "PM": "91; was see under INDOLES 1975-90", "HN": "91(75); was see under INDOLES 1975-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007510"}, {"RECTYPE": "D", "MH": "Ischemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ischemias", "MN": "C23.550.513", "FX": "Reperfusion Injury", "MH_TH": "NLM (1978)", "ST": "T046", "AN": "general or unspecified; prefer specifics; coordinate with specific organ /\u200cblood supply; for prevention and control, consider ISCHEMIC PRECONDITIONING; note ISCHEMIA-REPERFUSION INJURY is available", "MS": "A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007511"}, {"RECTYPE": "D", "MH": "Ischium", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A02.835.232.043.825.548", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "One of three bones that make up the coxal bone of the pelvic girdle. In tetrapods, it is the part of the pelvis that projects backward on the ventral side, and in primates, it bears the weight of the sitting animal.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007512"}, {"RECTYPE": "D", "MH": "Isethionic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxyethylsulfonic Acid|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Isethionate, Sodium", "MN": "D02.886.645.600.055.300", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Ethanesulfonic acid, 2-hydroxy-", "RN": "97J3QN9884", "RR": "57267-78-4 (mono-NH4 salt)", "PI": "Alkyl Sulfonates (1973-1974)", "MS": "A colorless, syrupy, strongly acidic liquid that can form detergents with oleic acid.", "PM": "91; was see under ALKYL SULFONATES 1975-90", "HN": "91(75); was see under ALKYL SULFONATES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007513"}, {"RECTYPE": "D", "MH": "Islam", "AQ": "HI PX", "PRINT ENTRY": "Muslims|T098|NON|REL|UNK (19XX)|750711|abcdef", "ENTRY": "Muslim", "MN": "K01.844.275", "FX": "Arabs", "MH_TH": "POPLINE (1978)", "ST": "T078", "AN": "specify geographic location if pertinent", "MS": "A monotheistic religion promulgated by the Prophet Mohammed with Allah as the deity.", "OL": "use ISLAM to search MOHAMMEDANISM 1966-75", "PM": "76; was MOHAMMEDANISM 1963-75", "HN": "76; was MOHAMMEDANISM 1963-75", "MR": "19991108", "DA": "19750718", "DC": "1", "DX": "19760101", "UI": "D007514"}, {"RECTYPE": "D", "MH": "Islets of Langerhans", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Pancreatic Islets|T023|NON|EQV|NLM (2003)|010822|abcdef", "ENTRY": "Pancreatic Islet", "MN": "A06.300.414", "EC": "transplantation:Islets of Langerhans Transplantation", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN.", "OL": "use ISLETS OF LANGERHANS to search ISLANDS OF LANGERHANS 1966-90", "PM": "91; was ISLANDS OF LANGERHANS 1963-90", "HN": "91; was ISLANDS OF LANGERHANS 1963-90", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007515"}, {"RECTYPE": "D", "MH": "Adenoma, Islet Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Pancreatic Islet Cell Tumors|T191|NON|BRD|ORD (2010)|200309|abcdef", "ENTRY": "Tumors, Islet Cell", "MN": "C19.344.421.249", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with PANCREATIC NEOPLASMS; ALPHA-CELL TUMOR see GLUCAGONOMA; BETA-CELL TUMOR see INSULINOMA and pancreatic delta-cell tumor see SOMATOSTATINOMA are available", "MS": "A benign tumor of the pancreatic ISLET CELLS. Usually it involves the INSULIN-producing PANCREATIC BETA CELLS, as in INSULINOMA, resulting in HYPERINSULINISM.", "OL": "use ADENOMA, ISLET CELL to search ISLET CELL TUMOR 1966-93", "PM": "94; was ISLET CELL TUMOR 1963-93", "HN": "94; was ISLET CELL TUMOR 1963-93", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D007516"}, {"RECTYPE": "D", "MH": "Isoamylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.450.585", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Glycogen 6-glucanohydrolase", "RN": "EC 3.2.1.68", "AN": "do not confuse with amylase isoenzymes (index under AMYLASES (IM) + ISOENZYMES (IM) )", "PI": "Polysaccharides (1974)", "MS": "An enzyme that hydrolyzes 1,6-alpha-glucosidic branch linkages in glycogen, amylopectin, and their beta-limit dextrins. It is distinguished from pullulanase (EC 3.2.1.41) by its inability to attack pullulan and by the feeble action of alpha-limit dextrins. It is distinguished from amylopectin 6-glucanohydrolase (EC 3.2.1.69) by its action on glycogen. With EC 3.2.1.69, it produces the activity called \"debranching enzyme\". EC 3.2.1.68.", "PM": "91; was see under GLYCOSIDE HYDROLASES 1975-90", "HN": "91(75); was see under GLYCOSIDE HYDROLASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007517"}, {"RECTYPE": "D", "MH": "Isoantibodies", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Alloantibodies|T129|NON|EQV|UNK (19XX)|780501|abcdef", "MN": "D12.776.377.715.548.114.664", "PA": "Immunologic Factors", "FX": "Blood Group Antigens", "MH_TH": "NLM (1964)", "ST": "T129", "RN": "0", "MS": "Antibodies from an individual that react with ISOANTIGENS of another individual of the same species.", "PM": "66", "HN": "66(64)", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007518"}, {"RECTYPE": "D", "MH": "Isoantigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Alloantigens|T129|NON|REL|UNK (19XX)|780501|abcdef", "ENTRY": "Isoantigen|T129|NON|EQV|NLM (2004)|030613|abcdef", "MN": "D23.050.705", "MH_TH": "NLM (1964)", "ST": "T129", "RN": "0", "MS": "Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS.", "PM": "67", "HN": "67(64)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007519"}, {"RECTYPE": "D", "MH": "Isocarboxazid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.385.300", "PA": "Monoamine Oxidase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3-Isoxazolecarboxylic acid, 5-methyl-, 2-(phenylmethyl)hydrazide", "RN": "34237V843T", "RR": "59-63-2 (Isocarboxazid)", "MS": "An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007520"}, {"RECTYPE": "D", "MH": "Isocitrate Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NAD Isocitrate Dehydrogenase|T116|T126|EQV|NLM (1992)|901102|abbdef", "ENTRY": "Isocitrate Dehydrogenase, NAD", "MN": "D08.811.682.047.820.475", "MH_TH": "NLM (1963)", "ST": "T126", "N1": "Isocitrate:NAD+ oxidoreductase (decarboxylating)", "RN": "EC 1.1.1.41", "MS": "An enzyme of the oxidoreductase class that catalyzes the conversion of isocitrate and NAD+ to yield 2-ketoglutarate, carbon dioxide, and NADH. It occurs in cell mitochondria. The enzyme requires Mg2+, Mn2+; it is activated by ADP, citrate, and Ca2+, and inhibited by NADH, NADPH, and ATP. The reaction is the key rate-limiting step of the citric acid (tricarboxylic) cycle. (From Dorland, 27th ed) (The NADP+ enzyme is EC 1.1.1.42.) EC 1.1.1.41.", "PM": "65", "HN": "65(63)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007521"}, {"RECTYPE": "D", "MH": "Isocitrate Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Isocitratase|T116|T126|NON|EQV|UNK (19XX)|760416|abbcdef", "ENTRY": "Lyase, Isocitrate", "MN": "D08.811.520.224.600.700", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "Isocitrate glyoxylate-lyase", "RN": "EC 4.1.3.1", "RR": "9045-78-7 (CAS RN)", "PI": "Ketoacid-Lyases (1973-1976)", "MS": "A key enzyme in the glyoxylate cycle. It catalyzes the conversion of isocitrate to succinate and glyoxylate. EC 4.1.3.1.", "PM": "91; was see under KETOACID-LYASES 1977-90", "HN": "91(77); was see under KETOACID-LYASES 1977-90", "MR": "20030709", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D007522"}, {"RECTYPE": "D", "MH": "Isocitrates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.081.901.434.498", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "Tricarboxylic Acids (1966-1970)", "MS": "Derivatives of isocitric acid, a structural isomer of CITRIC ACID, including its salts and esters.", "PM": "73", "HN": "73(71)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007523"}, {"RECTYPE": "D", "MH": "Isodesmosine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D12.125.072.415", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Pyridinium, 2-(4-amino-4-carboxybutyl)-1-(5-amino-5-carboxypentyl)-3,5-bis(3-amino-3-carboxypropyl)-", "RN": "991-01-5", "PI": "Pyridinium Compounds (1970-1974)", "MS": "2-(4-Amino-4-carboxybutyl)-1-(5-amino-5-carboxypentyl)-3,5-bis(3-amino-3-carboxypropyl)pyridinium. A rare amino acid found in elastin, formed by condensation of four molecules of lysine into a pyridinium ring.", "PM": "91; was see under AMINO ACIDS 1975-90", "HN": "91(75); was see under AMINO ACIDS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007524"}, {"RECTYPE": "D", "MH": "Isoelectric Focusing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Electrofocusing|T059|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Focusing, Isoelectric", "MN": "E05.301.300.663", "MH_TH": "NLM (1970)", "ST": "T059", "AN": "a type of electrophoresis; NIM", "PI": "Electrophoresis (1966-1969)", "MS": "Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point.", "PM": "74", "HN": "74(70)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007525"}, {"RECTYPE": "D", "MH": "Isoelectric Point", "ENTRY": "Points, Isoelectric", "MN": "G02.300.500", "MH_TH": "NLM (1975)", "ST": "T081", "AN": "usually NIM", "MS": "The pH in solutions of proteins and related compounds at which the dipolar ions are at a maximum.", "PM": "91; was see under HYDROGEN-ION CONCENTRATION 1975-90", "HN": "91(75); was see under HYDROGEN-ION CONCENTRATION 1975-90", "MR": "20080708", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D007526"}, {"RECTYPE": "D", "MH": "Isoenzymes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Isozymes|T116|T126|NON|EQV|UNK (19XX)|880512|abbcdef", "ENTRY": "Allozymes|T116|T126|NON|NRW|NLM (2009)|071011|abbcdef", "MN": "D12.776.800.300", "MH_TH": "NLM (1965)", "ST": "T126", "RN": "0", "AN": "IM general only; coordinate NIM with specific enzyme (IM)", "MS": "Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics.", "PM": "67", "HN": "67(65)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007527"}, {"RECTYPE": "D", "MH": "Isoetharine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Etyprenalinum|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Mesylate, Isoetharine", "MN": "D02.092.063.400", "PA": "Bronchodilator Agents", "MH_TH": "USAN (1962)", "ST": "T121", "N1": "1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)butyl)-", "RN": "YV0SN3276Q", "RR": "DV74WJ5PJB", "PI": "Propylamines (1972-1974)", "MS": "Adrenergic beta-2 agonist used as bronchodilator for emphysema, bronchitis and asthma.", "PM": "91; was see under AMINO ALCOHOLS 1975-90", "HN": "91(75); was see under AMINO ALCOHOLS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007528"}, {"RECTYPE": "D", "MH": "Isoflavones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isoflavone Derivative|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Derivatives, Isoflavone", "MN": "D03.633.100.150.266.450.400", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Flavones (1966-1974)", "MS": "3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position.", "PM": "91; was see under FLAVONES 1975-90", "HN": "91(75); was see under FLAVONES 1975-90", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D007529"}, {"RECTYPE": "D", "MH": "Isoflurane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.355.601.570", "PA": "Anesthetics, Inhalation", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Ethane, 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-", "RN": "CYS9AKD70P", "RR": "26675-46-7 (Isoflurane)", "PI": "Hydrocarbons, Fluorinated (1974)", "MS": "A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.", "PM": "87; was see under METHYL ETHERS 1975-86", "HN": "87(75); was see under METHYL ETHERS 1975-86", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19870101", "UI": "D007530"}, {"RECTYPE": "D", "MH": "Isoflurophate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluostigmine|T109|T121|T131|NON|EQV|UNK (19XX)|770317|abbbcdef", "ENTRY": "Di isopropylphosphorofluoridate", "MN": "D02.705.429.750.249", "PA": "Protease Inhibitors", "MH_TH": "USP (19XX)", "ST": "T131", "N1": "Phosphorofluoridic acid, bis(1-methylethyl) ester", "RN": "12UHW9R67N", "RR": "55-91-4 (Isoflurophate)", "MS": "A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007531"}, {"RECTYPE": "D", "MH": "Isoleucine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L-Isomer Isoleucine", "MN": "D12.125.142.383", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "Isoleucine", "RN": "04Y7590D77", "RR": "73-32-5 (Isoleucine)", "AN": "/biosyn /defic /physiol permitted", "MS": "An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of LEUCINE. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007532"}, {"RECTYPE": "D", "MH": "Isoleucine-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Isoleucyl-tRNA Synthetase ILES1|T116|T126|NON|EQV|NLM (2022)|210603|abbcdef", "ENTRY": "Synthetase, Isoleucyl-tRNA", "MN": "D08.811.464.263.200.450", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Isoleucine:tRNA(Ile) ligase (AMP-forming)", "RN": "EC 6.1.1.5", "PI": "Isoleucine (1972-1974)", "MS": "An enzyme that activates isoleucine with its specific transfer RNA. EC 6.1.1.5.", "PM": "1998; see ISOLEUCYL TRNA SYNTHETASE 1991-1997; see AMINO ACYL TRNA SYNTHETASES 1975-1990", "HN": "1998(1975)", "MR": "20210701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007533"}, {"RECTYPE": "D", "MH": "Isomaltose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.947.750.320", "MH_TH": "NLM (1979)", "ST": "T123", "N1": "D-Glucose, 6-O-alpha-D-glucopyranosyl-", "RN": "67I334IX2M", "RR": "499-40-1 (Isomaltose)", "PI": "Disaccharides (1966-1978)", "MS": "A disaccharide consisting of two glucose units in an alpha (1-6) glycosidic linkage.", "PM": "91; was see under DISACCHARIDES 1979-90", "HN": "91(79); was see under DISACCHARIDES 1979-90", "MR": "20170410", "DA": "19771215", "DC": "1", "DX": "19910101", "UI": "D007534"}, {"RECTYPE": "D", "MH": "Isomerases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Isomerase|T116|T126|NON|EQV|NLM (2021)|191119|abbcdef", "MN": "D08.811.399", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 5.-", "AN": "general or unspecified; prefer specifics", "MS": "A class of enzymes that catalyze geometric or structural changes within a molecule to form a single product. The reactions do not involve a net change in the concentrations of compounds other than the substrate and the product.(from Dorland, 28th ed) EC 5.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007535"}, {"RECTYPE": "D", "MH": "Isomerism", "ENTRY": "Isomerisms", "MN": "G02.607.445", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "usually NIM", "PI": "Chemistry, Organic (1966-1970)", "MS": "The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "PM": "74", "HN": "74(71)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007536"}, {"RECTYPE": "D", "MH": "Isometric Contraction", "AQ": "DE ES GE IM PH RE", "ENTRY": "Isometric Contractions", "MN": "G11.427.494.472", "MH_TH": "NLM (1977)", "ST": "T042", "AN": "do not confuse with ISOTONIC CONTRACTION", "PI": "Exertion (1966-1976)", "MS": "Muscular contractions characterized by increase in tension without change in length.", "OL": "use ISOMETRIC CONTRACTION to search EXERCISE, ISOMETRIC 1977-83", "PM": "91; was see under MUSCLE CONTRACTION 1984-90; was EXERCISE, ISOMETRIC see under EXERTION 1977-83", "HN": "91(84); was see under MUSCLE CONTRACTION 1984-90; was EXERCISE, ISOMETRIC see under EXERTION 1977-83", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D007537"}, {"RECTYPE": "D", "MH": "Isoniazid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isonicotinic Acid Hydrazide|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbcdeef", "ENTRY": "Vanillylidenehydrazide, Isonicotinic Acid", "MN": "D03.383.725.394.582", "PA": "Fatty Acid Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4-Pyridinecarboxylic acid, hydrazide", "RN": "V83O1VOZ8L", "RR": "54-85-3 (Isoniazid)", "MS": "Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.", "PM": "/adverse effects /poisoning /toxicity were ISONIAZID TOXICOLOGY 1963-65", "HN": "/adv eff-pois-tox was ISONIAZID TOXICOLOGY 1963-65", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007538"}, {"RECTYPE": "D", "MH": "Isonicotinic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Isonicotinic", "MN": "D03.383.725.394", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "RR": "Y8SYN761TQ", "MS": "Heterocyclic acids that are derivatives of 4-pyridinecarboxylic acid (isonicotinic acid).", "OL": "use ISONICOTINIC ACIDS to search ISONICOTINIC ACID 1966-74", "PM": "75; was ISONICOTINIC ACID 1963-74", "HN": "75; was ISONICOTINIC ACID 1963-74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D007539"}, {"RECTYPE": "D", "MH": "Isonipecotic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Isonipecotic", "MN": "D03.383.621.349", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007540"}, {"RECTYPE": "D", "MH": "Isopentenyladenosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "N(6)-(delta(2)-Isopentenyl)Adenosine|T114|T123|NON|EQV|UNK (19XX)|820603|abbcdef", "MN": "D13.570.800.096.500", "PA": "Plant Growth Regulators", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Adenosine, N-(3-methyl-2-butenyl)-", "RN": "7724-76-7", "PI": "Alkenes (1972-1974)", "MS": "N(6)-[delta(3)-isopentenyl]adenosine. Isopentenyl derivative of adenosine which is a member of the cytokinin family of plant growth regulators.", "PM": "91; was see under ADENOSINE 1975-90", "HN": "91(75); was see under ADENOSINE 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007541"}, {"RECTYPE": "D", "MH": "Inosine Pranobex", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methisoprinol|T114|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|750701|abbcdeef", "ENTRY": "Pranobex, Inosine", "MN": "D13.570.800.573.450", "PA": "Antiviral Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Inosine, compd. with 1-(dimethylamino)-2-propanol 4-(acetylamino)benzoate (salt) (1:3)", "RN": "W1SO0V223F", "RR": "36703-88-5 (Inosine Pranobex)", "PI": "Inosine (1974) /analogs & derivatives (1975)", "MS": "An alkylamino-alcohol complex of inosine used in the treatment of a variety of viral infections. Unlike other antiviral agents, it acts by modifying or stimulating cell-mediated immune processes rather than acting on the virus directly.", "PM": "96; was ISOPRINOSINE 1976-95 (see under INOSINE 1976-90)", "HN": "96; was ISOPRINOSINE 1976-95 (see under INOSINE 1976-90)", "MR": "20160425", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D007542"}, {"RECTYPE": "D", "MH": "Isopropyl Thiogalactoside", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Thiogalactoside, Isopropyl", "MN": "D09.408.903.600.500", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "beta-D-Galactopyranoside, 1-methylethyl 1-thio-", "RN": "367-93-1", "PI": "Thioglycosides (1974)", "MS": "A non-metabolizable galactose analog that induces expression of the LAC OPERON.", "PM": "91; was see under THIOGLYCOSIDES 1975-90", "HN": "91(75); was see under THIOGLYCOSIDES 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007544"}, {"RECTYPE": "D", "MH": "Isoproterenol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isopropylarterenol|T109|T121|NON|EQV|UNK (19XX)|790305|abbcdef", "ENTRY": "Sulfate, Isoproterenol", "MN": "D02.455.426.559.389.657.166.175.649", "PA": "Sympathomimetics", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-", "RN": "L628TT009W", "RR": "DIA2A74855", "MS": "Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007545"}, {"RECTYPE": "D", "MH": "Isoquinolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.531", "MH_TH": "NLM (1969)", "ST": "T109", "RN": "0", "PI": "Quinolines (1966-1968)", "MS": "A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)", "OL": "use ISOQUINOLINES to search TYLOCREBRINE 1972-84 (as Prov 1972)", "PM": "69; TYLOCREBRINE was heading 1973-84", "HN": "69; TYLOCREBRINE was heading 1972-84 (Prov 1972)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D007546"}, {"RECTYPE": "D", "MH": "Isosorbide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dianhydrosorbitol|T109|T121|NON|BRD|UNK (19XX)|810305|abbcdef", "MN": "D09.853.813.480", "PA": "Diuretics, Osmotic", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "D-Glucitol, 1,4:3,6-dianhydro-", "RN": "WXR179L51S", "RR": "652-67-5 (Isosorbide)", "AN": "a diuretic", "PI": "Sorbitol (1974)", "MS": "1,4:3,6-Dianhydro D-glucitol. Chemically inert osmotic diuretic used mainly to treat hydrocephalus; also used in glaucoma.", "PM": "91; was see under SORBITOL 1975-90", "HN": "91(75); was see under SORBITOL 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D007547"}, {"RECTYPE": "D", "MH": "Isosorbide Dinitrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isoket Retard120", "MN": "D09.853.813.480.500", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "D-Glucitol, 1,4:3,6-dianhydro-, dinitrate", "RN": "IA7306519N", "RR": "87-33-2 (Isosorbide Dinitrate)", "MS": "A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action.", "PM": "74", "HN": "74(66)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007548"}, {"RECTYPE": "D", "MH": "Isospora", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Isosporas", "MN": "B01.043.075.189.250.250.400", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid56625", "MS": "A genus of protozoan parasites found in the intestines of birds, amphibians, reptiles, and mammals, including man. The oocysts produce two sporocysts, each with four sporozoites. Many species are parasitic in wild and domestic animals.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007549"}, {"RECTYPE": "D", "MH": "Isothiuronium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "AHR1911", "MN": "D02.886.904.390", "MH_TH": "NLM (1976)", "ST": "T121", "N1": "Carbamimidothioic acid, 10-undecenyl ester, monohydriodide", "RN": "22584-04-9", "PI": "Undecylenic Acids (1973-1975)", "MS": "An undecenyl THIOUREA which may have topical anti-inflammatory activity.", "PM": "91; was see under THIOUREA 1976-90", "HN": "91(76); was see under THIOUREA 1976-90", "MR": "20200527", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D007550"}, {"RECTYPE": "D", "MH": "Isotonic Contraction", "AQ": "DE ES GE IM PH RE", "ENTRY": "Isotonic Contractions", "MN": "G11.427.494.493", "MH_TH": "NLM (1984)", "ST": "T042", "AN": "do not confuse with ISOMETRIC CONTRACTION", "PI": "Muscles (1966-1983)", "MS": "Muscle contraction with negligible change in the force of contraction but shortening of the distance between the origin and insertion.", "PM": "91; was see under MUSCLE CONTRACTION 1984-90", "HN": "91(84); was see under MUSCLE CONTRACTION 1984-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19830615", "DC": "1", "DX": "19910101", "UI": "D007551"}, {"RECTYPE": "D", "MH": "Isotonic Solutions", "DE": "ISOTONIC SOL", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Solutions, Isotonic", "MN": "D26.776.498", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; no qualifiers when NIM coordinate", "MS": "Solutions having the same osmotic pressure as blood serum, or another solution with which they are compared. (From Grant & Hackh's Chemical Dictionary, 5th ed & Dorland, 28th ed)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007552"}, {"RECTYPE": "D", "MH": "Isotope Labeling", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tagging, Isotopically-Coded Affinity", "MN": "E05.522", "MH_TH": "NLM (1971)", "ST": "T062", "PI": "specific isotope (1966-1971)", "MS": "Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007553"}, {"RECTYPE": "D", "MH": "Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isotope|T196|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D01.496", "FX": "Radioisotopes", "MH_TH": "NLM (1974)", "ST": "T196", "RN": "0", "AN": "for stable isotopes only; general or unspecified; prefer specifics; m for metastable equals RADIOISOTOPES or specific pre-coordinated radioisotope", "MS": "Atomic species differing in mass number but having the same atomic number. (Grant & Hackh's Chemical Dictionary, 5th ed)", "OL": "search RADIOISOTOPES 1966-73", "PM": "74; was see under RADIOISOTOPES 1963-73", "HN": "74; was see under RADIOISOTOPES 1963-73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007554"}, {"RECTYPE": "D", "MH": "Isoxazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isoxazole|T109|NON|EQV|NLM (2021)|200121|abcdef", "MN": "D03.383.129.385", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "1-Oxa-2-azacyclopentadiene", "RN": "0", "MS": "Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions.", "OL": "search OXAZOLES 1966-74", "PM": "91; was see under OXAZOLES 1975-90", "HN": "91(75); was see under OXAZOLES 1975-90", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007555"}, {"RECTYPE": "D", "MH": "Isoxsuprine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Isoxsuprine", "MN": "D02.092.471.683.560", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenemethanol, 4-hydroxy-alpha-(1-((1-methyl-2-phenoxyethyl)amino)ethyl)-", "RN": "R15UI3245N", "RR": "V74TEQ36CO", "PI": "Sympathomimetics (1966-1971)", "MS": "A beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor.", "PM": "73", "HN": "73(72)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007556"}, {"RECTYPE": "D", "MH": "Israel", "AQ": "EH EP", "MN": "Z01.252.245.500.375", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. The capital is Jerusalem.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007557"}, {"RECTYPE": "D", "MH": "Italy", "AQ": "EH EP", "PRINT ENTRY": "Sardinia|T083|NAM|NRW|UNK (19XX)|750101|abcdef", "MN": "Z01.542.489", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "ROME & VATICAN CITY are also available", "MS": "A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007558"}, {"RECTYPE": "D", "MH": "Ivermectin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MK933", "MN": "D02.540.576.500.997", "PA": "Insecticides", "MH_TH": "USAN (1979)", "ST": "T121", "N1": "Ivermectin", "RN": "70288-86-7", "PI": "Lactones (1966-1986)", "MS": "A mixture of mostly avermectin H2B1a (RN 71827-03-7) with some avermectin H2B1b (RN 70209-81-3), which are macrolides from STREPTOMYCES avermitilis. It binds glutamate-gated chloride channel to cause increased permeability and hyperpolarization of nerve and muscle cells. It also interacts with other CHLORIDE CHANNELS. It is a broad spectrum antiparasitic that is active against microfilariae of ONCHOCERCA VOLVULUS but not the adult form.", "PM": "1987; for MECTIZAN see IVERMECTIN 1987-1999", "HN": "1987; for MECTIZAN use IVERMECTIN (NM) 1987-1999", "MR": "20160701", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D007559"}, {"RECTYPE": "D", "MH": "Cote d'Ivoire", "AQ": "EH EP", "PRINT ENTRY": "Ivory Coast|T083|NAM|EQV|NLM (1994)|930309|abcdef", "ENTRY": "Republic of Cote diIvoire|T083|NON|EQV|NLM (2009)|080326|abcdef", "MN": "Z01.058.290.190.272", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "in translations use the French name C\u00f4te d'Ivoire with circumflex", "MS": "A republic in western Africa, south of MALI and BURKINA FASO, bordered by GHANA on the east. Its administrative capital is Abidjan and Yamoussoukro has been the official capital since 1983. The country was formerly called Ivory Coast.", "OL": "use COTE D'IVOIRE to search IVORY COAST 1971-93", "HN": "94; was IVORY COAST 1971-93", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19940101", "UI": "D007560"}, {"RECTYPE": "D", "MH": "Creutzfeldt-Jakob Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Spongiform Encephalopathy, Subacute|T047|NON|EQV|NLM (2000)|991108|SPONGIFORM ENCEPH SUBACUTE|abcdefv", "ENTRY": "Variant Creutzfeldt Jakob Disease", "MN": "F03.615.400.300", "MH_TH": "NLM (1969)", "ST": "T047", "PI": "Central Nervous System Diseases (1966-1968)", "MS": "A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD (potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM) have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS. (From N Engl J Med, 1998 Dec 31;339(27))", "PM": "1991; see JAKOB-CREUTZFELDT SYNDROME 1981-1990, see CREUTZFELDT-JAKOB DISEASE 1973-1980", "HN": "1991; use JAKOB-CREUTZFELDT SYNDROME 1981-1990, use CREUTZFELDT-JAKOB DISEASE 1969-1980", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007562"}, {"RECTYPE": "D", "MH": "Jamaica", "AQ": "EH EP", "MN": "Z01.639.880.525", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island in the Greater Antilles in the West Indies", "MS": "An island in the Greater Antilles in the West Indies. Its capital is Kingston. It was discovered in 1494 by Columbus and was a Spanish colony 1509-1655 until captured by the English. Its flourishing slave trade was abolished in the 19th century. It was a British colony 1655-1958 and a territory of the West Indies Federation 1958-62. It achieved full independence in 1962. The name is from the Arawak Xaymaca, rich in springs or land of springs. (From Webster's New Geographical Dictionary, 1988, p564 & Room, Brewer's Dictionary of Names, 1992, p267)", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007563"}, {"RECTYPE": "D", "MH": "Japan", "AQ": "EH EP", "PRINT ENTRY": "Bonin Islands|T083|NAM|NRW|UNK (19XX)|830201|abcdef", "MN": "Z01.639.595", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "TOKYO is also available.", "MS": "A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo.", "MR": "20171211", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007564"}, {"RECTYPE": "D", "MH": "Jaundice", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Jaundice, Hemolytic|T184|NON|REL|UNK (19XX)|740329|abcdef", "ENTRY": "Jaundices, Hemolytic", "MN": "C23.888.885.375", "MH_TH": "NLM (1965)", "ST": "T184", "AN": "general or unspecified; prefer specifics", "MS": "A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.", "PM": "1965; for JAUNDICE, HEMOLYTIC see ANEMIA, HEMOLYTIC 1975-2012", "HN": "1965; for JAUNDICE, HEMOLYTIC use ANEMIA, HEMOLYTIC 1975-2012", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007565"}, {"RECTYPE": "D", "MH": "Jaundice, Chronic Idiopathic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dubin-Johnson Syndrome|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|740330|abcdeeeef", "ENTRY": "Syndrome, Dubin-Johnson", "MN": "C23.550.291.500.479", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A benign, autosomally recessive inherited hyperbilirubinemia characterized by the presence of a dark pigment in the centrilobular region of the liver cells. There is a functional defect in biliary excretion of bilirubin, cholephilic dyes, and porphyrins. Affected persons may be asymptomatic or have vague constitutional or gastrointestinal symptoms. The liver may be slightly enlarged, and oral and intravenous cholangiography fails to visualize the biliary tract.", "CATSH": "CAT LIST", "MR": "20210312", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007566"}, {"RECTYPE": "D", "MH": "Jaundice, Neonatal", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neonatal Jaundice, Physiological", "MN": "C23.550.429.249.500", "FX": "Hyperbilirubinemia, Neonatal", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "check the tag INFANT, NEWBORN", "MS": "Yellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES.", "PM": "1966; for ICTERUS GRAVIS NEONATORUM see ERYTHROBLASTOSIS FETAL 1975-2005", "HN": "1966; for ICTERUS GRAVIS NEONATORUM use ERYTHROBLASTOSIS FETAL 1975-2005", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007567"}, {"RECTYPE": "D", "MH": "Jaw", "AQ": "AH BS CH CY DE DG EM EN IM IN IR ME MI PA PH PP PS RE TR UL VI", "ENTRY": "Jaws", "MN": "A14.521", "FX": "Temporomandibular Joint", "EC": "surgery:Orthognathic Surgical Procedures", "MH_TH": "NLM (1965)", "ST": "T023", "CX": "consider also terms at MANDIB- and MAXILL-", "MS": "Bony structure of the mouth that holds the teeth. It consists of the MANDIBLE and the MAXILLA.", "PM": "1965; was JAWS 1963-1964", "HN": "1965; was JAWS 1963-1964", "MR": "20180710", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007568"}, {"RECTYPE": "D", "MH": "Jaw Abnormalities", "DE": "JAW ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Jaw Abnormality", "MN": "C16.131.850.500.460", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics: MAXILLA /abnorm or MANDIBLE /abnorm", "MS": "Congenital absence of or defects in structures of the jaw.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19771207", "DC": "1", "DX": "19660101", "UI": "D007569"}, {"RECTYPE": "D", "MH": "Jaw Cysts", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Jaw Cyst", "MN": "C07.320.450", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "non-neoplastic; coordinate with precoordinated organ/disease term ", "PI": "specific jaw neoplasm", "MS": "Saccular lesions lined with epithelium and contained within pathologically formed cavities in the jaw; also nonepithelial cysts (pseudocysts) as they apply to the jaw, e.g., traumatic or solitary cyst, static bone cavity, and aneurysmal bone cyst. True jaw cysts are classified as odontogenic or nonodontogenic.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "19900605", "DA": "19790425", "DC": "1", "DX": "19800101", "UI": "D007570"}, {"RECTYPE": "D", "MH": "Jaw Diseases", "DE": "JAW DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Jaw Disease", "MN": "C07.320", "MH_TH": "NLM (1967)", "ST": "T047", "PI": "Maxilla (1966)", "MS": "Diseases involving the JAW.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007571"}, {"RECTYPE": "D", "MH": "Jaw Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fractured Bone of Jaw|T037|NON|EQV|NLM (2023)|210901|abcdef", "ENTRY": "Jaw Fractured Bones", "MN": "C26.915.300.425.500.400", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "general or unspecified; prefer specifics", "MS": "Fractures of the upper or lower jaw.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007572"}, {"RECTYPE": "D", "MH": "Jaw Neoplasms", "DE": "JAW NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Jaw Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Jaw", "MN": "C07.320.515", "MH_TH": "NLM (1967)", "ST": "T191", "AN": "general or unspecified; prefer specifics; coordinate with histological type of neoplasm", "PI": "Maxillary Neoplasms (1966)", "MS": "Cancers or tumors of the MAXILLA or MANDIBLE unspecified. For neoplasms of the maxilla, MAXILLARY NEOPLASMS is available and of the mandible, MANDIBULAR NEOPLASMS is available.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007573"}, {"RECTYPE": "D", "MH": "Jaw Relation Record", "DE": "JAW RELAT RECORD", "AQ": "IS MT", "PRINT ENTRY": "Sirognathography|T060|NON|REL|NLM (1996)|950209|SIROGNATHOGR|abcdefv", "ENTRY": "Registrations, Bite", "MN": "E06.520", "MH_TH": "NLM (1970)", "ST": "T034", "AN": "usually NIM", "PI": "Dental Occlusion (1966-1969)", "MS": "A registration of any positional relationship of the mandible in reference to the maxillae. These records may be any of the many vertical, horizontal, or orientation relations. (Jablonski, Illustrated Dictionary of Dentistry)", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "19950313", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D007574"}, {"RECTYPE": "D", "MH": "Jaw, Edentulous", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Jaws, Edentulous", "MN": "C07.793.597.425", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Mouth, Edentulous (1966-1979)", "MS": "The total absence of teeth from either the mandible or the maxilla, but not both. Total absence of teeth from both is MOUTH, EDENTULOUS. Partial absence of teeth in either is JAW, EDENTULOUS, PARTIALLY.", "OL": "search MOUTH, EDENTULOUS 1966-79", "PM": "80; was included in MOUTH, EDENTULOUS 1965-79", "HN": "80; was included in MOUTH, EDENTULOUS 1965-79", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19790425", "DC": "1", "DX": "19800101", "UI": "D007575"}, {"RECTYPE": "D", "MH": "Jaw, Edentulous, Partially", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C07.793.597.425.450", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "see note on JAW, EDENTULOUS for definition; coord IM with MANDIBLE (NIM) or MAXILLA (NIM)", "PI": "Mouth, Edentulous (1966-1979)", "MS": "Absence of teeth from a portion of the mandible and/or maxilla.", "OL": "search MOUTH, EDENTULOUS 1966-79", "PM": "80; was included in MOUTH, EDENTULOUS 1965-79", "HN": "80; was included in MOUTH, EDENTULOUS 1965-79", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19790425", "DC": "1", "DX": "19800101", "UI": "D007576"}, {"RECTYPE": "D", "MH": "JC Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Polyomavirus, JC|T005|EPO|EQV|NLM (2002)|010306|abcdef", "ENTRY": "Virus, John Cunningham", "MN": "B04.613.204.670.615.400", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10632", "AN": "do not confuse with JAMESTOWN CANYON VIRUS see ENCEPHALITIS VIRUS, CALIFORNIA; infection: coordinate IM with POLYOMAVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) but consider also LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL", "PI": "Polyomaviruses (1971-1982)", "MS": "A species of POLYOMAVIRUS, originally isolated from the brain of a patient with progressive multifocal leukoencephalopathy. The patient's initials J.C. gave the virus its name. Infection is not accompanied by any apparent illness but serious demyelinating disease can appear later, probably following reactivation of latent virus.", "PM": "2002; see POLYOMAVIRUS HOMINIS 2 1994-2001, see JC VIRUS 1983-93", "HN": "2002, 1983-1993", "MR": "20200813", "DA": "19820426", "DC": "1", "DX": "19910101", "UI": "D007577"}, {"RECTYPE": "D", "MH": "Jealousy", "PRINT ENTRY": "Envy|T041|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "MN": "F01.470.653", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "human & animal", "MS": "An irrational reaction compounded of grief, loss of self-esteem, enmity against the rival and and self-criticism.", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007578"}, {"RECTYPE": "D", "MH": "Jejunal Diseases", "DE": "JEJUNAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Jejunal Disease", "MN": "C06.405.469.600", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "inflamm dis or jejunitis: coord IM with ENTERITIS (IM)", "PI": "specific intestinal disease", "MS": "Pathological development in the JEJUNUM region of the SMALL INTESTINE.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19790427", "DC": "1", "DX": "19800101", "UI": "D007579"}, {"RECTYPE": "D", "MH": "Jejunal Neoplasms", "DE": "JEJUNAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasms, Jejunal", "MN": "C06.405.469.600.523", "MH_TH": "NLM (1980)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "PI": "Jejunum (1966-1979)", "MS": "Tumors or cancer in the JEJUNUM region of the small intestine (INTESTINE, SMALL).", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19790425", "DC": "1", "DX": "19800101", "UI": "D007580"}, {"RECTYPE": "D", "MH": "Jejunoileal Bypass", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Intestinal Bypass|T061|NON|BRD|UNK (19XX)|850617|abcdef", "ENTRY": "Jejunoileal Bypasses", "MN": "E04.210.626", "MH_TH": "NLM (1986)", "ST": "T061", "PI": "Obesity (1966-1985)", "MS": "A procedure consisting of the SURGICAL ANASTOMOSIS of the proximal part of the JEJUNUM to the distal portion of the ILEUM, so as to bypass the nutrient-absorptive segment of the SMALL INTESTINE. Due to the severe malnutrition and life-threatening metabolic complications, this method is no longer used to treat MORBID OBESITY.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20200221", "DA": "19850617", "DC": "1", "DX": "19860101", "UI": "D007581"}, {"RECTYPE": "D", "MH": "Jejunostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Jejunostomies", "MN": "E04.579.338.523", "FX": "Surgical Stomas", "MH_TH": "NLM (1988)", "ST": "T061", "AN": "JEJUNOILEAL BYPASS & PANCREATICOJEJUNOSTOMY are available", "PI": "Jejunum/surgery (1966-1987)", "MS": "Surgical formation of an opening through the ABDOMINAL WALL into the JEJUNUM, usually for enteral hyperalimentation.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19870319", "DC": "1", "DX": "19880101", "UI": "D007582"}, {"RECTYPE": "D", "MH": "Jejunum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Jejunums", "MN": "A03.556.249.750", "FX": "Jejunostomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007583"}, {"RECTYPE": "D", "MH": "Jews", "AQ": "CL ED GE HI LJ PX SN", "ENTRY": "Jew", "MN": "M01.270.976", "FX": "Judaism", "MH_TH": "NLM (1999)", "ST": "T098", "AN": "specify geog if relevant", "MS": "An ethnic group with historical ties to the land of ISRAEL and the religion of JUDAISM.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007585"}, {"RECTYPE": "D", "MH": "Job Application", "PRINT ENTRY": "Resume, Job|T073|T170|NON|REL|UNK (19XX)|820428|abbcdef", "ENTRY": "Resumes, Job", "MN": "N04.452.677.400", "MH_TH": "NLM (1983)", "ST": "T068", "PI": "Personnel Management (1966-1982)", "MS": "Process of applying for employment. It includes written application for employment or personal appearance.", "PM": "91; was see under PERSONNEL MANAGEMENT 1983-90", "HN": "91(83); was see under PERSONNEL MANAGEMENT 1983-90", "MR": "19910610", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D007586"}, {"RECTYPE": "D", "MH": "Job Description", "AQ": "ST", "PRINT ENTRY": "Position Description|T170|NON|EQV|UNK (19XX)|770511|abcdef", "ENTRY": "Position Descriptions", "MN": "N04.452.677.410", "MH_TH": "POPLINE (1981)", "ST": "T170", "MS": "Statement of the position requirements, qualifications for the position, wage range, and any special conditions expected of the employee.", "PM": "91; was see under PERSONNEL MANAGEMENT Aug 1977-90", "HN": "91(Aug 77); was see under PERSONNEL MANAGEMENT 1977-90", "MR": "19920514", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D007587"}, {"RECTYPE": "D", "MH": "Job Satisfaction", "PRINT ENTRY": "Work Satisfaction|T041|NON|EQV|UNK (19XX)|750702|abcdef", "ENTRY": "Work Satisfactions", "MN": "F02.784.692.425", "MH_TH": "NLM (1976)", "ST": "T041", "PI": "Personal Satisfaction (1972-1975)", "MS": "Personal satisfaction relative to the work situation.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D007588"}, {"RECTYPE": "D", "MH": "Job Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Job's Syndrome|T047|EPO|EQV|GHR (2014)|NLM (1975)|990101|abcdeef", "ENTRY": "Syndromes, Job", "MN": "C20.673.795.688", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "Primary immunodeficiency syndrome characterized by recurrent infections and hyperimmunoglobulinemia E. Most cases are sporadic. Of the rare familial forms, the dominantly inherited subtype has additional connective tissue, dental and skeletal involvement that the recessive type does not share.", "PM": "2014; see JOB'S SYNDROME 1991-2013; see PHAGOCYTE BACTERICIDAL DYSFUNCTION 1975-1990", "HN": "2014 (1975);use PHAGOCYTE BACTERICIDAL DYSFUNCTION 1975-1990", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007589"}, {"RECTYPE": "D", "MH": "Jogging", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Joggings", "MN": "I03.450.642.845.610.320", "MH_TH": "NLM (1976)", "ST": "T056", "AN": "human & animal; /inj: coord IM with specific inj (IM); /physiol permitted", "PI": "Physical Fitness (1966-1975)", "MS": "Running at a low rate of speed. It can be done as a means of conditioning or for general health and well being.", "PM": "90; was see under RUNNING 1980-89; was see under SPORTS 1976-79", "HN": "90(76); was see under RUNNING 1980-89; was see under SPORTS 1976-79", "MR": "20160630", "DA": "19750725", "DC": "1", "DX": "19900101", "UI": "D007590"}, {"RECTYPE": "D", "MH": "Joint Commission on Accreditation of Healthcare Organizations", "AQ": "EC HI LJ OG", "PRINT ENTRY": "Joint Commission on Accreditation of Hospitals|T093|NON|NRW|UNK (19XX)|880519|JCAH|abcdefv", "ENTRY": "Joint Commission on Accreditation, Healthcare Organizations|T093|NON|EQV|UNK (19XX)|880519|JOINT COMMISSION ON ACCREDITATION HEALTHCARE ORGAN|abcdefv", "MN": "N05.700.200.100.420", "MH_TH": "NLM (1979)", "ST": "T093", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "MS": "A private, voluntary, not-for-profit organization which establishes standards for the operation of health facilities and services, conducts surveys, and awards accreditation.", "OL": "use JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS to search JOINT COMMISSION ON ACCREDITATION OF HOSPITALS 1979-88", "PM": "91; was see under ACCREDITATION 1989-90; was JOINT COMMISSION ON ACCREDITATION OF HOSPITALS see under ACCREDITATION 1979-88", "HN": "91(89); was see under ACCREDITATION 1989-90; was JOINT COMMISSION ON ACCREDITATION OF HOSPITALS see under ACCREDITATION 1979-88", "MR": "20150605", "DA": "19780504", "DC": "1", "DX": "19910101", "UI": "D007591"}, {"RECTYPE": "D", "MH": "Joint Diseases", "DE": "JOINT DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Joint Disease", "MN": "C05.550", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases involving the JOINTS.", "PM": "SHOULDER ARTHROSES was heading 1963-64", "HN": "SHOULDER ARTHROSES was heading 1963-64", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D007592"}, {"RECTYPE": "D", "MH": "Joint Instability", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Laxity, Joint|T184|NON|REL|UNK (19XX)|820427|abcdef", "ENTRY": "Laxities, Joint", "MN": "C05.550.521", "FX": "Joint Dislocations", "MH_TH": "NLM (1983)", "ST": "T184", "PI": "Ligaments, Articular (1966-1982)", "MS": "Lack of stability of a joint or joint prosthesis.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20160304", "DA": "19820427", "DC": "1", "DX": "19830101", "UI": "D007593"}, {"RECTYPE": "D", "MH": "Joint Loose Bodies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Loose Bodies, Joint|T020|NON|EQV|UNK (19XX)|820422|abcdef", "ENTRY": "Loose Body, Joint", "MN": "C05.550.535", "MH_TH": "NLM (1983)", "ST": "T020", "AN": "note category: \"fragments in a synovial joint\"", "PI": "Synovial Membrane (1966-1982)", "MS": "Fibrous, bony, cartilaginous and osteocartilaginous fragments in a synovial joint. Major causes are osteochondritis dissecans, synovial chondromatosis, osteophytes, fractured articular surfaces and damaged menisci.", "PM": "91; was see under JOINT DISEASES 1983-90", "HN": "91(83); was see under JOINT DISEASES 1983-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19820422", "DC": "1", "DX": "19910101", "UI": "D007594"}, {"RECTYPE": "D", "MH": "Joint Prosthesis", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Prosthesis, Joint", "MN": "E07.695.400", "FX": "Arthroplasty, Replacement", "MH_TH": "NLM (1971)", "ST": "T074", "AN": "HIP PROSTHESIS & KNEE PROSTHESIS are also available", "PI": "specific joint (1966-1970)", "MS": "Prostheses used to partially or totally replace a human or animal joint. (from UMDNS, 1999)", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D007595"}, {"RECTYPE": "D", "MH": "Joints", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Joint", "MN": "A02.835.583", "FX": "Arthroscopy", "MH_TH": "NLM (1966)", "ST": "T030", "CX": "consider also terms at ARTHR-", "MS": "Also known as articulations, these are points of connection between the ends of certain separate bones, or where the borders of other bones are juxtaposed.", "PM": "STERNOCOSTAL JOINTS was see under RIBS 1963-78", "MR": "20160809", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007596"}, {"RECTYPE": "D", "MH": "Jordan", "AQ": "EH EP", "MN": "Z01.252.245.500.400", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in the MIDDLE EAST, northwest of Saudi Arabia, between Israel and Iraq. The capital is Amman.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007597"}, {"RECTYPE": "D", "MH": "Journalism, Dental", "DE": "JOURNALISM DENT", "AQ": "HI ST", "PRINT ENTRY": "Publishing, Dental Periodicals|T091|NON|NRW|UNK (19XX)|810224|PUBLISHING DENT PERIODICALS|abcdefv", "ENTRY": "Dental Periodicals Publishing|T091|NON|NRW|NLM (1991)|900129|DENT PERIODICALS PUBLISHING|abcdefv", "MN": "L01.737.498.500", "MH_TH": "NLM (1964)", "ST": "T091", "AN": "writing for or in dent publ or on dent subjects; dental journals go under PERIODICALS AS TOPIC and required coord, not here", "MS": "Content, management, editing, policies, and printing of dental periodicals such as journals, newsletters, tabloids, and bulletins.", "PM": "91; was see under PUBLISHING 1964-90", "HN": "91(64); was see under PUBLISHING 1964-90", "MR": "20070711", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007598"}, {"RECTYPE": "D", "MH": "Judaism", "AQ": "HI PX", "ENTRY": "Ethics, Jewish", "MN": "K01.844.385", "FX": "Jews", "MH_TH": "NLM (1978)", "ST": "T078", "AN": "the religion: JEWS are the ethnic group; specify geog if pertinent", "MS": "The monotheistic religion of the Jews based on the teachings of the Hebrew Scriptures (Torah).", "MR": "20171208", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007599"}, {"RECTYPE": "D", "MH": "Judgment", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Judgement|T041|NON|EQV|NLM (2023)|210805|abcdef", "ENTRY": "Judgments", "MN": "F02.463.785.626", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "The process of discovering or asserting an objective or intrinsic relation between two objects or concepts; a faculty or power that enables a person to make judgments; the process of bringing to light and asserting the implicit meaning of a concept; a critical evaluation of a person or situation.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20211202", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007600"}, {"RECTYPE": "D", "MH": "Jugular Veins", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Jugular", "MN": "A07.015.908.498", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Veins in the neck which drain the brain, face, and neck into the brachiocephalic or subclavian veins.", "OL": "use JUGULAR VEINS to search JUGULAR VEIN 1966-77", "PM": "78; was JUGULAR VEIN 1963-77", "HN": "78; was JUGULAR VEIN 1963-77", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D007601"}, {"RECTYPE": "D", "MH": "Jungian Theory", "AQ": "HI", "ENTRY": "Theory, Jungian", "MN": "F02.739.794.471", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "A theoretical psychoanalytical system centered around symbols of the unconscious with the unconscious material derived from two sources - the personal unconscious (repressed or forgotten experiences, thoughts and feelings) and the collective or objective unconscious (the universal inherited qualities which dispose individuals to behave in ways similar to their ancestors).", "OL": "search PSYCHOANALYTIC THEORY 1969-74", "PM": "91; was see under PSYCHOANALYTIC THEORY 1975-90", "HN": "91(75); was see under PSYCHOANALYTIC THEORY 1975-90", "CATSH": "CAT LIST", "MR": "20040728", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007602"}, {"RECTYPE": "D", "MH": "Jurisprudence", "AQ": "HI", "PRINT ENTRY": "Medical Jurisprudence|T078|NON|NRW|NLM (1991)|891201|MED JURISPRUDENCE|abcdefv", "ENTRY": "Status, Legal", "MN": "N03.706.535", "FX": "Lawyers", "MH_TH": "BIOETHICS (1989)", "ST": "T064", "AN": "general or unspecified; prefer specifics or /legis with a specific MeSH term; specify geographic location if pertinent; entry term MEDICAL JURISPRUDENCE: do not coordinate with MEDICINE; for civil suits: differentiate from FORENSIC MEDICINE which is for crime and identification", "MS": "The science or philosophy of law. Also, the application of the principles of law and justice to health and medicine.", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007603"}, {"RECTYPE": "D", "MH": "Juvenile Delinquency", "AQ": "CL EC EH ES HI LJ PC PX RH SN TD", "ENTRY": "Delinquency, Juvenile", "MN": "I01.880.735.479", "MH_TH": "NLM (1966)", "ST": "T055", "AN": "IM", "MS": "The antisocial acts of children or persons under age which are illegal or lawfully interpreted as constituting delinquency.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007604"}, {"RECTYPE": "D", "MH": "Juvenile Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Juvenile Hormone|T125|NON|EQV|NLM (2021)|191126|abcdef", "ENTRY": "Regulator, Insect Growth", "MN": "D06.472.445.573.666", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "0", "AN": "insects only; coord IM with specific insect (IM)", "MS": "Compounds, either natural or synthetic, which block development of the growing insect.", "PM": "72", "HN": "72(66)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D007605"}, {"RECTYPE": "D", "MH": "Juxtaglomerular Apparatus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Apparatus, Juxtaglomerular", "MN": "A05.810.453.736.520.520", "FX": "Renin", "MH_TH": "NLM (1964)", "ST": "T023", "MS": "A complex of cells consisting of juxtaglomerular cells, extraglomerular mesangium lacis cells, the macula densa of the distal convoluted tubule, and granular epithelial peripolar cells. Juxtaglomerular cells are modified SMOOTH MUSCLE CELLS found in the walls of afferent glomerular arterioles and sometimes the efferent arterioles. Extraglomerular mesangium lacis cells are located in the angle between the afferent and efferent glomerular arterioles. Granular epithelial peripolar cells are located at the angle of reflection of the parietal to visceral angle of the renal corpuscle.", "PM": "66", "HN": "66(64)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007606"}, {"RECTYPE": "D", "MH": "Kainic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Digenic Acid|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|770418|abbcdeef", "ENTRY": "Acid, Kainic", "MN": "D03.383.773.400", "PA": "Excitatory Amino Acid Agonists", "FX": "Receptors, Kainic Acid", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "3-Pyrrolidineacetic acid, 2-carboxy-4-(1-methylethenyl)-, (2S-(2alpha,3beta,4beta))-", "RN": "SIV03811UC", "RR": "487-79-6 (Kainic Acid)", "AN": "an antinematodal agent & excitatory amino acid agonist", "PI": "Pyrrolidines (1966-1977)", "MS": "(2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose.", "PM": "86; was see under PYRROLIDINES 1978-85", "HN": "86(78); was see under PYRROLIDINES 1978-85", "MR": "20160531", "DA": "19770422", "DC": "1", "DX": "19860101", "UI": "D007608"}, {"RECTYPE": "D", "MH": "Kallidin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lysyl Bradykinin|T116|T121|T123|NON|EQV|NLM (1992)|910319|abbbcdef", "ENTRY": "Tetraacetate, Kallidin", "MN": "D23.529.812.169.400", "PA": "Vasodilator Agents", "MH_TH": "NLM (1964)", "ST": "T123", "N1": "Bradykinin, N2-L-lysyl-", "RN": "342-10-9", "RR": "84640-50-6 (tetra-acetate)", "AN": "/biosyn /drug eff /physiol permitted", "MS": "A decapeptide bradykinin homolog cleaved from kininogen by kallikreins. It is a smooth-muscle stimulant and hypotensive agent that acts by vasodilatation.", "PM": "66", "HN": "66(64)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007609"}, {"RECTYPE": "D", "MH": "Kallikreins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Kininogenase|T116|T121|T126|NON|EQV|NLM (1976)|741018|abbbcdef", "ENTRY": "beta Kallikrein B", "MN": "D23.119.597", "PA": "Fertility Agents, Male", "FX": "Coagulants", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.4.21.-", "RR": "9001-01-8 (kallidinogenase)", "AN": "/antag permitted but consider KALLIKREIN-TRYPSIN INACTIVATOR", "MS": "Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77).", "PM": "2000; see KALLIKREIN 1963-1999", "HN": "2000(1963)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D007610"}, {"RECTYPE": "D", "MH": "Aprotinin", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Trypsin Inhibitor, Kunitz, Pancreatic|T116|T121|T123|EPO|EQV|UNK (19XX)|770401|TRYPSIN INHIB KUNITZ PANCREATIC|abbbcdefv", "ENTRY": "Kallikrein Trypsin Inactivator", "MN": "D12.776.083", "PA": "Trypsin Inhibitors", "MH_TH": "USAN (1968)", "ST": "T123", "RN": "9087-70-1", "RR": "9004-04-0 (other number)", "MS": "A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)", "OL": "use APROTININ to search KALLIKREIN-TRYPSIN INACTIVATOR 1966-89", "PM": "90; was KALLIKREIN-TRYPSIN INACTIVATOR 1966-89", "HN": "90; was KALLIKREIN-TRYPSIN INACTIVATOR 1966-89", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007611"}, {"RECTYPE": "D", "MH": "Kanamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Kantrex|T109|T195|TRD|NRW|UNK (19XX)|861103|abbcdef", "MN": "D09.408.051.476", "PA": "Protein Synthesis Inhibitors", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-2-deoxy-", "RN": "59-01-8", "RR": "J80EX28SMQ", "MS": "Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components.", "MR": "20140808", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007612"}, {"RECTYPE": "D", "MH": "Kanamycin Resistance", "AQ": "DE EH GE IM PH RE", "MN": "G07.690.773.984.269.347.875", "MH_TH": "NLM (1988)", "ST": "T032", "PI": "Kanamycin (1966-1987)", "MS": "Nonsusceptibility of bacteria to the antibiotic KANAMYCIN, which can bind to their 70S ribosomes and cause misreading of messenger RNA.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19870509", "DC": "1", "DX": "19880101", "UI": "D007613"}, {"RECTYPE": "D", "MH": "Macropodidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Wallaroo|T015|NON|NRW|NLM (2005)|040220|abcdef", "ENTRY": "Wallaroos", "MN": "B01.050.150.900.649.573.500", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid9307", "RR": "txid9324", "MS": "A family of herbivorous leaping MAMMALS of Australia, New Guinea, and adjacent islands. Members include kangaroos, wallabies, quokkas, and wallaroos.", "PM": "2005; see KANGAROOS 1991-2004, see MARSUPIALIA 1975-1990", "HN": "2005 (1975)", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D007614"}, {"RECTYPE": "D", "MH": "Kansas", "AQ": "EH EP", "MN": "Z01.107.567.875.510.390", "MH_TH": "NLM (1998)", "ST": "T083", "MS": "State bounded on the north by Nebraska on the east by Missouri, on the south by Oklahoma, and on the west by Colorado.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007615"}, {"RECTYPE": "D", "MH": "Kaolin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Kaolinite|T197|NON|REL|FDA SRS (2014)|UNK (19XX)|820519|abcdeef", "MN": "D01.837.725.700.760.050.400", "PA": "Antidiarrheals", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Kaolin", "RN": "24H4NWX5CO", "RR": "1332-58-7 (Kaolin)", "AN": "an antidiarrheal", "MS": "The most common mineral of a group of hydrated aluminum silicates, approximately H2Al2Si2O8-H2O. It is prepared for pharmaceutical and medicinal purposes by levigating with water to remove sand, etc. (From Merck Index, 11th ed) The name is derived from Kao-ling (Chinese: \"high ridge\"), the original site. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20160607", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007616"}, {"RECTYPE": "D", "MH": "Kaposi Varicelliform Eruption", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Eczema Vaccinatum|T047|NON|NRW|UNK (19XX)|760430|abcdef", "ENTRY": "Varicelliform Eruption, Kaposi's", "MN": "C17.800.838.790.320.410", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A disseminated vesicular-pustular eruption caused by the herpes simplex virus (HERPESVIRUS HOMINIS), the VACCINIA VIRUS, or Varicella zoster (HERPESVIRUS 3, HUMAN). It is usually superimposed on a preexisting, inactive or active, atopic dermatitis (DERMATITIS, ATOPIC).", "PM": "98; was KAPOSI'S VARICELLIFORM ERUPTION 1963-97", "HN": "98; was KAPOSI'S VARICELLIFORM ERUPTION 1963-97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D007617"}, {"RECTYPE": "D", "MH": "Karaya Gum", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tragacanth, Indian|T109|T121|EPO|EQV|NLM (2003)|020102|abbcdef", "ENTRY": "Karaya, Gum", "MN": "D20.215.721.249.625", "PA": "Tissue Adhesives", "MH_TH": "NLM (1978)", "ST": "T121", "N1": "Karaya gum", "RN": "9000-36-6", "PI": "Resins (1966-1977)", "MS": "Polysaccharide gum from Sterculia urens (STERCULIA). It is used as a suspending or stabilizing agent in foods, cosmetics and pharmaceuticals; a bulk-forming laxative; a surgical lubricant and adhesive; and in the treatment of skin ulcers.", "PM": "91; was see under POLYSACCHARIDES 1978-90", "HN": "91(78); was see under POLYSACCHARIDES 1978-90", "MR": "20130709", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D007618"}, {"RECTYPE": "D", "MH": "Kartagener Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Kartagener Triad|T019|T047|EPO|EQV|NLM (2002)|010424|abbcdef", "ENTRY": "Syndrome, Siewert", "MN": "C16.320.480", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An autosomal recessive disorder characterized by a triad of DEXTROCARDIA; INFERTILITY; and SINUSITIS. The syndrome is caused by mutations of DYNEIN genes encoding motility proteins which are components of sperm tails, and CILIA in the respiratory and the reproductive tracts.", "PM": "2002; see KARTAGENER'S SYNDROME 1990-2001; see KARTAGENER TRIAD 1963-1989; for CILIARY DYSKINESIA, PRIMARY see CILIARY MOTILITY DISORDERS 1992-2001", "HN": "2002 (1963); for CILIARY DYSKINESIA, PRIMARY use CILIARY MOTILITY DISORDERS 1992-2001", "CATSH": "CAT LIST", "MR": "20180301", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D007619"}, {"RECTYPE": "D", "MH": "Karyometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Karyometric Image Analyses", "MN": "E05.242.384.467", "FX": "Karyotyping", "MH_TH": "NLM (1964)", "ST": "T059", "MS": "Microscopic study of the spacial distribution pattern of CHROMATIN in CELL NUCLEI and CELL NUCLEOLI.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007620"}, {"RECTYPE": "D", "MH": "Karyotyping", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Methods, Karyotype Analysis", "MN": "E05.393.285.475", "FX": "Karyotype", "MH_TH": "NLM (1965)", "ST": "T063", "MS": "Mapping of the KARYOTYPE of a cell.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007621"}, {"RECTYPE": "D", "MH": "Kazakhstan", "AQ": "EH EP", "PRINT ENTRY": "Kazakh S.S.R.|T083|NAM|EQV|NLM (1993)|920422|abcdef", "ENTRY": "Kazakh SSR|T083|NAM|EQV|NLM (1993)|920422|abcdef", "MN": "Z01.586.950.440", "MH_TH": "NLM (1993)", "ST": "T083", "MS": "A country in central Asia, northwest of China. The capital is Astana.", "OL": "use KAZAKHSTAN to search KAZAKH S.S.R. 1982-92", "HN": "93; was KAZAKH S.S.R. 1982-92; was heading 1963-81", "MR": "20170717", "DA": "19990101", "DC": "4", "DX": "19930101", "UI": "D007623"}, {"RECTYPE": "D", "MH": "KB Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "KB Cell", "MN": "A11.436.340.500", "MH_TH": "NLM (1985)", "ST": "T025", "AN": "almost always NIM with no subheadings; check HUMAN; do not routinely add neoplasm term", "PI": "Tissue Culture (1966-1971)", "MS": "This line KB is now known to be a subline of the ubiquitous KERATIN-forming tumor cell line HeLa. It was originally thought to be derived from an epidermal carcinoma of the mouth, but was subsequently found, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, to have been established via contamination by HELA CELLS. The cells are positive for keratin by immunoperoxidase staining. KB cells have been reported to contain human papillomavirus18 (HPV-18) sequences.", "PM": "85", "HN": "85", "MR": "20050630", "DA": "19840405", "DC": "1", "DX": "19850101", "UI": "D007624"}, {"RECTYPE": "D", "MH": "Kearns-Sayre Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Kearns Syndrome|T047|EPO|EQV|NLM (1983)|990101|abcdef", "ENTRY": "Syndromes, Ophthalmoplegia-Plus", "MN": "C23.888.592.636.447.511.500", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Retinitis Pigmentosa (1966-1982)", "MS": "A mitochondrial disorder featuring the triad of chronic progressive EXTERNAL OPHTHALMOPLEGIA, cardiomyopathy (CARDIOMYOPATHIES) with conduction block (HEART BLOCK), and RETINITIS PIGMENTOSA. Disease onset is in the first or second decade. Elevated CSF protein, sensorineural deafness, seizures, and pyramidal signs may also be present. Ragged-red fibers are found on muscle biopsy. (Adams et al., Principles of Neurology, 6th ed, p984)", "PM": "2010; see KEARNS-SAYER SYNDROME 2000-2009, see KEARNS SYNDROME 1991-2004, see OPHTHALMOPLEGIA 1983-1990", "HN": "2010 (1983)", "CATSH": "CAT LIST", "MR": "20210601", "DA": "19820426", "DC": "1", "DX": "19910101", "UI": "D007625"}, {"RECTYPE": "D", "MH": "Kell Blood-Group System", "AQ": "AD AE AN BI BL CF CH CL EC GE HI IM IP ME PD PH PO TO TU UL UR", "ENTRY": "System, Kell Blood-Group", "MN": "D23.050.705.230.533", "MH_TH": "NLM (1976)", "ST": "T022", "RN": "0", "AN": "IM; coord with disease /blood (IM), not /immunol nor /genet; TN 230", "PI": "Blood Groups (1966-1975)", "MS": "Multiple erythrocytic antigens that comprise at least three pairs of alternates and amorphs, determined by one complex gene or possibly several genes at closely linked loci. The system is important in transfusion reactions. Its expression involves the X-chromosome.", "PM": "91; was see under BLOOD GROUPS 1976-90", "HN": "91(76); was see under BLOOD GROUPS 1976-90", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D007626"}, {"RECTYPE": "D", "MH": "Keloid", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Keloids", "MN": "C23.550.355.274.510", "FX": "Cicatrix, Hypertrophic", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with CICATRIX, HYPERTROPHIC; follow text of author; ACNE KELOID is also available", "MS": "A sharply elevated, irregularly shaped, progressively enlarging scar resulting from formation of excessive amounts of collagen in the dermis during connective tissue repair. It is differentiated from a hypertrophic scar (CICATRIX, HYPERTROPHIC) in that the former does not spread to surrounding tissues.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007627"}, {"RECTYPE": "D", "MH": "Kentucky", "AQ": "EH EP", "MN": "Z01.107.567.875.510.400", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "A state bounded on the north by Illinois, Indiana, and Ohio; on the east by Virginia and west Virginia; on the south by Tennessee, and on the west by Missouri.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007629"}, {"RECTYPE": "D", "MH": "Kenya", "AQ": "EH EP", "ENTRY": "Republic of Kenya|T083|NAM|EQV|NLM (2009)|080304|abcdef", "MN": "Z01.058.290.120.400", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in eastern Africa, south of ETHIOPIA, west of SOMALIA with TANZANIA to its south, and coastline on the Indian Ocean. Its capital is Nairobi.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007630"}, {"RECTYPE": "D", "MH": "Chlordecone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Kepone|T109|T131|TRD|NRW|NLM (1996)|940714|abbcdef", "MN": "D02.455.526.439.190", "PA": "Insecticides", "MH_TH": "NLM (1977)", "ST": "T131", "N1": "1,3,4-Metheno-2H-cyclobuta(cd)pentalen-2-one, 1,1a,3,3a,4,5,5,5a,5b,6-decachlorooctahydro-", "RN": "RG5XJ88UDF", "RR": "143-50-0 (Chlordecone)", "PI": "Insecticides, Organochlorine (1973-1976)", "MS": "A highly chlorinated polycyclic hydrocarbon insecticide whose large number of chlorine atoms makes it resistant to degradation. It has been shown to be toxic to mammals and causes abnormal cellular changes in laboratory animals.", "PM": "96; was KEPONE 1977-95 (see under INSECTICIDES, ORGANOCHLORINE 1977-90); CHLORDECONE was see KEPONE 1977-95", "HN": "96; was KEPONE 1977-95 (see under INSECTICIDES, ORGANOCHLORINE 1977-90); CHLORDECONE was see KEPONE 1977-95", "MR": "20130708", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D007631"}, {"RECTYPE": "D", "MH": "Keratan Sulfate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Keratosulfate|T109|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Sulfate, Keratan", "MN": "D09.698.373.550", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Keratosulfate", "RN": "9056-36-4", "AN": "/biosyn /physiol permitted", "PI": "Mucopolysaccharides (1970-1974)", "MS": "A sulfated mucopolysaccharide initially isolated from bovine cornea. At least two types are known. Type I, found mostly in the cornea, contains D-galactose and D-glucosamine-6-O-sulfate as the repeating unit; type II, found in skeletal tissues, contains D-galactose and D-galactosamine-6-O-sulfate as the repeating unit.", "PM": "91; was see under MUCOPOLYSACCHARIDES 1975-90", "HN": "91(75); was see under MUCOPOLYSACCHARIDES 1975-90", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007632"}, {"RECTYPE": "D", "MH": "Keratins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Keratin Associated Protein|T116|T123|NON|NRW|NLM (2021)|191121|abbcdef", "ENTRY": "alpha Keratin", "MN": "D12.776.860.607", "FX": "Keratinocytes", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "68238-35-7", "RR": "9008-18-8 (other number)", "MS": "A class of fibrous proteins or scleroproteins that represents the principal constituent of EPIDERMIS; HAIR; NAILS; horny tissues, and the organic matrix of tooth ENAMEL. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms a coiled-coil alpha helical structure consisting of TYPE I KERATIN and a TYPE II KERATIN, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. alpha-Keratins have been classified into at least 20 subtypes. In addition multiple isoforms of subtypes have been found which may be due to GENE DUPLICATION.", "PM": "2007; see KERATIN 1966-2006; KERATIN-ASSOCIATED PROTEINS was indexed under KERATIN 2000-2006, & under PROTEINS 1993-1999", "HN": "2007(1966)", "MR": "20220407", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D007633"}, {"RECTYPE": "D", "MH": "Keratitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Keratitides", "MN": "C11.204.564", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Inflammation of the cornea.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007634"}, {"RECTYPE": "D", "MH": "Keratitis, Dendritic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Keratitis, Furrow|T047|NON|EQV|NLM (1990)|890414|abcdef", "ENTRY": "Keratitides, Furrow", "MN": "C11.294.800.475.450", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a form of herpetic keratitis with dendritic (branching) ulcers", "MS": "A form of herpetic keratitis characterized by the formation of small vesicles which break down and coalesce to form recurring dendritic ulcers, characteristically irregular, linear, branching, and ending in knoblike extremities. (Dictionary of Visual Science, 3d ed)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007635"}, {"RECTYPE": "D", "MH": "Keratoacanthoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Keratoacanthomas", "MN": "C17.800.417", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "note category: non-neoplastic; coord IM with precoord organ/dis term (IM); do not confuse with ACANTHAMOEBA KERATITIS", "MS": "A benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007636"}, {"RECTYPE": "D", "MH": "Keratoconjunctivitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Keratoconjunctivitides", "MN": "C11.204.564.585", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "inflamm of cornea & conjunctiva", "MS": "Simultaneous inflammation of the cornea and conjunctiva.", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007637"}, {"RECTYPE": "D", "MH": "Keratoconjunctivitis Sicca", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sicca, Keratoconjunctivitis", "MN": "C11.496.260.394", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "if with xerostomia or xerostomia & connective tissue dis, index as SJOGREN'S SYNDROME", "PI": "Keratoconjunctivitis (1966-1985)", "MS": "Drying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. When found in association with XEROSTOMIA and polyarthritis, it is called SJOGREN'S SYNDROME.", "PM": "91; was see under KERATOCONJUNCTIVITIS 1986-90", "HN": "91(86); was see under KERATOCONJUNCTIVITIS 1986-90", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19850605", "DC": "1", "DX": "19910101", "UI": "D007638"}, {"RECTYPE": "D", "MH": "Keratoconjunctivitis, Infectious", "DE": "KERATOCONJUNCTIVITIS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Infectious Keratoconjunctivitis|T047|NON|EQV|UNK (19XX)|850605|INFECT KERATOCONJUNCTIVITIS|abcdefv", "ENTRY": "Keratoconjunctivitides, Infectious", "MN": "C22.500", "MH_TH": "NLM (1986)", "ST": "T047", "AN": "animal only; check tag ANIMALS; coord IM with organism/infect heading /vet (IM)", "PI": "Moraxella (1966-1985)", "MS": "Infectious diseases of cattle, sheep, and goats, characterized by blepharospasm, lacrimation, conjunctivitis, and varying degrees of corneal opacity and ulceration. In cattle the causative agent is MORAXELLA (MORAXELLA) BOVIS; in sheep, MYCOPLASMA; RICKETTSIA; CHLAMYDIA; or ACHOLEPLASMA; in goats, RICKETTSIA.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19850605", "DC": "1", "DX": "19860101", "UI": "D007639"}, {"RECTYPE": "D", "MH": "Keratoconus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pellucid Marginal Degeneration|T047|NON|REL|NLM (2023)|220502|abcdef", "ENTRY": "Pellucid Marginal Degenerations", "MN": "C11.204.627", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "cone-shaped protrusion of cornea", "MS": "A noninflammatory, usually bilateral protrusion and thinning of the CORNEA, the apex being displaced downward and nasally. It occurs most commonly in females at about puberty. Two closely related noninflammatory corneal ectasias are pellucid marginal degeneration and keratoglobus.", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007640"}, {"RECTYPE": "D", "MH": "Keratolytic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Desquamating Agents|T121|NON|EQV|UNK (19XX)|800331|abcdef", "ENTRY": "Skin Peeling Agents", "MN": "D27.505.954.444.400", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "GEN or unspecified; prefer specifics", "PI": "Skin Diseases (1966)", "MS": "Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.", "OL": "search DERMATOLOGIC AGENTS 1967-74", "PM": "91; was see under DERMATOLOGIC AGENTS 1975-90", "HN": "91(75); was see under DERMATOLOGIC AGENTS 1975-90", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007641"}, {"RECTYPE": "D", "MH": "Keratosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Keratosis Blennorrhagica|T047|NON|NRW|NLM (1997)|960415|abcdef", "ENTRY": "Keratosis Blennorrhagicas", "MN": "C17.800.428", "MH_TH": "NLM (1966)", "ST": "T020", "AN": "a horny skin dis", "MS": "Any horny growth such as a wart or callus.", "OL": "use GONORRHEA to search KERATODERMA BLENNORRHAGICUM 1966-74", "PM": "KERATODERMA BLENNORRHAGICUM was heading 1975-96 (was KERATOSIS BLENNORRHAGICA 1963-92 (see under KERATOSIS 1979-90, see under GONORRHEA 1975-78)), was see under GONORRHEA 1963-74; KERATOSIS BLENNORRHAGICA was see KERATODERMA BLENNORRHAGICUM 1993-96", "HN": "KERATODERMA BLENNORRHAGICUM was heading 1975-96 (was KERATOSIS BLENNORRHAGICA 1963-92 (see under KERATOSIS 1979-90, see under GONORRHEA 1975-78)), was see under GONORRHEA 1963-74; KERATOSIS BLENNORRHAGICA was see KERATODERMA BLENNORRHAGICUM 1993-96", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007642"}, {"RECTYPE": "D", "MH": "Darier Disease", "DE": "DARIER DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Keratosis Follicularis|T047|NON|EQV|GHR (2014)|NLM (1966)|OMIM (2013)|ORD (2010)|990101|abcdeeeef", "ENTRY": "Verruciformis, Acrokeratosis", "MN": "C17.800.827.190", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "An autosomal dominantly inherited skin disorder characterized by warty malodorous papules that coalesce into plaques. It is caused by mutations in the ATP2A2 gene encoding SERCA2 protein, one of the SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES. The condition is similar, clinically and histologically, to BENIGN FAMILIAL PEMPHIGUS, another autosomal dominant skin disorder. Both diseases have defective calcium pumps (CALCIUM-TRANSPORTING ATPASES) and unstable desmosomal adhesion junctions (DESMOSOMES) between KERATINOCYTES.", "PM": "2009; see KERATOSIS FOLLICULARIS 1966-2008", "HN": "2009 (1966)", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D007644"}, {"RECTYPE": "D", "MH": "Keratoderma, Palmoplantar", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Palmoplantar Keratoderma|T019|T047|NON|EQV|NLM (1990)|ORD (2010)|890501|abbcdeef", "ENTRY": "de Meleda, Mal", "MN": "C17.800.827.475", "FX": "Erythrokeratodermia Variabilis", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "KERATODERMA, PALMOPLANTAR, DIFFUSE is also available; do not confuse entry term HYPERKERATOSIS PALMARIS ET PLANTARIS with POROKERATOSIS PALMARIS ET PLANTARIS DISSEMINATA see POROKERATOSIS", "MS": "Group of mostly hereditary disorders characterized by thickening of the palms and soles as a result of excessive keratin formation leading to hypertrophy of the stratum corneum (hyperkeratosis).", "OL": "use KERATODERMA, PALMOPLANTAR to search KERATOSIS PALMARIS ET PLANTARIS 1974-92", "PM": "93; was KERATOSIS PALMARIS ET PLANTARIS 1974-92; KERATODERMA, PALMOPLANTAR was see KERATOSIS PALMARIS ET PLANTARIS 1990-92", "HN": "93; was KERATOSIS PALMARIS ET PLANTARIS 1974-92; KERATODERMA, PALMOPLANTAR was see KERATOSIS PALMARIS ET PLANTARIS 1990-92", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007645"}, {"RECTYPE": "D", "MH": "Keratotomy, Radial", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Radial Keratotomy|T061|NON|EQV|UNK (19XX)|860620|abcdef", "ENTRY": "Radial Keratotomies", "MN": "E04.540.825.550", "MH_TH": "NLM (1987)", "ST": "T061", "PI": "Myopia (1966-1986)", "MS": "A procedure to surgically correct REFRACTIVE ERRORS by cutting radial slits into the CORNEA to change its refractive properties.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19860620", "DC": "1", "DX": "19870101", "UI": "D007646"}, {"RECTYPE": "D", "MH": "Kernicterus", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperbilirubinemic Encephalopathy|T047|NON|EQV|NLM (2000)|991103|HYPERBILIRUBINEMIC ENCEPH|abcdefv", "ENTRY": "Hyperbilirubinemic Encephalopathies", "MN": "C23.550.429.750", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A term used pathologically to describe BILIRUBIN staining of the BASAL GANGLIA; BRAIN STEM; and CEREBELLUM and clinically to describe a syndrome associated with HYPERBILIRUBINEMIA. Clinical features include athetosis, MUSCLE SPASTICITY or hypotonia, impaired vertical gaze, and DEAFNESS. Nonconjugated bilirubin enters the brain and acts as a neurotoxin, often in association with conditions that impair the BLOOD-BRAIN BARRIER (e.g., SEPSIS). This condition occurs primarily in neonates (INFANT, NEWBORN), but may rarely occur in adults. (Menkes, Textbook of Child Neurology, 5th ed, p613)", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007647"}, {"RECTYPE": "D", "MH": "Kerosene", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Kerosine|T167|NON|EQV|NLM (1998)|961015|abcdef", "MN": "N06.230.132.258.630.600", "MH_TH": "NLM (1963)", "ST": "T167", "RN": "0", "MS": "A refined petroleum fraction used as a fuel as well as a solvent.", "OL": "use KEROSINE to search KEROSENE 1966-81 (as Prov 1966-74, as Cat D & H heading 1968-74, as Cat D heading 1966-67)", "PM": "98; was KEROSINE 1982-97 (see under PETROLEUM 1982-90); was KEROSENE see under PETROLEUM 1975-81; was Cat J heading only 1975-81", "HN": "98; was KEROSINE 1982-97 (see under PETROLEUM 1982-90); was KEROSENE see under PETROLEUM 1963-81 (Prov 1963-74); was Cat J heading only 1975-81, Cat D & H heading 1968-74, Cat D heading only 1963-67", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007648"}, {"RECTYPE": "D", "MH": "Ketamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CI581", "MN": "D02.455.426.392.368.367.652", "PA": "Excitatory Amino Acid Antagonists", "MH_TH": "JAN (19XX)", "ST": "T121", "N1": "Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)-", "RN": "690G0D6V8H", "RR": "O18YUO0I83", "PI": "Cyclohexanes (1968-1972)", "MS": "A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.", "OL": "use KETAMINE to search CI-581 1969-72 (as Prov)", "PM": "73", "HN": "73; was CI-581 1969-72 (Prov)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007649"}, {"RECTYPE": "D", "MH": "Ketanserin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R41468", "MN": "D03.633.100.786.830.333", "PA": "Serotonin Antagonists", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "2,4(1H,3H)-Quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-", "RN": "97F9DE4CT4", "RR": "74050-98-9 (Ketanserin)", "PI": "Piperidines (1966-1986)", "MS": "A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.", "PM": "87", "HN": "87", "MR": "20160531", "DA": "19860409", "DC": "1", "DX": "19870101", "UI": "D007650"}, {"RECTYPE": "D", "MH": "Keto Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Oxo", "MN": "D02.241.755", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Carboxylic acids that contain a KETONE group.", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007651"}, {"RECTYPE": "D", "MH": "Oxo-Acid-Lyases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ketoacid-Lyases|T116|T126|NON|EQV|NLM (1998)|961118|abbcdef", "ENTRY": "Oxo Acid Lyases", "MN": "D08.811.520.224.600", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 4.1.3.-", "PI": "Lyases (1966-1972)", "MS": "Enzymes that catalyze the cleavage of a carbon-carbon bond of a 3-hydroxy acid. (Dorland, 28th ed) EC 4.1.3.", "PM": "98; see KETOACID-LYASES 1973-97", "HN": "98(73)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007652"}, {"RECTYPE": "D", "MH": "Ketocholesterols", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxocholesterols|T109|NON|EQV|UNK (19XX)|790221|abcdef", "MN": "D10.570.938.208.825.750", "MH_TH": "NLM (1980)", "ST": "T109", "RN": "0", "PI": "Cholesterol (1966-1974) /analogs & derivatives (1975-1979)", "MS": "Cholesterol substituted in any position by a keto moiety. The 7-keto isomer inhibits cholesterol uptake in the coronary arteries and aorta by blocking 3-hydroxy-3-methylglutaryl-CoA reductase activity.", "PM": "91; was see under CHOLESTEROL 1980-90", "HN": "91(80); was see under CHOLESTEROL 1980-90", "MR": "20160606", "DA": "19790221", "DC": "1", "DX": "19910101", "UI": "D007653"}, {"RECTYPE": "D", "MH": "Ketoconazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R 41400", "MN": "D03.383.606.560", "PA": "Cytochrome P-450 CYP3A Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Piperazine, 1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-, cis-", "RN": "R9400W927I", "RR": "65277-42-1 (Ketoconazole)", "PI": "Piperazines (1966-1983)", "MS": "Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.", "PM": "84", "HN": "84", "MR": "20170524", "DA": "19830311", "DC": "1", "DX": "19840101", "UI": "D007654"}, {"RECTYPE": "D", "MH": "Ketoglutarate Dehydrogenase Complex", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Ketoglutarate Dehydrogenase Complex", "MN": "D08.811.682.657.350.750", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "2-Oxoglutarate:lipoamide 2-oxidoreductase (decarboxylating and acceptor-succinylating)", "RN": "EC 1.2.4.2", "PM": "91; was see under KETONE OXIDOREDUCTASES 1973-90", "HN": "91(73); was see under KETONE OXIDOREDUCTASES 1973-90", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007655"}, {"RECTYPE": "D", "MH": "Ketoglutaric Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxoglutarates|T109|T123|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "alpha-Ketoglutarate, Calcium", "MN": "D02.241.755.465", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "RR": "997-43-3", "MS": "A family of compounds containing an oxo group with the general structure of 1,5-pentanedioic acid. (From Lehninger, Principles of Biochemistry, 1982, p442)", "OL": "use KETOGLUTARIC ACIDS to search KETOGLUTARIC ACID 1966-74", "PM": "2019; ALPHA-KETOGLUTARIC ACID was indexed under KETOGLUTARIC ACIDS 1981-2018; see KETOGLUTARIC ACID 1963-1974", "HN": "2019 (1975)", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D007656"}, {"RECTYPE": "D", "MH": "Ketone Bodies", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acetone Bodies|T109|T123|NON|NRW|UNK (19XX)|740330|abbcdef", "ENTRY": "Bodies, Ketone", "MN": "D02.522.585", "FX": "Ketosis", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "ketogenesis is probably KETONE BODIES /biosyn", "MS": "The metabolic substances ACETONE; 3-HYDROXYBUTYRIC ACID; and acetoacetic acid (ACETOACETATES). They are produced in the liver and kidney during FATTY ACIDS oxidation and used as a source of energy by the heart, muscle and brain.", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007657"}, {"RECTYPE": "D", "MH": "Ketone Oxidoreductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidoreductases, Ketone", "MN": "D08.811.682.657.350", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 1.2.-", "PI": "Oxidoreductases (1966-1972)", "MS": "Oxidoreductases that are specific for KETONES.", "PM": "73", "HN": "73", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007658"}, {"RECTYPE": "D", "MH": "Ketones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ketone|T109|NON|EQV|NLM (2021)|191230|abcdef", "MN": "D02.522", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "KETO ACIDS & KETOSES are also available; ketogenesis is probably KETONE BODIES /biosyn", "MS": "Organic compounds containing a carbonyl group =C=O bonded to two hydrocarbon groups.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007659"}, {"RECTYPE": "D", "MH": "Ketoprofen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzoylhydratropic Acid|T109|T121|NON|EQV|UNK (19XX)|800519|abbcdef", "ENTRY": "RP19583", "MN": "D02.241.223.701.480", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzeneacetic acid, 3-benzoyl-alpha-methyl-", "RN": "90Y4QC304K", "RR": "22071-15-4 (Ketoprofen)", "PI": "Propionates (1966-1967)", "MS": "An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.", "PM": "90; was see under PHENYLPROPIONATES 1978-89; was see under BENZOPHENONES 1975-77", "HN": "90(75); was see under PHENYLPROPIONATES 1978-89; was see under BENZOPHENONES 1975-77", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19900101", "UI": "D007660"}, {"RECTYPE": "D", "MH": "Ketoses", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ketose|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Sugars, Keto", "MN": "D09.947.875.465", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "monosaccharides; do not confuse with KETOSIS, a disease", "MS": "MONOSACCHARIDES containing one ketone group per molecule.", "PM": "74", "HN": "74", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007661"}, {"RECTYPE": "D", "MH": "Ketosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Metabolic Ketosis|T046|T047|NON|NRW|NLM (2011)|100303|abbcdef", "ENTRY": "Metabolic Ketoses", "MN": "C18.452.076.176.652", "FX": "Ketone Bodies", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "high levels of ketone bodies; do not confuse with KETOSES (monosaccharides); ketogenesis is probably KETONE BODIES /biosyn", "MS": "A condition characterized by an abnormally elevated concentration of KETONE BODIES in the blood (acetonemia) or urine (acetonuria). It is a sign of DIABETES COMPLICATION, starvation, alcoholism or a mitochondrial metabolic disturbance (e.g., MAPLE SYRUP URINE DISEASE).", "OL": "search ACIDOSIS 1966-74", "PM": "91; was see under ACIDOSIS 1975-90", "HN": "91(75); was see under ACIDOSIS 1975-90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007662"}, {"RECTYPE": "D", "MH": "Ketosteroids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxosteroids|T109|NON|EQV|NLM (1994)|930217|abcdef", "MN": "D04.210.500.578", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "AN": "/physiol permitted", "PI": "appropriate steroid class (1971-1973)", "MS": "Steroid derivatives formed by oxidation of a methyl group on the side chain or a methylene group in the ring skeleton to form a ketone.", "PM": "74", "HN": "74(71)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007664"}, {"RECTYPE": "D", "MH": "Ketotifen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Fumarate, Ketotifen", "MN": "D03.383.903.370", "PA": "Histamine H1 Antagonists", "MH_TH": "NLM (1982)", "ST": "T121", "N1": "10H-Benzo(4,5)cyclohepta(1,2-b)thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-", "RN": "X49220T18G", "RR": "HBD503WORO", "PI": "Thiophenes (1966-1981)", "MS": "A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.", "PM": "82", "HN": "82", "MR": "20160531", "DA": "19810513", "DC": "1", "DX": "19820101", "UI": "D007665"}, {"RECTYPE": "D", "MH": "Khellin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Visammin|T109|T121|NON|EQV|UNK (19XX)|740330|abbcdef", "MN": "D03.633.300.770.300", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "5H-Furo(3,2-g)(1)benzopyran-5-one, 4,9-dimethoxy-7-methyl-", "RN": "5G117T0TJZ", "RR": "82-02-0 (Khellin)", "MS": "A vasodilator that also has bronchodilatory action. It has been employed in the treatment of angina pectoris, in the treatment of asthma, and in conjunction with ultraviolet light A, has been tried in the treatment of vitiligo. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1024)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007666"}, {"RECTYPE": "D", "MH": "Kidd Blood-Group System", "AQ": "AD AE AN BI BL CF CH CL EC GE HI IM IP ME PD PH PO TO TU UL UR", "ENTRY": "System, Kidd Blood-Group", "MN": "D23.050.705.230.538", "MH_TH": "NLM (1976)", "ST": "T022", "RN": "0", "AN": "IM; coord with disease /blood (IM), not /immunol nor /genet; TN 230", "PI": "Blood Groups (1966-1975)", "MS": "A group of antigens consisting principally of Jk(a) and Jk(b), determined by allelic genes. Amorphs are encountered. Antibodies of these substances are usually weak and quite labile, stimulated by erythrocytes.", "PM": "91; was see under BLOOD GROUPS 1976-90", "HN": "91(76); was see under BLOOD GROUPS 1976-90", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D007667"}, {"RECTYPE": "D", "MH": "Kidney", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Kidneys|T023|NON|EQV|BIOETHICS (1974)|770317|abcdef", "MN": "A05.810.453", "FX": "Renal Circulation", "EC": "transplantation:Kidney Transplantation", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at GLOMERUL-, NEPHR-, PYEL-, and RENAL", "MS": "Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.", "PM": "/transplantation was KIDNEY TRANSPLANTATION 1963-65; was KIDNEY/transplantation 1966-89", "HN": "/transplantation was KIDNEY TRANSPLANTATION 1963-65; was KIDNEY/transplantation 1966-89", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007668"}, {"RECTYPE": "D", "MH": "Kidney Calculi", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Renal Calculi|T031|NON|EQV|UNK (19XX)|880607|abcdef", "ENTRY": "Stones, Kidney", "MN": "C23.300.175.850.550", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE.", "OL": "to search for chem composition of kidney calculi, use KIDNEY CALCULI/anal 1987-90 & KIDNEY CALCULI/metab 1966-86", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007669"}, {"RECTYPE": "D", "MH": "Kidney Calices", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Kidney Calice", "MN": "A05.810.453.537.503", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "a part of the kidney pelvis", "MS": "Recesses of the kidney pelvis which divides into two wide, cup-shaped major renal calices, with each major calix subdivided into 7 to 14 minor calices. Urine empties into a minor calix from collecting tubules, then passes through the major calix, renal pelvis, and ureter to enter the urinary bladder. (From Moore, Clinically Oriented Anatomy, 3d ed, p211)", "OL": "search KIDNEY PELVIS 1968-74", "PM": "91; was see under KIDNEY PELVIS 1975-90", "HN": "91(75); was see under KIDNEY PELVIS 1975-90", "MR": "19950313", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007670"}, {"RECTYPE": "D", "MH": "Kidney Concentrating Ability", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Urine Concentrating Ability|T042|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Urine Concentrating Abilities", "MN": "G08.852.536", "MH_TH": "NLM (1967)", "ST": "T042", "PI": "Kidney/physiology (1966)", "MS": "The ability of the kidney to excrete in the urine high concentrations of solutes from the blood plasma.", "PM": "70", "HN": "70(67)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D007671"}, {"RECTYPE": "D", "MH": "Kidney Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cortex, Kidney", "MN": "A05.810.453.324", "MH_TH": "NLM (1973)", "ST": "T023", "PI": "Kidney (1966-1972)", "MS": "The outer zone of the KIDNEY, beneath the capsule, consisting of KIDNEY GLOMERULUS; KIDNEY TUBULES, DISTAL; and KIDNEY TUBULES, PROXIMAL.", "PM": "74", "HN": "74(73)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007672"}, {"RECTYPE": "D", "MH": "Kidney Cortex Necrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Renal Cortical Necrosis|T033|T047|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Necrosis, Renal Tubule", "MN": "C12.950.419.393", "MH_TH": "NLM (1967)", "ST": "T047", "MS": "Death of cells in the KIDNEY CORTEX, a common final result of various renal injuries including HYPOXIA; ISCHEMIA; and drug toxicity.", "OL": "use KIDNEY CORTEX NECROSIS to search NECROSIS, RENAL CORTICAL 1966 (as Prov)", "PM": "67", "HN": "67; was NECROSIS, RENAL CORTICAL 1964-66 (Prov)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007673"}, {"RECTYPE": "D", "MH": "Kidney Diseases", "DE": "KIDNEY DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Kidney Disease", "MN": "C12.950.419", "MH_TH": "BIOETHICS (1974)", "ST": "T047", "MS": "Pathological processes of the KIDNEY or its component tissues.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007674"}, {"RECTYPE": "D", "MH": "Kidney Failure, Chronic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Renal Failure, End-Stage|T047|NON|EQV|NLM (1993)|911001|abcdef", "ENTRY": "Renal Failure, End Stage", "MN": "C23.550.291.500.906.500", "FX": "Uremia", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "RENAL INSUFFICIENCY, CHRONIC is also available", "MS": "The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.", "PM": "67", "HN": "67(66)", "CATSH": "CAT LIST", "MR": "20210607", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007676"}, {"RECTYPE": "D", "MH": "Kidney Function Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Kidney Function", "MN": "E01.370.390.400", "MH_TH": "NLM (1966)", "ST": "T059", "MS": "Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine.", "CATSH": "CAT LIST", "MR": "20150522", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007677"}, {"RECTYPE": "D", "MH": "Kidney Glomerulus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Glomerulus, Kidney", "MN": "A05.810.453.736.520", "FX": "Renal Plasma Flow, Effective", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007678"}, {"RECTYPE": "D", "MH": "Kidney Medulla", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Kidney Papilla|T023|NON|NRW|UNK (19XX)|780126|abcdef", "ENTRY": "Papillas, Kidney", "MN": "A05.810.453.466", "MH_TH": "NLM (1973)", "ST": "T023", "PI": "Kidney (1966-1972)", "MS": "The internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces.", "PM": "79; was see under KIDNEY 1975-78", "HN": "79(73); was see under KIDNEY 1975-78", "MR": "19910107", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D007679"}, {"RECTYPE": "D", "MH": "Kidney Neoplasms", "DE": "KIDNEY NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Renal Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Renal Neoplasm", "MN": "C12.950.983.535", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "general prefer specifics; coordinate IM with histological type of neoplasm (IM)", "MS": "Tumors or cancers of the KIDNEY.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007680"}, {"RECTYPE": "D", "MH": "Kidney Papillary Necrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Renal Papillitis, Necrotizing|T033|T047|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Renal Papillitides, Necrotizing", "MN": "C12.950.419.493", "MH_TH": "NLM (1967)", "ST": "T047", "MS": "A complication of kidney diseases characterized by cell death involving KIDNEY PAPILLA in the KIDNEY MEDULLA. Damages to this area may hinder the kidney to concentrate urine resulting in POLYURIA. Sloughed off necrotic tissue may block KIDNEY PELVIS or URETER. Necrosis of multiple renal papillae can lead to KIDNEY FAILURE.", "OL": "use KIDNEY PAPILLARY NECROSIS to search PYELONEPHRITIS, ACUTE NECROTIZING 1966", "PM": "67; was PYELONEPHRITIS, ACUTE NECROTIZING 1963-66", "HN": "67; was PYELONEPHRITIS, ACUTE NECROTIZING 1963-66", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007681"}, {"RECTYPE": "D", "MH": "Kidney Pelvis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Renal Pelvis|T023|NON|EQV|NLM (2007)|051020|abcdef", "ENTRY": "Pelvis, Renal", "MN": "A05.810.453.537", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at PYEL-", "MS": "The flattened, funnel-shaped expansion connecting the URETER to the KIDNEY CALICES.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007682"}, {"RECTYPE": "D", "MH": "Kidney Tubular Necrosis, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lower Nephron Nephrosis|T047|NON|EQV|UNK (19XX)|780227|abcdef", "ENTRY": "Nephrosis, Lower Nephron", "MN": "C12.950.419.780.050.500", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Acute kidney failure resulting from destruction of EPITHELIAL CELLS of the KIDNEY TUBULES. It is commonly attributed to exposure to toxic agents or renal ISCHEMIA following severe TRAUMA.", "OL": "use KIDNEY TUBULAR NECROSIS, ACUTE to search LOWER NEPHRON NEPHROSIS 1975-78; use KIDNEY FAILURE, ACUTE 1966-74", "PM": "91; was see under KIDNEY FAILURE, ACUTE 1975-90; LOWER NEPHRON NEPHROSIS was see under KIDNEY FAILURE, ACUTE 1971-78, was see KIDNEY FAILURE, ACUTE 1967-70, was see ACUTE RENAL FAILURE 1963-66", "HN": "91(75); was see under KIDNEY FAILURE, ACUTE 1975-90; LOWER NEPHRON NEPHROSIS was see under KIDNEY FAILURE, ACUTE 1971-78, was see KIDNEY FAILURE, ACUTE 1967-70, was see ACUTE RENAL FAILURE 1963-66", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007683"}, {"RECTYPE": "D", "MH": "Kidney Tubules", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tubules, Kidney", "MN": "A05.810.453.736.560", "MH_TH": "NLM (1963)", "ST": "T023", "MS": "Long convoluted tubules in the nephrons. They collect filtrate from blood passing through the KIDNEY GLOMERULUS and process this filtrate into URINE. Each renal tubule consists of a BOWMAN CAPSULE; PROXIMAL KIDNEY TUBULE; LOOP OF HENLE; DISTAL KIDNEY TUBULE; and KIDNEY COLLECTING DUCT leading to the central cavity of the kidney (KIDNEY PELVIS) that connects to the URETER.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007684"}, {"RECTYPE": "D", "MH": "Kidney Tubules, Collecting", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Kidney Collecting Ducts|T023|NON|EQV|UNK (19XX)|780123|abcdef", "ENTRY": "Collecting Ducts, Kidney", "MN": "A05.810.453.736.560.510", "MH_TH": "NLM (1979)", "ST": "T023", "PI": "Kidney Tubules, Distal (1973-1978)", "MS": "Straight tubes commencing in the radiate part of the kidney cortex where they receive the curved ends of the distal convoluted tubules. In the medulla the collecting tubules of each pyramid converge to join a central tube (duct of Bellini) which opens on the summit of the papilla.", "PM": "91; was see under KIDNEY TUBULES 1979-90", "HN": "91(79); was see under KIDNEY TUBULES 1979-90", "MR": "20060705", "DA": "19780123", "DC": "1", "DX": "19910101", "UI": "D007685"}, {"RECTYPE": "D", "MH": "Kidney Tubules, Distal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tubules, Distal Renal", "MN": "A05.810.453.736.560.540", "MH_TH": "NLM (1973)", "ST": "T023", "PI": "Kidney Tubules (1966-1972)", "MS": "The portion of renal tubule that begins from the enlarged segment of the ascending limb of the LOOP OF HENLE. It reenters the KIDNEY CORTEX and forms the convoluted segments of the distal tubule.", "PM": "91; was see under KIDNEY TUBULES 1973-90", "HN": "91(73); was see under KIDNEY TUBULES 1973-90", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007686"}, {"RECTYPE": "D", "MH": "Kidney Tubules, Proximal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tubules, Proximal Renal", "MN": "A05.810.453.736.560.570", "MH_TH": "NLM (1973)", "ST": "T023", "PI": "Kidney Tubules (1966-1972)", "MS": "The renal tubule portion that extends from the BOWMAN CAPSULE in the KIDNEY CORTEX into the KIDNEY MEDULLA. The proximal tubule consists of a convoluted proximal segment in the cortex, and a distal straight segment descending into the medulla where it forms the U-shaped LOOP OF HENLE.", "PM": "74", "HN": "74(73)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007687"}, {"RECTYPE": "D", "MH": "Kidneys, Artificial", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Kidney, Artificial|T074|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Renal Dialysis Machines", "MN": "E07.858.082.585", "FX": "Renal Dialysis", "MH_TH": "NLM (2013)", "ST": "T074", "MS": "Devices which can substitute for normally functioning KIDNEYS in removing components from the blood by DIALYSIS that are normally eliminated in the URINE.", "PM": "2013; see KIDNEY, ARTIFICIAL 1966-2012", "HN": "2013 (1966)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "20130101", "UI": "D007688"}, {"RECTYPE": "D", "MH": "Polycystic Kidney Diseases", "DE": "POLYCYSTIC KIDNEY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Renal Diseases, Polycystic", "MN": "C16.320.184.625", "MH_TH": "NLM (2001)", "ST": "T047", "AN": "KIDNEY, CYSTIC and MULTICYSTIC DYSPLASTIC KIDNEY are also available; prefer specifics", "MS": "Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance.", "PM": "1991; see POLYCYSTIC KIDNEY 1991-2000", "HN": "1991", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007690"}, {"RECTYPE": "D", "MH": "Medullary Sponge Kidney", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Cacchi-Ricci", "MN": "C12.950.419.403.500", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A non-hereditary KIDNEY disorder characterized by the abnormally dilated (ECTASIA) medullary and inner papillary portions of the collecting ducts. These collecting ducts usually contain CYSTS or DIVERTICULA filled with jelly-like material or small calculi (KIDNEY STONES) leading to infections or obstruction. It should be distinguished from congenital or hereditary POLYCYSTIC KIDNEY DISEASES.", "PM": "2006; see KIDNEY, SPONGE 1965-2005", "HN": "2006 (1965)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007691"}, {"RECTYPE": "D", "MH": "Diatomaceous Earth", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Kieselguhr|T197|NON|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Earth, Infusorial", "MN": "D01.837.725.400", "MH_TH": "NLM (1991)", "ST": "T197", "N1": "Kieselguhr", "RN": "61790-53-2", "MS": "A form of SILICON DIOXIDE composed of skeletons of prehistoric aquatic plants which is used for its ABSORPTION quality, taking up 1.5-4 times its weight in water. The microscopic sharp edges are useful for insect control but can also be an inhalation hazard. It has been used in baked goods and animal feed. Kieselguhr is German for flint + earthy sediment.", "OL": "use SILICA to search KIESELGUHR 1968-74", "PM": "91; was see under SILICA 1975-90", "HN": "91(75); was see under SILICA 1975-90", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007692"}, {"RECTYPE": "D", "MH": "Killer Cells, Natural", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Natural Killer Cells|T025|NON|EQV|UNK (19XX)|820429|abcdef", "ENTRY": "Natural Killer Cell", "MN": "A15.382.490.555.567.537", "FX": "Receptors, Natural Killer Cell", "MH_TH": "NLM (1983)", "ST": "T025", "AN": "do not confuse with NATURAL KILLER T-CELLS; if subpopulations are discussed, coordinate IM with LYMPHOCYTE SUBSETS (IM)", "PI": "Killer Cells (1978-1982)", "MS": "Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type.", "PM": "1983", "HN": "1983", "MR": "20130709", "DA": "19820429", "DC": "1", "DX": "19830101", "UI": "D007694"}, {"RECTYPE": "D", "MH": "Killifishes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Pupfishes|T013|NON|NRW|NLM (2002)|000808|abcdef", "MN": "B01.050.150.900.493.850.280.500", "MH_TH": "NLM (2002)", "ST": "T013", "RN": "txid8076", "RR": "txid28741", "AN": "KILLIFISH; ATLANTIC KILLIFISH; GULF KILLIFISH see FUNDULIDAE and JAPANESE KILLIFISH see ORYZIAS are available; killifish unspecified goes here", "MS": "Small oviparous fishes mostly in the family Cyprinodontidae but also some members of families Aplocheilidae, Fundulidae, Profundulidae, and Rivulidae. Some killifishes are used in mosquito control. Killifishes are vertebrate model organisms in various fields, e.g., environmental toxicology and neurobiology, because of their short lifespans, ease of maintenance and large number of eggs produced.", "PM": "2002; see KILLIFISH 1991-2001, see CYPRINODONTIFORMES 1987-1990, was see FISHES 1975-1986", "HN": "2002(1975); was see under CYPRINODONTIFORMES 1987-90; was see under FISHES 1975-86", "MR": "20230226", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D007695"}, {"RECTYPE": "D", "MH": "Kindling, Neurologic", "AQ": "DE ES GE IM ME PA PH RE", "ENTRY": "Neurologic Kindlings", "MN": "G11.561.484", "FX": "Seizures", "MH_TH": "NLM (2007)", "ST": "T046", "PI": "Electric Stimulation (1966-1981)", "MS": "The repeated weak excitation of brain structures, that progressively increases sensitivity to the same stimulation. Over time, this can lower the threshold required to trigger seizures.", "PM": "2007; see KINDLING (NEUROLOGY) 1982-2006", "HN": "2007(1982)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19810224", "DC": "1", "DX": "19820101", "UI": "D007696"}, {"RECTYPE": "D", "MH": "Kinesics", "PRINT ENTRY": "Body Language|T040|NON|NRW|UNK (19XX)|780428|abcdef", "ENTRY": "Languages, Body", "MN": "F01.145.209.530.538", "FX": "Posture", "MH_TH": "NLM (1968)", "ST": "T090", "AN": "do not confuse with KINETICS or KINESIS", "PI": "Communication (1966-1967)", "MS": "Systematic study of the body and the use of its static and dynamic position as a means of communication.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007697"}, {"RECTYPE": "D", "MH": "Kinesis", "AQ": "CL DE ES PH RE", "ENTRY": "Kineses", "MN": "F01.145.113.700", "MH_TH": "NLM (1975)", "ST": "T055", "AN": "do not confuse with KINETICS or KINESICS", "MS": "Locomotor behavior not involving a steering reaction, but in which there may be a turning random in direction. It includes orthokinesis, the rate of movement and klinokinesis, the amount of turning, which are related to the intensity of stimulation.", "OL": "search ORIENTATION 1968-74", "PM": "91; was see under ORIENTATION 1975-90", "HN": "91(75); was see under ORIENTATION 1975-90", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007698"}, {"RECTYPE": "D", "MH": "Kinesthesis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Kinesthesia|T041|T042|NON|EQV|NLM (2009)|080310|abbcdef", "ENTRY": "Movement Sensations", "MN": "G11.561.790.541.587", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "do not confuse with MOTION PERCEPTION", "MS": "Sense of movement of a part of the body, such as movement of fingers, elbows, knees, limbs, or weights.", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007699"}, {"RECTYPE": "D", "MH": "Kinetics", "MN": "G02.111.490", "MH_TH": "NLM (1964)", "ST": "T078", "AN": "almost never IM; do not confuse with KINESICS (\"use of posture or gesture for communication\") or KINESIS (a form of movement); pharmacokinetics of chemicals and drugs is PHARMACOKINETICS or better, specific drug term /pharmacokin", "MS": "The rate dynamics in chemical or physical systems.", "PM": "66", "HN": "66(64)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007700"}, {"RECTYPE": "D", "MH": "Kinetin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "6 Furfurylaminopurine", "MN": "D03.633.100.759.138.525.400", "PA": "Plant Growth Regulators", "MH_TH": "NLM (2006)", "ST": "T121", "RN": "P39Y9652YJ", "RR": "525-79-1 (Kinetin)", "AN": "do not confuse with kinectin", "MS": "A furanyl adenine found in PLANTS and FUNGI. It has plant growth regulation effects.", "PM": "2006; see KINETINS 1991-2005, see PLANT GROWTH REGULATORS 1975-1990", "HN": "2006(1975); for KINETIN use KINETINS (NM) 1974-2005; use PLANT GROWTH REGULATORS 1975-1990", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007701"}, {"RECTYPE": "D", "MH": "Kinetocardiography", "DE": "KINETOCARDIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Vibrocardiography|T060|NON|EQV|UNK (19XX)|740330|VIBROCARDIOGR|abcdefv", "ENTRY": "Vibrocardiographies", "MN": "E01.370.370.380.450", "MH_TH": "NLM (1964)", "ST": "T060", "MS": "The graphic recording of chest wall movement due to cardiac impulses.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007702"}, {"RECTYPE": "D", "MH": "Peptidyl-Dipeptidase A", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptidase P|T116|T126|T129|NON|EQV|NLM (2022)|210409|abbbcdef", "ENTRY": "Peptidyl Dipeptidase A", "MN": "D08.811.277.656.350.350.687", "EC": "antagonists & inhibitors:Angiotensin-Converting Enzyme Inhibitors", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "EC 3.4.15.1", "PI": "Peptide Peptidohydrolases (1966-1972)", "MS": "A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020).", "PM": "1994; see KININASE II 1974-93; for TONIN see KININASE II 1984-93", "HN": "1994; for TONIN use KININASE II 1984-93", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007703"}, {"RECTYPE": "D", "MH": "Kininogens", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cystatins, Kininogen|T116|T123|NON|EQV|NLM (1990)|890525|abbcdef", "ENTRY": "T Kininogen", "MN": "D23.529.812.654", "PA": "Cysteine Proteinase Inhibitors", "MH_TH": "NLM (1972)", "ST": "T123", "RN": "0", "AN": "cysteine proteinase inhib; /drug eff /physiol permitted", "PI": "Proteins (1966-1971)", "MS": "Endogenous peptides present in most body fluids. Certain enzymes convert them to active KININS which are involved in inflammation, blood clotting, complement reactions, etc. Kininogens belong to the cystatin superfamily. They are cysteine proteinase inhibitors. HIGH-MOLECULAR-WEIGHT KININOGEN; (HMWK); is split by plasma kallikrein to produce BRADYKININ. LOW-MOLECULAR-WEIGHT KININOGEN; (LMWK); is split by tissue kallikrein to produce KALLIDIN.", "PM": "74", "HN": "74(72)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007704"}, {"RECTYPE": "D", "MH": "Kinins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Kinin|T116|T123|NON|EQV|NLM (2021)|200312|abbcdef", "MN": "D23.529.812", "MH_TH": "NLM (1964)", "ST": "T123", "RN": "0", "AN": "a group of polypeptide autacoids", "MS": "A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588)", "PM": "66", "HN": "66(64)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007705"}, {"RECTYPE": "D", "MH": "Menkes Kinky Hair Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Steely Hair Syndrome|T047|NON|EQV|GHR (2014)|UNK (19XX)|760505|abcdeef", "ENTRY": "X-Linked Copper Deficiencies", "MN": "C18.452.648.618.590", "FX": "Superoxide Dismutase", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Brain Diseases (1966-1976)", "MS": "An inherited disorder of copper metabolism transmitted as an X-linked trait and characterized by the infantile onset of HYPOTHERMIA, feeding difficulties, hypotonia, SEIZURES, bony deformities, pili torti (twisted hair), and severely impaired intellectual development. Defective copper transport across plasma and endoplasmic reticulum membranes results in copper being unavailable for the synthesis of several copper containing enzymes, including PROTEIN-LYSINE 6-OXIDASE; CERULOPLASMIN; and SUPEROXIDE DISMUTASE. Pathologic changes include defects in arterial elastin, neuronal loss, and gliosis. (From Menkes, Textbook of Child Neurology, 5th ed, p125)", "PM": "2000; see KINKY HAIR SYNDROME 1991-1999; see BRAIN DISEASES, METABOLIC 1977-1990", "HN": "2000(1977)", "CATSH": "CAT LIST", "MR": "20190711", "DA": "19760505", "DC": "1", "DX": "19910101", "UI": "D007706"}, {"RECTYPE": "D", "MH": "Kyrgyzstan", "AQ": "EH EP", "PRINT ENTRY": "Kyrgyz Republic|T083|NAM|EQV|NLM (1995)|940420|abcdef", "ENTRY": "Kirghizia|T083|NAM|EQV|POPLINE (1993)|UNK (19XX)|810302|abcdeef", "MN": "Z01.586.950.450", "MH_TH": "NLM (1966)", "ST": "T083", "MS": "A country in located Central Asia, west of China, south of Kazakhstan.", "OL": "use KYRGYZSTAN to search KIRGHIZ S.S.R. 1982-92 & KIRGHIZIA 1966-81", "HN": "93; was KIRGHIZ S.S.R. 1982-92; was KIRGHIZIA 1963-81", "MR": "20170717", "DA": "19990101", "DC": "4", "DX": "19930101", "UI": "D007707"}, {"RECTYPE": "D", "MH": "Kirsten murine sarcoma virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Kirsten Sarcoma Virus|T005|EPO|EQV|NLM (1980)|990101|abcdef", "ENTRY": "Virus, Kirsten Sarcoma", "MN": "B04.820.650.375.860.500", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11808", "AN": "infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + SARCOMA, EXPERIMENTAL (IM)", "PI": "Mouse Tumor Viruses (1966-1974)", "MS": "A replication-defective murine sarcoma virus (SARCOMA VIRUSES, MURINE) capable of transforming mouse lymphoid cells and producing erythroid leukemia after superinfection with murine leukemia viruses (LEUKEMIA VIRUS, MURINE). It has also been found to transform cultured human fibroblasts, rat liver epithelial cells, and rat adrenocortical cells.", "PM": "2002; see KIRSTEN SARCOMA VIRUS 1991-2001, see MOUSE SARCOMA VIRUSES 1980-1990", "HN": "2002 (1980)", "MR": "20200813", "DA": "19790418", "DC": "1", "DX": "19910101", "UI": "D007708"}, {"RECTYPE": "D", "MH": "Klebsiella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.400", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid570", "AN": "KLEBSIELLA AEROGENES and KLEBSIELLA MOBILUS see ENTEROBACTER AEROGENES are also available", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms arrange singly, in pairs, or short chains. This genus is commonly found in the intestinal tract and is an opportunistic pathogen that can give rise to bacteremia, pneumonia, urinary tract and several other types of human infection.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007709"}, {"RECTYPE": "D", "MH": "Klebsiella Infections", "DE": "KLEBSIELLA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Klebsiella Infection", "MN": "C01.150.252.400.310.503", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "gram-neg bact infect; coord IM with various species (IM)", "PI": "Klebsiella (1966-1967)", "MS": "Infections with bacteria of the genus KLEBSIELLA.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007710"}, {"RECTYPE": "D", "MH": "Klebsiella pneumoniae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Klebsiella pneumoniae aerogenes|T007|NON|EQV|NLM (2021)|190919|abcdef", "ENTRY": "Klebsiella rhinoscleromatis|T007|NON|NRW|NLM (1972)|990101|abcdef", "MN": "B03.660.250.150.400.590", "FX": "Enterobacter aerogenes", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid573", "RR": "txid39831", "AN": "infection: coordinate with KLEBSIELLA INFECTIONS", "PI": "Klebsiella (1966-1971)", "MS": "Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.", "PM": "1974; for KLEBSIELLA RHINOSCLEROMATIS see KLEBSIELLA RHINOSCLEROMATIS 1972-2003", "HN": "1974(1972)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007711"}, {"RECTYPE": "D", "MH": "Klinefelter Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Xxyy Syndromes", "MN": "C19.391.482.629", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "index here karyotypes XXXY, XXXXY, XXYY, XXXYY, XX/XXY, XX/YY, XY/XXY, XXY/XXXY, XXY/XXYY, XY/XXY/XXXY if called KLINEFELTER SYNDROME by author but if not so named by author, index under SEX CHROMOSOME DISORDERS", "MS": "A form of male HYPOGONADISM, characterized by the presence of an extra X CHROMOSOME, small TESTES, seminiferous tubule dysgenesis, elevated levels of GONADOTROPINS, low serum TESTOSTERONE, underdeveloped secondary sex characteristics, and male infertility (INFERTILITY, MALE). Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several karyotype variants include 48,XXYY; 48,XXXY; 49,XXXXY, and mosaic patterns ( 46,XY/47,XXY; 47,XXY/48,XXXY, etc.).", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007713"}, {"RECTYPE": "D", "MH": "Klippel-Feil Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dystrophia Brevicollis Congenita|T019|NON|EQV|UNK (19XX)|740330|DYSTROPHIA BREVICOLLIS CONGEN|abcdefv", "ENTRY": "Syndrome, Klippel-Feil", "MN": "C16.131.621.551", "MH_TH": "NLM (1966)", "ST": "T019", "AN": "short neck as result of vertebral abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "A syndrome characterised by a low hairline and a shortened neck resulting from a reduced number of vertebrae or the fusion of multiple hemivertebrae into one osseous mass.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007714"}, {"RECTYPE": "D", "MH": "Klippel-Trenaunay-Weber Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Klippel-Trenaunay Disease|T047|EPO|EQV|GHR (2014)|NLM (1994)|930401|KLIPPEL TRENAUNAY DIS|abcdeefv", "ENTRY": "Syndromes, Klippel-Trenaunay", "MN": "C14.907.077.410", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A congenital disorder that is characterized by a triad of capillary malformations (HEMANGIOMA), venous malformations (ARTERIOVENOUS FISTULA), and soft tissue or bony hypertrophy of the limb. This syndrome is caused by mutations in the VG5Q gene which encodes a strong angiogenesis stimulator.", "OL": "use KLIPPEL-TRENAUNAY-WEBER SYNDROME to search KLIPPEL-TRENAUNAY DISEASE 1975-93; search ANGIOMATOSIS 1966-74", "PM": "94; was KLIPPEL-TRENAUNAY DISEASE 1975-93 (see under ANGIOMATOSIS 1975-90)", "HN": "94; was KLIPPEL-TRENAUNAY DISEASE 1975-93 (see under ANGIOMATOSIS 1975-90)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007715"}, {"RECTYPE": "D", "MH": "Kluyveromyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Kluyveromyce", "MN": "B01.300.930.536", "MH_TH": "NLM (1986)", "ST": "T004", "RN": "txid4910", "PI": "Endomycetales (1975-1985)", "MS": "An ascomycetous yeast of the fungal family Saccharomycetaceae, order SACCHAROMYCETALES.", "PM": "91; see ENDOMYCETALES 1986-90", "HN": "91(86)", "MR": "20200813", "DA": "19850207", "DC": "1", "DX": "19910101", "UI": "D007716"}, {"RECTYPE": "D", "MH": "Knee", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "MN": "A01.378.610.450", "EC": "injuries:Knee Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "A region of the lower extremity immediately surrounding and including the KNEE JOINT.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007717"}, {"RECTYPE": "D", "MH": "Knee Injuries", "DE": "KNEE INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Knee Injury", "MN": "C26.558.554", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "consider also PATELLA /inj", "MS": "Injuries to the knee or the knee joint.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007718"}, {"RECTYPE": "D", "MH": "Knee Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Tibiofibular Joint, Superior", "MN": "A02.835.583.475", "EC": "injuries:Knee Injuries", "MH_TH": "NLM (1965)", "ST": "T030", "AN": "primates only; differentiate from KNEE", "MS": "A synovial hinge connection formed between the bones of the FEMUR; TIBIA; and PATELLA.", "PM": "65", "HN": "65", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007719"}, {"RECTYPE": "D", "MH": "Knee Prosthesis", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Prosthesis, Knee", "MN": "E07.695.400.410", "FX": "Arthroplasty, Replacement, Knee", "MH_TH": "NLM (1980)", "ST": "T074", "PI": "Prosthesis (1966-1970)", "MS": "Replacement for a knee joint.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19781219", "DC": "1", "DX": "19800101", "UI": "D007720"}, {"RECTYPE": "D", "MH": "Knowledge of Results, Psychological", "PRINT ENTRY": "Knowledge of Results, Psychology|T169|NON|EQV|NLM (2020)|190118|abcdef", "ENTRY": "Results Knowledge (Psychology)", "MN": "F02.463.425.770.379", "FX": "Feedback", "MH_TH": "NLM (2020)", "ST": "T169", "MS": "A principle that learning is facilitated when the learner receives immediate evaluation of learning performance. The concept also hypothesizes that learning is facilitated when the learner is promptly informed whether a response is correct, and, if incorrect, of the direction of error.", "PM": "2020; was KNOWLEDGE OF RESULTS (PSYCHOLOGY) 1979-2019; was KNOWLEDGE OF RESULTS 1965-1978", "HN": "2020 (1965); was KNOWLEDGE OF RESULTS (PSYCHOLOGY) 1979-2019; was KNOWLEDGE OF RESULTS 1965-1978", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007721"}, {"RECTYPE": "D", "MH": "Health Knowledge, Attitudes, Practice", "AQ": "EH", "ENTRY": "Knowledge, Attitudes, Practice|T041|T054|T055|NON|EQV|BIOETHICS (1998)|NLM (1975)|990101|abbbcdeef", "MN": "N05.300.150.410", "MH_TH": "NLM (2004)", "ST": "T055", "MS": "Knowledge, attitudes, and associated behaviors which pertain to health-related topics such as PATHOLOGIC PROCESSES or diseases, their prevention, and treatment. This term refers to non-health workers and health workers (HEALTH PERSONNEL).", "PM": "2004; see KNOWLEDGE ATTITUDES PRACTICE 1975-2003", "HN": "2004 (1975)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19741111", "DC": "1", "DX": "19900101", "UI": "D007722"}, {"RECTYPE": "D", "MH": "Korea", "AQ": "EH EP", "MN": "Z01.586.407", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "prefer DEMOCRATIC PEOPLE'S REPUBLIC OF KOREA or REPUBLIC OF KOREA", "MS": "Former kingdom, located on Korea Peninsula between Sea of Japan and Yellow Sea on east coast of Asia. In 1948, the kingdom ceased and two independent countries were formed, divided by the 38th parallel.", "MR": "20090713", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007723"}, {"RECTYPE": "D", "MH": "Vulvar Lichen Sclerosus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vulvae, Kraurosis", "MN": "C12.100.250.944.815", "MH_TH": "NLM (2006)", "ST": "T047", "MS": "Atrophy and shriveling of the SKIN of the VULVA that is characterized by the whitish LICHEN SCLEROSUS appearance, inflammation, and PRURITUS.", "PM": "2006; see KRAUROSIS VULVAE 1963-2005", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D007724"}, {"RECTYPE": "D", "MH": "Krukenberg Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumor, Krukenberg's", "MN": "C04.557.470.590.415.410", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate with OVARIAN NEOPLASMS", "PI": "Ovarian Neoplasms (1966-1974)", "MS": "Mucocellular carcinoma of the ovary, usually metastatic from the gastrointestinal tract, characterized by areas of mucoid degeneration and the presence of signet-ring-like cells. It accounts for 30%-40% of metastatic cancers to the ovaries and possibly 1%-2% of all malignant ovarian tumors. The lesions may not be discovered until the primary disease is advanced, and most patients die of their disease within a year. In some cases, a primary tumor is not found. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1685)", "PM": "1994; see KRUKENBERG'S TUMOR 1975-1993", "HN": "1994; use KRUKENBERG'S TUMOR 1975-1993", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D007725"}, {"RECTYPE": "D", "MH": "Krypton", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.362.641.468", "FX": "Krypton Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Krypton", "RN": "5I8I620HVX", "RR": "7439-90-9 (Krypton)", "MS": "A noble gas that is found in the atmosphere. It has the atomic symbol Kr, atomic number 36, atomic weight 83.80, and has been used in electric bulbs.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007726"}, {"RECTYPE": "D", "MH": "Krypton Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Krypton", "MN": "D01.496.749.540", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1987)", "MS": "Unstable isotopes of krypton that decay or disintegrate emitting radiation. Kr atoms with atomic weights 74-77, 79, 81, 85, and 87-94 are radioactive krypton isotopes.", "PM": "88", "HN": "88", "MR": "20170703", "DA": "19870408", "DC": "1", "DX": "19880101", "UI": "D007727"}, {"RECTYPE": "D", "MH": "Kupffer Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Kupffer Cell|T025|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Cells, Kupffer", "MN": "A15.382.680.397.588", "MH_TH": "NLM (1973)", "ST": "T025", "AN": "also called reticuloendothelial cells of liver", "PI": "Macrophages (1966-1972)", "MS": "Specialized phagocytic cells of the MONONUCLEAR PHAGOCYTE SYSTEM found on the luminal surface of the hepatic sinusoids. They filter bacteria and small foreign proteins out of the blood and dispose of worn out red blood cells.", "PM": "73", "HN": "73", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007728"}, {"RECTYPE": "D", "MH": "Kuru", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Kuru Encephalopathy|T047|NON|EQV|NLM (2000)|991103|KURU ENCEPH|abcdefv", "ENTRY": "Encephalopathy, Kuru|T047|NON|EQV|NLM (2000)|991103|ENCEPH KURU|abcdefv", "MN": "C10.574.843.625", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with KORO, a depersonalization disord", "MS": "A prion disease found exclusively among the Fore linguistic group natives of the highlands of NEW GUINEA. The illness is primarily restricted to adult females and children of both sexes. It is marked by the subacute onset of tremor and ataxia followed by motor weakness and incontinence. Death occurs within 3-6 months of disease onset. The condition is associated with ritual cannibalism, and has become rare since this practice has been discontinued. Pathologic features include a noninflammatory loss of neurons that is most prominent in the cerebellum, glial proliferation, and amyloid plaques. (From Adams et al., Principles of Neurology, 6th ed, p773)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007729"}, {"RECTYPE": "D", "MH": "Kuwait", "AQ": "EH EP", "MN": "Z01.252.245.500.425", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country located in the MIDDLE EAST, bordering the Persian Gulf, between IRAQ and SAUDI ARABIA. The capital is Kuwait City.", "MR": "20161222", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007730"}, {"RECTYPE": "D", "MH": "Kveim Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Test, Kveim", "MN": "E05.478.594.890.300.540", "MH_TH": "NLM (1975)", "ST": "T060", "MS": "Intradermal injection of a heated (pasteurized) saline suspension of sarcoid tissue obtained from a sarcoid spleen or lymph node. In patients with active sarcoidosis a dusky red nodule develops slowly over the next few weeks at the injection site. Histologic examination, an essential part of the complete test, reveals sarcoid tissue.", "PM": "91; was see under SKIN TESTS 1975-90", "HN": "91(75); was see under SKIN TESTS 1975-90", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D007731"}, {"RECTYPE": "D", "MH": "Kwashiorkor", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Kwashiorkors", "MN": "C18.654.521.719.500", "MH_TH": "POPLINE (1978)", "ST": "T047", "AN": "severe form of protein malnutrition", "MS": "A syndrome produced by severe protein deficiency, characterized by retarded growth, changes in skin and hair pigment, edema, and pathologic changes in the liver, including fatty infiltration, necrosis, and fibrosis. The word is a local name in Gold Coast, Africa, meaning \"displaced child\". Although first reported from Africa, kwashiorkor is now known throughout the world, but mainly in the tropics and subtropics. It is considered to be related to marasmus. (From Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20141016", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007732"}, {"RECTYPE": "D", "MH": "Kyasanur Forest Disease", "DE": "KYASANUR FOREST DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Kyasanur Forest Disease Virus Infection|T047|NON|EQV|NLM (2020)|180904|abcdef", "MN": "C01.925.782.417.475", "MH_TH": "ORD (2011)", "ST": "T047", "PI": "Hemorrhagic Fevers, Viral (1966-1974)", "MS": "Tick-borne flavivirus infection occurring in the Kyasanur Forest in India.", "PM": "78; was see under ARBOVIRUS INFECTIONS 1977, was see under EPIDEMIC HEMORRHAGIC FEVER 1975-76", "HN": "78(75); was see under ARBOVIRUS INFECTIONS 1977, was see under EPIDEMIC HEMORRHAGIC FEVER 1975-76", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D007733"}, {"RECTYPE": "D", "MH": "Kymography", "DE": "KYMOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Kymographies", "MN": "E01.370.475", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "The recording of wavelike motions or undulations. It is usually used on arteries to detect variations in blood pressure.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007734"}, {"RECTYPE": "D", "MH": "Kynuramine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diaminopropiophenone|T109|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "2,3 Diaminopropiophenone", "MN": "D02.522.818.600", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "1-Propanone, 3-amino-1-(2-aminophenyl)-", "RN": "363-36-0", "PI": "Propiophenones (1972-1974)", "MS": "An aromatic ketone containing the aniline structure (ANILINE COMPOUNDS).", "PM": "91; was see under PROPIOPHENONES 1975-90", "HN": "91(75); was see under PROPIOPHENONES 1975-90", "MR": "20170620", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007735"}, {"RECTYPE": "D", "MH": "Kynurenic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Kynurenic", "MN": "D03.633.100.810.350.400", "PA": "Excitatory Amino Acid Antagonists", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "2-Quinolinecarboxylic acid, 4-hydroxy-", "RN": "H030S2S85J", "RR": "492-27-3 (Kynurenic Acid)", "MS": "A broad-spectrum excitatory amino acid antagonist used as a research tool.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007736"}, {"RECTYPE": "D", "MH": "Kynurenine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.125.608", "FX": "Tryptophan", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Benzenebutanoic acid, alpha,2-diamino-gamma-oxo-", "RN": "343-65-7", "MS": "A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.", "MR": "20170208", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007737"}, {"RECTYPE": "D", "MH": "Kyphosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperkyphosis|T020|NON|EQV|NLM (2020)|190118|abcdef", "ENTRY": "Kyphoses", "MN": "C05.116.900.800.500", "MH_TH": "NLM (1966)", "ST": "T020", "MS": "Deformities of the SPINE characterized by an exaggerated convexity of the vertebral column. The forward bending of the thoracic region usually is more than 40 degrees. This deformity sometimes is called round back or hunchback.", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007738"}, {"RECTYPE": "D", "MH": "L Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Strain L Cells|T025|NON|EQV|NLM (2023)|210923|abcdef", "ENTRY": "Strain L Cell", "MN": "A11.329.228.505", "MH_TH": "NLM (2020)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMALS & MICE; do not routinely add FIBROBLASTS", "MS": "A cultured line of C3H mouse FIBROBLASTS that do not adhere to one another and do not express CADHERINS.", "PM": "2020; was L CELLS (CELL LINE); 1998-2019; see L CELLS 1964-1997", "HN": "2020 (1964); was L CELLS (CELL LINE); 1998-2019; use L CELLS 1964-1997", "MR": "20220408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007739"}, {"RECTYPE": "D", "MH": "L Forms", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B05.110.422", "MH_TH": "NLM (1965)", "ST": "T007", "AN": "coord IM with specific bacterium (IM)", "MS": "Bacterial variants, unable to form a complete cell wall, which are formed in cultures by various bacteria; granules (L bodies) appear, unite, and grow into amorphous bodies which multiply and give rise to bacterial cells morphologically indistinguishable from the parent strain.", "PM": "66", "HN": "66(65)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007740"}, {"RECTYPE": "D", "MH": "Labetalol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SCH19927", "MN": "D02.092.063.291.460", "PA": "Sympathomimetics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-", "RN": "R5H8897N95", "RR": "P6629XE33T", "PI": "Salicylamides (1974)", "MS": "A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.", "OL": "use LABETALOL to search AH 5158 1975-77", "PM": "86; was see under ETHANOLAMINES 1978-85; was AH 5158 see under ETHANOLAMINES 1975-77", "HN": "86(78); was see under ETHANOLAMINES 1978-85; was AH 5158 see under ETHANOLAMINES 1975-77", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D007741"}, {"RECTYPE": "D", "MH": "Labial Frenum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Upper Labial Frenum|T023|NON|NRW|NLM (2024)|221003|abcdef", "ENTRY": "Upper Labial Frenums", "MN": "A14.549.336.505", "MH_TH": "NLM (1965)", "ST": "T023", "MS": "ORAL MUCOSA that connect the GINGIVA to the midline of the upper or lower lips.", "PM": "65", "HN": "65", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007742"}, {"RECTYPE": "D", "MH": "Labor, Obstetric", "AQ": "BL CF DE EH GE HI IM ME PH PX RE UR", "PRINT ENTRY": "Obstetric Labor|T040|NON|EQV|NLM (2003)|011120|abcdef", "MN": "G08.686.784.769.326", "FX": "Trial of Labor", "MH_TH": "NLM (2003)", "ST": "T040", "AN": "check tags FEMALE & PREGNANCY; LABOR, INDUCED is also available", "MS": "The repetitive uterine contraction during childbirth which is associated with the progressive dilation of the uterine cervix (CERVIX UTERI). Successful labor results in the expulsion of the FETUS and PLACENTA. Obstetric labor can be spontaneous or induced (LABOR, INDUCED).", "PM": "2003; see LABOR 1966-2002", "HN": "2003", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "20030101", "UI": "D007743"}, {"RECTYPE": "D", "MH": "Obstetric Labor Complications", "DE": "OBSTETRIC LABOR COMPL", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Labor Complications|T047|NON|EQV|NLM (1964)|990101|abcdef", "ENTRY": "Obstetric Labor Complication", "MN": "C12.050.703.420", "MH_TH": "NLM (2006)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY", "MS": "Medical problems associated with OBSTETRIC LABOR, such as BREECH PRESENTATION; PREMATURE OBSTETRIC LABOR; HEMORRHAGE; or others. These complications can affect the well-being of the mother, the FETUS, or both.", "PM": "2006; see LABOR COMPLICATIONS 1964-2005", "HN": "2006 (1964)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D007744"}, {"RECTYPE": "D", "MH": "Labor Onset", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "ENTRY": "Onsets, Labor", "MN": "G08.686.784.769.326.500", "MH_TH": "NLM (1975)", "ST": "T079", "AN": "human only; check tags FEMALE & PREGNANCY", "MS": "The beginning of true OBSTETRIC LABOR which is characterized by the cyclic uterine contractions of increasing frequency, duration, and strength causing CERVICAL DILATATION to begin (LABOR STAGE, FIRST ).", "PM": "91; was see under LABOR 1975-90", "HN": "91(75); was see under LABOR 1975-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D007745"}, {"RECTYPE": "D", "MH": "Labor Presentation", "PRINT ENTRY": "Presentation, Fetal|T032|T082|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Presentation, Labor", "MN": "G08.686.784.769.326.520", "FX": "Version, Fetal", "MH_TH": "NLM (1966)", "ST": "T082", "AN": "check tags FEMALE & PREGNANCY", "MS": "The position or orientation of the FETUS at near term or during OBSTETRIC LABOR, determined by its relation to the SPINE of the mother and the birth canal. The normal position is a vertical, cephalic presentation with the fetal vertex flexed on the NECK.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007746"}, {"RECTYPE": "D", "MH": "Labor Stage, First", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Labor, First Stage|T079|NON|EQV|UNK (19XX)|760512|abcdef", "ENTRY": "First Stage Labor", "MN": "G08.686.784.769.326.500.080", "MH_TH": "NLM (1975)", "ST": "T079", "AN": "human only; check tags FEMALE & PREGNANCY", "MS": "Period from the onset of true OBSTETRIC LABOR to the complete dilatation of the CERVIX UTERI.", "OL": "use LABOR STAGE, FIRST to search LABOR, FIRST STAGE 1975-76", "PM": "91; was see under LABOR 1977-90; was LABOR, FIRST STAGE see under LABOR 1975-76", "HN": "91(77); was see under LABOR 1977-90; was LABOR, FIRST STAGE see under LABOR 1975-76", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D007747"}, {"RECTYPE": "D", "MH": "Labor Stage, Second", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Labor, Second Stage|T079|NON|EQV|UNK (19XX)|760512|abcdef", "ENTRY": "Stages, Second Labor", "MN": "G08.686.784.769.326.500.090", "MH_TH": "NLM (1975)", "ST": "T079", "AN": "human only; check tags FEMALE & PREGNANCY", "MS": "The period of OBSTETRIC LABOR that is from the complete dilatation of the CERVIX UTERI to the expulsion of the FETUS.", "OL": "use LABOR STAGE, SECOND to search LABOR, SECOND STAGE 1975-76", "PM": "91; was see under LABOR 1977-90; was LABOR, SECOND STAGE see under LABOR 1975-76", "HN": "91(77); was see under LABOR 1977-90; was LABOR, SECOND STAGE see under LABOR 1975-76", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D007748"}, {"RECTYPE": "D", "MH": "Labor Stage, Third", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Labor, Third Stage|T079|NON|EQV|UNK (19XX)|760512|abcdef", "ENTRY": "Third Stage Labor", "MN": "G08.686.784.769.326.500.110", "MH_TH": "NLM (1975)", "ST": "T079", "AN": "human only; check tags FEMALE & PREGNANCY", "MS": "The final period of OBSTETRIC LABOR that is from the expulsion of the FETUS to the expulsion of the PLACENTA.", "OL": "use LABOR STAGE, THIRD to search LABOR, THIRD STAGE 1975-76", "PM": "91; was see under LABOR 1977-90; was LABOR, THIRD STAGE see under LABOR 1975-76", "HN": "91(77); was see under LABOR 1977-90; was LABOR, THIRD STAGE see under LABOR 1975-76", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D007749"}, {"RECTYPE": "D", "MH": "Labor Unions", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Trade Unions|T092|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Unions, Trade", "MN": "N03.540.571", "FX": "Strikes, Employee", "MH_TH": "POPLINE (1978)", "ST": "T092", "MS": "Organizations comprising wage and salary workers in health-related fields for the purpose of improving their status and conditions. The concept includes labor union activities toward providing health services to members.", "PM": "67", "HN": "67(64)", "MR": "19930916", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007750"}, {"RECTYPE": "D", "MH": "Labor, Induced", "DE": "LABOR IND", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Labor Inductions", "MN": "E04.520.252.968", "FX": "Oxytocics", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "check tags FEMALE & PREGNANCY", "MS": "Artificially induced UTERINE CONTRACTION.", "CATSH": "CAT LIST", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007751"}, {"RECTYPE": "D", "MH": "Obstetric Labor, Premature", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Preterm Labor|T047|NON|EQV|NLM (2006)|041117|abcdef", "ENTRY": "Labor, Preterm", "MN": "C12.050.703.420.491", "FX": "Tocolytic Agents", "MH_TH": "NLM (2006)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY; PREMATURE BIRTH is also available", "MS": "Onset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE).", "PM": "2006; see LABOR, PREMATURE 1964-2005", "HN": "2006 (1964)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007752"}, {"RECTYPE": "D", "MH": "Laboratories", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Laboratory", "MN": "N02.278.487", "FX": "Clinical Laboratory Techniques", "MH_TH": "NLM (1966)", "ST": "T092", "MS": "Facilities equipped to carry out investigative procedures.", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007753"}, {"RECTYPE": "D", "MH": "Laboratories, Dental", "DE": "LABORATORIES DENT", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Laboratory, Dental|T073|T093|NON|EQV|NLM (1991)|900126|LABORATORY DENT|abbcdefv", "MN": "N02.278.192.631", "MH_TH": "NLM (1972)", "ST": "T093", "MS": "Facilities for the performance of services related to dental treatment but not done directly in the patient's mouth.", "PM": "74", "HN": "74(72)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007754"}, {"RECTYPE": "D", "MH": "Laboratories, Hospital", "DE": "LABORATORIES HOSP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Laboratories|T073|T093|NON|EQV|UNK (19XX)|870502|HOSP LABORATORIES|abbcdefv", "ENTRY": "Laboratory, Hospital|T073|T093|NON|EQV|NLM (1992)|901010|LABORATORY HOSP|abbcdefv", "MN": "N04.452.442.452.422.420", "MH_TH": "NLM (1988)", "ST": "T093", "PI": "Laboratories (1966-1987)", "MS": "Hospital facilities equipped to carry out investigative procedures.", "PM": "88", "HN": "88", "MR": "20190709", "DA": "19870502", "DC": "1", "DX": "19880101", "UI": "D007755"}, {"RECTYPE": "D", "MH": "Laboratory Animal Science", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sciences, Laboratory Animal", "MN": "H01.158.273.368", "MH_TH": "NLM (1987)", "ST": "T091", "PI": "Animals, Laboratory (1966-1986)", "MS": "The science and technology dealing with the procurement, breeding, care, health, and selection of animals used in biomedical research and testing.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860528", "DC": "1", "DX": "19870101", "UI": "D007756"}, {"RECTYPE": "D", "MH": "Laboratory Infection", "DE": "LABORATORY INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Laboratory Infections", "MN": "C24.506", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "\"accidentally acquired infect in laboratory\"; IM; coord with specific infection (IM) + lab animal (IM)", "MS": "Accidentally acquired infection in laboratory workers.", "PM": "68", "HN": "68(64)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007757"}, {"RECTYPE": "D", "MH": "Ear, Inner", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Labyrinth|T023|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Membranous Labyrinths", "MN": "A09.246.300", "FX": "Endolymph", "MH_TH": "NLM (2006)", "ST": "T023", "MS": "The essential part of the hearing organ consists of two labyrinthine compartments: the bony labyrinthine and the membranous labyrinth. The bony labyrinth is a complex of three interconnecting cavities or spaces (COCHLEA; VESTIBULAR LABYRINTH; and SEMICIRCULAR CANALS) in the TEMPORAL BONE. Within the bony labyrinth lies the membranous labyrinth which is a complex of sacs and tubules (COCHLEAR DUCT; SACCULE AND UTRICLE; and SEMICIRCULAR DUCTS) forming a continuous space enclosed by EPITHELIUM and connective tissue. These spaces are filled with LABYRINTHINE FLUIDS of various compositions.", "PM": "2006; see LABYRINTH 1963-2005", "HN": "2006 (1963)", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D007758"}, {"RECTYPE": "D", "MH": "Labyrinth Diseases", "DE": "LABYRINTH DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Inner Ear Disease|T047|NON|EQV|NLM (2008)|070201|abcdef", "ENTRY": "Labyrinth Disease", "MN": "C09.218.568", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes of the inner ear (LABYRINTH) which contains the essential apparatus of hearing (COCHLEA) and balance (SEMICIRCULAR CANALS).", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007759"}, {"RECTYPE": "D", "MH": "Labyrinth Supporting Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Supporting Cells, Labyrinth|T025|NON|EQV|UNK (19XX)|780519|abcdef", "ENTRY": "Supporting Cell, Labyrinth", "MN": "A11.436.495", "MH_TH": "NLM (1979)", "ST": "T025", "PI": "Organ of Corti (1967-1978)", "MS": "Cells forming a framework supporting the sensory AUDITORY HAIR CELLS in the organ of Corti. Lateral to the medial inner hair cells, there are inner pillar cells, outer pillar cells, Deiters cells, Hensens cells, Claudius cells, Boettchers cells, and others.", "PM": "91; was see under ORGAN OF CORTI 1979-90", "HN": "91(79); was see under ORGAN OF CORTI 1979-90", "MR": "20180702", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D007760"}, {"RECTYPE": "D", "MH": "Labyrinthine Fluids", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Labyrinthine Fluid", "MN": "A12.207.270.517", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "Fluids found within the osseous labyrinth (PERILYMPH) and the membranous labyrinth (ENDOLYMPH) of the inner ear. (From Gray's Anatomy, 30th American ed, p1328, 1332)", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007761"}, {"RECTYPE": "D", "MH": "Labyrinthitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Otitis Interna|T047|NON|EQV|UNK (19XX)|780522|abcdef", "ENTRY": "Labyrinthitides", "MN": "C09.218.705.371", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Inflammation of the inner ear (LABYRINTH).", "OL": "use LABYRINTHITIS to search OTITIS INTERNA 1975-78; use LABYRINTH DISEASES 1966-74", "PM": "91; was see under LABYRINTH DISEASES 1979-90; was OTITIS INTERNA see under LABYRINTH DISEASES 1963-78", "HN": "91(79); was see under LABYRINTH DISEASES 1979-90; was OTITIS INTERNA see under LABYRINTH DISEASES 1963-78", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007762"}, {"RECTYPE": "D", "MH": "Lac Operon", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Lactose Operon|T028|NON|EQV|NLM (2002)|010228|abcdef", "ENTRY": "Operons, Lactose", "MN": "G05.360.340.358.207.500.545", "MH_TH": "NLM (1979)", "ST": "T028", "AN": "note category; consider also LAC REPRESSORS (see note on REPRESSOR PROTEINS)", "PI": "Operon (1969-1978)", "MS": "The genetic unit consisting of three structural genes, an operator and a regulatory gene. The regulatory gene controls the synthesis of the three structural genes: BETA-GALACTOSIDASE and beta-galactoside permease (involved with the metabolism of lactose), and beta-thiogalactoside acetyltransferase.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19780303", "DC": "1", "DX": "19790101", "UI": "D007763"}, {"RECTYPE": "D", "MH": "Lacquer", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Lacquers", "MN": "J01.637.597.422", "MH_TH": "NLM (1975)", "ST": "T073", "MS": "A liquid resinous varnish solubilized in a volatile solvent which may be combined with a pigment. It forms a hard, glossy, and protective coating when applied to wood or metal.", "OL": "use PAINT to search LACQUER 1966-74", "PM": "91; was see under PAINT 1975-90", "HN": "91(75); was see under PAINT 1975-90", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007764"}, {"RECTYPE": "D", "MH": "Lacrimal Apparatus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Nasolacrimal Apparatus|T023|NON|EQV|NLM (2022)|210507|abcdef", "ENTRY": "Sac, Conjunctival", "MN": "A10.336.422", "FX": "Tears", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The tear-forming and tear-conducting system which includes the lacrimal glands, eyelid margins, conjunctival sac, and the tear drainage system.", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007765"}, {"RECTYPE": "D", "MH": "Lacrimal Apparatus Diseases", "DE": "LACRIMAL APPARATUS DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Epiphora|T047|NON|REL|NLM (1998)|960710|abcdef", "ENTRY": "Lacrimal Apparatus Disease", "MN": "C11.496", "MH_TH": "NLM (1976)", "ST": "T047", "PI": "specific lacrimal apparatus disease heading", "MS": "Diseases of the LACRIMAL APPARATUS.", "PM": "76", "HN": "76; was NON MESH before 1976", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D007766"}, {"RECTYPE": "D", "MH": "Lacrimal Duct Obstruction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT TH UR VE VI", "PRINT ENTRY": "Nasolacrimal Duct Obstruction|T046|NON|NRW|NLM (2020)|190208|abcdef", "ENTRY": "Tear Duct Obstructions", "MN": "C11.496.456", "EC": "surgery:Dacryocystorhinostomy", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007767"}, {"RECTYPE": "D", "MH": "Lactalbumin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Lactalbumin C", "MN": "D12.776.256.159.750.816.250", "MH_TH": "NLM (1973)", "ST": "T123", "N1": "Lactalbumins", "RN": "9013-90-5", "PI": "Albumins (1966-1972)", "MS": "A major protein fraction of milk obtained from the WHEY.", "OL": "search ALBUMINS 1966-72", "PM": "73; was see under ALBUMINS 1963-72", "HN": "73; was see under ALBUMINS 1963-72", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007768"}, {"RECTYPE": "D", "MH": "Lactams", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lactim|T109|NON|NRW|NLM (2021)|191118|abcdef", "ENTRY": "Lactims|T109|NON|NRW|NLM (2005)|031121|abcdef", "MN": "D03.383.411", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1972)", "ST": "T195", "RN": "0", "PI": "Amides (1966-1971)", "MS": "Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams.", "PM": "74", "HN": "74(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007769"}, {"RECTYPE": "D", "MH": "L-Lactate Dehydrogenase", "DS": "LACTATE DEHYDROGENASE L", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lactate Dehydrogenase|T116|T126|NON|EQV|NLM (1966)|990101|LDH|abbcdefv", "ENTRY": "L Lactate Dehydrogenase", "MN": "D08.811.682.047.820.493", "MH_TH": "NLM (2004)", "ST": "T126", "N1": "(S)-Lactate:NAD+ oxidoreductase", "RN": "EC 1.1.1.27", "MS": "A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist.", "PM": "2004; see LACTATE DEHYDROGENASE 1966-2003", "HN": "2004(1966)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D007770"}, {"RECTYPE": "D", "MH": "Lactate dehydrogenase-elevating virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Riley Virus|T005|EPO|EQV|UNK (19XX)|760518|abcdef", "ENTRY": "Lactic Dehydrogenase Viruses", "MN": "B04.820.578.500.080.500.500", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11048", "AN": "infection: coord IM with ARTERIVIRUS INFECTIONS (IM)", "PI": "RNA Viruses (1966-1974)", "MS": "A species ARTERIVIRUS, occurring in a number of transplantable mouse tumors. Infected mice have permanently elevated serum levels of lactate dehydrogenase.", "PM": "2002; see LACTATE DEHYDROGENASE VIRUS 1977-2001, see RNA VIRUSES 1969-1976; for RILEY VIRUS see RNA VIRUSES 1969-1976, see VERTEBRATE VIRUSES, UNCLASSIFIED 1967-1968; for LACTIC DEHYDROGENASE VIRUSES see LACTATE DEHYDROGENASE VIRUS 1977-1993, was see RILEY VIRUS 1975-1976", "HN": "2002(1969); for LACTIC DEHYDROGENASE VIRUSES use LACTATE DEHYDROGENASE VIRUS 1977-1993, use RILEY VIRUS 1975-1976", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D007772"}, {"RECTYPE": "D", "MH": "Lactates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.511.459", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with LACTATE see LACTIC ACID", "MS": "Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007773"}, {"RECTYPE": "D", "MH": "Lactation", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Lactation, Prolonged|T042|T079|NON|REL|NLM (1975)|960415|abbcdef", "ENTRY": "Prolonged Lactations", "MN": "G08.686.702.500", "FX": "Milk, Human", "MH_TH": "NLM (1963)", "ST": "T042", "AN": "check the tag FEMALE usually but occasionally MALE; \"postpartum amenorrhea\" is indexed under PUERPERIUM + AMENORRHEA and not LACTATION unless lactation is particularly discussed; ANIMALS, SUCKLING is available but the suckling of an animal goes here: human suckling goes under BREAST FEEDING", "MS": "The processes of milk secretion by the maternal MAMMARY GLANDS after PARTURITION. The proliferation of the mammary glandular tissue, milk synthesis, and milk expulsion or let down are regulated by the interactions of several hormones including ESTRADIOL; PROGESTERONE; PROLACTIN; and OXYTOCIN.", "PM": "LACTATION, PROLONGED was heading 1975-96 (see under LACTATION 1975-90)", "HN": "LACTATION, PROLONGED was heading 1975-96 (see under LACTATION 1975-90)", "CATSH": "CAT LIST", "MR": "20180614", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007774"}, {"RECTYPE": "D", "MH": "Lactation Disorders", "DE": "LACTATION DIS", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypogalactia|T047|NON|NRW|UNK (19XX)|780323|abcdef", "ENTRY": "Lactation Disorder", "MN": "C17.800.090.937", "FX": "Galactorrhea", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Disturbances of MILK secretion in either SEX, not necessarily related to PREGNANCY.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007775"}, {"RECTYPE": "D", "MH": "Lactobacillaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.450", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid33958", "PI": "Bacteria (1966-1974)", "MS": "A family of gram-positive bacteria found regularly in the mouth and intestinal tract of man and other animals, in food and dairy products, and in fermenting vegetable juices. A few species are highly pathogenic.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D007777"}, {"RECTYPE": "D", "MH": "Lactobacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.450.475", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1578", "MS": "A genus of gram-positive, microaerophilic, rod-shaped bacteria occurring widely in nature. Its species are also part of the many normal flora of the mouth, intestinal tract, and vagina of many mammals, including humans. Lactobacillus species are homofermentative and ferment a broad spectrum of carbohydrates often host-adapted but do not ferment PENTOSES. Most members were previously assigned to the Lactobacillus delbrueckii group. Pathogenicity from this genus is rare.", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007778"}, {"RECTYPE": "D", "MH": "Lactobacillus acidophilus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Lactobacillus amylovorus|T007|NON|REL|NLM (1999)|980220|abcdef", "MN": "B03.510.550.450.475.100", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1579", "RR": "txid1604", "MS": "A species of gram-positive, rod-shaped bacteria isolated from the intestinal tract of humans and animals, the human mouth, and vagina. This organism produces the fermented product, acidophilus milk.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007779"}, {"RECTYPE": "D", "MH": "Lacticaseibacillus casei", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Lactobacillus casei|T007|NON|EQV|NLM (1972)|990101|abcdef", "MN": "B03.510.550.450.606.500", "MH_TH": "NLM (2023)", "ST": "T007", "RN": "txid1582", "PI": "Lactobacillus (1966-1971)", "MS": "A rod-shaped bacterium isolated from milk and cheese, dairy products and dairy environments, sour dough, cow dung, silage, and human mouth, human intestinal contents and stools, and the human vagina. L. casei is CATALASE positive.", "PM": "2023; see Lacticaseibacillus casei 1974-2022", "HN": "2023(1974)", "MR": "20221031", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007780"}, {"RECTYPE": "D", "MH": "Lactoferrin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lactotransferrin|T116|T123|NON|EQV|UNK (19XX)|801120|abbcdef", "MN": "D12.776.556.579.750.249", "PA": "Anti-Infective Agents", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "EC 3.4.21.-", "MS": "An iron-binding protein that was originally characterized as a milk protein. It is widely distributed in secretory fluids and is found in the neutrophilic granules of LEUKOCYTES. The N-terminal part of lactoferrin possesses a serine protease which functions to inactivate the TYPE III SECRETION SYSTEM used by bacteria to export virulence proteins for host cell invasion.", "PM": "91; was see under LACTOGLOBULINS 1973-90", "HN": "91(73); was see under LACTOGLOBULINS 1973-90", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007781"}, {"RECTYPE": "D", "MH": "Lactoglobulins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lactoglobulin|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "beta Lactoglobulin I", "MN": "D12.776.377.457", "MH_TH": "NLM (1963)", "ST": "T123", "RN": "0", "MS": "Globulins of milk obtained from the WHEY.", "OL": "use LACTOGLOBULINS to search LACTOGLOBULIN 1966 (as Prov)", "PM": "67; was LACTOGLOBULIN see under GLOBULINS 1963-66", "HN": "67; was LACTOGLOBULIN see under GLOBULINS 1963-66 (Prov)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007782"}, {"RECTYPE": "D", "MH": "Lactones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lactone|T109|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D02.540", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "pyran-2-ones: index PYRONES + LACTONES but BENZOPYRAN-2-ONES is available; for cyclic lactones over 12 atoms consider MACROLIDES", "MS": "Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007783"}, {"RECTYPE": "D", "MH": "Lactoperoxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.682.732.550", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.11.1.-", "PI": "Peroxidases (1969-1974)", "MS": "An enzyme derived from cow's milk. It catalyzes the radioiodination of tyrosine and its derivatives and of peptides containing tyrosine.", "PM": "91; was see under PEROXIDASES 1975-90", "HN": "91(75); was see under PEROXIDASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007784"}, {"RECTYPE": "D", "MH": "Lactose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Lactose, Anhydrous", "MN": "D09.947.750.340", "PA": "Sweetening Agents", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "D-Glucose, 4-O-beta-D-galactopyranosyl-", "RN": "J2B2A4N98G", "RR": "63-42-3 (lactose)", "MS": "A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry.", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007785"}, {"RECTYPE": "D", "MH": "Lactose Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lac Factors|T114|T123|NON|EQV|UNK (19XX)|770509|abbcdef", "ENTRY": "Factors, Lactose", "MN": "G05.360.600.500", "MH_TH": "NLM (1978)", "ST": "T123", "AN": "note category; plasmids determing ability of bact to ferment lactose", "PI": "Plasmids (1975-1977)", "MS": "Plasmids which determine the ability of a bacterium to ferment lactose.", "PM": "91; was see under PLASMIDS 1978-90", "HN": "91(78); was see under PLASMIDS 1978-90", "MR": "20080708", "DA": "19770509", "DC": "1", "DX": "19910101", "UI": "D007786"}, {"RECTYPE": "D", "MH": "Lactose Intolerance", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lactose Malabsorption|T047|NON|EQV|GHR (2014)|NLM (1998)|960717|abcdeef", "ENTRY": "Malabsorption, Lactose", "MN": "C18.452.648.202.589", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "The condition resulting from the absence or deficiency of LACTASE in the MUCOSA cells of the GASTROINTESTINAL TRACT, and the inability to break down LACTOSE in milk for ABSORPTION. Bacterial fermentation of the unabsorbed lactose leads to symptoms that range from a mild indigestion (DYSPEPSIA) to severe DIARRHEA. Lactose intolerance may be an inborn error or acquired.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007787"}, {"RECTYPE": "D", "MH": "Lactose Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lactose Synthetase|T116|T126|NON|EQV|NLM (1992)|901231|abbcdef", "ENTRY": "Synthetase, Lactose", "MN": "D08.811.913.400.450.400.500", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "UDPgalactose:D-glucose 4-beta-D-galactosyltransferase", "RN": "EC 2.4.1.22", "RR": "9030-11-9 (CAS RN)", "PI": "Transferases (1966-1971)", "MS": "An enzyme complex that catalyzes the transfer of GALACTOSE from UDP GALACTOSE to GLUCOSE, forming LACTOSE. The enzyme complex is composed of a B subunit, ALPHA-LACTALBUMIN, which changes the substrate specificity of the A subunit, N-ACETYLLACTOSAMINE SYNTHASE, from N-ACETYLGLUCOSAMINE to glucose making lactose synthesis the preferred reaction.", "OL": "use LACTOSE SYNTHASE to search LACTOSE SYNTHETASE 1972-91 (as Prov 1972-73)", "PM": "92; was LACTOSE SYNTHETASE 1974-91", "HN": "92: was LACTOSE SYNTHETASE 1972-91 (Prov 1972-73)", "MR": "20150612", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007788"}, {"RECTYPE": "D", "MH": "Lactose Tolerance Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tolerance Tests, Lactose", "MN": "E05.200.124.100.450", "MH_TH": "NLM (1974)", "ST": "T059", "AN": "NIM", "MS": "A measure of a patient's ability to break down lactose.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20150526", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007789"}, {"RECTYPE": "D", "MH": "Lactosylceramides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lactosyl Ceramides|T109|NON|EQV|UNK (19XX)|780516|abcdef", "ENTRY": "Ceramides, Lactosyl", "MN": "D10.570.877.360.612.200.612", "MH_TH": "NLM (1979)", "ST": "T109", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Glycosphingolipids (1975-1978)", "MS": "Glycosphingolipids which contain as their polar head group a lactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in lactosylceramide beta-galactosidase, is the cause of lactosylceramidosis.", "PM": "91; was see under GLYCOSPHINGOLIPIDS 1979-90", "HN": "91(79); was see under GLYCOSPHINGOLIPIDS 1979-90", "MR": "20060705", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D007790"}, {"RECTYPE": "D", "MH": "Lactoylglutathione Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Methylglyoxalase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Lyase, Lactoylglutathione", "MN": "D08.811.520.300.500", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "S-Lactoyl-glutathione methylglyoxal-lyase (isomerizing)", "RN": "EC 4.4.1.5", "RR": "9033-12-9 (CAS RN)", "PI": "Lyases (1973-1974)", "MS": "An enzyme that catalyzes the interconversion of methylglyoxal and lactate, with glutathione serving as a coenzyme. EC 4.4.1.5.", "PM": "98; see LACTOYL GLUTATHIONE LYASE 1991-97, see LYASES 1975-90", "HN": "98(75)", "MR": "20160628", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007791"}, {"RECTYPE": "D", "MH": "Lactulose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Normase|T109|T121|TRD|NRW|NLM (1998)|961112|abbcdef", "MN": "D09.947.750.423", "PA": "Gastrointestinal Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "D-Fructose, 4-O-beta-D-galactopyranosyl-", "RN": "4618-18-2", "AN": "do not confuse with LACTOSE", "MS": "A synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It has also been used in the diagnosis of gastrointestinal disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p887)", "PM": "91; was see under DISACCHARIDES 1973-90", "HN": "91(73); was see under DISACCHARIDES 1973-90", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007792"}, {"RECTYPE": "D", "MH": "Lagomorpha", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Pikas|T015|NON|NRW|NLM (2003)|011129|abcdef", "ENTRY": "Pika", "MN": "B01.050.150.900.649.313.968", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9975", "RR": "txid9979", "MS": "An order of small mammals comprising two families, Ochotonidae (pikas) and Leporidae (RABBITS and HARES). Head and body length ranges from about 125 mm to 750 mm. Hares and rabbits have a short tail, and the pikas lack a tail. Rabbits are born furless and with both eyes and ears closed. HARES are born fully haired with eyes and ears open. All are vegetarians. (From Nowak, Walker's Mammals of the World, 5th ed, p539-41)", "OL": "use RABBITS to search LAGOMORPHA 1966-74", "PM": "91; was see under MAMMALS 1975-90; was see under RABBITS 1963-74", "HN": "91(75); was see under MAMMALS 1975-90; was see under RABBITS 1963-74", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007793"}, {"RECTYPE": "D", "MH": "Lameness, Animal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Gait Disorders, Animal|T184|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Lamenesses, Animal", "MN": "C22.510", "MH_TH": "NLM (1976)", "ST": "T184", "AN": "coord IM with precoord animal/dis term (IM) + animal (NIM); don't forget also check tag ANIMALS", "PI": "Gait (1966-1975)", "MS": "A departure from the normal gait in animals.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D007794"}, {"RECTYPE": "D", "MH": "Laminaria", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Saccharina|T204|NON|REL|NLM (2023)|210812|abcdef", "ENTRY": "Laminaria Tent", "MN": "B01.750.600.425.500", "FX": "Edible Seaweeds", "MH_TH": "NLM (1980)", "ST": "T204", "RN": "txid33637", "AN": "for dried Laminaria for cervical dilation & \"laminaria tent\" (note X ref and read MeSH definition), use no qualifers", "PI": "Seaweed (1966-1979)", "MS": "A genus of BROWN ALGAE in the family Laminariaceae. Dried pencil-like pieces may be inserted in the cervix where they swell as they absorb moisture, serving as osmotic dilators.", "PM": "91; was see under SEAWEED 1980-90", "HN": "91(80); was see under SEAWEED 1980-90", "MR": "20230606", "DA": "19781221", "DC": "1", "DX": "19910101", "UI": "D007795"}, {"RECTYPE": "D", "MH": "Laminectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Laminotomies", "MN": "E04.555.350", "MH_TH": "NLM (1964)", "ST": "T061", "MS": "A surgical procedure that entails removing all (laminectomy) or part (laminotomy) of selected vertebral lamina to relieve pressure on the SPINAL CORD and/or SPINAL NERVE ROOTS. Vertebral lamina is the thin flattened posterior wall of vertebral arch that forms the vertebral foramen through which pass the spinal cord and nerve roots.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007796"}, {"RECTYPE": "D", "MH": "Laminin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Merosin|T116|T123|NON|NRW|NLM (1997)|951127|abbcdef", "ENTRY": "M Chain, Laminin", "MN": "D12.776.860.300.675", "FX": "Receptors, Laminin", "MH_TH": "NLM (1984)", "ST": "T123", "RN": "0", "AN": "an extracellular matrix protein; /biosyn /physiol permitted", "PI": "Neoplasm Proteins (1966-1983)", "MS": "Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion.", "PM": "84", "HN": "84", "MR": "20230316", "DA": "19830531", "DC": "1", "DX": "19840101", "UI": "D007797"}, {"RECTYPE": "D", "MH": "Lampreys", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Petromyzontidae|T013|NON|EQV|NLM (2002)|000809|abcdef", "ENTRY": "Lamprey Eels", "MN": "B01.050.150.900.493.559", "MH_TH": "NLM (1975)", "ST": "T013", "RN": "txid7746", "RR": "txid7745", "MS": "Common name for the only family (Petromyzontidae) of eellike fish in the order Petromyzontiformes. They are jawless but have a sucking mouth with horny teeth.", "OL": "search CYCLOSTOMES 1968-74", "PM": "91; was see under CYCLOSTOMES 1975-90", "HN": "91(75); was see under CYCLOSTOMES 1975-90", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007798"}, {"RECTYPE": "D", "MH": "Lanatosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Digilanides|T109|T121|NON|EQV|UNK (19XX)|740330|abbcdef", "MN": "D09.408.180.261.657", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Glycosides from DIGITALIS lanata leaf. Lanatoside C has actions similar to DIGOXIN. Mixtures of lanatosides A, B, and C have also been used. (From Martindale, The Extra Pharmacopoeia, 30th ed, p670)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007799"}, {"RECTYPE": "D", "MH": "Langerhans Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Langerhans Cell|T025|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Skin Dendritic Cell", "MN": "A15.382.670.260.500", "MH_TH": "NLM (1969)", "ST": "T025", "AN": "cutaneous cells: do not confuse with ISLETS OF LANGERHANS (pancreas) nor with GIANT CELLS, LANGHANS (macrophages)", "PI": "Skin (1966-1968)", "MS": "Recirculating, dendritic, antigen-presenting cells containing characteristic racket-shaped granules (Birbeck granules). They are found principally in the stratum spinosum of the EPIDERMIS and are rich in Class II MAJOR HISTOCOMPATIBILITY COMPLEX molecules. Langerhans cells were the first dendritic cell to be described and have been a model of study for other dendritic cells (DCs), especially other migrating DCs such as dermal DCs and INTERSTITIAL DENDRITIC CELLS.", "PM": "73", "HN": "73(69)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007801"}, {"RECTYPE": "D", "MH": "Language", "AQ": "HI", "PRINT ENTRY": "Dialect|T171|NON|NRW|NLM (2020)|181218|abcdef", "ENTRY": "Languages", "MN": "L01.559", "FX": "Sign Language", "MH_TH": "NLM (1978)", "ST": "T171", "AN": "what is spoken or written; do not confuse with LINGUISTICS (see note there) or SPEECH (language as it comes out of the mouth)", "MS": "A verbal or nonverbal means of communicating ideas or feelings.", "CATSH": "CAT LIST", "MR": "20190226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007802"}, {"RECTYPE": "D", "MH": "Language Arts", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Language Art", "MN": "L01.559.423", "MH_TH": "NLM (1974)", "ST": "T090", "AN": "emphasis here is on skill & applic of language: differentiate from LANGUAGE itself: see note there; GEN or unspecified; prefer specifics", "PI": "Language Development (1968-1997)", "MS": "Skills in the use of language which lead to proficiency in written or spoken communication.", "PM": "98", "HN": "98; use explode 1975-97", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D007803"}, {"RECTYPE": "D", "MH": "Language Development", "PRINT ENTRY": "Language Acquisition|T041|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Development, Language", "MN": "F01.525.200.310", "FX": "Speech", "MH_TH": "OBSSR (2021)", "ST": "T041", "PI": "Speech (1966-1967)", "MS": "The gradual expansion in complexity and meaning of symbols and sounds as perceived and interpreted by the individual through a maturational and learning process. Stages in development include babbling, cooing, word imitation with cognition, and use of short sentences.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007804"}, {"RECTYPE": "D", "MH": "Language Development Disorders", "DE": "LANGUAGE DEVELOPMENT DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Speech Delay|T048|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Speech Delays", "MN": "C23.888.592.604.150.500.550", "MH_TH": "NLM (1980)", "ST": "T048", "AN": "do not confuse with LANGUAGE DISORDERS, disord of use or comprehension of language: LANGUAGE DEVELOPMENT DISORDERS is \"failure to understand or speak the language at the expected age\"", "PI": "Language Disorders (1967-1979)", "MS": "Conditions characterized by language abilities (comprehension and expression of speech and writing) that are below the expected level for a given age, generally in the absence of an intellectual impairment. These conditions may be associated with DEAFNESS; BRAIN DISEASES; MENTAL DISORDERS; or environmental factors.", "PM": "1986; see LANGUAGE DISORDERS 1980-1985", "HN": "1986(1980)", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19790221", "DC": "1", "DX": "19860101", "UI": "D007805"}, {"RECTYPE": "D", "MH": "Language Disorders", "DE": "LANGUAGE DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Language Disorder, Acquired", "MN": "C23.888.592.604.150.500", "FX": "Speech Disorders", "MH_TH": "NLM (1967)", "ST": "T048", "AN": "/ther: consider also LANGUAGE THERAPY; do not confuse with SPEECH DISORDERS: read differentiation of LANGUAGE & SPEECH under LANGUAGE; do not confuse with LANGUAGE DEVELOPMENT DISORDERS: see note there", "PI": "Language (1966)", "MS": "Conditions characterized by deficiencies of comprehension or expression of written and spoken forms of language. These include acquired and developmental disorders.", "PM": "1967", "HN": "1967", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007806"}, {"RECTYPE": "D", "MH": "Language Tests", "AQ": "HI SN ST", "PRINT ENTRY": "Vocabulary Tests|T170|NAM|NRW|UNK (19XX)|780522|abcdef", "ENTRY": "Language Test", "MN": "F04.711.513.240", "MH_TH": "NLM (1979)", "ST": "T170", "PI": "Language Development (1968-1978)", "MS": "Tests designed to assess language behavior and abilities. They include tests of vocabulary, comprehension, grammar and functional use of language, e.g., Development Sentence Scoring, Receptive-Expressive Emergent Language Scale, Parsons Language Sample, Utah Test of Language Development, Michigan Language Inventory and Verbal Language Development Scale, Illinois Test of Psycholinguistic Abilities, Northwestern Syntax Screening Test, Peabody Picture Vocabulary Test, Ammons Full-Range Picture Vocabulary Test, and Assessment of Children's Language Comprehension.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D007807"}, {"RECTYPE": "D", "MH": "Language Therapy", "DE": "LANGUAGE THER", "AQ": "CL EC ED ES HI IS LJ MT OG PX SN ST TD", "PRINT ENTRY": "Language Training|T065|NON|NRW|UNK (19XX)|790221|abcdef", "ENTRY": "Trainings, Language", "MN": "E02.831.727.344", "MH_TH": "NLM (1980)", "ST": "T061", "AN": "do not confuse with SPEECH THERAPY: LANGUAGE THERAPY is for LANGUAGE DISORDERS; SPEECH THERAPY is for SPEECH DISORDERS; coord IM with specific lang disord /ther (IM), not /rehabil", "PI": "Speech Therapy (1966-1979)", "MS": "Rehabilitation of persons with language disorders or training of children with language development disorders.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19790221", "DC": "1", "DX": "19800101", "UI": "D007808"}, {"RECTYPE": "D", "MH": "Lanolin", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D10.945.507", "PA": "Cosmetics", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "8006-54-0", "MS": "A yellow fat obtained from sheep's wool. It is used as an emollient, cosmetic, and pharmaceutic aid.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007809"}, {"RECTYPE": "D", "MH": "Lanosterol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Kryptosterol|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbcdeef", "ENTRY": "4,4,14 alpha-trimethyl-5 alpha-cholesta-8,24-dien-3 beta-ol|T109|T123|NON|EQV|UNK (19XX)|831014|abbcdef", "MN": "D10.570.938.590", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "Lanosta-8,24-dien-3-ol, (3beta)-", "RN": "1J05Z83K3M", "RR": "79-63-0 (Lanosterol)", "PI": "Sterols (1966-1971)", "MS": "A triterpene that derives from the chair-boat-chair-boat folding of 2,3-oxidosqualene. It is metabolized to CHOLESTEROL and CUCURBITACINS.", "PM": "74", "HN": "74(72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007810"}, {"RECTYPE": "D", "MH": "Lanthanum", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.500", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Lanthanum", "RN": "6I3K30563S", "RR": "7439-91-0 (Lanthanum)", "MS": "The prototypical element in the rare earth family of metals. It has the atomic symbol La, atomic number 57, and atomic weight 138.91. Lanthanide ion is used in experimental biology as a calcium antagonist; lanthanum oxide improves the optical properties of glass.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007811"}, {"RECTYPE": "D", "MH": "Laos", "AQ": "EH EP", "MN": "Z01.252.145.435", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in Southeastern Asia, northeast of Thailand, west of Vietnam. The capital is Vientiane.", "MR": "20161222", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007812"}, {"RECTYPE": "D", "MH": "Laparotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Minilaparotomies", "MN": "E04.406", "MH_TH": "POPLINE (1978)", "ST": "T061", "AN": "avoid: not a coordinate for operative surgery on abdominal organs; prefer / surg with specific organ; restrict to technique of surgical incision of abdominal wall at any point; usually exploratory", "MS": "Incision into the side of the abdomen between the ribs and pelvis.", "CATSH": "CAT LIST", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007813"}, {"RECTYPE": "D", "MH": "Larva", "AQ": "AH CH CL CY DE EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Tadpoles|T204|NON|NRW|NLM (1999)|980518|abcdef", "ENTRY": "Tadpole|T204|NON|NRW|NLM (1999)|980518|abcdef", "MN": "G07.345.500.550.500.500", "FX": "Imaginal Discs", "MH_TH": "NLM (1970)", "ST": "T204", "AN": "only for metamorphosing animals; do not use /embryol with reference to larvae; maggot is the larval form of a fly", "PI": "Metamorphosis, Biological (1966-1969)", "MS": "Wormlike or grublike stage, following the egg in the life cycle of insects, worms, and other metamorphosing animals.", "PM": "74", "HN": "74(70)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007814"}, {"RECTYPE": "D", "MH": "Larva Migrans", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Ocular Larva Migrans|T047|NON|NRW|ORD (2010)|UNK (19XX)|880602|abcdeef", "ENTRY": "Itchs, Ground", "MN": "C17.800.838.775.424", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "note category: a disease; restrict this dis to nematode infections; Ancylostoma brasiliensis causes cutaneous larva migrans, Toxocara causes visceral", "MS": "Infections caused by nematode larvae which never develop into the adult stage and migrate through various body tissues. They commonly infect the skin, eyes, and viscera in man. Ancylostoma brasiliensis causes cutaneous larva migrans. Toxocara causes visceral larva migrans.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007815"}, {"RECTYPE": "D", "MH": "Larva Migrans, Visceral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Visceral Larva Migrans Syndrome|T047|NON|EQV|NLM (2010)|ORD (2010)|090505|abcdeef", "ENTRY": "Visceral Larva Migrans", "MN": "C01.610.335.508.700.100.868.420", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Larva Migrans (1966-1967)", "MS": "A condition produced in man by the prolonged migration of animal nematode larvae in extraintestinal tissues other than skin; characterized by persistent hypereosinophilia, hepatomegaly, and frequently pneumonitis, commonly caused by Toxocara canis and Toxocara cati.", "PM": "1968", "HN": "1968", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007816"}, {"RECTYPE": "D", "MH": "Laryngeal Cartilages", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Laryngeal Cartilage", "MN": "A04.329.591", "MH_TH": "NLM (1966)", "ST": "T024", "AN": "general or unspecified; prefer specifics", "MS": "The nine cartilages of the larynx, including the cricoid, thyroid and epiglottic, and two each of arytenoid, corniculate and cuneiform.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007817"}, {"RECTYPE": "D", "MH": "Laryngeal Diseases", "DE": "LARYNGEAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Laryngeal Perichondritis|T047|NON|NRW|NLM (1997)|960415|abcdef", "ENTRY": "Perichondritis, Laryngeal", "MN": "C09.400", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes involving any part of the LARYNX which coordinates many functions such as voice production, breathing, swallowing, and coughing.", "PM": "66; LARYNGEAL PERICHONDRITIS was heading 1963-96", "HN": "66; LARYNGEAL PERICHONDRITIS was heading 1963-96", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007818"}, {"RECTYPE": "D", "MH": "Laryngeal Edema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Edema, Laryngeal|T033|T046|NON|EQV|NLM (2009)|071019|abbcdef", "ENTRY": "Laryngeal Edemas", "MN": "C09.400.313", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Abnormal accumulation of fluid in tissues of any part of the LARYNX, commonly associated with laryngeal injuries and allergic reactions.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007819"}, {"RECTYPE": "D", "MH": "Laryngeal Mucosa", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Laryngeal Epithelium|T024|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Mucosa, Laryngeal", "MN": "A10.615.550.760.520", "MH_TH": "NLM (1979)", "ST": "T024", "PI": "Mucous Membrane (1966-1978)", "MS": "The mucous lining of the LARYNX, consisting of various types of epithelial cells ranging from stratified squamous EPITHELIUM in the upper larynx to ciliated columnar epithelium in the rest of the larynx, mucous GOBLET CELLS, and glands containing both mucous and serous cells.", "PM": "91; was see under LARYNX 1979-90", "HN": "91(79); was see under LARYNX 1979-90", "MR": "20050630", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D007820"}, {"RECTYPE": "D", "MH": "Laryngeal Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cricothyroid Muscles|T023|NON|NRW|NLM (2009)|071016|abcdef", "ENTRY": "Vocalis Muscles", "MN": "A04.329.604", "MH_TH": "NLM (1979)", "ST": "T023", "AN": "/growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent", "PI": "Muscles (1966-1978)", "MS": "The striated muscle groups which move the LARYNX as a whole or its parts, such as altering tension of the VOCAL CORDS, or size of the slit (RIMA GLOTTIDIS).", "PM": "91; was see under MUSCLES 1979-90", "HN": "91(79); was see under MUSCLES 1979-90", "MR": "20080708", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D007821"}, {"RECTYPE": "D", "MH": "Laryngeal Neoplasms", "DE": "LARYNGEAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Larynx Neoplasms|T191|NON|EQV|NLM (2000)|991103|LARYNX NEOPL|abcdefv", "ENTRY": "Neoplasms, Larynx", "MN": "C09.647.481", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.", "CATSH": "CAT LIST", "MR": "20050715", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007822"}, {"RECTYPE": "D", "MH": "Laryngeal Nerves", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Laryngeal Nerve, Superior|T023|NON|NRW|NLM (1994)|930119|abcdef", "ENTRY": "Superior Laryngeal Nerves", "MN": "A08.800.800.120.900.450", "EC": "injuries:Laryngeal Nerve Injuries", "MH_TH": "NLM (1965)", "ST": "T023", "AN": "disease: coordinate IM with CRANIAL NERVE DISEASES (IM); neoplasm: coordinate IM with CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM)", "MS": "Branches of the VAGUS NERVE. The superior laryngeal nerves originate near the nodose ganglion and separate into external branches, which supply motor fibers to the cricothyroid muscles, and internal branches, which carry sensory fibers. The RECURRENT LARYNGEAL NERVE originates more caudally and carries efferents to all muscles of the larynx except the cricothyroid. The laryngeal nerves and their various branches also carry sensory and autonomic fibers to the laryngeal, pharyngeal, tracheal, and cardiac regions.", "PM": "65", "HN": "65", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007823"}, {"RECTYPE": "D", "MH": "Laryngectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Laryngectomies", "MN": "E04.580.369", "FX": "Speech, Alaryngeal", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Total or partial excision of the larynx.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007825"}, {"RECTYPE": "D", "MH": "Laryngismus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Laryngospasm|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Spasms, Laryngeal", "MN": "C09.400.895.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "LARYNGOSTENOSIS is also available", "MS": "A disorder in which the adductor muscles of the VOCAL CORDS exhibit increased activity leading to laryngeal spasm. Laryngismus causes closure of the VOCAL FOLDS and airflow obstruction during inspiration.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007826"}, {"RECTYPE": "D", "MH": "Laryngitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Laryngitides", "MN": "C09.400.535", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the LARYNGEAL MUCOSA, including the VOCAL CORDS. Laryngitis is characterized by irritation, edema, and reduced pliability of the mucosa leading to VOICE DISORDERS such as APHONIA and HOARSENESS.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007827"}, {"RECTYPE": "D", "MH": "Laryngoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Laryngoscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES LARYNGOSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Laryngoscopic", "MN": "E04.580.373", "FX": "Laryngoscopes", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "/ instrum permitted but consider also LARYNGOSCOPES", "MS": "Examination, therapy or surgery of the interior of the larynx performed with a specially designed endoscope.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007828"}, {"RECTYPE": "D", "MH": "Laryngostenosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Laryngeal Stenosis|T019|T020|T047|NON|EQV|NLM (1990)|890328|abbbcdef", "ENTRY": "Subglottic Stenosis, Congenital", "MN": "C16.131.740.658", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Developmental or acquired stricture or narrowing of the LARYNX. Symptoms of respiratory difficulty depend on the degree of laryngeal narrowing.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007829"}, {"RECTYPE": "D", "MH": "Larynx", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Posterior Commissures, Larynx", "MN": "A04.329", "FX": "Laryngoscopy", "EC": "innervation:Laryngeal Nerves", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at VOCAL and VOICE", "MS": "A tubular organ of VOICE production. It is located in the anterior neck, superior to the TRACHEA and inferior to the tongue and HYOID BONE.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007830"}, {"RECTYPE": "D", "MH": "Larynx, Artificial", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Voice Prosthesis|T074|NON|NRW|UNK (19XX)|781221|abcdef", "ENTRY": "Voice Prostheses", "MN": "E07.858.082.595", "FX": "Speech, Alaryngeal", "MH_TH": "NLM (1980)", "ST": "T074", "PI": "Speech, Alaryngeal (1968-1979)", "MS": "A device, activated electronically or by expired pulmonary air, which simulates laryngeal activity and enables a laryngectomized person to speak. Examples of the pneumatic mechanical device are the Tokyo and Van Hunen artificial larynges. Electronic devices include the Western Electric electrolarynx, Tait oral vibrator, Cooper-Rand electrolarynx and the Ticchioni pipe.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19781221", "DC": "1", "DX": "19800101", "UI": "D007831"}, {"RECTYPE": "D", "MH": "Lasalocid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "X537A", "MN": "D04.345.674.625.250", "PA": "Ionophores", "MH_TH": "USAN (1973)", "ST": "T121", "N1": "Benzoic acid, 6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl-, (2R-(2alpha(2S*(3R*,4S*,5S*,7R*),3S*,5S*),5alpha,6beta))-", "RN": "W7V2ZZ2FWB", "RR": "25999-31-9 (Lasalocid)", "PI": "Benzoates (1973-1974)", "MS": "Cationic ionophore antibiotic obtained from Streptomyces lasaliensis that, among other effects, dissociates the calcium fluxes in muscle fibers. It is used as a coccidiostat, especially in poultry.", "OL": "use LASALOCID to search X 537A 1975-77", "PM": "80; was indexed under ANTIBIOTICS 1975-79", "HN": "80(78); was see under ANTIBIOTICS 1978-79; was X 537A see under ANTIBIOTICS 1975-77", "MR": "20230226", "DA": "19741119", "DC": "1", "DX": "19800101", "UI": "D007832"}, {"RECTYPE": "D", "MH": "Lasers", "AQ": "AE CL HI SD SN ST", "PRINT ENTRY": "Masers|T073|NON|REL|NLM (2008)|060724|abcdef", "ENTRY": "Q-Switched Laser", "MN": "E07.710.520", "FX": "Optical Tweezers", "EC": "therapeutic use:Laser Therapy", "MH_TH": "NLM (1963)", "ST": "T073", "MS": "An optical source that emits photons in a coherent beam. Light Amplification by Stimulated Emission of Radiation (LASER) is brought about using devices that transform light of varying frequencies into a single intense, nearly nondivergent beam of monochromatic radiation. Lasers operate in the infrared, visible, ultraviolet, or X-ray regions of the spectrum.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007834"}, {"RECTYPE": "D", "MH": "Lassa Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Lassa Virus Infection|T047|NON|EQV|NLM (2020)|181105|abcdef", "ENTRY": "Virus Infection, Lassa", "MN": "C01.925.782.417.505", "MH_TH": "NLM (1977)", "ST": "T047", "PI": "Hemorrhagic Fevers, Viral (1966-1976)", "MS": "An acute febrile human disease caused by the LASSA VIRUS.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20190529", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D007835"}, {"RECTYPE": "D", "MH": "Lassa virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.480.500.070.100.500", "MH_TH": "NLM (1972)", "ST": "T005", "RN": "txid11620", "PI": "RNA Viruses (1966-1971)", "MS": "A species of ARENAVIRUS, part of the Old World Arenaviruses (ARENAVIRUSES, OLD WORLD), and the etiologic agent of LASSA FEVER. LASSA VIRUS is a common infective agent in humans in West Africa. Its natural host is the multimammate mouse Mastomys natalensis.", "PM": "91; was see under ARENAVIRIDAE 1981-90; was see under ARENAVIRUSES 1978-80; was see under RNA VIRUSES 1972-77", "HN": "91(72); was see under ARENAVIRIDAE 1981-90; was see under ARENAVIRUSES 1978-80; was see under RNA VIRUSES 1972-77", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007836"}, {"RECTYPE": "D", "MH": "Latency Period, Psychological", "PRINT ENTRY": "Latency Period, Psychology|T079|NON|EQV|NLM (2020)|190118|abcdef", "ENTRY": "Psychology Latency Periods", "MN": "F02.739.794.793.458", "MH_TH": "NLM (2020)", "ST": "T079", "MS": "The period from about 5 to 7 years to adolescence when there is an apparent cessation of psychosexual development.", "PM": "2020; was LATENCY PERIOD (PSYCHOLOGY) 1991-2019; was indexed under PSYCHOSEXUAL DEVELOPMENT 1975-1990", "HN": "2020 (1975); was LATENCY PERIOD (PSYCHOLOGY) 1991-2019; was indexed under PSYCHOSEXUAL DEVELOPMENT 1975-1990", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007837"}, {"RECTYPE": "D", "MH": "Functional Laterality", "AQ": "CL DE ES GE PH RE", "PRINT ENTRY": "Mirror Writing|T184|NON|NRW|UNK (19XX)|750716|abcdef", "ENTRY": "Writings, Mirror", "MN": "G11.561.225.425", "FX": "Split-Brain Procedure", "MH_TH": "NLM (2007)", "ST": "T032", "AN": "restrict to neurological & psychological sense; sidedness or laterality of disease, index the disease with /pathol or /physiopathol; for unilateral or bilateral surgery, index the surgical technique with /methods if pertinent", "MS": "Behavioral manifestations of cerebral dominance in which there is preferential use and superior functioning of either the left or the right side, as in the preferred use of the right hand or right foot.", "PM": "2007; see LATERALITY 1966-2006; for AMBIDEXTERITY see LATERALITY 1966-1974; for MIRROR WRITING see DOMINANCE, CEREBRAL 1976-2006 & HANDWRITING 1963-1975", "HN": "2007(1966); for MIRROR WRITING use DOMINANCE, CEREBRAL 1976-2006 & HANDWRITING 1963-1975", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D007839"}, {"RECTYPE": "D", "MH": "Latex", "AQ": "AD AE AN BI CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Latice", "MN": "J01.637.051.720.540", "FX": "Latex Hypersensitivity", "MH_TH": "NLM (1981)", "ST": "T122", "RN": "0", "AN": "coordinate with source plant (commonly HEVEA)", "PI": "Rubber (1966-1980)", "MS": "A milky, product excreted from the latex canals of a variety of plant species that contain cauotchouc. Latex is composed of 25-35% caoutchouc, 60-75% water, 2% protein, 2% resin, 1.5% sugar & 1% ash. RUBBER is made by the removal of water from latex.(From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed). Hevein proteins are responsible for LATEX HYPERSENSITIVITY. Latexes are used as inert vehicles to carry antibodies or antigens in LATEX FIXATION TESTS.", "PM": "1981; see LATEX RUBBER 1968-1980, see RUBBER 1963-1967; LATEX PARTICLES was heading 1968-1980; for LATICES see LATEX 1981-1995", "HN": "1981(1963-1967); use LATEX RUBBER 1968-1980", "MR": "20060705", "DA": "19800520", "DC": "1", "DX": "19810101", "UI": "D007840"}, {"RECTYPE": "D", "MH": "Latex Fixation Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Latex Agglutination Tests|T059|T060|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Tests, Latex Fixation", "MN": "E05.478.594.760.050.450", "MH_TH": "NLM (1964)", "ST": "T060", "AN": "NIM", "MS": "Passive agglutination tests in which antigen is adsorbed onto latex particles which then clump in the presence of antibody specific for the adsorbed antigen. (From Stedman, 26th ed)", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007841"}, {"RECTYPE": "D", "MH": "Lathyrism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neurolathyrism|T037|NON|NRW|NLM (2007)|060221|abcdef", "MN": "C25.723.756.558", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "A paralytic condition of the legs caused by ingestion of lathyrogens, especially BETA-AMINOPROPIONITRILE or beta-N-oxalyl amino-L-alanine, which are found in the seeds of plants of the genus LATHYRUS.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007842"}, {"RECTYPE": "D", "MH": "Latin America", "AQ": "EH EP", "MN": "Z01.107.424", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "general or unspecified; prefer specific country", "MS": "The geographic area of Mexico, Central America, continent of South America and the islands of the Caribbean where Spanish or other Romance language is spoken.", "HN": "75", "MR": "20220708", "DA": "19990101", "DC": "4", "DX": "19750101", "UI": "D007843"}, {"RECTYPE": "D", "MH": "Latvia", "AQ": "EH EP", "ENTRY": "Republic of Latvia|T083|NON|EQV|NLM (2018)|161222|abcdef", "MN": "Z01.542.248.136.560", "MH_TH": "NLM (1993)", "ST": "T083", "MS": "A country located in Eastern Europe, bordering the Baltic Sea, between Estonia and Lithuania. The capital is Riga.", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007844"}, {"RECTYPE": "D", "MH": "Laughter", "AQ": "PH PX", "MN": "F01.145.209.530.614", "FX": "Wit and Humor as Topic", "EC": "therapeutic use:Laughter Therapy", "MH_TH": "NLM (1966)", "ST": "T054", "MS": "An involuntary expression of merriment and pleasure; it includes the patterned motor responses as well as the inarticulate vocalization.", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007845"}, {"RECTYPE": "D", "MH": "Laundering", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "J01.576.549", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "The process of washing clothes, linens or other fabric.", "MR": "20151130", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007846"}, {"RECTYPE": "D", "MH": "Laundry Service, Hospital", "DE": "LAUNDRY SERV HOSP", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Hospital Laundry Service|T093|NON|EQV|UNK (19XX)|790411|HOSP LAUNDRY SERV|abcdefv", "ENTRY": "Services, Hospital Laundry", "MN": "N04.452.442.452.422.428", "FX": "Bedding and Linens", "MH_TH": "NLM (1980)", "ST": "T093", "PI": "Laundering (1966-1979)", "MS": "Hospital department which administers all activities pertaining to the hospital laundry service.", "PM": "80", "HN": "80", "MR": "20190709", "DA": "19790411", "DC": "1", "DX": "19800101", "UI": "D007847"}, {"RECTYPE": "D", "MH": "Laurates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dodecanoates|T109|NON|EQV|UNK (19XX)|741111|abcdef", "MN": "D10.251.500.410", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Fatty Acids (1966-1974)", "MS": "Salts and esters of the 12-carbon saturated monocarboxylic acid--lauric acid.", "PM": "91; was see under LAURIC ACIDS 1975-90", "HN": "91(75); was see under LAURIC ACIDS 1975-90", "MR": "20030709", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D007848"}, {"RECTYPE": "D", "MH": "Laurence-Moon Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Laurence-Moon-Biedl Syndrome|T019|T047|EPO|EQV|GHR (2014)|NLM (1966)|990101|abbcdeef", "ENTRY": "Syndrome, Laurence-Moon-Biedl", "MN": "C16.131.077.509", "FX": "Intellectual Disability", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "note entry term: do not confuse with LAURENCE-MOON-BARDET-BIEDL SYNDROME see BARDET-BIEDL SYNDROME", "MS": "An autosomal recessive condition characterized by hypogonadism; spinocerebellar degeneration; MENTAL RETARDATION; RETINITIS PIGMENTOSA; and OBESITY. This syndrome was previously referred to as Laurence-Moon-Biedl syndrome until BARDET-BIEDL SYNDROME was identified as a distinct entity. (From N Engl J Med. 1989 Oct 12;321(15):1002-9)", "PM": "2000; see LAURENCE-MOON-BIEDL SYNDROME 1966-1999", "HN": "2000 (1966)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D007849"}, {"RECTYPE": "D", "MH": "Lauric Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dodecanoic Acids|T109|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Acids, Lauric", "MN": "D10.251.500", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Fatty Acids (1966-1974)", "MS": "12-Carbon saturated monocarboxylic acids.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D007850"}, {"RECTYPE": "D", "MH": "Dodecanol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lauryl Alcohol|T109|NON|EQV|FDA SRS (2014)|NLM (1998)|970220|abcdeef", "ENTRY": "n Dodecyl Alcohol", "MN": "D10.289.220", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "1-Dodecanol", "RN": "178A96NLP2", "RR": "112-53-8 (Dodecanol)", "PI": "Fatty Alcohols (1972-1974)", "MS": "A saturated 12-carbon fatty alcohol obtained from coconut oil fatty acids. It has a floral odor and is used in detergents, lubricating oils, and pharmaceuticals. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "PM": "98; see LAURYL ALCOHOL 1991-97; see FATTY ALCOHOLS 1975-90", "HN": "98(75)", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D007851"}, {"RECTYPE": "D", "MH": "Lawrencium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.423", "MH_TH": "NLM (1975)", "ST": "T196", "N1": "Lawrencium", "RN": "QRT37X99RQ", "RR": "22537-19-5 (Lawrencium)", "PI": "Elements (1966-1974)", "MS": "A radioactive actinide discovered in 1961. It has the atomic symbol Lr, and atomic number 103. There are twelve isotopes with mass numbers 252\u2013262 and 266.", "PM": "75", "HN": "75", "MR": "20170414", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D007852"}, {"RECTYPE": "D", "MH": "Lead", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK RE SD ST TO TU UR", "MN": "D01.552.544.435", "FX": "Lead Radioisotopes", "EC": "poisoning:Lead Poisoning", "MH_TH": "POPLINE (1978)", "ST": "T196", "N1": "Lead", "RN": "2P299V784P", "RR": "7439-92-1 (Lead)", "MS": "A soft, grayish metal with poisonous salts; atomic number 82, atomic weight 207.2, symbol Pb.", "MR": "20170704", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007854"}, {"RECTYPE": "D", "MH": "Lead Poisoning", "DE": "LEAD POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Poisonings, Lead", "MN": "C25.723.522.750", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "occupational lead poisoning: coordinate with OCCUPATIONAL DISEASES but not also with OCCUPATIONAL EXPOSURE; in infant or child, consider LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD; in adolescent or adult, consider LEAD POISONING, NERVOUS SYSTEM, ADULT", "MS": "Poisoning that results from chronic or acute ingestion, injection, inhalation, or skin absorption of LEAD or lead compounds.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007855"}, {"RECTYPE": "D", "MH": "Lead Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Lead", "MN": "D01.496.749.560", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1987)", "MS": "Unstable isotopes of lead that decay or disintegrate emitting radiation. Pb atoms with atomic weights 194-203, 205, and 209-214 are radioactive lead isotopes.", "PM": "88", "HN": "88", "MR": "20170704", "DA": "19870408", "DC": "1", "DX": "19880101", "UI": "D007856"}, {"RECTYPE": "D", "MH": "Leadership", "ENTRY": "Influentials|T078|NON|REL|POPLINE (1978)|781226|abcdef", "MN": "N04.452.677.415", "MH_TH": "NLM (1966)", "ST": "T054", "MS": "The function of directing or controlling the actions or attitudes of an individual or group with more or less willing acquiescence of the followers.", "CATSH": "CAT LIST", "MR": "20210526", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007857"}, {"RECTYPE": "D", "MH": "Learning", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Phenomenography|T041|NON|REL|NLM (2008)|070127|abcdef", "MN": "F02.784.629.529", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "policy: Manual 30.12", "MS": "Relatively permanent change in behavior that is the result of past experience or practice. The concept includes the acquisition of knowledge.", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007858"}, {"RECTYPE": "D", "MH": "Learning Disabilities", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Learning Disorders|T048|NON|REL|NLM (2021)|200330|abcdef", "ENTRY": "Learning Disturbances", "MN": "F03.625.562", "FX": "Dyslexia", "MH_TH": "NLM (2000)", "ST": "T048", "MS": "Conditions characterized by a significant discrepancy between an individual's perceived level of intellect and their ability to acquire new language and other cognitive skills. These may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, DYSCALCULIA, and DYSGRAPHIA.", "PM": "2020; see LEARNING DISORDERS 1966-2019", "HN": "2020(1966)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007859"}, {"RECTYPE": "D", "MH": "Leasing, Property", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Property Leasings", "MN": "N03.219.463.500", "MH_TH": "NLM (1978)", "ST": "T057", "MS": "Contractual arrangement between the lessor (owner) and the lessee in which the use of equipment or facilities is granted to the lessee for a period of time and at a specified rate.", "PM": "91; was see under FINANCIAL MANAGEMENT 1978-90", "HN": "91(78); was see under FINANCIAL MANAGEMENT 1978-90", "MR": "19980610", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D007860"}, {"RECTYPE": "D", "MH": "Lebanon", "AQ": "EH EP", "ENTRY": "Lebanese Republic|T083|NON|EQV|NLM (2018)|161222|abcdef", "MN": "Z01.252.245.500.450", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country located in the Middle East, bordering the Mediterranean Sea, between Israel and Syria. The capital is Beirut.", "MR": "20161222", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007861"}, {"RECTYPE": "D", "MH": "Phosphatidylcholine-Sterol O-Acyltransferase", "DS": "PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE O", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lecithin Cholesterol Acyltransferase|T116|T126|NON|EQV|UNK (19XX)|750206|abbcdef", "ENTRY": "Phosphatidylcholine Sterol O Acyltransferase", "MN": "D08.811.913.050.625", "EC": "deficiency:Lecithin Cholesterol Acyltransferase Deficiency", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Phosphatidylcholine:sterol O-acyltransferase", "RN": "EC 2.3.1.43", "RR": "9031-14-5 (CAS RN)", "PI": "Phosphatidylcholines (1966-1974)", "MS": "An enzyme secreted from the liver into the plasma of many mammalian species. It catalyzes the esterification of the hydroxyl group of lipoprotein cholesterol by the transfer of a fatty acid from the C-2 position of lecithin. In familial lecithin:cholesterol acyltransferase deficiency disease, the absence of the enzyme results in an excess of unesterified cholesterol in plasma.", "PM": "98; see LECITHIN ACYLTRANSFERASE 1978-97; see ACYLTRANSFERASES 1975-77", "HN": "98(75)", "MR": "20160701", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D007862"}, {"RECTYPE": "D", "MH": "Lecithin Cholesterol Acyltransferase Deficiency", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "alpha LCAT Deficiency", "MN": "C18.452.648.398.500.330.500", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Lipoproteins (1966-1977)", "MS": "An autosomal recessive disorder of lipoprotein metabolism caused by mutation of LECITHIN CHOLESTEROL ACYLTRANSFERASE gene. It is characterized by low HDL-cholesterol levels, and the triad of CORNEAL OPACITIES; HEMOLYTIC ANEMIA; and PROTEINURIA with renal failure.", "PM": "2017; see LECITHIN ACYLTRANSFERASE DEFICIENCY 1991-2016; HYPOLIPOPROTEINEMIA 1980-1990; HYPOLIPOPROTEINEMIAS 1978-1979", "HN": "2017(1978); use LECITHIN ACYLTRANSFERASE DEFICIENCY 1991-2016; HYPOLIPOPROTEINEMIA 1980-1990; HYPOLIPOPROTEINEMIAS 1978-1979", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19770429", "DC": "1", "DX": "19910101", "UI": "D007863"}, {"RECTYPE": "D", "MH": "Leeches", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Hirudinea|T204|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Leeche", "MN": "B01.050.500.091.426", "FX": "Leeching", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid55824", "MS": "Annelids of the class Hirudinea. Some species, the bloodsuckers, may become temporarily parasitic upon animals, including man. Medicinal leeches (HIRUDO MEDICINALIS) have been used therapeutically for drawing blood since ancient times.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007865"}, {"RECTYPE": "D", "MH": "Leg", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU TR VI", "ENTRY": "Legs", "MN": "A01.378.610.500", "FX": "Leg Bones", "EC": "injuries:Leg Injuries", "MH_TH": "NLM (1963)", "ST": "T029", "AN": "primates only but see note on LEG INJURIES; for whole leg or lower leg (THIGH is available for upper leg); for bones use TIBIA or FIBULA; Manual 21.58: table of human, primate & non-primate extremities", "MS": "The inferior part of the lower extremity between the KNEE and the ANKLE.", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D007866"}, {"RECTYPE": "D", "MH": "Leg Bones", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Bones of Leg|T023|NON|EQV|NLM (1998)|970311|abcdef", "ENTRY": "Leg Bone", "MN": "A02.835.232.043.650", "MH_TH": "NLM (1974)", "ST": "T023", "AN": "general or unspecified; prefer specifics; primates only; Manual 21.58", "PI": "specific bones of leg (1966-1997)", "MS": "The bones of the free part of the lower extremity in humans and of any of the four extremities in animals. It includes the PATELLA; TIBIA; and FIBULA.", "PM": "98", "HN": "98; use explode 1975-97", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D007867"}, {"RECTYPE": "D", "MH": "Leg Dermatoses", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dermatosis, Leg", "MN": "C17.800.446", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; a coordinate for specific skin diseases of the leg but not a coordinate for neoplasms on the leg (index neoplasm terms and LEG); consider synonym for leg dermatitis and do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH", "MS": "A nonspecific term used to denote any cutaneous lesion or group of lesions, or eruptions of any type on the leg. (From Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007868"}, {"RECTYPE": "D", "MH": "Leg Injuries", "DE": "LEG INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Leg Injury", "MN": "C26.558", "FX": "Tibial Neuropathy", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "general or unspecified; prefer specifics; consider also /inj with specific parts of the leg; /vet permitted for non-primates", "MS": "General or unspecified injuries involving the leg.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007869"}, {"RECTYPE": "D", "MH": "Leg Length Inequality", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Length Inequality, Leg", "MN": "C23.300.808", "FX": "Bone Lengthening", "MH_TH": "NLM (1972)", "ST": "T190", "AN": "correction of inequality: coord IM with BONE LENGTHENING (IM) or specifically ILIZAROV TECHNIQUE (IM) if pertinent", "MS": "A condition in which one of a pair of legs fails to grow as long as the other, which could result from injury or surgery.", "OL": "use LEG LENGTH INEQUALITY to search LEG LENGTHENING 1966-71 (as Prov 1966)", "PM": "72; LEG LENGTHENING was heading 1967-71", "HN": "72; LEG LENGTHENING was heading 1964-71 (Prov 1964-66)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D007870"}, {"RECTYPE": "D", "MH": "Leg Ulcer", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ulcers, Leg", "MN": "C17.800.893.592", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "if varicose, index instead under VARICOSE ULCER; FOOT ULCER is also available", "MS": "Ulceration of the skin and underlying structures of the lower extremity. About 90% of the cases are due to venous insufficiency (VARICOSE ULCER), 5% to arterial disease, and the remaining 5% to other causes.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007871"}, {"RECTYPE": "D", "MH": "Legal Guardians", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Legal Guardian", "MN": "M01.380", "FX": "Third-Party Consent", "MH_TH": "BIOETHICS (1974)", "ST": "T098", "AN": "specify state or country if pertinent", "MS": "A legal concept for individuals who are designated to act on behalf of persons who are considered incapable of acting in their own behalf, e.g., minors and persons found to be not mentally competent.", "PM": "78", "HN": "78", "MR": "19991103", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D007872"}, {"RECTYPE": "D", "MH": "Legg-Calve-Perthes Disease", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Perthes Disease|T047|EPO|EQV|NLM (1991)|OMIM (2013)|900329|PERTHES DIS|abcdeefv", "ENTRY": "Syndrome, Legg-Calv\u00e9-Perthes", "MN": "C05.116.852.175.570", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Osteochondritis (1966-1974)", "MS": "A particular type of FEMUR HEAD NECROSIS occurring in children, mainly male, with a course of four years or so.", "PM": "2012; see LEGG-PERTHES DISEASE 1991-2011, FEMUR HEAD NECROSIS 1979-1990, see OSTEOCHRONDRITIS 1963-1978; for COXA PLANA see OSTEOCHRONDRITIS 1963-1978", "HN": "2012 (1963); for COXA PLANA see OSTEOCHRONDRITIS 1963-1978", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007873"}, {"RECTYPE": "D", "MH": "Leghemoglobin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Leghemoglobin A|T116|T123|NON|NRW|UNK (19XX)|830916|abbcdef", "MN": "D12.776.765.500", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "from leguminous plants", "PI": "Plant Proteins (1972-1974)", "MS": "A hemoglobin-like oxygen-binding hemeprotein present in the nitrogen-fixing root nodules of leguminous plants. The red pigment has a molecular weight approximately 1/4 that of hemoglobin and has been suggested to act as an oxido-reduction catalyst in symbiotic nitrogen fixation.", "PM": "91; was see under HEMEPROTEINS 1975-90", "HN": "91(75); was see under HEMEPROTEINS 1975-90", "MR": "20080708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007874"}, {"RECTYPE": "D", "MH": "Legionella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.460.460", "MH_TH": "NLM (1981)", "ST": "T007", "RN": "txid445", "PI": "Legionnaires' Disease (1978-1980)", "MS": "Gram-negative aerobic rods, isolated from surface water or thermally polluted lakes or streams. Member are pathogenic for man. Legionella pneumophila is the causative agent for LEGIONNAIRES' DISEASE.", "PM": "81", "HN": "81", "MR": "20200813", "DA": "19800514", "DC": "1", "DX": "19810101", "UI": "D007875"}, {"RECTYPE": "D", "MH": "Legionellosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Legionelloses", "MN": "C08.730.382", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Pneumonia (1966-1986)", "MS": "Infections with bacteria of the genus LEGIONELLA.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D007876"}, {"RECTYPE": "D", "MH": "Legionnaires' Disease", "DE": "LEGIONNAIRES DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Legionella pneumophila Infections|T047|NON|EQV|NLM (1992)|910412|LEGIONELLA PNEUMOPHILA INFECT|abcdefv", "ENTRY": "Legionnaires Disease", "MN": "C08.730.382.380", "MH_TH": "NLM (1978)", "ST": "T047", "PI": "Disease Outbreaks (1976-1978)", "MS": "An acute, sometimes fatal, pneumonia-like bacterial infection characterized by high fever, malaise, muscle aches, respiratory disorders and headache. It is named for an outbreak at the 1976 Philadelphia convention of the American Legion.", "PM": "79; was see under RESPIRATORY TRACT INFECTIONS 1978", "HN": "79(78); was see under RESPIRATORY TRACT INFECTIONS 1978", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19780215", "DC": "1", "DX": "19790101", "UI": "D007877"}, {"RECTYPE": "D", "MH": "Legislation as Topic", "AQ": "CL EC ES HI OG SN ST TD", "PRINT ENTRY": "Health Legislation|T089|NON|NRW|UNK (19XX)|770421|HEALTH LEGIS|abcdefv", "ENTRY": "Population Laws", "MN": "N03.706.615", "FX": "Licensure", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "general or unspecified; prefer specifics; prefer the qualifier / legis with a specific term; specify country or state; do not confuse with the Publication Type LEGISLATION", "MS": "Works about the enactment of laws and ordinances and their regulation by official organs of a nation, state, or other legislative organization. It refers also to health-related laws and regulations in general or for which there is no specific descriptor.", "PM": "2008; see LEGISLATION 1963-2007", "HN": "2008(1963)", "MR": "20161216", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D007878"}, {"RECTYPE": "D", "MH": "Legislation, Dental", "DE": "LEGIS DENT", "AQ": "CL EC ES HI OG SN ST TD", "ENTRY": "Dental Legislation|T089|NON|EQV|UNK (19XX)|860101|DENT LEGIS|abcdefv", "MN": "N03.706.615.331", "MH_TH": "NLM (1966)", "ST": "T089", "AN": "specify country or state", "MS": "Laws and regulations pertaining to the field of dentistry, proposed for enactment or recently enacted by a legislative body.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007879"}, {"RECTYPE": "D", "MH": "Legislation, Drug", "DE": "LEGIS DRUG", "AQ": "CL EC ES HI OG SN ST TD", "PRINT ENTRY": "Narcotic Laws|T089|NON|NRW|UNK (19XX)|780504|abcdef", "ENTRY": "Narcotic Law", "MN": "N03.706.615.402", "FX": "Drug Prescriptions", "MH_TH": "NLM (1968)", "ST": "T089", "AN": "specify country or state", "PI": "Legislation, Medical (1966-1967)", "MS": "Laws concerned with manufacturing, dispensing, and marketing of drugs.", "OL": "search FOOD AND DRUG LAWS under LEGISLATION, DRUG 1968-78; search FOOD, DRUG AND COSMETIC ACT under LEGISLATION, DRUG 1968-77", "PM": "68; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78", "HN": "68; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78; FOOD, DRUG AND COSMETIC ACT was see under LEGISLATION, DRUG 1968-77", "MR": "20080710", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007880"}, {"RECTYPE": "D", "MH": "Legislation, Food", "DE": "LEGIS FOOD", "AQ": "CL EC ES HI OG SN ST TD", "PRINT ENTRY": "Food Laws|T089|NON|EQV|UNK (19XX)|780504|abcdef", "ENTRY": "Laws, Food", "MN": "N03.706.615.412", "MH_TH": "NLM (1979)", "ST": "T089", "AN": "specify country or state", "PI": "Legislation, Drug (1975-1978)", "MS": "Laws and regulations concerned with industrial processing and marketing of foods and beverages.", "OL": "search FOOD AND DRUG LAWS under LEGISLATION, DRUG 1968-78", "PM": "79; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78", "HN": "79; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78", "MR": "20190510", "DA": "19780504", "DC": "1", "DX": "19790101", "UI": "D007881"}, {"RECTYPE": "D", "MH": "Legislation, Hospital", "DE": "LEGIS HOSP", "AQ": "CL EC ES HI OG SN ST TD", "ENTRY": "Legislations, Hospital", "MN": "N03.706.615.420", "MH_TH": "NLM (1978)", "ST": "T089", "AN": "specify country or state", "MS": "Laws and regulations concerning hospitals, which are proposed for enactment or enacted by a legislative body.", "PM": "78", "HN": "78", "MR": "19991103", "DA": "19770511", "DC": "1", "DX": "19780101", "UI": "D007882"}, {"RECTYPE": "D", "MH": "Legislation, Medical", "DE": "LEGIS MED", "AQ": "CL EC ES HI OG SN ST TD", "ENTRY": "Medical Legislation|T089|NON|EQV|UNK (19XX)|860101|MED LEGIS|abcdefv", "MN": "N03.706.615.473", "MH_TH": "NLM (1966)", "ST": "T089", "AN": "specify country or state", "MS": "Laws and regulations, pertaining to the field of medicine, proposed for enactment or enacted by a legislative body.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007883"}, {"RECTYPE": "D", "MH": "Legislation, Nursing", "DE": "LEGIS NURS", "AQ": "CL EC ES HI OG SN ST TD", "ENTRY": "Nursing Legislations", "MN": "N03.706.615.544", "MH_TH": "NLM (1966)", "ST": "T089", "AN": "specify country or state", "MS": "Laws and regulations, pertaining to the field of nursing, proposed for enactment by a legislative body.", "PM": "66", "HN": "66", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007884"}, {"RECTYPE": "D", "MH": "Legislation, Pharmacy", "DE": "LEGIS PHARM", "AQ": "CL EC ES HI OG SN ST TD", "ENTRY": "Pharmacy Laws", "MN": "N03.706.615.615", "MH_TH": "NLM (1968)", "ST": "T089", "AN": "specify country or state", "PI": "Pharmacy (1966-1967)", "MS": "Laws and regulations, pertaining to the field of pharmacy, proposed for enactment or enacted by a legislative body.", "PM": "68", "HN": "68", "MR": "20170711", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007885"}, {"RECTYPE": "D", "MH": "Legislation, Veterinary", "DE": "LEGIS VET", "AQ": "CL EC ES HI OG SN ST TD", "ENTRY": "Veterinary Legislations", "MN": "N03.706.615.686", "MH_TH": "NLM (1966)", "ST": "T089", "AN": "specify country or state", "MS": "Laws and regulations, pertaining to the field of veterinary medicine, proposed for enactment or enacted by a legislative body.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007886"}, {"RECTYPE": "D", "MH": "Fabaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Stryphnodendron|T002|NON|NRW|NLM (2004)|030418|abcdef", "ENTRY": "Pea Families", "MN": "B01.875.800.575.912.250.401", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3803", "RR": "txid72432", "MS": "The large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of \"beans\" belong to this family.", "PM": "2002; see LEGUMES 1978-2001", "HN": "2002", "MR": "20210630", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D007887"}, {"RECTYPE": "D", "MH": "Leigh Disease", "DE": "LEIGH DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Encephalopathy, Subacute Necrotizing|T047|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Subacute Necrotizing Encephalopathies", "MN": "C18.452.660.520", "FX": "Pyruvate Dehydrogenase Complex Deficiency Disease", "MH_TH": "NLM (1985)", "ST": "T047", "PI": "Pyruvate Carboxylase/deficiency (1975-1984)", "MS": "A group of metabolic disorders primarily of infancy characterized by the subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, dysphagia, and lactic acidosis. Pathological features include spongy degeneration of the neuropile of the basal ganglia, thalamus, brain stem, and spinal cord. Patterns of inheritance include X-linked recessive, autosomal recessive, and mitochondrial. Leigh disease has been associated with mutations in genes for the PYRUVATE DEHYDROGENASE COMPLEX; CYTOCHROME-C OXIDASE; ATP synthase subunit 6; and subunits of mitochondrial complex I. (From Menkes, Textbook of Child Neurology, 5th ed, p850).", "PM": "1991; see BRAIN DISEASES, METABOLIC 1985-1990", "HN": "1991(1985)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19840406", "DC": "1", "DX": "19910101", "UI": "D007888"}, {"RECTYPE": "D", "MH": "Leiomyoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Fibromyoma|T191|NON|EQV|NLM (1994)|930326|abcdef", "ENTRY": "Uterus, Fibroid", "MN": "C04.557.450.590.450", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues.", "OL": "use UTERINE NEOPLASMS to search FIBROIDS, UTERINE 1991-93", "PM": "FIBROIDS, UTERINE was see UTERINE NEOPLASMS 1991-93", "HN": "FIBROIDS, UTERINE was see UTERINE NEOPLASMS 1991-93", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D007889"}, {"RECTYPE": "D", "MH": "Leiomyosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Leiomyosarcoma, Myxoid|T191|NON|REL|NLM (1994)|930326|abcdef", "ENTRY": "Myxoid Leiomyosarcomas", "MN": "C04.557.450.795.455", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007890"}, {"RECTYPE": "D", "MH": "Leishmania", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Leishmania (Viannia)|T204|NON|NRW|NLM (1994)|930331|abcdef", "ENTRY": "viannias, Leishmania", "MN": "B01.268.475.868.488", "FX": "Leishmaniavirus", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5658", "MS": "A genus of flagellate protozoa comprising several species that are pathogenic for humans. Organisms of this genus have an amastigote and a promastigote stage in their life cycles. As a result of enzymatic studies this single genus has been divided into two subgenera: Leishmania leishmania and Leishmania viannia. Species within the Leishmania leishmania subgenus include: L. aethiopica, L. arabica, L. donovani, L. enrietti, L. gerbilli, L. hertigi, L. infantum, L. major, L. mexicana, and L. tropica. The following species are those that compose the Leishmania viannia subgenus: L. braziliensis, L. guyanensis, L. lainsoni, L. naiffi, and L. shawi.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007891"}, {"RECTYPE": "D", "MH": "Leishmania braziliensis", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Leishmania braziliensis braziliensis|T204|NON|NRW|NLM (1992)|910213|abcdef", "ENTRY": "Leishmania viannia braziliensis|T204|NON|EQV|NLM (1994)|930402|abcdef", "MN": "B01.268.475.868.488.080", "MH_TH": "NLM (1986)", "ST": "T204", "RN": "txid5660", "RR": "txid1448350", "PI": "Leishmania (1966-1985)", "MS": "A parasitic hemoflagellate of the subgenus Leishmania viannia that infects man and animals. It causes cutaneous (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), and mucocutaneous leishmaniasis (LEISHMANIASIS, MUCOCUTANEOUS) depending on the subspecies of this organism. The sandfly, Lutzomyia, is the vector. The Leishmania braziliensis complex includes the subspecies braziliensis and peruviana. Uta, a form of cutaneous leishmaniasis in the New World, is caused by the subspecies peruviana.", "OL": "use LEISHMANIA BRAZILIENSIS to search LEISHMANIA PERUVIANA 1986-91", "PM": "91; was see under LEISHMANIA 1986-90; LEISHMANIA PERUVIANA was see LEISHMANIA BRAZILIENSIS 1986-91", "HN": "91(86); was see under LEISHMANIA 1986-90; LEISHMANIA PERUVIANA was see LEISHMANIA BRAZILIENSIS 1986-91", "MR": "20210305", "DA": "19850320", "DC": "1", "DX": "19910101", "UI": "D007892"}, {"RECTYPE": "D", "MH": "Leishmania donovani", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Leishmania (Leishmania) donovani|T204|NON|EQV|NLM (1994)|930331|abcdef", "ENTRY": "leishmania donovanus, Leishmania", "MN": "B01.268.475.868.488.230", "MH_TH": "NLM (1986)", "ST": "T204", "RN": "txid5661", "AN": "do not confuse with LEISHMANIA DONOVANI CHAGASI see LEISHMANIA INFANTUM or LEISHMANIA DONOVANI INFANTUM see LEISHMANIA INFANTUM; infection: coord IM with LEISHMANIASIS, VISCERAL (IM); for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN", "PI": "Leishmania (1966-1985)", "MS": "A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). The sandfly genera Phlebotomus and Lutzomyia are the vectors.", "PM": "86", "HN": "86", "MR": "20200813", "DA": "19850320", "DC": "1", "DX": "19860101", "UI": "D007893"}, {"RECTYPE": "D", "MH": "Leishmania mexicana", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Leishmania mexicana mexicana|T204|NON|NRW|NLM (1992)|910213|abcdef", "ENTRY": "mexicanas, Leishmania leishmania", "MN": "B01.268.475.868.488.410", "MH_TH": "NLM (1986)", "ST": "T204", "RN": "txid5665", "RR": "txid5659", "AN": "infection: coord IM with LEISHMANIASIS, CUTANEOUS (IM) or LEISHMANIASIS, DIFFUSE CUTANEOUS (IM); for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN", "PI": "Leishmania (1966-1985)", "MS": "A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals including rodents. The Leishmania mexicana complex causes both cutaneous (LEISHMANIASIS, CUTANEOUS) and diffuse cutaneous leishmaniasis (LEISHMANIASIS, DIFFUSE CUTANEOUS) and includes the subspecies amazonensis, garnhami, mexicana, pifanoi, and venezuelensis. L. m. mexicana causes chiclero ulcer, a form of cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) in the New World. The sandfly, Lutzomyia, appears to be the vector.", "PM": "86", "HN": "86", "MR": "20200813", "DA": "19850320", "DC": "1", "DX": "19860101", "UI": "D007894"}, {"RECTYPE": "D", "MH": "Leishmania tropica", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Leishmania tropica minor|T204|NON|EQV|NLM (1992)|910305|abcdef", "ENTRY": "Leishmania tropicas", "MN": "B01.268.475.868.488.680", "MH_TH": "NLM (1986)", "ST": "T204", "RN": "txid5666", "AN": "infection: coordinate with probably LEISHMANIASIS, CUTANEOUS or other specific leishmaniasis term if appropriate; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Leishmania (1966-1985)", "MS": "A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects humans and rodents. This taxonomic complex includes species which cause a disease called Oriental sore which is a form of cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) of the Old World.", "OL": "use LEISHMANIA TROPICA to search LEISHMANIA MINOR 1986-91", "PM": "86; LEISHMANIA TROPICA MINOR was LEISHMANIA MINOR see LEISHMANIA TROPICA 1986-91", "HN": "86; LEISHMANIA TROPICA MINOR was LEISHMANIA MINOR see LEISHMANIA TROPICA 1986-91", "MR": "20220714", "DA": "19850320", "DC": "1", "DX": "19860101", "UI": "D007895"}, {"RECTYPE": "D", "MH": "Leishmaniasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Leishmaniases", "MN": "C17.800.838.775.560", "MH_TH": "POPLINE (1994)", "ST": "T047", "MS": "A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007896"}, {"RECTYPE": "D", "MH": "Leishmaniasis, Mucocutaneous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Mucocutaneous Leishmaniasis", "MN": "C17.800.838.775.560.400.385", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "MS": "A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007897"}, {"RECTYPE": "D", "MH": "Leishmaniasis, Visceral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Kala-Azar|T047|NON|EQV|ORD (2010)|UNK (19XX)|740330|abcdeef", "ENTRY": "Visceral Leishmaniasis", "MN": "C01.920.813.510", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent; do not confuse entry term BLACK FEVER with BLACKWATER FEVER or AMAZON BLACK FEVER see HEPATITIS D", "MS": "A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007898"}, {"RECTYPE": "D", "MH": "Leisure Activities", "AQ": "CL EC PX", "ENTRY": "Leisures", "MN": "I03.450", "MH_TH": "POPLINE (1986)", "ST": "T056", "PI": "Recreation (1966-1969)", "MS": "Voluntary use of free time for activities outside the daily routine.", "PM": "70", "HN": "70", "MR": "19920325", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D007899"}, {"RECTYPE": "D", "MH": "Lemur", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Lemurs|T015|NON|EQV|UNK (19XX)|800509|abcdef", "MN": "B01.050.150.900.649.313.988.700.508.490", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9446", "AN": "LEMUR, DWARF and LEMUR, MOUSE see CHEIROGALEIDAE are also available", "MS": "A genus of the family Lemuridae consisting of five species: L. catta (ring-tailed lemur), L. fulvus, L. macaco (acoumba or black lemur), L. mongoz (mongoose lemur), and L. variegatus (white lemur). Most members of this genus occur in forested areas on Madagascar and the Comoro Islands.", "OL": "use LEMUR to search LEMURS 1975-80", "PM": "91; was see under LEMURIDAE 1981-90; was LEMURS see under PROSIMIANS 1975-80", "HN": "91(81); was see under LEMURIDAE 1981-90; was LEMURS see under PROSIMIANS 1975-80", "MR": "20200813", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D007900"}, {"RECTYPE": "D", "MH": "Lemuridae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Varecia|T015|NON|NRW|NLM (1992)|901001|abcdef", "ENTRY": "True Lemur", "MN": "B01.050.150.900.649.313.988.700.508", "MH_TH": "NLM (1981)", "ST": "T015", "RN": "txid9445", "RR": "txid9454", "MS": "A family of the order PRIMATES, suborder STREPSIRHINI, containing four genera which inhabit Madagascar and the Comoro Island. Most of the lemurs prefer wooded areas. The four genera are Hapalemur, LEMUR, Lepilemur, and Varecia.", "PM": "81", "HN": "81", "MR": "20200902", "DA": "19800507", "DC": "1", "DX": "19810101", "UI": "D007901"}, {"RECTYPE": "D", "MH": "Length of Stay", "AQ": "EC LJ SN TD", "ENTRY": "Stays, Hospital", "MN": "N02.421.585.400.480", "MH_TH": "NLM (1969)", "ST": "T081", "PI": "Hospitalization (1966-1968)", "MS": "The period of confinement of a patient to a hospital or other health facility.", "PM": "72", "HN": "72(69)", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D007902"}, {"RECTYPE": "D", "MH": "Lens Capsule, Crystalline", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Lens Capsules, Crystalline", "MN": "A09.371.060.500.155", "FX": "Capsulorhexis", "MH_TH": "NLM (1983)", "ST": "T023", "PI": "Lens, Crystalline (1966-1982)", "MS": "The thin noncellular outer covering of the CRYSTALLINE LENS composed mainly of COLLAGEN TYPE IV and GLYCOSAMINOGLYCANS. It is secreted by the embryonic anterior and posterior epithelium. The embryonic posterior epithelium later disappears.", "PM": "91; was see under LENS, CRYSTALLINE 1983-90", "HN": "91(83); was see under LENS, CRYSTALLINE 1983-90", "MR": "20070709", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D007903"}, {"RECTYPE": "D", "MH": "Lens Cortex, Crystalline", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Crystalline Lens Cortex", "MN": "A09.371.060.500.225", "MH_TH": "NLM (1983)", "ST": "T023", "PI": "Lens, Crystalline (1966-1982)", "MS": "The portion of the crystalline lens surrounding the nucleus and bound anteriorly by the epithelium and posteriorly by the capsule. It contains lens fibers and amorphous, intercellular substance.", "PM": "91; was see under LENS, CRYSTALLINE 1983-90", "HN": "91(83); was see under LENS, CRYSTALLINE 1983-90", "MR": "20070709", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D007904"}, {"RECTYPE": "D", "MH": "Lens Diseases", "DE": "LENS DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lens Disease", "MN": "C11.510", "MH_TH": "NLM (1978)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Lens, Crystalline (1966-1977)", "MS": "Diseases involving the CRYSTALLINE LENS.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19770411", "DC": "1", "DX": "19780101", "UI": "D007905"}, {"RECTYPE": "D", "MH": "Lens Subluxation", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lens Dislocation|T037|T047|NON|REL|NLM (1990)|890316|abbcdef", "ENTRY": "Subluxations, Lens", "MN": "C11.510.598", "EC": "congenital:Ectopia Lentis", "MH_TH": "NLM (1978)", "ST": "T047", "PI": "Lens, Crystalline (1966-1977)", "MS": "Incomplete rupture of the zonule with the displaced lens remaining behind the pupil. In dislocation, or complete rupture, the lens is displaced forward into the anterior chamber or backward into the vitreous body. When congenital, this condition is known as ECTOPIA LENTIS.", "OL": "use LENS SUBLUXATION to search LENS DISLOCATION AND SUBLUXATION 1978-89", "PM": "90; was LENS DISLOCATION AND SUBLUXATION 1978-89", "HN": "90; was LENS DISLOCATION AND SUBLUXATION 1978-89", "CATSH": "CAT LIST", "MR": "19920325", "DA": "19770411", "DC": "1", "DX": "19780101", "UI": "D007906"}, {"RECTYPE": "D", "MH": "Lens Nucleus, Crystalline", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nucleus, Crystalline Lens", "MN": "A09.371.060.500.670", "MH_TH": "NLM (1983)", "ST": "T023", "PI": "Lens, Crystalline (1966-1982)", "MS": "The core of the crystalline lens, surrounded by the cortex.", "PM": "91; was see under LENS, CRYSTALLINE 1983-90", "HN": "91(83); was see under LENS, CRYSTALLINE 1983-90", "MR": "20070709", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D007907"}, {"RECTYPE": "D", "MH": "Lens, Crystalline", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Lens, Eye|T023|NON|EQV|NLM (2003)|020313|abcdef", "ENTRY": "Crystalline Lens|T023|NON|EQV|NLM (2006)|041014|abcdef", "MN": "A09.371.060.500", "FX": "Aphakia", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A transparent, biconvex structure of the EYE, enclosed in a capsule and situated behind the IRIS and in front of the vitreous humor (VITREOUS BODY). It is slightly overlapped at its margin by the ciliary processes. Adaptation by the CILIARY BODY is crucial for OCULAR ACCOMMODATION.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007908"}, {"RECTYPE": "D", "MH": "Lenses", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "MN": "E07.632.500", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Pieces of glass or other transparent materials used for magnification or increased visual acuity.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007909"}, {"RECTYPE": "D", "MH": "Lenses, Intraocular", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Lens, Implantable Contact", "MN": "E07.695.460", "FX": "Lens Implantation, Intraocular", "MH_TH": "NLM (1979)", "ST": "T074", "AN": "artificial lens: do not confuse with LENS, CRYSTALLINE (Category A); commonly used after cataract extraction but do not coordinate with CATARACT EXTRACTION unless particularly discussed; PSEUDOPHAKIA is available for the state of the eye in the presence of an intraocular lens after cataract extraction", "PI": "Prosthesis (1966-1978)", "MS": "Artificial implanted lenses.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20170707", "DA": "19780126", "DC": "1", "DX": "19790101", "UI": "D007910"}, {"RECTYPE": "D", "MH": "Lentigo", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lentiginosis|T047|NON|EQV|NLM (1993)|920406|abcdef", "ENTRY": "Lentigos", "MN": "C17.800.621.430.530.550", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a form of melanosis", "MS": "Small circumscribed melanoses resembling, but differing histologically from, freckles. The concept includes senile lentigo ('liver spots') and nevoid lentigo (nevus spilus, lentigo simplex) and may also occur in association with multiple congenital defects or congenital syndromes (e.g., Peutz-Jeghers syndrome).", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007911"}, {"RECTYPE": "D", "MH": "Lentinan", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D09.698.365.089.500", "PA": "Antineoplastic Agents", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Lentinan", "RN": "37339-90-5", "PI": "Polysaccharides (1972-1974)", "MS": "Polysaccharide isolated from the edible mushroom LENTINULA EDODES. The exact composition is unknown.", "PM": "91; was see under POLYSACCHARIDES 1975-90", "HN": "91(71)", "MR": "20040713", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007912"}, {"RECTYPE": "D", "MH": "Herpesvirus 1, Ranid", "DS": "HERPESVIRUS RANID 01", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Lucke Tumor Virus|T005|EPO|EQV|UNK (19XX)|741211|abcdef", "ENTRY": "Tumor Virus, Lucke", "MN": "B04.613.204.550", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid85655", "AN": "infection: coord IM with HERPESVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "MS": "A species of the family HERPESVIRIDAE, whose genus is so far unassigned. It is probably the causative agent of ADENOMA or ADENOCARCINOMA in the kidneys of certain frogs.", "OL": "use HERPESVIRUS 1, RANID to search LEOPARD FROG CARCINOMA VIRUS 1975-93", "PM": "94; was LEOPARD FROG CARCINOMA VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80)", "HN": "94; was LEOPARD FROG CARCINOMA VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D007913"}, {"RECTYPE": "D", "MH": "Leper Colonies", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Leper Colony", "MN": "N02.278.524", "MH_TH": "NLM (1966)", "ST": "T093", "AN": "specify geog", "MS": "Residential treatment centers for individuals with leprosy.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007914"}, {"RECTYPE": "D", "MH": "Lepidoptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.720.500.500.937", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid7088", "PI": "Insects (1966-1974)", "MS": "A large order of insects comprising the butterflies and moths.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D007915"}, {"RECTYPE": "D", "MH": "Lepromin", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "MN": "D23.050.161.386", "MH_TH": "NLM (1965)", "ST": "T130", "RN": "11006-67-0", "AN": "for lepromin test or lepromin reaction do not coord with SKIN TESTS", "PM": "73", "HN": "73(65)", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007916"}, {"RECTYPE": "D", "MH": "Leprostatic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antileprotic Agents|T121|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Agents, Leprostatic", "MN": "D27.505.954.122.085.777", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "-static or -cidal; consider also MYCOBACTERIUM LEPRAE /drug eff & LEPROSY /drug ther", "PI": "Anti-Infective Agents (1966-1974)", "MS": "Substances that suppress Mycobacterium leprae, ameliorate the clinical manifestations of leprosy, and/or reduce the incidence and severity of leprous reactions.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D007917"}, {"RECTYPE": "D", "MH": "Leprosy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Hansen's Disease|T047|EPO|EQV|ORD (2010)|UNK (19XX)|740330|HANSENS DIS|abcdeefv", "ENTRY": "Hansen Disease|T047|EPO|EQV|NLM (1992)|910412|HANSEN DIS|abcdefv", "MN": "C01.150.252.410.040.552.475.371", "FX": "Leprostatic Agents", "MH_TH": "POPLINE (1994)", "ST": "T047", "MS": "A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007918"}, {"RECTYPE": "D", "MH": "Leptospira", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.851.475.475", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid171", "MS": "A genus of aerobic, helical spirochetes, some species of which are pathogenic, others free-living or saprophytic.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007919"}, {"RECTYPE": "D", "MH": "Leptospira interrogans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Spirochaeta nodosa|T007|NON|EQV|NLM (2021)|190918|abcdef", "MN": "B03.851.475.475.400", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid173", "AN": "Leptospira interrogans seroGROUPS go here; infection: coord IM with probably LEPTOSPIROSIS (IM)", "MS": "A genus of question mark-shaped bacteria spirochetes which is found in fresh water that is contaminated by animal urine. It causes LEPTOSPIROSIS.", "PM": "1976; use LEPTOSPIRA ICTEROHAEMORRHAGIAE 1963-1975", "HN": "1976 (1963)", "MR": "20200724", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D007921"}, {"RECTYPE": "D", "MH": "Leptospirosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Swineherd's Diseases", "MN": "C01.150.252.400.794.511", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "gram-neg bact infect; a spirochete infect", "MS": "Infections with bacteria of the genus LEPTOSPIRA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007922"}, {"RECTYPE": "D", "MH": "Leriche Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Leriche's", "MN": "C14.907.137.427", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "A condition caused by occlusion of terminal aorta, the primary branches of the ABDOMINAL AORTA, as in aortoiliac obstruction. Leriche syndrome usually occurs in males and is characterized by IMPOTENCE, absence of a pulse in the femoral arteries, weakness and numbness in the lower back, buttocks, hips, and lower limbs.", "PM": "2008; see LERICHE'S SYNDROME 1963-2007", "HN": "2008 (1963)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D007925"}, {"RECTYPE": "D", "MH": "Lesch-Nyhan Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypoxanthine-Phosphoribosyl-Transferase Deficiency Disease|T047|NON|EQV|NLM (2000)|991103|HYPOXANTHINE PHOSPHORIBOSYL TRANSFERASE DEFIC DIS|abcdefv", "ENTRY": "X-Linked Primary Hyperuricemias", "MN": "C18.452.648.798.594", "FX": "Hypoxanthine Phosphoribosyltransferase", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Self Mutilation (1966-1970)", "MS": "An inherited disorder transmitted as a sex-linked trait and caused by a deficiency of an enzyme of purine metabolism; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE. Affected individuals are normal in the first year of life and then develop psychomotor retardation, extrapyramidal movement disorders, progressive spasticity, and seizures. Self-destructive behaviors such as biting of fingers and lips are seen frequently. Intellectual impairment may also occur but is typically not severe. Elevation of uric acid in the serum leads to the development of renal calculi and gouty arthritis. (Menkes, Textbook of Child Neurology, 5th ed, pp127)", "PM": "1973", "HN": "1973(1971)", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007926"}, {"RECTYPE": "D", "MH": "Lesotho", "AQ": "EH EP", "PRINT ENTRY": "Basutoland|T083|NAM|EQV|NLM (1996)|940804|abcdef", "ENTRY": "Kingdom of Lesotho|T083|NAM|EQV|NLM (2009)|080326|abcdef", "MN": "Z01.058.290.175.400", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A kingdom in southern Africa, within the republic of SOUTH AFRICA. Its capital is Maseru.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007927"}, {"RECTYPE": "D", "MH": "Lethal Dose 50", "PRINT ENTRY": "LD50|T081|ABB|EQV|UNK (19XX)|750716|LD 50|abcdefs", "ENTRY": "Dose 50, Lethal", "MN": "G07.690.936.500.750", "MH_TH": "NLM (1971)", "ST": "T081", "AN": "usually NIM; do not coordinate with /mortal in experimental studies", "PI": "specific drug/toxicity (1966-1970)", "MS": "The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population.", "PM": "76; was see under TOXICOLOGY 1975", "HN": "76(71); was see under TOXICOLOGY 1975", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D007928"}, {"RECTYPE": "D", "MH": "Leucine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Leucine, L Isomer", "MN": "D12.125.142.441", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "L-Leucine", "RN": "GMW67QNF9C", "RR": "7005-03-0", "AN": "/biosyn /defic /physiol permitted", "MS": "An essential branched-chain amino acid important for hemoglobin formation.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007930"}, {"RECTYPE": "D", "MH": "Leucyl Aminopeptidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Leucine Aminopeptidase|T116|T126|NON|EQV|NLM (1999)|971106|abbcdef", "ENTRY": "Zinc Manganese Leucine Aminopeptidase", "MN": "D08.811.277.656.675.555.700", "MH_TH": "NLM (1965)", "ST": "T126", "RN": "EC 3.4.11.1", "MS": "A zinc containing enzyme of the hydrolase class that catalyzes the removal of the N-terminal amino acid from most L-peptides, particularly those with N-terminal leucine residues but not those with N-terminal lysine or arginine residues. This occurs in tissue cell cytosol, with high activity in the duodenum, liver, and kidney. The activity of this enzyme is commonly assayed using a leucine arylamide chromogenic substrate such as leucyl beta-naphthylamide.", "PM": "1999; see LEUCINE AMINOPEPTIDASE 1965-1998; PEPTIDASE S was indexed under AMINOPEPTIDASES 1979-1998; for LEUCYL-BETA-NAPTHYLAMIDASE see LEUCYL-BETA-NAPTHYLAMIDASE 1991-2009", "HN": "1999(1965)", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007931"}, {"RECTYPE": "D", "MH": "Leucogenenol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.711.511", "MH_TH": "NLM (1973)", "ST": "T109", "N1": "Leucogenenol", "RN": "29101-95-9", "PI": "Spiro Compounds (1971-1972)", "MS": "A heterocyclic enolic thymothyroid hormone synthesized by the THYMUS and/or THYROID.", "PM": "91; was see under SPIRO COMPOUNDS 1973-90", "HN": "91(73); was see under SPIRO COMPOUNDS 1973-90", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007932"}, {"RECTYPE": "D", "MH": "Leucomycins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.540.576.500.999", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1976)", "ST": "T195", "RN": "0", "AN": "do not confuse with LEUCOMYCIN see KITASAMYCIN", "PI": "Lactones (1973-1975)", "MS": "An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities.", "OL": "use LEUCOMYCINS to search KITASAMYCINS 1976-80", "PM": "81; was KITASAMYCINS see under ANTIBIOTICS 1976-80", "HN": "81; was KITASAMYCINS see under ANTIBIOTICS 1976-80", "MR": "20150623", "DA": "19750725", "DC": "1", "DX": "19810101", "UI": "D007933"}, {"RECTYPE": "D", "MH": "Leuconostoc", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Leukonostoc|T007|NON|EQV|UNK (19XX)|790103|abcdef", "MN": "B03.510.550.475.450", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1243", "AN": "in plant & dairy products", "MS": "A genus of gram-positive, facultatively anaerobic bacteria whose growth is dependent on the presence of a fermentable carbohydrate. It is nonpathogenic to plants and animals, including humans.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007934"}, {"RECTYPE": "D", "MH": "Leucine-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Leucyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961105|abbdef", "ENTRY": "Synthetase, Leucine-tRNA", "MN": "D08.811.464.263.200.500", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Leucine:tRNA(Leu) ligase (AMP-forming)", "RN": "EC 6.1.1.4", "PI": "Leucine (1972-1974)", "MS": "An enzyme that activates leucine with its specific transfer RNA. EC 6.1.1.4.", "PM": "98; see LEUCYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007935"}, {"RECTYPE": "D", "MH": "Leukapheresis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Lymphocytapheresis|T061|NON|NRW|UNK (19XX)|850617|abcdef", "ENTRY": "Lymphophereses", "MN": "E05.242.363.171.570", "MH_TH": "NLM (1979)", "ST": "T061", "PI": "Leukocytes (1966-1978)", "MS": "The preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor.", "OL": "use PLASMAPHERESIS to search LEUKAPHERESIS 1978", "PM": "79; was see PLASMAPHERESIS 1978", "HN": "79; was see PLASMAPHERESIS 1978", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19780126", "DC": "1", "DX": "19790101", "UI": "D007937"}, {"RECTYPE": "D", "MH": "Leukemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Leukemias", "MN": "C15.378.508", "FX": "Leukemic Infiltration", "MH_TH": "NLM (1978)", "ST": "T191", "AN": "general or unspecified; many specific leukemia types are available", "MS": "A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007938"}, {"RECTYPE": "D", "MH": "Leukemia L1210", "DS": "LEUKEMIA L 1210", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "ENTRY": "L1210, Leukemia", "MN": "C15.378.508.372.594", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "An experimental LYMPHOCYTIC LEUKEMIA of mice.", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007939"}, {"RECTYPE": "D", "MH": "Leukemia L5178", "DS": "LEUKEMIA L 5178", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "PRINT ENTRY": "Lymphoma L5178|T050|T191|NON|EQV|UNK (19XX)|781220|LYMPHOMA L 5178|abbcdefs", "ENTRY": "L5178, Lymphoma", "MN": "C15.378.508.372.602", "MH_TH": "NLM (1980)", "ST": "T191", "PI": "Lymphoma (1966-1979)", "MS": "An experimental lymphocytic leukemia of mice.", "PM": "91; was see under LEUKEMIA, EXPERIMENTAL 1980-90", "HN": "91(80); was see under LEUKEMIA, EXPERIMENTAL 1980-90", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19781220", "DC": "1", "DX": "19910101", "UI": "D007940"}, {"RECTYPE": "D", "MH": "Leukemia P388", "DS": "LEUKEMIA P 388", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "PRINT ENTRY": "P388D(1) Leukemia|T050|T191|NON|EQV|NLM (2002)|001002|P A 388 D 1 LEUKEMIA|abbcdefs", "ENTRY": "P388, Leukemia", "MN": "C15.378.508.372.782", "MH_TH": "NLM (1980)", "ST": "T191", "PI": "Neoplasms, Experimental (1966-1979)", "MS": "An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.", "PM": "91; was see under LEUKEMIA, EXPERIMENTAL 1980-90", "HN": "91(80); was see under LEUKEMIA, EXPERIMENTAL 1980-90", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19781220", "DC": "1", "DX": "19910101", "UI": "D007941"}, {"RECTYPE": "D", "MH": "Leukemia, Experimental", "DE": "LEUKEMIA EXPER", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "ENTRY": "Leukemia Models, Animal", "MN": "E05.598.500.496.500", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007942"}, {"RECTYPE": "D", "MH": "Leukemia, Hairy Cell", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Reticuloendotheliosis, Leukemic|T191|NON|EQV|UNK (19XX)|770426|abcdef", "ENTRY": "Reticuloendothelioses, Leukemic", "MN": "C20.683.515.517", "MH_TH": "NLM (1978)", "ST": "T191", "AN": "since the disease is chronic, do not coordinate with CHRONIC DISEASE; note entry term RETICULOENDOTHELIOSIS, LEUKEMIC;: RETICULOENDOTHELIOSIS, AVIAN is also available", "PI": "Splenomegaly (1966-1977)", "MS": "A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of \"hairy\" or \"flagellated\" cells in the blood and bone marrow.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D007943"}, {"RECTYPE": "D", "MH": "Leukemia, Lymphoid", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lymphoid Leukemia|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Lymphoid Leukemias", "MN": "C20.683.515.528", "MH_TH": "UNK (19XX)", "ST": "T191", "AN": "general or unspecified: prefer specifics", "MS": "Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.", "PM": "2008; see LEUKEMIA, LYMPHOCYTIC 1963-2007; for LEUKEMIA, LYMPHOBLASTIC see LEUKEMIA, LYMPHOBLASTIC 1967-1988", "HN": "2008 (1963)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D007945"}, {"RECTYPE": "D", "MH": "Leukemia, Mast-Cell", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mast-Cell Leukemia|T191|NON|EQV|ORD (2010)|UNK (19XX)|860327|abcdeef", "ENTRY": "Mast-Cell Leukemias", "MN": "C20.762.750.750.500", "MH_TH": "ORD (2010)", "ST": "T191", "PI": "Mast Cells (1966-1986)", "MS": "A form of systemic mastocytosis (MASTOCYTOSIS, SYSTEMIC) characterized by the presence of large numbers of tissue MAST CELLS in the peripheral blood without skin lesions. It is a high-grade LEUKEMIA disease with bone marrow smear of >20% MAST CELLS, multi-organ failure and a short survival.", "OL": "use LEUKEMIA, MAST-CELL to search LEUKEMIA, MAST CELL 1987-91", "PM": "92; was LEUKEMIA, MAST CELL 1987-91", "HN": "92; was LEUKEMIA, MAST CELL 1987-91", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19860327", "DC": "1", "DX": "19870101", "UI": "D007946"}, {"RECTYPE": "D", "MH": "Leukemia, Megakaryoblastic, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myeloid Leukemia, Acute, M7|T191|NON|EQV|UNK (19XX)|880609|MYELOID LEUKEMIA ACUTE M 07|abcdefs", "ENTRY": "Megakaryocytic Leukemias, Acute", "MN": "C15.378.508.539.275.450", "MH_TH": "UNK (19XX)", "ST": "T191", "PI": "Thrombocythemia, Hemorrhagic (1986)", "MS": "An acute myeloid leukemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. MYELOFIBROSIS or increased bone marrow RETICULIN is common.", "PM": "2008; see LEUKEMIA, MEGAKARYOBLASTIC, ACUTE 1989-2007, see LEUKEMIA, MEGAKARYOBLASTIC 1987-1988; for LEUKEMIA, MEGAKARYOCYTIC see THROMBOCYTHEMIA, HEMORRHAGIC 1967-1995", "HN": "2008 (1987); for LEUKEMIA, MEGAKARYOCYTIC see THROMBOCYTHEMIA, HEMORRHAGIC 1967-1995", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19860327", "DC": "1", "DX": "19870101", "UI": "D007947"}, {"RECTYPE": "D", "MH": "Leukemia, Monocytic, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myeloid Leukemia, Schilling-Type|T191|EPO|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Schilling-Type Myeloid Leukemia", "MN": "C15.378.508.539.275.484", "MH_TH": "NLM (1967)", "ST": "T191", "PI": "Leukemia, Monocytic, Chronic (1966)", "MS": "An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES.", "OL": "use LEUKEMIA, MONOCYTIC, ACUTE to search LEUKEMIA, MONOBLASTIC 1967-88; use LEUKEMIA, MONOCYTIC, CHRONIC to search LEUKEMIA, SCHILLING-TYPE 1975-88", "PM": "89; was LEUKEMIA, MONOBLASTIC 1967-88; LEUKEMIA, SCHILLING-TYPE was see LEUKEMIA, MONOCYTIC 1975-88", "HN": "89; was LEUKEMIA, MONOBLASTIC 1967-88; LEUKEMIA, SCHILLING-TYPE was see LEUKEMIA, MONOCYTIC 1975-88", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007948"}, {"RECTYPE": "D", "MH": "Leukemia, Myeloid", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myeloid Leukemia|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Myeloid Leukemias", "MN": "C15.378.508.539", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "general or unspecified: prefer specifics; index here for CD4+/CD56+ hematodermic neoplasms", "PI": "Leukemia, Myelocytic (1966-1988)", "MS": "Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.", "PM": "1989; for LEUKEMIA, MONOCYTIC, CHRONIC see LEUKEMIA, MONOCYTIC,CHRONIC 1989-2007; for LEUKEMIA, MYELOCYTIC see 1963-1988; for LEUKEMIA, GRANULOCYTIC see LEUKEMIA, MYELOCYTIC 1974-1988", "HN": "1989", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19890101", "UI": "D007951"}, {"RECTYPE": "D", "MH": "Leukemia, Plasma Cell", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Plasmacytic Leukemia|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Plasmacytic Leukemias", "MN": "C20.683.515.845.500", "MH_TH": "UNK (19XX)", "ST": "T191", "PI": "Leukemia (1966)", "MS": "A rare, aggressive variant of MULTIPLE MYELOMA characterized by the circulation of excessive PLASMA CELLS in the peripheral blood. It can be a primary manifestation of multiple myeloma or develop as a terminal complication during the disease.", "PM": "2008; see LEUKEMIA, PLASMACYTIC 1967-2007", "HN": "2008 (1967)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007952"}, {"RECTYPE": "D", "MH": "Leukemia, Radiation-Induced", "DE": "LEUKEMIA RAD IND", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Radiation-Induced Leukemias", "MN": "G01.750.748.500.345", "FX": "Radiation Leukemia Virus", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with specific type of LEUKEMIA (IM); solitary myeloma goes here", "MS": "Leukemia produced by exposure to IONIZING RADIATION or NON-IONIZING RADIATION.", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007953"}, {"RECTYPE": "D", "MH": "Leukemoid Reaction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Reactions, Leukemoid", "MN": "C15.378.553.475.428", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "extreme leukocytosis resembling leukemia", "MS": "A peripheral blood picture resembling that of leukemia or indistinguishable from it on the basis of morphologic appearance alone. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007955"}, {"RECTYPE": "D", "MH": "Leukocidins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Proteins, Leukocidin", "MN": "D12.776.543.695.750", "PA": "Cytotoxins", "MH_TH": "NLM (1965)", "ST": "T116", "RN": "0", "AN": "/antag permitted but consider also ANTITOXINS", "MS": "Pore forming proteins originally discovered for toxic activity to LEUKOCYTES. They are EXOTOXINS produced by some pathogenic STAPHYLOCOCCUS and STREPTOCOCCUS that destroy leukocytes by lysis of the cytoplasmic granules and are partially responsible for the pathogenicity of the organisms.", "OL": "use LEUKOCIDINS to search LEUKOCIDIN 1966-77", "PM": "78; was LEUKOCIDIN 1965-77", "HN": "78; was LEUKOCIDIN 1965-77", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007956"}, {"RECTYPE": "D", "MH": "Leukocyte Adherence Inhibition Test", "DE": "LEUKOCYTE ADHERENCE INHIB TEST", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, LAI", "MN": "E05.478.594.500", "MH_TH": "NLM (1977)", "ST": "T059", "PI": "Leukocytes (1966-1976)", "MS": "Test for cell-mediated antitumor immunity and related serum blocking factors based on the finding that leukocytes from cancer patients, but not from controls, when mixed in vitro with antigenic extracts of tumors of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumor-bearing patients block the LAI reaction of their own leukocytes or those of other patients with the same type of tumor.", "PM": "91; was see under IMMUNOLOGIC TECHNIQUES 1977-90", "HN": "91(77); was see under IMMUNOLOGIC TECHNIQUES 1977-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D007957"}, {"RECTYPE": "D", "MH": "Leukocyte Count", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "White Blood Cell Count|T034|T081|NON|EQV|NLM (1993)|911008|abbcdef", "ENTRY": "Numbers, Leukocyte", "MN": "G09.188.105.595", "FX": "Leukocytosis", "MH_TH": "NLM (1966)", "ST": "T081", "AN": "usually NIM; coord NIM with specific leukocyte (IM) but LYMPHOCYTE COUNT is also available; coord with disease /blood, not /physiopathol", "MS": "The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007958"}, {"RECTYPE": "D", "MH": "Lymphocyte Culture Test, Mixed", "AQ": "AE CL EC ES HI IS MO MT SN ST TD VE", "PRINT ENTRY": "Mixed Lymphocyte Reaction|T059|NON|EQV|NLM (1993)|910916|abcdef", "ENTRY": "Mixed Lymphocyte Reactions", "MN": "E05.478.594.385.429", "MH_TH": "NLM (1973)", "ST": "T059", "AN": "NIM", "PI": "Leukocytes (1966-1972)", "MS": "Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.", "OL": "use LYMPHOCYTE CULTURE TEST, MIXED to search LEUKOCYTE CULTURE TEST, MIXED 1973-92", "PM": "93; was LEUKOCYTE CULTURE TEST, MIXED 1973-92; LYMPHOCYTE CULTURE TEST, MIXED was see LEUKOCYTE CULTURE TEST, MIXED 1981-92", "HN": "93; was LEUKOCYTE CULTURE TEST, MIXED 1973-92; LYMPHOCYTE CULTURE TEST, MIXED was see LEUKOCYTE CULTURE TEST, MIXED 1981-92", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007959"}, {"RECTYPE": "D", "MH": "Leukocyte Disorders", "DE": "LEUKOCYTE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Leukocyte Disorder", "MN": "C15.378.553", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.", "PM": "98", "HN": "98; use explode 1967-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D007960"}, {"RECTYPE": "D", "MH": "Leukocyte Migration-Inhibitory Factors", "DE": "LMIF", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Migration-Inhibition Factors, Leukocyte|T116|T129|NON|EQV|UNK (19XX)|790501|MIGRATION INHIB FACTORS LEUKOCYTE|abbcdefv", "ENTRY": "Migration Inhibitory Factors, Leukocyte", "MN": "D23.529.374.480.428", "MH_TH": "NLM (1980)", "ST": "T129", "RN": "0", "PI": "Macrophage Migration-Inhibitory Factors (1974-1979)", "MS": "Protein factor(s) released by sensitized lymphocytes (and possibly other cells) that inhibit the movement of LEUKOCYTES, especially polymorphonuclear cells, away from their site of release. Assays for these factors are used as tests for cellular immunity. Two of the common assays are the LEUKOCYTE MIGRATION CAPILLARY TUBE TECHNIQUE (LMCT) and the LEUKOCYTE MIGRATION AGAROSE TEST (LMAT).", "OL": "use LEUKOCYTE MIGRATION-INHIBITORY FACTORS to search LEUKOCYTE MIGRATION INHIBITORY FACTORS 1980-90", "PM": "91; was LEUKOCYTE MIGRATION INHIBITORY FACTORS see under LYMPHOKINES 1980-90", "HN": "91(80); was LEUKOCYTE MIGRATION INHIBITORY FACTORS see under LYMPHOKINES 1980-90", "MR": "20090803", "DA": "19790501", "DC": "1", "DX": "19910101", "UI": "D007961"}, {"RECTYPE": "D", "MH": "Leukocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "White Blood Cells|T025|NON|EQV|NLM (1993)|911008|abcdef", "ENTRY": "White Blood Corpuscle", "MN": "A15.382.490", "FX": "Phagocytosis", "EC": "transplantation:Leukocyte Transfusion", "MH_TH": "NLM (1966)", "ST": "T025", "AN": "decrease in no. of leukocytes: consider LEUKOPENIA; increase in number of leukocytes: consider LEUKOCYTOSIS; CELL MIGRATION ASSAYS, LEUKOCYTE is available", "MS": "White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES).", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007962"}, {"RECTYPE": "D", "MH": "Leukocytes, Mononuclear", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Peripheral Blood Mononuclear Cells|T025|NON|REL|NLM (2021)|191018|abcdef", "ENTRY": "Leukocyte, Mononuclear", "MN": "A15.382.490.555", "MH_TH": "NLM (1988)", "ST": "T025", "AN": "do not confuse with MONOCYTES; Peripheral Blood Mononuclear Cells (PBMC) unspecified goes here; prefer specific indentions", "PI": "Monocytes (1966-1987)", "MS": "Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules.", "PM": "88", "HN": "88", "MR": "20200228", "DA": "19870507", "DC": "1", "DX": "19880101", "UI": "D007963"}, {"RECTYPE": "D", "MH": "Leukocytosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pleocytosis|T034|T046|NON|NRW|NLM (1999)|980227|abbcdef", "ENTRY": "Pleocytoses", "MN": "C23.550.526", "FX": "Leukocyte Count", "MH_TH": "POPLINE (1978)", "ST": "T046", "AN": "coord with type of white cell and body fluid, using available subheadings when appropriate", "MS": "A transient increase in the number of leukocytes in a body fluid.", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007964"}, {"RECTYPE": "D", "MH": "Leukodystrophy, Globoid Cell", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Krabbe Disease|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|740330|KRABBE DIS|abcdeeeefv", "ENTRY": "beta-Galactosidase Deficiency, Galactosylceramide", "MN": "C18.452.648.595.554.825.590", "FX": "Galactosylceramidase", "MH_TH": "NLM (1974)", "ST": "T047", "MS": "An autosomal recessive metabolic disorder caused by a deficiency of GALACTOSYLCERAMIDASE leading to intralysosomal accumulation of galactolipids such as GALACTOSYLCERAMIDES and PSYCHOSINE. It is characterized by demyelination associated with large multinucleated globoid cells, predominantly involving the white matter of the central nervous system. The loss of MYELIN disrupts normal conduction of nerve impulses.", "PM": "1974; see CEREBRAL SCLEROSIS, DIFFUSE 1963-1973; for LEUKODYSTROPHIES see CEREBRAL SCLEROSIS, DIFFUSE 1963-1973; for KRABBE DISEASE see KRABBE'S DISEASE 1974-1997", "HN": "1974(1963)", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007965"}, {"RECTYPE": "D", "MH": "Leukodystrophy, Metachromatic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cerebroside Sulphatase Deficiency Disease|T047|NON|EQV|GHR (2014)|NLM (2000)|991103|CEREBROSIDE SULPHATASE DEFIC DIS|abcdeefv", "ENTRY": "Sulfatase Deficiency, Cerebroside", "MN": "C18.452.648.595.554.825.850.500", "FX": "Cerebroside-Sulfatase", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An autosomal recessive metabolic disease caused by a deficiency of CEREBROSIDE-SULFATASE leading to intralysosomal accumulation of cerebroside sulfate (SULFOGLYCOSPHINGOLIPIDS) in the nervous system and other organs. Pathological features include diffuse demyelination, and metachromatically-staining granules in many cell types such as the GLIAL CELLS. There are several allelic and nonallelic forms with a variety of neurological symptoms.", "PM": "1974", "HN": "1974", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007966"}, {"RECTYPE": "D", "MH": "Leukoedema, Oral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Oral Leukoedemas", "MN": "C07.465.385", "MH_TH": "NLM (1972)", "ST": "T047", "AN": "disord of buccal mucosa", "PI": "Mouth Diseases (1966-1971)", "MS": "A disorder of the buccal mucosa resembling early leukoplakia, characterized by the presence of filmy opalescence of the mucosa in the early stages to a whitish gray cast with a coarsely wrinkled surface in the later stages, associated with intracellular edema of the spinous or malpighian layer. (Dorland, 27th ed)", "PM": "91; was see under MOUTH DISEASES 1972-90", "HN": "91(72); was see under MOUTH DISEASES 1972-90", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D007967"}, {"RECTYPE": "D", "MH": "Leukoencephalopathy, Progressive Multifocal", "DE": "LEUKOENCEPH PROGRESSIVE MULTIFOCAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Progressive Multifocal Leukoencephalopathy|T047|NON|EQV|NLM (2000)|ORD (2010)|991103|PROGRESSIVE MULTIFOCAL LEUKOENCEPH|abcdeefv", "ENTRY": "Progressive Multifocal Leukoencephalopathies", "MN": "C10.586.250.520.750.500", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Demyelinating Diseases (1966-1970)", "MS": "An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7)", "PM": "1973", "HN": "1973(1971)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D007968"}, {"RECTYPE": "D", "MH": "Leukomalacia, Periventricular", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Periventricular Leukomalacia|T047|NON|EQV|UNK (19XX)|860616|abcdef", "ENTRY": "Periventricular Leukomalacias, Cystic", "MN": "C16.614.521.450", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "periventricular refers to the cerebral ventricles", "PI": "Infant, Premature, Diseases (1966-1986)", "MS": "Degeneration of white matter adjacent to the CEREBRAL VENTRICLES following cerebral hypoxia or BRAIN ISCHEMIA in neonates. The condition primarily affects white matter in the perfusion zone between superficial and deep branches of the MIDDLE CEREBRAL ARTERY. Clinical manifestations include VISION DISORDERS; CEREBRAL PALSY; PARAPLEGIA; SEIZURES; and cognitive disorders. (From Adams et al., Principles of Neurology, 6th ed, p1021; Joynt, Clinical Neurology, 1997, Ch4, pp30-1)", "PM": "1991; see ENCEPHALOMALACIA 1987-90", "HN": "1991(1987)", "CATSH": "CAT LIST", "MR": "20050712", "DA": "19860616", "DC": "1", "DX": "19910101", "UI": "D007969"}, {"RECTYPE": "D", "MH": "Leukopenia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Leukocytopenia|T034|T046|NON|EQV|NLM (1993)|911010|abbcdef", "ENTRY": "Leukopenias", "MN": "C15.378.553.546", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007970"}, {"RECTYPE": "D", "MH": "Leukoplakia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Leukoplakic Lesion", "MN": "C23.300.816", "MH_TH": "NLM (1966)", "ST": "T190", "MS": "A white patch lesion found on a MUCOUS MEMBRANE that cannot be scraped off. Leukoplakia is generally considered a precancerous condition, however its appearance may also result from a variety of HEREDITARY DISEASES.", "CATSH": "CAT LIST", "MR": "20170707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007971"}, {"RECTYPE": "D", "MH": "Leukoplakia, Oral", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Keratosis, Oral|T191|NON|EQV|NLM (1998)|960718|abcdef", "ENTRY": "Oral Leukoplakias", "MN": "C23.300.816.513", "MH_TH": "NLM (1970)", "ST": "T191", "PI": "Mouth Neoplasms (1966-1969)", "MS": "A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia (LEUKOPLAKIA, HAIRY).", "PM": "1972", "HN": "1972 (1970)", "CATSH": "CAT LIST", "MR": "20180622", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D007972"}, {"RECTYPE": "D", "MH": "Leukorrhea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Leukorrheas", "MN": "C12.100.250.894.700.500", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A clear or white discharge from the VAGINA, consisting mainly of MUCUS.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007973"}, {"RECTYPE": "D", "MH": "Leukotriene B4", "DS": "LEUKOTRIENE B 04", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "LTB4|T109|ABB|EQV|FDA SRS (2014)|NLM (1994)|930319|LTB A 04|LTB 4|abcdeefsv", "ENTRY": "Leukotriene B 4", "MN": "D23.469.050.175.450.415", "MH_TH": "NLM (1983)", "ST": "T109", "N1": "6,8,10,14-Eicosatetraenoic acid, 5,12-dihydroxy-, (S-(R*,S*-(E,Z,E,Z)))-", "RN": "1HGW4DR56D", "RR": "71160-24-2 (Leukotriene B4)", "PI": "Arachidonic Acids (1967-1982)", "MS": "The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990)", "OL": "use LEUKOTRIENE B4 to search LEUKOTRIENES B 1983-93", "PM": "94; was LEUKOTRIENES B 1983-93; LEUKOTRIENE B4 was see LEUKOTRIENES B 1983-93", "HN": "94; was LEUKOTRIENES B 1983-93; LEUKOTRIENE B4 was see LEUKOTRIENES B 1983-93", "MR": "20150608", "DA": "19820430", "DC": "1", "DX": "19830101", "UI": "D007975"}, {"RECTYPE": "D", "MH": "Leupeptins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.644.456.580", "PA": "Protease Inhibitors", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "protease inhib", "PI": "Oligopeptides (1973-1974)", "MS": "A group of acylated oligopeptides produced by Actinomycetes that function as protease inhibitors. They have been known to inhibit to varying degrees trypsin, plasmin, KALLIKREINS, papain and the cathepsins.", "PM": "91; was see under OLIGOPEPTIDES 1975-90", "HN": "91(75); was see under OLIGOPEPTIDES 1975-90", "MR": "19991109", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D007976"}, {"RECTYPE": "D", "MH": "Levallorphan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Naloxiphan|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Lorfan|T109|T121|TRD|NRW|UNK (19XX)|810318|abbcdef", "MN": "D04.615.723.795.413", "PA": "Narcotic Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Morphinan-3-ol, 17-(2-propenyl)-", "RN": "353613BU4U", "RR": "152-02-3 (Levallorphan)", "MS": "An opioid antagonist with properties similar to those of NALOXONE; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, 30th ed, p683)", "PM": "65; was see under NARCOTIC ANTAGONISTS 1963-64", "HN": "65; was see under NARCOTIC ANTAGONISTS 1963-64", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007977"}, {"RECTYPE": "D", "MH": "Levamisole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Levotetramisole|T109|T121|NON|EQV|UNK (19XX)|760515|abbcdef", "ENTRY": "Hydrochloride, Levamisole", "MN": "D03.383.129.708.346", "PA": "Antirheumatic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (S)-", "RN": "2880D3468G", "RR": "DL9055K809", "MS": "An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6)", "PM": "74", "HN": "74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007978"}, {"RECTYPE": "D", "MH": "Levocardia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Levocardia, Isolated", "MN": "C16.131.810.700", "MH_TH": "NLM (1975)", "ST": "T019", "MS": "Congenital abnormalities in which the HEART is in the normal position (levocardia) in the left side of the chest but some or all of the THORAX or ABDOMEN viscera are transposed laterally (SITUS INVERSUS). It is also known as situs inversus with levocardia, or isolated levocardia. This condition is often associated with severe heart defects and splenic abnormalities such as asplenia or polysplenia.", "PM": "91; was see under HEART DEFECTS, CONGENITAL 1975-90", "HN": "91(75); was see under HEART DEFECTS, CONGENITAL 1975-90", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D007979"}, {"RECTYPE": "D", "MH": "Levodopa", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "L-Dopa|T116|T121|T123|EQV|FDA SRS (2014)|UNK (19XX)|760630|DOPA A L|abbbdeefs", "ENTRY": "L Dopa", "MN": "D12.125.072.050.875.130.500", "PA": "Dopamine Agents", "FX": "Dopamine", "MH_TH": "USP (19XX)", "ST": "T123", "RN": "46627O600J", "PI": "Dopa (1966-1974)", "MS": "The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.", "OL": "search DOPA 1972-74", "PM": "75; was see DOPA 1972-74", "HN": "75; was see DOPA 1972-74", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D007980"}, {"RECTYPE": "D", "MH": "Levorphanol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Levorphan|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Tartrate, Levorphanol", "MN": "D04.615.723.795.463", "PA": "Narcotics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Morphinan-3-ol, 17-methyl-", "RN": "27618J1N2X", "RR": "77-07-6 (Levorphanol)", "MS": "A narcotic analgesic that may be habit-forming. It is nearly as effective orally as by injection.", "PM": "65; was LEVORPHAN see under MORPHINE 1963-64", "HN": "65; was LEVORPHAN see under MORPHINE 1963-64", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007981"}, {"RECTYPE": "D", "MH": "Levulinic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Levulinic", "MN": "D02.241.755.547", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Keto acids that are derivatives of 4-oxopentanoic acids (levulinic acid).", "OL": "use LEVULINIC ACIDS to search LEVULINIC ACID 1966-74", "PM": "75; was LEVULINIC ACID 1963-74", "HN": "75; was LEVULINIC ACID 1963-74", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D007982"}, {"RECTYPE": "D", "MH": "Lewis Blood Group Antigens", "AQ": "AD AE AN BI BL CF CH CL EC GE HI IM IP ME PD PH PO TO TU UL UR", "PRINT ENTRY": "Sialyl Lewis Antigens|T088|T109|T129|EPO|REL|NLM (2020)|190307|abbbcdef", "ENTRY": "Lewis Blood Group System", "MN": "D23.050.705.230.544", "MH_TH": "NLM (2020)", "ST": "T129", "RN": "0", "AN": "coordinate with disease  /blood, not  /immunol nor  /genet", "MS": "Carbohydrate antigens structurally related to the ABH BLOOD-GROUP SYSTEM. They may occur as a modification of saccharide chains on glycolipids or glycoproteins on cell surfaces or in plasma, or as free oligosaccharides in secretions. Lewis  antigens are not synthesized in blood cells. Instead Lewis glycolipids present in plasma are absorbed onto the surface of ERYTHROCYTES; LYMPHOCYTES; and PLATELETS. The phenotypes Le(a) and Le(b) are the result of the actions of two genes the Le gene (fucosyltransferase FUT3) and the Se gene (fucosyltransferase FUT2) on the precursor carbohydrate, glycolipid or glycoprotein. Other FUCOSYLTRANSFERASES can also synthesize the Lewis antigens.", "PM": "2020; see LEWIS BLOOD GROUP SYSTEM 1974-2019", "HN": "2020 (1963)", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007983"}, {"RECTYPE": "D", "MH": "Leydig Cell Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Interstitial Cell Tumor|T191|NON|EQV|NLM (1994)|930326|abcdef", "ENTRY": "Tumors, Interstitial Cell", "MN": "C19.391.829.782.500.249", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with TESTICULAR NEOPLASMS in male or OVARIAN NEOPLASMS if in female", "MS": "Gonadal interstitial or stromal cell neoplasm composed of only LEYDIG CELLS. These tumors may produce one or more of the steroid hormones such as ANDROGENS; ESTROGENS; and CORTICOSTEROIDS. Clinical symptoms include testicular swelling, GYNECOMASTIA, sexual precocity in children, or virilization (VIRILISM) in females.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007984"}, {"RECTYPE": "D", "MH": "Leydig Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Testicular Interstitial Cells|T025|NON|EQV|UNK (19XX)|780523|abcdef", "ENTRY": "Interstitial Cell, Testicular", "MN": "A11.436.513", "MH_TH": "NLM (1964)", "ST": "T025", "MS": "Steroid-producing cells in the interstitial tissue of the TESTIS. They are under the regulation of PITUITARY HORMONES; LUTEINIZING HORMONE; or interstitial cell-stimulating hormone. TESTOSTERONE is the major androgen (ANDROGENS) produced.", "PM": "68", "HN": "68(64)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007985"}, {"RECTYPE": "D", "MH": "Luteinizing Hormone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lutropin|T116|T125|NON|EQV|UNK (19XX)|770426|abbcdef", "ENTRY": "Interstitial Cell Stimulating Hormone", "MN": "D12.644.548.691.525.343.463", "FX": "Receptors, LH", "MH_TH": "POPLINE (1978)", "ST": "T125", "N1": "Luteinizing hormone", "RN": "9002-67-9", "AN": "do not confuse entry term LUTROPIN with PLACENTAL LUTEOTROPIN; for alpha subunit, coordinate with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; LUTEINIZING HORMONE, BETA SUBUNIT is also available", "MS": "A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity.", "PM": "2003; see ICSH 1963-1967", "HN": "2003 (1968); use ICSH 1963-1967", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007986"}, {"RECTYPE": "D", "MH": "Gonadotropin-Releasing Hormone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Luteinizing Hormone-Releasing Hormone|T116|T121|T125|NON|EQV|NLM (1991)|900402|abbbcdef", "ENTRY": "Releasing Hormone, LHFSH", "MN": "D12.776.631.650.405.740.320", "FX": "Receptors, LHRH", "MH_TH": "NLM (1991)", "ST": "T125", "N1": "5-oxoPro-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 (human or pig)", "RN": "33515-09-2", "RR": "52699-48-6 (Acetate)", "MS": "A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND.", "PM": "2007; see PITUITARY HORMONE RELEASING HORMONES 1977-1990, see LH-FSH RELEASING HORMONE 1974-1990", "HN": "2007 (1974)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D007987"}, {"RECTYPE": "D", "MH": "Liberia", "AQ": "EH EP", "ENTRY": "Republic of Liberia|T083|NAM|EQV|NLM (2009)|080327|abcdef", "MN": "Z01.058.290.190.425", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in western Africa, south of GUINEA and east of COTE D'IVOIRE. Its capital is Monrovia.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D007988"}, {"RECTYPE": "D", "MH": "Libido", "AQ": "CL DE ES PH RE", "ENTRY": "Libido, Increased", "MN": "F02.739.794.511", "MH_TH": "NLM (1968)", "ST": "T041", "MS": "The psychic drive or energy associated with sexual instinct in the broad sense (pleasure and love-object seeking). It may also connote the psychic energy associated with instincts in general that motivate behavior.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19920325", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D007989"}, {"RECTYPE": "D", "MH": "Libraries", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Library", "MN": "L01.462.625.596", "MH_TH": "NLM (1966)", "ST": "T092", "AN": "specify geographic or other site", "MS": "Collections of systematically acquired and organized information resources, and usually providing assistance to users. (ERIC Thesaurus, http://www.eric.ed.gov/ accessed 2/1/2008)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007990"}, {"RECTYPE": "D", "MH": "Libraries, Dental", "DE": "LIBRARIES DENT", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Library, Dental|T073|T093|NON|EQV|NLM (1991)|900126|LIBRARY DENT|abbcdefv", "MN": "L01.462.625.596.719.500", "MH_TH": "NLM (1965)", "ST": "T093", "AN": "IM; specify geog or other site", "MS": "Collections of information resources relevant to DENTISTRY.", "PM": "65", "HN": "65", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D007991"}, {"RECTYPE": "D", "MH": "Libraries, Hospital", "DE": "LIBRARIES HOSP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Libraries|T093|NON|EQV|NLM (1995)|940527|HOSP LIBRARIES|abcdefv", "ENTRY": "Library, Hospital|T093|NON|EQV|NLM (1995)|940527|LIBRARY HOSP|abcdefv", "MN": "N04.452.442.452.600", "MH_TH": "NLM (1966)", "ST": "T093", "AN": "IM; specify geog or other site", "MS": "Information centers primarily serving the needs of hospital medical staff and sometimes also providing patient education and other services.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007992"}, {"RECTYPE": "D", "MH": "Libraries, Medical", "DE": "LIBRARIES MED", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Libraries, Health Science|T073|T093|NON|BRD|UNK (19XX)|840406|abbcdef", "ENTRY": "Library, Biomedical", "MN": "L01.462.625.596.719.875", "MH_TH": "NLM (1966)", "ST": "T093", "AN": "private & public libraries; includes private collections of books; specify geographic or other site", "MS": "Collection of information resources relevant to MEDICINE.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007993"}, {"RECTYPE": "D", "MH": "Libraries, Nursing", "DE": "LIBRARIES NURS", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Nursing Libraries|T073|T093|NON|EQV|NLM (1992)|901227|NURS LIBRARIES|abbcdefv", "ENTRY": "Nursing Library", "MN": "L01.462.625.596.719.937", "MH_TH": "NLM (1965)", "ST": "T093", "AN": "IM; specify geog or other site", "MS": "Collections of information resources relevant to NURSING.", "PM": "67", "HN": "67(65)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D007994"}, {"RECTYPE": "D", "MH": "Library Administration", "DE": "LIBRARY ADMIN", "AQ": "CL EC ED ES HI IS LJ MT SN ST TD", "ENTRY": "Library Administrations", "MN": "L01.583.363", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "Planning, organizing, staffing, direction, and control of libraries.", "MR": "19890626", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007995"}, {"RECTYPE": "D", "MH": "Library Associations", "DE": "LIBRARY ASSOC", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Library Association", "MN": "L01.583.390", "MH_TH": "NLM (1966)", "ST": "T094", "AN": "medical library associations: do not coordinate with MEDICINE", "MS": "Organizations of persons and institutions associated with a type of library or region.", "MR": "20180308", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007996"}, {"RECTYPE": "D", "MH": "Library Schools", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Schools, Library|T092|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "School, Library", "MN": "L01.583.430", "MH_TH": "NLM (1966)", "ST": "T092", "AN": "specify geog if pertinent", "MS": "Educational institutions for individuals specializing in the field of library science or information.", "MR": "20160608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007997"}, {"RECTYPE": "D", "MH": "Library Science", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Librarianship|T090|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Sciences, Library", "MN": "L01.583", "MH_TH": "NLM (1966)", "ST": "T090", "AN": " medical librarianship: do not coordinate with MEDICINE", "MS": "Study of the principles and practices of library administration and services.", "MR": "19900507", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D007998"}, {"RECTYPE": "D", "MH": "Library Services", "DE": "LIBRARY SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Service, Library", "MN": "L01.583.464", "MH_TH": "NLM (1976)", "ST": "T057", "PI": "specific library or library science heading (1966-1975)", "MS": "Services offered to the library user. They include reference and circulation.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20220712", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D007999"}, {"RECTYPE": "D", "MH": "Library Surveys", "AQ": "CL EC ES HI LJ MT SD SN ST TD", "ENTRY": "Surveys, Library", "MN": "L01.583.564", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "IM", "MS": "Collection and analysis of data pertaining to operations of a particular library, library system, or group of independent libraries, with recommendations for improvement and/or ordered plans for further development.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008000"}, {"RECTYPE": "D", "MH": "Library Technical Services", "DE": "LIBRARY TECHNICAL SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Technical Services Libraries", "MN": "L01.583.782", "MH_TH": "NLM (1976)", "ST": "T057", "PI": "specific library or library science heading(1966-1975)", "MS": "Acquisition, organization, and preparation of library materials for use, including selection, weeding, cataloging, classification, and preservation.", "PM": "76", "HN": "76; was LIBRARY TECHNICAL PROCESSES (NON MESH) before 1976", "MR": "20220712", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D008001"}, {"RECTYPE": "D", "MH": "Libya", "AQ": "EH EP", "MN": "Z01.058.266.513", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in northern Africa, bordering the Mediterranean Sea, between Egypt, Tunisia, and Algeria, having southern border with Chad, Niger, and Sudan. Its capital is Tripoli.", "MR": "20150527", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008002"}, {"RECTYPE": "D", "MH": "Phthiraptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Rhyncophthirina|T204|NON|NRW|NLM (1999)|971030|abcdef", "ENTRY": "Louse|T204|NON|EQV|NLM (1990)|891017|abcdef", "MN": "B01.050.500.131.617.690", "FX": "Lice Infestations", "MH_TH": "UNK (19XX)", "ST": "T204", "RN": "txid85819", "RR": "txid85820", "MS": "An order of small, wingless parasitic insects, commonly known as lice. The suborders include ANOPLURA (sucking lice); AMBLYCERA; ISCHNOCERA; and Rhynchophthirina (elephant and warthog lice).", "PM": "2011, 1975-1979; see LICE 1980-2010 & 1963-1974", "HN": "2011, 1975-1979", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "20110101", "UI": "D008003"}, {"RECTYPE": "D", "MH": "Licensure", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Licensure, Institutional, Personnel|T064|NON|NRW|UNK (19XX)|770421|abcdef", "ENTRY": "Personnel Licensures, Institutional", "MN": "N05.700.200.450", "FX": "Certification", "MH_TH": "NLM (1966)", "ST": "T064", "AN": "by the state; differentiate from ACCREDITATION (by the profession); IM; various boards can go here; specify geog", "MS": "The legal authority or formal permission from authorities to carry on certain activities which by law or regulation require such permission. It may be applied to licensure of institutions as well as individuals.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008004"}, {"RECTYPE": "D", "MH": "Licensure, Dental", "DE": "LICENSURE DENT", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Licensures, Dental", "MN": "N05.700.200.450.300", "MH_TH": "NLM (1966)", "ST": "T064", "AN": "by the state; differentiate from ACCREDITATION (by the profession); various boards can go here; specify geographic location", "MS": "The granting of a license to practice dentistry.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008005"}, {"RECTYPE": "D", "MH": "Licensure, Hospital", "DE": "LICENSURE HOSP", "AQ": "CL EC ES HI OG SN ST TD", "PRINT ENTRY": "Hospital Licensure|T064|NON|EQV|UNK (19XX)|770511|HOSP LICENSURE|abcdefv", "ENTRY": "Licensures, Hospital", "MN": "N05.700.200.450.380", "MH_TH": "NLM (1977)", "ST": "T064", "AN": "by the state; differentiate from ACCREDITATION (by the profession); IM; specify geog", "MS": "The granting of a license to a hospital.", "PM": "91; was see under LICENSURE Aug 1977-90", "HN": "91(Aug 77); was see under LICENSURE 1977-90", "MR": "19991103", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D008006"}, {"RECTYPE": "D", "MH": "Licensure, Medical", "DE": "LICENSURE MED", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Medical Licensure|T064|NON|EQV|NLM (1991)|891129|MED LICENSURE|abcdefv", "MN": "N05.700.200.450.500", "MH_TH": "NLM (1966)", "ST": "T064", "AN": "by the state; differentiate from ACCREDITATION (by the profession); various boards can go here; specify geographic location", "MS": "The granting of a license to practice medicine.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008007"}, {"RECTYPE": "D", "MH": "Licensure, Nursing", "DE": "LICENSURE NURS", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Nursing Licensures|T064|NON|EQV|NLM (1991)|900105|NURS LICENSURES|abcdefv", "MN": "N05.700.200.450.550", "MH_TH": "NLM (1966)", "ST": "T064", "AN": "by the state; differentiate from ACCREDITATION (by the profession); various boards can go here; specify geographic location", "MS": "The granting of a license to practice the profession of nursing.", "PM": "66", "HN": "66", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008008"}, {"RECTYPE": "D", "MH": "Licensure, Pharmacy", "DE": "LICENSURE PHARM", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Pharmacy Licensures", "MN": "N05.700.200.450.625", "MH_TH": "NLM (1968)", "ST": "T064", "AN": "by the state; differentiate from ACCREDITATION (by the profession); various boards can go here; specify geographic location", "PI": "Pharmacy (1966-1967)", "MS": "The granting of a license to practice pharmacy.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008009"}, {"RECTYPE": "D", "MH": "Lichen Planus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mucosal Lichen Planus|T047|NON|NRW|NLM (2022)|210322|abcdef", "ENTRY": "Planopilaris, Lichen", "MN": "C17.800.859.475.560", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a skin disease; sometimes called simply \"lichen\": check text; lichen planus atrophicus: index here & do not confuse with LICHEN SCLEROSUS ET ATROPHICUS", "MS": "An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a \"saw-tooth\" pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown.", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008010"}, {"RECTYPE": "D", "MH": "Lichens", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Lichen", "MN": "B05.350", "MH_TH": "NLM (1966)", "ST": "T002", "AN": "plant, not skin disease", "MS": "Any of a group of plants formed by a symbiotic combination of a fungus with an algae or CYANOBACTERIA, and sometimes both. The fungal component makes up the bulk of the lichen and forms the basis for its name.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008011"}, {"RECTYPE": "D", "MH": "Lidocaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lignocaine|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|741223|abbcdeef", "ENTRY": "Xyloneural|T109|T121|TRD|NRW|UNK (19XX)|840920|abbcdef", "MN": "D02.092.146.113.092.500", "PA": "Voltage-Gated Sodium Channel Blockers", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-", "RN": "98PI200987", "RR": "V13007Z41A", "MS": "A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008012"}, {"RECTYPE": "D", "MH": "Lidoflazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ordiflazine|T109|T121|TRD|NRW|UNK (19XX)|771123|abbcdef", "MN": "D03.383.606.596", "PA": "Vasodilator Agents", "MH_TH": "USAN (1966)", "ST": "T121", "N1": "1-Piperazineacetamide, 4-(4,4-bis(4-fluorophenyl)butyl)-N-(2,6-dimethylphenyl)-", "RN": "J4ZHN3HBTE", "RR": "3416-26-0 (Lidoflazine)", "PI": "Xylenes (1966-1972)", "MS": "Coronary vasodilator with some antiarrhythmic action.", "PM": "91; was see under PIPERAZINES 1973-90", "HN": "91(73); was see under PIPERAZINES 1973-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008013"}, {"RECTYPE": "D", "MH": "Lie Detection", "AQ": "PX", "ENTRY": "Lie Detections", "MN": "I01.198.780.937.619", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "Ascertaining of deception through detection of emotional disturbance as manifested by changes in physiologic processes usually using a polygraph.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008014"}, {"RECTYPE": "D", "MH": "Liechtenstein", "AQ": "EH EP", "ENTRY": "Leichtenstein|T083|NAM|EQV|UNK (19XX)|790103|abcdef", "MN": "Z01.542.524", "MH_TH": "NLM (1983)", "ST": "T083", "MS": "Principality in central Europe, located between Austria and Switzerland. The capital is Vaduz.", "MR": "20160707", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008015"}, {"RECTYPE": "D", "MH": "Life Change Events", "AQ": "HI", "PRINT ENTRY": "Life Experiences|T067|NON|BRD|UNK (19XX)|760414|abcdef", "ENTRY": "Life Experience", "MN": "F01.829.458.410", "MH_TH": "NLM (1977)", "ST": "T067", "AN": "human only: do not confuse with life cycles & life stages of animals & lower organisms; FAMILY LIFE CYCLES see FAMILY is also available for \"transitional stages through which the family evolves...e.g., marriage, childbearing & death\"", "PI": "Stress, Psychological (1969-1976)", "MS": "Those occurrences, including social, psychological, and environmental, which require an adjustment or effect a change in an individual's pattern of living.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20230830", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D008016"}, {"RECTYPE": "D", "MH": "Life Expectancy", "AQ": "EH HI TD", "ENTRY": "Life Expectancies", "MN": "N06.850.520.308.985.450", "FX": "Mortality, Premature", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "IM for human, NIM for animal; consider also LONGEVITY", "MS": "Based on known statistical data, the number of years which any person of a given age may reasonably be expected to live.", "HN": "was in Cat H & N 1979-81; was in Cat N only 1968-78; was in Cat G only 1967; was in Cat G & I 1963-66", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008017"}, {"RECTYPE": "D", "MH": "Life Cycle Stages", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Life Cycle|T079|NON|EQV|POPLINE (1987)|961202|abcdef", "ENTRY": "Stages, Life History", "MN": "G07.345.500.550.500", "FX": "Life History Traits", "MH_TH": "NLM (1974)", "ST": "T079", "AN": "general or unspecified; prefer specifics; coordinate IM with specific organism /growth (IM)", "PI": "specific organism/growth & development (1967-1997)", "MS": "The continuous sequence of changes undergone by living organisms during the post-embryonic developmental process, such as metamorphosis in insects and amphibians. This includes the developmental stages of apicomplexans such as the malarial parasite, PLASMODIUM FALCIPARUM.", "PM": "98", "HN": "98; use explode 1975-97", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D008018"}, {"RECTYPE": "D", "MH": "Life Style", "AQ": "EH HI", "PRINT ENTRY": "Lifestyle Factors|T054|NON|REL|NLM (2021)|191119|abcdef", "ENTRY": "Lifestyles", "MN": "F01.829.458", "FX": "Quality of Life", "MH_TH": "NLM (1986)", "ST": "T054", "PI": "Personality Development (1968-1969)", "MS": "Typical way of life or manner of living characteristic of an individual or group. (From APA, Thesaurus of Psychological Index Terms, 8th ed)", "PM": "72", "HN": "72(70)", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008019"}, {"RECTYPE": "D", "MH": "Life Support Care", "AQ": "CL EC ES HI IS LJ MT OG PX SN ST TD", "PRINT ENTRY": "Extraordinary Treatment|T080|NON|NRW|BIOETHICS (1989)|770420|abcdef", "ENTRY": "Treatments, Extraordinary", "MN": "N02.421.585.440", "FX": "Resuscitation Orders", "MH_TH": "NLM (1978)", "ST": "T058", "AN": "extraordinary measures in patient care: do not confuse with LIFE SUPPORT SYSTEMS which is non-med", "PI": "Longevity (1966-1977)", "MS": "Care provided patients requiring extraordinary therapeutic measures in order to sustain and prolong life.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D008020"}, {"RECTYPE": "D", "MH": "Life Support Systems", "AQ": "CL EC ES HI IS LJ SN ST", "ENTRY": "Systems, Life Support", "MN": "N06.230.150.391", "FX": "Incubators", "MH_TH": "NLM (1966)", "ST": "T068", "AN": "do not confuse with LIFE SUPPORT CARE: read MeSH definition", "MS": "Systems that provide all or most of the items necessary for maintaining life and health. Provisions are made for the supplying of oxygen, food, water, temperature and pressure control, disposition of carbon dioxide and body waste. The milieu may be a spacecraft, a submarine, or the surface of the moon. In medical care, usually under hospital conditions, LIFE SUPPORT CARE is available. (From Webster's New Collegiate Dictionary)", "PM": "91; was see under SEALED CABIN ECOLOGY 1966-90", "HN": "91(66); was see under SEALED CABIN ECOLOGY 1966-90", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008021"}, {"RECTYPE": "D", "MH": "Ligaments", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Interosseous Ligament|T024|NON|NRW|NLM (2020)|190502|abcdef", "ENTRY": "Ligament, Interosseous", "MN": "A10.165.669", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "Shiny, flexible bands of fibrous tissue connecting together articular extremities of bones. They are pliant, tough, and inextensile.", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008022"}, {"RECTYPE": "D", "MH": "Ligaments, Articular", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ligament, Articular", "MN": "A10.165.669.514", "MH_TH": "NLM (1965)", "ST": "T023", "AN": "coordinate IM with specific joint (IM)", "MS": "Fibrous cords of CONNECTIVE TISSUE that attach bones to each other and hold together the many types of joints in the body. Articular ligaments are strong, elastic, and allow movement in only specific directions, depending on the individual joint.", "PM": "65", "HN": "65", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008023"}, {"RECTYPE": "D", "MH": "Ligands", "PRINT ENTRY": "Ligand|T103|NON|EQV|NLM (2021)|191126|abcdef", "MN": "D27.720.470.480", "FX": "Receptors, Cell Surface", "MH_TH": "NLM (1973)", "ST": "T103", "RN": "0", "AN": "IM general only; usually NIM with specific compound IM", "PI": "Organometallic Compounds (1968-1972)", "MS": "A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed)", "PM": "74", "HN": "74(73)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008024"}, {"RECTYPE": "D", "MH": "Ligases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Synthetases|T116|T126|NON|EQV|UNK (19XX)|870505|abbcdef", "ENTRY": "Synthetase|T116|T126|NON|EQV|NLM (1988)|870505|abbcdef", "MN": "D08.811.464", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 6.-", "MS": "A class of enzymes that catalyze the formation of a bond between two substrate molecules, coupled with the hydrolysis of a pyrophosphate bond in ATP or a similar energy donor. (Dorland, 28th ed) EC 6.", "OL": "use LIGASES & CARBOXY-LYASES to search CARBOXYLASES 1966-74", "PM": "CARBOXYLASES was see under CARBOXY-LYASES & LIGASES 1964-74, was heading 1963; CARBAMYL PHOSPHATE SYNTHASE (AMMONIA) & CARBAMYL PHOSPHATE SYNTHASE (GLUTAMINE) were see under PHOSPHOTRANSFERASES, ATP 1975-80", "HN": "CARBOXYLASES was see under CARBOXY-LYASES & LIGASES 1964-74, was heading 1963", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D008025"}, {"RECTYPE": "D", "MH": "Ligation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Ligatures", "MN": "E04.426", "MH_TH": "NLM (1971)", "ST": "T061", "AN": "usually NIM", "PI": "specific heading/surgery (1966-1970)", "MS": "Application of a ligature to tie a vessel or strangulate a part.", "PM": "77", "HN": "77(71)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D008026"}, {"RECTYPE": "D", "MH": "Light", "AQ": "AE", "PRINT ENTRY": "Radiation, Visible|T070|NON|NRW|UNK (19XX)|800520|RAD VISIBLE|abcdefv", "ENTRY": "Visible Radiations", "MN": "G01.750.770.578", "FX": "Ultraviolet Therapy", "EC": "therapeutic use:Phototherapy", "MH_TH": "NLM (1966)", "ST": "T070", "CX": "consider also terms at PHOTIC and PHOTO-", "MS": "That portion of the electromagnetic spectrum in the visible, ultraviolet, and infrared range.", "MR": "20150624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008027"}, {"RECTYPE": "D", "MH": "Light Coagulation", "DE": "LIGHT COAG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Photocoagulation|T061|NON|EQV|UNK (19XX)|740330|PHOTOCOAG|abcdefv", "ENTRY": "Photocoagulations", "MN": "E04.540.630", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "do not confuse with LASER COAGULATION; coordinate with anatomical term or disease /surg", "MS": "The coagulation of tissue by an intense beam of light, including laser (LASER COAGULATION). In the eye it is used in the treatment of retinal detachments, retinal holes, aneurysms, hemorrhages, and malignant and benign neoplasms. (Dictionary of Visual Science, 3d ed)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008028"}, {"RECTYPE": "D", "MH": "Lighting", "AQ": "AE CL EC ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Illumination|T068|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "N06.230.150.410", "MH_TH": "NLM (1966)", "ST": "T068", "AN": "the environment: differentiate from LIGHT, a principle of physics; /adv eff permitted but do not confuse with LIGHT /adv eff", "MS": "The illumination of an environment and the arrangement of lights to achieve an effect or optimal visibility. Its application is in domestic or in public settings and in medical and non-medical environments.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008029"}, {"RECTYPE": "D", "MH": "Lightning", "ENTRY": "Lightnings", "MN": "N06.230.300.100.725.375", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "adverse effects of lightning is probably LIGHTNING INJURIES", "MS": "An abrupt high-current electric discharge that occurs in the ATMOSPHERE and that has a path length ranging from hundreds of feet to tens of miles. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008030"}, {"RECTYPE": "D", "MH": "Lignin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lignins", "MN": "J01.637.051.720.099.687", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Lignin", "RN": "9005-53-2", "AN": "do not confuse with LIGNANS", "MS": "The most abundant natural aromatic organic polymer found in all vascular plants. Lignin together with cellulose and hemicellulose are the major cell wall components of the fibers of all wood and grass species. Lignin is composed of coniferyl, p-coumaryl, and sinapyl alcohols in varying ratios in different plant species. (From Merck Index, 11th ed)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008031"}, {"RECTYPE": "D", "MH": "Limbic System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Systems, Limbic", "MN": "A08.186.211.180", "MH_TH": "NLM (1966)", "ST": "T022", "MS": "A set of forebrain structures common to all mammals that is defined functionally and anatomically. It is implicated in the higher integration of visceral, olfactory, and somatic information as well as homeostatic responses including fundamental survival behaviors (feeding, mating, emotion). For most authors, it includes the AMYGDALA; EPITHALAMUS; GYRUS CINGULI; hippocampal formation (see HIPPOCAMPUS); HYPOTHALAMUS; PARAHIPPOCAMPAL GYRUS; SEPTAL NUCLEI; anterior nuclear group of thalamus, and portions of the basal ganglia. (Parent, Carpenter's Human Neuroanatomy, 9th ed, p744; NeuroNames, http://rprcsgi.rprc.washington.edu/neuronames/index.html (September 2, 1998)).", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008032"}, {"RECTYPE": "D", "MH": "Limulus Test", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Tests, Limulus", "MN": "E05.200.875.150.570", "MH_TH": "NLM (1978)", "ST": "T059", "AN": "for detection of bact endotoxins using horseshoe crab blood", "PI": "Endotoxins (1966-1977)", "MS": "Sensitive method for detection of bacterial endotoxins and endotoxin-like substances that depends on the in vitro gelation of Limulus amebocyte lysate (LAL), prepared from the circulating blood (amebocytes) of the horseshoe crab, by the endotoxin or related compound. Used for detection of endotoxin in body fluids and parenteral pharmaceuticals.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D008033"}, {"RECTYPE": "D", "MH": "Lincomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lincomycin, (2S-cis)-Isomer|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef", "ENTRY": "Hemihydrate Lincomycin Monohydrochloride", "MN": "D09.408.471.500", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USAN (1962)", "ST": "T195", "N1": "D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, (2S-trans)-", "RN": "BOD072YW0F", "RR": "M6T05Z2B68", "MS": "An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.", "PM": "66", "HN": "66(64)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008034"}, {"RECTYPE": "D", "MH": "Lingual Frenum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Frenum, Lingual|T023|NON|EQV|UNK (19XX)|771201|abcdef", "ENTRY": "Lingual Frenums", "MN": "A14.549.885.431", "MH_TH": "NLM (1965)", "ST": "T023", "MS": "MUCOUS MEMBRANE extending from floor of mouth to the under-surface of the tongue.", "PM": "65", "HN": "65", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008035"}, {"RECTYPE": "D", "MH": "Lingual Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nerves, Lingual", "MN": "A08.800.800.120.760.500.450", "EC": "injuries:Lingual Nerve Injuries", "MH_TH": "NLM (1971)", "ST": "T023", "AN": "disease: coordinate IM with CRANIAL NERVE DISEASES (IM); neoplasm: coordinate IM with CRANIAL NERVE NEOPLASMS (1M) + histological type of neoplasm (IM)", "PI": "Mandibular Nerve (1966-1970)", "MS": "A sensory branch of the MANDIBULAR NERVE, which is part of the trigeminal (5th cranial) nerve. The lingual nerve carries general afferent fibers from the anterior two-thirds of the tongue, the floor of the mouth, and the mandibular gingivae.", "PM": "91; was see under MANDIBULAR NERVE 1971-90", "HN": "91(71); was see under MANDIBULAR NERVE 1971-90", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008036"}, {"RECTYPE": "D", "MH": "Linguistics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Linguistic", "MN": "L01.559.598", "MH_TH": "NLM (1965)", "ST": "T090", "AN": "do not confuse with LANGUAGE, SEMANTICS, TERMINOLOGY AS TOPIC, PHONETICS, LITERATURE, PHILOLOGY or VOCABULARY; grammar, syntax, accent go here", "MS": "The science of language, including phonetics, phonology, morphology, syntax, semantics, pragmatics, and historical linguistics. (Random House Unabridged Dictionary, 2d ed)", "PM": "67", "HN": "67(65)", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008037"}, {"RECTYPE": "D", "MH": "Liniments", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D26.255.480", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "AN": "IM for general only, qualif permitted; NIM (no qualif) with specific drug IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in liniment form, not the liniment", "MS": "Heat-generating liquids that are thinner than ointments and are applied to the skin with friction. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008038"}, {"RECTYPE": "D", "MH": "Linitis Plastica", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "MN": "C04.557.470.200.025.095.410", "MH_TH": "NLM (1975)", "ST": "T191", "AN": "neoplastic; coordinate with STOMACH NEOPLASMS", "MS": "A condition where the stomach wall becomes thickened, rubbery and loses its ability to distend. The stomach assumes a \"leather bottle\" shape. It is most often seen in adenocarcinoma of the stomach. The term is often used synonymously with diffuse adenocarcinoma of the stomach.", "OL": "search CARCINOMA, SCIRRHOUS 1966-74", "PM": "91; was see under CARCINOMA, SCIRRHOUS 1975-90", "HN": "91(75); was see under CARCINOMA, SCIRRHOUS 1975-90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008039"}, {"RECTYPE": "D", "MH": "Genetic Linkage", "DE": "GENET LINKAGE", "AQ": "DE ES GE IM PH RE", "ENTRY": "Linkage Analysis, Genetic", "MN": "G05.348", "FX": "Synteny", "MH_TH": "NLM (2001)", "ST": "T044", "PI": "Genetics (1966-1969)", "MS": "The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME.", "PM": "2011; see LINKAGE (GENETICS) 1973-2010", "HN": "2011 (1970)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008040"}, {"RECTYPE": "D", "MH": "Linoleic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Linoleic", "MN": "D10.251.355.343.500", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with LINOLENIC ACIDS", "MS": "Eighteen-carbon essential fatty acids that contain two double bonds.", "OL": "use LINOLEIC ACIDS to search LINOLEIC ACID 1966-74", "PM": "75; was LINOLEIC ACID 1963-74", "HN": "75; was LINOLEIC ACID 1963-74", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D008041"}, {"RECTYPE": "D", "MH": "Linolenic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D10.251.355.310.640", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "AN": "do not confuse with LINOLEIC ACIDS", "PI": "Fatty Acids, Essential (1966-1972)", "MS": "Eighteen-carbon essential fatty acids that contain three double bonds.", "OL": "use LINOLENIC ACIDS to search LINOLENIC ACID 1973-74; use FATTY ACIDS, ESSENTIAL 1966-72", "PM": "75; was LINOLENIC ACID 1973-74, was LINOLENIC ACID see under FATTY ACIDS, ESSENTIAL 1963-72", "HN": "75; was LINOLENIC ACID 1973-74, was LINOLENIC ACID see under FATTY ACIDS, ESSENTIAL 1963-72", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008042"}, {"RECTYPE": "D", "MH": "Linseed Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Flaxseed Oil|T109|T123|NON|EQV|NLM (1998)|960823|abbcdef", "ENTRY": "Oil, Linseed", "MN": "D20.215.784.750.615", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Linseed oil", "RN": "8001-26-1", "AN": "D25-26 qualif", "MS": "The fixed oil obtained from the dried ripe seed of linseed, Linum usitatissimum (L. Linaceae). It is used as an emollient in liniments, pastes, and medicinal soaps, and in veterinary medicine as a laxative. It is also called flaxseed oil. (Dorland, 28th ed)", "OL": "use LINSEED OIL to search LINSEED 1966-86", "PM": "87; was LINSEED 1963-86", "HN": "87; was LINSEED 1963-86", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D008043"}, {"RECTYPE": "D", "MH": "Linuron", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Afalon|T109|T131|TRD|NRW|UNK (19XX)|840919|abbcdef", "MN": "D02.455.426.559.389.703.515", "PA": "Herbicides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Urea, N'-(3,4-dichlorophenyl)-N-methoxy-N-methyl-", "RN": "01XP1SU59O", "RR": "330-55-2 (Linuron)", "PI": "Urea (1966-1971)", "MS": "A selective pre- and post-emergence herbicide. (From Merck Index, 11th ed)", "PM": "91; was see under HERBICIDES, UREA 1972-90", "HN": "91(72); was see under HERBICIDES, UREA 1972-90", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008044"}, {"RECTYPE": "D", "MH": "Lions", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Panthera leo|T015|NON|EQV|NLM (1998)|961028|abcdef", "ENTRY": "Lion", "MN": "B01.050.150.900.649.313.750.377.750.600.500", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9689", "MS": "Large, chiefly nocturnal mammals of the cat family FELIDAE, species Panthera leo. They are found in Africa and southern Asia.", "PM": "91; was see under CARNIVORA 1975-90", "HN": "91(75); was see under CARNIVORA 1975-90", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D008045"}, {"RECTYPE": "D", "MH": "Lip", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Philtrum|T029|NON|NRW|NLM (2010)|080811|abcdef", "ENTRY": "Philtrums", "MN": "A14.549.336", "MH_TH": "NLM (1965)", "ST": "T029", "MS": "Either of the two fleshy, full-blooded margins of the mouth.", "PM": "65; was LIPS 1963-64", "HN": "65; was LIPS 1963-64", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008046"}, {"RECTYPE": "D", "MH": "Lip Diseases", "DE": "LIP DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lip Disease", "MN": "C07.465.409", "MH_TH": "NLM (1972)", "ST": "T047", "PI": "Mouth Diseases (1966-1971)", "MS": "Diseases involving the LIP.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008047"}, {"RECTYPE": "D", "MH": "Lip Neoplasms", "DE": "LIP NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Lip Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Lip", "MN": "C07.465.530.550", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the LIP.", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008048"}, {"RECTYPE": "D", "MH": "Lipase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Triglyceride Lipase|T116|T126|NON|EQV|UNK (19XX)|840525|abbcdef", "ENTRY": "Lipase, Triglyceride", "MN": "D08.811.277.352.100.400", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Triacylglycerol acylhydrolase", "RN": "EC 3.1.1.3", "AN": "/defic: consider also LIPID METABOLISM, INBORN ERRORS & CHOLESTEROL ESTER STORAGE DISEASE & WOLMAN DISEASE; LIPOPROTEIN LIPASE is also available", "MS": "An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. It is produced by glands on the tongue and by the pancreas and initiates the digestion of dietary fats. (From Dorland, 27th ed) EC 3.1.1.3.", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008049"}, {"RECTYPE": "D", "MH": "Lipid A", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.946.123.329.500.500", "MH_TH": "NLM (1977)", "ST": "T129", "RN": "0", "PI": "Lipopolysaccharides (1972-1976)", "MS": "Lipid A is the biologically active component of lipopolysaccharides. It shows strong endotoxic activity and exhibits immunogenic properties.", "PM": "84; was see under LIPOPOLYSACCHARIDES 1977-83", "HN": "1984; use LIPOPOLYSACCHARIDES 1977-1983", "MR": "20220523", "DA": "19760413", "DC": "1", "DX": "19840101", "UI": "D008050"}, {"RECTYPE": "D", "MH": "Lipid Bilayers", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bilayers, Lipid|T026|T109|NON|EQV|UNK (19XX)|790524|abbcdef", "ENTRY": "Lipid Bilayer", "MN": "J01.637.087.500.510", "FX": "Liposomes", "MH_TH": "NLM (1980)", "ST": "T109", "RN": "0", "AN": "coord IM with specific lipid (IM or NIM)", "PI": "Membranes, Artificial (1966-1979)", "MS": "Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes.", "PM": "80", "HN": "80", "MR": "20040707", "DA": "19790524", "DC": "1", "DX": "19800101", "UI": "D008051"}, {"RECTYPE": "D", "MH": "Lipid Metabolism, Inborn Errors", "DE": "LIPID METAB INBORN ERR", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lipid Metabolism, Inborn Error|T047|NON|EQV|NLM (1991)|900524|LIPID METAB INBORN ERRORS|abcdefv", "MN": "C18.452.648.398", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "coordinate with specific lipid /metab", "MS": "Errors in the metabolism of LIPIDS resulting from inborn genetic MUTATIONS that are heritable.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008052"}, {"RECTYPE": "D", "MH": "Lipid Mobilization", "AQ": "DE ES GE IM PH RE", "ENTRY": "Mobilizations, Lipid", "MN": "G03.458.500.500", "MH_TH": "NLM (1970)", "ST": "T042", "PI": "Lipids/metabolism (1966-1969)", "MS": "LIPOLYSIS of stored LIPIDS in the ADIPOSE TISSUE to release FREE FATTY ACIDS. Mobilization of stored lipids is under the regulation of lipolytic signals (CATECHOLAMINES) or anti-lipolytic signals (INSULIN) via their actions on the hormone-sensitive LIPASE. This concept does not include lipid transport.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D008053"}, {"RECTYPE": "D", "MH": "Lipid Peroxides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lipoperoxide|T109|NON|EQV|NLM (2021)|200227|abcdef", "ENTRY": "Peroxides, Lipid", "MN": "D10.440", "MH_TH": "NLM (1980)", "ST": "T109", "RN": "0", "PI": "Peroxides (1966-1979)", "MS": "Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension.", "PM": "80", "HN": "80", "MR": "20230226", "DA": "19790221", "DC": "1", "DX": "19800101", "UI": "D008054"}, {"RECTYPE": "D", "MH": "Lipids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lipid|T109|NON|EQV|NLM (2021)|191113|abcdef", "MN": "D10", "RH": "D10 - LIPIDS", "FX": "Hypolipidemic Agents", "EC": "metabolism:Lipid Metabolism", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics; differentiate from FATS; /\u200cblood: consider also HYPERLIPIDEMIAS & specifics; dyslipidemia, especially in foreign literature, is probably HYPERLIPIDEMIAS or its specifics; DIETARY FATS is also available ", "MS": "A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "/blood was BLOOD LIPIDS 1963-67; /metabolism was LIPID METABOLISM 1963-65", "HN": "/blood was BLOOD LIPIDS 1963-67; /metabolism was LIPID METABOLISM 1963-65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008055"}, {"RECTYPE": "D", "MH": "Dihydrolipoamide Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NADH Diaphorase|T116|T126|ABX|EQV|UNK (19XX)|741018|abbcdef", "ENTRY": "Glycine Decarboxylase Complex L Protein", "MN": "D12.776.331.192", "MH_TH": "UNK (19XX)", "ST": "T126", "N1": "Dihydrolipoamide: NAD+ oxidoreductase", "RN": "EC 1.8.1.4", "RR": "EC 1.8.1.4", "MS": "A flavoprotein containing oxidoreductase that catalyzes the reduction of lipoamide by NADH to yield dihydrolipoamide and NAD+. The enzyme is a component of several MULTIENZYME COMPLEXES.", "PM": "2004; see LIPOAMIDE DEHYDROGENASE 1966-2003", "HN": "2004(1966)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D008058"}, {"RECTYPE": "D", "MH": "Mucopolysaccharidosis I", "DE": "MPS I", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Scheie's Syndrome|T047|EPO|NRW|NLM (1992)|900911|abcdef", "ENTRY": "alpha-L-Iduronidase Deficiencies", "MN": "C18.452.648.595.600.640", "FX": "Mucopolysaccharidosis II", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase (IDURONIDASE) and characterized by progressive physical deterioration with urinary excretion of DERMATAN SULFATE and HEPARAN SULFATE. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome (formerly mucopolysaccharidosis V). Symptoms may include DWARFISM; hepatosplenomegaly; thick, coarse facial features with low nasal bridge; corneal clouding; cardiac complications; and noisy breathing.", "PM": "1992; see LIPOCHONDRODYSTROPHY 1966-91; MUCOPOLYSACCHARIDOSIS 5 was heading 1991, see MUCOPOLYSACCHARIDOSIS 1975-1990; for MUCOPOLYSACCHARIDOSIS 1 see LIPOCHONDRODYSTROPHY 1976-1991; for HURLER'S DISEASE see LIPOCHONDRODYSTROPHY 1975-1991; for SCHEIE'S SYNDROME see MUCOPOLYSACCHARIDOSIS 5 1975-1991", "HN": "1992; use LIPOCHONDRODYSTROPHY 1966-1991; MUCOPOLYSACCHARIDOSIS 5 was heading 1991, use MUCOPOLYSACCHARIDOSIS 1975-1990; for MUCOPOLYSACCHARIDOSIS 1 use LIPOCHONDRODYSTROPHY 1976-1991; for HURLER'S DISEASE use LIPOCHONDRODYSTROPHY 1975-1991; for SCHEIE'S SYNDROME use MUCOPOLYSACCHARIDOSIS 5 1975-1991;", "CATSH": "CAT LIST", "MR": "20151021", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D008059"}, {"RECTYPE": "D", "MH": "Lipodystrophy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lipodystrophies", "MN": "C18.452.880.391", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008060"}, {"RECTYPE": "D", "MH": "Whipple Disease", "DE": "WHIPPLE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Whipple's Disease|T047|EPO|EQV|NLM (1966)|990101|WHIPPLES DIS|abcdefv", "ENTRY": "Whipples Disease", "MN": "C18.452.603.925", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "A chronic systemic infection by a gram-positive bacterium, Tropheryma whippelii, mainly affecting the SMALL INTESTINE but also the JOINTS; CARDIOVASCULAR SYSTEM; and the CENTRAL NERVOUS SYSTEM. The disease is characterized by fat deposits in the INTESTINAL MUCOSA and LYMPH NODES, malabsorption, DIARRHEA with fatty stools, MALNUTRITION, and ARTHRITIS.", "PM": "2004; see WHIPPLE'S DISEASE 1996-2003, see LIPODYSTROPHY, INTESTINAL 1963-1995", "HN": "2004 (1996); use LIPODYSTROPHY, INTESTINAL 1963-1995", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D008061"}, {"RECTYPE": "D", "MH": "Lipofuscin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.767.550", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "a lipid pigment", "PI": "Pigments (1972-1974)", "MS": "A naturally occurring lipid pigment with histochemical characteristics similar to ceroid. It accumulates in various normal tissues and apparently increases in quantity with age.", "PM": "91; was see under PIGMENTS 1975-90", "HN": "91(75); was see under PIGMENTS 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008062"}, {"RECTYPE": "D", "MH": "Thioctic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lipoic Acid|T109|T127|NON|EQV|NLM (1991)|900228|abbcdef", "ENTRY": "espalipon", "MN": "D10.251.941", "PA": "Vitamin B Complex", "MH_TH": "NLM (1966)", "ST": "T127", "N1": "1,2-Dithiolane-3-pentanoic acid", "RN": "73Y7P0K73Y", "RR": "62-46-4 (Thioctic Acid)", "MS": "An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.", "OL": "use THIOCTIC ACID to search LIPOIC ACID 1966-90", "PM": "91; was LIPOIC ACID 1963-90", "HN": "91; was LIPOIC ACID 1963-90", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008063"}, {"RECTYPE": "D", "MH": "Lipidoses", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lipoidosis|T047|NON|EQV|NLM (1966)|990101|abcdef", "MN": "C18.452.648.398.641", "MH_TH": "NLM (2007)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.", "PM": "2007; see LIPOIDOSIS 1966-2006", "HN": "2007 (1966)", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D008064"}, {"RECTYPE": "D", "MH": "Lipoid Proteinosis of Urbach and Wiethe", "DE": "LIPOID PROTEINOSIS URBACH AND WIETHE", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Urbach-Wiethe Disease|T047|EPO|EQV|NLM (2007)|050803|URBACH WIETHE DIS|abcdefv", "ENTRY": "Urbach Wiethe Lipoid Proteinosis", "MN": "C16.320.850.595", "FX": "Hyaline Fibromatosis Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An autosomal recessive disorder characterized by glassy degenerative thickening (hyalinosis) of SKIN; MUCOSA; and certain VISCERA. This disorder is caused by mutation in the extracellular matrix protein 1 gene (ECM1). Clinical features include hoarseness and skin eruption due to widespread deposition of HYALIN.", "PM": "2007; see LIPOIDPROTEINOSIS 1991-2006, see LIPOIDOSIS 1975-1990", "HN": "2007 (1975)", "CATSH": "CAT LIST", "MR": "20230731", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008065"}, {"RECTYPE": "D", "MH": "Lipolysis", "AQ": "DE GE IM PH RE", "ENTRY": "Lipolyses", "MN": "G03.458.500", "MH_TH": "NLM (1980)", "ST": "T040", "PI": "Lipids/metabolism (1966-1979)", "MS": "The metabolic process of breaking down LIPIDS to release FREE FATTY ACIDS, the major oxidative fuel for the body. Lipolysis may involve dietary lipids in the DIGESTIVE TRACT, circulating lipids in the BLOOD, and stored lipids in the ADIPOSE TISSUE or the LIVER. A number of enzymes are involved in such lipid hydrolysis, such as LIPASE and LIPOPROTEIN LIPASE from various tissues.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19790524", "DC": "1", "DX": "19800101", "UI": "D008066"}, {"RECTYPE": "D", "MH": "Lipoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Lipoma, Pleomorphic|T191|NON|NRW|NLM (1994)|930326|abcdef", "ENTRY": "Tumors, Fatty", "MN": "C04.557.450.550.400", "MH_TH": "OMIM (2013)", "ST": "T191", "AN": "solitary neoplastic; for non-neoplastic see LIPOMATOSIS; coordinate with precoordinated organ/neoplasm term ", "MS": "A benign tumor composed of fat cells (ADIPOCYTES). It can be surrounded by a thin layer of connective tissue (encapsulated), or diffuse without the capsule.", "OL": "use LIPOMA to search FATTY TUMOR 1966-67", "PM": "FATTY TUMOR was heading 1963-67", "HN": "FATTY TUMOR was heading 1963-67", "CATSH": "CAT LIST", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008067"}, {"RECTYPE": "D", "MH": "Lipomatosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lipomatoses", "MN": "C18.452.584.718", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "not neoplastic, for neoplastic see LIPOMA; coordinate with precoordinated organ/disease term if relevant; note specifics", "MS": "A disorder characterized by the accumulation of encapsulated or unencapsulated tumor-like fatty tissue resembling LIPOMA.", "CATSH": "CAT LIST", "MR": "20160304", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008068"}, {"RECTYPE": "D", "MH": "Lipomatosis, Multiple Symmetrical", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Madelung Disease|T047|EPO|EQV|NLM (2007)|ORD (2010)|050715|abcdeef", "ENTRY": "Symmetrical Lipomatosis, Multiple", "MN": "C18.452.584.718.750", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Lipomatosis (1966-1986)", "MS": "A condition characterized by the growth of unencapsulated masses of ADIPOSE TISSUE symmetrically deposited around the neck, shoulders, or other sites around the body.", "PM": "1991; see LIPOMATOSIS 1987-1990", "HN": "1991(1987); use LIPOMATOSIS 1987-1990", "CATSH": "CAT LIST", "MR": "20200110", "DA": "19860623", "DC": "1", "DX": "19910101", "UI": "D008069"}, {"RECTYPE": "D", "MH": "Lipopolysaccharides", "DE": "LPS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lipopolysaccharide|T109|NON|EQV|NLM (2021)|191113|abcdef", "ENTRY": "Lipoglycans|T109|NON|EQV|UNK (19XX)|810427|abcdef", "MN": "D23.946.123.329.500", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "oordinate with specific bacterium if pertinent ", "MS": "Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed)", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008070"}, {"RECTYPE": "D", "MH": "Lipoprotein Lipase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lipemia-Clearing Factor|T116|T126|NON|EQV|UNK (19XX)|800522|abbcdef", "ENTRY": "Post Heparin Lipase", "MN": "D08.811.277.352.100.430", "FX": "Hyperlipoproteinemia Type I", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Triacylglycero-protein acylhydrolase", "RN": "EC 3.1.1.34", "AN": "/defic: consider also HYPERLIPOPROTEINEMIA TYPE I", "MS": "An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. (Dorland, 27th ed) EC 3.1.1.34.", "OL": "use LIPOPROTEIN LIPASE to search HEPARIN-CLEARING FACTOR & LIPEMIA-CLEARING FACTOR 1966-80", "HN": "HEPARIN-CLEARING FACTOR & LIPEMIA-CLEARING FACTOR were see under LIPOPROTEIN LIPASE 1963-80", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008071"}, {"RECTYPE": "D", "MH": "Hyperlipoproteinemia Type I", "DS": "HYPERLIPOPROTEINEMIA TYPE 01", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lipoprotein Lipase Deficiency, Familial|T047|NON|EQV|GHR (2014)|NLM (1980)|990101|LIPOPROTEIN LIPASE DEFIC FAMILIAL|abcdeefv", "ENTRY": "Type Ib Hyperlipoproteinemias", "MN": "C18.452.648.398.465", "FX": "Lipoprotein Lipase", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Hyperlipidemia/familial & genetic (1966-1979)", "MS": "An inherited condition due to a deficiency of either LIPOPROTEIN LIPASE or APOLIPOPROTEIN C-II (a lipase-activating protein). The lack of lipase activities results in inability to remove CHYLOMICRONS and TRIGLYCERIDES from the blood which has a creamy top layer after standing.", "PM": "2007; see LIPOPROTEIN LIPASE DEFICIENCY, FAMILIAL 1991-2006, see HYPERLIPOPROTEINEMIA 1980-1990", "HN": "2007 (1980)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19790423", "DC": "1", "DX": "19910101", "UI": "D008072"}, {"RECTYPE": "D", "MH": "Lipoprotein-X", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lipoprotein X|T116|T123|NON|EQV|UNK (19XX)|790523|abbcdef", "MN": "D12.776.521.450", "MH_TH": "NLM (1980)", "ST": "T123", "RN": "0", "PI": "Lipoproteins, LDL (1972-1979)", "MS": "An abnormal lipoprotein present in large amounts in patients with obstructive liver diseases such as INTRAHEPATIC CHOLESTASIS. LP-X derives from the reflux of BILE lipoproteins into the bloodstream. LP-X is a low-density lipoprotein rich in free CHOLESTEROL and PHOSPHOLIPIDS but poor in TRIGLYCERIDES; CHOLESTEROL ESTERS; and protein.", "PM": "80", "HN": "80", "MR": "20060705", "DA": "19790523", "DC": "1", "DX": "19800101", "UI": "D008073"}, {"RECTYPE": "D", "MH": "Lipoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lipoproteins, Circulating", "MN": "D12.776.521", "FX": "Receptors, Lipoprotein", "MH_TH": "NLM (1966)", "ST": "T116", "RN": "0", "AN": "general or unspecified; prefer specifics; /blood: consider also HYPERLIPOPROTEINEMIA; /defic: consider also HYPOLIPOPROTEINEMIAS & specifics; do not confuse with PROTEOLIPIDS or LIPID-LINKED PROTEINS", "MS": "Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes.", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008074"}, {"RECTYPE": "D", "MH": "Lipoproteins, HDL", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-Lipoproteins|T109|T116|T123|NON|EQV|UNK (19XX)|740330|abbbcdef", "ENTRY": "alpha Lipoproteins", "MN": "D12.776.521.479", "FX": "Tangier Disease", "MH_TH": "NLM (1972)", "ST": "T123", "RN": "0", "PI": "Lipoproteins (1966-1971)", "MS": "A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases.", "PM": "74", "HN": "74(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008075"}, {"RECTYPE": "D", "MH": "Cholesterol, HDL", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "High Density Lipoprotein Cholesterol|T109|T123|NON|EQV|UNK (19XX)|840525|abbcdef", "ENTRY": "alpha Lipoprotein Cholesterol", "MN": "D12.776.521.479.470", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Lipoproteins, HDL (1972-1984)", "MS": "Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol.", "PM": "2007; see LIPOPROTEINS, HDL CHOLESTEROL 1985-2006", "HN": "2007 (1985)", "MR": "20160528", "DA": "19840525", "DC": "1", "DX": "19850101", "UI": "D008076"}, {"RECTYPE": "D", "MH": "Lipoproteins, LDL", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Lipoproteins|T109|T116|T123|NON|EQV|UNK (19XX)|741223|abbbcdef", "ENTRY": "beta Lipoproteins", "MN": "D12.776.521.550", "FX": "Receptors, LDL", "MH_TH": "NLM (1972)", "ST": "T123", "RN": "0", "AN": "/defic: consider also HYPOBETALIPOPROTEINEMIAS", "PI": "Lipoproteins (1966-1971)", "MS": "A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues.", "PM": "74", "HN": "74(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008077"}, {"RECTYPE": "D", "MH": "Cholesterol, LDL", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "LDL Cholesterol|T109|T123|ACX|EQV|UNK (19XX)|840524|abbcdef", "ENTRY": "beta Lipoprotein Cholesterol", "MN": "D12.776.521.550.500", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Lipoproteins, LDL (1972-1984)", "MS": "Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol.", "PM": "2007; see LIPOPROTEINS, LDL CHOLESTEROL 1985-2006", "HN": "2007 (1985)", "MR": "20160528", "DA": "19840524", "DC": "1", "DX": "19850101", "UI": "D008078"}, {"RECTYPE": "D", "MH": "Lipoproteins, VLDL", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Very-Low-Density Lipoproteins|T109|T116|T123|NON|EQV|UNK (19XX)|740330|abbbcdef", "ENTRY": "Very Low Density Lipoproteins", "MN": "D12.776.521.622", "MH_TH": "NLM (1972)", "ST": "T123", "RN": "0", "PI": "Lipoproteins (1966-1971)", "MS": "A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues.", "PM": "74; VERY-LOW-DENSITY LIPOPROTEINS was VERY LOW DENSITY LIPOPROTEINS 1974-95", "HN": "74(72); VERY-LOW-DENSITY LIPOPROTEINS was VERY LOW DENSITY LIPOPROTEINS 1972-95", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008079"}, {"RECTYPE": "D", "MH": "Liposarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Liposarcoma, Pleomorphic|T191|NON|REL|NLM (1994)|930326|abcdef", "ENTRY": "Well Differentiated Liposarcomas", "MN": "C04.557.450.795.465", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20180308", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008080"}, {"RECTYPE": "D", "MH": "Liposomes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ultradeformable Liposomes|T109|NON|NRW|NLM (2007)|051130|abcdef", "ENTRY": "Ultradeformable Liposome", "MN": "J01.637.087.500.517", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "AN": "when used as a vehicle in drug therapy, index specific drug / admin (IM) + LIPOSOMES (NIM without qualifiers); differentiate from LIPID DROPLETS which are organelles", "PI": "Membranes, Artificial (1966-1972)", "MS": "Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins.", "PM": "73", "HN": "73", "MR": "20140617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008081"}, {"RECTYPE": "D", "MH": "Lipotropic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lipotropic Factors|T109|T121|T123|NON|NRW|NLM (1996)|941116|abbbcdef", "ENTRY": "Factors, Lipotropic", "MN": "D27.505.954.557.500.601", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Endogenous factors or drugs that increase the transport and metabolism of LIPIDS including the synthesis of LIPOPROTEINS by the LIVER and their uptake by extrahepatic tissues.", "PM": "96; was LIPOTROPIC FACTORS 1963-95", "HN": "96; was LIPOTROPIC FACTORS 1963-95", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008082"}, {"RECTYPE": "D", "MH": "beta-Lipotropin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lipotropin|T116|T125|NON|EQV|NLM (1965)|990101|abbcdef", "ENTRY": "beta Lipotropin", "MN": "D12.776.631.650.405.935.480", "MH_TH": "UNK (19XX)", "ST": "T125", "N1": "Lipotropin", "RN": "9035-55-6", "MS": "A 90-amino acid peptide derived from post-translational processing of pro-opiomelanocortin (POMC) in the PITUITARY GLAND and the HYPOTHALAMUS. It is the C-terminal fragment of POMC with lipid-mobilizing activities, such as LIPOLYSIS and steroidogenesis. Depending on the species and the tissue sites, beta-LPH may be further processed to yield active peptides including GAMMA-LIPOTROPIN; BETA-MSH; and ENDORPHINS.", "PM": "2007; see LIPOTROPIN 1974-2006", "HN": "2007(1965)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008083"}, {"RECTYPE": "D", "MH": "Lipoxygenase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lipoxidase|T116|T126|NON|EQV|NLM (1992)|910403|abbcdef", "ENTRY": "Oxidoreductase, Linoleate-Oxygen", "MN": "D12.776.556.579.374.568.750", "EC": "antagonists & inhibitors:Lipoxygenase Inhibitors", "MH_TH": "NLM (1974)", "ST": "T126", "N1": "Linoleate:oxygen 13-oxidoreductase", "RN": "EC 1.13.11.12", "AN": "LIPOXYGENASES is also available", "MS": "An enzyme of the oxidoreductase class primarily found in PLANTS. It catalyzes reactions between linoleate and other fatty acids and oxygen to form hydroperoxy-fatty acid derivatives.", "OL": "use LIPOXYGENASE to search LIPOXYGENASES 1974-91", "PM": "92; was LIPOXYGENASES 1974-91", "HN": "92; was LIPOXYGENASES 1974-91", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008084"}, {"RECTYPE": "D", "MH": "Lipreading", "PRINT ENTRY": "Speechreading|T052|NON|EQV|UNK (19XX)|760517|abcdef", "ENTRY": "Speechreadings", "MN": "L01.143.649.526.334", "FX": "Deafness", "MH_TH": "NLM (1966)", "ST": "T052", "MS": "The process by which an observer comprehends speech by watching the movements of the speaker's lips without hearing the speaker's voice.", "OL": "use LIPREADING to search LIP READING 1966-76", "PM": "77; was LIP READING 1963-76", "HN": "77; was LIP READING 1963-76", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D008085"}, {"RECTYPE": "D", "MH": "Lissamine Green Dyes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Green Dyes, Lissamine", "MN": "D02.886.645.600.080.050.550", "PA": "Coloring Agents", "MH_TH": "NLM (1976)", "ST": "T130", "RN": "0", "PI": "Ammonium Compounds (1969-1975)", "MS": "Green dyes containing ammonium and aryl sulfonate moieties that facilitate the visualization of tissues, if given intravenously. They have mostly been used in the study of kidney physiology.", "PM": "91; was see under AMMONIUM COMPOUNDS 1976-90", "HN": "91(76); was see under AMMONIUM COMPOUNDS 1976-90", "MR": "20050630", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D008086"}, {"RECTYPE": "D", "MH": "Listeria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.485", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid1637", "AN": "in feces, on plants, in silage", "PI": "Corynebacteriaceae (1975)", "MS": "A genus of bacteria which may be found in the feces of animals and man, on vegetation, and in silage. Its species are parasitic on cold-blooded and warm-blooded animals, including man.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D008087"}, {"RECTYPE": "D", "MH": "Listeriosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Listeria Infections|T047|NON|EQV|NLM (1966)|990101|LISTERIA INFECT|abcdefv", "ENTRY": "Listerioses", "MN": "C01.150.252.410.514", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "MENINGITIS, LISTERIA is available", "MS": "Infections with bacteria of the genus LISTERIA.", "PM": "2011(1966)", "HN": "2011(1966)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "20110101", "UI": "D008088"}, {"RECTYPE": "D", "MH": "Listeria monocytogenes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.485.500", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1639", "MS": "A species of gram-positive, rod-shaped bacteria widely distributed in nature. It has been isolated from sewage, soil, silage, and from feces of healthy animals and man. Infection with this bacterium leads to encephalitis, meningitis, endocarditis, and abortion.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008089"}, {"RECTYPE": "D", "MH": "Lisuride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylergol Carbamide|T109|T121|NON|EQV|UNK (19XX)|780208|abbcdef", "ENTRY": "Mesylate, Lisuride", "MN": "D03.633.400.439.560", "PA": "Serotonin Receptor Agonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Urea, N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethyl-", "RN": "E0QN3D755O", "RR": "UV1635N8XW", "PI": "Ergot Alkaloids (1966-1968)", "MS": "An ergot derivative that acts as an agonist at dopamine D2 receptors (DOPAMINE AGONISTS). It may also act as an antagonist at dopamine D1 receptors, and as an agonist at some serotonin receptors (SEROTONIN RECEPTOR AGONISTS).", "PM": "91; was see under ERGOLINES 1979-90", "HN": "91(79); was see under ERGOLINES 1979-90", "MR": "20170524", "DA": "19780208", "DC": "1", "DX": "19910101", "UI": "D008090"}, {"RECTYPE": "D", "MH": "Literature", "AQ": "HI", "ENTRY": "Literatures", "MN": "K01.517", "FX": "Medicine in Literature", "MH_TH": "BIOETHICS (1975)", "ST": "T170", "AN": "differentiate from BIBLIOGRAPHIES AS TOPIC and BOOKS", "MS": "Writings having excellence of form or expression and expressing ideas of permanent or universal interest. The body of written works produced in a particular language, country, or age. (Webster, 3d ed)", "MR": "20190710", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008091"}, {"RECTYPE": "D", "MH": "Literature, Medieval", "DE": "LIT MEDIEVAL", "AQ": "HI", "ENTRY": "Medieval Literatures", "MN": "K01.517.495", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "coordinate with specific type of literature if relevant", "MS": "Writings originating in the 5th century A.D. through the 15h century.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008092"}, {"RECTYPE": "D", "MH": "Literature, Modern", "DE": "LIT MODERN", "AQ": "HI", "ENTRY": "Modern Literature|T170|NON|EQV|NLM (1991)|900110|MODERN LIT|abcdefv", "MN": "K01.517.533", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "starts with 15th cent; coord IM with POETRY AS TOPIC (IM) or DRAMA (IM); DF: LIT MODERN", "MS": "Writings originating from the 15th century A.D. to the present", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008093"}, {"RECTYPE": "D", "MH": "Lithium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Lithium 7", "MN": "D01.552.547.290", "FX": "Lithium Compounds", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "9FN79X2M3F", "RR": "7439-93-2 (Lithium)", "MS": "An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER.", "MR": "20170704", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008094"}, {"RECTYPE": "D", "MH": "Lithocholic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lithocholate|T109|T121|T123|NON|NRW|UNK (19XX)|770210|abbbcdef", "ENTRY": "Acid, Lithocholic", "MN": "D04.210.500.221.430.622", "PA": "Detergents", "MH_TH": "NLM (1973)", "ST": "T123", "N1": "Cholan-24-oic acid, 3-hydroxy-, (3alpha,5beta)-", "RN": "5QU0I8393U", "RR": "434-13-9 (Lithocholic Acid)", "AN": "a bile acid; /biosyn /physiol permitted", "MS": "A bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as cholagogue and choleretic.", "PM": "78", "HN": "78(73)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D008095"}, {"RECTYPE": "D", "MH": "Lithotripsy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ultrasonic Lithotripsy|T061|NON|NRW|UNK (19XX)|850607|abcdef", "ENTRY": "Ultrasonic Lithotripsy, Percutaneous", "MN": "E04.943.500", "FX": "High-Energy Shock Waves", "MH_TH": "NLM (1986)", "ST": "T061", "AN": "litholysis (dissolving calculi by acid) is disease /ther, not LITHOTRIPSY", "PI": "Ultrasonic Therapy (1966-1985)", "MS": "The destruction of a calculus of the kidney, ureter, bladder, or gallbladder by physical forces, including crushing with a lithotriptor through a catheter. Focused percutaneous ultrasound and focused hydraulic shock waves may be used without surgery. Lithotripsy does not include the dissolving of stones by acids or litholysis. Lithotripsy by laser is LITHOTRIPSY, LASER.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19850607", "DC": "1", "DX": "19860101", "UI": "D008096"}, {"RECTYPE": "D", "MH": "Lithuania", "AQ": "EH EP", "MN": "Z01.542.248.136.580", "MH_TH": "NLM (1993)", "ST": "T083", "MS": "Country in eastern Europe, bordering the Baltic Sea, between Latvia and Russia, west of Belarus. The capital is Vilnius.", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008097"}, {"RECTYPE": "D", "MH": "Litter Size", "AQ": "DE GE IM PH RE", "ENTRY": "Sizes, Litter", "MN": "G08.686.784.769.498.300", "FX": "Viviparity, Nonmammalian", "MH_TH": "NLM (1975)", "ST": "T081", "AN": "viviparous animals only: see also note under TWINS; for oviparous or ovoviviparous animals use CLUTCH SIZE; relation to PREGNANCY: Manual 28.16.4", "PI": "Animals, Newborn (1966-1974)", "MS": "The number of offspring produced at one birth by a viviparous animal.", "PM": "76; was see under ANIMALS, NEWBORN 1975", "HN": "76(75); was see under ANIMALS, NEWBORN 1975", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19760101", "UI": "D008098"}, {"RECTYPE": "D", "MH": "Liver", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Livers|T023|NON|EQV|BIOETHICS (1983)|931201|abcdef", "MN": "A03.620", "FX": "Hepatectomy", "EC": "transplantation:Liver Transplantation", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at HEPAT-", "MS": "A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.", "PM": "/cytology was LIVER CYTOLOGY 1964-65; /enzymology was LIVER ENZYMOLOGY 1964-65; /physiology was LIVER FUNCTION 1964-65", "HN": "/cytology was LIVER CYTOLOGY 1964-65; /enzymology was LIVER ENZYMOLOGY 1964-65; /physiology was LIVER FUNCTION 1964-65", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008099"}, {"RECTYPE": "D", "MH": "Liver Abscess", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Abscess, Hepatic|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Liver Abscesses", "MN": "C06.552.597", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific organism infection term (IM); LIVER ABSCESS, AMEBIC and LIVER ABSCESS, PYOGENIC are also available", "MS": "Solitary or multiple collections of PUS within the liver as a result of infection by bacteria, protozoa, or other agents.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008100"}, {"RECTYPE": "D", "MH": "Liver Abscess, Amebic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Hepatic Entamoebiasis|T047|NON|NRW|NLM (1992)|910205|abcdef", "ENTRY": "Liver Abscesses, Amoebic", "MN": "C06.552.664.642", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific organism (IM)", "MS": "Single or multiple areas of PUS due to infection by any ameboid protozoa (AMEBIASIS). A common form is caused by the ingestion of ENTAMOEBA HISTOLYTICA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008101"}, {"RECTYPE": "D", "MH": "Liver Circulation", "DE": "LIVER CIRC", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Hepatic Circulation|T042|NON|EQV|NLM (2004)|030514|abcdef", "ENTRY": "Circulation, Hepatic", "MN": "G09.330.100.881.552", "FX": "Portal System", "MH_TH": "NLM (1964)", "ST": "T042", "AN": "consider also LIVER /blood supply & ENTEROHEPATIC CIRCULATION ", "MS": "The circulation of BLOOD through the LIVER.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D008102"}, {"RECTYPE": "D", "MH": "Liver Cirrhosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Liver Fibrosis|T033|T047|NON|REL|UNK (19XX)|860325|abbcdef", "ENTRY": "Cirrhosis, Hepatic", "MN": "C23.550.355.412", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.", "OL": "use LIVER CIRRHOSIS to search LIVER CIRRHOSIS, POSTNECROTIC 1966-77", "PM": "LIVER CIRRHOSIS, POSTNECROTIC was heading 1963-77", "HN": "LIVER CIRRHOSIS, POSTNECROTIC was heading 1963-77", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008103"}, {"RECTYPE": "D", "MH": "Liver Cirrhosis, Alcoholic", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Alcoholic Cirrhosis|T047|NON|EQV|UNK (19XX)|770329|abcdef", "ENTRY": "Alcoholic Liver Cirrhosis", "MN": "C25.775.100.087.645.550", "MH_TH": "NLM (1978)", "ST": "T047", "PI": "Liver Cirrhosis (1966-1977)", "MS": "FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19770329", "DC": "1", "DX": "19780101", "UI": "D008104"}, {"RECTYPE": "D", "MH": "Liver Cirrhosis, Biliary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Primary Biliary Cholangitis|T047|NON|NRW|NLM (2020)|190618|abcdef", "ENTRY": "Secondary Biliary Cholangitides", "MN": "C23.550.355.412.400", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.", "OL": "use LIVER CIRRHOSIS, BILIARY to search LIVER CIRRHOSIS, OBSTRUCTIVE 1966-77", "PM": "78; was LIVER CIRRHOSIS, OBSTRUCTIVE 1963-77", "HN": "78; was LIVER CIRRHOSIS, OBSTRUCTIVE 1963-77", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D008105"}, {"RECTYPE": "D", "MH": "Liver Cirrhosis, Experimental", "DE": "LIVER CIRRHOSIS EXPER", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hepatic Cirrhosis, Experimental|T050|NON|EQV|NLM (2005)|030912|HEPATIC CIRRHOSES EXPER|abcdefv", "ENTRY": "Experimental Hepatic Cirrhosis", "MN": "E05.598.500.468", "MH_TH": "NLM (1966)", "ST": "T050", "MS": "Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008106"}, {"RECTYPE": "D", "MH": "Liver Diseases", "DE": "LIVER DIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Liver Dysfunctions", "MN": "C06.552", "EC": "chemically induced:Chemical and Drug Induced Liver Injury", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes of the LIVER.", "PM": "ACUTE YELLOW ATROPHY was heading 1963-96", "HN": "ACUTE YELLOW ATROPHY was heading 1963-96", "CATSH": "CAT LIST", "MR": "20160718", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008107"}, {"RECTYPE": "D", "MH": "Liver Diseases, Alcoholic", "DE": "LIVER DIS ALCOHOLIC", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Alcoholic Liver Diseases|T047|NON|EQV|UNK (19XX)|780126|ALCOHOLIC LIVER DIS|abcdefv", "ENTRY": "Liver Disease, Alcoholic", "MN": "C25.775.100.087.645", "MH_TH": "NLM (1979)", "ST": "T047", "PI": "specific liver disease", "MS": "Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19780126", "DC": "1", "DX": "19790101", "UI": "D008108"}, {"RECTYPE": "D", "MH": "Liver Diseases, Parasitic", "DE": "LIVER DIS PARASITIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Parasitic Liver Diseases|T047|NON|EQV|NLM (1995)|940105|PARASITIC LIVER DIS|abcdefv", "ENTRY": "Parasitic Liver Disease", "MN": "C06.552.664", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific parasitic dis (IM) but note that also available are ECHINOCOCCOSIS, HEPATIC; FASCIOLIASIS & LIVER ABSCESS, AMEBIC", "MS": "Liver diseases caused by infections with PARASITES, such as tapeworms (CESTODA) and flukes (TREMATODA).", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008109"}, {"RECTYPE": "D", "MH": "Liver Extracts", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Extracts, Liver", "MN": "D20.777.351", "PA": "Hematinics", "MH_TH": "BAN (19XX)", "ST": "T123", "RN": "0", "MS": "Extracts of liver tissue containing uncharacterized specific factors with specific activities; a soluble thermostable fraction of mammalian liver is used in the treatment of pernicious anemia.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008110"}, {"RECTYPE": "D", "MH": "Liver Function Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Liver Function", "MN": "E01.370.372.460", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "NIM", "MS": "Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions.", "CATSH": "CAT LIST", "MR": "20150522", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008111"}, {"RECTYPE": "D", "MH": "Liver Glycogen", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hepatic Glycogen|T109|T123|NON|EQV|NLM (1996)|941103|abbcdef", "ENTRY": "Glycogen, Liver", "MN": "D09.698.365.388.518", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Glycogen stored in the liver. (Dorland, 28th ed)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008112"}, {"RECTYPE": "D", "MH": "Liver Neoplasms", "DE": "LIVER NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Liver Cancer|T191|NON|NRW|NLM (2000)|OMIM (2013)|991104|abcdeef", "ENTRY": "Neoplasm, Liver", "MN": "C06.552.697", "MH_TH": "NLM (1963)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM), including HEPATOMA (IM); LIVER NEOPLASMS, EXPERIMENTAL is available; be careful: do not confuse \"hepatic neopl\" with \"intrahepatic neopl\": \"intrahepatic neopl\" may refer to BILE DUCT NEOPLASMS with regard to BILE DUCTS, INTRAHEPATIC, not LIVER NEOPLASMS", "MS": "Tumors or cancer of the LIVER.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008113"}, {"RECTYPE": "D", "MH": "Liver Neoplasms, Experimental", "DE": "LIVER NEOPL EXPER", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "PRINT ENTRY": "Hepatoma, Novikoff|T050|T191|EPO|NRW|UNK (19XX)|771206|abbcdef", "ENTRY": "Novikoff Hepatoma", "MN": "E05.598.500.496.750", "MH_TH": "NLM (1979)", "ST": "T191", "AN": "animal only", "PI": "Neoplasms, Experimental (1966-1978)", "MS": "Experimentally induced tumors of the LIVER.", "OL": "use LIVER NEOPLASMS, EXPERIMENTAL to search HEPATOMA, EXPERIMENTAL 1979-84", "PM": "85; was HEPATOMA, EXPERIMENTAL 1979-84", "HN": "85; was HEPATOMA, EXPERIMENTAL 1979-84", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19771206", "DC": "1", "DX": "19790101", "UI": "D008114"}, {"RECTYPE": "D", "MH": "Liver Regeneration", "AQ": "DE ES GE IM PH RE", "ENTRY": "Regenerations, Liver", "MN": "G16.762.468", "MH_TH": "NLM (1964)", "ST": "T042", "AN": "IM", "MS": "Repair or renewal of hepatic tissue.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D008115"}, {"RECTYPE": "D", "MH": "Lizards", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Lizard", "MN": "B01.050.150.900.833.393", "MH_TH": "NLM (1968)", "ST": "T014", "AN": "includes IGUANAS, geckos, chameleons, Gila monsters", "PI": "Reptiles (1966-1967)", "MS": "Reptiles within the order Squamata that generally possess limbs, moveable EYELIDS, and EXTERNAL EAR openings, although there are some species which lack one or more of these structures.", "PM": "68", "HN": "68", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008116"}, {"RECTYPE": "D", "MH": "Loa", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Loa loa|T204|NON|NRW|UNK (19XX)|850319|abcdef", "ENTRY": "Loas", "MN": "B01.050.500.500.294.400.937.463.410", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid7208", "RR": "txid7209", "MS": "A genus of parasitic nematodes found throughout the rain-forest areas of the Sudan and the basin of the Congo. L. loa inhabits the subcutaneous tissues, which it traverses freely.", "OL": "use LOA to search LOA LOA 1979-85", "PM": "LOA LOA was see under LOA 1979-85", "HN": "LOA LOA was see under LOA 1979-85", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008117"}, {"RECTYPE": "D", "MH": "Loiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Loaiasis|T047|NON|EQV|UNK (19XX)|880519|abcdef", "ENTRY": "Loiases", "MN": "C01.610.335.508.700.750.361.518", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "/drug ther: consider FILARICIDES", "MS": "A parasitic infection caused by the nematode Loa loa. The vector in the transmission of this infection is the horsefly (Tabanus) or the deerfly or mango fly (Chrysops). The larvae may be seen just beneath the skin or passing through the conjunctiva. Eye lesions are not uncommon. The disease is generally mild and painless.", "OL": "(75); use LOIASIS to search LOAIASIS 1975-88; search FILARIASIS 1967-74", "PM": "91; was see under FILARIASIS 1989-90; was LOAIASIS see under FILARIASIS 1975-88", "HN": "91(75); was see under FILARIASIS 1989-90; was LOAIASIS see under FILARIASIS 1975-88", "CATSH": "CAT LIST", "MR": "20200128", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008118"}, {"RECTYPE": "D", "MH": "Lobbying", "ENTRY": "Lobbyings", "MN": "I01.738.610", "MH_TH": "NLM (1982)", "ST": "T057", "PI": "Politics (1968-1981)", "MS": "A process whereby representatives of a particular interest group attempt to influence governmental decision makers to accept the policy desires of the lobbying organization.", "PM": "91; was see under POLITICS 1982-90", "HN": "91(82); was see under POLITICS 1982-90", "MR": "19900413", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D008119"}, {"RECTYPE": "D", "MH": "Lobeline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Lobeline", "MN": "D03.383.621.418", "PA": "Respiratory System Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Ethanone, 2-(6-(2-hydroxy-2-phenylethyl)-1-methyl-2-piperidinyl)-1-phenyl-, (2R-(2alpha,6alpha(S*)))-", "RN": "D0P25S3P81", "RR": "90-69-7 (Lobeline)", "AN": "/biosyn permitted if by plant", "MS": "An alkaloid that has actions similar to NICOTINE on nicotinic cholinergic receptors but is less potent. It has been proposed for a variety of therapeutic uses including in respiratory disorders, peripheral vascular disorders, insomnia, and smoking cessation.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008120"}, {"RECTYPE": "D", "MH": "Nephropidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Lobsters, Clawed|T204|NON|EQV|NLM (2003)|011024|abcdef", "ENTRY": "Lobster, Clawed", "MN": "B01.050.500.131.365.190.550", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6704", "RR": "txid6705", "AN": "as animal & food; unspecified lobster as food probably goes here and is coord IM with SHELLFISH (IM)", "PI": "Crustacea (1966-1971)", "MS": "Family of large marine CRUSTACEA, in the order DECAPODA. These are called clawed lobsters because they bear pincers on the first three pairs of legs. The American lobster and Cape lobster in the genus Homarus are commonly used for food.", "PM": "2003; see LOBSTERS 1972-2002", "HN": "2003 (1972)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008121"}, {"RECTYPE": "D", "MH": "Local Area Networks", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "PRINT ENTRY": "LAN|T073|ABB|EQV|NLM (1991)|900502|abcdef", "ENTRY": "Networks, Local Area", "MN": "L01.224.230.110.600", "MH_TH": "NLM (1987)", "ST": "T073", "AN": "IM", "MS": "Communications networks connecting various hardware devices together within or between buildings by means of a continuous cable or voice data telephone system.", "PM": "91; was see under COMPUTER SYSTEMS 1987-90", "HN": "91(87); was see under COMPUTER SYSTEMS 1987-90", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19910101", "UI": "D008122"}, {"RECTYPE": "D", "MH": "Location Directories and Signs", "DE": "LOCATION DIRECTORIES SIGNS", "AQ": "CL SN ST", "PRINT ENTRY": "Signs and Location Directories|T073|NON|EQV|UNK (19XX)|810302|SIGNS LOCATION DIRECTORIES|abcdefv", "ENTRY": "Signs, Location", "MN": "J01.086.339.400", "MH_TH": "NLM (1977)", "ST": "T073", "MS": "Directory signs or listings of designated areas within or without a facility.", "OL": "use LOCATION DIRECTORIES AND SIGNS to search LOCATION DIRECTORIES Aug 1977-81", "PM": "91; was see under FACILITY DESIGN AND CONSTRUCTION 1982-90; was LOCATION DIRECTORIES see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-81", "HN": "91(82); was see under FACILITY DESIGN AND CONSTRUCTION 1982-90; was LOCATION DIRECTORIES see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-81", "MR": "19920325", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D008123"}, {"RECTYPE": "D", "MH": "Locomotion", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Locomotor Activity|T040|NON|EQV|NLM (1998)|960731|abcdef", "ENTRY": "Locomotor Activities", "MN": "G11.427.410.568", "FX": "Gait", "MH_TH": "NLM (1966)", "ST": "T040", "AN": "differentiate LOCOMOTION (getting from one point to another) from GAIT (manner or style of walking), MOVEMENT (without necessarily locomotion), MOTOR ACTIVITY (movement associated with behavior), WALKING (purposeful locomotion to get somewhere or for recreation, fitness or competition); CELL LOCOMOTION see CELL MOVEMENT is available", "MS": "Movement or the ability to move from one place or another. It can refer to humans, vertebrate or invertebrate animals, and microorganisms.", "CATSH": "CAT LIST", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008124"}, {"RECTYPE": "D", "MH": "Locus Coeruleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Locus Caeruleus Complex|T023|NON|BRD|NLM (2022)|200918|abcdef", "ENTRY": "Pontis, Nucleus Pigmentosus", "MN": "A08.186.211.132.810.428.600.650.437", "MH_TH": "NLM (1978)", "ST": "T023", "PI": "Pons (1966-1977)", "MS": "Bluish-colored region in the superior angle of the FOURTH VENTRICLE floor, corresponding to melanin-like pigmented nerve cells which lie lateral to the PERIAQUEDUCTAL GRAY.", "PM": "78", "HN": "78", "MR": "20210305", "DA": "19770411", "DC": "1", "DX": "19780101", "UI": "D008125"}, {"RECTYPE": "D", "MH": "Lod Score", "ENTRY": "Scores, Lod", "MN": "G05.348.750", "MH_TH": "NLM (1981)", "ST": "T081", "PI": "Linkage (Genetics) (1970-1980)", "MS": "The total relative probability, expressed on a logarithmic scale, that a linkage relationship exists among selected loci. Lod is an acronym for \"logarithmic odds.\"", "PM": "91; was see under LINKAGE (GENETICS) 1981-90", "HN": "91(81); was see under LINKAGE (GENETICS) 1981-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19800514", "DC": "1", "DX": "19910101", "UI": "D008126"}, {"RECTYPE": "D", "MH": "Lofepramine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lopramine|T109|T121|NON|EQV|UNK (19XX)|780320|abbcdef", "ENTRY": "Hydrochloride, Lofepramine", "MN": "D03.633.300.240.520", "PA": "Antidepressive Agents, Tricyclic", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Ethanone, 1-(4-chlorophenyl)-2-((3-(10,11-dihydro-5H-dibenz(b,f)azepin-5-yl)propyl)methylamino)-", "RN": "OCA4JT7PAW", "RR": "Z24K96F991", "PI": "Dibenzazepines (1969-1978)", "MS": "A psychotropic IMIPRAMINE derivative that acts as a tricyclic antidepressant and possesses few anticholinergic properties. It is metabolized to DESIPRAMINE.", "PM": "91; was see under DIBENZAZEPINES 1979-90", "HN": "91(79); was see under DIBENZAZEPINES 1979-90", "MR": "20170524", "DA": "19780320", "DC": "1", "DX": "19910101", "UI": "D008127"}, {"RECTYPE": "D", "MH": "Logic", "ENTRY": "Logics", "MN": "K01.752.448", "MH_TH": "NLM (1966)", "ST": "T078", "MS": "The science that investigates the principles governing correct or reliable inference and deals with the canons and criteria of validity in thought and demonstration. This system of reasoning is applicable to any branch of knowledge or study. (Random House Unabridged Dictionary, 2d ed & Sippl, Computer Dictionary, 4th ed)", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008128"}, {"RECTYPE": "D", "MH": "Lolium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ryegrass|T002|NON|EQV|UNK (19XX)|850503|abcdef", "ENTRY": "Grass, Rye", "MN": "B01.875.800.575.912.250.822.500", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid4520", "AN": "do not confuse entry term RYE GRASS with RYE see SECALE", "PI": "Rye (1966-1985)", "MS": "Common member of the Gramineae family used as cattle FODDER. It harbors several fungi and other parasites toxic to livestock and people and produces allergenic compounds, especially in its pollen. The most commonly seen varieties are L. perenne, L. multiflorum, and L. rigidum.", "PM": "91; was see under GRASSES 1986-90", "HN": "91(86); was see under GRASSES 1986-90", "MR": "20210630", "DA": "19850503", "DC": "1", "DX": "19910101", "UI": "D008129"}, {"RECTYPE": "D", "MH": "Lomustine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "CCNU|T109|T121|TRD|NRW|UNK (19XX)|741111|abbcdef", "ENTRY": "NSC79037", "MN": "D02.654.692.440", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "USAN (1972)", "ST": "T121", "N1": "Urea, N-(2-chloroethyl)-N'-cyclohexyl-N-nitroso-", "RN": "7BRF0Z81KG", "RR": "13010-47-4 (Lomustine)", "PI": "Nitrosourea Compounds (1972-1974)", "MS": "An alkylating agent of value against both hematologic malignancies and solid tumors.", "PM": "84; was see under NITROSOUREA COMPOUNDS 1975-83", "HN": "84(75); was see under NITROSOUREA COMPOUNDS 1975-83", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19840101", "UI": "D008130"}, {"RECTYPE": "D", "MH": "London", "AQ": "EH EP", "MN": "Z01.542.363.300.553", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "early & modern LONDON", "MS": "The capital of the United Kingdom. It is located in England.", "MR": "20161222", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008131"}, {"RECTYPE": "D", "MH": "Loneliness", "AQ": "PX", "PRINT ENTRY": "Homesickness|T048|NON|NRW|NLM (1963)|970618|abcdef", "MN": "I01.880.853.748.435", "MH_TH": "NLM (1975)", "ST": "T041", "MS": "The state of feeling sad or dejected as a result of lack of companionship or being separated from others.", "PM": "91; was see under SOCIAL ISOLATION 1973-90; for HOMESICKNESS see ANXIETY, SEPARATION 1975-97; see EMOTIONS 1963-74", "HN": "91(73); see SOCIAL ISOLATION 1973-90; HOMESICKNESS see ANXIETY, SEPARATION 1975-78; see EMOTIONS 1963-74", "CATSH": "CAT LIST", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008132"}, {"RECTYPE": "D", "MH": "Long QT Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Electrocardiogram QT Prolonged|T033|NON|REL|NLM (2020)|190507|abcdef", "MN": "C23.550.073.547", "MH_TH": "NLM (1986)", "ST": "T047", "PI": "Tachycardia (1966-1985)", "MS": "A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.", "PM": "1991; see ARRHYTHMIA 1986-1990", "HN": "1991(1986); use ARRHYTHMIA 1986-1990", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19850311", "DC": "1", "DX": "19910101", "UI": "D008133"}, {"RECTYPE": "D", "MH": "Long-Term Care", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "ENTRY": "Long Term Care", "MN": "N02.421.585.476", "FX": "Insurance, Long-Term Care", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "NIM", "PI": "Chronic Disease (1966-1967)", "MS": "Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care.", "OL": "use LONG-TERM CARE to search LONG TERM CARE 1968-91", "PM": "92; was LONG TERM CARE 1968-91", "HN": "92; was LONG TERM CARE 1968-91", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008134"}, {"RECTYPE": "D", "MH": "Long-Acting Thyroid Stimulator", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Thyrotropin Receptor Autoantibody|T116|T129|NON|EQV|NLM (2023)|210924|abbcdef", "ENTRY": "Thyroid Stimulator, Long Acting", "MN": "D12.776.377.715.548.114.619.393.550", "PA": "Immunologic Factors", "FX": "Receptors, Thyroid Hormone", "MH_TH": "NLM (1965)", "ST": "T129", "RN": "9034-48-4", "MS": "An immunoglobulin G, often found in the blood of hyperthyroid individuals. It stimulates the thyroid for a longer duration than does thyrotoxin and may cause hyperthyroidism in newborns due to placental transmission.", "PM": "68", "HN": "68(65)", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008135"}, {"RECTYPE": "D", "MH": "Longevity", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Length of Life|T079|NON|EQV|POPLINE (1984)|890501|abcdef", "ENTRY": "Lifespans", "MN": "G07.540", "FX": "Life Expectancy", "MH_TH": "NLM (1966)", "ST": "T079", "AN": "human & animal; consider also LIFE EXPECTANCY", "MS": "The normal length of time of an organism's life.", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008136"}, {"RECTYPE": "D", "MH": "Longitudinal Studies", "ENTRY": "Tuskegee Syphilis Studies", "MN": "N06.850.520.450.500.750.500", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "IM general only; coordinate NIM with specific disease; add geographic term if pertinent; CATALOGER: Coordinate specific studies with NAF entry  if applicable ", "PI": "Epidemiologic Methods (1966-1974)", "MS": "Studies in which variables relating to an individual or group of individuals are assessed over a period of time.", "PM": "79; was see under EPIDEMIOLOGIC METHODS 1975-78", "HN": "79(75); was see under EPIDEMIOLOGIC METHODS 1975-78", "CATSH": "CAT LIST", "MR": "20220715", "DA": "19741119", "DC": "1", "DX": "19790101", "UI": "D008137"}, {"RECTYPE": "D", "MH": "Loop of Henle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Henle Loop", "MN": "A05.810.453.736.560.610", "MH_TH": "NLM (1973)", "ST": "T023", "PI": "Kidney Tubules (1966-1972)", "MS": "The U-shaped portion of the renal tubule in the KIDNEY MEDULLA, consisting of a descending limb and an ascending limb. It is situated between the PROXIMAL KIDNEY TUBULE and the DISTAL KIDNEY TUBULE.", "PM": "91; was see under KIDNEY TUBULES 1973-90", "HN": "91(73); was see under KIDNEY TUBULES 1973-90", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008138"}, {"RECTYPE": "D", "MH": "Loperamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R18553", "MN": "D03.383.621.440", "PA": "Antidiarrheals", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-", "RN": "6X9OC3H4II", "RR": "77TI35393C", "PI": "Piperidines (1974-1975)", "MS": "One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.", "PM": "91; was see under PIPERIDINES 1976-90", "HN": "91(76); was see under PIPERIDINES 1976-90", "MR": "20160531", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D008139"}, {"RECTYPE": "D", "MH": "Lorazepam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Wyeth, Orfidal", "MN": "D03.633.100.079.080.070.450", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (1969)", "ST": "T121", "N1": "2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-", "RN": "O26FZP769L", "RR": "846-49-1 (Lorazepam)", "PI": "Chlorobenzenes (1974)", "MS": "A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.", "PM": "84; was see under BENZODIAZEPINE TRANQUILIZERS 1975-83", "HN": "84(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-83", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19840101", "UI": "D008140"}, {"RECTYPE": "D", "MH": "Lordosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C05.116.900.800.750", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "a type of spinal curvature; disease only; for normal lordosis index under SPINE; for lordosis in animal sex exper use POSTURE + SEXUAL BEHAVIOR, ANIMAL", "CATSH": "CAT LIST", "MR": "20060707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008141"}, {"RECTYPE": "D", "MH": "Lorisidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Slow Lorises|T015|NON|NRW|NLM (2020)|190401|abcdef", "ENTRY": "Slow Loris", "MN": "B01.050.150.900.649.313.988.700.572", "MH_TH": "NLM (1981)", "ST": "T015", "RN": "txid9461", "RR": "txid9472", "PI": "Prosimii (1975-1980)", "MS": "A family of Primates of the suborder Strepsirhini containing four genera. The family is distributed in parts of Africa and Southeast Asian. The four genera are: Arctocebus (angwantibos) and Perodicticus (pottos) in the subfamily Perodicticinae and Loris (slender lorises) and Nycticebus (slow lorises) in the subfamily Lorisinae. All are arboreal and nocturnal. Genus GALAGO is now classified in the family GALAGIDAE.", "PM": "81; NYCTICEBUS was NYCETIBUS 1981-92", "HN": "81; NYCTICEBUS was NYCETIBUS 1981-92", "MR": "20200902", "DA": "19800507", "DC": "1", "DX": "19810101", "UI": "D008142"}, {"RECTYPE": "D", "MH": "Loudness Perception", "AQ": "CL DE ES PH RE", "ENTRY": "Perceptions, Loudness", "MN": "G07.888.125.576", "MH_TH": "NLM (1979)", "ST": "T041", "PI": "Auditory Threshold (1968-1978)", "MS": "The perceived attribute of a sound which corresponds to the physical attribute of intensity.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D008144"}, {"RECTYPE": "D", "MH": "Louisiana", "AQ": "EH EP", "MN": "Z01.107.567.875.750.480", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded by Arkansas on the north, by Mississippi on the east, the Gulf of Mexico on the south and Texas on the west.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008145"}, {"RECTYPE": "D", "MH": "Louping Ill", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Ill, Louping", "MN": "C22.836.435", "MH_TH": "NLM (1971)", "ST": "T047", "AN": "caused by a tick-transm flavivirus; usually animal, generally sheep; \"louping\" is Scottish dialect for \"leaping\" with ref to musc manifest of infected animal; check tag ANIMALS; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES", "PI": "Sheep Diseases (1966-1970)", "MS": "An acute tick-borne arbovirus infection causing meningoencephalomyelitis of sheep.", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D008146"}, {"RECTYPE": "D", "MH": "Lovastatin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mevinolin|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|870504|abbcdeef", "ENTRY": "alpha-Isomer Lovastatin, 1", "MN": "D04.615.638.400", "PA": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-", "RN": "9LHU78OQFD", "RR": "79952-44-6 ((1 alpha(S*))-isomer)", "PI": "Naphthalenes (1966-1987)", "MS": "A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver.", "PM": "88; MONACOLIN K was indexed under NAPHTHALENES 1981-98 & ANTIBIOTICS 1980", "HN": "88; for MONACOLIN K use LOVASTATIN (NM) 1980-98", "MR": "20150623", "DA": "19870504", "DC": "1", "DX": "19880101", "UI": "D008148"}, {"RECTYPE": "D", "MH": "Love", "ENTRY": "Loves", "MN": "F01.470.734", "FX": "Courtship", "MH_TH": "BIOETHICS (1974)", "ST": "T041", "MS": "Affection; in psychiatry commonly refers to pleasure, particularly as it applies to gratifying experiences between individuals.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008149"}, {"RECTYPE": "D", "MH": "Lower Body Negative Pressure", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "LBNP|T060|T061|T062|ABB|EQV|NLM (1998)|970203|abbbcdef", "MN": "E02.278.500", "MH_TH": "NLM (1980)", "ST": "T062", "AN": "\"external decompression applied to the lower body\"; used in physiol research & ther", "PI": "Pressure (1966-1979)", "MS": "External decompression applied to the lower body. It is used to study orthostatic intolerance and the effects of gravitation and acceleration, to produce simulated hemorrhage in physiologic research, to assess cardiovascular function, and to reduce abdominal stress during childbirth.", "PM": "91; was see under DECOMPRESSION 1980-90", "HN": "91(80); was see under DECOMPRESSION 1980-90", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19790308", "DC": "1", "DX": "19910101", "UI": "D008150"}, {"RECTYPE": "D", "MH": "Lown-Ganong-Levine Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Short PR-Normal QRS Complex Syndrome|T047|NON|EQV|UNK (19XX)|850311|abcdef", "ENTRY": "Syndrome, Lown-Ganong-Levine", "MN": "C14.280.123.750.560", "MH_TH": "NLM (1986)", "ST": "T047", "PI": "Tachycardia, Paroxysmal (1966-1985)", "MS": "A form of ventricular pre-excitation characterized by a short PR interval and a normal QRS complex. In this syndrome, the atrial impulse conducts via the JAMES FIBERS which connect the atrium to BUNDLE OF HIS bypassing the upper ATRIOVENTRICULAR NODE. HEART VENTRICLES are depolarized normally through the His-Purkinje system.", "PM": "91; was see under PRE-EXCITATION SYNDROMES 1986-90", "HN": "91(86); was see under PRE-EXCITATION SYNDROMES 1986-90", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19850311", "DC": "1", "DX": "19910101", "UI": "D008151"}, {"RECTYPE": "D", "MH": "Loxapine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxilapine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Succinate, Loxapine", "MN": "D03.633.300.347.500", "PA": "Dopamine Antagonists", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-", "RN": "LER583670J", "RR": "X59SG0MRYU", "PI": "Piperazines (1971-1974)", "MS": "An antipsychotic agent used in SCHIZOPHRENIA.", "PM": "91; was see under DIBENZOXAZEPINES 1975-90", "HN": "91(75); was see under DIBENZOXAZEPINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008152"}, {"RECTYPE": "D", "MH": "Lubrication", "AQ": "AE MT ST", "ENTRY": "Lubrications", "MN": "E05.830.583", "MH_TH": "NLM (1964)", "ST": "T052", "MS": "The application of LUBRICANTS to diminish FRICTION between two surfaces.", "PM": "91; was see under PHYSICS 1964-90", "HN": "91(64); was see under PHYSICS 1964-90", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008153"}, {"RECTYPE": "D", "MH": "Lucanthone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tixantone|T109|T121|TRD|NRW|UNK (19XX)|770317|abbcdef", "MN": "D03.633.300.953.852.388", "PA": "Schistosomicides", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "9H-Thioxanthen-9-one, 1-((2-(diethylamino)ethyl)amino)-4-methyl-", "RN": "FC6D57000M", "RR": "918K9N56QZ", "MS": "One of the SCHISTOSOMICIDES, it has been replaced largely by HYCANTHONE and more recently PRAZIQUANTEL. (From Martindale The Extrapharmacopoeia, 30th ed., p46)", "OL": "use LUCANTHONE to search MIRACIL 1966", "PM": "67; was MIRACIL 1963-66", "HN": "67; was MIRACIL 1963-66", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008154"}, {"RECTYPE": "D", "MH": "Lucensomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lucimycin|T109|T195|NON|EQV|FDA SRS (2015)|INN (19XX)|USAN (19XX)|741111|abbcdeeef", "ENTRY": "Etruscomycin|T109|T195|TRD|NRW|UNK (19XX)|801120|abbcdef", "MN": "D02.540.505.450", "PA": "Antifungal Agents", "MH_TH": "NLM (1975)", "ST": "T195", "N1": "Lucensomycin", "RN": "3K1B4B63D0", "RR": "13058-67-8", "PI": "Glycosides (1972-1974)", "MS": "A macrolide antibiotic isolated from cultures of Streptomyces lucensis.", "PM": "91; was see under ANTIBIOTICS, MACROLIDE 1990-90; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89", "HN": "91(75); was see under ANTIBIOTICS, MACROLIDE 1990-90; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89", "MR": "20150527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008155"}, {"RECTYPE": "D", "MH": "Luciferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Luciferase|T116|T126|T130|NON|EQV|NLM (1963)|990101|abbbcdef", "MN": "D12.776.532.510", "PA": "Luminescent Agents", "MH_TH": "NLM (2005)", "ST": "T130", "RN": "EC 1.13.12.-", "AN": "general; prefer specifics; note species specific luciferases in SCR", "MS": "Enzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates.", "PM": "2005; see LUCIFERASE 1963-2004", "HN": "2005(1963)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008156"}, {"RECTYPE": "D", "MH": "Ludwig's Angina", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Submandibular Space Infections", "MN": "C07.465.433", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Severe cellulitis of the submaxillary space with secondary involvement of the perimandibular spaces. It usually results from infection in the lower molar area or from an infection following a penetrating injury to the MOUTH FLOOR.", "CATSH": "CAT LIST", "MR": "20190528", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008158"}, {"RECTYPE": "D", "MH": "Lumbar Vertebrae", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vertebrae, Lumbar", "MN": "A02.835.232.834.519", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "VERTEBRAE in the region of the lower BACK below the THORACIC VERTEBRAE and above the SACRAL VERTEBRAE.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008159"}, {"RECTYPE": "D", "MH": "Lumbosacral Plexus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Sacral Plexus|T023|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Plexus, Sacral", "MN": "A08.800.800.720.450", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "a network of spinal nerves", "MS": "The lumbar and sacral plexuses taken together. The fibers of the lumbosacral plexus originate in the lumbar and upper sacral spinal cord (L1 to S3) and innervate the lower extremities.", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008160"}, {"RECTYPE": "D", "MH": "Lumbosacral Region", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "Lumbar Region|T029|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Regions, Lumbosacral", "MN": "A01.923.176.519", "FX": "Low Back Pain", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "NIM when merely locational", "MS": "Region of the back including the LUMBAR VERTEBRAE, SACRUM, and nearby structures.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008161"}, {"RECTYPE": "D", "MH": "Lumicolchicines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "gamma Lumicolchicine", "MN": "D03.132.225.500", "MH_TH": "NLM (1980)", "ST": "T109", "RN": "0", "AN": "/biosyn permitted if by plant", "PI": "Colchicine (1966-1974) /AA (1975-1979)", "MS": "Three, alpha, beta, and gamma isomers of ultraviolet degradation products of colchicine that lack many of the physiological actions of the parent; used as experimental control for colchicine actions.", "PM": "91; was see under COLCHICINE 1980-90", "HN": "91(80); was see under COLCHICINE 1980-90", "MR": "20000622", "DA": "19790302", "DC": "1", "DX": "19910101", "UI": "D008162"}, {"RECTYPE": "D", "MH": "Luminescent Measurements", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Techniques, Luminescent", "MN": "E05.196.712.516", "MH_TH": "NLM (2005)", "ST": "T081", "MS": "Techniques used for determining the values of photometric parameters of light resulting from LUMINESCENCE.", "PM": "2005; see LUMINESCENCE 1963-2004; for CHEMILUMINESCENT MEASUREMENTS see CHEMILUMINESCENT MEASUREMENTS 2005-2011, see CHEMILUMINESCENCE 1993-2004", "HN": "2005(1963)", "MR": "20110701", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D008163"}, {"RECTYPE": "D", "MH": "Luminescent Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Photoproteins|T116|T123|NON|EQV|UNK (19XX)|780309|abbcdef", "ENTRY": "Proteins, Luminescent", "MN": "D12.776.532", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Proteins (1966-1978)", "MS": "Proteins which are involved in the phenomenon of light emission in living systems. Included are the \"enzymatic\" and \"non-enzymatic\" types of system with or without the presence of oxygen or co-factors.", "PM": "79; AEQUORIN was see under PROTEINS 1975-78", "HN": "79", "MR": "20200527", "DA": "19780309", "DC": "1", "DX": "19790101", "UI": "D008164"}, {"RECTYPE": "D", "MH": "Luminol", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D03.383.710.350", "PA": "Luminescent Agents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "1,4-Phthalazinedione, 5-amino-2,3-dihydro-", "RN": "5EXP385Q4F", "RR": "521-31-3 (Luminol)", "AN": "do not confuse with Luminal, a brand of PHENOBARBITAL", "PI": "Pyridazines (1968-1974)", "MS": "5-Amino-2,3-dihydro-1,4-phthalazinedione. Substance that emits light on oxidation. It is used in chemical determinations.", "PM": "91; was see under PYRIDAZINES 1975-90", "HN": "91(75); was see under PYRIDAZINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008165"}, {"RECTYPE": "D", "MH": "Lumpy Skin Disease", "DE": "LUMPY SKIN DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Skin Diseases, Lumpy", "MN": "C22.196.497", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "caused by a poxvirus; usually animal; check tag ANIMALS; don't forget also CATTLE (NIM) but do not index under CATTLE DISEASES", "PI": "Virus Diseases (1966-1969)", "MS": "A poxvirus infection of cattle characterized by the appearance of nodules on all parts of the skin.", "PM": "91,70; was see under POXVIRUS INFECTIONS 1990", "HN": "91(90)70; was see under POXVIRUS INFECTIONS 1990", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D008166"}, {"RECTYPE": "D", "MH": "Lumpy skin disease virus", "DE": "LUMPY SKIN DIS VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Neethling Virus|T005|EPO|EQV|UNK (19XX)|741211|abcdef", "MN": "B04.280.650.160.150.500", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid59509", "MS": "A species of CAPRIPOXVIRUS causing a cattle disease occurring in Africa.", "PM": "91; was see under POXVIRIDAE 1981-90; was see under POXVIRUSES 1975-80", "HN": "91(75); was see under POXVIRIDAE 1981-90; was see under POXVIRUSES 1975-80", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D008167"}, {"RECTYPE": "D", "MH": "Lung", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Lungs", "MN": "A04.411", "FX": "Respiration", "EC": "transplantation:Lung Transplantation", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at PNEUMO- and PULMON-", "MS": "Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.", "MR": "20080709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008168"}, {"RECTYPE": "D", "MH": "Lung Abscess", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Abscess, Pulmonary|T047|NON|EQV|UNK (19XX)|740330|ABSCESS PULM|abcdefv", "ENTRY": "Lung Abscesses", "MN": "C08.730.407", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with precoordinated organism/infection term (IM); if unspecified bacterial abscess, do not coordinate with BACTERIAL INFECTIONS since most abscesses are bacterial", "MS": "Solitary or multiple collections of PUS within the lung parenchyma as a result of infection by bacteria, protozoa, or other agents.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008169"}, {"RECTYPE": "D", "MH": "Lung Compliance", "AQ": "DE ES GE IM PH RE", "ENTRY": "Lung Compliances", "MN": "G09.772.540", "FX": "Respiratory Mechanics", "MH_TH": "NLM (1968)", "ST": "T060", "AN": "usually NIM", "PI": "Lung/physiology (1966-1967)", "MS": "The capability of the LUNGS to distend under pressure as measured by pulmonary volume change per unit pressure change. While not a complete description of the pressure-volume properties of the lung, it is nevertheless useful in practice as a measure of the comparative stiffness of the lung. (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p562)", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D008170"}, {"RECTYPE": "D", "MH": "Lung Diseases", "DE": "LUNG DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulmonary Diseases|T047|NON|EQV|UNK (19XX)|740330|PULM DIS|abcdefv", "ENTRY": "Lung Disease", "MN": "C08.381", "FX": "Pulmonary Heart Disease", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes involving any part of the LUNG.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008171"}, {"RECTYPE": "D", "MH": "Lung Diseases, Fungal", "DE": "LUNG DIS FUNGAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pulmonary Fungal Infections|T047|NON|EQV|NLM (2009)|080327|abcdef", "ENTRY": "Pulmonary Fungal Infection", "MN": "C08.730.435", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific fungal disease (IM)", "MS": "Pulmonary diseases caused by fungal infections, usually through hematogenous spread.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008172"}, {"RECTYPE": "D", "MH": "Lung Diseases, Obstructive", "DE": "LUNG DIS OBSTRUCTIVE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pulmonary Diseases, Obstructive", "MN": "C08.381.495", "FX": "Airway Obstruction", "MH_TH": "NLM (1971)", "ST": "T047", "AN": "PULMONARY DISEASE, CHRONIC OBSTRUCTIVE and AIRWAY OBSTRUCTION are also available", "PI": "Lung Diseases (1966-1970)", "MS": "Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.", "PM": "72", "HN": "72(71)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008173"}, {"RECTYPE": "D", "MH": "Lung Diseases, Parasitic", "DE": "LUNG DIS PARASITIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Parasitic Lung Diseases|T047|NON|EQV|NLM (1995)|940105|PARASITIC LUNG DIS|abcdefv", "ENTRY": "Pulmonary Parasitic Infection", "MN": "C08.730.450", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific parasitic disease (IM); ECHINOCOCCOSIS, PULMONARY is also available", "MS": "Infections of the lungs with parasites, most commonly by parasitic worms (HELMINTHS).", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008174"}, {"RECTYPE": "D", "MH": "Lung Neoplasms", "DE": "LUNG NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pulmonary Neoplasms|T191|NON|EQV|UNK (19XX)|740330|PULM NEOPL|abcdefv", "ENTRY": "Pulmonary Neoplasm", "MN": "C08.785.520", "FX": "Carcinoma, Small Cell", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the LUNG.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008175"}, {"RECTYPE": "D", "MH": "Lung Volume Measurements", "AQ": "IS MT VE", "PRINT ENTRY": "Lung Volumes|T042|NON|REL|NLM (2021)|191122|abcdef", "ENTRY": "Volume, Lung", "MN": "E01.370.386.700.485", "MH_TH": "NLM (1975)", "ST": "T060", "AN": "NIM; see FORCED EXPIRATORY FLOW RATES & FORCED EXPIRATORY VOLUME for more cross-refs", "PI": "Respiratory Function Tests (1966-1974)", "MS": "Measurement of the amount of air that the lungs may contain at various points in the respiratory cycle.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D008176"}, {"RECTYPE": "D", "MH": "Lupus Vulgaris", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C17.800.838.765.820.470", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "do not confuse with LUPUS ERYTHEMATOSUS, CUTANEOUS", "MS": "A form of cutaneous tuberculosis. It is seen predominantly in women and typically involves the NASAL MUCOSA; BUCCAL MUCOSA; and conjunctival mucosa.", "PM": "2008; see LUPUS 1966-2007", "HN": "2008", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D008177"}, {"RECTYPE": "D", "MH": "Lupus Erythematosus, Cutaneous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lupus Erythematosus, Subacute Cutaneous|T047|NON|NRW|UNK (19XX)|860404|abcdef", "ENTRY": "Cutaneous Lupus Erythematosus", "MN": "C17.800.480", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "acute: consider LUPUS ERYTHEMATOSUS, SYSTEMIC if skin lesions are paramount", "PI": "Lupus Erythematosus, Systemic (1966-1986)", "MS": "A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19860404", "DC": "1", "DX": "19870101", "UI": "D008178"}, {"RECTYPE": "D", "MH": "Lupus Erythematosus, Discoid", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lupus Erythematosus, Cutaneous, Chronic|T047|NON|EQV|NLM (1993)|920423|abcdef", "ENTRY": "Discoid Lupus Erythematosus", "MN": "C17.800.480.479", "FX": "Panniculitis, Lupus Erythematosus", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with systemic or disseminated: discoid is usually in dermatol jrnls, systemic in arthritis or rheumat jrnls; when unspecified in title, \"discoid\" is usually discernible from text or bibliog refs; note X ref: do not confuse with LUPUS ERYTHEMATOSUS, CUTANEOUS", "MS": "A chronic form of cutaneous lupus erythematosus (LUPUS ERYTHEMATOSUS, CUTANEOUS) in which the skin lesions mimic those of the systemic form but in which systemic signs are rare. It is characterized by the presence of discoid skin plaques showing varying degrees of edema, erythema, scaliness, follicular plugging, and skin atrophy. Lesions are surrounded by an elevated erythematous border. The condition typically involves the face and scalp, but widespread dissemination may occur.", "CATSH": "CAT LIST", "MR": "19920522", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008179"}, {"RECTYPE": "D", "MH": "Lupus Erythematosus, Systemic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Systemic Lupus Erythematosus|T047|NON|EQV|NLM (1987)|OMIM (2013)|861231|SLE|abcdeefv", "ENTRY": "Libman Sacks Disease", "MN": "C20.111.590", "FX": "Vasculitis, Central Nervous System", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "if not specified as \"systemic\" it is still probably correct to index here, not also discoid; LE CELLS see NEUTROPHILS is also available", "MS": "A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008180"}, {"RECTYPE": "D", "MH": "Lupus Nephritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nephritis, Lupus|T047|NON|EQV|UNK (19XX)|860618|abcdef", "ENTRY": "Nephritides, Lupus", "MN": "C20.111.590.560", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Nephritis (1966-1986)", "MS": "Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D008181"}, {"RECTYPE": "D", "MH": "Luria-Nebraska Neuropsychological Battery", "DE": "LURIA", "AQ": "HI SN ST", "ENTRY": "Neuropsychological Battery, Luria Nebraska", "MN": "F04.711.513.300", "MH_TH": "NLM (1985)", "ST": "T060", "PI": "Psychological Tests (1966-1984)", "MS": "A series of tests designed to assess neuropsychological function. The battery is used to diagnose specific cerebral dysfunction and also to determine lateralization.", "PM": "91; was see under NEUROPSYCHOLOGICAL TESTS 1985-90", "HN": "91(85); was see under NEUROPSYCHOLOGICAL TESTS 1985-90", "CATSH": "CAT LIST", "MR": "19930604", "DA": "19840413", "DC": "1", "DX": "19910101", "UI": "D008182"}, {"RECTYPE": "D", "MH": "Luteal Phase", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Postovulatory Phase|T079|NON|EQV|UNK (19XX)|840531|abcdef", "ENTRY": "Secretory Phase, Menstrual", "MN": "G08.686.605.410", "MH_TH": "NLM (1975)", "ST": "T079", "MS": "The period in the MENSTRUAL CYCLE that follows OVULATION, characterized by the development of CORPUS LUTEUM, increase in PROGESTERONE production by the OVARY and secretion by the glandular epithelium of the ENDOMETRIUM. The luteal phase begins with ovulation and ends with the onset of MENSTRUATION.", "PM": "1985; was MENSTRUATION, LUTEAL PHASE see under MENSTRUATION 1975-1984; for MENSTRUAL SECRETORY PHASE see MENSTRUAL CYCLE 1985-2002", "HN": "1985(1975); was MENSTRUATION, LUTEAL PHASE see under MENSTRUATION 1975-1984; for MENSTRUAL SECRETORY PHASE use MENSTRUAL CYCLE 1985-2002", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741111", "DC": "1", "DX": "19850101", "UI": "D008183"}, {"RECTYPE": "D", "MH": "Luteal Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Lutein Cells|T025|NON|EQV|NLM (1975)|990101|abcdef", "ENTRY": "cells, Theca-Luteal", "MN": "A11.436.566", "MH_TH": "NLM (2003)", "ST": "T025", "MS": "PROGESTERONE-producing cells in the CORPUS LUTEUM. The large luteal cells derive from the GRANULOSA CELLS. The small luteal cells derive from the THECA CELLS.", "PM": "91; was see under CORPUS LUTEUM 1975-90", "HN": "91(75); was see under CORPUS LUTEUM 1975-90", "MR": "20180630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008184"}, {"RECTYPE": "D", "MH": "Lutembacher Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Lutembacher's", "MN": "C16.131.240.400.560.375.518", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "A condition characterized by a combination of OSTIUM SECUNDUM ATRIAL SEPTAL DEFECT and an acquired MITRAL VALVE STENOSIS.", "PM": "2008; see LUTEMBACHER'S SYNDROME 1991-2007, see HEART SEPTAL DEFECTS, ATRIAL 1964-1990, see HEART DEFECTS, CONGENITAL 1963", "HN": "2008 (1963)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008185"}, {"RECTYPE": "D", "MH": "Luteolytic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Luteolytic Agent|T121|NON|EQV|NLM (2022)|201020|abcdef", "ENTRY": "Effects, Luteolytic", "MN": "D27.505.954.705.610", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "note entry term LUTEOLYTIC EFFECT: use only for the luteolytic effect of a chemical substance", "PI": "Corpus Luteum/drug effects (1968-1974)", "MS": "Chemical compounds that cause LUTEOLYSIS or degeneration of the CORPUS LUTEUM.", "PM": "1975", "HN": "1975", "MR": "20210630", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D008186"}, {"RECTYPE": "D", "MH": "Lutetium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.562", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Lutetium", "RN": "5H0DOZ21UJ", "RR": "7439-94-3 (Lutetium)", "MS": "An element of the rare earth family of metals. It has the atomic symbol Lu, atomic number 71, and atomic weight 175.", "MR": "20170704", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008187"}, {"RECTYPE": "D", "MH": "Lutheran Blood-Group System", "AQ": "AD AE AN BI BL CF CH CL EC GE HI IM IP ME PD PH PO TO TU UL UR", "ENTRY": "System, Lutheran Blood-Group", "MN": "D23.050.705.230.552", "MH_TH": "NLM (1976)", "ST": "T022", "RN": "0", "AN": "IM; coord with disease /blood (IM), not /immunol nor /genet; TN 230", "PI": "Blood Groups (1966-1975)", "MS": "A complex blood group system having pairs of alternate antigens and amorphic genes, but also subject to a dominant independently segregating repressor.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D008188"}, {"RECTYPE": "D", "MH": "Luxembourg", "AQ": "EH EP", "ENTRY": "Luxemburg|T083|NAM|EQV|UNK (19XX)|781214|abcdef", "MN": "Z01.542.550", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "Country in Europe, between France and Germany.", "MR": "20160707", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008189"}, {"RECTYPE": "D", "MH": "Lyases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lyase|T116|T126|NON|EQV|NLM (2021)|191118|abbcdef", "MN": "D08.811.520", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 4.-", "MS": "A class of enzymes that catalyze the cleavage of C-C, C-O, and C-N, and other bonds by other means than by hydrolysis or oxidation. (Enzyme Nomenclature, 1992) EC 4.", "OL": "use LYASES to search DESMOLASES 1966-80", "PM": "DESMOLASES was see under LYASES 1963-80", "HN": "DESMOLASES was see under LYASES 1963-80", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D008190"}, {"RECTYPE": "D", "MH": "Lye", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D01.248.497.158.459.344", "PA": "Caustics", "MH_TH": "NLM (1975)", "ST": "T197", "RN": "0", "AN": "a caustic", "MS": "Generally speaking, it is the alkaline substance obtained from wood ashes by percolation. Preparations of lye can be solutions of either potassium or sodium hydroxide. The term lye, is also used to refer to the household product which is a mixture of sodium hydroxide and sodium carbonate.", "OL": "search CAUSTICS 1966-74", "PM": "91; was see under CAUSTICS 1975-90", "HN": "91(75); was see under CAUSTICS 1975-90", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008191"}, {"RECTYPE": "D", "MH": "Deception", "PRINT ENTRY": "Lying|T055|NON|REL|NLM (1998)|970528|abcdef", "ENTRY": "False Allegation", "MN": "F01.145.813.157", "FX": "Quackery", "MH_TH": "BIOETHICS (1989)", "ST": "T055", "MS": "The act of deceiving or the fact of being deceived.", "PM": "98; see LYING 1966-97", "HN": "98(66)", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D008192"}, {"RECTYPE": "D", "MH": "Lyme Disease", "DE": "LYME DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Lyme Borreliosis|T047|EPO|EQV|NLM (1992)|910109|abcdef", "ENTRY": "Disease, Lyme", "MN": "C01.920.930.513", "MH_TH": "NLM (1985)", "ST": "T047", "AN": "coord IM with specific Borrelia (IM)", "PI": "Spirochaetales Infections (1982-1984)", "MS": "An infectious disease caused by a spirochete, BORRELIA BURGDORFERI, which is transmitted chiefly by Ixodes dammini (see IXODES) and pacificus ticks in the United States and Ixodes ricinis (see IXODES) in Europe. It is a disease with early and late cutaneous manifestations plus involvement of the nervous system, heart, eye, and joints in variable combinations. The disease was formerly known as Lyme arthritis and first discovered at Old Lyme, Connecticut.", "OL": "search ARTHRITIS, INFECTIOUS 1979-84", "PM": "85; was LYME ARTHRITIS see ARTHRITIS, INFECTIOUS 1979-84", "HN": "85; was LYME ARTHRITIS see ARTHRITIS, INFECTIOUS l979-84", "CATSH": "CAT LIST", "MR": "20190613", "DA": "19840406", "DC": "1", "DX": "19850101", "UI": "D008193"}, {"RECTYPE": "D", "MH": "Lymecycline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetracycline-L-Methylene Lysine|T109|T121|NON|EQV|UNK (19XX)|770404|TETRACYCLINE METHYLENE LYSINE L|abbcdefs", "ENTRY": "Tetracycline L Methylene Lysine", "MN": "D04.615.562.900.450", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "L-Lysine, N6-((((4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenyl)carbonyl)amino)methyl)-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-", "RN": "7D6EM3S13P", "RR": "992-21-2 (Lymecycline)", "MS": "A semisynthetic antibiotic related to TETRACYCLINE. It is more readily absorbed than TETRACYCLINE and can be used in lower doses.", "OL": "use LYMECYCLINE to search TETRACYCLINE-L-METHYLENE LYSINE 1966-77 (as Prov 1966-74)", "PM": "91; was see under TETRACYCLINES 1978-90; was TETRACYCLINE-L-METHYLENE LYSINE see under TETRACYCLINE 1975-77", "HN": "91(78); was see under TETRACYCLINES 1978-90; was TETRACYCLINE-L-METHYLENE LYSINE see under TETRACYCLINE 1963-77 (Prov 1963-74)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008194"}, {"RECTYPE": "D", "MH": "Lymnaea", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Lymneas", "MN": "B01.050.500.644.400.750.645", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid6522", "AN": "freshwater snail; /microbiol /parasitol /virol permitted", "PI": "Snails (1966-1971)", "MS": "A genus of dextrally coiled freshwater snails that includes some species of importance as intermediate hosts of parasitic flukes.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008195"}, {"RECTYPE": "D", "MH": "Lymph", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Lymphs", "MN": "A15.382.520.150", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "The interstitial fluid that is in the LYMPHATIC SYSTEM.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008196"}, {"RECTYPE": "D", "MH": "Lymph Node Excision", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Lymphadenectomy|T061|NON|EQV|NLM (1992)|901102|abcdef", "ENTRY": "Node Dissections, Lymph", "MN": "E04.446", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "coordinate with site of lymph nodes but note NECK DISSECTION is available", "MS": "Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966)", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008197"}, {"RECTYPE": "D", "MH": "Lymph Nodes", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nodes, Lymph", "MN": "A15.382.520.604.412", "FX": "Lymphography", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system.", "MR": "20160419", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008198"}, {"RECTYPE": "D", "MH": "Lymphadenitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Adenitis|T046|NON|BRD|UNK (19XX)|740330|abcdef", "ENTRY": "Lymphadenitides", "MN": "C15.604.315", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "inflamm of lymph nodes: do not confuse with LYMPHANGITIS, inflamm of lymphatic vessels; consider also MESENTERIC LYMPHADENITIS", "MS": "Inflammation of the lymph nodes.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008199"}, {"RECTYPE": "D", "MH": "Lymphangiectasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lymphangiectases", "MN": "C15.604.360", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A transient dilatation of the lymphatic vessels.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008200"}, {"RECTYPE": "D", "MH": "Lymphangiectasis, Intestinal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lymphangiectases, Intestinal", "MN": "C16.131.482.500", "MH_TH": "NLM (1975)", "ST": "T190", "MS": "Dilatation of the intestinal lymphatic system usually caused by an obstruction in the intestinal wall. It may be congenital or acquired and is characterized by DIARRHEA; HYPOPROTEINEMIA; peripheral and/or abdominal EDEMA; and PROTEIN-LOSING ENTEROPATHIES.", "OL": "search PROTEIN-LOSING ENTEROPATHIES 1966-74", "PM": "91; was see under PROTEIN-LOSING ENTEROPATHIES 1975-90", "HN": "91(75); was see under PROTEIN-LOSING ENTEROPATHIES 1975-90", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008201"}, {"RECTYPE": "D", "MH": "Lymphangioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Lymphangioma, Cavernous|T191|NON|NRW|NLM (1994)|930326|abcdef", "ENTRY": "Lymphatic Endotheliomas", "MN": "C04.557.375.450", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "MS": "A benign tumor resulting from a congenital malformation of the lymphatic system. Lymphangioendothelioma is a type of lymphangioma in which endothelial cells are the dominant component.", "OL": "use LYMPHANGIOMA to search LYMPHANGIOENDOTHELIOMA 1966-83", "PM": "LYMPHANGIOENDOTHELIOMA was heading 1963-83", "HN": "LYMPHANGIOENDOTHELIOMA was heading 1963-83", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008202"}, {"RECTYPE": "D", "MH": "Lymphangiomyoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Lymphangioleiomyoma|T191|NON|EQV|UNK (19XX)|790524|abcdef", "ENTRY": "Lymphangiomyomas", "MN": "C20.683.515.710", "MH_TH": "NLM (1980)", "ST": "T191", "AN": "differentiate from LYMPHANGIOMYOMATOSIS; coordinate IM with precoordinated organ/neoplasm terms (IM)", "PI": "Lymphatic Diseases (1968-1979)", "MS": "A tumorlike condition characterized by SMOOTH MUSCLE and ENDOTHELIUM proliferation of LYMPHATIC VESSELS and LYMPH NODES in the MEDIASTINUM and retroperitoneum, also in the lung. It may be manifested by chylous PLEURAL EFFUSION and ASCITES.", "PM": "91; was see under LYMPHOPROLIFERATIVE DISORDERS 1980-90", "HN": "91(80); was see under LYMPHOPROLIFERATIVE DISORDERS 1980-90", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19790524", "DC": "1", "DX": "19910101", "UI": "D008203"}, {"RECTYPE": "D", "MH": "Lymphangiosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Lymphangioendothelioma, Malignant|T191|NON|EQV|UNK (19XX)|830504|abcdef", "ENTRY": "Malignant Lymphangioendotheliomas", "MN": "C04.557.450.795.480", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A malignant tumor originating from the endothelial cells of lymphatic vessels. Most lymphangiosarcomas arise in an arm secondary to radical mastectomy but they sometimes complicate idiopathic lymphedema. The lymphedema has usually been present for 6 to 10 years before malignant changes develop. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008204"}, {"RECTYPE": "D", "MH": "Lymphangitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lymphangitides", "MN": "C15.604.406", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with LYMPHADENITIS, inflammation of lymph nodes", "MS": "A lymphatic disease characterized by INFLAMMATION of LYMPHATIC VESSELS.", "OL": "use LYMPHANGITIS /VE to search LYMPHANGITIS, EPIZOOTIC 1970-81", "PM": "LYMPHANGITIS, EPIZOOTIC was heading 1970-81", "HN": "LYMPHANGITIS, EPIZOOTIC was heading 1970-81", "CATSH": "CAT LIST", "MR": "20151209", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008205"}, {"RECTYPE": "D", "MH": "Lymphatic Diseases", "DE": "LYMPHATIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Status Lymphaticus|T047|NON|NRW|NLM (1998)|960710|abcdef", "ENTRY": "Lymphatic Disease", "MN": "C15.604", "FX": "Lymphoma", "MH_TH": "NLM (1968)", "ST": "T047", "PI": "Lymphatic System (1966-1967)", "MS": "Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS.", "OL": "use LYMPHATIC DISEASES to search LYMPHATISM 1966-78", "PM": "70; LYMPHATISM was heading 1963-78", "HN": "70(68); LYMPHATISM was heading 1963-78", "CATSH": "CAT LIST", "MR": "20160609", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D008206"}, {"RECTYPE": "D", "MH": "Lymphatic Metastasis", "AQ": "DG DI DT GE IM PA PC PP RT TH UL", "PRINT ENTRY": "Lymph Node Metastasis|T191|NON|REL|NLM (2021)|191129|abcdef", "ENTRY": "Metastasis, Lymph Node", "MN": "C23.550.727.650.560", "FX": "Sentinel Lymph Node", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.", "CATSH": "CAT LIST", "MR": "20200221", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008207"}, {"RECTYPE": "D", "MH": "Lymphatic System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Lymphatic Systems", "MN": "A15.382.520", "FX": "Lymphography", "MH_TH": "NLM (1966)", "ST": "T022", "MS": "A system of organs and tissues that process and transport immune cells and LYMPH.", "MR": "20160809", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008208"}, {"RECTYPE": "D", "MH": "Lymphedema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Milroy's Disease|T047|EPO|NRW|GHR (2014)|UNK (19XX)|830504|MILROYS DIS|abcdeefv", "ENTRY": "Primary Congenital Lymphedemas", "MN": "C15.604.496", "FX": "Yellow Nail Syndrome", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "entry term MILROY'S DISEASE goes under LYMPHEDEMA/ congen", "MS": "Edema due to obstruction of lymph vessels or disorders of the lymph nodes.", "OL": "use LYMPHEDEMA/congenital to search MILROY'S DISEASE 1966-1983", "PM": "MILROY'S DISEASE was heading 1963-1983", "HN": "MILROY'S DISEASE was heading 1963-1983", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008209"}, {"RECTYPE": "D", "MH": "Lymphocele", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Lymphatic Cyst|T047|NON|EQV|UNK (19XX)|870325|abcdef", "ENTRY": "Lymphocoeles", "MN": "C15.604.510", "MH_TH": "NLM (1988)", "ST": "T047", "AN": "non-neoplastic; coordinate with organ/disease term if relevant", "PI": "Lymphatic Diseases (1966-1987)", "MS": "Cystic mass containing lymph from diseased lymphatic channels or following surgical trauma or other injury.", "OL": "use LYMPHANGIOMA to search LYMPHOCELE 1966-74", "PM": "91; was see under LYMPHATIC DISEASES 1988-90; was see under LYMPHANGIOMA 1966-87", "HN": "91(88); was see under LYMPHATIC DISEASES 1988-90; was see under LYMPHANGIOMA 1966-87", "CATSH": "CAT LIST", "MR": "19910723", "DA": "19870325", "DC": "1", "DX": "19910101", "UI": "D008210"}, {"RECTYPE": "D", "MH": "Lymphocyte Cooperation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Lymphocyte Cooperations", "MN": "G12.575", "MH_TH": "NLM (1978)", "ST": "T043", "PI": "T-Lymphocytes (1973-1977)", "MS": "T-cell enhancement of the B-cell response to thymic-dependent antigens.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19770301", "DC": "1", "DX": "19780101", "UI": "D008211"}, {"RECTYPE": "D", "MH": "Lymphocyte Depletion", "AQ": "AE EC ES IS MO MT SN ST VE", "ENTRY": "Depletion, Lymphocyte", "MN": "E05.478.610.570", "FX": "T-Cell Exhaustion", "MH_TH": "NLM (1972)", "ST": "T061", "PI": "Immunosuppression (1971)", "MS": "Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation.", "PM": "74", "HN": "74(72)", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008212"}, {"RECTYPE": "D", "MH": "Lymphocyte Activation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Lymphocyte Transformation|T043|T059|NON|EQV|NLM (1969)|990101|LYMPHOCYTE TRANSFORM|abbcdefv", "ENTRY": "Stimulation, Lymphocyte", "MN": "G12.565", "FX": "Blast Crisis", "MH_TH": "UNK (19XX)", "ST": "T059", "PI": "Lymphocytes/immunology (1966-1968)", "MS": "Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION.", "PM": "2003; see LYMPHOCYTE TRANSFORMATION 1972-2002; for BLAST TRANSFORMATION see BLAST CRISIS 1987-1992", "HN": "2003 (1969); for BLAST TRANSFORMATION use BLAST CRISIS 1987-1992", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008213"}, {"RECTYPE": "D", "MH": "Lymphocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Lymphoid Cells|T025|NON|BRD|UNK (19XX)|770428|abcdef", "ENTRY": "Lymphoid Cell", "MN": "A15.382.490.555.567", "FX": "Antilymphocyte Serum", "EC": "transplantation:Lymphocyte Transfusion", "MH_TH": "NLM (1966)", "ST": "T025", "MS": "White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008214"}, {"RECTYPE": "D", "MH": "Lymphocytes, Null", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Null Cells|T025|NON|EQV|UNK (19XX)|810520|abcdef", "ENTRY": "Null Lymphocytes", "MN": "A15.382.490.555.567.622", "MH_TH": "NLM (1982)", "ST": "T025", "AN": "subpopulations: coordinate with LYMPHOCYTE SUBSETS ", "PI": "T Lymphocytes (1973-1981)", "MS": "A class of lymphocytes characterized by the lack of surface markers specific for either T or B lymphocytes.", "PM": "82", "HN": "82", "MR": "20030709", "DA": "19810520", "DC": "1", "DX": "19820101", "UI": "D008215"}, {"RECTYPE": "D", "MH": "Lymphocytic Choriomeningitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Armstrong Syndrome|T047|EPO|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Syndrome, Armstrong's", "MN": "C10.586.625.400.500", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A form of meningitis caused by LYMPHOCYTIC CHORIOMENINGITIS VIRUS. MICE and other rodents serve as the natural hosts, and infection in humans usually occurs through inhalation or ingestion of infectious particles. Clinical manifestations include an influenza-like syndrome followed by stiff neck, alterations of mentation, ATAXIA, and incontinence. Maternal infections may result in fetal malformations and injury, including neonatal HYDROCEPHALUS, aqueductal stenosis, CHORIORETINITIS, and MICROCEPHALY. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008216"}, {"RECTYPE": "D", "MH": "Lymphocytic choriomeningitis virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "LCMV|T005|ACR|EQV|NLM (2002)|010509|abcdef", "ENTRY": "Lymphocytic choriomeningitis viruses", "MN": "B04.820.480.500.070.100.550", "MH_TH": "NLM (1965)", "ST": "T005", "RN": "txid11623", "MS": "The type species of ARENAVIRUS, part of the Old World Arenaviruses (ARENAVIRUSES, OLD WORLD), producing a silent infection in house and laboratory mice. In humans, infection with LCMV can be inapparent, or can present with an influenza-like illness, a benign aseptic meningitis, or a severe meningoencephalomyelitis. The virus can also infect monkeys, dogs, field mice, guinea pigs, and hamsters, the latter an epidemiologically important host.", "PM": "73", "HN": "73(65)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008217"}, {"RECTYPE": "D", "MH": "Lymphocytosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lymphocytoses", "MN": "C15.378.553.475.604", "FX": "Leukemia, Large Granular Lymphocytic", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "increase in number of lymphocytes", "MS": "Excess of normal lymphocytes in the blood or in any effusion.", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008218"}, {"RECTYPE": "D", "MH": "Lymphogranuloma Venereum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Lymphogranuloma Inguinale|T047|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "C12.100.937.281.301.490", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by Chlamydia trachomatis", "MS": "Subacute inflammation of the inguinal lymph glands caused by certain immunotypes of CHLAMYDIA TRACHOMATIS. It is a sexually transmitted disease in the U.S. but is more widespread in developing countries. It is distinguished from granuloma venereum (see GRANULOMA INGUINALE), which is caused by Calymmatobacterium granulomatis.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008219"}, {"RECTYPE": "D", "MH": "Lymphography", "DE": "LYMPHOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Lymphangiography|T060|NON|NRW|IOM (1990)|890417|LYMPHANGIOGR|abcdefv", "ENTRY": "Lymphographies", "MN": "E01.370.350.700.475", "MH_TH": "NLM (1963)", "ST": "T060", "MS": "Radiographic study of the lymphatic system following injection of dye or contrast medium.", "PM": "64", "HN": "64(63)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D008220"}, {"RECTYPE": "D", "MH": "Lymphoid Tissue", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tissues, Lymphoid", "MN": "A15.382.520.604", "FX": "Lymphography", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008221"}, {"RECTYPE": "D", "MH": "Lymphokines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lymphocyte Mediators|T116|T129|NON|EQV|NLM (1991)|900226|abbcdef", "ENTRY": "Mediators, Lymphocyte", "MN": "D23.529.374.480", "FX": "Immunity, Cellular", "MH_TH": "NLM (1974)", "ST": "T129", "RN": "0", "AN": "/biosyn /drug eff /physiol /ultrastruct permitted", "MS": "Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity.", "PM": "74", "HN": "74", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008222"}, {"RECTYPE": "D", "MH": "Lymphoma", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Sarcoma, Germinoblastic|T191|NON|EQV|UNK (19XX)|800509|abcdef", "ENTRY": "Sarcomas, Germinoblastic", "MN": "C20.683.515.761", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "general or unspecified: prefer specifics; do not confuse entry term LYMPHOMA, MALIGNANT with LYMPHOGRANULOMA, MALIGNANT see HODGKIN DISEASE", "MS": "A general term for various neoplastic diseases of the lymphoid tissue.", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008223"}, {"RECTYPE": "D", "MH": "Lymphoma, Follicular", "DE": "LYMPHOMA FOLLIC", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Lymphoma, Nodular|T191|NON|EQV|NLM (1991)|900513|abcdef", "ENTRY": "Small Follicular Center Cell Lymphoma", "MN": "C20.683.515.761.480.350", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the LYMPH NODES. The nodules resemble to some extent the GERMINAL CENTER of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-LYMPHOCYTES.", "OL": "use LYMPHOMA, FOLLICULAR to search LYMPHOMA, GIANT FOLLICULAR 1966-90 & BRILL-SYMMERS DISEASE 1975-90", "PM": "91; was LYMPHOMA, GIANT FOLLICULAR 1963-90; BRILL-SYMMERS DISEASE was see LYMPHOMA, GIANT FOLLICULAR 1975-90", "HN": "91; was LYMPHOMA, GIANT FOLLICULAR 1963-90; BRILL-SYMMERS DISEASE was see LYMPHOMA, GIANT FOLLICULAR 1975-90", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008224"}, {"RECTYPE": "D", "MH": "Lymphoma, Non-Hodgkin", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Non-Hodgkin Lymphoma|T191|EPO|EQV|NLM (1991)|OMIM (2013)|900531|NONHODGKIN LYMPHOMA|abcdeefs", "ENTRY": "Undifferentiated Lymphomas", "MN": "C20.683.515.761.480", "MH_TH": "NLM (1987)", "ST": "T191", "AN": "general & unspecified only: prefer specifics", "PI": "Lymphoma (1966-1986)", "MS": "Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.", "PM": "1997; see LYMPHOMA, NON-HODGKIN'S 1987-1997; for LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE see LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE 1991-2007; for LYMPHOMA, SMALL NONCLEAVED-CELL see LYMPHOMA, SMALL NONCLEAVED-CELL 1991-2007; for LYMPHOMA, MIXED-CELL, DIFFUSE see LYMPHOMA, MIXED-CELL, DIFFUSE 1991-2007; for LYMPHOMA, DIFFUSE see LYMPHOMA, DIFFUSE 1991-2007; for LYMPHOSARCOMA see LYMPHOMA, DIFFUSE 1991-2007, see LYMPHOMA, NON-HODGKIN'S 1987-1990, see LYMPHOSARCOMA 1963-1986; for LYMPHOMA, HIGH-GRADE see LYMPHOMA, HIGH-GRADE 1991-2007; for LYMPHOMA, INTERMEDIATE-GRADE see LYMPHOMA, INTERMEDIATE-GRADE 1991-2007; for RETICULUM-CELL SARCOMA see LYMPHOMA, LARGE B-CELL, DIFFUSE 1987-2007; for LYMPHOMA, LOW-GRADE see LYMPHOMA, LOW-GRADE 1991-2007; for LYMPHOMA, MIXED-CELL see LYMPHOMA, MIXED-CELL 1991-2007, see LYMPHOMA, MIXED 1987-1990; for SARCOMA, RETICULUM-CELL see LYMPHOMA, LARGE-CELL 1991-2007, see LYMPHOMA, HISTIOCYTIC 1987-1990, see SARCOMA, RETICULUM-CELL 1963-1986", "HN": "1997(1987)", "CATSH": "CAT LIST", "MR": "20190506", "DA": "19860624", "DC": "1", "DX": "19870101", "UI": "D008228"}, {"RECTYPE": "D", "MH": "Lymphomatoid Granulomatosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Granulomatosis, Lymphomatoid|T191|NON|EQV|UNK (19XX)|790525|abcdef", "ENTRY": "Lymphomatoid Granulomatoses", "MN": "C20.683.515.761.480.150.600", "MH_TH": "NLM (1980)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "PI": "Lymphoma (1966-1979)", "MS": "An angiocentric and angiodestructive lymphoproliferative disorder primarily involving the lungs. It is caused by an Epstein-Barr virus-induced transformation of the B-cells, in a T-cell rich environment. Clinically and pathologically it resembles EXTRANODAL NK-T-CELL LYMPHOMA.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19790525", "DC": "1", "DX": "19800101", "UI": "D008230"}, {"RECTYPE": "D", "MH": "Lymphopenia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lymphocytopenia|T033|T047|NON|EQV|UNK (19XX)|750101|abbcdef", "ENTRY": "Lymphopenias", "MN": "C20.673.627", "FX": "Protein-Losing Enteropathies", "MH_TH": "NLM (1970)", "ST": "T047", "PI": "Lymphocytes (1966-1969)", "MS": "Reduction in the number of lymphocytes.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D008231"}, {"RECTYPE": "D", "MH": "Lymphoproliferative Disorders", "DE": "LYMPHOPROLIFERATIVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "X-Linked Lymphoproliferative Syndrome|T047|NON|NRW|NLM (1991)|900420|XLP|abcdefv", "ENTRY": "X-Linked Lymphoproliferative Syndromes", "MN": "C20.683.515", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Disorders characterized by proliferation of lymphoid tissue, general or unspecified.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D008232"}, {"RECTYPE": "D", "MH": "Lymphotoxin-alpha", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor-beta|T116|T129|NON|EQV|NLM (1990)|890323|TUMOR NECROSIS FACTOR BETA|abbcdefs", "ENTRY": "alpha Lymphotoxin", "MN": "D23.529.374.750.500", "MH_TH": "NLM (2005)", "ST": "T129", "RN": "0", "AN": "for \"lymphocytotoxin\" use CYTOTOXINS and LYMPHOCYTES", "MS": "A tumor necrosis factor family member that is released by activated LYMPHOCYTES. Soluble lymphotoxin is specific for TUMOR NECROSIS FACTOR RECEPTOR TYPE I; TUMOR NECROSIS FACTOR RECEPTOR TYPE II; and TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14. Lymphotoxin-alpha can form a membrane-bound heterodimer with LYMPHOTOXIN-BETA that has specificity for the LYMPHOTOXIN BETA RECEPTOR.", "PM": "2007; was LYMPHOTOXIN 1990-2006; LYMPHOTOXIN-ALPHA was indexed under LYMPHOTOXIN see LYMPHOTOXINS 1978-1989; see LYMPHOTOXIN 1974-1977; for TUMOR NECROSIS FACTOR-BETA & TNF-BETA see TUMOR NECROSIS FACTOR 1988-1989", "HN": "2007 (1974-1977); for TUMOR NECROSIS FACTOR-BETA & TNF-BETA use TUMOR NECROSIS FACTOR 1988-1989", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008233"}, {"RECTYPE": "D", "MH": "Lynestrenol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethinylestrenol|T109|T121|T125|NON|EQV|UNK (19XX)|761230|abbbcdef", "ENTRY": "Lynoestrenol|T109|T121|T125|NON|EQV|BAN (19XX)|FDA SRS (2014)|NLM (1999)|971208|abbbcdeeef", "MN": "D04.210.500.668.651.693.494", "PA": "Contraceptives, Oral, Synthetic", "MH_TH": "USAN (1967)", "ST": "T125", "RN": "N2Z8ALG4U5", "RR": "52-76-6 (Lynestrenol)", "MS": "A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive (CONTRACEPTIVES, ORAL).", "PM": "65", "HN": "65(64)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008234"}, {"RECTYPE": "D", "MH": "Lyngbya Toxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lyngbyatoxins|T131|NON|EQV|NLM (2021)|200121|abcdef", "ENTRY": "Toxin, Lyngbya", "MN": "D23.946.580.565", "PA": "Poisons", "FX": "Lyngbya", "MH_TH": "NLM (1985)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTITOXINS; coordinate with source only if particularly discussed", "PI": "Toxins (1966-1984)", "MS": "Toxins isolated from any species of the genus LYNGBYA or similar chemicals from other sources, including mollusks and micro-organisms. These have been found to be potent tumor promoters. They are biosynthesized from TRYPTOPHAN; VALINE; and METHIONINE nonribosomally (PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT).", "PM": "85", "HN": "85", "MR": "20210510", "DA": "19840501", "DC": "1", "DX": "19850101", "UI": "D008235"}, {"RECTYPE": "D", "MH": "Lypressin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vasopressin, Lysine|T116|T121|T125|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Vasopressin, Lysyl", "MN": "D12.776.631.650.937.400", "PA": "Vasoconstrictor Agents", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2, cyclic 1-6 disulfide", "RN": "50-57-7", "PI": "Vasopressins (1966-1974)", "MS": "The porcine antidiuretic hormone (VASOPRESSINS). It is a cyclic nonapeptide that differs from ARG-VASOPRESSIN by one amino acid, containing a LYSINE at residue 8 instead of an ARGININE. Lys-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.", "PM": "2010, 1979-2006; see LYSINE VASOPRESSIN 2007-2009, see VASOPRESSIN 1975-1978", "HN": "2010, 1979-2006 (1975)", "MR": "20151124", "DA": "19741111", "DC": "1", "DX": "19790101", "UI": "D008236"}, {"RECTYPE": "D", "MH": "Lysergic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Lysergic", "MN": "D03.633.400.439.572", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "Ergoline-8-carboxylic acid, 9,10-didehydro-6-methyl-, (8beta)-", "RN": "ITO20DAO7J", "RR": "82-58-6 (Lysergic Acid)", "OL": "search ERGOLINES 1969-74", "PM": "91; was see under ERGOLINES 1975-90", "HN": "91(75); was see under ERGOLINES 1975-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008237"}, {"RECTYPE": "D", "MH": "Lysergic Acid Diethylamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lysergide|T109|T121|T131|NON|EQV|FDA SRS (2014)|INN (19XX)|750101|abbbcdeef", "ENTRY": "LSD 25", "MN": "D03.633.400.439.572.522", "PA": "Serotonin Receptor Agonists", "MH_TH": "FDA SRS (2014)", "ST": "T131", "N1": "Ergoline-8-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl-, (8beta)-", "RN": "8NA5SWF92O", "RR": "50-37-3 (Lysergic Acid Diethylamide)", "MS": "Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008238"}, {"RECTYPE": "D", "MH": "Lysine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L Lysine", "MN": "D12.125.142.497", "MH_TH": "USAN (1979)", "ST": "T123", "N1": "L-Lysine", "RN": "K3Z4F929H6", "RR": "TTL6G7LIWZ", "AN": "/biosyn /defic /physiol permitted; POLYLYSINE is also available", "MS": "An essential amino acid. It is often added to animal feed.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008239"}, {"RECTYPE": "D", "MH": "Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protocollagen Lysyl Hydroxylase|T116|T126|NON|EQV|UNK (19XX)|760426|abbcdef", "ENTRY": "Procollagen Lysine, 2 Oxoglutarate 5 Dioxygenase", "MN": "D08.811.682.690.708.660", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "Procollagen-L-lysine,2-oxoglutarate:oxygen oxidoreductase (5-hydroxylating)", "RN": "EC 1.14.11.4", "PI": "Lysine (1966-1976)", "MS": "A mixed-function oxygenase that catalyzes the hydroxylation of peptidyllysine, usually in protocollagen, to peptidylhydroxylysine. The enzyme utilizes molecular oxygen with concomitant oxidative decarboxylation of the cosubstrate 2-oxoglutarate to succinate. EC 1.14.11.4.", "OL": "use PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE to search LYSINE HYDROXYLASE 1977-91", "PM": "92; was LYSINE HYDROXYLASE 1977-91 (see under HYDROXYLASES 1977-90)", "HN": "92; was LYSINE HYDROXYLASE 1977-91 (see under HYDROXYLASES 1977-90)", "MR": "20040707", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D008240"}, {"RECTYPE": "D", "MH": "Lysinoalanine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D12.125.095.647.575", "MH_TH": "NLM (1979)", "ST": "T121", "N1": "L-Lysine, N6-(2-amino-2-carboxyethyl)-", "RN": "18810-04-3", "AN": "\"an unusual amino acid...found in proteins of cooked foods\"", "PI": "Lysine (1966-1978)", "MS": "N(6)-(2-Amino-2-carboxyethyl)-L-lysine. An unusual amino acid, not a dipeptide, which has been found in proteins of cooked foods. It is formed in food that is heated or treated with alkali. Has been implicated in nephrocytomegalia in rats.", "PM": "91; was see under LYSINE 1979-90", "HN": "91(79); was see under LYSINE 1979-90", "MR": "20010725", "DA": "19780309", "DC": "1", "DX": "19910101", "UI": "D008241"}, {"RECTYPE": "D", "MH": "Lysogeny", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Prophage Integration|T070|NON|EQV|UNK (19XX)|790523|abcdef", "ENTRY": "Prophage Integrations", "MN": "G06.920.877.500", "FX": "Virus Activation", "MH_TH": "NLM (1968)", "ST": "T070", "AN": "for bacteriophages only", "PI": "specific bacterium (1966-1967)", "MS": "The phenomenon by which a temperate phage incorporates itself into the DNA of a bacterial host, establishing a kind of symbiotic relation between PROPHAGE and bacterium which results in the perpetuation of the prophage in all the descendants of the bacterium. Upon induction (VIRUS ACTIVATION) by various agents, such as ultraviolet radiation, the phage is released, which then becomes virulent and lyses the bacterium.", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D008242"}, {"RECTYPE": "D", "MH": "1-Acylglycerophosphocholine O-Acyltransferase", "DS": "ACYLGLYCEROPHOSPHOCHOLINE ACYLTRANSFERASE 001 O", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lysolecithin Acyltransferase|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef", "ENTRY": "O-Acyltransferase, 1-Acylglycerophosphocholine", "MN": "D08.811.913.050.175", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "Acyl-CoA:1-acyl-sn-glycero-3-phosphocholine O-acyltransferase", "RN": "EC 2.3.1.23", "RR": "9027-64-9 (CAS RN)", "PI": "Lysophosphatidylcholines (1972-1975)", "MS": "An enzyme localized predominantly within the plasma membrane of lymphocytes. It catalyzes the transfer of long-chain fatty acids, preferentially unsaturated fatty acids, to lysophosphatides with the formation of 1,2-diacylglycero-3-phosphocholine and CoA. EC 2.3.1.23.", "PM": "98; see LYSOLECITHIN ACYLTRANSFERASE 1991-97; 1-ACYLGLYCEROPHOSPHOCHOLINE ACYLTRANSFERASE was indexed under ACYLTRANSFERASES 1982-97, see ACYLTRANSFERASES 1976-90", "HN": "98; for 1-ACYLGLYCEROPHOSPHOCHOLINE ACYLTRANSFERASE use 1-ACYLGLYCEROPHOSPHOCHOLINE O-ACYLTRANSFERASE (NM) 1982-97, see ACYLTRANSFERASES 1976-90", "MR": "20030709", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D008243"}, {"RECTYPE": "D", "MH": "Lysophosphatidylcholines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lysolecithins|T109|NON|EQV|UNK (19XX)|760517|abcdef", "ENTRY": "Lysophosphatidylcholine|T109|NON|EQV|UNK (19XX)|860930|abcdef", "MN": "D10.570.755.375.760.550.550", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "MS": "Derivatives of PHOSPHATIDYLCHOLINES obtained by their partial hydrolysis which removes one of the fatty acid moieties.", "OL": "use LYSOPHOSPHATIDYLCHOLINES to search LYSOLECITHIN 1966-76", "PM": "77; was LYSOLECITHIN 1963-76", "HN": "77; was LYSOLECITHIN 1963-76", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D008244"}, {"RECTYPE": "D", "MH": "Lysophospholipase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phospholipase B|T116|T126|NON|EQV|UNK (19XX)|790221|abbcdef", "ENTRY": "Lysolecithin Lysolecithin Acyltransferase", "MN": "D08.811.277.352.100.680.510", "MH_TH": "NLM (1980)", "ST": "T126", "N1": "2-Lysophosphatidylcholine acylhydrolase", "RN": "EC 3.1.1.5", "PI": "Phospholipases (1966-1979)", "MS": "An enzyme that catalyzes the hydrolysis of a single fatty acid ester bond in lysoglycerophosphatidates with the formation of glyceryl phosphatidates and a fatty acid. EC 3.1.1.5.", "PM": "91; was see under PHOSPHOLIPASES 1980-90", "HN": "91(80); was see under PHOSPHOLIPASES 1980-90", "MR": "20160628", "DA": "19790221", "DC": "1", "DX": "19910101", "UI": "D008245"}, {"RECTYPE": "D", "MH": "Lysophospholipids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lysophospholipid|T109|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Acids, Lysophosphatidic", "MN": "D10.570.755.375.760.550", "MH_TH": "NLM (1988)", "ST": "T109", "RN": "0", "PI": "Phospholipids (1966-1987)", "MS": "Derivatives of PHOSPHATIDIC ACIDS that lack one of its fatty acyl chains due to its hydrolytic removal.", "PM": "88", "HN": "88", "MR": "20200527", "DA": "19870323", "DC": "1", "DX": "19880101", "UI": "D008246"}, {"RECTYPE": "D", "MH": "Lysosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Autolysosomes|T026|NON|REL|NLM (2021)|190911|abcdef", "ENTRY": "Lysosome|T026|NON|EQV|NLM (1991)|891012|abcdef", "MN": "A11.284.430.214.190.875.190.550", "MH_TH": "NLM (1964)", "ST": "T026", "MS": "A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed).", "PM": "65", "HN": "65(64)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008247"}, {"RECTYPE": "D", "MH": "Lysostaphin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D08.811.277.656.675.374.452", "PA": "Anti-Infective Agents, Local", "MH_TH": "USAN (1966)", "ST": "T126", "N1": "Lysostaphin", "RN": "EC 3.4.24.75", "RR": "9011-93-2 (CAS RN)", "MS": "A 25-kDa peptidase produced by Staphylococcus simulans which cleaves a glycine-glcyine bond unique to an inter-peptide cross-bridge of the STAPHYLOCOCCUS AUREUS cell wall.", "PM": "73", "HN": "73(65)", "MR": "20190703", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008248"}, {"RECTYPE": "D", "MH": "Protein-Lysine 6-Oxidase", "DS": "PROTEIN LYSINE OXIDASE 06", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lysyl Oxidase|T116|T126|NON|EQV|NLM (1995)|940112|abbcdef", "ENTRY": "Protein Lysine 6 Oxidase", "MN": "D08.811.682.664.500.848", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Protein-L-lysine:oxygen 6-oxidoreductase (deaminating)", "RN": "EC 1.4.3.13", "PI": "Lysine (1972-1974)", "MS": "An enzyme oxidizing peptidyl-lysyl-peptide in the presence of water & molecular oxygen to yield peptidyl-allysyl-peptide plus ammonia & hydrogen peroxide. EC 1.4.3.13.", "OL": "use PROTEIN-LYSINE 6-OXIDASE to search LYSYL OXIDASE 1975-94; use PROTEIN-LYSINE 6-OXIDASE (NM) to search PROTEIN-LYSINE 6-OXIDASE 1985-94", "PM": "95; was LYSYL OXIDASE 1975-94 (see under AMINO ACID OXIDOREDUCTASES 1975-90); PROTEIN-LYSINE 6-OXIDASE was indexed under AMINO ACID OXIDOREDUCTASES 1986-92 & LYSYL OXIDASE 1993-94", "HN": "95; was LYSYL OXIDASE 1975-94 (see under AMINO ACID OXIDOREDUCTASES 1975-90); PROTEIN-LYSINE 6-OXIDASE was NM 1985-94", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008249"}, {"RECTYPE": "D", "MH": "Lysine-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lysyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961105|abbdef", "ENTRY": "Synthetase, Lysyl-tRNA", "MN": "D08.811.464.263.200.550", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Lysine:tRNA(Lys) ligase (AMP-forming)", "RN": "EC 6.1.1.6", "PI": "Lysine (1972-1974)", "MS": "An enzyme that activates lysine with its specific transfer RNA. EC 6.1.1.6.", "PM": "98; see LYSYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008250"}, {"RECTYPE": "D", "MH": "Macaca", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Macaque|T015|NON|EQV|UNK (19XX)|800509|abcdef", "ENTRY": "Macaques", "MN": "B01.050.150.900.649.313.988.400.112.199.120.510", "MH_TH": "NLM (1971)", "ST": "T015", "RN": "txid9539", "RR": "txid9546", "AN": "Old World monkey, not ape despite entry terms; NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "PI": "Anthropoidea (1966-1970)", "MS": "A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of 16 species inhabiting forests of Africa, Asia, and the islands of Borneo, Philippines, and Celebes.", "OL": "use MACACA to search BARBARY APES 1973-80", "PM": "73", "HN": "73(71); APE, BARBARY was BARBARY APES see under MACACA 1973-80", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008251"}, {"RECTYPE": "D", "MH": "Macaca fascicularis", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Monkey, Cynomolgus|T015|NON|EQV|UNK (19XX)|800509|abcdef", "ENTRY": "Monkey, Crab Eating", "MN": "B01.050.150.900.649.313.988.400.112.199.120.510.520", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9541", "RR": "txid1747270", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "MS": "A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula.", "OL": "use MACACA FASCICULARIS to search CYNOMOLGUS MONKEYS 1975-80", "PM": "91; was see under MACACA 1981-90; was CYNOMOLGUS MONKEYS see under MACACA 1975-80", "HN": "91(81); was see under MACACA 1981-90; was CYNOMOLGUS MONKEYS see under MACACA 1975-80", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008252"}, {"RECTYPE": "D", "MH": "Macaca mulatta", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rhesus Monkey|T015|NON|EQV|NLM (1992)|901128|abcdef", "ENTRY": "Rhesus Monkeys", "MN": "B01.050.150.900.649.313.988.400.112.199.120.510.550", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9544", "RR": "txid1449913", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "MS": "A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans.", "OL": "use MACACA MULATTA to search RHESUS MONKEYS 1975-80", "PM": "91; was see under MACACA 1981-90; was RHESUS MONKEYS see under MACACA 1975-80", "HN": "91(81); was see under MACACA 1981-90; was RHESUS MONKEYS see under MACACA 1975-80", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008253"}, {"RECTYPE": "D", "MH": "Macaca nemestrina", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Pig-Tailed Monkey|T015|NON|EQV|NLM (1992)|901128|abcdef", "ENTRY": "Pigtailed Monkeys", "MN": "B01.050.150.900.649.313.988.400.112.199.120.510.560", "MH_TH": "NLM (1981)", "ST": "T015", "RN": "txid9545", "RR": "txid90387", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "PI": "Macaca (1971-1980)", "MS": "A species of the genus MACACA which inhabits Malaya, Sumatra, and Borneo. It is one of the most arboreal species of Macaca. The tail is short and untwisted.", "PM": "91; was see under MACACA 1981-90", "HN": "91(81); was see under MACACA 1981-90", "MR": "20211018", "DA": "19800507", "DC": "1", "DX": "19910101", "UI": "D008254"}, {"RECTYPE": "D", "MH": "Macaca radiata", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Monkey, Bonnet|T015|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "radiata, Macaca", "MN": "B01.050.150.900.649.313.988.400.112.199.120.510.570", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9548", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "MS": "A species of macaque monkey that mainly inhabits the forest of southern India. They are also called bonnet macaques or bonnet monkeys.", "PM": "91; was see under MACACA 1975-90", "HN": "91(75); was see under MACACA 1975-90", "MR": "20200813", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008255"}, {"RECTYPE": "D", "MH": "Macau", "AQ": "EH EP", "ENTRY": "Macao|T083|NAM|EQV|NLM (1978)|990101|abcdef", "MN": "Z01.639.610", "MH_TH": "NLM (1983)", "ST": "T083", "PI": "Portugal (1966-1977)", "MS": "Special Administrative Region of the People's Republic of China since December 20, 1999 with its own constitution. The island of Macau and adjacent islands are located off the southeast coast of China.", "HN": "2009; was MACAO 1978-2008; was see PORTUGAL 1977", "MR": "20130709", "DA": "19770513", "DC": "4", "DX": "19780101", "UI": "D008256"}, {"RECTYPE": "D", "MH": "Machiavellianism", "PRINT ENTRY": "Manipulation, Psychological|T054|NON|BRD|UNK (19XX)|780510|MANIPULATION PSYCHOL|abcdefv", "ENTRY": "Psychological Manipulations", "MN": "F01.752.650", "MH_TH": "NLM (1979)", "ST": "T041", "PI": "Personality (1966-1978)", "MS": "A personality dimension characterized by the manipulation of others.", "PM": "91; was see under PERSONALITY 1979-90", "HN": "91(79); was see under PERSONALITY 1979-90", "CATSH": "CAT LIST", "MR": "19910611", "DA": "19780510", "DC": "1", "DX": "19910101", "UI": "D008257"}, {"RECTYPE": "D", "MH": "Waldenstrom Macroglobulinemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Macroglobulinemia|T191|NON|EQV|NLM (1992)|910115|abcdef", "ENTRY": "Waldenstroms Macroglobulinemia", "MN": "C20.683.780.925", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "in titles & translations use diacritic: Waldenstr\u00f6m", "MS": "A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity.", "PM": "1999; see WALDENSTROM'S MACROGLOBULINEMIA 1992-98, see MACROGLOBULINEMIA 1963-91; for LYMPHOMA, LYMPHOCYTIC, PLASMACYTOID see LYMPHOMA, SMALL CELL 1991-2007", "HN": "1999 (1963)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D008258"}, {"RECTYPE": "D", "MH": "Macroglobulins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.377.715.647", "MH_TH": "NLM (1965)", "ST": "T129", "RN": "0", "AN": "serum globulins; ALPHA MACROGLOBULINS is also available", "MS": "Serum globulins with high molecular weight. (Dorland, 28th ed)", "PM": "65", "HN": "65", "MR": "19950317", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008259"}, {"RECTYPE": "D", "MH": "Macroglossia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Macroglossias", "MN": "C07.465.910.460", "FX": "Beckwith-Wiedemann Syndrome", "MH_TH": "ORD (2010)", "ST": "T019", "AN": "overlarge tongue, congen or acquired", "PI": "Tongue/abnormalities (1969-1974)", "MS": "The presence of an excessively large tongue, which may be congenital or may develop as a result of a tumor or edema due to obstruction of lymphatic vessels, or it may occur in association with hyperpituitarism or acromegaly. It also may be associated with malocclusion because of pressure of the tongue on the teeth. (From Jablonski, Dictionary of Dentistry, 1992)", "OL": "search TONGUE /AB 1969-74", "PM": "76; was see under TONGUE 1975; was see under TONGUE/abnormalities 1969-74", "HN": "76(75); was see under TONGUE 1975; was see under TONGUE/abnormalities 1969-74", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D008260"}, {"RECTYPE": "D", "MH": "Macrophage Activation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Macrophage Activations", "MN": "G12.287.500", "MH_TH": "NLM (1982)", "ST": "T043", "PI": "Macrophages (1966-1981)", "MS": "The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19810520", "DC": "1", "DX": "19820101", "UI": "D008262"}, {"RECTYPE": "D", "MH": "Macrophage Migration-Inhibitory Factors", "DE": "MMIF", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Migration Inhibition Factors, Macrophage|T116|T129|NON|EQV|UNK (19XX)|790501|MIGRATION INHIB FACTORS MACROPHAGE|abbcdefv", "ENTRY": "Migration-Inhibitory Factors, Macrophage", "MN": "D23.529.374.480.625", "MH_TH": "NLM (1974)", "ST": "T129", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Cell Movement (1970-1971)", "MS": "Proteins released by sensitized LYMPHOCYTES and possibly other cells that inhibit the migration of MACROPHAGES away from the release site. The structure and chemical properties may vary with the species and type of releasing cell.", "OL": "use MACROPHAGE MIGRATION-INHIBITORY FACTORS to search MACROPHAGE MIGRATION INHIBITORY FACTORS 1980-90 & MIGRATION INHIBITORY FACTOR 1974-79", "PM": "91; was MACROPHAGE MIGRATION INHIBITORY FACTORS 1980-90; was MIGRATION INHIBITORY FACTOR 1974-79", "HN": "91; was MACROPHAGE MIGRATION INHIBITORY FACTORS 1980-90; was MIGRATION INHIBITORY FACTOR 1974-79", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008263"}, {"RECTYPE": "D", "MH": "Macrophages", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Monocyte-Derived Macrophages|T025|NON|EQV|NLM (2006)|050415|abcdef", "ENTRY": "Monocyte-Derived Macrophage", "MN": "A15.382.680.397", "FX": "Phagocytosis", "MH_TH": "NLM (1966)", "ST": "T025", "MS": "The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.)", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008264"}, {"RECTYPE": "D", "MH": "Macrostomia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Macrostomias", "MN": "C16.131.850.525.480", "MH_TH": "NLM (1965)", "ST": "T019", "AN": "overwide mouth; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Greatly exaggerated width of the mouth, resulting from failure of union of the maxillary and mandibular processes, with extension of the oral orifice toward the ear. The defect may be unilateral or bilateral. (Dorland, 27th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008265"}, {"RECTYPE": "D", "MH": "Macula Lutea", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Macula Luteas", "MN": "A09.371.729.522", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "a depression on the retina; macular dis: coord IM with RETINAL DISEASES (IM)", "MS": "An oval area in the retina, 3 to 5 mm in diameter, usually located temporal to the posterior pole of the eye and slightly below the level of the optic disk. It is characterized by the presence of a yellow pigment diffusely permeating the inner layers, contains the fovea centralis in its center, and provides the best phototropic visual acuity. It is devoid of retinal blood vessels, except in its periphery, and receives nourishment from the choriocapillaris of the choroid. (From Cline et al., Dictionary of Visual Science, 4th ed)", "MR": "20040728", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008266"}, {"RECTYPE": "D", "MH": "Acoustic Maculae", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Maculae, Acoustic|T023|NON|EQV|NLM (1995)|930915|abcdef", "ENTRY": "Maculas, Acoustic", "MN": "A09.923.500.625.125", "MH_TH": "NLM (1979)", "ST": "T023", "PI": "Labyrinth (1966-1978)", "MS": "The sensory areas on the vertical wall of the saccule and in the floor of the utricle. The hair cells in the maculae are innervated by fibers of the VESTIBULAR NERVE.", "OL": "use ACOUSTIC MACULAE to search MACULAE, ACOUSTIC 1979-94", "PM": "95; was MACULAE, ACOUSTIC 1979-94 (see under SACCULE AND UTRICLE 1983-90, see under LABYRINTH 1979-82)", "HN": "95; was MACULAE, ACOUSTIC 1979-94 (see under SACCULE AND UTRICLE 1983-90, see under LABYRINTH 1979-82)", "MR": "20210630", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D008267"}, {"RECTYPE": "D", "MH": "Macular Degeneration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Maculopathy, Age-Related|T047|NON|NRW|NLM (1995)|930913|MACULOPATHY AGE RELAT|abcdefv", "ENTRY": "Maculopathy, Age Related", "MN": "C11.768.585.439", "FX": "Vitelliform Macular Dystrophy", "MH_TH": "NLM (1975)", "ST": "T047", "PI": "Retinal Degeneration (1970-1978)", "MS": "Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.", "OL": "search RETINAL DEGENERATION 1970-74", "PM": "79; was see under RETINAL DEGENERATION 1970-78", "HN": "79(75); was see under RETINAL DEGENERATION 1970-78", "CATSH": "CAT LIST", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D008268"}, {"RECTYPE": "D", "MH": "Macular Edema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Macular Edema, Cystoid|T047|NON|NRW|NLM (1984)|OMIM (2013)|990101|abcdeef", "ENTRY": "Syndrome, Irvine-Gass", "MN": "C11.768.585.439.245", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Macula Lutea (1966-1983)", "MS": "Fluid accumulation in the outer layer of the MACULA LUTEA that results from intraocular or systemic insults. It may develop in a diffuse pattern where the macula appears thickened or it may acquire the characteristic petaloid appearance referred to as cystoid macular edema. Although macular edema may be associated with various underlying conditions, it is most commonly seen following intraocular surgery, venous occlusive disease, DIABETIC RETINOPATHY, and posterior segment inflammatory disease. (From Survey of Ophthalmology 2004; 49(5) 470-90)", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19830207", "DC": "1", "DX": "19840101", "UI": "D008269"}, {"RECTYPE": "D", "MH": "Madagascar", "AQ": "EH EP", "PRINT ENTRY": "Malagasy Republic|T083|NAM|EQV|UNK (19XX)|790530|abcdef", "MN": "Z01.639.520.500", "MH_TH": "POPLINE (1980)", "ST": "T083", "AN": "the largest of the Indian Ocean Islands; entry term MALAGASY REPUBLIC was its former name", "MS": "One of the Indian Ocean Islands off the southeast coast of Africa. Its capital is Antananarivo. It was formerly called the Malagasy Republic. Discovered by the Portuguese in 1500, its history has been tied predominantly to the French, becoming a French protectorate in 1882, a French colony in 1896, and a territory within the French union in 1946. The Malagasy Republic was established in the French Community in 1958 but it achieved independence in 1960. Its name was changed to Madagascar in 1975. (From Webster's New Geographical Dictionary, 1988, p714)", "OL": "use MADAGASCAR to search MALAGASY REPUBLIC 1966-79", "HN": "80; was MALAGASY REPUBLIC 1964-79", "MR": "20220708", "DA": "19990101", "DC": "4", "DX": "19800101", "UI": "D008270"}, {"RECTYPE": "D", "MH": "Mycetoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Maduromycosis|T047|NON|NRW|NLM (1963)|990101|abcdef", "ENTRY": "Eumycetoma|T047|NON|NRW|NLM (2009)|080331|abcdef", "MN": "C17.800.838.765.557", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "coordinate with causative organism (IM) or precoordinate organism/dis (IM) if pertinent", "MS": "A chronic progressive subcutaneous infection caused by species of fungi (eumycetoma), or actinomycetes (actinomycetoma). It is characterized by tumefaction, abscesses, and tumor-like granules representing microcolonies of pathogens, such as MADURELLA fungi and bacteria ACTINOMYCETES, with different grain colors.", "PM": "2009; see MADUROMYCOSIS 1963-2008", "HN": "2009 (1963)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D008271"}, {"RECTYPE": "D", "MH": "Mafenide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfabenzamine|T109|T195|NON|NRW|UNK (19XX)|790509|abbcdef", "ENTRY": "4 Homosulfanilamide", "MN": "D02.886.590.700.570", "PA": "Anti-Infective Agents, Local", "MH_TH": "USAN (1967)", "ST": "T121", "N1": "Benzenesulfonamide, 4-(aminomethyl)-", "RN": "58447S8P4L", "RR": "RQ6LP6Z0WY", "PI": "Tosyl Compounds (1973-1974)", "MS": "A sulfonamide that inhibits the enzyme CARBONIC ANHYDRASE and is used as a topical anti-bacterial agent, especially in burn therapy.", "PM": "1991; was see under SULFONAMIDES 1975-1990", "HN": "1991 (1975); was see under SULFONAMIDES 1975-1990", "MR": "20230608", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008272"}, {"RECTYPE": "D", "MH": "Magic", "AQ": "HI PX", "ENTRY": "Magics", "MN": "I01.076.201.450.897.439", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "IM; consider also WITCHCRAFT", "MS": "Beliefs and practices concerned with producing desired results through supernatural forces or agents as with the manipulation of fetishes or rituals.", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008273"}, {"RECTYPE": "D", "MH": "Magnesium", "AQ": "AD AE AG AN BL CF CH CL EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.547.500", "EC": "deficiency:Magnesium Deficiency", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Magnesium", "RN": "I38ZP9992A", "RR": "7439-95-4 (Magnesium)", "MS": "A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008274"}, {"RECTYPE": "D", "MH": "Magnesium Deficiency", "DE": "MAGNESIUM DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Magnesium Deficiencies", "MN": "C18.654.521.500.439", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear. Deficiency of body magnesium can exist even when serum values are normal. In addition, magnesium deficiency may be organ-selective, since certain tissues become deficient before others. (Harrison's Principles of Internal Medicine, 12th ed, p1936)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008275"}, {"RECTYPE": "D", "MH": "Magnesium Hydroxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Brucite|T121|T197|NON|NRW|UNK (19XX)|760413|abbcdef", "ENTRY": "Hydroxide, Magnesium", "MN": "D01.524.485", "PA": "Antacids", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Magnesium hydroxide (Mg(OH)2)", "RN": "NBZ3QY004S", "RR": "1309-42-8 (Magnesium Hydroxide)", "PI": "Magnesium (1966-1976)", "MS": "An inorganic compound that occurs in nature as the mineral brucite. It acts as an antacid with cathartic effects.", "PM": "91; was see under MAGNESIUM 1977-90", "HN": "91(77); was see under MAGNESIUM 1977-90", "MR": "20150623", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D008276"}, {"RECTYPE": "D", "MH": "Magnesium Oxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxide, Magnesium", "MN": "D01.650.550.575", "PA": "Antacids", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Magnesium oxide (MgO)", "RN": "3A3U0GI71G", "RR": "1309-48-4 (Magnesium Oxide)", "AN": "an antacid & cathartic", "MS": "Magnesium oxide (MgO). An inorganic compound that occurs in nature as the mineral periclase. In aqueous media combines quickly with water to form magnesium hydroxide. It is used as an antacid and mild laxative and has many nonmedicinal uses.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008277"}, {"RECTYPE": "D", "MH": "Magnesium Sulfate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Magnesium", "MN": "D01.875.800.800.850.500", "PA": "Tocolytic Agents", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Sulfuric acid magnesium salt (1:1)", "RN": "7487-88-9", "RR": "10034-99-8 (heptahydrate)", "MS": "A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008278"}, {"RECTYPE": "D", "MH": "Magnetic Resonance Imaging", "DE": "MRI", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "fMRI|T060|ABB|NRW|NLM (1997)|960516|abcdef", "ENTRY": "Steady State Free Precession MRI", "MN": "E01.370.350.825.500", "FX": "Magnetic Resonance Spectroscopy", "MH_TH": "NLM (1988)", "ST": "T060", "AN": "general or unspecified; prefer specifics; do not confuse with MAGNETIC RESONANCE SPECTROSCOPY: check text", "PI": "Nuclear Magnetic Resonance (1966-1987)", "MS": "Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.", "PM": "1988; NMR TOMOGRAPHY & TOMOGRAPHY, NMR & TOMOGRAPHY, PROTON SPIN were see NUCLEAR MAGNETIC RESONANCE 1985-1987; for CHEMICAL SHIFT IMAGING see NUCLEAR MAGNETIC RESONANCE 1995-2000", "HN": "1988; for NMR TOMOGRAPHY & TOMOGRAPHY, NMR & TOMOGRAPHY, PROTON SPIN use MAGNETIC RESONANCE SPECTROSCOPY 1985-1987; for CHEMICAL SHIFT IMAGING use MAGNETIC RESONANCE SPECTROSCOPY 1995-2000", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19870508", "DC": "1", "DX": "19880101", "UI": "D008279"}, {"RECTYPE": "D", "MH": "Magnetics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Magnetic", "MN": "H01.671.493", "FX": "Magnets", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use MAGNETIC PHENOMENA for characteristics of magnetic substances; MAGNETIC FIELDS is also available", "MS": "The study of MAGNETIC PHENOMENA.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008280"}, {"RECTYPE": "D", "MH": "Maine", "AQ": "EH EP", "MN": "Z01.107.567.875.550.500", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A state bounded on the east by the Atlantic Ocean, on the north by Canada, and on the south and west by New Hampshire.", "MR": "20160628", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008281"}, {"RECTYPE": "D", "MH": "Mainstreaming, Education", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Mainstreaming, Educational|T065|NON|EQV|NLM (2020)|190118|abcdef", "ENTRY": "Education Mainstreaming", "MN": "I02.233.213.600", "MH_TH": "NLM (2020)", "ST": "T065", "PI": "Education, Special/trends (1968-1986)", "MS": "Most frequently refers to the integration of a physically or mentally disabled child into the regular class of normal peers and provision of the appropriately determined educational program.", "PM": "2020; was MAINSTREAMING (EDUCATION) 1987-2019", "HN": "2020 (1987); was MAINSTREAMING (EDUCATION) 1987-2019", "MR": "20190118", "DA": "19860415", "DC": "1", "DX": "19870101", "UI": "D008282"}, {"RECTYPE": "D", "MH": "Maintenance", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Maintenances", "MN": "N02.628", "MH_TH": "NLM (1973)", "ST": "T057", "AN": "\"upkeep of property or equipment\"; NIM", "MS": "The upkeep of property or equipment.", "PM": "73", "HN": "73", "MR": "19991105", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008283"}, {"RECTYPE": "D", "MH": "Maintenance and Engineering, Hospital", "DE": "MAINTENANCE ENGINEERING HOSP", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Landscaping, Hospital|T090|NON|NRW|UNK (19XX)|770519|LANDSCAPING HOSP|abcdefv", "ENTRY": "Maintenance, Hospital|T093|NON|NRW|UNK (19XX)|790410|MAINTENANCE HOSP|abcdefv", "MN": "N04.452.442.452.422.450", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "Hospital department whose primary function is the upkeep and supervision of the buildings and grounds and the maintenance of hospital physical plant and equipment which requires engineering expertise.", "OL": "use MAINTENANCE AND ENGINEERING, HOSPITAL to search MAINTENANCE, HOSPITAL 1978-79 & HOSPITAL MAINTENANCE 1966-77", "PM": "80; was MAINTENANCE, HOSPITAL 1978-79; was HOSPITAL MAINTENANCE 1963-77", "HN": "80; was MAINTENANCE, HOSPITAL 1978-79; was HOSPITAL MAINTENANCE 1963-77", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D008284"}, {"RECTYPE": "D", "MH": "Major Histocompatibility Complex", "DE": "MHC", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Histocompatibility Complex|T028|NON|EQV|UNK (19XX)|780320|abcdef", "ENTRY": "Major Histocompatibility Complices", "MN": "G12.500.500", "FX": "Genes, MHC Class I", "MH_TH": "NLM (1979)", "ST": "T028", "PI": "Histocompatibility Antigens (1973-1978)", "MS": "The genetic region which contains the loci of genes which determine the structure of the serologically defined (SD) and lymphocyte-defined (LD) TRANSPLANTATION ANTIGENS, genes which control the structure of the IMMUNE RESPONSE-ASSOCIATED ANTIGENS, HUMAN; the IMMUNE RESPONSE GENES which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19780320", "DC": "1", "DX": "19790101", "UI": "D008285"}, {"RECTYPE": "D", "MH": "Malabsorption Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Malabsorption", "MN": "C18.452.603", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients.", "PM": "65; MALABSORPTION SYNDROME was see SPRUE 1963-64; MALABSORPTION SYNDROME, CHILDHOOD was see CELIAC DISEASE 1963-64", "HN": "65; MALABSORPTION SYNDROME was see SPRUE 1963-64; MALABSORPTION SYNDROME, CHILDHOOD was see CELIAC DISEASE 1963-64", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008286"}, {"RECTYPE": "D", "MH": "Malacoplakia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Malakoplakias", "MN": "C23.550.548", "MH_TH": "ORD (2010)", "ST": "T046", "MS": "The formation of soft patches on the mucous membrane of a hollow organ, such as the urogenital tract or digestive tract.", "PM": "1973", "HN": "1973(1965)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008287"}, {"RECTYPE": "D", "MH": "Malaria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Remittent Fever|T047|NON|EQV|NLM (2006)|050114|abcdef", "ENTRY": "Plasmodium Infection", "MN": "C01.920.852.750", "FX": "Antimalarials", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "general or unspecified; prefer specifics; specify Plasmodium species if possible but note P. falciparum malaria equals MALARIA, FALCIPARUM; P. vivax malaria equals MALARIA, VIVAX; tertian malaria equals MALARIA, VIVAX, quartan malaria: coordinate with PLASMODIUM MALARIAE; malariotherapy equals HYPERTHERMIA, INDUCED: do not confuse with MALARIA /ther", "MS": "A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.", "OL": "use MALARIA to search MALARIA CONTROL 1966", "PM": "MALARIA CONTROL was heading 1963-66", "HN": "MALARIA CONTROL was heading 1963-66", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008288"}, {"RECTYPE": "D", "MH": "Malaria, Avian", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Malarias, Avian", "MN": "C22.131.498", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord with BIRDS (NIM) or specific bird or fowl (IM)", "MS": "Any of a group of infections of fowl caused by protozoa of the genera PLASMODIUM, Leucocytozoon, and Haemoproteus. The life cycles of these parasites and the disease produced bears strong resemblance to those observed in human malaria.", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008289"}, {"RECTYPE": "D", "MH": "Malassezia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Saccharomyces ovalis|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Pityrosporum orbiculare|T004|NON|NRW|NLM (1999)|980226|abcdef", "MN": "B01.300.930.574", "FX": "Tinea Versicolor", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid55193", "RR": "txid55194", "AN": "infection: coordinate with DERMATOMYCOSES or TINEA VERSICOLOR ", "MS": "A mitosporic fungal genus that causes a variety of skin disorders. Malassezia furfur (Pityrosporum orbiculare) causes TINEA VERSICOLOR.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008290"}, {"RECTYPE": "D", "MH": "Malate Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NAD Malate Dehydrogenase", "MN": "D08.811.682.047.820.496", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "(S)-Malate:NAD+ oxidoreductase", "RN": "EC 1.1.1.37", "RR": "9001-64-3 (CAS RN)", "MS": "An enzyme that catalyzes the conversion of (S)-malate and NAD+ to oxaloacetate and NADH. EC 1.1.1.37.", "OL": "use MALATE DEHYDROGENASE to search MALIC ENZYME 1983-93", "PM": "MALIC ENZYME was see MALATE DEHYDROGENASE 1983-93", "HN": "MALIC ENZYME was see MALATE DEHYDROGENASE 1983-93", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D008291"}, {"RECTYPE": "D", "MH": "Malate Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Malate Synthetase|T116|T126|NON|EQV|UNK (19XX)|760414|abbcdef", "ENTRY": "Transacetylase, Glyoxylate", "MN": "D08.811.913.050.618", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "L-Malate glyoxylate-lyase (CoA-acetylating)", "RN": "EC 2.3.3.9", "RR": "9013-48-3 (CAS RN)", "PI": "Malates (1973-1976)", "MS": "An important enzyme in the glyoxylic acid cycle which reversibly catalyzes the synthesis of L-malate from acetyl-CoA and glyoxylate. This enzyme was formerly listed as EC 4.1.3.2.", "PM": "91; was see under KETOACID-LYASES 1977-90", "HN": "91(77); was see under KETOACID-LYASES 1977-90", "MR": "20050630", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D008292"}, {"RECTYPE": "D", "MH": "Malates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.511.505", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with MALEATES", "MS": "Derivatives of malic acid (the structural formula: (COO-)2CH2CHOH), including its salts and esters.", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008293"}, {"RECTYPE": "D", "MH": "Malathion", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Sadophos|T109|T131|TRD|NRW|UNK (19XX)|800801|abbcdef", "MN": "D02.886.300.692.500", "PA": "Insecticides", "MH_TH": "USP (19XX)", "ST": "T131", "N1": "Butanedioic acid, ((dimethoxyphosphinothioyl)thio)-, diethyl ester", "RN": "U5N7SU872W", "RR": "121-75-5 (Malathion)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Thiomalates (1966-1971)", "MS": "A wide spectrum aliphatic organophosphate insecticide widely used for both domestic and commercial agricultural purposes.", "PM": "72", "HN": "72", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008294"}, {"RECTYPE": "D", "MH": "Malawi", "AQ": "EH EP", "PRINT ENTRY": "Nyasaland|T083|NAM|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Republic of Malawi|T083|NAM|EQV|NLM (2009)|080326|abcdef", "MN": "Z01.058.290.175.500", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in southern Africa east of ZAMBIA and MOZAMBIQUE. Its capital is Lilongwe. It was formerly called Nyasaland.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008295"}, {"RECTYPE": "D", "MH": "Malaysia", "AQ": "EH EP", "PRINT ENTRY": "Sarawak|T083|NAM|NRW|NLM (1976)|750101|abcdef", "MN": "Z01.252.145.487", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "A parliamentary democracy with a constitutional monarch in southeast Asia, consisting of 11 states (West Malaysia) on the Malay Peninsula and two states (East Malaysia) on the island of BORNEO. It is also called the Federation of Malaysia. Its capital is Kuala Lumpur. Before 1963 it was the Union of Malaya. It reorganized in 1948 as the Federation of Malaya, becoming independent from British Malaya in 1957 and becoming Malaysia in 1963 as a federation of Malaya, Sabah, Sarawak, and Singapore (which seceded in 1965). The form Malay- probably derives from the Tamil malay, mountain, with reference to its geography. (From Webster's New Geographical Dictionary, 1988, p715 & Room, Brewer's Dictionary of Names, 1992, p329)", "MR": "20220818", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008296"}, {"RECTYPE": "D", "MH": "Male", "ENTRY": "Males|T032|NON|EQV|UNK (19XX)|790529|abcdef", "MH_TH": "NLM (1966)", "ST": "T032", "AN": "check tag only for male organs, diseases, physiol processes, genetics, etc.; do not confuse with MEN as a social, cultural, political, economic force; CATALOGER: Do not use", "HN": "1966", "MR": "20180709", "DA": "19990101", "DC": "3", "DX": "19660101", "UI": "D008297"}, {"RECTYPE": "D", "MH": "Maleates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.081.337.502", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with MALATES", "MS": "Derivatives of maleic acid (the structural formula (COO-)-C=C-(COO-)), including its salts and esters.", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008298"}, {"RECTYPE": "D", "MH": "Maleic Anhydrides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2,5-Furandiones|T109|T130|NON|EQV|UNK (19XX)|760512|FURANDIONES 02 05|abbcdefs", "ENTRY": "Anhydrides, Maleic", "MN": "D03.383.312.520", "MH_TH": "NLM (1977)", "ST": "T130", "RN": "0", "RR": "V5877ZJZ25", "PI": "Maleates (1966-1976)", "MS": "Used in copolymerization reactions, in the Diels-Alder(diene)synthesis, in the preparation of resins, pharmaceuticals and agricultural chemicals. It is a powerful irritant and causes burns.", "OL": "use MALEIC ANHYDRIDES to search MALEIC ANHYDRIDE 1977-78", "PM": "91; was see under FURANS 1979-90; was MALEIC ANHYDRIDE see under FURANS 1977-78", "HN": "91(79); was see under FURANS 1979-90; was MALEIC ANHYDRIDE see under FURANS 1977-78", "MR": "20160531", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D008299"}, {"RECTYPE": "D", "MH": "Maleic Hydrazide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Maleic Acid Hydrazide|T109|T131|NON|EQV|UNK (19XX)|760512|abbcdef", "ENTRY": "Hydrazide, Maleic Acid", "MN": "D03.383.710.400", "PA": "Plant Growth Regulators", "MH_TH": "NLM (1977)", "ST": "T131", "N1": "3,6-Pyridazinedione, 1,2-dihydro-", "RN": "TQ7L3FCV66", "RR": "123-33-1 (Maleic Hydrazide)", "PI": "Pyridazines (1966-1976)", "MS": "1,2-Dihydro-3,6-pyridazinedione. A herbicide and plant growth regulator; also used to control suckering of tobacco. Its residue in food and tobacco is highly toxic, causing CNS disturbances and liver damage.", "PM": "91; was see under PYRIDAZINES 1977-90", "HN": "91(77); was see under PYRIDAZINES 1977-90", "MR": "20160531", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D008300"}, {"RECTYPE": "D", "MH": "Maleimides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.578.399", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Maleates (1966-1971)", "MS": "Derivatives of maleimide (the structural formula H2C2(CO)2NH) containing a pyrroledione ring where the hydrogen atom of the NH group is replaced with aliphatic or aromatic groups.", "PM": "74", "HN": "74(72)", "MR": "20160426", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008301"}, {"RECTYPE": "D", "MH": "Mali", "AQ": "EH EP", "ENTRY": "Republic of Mali|T083|NAM|EQV|NLM (2009)|080701|abcdef", "MN": "Z01.058.290.190.500", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in western Africa, east of MAURITANIA and south of ALGERIA. Its capital is Bamako. From 1904-1920 it was known as Upper Senegal-Niger; prior to 1958, as French Sudan; 1958-1960 as the Sudanese Republic and 1959-1960 it joined Senegal in the Mali Federation. It became an independent republic in 1960.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008302"}, {"RECTYPE": "D", "MH": "Malignant Carcinoid Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Malignant Carcinoid", "MN": "C04.557.580.625.650.200.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "for cardiac manifestation index CARCINOID HEART DISEASE", "MS": "A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008303"}, {"RECTYPE": "D", "MH": "Malignant Catarrh", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Malignant Catarrhs", "MN": "C22.196.540", "MH_TH": "NLM (1971)", "ST": "T047", "AN": "caused by a herpesvirus; usually animal; check tag ANIMALS; don't forget also CATTLE (NIM) but do not index under CATTLE DISEASES", "PI": "Herpesvirus Infections/VE (1966-1970)", "MS": "A herpesvirus infection of cattle characterized by catarrhal inflammation of the upper respiratory and alimentary epithelia, keratoconjunctivitis, encephalitis and lymph node enlargement. Syn: bovine epitheliosis, snotsiekte.", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D008304"}, {"RECTYPE": "D", "MH": "Malignant Hyperthermia", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Malignant Hyperpyrexia|T033|T046|NON|EQV|GHR (2014)|ORD (2010)|UNK (19XX)|740330|abbcdeeef", "ENTRY": "Malignant Hyperpyrexias", "MN": "C23.888.119.455.500", "FX": "Fever", "MH_TH": "ORD (2010)", "ST": "T046", "PI": "Fever (1966-1972)", "MS": "Rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008305"}, {"RECTYPE": "D", "MH": "Malingering", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "MN": "F01.145.126.925", "MH_TH": "NLM (1966)", "ST": "T055", "MS": "Simulation of symptoms of illness or injury with intent to deceive in order to obtain a goal, e.g., a claim of physical illness to avoid jury duty.", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008306"}, {"RECTYPE": "D", "MH": "Malleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A09.246.397.247.524", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "one of the 3 ear ossicles", "MS": "The largest of the auditory ossicles, and the one attached to the membrana tympani (TYMPANIC MEMBRANE). Its club-shaped head articulates with the INCUS.", "OL": "search EAR OSSICLES 1966-74", "PM": "91; was see under EAR OSSICLES 1975-90", "HN": "91(75); was see under EAR OSSICLES 1975-90", "MR": "19950313", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008307"}, {"RECTYPE": "D", "MH": "Mallory-Weiss Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Mallory-Weiss", "MN": "C06.405.117.468.524", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A condition characterized by mucosal tears at the ESOPHAGOGASTRIC JUNCTION, sometimes with HEMATEMESIS. Typically it is caused by forceful bouts of retching or VOMITING.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008309"}, {"RECTYPE": "D", "MH": "Malocclusion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tooth Crowding|T047|NON|NRW|UNK (19XX)|830310|abcdef", "ENTRY": "Malocclusions", "MN": "C07.793.494", "FX": "Prognathism", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "entry term ANGLE'S CLASSIFICATION: Angle's classes MALOCCLUSION, ANGLE CLASS I & MALOCCLUSION, ANGLE CLASS II & MALOCCLUSION, ANGLE CLASS III are also available but index Angle's classification in general or unspecified as MALOCCLUSION /class", "MS": "Such malposition and contact of the maxillary and mandibular teeth as to interfere with the highest efficiency during the excursive movements of the jaw that are essential for mastication. (Jablonski, Illustrated Dictionary of Dentistry, 1982)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008310"}, {"RECTYPE": "D", "MH": "Malocclusion, Angle Class I", "DS": "MALOCCLUSION ANGLE CLASS 01", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Angle Class I|T047|EPO|EQV|UNK (19XX)|780126|ANGLE CLASS 01|abcdefs", "ENTRY": "Class I, Angle", "MN": "C07.793.494.610", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "Angle refers to Edward Hartley Angle, Amer orthodontist", "PI": "Malocclusion (1966-1978)", "MS": "Malocclusion in which the mandible and maxilla are anteroposteriorly normal as reflected by the relationship of the first permanent molar (i.e., in neutroclusion), but in which individual teeth are abnormally related to each other.", "PM": "91; was see under MALOCCLUSION 1979-90", "HN": "91(79); was see under MALOCCLUSION 1979-90", "CATSH": "CAT LIST", "MR": "19910618", "DA": "19780126", "DC": "1", "DX": "19910101", "UI": "D008311"}, {"RECTYPE": "D", "MH": "Malocclusion, Angle Class II", "DS": "MALOCCLUSION ANGLE CLASS 02", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Angle Class II|T047|EPO|EQV|UNK (19XX)|780126|ANGLE CLASS 02|abcdefs", "ENTRY": "Class II, Angle", "MN": "C07.793.494.630", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "Angle refers to Edward Hartley Angle, Amer orthodontist", "PI": "Malocclusion (1966-1978)", "MS": "Malocclusion in which the mandible is posterior to the maxilla as reflected by the relationship of the first permanent molar (distoclusion).", "PM": "91; was see under MALOCCLUSION 1979-90", "HN": "91(79); was see under MALOCCLUSION 1979-90", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19780126", "DC": "1", "DX": "19910101", "UI": "D008312"}, {"RECTYPE": "D", "MH": "Malocclusion, Angle Class III", "DS": "MALOCCLUSION ANGLE CLASS 03", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Angle Class III|T047|EPO|EQV|UNK (19XX)|780126|ANGLE CLASS 03|abcdefs", "ENTRY": "Underbite|T047|NON|EQV|NLM (2011)|090930|abcdef", "MN": "C07.793.494.650", "FX": "Prognathism", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "Angle refers to Edward Hartley Angle, American orthodontist", "PI": "Malocclusion (1966-1978)", "MS": "Malocclusion in which the mandible is anterior to the maxilla as reflected by the first relationship of the first permanent molar (mesioclusion).", "PM": "91; was see under MALOCCLUSION 1979-90", "HN": "91(79); was see under MALOCCLUSION 1979-90", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19780126", "DC": "1", "DX": "19910101", "UI": "D008313"}, {"RECTYPE": "D", "MH": "Malonates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.081.337.540", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of malonic acid (the structural formula CH2(COOH)2), including its salts and esters.", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008314"}, {"RECTYPE": "D", "MH": "Malondialdehyde", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Propanedial|T109|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abcdeef", "ENTRY": "Malondialdehyde, Sodium", "MN": "D02.047.700", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "Propanedial", "RN": "4Y8F71G49Q", "RR": "ZRM642YYUE", "PI": "Malonates (1971-1974)", "MS": "The dialdehyde of malonic acid.", "PM": "91; was see under MALONATES 1975-90", "HN": "91(75); was see under MALONATES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008315"}, {"RECTYPE": "D", "MH": "Malonyl Coenzyme A", "AQ": "AA AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Malonyl CoA|T109|T114|T123|EQV|UNK (19XX)|770525|abbbdef", "ENTRY": "Coenzyme A, Malonyl", "MN": "D13.695.827.068.382.300.500", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Coenzyme A, S-(hydrogen propanedioate)", "RN": "524-14-1", "PI": "Malonates (1966-1977)", "MS": "A coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems.", "PM": "91; was see under ACYL COENZYME A 1978-90", "HN": "91(78); was see under ACYL COENZYME A 1978-90", "MR": "20160701", "DA": "19770520", "DC": "1", "DX": "19910101", "UI": "D008316"}, {"RECTYPE": "D", "MH": "Malpighian Tubules", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Malpighian Tubule|T023|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Tubules, Malpighian", "MN": "A13.574", "MH_TH": "NLM (1964)", "ST": "T023", "AN": "in intestines of arthropods; \"malpighian\" is not capitalized in titles or translations", "MS": "Slender tubular or hairlike excretory structures found in insects. They emerge from the alimentary canal between the mesenteron (midgut) and the proctodeum (hindgut).", "PM": "91; was see under CLOACA 1964-90", "HN": "91(64); was see under CLOACA 1964-90", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008317"}, {"RECTYPE": "D", "MH": "Malpractice", "AQ": "CL EC HI LJ SN TD", "PRINT ENTRY": "Professional Negligence|T080|NON|REL|NLM (2024)|230420|abcdef", "ENTRY": "Professional Negligences", "MN": "N03.706.535.606", "FX": "Professional Misconduct", "MH_TH": "BIOETHICS (1977)", "ST": "T080", "AN": "not restricted to med malpractice; coord IM with specialty (IM)", "MS": "Failure of a professional person, a physician or lawyer, to render proper services through reprehensible ignorance or negligence or through criminal intent, especially when injury or loss follows. (Random House Unabridged Dictionary, 2d ed)", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008318"}, {"RECTYPE": "D", "MH": "Malta", "AQ": "EH EP", "MN": "Z01.639.640.650", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "a state of 3 islands south of Sicily", "MS": "An independent state consisting of three islands: Malta, Comino and Gozo, located in the Mediterranean Sea, south of Sicily. Its capital is Valetta.", "HN": "75", "MR": "20160707", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D008319"}, {"RECTYPE": "D", "MH": "Maltose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.947.750.523", "PA": "Sweetening Agents", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "D-Glucose, 4-O-alpha-D-glucopyranosyl-", "RN": "69-79-4", "AN": "ISOMALTOSE is available", "MS": "A dextrodisaccharide from malt and starch. It is used as a sweetening agent and fermentable intermediate in brewing. (Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008320"}, {"RECTYPE": "D", "MH": "Mammary Glands, Animal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Udder|T023|NON|BRD|UNK (19XX)|780504|abcdef", "ENTRY": "Udders", "MN": "A13.589", "MH_TH": "UNK (19XX)", "ST": "T023", "MS": "MAMMARY GLANDS in the non-human MAMMALS.", "PM": "2004; for UDDER see UDDER 1968-1978", "HN": "2004 (1966)", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D008321"}, {"RECTYPE": "D", "MH": "Mammals", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Mammalia|T015|NON|EQV|NLM (2009)|070716|abcdef", "ENTRY": "Mammal", "MN": "B01.050.150.900.649", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid40674", "AN": "avoid: too general: prefer specifics", "MS": "Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008322"}, {"RECTYPE": "D", "MH": "Mammary Arteries", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Internal Thoracic Artery|T023|NON|NRW|NLM (1999)|980213|abcdef", "ENTRY": "Thoracic Artery, Internal", "MN": "A07.015.114.891.525", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "Arteries originating from the subclavian or axillary arteries and distributing to the anterior thoracic wall, mediastinal structures, diaphragm, pectoral muscles and mammary gland.", "OL": "search THORACIC ARTERIES 1966-74", "PM": "91; was see under THORACIC ARTERIES 1975-90", "HN": "91(75); was see under THORACIC ARTERIES 1975-90", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008323"}, {"RECTYPE": "D", "MH": "Mammary Tumor Virus, Mouse", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Mouse mammary tumor virus|T005|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Mammary Tumor Viruses, Mouse|T005|NON|EQV|NLM (1966)|990101|abcdef", "MN": "B04.820.650.124.500", "FX": "Minor Lymphocyte Stimulatory Loci", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11757", "AN": "infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + (if pertinent) MAMMARY NEOPLASMS, EXPERIMENTAL (IM)", "MS": "The type species of BETARETROVIRUS commonly latent in mice. It causes mammary adenocarcinoma in a genetically susceptible strain of mice when the appropriate hormonal influences operate.", "PM": "2002; see MAMMARY TUMOR VIRUSES, MOUSE 1994-2001, see MAMMARY CANCER VIRUS 1966-1993", "HN": "2002 (1966)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008324"}, {"RECTYPE": "D", "MH": "Mammary Neoplasms, Experimental", "DE": "MAMMARY NEOPL EXPER", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "ENTRY": "Neoplasm, Experimental Mammary", "MN": "E05.598.500.496.843", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "animal only; coordinate IM with histological type of neoplasm (IM) + specific animal (NIM) + check tag ANIMALS", "MS": "Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008325"}, {"RECTYPE": "D", "MH": "Mammillary Bodies", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Mamillary Bodies|T023|NON|EQV|NLM (1971)|990101|abcdef", "ENTRY": "Mammillary Body", "MN": "A08.186.211.200.317.357.362.500", "MH_TH": "NLM (1992)", "ST": "T023", "PI": "Hypothalamus (1966-1970)", "MS": "A pair of nuclei and associated GRAY MATTER in the interpeduncular space rostral to the posterior perforated substance in the POSTERIOR HYPOTHALAMUS.", "OL": "use MAMILLARY BODIES to search MAMMILLARY BODIES 1971-91", "PM": "1992; was MAMMILLARY BODIES 1971-1991 and 1992-2014; was MAMMILLARY BODIES see under HYPOTHALAMUS 1963-70", "HN": "2015(1992); was MAMMILLARY BODIES 1971-1991 and 1992-2014; was MAMMILLARY BODIES see under HYPOTHALAMUS 1963-70;", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D008326"}, {"RECTYPE": "D", "MH": "Mammography", "DE": "MAMMOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "X-ray Breast Tomosyntheses", "MN": "E01.370.350.700.500", "MH_TH": "NLM (1964)", "ST": "T060", "MS": "Radiographic examination of the breast.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20160606", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008327"}, {"RECTYPE": "D", "MH": "Man-Machine Systems", "ENTRY": "Systems, Man-Machine", "MN": "J01.897.441", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "with computers, USER-COMPUTER INTERFACE is also available", "MS": "A system in which the functions of the man and the machine are interrelated and necessary for the operation of the system.", "PM": "70", "HN": "70(66)", "CATSH": "CAT LIST", "MR": "19910108", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D008328"}, {"RECTYPE": "D", "MH": "Managed Care Programs", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Managed Health Care Insurance Plans|T058|NON|EQV|NLM (1992)|910102|abcdef", "ENTRY": "Programs, Managed Care", "MN": "N04.590.374.410", "MH_TH": "BIOETHICS (1994)", "ST": "T058", "AN": "specify geog", "MS": "Health insurance plans intended to reduce unnecessary health care costs through a variety of mechanisms, including: economic incentives for physicians and patients to select less costly forms of care; programs for reviewing the medical necessity of specific services; increased beneficiary cost sharing; controls on inpatient admissions and lengths of stay; the establishment of cost-sharing incentives for outpatient surgery; selective contracting with health care providers; and the intensive management of high-cost health care cases. The programs may be provided in a variety of settings, such as HEALTH MAINTENANCE ORGANIZATIONS and PREFERRED PROVIDER ORGANIZATIONS.", "PM": "90; was see under DELIVERY OF HEALTH CARE 1988-89", "HN": "90(88); was see under DELIVERY OF HEALTH CARE 1988-89", "MR": "19991103", "DA": "19870502", "DC": "1", "DX": "19900101", "UI": "D008329"}, {"RECTYPE": "D", "MH": "Management Audit", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Operational Audit|T058|NON|EQV|UNK (19XX)|810226|abcdef", "ENTRY": "Operational Audits", "MN": "N04.452.500", "MH_TH": "NLM (1982)", "ST": "T058", "MS": "Management review designed to evaluate efficiency and to identify areas in need of management improvement within the institution in order to ensure effectiveness in meeting organizational goals.", "PM": "91; was see under ORGANIZATION AND ADMINISTRATION 1982-90", "HN": "91(82); was see under ORGANIZATION AND ADMINISTRATION 1982-90", "MR": "19940505", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D008330"}, {"RECTYPE": "D", "MH": "Management Information Systems", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Systems, Management Information", "MN": "N04.452.515", "MH_TH": "NLM (1983)", "ST": "T170", "AN": "for automated systems do not coord with ELECTRONIC DATA PROCESSING", "PI": "Organization and Administration (1968-1982)", "MS": "Systems designed to provide information primarily concerned with the administrative functions associated with the provision and utilization of services; also includes program planning, etc.", "PM": "87; was see under INFORMATION SYSTEMS 1983-86", "HN": "87(83); was see under INFORMATION SYSTEMS 1983-86", "MR": "20180713", "DA": "19820428", "DC": "1", "DX": "19870101", "UI": "D008331"}, {"RECTYPE": "D", "MH": "Management Quality Circles", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Quality Circles|T057|NON|BRD|UNK (19XX)|840411|abcdef", "ENTRY": "Quality Circles, Management", "MN": "N04.452.677.420", "MH_TH": "NLM (1985)", "ST": "T057", "AN": "personnel & management as a labor-management team", "PI": "Quality Assurance, Health Care (1980-1984)", "MS": "Participation of employees with management as a labor-management team, in decisions pertaining to the operational activities of the organization or industry.", "PM": "91; was see under PERSONNEL MANAGEMENT 1985-90", "HN": "91(85); was see under PERSONNEL MANAGEMENT 1985-90", "MR": "19940505", "DA": "19840411", "DC": "1", "DX": "19910101", "UI": "D008332"}, {"RECTYPE": "D", "MH": "Mandelic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Mandelic", "MN": "D02.241.511.536", "PA": "Anti-Infective Agents, Urinary", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "a urinary anti-infective", "MS": "Analogs or derivatives of mandelic acid (alpha-hydroxybenzeneacetic acid).", "OL": "use MANDELIC ACIDS to search MANDELIC ACID 1966-74", "PM": "75; was MANDELIC ACID 1963-74", "HN": "75; was MANDELIC ACID 1963-74", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D008333"}, {"RECTYPE": "D", "MH": "Mandible", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ridges, Mylohyoid", "MN": "A14.521.632", "FX": "Temporomandibular Joint", "EC": "injuries:Mandibular Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "/growth: consider also MAXILLOFACIAL DEVELOPMENT; /innerv: consider also MANDIBULAR NERVE", "MS": "The largest and strongest bone of the FACE constituting the lower jaw. It supports the lower teeth.", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008334"}, {"RECTYPE": "D", "MH": "Mandibular Condyle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Mandibular Condyles", "MN": "A14.521.632.600", "FX": "Temporomandibular Joint", "MH_TH": "NLM (1965)", "ST": "T023", "MS": "The posterior process on the ramus of the mandible composed of two parts: a superior part, the articular portion, and an inferior part, the condylar neck.", "PM": "65", "HN": "65", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008335"}, {"RECTYPE": "D", "MH": "Mandibular Diseases", "DE": "MANDIBULAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mandibular Disease", "MN": "C07.320.610", "MH_TH": "NLM (1967)", "ST": "T047", "PI": "Mandible (1966)", "MS": "Diseases involving the MANDIBLE.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20151009", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008336"}, {"RECTYPE": "D", "MH": "Mandibular Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mandibular Fracture", "MN": "C26.915.300.425.500.400.255", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Fractures of the lower jaw.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008337"}, {"RECTYPE": "D", "MH": "Mandibular Injuries", "DE": "MANDIBULAR INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mandibular Injury", "MN": "C26.915.300.425.500.500", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Injuries to the lower jaw bone.", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008338"}, {"RECTYPE": "D", "MH": "Mandibular Neoplasms", "DE": "MANDIBULAR NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasms, Mandibular", "MN": "C07.320.610.583", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with histological type of neoplasm", "MS": "Tumors or cancer of the MANDIBLE.", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008339"}, {"RECTYPE": "D", "MH": "Mandibular Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Mylohyoid Nerve|T023|NON|NRW|NLM (2020)|190220|abcdef", "ENTRY": "Temporal Nerves, Deep", "MN": "A08.800.800.120.760.500", "EC": "injuries:Mandibular Nerve Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "disease: coordinate with CRANIAL NERVE DISEASES; neoplasms: coordinate with CRANIAL NERVE NEOPLASMS + histological type of neoplasm ", "MS": "A branch of the trigeminal (5th cranial) nerve. The mandibular nerve carries motor fibers to the muscles of mastication and sensory fibers to the teeth and gingivae, the face in the region of the mandible, and parts of the dura.", "MR": "20190521", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008340"}, {"RECTYPE": "D", "MH": "Mandibular Prosthesis", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Prosthesis, Mandibular", "MN": "E07.695.510.500", "FX": "Mandibular Prosthesis Implantation", "MH_TH": "NLM (1967)", "ST": "T074", "PI": "Prosthesis (1966)", "MS": "A prosthetic appliance for the replacement of areas of the mandible missing or defective as a result of deformity, disease, injury, or surgery.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008341"}, {"RECTYPE": "D", "MH": "Mandibulofacial Dysostosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Treacher Collins Syndrome|T019|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|760526|abcdeeeef", "ENTRY": "Treacher Collins-Franceschetti Syndromes", "MN": "C16.131.621.207.231.576", "MH_TH": "ORD (2010)", "ST": "T019", "MS": "A hereditary disorder occurring in two forms: the complete form (Franceschetti's syndrome) is characterized by a slant of the palpebral fissures, COLOBOMA of the lower lid, MICROGNATHIA and hypoplasia of the ZYGOMATIC ARCHES, and CONGENITAL MICROTIA. It is transmitted as an autosomal trait. The incomplete form (Treacher Collins syndrome) is characterized by the same anomalies in less pronounced degree. It occurs sporadically, but an autosomal dominant mode of transmission is suspected. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008342"}, {"RECTYPE": "D", "MH": "Maneb", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Manganese, ((1,2-ethanediylbis(carbamodithioato))(2-))-|T109|T131|NON|EQV|NLM (2020)|190701|abbcdef", "MN": "D02.886.706.250.500", "PA": "Fungicides, Industrial", "MH_TH": "NLM (1972)", "ST": "T131", "RN": "12427-38-2", "PI": "Thiocarbamates (1966-1971)", "MS": "Manganese derivative of ethylenebisdithiocarbamate. It is used in agriculture as a fungicide and has been shown to cause irritation to the eyes, nose, skin, and throat.", "PM": "91; was see under THIOCARBAMATES 1972-90", "HN": "91(72); was see under THIOCARBAMATES 1972-90", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008344"}, {"RECTYPE": "D", "MH": "Manganese", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK RE SD ST TO TU UR", "MN": "D01.552.544.484", "PA": "Trace Elements", "EC": "poisoning:Manganese Poisoning", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Manganese", "RN": "42Z2K6ZL8P", "RR": "7439-96-5 (Manganese)", "MS": "A trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. (From AMA Drug Evaluations Annual 1992, p2035)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008345"}, {"RECTYPE": "D", "MH": "Manifest Anxiety Scale", "AQ": "HI SN ST", "PRINT ENTRY": "Taylor Manifest Anxiety Scale|T060|EPO|NRW|UNK (19XX)|780503|abcdef", "ENTRY": "Scales, Manifest Anxiety", "MN": "F04.711.647.513.463", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "True-false questionnaire made up of items believed to indicate anxiety, in which the subject answers verbally the statement that describes him.", "OL": "search PERSONALITY INVENTORY 1968-74", "PM": "91; was see under PERSONALITY INVENTORY 1975-90", "HN": "91(75); was see under PERSONALITY INVENTORY 1975-90", "CATSH": "CAT LIST", "MR": "19920514", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008347"}, {"RECTYPE": "D", "MH": "Manikins", "PRINT ENTRY": "Mannequins|T073|NON|EQV|UNK (19XX)|780119|abcdef", "ENTRY": "Mannequin", "MN": "L01.462.500.820.090.545.129.400", "MH_TH": "NLM (1975)", "ST": "T073", "MS": "Inanimate physical models which bear likeness to human beings and are used for various purposes in place of humans.", "OL": "search MODELS, STRUCTURAL 1971-74", "PM": "91; was see under MODELS, ANATOMIC 1984-90; was see under MODELS, STRUCTURAL 1971-83", "HN": "91(75); was see under MODELS, ANATOMIC 1984-90; was see under MODELS, STRUCTURAL 1971-83", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008348"}, {"RECTYPE": "D", "MH": "Manipulation, Orthopedic", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Orthopedic Manipulation|T061|NON|EQV|NLM (1996)|950331|abcdef", "MN": "E02.831.535.867.433", "FX": "Chiropractic", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The planned and carefully managed manual movement of the musculoskeletal system, extremities, and spine to produce increased motion. The term is sometimes used to denote a precise sequence of movements of a joint to determine the presence of disease or to reduce a dislocation. In the case of fractures, orthopedic manipulation can produce better position and alignment of the fracture. (From Blauvelt & Nelson, A Manual of Orthopaedic Terminology, 5th ed, p264)", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008349"}, {"RECTYPE": "D", "MH": "Manitoba", "AQ": "EH EP", "MN": "Z01.107.567.176.410", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a province of Canada", "MS": "A province of Canada, lying between the provinces of Saskatchewan and Ontario. Its capital is Winnipeg. Taking its name from Lake Manitoba, itself named for one of its islands, the name derived from Algonquian Manitou, great spirit. (From Webster's New Geographical Dictionary, 1988, p724 & Room, Brewer's Dictionary of Names, 1992, p332)", "MR": "19950221", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008350"}, {"RECTYPE": "D", "MH": "Mannans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Mannan|T109|NON|EQV|UNK (19XX)|871112|abcdef", "MN": "D09.698.550", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Polysaccharides (1971-1974)", "MS": "Polysaccharides consisting of mannose units.", "PM": "84; was see under POLYSACCHARIDES 1975-83", "HN": "84(75); was see under POLYSACCHARIDES 1975-83", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D008351"}, {"RECTYPE": "D", "MH": "Mannich Bases", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mannich Base|T109|T130|NON|EQV|NLM (2021)|200204|abbcdef", "ENTRY": "Bases, Mannich", "MN": "D02.522.650", "MH_TH": "NLM (1977)", "ST": "T130", "RN": "0", "AN": "IM general only", "PI": "Amines (1966-1976)", "MS": "Ketonic amines prepared from the condensation of a ketone with formaldehyde and ammonia or a primary or secondary amine. A Mannich base can act as the equivalent of an alpha,beta unsaturated ketone in synthesis or can be reduced to form physiologically active amino alcohols.", "PM": "91; was see under AMINES 1977-90", "HN": "91(77); was see under AMINES 1977-90", "MR": "20200527", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D008352"}, {"RECTYPE": "D", "MH": "Mannitol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Osmofundin|T109|T121|TRD|NRW|NLM (1992)|910320|abbcdef", "MN": "D09.853.609", "PA": "Sweetening Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "D-Mannitol", "RN": "3OWL53L36A", "RR": "87-78-5 (cpd without stereochemical designation)", "MS": "A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008353"}, {"RECTYPE": "D", "MH": "Mannitol Dehydrogenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mannitol Dehydrogenase|T116|T126|NON|EQV|NLM (1965)|990101|abbcdef", "ENTRY": "Mannitol 2 Dehydrogenase", "MN": "D08.811.682.047.150.700.649", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 1.1.-", "RR": "EC 1.1.2.2", "MS": "Sugar alcohol dehydrogenases that have specificity for MANNITOL. Enzymes in this category are generally classified according to their preference for a specific reducing cofactor.", "PM": "2008; see MANNITOL DEHYDROGENASE 1966-2008", "HN": "2008(1966)", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008354"}, {"RECTYPE": "D", "MH": "Mannitol Phosphates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phosphates, Mannitol", "MN": "D09.894.500", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Sugar Phosphates (1974-1977)", "MS": "Phosphoric acid esters of mannitol.", "PM": "91; was see under SUGAR PHOSPHATES 1978-90", "HN": "91(78); was see under SUGAR PHOSPHATES 1978-90", "MR": "20040707", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D008355"}, {"RECTYPE": "D", "MH": "Mannoheptulose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mannoketoheptose|T109|NON|EQV|UNK (19XX)|741111|abcdef", "MN": "D09.947.875.465.500", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "manno-2-Heptulose", "RN": "654-29-5", "PI": "Ketoses (1974)", "MS": "A 7-carbon keto sugar having the mannose configuration.", "PM": "91; was see under HEPTOSES 1975-90", "HN": "91(75); was see under HEPTOSES 1975-90", "MR": "20170410", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008356"}, {"RECTYPE": "D", "MH": "Mannomustine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mannitol Nitrogen Mustard|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Nitrogen Mustard, Mannitol", "MN": "D02.455.526.728.650.463", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "D-Mannitol, 1,6-bis((2-chloroethyl)amino)-1,6-dideoxy-", "RN": "E60VWA40D2", "RR": "576-68-1 (Mannomustine)", "MS": "Nitrogen mustard derivative alkylating agent used as antineoplastic. It causes severe bone marrow depression and is a powerful vesicant.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008357"}, {"RECTYPE": "D", "MH": "Mannose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "D Mannose", "MN": "D09.947.875.359.588", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Mannose", "RN": "PHA4727WTP", "RR": "31103-86-3 (Mannose)", "MS": "A hexose or fermentable monosaccharide and isomer of glucose from manna, the ash Fraxinus ornus and related plants. (From Grant & Hackh's Chemical Dictionary, 5th ed & Random House Unabridged Dictionary, 2d ed)", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008358"}, {"RECTYPE": "D", "MH": "Mannose-6-Phosphate Isomerase", "DS": "MANNOSEPHOSPHATE ISOMERASE 06", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphomannose Isomerase|T116|T126|NON|EQV|UNK (19XX)|770331|abbcdef", "ENTRY": "Mannose 6 Phosphate Isomerase", "MN": "D08.811.399.475.200.550", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "D-Mannose-6-phosphate ketol isomerase", "RN": "EC 5.3.1.8", "RR": "9023-88-5 (CAS RN)", "PI": "Carbohydrate Isomerases (1973-1977)", "MS": "An enzyme that catalyzes the reversible isomerization of D-mannose-6-phosphate to form D-fructose-6-phosphate, an important step in glycolysis. EC 5.3.1.8.", "PM": "98; see MANNOSEPHOSPHATE ISOMERASE 1991-97, see CARBOHYDRATE ISOMERASES 1978-90; for MANNOSE-6-PHOSPHATE ISOMERASE see MANNOSEPHOSPHATE ISOMERASE 1978-97", "HN": "98(78)", "MR": "20030709", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D008359"}, {"RECTYPE": "D", "MH": "Mannosephosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D09.894.417.650", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Mannose (1966-1977)", "MS": "Phosphoric acid esters of mannose.", "PM": "91; was see under HEXOSEPHOSPHATES 1978-90", "HN": "91(78); was see under HEXOSEPHOSPHATES 1978-90", "MR": "20040707", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D008360"}, {"RECTYPE": "D", "MH": "Mannosidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mannosidase|T116|T126|NON|EQV|NLM (2021)|200210|abbcdef", "MN": "D08.811.277.450.625", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.2.1.-", "AN": "ALPHA-MANNOSIDASE and BETA-MANNOSIDASE are also available; /defic: consider also MANNOSIDASE DEFICIENCY DISEASES", "PI": "Mannose (1966-1974)", "MS": "Glycoside hydrolases that catalyze the hydrolysis of alpha or beta linked MANNOSE.", "PM": "78; was see under DISACCHARIDASES 1975-77", "HN": "78(75); was see under DISACCHARIDASES 1975-77", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19780101", "UI": "D008361"}, {"RECTYPE": "D", "MH": "Mannosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mannoside|T109|NON|EQV|NLM (2021)|191120|abcdef", "MN": "D09.408.490", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Mannose (1966-1974)", "MS": "Glycosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of mannose with an alcohol to form an acetal. They include both alpha- and beta-mannosides.", "PM": "91; was see under GLYCOSIDES 1975-90", "HN": "91(75); was see under GLYCOSIDES 1975-90", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008362"}, {"RECTYPE": "D", "MH": "alpha-Mannosidosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mannosidosis, alpha B, Lysosomal|T047|NON|EQV|NLM (2004)|OMIM (2013)|030306|abcdeef", "ENTRY": "alpha-Mannosidoses", "MN": "C18.452.648.595.577.500", "FX": "alpha-Mannosidase", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Metabolism, Inborn Errors (1966-1984)", "MS": "An inborn error of metabolism marked by a defect in the lysosomal isoform of ALPHA-MANNOSIDASE activity that results in lysosomal accumulation of mannose-rich intermediate metabolites. Virtually all patients have psychomotor retardation, facial coarsening, and some degree of dysostosis multiplex. It is thought to be an autosomal recessive disorder.", "PM": "2004; see MANNOSIDOSIS 1984-2003", "HN": "2004(1985)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19840529", "DC": "1", "DX": "19850101", "UI": "D008363"}, {"RECTYPE": "D", "MH": "Mannosyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mannosyltransferase|T116|T126|NON|EQV|NLM (2021)|191118|abbcdef", "MN": "D08.811.913.400.450.560", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 2.4.1.-", "RR": "9055-06-5 (CAS RN)", "PI": "Mannose (1973-1974)", "MS": "Enzymes that catalyze the transfer of mannose from a nucleoside diphosphate mannose to an acceptor molecule which is frequently another carbohydrate. The group includes EC 2.4.1.32, EC 2.4.1.48, EC 2.4.1.54, and EC 2.4.1.57.", "PM": "91; was see under HEXOSYLTRANSFERASES 1975-90", "HN": "91(75); was see under HEXOSYLTRANSFERASES 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008364"}, {"RECTYPE": "D", "MH": "Manometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tonometry|T059|NON|REL|NLM (1966)|990101|abcdef", "ENTRY": "Manometries", "MN": "E05.559", "MH_TH": "NLM (1963)", "ST": "T059", "AN": "for measurement of intraocular pressure use TONOMETRY, OCULAR; NIM", "MS": "Measurement of the pressure or tension of liquids or gases with a manometer.", "PM": "1963; for TONOMETRY see TONOMETRY 1963-2003", "HN": "1963; for TONOMETRY use TONOMETRY 1963-2003", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D008365"}, {"RECTYPE": "D", "MH": "Mansonella", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Tetrapetalonema|T204|NON|EQV|UNK (19XX)|850311|abcdef", "ENTRY": "Tetrapetalonemas", "MN": "B01.050.500.500.294.400.937.463.438", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid42230", "RR": "txid42231", "MS": "A genus of parasitic nematodes whose organisms are distributed in Central and South America. Characteristics include a smooth cuticle and an enlarged anterior end.", "PM": "MANSONELLA OZZARDI was heading 1975-96 (see under MANSONELLA 1979-90, was FILARIA OZZARDI see under MANSONELLA 1975-78), was FILARIA OZZARDI see under MANSONELLA 1963-74; FILARIA DEMARQUAYI was see under MANSONELLA 1963-78, was see MANSONELLA OZZARDI 1979-96; FILARIA OZZARDI was see MANSONELLA OZZARDI 1979-96", "HN": "MANSONELLA OZZARDI was heading 1975-96 (see under MANSONELLA 1979-90, was FILARIA OZZARDI see under MANSONELLA 1975-78), was FILARIA OZZARDI see under MANSONELLA 1963-74; FILARIA DEMARQUAYI was see under MANSONELLA 1963-78, was see MANSONELLA OZZARDI 1979-96; FILARIA OZZARDI was see MANSONELLA OZZARDI 1979-96", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008366"}, {"RECTYPE": "D", "MH": "Mansonelliasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "perstans Infections, Mansonella", "MN": "C01.610.335.508.700.750.361.588", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Infection with nematodes of the genus MANSONELLA. Symptoms include pruritus, headache, and articular swelling.", "OL": "search FILARIASIS 1967-74", "PM": "91; was see under FILARIASIS 1975-90", "HN": "91(75); was see under FILARIASIS 1975-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008368"}, {"RECTYPE": "D", "MH": "Manual Communication", "ENTRY": "Manual Communications", "MN": "L01.143.649.526", "MH_TH": "NLM (1972)", "ST": "T054", "AN": "SIGN LANGUAGE & NONVERBAL COMMUNICATION are also available", "PI": "Nonverbal Communication (1970-1971)", "MS": "Method of nonverbal communication utilizing hand movements as speech equivalents.", "PM": "74; SIGN LANGUAGE was heading 1963-65", "HN": "74(72)", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008369"}, {"RECTYPE": "D", "MH": "Manuals as Topic", "AQ": "ST", "MN": "L01.462.500.820.500", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with the Publication Type LABORATORY MANUAL", "PI": "Books (1966-1968)", "MS": "Works about presentation designed to give factual information or instructions.", "PM": "2008; see MANUALS 1974-2007", "HN": "2008(1969)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008370"}, {"RECTYPE": "D", "MH": "Manubrium", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A02.835.232.570.750.442", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "The upper or most anterior segment of the STERNUM which articulates with the CLAVICLE and first two pairs of RIBS.", "OL": "search STERNUM 1966-74", "PM": "91; was see under STERNUM 1975-90", "HN": "91(75); was see under STERNUM 1975-90", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008371"}, {"RECTYPE": "D", "MH": "Manure", "AQ": "AN CL MI PS RE VI", "MN": "D20.601", "FX": "Feces", "MH_TH": "NLM (1979)", "ST": "T167", "RN": "0", "AN": "includes slurry", "PI": "Feces (1966-1978)", "MS": "Accumulations of solid or liquid animal excreta usually from stables and barnyards with or without litter material. Its chief application is as a fertilizer. (From Webster's 3d ed)", "PM": "79", "HN": "79", "MR": "20030709", "DA": "19771206", "DC": "1", "DX": "19790101", "UI": "D008372"}, {"RECTYPE": "D", "MH": "Manuscripts as Topic", "AQ": "HI", "MN": "L01.462.500.682.608", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "IM; includes books prepared by hand before invention of printing; also handwritten or typescript drafts of pre-print papers, correspondence, diaries, notebooks, memoranda, etc.; check century tag if appropriate; do not confuse with the Publication Type MANUSCRIPT", "MS": "Works about compositions written by hand, as one written before the invention or adoption of printing.", "PM": "2008; see MANUSCRIPTS 1963-2007", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D008373"}, {"RECTYPE": "D", "MH": "Manuscripts, Medical as Topic", "AQ": "HI", "MN": "L01.462.500.682.608.526", "MH_TH": "NLM (2018)", "ST": "T170", "AN": "do not confuse with the Publication Type MANUSCRIPT, MEDICAL", "MS": "Works about unpublished medical works.", "PM": "2018; see MANUSCRIPTS, MEDICAL 1966-2017", "HN": "2018(1966)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008374"}, {"RECTYPE": "D", "MH": "Maple Syrup Urine Disease", "DE": "MAPLE SYRUP URINE DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thiamine Responsive Maple Syrup Urine Disease|T047|NON|NRW|NLM (2000)|991103|THIAMINE RESPONSIVE MAPLE SYRUP URINE DIS|abcdefv", "ENTRY": "Ketoacidurias, Branched-Chain", "MN": "C18.452.648.189.520", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An autosomal recessive inherited disorder with multiple forms of phenotypic expression, caused by a defect in the oxidative decarboxylation of branched-chain amino acids (AMINO ACIDS, BRANCHED-CHAIN). These metabolites accumulate in body fluids and render a \"maple syrup\" odor. The disease is divided into classic, intermediate, intermittent, and thiamine responsive subtypes. The classic form presents in the first week of life with ketoacidosis, hypoglycemia, emesis, neonatal seizures, and hypertonia. The intermediate and intermittent forms present in childhood or later with acute episodes of ataxia and vomiting. (From Adams et al., Principles of Neurology, 6th ed, p936)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008375"}, {"RECTYPE": "D", "MH": "Maprotiline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Novo Maprotiline", "MN": "D04.615.125.600", "PA": "Antidepressive Agents, Second-Generation", "MH_TH": "USAN (1971)", "ST": "T121", "N1": "9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-", "RN": "2U1W68TROF", "RR": "7C8J54PVFI", "PI": "Propylamines (1972-1974)", "MS": "A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.", "PM": "91; was see under ANTHRACENES 1975-90", "HN": "91(75); was see under ANTHRACENES 1975-90", "MR": "20230607", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008376"}, {"RECTYPE": "D", "MH": "Maps as Topic", "ENTRY": "Maps as Topics", "MN": "L01.462.500.820.090.426", "FX": "Geographic Mapping", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with Publication Type MAPS", "MS": "Works about representations, normally to scale and on a flat medium, of a selection of material or abstract features on the surface of the earth, the heavens, or celestial bodies.", "PM": "2008; see MAPS 1963-2007", "HN": "2008 (1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D008377"}, {"RECTYPE": "D", "MH": "Marburg Virus Disease", "DE": "MARBURG VIRUS DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Marburg Virus Infection|T047|NON|EQV|NLM (2024)|230214|abcdef", "ENTRY": "Virus Infection, Marburg", "MN": "C22.735.500.500", "FX": "Hemorrhagic Fever, Ebola", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Virus Diseases (1966-1974)", "MS": "An RNA virus infection of rhesus, vervet, and squirrel monkeys transmissible to man.", "PM": "1975", "HN": "1975", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D008379"}, {"RECTYPE": "D", "MH": "Marek Disease", "DE": "MAREK DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Marek's Disease|T191|EPO|EQV|NLM (1972)|ORD (2010)|990101|MAREKS DIS|abcdeefv", "ENTRY": "Paralysis, Fowl", "MN": "C22.131.546", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "add BIRDS or POULTRY (NIM) or specific bird or fowl (IM)", "PI": "Poultry Diseases (1966-1971)", "MS": "A transmissible viral disease of birds caused by avian herpesvirus 2 (HERPESVIRUS 2, GALLID) and other MARDIVIRUS. There is lymphoid cell infiltration or lymphomatous tumor formation in the peripheral nerves and gonads, but may also involve visceral organs, skin, muscle, and the eye.", "PM": "73", "HN": "73(72)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008380"}, {"RECTYPE": "D", "MH": "Herpesvirus 2, Gallid", "DS": "HERPESVIRUS GALLID 02", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Neurolymphomatosis Virus|T005|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Paralysis Viruses, Fowl", "MN": "B04.280.382.100.562.400", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid10390", "PI": "Herpesviridae (1966-1974)", "MS": "The type species of the genus MARDIVIRUS in the family HERPESVIRIDAE. It is the etiologic agent of MAREK DISEASE, infecting domestic fowl and wild birds.", "OL": "use HERPESVIRUS 2, GALLID to search MAREK'S DISEASE VIRUS 1975-96", "PM": "94; was MAREK'S DISEASE VIRUS 1975-93; MAREK'S DISEASE HERPESVIRUS 1 was MAREK'S DISEASE VIRUS see HERPESVIRUS 2, GALLID 1994-96", "HN": "94; was MAREK'S DISEASE VIRUS 1975-93; MAREK'S DISEASE HERPESVIRUS 1 was MAREK'S DISEASE VIRUS see HERPESVIRUS 2, GALLID 1994-96", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D008381"}, {"RECTYPE": "D", "MH": "Marfan Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Marfan Syndrome, Type II|T047|EPO|NRW|NLM (2022)|210324|abcdef", "ENTRY": "Marfans Syndrome", "MN": "C17.300.500", "FX": "Weill-Marchesani Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE; AORTIC ANEURYSM; and AORTIC DISSECTION. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue.  Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan syndrome type 2.", "PM": "1985; see ARACHNODACTYLY 1963-1984", "HN": "1985; use ARACHNODACTYLY 1963-1984", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D008382"}, {"RECTYPE": "D", "MH": "Margarine", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "MN": "J02.500.375.650", "MH_TH": "NLM (1966)", "ST": "T168", "N1": "Margarine", "RN": "8029-82-1", "AN": "a butter substitute", "MS": "A butterlike product made of refined vegetable oils, sometimes blended with animal fats, and emulsified usually with water or milk. It is used as a butter substitute. (From Random House Unabridged Dictionary, 2d ed)", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008383"}, {"RECTYPE": "D", "MH": "Marijuana Smoking", "AQ": "AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PC PP PX TD TH UR", "PRINT ENTRY": "Hashish Smoking|T055|NON|REL|NLM (1990)|890322|abcdef", "ENTRY": "Smokings, Blunts", "MN": "F01.145.805.250.500", "MH_TH": "NLM (1988)", "ST": "T055", "AN": "consider also MARIJUANA ABUSE", "PI": "Cannabis (1966-1987)", "MS": "Inhaling and exhaling SMOKE from CANNABIS.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19870302", "DC": "1", "DX": "19880101", "UI": "D008385"}, {"RECTYPE": "D", "MH": "Marine Biology", "DE": "MARINE BIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Hydrobiology, Marine", "MN": "H01.277.750.500", "FX": "Plankton", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "MS": "The study of the origin, structure, development, growth, function, genetics, and reproduction of organisms which inhabit the OCEANS AND SEAS.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008386"}, {"RECTYPE": "D", "MH": "Marine Toxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phycotoxins|T131|NON|REL|NLM (2024)|220923|abcdef", "MN": "D23.946.580", "PA": "Poisons", "MH_TH": "NLM (1974)", "ST": "T131", "RN": "0", "MS": "Toxic or poisonous substances elaborated by marine flora or fauna. They include also specific, characterized poisons or toxins for which there is no more specific heading, like those from poisonous FISHES.", "PM": "74", "HN": "74", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008387"}, {"RECTYPE": "D", "MH": "Marital Therapy", "DE": "MARITAL THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Marriage Therapy|T061|NON|EQV|NLM (1991)|900109|MARRIAGE THER|abcdefv", "ENTRY": "Therapies, Marriage", "MN": "F04.754.864.581.136.500", "FX": "Couples Therapy", "MH_TH": "NLM (1973)", "ST": "T061", "PI": "Marriage (1966-1972)", "MS": "A form of psychotherapy involving both spouses and directed to improving the marital relationship.", "OL": "use MARITAL THERAPY to search MARRIAGE THERAPY 1973-75", "PM": "76; was MARRIAGE THERAPY 1973-75", "HN": "76; was MARRIAGE THERAPY 1973-75", "CATSH": "CAT LIST", "MR": "20180527", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D008388"}, {"RECTYPE": "D", "MH": "Marketing of Health Services", "DE": "MARKETING HEALTH SERV", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Health Services Marketing|T058|NON|EQV|UNK (19XX)|780509|HEALTH SERV MARKETING|abcdefv", "ENTRY": "Marketing Service, Health", "MN": "N05.300.430.500", "MH_TH": "NLM (1979)", "ST": "T058", "MS": "Application of marketing principles and techniques to maximize the use of health care resources.", "PM": "80; was see under HEALTH RESOURCES 1979", "HN": "80(79); was see under HEALTH RESOURCES 1979", "MR": "20020703", "DA": "19780509", "DC": "1", "DX": "19800101", "UI": "D008389"}, {"RECTYPE": "D", "MH": "Markov Chains", "PRINT ENTRY": "Markov Process|T081|NON|EQV|NLM (1990)|890512|abcdef", "ENTRY": "Processes, Markov", "MN": "N06.850.520.830.996.500", "MH_TH": "NLM (1975)", "ST": "T081", "MS": "A stochastic process such that the conditional probability distribution for a state at any future instant, given the present state, is unaffected by any additional knowledge of the past history of the system.", "OL": "search PROBABILITY 1968-74", "PM": "91; was see under PROBABILITY 1975-90", "HN": "91(75); was see under PROBABILITY 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008390"}, {"RECTYPE": "D", "MH": "Marmota", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Woodchucks|T015|NON|REL|UNK (19XX)|741205|abcdef", "ENTRY": "Woodchuck", "MN": "B01.050.150.900.649.313.992.750.460", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9992", "RR": "txid9995", "AN": "do not confuse with MARMOSETS see CALLITHRIX", "MS": "A genus of Sciuridae consisting of 14 species. They are shortlegged, burrowing rodents which hibernate in winter.", "OL": "use MARMOTA to search MARMOTS 1975-81", "PM": "91; was see under SCIURIDAE 1982-90; was MARMOTS see under RODENTS 1975-81", "HN": "91(82); was see under SCIURIDAE 1982-90; was MARMOTS see under RODENTS 1975-81", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D008392"}, {"RECTYPE": "D", "MH": "Marriage", "AQ": "EH HI LJ PX SN TD", "PRINT ENTRY": "Marital Relationship|T054|NON|NRW|BIOETHICS (1974)|770322|MARITAL RELAT|abcdefv", "ENTRY": "Unions, Consensual", "MN": "N01.824.308.500.500", "FX": "Spouses", "MH_TH": "POPLINE (1978)", "ST": "T054", "AN": "a sociological & anthropological concept: differentiate from MARITAL STATUS, a demographic & statistical concept; SPOUSES is available for the husband or wife as a person", "MS": "The social institution involving legal and/or religious sanction whereby individuals are joined together.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008393"}, {"RECTYPE": "D", "MH": "Marsupialia", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Metatheria|T015|NON|EQV|NLM (2005)|040224|abcdef", "ENTRY": "Marsupial", "MN": "B01.050.150.900.649.573", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid9263", "MS": "An infraclass of MAMMALS, also called Metatheria, where the young are born at an early stage of development and continue to develop in a pouch (marsupium). In contrast to Eutheria (placentals), marsupials have an incomplete PLACENTA.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008394"}, {"RECTYPE": "D", "MH": "Martinique", "AQ": "EH EP", "MN": "Z01.639.880.600", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island in the Lesser Antilles in the West Indies", "MS": "An island in the Lesser Antilles, one of the Windward Islands. Its capital is Fort-de-France. It was discovered by Columbus in 1502 and from its settlement in 1635 by the French it passed into and out of Dutch and British hands. It was made a French overseas department in 1946. One account of the name tells of native women on the shore calling \"Madinina\" as Columbus approached the island. The meaning was never discovered but was entered on early charts as Martinique, influenced by the name of St. Martin. (From Webster's New Geographical Dictionary, 1988, p734 & Room, Brewer's Dictionary of Names, 1992, p339)", "HN": "75", "MR": "20120703", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D008395"}, {"RECTYPE": "D", "MH": "Maryland", "AQ": "EH EP", "MN": "Z01.107.567.875.500.500", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "BALTIMORE is also available", "MS": "A state bounded on the north by Pennsylvania, on the east by Delaware and the Atlantic Ocean, on the south by Virginia and West Virginia, and on the west by West Virginia.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008396"}, {"RECTYPE": "D", "MH": "Masks", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Mask", "MN": "J01.637.708.560.782", "MH_TH": "NLM (1966)", "ST": "T074", "AN": "includes surgical masks; GAS MASKS see RESPIRATORY PROTECTIVE DEVICES is available", "MS": "Devices that cover the nose and mouth to maintain aseptic conditions often for the prevention of the spread of infections (e.g. COVID19) or to administer inhaled anesthetics or other gases.", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008397"}, {"RECTYPE": "D", "MH": "Masochism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Sexual Masochism|T048|NON|NRW|NLM (1998)|970319|abcdef", "ENTRY": "Sexual Masochisms", "MN": "F03.657.500", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "Pleasure derived from being physically or psychologically abused, whether inflicted by oneself or by others. Masochism includes sexual masochism.", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008398"}, {"RECTYPE": "D", "MH": "Mass Behavior", "PRINT ENTRY": "Group Behavior|T054|NON|REL|NLM (2022)|210405|abcdef", "ENTRY": "Mass Behaviors", "MN": "F01.145.813.527", "FX": "Riots", "MH_TH": "NLM (1974)", "ST": "T054", "AN": "differentiate from GROUP PROCESSES", "MS": "Collective behavior of an aggregate of individuals giving the appearance of unity of attitude, feeling, and motivation.", "PM": "1974; for MASS BEHAVIOR see MASS GATHTERINGS 2022", "HN": "1974; for MASS BEHAVIOR use MASS GATHTERINGS 2022", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008399"}, {"RECTYPE": "D", "MH": "Mass Chest X-Ray", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Xrays, Mass Chest", "MN": "N06.850.780.500.500", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "X-ray screening of large groups of persons for diseases of the lung and heart by means of radiography of the chest.", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008400"}, {"RECTYPE": "D", "MH": "Gas Chromatography-Mass Spectrometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Spectrum Analysis, Mass-Gas Chromatography|T059|NON|EQV|UNK (19XX)|790104|SPECTRUM ANAL MASS GAS CHROMATOGR|abcdefv", "ENTRY": "Spectrum Analysis, Mass Gas Chromatography", "MN": "E05.196.566.500", "MH_TH": "NLM (1995)", "ST": "T059", "PI": "Spectrum Analysis, Mass (1971-1976)", "MS": "A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds.", "PM": "2007; see MASS FRAGMENTOGRAPHY 1977-2006; see CHROMATOGRAPHY, GAS 1976", "HN": "2007 (1976)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19750725", "DC": "1", "DX": "19770101", "UI": "D008401"}, {"RECTYPE": "D", "MH": "Mass Media", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Media, Printed", "MN": "L01.462.500.590", "MH_TH": "POPLINE (1978)", "ST": "T068", "AN": "IM with general reference to NEWSPAPERS; PERIODICALS; RADIO; TELEVISION; MOTION PICTURES; etc., as mass media; do not use as routine coord with the specific: coord only when specific is discussed as a mass medium, as \"magazines as mass media\"", "PI": "Television (1966-1979)", "MS": "Instruments or technological means of communication that reach large numbers of people with a common message: press, radio, television, etc.", "PM": "80", "HN": "80", "MR": "20220712", "DA": "19790221", "DC": "1", "DX": "19800101", "UI": "D008402"}, {"RECTYPE": "D", "MH": "Mass Screening", "AQ": "AE CL EC ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Screenings, Mass", "MN": "N06.850.780.500", "FX": "Sensitivity and Specificity", "MH_TH": "BIOETHICS (1974)", "ST": "T062", "AN": "coord with disease/diag or /epidemiol or /prev", "MS": "Organized periodic procedures performed on large groups of people for the purpose of detecting disease.", "OL": "use MASS SCREENING to search MASS SCREENING TECHNICS 1966-67", "PM": "68; was MASS SCREENING TECHNICS 1963-67", "HN": "68; was MASS SCREENING TECHNICS 1963-67", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008403"}, {"RECTYPE": "D", "MH": "Massachusetts", "AQ": "EH EP", "MN": "Z01.107.567.875.550.510", "MH_TH": "NLM (1998)", "ST": "T083", "AN": "BOSTON is also available", "MS": "State bounded on the north by New Hampshire and Vermont, on the east by the Atlantic Ocean, on the south by Connecticut and Rhode Island, and on the west by New York.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008404"}, {"RECTYPE": "D", "MH": "Massage", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Zone Therapy|T061|NON|NRW|NLM (1990)|890207|ZONE THER|abcdefv", "ENTRY": "Zone Therapies", "MN": "E02.831.535.867.880.750", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "do not confuse entry term REFLEXOLOGY with REFLEXOTHERAPY; do not confuse with THERAPEUTIC TOUCH", "MS": "The systematic and methodical manipulations of body tissues best performed with the hands for the purpose of affecting the nervous and muscular systems and the general circulation.", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008405"}, {"RECTYPE": "D", "MH": "Masseter Muscle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Muscles, Masseter", "MN": "A14.530.630", "MH_TH": "NLM (1980)", "ST": "T023", "AN": "/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent", "PI": "Muscles (1966-1979)", "MS": "A masticatory muscle whose action is closing the jaws.", "PM": "91; was see under MASTICATORY MUSCLES 1980-90", "HN": "91(80); was see under MASTICATORY MUSCLES 1980-90", "MR": "20080708", "DA": "19790312", "DC": "1", "DX": "19910101", "UI": "D008406"}, {"RECTYPE": "D", "MH": "Mast Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Basophils, Tissue|T025|NON|EQV|UNK (19XX)|840406|abcdef", "ENTRY": "Tissue Basophils", "MN": "A15.382.652", "MH_TH": "NLM (1966)", "ST": "T025", "AN": "MAST-CELL DISEASE see MASTOCYTOSIS is available", "MS": "Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR.", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008407"}, {"RECTYPE": "D", "MH": "Mastectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Mastectomies", "MN": "E04.466", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "MS": "Surgical procedure to remove one or both breasts.", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008408"}, {"RECTYPE": "D", "MH": "Mastication", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Chewing|T042|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "G10.261.330.500", "FX": "Tooth", "MH_TH": "NLM (1966)", "ST": "T042", "MS": "The act and process of chewing and grinding food in the mouth.", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008409"}, {"RECTYPE": "D", "MH": "Masticatory Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Muscles, Masticatory", "MN": "A14.530", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "general or unspecified; prefer specifics; /growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent", "MS": "Muscles arising in the zygomatic arch that close the jaw. Their nerve supply is masseteric from the mandibular division of the trigeminal nerve. (From Stedman, 25th ed)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008410"}, {"RECTYPE": "D", "MH": "Chytridiomycota", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mastigomycotina|T004|NON|EQV|NLM (1999)|971125|abcdef", "MN": "B01.300.283", "MH_TH": "NLM (1986)", "ST": "T004", "RN": "txid4761", "PI": "Phycomyces (1966-1985)", "MS": "A phylum of fungi that was formerly considered a subdivision of Phycomycetes. They are the only fungi that produce motile spores (zoospores) at some stage in their life cycle. Most are saprobes but they also include examples of plant, animal, and fungal pathogens.", "PM": "99; see MASTIGOMYCOTINA 1986-98", "HN": "99(86)", "MR": "20200813", "DA": "19850212", "DC": "1", "DX": "19860101", "UI": "D008411"}, {"RECTYPE": "D", "MH": "Mastitis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.090.968", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "CHRONIC CYSTIC MASTITIS see FIBROCYSTIC BREAST DISEASE is also available; MASTITIS, BOVINE is also available", "MS": "INFLAMMATION of the BREAST, or MAMMARY GLAND.", "PM": "1966", "HN": "1966", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008413"}, {"RECTYPE": "D", "MH": "Mastitis, Bovine", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Mastitides, Bovine", "MN": "C22.196.581", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "don't forget also CATTLE (NIM) & check tags ANIMALS & FEMALE", "MS": "INFLAMMATION of the UDDER in cows.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008414"}, {"RECTYPE": "D", "MH": "Mastocytosis", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "MN": "C20.762.750", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "general or unspecified; prefer specifics", "PI": "Urticaria Pigmentosa (1966-1986)", "MS": "A rare neoplastic disorder characterized by a clonal proliferation of MAST CELLS, associated with KIT-D816 mutations, and accompanied by aberrant mast cell activation. The abnormal increase of MAST CELLS may occur in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).", "PM": "1987; see URTICARIA PIGMENTOSA 1975-1986", "HN": "1987; use URTICARIA PIGMENTOSA 1975-1986", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19860407", "DC": "1", "DX": "19870101", "UI": "D008415"}, {"RECTYPE": "D", "MH": "Mastoid", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Mastoid Foramen|T023|NON|NRW|NLM (2020)|190220|abcdef", "ENTRY": "Process, Mastoid", "MN": "A02.835.232.781.885.444", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The posterior part of the temporal bone. It is a projection of the petrous bone.", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008416"}, {"RECTYPE": "D", "MH": "Mastoiditis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mastoiditides", "MN": "C09.218.705.663.652", "FX": "Lateral Sinus Thrombosis", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the honeycomb-like MASTOID BONE in the skull just behind the ear. It is usually a complication of OTITIS MEDIA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008417"}, {"RECTYPE": "D", "MH": "Masturbation", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Masturbations", "MN": "F01.145.802.526", "MH_TH": "NLM (1966)", "ST": "T055", "AN": "human & animal", "MS": "Sexual stimulation or gratification of the self.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008418"}, {"RECTYPE": "D", "MH": "Materia Medica", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Nosodes|T121|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Remedies, Homeopathic", "MN": "D26.526", "FX": "Plant Extracts", "MH_TH": "NLM (1988)", "ST": "T121", "RN": "0", "AN": "prefer the more specific PHYTOTHERAPY or HOMEOPATHY; coord IM with specific substance IM; for use in therapy coord /ther use (IM) with substance /ther use (IM) if permitted + disease /*drug ther (IM); do not capitalize Chinese names of various substances in titles or translations", "PI": "Medicine, Traditional (1966-1987)", "MS": "Materials or substances used in the composition of traditional medical remedies. The use of this term in MeSH was formerly restricted to historical articles or those concerned with traditional medicine, but it can also refer to homeopathic remedies. Nosodes are specific types of homeopathic remedies prepared from causal agents or disease products.", "PM": "88", "HN": "88", "MR": "20030709", "DA": "19870323", "DC": "1", "DX": "19880101", "UI": "D008419"}, {"RECTYPE": "D", "MH": "Manufactured Materials", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Materials, Manufactured", "MN": "J01.637", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "general or unspecified; prefer specifics", "MS": "Substances and materials manufactured for use in various technologies and industries and for domestic use.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D008420"}, {"RECTYPE": "D", "MH": "Materials Management, Hospital", "DE": "MATERIALS MANAGEMENT HOSP", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Storerooms|T073|NON|REL|UNK (19XX)|770426|abcdef", "ENTRY": "Material Managements, Hospital", "MN": "N04.452.442.452.650", "MH_TH": "NLM (1976)", "ST": "T058", "MS": "The management of all procurement, distribution, and storage of equipment and supplies, as well as logistics management including laundry, processing of reusables, etc.", "OL": "use MATERIALS MANAGEMENT, HOSPITAL to search HOSPITAL MATERIALS MANAGEMENT 1976-77", "PM": "78; was HOSPITAL MATERIALS MANAGEMENT see under HOSPITAL ADMINISTRATION 1976-77", "HN": "78; was HOSPITAL MATERIALS MANAGEMENT see under HOSPITAL ADMINISTRATION 1976-77", "MR": "20210705", "DA": "19750725", "DC": "1", "DX": "19780101", "UI": "D008421"}, {"RECTYPE": "D", "MH": "Materials Testing", "AQ": "EC IS MT SN ST VE", "PRINT ENTRY": "Testing, Biocompatible Materials|T062|NON|NRW|UNK (19XX)|860620|abcdef", "ENTRY": "Testings, Biocompatibility", "MN": "E05.570", "FX": "Hemorheology", "MH_TH": "NLM (1987)", "ST": "T057", "AN": "do not confuse HEMOCOMPATIBILITY TESTING with HISTOCOMPATIBILITY TESTING", "PI": "Stress, Mechanical (1971-1986)", "MS": "The testing of materials and devices, especially those used for PROSTHESES AND IMPLANTS; SUTURES; TISSUE ADHESIVES; etc., for hardness, strength, durability, safety, efficacy, and biocompatibility.", "PM": "1987", "HN": "1987", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19860620", "DC": "1", "DX": "19870101", "UI": "D008422"}, {"RECTYPE": "D", "MH": "Maternal Age", "ENTRY": "Maternal Ages", "MN": "N06.850.490.250.550", "MH_TH": "NLM (1967)", "ST": "T079", "MS": "The age of the mother in PREGNANCY.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008423"}, {"RECTYPE": "D", "MH": "Maternal Behavior", "AQ": "DE EH HI PH PX RE", "PRINT ENTRY": "Maternal Patterns of Care|T054|NON|NRW|NLM (1992)|910503|abcdef", "ENTRY": "Patterns, Maternal Care", "MN": "F01.829.263.370.215", "MH_TH": "NLM (1968)", "ST": "T054", "AN": "human & animal; /drug eff permitted only if the drug affects the mother's behavior: do not use for eff of a drug on the offspring after admin of drug to pregn mother", "PI": "Parent-Child Relations (1966-1967)", "MS": "The behavior patterns associated with or characteristic of a mother.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008425"}, {"RECTYPE": "D", "MH": "Maternal Deprivation", "AQ": "EH", "ENTRY": "Maternal Deprivations", "MN": "F01.829.263.370.240", "MH_TH": "NLM (1966)", "ST": "T067", "AN": "human & animal", "MS": "Prolonged separation of the offspring from the mother.", "PM": "69", "HN": "69(66)", "CATSH": "CAT LIST", "MR": "19920514", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D008426"}, {"RECTYPE": "D", "MH": "Maternal Health Services", "DE": "MATERNAL HEALTH SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Maternal Health Service", "MN": "N02.421.800.500", "FX": "Maternal Welfare", "MH_TH": "NLM (1978)", "ST": "T058", "AN": "check also tags HUMAN; FEMALE & PREGNANCY; specify geographic location if pertinent", "PI": "Prenatal Care (1966-1967)", "MS": "Organized services to provide health care to expectant and nursing mothers.", "PM": "68", "HN": "68", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008427"}, {"RECTYPE": "D", "MH": "Maternal Mortality", "DE": "MATERNAL MORTAL", "AQ": "EH HI TD", "ENTRY": "Mortalities, Maternal", "MN": "N06.850.520.308.985.550.500", "MH_TH": "POPLINE (1978)", "ST": "T081", "AN": "a statistical concept; do not confuse with MATERNAL DEATH; IM general only; coordinate NIM with disease / mortal (IM); specify geographic term if pertinent", "MS": "Maternal deaths resulting from complications of pregnancy and childbirth in a given population.", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008428"}, {"RECTYPE": "D", "MH": "Maternal Welfare", "AQ": "CL EC EH ES HI LJ PX SN TD", "ENTRY": "Welfare, Maternal", "MN": "I01.880.787.678", "FX": "Maternal Health Services", "MH_TH": "NLM (1966)", "ST": "T081", "AN": "specify geog", "MS": "Organized efforts by communities or organizations to improve the health and well-being of the mother.", "MR": "20150305", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008429"}, {"RECTYPE": "D", "MH": "Maternal-Child Health Centers", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Maternal-Child Health Center", "MN": "N02.278.035.310", "MH_TH": "NLM (1979)", "ST": "T093", "AN": "check also tag CHILD or specific", "PI": "Maternal Health Services (1968-1978)", "MS": "Facilities which administer the delivery of health care services to mothers and children.", "PM": "91; was see under HEALTH FACILITIES 1979-90", "HN": "91(79); was see under HEALTH FACILITIES 1979-90", "MR": "20150305", "DA": "19780517", "DC": "1", "DX": "19910101", "UI": "D008430"}, {"RECTYPE": "D", "MH": "Maternal-Fetal Exchange", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Transplacental Exposure|T040|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Maternal Fetal Exchange", "MN": "G08.686.784.769.455", "FX": "Placental Circulation", "MH_TH": "NLM (1963)", "ST": "T040", "AN": "check the tags FEMALE & PREGNANCY; note that FETOMATERNAL TRANSFUSION (Cat C) & IMMUNITY, MATERNALLY-ACQUIRED (Cat G) exist", "MS": "Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008431"}, {"RECTYPE": "D", "MH": "Mathematical Computing", "PRINT ENTRY": "Statistical Computing|T066|NON|NRW|UNK (19XX)|860618|STATIST COMPUTING|abcdefv", "ENTRY": "Statistical Computings", "MN": "L01.224.680", "MH_TH": "NLM (1987)", "ST": "T066", "MS": "Computer-assisted interpretation and analysis of various mathematical functions related to a particular problem.", "PM": "87", "HN": "87", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D008432"}, {"RECTYPE": "D", "MH": "Mathematics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Mathematic", "MN": "H01.548", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use MATHEMATICAL CONCEPTS or specifics treed under it for numeric concepts including concepts in arithmetic, geometry and calculus", "MS": "The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008433"}, {"RECTYPE": "D", "MH": "Matrix Bands", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Matrix Band", "MN": "E07.222.501.630", "MH_TH": "NLM (1975)", "ST": "T074", "MS": "Devices which provide an artificial temporary wall, or matrix, used in filling a prepared cavity.", "OL": "use DENTAL MATERIALS to search MATRIX BAND 1969-74; use MATRIX BANDS 1975-79", "PM": "91; was see under DENTAL INSTRUMENTS 1980-90; was MATRIX BAND see under DENTAL MATERIALS 1969-79", "HN": "91(80); was see under DENTAL INSTRUMENTS 1980-90; was MATRIX BAND see under DENTAL MATERIALS 1969-79", "CATSH": "CAT LIST", "MR": "19920514", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008434"}, {"RECTYPE": "D", "MH": "Mauritania", "AQ": "EH EP", "MN": "Z01.058.290.190.520", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in western Africa, southwest of ALGERIA and west of MALI. Its capital is Nouakchott.", "HN": "1975", "MR": "20080708", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D008435"}, {"RECTYPE": "D", "MH": "Mauritius", "AQ": "EH EP", "PRINT ENTRY": "Agalega Islands|T083|NAM|NRW|UNK (19XX)|741111|abcdef", "MN": "Z01.639.520.520", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "one of the Indian Ocean Islands", "MS": "One of the Indian Ocean Islands, east of Madagascar. Its capital is Port Louis. It was discovered by the Portuguese in 1505, occupied by the Dutch 1598-1710, held by the French 1715-1810 when the British captured it, formally ceded to the British in 1814, and became independent in 1968. It was named by the Dutch in honor of Maurice of Nassau, Prince of Orange (1567-1625). (From Webster's New Geographical Dictionary, 1988, p742 & Room, Brewer's Dictionary of Names, 1992, p341)", "MR": "20120703", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D008436"}, {"RECTYPE": "D", "MH": "Maxilla", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Maxillas", "MN": "A14.521.645", "FX": "Maxillofacial Development", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "the upper jaw bone (jawbone) only; check text for loose use of \"maxillary\" to mean \"jaw\", not precisely MAXILLA; /blood supply: consider also MAXILLARY ARTERY; /growth: consider also MAXILLOFACIAL DEVELOPMENT; /inj: consider also MAXILLOFACIAL INJURIES; /innerv: consider also MAXILLARY NERVE", "MS": "One of a pair of irregularly shaped bones that form the upper jaw. A maxillary bone provides tooth sockets for the superior teeth, forms part of the ORBIT, and contains the MAXILLARY SINUS.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008437"}, {"RECTYPE": "D", "MH": "Maxillary Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Maxillary Arteries", "MN": "A07.015.114.523", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A branch of the external carotid artery which distributes to the deep structures of the face (internal maxillary) and to the side of the face and nose (external maxillary).", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008438"}, {"RECTYPE": "D", "MH": "Maxillary Diseases", "DE": "MAXILLARY DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Maxillary Disease", "MN": "C07.320.660", "MH_TH": "NLM (1967)", "ST": "T047", "PI": "Maxilla (1966)", "MS": "Diseases involving the MAXILLA.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20151009", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008439"}, {"RECTYPE": "D", "MH": "Maxillary Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Maxillary Fracture", "MN": "C26.915.300.425.500.400.510", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Fractures of the upper jaw.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008440"}, {"RECTYPE": "D", "MH": "Maxillary Neoplasms", "DE": "MAXILLARY NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasms, Maxillary", "MN": "C07.320.660.601", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "Cancer or tumors of the MAXILLA or upper jaw.", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008441"}, {"RECTYPE": "D", "MH": "Maxillary Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Alveolar Nerve, Superior|T023|NON|NRW|NLM (1993)|911107|abcdef", "ENTRY": "Superior Alveolar Nerves", "MN": "A08.800.800.120.760.550", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "a branch of the trigeminal (5th cranial) nerve; dis: coord IM with CRANIAL NERVE DISEASES (IM); neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "The intermediate sensory division of the trigeminal (5th cranial) nerve. The maxillary nerve carries general afferents from the intermediate region of the face including the lower eyelid, nose and upper lip, the maxillary teeth, and parts of the dura.", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008442"}, {"RECTYPE": "D", "MH": "Maxillary Sinus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Maxillary Ostium|T030|NON|REL|NLM (2024)|230209|abcdef", "ENTRY": "Sinus, Maxillary", "MN": "A04.531.621.578", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "The air space located in the body of the MAXILLARY BONE near each cheek. Each maxillary sinus communicates with the middle passage (meatus) of the NASAL CAVITY on the same side.", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008443"}, {"RECTYPE": "D", "MH": "Maxillary Sinus Neoplasms", "DE": "MAXILLARY SINUS NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cancer of Maxillary Sinus|T191|NON|NRW|NLM (2009)|071221|abcdef", "ENTRY": "Neoplasm, Maxillary Sinus", "MN": "C09.647.685.693.575", "MH_TH": "NLM (1984)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM)", "PI": "Paranasal Sinus Neoplasms (1966-1983)", "MS": "Tumors or cancer of the MAXILLARY SINUS. They represent the majority of paranasal neoplasms.", "PM": "91; was see under PARANASAL SINUS NEOPLASMS 1984-90", "HN": "91(84); was see under PARANASAL SINUS NEOPLASMS 1984-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19830531", "DC": "1", "DX": "19910101", "UI": "D008444"}, {"RECTYPE": "D", "MH": "Maxillofacial Development", "AQ": "DE GE IM PH RE", "ENTRY": "Maxillofacial Developments", "MN": "G11.427.578.050.500.478", "FX": "Vertical Dimension", "MH_TH": "NLM (1965)", "ST": "T040", "AN": "long face syndrome does not go here: index under FACIAL BONES /abnorm (IM) + MALOCCLUSION or specific type (IM) + SYNDROME (NIM)", "MS": "The process of growth and differentiation of the jaws and face.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20180206", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008445"}, {"RECTYPE": "D", "MH": "Maxillofacial Injuries", "DE": "MAXILLOFACIAL INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Maxillofacial Injury", "MN": "C26.915.300.425.500", "MH_TH": "NLM (1965)", "ST": "T037", "AN": "general or unspecified; prefer specifics; involving both a jaw and the face: not a substitute for MANDIBULAR INJURIES or MAXILLA /inj or FACIAL INJURIES or FACIAL BONES /inj", "MS": "General or unspecified injuries involving the face and jaw (either upper, lower, or both).", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008446"}, {"RECTYPE": "D", "MH": "Maxillofacial Prosthesis", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Maxillary Prosthesis|T074|NON|NRW|NLM (1991)|900420|abcdef", "ENTRY": "Prosthesis, Maxillofacial", "MN": "E07.695.510", "FX": "Maxillofacial Prosthesis Implantation", "MH_TH": "NLM (1967)", "ST": "T074", "MS": "A prosthetic appliance for the replacement of areas of the maxilla, mandible, and face, missing as a result of deformity, disease, injury, or surgery. When the prosthesis replaces portions of the mandible only, it is referred to as MANDIBULAR PROSTHESIS.", "PM": "67", "HN": "67(66)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008447"}, {"RECTYPE": "D", "MH": "Maximal Expiratory Flow Rate", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Forced Expiratory Flow 200-1200|T034|T042|NON|EQV|UNK (19XX)|741205|abbcdef", "ENTRY": "Forced Expiratory Flow 200 1200", "MN": "G09.772.650.300.590", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "usually NIM; do not confuse with MAXIMAL MIDEXPIRATORY FLOW RATE; (MMFR)", "MS": "The airflow rate measured during the first liter expired after the first 200 ml have been exhausted during a FORCED VITAL CAPACITY determination. Common abbreviations are MEFR, FEF 200-1200, and FEF 0.2-1.2.", "PM": "91; was see under FORCED EXPIRATORY FLOW RATES 1975-90", "HN": "91(75); was see under FORCED EXPIRATORY FLOW RATES 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D008448"}, {"RECTYPE": "D", "MH": "Maximal Expiratory Flow-Volume Curves", "DE": "MEFV", "AQ": "DE ES GE IM PH RE", "ENTRY": "Maximal Expiratory Flow Volume Curves|T034|NON|EQV|UNK (19XX)|771207|abcdef", "MN": "G09.772.650.300.630", "MH_TH": "NLM (1975)", "ST": "T034", "AN": "usually NIM; do not confuse with MAXIMAL EXPIRATORY FLOW RATE; (MEFR)", "MS": "Curves depicting MAXIMAL EXPIRATORY FLOW RATE, in liters/second, versus lung inflation, in liters or percentage of lung capacity, during a FORCED VITAL CAPACITY determination. Common abbreviation is MEFV.", "PM": "91; was see under FORCED EXPIRATORY FLOW RATES 1975-90", "HN": "91(75); was see under FORCED EXPIRATORY FLOW RATES 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D008449"}, {"RECTYPE": "D", "MH": "Maximal Midexpiratory Flow Rate", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Forced Expiratory Flow 025-075 Percent|T034|T042|NON|EQV|UNK (19XX)|741205|abbcdef", "ENTRY": "Percents, FEF 25-75", "MN": "G09.772.650.300.670", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "usually NIM; do not confuse with MAXIMAL EXPIRATORY FLOW RATE; (MEFR)", "MS": "Measurement of rate of airflow over the middle half of a FORCED VITAL CAPACITY determination (from the 25 percent level to the 75 percent level). Common abbreviations are MMFR and FEF 25%-75%.", "PM": "91; was see under FORCED EXPIRATORY FLOW RATES 1975-90", "HN": "91(75); was see under FORCED EXPIRATORY FLOW RATES 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D008450"}, {"RECTYPE": "D", "MH": "Maximal Voluntary Ventilation", "DE": "MVV", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Maximal Breathing Capacity|T034|T042|NON|EQV|UNK (19XX)|741205|MAXIMAL BREATHING CAPAC|abbcdefv", "ENTRY": "Voluntary Ventilations, Maximal", "MN": "G09.772.650.630", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "usually NIM ", "MS": "Measure of the maximum amount of air that can be breathed in and blown out over a sustained interval such as 15 or 20 seconds. Common abbreviations are MVV and MBC.", "PM": "91; was see under RESPIRATORY AIRFLOW 1975-90", "HN": "91(75); was see under RESPIRATORY AIRFLOW 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D008451"}, {"RECTYPE": "D", "MH": "Maximum Allowable Concentration", "PRINT ENTRY": "Maximum Permissible Exposure Level|T081|NON|EQV|NLM (1969)|990101|abcdef", "ENTRY": "Maximum Allowable Concentrations", "MN": "N06.850.460.350.600.615", "MH_TH": "UNK (19XX)", "ST": "T081", "AN": "usually NIM; coordinate with specific drug or substance (without qualifiers)", "PI": "specific agent (1966-1968)", "MS": "The maximum exposure to a biologically active physical or chemical agent that is allowed during an 8-hour period (a workday) in a population of workers, or during a 24-hour period in the general population, which does not appear to cause appreciable harm, whether immediate or delayed for any period, in the target population. (From Lewis Dictionary of Toxicology, 1st ed)", "PM": "1991; see MAXIMUM PERMISSIBLE EXPOSURE LEVEL 1991-1999, see ENVIRONMENTAL EXPOSURE 1975-1990; for MAXIMUM ALLOWABLE CONCENTRATION see MAXIMUM PERMISSIBLE EXPOSURE LEVEL 1976-1999", "HN": "2000(1991)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008452"}, {"RECTYPE": "D", "MH": "Maytansine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Maitansine|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|820429|abbcdeef", "ENTRY": "DMMO Maytansine", "MN": "D04.345.295.500", "PA": "Tubulin Modulators", "MH_TH": "USAN (1978)", "ST": "T121", "RN": "14083FR882", "RR": "35846-53-8 (Maytansine)", "PI": "Oxazines (1976)", "MS": "An ansa macrolide isolated from the MAYTENUS genus of East African shrubs.", "PM": "91; was see under OXAZINES 1977-90", "HN": "91(77); was see under OXAZINES 1977-90", "MR": "20180702", "DA": "19760503", "DC": "1", "DX": "19910101", "UI": "D008453"}, {"RECTYPE": "D", "MH": "Mazindol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "AN448", "MN": "D03.633.100.513.500", "PA": "Dopamine Uptake Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3H-Imidazo(2,1-a)isoindol-5-ol, 5-(4-chlorophenyl)-2,5-dihydro-", "RN": "C56709M5NH", "RR": "22232-71-9 (Mazindol)", "PI": "Indoles (1972-1974)", "MS": "Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.", "PM": "91; was see under INDOLES 1975-90", "HN": "91(75); was see under INDOLES 1975-90", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008454"}, {"RECTYPE": "D", "MH": "(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride", "DS": "CHLOROPHENYLCARBAMOYLOXY 2 BUTYNYL TRIMETHYLAMMONIUM CHLORIDE 4 M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "McNA343", "MN": "D02.675.276.210", "PA": "Nicotinic Agonists", "MH_TH": "NLM (2005)", "ST": "T121", "N1": "2-Butyn-1-aminium, 4-((((3-chlorophenyl)amino)carbonyl)oxy)-N,N,N-trimethyl-, chloride", "RN": "55-45-8", "AN": "McN stands for McNeil (a pharmaceut co)", "PI": "Carbamates (1968-1974)", "MS": "A drug that selectively activates certain subclasses of muscarinic receptors and also activates postganglionic nicotinic receptors. It is commonly used experimentally to distinguish muscarinic receptor subtypes.", "PM": "2005; see McN-A-343 1991-2004; see AMMONIUM COMPOUNDS 1975-1990", "HN": "2005(1975)", "MR": "20160628", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008455"}, {"RECTYPE": "D", "MH": "2-Methyl-4-chlorophenoxyacetic Acid", "DS": "METHYLCHLOROPHENOXYACETIC ACID 02 04", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "MCPA|T109|T131|ACR|EQV|FDA SRS (2014)|NLM (1975)|990101|abbcdeef", "ENTRY": "2 Methyl 4 chlorophenoxyacetic Acid", "MN": "D02.241.511.316.682.224", "PA": "Herbicides", "MH_TH": "UNK (19XX)", "ST": "T131", "N1": "Acetic acid, (4-chloro-2-methylphenoxy)-", "RN": "D888C394VO", "RR": "94-74-6 (2-Methyl-4-chlorophenoxyacetic Acid)", "PI": "Toluene (1974)", "MS": "A powerful herbicide used as a selective weed killer.", "PM": "2001; see MCPA 1991-2000 & GLYCOLATES 1975-90", "HN": "2001(1975)", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008456"}, {"RECTYPE": "D", "MH": "Measles", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Rubeola|T047|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "C01.925.782.580.600.500.500", "MH_TH": "POPLINE (1987)", "ST": "T047", "MS": "A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008457"}, {"RECTYPE": "D", "MH": "Measles Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccine, Measles", "MN": "D20.215.894.899.404", "MH_TH": "NLM (1964)", "ST": "T129", "RN": "0", "MS": "A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed)", "PM": "64", "HN": "64", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D008458"}, {"RECTYPE": "D", "MH": "Measles virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Edmonston virus|T005|EPO|NRW|NLM (2002)|010410|abcdef", "MN": "B04.820.480.937.600.650.500.500", "FX": "Subacute Sclerosing Panencephalitis", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid11234", "MS": "The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008459"}, {"RECTYPE": "D", "MH": "Meat", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Meats", "MN": "J02.500.600", "MH_TH": "NLM (1966)", "ST": "T168", "MS": "The edible portions of any animal used for food including cattle, swine, goats/sheep, poultry, fish, shellfish, and game.", "PM": "1966", "HN": "1966", "MR": "20211124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008460"}, {"RECTYPE": "D", "MH": "Meat Products", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Products, Meat", "MN": "J02.500.600.500", "MH_TH": "NLM (1978)", "ST": "T168", "MS": "Articles of food which are derived by a process of manufacture from any portion of carcasses of any animal used for food (e.g., head cheese, sausage, scrapple).", "PM": "91; was see under MEAT 1978-90", "HN": "91(78); was see under MEAT 1978-90", "MR": "20141014", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D008461"}, {"RECTYPE": "D", "MH": "Meat-Packing Industry", "DE": "MEAT PACKING INDUST", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Meat-Packing Industries", "MN": "J01.576.423.200.700", "MH_TH": "NLM (1966)", "ST": "T092", "MS": "The aggregate enterprise of technically producing packaged meat.", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008462"}, {"RECTYPE": "D", "MH": "Mebendazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Anti Worm", "MN": "D03.633.100.103.600", "PA": "Tubulin Modulators", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester", "RN": "81G6I5V05I", "RR": "31431-39-7 (Mebendazole)", "PI": "Carbamates (1971-1974)", "MS": "A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.", "PM": "86; was see under BENZIMIDAZOLES 1975-85", "HN": "86(75); was see under BENZIMIDAZOLES 1975-85", "MR": "20171213", "DA": "19741111", "DC": "1", "DX": "19860101", "UI": "D008463"}, {"RECTYPE": "D", "MH": "Mecamylamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.075.080.500.500", "PA": "Nicotinic Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Bicyclo(2.2.1)heptan-2-amine, N,2,3,3-tetramethyl-", "RN": "6EE945D3OK", "RR": "60-40-2 (Mecamylamine)", "MS": "A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008464"}, {"RECTYPE": "D", "MH": "Mechanoreceptors", "DE": "MECHANORECEPT", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Stretch Receptors|T023|NON|NRW|NLM (1994)|930119|STRETCH RECEPT|abcdefv", "ENTRY": "Tendon Organs, Golgi", "MN": "A11.671.650.915.750", "FX": "Proprioception", "MH_TH": "NLM (1971)", "ST": "T025", "PI": "Receptors, Sensory (1966-1970)", "MS": "Cells specialized to transduce mechanical stimuli and relay that information centrally in the nervous system. Mechanoreceptor cells include the INNER EAR hair cells, which mediate hearing and balance, and the various somatosensory receptors, often with non-neural accessory structures.", "OL": "use MECHANORECEPTORS to search NEUROTENDINOUS SPINDLES 1975-96 & GOLGI TENDON ORGANS 1994-96; use RECEPTORS, NEURAL to search NEUROTENDINOUS SPINDLES 1972-74, use NERVE ENDINGS 1966-71; use THERMORECEPTORS to search KRAUSE'S END BULBS & RUFFINI'S CORPUSCLES 1975-93; use RECEPTORS, SENSORY 1972-74 & NERVE ENDINGS 1966-71", "PM": "71; NEUROTENDINOUS SPINDLES was heading 1975-96 (see under MECHANORECEPTORS 1977-90, see under RECEPTORS, NEURAL 1975-76), was see under RECEPTORS, NEURAL 1972-74, was see under NERVE ENDINGS 1963-71; GOLGI TENDON ORGANS was see NEUROTENDINOUS SPINDLES 1994-96; KRAUSE'S END BULBS & RUFFINI'S CORPUSCLES were see THERMORECEPTORS 1979-93; were see under THERMORECEPTORS 1975-78; were see under RECEPTORS, NEURAL 1972-74; were see under NERVE ENDINGS 1963-71", "HN": "71; NEUROTENDINOUS SPINDLES was heading 1975-96 (see under MECHANORECEPTORS 1977-90, see under RECEPTORS, NEURAL 1975-76), was see under RECEPTORS, NEURAL 1972-74, was see under NERVE ENDINGS 1963-71; GOLGI TENDON ORGANS was see NEUROTENDINOUS SPINDLES 1994-96; KRAUSE'S END BULBS & RUFFINI'S CORPUSCLES were see THERMORECEPTORS 1979-93; were see under THERMORECEPTORS 1975-78; were see under RECEPTORS, NEURAL 1972-74; were see under NERVE ENDINGS 1963-71", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D008465"}, {"RECTYPE": "D", "MH": "Mechlorethamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrogen Mustard N-Oxide|T109|T121|T131|NON|NRW|NLM (1992)|910320|abbbcdef", "ENTRY": "Nitrogen Mustard N Oxide", "MN": "D02.455.526.728.650.529", "PA": "Irritants", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Ethanamine, 2-chloro-N-(2-chloroethyl)-N-methyl-", "RN": "50D9XSG0VR", "RR": "L0MR697HHI", "MS": "A biologic alkylating agent that exerts its cytotoxic effects by forming DNA ADDUCTS and DNA interstrand crosslinks, thereby inhibiting rapidly proliferating cells. The hydrochloride is an antineoplastic agent used to treat HODGKIN DISEASE and LYMPHOMA.", "OL": "use MECHLORETHAMINE to search MECHLORETHAMINE OXIDE 1966-79; use MECHLORETHAMINE (NM) to search NITROGEN MUSTARD N-OXIDE (NM) 1984-91", "PM": "MECHLORETHAMINE OXIDE was heading 1963-79; NITROGEN MUSTARD N-OXIDE was indexed under NITROGEN MUSTARD COMPOUNDS 1984-91", "HN": "MECHLORETHAMINE OXIDE was heading 1963-79; NITROGEN MUSTARD N-OXIDE was NITROGEN MUSTARD N-OXIDE (NM) 1984-91", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D008466"}, {"RECTYPE": "D", "MH": "Meckel Diverticulum", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Meckel's Diverticulum|T019|T047|EPO|EQV|NLM (1966)|990101|abbcdef", "MN": "C23.300.415.750", "FX": "Vitelline Duct", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "Meckel's diverticulitis: coord IM with DIVERTICULITIS (IM)", "MS": "A congenital abnormality characterized by the outpouching or sac formation in the ILEUM. It is a remnant of the embryonic YOLK SAC in which the VITELLINE DUCT failed to close.", "PM": "2004; see MECKEL'S DIVERTICULUM 1966-2003", "HN": "2004 (1966)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D008467"}, {"RECTYPE": "D", "MH": "Meclizine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Parachloramine|T109|T121|NON|EQV|UNK (19XX)|770317|abbcdef", "ENTRY": "Ru Vert M", "MN": "D03.383.606.650", "PA": "Histamine H1 Antagonists", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)-", "RN": "3L5TQ84570", "RR": "HDP7W44CIO", "MS": "A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.", "MR": "20200925", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008468"}, {"RECTYPE": "D", "MH": "Meclofenamic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Meclofenamate, Sodium", "MN": "D02.455.426.559.389.127.020.906.750.500", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "Benzoic acid, 2-((2,6-dichloro-3-methylphenyl)amino)-", "RN": "48I5LU4ZWD", "RR": "9MMQ0YER4E", "PI": "Toluene (1972-1974)", "MS": "A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.", "PM": "1991; MECLOFENAMIC ACID was indexed under ANTHRANILIC ACIDS 1975-1990", "HN": "1991 (1975)", "MR": "20180410", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008469"}, {"RECTYPE": "D", "MH": "Meconium", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Meconiums", "MN": "A16.378.529", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "check the tag INFANT, NEWBORN", "MS": "The thick green-to-black mucilaginous material found in the intestines of a full-term fetus. It consists of secretions of the INTESTINAL GLANDS; BILE PIGMENTS; FATTY ACIDS; AMNIOTIC FLUID; and intrauterine debris. It constitutes the first stools passed by a newborn.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008470"}, {"RECTYPE": "D", "MH": "Meconium Aspiration Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Meconium Aspiration", "MN": "C16.614.580", "MH_TH": "NLM (2006)", "ST": "T047", "PI": "Respiratory Distress Syndrome (1971-1987)", "MS": "A condition caused by inhalation of MECONIUM into the LUNG of FETUS or NEWBORN, usually due to vigorous respiratory movements during difficult PARTURITION or respiratory system abnormalities. Meconium aspirate may block small airways leading to difficulties in PULMONARY GAS EXCHANGE and ASPIRATION PNEUMONIA.", "PM": "2006; see MECONIUM ASPIRATION 1988-2005", "HN": "2006 (1988)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19870325", "DC": "1", "DX": "19880101", "UI": "D008471"}, {"RECTYPE": "D", "MH": "Medazepam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro 54556", "MN": "D03.633.100.079.080.550", "PA": "Muscle Relaxants, Central", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1H-1,4-Benzodiazepine, 7-chloro-2,3-dihydro-1-methyl-5-phenyl-", "RN": "P0J3387W3S", "RR": "ETM878JC9K", "PI": "Benzazepines (1970-1974)", "MS": "A benzodiazepine derivative used in the treatment of anxiety. It has sedative, muscle relaxant, and anticonvulsant properties. One of its metabolites is DIAZEPAM and one of its excretion products is OXAZEPAM.", "PM": "91; was see under BENZODIAZEPINE TRANQUILIZERS 1975-90", "HN": "91(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-90", "MR": "20170524", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D008472"}, {"RECTYPE": "D", "MH": "Median Eminence", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Medianas, Eminentia", "MN": "A08.713.357.500", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "diseases: coordinate IM with BRAIN DISEASES (IM)", "MS": "Raised area at the infundibular region of the HYPOTHALAMUS at the floor of the BRAIN, ventral to the THIRD VENTRICLE and adjacent to the ARCUATE NUCLEUS OF HYPOTHALAMUS. It contains the terminals of hypothalamic neurons and the capillary network of hypophyseal portal system, thus serving as a neuroendocrine link between the brain and the PITUITARY GLAND.", "PM": "83; was see under HYPOTHALAMO-HYPOPHYSEAL SYSTEM 1974-82", "HN": "83(75); was see under HYPOTHALAMO-HYPOPHYSEAL SYSTEM 1974-82", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19830101", "UI": "D008473"}, {"RECTYPE": "D", "MH": "Medial Forebrain Bundle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Median Forebrain Bundle|T023|NON|EQV|NLM (1990)|881202|abcdef", "ENTRY": "Median Forebrain Bundles", "MN": "A08.612.492", "MH_TH": "NLM (1977)", "ST": "T023", "PI": "Neural Pathways (1974-1976)", "MS": "A complex group of fibers arising from the basal olfactory regions, the periamygdaloid region, and the septal nuclei, and passing to the lateral hypothalamus. Some fibers continue into the tegmentum.", "OL": "use MEDIAL FOREBRAIN BUNDLE to search MEDIAN FOREBRAIN BUNDLE 1975-89", "PM": "90; was MEDIAN FOREBRAIN BUNDLE see under NEURAL PATHWAYS 1975-89", "HN": "90(75); was MEDIAN FOREBRAIN BUNDLE see under NEURAL PATHWAYS 1975-89", "MR": "19920514", "DA": "19760519", "DC": "1", "DX": "19900101", "UI": "D008474"}, {"RECTYPE": "D", "MH": "Median Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nerves, Median", "MN": "A08.800.800.720.050.500", "FX": "Carpal Tunnel Syndrome", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A major nerve of the upper extremity. In humans, the fibers of the median nerve originate in the lower cervical and upper thoracic spinal cord (usually C6 to T1), travel via the brachial plexus, and supply sensory and motor innervation to parts of the forearm and hand.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008475"}, {"RECTYPE": "D", "MH": "Mediastinal Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Tracheal Cyst|T020|T047|NON|NRW|UNK (19XX)|880418|abbcdef", "ENTRY": "Tracheal Cysts", "MN": "C08.846.187.145", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "non-neoplastic; simple mediastinal cysts commonly adjacent to pericardium; note X refs: do not coord pericardial, thoracic, thymic or tracheal cysts with respective organs or organ/dis precoord: index only under MEDIASTINAL CYST", "MS": "Cysts of one of the parts of the mediastinum: the superior part, containing the trachea, esophagus, thoracic duct and thymus organs; the inferior middle part, containing the pericardium; the inferior anterior part containing some lymph nodes; and the inferior posterior part, containing the thoracic duct and esophagus.", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008476"}, {"RECTYPE": "D", "MH": "Mediastinal Diseases", "DE": "MEDIASTINAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mediastinal Disease", "MN": "C08.846.187", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Disorders of the mediastinum, general or unspecified.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008477"}, {"RECTYPE": "D", "MH": "Mediastinal Emphysema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulmonary Interstitial Emphysema|T046|NON|BRD|NLM (2024)|220927|abcdef", "ENTRY": "Pulmonary Interstitial Emphysemas", "MN": "C23.550.325.250", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "note category: do not confuse with PNEUMOMEDIASTINUM, DIAGNOSTIC", "MS": "Presence of air in the mediastinal tissues due to leakage of air from the tracheobronchial tree, usually as a result of trauma.", "CATSH": "CAT LIST", "MR": "20230426", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008478"}, {"RECTYPE": "D", "MH": "Mediastinal Neoplasms", "DE": "MEDIASTINAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Mediastinal Cancer|T191|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Neoplasms, Mediastinum", "MN": "C08.846.187.580", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the MEDIASTINUM.", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008479"}, {"RECTYPE": "D", "MH": "Mediastinitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mediastinum Inflammation|T047|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Mediastinum Inflammations", "MN": "C08.846.187.790", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the mediastinum, the area between the pleural sacs.", "CATSH": "CAT LIST", "MR": "19991104", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008480"}, {"RECTYPE": "D", "MH": "Mediastinoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Mediastinoscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES MEDIASTINOSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Mediastinoscopic", "MN": "E04.928.490", "FX": "Mediastinoscopes", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "/ instrum permitted but consider also MEDIASTINOSCOPES", "MS": "Endoscopic examination, therapy or surgery of the anterior superior mediastinum of the thorax.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008481"}, {"RECTYPE": "D", "MH": "Mediastinum", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "MN": "A01.923.761.800.500", "FX": "Pneumomediastinum, Diagnostic", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "A membrane in the midline of the THORAX of mammals. It separates the lungs between the STERNUM in front and the VERTEBRAL COLUMN behind. It also surrounds the HEART, TRACHEA, ESOPHAGUS, THYMUS, and LYMPH NODES.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008482"}, {"RECTYPE": "D", "MH": "Medical Assistance", "DE": "MED ASSISTANCE", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Assistance, Medical|T058|T064|NON|EQV|NLM (1991)|891129|ASSISTANCE MED|abbcdefv", "MN": "N03.219.521.346.506.564", "MH_TH": "NLM (1968)", "ST": "T064", "PI": "Social Welfare (1966-1967)", "MS": "Financing of medical care provided to public assistance recipients.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008483"}, {"RECTYPE": "D", "MH": "Medicaid", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Medical Assistance, Title 19|T064|T089|NON|NRW|POPLINE (1978)|900419|MED ASSISTANCE TITLE 19|abbcdefv", "ENTRY": "Programs, Dental Medicaid", "MN": "N03.706.615.693", "MH_TH": "NLM (1971)", "ST": "T089", "AN": "specify geog; Public Law 89-97", "PI": "Medical Assistance (1968-1970)", "MS": "Federal program, created by Public Law 89-97, Title XIX, a 1965 amendment to the Social Security Act, administered by the states, that provides health care benefits to indigent and medically indigent persons.", "OL": "use MEDICAID to search MEDICAL ASSISTANCE, TITLE 19 1971-90; use MEDICAL ASSISTANCE to search DENTAL MEDICAID PROGRAM 1969-73", "PM": "91; was MEDICAL ASSISTANCE, TITLE 19 1971-90; MEDICAID was see MEDICAL ASSISTANCE, TITLE 19 1975-90, was see under MEDICAL ASSISTANCE 1969-70; DENTAL MEDICAID PROGRAM was see under MEDICAL ASSISTANCE, TITLE 19 1979-85, was DENTICAID see under MEDICAL ASSISTANCE, TITLE 19 1974-78, was DENTICAID see under MEDICAL ASSISTANCE 1969-73", "HN": "91; was MEDICAL ASSISTANCE, TITLE 19 1971-90; MEDICAID was see MEDICAL ASSISTANCE, TITLE 19 1975-90, was see under MEDICAL ASSISTANCE 1969-70; DENTAL MEDICAID PROGRAM was see under MEDICAL ASSISTANCE, TITLE 19 1979-85, was DENTICAID see under MEDICAL ASSISTANCE, TITLE 19 1974-78, was DENTICAID see under MEDICAL ASSISTANCE 1969-73", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D008484"}, {"RECTYPE": "D", "MH": "Medical Audit", "DE": "MED AUDIT", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Medical Audits|T058|NON|EQV|NLM (1991)|891129|MED AUDITS|abcdefv", "MN": "N05.700.175.500", "MH_TH": "NLM (1968)", "ST": "T058", "PI": "Hospital Administration (1966-1967)", "MS": "A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of medical care.", "PM": "68", "HN": "68", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008485"}, {"RECTYPE": "D", "MH": "Physician Executives", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Medical Directors|T097|NON|EQV|NLM (1997)|960501|MED DIRECTORS|abcdefv", "ENTRY": "Physician Executive", "MN": "N02.360.800", "MH_TH": "NLM (1978)", "ST": "T097", "MS": "Physicians who serve in a medical and administrative capacity as head of an organized medical staff and who also may serve as liaison for the medical staff with the administration and governing board.", "PM": "97; was MEDICAL DIRECTORS 1978-96", "HN": "97; was MEDICAL DIRECTORS 1978-96", "MR": "20180629", "DA": "19770511", "DC": "1", "DX": "19780101", "UI": "D008486"}, {"RECTYPE": "D", "MH": "Medical History Taking", "DE": "MED HIST TAKING", "AQ": "MT SN ST VE", "PRINT ENTRY": "Previous Medical History|T060|NON|REL|NLM (2023)|211018|abcdef", "ENTRY": "Previous Medical Histories", "MN": "E01.370.510", "FX": "Data Collection", "MH_TH": "NLM (1967)", "ST": "T060", "PI": "Diagnosis (1966)", "MS": "Acquiring information from a patient on past medical conditions and treatments.", "PM": "70", "HN": "70(67)", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D008487"}, {"RECTYPE": "D", "MH": "Medical Illustration", "DE": "MED ILLUSTRATION", "AQ": "ED HI", "PRINT ENTRY": "Illustration, Medical|T073|T091|NON|EQV|UNK (19XX)|740330|ILLUSTRATION MED|abbcdefv", "ENTRY": "Medical Illustrations", "MN": "L01.462.500.820.090.480", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "MODELS, ANATOMIC is also available; anatomical atlases go here (IM) + ANATOMY, ARTISTIC (IM) if general; if specific coord IM with specific subject illustrated (IM) + illus medium (IM or NIM)", "MS": "The field which deals with illustrative clarification of biomedical concepts, as in the use of diagrams and drawings. The illustration may be produced by hand, photography, computer, or other electronic or mechanical methods.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008488"}, {"RECTYPE": "D", "MH": "Medical Indigency", "DE": "MED INDIGENCY", "AQ": "EC EH HI LJ PX SN TD", "PRINT ENTRY": "Indigency, Medical|T078|NON|EQV|UNK (19XX)|740330|INDIGENCY MED|abcdefv", "ENTRY": "Medical Indigencies", "MN": "N03.219.780", "FX": "Uncompensated Care", "MH_TH": "NLM (1968)", "ST": "T078", "MS": "The condition in which individuals are financially unable to access adequate medical care without depriving themselves and their dependents of food, clothing, shelter, and other essentials of living.", "OL": "use MEDICAL INDIGENCY to search INDIGENT CARE 1966-67", "PM": "68; was INDIGENT CARE 1963-67", "HN": "68; was INDIGENT CARE 1963-67", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008489"}, {"RECTYPE": "D", "MH": "Medical Informatics", "DE": "MED INFORMATICS", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Medical Information Science|T091|NON|BRD|UNK (19XX)|860617|MED INFORMATION SCIENCE|abcdefv", "ENTRY": "Technology, Health Information", "MN": "L01.313.500", "FX": "Biomedical Technology", "MH_TH": "NLM (1987)", "ST": "T091", "PI": "Information Systems (1982-1986)", "MS": "The field of information science concerned with the analysis and dissemination of medical data through the application of computers to various aspects of health care and medicine.", "PM": "87", "HN": "87", "MR": "20170224", "DA": "19860617", "DC": "1", "DX": "19870101", "UI": "D008490"}, {"RECTYPE": "D", "MH": "Medical Informatics Applications", "DE": "MED INFORMATICS APPLICATIONS", "ENTRY": "Medical Informatics Application", "MN": "L01.313.500.750", "MH_TH": "NLM (1987)", "ST": "T170", "MS": "Automated systems applied to the patient care process including diagnosis, therapy, and systems of communicating medical data within the health care setting.", "PM": "87", "HN": "87", "MR": "20150623", "DA": "19860617", "DC": "1", "DX": "19870101", "UI": "D008491"}, {"RECTYPE": "D", "MH": "Medical Informatics Computing", "DE": "MED INFORMATICS COMPUTING", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Informatics Computing, Medical|T066|T091|NON|EQV|NLM (1991)|900112|INFORMATICS COMPUTING MED|abbcdefv", "MN": "L01.313.500.875", "MH_TH": "NLM (1987)", "ST": "T091", "MS": "Precise procedural mathematical and logical operations utilized in the study of medical information pertaining to health care.", "PM": "87", "HN": "87", "MR": "20150623", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D008492"}, {"RECTYPE": "D", "MH": "Medical Missions", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Missions, Official Medical|T058|NON|NRW|NLM (1991)|900116|MISSIONS OFFICIAL MED|abcdefv", "ENTRY": "Official Medical Mission", "MN": "I01.615.500.750", "FX": "Religious Missions", "MH_TH": "NLM (2019)", "ST": "T058", "AN": "RELIGIOUS MISSIONS and MISSIONARIES are also available", "MS": "Travel by a group for the purpose of undertaking a health-care related project of short-term duration.", "PM": "2019", "HN": "2019(1966)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008493"}, {"RECTYPE": "D", "MH": "Medical Office Buildings", "DE": "MED OFFICE BUILDINGS", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Office Buildings, Medical|T073|NON|EQV|NLM (1991)|900116|OFFICE BUILDINGS MED|abcdefv", "ENTRY": "Office Building, Medical", "MN": "N02.278.562", "MH_TH": "NLM (1980)", "ST": "T073", "PI": "Health Facilities (1968-1979)", "MS": "Office and laboratory facilities constructed for the use of physicians and other health personnel.", "PM": "91; was see under HEALTH FACILITIES 1980-90", "HN": "91(80); was see under HEALTH FACILITIES 1980-90", "MR": "20180629", "DA": "19790411", "DC": "1", "DX": "19910101", "UI": "D008494"}, {"RECTYPE": "D", "MH": "Medical Oncology", "DE": "MED ONCOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Oncology, Medical|T091|NON|EQV|UNK (19XX)|780509|ONCOL MED|abcdefv", "ENTRY": "Oncology, Clinical", "MN": "H02.403.429.515", "FX": "Neoplasms", "MH_TH": "NLM (1979)", "ST": "T091", "AN": "use for the specialty only RADIATION ONCOLOGY is also available", "PI": "Specialties, Medical (1968-1978)", "MS": "A subspecialty of internal medicine concerned with the study of neoplasms.", "PM": "79", "HN": "79", "MR": "20160610", "DA": "19780509", "DC": "1", "DX": "19790101", "UI": "D008495"}, {"RECTYPE": "D", "MH": "Medical Receptionists", "DE": "MED RECEPTIONISTS", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Receptionists, Medical|T097|NON|EQV|NLM (1992)|910412|RECEPTIONISTS MED|abcdefv", "MN": "N02.360.067.600.630", "MH_TH": "NLM (1975)", "ST": "T097", "MS": "Individuals who receive patients in a medical office.", "OL": "search MEDICAL SECRETARIES 1968-74", "PM": "91; was see under MEDICAL SECRETARIES 1975-90", "HN": "91(75); was see under MEDICAL SECRETARIES 1975-90", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008496"}, {"RECTYPE": "D", "MH": "Medical Record Administrators", "DE": "MED RECORD ADMINISTRATORS", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Technician, Medical Record", "MN": "N02.360.067.550", "MH_TH": "NLM (1966)", "ST": "T097", "AN": "includes med rec librarians & med rec technicians", "MS": "Individuals professionally qualified in the management of patients' records. Duties may include planning, designing, and managing systems for patient administrative and clinical data, as well as patient medical records. The concept includes medical record technicians.", "OL": "use MEDICAL RECORD ADMINISTRATORS to search MEDICAL RECORDS LIBRARIANS 1966-76", "PM": "77; was MEDICAL RECORDS LIBRARIANS 1963-76", "HN": "77; was MEDICAL RECORDS LIBRARIANS 1963-76", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D008497"}, {"RECTYPE": "D", "MH": "Medical Record Linkage", "DE": "MED RECORD LINKAGE", "AQ": "IS MT ST", "PRINT ENTRY": "Record Linkage, Medical|T062|T078|NON|EQV|NLM (1990)|890525|RECORD LINKAGE MED|abbcdefv", "ENTRY": "Record Linkages, Medical", "MN": "N06.850.520.308.940.968.500", "FX": "Electronic Health Records", "MH_TH": "NLM (1975)", "ST": "T078", "PI": "Medical Records (1966-1989)", "MS": "The creation and maintenance of medical and vital records in multiple institutions in a manner that will facilitate the combined use of the records of identified individuals.", "PM": "91; was see under MEDICAL RECORDS 1975-90", "HN": "91(75); was see under MEDICAL RECORDS 1975-90", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008498"}, {"RECTYPE": "D", "MH": "Medical Records", "DE": "MED RECORDS", "AQ": "CL EC LJ SN ST", "PRINT ENTRY": "Medical Transcription|T057|NON|REL|NLM (1996)|950330|MED TRANSCRIPTION|abcdefv", "ENTRY": "Transcriptions, Medical", "MN": "N06.850.520.308.940.968", "FX": "Medical History Taking", "MH_TH": "BIOETHICS (1974)", "ST": "T170", "MS": "Recording of pertinent information concerning patient's illness or illnesses.", "CATSH": "CAT LIST", "MR": "20180713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008499"}, {"RECTYPE": "D", "MH": "Medical Records Department, Hospital", "DE": "MED REC DEP HOSP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Medical Records Department|T093|NON|EQV|UNK (19XX)|770519|HOSP MED RECORDS DEP|abcdefv", "ENTRY": "Records Departments, Medical", "MN": "N04.452.442.452.422.465", "MH_TH": "NLM (1977)", "ST": "T093", "MS": "Hospital department responsible for the creating, care, storage and retrieval of medical records. It also provides statistical information for the medical and administrative staff.", "PM": "91; was see under HOSPITAL DEPARTMENTS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90", "MR": "20190709", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D008500"}, {"RECTYPE": "D", "MH": "Medical Records, Problem-Oriented", "DE": "POMR", "AQ": "SN ST", "PRINT ENTRY": "Problem-Oriented Medical Records|T073|T170|NON|EQV|NLM (1990)|890525|PROBLEM ORIENTED MED RECORDS|abbcdefv", "ENTRY": "Records, Problem Oriented Medical", "MN": "N06.850.520.308.940.968.550", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "A system of record keeping in which a list of the patient's problems is made and all history, physical findings, laboratory data, etc. pertinent to each problem are placed under that heading.", "OL": "use MEDICAL RECORDS, PROBLEM-ORIENTED to search MEDICAL RECORDS, PROBLEM ORIENTED 1975-89", "PM": "91; was see under MEDICAL RECORDS 1975-90; was MEDICAL RECORDS, PROBLEM ORIENTED 1975-89", "HN": "91(89); was see under MEDICAL RECORDS 1975-90; was MEDICAL RECORDS, PROBLEM ORIENTED 1975-89", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008501"}, {"RECTYPE": "D", "MH": "Medical Secretaries", "DE": "MED SECRETARIES", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Secretary, Medical|T097|NON|EQV|NLM (1992)|910612|SECRETARY MED|abcdefv", "MN": "N02.360.067.600", "MH_TH": "NLM (1966)", "ST": "T097", "MS": "Individuals responsible for various duties pertaining to the medical office routine.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008502"}, {"RECTYPE": "D", "MH": "Medical Staff", "DE": "MED STAFF", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Staffs, Medical|T097|NON|EQV|NLM (1992)|910612|STAFFS MED|abcdefv", "MN": "N02.360.630", "MH_TH": "NLM (1973)", "ST": "T097", "MS": "Professional medical personnel who provide care to patients in an organized facility, institution or agency.", "PM": "73", "HN": "73", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008503"}, {"RECTYPE": "D", "MH": "Medical Staff Privileges", "DE": "MED STAFF PRIVILEGES", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Medical Staff Privileges, Nonphysician|T078|NON|NRW|UNK (19XX)|840406|MED STAFF PRIVILEGES NONPHYSICIAN|abcdefv", "ENTRY": "Staff Privilege, Medical", "MN": "N04.452.758.275.500", "MH_TH": "NLM (1977)", "ST": "T078", "PI": "Medical Staff, Hospital (1966-Jul 1977)", "MS": "Those rights or activities which are specific to members of the institution's medical staff, including the right to admit private patients.", "PM": "91; was see under MEDICAL STAFF, HOSPITAL Aug 1977-90", "HN": "91(Aug 77); was see under MEDICAL STAFF, HOSPITAL 1977-90", "MR": "20190709", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D008504"}, {"RECTYPE": "D", "MH": "Medical Staff, Hospital", "DE": "MED STAFF HOSP", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Registrars, Hospital|T097|NON|NRW|NLM (1998)|960712|abcdef", "ENTRY": "Staffs, Hospital Medical", "MN": "N02.360.740.422", "MH_TH": "NLM (1966)", "ST": "T097", "MS": "Professional medical personnel approved to provide care to patients in a hospital.", "OL": "use MEDICAL STAFF, HOSPITAL to search HOSPITAL MEDICAL STAFF 1966-77", "PM": "78; was HOSPITAL MEDICAL STAFF 1963-77", "HN": "78; was HOSPITAL MEDICAL STAFF 1963-77", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D008505"}, {"RECTYPE": "D", "MH": "Medical Waste", "DE": "MED WASTE", "AQ": "AE AN CL EC ES HI LJ PC SN", "PRINT ENTRY": "Pathological Waste|T031|NON|NRW|UNK (19XX)|770513|PATHOL WASTE|abcdefv", "ENTRY": "Wastes, Pathological", "MN": "N06.850.460.710.460", "FX": "Blood-Borne Pathogens", "MH_TH": "NLM (1978)", "ST": "T031", "RN": "0", "AN": "DENTAL WASTE is also available", "PI": "Refuse Disposal (1966-1977)", "MS": "Blood, mucus, tissue removed at surgery or autopsy, soiled surgical dressings, and other materials requiring special disposal procedures.", "PM": "91; was see under WASTE PRODUCTS 1978-90", "HN": "91(78); was see under WASTE PRODUCTS 1978-90", "MR": "20080708", "DA": "19770513", "DC": "1", "DX": "19910101", "UI": "D008506"}, {"RECTYPE": "D", "MH": "Medically Underserved Area", "DE": "MED UNDERSERV AREA", "PRINT ENTRY": "Physician Shortage Area|T080|NON|NRW|UNK (19XX)|770512|abcdef", "ENTRY": "Underserved Populations, Medically", "MN": "N05.300.450.520", "FX": "Health Services Accessibility", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A geographic location which has insufficient health resources (manpower and/or facilities) to meet the medical needs of the resident population.", "PM": "78", "HN": "78", "MR": "20180227", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D008507"}, {"RECTYPE": "D", "MH": "Medication Errors", "DE": "MEDICATION ERR", "AQ": "AE CL EC ES HI LJ MO NU PC PX SN TD VE", "ENTRY": "Medication Errors, LASA", "MN": "N02.421.450.500", "FX": "Drug Overdose", "MH_TH": "NLM (1966)", "ST": "T080", "MS": "Errors in prescribing, dispensing, or administering medication with the result that the patient fails to receive the correct drug or the indicated proper drug dosage.", "PM": "67", "HN": "67(66)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008508"}, {"RECTYPE": "D", "MH": "Medication Systems", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Unit Dose Drug Distribution Systems|T074|NON|NRW|UNK (19XX)|820426|abcdef", "ENTRY": "Systems, Medication", "MN": "N04.452.528", "MH_TH": "NLM (1973)", "ST": "T170", "AN": "an organizational concept in patient care for providing medication; do not confuse with DRUG DELIVERY SYSTEMS for admin of a drug to a patient or animal for \"controlled delivery so that an optimum amount reaches the target site\"; MEDICATION SYSTEMS, HOSPITAL is also available", "MS": "Overall systems, traditional or automated, to provide medication to patients.", "PM": "73", "HN": "73", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008509"}, {"RECTYPE": "D", "MH": "Medication Systems, Hospital", "DE": "MEDICATION SYSTEMS HOSP", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Medication System, Hospital|T074|T170|NON|EQV|NLM (1997)|951003|MEDICATION SYSTEM HOSP|abbcdefv", "ENTRY": "Systems, Hospital Medication", "MN": "N04.452.528.473", "FX": "Medical Order Entry Systems", "MH_TH": "NLM (1968)", "ST": "T170", "AN": "an organizational concept in hospital patient care for providing medication; do not confuse with DRUG DELIVERY SYSTEMS", "PI": "Pharmacy Service, Hospital (1966-1967)", "MS": "Overall systems, traditional or automated, to provide medication to patients in hospitals. Elements of the system are: handling the physician's order, transcription of the order by nurse and/or pharmacist, filling the medication order, transfer to the nursing unit, and administration to the patient.", "OL": "use MEDICATION SYSTEMS, HOSPITAL to search HOSPITAL MEDICATION SYSTEMS 1968-77", "PM": "78; was HOSPITAL MEDICATION SYSTEMS 1968-77", "HN": "78; was HOSPITAL MEDICATION SYSTEMS 1968-77", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008510"}, {"RECTYPE": "D", "MH": "Medicine", "AQ": "CL IS MT OG SN ST TD", "PRINT ENTRY": "Insurance Medicine|T058|NON|NRW|NLM (2022)|201228|abcdef", "ENTRY": "Speciality, Medical", "MN": "H02.403", "FX": "Legislation, Medical", "EC": "legislation & jurisprudence:Legislation, Medical", "MH_TH": "NLM (1963)", "ST": "T091", "MS": "The art and science of studying, performing research on, preventing, diagnosing, and treating disease, as well as the maintenance of health.", "PM": "1963; for SPECIALTIES, MEDICAL see SPECIALTIES, MEDICAL 1968-2009", "HN": "1963", "MR": "20210706", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D008511"}, {"RECTYPE": "D", "MH": "Medicine in the Arts", "AQ": "HI", "PRINT ENTRY": "Medicine in Art|T078|NON|EQV|NLM (1966)|990101|MED ART|abcdefv", "ENTRY": "Medicine in Arts", "MN": "K01.093.530", "MH_TH": "NLM (2018)", "ST": "T078", "AN": "coordinate IM with medical aspect (IM) + specific art heading (IM)", "MS": "Depiction of medical issues or themes via the arts including visual, oral, or written forms of expression.", "PM": "2018; see Medicine in Art 1966-2017", "HN": "2018(1966)", "MR": "20210304", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008512"}, {"RECTYPE": "D", "MH": "Medicine in Literature", "DE": "MED LIT", "AQ": "HI", "ENTRY": "in Literature, Medicine", "MN": "K01.517.584", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "coordinate IM with medical aspect (IM) + specific literature heading (IM) + literary type if pertinent (as POETRY; DRAMA, etc.) (IM)", "MS": "Written or other literary works whose subject matter is medical or about the profession of medicine and related areas.", "MR": "20170709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008513"}, {"RECTYPE": "D", "MH": "Medicine, Arabic", "DE": "MED ARABIC", "AQ": "AE EC HI IS MT PX SN ST TD", "ENTRY": "Arabic Medicine|T091|EPO|EQV|NLM (1991)|891201|ARABIC MED|abcdefv", "MN": "I01.076.201.450.654.510", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "Traditional concepts of medicine and associated methods reflected in medicine in the ARAB WORLD.", "CATSH": "CAT LIST", "MR": "20210702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008514"}, {"RECTYPE": "D", "MH": "Medicine, Ayurvedic", "DE": "MED AYURVEDIC", "AQ": "AE EC HI IS MT PX SN ST TD", "PRINT ENTRY": "Siddha Medicine|T058|T091|NON|NRW|NLM (2004)|020918|abbcdef", "ENTRY": "Medicine, Siddha", "MN": "I01.076.201.450.654.515", "MH_TH": "NLM (1964)", "ST": "T091", "MS": "The traditional medicine which is based on customs, beliefs, and practices of the Hindu culture.", "OL": "use MEDICINE, AYURVEDIC to search MEDICINE, HINDU 1966-80", "PM": "81; was MEDICINE, HINDU 1964-80", "HN": "81; was MEDICINE, HINDU 1964-80", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D008515"}, {"RECTYPE": "D", "MH": "Medicine, Chinese Traditional", "DE": "MED CHINESE TRADITIONAL", "AQ": "AE EC HI IS MT PX SN ST TD", "PRINT ENTRY": "Zhong Yi Xue|T058|NON|EQV|NLM (1994)|921230|abcdef", "ENTRY": "Traditional Tongue Diagnoses", "MN": "I01.076.201.450.654.558.520", "FX": "Yin Deficiency", "MH_TH": "NLM (1975)", "ST": "T058", "MS": "A system of traditional medicine which is based on the beliefs and practices of the Chinese culture.", "OL": "to search MEDICINE, CHINESE & CHINESE MEDICINE use MEDICINE, CHINESE TRADITIONAL 1975-83 & MEDICINE, ORIENTAL TRADITIONAL 1967-74", "PM": "88; was see under MEDICINE, ORIENTAL TRADITIONAL 1984-87; was MEDICINE, CHINESE see under MEDICINE, ORIENTAL 1981-83; was CHINESE MEDICINE see under MEDICINE, ORIENTAL 1967-80", "HN": "88(84); was see under MEDICINE, ORIENTAL TRADITIONAL 1984-87; was MEDICINE, CHINESE see under MEDICINE, ORIENTAL 1981-83; was CHINESE MEDICINE see under MEDICINE, ORIENTAL 1967-80", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19880101", "UI": "D008516"}, {"RECTYPE": "D", "MH": "Phytotherapy", "DE": "PHYTOTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Herb Therapy|T061|NON|EQV|NLM (2002)|010410|HERB THER|abcdefv", "ENTRY": "Herbal Therapy|T061|NON|EQV|NLM (2002)|010410|HERBAL THER|abcdefv", "MN": "E02.190.755", "FX": "Traditional Medicine Practitioners", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "coordinate IM with disease / drug ther (IM) + specific plant (IM) + PLANT PREPARATIONS or specifics / ther use (IM or NIM)", "MS": "Use of plants or herbs to treat diseases or to alleviate pain.", "PM": "2002; see MEDICINE, HERBAL 1981-2001, see HERBALISM 1963-1980", "HN": "2002(1963)", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008517"}, {"RECTYPE": "D", "MH": "Medicine, East Asian Traditional", "AQ": "AE EC HI IS MT PX SN ST TD", "PRINT ENTRY": "Traditional Medicine, East Asia|T058|NON|EQV|NLM (2009)|080314|abcdef", "ENTRY": "Traditional Oriental Medicines", "MN": "I01.076.201.450.654.558", "FX": "Acupuncture Therapy", "MH_TH": "NLM (2009)", "ST": "T058", "MS": "Medical practice or discipline that is based on the knowledge, cultures, and beliefs of the people in EAST ASIA.", "PM": "2009; see MEDICINE, ORIENTAL TRADITIONAL 1984-2008, see MEDICINE, ORIENTAL 1963-1983", "HN": "2009 (1963)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D008518"}, {"RECTYPE": "D", "MH": "Medicine, Traditional", "DE": "MED TRADITIONAL", "AQ": "AE EC HI IS MT PX SN ST TD", "PRINT ENTRY": "Medicine, Primitive|T058|NON|NRW|UNK (19XX)|800509|MED PRIMITIVE|abcdefv", "ENTRY": "Remedy, Home", "MN": "I01.076.201.450.654", "FX": "Traditional Pulse Diagnosis", "MH_TH": "POPLINE (1981)", "ST": "T058", "AN": "includes medicine among aborigines and other primitive cultures and folk medicine among non-primitive cultures; specify geographical term", "MS": "Systems of medicine based on cultural beliefs and practices handed down from generation to generation. The concept includes mystical and magical rituals (SPIRITUAL THERAPIES); PHYTOTHERAPY; and other treatments which may not be explained by modern medicine.", "OL": "use MEDICINE, TRADITIONAL to search MEDICINE, PRIMITIVE 1966-80, FOLK MEDICINE 1966-77, & FOLKLORE 1968-77", "PM": "81; was MEDICINE, PRIMITIVE 1963-80; FOLK MEDICINE was see under FOLKLORE 1968-77", "HN": "81; was MEDICINE, PRIMITIVE 1963-80; FOLK MEDICINE was see under FOLKLORE 1968-77", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D008519"}, {"RECTYPE": "D", "MH": "Medigoxin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Methyldigoxin|T109|T121|NON|EQV|UNK (19XX)|780320|abbcdef", "ENTRY": "beta Methyldigoxin", "MN": "D09.408.180.261.436.500", "PA": "Enzyme Inhibitors", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Card-20(22)-enolide, 3-((O-2,6-dideoxy-4-O-methyl-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-", "RN": "I7GG1YUC5V", "RR": "30685-43-9 (Medigoxin)", "PI": "Digoxin (1966-1978)", "MS": "A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to DIGOXIN in the liver. It has been used in the treatment of congestive heart failure (HEART FAILURE).", "PM": "91; was see under DIGOXIN 1979-90", "HN": "91(79); was see under DIGOXIN 1979-90", "MR": "20170524", "DA": "19780320", "DC": "1", "DX": "19910101", "UI": "D008520"}, {"RECTYPE": "D", "MH": "Mediterranean Islands", "AQ": "EH EP", "PRINT ENTRY": "Mediterranean Island|T083|NON|EQV|NLM (2021)|191120|abcdef", "MN": "Z01.639.640", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "CYPRUS; MALTA; & SICILY are available; for Corsica, coord with FRANCE; for Crete, coord with GREECE", "MS": "Islands in the Mediterranean Sea. The chief islands are the Balearic Islands, Corsica, Crete, Cyprus, the Cyclades, Dodecanese and Ionian Islands, Malta, Sardinia and Sicily.", "MR": "20200527", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008521"}, {"RECTYPE": "D", "MH": "Mediterranean Sea", "AQ": "EH EP", "MN": "Z01.756.592", "MH_TH": "NLM (1987)", "ST": "T083", "MS": "An inland sea enclosed by Europe on the west and north, by Asia on the east, and Africa on the south.", "HN": "87", "MR": "20161219", "DA": "19860402", "DC": "4", "DX": "19870101", "UI": "D008522"}, {"RECTYPE": "D", "MH": "MEDLARS", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Medical Literature Analysis and Retrieval System|T062|T170|NON|EQV|NLM (1991)|900322|abbcdef", "ENTRY": "System, MEDLARS-MEDLINE Information", "MN": "L01.313.500.750.300.710", "MH_TH": "NLM (1978)", "ST": "T170", "AN": "CATALOGER: Use NAF entry", "PI": "National Library of Medicine (U.S.) (1966-1977)", "MS": "A computerized biomedical bibliographic storage and retrieval system operated by the NATIONAL LIBRARY OF MEDICINE. MEDLARS stands for Medical Literature Analysis and Retrieval System, which was first introduced in 1964 and evolved into an online system in 1971 called MEDLINE (MEDLARS Online). As other online databases were developed, MEDLARS became the name of the entire NLM information system while MEDLINE became the name of the premier database. MEDLARS was used to produce the former printed Cumulated Index Medicus, and the printed monthly Index Medicus, until that publication ceased in December 2004.", "PM": "1991; see MEDLARS-MEDLINE INFORMATION SYSTEM 1978-1990", "HN": "1991 (1978)", "MR": "20180629", "DA": "19770511", "DC": "1", "DX": "19780101", "UI": "D008523"}, {"RECTYPE": "D", "MH": "Medrogestone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Prothil|T109|T121|T125|TRD|NRW|DE|041013|abbbcdef", "MN": "D04.210.500.745.432.481", "PA": "Antineoplastic Agents, Hormonal", "MH_TH": "USAN (1964)", "ST": "T125", "N1": "Pregna-4,6-diene-3,20-dione, 6,17-dimethyl-", "RN": "077DN93G5B", "RR": "977-79-7 (Medrogestone)", "AN": "a synthetic progestational hormone", "PI": "Progestational Hormones (1966-1971)", "MS": "6,17-Dimethylpregna-4,6-diene-3,20-dione. A synthetic progestational hormone with actions similar to those of progesterone. It is used in the treatment of menstrual irregularities and has also been employed in the treatment of prostatic hypertrophy and endometrial carcinoma.", "PM": "91; was see under PREGNADIENES 1972-90", "HN": "91(72); was see under PREGNADIENES 1972-90", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008524"}, {"RECTYPE": "D", "MH": "Medroxyprogesterone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)-|T109|T121|T125|NON|EQV|NLM (2020)|190708|abbbcdef", "ENTRY": "17 alpha Hydroxy 6 alpha Methylprogesterone", "MN": "D04.210.500.745.745.654.829.395.700", "PA": "Contraceptives, Oral, Synthetic", "MH_TH": "INN (19XX)", "ST": "T125", "RN": "HSU1C9YRES", "RR": "520-85-4 (Medroxyprogesterone)", "MS": "A synthetic progestational hormone used in veterinary practice as an estrus regulator.", "OL": "use MEDROXYPROGESTERONE to search METHYPREGNONE 1977-93", "PM": "METHYPREGNONE was see MEDROXYPROGESTERONE 1977-93", "HN": "METHYPREGNONE was see MEDROXYPROGESTERONE 1977-93", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D008525"}, {"RECTYPE": "D", "MH": "Medulla Oblongata", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nucleus, Lateral Cuneate", "MN": "A08.186.211.132.810.591.500", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The lower portion of the BRAIN STEM. It is inferior to the PONS and anterior to the CEREBELLUM. Medulla oblongata serves as a relay station between the brain and the spinal cord, and contains centers for regulating respiratory, vasomotor, cardiac, and reflex activities.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008526"}, {"RECTYPE": "D", "MH": "Medulloblastoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Sarcoma, Cerebellar, Circumscribed Arachnoidal|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Melanocytic Medulloblastomas", "MN": "C04.557.580.625.600.590.500", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coord IM with CEREBELLAR NEOPLASMS (IM)", "MS": "A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008527"}, {"RECTYPE": "D", "MH": "Mefenamic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "PMS Mefenamic Acid", "MN": "D02.455.426.559.389.127.020.906.750.555", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzoic acid, 2-((2,3-dimethylphenyl)amino)-", "RN": "367589PJ2C", "RR": "61-68-7 (Mefenamic Acid)", "MS": "A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.", "PM": "1972", "HN": "1972 (1965)", "MR": "20180410", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008528"}, {"RECTYPE": "D", "MH": "Mefruside", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.886.590.700.575", "PA": "Diuretics", "MH_TH": "USAN (1967)", "ST": "T121", "N1": "1,3-Benzenedisulfonamide, 4-chloro-N1-methyl-N1-((tetrahydro-2-methyl-2-furanyl)methyl)-", "RN": "X1NS9SNS92", "RR": "7195-27-9 (Mefruside)", "PI": "Furans (1972-1975)", "MS": "A benzene-sulfonamide-furan. It is used as a diuretic that affects the concentrating ability of the KIDNEY, increases SODIUM CHLORIDE excretion, but may not spare POTASSIUM. It inhibits CARBONIC ANHYDRASES and may increase the blood URIC ACID level.", "PM": "91; was see under DIURETICS, SULFAMYL 1976-90", "HN": "91(76); was see under DIURETICS, SULFAMYL 1976-90", "MR": "20130708", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D008529"}, {"RECTYPE": "D", "MH": "Megacins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Megacin A|T116|T195|NON|NRW|UNK (19XX)|840920|abbcdef", "MN": "D12.776.097.151.615", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Megacin (1975-1978)", "MS": "Bacteriocins elaborated by mutant strains of Bacillus megaterium. They are protein or protein-lipopolysaccharide complexes lethal to other strains of the same species.", "OL": "use MEGACINS to search MEGACIN 1975-78; use BACTERIOCINS 1968-74; use ANTIBIOTICS 1966-67", "PM": "91; was see under BACTERIOCINS 1979-80; was MEGACIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67", "HN": "91(79); was see under BACTERIOCINS 1979-90; was MEGACIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008530"}, {"RECTYPE": "D", "MH": "Megacolon", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Megacolons", "MN": "C06.405.469.158.701", "EC": "congenital:Hirschsprung Disease", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Dilatation of the COLON, often to alarming dimensions. There are various types of megacolon including congenital megacolon in HIRSCHSPRUNG DISEASE, idiopathic megacolon in CONSTIPATION, and TOXIC MEGACOLON.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008531"}, {"RECTYPE": "D", "MH": "Megacolon, Toxic", "DE": "MEGACOLON TOX", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Toxic Megacolon|T047|NON|EQV|NLM (1991)|900601|TOX MEGACOLON|abcdefv", "MN": "C06.405.469.158.701.591", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "An acute form of MEGACOLON, severe pathological dilatation of the COLON. It is associated with clinical conditions such as ULCERATIVE COLITIS; CROHN DISEASE; AMEBIC DYSENTERY; or CLOSTRIDIUM ENTEROCOLITIS.", "OL": "use COLITIS, ULCERATIVE to search MEGACOLON, TOXIC 1966-74", "PM": "91; was see under COLITIS, ULCERATIVE 1967-90", "HN": "91(75)(64-66); was see under COLITIS, ULCERATIVE 1964-90 (Prov 1964-66)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008532"}, {"RECTYPE": "D", "MH": "Megakaryocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Megakaryocyte", "MN": "A15.378.316.479", "MH_TH": "NLM (1966)", "ST": "T025", "AN": "MEGAKARYOCYTE PROGENITOR CELLS and MEGAKARYOCYTE-ERYTHROID PROGENITOR CELLS are also available", "MS": "Very large BONE MARROW CELLS which release mature BLOOD PLATELETS.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008533"}, {"RECTYPE": "D", "MH": "Megaloblasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Megaloblast", "MN": "A15.378.316.378.590.837.250.200.500", "FX": "Anemia, Megaloblastic", "MH_TH": "NLM (1975)", "ST": "T025", "MS": "Red blood cell precursors, corresponding to ERYTHROBLASTS, that are larger than normal, usually resulting from a FOLIC ACID DEFICIENCY or VITAMIN B 12 DEFICIENCY.", "OL": "search ERYTHROCYTES 1966-74", "PM": "91; was see under ERYTHROCYTES, ABNORMAL 1975-90; was see under ERYTHROCYTES 1963-74", "HN": "91(75); was see under ERYTHROCYTES, ABNORMAL 1975-90; was see under ERYTHROCYTES 1963-74", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008534"}, {"RECTYPE": "D", "MH": "Megestrol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-|T109|T121|T125|NON|EQV|NLM (2020)|190708|abbbcdef", "MN": "D04.210.500.745.432.531", "PA": "Contraceptives, Oral, Synthetic", "MH_TH": "INN (19XX)", "ST": "T125", "RN": "EA6LD1M70M", "RR": "3562-63-8 (Megestrol)", "AN": "a synthetic progestational hormone", "MS": "A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer.", "PM": "72", "HN": "72(63)", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008535"}, {"RECTYPE": "D", "MH": "Meglumine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylglucamine|T109|NON|EQV|UNK (19XX)|760416|abcdef", "MN": "D09.853.813.550", "PA": "Contrast Media", "MH_TH": "USP (19XX)", "ST": "T109", "N1": "D-Glucitol, 1-deoxy-1-(methylamino)-", "RN": "6HG8UB2MUY", "RR": "6284-40-8 (Meglumine)", "PI": "Sorbitol (1969-1976)", "MS": "1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium.", "PM": "91; was see under SORBITOL 1977-90", "HN": "91(77); was see under SORBITOL 1977-90", "MR": "20130708", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D008536"}, {"RECTYPE": "D", "MH": "Meibomian Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Glandulae Tarsales|T023|NON|EQV|NLM (2020)|190211|abcdef", "ENTRY": "Tarsal Gland", "MN": "A10.336.827.600", "FX": "Chalazion", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "The sebaceous glands situated on the inner surface of the eyelids between the tarsal plates and CONJUNCTIVA.", "OL": "search EYELIDS 1966-74", "PM": "91; was see under EYELIDS 1975-90", "HN": "91(75); was see under EYELIDS 1975-90", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008537"}, {"RECTYPE": "D", "MH": "Meige Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Idiopathic Orofacial Dyskinesia|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Orofacial Dyskinesias, Idiopathic", "MN": "C10.228.662.300.500", "MH_TH": "NLM (1985)", "ST": "T047", "PI": "Facial Muscles (1966-1984)", "MS": "A syndrome characterized by orofacial DYSTONIA; including BLEPHAROSPASM; forceful jaw opening; lip retraction; platysma muscle spasm; and tongue protrusion. It primarily affects older adults, with an incidence peak in the seventh decade of life. (From Adams et al., Principles of Neurology, 6th ed, p108)", "PM": "1991; see BASAL GANGLIA DISEASES 1985-1990", "HN": "1991(1985)", "CATSH": "CAT LIST", "MR": "20050701", "DA": "19840605", "DC": "1", "DX": "19910101", "UI": "D008538"}, {"RECTYPE": "D", "MH": "Meigs Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Meig's Syndrome", "MN": "C19.391.630.705.531", "MH_TH": "NLM (2006)", "ST": "T191", "AN": "do not confuse with MEIGE SYNDROME", "MS": "The triad of benign FIBROMA or other ovarian tumors with ASCITES, and HYDROTHORAX due to large PLEURAL EFFUSIONS.", "PM": "2006; see MEIGS' SYNDROME 1964-2005", "HN": "2006 (1964)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008539"}, {"RECTYPE": "D", "MH": "Meiosis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "M Phase, Meiotic|T043|T079|NON|REL|NLM (2005)|040316|abbcdef", "ENTRY": "Phases, Meiotic M", "MN": "G05.113.220.687", "FX": "Maturation-Promoting Factor", "MH_TH": "NLM (1968)", "ST": "T043", "PI": "Cell Division (1966-1967)", "MS": "A type of CELL NUCLEUS division, occurring during maturation of the GERM CELLS. Two successive cell nucleus divisions following a single chromosome duplication (S PHASE) result in daughter cells with half the number of CHROMOSOMES as the parent cells.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008540"}, {"RECTYPE": "D", "MH": "Mekong Valley", "AQ": "EH EP", "MN": "Z01.252.145.530", "MH_TH": "NLM (1975)", "ST": "T083", "MS": "The geographic area of the Mekong Valley in general or when the specific country or countries are not indicated.", "HN": "75", "MR": "20170224", "DA": "19990101", "DC": "4", "DX": "19750101", "UI": "D008541"}, {"RECTYPE": "D", "MH": "Melanesia", "AQ": "EH EP", "PRINT ENTRY": "Solomon Islands|T083|NAM|NRW|POPLINE (1983)|930108|abcdef", "ENTRY": "Norfolk Island|T083|NAM|NRW|POPLINE (1978)|861231|abcdef", "MN": "Z01.639.760.590", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "a group of islands northeast of Australia; includes, in addition to indentions & X refs, Norfolk Island; Melanesians are of Negroid race unless otherwise specified", "MS": "The collective name for the islands of the Pacific Ocean northeast of Australia, including NEW CALEDONIA; VANUATU; New Hebrides, Solomon Islands, Admiralty Islands, Bismarck Archipelago, FIJI, etc. Melanesia (from the Greek melas, black + nesos, island) is so called from the black color of the natives who are generally considered to be descended originally from the Negroid Papuans and the Polynesians or Malays. (From Webster's New Geographical Dictionary, 1988, p748 & Room, Brewer's Dictionary of Names, 1992, p344)", "HN": "68", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19680101", "UI": "D008542"}, {"RECTYPE": "D", "MH": "Melanins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Phaeomelanins|T109|NON|NRW|NLM (2006)|040922|abcdef", "MN": "D23.767.620", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Insoluble polymers of TYROSINE derivatives found in and causing darkness in skin (SKIN PIGMENTATION), hair, and feathers providing protection against SUNBURN induced by SUNLIGHT. CAROTENES contribute yellow and red coloration.", "OL": "use MELANINS to search MELANIN 1966-77", "PM": "78; was MELANIN 1963-77", "HN": "78; was MELANIN 1963-77", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D008543"}, {"RECTYPE": "D", "MH": "Melanocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Melanocyte", "MN": "A11.436.613", "MH_TH": "NLM (1969)", "ST": "T025", "AN": "do not confuse with MELANOPHORES", "PI": "Chromatophores (1966-1968)", "MS": "Mammalian pigment cells that produce MELANINS, pigments found mainly in the EPIDERMIS, but also in the eyes and the hair, by a process called melanogenesis. Coloration can be altered by the number of melanocytes or the amount of pigment produced and stored in the organelles called MELANOSOMES. The large non-mammalian melanin-containing cells are called MELANOPHORES.", "PM": "72", "HN": "72(69)", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008544"}, {"RECTYPE": "D", "MH": "Melanoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Malignant Melanoma|T191|NON|EQV|NLM (1994)|930401|abcdef", "ENTRY": "Melanomas, Malignant", "MN": "C17.800.882.445", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term; MELANOMA, EXPERIMENTAL is also available", "MS": "A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)", "CATSH": "CAT LIST", "MR": "20230522", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008545"}, {"RECTYPE": "D", "MH": "Melanoma, Experimental", "DE": "MELANOMA EXPER", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "PRINT ENTRY": "Melanoma, Harding-Passey|T050|T191|EPO|NRW|UNK (19XX)|860624|abbcdef", "ENTRY": "S91 Melanoma, Cloudman", "MN": "E05.598.500.496.937", "MH_TH": "NLM (1987)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM) ( most likely SKIN NEOPLASMS)", "PI": "Melanoma (1966-1986)", "MS": "Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19860624", "DC": "1", "DX": "19870101", "UI": "D008546"}, {"RECTYPE": "D", "MH": "Melanophores", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Melanophore", "MN": "A11.436.265.531", "MH_TH": "NLM (1975)", "ST": "T025", "AN": "do not confuse with MELANOCYTES", "PI": "Chromatophores (1966-1974)", "MS": "Chromatophores (large pigment cells of fish, amphibia, reptiles and many invertebrates) which contain melanin. Short term color changes are brought about by an active redistribution of the melanophores pigment containing organelles (MELANOSOMES). Mammals do not have melanophores; however they have retained smaller pigment cells known as MELANOCYTES.", "OL": "search CHROMATOPHORES 1966-74", "PM": "78; was see under CHROMATOPHORES 1963-77", "HN": "78(75); was see under CHROMATOPHORES 1963-77", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D008547"}, {"RECTYPE": "D", "MH": "Melanosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Melasma|T047|NON|REL|POPLINE (1978)|781226|abcdef", "ENTRY": "Melasmas", "MN": "C17.800.621.430.530", "MH_TH": "POPLINE (1978)", "ST": "T047", "AN": "for neurocutaneous melanosis, coord with NEUROCUTANEOUS SYNDROMES", "MS": "Disorders of increased melanin pigmentation that develop without preceding inflammatory disease.", "OL": "use LENTIGO to search FRECKLES 1966-79", "PM": "FRECKLES was see LENTIGO 1963-79", "HN": "FRECKLES was see LENTIGO 1963-79", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008548"}, {"RECTYPE": "D", "MH": "Melarsoprol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MelarsenoxidBAL", "MN": "D02.129.500", "PA": "Trypanocidal Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1,3,2-Dithiarsolane-4-methanol, 2-(4-((4,6-diamino-1,3,5-triazin-2-yl)amino)phenyl)-", "RN": "ZF3786Q2E8", "RR": "494-79-1 (Melarsoprol)", "PI": "Triazines (1968-1974)", "MS": "Arsenical used in trypanosomiases. It may cause fatal encephalopathy and other undesirable side effects.", "PM": "91; was see under ARSENICALS 1975-90", "HN": "91(75); was see under ARSENICALS 1975-90", "MR": "20190701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008549"}, {"RECTYPE": "D", "MH": "Melatonin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D06.472.506", "PA": "Central Nervous System Depressants", "MH_TH": "NLM (1965)", "ST": "T125", "N1": "Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-", "RN": "JL5DK93RCL", "RR": "73-31-4 (Melatonin)", "MS": "A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.", "PM": "68", "HN": "68(65)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008550"}, {"RECTYPE": "D", "MH": "Melena", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Melenas", "MN": "C23.550.414.788.600", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "The black, tarry, foul-smelling FECES that contain degraded blood.", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008551"}, {"RECTYPE": "D", "MH": "Melengestrol Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acetate, Melengestrol", "MN": "D04.210.500.745.432.581", "PA": "Glucocorticoids", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-16-methylene-, acetate", "RN": "4W5HDS3936", "RR": "BX98J4T6JU", "PI": "Progestational Hormones (1966-1972)", "MS": "A 6-methyl PROGESTERONE acetate with reported glucocorticoid activity and effect on ESTRUS.", "PM": "97; was MELENGESTROL 1973-96 (see under PREGNADIENES 1973-90)", "HN": "97; was MELENGESTROL 1973-96 (see under PREGNADIENES 1973-90)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008552"}, {"RECTYPE": "D", "MH": "Melibiose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.947.750.540", "MH_TH": "NLM (1979)", "ST": "T109", "N1": "D-Glucose, 6-O-alpha-D-galactopyranosyl-", "RN": "9B1VBE526I", "RR": "585-99-9 (Melibiose)", "PI": "Disaccharides (1966-1978)", "MS": "A disaccharide consisting of one galactose and one glucose moiety in an alpha (1-6) glycosidic linkage.", "PM": "91; was see under DISACCHARIDES 1979-90", "HN": "91(79); was see under DISACCHARIDES 1979-90", "MR": "20170410", "DA": "19771215", "DC": "1", "DX": "19910101", "UI": "D008553"}, {"RECTYPE": "D", "MH": "Melioidosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Whitmore's Disease|T047|EPO|EQV|NLM (2024)|220728|abcdef", "ENTRY": "Whitmore Disease", "MN": "C01.150.252.400.170.531", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by Burkholderia pseudomallei; in India, Malay & Indonesia", "MS": "A disease of humans and animals that resembles GLANDERS. It is caused by BURKHOLDERIA PSEUDOMALLEI and may range from a dormant infection to a condition that causes multiple abscesses, PNEUMONIA and BACTEREMIA.", "CATSH": "CAT LIST", "MR": "20230703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008554"}, {"RECTYPE": "D", "MH": "Melitten", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mellitin|T116|T123|T131|NON|EQV|UNK (19XX)|771123|abbbcdef", "MN": "D23.946.833.065.115.580", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Melittin (honeybee)", "RN": "20449-79-0", "AN": "/antag permitted but consider also ANTIVENINS", "PI": "Venoms (1973-1974)", "MS": "Basic polypeptide from the venom of the honey bee (Apis mellifera). It contains 26 amino acids, has cytolytic properties, causes contracture of muscle, releases histamine, and disrupts surface tension, probably due to lysis of cell and mitochondrial membranes.", "PM": "91; was see under BEE VENOMS 1978-90; was see under VENOMS 1975-77", "HN": "91(75); was see under BEE VENOMS 1978-90; was see under VENOMS 1975-77", "MR": "20210510", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008555"}, {"RECTYPE": "D", "MH": "Melkersson-Rosenthal Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Granulomatous Cheilitis|T047|NON|NRW|NLM (1991)|900308|abcdef", "ENTRY": "Rosenthal Melkersson Syndrome", "MN": "C10.292.319.800", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An idiopathic syndrome characterized by one or more of the following; recurrent orofacial swelling, relapsing facial paralysis, and fissured tongue (lingua plicata). The onset is usually in childhood and relapses are common. Cheilitis granulomatosa is a monosymptomatic variant of this condition. (Dermatol Clin 1996 Apr;14(2):371-9; Magalini & Magalini, Dictionary of Medical Syndromes, 4th ed, p531)", "PM": "64", "HN": "64(63)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D008556"}, {"RECTYPE": "D", "MH": "Melorheostosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Melorheostoses", "MN": "C05.116.099.708.702.593", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a form of osteosclerosis", "MS": "A form of osteosclerosis extending in a linear track mainly through one of the long bones of the upper and lower limbs.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008557"}, {"RECTYPE": "D", "MH": "Melphalan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sarkolysin|T116|T121|NON|REL|UNK (19XX)|740330|abbcdef", "ENTRY": "Mustard, Phenylalanine", "MN": "D12.125.072.050.685.500", "PA": "Myeloablative Agonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-", "RN": "Q41OR9510P", "RR": "148-82-3 (Melphalan)", "MS": "An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen.", "PM": "PEPTICHEMIO was see under NITROGEN MUSTARD COMPOUNDS 1975-80", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008558"}, {"RECTYPE": "D", "MH": "Memantine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "1,3-Dimethyl-5-aminoadamantane|T109|T121|NON|EQV|UNK (19XX)|750820|DIMETHYLAMINOADAMANTANE 01 03 05|abbcdefs", "ENTRY": "D 145", "MN": "D02.455.426.100.050.035.500", "PA": "Excitatory Amino Acid Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Tricyclo(3.3.1.13,7)decan-1-amine, 3,5-dimethyl-", "RN": "W8O17SJF3T", "RR": "JY0WD0UA60", "PI": "Amantadine (1974)/analogs & derivatives (1975)", "MS": "AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.", "OL": "use MEMANTINE to search D 145 1976-83", "PM": "91; was see under AMANTADINE 1984-90; was D 145 see under AMANTADINE 1976-83", "HN": "91(84); was see under AMANTADINE 1984-90; was D 145 see under AMANTADINE 1976-83", "MR": "20160701", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D008559"}, {"RECTYPE": "D", "MH": "Membrane Fluidity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Bilayer Fluidity|T044|NON|EQV|UNK (19XX)|780519|abcdef", "ENTRY": "Membrane Fluidities", "MN": "G04.570", "MH_TH": "NLM (1979)", "ST": "T044", "AN": "permitted with artificial membranes", "PI": "Phospholipids (1966-1976)", "MS": "The motion of phospholipid molecules within the lipid bilayer, dependent on the classes of phospholipids present, their fatty acid composition and degree of unsaturation of the acyl chains, the cholesterol concentration, and temperature.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D008560"}, {"RECTYPE": "D", "MH": "Membrane Fusion", "AQ": "DE ES GE IM PH RE", "ENTRY": "Membrane Fusions", "MN": "G04.575", "FX": "HIV Fusion Inhibitors", "MH_TH": "NLM (1982)", "ST": "T044", "PI": "Cell Membrane (1966-1981)", "MS": "The adherence and merging of cell membranes, intracellular membranes, or artificial membranes to each other or to viruses, parasites, or interstitial particles through a variety of chemical and physical processes.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19810520", "DC": "1", "DX": "19820101", "UI": "D008561"}, {"RECTYPE": "D", "MH": "Membrane Glycoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Surface Glycoproteins|T116|T123|NON|EQV|UNK (19XX)|870505|abbcdef", "ENTRY": "Surface Glycoproteins, Cell", "MN": "D12.776.543.550", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1977-1987)", "MS": "Glycoproteins found on the membrane or surface of cells.", "PM": "88", "HN": "88", "MR": "20230316", "DA": "19870505", "DC": "1", "DX": "19880101", "UI": "D008562"}, {"RECTYPE": "D", "MH": "Membrane Lipids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Membrane Lipid|T109|NON|EQV|NLM (2021)|191227|abcdef", "ENTRY": "Membrane Lipids, Cell", "MN": "D10.570", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Phospholipids (1966-1976)", "MS": "Lipids, predominantly phospholipids, cholesterol and small amounts of glycolipids found in membranes including cellular and intracellular membranes. These lipids may be arranged in bilayers in the membranes with integral proteins between the layers and peripheral proteins attached to the outside. Membrane lipids are required for active transport, several enzymatic activities and membrane formation.", "PM": "77", "HN": "77", "MR": "20200527", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D008563"}, {"RECTYPE": "D", "MH": "Membrane Potentials", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Transmembrane Potentials|T043|T081|NON|EQV|NLM (1991)|900404|abbcdef", "ENTRY": "Transmembrane Potential Differences", "MN": "G11.561.570", "MH_TH": "NLM (1967)", "ST": "T081", "AN": "coordinate with organ /physiol", "PI": "Electrophysiology (1966)", "MS": "The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization).", "PM": "68", "HN": "68(67)", "CATSH": "CAT LIST", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008564"}, {"RECTYPE": "D", "MH": "Membrane Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Surface Proteins|T116|T123|NON|EQV|UNK (19XX)|870505|abbcdef", "ENTRY": "Surface Protein, Cell", "MN": "D12.776.543", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "/biosyn /drug eff /physiol /ultrastruct permitted", "PI": "Proteins (1966-1976)", "MS": "Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.", "PM": "77", "HN": "77", "MR": "20200527", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D008565"}, {"RECTYPE": "D", "MH": "Membranes", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tissues, Membrane", "MN": "A10.615", "FX": "Synovial Membrane", "MH_TH": "NLM (1966)", "ST": "T024", "AN": "general; prefer specifics; almost never IM", "MS": "Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures.", "PM": "68", "HN": "68(66)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008566"}, {"RECTYPE": "D", "MH": "Membranes, Artificial", "PRINT ENTRY": "Artificial Membranes|T073|NON|EQV|NLM (1998)|961126|abcdef", "ENTRY": "Membrane, Artificial", "MN": "J01.637.087.500", "MH_TH": "NLM (1966)", "ST": "T073", "RN": "0", "MS": "Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION.", "PM": "68", "HN": "68(66)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008567"}, {"RECTYPE": "D", "MH": "Memory", "AQ": "CL DE PH RE", "MN": "F02.463.425.540", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "human & animal", "MS": "Complex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008568"}, {"RECTYPE": "D", "MH": "Memory Disorders", "DE": "MEMORY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Memory Loss|T048|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Spatial Memory Disorders", "MN": "F01.700.625", "MH_TH": "NLM (1969)", "ST": "T048", "PI": "Memory (1966-1968)", "MS": "Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.", "PM": "1969", "HN": "1969", "CATSH": "CAT LIST", "MR": "19991206", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D008569"}, {"RECTYPE": "D", "MH": "Memory, Short-Term", "AQ": "CL DE PH RE", "PRINT ENTRY": "Working Memory|T041|NON|EQV|NLM (2010)|081124|abcdef", "ENTRY": "Working Memories", "MN": "F02.463.425.540.407", "MH_TH": "NLM (1969)", "ST": "T041", "PI": "Memory (1966-1968)", "MS": "Remembrance of information for a few seconds to hours.", "OL": "use MEMORY, SHORT-TERM to search IMMEDIATE RECALL 1969-78", "PM": "69", "HN": "69; IMMEDIATE RECALL was see under MEMORY, SHORT-TERM 1969-78", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D008570"}, {"RECTYPE": "D", "MH": "Men", "AQ": "ED PX", "ENTRY": "Boys|T098|NON|NRW|NLM (2017)|151123|abcdef", "MN": "M01.390", "MH_TH": "BIOETHICS (1974)", "ST": "T098", "AN": "for men or boys only as a cultural, social, sociological, political, economic force; do not confuse with the check tag MALE; when indexing MEN, check the tags HUMANS & MALE; CATALOGER: Coordinate with age group if appropriate", "PI": "Male (1966-1979)", "MS": "Human males as cultural, psychological, sociological, political, and economic entities.", "PM": "1980; see MALE 1966-1979", "HN": "1980; use MALE 1966-1979", "MR": "20171208", "DA": "19790427", "DC": "1", "DX": "19800101", "UI": "D008571"}, {"RECTYPE": "D", "MH": "Menarche", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "MN": "G08.686.841.374.410", "MH_TH": "NLM (1973)", "ST": "T040", "PI": "Puberty (1966-1968)", "MS": "The first MENSTRUAL CYCLE marked by the initiation of MENSTRUATION.", "PM": "73", "HN": "73(69)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008572"}, {"RECTYPE": "D", "MH": "Mendelevium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.494", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Mendelevium", "RN": "LW3E571O0Z", "RR": "7440-11-1 (Mendelevium)", "MS": "A man-made radioactive element of the actinide family with atomic symbol Md, and atomic number 101.", "MR": "20170414", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008573"}, {"RECTYPE": "D", "MH": "Mengovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Virus, Mengo", "MN": "B04.820.578.750.170.200.500", "MH_TH": "NLM (1973)", "ST": "T005", "RN": "txid12107", "AN": "a strain of ENCEPHALOMYOCARDITIS VIRUS; Mengo is in Uganda; infection: coord IM with CARDIOVIRUS INFECTIONS (IM)", "PI": "Encephalomyocarditis Viruses (1966-1972)", "MS": "A strain of ENCEPHALOMYOCARDITIS VIRUS, a species of CARDIOVIRUS, isolated from rodents and lagomorphs and occasionally causing febrile illness in man.", "OL": "use MENGOVIRUS to search MENGO VIRUS 1973-93", "PM": "94; was MENGO VIRUS 1973-93", "HN": "94; was MENGO VIRUS 1973-93", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008574"}, {"RECTYPE": "D", "MH": "Meniere Disease", "DE": "MENIERE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vertigo, Aural|T047|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Vertigos, Otogenic", "MN": "C09.218.568.217.500", "FX": "Transtympanic Micropressure Treatment", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "spell with one accent (Meni\u00e8re's) in translations", "MS": "A disease of the inner ear (LABYRINTH) that is characterized by fluctuating SENSORINEURAL HEARING LOSS; TINNITUS; episodic VERTIGO; and aural fullness. It is the most common form of endolymphatic hydrops.", "PM": "2008; see MENIERE'S DISEASE 1963-2007", "HN": "2008 (1963)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D008575"}, {"RECTYPE": "D", "MH": "Meningeal Arteries", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Meningeal Artery", "MN": "A07.015.114.545", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Arteries which supply the dura mater.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008576"}, {"RECTYPE": "D", "MH": "Meningeal Neoplasms", "DE": "MENINGEAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Spinal Meningeal Neoplasms|T191|NON|NRW|NLM (2000)|991108|SPINAL MENINGEAL NEOPL|abcdefv", "ENTRY": "Tumors, Meningeal", "MN": "C10.551.240.500", "MH_TH": "NLM (1978)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM); for intracranial or spinal meningioma, see note on MENINGIOMA; intradural extramedullary neopl do not go here: index under SPINAL CORD NEOPLASMS & do not try to locate \"intradural\" or \"extramedullary\"; meningeal leukemia does not go here: index under MENINGES /pathol (IM) + LEUKEMIC INFILTRATION (IM) (see note there) + specific type of leukemia (IM) if relevant", "PI": "Neoplasms (1966-1977)", "MS": "Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D008577"}, {"RECTYPE": "D", "MH": "Meninges", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "MN": "A08.186.566", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The three membranes that cover the BRAIN and the SPINAL CORD. They are the dura mater, the arachnoid, and the pia mater.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008578"}, {"RECTYPE": "D", "MH": "Meningioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Meningiomatosis|T191|NON|NRW|NLM (1994)|930331|abcdef", "ENTRY": "Xanthomatous Meningiomas", "MN": "C10.551.240.500.500", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "benign or malignant; coord IM with MENINGEAL NEOPLASMS (IM) but not with BRAIN NEOPLASMS nor SPINAL CORD NEOPLASMS for intracranial or spinal meningioma unless site is particularly discussed", "MS": "A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7)", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008579"}, {"RECTYPE": "D", "MH": "Meningism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pseudomeningitis|T047|T184|NON|EQV|NLM (2000)|991104|abbcdef", "ENTRY": "Syndrome, Dupre's", "MN": "C23.888.592.544", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A condition characterized by neck stiffness, headache, and other symptoms suggestive of meningeal irritation, but without actual inflammation of the meninges (MENINGITIS). Spinal fluid pressure may be elevated but spinal fluid is normal. (DeJong, The Neurologic Examination, 4th ed, p673)", "CATSH": "CAT LIST", "MR": "19991104", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008580"}, {"RECTYPE": "D", "MH": "Meningitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pachymeningitis|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Pachymeningitides", "MN": "C10.586.625", "FX": "Subdural Effusion", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general; prefer specifics; for pachymeningitis (DURA MATER) or leptomeningitis (ARACHNOIDITIS or PIA MATER) do not specify meninx unless particularly discussed; purulent, suppurative or pyogenic: do not coordinate with SUPPURATION (NIM) unless particularly discussed", "MS": "Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008581"}, {"RECTYPE": "D", "MH": "Meningitis, Aseptic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aseptic Meningitis|T047|NON|EQV|NLM (2000)|991103|abcdef", "MN": "C10.586.625.220", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "coordinate IM with specific cause (IM) if pertinent", "PI": "Meningitis (1966-1976)", "MS": "A syndrome characterized by headache, neck stiffness, low grade fever, and CSF lymphocytic pleocytosis in the absence of an acute bacterial pathogen. Viral meningitis is the most frequent cause although MYCOPLASMA INFECTIONS; RICKETTSIA INFECTIONS; diagnostic or therapeutic procedures; NEOPLASTIC PROCESSES; septic perimeningeal foci; and other conditions may result in this syndrome. (From Adams et al., Principles of Neurology, 6th ed, p745)", "PM": "1991; see MENINGITIS 1977-1990", "HN": "1991(1977)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D008582"}, {"RECTYPE": "D", "MH": "Meningitis, Haemophilus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Meningitides, Hemophilus", "MN": "C10.586.625.280.393", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with Haemophilus species (IM) if available", "MS": "Infections of the nervous system caused by bacteria of the genus HAEMOPHILUS, and marked by prominent inflammation of the MENINGES. HAEMOPHILUS INFLUENZAE TYPE B is the most common causative organism. The condition primarily affects children under 6 years of age but may occur in adults.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008583"}, {"RECTYPE": "D", "MH": "Meningitis, Listeria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Meningoencephalitis, Listeria|T047|NON|BRD|NLM (2000)|991104|MENINGOENCEPH LISTERIA|abcdefv", "ENTRY": "Meningoencephalitides, Listeria", "MN": "C10.586.625.280.449", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not coord with LISTERIA MONOCYTOGENES unless organism is particularly discussed", "MS": "Inflammation of the meninges caused by LISTERIA MONOCYTOGENES infection, usually occurring in individuals under the age of 3 years or over the age of 50 years. It may occur at any age in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES. Clinical manifestations include FEVER, altered mentation, HEADACHE, meningeal signs, focal neurologic signs, and SEIZURES. (From Medicine 1998 Sep;77(5):313-36)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008584"}, {"RECTYPE": "D", "MH": "Meningitis, Meningococcal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Neisseria Meningitis|T047|NON|EQV|NLM (2024)|230214|abcdef", "ENTRY": "Serogroup W 135, Meningococcal Meningitis", "MN": "C10.586.625.280.505", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not coord with NEISSERIA MENINGITIDIS unless organism is particularly discussed but coord with specific serogroup (IM) if given", "MS": "A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8)", "PM": "1978; see MENINGITIS, MENINGOCOCCIC 1963-1977", "HN": "1978(1963)", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D008585"}, {"RECTYPE": "D", "MH": "Meningitis, Pneumococcal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Meningitis, Streptococcus pneumoniae|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Streptococcus pneumoniae Meningitis", "MN": "C10.586.625.280.560", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not coordinate with STREPTOCOCCUS PNEUMONIAE unless organism is particularly discussed", "MS": "An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008586"}, {"RECTYPE": "D", "MH": "Meningitis, Viral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Viral Meningitis|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Viral Meningitides", "MN": "C10.586.625.400", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific virus disease (IM)", "MS": "Viral infections of the leptomeninges and subarachnoid space. TOGAVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; RUBELLA; BUNYAVIRIDAE INFECTIONS; ORBIVIRUS infections; PICORNAVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RHABDOVIRIDAE INFECTIONS; ARENAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; JC VIRUS infections; and RETROVIRIDAE INFECTIONS may cause this form of meningitis. Clinical manifestations include fever, headache, neck pain, vomiting, PHOTOPHOBIA, and signs of meningeal irritation. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008587"}, {"RECTYPE": "D", "MH": "Meningocele", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Meningeal Herniation|T190|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Traumatic Meningoceles", "MN": "C23.300.707.968", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "meningoencephalocele: coordinate IM with ENCEPHALOCELE (IM)", "MS": "A congenital or acquired protrusion of the meninges, unaccompanied by neural tissue, through a bony defect in the skull or vertebral column.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008588"}, {"RECTYPE": "D", "MH": "Meningococcal Infections", "DE": "MENINGOCOCCAL INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Meningococcal Septicemia|T047|NON|REL|NLM (2024)|230214|abcdef", "ENTRY": "Septicemia, Meningococcal", "MN": "C01.150.252.400.625.549", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "MENINGITIS, MENINGOCOCCAL is also available; coord IM with specific Neisseria meningitidis serogroup (IM) if given", "MS": "Infections with bacteria of the species NEISSERIA MENINGITIDIS.", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008589"}, {"RECTYPE": "D", "MH": "Meningoencephalitis", "DE": "MENINGOENCEPH", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Cerebromeningitis|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Meningoencephalitides", "MN": "C10.586.625.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific infection term (IM) or other cause (IM)", "MS": "An inflammatory process involving the brain (ENCEPHALITIS) and meninges (MENINGITIS), most often produced by pathogenic organisms which invade the central nervous system, and occasionally by toxins, autoimmune disorders, and other conditions.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008590"}, {"RECTYPE": "D", "MH": "Meningomyelocele", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myelomeningocele|T019|NON|EQV|NLM (1991)|900111|abcdef", "ENTRY": "Myelomeningoceles, Acquired", "MN": "C16.131.666.680.610", "MH_TH": "NLM (1975)", "ST": "T019", "PI": "Spina Bifida (1966-1974)", "MS": "Congenital, or rarely acquired, herniation of meningeal and spinal cord tissue through a bony defect in the vertebral column. The majority of these defects occur in the lumbosacral region. Clinical features include PARAPLEGIA, loss of sensation in the lower body, and incontinence. This condition may be associated with the ARNOLD-CHIARI MALFORMATION and HYDROCEPHALUS. (From Joynt, Clinical Neurology, 1992, Ch55, pp35-6)", "OL": "search SPINA BIFIDA 1966-74; use SPINA BIFIDA to search MYELOCELE 1966-77", "PM": "78; was see under SPINA BIFIDA 1963-77; MYELOCELE was see under SPINA BIFIDA 1963-77", "HN": "78(75); was see under SPINA BIFIDA 1963-77; MYELOCELE was see under SPINA BIFIDA 1963-77", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D008591"}, {"RECTYPE": "D", "MH": "Menisci, Tibial", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Tibial Menisci|T023|NON|EQV|UNK (19XX)|860402|abcdef", "ENTRY": "Semilunar Cartilage", "MN": "A10.165.382.350.163.500", "EC": "injuries:Tibial Meniscus Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The interarticular fibrocartilages of the superior surface of the tibia.", "OL": "use MENISCI, TIBIAL to search SEMILUNAR CARTILAGES 1966-86", "PM": "87; was SEMILUNAR CARTILAGES 1963-86", "HN": "87; was SEMILUNAR CARTILAGES 1963-86", "MR": "20160504", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D008592"}, {"RECTYPE": "D", "MH": "Menopause", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Change of Life, Female|T039|T079|NON|EQV|NLM (1998)|961217|abbcdef", "MN": "G08.686.841.249.500", "FX": "Premenopause", "MH_TH": "NLM (1966)", "ST": "T079", "AN": "PERIMENOPAUSE; PREMENOPAUSE; and POSTMENOPAUSE are available", "MS": "The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008593"}, {"RECTYPE": "D", "MH": "Menopause, Premature", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "ENTRY": "Premature Menopause", "MN": "G08.686.841.249.500.500", "FX": "Primary Ovarian Insufficiency", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "The premature cessation of menses (MENSTRUATION) when the last menstrual period occurs in a woman under the age of 40. It is due to the depletion of OVARIAN FOLLICLES. Premature MENOPAUSE can be caused by diseases; OVARIECTOMY; RADIATION; chemicals; and chromosomal abnormalities.", "PM": "91; was see under MENOPAUSE 1975-90", "HN": "91(75); was see under MENOPAUSE 1975-90", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008594"}, {"RECTYPE": "D", "MH": "Menorrhagia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypermenorrhea|T033|T046|NON|EQV|UNK (19XX)|850321|abbcdef", "ENTRY": "Menstrual Bleeding, Heavy", "MN": "C23.550.568.875", "MH_TH": "NLM (1963)", "ST": "T046", "AN": "do not confuse with METRORRHAGIA", "MS": "Excessive uterine bleeding during MENSTRUATION.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008595"}, {"RECTYPE": "D", "MH": "Menotropins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Human Menopausal Gonadotropin|T116|T121|T125|NON|EQV|NLM (2021)|200227|abbbcdef", "ENTRY": "Pergonal500", "MN": "D20.215.535", "PA": "Fertility Agents, Female", "FX": "Receptors, Gonadotropin", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Gonadotropin, menopausal", "RN": "61489-71-2", "RR": "97048-13-0 (Urofollitropin)", "PI": "Gonadotropins, Pituitary (1966-1972)", "MS": "Extracts of urine from menopausal women that contain high concentrations of pituitary gonadotropins, FOLLICLE STIMULATING HORMONE and LUTEINIZING HORMONE. Menotropins are used to treat infertility. The FSH:LH ratio and degree of purity vary in different preparations.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008596"}, {"RECTYPE": "D", "MH": "Menstrual Cycle", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Ovarian Cycle|T039|NON|NRW|UNK (19XX)|840531|abcdef", "ENTRY": "Ovarian Cycles", "MN": "G08.686.605", "FX": "Estrous Cycle", "MH_TH": "NLM (1975)", "ST": "T039", "AN": "human & other primates only; for non-primates use ESTROUS CYCLE; do not confuse with MENSTRUATION", "PI": "Menstruation (1966-1984)", "MS": "The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase.", "PM": "85", "HN": "85", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19840531", "DC": "1", "DX": "19850101", "UI": "D008597"}, {"RECTYPE": "D", "MH": "Menstruation", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "MN": "G08.686.605.428", "FX": "Premenstrual Syndrome", "MH_TH": "NLM (1963)", "ST": "T040", "MS": "The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.", "CATSH": "CAT LIST", "MR": "20180527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008598"}, {"RECTYPE": "D", "MH": "Menstruation Disturbances", "DE": "MENSTRUATION DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polymenorrhea|T047|NON|NRW|UNK (19XX)|850321|abcdef", "ENTRY": "Retrograde Menstruation", "MN": "C23.550.568", "MH_TH": "NLM (2000)", "ST": "T046", "AN": "human only", "MS": "Variations of MENSTRUATION which may be indicative of disease.", "PM": "2000; see MENSTRUATION DISORDERS 1963-1999; for HYPOMENORRHEA, POLYMENORRHEA & MENSTRUATION, RETROGRADE see MENSTRUATION DISORDERS 1975-1985", "HN": "2000(1963)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D008599"}, {"RECTYPE": "D", "MH": "Menstruation-Inducing Agents", "DE": "MENSTRUATION IND AGENTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Emmenagogues|T121|NON|EQV|UNK (19XX)|750116|abcdef", "ENTRY": "Menstruation Inducing Agents", "MN": "D27.505.954.705.650", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "consider also MENSTRUATION /drug eff", "PI": "Menstruation/drug effects (1968-1974)", "MS": "Chemical compounds that induce menstruation either through direct action on the reproductive organs or through indirect action by relieving another condition of which amenorrhea is a secondary result. (From Dorland, 27th ed)", "PM": "1994; was MENSTRUATION INDUCING AGENTS 1975-1993", "HN": "1994; was MENSTRUATION INDUCING AGENTS 1975-1993", "MR": "20190116", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D008600"}, {"RECTYPE": "D", "MH": "Mental Healing", "AQ": "HI PX", "ENTRY": "Healing, Mental", "MN": "E02.190.901.500", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The use of mind to cure disease, particularly physical illness.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008602"}, {"RECTYPE": "D", "MH": "Mental Health", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "PRINT ENTRY": "Mental Hygiene|T078|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Hygiene, Mental", "MN": "N01.400.500", "MH_TH": "NLM (1974)", "ST": "T078", "MS": "Emotional, psychological, and social well-being of an individual or group.", "OL": "use MENTAL HEALTH to search MENTAL HYGIENE 1966", "PM": "67; was MENTAL HYGIENE 1963-66", "HN": "67; was MENTAL HYGIENE 1963-66", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008603"}, {"RECTYPE": "D", "MH": "Mental Health Associations", "DE": "MENTAL HEALTH ASSOC", "AQ": "EC HI OG", "ENTRY": "Mental Health Association", "MN": "N03.540.630.780.500", "MH_TH": "NLM (1975)", "ST": "T093", "AN": "specify geog", "PI": "Voluntary Health Agencies (1966-1974)", "MS": "Voluntary organizations which support educational programs and research in psychiatry with the objective of the promotion of mental health. An early association in the United States was founded as the National Committee for Mental Hygiene in 1909, became the Mental Health Association in 1976 and later the National Mental Health Association in 1980. State and local mental health associations in this country are chartered by the national organization and affiliated with it.", "OL": "use MENTAL HEALTH ASSOCIATIONS to search MENTAL HEALTH ASSOCIATION 1975-93; search VOLUNTARY HEALTH AGENCIES 1967-74", "PM": "94; was MENTAL HEALTH ASSOCIATION 1975-93 (see under VOLUNTARY HEALTH AGENCIES 1975-90)", "HN": "94; was MENTAL HEALTH ASSOCIATION 1975-93 (see under VOLUNTARY HEALTH AGENCIES 1975-90)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008604"}, {"RECTYPE": "D", "MH": "Mental Health Services", "DE": "MENTAL HEALTH SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Mental Hygiene Services|T058|NON|EQV|UNK (19XX)|740330|MENTAL HYGIENE SERV|abcdefv", "ENTRY": "Service, Mental Hygiene", "MN": "N02.421.461", "MH_TH": "NLM (1967)", "ST": "T058", "AN": "COMMUNITY MENTAL HEALTH SERVICES & specifics are also available; Public Laws 89-105 & 89-164", "MS": "Organized services to provide mental health care.", "OL": "use MENTAL HEALTH SERVICES to search MENTAL HYGIENE SERVICES 1966", "PM": "67; was MENTAL HYGIENE SERVICES 1963-66", "HN": "67; was MENTAL HYGIENE SERVICES 1963-66", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008605"}, {"RECTYPE": "D", "MH": "Mental Processes", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Information Processing, Human|T041|NON|EQV|NLM (1990)|890110|abcdef", "ENTRY": "Human Information Processing|T041|NON|EQV|LCSH (1986)|890405|abcdef", "MN": "F02.463", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "Conceptual functions or thinking in all its forms.", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008606"}, {"RECTYPE": "D", "MH": "Intellectual Disability", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Retardation, Mental|T048|NON|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Retardations, Psychosocial Mental", "MN": "F03.625.539", "EC": "education:Education of Intellectually Disabled", "MH_TH": "NLM (2012)", "ST": "T048", "AN": "do not equate /rehabil with EDUCATION OF INTELLECTUALLY DISABLED", "MS": "Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)", "PM": "1967; see MENTAL DEFICIENCY 1963-1966; see IDIOCY 1963-1984; see MENTAL RETARDATION, PSYCHOSOCIAL 1969-1997", "HN": "1967(1963)", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008607"}, {"RECTYPE": "D", "MH": "Mental Status Schedule", "AQ": "HI SN ST", "MN": "F04.711.513.653.574", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "Standardized clinical interview used to assess current psychopathology by scaling patient responses to the questions.", "OL": "search PSYCHIATRIC STATUS RATING SCALES 1969-74", "PM": "91; was see under PSYCHIATRIC STATUS RATING SCALES 1975-90", "HN": "91(75); was see under PSYCHIATRIC STATUS RATING SCALES 1975-90", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008609"}, {"RECTYPE": "D", "MH": "Menthol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclohexanol, 5-methyl-2-(1-methylethyl)-|T109|T121|NON|EQV|NLM (2020)|190626|abbcdef", "ENTRY": "Menthol, (1alpha,2beta,5alpha)-Isomer|T109|T121|REL|NLM (1999)|990913|abbdef", "MN": "D10.289.510.500.605", "PA": "Antipruritics", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "1490-04-6", "RR": "89-78-1 ((1alpha,2beta,5alpha)-isomer)", "MS": "A monoterpene cyclohexanol produced from mint oils.", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008610"}, {"RECTYPE": "D", "MH": "Mentors", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Mentorships|T065|NON|REL|UNK (19XX)|870312|abcdef", "ENTRY": "Mentorship", "MN": "M01.395", "MH_TH": "NLM (1988)", "ST": "T098", "MS": "Senior professionals who provide guidance, direction and support to those persons desirous of improvement in academic positions, administrative positions or other career development situations.", "PM": "88", "HN": "88", "MR": "20150623", "DA": "19870314", "DC": "1", "DX": "19880101", "UI": "D008611"}, {"RECTYPE": "D", "MH": "Menu Planning", "AQ": "EC MT ST TD", "ENTRY": "Planning, Menu", "MN": "N02.421.242.472.310", "MH_TH": "NLM (1977)", "ST": "T057", "AN": "domestic, commercial, institutional, hospital, etc.", "PI": "Food Services (Jan-Jul 1977)", "MS": "A food service control process involving scheduling of meals in advance.", "PM": "91; was see under FOOD SERVICES Aug 1977-90", "HN": "91(Aug 77); was see under FOOD SERVICES 1977-90", "MR": "20160505", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D008612"}, {"RECTYPE": "D", "MH": "Mepartricin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylpartricin|T109|T195|NON|EQV|UNK (19XX)|800523|abbcdef", "ENTRY": "SPAS 160", "MN": "D02.540.505.497", "PA": "Urological Agents", "MH_TH": "USAN (1975)", "ST": "T195", "N1": "Partricin, methyl ester", "RN": "11121-32-7", "RR": "L13V8793FQ", "PI": "Polyenes (1974-1975)", "MS": "Polyene macrolide antibiotic with unknown composition. It is obtained from Streptomyces aureofaciens. It is used as an antifungal agent, an antiprotozoal agent, and in the treatment of BENIGN PROSTATIC HYPERTROPHY.", "OL": "use MEPARTRICIN to search METHYL PARTRICIN 1976-80", "PM": "91; was see under POLYENES 1981-90; was METHYL PARTRICIN see under POLYENES 1976-80", "HN": "91(81); was see under POLYENES 1981-90; was METHYL PARTRICIN see under POLYENES 1976-80", "MR": "20130708", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D008613"}, {"RECTYPE": "D", "MH": "Meperidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pethidine|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|740330|abbcdeeef", "ENTRY": "Operidine EPJ I", "MN": "D03.383.621.349.450", "PA": "Narcotics", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester", "RN": "9E338QE28F", "RR": "N8E7F7Q170", "MS": "A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration.", "OL": "use MEPERIDINE to search OPERIDINE 1978-91 (use PHENOPERIDINE 1992 forward)", "PM": "OPERIDINE was see MEPERIDINE 1978-91", "HN": "OPERIDINE was see MEPERIDINE 1978-91", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008614"}, {"RECTYPE": "D", "MH": "Mephenesin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "D\u00e9contractyl|T109|T121|TRD|NRW|FR|041014|abbcdef", "MN": "D02.033.455.706.517", "PA": "Muscle Relaxants, Central", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1,2-Propanediol, 3-(2-methylphenoxy)-", "RN": "7B8PIR2954", "RR": "59-47-2 (Mephenesin)", "MS": "A centrally acting muscle relaxant with a short duration of action.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008615"}, {"RECTYPE": "D", "MH": "Mephentermine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Mephentermine", "MN": "D02.092.471.683.152.766.617", "PA": "Vasoconstrictor Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzeneethanamine, N,alpha,alpha-trimethyl-", "RN": "TEZ91L71V4", "RR": "580655Z8RR", "MS": "A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008616"}, {"RECTYPE": "D", "MH": "Mephenytoin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methyl Phenetoin|T109|T121|NON|EQV|UNK (19XX)|790509|abbcdef", "ENTRY": "Phenetoin, Methyl", "MN": "D03.383.129.308.432.555.620", "PA": "Anticonvulsants", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4-Imidazolidinedione, 5-ethyl-3-methyl-5-phenyl-", "RN": "R420KW629U", "RR": "50-12-4 (Mephenytoin)", "PI": "Hydantoins (1969-1974)", "MS": "An anticonvulsant effective in tonic-clonic epilepsy (EPILEPSY, TONIC-CLONIC). It may cause blood dyscrasias.", "PM": "91; see HYDANTOINS 1975-90; for PHENANTION use PHENYTOIN 1978-97", "HN": "91(75); see HYDANTOINS 1975-90; for PHENANTION use PHENYTOIN 1978-97", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008617"}, {"RECTYPE": "D", "MH": "Mephobarbital", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylphenobarbital|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|740330|abbcdeef", "ENTRY": "Prominal|T109|T121|TRD|NRW|AU|810608|abbcdef", "MN": "D03.383.742.698.253.434", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-1-methyl-5-phenyl-", "RN": "5NC67NU76B", "RR": "115-38-8 (Mephobarbital)", "AN": "do not confuse with mephebarbital", "MS": "A barbiturate that is metabolized to PHENOBARBITAL. It has been used for similar purposes, especially in EPILEPSY, but there is no evidence mephobarbital offers any advantage over PHENOBARBITAL.", "OL": "use MEPHOBARBITAL to search METHYLPHENOBARBITOL 1973-94", "PM": "73; METHYLPHENOBARBITOL was see MEPHOBARBITOL 1973-94", "HN": "73(63); METHYLPHENOBARBITOL was see MEPHOBARBITOL 1973-94", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008618"}, {"RECTYPE": "D", "MH": "Mepivacaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbocaine|T109|T121|TRD|NRW|AU|CA|US|740330|abbcdeeef", "ENTRY": "Mepivacain Injektopas", "MN": "D03.383.621.450", "PA": "Anesthetics, Local", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-", "RN": "B6E06QE59J", "RR": "96-88-8 (Mepivacaine)", "MS": "A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)", "MR": "20180301", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008619"}, {"RECTYPE": "D", "MH": "Meprobamate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Visano|T109|T121|TRD|NRW|DE|041014|abbcdef", "MN": "D02.241.081.251.510", "PA": "Muscle Relaxants, Central", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,3-Propanediol, 2-methyl-2-propyl-, dicarbamate", "RN": "9I7LNY769Q", "RR": "57-53-4 (Meprobamate)", "MS": "A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008620"}, {"RECTYPE": "D", "MH": "Meptazinol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "WY22811", "MN": "D03.383.066.400", "PA": "Narcotics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Phenol, 3-(3-ethylhexahydro-1-methyl-1H-azepin-3-yl)-", "RN": "18Y7S5JKZD", "RR": "T62FQ4ZCPA", "PI": "Phenols (1966-1976)", "MS": "A narcotic antagonist with analgesic properties. It is used for the control of moderate to severe pain.", "PM": "91; was see under AZEPINES 1980-90", "HN": "91(80); was see under AZEPINES 1980-90", "MR": "20160701", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D008621"}, {"RECTYPE": "D", "MH": "Merbromin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mercury, (2',7'-dibromo-3',6'-dihydroxy-3-oxospiro(isobenzofuran-1(3H),9'-(9H)xanthen)-4'-yl)hydroxy-, disodium salt|T109|T121|NON|EQV|NLM (2023)|220330|abbcdef", "ENTRY": "2,7 Dibromo 4 Hydroxymercurifluoresceine", "MN": "D04.711.347.550", "MH_TH": "INN (19XX)", "ST": "T121", "RN": "M0T18YH28D", "RR": "129-16-8 (Merbromin)", "PI": "Mercury (1972-1974)", "MS": "A once-popular mercury containing topical antiseptic.", "OL": "use MERBROMIN to search MERCURESCEINE 1975-95", "PM": "96; was MERBROMINE 1975-95 (see under FLUORESCEINS 1975-90); MERCURESCEINE was see MERBROMINE 1975-95", "HN": "96; was MERBROMINE 1975-95 (see under FLUORESCEINS 1975-90); MERCURESCEINE was see MERBROMINE 1975-95", "MR": "20220523", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008622"}, {"RECTYPE": "D", "MH": "Mercaptoethanol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "2 Mercaptoethanol", "MN": "D02.886.489.409", "MH_TH": "NLM (1964)", "ST": "T109", "N1": "Ethanol, 2-mercapto-", "RN": "60-24-2", "MS": "A water-soluble thiol derived from hydrogen sulfide and ethanol. It is used as a reducing agent for disulfide bonds and to protect sulfhydryl groups from oxidation.", "PM": "66", "HN": "66(64)", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008623"}, {"RECTYPE": "D", "MH": "Mercaptoethylamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.886.489.472", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Ethylamines, including CYSTEAMINE, that contain a sulfhydryl group in their structure.", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008624"}, {"RECTYPE": "D", "MH": "Tiopronin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiopronine|T116|T121|NON|EQV|INN (19XX)|800804|abbcdef", "ENTRY": "alpha Mercaptopropionylglycine", "MN": "D12.125.481.700.760", "MH_TH": "UNK (19XX)", "ST": "T121", "N1": "Glycine, N-(2-mercapto-1-oxopropyl)-", "RN": "C5W04GO61S", "RR": "1953-02-2 (Tiopronin)", "PI": "Glycine (1974)", "MS": "Sulfhydryl acylated derivative of GLYCINE.", "PM": "2011; see THIOPRONINE 2004-2010, MERCAPTOPROPIONYLGLYCINE 1989-2003 & see AMINO ACIDS, SULFUR 1975-1988", "HN": "2011(1975)", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19890101", "UI": "D008625"}, {"RECTYPE": "D", "MH": "Mercuribenzoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Mercuribenzoic", "MN": "D02.691.750.740.644", "PA": "Sulfhydryl Reagents", "MH_TH": "NLM (1972)", "ST": "T130", "RN": "0", "PI": "Organometallic Compounds (1968-1971)", "MS": "Mercury-containing benzoic acid derivatives.", "PM": "72", "HN": "72", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008626"}, {"RECTYPE": "D", "MH": "Mercuric Chloride", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mercury Dichloride|T121|T131|T197|NON|EQV|UNK (19XX)|840530|abbbcdef", "ENTRY": "Sublimate, Corrosive", "MN": "D01.538.500", "PA": "Disinfectants", "MH_TH": "NLM (1985)", "ST": "T197", "N1": "Mercury chloride (HgCl2)", "RN": "53GH7MZT1R", "RR": "7487-94-7 (Mercuric Chloride)", "AN": "a local anti-infective", "PI": "Mercury (1966-1984)", "MS": "Mercury chloride (HgCl2). A highly toxic compound that volatizes slightly at ordinary temperature and appreciably at 100 degrees C. It is corrosive to mucous membranes and used as a topical antiseptic and disinfectant.", "PM": "85", "HN": "85", "MR": "20130708", "DA": "19840530", "DC": "1", "DX": "19850101", "UI": "D008627"}, {"RECTYPE": "D", "MH": "Mercury", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK RE SD ST TO TU UR", "MN": "D01.552.544.504", "FX": "Organomercury Compounds", "EC": "poisoning:Mercury Poisoning", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Mercury", "RN": "FXS1BY2PGL", "RR": "7439-97-6 (Mercury)", "MS": "A silver metallic element that exists as a liquid at room temperature. It has the atomic symbol Hg (from hydrargyrum, liquid silver), atomic number 80, and atomic weight 200.59. Mercury is used in many industrial applications and its salts have been employed therapeutically as purgatives, antisyphilitics, disinfectants, and astringents. It can be absorbed through the skin and mucous membranes which leads to MERCURY POISONING. Because of its toxicity, the clinical use of mercury and mercurials is diminishing.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008628"}, {"RECTYPE": "D", "MH": "Mercury Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mercury Isotope|T196|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Isotopes, Mercury", "MN": "D01.552.544.504.500", "MH_TH": "NLM (1967)", "ST": "T196", "RN": "0", "PI": "Mercury (1966)", "MS": "Stable mercury atoms that have the same atomic number as the element mercury but differ in atomic weight. Hg-196, 198-201, and 204 are stable mercury isotopes.", "PM": "68", "HN": "68(67)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008629"}, {"RECTYPE": "D", "MH": "Mercury Poisoning", "DE": "MERCURY POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Poisonings, Mercury", "MN": "C25.723.522.875", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with specific mercury compound /pois if pertinent; occupational mercury poisoning: coordinate with OCCUPATIONAL DISEASES but not also OCCUPATIONAL EXPOSURE", "MS": "Poisoning that results from chronic or acute ingestion, injection, inhalation, or skin absorption of MERCURY or MERCURY COMPOUNDS.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008630"}, {"RECTYPE": "D", "MH": "Mercury Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Mercury", "MN": "D01.552.544.504.500.500", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1968-1974)", "MS": "Unstable isotopes of mercury that decay or disintegrate emitting radiation. Hg atoms with atomic weights 185-195, 197, 203, 205, and 206 are radioactive mercury isotopes.", "OL": "search MERCURY ISOTOPES 1967-74 (as Prov 1967)", "PM": "75", "HN": "75", "MR": "20170425", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D008631"}, {"RECTYPE": "D", "MH": "Mermithoidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Romanomermis|T204|NON|NRW|NLM (1993)|911107|abcdef", "ENTRY": "Romanomermi", "MN": "B01.050.500.500.294.100.275.570", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid211382", "RR": "txid13657", "AN": "a superfamily of nematodes; infection (probably accidental through food contam): coord IM with ENOPLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "MS": "A superfamily of nematodes of the order ENOPLIDA. Characteristics include a reduced alimentary tract and the presence of a trophosome. Its organisms can be present in the human intestine through ingestion of unwashed or contaminated raw vegetables.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008632"}, {"RECTYPE": "D", "MH": "Mersalyl", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mercuramide|T109|T121|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|790510|abbbcdeef", "ENTRY": "Acid, Mersalyl", "MN": "D02.691.750.100.710", "PA": "Enzyme Inhibitors", "MH_TH": "INN (19XX)", "ST": "T131", "N1": "Mercurate(1-), (3-((2-(carboxylatomethoxy)benzoyl)amino)-2-methoxypropyl)hydroxy-, sodium", "RN": "5X1IO031V8", "RR": "7RDI07K19U", "MS": "A toxic thiol mercury salt formerly used as a diuretic. It inhibits various biochemical functions, especially in mitochondria, and is used to study those functions.", "OL": "use DIURETICS, MERCURIAL to search MERSALYL 1966-74", "PM": "91; was see under DIURETICS, MERCURIAL 1975-90", "HN": "91(75); was see under DIURETICS, MERCURIAL 1975-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008634"}, {"RECTYPE": "D", "MH": "Mescaline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trimethoxyphenethylamine|T109|T121|T131|NON|EQV|UNK (19XX)|780201|abbbcdef", "ENTRY": "3,4,5-Trimethoxyphenethylamine|T109|T121|T131|NON|EQV|NLM (1998)|970127|abbbcdef", "MN": "D03.132.524", "PA": "Serotonin Receptor Agonists", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Benzeneethanamine, 3,4,5-trimethoxy-", "RN": "RHO99102VC", "RR": "54-04-6 (Mescaline)", "AN": "a peyote alkaloid from Mexican cactus called mescal", "MS": "Hallucinogenic alkaloid isolated from the flowering heads (peyote) of Lophophora (formerly Anhalonium) williamsii, a Mexican cactus used in Indian religious rites and as an experimental psychotomimetic. Among its cellular effects are agonist actions at some types of serotonin receptors. It has no accepted therapeutic uses although it is legal for religious use by members of the Native American Church.", "OL": "use MESCALINE to search PEYOTE 1966-78", "HN": "PEYOTE was see under MESCALINE 1963-78", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008635"}, {"RECTYPE": "D", "MH": "Mesencephalon", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Midbrain|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Midbrains", "MN": "A08.186.211.132.659", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The middle of the three primitive cerebral vesicles of the embryonic brain. Without further subdivision, midbrain develops into a short, constricted portion connecting the PONS and the DIENCEPHALON. Midbrain contains two major parts, the dorsal TECTUM MESENCEPHALI and the ventral TEGMENTUM MESENCEPHALI, housing components of auditory, visual, and other sensorimoter systems.", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008636"}, {"RECTYPE": "D", "MH": "Mesenchymoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Mesenchymomas", "MN": "C04.557.435.500", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "benign or malignant; coordinate with precoordinated organ/neoplasm term", "MS": "A mixed mesenchymal tumor composed of two or more mesodermal cellular elements not commonly associated, not counting fibrous tissue as one of the elements. Mesenchymomas are widely distributed in the body and about 75% are malignant. (Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008637"}, {"RECTYPE": "D", "MH": "Mesenteric Arteries", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Mesenteric Artery", "MN": "A07.015.114.565", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "prefer MESENTERIC ARTERY, INFERIOR or MESENTERIC ARTERY, SUPERIOR; occlusion or obstruction: coordinate with MESENTERIC VASCULAR OCCLUSION; embolism or thrombosis: index under MESENTERIC VASCULAR OCCLUSION and EMBOLISM or THROMBOSIS and MESENTERIC ARTERIES", "MS": "Arteries which arise from the abdominal aorta and distribute to most of the intestines.", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008638"}, {"RECTYPE": "D", "MH": "Mesenteric Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Mesenteric Cysts", "MN": "C06.844.620.500", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "A rare intra-abdominal tumor in the MESENTERY. Mesenteric cysts are usually benign and can be very large fluid-filled (2000 mL) lesions.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008639"}, {"RECTYPE": "D", "MH": "Mesenteric Lymphadenitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mesenteric Lymphadenitides", "MN": "C15.604.315.618", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific infection (IM) if pertinent", "MS": "INFLAMMATION of LYMPH NODES in the MESENTERY.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008640"}, {"RECTYPE": "D", "MH": "Mesenteric Vascular Occlusion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vascular Occlusions, Mesenteric", "MN": "C14.907.137.534", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with MESENTERIC ARTERIES (NIM) or MESENTERIC VEINS (NIM); embolism or thrombosis: see notes under MESENTERIC ARTERIES & MESENTERIC VEINS; coord IM with target organ losing its blood supply (COLON /blood supply, JEJUNUM /blood supply) (IM or NIM) only if particularly discussed; do not confuse with SUPERIOR MESENTERIC ARTERY SYNDROME (duodenal compression BY the superior mesenteric artery, not OF)", "MS": "Obstruction of the flow in the SPLANCHNIC CIRCULATION by ATHEROSCLEROSIS; EMBOLISM; THROMBOSIS; STENOSIS; TRAUMA; and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as PERIARTERITIS NODOSA and THROMBOANGIITIS OBLITERANS. (From Juergens et al., Peripheral Vascular Diseases, 5th ed, pp295-6)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008641"}, {"RECTYPE": "D", "MH": "Mesenteric Veins", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Mesenteric", "MN": "A07.015.908.670.385", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "occlusion or obstruction: coord NIM with MESENTERIC VASCULAR OCCLUSION (IM); venous thrombosis: index under MESENTERIC VASCULAR OCCLUSION (IM) + VENOUS THROMBOSIS (IM) + MESENTERIC VEINS (NIM)", "MS": "Veins which return blood from the intestines; the inferior mesenteric vein empties into the splenic vein, the superior mesenteric vein joins the splenic vein to form the portal vein.", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008642"}, {"RECTYPE": "D", "MH": "Mesentery", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Mesenteries", "MN": "A01.923.047.025.600.451", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "avoid /blood supply: prefer MESENTERIC ARTERIES or MESENTERIC VEINS; for mesenteric circulation use SPLANCHNIC CIRCULATION; diseases: coordinate with PERITONEAL DISEASES; neoplasms: coordinate  with PERITONEAL NEOPLASMS", "MS": "A layer of the peritoneum which attaches the abdominal viscera to the ABDOMINAL WALL and conveys their blood vessels and nerves.", "MR": "20160613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008643"}, {"RECTYPE": "D", "MH": "Mesial Movement of Teeth", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Teeth Mesial Movement", "MN": "G10.549.830.535", "MH_TH": "NLM (1975)", "ST": "T046", "MS": "Migration of the teeth toward the midline or forward in the DENTAL ARCH. (From Boucher's Clinical Dental Terminology, 4th ed)", "OL": "search TOOTH MIGRATION 1966-74", "PM": "91; was see under TOOTH MIGRATION 1975-90", "HN": "91(75); was see under TOOTH MIGRATION 1975-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008644"}, {"RECTYPE": "D", "MH": "Mesocestoides", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Mesocestoide", "MN": "B01.050.500.500.736.215.520", "MH_TH": "NLM (1986)", "ST": "T204", "RN": "txid53467", "AN": "infection: coordinate with CESTODE INFECTIONS; coordinate with specific helminth terms (ANTIGENS, HELMINTH, etc.) if pertinent", "PI": "Cestoda (1966-1985)", "MS": "A genus of tapeworm, containing several species, found as adults in birds and mammals. The larvae or cysticercoid stage develop in invertebrates. Human infection has been reported and is probably acquired from eating inadequately cooked meat of animals infected with the second larval stage known as the tetrahythridium.", "OL": "use MESOCESTOIDES to search MESOCESTROIDES 1986", "PM": "91; was see under CESTODA 1987-90; was MESOCESTROIDES see under CESTODA 1986", "HN": "91(87); was see under CESTODA 1987-90; was MESOCESTROIDES see under CESTODA 1986", "MR": "20200813", "DA": "19850315", "DC": "1", "DX": "19910101", "UI": "D008645"}, {"RECTYPE": "D", "MH": "Mesocolon", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Mesosigmoid|T023|NON|NRW|UNK (19XX)|771205|abcdef", "ENTRY": "Mesosigmoids", "MN": "A01.923.047.025.600.451.535", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "diseases: coord IM with PERITONEAL DISEASES (IM); neopl: coord IM with PERITONEAL NEOPLASMS (IM)", "MS": "The fold of peritoneum by which the COLON is attached to the posterior ABDOMINAL WALL.", "OL": "use MESOCOLON to search MESOSIGMOID 1966-78", "HN": "MESOSIGMOID was see under MESOCOLON 1963-78", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D008646"}, {"RECTYPE": "D", "MH": "Mesocricetus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Syrian Hamster|T015|EPO|NRW|NLM (2021)|191115|abcdef", "ENTRY": "Syrian Hamsters", "MN": "B01.050.150.900.649.313.992.635.075.250.500", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid10035", "RR": "txid10036", "AN": "NIM when experimental animal", "MS": "A genus in the order Rodentia and family Cricetidae. One species, Mesocricetus auratus or golden hamster is widely used in biomedical research.", "OL": "search HAMSTERS 1966-74", "PM": "91; was see under HAMSTERS 1975-90", "HN": "91(75); was see under HAMSTERS 1975-90", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008647"}, {"RECTYPE": "D", "MH": "Mesoderm", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Mesenchyme|T018|NON|NRW|NLM (1993)|911107|abcdef", "ENTRY": "Plate Mesoderms, Lateral", "MN": "A16.504.660", "MH_TH": "NLM (1966)", "ST": "T018", "MS": "The middle germ layer of an embryo derived from three paired mesenchymal aggregates along the neural tube.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008648"}, {"RECTYPE": "D", "MH": "Mesonephroma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Mesonephromas", "MN": "C04.557.465.510", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "benign or malignant; coordinate with precoordinated organ/neoplasm term", "MS": "A rare tumor of the female genital tract, most often the ovary, formerly considered to be derived from mesonephric rests. Two varieties are recognized: (1) clear cell carcinoma, so called because of its histologic resemblance to renal cell carcinoma, and now considered to be of muellerian duct derivation and (2) an embryonal tumor (called also ENDODERMAL SINUS TUMOR and yolk sac tumor), occurring chiefly in children. The latter variety may also arise in the testis. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008649"}, {"RECTYPE": "D", "MH": "Mesonephros", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Wolffian Body|T018|EPO|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Body, Wolffian", "MN": "A16.599", "MH_TH": "NLM (1975)", "ST": "T018", "PI": "Kidney (1966-1974)", "MS": "One of a pair of excretory organs (mesonephroi) which grows caudally to the first pair (PRONEPHROI) during development. Mesonephroi are the permanent kidneys in adult amphibians and fish. In higher vertebrates, proneprhoi and most of mesonephroi degenerate with the appearance of metanephroi. The remaining ducts become WOLFFIAN DUCTS.", "PM": "75", "HN": "75", "MR": "20110624", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D008650"}, {"RECTYPE": "D", "MH": "Mesons", "AQ": "AE CL HI TU", "PRINT ENTRY": "pi-Mesons|T081|NON|NRW|UNK (19XX)|840224|abcdef", "ENTRY": "pi-Meson", "MN": "G01.249.600", "MH_TH": "NLM (1985)", "ST": "T081", "AN": "elementary particles; IM", "PI": "Nuclear Physics (1966-1974)", "MS": "Short-lived elementary particles found in cosmic radiation or produced from nuclear disintegration. Their mass is between that of protons and electrons and they can be negative, positive, or neutral. pi-Mesons (pions) are heavier than mu-mesons (muons) and are proposed for cancer radiotherapy because their capture and disintegration by matter produces powerful, but short-lived, secondary radiation.", "OL": "use ELEMENTARY PARTICLES to search MESONS & MUONS 1975-84", "PM": "91; was see under ELEMENTARY PARTICLES 1985-90, was see ELEMENTARY PARTICLES 1975-84; MUONS was see ELEMENTARY PARTICLES 1975-84", "HN": "91(85); was see under ELEMENTARY PARTICLES 1985-90, was see ELEMENTARY PARTICLES 1975-84; MUONS was see ELEMENTARY PARTICLES 1975-84", "MR": "20080708", "DA": "19840224", "DC": "1", "DX": "19910101", "UI": "D008651"}, {"RECTYPE": "D", "MH": "Mesoporphyrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.767.727.620", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Porphyrins (1968-1974)", "MS": "Porphyrins with four methyl, two ethyl, and two propionic acid side chains attached to the pyrrole rings.", "PM": "91; was see under PORPHYRINS 1975-90", "HN": "91(75); was see under PORPHYRINS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008652"}, {"RECTYPE": "D", "MH": "Mesoridazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Serentil|T109|T121|TRD|NRW|UNK (19XX)|861103|abbcdef", "MN": "D03.633.300.783.470", "PA": "Dopamine Antagonists", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "10H-Phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylsulfinyl)-", "RN": "5XE4NWM740", "RR": "5588-33-0 (Mesoridazine)", "PI": "Tranquilizing Agents (1966-1971)", "MS": "A phenothiazine antipsychotic with effects similar to CHLORPROMAZINE.", "PM": "73", "HN": "73(72)", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008653"}, {"RECTYPE": "D", "MH": "Mesothelioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Mesotheliomas", "MN": "C04.557.470.660.510", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "benign or malignant; coordinate IM with precoordinated organ/neoplasm term (IM); LOCALIZED MESOTHELIOMA and FIBROUS MESOTHELIOMA see SOLITARY FIBROUS TUMOR, PLEURAL is also available", "MS": "A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008654"}, {"RECTYPE": "D", "MH": "Mesterolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vistimon|T109|T121|TRD|NRW|DE|041018|abbcdef", "MN": "D04.210.500.054.040.248.450", "PA": "Anabolic Agents", "MH_TH": "USAN (1966)", "ST": "T121", "N1": "Androstan-3-one, 17-hydroxy-1-methyl-, (1alpha,5alpha,17beta)-", "RN": "0SRQ75X9I9", "RR": "1424-00-6 (Mesterolone)", "AN": "an anabolic steroid", "PI": "Stanolone (1972-1974)", "MS": "17 beta-Hydroxy-1 alpha-methyl-5 alpha-androstan-3-one. A synthetic steroid with anabolic and androgenic activities.", "PM": "91; was see under STANOLONE 1975-90", "HN": "91(75); was see under STANOLONE 1975-90", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008655"}, {"RECTYPE": "D", "MH": "Mestranol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethinyl Estradiol 3-Methyl Ether|T109|T121|T125|NON|EQV|UNK (19XX)|750101|ETHINYL ESTRADIOL METHYL ETHER 03|abbbcdefs", "ENTRY": "Ethinyl Estradiol 3 Methyl Ether", "MN": "D06.472.334.851.437.968.500.500", "PA": "Estrogens", "MH_TH": "USP (19XX)", "ST": "T125", "RN": "B2V233XGE7", "RR": "72-33-3 (Mestranol)", "MS": "The 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL CONTRACEPTIVES.", "PM": "65", "HN": "65(64)", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008656"}, {"RECTYPE": "D", "MH": "Metabolic Clearance Rate", "DE": "METAB CLEARANCE RATE", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Total Body Clearance Rate|T034|T059|NON|NRW|UNK (19XX)|870420|abbcdef", "ENTRY": "Rates, Metabolic Clearance", "MN": "G07.690.725.513", "FX": "Renal Elimination", "MH_TH": "NLM (1968)", "ST": "T201", "AN": "NIM with specific drug /pharmacokin (IM); not for metabolic rate: read restricted MeSH definition", "PI": "specific heading/metabolism (1966-1967)", "MS": "Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008657"}, {"RECTYPE": "D", "MH": "Inactivation, Metabolic", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Metabolic Detoxication, Drug|T040|NON|NRW|NLM (1975)|990101|METAB DETOX DRUG|abcdefv", "ENTRY": "Metabolic Inactivation", "MN": "G07.690.725.225.450", "MH_TH": "NLM (2015)", "ST": "T040", "AN": "restrict to chemical changes of exogenous substances; IM general only; coordinate NIM with specific drug /pharmacokin (IM) or /metab", "MS": "Reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion.", "PM": "2015; see METABOLIC DETOXICATION, DRUG 1980-2014; see BIOTRANSFORMATION 1970-1979", "HN": "2015 (1970); use BIOTRANSFORMATION 1970-1979", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D008658"}, {"RECTYPE": "D", "MH": "Metabolic Diseases", "DE": "METAB DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thesaurismosis|T047|NON|EQV|NLM (1998)|960719|abcdef", "ENTRY": "Thesaurismoses", "MN": "C18.452", "EC": "congenital:Metabolism, Inborn Errors", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; differentiate from DEFICIENCY DISEASES", "MS": "Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008659"}, {"RECTYPE": "D", "MH": "Metabolism", "DE": "METAB", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Metabolic Processes|T040|NON|EQV|NLM (1998)|960927|METAB PROCESSES|abcdefv", "ENTRY": "Phenomenon, Metabolic", "MN": "G03", "MH_TH": "NLM (1966)", "ST": "T040", "AN": "general only as metabolic process/phenomena irrespective of substance; prefer /metab with organs, organisms, diseases, substances", "MS": "The chemical reactions in living organisms by which energy is provided for vital processes and activities and new material is assimilated.", "PM": "TISSUE METABOLISM was heading 1963-65", "HN": "METABOLIC PROCESSES was NON MESH 1992-97; TISSUE METABOLISM was heading 1963-65", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008660"}, {"RECTYPE": "D", "MH": "Metabolism, Inborn Errors", "DE": "METAB INBORN ERR", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Inborn Errors of Metabolism|T047|NON|EQV|UNK (19XX)|740330|INBORN ERR METAB|abcdefv", "ENTRY": "Metabolisms, Inborn Errors", "MN": "C18.452.648", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "general or unspecified; prefer specific types; differentiate from DEFICIENCY DISEASES", "MS": "Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008661"}, {"RECTYPE": "D", "MH": "Metacarpophalangeal Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Metacarpophalangeal Joints", "MN": "A02.835.583.405.500", "MH_TH": "NLM (1977)", "ST": "T030", "AN": "primates only", "PI": "Metacarpus (1966-1976)", "MS": "The articulation between a metacarpal bone and a phalanx.", "PM": "1990; was see under FINGER JOINT 1977-1989", "HN": "1990(1977); was see under FINGER JOINT 1977-1989", "MR": "20190701", "DA": "19760427", "DC": "1", "DX": "19900101", "UI": "D008662"}, {"RECTYPE": "D", "MH": "Metacarpus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A01.378.800.667.572", "FX": "Metacarpal Bones", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "not restricted to primates; METACARPUS refers to the anatomical region, METACARPAL BONES is available for the bones", "MS": "The region of the HAND between the WRIST and the FINGERS.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008663"}, {"RECTYPE": "D", "MH": "Metal Metabolism, Inborn Errors", "DE": "METAL METAB INBORN ERR", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Metal Metabolism, Inborn Error|T047|T049|NON|EQV|NLM (1991)|900524|METAL METAB INBORN ERRORS|abbcdefv", "MN": "C18.452.648.618", "MH_TH": "NLM (1965)", "ST": "T049", "AN": "coordinate with specific metal /metab", "MS": "Dysfunctions in the metabolism of metals resulting from inborn genetic mutations that are inherited or acquired in utero.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008664"}, {"RECTYPE": "D", "MH": "Metalloporphyrins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Metalloporphyrin|T109|T123|NON|EQV|NLM (2021)|200123|abbcdef", "MN": "D23.767.727.640", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "PI": "specific porphyrin (1966-1976)", "MS": "Porphyrins which are combined with a metal ion. The metal is bound equally to all four nitrogen atoms of the pyrrole rings. They possess characteristic absorption spectra which can be utilized for identification or quantitative estimation of porphyrins and porphyrin-bound compounds.", "PM": "77", "HN": "77", "MR": "20200527", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D008665"}, {"RECTYPE": "D", "MH": "Metalloendopeptidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Metalloendopeptidase|T116|T126|NON|EQV|UNK (19XX)|870504|abbcdef", "MN": "D08.811.277.656.675.374", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 3.4.24.-", "PI": "Peptide Peptidohydrolases (1966-1987)", "MS": "ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism.", "PM": "2000; see METALLOPROTEINASES 1988-1999", "HN": "2000(1988)", "MR": "20060705", "DA": "19870504", "DC": "1", "DX": "19880101", "UI": "D008666"}, {"RECTYPE": "D", "MH": "Metalloproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Metalloprotein|T116|T123|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D12.776.556", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "AN": "coord IM with specific metal (IM)", "PI": "specific metal (1966-1972)", "MS": "Proteins that have one or more tightly bound metal ions forming part of their structure. (Dorland, 28th ed)", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008667"}, {"RECTYPE": "D", "MH": "Metallothionein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Metallothionein IIA|T116|T123|NON|NRW|UNK (19XX)|840919|abbcdef", "MN": "D12.776.556.670", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Metallothioneins", "RN": "9038-94-2", "AN": "/biosyn /physiol permitted", "PI": "Metalloproteins (1973-1974)", "MS": "A low-molecular-weight (approx. 10 kD) protein occurring in the cytoplasm of kidney cortex and liver. It is rich in cysteinyl residues and contains no aromatic amino acids. Metallothionein shows high affinity for bivalent heavy metals.", "PM": "84; was see under METALLOPROTEINS 1975-83", "HN": "84(75); was see under METALLOPROTEINS 1975-83", "MR": "19970620", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D008668"}, {"RECTYPE": "D", "MH": "Metallurgy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Heavy Industries|T090|NON|NRW|NLM (1998)|961127|HEAVY INDUST|abcdefv", "ENTRY": "Industry, Heavy", "MN": "J01.576.655.875.400", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "note entry term HEAVY INDUSTRIES for iron, steel, etc., industries; in dental literature, the working & manipulation of metals for orthodontic or prosthodontic appliances is probably DENTAL SOLDERING but if not soldering, coordinate specific appliance with METALLURGY (NIM)", "MS": "The science, art, or technology dealing with processes involved in the separation of metals from their ores, the technique of making or compounding the alloys, the techniques of working or heat-treating metals, and the mining of metals. It includes industrial metallurgy as well as metallurgical techniques employed in the preparation and working of metals used in dentistry, with special reference to orthodontic and prosthodontic appliances. (From Jablonski, Dictionary of Dentistry, 1992, p494)", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008669"}, {"RECTYPE": "D", "MH": "Metals", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Metal|T197|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D01.552", "FX": "Organometallic Compounds", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "general or unspecified: prefer specific metal groups or specific metals; allergic reactions to metals is probably DERMATITIS, CONTACT, not DRUG HYPERSENSITIVITY; METALLOIDS is also available", "MS": "Electropositive chemical elements characterized by ductility, malleability, luster, and conductance of heat and electricity. They can replace the hydrogen of an acid and form bases with hydroxyl radicals. (Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008670"}, {"RECTYPE": "D", "MH": "Actinoid Series Elements", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "PRINT ENTRY": "Metals, Actinoid|T197|NON|EQV|NLM (1976)|990101|abcdef", "ENTRY": "Elements, Actinoid Series", "MN": "D01.552.020", "MH_TH": "NLM (2002)", "ST": "T197", "RN": "0", "AN": "general; prefer specifics", "PI": "Metals (1966-1975)", "MS": "A series of radioactive elements from ACTINIUM, atomic number 89, to and including LAWRENCIUM, atomic number 103.", "PM": "2002; see METALS, ACTINIDE 1994-2001, see METALS, ACTINOID 1976-1993", "HN": "2002(1976)", "MR": "20170414", "DA": "19750718", "DC": "1", "DX": "19940101", "UI": "D008671"}, {"RECTYPE": "D", "MH": "Metals, Alkali", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Group 1 Element|T196|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Metal, Alkali", "MN": "D01.552.528", "MH_TH": "NLM (1976)", "ST": "T196", "RN": "0", "AN": "do not confuse with METALS, ALKALINE EARTH; GEN: prefer specifics", "PI": "Metals (1966-1975)", "MS": "Metals that constitute group 1(formerly group IA) of the periodic table. They are the most strongly electropositive of the metals. Note that HYDROGEN is not considered an alkali metal even though it falls under the group 1 heading in the periodic table.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20210630", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D008672"}, {"RECTYPE": "D", "MH": "Metals, Alkaline Earth", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Group 2 Element|T196|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Metal, Alkaline Earth", "MN": "D01.552.539", "MH_TH": "NLM (1976)", "ST": "T196", "RN": "0", "AN": "do not confuse with METALS, ALKALI; GEN: prefer specifics", "PI": "Metals (1966-1975)", "MS": "Metals that constitute the group 2 (formerly group IIA) of the periodic table.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20210630", "DA": "19750718", "DC": "1", "DX": "19760101", "UI": "D008673"}, {"RECTYPE": "D", "MH": "Metals, Rare Earth", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rare Earth Metals|T196|NON|EQV|NLM (1994)|921221|abcdef", "ENTRY": "Metal, Rare Earth", "MN": "D01.552.550", "MH_TH": "NLM (1976)", "ST": "T196", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Metals (1966-1975)", "MS": "A group of elements that include SCANDIUM; YTTRIUM; and the LANTHANOID SERIES ELEMENTS. Historically, the rare earth metals got their name from the fact that they were never found in their pure elemental form, but as an oxide. In addition, they were very difficult to purify. They are not truly rare and comprise about 25% of the metals in the earth's crust.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20210630", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D008674"}, {"RECTYPE": "D", "MH": "Metamorphosis, Biological", "DE": "METAMORPHOSIS BIOL", "AQ": "DE GE IM PH RE", "ENTRY": "Metamorphoses, Biological", "MN": "G07.345.500.550", "MH_TH": "NLM (1966)", "ST": "T049", "MS": "Profound physical changes during maturation of living organisms from the immature forms to the adult forms, such as from TADPOLES to frogs; caterpillars to BUTTERFLIES.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008675"}, {"RECTYPE": "D", "MH": "Metanephrine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Metadrenaline|T109|T123|NON|EQV|UNK (19XX)|810625|abbcdef", "MN": "D02.455.426.559.389.657.166.175.461.400", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Benzenemethanol, 4-hydroxy-3-methoxy-alpha-((methylamino)methyl)-", "RN": "5001-33-2", "PI": "Methyl Ethers (1974)", "MS": "Product of epinephrine O-methylation. It is a commonly occurring, pharmacologically and physiologically inactive metabolite of epinephrine.", "PM": "1991; METANEPHRINE was indexed under EPINEPHRINE 1975-1990", "HN": "1991 (1975)", "MR": "20180529", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008676"}, {"RECTYPE": "D", "MH": "Metaphase", "AQ": "DE GE IM PH RE", "MN": "G05.113.220.781.625", "MH_TH": "NLM (1978)", "ST": "T079", "PI": "Mitosis (1968-1977)", "MS": "The phase of cell nucleus division following PROMETAPHASE, in which the CHROMOSOMES line up across the equatorial plane of the SPINDLE APPARATUS prior to separation.", "OL": "search MITOSIS 1975-77", "PM": "81; was see under CELL CYCLE 1978-80, was see MITOSIS 1975-77", "HN": "81(78); was see under CELL CYCLE 1978-80, was see MITOSIS 1975-77", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19770510", "DC": "1", "DX": "19810101", "UI": "D008677"}, {"RECTYPE": "D", "MH": "Metaphysics", "AQ": "HI", "ENTRY": "Metaphysic", "MN": "K01.752.511", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "only /hist", "MS": "The branch of philosophy that treats of first principles, including ontology (the nature of existence or being) and cosmology (the origin and structure of the universe). (From Random House Unabridged Dictionary, 2d ed)", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008678"}, {"RECTYPE": "D", "MH": "Metaplasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.550.589", "MH_TH": "NLM (1966)", "ST": "T049", "AN": "NIM; coord with organ /pathol (IM)", "MS": "A condition in which there is a change of one adult cell type to another similar adult cell type.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008679"}, {"RECTYPE": "D", "MH": "Metaraminol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "meta-Hydroxynorephedrine|T109|T121|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "meta Hydroxynorephedrine", "MN": "D02.092.063.624.706.500", "PA": "Vasoconstrictor Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenemethanol, alpha-(1-aminoethyl)-3-hydroxy-, (R-(R*,S*))-", "RN": "818U2PZ2EH", "RR": "ZC4202M9P3", "MS": "A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.", "MR": "20170117", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008680"}, {"RECTYPE": "D", "MH": "Metastrongyloidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Metastrongyloideas", "MN": "B01.050.500.500.294.400.968.588", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6310", "AN": " infection: coordinate with STRONGYLIDA INFECTIONS; coordinate with specific helminth terms (ANTIGENS, HELMINTH, etc.) if pertinent", "MS": "A superfamily of nematodes of the order STRONGYLIDA. Characteristics include a fluid-filled outer layer of cuticle and a reduced mouth and bursa.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008681"}, {"RECTYPE": "D", "MH": "Metatarsal Bones", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Metatarsals|T023|NON|EQV|UNK (19XX)|870402|abcdef", "ENTRY": "Metatarsal Bone", "MN": "A02.835.232.043.300.492", "FX": "Metatarsus", "MH_TH": "NLM (1988)", "ST": "T023", "AN": "do not confuse with METATARSUS, the anatomical region", "MS": "The five long bones of the METATARSUS, articulating with the TARSAL BONES proximally and the PHALANGES OF TOES distally.", "PM": "88", "HN": "88", "MR": "20180629", "DA": "19870402", "DC": "1", "DX": "19880101", "UI": "D008682"}, {"RECTYPE": "D", "MH": "Metatarsophalangeal Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Metatarsophalangeal Joints", "MN": "A02.835.583.378.531", "MH_TH": "NLM (1975)", "ST": "T030", "AN": "primates only", "PI": "Toe Joint (1966-1974)", "MS": "The articulation between a metatarsal bone (METATARSAL BONES) and a phalanx.", "PM": "1990; was see under TOE JOINT 1966-1989", "HN": "1990(1975); was see under TOE JOINT 1966-1989", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D008683"}, {"RECTYPE": "D", "MH": "Metatarsus", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "MN": "A01.378.610.250.300.480", "FX": "Metatarsal Bones", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "not restricted to primates; METATARSUS refers to the anat area, METATARSAL BONES is available for the bones", "MS": "The part of the foot between the tarsa and the TOES.", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008684"}, {"RECTYPE": "D", "MH": "Meteorological Concepts", "PRINT ENTRY": "Meteorological Factors|T070|NON|REL|NLM (1977)|990101|METEOROL FACTORS|abcdefv", "ENTRY": "Meteorological Factor", "MN": "N06.230.300", "MH_TH": "NLM (2009)", "ST": "T070", "PI": "Weather (1966-1974)", "MS": "The atmospheric properties, characteristics and other atmospheric phenomena especially pertaining to WEATHER or CLIMATE.", "PM": "2009; see METEOROLOGICAL FACTORS 1977-2008, see WEATHER 1963-1976", "HN": "2009 (1977)", "MR": "20080708", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D008685"}, {"RECTYPE": "D", "MH": "Metestrus", "AQ": "BL CF DE GE IM ME PH RE UR", "MN": "G08.686.195.750", "MH_TH": "NLM (1975)", "ST": "T079", "AN": "non-primate mammals only", "MS": "The period following ESTRUS during which the phenomena of estrus subside in those animals in which pregnancy or pseudopregnancy does not occur.", "PM": "91; was see under ESTRUS 1975-90", "HN": "91(75); was see under ESTRUS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008686"}, {"RECTYPE": "D", "MH": "Metformin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dimethylguanylguanidine|T109|T121|NON|EQV|UNK (19XX)|761224|abbcdef", "ENTRY": "Hydrochloride, Metformin", "MN": "D02.078.370.141.450", "PA": "Hypoglycemic Agents", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "Imidodicarbonimidic diamide, N,N-dimethyl-", "RN": "9100L32L2N", "RR": "786Z46389E", "AN": "a hypoglycemic", "MS": "A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)", "MR": "20150526", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008687"}, {"RECTYPE": "D", "MH": "Methacholine Compounds", "DE": "METHACHOLINE CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Methacholine", "MN": "D02.675.276.534", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A group of compounds that are derivatives of beta-methylacetylcholine (methacholine).", "OL": "use METHACHOLINE COMPOUNDS to search MECHOLYL BROMIDE 1966-76", "PM": "MECHOLYL BROMIDE was see under METHACHOLINE COMPOUNDS 1963-76", "HN": "MECHOLYL BROMIDE was see under METHACHOLINE COMPOUNDS 1963-76", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D008688"}, {"RECTYPE": "D", "MH": "Methacrylates", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Methacrylate|T109|NON|EQV|NLM (2021)|191118|abcdef", "MN": "D02.241.081.069.600", "FX": "Polymethacrylic Acids", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Acrylates (1968-1974)", "MS": "Acrylic acids or acrylates which are substituted in the C-2 position with a methyl group.", "PM": "91; was see under ACRYLATES 1975-90", "HN": "91(75); was see under ACRYLATES 1975-90", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008689"}, {"RECTYPE": "D", "MH": "Methacycline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Methacycline", "MN": "D04.615.562.900.525", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1962)", "ST": "T195", "N1": "2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,12aalpha))-", "RN": "IR235I7C5P", "RR": "914-00-1 (Methacycline)", "MS": "A broad-spectrum semisynthetic antibiotic related to TETRACYCLINE but excreted more slowly and maintaining effective blood levels for a more extended period.", "PM": "68", "HN": "68(65)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008690"}, {"RECTYPE": "D", "MH": "Methadone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Methadone", "MN": "D02.522.675", "PA": "Narcotics", "FX": "Opiate Substitution Treatment", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "3-Heptanone, 6-(dimethylamino)-4,4-diphenyl-", "RN": "UC6VBE7V1Z", "RR": "76-99-3 (Methadone)", "AN": "for methadone maintenance treatment, coordinate with OPIATE SUBSTITUTION TREATMENT", "MS": "A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008691"}, {"RECTYPE": "D", "MH": "Methadyl Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alphacetylmethadol|T109|T121|NON|NRW|INN (19XX)|UNK (19XX)|771123|abbcdeef", "ENTRY": "Levo alpha Acetylmethadol", "MN": "D02.522.675.500", "PA": "Analgesics, Opioid", "MH_TH": "USAN (1970)", "ST": "T121", "N1": "Benzeneethanol, beta-(2-(dimethylamino)propyl)-alpha-ethyl-beta-phenyl-, acetate (ester)", "RN": "L59OC40KWJ", "RR": "R3B637Y991", "PI": "Methadone (1973-1974)", "MS": "A narcotic analgesic with a long onset and duration of action.", "PM": "91; was see under METHADONE 1975-90", "HN": "91(75); was see under METHADONE 1975-90", "MR": "20141014", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008692"}, {"RECTYPE": "D", "MH": "Methallibure", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ICI33,828", "MN": "D02.886.904.425", "PA": "Hormone Antagonists", "MH_TH": "USAN (1967)", "ST": "T121", "N1": "1,2-Hydrazinedicarbothioamide, N-methyl-N'-(1-methyl-2-propenyl)-", "RN": "MBU5XJ97C4", "RR": "926-93-2 (Methallibure)", "PI": "Thiourea (1973-1974)", "MS": "A dithiobiurea compound with anti-gonadotropic activity.", "PM": "91; was see under THIOUREA 1975-90", "HN": "91(75); was see under THIOUREA 1975-90", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008693"}, {"RECTYPE": "D", "MH": "Methamphetamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Deoxyephedrine|T109|T121|T131|NON|EQV|UNK (19XX)|740330|abbbcdef", "ENTRY": "N Methylamphetamine", "MN": "D02.092.471.683.152.619", "PA": "Sympathomimetics", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Benzeneethanamine, N,alpha-dimethyl-, (S)-", "RN": "44RAL3456C", "RR": "997F43Z9CV", "AN": "a CNS stimulant; smokable crystal methamphetamine, called \"ice\" by drug abusers, goes here", "MS": "A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008694"}, {"RECTYPE": "D", "MH": "Methandriol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylandrostenediol|T109|T121|NON|EQV|UNK (19XX)|750101|abbcdef", "ENTRY": "Madiol|T109|T121|TRD|NRW|UNK (19XX)|810318|abbcdef", "MN": "D04.210.500.054.079.429.154.600", "PA": "Anabolic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Androst-5-ene-3,17-diol, 17-methyl-, (3beta,17beta)-", "RN": "5730Z864KG", "RR": "521-10-8 (Methandriol)", "MS": "A synthetic steroid with anabolic and androgenic properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1188)", "OL": "search ANABOLIC STEROIDS 1966-74", "PM": "91; was see under ANDROSTENEDIOLS 1975-90; was see under ANABOLIC STEROIDS 1964-74", "HN": "91(75); was see under ANDROSTENEDIOLS 1975-90; was see under ANABOLIC STEROIDS 1964-74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008695"}, {"RECTYPE": "D", "MH": "Methandrostenolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methandienone|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|750101|abbcdeef", "ENTRY": "Nerobol|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef", "MN": "D04.210.500.054.079.129.453", "PA": "Anabolic Agents", "MH_TH": "NLM (1963)", "ST": "T121", "N1": "Androsta-1,4-dien-3-one, 17-hydroxy-17-methyl-, (17beta)-", "RN": "COZ1R7EOCC", "RR": "72-63-9 (Methandrostenolone)", "MS": "A synthetic steroid with anabolic properties that are more pronounced than its androgenic effects. It has little progestational activity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1188)", "PM": "65", "HN": "65(63)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008696"}, {"RECTYPE": "D", "MH": "Methane", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.326.146.571", "MH_TH": "NLM (1966)", "ST": "T109", "N1": "Methane", "RN": "OP0UW79H66", "RR": "74-82-8 (Methane)", "MS": "The simplest saturated hydrocarbon. It is a colorless, flammable gas, slightly soluble in water. It is one of the chief constituents of natural gas and is formed in the decomposition of organic matter. (Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008697"}, {"RECTYPE": "D", "MH": "Mesylates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methanesulfonates|T109|NON|EQV|NLM (1994)|920902|abcdef", "ENTRY": "Methylenesulfonates|T109|NON|EQV|UNK (19XX)|770524|abcdef", "MN": "D02.886.645.600.055.050.510", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Organic salts or esters of methanesulfonic acid.", "OL": "use MESYLATES to search METHANESULFONATES 1974-93", "PM": "94; was METHANESULFONATES 1974-93", "HN": "94; was METHANESULFONATES 1974-93", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008698"}, {"RECTYPE": "D", "MH": "Methapyrilene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thenylpyramine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|760430|abbcdeef", "ENTRY": "Thionylan|T109|T121|TRD|NRW|NLM (1991)|900601|abbcdef", "MN": "D03.383.725.050.440", "PA": "Hypnotics and Sedatives", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1,2-Ethanediamine, N,N-dimethyl-N'-2-pyridinyl-N'-(2-thienylmethyl)-", "RN": "A01LX40298", "RR": "91-80-5 (Methapyrilene)", "MS": "Histamine H1 antagonist with sedative action used as a hypnotic and in allergies.", "OL": "use HISTAMINE H1 RECEPTOR BLOCKADERS to search METHAPYRILENE 1966-74", "PM": "91; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78; was see under ANTIHISTAMINICS 1963-74", "HN": "91(75); was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78; was see under ANTIHISTAMINICS 1963-74", "MR": "20160531", "DA": "19771208", "DC": "1", "DX": "19910101", "UI": "D008701"}, {"RECTYPE": "D", "MH": "Methaqualone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ortonal|T109|T121|NON|EQV|UNK (19XX)|770428|abbcdef", "ENTRY": "Hydrochloride, Methaqualone", "MN": "D03.633.100.786.830.666", "PA": "Hypnotics and Sedatives", "MH_TH": "USAN (1962)", "ST": "T121", "N1": "4(3H)-Quinazolinone, 2-methyl-3-(2-methylphenyl)-", "RN": "7ZKH8MQW6T", "RR": "RJQ4G25ZRH", "PI": "Tranquilizing Agents (1966-1967)", "MS": "A quinazoline derivative with hypnotic and sedative properties. It has been withdrawn from the market in many countries because of problems with abuse. (From Martindale, The Extra Pharmacopoeia, 30th ed, p604)", "PM": "68", "HN": "68", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008702"}, {"RECTYPE": "D", "MH": "Methazolamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "N Methylacetazolamide", "MN": "D03.383.129.708.867.537", "PA": "Diuretics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Acetamide, N-(5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-", "RN": "W733B0S9SD", "RR": "554-57-4 (Methazolamide)", "AN": "a carbonic anhydrase inhib", "MS": "A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.", "PM": "91; was see under THIADIAZOLES 1975-90; was see under CARBONIC ANHYDRASE INHIBITORS 1965-74", "HN": "91(63); was see under THIADIAZOLES 1975-90; was see under CARBONIC ANHYDRASE INHIBITORS 1965-74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008704"}, {"RECTYPE": "D", "MH": "Methemalbumin", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.422.680", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "PI": "Serum Albumin (1966-1976)", "MS": "A 1:1 molar complex of heme or hematin and albumin formed after the dissociation of methemoglobin into heme or hematin and globin in plasma. This complex, which imparts a coffee-brown color to plasma, occurs in hemolytic and hemorrhagic disorders. Its presence in plasma is used as a test to differentiate between hemorrhagic and edematous pancreatitis.", "PM": "91; was see under HEMEPROTEINS 1977-90", "HN": "91(77); was see under HEMEPROTEINS 1977-90", "MR": "20170703", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D008705"}, {"RECTYPE": "D", "MH": "Methemoglobin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ferrihemoglobin|T116|T123|NON|EQV|UNK (19XX)|750708|abbcdef", "MN": "D12.776.422.316.762.571", "EC": "blood:Methemoglobinemia", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Hemoglobins, met-", "RN": "9008-37-1", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008706"}, {"RECTYPE": "D", "MH": "Methemoglobinemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Methemoglobinemias", "MN": "C15.378.619", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "presence of methemoglobin in blood", "MS": "The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19940628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008708"}, {"RECTYPE": "D", "MH": "Methenamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hexamine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|770428|abbcdeef", "ENTRY": "Silver, Methenamine", "MN": "D02.455.426.100.050.392", "PA": "Anti-Infective Agents, Urinary", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,3,5,7-Tetraazatricyclo(3.3.1.13,7)decane", "RN": "J50OIX95QV", "RR": "100-97-0 (Methenamine)", "MS": "An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. (From Martindale, The Extra Pharmacopoeia, 30th ed, p173)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008709"}, {"RECTYPE": "D", "MH": "Methenolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Metenolone|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1996)|950522|abbcdeef", "MN": "D04.210.500.054.079.429.824.537", "PA": "Anabolic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Androst-1-en-3-one, 17-hydroxy-1-methyl-, (5alpha,17beta)-", "RN": "9062ZT8Q5C", "RR": "153-00-4 (Methenolone)", "MS": "A synthetic steroid that has been used for its anabolic action.", "PM": "66", "HN": "66", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008710"}, {"RECTYPE": "D", "MH": "Metergoline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methergoline|T109|T121|NON|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "Liserdol|T109|T121|TRD|NRW|DE|041018|abbcdef", "MN": "D03.633.400.439.630", "PA": "Serotonin Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Carbamic acid, (((8beta)-1,6-dimethylergolin-8-yl)methyl)-, phenylmethyl ester", "RN": "1501393LY5", "RR": "17692-51-2 (Metergoline)", "PI": "Ergolines (1971-1974)", "MS": "A dopamine agonist and serotonin antagonist. It has been used similarly to BROMOCRIPTINE as a dopamine agonist and also for MIGRAINE DISORDERS therapy.", "PM": "2002; see METHERGOLINE 1991-2001, see ERGOLINES 1975-1990", "HN": "2002(1975)", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008711"}, {"RECTYPE": "D", "MH": "Methicillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Penicillin, Dimethoxyphenyl|T109|T195|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Dimethoxyphenyl Penicillin", "MN": "D03.633.100.300.750.500", "PA": "Anti-Bacterial Agents", "FX": "Methicillin Resistance", "MH_TH": "FDA SRS (2014)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-", "RN": "Q91FH1328A", "RR": "AO9YF4MN30", "MS": "One of the PENICILLINS which is resistant to PENICILLINASE but susceptible to a penicillin-binding protein. It is inactivated by gastric acid so administered by injection.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008712"}, {"RECTYPE": "D", "MH": "Methimazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiamazole|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|UNK (19XX)|761231|abbcdeeef", "ENTRY": "Hexal, Thiamazol", "MN": "D03.383.129.308.535", "PA": "Antithyroid Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-Imidazole-2-thione, 1,3-dihydro-1-methyl-", "RN": "554Z48XN5E", "RR": "60-56-0 (Methimazole)", "PI": "Thyroid Antagonists (1966-1967)", "MS": "A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme.", "OL": "search THYROID ANTAGONISTS 1966-67", "PM": "73; was see under THYROID ANTAGONISTS 1963-72", "HN": "73(68); was see under THYROID ANTAGONISTS 1963-72", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008713"}, {"RECTYPE": "D", "MH": "Methiocarb", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.081.251.583.555", "PA": "Molluscacides", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Phenol, 3,5-dimethyl-4-(methylthio)-, methylcarbamate", "RN": "JI9431OS31", "RR": "2032-65-7 (Methiocarb)", "PI": "Xylenes (1973-1974)", "MS": "Insecticide, molluscacide, acaricide.", "PM": "91; was see under INSECTICIDES, CARBAMATE 1975-90", "HN": "91(75); was see under INSECTICIDES, CARBAMATE 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008714"}, {"RECTYPE": "D", "MH": "Methionine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Methionine, L Isomer", "MN": "D12.125.166.676", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "Methionine", "RN": "AE28F7PNPL", "RR": "7005-18-7", "MS": "A sulfur-containing essential L-amino acid that is important in many body functions.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008715"}, {"RECTYPE": "D", "MH": "Methionine Adenosyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "S-Adenosylmethionine Synthetase|T116|T126|NON|EQV|UNK (19XX)|741111|ADENOSYLMETHIONINE SYNTHETASE S|abbcdefs", "ENTRY": "Synthetase, S-Adenosylmethionine", "MN": "D08.811.913.225.650", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "ATP:L-methionine S-adenosyltransferase", "RN": "EC 2.5.1.6", "RR": "9012-52-6 (CAS RN)", "PI": "Transferases (1972-1974)", "MS": "An enzyme that catalyzes the synthesis of S-adenosylmethionine from methionine and ATP. EC 2.5.1.6.", "PM": "91; was see under TRANSFERASES 1975-90", "HN": "91(75); was see under TRANSFERASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008716"}, {"RECTYPE": "D", "MH": "Methionine Sulfoximine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfoximine, Methionine", "MN": "D12.125.166.676.620", "MH_TH": "NLM (1964)", "ST": "T131", "N1": "Butanoic acid, 2-amino-4-(S-methylsulfonimidoyl)-", "RN": "1982-67-8", "PM": "73", "HN": "73(64)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008717"}, {"RECTYPE": "D", "MH": "Methionine-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Methionyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961106|abbdef", "ENTRY": "Synthetase, Methionyl-tRNA", "MN": "D08.811.464.263.200.600", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Methionine:tRNA(Met) ligase (AMP-forming)", "RN": "EC 6.1.1.10", "PI": "Methionine (1972-1974)", "MS": "An enzyme that activates methionine with its specific transfer RNA. EC 6.1.1.10.", "PM": "98; see METHIONYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008718"}, {"RECTYPE": "D", "MH": "Methiothepin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Metitepine|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|770427|abbcdeef", "ENTRY": "Maleate, Methiothepin", "MN": "D03.633.300.311.520", "PA": "Serotonin Antagonists", "MH_TH": "NLM (1976)", "ST": "T121", "N1": "Piperazine, 1-(10,11-dihydro-8-(methylthio)dibenzo(b,f)thiepin-10-yl)-4-methyl-", "RN": "55D94103HL", "RR": "20229-30-5 (Methiothepin)", "PI": "Sulfides (1973-1975)", "MS": "A serotonin receptor antagonist in the CENTRAL NERVOUS SYSTEM used as an antipsychotic.", "PM": "91; was see under DIBENZOTHIEPINS 1976-90", "HN": "91(76); was see under DIBENZOTHIEPINS 1976-90", "MR": "20160531", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D008719"}, {"RECTYPE": "D", "MH": "Methisazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Metisazone|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|741111|abbcdeef", "MN": "D03.633.100.473.615", "PA": "Antiviral Agents", "MH_TH": "USAN (1964)", "ST": "T121", "N1": "Hydrazinecarbothioamide, 2-(1,2-dihydro-1-methyl-2-oxo-3H-indol-3-ylidene)-", "RN": "K3QML4J07E", "RR": "1910-68-5 (Methisazone)", "PI": "Thiosemicarbazones (1971-1974)", "MS": "An antiviral agent effective against pox viruses.", "PM": "91; was see under THIOSEMICARBAZONES 1975-90", "HN": "91(75); was see under THIOSEMICARBAZONES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008720"}, {"RECTYPE": "D", "MH": "Methocarbamol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Guaiphenesin Carbamate|T109|T121|NON|EQV|UNK (19XX)|770428|abbcdef", "ENTRY": "Carbamate, Guaiphenesin", "MN": "D02.455.426.559.389.657.654.453.400.500", "PA": "Muscle Relaxants, Central", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,2-Propanediol, 3-(2-methoxyphenoxy)-, 1-carbamate", "RN": "125OD7737X", "RR": "532-03-6 (Methocarbamol)", "MS": "A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008721"}, {"RECTYPE": "D", "MH": "Methods", "PRINT ENTRY": "Techniques|T170|NON|REL|NLM (2023)|210810|abcdef", "ENTRY": "Technique", "MN": "E05.581", "MH_TH": "BIOETHICS (1975)", "ST": "T170", "AN": "prefer / methods with techniques, procedures or programs", "MS": "A series of steps taken in order to conduct research.", "OL": "use SCIENCE to search METHODS 1969-74", "PM": "91; was see under SCIENCE 1967-90", "HN": "91(67); was see under SCIENCE 1967-90", "CATSH": "CAT LIST", "MR": "20211128", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008722"}, {"RECTYPE": "D", "MH": "Methohexital", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methohexitone|T109|T121|NON|EQV|BAN (19XX)|761224|abbcdef", "ENTRY": "Sodium, Methohexital", "MN": "D03.383.742.698.253.488", "PA": "Anesthetics, Intravenous", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4,6(1H,3H,5H)-pyrimidinetrione, 1-methyl-5-(1-methyl-2-pentynyl)-5-(2-propenyl)-, (+/-)-", "RN": "E5B8ND5IPE", "RR": "60200PNZ7Q", "MS": "An intravenous anesthetic with a short duration of action that may be used for induction of anesthesia.", "OL": "use METHOHEXITAL to search ENALLYNYMALUM 1977-94", "PM": "ENALLYNYMALUM was see METHOHEXITAL 1977-94", "HN": "ENALLYNYMALUM was see METHOHEXITAL 1977-94", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D008723"}, {"RECTYPE": "D", "MH": "Methomyl", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Lannate 20|T109|T131|TRD|NRW|UNK (19XX)|870617|abbcdef", "MN": "D02.886.706.537", "PA": "Insecticides", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Ethanimidothioic acid, N-(((methylamino)carbonyl)oxy)-, methyl ester", "RN": "1NQ08HN02S", "RR": "16752-77-5 (Methomyl)", "AN": "for effect on insects, see note at INSECTICIDES", "PI": "Sulfides (1971-1974)", "MS": "A carbamate insecticide with anticholinesterase activity.", "PM": "91; was see under INSECTICIDES, CARBAMATE 1975-90", "HN": "91(75); was see under INSECTICIDES, CARBAMATE 1975-90", "MR": "20160628", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008724"}, {"RECTYPE": "D", "MH": "Bis-Trimethylammonium Compounds", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methonium Compounds|T109|NON|REL|NLM (1966)|990101|METHONIUM CPDS|abcdefv", "ENTRY": "Bis Trimethylammonium Compounds", "MN": "D02.675.276.558", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "MS": "Compounds containing polymethylene bis-trimethylammonium cations. Members of this group frequently act as ganglionic blockers and neuromuscular depolarizing agents.", "PM": "2006; see METHONIUM COMPOUNDS 1963-2005", "HN": "2006(1963)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D008725"}, {"RECTYPE": "D", "MH": "Methoprene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ZR515", "MN": "D06.472.445.573.666.500", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "2,4-Dodecadienoic acid, 11-methoxy-3,7,11-trimethyl-, 1-methylethyl ester, (E,E)-", "RN": "8B830OJ2UX", "RR": "40596-69-8 (Methoprene)", "PI": "Methyl Ethers (1974)", "MS": "Juvenile hormone analog and insect growth regulator used to control insects by disrupting metamorphosis. Has been effective in controlling mosquito larvae.", "PM": "91; was see under JUVENILE HORMONES 1975-90", "HN": "91(75); was see under JUVENILE HORMONES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008726"}, {"RECTYPE": "D", "MH": "Methotrexate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amethopterin|T109|T121|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Sodium, Methotrexate", "MN": "D03.633.100.733.631.192.500", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "L-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-", "RN": "YL5FZ2Y5U1", "RR": "86669-44-5 (di-Cs salt)", "MS": "An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008727"}, {"RECTYPE": "D", "MH": "Methotrimeprazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Levomepromazine|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|USAN (19XX)|740330|abbcdeeef", "ENTRY": "Tizertsin|T109|T121|TRD|NRW|UNK (19XX)|880423|abbcdef", "MN": "D03.633.300.783.513", "PA": "Dopamine Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "10H-Phenothiazine-10-propanamine, 2-methoxy-N,N,beta-trimethyl-, (R)-", "RN": "9G0LAW7ATQ", "RR": "60-99-1 (Methotrimeprazine)", "MS": "A phenothiazine with pharmacological activity similar to that of both CHLORPROMAZINE and PROMETHAZINE. It has the histamine-antagonist properties of the antihistamines together with CENTRAL NERVOUS SYSTEM effects resembling those of chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p604)", "OL": "use METHOTRIMEPRAZINE to search LEVOMEPROMAZINE 1966-67", "PM": "68; was LEVOMEPROMAZINE 1963-67", "HN": "68; was LEVOMEPROMAZINE 1963-67", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008728"}, {"RECTYPE": "D", "MH": "Methoxamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methoxamedrin|T109|T121|NON|EQV|UNK (19XX)|761224|abbcdef", "ENTRY": "Wellcome, Metoxamine", "MN": "D02.092.471.683.661", "PA": "Vasoconstrictor Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenemethanol, alpha-(1-aminoethyl)-2,5-dimethoxy-", "RN": "HUQ1KC1YLI", "RR": "8MB4MJ9R7L", "AN": "do not confuse with methoxyamine", "MS": "An alpha-1 adrenergic agonist that causes prolonged peripheral VASOCONSTRICTION.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008729"}, {"RECTYPE": "D", "MH": "Methoxsalen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Xanthotoxin|T109|T121|T123|NON|EQV|UNK (19XX)|780313|abbbcdef", "ENTRY": "Oxsoralen Ultra", "MN": "D03.633.300.770.500", "PA": "Photosensitizing Agents", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "7H-Furo(3,2-g)(1)benzopyran-7-one, 9-methoxy-", "RN": "U4VJ29L7BQ", "RR": "298-81-7 (Methoxsalen)", "AN": "do not index here for use in PUVA THERAPY unless particularly discussed", "MS": "A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008730"}, {"RECTYPE": "D", "MH": "Methoxychlor", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dianisyl Trichloroethane|T109|T131|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Trichloroethane, Dianisyl", "MN": "D02.455.526.439.610", "PA": "Insecticides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Benzene, 1,1'-(2,2,2-trichloroethylidene)bis(4-methoxy)-", "RN": "RIA79UD69L", "RR": "72-43-5 (Methoxychlor)", "PI": "Insecticides (1966-1972)", "MS": "An insecticide. Methoxychlor has estrogenic effects in mammals, among other effects.", "PM": "74", "HN": "74(72)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008731"}, {"RECTYPE": "D", "MH": "Methoxydimethyltryptamines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylbufotenin|T109|T123|NON|NRW|UNK (19XX)|790302|abbcdef", "ENTRY": "N,N Dimethyl 5 Methoxytryptamine", "MN": "D03.633.100.473.914.814.150.500", "MH_TH": "NLM (1980)", "ST": "T109", "RN": "0", "RR": "X0MKX3GWU9", "AN": "/biosyn /physiol permitted", "PI": "Tryptamines (1966-1973)", "MS": "Compounds that contain the biogenic monoamine tryptamine and are substituted with one methoxy group and two methyl groups. Members of this group include several potent serotonergic hallucinogens found in several unrelated plants, skins of certain toads, and in mammalian brains. They are possibly involved in the etiology of schizophrenia.", "OL": "use METHOXYDIMETHYLTRYPTAMINES to search METHOXYDIMETHYLTRYPTAMINE 1980-83", "PM": "91; was see under TRYPTAMINES 1989-90; was see under SEROTONIN 1984-88; was METHOXYDIMETHYLTRYPTAMINE see under SEROTONIN 1980-83", "HN": "91(84); was see under TRYPTAMINES 1989-90; was see under SEROTONIN 1984-88; was METHOXYDIMETHYLTRYPTAMINE see under SEROTONIN 1980-83", "MR": "20160531", "DA": "19790302", "DC": "1", "DX": "19910101", "UI": "D008732"}, {"RECTYPE": "D", "MH": "Methoxyflurane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methofluranum|T109|T121|NON|EQV|UNK (19XX)|770428|abbcdef", "ENTRY": "Pentrane|T109|T121|TRD|NRW|UNK (19XX)|800804|abbcdef", "MN": "D02.355.601.620", "PA": "Anesthetics, Inhalation", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Ethane, 2,2-dichloro-1,1-difluoro-1-methoxy-", "RN": "30905R8O7B", "RR": "76-38-0 (Methoxyflurane)", "MS": "An inhalation anesthetic. Currently, methoxyflurane is rarely used for surgical, obstetric, or dental anesthesia. If so employed, it should be administered with NITROUS OXIDE to achieve a relatively light level of anesthesia, and a neuromuscular blocking agent given concurrently to obtain the desired degree of muscular relaxation. (From AMA Drug Evaluations Annual, 1994, p180)", "PM": "65", "HN": "65(63)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008733"}, {"RECTYPE": "D", "MH": "Methoxyhydroxyphenylglycol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vanylglycol|T109|T123|NON|EQV|NLM (1991)|900228|abbcdef", "ENTRY": "4 Hydroxy 3 methoxyphenylglycol", "MN": "D02.033.455.250.610", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "1,2-Ethanediol, 1-(4-hydroxy-3-methoxyphenyl)-", "RN": "534-82-7", "RR": "87171-18-4 ((-)-isomer)", "PI": "Glycols (1966-1974)", "MS": "Synthesized from endogenous epinephrine and norepinephrine in vivo. It is found in brain, blood, CSF, and urine, where its concentrations are used to measure catecholamine turnover.", "OL": "use METHOXYHYDROXYPHENYLGLYCOL to search METHOXYHYDROXYPHENYL GLYCOL 1973-76 (as Prov 1973-74)", "PM": "91; was see under GLYCOLS 1977-90; was METHOXYHYDROXYPHENYL GLYCOL see under GLYCOLS 1975-76", "HN": "91(77); was see under GLYCOLS 1977-90; was METHOXYHYDROXYPHENYL GLYCOL see under GLYCOLS 1975-76; was METHOXYHYDROXYPHENYL GLYCOL 1973-74 (Prov)", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008734"}, {"RECTYPE": "D", "MH": "5-Methoxytryptamine", "DS": "METHOXYTRYPTAMINE 05", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "5 Methoxytryptamine", "MN": "D03.633.100.473.914.814.400", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "1H-Indole-3-ethanamine, 5-methoxy-", "RN": "3VMW6141KC", "RR": "608-07-1 (5-Methoxytryptamine)", "MS": "Serotonin derivative proposed as potentiator for hypnotics and sedatives.", "OL": "use 5-METHOXYTRYPTAMINE to search METHOXYTRYPTAMINE 1975-88; use TRYPTAMINES 1966-74", "PM": "91; was see under SEROTONIN 1989-90; was METHOXYTRYPTAMINE see under TRYPTAMINES 1966-88", "HN": "91(89); was see under SEROTONIN 1989-90; was METHOXYTRYPTAMINE see under TRYPTAMINES 1966-88", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008735"}, {"RECTYPE": "D", "MH": "Methyclothiazide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.174.620", "PA": "Sodium Chloride Symporter Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-, 1,1-dioxide", "RN": "L3H46UAC61", "RR": "135-07-9 (Methyclothiazide)", "MS": "A thiazide diuretic with properties similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p825)", "PM": "65", "HN": "65(63)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008736"}, {"RECTYPE": "D", "MH": "Methyl Chloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chloride, Methyl", "MN": "D02.455.526.439.632", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Methane, chloro-", "RN": "A6R43525YO", "RR": "74-87-3 (Methyl Chloride)", "AN": "do not confuse with METHYLENE CHLORIDE", "MS": "A hydrocarbon used as an industrial solvent. It has been used as an aerosal propellent, as a refrigerant and as a local anesthetic. (From Martindale, The Extra Pharmacopoeia, 31st ed, p1403)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008737"}, {"RECTYPE": "D", "MH": "Methyl Ethers", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ethers, Methyl", "MN": "D02.355.601", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Ethers (1966-1971)", "MS": "A group of compounds that contain the general formula R-OCH3.", "OL": "use METHYL ETHERS to search METHYL ETHER 1972-73 (as Prov)", "PM": "74", "HN": "74; was METHYL ETHER 1972-73 (Prov)", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008738"}, {"RECTYPE": "D", "MH": "Methyl Green", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Green, Methyl", "MN": "D02.092.146.475", "PA": "Coloring Agents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Benzenaminium, 4-((4-(dimethylamino)phenyl)(4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene)methyl)-N,N,N-trimethyl-, dichloride", "RN": "82-94-0", "PI": "Rosaniline Dyes (1972-1974)", "MS": "A tri-benzene-ammonium usually compounded with zinc chloride. It is used as a biological stain and for the dyeing and printing of textiles.", "PM": "91; was see under ROSANILINE DYES 1975-90", "HN": "91(75); was see under ROSANILINE DYES 1975-90", "MR": "20050706", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D008739"}, {"RECTYPE": "D", "MH": "Methyl Methanesulfonate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylmethane Sulfonate|T109|T121|T131|NON|EQV|UNK (19XX)|800710|abbbcdef", "ENTRY": "Methyl Mesilate", "MN": "D02.886.645.600.055.050.510.500", "PA": "Mutagens", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Methanesulfonic acid, methyl ester", "RN": "AT5C31J09G", "RR": "66-27-3 (Methyl Methanesulfonate)", "PI": "Sulfonic Acids (1966-1973)", "MS": "An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA.", "OL": "use METHYL METHANESULFONATE to search MESILATE, METHYL & METHYLMESYLATE 1981-93 and METHYL MESILATE 1980-93", "PM": "80; was see under METHANESULFONATES 1975-79; MESILATE, METHYL & METHYLMESYLATE were see METHYL METHANESULFONATE 1981-93; METHYL MESILATE was see METHYL METHANESULFONATE 1980-93", "HN": "80(75); was see under METHANESULFONATES 1975-79; MESILATE, METHYL & METHYLMESYLATE were see METHYL METHANESULFONATE 1981-93; METHYL MESILATE was see METHYL METHANESULFONATE 1980-93", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19800101", "UI": "D008741"}, {"RECTYPE": "D", "MH": "Methyl n-Butyl Ketone", "DS": "METHYL BUTYL KETONE N", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hexan-2-one|T109|T131|NON|EQV|NLM (2004)|020228|HEXAN 002|abbcdefs", "ENTRY": "n-Butyl Ketone, Methyl", "MN": "D02.522.520.500", "MH_TH": "NLM (1977)", "ST": "T131", "N1": "2-Hexanone", "RN": "6QDY60NH6N", "RR": "591-78-6 (Methyl n-Butyl Ketone)", "PI": "Ketones (1966-1976)", "MS": "An industrial solvent which causes nervous system degeneration. MBK is an acronym often used to refer to it.", "PM": "1991; see KETONES 1977-90; HEXAN-2-ONE was indexed under HEXANONES 2002-2003", "HN": "1991(1977); use KETONES 1977-1990; for HEXAN-2-ONE use HEXANONES 2002-2003", "MR": "20130708", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D008742"}, {"RECTYPE": "D", "MH": "Methyl Parathion", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "PRINT ENTRY": "Parathion Methyl|T109|T131|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Wofatox|T109|T131|TRD|NRW|UNK (19XX)|820203|abbcdef", "MN": "D02.886.300.692.600.500", "PA": "Insecticides", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Phosphorothioic acid, O,O-dimethyl O-(4-nitrophenyl) ester", "RN": "41BCL2O91D", "RR": "298-00-0 (Methyl Parathion)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Parathion (1973-1974)", "MS": "The methyl homolog of parathion. An effective, but highly toxic, organothiophosphate insecticide and cholinesterase inhibitor.", "PM": "91; was see under PARATHION 1975-90", "HN": "91(75); was see under PARATHION 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008743"}, {"RECTYPE": "D", "MH": "Methylamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.092.668", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "Amines (1966-1970)", "MS": "Derivatives of methylamine (the structural formula CH3NH2).", "PM": "73", "HN": "73(71)", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008744"}, {"RECTYPE": "D", "MH": "Methylation", "AQ": "DE RE", "ENTRY": "Methylations", "MN": "G03.059.538", "MH_TH": "NLM (1964)", "ST": "T070", "AN": "almost never IM; enzymatic methylation: coord NIM with METHYLTRANSFERASES (IM) + substrate (NIM) or specific methyltransferase (IM); DNA METHYLATION is also available", "MS": "Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed)", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008745"}, {"RECTYPE": "D", "MH": "Methylazoxymethanol Acetate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Acetate, Methylazoxymethanol", "MN": "D02.172.080.600", "PA": "Protein Synthesis Inhibitors", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Methanol, (methyl-ONN-azoxy)-, acetate (ester)", "RN": "592-62-1", "PI": "Azo Compounds (1973-1974)", "MS": "The aglycone of CYCASIN. It acts as a potent carcinogen and neurotoxin and inhibits hepatic DNA, RNA, and protein synthesis.", "PM": "91; was see under AZO COMPOUNDS 1975-90", "HN": "91(75); was see under AZO COMPOUNDS 1975-90", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008746"}, {"RECTYPE": "D", "MH": "Methylcellulose", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Cellulose, Methyl", "MN": "D09.698.365.180.663", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "Cellulose, methyl ether", "RN": "9004-67-5", "AN": "used in pharm & cosmetic indust; also a cathartic", "MS": "Methylester of cellulose. Methylcellulose is used as an emulsifying and suspending agent in cosmetics, pharmaceutics and the chemical industry. It is used therapeutically as a bulk laxative.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008747"}, {"RECTYPE": "D", "MH": "Methylcholanthrene", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "3 Methylcholanthrene", "MN": "D04.615.149.500", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Benz(j)aceanthrylene, 1,2-dihydro-3-methyl-", "RN": "56-49-5", "RR": "214U33M1RL", "MS": "A carcinogen that is often used in experimental cancer studies.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008748"}, {"RECTYPE": "D", "MH": "Methyldimethylaminoazobenzene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "MeDAB|T109|T131|ABB|EQV|UNK (19XX)|790510|abbcdef", "ENTRY": "3' Methyl 4 dimethylaminoazobenzene", "MN": "D02.092.146.325.500", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Benzenamine, N,N-dimethyl-4-((3-methylphenyl)azo)-", "RN": "55-80-1", "PI": "Methane (1973-1974)", "MS": "A very potent liver carcinogen.", "PM": "91; was see under DIMETHYLAMINOAZOBENZENE 1975-90", "HN": "91(75); was see under DIMETHYLAMINOAZOBENZENE 1975-90", "MR": "20000622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008749"}, {"RECTYPE": "D", "MH": "Methyldopa", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "alpha-Methyldopa|T116|T121|T123|EQV|FDA SRS (2014)|NLM (1995)|940425|abbbdeef", "ENTRY": "alpha Methyldopa", "MN": "D12.125.072.050.875.130.600", "PA": "Sympatholytics", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "L-Tyrosine, 3-hydroxy-alpha-methyl-", "RN": "56LH93261Y", "RR": "555-30-6 (Methyldopa)", "MS": "An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent.", "OL": "use METHYLDOPA to search ALPHAMETHYLDOPA 1977-94", "PM": "65; ALPHAMETHYLDOPA was see METHYLDOPA 1977-94", "HN": "65(63); ALPHAMETHYLDOPA was see METHYLDOPA 1977-94", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008750"}, {"RECTYPE": "D", "MH": "Methylene Blue", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Swiss Blue|T109|T121|T130|NON|EQV|UNK (19XX)|770426|abbbcdef", "ENTRY": "Blue, Urolene", "MN": "D03.633.300.783.517", "PA": "Enzyme Inhibitors", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride", "RN": "T42P99266K", "RR": "61-73-4 (Methylene Blue)", "MS": "A compound consisting of dark green crystals or crystalline powder, having a bronze-like luster. Solutions in water or alcohol have a deep blue color. Methylene blue is used as a bacteriologic stain and as an indicator. It inhibits GUANYLATE CYCLASE, and has been used to treat cyanide poisoning and to lower levels of METHEMOGLOBIN.", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008751"}, {"RECTYPE": "D", "MH": "Methylene Chloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylene Dichloride|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Dichloride, Methylene", "MN": "D02.455.526.439.642", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Methane, dichloro-", "RN": "588X2YUY0A", "RR": "75-09-2 (Methylene Chloride)", "AN": "do not confuse with METHYL CHLORIDE", "PI": "Methane (1974)", "MS": "A chlorinated hydrocarbon that has been used as an inhalation anesthetic and acts as a narcotic in high concentrations. Its primary use is as a solvent in manufacturing and food technology.", "PM": "91; was see under HYDROCARBONS, CHLORINATED 1975-90", "HN": "91(75); was see under HYDROCARBONS, CHLORINATED 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008752"}, {"RECTYPE": "D", "MH": "Methylenebis(chloroaniline)", "DS": "METHYLENEBISCHLOROANILINE", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Methylene Bis(chloroaniline)|T109|T131|NON|EQV|UNK (19XX)|790628|METHYLENE BISCHLOROANILINE|abbcdefs", "ENTRY": "MBOCA|T109|T131|ABB|EQV|NLM (2018)|160902|abbcdef", "MN": "D02.455.426.559.389.115.500", "MH_TH": "NLM (1977)", "ST": "T131", "N1": "Benzenamine, 4,4'-methylenebis(2-chloro)-", "RN": "3L2W5VTT2A", "RR": "101-14-4 (Methylenebis(chloroaniline))", "PI": "Hydrocarbons, Chlorinated (1974)", "MS": "Aromatic diamine used in the plastics industry as curing agent for epoxy resins and urethane rubbers. It causes bladder, liver, lung, and other neoplasms.", "PM": "91; was see under BENZHYDRYL COMPOUNDS 1977-90", "HN": "91(77); was see under BENZHYDRYL COMPOUNDS 1977-90", "MR": "20170224", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D008753"}, {"RECTYPE": "D", "MH": "Methylenetetrahydrofolate Dehydrogenase (NADP)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Methylenetetrahydrofolate Dehydrogenase (NADP+)|T116|T126|ABX|EQV|NLM (1990)|890421|abbcdef", "ENTRY": "Dehydrogenase, Methylenetetrahydrofolate", "MN": "D08.811.682.662.253", "FX": "Methenyltetrahydrofolate Cyclohydrolase", "MH_TH": "NLM (2004)", "ST": "T126", "N1": "5,10-Methylenetetrahydrofolate:NADP+ oxidoreductase", "RN": "EC 1.5.1.5", "AN": "do not confuse with METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NAD+)", "PI": "Tetrahydrofolates (1973-1974)", "MS": "An NADP-dependent oxidoreductase that catalyses the conversion of 5,10-methyleneterahydrofolate to 5,10-methenyl-tetrahydrofolate. In higher eukaryotes a trifunctional enzyme exists with additional METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE and FORMATE-TETRAHYDROFOLATE LIGASE activity. The enzyme plays an important role in the synthesis of 5-methyltetrahydrofolate, the methyl donor for the VITAMIN B12-dependent remethylation of HOMOCYSTEINE to METHIONINE via METHIONINE SYNTHETASE.", "PM": "2004; see METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1991-2003; see OXIDOREDUCTASES 1975-1990", "HN": "2004(1975);", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008754"}, {"RECTYPE": "D", "MH": "Methylergonovine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylergometrin|T109|T121|NON|EQV|UNK (19XX)|761224|abbcdef", "ENTRY": "M\u00e9thergin|T109|T121|TRD|NRW|FR|041019|abbcdef", "MN": "D03.633.400.439.262.538", "PA": "Oxytocics", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-6-methyl-, (8beta(S))-", "RN": "W53L6FE61V", "RR": "IR84JPZ1RK", "MS": "A homolog of ERGONOVINE containing one more CH2 group. (Merck Index, 11th ed)", "PM": "1966; for METHLERGOMETRINE MALEATE was indexed under METHYLERGONOVINE (NM) 1966-2001", "HN": "1966; for METHLERGOMETRINE MALEATE use METHYLERGONOVINE (NM) 1966-2001", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008755"}, {"RECTYPE": "D", "MH": "Methylgalactosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylgalactose|T109|NON|NRW|UNK (19XX)|750101|abcdef", "MN": "D09.408.514.455", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "OL": "search METHYLGLYCOSIDES 1974", "PM": "91; was see under METHYLGLYCOSIDES 1975-90", "HN": "91(75); was see under METHYLGLYCOSIDES 1975-90", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008756"}, {"RECTYPE": "D", "MH": "Methylglucosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylglucopyranosides|T109|NON|EQV|UNK (19XX)|760324|abcdef", "MN": "D09.408.514.622", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with METHYLGLYCOSIDES", "OL": "search METHYLGLYCOSIDES 1974", "PM": "91; was see under METHYLGLYCOSIDES 1975-90", "HN": "91(75); was see under METHYLGLYCOSIDES 1975-90", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008757"}, {"RECTYPE": "D", "MH": "Methylglycosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D09.408.514", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "do not confuse with METHYLGLUCOSIDES", "PM": "74", "HN": "74", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008759"}, {"RECTYPE": "D", "MH": "Methylguanidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.078.370.570", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Guanidine, methyl-", "RN": "5L0H5Q9VAG", "RR": "471-29-4 (Methylguanidine)", "PI": "Guanidines (1969-1974)", "MS": "A product of putrefaction. Poisonous.", "PM": "91; was see under GUANIDINES 1975-90", "HN": "91(75); was see under GUANIDINES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008760"}, {"RECTYPE": "D", "MH": "Methylhistamines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.383.129.308.373.500", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "PI": "Histamine (1970-1976)", "MS": "Histamine substituted in any position with one or more methyl groups. Many of these are agonists for the H1, H2, or both histamine receptors.", "PM": "77", "HN": "77", "MR": "20160531", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D008761"}, {"RECTYPE": "D", "MH": "Methylhistidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Methylhistidine|T116|NON|EQV|UNK (19XX)|800515|abcdef", "MN": "D12.125.072.329.539", "MH_TH": "NLM (1972)", "ST": "T116", "RN": "0", "PI": "Histidine (1966-1971)", "MS": "Histidine substituted in any position with one or more methyl groups.", "OL": "use METHYLHISTIDINES to search METHYLHISTIDINE 1972-80 (as Prov 1972-74)", "PM": "91; was see under HISTIDINE/analogs & derivatives 1981-90; was METHYLHISTIDINE see under HISTIDINE 1975-80", "HN": "91(81); was see under HISTIDINE/analogs & derivatives 1981-90; was METHYLHISTIDINE see under HISTIDINE 1972-80 (Prov 1972-74)", "MR": "19940616", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008762"}, {"RECTYPE": "D", "MH": "Methylhydrazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.442.600", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Hydrazines (1966-1974)", "MS": "Hydrazines substituted by one or more methyl groups in any position.", "OL": "to search METHYLHYDRAZINE use METHYLHYDRAZINES 1975-77 & HYDRAZINES 1967-74", "PM": "78; was METHYLHYDRAZINE see under HYDRAZINES 1967-77; DIMETHYLHYDRAZINES was 1,2 DIMETHYLHYDRAZINE see under HYDRAZINES 1975-77; MONOMETHYLHYDRAZINE was METHYLHYDRAZINE see under HYDRAZINES 1966-77", "HN": "78; was METHYLHYDRAZINE see under HYDRAZINES 1967-77", "MR": "19950518", "DA": "19770523", "DC": "1", "DX": "19780101", "UI": "D008763"}, {"RECTYPE": "D", "MH": "Methylmalonic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Methylmalonic", "MN": "D02.241.081.337.540.500", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Propanedioic acid, methyl-", "RN": "8LL8S712J7", "RR": "516-05-2 (Methylmalonic Acid)", "AN": "/biosyn /physiol permitted", "PI": "Malonates (1974)", "MS": "A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA.", "PM": "91; was see under MALONATES 1975-90", "HN": "91(75); was see under MALONATES 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008764"}, {"RECTYPE": "D", "MH": "Methylmalonyl-CoA Mutase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Methylmalonyl-CoA Isomerase|T116|T126|EQV|UNK (19XX)|750208|abbdef", "ENTRY": "Mutase, Methylmalonyl-CoA", "MN": "D08.811.399.520.625", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "(R)-2-Methyl-3-oxopropanoyl-CoA CoA-carbonylmutase", "RN": "EC 5.4.99.2", "RR": "9023-90-9 (CAS RN)", "AN": "/defic: consider also METHYLMALONIC ACID /urine (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM)", "PI": "Malonates (1969-1974)", "MS": "An enzyme that catalyzes the conversion of methylmalonyl-CoA to succinyl-CoA by transfer of the carbonyl group. It requires a cobamide coenzyme. A block in this enzymatic conversion leads to the metabolic disease, methylmalonic aciduria. EC 5.4.99.2.", "PM": "91; was see under ISOMERASES 1975-90", "HN": "91(75); was see under ISOMERASES 1975-90", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008765"}, {"RECTYPE": "D", "MH": "Methylmannosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylmannopyranosides|T109|NON|EQV|UNK (19XX)|760324|abcdef", "MN": "D09.408.514.700", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Methylglycosides (1974)", "MS": "Mannosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of mannose with methyl alcohol. They include both alpha- and beta-methylmannosides.", "PM": "91; was see under METHYLGLYCOSIDES 1975-90", "HN": "91(75); was see under METHYLGLYCOSIDES 1975-90", "MR": "20040707", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008766"}, {"RECTYPE": "D", "MH": "Methylmercury Compounds", "DE": "METHYLMERCURY CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methyl Mercury Compounds|T109|T131|NON|EQV|UNK (19XX)|790523|METHYL MERCURY CPDS|abbcdefv", "ENTRY": "Mercury Compounds, Methyl", "MN": "D02.691.750.100.738", "MH_TH": "NLM (1972)", "ST": "T131", "RN": "0", "PI": "Organometallic Compounds (1968-1971)", "MS": "Organic compounds in which mercury is attached to a methyl group.", "OL": "use METHYLMERCURY COMPOUNDS to search METHYL MERCURY COMPOUNDS 1972-79 (as Prov 1972-73)", "PM": "80; was METHYL MERCURY COMPOUNDS 1974-79", "HN": "80; was METHYL MERCURY COMPOUNDS 1972-79 (Prov 1972-73)", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008767"}, {"RECTYPE": "D", "MH": "Methylmethacrylates", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "J01.637.051.720.716.822.111.650.605", "MH_TH": "NLM (1972)", "ST": "T122", "RN": "0", "PI": "Acrylic Resins (1966-1971)", "MS": "The methyl esters of methacrylic acid that polymerize easily and are used as tissue cements, dental materials, and absorbent for biological substances.", "OL": "to search METHYLMETHACRYLATE use METHYLMETHACRYLATES 1972-82 (as Prov 1972) & ACRYLIC RESINS 1966-71", "PM": "83; was METHYLMETHACRYLATE 1973-82, was METHYLMETHACRYLATE see under ACRYLIC RESINS 1963-72", "HN": "83; was METHYLMETHACRYLATE 1972-82 (Prov 1972), was METHYLMETHACRYLATE see under ACRYLIC RESINS 1963-72", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008768"}, {"RECTYPE": "D", "MH": "Methylnitronitrosoguanidine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Nitrosonitromethylguanidine|T109|T131|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "N Methyl N' nitro N nitrosoguanidine", "MN": "D02.654.567.400", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Guanidine, N-methyl-N'-nitro-N-nitroso-", "RN": "12H3O2UGSF", "RR": "70-25-7 (Methylnitronitrosoguanidine)", "PI": "Nitrosoguanidines (1973-1974)", "MS": "A nitrosoguanidine derivative with potent mutagenic and carcinogenic properties.", "PM": "77; was see under NITROSOGUANIDINES 1975-76", "HN": "77(75); was see under NITROSOGUANIDINES 1975-76", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19770101", "UI": "D008769"}, {"RECTYPE": "D", "MH": "Methylnitrosourea", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Nitrosomethylurea|T109|T131|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "NSC23909", "MN": "D02.654.692.480", "PA": "Alkylating Agents", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Urea, N-methyl-N-nitroso-", "RN": "684-93-5", "PI": "Nitrosourea Compounds (1973-1974)", "MS": "A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.", "PM": "86; was see under NITROSOUREA COMPOUNDS 1975-85", "HN": "86(75); was see under NITROSOUREA COMPOUNDS 1975-85", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19860101", "UI": "D008770"}, {"RECTYPE": "D", "MH": "Nordefrin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylnorepinephrine|T109|T121|NON|BRD|NLM (1991)|900601|abbcdef", "ENTRY": "alpha Methylnorepinephrine", "MN": "D02.455.426.559.389.657.166.175.830.400", "PA": "Vasoconstrictor Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "1,2-Benzenediol, 4-(2-amino-1-hydroxypropyl)-", "RN": "R81X549E70", "RR": "V008L6478D", "MS": "A norepinephrine derivative used as a vasoconstrictor agent.", "OL": "use NORDEFRIN to search METHYLNOREPINEPHRINE 1975-90; use NORMETANEPHRINE 1966-74", "PM": "91; was METHYLNOREPINEPHRINE see under NOREPINEPHRINE/analogs & derivatives 1975-90, see under NORMETANEPHRINE 1971-74, & see NORMETANEPHRINE 1966-70", "HN": "91(75); was METHYLNOREPINEPHRINE see under NOREPINEPHRINE/analogs & derivatives 1975-90, see under NORMETANEPHRINE 1971-74, & see NORMETANEPHRINE 1966-70", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008771"}, {"RECTYPE": "D", "MH": "Methylococcaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Methylomonadaceae|T007|NON|EQV|NLM (1992)|910326|abcdef", "ENTRY": "Methylmonadaceae|T007|NON|EQV|UNK (19XX)|790418|abcdef", "MN": "B03.660.250.500", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid403", "PI": "Bacteria (1966-1974)", "MS": "A family of gram-negative, aerobic bacteria utilizing only one-carbon organic compounds and isolated from in soil and water.", "OL": "use METHYLOCOCCACEAE to search METHYLOMONADACEAE 1976-91 & METHANOMONADACEAE 1975", "PM": "92; was METHYLOMONADACEAE 1976-91, was METHANOMONADACEAE 1975", "HN": "92; was METHYLOMONADACEAE 1976-91, was METHANOMONADACEAE 1975", "MR": "20200813", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D008772"}, {"RECTYPE": "D", "MH": "Methylphenazonium Methosulfate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Phenazine Methosulfate|T109|T130|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Sulfate, 5-Methylphenazinium Methyl", "MN": "D03.633.300.704.550", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Phenazinium, 5-methyl-, methyl sulfate", "RN": "299-11-6", "PI": "Sulfuric Acids (1972-1974)", "MS": "Used as an electron carrier in place of the flavine enzyme of Warburg in the hexosemonophosphate system and also in the preparation of SUCCINIC DEHYDROGENASE.", "PM": "91; was see under PHENAZINES 1975-90", "HN": "91(75); was see under PHENAZINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008773"}, {"RECTYPE": "D", "MH": "Methylphenidate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ritalin SR", "MN": "D03.383.621.460", "PA": "Dopamine Uptake Inhibitors", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "2-Piperidineacetic acid, alpha-phenyl-, methyl ester", "RN": "207ZZ9QZ49", "RR": "4B3SC438HI", "MS": "A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.", "OL": "use METHYLPHENIDATE to search PHENIDYLATE 1978-94", "PM": "PHENIDYLATE was see METHYLPHENIDATE 1978-94", "HN": "PHENIDYLATE was see METHYLPHENIDATE 1978-94", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008774"}, {"RECTYPE": "D", "MH": "Methylprednisolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "6 Methylprednisolone", "MN": "D04.210.500.745.432.769.795.539", "PA": "Neuroprotective Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6-methyl-, (6alpha,11beta)-", "RN": "X4W7ZR7023", "RR": "83-43-2 (Methylprednisolone)", "MS": "A PREDNISOLONE derivative with similar anti-inflammatory action.", "OL": "use METHYLPREDNISOLONE (NM) to search METIPRED 1989-93", "PM": "METIPRED was indexed under GLUCOCORTICOIDS, SYNTHETIC 1989-93", "HN": "METIPRED was (NM) 1989-93", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D008775"}, {"RECTYPE": "D", "MH": "Methylprednisolone Hemisuccinate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylprednisolone Succinate|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1991)|900402|abbcdeef", "ENTRY": "UrbasonSoluble", "MN": "D04.210.500.745.432.769.795.539.500", "PA": "Neuroprotective Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-", "RN": "5GMR90S4KN", "RR": "LEC9GKY20K", "PI": "Succinates (1966-1979)", "MS": "A water-soluble ester of METHYLPREDNISOLONE used for cardiac, allergic, and hypoxic emergencies.", "OL": "use METHYLPREDNISOLONE HEMISUCCINATE to search METHYLPREDNISOLONE SUCCINATE 1980-90", "PM": "91; was METHYLPREDNISOLONE SUCCINATE see under METHYLPREDNISOLONE/analogs & derivatives 1980-90", "HN": "91(80); was METHYLPREDNISOLONE SUCCINATE see under METHYLPREDNISOLONE/analogs & derivatives 1980-90", "MR": "20160531", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D008776"}, {"RECTYPE": "D", "MH": "Methyltestosterone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Android 5", "MN": "D04.210.500.054.079.429.824.664", "PA": "Antineoplastic Agents, Hormonal", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Androst-4-en-3-one, 17-hydroxy-17-methyl-, (17beta)-", "RN": "V9EFU16ZIF", "RR": "58-18-4 (Methyltestosterone)", "MS": "A synthetic hormone used for androgen replacement therapy and as an hormonal antineoplastic agent (ANTINEOPLASTIC AGENTS, HORMONAL).", "MR": "20180612", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008777"}, {"RECTYPE": "D", "MH": "Methylthioinosine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "6-Methylmercaptopurine Riboside|T114|T121|NON|EQV|UNK (19XX)|790523|METHYLMERCAPTOPURINE RIBOSIDE 06|abbcdefs", "ENTRY": "Riboside, 6-Methylthiopurine", "MN": "D13.570.900.800.500", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Inosine, 6-S-methyl-6-thio-", "RN": "342-69-8", "PI": "Sulfides (1972-1974)", "MS": "6-(Methylthio)-9-beta-D-ribofuranosylpurine. An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position.", "PM": "91; was see under INOSINE 1975-90", "HN": "91(75); was see under INOSINE 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008778"}, {"RECTYPE": "D", "MH": "Methylthiouracil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Thimecil|T114|T121|TRD|NRW|US|041029|abbcdef", "MN": "D03.383.742.698.875.842.455", "PA": "Antithyroid Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "4(1H)-Pyrimidinone, 2,3-dihydro-6-methyl-2-thioxo-", "RN": "QW24888U5F", "RR": "56-04-2 (Methylthiouracil)", "MS": "A thiourea antithyroid agent that inhibits the synthesis of thyroid hormone. It is used in the treatment of hyperthyroidism.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008779"}, {"RECTYPE": "D", "MH": "Methyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Methyltransferase|T116|T126|NON|EQV|NLM (2021)|191129|abbcdef", "MN": "D08.811.913.555.500", "MH_TH": "NLM (1971)", "ST": "T126", "RN": "EC 2.1.1.-", "RR": "9033-25-4 (CAS RN)", "PI": "Transferases (1966-1970)", "MS": "A subclass of enzymes of the transferase class that catalyze the transfer of a methyl group from one compound to another. (Dorland, 28th ed) EC 2.1.1.", "PM": "72", "HN": "72(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008780"}, {"RECTYPE": "D", "MH": "Methyltyrosines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.125.072.050.875.485", "MH_TH": "NLM (1965)", "ST": "T116", "RN": "0", "MS": "A group of compounds that are methyl derivatives of the amino acid TYROSINE.", "OL": "use METHYLTYROSINES to search METHYLTYROSINE 1966-67 (as Prov)", "PM": "68", "HN": "68; was METHYLTYROSINE 1965-67 (Prov)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008781"}, {"RECTYPE": "D", "MH": "Methylurea Compounds", "DE": "METHYLUREA CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Methylurea", "MN": "D02.065.950.511", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Urea (1966-1974)", "MS": "Urea compounds which are substituted with one or more methyl groups.", "PM": "75", "HN": "75", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D008782"}, {"RECTYPE": "D", "MH": "Methysergide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylmethylergonovine|T109|T121|NON|EQV|UNK (19XX)|761224|abbcdef", "ENTRY": "UML491", "MN": "D03.633.400.439.689", "PA": "Vasoconstrictor Agents", "MH_TH": "USAN (1970)", "ST": "T121", "N1": "Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8beta(S))-", "RN": "XZA9HY6Z98", "RR": "361-37-5 (Methysergide)", "MS": "An ergot derivative that is a congener of LYSERGIC ACID DIETHYLAMIDE. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome.", "OL": "use METHYSERGIDE/analogs & derivatives to search METHYSERGIDE DERIVATIVES 1975-77; use ERGOLINES 1969-74", "PM": "65; METHYSERGIDE DERIVATIVES was see under METHYSERGIDE 1975-77; was see under ERGOLINES 1969-74", "HN": "65(63); METHYSERGIDE DERIVATIVES was see under METHYSERGIDE 1975-77; was see under ERGOLINES 1969-74", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008784"}, {"RECTYPE": "D", "MH": "Metiamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SKF92058", "MN": "D02.886.904.455", "PA": "Histamine H2 Antagonists", "MH_TH": "USAN (1973)", "ST": "T121", "N1": "Thiourea, N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)-", "RN": "3K7670861M", "RR": "52373-56-5 (mono-HCl)", "PI": "Thiourea (1974)", "MS": "A histamine H2 receptor antagonist that is used as an anti-ulcer agent.", "PM": "91; was see under THIOUREA 1975-90", "HN": "91(75); was see under THIOUREA 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008785"}, {"RECTYPE": "D", "MH": "Metmyoglobin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ferrimyoglobin|T116|T123|NON|EQV|UNK (19XX)|780516|abbcdef", "MN": "D12.776.422.316.940.500", "MH_TH": "NLM (1979)", "ST": "T123", "N1": "Myoglobins, met-", "RN": "12772-23-5", "PI": "Myoglobin (1966-1978)", "MS": "Myoglobin which is in the oxidized ferric or hemin form. The oxidation causes a change in color from red to brown.", "PM": "91; was see under HEMEPROTEINS 1979-90", "HN": "91(79); was see under HEMEPROTEINS 1979-90", "MR": "20080708", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D008786"}, {"RECTYPE": "D", "MH": "Metoclopramide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Metoclopramide", "MN": "D02.455.426.559.389.657.654.638.625", "PA": "Dopamine D2 Receptor Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy-", "RN": "L4YEB44I46", "RR": "W1792A2RVD", "MS": "A dopamine D2 antagonist that is used as an antiemetic.", "PM": "74", "HN": "74", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008787"}, {"RECTYPE": "D", "MH": "Metolazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SR72022", "MN": "D03.633.100.786.830.688", "PA": "Sodium Chloride Symporter Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-", "RN": "TZ7V40X7VX", "RR": "17560-51-9 (Metolazone)", "PI": "Quinazolines (1971-1974)", "MS": "A quinazoline-sulfonamide derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.", "PM": "91; was see under DIURETICS, SULFAMYL 1975-90", "HN": "91(75); was see under DIURETICS, SULFAMYL 1975-90", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008788"}, {"RECTYPE": "D", "MH": "Metoprolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Toprol XL", "MN": "D02.092.063.624.698.573", "PA": "Sympatholytics", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-", "RN": "GEB06NHM23", "RR": "W5S57Y3A5L", "PI": "Propylamines (1974-1976)", "MS": "A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.", "PM": "84; was see under PROPANOLAMINES 1977-83", "HN": "84(77); was see under PROPANOLAMINES 1977-83", "MR": "20180301", "DA": "19760413", "DC": "1", "DX": "19840101", "UI": "D008790"}, {"RECTYPE": "D", "MH": "Metrial Gland", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Metrial Glands", "MN": "A13.600", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "female; animal only", "PI": "Uterus (1966-1974)", "MS": "Collection of granular epithelial cells in the uterine muscle beneath the placenta that develop during pregnancy in certain species of animals.", "PM": "75", "HN": "75", "MR": "19781207", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D008791"}, {"RECTYPE": "D", "MH": "Metric System", "AQ": "HI IS ST", "ENTRY": "Systems, Metric", "MN": "E05.978.539", "MH_TH": "NLM (1974)", "ST": "T081", "MS": "A system of units used in scientific work throughout the world and employed in general commercial transactions and engineering applications. Its units of length, time, and mass are the meter, second, and kilogram respectively, or decimal multiples and submultiples thereof. ( McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "74", "HN": "74", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008792"}, {"RECTYPE": "D", "MH": "Metrizamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Amipaque|T109|T121|T130|TRD|NRW|UNK (19XX)|800815|abbbcdef", "MN": "D09.408.051.545", "PA": "Contrast Media", "MH_TH": "USAN (1975)", "ST": "T130", "N1": "D-Glucose, 2-((3-(acetylamino)-5-(acetylmethylamino)-2,4,6-triiodobenzoyl)amino)-2-deoxy-", "RN": "RHH3W8F1CO", "RR": "31112-62-6 (Metrizamide)", "PI": "Iodobenzoates (1972-1977)", "MS": "A solute for density gradient centrifugation offering higher maximum solution density without the problems of increased viscosity. It is also used as a resorbable, non-ionic contrast medium.", "PM": "78; was see under IODOBENZOATES 1975-77", "HN": "78(75); was see under IODOBENZOATES 1975-77", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19780101", "UI": "D008793"}, {"RECTYPE": "D", "MH": "Metrizoic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Metrizoate|T109|T130|NON|REL|BAN (19XX)|INN (19XX)|990101|abbcdeef", "ENTRY": "Triosil|T109|T130|TRD|NRW|UNK (19XX)|811026|abbcdef", "MN": "D02.455.426.559.389.127.375.880.530", "PA": "Contrast Media", "MH_TH": "NLM (2018)", "ST": "T130", "RN": "CM1N99QR1M", "RR": "O65Q227UIC", "PI": "Salts (1972-1974)", "MS": "A diagnostic radiopaque that usually occurs as the sodium salt.", "PM": "2018; see METROZOATE 1991-2017; see IODOBENZOATES 1975-2017", "HN": "2018(1975)", "MR": "20180612", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008794"}, {"RECTYPE": "D", "MH": "Metronidazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "2 Methyl 5 nitroimidazole 1 ethanol", "MN": "D03.383.129.308.658.500", "PA": "Antiprotozoal Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Imidazole-1-ethanol, 2-methyl-5-nitro-", "RN": "140QMO216E", "RR": "L500PR95QA", "MS": "A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.", "HN": "1964", "MR": "20180521", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008795"}, {"RECTYPE": "D", "MH": "Metrorrhagia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Uterine Bleeding, Dysfunctional", "MN": "C23.550.414.993.700", "MH_TH": "NLM (1963)", "ST": "T046", "AN": "do not confuse with MENORRHAGIA", "MS": "Abnormal uterine bleeding that is not related to MENSTRUATION, usually in females without regular MENSTRUAL CYCLE. The irregular and unpredictable bleeding usually comes from a dysfunctional ENDOMETRIUM.", "PM": "1963; for BREAKTHROUGH BLEEDING & SPOTTING see UTERINE HEMORRHAGE 1980-2005", "HN": "1963; for BREAKTHROUGH BLEEDING & SPOTTING use UTERINE HEMORRHAGE 1980-2005", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D008796"}, {"RECTYPE": "D", "MH": "Metyrapone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methopyrapone|T109|T121|T130|NON|EQV|UNK (19XX)|740330|abbbcdef", "ENTRY": "SU 4885|T109|T121|T130|LAB|NRW|UNK (19XX)|800731|abbbcdef", "MN": "D03.383.725.463", "PA": "Enzyme Inhibitors", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "1-Propanone, 2-methyl-1,2-di-3-pyridinyl-", "RN": "ZS9KD92H6V", "RR": "54-36-4 (Metyrapone)", "MS": "An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.", "PM": "66", "HN": "66(64)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008797"}, {"RECTYPE": "D", "MH": "Mevalonic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Mevalonic", "MN": "D02.241.511.579", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Pentanoic acid, 3,5-dihydroxy-3-methyl-", "RN": "S5UOB36OCZ", "RR": "150-97-0 (Mevalonic Acid)", "MS": "A dihydroxy monocarboxylic acid and precursor in the biosynthetic pathway known as the mevalonate pathway, which produces terpenes and steroids that are vital for diverse cellular functions.", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008798"}, {"RECTYPE": "D", "MH": "Mevinphos", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Phosdrin|T109|T131|TRD|NRW|UNK (19XX)|831020|abbcdef", "MN": "D02.705.400.501", "PA": "Insecticides", "MH_TH": "NLM (1973)", "ST": "T131", "N1": "2-Butenoic acid, 3-((dimethoxyphosphinyl)oxy)-, methyl ester", "RN": "7786-34-7", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "MS": "An organophosphate cholinesterase inhibitor that is used as an insecticide.", "PM": "91; was see under INSECTICIDES, ORGANOPHOSPHATE 1973-90", "HN": "91(73); was see under INSECTICIDES, ORGANOPHOSPHATE 1973-90", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008799"}, {"RECTYPE": "D", "MH": "Mexico", "AQ": "EH EP", "MN": "Z01.107.567.589", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "Indians of Mexico are indexed  MEXICO + INDIANS, NORTH AMERICAN", "MS": "A country in NORTH AMERICA, bordering the Caribbean Sea and the Gulf of Mexico, between BELIZE and the UNITED STATES, and bordering the North Pacific Ocean, between Guatemala and the UNITED STATES.", "MR": "20151216", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008800"}, {"RECTYPE": "D", "MH": "Mexiletine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Novo Mexiletine", "MN": "D02.455.426.559.389.657.654.675", "PA": "Voltage-Gated Sodium Channel Blockers", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Propanamine, 1-(2,6-dimethylphenoxy)-", "RN": "1U511HHV4Z", "RR": "606D60IS38", "PI": "Propylamines (1972-1974)", "MS": "Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.", "PM": "87; was see under PROPYLAMINES 1975-86", "HN": "87(75); was see under PROPYLAMINES 1975-86", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D008801"}, {"RECTYPE": "D", "MH": "Mezlocillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Mezlocillin", "MN": "D03.633.100.300.750.750.050.500", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1976)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(((((3-(methylsulfonyl)-2-oxo-1-imidazolidinyl)carbonyl)amino)phenylacetyl)amino)-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))-", "RN": "OH2O403D1G", "RR": "RX227TP94U", "PI": "Penicillins (1966-1983)", "MS": "Semisynthetic ampicillin-derived acylureido penicillin. It has been proposed for infections with certain anaerobes and may be useful in inner ear, bile, and CNS infections.", "PM": "84", "HN": "84", "MR": "20170524", "DA": "19830404", "DC": "1", "DX": "19840101", "UI": "D008802"}, {"RECTYPE": "D", "MH": "Mianserin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Mianserin", "MN": "D03.633.300.240.550", "PA": "Serotonin Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-", "RN": "250PJI13LM", "RR": "2X03TN217S", "PI": "Pyrazines (1972-1974)", "MS": "A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.", "PM": "87; was see under DIBENZAZEPINES 1975-86", "HN": "87(75); was see under DIBENZAZEPINES 1975-86", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D008803"}, {"RECTYPE": "D", "MH": "Mice, Inbred A", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Inbred A Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.400.300", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mice (1966-1971)", "MS": "An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research.", "PM": "74", "HN": "74(72)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008805"}, {"RECTYPE": "D", "MH": "Mice, Inbred AKR", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Inbred AKR Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.400.318", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mice (1966-1971)", "MS": "An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research.", "PM": "74", "HN": "74(72)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008806"}, {"RECTYPE": "D", "MH": "Mice, Inbred BALB C", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "BALB C Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.400.338", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mice (1966-1971)", "MS": "An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research.", "PM": "74", "HN": "74(72)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008807"}, {"RECTYPE": "D", "MH": "Mice, Inbred CBA", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Inbred CBA Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.400.440", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mice (1966-1971)", "MS": "An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH.", "PM": "74", "HN": "74(72)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008808"}, {"RECTYPE": "D", "MH": "Mice, Inbred C3H", "DS": "MICE INBRED CA03H", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Inbred C3H Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.400.388", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mice (1966-1971)", "MS": "An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research.", "PM": "74", "HN": "74(72)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008809"}, {"RECTYPE": "D", "MH": "Mice, Inbred C57BL", "DS": "MICE INBRED CA57BL", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Inbred C57BL Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.400.420", "FX": "Carcinoma, Lewis Lung", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mice (1966-1971)", "MS": "One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases.", "PM": "74", "HN": "74(72)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008810"}, {"RECTYPE": "D", "MH": "Mice, Inbred DBA", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Inbred DBA Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.400.500", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mice (1966-1971)", "MS": "An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS.", "PM": "74", "HN": "74(72)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008811"}, {"RECTYPE": "D", "MH": "Mice, Hairless", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Mice, hr|T015|NON|NRW|NLM (2009)|080403|abcdef", "ENTRY": "Mouse, Hairless", "MN": "B01.050.150.900.649.313.992.635.505.500.550.230", "MH_TH": "UNK (19XX)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal; do not confuse with MICE, NUDE", "MS": "Mutant strains of mice that produce little or no hair.", "PM": "2009; see MICE, INBRED HRS 1982-2008, see MICE, NUDE 1975-81", "HN": "2009 (1982); use MICE, NUDE 1975-1981", "MR": "20200902", "DA": "19810514", "DC": "1", "DX": "19820101", "UI": "D008812"}, {"RECTYPE": "D", "MH": "Mice, Inbred ICR", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Mice, Inbred ICRC|T015|NRW|NLM (1998)|961011|abdef", "ENTRY": "Inbred ICRC Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.400.510", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mice (1966-1971)", "MS": "An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER.", "PM": "74", "HN": "74(72)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008813"}, {"RECTYPE": "D", "MH": "Mice, Inbred NZB", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "NZB Mouse, Inbred", "MN": "B01.050.150.900.649.313.992.635.505.500.400.580", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mice (1966-1971)", "MS": "An inbred strain of mouse that is widely used as a model for AUTOIMMUNE DISEASES such as SYSTEMIC LUPUS ERYTHEMATOSUS.", "PM": "74", "HN": "74(72)", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008814"}, {"RECTYPE": "D", "MH": "Mice, Inbred Strains", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Strains, Inbred Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.400", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "general or unspecified; prefer specifics; NIM with no qualifiers when experimental animal ", "PI": "Mice (1966-1971)", "MS": "Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation.", "PM": "72", "HN": "72", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008815"}, {"RECTYPE": "D", "MH": "Mice, Jimpy", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Jimpy Mice", "MN": "B01.050.150.900.649.313.992.635.505.500.550.430", "MH_TH": "NLM (1979)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mice, Inbred Strains (1972-1978)", "MS": "Myelin-deficient mutants which are from the inbred Tabby-Jimpy strain.", "PM": "91; was see under MICE, NEUROLOGIC MUTANTS 1979-90", "HN": "91(79); was see under MICE, NEUROLOGIC MUTANTS 1979-90", "MR": "20200902", "DA": "19780320", "DC": "1", "DX": "19910101", "UI": "D008816"}, {"RECTYPE": "D", "MH": "Mice, Mutant Strains", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Strains, Mutant Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.550", "MH_TH": "NLM (1979)", "ST": "T015", "AN": "general or unspecified; prefer specifics; NIM with no qualifiers when experimental animal", "MS": "Mice bearing mutant genes which are phenotypically expressed in the animals.", "PM": "79", "HN": "79", "MR": "20200902", "DA": "19780426", "DC": "1", "DX": "19790101", "UI": "D008817"}, {"RECTYPE": "D", "MH": "Mice, Neurologic Mutants", "DE": "MICE NEUROL MUTANTS", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Weaver Mice|T015|NON|NRW|UNK (19XX)|780517|abcdef", "ENTRY": "Neurologic Mutant Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.550.480", "MH_TH": "NLM (1979)", "ST": "T015", "AN": "NIM no qualifiers when experimental animal; check the tag MICE", "PI": "Mice, Inbred Strains (1972-1978)", "MS": "Mice which carry mutant genes for neurologic defects or abnormalities.", "PM": "79", "HN": "79", "MR": "20200902", "DA": "19780517", "DC": "1", "DX": "19790101", "UI": "D008818"}, {"RECTYPE": "D", "MH": "Mice, Nude", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Nude Mice|T015|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Nude Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.550.500", "MH_TH": "NLM (1975)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal; do not confuse with MICE, HAIRLESS", "PI": "Mice (1966-1974)", "MS": "Mutant mice homozygous for the recessive gene \"nude\" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.", "PM": "75", "HN": "75", "MR": "20200902", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D008819"}, {"RECTYPE": "D", "MH": "Mice, Obese", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Obese Mice|T015|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Obese Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.550.530", "MH_TH": "NLM (1975)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal; for entry terms HYPERGLYCEMIC MICE and OBESE MICE, do not add HYPERGLYCEMIA or OBESITY unless particularly discussed as diseases", "PI": "Mice (1966-1974)", "MS": "Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid.", "PM": "75", "HN": "75", "MR": "20200902", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D008820"}, {"RECTYPE": "D", "MH": "Mice, Quaking", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Quaking Mice", "MN": "B01.050.150.900.649.313.992.635.505.500.550.560", "MH_TH": "NLM (1978)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mutation (1966-1977)", "MS": "Mice homozygous for the mutant autosomal recessive gene, quaking (qk), associated with disorder in myelin formation and manifested by axial tremors.", "PM": "78", "HN": "78", "MR": "20200902", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D008821"}, {"RECTYPE": "D", "MH": "Mice, Transgenic", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Transgenic Mice|T015|NON|EQV|UNK (19XX)|870508|abcdef", "ENTRY": "Transgenic Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.800", "MH_TH": "NLM (1988)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal; check the tag MICE; for transgenic founder mice, coordinate with FOUNDER EFFECT", "MS": "Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.", "PM": "88", "HN": "88", "MR": "20200902", "DA": "19870508", "DC": "1", "DX": "19880101", "UI": "D008822"}, {"RECTYPE": "D", "MH": "Micelles", "PRINT ENTRY": "Micelle|T167|NON|EQV|NLM (2021)|191126|abcdef", "MN": "D26.255.560", "FX": "Emulsions", "MH_TH": "NLM (1975)", "ST": "T167", "RN": "0", "PI": "Colloids (1968-1974)", "MS": "Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS.", "PM": "91; was see under COLLOIDS 1975-90", "HN": "91(75); was see under COLLOIDS 1975-90", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008823"}, {"RECTYPE": "D", "MH": "Michigan", "AQ": "EH EP", "MN": "Z01.107.567.875.510.500", "MH_TH": "NLM (1998)", "ST": "T083", "MS": "State bounded on the north by the Great Lakes, on the east by Canada, on the south by Wisconsin, Indiana, and Ohio, and on the west by Lake Michigan and Wisconsin.", "MR": "20160608", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008824"}, {"RECTYPE": "D", "MH": "Miconazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R14,889", "MN": "D03.383.129.308.550", "PA": "Cytochrome P-450 CYP3A Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-", "RN": "7NNO0D7S5M", "RR": "VW4H1CYW1K", "PI": "Imidazoles (1971-1974)", "MS": "An imidazole antifungal agent that is used topically and by intravenous infusion.", "PM": "1984; see IMIDAZOLES 1975-1983, MONISTAT was indexed under IMIDAZOLES 2004-2010", "HN": "1984(1975); for MONISTAT use TIOCONAZOLE (NM) 2004-2010", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D008825"}, {"RECTYPE": "D", "MH": "Microbial Sensitivity Tests", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Minimum Inhibitory Concentration|T059|NON|NRW|NLM (1998)|960712|abcdef", "ENTRY": "Tests, Microbial Sensitivity", "MN": "E05.337.550.400", "FX": "Parasitic Sensitivity Tests", "MH_TH": "NLM (1970)", "ST": "T059", "AN": "IM when general; NIM when with specific drug (IM) & specific micro-organisms (IM); note entry term MINIMUM INHIBITORY CONCENTRATION but bactericidal effect of an antimicrobial drug using patient's blood (= SERUM BACTERICIDAL TEST + specific drug); PARASITIC SENSITIVITY TESTS is also available", "PI": "Drug Resistance, Microbial (1966-1969)", "MS": "Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20110701", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D008826"}, {"RECTYPE": "D", "MH": "Microbiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Microbiological Processes|T070|NON|NRW|NLM (2009)|080317|abcdef", "ENTRY": "Processes, Microbiological", "MN": "G06", "RH": "G6 - MICROBIOLOGICAL PHENOMENA", "FX": "Dysbiosis", "MH_TH": "UNK (19XX)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "Physiological processes and properties of microorganisms, such as ARCHAEA; BACTERIA; RICKETTSIA; VIRUSES; and FUNGI.", "PM": "2009; see MICROBIOLOGIC PHENOMENA 1998-2008; for MICROBIOLOGICAL PROCESSES see 2009-2016", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D008827"}, {"RECTYPE": "D", "MH": "Microbiological Techniques", "DE": "MICROBIOL TECHNIQUES", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Techniques, Microbiological", "MN": "E05.200.875", "MH_TH": "NLM (1978)", "ST": "T059", "PI": "Parasitology (1966-1977)", "MS": "Techniques used in microbiology.", "OL": "use MICROBIOLOGICAL TECHNIQUES to search MICROBIOLOGICAL TECHNICS 1978-90", "PM": "91; was MICROBIOLOGICAL TECHNICS 1978-90", "HN": "91; was MICROBIOLOGICAL TECHNICS 1978-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19770301", "DC": "1", "DX": "19780101", "UI": "D008828"}, {"RECTYPE": "D", "MH": "Microbiology", "DE": "MICROBIOL", "AQ": "CL EC ED ES HI IS LJ OG SN ST TD", "MN": "H01.158.273.540", "FX": "Viruses", "EC": "methods:Microbiological Techniques", "MH_TH": "BIOETHICS (1979)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use MICROBIOLOGICAL PHENOMENA or specifics treed under it for physiologic characteristics and processes of microorganisms, or the qualifier /microbiol with specific anatomical terms, organisms and diseases", "MS": "The study of microorganisms such as fungi, bacteria, algae, archaea, and viruses.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008829"}, {"RECTYPE": "D", "MH": "Microbodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Glycosomes|T026|NON|NRW|NLM (2001)|000508|abcdef", "ENTRY": "Microbody", "MN": "A11.284.430.214.190.875.190.190.755", "MH_TH": "NLM (1973)", "ST": "T026", "PI": "Organoids (1966-1972)", "MS": "Electron-dense cytoplasmic particles bounded by a single membrane, such as PEROXISOMES; GLYOXYSOMES; and glycosomes.", "PM": "84; was see under ORGANOIDS 1975-83", "HN": "84(73); was see under ORGANOIDS 1975-83", "MR": "20050722", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D008830"}, {"RECTYPE": "D", "MH": "Microcephaly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Microlissencephaly|T047|NON|REL|NLM (2008)|061017|abcdef", "ENTRY": "Severe Congenital Microcephalies", "MN": "C16.131.666.507.400.500", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A congenital abnormality in which the CEREBRUM is underdeveloped, the fontanels close prematurely, and, as a result, the head is small. (Desk Reference for Neuroscience, 2nd ed.)", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008831"}, {"RECTYPE": "D", "MH": "Microchemistry", "DE": "MICROCHEM", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.181.650", "FX": "Nanotechnology", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "The development and use of techniques and equipment to study or perform chemical reactions, with small quantities of materials, frequently less than a milligram or a milliliter.", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008832"}, {"RECTYPE": "D", "MH": "Microcirculation", "DE": "MICROCIRC", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Microvascular Circulation|T042|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Microvascular Circulations", "MN": "G09.330.100.645", "MH_TH": "NLM (1970)", "ST": "T042", "PI": "Capillaries (1966-1969)", "MS": "The circulation of the BLOOD through the MICROVASCULAR NETWORK.", "PM": "72", "HN": "72(70)", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008833"}, {"RECTYPE": "D", "MH": "Microclimate", "ENTRY": "Microclimates", "MN": "N06.230.300.100.250.450", "MH_TH": "NLM (1975)", "ST": "T070", "MS": "The climate of a very small area.", "PM": "91; was see under CLIMATE 1975-90", "HN": "91(75); was see under CLIMATE 1975-90", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D008834"}, {"RECTYPE": "D", "MH": "Micrococcaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.500", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid1268", "PI": "Bacteria (1966-1974)", "MS": "A family of bacteria ranging from free living and saprophytic to parasitic and pathogenic forms.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D008835"}, {"RECTYPE": "D", "MH": "Micrococcal Nuclease", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Staphylococcal Nuclease|T116|T126|NON|EQV|UNK (19XX)|741018|STAPH NUCLEASE|abbcdefv", "ENTRY": "Nuclease, Thermostable", "MN": "D08.811.277.352.700.350.500", "MH_TH": "NLM (1965)", "ST": "T126", "RN": "EC 3.1.31.1", "MS": "An enzyme that catalyzes the endonucleolytic cleavage to 3'-phosphomononucleotide and 3'-phospholigonucleotide end-products. It can cause hydrolysis of double- or single-stranded DNA or RNA. (From Enzyme Nomenclature, 1992) EC 3.1.31.1.", "PM": "73", "HN": "73(65)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008836"}, {"RECTYPE": "D", "MH": "Micrococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.500.500", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1269", "AN": "found in soil & fresh water & on mammalian skin", "MS": "A genus of gram-positive, spherical bacteria found in soils and fresh water, and frequently on the skin of man and other animals.", "OL": "use MICROCOCCUS to search GAFFKYA TETRAGENA 1979-91 & GAFFKYA 1966-78", "PM": "GAFFKYA TETRAGENA was see MICROCOCCUS 1979-91; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75", "HN": "GAFFKYA TETRAGENA was see MICROCOCCUS 1979-91; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008837"}, {"RECTYPE": "D", "MH": "Microcomputers", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Microprocessors|T073|NON|NRW|UNK (19XX)|790531|abcdef", "ENTRY": "Personal Computers", "MN": "L01.224.230.260.550", "MH_TH": "POPLINE (1987)", "ST": "T073", "AN": "do not confuse with MINICOMPUTERS", "PI": "Computers (1966-1979)", "MS": "Small computers using LSI (large-scale integration) microprocessor chips as the CPU (central processing unit) and semiconductor memories for compact, inexpensive storage of program instructions and data. They are smaller and less expensive than minicomputers and are usually built into a dedicated system where they are optimized for a particular application. \"Microprocessor\" may refer to just the CPU or the entire microcomputer.", "PM": "89; was see under COMPUTERS 1980-88", "HN": "89(80); was see under COMPUTERS 1980-88", "MR": "20170703", "DA": "19790531", "DC": "1", "DX": "19890101", "UI": "D008838"}, {"RECTYPE": "D", "MH": "Microelectrodes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Electrodes, Miniaturized|T073|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Miniaturized Electrodes", "MN": "E07.305.250.500", "MH_TH": "NLM (1971)", "ST": "T073", "AN": "NIM", "PI": "Electrodes (1968-1970)", "MS": "Electrodes with an extremely small tip, used in a voltage clamp or other apparatus to stimulate or record bioelectric potentials of single cells intracellularly or extracellularly. (Dorland, 28th ed)", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008839"}, {"RECTYPE": "D", "MH": "Microfilament Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Microfilament Protein|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Proteins, Microfilament", "MN": "D12.776.220.525", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "MS": "Monomeric subunits of primarily globular ACTIN and found in the cytoplasmic matrix of almost all cells. They are often associated with microtubules and may play a role in cytoskeletal function and/or mediate movement of the cell or the organelles within the cell.", "PM": "85", "HN": "85", "MR": "20200527", "DA": "19840611", "DC": "1", "DX": "19850101", "UI": "D008840"}, {"RECTYPE": "D", "MH": "Actin Cytoskeleton", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Microfilaments|T026|NON|EQV|NLM (1986)|990101|abcdef", "ENTRY": "Microfilaments, Actin", "MN": "A11.284.430.214.190.750.050", "MH_TH": "NLM (2012)", "ST": "T026", "PI": "Cytoskeleton (1977-1985)", "MS": "Fibers composed of MICROFILAMENT PROTEINS, which are predominately ACTIN. They are the smallest of the cytoskeletal filaments.", "PM": "2012; see MICROFILAMENTS 1991-2011, see CYTOSKELETON 1986-1990, see CYTOPLASMIC FILAMENTS 1980-1985, see CYTOPLASM 1977-1979", "HN": "2012 (1977); use CYTOPLASMIC FILAMENTS 1980-1985", "MR": "20130708", "DA": "19850225", "DC": "1", "DX": "19910101", "UI": "D008841"}, {"RECTYPE": "D", "MH": "Microfilariae", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Microfilaria|T204|NON|EQV|NLM (1975)|990101|abcdef", "MN": "B05.525", "MH_TH": "NLM (2017)", "ST": "T204", "AN": "coordinate with specific helminth terms (ANTIGENS, HELMINTH, etc.) if pertinent", "MS": "The prelarval stage of Filarioidea found in the blood and tissues of mammals, birds and intermediate hosts (vector).", "OL": "search FILARIOIDEA 1966-74", "PM": "91; was see under FILARIOIDEA 1975-90", "HN": "91(75); was see under FILARIOIDEA 1975-90", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008842"}, {"RECTYPE": "D", "MH": "Microfilming", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Microfilmings", "MN": "L01.280.630", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "Process of capturing very reduced images for preservation and storage.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008843"}, {"RECTYPE": "D", "MH": "Micrognathism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Micrognathisms, Mandibular", "MN": "C16.131.850.500.460.457", "MH_TH": "NLM (1964)", "ST": "T019", "AN": "abnormally small jaw; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Abnormally small jaw.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008844"}, {"RECTYPE": "D", "MH": "Microinjections", "DE": "MICROINJECT", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Microinjection", "MN": "E05.591.570", "MH_TH": "NLM (1973)", "ST": "T061", "PI": "Injections (1966-1972)", "MS": "The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008845"}, {"RECTYPE": "D", "MH": "Micromanipulation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Micromanipulations", "MN": "E05.591", "FX": "Microchip Analytical Procedures", "MH_TH": "NLM (1964)", "ST": "T059", "MS": "The performance of dissections, injections, surgery, etc., by the use of micromanipulators (attachments to a microscope) that manipulate tiny instruments.", "PM": "73", "HN": "73(64)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008846"}, {"RECTYPE": "D", "MH": "Micromonospora", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Micromonospora echinospora|T007|NON|NRW|NLM (2020)|190219|abcdef", "MN": "B03.510.460.410.500.500", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1873", "RR": "txid1877", "AN": "in soil; a genus: do not confuse with the family MICROMONOSPORACEAE", "MS": "A genus of gram-positive bacteria that forms a branched mycelium. It commonly occurs as a saprophytic form in soil and aquatic environments.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008847"}, {"RECTYPE": "D", "MH": "Micromonosporaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.500", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid28056", "PI": "Streptomycetaceae (1975)", "MS": "A family of gram-positive, saprophytic bacteria occurring in soil and aquatic environments.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750721", "DC": "1", "DX": "19760101", "UI": "D008848"}, {"RECTYPE": "D", "MH": "Micronesia", "AQ": "EH EP", "PRINT ENTRY": "Tuvalu|T083|NAM|REL|POPLINE (1981)|921123|abcdef", "ENTRY": "Pacific Islands (Trust Territory)|T083|NAM|NRW|NLM (1994)|930108|abcdef", "MN": "Z01.639.760.680", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "a group of islands east of the Philippines; includes Christmas Island; of the entry term MARIANA ISLANDS; GUAM is available; PALAU is also available", "MS": "The collective name for islands of the Pacific Ocean east of the Philippines, including the Mariana, PALAU, Caroline, Marshall, and Kiribati Islands. (From Webster's New Geographical Dictionary, 1988, p761 & Room, Brewer's Dictionary of Names, 1992, p350)", "HN": "68", "MR": "20130709", "DA": "19990101", "DC": "4", "DX": "19680101", "UI": "D008849"}, {"RECTYPE": "D", "MH": "Microphthalmos", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Microphthalmia|T019|NON|EQV|GHR (2014)|NLM (2010)|090407|abcdeef", "MN": "C16.131.384.666", "MH_TH": "NLM (1964)", "ST": "T019", "AN": "abnormally small eyeball; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Congenital or developmental anomaly in which the eyeballs are abnormally small.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008850"}, {"RECTYPE": "D", "MH": "Micropore Filters", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Millipore Filter", "MN": "E07.560", "MH_TH": "NLM (1972)", "ST": "T073", "AN": "includes millipore filters", "PI": "Filtration (1966-1971)", "MS": "A membrane or barrier with micrometer sized pores used for separation purification processes.", "PM": "73", "HN": "73(72)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008851"}, {"RECTYPE": "D", "MH": "Microradiography", "DE": "MICRORADIOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Microradiographies", "MN": "E01.370.350.700.510", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Production of a radiographic image of a small or very thin object on fine-grained photographic film under conditions which permit subsequent microscopic examination or enlargement of the radiograph at linear magnifications of up to several hundred and with a resolution approaching the resolving power of the photographic emulsion (about 1000 lines per millimeter).", "CATSH": "CAT LIST", "MR": "20160311", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008852"}, {"RECTYPE": "D", "MH": "Microscopy", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Microscopy, Simple", "MN": "H01.671.617.562", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "do not index here routinely for histol & cytol studies: Manual 26.12+", "MS": "The use of instrumentation and techniques for visualizing material and details that cannot be seen by the unaided eye. It is usually done by enlarging images, transmitted by light or electron beams, with optical or magnetic lenses that magnify the entire image field. With scanning microscopy, images are generated by collecting output from the specimen in a point-by-point fashion, on a magnified scale, as it is scanned by a narrow beam of light or electrons, a laser, a conductive probe, or a topographical probe.", "CATSH": "CAT LIST", "MR": "20170712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008853"}, {"RECTYPE": "D", "MH": "Microscopy, Electron", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Electron Microscopy|T059|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "E05.595.402", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "general or unspecified; prefer specifics", "MS": "Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen.", "CATSH": "CAT LIST", "MR": "20040728", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008854"}, {"RECTYPE": "D", "MH": "Microscopy, Electron, Scanning", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Scanning Electron Microscopy|T059|NON|EQV|NLM (1991)|900323|abcdef", "ENTRY": "Scanning Microscopy, Electron", "MN": "E05.595.402.541", "FX": "Corrosion Casting", "MH_TH": "NLM (1969)", "ST": "T059", "AN": "do not confuse with MICROSCOPY, ELECTRON, SCANNING TRANSMISSION or STEM", "PI": "Microscopy, Electron (1966-1968)", "MS": "Microscopy in which the object is examined directly by an electron beam scanning the specimen point-by-point. The image is constructed by detecting the products of specimen interactions that are projected above the plane of the sample, such as backscattered electrons. Although SCANNING TRANSMISSION ELECTRON MICROSCOPY also scans the specimen point by point with the electron beam, the image is constructed by detecting the electrons, or their interaction products that are transmitted through the sample plane, so that is a form of TRANSMISSION ELECTRON MICROSCOPY.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "20160208", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008855"}, {"RECTYPE": "D", "MH": "Microscopy, Fluorescence", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Microscopy, Immunofluorescence|T059|NON|NRW|NLM (1991)|900323|abcdef", "ENTRY": "Microscopies, Immunofluorescence", "MN": "E05.595.458", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "NIM", "MS": "Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008856"}, {"RECTYPE": "D", "MH": "Microscopy, Interference", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Microinterferometry|T059|NON|EQV|UNK (19XX)|760410|abcdef", "ENTRY": "Reflection Microscopy, Interference", "MN": "E05.595.513", "MH_TH": "NLM (1964)", "ST": "T059", "MS": "The science and application of a double-beam transmission interference microscope in which the illuminating light beam is split into two paths. One beam passes through the specimen while the other beam reflects off a reference mirror before joining and interfering with the other. The observed optical path difference between the two beams can be measured and used to discriminate minute differences in thickness and refraction of non-stained transparent specimens, such as living cells in culture.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20040728", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008857"}, {"RECTYPE": "D", "MH": "Microscopy, Phase-Contrast", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Phase-Contrast Microscopy|T059|NON|EQV|NLM (1991)|900327|abcdef", "ENTRY": "Phase-Contrast Microscopies", "MN": "E05.595.513.569", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "NIM", "MS": "A form of interference microscopy in which variations of the refracting index in the object are converted into variations of intensity in the image. This is achieved by the action of a phase plate.", "OL": "use MICROSCOPY, PHASE-CONTRAST to search MICROSCOPY, PHASE CONTRAST 1966-90", "PM": "91; was MICROSCOPY, PHASE CONTRAST 1963-90", "HN": "91; was MICROSCOPY, PHASE CONTRAST 1963-90", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008858"}, {"RECTYPE": "D", "MH": "Microscopy, Polarization", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Polarization Microscopy|T059|NON|EQV|NLM (1991)|900327|abcdef", "ENTRY": "Polarized Light Microscopy", "MN": "E05.595.624", "MH_TH": "NLM (1964)", "ST": "T059", "AN": "NIM", "MS": "Microscopy using polarized light in which phenomena due to the preferential orientation of optical properties with respect to the vibration plane of the polarized light are made visible and correlated parameters are made measurable.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008859"}, {"RECTYPE": "D", "MH": "Microscopy, Ultraviolet", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ultraviolet Microscopy|T059|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Ultraviolet Microscopies", "MN": "E05.595.680", "MH_TH": "NLM (1973)", "ST": "T059", "AN": "NIM", "PI": "Ultraviolet Rays (1966-1972)", "MS": "Microscopy in which the image is formed by ultraviolet radiation and is displayed and recorded by means of photographic film.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008860"}, {"RECTYPE": "D", "MH": "Microsomes", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Microsome", "MN": "A11.284.835.540", "MH_TH": "NLM (1964)", "ST": "T026", "MS": "Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)", "PM": "65", "HN": "65(64)", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008861"}, {"RECTYPE": "D", "MH": "Microsomes, Liver", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Liver Microsomes|T026|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Microsome, Liver", "MN": "A11.284.835.540.541", "MH_TH": "NLM (1970)", "ST": "T026", "PI": "Microsomes (1966-1969)", "MS": "Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough.", "PM": "70", "HN": "70", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D008862"}, {"RECTYPE": "D", "MH": "Microspheres", "PRINT ENTRY": "Latex Spheres|T073|NON|NRW|NLM (1998)|961011|abcdef", "ENTRY": "Spheres, Latex", "MN": "E07.565", "FX": "Microplastics", "MH_TH": "NLM (1972)", "ST": "T073", "AN": "note entry terms: do not coord with LATEX unless particularly discussed; note MICROCAPSULES see CAPSULES: do not coord with MICROSPHERES", "MS": "Small uniformly-sized spherical particles, of micrometer dimensions, frequently labeled with radioisotopes or various reagents acting as tags or markers.", "OL": "use MICROSPHERES + LATEX to search LATEX PARTICLES 1968-80", "PM": "74; LATEX PARTICLES was heading 1968-80", "HN": "74(72); LATEX PARTICLES was heading 1968-80", "CATSH": "CAT LIST", "MR": "20200409", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008863"}, {"RECTYPE": "D", "MH": "Microsporum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Microsporon|T004|NON|EQV|NLM (1999)|980115|abcdef", "ENTRY": "Microsporums", "MN": "B01.300.381.560", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid34392", "AN": "do not confuse with the phylum MICROSPORIDIA, the class MICROSPOREA, nor with the order MICROSPORIDA; infection: coordinate IM with DERMATOMYCOSES (IM) or specific (IM); do not confuse with MICROSPORIDIOSIS", "MS": "A mitosporic Oxygenales fungal genus causing various diseases of the skin and hair. The species Microsporum canis produces TINEA CAPITIS and tinea corporis, which usually are acquired from domestic cats and dogs. Teleomorphs includes Arthroderma (Nannizzia). (Alexopoulos et al., Introductory Mycology, 4th edition, p305)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008864"}, {"RECTYPE": "D", "MH": "Microstomia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Microstomias", "MN": "C16.131.850.525.520", "MH_TH": "NLM (1971)", "ST": "T019", "AN": "unusually small mouth; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Mouth Diseases (1966-1970)", "MS": "A congenital defect in which the mouth is unusually small. (Dorland, 27th ed)", "PM": "91; was see under MOUTH DISEASES 1971-90", "HN": "91(71); was see under MOUTH DISEASES 1971-90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008865"}, {"RECTYPE": "D", "MH": "Microsurgery", "DE": "MICROSURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "MN": "E05.591.580", "FX": "Microdissection", "MH_TH": "POPLINE (1981)", "ST": "T061", "PI": "Surgical Procedures, Operative (1966-1968)", "MS": "The performance of surgical procedures with the aid of a microscope.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008866"}, {"RECTYPE": "D", "MH": "Microtomy", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Ultramicrotomy|T059|NON|NRW|NLM (1992)|901029|abcdef", "ENTRY": "Thin Sectionings", "MN": "E05.200.750.600.530", "MH_TH": "NLM (1966)", "ST": "T059", "MS": "The technique of using a microtome to cut thin or ultrathin sections of tissues embedded in a supporting substance. The microtome is an instrument that hold a steel, glass or diamond knife in clamps at an angle to the blocks of prepared tissues, which it cuts in sections of equal thickness.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008867"}, {"RECTYPE": "D", "MH": "Microtubule Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Microtubule", "MN": "D12.776.220.600", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "AN": "/biosyn /drug eff /physiol permitted; TUBULIN is available", "PI": "Tubulin (1975-1984)", "MS": "Proteins found in the microtubules.", "PM": "85", "HN": "85", "MR": "20050630", "DA": "19840525", "DC": "1", "DX": "19850101", "UI": "D008868"}, {"RECTYPE": "D", "MH": "Microtubule-Associated Proteins", "DE": "MICROTUBULE ASSOC PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Microtubule-Associated Protein 7|T116|T123|NON|NRW|NLM (2023)|220408|abbcdef", "ENTRY": "Protein, Microtubule-Associated", "MN": "D12.776.631.560", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "PI": "Proteins (1966-1984)", "MS": "High molecular weight proteins found in the MICROTUBULES of the cytoskeletal system. Under certain conditions they are required for TUBULIN assembly into the microtubules and stabilize the assembled microtubules.", "PM": "1985; for MICROTUBULE-ASSOCIATED PROTEIN 7 use MICROTUBULE-ASSOCIATED PROTEINS 1993-2022", "HN": "1985; for MICROTUBULE-ASSOCIATED PROTEIN 7 use MICROTUBULE-ASSOCIATED PROTEINS 1993-2022", "MR": "20220713", "DA": "19840611", "DC": "1", "DX": "19850101", "UI": "D008869"}, {"RECTYPE": "D", "MH": "Microtubules", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Microtubule", "MN": "A11.284.430.214.190.750.602", "FX": "Tubulin Modulators", "MH_TH": "NLM (1970)", "ST": "T026", "PI": "Organoids (1966-1969)", "MS": "Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS.", "PM": "72", "HN": "72(70)", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D008870"}, {"RECTYPE": "D", "MH": "Microvilli", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Striated Border|T026|NON|BRD|UNK (19XX)|770426|abcdef", "ENTRY": "Striated Borders", "MN": "A11.284.180.565", "MH_TH": "NLM (1978)", "ST": "T026", "AN": "coordinate with specific cell / ultrastruct", "PI": "Kidney Tubules, Proximal (1973-1977)", "MS": "Minute projections of cell membranes which greatly increase the surface area of the cell.", "PM": "84; was see under CELL MEMBRANE 1978-83", "HN": "84(78); was see under CELL MEMBRANE 1978-83", "MR": "20140613", "DA": "19770427", "DC": "1", "DX": "19840101", "UI": "D008871"}, {"RECTYPE": "D", "MH": "Microwaves", "AQ": "AE CL HI TU", "PRINT ENTRY": "Ultrahigh Frequency Waves|T070|NON|NRW|NLM (1998)|961202|UHF WAVES|abcdefv", "ENTRY": "Waves, Micro", "MN": "G01.750.770.721.500", "FX": "Diathermy", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "/ther use: coordinate with RADIOFREQUENCY THERAPY", "MS": "That portion of the electromagnetic spectrum from the UHF (ultrahigh frequency) radio waves and extending into the INFRARED RAYS frequencies.", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008872"}, {"RECTYPE": "D", "MH": "Mid-Atlantic Region", "AQ": "EH EP", "PRINT ENTRY": "Middle Atlantic States|T083|NAM|EQV|NLM (1990)|890426|abcdef", "ENTRY": "Mid Atlantic Region|T083|NAM|EQV|NLM (1990)|890405|abcdef", "MN": "Z01.107.567.875.500", "MH_TH": "NLM (1975)", "ST": "T083", "AN": "index specific states as needed but use MID-ATLANTIC REGION when text uses the term & when the region is the intent of the author; CATALOGER: Use for 4 or more states", "MS": "A geographical area of the United States comprising the District of Columbia, Delaware, Maryland, New Jersey, New York, and Pennsylvania.", "OL": "use MID-ATLANTIC REGION to search MID ATLANTIC REGION 1975-89", "HN": "90; was MID ATLANTIC REGION 1975-89", "MR": "20150605", "DA": "19990101", "DC": "4", "DX": "19750101", "UI": "D008873"}, {"RECTYPE": "D", "MH": "Midazolam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro 213981", "MN": "D03.633.100.079.080.575", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4H-Imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-", "RN": "R60L0SM5BC", "RR": "W7TTW573JJ", "PI": "Benzodiazepines (1975-1986)", "MS": "A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.", "PM": "87", "HN": "87", "MR": "20160531", "DA": "19860409", "DC": "1", "DX": "19870101", "UI": "D008874"}, {"RECTYPE": "D", "MH": "Middle Aged", "AQ": "PH PX", "ENTRY": "Middle Age|T079|NON|REL|NLM (1999)|990101|abcdef", "MN": "M01.060.116.630", "MH_TH": "NLM (1986)", "ST": "T100", "AN": "IM as psychological or sociological entity; NIM as check tag ", "MS": "An adult aged 45 - 64 years.", "HN": "2004(1966); was MIDDLE AGE 1966-2003", "MR": "20171211", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D008875"}, {"RECTYPE": "D", "MH": "Middle Ear Ventilation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Ventilation, Middle Ear|T061|NON|EQV|UNK (19XX)|820422|abcdef", "ENTRY": "Ventilations, Middle Ear", "MN": "E04.580.450.472", "FX": "Tympanocentesis", "MH_TH": "NLM (1983)", "ST": "T061", "PI": "Tympanic Membrane (1966-1982)", "MS": "Ventilation of the middle ear in the treatment of secretory (serous) OTITIS MEDIA, usually by placement of tubes or grommets which pierce the TYMPANIC MEMBRANE.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19820422", "DC": "1", "DX": "19830101", "UI": "D008876"}, {"RECTYPE": "D", "MH": "Middle East", "AQ": "EH EP", "PRINT ENTRY": "West Bank|T083|NAM|NRW|NLM (1996)|950221|abcdef", "ENTRY": "Gaza Strip (Palestine)|T083|NAM|NRW|NLM (1983)|930108|abcdef", "MN": "Z01.252.245.500", "MH_TH": "NLM (1982)", "ST": "T083", "PI": "specific Middle East country (1966-1981)", "MS": "The region of southwest Asia and northeastern Africa usually considered as extending from Libya on the west to Afghanistan on the east. (From Webster's New Geographical Dictionary, 1988)", "OL": "use ASIA, WESTERN to search NEAR EAST 1994-95", "HN": "82; NEAR EAST was see ASIA, WESTERN 1994-95", "MR": "20161222", "DA": "19810224", "DC": "4", "DX": "19820101", "UI": "D008877"}, {"RECTYPE": "D", "MH": "Middle Lobe Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Brock's Syndrome|T047|EPO|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Syndromes, Middle Lobe", "MN": "C08.381.730.542", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "atelectasis of middle lobe of right lung", "MS": "Atelectasis of the right middle pulmonary lobe, with chronic pneumonitis. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008878"}, {"RECTYPE": "D", "MH": "Midodrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ST1085", "MN": "D02.092.063.291.480", "PA": "Vasoconstrictor Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-", "RN": "6YE7PBM15H", "RR": "59JV96YTXV", "PI": "Hydroquinones (1973-1974)", "MS": "An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.", "PM": "96; was MIDODRIN 1975-95 (see under ETHANOLAMINES 1975-90)", "HN": "96; was MIDODRIN 1975-95 (see under ETHANOLAMINES 1975-90)", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008879"}, {"RECTYPE": "D", "MH": "Midwifery", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Traditional Birth Attendant|T097|NON|REL|UNK (19XX)|750619|abcdef", "ENTRY": "Traditional Birth Attendants", "MN": "H02.478.676.416", "FX": "Nurse Midwives", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "The practice of assisting women in childbirth.", "PM": "66; was MIDWIVES 1963-65", "HN": "66; was MIDWIVES 1963-65", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008880"}, {"RECTYPE": "D", "MH": "Migraine Disorders", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Status Migrainosus|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Variants, Migraine", "MN": "C10.228.140.546.399.750", "MH_TH": "NLM (2006)", "ST": "T047", "AN": "note many specifics; use word of text", "MS": "A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)", "PM": "2006; see MIGRAINE 1963-2005", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D008881"}, {"RECTYPE": "D", "MH": "Mikulicz' Disease", "DE": "MIKULICZ DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mikulicz's Disease|T047|EPO|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Mikuliczs Disease", "MN": "C07.465.815.355", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "an inflamm dis of the lacrimal & salivary glands", "MS": "A chronic, benign, and usually painless inflammatory swelling of the lacrimal and salivary glands. It is considered by some to include the glandular enlargement associated with other diseases, such as Sjogren's syndrome, sarcoidosis, lupus erythematosus, etc.", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008882"}, {"RECTYPE": "D", "MH": "Miliaria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Miliaria Rubra|T047|NON|NRW|NLM (1993)|920407|abcdef", "ENTRY": "Heat, Prickly", "MN": "C17.800.946.492", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a sweat gland dis", "MS": "A syndrome of cutaneous changes associated with sweat retention and extravasation of sweat at different levels in the skin. Miliaria rubra, or prickly heat, results from apocrine duct obstruction. The sweat then seeps into the epidermis, producing pruritic erythematous papulovesicles. (From Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008883"}, {"RECTYPE": "D", "MH": "Milieu Therapy", "DE": "MILIEU THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Situational Therapy|T061|NON|EQV|NLM (1992)|901228|SITUATIONAL THER|abcdefv", "ENTRY": "Therapies, Situational", "MN": "F04.754.864.392", "MH_TH": "NLM (1967)", "ST": "T061", "PI": "Psychotherapy (1966)", "MS": "A treatment program based on manipulation of the patient's environment by the medical staff. The patient does not participate in planning the treatment regimen.", "OL": "use SOCIOENVIRONMENTAL THERAPY to search SITUATIONAL THERAPY 1973-91", "PM": "69; SITUATIONAL THERAPY was see SOCIOENVIRONMENTAL THERAPY 1979-91, was see under SOCIOENVIRONMENTAL THERAPY 1973-78", "HN": "69(67); SITUATIONAL THERAPY was see SOCIOENVIRONMENTAL THERAPY 1979-91, was see under SOCIOENVIRONMENTAL THERAPY 1973-78", "CATSH": "CAT LIST", "MR": "19950531", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D008884"}, {"RECTYPE": "D", "MH": "Military Dentistry", "DE": "MILITARY DENT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Military Dentistries", "MN": "H02.163.592", "MH_TH": "NLM (1965)", "ST": "T091", "AN": "specify country", "MS": "The practice of dentistry as applied to special circumstances associated with military operations.", "PM": "65", "HN": "65", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008885"}, {"RECTYPE": "D", "MH": "Military Hygiene", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Hygiene, Military", "MN": "N06.850.670.300", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "Science dealing with the maintenance of health in servicemen.", "MR": "20151130", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008886"}, {"RECTYPE": "D", "MH": "Military Medicine", "DE": "MILITARY MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Military|T091|NON|EQV|NLM (1991)|891204|MED MILITARY|abcdefv", "MN": "H02.403.500", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty only; specify country; Uniformed Services University of the Health Sciences, under US Dept. of Defense, goes under SCHOOLS, MEDICAL + UNITED STATES ", "MS": "The practice of medicine as applied to special circumstances associated with military operations.", "MR": "20190529", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008887"}, {"RECTYPE": "D", "MH": "Military Nursing", "DE": "MILITARY NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Nursing, Military and Naval|T091|NON|BRD|UNK (19XX)|740330|NURS MILITARY NAVAL|abcdefv", "ENTRY": "Nursings, Military", "MN": "H02.478.676.458", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specify country", "MS": "The practice of nursing in military environments.", "MR": "20140616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008888"}, {"RECTYPE": "D", "MH": "Military Personnel", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Submariners|T097|NON|NRW|NLM (1998)|961202|abcdef", "ENTRY": "Submariner", "MN": "M01.526.625", "FX": "Veterans", "MH_TH": "POPLINE (1986)", "ST": "T097", "AN": "their physiology & diseases go here: reserve MILITARY MEDICINE for the specialty; includes all uniformed personnel: note entry terms; /\u200cpsychol: consider also the specialties PSYCHOLOGY, MILITARY & MILITARY PSYCHIATRY; specify country", "MS": "Persons including soldiers involved with the armed forces.", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008889"}, {"RECTYPE": "D", "MH": "Military Psychiatry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Psychiatry, Military|T091|NON|EQV|UNK (19XX)|790529|abcdef", "MN": "H02.403.690.508", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty only; not for MENTAL DISORDERS in soldiers, etc.", "MS": "Branch of psychiatry concerned with problems related to the prevention, diagnosis, etiology, and treatment of mental or emotional disorders of Armed Forces personnel.", "OL": "use MILITARY PSYCHIATRY to search PSYCHIATRY, MILITARY 1966-79", "PM": "80; was PSYCHIATRY, MILITARY 1963-79", "HN": "80; was PSYCHIATRY, MILITARY 1963-79", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D008890"}, {"RECTYPE": "D", "MH": "Military Science", "AQ": "CL EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Naval Science|T090|NON|NRW|UNK (19XX)|820429|abcdef", "ENTRY": "Sciences, Naval", "MN": "J01.675", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "Study of the causes as well as tactical and strategic principles of WARFARE.", "OL": "use MILITARY SCIENCE to search NAVAL SCIENCE 1966-82", "PM": "NAVAL SCIENCE was heading 1963-82", "HN": "NAVAL SCIENCE was heading 1963-82", "MR": "20180227", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008891"}, {"RECTYPE": "D", "MH": "Milk", "AQ": "AE CH CL CY DE DG EC EN HI IM LJ ME MI PH PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Cow's Milk|T031|NON|REL|NLM (2021)|191119|abcdef", "ENTRY": "Milk, Cow's", "MN": "J02.500.350.525", "FX": "Lactation", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "assume to be cow's milk & do not coordinate with CATTLE; coordinate with other animal source (NIM); MILK SECRETION see  LACTATION is also available; /\u200cadv \u200ceff; consider also MILK HYPERSENSITIVITY ", "MS": "The off-white liquid secreted by the mammary glands of humans and other mammals. It contains proteins, sugar, lipids, vitamins, and minerals.", "MR": "20200221", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008892"}, {"RECTYPE": "D", "MH": "Milk Ejection", "AQ": "DE PH RE", "ENTRY": "Milk Let down", "MN": "G08.686.702.500.460", "FX": "Breast Milk Expression", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "human & animal", "MS": "Expulsion of milk from the mammary alveolar lumen, which is surrounded by a layer of milk-secreting EPITHELIAL CELLS and a network of myoepithelial cells. Contraction of the myoepithelial cells is regulated by neuroendocrine signals.", "PM": "91; was see under LACTATION 1975-90", "HN": "91(75); was see under LACTATION 1975-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D008893"}, {"RECTYPE": "D", "MH": "Milk Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Milk", "MN": "J02.500.428.159.750", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "PI": "Lactoglobulins (1966-1972)", "MS": "The major protein constituents of milk are CASEINS and whey proteins such as LACTALBUMIN and LACTOGLOBULINS. IMMUNOGLOBULINS occur in high concentrations in COLOSTRUM and in relatively lower concentrations in milk. (Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed, p554)", "PM": "73", "HN": "73", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008894"}, {"RECTYPE": "D", "MH": "Milk, Human", "AQ": "CH CY DE DG EN IM LJ ME MI PH PS RE VI", "PRINT ENTRY": "Breast Milk|T031|NON|EQV|NLM (1997)|951215|abcdef", "ENTRY": "Milk, Breast", "MN": "J02.500.350.525.500", "FX": "Milk Banks", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "for secretion, coordinate with MILK SECRETION ", "MS": "Milk that is produced by HUMAN MAMMARY GLANDS.", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008895"}, {"RECTYPE": "D", "MH": "Panicum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Panicgrass|T002|NON|EQV|NLM (2003)|011015|abcdef", "ENTRY": "miliaceums, Panicum", "MN": "B01.875.800.575.912.250.822.680", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid4539", "RR": "txid4540", "AN": "other millet plants are available", "MS": "A plant genus of the family POACEAE. The seed is one of the EDIBLE GRAINS used in millet cereals and in feed for birds and livestock (ANIMAL FEED). It contains diosgenin (SAPONINS).", "PM": "2003; see MILLET 1991-2002, see CEREALS 1985-1990, see GRAIN 1963-1984", "HN": "2003(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008897"}, {"RECTYPE": "D", "MH": "Mimosine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Leucenol|T116|T121|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Leucaenol|T116|T121|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "MN": "D12.125.042.500", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "1(4H)-Pyridinepropanoic acid, alpha-amino-3-hydroxy-4-oxo-, (S)-", "RN": "500-44-7", "AN": "an antineoplastic", "PI": "Pyridones (1969-1974)", "MS": "3-Hydroxy-4-oxo-1(4H)-pyridinealanine. An antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca.", "PM": "91; was see under PYRIDONES 1975-90", "HN": "91(75); was see under PYRIDONES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008898"}, {"RECTYPE": "D", "MH": "Mineral Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Petrolatum, Liquid|T109|T121|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Paraffin, Liquid", "MN": "D02.455.699.500", "PA": "Emollients", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Hydrocarbon oils", "RN": "8020-83-5", "MS": "A mixture of liquid hydrocarbons obtained from petroleum. It is used as laxative, lubricant, ointment base, and emollient.", "PM": "66; was PETROLATUM, LIQUID 1963-65", "HN": "66; was in Cat D only 1966-82, was PETROLATUM LIQUID in Cat D only 1963-65", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008899"}, {"RECTYPE": "D", "MH": "Mineral Waters", "AQ": "AD AE AN CL EC HI MI PO PS RE SD SN ST TO TU VI", "ENTRY": "Waters, Mineral", "MN": "D01.650.550.925.600", "FX": "Natural Springs", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "coordinate with DRINKING WATER or BALNEOLOGY as appropriate", "MS": "Water naturally or artificially infused with mineral salts or gases.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008900"}, {"RECTYPE": "D", "MH": "Mineralocorticoids", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mineralocorticoid|T109|T125|NON|EQV|NLM (2021)|191231|abbcdef", "ENTRY": "Effects, Mineralocorticoid", "MN": "D27.505.696.399.472.673", "MH_TH": "NLM (1967)", "ST": "T125", "RN": "0", "AN": "note entry term MINERALOCORTICOID EFFECT: use only for the mineralocorticoid effect of a chemical substance", "PI": "Adrenal Cortex Hormones (1966)", "MS": "A group of CORTICOSTEROIDS primarily associated with water and electrolyte balance. This is accomplished through the effect on ION TRANSPORT in renal tubules, resulting in retention of sodium and loss of potassium. Mineralocorticoid secretion is itself regulated by PLASMA VOLUME, serum potassium, and ANGIOTENSIN II.", "PM": "67", "HN": "67", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008901"}, {"RECTYPE": "D", "MH": "Minerals", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mineral|T197|NON|EQV|NLM (2021)|191126|abcdef", "MN": "D01.578", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions. They may occur as individual crystals or may be disseminated in some other mineral or rock. (Grant & Hackh's Chemical Dictionary, 5th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "/metabolism was MINERAL METABOLISM 1963-65", "HN": "/metabolism was MINERAL METABOLISM 1963-65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008903"}, {"RECTYPE": "D", "MH": "Miniaturization", "AQ": "IS MT SN ST", "ENTRY": "Miniaturizations", "MN": "J01.897.520", "FX": "Microchemistry", "MH_TH": "NLM (1966)", "ST": "T068", "MS": "The design or construction of objects greatly reduced in scale.", "PM": "91; was see under ELECTRONICS 1966-90", "HN": "91(66); was see under ELECTRONICS 1966-90", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008904"}, {"RECTYPE": "D", "MH": "Minicomputers", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Minicomputer", "MN": "L01.224.230.260.580", "MH_TH": "NLM (1980)", "ST": "T073", "AN": "do not confuse with MICROCOMPUTERS; personal computers: index under MICROCOMPUTERS", "PI": "Computers (1966-1979)", "MS": "Small computers that lack the speed, memory capacity, and instructional capability of the full-size computer but usually retain its programmable flexibility. They are larger, faster, and more flexible, powerful, and expensive than microcomputers.", "PM": "91; was see under COMPUTERS 1980-90", "HN": "91(80); was see under COMPUTERS 1980-90", "MR": "20170703", "DA": "19790531", "DC": "1", "DX": "19910101", "UI": "D008905"}, {"RECTYPE": "D", "MH": "Mining", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "J01.576.655.875.500", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "coordinate with substance being mined; COAL MINING is also available", "MS": "The process of extracting mineral deposits from the earth.", "MR": "20151130", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008906"}, {"RECTYPE": "D", "MH": "Mink", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Sea Mink|T015|NON|NRW|NLM (1998)|961028|abcdef", "ENTRY": "vison, Neovison", "MN": "B01.050.150.900.649.313.750.250.575.500", "MH_TH": "NLM (1968)", "ST": "T015", "RR": "txid9666", "PI": "Carnivora (1966-1967)", "MS": "Carnivores of genera Mustela and Neovison of the family MUSTELIDAE. The European mink has white upper and lower lips while the American mink lacks white upper lip.", "PM": "68", "HN": "68", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008907"}, {"RECTYPE": "D", "MH": "Mink Cell Focus-Inducing Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "MCF Viruses|T005|EQV|UNK (19XX)|850509|abdef", "ENTRY": "Viruses, MCF", "MN": "B04.820.650.375.525.580", "MH_TH": "NLM (1986)", "ST": "T005", "RN": "txid11785", "AN": "infection: coordinate IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM); add also LEUKEMIA, EXPERIMENTAL (IM), or LEUKEMIA (IM) (for spontaneous leukemia), or ERYTHROLEUKEMIA (IM) if pertinent", "PI": "Mouse Leukemia Viruses (1966-1985)", "MS": "Strains of MURINE LEUKEMIA VIRUS discovered in 1976 by Hartley, Wolford, Old, and Rowe and so named because the viruses originally isolated had the capacity to transform cell foci in mink cell cultures. MCF viruses are generated by recombination with ecotropic murine leukemia viruses including AKR, Friend, Moloney, and Rauscher, causing ERYTHROLEUKEMIA and severe anemia in mice.", "PM": "91; was see under MOUSE LEUKEMIA VIRUSES 1986-90", "HN": "91(86); was see under MOUSE LEUKEMIA VIRUSES 1986-90", "MR": "20200813", "DA": "19850509", "DC": "1", "DX": "19910101", "UI": "D008908"}, {"RECTYPE": "D", "MH": "Minnesota", "AQ": "EH EP", "MN": "Z01.107.567.875.510.510", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bordered on the north by Canada, on the east by Lake Superior and Wisconsin, on the south by Iowa, and on the west by North Dakota and South Dakota.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008910"}, {"RECTYPE": "D", "MH": "Minocycline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Minocycline", "MN": "D04.615.562.900.550", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1966)", "ST": "T195", "N1": "2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,12aalpha))-", "RN": "FYY3R43WGO", "RR": "43168-51-0", "PI": "Tetracycline (1966-1972)", "MS": "A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.", "PM": "91; was see under TETRACYCLINES 1973-90", "HN": "91(73); was see under TETRACYCLINES 1973-90", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008911"}, {"RECTYPE": "D", "MH": "Minor Histocompatibility Loci", "DE": "MHL", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Histocompatibility Loci, Minor|T028|NON|EQV|UNK (19XX)|820419|abcdef", "ENTRY": "Minor Histocompatibility Locus", "MN": "G12.500.530", "MH_TH": "NLM (1983)", "ST": "T028", "PI": "T Lymphocytes (1973-1982)", "MS": "Genetic loci responsible for the encoding of histocompatibility antigens other than those encoded by the MAJOR HISTOCOMPATIBILITY COMPLEX. The antigens encoded by these genes are often responsible for graft rejection in cases where histocompatibility has been established by standard tests. The location of some of these loci on the X and Y chromosomes explains why grafts from males to females may be rejected while grafts from females to males are accepted. In the mouse roughly 30 minor histocompatibility loci have been recognized, comprising more than 500 genes.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19820419", "DC": "1", "DX": "19830101", "UI": "D008912"}, {"RECTYPE": "D", "MH": "Minority Groups", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Minority Group", "MN": "I01.880.853.300", "FX": "Minority Health", "MH_TH": "POPLINE (1978)", "ST": "T098", "AN": "IM; coord with specific minority group (IM) & geog", "PI": "Prejudice (1966-1967)", "MS": "A subgroup having special characteristics within a larger group, often bound together by special ties which distinguish it from the larger group.", "PM": "1968", "HN": "1968", "MR": "20210705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008913"}, {"RECTYPE": "D", "MH": "Minoxidil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "U 10858|T109|T121|LAB|NRW|UNK (19XX)|800326|abbcdef", "MN": "D03.383.742.418", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4-Pyrimidinediamine, 6-(1-piperidinyl)-, 3-oxide", "RN": "5965120SH1", "RR": "38304-91-5 (Minoxidil)", "PI": "Pyrimidines (1966-1971)", "MS": "A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)", "PM": "86; was see under PYRIMIDINES 1975-85", "HN": "86(72); was see under PYRIMIDINES 1975-85, was Prov 1972-74", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D008914"}, {"RECTYPE": "D", "MH": "Minute Virus of Mice", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Mice Minute Virus|T005|NON|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Minute Virus, Mice", "MN": "B04.280.580.650.600.550", "MH_TH": "NLM (2016)", "ST": "T005", "RN": "txid10794", "AN": "infection: coordinate IM with PARVOVIRIDAE INFECTIONS (IM)", "MS": "The type species of PARVOVIRUS prevalent in mouse colonies and found as a contaminant of many transplanted tumors or leukemias.", "PM": "2016; see Minute virus of mice 2007-2015, MICE MINUTE VIRUS 1997-2006, MINUTE VIRUS OF MICE 1991-1996, PARVOVIRIDAE 1981-1990, PARVOVIRSEES 1975-1980", "HN": "2016; use Minute virus of mice 2007-2015, MICE MINUTE VIRUS 1997-2006, MINUTE VIRUS OF MICE 1991-1996, PARVOVIRIDAE 1981-1990, PARVOVIRUSES 1975-1980", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D008915"}, {"RECTYPE": "D", "MH": "Miotics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Miotic", "MN": "D27.505.696.663.050.495", "FX": "Sympatholytics", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "do not confuse with \"mitotic\"; note entry term MIOTIC EFFECT: use only for the miotic effect of a chemical substance", "MS": "Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008916"}, {"RECTYPE": "D", "MH": "Mirex", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.526.439.659", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "1,3,4-Metheno-1H-cyclobuta(cd)pentalene, 1,1a,2,2,3,3a,4,5,5,5a,5b,6-dodecachlorooctahydro-", "RN": "Z917AN264P", "RR": "2385-85-5 (Mirex)", "PI": "Insecticides (1966-1972)", "MS": "An organochlorine insecticide that is carcinogenic.", "PM": "91; was see under INSECTICIDES, ORGANOCHLORINE 1972-90", "HN": "91(72); was see under INSECTICIDES, ORGANOCHLORINE 1972-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008917"}, {"RECTYPE": "D", "MH": "Investigative Techniques", "ENTRY": "Techniques, Investigative", "MN": "E05", "RH": "E5 - PROCEDURES AND TECHNIQUES- INVESTIGATIVE", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Investigative techniques used in pre-clinical and clinical research, epidemiology, chemistry, immunology, genetics, etc. They do not include techniques specifically applied to DIAGNOSIS; THERAPEUTICS; anesthesia and analgesia; SURGICAL PROCEDURES, OPERATIVE; and DENTISTRY.", "PM": "1998", "HN": "1998", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D008919"}, {"RECTYPE": "D", "MH": "Misonidazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro 70582", "MN": "D03.383.129.308.658.530", "PA": "Radiation-Sensitizing Agents", "MH_TH": "USAN (1978)", "ST": "T121", "N1": "1H-Imidazole-1-ethanol, alpha-(methoxymethyl)-2-nitro-", "RN": "8FE7LTN8XE", "RR": "13551-87-6 (Misonidazole)", "PI": "Nitroimidazoles (1974-1978)", "MS": "A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation. It may also be directly cytotoxic to hypoxic cells and has been proposed as an antineoplastic.", "PM": "86; was see under NITROIMIDAZOLES 1979-85", "HN": "86(79); was see under NITROIMIDAZOLES 1979-85", "MR": "20160531", "DA": "19780503", "DC": "1", "DX": "19860101", "UI": "D008920"}, {"RECTYPE": "D", "MH": "Religious Missions", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Missions|T092|NON|EQV|UNK (19XX)|790329|abcdef", "ENTRY": "Religious Mission", "MN": "N03.540.297.500", "FX": "Nuns", "MH_TH": "NLM (2015)", "ST": "T092", "AN": "MEDICAL MISSIONS and MISSIONARIES are also available", "MS": "Programs or projects established by religious groups or institution to support and provide missionary activities, including sharing faith or providing educational, medical, or other assistance.", "PM": "2015; was indexed under MISSIONS AND MISSIONARIES 1992-2014", "HN": "2015(1991); was indexed under MISSIONS AND MISSIONARIES 1992-2014", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008921"}, {"RECTYPE": "D", "MH": "Mississippi", "AQ": "EH EP", "MN": "Z01.107.567.875.750.500", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Tennessee, on the east by Alabama, on the south by Louisiana and Gulf of Mexico, and on the west by Arkansas and Louisiana.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008922"}, {"RECTYPE": "D", "MH": "Missouri", "AQ": "EH EP", "MN": "Z01.107.567.875.510.515", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the east by Illinois and Kentucky, on the south by Arkansas, on the west by Kansas, and on the north by Iowa.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008923"}, {"RECTYPE": "D", "MH": "Mite Infestations", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Mange|T047|NON|NRW|UNK (19XX)|760517|abcdef", "ENTRY": "Mite Infestation", "MN": "C01.610.858.211.480", "MH_TH": "NLM (1968)", "ST": "T047", "MS": "Infestations with arthropods of the subclass ACARI, superorder Acariformes.", "PM": "1968; see ACARIASIS 1963-1967", "HN": "1968", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008924"}, {"RECTYPE": "D", "MH": "Mites", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Acarus|T204|NON|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Mite", "MN": "B01.050.500.131.166.132.419", "MH_TH": "NLM (1966)", "ST": "T204", "RR": "txid66545", "MS": "Any arthropod of the subclass ACARI except the TICKS. They are minute animals related to the spiders, usually having transparent or semitransparent bodies. They may be parasitic on humans and domestic animals, producing various irritations of the skin (MITE INFESTATIONS). Many mite species are important to human and veterinary medicine as both parasite and vector. Mites also infest plants.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008925"}, {"RECTYPE": "D", "MH": "Plicamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mithramycin|T121|T130|T195|NON|EQV|NLM (1993)|920221|abbbcdef", "ENTRY": "Mitramycin|T121|T130|T195|NON|EQV|UNK (19XX)|800523|abbbcdef", "MN": "D09.408.051.059.650", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Mithramycin", "RN": "NIJ123W41V", "RR": "18378-89-7 (Plicamycin)", "PI": "Antibiotics, Antineoplastic (1967-1970)", "MS": "A tricyclic pentaglycosidic antibiotic from Streptomyces strains that inhibits RNA and protein synthesis by adhering to DNA. It is used as a fluorescent dye and as an antineoplastic agent, especially in bone and testicular tumors. Plicamycin is also used to reduce hypercalcemia, especially that due to malignancies.", "OL": "use PLICAMYCIN to search MITHRAMYCIN 1971-92 (as Prov 1971-72)", "PM": "93; was MITHRAMYCIN 1973-92", "HN": "93; was MITHRAMYCIN 1971-92 (Prov 1971-72)", "MR": "20180522", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008926"}, {"RECTYPE": "D", "MH": "Mitobronitol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dibromomannitol|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "NSC94100", "MN": "D09.853.609.500", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "D-Mannitol, 1,6-dibromo-1,6-dideoxy-", "RN": "5UP30YED7N", "RR": "488-41-5 (Mitobronitol)", "PI": "Mannitol (1971-1974)", "MS": "Brominated analog of MANNITOL which is an antineoplastic agent appearing to act as an alkylating agent.", "PM": "91; was see under MANNITOL 1975-90", "HN": "91(75); was see under MANNITOL 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008927"}, {"RECTYPE": "D", "MH": "Mitochondria", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Mitochondrial Contraction|T043|NON|REL|NLM (1997)|960416|abcdef", "ENTRY": "Mitochondrial Contractions", "MN": "A11.284.835.626", "MH_TH": "NLM (1966)", "ST": "T026", "AN": "coordinate with organ /metab but not also organ /ultrastruct for metabolic studies; coordinate with organ /ultrastruct for morphological studies; mitochondria of vascular or smooth muscle tissue goes under MITOCHONDRIA, MUSCLE ", "MS": "Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed)", "PM": "MITOCHONDRIAL CONTRACTION was heading 1975-96 (see under MITOCHONDRIA 1975)", "HN": "MITOCHONDRIAL CONTRACTION was heading 1969-96 (was see under MITOCHONDRIA 1975, was Prov 1969-74)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D008928"}, {"RECTYPE": "D", "MH": "Mitochondria, Heart", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Myocardial Mitochondria|T026|NON|EQV|UNK (19XX)|770426|abcdef", "ENTRY": "Mitochondria, Myocardial", "MN": "A11.284.835.626.627.603", "MH_TH": "NLM (1978)", "ST": "T026", "PI": "Myocardium (1966-1977)", "MS": "The mitochondria of the myocardium.", "PM": "78", "HN": "78", "MR": "20030709", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D008929"}, {"RECTYPE": "D", "MH": "Mitochondria, Liver", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Liver Mitochondria|T026|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Mitochondrion, Liver|T026|NON|EQV|NLM (1995)|940513|abcdef", "MN": "A11.284.835.626.461", "MH_TH": "NLM (1968)", "ST": "T026", "PI": "Mitochondria (1966-1967)", "MS": "Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4)", "PM": "68", "HN": "68", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008930"}, {"RECTYPE": "D", "MH": "Mitochondria, Muscle", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Sarcosomes|T026|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Sarcosome", "MN": "A11.284.835.626.627", "FX": "Mitochondrial Myopathies", "MH_TH": "NLM (1968)", "ST": "T026", "AN": "for vascular & smooth muscle mitochondria, do not coordinate with MUSCLE, SMOOTH or MUSCLE, SMOOTH, VASCULAR unless particularly discussed  ", "PI": "Myocardium (1966-1967)", "MS": "Mitochondria of skeletal and smooth muscle. It does not include myocardial mitochondria for which MITOCHONDRIA, HEART is available.", "PM": "68", "HN": "68", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008931"}, {"RECTYPE": "D", "MH": "Mitochondrial Swelling", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Mitochondrial Hypertrophy|T043|NON|REL|NLM (2023)|210901|abcdef", "ENTRY": "Swelling, Mitochondrial", "MN": "G04.590", "FX": "Mitochondrial Size", "MH_TH": "NLM (1969)", "ST": "T043", "PI": "Mitochondria, Muscle (1968)", "MS": "An increase in MITOCHONDRIAL VOLUME due to an influx of fluid; it occurs in hypotonic solutions due to osmotic pressure and in isotonic solutions as a result of altered permeability of the membranes of respiring mitochondria.", "PM": "76; was see under MITOCHONDRIA 1975", "HN": "76(69); was see under MITOCHONDRIA 1975", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D008933"}, {"RECTYPE": "D", "MH": "Mitogens", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phytomitogen|T116|T123|NON|NRW|NLM (2021)|200227|abbcdef", "ENTRY": "Phytomitogens|T116|T123|NON|NRW|UNK (19XX)|780508|abbcdef", "MN": "D27.505.519.593.624", "FX": "Receptors, Mitogen", "MH_TH": "NLM (1972)", "ST": "T121", "RN": "0", "PI": "Mitosis/drug effects (1966-1971)", "MS": "Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed)", "PM": "1973; for PHYTOMITOGENS see PLANT LECTINS 1978-2002", "HN": "1973(1972); for PHYTOMITOGENS use PLANT LECTINS 1978-2002", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008934"}, {"RECTYPE": "D", "MH": "Mitoguazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylglyoxal Bis(guanylhydrazone)|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "NSC32946", "MN": "D02.078.370.600", "PA": "Enzyme Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Hydrazinecarboximidamide, 2,2'-(1-methyl-1,2-ethanediylidene)bis-", "RN": "OD5Q0L447W", "RR": "459-86-9 (Mitoguazone)", "PI": "Hydrazones (1973-1974)", "MS": "Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase.", "PM": "86; was see under GUANIDINES 1975-85", "HN": "86(75); was see under GUANIDINES 1975-85", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D008935"}, {"RECTYPE": "D", "MH": "Mitolactol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dibromodulcitol|T109|T121|NON|EQV|UNK (19XX)|800520|abbcdef", "ENTRY": "NSC104800", "MN": "D09.853.400.500", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Galactitol, 1,6-dibromo-1,6-dideoxy-", "RN": "LJ2P1SIK8Y", "RR": "10318-26-0 (Mitolactol)", "PI": "Bromine (1966-1973)", "MS": "Alkylating antineoplastic toxic to bone marrow; used in breast cancer, also in combination with other drugs.", "OL": "use MITOLACTOL to search DIBROMODULCITOL 1974-80", "PM": "81; was DIBROMODULCITOL 1974-80", "HN": "81; was DIBROMODULCITOL 1974-80", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D008936"}, {"RECTYPE": "D", "MH": "Mitomycins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.473.412.249", "PA": "Antibiotics, Antineoplastic", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "MITOMYCIN is also available", "MS": "A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.", "OL": "use MITOMYCINS to search MITOMYCIN 1966-81", "PM": "82; was MITOMYCIN 1963-81", "HN": "82; was MITOMYCIN 1963-81", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19820101", "UI": "D008937"}, {"RECTYPE": "D", "MH": "Mitosis", "AQ": "DE GE IM PH RE", "ENTRY": "Phases, Mitotic M", "MN": "G05.113.220.781", "FX": "Mitotic Index", "MH_TH": "NLM (1968)", "ST": "T043", "PI": "Cell Division (1966-1967)", "MS": "A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species.", "OL": "search CELL DIVISION 1966-67; use CELL DIVISION to search KARYOKINESIS 1966-80", "PM": "68; was see under CELL DIVISION 1963-67; KARYOKINESIS was see under CELL DIVISION 1963-80", "HN": "68; was see under CELL DIVISION 1963-67; KARYOKINESIS was see under CELL DIVISION 1963-80", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008938"}, {"RECTYPE": "D", "MH": "Mitotane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ortho,para-DDD|T109|T121|EQV|UNK (19XX)|760517|ORTHO PARA DDD|abbdefs", "ENTRY": "ortho,para DDD", "MN": "D02.455.526.439.681", "PA": "Antineoplastic Agents, Hormonal", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzene, 1-chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)-", "RN": "78E4J5IB5J", "RR": "53-19-0 (Mitotane)", "PI": "DDD/PD (1966-1972)", "MS": "A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.", "PM": "73", "HN": "73", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008939"}, {"RECTYPE": "D", "MH": "Mitotic Index", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Mitotic Indices", "MN": "E05.242.385.500", "MH_TH": "NLM (1975)", "ST": "T034", "MS": "An expression of the number of mitoses found in a stated number of cells.", "PM": "91; was see under MITOSIS 1975-90", "HN": "91(75); was see under MITOSIS 1975-90", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D008940"}, {"RECTYPE": "D", "MH": "Spindle Apparatus", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Spindle Apparatus, Mitotic|T026|NON|NRW|UNK (19XX)|830224|abcdef", "ENTRY": "Spindles, Mitotic", "MN": "A11.284.430.214.190.750.820", "FX": "Microtubules", "MH_TH": "NLM (2014)", "ST": "T026", "AN": "coordinate with MITOSIS or MEIOSIS if pertinent", "PI": "Mitosis (1968-1983)", "MS": "A microtubule structure that forms during CELL DIVISION. It consists of two SPINDLE POLES, and sets of MICROTUBULES that may include the astral microtubules, the polar microtubules, and the kinetochore microtubules.", "PM": "84", "HN": "84", "MR": "20130708", "DA": "19830224", "DC": "1", "DX": "19840101", "UI": "D008941"}, {"RECTYPE": "D", "MH": "Mitoxantrone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mitozantrone|T109|T121|NON|EQV|BAN (19XX)|870504|abbcdef", "ENTRY": "NSC301739D", "MN": "D04.615.125.380.625.500", "PA": "Topoisomerase II Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-", "RN": "BZ114NVM5P", "RR": "U6USW86RD0", "PI": "Anthraquinones (1966-1986)", "MS": "An anthracenedione-derived antineoplastic agent.", "PM": "87", "HN": "87", "MR": "20230607", "DA": "19860603", "DC": "1", "DX": "19870101", "UI": "D008942"}, {"RECTYPE": "D", "MH": "Mitral Valve", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Bicuspid Valve|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Valves, Mitral", "MN": "A07.541.510.507", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "atresia: index MITRAL VALVE /abnorm", "MS": "The valve between the left atrium and left ventricle of the heart.", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008943"}, {"RECTYPE": "D", "MH": "Mitral Valve Insufficiency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mitral Valve Incompetence|T047|NON|EQV|NLM (1993)|910924|abcdef", "ENTRY": "Valve Regurgitation, Mitral", "MN": "C14.280.484.461", "MH_TH": "NLM (1967)", "ST": "T047", "MS": "Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.", "OL": "use MITRAL VALVE INSUFFICIENCY to search MITRAL INSUFFICIENCY 1966", "PM": "67; was MITRAL INSUFFICIENCY 1963-66", "HN": "67; was MITRAL INSUFFICIENCY 1963-66", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008944"}, {"RECTYPE": "D", "MH": "Mitral Valve Prolapse", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Systolic Click-Murmur Syndrome|T047|NON|EQV|UNK (19XX)|771206|abcdef", "ENTRY": "Valves, Prolapsed Mitral", "MN": "C14.280.484.400.500", "MH_TH": "NLM (1979)", "ST": "T047", "PI": "Prolapse (1977-1978)", "MS": "Abnormal protrusion or billowing of one or both of the leaflets of MITRAL VALVE into the LEFT ATRIUM during SYSTOLE. This allows the backflow of blood into left atrium leading to MITRAL VALVE INSUFFICIENCY; SYSTOLIC MURMURS; or CARDIAC ARRHYTHMIA.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19771206", "DC": "1", "DX": "19790101", "UI": "D008945"}, {"RECTYPE": "D", "MH": "Mitral Valve Stenosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mitral Stenosis|T047|NON|EQV|NLM (1998)|960801|abcdef", "ENTRY": "Valve Stenosis, Mitral", "MN": "C14.280.484.517", "MH_TH": "NLM (1967)", "ST": "T047", "MS": "Narrowing of the passage through the MITRAL VALVE due to FIBROSIS, and CALCINOSIS in the leaflets and chordal areas. This elevates the left atrial pressure which, in turn, raises pulmonary venous and capillary pressure leading to bouts of DYSPNEA and TACHYCARDIA during physical exertion. RHEUMATIC FEVER is its primary cause.", "OL": "use MITRAL VALVE STENOSIS to search MITRAL STENOSIS 1966", "PM": "67; was MITRAL STENOSIS 1963-66", "HN": "67; was MITRAL STENOSIS 1963-66", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008946"}, {"RECTYPE": "D", "MH": "Mixed Connective Tissue Disease", "DE": "MIXED CONNECTIVE TISSUE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sharp Syndrome|T047|EPO|EQV|UNK (19XX)|780515|abcdef", "ENTRY": "Syndrome, Sharp", "MN": "C17.300.540", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "a specific disease entity; do not confuse with CONNECTIVE TISSUE DISEASES", "PI": "Scleroderma, Systemic (1972-1978)", "MS": "A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a \"speckled\" epidermal nuclear staining pattern on direct immunofluorescence.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19780515", "DC": "1", "DX": "19790101", "UI": "D008947"}, {"RECTYPE": "D", "MH": "Adenoma, Pleomorphic", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Syringoma, Chondroid|T191|NON|EQV|NLM (1994)|930423|abcdef", "ENTRY": "Syringomas, Chondroid", "MN": "C04.557.470.035.155", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with SALIVARY GLAND NEOPLASMS or specific salivary gland neoplasm precoordinated term; if of a minor salivary gland, coordinate with SALIVARY GLAND NEOPLASMS + SALIVARY GLANDS, MINOR; for X ref SYRINGOMA, CHONDROID, coordinate with SWEAT GLAND NEOPLASMS", "MS": "A benign, slow-growing tumor, most commonly of the salivary gland, occurring as a small, painless, firm nodule, usually of the parotid gland, but also found in any major or accessory salivary gland anywhere in the oral cavity. It is most often seen in women in the fifth decade. Histologically, the tumor presents a variety of cells: cuboidal, columnar, and squamous cells, showing all forms of epithelial growth. (Dorland, 27th ed)", "OL": "use ADENOMA, PLEOMORPHIC to search MIXED SALIVARY GLAND TUMOR 1966-93; use ADENOMA, SWEAT GLAND to search SYRINGOMA, CHONDROID 1985-93", "PM": "94; was MIXED SALIVARY GLAND TUMOR 1963-93; SYRINGOMA, CHONDROID was see HIDRADENOMA (now ADENOMA, SWEAT GLAND) 1985-93", "HN": "94; was MIXED SALIVARY GLAND TUMOR 1963-93; SYRINGOMA, CHONDROID was see HIDRADENOMA (now ADENOMA, SWEAT GLAND) 1985-93", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D008949"}, {"RECTYPE": "D", "MH": "MMPI", "AQ": "HI SN ST", "PRINT ENTRY": "Minnesota Multiphasic Personality Inventory|T060|T170|EPO|EQV|UNK (19XX)|740330|abbcdef", "MN": "F04.711.647.513.607", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "A personality inventory consisting of statements to be asserted or denied by the individual. The patterns of response are characteristic of certain personality attributes.", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008950"}, {"RECTYPE": "D", "MH": "MNSs Blood-Group System", "AQ": "AD AE AN BI BL CF CH CL EC GE HI IM IP ME PD PH PO TO TU UL UR", "ENTRY": "Systems, MNSs Blood-Group", "MN": "D23.050.705.230.606", "MH_TH": "NLM (1976)", "ST": "T022", "RN": "0", "AN": "IM; coord with disease /blood (IM), not /immunol nor /genet; TN 230", "PI": "Blood Groups (1966-1975)", "MS": "A system of universal human blood group isoantigens with many associated subgroups. The M and N traits are codominant and the S and s traits are probably very closely linked alleles, including the U antigen. This system is most frequently used in paternity studies.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D008951"}, {"RECTYPE": "D", "MH": "Mobile Health Units", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Vans, Mobile Health", "MN": "N02.421.726.233.628", "MH_TH": "POPLINE (1978)", "ST": "T093", "PI": "Health Facilities (1968-1969)", "MS": "Movable or portable facilities in which diagnostic and therapeutic services are provided to the community.", "PM": "1970; FIELD HOSPITALS was a heading 2013", "HN": "1970", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D008952"}, {"RECTYPE": "D", "MH": "Models, Anatomic", "DE": "MODELS ANAT", "PRINT ENTRY": "Moulages|T073|T170|NON|NRW|UNK (19XX)|830620|abbcdef", "ENTRY": "Surgical Models", "MN": "L01.462.500.820.090.545.129", "FX": "Manikins", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "Three-dimensional representation to show anatomic structures. Models may be used in place of intact animals or organisms for teaching, practice, and study.", "OL": "use MODELS, ANATOMIC to search ANATOMIC MODELS 1975-83; use MODELS, STRUCTURAL 1968-74; use MODELS, ANATOMIC to search MOULAGES 1975-83; use MEDICAL ILLUSTRATION 1966-74", "PM": "84; was ANATOMIC MODELS see under MODELS, STRUCTURAL 1963-83; MOULAGES was see under MEDICAL ILLUSTRATION 1963-83", "HN": "84(75); was ANATOMIC MODELS see under MODELS, STRUCTURAL 1968-83; MOULAGES was see under MEDICAL ILLUSTRATION 1963-83", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D008953"}, {"RECTYPE": "D", "MH": "Models, Biological", "DE": "MODELS BIOL", "ENTRY": "Model, Biologic", "MN": "E05.599.395", "FX": "Patient-Specific Modeling", "MH_TH": "NLM (1973)", "ST": "T170", "PI": "Models, Theoretical (1966-1967)", "MS": "Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.", "OL": "use MODELS, BIOLOGICAL to search MODELS, BIOLOGIC 1968-72", "PM": "73; was MODELS, BIOLOGIC 1968-72", "HN": "73; was MODELS, BIOLOGIC 1968-72", "MR": "20200429", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008954"}, {"RECTYPE": "D", "MH": "Models, Cardiovascular", "ENTRY": "Model, Cardiovascular", "MN": "E05.599.395.161", "MH_TH": "NLM (1980)", "ST": "T170", "PI": "Models, Biological (1968-1979)", "MS": "Theoretical representations that simulate the behavior or activity of the cardiovascular system, processes, or phenomena; includes the use of mathematical equations, computers and other electronic equipment.", "PM": "80", "HN": "80", "MR": "20080708", "DA": "19790525", "DC": "1", "DX": "19800101", "UI": "D008955"}, {"RECTYPE": "D", "MH": "Models, Chemical", "DE": "MODELS CHEM", "PRINT ENTRY": "Chemical Models|T075|T170|NON|EQV|NLM (1990)|890502|CHEM MODELS|abbcdefv", "ENTRY": "Model, Chemical", "MN": "E05.599.495", "MH_TH": "NLM (1968)", "ST": "T170", "PI": "Models, Theoretical (1966-1967)", "MS": "Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment.", "PM": "68", "HN": "68", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008956"}, {"RECTYPE": "D", "MH": "Models, Genetic", "DE": "MODELS GENET", "ENTRY": "Model, Genetic", "MN": "E05.599.395.397", "MH_TH": "NLM (1980)", "ST": "T170", "PI": "Models, Biological (1968-1979)", "MS": "Theoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19790525", "DC": "1", "DX": "19800101", "UI": "D008957"}, {"RECTYPE": "D", "MH": "Models, Molecular", "DE": "MODELS MOL", "PRINT ENTRY": "Molecular Models|T170|NON|EQV|UNK (19XX)|830620|abcdef", "ENTRY": "Molecular Model", "MN": "E05.599.595", "FX": "Molecular Structure", "MH_TH": "NLM (1975)", "ST": "T170", "AN": "do not confuse with MODELS, CHEMICAL", "MS": "Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.", "OL": "use MODELS, MOLECULAR to search MOLECULAR MODELS 1975-83; use MODELS, STRUCTURAL 1969-74", "PM": "84; was MOLECULAR MODELS see under MODELS, STRUCTURAL 1969-83", "HN": "84(75); was MOLECULAR MODELS see under MODELS, STRUCTURAL 1969-83", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D008958"}, {"RECTYPE": "D", "MH": "Models, Neurological", "DE": "MODELS NEUROL", "PRINT ENTRY": "Neurologic Models|T170|NON|EQV|NLM (1990)|890502|NEUROL MODELS|abcdefv", "ENTRY": "Models, Neurologic", "MN": "E05.599.395.642", "FX": "Kindling, Neurologic", "MH_TH": "NLM (1968)", "ST": "T170", "PI": "Models, Theoretical (1966-1967)", "MS": "Theoretical representations that simulate the behavior or activity of the neurological system, processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment.", "OL": "use MODELS, NEUROLOGICAL to search MODELS, NEUROLOGIC 1968-76", "PM": "77; was MODELS, NEUROLOGIC 1968-76", "HN": "77; was MODELS, NEUROLOGIC 1968-76", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008959"}, {"RECTYPE": "D", "MH": "Models, Psychological", "DE": "MODELS PSYCHOL", "ENTRY": "Psychological Model", "MN": "E05.599.695", "FX": "Probability Learning", "MH_TH": "NLM (1973)", "ST": "T170", "PI": "Models, Theoretical (1966-1967)", "MS": "Theoretical representations that simulate psychological processes and/or social processes. These include the use of mathematical equations, computers, and other electronic equipment.", "OL": "use MODELS, PSYCHOLOGICAL to search MODELS, PSYCHOLOGIC 1968-72", "PM": "73; was MODELS, PSYCHOLOGIC 1968-72", "HN": "73; was MODELS, PSYCHOLOGIC 1968-72", "CATSH": "CAT LIST", "MR": "20181105", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008960"}, {"RECTYPE": "D", "MH": "Models, Structural", "ENTRY": "Structural Models", "MN": "L01.462.500.820.090.545", "MH_TH": "NLM (1968)", "ST": "T073", "MS": "A representation, generally small in scale, to show the structure, construction, or appearance of something. (From Random House Unabridged Dictionary, 2d ed)", "PM": "68", "HN": "68", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008961"}, {"RECTYPE": "D", "MH": "Models, Theoretical", "ENTRY": "Theoretical Studies", "MN": "E05.599", "MH_TH": "NLM (1978)", "ST": "T170", "AN": "general; prefer specifics", "MS": "Theoretical representations that simulate the behavior or activity of systems, processes, or phenomena. They include the use of mathematical equations, computers, and other electronic equipment.", "OL": "use MODELS, THEORETICAL to search MODELS 1966-67", "PM": "68; MODELS was heading 1966-67", "HN": "68; MODELS was heading 1966-67", "MR": "20150109", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008962"}, {"RECTYPE": "D", "MH": "Molar", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Molars", "MN": "A14.549.167.860.525", "MH_TH": "NLM (1965)", "ST": "T023", "AN": "the most posterior teeth; for grinding; NIM when merely locational", "MS": "The most posterior teeth on either side of the jaw, totaling eight in the deciduous dentition (2 on each side, upper and lower), and usually 12 in the permanent dentition (three on each side, upper and lower). They are grinding teeth, having large crowns and broad chewing surfaces. (Jablonski, Dictionary of Dentistry, 1992, p821)", "PM": "65", "HN": "65", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D008963"}, {"RECTYPE": "D", "MH": "Molar, Third", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Tooth, Wisdom|T023|NON|EQV|UNK (19XX)|810224|abcdef", "ENTRY": "Wisdom Tooth", "MN": "A14.549.167.860.525.500", "MH_TH": "NLM (1982)", "ST": "T023", "AN": "the last tooth, behind the 2d molar; human only; IM", "PI": "Molar (1966-1981)", "MS": "The aftermost permanent tooth on each side in the maxilla and mandible.", "PM": "82", "HN": "82", "MR": "20040713", "DA": "19810224", "DC": "1", "DX": "19820101", "UI": "D008964"}, {"RECTYPE": "D", "MH": "Molasses", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Molasse", "MN": "J02.500.662", "PA": "Sweetening Agents", "MH_TH": "NLM (1966)", "ST": "T168", "MS": "The syrup remaining after sugar is crystallized out of SUGARCANE or sugar beet juice. It is also used in ANIMAL FEED, and in a fermented form, is used to make industrial ETHYL ALCOHOL and ALCOHOLIC BEVERAGES.", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008965"}, {"RECTYPE": "D", "MH": "Moldova", "AQ": "EH EP", "PRINT ENTRY": "Moldavian S.S.R.|T083|NAM|EQV|NLM (1993)|920422|abcdef", "ENTRY": "Moldavian SSR|T083|NAM|EQV|NLM (1993)|920422|abcdef", "MN": "Z01.586.950.540", "MH_TH": "NLM (1993)", "ST": "T083", "MS": "Country in Europe south and west of Ukraine and east of Romania. The capital is Chisinau.", "OL": "use MOLDOVA to search MOLDAVIAN S.S.R. 1982-92 & MOLDAVIA 1966-81", "HN": "93; was MOLDAVIAN S.S.R. 1982-92; was MOLDAVIA 1963-81", "MR": "20170717", "DA": "19990101", "DC": "4", "DX": "19930101", "UI": "D008966"}, {"RECTYPE": "D", "MH": "Molecular Biology", "DE": "MOL BIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Molecular Genetic", "MN": "H01.181.122.650", "FX": "Genetic Structures", "MH_TH": "NLM (1968)", "ST": "T091", "AN": "use for the discipline only (education, history, etc)", "PI": "Biology (1966-1967)", "MS": "A discipline concerned with studying biological phenomena in terms of the chemical and physical interactions of molecules.", "PM": "70", "HN": "70(68)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D008967"}, {"RECTYPE": "D", "MH": "Molecular Conformation", "DE": "MOL CONFORMATION", "AQ": "DE RE", "PRINT ENTRY": "Molecular Configuration|T044|T082|NON|EQV|NLM (1993)|911003|MOL CONFIGURATION|abbcdefv", "ENTRY": "Structures, 3D Molecular", "MN": "G02.111.570.820", "FX": "Models, Molecular", "MH_TH": "NLM (1973)", "ST": "T082", "AN": "general or unspecified; prefer specifics; do not confuse with MOLECULAR STRUCTURE", "MS": "The characteristic three-dimensional shape of a molecule.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D008968"}, {"RECTYPE": "D", "MH": "Molecular Sequence Data", "DE": "MOL SEQ DATA", "PRINT ENTRY": "Sequence Data, Molecular|T085|T170|NON|EQV|UNK (19XX)|870509|SEQ DATA MOL|abbcdefv", "ENTRY": "Sequencing Data, Molecular", "MN": "L01.462.750.245.667", "FX": "Sequence Alignment", "MH_TH": "NLM (1988)", "ST": "T170", "AN": "index only for general articles on sequence data; 1988-2016 indexed for articles which contained databank accession numbers for sequences deposited in a molecular sequence databank such as GenBank or for the presence of molecular sequences in the text", "PI": "Information Systems (1983-1987)", "MS": "Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19870509", "DC": "1", "DX": "19880101", "UI": "D008969"}, {"RECTYPE": "D", "MH": "Molecular Weight", "DE": "MOL WEIGHT", "ENTRY": "Weights, Molecular", "MN": "G02.494", "MH_TH": "NLM (1964)", "ST": "T081", "AN": "NIM", "MS": "The sum of the weight of all the atoms in a molecule.", "PM": "67", "HN": "67(64)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D008970"}, {"RECTYPE": "D", "MH": "Moles", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Mole", "MN": "B01.050.150.900.649.313.961.450", "MH_TH": "NLM (1975)", "ST": "T015", "MS": "Any of numerous burrowing mammals found in temperate regions and having minute eyes often covered with skin.", "PM": "91; was see under INSECTIVORA 1975-90", "HN": "91(75); was see under INSECTIVORA 1975-90", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D008971"}, {"RECTYPE": "D", "MH": "Molindone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Molindone", "MN": "D03.633.100.473.629", "PA": "Antipsychotic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "4H-Indol-4-one, 3-ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-", "RN": "RT3Y3QMF8N", "RR": "7416-34-4 (Molindone)", "PI": "Indoles (1966-1971)", "MS": "An indole derivative effective in schizophrenia and other psychoses and possibly useful in the treatment of the aggressive type of undersocialized conduct disorder. Molindone has much lower affinity for D2 receptors than most antipsychotic agents and has a relatively low affinity for D1 receptors. It has only low to moderate affinity for cholinergic and alpha-adrenergic receptors. Some electrophysiologic data from animals indicate that molindone has certain characteristics that resemble those of CLOZAPINE. (From AMA Drug Evaluations Annual, 1994, p283)", "PM": "91; was see under INDOLES 1972-90", "HN": "91(72); was see under INDOLES 1972-90", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008972"}, {"RECTYPE": "D", "MH": "Tenericutes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mollicutes|T007|NON|NRW|NLM (1976)|990101|abcdef", "MN": "B03.440.860", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid544448", "RR": "txid31969", "MS": "A phylum of gram-negative bacteria consisting of cells bounded by a plasma membrane. Its organisms differ from other bacteria in that they are devoid of cell walls. This phylum was formerly the class Mollicutes. Mollicutes is now the sole class in the phylum Tenericutes.", "PM": "2011; see MOLLICUTES 1992-2010", "HN": "2011 (1976)", "MR": "20200813", "DA": "19750718", "DC": "1", "DX": "19920101", "UI": "D008973"}, {"RECTYPE": "D", "MH": "Mollusca", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Mollusk", "MN": "B01.050.500.644", "FX": "Shellfish", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6447", "AN": "as animal & food; IM; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)", "MS": "A phylum of the kingdom Metazoa. Mollusca have soft, unsegmented bodies with an anterior head, a dorsal visceral mass, and a ventral foot. Most are encased in a protective calcareous shell. It includes the classes GASTROPODA; BIVALVIA; CEPHALOPODA; Aplacophora; Scaphopoda; Polyplacophora; and Monoplacophora.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008974"}, {"RECTYPE": "D", "MH": "Molluscacides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D27.888.723.596", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "MS": "Agents destructive to snails and other mollusks.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008975"}, {"RECTYPE": "D", "MH": "Molluscum Contagiosum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C17.800.838.790.550", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a skin dis caused by a poxvirus", "MS": "A common, benign, usually self-limited viral infection of the skin and occasionally the conjunctivae by a poxvirus (MOLLUSCUM CONTAGIOSUM VIRUS). (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008976"}, {"RECTYPE": "D", "MH": "Molluscum contagiosum virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Molluscum contagiosum viruses", "MN": "B04.280.650.160.550.500", "MH_TH": "NLM (1963)", "ST": "T005", "RN": "txid10279", "MS": "A species of MOLLUSCIPOXVIRUS causing skin lesions in humans. It is transmitted by direct contact or from non-living reservoirs (fomites), such as books or clothing.", "PM": "66; was see under TUMOR VIRUSES (now see ONCOGENIC VIRUSES) 1963-65", "HN": "66(63); was see under TUMOR VIRUSES (now see ONCOGENIC VIRUSES) 1963-65", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008977"}, {"RECTYPE": "D", "MH": "Mollusk Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Snail Venoms|T123|T131|NON|NRW|UNK (19XX)|860325|abbcdef", "ENTRY": "Venoms, Snail", "MN": "D23.946.833.590", "PA": "Poisons", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTIVENINS; /enzymol permitted; coordinate IM with specific mollusk (IM or NIM)", "PI": "Venoms (1966-1977)", "MS": "Venoms from mollusks, including CONUS and OCTOPUS species. The venoms contain proteins, enzymes, choline derivatives, slow-reacting substances, and several characterized polypeptide toxins that affect the nervous system. Mollusk venoms include cephalotoxin, venerupin, maculotoxin, surugatoxin, conotoxins, and murexine.", "PM": "78", "HN": "78", "MR": "20050630", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D008978"}, {"RECTYPE": "D", "MH": "Moloney murine leukemia virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Moloney Leukemia Virus|T005|EPO|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Virus, Moloney Leukemia", "MN": "B04.820.650.375.525.596", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11801", "AN": "infection: coord IM with RETROVIRIDAE INFECTIONS (IM)+ TUMOR VIRUS INFECTIONS (IM) + LEUKEMIA, EXPERIMENTAL (IM) or LEUKEMIA (IM) (for spontaneous leukemia)", "MS": "A strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) arising during the propagation of S37 mouse sarcoma, and causing lymphoid leukemia in mice. It also infects rats and newborn hamsters. It is apparently transmitted to embryos in utero and to newborns through mother's milk.", "PM": "2002; see MOLONEY LEUKEMIA VIRUS 1985-2001, see MOLONEY VIRUS 1966-1984", "HN": "2002 (1966)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008979"}, {"RECTYPE": "D", "MH": "Moloney murine sarcoma virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Moloney Sarcoma Virus|T005|EPO|EQV|NLM (1985)|990101|abcdef", "ENTRY": "Virus, Moloney Sarcoma", "MN": "B04.820.650.375.860.600", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11809", "AN": "infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + SARCOMA, EXPERIMENTAL (IM)", "PI": "Mouse Sarcoma Viruses (1980-1984)", "MS": "A replication-defective murine sarcoma virus (SARCOMA VIRUSES, MURINE) isolated from a rhabdomyosarcoma by Moloney in 1966.", "PM": "2002; see MOLONEY SARCOMA VIRUS 1991-2001, see MOUSE SARCOMA VIRUSES 1985-1990", "HN": "2002 (1985)", "MR": "20200813", "DA": "19840406", "DC": "1", "DX": "19910101", "UI": "D008980"}, {"RECTYPE": "D", "MH": "Molsidomine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Morsydomine|T109|T121|NON|EQV|UNK (19XX)|860612|abbcdef", "ENTRY": "Von Ct, Molsidomin", "MN": "D03.383.533.640.362", "PA": "Vasodilator Agents", "MH_TH": "USAN (1980)", "ST": "T121", "N1": "Sydnone imine, N-(ethoxycarbonyl)-3-(4-morpholinyl)-", "RN": "D46583G77X", "RR": "25717-80-0 (Molsidomine)", "PI": "Sydnones (1975-1986)", "MS": "A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.", "PM": "87", "HN": "87", "MR": "20170524", "DA": "19860612", "DC": "1", "DX": "19870101", "UI": "D008981"}, {"RECTYPE": "D", "MH": "Molybdenum", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Molybdenum 98", "MN": "D01.552.544.555", "PA": "Trace Elements", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Molybdenum", "RN": "81AH48963U", "RR": "7439-98-7 (Molybdenum)", "MS": "A metallic element with the atomic symbol Mo, atomic number 42, and atomic weight 95.95. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase.", "MR": "20170704", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008982"}, {"RECTYPE": "D", "MH": "Molybdoferredoxin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Molybdenum-Iron Protein|T116|T123|NON|EQV|UNK (19XX)|760413|abbcdef", "ENTRY": "Molybdenum Iron Protein", "MN": "D12.776.556.579.374.375.275.450", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "from bacteria; a component of nitrogenase", "PI": "Molybdenum (1966-1976)", "MS": "A non-heme iron-sulfur protein isolated from Clostridium pasteurianum and other bacteria. It is a component of NITROGENASE, which is active in nitrogen fixation, and consists of two subunits with molecular weights of 59.5 kDa and 50.7 kDa, respectively.", "PM": "91; was see under FERREDOXINS 1977-90", "HN": "91(77); was see under FERREDOXINS 1977-90", "MR": "20210628", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D008983"}, {"RECTYPE": "D", "MH": "Monaco", "AQ": "EH EP", "MN": "Z01.542.616", "MH_TH": "NLM (1983)", "ST": "T083", "MS": "European Principality bordering the Mediterranean Sea on the southern coast of France, near the border with Italy.", "MR": "20160707", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008984"}, {"RECTYPE": "D", "MH": "Monensin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monensin A Sodium Complex", "MN": "D04.345.674.625.500", "PA": "Sodium Ionophores", "MH_TH": "USAN (1968)", "ST": "T195", "N1": "Monensin", "RN": "906O0YJ6ZP", "RR": "22373-78-0 (mono-Na salt)", "PI": "Pyrans (1974)", "MS": "An antiprotozoal agent produced by Streptomyces cinnamonensis. It exerts its effect during the development of first-generation trophozoites into first-generation schizonts within the intestinal epithelial cells. It does not interfere with hosts' development of acquired immunity to the majority of coccidial species. Monensin is a sodium and proton selective ionophore and is widely used as such in biochemical studies.", "PM": "87; was see under FURANS 1975-86", "HN": "87(75); was see under FURANS 1975-86", "MR": "20230226", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D008985"}, {"RECTYPE": "D", "MH": "Mongolia", "AQ": "EH EP", "MN": "Z01.252.474.651", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "= Outer Mongolia; INNER MONGOLIA is see CHINA", "MS": "The country is bordered by RUSSIA on the north and CHINA on the west, south, and east. The capita is Ulaanbaatar.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D008986"}, {"RECTYPE": "D", "MH": "Herpestidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Mungos|T015|NON|NRW|NLM (1998)|961028|abcdef", "ENTRY": "Mongooses, Dwarf", "MN": "B01.050.150.900.649.313.750.377.875", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid9697", "RR": "txid9699", "AN": "note entry terms: MONGOOSE, RING-TAILED; MONGOOSE, BROWN-TAILED; and MALAGASY MONGOOSE see EUPLERIDAE are also available", "MS": "The family of agile, keen-sighted mongooses of Asia and Africa that feed on RODENTS and SNAKES.", "PM": "2005; see MONGOOSES 1998-2004, see MONGOOSE 1991-1997, see CARNIVORA 1975-1990", "HN": "2005 (1975)", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D008988"}, {"RECTYPE": "D", "MH": "Monieziasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Monieziases", "MN": "C22.674.377.656", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "tapeworm infect; usually animal; check tag ANIMAL; for organism index CESTODA (IM) + MONIEZIASIS (NIM)", "PI": "Cestode Infections (1966-1967)", "MS": "Infection of ruminants with tapeworms of the genus Moniezia.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D008989"}, {"RECTYPE": "D", "MH": "Moniliformis", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Moniliformi", "MN": "B01.050.500.500.132.546", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid10236", "AN": "infection: coordinate with HELMINTHIASIS; coordinate with specific helminth terms (ANTIGENS, HELMINTH, etc.) if pertinent", "MS": "A genus of roundworms of the phylum Acanthocephala, parasitic in rats, mice, hamsters, dogs and cats. Occasional infection in man produces inflammation and ulceration of the intestinal mucosa.", "OL": "search ACANTHOCEPHALA 1974", "PM": "91; was see under ACANTHOCEPHALA 1975-90", "HN": "91(75); was see under ACANTHOCEPHALA 1975-90", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008990"}, {"RECTYPE": "D", "MH": "Monitoring, Physiologic", "DE": "MONITORING PHYSIOL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Patient Monitoring|T058|NON|BRD|UNK (19XX)|850607|abcdef", "ENTRY": "Physiological Monitoring", "MN": "E01.370.520", "FX": "Signal Processing, Computer-Assisted", "MH_TH": "NLM (1965)", "ST": "T058", "AN": "IM GEN only; avoid indexing routinely word \"monitoring\": must be \"continuous\" (see MeSH definition); note see related: there emphasis is on the computer-assisted processing", "MS": "The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine.", "OL": "use MONITORING, PHYSIOLOGIC to search MONITORING SYSTEMS 1966-77", "PM": "78; MONITORING SYSTEMS was heading 1966-77", "HN": "78; MONITORING SYSTEMS was heading 1966-77", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008991"}, {"RECTYPE": "D", "MH": "Monkey Diseases", "DE": "MONKEY DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Monkey Disease", "MN": "C22.735.500", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases of Old World and New World monkeys. This term includes diseases of baboons but not of chimpanzees or gorillas (= APE DISEASES).", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008992"}, {"RECTYPE": "D", "MH": "Monkeypox virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Mpox Virus|T005|NON|EQV|NLM (2024)|230201|abcdef", "ENTRY": "Viruses, Mpox", "MN": "B04.280.650.160.650.500", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid10244", "MS": "A species of ORTHOPOXVIRUS that is the etiological agent of MPOX (MONKEYPOX).", "OL": "use MONKEYPOX VIRUS to search MONKEYPOXVIRUS 1994-96 & MONKEY POX VIRUS 1975-93", "PM": "97; was MONKEYPOXVIRUS 1994-96; was MONKEY POX VIRUS 1975-93 (see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80)", "HN": "97; was MONKEYPOXVIRUS 1994-96; was MONKEY POX VIRUS 1975-93 (see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80)", "MR": "20230727", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D008993"}, {"RECTYPE": "D", "MH": "Monoacylglycerol Lipases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Monoglyceride Lipases|T116|T126|NON|EQV|UNK (19XX)|750208|abbcdef", "ENTRY": "Monoester Hydrolases, Glycerol", "MN": "D08.811.277.352.100.500", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Glycerol-ester acylhydrolase", "RN": "EC 3.1.1.23", "PI": "Glycerides (1970-1974)", "MS": "An enzyme that catalyzes the hydrolysis of glycerol monoesters of long-chain fatty acids EC 3.1.1.23.", "PM": "91; was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975", "HN": "91(75); was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D008994"}, {"RECTYPE": "D", "MH": "Monoamine Oxidase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "MAO|T116|T126|ABB|EQV|NLM (1999)|971222|abbcdef", "ENTRY": "Oxidase, Tyramine", "MN": "D08.811.682.664.750", "EC": "antagonists & inhibitors:Monoamine Oxidase Inhibitors", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Amine:oxygen oxidoreductase (deaminating) (flavin-containing)", "RN": "EC 1.4.3.4", "RR": "9001-66-5 (CAS RN)", "MS": "An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4.", "PM": "63; TYRAMINE OXIDASE was indexed under AMINE OXIDOREDUCTASES 1980-98", "HN": "63; for TYRAMINE OXIDASE use MONOAMINE OXIDASE (NM) 1980-98", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D008995"}, {"RECTYPE": "D", "MH": "Monoamine Oxidase Inhibitors", "DE": "MAO INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Reversible Inhibitors of Monoamine Oxidase|T109|T121|NON|NRW|NLM (2000)|991103|REVERSIBLE INHIB MONOAMINE OXIDASE|abbcdefv", "ENTRY": "Inhibitors, Monoamine Oxidase", "MN": "D27.505.519.389.616", "FX": "Antidepressive Agents", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)", "MR": "20200617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D008996"}, {"RECTYPE": "D", "MH": "Monobactams", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Lactams, Monocyclic|T195|NON|EQV|UNK (19XX)|850614|abcdef", "ENTRY": "beta-Lactam, Monocyclic", "MN": "D03.633.100.300.500", "MH_TH": "NLM (1986)", "ST": "T195", "RN": "0", "AN": "do not use /biosyn unless by living matter", "PI": "Antibiotics, Lactam (1983-1985)", "MS": "Monocyclic, bacterially produced or semisynthetic beta-lactam antibiotics. They lack the double ring construction of the traditional beta-lactam antibiotics and can be easily synthesized.", "PM": "86", "HN": "86", "MR": "20200527", "DA": "19850614", "DC": "1", "DX": "19860101", "UI": "D008997"}, {"RECTYPE": "D", "MH": "Monoclonal Gammopathy of Undetermined Significance", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Monoclonal Gammopathies, Benign|T047|NON|EQV|NLM (1986)|990101|abcdef", "ENTRY": "Monoclonal Gammopathy, Benign", "MN": "C20.683.780.640", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Hypergammaglobulinemia (1969-1985)", "MS": "Conditions characterized by the presence of M protein (Monoclonal protein) in serum or urine without clinical manifestations of plasma cell dyscrasia.", "PM": "1991; see HYPERGAMMAGLOBULINEMIA 1986-1990", "HN": "1991(1986); use HYPERGAMMAGLOBULINEMIA 1986-1990", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19850225", "DC": "1", "DX": "19910101", "UI": "D008998"}, {"RECTYPE": "D", "MH": "Monocrotophos", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "SD9,129", "MN": "D02.705.400.550", "PA": "Mutagens", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Phosphoric acid, dimethyl 1-methyl-3-(methylamino)-3-oxo-1-propenyl ester, (E)-", "RN": "6923-22-4", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides (1966-1971)", "MS": "An organophosphate insecticide that inhibits monoamine oxidase and acetylcholinesterase. It has been shown to be genotoxic.", "PM": "91; was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90", "HN": "91(72); was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D008999"}, {"RECTYPE": "D", "MH": "Monocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Monocyte|T025|NON|EQV|NLM (2004)|021230|abcdef", "MN": "A15.382.680.547", "MH_TH": "NLM (1966)", "ST": "T025", "AN": "do not confuse with LEUKOCYTES, MONONUCLEAR", "MS": "Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles.", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009000"}, {"RECTYPE": "D", "MH": "Monomethylhydrazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylhydrazine|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|770523|abbcdeef", "MN": "D02.442.600.601", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Hydrazine, methyl-", "RN": "UWA30B5Z1J", "RR": "60-34-4 (Monomethylhydrazine)", "MS": "Hydrazine substituted by one methyl group.", "OL": "to search METHYLHYDRAZINE use MONOMETHYLHYDRAZINE 1975-77 & HYDRAZINES 1966-74", "PM": "91; was see under METHYLHYDRAZINES 1978-90; was METHYLHYDRAZINE see under HYDRAZINES 1966-77", "HN": "91(78); was see under METHYLHYDRAZINES 1978-90; was METHYLHYDRAZINE see under HYDRAZINES 1966-77", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009002"}, {"RECTYPE": "D", "MH": "Monosaccharide Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hexose Transport Proteins|T116|T123|NON|NRW|UNK (19XX)|850605|abbcdef", "ENTRY": "Transport-Inducing Protein, Glucose", "MN": "D12.776.543.585.500", "MH_TH": "NLM (1986)", "ST": "T123", "RN": "0", "PI": "Monosaccharides (1966-1985)", "MS": "A large group of membrane transport proteins that shuttle MONOSACCHARIDES across CELL MEMBRANES.", "PM": "86", "HN": "86", "MR": "20050630", "DA": "19850605", "DC": "1", "DX": "19860101", "UI": "D009004"}, {"RECTYPE": "D", "MH": "Monosaccharides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Simple Sugar|T109|NON|EQV|NLM (2021)|200127|abcdef", "ENTRY": "Sugars, Simple", "MN": "D09.947.875", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified only; prefer specifics", "MS": "Single chain carbohydrates that are the most basic units of CARBOHYDRATES. They are typically colorless crystalline substances with a sweet taste and have the same general formula CnH2nOn.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009005"}, {"RECTYPE": "D", "MH": "Monosomy", "AQ": "DI GE IM PA PP", "ENTRY": "Monosomies", "MN": "G05.700.131.500", "MH_TH": "NLM (1985)", "ST": "T019", "AN": "\"one chromosome of a pair is missing\"", "PI": "Chromosome Deletion (1975-1984)", "MS": "The condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1.", "PM": "91; was see under CHROMOSOME DELETION 1985-90", "HN": "91(85); was see under CHROMOSOME DELETION 1985-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19840405", "DC": "1", "DX": "19910101", "UI": "D009006"}, {"RECTYPE": "D", "MH": "Monotremata", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Monotrematas", "MN": "B01.050.150.900.649.627", "MH_TH": "NLM (1973)", "ST": "T015", "RN": "txid9255", "PI": "Mammals (1966-1972)", "MS": "An order of egg-laying mammals that includes the PLATYPUS and TACHYGLOSSIDAE.", "PM": "1975, 1963-1967", "HN": "1975(1963)", "MR": "20210712", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D009007"}, {"RECTYPE": "D", "MH": "Abnormalities, Severe Teratoid", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Teratoid Abnormality, Severe", "MN": "C16.131.085", "MH_TH": "NLM (2010)", "ST": "T019", "AN": "fetus in fetu: index under FETUS /abnorm; \"monsters\" in historical literature goes here", "MS": "Marked developmental anomalies of a fetus or infant.", "PM": "2010; see MONSTERS 1963-2009", "HN": "2010 (1963)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "20100101", "UI": "D009008"}, {"RECTYPE": "D", "MH": "Montana", "AQ": "EH EP", "MN": "Z01.107.567.875.560.500", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Canada, on the east by North Dakota and South Dakota, on the south by Idaho and Wyoming, and on the west by Idaho and Utah.", "MR": "20160608", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009009"}, {"RECTYPE": "D", "MH": "Monte Carlo Method", "ENTRY": "Method, Monte Carlo", "MN": "N06.850.520.830.525", "MH_TH": "NLM (1975)", "ST": "T081", "MS": "In statistics, a technique for numerically approximating the solution of a mathematical problem by studying the distribution of some random variable, often generated by a computer. The name alludes to the randomness characteristic of the games of chance played at the gambling casinos in Monte Carlo. (From Random House Unabridged Dictionary, 2d ed, 1993)", "OL": "search OPERATIONS RESEARCH 1966-74", "PM": "91; was see under OPERATIONS RESEARCH 1975-90", "HN": "91(75); was see under OPERATIONS RESEARCH 1975-90", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009010"}, {"RECTYPE": "D", "MH": "Monteggia's Fracture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Monteggia Fracture Dislocations|T037|EPO|EQV|NLM (2023)|210929|abcdef", "ENTRY": "Monteggias Fracture", "MN": "C26.404.937.547", "MH_TH": "NLM (1975)", "ST": "T037", "MS": "Fracture in the proximal half of the shaft of the ulna, with dislocation of the head of the radius.", "OL": "search ULNA FRACTURES 1973-74", "PM": "91; was see under ULNA FRACTURES 1975-90", "HN": "91(75); was see under ULNA FRACTURES 1975-90", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009011"}, {"RECTYPE": "D", "MH": "Mopidamol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Rapenton|T109|T121|TRD|NRW|UNK (19XX)|870810|abbcdef", "MN": "D03.383.742.430", "PA": "Antineoplastic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Ethanol, 2,2',2'',2'''-((4-(1-piperidinyl)pyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis-", "RN": "4Q0IWP8B8O", "RR": "13665-88-8 (Mopidamol)", "PI": "Pyrimidines (1971-1974)", "MS": "A phosphodiesterase inhibitor which inhibits platelet aggregation. Formerly used as an antineoplastic.", "OL": "use MOPIDAMOL to search RA 233 1975-84", "PM": "91; was see under PYRIMIDINES 1985-90; was RA 233 see under PYRIMIDINES 1975-84", "HN": "91(85); was see under PYRIMIDINES 1985-90; was RA 233 see under PYRIMIDINES 1975-84", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009012"}, {"RECTYPE": "D", "MH": "Morale", "ENTRY": "Morales", "MN": "F01.829.477", "FX": "Courage", "MH_TH": "NLM (1966)", "ST": "T078", "MS": "The prevailing temper or spirit of an individual or group in relation to the tasks or functions which are expected.", "CATSH": "CAT LIST", "MR": "20140606", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009013"}, {"RECTYPE": "D", "MH": "Morals", "ENTRY": "Morality|T078|NON|BRD|BIOETHICS (1974)|UNK (19XX)|770317|abcdeef", "MN": "K01.752.566", "FX": "Retrospective Moral Judgment", "MH_TH": "NLM (1966)", "ST": "T078", "MS": "Standards of conduct that distinguish right from wrong.", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009014"}, {"RECTYPE": "D", "MH": "Morantel", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tartrate, Morantel", "MN": "D03.383.903.440", "PA": "Antinematodal Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(3-methyl-2-thienyl)ethenyl)-, (E)-", "RN": "7NJ031HAX5", "RR": "5WF7E9QC3F", "PI": "Thiophenes (1972-1974)", "MS": "Antinematodal agent used mainly for livestock.", "PM": "91; was see under PYRIMIDINES 1975-90", "HN": "91(75); was see under PYRIMIDINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009015"}, {"RECTYPE": "D", "MH": "Moraxella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.530.525", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid475", "AN": "infection: coord IM with MORAXELLACEAE INFECTIONS (IM); note specifics but MORAXELLA KINGAE see KINGELLA KINGAE is available", "MS": "A genus of gram-negative, aerobic bacteria occurring as rods (subgenus Moraxella) or cocci (subgenus Branhamella). Its organisms are parasitic on the mucous membranes of humans and other warm-blooded animals.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009016"}, {"RECTYPE": "D", "MH": "Morbidity", "AQ": "TD", "ENTRY": "Morbidities", "MN": "N06.850.520.308.985.525", "MH_TH": "BIOETHICS (1974)", "ST": "T102", "AN": "IM GEN only; coord NIM with disease /epidemiol (IM); specify geog if possible", "MS": "The proportion of patients with a particular disease during a given year per given unit of population.", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009017"}, {"RECTYPE": "D", "MH": "Morocco", "AQ": "EH EP", "ENTRY": "Ifni|T083|NAM|NRW|UNK (19XX)|781226|abcdef", "MN": "Z01.058.266.629", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country located in north Africa, bordering the Atlantic Ocean and the Mediterranean Sea, with a southern border with Western Sahara, eastern border with Algeria. The capital is Rabat.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009018"}, {"RECTYPE": "D", "MH": "Morphinans", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Morphinan|T109|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D04.615.723.795", "MH_TH": "NLM (1969)", "ST": "T109", "RN": "0", "PI": "Thebaine (1966-1968)", "MS": "Compounds based on a partially saturated iminoethanophenanthrene, which can be described as ethylimino-bridged benzo-decahydronaphthalenes. They include some of the OPIOIDS found in PAPAVER that are used as ANALGESICS.", "PM": "69; BENZOMORPHAN was see under BRIDGED COMPOUNDS 1966-72", "HN": "69", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D009019"}, {"RECTYPE": "D", "MH": "Morphine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Morphine Sulfate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1997)|USP (19XX)|951129|abbcdeeef", "ENTRY": "Sulfate, Morphine", "MN": "D04.615.723.795.576.571", "PA": "Narcotics", "FX": "Receptors, Opioid", "EC": "analogs & derivatives:Morphine Derivatives", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-", "RN": "76I7G6D29C", "RR": "X3P646A2J0", "MS": "The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.", "PM": "MORPHINE SULFATE was indexed under MORPHINE 1980-96", "HN": "MORPHINE SULFATE was (NM) 1980-96", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009020"}, {"RECTYPE": "D", "MH": "Morphine Dependence", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Morphine Addiction|T048|NON|EQV|NLM (1998)|960816|abcdef", "ENTRY": "Dependence, Morphine", "MN": "F03.900.647.500.600", "MH_TH": "NLM (1966)", "ST": "T048", "AN": "HEROIN DEPENDENCE is also available", "MS": "Strong dependence, both physiological and emotional, upon morphine.", "OL": "use MORPHINE DEPENDENCE to search MORPHINE ADDICTION 1966-80", "PM": "81; was MORPHINE ADDICTION 1963-80", "HN": "81; was MORPHINE ADDICTION 1963-80", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D009021"}, {"RECTYPE": "D", "MH": "Morphine Derivatives", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Morphines|T109|T121|NON|EQV|NLM (2014)|130607|abbcdef", "MN": "D04.615.723.795.576", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Morphine (1966-1974)", "MS": "Analogs or derivatives of morphine.", "OL": "search MORPHINANS 1969-74", "PM": "78; was see under MORPHINE 1975-77, was see under MORPHINANS 1969-74", "HN": "78(75); was see under MORPHINE 1975-77, was see under MORPHINANS 1969-74", "MR": "20160531", "DA": "19770504", "DC": "1", "DX": "19780101", "UI": "D009022"}, {"RECTYPE": "D", "MH": "Morphogenesis", "AQ": "DE GE IM PH RE", "MN": "G07.345.500", "MH_TH": "NLM (1968)", "ST": "T040", "AN": "coordinate with specific organ or organism / embryol or /growth", "PI": "Growth (1966-1967)", "MS": "The development of anatomical structures to create the form of a single- or multi-cell organism. Morphogenesis provides form changes of a part, parts, or the whole organism.", "PM": "72", "HN": "72(68)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009024"}, {"RECTYPE": "D", "MH": "Morpholines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetrahydro-1,4-Oxazines|T109|NON|EQV|UNK (19XX)|770520|TETRAHYDROOXAZINES 01 04|abcdefs", "ENTRY": "Tetrahydro 1,4 Oxazines", "MN": "D03.383.533.640", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009025"}, {"RECTYPE": "D", "MH": "Mortality", "DE": "MORTAL", "AQ": "EH HI TD", "PRINT ENTRY": "Death Rate|T081|NON|EQV|NLM (1975)|740330|abcdef", "ENTRY": "Rates, Case Fatality", "MN": "N06.850.520.308.985.550", "FX": "Fatal Outcome", "MH_TH": "NLM (1963)", "ST": "T081", "MS": "All deaths reported in a given population.", "PM": "1963; for MORTALITY, PREMATURE see INFANT MORTALITY 1995-2004", "HN": "1963; for MORTALITY, PREMATURE use INFANT MORTALITY 1995-2004", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D009026"}, {"RECTYPE": "D", "MH": "Mortuary Practice", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Funeral Undertaking|T090|NON|EQV|NLM (2020)|191025|abcdef", "ENTRY": "Undertaking, Funeral", "MN": "H02.438", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "Activities associated with the disposition of the dead. It excludes cultural practices such as FUNERAL RITES.", "MR": "20191025", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009027"}, {"RECTYPE": "D", "MH": "Morula", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Morulas", "MN": "A16.615", "MH_TH": "NLM (1980)", "ST": "T018", "MS": "An early embryo that is a compact mass of about 16 BLASTOMERES. It resembles a cluster of mulberries with two types of cells, outer cells and inner cells. Morula is the stage before BLASTULA in non-mammalian animals or a BLASTOCYST in mammals.", "PM": "91; was see under CLEAVAGE STAGE, OVUM 1980-90", "HN": "91(80); was see under CLEAVAGE STAGE, OVUM 1980-90", "MR": "20070709", "DA": "19790417", "DC": "1", "DX": "19910101", "UI": "D009028"}, {"RECTYPE": "D", "MH": "Mosaic Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, Mosaic", "MN": "B04.715.464", "MH_TH": "NLM (1973)", "ST": "T005", "AN": "general or unspecified; prefer specifics; coordinate IM with specific plant / virol (IM or NIM)", "PI": "Plant Viruses (1966-1978)", "MS": "Viruses which produce a mottled appearance of the leaves of plants.", "PM": "79; was see under PLANT VIRUSES 1975-78", "HN": "79(73); was see under PLANT VIRUSES 1975-78", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D009029"}, {"RECTYPE": "D", "MH": "Mosaicism", "AQ": "CI CL DE EM RE SN VE", "MN": "G05.365.590.175.595", "FX": "Mice, Transgenic", "MH_TH": "NLM (1964)", "ST": "T032", "MS": "The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from a single ZYGOTE, as opposed to CHIMERISM in which the different cell populations are derived from more than one zygote.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009030"}, {"RECTYPE": "D", "MH": "Moscow", "AQ": "EH EP", "MN": "Z01.542.248.775.510", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "for pre- & post-1917 Moscow", "MS": "The capital of Russia.", "HN": "66", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009031"}, {"RECTYPE": "D", "MH": "Mosquito Control", "AQ": "EC ES HI IS LJ MT OG SN ST TD", "ENTRY": "Control, Mosquito", "MN": "N06.850.780.200.650.425.500", "FX": "Pest Control, Biological", "MH_TH": "NLM (1966)", "ST": "T068", "AN": "coord IM with specific mosquito (IM) if pertinent", "MS": "The reduction or regulation of the population of mosquitoes through chemical, biological, or other means.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009032"}, {"RECTYPE": "D", "MH": "Culicidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Mosquitoes|T204|NON|EQV|NLM (1995)|930930|abcdef", "ENTRY": "Mosquito", "MN": "B01.050.500.131.617.720.500.500.750.712.500.875", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid7157", "MS": "A family of the order DIPTERA that comprises the mosquitoes. The larval stages are aquatic, and the adults can be recognized by the characteristic WINGS, ANIMAL venation, the scales along the wing veins, and the long proboscis. Many species are of particular medical importance.", "OL": "use CULICIDAE to search MOSQUITOES 1966-94", "PM": "95; was MOSQUITOES 1963-94", "HN": "95; was MOSQUITOES 1963-94", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19950101", "UI": "D009033"}, {"RECTYPE": "D", "MH": "Mother-Child Relations", "DE": "MOTHER CHILD RELAT", "AQ": "EH LJ PX", "ENTRY": "Relationships, Mother-Child", "MN": "F01.829.263.370.290.170", "MH_TH": "NLM (1968)", "ST": "T054", "AN": "human only", "PI": "Parent-Child Relations (1966-1967)", "MS": "Interaction between a mother and child.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009034"}, {"RECTYPE": "D", "MH": "Mothers", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Mothers' Club", "MN": "M01.620.630", "FX": "Maternal Behavior", "MH_TH": "POPLINE (1981)", "ST": "T099", "AN": "human & animal; /psychol: consider also MOTHER-CHILD RELATIONS; permitted for legal aspects of establishing maternity (as counterpart of PATERNITY); note category: do not confuse with PREGNANCY, a physiol state", "PI": "Mother-Child Relations (1968-1977)", "MS": "Female parents, human or animal.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D009035"}, {"RECTYPE": "D", "MH": "Moths", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Silkworms, Giant|T204|NON|NRW|NLM (1998)|970123|abcdef", "ENTRY": "Silkworm, Giant", "MN": "B01.050.500.131.617.720.500.500.937.650", "MH_TH": "NLM (1975)", "ST": "T204", "RR": "txid7118", "AN": "/microbiol /parasitol /virol permitted; don't forget BOMBYX exists; TN 111 for eff of insecticides", "MS": "Insects of the suborder Heterocera of the order LEPIDOPTERA.", "PM": "91; was see under LEPIDOPTERA 1975-90", "HN": "91(75); was see under LEPIDOPTERA 1975-90", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D009036"}, {"RECTYPE": "D", "MH": "Motilin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.776.631.650.463", "PA": "Gastrointestinal Agents", "MH_TH": "NLM (1977)", "ST": "T125", "RN": "52906-92-0", "PI": "Peptides (1972-1976)", "MS": "A peptide of about 22-amino acids isolated from the DUODENUM. At low pH it inhibits gastric motor activity, whereas at high pH it has a stimulating effect.", "PM": "86; was see under GASTROINTESTINAL HORMONES 1977-85", "HN": "86(77); was see under GASTROINTESTINAL HORMONES 1977-85", "MR": "20151124", "DA": "19760413", "DC": "1", "DX": "19860101", "UI": "D009037"}, {"RECTYPE": "D", "MH": "Motion", "ENTRY": "Motions", "MN": "G01.482", "FX": "Movement", "MH_TH": "NLM (1968)", "ST": "T070", "AN": "a concept in physics; differentiate from MOVEMENT, a physiological concept", "PI": "Movement (1966-1967)", "MS": "Physical motion, i.e., a change in position of a body or subject as a result of an external force. It is distinguished from MOVEMENT, a process resulting from biological activity.", "OL": "search MOVEMENT 1966-67", "PM": "68; was see under MOVEMENT 1963-67", "HN": "68; was see under MOVEMENT 1963-67", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009038"}, {"RECTYPE": "D", "MH": "Motion Perception", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Movement Perception|T041|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Perception, Movement", "MN": "F02.463.593.932.567", "FX": "Motion Capture", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "do not confuse with KINESTHESIS", "MS": "The real or apparent movement of objects through the visual field.", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009039"}, {"RECTYPE": "D", "MH": "Motion Pictures", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "PRINT ENTRY": "Movie|T170|NON|REL|NLM (2021)|191121|abcdef", "ENTRY": "Pictures, Motion", "MN": "L01.462.500.820.090.598", "FX": "Cineradiography", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "docudrama, if a motion picture, goes here; do not confuse with Publication Type DOCUMENTARIES AND FACTUAL FILMS", "MS": "The art, technique, or business of producing motion pictures for entertainment, propaganda, or instruction.", "PM": "2018; see MOTION PICTURES AS TOPIC 2008-2018; see MOTION PICTURES 1963-2007", "HN": "2018(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D009040"}, {"RECTYPE": "D", "MH": "Motion Sickness", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Seasickness|T047|NON|NRW|UNK (19XX)|780127|abcdef", "ENTRY": "Sickness, Sea", "MN": "C23.888.571", "FX": "Travel-Related Illness", "MH_TH": "OMIM (2013)", "ST": "T184", "AN": "SPACE MOTION SICKNESS is also available", "MS": "Disorder caused by motion. It includes sea sickness, train sickness, roller coaster rides, rocking chair, hammock swing, car sickness, air sickness, or SPACE MOTION SICKNESS. Symptoms include nausea, vomiting and/or dizziness.", "OL": "use MOTION SICKNESS to search AIRSICKNESS, CARSICKNESS & SEASICKNESS 1966-78", "HN": "AIRSICKNESS, CARSICKNESS & SEASICKNESS were see under MOTION SICKNESS 1963-78", "CATSH": "CAT LIST", "MR": "20170710", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009041"}, {"RECTYPE": "D", "MH": "Motivation", "AQ": "CL DE ES GE PH RE", "PRINT ENTRY": "Incentives|T080|NON|NRW|NL|770317|abcdef", "ENTRY": "Motivations", "MN": "F01.752.543.500.750", "FX": "Libido", "MH_TH": "NLM (1974)", "ST": "T041", "AN": "human & animal", "MS": "Those factors which cause an organism to behave or act in either a goal-seeking or satisfying manner. They may be influenced by physiological drives or by external stimuli.", "CATSH": "CAT LIST", "MR": "20180227", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009042"}, {"RECTYPE": "D", "MH": "Motor Activity", "AQ": "DE ES GE IM PH RE", "ENTRY": "Motor Activities", "MN": "G11.427.410.698", "FX": "Psychomotor Performance", "MH_TH": "NLM (1968)", "ST": "T055", "AN": "differentiate from MOVEMENT; animal running in exercise wheel goes here or under PHYSICAL EXERTION", "PI": "Behavior, Animal (1966-1967)", "MS": "Body movements of a human or an animal as a behavioral phenomenon.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009043"}, {"RECTYPE": "D", "MH": "Motor Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Premotor and Supplementary Motor Cortices|T023|NON|NRW|NLM (2022)|201007|abcdef", "ENTRY": "Supplementary Motor Areas", "MN": "A08.186.211.200.885.287.500.814.624", "MH_TH": "NLM (1971)", "ST": "T023", "PI": "Cerebral Cortex (1966-1970)", "MS": "Area of the FRONTAL LOBE concerned with primary motor control located in the dorsal PRECENTRAL GYRUS immediately anterior to the central sulcus. It is comprised of three areas: the primary motor cortex located on the anterior paracentral lobule on the medial surface of the brain; the premotor cortex located anterior to the primary motor cortex; and the supplementary motor area located on the midline surface of the hemisphere anterior to the primary motor cortex.", "PM": "1971; for PRECENTRAL GYRUS see FRONTAL LOBE 2015-2021", "HN": "1971; for PRECENTRAL GYRUS use FRONTAL LOBE 2015-2021", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D009044"}, {"RECTYPE": "D", "MH": "Motor Endplate", "AQ": "AB AH BS CH CY DE DG EM EN GD GE IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Motor Endplates", "MN": "A11.284.149.165.420.780.550.550.500", "MH_TH": "NLM (1975)", "ST": "T026", "AN": "do not confuse with NERVE ENDINGS", "MS": "The specialized postsynaptic region of a muscle cell. The motor endplate is immediately across the synaptic cleft from the presynaptic axon terminal. Among its anatomical specializations are junctional folds which harbor a high density of cholinergic receptors.", "OL": "search NEUROMUSCULAR JUNCTION 1968-74", "PM": "91; was see under NEUROMUSCULAR JUNCTION 1975-90", "HN": "91(75); was see under NEUROMUSCULAR JUNCTION 1975-90", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009045"}, {"RECTYPE": "D", "MH": "Motor Neurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Neurons, Motor|T025|NON|EQV|NLM (1994)|930121|abcdef", "ENTRY": "Neuron, Motor", "MN": "A11.671.655.500", "FX": "Neuromuscular Junction", "MH_TH": "NLM (1964)", "ST": "T025", "MS": "Neurons which activate MUSCLE CELLS.", "PM": "66", "HN": "66(64)", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009046"}, {"RECTYPE": "D", "MH": "Motor Neurons, Gamma", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Neurons, Gamma Motor|T025|NON|EQV|UNK (19XX)|780522|abcdef", "ENTRY": "Neurons, Gamma-Efferent Motor", "MN": "A11.671.655.500.525", "FX": "Muscle Spindles", "MH_TH": "NLM (1975)", "ST": "T025", "MS": "Motor neurons which activate the contractile regions of intrafusal SKELETAL MUSCLE FIBERS, thus adjusting the sensitivity of the MUSCLE SPINDLES to stretch. Gamma motor neurons may be \"static\" or \"dynamic\" according to which aspect of responsiveness (or which fiber types) they regulate. The alpha and gamma motor neurons are often activated together (alpha gamma coactivation) which allows the spindles to contribute to the control of movement trajectories despite changes in muscle length.", "OL": "use MOTOR NEURONS, GAMMA to search MOTOR NEURONS, GAMMA EFFERENT 1975-78", "PM": "91; was see under MOTOR NEURONS 1979-90; was MOTOR NEURONS, GAMMA EFFERENT see under MOTOR NEURONS 1975-78", "HN": "91(79); was see under MOTOR NEURONS 1979-90; was MOTOR NEURONS, GAMMA EFFERENT see under MOTOR NEURONS 1975-78", "MR": "20140613", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D009047"}, {"RECTYPE": "D", "MH": "Motor Skills", "AQ": "CL DE ES PH RE", "ENTRY": "Skills, Motor", "MN": "F02.808.260", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "Performance of complex motor acts.", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009048"}, {"RECTYPE": "D", "MH": "Motorcycles", "AQ": "CL EC ES HI LJ SD SN ST", "PRINT ENTRY": "Mopeds|T073|NON|NRW|UNK (19XX)|860418|abcdef", "ENTRY": "Motorcycle", "MN": "J01.937.500.500", "FX": "Off-Road Motor Vehicles", "MH_TH": "NLM (1987)", "ST": "T073", "AN": "MOTORCYCLES are public-road vehicles: OFF-ROAD MOTOR VEHICLES is also available", "PI": "Transportation (1976-1986)", "MS": "Two-wheeled, engine-driven vehicles.", "PM": "87", "HN": "87", "MR": "20180629", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D009049"}, {"RECTYPE": "D", "MH": "Fluorosis, Dental", "DE": "FLUOROSIS DENT", "AQ": "BL CF CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mottled Teeth|T184|NON|REL|NLM (2024)|221013|abcdef", "ENTRY": "Teeth, Mottled", "MN": "C16.131.850.800.295.500.500", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "do not confuse with TOOTH DISCOLORATION", "MS": "A chronic endemic form of ENAMEL HYPOMINERALIZATION caused by drinking water with a high fluorine content during the time of tooth formation, and characterized by defective calcification that gives a white chalky appearance to the enamel, which gradually undergoes brown discoloration. (Jablonski's Dictionary of Dentistry, 1992, p286)", "PM": "97; was MOTTLED ENAMEL 1965-96; FLUOROSIS, DENTAL was see MOTTLED ENAMEL 1987-96", "HN": "97; was MOTTLED ENAMEL 1965-96; FLUOROSIS, DENTAL was see MOTTLED ENAMEL 1987-96", "CATSH": "CAT LIST", "MR": "20230703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009050"}, {"RECTYPE": "D", "MH": "Mountaineering", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Mountaineerings", "MN": "I03.450.642.845.582", "FX": "Altitude", "MH_TH": "NLM (1966)", "ST": "T056", "AN": "/inj: coordinate with specific injury", "MS": "A sport involving mountain climbing techniques.", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009051"}, {"RECTYPE": "D", "MH": "Leukemia Virus, Murine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Graffi's Chloroleukemic Strain|T005|EPO|NRW|NLM (1992)|910401|abcdef", "ENTRY": "Leukemia Viruses, Mouse", "MN": "B04.820.650.375.525", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11786", "AN": "infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + LEUKEMIA, EXPERIMENTAL (IM)", "MS": "Species of GAMMARETROVIRUS, containing many well-defined strains, producing leukemia in mice. Disease is commonly induced by injecting filtrates of propagable tumors into newborn mice.", "PM": "2002; see LEUKEMIA VIRUSES, MURINE 1994-2001, see MOUSE LEUKEMIA VIRUSES 1966-1993; for GRAFFI VIRUS see GRAFFI VIRUS 1991, see MOUSE LEUKEMIA VIRUSES 1975-1990; for GRAFFI'S CHLOROLEUKEMIC STRAIN see GRAFFI VIRUS 1975-1991", "HN": "2002 (1966); was MOUSE LEUKEMIA VIRUSES 1966-93; for GRAFFI VIRUS use GRAFFI VIRUS 1991, use MOUSE LEUKEMIA VIRUSES 1975-1990; for GRAFFI'S CHLOROLEUKEMIC STRAIN use GRAFFI VIRUS 1975-1991", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009052"}, {"RECTYPE": "D", "MH": "Sarcoma Viruses, Murine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Mouse Sarcoma Viruses|T005|NON|EQV|NLM (1994)|930223|abcdef", "ENTRY": "Sarcoma Viruses, Mouse", "MN": "B04.820.650.375.860", "MH_TH": "NLM (1975)", "ST": "T005", "RR": "txid353765", "AN": "infection: coordinate IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM); add SARCOMA, EXPERIMENTAL (IM) if pertinent", "PI": "Mouse Tumor Viruses (1966-1974)", "MS": "A group of replication-defective viruses, in the genus GAMMARETROVIRUS, which are capable of transforming cells, but which replicate and produce tumors only in the presence of Murine leukemia viruses (LEUKEMIA VIRUS, MURINE).", "OL": "use SARCOMA VIRUSES, MURINE to search MOUSE SARCOMA VIRUSES 1980-93 & MOUSE SARCOMA VIRUS 1975-79", "PM": "94; was MOUSE SARCOMA VIRUSES 1980-93; was MOUSE SARCOMA VIRUS see under MOUSE TUMOR VIRUSES 1975-79", "HN": "94; was MOUSE SARCOMA VIRUSES 1980-93; was MOUSE SARCOMA VIRUS see under MOUSE TUMOR VIRUSES 1975-79", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19800101", "UI": "D009053"}, {"RECTYPE": "D", "MH": "Mouth", "AQ": "AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Oral Cavity|T029|NON|EQV|NLM (2003)|020226|abcdef", "ENTRY": "Cavity, Oral", "MN": "A14.549", "FX": "Surgery, Oral", "EC": "abnormalities:Mouth Abnormalities", "MH_TH": "NLM (1966)", "ST": "T029", "CX": "consider also terms at ORAL, ORO-, and STOMAT-", "MS": "The oval-shaped oral cavity located at the apex of the digestive tract and consisting of two parts: the vestibule and the oral cavity proper.", "OL": "use MOUTH to search MOUTH MICROORGANISMS 1966-67", "PM": "/microbiology was MOUTH MICROORGANISMS 1965-67", "HN": "/microbiology was MOUTH MICROORGANISMS 1965-67", "MR": "20040728", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009055"}, {"RECTYPE": "D", "MH": "Mouth Abnormalities", "DE": "MOUTH ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mouth Abnormality", "MN": "C16.131.850.525", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Congenital absence of or defects in structures of the mouth.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009056"}, {"RECTYPE": "D", "MH": "Stomatognathic Diseases", "DE": "STOMATOGNATHIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dental Diseases|T047|NON|NRW|NLM (2007)|050811|abcdef", "ENTRY": "Stomatognathic Disease", "MN": "C07", "RH": "C7 - DISEASES-STOMATOGNATHIC", "MH_TH": "NLM (1974)", "ST": "T047", "AN": "general: prefer specifics; index here for \"stomatol diseases\" of foreign literature", "MS": "General or unspecified diseases of the stomatognathic system, comprising the mouth, teeth, jaws, and pharynx.", "HN": "1989; was MOUTH AND TOOTH DISEASES (NON MESH) 1975-88", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19890101", "UI": "D009057"}, {"RECTYPE": "D", "MH": "Mouth Breathing", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mouth Breathings", "MN": "C23.888.852.761", "MH_TH": "NLM (1968)", "ST": "T184", "AN": "note category: use all pertinent qualif", "PI": "Respiration (1966-1967)", "MS": "Abnormal breathing through the mouth, usually associated with obstructive disorders of the nasal passages.", "PM": "72", "HN": "72(68)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009058"}, {"RECTYPE": "D", "MH": "Mouth Diseases", "DE": "MOUTH DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mouth Disease", "MN": "C07.465", "FX": "Oral Manifestations", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Diseases involving the MOUTH.", "OL": "search MOUTH MICROORGANISMS under MOUTH 1966-67", "PM": "65; was STOMATOLOGY 1963-64; MOUTH MICROORGANISMS was heading 1965-67", "HN": "65; was STOMATOLOGY 1963-64; MOUTH MICROORGANISMS was heading 1965-67", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009059"}, {"RECTYPE": "D", "MH": "Mouth Floor", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Sublingual Region|T029|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Sublingual Regions", "MN": "A14.549.441", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "The area of the mouth beneath the TONGUE.", "OL": "use MOUTH FLOOR to search SUBLINGUAL REGION 1972-73 (as Prov)", "PM": "74", "HN": "74; was SUBLINGUAL REGION 1972-73 (Prov)", "MR": "20151209", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009060"}, {"RECTYPE": "D", "MH": "Mouth Mucosa", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Oral Mucosa|T024|NON|EQV|NLM (1996)|950314|abcdef", "ENTRY": "Mucosa, Oral", "MN": "A14.549.512", "MH_TH": "NLM (1965)", "ST": "T024", "AN": "/surg: consider also VESTIBULOPLASTY; mucositis: coordinate NIM with STOMATITIS (IM)", "MS": "Lining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations.", "PM": "65", "HN": "65", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009061"}, {"RECTYPE": "D", "MH": "Mouth Neoplasms", "DE": "MOUTH NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Oral Neoplasms|T191|NON|EQV|NLM (2000)|991105|ORAL NEOPL|abcdefv", "ENTRY": "Oral Neoplasm", "MN": "C07.465.530", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the MOUTH.", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009062"}, {"RECTYPE": "D", "MH": "Dental Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Dental Physiology|T042|NON|EQV|NLM (1966)|990101|DENT PHYSIOL|abcdefv", "ENTRY": "Processes, Dental Physiological", "MN": "G10.549", "MH_TH": "NLM (2009)", "ST": "T042", "AN": "general or unspecified; prefer specifics; consider also MOUTH /physiol or /physiol with specific parts of the mouth", "PI": "Tooth/physiology (1966-1997)", "MS": "Physiological processes and properties of the DENTITION.", "PM": "2009; see DENTAL PHYSIOLOGY 1998-2008; for DENTAL PHYSIOLOGICAL PROCESSES see DENTAL PHYSIOLOGICAL PROCESSES 2009-2016", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009063"}, {"RECTYPE": "D", "MH": "Mouth Protectors", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Mouthpieces, Protective|T074|NON|EQV|NLM (1998)|970116|abcdef", "ENTRY": "Protectors, Mouth", "MN": "J01.637.708.560.813", "MH_TH": "NLM (1965)", "ST": "T074", "AN": "coord IM with specific instrum of relevant subject area (IM) or procedure (IM)", "MS": "Devices or pieces of equipment placed in or around the mouth or attached to instruments to protect the external or internal tissues of the mouth and the teeth.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009064"}, {"RECTYPE": "D", "MH": "Mouth Rehabilitation", "DE": "MOUTH REHABIL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Rehabilitations, Mouth", "MN": "E06.584", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "general only; prefer specific procedures", "MS": "Process of restoring damaged or decayed teeth using various restorative and non-cosmetic materials so that oral health is improved.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009065"}, {"RECTYPE": "D", "MH": "Mouth, Edentulous", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Toothless Mouth", "MN": "C07.793.597", "FX": "Tooth Loss", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "do not confuse with ANODONTIA (congenital absence of one or more teeth); differentiate from JAW, EDENTULOUS & JAW, EDENTULOUS, PARTIALLY (see definitions under JAW, EDENTULOUS)", "MS": "Total lack of teeth through disease or extraction.", "PM": "65; included total & partial edentulous state 1965-79", "HN": "65; included total & partial edentulous state 1965-79", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009066"}, {"RECTYPE": "D", "MH": "Mouthwashes", "AQ": "AD AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO TU", "ENTRY": "Wash, Mouth", "MN": "J01.637.051.583", "FX": "Dentifrices", "MH_TH": "NLM (1965)", "ST": "T122", "RN": "0", "MS": "Solutions for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. (From Boucher's Clinical Dental Terminology, 4th ed)", "PM": "65", "HN": "65", "MR": "20190501", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009067"}, {"RECTYPE": "D", "MH": "Movement", "AQ": "DE PH RE", "ENTRY": "Movements", "MN": "G11.427.410", "FX": "Motion", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "The act, process, or result of passing from one place or position to another. It differs from LOCOMOTION in that locomotion is restricted to the passing of the whole body from one place to another, while movement encompasses both locomotion but also a change of the position of the whole body or any of its parts. Movement may be used with reference to humans, vertebrate and invertebrate animals, and microorganisms. Differentiate also from MOTOR ACTIVITY, movement associated with behavior.", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009068"}, {"RECTYPE": "D", "MH": "Movement Disorders", "DE": "MOVEMENT DIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Status Marmoratus|T033|T047|NON|REL|NLM (2000)|991103|abbcdef", "ENTRY": "Movement Disorder Syndrome", "MN": "C10.228.662", "FX": "Psychomotor Disorders", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "consider DYSKINESIAS for abnormal involuntary movements as a manifestation of an underlying disease", "MS": "Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.", "PM": "1963; for ORAL DYSKINESIA & LINGUAL-FACIAL-BUCCAL DYSKINESIA see DYSKINESIA, DRUG-INDUCED 2000-2007", "HN": "1963; for ORAL DYSKINESIA & LINGUAL-FACIAL-BUCCAL DYSKINESIA use DYSKINESIA, DRUG-INDUCED 2000-2007", "CATSH": "CAT LIST", "MR": "20170405", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D009069"}, {"RECTYPE": "D", "MH": "Moxalactam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "1-Oxacephalosporin|T109|T195|NON|NRW|UNK (19XX)|830404|OXACEPHALOSPORIN 01|abbcdefs", "ENTRY": "S6059", "MN": "D03.633.100.300.625", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1984)", "ST": "T195", "N1": "5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-", "RN": "VUF6C936Z3", "RR": "64952-97-2 (Moxalactam)", "PI": "Lactams (1972-1980)", "MS": "Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections.", "PM": "84", "HN": "84", "MR": "20160531", "DA": "19830404", "DC": "1", "DX": "19840101", "UI": "D009070"}, {"RECTYPE": "D", "MH": "Moxibustion", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Moxabustion|T061|NON|EQV|NLM (2002)|010131|abcdef", "MN": "E02.190.044.588", "MH_TH": "NLM (1967)", "ST": "T061", "AN": "coordinate with disease /ther, not disease /drug ther", "MS": "The burning of a small, thimble sized, smoldering plug of dried leaves on the SKIN at an ACUPUNCTURE point. Usually the plugs contain leaves of MUGWORT or moxa.", "OL": "use MOXIBUSTION to search MOXA 1966", "PM": "67; was MOXA 1963-66", "HN": "67; was MOXA 1963-66", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009071"}, {"RECTYPE": "D", "MH": "Moyamoya Disease", "DE": "MOYAMOYA DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Progressive Intracranial Occlusive Arteropathy (Moyamoya)|T047|EPO|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Secondary Moyamoya Disease", "MN": "C14.907.253.560.200.737", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Cerebrovascular Disorders (1966-1977)", "MS": "A noninflammatory, progressive occlusion of the intracranial CAROTID ARTERIES and the formation of netlike collateral arteries arising from the CIRCLE OF WILLIS. Cerebral angiogram shows the puff-of-smoke (moyamoya) collaterals at the base of the brain. It is characterized by endothelial HYPERPLASIA and FIBROSIS with thickening of arterial walls. This disease primarily affects children but can also occur in adults.", "PM": "1991; see ARTERIAL OCCLUSIVE DISEASES 1978-1990", "HN": "1991(1978)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D009072"}, {"RECTYPE": "D", "MH": "Mozambique", "AQ": "EH EP", "ENTRY": "Republic of Mozambique|T083|NAM|EQV|NLM (2009)|080326|abcdef", "MN": "Z01.058.290.175.545", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in southern Africa, south of TANZANIA, east of ZAMBIA and ZIMBABWE, bordered on the west by the Indian Ocean. Its capital is Maputo. It was formerly called Portuguese East Africa.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009073"}, {"RECTYPE": "D", "MH": "Melanocyte-Stimulating Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Melanotropin|T116|T121|T123|T125|NON|EQV|UNK (19XX)|760515|abbbbcdef", "ENTRY": "Stimulating Hormone, Melanophore", "MN": "D12.776.631.650.460", "PA": "Hormones", "MH_TH": "UNK (19XX)", "ST": "T125", "RN": "9002-79-3", "MS": "Peptides with the ability to stimulate pigmented cells MELANOCYTES in mammals and MELANOPHORES in lower vertebrates. By stimulating the synthesis and distribution of MELANIN in these pigmented cells, they increase coloration of skin and other tissue. MSHs, derived from pro-opiomelanocortin (POMC), are produced by MELANOTROPHS in the INTERMEDIATE LOBE OF PITUITARY; CORTICOTROPHS in the ANTERIOR LOBE OF PITUITARY, and the hypothalamic neurons in the ARCUATE NUCLEUS OF HYPOTHALAMUS.", "PM": "2006; see MSH 1968-2005, INTERMEDIN 1963-67", "HN": "2006(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009074"}, {"RECTYPE": "D", "MH": "MSH Release-Inhibiting Hormone", "DE": "MSHRIH", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prolyl-Leucyl-Glycinamide|T116|T121|T123|T125|NON|EQV|UNK (19XX)|830317|abbbbcdef", "ENTRY": "Prolyl Leucyl Glycinamide", "MN": "D12.776.631.650.405.700.500", "PA": "Hormones", "MH_TH": "NLM (1975)", "ST": "T125", "RN": "9083-38-9", "RR": "2002-44-0 (L-Prolyl-L-leucyl-glycinamide)", "PI": "Pituitary Hormone-Releasing Hormones (1971-1974)", "MS": "A hypothalamic tripeptide, enzymatic degradation product of OXYTOCIN, that inhibits the release of MELANOCYTE-STIMULATING HORMONES.", "PM": "75", "HN": "75", "MR": "20151124", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D009075"}, {"RECTYPE": "D", "MH": "Mucins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mucin|T116|T123|NON|EQV|UNK (19XX)|771129|abbcdef", "MN": "D12.776.395.560.631", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "coordinate with MEMBRANE GLYCOPROTEINS if membrane-bound", "MS": "High molecular weight mucoproteins that protect the surface of EPITHELIAL CELLS by providing a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface.", "OL": "use MUCINS to search MUCIN 1966-78", "PM": "79; was MUCIN 1963-78", "HN": "79; was MUCIN 1963-78", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D009077"}, {"RECTYPE": "D", "MH": "Mucocele", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Mucoceles", "MN": "C04.182.511", "FX": "Ranula", "MH_TH": "NLM (1965)", "ST": "T020", "AN": "a type of cyst; non-neoplastic", "MS": "A retention cyst of the salivary gland, lacrimal sac, paranasal sinuses, appendix, or gallbladder. (Stedman, 26th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009078"}, {"RECTYPE": "D", "MH": "Mucociliary Clearance", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Mucociliary Transport|T034|T042|NON|EQV|UNK (19XX)|870325|abbcdef", "ENTRY": "Transports, Mucociliary", "MN": "G09.772.555", "MH_TH": "NLM (1988)", "ST": "T042", "PI": "specific respiratory organ/tissue (1966-1987)", "MS": "A non-specific host defense mechanism that removes MUCUS and other material from the LUNGS by ciliary and secretory activity of the tracheobronchial submucosal glands. It is measured in vivo as mucus transfer, ciliary beat frequency, and clearance of radioactive tracers.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19870325", "DC": "1", "DX": "19880101", "UI": "D009079"}, {"RECTYPE": "D", "MH": "Mucocutaneous Lymph Node Syndrome", "DE": "MLNS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lymph Node Syndrome, Mucocutaneous|T047|NON|EQV|UNK (19XX)|760516|abcdef", "ENTRY": "Kawasaki Syndrome|T047|EPO|EQV|GHR (2014)|NLM (2010)|ORD (2010)|090513|abcdeeef", "MN": "C17.800.862.560", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.", "PM": "1984; see LYMPHATIC DISEASES 1977-1983", "HN": "1984(77); use LYMPHATIC DISEASES 1977-1983", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19760519", "DC": "1", "DX": "19840101", "UI": "D009080"}, {"RECTYPE": "D", "MH": "Mucolipidoses", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sialidosis|T047|NON|EQV|GHR (2014)|NLM (2000)|991103|abcdeef", "ENTRY": "Type IV Mucolipidoses", "MN": "C18.452.648.595.554.590", "FX": "Gangliosidoses", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Mucopolysaccharidosis (1974-1976)", "MS": "A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. INTELLECTUAL DISABILITY and skeletal changes, most notably dysostosis multiplex, occur frequently. (From Joynt, Clinical Neurology, 1992, Ch56, pp36-7)", "PM": "2000", "HN": "2000(1977)", "CATSH": "CAT LIST", "MR": "20160226", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D009081"}, {"RECTYPE": "D", "MH": "Mucopolysaccharidoses", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mucopolysaccharidosis|T019|T047|NON|EQV|NLM (1992)|900911|abbcdef", "MN": "C18.452.648.595.600", "MH_TH": "NLM (1974)", "ST": "T047", "MS": "Group of lysosomal storage diseases each caused by an inherited deficiency of an enzyme involved in the degradation of glycosaminoglycans (mucopolysaccharides). The diseases are progressive and often display a wide spectrum of clinical severity within one enzyme deficiency.", "OL": "use MUCOPOLYSACCHARIDOSES to search MUCOPOLYSACCHARIDOSIS 1974-91", "PM": "92; was MUCOPOLYSACCHARIDOSIS 1974-91", "HN": "92; was MUCOPOLYSACCHARIDOSIS 1974-91", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009083"}, {"RECTYPE": "D", "MH": "Mucopolysaccharidosis III", "DE": "MPS III", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sanfilippo's Syndrome|T019|T047|EPO|EQV|UNK (19XX)|741205|abbcdef", "ENTRY": "Syndromes, Sanfilippo", "MN": "C18.452.648.595.600.650", "MH_TH": "NLM (1975)", "ST": "T047", "PI": "Mucopolysaccharidosis (1974)", "MS": "Mucopolysaccharidosis characterized by heparitin sulfate in the urine, progressive mental retardation, mild dwarfism, and other skeletal disorders. There are four clinically indistinguishable but biochemically distinct forms, each due to a deficiency of a different enzyme.", "OL": "use MUCOPOLYSACCHARIDOSIS III to search MUCOPOLYSACCHARIDOSIS 3 1975-91", "PM": "92; was MUCOPOLYSACCHARIDOSIS 3 1991; was see under MUCOPOLYSACCHARIDOSIS 1975-90", "HN": "92; was MUCOPOLYSACCHARIDOSIS 3 1991; was see under MUCOPOLYSACCHARIDOSIS 1975-90", "CATSH": "CAT LIST", "MR": "20160628", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D009084"}, {"RECTYPE": "D", "MH": "Mucopolysaccharidosis IV", "DE": "MPS IV", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Morquio's Disease|T047|EPO|EQV|GHR (2014)|NLM (1992)|900912|MORQUIOS DIS|abcdeefv", "ENTRY": "Type IVs, Mucopolysaccharidosis", "MN": "C18.452.648.595.600.655", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Genetic disorder of mucopolysaccharide metabolism characterized by skeletal abnormalities, joint instability, development of cervical myelopathy, and excessive urinary keratan sulfate. There are two biochemically distinct forms, each due to a deficiency of a different enzyme.", "PM": "1992; see MUCOPOLYSACCHARIDOSIS 4 1980-1991, see ECCENTROOSTEOCHONDRODYSPLASIA 1963-1979; MORQUIO'S DISEASE was MORQUIO DISEASE see MUCOPOLYSACCHARIDOSIS 4 1980-1991", "HN": "1992; use MUCOPOLYSACCHARIDOSIS 4 1980-1991, use ECCENTROOSTEOCHONDRODYSPLASIA 1963-1979; for MORQUIO'S DISEASE use MUCOPOLYSACCHARIDOSIS 4 1980-1991", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D009085"}, {"RECTYPE": "D", "MH": "Mucopolysaccharidosis VI", "DE": "MPS VI", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polydystrophic Dwarfism|T019|T047|NON|EQV|GHR (2014)|UNK (19XX)|741205|abbcdeef", "ENTRY": "Type VI, Mucopolysaccharidosis", "MN": "C18.452.648.595.600.670", "MH_TH": "NLM (1975)", "ST": "T047", "PI": "Mucopolysaccharidosis (1974)", "MS": "Mucopolysaccharidosis with excessive CHONDROITIN SULFATE B in urine, characterized by dwarfism and deafness. It is caused by a deficiency of N-ACETYLGALACTOSAMINE-4-SULFATASE (arylsulfatase B).", "OL": "use MUCOPOLYSACCHARIDOSIS VI to search MUCOPOLYSACCHARIDOSIS 6 1975-91", "PM": "92; was MUCOPOLYSACCHARIDOSIS 6 1991; was see under MUCOPOLYSACCHARIDOSIS 1975-90", "HN": "92; was MUCOPOLYSACCHARIDOSIS 6 1991; was see under MUCOPOLYSACCHARIDOSIS 1975-90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D009087"}, {"RECTYPE": "D", "MH": "Mucoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.395.560", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "includes mucoids & mucopeptides", "MS": "Conjugated proteins in which mucopolysaccharides are combined with proteins. The mucopolysaccharide moiety is the predominant group with the protein making up only a small percentage of the total weight.", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009088"}, {"RECTYPE": "D", "MH": "Mucor", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Mucors", "MN": "B01.300.300.500.500", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid4830", "MS": "A genus of zygomycetous fungi of the family Mucoraceae, order Mucorales. It is primarily saprophytic, but may cause MUCORMYCOSIS in man from spores germinating in the lungs.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009089"}, {"RECTYPE": "D", "MH": "Mucorales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Thamnidiaceae|T004|NON|NRW|NLM (2022)|210316|abcdef", "MN": "B01.300.300.500", "FX": "Mucormycosis", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid4827", "RR": "txid34489", "PI": "Phycomyces (1966-1974)", "MS": "An order of zygomycetous fungi, usually saprophytic, causing damage to food in storage, but which may cause respiratory infection or MUCORMYCOSIS in persons suffering from other debilitating diseases.", "PM": "79; see PHYCOMYCETES 1963-78; for PHYCOMYCES see PHYCOMYCETES 1975-85", "HN": "79; use FUNGI 1963-78", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D009090"}, {"RECTYPE": "D", "MH": "Mucormycosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Mucormycoses|T047|NON|EQV|NLM (2021)|200228|abcdef", "ENTRY": "Mucormycose", "MN": "C01.150.703.980.600", "FX": "Mucorales", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Infection in humans and animals caused by any fungus in the order MUCORALES (e.g., RHIZOPUS; MUCOR; CUNNINGHAMELLA; APOPHYSOMYCES; ABSIDIA; SAKSENAEA and RHIZOMUCOR) There are many clinical types associated with infection including central nervous system, lung, gastrointestinal tract, skin, orbit and paranasal sinuses. In humans, it usually occurs as an OPPORTUNISTIC INFECTION.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009091"}, {"RECTYPE": "D", "MH": "Mucous Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Muscularis Mucosae|T024|NON|NRW|NLM (2006)|041022|abcdef", "ENTRY": "Tissues, Mucosal", "MN": "A10.615.550", "FX": "Administration, Mucosal", "MH_TH": "NLM (1966)", "ST": "T024", "AN": "general or unspecified; prefer specifics; coordinate NIM with specific organ (IM)", "MS": "An EPITHELIUM with MUCUS-secreting cells, such as GOBLET CELLS. It forms the lining of many body cavities, such as the DIGESTIVE TRACT, the RESPIRATORY TRACT, and the reproductive tract. Mucosa, rich in blood and lymph vessels, comprises an inner epithelium, a middle layer (lamina propria) of loose CONNECTIVE TISSUE, and an outer layer (muscularis mucosae) of SMOOTH MUSCLE CELLS that separates the mucosa from submucosa.", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009092"}, {"RECTYPE": "D", "MH": "Mucus", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "MN": "A12.200.503", "FX": "Drainage, Postural", "MH_TH": "NLM (1963)", "ST": "T031", "AN": "mucus glands: index MUCUS (IM) + EXOCRINE GLANDS (IM)", "MS": "The viscous secretion of mucous membranes. It contains mucin, white blood cells, water, inorganic salts, and exfoliated cells.", "PM": "66", "HN": "66(63)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009093"}, {"RECTYPE": "D", "MH": "Mud Therapy", "DE": "MUD THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Pelotherapy|T061|NON|EQV|NLM (1998)|961011|PELOTHER|abcdefv", "ENTRY": "Packs, Mud", "MN": "E02.056.610", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "includes earth & clay", "MS": "The therapeutic use of mud in packs or baths taking advantage of the absorptive qualities of the mud. It has been used for rheumatism and skin problems.", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009094"}, {"RECTYPE": "D", "MH": "Mullerian Ducts", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Mullerian Duct|T018|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Ducts, Mullerian", "MN": "A16.623", "MH_TH": "NLM (1965)", "ST": "T018", "MS": "A pair of ducts near the WOLFFIAN DUCTS in a developing embryo. In the male embryo, they degenerate with the appearance of testicular ANTI-MULLERIAN HORMONE. In the absence of anti-mullerian hormone, mullerian ducts give rise to the female reproductive tract, including the OVIDUCTS; UTERUS; CERVIX; and VAGINA.", "PM": "72", "HN": "72(65)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009095"}, {"RECTYPE": "D", "MH": "Multi-Institutional Systems", "DS": "MULTIINSTITUTIONAL SYSTEMS", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Multi-Hospital Systems|T093|NON|NRW|UNK (19XX)|790601|MULTIHOSPITAL SYSTEMS|MULTI HOSP SYSTEMS|abcdefsv", "ENTRY": "Systems, Multihospital", "MN": "N04.452.540", "MH_TH": "NLM (1980)", "ST": "T093", "AN": "IM; coord with institutions or specialty (IM); specify geog", "PI": "Hospital Shared Services (1968-1979)", "MS": "Institutional systems consisting of more than one health facility which have cooperative administrative arrangements through merger, affiliation, shared services, or other collective ventures.", "PM": "80", "HN": "80", "MR": "19991103", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D009096"}, {"RECTYPE": "D", "MH": "Multienzyme Complexes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Complexes, Multienzyme", "MN": "D08.811.600", "FX": "Multifunctional Enzymes", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "0", "AN": "MULTIPROTEIN COMPLEXES and MULTIFUNCTIONAL ENZYMES are also available", "PI": "specific enzymes or enzyme groups (1966-1973)", "MS": "Systems of enzymes which function sequentially by catalyzing consecutive reactions linked by common metabolic intermediates. They may involve simply a transfer of water molecules or hydrogen atoms and may be associated with large supramolecular structures such as MITOCHONDRIA or RIBOSOMES.", "PM": "73", "HN": "73", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009097"}, {"RECTYPE": "D", "MH": "Multiphasic Screening", "AQ": "AE CL EC ES HI IS LJ MO MT NU OG PX ST TD VE", "PRINT ENTRY": "Automated Multiphasic Health Testing|T060|NON|NRW|UNK (19XX)|860617|abcdef", "ENTRY": "Screenings, Multiphasic", "MN": "N06.850.780.500.560", "MH_TH": "NLM (1968)", "ST": "T062", "PI": "Physical Examination (1966-1967)", "MS": "The simultaneous use of multiple laboratory procedures for the detection of various diseases. These are usually performed on groups of people.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009098"}, {"RECTYPE": "D", "MH": "Multiple Birth Offspring", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Sextuplets|T099|NON|NRW|NLM (1998)|960923|abcdef", "ENTRY": "Sextuplet", "MN": "M01.438", "MH_TH": "NLM (1974)", "ST": "T099", "AN": "note specifics; human & animal; for animals, consider also LITTER SIZE", "PI": "specific multiple birth (1966-1997)", "MS": "The offspring in multiple pregnancies (PREGNANCY, MULTIPLE): TWINS; TRIPLETS; QUADRUPLETS; QUINTUPLETS; etc.", "PM": "98", "HN": "98; use explode 1975-97", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009099"}, {"RECTYPE": "D", "MH": "Multiple Carboxylase Deficiency", "DE": "MULTIPLE CARBOXYLASE DEFIC", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Combined Carboxylase Deficiency|T047|NON|EQV|UNK (19XX)|860418|COMBINED CARBOXYLASE DEFIC|abcdefv", "ENTRY": "Multiple Carboxylase Deficiencies", "MN": "C18.452.648.202.720", "FX": "Biotin", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "specific enzyme/deficiency (1975-1986)", "MS": "A deficiency in the activities of biotin-dependent enzymes (propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, and PYRUVATE CARBOXYLASE) due to one of two defects in BIOTIN metabolism. The neonatal form is due to HOLOCARBOXYLASE SYNTHETASE DEFICIENCY. The late-onset form is due to BIOTINIDASE DEFICIENCY.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D009100"}, {"RECTYPE": "D", "MH": "Multiple Myeloma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Myeloma, Plasma-Cell|T191|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Plasma-Cell Myelomas", "MN": "C20.683.780.650", "FX": "Myeloma Proteins", "MH_TH": "ORD (2010)", "ST": "T191", "MS": "A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009101"}, {"RECTYPE": "D", "MH": "Multiple Organ Failure", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Organ Failure, Multiple|T033|T046|NON|EQV|UNK (19XX)|820426|abbcdef", "ENTRY": "Multiple Organ Failures", "MN": "C23.550.835.525", "FX": "Organ Dysfunction Scores", "MH_TH": "NLM (1983)", "ST": "T046", "MS": "A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19820426", "DC": "1", "DX": "19830101", "UI": "D009102"}, {"RECTYPE": "D", "MH": "Multiple Sclerosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sclerosis, Disseminated|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Sclerosis, Multiple", "MN": "C20.111.258.250.500", "FX": "Myelitis, Transverse", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009103"}, {"RECTYPE": "D", "MH": "Multiple Trauma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wounds, Multiple|T037|NON|EQV|UNK (19XX)|870430|abcdef", "ENTRY": "Wound, Multiple", "MN": "C26.640", "MH_TH": "NLM (1988)", "ST": "T037", "AN": "coordinate IM with specific injury term or organ/inj IM or NIM if pertinent", "PI": "Wounds and Injuries (1966-1987)", "MS": "Multiple physical insults or injuries occurring simultaneously.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19870430", "DC": "1", "DX": "19880101", "UI": "D009104"}, {"RECTYPE": "D", "MH": "Dissociative Identity Disorder", "DE": "DISSOCIATIVE IDENTITY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Multiple Personality Disorder|T048|NON|EQV|NLM (1975)|990101|MULTIPLE PERSONALITY DIS|abcdefv", "ENTRY": "Personality, Multiple", "MN": "F03.300.500", "MH_TH": "NLM (1998)", "ST": "T048", "MS": "A dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behavior patterns and social friendships. Transition from one personality to another is sudden.", "PM": "2019; for MULTIPLE PERSONALITIES see DUAL PERSONALITY 1968-78", "HN": "2019(1968)", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D009105"}, {"RECTYPE": "D", "MH": "Mummies", "AQ": "DG HI MI PA PS VI", "ENTRY": "Mummy", "MN": "I01.076.368.584.500", "MH_TH": "NLM (1966)", "ST": "T015", "AN": "do not routinely check the tag ANCIENT HISTORY unless the historical & ancient medical aspects are particularly discussed; /pathol: do not coordinate with PALEOPATHOLOGY; FETAL MUMMIFICATION see FETAL DEATH and PULP MUMMIFICATION see DENTAL PULP NECROSIS are also available", "MS": "Bodies preserved either by the ancient Egyptian technique or due to chance under favorable climatic conditions.", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009106"}, {"RECTYPE": "D", "MH": "Mumps", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Parotitis, Epidemic|T047|NON|EQV|NLM (1998)|960806|abcdef", "ENTRY": "Parotitides, Epidemic", "MN": "C07.465.815.470.800.630", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by the MUMPS VIRUS, a rubulavirus", "MS": "An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009107"}, {"RECTYPE": "D", "MH": "Mumps Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccine, Mumps", "MN": "D20.215.894.899.488", "MH_TH": "NLM (1969)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1966-1968)", "MS": "Vaccines used to prevent infection by MUMPS VIRUS. Best known is the live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.", "PM": "72", "HN": "72(69)", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009108"}, {"RECTYPE": "D", "MH": "Mumps virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Myxovirus parotitidis|T005|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Mumps viruses", "MN": "B04.820.480.937.600.650.750.550", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid1979165", "MS": "The type species of RUBULAVIRUS that causes an acute infectious disease in humans, affecting mainly children. Transmission occurs by droplet infection.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009109"}, {"RECTYPE": "D", "MH": "Munchausen Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Hospital-Addiction Syndrome|T048|NON|EQV|UNK (19XX)|800520|HOSP ADDICTION SYNDROME|abcdefv", "ENTRY": "Syndromes, Hospital-Addiction", "MN": "F03.875.375.600", "FX": "Health Services Misuse", "MH_TH": "NLM (1964)", "ST": "T048", "AN": "dis symptoms fabricated by a person seeking hospitalization repeatedly; MUNCHAUSEN SYNDROME BY PROXY is available", "MS": "A factitious disorder characterized by habitual presentation for hospital treatment of an apparent acute illness, the patient giving a plausible and dramatic history, all of which is false.", "PM": "68", "HN": "68(64)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009110"}, {"RECTYPE": "D", "MH": "Local Government", "AQ": "HI", "PRINT ENTRY": "Municipal Government|T092|NON|NRW|BIOETHICS (1976)|NLM (1966)|980304|abcdeef", "ENTRY": "Government, Municipal", "MN": "N03.540.348.750", "MH_TH": "BIOETHICS (1976)", "ST": "T092", "AN": "specify geography", "MS": "Smallest political subdivisions within a country at which general governmental functions are carried-out.", "PM": "99; was MUNICIPAL GOVERNMENT 1966-98", "HN": "99; was MUNICIPAL GOVERNMENT 1966-98", "MR": "20090730", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D009111"}, {"RECTYPE": "D", "MH": "Muramic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Muramic", "MN": "D09.811.522", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "PI": "Hexosamines (1966-1972)", "MS": "Compounds consisting of glucosamine and lactate joined by an ether linkage. They occur naturally as N-acetyl derivatives in peptidoglycan, the characteristic polysaccharide composing bacterial cell walls. (From Dorland, 28th ed)", "OL": "use MURAMIC ACIDS to search MURAMIC ACID 1973-74 (as Prov)", "PM": "91; was see under SUGAR ACIDS 1975-90; was MURAMIC ACID 1973-74 (Prov)", "HN": "91(75); was see under SUGAR ACIDS 1975-90; was MURAMIC ACID 1973-74 (Prov)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009112"}, {"RECTYPE": "D", "MH": "Muramidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lysozyme|T116|T121|T126|NON|EQV|UNK (19XX)|740330|abbbcdef", "ENTRY": "N Acetylmuramide Glycanhydrolase", "MN": "D08.811.277.450.642", "PA": "Anti-Infective Agents", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Peptidoglycan N-acetylmuramoylhydrolase", "RN": "EC 3.2.1.17", "AN": "an anti-infective glycoside hydrolase", "MS": "A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009113"}, {"RECTYPE": "D", "MH": "Murexide", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Ammonium Purpurate|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Purpurate, Ammonium", "MN": "D03.383.742.698.253.500", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-((hexahydro-2,4,6-trioxo-5-pyrimidinyl)imino)-, monoammonium salt", "RN": "4W6L62S876", "RR": "3051-09-0 (Murexide)", "PI": "Barbiturates (1969-1974)", "MS": "5,5'-Nitrilodibarbituric acid ammonium derivative. Used as an indicator for complexometric titrations.", "PM": "91; was see under BARBITURATES 1975-90", "HN": "91(75); was see under BARBITURATES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009114"}, {"RECTYPE": "D", "MH": "Muridae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Murids|T015|NON|EQV|UNK (19XX)|810514|abcdef", "ENTRY": "Murid", "MN": "B01.050.150.900.649.313.992.635", "MH_TH": "NLM (1982)", "ST": "T015", "RN": "txid10066", "AN": "do not check tags MICE or RATS", "PI": "Rodentia (1966-1981)", "MS": "A family of the order Rodentia containing 250 genera including the two genera Mus (MICE) and Rattus (RATS), from which the laboratory inbred strains are developed. The fifteen subfamilies are SIGMODONTINAE (New World mice and rats), CRICETINAE, Spalacinae, Myospalacinae, Lophiomyinae, ARVICOLINAE, Platacanthomyinae, Nesomyinae, Otomyinae, Rhizomyinae, GERBILLINAE, Dendromurinae, Cricetomyinae, MURINAE (Old World mice and rats), and Hydromyinae.", "PM": "82", "HN": "82", "MR": "20200813", "DA": "19810514", "DC": "1", "DX": "19820101", "UI": "D009115"}, {"RECTYPE": "D", "MH": "Muscarine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.132.545", "PA": "Parasympathomimetics", "MH_TH": "NLM (1977)", "ST": "T131", "N1": "2-Furanmethanaminium, tetrahydro-4-hydroxy-N,N,N,5-tetramethyl-, (2S-(2alpha,4beta,5alpha))-", "RN": "7T101UWZ5W", "RR": "300-54-9 (Muscarine)", "AN": "/biosyn if permitted by plant; do not confuse with the dye muscarine", "PI": "Parasympathomimetics (1966-1976)", "MS": "A toxic alkaloid found in Amanita muscaria (fly fungus) and other fungi of the Inocybe species. It is the first parasympathomimetic substance ever studied and causes profound parasympathetic activation that may end in convulsions and death. The specific antidote is atropine.", "OL": "search PARASYMPATHOMIMETICS 1966-68", "HN": "77; was see under PARASYMPATHOMIMETICS 1963-68", "MR": "20130708", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D009116"}, {"RECTYPE": "D", "MH": "Muscidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Stomoxys calcitrans|T204|NON|REL|UNK (19XX)|870504|abcdef", "ENTRY": "irritan, Haematobia", "MN": "B01.050.500.131.617.720.500.500.750.642", "MH_TH": "NLM (1988)", "ST": "T204", "RN": "txid7366", "RR": "txid95468", "AN": "do not use /drug eff for insecticides: TN 111; note MUSCA DOMESTICA see HOUSEFLIES", "PI": "Houseflies (1966-1987)", "MS": "A family of the order DIPTERA with over 700 species. Important species that may be mechanical vectors of disease include Musca domesticus (HOUSEFLIES), Musca autumnalis (face fly), Stomoxys calcitrans (stable fly), Haematobia irritans (horn fly) and Fannia spp.", "PM": "88", "HN": "88", "MR": "20200813", "DA": "19870502", "DC": "1", "DX": "19880101", "UI": "D009117"}, {"RECTYPE": "D", "MH": "Muscimol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pantherine|T109|T121|NON|EQV|UNK (19XX)|780503|abbcdef", "MN": "D23.946.587.587", "PA": "GABA-A Receptor Agonists", "FX": "Receptors, GABA-A", "MH_TH": "NLM (1979)", "ST": "T121", "N1": "3(2H)-Isoxazolone, 5-(aminomethyl)-", "RN": "2763-96-4", "PI": "Toxins (1966)", "MS": "A neurotoxic isoxazole isolated from species of AMANITA. It is obtained by decarboxylation of IBOTENIC ACID. Muscimol is a potent agonist of GABA-A RECEPTORS and is used mainly as an experimental tool in animal and tissue studies.", "PM": "86; was see under OXAZOLES 1979-85", "HN": "86(79); was see under OXAZOLES 1979-85", "MR": "20160531", "DA": "19780503", "DC": "1", "DX": "19860101", "UI": "D009118"}, {"RECTYPE": "D", "MH": "Muscle Contraction", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Inotropism|T067|NON|REL|UNK (19XX)|790410|abcdef", "ENTRY": "Muscular Contractions", "MN": "G11.427.494", "FX": "Muscle Strength", "MH_TH": "NLM (1964)", "ST": "T042", "MS": "A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009119"}, {"RECTYPE": "D", "MH": "Muscle Cramp", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Limb Cramp|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Muscular Cramps", "MN": "C23.888.592.608.500", "FX": "Spasm", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A sustained and usually painful contraction of muscle fibers. This may occur as an isolated phenomenon or as a manifestation of an underlying disease process (e.g., UREMIA; HYPOTHYROIDISM; MOTOR NEURON DISEASE; etc.). (From Adams et al., Principles of Neurology, 6th ed, p1398)", "CATSH": "CAT LIST", "MR": "20030725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009120"}, {"RECTYPE": "D", "MH": "Muscle Denervation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Muscle Denervations", "MN": "E04.525.210.560.500", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "coordinate with specific muscle /innerv; NIM when a study technique", "MS": "The resection or removal of the innervation of a muscle or muscle tissue.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009121"}, {"RECTYPE": "D", "MH": "Muscle Hypertonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Muscular Hypertonicity|T184|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Transient Hypertonias", "MN": "C23.888.592.608.550", "MH_TH": "NLM (1979)", "ST": "T184", "AN": "coord IM with specific muscle/physiopathol (IM) if available", "PI": "Spasm (1966-1976)", "MS": "Abnormal increase in skeletal or smooth muscle tone. Skeletal muscle hypertonicity may be associated with PYRAMIDAL TRACT lesions or BASAL GANGLIA DISEASES.", "PM": "1979", "HN": "1979", "CATSH": "CAT LIST", "MR": "19991206", "DA": "19780517", "DC": "1", "DX": "19790101", "UI": "D009122"}, {"RECTYPE": "D", "MH": "Muscle Hypotonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypotonia|T184|NON|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Tone Poor, Muscle", "MN": "C23.888.592.608.575", "MH_TH": "NLM (1977)", "ST": "T184", "PI": "Muscular Diseases (1966-1976)", "MS": "A diminution of the skeletal muscle tone marked by a diminished resistance to passive stretching.", "PM": "1977", "HN": "1977", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D009123"}, {"RECTYPE": "D", "MH": "Muscle Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Muscle", "MN": "D12.776.210.500", "MH_TH": "NLM (1966)", "ST": "T116", "RN": "0", "AN": "/biosyn /drug eff /physiol permitted; for contractile proteins in muscle, index only under MUSCLE PROTEINS or specifics & not also under CONTRACTILE PROTEINS", "MS": "The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009124"}, {"RECTYPE": "D", "MH": "Muscle Relaxants, Central", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Centrally Acting Muscle Relaxants|T121|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Relaxants, Central Muscle", "MN": "D27.505.954.427.525", "FX": "Parasympatholytics", "MH_TH": "NLM (1970)", "ST": "T121", "RN": "0", "PI": "Muscles (1966-1969)", "MS": "A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)", "OL": "search MUSCLE RELAXANTS under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 & MUSCLES 1966-69", "PM": "70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69", "HN": "70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D009125"}, {"RECTYPE": "D", "MH": "Muscle Relaxation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Relaxations, Muscle", "MN": "G11.427.494.554", "MH_TH": "NLM (1977)", "ST": "T042", "PI": "Muscle Contraction (1966-1976)", "MS": "That phase of a muscle twitch during which a muscle returns to a resting position.", "PM": "91; was see under MUSCLE CONTRACTION 1977-90", "HN": "91(77); was see under MUSCLE CONTRACTION 1977-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D009126"}, {"RECTYPE": "D", "MH": "Muscle Rigidity", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rigidity, Muscular|T184|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Rigidity, Nuchal", "MN": "C23.888.592.608.550.500", "MH_TH": "NLM (1972)", "ST": "T184", "PI": "Muscular Diseases (1966-1971)", "MS": "Continuous involuntary sustained muscle contraction which is often a manifestation of BASAL GANGLIA DISEASES. When an affected muscle is passively stretched, the degree of resistance remains constant regardless of the rate at which the muscle is stretched. This feature helps to distinguish rigidity from MUSCLE SPASTICITY. (From Adams et al., Principles of Neurology, 6th ed, p73)", "PM": "1973", "HN": "1973(1972)", "CATSH": "CAT LIST", "MR": "19991206", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009127"}, {"RECTYPE": "D", "MH": "Muscle Spasticity", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Clasp-Knife Spasticity|T184|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Spasticity, Muscle", "MN": "C23.888.592.608.550.550", "FX": "Spasm", "MH_TH": "NLM (1977)", "ST": "T184", "AN": "skeletal muscle only; note category: not physiological; spastic paralysis: coord NIM with PARALYSIS (IM); spasticity in cerebral palsy: coord NIM with CEREBRAL PALSY only if musc spasticity is especially discussed", "PI": "Spasm (1966-1976)", "MS": "A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a \"free interval\") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)", "PM": "1977", "HN": "1977", "CATSH": "CAT LIST", "MR": "19991206", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D009128"}, {"RECTYPE": "D", "MH": "Muscle Tonus", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Muscle Tension|T042|NON|EQV|NLM (1998)|960710|abcdef", "ENTRY": "Tonus, Muscle", "MN": "G11.427.565", "FX": "Muscle Hypotonia", "MH_TH": "NLM (1970)", "ST": "T042", "PI": "Muscle Contraction (1966-1969)", "MS": "The state of activity or tension of a muscle beyond that related to its physical properties, that is, its active resistance to stretch. In skeletal muscle, tonus is dependent upon efferent innervation. (Stedman, 25th ed)", "PM": "72; for MUSCLE TENSION see MUSCLE CONTRACTION 1998-2006", "HN": "72(70)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009129"}, {"RECTYPE": "D", "MH": "Muscle, Smooth", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Smooth Muscle|T024|NON|EQV|NLM (2008)|070402|abcdef", "ENTRY": "Smooth Muscles", "MN": "A10.690.467", "MH_TH": "NLM (1966)", "ST": "T024", "AN": "coordinate with specific organ if pertinent; /growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent", "MS": "Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009130"}, {"RECTYPE": "D", "MH": "Muscle, Smooth, Vascular", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Vascular Smooth Muscle|T024|NON|EQV|NLM (1995)|940204|abcdef", "ENTRY": "Vascular Smooth Muscles", "MN": "A10.690.467.491", "MH_TH": "NLM (1980)", "ST": "T024", "AN": "coord IM with specific vein or artery (NIM & then only if pertinent); /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent", "PI": "Muscle, Smooth (1966-1979)", "MS": "The nonstriated involuntary muscle tissue of blood vessels.", "PM": "80", "HN": "80", "MR": "20180701", "DA": "19790425", "DC": "1", "DX": "19800101", "UI": "D009131"}, {"RECTYPE": "D", "MH": "Muscles", "AQ": "AB AH BS CH CY DE DG EM EN IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tissues, Muscle", "MN": "A10.690", "FX": "Sarcoplasmic Reticulum", "EC": "growth & development:Muscle Development", "MH_TH": "NLM (1966)", "ST": "T024", "CX": "consider also terms at MYO-", "MS": "Contractile tissue that produces movement in animals.", "PM": "/transplantation was MUSCLE TRANSPLANTATION 1963-65", "HN": "/transplantation was MUSCLE TRANSPLANTATION 1963-65", "MR": "20160613", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009132"}, {"RECTYPE": "D", "MH": "Muscular Atrophy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neurogenic Muscular Atrophy|T046|T184|NON|NRW|NLM (2000)|991104|abbcdef", "ENTRY": "Neurotrophic Muscular Atrophies", "MN": "C23.888.592.608.612", "FX": "Muscular Disorders, Atrophic", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "MUSCULAR ATROPHY, SPINAL is also available", "MS": "Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.", "CATSH": "CAT LIST", "MR": "19991104", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009133"}, {"RECTYPE": "D", "MH": "Muscular Atrophy, Spinal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spinal Muscular Atrophy|T047|NON|EQV|GHR (2014)|UNK (19XX)|870310|abcdeef", "ENTRY": "Spinal Amyotrophies", "MN": "C10.668.467.500", "MH_TH": "NLM (1988)", "ST": "T047", "AN": "MUSCULAR ATROPHY, SPINAL, INFANTILE see SPINAL MUSCULAR ATROPHIES OF CHILDHOOD is also available", "PI": "Spinal Cord Diseases (1966-1987)", "MS": "A group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. (Adams et al., Principles of Neurology, 6th ed, p1089)", "PM": "1988", "HN": "1988", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19870310", "DC": "1", "DX": "19880101", "UI": "D009134"}, {"RECTYPE": "D", "MH": "Muscular Diseases", "DE": "MUSCULAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myopathies|T047|NON|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Myopathy", "MN": "C10.668.491", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; inflammatory disease equals MYOSITIS; /congen: consider also Myopathies, Structural, Congenital & its indentions", "MS": "Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009135"}, {"RECTYPE": "D", "MH": "Muscular Dystrophies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "PRINT ENTRY": "Muscular Dystrophy|T047|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Myodystrophies", "MN": "C16.320.577", "FX": "Mice, Inbred mdx", "EC": "veterinary:Muscular Dystrophy, Animal", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "general or unspecified; prefer specifics; do not confuse with MYOTONIC DYSTROPHY", "MS": "A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.", "PM": "2000; see MUSCULAR DYSTROPHY 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19991108", "DC": "1", "DX": "19660101", "UI": "D009136"}, {"RECTYPE": "D", "MH": "Muscular Dystrophy, Animal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Muscular Dystrophies, Animal", "MN": "C22.595", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "experimental or veterinary", "PI": "Muscular Dystrophy (1966-1969)", "MS": "MUSCULAR DYSTROPHY that occurs in VERTEBRATE animals.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20151209", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D009137"}, {"RECTYPE": "D", "MH": "Musculocutaneous Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nerves, Musculocutaneous", "MN": "A08.800.800.720.050.540", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES (IM); neopl: coord IM with PERIPHERAL NERVE NEOPLASMS (IM) + histol type of neopl", "MS": "A major nerve of the upper extremity. The fibers of the musculocutaneous nerve originate in the lower cervical spinal cord (usually C5 to C7), travel via the lateral cord of the brachial plexus, and supply sensory and motor innervation to the upper arm, elbow, and forearm.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009138"}, {"RECTYPE": "D", "MH": "Musculoskeletal Abnormalities", "DE": "MUSCULOSKELETAL ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Musculoskeletal Abnormality", "MN": "C16.131.621", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics or specific organ /abnorm", "PI": "Musculoskeletal System/abnormalities (1966-1997)", "MS": "Congenital structural abnormalities and deformities of the musculoskeletal system.", "PM": "98", "HN": "98; use explode 1971-97", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009139"}, {"RECTYPE": "D", "MH": "Musculoskeletal Diseases", "DE": "MUSCULOSKELETAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Orthopedic Disorder", "MN": "C05", "RH": "C5 - DISEASES-MUSCULOSKELETAL", "MH_TH": "NLM (1967)", "ST": "T047", "AN": "general; prefer MUSCULAR DISEASES or BONE DISEASES or specifics", "PI": "Musculoskeletal System (1966)", "MS": "Diseases of the muscles and their associated ligaments and other connective tissue and of the bones and cartilage viewed collectively.", "PM": "1992", "HN": "1992; was MUSCULOSKELETAL DISEASES (NON MESH) 1967-91", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D009140"}, {"RECTYPE": "D", "MH": "Musculoskeletal System", "AQ": "AH BS CH CY DE DG EM EN IM IN IR ME MI PA PP PS RE SU UL VI", "ENTRY": "Systems, Musculoskeletal", "MN": "A02", "RH": "A2 - ANATOMY-MUSCULOSKELETAL SYSTEM", "FX": "Musculoskeletal Development", "EC": "physiology:Musculoskeletal Physiological Phenomena", "MH_TH": "NLM (1966)", "ST": "T022", "AN": "general or unspecified; prefer specifics; must be both musculo + skeletal, otherwise prefer BONE AND BONES or MUSCLES", "MS": "The MUSCLES, bones (BONE AND BONES), and CARTILAGE of the body.", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009141"}, {"RECTYPE": "D", "MH": "Musculoskeletal Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Musculoskeletal Physiology|T042|NON|EQV|NLM (1966)|990101|MUSCULOSKELETAL PHYSIOL|abcdefv", "ENTRY": "Processes, Musculoskeletal Physiological", "MN": "G11.427", "MH_TH": "NLM (2009)", "ST": "T042", "AN": "general or unspecified; prefer specifics; consider also MUSCLES /physiol & BONE AND BONES /physiol or /physiol with specific muscle & bone terms", "PI": "Musculoskeletal System/physiology (1966-1997)", "MS": "Processes and properties of the MUSCULOSKELETAL SYSTEM.", "PM": "2009; see MUSCULOSKELETAL PHYSIOLOGY 1998-2008; for MUSCULOSKELETAL PHYSIOLOGICAL PROCESSES see MUSCULOSKELETAL PHYSIOLOGICAL PROCESSES 2004-2016", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20160511", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009142"}, {"RECTYPE": "D", "MH": "Museums", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Museum", "MN": "K01.400.152.552", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "medical museums: do not coordinate with MEDICINE", "MS": "Facility for the procurement, care, study, and display of objects of scholarly interest or value.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009144"}, {"RECTYPE": "D", "MH": "Mushroom Poisoning", "DE": "MUSHROOM POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Poisonings, Mushroom", "MN": "C25.723.680.551", "FX": "Mycotoxins", "MH_TH": "NLM (1968)", "ST": "T037", "AN": "= pois by mushroom toxins; TN 133: relation to food pois from canned mushrooms", "PI": "Mushrooms (1966-1967)", "MS": "Poisoning from ingestion of mushrooms, primarily from, but not restricted to, toxic varieties.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009145"}, {"RECTYPE": "D", "MH": "Music", "AQ": "HI PX", "ENTRY": "Vocal Melodies", "MN": "K01.602", "FX": "Singing", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "MUSIC THERAPY is also available", "MS": "Sound that expresses emotion through rhythm, melody, and harmony.", "PM": "1966; for SONGS and VOCAL MELODY, see SINGING 2013", "HN": "1966; for SONGS and VOCAL MELODY, use SINGING 2013", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009146"}, {"RECTYPE": "D", "MH": "Music Therapy", "DE": "MUSIC THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapy, Music|T061|NON|EQV|UNK (19XX)|860101|THER MUSIC|abcdefv", "MN": "F04.754.549", "FX": "Acoustic Stimulation", "MH_TH": "NLM (1974)", "ST": "T061", "MS": "The use of music as an adjunctive therapy in the treatment of neurological, mental, or behavioral disorders.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009147"}, {"RECTYPE": "D", "MH": "Mustard Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mustard|T002|T168|NON|NRW|NLM (1986)|990101|abbcdef", "ENTRY": "Mustards", "MN": "B01.875.800.575.912.250.157.200.500", "FX": "Sinapis", "MH_TH": "NLM (2004)", "ST": "T002", "RR": "txid3710", "MS": "Any of several BRASSICA species that are commonly called mustard. Brassica juncea is brown or Chinese mustard, and Brassica nigra is black, brown, or red mustard. The plant is grown both for mustard seed from which oil is extracted or used as SPICES, and for its greens used as VEGETABLES or ANIMAL FEED. There is no relationship to MUSTARD COMPOUNDS. A species from a related genus SINAPIS ALBA is white mustard.", "PM": "2004; see MUSTARD 1991-2003, see BRASSICA 1986-1990, see MUSTARD 1963-1985", "HN": "2004(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009149"}, {"RECTYPE": "D", "MH": "Mustard Compounds", "DE": "MUSTARD CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Mustard", "MN": "D02.455.526.728", "MH_TH": "POPLINE (1984)", "ST": "T131", "RN": "0", "MS": "Strong alkylating and immunosuppressive agents whose biological activity is based on the presence of bis(2-chloroethyl)- groups. Although otherwise structurally diverse, the compounds have in common the capacity to contribute alkyl groups to DNA. They are generally highly toxic but include among their number many widely used and effective antineoplastic agents.", "PM": "68; MUSTARD GAS was heading 1963-67", "HN": "68", "MR": "19930603", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009150"}, {"RECTYPE": "D", "MH": "Mustard Gas", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sulfur Mustard|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|800401|abbcdeef", "ENTRY": "Sulfide, Dichlorodiethyl", "MN": "D02.455.526.728.468", "PA": "Dermatologic Agents", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Ethane, 1,1'-thiobis(2-chloro)-", "RN": "T8KEC9FH9P", "RR": "505-60-2 (Mustard Gas)", "MS": "Severe irritant and vesicant of skin, eyes, and lungs. It may cause blindness and lethal lung edema and was formerly used as a war gas. The substance has been proposed as a cytostatic and for treatment of psoriasis. It has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP-85-002, 1985) (Merck, 11th ed).", "OL": "use MUSTARD COMPOUNDS to search MUSTARD GAS 1966-74", "PM": "91,63-67; was see under MUSTARD COMPOUNDS 1968-90; was heading 1963-67", "HN": "91(75)63-67; was see under MUSTARD COMPOUNDS 1968-90; was heading 1963-67", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009151"}, {"RECTYPE": "D", "MH": "Mutagenicity Tests", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Mutagen Screening|T059|T063|NON|EQV|UNK (19XX)|800519|abbcdef", "ENTRY": "Toxicity Test, Genetic", "MN": "E05.940.560", "FX": "Carcinogenicity Tests", "MH_TH": "NLM (1981)", "ST": "T063", "AN": "NIM", "PI": "Mutation (1966-1980)", "MS": "Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19800519", "DC": "1", "DX": "19810101", "UI": "D009152"}, {"RECTYPE": "D", "MH": "Mutagens", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Mutagen|T131|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D27.888.569.468", "FX": "Mutagenesis", "MH_TH": "NLM (1965)", "ST": "T131", "RN": "0", "AN": "consider also MUTATION", "MS": "Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes.", "PM": "66", "HN": "66(65)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009153"}, {"RECTYPE": "D", "MH": "Mutation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Mutations", "MN": "G05.365.590", "FX": "Suppression, Genetic", "MH_TH": "NLM (1964)", "ST": "T045", "MS": "Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D009154"}, {"RECTYPE": "D", "MH": "Mutism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Selective Mutism|T048|NON|NRW|NLM (1998)|970312|abcdef", "ENTRY": "Voluntary Mutisms", "MN": "F03.625.875", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "The inability to generate oral-verbal expression, despite normal comprehension of speech. This may be associated with BRAIN DISEASES or MENTAL DISORDERS. Organic mutism may be associated with damage to the FRONTAL LOBE; BRAIN STEM; THALAMUS; and CEREBELLUM. Selective mutism is a psychological condition that usually affects children characterized by continuous refusal to speak in social situations by a child who is able and willing to speak to selected persons. Kussmal aphasia refers to mutism in psychosis. (From Fortschr Neurol Psychiatr 1994; 62(9):337-44)", "PM": "1969; see DEAF-MUTISM & SPEECH DISORDERS 1963-68", "HN": "1969(1963)", "CATSH": "CAT LIST", "MR": "20150210", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D009155"}, {"RECTYPE": "D", "MH": "Muzolimine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "G 2821, Bay", "MN": "D03.383.129.539.550", "PA": "Diuretics", "MH_TH": "USAN (1977)", "ST": "T121", "N1": "3H-Pyrazol-3-one, 5-amino-2-(1-(3,4-dichlorophenyl)ethyl)-2,4-dihydro-", "RN": "07Z36289ZX", "RR": "55294-15-0 (Muzolimine)", "PI": "Pyrazoles (1966-1979)", "MS": "A pyrazole diuretic with long duration and high capacity of action. It was proposed for kidney failure and hypertension but was withdrawn worldwide because of severe neurological effects.", "PM": "91; was see under PYRAZOLES 1980-90", "HN": "91(80); was see under PYRAZOLES 1980-90", "MR": "20160701", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D009156"}, {"RECTYPE": "D", "MH": "Myasthenia Gravis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis|T047|NON|NRW|NLM (2020)|190122|abcdef", "ENTRY": "Ocular Myasthenia Gravis", "MN": "C20.111.258.500", "FX": "Thymus Hyperplasia", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "\"myasthenia\" unqualified in foreign titles is more often MYASTHENIA GRAVIS than MUSCLE WEAKNESS but check text; congenital: consider MYASTHENIC SYNDROMES, CONGENITAL or specifics ", "MS": "A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.", "CATSH": "CAT LIST", "MR": "20190415", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009157"}, {"RECTYPE": "D", "MH": "Mycobacillin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D12.644.641.515", "PA": "Antifungal Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Mycobacillin", "RN": "18524-67-9", "PI": "Peptides, Cyclic (1973-1974)", "MS": "A cyclic polypeptide antibiotic isolated from culture filtrates of Bacillus subtilis that acts as an antifungal agent.", "PM": "91; was see under ANTIBIOTICS, ANTIFUNGAL 1975-90", "HN": "91(75); was see under ANTIBIOTICS, ANTIFUNGAL 1975-90", "MR": "20090706", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009158"}, {"RECTYPE": "D", "MH": "Mycobacteriaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.552", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid1762", "PI": "Bacteria (1966-1974)", "MS": "A family of gram-positive bacteria found in soil and dairy products and as parasites on animals and man. Several are important pathogens.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D009159"}, {"RECTYPE": "D", "MH": "Mycobacteriophages", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Mycobacteriophage", "MN": "B04.123.502", "MH_TH": "NLM (1966)", "ST": "T005", "AN": "IM; specify species of Mycobacterium if possible (IM or NIM)", "MS": "Viruses whose host is one or more Mycobacterium species. They include both temperate and virulent types.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009160"}, {"RECTYPE": "D", "MH": "Mycobacterium", "DE": "MYCOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Mycobacteria|T007|NON|EQV|NLM (2018)|160915|abcdef", "MN": "B03.510.460.400.410.552.552", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1763", "MS": "A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009161"}, {"RECTYPE": "D", "MH": "Mycobacterium avium", "DE": "MYCOBACT AVIUM", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.552.552.300", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid1764", "MS": "A bacterium causing tuberculosis in domestic fowl and other birds. In pigs, it may cause localized and sometimes disseminated disease. The organism occurs occasionally in sheep and cattle. It should be distinguished from the M. avium complex, which infects primarily humans.", "PM": "87; was see under MYCOBACTERIUM 1975-86", "HN": "87(75); was see under MYCOBACTERIUM 1975-86", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19870101", "UI": "D009162"}, {"RECTYPE": "D", "MH": "Mycobacterium bovis", "DE": "MYCOBACT BOVIS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Calmette-Guerin Bacillus|T007|EPO|REL|UNK (19XX)|790522|abcdef", "MN": "B03.510.460.400.410.552.552.402", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1765", "RR": "txid33892", "MS": "The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis.", "OL": "use MYCOBACTERIUM BOVIS to search BCG 1975-78", "HN": "BCG was see under MYCOBACTERIUM BOVIS 1975-79", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009163"}, {"RECTYPE": "D", "MH": "Mycobacterium Infections", "DE": "MYCOBACT INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Mycobacterium Infection", "MN": "C01.150.252.410.040.552", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "general; consider also TUBERCULOSIS", "MS": "Infections with bacteria of the genus MYCOBACTERIUM.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D009164"}, {"RECTYPE": "D", "MH": "Mycobacterium Infections, Nontuberculous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Mycobacterium Infections, Atypical|T047|NON|EQV|NLM (1977)|990101|MYCOBACT INFECT ATYPICAL|abcdefv", "ENTRY": "Nontuberculous Mycobacterium Infections", "MN": "C01.150.252.410.040.552.475", "MH_TH": "NLM (2012)", "ST": "T047", "AN": "for a list of specific nontuberculous mycobacteria, see MeSH definition here or NONTUBERCULOUS MYCOBACTERIA entry terms and indentions", "PI": "Mycobacterium Infections (1966-1976)", "MS": "Infections with nontuberculous mycobacteria (atypical mycobacteria): M. kansasii, M. marinum, M. scrofulaceum, M. flavescens, M. gordonae, M. obuense, M. gilvum, M. duvali, M. szulgai, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. xenopi (littorale), M. ulcerans, M. buruli, M. terrae, M. fortuitum (minetti, giae), M. chelonae, M. leprae.", "PM": "2012; see MYCOBACTERIUM INFECTIONS, ATYPICAL 1991-2011, see MYCOBACTERIUM INFECTIONS 1977-1990", "HN": "2012 (1977)", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D009165"}, {"RECTYPE": "D", "MH": "Mycobacterium leprae", "DE": "MYCOBACT LEPRAE", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.552.552.502", "FX": "Leprostatic Agents", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1769", "MS": "A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009166"}, {"RECTYPE": "D", "MH": "Mycobacterium lepraemurium", "DE": "MYCOBACT LEPRAEMURIUM", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.552.552.602", "MH_TH": "NLM (1973)", "ST": "T007", "RN": "txid64667", "AN": "rat leprosy bacillus; infection: coord IM with MYCOBACTERIUM INFECTIONS (IM)", "PI": "Mycobacterium (1966-1972)", "MS": "The etiologic agent of rat leprosy, also known as murine leprosy.", "PM": "73", "HN": "73", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009167"}, {"RECTYPE": "D", "MH": "Mycobacterium phlei", "DE": "MYCOBACT PHLEI", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.552.552.640", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid1771", "MS": "A saprophytic bacterium widely distributed in soil and dust and on plants.", "PM": "91; was see under MYCOBACTERIUM 1975-90", "HN": "91(75); was see under MYCOBACTERIUM 1975-90", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D009168"}, {"RECTYPE": "D", "MH": "Mycobacterium tuberculosis", "DE": "M TUBERC", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Mycobacterium tuberculosis H37Rv|T007|NON|NRW|NLM (2005)|040212|abcdef", "MN": "B03.510.460.400.410.552.552.702", "FX": "Antitubercular Agents", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1773", "RR": "txid83332", "MS": "A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009169"}, {"RECTYPE": "D", "MH": "Nontuberculous Mycobacteria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Tuberculoid Bacillus|T007|NON|EQV|UNK (19XX)|760518|abcdef", "ENTRY": "Nontuberculous Mycobacterium|T007|NON|EQV|NLM (2012)|100716|abcdef", "MN": "B03.510.460.400.410.552.552.720", "MH_TH": "NLM (2012)", "ST": "T007", "RR": "txid39688", "PI": "Mycobacterium, Atypical (1977-1998)", "MS": "So-called atypical species of the genus MYCOBACTERIUM that do not cause tuberculosis. They are also called tuberculoid bacilli, i.e.: M. abscessus, M. buruli, M. chelonae, M. duvalii, M. flavescens, M. fortuitum, M. gilvum, M. gordonae, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. kansasii, M. marinum, M. obuense, M. scrofulaceum, M. szulgai, M. terrae, M. ulcerans, M. xenopi.", "PM": "2012; see MYCOBACTERIA, ATYPICAL 1999-2011, see MYCOBACTERIUM, ATYPICAL 1977-1998", "HN": "2012 (1999)", "MR": "20200902", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D009170"}, {"RECTYPE": "D", "MH": "Mycolic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Mycolic", "MN": "D10.251.572", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "PI": "Fatty Acids (1966-1972)", "MS": "Long fatty acids found in the CELL WALLS of some ACTINOBACTERIA, including MYCOBACTERIUM TUBERCULOSIS.", "PM": "73", "HN": "73", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009171"}, {"RECTYPE": "D", "MH": "Mycology", "DE": "MYCOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.158.273.540.553", "FX": "Infectious Disease Medicine", "MH_TH": "NLM (1972)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "PI": "Mycoses (1966-1971)", "MS": "The study of the structure, growth, function, genetics, and reproduction of fungi, and MYCOSES.", "PM": "72", "HN": "72", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009172"}, {"RECTYPE": "D", "MH": "Mycophenolic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RS61443", "MN": "D10.251.618", "PA": "Enzyme Inhibitors", "MH_TH": "USAN (1970)", "ST": "T195", "N1": "-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (E)-", "RN": "HU9DX48N0T", "RR": "WX877SQI1G", "PI": "Caproates (1967-1971)", "MS": "Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION.", "PM": "2017; MYCOPHENOLATE MOFETIL was indexed under MYCOPHENOLIC ACID 1990-2016", "HN": "2017 (1999)", "MR": "20160711", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009173"}, {"RECTYPE": "D", "MH": "Mycoplasma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pleuropneumonia-Like Organisms|T007|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Pleuropneumonia Like Organisms|T007|NON|REL|UNK (19XX)|840425|abcdef", "MN": "B03.440.860.580.553.553", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid2093", "RR": "txid2123", "MS": "A genus of gram-negative, mostly facultatively anaerobic bacteria in the family MYCOPLASMATACEAE. The cells are bounded by a PLASMA MEMBRANE and lack a true CELL WALL. Its organisms are pathogens found on the MUCOUS MEMBRANES of humans, ANIMALS, and BIRDS.", "PM": "1963; for EPERYTHROZOON see EPERYTHROZOON 1966-2003; for HAEMOBARTONELLA see ANAPLASMATACEAE 1997-2003, see HAEMOBARTONELLA 1980-1996; for PLEUROPNEUMONIA-LIKE ORGANISMS see PLEUROPNEUMONIA-LIKE ORGANISMS 1963-1965", "HN": "1963; for HAEMOBARTONELLA use ANAPLASMATACEAE 1980-2003", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D009174"}, {"RECTYPE": "D", "MH": "Mycoplasma Infections", "DE": "MYCOPLASMA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Eperythrozoonosis|T047|NON|NRW|NLM (1975)|990101|abcdef", "ENTRY": "Mycoplasma Infection", "MN": "C01.150.252.400.610.610", "MH_TH": "NLM (1968)", "ST": "T047", "PI": "Mycoplasma (1966-1967)", "MS": "Infections with species of the genus MYCOPLASMA.", "PM": "1968; for EPERYTHROZOONOSIS see EPERYTHROZOONOSIS 1991-2003, see ANAPLASMATACEAE INFECTIONS 1977-1990, see BARTONELLA INFECTIONS 1975-1976", "HN": "1968; for EPERYTHROZOONOSIS use ANAPLASMATACEAE INFECTIONS 1977-1990, use BARTONELLA INFECTIONS 1975-1976", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009175"}, {"RECTYPE": "D", "MH": "Mycoplasma mycoides", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.585", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid2102", "AN": "causes pleuropneumonia in cattle & goats; infection: coord IM with PLEUROPNEUMONIA, CONTAGIOUS (IM)", "PI": "Mycoplasma (1966-1971)", "MS": "The etiological agent of contagious pleuropneumonia (PLEUROPNEUMONIA, CONTAGIOUS) of cattle and goats.", "PM": "74", "HN": "74(72)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009176"}, {"RECTYPE": "D", "MH": "Mycoplasma pneumoniae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Eaton Agent|T007|EPO|EQV|NLM (1992)|910404|abcdef", "MN": "B03.440.860.580.553.553.650", "MH_TH": "NLM (1980)", "ST": "T007", "RN": "txid2104", "PI": "Mycoplasma (1966-1979)", "MS": "Short filamentous organism of the genus Mycoplasma, which binds firmly to the cells of the respiratory epithelium. It is one of the etiologic agents of non-viral primary atypical pneumonia in man.", "OL": "use MYCOPLASMA to search EATON AGENT 1967-91", "PM": "80; EATON AGENT was see MYCOPLASMA 1967-91", "HN": "80; EATON AGENT was see MYCOPLASMA 1967-91", "MR": "20200813", "DA": "19781221", "DC": "1", "DX": "19800101", "UI": "D009177"}, {"RECTYPE": "D", "MH": "Mycoplasmataceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid2092", "AN": "infection: coord IM with MYCOPLASMATALES INFECTIONS (IM)", "PI": "Bacteria (1966-1974)", "MS": "A family of gram-negative, non-motile bacteria from human and animal sources. One saprophytic species is known.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D009178"}, {"RECTYPE": "D", "MH": "Mycoplasmatales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid2085", "PI": "Bacteria (1966-1974)", "MS": "An order of highly pleomorphic, gram-negative bacteria including both pathogenic and saprophytic species.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D009179"}, {"RECTYPE": "D", "MH": "Mycoplasmatales Infections", "DE": "MYCOPLASMATALES INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Mycoplasmatales Infection", "MN": "C01.150.252.400.610", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "gram-neg bact infect", "PI": "Bacterial Infections (1970-1976)", "MS": "Infections with bacteria of the order MYCOPLASMATALES.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D009180"}, {"RECTYPE": "D", "MH": "Mycoses", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Fungus Diseases|T047|NON|EQV|UNK (19XX)|740330|FUNGUS DIS|abcdefv", "ENTRY": "Infections, Fungus", "MN": "C01.150.703", "FX": "Antifungal Agents", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases caused by FUNGI.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009181"}, {"RECTYPE": "D", "MH": "Mycosis Fungoides", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "MN": "C20.683.515.761.480.750.800.550", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with SKIN NEOPLASMS (IM)", "MS": "A chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected.", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009182"}, {"RECTYPE": "D", "MH": "Mycotoxins", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mycotoxin|T109|T123|T131|NON|EQV|NLM (2021)|191114|abbbcdef", "ENTRY": "Toxins, Fungal", "MN": "D23.946.587", "PA": "Poisons", "FX": "Mushroom Poisoning", "MH_TH": "NLM (1967)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTITOXINS", "PI": "Toxins (1966)", "MS": "Toxic compounds produced by FUNGI.", "PM": "67; GLIOTOXINS was GLIOTOXIN see under ANTIBIOTICS 1975-80", "HN": "67", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009183"}, {"RECTYPE": "D", "MH": "Mydriatics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mydriatic|T121|NON|EQV|NLM (2022)|200930|abcdef", "ENTRY": "Effects, Mydriatic", "MN": "D27.505.696.663.050.500", "MH_TH": "NLM (1964)", "ST": "T121", "RN": "0", "AN": "note entry term MYDRIATIC EFFECT: use only for the mydriatic effect of a chemical substance", "MS": "Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics.", "OL": "use MYDRIATICS to search CYCLOPLEGICS 1966-78", "PM": "CYCLOPLEGICS was heading 1963-78", "HN": "CYCLOPLEGICS was heading 1963-78", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D009184"}, {"RECTYPE": "D", "MH": "Myelin Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myelin Protein|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Proteins, Myelin", "MN": "D12.776.631.580", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics; do not confuse with MYELIN see MYELIN SHEATH; do not coordinate with MYELIN SHEATH unless this is particularly discussed", "PI": "Nerve Tissue Proteins (1966-1976)", "MS": "MYELIN-specific proteins that play a structural or regulatory role in the genesis and maintenance of the lamellar MYELIN SHEATH structure.", "PM": "77", "HN": "77", "MR": "20200527", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D009185"}, {"RECTYPE": "D", "MH": "Myelin Sheath", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Myelin|T026|NON|NRW|NLM (1998)|960719|abcdef", "ENTRY": "Sheaths, Myelin", "MN": "A11.671.501.512.560", "MH_TH": "NLM (1966)", "ST": "T026", "AN": "note entry term MYELIN; do not confuse with MYELIN PROTEINS; myelination: index under MYELIN SHEATH / physiol", "MS": "The lipid-rich sheath surrounding AXONS in both the CENTRAL NERVOUS SYSTEMS and PERIPHERAL NERVOUS SYSTEM. The myelin sheath is an electrical insulator and allows faster and more energetically efficient conduction of impulses. The sheath is formed by the cell membranes of glial cells (SCHWANN CELLS in the peripheral and OLIGODENDROGLIA in the central nervous system). Deterioration of the sheath in DEMYELINATING DISEASES is a serious clinical problem.", "MR": "20220603", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009186"}, {"RECTYPE": "D", "MH": "Myelitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subacute Necrotizing Myelitis|T047|NON|NRW|NLM (2020)|190618|abcdef", "ENTRY": "Subacute Necrotizing Myelitides", "MN": "C10.586.750", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the spinal cord. Relatively common etiologies include infections; AUTOIMMUNE DISEASES; SPINAL CORD; and ischemia (see also SPINAL CORD VASCULAR DISEASES). Clinical features generally include weakness, sensory loss, localized pain, incontinence, and other signs of autonomic dysfunction.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009187"}, {"RECTYPE": "D", "MH": "Myelitis, Transverse", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Transverse Myelitis|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Transverse Myelopathy Syndromes", "MN": "C20.111.258.250.550", "FX": "Multiple Sclerosis, Relapsing-Remitting", "MH_TH": "NLM (1971)", "ST": "T047", "AN": "post-vaccinal or postinfectious inflammation of the spinal cord only goes here, in central nervous system or brain see X refs at ENCEPHALOMYELITIS, ACUTE DISSEMINATED", "PI": "Myelitis (1966-1970)", "MS": "Inflammation of a transverse portion of the spinal cord characterized by acute or subacute segmental demyelination or necrosis. The condition may occur sporadically, follow an infection or vaccination, or present as a paraneoplastic syndrome (see also ENCEPHALOMYELITIS, ACUTE DISSEMINATED). Clinical manifestations include motor weakness, sensory loss, and incontinence. (Adams et al., Principles of Neurology, 6th ed, pp1242-6)", "PM": "1991; see MYELITIS 1971-1990", "HN": "1991(1971); see MYELITIS 1971-1990", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009188"}, {"RECTYPE": "D", "MH": "Avian Myeloblastosis Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Myeloblastosis Virus, Avian|T005|NON|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Viruses, Avian Myeloblastosis", "MN": "B04.820.650.070.110", "MH_TH": "UNK (19XX)", "ST": "T005", "RN": "txid11866", "MS": "A species of ALPHARETROVIRUS causing anemia in fowl.", "PM": "2007; see MYELOBLASTOSIS VIRUS, AVIAN 1991-2006, see AVIAN LEUKOSIS VIRUSES 1975-1990, see AVIAN LEUKOSIS VIRUS 1963-1974", "HN": "2007 (1963)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009189"}, {"RECTYPE": "D", "MH": "Myelodysplastic Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dysmyelopoietic Syndromes|T191|NON|EQV|UNK (19XX)|850606|abcdef", "ENTRY": "Syndromes, Myelodysplastic", "MN": "C15.378.190.625", "MH_TH": "ORD (2010)", "ST": "T191", "PI": "Preleukemia (1977-1985)", "MS": "Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D009190"}, {"RECTYPE": "D", "MH": "Myelography", "DE": "MYELOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Cisternography, Myelographic|T060|NON|NRW|UNK (19XX)|760512|CISTERNOGR MYELOGR|abcdefv", "ENTRY": "Myelographies", "MN": "E05.629.937.505", "MH_TH": "NLM (1964)", "ST": "T060", "MS": "X-ray visualization of the spinal cord following injection of contrast medium into the spinal arachnoid space.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009192"}, {"RECTYPE": "D", "MH": "Myeloma Proteins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Myeloma", "MN": "D12.776.624.553", "PA": "Immunologic Factors", "FX": "Multiple Myeloma", "MH_TH": "NLM (1972)", "ST": "T123", "RN": "0", "PI": "Serum Globulins (1966-1971)", "MS": "Abnormal immunoglobulins characteristic of MULTIPLE MYELOMA.", "PM": "72", "HN": "72", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009194"}, {"RECTYPE": "D", "MH": "Peroxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myeloperoxidase|T116|T126|NON|EQV|NLM (1994)|930317|abbcdef", "ENTRY": "Hemi Myeloperoxidase", "MN": "D08.811.682.732.700", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Donor:hydrogen-peroxide oxidoreductase", "RN": "EC 1.11.1.7", "AN": "a hemeprotein synthesized by leukocytes: do not confuse with PEROXIDASES, a subclass of oxidoreductases", "PI": "Peroxidases (1970-1974)", "MS": "A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7.", "OL": "use PEROXIDASE to search MYELOPEROXIDASE 1975-93 and GUAIACOL PEROXIDASE & HYDROPEROXIDASE II 1989-93", "PM": "94; was MYELOPEROXIDASE 1975-93 (see under PEROXIDASES 1975-85); GUAIACOL PEROXIDASE & HYDROPEROXIDASE II were see MYELOPEROXIDASE 1989-93", "HN": "94; was MYELOPEROXIDASE 1975-93 (see under PEROXIDASES 1975-85); GUAIACOL PEROXIDASE & HYDROPEROXIDASE II were see MYELOPEROXIDASE 1989-93", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D009195"}, {"RECTYPE": "D", "MH": "Myeloproliferative Disorders", "DE": "MYELOPROLIFERATIVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Myeloproliferative Disorder", "MN": "C15.378.190.636", "FX": "Leukemia", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.", "PM": "70", "HN": "70(66)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D009196"}, {"RECTYPE": "D", "MH": "Myenteric Plexus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Auerbach's Plexus|T023|EPO|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Plexus, Myenteric", "MN": "A08.800.800.060.500", "MH_TH": "NLM (1965)", "ST": "T023", "AN": "a neural network in the enteric nerv syst", "MS": "One of two ganglionated neural networks which together form the ENTERIC NERVOUS SYSTEM. The myenteric (Auerbach's) plexus is located between the longitudinal and circular muscle layers of the gut. Its neurons project to the circular muscle, to other myenteric ganglia, to submucosal ganglia, or directly to the epithelium, and play an important role in regulating and patterning gut motility. (From FASEB J 1989;3:127-38)", "PM": "65", "HN": "65", "MR": "19930618", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009197"}, {"RECTYPE": "D", "MH": "Myiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Maggot Infestations|T047|NON|EQV|NLM (1991)|900320|abcdef", "ENTRY": "Myiases", "MN": "C01.610.858.211.503", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "infestation by fly maggots", "MS": "The invasion of living tissues of man and other mammals by dipterous larvae.", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009198"}, {"RECTYPE": "D", "MH": "Myocardial Contraction", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Inotropism, Cardiac|T067|NON|REL|UNK (19XX)|790501|abcdef", "ENTRY": "Myocardial Contractions", "MN": "G11.427.494.570", "FX": "Myocardial Stunning", "MH_TH": "NLM (1975)", "ST": "T042", "PI": "Heart (1966-1974)", "MS": "Contractile activity of the MYOCARDIUM.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D009200"}, {"RECTYPE": "D", "MH": "Myocardial Depressant Factor", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Factor, Myocardial Depressant", "MN": "D12.644.370", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "/biosyn /physiol permitted; do not confuse with MYOCARDIAL DEPRESSANTS (see ANTI-ARRHYTHMIA AGENTS)", "PI": "Peptides (1973-1974)", "MS": "A low molecular weight peptide of about 800-1000 having a negative inotropic effect. It is released into the circulation during experimental hemorrhagic pancreatitis, severe ischemia, and postoligemic shock.", "PM": "91; was see under PEPTIDES 1975-90", "HN": "91(75); was see under PEPTIDES 1975-90", "MR": "19920522", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009201"}, {"RECTYPE": "D", "MH": "Cardiomyopathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Primary Myocardial Disease|T047|NON|NRW|NLM (2022)|200824|abcdef", "ENTRY": "Secondary Myocardial Disease", "MN": "C14.280.238", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "general or unspecified; prefer specifics; for infections of the myocardium, coordinate here with infection term, not with HEART DISEASES  ", "MS": "A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).", "PM": "2005; see MYOCARDIAL DISEASES 1979-2004; MYOCARDIAL DISEASES, PRIMARY & MYOCARDIAL DISEASES, SECONDARY were headings 1966-1978", "HN": "2005 (1979)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D009202"}, {"RECTYPE": "D", "MH": "Myocardial Infarction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Strokes, Cardiovascular", "MN": "C23.550.717.489.750", "FX": "Heart Rupture, Post-Infarction", "MH_TH": "POPLINE (1984)", "ST": "T047", "AN": "do not coordinate with ACUTE DISEASE for \"acute infarct\"", "MS": "NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).", "OL": "use MYOCARDIAL INFARCTION to search MYOCARDIAL INFARCT 1966-78", "PM": "79; was MYOCARDIAL INFARCT 1963-78", "HN": "79; was MYOCARDIAL INFARCT 1963-78", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009203"}, {"RECTYPE": "D", "MH": "Myocardial Revascularization", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Internal Mammary Artery Implantation|T061|NON|NRW|NLM (1995)|931210|abcdef", "ENTRY": "Revascularizations, Myocardial", "MN": "E04.928.220.520", "MH_TH": "NLM (1973)", "ST": "T061", "PI": "Myocardial Infarct/surgery (1966-1971)", "MS": "The restoration of blood supply to the myocardium. (From Dorland, 28th ed)", "OL": "use MYOCARDIAL REVASCULARIZATION to search INTERNAL MAMMARY ARTERY IMPLANTATION 1975-94", "PM": "73; INTERNAL MAMMARY ARTERY IMPLANTATION was heading 1975-94 (see under MYOCARDIAL REVASCULARIZATION 1975-90)", "HN": "73; INTERNAL MAMMARY ARTERY IMPLANTATION was heading 1975-94 (see under MYOCARDIAL REVASCULARIZATION 1975-90)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009204"}, {"RECTYPE": "D", "MH": "Myocarditis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Carditis|T047|NON|BRD|NLM (1998)|960710|abcdef", "ENTRY": "Myocarditides", "MN": "C14.280.238.625", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009205"}, {"RECTYPE": "D", "MH": "Myocardium", "AQ": "CH CY EN IM ME PA UL", "PRINT ENTRY": "Muscle, Heart|T024|NON|EQV|NLM (2001)|000113|abcdef", "ENTRY": "Muscles, Heart", "MN": "A10.690.552.750", "EC": "virology:Heart:virology", "MH_TH": "NLM (1966)", "ST": "T024", "CX": "consider also terms at CARDIAC and HEART", "MS": "The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009206"}, {"RECTYPE": "D", "MH": "Myoclonus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polymyoclonus|T184|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Upper Extremity Myoclonus", "MN": "C23.888.592.350.500", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "for \"myoclonic seizure\" consider MYOCLONUS or EPILEPSY, MYOCLONIC or SPASMS, INFANTILE; note other myoclonus terms are also available", "MS": "Involuntary shock-like contractions, irregular in rhythm and amplitude, followed by relaxation, of a muscle or a group of muscles. This condition may be a feature of some CENTRAL NERVOUS SYSTEM DISEASES; (e.g., EPILEPSY, MYOCLONIC). Nocturnal myoclonus is the principal feature of the NOCTURNAL MYOCLONUS SYNDROME. (From Adams et al., Principles of Neurology, 6th ed, pp102-3).", "PM": "1963; for MYOCLONIC JERKING see EPILEPSY, MYOCLONIC 1992-1999; for MYOCLONIC JERKING, MASSIVE see SPASMS, INFANTILE 1977-1999", "HN": "1963; for MYOCLONIC JERKING use EPILEPSY, MYOCLONIC 1992-1999; for MYOCLONIC JERKING, MASSIVE use SPASMS, INFANTILE 1977-1999", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D009207"}, {"RECTYPE": "D", "MH": "Myoepithelioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Myoepithelial Tumor|T191|NON|EQV|NLM (1994)|930326|abcdef", "ENTRY": "Tumors, Myoepithelial", "MN": "C04.557.435.585", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with precoord organ/neopl term (IM)", "MS": "A usually benign tumor made up predominantly of myoepithelial cells.", "OL": "use MYOEPITHELIOMA to search MYOEPITHELIAL TUMOR 1966-93", "PM": "94; was MYOEPITHELIAL TUMOR 1963-93; MYOEPITHELIOMA was see MYOEPITHELIAL TUMOR 1984-93", "HN": "94; was MYOEPITHELIAL TUMOR 1963-93; MYOEPITHELIOMA was see MYOEPITHELIAL TUMOR 1984-93", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D009208"}, {"RECTYPE": "D", "MH": "Myofascial Pain Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Myofascial Pain", "MN": "C05.651.550", "MH_TH": "NLM (1982)", "ST": "T047", "AN": "do not confuse with MYOFASCIAL PAIN DYSFUNCTION SYNDROME, TEMPOROMANDIBULAR JOINT see TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME; for myofasciaI trigger point injections coordinate, MYOFASCIAL PAIN SYNDROMES/ drug ther with TRIGGER POINTS + INJECTIONS or specifics", "MS": "Muscular pain in numerous body regions that can be reproduced by pressure on TRIGGER POINTS, localized hardenings in skeletal muscle tissue. Pain is referred to a location distant from the trigger points. A prime example is the TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20110701", "DA": "19810224", "DC": "1", "DX": "19820101", "UI": "D009209"}, {"RECTYPE": "D", "MH": "Myofibrils", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Myofilaments|T026|NON|NRW|UNK (19XX)|850225|abcdef", "ENTRY": "Myofilament", "MN": "A11.620.500.500", "FX": "Muscle Contraction", "MH_TH": "NLM (1965)", "ST": "T026", "MS": "The long cylindrical contractile organelles of STRIATED MUSCLE cells composed of ACTIN FILAMENTS; MYOSIN filaments; and other proteins organized in arrays of repeating units called SARCOMERES .", "PM": "1965; for MYOFILAMENTS see ACTIN CYTOSKELETON 1986-2011", "HN": "1965; for MYOFILAMENTS use ACTIN CYTOSKELETON 1986-2011", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009210"}, {"RECTYPE": "D", "MH": "Myoglobin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "MN": "D12.776.422.316.940", "EC": "urine:Myoglobinuria", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "a hemeprotein & muscle protein; /biosyn /physiol permitted", "MS": "A conjugated protein which is the oxygen-transporting pigment of muscle. It is made up of one globin polypeptide chain and one heme group.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009211"}, {"RECTYPE": "D", "MH": "Myoglobinuria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Myoglobinurias", "MN": "C05.651.807.628", "MH_TH": "NLM (1965)", "ST": "T034", "AN": "myoglobinuria in rhabdomyolysis: index  RHABDOMYOLYSIS  + MYOGLOBINURIA only if myoglobinuria is particularly discussed", "MS": "The presence of MYOGLOBIN in URINE usually as a result of rhabdomyolysis.", "PM": "91,65-83; was see under RHABDOMYOLYSIS 1984-90; was heading 1965-83", "HN": "91(84)65(63); was see under RHABDOMYOLYSIS 1984-90; was heading 1965-83; was Prov 1963-64", "CATSH": "CAT LIST", "MR": "20151209", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009212"}, {"RECTYPE": "D", "MH": "Myography", "DE": "MYOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Myographies", "MN": "E01.370.530", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "The recording of muscular movements. The apparatus is called a myograph, the record or tracing, a myogram. (From Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009213"}, {"RECTYPE": "D", "MH": "Myoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Myomas", "MN": "C04.557.450.590.540", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "A benign neoplasm of muscular tissue. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009214"}, {"RECTYPE": "D", "MH": "Myometrium", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Uterine Muscle|T023|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Uterine Muscles", "MN": "A10.690.467.500", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "/growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent", "PI": "Uterus (1966-1974)", "MS": "The smooth muscle coat of the uterus, which forms the main mass of the organ.", "PM": "84; was see under UTERUS 1975-83", "HN": "84(75); was see under UTERUS 1975-83", "MR": "20080708", "DA": "19741111", "DC": "1", "DX": "19840101", "UI": "D009215"}, {"RECTYPE": "D", "MH": "Myopia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nearsightedness|T047|NON|EQV|NLM (1994)|920929|abcdef", "ENTRY": "Nearsightednesses", "MN": "C11.744.636", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "MYOPIA, DEGENERATIVE is also available", "MS": "A refractive error in which rays of light entering the EYE parallel to the optic axis are brought to a focus in front of the RETINA when accommodation (ACCOMMODATION, OCULAR) is relaxed. This results from an overly curved CORNEA or from the eyeball being too long from front to back. It is also called nearsightedness.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009216"}, {"RECTYPE": "D", "MH": "Myosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Myosarcomas", "MN": "C04.557.450.795.550", "MH_TH": "NLM (1986)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A general term for a malignant neoplasm derived from muscular tissue. (Stedman, 25th ed)", "PM": "91,63-85; was see under SARCOMA 1986-90; was heading 1963-85", "HN": "91(86)63; was see under SARCOMA 1986-90; was heading 1963-85", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009217"}, {"RECTYPE": "D", "MH": "Myosins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myosin ATPase|T116|T126|NON|EQV|NLM (1989)|990101|abbcdef", "ENTRY": "Myosin Adenosine Triphosphatase", "MN": "D12.776.220.525.475", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.4.1", "RR": "EC 3.6.4.1", "AN": "general or unspecified; prefer specifics", "PI": "Muscle Proteins (1966-1970)", "MS": "A diverse superfamily of proteins that function as translocating proteins. They share the common characteristics of being able to bind ACTINS and hydrolyze MgATP. Myosins generally consist of heavy chains which are involved in locomotion, and light chains which are involved in regulation. Within the structure of myosin heavy chain are three domains: the head, the neck and the tail. The head region of the heavy chain contains the actin binding domain and MgATPase domain which provides energy for locomotion. The neck region is involved in binding the light-chains. The tail region provides the anchoring point that maintains the position of the heavy chain. The superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain.", "PM": "2002; see MYOSIN 1973-2001, see MUSCLE PROTEINS 1969-1972; see ADENOSINE TRIPHOSPHATASE 1963-1968; for MYOSIN ATPASE see MYOSIN ATPASE 1993-2001, see ADENOSINE TRIPHOSPHATASE, MYOSIN 1989-1992, see ADENOSINE TRIPHOSPHATASE 1984-1988; for ADENOSINE TRIPHOSPHATASE, MYOSIN & MYOSIN ADENOSINETRIPHOSPHATASE see MYOSIN ATPASE 1993-2001; for ACTOMYOSIN ADENOSINETRIPHOSPHATASE & ADENOSINETRIPHOSPHATASE, ACTOMYOSIN see MYOSIN ATPASE 1993-2001, see ADENOSINE TRIPHOSPHATASE, MYOSIN 1989-92; for ACTOMYOSIN ATPASE see MYOSIN ATPASE 1993-2001, see ADENOSINE TRIPHOSPHATASE, MYOSIN 1989-1992, see ADENOSINE TRIPHOSPHATASE 1985-1988", "HN": "2002(1971); use ADENOSINE TRIPHOSPHATASE 1963-1968; for MYOSIN ATPASE use ADENOSINETRIPHOSPHATASE 1984-1988; for ACTOMYOSIN ATPASE use ADENOSINETRIPHOSPHATASE 1985-1988", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009218"}, {"RECTYPE": "D", "MH": "Myosin-Light-Chain Kinase", "DE": "MLCK", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myosin Kinase|T116|T126|NON|EQV|UNK (19XX)|860616|abbcdef", "ENTRY": "Myosin Regulatory Light Chain Kinase", "MN": "D12.776.476.563.125.500", "MH_TH": "NLM (1987)", "ST": "T126", "N1": "ATP:myosin-light-chain O-phosphotransferase", "RN": "EC 2.7.11.18", "PI": "Protein Kinases (1973-1986)", "MS": "An enzyme that phosphorylates myosin light chains in the presence of ATP to yield myosin-light chain phosphate and ADP, and requires calcium and CALMODULIN. The 20-kDa light chain is phosphorylated more rapidly than any other acceptor, but light chains from other myosins and myosin itself can act as acceptors. The enzyme plays a central role in the regulation of smooth muscle contraction.", "PM": "87", "HN": "87", "MR": "20210521", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D009219"}, {"RECTYPE": "D", "MH": "Myositis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myositis, Infectious|T047|NON|NRW|NLM (2000)|991109|MYOSITIS INFECT|abcdefv", "ENTRY": "Proliferative Myositis", "MN": "C10.668.491.562", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "note many specific myositis terms are available", "MS": "Inflammation of a muscle or muscle tissue.", "PM": "MYOSITIS, EOSINOPHILIC was heading 1970-1980", "HN": "MYOSITIS, EOSINOPHILIC was heading 1970-1980", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009220"}, {"RECTYPE": "D", "MH": "Myositis Ossificans", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fibrodysplasia Ossificans Progressiva|T047|NON|NRW|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|781219|abcdeeeef", "ENTRY": "Progressive Ossifying Myositis|T047|NON|NRW|NLM (2014)|130418|abcdef", "MN": "C05.651.594.638", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "myositis with bony deposits or muscle ossification", "MS": "A disease characterized by bony deposits or the ossification of muscle tissue.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009221"}, {"RECTYPE": "D", "MH": "Myotonia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Phenomenons, Myotonic", "MN": "C23.888.592.608.700", "EC": "congenital:Myotonia Congenita", "MH_TH": "NLM (1966)", "ST": "T033", "MS": "Prolonged failure of muscle relaxation after contraction. This may occur after voluntary contractions, muscle percussion, or electrical stimulation of the muscle. Myotonia is a characteristic feature of MYOTONIC DISORDERS.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009222"}, {"RECTYPE": "D", "MH": "Myotonic Dystrophy", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Steinert Disease|T047|EPO|EQV|NLM (1992)|OMIM (2013)|ORD (2010)|900904|STEINERT DIS|abcdeeefv", "ENTRY": "Syndrome, Ricker", "MN": "C16.320.577.500", "FX": "Trinucleotide Repeat Expansion", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "do not confuse with MUSCULAR DYSTROPHIES", "MS": "Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.", "PM": "2000; see MYOTONIA ATROPHICA 1966-1999; for MYOTONIC DYSTROPHY see MYOTONIC ATROPHICA 1993-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20140620", "DA": "19991108", "DC": "1", "DX": "19660101", "UI": "D009223"}, {"RECTYPE": "D", "MH": "Myotonia Congenita", "DE": "MYOTONIA CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thomsen Disease|T047|EPO|NRW|OMIM (2013)|ORD (2010)|UNK (19XX)|840615|THOMSEN DIS|abcdeeefv", "ENTRY": "Thomsen Generalized Myotonia", "MN": "C16.320.400.540", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Inherited myotonic disorders with early childhood onset MYOTONIA. Muscular hypertrophy is common and myotonia may impair ambulation and other movements. It is classified as Thomsen (autosomal dominant) or Becker (autosomal recessive) generalized myotonia mainly based on the inheritance pattern. Becker type is also clinically more severe. An autosomal dominant variant with milder symptoms and later onset is known as myotonia levior. Mutations in the voltage-dependent skeletal muscle chloride channel are associated with the disorders.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009224"}, {"RECTYPE": "D", "MH": "Myringoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Myringoplasties", "MN": "E04.580.450.505", "FX": "Tympanoplasty", "MH_TH": "NLM (1964)", "ST": "T061", "MS": "Surgical restoration of a perforated tympanic membrane by grafting. (Dorland, 28th ed.)", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009225"}, {"RECTYPE": "D", "MH": "Myristates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetradecanoates|T109|NON|EQV|UNK (19XX)|741111|abcdef", "MN": "D10.251.640.610", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Fatty Acids (1966-1974)", "MS": "Salts and esters of the 14-carbon saturated monocarboxylic acid--myristic acid.", "PM": "91; was see under MYRISTIC ACIDS 1975-90", "HN": "91(75); was see under MYRISTIC ACIDS 1975-90", "MR": "20030709", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D009226"}, {"RECTYPE": "D", "MH": "Myristic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetradecanoic Acids|T109|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Acids, Tetradecanoic", "MN": "D10.251.640", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Fatty Acids (1966-1974)", "MS": "14-carbon saturated monocarboxylic acids.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D009227"}, {"RECTYPE": "D", "MH": "Mysticism", "AQ": "HI PX", "ENTRY": "Mysticisms", "MN": "K01.844.799.430", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "IM; specify geog if pertinent", "MS": "A philosophy based upon spiritual intuition that is believed to transcend ordinary sensory experiences or understanding.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009228"}, {"RECTYPE": "D", "MH": "Mythology", "DE": "MYTHOL", "AQ": "HI PX", "MN": "K01.517.647", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "medical mythology: do not coordinate with MEDICINE", "MS": "A body of stories, the origins of which may be unknown or forgotten, that explain practices, beliefs, institutions or natural phenomena. Mythology includes legends and folk tales. It may refer to classical mythology or to a body of modern thought and modern life. (From Webster's 1st ed)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009229"}, {"RECTYPE": "D", "MH": "Myxedema", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Myxedemas", "MN": "C19.874.482.638", "FX": "Scleromyxedema", "EC": "congenital:Congenital Hypothyroidism", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009230"}, {"RECTYPE": "D", "MH": "Myxococcales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Slime Bacteria|T007|NON|EQV|UNK (19XX)|780130|SLIME BACT|abcdefv", "MN": "B03.660.125.500", "MH_TH": "NLM (1974)", "ST": "T007", "RN": "txid29", "RR": "txid55", "MS": "An order of rod-shaped, gram-negative fruiting gliding bacteria found in SOIL; WATER; and HUMUS.", "PM": "1992; see MYXOBACTERALES 1974-1991; for POLYANGIACEAE see POLYANGIACEAE 1975-1981; for POLYANGIUM see POLYANGIUM 1963-1981; for SLIME BACTERIA see MYXOBACTERALES 1974-1978", "HN": "1992 (1974)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009231"}, {"RECTYPE": "D", "MH": "Myxoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Angiomyxoma|T191|NON|REL|NLM (1994)|930326|abcdef", "ENTRY": "Myxomas", "MN": "C04.557.450.565.550", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A benign neoplasm derived from connective tissue, consisting chiefly of polyhedral and stellate cells that are loosely embedded in a soft mucoid matrix, thereby resembling primitive mesenchymal tissue. It occurs frequently intramuscularly where it may be mistaken for a sarcoma. It appears also in the jaws and the skin. (From Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009232"}, {"RECTYPE": "D", "MH": "Myxoma virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Poxvirus Myxomatis|T005|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Myxomatosis Viruses", "MN": "B04.613.204.600.550", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid10273", "AN": "infection: coord IM with POXVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) or index if pertinent under MYXOMATOSIS, INFECTIOUS instead", "MS": "The type species of LEPORIPOXVIRUS causing infectious myxomatosis, a severe generalized disease, in rabbits. Tumors are not always present.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009233"}, {"RECTYPE": "D", "MH": "Myxomatosis, Infectious", "DE": "MYXOMATOSIS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Myxomatoses, Infectious", "MN": "C22.627", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases caused by MYXOMA VIRUS.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009234"}, {"RECTYPE": "D", "MH": "Myxomycetes", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Slime Molds, True|T204|NON|EQV|NLM (1999)|971215|abcdef", "ENTRY": "True Slime Molds", "MN": "B01.046.550.550", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid33680", "RR": "txid435411", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A division of organisms that exist vegetatively as complex mobile plasmodia, reproduce by means of spores, and have complex life cycles. They are now classed as protozoa but formerly were considered fungi.", "PM": "99; see MYXOMYCOTA 1986-98, see MYXOMYCETES 1963-85", "HN": "99(63)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D009235"}, {"RECTYPE": "D", "MH": "Myxosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Myxosarcomas", "MN": "C04.557.450.795.560", "MH_TH": "NLM (1986)", "ST": "T191", "MS": "A sarcoma, usually a liposarcoma or malignant fibrous histiocytoma, with an abundant component of myxoid tissue resembling primitive mesenchyme containing connective tissue mucin. (Stedman, 25th ed)", "PM": "91,63-85; was see under SARCOMA 1986-90; was heading 1963-85", "HN": "91(86)63; was see under SARCOMA 1986-90; was heading 1963-85", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009236"}, {"RECTYPE": "D", "MH": "N-Acetyllactosamine Synthase", "DS": "ACETYLLACTOSAMINE SYNTHASE N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "UDP Galactose Acetylglucosamine Galactosyltransferase|T116|T126|EQV|UNK (19XX)|750211|abbdef", "ENTRY": "beta-D-Galactosyltransferase, N-Acetylglucosamine", "MN": "D08.811.913.400.450.400.500.100", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "UDPgalactose:N-acetyl-D-glucosamine 4-beta-D-galactosyltransferase", "RN": "EC 2.4.1.90", "RR": "9054-94-8 (CAS RN)", "PI": "Lactose Synthase (1973-1974)", "MS": "The A protein of the lactose synthase complex. In the presence of the B protein (LACTALBUMIN) specificity is changed from N-acetylglucosamine to glucose. EC 2.4.1.90.", "OL": "use N-ACETYLLACTOSAMINE SYNTHASE to search N-ACETYLLACTOSAMINE SYNTHETASE 1975-91", "PM": "92; was N-ACETYLLACTOSAMINE SYNTHETASE 1975-91 (see under LACTOSE SYNTHASE 1975-90)", "HN": "92; was N-ACETYLLACTOSAMINE SYNTHETASE 1975-91 (see under LACTOSE SYNTHASE 1975-90)", "MR": "20150612", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009237"}, {"RECTYPE": "D", "MH": "N-Acetylmuramoyl-L-alanine Amidase", "DS": "ACETYLMURAMOYL ALANINE AMIDASE N L", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mucopeptide Amidohydrolase|T116|T126|NON|EQV|UNK (19XX)|780516|abbcdef", "ENTRY": "N Acetylmuramoyl L alanine Amidase", "MN": "D08.811.277.087.030", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "Peptidoglycan amidohydrolase", "RN": "EC 3.5.1.28", "PI": "Muramic Acids (1973-1978)", "MS": "An autolytic enzyme bound to the surface of bacterial cell walls. It catalyzes the hydrolysis of the link between N-acetylmuramoyl residues and L-amino acid residues in certain cell wall glycopeptides, particularly peptidoglycan. EC 3.5.1.28.", "PM": "91; was see under AMIDOHYDROLASES 1979-90", "HN": "91(79); was see under AMIDOHYDROLASES 1979-90", "MR": "20030709", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D009238"}, {"RECTYPE": "D", "MH": "N-Formylmethionine", "DS": "FORMYLMETHIONINE N", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Formylmethionine, N", "MN": "D12.125.166.676.450", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "L-Methionine, N-formyl-", "RN": "4289-98-9", "PI": "Methionine (1974)", "MS": "Effective in the initiation of protein synthesis. The initiating methionine residue enters the ribosome as N-formylmethionyl tRNA. This process occurs in Escherichia coli and other bacteria as well as in the mitochondria of eucaryotic cells.", "PM": "91; was see under METHIONINE 1975-90", "HN": "91(75); was see under METHIONINE 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009239"}, {"RECTYPE": "D", "MH": "N-Formylmethionine Leucyl-Phenylalanine", "DE": "FMLP", "DS": "FORMYLMETHIONINELEUCYLPHENYLALANINE N", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "N-Formyl-Methionyl-Leucyl-Phenylalanine|T116|T123|NON|EQV|UNK (19XX)|840608|FORMYLMETHIONYLLEUCYLPHENYLALANINE N|abbcdefs", "ENTRY": "fMet Leu Phe", "MN": "D23.125.685", "MH_TH": "NLM (1984)", "ST": "T123", "N1": "L-Phenylalanine, N-(N-(N-formyl-L-methionyl)-L-leucyl)-", "RN": "59880-97-6", "PI": "Peptides (1966-1972)", "MS": "A formylated tripeptide originally isolated from bacterial filtrates that is positively chemotactic to polymorphonuclear leucocytes, and causes them to release lysosomal enzymes and become metabolically activated.", "OL": "use N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE to search N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE 1984", "PM": "85; was N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE 1984; CHEMOTACTIC PEPTIDE was see N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE 1984-90", "HN": "85; was N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE 1984; CHEMOTACTIC PEPTIDE was see N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE 1984-90", "MR": "20150602", "DA": "19830613", "DC": "1", "DX": "19840101", "UI": "D009240"}, {"RECTYPE": "D", "MH": "Ipratropium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "N-Isopropylatropine|T109|T121|NON|EQV|NLM (1993)|920405|ISOPROPYLATROPINE N|abbcdefs", "ENTRY": "Sch1178", "MN": "D03.605.869.229.400", "PA": "Cholinergic Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "8-Azoniabicyclo(3.2.1)octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, (endo,syn)-(+-)-", "RN": "GR88G0I6UL", "RR": "VJV4X1P2Z1", "PI": "Propane (1973-1974)", "MS": "A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.", "OL": "use IPRATROPIUM to search N-ISOPROPYLATROPINE 1975-92 & IPRATROPIUM BROMIDE 1976-92", "PM": "93; was N-ISOPROPYLATROPINE 1975-92 (see under ATROPINE DERIVATIVES 1978-90, see under ATROPINE 1975-77); IPRATROPIUM BROMIDE was see N-ISOPROPYLATROPINE 1976-92", "HN": "93; was N-ISOPROPYLATROPINE 1975-92 (see under ATROPINE DERIVATIVES 1978-90 & see under ATROPINE 1975-77); IPRATROPIUM BROMIDE was see N-ISOPROPYLATROPINE 1976-92", "MR": "20180227", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009241"}, {"RECTYPE": "D", "MH": "N-Nitrosopyrrolidine", "DS": "NITROSOPYRROLIDINE N", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "N Nitrosopyrrolidine", "MN": "D03.383.773.630", "MH_TH": "NLM (1979)", "ST": "T131", "N1": "Pyrrolidine, 1-nitroso-", "RN": "SZ4J5WK201", "RR": "930-55-2 (N-Nitrosopyrrolidine)", "PI": "Nitrosamines (1966-1978)", "MS": "Carcinogenic nitrosamine that may be formed from preservatives in meats during their preparation or in the liver during metabolism.", "PM": "91; was see under NITROSAMINES 1979-90", "HN": "91(79); was see under NITROSAMINES 1979-90", "MR": "20160531", "DA": "19780503", "DC": "1", "DX": "19910101", "UI": "D009242"}, {"RECTYPE": "D", "MH": "NAD", "AQ": "AA AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nicotinamide-Adenine Dinucleotide|T114|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbcdeef", "ENTRY": "Nucleotide, Diphosphopyridine", "MN": "D13.695.827.068.694", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Adenosine 5'-(trihydrogen diphosphate), P'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt", "RN": "0U46U6E8UK", "RR": "53-84-9 (NAD)", "AN": "a coenzyme; NAD or NADP probably correct for indexing of pyridine nucleotides", "MS": "A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009243"}, {"RECTYPE": "D", "MH": "NAD+ Nucleosidase", "DS": "NAD NUCLEOSIDASE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NADase|T116|T126|EQV|UNK (19XX)|741111|abbdef", "ENTRY": "Nucleotidases, Diphosphopyridine", "MN": "D08.811.913.400.725.115.660", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "NAD+ glycohydrolase", "RN": "EC 3.2.2.5", "RR": "EC 3.2.2.6", "PI": "Nucleosidases (1973-1974)", "MS": "An enzyme that catalyzes the hydrolysis of nicotinamide adenine dinucleotide (NAD) to NICOTINAMIDE and ADENOSINE DIPHOSPHATE RIBOSE. Some are extracellular (ectoenzymes).The enzyme from some sources also catalyses the hydrolysis of nicotinamide adenine dinucleotide phosphate (NADP).", "PM": "1994; see NAD NUCLEOSIDASE 1975-1993; NAD(P) NUCLEOSIDASE was indexed under N-GLYCOSYL HYDROLASES 1982-2002, NAD 1973-1981", "HN": "1994 (1975); use NAD NUCLEOSIDASE 1977-1993; for NAD(P) NUCLEOSIDASE use NAD+ NUCLEOSIDASE (NM) 1973-2002", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19770101", "UI": "D009244"}, {"RECTYPE": "D", "MH": "NADH Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NADH Cytochrome c Reductase|T116|T126|ABX|EQV|UNK (19XX)|790523|abbcdef", "ENTRY": "Dehydrogenase, NADH", "MN": "D12.776.556.579.374.375.140.500", "MH_TH": "NLM (1980)", "ST": "T126", "N1": "NADH:(acceptor) oxidoreductase", "RN": "EC 1.6.99.3", "AN": "do not confuse with NADPH DEHYDROGENASE; do not confuse entry term NADH CYTOCHROME C REDUCTASE with NADPH CYTOCHROME C REDUCTASE", "PI": "Oxidoreductases (1966-1972)", "MS": "A flavoprotein and iron sulfur-containing oxidoreductase that catalyzes the oxidation of NADH to NAD. In eukaryotes the enzyme can be found as a component of mitochondrial electron transport complex I. Under experimental conditions the enzyme can use CYTOCHROME C GROUP as the reducing cofactor. The enzyme was formerly listed as EC 1.6.2.1.", "PM": "91; was see under CYTOCHROME REDUCTASES 1980-90", "HN": "91(80); was see under CYTOCHROME REDUCTASES 1980-90", "MR": "20060705", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D009245"}, {"RECTYPE": "D", "MH": "NADH Tetrazolium Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tetrazolium Reductase, NADH2", "MN": "D08.811.682.608.530", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.6.-", "PI": "Tetrazolium Salts (1973-1974)", "MS": "Catalyzes the reduction of tetrazolium compounds in the presence of NADH.", "PM": "91; was see under NADH, NADPH OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under NADH, NADPH OXIDOREDUCTASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009246"}, {"RECTYPE": "D", "MH": "NADH, NADPH Oxidoreductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Oxidoreductases, NADH, NADPH|T116|T126|EQV|UNK (19XX)|740330|abbdef", "ENTRY": "Oxidoreductases NADH, NADPH", "MN": "D08.811.682.608", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 1.6.-", "PI": "Oxidoreductases (1966-1972)", "MS": "A group of oxidoreductases that act on NADH or NADPH. In general, enzymes using NADH or NADPH to reduce a substrate are classified according to the reverse reaction, in which NAD+ or NADP+ is formally regarded as an acceptor. This subclass includes only those enzymes in which some other redox carrier is the acceptor. (Enzyme Nomenclature, 1992, p100) EC 1.6.", "PM": "74", "HN": "74(73)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009247"}, {"RECTYPE": "D", "MH": "Nadolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SQ11725", "MN": "D02.092.063.624.698.601", "PA": "Sympatholytics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,3-Naphthalenediol, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-", "RN": "42200-33-9", "PI": "Propanolamines (1974-1986)", "MS": "A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for MIGRAINE DISORDERS and for tremor.", "PM": "87", "HN": "87", "MR": "20130708", "DA": "19860625", "DC": "1", "DX": "19870101", "UI": "D009248"}, {"RECTYPE": "D", "MH": "NADP", "AQ": "AA AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Triphosphopyridine Nucleotide|T114|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Phosphate, Nicotinamide-Adenine Dinucleotide", "MN": "D13.695.827.068.749", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt", "RN": "53-59-8", "AN": "a coenzyme; NADP or NAD probably correct for indexing of pyridine nucleotides", "MS": "Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009249"}, {"RECTYPE": "D", "MH": "NADP Transhydrogenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pyridine Nucleotide Transhydrogenase|T116|T126|NON|EQV|UNK (19XX)|780313|abbcdef", "ENTRY": "Transhydrogenases, NADP", "MN": "D08.811.682.608.540", "MH_TH": "NLM (2012)", "ST": "T126", "RN": "EC 1.6.1.-", "PI": "Oxidoreductases (1966-1972)", "MS": "Enzymes that catalyze the reversible reduction of NAD by NADPH to yield NADP and NADH. This reaction permits the utilization of the reducing properties of NADPH by the respiratory chain and in the reverse direction it allows the reduction of NADP for biosynthetic purposes.", "PM": "2012; see NADP Transhydrogenase 1991-2011, see NADH, NADPH OXIDOREDUCTASES 1979-1990", "HN": "2012(1991)", "MR": "20110624", "DA": "19780313", "DC": "1", "DX": "19910101", "UI": "D009250"}, {"RECTYPE": "D", "MH": "NADPH-Ferrihemoprotein Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NADPH Cytochrome c Reductase|T116|T126|NON|EQV|NLM (1992)|910328|abbcdef", "ENTRY": "Reductase, NADPH-P450", "MN": "D08.811.682.608.191.500", "FX": "Antley-Bixler Syndrome Phenotype", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "NADPH:ferrihemoprotein oxidoreductase", "RN": "EC 1.6.2.4", "PI": "Oxidoreductases (1966-1974)", "MS": "A flavoprotein that catalyzes the reduction of heme-thiolate-dependent monooxygenases and is part of the microsomal hydroxylating system. EC 1.6.2.4.", "PM": "1992; see NADPH CYTOCHROME C REDUCTASE 1980-1991 & CYTOCHROME REDUCTASES 1975-1979; CYTOCHROME P-450 OXIDASE was indexed under NADH, NADPH OXIDOREDUCTASES 1997-2000 & OXIDOREDUCTASES 1983-1996", "HN": "1992(1975); for CYTOCHROME P-450 OXIDASE use NADPH-FERRIHEMOPROTEIN REDUCTASE (NM) 1983-2000", "MR": "20120703", "DA": "19741119", "DC": "1", "DX": "19800101", "UI": "D009251"}, {"RECTYPE": "D", "MH": "NADPH Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TPN Diaphorase|T116|T126|EQV|UNK (19XX)|790615|abbdef", "ENTRY": "Enzyme, Old Yellow", "MN": "D08.811.682.608.550", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "NADPH:(acceptor) oxidoreductase", "RN": "EC 1.6.99.1", "AN": "do not confuse with NADH DEHYDROGENASE", "MS": "A flavoprotein that reversibly oxidizes NADPH to NADP and a reduced acceptor. EC 1.6.99.1.", "OL": "use NADPH DEHYDROGENASE to search OLD YELLOW ENZYME 1975-79 & OXIDOREDUCTASES 1967-74; use NADPH DEHYDROGENASE to search NADP DIAPHORASE 1975-79", "PM": "91; was see under NADH, NADPH OXIDOREDUCTASES 1980-90; was OLD YELLOW ENZYME see under NADH, NADPH OXIDOREDUCTASES 1975-79, see under OXIDOREDUCTASES 1967-74; NADP DIAPHORASE was see under LIPOAMIDE DEHYDROGENASE 1975-79", "HN": "91(80); was see under NADH, NADPH OXIDOREDUCTASES 1980-90; was OLD YELLOW ENZYME see under NADH, NADPH OXIDOREDUCTASES 1975-79, see under OXIDOREDUCTASES 1967-74; NADP DIAPHORASE was see under LIPOAMIDE DEHYDROGENASE 1975-79", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009252"}, {"RECTYPE": "D", "MH": "Naegleria", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Naeglerias", "MN": "B01.046.500.700.710", "MH_TH": "NLM (1988)", "ST": "T204", "RN": "txid5761", "AN": "infection: coordinate IM with CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Amoeba (1966-1987)", "MS": "A free-living soil amoeba pathogenic to humans and animals. It occurs also in water and sewage. The most commonly found species in man is NAEGLERIA FOWLERI which is the pathogen for primary amebic meningoencephalitis in primates.", "PM": "88", "HN": "88", "MR": "20200813", "DA": "19870430", "DC": "1", "DX": "19880101", "UI": "D009253"}, {"RECTYPE": "D", "MH": "Nafcillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sodium Nafcillin|T109|T195|NON|NRW|UNK (19XX)|761224|abbcdef", "ENTRY": "Sodium, Nafcillin", "MN": "D03.633.100.300.750.562", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2-ethoxy-1-naphthalenyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-", "RN": "4CNZ27M7RV", "RR": "985-16-0 (mono-Na salt, anhydrous)", "MS": "A semi-synthetic antibiotic related to penicillin.", "PM": "68", "HN": "68(65)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009254"}, {"RECTYPE": "D", "MH": "Nafenopin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SU13,437", "MN": "D02.241.081.751.512", "PA": "Peroxisome Proliferators", "MH_TH": "USAN (1970)", "ST": "T121", "N1": "Propanoic acid, 2-methyl-2-(4-(1,2,3,4-tetrahydro-1-naphthalenyl)phenoxy)-", "RN": "093W78U96W", "RR": "3771-19-5 (Nafenopin)", "PI": "Propionates (1966-1972)", "MS": "A peroxisome proliferator that is used experimentally to promote liver tumors. It has been used as an antihyperlipoproteinemic agent.", "PM": "91; was see under PROPIONATES 1973-90", "HN": "91(73); was see under PROPIONATES 1973-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009255"}, {"RECTYPE": "D", "MH": "Nafoxidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "U11000A", "MN": "D03.383.773.589", "PA": "Estrogen Antagonists", "MH_TH": "POPLINE (1978)", "ST": "T121", "N1": "Pyrrolidine, 1-(2-(4-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthalenyl)phenoxy)ethyl)-", "RN": "4RIY10WM82", "RR": "SU8WBD61G1", "MS": "An estrogen antagonist that has been used in the treatment of breast cancer.", "PM": "91; was see under PYRROLIDINES 1973-90", "HN": "91(73); was see under PYRROLIDINES 1973-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009256"}, {"RECTYPE": "D", "MH": "Nafronyl", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Naftidrofuryl|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|741111|abbcdeeef", "ENTRY": "Oxalate, Naftifurin", "MN": "D03.383.312.620", "PA": "Vasodilator Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "2-Furanpropanoic acid, tetrahydro-alpha-(1-naphthalenylmethyl)-, 2-(diethylamino)ethyl ester", "RN": "42H8PQ0NMJ", "RR": "5ADB8D9388", "PI": "Propionates (1971-1974)", "MS": "A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.", "PM": "91; was see under FURANS 1975-90", "HN": "91(75); was see under FURANS 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009257"}, {"RECTYPE": "D", "MH": "Nail Biting", "AQ": "AE PX TH", "PRINT ENTRY": "Onychophagia|T055|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Biting, Nail", "MN": "F01.145.466.554", "MH_TH": "NLM (1966)", "ST": "T055", "MS": "Common form of habitual body manipulation which is an expression of tension.", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009259"}, {"RECTYPE": "D", "MH": "Nail Diseases", "DE": "NAIL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Nail Disease", "MN": "C17.800.529", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "primates only; neopl: coord IM with SKIN NEOPLASMS (IM)", "PI": "Nails (1966-1978)", "MS": "Diseases of the nail plate and tissues surrounding it. The concept is limited to primates.", "PM": "79", "HN": "79; was NON MESH before 1979", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D009260"}, {"RECTYPE": "D", "MH": "Nail-Patella Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Turner-Kieser Syndrome|T019|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|740330|abbcdeeeef", "ENTRY": "Turner Kieser Syndrome", "MN": "C17.800.529.400", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A syndrome of multiple abnormalities characterized by the absence or hypoplasia of the PATELLA and congenital nail dystrophy. It is a genetically determined autosomal dominant trait.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009261"}, {"RECTYPE": "D", "MH": "Nails", "AQ": "AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Toenails|T029|NON|NRW|NLM (2003)|011219|abcdef", "ENTRY": "Toenail", "MN": "A17.600", "EC": "abnormalities:Nails, Malformed", "MH_TH": "NLM (1966)", "ST": "T017", "AN": "primates only: use HOOF AND CLAW for other vertebrates: Manual 21.58;", "CX": "consider also terms at ONYCHO-", "MS": "The thin, horny plates that cover the dorsal surfaces of the distal phalanges of the fingers and toes of primates.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009262"}, {"RECTYPE": "D", "MH": "Nails, Ingrown", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Onychocryptosis|T020|T033|T047|NON|EQV|NLM (2021)|200227|abbbcdef", "ENTRY": "Onychocryptoses", "MN": "C17.800.529.406", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Excessive lateral nail growth into the nail fold. Because the lateral margin of the nail acts as a foreign body, inflammation and granulation may result. It is caused by improperly fitting shoes and by improper trimming of the nail.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009263"}, {"RECTYPE": "D", "MH": "Nails, Malformed", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Onychogryposis|T047|NON|NRW|NLM (2024)|220927|abcdef", "ENTRY": "Nail, Malformed", "MN": "C23.300.820", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Deformities in nail structure or appearance, including hypertrophy, splitting, clubbing, furrowing, etc. Genetic diseases such as PACHYONYCHIA CONGENITA can result in malformed nails.", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009264"}, {"RECTYPE": "D", "MH": "Nairobi Sheep Disease", "DE": "NAIROBI SHEEP DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Sheep Disease, Nairobi", "MN": "C22.836.583", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "caused by a nairovirus; don't forget also SHEEP (NIM) & check tag ANIMALS", "PI": "Sheep Diseases (1966-1969)", "MS": "An arbovirus infection of sheep and goats transmitted by ticks. It is characterized by high fever and hemorrhagic gastroenteritis.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D009265"}, {"RECTYPE": "D", "MH": "Nalbuphine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "EN2234A", "MN": "D04.615.723.795.606", "PA": "Analgesics, Opioid", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, (5alpha,6alpha)-", "RN": "L2T84IQI2K", "RR": "ZU4275277R", "PI": "Narcotic Antagonists (1966-1971)", "MS": "A narcotic used as a pain medication. It appears to be an agonist at KAPPA RECEPTORS and an antagonist or partial agonist at MU RECEPTORS.", "PM": "1991; NALBUPHINE was indexed under MORPHINANS 1972-1990", "HN": "1991 (1972)", "MR": "20180410", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009266"}, {"RECTYPE": "D", "MH": "Naled", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Dibrom|T109|T131|TRD|NRW|UNK (19XX)|810305|abbcdef", "MN": "D02.705.400.600", "PA": "Insecticides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Phosphoric acid, 1,2-dibromo-2,2-dichloroethyl dimethyl ester", "RN": "PAM1AI9KU1", "RR": "300-76-5 (Naled)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides (1966-1971)", "MS": "An organophosphate cholinesterase inhibitor that is used as an insecticide and as an acaricide.", "PM": "91; was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90", "HN": "91(72); was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009267"}, {"RECTYPE": "D", "MH": "Nalidixic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nalidixin|T109|T121|NON|EQV|UNK (19XX)|761224|abbcdef", "ENTRY": "Sodium, Nalidixate", "MN": "D03.633.100.810.835.830.500", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-", "RN": "3B91HWA56M", "RR": "Y7NU182221", "MS": "A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE.", "PM": "66", "HN": "66(64)", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009268"}, {"RECTYPE": "D", "MH": "Nalorphine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Allylnormorphine|T109|T121|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Hydrochloride, Nalorphine", "MN": "D04.615.723.795.656", "PA": "Narcotic Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-(2-propenyl)-, (5alpha,6alpha)-", "RN": "U59WB2WRY2", "RR": "9FPE56Z2TW", "MS": "A narcotic antagonist with some agonist properties. It is an antagonist at mu opioid receptors and an agonist at kappa opioid receptors. Given alone it produces a broad spectrum of unpleasant effects and it is considered to be clinically obsolete.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009269"}, {"RECTYPE": "D", "MH": "Naloxone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Naloxon Ratiopharm", "MN": "D04.615.723.795.706", "PA": "Narcotic Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)-", "RN": "36B82AMQ7N", "RR": "F850569PQR", "PI": "Narcotic Antagonists (1966-1971)", "MS": "A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.", "PM": "1973; for MRZ-2593 see OXYMORPHONE 1985-2009", "HN": "1973(1972); for MRZ-2593 use OXYMORPHONE 1985-2009", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009270"}, {"RECTYPE": "D", "MH": "Naltrexone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "EN1639A", "MN": "D04.615.723.795.706.550", "PA": "Narcotic Antagonists", "MH_TH": "USAN (1963)", "ST": "T121", "N1": "Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5alpha)-", "RN": "5S6W795CQM", "RR": "Z6375YW9SF", "PI": "Naloxone/analogs & derivatives (1975)", "MS": "Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.", "PM": "1986; NALTREXONE was indexed under NALOXONE 1976-1985", "HN": "1986 (1976)", "MR": "20180410", "DA": "19750723", "DC": "1", "DX": "19860101", "UI": "D009271"}, {"RECTYPE": "D", "MH": "Persons", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Person", "MN": "M01", "RH": "M1 - PERSONS", "MH_TH": "NLM (1966)", "ST": "T098", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Persons as individuals (e.g., ABORTION APPLICANTS) or as members of a group (e.g., HISPANIC AMERICANS). It is not used for members of the various professions (e.g., PHYSICIANS) or occupations (e.g., LIBRARIANS) for which OCCUPATIONAL GROUPS is available.", "PM": "98", "HN": "98; use explode", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009272"}, {"RECTYPE": "D", "MH": "Age Groups", "ENTRY": "Group, Age", "MN": "M01.060", "MH_TH": "NLM (1974)", "ST": "T100", "AN": "INDEXER: Do not use; CATALOGER: Do not use", "PI": "specific age group (1966-1997)", "MS": "Persons classified by age from birth (INFANT, NEWBORN) to octogenarians and older (AGED, 80 AND OVER).", "PM": "98", "HN": "98; use explode 1975-97", "MR": "20210326", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009273"}, {"RECTYPE": "D", "MH": "Occupational Groups", "DE": "OCCUP GROUPS", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Workers|T097|NON|EQV|NLM (2020)|190414|abcdef", "ENTRY": "Occupational Group|T097|NON|EQV|NLM (1998)|970107|OCCUP GROUP|abcdefv", "MN": "M01.526", "FX": "Occupations", "MH_TH": "NLM (1974)", "ST": "T097", "AN": "INDEXER: Do not use", "PI": "specific occupational group (1966-1997)", "MS": "Members of the various professions (e.g., PHYSICIANS) or occupations (e.g., POLICE).", "PM": "98", "HN": "98; use explode 1975-97", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009274"}, {"RECTYPE": "D", "MH": "Names", "PRINT ENTRY": "Isonymy|T170|NON|NRW|NLM (1995)|930913|abcdef", "ENTRY": "Name", "MN": "L01.559.598.400.556", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "for articles & books on personal given or surnames; history of names & name changes of agencies, societies, organizations, universities, medical schools, hospitals & other corporate bodies go here (NIM) + specific body if in MeSH as main heading (IM) or GOVERNMENT AGENCIES; SOCIETIES; UNIVERSITIES; HOSPITALS or other generic heading if specific corporate body is not in MeSH (IM)", "MS": "Personal names, given or surname, as cultural characteristics, as ethnological or religious patterns, as indications of the geographic distribution of families and inbreeding, etc. Analysis of isonymy, the quality of having the same or similar names, is useful in the study of population genetics. NAMES is used also for the history of names or name changes of corporate bodies, such as medical societies, universities, hospitals, government agencies, etc.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009275"}, {"RECTYPE": "D", "MH": "Namibia", "AQ": "EH EP", "ENTRY": "Southwest Africa|T083|NAM|EQV|NLM (1992)|910611|abcdef", "MN": "Z01.058.290.175.580", "MH_TH": "NLM (1981)", "ST": "T083", "PI": "South Africa (1966-1974)", "MS": "A republic in southern Africa, south of ANGOLA and west of BOTSWANA. Its capital is Windhoek.", "HN": "1978", "MR": "20080708", "DA": "19770513", "DC": "4", "DX": "19780101", "UI": "D009276"}, {"RECTYPE": "D", "MH": "Nandrolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nortestosterone|T109|T121|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "17beta Hydroxy 19 Nor 4 Androsten 3 One", "MN": "D06.472.334.851.968.976", "PA": "Androgens", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Estr-4-en-3-one, 17-hydroxy-, (17beta)-", "RN": "6PG9VR430D", "RR": "434-22-0 (Nandrolone)", "MS": "C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of ESTRADIOL to resemble TESTOSTERONE but less one carbon at the 19 position.", "PM": "65; was NORTESTOSTERONE 1963-64", "HN": "65; was NORTESTOSTERONE 1963-64", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009277"}, {"RECTYPE": "D", "MH": "Naphazoline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tele Stulln", "MN": "D03.383.129.308.585", "PA": "Nasal Decongestants", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-", "RN": "H231GF11BV", "RR": "SC99GR1T5S", "MS": "An adrenergic vasoconstrictor agent used as a decongestant.", "PM": "91; was see under IMIDAZOLES 1975-90; was see under VASOCONSTRICTOR AGENTS, NASAL 1967-74; was see under SYMPATHOMIMETICS 1963-66", "HN": "91(63); was see under IMIDAZOLES 1975-90; was see under VASOCONSTRICTOR AGENTS, NASAL 1967-74; was see under SYMPATHOMIMETICS 1963-66", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009278"}, {"RECTYPE": "D", "MH": "Naphthacenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetracenes|T109|NON|EQV|NLM (2004)|030203|abcdef", "ENTRY": "Benz(b)Anthracenes|T109|NON|EQV|NLM (2005)|040105|abcdef", "MN": "D04.615.562", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Polyacenes with four ortho-fused benzene rings in a straight linear arrangement. This group is best known for the subclass called TETRACYCLINES.", "PM": "66", "HN": "66", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009279"}, {"RECTYPE": "D", "MH": "Naphthaleneacetic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Naphthaleneacetic", "MN": "D04.615.638.472", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Naphthalene derivatives containing the -CH2CCO2H radical at the 1-position, the 2-position, or both. Compounds are used as plant growth regulators to delay sprouting, exert weed control, thin fruit, etc.", "PM": "68", "HN": "68", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009280"}, {"RECTYPE": "D", "MH": "Naphthalenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.638", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "aromatic hydrocarbons", "MS": "Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009281"}, {"RECTYPE": "D", "MH": "Naphthalenesulfonates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.638.555", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "A class of organic compounds that contains a naphthalene moiety linked to a sulfonic acid salt or ester.", "PM": "74", "HN": "74", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009282"}, {"RECTYPE": "D", "MH": "Naphthol AS D Esterase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-Naphthyl Acetate Esterase|T116|T126|NON|EQV|UNK (19XX)|830531|abbcdef", "ENTRY": "alpha Naphthylacetate Esterase", "MN": "D08.811.277.352.100.550", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.1.-", "PI": "Naphthols (1972-1974)", "MS": "Hydrolytic enzyme activity used as a histocytochemical test for the presence of esterases in tissue. Substrate used is 3-hydroxy-4'-nitro-2-naphthanilide chloroacetate (naphthol AS-D).", "PM": "85; was see under CARBOXYLIC ESTER HYDROLASES 1976-84, was see under ESTERASES 1975", "HN": "85(75); was see under CARBOXYLIC ESTER HYDROLASES 1976-84, was see under ESTERASES 1975", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19850101", "UI": "D009283"}, {"RECTYPE": "D", "MH": "Naphthols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Naphthol|T109|NON|EQV|NLM (2021)|200225|abcdef", "MN": "D04.615.638.638", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Naphthalenes (1966-1971)", "MS": "Naphthalene derivatives carrying one or more hydroxyl (-OH) groups at any ring position. They are often used in dyes and pigments, as antioxidants for rubber, fats, and oils, as insecticides, in pharmaceuticals, and in numerous other applications.", "PM": "73", "HN": "73(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009284"}, {"RECTYPE": "D", "MH": "Naphthoquinones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Naphthoquinone|T109|NON|EQV|NLM (2021)|191227|abcdef", "MN": "D04.615.638.721", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009285"}, {"RECTYPE": "D", "MH": "Naphthylvinylpyridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.638.900", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Pyridine, 4-(2-(1-naphthalenyl)ethenyl)-", "RN": "16375-56-7", "AN": "a cholinesterase inhib", "PI": "Vinyl Compounds (1971-1974)", "MS": "4(1-Naphthylvinyl)pyridine hydrochloride. Cholinesterase inhibitor. Synonym: YuB 25.", "PM": "91; was see under PYRIDINES 1975-90", "HN": "91(75); was see under PYRIDINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009286"}, {"RECTYPE": "D", "MH": "Naphthyridines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.612", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A group of two-ring heterocyclic compounds consisting of a NAPHTHALENES double ring in which two carbon atoms, one per each ring, are replaced with nitrogens.", "MR": "20190408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009287"}, {"RECTYPE": "D", "MH": "Naproxen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Naproxen", "MN": "D04.615.638.472.450", "PA": "Gout Suppressants", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (S)-", "RN": "57Y76R9ATQ", "RR": "9TN87S3A3C", "PI": "Propionates (1972-1974)", "MS": "An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.", "PM": "78; was see under NAPHTHALENEACETIC ACIDS 1975-77", "HN": "78(75); was see under NAPHTHALENEACETIC ACIDS 1975-77", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D009288"}, {"RECTYPE": "D", "MH": "Narcissism", "ENTRY": "Narcissisms", "MN": "F02.739.794.582", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "A psychoanalytic term meaning self-love.", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "19890502", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009289"}, {"RECTYPE": "D", "MH": "Narcolepsy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paroxysmal Sleep|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Syndromes, Narcoleptic", "MN": "F03.870.400.800.200.750", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7)", "PM": "67", "HN": "67(63)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009290"}, {"RECTYPE": "D", "MH": "Narcotherapy", "DE": "NARCOTHER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Narcosynthesis|T061|NON|NRW|UNK (19XX)|780503|NARCOSYN|abcdefv", "ENTRY": "Narcotherapies", "MN": "F04.570.505.557", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Intravenous injections of sodium amytal or sodium pentothal to induce a state in which the patient is more relaxed and communicative. Narcosuggestion, narcosynthesis, and narcoanalysis are therapeutic processes using these drug adjuncts.", "OL": "use NARCOTHERAPY to search NARCOSYNTHESIS 1968-78", "HN": "NARCOSYNTHESIS was see under NARCOTHERAPY 1968-78", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009291"}, {"RECTYPE": "D", "MH": "Narcotic Antagonists", "DE": "NARCOTIC ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Opioid Reversal Agent|T121|NON|REL|NLM (2021)|191119|abcdef", "ENTRY": "Reversal Agents, Opioid", "MN": "D27.505.954.427.550", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Agents inhibiting the effect of narcotics on the central nervous system.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009292"}, {"RECTYPE": "D", "MH": "Opioid-Related Disorders", "DE": "OPIOID RELATED DIS", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Prescription Opioid Misuse|T048|NON|NRW|NLM (2021)|191129|abcdef", "ENTRY": "Prescription Opioid Misuses", "MN": "F03.900.647.500", "MH_TH": "NLM (1980)", "ST": "T048", "AN": "coordinate with specific opioid but note MORPHINE DEPENDENCE,  HEROIN DEPENDENCE and OPIUM DEPENDENCE are available ", "PI": "Substance Dependence (1966-1979)", "MS": "Disorders related to or resulting from abuse or misuse of OPIOIDS.", "PM": "98; see NARCOTIC DEPENDENCE 1981-97, see NARCOTIC ADDICTION 1980", "HN": "98(80)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D009293"}, {"RECTYPE": "D", "MH": "Narcotics", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Narcotic Analgesics|T103|T121|NON|NRW|UNK (19XX)|750717|abbcdef", "ENTRY": "Effects, Narcotic", "MN": "D27.505.954.427.210.600", "FX": "Receptors, Opioid", "EC": "antagonists & inhibitors:Narcotic Antagonists", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "NARCOTIC-RELATED DISORDERS is available; note entry term NARCOTIC EFFECT: use only for the narcotic effect of a chemical substance", "MS": "Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS.", "PM": "for NARCOTIC ANALGESICS see ANALGESICS, OPIOID 1975-2006", "HN": "for NARCOTIC ANALGESICS use ANALGESICS, OPIOID 1975-2006", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009294"}, {"RECTYPE": "D", "MH": "Nasal Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Bones, Nasal", "MN": "A04.531.378", "FX": "Rhinoplasty", "MH_TH": "NLM (1975)", "ST": "T023", "PI": "Nose (1966-1974)", "MS": "Either one of the two small elongated rectangular bones that together form the bridge of the nose.", "OL": "search NOSE 1966-74", "PM": "78; was see under NOSE 1963-77", "HN": "78(75); was see under NOSE 1963-77", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D009295"}, {"RECTYPE": "D", "MH": "Nasal Cavity", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Cavity, Nasal", "MN": "A04.531.449", "MH_TH": "NLM (1975)", "ST": "T030", "PI": "Nose (1966-1974)", "MS": "The proximal portion of the respiratory passages on either side of the NASAL SEPTUM. Nasal cavities, extending from the nares to the NASOPHARYNX, are lined with ciliated NASAL MUCOSA.", "OL": "search NOSE 1966-74", "PM": "78; was see under NOSE 1963-77", "HN": "78(75); was see under NOSE 1963-77", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D009296"}, {"RECTYPE": "D", "MH": "Nasal Mucosa", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Nasal Epithelium|T024|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Mucosa, Nasal", "MN": "A10.615.550.760.600", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells.", "MR": "20180206", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009297"}, {"RECTYPE": "D", "MH": "Nasal Polyps", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Polyps, Nasal", "MN": "C23.300.825.557", "MH_TH": "NLM (1966)", "ST": "T190", "MS": "Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009298"}, {"RECTYPE": "D", "MH": "Nasal Provocation Tests", "DE": "NP TESTS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Provocation Tests, Nasal|T060|NON|EQV|UNK (19XX)|790308|abcdef", "ENTRY": "Tests, Nasal Provocation", "MN": "E01.370.386.550", "MH_TH": "NLM (1980)", "ST": "T060", "PI": "Nasal Mucosa (1966-1979)", "MS": "Application of allergens to the nasal mucosa. Interpretation includes observation of nasal symptoms, rhinoscopy, and rhinomanometry. Nasal provocation tests are used in the diagnosis of nasal hypersensitivity, including RHINITIS, ALLERGIC, SEASONAL.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19790308", "DC": "1", "DX": "19800101", "UI": "D009299"}, {"RECTYPE": "D", "MH": "Nasal Septum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Septums, Nasal", "MN": "A04.531.591", "FX": "Nasal Septal Perforation", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The partition separating the two NASAL CAVITIES in the midplane. It is formed by the SEPTAL NASAL CARTILAGE, parts of skull bones (ETHMOID BONE; VOMER), and membranous parts.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009300"}, {"RECTYPE": "D", "MH": "Nasolacrimal Duct", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tear Ducts", "MN": "A09.371.463.640", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "A tubular duct that conveys TEARS from the LACRIMAL GLAND to the nose.", "OL": "search LACRIMAL APPARATUS 1966-74", "PM": "91; was see under LACRIMAL APPARATUS 1975-90", "HN": "91(75); was see under LACRIMAL APPARATUS 1975-90", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009301"}, {"RECTYPE": "D", "MH": "Nasopharyngeal Diseases", "DE": "NASOPHARYNGEAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Nasopharynx Diseases", "MN": "C09.775.350", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes involving the NASOPHARYNX.", "PM": "66", "HN": "66; NASOPHARYNGITIS was see under PHARYNGITIS 1965-89", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009302"}, {"RECTYPE": "D", "MH": "Nasopharyngeal Neoplasms", "DE": "NASOPHARYNGEAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Nasopharyngeal Cancer|T191|NON|NRW|NLM (2000)|OMIM (2013)|ORD (2010)|991105|abcdeeef", "ENTRY": "Neoplasms, Nasopharynx", "MN": "C09.775.549.650", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM)", "MS": "Tumors or cancer of the NASOPHARYNX.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009303"}, {"RECTYPE": "D", "MH": "Nasopharyngitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Nasopharyngitides", "MN": "C09.775.649.500", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "inflammation of nasopharyngeal portion of PHARYNX, not nose & pharynx", "MS": "Inflammation of the NASOPHARYNX, usually including its mucosa, related lymphoid structure, and glands.", "OL": "search PHARYNGITIS 1966-74", "PM": "91; was see under NASOPHARYNGEAL DISEASES 1990; was see under PHARYNGITIS 1965-89", "HN": "91(65); was see under NASOPHARYNGEAL DISEASES 1990; was see under PHARYNGITIS 1965-89", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009304"}, {"RECTYPE": "D", "MH": "Nasopharynx", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Rhinopharynx|T023|NON|EQV|UNK (19XX)|790525|abcdef", "ENTRY": "Rhinopharynxes|T023|NON|EQV|NLM (1990)|890306|abcdef", "MN": "A14.724.557", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The top portion of the pharynx situated posterior to the nose and superior to the SOFT PALATE. The nasopharynx is the posterior extension of the nasal cavities and has a respiratory function.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009305"}, {"RECTYPE": "D", "MH": "Natal Teeth", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Tooth, Natal|T023|NON|EQV|NLM (1994)|930201|abcdef", "ENTRY": "Teeth, Natal", "MN": "A14.549.167.860.700.500", "MH_TH": "OMIM (2013)", "ST": "T023", "AN": "\"predeciduous teeth present at birth\"", "MS": "Predeciduous teeth present at birth. They may be well formed and normal or may represent hornified epithelial structures without roots. They are found on the gingivae over the crest of the ridge and arise from accessory buds of the dental lamina ahead of the deciduous buds or from buds of the accessory dental lamina. (From Jablonski, Dictionary of Dentistry, 1992)", "OL": "search TOOTH, DECIDUOUS 1966-74", "PM": "91; was see under TOOTH, DECIDUOUS 1975-90", "HN": "91(75); was see under TOOTH, DECIDUOUS 1975-90", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009306"}, {"RECTYPE": "D", "MH": "National Academy of Sciences, U.S.", "AQ": "HI OG", "PRINT ENTRY": "United States National Academy of Sciences|T092|NAM|EQV|UNK (19XX)|810605|UNITED STATES NATIONAL ACAD SCIENCES|abcdefv", "ENTRY": "Sciences National Academy (U.S.)", "MN": "N03.540.052.500", "MH_TH": "NLM (2020)", "ST": "T092", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, NON-U.S. GOV'T; CATALOGER: Use NAF entry", "MS": "A United States organization of distinguished scientists and engineers established for the purpose of investigating and reporting upon any subject of art or science as requested by any department of government. The National Research Council organized by NAS serves as the principal operating agency to stimulate and support research.", "PM": "2020; was NATIONAL ACADEMY OF SCIENCES (U.S.) 1990-2019; see ORGANIZATIONS 1982-1989; was NATIONAL ACADEMY OF SCIENCES see ORGANIZATIONS 1980-1981", "HN": "2020 (1982); was NATIONAL ACADEMY OF SCIENCES (U.S.) 1990-2019; use ORGANIZATIONS 1982-1989; was NATIONAL ACADEMY OF SCIENCES use ORGANIZATIONS 1980-1981", "MR": "20190118", "DA": "19781222", "DC": "1", "DX": "19900101", "UI": "D009307"}, {"RECTYPE": "D", "MH": "National Center for Health Care Technology, U.S.", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "National Center for Health Care Technology (U.S.)|T093|NAM|EQV|UNK (19XX)|810519|NATIONAL CENTER FOR HEALTH CARE TECHNOL US|abcdefv", "ENTRY": "United States National Center for Health Care Technology|T093|NAM|EQV|NLM (2020)|181010|abcdef", "MN": "N03.540.348.500.500.600.650.400", "MH_TH": "NLM (2020)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; CATALOGER: Use NAF entry", "MS": "A center in the PUBLIC HEALTH SERVICE which coordinates and administers a program of research, demonstrations, and evaluations of medical technologies and assessments of health care technology.", "PM": "2020; was NATIONAL CENTER FOR HEALTH CARE TECHNOLOGY (U.S.) 1982-2019; see UNITED STATES PUBLIC HEALTH SERVICE 1982-1990", "HN": "2020 (1982); was NATIONAL CENTER FOR HEALTH CARE TECHNOLOGY (U.S.) 1982-2019; use UNITED STATES PUBLIC HEALTH SERVICE 1982-1990", "MR": "20190118", "DA": "19810519", "DC": "1", "DX": "19910101", "UI": "D009308"}, {"RECTYPE": "D", "MH": "National Center for Health Statistics, U.S.", "AQ": "EC HI LJ OG", "PRINT ENTRY": "United States National Center for Health Statistics|T093|NAM|EQV|UNK (19XX)|820614|UNITED STATES NATIONAL CENTER FOR HEALTH STATIST|abcdefv", "ENTRY": "National Center for Health Statistics|T093|NAM|EQV|UNK (19XX)|810605|NATIONAL CENTER FOR HEALTH STATIST|abcdefv", "MN": "N03.540.348.500.500.600.650.225.260", "MH_TH": "NLM (2020)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; CATALOGER: Use NAF entry", "MS": "A unit of the CENTERS FOR DISEASE CONTROL AND PREVENTION. It is primarily concerned with the collection, analysis, and dissemination of health statistics on vital events and health activities to reflect the health status of people, health needs, and health resources.", "PM": "2020; was NATIONAL CENTER FOR HEALTH STATISTICS (U.S.) 1982-2019; see UNITED STATES PUBLIC HEALTH SERVICE 1982-1990", "HN": "2020 (1982); was NATIONAL CENTER FOR HEALTH STATISTICS (U.S.) 1982-2019; use UNITED STATES PUBLIC HEALTH SERVICE 1982-1990", "MR": "20190118", "DA": "19810519", "DC": "1", "DX": "19910101", "UI": "D009309"}, {"RECTYPE": "D", "MH": "National Health Insurance, United States", "DE": "NATL HEALTH INSUR US", "AQ": "EC ES HI LJ SN ST TD", "PRINT ENTRY": "United States National Health Insurance|T064|NON|EQV|UNK (19XX)|770513|abcdef", "MN": "N03.349.550.610", "MH_TH": "NLM (1978)", "ST": "T064", "PI": "National Health Programs (1975-1977)", "MS": "Federal system administering national health insurance in the United States.", "PM": "78", "HN": "78", "MR": "20180201", "DA": "19770513", "DC": "1", "DX": "19780101", "UI": "D009310"}, {"RECTYPE": "D", "MH": "National Health Planning Information Center, U.S.", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "United States National Health Planning Information Center|T093|NAM|EQV|UNK (19XX)|810605|abcdef", "ENTRY": "National Health Planning Information Center|T093|NAM|EQV|NLM (1980)|990101|abcdef", "MN": "N03.540.348.500.500.600.650.790.525", "MH_TH": "NLM (2020)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; CATALOGER: Use NAF entry", "MS": "A center in the HEALTH RESOURCES ADMINISTRATION Division of Planning Methods and Technology which provides access to current information on health planning and resources development.", "PM": "2020; was NATIONAL HEALTH PLANNING INFORMATION CENTER (U.S.) 1991-2019; see UNITED STATES HEALTH RESOURCES AND SERVICES ADMINISTRATION 1980-1990", "HN": "2020 (1980); was NATIONAL HEALTH PLANNING INFORMATION CENTER (U.S.) 1991-2019; use UNITED STATES HEALTH RESOURCES AND SERVICES ADMINISTRATION 1980-1990", "MR": "20190118", "DA": "19790601", "DC": "1", "DX": "19910101", "UI": "D009312"}, {"RECTYPE": "D", "MH": "National Health Programs", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "National Health Insurance, Non-U.S.|T170|NRW|UNK (19XX)|840406|abdef", "ENTRY": "Service, National Health", "MN": "N03.349.550", "FX": "Government Programs", "MH_TH": "POPLINE (1978)", "ST": "T058", "AN": "specify country", "MS": "Components of a national health care system which administer specific services, e.g., national health insurance.", "OL": "search STATE MEDICINE 1966-74", "PM": "77; was see under STATE MEDICINE 1963-76", "HN": "77(75); was see under STATE MEDICINE 1963-76", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D009313"}, {"RECTYPE": "D", "MH": "National Institute for Occupational Safety and Health, U.S.", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "United States National Institute for Occupational Safety and Health|T064|NAM|EQV|NLM (2020)|181211|abcdef", "ENTRY": "National Institute for Occupational Safety and Health|T064|NAM|EQV|NLM (1984)|990101|abcdef", "MN": "N03.540.348.500.500.600.650.225.520", "MH_TH": "NLM (2020)", "ST": "T064", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; CATALOGER: Use NAF entry", "MS": "An institute of the CENTERS FOR DISEASE CONTROL AND PREVENTION which is responsible for assuring safe and healthful working conditions and for developing standards of safety and health. Research activities are carried out pertinent to these goals.", "PM": "2020; was NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH (U.S.) 2008-2019; see NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH 1991-2007, see CENTERS FOR DISEASE CONTROL (U.S.) 1984-1990", "HN": "2020 (1984); was NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH (U.S.) 2008-2019; use NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH 1991-2007, use CENTERS FOR DISEASE CONTROL (U.S.) 1984-1990", "MR": "20190118", "DA": "19830613", "DC": "1", "DX": "19910101", "UI": "D009314"}, {"RECTYPE": "D", "MH": "National Institute of Mental Health (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NIMH|T093|ACR|EQV|NLM (2008)|070131|abcdef", "ENTRY": "United States National Institute of Mental Health|T093|NAM|EQV|UNK (19XX)|810605|abcdef", "MN": "N03.540.348.500.500.600.650.496.460", "MH_TH": "NLM (1975)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "MS": "A component of the NATIONAL INSTITUTES OF HEALTH concerned with research, overall planning, promoting, and administering mental health programs and research. It was established in 1949.", "PM": "91; was see under UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1982-90; was UNITED STATES NATIONAL INSTITUTE OF MENTAL HEALTH see under UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1978-81; was NATIONAL INSTITUTE OF MENTAL HEALTH see under UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-74", "HN": "1991(1982)", "MR": "20161216", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009315"}, {"RECTYPE": "D", "MH": "National Institutes of Health (U.S.)", "DE": "NIH", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "United States National Institutes of Health|T093|NAM|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "National Institutes of Health|T093|NAM|EQV|UNK (19XX)|810605|abcdef", "MN": "N03.540.348.500.500.600.650.496", "MH_TH": "NLM (1966)", "ST": "T093", "AN": "add UNITED STATES; CONSENSUS DEVELOPMENT CONFERENCES, NIH AS TOPIC is available: see note there; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "MS": "An operating division of the US Department of Health and Human Services. It is concerned with the overall planning, promoting, and administering of programs pertaining to health and medical research.", "PM": "1982; was UNITED STATES NATIONAL INSTITUTES OF HEALTH 1966-81", "HN": "1982(1966)", "MR": "20161216", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009316"}, {"RECTYPE": "D", "MH": "National Library of Medicine (U.S.)", "DE": "NLM", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "United States National Library of Medicine|T093|NAM|EQV|UNK (19XX)|810605|UNITED STATES NATIONAL LIBRARY OF MED|abcdefv", "ENTRY": "National Medical Library|T093|NAM|EQV|NLM (1991)|891204|NATIONAL MED LIBRARY|abcdefv", "MN": "N03.540.348.500.500.600.650.496.742", "FX": "Unified Medical Language System", "MH_TH": "NLM (1965)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "MS": "An agency of the NATIONAL INSTITUTES OF HEALTH concerned with overall planning, promoting, and administering programs pertaining to advancement of medical and related sciences. Major activities of this institute include the collection, dissemination, and exchange of information important to the progress of medicine and health, research in medical informatics and support for medical library development.", "PM": "1982; was UNITED STATES NATIONAL LIBRARY OF MEDICINE 1966-1981", "HN": "1982(1965)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009317"}, {"RECTYPE": "D", "MH": "Natriuresis", "AQ": "DE GE IM PH RE", "ENTRY": "Natriureses", "MN": "G08.852.179.557", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "differentiate from SODIUM /urine in that in natriuresis emphasis is on the physiological process of urinary excretion of sodium; NATRIURETIC HORMONES is available", "MS": "Sodium excretion by URINATION.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009318"}, {"RECTYPE": "D", "MH": "Atrial Natriuretic Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Natriuretic Peptides, Atrial|T116|T123|NON|EQV|NLM (1992)|910405|abbcdef", "ENTRY": "gamma Atrial Natriuretic Peptide", "MN": "D12.644.548.585.500", "FX": "Receptors, Atrial Natriuretic Factor", "MH_TH": "NLM (1986)", "ST": "T123", "N1": "Atriopeptin", "RN": "85637-73-6", "PI": "Muscle Proteins (1966-1985)", "MS": "A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS.", "PM": "1992, see NATRIURETIC PEPTIDES, ATRIAL 1986-1991; ATRIAL NATRIURETIC FACTOR (99-126) was indexed under ATRIAL NATRIURETIC FACTOR 1987-2003; ATRIAL NATRIURETIC FACTOR (1-28) was indexed under ATRIAL NATRIURETIC FACTOR 1992-2003; CARDIONATRIN IV was indexed under ATRIAL NATRIURETIC FACTOR 1986-2003; ATRIOPEPTIGEN was indexed under MUSCLE PROTEINS 1985-2003; ATRIAL NATRIURETIC FACTOR PRECURSORS was indexed under ATRIAL NATRIURETIC FACTOR 1985-2003", "HN": "1992, use NATRIURETIC PEPTIDES, ATRIAL 1986-1991; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIAL NATRIURETIC FACTOR (99-126) 1987-2003; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIAL NATRIURETIC FACTOR (1-28) 1992-2003; use ATRIAL NATRIURETIC FACTOR (NM) for CARDIONATRIN IV 1986-2003; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIOPEPTIGEN 1985-2003; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIAL NATRIURETIC FACTOR PRECURSORS 1985-2003", "MR": "20200527", "DA": "19850425", "DC": "1", "DX": "19860101", "UI": "D009320"}, {"RECTYPE": "D", "MH": "Natural Childbirth", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Water Births", "MN": "G08.686.784.769.490.249", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "check tags FEMALE & PREGNANCY", "MS": "Labor and delivery without medical intervention, usually involving RELAXATION THERAPY.", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009321"}, {"RECTYPE": "D", "MH": "Natural Language Processing", "ENTRY": "Processings, Natural Language", "MN": "L01.224.050.375.580", "MH_TH": "NLM (1987)", "ST": "T066", "MS": "Computer processing of a language with rules that reflect and describe current usage rather than prescribed usage.", "PM": "91; was see under ARTIFICIAL INTELLIGENCE 1987-90", "HN": "91(87); was see under ARTIFICIAL INTELLIGENCE 1987-90", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19910101", "UI": "D009323"}, {"RECTYPE": "D", "MH": "Naturopathy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Medicine, Naturopathic|T061|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Naturopathic Medicine", "MN": "E02.190.655", "FX": "Herbal Medicine", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "A drugless system of therapy, making use of physical forces such as air, light, water, heat, massage. Treatments are often diet- and nutrition-oriented with attention given to the patient's personal history and lifestyle. (From Cassileth, Alternative Medicine Handbook, 1998, p329)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009324"}, {"RECTYPE": "D", "MH": "Nausea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.821.712", "FX": "Emetics", "MH_TH": "POPLINE (1978)", "ST": "T184", "AN": "/chem ind: consider also EMETICS; /drug ther: consider also ANTIEMETICS", "MS": "An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009325"}, {"RECTYPE": "D", "MH": "Naval Medicine", "DE": "NAVAL MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Nautical Medicine|T091|NON|EQV|UNK (19XX)|750101|NAUTICAL MED|abcdefv", "ENTRY": "Medicine, Naval|T091|NON|EQV|NLM (1991)|891204|MED NAVAL|abcdefv", "MN": "H02.403.560", "FX": "Ships", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use as coordinate for physiology, psychology & diseases of nautical personnel whether of national navy, merchant marine or liner", "MS": "The practice of medicine concerned with conditions affecting the health of individuals associated with the marine environment.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009326"}, {"RECTYPE": "D", "MH": "4-Chloro-7-nitrobenzofurazan", "DS": "CHLORONITROBENZOFURAN 04 07", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "NBD Chloride|T109|T130|ACX|EQV|NLM (1976)|990101|abbcdef", "ENTRY": "NBF Cl", "MN": "D03.383.129.462.580.400", "PA": "Indicators and Reagents", "MH_TH": "UNK (19XX)", "ST": "T130", "N1": "Benzofurazan, 4-chloro-7-nitro-", "RN": "EQF2794IRE", "RR": "10199-89-0 (4-Chloro-7-nitrobenzofurazan)", "PI": "Oxadiazoles (1972-1975)", "MS": "A benzofuran derivative used as a protein reagent since the terminal N-NBD-protein conjugate possesses interesting fluorescence and spectral properties. It has also been used as a covalent inhibitor of both beef heart mitochondrial ATPase and bacterial ATPase.", "PM": "2001; see NBD CHLORIDE 1991-2000 & OXADIAZOLES 1976-90", "HN": "2001(1976);", "MR": "20160527", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D009327"}, {"RECTYPE": "D", "MH": "Nebramycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D09.408.051.476.600", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1968)", "ST": "T195", "N1": "Nebramycin", "RN": "11048-13-8", "PI": "Antibiotics (1971-1974)", "MS": "A complex of antibiotic substances produced by Streptomyces tenebrarius.", "PM": "91; was see under ANTIBIOTICS 1975-90", "HN": "91(75); was see under ANTIBIOTICS 1975-90", "MR": "20040707", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D009328"}, {"RECTYPE": "D", "MH": "Nebraska", "AQ": "EH EP", "MN": "Z01.107.567.875.510.520", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by South Dakota, on the east by Iowa and Missouri, on the south by Kansas and Colorado, and on the west by Colorado and Wyoming.", "MR": "20160628", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009329"}, {"RECTYPE": "D", "MH": "Nebulizers and Vaporizers", "DE": "NEBULIZERS VAPORIZERS", "AQ": "CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Vaporizers|T074|NON|NRW|UNK (19XX)|860604|abcdef", "ENTRY": "Vaporizer", "MN": "E07.605", "FX": "Aerosols", "MH_TH": "NLM (1987)", "ST": "T074", "PI": "Volatilization (1971-1986)", "MS": "Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20170531", "DA": "19860604", "DC": "1", "DX": "19870101", "UI": "D009330"}, {"RECTYPE": "D", "MH": "Necator", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Necators", "MN": "B01.050.500.500.294.400.968.100.550", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid51030", "MS": "A genus of intestinal parasite worms which includes one of the most important hookworms of man, NECATOR AMERICANUS. The only other known species, N. suillus, has been recovered from pigs.", "OL": "use NECATOR to search ANCYLOSTOMA AMERICANA 1979-92 & UNCINARIA AMERICANA 1977-92", "PM": "ANCYLOSTOMA AMERICANA was see NECATOR 1979-92; UNCINARIA AMERICANA was see NECATOR 1977-92", "HN": "ANCYLOSTOMA AMERICANA was see NECATOR 1979-92; UNCINARIA AMERICANA was see NECATOR 1977-92", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009331"}, {"RECTYPE": "D", "MH": "Necatoriasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Necatoriases", "MN": "C01.610.335.508.700.775.455.683", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "hookworm infect; human & animal", "PI": "Hookworm Infections (1966-1978)", "MS": "Infection of humans or animals with hookworms of the genus NECATOR. The resulting anemia from this condition is less severe than that from ANCYLOSTOMIASIS.", "OL": "search HOOKWORM INFECTIONS 1967-74", "PM": "79; was see under HOOKWORM INFECTIONS 1973-78, was see under HOOKWORM INFECTION 1967-72", "HN": "79(75); was see under HOOKWORM INFECTIONS 1973-78, was see under HOOKWORM INFECTION 1967-72", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D009332"}, {"RECTYPE": "D", "MH": "Neck", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "ENTRY": "Necks", "MN": "A01.598", "FX": "Neck Muscles", "EC": "injuries:Neck Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "CX": "consider also terms at CERVICAL and CERVICO-", "MS": "The part of a human or animal body connecting the HEAD to the rest of the body.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009333"}, {"RECTYPE": "D", "MH": "Neck Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Neck Muscle", "MN": "A02.633.567.650", "MH_TH": "NLM (1979)", "ST": "T023", "AN": "restrict to muscles of the neck as specified by MeSH definition: do not use for or include muscles of organs located in the neck, as the larynx (LARYNGEAL MUSCLES) or pharynx (PHARYNGEAL MUSCLES); /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent", "PI": "Neck (1966-1978)", "MS": "The neck muscles consist of the platysma, splenius cervicis, sternocleidomastoid(eus), longus colli, the anterior, medius, and posterior scalenes, digastric(us), stylohyoid(eus), mylohyoid(eus), geniohyoid(eus), sternohyoid(eus), omohyoid(eus), sternothyroid(eus), and thyrohyoid(eus).", "PM": "91; was see under MUSCLES 1979-90", "HN": "91(79); was see under MUSCLES 1979-90", "MR": "20080708", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D009334"}, {"RECTYPE": "D", "MH": "Necrobiosis Lipoidica", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diabeticorum, Necrobiosis Lipoidica", "MN": "C18.452.880.495", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "note entry term NECROBIOSIS LIPOIDICA DIABETICORUM: do not index also under DIABETES MELLITUS unless particularly discussed", "MS": "A degenerative disease of the dermal connective tissue characterized by the development of erythematous papules or nodules in the pretibial area. The papules form plaques covered with telangiectatic vessels. More than half of the affected patients have diabetes.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009335"}, {"RECTYPE": "D", "MH": "Necrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.550.717", "FX": "Tumor Necrosis Factor-alpha", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009336"}, {"RECTYPE": "D", "MH": "Necturus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Mudpuppy|T011|NON|EQV|UNK (19XX)|800403|abcdef", "ENTRY": "Mudpuppies", "MN": "B01.050.150.900.090.608.630.510", "MH_TH": "NLM (1981)", "ST": "T011", "RN": "txid42756", "AN": "NIM when experimental animal", "PI": "Urodela (1966-1980)", "MS": "A genus of the Proteidae family with five recognized species, which inhabit the Atlantic and Gulf drainages.", "PM": "81", "HN": "81", "MR": "20200813", "DA": "19800403", "DC": "1", "DX": "19810101", "UI": "D009337"}, {"RECTYPE": "D", "MH": "Necturus maculosus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.090.608.630.510.508", "MH_TH": "NLM (1981)", "ST": "T011", "RN": "txid42757", "AN": "NIM when experimental animal", "PI": "Urodela (1966-1980)", "MS": "A neotenic aquatic species of mudpuppy (Necturus) occurring from Manitoba to Louisiana and Texas.", "PM": "91; was see under NECTURUS 1981-90", "HN": "91(81); was see under NECTURUS 1981-90", "MR": "20200813", "DA": "19800403", "DC": "1", "DX": "19910101", "UI": "D009338"}, {"RECTYPE": "D", "MH": "Needles", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Needles, Hypodermic", "MN": "E07.612", "MH_TH": "NLM (1971)", "ST": "T073", "AN": "Disinfection of needles with household bleach as by intravenous drug users index NEEDLES + DISINFECTION + SODIUM HYPOCHLORITE", "PI": "appropriate heading/instrumentation (1966-1970)", "MS": "Sharp instruments used for puncturing or suturing.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009339"}, {"RECTYPE": "D", "MH": "Nefopam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nefopam, Silentan", "MN": "D03.383.113.767.500", "PA": "Analgesics, Non-Narcotic", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1H-2,5-Benzoxazocine, 3,4,5,6-tetrahydro-5-methyl-1-phenyl-", "RN": "4UP8060B7J", "RR": "685J48E13W", "PI": "Benzene Derivatives (1972-1974)", "MS": "Non-narcotic analgesic chemically similar to ORPHENADRINE. Its mechanism of action is unclear. It is used for the relief of acute and chronic pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p26)", "PM": "91; was see under OXAZOCINES 1975-90", "HN": "91(75); was see under OXAZOCINES 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009340"}, {"RECTYPE": "D", "MH": "Negativism", "MN": "F01.752.698", "MH_TH": "NLM (1975)", "ST": "T041", "MS": "State of mind or behavior characterized by extreme skepticism and persistent opposition or resistance to outside suggestions or advice. (APA, Thesaurus of Psychological Index Terms, 1994)", "OL": "search DEFENSE MECHANISMS 1966-74", "PM": "91; was see under DEFENSE MECHANISMS 1975-90", "HN": "91(75); was see under DEFENSE MECHANISMS 1975-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009341"}, {"RECTYPE": "D", "MH": "Neisseria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.525.520", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid482", "MS": "A genus of gram-negative, aerobic, coccoid bacteria whose organisms are part of the normal flora of the oropharynx, nasopharynx, and genitourinary tract. Some species are primary pathogens for humans.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009343"}, {"RECTYPE": "D", "MH": "Neisseria gonorrhoeae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Micrococcus gonorrhoeae|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.075.525.520.400", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid485", "MS": "A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA.", "MR": "20200128", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009344"}, {"RECTYPE": "D", "MH": "Neisseria meningitidis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Neisseria weichselbaumii|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.075.525.520.500", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid487", "AN": "specific serogroups are also available; infection: probably MENINGITIS, MENINGOCOCCAL or, if not meningitis, MENINGOCOCCAL INFECTIONS", "MS": "A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype.", "MR": "20200128", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009345"}, {"RECTYPE": "D", "MH": "Neisseriaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.525", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid481", "PI": "Bacteria (1966-1974)", "MS": "A family of gram-negative, parasitic bacteria including several important pathogens of man.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D009346"}, {"RECTYPE": "D", "MH": "Nelson Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C19.700.734.145.500", "MH_TH": "ORD (2010)", "ST": "T191", "PI": "Pituitary Neoplasms (1966-1977)", "MS": "A syndrome characterized by HYPERPIGMENTATION, enlarging pituitary mass, visual defects secondary to compression of the OPTIC CHIASM, and elevated serum ACTH. It is caused by the expansion of an underlying ACTH-SECRETING PITUITARY ADENOMA that grows in the absence of feedback inhibition by adrenal CORTICOSTEROIDS, usually after ADRENALECTOMY.", "PM": "1991; see PITUITARY NEOPLASMS 1978-90", "HN": "1991(1978)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D009347"}, {"RECTYPE": "D", "MH": "Nematoda", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sipunculida|T204|NON|NRW|UNK (19XX)|840417|abcdef", "MN": "B01.050.500.500.294", "FX": "Antinematodal Agents", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6231", "MS": "A phylum of unsegmented helminths with fundamental bilateral symmetry and secondary triradiate symmetry of the oral and esophageal structures. Many species are parasites.", "OL": "use NEMATODA to search SIPUNCULIDA 1980-84", "PM": "SIPUNCULIDA was heading 1980-84", "HN": "SIPUNCULIDA was heading 1980-84", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009348"}, {"RECTYPE": "D", "MH": "Nematode Infections", "DE": "NEMATODE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Nematode Infection", "MN": "C01.610.335.508", "FX": "Antinematodal Agents", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Infections by nematodes, general or unspecified.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009349"}, {"RECTYPE": "D", "MH": "Nematospiroides dubius", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Heligmosomoides polygyrus|T204|NON|EQV|UNK (19XX)|850311|abcdef", "MN": "B01.050.500.500.294.400.968.400.550.275", "MH_TH": "NLM (1986)", "ST": "T204", "RN": "txid6339", "AN": "a species of nematode; infection: coord IM with STRONGYLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Trichostrongyloidea (1966-1985)", "MS": "A species of intestinal nematode parasites which occur most commonly in mice. Infection is by ingesting larvae. This particular species is used extensively in immunological research.", "PM": "91; was see under HELIGMOSOMATOIDEA 1986-90", "HN": "91(86); was see under HELIGMOSOMATOIDEA 1986-90", "MR": "20200813", "DA": "19850311", "DC": "1", "DX": "19910101", "UI": "D009351"}, {"RECTYPE": "D", "MH": "Zinostatin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neocarzinostatin|T109|T121|NON|EQV|NLM (1993)|920401|abbcdef", "MN": "D02.455.326.397.680.500.500.500", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "USAN (1978)", "ST": "T121", "RN": "9014-02-2", "PI": "Bacterial Proteins (1974)", "MS": "An enediyne that alkylates DNA and RNA like MITOMYCIN does, so it is cytotoxic.", "OL": "use ZINOSTATIN to search NEOCARZINOSTATIN 1975-92", "PM": "93; was NEOCARZINOSTATIN 1975-92 (see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90)", "HN": "93; was NEOCARZINOSTATIN 1975-92 (see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90)", "MR": "20180705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009353"}, {"RECTYPE": "D", "MH": "Neodymium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.625", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Neodymium", "RN": "2I87U3734A", "RR": "7440-00-8 (Neodymium)", "MS": "An element of the rare earth family of metals. It has the atomic symbol Nd, atomic number 60, and atomic weight 144.24, and is used in industrial applications.", "MR": "20170704", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009354"}, {"RECTYPE": "D", "MH": "Neomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Neomycin Sulfate|T109|T195|NON|NRW|FDA SRS (2018)|USP (19XX)|850103|abbcdeef", "MN": "D09.408.051.623", "PA": "Protein Synthesis Inhibitors", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "Neomycin", "RN": "I16QD7X297", "RR": "3I9J454G9F", "MS": "Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis.", "MR": "20180410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009355"}, {"RECTYPE": "D", "MH": "Neon", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.362.641.592", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Neon", "RN": "4VB4Y46AHD", "RR": "7440-01-9 (Neon)", "MS": "A noble gas with the atomic symbol Ne, atomic number 10, and atomic weight 20.18. It is found in the earth's crust and atmosphere as an inert, odorless gas and is used in vacuum tubes and incandescent lamps.", "MR": "20170704", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009356"}, {"RECTYPE": "D", "MH": "Neonatal Abstinence Syndrome", "AQ": "BL CF CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Substance Withdrawal, Neonatal|T047|NON|EQV|UNK (19XX)|870430|abcdef", "ENTRY": "Withdrawal, Neonatal Substance", "MN": "F03.900.650", "MH_TH": "NLM (1988)", "ST": "T047", "AN": "substance-withdrawal symptoms in inf born of an addicted mother; do not use /congen; coord IM with specific substance /adv eff (IM) + check tag INFANT, NEWBORN", "PI": "Substance Withdrawal Syndrome (1966-1987)", "MS": "Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19870430", "DC": "1", "DX": "19880101", "UI": "D009357"}, {"RECTYPE": "D", "MH": "Congenital, Hereditary, and Neonatal Diseases and Abnormalities", "DE": "CONGENITAL HEREDITARY NEONATAL DIS ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neonatal Diseases and Abnormalities|T019|T047|NON|NRW|NLM (1966)|990101|NEONATAL DIS ABNORM|abbcdefv", "ENTRY": "Disorder, Congenital", "MN": "C16", "RH": "C16 - DISEASES-CONGENITAL AND NEONATAL AND ABNORMALITIES", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Diseases existing at birth and often before birth, or that develop during the first month of life (INFANT, NEWBORN, DISEASES), regardless of causation. Of these diseases, those characterized by structural deformities are termed CONGENITAL ABNORMALITIES.", "PM": "2002; see NEONATAL DISEASES AND ABNORMALTIES 1998-2001", "HN": "2002; use explode 1971-1997", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009358"}, {"RECTYPE": "D", "MH": "Neonatology", "DE": "NEONATOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.670.400", "FX": "Infant, Newborn", "MH_TH": "NLM (1977)", "ST": "T091", "AN": "differentiate from INFANT, NEWBORN, the physiological, psychological or social entity; differentiate from PERINATOLOGY: NEONATOLOGY covers newborn infant only, PERINATOLOGY covers fetus & infant", "PI": "Pediatrics (1966-1976)", "MS": "A subspecialty of Pediatrics concerned with the newborn infant.", "PM": "77", "HN": "77", "MR": "20090706", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D009359"}, {"RECTYPE": "D", "MH": "Neoplastic Cells, Circulating", "AQ": "CH CL DE IM ME PA RE UL", "PRINT ENTRY": "Tumor Cells, Embolic|T025|NON|NRW|UNK (19XX)|830224|abcdef", "ENTRY": "Tumor Embolisms", "MN": "C23.550.727.650.900", "MH_TH": "NLM (2009)", "ST": "T025", "MS": "Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors.", "PM": "2009; see NEOPLASM CIRCULATING CELLS 1966-2008", "HN": "2009 (1965)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009360"}, {"RECTYPE": "D", "MH": "Neoplasm Invasiveness", "DE": "NEOPL INVASIVENESS", "AQ": "DG DI GE IM PA PC PP UL", "PRINT ENTRY": "Invasiveness, Neoplasm|T046|NON|EQV|UNK (19XX)|760516|INVASIVENESS NEOPL|abcdefv", "ENTRY": "Invasion, Neoplasm", "MN": "C23.550.727.645", "FX": "Leukemic Infiltration", "MH_TH": "NLM (1977)", "ST": "T046", "AN": "IM general only or for invasive process; coordinate NIM with specific neoplasm terms / pathol (IM)", "MS": "Ability of neoplasms to infiltrate and actively destroy surrounding tissue.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20160601", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D009361"}, {"RECTYPE": "D", "MH": "Neoplasm Metastasis", "DE": "NEOPL METASTASIS", "AQ": "DG DI DT GE IM PA PC PP RT TH UL", "PRINT ENTRY": "Metastasis|T191|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Metastases", "MN": "C23.550.727.650", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "use only for metastatic process or neoplasm metastasis in general; unlikely as NIM coordinate: prefer /second with organ/neoplasm and histological type for metastatic neoplasms; do not confuse with NEOPLASM INVASIVENESS; LEUKEMIC INFILTRATION; NEOPLASMS, SECOND PRIMARY or NEOPLASM, RESIDUAL", "MS": "The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009362"}, {"RECTYPE": "D", "MH": "Neoplasm Proteins", "DE": "NEOPL PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Neoplasm", "MN": "D12.776.624", "FX": "Biomarkers, Tumor", "MH_TH": "NLM (1963)", "ST": "T123", "RN": "0", "AN": "IM & coord with specific protein (IM) + specific histol type (IM) + specific organ/neoplasms term (IM); Manual 24.4.4.4", "MS": "Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.", "MR": "20150713", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D009363"}, {"RECTYPE": "D", "MH": "Neoplasm Recurrence, Local", "DE": "NEOPL RECURRENCE LOCAL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Recurrences, Locoregional Neoplasm", "MN": "C23.550.727.655", "MH_TH": "NLM (1964)", "ST": "T191", "AN": "IM; differentiate from NEOPLASMS, MULTIPLE PRIMARY and NEOPLASMS, SECOND PRIMARY; do not confuse with NEOPLASM, RESIDUAL", "MS": "The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009364"}, {"RECTYPE": "D", "MH": "Neoplasm Regression, Spontaneous", "DE": "NEOPL REGRESSION SPONTANEOUS", "AQ": "GE IM PA PP", "PRINT ENTRY": "Remission, Spontaneous Neoplasm|T043|NON|EQV|UNK (19XX)|860623|REMISSION SPONTANEOUS NEOPL|abcdefv", "ENTRY": "Spontaneous Neoplasm Remission|T043|NON|EQV|NLM (1992)|900918|SPONTANEOUS NEOPL REMISSION|abcdefv", "MN": "G16.767.500", "MH_TH": "NLM (1964)", "ST": "T043", "AN": "must be spontaneous: for regression or remission after therapy, use REMISSION INDUCTION", "MS": "Disappearance of a neoplasm or neoplastic state without the intervention of therapy.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D009365"}, {"RECTYPE": "D", "MH": "Neoplasm Seeding", "DE": "NEOPL SEEDING", "ENTRY": "Seeding, Neoplasm|T046|NON|EQV|NLM (1995)|930831|SEEDING NEOPL|abcdefv", "MN": "C23.550.727.650.830", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "includes seeding by surgery biopsy, palpation, etc.", "MS": "The local implantation of tumor cells by contamination of instruments and surgical equipment during and after surgical resection, resulting in local growth of the cells and tumor formation.", "PM": "70", "HN": "70(66)", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D009366"}, {"RECTYPE": "D", "MH": "Neoplasm Staging", "DE": "NEOPL STAGING", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tumor Staging|T060|T080|NON|EQV|UNK (19XX)|770418|abbcdef", "ENTRY": "TNM Staging Systems", "MN": "E01.789.625", "FX": "Nomograms", "MH_TH": "NLM (1978)", "ST": "T080", "AN": "IM general only; coordinate NIM with no qualifiers with neoplasm terms /diag, /diag image and/or /pathol; do not confuse with NEOPLASM GRADING; staging is given in Roman numerals, grading in Arabic numerals", "MS": "Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20170501", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D009367"}, {"RECTYPE": "D", "MH": "Neoplasm Transplantation", "DE": "NEOPL TRANSPL", "AQ": "AE CL DG EC ED ES HI IM IS LJ MO MT NU PA PH PX RH SN ST TD VE", "ENTRY": "Transplantations, Neoplasm", "MN": "E05.624", "MH_TH": "NLM (1964)", "ST": "T062", "MS": "Experimental transplantation of neoplasms in laboratory animals for research purposes.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009368"}, {"RECTYPE": "D", "MH": "Neoplasms", "DE": "NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Tumors|T191|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Neoplasms, Malignant", "MN": "C04", "RH": "C4 - DISEASES-NEOPLASMS", "EC": "secondary:Neoplasm Metastasis", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "general; prefer specifics; familial: consider also NEOPLASTIC SYNDROMES, HEREDITARY; metastatic cancer of unknown origin: index NEOPLASM METASTASIS", "CX": "consider also terms at CANCER, CARCINO-, ONCO-, and TUMOR", "MS": "New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.", "PM": "/diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977", "HN": "/diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009369"}, {"RECTYPE": "D", "MH": "Neoplasms by Histologic Type", "DE": "NEOPL HISTOL TYPE", "ENTRY": "Neoplasms Histological Types", "MN": "C04.557", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "A collective term for the various histological types of NEOPLASMS. It is more likely to be used by searchers than by indexers and catalogers.", "PM": "98", "HN": "98; use explode", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009370"}, {"RECTYPE": "D", "MH": "Neoplasms by Site", "DE": "NEOPL SITE", "ENTRY": "Neoplasm Sites", "MN": "C04.588", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "A collective term for precoordinated organ/neoplasm headings locating neoplasms by organ, as BRAIN NEOPLASMS; DUODENAL NEOPLASMS; LIVER NEOPLASMS; etc.", "PM": "98", "HN": "98; use explode", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009371"}, {"RECTYPE": "D", "MH": "Neoplasms, Connective Tissue", "DE": "NEOPL CONNECTIVE TISSUE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasm, Connective Tissue", "MN": "C17.300.680", "FX": "Soft Tissue Neoplasms", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "neoplasms composed of connective tissue, NOT neoplasms located in connective tissue: coordinate with precoordinated organ/neoplasm term", "MS": "Neoplasms composed of connective tissue, including elastic, mucous, reticular, osseous, and cartilaginous tissue. The concept does not refer to neoplasms located in connective tissue.", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009372"}, {"RECTYPE": "D", "MH": "Neoplasms, Germ Cell and Embryonal", "DE": "NEOPL GERM CELL EMBRYONAL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Neoplasms, Embryonal and Mixed|T191|NON|REL|NLM (1994)|930513|abcdef", "ENTRY": "Tumors, Germ Cell", "MN": "C04.557.465", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "neoplasms composed of germ cells or embryonic tissue, NOT neoplasms located in germ cells or embryonic tissue; coordinate with precoordinated organ/neoplasm term ", "MS": "Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS.", "PM": "1994; see NEOPLASMS, EMBRYONAL AND MIXED 1963-1993; for GERM CELL TUMOR see GERMINOMA 1994-2005", "HN": "1994 (1963); for GERM CELL TUMOR use GERMINOMA 1994-2005", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D009373"}, {"RECTYPE": "D", "MH": "Neoplasms, Experimental", "DE": "NEOPL EXPER", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "ENTRY": "Neoplasm, Experimental", "MN": "E05.598.500.496", "FX": "Tumor Virus Infections", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "IM general only; not a routine coordinate for specific neoplasms in experimental animals; policy: Manual 24.5+; /chem ind: Manual 24.5.6+; spontaneous: Manual 24.5.5", "MS": "Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009374"}, {"RECTYPE": "D", "MH": "Neoplasms, Glandular and Epithelial", "DE": "NEOPL GLANDULAR EPITHELIAL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Glandular Cell Neoplasms|T191|NON|NRW|NLM (2023)|210901|abcdef", "ENTRY": "Neoplasm, Glandular Epithelial", "MN": "C04.557.470", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "neoplasms composed of glandular & epithelial tissue, NOT neoplasms located in various glands or epithelium; coordinate with precoordinated organ/neoplasm term", "MS": "Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.", "OL": "use NEOPLASMS, GLANDULAR AND EPITHELIAL to search NEOPLASMS, GLANDULAR EPITHELIAL 1966-93", "PM": "94; was NEOPLASMS, GLANDULAR EPITHELIAL 1963-93", "HN": "94; was NEOPLASMS, GLANDULAR EPITHELIAL 1963-93", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D009375"}, {"RECTYPE": "D", "MH": "Neoplasms, Hormone-Dependent", "DE": "NEOPL HORMONE DEPENDENT", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Hormone-Dependent Neoplasms|T191|NON|EQV|UNK (19XX)|780519|HORMONE DEPENDENT NEOPL|abcdefv", "ENTRY": "Neoplasms, Hormone Dependent", "MN": "C04.626", "FX": "Antineoplastic Agents, Hormonal", "MH_TH": "NLM (1979)", "ST": "T191", "AN": "IM general only; prefer specific neoplasm term(s) and do not routinely add Neoplasms, Hormone, Dependent; coordinate with specific hormone if pertinent", "MS": "Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D009376"}, {"RECTYPE": "D", "MH": "Multiple Endocrine Neoplasia", "DE": "MULTIPLE ENDOCRINE NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Neoplasms, Multiple Endocrine|T191|NON|EQV|NLM (1995)|940401|abcdef", "ENTRY": "Multiple Endocrine Adenopathies", "MN": "C19.344.400", "MH_TH": "NLM (1964)", "ST": "T191", "AN": "general or unspecified; prefer specifics; coordinate IM with specific endocrine/neoplasm pre-coordinates (IM) + specific histological type (IM) if pertinent", "MS": "A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively.", "OL": "use MULTIPLE ENDOCRINE NEOPLASIA to search NEOPLASMS, MULTIPLE ENDOCRINE 1983-94 & ADENOMATOSIS, FAMILIAL ENDOCRINE 1966-82", "PM": "95; was NEOPLASMS, MULTIPLE ENDOCRINE 1983-94; was ADENOMATOSIS, FAMILIAL ENDOCRINE 1965-82", "HN": "95; was NEOPLASMS, MULTIPLE ENDOCRINE 1983-94; was ADENOMATOSIS, FAMILIAL ENDOCRINE 1965-82 (Prov 1964)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009377"}, {"RECTYPE": "D", "MH": "Neoplasms, Multiple Primary", "DE": "NEOPL MULTIPLE PRIMARY", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Neoplasms, Synchronous Multiple Primary|T191|NON|EQV|NLM (1995)|931122|NEOPL SYNCHRONOUS MULTIPLE PRIMARY|abcdefv", "ENTRY": "Synchronous Neoplasm", "MN": "C04.651", "FX": "Neoplasms, Second Primary", "MH_TH": "NLM (1965)", "ST": "T191", "AN": "2 or more neoplasms occurring simultaneously: do not confuse with NEOPLASMS, SECOND PRIMARY, a neoplasm following an earlier neoplasm but not its metastasis; coordinate with histological type(s) (IM) & each precoordinated organ/neoplasm term(s) (IM); do not use /compl with specific multiple neoplasm terms to show multiplicity; differentiate from NEOPLASM METASTASIS & NEOPLASM RECURRENCE, LOCAL: Manual 24.4.1.5, 24.4.1.6; MULTIPLE ENDOCRINE NEOPLASIA & its specifics are also available; DF: NEOPL MULTIPLE PRIMARY", "MS": "Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009378"}, {"RECTYPE": "D", "MH": "Neoplasms, Muscle Tissue", "DE": "NEOPL MUSCLE TISSUE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Myofibroblastoma|T191|NON|NRW|NLM (1995)|930929|abcdef", "ENTRY": "Neoplasm, Muscle Tissue", "MN": "C04.557.450.590", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "neoplasms composed of muscle tissue, NOT neoplasms located in muscles; coord IM with precoord organ/neopl term (IM)", "MS": "Neoplasms composed of muscle tissue: skeletal, cardiac, or smooth. The concept does not refer to neoplasms located in muscles.", "OL": "use NEOPLASMS, MUSCLE TISSUE to search MYOBLASTOMA 1966-93", "PM": "MYOBLASTOMA was heading 1963-93", "HN": "MYOBLASTOMA was heading 1963-93", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009379"}, {"RECTYPE": "D", "MH": "Neoplasms, Nerve Tissue", "DE": "NEOPL NERVE TISSUE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Nervous Tissue Neoplasm", "MN": "C04.557.580", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "Neoplasms composed of nerve tissue. This concept does not refer to neoplasms located in the nervous system or its component nerves.", "OL": "use NEOPLASMS, NERVE TISSUE to search NEOPLASMS, NERVOUS TISSUE 1966-93", "PM": "94; was NEOPLASMS, NERVOUS TISSUE 1963-93", "HN": "94; was NEOPLASMS, NERVOUS TISSUE 1963-93", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D009380"}, {"RECTYPE": "D", "MH": "Neoplasms, Radiation-Induced", "DE": "NEOPL RAD IND", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Radiation-Induced Cancer|T191|NON|NRW|NLM (2000)|991103|RAD IND CANCER|abcdefv", "ENTRY": "Radiation-Induced Neoplasm", "MN": "G01.750.748.500.476", "FX": "Neoplasms, Second Primary", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "IM; coord with specific histol type (IM) and organ/neopl term (IM); Manual 24.4.3.2+", "MS": "Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009381"}, {"RECTYPE": "D", "MH": "Neoplasms, Unknown Primary", "DE": "NEOPL UNKNOWN PRIMARY", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Unknown Primary Tumors|T191|NON|NRW|UNK (19XX)|860418|abcdef", "ENTRY": "Unknown Primary Tumor", "MN": "C23.550.727.650.895", "MH_TH": "NLM (1987)", "ST": "T191", "AN": "IM; do not use /second; coord IM with organ/neopl term with /second (IM) + histol type /second (IM); Manual 24.4.1.8", "MS": "Metastases in which the tissue of origin is unknown.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D009382"}, {"RECTYPE": "D", "MH": "Neoplasms, Vascular Tissue", "DE": "NEOPL VASCULAR TISSUE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Blood Vessel Tumors|T191|NON|REL|NLM (1994)|930401|abcdef", "ENTRY": "Vascular Tissue Neoplasm", "MN": "C04.557.645", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "Neoplasms composed of vascular tissue. This concept does not refer to neoplasms located in blood vessels.", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009383"}, {"RECTYPE": "D", "MH": "Paraneoplastic Endocrine Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ectopic Hormone Syndromes|T047|NON|EQV|UNK (19XX)|790524|abcdef", "ENTRY": "Syndromes, Paraneoplastic Endocrine", "MN": "C19.344.473", "FX": "Hormones, Ectopic", "MH_TH": "NLM (2005)", "ST": "T047", "AN": "coordinate with precoordinated organ/neoplasm term + histological type of neoplasm + specific hormone; ACTH SYNDROME, ECTOPIC is also available", "PI": "Hormones, Ectopic (1968-1972)", "MS": "Syndromes resulting from inappropriate production of HORMONES or hormone-like materials by NEOPLASMS in non-endocrine tissues or not by the usual ENDOCRINE GLANDS. Such hormone outputs are called ectopic hormone (HORMONES, ECTOPIC) secretion.", "PM": "2005; see NEOPLASTIC ENDOCRINE-LIKE SYNDROMES 1973-2004", "HN": "2005 (1973)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009384"}, {"RECTYPE": "D", "MH": "Neoplastic Processes", "DE": "NEOPL PROCESSES", "ENTRY": "Processes, Neoplastic|T191|NON|EQV|NLM (1998)|960905|PROCESSES NEOPL|abcdefv", "MN": "C23.550.727", "MH_TH": "NLM (1982)", "ST": "T191", "AN": "general or unspecified; prefer specifics", "PI": "specific neoplastic process (1966-1997)", "MS": "The pathological mechanisms and forms taken by tissue during degeneration into a neoplasm and its subsequent activity.", "PM": "98", "HN": "98; use explode 1982-97", "CATSH": "CAT LIST", "MR": "20080714", "DA": "19810519", "DC": "1", "DX": "19980101", "UI": "D009385"}, {"RECTYPE": "D", "MH": "Neoplastic Syndromes, Hereditary", "DE": "NEOPL SYNDROMES HEREDITARY", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cancer Syndromes, Hereditary|T191|NON|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Syndromes, Hereditary Neoplastic", "MN": "C16.320.700", "MH_TH": "NLM (1987)", "ST": "T191", "AN": "coordinate with specific hereditary organ/neoplasm term or specific hereditary histological type", "MS": "The condition of a pattern of malignancies within a family, but not every individual's necessarily having the same neoplasm. Characteristically the tumor tends to occur at an earlier than average age, individuals may have more than one primary tumor, the tumors may be multicentric, usually more than 25 percent of the individuals in direct lineal descent from the proband are affected, and the cancer predisposition in these families behaves as an autosomal dominant trait with about 60 percent penetrance.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19860623", "DC": "1", "DX": "19870101", "UI": "D009386"}, {"RECTYPE": "D", "MH": "Neoprene", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polychloroprene|T109|T122|T131|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Polychloroprenes", "MN": "J01.637.412.767.480", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "9010-98-4", "PI": "Polymers (1971-1974)", "MS": "An oil-resistant synthetic rubber made by the polymerization of chloroprene.", "PM": "91; was see under POLYENES 1975-90", "HN": "91(75); was see under POLYENES 1975-90", "MR": "20190429", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009387"}, {"RECTYPE": "D", "MH": "Neostigmine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Synstigmin|T109|T121|NON|EQV|UNK (19XX)|761224|abbcdef", "ENTRY": "Methylsulfate, Neostigmine", "MN": "D02.675.276.602", "PA": "Parasympathomimetics", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-", "RN": "3982TWQ96G", "RR": "98IMH7M386", "MS": "A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009388"}, {"RECTYPE": "D", "MH": "Neovascularization, Pathologic", "DE": "NEOVASC PATHOL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Angiogenesis, Pathologic|T033|T046|NON|EQV|UNK (19XX)|790423|ANGIOGENESIS PATHOL|abbcdefv", "ENTRY": "Pathological Neovascularization", "MN": "G09.330.020.500", "FX": "Vascular Remodeling", "MH_TH": "NLM (1980)", "ST": "T046", "AN": "coordinate with organ / blood supply; NEOVASCULARIZATION, PHYSIOLOGIC is also available", "MS": "A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions.", "OL": "use NEOVASCULARIZATION, PATHOLOGIC to search NEOVASCULARIZATION & ANGIOGENESIS 1980-95", "PM": "96; was NEOVASCULARIZATION 1980-95; ANGIOGENESIS, PATHOLOGIC was ANGIOGENESIS 1980-85", "HN": "96; was NEOVASCULARIZATION 1980-95; ANGIOGENESIS, PATHOLOGIC was ANGIOGENESIS 1980-85; was in Cat G 1980-82", "CATSH": "CAT LIST", "MR": "20230522", "DA": "19790423", "DC": "1", "DX": "19800101", "UI": "D009389"}, {"RECTYPE": "D", "MH": "Nepal", "AQ": "EH EP", "ENTRY": "Federal Democratic Republic of Nepal|T083|NON|EQV|NLM (2018)|161222|abcdef", "MN": "Z01.252.245.782.937", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "Country located in southern Asia, between China and India. The capital is Kathmandu.", "MR": "20220708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009390"}, {"RECTYPE": "D", "MH": "Nephelometry and Turbidimetry", "DE": "NEPHELOMETRY TURBIDIMETRY", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Turbidimetry|T059|T081|NON|NRW|UNK (19XX)|800513|abbcdef", "ENTRY": "Turbidimetry and Nephelometry", "MN": "E05.196.712.650", "MH_TH": "NLM (1975)", "ST": "T059", "MS": "Chemical analysis based on the phenomenon whereby light, passing through a medium with dispersed particles of a different refractive index from that of the medium, is attenuated in intensity by scattering. In turbidimetry, the intensity of light transmitted through the medium, the unscattered light, is measured. In nephelometry, the intensity of the scattered light is measured, usually, but not necessarily, at right angles to the incident light beam.", "OL": "use NEPHELOMETRY AND TURBIDIMETRY to search TURBIDIMETRY 1975-80; use DENSITOMETRY 1969-74", "PM": "81; was TURBIDIMETRY see under PHOTOMETRY 1975-80; was TURBIDIMETRY see under DENSITOMETRY 1969-74", "HN": "81; was TURBIDIMETRY see under PHOTOMETRY 1975-80; was TURBIDIMETRY see under DENSITOMETRY 1969-74", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D009391"}, {"RECTYPE": "D", "MH": "Nephrectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Nephrectomies", "MN": "E04.950.774.435", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Excision of kidney.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009392"}, {"RECTYPE": "D", "MH": "Nephritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Nephritides", "MN": "C12.950.419.570", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "familial: consider also NEPHRITIS, HEREDITARY", "MS": "Inflammation of any part of the KIDNEY.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009393"}, {"RECTYPE": "D", "MH": "Nephritis, Hereditary", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nephritis, Familial|T047|NON|EQV|UNK (19XX)|760425|abcdef", "ENTRY": "X-Linked Alport Syndrome", "MN": "C17.300.200.517", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "A group of inherited conditions characterized initially by HEMATURIA and slowly progressing to RENAL INSUFFICIENCY. The most common form is the Alport syndrome (hereditary nephritis with HEARING LOSS) which is caused by mutations in genes for TYPE IV COLLAGEN and defective GLOMERULAR BASEMENT MEMBRANE.", "OL": "use NEPHRITIS, HEREDITARY to search ALPORT'S SYNDROME 1966-76 (as Prov 1966-69)", "PM": "77; was ALPORT'S SYNDROME 1970-76", "HN": "77; was ALPORT'S SYNDROME 1964-76 (Prov 1964-69)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D009394"}, {"RECTYPE": "D", "MH": "Nephritis, Interstitial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tubulointerstitial Nephritis|T047|NON|NRW|UNK (19XX)|810223|abcdef", "ENTRY": "Tubulointerstitial Nephritides", "MN": "C12.950.419.570.643", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "Inflammation of the interstitial tissue of the kidney. This term is generally used for primary inflammation of KIDNEY TUBULES and/or surrounding interstitium. For primary inflammation of glomerular interstitium, see GLOMERULONEPHRITIS. Infiltration of the inflammatory cells into the interstitial compartment results in EDEMA, increased spaces between the tubules, and tubular renal dysfunction.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D009395"}, {"RECTYPE": "D", "MH": "Wilms Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Nephroblastoma|T191|NON|EQV|NLM (1966)|OMIM (2013)|ORD (2010)|990101|abcdeeef", "ENTRY": "Wilms Tumor, Bilateral", "MN": "C16.320.700.900", "FX": "WT1 Proteins", "MH_TH": "NLM (2000)", "ST": "T191", "AN": "coordinate IM with KIDNEY NEOPLASMS (IM); /genet: consider also GENES, WILMS TUMOR", "MS": "A malignant kidney tumor, caused by the uncontrolled multiplication of renal stem (blastemal), stromal (STROMAL CELLS), and epithelial (EPITHELIAL CELLS) elements. However, not all three are present in every case. Several genes or chromosomal areas have been associated with Wilms tumor which is usually found in childhood as a firm lump in a child's side or ABDOMEN.", "PM": "2006; see NEPHROBLASTOMA 1994-2005, WILMS' TUMOR 1991-1993, see NEPHROBLASTOMA 1963-1990", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D009396"}, {"RECTYPE": "D", "MH": "Nephrocalcinosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Nephrocalcinoses", "MN": "C18.452.174.130.560", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A condition characterized by calcification of the renal tissue itself. It is usually seen in distal RENAL TUBULAR ACIDOSIS with calcium deposition in the DISTAL KIDNEY TUBULES and the surrounding interstitium. Nephrocalcinosis causes RENAL INSUFFICIENCY.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009397"}, {"RECTYPE": "D", "MH": "Nephrology", "DE": "NEPHROL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.429.580", "FX": "Kidney Diseases", "MH_TH": "NLM (1980)", "ST": "T091", "PI": "Kidney Diseases (1966-1979)", "MS": "A subspecialty of internal medicine concerned with the anatomy, physiology, and pathology of the kidney.", "PM": "80", "HN": "80", "MR": "20090706", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D009398"}, {"RECTYPE": "D", "MH": "Nephrons", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nephron", "MN": "A05.810.453.736", "MH_TH": "NLM (1973)", "ST": "T023", "PI": "Kidney (1966-1972)", "MS": "The functional units of the kidney, consisting of the glomerulus and the attached tubule.", "PM": "79; was see under KIDNEY 1975-78", "HN": "79(73); was see under KIDNEY 1975-78", "MR": "19910107", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D009399"}, {"RECTYPE": "D", "MH": "Nephrosclerosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Nephroscleroses", "MN": "C12.950.419.610", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Hardening of the KIDNEY due to infiltration by fibrous connective tissue (FIBROSIS), usually caused by renovascular diseases or chronic HYPERTENSION. Nephrosclerosis leads to renal ISCHEMIA.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009400"}, {"RECTYPE": "D", "MH": "Nephrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Nephroses", "MN": "C12.950.419.630", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "do not diagnose: use term of text; LOWER NEPHRON NEPHROSIS see KIDNEY TUBULAR NECROSIS, ACUTE is also available", "MS": "Pathological processes of the KIDNEY without inflammatory or neoplastic components. Nephrosis may be a primary disorder or secondary complication of other diseases. It is characterized by the NEPHROTIC SYNDROME indicating the presence of PROTEINURIA and HYPOALBUMINEMIA with accompanying EDEMA.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009401"}, {"RECTYPE": "D", "MH": "Nephrosis, Lipoid", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nephrotic Syndrome, Minimal Change|T047|NON|REL|UNK (19XX)|820420|abcdef", "ENTRY": "Nephroses, Lipoid", "MN": "C12.950.419.630.477", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A kidney disease with no or minimal histological glomerular changes on light microscopy and with no immune deposits. It is characterized by lipid accumulation in the epithelial cells of KIDNEY TUBULES and in the URINE. Patients usually show NEPHROTIC SYNDROME indicating the presence of PROTEINURIA with accompanying EDEMA.", "CATSH": "CAT LIST", "MR": "20230426", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009402"}, {"RECTYPE": "D", "MH": "Nephrostomy, Percutaneous", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Percutaneous Nephrostomy|T061|NON|EQV|UNK (19XX)|850228|abcdef", "ENTRY": "Percutaneous Nephrostomies", "MN": "E04.950.774.852.642", "MH_TH": "NLM (1986)", "ST": "T061", "PI": "Urinary Diversion (1966-1985)", "MS": "The insertion of a catheter through the skin and body wall into the kidney pelvis, mainly to provide urine drainage where the ureter is not functional. It is used also to remove or dissolve renal calculi and to diagnose ureteral obstruction.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20170421", "DA": "19850228", "DC": "1", "DX": "19860101", "UI": "D009403"}, {"RECTYPE": "D", "MH": "Nephrotic Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Steroid-Sensitive Nephrotic Syndrome|T047|NON|NRW|NLM (2023)|210930|abcdef", "ENTRY": "Syndrome, Steroid-Sensitive Nephrotic", "MN": "C12.950.419.630.643", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009404"}, {"RECTYPE": "D", "MH": "Neptunium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.600", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Neptunium", "RN": "6200K977BQ", "RR": "7439-99-8 (Neptunium)", "MS": "A radioactive element of the actinide metals family. It has the atomic symbol Np, and atomic number 93.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009405"}, {"RECTYPE": "D", "MH": "Nerve Block", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Neurolysis, Chemical", "MN": "E04.525.210.550", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "differentiate from NEUROMUSCULAR BLOCKADE; coordinate with substance used to induce the block with no qualifiers if particularly discussed; AUTONOMIC NERVE BLOCK is also available", "MS": "Interruption of NEURAL CONDUCTION in peripheral nerves or nerve trunks by the injection of a local anesthetic agent (e.g., LIDOCAINE; PHENOL; BOTULINUM TOXINS) to manage or treat pain.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20110627", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009407"}, {"RECTYPE": "D", "MH": "Nerve Compression Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nerve Entrapments|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Syndromes, Nerve Compression", "MN": "C10.668.829.550", "MH_TH": "NLM (1970)", "ST": "T047", "AN": "coordinate with specific nerve disease or specific nerve ", "PI": "Peripheral Nerve Diseases (1966-1969)", "MS": "Mechanical compression of nerves or nerve roots from internal or external causes. These may result in a conduction block to nerve impulses (due to MYELIN SHEATH dysfunction) or axonal loss. The nerve and nerve sheath injuries may be caused by ISCHEMIA; INFLAMMATION; or a direct mechanical effect.", "PM": "1973", "HN": "1973(1972)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009408"}, {"RECTYPE": "D", "MH": "Nerve Crush", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Crush, Nerve", "MN": "E04.525.210.560", "MH_TH": "NLM (1963)", "ST": "T061", "MS": "Treatment of muscles and nerves under pressure as a result of crush injuries.", "PM": "74", "HN": "74(63)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009409"}, {"RECTYPE": "D", "MH": "Nerve Degeneration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuron Degeneration|T049|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Neuron Degenerations", "MN": "C23.550.737", "MH_TH": "NLM (1964)", "ST": "T049", "AN": "IM as a pathol process; coord with specific neurol dis /pathol (IM) or specific nerve /pathol (IM or NIM) if pertinent", "MS": "Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009410"}, {"RECTYPE": "D", "MH": "Nerve Endings", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Nerve Ending", "MN": "A08.800.550", "FX": "Presynaptic Terminals", "MH_TH": "NLM (1966)", "ST": "T030", "AN": "do not confuse with MOTOR ENDPLATE", "MS": "Branch-like terminations of NERVE FIBERS, sensory or motor NEURONS. Endings of sensory neurons are the beginnings of afferent pathway to the CENTRAL NERVOUS SYSTEM. Endings of motor neurons are the terminals of axons at the muscle cells. Nerve endings which release neurotransmitters are called PRESYNAPTIC TERMINALS.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009411"}, {"RECTYPE": "D", "MH": "Nerve Fibers", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Mossy Fibers, Cerebellar|T023|NON|NRW|NLM (1998)|960826|abcdef", "ENTRY": "Nerve Fiber", "MN": "A11.671.501", "MH_TH": "NLM (1977)", "ST": "T026", "AN": "do not confuse entry term MOSSY FIBERS, CEREBELLAR with MOSSY FIBERS, HIPPOCAMPAL", "PI": "Neurons (1966-1976)", "MS": "Slender processes of NEURONS, including the AXONS and their glial envelopes (MYELIN SHEATH). Nerve fibers conduct nerve impulses to and from the CENTRAL NERVOUS SYSTEM.", "OL": "search NERVE FIBERS, MYELINATED 1969-71 (as Prov)", "PM": "77", "HN": "77(69-71)", "MR": "20140613", "DA": "19760503", "DC": "1", "DX": "19770101", "UI": "D009412"}, {"RECTYPE": "D", "MH": "Nerve Fibers, Myelinated", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "B Fibers|T024|NON|NRW|UNK (19XX)|760430|abcdef", "ENTRY": "Nerve Fiber, Myelinated", "MN": "A11.671.514", "FX": "White Matter", "MH_TH": "NLM (1972)", "ST": "T026", "PI": "Neurons (1966-1971)", "MS": "A class of nerve fibers as defined by their structure, specifically the nerve sheath arrangement. The AXONS of the myelinated nerve fibers are completely encased in a MYELIN SHEATH. They are fibers of relatively large and varied diameters. Their NEURAL CONDUCTION rates are faster than those of the unmyelinated nerve fibers (NERVE FIBERS, UNMYELINATED). Myelinated nerve fibers are present in somatic and autonomic nerves.", "PM": "1974; for B FIBERS see AUTONOMIC FIBERS, PREGANGLIONIC 1976-2002", "HN": "1974 (1972); for B FIBERS use AUTONOMIC FIBERS, PREGANGLIONIC 1976-2002", "MR": "20220714", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009413"}, {"RECTYPE": "D", "MH": "Nerve Growth Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neurotrophins|T116|T123|NON|EQV|NLM (2000)|991103|abbcdef", "ENTRY": "Protein, Neuronal Growth-Associated", "MN": "D23.529.850", "FX": "Receptors, Nerve Growth Factor", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "NERVE GROWTH FACTOR is also available", "MS": "Factors which enhance the growth potentialities of sensory and sympathetic nerve cells.", "PM": "1980; see NERVE GROWTH FACTOR 1972-1979; NEUROTROPHIC PROTEIN was indexed under NERVE TISSUE PROTEINS 1978-1999", "HN": "1980; use NERVE GROWTH FACTOR 1966-1979; for NEUROTROPHIC PROTEIN use NERVE GROWTH FACTORS (NM) 1978-1999", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009414"}, {"RECTYPE": "D", "MH": "Nerve Net", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Neural Networks (Anatomic)|T023|NON|BRD|NLM (1992)|901009|abcdef", "ENTRY": "Neural Network (Anatomic)", "MN": "A08.511", "MH_TH": "NLM (1964)", "ST": "T023", "AN": "note entry term NEURAL NETWORKS (ANATOMIC): NEURAL NETWORKS, COMPUTER is also available", "MS": "A meshlike structure composed of interconnecting nerve cells that are separated at the synaptic junction or joined to one another by cytoplasmic processes. In invertebrates, for example, the nerve net allows nerve impulses to spread over a wide area of the net because synapses can pass information in any direction.", "PM": "91; was see under NERVOUS SYSTEM 1964-90", "HN": "91(64); was see under NERVOUS SYSTEM 1964-90", "MR": "19940512", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009415"}, {"RECTYPE": "D", "MH": "Nerve Regeneration", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Neural Tissue Regeneration|T043|NON|NRW|NLM (2020)|190408|abcdef", "ENTRY": "Tissue Regeneration, Neural", "MN": "G16.762.611", "MH_TH": "NLM (1966)", "ST": "T043", "AN": "coordinate with specific nerve /physiol not /growth", "MS": "Renewal or physiological repair of damaged nerve tissue.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20190415", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009416"}, {"RECTYPE": "D", "MH": "Nerve Tissue", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tissues, Nervous", "MN": "A10.755", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "Differentiated tissue of the central nervous system composed of NERVE CELLS, fibers, DENDRITES, and specialized supporting cells.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009417"}, {"RECTYPE": "D", "MH": "S100 Proteins", "DS": "S A 100 PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "S100 Protein|T116|T123|NON|EQV|NLM (2021)|200106|abbcdef", "ENTRY": "S 100 Protein", "MN": "D12.776.631.658", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1966-1972)", "MS": "A family of highly acidic calcium-binding proteins found in large concentration in the brain and believed to be glial in origin. They are also found in other organs in the body. They have in common the EF-hand motif (EF HAND MOTIFS) found on a number of calcium binding proteins. The name of this family derives from the property of being soluble in a 100% saturated ammonium sulfate solution.", "PM": "2003; see NERVE TISSUE PROTEIN S 100 1984-2002, see NERVE TISSUE PROTEINS 1975-1983", "HN": "2003(1973)", "MR": "20230609", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D009418"}, {"RECTYPE": "D", "MH": "Nerve Tissue Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tissue Proteins, Nerve", "MN": "D12.776.631", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "IM & coord with specific protein (IM) + specific nerve or nerve tissue (IM); /biosyn /drug eff /physiol /ultrastruct permitted", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009419"}, {"RECTYPE": "D", "MH": "Nervous System", "AQ": "AH BS CH CY DE DG EM EN GD IM ME MI PA PP PS RE UL VI", "ENTRY": "Systems, Nervous", "MN": "A08", "RH": "A8 - ANATOMY-NERVOUS SYSTEM", "FX": "Neurologic Manifestations", "EC": "surgery:Neurosurgical Procedures", "MH_TH": "NLM (1966)", "ST": "T022", "AN": "general; prefer specifics; /innerv is available for organs; use for \"nerves\" but note NERVE TISSUE and terms for many specific nerves are available", "CX": "consider also terms at NERVE and NEUR-", "MS": "The entire nerve apparatus, composed of a central part, the brain and spinal cord, and a peripheral part, the cranial and spinal nerves, autonomic ganglia, and plexuses. (Stedman, 26th ed)", "MR": "20160419", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009420"}, {"RECTYPE": "D", "MH": "Nervous System Malformations", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nervous System Abnormalities|T019|T047|NON|EQV|NLM (1966)|990101|NERVOUS SYSTEM ABNORM|abbcdefv", "ENTRY": "Nervous System Malformation", "MN": "C16.131.666", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "for congenital structural abnormalities only; general or unspecified; prefer specifics or specific organ/abnorm", "PI": "Nervous System/abnormalities (1966-1997)", "MS": "Structural abnormalities of the central or peripheral nervous system resulting primarily from defects of embryogenesis.", "PM": "2000; see NERVOUS SYSTEM ABNORMALITIES 1966-1999", "HN": "2000(1966); use explode 1971-1997", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009421"}, {"RECTYPE": "D", "MH": "Nervous System Diseases", "DE": "NERVOUS SYSTEM DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neurologic Disorders|T047|NON|EQV|NLM (2000)|991103|NEUROLOG DIS|abcdefv", "ENTRY": "Neurological Disorder", "MN": "C10", "RH": "C10 - DISEASES-NEUROLOGIC", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "general or unspecified; prefer specifics; /diag: consider also DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; inflammatory disease equals NEURITIS; \"diabetic neuropathy\" and \"diabetic peripheral neuropathy\": index only under DIABETIC NEUROPATHIES;/chem ind: consider NEUROTOXICITY SYNDROMES", "MS": "Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.", "PM": "1965", "HN": "1965", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009422"}, {"RECTYPE": "D", "MH": "Nervous System Neoplasms", "DE": "NERVOUS SYSTEM NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Neoplasms, Nervous System|T191|NON|EQV|NLM (2000)|991103|NEOPL NERVOUS SYSTEM|abcdefv", "ENTRY": "Tumors, Nervous System", "MN": "C10.551", "MH_TH": "NLM (1980)", "ST": "T191", "AN": "general or unspecified; prefer specifics; do not confuse with NEOPLASMS, NERVOUS TISSUE (neoplasms composed of nerve tissue); coordinate with histological type of neoplasm", "PI": "Nervous System Diseases (1966-1979)", "MS": "Benign and malignant neoplastic processes arising from or involving components of the central, peripheral, and autonomic nervous systems, cranial nerves, and meninges. Included in this category are primary and metastatic nervous system neoplasms.", "PM": "80", "HN": "80; was NON MESH before 1980", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D009423"}, {"RECTYPE": "D", "MH": "Nervous System Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Nervous System Physiology|T070|NON|EQV|NLM (1966)|990101|NERVOUS SYSTEM PHYSIOL|abcdefv", "ENTRY": "System Physiology, Nervous", "MN": "G11.561", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "PI": "Nervous System/physiology (1966-1997)", "MS": "Characteristic properties and processes of the NERVOUS SYSTEM as a whole or with reference to the peripheral or the CENTRAL NERVOUS SYSTEM.", "PM": "2009; see NERVOUS SYSTEM PHYSIOLOGY 1998-2008; for NERVOUS SYSTEM PHYSIOLOGICAL PROCESSES see NERVOUS SYSTEM PHYSIOLOGICAL PROCESSES 2009-2016", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009424"}, {"RECTYPE": "D", "MH": "Nesting Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Nesting Behaviors", "MN": "F01.145.113.252.478", "MH_TH": "NLM (1967)", "ST": "T054", "AN": "animal only", "PI": "Behavior, Animal (1966)", "MS": "Animal behavior associated with the nest; includes construction, effects of size and material; behavior of the adult during the nesting period and the effect of the nest on the behavior of the young.", "PM": "69", "HN": "69(67)", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D009425"}, {"RECTYPE": "D", "MH": "Netherlands", "AQ": "EH EP", "ENTRY": "Kingdom of the Netherlands|T083|NON|EQV|NLM (2013)|120213|abcdef", "MN": "Z01.542.651", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "Country located in EUROPE. It is bordered by the NORTH SEA, BELGIUM, and GERMANY. Constituent areas are Aruba, Curacao, and Sint Maarten, formerly included in the NETHERLANDS ANTILLES.", "HN": "Use West Indies for Aruba 2013-2015", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009426"}, {"RECTYPE": "D", "MH": "Netherlands Antilles", "AQ": "EH EP", "MN": "Z01.586.575", "MH_TH": "NLM (1992)", "ST": "T083", "MS": "Former Netherlands overseas territory in the Lesser Antilles in the West Indies. It had included the islands of Aruba, Bonaire, Curacao, Saba, St. Eustatius, and the southern part of St. Martin. The Netherlands Antilles dissolved on October 10, 2010.", "MR": "20161222", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009427"}, {"RECTYPE": "D", "MH": "Netilmicin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sch20569", "MN": "D09.408.051.374.785.525", "PA": "Protein Synthesis Inhibitors", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "D-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-4))-2-deoxy-N1-ethyl-", "RN": "4O5J85GJJB", "RR": "S741ZJS97U", "PI": "Sisomicin (1975-1978)", "MS": "Semisynthetic 1-N-ethyl derivative of SISOMYCIN, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity.", "PM": "86; was see under GENTAMICINS 1979-85", "HN": "86(79); was see under GENTAMICINS 1979-85", "MR": "20160701", "DA": "19780503", "DC": "1", "DX": "19860101", "UI": "D009428"}, {"RECTYPE": "D", "MH": "Netropsin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sinanomycin|T116|T195|NON|EQV|FDA SRS (2014)|UNK (19XX)|760626|abbcdeef", "ENTRY": "Hydrochloride, Netropsin", "MN": "D12.644.456.650", "PA": "Antiviral Agents", "MH_TH": "NLM (1977)", "ST": "T195", "N1": "1H-Pyrrole-2-carboxamide, 4-((((aminoiminomethyl)amino)acetyl)amino)-N-(5-(((3-amino-3-iminopropyl)amino)carbonyl)-1-methyl-1H-pyrrol-3-yl)-1-methyl-", "RN": "64B3O0RD7N", "RR": "63770-20-7 (HCl)", "PI": "Pyrroles (1966-1976)", "MS": "A basic polypeptide isolated from Streptomyces netropsis. It is cytotoxic and its strong, specific binding to A-T areas of DNA is useful to genetics research.", "OL": "use NETROPSIN (NM) to search CONGOCIDINE 1980-93", "PM": "91; was see under GUANIDINES 1977-90; CONGOCIDINE was indexed under PYRROLES 1983-93, GUANIDINES 1973-83 & AMIDINES 1973-76", "HN": "91(77); was see under GUANIDINES 1977-90; CONGOCIDINE was (NM) 1973-93", "MR": "20130708", "DA": "19760503", "DC": "1", "DX": "19910101", "UI": "D009429"}, {"RECTYPE": "D", "MH": "Neural Analyzers", "DE": "NEURAL ANAL", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Analyzers, Neural|T023|NON|EQV|UNK (19XX)|740330|ANAL NEURAL|abcdefv", "ENTRY": "Neural Analyzer", "MN": "A08.675.575", "MH_TH": "NLM (1964)", "ST": "T023", "MS": "A term used in Eastern European research literature for the functional neural unit that provides the basis for differential sensitivity; the analyzer consists of receptor, afferent nerves, and their central connections. (From Campbell's Psychiatric Dictionary, 8th ed.)", "PM": "65", "HN": "65(64)", "MR": "20140610", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009430"}, {"RECTYPE": "D", "MH": "Neural Conduction", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Nerve Conduction|T042|T043|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Neural Conductions", "MN": "G11.561.601", "FX": "Synaptic Transmission", "MH_TH": "NLM (1968)", "ST": "T043", "AN": "along a single nerve; differentiate from NEURAL TRANSMISSION (between nerves)", "MS": "The propagation of the NERVE IMPULSE along the nerve away from the site of an excitation stimulus.", "PM": "1968; see NERVE CONDUCTION 1965-1967", "HN": "1968 (1965)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009431"}, {"RECTYPE": "D", "MH": "Neural Crest", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Neural Grooves", "MN": "A16.627", "MH_TH": "NLM (1979)", "ST": "T018", "PI": "Nervous System/EM (1966-1978)", "MS": "The two longitudinal ridges along the PRIMITIVE STREAK appearing near the end of GASTRULATION during development of nervous system (NEURULATION). The ridges are formed by folding of NEURAL PLATE. Between the ridges is a neural groove which deepens as the fold become elevated. When the folds meet at midline, the groove becomes a closed tube, the NEURAL TUBE.", "PM": "79", "HN": "79", "MR": "20140613", "DA": "19771205", "DC": "1", "DX": "19790101", "UI": "D009432"}, {"RECTYPE": "D", "MH": "Neural Inhibition", "DE": "NEURAL INHIB", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Inhibition, Neural|T042|T043|NON|EQV|UNK (19XX)|740330|INHIB NEURAL|abbcdefv", "MN": "G11.561.616", "FX": "Refractory Period, Electrophysiological", "MH_TH": "NLM (1972)", "ST": "T043", "PI": "specific neuroanatomic site (1966-1971)", "MS": "The function of opposing or restraining the excitation of neurons or their target excitable cells.", "OL": "use NEURAL INHIBITION to search INHIBITION, NEURAL 1972-73 (as Prov)", "PM": "74", "HN": "74; was INHIBITION, NEURAL 1972-73 (Prov)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009433"}, {"RECTYPE": "D", "MH": "Neural Pathways", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Neural Interconnections|T023|NON|NRW|NLM (1991)|891213|abcdef", "ENTRY": "Pathways, Neural", "MN": "A08.612", "MH_TH": "NLM (1969)", "ST": "T023", "AN": "= \"neural tracts\"; coord NIM with origin (IM) + termination (IM)", "MS": "Neural tracts connecting one part of the nervous system with another.", "OL": "use NEURAL PATHWAYS to search NEURAL INTERCONNECTIONS 1969-76 (as Prov 1969-74)", "PM": "77; was NEURAL INTERCONNECTIONS see under NERVOUS SYSTEM 1975-76", "HN": "77; was NEURAL INTERCONNECTIONS see under NERVOUS SYSTEM 1975-76, was NEURAL INTERCONNECTIONS 1969-74 (Prov)", "MR": "19950518", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D009434"}, {"RECTYPE": "D", "MH": "Synaptic Transmission", "DE": "SYNAPTIC TRANSM", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Neurotransmission|T043|NON|EQV|NLM (2009)|080109|abcdef", "ENTRY": "Transmission, Synaptic|T043|NON|EQV|NLM (1994)|930121|TRANSM SYNAPTIC|abcdefv", "MN": "G11.561.830", "FX": "Synapses", "MH_TH": "NLM (1968)", "ST": "T043", "PI": "Neural Conduction (1966-1967)", "MS": "The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES.", "OL": "use SYNAPTIC TRANSMISSION to search NEURAL TRANSMISSION 1969-93, NEUROHUMORAL TRANSMISSION 1968, & NERVE TRANSMISSION 1968-93", "PM": "94; was NEURAL TRANSMISSION 1969-93, was NEUROHUMORAL TRANSMISSION 1968; NERVE TRANSMISSION was see NEURAL TRANSMISSION", "HN": "94; was NEURAL TRANSMISSION 1969-93, was NEUROHUMORAL TRANSMISSION 1968; NERVE TRANSMISSION was see NEURAL TRANSMISSION 1969-93", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009435"}, {"RECTYPE": "D", "MH": "Neural Tube Defects", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tethered Cord Syndrome|T019|NON|NRW|NLM (1991)|900112|abcdef", "ENTRY": "Tethered Cord Syndromes", "MN": "C16.131.666.680", "MH_TH": "ORD (2010)", "ST": "T019", "AN": "do not confuse entry term SPINAL CORD MYELODYSPLASIA with MYELODYSPLASTIC SYNDROMES, a defect of bone marrow formation", "PI": "Spina Bifida (1966-1978)", "MS": "Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy generally occurring between days 18-29 of gestation. Ectodermal and mesodermal malformations (mainly involving the skull and vertebrae) may occur as a result of defects of neural tube closure. (From Joynt, Clinical Neurology, 1992, Ch55, pp31-41)", "PM": "1979; for DIASTEMATOMYELIA and TETHERED CORD SYNDROME see SPINA BIFIDA OCCULTA 1991-1999; for NEURENTERIC CYST see SPINA BIFIDA OCCULTA 1991-1999, see NEURAL TUBE DEFECTS 1979-1990", "HN": "1979; for DIASTEMATOMYELIA and TETHERED CORD SYNDROME use SPINA BIFIDA OCCULTA 1991-1999; for NEURENTERIC CYST use SPINA BIFIDA OCCULTA 1991-1999, use NEURAL TUBE DEFECTS 1979-1990", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19780515", "DC": "1", "DX": "19790101", "UI": "D009436"}, {"RECTYPE": "D", "MH": "Neuralgia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paroxysmal Nerve Pain|T184|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Vidian Neuralgias", "MN": "C23.888.592.612.664", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "coordinate IM with specific nerve (IM) if pertinent", "MS": "Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009437"}, {"RECTYPE": "D", "MH": "Neuraminic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Neuraminic", "MN": "D09.811.589", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Nine-carbon deoxyamino SUGAR ACIDS that are substrates for NEURAMINIDASE. Their derivatives include SIALIC ACIDS.", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009438"}, {"RECTYPE": "D", "MH": "Neuraminidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sialidase|T116|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Sialidase, Oligosaccharide", "MN": "D08.811.277.450.692", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Acylneuraminyl hydrolase", "RN": "EC 3.2.1.18", "MS": "An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009439"}, {"RECTYPE": "D", "MH": "Neurasthenia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Neuroses, Neurasthenic|T048|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Distress Disorder, Bodily", "MN": "F03.875.600", "FX": "Fatigue Syndrome, Chronic", "MH_TH": "NLM (1966)", "ST": "T048", "AN": "NEUROCIRCULATORY ASTHENIA is also available", "MS": "A mental disorder characterized by chronic fatigue and concomitant physiologic symptoms.", "CATSH": "CAT LIST", "MR": "20210702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009440"}, {"RECTYPE": "D", "MH": "Neurilemma", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Neurolemma|T024|NON|EQV|NLM (1994)|921201|abcdef", "ENTRY": "Sheath, Schwann", "MN": "A11.671.501.512.560.550", "MH_TH": "NLM (1965)", "ST": "T024", "MS": "The outermost cytoplasmic layer of the SCHWANN CELLS covering NERVE FIBERS.", "PM": "65", "HN": "65", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009441"}, {"RECTYPE": "D", "MH": "Neurilemmoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Schwannomatosis, Plexiform|T191|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Schwannomas", "MN": "C04.557.580.625.650.595", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "benign or malignant; coordinate IM with precoordinated organ/neoplasm term (IM)", "MS": "A neoplasm that arises from SCHWANN CELLS of the cranial, peripheral, and autonomic nerves. Clinically, these tumors may present as a cranial neuropathy, abdominal or soft tissue mass, intracranial lesion, or with spinal cord compression. Histologically, these tumors are encapsulated, highly vascular, and composed of a homogenous pattern of biphasic fusiform-shaped cells that may have a palisaded appearance. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp964-5)", "PM": "1999; for MALIGNANT PERIPHERAL NERVE SHEATH TUMORS see NERVE SHEATH NEOPLASMS 1998-2013", "HN": "1999 (1966)", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D009442"}, {"RECTYPE": "D", "MH": "Neuritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polyneuritis|T047|NON|NRW|NLM (1966)|990101|abcdef", "ENTRY": "Sensory Neuritis", "MN": "C10.668.829.650", "FX": "Vestibular Neuronitis", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A general term indicating inflammation of a peripheral or cranial nerve. Clinical manifestation may include PAIN; PARESTHESIAS; PARESIS; or HYPESTHESIA.", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009443"}, {"RECTYPE": "D", "MH": "Neuritis, Autoimmune, Experimental", "DE": "NEURITIS AUTOIMMUNE EXPER", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuritis, Experimental Allergic|T050|NON|EQV|NLM (1982)|990101|NEURITIS EXPER ALLERGIC|abcdefv", "ENTRY": "Neuropathy, Experimental Autoimmune", "MN": "E05.598.500.500.875", "MH_TH": "NLM (2005)", "ST": "T050", "AN": "coordinate with GUILLAINE-BARRE SYNDROME if pertinent", "PI": "Peripheral Nerves (1966-1981)", "MS": "An experimental animal model for the demyelinating disease of GUILLAINE-BARRE SYNDROME. In the most frequently used protocol, animals are injected with a peripheral nerve tissue protein homogenate. After approximately 2 weeks the animals develop a neuropathy secondary to a T cell-mediated autoimmune response directed towards the MYELIN P2 PROTEIN in peripheral nerves. Pathologic findings include a perivascular accumulation of macrophages and T lymphocytes in the peripheral nervous system, similar to that seen in the Guillaine-Barre syndrome. (From Adams et al., Principles of Neurology, 6th ed, p1314; J Neuroimmunol 1998 Apr 1;84(1):40-52)", "PM": "2005; see NEURITIS, EXPERIMENTAL ALLERGIC 1982-2004", "HN": "2005 (1982)", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19810223", "DC": "1", "DX": "19820101", "UI": "D009444"}, {"RECTYPE": "D", "MH": "Neuroanatomy", "DE": "NEUROANAT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Neuroanatomies", "MN": "H01.158.610.060", "MH_TH": "NLM (1976)", "ST": "T091", "AN": "use for the discipline only; not for NERVOUS SYSTEM /anat", "PI": "specific nervous system heading/anatomy & histology (1966-1975)", "MS": "Study of the anatomy of the nervous system as a specialty or discipline.", "PM": "76", "HN": "76", "MR": "20080708", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D009445"}, {"RECTYPE": "D", "MH": "Neurobiology", "DE": "NEUROBIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Molecular Neurobiology|T091|NON|NRW|UNK (19XX)|850606|MOL NEUROBIOL|abcdefv", "ENTRY": "Neurobiology, Molecular|T091|NON|NRW|NLM (1992)|900926|NEUROBIOL MOL|abcdefv", "MN": "H01.158.610.080", "MH_TH": "NLM (1986)", "ST": "T091", "AN": "use for the discipline (education, history, etc) only", "MS": "The study of the structure, growth, activities, and functions of NEURONS and the NERVOUS SYSTEM.", "PM": "86", "HN": "86", "MR": "20090706", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D009446"}, {"RECTYPE": "D", "MH": "Neuroblastoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neuroblastomas", "MN": "C04.557.580.625.600.590.650.550", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coord IM with precoord organ/neopl term (IM); for NEUROBLASTOMA, RETINAL see RETINOBLASTOMA", "MS": "A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009447"}, {"RECTYPE": "D", "MH": "Neurochemistry", "DE": "NEUROCHEM", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Neurochemistries", "MN": "H01.181.122.709", "MH_TH": "NLM (1964)", "ST": "T091", "AN": "the discipline only (education, history, etc); for the chemistry of the nervous system, use the qualifier /chem with NERVOUS SYSTEM or specific nervous system component", "MS": "The study of the composition, chemical structures, and chemical reactions of the NERVOUS SYSTEM or its components.", "PM": "64", "HN": "64", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D009448"}, {"RECTYPE": "D", "MH": "Neurocirculatory Asthenia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Phobia, Cardiac|T047|NON|EQV|NLM (2022)|210921|abcdef", "ENTRY": "Syndrome, Hyperkinetic Heart", "MN": "F03.080.500", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "NEURASTHENIA is also available", "MS": "A clinical syndrome characterized by palpitation, SHORTNESS OF BREATH, labored breathing, subjective complaints of effort and discomfort, all following slight PHYSICAL EXERTION. Other symptoms may be DIZZINESS, tremulousness, SWEATING, and INSOMNIA. Neurocirculatory asthenia is most typically seen as a form of anxiety disorder.", "CATSH": "CAT LIST", "MR": "20210921", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009449"}, {"RECTYPE": "D", "MH": "Neurodermatitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neurodermatitis, Localized|T047|NON|NRW|NLM (1993)|920402|abcdef", "ENTRY": "Neurodermatitides, Localized", "MN": "C17.800.815.660", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "eczematous skin dis with intense itching", "MS": "An extremely variable eczematous skin disease that is presumed to be a response to prolonged vigorous scratching, rubbing, or pinching to relieve intense pruritus. It varies in intensity, severity, course, and morphologic expression in different individuals. Neurodermatitis is believed by some to be psychogenic. The circumscribed or localized form is often referred to as lichen simplex chronicus.", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009450"}, {"RECTYPE": "D", "MH": "Neuroeffector Junction", "AQ": "AB AH BS CH CY DE DG EM EN GD GE IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Neuroeffector Junctions", "MN": "A11.284.149.165.420.780.550", "MH_TH": "NLM (1968)", "ST": "T030", "AN": "a synapse between a neuron & an effector cell", "PI": "Nerve Endings (1966-1967)", "MS": "The synapse between a neuron (presynaptic) and an effector cell other than another neuron (postsynaptic). Neuroeffector junctions include synapses onto muscles and onto secretory cells.", "PM": "68", "HN": "68", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009451"}, {"RECTYPE": "D", "MH": "Neuroendocrinology", "DE": "NEUROENDOCRINOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.158.782.323.200", "MH_TH": "NLM (1986)", "ST": "T091", "AN": "do not use as a coordinate for NERVOUS SYSTEM + ENDOCRINE GLANDS nor for ENDOCRINE GLANDS /innerv; NEUROENDOCRINE SYSTEM see NEUROSECRETORY SYSTEM is also available", "MS": "The study of the anatomical and functional relationships between the nervous system and the endocrine system.", "PM": "86", "HN": "86", "MR": "20080708", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D009452"}, {"RECTYPE": "D", "MH": "Neurofibrils", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Neurofibril", "MN": "A11.671.573", "FX": "Neurofibrillary Tangles", "MH_TH": "NLM (1965)", "ST": "T026", "AN": "do not confuse with NERVE FIBERS", "MS": "The delicate interlacing threads, formed by aggregations of neurofilaments and neurotubules, coursing through the CYTOPLASM of the body of a NEURON and extending from one DENDRITE into another or into the AXON.", "PM": "65", "HN": "65", "MR": "20140620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009454"}, {"RECTYPE": "D", "MH": "Neurofibroma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Neurofibromas", "MN": "C10.668.829.725.500.600", "MH_TH": "ORD (2010)", "ST": "T191", "MS": "A moderately firm, benign, encapsulated tumor resulting from proliferation of SCHWANN CELLS and FIBROBLASTS that includes portions of nerve fibers. The tumors usually develop along peripheral or cranial nerves and are a central feature of NEUROFIBROMATOSIS 1, where they may occur intracranially or involve spinal roots. Pathologic features include fusiform enlargement of the involved nerve. Microscopic examination reveals a disorganized and loose cellular pattern with elongated nuclei intermixed with fibrous strands. (From Adams et al., Principles of Neurology, 6th ed, p1016)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009455"}, {"RECTYPE": "D", "MH": "Neurofibromatosis 1", "DS": "NEUROFIBROMATOSIS A 01", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "von Recklinghausen Disease|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|880608|VON RECKLINGHAUSEN DIS|abcdeeeefv", "ENTRY": "von Recklinghausens Disease", "MN": "C16.320.700.633.650", "FX": "Noonan Syndrome", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with NEUROFIBROMATOSIS 2; coord IM with precoord organ/neopl term (IM) if relevant", "MS": "An autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. NF1 is caused by mutations which inactivate the NF1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS).", "PM": "1992; see NEUROFIBROMATOSIS 1966-91; for NEUROFIBROMATOSIS, PERIPHERAL, NF1 see NEUROFIBROMATOSIS 1989-1991", "HN": "1992(1966); for NEUROFIBROMATOSIS, PERIPHERAL, NF1 use NEUROFIBROMATOSIS 1989-1991", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D009456"}, {"RECTYPE": "D", "MH": "Neuroglia", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Satellite Glial Cells|T025|NON|NRW|NLM (2021)|191122|abcdef", "ENTRY": "Satellite Glias", "MN": "A11.650", "MH_TH": "NLM (1966)", "ST": "T025", "MS": "The non-neuronal cells of the nervous system. They not only provide physical support, but also respond to injury, regulate the ionic and chemical composition of the extracellular milieu, participate in the BLOOD-BRAIN BARRIER and BLOOD-RETINAL BARRIER, form the myelin insulation of nervous pathways, guide neuronal migration during development, and exchange metabolites with neurons. Neuroglia have high-affinity transmitter uptake systems, voltage-dependent and transmitter-gated ion channels, and can release transmitters, but their role in signaling (as in many other functions) is unclear.", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009457"}, {"RECTYPE": "D", "MH": "Neuroleptanalgesia", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Neuroleptoanalgesia|T061|NON|EQV|UNK (19XX)|780313|abcdef", "MN": "E03.091.646", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "A form of analgesia accompanied by general quiescence and psychic indifference to environmental stimuli, without loss of consciousness, and produced by the combined administration of a major tranquilizer (neuroleptic) and a narcotic.", "OL": "use NEUROLEPTANALGESIA to search NEUROLEPTOANALGESIA 1966-78 (as Prov 1966-67)", "PM": "79; was NEUROLEPTOANALGESIA 1968-78", "HN": "79; was NEUROLEPTOANALGESIA 1966-78 (Prov 1966-67)", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009458"}, {"RECTYPE": "D", "MH": "Neuroleptic Malignant Syndrome", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuroleptic-Malignant Syndrome, Neuroleptic Induced|T047|NON|NRW|NLM (2000)|991103|NEUROLEPTIC MALIGNANT SYNDROME NEUROLEPTIC IND|abcdefv", "ENTRY": "Syndromes, Neuroleptic Malignant", "MN": "C25.723.705.600", "MH_TH": "NLM (1985)", "ST": "T047", "AN": "caused by tranquilizing agents so do not use /chem ind", "PI": "Tranquilizing Agents, Major (1975-1984)", "MS": "A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)", "PM": "1986; see BASAL GANGLIA DISEASES 1985", "HN": "1986(1985)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19840605", "DC": "1", "DX": "19860101", "UI": "D009459"}, {"RECTYPE": "D", "MH": "Neurologic Examination", "DE": "NEUROL EXAM", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Neurological Examinations", "MN": "E01.370.600.550", "MH_TH": "NLM (1964)", "ST": "T060", "MS": "Assessment of sensory and motor responses and reflexes that is used to determine impairment of the nervous system.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009460"}, {"RECTYPE": "D", "MH": "Neurologic Manifestations", "DE": "NEUROL MANIFESTATIONS", "PRINT ENTRY": "Neurologic Signs and Symptoms|T033|NON|EQV|NLM (2000)|991108|NEUROL SIGNS SYMPTOMS|abcdefv", "ENTRY": "Symptoms, Neurologic", "MN": "C23.888.592", "MH_TH": "NLM (1966)", "ST": "T033", "AN": "not used for indexing since 1989; prior to 1989 used for neurol manifest of non-neural diseases", "MS": "Clinical signs and symptoms caused by nervous system injury or dysfunction.", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009461"}, {"RECTYPE": "D", "MH": "Neurology", "DE": "NEUROL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.600", "FX": "Nervous System Diseases", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "A medical specialty concerned with the study of the structures, functions, and diseases of the nervous system.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009462"}, {"RECTYPE": "D", "MH": "Neuroma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Neuromas", "MN": "C04.557.580.600.610", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term ", "MS": "A tumor made up of nerve cells and nerve fibers. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009463"}, {"RECTYPE": "D", "MH": "Neuroma, Acoustic", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Schwannoma, Vestibular|T048|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Vestibular Schwannomas, Melanocytic", "MN": "C10.292.910.600", "MH_TH": "NLM (1978)", "ST": "T048", "PI": "Neurilemmoma (1966-1977)", "MS": "A benign SCHWANNOMA of the eighth cranial nerve (VESTIBULOCOCHLEAR NERVE), mostly arising from the vestibular branch (VESTIBULAR NERVE) during the fifth or sixth decade of life. Clinical manifestations include HEARING LOSS; HEADACHE; VERTIGO; TINNITUS; and FACIAL PAIN. Bilateral acoustic neuromas are associated with NEUROFIBROMATOSIS 2. (From Adams et al., Principles of Neurology, 6th ed, p673)", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D009464"}, {"RECTYPE": "D", "MH": "Neuromuscular Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Skeletal Muscle Relaxants|T121|NON|NRW|NLM (1995)|940315|abcdef", "ENTRY": "Relaxants, Skeletal Muscle", "MN": "D27.505.696.663.700", "MH_TH": "NLM (1974)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; note entry term NEUROMUSCULAR EFFECT: use only for the neuromuscular effect of a chemical substance", "MS": "Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS.", "OL": "use MUSCLE RELAXANTS, CENTRAL to search SKELETAL MUSCLE RELAXANTS 1977-94", "PM": "95; SKELETAL MUSCLE RELAXANTS was see MUSCLE RELAXANTS, CENTRAL 1977-94", "HN": "95; was NON MESH 1974-94; SKELETAL MUSCLE RELAXANTS was see MUSCLE RELAXANTS, CENTRAL 1977-94", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19950101", "UI": "D009465"}, {"RECTYPE": "D", "MH": "Neuromuscular Blocking Agents", "DE": "NEUROMUSCULAR BLOCK AGENTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neuromuscular Blocking Agent|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Blocking Agents, Neuromuscular", "MN": "D27.505.696.663.700.710", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Neuromuscular Depolarizing Agents (1970-1974)", "MS": "Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc.", "OL": "search CURARE-LIKE AGENTS & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74", "PM": "75; was see under CURARE-LIKE AGENTS & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74", "HN": "75; was see under CURARE-LIKE AGENTS & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D009466"}, {"RECTYPE": "D", "MH": "Neuromuscular Depolarizing Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Muscle Relaxants, Depolarizing|T121|NON|EQV|UNK (19XX)|780410|abcdef", "ENTRY": "Relaxants, Depolarizing Muscle", "MN": "D27.505.696.663.700.710.550", "MH_TH": "NLM (1970)", "ST": "T121", "RN": "0", "PI": "Muscles (1966-1969)", "MS": "Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation.", "OL": "use NEUROMUSCULAR DEPOLARIZING AGENTS to search LEPTOCURARES 1970-92; search MUSCLE RELAXANTS under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 & MUSCLES 1966-69", "PM": "70; LEPTOCURARES was see NEUROMUSCULAR DEPOLARIZING AGENTS 1970-92; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69", "HN": "70; LEPTOCURARES was see NEUROMUSCULAR DEPOLARIZING AGENTS 1970-92; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D009467"}, {"RECTYPE": "D", "MH": "Neuromuscular Diseases", "DE": "NEUROMUSCULAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Oppenheim Disease|T019|EPO|REL|NLM (1997)|OMIM (2013)|960411|OPPENHEIM DIS|abcdeefv", "ENTRY": "Syndromes, Cramp-Fasciculation", "MN": "C10.668", "MH_TH": "NLM (1971)", "ST": "T047", "AN": "general or unspecified; prefer specifics; do not confuse entry term AMYOTONIA CONGENITA with MYOTONIA CONGENITA", "PI": "Nervous System Diseases (1966-1970)", "MS": "A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.", "PM": "1971; AMYOTONIA CONGENITA was heading 1963-96; for MYATONIA CONGENITA & OPPENHEIM'S DISEASE see AMYOTONIA CONGENITA 1963-1996", "HN": "1971; AMYOTONIA CONGENITA was heading 1963-96", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D009468"}, {"RECTYPE": "D", "MH": "Neuromuscular Junction", "AQ": "AB AH BS CH CY DE DG EM EN GD GE IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Nerve-Muscle Preparation|T023|NON|REL|NLM (1998)|960711|abcdef", "ENTRY": "Preparations, Nerve-Muscle", "MN": "A11.284.149.165.420.780.550.550", "FX": "Receptors, Cholinergic", "MH_TH": "NLM (1968)", "ST": "T030", "MS": "The synapse between a neuron and a muscle.", "OL": "use NEUROMUSCULAR JUNCTION to search MYONEURAL JUNCTION 1966-67", "PM": "68; was MYONEURAL JUNCTION 1963-67", "HN": "68; was MYONEURAL JUNCTION 1963-67", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009469"}, {"RECTYPE": "D", "MH": "Muscle Spindles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Stretch Receptors, Muscle|T023|NON|EQV|NLM (1994)|921118|STRETCH RECEPT MUSCLE|abcdefv", "ENTRY": "Stretch Receptor, Muscle", "MN": "A11.671.650.915.750.500", "FX": "Reflex, Stretch", "MH_TH": "NLM (1963)", "ST": "T023", "MS": "Skeletal muscle structures that function as the MECHANORECEPTORS responsible for the stretch or myotactic reflex (REFLEX, STRETCH). They are composed of a bundle of encapsulated SKELETAL MUSCLE FIBERS, i.e., the intrafusal fibers (nuclear bag 1 fibers, nuclear bag 2 fibers, and nuclear chain fibers) innervated by SENSORY NEURONS.", "OL": "use MUSCLE SPINDLES to search NEUROMUSCULAR SPINDLES 1966-92", "PM": "93; was NEUROMUSCULAR SPINDLES 1965-92; was see under NERVE ENDINGS 1963-64", "HN": "93; was NEUROMUSCULAR SPINDLES 1965-92; was see under NERVE ENDINGS 1963-64", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009470"}, {"RECTYPE": "D", "MH": "Neuromyelitis Optica", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Devic's Neuromyelitis Optica|T047|EPO|EQV|NLM (2010)|ORD (2010)|090512|abcdeef", "ENTRY": "Syndrome, Devic's", "MN": "C20.111.258.250.775", "FX": "Aquaporin 4", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A syndrome characterized by acute OPTIC NEURITIS; MYELITIS, TRANSVERSE; demyelinating and/or necrotizing lesions in the OPTIC NERVES and SPINAL CORD; and presence of specific autoantibodies to AQUAPORIN 4.", "PM": "1991; see DEMYELINATING DISEASES 1979-1990, see MULTIPLE SCLEROSIS 1963-1978 ; for DEVIC DISEASE see DEVIC'S DISEASE 1997", "HN": "1991(1975); use DEMYELINATING DISEASES 1979-1990, use MULTIPLE SCLEROSIS 1963-1978 ; for DEVIC DISEASE use DEVIC'S DISEASE 1997", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009471"}, {"RECTYPE": "D", "MH": "Neuronal Ceroid-Lipofuscinoses", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spielmeyer-Vogt Disease|T047|EPO|NRW|GHR (2014)|NLM (2000)|991108|SPIELMEYER VOGT DIS|abcdeefv", "ENTRY": "Storage Disease, Lipofuscin", "MN": "C18.452.648.398.641.509", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Pigments (1966-1982)", "MS": "A group of severe neurodegenerative diseases characterized by intracellular accumulation of autofluorescent wax-like lipid materials (CEROID; LIPOFUSCIN) in neurons. There are several subtypes based on mutations of the various genes, time of disease onset, and severity of the neurological defects such as progressive DEMENTIA; SEIZURES; and visual failure.", "PM": "2007; see NEURONAL CEROID-LIPOFUSCINOSIS 1983-2006", "HN": "2007 (1983)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19820428", "DC": "1", "DX": "19830101", "UI": "D009472"}, {"RECTYPE": "D", "MH": "Neuronal Plasticity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Plasticity, Neuronal|T042|NON|EQV|UNK (19XX)|810224|abcdef", "ENTRY": "Synaptic Prunings", "MN": "G11.561.638", "FX": "Cell Plasticity", "MH_TH": "NLM (1982)", "ST": "T042", "PI": "Visual Pathways (1971-1981)", "MS": "The capacity of the NERVOUS SYSTEM to change its reactivity as the result of successive activations.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20181211", "DA": "19810224", "DC": "1", "DX": "19820101", "UI": "D009473"}, {"RECTYPE": "D", "MH": "Neurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Nerve Cells|T025|NON|EQV|UNK (19XX)|750116|abcdef", "ENTRY": "Neuron", "MN": "A11.671", "FX": "Neural Conduction", "MH_TH": "NLM (1966)", "ST": "T025", "AN": "do not use as a substitute or synonym for BRAIN /cytol", "MS": "The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.", "OL": "to search NERVE CELLS use NEUROGLIA & NEURONS 1966-74", "PM": "NERVE CELLS was see under NEUROGLIA & NEURONS 1963-74", "HN": "NERVE CELLS was see under NEUROGLIA & NEURONS 1963-74", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009474"}, {"RECTYPE": "D", "MH": "Neurons, Afferent", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Neuron, Afferent", "MN": "A11.671.650", "FX": "Sensory Receptor Cells", "MH_TH": "NLM (1969)", "ST": "T025", "AN": "do not confuse with NEURONS, EFFERENT which activate muscle and secretory cells", "PI": "Neurons (1966-1968)", "MS": "Neurons which conduct NERVE IMPULSES to the CENTRAL NERVOUS SYSTEM.", "PM": "77", "HN": "77(69)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D009475"}, {"RECTYPE": "D", "MH": "Neurons, Efferent", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Neuron, Efferent", "MN": "A11.671.655", "FX": "Neuroeffector Junction", "MH_TH": "NLM (1969)", "ST": "T025", "AN": "do not confuse with NEURONS, AFFERENT which are sensory neurons", "PI": "Neurons (1966-1968)", "MS": "Neurons which send impulses peripherally to activate muscles or secretory cells.", "PM": "77", "HN": "77(69)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D009476"}, {"RECTYPE": "D", "MH": "Hereditary Sensory and Autonomic Neuropathies", "DE": "HEREDITARY SENSORY AUTONOMIC NEUROPATHIES", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sensory and Autonomic Neuropathies, Hereditary|T047|NON|EQV|UNK (19XX)|880607|SENSORY AUTONOMIC NEUROPATHIES HEREDITARY|abcdefv", "ENTRY": "Type IV, HSAN", "MN": "C16.320.400.415", "FX": "Pain Insensitivity, Congenital", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "do not confuse with HEREDITARY SENSORY AND MOTOR NEUROPATHY; note entry terms for HSAN types: HSAN TYPE III see DYSAUTONOMIA, FAMILIAL is also available", "PI": "Sensation (1966-1978)", "MS": "A group of inherited disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and clinically by loss of sensation and autonomic dysfunction. There are five subtypes. Type I features autosomal dominant inheritance and distal sensory involvement. Type II is characterized by autosomal inheritance and distal and proximal sensory loss. Type III is DYSAUTONOMIA, FAMILIAL. Type IV features insensitivity to pain, heat intolerance, and mental deficiency. Type V is characterized by a selective loss of pain with intact light touch and vibratory sensation. (From Joynt, Clinical Neurology, 1995, Ch51, pp142-4)", "PM": "2000; see NEUROPATHIES, HEREDITARY SENSORY AND AUTONOMIC 1989-1999; see NEUROPATHY, HEREDITARY SENSORY 1979-1988", "HN": "2000(1989); use NEUROPATHY, HEREDITARY SENSORY 1979-1988", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19991108", "DC": "1", "DX": "19790101", "UI": "D009477"}, {"RECTYPE": "D", "MH": "Neuropeptide Y", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neuropeptide Y-Like Immunoreactive Peptide|T116|T123|NON|REL|UNK (19XX)|860414|abbcdef", "ENTRY": "Tyrosine, Neuropeptide", "MN": "D12.776.631.650.500", "FX": "Receptors, Neuropeptide Y", "MH_TH": "NLM (1987)", "ST": "T123", "RN": "0", "AN": "a neurotransmitter; /biosyn /physiol permitted", "PI": "Nerve Tissue Proteins (1966-1986)", "MS": "A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones.", "PM": "87", "HN": "87", "MR": "20160705", "DA": "19860414", "DC": "1", "DX": "19870101", "UI": "D009478"}, {"RECTYPE": "D", "MH": "Neuropeptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Neuropeptide|T116|T123|NON|EQV|UNK (1994)|870505|abbcdef", "MN": "D12.776.631.650", "FX": "Receptors, Neuropeptide", "MH_TH": "NLM (1987)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Nerve Tissue Proteins (1966-1986)", "MS": "Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells.", "PM": "87", "HN": "87", "MR": "20151124", "DA": "19860411", "DC": "1", "DX": "19870101", "UI": "D009479"}, {"RECTYPE": "D", "MH": "Neuropharmacology", "DE": "NEUROPHARMACOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Neuropharmacologies", "MN": "H02.628.280", "MH_TH": "NLM (1986)", "ST": "T091", "AN": "a branch of pharmacology; not for NERVOUS SYSTEM /drug eff", "MS": "The branch of pharmacology dealing especially with the action of drugs upon various parts of the nervous system.", "PM": "86", "HN": "86", "MR": "20080708", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D009480"}, {"RECTYPE": "D", "MH": "Neurophysins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neurophysin|T116|T123|NON|EQV|NLM (2022)|201021|abbcdef", "ENTRY": "Vasopressin Associated Neurophysin", "MN": "D12.776.631.650.525", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1966-1972)", "MS": "Carrier proteins for OXYTOCIN and VASOPRESSIN. They are polypeptides of about 10-kDa, synthesized in the HYPOTHALAMUS. Neurophysin I is associated with oxytocin and neurophysin II is associated with vasopressin in their respective precursors and during transportation down the axons to the neurohypophysis (PITUITARY GLAND, POSTERIOR).", "PM": "73", "HN": "73", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009481"}, {"RECTYPE": "D", "MH": "Neurophysiology", "DE": "NEUROPHYSIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.158.782.562", "MH_TH": "NLM (1965)", "ST": "T091", "AN": "specialty only: not for NERVOUS SYSTEM PHYSIOLOGY", "MS": "The scientific discipline concerned with the physiology of the nervous system.", "PM": "65", "HN": "65", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009482"}, {"RECTYPE": "D", "MH": "Neuropsychological Tests", "DE": "NEUROPSYCHOL TESTS", "AQ": "HI SN ST", "PRINT ENTRY": "Neuropsychological Testing|T170|NON|EQV|NLM (2021)|200115|abcdef", "ENTRY": "Tests, Cognitive", "MN": "F04.711.513", "MH_TH": "NLM (1985)", "ST": "T170", "MS": "Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury.", "OL": "use NEUROPSYCHOLOGICAL TESTS to search APHASIA 1979-84 & MEMORY FOR DESIGNS TEST 1971-84 (as Prov 1971-72)", "PM": "85; MEMORY FOR DESIGNS TEST was heading 1973-84; APHASIA TESTS was see under LANGUAGE TESTS 1979-84", "HN": "85; was NON MESH before 1985; MEMORY FOR DESIGNS TEST was heading 1971-84 (Prov 1971-72); APHASIA TESTS was see under LANGUAGE TESTS 1979-84", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D009483"}, {"RECTYPE": "D", "MH": "Neuropsychology", "DE": "NEUROPSYCHOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Neuropsychologies", "MN": "H01.158.782.795.110", "FX": "Neuropsychiatry", "MH_TH": "NLM (1985)", "ST": "T091", "AN": "specialty: not a coordinate with NERVOUS SYSTEM DISEASES /psychol", "MS": "A branch of psychology which investigates the correlation between experience or behavior and the basic neurophysiological processes. The term neuropsychology stresses the dominant role of the nervous system. It is a more narrowly defined field than physiological psychology or psychophysiology.", "PM": "85", "HN": "85", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19840501", "DC": "1", "DX": "19850101", "UI": "D009484"}, {"RECTYPE": "D", "MH": "Neuroradiography", "DE": "NEURORADIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Neuroradiographies", "MN": "E05.629.937", "MH_TH": "NLM (1973)", "ST": "T060", "AN": "IM general only; avoid as NIM coordinate with terms treed under CENTRAL NERVOUS SYSTEM with /diag image; instead prefer specific radiographic technique", "PI": "Radiography (1966-1972)", "MS": "Radiography of the central nervous system.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009485"}, {"RECTYPE": "D", "MH": "Neurosciences", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Neuroscience", "MN": "H01.158.610", "MH_TH": "NLM (1986)", "ST": "T091", "AN": "use for the discipline only (education, history, etc) only", "MS": "The scientific disciplines concerned with the embryology, anatomy, physiology, biochemistry, pharmacology, etc., of the nervous system.", "PM": "86", "HN": "86", "MR": "20090706", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D009488"}, {"RECTYPE": "D", "MH": "Neurosecretion", "DE": "NEUROSECRET", "AQ": "DE ES GE IM PH RE", "ENTRY": "Neurosecretions", "MN": "G11.561.653", "FX": "Pituitary Hormone-Releasing Hormones", "MH_TH": "NLM (1964)", "ST": "T042", "MS": "The production and release of substances such as NEUROTRANSMITTERS or HORMONES from nerve cells.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009489"}, {"RECTYPE": "D", "MH": "Neurosecretory Systems", "DE": "NEUROSECRET SYSTEMS", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Neuroendocrine System|T022|NON|EQV|UNK (19XX)|840406|abcdef", "ENTRY": "Systems, Neurosecretory", "MN": "A08.713", "FX": "Neurosecretion", "MH_TH": "NLM (1970)", "ST": "T022", "AN": "/physiol: consider also NEUROSECRETION", "PI": "Neurosecretion (1966-1969)", "MS": "A system of NEURONS that has the specialized function to produce and secrete HORMONES, and that constitutes, in whole or in part, an ENDOCRINE SYSTEM or organ.", "OL": "use NEUROSECRETORY SYSTEMS to search NEUROHEMAL ORGAN 1970-83", "PM": "70", "HN": "70; NEUROHEMAL ORGAN was see under NEUROSECRETORY SYSTEMS 1970-83", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D009490"}, {"RECTYPE": "D", "MH": "Neurospora", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Neurosporas", "MN": "B01.300.107.800.629", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid5140", "AN": "an ascomycete much used in genetic & enzyme research; do not confuse with NEOSPORA, a protozoon", "MS": "A genus of ascomycetous fungi, family Sordariaceae, order SORDARIALES, comprising bread molds. They are capable of converting tryptophan to nicotinic acid and are used extensively in genetic and enzyme research. (Dorland, 27th ed)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009491"}, {"RECTYPE": "D", "MH": "Neurospora crassa", "DE": "N CRASSA", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Chrysonilia crassa|T004|NON|EQV|NLM (2021)|200318|abcdef", "MN": "B01.300.107.800.629.564", "MH_TH": "NLM (1972)", "ST": "T004", "RN": "txid5141", "AN": "do not confuse with NEOSPORA, a protozoan", "PI": "Neurospora (1966-1971)", "MS": "A species of ascomycetous fungi of the family Sordariaceae, order SORDARIALES, much used in biochemical, genetic, and physiologic studies.", "PM": "91; see NEUROSPORA 1972-90", "HN": "91(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009492"}, {"RECTYPE": "D", "MH": "Neurosurgery", "DE": "NEUROSURG", "AQ": "CL EC ED ES HI IS LJ MT NU OG PX RH SN ST TD VE", "ENTRY": "Neurosurgeries", "MN": "H02.403.810.425", "FX": "Neurosurgical Procedures", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "A surgical specialty concerned with the treatment of diseases and disorders of the brain, spinal cord, and peripheral and sympathetic nervous system.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009493"}, {"RECTYPE": "D", "MH": "Neurosyphilis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Syphilis, Central Nervous System|T047|NON|EQV|NLM (2000)|991103|SYPHILIS CNS|abcdefv", "ENTRY": "Syphilis, CNS|T047|NON|EQV|NLM (2000)|991103|abcdef", "MN": "C10.228.228.180.600", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Infections of the central nervous system caused by TREPONEMA PALLIDUM which present with a variety of clinical syndromes. The initial phase of infection usually causes a mild or asymptomatic meningeal reaction. The meningovascular form may present acutely as BRAIN INFARCTION. The infection may also remain subclinical for several years. Late syndromes include general paresis; TABES DORSALIS; meningeal syphilis; syphilitic OPTIC ATROPHY; and spinal syphilis. General paresis is characterized by progressive DEMENTIA; DYSARTHRIA; TREMOR; MYOCLONUS; SEIZURES; and Argyll-Robertson pupils. (Adams et al., Principles of Neurology, 6th ed, pp722-8)", "PM": "1966; for GENERAL PARALYSIS & PARALYSIS, GENERAL see PARESIS 1963-93", "HN": "1963; for GENERAL PARALYSIS & PARALYSIS, GENERAL use PARESIS 1963-93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D009494"}, {"RECTYPE": "D", "MH": "Neurotensin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.776.631.650.550", "FX": "Receptors, Neurotensin", "MH_TH": "NLM (1978)", "ST": "T125", "N1": "Neurotensin", "RN": "39379-15-2", "AN": "a neurotransmitter isolated from the hypothalamus; /biosyn /physiol permitted", "PI": "Peptides (1966-1977)", "MS": "A biologically active tridecapeptide isolated from the hypothalamus. It has been shown to induce hypotension in the rat, to stimulate contraction of guinea pig ileum and rat uterus, and to cause relaxation of rat duodenum. There is also evidence that it acts as both a peripheral and a central nervous system neurotransmitter.", "PM": "78", "HN": "78", "MR": "20151124", "DA": "19770523", "DC": "1", "DX": "19780101", "UI": "D009496"}, {"RECTYPE": "D", "MH": "Neurotic Disorders", "DE": "NEUROTIC DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Psychoneuroses|T048|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Neurotic Disorder", "MN": "F03.650", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.", "OL": "use NEUROTIC DISORDERS to search NEUROSES 1966-80", "PM": "81; was NEUROSES 1963-80", "HN": "81; was NEUROSES 1963-80", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D009497"}, {"RECTYPE": "D", "MH": "Neurotoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neurotoxin|T131|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Neurotoxins, Excitatory", "MN": "D27.888.569.504", "FX": "Neurotransmitter Agents", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "PI": "Toxins (1966-1977)", "MS": "Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept.", "PM": "78", "HN": "78", "MR": "20210510", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D009498"}, {"RECTYPE": "D", "MH": "Neutral Red", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Toluylene Red|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Red, Toluylene", "MN": "D03.633.300.704.600", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "2,8-Phenazinediamine, N8,N8,3-trimethyl-, monohydrochloride", "RN": "261QK3SSBH", "RR": "553-24-2 (Neutral Red)", "PI": "Phenazines (1969-1974)", "MS": "A vital dye used as an indicator and biological stain. Various adverse effects have been observed in biological systems.", "PM": "91; was see under PHENAZINES 1975-90", "HN": "91(75); was see under PHENAZINES 1975-90", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D009499"}, {"RECTYPE": "D", "MH": "Neutralization Tests", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Tests, Neutralization", "MN": "E05.478.594.760.550", "FX": "Antibodies, Neutralizing", "MH_TH": "NLM (1966)", "ST": "T059", "MS": "The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50).", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009500"}, {"RECTYPE": "D", "MH": "Neutron Activation Analysis", "DE": "NEUTRON ACTIVATION ANAL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Neutron Activation Analyses", "MN": "E05.196.039.564", "MH_TH": "NLM (1975)", "ST": "T059", "AN": "usually NIM", "MS": "Activation analysis in which the specimen is bombarded with neutrons. Identification is made by measuring the resulting radioisotopes. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "OL": "search ACTIVATION ANALYSIS 1967-74", "PM": "91; was see under ACTIVATION ANALYSIS 1975-90", "HN": "91(75); was see under ACTIVATION ANALYSIS 1975-90", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009501"}, {"RECTYPE": "D", "MH": "Neutrons", "AQ": "AE CL HI TU", "ENTRY": "Neutron", "MN": "G01.249.660.250", "MH_TH": "NLM (1966)", "ST": "T081", "AN": "elementary particles; IM; FAST NEUTRONS is available", "MS": "Electrically neutral elementary particles found in all atomic nuclei except light hydrogen; the mass is equal to that of the proton and electron combined and they are unstable when isolated from the nucleus, undergoing beta decay. Slow, thermal, epithermal, and fast neutrons refer to the energy levels with which the neutrons are ejected from heavier nuclei during their decay.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009502"}, {"RECTYPE": "D", "MH": "Neutropenia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neutropenias", "MN": "C15.378.553.546.184.564", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "A decrease in the number of NEUTROPHILS found in the blood.", "OL": "search AGRANULOCYTOSIS 1966-74", "PM": "91; was see under AGRANULOCYTOSIS 1975-90", "HN": "91(75); was see under AGRANULOCYTOSIS 1975-90", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009503"}, {"RECTYPE": "D", "MH": "Neutrophils", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Polymorphonuclear Neutrophils|T025|NON|EQV|NLM (2022)|201125|abcdef", "ENTRY": "Polymorphonuclear Neutrophil", "MN": "A15.382.680.689", "FX": "Extracellular Traps", "MH_TH": "NLM (1965)", "ST": "T025", "MS": "Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.", "PM": "65; LE CELLS was heading 1965-95", "HN": "65; LE CELLS was heading 1963-95 (Prov 1963-64)", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009504"}, {"RECTYPE": "D", "MH": "Nevada", "AQ": "EH EP", "MN": "Z01.107.567.875.760.550", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Oregon and Idaho, on the east by Utah, on the south and west by California.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009505"}, {"RECTYPE": "D", "MH": "Nevus", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Skin Mole|T191|NON|EQV|NLM (2007)|060126|abcdef", "ENTRY": "Skin Moles|T191|NON|EQV|NLM (2010)|080806|abcdef", "MN": "C04.557.665.560", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with SKIN NEOPLASMS (IM) + site (IM or NIM) if relevant; general; note many specific nevus terms", "MS": "A circumscribed stable malformation of the skin and occasionally of the oral mucosa, which is not due to external causes and therefore presumed to be of hereditary origin.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009506"}, {"RECTYPE": "D", "MH": "Nevus of Ota", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Ota's Nevus|T191|EPO|EQV|UNK (19XX)|860418|abcdef", "ENTRY": "Otas Nevus", "MN": "C04.557.665.560.615.585", "MH_TH": "NLM (1987)", "ST": "T191", "AN": "coordinate with SKIN NEOPLASMS + site if relevant", "PI": "Nevus, Pigmented (1966-1986)", "MS": "A macular lesion on the side of the FACE, involving the CONJUNCTIVA and EYELIDS, as well as the adjacent facial skin, SCLERA; OCULOMOTOR MUSCLES; and PERIOSTEUM. Histological features vary from those of a MONGOLIAN SPOT to those of a BLUE NEVUS.", "PM": "91; was see under NEVUS, PIGMENTED 1987-90", "HN": "91(87); was see under NEVUS, PIGMENTED 1987-90", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19860418", "DC": "1", "DX": "19910101", "UI": "D009507"}, {"RECTYPE": "D", "MH": "Nevus, Pigmented", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Nevus, Melanocytic|T191|NON|EQV|NLM (1994)|930326|abcdef", "ENTRY": "Pigmented Nevus", "MN": "C04.557.665.560.615", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with SKIN NEOPLASMS + site if relevant", "MS": "A nevus containing melanin. The term is usually restricted to nevocytic nevi (round or oval collections of melanin-containing nevus cells occurring at the dermoepidermal junction of the skin or in the dermis proper) or moles, but may be applied to other pigmented nevi.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009508"}, {"RECTYPE": "D", "MH": "New Brunswick", "AQ": "EH EP", "MN": "Z01.107.567.176.494", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a province of eastern Canada", "MS": "A province of eastern Canada, one of the Maritime Provinces with NOVA SCOTIA; PRINCE EDWARD ISLAND; and sometimes NEWFOUNDLAND AND LABRADOR. Its capital is Fredericton. It was named in honor of King George III, of the House of Hanover, also called Brunswick. (From Webster's New Geographical Dictionary, 1988, p828 & Room, Brewer's Dictionary of Names, 1992, p375)", "MR": "20070711", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009509"}, {"RECTYPE": "D", "MH": "New Caledonia", "AQ": "EH EP", "MN": "Z01.639.760.590.620", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island group in Melanesia", "MS": "A group of islands in Melanesia constituting a French overseas territory. The group includes New Caledonia (the main island), Ile des Pins, Loyalty Island, and several other islet groups. The capital is Noumea. It was discovered by Captain Cook in 1774 and visited by various navigators, explorers, and traders from 1792 to 1840. Occupied by the French in 1853, it was set up as a penal colony 1864-94. In 1946 it was made a French overseas territory. It was named by Captain Cook with the 5th and 6th century A.D. Latin name for Scotland, Caledonia. (From Webster's New Geographical Dictionary, 1988, p830 & Room, Brewer's Dictionary of Names, 1992, p375)", "HN": "75", "MR": "20120703", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D009510"}, {"RECTYPE": "D", "MH": "New England", "AQ": "EH EP", "PRINT ENTRY": "Northeastern United States|T083|NAM|EQV|NLM (1990)|890330|abcdef", "MN": "Z01.107.567.875.550", "MH_TH": "NLM (1975)", "ST": "T083", "AN": "index specific states as needed but use NEW ENGLAND when text uses the term & when the region is the intent of the author; CATALOGER: Use for 4 or more states", "MS": "The geographic area of New England in general and when the specific state or states are not indicated. States usually included in this region are Maine, New Hampshire, Vermont, Massachusetts, Connecticut, and Rhode Island.", "HN": "75", "MR": "20150605", "DA": "19990101", "DC": "4", "DX": "19750101", "UI": "D009511"}, {"RECTYPE": "D", "MH": "New Guinea", "AQ": "EH EP", "MN": "Z01.586.650", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "East New Guinea is a part of Papua New Guinea & West New Guinea is part of Indonesia", "MS": "Originally an island of the Malay Archipelago, the second largest island in the world. It divided, West New Guinea becoming part of Indonesia and East New Guinea becoming Papua New Guinea.", "MR": "19930422", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009512"}, {"RECTYPE": "D", "MH": "New Hampshire", "AQ": "EH EP", "MN": "Z01.107.567.875.550.580", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Canada, on the east by Maine, on the west by Vermont, and on the south by Massachusetts.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009513"}, {"RECTYPE": "D", "MH": "Vanuatu", "AQ": "EH EP", "PRINT ENTRY": "New Hebrides|T083|NAM|EQV|NLM (1990)|890215|abcdef", "MN": "Z01.639.760.590.736", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "an island group in Melanesia; entry term NEW HEBRIDES was its former name", "MS": "A republic consisting of an island group in Melanesia, in the southwest Pacific Ocean. Its capital is Port-Vila. It was called New Hebrides until 1980. It was discovered in 1606 by the Portuguese, forgotten for 160 years, then visited by Bougainville in 1768 and Captain Cook in 1774. It was under joint British and French administration from 1906 until it became independent in 1980 under the name of Vanuatu. The name is native, meaning our land. (From Webster's New Geographical Dictionary, 1988, p833 & Room, Brewer's Dictionary of Names, 1992, p570)", "OL": "use VANUATU to search NEW HEBRIDES 1975-89", "HN": "90; was NEW HEBRIDES 1975-89", "MR": "20120703", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D009514"}, {"RECTYPE": "D", "MH": "New Jersey", "AQ": "EH EP", "MN": "Z01.107.567.875.500.525", "MH_TH": "NLM (1998)", "ST": "T083", "MS": "State bounded on the north by New York and Pennsylvania, on the east by New York and the Atlantic Ocean, on the south by Delaware Bay, and on the west by Pennsylvania.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009515"}, {"RECTYPE": "D", "MH": "New Mexico", "AQ": "EH EP", "MN": "Z01.107.567.875.760.560", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Colorado, on the east by Oklahoma and Texas, on the south by Texas and Mexico, and on the west by Arizona.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009516"}, {"RECTYPE": "D", "MH": "New South Wales", "AQ": "EH EP", "MN": "Z01.678.100.373.750", "MH_TH": "NLM (1988)", "ST": "T083", "AN": "a state of Australia", "PI": "Australia (1966-1987)", "MS": "A state in southeastern Australia. Its capital is Sydney. It was discovered by Captain Cook in 1770 and first settled at Botany Bay by marines and convicts in 1788. It was named by Captain Cook who thought its coastline resembled that of South Wales. (From Webster's New Geographical Dictionary, 1988, p840 & Room, Brewer's Dictionary of Names, 1992, p377)", "HN": "88", "MR": "20150623", "DA": "19870314", "DC": "4", "DX": "19880101", "UI": "D009517"}, {"RECTYPE": "D", "MH": "New York", "AQ": "EH EP", "MN": "Z01.107.567.875.500.530", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "NEW YORK CITY is also available", "MS": "State bounded on the north by Lake Ontario and Canada, on the east by Vermont, Massachusetts, and Connecticut, on the south by the Atlantic Ocean, New Jersey, and Pennsylvania, and on the west by Pennsylvania, Lake Erie, and Canada.", "MR": "20160628", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009518"}, {"RECTYPE": "D", "MH": "New York City", "AQ": "EH EP", "MN": "Z01.433.741", "MH_TH": "NLM (1998)", "ST": "T083", "MS": "City located at the mouth of the Hudson River, in New York State.", "MR": "20160628", "DA": "19750324", "DC": "4", "DX": "19700101", "UI": "D009519"}, {"RECTYPE": "D", "MH": "New Zealand", "AQ": "EH EP", "MN": "Z01.678.100.747", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "Maori are Polynesians native to New Zealand; Australasia refers to Australia, New Zealand or both: check text", "MS": "A group of islands in the southwest Pacific. Its capital is Wellington. It was discovered by the Dutch explorer Abel Tasman in 1642 and circumnavigated by Cook in 1769. Colonized in 1840 by the New Zealand Company, it became a British crown colony in 1840 until 1907 when colonial status was terminated. New Zealand is a partly anglicized form of the original Dutch name Nieuw Zeeland, new sea land, possibly with reference to the Dutch province of Zeeland. (From Webster's New Geographical Dictionary, 1988, p842 & Room, Brewer's Dictionary of Names, 1992, p378)", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009520"}, {"RECTYPE": "D", "MH": "Newcastle Disease", "DE": "NEWCASTLE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Disease, Newcastle", "MN": "C22.131.630", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "don't forget also BIRDS (NIM) or POULTRY (NIM) or specific bird or fowl (IM) & check tag ANIMALS", "MS": "An acute febrile, contagious, viral disease of birds caused by an AVULAVIRUS called NEWCASTLE DISEASE VIRUS. It is characterized by respiratory and nervous symptoms in fowl and is transmissible to man causing a severe, but transient conjunctivitis.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009521"}, {"RECTYPE": "D", "MH": "Newcastle disease virus", "DE": "NEWCASTLE DIS VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Paramyxovirus 1, Avian|T005|NON|EQV|NLM (1994)|930209|PARAMYXOVIRUS AVIAN 01|abcdefs", "MN": "B04.820.480.937.600.650.070.600", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid11176", "MS": "The most well known avian paramyxovirus in the genus AVULAVIRUS and the cause of a highly infectious pneumoencephalitis in fowl. It is also reported to cause CONJUNCTIVITIS in humans. Transmission is by droplet inhalation or ingestion of contaminated water or food.", "OL": "use NEWCASTLE DISEASE VIRUS to search AVIAN PARAMYXOVIRUS TYPE 1 1994-96 & PARAMYXOVIRUS TYPE 1, AVIAN 1994-96", "PM": "63; AVIAN PARAMYXOVIRUS 1 was AVIAN PARAMYXOVIRUS TYPE 1 1994-96; PARAMYXOVIRUS 1, AVIAN was PARAMYXOVIRUS TYPE 1, AVIAN 1994-96", "HN": "63; AVIAN PARAMYXOVIRUS 1 was AVIAN PARAMYXOVIRUS TYPE 1 1994-96; PARAMYXOVIRUS 1, AVIAN was PARAMYXOVIRUS TYPE 1, AVIAN 1994-96", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D009522"}, {"RECTYPE": "D", "MH": "Newfoundland and Labrador", "AQ": "EH EP", "PRINT ENTRY": "Labrador|T083|NAM|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Newfoundland|T083|NAM|NRW|NLM (1966)|990101|abcdef", "MN": "Z01.107.567.176.540", "MH_TH": "NLM (2008)", "ST": "T083", "MS": "Province of Canada consisting of the island of Newfoundland and an area of Labrador. Its capital is St. John's.", "MR": "20070709", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009523"}, {"RECTYPE": "D", "MH": "Newspapers as Topic", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Topics, Newspapers as", "MN": "L01.462.500.682.829.481", "MH_TH": "NLM (2016)", "ST": "T170", "AN": "medical newspapers: do not coordinate with MEDICINE; do not confuse with NEWSLETTERS see PERIODICALS AS TOPIC; do not confuse with Publication Types NEWS or NEWSPAPER ARTICLE", "MS": "Publications printed and distributed daily, weekly, or at some other regular and usually short interval, containing news, articles of opinion (as editorials and letters), features, advertising, and announcements of current interest. (Webster's 3d ed)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009524"}, {"RECTYPE": "D", "MH": "Niacin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nicotinic Acid|T109|T127|NON|EQV|BAN (19XX)|FDA SRS (2015)|INN (19XX)|UNK (19XX)|USAN (19XX)|820506|abbcdeeeeef", "ENTRY": "Tosylate, Niacin", "MN": "D03.383.725.547.475", "PA": "Vitamin B Complex", "MH_TH": "USP (19XX)", "ST": "T127", "N1": "3-Pyridinecarboxylic acid", "RN": "2679MF687A", "RR": "99148-57-9 (tosylate)", "AN": "/defic: consider also PELLAGRA; /ther use: coordinate with disease term with either /drug ther or /diet ther depending on whether niacin is discussed as a drug or a dietary supplement", "PI": "Nicotinic Acids (1966-1982)", "MS": "A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.", "OL": "search NICOTINIC ACIDS 1966-82", "PM": "83; was see NICOTINIC ACIDS 1975-82 & NICOTINIC ACID 1963-74", "HN": "83; was see NICOTINIC ACIDS 1975-82 & NICOTINIC ACID 1963-74", "MR": "20160531", "DA": "19820506", "DC": "1", "DX": "19830101", "UI": "D009525"}, {"RECTYPE": "D", "MH": "Nialamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.725.394.628", "PA": "Monoamine Oxidase Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "4-Pyridinecarboxylic acid, 2-(3-oxo-3-((phenylmethyl)amino)propyl)hydrazide", "RN": "T2Q0RYM725", "RR": "51-12-7 (Nialamide)", "MS": "An MAO inhibitor that is used as an antidepressive agent.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009526"}, {"RECTYPE": "D", "MH": "Nicaragua", "AQ": "EH EP", "MN": "Z01.107.169.690", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in CENTRAL AMERICA, bordering both the Caribbean Sea and the North Pacific Ocean, between COSTA RICA and HONDURAS.", "MR": "20151124", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009527"}, {"RECTYPE": "D", "MH": "Nicarbazin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nicarbazine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D03.383.742.470", "PA": "Coccidiostats", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Urea, N,N'-bis(4-nitrophenyl)-, compd. with 4,6-dimethyl-2(1H)-pyrimidinone (1:1)", "RN": "11P9NUA12U", "RR": "330-95-0 (Nicarbazin)", "PI": "Pyrimidines (1969-1974)", "MS": "An equimolar complex of 4,4'-Dinitrocarbanilide and 2-Hydroxy-4,6-dimethylpyrimidine. A coccidiostat for poultry.", "PM": "91; was see under CARBANILIDES 1975-90", "HN": "91(75); was see under CARBANILIDES 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009528"}, {"RECTYPE": "D", "MH": "Nicardipine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Y93", "MN": "D03.383.725.203.510", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester", "RN": "CZ5312222S", "RR": "K5BC5011K3", "PI": "Pyridines (1966-1974)", "MS": "A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.", "PM": "87", "HN": "87", "MR": "20170524", "DA": "19860602", "DC": "1", "DX": "19870101", "UI": "D009529"}, {"RECTYPE": "D", "MH": "Nicergoline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nimergoline|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Von Ct, Nicergolin", "MN": "D03.633.400.439.730", "PA": "Vasodilator Agents", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, 5-bromo-3-pyridinecarboxylate (ester), (8beta)-", "RN": "JCV8365FWN", "RR": "27848-84-6 (Nicergoline)", "PI": "Nicotinic Acids (1972-1974)", "MS": "An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It may ameliorate cognitive deficits in CEREBROVASCULAR DISORDERS.", "PM": "91; was see under ERGOLINES 1975-90", "HN": "91(75); was see under ERGOLINES 1975-90", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D009530"}, {"RECTYPE": "D", "MH": "Niceritrol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pentaerythritol Tetranicotinate|T109|T121|NON|EQV|UNK (19XX)|760412|abbcdef", "ENTRY": "Tetranicotinate, Pentaerythritol", "MN": "D03.383.725.547.540", "PA": "Hypolipidemic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "3-Pyridinecarboxylic acid, 2,2-bis(((3-pyridinylcarbonyl)oxy)methyl)-1,3-propanediyl ester", "RN": "F54EHJ34MV", "RR": "5868-05-3 (Niceritrol)", "PI": "Propanediols (1971-1976)", "MS": "An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.", "PM": "91; was see under NICOTINIC ACIDS 1977-90", "HN": "91(77); was see under NICOTINIC ACIDS 1977-90", "MR": "20160531", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D009531"}, {"RECTYPE": "D", "MH": "Nickel", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.607", "PA": "Trace Elements", "MH_TH": "POPLINE (1978)", "ST": "T196", "N1": "Nickel", "RN": "7OV03QG267", "RR": "7440-02-0 (Nickel)", "MS": "A trace element with the atomic symbol Ni, atomic number 28, and atomic weight 58.69. It is a cofactor of the enzyme UREASE.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009532"}, {"RECTYPE": "D", "MH": "Niclofolan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Menichlopholan|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Niclofan|T109|T121|NON|EQV|UNK (19XX)|800319|abbcdef", "MN": "D02.640.743.600", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "(1,1'-Biphenyl)-2,2'-diol, 5,5'-dichloro-3,3'-dinitro-", "RN": "82KFT81F6W", "RR": "10331-57-4 (Niclofolan)", "PI": "Nitrophenols (1972-1974)", "MS": "Proposed fasciolacide. Synonyms: Dertil; Bilevon; Bay 9015.", "PM": "91; was see under NITROPHENOLS 1975-90", "HN": "91(75); was see under NITROPHENOLS 1975-90", "MR": "20160628", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009533"}, {"RECTYPE": "D", "MH": "Niclosamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Yomesan|T109|T121|T131|TRD|NRW|AU|DE|NL|951127|abbbcdeeef", "MN": "D02.092.146.113.860.470", "PA": "Molluscacides", "MH_TH": "USAN (1966)", "ST": "T131", "N1": "Benzamide, 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxy-", "RN": "8KK8CQ2K8G", "RR": "QT8YUD1Z0W", "MS": "An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)", "OL": "use NICLOSAMIDE to search YOMESAN 1966-77 (as Prov 1966-72)", "PM": "78; was YOMESAN 1973-77; YOMESAN was see NICLOSAMIDE 1978-96; CLONITRALIDE was indexed under NICLOSAMIDE/analogs & derivatives 1983-96 & ETHANOLAMINES 1975-82", "HN": "78; was YOMESAN 1963-77 (Prov 1963-72); YOMESAN was see NICLOSAMIDE 1978-96; CLONITRALIDE was (NM) 1975-96", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009534"}, {"RECTYPE": "D", "MH": "Nicotinamidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nicotinamide Deamidase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Deamidase, Nicotinamide", "MN": "D08.811.277.087.610", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Nicotinamide amidohydrolase", "RN": "EC 3.5.1.19", "PI": "Nicotinamide (1972-1974)", "MS": "An enzyme that catalyzes the hydrolysis of nicotinamide to nicotinate and ammonia. EC 3.5.1.19.", "PM": "91; was see under AMIDOHYDROLASES 1975-90", "HN": "91(75); was see under AMIDOHYDROLASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009535"}, {"RECTYPE": "D", "MH": "Niacinamide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitamin PP|T109|T121|T127|EQV|UNK (19XX)|740330|abbbdef", "ENTRY": "Jenapharm, Nicotins\u00e4ureamid", "MN": "D03.383.725.547.530", "PA": "Vitamin B Complex", "MH_TH": "USP (19XX)", "ST": "T127", "N1": "3-Pyridinecarboxamide", "RN": "25X51I8RD4", "RR": "98-92-0 (Niacinamide)", "AN": "/defic: consider also PELLAGRA; /ther use: coordinate disease with /drug ther, not /diet ther", "MS": "An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake.", "OL": "use NIACINAMIDE to search NICOTINAMIDE 1966-92", "PM": "93; was NICOTINAMIDE 1963-92; NIACINAMIDE was see NICOTINAMIDE 1963-92", "HN": "93; was NICOTINAMIDE 1963-92; NIACINAMIDE was see NICOTINAMIDE 1963-92", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D009536"}, {"RECTYPE": "D", "MH": "Nicotinamide Mononucleotide", "DE": "NMN", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Mononucleotide, Nicotinamide", "MN": "D13.695.827.648", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "Pyridinium, 3-(aminocarbonyl)-1-(5-O-phosphono-beta-D-ribofuranosyl)-, inner salt", "RN": "1094-61-7", "PI": "Ribonucleotides (1966-1972)", "MS": "3-Carbamoyl-1-beta-D-ribofuranosyl pyridinium hydroxide-5'phosphate, inner salt. A nucleotide in which the nitrogenous base, nicotinamide, is in beta-N-glycosidic linkage with the C-1 position of D-ribose. Synonyms: Nicotinamide Ribonucleotide; NMN.", "PM": "77", "HN": "77(72)", "MR": "19900530", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D009537"}, {"RECTYPE": "D", "MH": "Nicotine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nicotine Tartrate|T109|T121|T131|NON|NRW|UNK (19XX)|840213|abbbcdef", "MN": "D03.383.725.518", "PA": "Nicotinic Agonists", "MH_TH": "USAN (19XX)", "ST": "T131", "N1": "Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)-", "RN": "6M3C89ZY6R", "RR": "R7M676M8YV", "MS": "Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.", "MR": "20180410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009538"}, {"RECTYPE": "D", "MH": "Nicotinic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Nicotinic", "MN": "D03.383.725.547", "PA": "Vitamin B Complex", "MH_TH": "NLM (1966)", "ST": "T127", "RN": "0", "AN": "/defic: consider also PELLAGRA; /ther use: coordinate disease with /drug ther, not /diet ther", "MS": "2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative (NIACIN) is active as a vitamin.", "OL": "use NICOTINIC ACIDS to search NICOTINIC ACID 1966-74", "PM": "75; was NICOTINIC ACID 1963-74", "HN": "75; was NICOTINIC ACID 1963-74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D009539"}, {"RECTYPE": "D", "MH": "Nicotinyl Alcohol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyridylcarbinol|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "beta Pyridylcarbinol", "MN": "D03.383.725.565", "PA": "Vasodilator Agents", "MH_TH": "USAN (1961)", "ST": "T121", "N1": "3-Pyridinemethanol", "RN": "9TF312056Y", "RR": "100-55-0 (Nicotinyl Alcohol)", "PI": "Pyridines (1969-1974)", "MS": "Alcohol analog of NICOTINIC ACID which is a direct-acting peripheral vasodilator that causes flushing and may decrease blood pressure. It is used in vasospasm and threatened GANGRENE.", "PM": "91; was see under PYRIDINES 1975-90", "HN": "91(75); was see under PYRIDINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009540"}, {"RECTYPE": "D", "MH": "Nictitating Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Third Eyelid|T023|NON|EQV|NLM (1998)|960729|abcdef", "ENTRY": "Third Eyelids", "MN": "A13.660", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "ptosis of entry term THIRD EYELID: coord IM with EYELID DISEASES /vet (IM), not BLEPHAROPTOSIS", "MS": "A fold of the mucous membrane of the CONJUNCTIVA in many animals. At rest, it is hidden in the medial canthus. It can extend to cover part or all of the cornea to help clean the CORNEA.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009541"}, {"RECTYPE": "D", "MH": "Niemann-Pick Diseases", "DE": "NIEMANN PICK DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Niemann-Pick Disease|T047|EPO|EQV|GHR (2014)|NLM (1966)|ORD (2010)|990101|abcdeeef", "ENTRY": "Sphingomyelinase Deficiency, Acid", "MN": "C18.452.648.595.554.825.700", "FX": "Sphingomyelin Phosphodiesterase", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "note specific types are available", "MS": "A group of autosomal recessive disorders in which harmful quantities of lipids accumulate in the viscera and the central nervous system. They can be caused by deficiencies of enzyme activities (SPHINGOMYELIN PHOSPHODIESTERASE) or defects in intracellular transport, resulting in the accumulation of SPHINGOMYELINS and CHOLESTEROL. There are various subtypes based on their clinical and genetic differences.", "PM": "2000; see NIEMANN-PICK DISEASE 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D009542"}, {"RECTYPE": "D", "MH": "Nifedipine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nifedipine GTIS", "MN": "D03.383.725.203.540", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, dimethyl ester", "RN": "I9ZF7L6G2L", "RR": "60299-11-8", "PI": "Pyridines (1972-1974)", "MS": "A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.", "PM": "84; was see under PYRIDINES 1975-83", "HN": "84(75); was see under PYRIDINES 1975-83", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19840101", "UI": "D009543"}, {"RECTYPE": "D", "MH": "Niflumic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Niflumic", "MN": "D03.383.725.547.550", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "3-Pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)-", "RN": "4U5MP5IUD8", "RR": "4394-00-7 (Niflumic Acid)", "PI": "Nicotinic Acids (1968-1974)", "MS": "An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.", "PM": "91; was see under NICOTINIC ACIDS 1975-90", "HN": "91(75); was see under NICOTINIC ACIDS 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009544"}, {"RECTYPE": "D", "MH": "Nifuratel", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiodinon|T109|T121|NON|EQV|UNK (19XX)|750716|abbcdef", "ENTRY": "Metilmercadon|T109|T121|NON|EQV|UNK (19XX)|750716|abbcdef", "MN": "D03.383.312.649.410", "PA": "Antitrichomonal Agents", "MH_TH": "USAN (1967)", "ST": "T121", "N1": "2-Oxazolidinone, 5-((methylthio)methyl)-3-(((5-nitro-2-furanyl)methylene)amino)-", "RN": "U60U6P08SP", "RR": "4936-47-4 (Nifuratel)", "PI": "Sulfides (1972-1975)", "MS": "Local antiprotozoal and antifungal agent that may also be given orally.", "PM": "91; was see under NITROFURANS 1976-90", "HN": "91(76); was see under NITROFURANS 1976-90", "MR": "20170524", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D009545"}, {"RECTYPE": "D", "MH": "Nifurtimox", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Lampit|T109|T121|TRD|NRW|UNK (19XX)|800730|abbcdef", "MN": "D03.383.855.400", "PA": "Trypanocidal Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "4-Thiomorpholinamine, 3-methyl-N-((5-nitro-2-furanyl)methylene)-, 1,1-dioxide", "RN": "M84I3K7C2O", "RR": "23256-30-6 (Nifurtimox)", "PI": "Thiazines (1973-1974)", "MS": "A nitrofuran thiazine that has been used against TRYPANOSOMIASIS.", "PM": "91; was see under NITROFURANS 1975-90", "HN": "91(75); was see under NITROFURANS 1975-90", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009547"}, {"RECTYPE": "D", "MH": "Niger", "AQ": "EH EP", "ENTRY": "Republic of Niger|T083|NAM|EQV|NLM (2009)|080701|abcdef", "MN": "Z01.058.290.190.560", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in western Africa, north of NIGERIA and west of CHAD. Its capital is Niamey.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009548"}, {"RECTYPE": "D", "MH": "Nigeria", "AQ": "EH EP", "ENTRY": "Federal Republic of Nigeria|T083|NAM|EQV|NLM (2009)|080401|abcdef", "MN": "Z01.058.290.190.565", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "do not confuse with NIGER, another western Africa republic to its north; Biafra goes here", "MS": "A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009549"}, {"RECTYPE": "D", "MH": "Nigericin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pandavir|T109|T195|TRD|NRW|NLM (1998)|961127|abbcdef", "MN": "D04.345.674.625.750", "PA": "Ionophores", "MH_TH": "NLM (1975)", "ST": "T195", "N1": "Nigericin", "RN": "RRU6GY95IS", "RR": "28380-24-7 (Nigericin)", "PI": "Carboxylic Acids (1973-1974)", "MS": "A polyether antibiotic which affects ion transport and ATPase activity in mitochondria. It is produced by Streptomyces hygroscopicus. (From Merck Index, 11th ed)", "PM": "91; was see under ANTIBIOTICS 1975-90", "HN": "91(75); was see under ANTIBIOTICS 1975-90", "MR": "20230226", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009550"}, {"RECTYPE": "D", "MH": "Night Care", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "ENTRY": "Night Cares", "MN": "N02.421.585.564", "FX": "After-Hours Care", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "institutional care only", "MS": "Institutional night care of patients.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009551"}, {"RECTYPE": "D", "MH": "Nikethamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nizethamid|T109|T121|NON|EQV|UNK (19XX)|770428|abbcdef", "ENTRY": "Diethylamide, Nicotinic", "MN": "D03.383.725.547.530.500", "PA": "Convulsants", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "3-Pyridinecarboxamide, N,N-diethyl-", "RN": "368IVD6M32", "RR": "59-26-7 (Nikethamide)", "MS": "A central nervous system stimulant. It was formerly used in the treatment of barbiturate overdose but is now considered to be of no value for such purposes and may be dangerous. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1229)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009552"}, {"RECTYPE": "D", "MH": "Nimodipine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "e 9736, Bay", "MN": "D03.383.725.547.570", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester", "RN": "57WA9QZ5WH", "RR": "66085-59-4 (Nimodipine)", "PI": "Nicotinic Acids (1966-1986)", "MS": "A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.", "PM": "87; NIMODIPINE was indexed under NICOTINIC ACIDS 1981-86", "HN": "87; use NIMODIPINE (NM) 1981-86", "MR": "20170524", "DA": "19860603", "DC": "1", "DX": "19870101", "UI": "D009553"}, {"RECTYPE": "D", "MH": "Nimorazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrimidazine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "K1900", "MN": "D03.383.129.308.658.580", "PA": "Antitrichomonal Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Morpholine, 4-(2-(5-nitro-1H-imidazol-1-yl)ethyl)-", "RN": "469ULX0H4G", "RR": "6506-37-2 (Nimorazole)", "PI": "Nitroimidazoles (1974)", "MS": "An antitrichomonal agent which is effective either topically or orally and whose urinary metabolites are also trichomonicidal.", "PM": "91; was see under NITROIMIDAZOLES 1975-90", "HN": "91(75); was see under NITROIMIDAZOLES 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009554"}, {"RECTYPE": "D", "MH": "Ninhydrin", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Indantrione Monohydrate|T109|T121|T130|NON|EQV|UNK (19XX)|800401|abbbcdef", "ENTRY": "Monohydrate, Indantrione", "MN": "D04.615.486.487.500", "PA": "Radiation-Sensitizing Agents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "1H-Indene-1,3(2H)-dione, 2,2-dihydroxy-", "RN": "HCL6S9K23A", "RR": "485-47-2 (Ninhydrin)", "MS": "2,2-Dihydroxy-1H-indene-1,3-(2H)-dione. Reagent toxic to skin and mucus membranes. It is used in chemical assay for peptide bonds, i.e., protein determinations and has radiosensitizing properties.", "OL": "search INDICATORS AND REAGENTS 1966-74", "PM": "91; was see under INDENES 1975-90; was see under INDICATORS AND REAGENTS 1963-74", "HN": "91(75); was see under INDENES 1975-90; was see under INDICATORS AND REAGENTS 1963-74", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009555"}, {"RECTYPE": "D", "MH": "Niobium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Niobium 93", "MN": "D01.552.544.615", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Niobium", "RN": "05175J654G", "RR": "7440-03-1 (Niobium)", "AN": "synonym: Columbium (Cb)", "MS": "A metal element atomic number 41, atomic weight 92.906, symbol Nb.", "MR": "20170704", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009556"}, {"RECTYPE": "D", "MH": "Nipecotic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Nipecotic", "MN": "D03.383.621.566", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009557"}, {"RECTYPE": "D", "MH": "Nipples", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nipple", "MN": "A01.236.500", "FX": "Nipple Aspirate Fluid", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "human & animal, male & female; for cow nipples, use UDDER; for teat, use UDDER; diseases: coordinate with BREAST DISEASES", "MS": "The conic organs which usually give outlet to milk from the mammary glands.", "PM": "91; was see under BREAST 1975-90", "HN": "91(75); was see under BREAST 1975-90", "MR": "20160615", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D009558"}, {"RECTYPE": "D", "MH": "Nippostrongylus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Rat Nematode|T204|NON|NRW|UNK (19XX)|741205|abcdef", "ENTRY": "Rat Nematodes", "MN": "B01.050.500.500.294.400.968.400.575", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid27834", "AN": "a genus of nematodes; infection: coord IM with STRONGYLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Ancylostomatoidea (1966-1974)", "MS": "A genus of intestinal nematode parasites belonging to the superfamily HELIGMOSOMATOIDEA, which commonly occurs in rats but has been experimentally transmitted to other rodents and rabbits. Infection is usually through the skin.", "PM": "79; was see under HOOKWORMS 1975-78", "HN": "79(75); was see under HOOKWORMS 1975-78", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19790101", "UI": "D009559"}, {"RECTYPE": "D", "MH": "Niridazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "BA, CIBA 32.644", "MN": "D03.383.129.708.482", "PA": "Schistosomicides", "MH_TH": "USAN (1968)", "ST": "T121", "N1": "2-Imidazolidinone, 1-(5-nitro-2-thiazolyl)-", "RN": "N116U8Y5QQ", "RR": "61-57-4 (Niridazole)", "PI": "Thiazoles (1966-1971)", "MS": "An antischistosomal agent that has become obsolete.", "PM": "73", "HN": "73(72)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009560"}, {"RECTYPE": "D", "MH": "Nisin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D12.776.543.695.110.700", "PA": "Food Preservatives", "MH_TH": "NLM (1973)", "ST": "T121", "RN": "1414-45-5", "PI": "Antibiotics (1966-1972)", "MS": "A 34-amino acid polypeptide antibiotic produced by Streptococcus lactis. It has been used as a food preservative in canned fruits and vegetables, and cheese.", "PM": "73", "HN": "73", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009561"}, {"RECTYPE": "D", "MH": "Nissl Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Nissl Granules|T026|NON|EQV|NLM (2001)|000210|abcdef", "ENTRY": "Nissl Granule", "MN": "A11.671.693", "MH_TH": "NLM (1964)", "ST": "T026", "MS": "Subcellular structures found in nerve cell bodies and DENDRITES. They consist of granular endoplasmic reticulum (ENDOPLASMIC RETICULUM, ROUGH) and RIBOSOMES.", "OL": "use NISSL BODIES to search CHROMATIN, NERVE 1973-94", "PM": "65; CHROMATIN, NERVE was see NISSL BODIES 1973-94", "HN": "65(64); CHROMATIN, NERVE was see NISSL BODIES 1973-94", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009562"}, {"RECTYPE": "D", "MH": "Nitracrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "C283", "MN": "D03.633.300.046.250.650", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1,3-Propanediamine, N,N-dimethyl-N'-(1-nitro-9-acridinyl)-", "RN": "712MLZ30SB", "RR": "4533-39-5 (Nitracrine)", "PI": "Nitro Compounds (1972-1974)", "MS": "Acridine antineoplastic agent used in mammary and ovarian tumors. It inhibits RNA synthesis.", "OL": "use NITRACRINE to search C 283 1975-84", "PM": "91; was see under AMINOACRIDINES 1985-90; was C 283 see under AMINOACRIDINES 1981-84; was C 283 see under ACRIDINES 1975-80", "HN": "91(85); was see under AMINOACRIDINES 1985-90; was C 283 see under AMINOACRIDINES 1981-84; was C 283 see under ACRIDINES 1975-80", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009564"}, {"RECTYPE": "D", "MH": "Nitrate Reductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductases, Nitrate", "MN": "D08.811.682.655.500", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 1.7.-", "AN": "general; prefer specifics; do not confuse with NITRITE REDUCTASES", "PI": "Oxidoreductases (1966-1972)", "MS": "Oxidoreductases that are specific for the reduction of NITRATES.", "PM": "74", "HN": "74(73)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009565"}, {"RECTYPE": "D", "MH": "Nitrates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrate|T104|NON|EQV|NLM (2021)|191113|abcdef", "MN": "D02.583", "MH_TH": "NLM (1966)", "ST": "T104", "RN": "0", "AN": "NITRATED COMPOUNDS is also available", "MS": "Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009566"}, {"RECTYPE": "D", "MH": "Nitrazepam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrodiazepam|T109|T121|NON|EQV|UNK (19XX)|761224|abbcdef", "ENTRY": "Rhoxal Nitrazepam", "MN": "D03.633.100.079.080.070.565", "PA": "Hypnotics and Sedatives", "MH_TH": "USAN (1966)", "ST": "T121", "N1": "2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-nitro-5-phenyl-", "RN": "9CLV70W7HS", "RR": "146-22-5 (Nitrazepam)", "PI": "Tranquilizing Agents (1966-1971)", "MS": "A benzodiazepine derivative used as an anticonvulsant and hypnotic.", "PM": "74", "HN": "74(72)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009567"}, {"RECTYPE": "D", "MH": "Nitrendipine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "nitrendipincorax", "MN": "D03.383.725.203.590", "PA": "Vasodilator Agents", "MH_TH": "USAN (1981)", "ST": "T121", "N1": "3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester", "RN": "9B627AW319", "RR": "39562-70-4 (Nitrendipine)", "PI": "Pyridines (1966-1981)", "MS": "A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.", "PM": "87", "HN": "87", "MR": "20170117", "DA": "19860603", "DC": "1", "DX": "19870101", "UI": "D009568"}, {"RECTYPE": "D", "MH": "Nitric Oxide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Vasodilator, Endogenous Nitrate", "MN": "D02.389.508.500", "PA": "Neurotransmitter Agents", "FX": "Nitric Oxide Donors", "MH_TH": "USAN (19XX)", "ST": "T197", "N1": "Nitrogen oxide (NO)", "RN": "31C4KY9ESH", "RR": "10102-43-9 (Nitric Oxide)", "MS": "A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP.", "PM": "1965", "HN": "1965", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009569"}, {"RECTYPE": "D", "MH": "Nitriles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrile|T109|NON|EQV|NLM (2021)|200121|abcdef", "MN": "D02.626", "FX": "Cyanides", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "organic cpds having -CN radical: differentiate from CYANIDES which are inorganic with -CN", "PI": "Cyanides (1966-1967)", "MS": "Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE.", "OL": "use CYANIDES to search NITRILES 1966-67", "PM": "68; was see under CYANIDES 1963-67", "HN": "68; was see under CYANIDES 1963-67", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009570"}, {"RECTYPE": "D", "MH": "Nitrilotriacetic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nitrilotriacetate, Trisodium", "MN": "D02.241.081.018.588", "PA": "Chelating Agents", "MH_TH": "NLM (1973)", "ST": "T130", "N1": "Glycine, N,N-bis(carboxymethyl)-", "RN": "KA90006V9D", "RR": "E3C8R2M0XD", "MS": "A derivative of acetic acid, N(CH2COOH)3. It is a complexing (sequestering) agent that forms stable complexes with Zn2+. (From Miall's Dictionary of Chemistry, 5th ed.)", "PM": "91; was see under ACETIC ACIDS 1973-90", "HN": "91(73); was see under ACETIC ACIDS 1973-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009571"}, {"RECTYPE": "D", "MH": "Nitrite Reductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductases, Nitrite", "MN": "D08.811.682.655.750", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 1.7.-", "AN": "do not confuse with NITRATE REDUCTASES", "PI": "Oxidoreductases (1966-1972)", "MS": "A group of enzymes that oxidize diverse nitrogenous substances to yield nitrite. (Enzyme Nomenclature, 1992) EC 1.", "OL": "use NITRITE REDUCTASES to search NITRITE REDUCTASE 1973-74 (as Prov)", "PM": "91; was see under NADH, NADPH OXIDOREDUCTASES 1975-90; was NITRITE REDUCTASE 1973-74 (Prov)", "HN": "91(75); was see under NADH, NADPH OXIDOREDUCTASES 1975-90; was NITRITE REDUCTASE 1973-74 (Prov)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009572"}, {"RECTYPE": "D", "MH": "Nitrites", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrite|T104|NON|EQV|NLM (2021)|191113|abcdef", "MN": "D02.633", "MH_TH": "NLM (1966)", "ST": "T104", "RN": "0", "MS": "Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009573"}, {"RECTYPE": "D", "MH": "Nitro Compounds", "DE": "NITRO CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nitrated Compounds|T109|NON|NRW|NLM (2007)|060217|abcdef", "MN": "D02.640", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "AN": "do not confuse entry term NITRATED COMPOUNDS with NITRATES", "PI": "specific compound containing nitro group (1971-1974)", "MS": "Compounds having the nitro group, -NO2, attached to carbon. When attached to nitrogen they are nitramines and attached to oxygen they are NITRATES.", "PM": "74", "HN": "74(71)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009574"}, {"RECTYPE": "D", "MH": "Nitroanisole O-Demethylase", "DS": "NITROANISOLE DEMETHYLASE O", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "O-Demethylase, Nitroanisole", "MN": "D08.811.682.670.550", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.-", "PI": "Oxidoreductases (1974)", "MS": "Oxidative enzyme which transforms p-nitroanisole into p-nitrophenol.", "PM": "91; was see under OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under OXIDOREDUCTASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009575"}, {"RECTYPE": "D", "MH": "Nitrobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.035.520", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid911", "MS": "A genus of gram-negative, rod-shaped bacteria that oxidizes nitrites to nitrates. Its organisms occur in aerobic environments where organic matter is being mineralized, including soil, fresh water, and sea water.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009576"}, {"RECTYPE": "D", "MH": "Nitrobenzenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.640.529", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "BENZENE derivatives carrying nitro group substituents.", "MR": "20161101", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009578"}, {"RECTYPE": "D", "MH": "Nitrobenzoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Nitrobenzoic", "MN": "D02.455.426.559.389.127.650", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Benzoates (1968-1974)", "MS": "Benzoic acid or benzoic acid esters substituted with one or more nitro groups.", "PM": "75", "HN": "75", "MR": "20120703", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D009579"}, {"RECTYPE": "D", "MH": "Nitroblue Tetrazolium", "DE": "NITRO BT", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Tetrazolium, Nitroblue", "MN": "D03.383.129.617.700.500", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "2H-Tetrazolium, 3,3'-(3,3'-dimethoxy(1,1'-biphenyl))-4,4'-diyl bis(2-(4-nitrophenyl))-5-phenyl-, dichloride", "RN": "298-83-9", "PI": "Tetrazolium Salts (1972-1974)", "MS": "Colorless to yellow dye that is reducible to blue or black formazan crystals by certain cells; formerly used to distinguish between nonbacterial and bacterial diseases, the latter causing neutrophils to reduce the dye; used to confirm diagnosis of chronic granulomatous disease.", "PM": "91; was see under TETRAZOLIUM SALTS 1975-90", "HN": "91(75); was see under TETRAZOLIUM SALTS 1975-90", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D009580"}, {"RECTYPE": "D", "MH": "Nitrofurans", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.312.649", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Compounds containing FURANS attached to a nitro group.", "MR": "20161129", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009581"}, {"RECTYPE": "D", "MH": "Nitrofurantoin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nitrofurantoin, Monohydrate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1999)|990913|abbcdeef", "MN": "D03.383.312.649.566", "PA": "Anti-Infective Agents, Urinary", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4-Imidazolidinedione, 1-(((5-nitro-2-furanyl)methylene)amino)-", "RN": "927AH8112L", "RR": "E1QI2CQQ1I", "MS": "A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression.", "MR": "20180521", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009582"}, {"RECTYPE": "D", "MH": "Nitrofurazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrofural|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|761224|abbcdeef", "ENTRY": "Nitrofurazone, Calcium (2:1) Salt|T109|T121|NRW|NLM (1999)|990913|abbdef", "MN": "D03.383.312.649.691", "PA": "Anti-Infective Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Hydrazinecarboxamide, 2-((5-nitro-2-furanyl)methylene)-", "RN": "X8XI70B5Z6", "RR": "59-87-0 (Nitrofurazone)", "MS": "A topical anti-infective agent effective against gram-negative and gram-positive bacteria. It is used for superficial WOUNDS AND INJURIES and skin infections. Nitrofurazone has also been administered orally in the treatment of TRYPANOSOMIASIS.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009583"}, {"RECTYPE": "D", "MH": "Nitrogen", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.362.625", "FX": "Nitrogen Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Nitrogen", "RN": "N762921K75", "RR": "7727-37-9 (Nitrogen)", "MS": "An element with the atomic symbol N, atomic number 7, and atomic weight [14.00643; 14.00728]. Nitrogen exists as a diatomic gas and makes up about 78% of the earth's atmosphere by volume. It is a constituent of proteins and nucleic acids and found in all living cells.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009584"}, {"RECTYPE": "D", "MH": "Nitrogen Dioxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Peroxide, Nitrogen", "MN": "D01.650.550.587.625", "PA": "Oxidants, Photochemical", "MH_TH": "NLM (1963)", "ST": "T197", "N1": "Nitrogen oxide (NO2)", "RN": "S7G510RUBH", "RR": "10102-44-0 (Nitrogen Dioxide)", "AN": "a highly poisonous gas", "MS": "Nitrogen oxide (NO2). A highly poisonous gas. Exposure produces inflammation of lungs that may only cause slight pain or pass unnoticed, but resulting edema several days later may cause death. (From Merck, 11th ed) It is a major atmospheric pollutant that is able to absorb UV light that does not reach the earth's surface.", "PM": "65", "HN": "65(63)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009585"}, {"RECTYPE": "D", "MH": "Nitrogen Fixation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Diazotrophy|T040|NON|REL|NLM (2007)|050711|abcdef", "ENTRY": "Fixation, Nitrogen", "MN": "G16.500.768.600", "FX": "Plant Root Nodulation", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "The process in certain BACTERIA; FUNGI; and CYANOBACTERIA converting free atmospheric NITROGEN to biologically usable forms of nitrogen, such as AMMONIA; NITRATES; and amino compounds.", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009586"}, {"RECTYPE": "D", "MH": "Nitrogen Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrogen Isotope|T196|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Isotopes, Nitrogen", "MN": "D01.496.586", "MH_TH": "NLM (1971)", "ST": "T196", "RN": "0", "PI": "Nitrogen (1966-1970)", "MS": "Stable nitrogen atoms that have the same atomic number as the element nitrogen but differ in atomic weight. N-15 is a stable nitrogen isotope.", "PM": "73", "HN": "73(71)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009587"}, {"RECTYPE": "D", "MH": "Nitrogen Mustard Compounds", "DE": "NITROGEN MUSTARD CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Mustard Compounds, Nitrogen", "MN": "D02.455.526.728.650", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "POPLINE (1978)", "ST": "T131", "RN": "0", "AN": "do not confuse with NITROGEN MUSTARD, a specific chemical", "MS": "A group of alkylating agents derived from mustard gas, with the sulfur replaced by nitrogen. They were formerly used as toxicants and vesicants, but now function as antineoplastic agents. These compounds are also powerful mutagens, teratogens, immunosuppressants, and carcinogens.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009588"}, {"RECTYPE": "D", "MH": "Nitrogen Oxides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrogen Oxide|T197|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Oxides, Nitrogen", "MN": "D01.650.550.587", "MH_TH": "NLM (1971)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics; NO equals NITRIC OXIDE; N2O equals NITROUS OXIDE; NO2 equals NITROGEN DIOXIDE", "PI": "Peroxides (1966-1970)", "MS": "Inorganic oxides that contain nitrogen.", "PM": "73", "HN": "73(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009589"}, {"RECTYPE": "D", "MH": "Nitrogen Radioisotopes", "AQ": "AD AE AH AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Nitrogen", "MN": "D01.496.749.615", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1971-1974)", "MS": "Unstable isotopes of nitrogen that decay or disintegrate emitting radiation. N atoms with atomic weights 12, 13, 16, 17, and 18 are radioactive nitrogen isotopes.", "OL": "search NITROGEN ISOTOPES 1971-74 (as Prov 1971-72)", "PM": "75", "HN": "75", "MR": "20170425", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D009590"}, {"RECTYPE": "D", "MH": "Nitrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dinitrogenase|T116|T126|NON|EQV|NLM (1992)|910405|abbcdef", "ENTRY": "Nitrogenase, Vanadium", "MN": "D08.811.682.647", "MH_TH": "NLM (1974)", "ST": "T126", "N1": "Reduced ferredoxin:dinitrogen oxidoreductase (ATP-hydrolysing)", "RN": "EC 1.18.6.1", "MS": "An enzyme system that catalyzes the fixing of nitrogen in soil bacteria and blue-green algae (CYANOBACTERIA). EC 1.18.6.1.", "PM": "74", "HN": "74", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009591"}, {"RECTYPE": "D", "MH": "Nitrohydroxyiodophenylacetate", "AQ": "AA AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "NIP-Hapten|T109|T121|T129|EQV|NLM (1992)|901029|abbbdef", "ENTRY": "NIP Hapten", "MN": "D23.050.550.480.641", "MH_TH": "NLM (1976)", "ST": "T129", "N1": "Benzeneacetic acid, 4-hydroxy-3-iodo-5-nitro-", "RN": "2646-51-7", "PI": "Phenylacetates (1974-1975)", "MS": "Also called 4-hydroxy-3-iodo-5-nitrophenylacetate. A haptenic determinant that can be radiolabeled and used as salts and derivatives for investigations of immunogenic specificity studies.", "PM": "91; was see under NITROPHENOLS 1976-90", "HN": "91(76); was see under NITROPHENOLS 1976-90", "MR": "20120703", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D009592"}, {"RECTYPE": "D", "MH": "Nitroimidazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitroimidazole|T109|NON|EQV|NLM (2021)|191230|abcdef", "MN": "D03.383.129.308.658", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "IMIDAZOLES having a nitro moiety.", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009593"}, {"RECTYPE": "D", "MH": "Nitromifene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CI 628", "MN": "D03.383.773.610", "PA": "Estrogen Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pyrrolidine, 1-(2-(4-(1-(4-methoxyphenyl)-2-nitro-2-phenylethenyl)phenoxy)ethyl)-", "RN": "5FS1NJ6Q8N", "RR": "TN5UQ266RA", "PI": "Styrenes (1972-1974)", "MS": "A non-steroidal estrogen antagonist (as the 1:1 citrate) most commonly used as a research tool in animal studies.", "OL": "use NITROMIFENE to search CI 628 1975-78", "PM": "91; was see under PYRROLIDINES 1979-90; was CI 628 see under PYRROLIDINES 1975-78", "HN": "91(79); was see under PYRROLIDINES 1979-90; was CI 628 see under PYRROLIDINES 1975-78", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D009594"}, {"RECTYPE": "D", "MH": "Nitroparaffins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.640.720", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "Alkanes having one or more nitro (NO2) groups attached to carbon atoms.", "OL": "search ALKANES 1968-74", "PM": "91; was see under ALKANES 1975-90", "HN": "91(75); was see under ALKANES 1975-90", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009595"}, {"RECTYPE": "D", "MH": "Nitrophenols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrophenol|T109|NON|EQV|NLM (2021)|200227|abcdef", "MN": "D02.640.743", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "PHENOLS carrying nitro group substituents.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009596"}, {"RECTYPE": "D", "MH": "4-Nitrophenylphosphatase", "DS": "NITROPHENYLPHOSPHATASE 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "para Nitrophenylphosphatase", "MN": "D08.811.277.352.650.575", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "4-Nitrophenylphosphate phosphohydrolase", "RN": "EC 3.1.3.41", "PI": "Organophosphorus Compounds (1973-1974)", "MS": "An enzyme that catalyzes the hydrolysis of nitrophenyl phosphates to nitrophenols. At acid pH it is probably ACID PHOSPHATASE (EC 3.1.3.2); at alkaline pH it is probably ALKALINE PHOSPHATASE (EC 3.1.3.1). EC 3.1.3.41.", "OL": "use 4-NITROPHENYLPHOSPHATASE to search 4-NITROPHENYL PHOSPHATASE 1992-93 & NITROPHENYL PHOSPHATASE 1975-91", "PM": "94; was 4-NITROPHENYL PHOSPHATASE 1992-93; was NITROPHENYL PHOSPHATASE 1975-91 (see under PHOSPHOMONOESTERASES 1975-90)", "HN": "94; was 4-NITROPHENYL PHOSPHATASE 1992-93; was NITROPHENYL PHOSPHATASE 1975-91 (see under PHOSPHOMONOESTERASES 1975-90)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009597"}, {"RECTYPE": "D", "MH": "Nitrophenylgalactosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrophenylgalactopyranosides|T109|NON|EQV|UNK (19XX)|870409|abcdef", "MN": "D09.408.320.550", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "beta-D-Galactopyranoside, nitrophenyl", "RN": "28347-45-7", "PI": "Nitrophenols (1973-1974)", "MS": "Includes ortho-, meta-, and para-nitrophenylgalactosides.", "OL": "use NITROPHENYLGALACTOSIDES to search NITROPHENYLGALACTOSIDE 1975-87", "PM": "91; was see under GLYCOSIDES 1988-90; was NITROPHENYLGALACTOSIDE see under GLYCOSIDES 1975-87", "HN": "91(88); was see under GLYCOSIDES 1988-90; was NITROPHENYLGALACTOSIDE see under GLYCOSIDES 1975-87", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009598"}, {"RECTYPE": "D", "MH": "Nitroprusside", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sodium Nitroprusside|T121|T130|T197|NON|NRW|FDA SRS (2014)|UK|US|USP (19XX)|741111|abbbcdeeeef", "ENTRY": "Nitroprusside, Sodium", "MN": "D01.625.400.100.325.550", "PA": "Vasodilator Agents", "MH_TH": "NLM (1975)", "ST": "T197", "N1": "Ferrate(2-), pentakis(cyano-C)nitrosyl-, (OC-6-22)-", "RN": "169D1260KM", "RR": "EAO03PE1TC", "PI": "Nitric Oxide (1966-1974)", "MS": "A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins.", "PM": "91; was see under FERRICYANIDES 1975-90", "HN": "91(75); was see under FERRICYANIDES 1975-90", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009599"}, {"RECTYPE": "D", "MH": "Nitroquinolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.810.470", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Quinolines (1966-1974)", "MS": "Quinolines substituted in any position by one or more nitro groups.", "PM": "75", "HN": "75", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D009600"}, {"RECTYPE": "D", "MH": "Nitroreductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nitroreductase|T116|T126|NON|EQV|NLM (2021)|191227|abbcdef", "ENTRY": "Oxidoreductases Acting on other Nitrogenous Compounds as Donors|T116|T126|NON|EQV|NLM (2006)|050225|abbcdef", "MN": "D08.811.682.655", "MH_TH": "NLM (1987)", "ST": "T126", "RN": "EC 1.7.-", "AN": "general; prefer specifics", "PI": "Oxidoreductases (1966-1986)", "MS": "Enzymes which reduce nitro groups (NITRO COMPOUNDS) and other nitrogenous compounds.", "PM": "91; was see under OXIDOREDUCTASES 1987-90", "HN": "91(87); was see under OXIDOREDUCTASES 1987-90", "MR": "20200527", "DA": "19860602", "DC": "1", "DX": "19910101", "UI": "D009601"}, {"RECTYPE": "D", "MH": "Nitrosamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitrosamine|T109|T131|NON|EQV|NLM (2021)|191118|abbcdef", "MN": "D02.654.442", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "carcinogens", "MS": "A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009602"}, {"RECTYPE": "D", "MH": "Nitroso Compounds", "DE": "NITROSO CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Nitroso", "MN": "D02.654", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Organic compounds containing the nitroso (-N=O) group attached to an organic moiety.", "MR": "20161129", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009603"}, {"RECTYPE": "D", "MH": "Nitrosoguanidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.654.567", "MH_TH": "NLM (1971)", "ST": "T121", "RN": "0", "PI": "Nitroso Compounds (1966-1970)", "MS": "Nitrosylated derivatives of guanidine. They are used as MUTAGENS in MOLECULAR BIOLOGY research.", "PM": "73", "HN": "73(71)", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009604"}, {"RECTYPE": "D", "MH": "Nitrosomethylurethane", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Methylnitrosourethane|T109|T131|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D02.654.585", "PA": "Alkylating Agents", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Carbamic acid, methylnitroso-, ethyl ester", "RN": "615-53-2", "PI": "Urethane (1972-1974)", "MS": "An alkylating carcinogen that produces gastrointestinal and probably lung and nervous system tumors.", "PM": "91; was see under URETHANE 1975-90", "HN": "91(75); was see under URETHANE 1975-90", "MR": "20000622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009605"}, {"RECTYPE": "D", "MH": "Nitrosomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.550.500", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid914", "MS": "A genus of gram-negative, ellipsoidal or rod-shaped bacteria whose major source of energy and reducing power is from the oxidation of ammonia to nitrite. Its species occur in soils, oceans, lakes, rivers, and sewage disposal systems.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009606"}, {"RECTYPE": "D", "MH": "Nitrosourea Compounds", "DE": "NITROSOUREA CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Nitrosourea", "MN": "D02.654.692", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "PI": "Urea (1966-1970)", "MS": "A class of compounds in which the core molecule is R-NO, where R is UREA.", "PM": "73", "HN": "73(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009607"}, {"RECTYPE": "D", "MH": "Nitrous Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Nitrous", "MN": "D01.625.600", "MH_TH": "NLM (1975)", "ST": "T197", "N1": "Nitrous acid", "RN": "T2I5UM75DN", "RR": "7782-77-6 (Nitrous Acid)", "AN": "do not confuse with NITRIC ACID", "MS": "Nitrous acid (HNO2). A weak acid that exists only in solution. It can form water-soluble nitrites and stable esters. (From Merck Index, 11th ed)", "OL": "search NITRITES 1966-74", "PM": "91; was see under NITRITES 1975-90", "HN": "91(75); was see under NITRITES 1975-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009608"}, {"RECTYPE": "D", "MH": "Nitrous Oxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxide, Nitrous", "MN": "D01.650.550.587.650", "PA": "Anesthetics, Inhalation", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Nitrogen oxide (N2O)", "RN": "K50XQU1029", "RR": "10024-97-2 (Nitrous Oxide)", "MS": "Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream.", "PM": "1963; for NITROGEN PROTOXIDE see NITRIC OXIDE 1982-2008", "HN": "1963; for NITROGEN PROTOXIDE use NITRIC OXIDE 1982-2008", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D009609"}, {"RECTYPE": "D", "MH": "Nitrovin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.312.649.750", "PA": "Anti-Infective Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Hydrazinecarboximidamide, 2-(3-(5-nitro-2-furanyl)-1-(2-(5-nitro-2-furanyl)ethenyl)-2-propenylidene)-", "RN": "4I203628MT", "RR": "804-36-4 (Nitrovin)", "PI": "Nitrofurans (1971-1974)", "MS": "An antibacterial growth promoter used in animal feeds.", "PM": "91; was see under NITROFURANS 1975-90", "HN": "91(75); was see under NITROFURANS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009610"}, {"RECTYPE": "D", "MH": "Nitroxinil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nitroxynil|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|741111|abbcdeef", "MN": "D02.640.743.620", "PA": "Antiplatyhelmintic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzonitrile, 4-hydroxy-3-iodo-5-nitro-", "RN": "9L0EXQ7125", "RR": "1689-89-0 (Nitroxinil)", "PI": "Nitrophenols (1972-1974)", "MS": "Proposed anthelmintic for fasciola and liver fluke infestations.", "PM": "91; was see under NITROPHENOLS 1975-90", "HN": "91(75); was see under NITROPHENOLS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009611"}, {"RECTYPE": "D", "MH": "Nicotinamide-Nucleotide Adenylyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nicotinamide Mononucleotide Adenylyltransferase|T116|T126|NON|EQV|UNK (19XX)|780313|abbcdef", "ENTRY": "Pyrophosphorylase, NAD", "MN": "D12.776.660.720.499", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "ATP:nicotinamide-nucleotide adenylyltransferase", "RN": "EC 2.7.7.1", "RR": "9032-70-6 (CAS RN)", "PI": "Transferases (1966-1967)", "MS": "An enzyme that catalyzes reversibly the transfer of the adenylyl moiety of ATP to the phosphoryl group of NMN to form NAD+ and pyrophosphate. The enzyme is found predominantly in the nuclei and catalyzes the final reaction in the major pathway for the biosynthesis of NAD in mammals.", "PM": "98; see NMN ADENYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1979-90", "HN": "98(79)", "MR": "20170524", "DA": "19780313", "DC": "1", "DX": "19910101", "UI": "D009612"}, {"RECTYPE": "D", "MH": "Nobel Prize", "AQ": "HI", "ENTRY": "Prize, Nobel", "MN": "K01.150.567", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "award for medicine: coordinate with specific field or specialty but not with MEDICINE", "MS": "Any of six international prizes awarded annually for outstanding work in physics, chemistry, physiology or medicine, literature, economics and the promotion of peace.", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009613"}, {"RECTYPE": "D", "MH": "Nobelium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.620", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Nobelium", "RN": "10028-14-5", "MS": "A man-made radioactive element of the actinide metal series. It has the atomic symbol No, and atomic number 102.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009614"}, {"RECTYPE": "D", "MH": "Nocardia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Micropolyspora|T007|NON|NRW|NLM (1993)|911010|abcdef", "MN": "B03.510.024.981.550", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1817", "MS": "A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for humans and animals.", "PM": "1963; for MICROPOLYSPORA see MICROMONOSPORACEAE 1993-2009", "HN": "1963; for MICROPOLYSPORA use MICROMONOSPORACEAE 1993-2009", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D009615"}, {"RECTYPE": "D", "MH": "Nocardia asteroides", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.024.981.550.550", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid1824", "AN": "infection: coord IM with NOCARDIA INFECTIONS (IM)", "PI": "Nocardia (1966-1971)", "MS": "A species of bacterium of the family NOCARDIACEAE, producing pulmonary infections in man.", "OL": "use NOCARDIA ASTEROIDES to search ACTINOMYCES ASTEROIDES 1974-91", "PM": "74; ACTINOMYCES ASTEROIDES was see NOCARDIA ASTEROIDES 1974-91", "HN": "74(72); ACTINOMYCES ASTEROIDES was see NOCARDIA ASTEROIDES 1974-91", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009616"}, {"RECTYPE": "D", "MH": "Nocardia Infections", "DE": "NOCARDIA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Pulmonary Nocardioses", "MN": "C01.150.252.410.040.692", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "gram-pos bact infect", "MS": "Infections with bacteria of the genus NOCARDIA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009617"}, {"RECTYPE": "D", "MH": "Nocardiaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.024.981", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid85025", "AN": "in soil, animals & man", "PI": "Actinomycetales (1966-1974)", "MS": "A family of gram-positive, aerobic actinomycetes found in soil and animal tissue. Some species are the cause of infection in man and animals.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750718", "DC": "1", "DX": "19760101", "UI": "D009618"}, {"RECTYPE": "D", "MH": "Nociceptors", "DE": "NOCICEPT", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Receptors, Pain|T025|NON|EQV|NLM (1994)|930111|RECEPT PAIN|abcdefv", "ENTRY": "Pain Receptor", "MN": "A11.671.650.915.875", "MH_TH": "NLM (1978)", "ST": "T025", "PI": "Pain (1966-1977)", "MS": "Peripheral AFFERENT NEURONS which are sensitive to injuries or pain, usually caused by extreme thermal exposures, mechanical forces, or other noxious stimuli. Their cell bodies reside in the DORSAL ROOT GANGLIA. Their peripheral terminals (NERVE ENDINGS) innervate target tissues and transduce noxious stimuli via axons to the CENTRAL NERVOUS SYSTEM.", "PM": "78", "HN": "78", "MR": "20080708", "DA": "19770411", "DC": "1", "DX": "19780101", "UI": "D009619"}, {"RECTYPE": "D", "MH": "Nodose Ganglion", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ganglion, Nodose", "MN": "A08.800.800.120.900.550", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "a ganglion of the vagus (10th cranial) nerve; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "The inferior (caudal) ganglion of the vagus (10th cranial) nerve. The unipolar nodose ganglion cells are sensory cells with central projections to the medulla and peripheral processes traveling in various branches of the vagus nerve.", "OL": "search VAGUS NERVE 1966-74", "PM": "91; was see under VAGUS NERVE 1975-90", "HN": "91(75); was see under VAGUS NERVE 1975-90", "MR": "19940603", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009620"}, {"RECTYPE": "D", "MH": "Nogalamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "U15167", "MN": "D09.408.051.059.200.650", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylic acid, 11-((6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-alpha-L-mannopyranosyl)oxy)-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, (2R-(2alpha,3beta,4alpha,5beta,6alpha,11beta,13alpha,14alpha))-", "RN": "L059DCD6IP", "RR": "1404-15-5 (Nogalamycin)", "PI": "Naphthacenes (1966-1975)", "MS": "An anthrocycline from a Streptomyces nogalater variant. It is a cytolytic antineoplastic that inhibits DNA-dependent RNA synthesis by binding to DNA.", "PM": "91; was see under DAUNORUBICIN 1981-90; was see under NAPHTHACENES 1976-80", "HN": "91(76); was see under DAUNORUBICIN 1981-90; was see under NAPHTHACENES 1976-80", "MR": "20130708", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D009621"}, {"RECTYPE": "D", "MH": "Noise", "AQ": "AE LJ PC", "ENTRY": "Pollution, Noise", "MN": "N06.850.460.610", "FX": "Hearing Loss, Noise-Induced", "MH_TH": "NLM (1966)", "ST": "T067", "MS": "Any sound which is unwanted or interferes with HEARING other sounds.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009622"}, {"RECTYPE": "D", "MH": "Noise, Occupational", "DE": "NOISE OCCUP", "AQ": "AE EC LJ PC SN", "PRINT ENTRY": "Occupational Noise|T067|NON|EQV|UNK (19XX)|780522|OCCUP NOISE|abcdefv", "ENTRY": "Occupational Noises", "MN": "N06.850.460.610.526", "MH_TH": "NLM (1979)", "ST": "T067", "AN": "coord IM with specific occupation (IM) if pertinent; consider also HEARING LOSS, NOISE-INDUCED", "PI": "Occupational Medicine (1966-1978)", "MS": "Noise present in occupational, industrial, and factory situations.", "PM": "91; was see under NOISE 1979-90", "HN": "91(79); was see under NOISE 1979-90", "MR": "20190524", "DA": "19780522", "DC": "1", "DX": "19910101", "UI": "D009623"}, {"RECTYPE": "D", "MH": "Noise, Transportation", "AQ": "AE EC LJ PC SN", "ENTRY": "Transportation Noises", "MN": "N06.850.460.610.680", "MH_TH": "NLM (1979)", "ST": "T069", "AN": "coord IM with specific mode of transport (AIRCRAFT; AUTOMOBILES; RAILROADS; etc.) (IM); consider also HEARING LOSS, NOISE-INDUCED", "PI": "Noise (1966-1978)", "MS": "Noise associated with transportation, particularly aircraft and automobiles.", "PM": "91; was see under NOISE 1979-90", "HN": "91(79); was see under NOISE 1979-90", "MR": "20120703", "DA": "19780522", "DC": "1", "DX": "19910101", "UI": "D009624"}, {"RECTYPE": "D", "MH": "Noma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stomatitis, Gangrenous|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Stomatitides, Gangrenous", "MN": "C07.465.604", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "severe gangrene of gingiva often spreading to face", "MS": "A severe gangrenous process occurring predominantly in debilitated and malnourished children, especially in underdeveloped countries. It typically begins as a small vesicle or ulcer on the gingiva that rapidly becomes necrotic and spreads to produce extensive destruction of the buccal and labial mucosa and tissues of the face, which may result in severe disfigurement and even death. Various bacteria have been implicated in the etiology. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009625"}, {"RECTYPE": "D", "MH": "Terminology as Topic", "PRINT ENTRY": "Nomenclature as Topic|T170|NON|NRW|NLM (2008)|070626|abcdef", "ENTRY": "Etymologies", "MN": "L01.559.598.400", "FX": "Dictionaries as Topic", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "\"medical nomenclature\": do not coordinate with MEDICINE; do not confuse with the Publication Type TERMINOLOGY", "MS": "Works about the terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area.", "PM": "2008; see TERMINOLOGY 1999-2007, see NOMENCLATURE 1966-1998", "HN": "2008(1966)", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D009626"}, {"RECTYPE": "D", "MH": "Nomifensine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Maleate, Nomifensine", "MN": "D03.633.100.531.535", "PA": "Dopamine Uptake Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "8-Isoquinolinamine, 1,2,3,4-tetrahydro-2-methyl-4-phenyl-", "RN": "1LGS5JRP31", "RR": "76S8CUH5MR", "PI": "Quinolines (1966-1968)", "MS": "An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)", "PM": "86; was see under ISOQUINOLINES 1978-85", "HN": "86(78); was see under ISOQUINOLINES 1978-85", "MR": "20160531", "DA": "19770422", "DC": "1", "DX": "19860101", "UI": "D009627"}, {"RECTYPE": "D", "MH": "Nonachlazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Azaclorzine|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|940822|abbcdeef", "ENTRY": "Nonakhlazin|T109|T121|NON|EQV|UNK (19XX)|780208|abbcdef", "MN": "D03.633.300.783.550", "PA": "Vasodilator Agents", "MH_TH": "NLM (1979)", "ST": "T121", "N1": "10H-Phenothiazine, 2-chloro-10-(3-(hexahydropyrrolo(1,2-a)pyrazin-2(1H)-yl)-1-oxopropyl)-, dihydrochloride", "RN": "7N4BHX8N3L", "RR": "49780-10-1 (Nonachlazine)", "PI": "Piperazines (1966-1978)", "MS": "Coronary vasodilator with a novel mechanism of action; proposed as antianginal agent.", "PM": "91; was see under PHENOTHIAZINES 1979-90", "HN": "91(79); was see under PHENOTHIAZINES 1979-90", "MR": "20180705", "DA": "19780208", "DC": "1", "DX": "19910101", "UI": "D009628"}, {"RECTYPE": "D", "MH": "Person-Centered Psychotherapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Rogerian Therapy|T061|EPO|BRD|UNK (19XX)|740330|ROGERIAN THER|abcdefv", "ENTRY": "Therapy, Client Centered", "MN": "F04.754.592", "MH_TH": "NLM (2019)", "ST": "T061", "MS": "A nondirective psychotherapy approach originated by Carl Rogers. The goals of therapy are to promote the client\u2019s congruence, self awareness, and self acceptance. This approach views the client as naturally directed toward self actualization, and only needing facilitative conditions in order to promote this tendency.", "PM": "2019; see PERSON-CENTERED THERAPY\u00a02016-2018; see THERAPY, NONDIRECTIVE 1965-2015", "HN": "2019(1969)", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D009629"}, {"RECTYPE": "D", "MH": "Nondisjunction, Genetic", "DE": "NONDISJUNCTION GENET", "AQ": "DE ES GE IM PH RE", "ENTRY": "Nondisjunctions, Genetic", "MN": "G05.558.620", "MH_TH": "NLM (1982)", "ST": "T049", "PI": "Meiosis (1968-1981)", "MS": "The failure of homologous CHROMOSOMES or CHROMATIDS to segregate during MITOSIS or MEIOSIS with the result that one daughter cell has both of a pair of parental chromosomes or chromatids and the other has none.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19810223", "DC": "1", "DX": "19820101", "UI": "D009630"}, {"RECTYPE": "D", "MH": "Nonodontogenic Cysts", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Nonodontogenic Cyst", "MN": "C07.320.450.640", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "non-neoplastic; of jaw; coordinate with precoordinated organ/disease term ", "MS": "Cysts formed from epithelial inclusions in the lines of fusion of the embryonic processes which form the jaws. They include nasopalatine or incisive canal cyst, incisive papilla cyst, globulomaxillary cyst, median palatal cyst, median alveolar cyst, median mandibular cyst, and nasoalveolar cyst.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009631"}, {"RECTYPE": "D", "MH": "Nonsuppressible Insulin-Like Activity", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NSILA-S|T116|T125|ABB|NRW|UNK (19XX)|760512|abbcdef", "ENTRY": "Nonsuppressible Insulin Like Activity", "MN": "D12.776.124.862.575", "MH_TH": "NLM (1977)", "ST": "T125", "RN": "0", "AN": "note category; a blood protein mimicking blood insulin", "PI": "Insulin (1966-1976)", "MS": "A blood protein (NSILA) which mimics the biological activity of insulin in serum, but is not suppressed by insulin antibodies. During acid-ethanol extraction of Cohn fraction III, 10% of the activity is found in the supernatant (NSILA-S) and the remaining activity in the precipitate (NSILA-P). The latter is a large molecular compound, much less stable than the soluble fraction. NSILA-S is a more potent growth factor than insulin and exhibits sulfation activity.", "PM": "77", "HN": "77", "MR": "20060705", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D009632"}, {"RECTYPE": "D", "MH": "Nonverbal Communication", "AQ": "PH PX", "PRINT ENTRY": "Non-Verbal Communication|T041|NON|EQV|NLM (2022)|OBSSR (2021)|210416|abcdeef", "ENTRY": "Nonverbal Communications", "MN": "L01.143.649", "FX": "Haptic Technology", "MH_TH": "NLM (1987)", "ST": "T041", "AN": "human only; for animals use ANIMAL COMMUNICATION or VOCALIZATION, ANIMAL; consider also MANUAL COMMUNICATION & SIGN LANGUAGE; for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "PI": "Verbal Behavior (1966-1969)", "MS": "Transmission of emotions, ideas, and attitudes between individuals in ways other than the spoken language.", "PM": "71", "HN": "71(70)", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D009633"}, {"RECTYPE": "D", "MH": "Noonan Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Turner Syndrome, Male|T047|EPO|NRW|NLM (2002)|001102|abcdef", "ENTRY": "Ullrich Noonan Syndrome", "MN": "C17.300.690", "FX": "Turner Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Turner's Syndrome (1966-1978)", "MS": "A genetically heterogeneous, multifaceted disorder characterized by short stature, webbed neck, ptosis, skeletal malformations, hypertelorism, hormonal imbalance, CRYPTORCHIDISM, multiple cardiac abnormalities (most commonly including PULMONARY VALVE STENOSIS), and some degree of INTELLECTUAL DISABILITY. The phenotype bears similarities to that of TURNER SYNDROME that occurs only in females and has its basis in a 45, X karyotype abnormality. Noonan syndrome occurs in both males and females with a normal karyotype (46,XX and 46,XY). Mutations in a several genes (PTPN11, KRAS, SOS1, NF1 and RAF1) have been associated the NS phenotype. Mutations in PTPN11 are the most common. LEOPARD SYNDROME, a disorder that has clinical features overlapping those of Noonan Syndrome, is also due to mutations in PTPN11. In addition, there is overlap with the syndrome called neurofibromatosis-Noonan syndrome due to mutations in NF1.", "PM": "1979", "HN": "1979", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19771205", "DC": "1", "DX": "19790101", "UI": "D009634"}, {"RECTYPE": "D", "MH": "Norandrostanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.668.100", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Norsteroids (1968-1974)", "MS": "Androstanes in which ring contractions have occurred or which are lacking carbon-18. Compounds with any degree of unsaturation are included. Androstanes which are lacking carbon-19 are ESTRANES.", "PM": "75", "HN": "75", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D009635"}, {"RECTYPE": "D", "MH": "Norbornanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Norcamphanes|T109|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Derivatives, Norbornene", "MN": "D04.075.080.500", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "AN": "includes norbornenes", "PI": "Terpenes (1970-1971)", "MS": "Compounds that include or are derivatives of norbornane(bicyclo[2.2.1]heptane).", "PM": "74", "HN": "74(72)", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009636"}, {"RECTYPE": "D", "MH": "Masoprocol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nordihydroguaiaretic Acid|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1987)|990101|abbcdeef", "ENTRY": "meso Nordihydroguaiaretic Acid", "MN": "D02.455.426.559.389.657.166.550", "PA": "Lipoxygenase Inhibitors", "MH_TH": "USAN (1990)", "ST": "T121", "N1": "1,2-Benzenediol, 4,4'-(2,3-dimethyl-1,4-butanediyl)bis-", "RN": "7BO8G1BYQU", "RR": "500-38-9 (Nordihydroguaiaretic Acid)", "PI": "Catechols (1966-1986)", "MS": "A potent lipoxygenase inhibitor that interferes with arachidonic acid metabolism. The compound also inhibits formyltetrahydrofolate synthetase, carboxylesterase, and cyclooxygenase to a lesser extent. It also serves as an antioxidant in fats and oils.", "PM": "2014; see NORDIHYDROGUAIARETIC ACID 1991-2013; see CATECHOLS 1987-1990", "HN": "2014(1987)", "MR": "20130708", "DA": "19860409", "DC": "1", "DX": "19910101", "UI": "D009637"}, {"RECTYPE": "D", "MH": "Norepinephrine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Noradrenaline|T109|T121|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbbcdeef", "ENTRY": "Norepinephrine, (+,-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef", "MN": "D02.455.426.559.389.657.166.175.830", "PA": "Vasoconstrictor Agents", "FX": "Receptors, Adrenergic", "MH_TH": "INN (19XX)", "ST": "T123", "N1": "1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-", "RN": "X4W3ENH1CV", "RR": "IFY5PE3ZRW", "MS": "Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic.", "PM": "1993; see ARTERENOL 1974-1993; see LEVONOREPINEPHRINE 1963-1965", "HN": "1993 (1963); use ARTERENOL 1974-1993; use LEVONOREPINEPHRINE 1963-1965", "MR": "20180619", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009638"}, {"RECTYPE": "D", "MH": "Norethandrolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethylnortestosterone|T109|T121|T125|NON|EQV|UNK (19XX)|761224|abbbcdef", "ENTRY": "Nilevar|T109|T121|T125|TRD|NRW|FR|040408|abbbcdef", "MN": "D04.210.500.668.651.693.595", "PA": "Anabolic Agents", "MH_TH": "INN (19XX)", "ST": "T125", "N1": "19-Norpregn-4-en-3-one, 17-hydroxy-, (17alpha)-", "RN": "P7W01638W6", "RR": "52-78-8 (Norethandrolone)", "MS": "A synthetic hormone with anabolic and androgenic properties and moderate progestational activity.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009639"}, {"RECTYPE": "D", "MH": "Norethindrone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Norpregneninolone|T109|T121|T125|NON|EQV|UNK (19XX)|761224|abbbcdef", "ENTRY": "NorQD", "MN": "D04.210.500.668.651.693.651", "PA": "Contraceptives, Oral, Synthetic", "MH_TH": "USP (19XX)", "ST": "T125", "RN": "T18F433X4S", "RR": "68-22-4 (Norethindrone)", "MS": "A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for CONTRACEPTION.", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009640"}, {"RECTYPE": "D", "MH": "Norethynodrel", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "19-Norpregn-5(10)-en-20-yn-3-one, 17-hydroxy-, (17alpha)-|T109|T121|T125|NON|EQV|NLM (2020)|190708|abbbcdef", "ENTRY": "Norethynodrel, (8 alpha)-(+-)-Isomer|T109|T121|T125|NRW|NLM (1999)|990913|abbbdef", "MN": "D04.210.500.668.651.693.706", "PA": "Contraceptives, Oral, Synthetic", "MH_TH": "USP (19XX)", "ST": "T125", "RN": "88181ACA0M", "RR": "68-23-5 (Norethynodrel)", "MS": "A synthetic progestational hormone with actions and uses similar to those of PROGESTERONE. It has been used in the treatment of functional uterine bleeding and ENDOMETRIOSIS. As a contraceptive (CONTRACEPTIVE AGENTS), it has usually been administered in combination with MESTRANOL.", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009641"}, {"RECTYPE": "D", "MH": "Norfenfluramine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nordexfenfluramine|T109|T121|NON|NRW|NLM (2009)|071016|abbcdef", "MN": "D02.092.471.683.467.500", "PA": "Serotonin Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Benzeneethanamine, alpha-methyl-3-(trifluoromethyl)-", "RN": "1886-26-6", "PI": "Phenethylamines (1973-1974)", "MS": "A FENFLURAMINE analog that inhibits serotonin uptake and may provoke release of serotonin. It is used as an appetite depressant and an experimental tool in animal studies.", "PM": "91; was see under FENFLURAMINE 1975-90", "HN": "91(75); was see under FENFLURAMINE 1975-90", "MR": "20220718", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009642"}, {"RECTYPE": "D", "MH": "Norfloxacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MK 366", "MN": "D03.633.100.810.835.322.374", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-", "RN": "N0F8P22L1P", "RR": "70458-96-7 (Norfloxacin)", "PI": "Nalidixic Acid (1966-1985)", "MS": "A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.", "PM": "86", "HN": "86", "MR": "20170524", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D009643"}, {"RECTYPE": "D", "MH": "Norgestrel", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(+-)-|T109|T121|T125|NON|EQV|NLM (2020)|190708|abbbcdef", "ENTRY": "Wy3707", "MN": "D04.210.500.668.651.693.762", "PA": "Contraceptives, Oral, Synthetic", "MH_TH": "USP (19XX)", "ST": "T125", "RN": "3J8Q1747Z2", "RR": "6533-00-2 (Norgestrel)", "PI": "Progestational Hormones (1966-1971)", "MS": "A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis.", "PM": "72", "HN": "72", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009644"}, {"RECTYPE": "D", "MH": "Norgestrienone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "A301", "MN": "D04.210.500.668.651.568.620", "PA": "Contraceptives, Oral, Synthetic", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "19-Norpregna-4,9,11-trien-20-yn-3-one, 17-hydroxy-, (17alpha)-", "RN": "89386PYU9O", "RR": "848-21-5 (Norgestrienone)", "PI": "Pregnatrienes (1973-1974)", "MS": "A synthetic steroid with progestational and contraceptive activities.", "PM": "91; was see under NORPREGNATRIENES 1975-90", "HN": "91(75); was see under NORPREGNATRIENES 1975-90", "MR": "20160531", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D009645"}, {"RECTYPE": "D", "MH": "Norleucine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Norleucine, L Isomer", "MN": "D12.125.213.568", "MH_TH": "NLM (1972)", "ST": "T130", "N1": "Norleucine", "RN": "832C8OV84S", "RR": "5157-09-5 (Norleucine)", "PI": "Aminocaproic Acids (1966-1971)", "MS": "An unnatural amino acid that is used experimentally to study protein structure and function. It is structurally similar to METHIONINE, however it does not contain SULFUR.", "PM": "91; was see under AMINOCAPROIC ACIDS 1972-90", "HN": "91(72); was see under AMINOCAPROIC ACIDS 1972-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009646"}, {"RECTYPE": "D", "MH": "Normetanephrine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "3 Methoxynoradrenaline", "MN": "D23.101.140.540", "MH_TH": "NLM (1963)", "ST": "T123", "N1": "Benzenemethanol, alpha-(aminomethyl)-4-hydroxy-3-methoxy-", "RN": "0J45DE6B88", "RR": "97-31-4 (Normetanephrine)", "MS": "A methylated metabolite of norepinephrine that is excreted in the urine and found in certain tissues. It is a marker for tumors.", "PM": "1966", "HN": "1966 (1963)", "MR": "20180529", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009647"}, {"RECTYPE": "D", "MH": "Norpregnadienes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.668.651.443", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Norpregnanes (1974)", "MS": "Pregnadienes which have undergone ring contractions or are lacking carbon-18 or carbon-19.", "OL": "search NORPREGNANES 1974", "PM": "75; was see under NORPREGNANES 1974", "HN": "75; was see under NORPREGNANES 1974", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D009649"}, {"RECTYPE": "D", "MH": "Norpregnanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.668.651", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "do not confuse with NORPREGNENES", "MS": "Pregnanes which have undergone ring contractions or are lacking carbon-18 or carbon-19. Unsaturation in the steroid ring system is not included.", "PM": "74", "HN": "74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009650"}, {"RECTYPE": "D", "MH": "Norpregnatrienes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.668.651.568", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Norpregnanes (1974)", "MS": "Pregnatrienes which have undergone ring contractions or are lacking carbon-18 or carbon-19.", "OL": "search NORPREGNANES 1974", "PM": "75; was see under NORPREGNANES 1974", "HN": "75; was see under NORPREGNANES 1974", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D009651"}, {"RECTYPE": "D", "MH": "Norpregnenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.668.651.693", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with NORPREGNANES", "PI": "Norpregnanes (1974)", "MS": "Pregnenes with one double bond or more than three double bonds which have undergone ring contractions or are lacking carbon-18 or carbon-19..", "OL": "search NORPREGNANES 1974", "PM": "75; was see under NORPREGNANES 1974", "HN": "75; was see under NORPREGNANES 1974", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D009652"}, {"RECTYPE": "D", "MH": "Norprogesterones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.668.651.693.820", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Progesterone (1974)", "MS": "Progesterones which have undergone ring contraction or which are lacking carbon 18 or 19.", "PM": "91; was see under NORPREGNENES 1975-90", "HN": "91(75); was see under NORPREGNENES 1975-90", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D009653"}, {"RECTYPE": "D", "MH": "Norsteroids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.668", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Steroids which have undergone contraction in ring size or reduction in side chains.", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009654"}, {"RECTYPE": "D", "MH": "Octopamine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "para-Octopamine|T109|T121|T123|NON|EQV|UNK (19XX)|810513|abbbcdef", "ENTRY": "alpha-(Aminoethyl)-4-hydroxybenzenemethanol|T109|T121|T123|NON|EQV|NLM (1995)|940317|abbbcdef", "MN": "D02.092.471.683.725", "PA": "Vasoconstrictor Agents", "MH_TH": "INN (19XX)", "ST": "T123", "N1": "Benzenemethanol, alpha-(aminomethyl)-4-hydroxy-", "RN": "14O50WS8JD", "RR": "104-14-3 (Octopamine)", "MS": "An alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D(-) form is more potent than the L(+) form in producing cardiovascular adrenergic responses. It is also a neurotransmitter in some invertebrates.", "OL": "use OCTOPAMINE to search NORSYNEPHRINE 1966-90", "PM": "91; NORSYNEPHRINE was heading 1963-90", "HN": "91; NORSYNEPHRINE was heading 1963-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009655"}, {"RECTYPE": "D", "MH": "North America", "AQ": "EH EP", "ENTRY": "Northern America|T083|NAM|NRW|POPLINE (1983)|861231|abcdef", "MN": "Z01.107.567", "MH_TH": "NLM (1983)", "ST": "T083", "MS": "The northern continent of the Western Hemisphere, extending northward from the Colombia-Panama border and including CENTRAL AMERICA, MEXICO, Caribbean area, the UNITED STATES, CANADA and GREENLAND. The term often refers more narrowly to MEXICO, continental UNITED STATES, AND CANADA.", "MR": "20160627", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009656"}, {"RECTYPE": "D", "MH": "North Carolina", "AQ": "EH EP", "MN": "Z01.107.567.875.750.530", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Virginia, on the east and Southeast by the Atlantic Ocean, on the south by Georgia and South Carolina, and on the west by Tennessee.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009657"}, {"RECTYPE": "D", "MH": "North Dakota", "AQ": "EH EP", "MN": "Z01.107.567.875.510.525", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Canada, on the east by Minnesota, on the south by South Dakota, and on the west by Montana.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009658"}, {"RECTYPE": "D", "MH": "North Sea", "AQ": "EH EP", "MN": "Z01.756.092.650", "MH_TH": "NLM (1987)", "ST": "T083", "MS": "An arm of the Atlantic Ocean extending between Europe on the south and east, Great Britain on the west.", "HN": "87", "MR": "20161219", "DA": "19860402", "DC": "4", "DX": "19870101", "UI": "D009659"}, {"RECTYPE": "D", "MH": "Northern Ireland", "AQ": "EH EP", "MN": "Z01.542.363.602", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "capital, Belfast; differentiate from IRELAND (Irish Free State, Eire)", "MS": "The northern one-sixth of the island of Ireland - between the North Atlantic Ocean and the North Sea; northwest of France. The capital is Belfast.", "MR": "20161222", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009660"}, {"RECTYPE": "D", "MH": "Nortriptyline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Desmethylamitriptylin|T109|T121|NON|EQV|UNK (19XX)|770428|abbcdef", "ENTRY": "ratio Nortriptyline", "MN": "D04.615.181.384.535", "PA": "Antidepressive Agents, Tricyclic", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Propanamine, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N-methyl-", "RN": "BL03SY4LXB", "RR": "894-71-3 (Nortriptyline Hydrochloride)", "MS": "A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.", "PM": "68", "HN": "68(65)", "MR": "20170117", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009661"}, {"RECTYPE": "D", "MH": "Nortropanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.605.869.744", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of 8-azabicyclo[3.2.1]octane.", "MR": "20160427", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009662"}, {"RECTYPE": "D", "MH": "Norwalk virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Norwalk Agent|T005|EPO|EQV|NLM (1994)|921113|abcdef", "MN": "B04.820.578.298.550.500", "MH_TH": "NLM (1982)", "ST": "T005", "RN": "txid11983", "AN": "infection: coord IM with CALICIVIRIDAE INFECTIONS (IM) + probably GASTROENTERITIS (IM)", "PI": "Gastroenteritis (1966-1981)", "MS": "The type species in the genus NOROVIRUS, first isolated in 1968 from the stools of school children in Norwalk, Ohio, who were suffering from GASTROENTERITIS. The virions are non-enveloped spherical particles containing a single protein. Multiple strains are named after the places where outbreaks have occurred.", "OL": "use NORWALK VIRUS to search NORWALK AGENT 1982-93", "PM": "94; was NORWALK AGENT 1982-93", "HN": "94; was NORWALK AGENT 1982-93", "MR": "20200813", "DA": "19810520", "DC": "1", "DX": "19820101", "UI": "D009663"}, {"RECTYPE": "D", "MH": "Norway", "AQ": "EH EP", "ENTRY": "Kingdom of Norway|T083|NON|EQV|NLM (2018)|161223|abcdef", "MN": "Z01.542.816.374", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country located in northern Europe, bordering the North Sea and the Atlantic Ocean, west of Sweden. The capital is Oslo.", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009664"}, {"RECTYPE": "D", "MH": "Noscapine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Narcotine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbcdeef", "ENTRY": "Tropfen, Capval", "MN": "D03.633.100.531.567", "PA": "Antitussive Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (S-(R*,S*))-", "RN": "8V32U4AOQU", "RR": "TTN62ITH9I", "MS": "A naturally occurring opium alkaloid that is a centrally acting antitussive agent.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009665"}, {"RECTYPE": "D", "MH": "Nose", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Noses, External", "MN": "A09.531", "FX": "Rhinoplasty", "EC": "metabolism:Nasal Mucosa:metabolism", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at NAS- and RHIN-", "MS": "A part of the upper respiratory tract. It contains the organ of SMELL. The term includes the external nose, the nasal cavity, and the PARANASAL SINUSES.", "MR": "20180614", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009666"}, {"RECTYPE": "D", "MH": "Nose Deformities, Acquired", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Nose Deformity, Acquired", "MN": "C09.603.619", "MH_TH": "NLM (1966)", "ST": "T020", "MS": "Abnormalities of the nose acquired after birth from injury or disease.", "OL": "use NOSE DEFORMITIES, ACQUIRED to search NOSE DEFORMITIES 1968-77", "PM": "78; was NOSE DEFORMITIES 1968-77", "HN": "78; was NOSE DEFORMITIES 1968-77", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D009667"}, {"RECTYPE": "D", "MH": "Nose Diseases", "DE": "NOSE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nasal Diseases|T047|NON|EQV|NLM (2009)|071030|abcdef", "ENTRY": "Nose Disease", "MN": "C09.603", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Disorders of the nose, general or unspecified.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009668"}, {"RECTYPE": "D", "MH": "Nose Neoplasms", "DE": "NOSE NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Nose Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Nose Neoplasm", "MN": "C09.647.685", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "soft or bony tissue; coordinate IM with specific site in nose (IM) + histological type of neoplasm (IM)", "MS": "Tumors or cancer of the NOSE.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009669"}, {"RECTYPE": "D", "MH": "Encephalitozoon cuniculi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Nosema cuniculi|T004|NON|EQV|NLM (1992)|910304|abcdef", "MN": "B01.300.360.500.500.100.175.175", "MH_TH": "NLM (1982)", "ST": "T004", "RN": "txid6035", "AN": "infection: coordinate with ENCEPHALITOZOONOSIS; coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc.) if pertinent", "PI": "Sporozoa (1966-1981)", "MS": "A species of parasitic FUNGI. This intracellular parasite is found in the BRAIN; HEART; and KIDNEYS of several MAMMALS. Transmission is probably by ingestion of the spores (SPORES, FUNGAL).", "OL": "use ENCEPHALITOZOON CUNICULI to search NOSEMA CUNICULI 1982-91", "PM": "92; was NOSEMA CUNICULI 1982-91 (see under SPOROZOA 1982-90); ENCEPHALITOZOON CUNICULI was see NOSEMA CUNICULI 1982-91", "HN": "92; was NOSEMA CUNICULI 1982-91 (see under SPOROZOA 1982-90); ENCEPHALITOZOON CUNICULI was see NOSEMA CUNICULI 1982-91", "MR": "20200527", "DA": "19810519", "DC": "1", "DX": "19910101", "UI": "D009670"}, {"RECTYPE": "D", "MH": "Nostrums", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D26.593", "FX": "Quackery", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "do not confuse with NONPRESCRIPTION DRUGS", "MS": "Medicines whose effectiveness is unproven and whose ingredients are often secret.", "MR": "20080709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009671"}, {"RECTYPE": "D", "MH": "Notochord", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Notochords", "MN": "A16.660", "MH_TH": "NLM (1979)", "ST": "T018", "PI": "Embryo (1966-1978)", "MS": "A cartilaginous rod of mesodermal cells at the dorsal midline of all CHORDATE embryos. In lower vertebrates, notochord is the backbone of support. In the higher vertebrates, notochord is a transient structure, and segments of the vertebral column will develop around it. Notochord is also a source of midline signals that pattern surrounding tissues including the NEURAL TUBE development.", "PM": "91; was see under EMBRYO 1979-90", "HN": "91(79); was see under EMBRYO 1979-90", "MR": "20070709", "DA": "19771205", "DC": "1", "DX": "19910101", "UI": "D009672"}, {"RECTYPE": "D", "MH": "Notophthalmus viridescens", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Triturus viridescens|T011|NON|EQV|UNK (19XX)|800512|abcdef", "ENTRY": "Red-Spotted Newts", "MN": "B01.050.150.900.090.608.700.500.480", "MH_TH": "NLM (1981)", "ST": "T011", "RN": "txid8316", "AN": "NIM when experimental animal", "PI": "Urodela (1966-1974)", "MS": "A species of newt in the Salamandridae family in which the larvae transform into terrestrial eft stage and later into an aquatic adult. They occur from Canada to southern United States. Viridescens refers to the greenish color often found in this species.", "PM": "91; was see under SALAMANDRIDAE 1981-90", "HN": "91(81); was see under SALAMANDRIDAE 1981-90", "MR": "20200902", "DA": "19800512", "DC": "1", "DX": "19910101", "UI": "D009673"}, {"RECTYPE": "D", "MH": "Nova Scotia", "AQ": "EH EP", "MN": "Z01.107.567.176.589", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a province of eastern Canada", "MS": "A province of eastern Canada, one of the Maritime Provinces with NEW BRUNSWICK; PRINCE EDWARD ISLAND; and sometimes NEWFOUNDLAND AND LABRADOR. Its capital is Halifax. The territory was granted in 1621 by James I to the Scotsman Sir William Alexander and was called Nova Scotia, the Latin for New Scotland. The territory had earlier belonged to the French, under the name of Acadia. (From Webster's New Geographical Dictionary, 1988, p871 & Room, Brewer's Dictionary of Names, 1992, p384)", "MR": "20070711", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009674"}, {"RECTYPE": "D", "MH": "Novobiocin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Streptonivicin|T109|T195|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Sodium, Novobiocin", "MN": "D09.408.554", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "Benzamide, N-(7-((3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-beta-L-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl)-", "RN": "17EC19951N", "RR": "RHW5BU180N", "MS": "An antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase (ATPase) activity. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009675"}, {"RECTYPE": "D", "MH": "Noxae", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D27.888.569", "MH_TH": "NLM (1974)", "ST": "T131", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Agents capable of exerting a harmful effect on the body.", "PM": "98", "HN": "98; use explode 1974-97", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009676"}, {"RECTYPE": "D", "MH": "Noxythiolin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Noxitiolin|T109|T121|NON|EQV|INN (19XX)|750701|abbcdef", "ENTRY": "NoxyflexS", "MN": "D02.886.904.500", "PA": "Anti-Infective Agents, Local", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Thiourea, N-(hydroxymethyl)-N'-methyl-", "RN": "4DN3AF1FU6", "RR": "15599-39-0 (Noxythiolin)", "PI": "Thiourea (1974) /analogs & derivatives (1975)", "MS": "Local antibacterial that probably acts by releasing formaldehyde in aqueous solutions. It is used for THERAPEUTIC IRRIGATION of infected body cavities - bladder, peritoneum, etc. and as a spray for burns.", "PM": "91; was see under THIOUREA 1976-90", "HN": "91(76); was see under THIOUREA 1976-90", "MR": "20200527", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D009677"}, {"RECTYPE": "D", "MH": "Nuclear Energy", "AQ": "EC ES HI LJ SN", "PRINT ENTRY": "Atomic Energy|T070|NON|EQV|UNK (19XX)|810519|abcdef", "ENTRY": "Energy, Nuclear", "MN": "N06.230.132.580", "FX": "Radioactive Waste", "MH_TH": "BIOETHICS (1978)", "ST": "T070", "AN": "NUCLEAR POWER PLANTS is also available", "MS": "Energy released by nuclear fission or nuclear fusion.", "OL": "use NUCLEAR ENERGY to search ATOMIC ENERGY 1966-81 (as Cat H heading)", "PM": "82; was ATOMIC ENERGY 1963-81", "HN": "82; was ATOMIC ENERGY (Cat H heading only) 1963-81", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19820101", "UI": "D009678"}, {"RECTYPE": "D", "MH": "Nuclear Family", "AQ": "EH HI PX", "ENTRY": "Son", "MN": "N06.850.505.400.400.580.750", "MH_TH": "NLM (2000)", "ST": "T099", "MS": "A family composed of spouses and their children.", "PM": "91; was see under FAMILY 1975-90", "HN": "91(75); was see under FAMILY 1975-90", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D009679"}, {"RECTYPE": "D", "MH": "Nuclear Fission", "ENTRY": "Nuclear Fissions", "MN": "N06.230.132.580.500", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "do not confuse with NUCLEAR FUSION", "PI": "Nuclear Energy (1966-1970)", "MS": "Nuclear reaction in which the nucleus of a heavy atom such as uranium or plutonium is split into two approximately equal parts by a neutron, charged particle, or photon.", "PM": "74", "HN": "74(71); was in Cat H only 1971-81", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009680"}, {"RECTYPE": "D", "MH": "Nuclear Fusion", "ENTRY": "Nuclear Fusions", "MN": "N06.230.132.580.520", "MH_TH": "NLM (1972)", "ST": "T070", "AN": "do not confuse with NUCLEAR FISSION", "PI": "Nuclear Energy (1966-1970)", "MS": "Thermonuclear reaction in which the nuclei of an element of low atomic weight unite under extremely high temperature and pressure to form a nucleus of a heavier atom.", "OL": "use NUCLEAR ENERGY to search NUCLEAR FUSION 1971-74 (as Prov)", "PM": "91; was see under NUCLEAR ENERGY 1982-90; was see under ATOMIC ENERGY 1975-81; was in Cat H only 1971-81", "HN": "91(71); was see under NUCLEAR ENERGY 1982-90; was see under ATOMIC ENERGY 1975-81; was Prov 1971-74; was in Cat H only 1971-81", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009681"}, {"RECTYPE": "D", "MH": "Magnetic Resonance Spectroscopy", "AQ": "AE CL EC HI IS MT SN ST TU", "PRINT ENTRY": "Spectroscopy, Nuclear Magnetic Resonance|T060|NON|NRW|UNK (19XX)|870508|abcdef", "ENTRY": "Spectroscopy, MR", "MN": "E05.196.867.519", "FX": "Magnetic Resonance Imaging", "MH_TH": "UNK (19XX)", "ST": "T060", "AN": "index element or isotope used in performing the NMR spectroscopy only if discussed (probably NIM); do not confuse with MAGNETIC RESONANCE IMAGING: check text; coordinate with disease, organ or tissue using pertinent qualifiers; for diagnostic use coordinate with disease /diag", "MS": "Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING).", "PM": "66", "HN": "66(65)", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009682"}, {"RECTYPE": "D", "MH": "Nuclear Medicine", "DE": "NUCLEAR MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Nuclear Radiology|T091|NON|NRW|UNK (19XX)|790529|NUCLEAR RADIOL|abcdefv", "ENTRY": "Radiology, Nuclear|T091|NON|NRW|NLM (1992)|900927|RADIOL NUCLEAR|abcdefv", "MN": "H02.403.740.500", "FX": "Radioisotopes", "MH_TH": "NLM (1967)", "ST": "T091", "PI": "Radioisotopes (1966)", "MS": "A specialty field of radiology concerned with diagnostic, therapeutic, and investigative use of radioactive compounds.", "PM": "67", "HN": "67", "MR": "20160302", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009683"}, {"RECTYPE": "D", "MH": "Nuclear Medicine Department, Hospital", "DE": "NUCLEAR MED DEP", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Hospital Nuclear Medicine Department|T093|NON|EQV|NLM (1991)|900110|HOSP NUCLEAR MED DEP|abcdefv", "ENTRY": "Nuclear Medicine Departments, Hospital|T093|NON|EQV|UNK (19XX)|830719|NUCLEAR MED DEP HOSP|abcdefv", "MN": "N04.452.442.452.688", "MH_TH": "NLM (1982)", "ST": "T093", "AN": "restrict to radioisotope diag & ther serv: do not confuse with RADIOLOGY DEPARTMENT, HOSPITAL (x-ray & radiocobalt only)", "PI": "Nuclear Medicine (1967-1981)", "MS": "Hospital department responsible for the administration and management of nuclear medicine services.", "PM": "91; was see under HOSPITAL DEPARTMENTS 1982-90", "HN": "91(82); was see under HOSPITAL DEPARTMENTS 1982-90", "MR": "20190709", "DA": "19810519", "DC": "1", "DX": "19910101", "UI": "D009684"}, {"RECTYPE": "D", "MH": "Nuclear Envelope", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Nuclear Membrane|T026|NON|EQV|NLM (1977)|990101|abcdef", "ENTRY": "Nuclear Membranes", "MN": "A11.284.835.514.700", "MH_TH": "UNK (19XX)", "ST": "T026", "PI": "Membranes (1968-1976)", "MS": "The membrane system of the CELL NUCLEUS that surrounds the nucleoplasm. It consists of two concentric membranes separated by the perinuclear space. The structures of the envelope where it opens to the cytoplasm are called the nuclear pores (NUCLEAR PORE).", "PM": "2001; for NUCLEAR ENVELOPE see NUCLEAR MEMBRANE 1977-2000", "HN": "2001", "MR": "20130709", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D009685"}, {"RECTYPE": "D", "MH": "Nuclear Physics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Physics, Nuclear", "MN": "H01.671.579", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "MS": "The study of the characteristics, behavior, and internal structures of the atomic nucleus and its interactions with other nuclei. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009686"}, {"RECTYPE": "D", "MH": "Nuclear Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleolar Proteins|T116|T123|NON|NRW|UNK (19XX)|870403|abbcdef", "ENTRY": "Proteins, Nucleolar", "MN": "D12.776.660", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "AN": "proteins in the cell nucleus: do not confuse with NUCLEOPROTEINS (proteins conjugated with nucleic acids)", "PI": "Proteins (1966-1987)", "MS": "Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.", "PM": "88", "HN": "88", "MR": "20200527", "DA": "19870403", "DC": "1", "DX": "19880101", "UI": "D009687"}, {"RECTYPE": "D", "MH": "Nuclear Reactors", "AQ": "CL EC HI IS LJ SD SN ST", "ENTRY": "Reactors, Nuclear", "MN": "E07.710.600", "FX": "Radioactive Hazard Release", "MH_TH": "NLM (1964)", "ST": "T073", "AN": "RADIONUCLIDE GENERATORS and NUCLEAR POWER PLANTS are also available", "MS": "Devices containing fissionable material in sufficient quantity and so arranged as to be capable of maintaining a controlled, self-sustaining NUCLEAR FISSION chain reaction. They are also known as atomic piles, atomic reactors, fission reactors, and nuclear piles, although such names are deprecated. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "68", "HN": "68(64)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009688"}, {"RECTYPE": "D", "MH": "Nuclear Warfare", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Atomic Warfare|T052|NON|EQV|UNK (19XX)|810519|abcdef", "ENTRY": "Warfare, Nuclear", "MN": "I01.880.735.950.500.600", "FX": "Radioactive Fallout", "MH_TH": "BIOETHICS (1982)", "ST": "T052", "MS": "Warfare involving the use of NUCLEAR WEAPONS.", "OL": "use NUCLEAR WARFARE to search ATOMIC WARFARE 1966-81", "PM": "82; was ATOMIC WARFARE 1963-81", "HN": "82; was ATOMIC WARFARE 1963-81", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19820101", "UI": "D009689"}, {"RECTYPE": "D", "MH": "Nucleic Acid Conformation", "AQ": "DE RE", "ENTRY": "RNA Conformations", "MN": "G05.360.580", "FX": "RNA Folding", "MH_TH": "NLM (1972)", "ST": "T082", "AN": "coord with DNA or RNA or specific", "PI": "Nucleic Acids (1966-1971)", "MS": "The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009690"}, {"RECTYPE": "D", "MH": "Nucleic Acid Denaturation", "AQ": "DE GE PD RE", "PRINT ENTRY": "RNA Denaturation|T070|NON|NRW|NLM (2006)|060525|abcdef", "ENTRY": "Nucleic Acid Denaturations", "MN": "G05.627", "FX": "RNA Stability", "MH_TH": "NLM (1967)", "ST": "T070", "AN": "IM general only; coord NIM with DNA or RNA or specific (IM)", "MS": "Disruption of the secondary structure of nucleic acids by heat, extreme pH or chemical treatment. Double strand DNA is \"melted\" by dissociation of the non-covalent hydrogen bonds and hydrophobic interactions. Denatured DNA appears to be a single-stranded flexible structure. The effects of denaturation on RNA are similar though less pronounced and largely reversible.", "PM": "70", "HN": "70(67)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D009691"}, {"RECTYPE": "D", "MH": "Nucleic Acid Heteroduplexes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heteroduplexes, Nucleic Acid|T114|NON|EQV|UNK (19XX)|790523|abcdef", "ENTRY": "DNA, Heteroduplex", "MN": "D13.444.500", "FX": "Heteroduplex Analysis", "MH_TH": "NLM (1980)", "ST": "T114", "RN": "0", "AN": "coord with specific DNA or RNA or both (IM)", "PI": "specific RNA (1966-1979)", "MS": "Double-stranded nucleic acid molecules (DNA-DNA or DNA-RNA) which contain regions of nucleotide mismatches (non-complementary). In vivo, these heteroduplexes can result from mutation or genetic recombination; in vitro, they are formed by nucleic acid hybridization. Electron microscopic analysis of the resulting heteroduplexes facilitates the mapping of regions of base sequence homology of nucleic acids.", "PM": "80", "HN": "80", "MR": "19980610", "DA": "19790523", "DC": "1", "DX": "19800101", "UI": "D009692"}, {"RECTYPE": "D", "MH": "Nucleic Acid Hybridization", "AQ": "DE ES GE IM MT PH RE", "PRINT ENTRY": "Genomic Hybridization|T070|NON|BRD|NLM (1997)|960410|abcdef", "ENTRY": "Nucleic Acid Hybridizations", "MN": "G02.111.611", "FX": "Blotting, Southern", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "IM general only; coord NIM with DNA or RNA or specific (IM); IN SITU HYBRIDIZATION & IN SITU HYBRIDIZATION, FLUORESCENCE are available", "PI": "RNA (1966-1970)", "MS": "Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503)", "PM": "72", "HN": "72(71)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009693"}, {"RECTYPE": "D", "MH": "Nucleic Acid Precursors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Precursors, Nucleic Acid", "MN": "D13.400", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "IM; coord with DNA or RNA or specific (IM); /drug eff /ultrastruct permitted", "PI": "Nucleic Acids (1968-1974)", "MS": "Use for nucleic acid precursors in general or for which there is no specific heading.", "PM": "75", "HN": "75", "MR": "19920519", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D009694"}, {"RECTYPE": "D", "MH": "Nucleic Acid Renaturation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Renaturations, Nucleic Acid", "MN": "G02.111.619", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "IM general only; coord NIM with DNA or RNA or specific (IM)", "PI": "RNA (1966-1970)", "MS": "The reformation of all, or part of, the native conformation of a nucleic acid molecule after the molecule has undergone denaturation.", "PM": "78; was see under NUCLEIC ACIDS 1975-77", "HN": "78(71); was see under NUCLEIC ACIDS 1975-77", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D009695"}, {"RECTYPE": "D", "MH": "Nucleic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleic Acid|T114|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Acids, Nucleic", "MN": "D13.444", "MH_TH": "NLM (1966)", "ST": "T114", "RN": "0", "AN": "general or unspecified; prefer RNA or DNA and specifics", "MS": "High molecular weight polymers containing a mixture of purine and pyrimidine nucleotides chained together by ribose or deoxyribose linkages.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009696"}, {"RECTYPE": "D", "MH": "Nucleolus Organizer Region", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Nucleolar Organizer|T026|T028|NON|EQV|UNK (19XX)|790525|abbcdef", "ENTRY": "Regions, Nucleolus Organizer", "MN": "G05.360.340.024.380.875", "MH_TH": "NLM (1980)", "ST": "T028", "PI": "specific human chromosome (1968-1979)", "MS": "The chromosome region which is active in nucleolus formation and which functions in the synthesis of ribosomal RNA.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19790525", "DC": "1", "DX": "19800101", "UI": "D009697"}, {"RECTYPE": "D", "MH": "Nucleoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nucleoprotein|T116|T123|NON|EQV|NLM (1991)|891012|abbcdef", "MN": "D12.776.664", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "proteins conjugated with nucleic acids: do not confuse with NUCLEAR PROTEINS (proteins in the cell nucleus)", "MS": "Proteins conjugated with nucleic acids.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009698"}, {"RECTYPE": "D", "MH": "N-Glycosyl Hydrolases", "DS": "GLYCOSYL HYDROLASES N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleoside Hydrolase|T116|T126|NON|NRW|NLM (2021)|200603|abbcdef", "ENTRY": "Nitrogen linked Glycoside Hydrolases", "MN": "D08.811.277.450.430", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "EC 3.2.2.-", "MS": "A class of enzymes involved in the hydrolysis of the N-glycosidic bond of nitrogen-linked sugars.", "PM": "2003; see NUCLEOSIDASES 1966-2002", "HN": "2003(1966)", "MR": "20200617", "DA": "19990101", "DC": "1", "DX": "20030101", "UI": "D009699"}, {"RECTYPE": "D", "MH": "Nucleoside Deaminases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Deaminases, Nucleoside", "MN": "D08.811.277.151.486", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.5.4.-", "AN": "do not confuse with NUCLEOTIDE DEAMINASES", "PI": "Aminohydrolases (1966-1974)", "MS": "Catalyze the hydrolysis of nucleosides with the elimination of ammonia.", "OL": "search AMINOHYDROLASES 1966-74", "PM": "75; was see under AMINOHYDROLASES 1974, was NUCLEOSIDE AND NUCLEOTIDE DEAMINASES see AMINOHYDROLASES 1963-73", "HN": "75; was see under AMINOHYDROLASES 1974, was NUCLEOSIDE AND NUCLEOTIDE DEAMINASES see AMINOHYDROLASES 1963-73", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D009700"}, {"RECTYPE": "D", "MH": "Nucleoside-Diphosphate Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nucleoside Diphosphate Kinases", "MN": "D08.811.913.696.650.550", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "ATP:nucleoside-diphosphate phosphotransferase", "RN": "EC 2.7.4.6", "RR": "9026-51-1 (CAS RN)", "PI": "Phosphotransferases, ATP (1974-1976)", "MS": "An enzyme that is found in mitochondria and in the soluble cytoplasm of cells. It catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside diphosphate, e.g., UDP, to form ADP and UTP. Many nucleoside diphosphates can act as acceptor, while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.6.", "OL": "use NUCLEOSIDE-DIPHOSPHATE KINASE to search NUCLEOSIDE DIPHOSPHATE KINASES 1977-93", "PM": "94; was NUCLEOSIDE DIPHOSPHATE KINASES 1977-93 (see under PHOSPHOTRANSFERASES, ATP 1977-90)", "HN": "94; was NUCLEOSIDE DIPHOSPHATE KINASES 1977-93 (see under PHOSPHOTRANSFERASES, ATP 1977-90)", "MR": "20030709", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D009701"}, {"RECTYPE": "D", "MH": "Nucleoside Diphosphate Sugars", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sugars, Nucleoside Diphosphate", "MN": "D13.695.827.708", "MH_TH": "NLM (1971)", "ST": "T123", "RN": "0", "PI": "specific nucleotide (1966-1972)", "PM": "73", "HN": "73(71)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009702"}, {"RECTYPE": "D", "MH": "Nucleoside-Phosphate Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nucleoside Phosphate Kinase", "MN": "D08.811.913.696.650.575", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "ATP:nucleoside-phosphate phosphotransferase", "RN": "EC 2.7.4.4", "RR": "9026-50-0 (CAS RN)", "PI": "Phosphotransferases, ATP (1974-1976)", "MS": "An enzyme that catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside monophosphate, e.g., UMP, to form ADP and UDP. Many nucleoside monophosphates can act as acceptor while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.4.", "OL": "use NUCLEOSIDE-PHOSPHATE KINASE to search NUCLEOSIDE MONOPHOSPHATE KINASES 1977-93", "PM": "94; was NUCLEOSIDE MONOPHOSPHATE KINASES 1977-93 (see under PHOSPHOTRANSFERASES, ATP 1977-90)", "HN": "94; was NUCLEOSIDE MONOPHOSPHATE KINASES 1977-93 (see under PHOSPHOTRANSFERASES, ATP 1977-90)", "MR": "20030709", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D009703"}, {"RECTYPE": "D", "MH": "Nucleoside Q", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Q Ribonucleoside", "MN": "D13.570.800.453.500", "MH_TH": "NLM (1980)", "ST": "T123", "N1": "4H-Pyrrolo(2,3-d)pyrimidin-4-one, 2-amino-5-(((4,5-dihydroxy-2-cyclopenten-1-yl)amino)methyl)-1,7-dihydro-7-beta-D-ribofuranosyl-, (1S-(1alpha,4beta,5beta))-", "RN": "57072-36-3", "RR": "70293-97-9 (nucleoside Q*)", "AN": "/biosyn /physiol permitted", "PI": "Nucleosides (1966-1971)", "MS": "A modified nucleoside which is present in the first position of the anticodon of tRNA-tyrosine, tRNA-histidine, tRNA-asparagine and tRNA-aspartic acid of many organisms. It is believed to play a role in the regulatory function of tRNA. Nucleoside Q can be further modified to nucleoside Q*, which has a mannose or galactose moiety linked to position 4 of its cyclopentenediol moiety.", "PM": "91; was see under GUANOSINE 1980-90", "HN": "91(80); was see under GUANOSINE 1980-90", "MR": "20160531", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D009704"}, {"RECTYPE": "D", "MH": "Nucleosides", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleoside Analog|T114|NON|REL|NLM (2021)|200210|abcdef", "ENTRY": "Analogs, Nucleoside", "MN": "D13.570", "MH_TH": "NLM (1966)", "ST": "T114", "RN": "0", "MS": "Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009705"}, {"RECTYPE": "D", "MH": "Nucleic Acids, Nucleotides, and Nucleosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D13", "RH": "D13 - NUCLEIC ACIDS, NUCLEOTIDES, AND NUCLEOSIDES", "MH_TH": "NLM (1974)", "ST": "T114", "RN": "0", "AN": "used for searching; NUCLEIC ACIDS; NUCLEOTIDES; & NUCLEOSIDES are available; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Complex compounds of high molecular weight occurring in living cells. These are basically of two types, ribonucleic (RNA) and deoxyribonucleic (DNA) acids, both of which consist of nucleotides (nucleoside phosphates linked together by phosphate bridges).", "PM": "98", "HN": "98; use explode", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009706"}, {"RECTYPE": "D", "MH": "Nucleosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Polynucleosome", "MN": "G05.360.160.180.625", "MH_TH": "NLM (1980)", "ST": "T123", "RN": "0", "PI": "Chromatin (1972-1979)", "MS": "The repeating structural units of chromatin, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4.", "PM": "80", "HN": "80", "MR": "20080708", "DA": "19781220", "DC": "1", "DX": "19800101", "UI": "D009707"}, {"RECTYPE": "D", "MH": "Nucleotidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.352.650.600", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.1.3.-", "MS": "A class of enzymes that catalyze the conversion of a nucleotide and water to a nucleoside and orthophosphate. EC 3.1.3.-.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009708"}, {"RECTYPE": "D", "MH": "Nucleotide Deaminases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Deaminases, Nucleotide", "MN": "D08.811.277.151.653", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.5.4.-", "AN": "do not confuse with NUCLEOSIDE DEAMINASES", "PI": "Aminohydrolases (1966-1974)", "MS": "Catalyze the hydrolysis of nucleotides with the elimination of ammonia.", "OL": "search AMINOHYDROLASES 1966-74", "PM": "75; was see under AMINOHYDROLASES 1974, was NUCLEOSIDE AND NUCLEOTIDE DEAMINASES see AMINOHYDROLASES 1963-73", "HN": "75; was see under AMINOHYDROLASES 1974, was NUCLEOSIDE AND NUCLEOTIDE DEAMINASES see AMINOHYDROLASES 1963-73", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D009709"}, {"RECTYPE": "D", "MH": "Nucleotide Mapping", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Fingerprints, Nucleotide|T059|NON|NRW|UNK (19XX)|860624|abcdef", "ENTRY": "Nucleotide Mappings", "MN": "E05.196.680", "MH_TH": "NLM (1987)", "ST": "T059", "AN": "2-dimensional separation & anal of nucleotides", "PI": "Electrophoresis, Paper (1973-1986)", "MS": "Two-dimensional separation and analysis of nucleotides.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19860624", "DC": "1", "DX": "19870101", "UI": "D009710"}, {"RECTYPE": "D", "MH": "Nucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nucleotide|T114|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D13.695", "FX": "Base Sequence", "MH_TH": "NLM (1966)", "ST": "T114", "RN": "0", "AN": "pyridine nucleotides are probably NAD or NADP; /anal: consider also NUCLEOTIDE MAPPING", "MS": "The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009711"}, {"RECTYPE": "D", "MH": "Nucleotides, Cyclic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclic Nucleotide|T114|NON|EQV|NLM (2021)|200106|abcdef", "ENTRY": "Nucleotide, Cyclic", "MN": "D13.695.462", "MH_TH": "NLM (1974)", "ST": "T114", "RN": "0", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009712"}, {"RECTYPE": "D", "MH": "Nucleotidyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleotidyltransferase|T116|T126|NON|EQV|NLM (2021)|200227|abbcdef", "MN": "D08.811.913.696.445", "MH_TH": "NLM (1968)", "ST": "T126", "RN": "EC 2.7.7.-", "MS": "A class of enzymes that transfers nucleotidyl residues. EC 2.7.7.", "OL": "use NUCLEOTIDYLTRANSFERASES to search NUCLEOTIDYL TRANSFERASES 1966-67", "PM": "68; was NUCLEOTIDYL TRANSFERASES 1963-67", "HN": "68; was NUCLEOTIDYL TRANSFERASES 1963-67", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009713"}, {"RECTYPE": "D", "MH": "Nucleus Accumbens", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Septus, Nucleus Accumbens", "MN": "A08.186.211.200.885.287.249.487.775.500", "MH_TH": "NLM (1978)", "ST": "T023", "PI": "Septal Nuclei (1972-1977)", "MS": "Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA.", "PM": "91; was see under SEPTAL NUCLEI 1978-90", "HN": "91(78); was see under SEPTAL NUCLEI 1978-90", "MR": "20180630", "DA": "19770329", "DC": "1", "DX": "19910101", "UI": "D009714"}, {"RECTYPE": "D", "MH": "Nudism", "AQ": "CL EC ES HI LJ PX SN TD", "ENTRY": "Nudisms", "MN": "I03.548", "MH_TH": "NLM (1966)", "ST": "T056", "MS": "The practice of living unclothed for reasons of comfort or health.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009715"}, {"RECTYPE": "D", "MH": "Numerical Analysis, Computer-Assisted", "DE": "NUMERICAL ANAL COMPUTER ASSISTED", "AQ": "IS", "ENTRY": "Numerical Analysis, Computer Assisted", "MN": "L01.224.680.700", "MH_TH": "NLM (1987)", "ST": "T057", "AN": "IM", "MS": "Computer-assisted study of methods for obtaining useful quantitative solutions to problems that have been expressed mathematically.", "PM": "91; was see under MATHEMATICAL COMPUTING 1987-90", "HN": "91(87); was see under MATHEMATICAL COMPUTING 1987-90", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19910101", "UI": "D009716"}, {"RECTYPE": "D", "MH": "Numismatics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Medals|T073|NON|REL|NLM (1998)|960717|abcdef", "ENTRY": "Medal", "MN": "K01.093.560", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "Study of coins, tokens, medals, etc. However, it usually refers to medals pertaining to the history of medicine.", "HN": "was in Cat I 1975-82, was in Cat E 1963-74", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009717"}, {"RECTYPE": "D", "MH": "Nurse Administrators", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Nurse Manager", "MN": "N02.360.650.580", "MH_TH": "NLM (1982)", "ST": "T097", "AN": "do not confuse with HEAD NURSES see NURSING, SUPERVISORY; in British journals \"matron\" goes here but nursing \"sisters\" go under NURSING, SUPERVISORY", "PI": "Nursing Service, Hospital (1968-1977)/organization & administration (1978-1981)", "MS": "Nurses professionally qualified in administration.", "PM": "91; was see under ADMINISTRATIVE PERSONNEL 1982-90", "HN": "91(82); was see under ADMINISTRATIVE PERSONNEL 1982-90", "MR": "20180629", "DA": "19810302", "DC": "1", "DX": "19910101", "UI": "D009718"}, {"RECTYPE": "D", "MH": "Nurse Anesthetists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Nurse Anesthetist", "MN": "N02.360.650.648.500", "MH_TH": "NLM (1975)", "ST": "T097", "MS": "Professional nurses who have completed postgraduate training in the administration of anesthetics.", "OL": "use NURSE ANESTHETISTS to search NURSE ANESTHETIST 1975-76", "PM": "77; was NURSE ANESTHETIST see under NURSES 1975-76", "HN": "77; was NURSE ANESTHETIST see under NURSES 1975-76", "MR": "20180629", "DA": "19741111", "DC": "1", "DX": "19770101", "UI": "D009719"}, {"RECTYPE": "D", "MH": "Nurse Clinicians", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Clinical Nurse Specialists|T097|NON|EQV|UNK (19XX)|770511|CLIN NURSE SPECIALISTS|abcdefv", "ENTRY": "Nurse Clinician", "MN": "N02.360.650.648.525", "MH_TH": "NLM (1978)", "ST": "T097", "PI": "Nurse Practitioners (1973-1977)", "MS": "Registered nurses who hold Master's degrees in nursing with an emphasis in clinical nursing and who function independently in coordinating plans for patient care.", "OL": "search NURSE PRACTITIONERS 1973-77", "PM": "78; was NURSE CLINICIAN see NURSE PRACTITIONERS 1976-77, see NURSE PRACTITIONER 1973-75", "HN": "78; was NURSE CLINICIAN see NURSE PRACTITIONERS 1976-77, see NURSE PRACTITIONER 1973-75", "MR": "20180629", "DA": "19770511", "DC": "1", "DX": "19780101", "UI": "D009720"}, {"RECTYPE": "D", "MH": "Nurse Midwives", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Nurse Midwife", "MN": "N02.360.650.648.762", "MH_TH": "BIOETHICS (1980)", "ST": "T097", "MS": "Professional nurses who have received postgraduate training in MIDWIFERY.", "OL": "use NURSE MIDWIVES to search NURSE MIDWIFE 1975-76", "PM": "77; was NURSE MIDWIFE see under NURSES 1975-76", "HN": "77; was NURSE MIDWIFE see under NURSES 1975-76", "MR": "20180629", "DA": "19741111", "DC": "1", "DX": "19770101", "UI": "D009721"}, {"RECTYPE": "D", "MH": "Nurse Practitioners", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Practitioners, Nurse", "MN": "N02.360.650.640", "MH_TH": "NLM (1976)", "ST": "T097", "MS": "Nurses who are specially trained to assume an expanded role in providing medical care under the supervision of a physician.", "OL": "use NURSE PRACTITIONERS to search NURSE PRACTITIONER 1973-75", "PM": "76; was NURSE PRACTITIONER 1973-75", "HN": "76; was NURSE PRACTITIONER 1973-75", "MR": "20180629", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D009722"}, {"RECTYPE": "D", "MH": "Nurse-Patient Relations", "DE": "NURSE PATIENT RELAT", "AQ": "ES", "ENTRY": "Relationships, Nurse Patient", "MN": "N05.300.660.560", "MH_TH": "NLM (1966)", "ST": "T054", "MS": "Interaction between the patient and nurse.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009723"}, {"RECTYPE": "D", "MH": "Nurseries, Infant", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Nurseries|T073|T092|NON|BRD|NLM (1973)|990101|abbcdef", "ENTRY": "Nursery, Infant", "MN": "N02.421.143.098.500", "MH_TH": "NLM (2020)", "ST": "T073", "AN": "NURSERIES, HOSPITAL is also available", "MS": "Facilities which provide care for infants.", "PM": "73", "HN": "2020(1973); was NURSERIES 1973-2019", "MR": "20190307", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009724"}, {"RECTYPE": "D", "MH": "Nurseries, Hospital", "DE": "NURSERIES HOSP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Nurseries|T073|T093|NON|EQV|UNK (19XX)|770519|HOSP NURSERIES|abbcdefv", "ENTRY": "Nursery, Hospital|T073|T093|NON|EQV|NLM (1997)|951004|NURSERY HOSP|abbcdefv", "MN": "N02.278.388.557", "MH_TH": "NLM (1972)", "ST": "T093", "AN": "NURSERIES, INFANT is also available", "PI": "Infant, Newborn, Diseases (1966-1971)", "MS": "Hospital facilities which provide care for newborn infants.", "OL": "use NURSERIES, HOSPITAL to search HOSPITAL NURSERIES 1972-77", "PM": "78; was HOSPITAL NURSERIES 1972-77", "HN": "78; was HOSPITAL NURSERIES 1972-77", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009725"}, {"RECTYPE": "D", "MH": "Nurses", "AQ": "CL EC LJ OG PX SD SN ST TD", "ENTRY": "Registered Nurse", "MN": "N02.360.650", "EC": "history:History of Nursing", "MH_TH": "BIOETHICS (1974)", "ST": "T097", "AN": "relation to nursing specialties: Manual 34.11.3", "MS": "Professionals qualified by graduation from an accredited school of nursing and by passage of a national licensing examination to practice nursing. They provide services to patients requiring assistance in recovering or maintaining their physical or mental health.", "PM": "67", "HN": "67(65)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009726"}, {"RECTYPE": "D", "MH": "Nurses, Male", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Nurse, Male", "MN": "N02.360.650.670", "MH_TH": "NLM (1967)", "ST": "T097", "AN": "relation to nurs specialties: Manual 34.11.3; use of check tags: Manual 34.6", "PI": "Nursing (1966)", "MS": "Nurses of the male sex.", "PM": "67", "HN": "67", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009727"}, {"RECTYPE": "D", "MH": "Nursing Assistants", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Nursing Auxiliaries|T097|NON|REL|NLM (1998)|961022|NURS AUXILIARIES|abcdefv", "ENTRY": "Nursing Auxiliary", "MN": "N02.360.067.652", "MH_TH": "NLM (2019)", "ST": "T097", "PM": "2019; see Nurses Aides 1966-2018", "HN": "2019(1966)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009728"}, {"RECTYPE": "D", "MH": "Nursing", "DE": "NURS", "AQ": "CL IS MT OG SN ST TD", "ENTRY": "Nursings", "MN": "N04.452.758.377", "FX": "Legislation, Nursing", "EC": "legislation & jurisprudence:Legislation, Nursing", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "The field of nursing care concerned with the promotion, maintenance, and restoration of health.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009729"}, {"RECTYPE": "D", "MH": "Nursing Assessment", "DE": "NURS ASSESS", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Nursing Protocols|T170|NON|NRW|NLM (1992)|910503|NURS PROTOCOLS|abcdefv", "ENTRY": "Protocol, Nursing", "MN": "N04.590.233.508.480", "MH_TH": "NLM (1975)", "ST": "T058", "AN": "to evaluate nature & extent of nurs problems of patient to plan patient care; do not confuse with NURSING AUDIT (to evaluate quality of nurs care)", "MS": "Evaluation of the nature and extent of nursing problems presented by a patient for the purpose of patient care planning.", "PM": "87; was see under NURSING PROCESS 1980-86, was NURSING DIAGNOSIS see under NURSING CARE 1975-79", "HN": "87(80); was see under NURSING PROCESS 1980-86, was NURSING DIAGNOSIS see under NURSING CARE 1975-79", "MR": "20190524", "DA": "19741111", "DC": "1", "DX": "19870101", "UI": "D009730"}, {"RECTYPE": "D", "MH": "Nursing Audit", "DE": "NURS AUDIT", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing Audits", "MN": "N05.700.175.520", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "to evaluate quality of nursing care; do not confuse with NURSING ASSESSMENT (to evaluate nursing problems of patient to plan care)", "PI": "Nursing Service, Hospital (1966-1967)", "MS": "A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of nursing care.", "PM": "68", "HN": "68", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009731"}, {"RECTYPE": "D", "MH": "Nursing Care", "DE": "NURS CARE", "AQ": "CL ES MT OG PX SN ST TD", "ENTRY": "Nursing Care Management|T058|NON|NRW|NLM (1992)|910503|NURS CARE MANAGEMENT|abcdefv", "MN": "N02.421.533", "EC": "legislation & jurisprudence:Legislation, Nursing", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "Care given to patients by nursing service personnel.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009732"}, {"RECTYPE": "D", "MH": "Nursing Diagnosis", "DE": "NURS DIAG", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Diagnosis, Nursing|T058|NON|EQV|UNK (19XX)|860530|DIAG NURS|abcdefv", "ENTRY": "Nursing Diagnoses", "MN": "N04.590.233.508.480.110", "MH_TH": "NLM (1987)", "ST": "T058", "PI": "Nursing Assessment (1980-1986)", "MS": "Conclusions derived from the nursing assessment that establish a health status profile for the patient and from which nursing interventions may be ordered.", "OL": "search NURSING ASSESSMENT 1975-86", "PM": "91; was see under NURSING ASSESSMENT 1987-90; was see NURSING ASSESSMENT 1980-86; was see under NURSING CARE 1975-79", "HN": "91(87)(75-79); was see under NURSING ASSESSMENT 1987-90; was see NURSING ASSESSMENT 1980-86; was see under NURSING CARE 1975-79", "MR": "19940505", "DA": "19860530", "DC": "1", "DX": "19910101", "UI": "D009733"}, {"RECTYPE": "D", "MH": "Nursing Faculty Practice", "DE": "NURS FACULTY PRACTICE", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Faculty Practice, Nursing|T058|NON|EQV|UNK (19XX)|870304|FACULTY PRACTICE NURS|abcdefv", "ENTRY": "Practices, Nursing Faculty", "MN": "N04.452.758.388", "MH_TH": "NLM (1988)", "ST": "T058", "AN": "clin practice by nurs faculty to maintain balanced professional activities", "PI": "Faculty, Nursing (1966-1987)", "MS": "Clinical practice by members of the nursing faculty in order to maintain a balance in their nursing activities--clinical, education, and research.", "PM": "88", "HN": "88", "MR": "19940505", "DA": "19870304", "DC": "1", "DX": "19880101", "UI": "D009734"}, {"RECTYPE": "D", "MH": "Nursing Homes", "DE": "NURS HOMES", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Nursing Home", "MN": "N02.278.825.610", "MH_TH": "BIOETHICS (1974)", "ST": "T093", "AN": "nursing homes for the aged: coordinate with HOMES FOR THE AGED ", "MS": "Facilities which provide nursing supervision and limited medical care to persons who do not require hospitalization.", "MR": "20210611", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009735"}, {"RECTYPE": "D", "MH": "Nursing Process", "DE": "NURS PROCESS", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Processes, Nursing", "MN": "N04.590.233.508", "MH_TH": "NLM (1980)", "ST": "T058", "AN": "\"total of nursing activities\"; do not confuse with NURSING (the profession), NURSING CARE (the patient), or NURSING SERVICES", "PI": "Patient Care Planning (1968-1979)", "MS": "The sum total of nursing activities which includes assessment (identifying needs), intervention (ministering to needs), and evaluation (validating the effectiveness of the help given).", "PM": "80", "HN": "80", "MR": "19940505", "DA": "19790411", "DC": "1", "DX": "19800101", "UI": "D009736"}, {"RECTYPE": "D", "MH": "Nursing Records", "DE": "NURS RECORDS", "AQ": "CL EC LJ SN ST", "ENTRY": "Record, Nursing", "MN": "N06.850.520.308.940.984", "FX": "Forms and Records Control", "MH_TH": "NLM (1967)", "ST": "T170", "AN": "FORMS AND RECORDS CONTROL, also available, is probably NIM when coord", "PI": "Medical Records (1966)", "MS": "Data recorded by nurses concerning the nursing care given to the patient, including judgment of the patient's progress.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009737"}, {"RECTYPE": "D", "MH": "Nursing Service, Hospital", "DE": "NURS SERV HOSP", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Hospital Nursing Service|T058|NON|EQV|UNK (19XX)|770519|HOSP NURS SERV|abcdefv", "ENTRY": "Services, Hospital Nursing", "MN": "N04.452.442.452.422.489", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "The hospital department which is responsible for the organization and administration of nursing activities.", "OL": "use NURSING SERVICE, HOSPITAL to search HOSPITAL NURSING SERVICE 1966-77", "PM": "78; was HOSPITAL NURSING SERVICE 1963-77", "HN": "78; was HOSPITAL NURSING SERVICE 1963-77", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D009738"}, {"RECTYPE": "D", "MH": "Nursing Services", "DE": "NURS SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Service, Nursing", "MN": "N02.421.539", "MH_TH": "NLM (1978)", "ST": "T058", "AN": "general or unspecified; prefer specifics", "MS": "A general concept referring to the organization and administration of nursing activities.", "PM": "78", "HN": "78", "MR": "20190524", "DA": "19770519", "DC": "1", "DX": "19780101", "UI": "D009739"}, {"RECTYPE": "D", "MH": "Nursing Staff", "DE": "NURS STAFF", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Staffs, Nursing|T097|NON|EQV|NLM (1992)|910612|STAFFS NURS|abcdefv", "MN": "N02.360.680", "MH_TH": "NLM (1973)", "ST": "T097", "MS": "Personnel who provide nursing service to patients in an organized facility, institution, or agency.", "PM": "73", "HN": "73", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009740"}, {"RECTYPE": "D", "MH": "Nursing Staff, Hospital", "DE": "NURS STAFF HOSP", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Hospital Nursing Staff|T097|NON|EQV|UNK (19XX)|770519|HOSP NURS STAFF|abcdefv", "ENTRY": "Staffs, Hospital Nursing|T097|NON|EQV|NLM (1992)|910612|STAFFS HOSP NURS|abcdefv", "MN": "N02.360.740.523", "MH_TH": "NLM (1968)", "ST": "T097", "PI": "Nursing Service, Hospital (1966-1967)", "MS": "Personnel who provide nursing service to patients in a hospital.", "OL": "use NURSING STAFF, HOSPITAL to search HOSPITAL NURSING STAFF 1968-77", "PM": "78; was HOSPITAL NURSING STAFF 1968-77", "HN": "78; was HOSPITAL NURSING STAFF 1968-77", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009741"}, {"RECTYPE": "D", "MH": "Nursing Theory", "DE": "NURS THEORY", "ENTRY": "Theories, Nursing", "MN": "H02.478.408", "FX": "Models, Nursing", "MH_TH": "NLM (1986)", "ST": "T078", "PI": "Philosophy, Nursing (1969-1985)", "MS": "Concepts, definitions, and propositions applied to the study of various phenomena which pertain to nursing and nursing research.", "PM": "86", "HN": "86", "MR": "20080708", "DA": "19850311", "DC": "1", "DX": "19860101", "UI": "D009742"}, {"RECTYPE": "D", "MH": "Nursing, Practical", "DE": "NURS PRACTICAL", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Practical Nursings", "MN": "N02.421.533.520", "FX": "Licensed Practical Nurses", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "The practice of nursing by licensed, non-registered persons qualified to provide routine care to the sick.", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009743"}, {"RECTYPE": "D", "MH": "Nursing, Private Duty", "DE": "NURS PRIVATE DUTY", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Private Practice Nursing|T058|NON|EQV|NLM (1991)|900403|PRIVATE PRACTICE NURS|abcdefv", "MN": "N04.452.758.377.500", "MH_TH": "NLM (1967)", "ST": "T058", "AN": "IM; coord with specific nurs specialty (IM)", "PI": "Nursing (1966)", "MS": "The practice of nursing by a registered or licensed nurse to care for a specific patient in a health facility or in the home.", "PM": "67", "HN": "67", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009744"}, {"RECTYPE": "D", "MH": "Nursing, Supervisory", "DE": "NURS SUPERVISORY", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Nurses, Head|T097|NON|REL|UNK (19XX)|810226|abcdef", "ENTRY": "Nurses, Charge", "MN": "N04.452.758.377.750", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "IM; in British jnls nursing \"sisters\" go here but \"matron\" goes under NURSE ADMINISTRATORS", "MS": "Administration of nursing services for one or more clinical units.", "PM": "66", "HN": "66", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009745"}, {"RECTYPE": "D", "MH": "Nursing, Team", "DE": "NURS TEAM", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Team Nursing|T058|NON|EQV|UNK (19XX)|860101|TEAM NURS|abcdefv", "MN": "N04.590.715.571", "MH_TH": "NLM (1965)", "ST": "T058", "AN": "consider also PATIENT CARE TEAM", "MS": "Coordination of nursing services by various nursing care personnel under the leadership of a professional nurse. The team may consist of a professional nurse, nurses' aides, and the practical nurse.", "PM": "67", "HN": "67(65)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009746"}, {"RECTYPE": "D", "MH": "Nutritional Physiological Phenomena", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Nutritional Physiology Phenomena|T040|NON|EQV|NLM (2009)|080701|abcdef", "ENTRY": "Processes, Nutritional", "MN": "G07.203.650", "FX": "Nutritional and Metabolic Diseases", "MH_TH": "NLM (2009)", "ST": "T040", "AN": "general or unspecified; prefer specifics; NUTRIENTS (see FOOD) and DIET are also available; use NUTRITIONAL SCIENCES for clinical nutrition as a specialty; use NUTRITION THERAPY or specifics for nutritional intervention", "MS": "The processes and properties of living organisms by which they take in and balance the use of nutritive materials for energy, heat production, or building material for the growth, maintenance, or repair of tissues and the nutritive properties of FOOD.", "PM": "2009; see NUTRITION PHYSIOLOGY 2007-2008, see NUTRITION 1963-2006; for NUTRITION PHENOMENA see NUTRITION PHENOMENA 2007-2008; for NUTRITION PROCESSES see NUTRITION PROCESSES 2007-2016", "HN": "2009 (1963)", "CATSH": "CAT LIST", "MR": "20160928", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D009747"}, {"RECTYPE": "D", "MH": "Nutrition Disorders", "DE": "NUTRITION DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Nutritional Disorder", "MN": "C18.654", "FX": "Feeding Behavior", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "differentiate from DEFICIENCY DISEASES (results from deficient intake) & METABOLIC DISEASES", "MS": "Disorders caused by nutritional imbalance, either overnutrition or undernutrition.", "OL": "use DEFICIENCY DISEASES to search MALNUTRITION 1966", "PM": "MALNUTRITION was see under DEFICIENCY DISEASES 1963-66", "HN": "MALNUTRITION was see under DEFICIENCY DISEASES 1963-66", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009748"}, {"RECTYPE": "D", "MH": "Nutrition Surveys", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "PRINT ENTRY": "National Health and Nutrition Examination Survey|T062|NON|NRW|NLM (1997)|960326|abcdef", "ENTRY": "Surveys, Nutritional", "MN": "N06.850.520.308.980.469", "MH_TH": "NLM (1978)", "ST": "T062", "AN": "do not confuse with NUTRITION ASSESSMENT: survey refers to a population in a given geographic area, assessment refers to an individual", "MS": "A systematic collection of factual data pertaining to the nutritional status of a human population within a given geographic area. Data from these surveys are used in preparing NUTRITION ASSESSMENTS.", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009749"}, {"RECTYPE": "D", "MH": "Nutritional and Metabolic Diseases", "DE": "NUTRITIONAL METAB DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C18", "RH": "C18 - DISEASES-NUTRITIONAL AND METABOLIC", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "A collective term for nutritional disorders resulting from poor absorption or nutritional imbalance, and metabolic disorders resulting from defects in biosynthesis (ANABOLISM) or breakdown (CATABOLISM) of endogenous substances.", "PM": "98", "HN": "98; use explode 1971-97", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009750"}, {"RECTYPE": "D", "MH": "Nutritional Requirements", "AQ": "DE EH GE IM PH RE", "ENTRY": "Requirements, Nutritional", "MN": "G07.203.650.620", "FX": "Sustenance", "MH_TH": "NLM (1968)", "ST": "T081", "PI": "specific nutrient", "MS": "The amounts of various substances in food needed by an organism to sustain healthy life.", "PM": "84; was see under NUTRITION 1975-83", "HN": "84(68); was see under NUTRITION 1975-83, was Prov 1968-74", "CATSH": "CAT LIST", "MR": "20200618", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D009751"}, {"RECTYPE": "D", "MH": "Nutritional Status", "AQ": "DE EH GE IM PH RE", "ENTRY": "Status, Nutritional", "MN": "N01.224.425.525", "MH_TH": "NLM (1987)", "ST": "T032", "AN": "restrict to humans and other vertebrates", "MS": "State of the body in relation to the consumption and utilization of nutrients.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D009752"}, {"RECTYPE": "D", "MH": "Nutritive Value", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Nutritional Availability|T080|T081|NON|EQV|UNK (19XX)|800515|abbcdef", "ENTRY": "Values, Nutritive", "MN": "N06.850.601.750", "MH_TH": "NLM (1979)", "ST": "T081", "AN": "coordinate with specific food (IM)", "PI": "Nutrition (1966-1978)", "MS": "An indication of the contribution of a food to the nutrient content of the diet. This value depends on the quantity of a food which is digested and absorbed and the amounts of the essential nutrients (protein, fat, carbohydrate, minerals, vitamins) which it contains. This value can be affected by soil and growing conditions, handling and storage, and processing.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D009753"}, {"RECTYPE": "D", "MH": "Nuts", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "ENTRY": "Nut", "MN": "J02.500.700", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "/adv eff; consider also NUT HYPERSENSITIVITY; PEANUTS see ARACHIS is also available", "MS": "Botanically, a type of single-seeded fruit in which the pericarp enclosing the seed is a hard woody shell. In common usage the term is used loosely for any hard, oil-rich kernel. Of those commonly eaten, only hazel, filbert, and chestnut are strictly nuts. Walnuts, pecans, almonds, and coconuts are really drupes. Brazil nuts, pistachios, macadamias, and cashews are really seeds with a hard shell derived from the testa rather than the pericarp.", "MR": "20150709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009754"}, {"RECTYPE": "D", "MH": "Night Blindness", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nyctalopia|T047|NON|EQV|OMIM (2013)|UNK (19XX)|740330|abcdeef", "ENTRY": "Blindness, Night", "MN": "C11.966.671", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Failure or imperfection of vision at night or in dim light, with good vision only on bright days. (Dorland, 27th ed)", "OL": "use NIGHT BLINDNESS to search NYCTALOPIA 1966-89", "PM": "90; was NIGHT BLINDNESS see NYCTALOPIA 1963-89", "HN": "90; was NIGHT BLINDNESS see NYCTALOPIA 1963-89", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D009755"}, {"RECTYPE": "D", "MH": "Nylidrin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Nylidrin", "MN": "D02.092.471.683.715", "PA": "Vasodilator Agents", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "Benzenemethanol, 4-hydroxy-alpha-(1-((1-methyl-3-phenylpropyl)amino)ethyl)-", "RN": "695DKH33EI", "RR": "EC69E3PW7E", "PI": "Sympathomimetics (1966-1971)", "MS": "A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.", "PM": "73", "HN": "73(72)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009756"}, {"RECTYPE": "D", "MH": "Nylons", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO", "PRINT ENTRY": "Polyamides|T073|T109|NON|EQV|UNK (19XX)|790502|abbcdef", "ENTRY": "Supramids", "MN": "J01.637.548", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Polymers where the main polymer chain comprises recurring amide groups. These compounds are generally formed from combinations of diamines, diacids, and amino acids and yield fibers, sheeting, or extruded forms used in textiles, gels, filters, sutures, contact lenses, and other biomaterials.", "OL": "use NYLONS to search NYLON 1966-79", "PM": "80; was NYLON 1963-79", "HN": "80; was NYLON in Cat D & J 1963-79", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009757"}, {"RECTYPE": "D", "MH": "Nymph", "AQ": "AH CH CL CY DE EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "G07.345.500.550.500.650", "MH_TH": "NLM (1973)", "ST": "T204", "AN": "do not use /embryol with reference to nymph", "PI": "specific insect (1973-1991)", "MS": "The immature stage in the life cycle of those orders of insects characterized by gradual metamorphosis, in which the young resemble the imago in general form of body, including compound eyes and external wings; also the 8-legged stage of mites and ticks that follows the first moult.", "PM": "91; was see under INSECTS 1973-90", "HN": "91(73); was see under INSECTS 1973-90", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009758"}, {"RECTYPE": "D", "MH": "Nystagmus, Pathologic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vertical Nystagmus|T047|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "See Saw Nystagmus", "MN": "C11.590.400", "FX": "Nystagmus, Physiologic", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "do not confuse with NYSTAGMUS, PHYSIOLOGIC; NYSTAGMUS, CONGENITAL is also available", "MS": "Involuntary movements of the eye that are divided into two types, jerk and pendular. Jerk nystagmus has a slow phase in one direction followed by a corrective fast phase in the opposite direction, and is usually caused by central or peripheral vestibular dysfunction. Pendular nystagmus features oscillations that are of equal velocity in both directions and this condition is often associated with visual loss early in life. (Adams et al., Principles of Neurology, 6th ed, p272)", "PM": "2000; see NYSTAGMUS 1966-1999; for NYSTAGMUS see NYSTAGMUS, PATHOLOGIC 2000", "HN": "2000", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D009759"}, {"RECTYPE": "D", "MH": "Nystagmus, Physiologic", "DE": "NYSTAGMUS PHYSIOL", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Nystagmus, Thermal|T039|T060|T184|NON|NRW|NLM (1993)|911010|abbbcdef", "ENTRY": "Thermal Nystagmus", "MN": "G14.350.378", "FX": "Nystagmus, Pathologic", "MH_TH": "NLM (1983)", "ST": "T042", "AN": "note category: NYSTAGMUS, PATHOLOGIC and NYSTAGMUS, CONGENITAL are available for the disease", "PI": "Eye Movements (1966-1982)", "MS": "Involuntary rhythmical movements of the eyes in the normal person. These can be naturally occurring as in end-position (end-point, end-stage, or deviational) nystagmus or induced by the optokinetic drum (NYSTAGMUS, OPTOKINETIC), caloric test, or a rotating chair.", "PM": "83; NYSTAGMUS, BARANY was NYSTAGMUS, BARANY'S 1993-97", "HN": "83; NYSTAGMUS, BARANY was NYSTAGMUS, BARANY'S 1993-97", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19820428", "DC": "1", "DX": "19830101", "UI": "D009760"}, {"RECTYPE": "D", "MH": "Nystatin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Stamycin|T109|T195|TRD|NRW|NLM (1992)|910115|abbcdef", "MN": "D02.540.505.575", "PA": "Ionophores", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Nystatin", "RN": "1400-61-9", "RR": "ZGT9EY838C", "MS": "Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009761"}, {"RECTYPE": "D", "MH": "o-Aminoazotoluene", "DS": "AMINOAZOTOLUENE O", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "ortho-Aminoazotoluene|T109|T131|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "ortho Aminoazotoluene", "MN": "D02.172.030", "PA": "Coloring Agents", "MH_TH": "NLM (1976)", "ST": "T131", "N1": "Benzenamine, 2-methyl-4-((2-methylphenyl)azo)-", "RN": "QHZ900P7ZA", "RR": "97-56-3 (o-Aminoazotoluene)", "PI": "Toluidines (1972-1975)", "MS": "An azo dye with carcinogenic properties.", "PM": "91; was see under AZO COMPOUNDS 1976-90", "HN": "91(76); was see under AZO COMPOUNDS 1976-90", "MR": "20130708", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D009762"}, {"RECTYPE": "D", "MH": "o-Chlorobenzylidenemalonitrile", "DS": "CHLOROBENZYLIDENEMALONITRILE O", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ortho-Chlorobenzylidenemalonitrile|T109|T131|NON|EQV|NLM (1991)|900413|abbcdef", "ENTRY": "ortho Chlorobenzylidenemalonitrile", "MN": "D02.626.310", "PA": "Riot Control Agents, Chemical", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Propanedinitrile, ((2-chlorophenyl)methylene)-", "RN": "2698-41-1", "PI": "Nitriles (1970-1974)", "MS": "A riot control agent which causes temporary irritation of the eyes and the mucosal surface of the respiratory tract. It is a more potent irritant than OMEGA-CHLOROACETOPHENONE, but less incapacitating.", "OL": "use O-CHLOROBENZYLIDENEMALONITRILE to search O-CHLOROBENZYLIDENE MALONITRILE 1975-90", "PM": "91; was O-CHLOROBENZYLIDENE MALONITRILE see under NITRILES 1975-90", "HN": "91(75); was O-CHLOROBENZYLIDENE MALONITRILE see under NITRILES 1975-90", "MR": "20030321", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D009763"}, {"RECTYPE": "D", "MH": "o-Phthalaldehyde", "DS": "PHTHALALDEHYDE O", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ortho-Phthalaldehyde|T109|T130|NON|EQV|UNK (19XX)|760426|abbcdef", "ENTRY": "ortho Phthalic Aldehyde", "MN": "D02.241.223.805.780", "PA": "Indicators and Reagents", "MH_TH": "NLM (1977)", "ST": "T130", "N1": "1,2-Benzenedicarboxaldehyde", "RN": "643-79-8", "PI": "Phthalic Acids (1966-1976)", "MS": "A reagent that forms fluorescent conjugation products with primary amines. It is used for the detection of many biogenic amines, peptides, and proteins in nanogram quantities in body fluids.", "PM": "91; was see under ALDEHYDES 1977-90", "HN": "91(77); was see under ALDEHYDES 1977-90", "MR": "19980610", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D009764"}, {"RECTYPE": "D", "MH": "Obesity", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.144.699.500", "FX": "Skinfold Thickness", "MH_TH": "OMIM (2013)", "ST": "T184", "AN": "obese hyperglycemic mice are indexed MICE, OBESE: do not add OBESITY or HYPERGLYCEMIA unless disease particularly discussed; /ther consider also OBESITY MANAGEMENT", "MS": "A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009765"}, {"RECTYPE": "D", "MH": "Obesity, Morbid", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Morbid Obesity|T184|NON|EQV|UNK (19XX)|860418|abcdef", "ENTRY": "Severe Obesity", "MN": "C23.888.144.699.500.500", "FX": "Jejunoileal Bypass", "MH_TH": "NLM (1987)", "ST": "T184", "AN": "/surg: consider also BARIATRIC SURGERY", "PI": "Obesity (1966-1986)", "MS": "The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D009767"}, {"RECTYPE": "D", "MH": "Obidoxime Chloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chloride, Obidoxime", "MN": "D03.383.725.762.600", "PA": "Cholinesterase Reactivators", "MH_TH": "USAN (1971)", "ST": "T121", "N1": "Pyridinium, 1,1'-(oxybis(methylene))bis(4-((hydroxyimino)methyl))-, dichloride", "RN": "3HXR312Z9M", "RR": "N6KNE1QA9O", "PI": "Oximes (1971)", "MS": "Cholinesterase reactivator occurring in two interchangeable isomeric forms, syn and anti.", "OL": "use OBIDOXIME CHLORIDE to search OBIDOXIME 1978-90 & TOXOGONIN 1972-77 (as Prov 1972-74)", "PM": "91; was OBIDOXIME see under OXIMES 1978-90; was TOXOGONIN see under OXIMES 1975-77", "HN": "91; was OBIDOXIME see under OXIMES 1978-90; was TOXOGONIN see under OXIMES 1972-77 (Prov 1972-74)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009768"}, {"RECTYPE": "D", "MH": "Object Attachment", "PRINT ENTRY": "Symbiotic Relations (Psychology)|T080|NON|NRW|UNK (19XX)|780503|SYMBIOTIC RELAT|abcdefv", "ENTRY": "Symbiotic Relation (Psychology)", "MN": "F02.739.794.624", "MH_TH": "NLM (1969)", "ST": "T041", "PI": "Psychoanalytic Theory (1966-1968)", "MS": "Emotional attachment to someone or something in the environment.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D009769"}, {"RECTYPE": "D", "MH": "Obsessive Behavior", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Obsessions|T041|NON|NRW|NLM (1998)|970313|abcdef", "ENTRY": "Obsessive Behaviors", "MN": "F01.145.126.950", "MH_TH": "NLM (1975)", "ST": "T055", "AN": "use Cat F3 qualif", "MS": "Persistent, unwanted idea or impulse which is considered normal when it does not markedly interfere with mental processes or emotional adjustment.", "OL": "use COMPULSIVE BEHAVIOR to search OBSESSIVE BEHAVIOR 1968-74; use OBSESSIVE-COMPULSIVE BEHAVIOR to search OBSESSION 1968-74", "PM": "91; was see under COMPULSIVE BEHAVIOR 1975-90; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78", "HN": "91(75); was see under COMPULSIVE BEHAVIOR 1975-90; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009770"}, {"RECTYPE": "D", "MH": "Obsessive-Compulsive Disorder", "DE": "OBSESSIVE COMPULSIVE DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Neurosis, Obsessive-Compulsive|T048|NON|EQV|UNK (19XX)|800605|abcdef", "ENTRY": "Personality, Anankastic", "MN": "F03.080.600", "MH_TH": "OMIM (2013)", "ST": "T048", "AN": "COMPULSIVE PERSONALITY DISORDER is also available", "MS": "An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.", "OL": "use OBSESSIVE-COMPULSIVE DISORDER to search NEUROSES, OBSESSIVE-COMPULSIVE 1966-80 & OBSESSION 1966-78", "PM": "81; was NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78", "HN": "81; was NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D009771"}, {"RECTYPE": "D", "MH": "Obstetrical Forceps", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Obstetrical Forcep", "MN": "E07.858.700.650", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "Surgical instrument designed to extract the newborn by the head from the maternal passages without injury to it or the mother.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009772"}, {"RECTYPE": "D", "MH": "Obstetric Nursing", "DE": "OBSTETRIC NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Obstetrical Nursing|T058|T091|NON|EQV|NLM (1967)|990101|OBSTETRICAL NURS|abbcdefv", "ENTRY": "Obstetrical Nursings", "MN": "N02.421.533.571", "MH_TH": "UNK (19XX)", "ST": "T091", "PI": "Obstetrics (1966)", "MS": "A nursing specialty involving nursing care given to the pregnant patient before, after, or during childbirth.", "PM": "67", "HN": "67", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009773"}, {"RECTYPE": "D", "MH": "Obstetrics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.810.450", "FX": "Pregnancy Complications", "MH_TH": "POPLINE (1994)", "ST": "T091", "MS": "A medical-surgical specialty concerned with management and care of women during pregnancy, parturition, and the puerperium.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009774"}, {"RECTYPE": "D", "MH": "Obstetrics and Gynecology Department, Hospital", "DE": "OBSTET GYNECOL DEP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Obstetrics and Gynecology Department|T093|NON|EQV|UNK (19XX)|770519|HOSP OBSTETRICS GYNECOL DEP|abcdefv", "ENTRY": "Obstetrics Departments", "MN": "N04.452.442.452.422.495", "MH_TH": "NLM (1977)", "ST": "T093", "AN": "check also tag PREGNANCY for obstet aspect", "PI": "Obstetrics (1966-Jul 1977)", "MS": "Hospital department responsible for the administration and management of services provided for obstetric and gynecologic patients.", "PM": "91; was see under HOSPITAL DEPARTMENTS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90", "MR": "20190709", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D009775"}, {"RECTYPE": "D", "MH": "Obturator Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Obturator Nerves", "MN": "A08.800.800.720.450.600", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES (IM); neopl: coord IM with PERIPHERAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "A nerve originating in the lumbar spinal cord (L2 to L4) and traveling through the lumbar plexus to the lower extremity. The obturator nerve provides motor innervation to the adductor muscles of the thigh and cutaneous sensory innervation of the inner thigh.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009776"}, {"RECTYPE": "D", "MH": "Occipital Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Basilar Bone|T023|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Occipital Bones", "MN": "A02.835.232.781.572", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Part of the back and base of the CRANIUM that encloses the FORAMEN MAGNUM.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009777"}, {"RECTYPE": "D", "MH": "Occipital Lobe", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sulcus, Occipital", "MN": "A08.186.211.200.885.287.500.571", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "diseases: coordinate IM with BRAIN DISEASES (IM); neoplasms: coordinate IM with BRAIN NEOPLASMS (IM)", "MS": "Posterior portion of the CEREBRAL HEMISPHERES responsible for processing visual sensory information. It is located posterior to the parieto-occipital sulcus and extends to the preoccipital notch.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009778"}, {"RECTYPE": "D", "MH": "Occlusive Dressings", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Dressings, Spray-On|T074|NON|REL|NLM (1998)|961011|abcdef", "ENTRY": "Spray-On Dressings", "MN": "E07.101.650", "MH_TH": "NLM (1963)", "ST": "T074", "AN": "to protect wounds from air or bact", "MS": "Material, usually gauze or absorbent cotton, used to cover and protect wounds, to seal them from contact with air or bacteria. (From Dorland, 27th ed)", "PM": "67", "HN": "67(63)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009779"}, {"RECTYPE": "D", "MH": "Occult Blood", "PRINT ENTRY": "Fecal Occult Blood Test|T060|NON|NRW|NLM (2021)|200115|abcdef", "ENTRY": "Blood, Occult", "MN": "E05.200.925", "FX": "Melena", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "if fecal occult blood, do not coordinate with FECES", "MS": "Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood.", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009780"}, {"RECTYPE": "D", "MH": "Occultism", "AQ": "HI PX", "ENTRY": "Occultisms", "MN": "K01.672", "FX": "Spiritual Therapies", "MH_TH": "NLM (1966)", "ST": "T078", "MS": "The belief in or study of practices and knowledge of magical, mystical, or supernatural powers. ALCHEMY, astrology, and many RELIGIOUS PHILOSOPHIES are based upon occult principles.", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009781"}, {"RECTYPE": "D", "MH": "Occupational Dentistry", "DE": "OCCUP DENT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Industrial Dentistry|T091|NON|NRW|UNK (19XX)|810519|INDUST DENT|abcdefv", "ENTRY": "Occupational Dentistries", "MN": "H02.163.640", "MH_TH": "NLM (1965)", "ST": "T091", "MS": "The branch of dentistry concerned with maintaining oral health of employees in occupational environments.", "OL": "use OCCUPATIONAL DENTISTRY to search INDUSTRIAL DENTISTRY 1966-81", "PM": "82; was INDUSTRIAL DENTISTRY 1965-81", "HN": "82; was INDUSTRIAL DENTISTRY 1965-81", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009782"}, {"RECTYPE": "D", "MH": "Dermatitis, Occupational", "DE": "DERMATITIS OCCUP", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Occupational Dermatitis|T047|NON|EQV|NLM (1993)|920402|OCCUP DERMATITIS|abcdefv", "ENTRY": "Occupational Dermatitides", "MN": "C24.270", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not restrict to -itis: use as if \"dermatoses\"; coord with specific skin dis with /chem ind; includes housewives' dermatoses caused by housekeeping agents", "MS": "A recurrent contact dermatitis caused by substances found in the work place.", "OL": "use DERMATITIS, OCCUPATIONAL to search OCCUPATIONAL DERMATITIS 1966-92", "PM": "93; was OCCUPATIONAL DERMATITIS 1963-92", "HN": "93; was OCCUPATIONAL DERMATITIS 1963-92", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D009783"}, {"RECTYPE": "D", "MH": "Occupational Diseases", "DE": "OCCUP DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Occupational Illnesse", "MN": "C24", "RH": "C24 - OCCUPATIONAL DISEASES", "FX": "Accidents, Occupational", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific disease (IM); Manual 31.14, 31.16", "MS": "Diseases caused by factors involved in one's employment.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009784"}, {"RECTYPE": "D", "MH": "Occupational Health Nursing", "DE": "OCCUP HEALTH NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Industrial Nursing|T091|NON|NRW|UNK (19XX)|780510|INDUST NURS|abcdefv", "ENTRY": "Occupational Health Nursings", "MN": "N02.421.533.585", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "The practice of nursing in the work environment.", "OL": "use OCCUPATIONAL HEALTH NURSING to search INDUSTRIAL NURSING 1966-78", "PM": "79; was INDUSTRIAL NURSING 1963-78", "HN": "79; was INDUSTRIAL NURSING 1963-78", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009785"}, {"RECTYPE": "D", "MH": "Occupational Health Services", "DE": "OCCUP HEALTH SERV", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Employee Health Services|T093|NON|EQV|UNK (19XX)|740330|EMPLOYEE HEALTH SERV|abcdefv", "ENTRY": "Services, Employment Based", "MN": "N02.421.143.740", "MH_TH": "NLM (1968)", "ST": "T093", "PI": "Occupational Medicine (1966-1967)", "MS": "Health services for employees, usually provided by the employer at the place of work.", "PM": "68", "HN": "68", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009786"}, {"RECTYPE": "D", "MH": "Occupational Medicine", "DE": "OCCUP MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Industrial Medicine|T091|NON|EQV|UNK (19XX)|780508|INDUST MED|abcdefv", "ENTRY": "Medicine, Occupational|T091|NON|EQV|NLM (1991)|891205|MED OCCUP|abcdefv", "MN": "H02.403.720.750.510", "FX": "Protective Devices", "MH_TH": "BIOETHICS (1981)", "ST": "T091", "AN": "specialty; do not confuse with OCCUPATIONAL HEALTH, the health of the worker or with OCCUPATIONAL DISEASES", "MS": "Medical specialty concerned with the promotion and maintenance of the physical and mental health of employees in occupational settings.", "OL": "use OCCUPATIONAL MEDICINE to search INDUSTRIAL MEDICINE 1966-78", "PM": "79; was INDUSTRIAL MEDICINE 1963-78", "HN": "79; was INDUSTRIAL MEDICINE 1963-78", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D009787"}, {"RECTYPE": "D", "MH": "Occupational Therapy", "DE": "OCCUP THER", "AQ": "CL EC ED ES HI IS LJ MT NU OG PX SN ST TD", "PRINT ENTRY": "Ergotherapy|T061|T091|NON|EQV|NLM (2022)|210525|abbcdef", "ENTRY": "Therapies, Occupational", "MN": "H02.010.500", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "coordinate with disease /rehabil not /ther", "MS": "Skilled treatment that helps individuals achieve independence in all facets of their lives. It assists in the development of skills needed for independent living.", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009788"}, {"RECTYPE": "D", "MH": "Occupational Therapy Department, Hospital", "DE": "OCCUP THER DEP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Occupational Therapy Department|T093|NON|EQV|UNK (19XX)|770519|HOSP OCCUP THER DEP|abcdefv", "ENTRY": "Occupational Therapy Departments, Hospital|T093|NON|EQV|UNK (19XX)|830714|OCCUP THER DEP HOSP|abcdefv", "MN": "N04.452.442.452.422.500", "MH_TH": "NLM (1977)", "ST": "T093", "PI": "Occupational Therapy (1966-Jul 1977)", "MS": "Hospital department responsible for the administration and provision of any occupational or work activity for remedial purposes.", "PM": "91; was see under HOSPITAL DEPARTMENTS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90", "MR": "20190709", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D009789"}, {"RECTYPE": "D", "MH": "Occupations", "DE": "OCCUP", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Vocations|T057|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Vocation", "MN": "N01.824.547", "FX": "Workplace", "MH_TH": "POPLINE (1978)", "ST": "T090", "AN": "differentiate from OCCUPATIONAL GROUPS: OCCUPATIONS is for the occupation itself, OCCUPATIONAL GROUPS is for the collective members of an occupation; OCCUPATIONAL MEDICINE and OCCUPATIONAL DISEASES are also available", "MS": "Crafts, trades, professions, or other means of earning a living.", "OL": "use OCCUPATIONS to search OCCUPATIONS AND PROFESSIONS 1966-67", "PM": "68; was OCCUPATIONS AND PROFESSIONS 1963-67", "HN": "68; was OCCUPATIONS AND PROFESSIONS 1963-67", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009790"}, {"RECTYPE": "D", "MH": "Oceanography", "DE": "OCEANOGR", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Oceanographies", "MN": "H01.277.750", "FX": "Submarine Medicine", "MH_TH": "NLM (1968)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "PI": "Submarine Medicine (1966-1967)", "MS": "The science that deals with the ocean and its phenomena. (Webster, 3d ed)", "PM": "68", "HN": "68", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009791"}, {"RECTYPE": "D", "MH": "Oceans and Seas", "DE": "OCEANS SEAS", "AQ": "EH EP", "PRINT ENTRY": "Seas|T083|NAM|NRW|UNK (19XX)|860402|abcdef", "ENTRY": "Seas and Oceans|T083|NAM|EQV|NLM (1992)|910611|SEAS OCEANS|abcdefv", "MN": "Z01.756", "FX": "Seawater", "MH_TH": "NLM (1987)", "ST": "T083", "AN": "for specific oceans or seas that are not a main heading, index only under OCEANS AND SEAS and not also under a geographic term", "MS": "A great expanse of continuous bodies of salt water which together cover more than 70 percent of the earth's surface. Seas may be partially or entirely enclosed by land, and are smaller than the five oceans (Atlantic, Pacific, Indian, Arctic, and Antarctic).", "HN": "87", "MR": "20150622", "DA": "19860402", "DC": "1", "DX": "19870101", "UI": "D009792"}, {"RECTYPE": "D", "MH": "Ochratoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ochratoxin|T109|T123|T131|NON|EQV|NLM (2021)|191118|abbbcdef", "MN": "D23.946.587.697", "PA": "Poisons", "MH_TH": "NLM (1971)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTITOXINS", "PI": "Mycotoxins (1967-1970)", "MS": "Isocoumarins found in ASPERGILLUS OCHRACEUS and other FUNGI. Ochratoxin contaminated FOOD has been responsible for cases of FOODBORNE DISEASES.", "PM": "74", "HN": "74(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009793"}, {"RECTYPE": "D", "MH": "Ochronosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ochronoses", "MN": "C23.550.744", "MH_TH": "ORD (2010)", "ST": "T046", "MS": "The yellowish discoloration of connective tissue due to deposition of HOMOGENTISIC ACID (a brown-black pigment). This is due to defects in the metabolism of PHENYLALANINE and TYROSINE. Ochronosis occurs in ALKAPTONURIA, but has also been associated with exposure to certain chemicals (e.g., PHENOL, trinitrophenol, BENZENE DERIVATIVES).", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009794"}, {"RECTYPE": "D", "MH": "Octanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isooctanes|T109|NON|NRW|UNK (19XX)|770520|abcdef", "MN": "D02.455.326.146.720", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Hydrocarbons (1966-1977)", "MS": "Eight-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives.", "PM": "78", "HN": "78", "MR": "19920519", "DA": "19770520", "DC": "1", "DX": "19780101", "UI": "D009795"}, {"RECTYPE": "D", "MH": "Ocular Hypertension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypertension, Ocular|T047|NON|EQV|NLM (1999)|980204|abcdef", "ENTRY": "Suspect Glaucomas", "MN": "C11.525", "MH_TH": "NLM (1983)", "ST": "T047", "AN": "do not equate with GLAUCOMA; do not confuse with OCULAR HYPOTENSION", "PI": "Intraocular Pressure (1966-1982)", "MS": "A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "19980610", "DA": "19820422", "DC": "1", "DX": "19830101", "UI": "D009798"}, {"RECTYPE": "D", "MH": "Ocular Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Ocular Physiology|T042|NON|EQV|NLM (1974)|990101|OCULAR PHYSIOL|abcdefv", "ENTRY": "Processes, Ocular Physiological", "MN": "G14", "RH": "G14 - OCULAR PHYSIOLOGICAL PHENOMENA", "MH_TH": "NLM (2009)", "ST": "T042", "AN": "general or unspecified; prefer specifics", "PI": "Eye/physiology (1966-1997)", "MS": "Processes and properties of the EYE as a whole or of any of its parts.", "PM": "2009; see OCULAR PHYSIOLOGY 1998-2008; for OCULAR PHYSIOLOGICAL PROCESSES see OCULAR PHYSIOLOGICAL PROCESSES 2009-2016", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009799"}, {"RECTYPE": "D", "MH": "Oculocerebrorenal Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lowe Syndrome|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|760512|abcdeeeef", "ENTRY": "Renal Oculocerebrodystrophy", "MN": "C18.452.648.189.640", "MH_TH": "NLM (1977)", "ST": "T047", "PI": "Kidney Diseases (1966-1976)", "MS": "A sex-linked recessive disorder affecting multiple systems including the EYE, the NERVOUS SYSTEM, and the KIDNEY. Clinical features include congenital CATARACT; MENTAL RETARDATION; and renal tubular dysfunction (FANCONI SYNDROME; RENAL TUBULAR ACIDOSIS; X-LINKED HYPOPHOSPHATEMIA or vitamin-D-resistant rickets) and SCOLIOSIS. This condition is due to a deficiency of phosphatidylinositol 4,5-bisphosphate-5-phosphatase leading to defects in PHOSPHATIDYLINOSITOL metabolism and INOSITOL signaling pathway. (from Menkes, Textbook of Child Neurology, 5th ed, p60; Am J Hum Genet 1997 Jun;60(6):1384-8)", "PM": "1991; see RENAL TUBULAR TRANSPORT, INBORN ERRORS 1977-1990", "HN": "1991(1977)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D009800"}, {"RECTYPE": "D", "MH": "Oculomotor Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Superior Oblique Muscles", "MN": "A02.633.567.700", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The muscles that move the eye. Included in this group are the medial rectus, lateral rectus, superior rectus, inferior rectus, inferior oblique, superior oblique, musculus orbitalis, and levator palpebrae superioris.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009801"}, {"RECTYPE": "D", "MH": "Oculomotor Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Third Cranial Nerve|T023|NON|EQV|NLM (1998)|960731|abcdef", "ENTRY": "Third Cranial Nerves", "MN": "A08.800.800.120.600", "EC": "injuries:Oculomotor Nerve Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The 3d cranial nerve. The oculomotor nerve sends motor fibers to the levator muscles of the eyelid and to the superior rectus, inferior rectus, and inferior oblique muscles of the eye. It also sends parasympathetic efferents (via the ciliary ganglion) to the muscles controlling pupillary constriction and accommodation. The motor fibers originate in the oculomotor nuclei of the midbrain.", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009802"}, {"RECTYPE": "D", "MH": "Sphincter of Oddi", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Oddi's Sphincter|T023|EPO|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Sphincter, Oddi's", "MN": "A03.556.875.249.160.572", "FX": "Sphincterotomy, Transduodenal", "MH_TH": "NLM (2004)", "ST": "T023", "AN": "diseases: coord IM with COMMON BILE DUCT DISEASES (IM); inflammation: coord IM with CHOLANGITIS (IM); neopl: coord IM with COMMON BILE DUCT NEOPLASMS (IM)", "MS": "The sphincter of the hepatopancreatic ampulla within the duodenal papilla. The COMMON BILE DUCT and main pancreatic duct pass through this sphincter.", "PM": "2004; see ODD'S SPHINCTER 1991-2003, see VATER'S AMPULLA 1975-1990", "HN": "2004 (1975)", "MR": "20170717", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009803"}, {"RECTYPE": "D", "MH": "Odontoblasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Odontoblast", "MN": "A11.329.522", "FX": "Dentin", "MH_TH": "NLM (1965)", "ST": "T025", "MS": "The mesenchymal cells which line the DENTAL PULP CAVITY and produce DENTIN. They have a columnar morphology in the coronal pulp but are cuboidal in the root pulp, or when adjacent to tertiary dentin.", "PM": "65", "HN": "65", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009804"}, {"RECTYPE": "D", "MH": "Odontogenesis", "AQ": "DE GE IM PH RE", "ENTRY": "Odontogeneses", "MN": "G07.345.500.325.377.750", "FX": "Tooth", "MH_TH": "NLM (1965)", "ST": "T042", "MS": "The process of TOOTH formation. It is divided into several stages including: the dental lamina stage, the bud stage, the cap stage, and the bell stage. Odontogenesis includes the production of tooth enamel (AMELOGENESIS), dentin (DENTINOGENESIS), and dental cementum (CEMENTOGENESIS).", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009805"}, {"RECTYPE": "D", "MH": "Odontogenic Cysts", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Keratocysts|T047|NON|NRW|NLM (1997)|960327|abcdef", "ENTRY": "Odontogenic Cyst", "MN": "C07.320.450.670", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Cysts found in the jaws and arising from epithelium involved in tooth formation. They include follicular cysts (e.g., primordial cyst, dentigerous cyst, multilocular cyst), lateral periodontal cysts, and radicular cysts. They may become keratinized (odontogenic keratocysts). Follicular cysts may give rise to ameloblastomas and, in rare cases, undergo malignant transformation.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009807"}, {"RECTYPE": "D", "MH": "Odontogenic Tumors", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Neoplasms, Dental Tissue|T191|NON|REL|UNK (19XX)|790425|NEOPL DENT TISSUE|abcdefv", "ENTRY": "Tumors, Odontogenic", "MN": "C04.557.695", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "benign or malignant; coordinate with precoordinated organ/neoplasm term", "MS": "Neoplasms produced from tooth-forming tissues.", "OL": "use ODONTOGENIC TUMORS to search ODONTOGENIC TUMOR & NEOPLASMS, DENTAL TISSUE 1966-79", "PM": "80; was ODONTOGENIC TUMOR 1963-79; NEOPLASMS, DENTAL TISSUE was heading 1963-79", "HN": "80; was ODONTOGENIC TUMOR 1963-79; NEOPLASMS, DENTAL TISSUE was heading 1963-79", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D009808"}, {"RECTYPE": "D", "MH": "Odontoid Process", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Dens Axis|T023|NON|EQV|UNK (19XX)|840406|abcdef", "ENTRY": "Processes, Odontoid", "MN": "A02.835.232.834.151.383.668", "MH_TH": "NLM (1985)", "ST": "T023", "AN": "a part of the AXIS; not a dental term", "PI": "Axis (1966-1984)", "MS": "The toothlike process on the upper surface of the axis, which articulates with the CERVICAL ATLAS above.", "PM": "91; was see under AXIS 1985-90", "HN": "91(85); was see under AXIS 1985-90", "MR": "20180629", "DA": "19840406", "DC": "1", "DX": "19910101", "UI": "D009809"}, {"RECTYPE": "D", "MH": "Odontoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Odontoma, Compound|T191|NON|REL|NLM (1994)|930326|abcdef", "ENTRY": "Odontomas, Compound", "MN": "C04.557.695.610", "MH_TH": "NLM (1975)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term; French \"odontome\" (a form of developmental anomaly): index under TOOTH ABNORMALITIES", "PI": "Odontogenic Tumors (1966-1974)", "MS": "A mixed tumor of odontogenic origin, in which both the epithelial and mesenchymal cells exhibit complete differentiation, resulting in the formation of tooth structures. (Jablonski, Illustrated Dictionary of Dentistry, 1982)", "OL": "search ODONTOGENIC TUMORS 1966-74", "PM": "91; was see under ODONTOGENIC TUMORS 1980-90; was see under ODONTOGENIC TUMOR 1975-79", "HN": "91(75); was see under ODONTOGENIC TUMORS 1980-90; was see under ODONTOGENIC TUMOR 1975-79", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009810"}, {"RECTYPE": "D", "MH": "Odontometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E06.623", "MH_TH": "NLM (1973)", "ST": "T081", "PI": "specific tooth heading", "MS": "Measurement of tooth characteristics.", "OL": "search CEPHALOMETRY 1969-72", "PM": "79; was see under CEPHALOMETRY 1969-78", "HN": "79(73); was see under CEPHALOMETRY 1969-78", "CATSH": "CAT LIST", "MR": "20150522", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D009811"}, {"RECTYPE": "D", "MH": "Odorants", "AQ": "AN LJ PC", "PRINT ENTRY": "Odors|T120|NON|REL|NLM (1966)|990101|abcdef", "ENTRY": "Scent", "MN": "N06.230.480", "FX": "Smell", "MH_TH": "NLM (2017)", "ST": "T120", "MS": "The volatile portions of chemical substances perceptible by the sense of smell.", "PM": "2017(1966)", "HN": "2017(1966)", "MR": "20181102", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009812"}, {"RECTYPE": "D", "MH": "Oedipus Complex", "ENTRY": "Complex, Oedipus", "MN": "F02.739.794.653", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "Attachment of the child to the parent of the opposite sex, accompanied by envious and aggressive feelings toward the parent of the same sex.", "OL": "search PSYCHOANALYTIC THEORY 1966-74", "PM": "91; was see under PSYCHOANALYTIC THEORY 1975-90", "HN": "91(75); was see under PSYCHOANALYTIC THEORY 1975-90", "CATSH": "CAT LIST", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009813"}, {"RECTYPE": "D", "MH": "Oesophagostomiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Oesophagostomiases", "MN": "C01.610.335.508.700.775.583", "MH_TH": "NLM (1967)", "ST": "T047", "AN": "nematode infect of intestines", "PI": "Hookworm Infections (1966)", "MS": "Infection of the intestinal tract with worms of the genus OESOPHAGOSTOMUM. This condition occurs mainly in animals other than man.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009814"}, {"RECTYPE": "D", "MH": "Oesophagostomum", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Oesophagostomums", "MN": "B01.050.500.500.294.400.968.710.600", "MH_TH": "NLM (1967)", "ST": "T204", "RN": "txid52564", "PI": "Ancylostomatoidea (1966)", "MS": "A genus of nematodes of the superfamily STRONGYLOIDEA, parasitic in the intestines of animals. The adults are usually free in the intestinal lumen; the larvae encyst in the wall.", "OL": "search ANCYLOSTOMATOIDEA 1966", "PM": "67; was see under HOOKWORMS 1963-66", "HN": "67; was see under HOOKWORMS 1963-66", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009815"}, {"RECTYPE": "D", "MH": "Office Automation", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Automation, Office|T057|NON|EQV|UNK (19XX)|860617|abcdef", "ENTRY": "Office Automations", "MN": "N04.452.515.708", "MH_TH": "NLM (1987)", "ST": "T057", "AN": "IM", "MS": "Use of computers or computer systems for doing routine clerical work, e.g., billing, records pertaining to the administration of the office, etc.", "PM": "87", "HN": "87", "MR": "20180629", "DA": "19860617", "DC": "1", "DX": "19870101", "UI": "D009816"}, {"RECTYPE": "D", "MH": "Office Management", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Management, Office", "MN": "N04.452.758.708.200", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "medical or non-medical offices", "MS": "Planning, organizing, and administering activities in an office.", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009817"}, {"RECTYPE": "D", "MH": "Office Nursing", "DE": "OFFICE NURS", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Office Nursings", "MN": "N04.452.758.377.875", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "Nursing practice limited to an office setting.", "PM": "73", "HN": "73(66)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009818"}, {"RECTYPE": "D", "MH": "Office Visits", "AQ": "EC SN TD", "ENTRY": "Visits, Office", "MN": "N04.452.758.635", "MH_TH": "NLM (1984)", "ST": "T058", "MS": "Visits made by patients to health service providers' offices for diagnosis, treatment, and follow-up.", "PM": "84", "HN": "84", "MR": "20180629", "DA": "19830606", "DC": "1", "DX": "19840101", "UI": "D009819"}, {"RECTYPE": "D", "MH": "Ohio", "AQ": "EH EP", "MN": "Z01.107.567.875.510.540", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Michigan and Lake Erie, on the east by Ohio River and Pennsylvania, on the south by Ohio River, and on the west by Indiana.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009820"}, {"RECTYPE": "D", "MH": "Oils", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D10.627", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specific oil groups & specific oils; coordinate with source of oil if relevant ", "MS": "Unctuous combustible substances that are liquid or easily liquefiable on warming, and are soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. Depending on their behavior on heating, they are volatile or fixed. (Dorland, 28th ed)", "MR": "20030709", "DA": "19770509", "DC": "1", "DX": "19660101", "UI": "D009821"}, {"RECTYPE": "D", "MH": "Oils, Volatile", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Volatile Oil|T109|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Volatile Oils", "MN": "D10.627.675", "FX": "Aromatherapy", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "coordinate with source of oil; /ther use: AROMATHERAPY is also available", "MS": "Oils which evaporate readily. The volatile oils occur in aromatic plants, to which they give odor and other characteristics. Most volatile oils consist of a mixture of two or more TERPENES or of a mixture of an eleoptene (the more volatile constituent of a volatile oil) with a stearopten (the more solid constituent). The synonym essential oils refers to the essence of a plant, as its perfume or scent, and not to its indispensability.", "MR": "20200114", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009822"}, {"RECTYPE": "D", "MH": "Ointment Bases", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Bases, Ointment", "MN": "D27.720.744.523", "FX": "Ointments", "MH_TH": "NLM (1975)", "ST": "T122", "RN": "0", "AN": "IM for general only; NIM when specific drug is IM; when IM, D25-26 qualif; when NIM, no qualif", "MS": "Various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons; vehicles for medicinal substances intended for external application; there are four classes: hydrocarbon base, absorption base, water-removable base and water-soluble base; several are also emollients.", "OL": "search PHARMACEUTIC AIDS 1968-74", "PM": "91; was see under PHARMACEUTIC AIDS 1975-90", "HN": "91(75); was see under PHARMACEUTIC AIDS 1975-90", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009823"}, {"RECTYPE": "D", "MH": "Ointments", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Unguent|T122|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Ointment, Skin", "MN": "D26.255.640", "FX": "Ointment Bases", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "AN": "IM general only; NIM (no qualifiers) with specific drug IM", "MS": "Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009824"}, {"RECTYPE": "D", "MH": "Oklahoma", "AQ": "EH EP", "MN": "Z01.107.567.875.510.550", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Kansas, on the east by Missouri and Arkansas, on the south by Texas, and on the west by New Mexico.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009825"}, {"RECTYPE": "D", "MH": "Old Age Assistance", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Security, Old Age", "MN": "N03.219.521.346.506.678", "MH_TH": "NLM (1975)", "ST": "T064", "AN": "specify geog", "MS": "Financial assistance for the impoverished elderly through public funding of programs, services, and individual income supplements.", "OL": "search PUBLIC ASSISTANCE 1968-74", "PM": "91; was see under PUBLIC ASSISTANCE 1975-90", "HN": "91(75); was see under PUBLIC ASSISTANCE 1975-90", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009826"}, {"RECTYPE": "D", "MH": "Oleandomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phosphate, Oleandomycin", "MN": "D02.540.505.600", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "Oleandomycin", "RN": "P8ZQ646136", "RR": "8681H0C27P", "MS": "Antibiotic macrolide produced by Streptomyces antibioticus.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009827"}, {"RECTYPE": "D", "MH": "Oleanolic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oleanol|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Triterpenes, Oleanane", "MN": "D02.455.849.919.650.600", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-", "RN": "6SMK8R7TGJ", "RR": "508-02-1 (Oleanolic Acid)", "PI": "Triterpenes (1974)", "MS": "A pentacyclic triterpene that occurs widely in many PLANTS as the free acid or the aglycone for many SAPONINS. It is biosynthesized from lupane. It can rearrange to the isomer, ursolic acid, or be oxidized to taraxasterol and amyrin.", "PM": "91; was see under SAPOGENINS 1979-90; was see under TRITERPENES 1975-78", "HN": "91(75); was see under SAPOGENINS 1979-90; was see under TRITERPENES 1975-78", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009828"}, {"RECTYPE": "D", "MH": "Oleic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Octadecenoic Acids|T109|NON|BRD|UNK (19XX)|760324|abcdef", "ENTRY": "Acids, Oleic", "MN": "D10.251.355.325.600", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with OLEIC ACID; do not confuse entry term OCTADECENOIC ACIDS with OCTADECANOIC ACIDS see STEARIC ACIDS", "MS": "A group of fatty acids that contain 18 carbon atoms and a double bond at the omega 9 carbon.", "OL": "use OLEIC ACIDS to search OLEIC ACID 1966-74", "PM": "75; was OLEIC ACID 1963-74; RICINOLEIC ACIDS was see under FATTY ACIDS, UNSATURATED 1975-87, was RICINOLEIC ACID see under FATTY ACIDS 1963-74; SODIUM RICINOLEATE was see under SCLEROSING SOLUTIONS 1963-74", "HN": "75; was OLEIC ACID 1963-74", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D009829"}, {"RECTYPE": "D", "MH": "Olfactory Bulb", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Olfactory Tract|T023|NON|REL|NLM (1993)|911220|abcdef", "ENTRY": "Tracts, Olfactory", "MN": "A08.186.211.200.885.388", "MH_TH": "NLM (1972)", "ST": "T023", "AN": "neoplasms: coordinate IM with BRAIN NEOPLASMS (IM) + histological type of neoplasm (IM)", "PI": "Limbic System (1966-1971)", "MS": "Ovoid body resting on the CRIBRIFORM PLATE of the ethmoid bone where the OLFACTORY NERVE terminates. The olfactory bulb contains several types of nerve cells including the mitral cells, on whose DENDRITES the olfactory nerve synapses, forming the olfactory glomeruli. The accessory olfactory bulb, which receives the projection from the VOMERONASAL ORGAN via the vomeronasal nerve, is also included here.", "OL": "search LIMBIC SYSTEM 1966-71", "PM": "1974; use LIMBIC SYSTEM 1963-1973; for OLFACTORY TRACT use OLFACTORY PATHWAYS 1993-2014", "HN": "1974(1972); use LIMBIC SYSTEM 1963-1973; for OLFACTORY TRACT use OLFACTORY PATHWAYS 1993-2014", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009830"}, {"RECTYPE": "D", "MH": "Olfactory Mucosa", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Olfactory Epithelium|T024|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Olfactory Membranes", "MN": "A10.615.550.760.600.640", "FX": "Vomeronasal Organ", "MH_TH": "NLM (1972)", "ST": "T024", "PI": "Nasal Mucosa (1966-1971)", "MS": "That portion of the nasal mucosa containing the sensory nerve endings for SMELL, located at the dome of each NASAL CAVITY. The yellow-brownish olfactory epithelium consists of OLFACTORY RECEPTOR NEURONS; brush cells; STEM CELLS; and the associated olfactory glands.", "PM": "72", "HN": "72", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009831"}, {"RECTYPE": "D", "MH": "Olfactory Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Nervus Olfactorius|T023|NON|EQV|NLM (2020)|190220|abcdef", "ENTRY": "Olfactory Nerves", "MN": "A08.800.800.120.640", "EC": "injuries:Olfactory Nerve Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The 1st cranial nerve. The olfactory nerve conveys the sense of smell. It is formed by the axons of OLFACTORY RECEPTOR NEURONS which project from the olfactory epithelium (in the nasal epithelium) to the OLFACTORY BULB.", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009832"}, {"RECTYPE": "D", "MH": "Olfactory Pathways", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Pathways, Olfactory", "MN": "A08.612.220.640", "MH_TH": "NLM (1972)", "ST": "T023", "PI": "specific brain site (1966-1971)", "MS": "Set of nerve fibers conducting impulses from olfactory receptors to the cerebral cortex. It includes the OLFACTORY NERVE; OLFACTORY BULB; OLFACTORY TRACT; OLFACTORY TUBERCLE; ANTERIOR PERFORATED SUBSTANCE; and OLFACTORY CORTEX.", "PM": "1991; see CENTRAL NERVOUS SYSTEM 1972-90", "HN": "1991(1972)", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009833"}, {"RECTYPE": "D", "MH": "Oligo-1,6-Glucosidase", "DS": "OLIGOGLUCOSIDASE 01 06", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Isomaltase|T116|T126|NON|EQV|UNK (19XX)|770329|abbcdef", "ENTRY": "Oligo 1,6 Glucosidase", "MN": "D08.811.277.450.770", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "Dextrin 6-alpha-D-glucanohydrolase", "RN": "EC 3.2.1.10", "AN": "consider also SUCRASE-ISOMALTASE COMPLEX; /defic: consider also SUCROSE /metab (IM) + CARBOHYDRATE METABOLISM, INBORN ERRORS (IM)", "PI": "Glycoside Hydrolases (1966-1977)", "MS": "An enzyme that catalyzes the endohydrolysis of 1,6-alpha-glucosidic linkages in isomaltose and dextrins produced from starch and glycogen by ALPHA-AMYLASES. EC 3.2.1.10.", "PM": "91; was see under GLYCOSIDE HYDROLASES 1978-90", "HN": "91(78); was see under GLYCOSIDE HYDROLASES 1978-90", "MR": "20080710", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D009834"}, {"RECTYPE": "D", "MH": "Oligochaeta", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Lumbricus terrestris|T204|NON|NRW|NLM (1998)|970123|abcdef", "ENTRY": "worm, Eisenia", "MN": "B01.050.500.091.657", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid6381", "RR": "txid6398", "PI": "Annelida (1966-1974)", "MS": "A class of annelid worms with few setae per segment. It includes the earthworms such as Lumbricus and Eisenia.", "OL": "search ANNELIDA 1969-74; use OLIGOCHAETA to search EARTHWORMS 1972-78", "PM": "79; was see under ANNELIDA 1969-78; EARTHWORMS was heading 1972-78", "HN": "79(75); was see under ANNELIDA 1969-78; EARTHWORMS was heading 1972-78", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D009835"}, {"RECTYPE": "D", "MH": "Oligodendroglia", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Satellite Cells, Perineuronal, Oligodendroglia|T025|NON|NRW|NLM (2003)|020104|abcdef", "ENTRY": "Satellite Oligodendrocytes, Perineuronal", "MN": "A11.650.600", "MH_TH": "NLM (1975)", "ST": "T025", "MS": "A class of large neuroglial (macroglial) cells in the central nervous system. Oligodendroglia may be called interfascicular, perivascular, or perineuronal (not the same as SATELLITE CELLS, PERINEURONAL of GANGLIA) according to their location. They form the insulating MYELIN SHEATH of axons in the central nervous system.", "OL": "search NEUROGLIA 1966-74", "PM": "90; was see under NEUROGLIA 1966-89", "HN": "90(75); was see under NEUROGLIA 1966-89", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D009836"}, {"RECTYPE": "D", "MH": "Oligodendroglioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Oligodendroblastoma|T191|NON|REL|NLM (1992)|910618|abcdef", "ENTRY": "Well-Differentiated Oligodendrogliomas", "MN": "C04.557.580.625.600.380.590", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with precoordinated brain/neoplasm term (IM) + site (IM); for MIXED OLIGODENDROGLIOMA-ASTROCYTOMA or MIXED OLIGODENDROGLIOMA-EPENDYMOMA index here only, do not coordinate with ASTROCYTOMA or EPENDYMOMA", "MS": "A relatively slow-growing glioma that is derived from oligodendrocytes and tends to occur in the cerebral hemispheres, thalamus, or lateral ventricle. They may present at any age, but are most frequent in the third to fifth decades, with an earlier incidence peak in the first decade. Histologically, these tumors are encapsulated, relatively avascular, and tend to form cysts and microcalcifications. Neoplastic cells tend to have small round nuclei surrounded by unstained nuclei. The tumors may vary from well-differentiated to highly anaplastic forms. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2052; Adams et al., Principles of Neurology, 6th ed, p655)", "OL": "use OLIGODENDROGLIOMA to search OLIGODENDROMA 1966-93", "PM": "68; was OLIGODENDROMA 1963-67; OLIGODENDROMA was see OLIGODENDROGLIOMA 1968-93", "HN": "68; was OLIGODENDROMA 1963-67; OLIGODENDROMA was see OLIGODENDROGLIOMA 1968-93", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009837"}, {"RECTYPE": "D", "MH": "Oligodeoxyribonucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oligodeoxyribonucleotide|T114|NON|EQV|NLM (2021)|200227|abcdef", "ENTRY": "Oligodeoxynucleotides|T114|NON|EQV|NLM (2009)|080416|abcdef", "MN": "D13.695.578.424.450", "MH_TH": "NLM (1976)", "ST": "T114", "RN": "0", "AN": "2-12 nucleotides", "PI": "Oligonucleotides (1974-1975)", "MS": "A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties.", "PM": "86; was see under OLIGONUCLEOTIDES 1976-85", "HN": "86(76); was see under OLIGONUCLEOTIDES 1976-85", "MR": "20200527", "DA": "19750725", "DC": "1", "DX": "19860101", "UI": "D009838"}, {"RECTYPE": "D", "MH": "Oligomenorrhea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Oligomenorrheas", "MN": "C23.550.568.937", "FX": "Amenorrhea", "MH_TH": "NLM (1975)", "ST": "T046", "MS": "Abnormally infrequent menstruation.", "PM": "91; was see under MENSTRUATION DISORDERS 1975-90", "HN": "91(75); was see under MENSTRUATION DISORDERS 1975-90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D009839"}, {"RECTYPE": "D", "MH": "Oligomycins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oligomycin|T109|T195|NON|EQV|UNK (19XX)|820113|abbcdef", "MN": "D02.540.505.620", "PA": "Uncoupling Agents", "MH_TH": "NLM (1963)", "ST": "T195", "RN": "0", "MS": "A closely related group of toxic substances elaborated by various strains of Streptomyces. They are 26-membered macrolides with lactone moieties and double bonds and inhibit various ATPases, causing uncoupling of phosphorylation from mitochondrial respiration. Used as tools in cytochemistry. Some specific oligomycins are RUTAMYCIN, peliomycin, and botrycidin (formerly venturicidin X).", "OL": "use OLIGOMYCINS to search OLIGOMYCIN 1966-81", "PM": "82; was OLIGOMYCIN 1966-81; RUTAMYCIN was see under ANTIBIOTICS, ANTIFUNGAL 1975-81", "HN": "82; was OLIGOMYCIN 1963-81 (Prov 1963-65)", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009840"}, {"RECTYPE": "D", "MH": "Oligonucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oligonucleotide|T114|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D13.695.578.424", "MH_TH": "NLM (1972)", "ST": "T114", "RN": "0", "AN": "2-12 nucleotides", "MS": "Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed)", "PM": "74", "HN": "74(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009841"}, {"RECTYPE": "D", "MH": "Oligopeptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oligopeptide|T116|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D12.644.456", "MH_TH": "NLM (1973)", "ST": "T116", "RN": "0", "AN": "2-12 amino acids (includes DIPEPTIDES, tripeptides, tetrapeptides, pentapeptides, etc.); GEN; prefer specifics; conformation: coord OLIGOPEPTIDES or specific peptide (IM) + PROTEIN CONFORMATION (NIM)", "PI": "Peptides (1966-1972)", "MS": "Peptides composed of between two and twelve amino acids.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009842"}, {"RECTYPE": "D", "MH": "Oligoribonucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D13.695.578.424.500", "MH_TH": "NLM (1976)", "ST": "T114", "RN": "0", "AN": "2-12 nucleotides", "PI": "Oligonucleotides (1974-1975)", "MS": "A group of ribonucleotides (up to 12) in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.", "PM": "86; was see under OLIGONUCLEOTIDES 1976-85", "HN": "86(76); was see under OLIGONUCLEOTIDES 1976-85", "MR": "19920519", "DA": "19750725", "DC": "1", "DX": "19860101", "UI": "D009843"}, {"RECTYPE": "D", "MH": "Oligosaccharides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Oligosaccharide|T109|NON|EQV|NLM (2021)|191129|abcdef", "MN": "D09.698.629", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Carbohydrates consisting of between two (DISACCHARIDES) and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009844"}, {"RECTYPE": "D", "MH": "Oligospermia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Low Sperm Count|T047|NON|EQV|NLM (2007)|060522|abcdef", "ENTRY": "Sperm Counts, Low", "MN": "C12.200.294.430.508", "MH_TH": "NLM (1975)", "ST": "T047", "PI": "Spermatozoa (1966-1974)", "MS": "A condition of suboptimal concentration of SPERMATOZOA in the ejaculated SEMEN to ensure successful FERTILIZATION of an OVUM. In humans, oligospermia is defined as a sperm count below 20 million per milliliter semen.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D009845"}, {"RECTYPE": "D", "MH": "Oliguria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Oligurias", "MN": "C23.888.942.400", "MH_TH": "NLM (1975)", "ST": "T184", "AN": "do not confuse with ANURIA", "MS": "Decreased URINE output that is below the normal range. Oliguria can be defined as urine output of less than or equal to 0.5 or 1 ml/kg/hr depending on the age.", "OL": "search ANURIA 1966-74", "PM": "91; was see under ANURIA 1975-90", "HN": "91(75); was see under ANURIA 1975-90", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009846"}, {"RECTYPE": "D", "MH": "Olivary Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Olivary Nuclei|T023|NON|EQV|NLM (2024)|220927|abcdef", "ENTRY": "Olivary Bodies", "MN": "A08.186.211.132.810.591.750", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A brainstem nuclear complex. in the hindbrain, also referred to as the olivary body.  The olivary nuclear complex is a part of the MEDULLA OBLONGATA and the PONTINE TEGMENTUM. It is involved with motor control and is a major source of sensory input to the CEREBELLUM.", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009847"}, {"RECTYPE": "D", "MH": "Olivomycins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Olivomycin|T109|T130|T195|NON|EQV|FDA SRS (2014)|INN (19XX)|800523|abbbcdeef", "MN": "D09.408.661", "PA": "Protein Synthesis Inhibitors", "MH_TH": "NLM (1965)", "ST": "T195", "RN": "44003517D1", "MS": "A mixture of several closely related glycosidic antibiotics obtained from Actinomyces (or Streptomyces) olivoreticuli. They are used as fluorescent dyes that bind to DNA and prevent both RNA and protein synthesis and are also used as antineoplastic agents.", "OL": "use OLIVOMYCINS to search OLIVOMYCIN 1965-80 (as Prov 1966-71)", "PM": "81; was OLIVOMYCIN 1972-80", "HN": "81; was OLIVOMYCIN 1965-80 (Prov 1965-71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009848"}, {"RECTYPE": "D", "MH": "Olivopontocerebellar Atrophies", "DE": "OPCA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Olivopontocerebellar Hypoplasia|T047|NON|REL|NLM (2024)|220927|abcdef", "ENTRY": "Syndrome, Dejerine-Thomas", "MN": "C16.320.400.780.750", "FX": "Olivary Degeneration", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Pons (1966-1986)", "MS": "A group of inherited and sporadic disorders which share progressive ataxia in combination with atrophy of the CEREBELLUM; PONS; and inferior olivary nuclei. Additional clinical features may include MUSCLE RIGIDITY; NYSTAGMUS, PATHOLOGIC; RETINAL DEGENERATION; MUSCLE SPASTICITY; DEMENTIA; URINARY INCONTINENCE; and OPHTHALMOPLEGIA. The familial form has an earlier onset (second decade) and may feature spinal cord atrophy. The sporadic form tends to present in the fifth or sixth decade, and is considered a clinical subtype of MULTIPLE SYSTEM ATROPHY. (From Adams et al., Principles of Neurology, 6th ed, p1085)", "PM": "2000; see OLIVOPONTOCEREBELLAR ATROPHY 1991-1999, see SPINOCEREBELLAR DEGENERATION 1987-1990", "HN": "2000(1987)", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19860331", "DC": "1", "DX": "19910101", "UI": "D009849"}, {"RECTYPE": "D", "MH": "Oman", "AQ": "EH EP", "PRINT ENTRY": "Muscat and Oman|T083|NAM|REL|UNK (19XX)|780503|MUSCAT OMAN|abcdefv", "ENTRY": "Muscat|T083|NAM|REL|NLM (1993)|920430|abcdef", "MN": "Z01.252.245.500.600", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "a sultanate on the southeast Arabian peninsula", "MS": "A sultanate on the southeast coast of the Arabian peninsula. Its capital is Masqat. Before the 16th century it was ruled by independent emirs but was captured and controlled by the Portuguese 1508-1648. In 1741 it was recovered by a descendent of Yemen's imam. After its decline in the 19th century, it became virtually a political and economic dependency within the British Government of India, retaining close ties with Great Britain by treaty from 1939 to 1970 when it achieved autonomy. The name was recorded by Pliny in the 1st century A.D. as Omana, said to be derived from the founder of the state, Oman ben Ibrahim al-Khalil. (From Webster's New Geographical Dictionary, 1988, p890; Oman Embassy, Washington; Room, Brewer's Dictionary of Names, 1992, p391)", "OL": "use OMAN to search MUSCAT & OMAN 1975-78", "HN": "79; was MUSCAT & OMAN 1975-78", "MR": "20150629", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D009850"}, {"RECTYPE": "D", "MH": "Omasum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Omasums", "MN": "A13.869.524", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "a ruminant's 3d stomach; dis: coord IM with STOMACH DISEASES /vet (IM); neopl: coord IM with STOMACH NEOPLASMS /vet + histol type /vet (IM); ulcer: coord IM with STOMACH ULCER /vet (IM)", "PI": "Stomach (1966-1967)", "MS": "The third stomach of ruminants, situated on the right side of the abdomen at a higher level than the fourth stomach and between this latter and the second stomach, with both of which it communicates. From its inner surface project large numbers of leaves or folia, each of which possesses roughened surfaces. In the center of each folium is a band of muscle fibers which produces a rasping movement of the leaf when it contracts. One leaf rubs against those on either side of it, and large particles of food material are ground down between the rough surfaces, preparatory to further digestion in the succeeding parts of the alimentary canal. (Black's Veterinary Dictionary, 17th ed)", "PM": "68", "HN": "68", "MR": "20040729", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009851"}, {"RECTYPE": "D", "MH": "Omentum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Omentums", "MN": "A01.923.047.025.600.573", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "dis: coord IM with PERITONEAL DISEASES (IM); neopl: coord IM with PERITONEAL NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "A double-layered fold of peritoneum that attaches the STOMACH to other organs in the ABDOMINAL CAVITY.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009852"}, {"RECTYPE": "D", "MH": "Omeprazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Omeprazole", "MN": "D03.633.100.103.034.500", "PA": "Proton Pump Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Benzimidazole, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-", "RN": "KG60484QX9", "RR": "KV03YZ6QLW", "PI": "Benzimidazoles (1966-1986)", "MS": "A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.", "PM": "87", "HN": "87", "MR": "20160531", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D009853"}, {"RECTYPE": "D", "MH": "Onchocerca", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Onchocercas", "MN": "B01.050.500.500.294.400.937.463.510", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6281", "MS": "A genus of parasitic nematodes whose organisms live and breed in skin and subcutaneous tissues. Onchocercal microfilariae may also be found in the urine, blood, or sputum.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009854"}, {"RECTYPE": "D", "MH": "Onchocerciasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Onchocerciases", "MN": "C17.800.838.775.690", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "MS": "Infection with nematodes of the genus ONCHOCERCA. Characteristics include the presence of firm subcutaneous nodules filled with adult worms, PRURITUS, and ocular lesions.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009855"}, {"RECTYPE": "D", "MH": "Oncogene Proteins, Viral", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-onc Proteins|T116|T123|NON|EQV|UNK (19XX)|850425|abbcdef", "ENTRY": "v onc Proteins", "MN": "D12.776.964.700", "MH_TH": "NLM (1986)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics; coordinate with specific virus ", "PI": "Viral Proteins (1966-1985)", "MS": "Products of viral oncogenes, most commonly retroviral oncogenes. They usually have transforming and often protein kinase activities.", "PM": "86", "HN": "86", "MR": "20050630", "DA": "19850425", "DC": "1", "DX": "19860101", "UI": "D009856"}, {"RECTYPE": "D", "MH": "Oncogenes", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Transforming Genes|T028|NON|EQV|UNK (19XX)|870509|abcdef", "ENTRY": "Genes, Transforming", "MN": "G05.360.340.024.340.375.500", "MH_TH": "NLM (1983)", "ST": "T028", "AN": "\"oncogene\" used by author may refer to ONCOGENES or PROTO-ONCOGENES; do not confuse with ONCOGENS see CARCINOGENS; Manual 24.4.4.3; do not confuse with GENES, NEOPLASM", "PI": "Genes, Viral (1978-1982)", "MS": "Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of \"v-\" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix \"c-\" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19820422", "DC": "1", "DX": "19830101", "UI": "D009857"}, {"RECTYPE": "D", "MH": "Oncogenic Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Tumor Viruses|T005|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Viruses, Tumor", "MN": "B04.613", "FX": "Tumor Virus Infections", "MH_TH": "NLM (1966)", "ST": "T005", "MS": "Viruses that produce tumors.", "PM": "66; was TUMOR VIRUSES 1963-65", "HN": "66; was TUMOR VIRUSES 1963-65", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009858"}, {"RECTYPE": "D", "MH": "Oncology Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Oncologic Nursing|T058|T091|NON|EQV|NLM (1985)|990101|ONCOL NURS|abbcdefv", "ENTRY": "Nursing, Oncology", "MN": "N02.421.533.600", "MH_TH": "NLM (2014)", "ST": "T091", "AN": "use ONCOLOGY NURSING for the nursing specialty; use NEOPLASMS/nurs for the patient", "PI": "Specialties, Nursing (1971-1984)", "MS": "A nursing specialty concerned with the care provided to cancer patients. It includes aspects of family functioning through education of both patient and family.", "PM": "85", "HN": "85", "MR": "20150629", "DA": "19840411", "DC": "1", "DX": "19850101", "UI": "D009859"}, {"RECTYPE": "D", "MH": "Onium Compounds", "DE": "ONIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Onium", "MN": "D02.675", "MH_TH": "NLM (1968)", "ST": "T104", "RN": "0", "MS": "Ions with the suffix -onium, indicating cations with coordination number 4 of the type RxA+ which are analogous to QUATERNARY AMMONIUM COMPOUNDS (H4N+). Ions include phosphonium R4P+, oxonium R3O+, sulfonium R3S+, chloronium R2Cl+", "PM": "68", "HN": "68", "MR": "20050701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009861"}, {"RECTYPE": "D", "MH": "Online Systems", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "On-Line Systems|T073|T170|NON|EQV|UNK (19XX)|780428|abbcdef", "ENTRY": "Systems, Online", "MN": "L01.313.500.750.300.742", "MH_TH": "NLM (1971)", "ST": "T170", "AN": "IM; coord with discipline, site or application where used (IM)", "PI": "Computers (1966-1970)", "MS": "Computer-based Information systems having real-time remote access to information or processes.", "OL": "use ONLINE SYSTEMS to search ON LINE SYSTEMS 1971-78 (as Prov 1971-73)", "PM": "79; was ON LINE SYSTEMS 1974-78", "HN": "79; was ON LINE SYSTEMS 1971-78 (Prov 1971-73)", "MR": "20180711", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009862"}, {"RECTYPE": "D", "MH": "Only Child", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Children, Only", "MN": "I01.880.853.150.625", "MH_TH": "POPLINE (1982)", "ST": "T099", "MS": "Child who has no siblings.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009863"}, {"RECTYPE": "D", "MH": "Ontario", "AQ": "EH EP", "MN": "Z01.107.567.176.639", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a province of Canada", "MS": "A province of Canada lying between the provinces of Manitoba and Quebec. Its capital is Toronto. It takes its name from Lake Ontario which is said to represent the Iroquois oniatariio, beautiful lake. (From Webster's New Geographical Dictionary, 1988, p892 & Room, Brewer's Dictionary of Names, 1992, p391)", "MR": "19950221", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009864"}, {"RECTYPE": "D", "MH": "Oocytes", "AQ": "CH CL CY DE EN GD IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Ovocytes|T025|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Ovocyte", "MN": "A11.497.497.600", "FX": "In Vitro Oocyte Maturation Techniques", "MH_TH": "NLM (1975)", "ST": "T025", "AN": "do not confuse with OOCYSTS life cycle stage in protozoa", "PI": "Ovum (1966-1974)", "MS": "Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM).", "PM": "84; was see under OVUM 1975-83", "HN": "84(75); was see under OVUM 1975-83", "MR": "20110624", "DA": "19741111", "DC": "1", "DX": "19840101", "UI": "D009865"}, {"RECTYPE": "D", "MH": "Oogenesis", "AQ": "DE GE IM PH RE", "ENTRY": "Oogeneses", "MN": "G08.686.784.310.500", "FX": "In Vitro Oocyte Maturation Techniques", "MH_TH": "POPLINE (1994)", "ST": "T042", "PI": "Ovum (1966-1974)", "MS": "The process of germ cell development in the female from the primordial germ cells through OOGONIA to the mature haploid ova (OVUM).", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D009866"}, {"RECTYPE": "D", "MH": "Oogonia", "AQ": "CH CL CY DE EN GD IM ME MI PA PH PS RE TR UL VI", "MN": "A11.497.497.650", "MH_TH": "NLM (1975)", "ST": "T025", "MS": "Euploid female germ cells of an early stage of OOGENESIS, derived from primordial germ cells during ovarian differentiation. Oogonia undergo MEIOSIS and give rise to haploid OOCYTES", "PM": "91; was see under OVUM 1975-90", "HN": "91(75); was see under OVUM 1975-90", "MR": "20020703", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D009867"}, {"RECTYPE": "D", "MH": "Oomycetes", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Oomycota|T204|NON|EQV|NLM (1999)|971125|abcdef", "ENTRY": "Oomycotas", "MN": "B01.750.580", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid4762", "AN": "general or unspecified; prefer specifics; infection: coordinate IM with INFECTION (IM)", "MS": "Eukaryotes in the group STRAMENOPILES, formerly considered FUNGI, whose exact taxonomic level is unsettled. Many consider Oomycetes (Oomycota) a phylum in the kingdom Stramenopila, or alternatively, as Pseudofungi in the phylum Heterokonta of the kingdom Chromista. They are morphologically similar to fungi but have no close phylogenetic relationship to them. Oomycetes are found in both fresh and salt water as well as in terrestrial environments. (Alexopoulos et al., Introductory Mycology, 4th ed, pp683-4). They produce flagellated, actively motile spores (zoospores) that are pathogenic to many crop plants and FISHES.", "PM": "91; see MASTIGOMYCOTINA 1986-90, see PHYCOMYCETES 1972-85", "HN": "91(75); use FUNGI 1972-74", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009868"}, {"RECTYPE": "D", "MH": "Oophoritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Oophoritides", "MN": "C19.391.630.450", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the OVARY, generally caused by an ascending infection of organisms from the endocervix.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009869"}, {"RECTYPE": "D", "MH": "Operating Room Information Systems", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Information Systems, Operating Room|T073|T170|NON|EQV|NLM (1991)|900410|abbcdef", "MN": "N04.452.515.360.555", "MH_TH": "NLM (1987)", "ST": "T170", "MS": "Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of operating room services and facilities.", "PM": "91; was see under HOSPITAL INFORMATION SYSTEMS 1987-90", "HN": "91(87); was see under HOSPITAL INFORMATION SYSTEMS 1987-90", "MR": "20190709", "DA": "19860617", "DC": "1", "DX": "19910101", "UI": "D009870"}, {"RECTYPE": "D", "MH": "Operating Room Nursing", "DE": "OPERATING ROOM NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Operating Room|T058|NON|EQV|UNK (19XX)|860101|NURS OPERATING ROOM|abcdefv", "MN": "N02.421.533.710.625", "MH_TH": "NLM (1974)", "ST": "T058", "MS": "The functions of the professional nurse in the operating room.", "PM": "74", "HN": "74", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009871"}, {"RECTYPE": "D", "MH": "Operating Room Technicians", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Technicians, Operating Room", "MN": "N02.360.067.700", "MH_TH": "NLM (1971)", "ST": "T097", "PI": "Operating Rooms/manpower (1968-1970)", "MS": "Specially trained personnel to assist in routine technical procedures in the operating room.", "PM": "71", "HN": "71", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D009872"}, {"RECTYPE": "D", "MH": "Operating Rooms", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Rooms, Operating", "MN": "N02.278.388.700", "FX": "Gas Scavengers", "MH_TH": "NLM (1966)", "ST": "T093", "MS": "Facilities equipped for performing surgery.", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009873"}, {"RECTYPE": "D", "MH": "Operations Research", "PRINT ENTRY": "Operational Research|T062|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Research, Operations", "MN": "L01.906.394", "FX": "Information Theory", "MH_TH": "NLM (1966)", "ST": "T062", "MS": "A group of techniques developed to apply scientific methods and tools to solve the problems of DECISION MAKING in complex organizations and systems. Operations research searches for optimal solutions in situations of conflicting GOALS and makes use of mathematical models from which solutions for actual problems may be derived. (From Psychiatric Dictionary, 6th ed)", "PM": "66", "HN": "66", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009874"}, {"RECTYPE": "D", "MH": "Operator Regions, Genetic", "AQ": "DE GE IM PH RE", "ENTRY": "Regions, Operator", "MN": "G05.360.340.358.207.500.645", "MH_TH": "NLM (2009)", "ST": "T123", "PI": "Operon (1969-1985)", "MS": "The regulatory elements of an OPERON to which activators or repressors bind thereby effecting the transcription of GENES in the operon.", "PM": "2009; see OPERATOR REGIONS (GENETICS) 1986-2008, see OPERON 1980-1985", "HN": "2009 (1986); use OPERON 1980-1985", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19850226", "DC": "1", "DX": "19860101", "UI": "D009875"}, {"RECTYPE": "D", "MH": "Operon", "AQ": "DE ES GE IM PH RE", "ENTRY": "Operons|T028|NON|EQV|NLM (2004)|021115|abcdef", "MN": "G05.360.340.358.207.500", "MH_TH": "NLM (1969)", "ST": "T028", "AN": "LAC OPERON & RRNA OPERON are also available", "PI": "Genetics, Biochemical (1968)", "MS": "In bacteria, a group of metabolically related genes, with a common promoter, whose transcription into a single polycistronic MESSENGER RNA is under the control of an OPERATOR REGION.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009876"}, {"RECTYPE": "D", "MH": "Endophthalmitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ophthalmia|T047|NON|EQV|NLM (1990)|890321|abcdef", "ENTRY": "Ophthalmias", "MN": "C11.294.265", "FX": "Panophthalmitis", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "restrict to endophthalmitis as a specific disease entity, not as a coordinate for inflammation of specific internal parts of the eye: these are available as -ITIS terms; ophthalmitis goes here; PANOPHTHALMITIS is also available: inflammation of all structures of the eye; EGYPTIAN OPHTHALMIA see TRACHOMA is also available", "MS": "Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.", "OL": "use ENDOPHTHALMITIS to search OPHTHALMIA 1966-89", "PM": "90; was OPHTHALMIA 1966-89", "HN": "90; was OPHTHALMIA 1966-89", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D009877"}, {"RECTYPE": "D", "MH": "Ophthalmia Neonatorum", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C16.614.677", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "bact conjunctivitis; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Acute conjunctival inflammation in the newborn, usually caused by maternal gonococcal infection. The causative agent is NEISSERIA GONORRHOEAE. The baby's eyes are contaminated during passage through the birth canal.", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009878"}, {"RECTYPE": "D", "MH": "Ophthalmia, Sympathetic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Uveitis, Sympathetic|T047|NON|EQV|NLM (1990)|890329|abcdef", "ENTRY": "Uveitides, Sympathetic", "MN": "C20.111.709", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a type of uveitis: note X ref", "MS": "Granulomatous uveitis which follows in one eye after a penetrating injury to the other eye; the secondarily affected eye is called the sympathizing eye, and the injured eye is called the exciting or activating eye.", "CATSH": "CAT LIST", "MR": "19900529", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009879"}, {"RECTYPE": "D", "MH": "Ophthalmic Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ophthalmic Arteries", "MN": "A07.015.114.622", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Artery originating from the internal carotid artery and distributing to the eye, orbit and adjacent facial structures.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009880"}, {"RECTYPE": "D", "MH": "Ophthalmic Assistants", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Ophthalmic Assistant", "MN": "N02.360.067.740.690", "MH_TH": "NLM (1975)", "ST": "T097", "MS": "Persons academically trained to care for patients with eye diseases or structural defects of the eye, under the supervision of an ophthalmologist.", "OL": "search PHYSICIANS' ASSISTANTS 1971-74", "PM": "91; was see under PHYSICIANS' ASSISTANTS 1975-90", "HN": "91(75); was see under PHYSICIANS' ASSISTANTS 1975-90", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009881"}, {"RECTYPE": "D", "MH": "Ophthalmic Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ophthalmic Nerves", "MN": "A08.800.800.120.760.650", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "a branch of the trigeminal (5th cranial) nerve; dis: coord IM with CRANIAL NERVE DISEASES (IM); neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "A sensory branch of the trigeminal (5th cranial) nerve. The ophthalmic nerve carries general afferents from the superficial division of the face including the eyeball, conjunctiva, upper eyelid, upper nose, nasal mucosa, and scalp.", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009882"}, {"RECTYPE": "D", "MH": "Ophthalmic Solutions", "DE": "OPHTHALMIC SOL", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Ophthalmic Solution|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Solutions, Ophthalmic", "MN": "D27.720.752.608", "MH_TH": "NLM (1967)", "ST": "T121", "RN": "0", "MS": "Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS.", "OL": "use OPHTHALMIC SOLUTIONS to search SOLUTIONS, OPHTHALMIC 1966", "PM": "67; was SOLUTIONS, OPHTHALMIC 1963-66", "HN": "67; was SOLUTIONS, OPHTHALMIC 1963-66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009883"}, {"RECTYPE": "D", "MH": "Ophthalmodynamometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Ophthalmodynamometries", "MN": "E01.370.380.550", "MH_TH": "NLM (1964)", "ST": "T060", "MS": "Measurement of the blood pressure of the retinal vessels. It is used also for the determination of the near point of convergence (CONVERGENCE, OCULAR). (From Cline, et al., Dictionary of Visual Science, 4th ed)", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009884"}, {"RECTYPE": "D", "MH": "Ophthalmology", "DE": "OPHTHALMOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Ocular Surgery|T091|NON|NRW|NLM (2022)|210428|abcdef", "ENTRY": "Surgery, Ocular", "MN": "H02.403.810.468", "FX": "Vision, Ocular", "MH_TH": "BIOETHICS (1980)", "ST": "T091", "MS": "A surgical specialty concerned with the structure and function of the eye and the medical and surgical treatment of its defects and diseases.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009885"}, {"RECTYPE": "D", "MH": "Ophthalmoplegia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Oculomotor Paralysis|T184|NON|EQV|UNK (19XX)|780517|abcdef", "ENTRY": "Paralysis, Oculomotor", "MN": "C23.888.592.636.447", "FX": "Oculomotor Nerve Diseases", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "do not confuse entry term OCULOMOTOR PARALYSIS with OCULOMOTOR NERVE PARALYSIS", "MS": "Paralysis of one or more of the ocular muscles due to disorders of the eye muscles, neuromuscular junction, supporting soft tissue, tendons, or innervation to the muscles.", "OL": "use OPHTHALMOPLEGIA to search OCULOMOTOR PARALYSIS 1966-78", "PM": "1979; was OCULOMOTOR PARALYSIS 1963-1978", "HN": "1979; was OCULOMOTOR PARALYSIS 1963-1978", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D009886"}, {"RECTYPE": "D", "MH": "Ophthalmoscopy", "AQ": "AE CL EC ES HI MO MT NU PX SN ST TD VE", "ENTRY": "Ophthalmoscopies", "MN": "E01.370.380.560", "EC": "instrumentation:Ophthalmoscopes", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Examination of the interior of the eye with an ophthalmoscope.", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009887"}, {"RECTYPE": "D", "MH": "Opipramol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Opipramol", "MN": "D03.633.300.240.625", "PA": "Antidepressive Agents, Tricyclic", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Piperazineethanol, 4-(3-(5H-dibenz(b,f)azepin-5-yl)propyl)-", "RN": "D23ZXO613C", "RR": "B49OBI656M", "MS": "A tricyclic antidepressant with actions similar to AMITRIPTYLINE.", "PM": "66", "HN": "66", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009888"}, {"RECTYPE": "D", "MH": "Opisthorchiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Opisthorchis viverrini Infections", "MN": "C01.610.335.865.685", "MH_TH": "NLM (1968)", "ST": "T047", "PI": "Trematode Infections (1966-1967)", "MS": "Infection with flukes of the genus Opisthorchis.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009889"}, {"RECTYPE": "D", "MH": "Opisthorchidae", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.736.715.520", "MH_TH": "NLM (1982)", "ST": "T204", "RN": "txid6196", "AN": "a family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Trematoda (1966-1981)", "MS": "A family of lanceolate liver flukes of the class Trematoda which occurs in animals and man. There are several genera including Amphimerus, Cyclorchis, Delphinicola, Metorchis, Parametorchis, Phocitrema, Clonorchis, and Opisthorchis.", "PM": "82", "HN": "82", "MR": "20200813", "DA": "19810515", "DC": "1", "DX": "19820101", "UI": "D009890"}, {"RECTYPE": "D", "MH": "Opisthorchis", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Opisthorchis viverrini|T204|NON|NRW|UNK (19XX)|810515|abcdef", "ENTRY": "viverrini, Opisthorchis", "MN": "B01.050.500.500.736.715.520.700", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6197", "RR": "txid6198", "MS": "A genus of trematode liver flukes of the family Opisthorchidae. It consists of the following species: O. felineus, O. noverca (Amphimerus noverca), and O. viverrini. The intermediate hosts are snails, fish, and AMPHIBIANS.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009891"}, {"RECTYPE": "D", "MH": "Opium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Papaveretum|T109|T121|NON|NRW|UNK (19XX)|840406|abbcdef", "ENTRY": "Pantopon|T109|T121|TRD|NRW|UNK (19XX)|790611|abbcdef", "MN": "D20.215.784.500.534", "PA": "Narcotics", "FX": "Opiate Alkaloids", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "8008-60-4", "AN": "OPIUM DEPENDENCE is also available", "MS": "The air-dried exudate from the unripe seed capsule of the opium poppy, Papaver somniferum, or its variant, P. album. It contains a number of alkaloids, but only a few - MORPHINE; CODEINE; and PAPAVERINE - have clinical significance. Opium has been used as an analgesic, antitussive, antidiarrheal, and antispasmodic.", "OL": "use OPIUM to search PANTOPON 1966-79", "PM": "PANTOPON was see under OPIUM 1963-79", "HN": "PANTOPON was see under OPIUM 1963-79", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D009892"}, {"RECTYPE": "D", "MH": "Opossums", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Didelphidae|T015|NON|EQV|NLM (2005)|040220|abcdef", "ENTRY": "Opossum", "MN": "B01.050.150.900.649.573.575", "MH_TH": "NLM (1968)", "ST": "T015", "RN": "txid9265", "AN": "possums are indexed under PHALANGERIDAE or specifics", "PI": "Marsupialia (1966-1967)", "MS": "New World marsupials of the family Didelphidae. Opossums are omnivorous, largely nocturnal and arboreal MAMMALS, grow to about three feet in length, including the scaly prehensile tail, and have an abdominal pouch in which the young are carried at birth.", "PM": "1968", "HN": "1968", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009893"}, {"RECTYPE": "D", "MH": "Opportunistic Infections", "DE": "OPPORTUNISTIC INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Opportunistic Infection", "MN": "C01.597", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "\"an infect caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression\"; coord IM with specific name of opportunistic infect (IM) + specific infect to which it is opportunistic (IM), using /compl for all 3", "PI": "specific infection (1966-1986)", "MS": "An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19860401", "DC": "1", "DX": "19870101", "UI": "D009894"}, {"RECTYPE": "D", "MH": "Opsonin Proteins", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Opsonins|T116|T129|NON|EQV|NLM (1964)|990101|abbcdef", "ENTRY": "Protein, Opsonin", "MN": "D12.776.124.486.657", "PA": "Immunologic Factors", "FX": "Opsonization", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "AN": "coordinate with ANTIBODIES or specific antibody term if relevant", "MS": "Proteins that bind to particles and cells to increase susceptibility to PHAGOCYTOSIS, especially ANTIBODIES bound to EPITOPES that attach to FC RECEPTORS. COMPLEMENT C3B may also participate.", "PM": "2006; see OPSONINS 1965-2004", "HN": "2006(1964)", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009895"}, {"RECTYPE": "D", "MH": "Optic Atrophy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Atrophy, Optic", "MN": "C11.640.451", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "/genet permitted but do not confuse with OPTIC ATROPHIES, HEREDITARY", "MS": "Atrophy of the optic disk which may be congenital or acquired. This condition indicates a deficiency in the number of nerve fibers which arise in the RETINA and converge to form the OPTIC DISK; OPTIC NERVE; OPTIC CHIASM; and optic tracts. GLAUCOMA; ISCHEMIA; inflammation, a chronic elevation of intracranial pressure, toxins, optic nerve compression, and inherited conditions (see OPTIC ATROPHIES, HEREDITARY) are relatively common causes of this condition.", "CATSH": "CAT LIST", "MR": "20050715", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009896"}, {"RECTYPE": "D", "MH": "Optic Chiasm", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Chiasma Opticum|T023|NON|EQV|NLM (1994)|930210|abcdef", "ENTRY": "Opticums, Chiasma", "MN": "A08.800.800.120.680.600", "MH_TH": "NLM (1964)", "ST": "T023", "AN": "neopl: coord IM with OPTIC NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "The X-shaped structure formed by the meeting of the two optic nerves. At the optic chiasm the fibers from the medial part of each retina cross to project to the other side of the brain while the lateral retinal fibers continue on the same side. As a result each half of the brain receives information about the contralateral visual field from both eyes.", "PM": "66", "HN": "66(64)", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009897"}, {"RECTYPE": "D", "MH": "Optic Disk", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Optic Papilla|T023|NON|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "Spot, Blind", "MN": "A09.371.729.690", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "The portion of the optic nerve seen in the fundus with the ophthalmoscope. It is formed by the meeting of all the retinal ganglion cell axons as they enter the optic nerve.", "PM": "78; was see under OPTIC NERVE 1975-77", "HN": "78(75); was see under OPTIC NERVE 1975-77", "MR": "20190408", "DA": "19741212", "DC": "1", "DX": "19770101", "UI": "D009898"}, {"RECTYPE": "D", "MH": "Optic Lobe, Nonmammalian", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Corpora Bigemina|T023|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Optic Lobes, Nonmammalian", "MN": "A13.686", "MH_TH": "NLM (2008)", "ST": "T023", "AN": "OPTIC LOBE, MAMMALIAN see SUPERIOR COLLICULI is also available", "MS": "In invertebrate zoology, a lateral lobe of the FOREBRAIN in certain ARTHROPODS. In vertebrate zoology, either of the corpora bigemina of non-mammalian VERTEBRATES. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1329)", "PM": "2008; see OPTIC LOBE 1970-2007", "HN": "2008(1964)", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D009899"}, {"RECTYPE": "D", "MH": "Optic Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Second Cranial Nerve|T023|NON|EQV|NLM (1998)|960731|abcdef", "ENTRY": "Second Cranial Nerves", "MN": "A08.800.800.120.680", "EC": "injuries:Optic Nerve Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The 2nd cranial nerve which conveys visual information from the RETINA to the brain. The nerve carries the axons of the RETINAL GANGLION CELLS which sort at the OPTIC CHIASM and continue via the OPTIC TRACTS to the brain. The largest projection is to the lateral geniculate nuclei; other targets include the SUPERIOR COLLICULI and the SUPRACHIASMATIC NUCLEI. Though known as the second cranial nerve, it is considered part of the CENTRAL NERVOUS SYSTEM.", "MR": "20190416", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009900"}, {"RECTYPE": "D", "MH": "Optic Nerve Diseases", "DE": "OPTIC NERVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Second Cranial Nerve Diseases|T047|NON|EQV|NLM (2000)|991104|SECOND CRANIAL NERVE DIS|abcdefv", "ENTRY": "Syndrome, Foster-Kennedy", "MN": "C11.640", "MH_TH": "NLM (1976)", "ST": "T047", "PI": "Optic Nerve (1966-1975)", "MS": "Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.", "PM": "76", "HN": "76; was NON MESH before 1976", "CATSH": "CAT LIST", "MR": "20190408", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D009901"}, {"RECTYPE": "D", "MH": "Optic Neuritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Retrobulbar Neuritis|T047|NON|REL|NLM (1998)|960711|abcdef", "ENTRY": "Retrobulbar Neuritides", "MN": "C11.640.576", "FX": "Neuritis", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "SMON (Subacute Myelo-Optico-Neuropathy) is indexed here + MYELITIS + SYNDROME", "MS": "Inflammation of the optic nerve. Commonly associated conditions include autoimmune disorders such as MULTIPLE SCLEROSIS, infections, and granulomatous diseases. Clinical features include retro-orbital pain that is aggravated by eye movement, loss of color vision, and contrast sensitivity that may progress to severe visual loss, an afferent pupillary defect (Marcus-Gunn pupil), and in some instances optic disc hyperemia and swelling. Inflammation may occur in the portion of the nerve within the globe (neuropapillitis or anterior optic neuritis) or the portion behind the globe (retrobulbar neuritis or posterior optic neuritis).", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009902"}, {"RECTYPE": "D", "MH": "Optical Illusions", "AQ": "CL DE ES PH RE", "ENTRY": "Optical Illusion", "MN": "F02.463.593.446.659", "MH_TH": "NLM (1975)", "ST": "T041", "MS": "An illusion of vision usually affecting spatial relations.", "OL": "search ILLUSIONS 1966-74", "PM": "91; was see under ILLUSIONS 1975-90", "HN": "91(75); was see under ILLUSIONS 1975-90", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009903"}, {"RECTYPE": "D", "MH": "Optical Rotation", "ENTRY": "Rotation, Optical", "MN": "G01.590.773", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "usually NIM", "PI": "Chemistry, Physical (1966-1970)", "MS": "The rotation of linearly polarized light as it passes through various media.", "PM": "74", "HN": "74(71)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009904"}, {"RECTYPE": "D", "MH": "Optical Rotatory Dispersion", "AQ": "IS MT", "ENTRY": "Rotatory Dispersion, Optical", "MN": "E05.196.867.576", "MH_TH": "NLM (1968)", "ST": "T059", "AN": "a type of spectrum anal; NIM", "PI": "Spectrum Analysis (1966-1967)", "MS": "The method of measuring the dispersion of an optically active molecule to determine the relative magnitude of right- or left-handed components and sometimes structural features of the molecule.", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D009905"}, {"RECTYPE": "D", "MH": "Optometry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Optometries", "MN": "H02.553", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "The professional practice of primary eye and vision care that includes the measurement of visual refractive power and the correction of visual defects with lenses or glasses.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009907"}, {"RECTYPE": "D", "MH": "Oral Health", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "ENTRY": "Health, Oral", "MN": "N01.400.535", "FX": "Mouth Rehabilitation", "MH_TH": "NLM (1965)", "ST": "T078", "AN": "differentiate from ORAL HYGIENE; oral health is the state of health of the mouth", "MS": "The optimal state of the mouth and normal functioning of the organs of the mouth without evidence of disease.", "PM": "65; DENTAL HYGIENE was heading 1963-64", "HN": "65; DENTAL HYGIENE was heading 1963-64", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009909"}, {"RECTYPE": "D", "MH": "Oral Hygiene", "AQ": "AE CL EC ED ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Dental Hygiene|T055|NON|EQV|NLM (1992)|910107|DENT HYGIENE|abcdefv", "ENTRY": "Hygiene, Oral", "MN": "E06.761.726", "FX": "Toothbrushing", "MH_TH": "NLM (1973)", "ST": "T055", "AN": "differentiate from ORAL HEALTH; oral hyg is care toward maintaining good oral health performed by the person himself or a caregiver in the case of invalid or disabled persons; differentiate also from DENTAL CARE, care by professionals; for oral hyg using dental floss, water picks, etc. use DENTAL DEVICES, HOME CARE or TOOTHBRUSHING", "PI": "Oral Health (1966-1972)", "MS": "The practice of personal hygiene of the mouth. It includes the maintenance of oral cleanliness, tissue tone, and general preservation of oral health.", "OL": "use DENTAL PROPHYLAXIS to search DENTAL HYGIENE 1991", "PM": "73; DENTAL HYGIENE was heading 1963-64, was see DENTAL PROPHYLAXIS 1991", "HN": "73; DENTAL HYGIENE was heading 1963-64, was see DENTAL PROPHYLAXIS 1991", "CATSH": "CAT LIST", "MR": "19921228", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009910"}, {"RECTYPE": "D", "MH": "Oral Hygiene Index", "ENTRY": "Oral Hygiene Indices", "MN": "N06.890.160.168", "MH_TH": "NLM (1975)", "ST": "T081", "MS": "A combination of the debris index and the dental calculus index to determine the status of oral hygiene.", "OL": "use DENTAL HEALTH SURVEYS to search ORAL HYGIENE INDEX 1973-74", "PM": "91; was see under DENTAL HEALTH SURVEYS 1975-90", "HN": "91(75); was see under DENTAL HEALTH SURVEYS 1975-90", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009911"}, {"RECTYPE": "D", "MH": "Oral Manifestations", "ENTRY": "Oral Manifestation", "MN": "C23.888.619", "MH_TH": "NLM (1965)", "ST": "T184", "AN": "not used for indexing since 1989; prior to 1989 used for oral manifest of non-oral diseases", "MS": "Disorders of the mouth attendant upon non-oral disease or injury.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009912"}, {"RECTYPE": "D", "MH": "Oral Stage", "PRINT ENTRY": "Oral Sadistic Stage|T079|NON|NRW|UNK (19XX)|780503|abcdef", "ENTRY": "Stage, Oral Sadistic", "MN": "F02.739.794.793.626", "MH_TH": "NLM (1975)", "ST": "T079", "MS": "The earliest of the stages of infantile psychosexual development, lasting from birth to 12 months or longer.", "OL": "search PSYCHOSEXUAL DEVELOPMENT 1968-74", "PM": "91; was see under PSYCHOSEXUAL DEVELOPMENT 1975-90", "HN": "91(75); was see under PSYCHOSEXUAL DEVELOPMENT 1975-90", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009913"}, {"RECTYPE": "D", "MH": "Oral Submucous Fibrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Submucous Fibrosis, Oral", "MN": "C07.465.654", "MH_TH": "NLM (1968)", "ST": "T047", "PI": "Mouth Diseases (1966-1967)", "MS": "Irreversible FIBROSIS of the submucosal tissue of the MOUTH.", "PM": "91; was see under MOUTH DISEASES 1968-90", "HN": "91(68); was see under MOUTH DISEASES 1968-90", "CATSH": "CAT LIST", "MR": "20151009", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009914"}, {"RECTYPE": "D", "MH": "Orbit", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sockets, Eye", "MN": "A02.835.232.781.324.690", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "Bony cavity that holds the eyeball and its associated tissues and appendages.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009915"}, {"RECTYPE": "D", "MH": "Orbital Diseases", "DE": "ORBITAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Orbital Disease", "MN": "C11.675", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Orbit (1966-1980)", "MS": "Diseases of the bony orbit and contents except the eyeball.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "19900529", "DA": "19800409", "DC": "1", "DX": "19810101", "UI": "D009916"}, {"RECTYPE": "D", "MH": "Orbital Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Orbital Fracture|T037|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Out Fractures, Blow", "MN": "C26.915.300.425.500.550", "MH_TH": "NLM (1983)", "ST": "T037", "AN": "ZYGOMATIC FRACTURES & MAXILLARY FRACTURES are also available", "PI": "Skull Fractures (1966-1982)", "MS": "Fractures of the bones in the orbit, which include parts of the frontal, ethmoidal, lacrimal, and sphenoid bones and the maxilla and zygoma.", "PM": "91; was see under SKULL FRACTURES 1983-90", "HN": "91(83); was see under SKULL FRACTURES 1983-90", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19820427", "DC": "1", "DX": "19910101", "UI": "D009917"}, {"RECTYPE": "D", "MH": "Orbital Neoplasms", "DE": "ORBITAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Orbital Neoplasm", "MN": "C11.675.659", "FX": "Eye Neoplasms", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "Neoplasms of the bony orbit and contents except the eyeball.", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009918"}, {"RECTYPE": "D", "MH": "Orchiectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Orchidectomy|T061|NON|EQV|UNK (19XX)|850606|abcdef", "ENTRY": "Orchiectomies", "MN": "E04.950.774.860.618", "FX": "Orchiopexy", "MH_TH": "NLM (1986)", "ST": "T061", "AN": "check tags MALE & ANIMALS or HUMAN", "PI": "Castration (1966-1985)", "MS": "The surgical removal of one or both testicles.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D009919"}, {"RECTYPE": "D", "MH": "Orchitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Orchitides", "MN": "C19.391.829.493", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of a TESTIS. It has many features of EPIDIDYMITIS, such as swollen SCROTUM; PAIN; PYURIA; and FEVER. It is usually related to infections in the URINARY TRACT, which likely spread to the EPIDIDYMIS and then the TESTIS through either the VAS DEFERENS or the lymphatics of the SPERMATIC CORD.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009920"}, {"RECTYPE": "D", "MH": "Metaproterenol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Orciprenaline|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|990101|abbcdeeef", "ENTRY": "Polistirex, Metaproterenol", "MN": "D02.455.426.559.389.657.166.175.660", "PA": "Tocolytic Agents", "MH_TH": "UNK (19XX)", "ST": "T121", "N1": "1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-", "RN": "53QOG569E0", "RR": "GJ20H50YF0", "MS": "A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.", "PM": "2011; see ORCIPRENALINE 1965-2010", "HN": "2011(1965)", "MR": "20180529", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009921"}, {"RECTYPE": "D", "MH": "Oregon", "AQ": "EH EP", "MN": "Z01.107.567.875.580.550", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Washington, on the east by Idaho, on the south by California and Nevada, and on the west by the Pacific Ocean.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D009922"}, {"RECTYPE": "D", "MH": "Orf virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Ecthyma contagiosum Virus|T005|NON|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "viruses, Orf", "MN": "B04.280.650.160.670.600", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid10258", "MS": "The type species of PARAPOXVIRUS which causes a skin infection in natural hosts, usually young sheep. Humans may contract local skin lesions by contact. The virus apparently persists in soil.", "PM": "91; was see under POXVIRIDAE 1981-90; was see under POXVIRUSES 1975-80", "HN": "91(75); was see under POXVIRIDAE 1981-90; was see under POXVIRUSES 1975-80", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D009923"}, {"RECTYPE": "D", "MH": "Organ Culture Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Organ Cultures", "MN": "E05.481.500.484", "FX": "Tissue Engineering", "MH_TH": "NLM (2005)", "ST": "T062", "AN": "NIM", "PI": "Tissue Culture (1966-1968)", "MS": "A technique for maintenance or growth of animal organs in vitro. It refers to three-dimensional cultures of undisaggregated tissue retaining some or all of the histological features of the tissue in vivo. (Freshney, Culture of Animal Cells, 3d ed, p1)", "PM": "2005; see ORGAN CULTURE 1972-2004", "HN": "2005 (1972)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009924"}, {"RECTYPE": "D", "MH": "Organ of Corti", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Spiral Organ|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Spiral Organs", "MN": "A09.246.300.246.577", "MH_TH": "NLM (1965)", "ST": "T023", "MS": "The spiral EPITHELIUM containing sensory AUDITORY HAIR CELLS and supporting cells in the cochlea. Organ of Corti, situated on the BASILAR MEMBRANE and overlaid by a gelatinous TECTORIAL MEMBRANE, converts sound-induced mechanical waves to neural impulses to the brain.", "PM": "68", "HN": "68(65)", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009925"}, {"RECTYPE": "D", "MH": "Organ Preservation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Preservations, Organ", "MN": "E05.760.833.660", "FX": "Tissue and Organ Harvesting", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "cryopreservation of organ: coord IM with organ (no qualif) + CRYOPRESERVATION", "MS": "The process by which organs are kept viable outside of the organism from which they were removed (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism).", "OL": "search TISSUE PRESERVATION 1969-74", "PM": "84; was see under TISSUE PRESERVATION 1970-83", "HN": "84(75); was see under TISSUE PRESERVATION 1969-83", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D009926"}, {"RECTYPE": "D", "MH": "Tissue and Organ Procurement", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Tissue Shortage|T058|NON|NRW|NLM (2022)|201102|abcdef", "ENTRY": "Tissue Shortages", "MN": "N02.421.911", "FX": "Tissue and Organ Harvesting", "MH_TH": "NLM (2005)", "ST": "T058", "PI": "Tissue Donors (1966-1986)", "MS": "The administrative procedures involved with acquiring TISSUES or organs for TRANSPLANTATION through various programs, systems, or organizations. These procedures include obtaining consent from TISSUE DONORS and arranging for transportation of donated tissues and organs, after TISSUE HARVESTING, to HOSPITALS for processing and transplantation.", "PM": "2005; see ORGAN PROCUREMENT 1987-2004", "HN": "2005 (1987)", "MR": "20220413", "DA": "19860530", "DC": "1", "DX": "19870101", "UI": "D009927"}, {"RECTYPE": "D", "MH": "Organ Specificity", "AQ": "DE GE IM PH RE", "ENTRY": "Tissue Specificities", "MN": "G07.650", "MH_TH": "NLM (1964)", "ST": "T042", "AN": "IM general only; coordinate NIM with specific organ (IM)", "MS": "Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009928"}, {"RECTYPE": "D", "MH": "Organ Size", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Organ Weight|T032|NON|NRW|NLM (1965)|990101|abcdef", "ENTRY": "Weight, Organ", "MN": "G07.345.249.690", "MH_TH": "NLM (2005)", "ST": "T032", "AN": "almost never IM; coordinate NIM with organ /anat (IM) or /growth (IM) or /pathol (IM) or disease /pathol (IM)", "MS": "The measurement of an organ in volume, mass, or heaviness.", "PM": "2005; see ORGAN WEIGHT 1966-2004", "HN": "2005 (1966)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009929"}, {"RECTYPE": "D", "MH": "Organic Chemicals", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Organic Chemical|T109|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Chemicals, Organic", "MN": "D02", "RH": "D2 - ORGANIC CHEMICALS", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specific groups or specific chemicals", "MS": "A broad class of substances containing carbon and its derivatives. Many of these chemicals will frequently contain hydrogen with or without oxygen, nitrogen, sulfur, phosphorus, and other elements. They exist in either carbon chain or carbon ring form.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D009930"}, {"RECTYPE": "D", "MH": "Organization and Administration", "DE": "ORGAN ADMIN", "AQ": "EC SN ST", "PRINT ENTRY": "Administration|T057|NON|NRW|UNK (19XX)|740330|ADMIN|abcdefv", "ENTRY": "Technique, Administrative", "MN": "N04.452", "MH_TH": "POPLINE (1978)", "ST": "T057", "AN": "general or unspecified; prefer specifics: prefer /organ", "MS": "The planning and managing of programs, services, and resources.", "OL": "use ORGANIZATION AND ADMINISTRATION to search ADMINISTRATIVE MANAGEMENT 1966-67", "PM": "68; was ADMINISTRATIVE MANAGEMENT 1963-67", "HN": "68; was ADMINISTRATIVE MANAGEMENT 1963-67", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009934"}, {"RECTYPE": "D", "MH": "Organizational Affiliation", "DE": "ORGAN AFFILIATION", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Organizational Affiliations", "MN": "N04.452.602", "MH_TH": "NLM (1968)", "ST": "T078", "AN": "medical or non-medical affiliation", "PI": "specific organization (1966-1967)", "MS": "Formal relationships established between otherwise independent organizations. These include affiliation agreements, interlocking boards, common controls, hospital medical school affiliations, etc.", "PM": "68", "HN": "68", "MR": "19940505", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009935"}, {"RECTYPE": "D", "MH": "Organizational Innovation", "DE": "ORGAN INNOVATION", "AQ": "EC", "PRINT ENTRY": "Organizational Change|T078|NON|BRD|UNK (19XX)|810616|ORGAN CHANGE|abcdefv", "ENTRY": "Organizational Innovations", "MN": "N04.452.610", "MH_TH": "NLM (1982)", "ST": "T057", "MS": "Introduction of changes which are new to the organization and are created by management.", "PM": "89; was see under ORGANIZATION AND ADMINISTRATION 1982-88", "HN": "89(82); was see under ORGANIZATION AND ADMINISTRATION 1982-88", "MR": "20160113", "DA": "19810519", "DC": "1", "DX": "19890101", "UI": "D009936"}, {"RECTYPE": "D", "MH": "Organizational Objectives", "AQ": "EC", "PRINT ENTRY": "Goals, Organizational|T078|NON|EQV|UNK (19XX)|810519|abcdef", "ENTRY": "Settings, Organizational Goal", "MN": "N04.452.615", "MH_TH": "NLM (1982)", "ST": "T078", "AN": "coordinate with specific organization", "MS": "The purposes, missions, and goals of an individual organization or its units, established through administrative processes. It includes an organization's long-range plans and administrative philosophy.", "PM": "91; was see under ORGANIZATION AND ADMINISTRATION 1982-90", "HN": "91(82); was see under ORGANIZATION AND ADMINISTRATION 1982-90", "MR": "20191121", "DA": "19810519", "DC": "1", "DX": "19910101", "UI": "D009937"}, {"RECTYPE": "D", "MH": "Organizations", "DE": "ORGAN", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Organizations, Non-Governmental", "MN": "N03.540", "FX": "Societies", "MH_TH": "POPLINE (1978)", "ST": "T092", "AN": "general or unspecified; prefer specifics; ORGANIZATIONS tends to be for groups with a common goal based on interest, SOCIETIES tends to be for groups with common educational or professional status; specify geographic location if pertinent", "PI": "specific organization (1966-1967)", "MS": "Groups of people working together in a structured manner to pursue common goals and objectives.", "PM": "68", "HN": "68", "MR": "20160503", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009938"}, {"RECTYPE": "D", "MH": "Organizations, Nonprofit", "DE": "ORGAN NONPROFIT", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Nonprofit Organizations|T092|NON|EQV|UNK (19XX)|810304|NONPROFIT ORGAN|abcdefv", "ENTRY": "Organizations, Non Profit", "MN": "N03.540.630", "MH_TH": "NLM (1982)", "ST": "T092", "MS": "Organizations which are not operated for a profit and may be supported by endowments or private contributions.", "PM": "82", "HN": "82", "MR": "19960610", "DA": "19810304", "DC": "1", "DX": "19820101", "UI": "D009939"}, {"RECTYPE": "D", "MH": "Organoids", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Organoid", "MN": "A10.802", "MH_TH": "NLM (1965)", "ST": "T024", "AN": "do not confuse with ORGANELLES: read MeSH definitions & follow text", "MS": "An organization of cells into an organ-like structure. Organoids can be generated in culture, e.g., self-organized three-dimensional tissue structures derived from STEM CELLS (see MICROPHYSIOLOGICAL SYSTEMS). They are also found in certain NEOPLASMS.", "PM": "1965", "HN": "1965", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009940"}, {"RECTYPE": "D", "MH": "Organomercury Compounds", "DE": "ORGANOMERCURY CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Organomercury", "MN": "D02.691.750", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "PI": "Organometallic Compounds (1968-1976)", "MS": "Organic compounds which contain mercury as an integral part of the molecule.", "PM": "77", "HN": "77", "MR": "20110624", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D009941"}, {"RECTYPE": "D", "MH": "Organometallic Compounds", "DE": "ORGANOMETALLIC CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Organometallic Compound|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Metallo Organic Compounds", "MN": "D02.691", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "68", "HN": "68", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D009942"}, {"RECTYPE": "D", "MH": "Organophosphorus Compounds", "DE": "ORGANOPHOSPHORUS CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "PRINT ENTRY": "Organopyrophosphorus Compound|T109|NON|NRW|NLM (2021)|191119|abcdef", "ENTRY": "Compounds, Organopyrophosphorus", "MN": "D02.705", "FX": "Phosphorus Compounds", "EC": "poisoning:Organophosphate Poisoning", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "Phosphorus (1966-1970)", "MS": "Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS.", "PM": "72", "HN": "72(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009943"}, {"RECTYPE": "D", "MH": "Organoplatinum Compounds", "DE": "ORGANOPLATINUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Organoplatinum", "MN": "D02.691.788", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Platinum (1966-1977)", "MS": "Organic compounds which contain platinum as an integral part of the molecule.", "PM": "78", "HN": "78", "MR": "20190705", "DA": "19770517", "DC": "1", "DX": "19780101", "UI": "D009944"}, {"RECTYPE": "D", "MH": "Organotherapy", "DE": "ORGANOTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Organotherapies", "MN": "E02.190.701", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "TISSUE THERAPY, HISTORICAL and  CELL- AND TISSUE BASED THERAPY are also available", "MS": "Historically, the treatment of disease by the administration of animal organs or their extracts (after Brown-Sequard). At present synthetic preparations substitute for the extracts of a gland. (From Stedman, 26th ed)", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009945"}, {"RECTYPE": "D", "MH": "Organothiophosphorus Compounds", "DE": "ORGANOTHIOPHOSPHORUS CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Organothiophosphorus", "MN": "D02.886.300", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "AN": "includes organothiophosphates; /antag permitted but consider also CHOLINESTERASE REACTIVATORS", "PI": "Phosphorus (1966-1970)", "MS": "Compounds containing carbon-phosphorus bonds in which the phosphorus component is also bonded to one or more sulfur atoms. Many of these compounds function as CHOLINERGIC AGENTS and as INSECTICIDES.", "PM": "72", "HN": "72(71)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009946"}, {"RECTYPE": "D", "MH": "Organotin Compounds", "DE": "ORGANOTIN CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Organotin", "MN": "D02.691.850", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Tin (1974)", "MS": "Organic compounds which contain tin in the molecule. Used widely in industry and agriculture.", "PM": "75", "HN": "75", "MR": "20110624", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D009947"}, {"RECTYPE": "D", "MH": "Orgasm", "AQ": "CL DE PH RE", "ENTRY": "Sexual Satisfactions", "MN": "G08.686.617", "MH_TH": "NLM (1969)", "ST": "T040", "MS": "The climax of sexual excitement in either humans or animals.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20211202", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D009948"}, {"RECTYPE": "D", "MH": "Orientation", "AQ": "CL DE ES PH RE", "ENTRY": "Psychological Orientations", "MN": "F02.830.606", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "human & animal", "MS": "Awareness of oneself in relation to time, place and person.", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009949"}, {"RECTYPE": "D", "MH": "Ornidazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro70207", "MN": "D03.383.129.308.658.700", "PA": "Radiation-Sensitizing Agents", "MH_TH": "USAN (1977)", "ST": "T121", "N1": "1H-Imidazole-1-ethanol, alpha-(chloromethyl)-2-methyl-5-nitro-", "RN": "62XCK0G93T", "RR": "16773-42-5 (Ornidazole)", "PI": "Nitroimidazoles (1974)", "MS": "A nitroimidazole antiprotozoal agent used in ameba and trichomonas infections. It is partially plasma-bound and also has radiation-sensitizing action.", "OL": "use ORNIDAZOLE to search RO 7-0207 1975-80", "PM": "91; was see under NITROIMIDAZOLES 1981-90; was RO 7-0207 see under NITROIMIDAZOLES 1975-80", "HN": "91(81); was see under NITROIMIDAZOLES 1981-90; was RO 7-0207 see under NITROIMIDAZOLES 1975-80", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009950"}, {"RECTYPE": "D", "MH": "Ornipressin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vasopressin, Ornithine|T116|T121|NON|EQV|UNK (19XX)|771209|abbcdef", "ENTRY": "Ornithine 8 Vasopressin", "MN": "D12.776.631.650.937.700", "PA": "Vasoconstrictor Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Vasopressin, 8-L-ornithine-", "RN": "1KTH6N080W", "RR": "3397-23-7 (Ornipressin)", "PI": "Vasopressins (1966-1978)", "MS": "A synthetic analog of vasopressin with ORNITHINE substitution at residue 8 of the cyclic nonapeptide. It is used as a local vasoconstrictor and hemostatic.", "PM": "91; was see under VASOPRESSINS 1979-90", "HN": "91(79); was see under VASOPRESSINS 1979-90", "MR": "20151124", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D009951"}, {"RECTYPE": "D", "MH": "Ornithine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "2,5 Diaminopentanoic Acid", "MN": "D12.125.095.765", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "E524N2IXA3", "RR": "99815-05-1 ((D)-isomer, HCl)", "MS": "An amino acid produced in the urea cycle by the splitting off of urea from arginine.", "MR": "20180612", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009952"}, {"RECTYPE": "D", "MH": "Ornithine-Oxo-Acid Transaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ornithine Transaminase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Transaminase, Ornithine-Oxo-Acid", "MN": "D08.811.913.477.700.700", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Ornithine:2-oxo-acid aminotransferase", "RN": "EC 2.6.1.13", "RR": "9030-42-6 (CAS RN)", "PI": "Ornithine (1969-1974)", "MS": "A pyridoxal phosphate enzyme that catalyzes the formation of glutamate gamma-semialdehyde and an L-amino acid from L-ornithine and a 2-keto-acid. EC 2.6.1.13.", "PM": "98; see ORNITHINE AMINOTRANSFERASE 1991-97; see AMINOTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D009953"}, {"RECTYPE": "D", "MH": "Ornithine Carbamoyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ornithine Transcarbamylase|T116|T126|NON|EQV|NLM (1998)|970425|abbcdef", "ENTRY": "Transferase, Ornithine Carbamylphosphate", "MN": "D08.811.913.555.275.600", "FX": "Ornithine Carbamoyltransferase Deficiency Disease", "EC": "deficiency:Ornithine Carbamoyltransferase Deficiency Disease", "MH_TH": "NLM (1964)", "ST": "T126", "N1": "Carbamoyl-phosphate:L-ornithine carbamoyltransferase", "RN": "EC 2.1.3.3", "RR": "9001-69-8 (CAS RN)", "MS": "A urea cycle enzyme that catalyzes the formation of orthophosphate and L-citrulline (CITRULLINE) from CARBAMOYL PHOSPHATE and L-ornithine (ORNITHINE). Deficiency of this enzyme may be transmitted as an X-linked trait. EC 2.1.3.3.", "PM": "1965", "HN": "1965(1964)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009954"}, {"RECTYPE": "D", "MH": "Ornithine Decarboxylase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ornithine Carboxy-lyase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Ornithine Carboxy lyase", "MN": "D08.811.520.224.125.425", "EC": "antagonists & inhibitors:Ornithine Decarboxylase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Ornithine carboxy-lyase", "RN": "EC 4.1.1.17", "RR": "9024-60-6 (CAS RN)", "PI": "Ornithine (1972-1974)", "MS": "A pyridoxal-phosphate protein, believed to be the rate-limiting compound in the biosynthesis of polyamines. It catalyzes the decarboxylation of ornithine to form putrescine, which is then linked to a propylamine moiety of decarboxylated S-adenosylmethionine to form spermidine.", "PM": "84; was see under CARBOXY-LYASES 1975-83", "HN": "84(75); was see under CARBOXY-LYASES 1975-83", "MR": "20140610", "DA": "19741111", "DC": "1", "DX": "19840101", "UI": "D009955"}, {"RECTYPE": "D", "MH": "Psittacosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Ornithosis|T047|NON|EQV|NLM (1966)|ORD (2010)|990101|abcdeef", "ENTRY": "Psittacoses", "MN": "C01.150.252.400.210.250.600", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "Infection with CHLAMYDOPHILA PSITTACI (formerly Chlamydia psittaci), transmitted to humans by inhalation of dust-borne contaminated nasal secretions or excreta of infected BIRDS. This infection results in a febrile illness characterized by PNEUMONITIS and systemic manifestations.", "PM": "2006; see ORNITHOSIS 1963-2005", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D009956"}, {"RECTYPE": "D", "MH": "Oroantral Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Oroantral Fistulas", "MN": "C23.300.575.500.550", "MH_TH": "NLM (1967)", "ST": "T190", "AN": "fistula policy: Manual 23.19+", "PI": "Fistula (1966)", "MS": "A fistula between the maxillary sinus and the oral cavity.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D009957"}, {"RECTYPE": "D", "MH": "Orofaciodigital Syndromes", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Papillon-Leage and Psaume Syndrome|T047|EPO|NRW|OMIM (2013)|UNK (19XX)|780320|PAPILLON LEAGE PSAUME SYNDROME|abcdeefv", "ENTRY": "Syndromes, Orofaciodigital", "MN": "C16.320.714", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Two syndromes of oral, facial, and digital malformations. Type I (Papillon-Leage and Psaume syndrome, Gorlin-Psaume syndrome) is inherited as an X-linked dominant trait and is found only in females and XXY males. Type II (Mohr syndrome) is inherited as an autosomal recessive trait.", "OL": "use OROFACIODIGITAL SYNDROMES to search OROFACIODIGITAL SYNDROME 1966-78(as Prov 1966-74)", "PM": "79; was OROFACIODIGITAL SYNDROME see under ABNORMALITIES, MULTIPLE 1975-78", "HN": "79; was OROFACIODIGITAL SYNDROME see under ABNORMALITIES, MULTIPLE 1975-78; was OROFACIODIGITAL SYNDROME 1964-74 (Prov)", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D009958"}, {"RECTYPE": "D", "MH": "Oropharyngeal Neoplasms", "DE": "OROPHARYNGEAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Oropharyngeal Cancer|T191|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Oropharynx Neoplasm", "MN": "C09.775.549.685", "MH_TH": "NLM (1985)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "PI": "Pharyngeal Neoplasms (1966-1984)", "MS": "Tumors or cancer of the OROPHARYNX.", "PM": "91; was see under PHARYNGEAL NEOPLASMS 1985-90", "HN": "91(85); was see under PHARYNGEAL NEOPLASMS 1985-90", "CATSH": "CAT LIST", "MR": "19991104", "DA": "19840529", "DC": "1", "DX": "19910101", "UI": "D009959"}, {"RECTYPE": "D", "MH": "Oropharynx", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Oropharynxs", "MN": "A14.724.603", "MH_TH": "NLM (1979)", "ST": "T023", "AN": "inflammation: index under PHARYNGITIS & do not bother to coordinate with OROPHARYNX (NIM) unless particularly discussed", "PI": "Pharynx (1966-1978)", "MS": "The middle portion of the pharynx that lies posterior to the mouth, inferior to the SOFT PALATE, and superior to the base of the tongue and EPIGLOTTIS. It has a digestive function as food passes from the mouth into the oropharynx before entering ESOPHAGUS.", "PM": "79", "HN": "79", "MR": "20080708", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D009960"}, {"RECTYPE": "D", "MH": "Orosomucoid", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha 1-Acid Seromucoid|T116|T123|NON|EQV|UNK (19XX)|760517|ALPHA ACID SEROMUCOID 01|abbcdefs", "ENTRY": "alpha 1 Glycoprotein Acid", "MN": "D12.776.395.560.742", "MH_TH": "NLM (1974)", "ST": "T123", "RN": "0", "AN": "an alpha-globulin", "PM": "74", "HN": "74", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009961"}, {"RECTYPE": "D", "MH": "Orotate Phosphoribosyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Orotidylic Acid Phosphorylase|T116|T126|NON|EQV|UNK (19XX)|760426|abbcdef", "ENTRY": "Pyrophosphorylase, Orotidine-5'-Phosphate", "MN": "D08.811.913.400.725.700", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "Orotidine-5'-phosphate:pyrophosphate phospho-alpha-D-ribosyltransferase", "RN": "EC 2.4.2.10", "RR": "9030-25-5 (CAS RN)", "AN": "/defic: consider also OROTIC ACID /urine (IM) + PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS (IM)", "PI": "Uracil Nucleotides (1975-1976)", "MS": "The enzyme catalyzing the formation of orotidine-5'-phosphoric acid (orotidylic acid) from orotic acid and 5-phosphoribosyl-1-pyrophosphate in the course of pyrimidine nucleotide biosynthesis. EC 2.4.2.10.", "PM": "91; was see under PENTOSYLTRANSFERASES 1977-90", "HN": "91(77); was see under PENTOSYLTRANSFERASES 1977-90", "MR": "20030709", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D009962"}, {"RECTYPE": "D", "MH": "Orotic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Orotate, Zinc", "MN": "D03.383.742.698.875.660", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-", "RN": "61H4T033E5", "RR": "Z722242H10", "MS": "An intermediate product in PYRIMIDINE synthesis which plays a role in chemical conversions between DIHYDROFOLATE and TETRAHYDROFOLATE.", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009963"}, {"RECTYPE": "D", "MH": "Orotidine-5'-Phosphate Decarboxylase", "DS": "OROTIDINE PHOSPHATE DECARBOXYLASE 05", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Orotidylate Decarboxylase|T116|T126|NON|EQV|UNK (19XX)|760426|abbcdef", "ENTRY": "Phosphate Carboxy-Lyase, Orotidine", "MN": "D08.811.520.224.125.450", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "Orotidine-5'-phosphate carboxy-lyase", "RN": "EC 4.1.1.23", "RR": "9024-62-8 (CAS RN)", "AN": "/defic: consider also OROTIC ACID /urine (IM) and PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS (IM)", "PI": "Uracil Nucleotides (1975-1976)", "MS": "Orotidine-5'-phosphate carboxy-lyase. Catalyzes the decarboxylation of orotidylic acid to yield uridylic acid in the final step of the pyrimidine nucleotide biosynthesis pathway. EC 4.1.1.23.", "PM": "91; was see under CARBOXY-LYASES 1977-90", "HN": "91(77); was see under CARBOXY-LYASES 1977-90", "MR": "20030709", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D009964"}, {"RECTYPE": "D", "MH": "Orphan Drug Production", "AQ": "CL EC ES HI IS LJ MT SN ST", "ENTRY": "Production, Orphan Drug", "MN": "J01.576.655.750.600", "MH_TH": "NLM (1985)", "ST": "T058", "PI": "Legislation, Medical (1966-1967)", "MS": "Production of drugs or biologicals which are unlikely to be manufactured by private industry unless special incentives are provided by others.", "PM": "91; was see under DRUG INDUSTRY 1985-90", "HN": "91(85); was see under DRUG INDUSTRY 1985-90", "MR": "19920515", "DA": "19840524", "DC": "1", "DX": "19910101", "UI": "D009965"}, {"RECTYPE": "D", "MH": "Orphenadrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methyldiphenylhydramine|T109|T121|NON|EQV|UNK (19XX)|770428|abbcdef", "ENTRY": "Orphenadrine Citrate, Norflex", "MN": "D02.455.426.559.389.115.600", "PA": "Parasympatholytics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-", "RN": "AL805O9OG9", "RR": "X0A40N8I4S", "MS": "A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.", "MR": "20140617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009966"}, {"RECTYPE": "D", "MH": "Orthodontic Appliances", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Orthodontic Appliance", "MN": "E06.658.453", "FX": "Dental Bonding", "MH_TH": "NLM (1965)", "ST": "T074", "MS": "Devices used for influencing tooth position. Orthodontic appliances may be classified as fixed or removable, active or retaining, and intraoral or extraoral. (Boucher's Clinical Dental Terminology, 4th ed, p19)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009967"}, {"RECTYPE": "D", "MH": "Orthodontic Appliances, Removable", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Removable Orthodontic Appliances", "MN": "E06.658.453.578", "MH_TH": "NLM (1971)", "ST": "T074", "PI": "Orthodontic Appliances (1966-1970)", "MS": "Dental devices such as RETAINERS, ORTHODONTIC used to improve gaps in teeth and structure of the jaws. These devices can be removed and reinserted at will.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D009968"}, {"RECTYPE": "D", "MH": "Orthodontic Wires", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Wires, Orthodontic", "MN": "E06.658.453.684", "MH_TH": "NLM (1982)", "ST": "T074", "PI": "Orthodontic Appliances (1966-1981)", "MS": "Wires of various dimensions and grades made of stainless steel or precious metal. They are used in orthodontic treatment.", "PM": "91; was see under ORTHODONTIC APPLIANCES 1982-90", "HN": "91(82); was see under ORTHODONTIC APPLIANCES 1982-90", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19810224", "DC": "1", "DX": "19910101", "UI": "D009969"}, {"RECTYPE": "D", "MH": "Orthodontics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.163.876.439", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty; orthop\u00e9die dento-faciale in French is indexed here", "MS": "A dental specialty concerned with the prevention and correction of dental and oral anomalies (malocclusion).", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009970"}, {"RECTYPE": "D", "MH": "Orthodontics, Corrective", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Corrective Orthodontics", "MN": "E06.658.578", "FX": "Malocclusion", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "The phase of orthodontics concerned with the correction of malocclusion with proper appliances and prevention of its sequelae (Jablonski's Illus. Dictionary of Dentistry).", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009971"}, {"RECTYPE": "D", "MH": "Orthodontics, Interceptive", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Interceptive Orthodontics", "MN": "E06.658.641", "MH_TH": "NLM (1975)", "ST": "T061", "PI": "Orthodontics, Preventive (1966-1974)", "MS": "Recognition and elimination of potential irregularities and malpositions in the developing dentofacial complex.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D009972"}, {"RECTYPE": "D", "MH": "Orthodontics, Preventive", "DE": "ORTHODONTICS PREV", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Preventive Orthodontics", "MN": "E06.658.703", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Treatment methods intended to prevent the development of crooked teeth that involve the use of space maintainers for BABY TEETH lost early or removal of PRIMARY TEETH that don't come out on their own. Commonly used in pediatric dentistry.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009973"}, {"RECTYPE": "D", "MH": "Orthomolecular Therapy", "DE": "ORTHOMOL THER", "AQ": "AE CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Megavitamin Therapy|T061|NON|EQV|UNK (19XX)|760512|MEGAVITAMIN THER|abcdefv", "ENTRY": "Therapies, Orthomolecular", "MN": "F04.570.400", "MH_TH": "NLM (1977)", "ST": "T061", "PI": "Vitamins (1974-1976)", "MS": "The use of very large doses of vitamins or other naturally occurring substances normally present in the body, frequently for the treatment of mental disorders.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D009974"}, {"RECTYPE": "D", "MH": "Orthomyxoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Myxoviruses|T005|NON|REL|UNK (19XX)|760505|abcdef", "ENTRY": "Orthomyxovirus", "MN": "B04.820.480.968", "MH_TH": "NLM (1977)", "ST": "T005", "RN": "txid11308", "MS": "A family of RNA viruses causing INFLUENZA and other respiratory diseases. Orthomyxoviridae includes INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; INFLUENZAVIRUS D; ISAVIRUS; and THOGOTOVIRUS.", "OL": "use ORTHOMYXOVIRIDAE to search ORTHOMYXOVIRUSES 1977-81, INFLUENZA VIRUSES 1966-76, MYXOVIRUSES 1975-76 & MYXOVIRUS 1966-74", "PM": "81; was ORTHOMYXOVIRUSES 1977-80; was INFLUENZA VIRUSES 1963-76; was MYXOVIRUSES 1975-76; was MYXOVIRUS 1963-74", "HN": "81; was ORTHOMYXOVIRUSES 1977-80; was INFLUENZA VIRUSES 1963-76; was MYXOVIRUSES 1975-76; was MYXOVIRUS 1963-74", "MR": "20230405", "DA": "19760505", "DC": "1", "DX": "19770101", "UI": "D009975"}, {"RECTYPE": "D", "MH": "Orthomyxoviridae Infections", "DE": "ORTHOMYXOVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Orthomyxovirus Infections|T047|NON|EQV|NLM (1994)|930511|ORTHOMYXOVIRUS INFECT|abcdefv", "ENTRY": "Orthomyxovirus Infection", "MN": "C01.925.782.620", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "coordinate IM with specific influenza virus (IM) if pertinent; note specific subtypes of INFLUENZA A VIRUS are available", "MS": "Virus diseases caused by the ORTHOMYXOVIRIDAE.", "OL": "use ORTHOMYXOVIRIDAE INFECTIONS to search ORTHOMYXOVIRUS INFECTIONS 1977-93 & MYXOVIRUS INFECTIONS 1966-76", "PM": "94; was ORTHOMYXOVIRUS INFECTIONS 1977-93; was MYXOVIRUS INFECTIONS 1963-76", "HN": "94; was ORTHOMYXOVIRUS INFECTIONS 1977-93; was MYXOVIRUS INFECTIONS 1963-76", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D009976"}, {"RECTYPE": "D", "MH": "Influenza A virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Orthomyxovirus Type A, Porcine|T005|NON|NRW|NLM (1997)|951018|abcdef", "ENTRY": "Virus, Fowl Plague", "MN": "B04.820.480.968.405.400", "MH_TH": "NLM (1977)", "ST": "T005", "RN": "txid11320", "RR": "txid2955291", "PI": "Orthomyxoviridae (1968-1976)", "MS": "The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces.", "PM": "1997; see ORTHOMYXOVIRUSES TYPE A 1977-1996; for ORTHOMYXOVIRUS TYPE A, HUMAN see INFLUENZA A VIRUS, HUMAN 1997-2005; for MYXOVIRUS INFLUENZAE-A HOMINIS see INFLUENZA A VIRUS 1974-2005; for ORTHOMYXOVIRUS TYPE A, AVIAN see INFLUENZA A VIRUS, AVIAN 1997-2005; for ORTHOMYXOVIRUS TYPE A, PORCINE see INFLUENZA A VIRUS, PORCINE 1995-2005", "HN": "1997 (1977)", "MR": "20230727", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D009980"}, {"RECTYPE": "D", "MH": "Influenza B virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Orthomyxoviruses Type B|T005|NON|EQV|NLM (1997)|951018|abcdef", "ENTRY": "Influenza B viruses", "MN": "B04.820.480.968.407.410", "MH_TH": "NLM (1985)", "ST": "T005", "RN": "txid11520", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans or ORTHOMYXOVIRIDAE INFECTIONS (IM) in animals; BETAINFLUENZAVIRUS is also available", "PI": "Orthomyxoviridae (1981-1984)", "MS": "Species of the genus BETAINFLUENZAVIRUS that cause HUMAN INFLUENZA and other diseases primarily in humans. Antigenic variation is less extensive than in type A viruses (INFLUENZA A VIRUS) and consequently there is no basis for distinct subtypes or variants. Epidemics are less likely than with INFLUENZA A VIRUS and there have been no pandemics. Previously only found in humans, Influenza B virus has been isolated from seals which may constitute the animal reservoir from which humans are exposed.", "PM": "97; was ORTHOMYXOVIRUSES TYPE B 1985-96", "HN": "97; was ORTHOMYXOVIRUSES TYPE B 1985-96", "MR": "20230727", "DA": "19840406", "DC": "1", "DX": "19850101", "UI": "D009981"}, {"RECTYPE": "D", "MH": "Gammainfluenzavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Orthomyxoviruses Type C|T005|NON|EQV|NLM (1997)|951018|abcdef", "ENTRY": "Virus, Influenza C", "MN": "B04.820.480.968.410", "MH_TH": "NLM (2024)", "ST": "T005", "RN": "txid197913", "RR": "txid11552", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans or ORTHOMYXOVIRIDAE INFECTIONS (IM) in animals", "PI": "Orthomyxoviridae (1981-1985)", "MS": "A genus of the family ORTHOMYXOVIRIDAE comprising viruses similar to types A and B but less common, more stable, more homogeneous, and lacking the neuraminidase protein. They have not been associated with epidemics but may cause mild influenza. Influenza C virus is the type species.", "PM": "2024; see INFLUENZAVIRUS C 1997-2023, ORTHOMYXOVIRUSES TYPE C 1991-1996, ORTHOMYXOVIRIDAE 1986-1990", "HN": "2024(1986)", "MR": "20230405", "DA": "19850507", "DC": "1", "DX": "19910101", "UI": "D009982"}, {"RECTYPE": "D", "MH": "Orthopedic Equipment", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Orthopedic Equipments", "MN": "E07.858.442", "MH_TH": "NLM (1966)", "ST": "T074", "AN": "nonexpendable & used by the orthopedic surgeon; do not confuse with ORTHOTIC DEVICES used on the patient", "MS": "Nonexpendable items used in the performance of orthopedic surgery and related therapy. They are differentiated from ORTHOTIC DEVICES, apparatus used to prevent or correct deformities in patients.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009983"}, {"RECTYPE": "D", "MH": "Orthopedic Fixation Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Orthopedic Fixation Device", "MN": "E07.858.690.725", "MH_TH": "NLM (1971)", "ST": "T074", "PI": "Orthopedic Equipment (1966-1970)", "MS": "Devices which are used in the treatment of orthopedic injuries and diseases.", "PM": "72", "HN": "72(71)", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D009984"}, {"RECTYPE": "D", "MH": "Orthopedics", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD VE", "MN": "H02.403.810.494", "FX": "Osteology", "EC": "nursing:Orthopedic Nursing", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty; ORTHOPEDIC PROCEURES is available for orthopedic therapeutic techniques", "MS": "A specialty which utilizes medical, surgical, and physical methods to treat and correct deformities, diseases, and injuries to the skeletal system, its articulations, and associated structures.", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009985"}, {"RECTYPE": "D", "MH": "Orthopsychiatry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "F04.096.544.528", "FX": "Mental Health", "MH_TH": "NLM (1974)", "ST": "T091", "AN": "specialty; MDs, psychologists, social workers, etc.", "MS": "The study and treatment of human behavior problems utilizing principles derived from the behavioral, medical, and social science with emphasis on promotion of mental health.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009986"}, {"RECTYPE": "D", "MH": "Orthoptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Ensifera|T204|NON|NRW|NLM (1999)|970822|abcdef", "ENTRY": "Orthopteras", "MN": "B01.050.500.131.617.678", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid6993", "RR": "txid7001", "AN": "do not use /drug eff for insecticides: TN 111", "PI": "Insects (1966-1974)", "MS": "An order of insects comprising two suborders: Caelifera and Ensifera. They consist of GRASSHOPPERS, locusts, and crickets (GRYLLIDAE).", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D009987"}, {"RECTYPE": "D", "MH": "Orthoptics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Pleoptics|T061|NON|EQV|NLM (1998)|960719|abcdef", "ENTRY": "Pleoptic", "MN": "H02.573", "FX": "Strabismus", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The study and treatment of defects in binocular vision resulting from defects in the optic musculature or of faulty visual habits. It involves a technique of eye exercises designed to correct the visual axes of eyes not properly coordinated for binocular vision.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009988"}, {"RECTYPE": "D", "MH": "Orthotic Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Orthosis|T074|NON|EQV|UNK (19XX)|870402|abcdef", "ENTRY": "Parapodiums", "MN": "E07.858.442.743", "MH_TH": "NLM (1972)", "ST": "T074", "AN": "includes slings, BRACES, etc.", "PI": "Orthopedic Equipment (1966-1971)", "MS": "Apparatus used to support, align, or augment the functioning of parts of the body.", "PM": "74", "HN": "74(72)", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009989"}, {"RECTYPE": "D", "MH": "Oryzias", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Medaka|T013|NON|BRD|UNK (19XX)|860415|abcdef", "ENTRY": "Medakas", "MN": "B01.050.150.900.493.850.139.650", "MH_TH": "NLM (1987)", "ST": "T013", "RN": "txid8089", "RR": "txid8090", "AN": "note entry terms JAPANESE KILLIFISH, and MEDAKA KILLIFISH; KILLIFISHES is also available", "PI": "Fishes (1966-1986)", "MS": "The only genus in the family Oryziinae, order BELONIFORMES. Oryzias are egg-layers; other fish of the same order are livebearers. Oryzias are used extensively in testing carcinogens.", "PM": "91; was see under CYPRINODONTIFORMES 1987-90", "HN": "91(87); was see under CYPRINODONTIFORMES 1987-90", "MR": "20200813", "DA": "19860415", "DC": "1", "DX": "19910101", "UI": "D009990"}, {"RECTYPE": "D", "MH": "Oscillometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Oscillometries", "MN": "E05.654", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "do not confuse with CHEST WALL OSCILLATION", "MS": "The measurement of frequency or oscillation changes.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009991"}, {"RECTYPE": "D", "MH": "Osmium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.660", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Osmium", "RN": "2E7M255OPY", "RR": "7440-04-2 (Osmium)", "MS": "A very hard, gray, toxic, and nearly infusible metal element, atomic number 76, atomic weight 190.2, symbol Os.", "MR": "20170704", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009992"}, {"RECTYPE": "D", "MH": "Osmium Tetroxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Osmic Acid|T131|T197|NON|EQV|UNK (19XX)|780320|abbcdef", "ENTRY": "Tetroxide, Osmium", "MN": "D01.650.550.600", "MH_TH": "NLM (1979)", "ST": "T197", "N1": "Osmium oxide (OsO4), (T-4)-", "RN": "P40W033BGM", "RR": "20816-12-0 (Osmium Tetroxide)", "AN": "indust & histol uses", "PI": "Oxides (1966-1978)", "MS": "(T-4)-Osmium oxide (OsO4). A highly toxic and volatile oxide of osmium used in industry as an oxidizing agent. It is also used as a histological fixative and stain and as a synovectomy agent in arthritic joints. Its vapor can cause eye, skin, and lung damage.", "PM": "91; was see under OSMIUM 1979-90", "HN": "91(79); was see under OSMIUM 1979-90", "MR": "20130708", "DA": "19780320", "DC": "1", "DX": "19910101", "UI": "D009993"}, {"RECTYPE": "D", "MH": "Osmolar Concentration", "PRINT ENTRY": "Osmolarity|T034|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Strengths, Ionic", "MN": "G02.640", "MH_TH": "NLM (1968)", "ST": "T034", "AN": "usually NIM", "PI": "Water-Electrolyte Balance (1966-1967)", "MS": "The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent.", "PM": "70", "HN": "70(68)", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D009994"}, {"RECTYPE": "D", "MH": "Osmosis", "AQ": "DE PH RE", "ENTRY": "Osmoses", "MN": "G02.723.495", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "coordinate with substance / pharmacokin or tissue / metab; OSMOTIC SHOCK see OSMOTIC PRESSURE is also available", "MS": "Tendency of fluids (e.g., water) to move from the less concentrated to the more concentrated side of a semipermeable membrane.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D009995"}, {"RECTYPE": "D", "MH": "Osmotic Fragility", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Saline Fragility|T034|T081|NON|NRW|UNK (19XX)|740330|abbcdef", "ENTRY": "Fragility, Saline", "MN": "G09.188.640", "MH_TH": "NLM (1965)", "ST": "T034", "AN": "do not coord with ERYTHROCYTES since this is defined in terms of erythrocytes; NIM", "MS": "RED BLOOD CELL sensitivity to change in OSMOTIC PRESSURE. When exposed to a hypotonic concentration of sodium in a solution, red cells take in more water, swell until the capacity of the cell membrane is exceeded, and burst.", "PM": "70", "HN": "70(65)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D009996"}, {"RECTYPE": "D", "MH": "Osmotic Pressure", "AQ": "DE PH RE", "PRINT ENTRY": "Osmotic Shock|T070|NON|REL|NLM (1998)|960719|abcdef", "ENTRY": "Stresses, Osmotic", "MN": "G02.723.661", "FX": "Water-Electrolyte Imbalance", "MH_TH": "NLM (1968)", "ST": "T070", "PI": "Osmosis (1966-1967)", "MS": "The pressure required to prevent the passage of solvent through a semipermeable membrane that separates a pure solvent from a solution of the solvent and solute or that separates different concentrations of a solution. It is proportional to the osmolality of the solution.", "PM": "74", "HN": "74(68)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D009997"}, {"RECTYPE": "D", "MH": "Ossicular Prosthesis", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "TORP|T074|ABB|NRW|UNK (19XX)|860327|abcdef", "ENTRY": "Replacement Implants, Ossicular", "MN": "E07.695.550", "FX": "Ossicular Replacement", "MH_TH": "NLM (1987)", "ST": "T074", "PI": "Tympanoplasty (1966-1986)", "MS": "An implant used to replace one or more of the ear ossicles. They are usually made of plastic, Gelfoam, ceramic, or stainless steel.", "PM": "98; see OSSICULAR REPLACEMENT PROSTHESIS 1987-97", "HN": "98(87)", "CATSH": "CAT LIST", "MR": "20021023", "DA": "19860327", "DC": "1", "DX": "19870101", "UI": "D009998"}, {"RECTYPE": "D", "MH": "Ossification, Heterotopic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ossification, Pathologic|T046|NON|EQV|NLM (1992)|901101|OSSIFICATION PATHOL|abcdefv", "ENTRY": "Pathological Ossification", "MN": "C23.550.751", "FX": "Synostosis", "MH_TH": "NLM (1965)", "ST": "T046", "MS": "The development of bony substance in normally soft structures.", "OL": "use OSSIFICATION, HETEROTOPIC to search OSSIFICATION, PATHOLOGIC 1966-91", "PM": "92; was OSSIFICATION, PATHOLOGIC 1965-91; OSSIFICATION was heading 1963-64", "HN": "92; was OSSIFICATION, PATHOLOGIC 1965-91; OSSIFICATION was heading 1963-64", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D009999"}, {"RECTYPE": "D", "MH": "Osteitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bone Inflammation|T047|NON|EQV|NLM (2003)|020628|BONE INFLAMM|abcdefv", "ENTRY": "Inflammation, Bone", "MN": "C05.116.680", "FX": "Osteochondritis", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific bone (IM) and BONE DISEASES, INFECTIOUS (IM) if pertinent", "MS": "Inflammation of the bone.", "CATSH": "CAT LIST", "MR": "20150702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010000"}, {"RECTYPE": "D", "MH": "Osteitis Deformans", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paget's Disease of Bone|T047|EPO|EQV|GHR (2014)|UNK (19XX)|740330|PAGETS DIS OF BONE|abcdeefv", "ENTRY": "Pagets Disease, Bone", "MN": "C05.116.692", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010001"}, {"RECTYPE": "D", "MH": "Osteitis Fibrosa Cystica", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Recklinghausen's Disease of Bone|T047|EPO|EQV|UNK (19XX)|740330|RECKLINGHAUSENS DIS OF BONE|abcdefv", "ENTRY": "Recklinghausens Disease, Bone", "MN": "C05.116.132.684", "MH_TH": "NLM (1967)", "ST": "T047", "MS": "A fibrous degeneration, cyst formation, and the presence of fibrous nodules in bone, usually due to HYPERPARATHYROIDISM.", "OL": "use OSTEITIS FIBROSA CYSTICA to search OSTEITIS FIBROSA 1966", "PM": "67; was OSTEITIS FIBROSA 1963-66", "HN": "67; was OSTEITIS FIBROSA 1963-66", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D010002"}, {"RECTYPE": "D", "MH": "Osteoarthritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Osteoarthrosis Deformans|T047|NON|NRW|UNK (19XX)|880411|abcdef", "ENTRY": "Osteoarthroses", "MN": "C05.799.613", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.", "PM": "2013; for Arthrosis see Joint Diseases 2017-2019", "HN": "2013; for Arthrosis use Joint Diseases 2017-2019", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010003"}, {"RECTYPE": "D", "MH": "Osteoarthropathy, Primary Hypertrophic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pachydermoperiostosis|T047|NON|EQV|ORD (2010)|UNK (19XX)|840406|abcdeef", "ENTRY": "Touraine Solente Gole Syndrome", "MN": "C16.320.718", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "OSTEOARTHROPATHY, SECONDARY HYPERTROPHIC is also available", "MS": "A condition chiefly characterized by thickening of the skin of the head and distal extremities, deep folds and furrows of the skin of the forehead, cheeks, and scalp, SEBORRHEA; HYPERHIDROSIS; periostosis of the long bones, digital clubbing, and spadelike enlargement of the hands and feet. It is more prevalent in the male, and is usually first evident during adolescence. Inheritance is primarily autosomal recessive, but an autosomal dominant form exists.", "PM": "2012; see OSTEOARTHROPATHY, PRIMARY HYPERTROPHIC 1964-2013; CRANIOOSTEOARTHROPATHY was indexed under OSTEOARTHROPATHY, PRIMARY HYPERTROPHIC 2012-2013; DIGITAL CLUBBING, ISOLATED CONGENITAL was indexed under NAILS, MALFORMED 2012-2013; HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT was indexed under OSTEOARTHROPATHY, PRIMARY HYPERTROPHIC 2012-2013", "HN": "2014(1964)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010004"}, {"RECTYPE": "D", "MH": "Osteoarthropathy, Secondary Hypertrophic", "DE": "OSTEOARTHROPATHY SECOND HYPERTROPHIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Marie-Bamberger Disease|T047|EPO|EQV|UNK (19XX)|740330|MARIE BAMBERGER DIS|abcdefv", "ENTRY": "Secondary Hypertrophic Osteoarthropathies", "MN": "C05.550.684", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "OSTEOARTHROPATHY, PRIMARY HYPERTROPHIC is also available", "MS": "Symmetrical osteitis of the four limbs, chiefly localized to the phalanges and the terminal epiphyses of the long bones of the forearm and leg, sometimes extending to the proximal ends of the limbs and the flat bones, and accompanied by dorsal kyphosis and joint involvement. It is often secondary to chronic conditions of the lungs and heart. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010005"}, {"RECTYPE": "D", "MH": "Osteoblasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Osteoblast", "MN": "A11.329.629", "FX": "Osteoclasts", "MH_TH": "NLM (1964)", "ST": "T025", "MS": "Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone.", "PM": "65", "HN": "65(64)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010006"}, {"RECTYPE": "D", "MH": "Osteochondritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Osteochondritides", "MN": "C17.300.182.520", "FX": "Osteitis", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of a bone and its overlaying CARTILAGE.", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010007"}, {"RECTYPE": "D", "MH": "Osteochondritis Dissecans", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dissecans, Osteochondritis", "MN": "C05.116.791.668", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Osteochondritis (1966-1984)", "MS": "A type of osteochondritis in which articular cartilage and associated bone becomes partially or totally detached to form joint loose bodies. Affects mainly the knee, ankle, and elbow joints.", "PM": "91; was see under OSTEOCHONDRITIS 1985-90", "HN": "91(85); was see under OSTEOCHONDRITIS 1985-90", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19840406", "DC": "1", "DX": "19910101", "UI": "D010008"}, {"RECTYPE": "D", "MH": "Osteochondrodysplasias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spondyloepiphyseal Dysplasia|T019|T047|NON|NRW|GHR (2014)|UNK (19XX)|840406|abbcdeef", "ENTRY": "X Linked Spondyloepiphyseal Dysplasia Tarda", "MN": "C16.320.728", "MH_TH": "NLM (1985)", "ST": "T047", "PI": "Bone Diseases, Developmental (1970-1984)", "MS": "Abnormal development of cartilage and bone.", "OL": "use OSTECHONDRODYSPLASIAS to search DYSCHONDROPLASIAS 1966-84; use MUCOPOLYSACCHARIDOSIS 4 to search SPONDYLOEPIPHYSEAL DYSPLASIA 1968-84", "PM": "85; DYSCHONDRODYSPLASIAS was heading DYSCHONDROPLASIA 1963-84; SPONDYLEPIPHYSEAL DYSPLASIA was see MUCOPOLYSACCHARIDOSIS 4 1980-84, was see ECCENTROOSTEOCHONDRODYSPLASIA 1968-79", "HN": "85; DYSCHONDRODYSPLASIAS was heading DYSCHONDROPLASIA 1963-84; SPONDYLOEPIPHYSEAL DYSPLASIA was see MUCOPOLYSACCHARIDOSIS 4 1980-84, was see ECCENTROOSTEOCHONDRODYSPLASIA 1968-79", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19840406", "DC": "1", "DX": "19850101", "UI": "D010009"}, {"RECTYPE": "D", "MH": "Osteoclasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Odontoclasts|T025|NON|NRW|UNK (19XX)|770510|abcdef", "ENTRY": "Osteoclast|T025|NON|EQV|NLM (2004)|021118|abcdef", "MN": "A11.627.482.700", "FX": "Osteoblasts", "MH_TH": "NLM (1966)", "ST": "T025", "MS": "A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption.", "OL": "use OSTEOCLASTS to search ODONTOCLASTS 1966-77", "PM": "ODONTOCLASTS was heading 1965-77", "HN": "ODONTOCLASTS was heading 1965-77", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D010010"}, {"RECTYPE": "D", "MH": "Osteocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Osteocyte", "MN": "A11.329.629.500", "MH_TH": "NLM (1965)", "ST": "T025", "MS": "Mature osteoblasts that have become embedded in the BONE MATRIX. They occupy a small cavity, called lacuna, in the matrix and are connected to adjacent osteocytes via protoplasmic projections called canaliculi.", "PM": "65", "HN": "65", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010011"}, {"RECTYPE": "D", "MH": "Osteogenesis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Ossification, Physiologic|T042|NON|REL|UNK (19XX)|840430|OSSIFICATION PHYSIOL|abcdefv", "ENTRY": "Physiological Ossification", "MN": "G11.427.578.050.500.729", "FX": "Osteoclasts", "MH_TH": "NLM (1965)", "ST": "T042", "AN": "BONE DEVELOPMENT is also available", "MS": "The process of bone formation. Histogenesis of bone including ossification.", "OL": "use OSTEOGENESIS to search OSSIFICATION, PHYSIOLOGIC 1966-84", "PM": "65; OSSIFICATION, PHYSIOLOGIC was heading 1965-84", "HN": "65; OSSIFICATION, PHYSIOLOGIC was heading 1965-84", "CATSH": "CAT LIST", "MR": "20180206", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010012"}, {"RECTYPE": "D", "MH": "Osteogenesis Imperfecta", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lobstein Disease|T047|EPO|NRW|UNK (19XX)|840615|LOBSTEIN DIS|abcdefv", "ENTRY": "Osteogenesis Imperfecta Tardas", "MN": "C17.300.200.540", "FX": "Dentinogenesis Imperfecta", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "COLLAGEN DISEASES characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. Most types are autosomal dominant and are associated with mutations in COLLAGEN TYPE I.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010013"}, {"RECTYPE": "D", "MH": "Osteolysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Osteolyses", "MN": "G11.427.213.150.570", "MH_TH": "NLM (1975)", "ST": "T046", "MS": "Dissolution of bone that particularly involves the removal or loss of calcium.", "OL": "search BONE RESORPTION 1966-74", "PM": "87; was see under BONE RESORPTION 1966-86", "HN": "87(75); was see under BONE RESORPTION 1966-86", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D010014"}, {"RECTYPE": "D", "MH": "Osteolysis, Essential", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Osteolysis, Massive|T047|NON|NRW|OMIM (2013)|UNK (19XX)|840406|abcdeef", "ENTRY": "Osteolyses, Essential", "MN": "C05.116.264.579.704", "FX": "Hajdu-Cheney Syndrome", "MH_TH": "NLM (1967)", "ST": "T190", "MS": "Syndromes of bone destruction where the cause is not obvious such as neoplasia, infection, or trauma. The destruction follows various patterns: massive (Gorham disease), multicentric (HAJDU-CHENEY SYNDROME), or carpal/tarsal.", "OL": "use BONE DISEASES to search OSTEOLYSIS, ESSENTIAL 1966 (as Prov)", "PM": "91; was see under OSTEOLYSIS 1987-90; was see under BONE RESORPTION 1980-86; was see under BONE DISEASES 1967-79", "HN": "91(65); was see under OSTEOLYSIS 1987-90; was see under BONE RESORPTION 1980-86; was see under BONE DISEASES 1965-79 (Prov 1965-66)", "CATSH": "CAT LIST", "MR": "20180206", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010015"}, {"RECTYPE": "D", "MH": "Osteoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Osteomas", "MN": "C04.557.450.565.575.625", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with BONE NEOPLASMS or specific precoordinated bone/neoplasm term or specific bone + BONE NEOPLASMS ", "MS": "A benign tumor composed of bone tissue or a hard tumor of bonelike structure developing on a bone (homoplastic osteoma) or on other structures (heteroplastic osteoma). (From Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010016"}, {"RECTYPE": "D", "MH": "Osteoma, Osteoid", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Osteomas, Osteoid", "MN": "C04.557.450.565.575.625.625", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with BONE NEOPLASMS (IM) or specific precoordinated bone/neoplasm term (IM) or specific bone (IM) + BONE NEOPLASMS (IM); do not confuse with OSTEOMA, GIANT OSTEOID see OSTEOBLASTOMA ", "MS": "A benign osteoblastic tumor with central vascularized nidus surrounded by normal reactive bone. It occurs especially in second decade of life most commonly in the femoral neck but can occur in any bone and any site within a bone.", "CATSH": "CAT LIST", "MR": "20180319", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010017"}, {"RECTYPE": "D", "MH": "Osteomalacia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Rickets, Adult", "MN": "C18.654.521.500.133.770.734.640", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010018"}, {"RECTYPE": "D", "MH": "Osteomyelitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Osteomyelitides", "MN": "C05.116.165.495", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010019"}, {"RECTYPE": "D", "MH": "Osteonecrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Necrosis, Avascular, of Bone|T046|NON|NRW|UNK (19XX)|760825|abcdef", "ENTRY": "Osteonecroses", "MN": "C23.550.717.732", "MH_TH": "NLM (1977)", "ST": "T046", "AN": "OSTEORADIONECROSIS & FEMUR HEAD NECROSIS are available", "PI": "Necrosis (1966-1976)", "MS": "Death of a bone or part of a bone, either atraumatic or posttraumatic.", "PM": "1977; for KIENBOCK DISEASE, see OSTEOCHONDRITIS 1963-2002", "HN": "1977; for KIENBOCK DISEASE, use OSTEOCHONDRITIS 1963-2002", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D010020"}, {"RECTYPE": "D", "MH": "Osteopathic Medicine", "DE": "OSTEOPATHIC MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Osteopathic Manipulative", "MN": "H02.403.640", "FX": "Osteopathic Physicians", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use for the medical discipline only; use OSTEOPATHIC MANIPULATION for therapy", "MS": "A medical discipline that is based on the philosophy that all body systems are interrelated and dependent upon one another for good health. This philosophy, developed in 1874 by Dr. Andrew Taylor Still, recognizes the concept of \"wellness\" and the importance of treating illness within the context of the whole body. Special attention is placed on the MUSCULOSKELETAL SYSTEM.", "OL": "use OSTEOPATHIC MEDICINE to search OSTEOPATHY 1966-86", "PM": "87; was OSTEOPATHY 1963-86", "HN": "87; was OSTEOPATHY 1963-86", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D010021"}, {"RECTYPE": "D", "MH": "Osteopetrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Osteosclerosis Fragilis|T019|T047|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Osteosclerosis Fragilis Generalisatas", "MN": "C05.116.099.708.702.678", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with OSTEOPOROSIS", "MS": "Excessive formation of dense trabecular bone leading to pathological fractures; OSTEITIS; SPLENOMEGALY with infarct; ANEMIA; and extramedullary hemopoiesis (HEMATOPOIESIS, EXTRAMEDULLARY).", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010022"}, {"RECTYPE": "D", "MH": "Osteopoikilosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Osteopoikiloses", "MN": "C17.300.705", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a form of osteosclerosis", "MS": "An asymptomatic, autosomal dominant trait in which pea-sized sclerotic spots, prominent in the metaphyseal area, are accompanied by unique cutaneous lesions. These are yellowish papules or plaques with increased elastin content. (From Cecil Textbook of Medicine, 19th ed, pp1434-35)", "PM": "91; was see under OSTEOSCLEROSIS 1970-90; was see under BONE DISEASES 1967-69", "HN": "91(64); was see under OSTEOSCLEROSIS 1970-90; was see under BONE DISEASES 1967-69", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010023"}, {"RECTYPE": "D", "MH": "Osteoporosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Senile Osteoporosis|T047|NON|NRW|NLM (1990)|890502|abcdef", "ENTRY": "Senile Osteoporoses", "MN": "C18.452.104.579", "MH_TH": "POPLINE (1994)", "ST": "T047", "AN": "related to aging: note X refs; age-related osteoporosis in men goes here; age-related osteoporosis in women is probably OSTEOPOROSIS, POSTMENOPAUSAL", "MS": "Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010024"}, {"RECTYPE": "D", "MH": "Osteoradionecrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Osteoradionecroses", "MN": "G01.750.748.500.579", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "bone necrosis after radiation inj; coord IM with bone/dis (IM), not organ /inj", "MS": "Necrosis of bone following radiation injury.", "PM": "91; was see under RADIATION INJURIES 1963-90", "HN": "91(63); was see under RADIATION INJURIES 1963-90", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010025"}, {"RECTYPE": "D", "MH": "Osteosclerosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Osteoscleroses", "MN": "C05.116.099.708.702", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An abnormal hardening or increased density of bone tissue.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010026"}, {"RECTYPE": "D", "MH": "Osteotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Osteotomies", "MN": "E04.555.580", "MH_TH": "NLM (1963)", "ST": "T061", "MS": "The surgical cutting of a bone. (Dorland, 28th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010027"}, {"RECTYPE": "D", "MH": "Ostertagia", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Ostertagia ostertagi|T204|NON|NRW|NLM (1993)|911108|abcdef", "ENTRY": "ostertagi, Ostertagia", "MN": "B01.050.500.500.294.400.968.746.432", "MH_TH": "NLM (1986)", "ST": "T204", "RN": "txid6316", "RR": "txid6317", "PI": "Trichostrongyloidea (1966-1985)", "MS": "A genus of parasitic nematodes occurring in the stomach of ruminants.", "PM": "86", "HN": "86", "MR": "20200813", "DA": "19850311", "DC": "1", "DX": "19860101", "UI": "D010028"}, {"RECTYPE": "D", "MH": "Ostertagiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Ostertagiases", "MN": "C01.610.335.508.700.775.825.580", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "roundworm infect", "MS": "A disease of herbivorous mammals, particularly cattle and sheep, caused by stomach worms of the genus OSTERTAGIA.", "OL": "search TRICHOSTRONGYLOIDIASIS 1968-74", "PM": "91; was see under TRICHOSTRONGYLOIDIASIS 1975-90", "HN": "91(75); was see under TRICHOSTRONGYLOIDIASIS 1975-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010029"}, {"RECTYPE": "D", "MH": "Ostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Ostomies", "MN": "E04.579", "MH_TH": "NLM (1988)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "PI": "Urinary Diversion (1973-1987)", "MS": "Surgical construction of an artificial opening (stoma) for external fistulization of a duct or vessel by insertion of a tube with or without a supportive stent.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19870515", "DC": "1", "DX": "19880101", "UI": "D010030"}, {"RECTYPE": "D", "MH": "Otitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Otitides", "MN": "C09.218.705", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Inflammation of the ear, which may be marked by pain (EARACHE), fever, HEARING DISORDERS, and VERTIGO. Inflammation of the external ear is OTITIS EXTERNA; of the middle ear, OTITIS MEDIA; of the inner ear, LABYRINTHITIS.", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010031"}, {"RECTYPE": "D", "MH": "Otitis Externa", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "External Otitis|T047|NON|EQV|NLM (2008)|070208|abcdef", "ENTRY": "Otitis, External", "MN": "C09.218.705.496", "FX": "Otomycosis", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the OUTER EAR including the external EAR CANAL, cartilages of the auricle (EAR CARTILAGE), and the TYMPANIC MEMBRANE.", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010032"}, {"RECTYPE": "D", "MH": "Otitis Media", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Inflammation, Middle Ear", "MN": "C09.218.705.663", "FX": "Lateral Sinus Thrombosis", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; nonsuppurative otitis media: index under OTITIS MEDIA WITH EFFUSION", "MS": "Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010033"}, {"RECTYPE": "D", "MH": "Otitis Media with Effusion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Otitis Media, Serous|T047|NON|NRW|UNK (19XX)|850509|abcdef", "ENTRY": "Serous Otitis Media", "MN": "C09.218.705.663.670", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "nonsuppurative otitis media", "PI": "Otitis Media (1966-1978)", "MS": "Inflammation of the middle ear with a clear pale yellow-colored transudate.", "OL": "use OTITIS MEDIA WITH EFFUSION to search OTITIS MEDIA, SEROUS 1979-85", "PM": "86; was OTITIS MEDIA, SEROUS see under OTITIS MEDIA 1979-85", "HN": "86; was OTITIS MEDIA, SEROUS see under OTITIS MEDIA 1979-85", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19780522", "DC": "1", "DX": "19860101", "UI": "D010034"}, {"RECTYPE": "D", "MH": "Otitis Media, Suppurative", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Otitis Media, Purulent|T047|NON|EQV|UNK (19XX)|780522|abcdef", "ENTRY": "Suppurative Otitis Media", "MN": "C09.218.705.663.680", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "suppurative refers to purulent discharge", "PI": "Otitis Media (1966-1978)", "MS": "Inflammation of the middle ear with purulent discharge.", "PM": "91; was see under OTITIS MEDIA 1979-90", "HN": "91(79); was see under OTITIS MEDIA 1979-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19780522", "DC": "1", "DX": "19910101", "UI": "D010035"}, {"RECTYPE": "D", "MH": "Otolaryngology", "DE": "OTOLARYNGOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Otorhinolaryngology|T091|NON|EQV|UNK (19XX)|790529|OTORHINOLARYNGOL|abcdefv", "ENTRY": "Laryngology|T091|NON|NRW|NLM (2013)|120306|abcdef", "MN": "H02.403.810.526", "FX": "Otorhinolaryngologic Surgical Procedures", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use for the specialty only; corresponding disease term is OTOLARYNGOLOGIC DISEASES or specifics", "MS": "A surgical specialty concerned with the study and treatment of disorders of the ear, nose, and throat.", "OL": "use OTOLARYNGOLOGY to search OTORHINOLARYNGOLOGY 1966-79", "PM": "80; was OTORHINOLARYNGOLOGY 1963-79", "HN": "80; was OTORHINOLARYNGOLOGY 1963-79", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D010036"}, {"RECTYPE": "D", "MH": "Otolithic Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Statoconia|T023|NON|NRW|UNK (19XX)|820422|abcdef", "ENTRY": "Statoconias", "MN": "A09.923.500.625.125.680", "MH_TH": "NLM (1983)", "ST": "T023", "PI": "Saccule and Utricle (1975-1982)", "MS": "A gelatinous membrane overlying the acoustic maculae of SACCULE AND UTRICLE. It contains minute crystalline particles (otoliths) of CALCIUM CARBONATE and protein on its outer surface. In response to head movement, the otoliths shift causing distortion of the vestibular hair cells which transduce nerve signals to the BRAIN for interpretation of equilibrium.", "PM": "91; was see under SACCULE AND UTRICLE 1983-90", "HN": "91(83); was see under SACCULE AND UTRICLE 1983-90", "MR": "20210630", "DA": "19820422", "DC": "1", "DX": "19910101", "UI": "D010037"}, {"RECTYPE": "D", "MH": "Otorhinolaryngologic Diseases", "DE": "ORL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Otolaryngologic Diseases|T047|NON|EQV|NLM (2008)|070110|abcdef", "ENTRY": "Otorhinolaryngological Diseases", "MN": "C09", "RH": "C9 - DISEASES-OTORHINOLARYNGOLOGIC", "FX": "Pharyngeal Diseases", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general; prefer specifics", "MS": "Pathological processes of the ear, the nose, and the throat, also known as the ENT diseases.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010038"}, {"RECTYPE": "D", "MH": "Otorhinolaryngologic Neoplasms", "DE": "ORL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Otorhinolaryngological Neoplasm", "MN": "C09.647", "MH_TH": "NLM (1984)", "ST": "T191", "AN": "general: prefer specifics; coordinate IM with histological type of neoplasm (IM)", "PI": "Otorhinolaryngological Diseases (1966-1983)", "MS": "A general concept for tumors or cancer of any part of the EAR; the NOSE; the THROAT; and the PHARYNX. It is used when there is no specific heading.", "PM": "84", "HN": "84; was NON MESH before 1984", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D010039"}, {"RECTYPE": "D", "MH": "Otosclerosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Otospongiosis|T047|NON|EQV|UNK (19XX)|780522|abcdef", "ENTRY": "Otospongioses", "MN": "C09.218.768", "FX": "Stapes Mobilization", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "Formation of spongy bone in the labyrinth capsule which can progress toward the STAPES (stapedial fixation) or anteriorly toward the COCHLEA leading to conductive, sensorineural, or mixed HEARING LOSS. Several genes are associated with familial otosclerosis with varied clinical signs.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010040"}, {"RECTYPE": "D", "MH": "Otters", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Sea Otters|T015|NON|NRW|NLM (1998)|961028|abcdef", "ENTRY": "Sea Otter", "MN": "B01.050.150.900.649.313.750.250.575.600", "MH_TH": "NLM (1975)", "ST": "T015", "RR": "txid9671", "AN": "do not confuse entry term ENHYDRA LUTRIS with ENHYDRA FLUCTUANS see ASTERACEAE", "MS": "Fish-eating carnivores of the family MUSTELIDAE, found on both hemispheres.", "PM": "91; was see under CARNIVORA 1975-90", "HN": "91(75); was see under CARNIVORA 1975-90", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D010041"}, {"RECTYPE": "D", "MH": "Ouabain", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "G-Strophanthin|T109|T121|EQV|FDA SRS (2014)|UNK (19XX)|760630|STROPHANTHIN G|abbdeefs", "ENTRY": "G Strophanthin", "MN": "D09.408.180.810.600", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1963)", "ST": "T121", "N1": "Card-20(22)-enolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-1,5,11,14,19-pentahydroxy-, (1beta,3beta,5beta,11alpha)-", "RN": "5ACL011P69", "RR": "630-60-4 (Ouabain)", "MS": "A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE.", "PM": "65; was see under STROPHANTHIN (now STROPHANTHINS) 1963-64", "HN": "65(63); was see under STROPHANTHIN (now STROPHANTHINS) 1963-64", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010042"}, {"RECTYPE": "D", "MH": "Outcome and Process Assessment, Health Care", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Outcome and Process Assessment (Health Care)|T058|T062|NON|EQV|NLM (1979)|990101|OUTCOME PROCESS ASSESS|abbcdefv", "ENTRY": "Triad, Donabedian", "MN": "N05.715.360.575", "MH_TH": "NLM (2020)", "ST": "T062", "AN": "must discuss both outcome & process: OUTCOME ASSESSMENT (HEALTH CARE) is available for only outcome, PROCESS ASSESSMENT (HEALTH CARE) is available for only process", "PI": "Quality of Health Care (1968-1978)", "MS": "Evaluation procedures that focus on both the outcome or status (OUTCOMES ASSESSMENT) of the patient at the end of an episode of care - presence of symptoms, level of activity, and mortality; and the process (ASSESSMENT, PROCESS) - what is done for the patient diagnostically and therapeutically.", "PM": "2020; was OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE) 1979-2019", "HN": "2020 (1979); was OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE) 1979-2019", "MR": "20190118", "DA": "19780516", "DC": "1", "DX": "19790101", "UI": "D010043"}, {"RECTYPE": "D", "MH": "Outpatient Clinics, Hospital", "DE": "OUTPATIENT CLINICS HOSP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Outpatient Clinics|T073|T093|NON|EQV|UNK (19XX)|770519|HOSP OUTPATIENT CLINICS|abbcdefv", "ENTRY": "Outpatient Clinic, Hospital", "MN": "N04.452.442.452.422.527", "FX": "Ambulatory Care", "MH_TH": "NLM (1968)", "ST": "T093", "AN": "IM", "MS": "Organized services in a hospital which provide medical care on an outpatient basis.", "OL": "use OUTPATIENT CLINICS, HOSPITAL to search HOSPITAL OUTPATIENT CLINICS 1968-77 & HOSPITAL OUTPATIENT SERVICE 1966-67", "PM": "78; was HOSPITAL OUTPATIENT CLINICS 1968-77, was HOSPITAL OUTPATIENT SERVICES 1963-67", "HN": "78; was HOSPITAL OUTPATIENT CLINICS 1968-77, was HOSPITAL OUTPATIENT SERVICES 1963-67", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010044"}, {"RECTYPE": "D", "MH": "Outpatients", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Outpatient", "MN": "M01.643.630", "FX": "Ambulatory Care", "MH_TH": "NLM (1980)", "ST": "T101", "PI": "Ambulatory Care (1966-1979)", "MS": "Persons who receive ambulatory care at an outpatient department or clinic without room and board being provided.", "OL": "search AMBULATORY CARE 1978-79", "PM": "91; was see under PATIENTS 1980-90; was see AMBULATORY CARE 1978-79", "HN": "91(80); was see under PATIENTS 1980-90; was see AMBULATORY CARE 1978-79", "MR": "20030709", "DA": "19781222", "DC": "1", "DX": "19910101", "UI": "D010045"}, {"RECTYPE": "D", "MH": "Oval Window, Ear", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Oval Windows, Ear", "MN": "A09.923.500.551", "MH_TH": "NLM (2008)", "ST": "T030", "AN": "do not confuse with ROUND WINDOW, EAR", "PI": "Ear, Middle (1966-1978)", "MS": "Fenestra or oval opening on the lateral wall of the vestibular labyrinth adjacent to the MIDDLE EAR. It is located above the cochlear round window and normally covered by the base of the STAPES.", "PM": "2008; see OVAL WINDOW 1991-2007, see VESTIBULE 1990, see VESTIBULAR APPARATUS 1979-1989", "HN": "2008 (1979)", "MR": "20210630", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D010046"}, {"RECTYPE": "D", "MH": "Ovalbumin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Serpin B14|T116|T123|NON|EQV|NLM (2010)|090210|abbcdef", "MN": "D12.776.872.557", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Ovalbumins", "RN": "9006-59-1", "AN": "differentiate OVALBUMIN (protein in egg white) from EGG WHITE (the food)", "MS": "An albumin obtained from the white of eggs. It is a member of the serpin superfamily.", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010047"}, {"RECTYPE": "D", "MH": "Ovarian Cysts", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Corpus Luteum Cyst|T047|NON|NRW|UNK (19XX)|840620|abcdef", "ENTRY": "Ovarian Cyst", "MN": "C19.391.630.580", "FX": "Ovarian Hyperstimulation Syndrome", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "non-neoplastic; POLYCYSTIC OVARY SYNDROME is also available", "PI": "Ovarian Diseases (1966-1967)", "MS": "General term for CYSTS and cystic diseases of the OVARY.", "OL": "use OVARIAN CYSTS to search CORPUS LUTEUM CYST 1966-84", "PM": "68; CORPUS LUTEUM CYST was heading 1963-84", "HN": "68; CORPUS LUTEUM CYST was heading 1963-84", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010048"}, {"RECTYPE": "D", "MH": "Ovarian Diseases", "DE": "OVARIAN DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ovarian Disease", "MN": "C19.391.630", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes of the OVARY.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010049"}, {"RECTYPE": "D", "MH": "Ovarian Function Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Ovarian Function", "MN": "E01.370.378.530", "MH_TH": "NLM (1975)", "ST": "T060", "AN": "NIM", "PI": "Ovary (1966-1974)", "MS": "Methods used for assessment of ovarian function.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D010050"}, {"RECTYPE": "D", "MH": "Ovarian Neoplasms", "DE": "OVARIAN NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Ovarian Cancer|T191|NON|NRW|NLM (1980)|OMIM (2013)|781226|abcdeef", "ENTRY": "Ovary Neoplasm", "MN": "C19.391.630.705", "FX": "Pseudomyxoma Peritonei", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with histologic type of neoplasm (IM)", "MS": "Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010051"}, {"RECTYPE": "D", "MH": "Ovariectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Oophorectomy|T061|NON|EQV|UNK (19XX)|850606|abcdef", "ENTRY": "Ovariectomy, Bilateral", "MN": "E04.950.300.680", "MH_TH": "NLM (1986)", "ST": "T061", "PI": "Castration (1966-1985)", "MS": "The surgical removal of one or both ovaries.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19850607", "DC": "1", "DX": "19860101", "UI": "D010052"}, {"RECTYPE": "D", "MH": "Ovary", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ovaries|T023|NON|EQV|NLM (2004)|030522|abcdef", "MN": "A06.300.312.497", "FX": "Ovariectomy", "MH_TH": "NLM (1963)", "ST": "T023", "CX": "consider also terms at OOPHOR- and THEC-", "MS": "The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010053"}, {"RECTYPE": "D", "MH": "Brief Psychiatric Rating Scale", "DE": "BPRS", "AQ": "HI SN ST", "PRINT ENTRY": "Overall and Gorham Brief Psychiatric Rating Scale|T060|T170|EPO|EQV|NLM (1995)|930914|OVERALL GORHAM BPRS|abbcdefv", "ENTRY": "Overall Gorham Brief Psychiatric Rating Scale", "MN": "F04.711.513.653.083", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "A scale comprising 18 symptom constructs chosen to represent relatively independent dimensions of manifest psychopathology. The initial intended use was to provide more efficient assessment of treatment response in clinical psychopharmacology research; however, the scale was readily adapted to other uses. (From Hersen, M. and Bellack, A.S., Dictionary of Behavioral Assessment Techniques, p. 87)", "OL": "use BRIEF PSYCHIATRIC RATING SCALE to search OVERALL AND GORHAM BRIEF PSYCHIATRIC RATING SCALE 1975-94; use PSYCHIATRIC STATUS RATING SCALES 1969-74", "PM": "95; OVERALL AND GORHAM BRIEF PSYCHIATRIC RATING SCALE was heading 1975-94 (see under PSYCHIATRIC STATUS RATING SCALES 1975-90)", "HN": "95; OVERALL AND GORHAM BRIEF PSYCHIATRIC RATING SCALE was heading 1975-94 (see under PSYCHIATRIC STATUS RATING SCALES 1975-90)", "CATSH": "CAT LIST", "MR": "20170502", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010054"}, {"RECTYPE": "D", "MH": "Overlearning", "AQ": "CL DE ES PH RE", "ENTRY": "Overlearnings", "MN": "F02.463.425.612", "MH_TH": "NLM (1964)", "ST": "T041", "MS": "Learning in which practice proceeds beyond the point where the act can just be performed with the required degree of excellence.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D010056"}, {"RECTYPE": "D", "MH": "Oviducts", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Oviduct", "MN": "A13.706", "FX": "Fallopian Tubes", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "non-mammals only; mammals, use FALLOPIAN TUBES; disease probably GENITAL DISEASES, FEMALE + OVIDUCTS", "MS": "Ducts that serve exclusively for the passage of eggs from the ovaries to the exterior of the body. In non-mammals, they are termed oviducts. In mammals, they are highly specialized and known as FALLOPIAN TUBES.", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010057"}, {"RECTYPE": "D", "MH": "Oviposition", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Larviposition|T042|NON|REL|NLM (2023)|220705|abcdef", "ENTRY": "Ovipositions", "MN": "G08.686.784.480", "FX": "Oviparity", "MH_TH": "NLM (1974)", "ST": "T042", "AN": "index ovipositor under specific insect only with /anat (IM) + OVIPOSITION (IM)", "MS": "The process of laying or shedding fully developed eggs (OVA) from the female body. The term is usually used for certain INSECTS or FISHES with an organ called ovipositor where eggs are stored or deposited before expulsion from the body.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010058"}, {"RECTYPE": "D", "MH": "Ovomucin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ovomucoid|T116|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D12.776.395.560.760", "PA": "Trypsin Inhibitors", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Ovomucoid II O", "RN": "37281-36-0", "AN": "a trypsin inhib; /drug eff /ultrastruct permitted", "PI": "Egg Proteins (1973-1974)", "MS": "A heterogeneous mixture of glycoproteins responsible for the gel structure of egg white. It has trypsin-inhibiting activity.", "PM": "91; was see under EGG PROTEINS 1975-90", "HN": "91(75); was see under EGG PROTEINS 1975-90", "MR": "20230316", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010059"}, {"RECTYPE": "D", "MH": "Ovulation", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "ENTRY": "Ovulations", "MN": "G08.686.784.690", "MH_TH": "NLM (1963)", "ST": "T042", "MS": "The discharge of an OVUM from a rupturing follicle in the OVARY.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010060"}, {"RECTYPE": "D", "MH": "Ovulation Detection", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Ovulation Detections", "MN": "E05.820.690", "FX": "Ovulation Prediction", "MH_TH": "NLM (1975)", "ST": "T060", "PI": "Ovulation (1966-1974)", "MS": "Method to determine the occurrence of OVULATION by direct or indirect means. Indirect methods examine the effects of PROGESTERONE on cervical mucus (CERVIX MUCUS), or basal body temperature. Direct ovulation detection, generally used in fertility treatment, involves analyses of circulating hormones in blood and ULTRASONOGRAPHY.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D010061"}, {"RECTYPE": "D", "MH": "Ovulation Induction", "DE": "OVULATION IND", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ovarian Stimulation|T061|T062|NON|BRD|NLM (2002)|010314|abbcdef", "ENTRY": "Stimulations, Ovarian", "MN": "E05.820.800.984", "FX": "Ovarian Hyperstimulation Syndrome", "MH_TH": "NLM (1978)", "ST": "T061", "PI": "Ovulation (1966-1977)", "MS": "Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum.", "PM": "1978", "HN": "1978", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19770301", "DC": "1", "DX": "19780101", "UI": "D010062"}, {"RECTYPE": "D", "MH": "Ovum", "AQ": "CH CL CY DE EN GD IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Egg|T025|NON|EQV|NLM (1989)|991103|abcdef", "ENTRY": "Unfertilized Eggs", "MN": "A16.690", "FX": "Ovarian Follicle", "MH_TH": "POPLINE (1978)", "ST": "T025", "CX": "consider also terms at OO-", "MS": "A mature haploid female germ cell extruded from the OVARY at OVULATION.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010063"}, {"RECTYPE": "D", "MH": "Embryo Implantation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Ovum Implantation|T040|NON|EQV|NLM (1965)|990101|abcdef", "ENTRY": "Ovum Implantations", "MN": "G08.686.784.170.104.500", "MH_TH": "NLM (2003)", "ST": "T040", "MS": "Endometrial implantation of EMBRYO, MAMMALIAN at the BLASTOCYST stage.", "PM": "2003; see OVUM IMPLANTATION 1985-2002; for OVUM IMPLANTATION see NIDATION 1967-1984", "HN": "2003 (1985); for OVUM IMPLANTATION use NIDATION 1965-1984 (Prov 1965-1966)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D010064"}, {"RECTYPE": "D", "MH": "Embryo Implantation, Delayed", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Ovum Implantation, Delayed|T042|T079|NON|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "Ovum Implantations, Delayed", "MN": "G08.686.784.170.104.500.100", "MH_TH": "NLM (2003)", "ST": "T079", "MS": "Delay in the attachment and implantation of BLASTOCYST to the uterine ENDOMETRIUM. The blastocyst remains unattached beyond the normal duration thus delaying embryonic development.", "OL": "use OVUM IMPLANTATION, DELAYED to search NIDATION, DELAYED 1975-84", "PM": "2003; see OVUM IMPLANTATION, DELAYED 1991-2002, see OVUM IMPLANTATION 1985-1990, see NIDATION 1975-1984; for NIDATION, DELAYED see OVUM IMPLANTATION 1985-1990, see NIDATION 1975-1984", "HN": "2003 (1991); for OVUM IMPLANTATION, DELAYED use OVUM IMPLANTATION 1985-1990, NIDATION 1975-1984; for NIDATION, DELAYED use OVUM IMPLANTATION, DELAYED 1985-1990, NIDATION 1975-1984", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010065"}, {"RECTYPE": "D", "MH": "Ovum Transport", "AQ": "DE GE IM PH RE", "MN": "G08.686.784.277.360", "MH_TH": "NLM (1976)", "ST": "T040", "PI": "Ovum (1966-1974)", "MS": "Transport of the OVUM or fertilized ovum (ZYGOTE) from the mammalian oviduct (FALLOPIAN TUBES) to the site of EMBRYO IMPLANTATION in the UTERUS.", "OL": "search OVUM 1974", "PM": "76; was see under OVUM 1974-75", "HN": "76(75); was see under OVUM 1974-75", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19760101", "UI": "D010066"}, {"RECTYPE": "D", "MH": "Ownership", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Rights, Property", "MN": "N04.452.633", "FX": "Practice Valuation and Purchase", "MH_TH": "POPLINE (1986)", "ST": "T081", "AN": "med or non-med contexts", "PI": "Hospital Administration (1966-1967)", "MS": "The legal relation between an entity (individual, group, corporation, or-profit, secular, government) and an object. The object may be corporeal, such as equipment, or completely a creature of law, such as a patent; it may be movable, such as an animal, or immovable, such as a building.", "PM": "68", "HN": "68", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010067"}, {"RECTYPE": "D", "MH": "Oxacillin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sodium Oxacillin|T109|T195|NON|NRW|UNK (19XX)|740330|abbcdef", "ENTRY": "Sodium, Oxacillin", "MN": "D03.633.100.300.750.625", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(((5-methyl-3-phenyl-4-isoxazolyl)carbonyl)amino)-7-oxo-, (2S-(2alpha,5alpha,6beta))-", "RN": "UH95VD7V76", "RR": "G0V6C994Q5", "MS": "An antibiotic similar to FLUCLOXACILLIN used in resistant staphylococci infections.", "PM": "66", "HN": "66(64)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010068"}, {"RECTYPE": "D", "MH": "Oxadiazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxadiazole|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D03.383.129.462.580", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010069"}, {"RECTYPE": "D", "MH": "Oxalates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxalate|T109|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Acids, Oxalic", "MN": "D02.241.081.337.593", "FX": "Hyperoxaluria, Primary", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "/urine: HYPEROXALURIA & HYPEROXALURIA, PRIMARY are also available", "MS": "Derivatives of OXALIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that are derived from the ethanedioic acid structure.", "PM": "1966; for OXALIC ACIDS see OXALIC ACIDS 1999-2012", "HN": "1966", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010070"}, {"RECTYPE": "D", "MH": "Oxaloacetates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxosuccinates|T109|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Oxaloacetic Acids|T109|NON|REL|NLM (1999)|990101|abcdef", "MN": "D02.241.755.648", "MH_TH": "NLM (1964)", "ST": "T109", "RN": "0", "MS": "Derivatives of OXALOACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include a 2-keto-1,4-carboxy aliphatic structure.", "PM": "66", "HN": "66(64)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010071"}, {"RECTYPE": "D", "MH": "Oxamic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxamidic Acid|T116|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Acid, Oxamidic", "MN": "D12.125.730", "MH_TH": "NLM (1975)", "ST": "T116", "N1": "Acetic acid, aminooxo-", "RN": "QU60N5OPLG", "RR": "471-47-6 (Oxamic Acid)", "PI": "Glyoxylates (1972-1974)", "MS": "Amino-substituted glyoxylic acid derivative.", "PM": "91; was see under AMINO ACIDS 1975-90", "HN": "91(75); was see under AMINO ACIDS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010072"}, {"RECTYPE": "D", "MH": "Oxamniquine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "UK4271", "MN": "D03.633.100.810.470.600", "PA": "Schistosomicides", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "6-Quinolinemethanol, 1,2,3,4-tetrahydro-2-(((1-methylethyl)amino)methyl)-7-nitro-", "RN": "0O977R722D", "RR": "21738-42-1 (Oxamniquine)", "PI": "Quinolines (1973-1974)", "MS": "An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martindale, The Extra Pharmacopoeia, 31st ed, p121)", "PM": "91; was see under NITROQUINOLINES 1975-90", "HN": "91(75); was see under NITROQUINOLINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010073"}, {"RECTYPE": "D", "MH": "Oxandrolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SC11585", "MN": "D04.210.500.054.040.581", "PA": "Androgens", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5alpha,17beta)-", "RN": "7H6TM3CT4L", "RR": "53-39-4 (Oxandrolone)", "MS": "A synthetic hormone with anabolic and androgenic properties.", "OL": "use OXANDROLONE to search ANAVAR 1966-93", "PM": "65; ANAVAR was see OXANDROLONE 1965-93", "HN": "65(64); ANAVAR was see OXANDROLONE 1965-93", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010074"}, {"RECTYPE": "D", "MH": "Oxathiins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxathins|T109|NON|EQV|UNK (19XX)|781214|abcdef", "MN": "D03.383.517", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "Heterocyclic Compounds (1966-1970)", "PM": "91; was see under HETEROCYCLIC COMPOUNDS 1971-90", "HN": "91(71); was see under HETEROCYCLIC COMPOUNDS 1971-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010075"}, {"RECTYPE": "D", "MH": "Oxazepam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tazepam|T109|T121|TRD|NRW|UNK (19XX)|831209|abbcdef", "MN": "D03.633.100.079.080.070.663", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-", "RN": "6GOW6DWN2A", "RR": "604-75-1 (Oxazepam)", "MS": "A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia.", "PM": "68", "HN": "68(65)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010076"}, {"RECTYPE": "D", "MH": "Oxazepines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.066.498", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "OL": "search AZEPINES 1974", "PM": "91; was see under AZEPINES 1975-90", "HN": "91(75); was see under AZEPINES 1975-90", "MR": "19920519", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010077"}, {"RECTYPE": "D", "MH": "Oxazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.533", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Six-membered heterocycles containing an oxygen and a nitrogen.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010078"}, {"RECTYPE": "D", "MH": "Oxazocines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.113.767", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Azocines (1966-1974)", "MS": "One ring heterocyclic compounds defined by C6H7NO. Permitted are any degree of hydrogenation, any substituents and any ortho-fused or ortho-peri-fused ring systems.", "PM": "75", "HN": "75", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D010079"}, {"RECTYPE": "D", "MH": "Oxazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxazole|T109|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "1,3 Oxazolium 5 Oxides", "MN": "D03.383.129.462", "MH_TH": "NLM (1966)", "ST": "T109", "N1": "1,3-Oxazole", "RN": "0", "AN": "includes oxazolines, oxazolidines", "MS": "Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions.", "PM": "TRIMETHADIONE was see under ANTICONVULSANTS 1963-74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010080"}, {"RECTYPE": "D", "MH": "Oxazolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "4 Ethoxymethylene 2 phenyloxazolone", "MN": "D03.383.129.462.620", "PA": "Adjuvants, Immunologic", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "5(4H)-Oxazolone, 4-(ethoxymethylene)-2-phenyl-", "RN": "15646-46-5", "PI": "Oxazoles (1974)", "MS": "Immunologic adjuvant and sensitizing agent.", "PM": "91; was see under OXAZOLES 1975-90", "HN": "91(75); was see under OXAZOLES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010081"}, {"RECTYPE": "D", "MH": "Oxepins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxepin|T109|NON|EQV|NLM (2003)|011227|abcdef", "MN": "D03.383.564", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Compounds based on a 7-membered heterocyclic ring including an oxygen. They can be considered a medium ring ether. A natural source is the MONTANOA plant genus. Some dibenzo-dioxepins, called depsidones, are found in GARCINIA plants.", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010082"}, {"RECTYPE": "D", "MH": "Oxidants, Photochemical", "DE": "OXIDANTS PHOTOCHEM", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Photochemical Oxidants", "MN": "D27.888.569.540.631", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "PI": "Photochemistry (1971-1974)", "MS": "Compounds that accept electrons in an oxidation-reduction reaction. The reaction is induced by or accelerated by exposure to electromagnetic radiation in the spectrum of visible or ultraviolet light.", "PM": "75", "HN": "75", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D010083"}, {"RECTYPE": "D", "MH": "Oxidation-Reduction", "AQ": "DE RE", "PRINT ENTRY": "Redox|T070|ABB|EQV|UNK (19XX)|771012|abcdef", "ENTRY": "Oxidation Reduction", "MN": "G03.295.531", "FX": "Reducing Agents", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "IM for general only; NIM with no qualif with specific drug IM", "MS": "A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471).", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010084"}, {"RECTYPE": "D", "MH": "Oxidative Phosphorylation", "DE": "OX PHOS", "AQ": "DE RE", "ENTRY": "Phosphorylations, Oxidative", "MN": "G03.796.550", "FX": "Uncoupling Agents", "MH_TH": "NLM (1966)", "ST": "T044", "MS": "Electron transfer through the cytochrome system liberating free energy which is transformed into high-energy phosphate bonds.", "PM": "66; was see under ENERGY METABOLISM 1963-65", "HN": "66; was see under ENERGY METABOLISM 1963-65", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010085"}, {"RECTYPE": "D", "MH": "Oxidative Phosphorylation Coupling Factors", "DE": "OX PHOS COUPLING FACTORS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.691", "MH_TH": "NLM (1972)", "ST": "T123", "RN": "0", "PI": "Oxidative Phosphorylation (1966-1971)", "PM": "74", "HN": "74(72)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010086"}, {"RECTYPE": "D", "MH": "Oxides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxide|T197|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D01.650.550", "FX": "Cyclic S-Oxides", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "MS": "Binary compounds of oxygen containing the anion O(2-). The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides.", "PM": "66", "HN": "66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010087"}, {"RECTYPE": "D", "MH": "Oxidoreductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Reductases|T116|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Reductase|T116|T126|NON|EQV|UNK (19XX)|870505|abbcdef", "MN": "D08.811.682", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 1.-", "AN": "entry terms OXIDASES; REDUCTASES, and DEHYDROGENASES are GEN only: see Tree D8 under OXIDOREDUCTASES for all indentions and choose the most specific", "MS": "The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9)", "PM": "DEHYDROGENASES & OXIDASES were headings 1963", "HN": "DEHYDROGENASES & OXIDASES were headings 1963", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D010088"}, {"RECTYPE": "D", "MH": "Oxidoreductases, N-Demethylating", "DS": "OXIDOREDUCTASES DEMETHYLATING N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "N-Demethylases|T116|T126|NON|EQV|UNK (19XX)|741211|DEMETHYLASES N|abbcdefs", "ENTRY": "N-Demethylating Oxidoreductases", "MN": "D08.811.682.662.582", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 1.5.-", "PI": "Oxidoreductases (1966-1972)", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010089"}, {"RECTYPE": "D", "MH": "Oxidoreductases, O-Demethylating", "DS": "OXIDOREDUCTASES DEMETHYLATING O", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "O-Demethylases|T116|T126|NON|EQV|UNK (19XX)|741111|DEMETHYLASES O|abbcdefs", "ENTRY": "O-Demethylating Oxidoreductases", "MN": "D08.811.682.670", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.-", "PI": "Oxidoreductases (1968-1974)", "MS": "Drug metabolizing enzymes which oxidize methyl ethers. Usually found in liver microsomes.", "PM": "91; was see under OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under OXIDOREDUCTASES 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010090"}, {"RECTYPE": "D", "MH": "Oximes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxime|T109|NON|EQV|NLM (2021)|191219|abcdef", "ENTRY": "Compounds, Hydroxyimino", "MN": "D02.092.570.665", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds that contain the radical R2C=N.OH derived from condensation of ALDEHYDES or KETONES with HYDROXYLAMINE. Members of this group are CHOLINESTERASE REACTIVATORS.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010091"}, {"RECTYPE": "D", "MH": "Oximetry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Pulse Oximetry|T060|NON|NRW|UNK (19XX)|870508|abcdef", "ENTRY": "Pulse Oximetries", "MN": "E05.200.124.100.100.600", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "The determination of oxygen-hemoglobin saturation of blood either by withdrawing a sample and passing it through a classical photoelectric oximeter or by electrodes attached to some translucent part of the body like finger, earlobe, or skin fold. It includes non-invasive oxygen monitoring by pulse oximetry.", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010092"}, {"RECTYPE": "D", "MH": "Oxolinic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxolinate, Sodium", "MN": "D03.633.100.810.835.830.580", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USAN (1968)", "ST": "T121", "N1": "1,3-Dioxolo(4,5-g)quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-", "RN": "L0A22B22FT", "RR": "8O78VP5TTM", "PI": "Quinolines (1966-1971)", "MS": "Synthetic antimicrobial related to NALIDIXIC ACID and used in URINARY TRACT INFECTIONS.", "PM": "73", "HN": "73(72)", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010093"}, {"RECTYPE": "D", "MH": "Oxonic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oteracil|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|NLM (2003)|USAN (2001)|020315|abbcdeeeef", "MN": "D03.383.931.640", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "1,3,5-Triazine-2-carboxylic acid, 1,4,5,6-tetrahydro-4,6-dioxo-", "RN": "5VT6420TIG", "RR": "937-13-3 (Oxonic Acid)", "PI": "Triazines (1971-1974)", "MS": "Antagonist of urate oxidase.", "PM": "91; was see under TRIAZINES 1975-90", "HN": "91(75); was see under TRIAZINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010094"}, {"RECTYPE": "D", "MH": "Oxotremorine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxytremorine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|811218|abbcdeef", "MN": "D03.383.773.812.498", "PA": "Muscarinic Agonists", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "2-Pyrrolidinone, 1-(4-(1-pyrrolidinyl)-2-butynyl)-", "RN": "5RY0UWH1JL", "RR": "70-22-4 (Oxotremorine)", "AN": "a muscarinic agonist used in exper", "PI": "Tremorine (1966-1971)", "MS": "A non-hydrolyzed muscarinic agonist used as a research tool.", "PM": "73", "HN": "73(72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010095"}, {"RECTYPE": "D", "MH": "Oxprenolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trasicor, Slow", "MN": "D02.092.063.624.698.633", "PA": "Vasodilator Agents", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "2-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-", "RN": "519MXN9YZR", "RR": "F4XSI7SNIU", "PI": "Sympatholytics (1966-1971)", "MS": "A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.", "PM": "73", "HN": "73(72)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010096"}, {"RECTYPE": "D", "MH": "Oxyclozanide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Zanil|T109|T121|TRD|NRW|UNK (19XX)|820519|abbcdef", "MN": "D02.092.146.113.860.500", "PA": "Antiplatyhelmintic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzamide, 2,3,5-trichloro-N-(3,5-dichloro-2-hydroxyphenyl)-6-hydroxy-", "RN": "1QS9G4876X", "RR": "2277-92-1 (Oxyclozanide)", "PI": "Salicylamides (1971-1974)", "MS": "Anthelmintic used in grazing animals for fasciola and cestode infestations.", "PM": "91; was see under SALICYLAMIDES 1975-90", "HN": "91(75); was see under SALICYLAMIDES 1975-90", "MR": "20151124", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010097"}, {"RECTYPE": "D", "MH": "Oxycodone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxycodeinon|T109|T121|NON|EQV|UNK (19XX)|750701|abbcdef", "ENTRY": "Theocodin|T109|T121|TRD|NRW|NLM (1991)|900117|abbcdef", "MN": "D04.615.723.795.576.149.575", "PA": "Narcotics", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5alpha)-", "RN": "CD35PMG570", "RR": "C1ENJ2TE6C", "PI": "Morphinans (1969-1975)", "MS": "A semisynthetic derivative of CODEINE.", "PM": "91; was see under CODEINE 1976-90", "HN": "91(76); was see under CODEINE 1976-90", "MR": "20170117", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D010098"}, {"RECTYPE": "D", "MH": "Oxyfedrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxyphedrin|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Oxiphedrin|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D02.522.818.800", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Propanone, 3-((2-hydroxy-1-methyl-2-phenylethyl)amino)-1-(3-methoxyphenyl)-, (R-(R*,S*))-", "RN": "DWL616XF1K", "RR": "15687-41-9 (Oxyfedrine)", "PI": "Propiophenones (1971-1974)", "MS": "A drug used in the treatment of angina pectoris, heart failure, conduction defects, and myocardial infarction. It is a partial agonist at beta adrenergic receptors and acts as a coronary vasodilator and cardiotonic agent.", "PM": "91; was see under PROPIOPHENONES 1975-90", "HN": "91(75); was see under PROPIOPHENONES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010099"}, {"RECTYPE": "D", "MH": "Oxygen", "AQ": "AD AE AG AN BL CF CH CL EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dioxygen|T196|NON|REL|NLM (2002)|abcde", "ENTRY": "Oxygen 16", "MN": "D01.362.670", "FX": "Oxygen Radioisotopes", "EC": "deficiency:Hypoxia", "MH_TH": "USP (19XX)", "ST": "T196", "N1": "Oxygen", "RN": "S88TT14065", "RR": "7782-44-7 (Oxygen)", "MS": "An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration.", "PM": "1963; DIOXYGEN was indexed under OXYGEN (NM) 1980-2001", "HN": "1963; for DIOXYGEN use OXYGEN (NM) 1980-2001", "MR": "20170704", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D010100"}, {"RECTYPE": "D", "MH": "Oxygen Consumption", "AQ": "DE ES GE IM PH RE", "ENTRY": "Oxygen Consumptions", "MN": "G03.680", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "TN 145: oxygen metab", "MS": "The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346)", "PM": "66; was see under ENERGY METABOLISM & TISSUE METABOLISM 1963-65", "HN": "66; was see under ENERGY METABOLISM & TISSUE METABOLISM 1963-65", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010101"}, {"RECTYPE": "D", "MH": "Oxygen Inhalation Therapy", "DE": "OXYGEN INHALATION THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapies, Oxygen Inhalation", "MN": "E02.880.690", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "coordinate with disease /ther, not disease /drug ther", "MS": "Inhalation of oxygen aimed at restoring toward normal any pathophysiologic alterations of gas exchange in the cardiopulmonary system, as by the use of a respirator, nasal catheter, tent, chamber, or mask. (From Dorland, 27th ed & Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "19950313", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010102"}, {"RECTYPE": "D", "MH": "Oxygen Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxygen Isotope|T196|NON|EQV|NLM (2022)|201021|abcdef", "ENTRY": "Isotopes, Oxygen", "MN": "D01.496.625", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable oxygen atoms that have the same atomic number as the element oxygen, but differ in atomic weight. O-17 and 18 are stable oxygen isotopes.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010103"}, {"RECTYPE": "D", "MH": "Oxygen Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Oxygen", "MN": "D01.496.749.635", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1974)", "MS": "Unstable isotopes of oxygen that decay or disintegrate emitting radiation. O atoms with atomic weights 13, 14, 15, 19, and 20 are radioactive oxygen isotopes.", "OL": "search OXYGEN ISOTOPES 1966-74", "PM": "75", "HN": "75", "MR": "20170425", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D010104"}, {"RECTYPE": "D", "MH": "Oxygenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Oxygenase|T116|T126|NON|EQV|NLM (2021)|191115|abbcdef", "MN": "D08.811.682.690", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 1.13.-", "MS": "Oxidases that specifically introduce DIOXYGEN-derived oxygen atoms into a variety of organic molecules.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010105"}, {"RECTYPE": "D", "MH": "Oxygenators", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Oxygenator", "MN": "E07.652", "FX": "Heart-Lung Machine", "MH_TH": "NLM (1972)", "ST": "T074", "PI": "Heart-Lung Machine (1966-1971)", "MS": "Devices which mechanically oxygenate venous blood extracorporeally. They are used in combination with one or more pumps for maintaining circulation during open heart surgery and for assisting the circulation in patients seriously ill with some cardiac and pulmonary disorders. (UMDNS, 1999)", "PM": "74", "HN": "74(72)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010106"}, {"RECTYPE": "D", "MH": "Oxygenators, Membrane", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Oxygenator, Membrane", "MN": "E07.652.582", "MH_TH": "NLM (1972)", "ST": "T074", "PI": "Membranes, Artificial (1966-1971)", "MS": "Devices in which blood and oxygen are separated by a semipermeable membrane, generally of Teflon or polypropylene, across which gas exchange occurs. The membrane may be arranged as a series of parallel plates or as a number of hollow fibers; in the latter arrangement, the blood may flow inside the fibers, which are surrounded by gas, or the blood may flow outside the fibers and the gas inside the fibers. (Dorland, 28th ed)", "PM": "74", "HN": "74(72)", "CATSH": "CAT LIST", "MR": "19991216", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010107"}, {"RECTYPE": "D", "MH": "Oxyhemoglobins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hemoglobin, Oxycobalt", "MN": "D12.776.422.316.762.687", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "Bohr effect is indexed OXYHEMOGLOBINS /metab (IM) + PH (NIM)", "PI": "Hemoglobins (1966-1972)", "MS": "A compound formed by the combination of hemoglobin and oxygen. It is a complex in which the oxygen is bound directly to the iron without causing a change from the ferrous to the ferric state.", "OL": "use OXYHEMOGLOBINS to search OXYHEMOGLOBIN 1973-78 (as Prov 1973-74)", "PM": "79; was OXYHEMOGLOBIN 1977-78, was OXYHEMOGLOBIN see under HEMOGLOBINS 1975-76", "HN": "79; was OXYHEMOGLOBIN 1977-78, was OXYHEMOGLOBIN see under HEMOGLOBINS 1975-76, was OXYHEMOGLOBIN 1973-74 (Prov)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D010108"}, {"RECTYPE": "D", "MH": "Oxymetazoline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Oxymetazoline", "MN": "D03.383.129.308.704", "PA": "Sympathomimetics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Phenol, 3-((4,5-dihydro-1H-imidazol-2-yl)methyl)-6-(1,1-dimethylethyl)-2,4-dimethyl-", "RN": "8VLN5B44ZY", "RR": "K89MJ0S5VY", "MS": "A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)", "PM": "91; was see under IMIDAZOLES 1966-90", "HN": "91(66); was see under IMIDAZOLES 1966-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010109"}, {"RECTYPE": "D", "MH": "Oxymetholone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxymetholone|T109|T121|T125|NON|EQV|UNK (19XX)|761230|abbbcdef", "ENTRY": "Oxymetholone, (5 alpha,17 alpha)-Isomer|T109|T121|T125|NRW|NLM (1999)|990913|abbbdef", "MN": "D04.210.500.054.040.632", "PA": "Androgens", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Androstan-3-one, 17-hydroxy-2-(hydroxymethylene)-17-methyl-, (5alpha,17beta)-", "RN": "L76T0ZCA8K", "RR": "434-07-1 (Oxymetholone)", "MS": "A synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. According to the Fourth Annual Report on Carcinogens (NTP 85-002), this compound may reasonably be anticipated to be a carcinogen. (From Merck Index, 11th ed)", "PM": "65", "HN": "65", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010110"}, {"RECTYPE": "D", "MH": "Oxymorphone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxymorphone Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USP (19XX)|941123|abbcdeef", "MN": "D04.615.723.795.576.692", "PA": "Narcotics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-methyl-, (5alpha)-", "RN": "9VXA968E0C", "RR": "76-41-5 (Oxymorphone)", "MS": "An opioid analgesic with actions and uses similar to those of MORPHINE, apart from an absence of cough suppressant activity. It is used in the treatment of moderate to severe pain, including pain in obstetrics. It may also be used as an adjunct to anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1092)", "PM": "1991; OXYMORPHONE HYDROCHLORIDE was indexed under OXYMORPHONE 2013 and under MORPHINE DERIVATIVES 2006-2012", "HN": "1991(1964)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010111"}, {"RECTYPE": "D", "MH": "Oxyphenbutazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxyphenylbutazone|T109|T121|NON|EQV|UNK (19XX)|770429|abbcdef", "ENTRY": "Tanderil|T109|T121|TRD|NRW|UK|041014|abbcdef", "MN": "D03.383.129.539.850.777.700", "PA": "Anti-Inflammatory Agents, Non-Steroidal", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-", "RN": "H806S4B3NS", "RR": "129-20-4 (Oxyphenbutazone)", "AN": "a non-steroidal anti-inflamm agent", "MS": "A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)", "PM": "64", "HN": "64(63)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D010113"}, {"RECTYPE": "D", "MH": "Oxyphenisatin Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenolisatin|T109|T121|NON|BRD|UNK (19XX)|741111|abbcdef", "ENTRY": "Acetate, Oxyphenisatin", "MN": "D03.633.100.473.725", "PA": "Cathartics", "MH_TH": "USAN (1962)", "ST": "T121", "N1": "2H-Indol-2-one, 3,3-bis(4-(acetyloxy)phenyl)-1,3-dihydro-", "RN": "U0Y1YAL65X", "RR": "3BT0VQG2GQ", "PI": "Phenols (1972-1974)", "MS": "A laxative that undergoes enterohepatic circulation. It may cause jaundice.", "OL": "use OXYPHENISATIN ACETATE to search OXYPHENISATIN 1975-82", "PM": "91; was see under INDOLES 1983-90; was OXYPHENISATIN see under INDOLES 1975-82", "HN": "91(83); was see under INDOLES 1983-90; was OXYPHENISATIN see under INDOLES 1975-82", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010114"}, {"RECTYPE": "D", "MH": "Oxyphenonium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxyphenonium Iodide|T109|T121|NON|NRW|NLM (1992)|901011|abbcdef", "ENTRY": "Iodide, Oxyphenonium", "MN": "D02.675.276.648", "PA": "Parasympatholytics", "MH_TH": "NLM (1964)", "ST": "T121", "N1": "Ethanaminium, 2-((cyclohexylhydroxyphenylacetyl)oxy)-N,N-diethyl-N-methyl-", "RN": "D2G5508Y7I", "RR": "S9421HWB3Z", "PI": "Oxyphenonium Bromide (1966-1991)", "MS": "A quaternary ammonium anticholinergic agent with peripheral side effects similar to those of ATROPINE. It is used as an adjunct in the treatment of gastric and duodenal ulcer, and to relieve visceral spasms. The drug has also been used in the form of eye drops for mydriatic effect.", "OL": "use OXYPHENONIUM to search OXYPHENONIUM BROMIDE 1966-91", "PM": "92; was OXYPHENONIUM BROMIDE 1964-91 (see under AMMONIUM COMPOUNDS 1964-90)", "HN": "92(64); was OXYPHENONIUM BROMIDE 1964-91 (see under AMMONIUM COMPOUNDS 1964-90)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010115"}, {"RECTYPE": "D", "MH": "Oxypurinol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxipurinol|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|741111|abbcdeef", "MN": "D03.383.742.550", "PA": "Enzyme Inhibitors", "MH_TH": "USAN (1967)", "ST": "T121", "N1": "1H-Pyrazolo(3,4-d)pyrimidine-4,6(5H,7H)-dione", "RN": "G97OZE5068", "RR": "2465-59-0 (Oxypurinol)", "AN": "a xanthine oxidase inhib", "PI": "Pyrimidines (1973-1974)", "MS": "A xanthine oxidase inhibitor.", "PM": "91; was see under PYRIMIDINES 1975-90", "HN": "91(75); was see under PYRIMIDINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010117"}, {"RECTYPE": "D", "MH": "Oxytetracycline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxytetracycline|T109|T195|NON|EQV|UNK (19XX)|770429|abbcdef", "ENTRY": "Terramycin|T109|T195|TRD|NRW|UNK (19XX)|801120|abbcdef", "MN": "D04.615.562.900.600", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-", "RN": "X20I9EN955", "RR": "SLF0D9077S", "MS": "A TETRACYCLINE analog isolated from the actinomycete STREPTOMYCES RIMOSUS and used in a wide variety of clinical conditions.", "OL": "use OXYTETRACYCLINE to search OXYTETRACID 1978-91", "PM": "OXYTETRACID was see OXYTETRACYCLINE 1978-91", "HN": "OXYTETRACID was see OXYTETRACYCLINE 1978-91", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010118"}, {"RECTYPE": "D", "MH": "Oxythiamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxythiamine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D03.383.129.708.540", "PA": "Antimetabolites", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Thiazolium, 3-((1,4-dihydro-2-methyl-4-oxo-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-", "RN": "136-16-3", "AN": "a thiamine antag", "PI": "Thiazoles (1970-1974)", "MS": "Thiamine antagonist, antimetabolite.", "PM": "91; was see under THIAZOLES 1975-90", "HN": "91(75); was see under THIAZOLES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010119"}, {"RECTYPE": "D", "MH": "Oxytocics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uterine Stimulants|T121|NON|EQV|NLM (1996)|950322|abcdef", "ENTRY": "Stimulants, Uterine", "MN": "D27.505.954.705.737", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "use no qualifiers for oxytocics when used to induce labor; note entry term OXYTOCIC EFFECT: use only for the oxytocic effect of a chemical substance", "MS": "Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010120"}, {"RECTYPE": "D", "MH": "Oxytocin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ocytocin|T116|T121|T125|NON|EQV|UNK (19XX)|761230|abbbcdef", "ENTRY": "Syntocinon|T116|T121|T125|TRD|NRW|UNK (19XX)|800821|abbbcdef", "MN": "D12.644.548.691.692.433", "PA": "Oxytocics", "FX": "Receptors, Oxytocin", "MH_TH": "NLM (1963)", "ST": "T125", "N1": "Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, cyclic 1-6 disulfide", "RN": "50-56-6", "MS": "A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION.", "OL": "use OXYTOCIN to search ALPHA-HYPOPHAMINE 1977-93 & ISOLEUCYL, LEUCYL VASOPRESSIN; VASOPRESSIN, ISOLEUCYL-LEUCYL; VASOTOCIN, LEUCYL, & 3-ISOLEUCINE,8-LEUCINE VASOPRESSIN 1983-93", "PM": "ALPHA-HYPOPHAMINE was see OXYTOCIN 1977-93; ISOLEUCYL, LEUCYL VASOPRESSIN; VASOPRESSIN, ISOLEUCYL-LEUCYL; VASOTOCIN, LEUCYL, & 3-ISOLEUCINE,8-LEUCINE VASOPRESSIN were see OXYTOCIN 1983-93", "HN": "ALPHA-HYPOPHAMINE was see OXYTOCIN 1977-93; ISOLEUCYL, LEUCYL VASOPRESSIN; VASOPRESSIN, ISOLEUCYL-LEUCYL; VASOTOCIN, LEUCYL, & 3-ISOLEUCINE,8-LEUCINE VASOPRESSIN were see OXYTOCIN 1983-93", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010121"}, {"RECTYPE": "D", "MH": "Cystinyl Aminopeptidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Oxytocinase|T116|T126|NON|EQV|NLM (1973)|990101|abbcdef", "ENTRY": "Vasopressinase|T116|T126|NON|EQV|UNK (19XX)|800818|abbcdef", "MN": "D08.811.277.656.675.555.400", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.4.11.3", "MS": "A zinc-containing sialoglycoprotein that is used to study aminopeptidase activity in the pathogenesis of hypertension. EC 3.4.11.3.", "PM": "2000; see OXYTOCINASE 1991-1999; see AMINOPEPTIDASES 1973-1990", "HN": "2000(1973)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010122"}, {"RECTYPE": "D", "MH": "Oxyuriasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Aspiculariasis|T047|NON|NRW|NLM (1993)|911118|abcdef", "ENTRY": "Oxyuriases", "MN": "C01.610.335.508.700.550.550", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "nematode infect caused by genera of the superfamily OXYUROIDEA; infect by Oxyuris species goes here but note entry term OXYURIS VERMICULARIS INFECTION see ENTEROBIASIS", "MS": "Infection with nematodes of the superfamily OXYUROIDEA.", "OL": "use NEMATODE INFECTIONS to search ASPICULARIASIS 1968-92", "PM": "ASPICULARIASIS was see NEMATODE INFECTIONS 1986-92; was heading 1968-85", "HN": "ASPICULARIASIS was see NEMATODE INFECTIONS 1986-92; was heading 1968-85", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010123"}, {"RECTYPE": "D", "MH": "Oxyuroidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Syphacia|T204|NON|NRW|UNK (19XX)|850319|abcdef", "ENTRY": "Syphacias", "MN": "B01.050.500.500.294.400.750.500", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid51025", "RR": "txid412122", "AN": "a superfamily of nematodes; infection: coord IM with OXYURIASIS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "MS": "A superfamily of parasitic nematodes consisting of several genera. ENTEROBIUS, which occurs in humans, and Oxyuris, which occurs in horses, are two of the most common. Other genera are: Skrjabinema, Passalurus, Dermatoxys, and Probstmayria.", "OL": "use OXYUROIDEA to search SYPHACIA 1966-85", "PM": "SYPHACIA was see under OXYUROIDEA 1963-85", "HN": "SYPHACIA was see under OXYUROIDEA 1963-85", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010124"}, {"RECTYPE": "D", "MH": "Ostreidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Oysters|T204|NON|EQV|NLM (1972)|990101|abcdef", "ENTRY": "Oyster", "MN": "B01.050.500.644.080.643", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6563", "AN": "as animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM); note entry term OYSTERS: oysters unspecified go here; OYSTERS, TRUE is also available", "PI": "Mollusca (1966-1971)", "MS": "A family of marine mollusks in the class BIVALVIA, commonly known as oysters. They have a rough irregular shell closed by a single adductor muscle.", "PM": "2006; see OYSTERS 1972-2006", "HN": "2006", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010125"}, {"RECTYPE": "D", "MH": "Ozone", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ozone, Tropospheric", "MN": "D01.362.670.600", "PA": "Oxidants, Photochemical", "MH_TH": "NLM (1966)", "ST": "T103", "N1": "Ozone", "RN": "66H7ZZK23N", "RR": "10028-15-6 (Ozone)", "AN": "OZONE DEPLETION is also available", "MS": "The unstable triatomic form of oxygen, O3. It is a powerful oxidant that is produced for various chemical and industrial uses. Its production is also catalyzed in the ATMOSPHERE by ULTRAVIOLET RAY irradiation of oxygen or other ozone precursors such as VOLATILE ORGANIC COMPOUNDS and NITROGEN OXIDES. About 90% of the ozone in the atmosphere exists in the stratosphere (STRATOSPHERIC OZONE).", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010126"}, {"RECTYPE": "D", "MH": "P Blood-Group System", "AQ": "AD AE AN BI BL CF CH CL EC GE HI IM IP ME PD PH PO TO TU UL UR", "ENTRY": "Systems, P Blood-Group", "MN": "D23.050.705.230.691", "MH_TH": "NLM (1976)", "ST": "T022", "RN": "0", "AN": "IM; coord with disease /blood (IM), not /immunol nor /genet; TN 230", "PI": "Blood Groups (1966-1975)", "MS": "A blood group related to the ABO, Lewis and I systems. At least five different erythrocyte antigens are possible, some very rare, others almost universal. Multiple alleles are involved in this blood group.", "PM": "91; was see under BLOOD GROUPS 1976-90", "HN": "91(76); was see under BLOOD GROUPS 1976-90", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D010127"}, {"RECTYPE": "D", "MH": "p-Aminoazobenzene", "DS": "AMINOAZOBENZENE P", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "para-Aminoazobenzene|T109|T130|NON|EQV|FDA SRS (2014)|NLM (2014)|760517|abbcdeef", "ENTRY": "para Aminoazobenzene", "MN": "D02.172.032", "PA": "Coloring Agents", "MH_TH": "NLM (1976)", "ST": "T130", "N1": "Benzenamine, 4-(phenylazo)-", "RN": "57X2AH42T1", "RR": "60-09-3 (p-Aminoazobenzene)", "PI": "Azo Compounds (1969-1975)", "MS": "Used in the form of its salts as a dye and as an intermediate in manufacture of Acid Yellow, diazo dyes, and indulines.", "PM": "1991; ANILINE YELLOW was indexed under ANILINE COMPOUNDS and AZO COMPOUNDS 2008-2013", "HN": "1991(1976)", "MR": "20130708", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D010128"}, {"RECTYPE": "D", "MH": "4-Aminobenzoic Acid", "DS": "AMINOBENZOIC ACID A 04", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "para-Aminobenzoic Acid|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|760518|abbcdeef", "ENTRY": "para-Aminobenzoate, Magnesium", "MN": "D02.455.426.559.389.127.020.937.640", "EC": "analogs & derivatives:para-Aminobenzoates", "MH_TH": "NLM (1977)", "ST": "T123", "N1": "Benzoic acid, 4-amino-", "RN": "TL2TJE8QTX", "RR": "41KZS5432U", "PI": "Aminobenzoic Acids (1966-1976)", "MS": "An aminobenzoic acid isomer that combines with pteridine and GLUTAMIC ACID to form FOLIC ACID. The fact that 4-aminobenzoic acid absorbs light throughout the UVB range has also resulted in its use as an ingredient in SUNSCREENS.", "PM": "1990; see AMINOBENZOIC ACIDS 1977-1989, see AMINOBENZOIC ACID 1965-1976; see PARA-AMINOBENZOIC ACID 1963-1964; for EPIT VIT and PABASAN see AMINOBENZOIC ACIDS 2005-2012, for EPITELPLAST see AMINOBENZOIC ACIDS 2003-2012, for HACHEMINA 2 see AMINOBENZOIC ACIDS 2005-2012, for PARAMINOL see AMINOBENZOIC ACIDS 1999-2012, for POTABA see AMINOBENZOIC ACIDS 1991-2012", "HN": "1990(1977); for EPIT VIT and PABASAN use AMINOBENZOATES 2005-2012, for EPITELPLAST use AMINOBENZOATES 2003-2012; for HACHEMINA 2 use AMINOBENZOATES 2005-2012, for PARAMINOL use AMINOBENZOATES 1999-2012, for POTABA use AMINONBENZOATES 1991-2012", "MR": "20160701", "DA": "19760519", "DC": "1", "DX": "19900101", "UI": "D010129"}, {"RECTYPE": "D", "MH": "p-Aminohippuric Acid", "DS": "AMINOHIPPURIC ACID P", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "para-Aminohippuric Acid|T109|T130|NON|EQV|UNK (19XX)|760518|abbcdef", "ENTRY": "para Aminohippuric Acid", "MN": "D02.455.426.559.389.127.085.067.100", "PA": "Indicators and Reagents", "EC": "analogs & derivatives:Aminohippuric Acids", "MH_TH": "NLM (1977)", "ST": "T130", "N1": "Glycine, N-(4-aminobenzoyl)-", "RN": "Y79XT83BJ9", "RR": "SUO3KVS1O9", "PI": "Aminohippuric Acids (1966-1976)", "MS": "The glycine amide of 4-aminobenzoic acid. Its sodium salt is used as a diagnostic aid to measure effective renal plasma flow (ERPF) and excretory capacity.", "OL": "use P-AMINOHIPPURIC ACID to search PARA-AMINOHIPPURIC ACID 1975-76; use AMINOHIPPURIC ACIDS 1966-74", "PM": "91; was see under AMINOHIPPURIC ACIDS 1977-90; was PARA-AMINOHIPPURIC ACID see under AMINOHIPPURIC ACID 1965-76; was PARA-AMINOHIPPURIC ACID 1963-64", "HN": "91(77); was see under AMINOHIPPURIC ACIDS 1977-90; was PARA-AMINOHIPPURIC ACID see under AMINOHIPPURIC ACID 1965-76; was PARA-AMINOHIPPURIC ACID 1963-64", "MR": "20160610", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D010130"}, {"RECTYPE": "D", "MH": "Aminosalicylic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "para-Aminosalicylic Acid|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|760518|abbcdeef", "ENTRY": "para Aminosalicylic Acid", "MN": "D02.455.426.559.389.657.410.595.100.060", "PA": "Antitubercular Agents", "EC": "analogs & derivatives:Aminosalicylic Acids", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzoic acid, 4-amino-2-hydroxy-", "RN": "5B2658E0N2", "RR": "S38B9W6AXW", "AN": "AMINOSALICYLIC ACIDS is also available", "PI": "Aminosalicylic Acids (1966-1976)", "MS": "An antitubercular agent often administered in association with ISONIAZID. The sodium salt of the drug is better tolerated than the free acid.", "PM": "2010,1963-1976. see p-Aminocalicylic acid. 1977-2009, see AMINOSALICYLIC ACIDS 1977-90; for PAS see AMINOSALICYCLIC ACID 1963-1967", "HN": "2010, 1963-1976", "MR": "20130708", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D010131"}, {"RECTYPE": "D", "MH": "p-Azobenzenearsonate", "DS": "AZOBENZENEARSONATE P", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "para-Azobenzenearsonate|T109|T121|EQV|UNK (19XX)|760517|abbdef", "ENTRY": "para Azobenzenearsonate", "MN": "D23.050.550.480.097", "MH_TH": "NLM (1976)", "ST": "T121", "N1": "Arsonic acid, (azodi-4,1-phenylene)bis-", "RN": "7334-23-8", "PI": "Azo Compounds (1972-1975)", "MS": "A hapten capable of eliciting both antibody formation and delayed hypersensitivity when bound to aromatic amino acids, polypeptides or proteins. It is used as an immunologic research tool.", "PM": "91; was see under AZO COMPOUNDS 1976-90", "HN": "91(76); was see under AZO COMPOUNDS 1976-90", "MR": "20190701", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D010132"}, {"RECTYPE": "D", "MH": "p-Chloroamphetamine", "DS": "CHLOROAMPHETAMINE P", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "para-Chloroamphetamine|T109|T121|NON|EQV|UNK (19XX)|760515|abbcdef", "ENTRY": "para Chloroamphetamine", "MN": "D02.092.471.683.152.200", "PA": "Serotonin Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Benzeneethanamine, 4-chloro-alpha-methyl-", "RN": "64-12-0", "PI": "Chlorine (1966-1974)", "MS": "Chlorinated analog of AMPHETAMINE. Potent neurotoxin that causes release and eventually depletion of serotonin in the CNS. It is used as a research tool.", "PM": "91; was see under AMPHETAMINES 1975-90", "HN": "91(75); was see under AMPHETAMINES 1975-90", "MR": "20000622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010133"}, {"RECTYPE": "D", "MH": "Fenclonine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "para-Chlorophenylalanine|T116|T121|NON|EQV|UNK (19XX)|760515|abbcdef", "ENTRY": "para Chlorophenylalanine", "MN": "D12.125.072.050.685.440", "PA": "Serotonin Antagonists", "MH_TH": "USAN (1967)", "ST": "T121", "N1": "DL-Phenylalanine, 4-chloro-", "RN": "R5J7E3L9SP", "RR": "7424-00-2 (Fenclonine)", "PI": "Phenylalanine (1966-1970)", "MS": "A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.", "PM": "93; see P-CHLOROPHENYLALANINE 1973-92; for FENCLONINE see P-CHLOROPHENYLALANINE 1978-92", "HN": "93(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010134"}, {"RECTYPE": "D", "MH": "p-Fluorophenylalanine", "DS": "FLUOROPHENYLALANINE P", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "para-Fluorophenylalanine|T116|T121|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "para Fluorophenylalanine", "MN": "D12.125.072.050.685.450", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Phenylalanine, 4-fluoro-", "RN": "60-17-3", "PI": "Phenylalanine (1972-1974)", "MS": "3-(p-Fluorophenyl)-alanine.", "PM": "91; was see under PHENYLALANINE 1975-90", "HN": "91(75); was see under PHENYLALANINE 1975-90", "MR": "20010725", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010135"}, {"RECTYPE": "D", "MH": "p-Hydroxyamphetamine", "DS": "HYDROXYAMPHETAMINE P", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "para-Hydroxyamphetamine|T109|T121|NON|EQV|UNK (19XX)|760515|abbcdef", "ENTRY": "para Hydroxyamphetamine", "MN": "D02.092.471.683.152.500", "PA": "Sympathomimetics", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Phenol, 4-(2-aminopropyl)-", "RN": "FQR280JW2N", "RR": "59IG47SZ0E", "PI": "Phenols (1968-1974)", "MS": "Amphetamine metabolite with sympathomimetic effects. It is sometimes called alpha-methyltyramine, which may also refer to the meta isomer, gepefrine.", "PM": "91; was see under AMPHETAMINES 1975-90", "HN": "91(75); was see under AMPHETAMINES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010136"}, {"RECTYPE": "D", "MH": "p-Hydroxynorephedrine", "DS": "HYDROXYNOREPHEDRINE P", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "para-Hydroxynorephedrine|T109|T121|NON|EQV|UNK (19XX)|760515|abbcdef", "ENTRY": "para Hydroxynorephedrine", "MN": "D02.092.063.624.706.400", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Benzenemethanol, alpha-(1-aminoethyl)-4-hydroxy-", "RN": "552-85-2", "PI": "Phenylpropanolamine (1972-1974)", "MS": "Parahydroxy analog of phenylpropanolamine with properties as a sympathomimetic.", "PM": "91; was see under PHENYLPROPANOLAMINE 1975-90", "HN": "91(75); was see under PHENYLPROPANOLAMINE 1975-90", "MR": "20000622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010137"}, {"RECTYPE": "D", "MH": "Pacemaker, Artificial", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Cardiac Pacemaker, Artificial|T074|NON|EQV|UNK (19XX)|770422|abcdef", "ENTRY": "Pacemakers, Artificial Cardiac", "MN": "E07.305.250.750", "MH_TH": "NLM (1966)", "ST": "T074", "AN": "coordinate disease with / ther, not / surg for treatment with pacemaker", "MS": "A device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary (external) or permanent (internal or internal-external).", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010138"}, {"RECTYPE": "D", "MH": "Pacific Islands", "AQ": "EH EP", "PRINT ENTRY": "Pacific Island|T083|NON|EQV|NLM (2021)|200325|abcdef", "ENTRY": "Micronesia-Polynesia|T083|NAM|NRW|POPLINE (1983)|931123|abcdef", "MN": "Z01.678.100.873", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "includes MELANESIA; MICRONESIA & POLYNESIA: see notes under each & indentions in trees", "MS": "The islands of the Pacific Ocean divided into MICRONESIA; MELANESIA; and POLYNESIA (including NEW ZEALAND). The collective name Oceania includes the aforenamed islands, adding AUSTRALIA; NEW ZEALAND; and the Malay Archipelago (INDONESIA). (Webster's New Geographical Dictionary, 1988, p910, 880)", "OL": "use PACIFIC ISLANDS to search SOUTH PACIFIC ISLANDS 1967-77", "HN": "78; was SOUTH PACIFIC ISLANDS 1967-77", "MR": "20200527", "DA": "19990101", "DC": "4", "DX": "19780101", "UI": "D010139"}, {"RECTYPE": "D", "MH": "Pacific Ocean", "AQ": "EH EP", "MN": "Z01.756.700", "MH_TH": "NLM (1987)", "ST": "T083", "MS": "Body of water between Asia and South America, extending from the Arctic circle to the Equator and from the Equator to the Antarctic.", "HN": "87", "MR": "20161219", "DA": "19860402", "DC": "4", "DX": "19870101", "UI": "D010140"}, {"RECTYPE": "D", "MH": "Pacinian Corpuscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Pacinian Corpuscle|T023|NON|EQV|NLM (2022)|201005|abcdef", "ENTRY": "Corpuscles, Pacinian", "MN": "A11.671.650.915.750.700", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "mechanoreceptors", "MS": "Rapidly adapting mechanoreceptors found in subcutaneous tissue beneath both hairy and glabrous skin. Pacinian corpuscles contain an afferent nerve fiber surrounded by a capsule with multiple concentric layers. They have large receptive fields and are most sensitive to high-frequency stimuli, such as vibration.", "OL": "search MECHANORECEPTORS 1972-74 & NERVE ENDINGS 1966-71", "PM": "91; was see under MECHANORECEPTORS 1972-90; was see under NERVE ENDINGS 1963-71", "HN": "91(75); was see under MECHANORECEPTORS 1972-90; was see under NERVE ENDINGS 1963-71", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010141"}, {"RECTYPE": "D", "MH": "Pactamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.657.410.450", "PA": "Protein Synthesis Inhibitors", "MH_TH": "NLM (1975)", "ST": "T195", "N1": "Benzoic acid, 2-hydroxy-6-methyl-, (5-((3-acetylphenyl)amino)-4-amino-3-(((dimethylamino)carbonyl)amino)-1,2-dihydroxy-3-(1-hydroxyethyl)-2-methylcyclopentyl)methyl ester, (1S-(1alpha,2beta,3alpha,3(R*),4alpha,5beta))-", "RN": "23668-11-3", "PI": "Antibiotics, Antineoplastic (1972-1974)", "MS": "Antibiotic produced by Streptomyces pactum used as an antineoplastic agent. It is also used as a tool in biochemistry because it inhibits certain steps in protein synthesis.", "PM": "91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90", "HN": "91(75); was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90", "MR": "20120703", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010142"}, {"RECTYPE": "D", "MH": "Paecilomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Paecilomyce", "MN": "B01.300.381.640", "MH_TH": "NLM (1986)", "ST": "T004", "RN": "txid33202", "AN": "infection: coordinate IM with MYCOSES (IM) or specific mycosis (IM)", "PI": "Hyphomycetes (1966-1985)", "MS": "A mitosporic fungal genus occasionally causing human diseases such as pulmonary infections, mycotic keratitis, endocarditis, and opportunistic infections. Its teleomorph is BYSSOCHLAMYS.", "PM": "91; see HYPHOMYCETES 1986-90", "HN": "91(86)", "MR": "20200813", "DA": "19850212", "DC": "1", "DX": "19910101", "UI": "D010143"}, {"RECTYPE": "D", "MH": "Paget's Disease, Mammary", "DE": "PAGETS DIS MAMMARY", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Paget's Disease of Breast|T191|EPO|EQV|NLM (1994)|930330|PAGETS DIS BREAST|abcdefv", "ENTRY": "Pagets Disease, Mammary", "MN": "C04.557.470.615.275.625", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with BREAST NEOPLASMS (IM)", "MS": "An intraductal in situ carcinoma of the breast, characterized clinically by eczema-like inflammatory skin changes and histologically by infiltration of the dermis by malignant cells (Paget's cells).", "OL": "use PAGET'S DISEASE, MAMMARY to search PAGET'S DISEASE OF BREAST 1975-93; search CARCINOMA, INTRADUCTAL, NONINFILTRATING 1966-74", "PM": "94; was PAGET'S DISEASE OF BREAST 1975-93 (see under CARCINOMA, DUCTAL 1975-90)", "HN": "94; was PAGET'S DISEASE OF BREAST 1975-93 (see under CARCINOMA, DUCTAL 1975-90)", "CATSH": "CAT LIST", "MR": "20160613", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010144"}, {"RECTYPE": "D", "MH": "Paget Disease, Extramammary", "DE": "PAGET DIS EXTRAMAMMARY", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Paget's Disease, Extramammary|T191|EPO|EQV|NLM (1966)|990101|PAGETS DIS EXTRAMAMMARY|abcdefv", "ENTRY": "Pagets Disease, Extramammary", "MN": "C04.557.470.615.660", "MH_TH": "UNK (19XX)", "ST": "T191", "AN": "neoplastic; coordinate with precoordinated organ/neoplasm term", "MS": "A rare cutaneous neoplasm that occurs in the elderly. It develops more frequently in women and predominantly involves apocrine gland-bearing areas, especially the vulva, scrotum, and perianal areas. The lesions develop as erythematous scaly patches that progress to crusted, pruritic, erythematous plaques. The clinical differential diagnosis includes squamous cell carcinoma in situ and superficial fungal infection. It is generally thought to be an adenocarcinoma of the epidermis, from which it extends into the contiguous epithelium of hair follicles and eccrine sweat ducts. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1478)", "PM": "2010; see PAGET'S DISEASE, EXTRAMAMMARY 1994-2009, see PAGET'S DISEASE, EXTRA-MAMMARY 1963-1993", "HN": "2010(1963)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "20100101", "UI": "D010145"}, {"RECTYPE": "D", "MH": "Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU UR VE VI", "PRINT ENTRY": "Suffering, Physical|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Sufferings, Physical", "MN": "G11.561.790.444", "FX": "Palliative Care", "EC": "therapy:Pain Management", "MH_TH": "NLM (1963)", "ST": "T184", "MS": "An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010146"}, {"RECTYPE": "D", "MH": "Pain Measurement", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Visual Analogue Pain Scale|T060|T081|NON|NRW|UNK (19XX)|860325|abbcdef", "ENTRY": "Tourniquet Pain Tests", "MN": "E01.370.600.550.324", "FX": "Sensory Thresholds", "MH_TH": "NLM (1987)", "ST": "T060", "PI": "Pain (1966-1986)", "MS": "Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20210326", "DA": "19860325", "DC": "1", "DX": "19870101", "UI": "D010147"}, {"RECTYPE": "D", "MH": "Pain, Intractable", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Refractory Pains", "MN": "C23.888.592.612.776", "MH_TH": "NLM (1974)", "ST": "T184", "AN": "usually chronic, so do not coordinate with CHRONIC PAIN", "MS": "Persistent pain that is refractory to some or all forms of treatment.", "PM": "1974", "HN": "1974", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010148"}, {"RECTYPE": "D", "MH": "Pain, Postoperative", "DE": "PAIN POSTOP", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Postsurgical Pain|T046|T184|NON|EQV|NLM (2021)|191025|abbcdef", "ENTRY": "Postsurgical Pain, Persistent", "MN": "C23.888.592.612.832", "MH_TH": "NLM (1974)", "ST": "T184", "MS": "Pain during the period after surgery.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010149"}, {"RECTYPE": "D", "MH": "Paint", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Varnish|T073|NON|REL|UNK (19XX)|780310|abcdef", "ENTRY": "Paints", "MN": "J01.637.597", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "An emulsion of solid color which when spread over a surface leaves a thin decorative and or protective coating.", "OL": "use PAINT to search VARNISH 1966-78", "HN": "VARNISH was see under PAINT 1963-78", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010150"}, {"RECTYPE": "D", "MH": "Paintings", "AQ": "CL ED ES HI PX SN TD", "ENTRY": "Painting", "MN": "K01.093.646", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "Works of art formed primarily by the direct application of pigments suspended in oil, water, egg yolk, molten wax, or other liquid, arranged in masses of color, onto a generally two-dimensional surface. (Getty ATT)", "OL": "search ART 1966-74", "PM": "91; was see under ART 1975-90", "HN": "91(75); was see under ART 1975-90", "MR": "20171211", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010151"}, {"RECTYPE": "D", "MH": "Pair Bond", "PRINT ENTRY": "Bond, Pair|T054|NON|EQV|UNK (19XX)|780503|abcdef", "ENTRY": "Pair Bonds", "MN": "F01.145.113.252.748.400", "MH_TH": "NLM (1975)", "ST": "T054", "AN": "animal only", "MS": "In animals, the social relationship established between a male and female for reproduction. It may include raising of young.", "PM": "91; was see under SEX BEHAVIOR, ANIMAL 1975-90", "HN": "91(75); was see under SEX BEHAVIOR, ANIMAL 1975-90", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010152"}, {"RECTYPE": "D", "MH": "Paired-Associate Learning", "AQ": "CL DE ES PH RE", "ENTRY": "Paired-Associate Learnings", "MN": "F02.463.425.952.500", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "Learning in which the subject must respond with one word or syllable when presented with another word or syllable.", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010153"}, {"RECTYPE": "D", "MH": "Pakistan", "AQ": "EH EP", "ENTRY": "Islamic Republic of Pakistan|T083|NON|EQV|NLM (2018)|161223|abcdef", "MN": "Z01.252.245.782.968", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country located in southern Asia, bordering the Arabian Sea, between India on the east and Iran and Afghanistan on the west and China in the north. The capital is Islamabad.", "MR": "20220708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D010154"}, {"RECTYPE": "D", "MH": "Palatal Expansion Technique", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Maxillary Expansion|T061|NON|NRW|NLM (1999)|980414|abcdef", "ENTRY": "Technique, Palatal Expansion", "MN": "E06.658.578.458", "MH_TH": "NLM (1973)", "ST": "T061", "PI": "Palate (1966-1972)", "MS": "An orthodontic method used for correcting narrow or collapsed maxillary arches and functional cross-bite. (From Jablonski's Dictionary of Dentistry),", "OL": "use PALATAL EXPANSION TECHNIQUE to search PALATAL EXPANSION TECHNIC 1973-90", "PM": "91; was PALATAL EXPANSION TECHNIC 1973-90", "HN": "91; was PALATAL EXPANSION TECHNIC 1973-90", "CATSH": "CAT LIST", "MR": "20220408", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010155"}, {"RECTYPE": "D", "MH": "Palatal Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Palatal Muscle", "MN": "A14.549.617.623", "MH_TH": "NLM (1979)", "ST": "T023", "AN": "/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent", "PI": "Palate (1966-1978)", "MS": "The muscles of the palate are the glossopalatine, palatoglossus, levator palati(ni), musculus uvulae, palatopharyngeus, and tensor palati(ni).", "PM": "91; was see under MUSCLES 1979-90", "HN": "91(79); was see under MUSCLES 1979-90", "MR": "20080708", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D010156"}, {"RECTYPE": "D", "MH": "Palatal Neoplasms", "DE": "PALATAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Palatal Neoplasm", "MN": "C07.465.530.692", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with histological type of neoplasm", "MS": "Tumors or cancer of the PALATE, including those of the hard palate, soft palate and UVULA.", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010157"}, {"RECTYPE": "D", "MH": "Palatal Obturators", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Obturators, Palatal|T074|NON|EQV|UNK (19XX)|820428|abcdef", "ENTRY": "Prosthesis, Cleft Palate", "MN": "E07.695.190.600", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "Appliances that close a cleft or fissure of the palate.", "OL": "use PALATAL OBTURATORS to search CLEFT PALATE PROSTHESIS 1966-82", "PM": "83; was CLEFT PALATE PROSTHESIS 1966-82", "HN": "83; was CLEFT PALATE PROSTHESIS 1966-82", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010158"}, {"RECTYPE": "D", "MH": "Palate", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Incisive Papilla|T023|NON|REL|NLM (1998)|960719|abcdef", "ENTRY": "Papillas, Incisive", "MN": "A14.549.617", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "entry term INCISIVE PAPILLA, a projection on the palate posterior to the central incisors: do not add INCISOR; PALATE, HARD, and PALATE, SOFT are also available", "MS": "The structure that forms the roof of the mouth. It consists of the anterior hard palate (PALATE, HARD) and the posterior soft palate (PALATE, SOFT).", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010159"}, {"RECTYPE": "D", "MH": "Palate, Soft", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Velum Palatinum|T023|NON|EQV|UNK (19XX)|790519|abcdef", "ENTRY": "Palatinum, Velum", "MN": "A14.549.617.780", "MH_TH": "NLM (1979)", "ST": "T023", "PI": "Palate (1966-1978)", "MS": "A movable fold suspended from the posterior border of the hard palate. The uvula hangs from the middle of the lower border.", "PM": "79", "HN": "79", "MR": "20030709", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D010160"}, {"RECTYPE": "D", "MH": "Paleodontology", "DE": "PALEODONTOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "I01.076.368.584.583", "FX": "Tooth", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "IM for the discipline (education, history, etc); NIM as a coordinate for studies involving fossil remains of teeth; check tags HISTORICAL ARTICLE & ANCIENT HISTORY or MEDIEVAL HISTORY; for prehistory, ANCIENT HISTORY tag is all right; paleodontology is for pre-Columbian, nothing later", "MS": "The study of the teeth of early forms of life through fossil remains.", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010161"}, {"RECTYPE": "D", "MH": "Paleography", "DE": "PALEOGR", "AQ": "HI IS", "MN": "L01.559.423.906.539.500", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "medical paleography: do not coordinate with MEDICINE", "MS": "The study of ancient inscriptions and modes of writing. It includes the deciphering of manuscripts and other forms to determine their date, provenance, etc. (Webster's 1st ed)", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010162"}, {"RECTYPE": "D", "MH": "Paleontology", "DE": "PALEONTOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Taphonomy|T090|NON|REL|NLM (2023)|220204|abcdef", "MN": "I01.076.368.584", "FX": "Phylogeography", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "specialty; used also as NIM coordinate; paleogenomics: coordinate with GENOMICS; do not routinely check tags HISTORICAL ARTICLE, and ANCIENT HISTORY or MEDIEVAL HISTORY: check only when the history, and ancient or medieval medical aspects are particularly discussed; for prehistory, ANCIENT HISTORY tag is all right; paleontology is for pre-Columbian, nothing later", "MS": "The study of early forms of life through fossil remains.", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010163"}, {"RECTYPE": "D", "MH": "Paleopathology", "DE": "PALEOPATHOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "I01.076.368.584.709", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty; used also as NIM coordinate; check tags HISTORICAL ARTICLE, and ANCIENT HISTORY or MEDIEVAL HISTORY; for prehistory, ANCIENT HISTORY tag is all right; paleopathology is for pre-Columbian, nothing later; consider also MUMMIES /pathol and do not coordinate with PALEOPATHOLOGY", "MS": "The study of disease in prehistoric times as revealed in bones, mummies, and archaeologic artifacts.", "MR": "20090713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010164"}, {"RECTYPE": "D", "MH": "Palladium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.680", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Palladium", "RN": "5TWQ1V240M", "RR": "7440-05-3 (Palladium)", "MS": "A chemical element having an atomic weight of 106.4, atomic number of 46, and the symbol Pd. It is a white, ductile metal resembling platinum, and following it in abundance and importance of applications. It is used in dentistry in the form of gold, silver, and copper alloys.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010165"}, {"RECTYPE": "D", "MH": "Palliative Care", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "PRINT ENTRY": "Palliative Treatment|T058|NON|EQV|NLM (1996)|941128|abcdef", "ENTRY": "Treatments, Palliative", "MN": "N02.421.585.666", "FX": "Palliative Medicine", "MH_TH": "NLM (1964)", "ST": "T058", "AN": "consider also PAIN MANAGEMENT", "MS": "Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed)", "PM": "96; was PALLIATIVE TREATMENT 1966-95", "HN": "96; was PALLIATIVE TREATMENT 1964-95 (Prov 1964-65)", "CATSH": "CAT LIST", "MR": "20180226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010166"}, {"RECTYPE": "D", "MH": "Pallor", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pallors", "MN": "C23.888.885.500", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A clinical manifestation consisting of an unnatural paleness of the skin.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010167"}, {"RECTYPE": "D", "MH": "Palmitates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Palmitate|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D10.251.694.600", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Fatty Acids (1966-1974)", "MS": "Salts and esters of the 16-carbon saturated monocarboxylic acid--palmitic acid.", "PM": "91; was see under PALMITIC ACIDS 1975-90", "HN": "91(75); was see under PALMITIC ACIDS 1975-90", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010168"}, {"RECTYPE": "D", "MH": "Palmitic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Palmitic", "MN": "D10.251.694", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "a group of fatty acids; do not confuse with PALMITIC ACID", "MS": "A group of 16-carbon fatty acids that contain no double bonds.", "OL": "use PALMITIC ACIDS to search PALMITIC ACID 1966-74", "PM": "75; was PALMITIC ACID 1963-74", "HN": "75; was PALMITIC ACID 1963-74", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D010169"}, {"RECTYPE": "D", "MH": "Palmitoyl-CoA Hydrolase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Palmitoyl Thioesterase|T116|T126|NON|EQV|UNK (19XX)|770517|abbcdef", "ENTRY": "Thioesterase, Palmitoyl", "MN": "D08.811.277.352.897.700", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "Palmitoyl-CoA hydrolase", "RN": "EC 3.1.2.2", "PI": "Thiolester Hydrolases (1973-1977)", "MS": "Enzyme catalyzing reversibly the hydrolysis of palmitoyl-CoA or other long-chain acyl coenzyme A compounds to yield CoA and palmitate or other acyl esters. The enzyme is involved in the esterification of fatty acids to form triglycerides. EC 3.1.2.2.", "PM": "91; was see under THIOLESTER HYDROLASES 1978-90", "HN": "91(78); was see under THIOLESTER HYDROLASES 1978-90", "MR": "20030709", "DA": "19770517", "DC": "1", "DX": "19910101", "UI": "D010170"}, {"RECTYPE": "D", "MH": "Palmitoyl Coenzyme A", "AQ": "AA AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Palmitoyl CoA|T109|T114|T123|EQV|UNK (19XX)|770520|abbbdef", "ENTRY": "Coenzyme A, Palmitoyl", "MN": "D13.695.827.068.382.300.700", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Coenzyme A, S-hexadecanoate", "RN": "1763-10-6", "PI": "Palmitic Acids (1966-1977)", "MS": "A fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis.", "PM": "91; was see under ACYL COENZYME A 1978-90", "HN": "91(78); was see under ACYL COENZYME A 1978-90", "MR": "20160701", "DA": "19770520", "DC": "1", "DX": "19910101", "UI": "D010171"}, {"RECTYPE": "D", "MH": "Palmitoylcarnitine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Palmitylcarnitine|T116|T127|NON|EQV|UNK (19XX)|770517|abbcdef", "ENTRY": "Hexadecanoylcarnitine|T116|T127|NON|EQV|NLM (1989)|890208|abbcdef", "MN": "D02.092.877.883.099.700", "PA": "Vitamin B Complex", "MH_TH": "NLM (1978)", "ST": "T127", "N1": "1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-((1-oxohexadecyl)oxy)-, inner salt", "RN": "1935-18-8", "PI": "Palmitic Acids (1966-1977)", "MS": "A long-chain fatty acid ester of carnitine which facilitates the transfer of long-chain fatty acids from cytoplasm into mitochondria during the oxidation of fatty acids.", "PM": "91; was see under CARNITINE 1978-90", "HN": "91(78); was see under CARNITINE 1978-90", "MR": "20130708", "DA": "19770517", "DC": "1", "DX": "19910101", "UI": "D010172"}, {"RECTYPE": "D", "MH": "Palpation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Palpations", "MN": "E01.370.600.600", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Application of fingers with light pressure to the surface of the body to determine consistence of parts beneath in physical diagnosis; includes palpation for determining the outlines of organs.", "CATSH": "CAT LIST", "MR": "20070710", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010173"}, {"RECTYPE": "D", "MH": "Pamphlets", "AQ": "HI", "PRINT ENTRY": "Brochures|T073|T170|NON|EQV|NLM (1992)|910307|abbcdef", "ENTRY": "Pamphlet", "MN": "L01.462.500.682.707", "MH_TH": "POPLINE (1978)", "ST": "T170", "MS": "Printed publications usually having a format with no binding and no cover and having fewer than some set number of pages. They are often devoted to a single subject.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010174"}, {"RECTYPE": "D", "MH": "Pan American Health Organization", "DE": "PAN AMERICAN HEALTH ORGAN", "AQ": "EC HI OG", "PRINT ENTRY": "PAHO|T093|ABB|EQV|NLM (1979)|POPLINE (1978)|890713|abcdeef", "MN": "N03.540.514.718.800.628", "MH_TH": "NLM (1973)", "ST": "T093", "AN": "CATALOGER: Use NAF entry", "PI": "World Health Organization (1966-1972)", "MS": "WHO regional office for the Americas acting as a coordinating agency for the improvement of health conditions in the hemisphere. The four main functions are: control or eradication of communicable diseases, strengthening of national and local health services, education and training, and research.", "PM": "73", "HN": "73", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010175"}, {"RECTYPE": "D", "MH": "Panama", "AQ": "EH EP", "MN": "Z01.107.169.772", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "do not confuse with PANAMA CANAL ZONE", "MS": "A country in CENTRAL AMERICA, bordering both the Caribbean Sea and the North Pacific Ocean, between COLOMBIA and COSTA RICA.", "MR": "20151124", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D010176"}, {"RECTYPE": "D", "MH": "Panama Canal Zone", "AQ": "EH EP", "ENTRY": "Canal Zone|T083|NON|EQV|NLM (2017)|151124|abcdef", "MN": "Z01.586.744", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "do not confuse with PANAMA", "MS": "The area across the Isthmus of Panama formerly administered by the UNITED STATES from 1903 to 1979 for the operation of the Panama Canal. Transfer to PANAMA was completed in 1999.", "MR": "20151124", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D010177"}, {"RECTYPE": "D", "MH": "Pancoast Syndrome", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumor, Pancoast", "MN": "C08.785.520.734", "MH_TH": "NLM (2009)", "ST": "T191", "AN": "an apicocostovertebral syndrome", "MS": "A condition caused by an apical lung tumor (Pancoast tumor) with involvement of the nearby vertebral column and the BRACHIAL PLEXUS. Symptoms include pain in the shoulder and the arm, and atrophy of the hand.", "PM": "2009; see PANCOAST'S SYNDROME 1963-2008", "HN": "2009 (1963)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D010178"}, {"RECTYPE": "D", "MH": "Pancreas", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "MN": "A03.734", "FX": "Pancreaticojejunostomy", "EC": "transplantation:Pancreas Transplantation", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.", "MR": "20050701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010179"}, {"RECTYPE": "D", "MH": "Pancreatectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Pancreatectomies", "MN": "E04.210.752", "FX": "Pancreaticojejunostomy", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Surgical removal of the pancreas. (Dorland, 28th ed)", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D010180"}, {"RECTYPE": "D", "MH": "Pancreatic Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Pancreatic Cysts", "MN": "C06.689.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "usually non-neoplastic; PANCREATIC PSEUDOCYST is also available", "MS": "A true cyst of the PANCREAS, distinguished from the much more common PANCREATIC PSEUDOCYST by possessing a lining of mucous EPITHELIUM. Pancreatic cysts are categorized as congenital, retention, neoplastic, parasitic, enterogenous, or dermoid. Congenital cysts occur more frequently as solitary cysts but may be multiple. Retention cysts are gross enlargements of PANCREATIC DUCTS secondary to ductal obstruction. (From Bockus Gastroenterology, 4th ed, p4145)", "CATSH": "CAT LIST", "MR": "20170711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010181"}, {"RECTYPE": "D", "MH": "Pancreatic Diseases", "DE": "PANCREATIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pancreatic Disease", "MN": "C06.689", "FX": "Hyperinsulinism", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes of the PANCREAS.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010182"}, {"RECTYPE": "D", "MH": "Pancreatic Ducts", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Wirsung's Duct|T023|EPO|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Wirsungs Duct", "MN": "A03.734.667", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "note entry term DUODENAL PAPILLA, MINOR: do not confuse with DUODENAL PAPILLA, MAJOR see VATER'S AMPULLA; \"duodenal papilla\" unspecified is probably DUODENAL PAPILLA, MAJOR", "MS": "Ducts that collect PANCREATIC JUICE from the PANCREAS and supply it to the DUODENUM.", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010183"}, {"RECTYPE": "D", "MH": "Pancreatic Extracts", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Tissue Extracts, Pancreatic", "MN": "D20.777.500", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "do not confuse with chemical substances \"extracted\" from the pancreas, as \"peptides extracted from the  pancreas\" (= PEPTIDES /anal + PANCREAS /chem)", "MS": "Extracts prepared from pancreatic tissue that may contain the pancreatic enzymes or other specific uncharacterized factors or proteins with specific activities. PANCREATIN is a specific extract containing digestive enzymes and used to treat pancreatic insufficiency.", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010184"}, {"RECTYPE": "D", "MH": "Pancreatic Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pancreatic Fistulas", "MN": "C23.300.575.185.775", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "fistula policy: Manual 23.19+", "MS": "Abnormal passage communicating with the PANCREAS.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010185"}, {"RECTYPE": "D", "MH": "Pancreatic Function Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Pancreatic Function", "MN": "E01.370.372.600", "MH_TH": "NLM (1980)", "ST": "T059", "PI": "specific pancreatic disease", "MS": "Tests based on the biochemistry and physiology of the exocrine pancreas and involving analysis of blood, duodenal contents, feces, or urine for products of pancreatic secretion.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19790312", "DC": "1", "DX": "19800101", "UI": "D010186"}, {"RECTYPE": "D", "MH": "Pancreatic Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Hormones, Pancreatic", "MN": "D12.644.548.586", "FX": "Receptors, Pancreatic Hormone", "MH_TH": "NLM (1974)", "ST": "T125", "RN": "0", "AN": "/biosyn /physiol permitted", "MS": "Peptide hormones secreted into the blood by cells in the ISLETS OF LANGERHANS of the pancreas. The alpha cells secrete glucagon; the beta cells secrete insulin; the delta cells secrete somatostatin; and the PP cells secrete pancreatic polypeptide.", "PM": "74", "HN": "74", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010187"}, {"RECTYPE": "D", "MH": "Exocrine Pancreatic Insufficiency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pancreatic Insufficiency|T047|NON|EQV|NLM (1981)|990101|abcdef", "ENTRY": "Pancreatic Insufficiency, Exocrine", "MN": "C06.689.276", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Pancreatitis (1966-1980)", "MS": "A malabsorption condition resulting from greater than 10% reduction in the secretion of pancreatic digestive enzymes (LIPASE; PROTEASES; and AMYLASE) by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS.", "PM": "2005; see PANCREATIC INSUFFICIENCY 1981-2004", "HN": "2005 (1981)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19800409", "DC": "1", "DX": "19810101", "UI": "D010188"}, {"RECTYPE": "D", "MH": "Pancreatic Juice", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Pancreatic Juices", "MN": "A12.200.567", "FX": "Trypsinogen", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "The fluid containing digestive enzymes secreted by the pancreas in response to food in the duodenum.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010189"}, {"RECTYPE": "D", "MH": "Pancreatic Neoplasms", "DE": "PANCREATIC NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pancreatic Cancer|T191|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Pancreatic Neoplasm", "MN": "C19.344.421", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM); available are ALPHA-CELL TUMOR see GLUCAGONOMA; BETA-CELL TUMOR see INSULINOMA; and pancreatic delta-cell tumor see SOMATOSTATINOMA", "MS": "Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).", "CATSH": "CAT LIST", "MR": "20230516", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010190"}, {"RECTYPE": "D", "MH": "Pancreatic Polypeptide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Pancreatic Prohormone|T116|NON|BRD|NLM (2007)|060328|abcdef", "MN": "D12.776.631.650.600", "PA": "Hormones", "MH_TH": "NLM (1979)", "ST": "T125", "RN": "59763-91-6", "PI": "Peptides (1966-1978)", "MS": "A 36-amino acid pancreatic hormone that is secreted mainly by endocrine cells found at the periphery of the ISLETS OF LANGERHANS and adjacent to cells containing SOMATOSTATIN and GLUCAGON. Pancreatic polypeptide (PP), when administered peripherally, can suppress gastric secretion, gastric emptying, pancreatic enzyme secretion, and appetite. A lack of pancreatic polypeptide (PP) has been associated with OBESITY in rats and mice.", "PM": "79", "HN": "79", "MR": "20151124", "DA": "19780518", "DC": "1", "DX": "19790101", "UI": "D010191"}, {"RECTYPE": "D", "MH": "Pancreatic Pseudocyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Pseudocysts, Pancreatic", "MN": "C06.689.500.692", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Pancreatic Cyst (1966-1980)", "MS": "Cyst-like space not lined by EPITHELIUM and contained within the PANCREAS. Pancreatic pseudocysts account for most of the cystic collections in the pancreas and are often associated with chronic PANCREATITIS.", "PM": "91; was see under PANCREATIC CYST 1981-90", "HN": "91(81); was see under PANCREATIC CYST 1981-90", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19800409", "DC": "1", "DX": "19910101", "UI": "D010192"}, {"RECTYPE": "D", "MH": "Pancreaticojejunostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Pancreatojejunostomy|T061|NON|EQV|UNK (19XX)|870319|abcdef", "ENTRY": "Pancreatojejunostomies", "MN": "E04.210.762", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Pancreatitis/surgery (1966-1987)", "MS": "Surgical anastomosis of the pancreatic duct, or the divided end of the transected pancreas, with the jejunum. (Dorland, 28th ed)", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19870319", "DC": "1", "DX": "19880101", "UI": "D010193"}, {"RECTYPE": "D", "MH": "Pancreatin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Panzytrat|T116|T121|T126|TRD|NRW|NLM (1990)|890612|abbbcdef", "MN": "D20.777.500.720", "PA": "Gastrointestinal Agents", "MH_TH": "USP (19XX)", "ST": "T126", "N1": "Pancreatin", "RN": "8049-47-6", "MS": "A mammalian pancreatic extract composed of enzymes with protease, amylase and lipase activities. It is used as a digestant in pancreatic malfunction.", "PM": "67; was see PANCREATIC EXTRACTS 1963-66", "HN": "67(64); was see PANCREATIC EXTRACTS 1963-66", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D010194"}, {"RECTYPE": "D", "MH": "Pancreatitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Peripancreatic Fat Necrosis|T047|NON|NRW|NLM (2020)|190510|abcdef", "ENTRY": "Peripancreatic Fat Necroses", "MN": "C06.689.750", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010195"}, {"RECTYPE": "D", "MH": "Pancreatic Elastase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pancreatopeptidase|T116|T126|NON|EQV|NLM (1965)|990101|abbcdef", "ENTRY": "Elastase, Pancreatic", "MN": "D08.811.277.656.959.350.560", "MH_TH": "NLM (1991)", "ST": "T126", "RN": "EC 3.4.21.36", "AN": "LEUKOCYTE ELASTASE is also available", "MS": "A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36.", "PM": "2000; see PANCREATOPEPTIDASE 1965-1999; for PANCREATIC ELASTASE see PANCREATOPEPTIDASE 1991-1999", "HN": "2000(1965)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010196"}, {"RECTYPE": "D", "MH": "Pancuronium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Bromide, Pancuronium", "MN": "D04.210.500.054.040.685", "PA": "Nicotinic Antagonists", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl-)", "RN": "J76UF062FS", "RR": "U9LY9Y75X2", "PI": "Curare-Like Agents (1970-1971)", "MS": "A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release.", "PM": "74", "HN": "74(72)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010197"}, {"RECTYPE": "D", "MH": "Pancytopenia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pancytopenias", "MN": "C15.378.243.875", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "combined defic of erythrocytes, leukocytes & platelets", "MS": "Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D010198"}, {"RECTYPE": "D", "MH": "Panic", "AQ": "CL DE ES PH RE", "ENTRY": "Panics", "MN": "F01.470.361.585", "MH_TH": "NLM (1975)", "ST": "T055", "AN": "note category: do not confuse with PANIC DISORDER (Cat F3)", "MS": "A state of extreme acute, intense anxiety and unreasoning fear accompanied by disorganization of personality function.", "OL": "search FEAR 1972-74", "PM": "91; was see under FEAR 1975-90", "HN": "91(75); was see under FEAR 1975-90", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010200"}, {"RECTYPE": "D", "MH": "Panniculitis, Nodular Nonsuppurative", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Weber-Christian Disease|T047|EPO|EQV|UNK (19XX)|740330|WEBER CHRISTIAN DIS|abcdefv", "ENTRY": "Weber Christian Disease", "MN": "C17.800.566.500", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "A form of panniculitis characterized by recurrent episodes of fever accompanied by the eruption of single or multiple erythematous subcutaneous nodules on the lower extremities. They normally resolve, but tend to leave depressions in the skin. The condition is most often seen in women, alone or in association with other disorders.", "PM": "65; was PANNICULITIS 1963-64", "HN": "65; was PANNICULITIS 1963-64", "CATSH": "CAT LIST", "MR": "19920522", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010201"}, {"RECTYPE": "D", "MH": "Panophthalmitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Panophthalmitides", "MN": "C11.941.879.960.580", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "inflamm of all struct of eye: a clin entity; do not use as a coord for inflamm of specific parts of eye: these are available as -ITIS headings in C11", "MS": "Acute suppurative inflammation of the inner eye with necrosis of the sclera (and sometimes the cornea) and extension of the inflammation into the orbit. Pain may be severe and the globe may rupture. In endophthalmitis the globe does not rupture.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010202"}, {"RECTYPE": "D", "MH": "Panstrongylus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.412.420.700.850.600", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid65342", "AN": "do not use /drug eff for insecticides: TN 111", "MS": "A genus of cone-nosed bugs of the subfamily TRIATOMINAE. Its species are vectors of TRYPANOSOMA CRUZI.", "OL": "search TRIATOMINAE 1973-74", "PM": "91; was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78", "HN": "91(75); was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010203"}, {"RECTYPE": "D", "MH": "Pantetheine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.886.489.700", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Butanamide, 2,4-dihydroxy-N-(3-((2-mercaptoethyl)amino)-3-oxopropyl)-3,3-dimethyl-, (R)-", "RN": "496-65-1", "AN": "do not confuse with pantethine", "PI": "Sulfhydryl Compounds (1972-1974)", "MS": "An intermediate in the pathway of coenzyme A formation in mammalian liver and some microorganisms.", "PM": "91; was see under SULFHYDRYL COMPOUNDS 1975-90", "HN": "91(75); was see under SULFHYDRYL COMPOUNDS 1975-90", "MR": "20000622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010204"}, {"RECTYPE": "D", "MH": "Pantothenic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitamin B 5|T116|T127|NON|EQV|NLM (2006)|041018|VITAMIN B A 05|abbcdefs", "ENTRY": "Pantothenate, Zinc", "MN": "D12.125.042.070.500", "PA": "Vitamin B Complex", "MH_TH": "NLM (1966)", "ST": "T127", "N1": "beta-Alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, (R)-", "RN": "19F5HK2737", "RR": "79-83-4 (Pantothenic Acid)", "AN": "deficiency: coordinate PANTOTHENIC ACID /defic (IM) with VITAMIN B DEFICIENCY (IM); ther use: coordinate disease with /drug ther, not /diet ther", "MS": "A butyryl-beta-alanine that can also be viewed as pantoic acid complexed with BETA ALANINE. It is incorporated into COENZYME A and protects cells against peroxidative damage by increasing the level of GLUTATHIONE.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010205"}, {"RECTYPE": "D", "MH": "Papain", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tromasin|T116|T121|TRD|NRW|UNK (19XX)|810625|abbcdef", "MN": "D08.811.277.656.300.200.585", "MH_TH": "USP (19XX)", "ST": "T126", "N1": "Papain", "RN": "EC 3.4.22.2", "RR": "9001-73-4 (CAS RN)", "MS": "A proteolytic enzyme obtained from Carica papaya. It is also the name used for a purified mixture of papain and CHYMOPAPAIN that is used as a topical enzymatic debriding agent. EC 3.4.22.2.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010206"}, {"RECTYPE": "D", "MH": "Papaver", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Poppy|T002|NON|EQV|UNK (19XX)|850514|abcdef", "ENTRY": "Poppy, Opium", "MN": "B01.875.800.575.912.250.836.500.500", "FX": "Opium", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid3468", "RR": "txid3469", "MS": "A genus of Eurasian herbaceous plants, the poppies (family PAPAVERACEAE of the dicotyledon class Magnoliopsida), that yield OPIUM from the latex of the unripe seed pods.", "PM": "1991, 1963-1985; see PLANTS, MEDICINAL 1986-1990", "HN": "1991(1986)1963", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010207"}, {"RECTYPE": "D", "MH": "Papaverine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Papaverine", "MN": "D03.633.100.531.085.666", "PA": "Vasodilator Agents", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-", "RN": "DAA13NKG2Q", "RR": "61-25-6 (HCl)", "MS": "An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010208"}, {"RECTYPE": "D", "MH": "Paper", "AQ": "HI ST", "ENTRY": "Papers", "MN": "J01.637.650", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Thin sheets made from wood pulp and other fibrous substances, used for writing, drawing, printing, image duplication or wrapping.", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010209"}, {"RECTYPE": "D", "MH": "Papillary Muscles", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Papillary Muscle", "MN": "A07.541.704.750", "FX": "Chordae Tendineae", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "Manual 21.52 as test tissue; for diseases of papillary muscles coordinate IM with MYOCARDIAL DISEASES; / growth: coordinate with MUSCLE DEVELOPMENT; / embryol: coordinate with MUSCLE DEVELOPMENT if pertinent", "MS": "Conical muscular projections from the walls of the cardiac ventricles, attached to the cusps of the atrioventricular valves by the chordae tendineae.", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010210"}, {"RECTYPE": "D", "MH": "Papilledema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Papillitis, Optic|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Retinal Edemas", "MN": "C11.640.710", "FX": "Ophthalmoscopy", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Swelling of the OPTIC DISK, usually in association with increased intracranial pressure, characterized by hyperemia, blurring of the disk margins, microhemorrhages, blind spot enlargement, and engorgement of retinal veins. Chronic papilledema may cause OPTIC ATROPHY and visual loss. (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p175)", "CATSH": "CAT LIST", "MR": "20190408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010211"}, {"RECTYPE": "D", "MH": "Papilloma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Papillomatosis|T191|NON|REL|NLM (1994)|930326|abcdef", "ENTRY": "Squamous Cell Papillomas", "MN": "C04.557.470.700.600", "FX": "Warts", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM); PAPILLOMA, CHOROID PLEXUS is also available", "MS": "A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010212"}, {"RECTYPE": "D", "MH": "Papillon-Lefevre Disease", "DE": "PAPILLON LEFEVRE DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Papillon Lefevre Syndrome", "MN": "C17.800.827.475.600", "FX": "Cathepsin C", "MH_TH": "NLM (2010)", "ST": "T047", "MS": "Rare, autosomal recessive disorder occurring between the first and fifth years of life. It is characterized by palmoplantar keratoderma with periodontitis followed by the premature shedding of both deciduous and permanent teeth. Mutations in the gene for CATHEPSIN C have been associated with this disease.", "OL": "search KERATODERMA, PALMOPLANTAR 1974", "PM": "91; was see under KERATOSIS PALMARIS ET PLANTARIS 1975-90 (which became KERATODERMA, PALMOPLANTAR 1993)", "HN": "91(75); was see under KERATOSIS PALMARIS ET PLANTARIS 1975-90 (which became KERATODERMA, PALMOPLANTAR 1993)", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010214"}, {"RECTYPE": "D", "MH": "Papio", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Savanna Baboons|T015|NON|EQV|NLM (1992)|901210|abcdef", "ENTRY": "Savanna Baboon", "MN": "B01.050.150.900.649.313.988.400.112.199.120.610", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9554", "AN": "NIM with no qualifiers when experimental animal; diseases: coord IM with MONKEY DISEASES (IM)", "MS": "A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of five named species: PAPIO URSINUS (chacma baboon), PAPIO CYNOCEPHALUS (yellow baboon), PAPIO PAPIO (western baboon), PAPIO ANUBIS (or olive baboon), and PAPIO HAMADRYAS (hamadryas baboon). Members of the Papio genus inhabit open woodland, savannahs, grassland, and rocky hill country. Some authors consider MANDRILLUS a subgenus of Papio.", "OL": "use PAPIO to search BABOONS 1971-80 (as Prov 1971-72)", "PM": "81; was see under BABOONS 1973-80; BABOONS was heading 1973-80", "HN": "81(75); was see under BABOONS 1973-80; BABOONS was heading 1971-80 (Prov 1971-72)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D010215"}, {"RECTYPE": "D", "MH": "Phlebotomus Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Sandfly Fever|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Sandfly Fevers", "MN": "C01.925.782.147.700", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by a bunyavirus", "MS": "Influenza-like febrile viral disease caused by several members of the BUNYAVIRIDAE family and transmitted mostly by the bloodsucking sandfly Phlebotomus papatasii.", "OL": "use PHLEBOTOMUS FEVER to search PAPPATACI FEVER 1966-91", "PM": "92; was PAPPATACI FEVER 1966-91; PHLEBOTOMUS FEVER was see PAPPATACI FEVER 1977-91", "HN": "92; was PAPPATACI FEVER 1966-91; PHLEBOTOMUS FEVER was see PAPPATACI FEVER 1977-91", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D010217"}, {"RECTYPE": "D", "MH": "Papua New Guinea", "AQ": "EH EP", "PRINT ENTRY": "New Guinea, Papua|T083|NAM|EQV|UNK (19XX)|810302|abcdef", "MN": "Z01.639.760.590.715", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "read MeSH definition for hist & geog scope; Papuans are of NEGROID RACE unless otherwise specified", "PI": "New Guinea (1966-1981)", "MS": "A country consisting of the eastern half of the island of New Guinea and adjacent islands, including New Britain, New Ireland, the Admiralty Islands, and New Hanover in the Bismarck Archipelago; Bougainville and Buka in the northern Solomon Islands; the D'Entrecasteaux and Trobriand Islands; Woodlark (Murua) Island; and the Louisiade Archipelago. It became independent on September 16, 1975. Formerly, the southern part was the Australian Territory of Papua, and the northern part was the UN Trust Territory of New Guinea, administered by Australia. They were administratively merged in 1949 and named Papua and New Guinea, and renamed Papua New Guinea in 1971.", "HN": "82", "MR": "20120703", "DA": "19810302", "DC": "4", "DX": "19820101", "UI": "D010219"}, {"RECTYPE": "D", "MH": "Para-Aortic Bodies", "DS": "PARAAORTIC BODIES", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Organs of Zuckerkandl|T023|NON|EQV|NLM (2005)|040421|abcdef", "ENTRY": "Zuckerkandl Organs", "MN": "A06.224.636", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "do not confuse with AORTIC BODIES", "MS": "Small masses of chromaffin cells found near the SYMPATHETIC GANGLIA along the ABDOMINAL AORTA, beginning cranial to the superior mesenteric artery (MESENTERIC ARTERY, SUPERIOR) or renal arteries and extending to the level of the aortic bifurcation or just beyond. They are also called the organs of Zuckerkandl and sometimes called aortic bodies (not to be confused with AORTIC BODIES in the THORAX). The para-aortic bodies are the dominant source of CATECHOLAMINES in the FETUS and normally regress after BIRTH.", "OL": "search CHROMAFFIN SYSTEM 1966-74", "PM": "91; was see under CHROMAFFIN SYSTEM 1975-90", "HN": "91(75); was see under CHROMAFFIN SYSTEM 1975-90", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010220"}, {"RECTYPE": "D", "MH": "Parainfluenza Virus 1, Human", "DS": "PARAINFLUENZA VIRUS HUMAN 001", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human parainfluenza virus 1|T005|NON|EQV|NLM (2002)|010412|HUMAN PARAINFLUENZA VIRUS 001|abcdefs", "ENTRY": "Para Influenza Virus Type 1", "MN": "B04.820.480.937.600.650.700.715", "MH_TH": "NLM (1963)", "ST": "T005", "RN": "txid12730", "AN": "infection: coord IM with RESPIROVIRUS INFECTIONS (IM)", "MS": "A species of RESPIROVIRUS also called hemadsorption virus 2 (HA2), which causes laryngotracheitis in humans, especially children.", "OL": "use PARAINFLUENZA VIRUS 1, HUMAN to search PARAINFLUENZA VIRUS TYPE 1 1994-96, PARA-INFLUENZA VIRUS TYPE 1 1977-93, & SENDAI VIRUS 1966-76", "PM": "97; was PARAINFLUENZA VIRUS TYPE 1 1994-96, was PARA-INFLUENZA VIRUS TYPE 1 1977-93, was SENDAI VIRUS 1964-76", "HN": "97; was PARAINFLUENZA VIRUS TYPE 1 1994-96, was PARA-INFLUENZA VIRUS TYPE 1 1977-93, was SENDAI VIRUS 1964-76", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010222"}, {"RECTYPE": "D", "MH": "Parainfluenza Virus 2, Human", "DS": "PARAINFLUENZA VIRUS HUMAN 002", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human parainfluenza virus 2|T005|NON|EQV|NLM (2002)|010413|HUMAN PARAINFLUENZA VIRUS 002|abcdefs", "ENTRY": "Para Influenza Virus Type 2", "MN": "B04.820.480.937.600.650.750.715", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid1979160", "AN": "do not confuse with PARAINFLUENZA VIRUS 1, HUMAN or PARAINFLUENZA VIRUS 3, HUMAN; infection: coord IM with CROUP (IM) if text confirms or RUBULAVIRUS INFECTIONS (IM) if not specified as CROUP or \"acute laryngotracheobronchitis\"", "MS": "A species of RUBULAVIRUS associated particularly with acute laryngotracheitis (CROUP) in children aged 6 months to 3 years.", "OL": "use PARAINFLUENZA VIRUS 2, HUMAN to search PARAINFLUENZA VIRUS TYPE 2 1994-96, PARA-INFLUENZA VIRUS TYPE 2 1977-93, & ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS 1975-93", "PM": "97; was PARAINFLUENZA VIRUS TYPE 2 1994-96, was PARA-INFLUENZA VIRUS TYPE 2 1977-93 (see under PARA-INFLUENZA VIRUSES 1977-90); was ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS see under PARA-INFLUENZA VIRUSES 1975-76; ACUTE LARYNGOTRACHEOBRONCHITIS VIRUS was ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS see PARAINFLUENZA VIRUS TYPE 2 1977-93", "HN": "97; was PARAINFLUENZA VIRUS TYPE 2 1994-96, was PARA-INFLUENZA VIRUS TYPE 2 1977-93 (see under PARA-INFLUENZA VIRUSES 1977-90); was ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS see under PARA-INFLUENZA VIRUSES 1975-76; ACUTE LARYNGOTRACHEOBRONCHITIS VIRUS was ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS see PARAINFLUENZA VIRUS TYPE 2 1977-93", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010223"}, {"RECTYPE": "D", "MH": "Parainfluenza Virus 3, Human", "DS": "PARAINFLUENZA VIRUS HUMAN 003", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human parainfluenza virus 3|T005|NON|EQV|NLM (2002)|010413|HUMAN PARAINFLUENZA VIRUS 003|abcdefs", "ENTRY": "Para Influenza Virus Type 3", "MN": "B04.820.480.937.600.650.700.735", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid11216", "AN": "infection: coord IM with RESPIROVIRUS INFECTIONS (IM)", "MS": "A species of RESPIROVIRUS frequently isolated from small children with pharyngitis, bronchitis, and pneumonia.", "OL": "use PARAINFLUENZA VIRUS 3, HUMAN to search PARAINFLUENZA VIRUS TYPE 3 1994-96 & PARA-INFLUENZA VIRUS TYPE 3 1975-93", "PM": "97; was PARAINFLUENZA VIRUS TYPE 3 1994-96, was PARA-INFLUENZA VIRUS TYPE 3 1975-93 (see under PARA-INFLUENZA VIRUSES 1975-90)", "HN": "97; was PARAINFLUENZA VIRUS TYPE 3 1994-96, was PARA-INFLUENZA VIRUS TYPE 3 1975-93 (see under PARA-INFLUENZA VIRUSES 1975-90)", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D010224"}, {"RECTYPE": "D", "MH": "Parabens", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "para-Hydroxybenzoic Acids|T109|T121|NON|REL|UNK (19XX)|760517|abbcdef", "ENTRY": "para Hydroxybenzoic Acids", "MN": "D02.455.426.559.389.657.410.460", "PA": "Preservatives, Pharmaceutical", "MH_TH": "NLM (1971)", "ST": "T121", "RN": "0", "PI": "Benzoates (1966-1970)", "MS": "Methyl, propyl, butyl, and ethyl esters of p-hydroxybenzoic acid. They have been approved by the FDA as antimicrobial agents for foods and pharmaceuticals. (From Hawley's Condensed Chemical Dictionary, 11th ed, p872)", "OL": "use PARABENS to search METHYLPARABEN 1966-71", "PM": "72; METHYLPARABEN was heading 1963-71", "HN": "72(71); METHYLPARABEN was heading 1963-71", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010226"}, {"RECTYPE": "D", "MH": "Parabiosis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Parabioses", "MN": "E05.660", "MH_TH": "NLM (1966)", "ST": "T062", "MS": "The experimental joining of two individuals for the purpose of studying the effects of one on the other.", "HN": "was in Cat G only 1963-78", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010227"}, {"RECTYPE": "D", "MH": "Paracoccidioides", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Loboa loboi|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Paracoccidioides brasiliensis|T004|NON|NRW|NLM (1999)|980417|abcdef", "MN": "B01.300.381.648", "MH_TH": "NLM (1972)", "ST": "T004", "RN": "txid38946", "RR": "txid121759", "PI": "Phycomyces (1966-1971)", "MS": "A mitosporic fungal genus. P. brasiliensis (previously Blastomyces brasiliensis) is the etiologic agent of PARACOCCIDIOIDOMYCOSIS.", "PM": "91; see HYPHOMYCETES 1986-90, see PHYCOMYCETES 1975-85", "HN": "91(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010228"}, {"RECTYPE": "D", "MH": "Paracoccidioidomycosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Paracoccidioidomycoses|T047|NON|EQV|NLM (2021)|200228|abcdef", "ENTRY": "South American Blastomycosis", "MN": "C01.150.703.700", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "note entry term BLASTOMYCOSIS, SOUTH AMERICAN: BLASTOMYCOSIS, NORTH AMERICAN see BLASTOMYCOSIS is also available", "PI": "Blastomycosis (1966-1974)", "MS": "A mycosis affecting the skin, mucous membranes, lymph nodes, and internal organs. It is caused most often by Paracoccidioides brasiliensis. It is also called paracoccidioidal granuloma.", "OL": "search BLASTOMYCOSIS 1966-74", "PM": "77; was see under BLASTOMYCOSIS 1963-76", "HN": "77(75); was see under BLASTOMYCOSIS 1963-76", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D010229"}, {"RECTYPE": "D", "MH": "Paracoccus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.750.600", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid265", "PI": "Micrococcus (1966-1975)", "MS": "Gram-negative non-motile bacteria found in soil or brines.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D010230"}, {"RECTYPE": "D", "MH": "Paracoccus denitrificans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Micrococcus denitrificans|T007|NON|EQV|UNK (19XX)|750711|abcdef", "MN": "B03.660.050.750.600.125", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid266", "PI": "Micrococcus (1966-1971)", "MS": "A species of bacteria isolated from soil.", "OL": "use PARACOCCUS DENITRIFICANS to search MICROCOCCUS DENITRIFICANS 1972-75", "PM": "76; was MICROCOCCUS DENITRIFICANS 1972-75", "HN": "76; was MICROCOCCUS DENITRIFICANS 1972-75", "MR": "20200128", "DA": "19750721", "DC": "1", "DX": "19760101", "UI": "D010231"}, {"RECTYPE": "D", "MH": "Paraffin", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Parafilm|T073|T109|TRD|REL|UNK (19XX)|861110|abbcdef", "MN": "D02.455.612", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "8002-74-2", "MS": "A mixture of solid hydrocarbons obtained from petroleum. It has a wide range of uses including as a stiffening agent in ointments, as a lubricant, and as a topical anti-inflammatory. It is also commonly used as an embedding material in histology.", "HN": "was in Cat D only 1963-82", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D010232"}, {"RECTYPE": "D", "MH": "Paraganglia, Chromaffin", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Chromaffin Paraganglia", "MN": "A06.224.736", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "Small bodies containing chromaffin cells occurring outside of the adrenal medulla, most commonly near the sympathetic ganglia and in organs such as the kidney, liver, heart and gonads.", "OL": "search CHROMAFFIN SYSTEM 1966-74", "PM": "91; was see under CHROMAFFIN SYSTEM 1975-90", "HN": "91(75); was see under CHROMAFFIN SYSTEM 1975-90", "MR": "20021024", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010233"}, {"RECTYPE": "D", "MH": "Paraganglia, Nonchromaffin", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Paraganglia, Non Chromaffin", "MN": "A11.671.650.915.500.600", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Several clusters of chemoreceptive and supporting cells associated with blood vessels and nerves (especially the glossopharyngeal and vagus). The nonchromaffin paraganglia sense pH, carbon dioxide, and oxygen concentrations in the blood and participate in respiratory, and perhaps circulatory, control. They include the CAROTID BODY; AORTIC BODIES; the GLOMUS JUGULARE; and the GLOMUS TYMPANICUM.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010234"}, {"RECTYPE": "D", "MH": "Paraganglioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Paraganglioma, Gangliocytic|T191|NON|EQV|NLM (1994)|930326|abcdef", "ENTRY": "Paragangliomatas", "MN": "C04.557.580.625.650.700", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland (usually called a chromaffinoma or pheochromocytoma). It is more common in women than in men. (Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992)", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010235"}, {"RECTYPE": "D", "MH": "Paraganglioma, Extra-Adrenal", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Paraganglioma, Nonchromaffin|T191|NON|EQV|NLM (1994)|930329|abcdef", "ENTRY": "Paragangliomas, Nonchromaffin", "MN": "C04.557.580.625.650.700.705", "FX": "Glomus Tumor", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "MS": "A relatively rare, usually benign neoplasm originating in the chemoreceptor tissue of the CAROTID BODY; GLOMUS JUGULARE; GLOMUS TYMPANICUM; AORTIC BODIES; and the female genital tract. It consists histologically of rounded or ovoid hyperchromatic cells that tend to be grouped in an alveolus-like pattern within a scant to moderate amount of fibrous stroma and a few large thin-walled vascular channels. (From Stedman, 27th ed)", "OL": "use PARAGANGLIOMA, EXTRA-ADRENAL to search PARAGANGLIOMA, NONCHROMAFFIN 1966-93", "PM": "94; was PARAGANGLIOMA, NONCHROMAFFIN 1963-93", "HN": "94; was PARAGANGLIOMA, NONCHROMAFFIN 1963-93", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D010236"}, {"RECTYPE": "D", "MH": "Paragonimiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Paragonimus westermani Infections", "MN": "C01.610.335.865.741", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "trematode infect", "MS": "Infection with TREMATODA of the genus PARAGONIMUS.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010237"}, {"RECTYPE": "D", "MH": "Paragonimus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.736.715.800.610", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid34503", "MS": "A genus of lung flukes of the family Troglotrematidae infecting humans and animals. This genus consists of several species one of which is PARAGONIMUS WESTERMANI, a common lung fluke in humans.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010238"}, {"RECTYPE": "D", "MH": "Paraguay", "AQ": "EH EP", "MN": "Z01.107.757.656", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in central South America, northeast of Argentina, southwest of Brazil. The capital is Asuncion.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D010239"}, {"RECTYPE": "D", "MH": "Parakeets", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Parakeet", "MN": "B01.050.150.900.248.710.672.650", "MH_TH": "NLM (1975)", "ST": "T012", "MS": "Common name for one of five species of small PARROTS, containing long tails.", "OL": "search PSITTACINES 1968-74", "PM": "91; was see under PSITTACINES 1975-90", "HN": "91(75); was see under PSITTACINES 1975-90", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010240"}, {"RECTYPE": "D", "MH": "Parakeratosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Parakeratoses", "MN": "C17.800.428.736", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "do not confuse with POROKERATOSIS", "MS": "Persistence of the nuclei of the keratinocytes into the stratum corneum of the skin. This is a normal state only in the epithelium of true mucous membranes in the mouth and vagina. (Dorland, 27th ed)", "OL": "search KERATOSIS 1968-74", "PM": "91; was see under KERATOSIS 1975-90", "HN": "91(75); was see under KERATOSIS 1975-90", "CATSH": "CAT LIST", "MR": "19920522", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010241"}, {"RECTYPE": "D", "MH": "Paraldehyde", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.047.064.586", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,3,5-Trioxane, 2,4,6-trimethyl-", "RN": "S6M3YBG8QA", "RR": "123-63-7 (Paraldehyde)", "MS": "A hypnotic and sedative with anticonvulsant effects. However, because of the hazards associated with its administration, its tendency to react with plastic, and the risks associated with its deterioration, it has largely been superseded by other agents. It is still occasionally used to control status epilepticus resistant to conventional treatment. (From Martindale, The Extra Pharmacopoeia, 30th ed, p608-9)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010242"}, {"RECTYPE": "D", "MH": "Paralysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Plegia|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Todds Paralysis", "MN": "C23.888.592.636", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)", "OL": "search PARALYSIS, SPASTIC under MUSCLE SPASTICITY 1966-78", "PM": "PARALYSIS, SPASTIC was heading 1963-78", "HN": "PARALYSIS, SPASTIC was heading 1963-78", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010243"}, {"RECTYPE": "D", "MH": "Bulbar Palsy, Progressive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paralysis, Bulbar|T047|NON|BRD|NLM (1966)|990101|abcdef", "ENTRY": "Syndrome, Fazio-Londe's", "MN": "C10.668.467.300", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "A motor neuron disease marked by progressive weakness of the muscles innervated by cranial nerves of the lower brain stem. Clinical manifestations include dysarthria, dysphagia, facial weakness, tongue weakness, and fasciculations of the tongue and facial muscles. The adult form of the disease is marked initially by bulbar weakness which progresses to involve motor neurons throughout the neuroaxis. Eventually this condition may become indistinguishable from AMYOTROPHIC LATERAL SCLEROSIS. Fazio-Londe syndrome is an inherited form of this illness which occurs in children and young adults. (Adams et al., Principles of Neurology, 6th ed, p1091; Brain 1992 Dec;115(Pt 6):1889-1900)", "PM": "2000; see PARALYSIS, BULBAR 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D010244"}, {"RECTYPE": "D", "MH": "Paralyses, Familial Periodic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Periodic Paralysis, Familial|T047|NON|EQV|NLM (2000)|991105|abcdef", "ENTRY": "Periodic Paralysis, Normokalemic", "MN": "C18.452.648.618.711", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "a specific disease entity: see MeSH definition", "MS": "A heterogenous group of inherited disorders characterized by recurring attacks of rapidly progressive flaccid paralysis or myotonia. These conditions have in common a mutation of the gene encoding the alpha subunit of the sodium channel in skeletal muscle. They are frequently associated with fluctuations in serum potassium levels. Periodic paralysis may also occur as a non-familial process secondary to THYROTOXICOSIS and other conditions. (From Adams et al., Principles of Neurology, 6th ed, p1481)", "PM": "2000; see PARALYSIS, FAMILIAL PERIODIC 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D010245"}, {"RECTYPE": "D", "MH": "Paralysis, Obstetric", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Paralyses, Obstetrical", "MN": "C26.141.587", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "refers to neonate; coord IM with specific paralysis or birth inj (IM); do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Paralysis of an infant resulting from injury received at birth. (From Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010246"}, {"RECTYPE": "D", "MH": "Paramecium", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Parameciums", "MN": "B01.043.185.650.375.550.637", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5884", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A genus of ciliate protozoa that is often large enough to be seen by the naked eye. Paramecia are commonly used in genetic, cytological, and other research.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010247"}, {"RECTYPE": "D", "MH": "Paramethasone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.908.727", "PA": "Glucocorticoids", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 6-fluoro-11,17,21-trihydroxy-16-methyl-, (6alpha,11beta,16alpha)-", "RN": "VFC6ZX3584", "RR": "53-33-8 (Paramethasone)", "MS": "A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)", "PM": "65", "HN": "65(63)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010248"}, {"RECTYPE": "D", "MH": "Parametritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cellulitis, Pelvic|T047|NON|EQV|UNK (19XX)|780320|abcdef", "ENTRY": "Pelvic Cellulitis", "MN": "C12.100.250.056.750.750", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "\"pelvic\" in X ref refers to pelvic floor", "MS": "Inflammation of the parametrium, the connective tissue of the pelvic floor, extending from the subserous coat of the uterus laterally between the layers of the BROAD LIGAMENT.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010249"}, {"RECTYPE": "D", "MH": "Paramphistomatidae", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Paramphistomum|T204|NON|NRW|UNK (19XX)|810515|abcdef", "ENTRY": "Paramphistomums", "MN": "B01.050.500.500.736.715.600", "MH_TH": "NLM (1982)", "ST": "T204", "RN": "txid758767", "RR": "txid758768", "AN": "a family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Trematoda (1966-1981)", "MS": "A family of flukes of the class Trematoda found in the intestinal tract and liver of animals and man. Some of the genera are Homalagaster, Gastrodiscus, Paramphistomum, Watsonius, Nilocotyle, Gigantocotyle, Gastrothylax, Macropotrema, Ceylonocotyle, Zygocotyle, Cotylophoron, and Calicophoron.", "PM": "82", "HN": "82", "MR": "20200902", "DA": "19810515", "DC": "1", "DX": "19820101", "UI": "D010250"}, {"RECTYPE": "D", "MH": "Paramyxoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Ferlaviruses", "MN": "B04.820.480.937.600", "MH_TH": "NLM (1971)", "ST": "T005", "RN": "txid11158", "RR": "txid1283308", "PI": "Orthomyxoviridae (1966-1970)", "MS": "A family of spherical viruses, of the order MONONEGAVIRALES, somewhat larger than the orthomyxoviruses, and containing single-stranded RNA. Subfamilies include PARAMYXOVIRINAE and PNEUMOVIRINAE.", "OL": "use PARAMYXOVIRIDAE to search PARAMYXOVIRUSES 1971-80 (as Prov 1971-72)", "PM": "81; was PARAMYXOVIRUSES 1973-80", "HN": "81; was PARAMYXOVIRUSES 1971-80 (Prov 1971-72)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010252"}, {"RECTYPE": "D", "MH": "Respirovirus Infections", "DE": "RESPIROVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Respirovirus|T047|NON|EQV|NLM (2002)|010515|INFECT RESPIROVIRUS|abcdefv", "MN": "C01.925.782.580.600.600", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "Orthomyxovirus Infections (1966-1976)", "MS": "Infections with viruses of the genus RESPIROVIRUS, family PARAMYXOVIRIDAE. Host cell infection occurs by adsorption, via HEMAGGLUTININ, to the cell surface.", "PM": "2002; see PARAMYXOVIRUS INFECTIONS 1977-2001", "HN": "2002 (1977)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D010253"}, {"RECTYPE": "D", "MH": "Paranasal Sinus Diseases", "DE": "PARANASAL SINUS DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sinus Diseases, Paranasal", "MN": "C09.603.692", "MH_TH": "NLM (1977)", "ST": "T047", "PI": "Paranasal Sinuses (1966-1976)", "MS": "Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.", "PM": "77", "HN": "77; was NON MESH before 1977", "CATSH": "CAT LIST", "MR": "19940523", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D010254"}, {"RECTYPE": "D", "MH": "Paranasal Sinus Neoplasms", "DE": "PARANASAL SINUS NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Paranasal Sinus Neoplasm", "MN": "C09.647.685.693", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with specific sinus (IM) + histological type of neoplasm (IM); note that MAXILLARY SINUS NEOPLASMS is also available", "MS": "Tumors or cancer of the PARANASAL SINUSES.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010255"}, {"RECTYPE": "D", "MH": "Paranasal Sinuses", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Supraorbital Ethmoid Cell|T030|NON|NRW|NLM (2024)|230209|abcdef", "ENTRY": "Tract, Sinonasal", "MN": "A04.531.621", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "Air-filled spaces located within the bones around the NASAL CAVITY. They are extensions of the nasal cavity and lined by the ciliated NASAL MUCOSA. Each sinus is named for the cranial bone in which it is located, such as the ETHMOID SINUS; the FRONTAL SINUS; the MAXILLARY SINUS; and the SPHENOID SINUS.", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010256"}, {"RECTYPE": "D", "MH": "Paraneoplastic Syndromes", "DE": "PARANEOPL SYNDROMES", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Paraneoplastic", "MN": "C04.730", "MH_TH": "NLM (1980)", "ST": "T191", "MS": "In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19790525", "DC": "1", "DX": "19800101", "UI": "D010257"}, {"RECTYPE": "D", "MH": "Paranoid Behavior", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Paranoid Behaviors", "MN": "F01.145.126.962", "MH_TH": "NLM (1979)", "ST": "T055", "PI": "Paranoid Personality Disorder (1969-1978)", "MS": "Behavior exhibited by individuals who are overly suspicious, but without the constellation of symptoms characteristic of paranoid personality disorder or paranoid type of schizophrenia.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19780504", "DC": "1", "DX": "19790101", "UI": "D010258"}, {"RECTYPE": "D", "MH": "Paranoid Disorders", "DE": "PARANOID DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Psychoses, Paranoid|T048|NON|EQV|UNK (19XX)|780504|abcdef", "ENTRY": "Paranoid Disorder", "MN": "F03.700.450", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "Chronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system (persecutory delusions or delusions of jealousy), accompanied by preservation of clear and orderly thinking. Emotional responses and behavior are consistent with the delusional state.", "OL": "use PARANOID DISORDERS to search PARANOIA 1966-80", "PM": "81; was PARANOIA 1963-80", "HN": "81; was PARANOIA 1963-80", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D010259"}, {"RECTYPE": "D", "MH": "Paranoid Personality Disorder", "DE": "PARANOID PERSONALITY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Personality Disorder, Paranoid|T048|NON|EQV|UNK (19XX)|780628|PERSONALITY DIS PARANOID|abcdefv", "ENTRY": "Personality, Paranoid", "MN": "F03.675.600", "MH_TH": "NLM (1975)", "ST": "T048", "MS": "A personality disorder characterized by the avoidance of accepting deserved blame and an unwarranted view of others as malevolent. The latter is expressed as suspiciousness, hypersensitivity, and mistrust.", "OL": "use PARANOID PERSONALITY DISORDER to search PARANOID PERSONALITY 1975-79; use PARANOID DISORDERS 1969-74", "PM": "91; was see under PERSONALITY DISORDERS 1979-90; was PARANOID PERSONALITY see under PARANOIA 1969-78", "HN": "91(79); was see under PERSONALITY DISORDERS 1979-90; was PARANOID PERSONALITY see under PARANOIA 1969-78", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010260"}, {"RECTYPE": "D", "MH": "Paraoxon", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Phosphate, Diethyl-p-Nitrophenyl", "MN": "D02.705.400.650", "PA": "Insecticides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Phosphoric acid, diethyl 4-nitrophenyl ester", "RN": "Q9CX8P80JW", "RR": "311-45-5 (Paraoxon)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides (1966-1971)", "MS": "An organophosphate cholinesterase inhibitor that is used as a pesticide.", "PM": "74", "HN": "74(72)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010261"}, {"RECTYPE": "D", "MH": "Paraphilic Disorders", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Sex Deviations|T048|NON|BRD|UNK (19XX)|800520|abcdef", "ENTRY": "Sex Deviation", "MN": "F03.657", "FX": "Sex Offenses", "MH_TH": "NLM (2016)", "ST": "T048", "MS": "Disorders that include recurrent, intense sexually arousing fantasies, sexual urges, or behaviors generally involving nonhuman objects, suffering of oneself or partners, or children or other nonconsenting partners. (from DSM-V)", "PM": "2016; was SEX DEVIATION 1963-1980", "HN": "2016(1981)", "CATSH": "CAT LIST", "MR": "20160427", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D010262"}, {"RECTYPE": "D", "MH": "Paraphimosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Paraphimoses", "MN": "C12.200.294.494.684.587", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "A condition in which the FORESKIN, once retracted, cannot return to its original position. If this condition persists, it can lead to painful constriction of GLANS PENIS, swelling, and impaired blood flow to the penis.", "OL": "search PHIMOSIS 1966-74", "PM": "91; was see under PHIMOSIS 1975-90", "HN": "91(75); was see under PHIMOSIS 1975-90", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010263"}, {"RECTYPE": "D", "MH": "Paraplegia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spastic Paraplegia|T047|NON|NRW|UNK (19XX)|880607|abcdef", "ENTRY": "Spinal Paraplegias", "MN": "C23.888.592.636.637", "MH_TH": "ORD (2010)", "ST": "T184", "AN": "also available is QUADRIPLEGIA; note X ref spastic paraplegia: SPASTIC PARAPLEGIA, HEREDITARY is also available", "MS": "Severe or complete loss of motor function in the lower extremities and lower portions of the trunk. This condition is most often associated with SPINAL CORD DISEASES, although BRAIN DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; and MUSCULAR DISEASES may also cause bilateral leg weakness.", "PM": "1966; for PARALYSIS, SPASTIC see MUSCLE SPASTICITY 1966-78, see PARALYSIS, SPASTICITY 1963-78", "HN": "1963", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D010264"}, {"RECTYPE": "D", "MH": "Paraproteinemias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Plasma Cell Dyscrasias|T191|NON|NRW|UNK (19XX)|750620|abcdef", "ENTRY": "Plasma Cell Dyscrasia", "MN": "C20.683.780", "MH_TH": "NLM (1976)", "ST": "T191", "PI": "specific immunoglobulin (1971-1975)", "MS": "A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D010265"}, {"RECTYPE": "D", "MH": "Paraproteins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Paraprotein|T116|T129|NON|EQV|NLM (2021)|191118|abbcdef", "MN": "D12.776.377.715.548.900", "PA": "Immunologic Factors", "MH_TH": "NLM (1976)", "ST": "T129", "RN": "0", "PI": "specific immunoglobulin (1966-1975)", "MS": "Abnormal immunoglobulins synthesized by atypical cells of the MONONUCLEAR PHAGOCYTE SYSTEM. Paraproteins containing only light chains lead to Bence Jones paraproteinemia, while the presence of only atypical heavy chains leads to heavy chain disease. Most of the paraproteins show themselves as an M-component (monoclonal gammopathy) in electrophoresis. Diclonal and polyclonal paraproteins are much less frequently encountered.", "PM": "76; was see under GLOBULINS 1963-65", "HN": "76; was see under GLOBULINS 1963-65", "MR": "20200527", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D010266"}, {"RECTYPE": "D", "MH": "Parapsoriasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Parapsoriasis en Plaques|T047|NON|NRW|NLM (1993)|ORD (2010)|920422|abcdeef", "ENTRY": "Parapsoriasis en Plaque", "MN": "C17.800.859.575", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a papulosquamous skin dis", "MS": "The term applied to a group of relatively uncommon inflammatory, maculopapular, scaly eruptions of unknown etiology and resistant to conventional treatment. Eruptions are both psoriatic and lichenoid in appearance, but the diseases are distinct from psoriasis, lichen planus, or other recognized dermatoses. Proposed nomenclature divides parapsoriasis into two distinct subgroups, PITYRIASIS LICHENOIDES and parapsoriasis en plaques (small- and large-plaque parapsoriasis).", "OL": "use PARAPSORIASIS to search PARAKERATOSIS VARIEGATA 1966-78", "HN": "PARAKERATOSIS VARIEGATA was see under PARAPSORIASIS 1963-78", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010267"}, {"RECTYPE": "D", "MH": "Parapsychology", "DE": "PARAPSYCHOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Psychical Research|T062|NON|NRW|UNK (19XX)|780503|abcdef", "ENTRY": "Research, Psychical", "MN": "H01.770.644.364", "FX": "Telepathy", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "Branch of psychology that deals with paranormal behavior and events such as telepathy, precognition, and clairvoyance, which are not explicable by present day \"natural laws\".", "OL": "use PARAPSYCHOLOGY to search CLAIRVOYANCE, EXTRASENSORY PERCEPTION & PSYCHICAL RESEARCH 1966-78", "HN": "CLAIRVOYANCE was see under PARAPSYCHOLOGY 1965-78; EXTRASENSORY PERCEPTION & PSYCHICAL RESEARCH were see under PARAPSYCHOLOGY 1963-78", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010268"}, {"RECTYPE": "D", "MH": "Paraquat", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methyl Viologen|T109|T131|NON|EQV|UNK (19XX)|760515|abbcdef", "ENTRY": "Viologen, Methyl", "MN": "D03.383.725.762.621", "PA": "Herbicides", "MH_TH": "NLM (1971)", "ST": "T131", "N1": "4,4'-Bipyridinium, 1,1'-dimethyl-", "RN": "PLG39H7695", "RR": "4685-14-7 (Paraquat)", "PI": "Pyridinium Compounds (1968-1970)", "MS": "A poisonous dipyridilium compound used as contact herbicide. Contact with concentrated solutions causes irritation of the skin, cracking and shedding of the nails, and delayed healing of cuts and wounds.", "PM": "73", "HN": "73(71)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010269"}, {"RECTYPE": "D", "MH": "Parasite Egg Count", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Parasite Egg Counts", "MN": "E05.200.932.600", "MH_TH": "NLM (1971)", "ST": "T059", "AN": "coordinate with specific parasite (IM) or parasitic disease (IM)", "PI": "specific specimen", "MS": "Determination of parasite eggs in feces.", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010270"}, {"RECTYPE": "D", "MH": "Parasites", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Parasite", "MN": "B01.050.500.714", "FX": "Parasite Load", "MH_TH": "NLM (1966)", "ST": "T204", "AN": "general or unspecified only: prefer specifics; in lower animals: Manual 22.20; relation to parasitic diseases: Manual 22.12-.20; parasites in food or parasitic contamination of food is indexed under FOOD PARASITOLOGY (IM) + specific parasite (IM) + specific food item /parasitol (IM) or (NIM)", "MS": "Invertebrate organisms that live on or in another organism (the host), and benefit at the expense of the other. Traditionally excluded from definition of parasites are pathogenic BACTERIA; FUNGI; VIRUSES; and PLANTS; though they may live parasitically.", "OL": "search PARASITICIDES under ANTIPROTOZOAL AGENTS 1966", "PM": "PARASITICIDES was heading 1963-66", "HN": "PARASITICIDES was heading 1963-66", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010271"}, {"RECTYPE": "D", "MH": "Parasitic Diseases", "DE": "PARASITIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "ENTRY": "Parasitic Infection", "MN": "C01.610", "RH": "C3 - DISEASES-PARASITIC", "EC": "veterinary:Parasitic Diseases, Animal", "MH_TH": "NLM (1978)", "ST": "T047", "MS": "Infections or infestations with PARASITES. They are often contracted through contact with an intermediate vector, but may occur as the result of direct exposure.", "OL": "search PARASITICIDES under ANTIPROTOZOAL AGENTS 1966", "PM": "PARASITICIDES was heading 1963-66", "HN": "PARASITICIDES was heading 1963-66", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010272"}, {"RECTYPE": "D", "MH": "Parasitic Diseases, Animal", "DE": "PARASITIC DIS ANIMAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Parasitic Infection, Animal", "MN": "C22.674", "MH_TH": "NLM (1974)", "ST": "T047", "AN": "experimental or veterinary; general or unspecified; prefer specific indentions or specific parasitic disease /vet", "PI": "Parasitic Diseases/veterinary (1966-1997)", "MS": "Animal diseases caused by PARASITES.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D010273"}, {"RECTYPE": "D", "MH": "Parasitology", "DE": "PARASITOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Parasitology, Medical", "MN": "H01.158.273.688", "FX": "Infectious Disease Medicine", "MH_TH": "NLM (1967)", "ST": "T091", "AN": "the discipline (education, history, etc) only; for parasitological studies, use the qualifier/ parasitol with specific anatomical terms, organisms & diseases", "PI": "Parasitic Diseases (1966)", "MS": "The study of parasites and PARASITIC DISEASES.", "PM": "67", "HN": "67", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D010274"}, {"RECTYPE": "D", "MH": "Parasympathetic Nervous System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Systems, Parasympathetic Nervous", "MN": "A08.800.050.600", "FX": "Parasympathomimetics", "MH_TH": "NLM (1966)", "ST": "T022", "AN": "/drug eff: consider also PARASYMPATHOMIMETICS & PARASYMPATHOLYTICS", "MS": "The craniosacral division of the autonomic nervous system. The cell bodies of the parasympathetic preganglionic fibers are in brain stem nuclei and in the sacral spinal cord. They synapse in cranial autonomic ganglia or in terminal ganglia near target organs. The parasympathetic nervous system generally acts to conserve resources and restore homeostasis, often with effects reciprocal to the sympathetic nervous system.", "MR": "19930630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010275"}, {"RECTYPE": "D", "MH": "Parasympatholytics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Spasmolytics|T121|NON|REL|UNK (19XX)|750716|abcdef", "ENTRY": "Parasympathetic Blocking Agents", "MN": "D27.505.696.663.050.650", "FX": "Muscle Relaxants, Central", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "note entry term PARASYMPATHOLYTIC EFFECT: use only for the parasympatholyic effect of a chemical substance", "MS": "Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.", "OL": "use PARASYMPATHOLYTICS to search ANTISPASMODICS & SPASMOLYTICS 1970-76; use MUSCLES 1966-69", "PM": "ANTISPASMODICS & SPASMOLYTICS were see MUSCLE RELAXANTS 1963-69", "HN": "ANTISPASMODICS & SPASMOLYTICS were see MUSCLE RELAXANTS 1963-69", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010276"}, {"RECTYPE": "D", "MH": "Parasympathomimetics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Parasympathomimetic", "MN": "D27.505.696.663.050.675", "FX": "Muscarinic Agonists", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "note entry term PARASYMPATHOMIMETIC EFFECT: use only for the parasympathomimetic effect of a chemical substance", "MS": "Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010277"}, {"RECTYPE": "D", "MH": "Parathion", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Parathion, Ethyl", "MN": "D02.886.300.692.600", "PA": "Insecticides", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Phosphorothioic acid, O,O-diethyl O-(4-nitrophenyl) ester", "RN": "61G466064D", "RR": "56-38-2 (Parathion)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "MS": "A highly toxic cholinesterase inhibitor that is used as an acaricide and as an insecticide.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010278"}, {"RECTYPE": "D", "MH": "Parathyroid Diseases", "DE": "PARATHYROID DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Parathyroid Disorder", "MN": "C19.642", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Pathological processes of the PARATHYROID GLANDS. They usually manifest as hypersecretion or hyposecretion of PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010279"}, {"RECTYPE": "D", "MH": "Parathyroid Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Parathyroid Gland", "MN": "A06.300.560", "FX": "Parathyroidectomy", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "/surg: consider also PARATHYROIDECTOMY", "MS": "Two pairs of small oval-shaped glands located in the front and the base of the NECK and adjacent to the two lobes of THYROID GLAND. They secrete PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body.", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010280"}, {"RECTYPE": "D", "MH": "Parathyroid Hormone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Natpara|T116|T121|TRD|REL|NLM (2021)|191004|abbcdef", "ENTRY": "Hormone, Parathyroid", "MN": "D12.644.548.587", "FX": "Parathyroid Hormone-Related Protein", "MH_TH": "UNK (19XX)", "ST": "T125", "RN": "0", "AN": "/defic: consider also HYPOPARATHYROIDISM", "MS": "A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates.", "PM": "2004; see PARATHYROID HORMONES 1982-2003, see PARATHYROID HORMONE 1963-1981; for PARATHYROID HORMONE PEPTIDE (1-34) see TERIPARATIDE 1997-2007; PARATHYROID HORMONE (1-34) was indexed under PARATHYROID HORMONE & PEPTIDE FRAGMENTS (2000-2007)", "HN": "2004(1963-1981); for PARATHYROID HORMONE PEPTIDE (1-34) use TERIPARATIDE 1997-2007", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D010281"}, {"RECTYPE": "D", "MH": "Parathyroid Neoplasms", "DE": "PARATHYROID NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Parathyroid Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Parathyroid Neoplasm", "MN": "C19.642.713", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM); parathyroid adenoma: coordinate IM with ADENOMA in spite of entry term PARATHYROID ADENOMA", "MS": "Tumors or cancer of the PARATHYROID GLANDS.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010282"}, {"RECTYPE": "D", "MH": "Paratuberculosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Johne's Disease|T047|EPO|EQV|UNK (19XX)|740330|JOHNES DIS|abcdefv", "ENTRY": "Paratuberculoses", "MN": "C22.688", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by Mycobacterium avium subsp. paratuberculosis; usually animal", "MS": "A chronic GASTROENTERITIS in RUMINANTS caused by MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS.", "CATSH": "CAT LIST", "MR": "20190626", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010283"}, {"RECTYPE": "D", "MH": "Paratyphoid Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Paratyphoid Fevers", "MN": "C01.150.252.400.310.821.438", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "specify Salmonella paratyphi species if possible (IM)", "MS": "A prolonged febrile illness commonly caused by several Paratyphi serotypes of SALMONELLA ENTERICA. It is similar to TYPHOID FEVER but less severe.", "OL": "use PARATYPHOID FEVER to search PARATYPHOID FEVERS 1966-91", "PM": "92; was PARATYPHOID FEVERS 1963-91", "HN": "92; was PARATYPHOID FEVERS 1963-91", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D010284"}, {"RECTYPE": "D", "MH": "Pseudocowpox Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, Pseudocowpox", "MN": "B04.280.650.160.670.650", "MH_TH": "NLM (2016)", "ST": "T005", "RN": "txid129726", "AN": "infection: coord IM with POXVIRIDAE INFECTIONS (IM)", "MS": "A species of PARAPOXVIRUS causing a pox-like disease on udders of cows that may spread to milkers.", "PM": "2016; see Pseudocowpox virus 1994-2015, PARAVACCINIA VIRUS 1975-1993", "HN": "2016; use Pseudocowpox virus 1994-2015, PARAVACCINIA VIRUS 1975-1993", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D010285"}, {"RECTYPE": "D", "MH": "Paraventricular Hypothalamic Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hypothalamic Paraventricular Nucleus|T023|NON|EQV|UNK (19XX)|880607|abcdef", "ENTRY": "Paraventricular Nucleus, Hypothalamic", "MN": "A08.186.211.200.317.357.342.400", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "Nucleus in the anterior part of the HYPOTHALAMUS.", "OL": "use PARAVENTRICULAR HYPOTHALAMIC NUCLEUS to search PARAVENTRICULAR NUCLEUS 1975-82", "PM": "83; was PARAVENTRICULAR NUCLEUS see under HYPOTHALAMUS 1975-82", "HN": "83; was PARAVENTRICULAR NUCLEUS see under HYPOTHALAMUS 1975-82", "MR": "20180701", "DA": "19741111", "DC": "1", "DX": "19830101", "UI": "D010286"}, {"RECTYPE": "D", "MH": "Parent-Child Relations", "DE": "PARENT CHILD RELAT", "AQ": "EH LJ", "PRINT ENTRY": "Parent-Offspring Interaction|T054|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Relationship, Parent-Child", "MN": "F01.829.263.370.290", "MH_TH": "NLM (1966)", "ST": "T054", "AN": "human only", "MS": "The interactions between parent and child.", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010287"}, {"RECTYPE": "D", "MH": "Parenteral Nutrition", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Parenteral Feeding|T061|NON|NRW|NLM (1992)|900927|abcdef", "ENTRY": "Parenteral Feedings", "MN": "E02.642.500.505", "FX": "Parenteral Nutrition Solutions", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "for nourishment: differentiate from FLUID THERAPY (to replace fluids) or ENTERAL NUTRITION or INFUSIONS, PARENTERAL (a method of administering drugs & chemicals); coordinate IM with disease / ther (IM), not / diet ther", "MS": "The administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered by a route other than the alimentary canal (e.g., intravenously, subcutaneously).", "OL": "use PARENTERAL NUTRITION to search PARENTERAL FEEDING 1966-91", "PM": "92; was PARENTERAL FEEDING 1966-91", "HN": "92; was PARENTERAL FEEDING 1966-91", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D010288"}, {"RECTYPE": "D", "MH": "Parenteral Nutrition, Total", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Total Parenteral Nutrition|T061|NON|EQV|NLM (1992)|901016|TPN|abcdefv", "ENTRY": "Hyperalimentation, Intravenous", "MN": "E02.642.500.505.750", "FX": "Protein Hydrolysates", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "coordinate with disease /ther, not disease /diet ther", "MS": "The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of TPN solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins.", "OL": "use PARENTERAL NUTRITION, TOTAL to search PARENTERAL HYPERALIMENTATION 1975-91", "PM": "92; was PARENTERAL HYPERALIMENTATION 1975-91 (see under PARENTERAL FEEDING 1975-85)", "HN": "92; was PARENTERAL HYPERALIMENTATION 1975-91 (see under PARENTERAL FEEDING 1975-85)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19741212", "DC": "1", "DX": "19860101", "UI": "D010289"}, {"RECTYPE": "D", "MH": "Parents", "AQ": "ED PX", "PRINT ENTRY": "Step-Parents|T099|NON|NRW|NLM (1996)|950324|STEPPARENTS|abcdefs", "ENTRY": "Stepparents", "MN": "M01.620", "FX": "Single Parent", "MH_TH": "POPLINE (1978)", "ST": "T099", "AN": "HUMAN only; /psychol: consider also PARENT-CHILD RELATIONS; \"unwed parent\": coord IM with ILLEGITIMACY (IM)", "PI": "Family (1966)", "MS": "Persons functioning as natural, adoptive, or substitute parents. The heading includes the concept of parenthood as well as preparation for becoming a parent.", "PM": "69", "HN": "69(67)", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D010290"}, {"RECTYPE": "D", "MH": "Paresis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Muscle Paresis|T184|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Upper Extremity Pareses", "MN": "C23.888.592.643", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A general term referring to a mild to moderate degree of muscular weakness, occasionally used as a synonym for PARALYSIS (severe or complete loss of motor function). In the older literature, paresis often referred specifically to paretic neurosyphilis (see NEUROSYPHILIS). \"General paresis\" and \"general paralysis\" may still carry that connotation. Bilateral lower extremity paresis is referred to as PARAPARESIS.", "PM": "1963; for HEMIPARESIS see HEMIPLEGIA 1974-1999", "HN": "1963; for HEMIPARESIS use HEMIPLEGIA 1974-1999", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D010291"}, {"RECTYPE": "D", "MH": "Paresthesia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dysesthesia|T184|NON|REL|NLM (2000)|991103|abcdef", "ENTRY": "Paresthesias, Painful", "MN": "C23.888.592.763.770.875", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "burning, tingling, prickling sensations go here", "MS": "Subjective cutaneous sensations (e.g., cold, warmth, tingling, pressure, etc.) that are experienced spontaneously in the absence of stimulation.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010292"}, {"RECTYPE": "D", "MH": "Pargyline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Pargyline", "MN": "D02.455.426.559.389.140.210.650", "PA": "Monoamine Oxidase Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenemethanamine, N-methyl-N-2-propynyl-", "RN": "9MV14S8G3E", "RR": "W70V6I2OMY", "MS": "A monoamine oxidase inhibitor with antihypertensive properties.", "PM": "65", "HN": "65(63)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010293"}, {"RECTYPE": "D", "MH": "Parietal Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Parietal Bones", "MN": "A02.835.232.781.651", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "One of a pair of irregularly shaped quadrilateral bones situated between the FRONTAL BONE and OCCIPITAL BONE, which together form the sides of the CRANIUM.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010294"}, {"RECTYPE": "D", "MH": "Parietal Cells, Gastric", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Oxyntic Cells|T025|NON|EQV|UNK (19XX)|830531|abcdef", "ENTRY": "Parietal Cell, Gastric", "MN": "A11.436.708", "FX": "Intrinsic Factor", "MH_TH": "NLM (1984)", "ST": "T025", "PI": "Stomach (1966-1983)", "MS": "Rounded or pyramidal cells of the GASTRIC GLANDS. They secrete HYDROCHLORIC ACID and produce gastric intrinsic factor, a glycoprotein that binds VITAMIN B12.", "PM": "84", "HN": "84", "MR": "20050630", "DA": "19830531", "DC": "1", "DX": "19840101", "UI": "D010295"}, {"RECTYPE": "D", "MH": "Parietal Lobe", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Superior Parietal Lobule|T023|NON|NRW|NLM (2022)|201007|abcdef", "ENTRY": "Superior Parietal Lobules", "MN": "A08.186.211.200.885.287.500.670", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "diseases: coordinate with BRAIN DISEASES; neoplasms: coordinate with BRAIN NEOPLASMS", "MS": "Upper central part of the cerebral hemisphere. It is located posterior to central sulcus, anterior to the OCCIPITAL LOBE, and superior to the TEMPORAL LOBES.", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010296"}, {"RECTYPE": "D", "MH": "Paris", "AQ": "EH EP", "MN": "Z01.542.286.588", "MH_TH": "NLM (1966)", "ST": "T083", "MS": "The capital city of France.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D010297"}, {"RECTYPE": "D", "MH": "Parity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Primiparity|T032|T081|NON|NRW|NLM (1990)|890501|abbcdef", "ENTRY": "Ratios, Parity Progression", "MN": "N06.850.490.812.600", "FX": "Gravidity", "MH_TH": "NLM (1970)", "ST": "T081", "AN": "human & animal; relation to PREGNANCY: Manual 28.16.4", "MS": "The number of offspring a female has borne. It is contrasted with GRAVIDITY, which refers to the number of pregnancies, regardless of outcome.", "PM": "70", "HN": "70(65)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D010298"}, {"RECTYPE": "D", "MH": "Parking Facilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Parking Facility", "MN": "J03.970.680", "MH_TH": "NLM (1977)", "ST": "T073", "MS": "Indoor or outdoor areas designated for the parking of vehicles.", "PM": "91; was see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-90", "HN": "91(Aug 77); was see under FACILITY DESIGN AND CONSTRUCTION 1977-90", "MR": "20160608", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D010299"}, {"RECTYPE": "D", "MH": "Parkinson Disease", "DE": "PARKINSON DIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Primary Parkinsonism|T047|EPO|EQV|GHR (2014)|NLM (2000)|991103|abcdeef", "ENTRY": "Parkinsonism, Primary", "MN": "C10.574.928.750", "FX": "Lewy Bodies", "EC": "chemically induced:Parkinson Disease, Secondary:chemically induced", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)", "PM": "1979; see PARKINSONISM 1967-1978, see PARALYSIS AGITANS 1963-1966", "HN": "1979(1963)", "CATSH": "CAT LIST", "MR": "20190521", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D010300"}, {"RECTYPE": "D", "MH": "Parkinson Disease, Postencephalitic", "DE": "PARKINSON DIS POSTENCEPH", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Postencephalitic Parkinsonism|T047|EPO|EQV|UNK (19XX)|740330|POSTENCEPH PARKINSONISM|abcdefv", "ENTRY": "Postencephalitis Parkinsonian Syndrome", "MN": "C10.228.662.600.700.500", "MH_TH": "NLM (1967)", "ST": "T047", "PI": "Parkinson Disease (1966)", "MS": "Parkinsonism following encephalitis, historically seen as a sequella of encephalitis lethargica (Von Economo Encephalitis). The early age of onset, the rapid progression of symptoms followed by stabilization, and the presence of a variety of other neurological disorders (e.g., sociopathic behavior; TICS; MUSCLE SPASMS; oculogyric crises; hyperphagia; and bizarre movements) distinguish this condition from primary PARKINSON DISEASE. Pathologic features include neuronal loss and gliosis concentrated in the MESENCEPHALON; SUBTHALAMUS; and HYPOTHALAMUS. (From Adams et al., Principles of Neurology, 6th ed, p754)", "PM": "1979; see PARKINSONISM, POSTENCEPHALITIC 1967-1978", "HN": "1979(1967)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D010301"}, {"RECTYPE": "D", "MH": "Parkinson Disease, Secondary", "DE": "PARKINSON DIS SECOND", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Symptomatic Parkinson Disease|T047|EPO|EQV|NLM (2000)|991103|SYMPTOMATIC PARKINSON DIS|abcdefv", "ENTRY": "Symptomatic Parkinsonism", "MN": "C10.228.662.600.700", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "/chem ind permitted: coord IM with drug /adv eff-pois-tox (IM); coord IM with other cause (IM)", "PI": "Parkinson Disease (1966-1972)", "MS": "Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)", "PM": "2000; see PARKINSON DISEASE, SYMPTOMATIC 1979-1999, see PARKINSONISM, SYMPTOMATIC 1973-1978", "HN": "2000(1973)", "CATSH": "CAT LIST", "MR": "20000103", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010302"}, {"RECTYPE": "D", "MH": "Paromomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neomycin E|T109|T195|NON|EQV|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef", "ENTRY": "beta-D-Glucopyranosyl-Isomer Paromomycin", "MN": "D09.408.051.706", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "D-Streptamine, O-2-amino-2-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-", "RN": "61JJC8N5ZK", "RR": "845NU6GJPS", "MS": "An aminoglycoside antibacterial and antiprotozoal agent produced by species of STREPTOMYCES.", "MR": "20180410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010303"}, {"RECTYPE": "D", "MH": "Paronychia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Paronychias", "MN": "C17.800.838.486", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "infect dis of skin surrounding nail; coord IM with specific infect (IM)", "MS": "An inflammatory reaction involving the folds of the skin surrounding the fingernail. It is characterized by acute or chronic purulent, tender, and painful swellings of the tissues around the nail, caused by an abscess of the nail fold. The pathogenic yeast causing paronychia is most frequently Candida albicans. Saprophytic fungi may also be involved. The causative bacteria are usually Staphylococcus, Pseudomonas aeruginosa, or Streptococcus. (Andrews' Diseases of the Skin, 8th ed, p271)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010304"}, {"RECTYPE": "D", "MH": "Parotid Diseases", "DE": "PAROTID DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Parotid Disease", "MN": "C07.465.815.470", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Salivary Gland Diseases (1966-1979)", "MS": "Diseases involving the PAROTID GLAND.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19790427", "DC": "1", "DX": "19800101", "UI": "D010305"}, {"RECTYPE": "D", "MH": "Parotid Gland", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Parotid Glands", "MN": "A14.549.760.464", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The largest of the three pairs of SALIVARY GLANDS. They lie on the sides of the FACE immediately below and in front of the EAR.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010306"}, {"RECTYPE": "D", "MH": "Parotid Neoplasms", "DE": "PAROTID NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Parotid Cancer|T191|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Parotid Neoplasm", "MN": "C07.465.815.718.589", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the PAROTID GLAND.", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010307"}, {"RECTYPE": "D", "MH": "Parotitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Parotitides", "MN": "C07.465.815.793.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "in translations use \"parotitis\", not \"parotiditis\" despite form of vernacular", "MS": "INFLAMMATION of the PAROTID GLAND.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010309"}, {"RECTYPE": "D", "MH": "Parovarian Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Parovarian Cysts", "MN": "C23.300.306.500", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "non-neoplastic", "MS": "A cyst (CYSTS) near the OVARY, derived from anomalies of the FALLOPIAN TUBES or the BROAD LIGAMENT. The paramesonephric type consists of ciliated cells similar to the oviduct epithelium. The mesonephric type consisted of an epithelium with minimally surface structures. They can be found on the thin oviduct (paratubal cysts) or near its fimbriated end (hydatid of Morgagni).", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010310"}, {"RECTYPE": "D", "MH": "Parrots", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Psittacidae|T012|NON|EQV|NLM (2005)|030926|abcdef", "ENTRY": "Parrot", "MN": "B01.050.150.900.248.710.672", "MH_TH": "NLM (1975)", "ST": "T012", "RN": "txid9224", "MS": "BIRDS of the large family Psittacidae, widely distributed in tropical regions and having a distinctive stout, curved hooked bill. The family includes LOVEBIRDS; AMAZON PARROTS; conures; PARAKEETS; and many other kinds of parrots.", "PM": "1991; see PSITTACINES 1975-1990", "HN": "1991(1975)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010311"}, {"RECTYPE": "D", "MH": "Parthenogenesis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Parthenogeneses", "MN": "G15.547", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "A unisexual reproduction without the fusion of a male and a female gamete (FERTILIZATION). In parthenogenesis, an individual is formed from an unfertilized OVUM that did not complete MEIOSIS. Parthenogenesis occurs in nature and can be artificially induced.", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010312"}, {"RECTYPE": "D", "MH": "Partial Pressure", "ENTRY": "Pressures, Partial", "MN": "G01.374.715.714", "MH_TH": "NLM (1964)", "ST": "T070", "AN": "NIM", "MS": "The pressure that would be exerted by one component of a mixture of gases if it were present alone in a container. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "68", "HN": "68(64)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010313"}, {"RECTYPE": "D", "MH": "Partial Thromboplastin Time", "DE": "PTT", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Thromboplastin Time, Partial|T034|NON|EQV|UNK (19XX)|790307|abcdef", "ENTRY": "Kaolin Cephalin Coagulation Time", "MN": "G09.188.660", "FX": "Blood Coagulation", "MH_TH": "NLM (1980)", "ST": "T034", "AN": "usually NIM", "PI": "Thromboplastin (1966-1979)", "MS": "The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy.", "PM": "91; was see under BLOOD COAGULATION TESTS 1980-90", "HN": "91(80); was see under BLOOD COAGULATION TESTS 1980-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19790307", "DC": "1", "DX": "19910101", "UI": "D010314"}, {"RECTYPE": "D", "MH": "Particle Accelerators", "AQ": "CL EC HI IS LJ SD SN ST", "PRINT ENTRY": "Linear Accelerators|T073|NON|NRW|UNK (19XX)|770426|abcdef", "ENTRY": "Particle Accelerator", "MN": "E07.710.680", "FX": "Radiosurgery", "MH_TH": "NLM (1978)", "ST": "T073", "AN": "CYCLOTRONS & SYNCHROTRONS are also available", "PI": "Nuclear Medicine (1967-1977)", "MS": "Devices which accelerate electrically charged atomic or subatomic particles, such as electrons, protons or ions, to high velocities so they have high kinetic energy.", "PM": "78", "HN": "78", "MR": "20180629", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D010315"}, {"RECTYPE": "D", "MH": "Particle Size", "ENTRY": "Sizes, Particle", "MN": "G02.712", "FX": "Particulate Matter", "MH_TH": "NLM (1973)", "ST": "T081", "MS": "Relating to the size of solids.", "PM": "73", "HN": "73", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010316"}, {"RECTYPE": "D", "MH": "Partnership Practice", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Practices, Partnership", "MN": "N04.452.758.671", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "coord IM with med or other specialty (IM); do not confuse with GROUP PRACTICE but do not interpret: use word of text", "PI": "Group Practice, Dental (1967)", "MS": "A voluntary contract between two or more doctors who may or may not share responsibility for the care of patients, with proportional sharing of profits and losses.", "PM": "68", "HN": "68", "MR": "19940505", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010317"}, {"RECTYPE": "D", "MH": "Partnership Practice, Dental", "DE": "PARTNERSHIP PRACTICE DENT", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Associateship Practice, Dental|T058|NON|NRW|UNK (19XX)|850311|ASSOCIATESHIP PRACTICE DENT|abcdefv", "ENTRY": "Practices, Dental Partnership|T058|NON|EQV|NLM (1991)|900206|PRACTICES DENT PARTNERSHIP|abcdefv", "MN": "N04.452.758.671.589", "MH_TH": "NLM (1972)", "ST": "T058", "AN": "coord IM with specific dent specialty (IM); do not confuse with GROUP PRACTICE, DENTAL but do not interpret: use word of text", "PI": "specific dentistry specialty", "MS": "A voluntary contract between two or more dentists who may or may not share responsibility for the care of patients, with proportional sharing of profits and losses.", "PM": "91; was see under PARTNERSHIP PRACTICE 1972-90", "HN": "91(72); was see under PARTNERSHIP PRACTICE 1972-90", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010318"}, {"RECTYPE": "D", "MH": "Parturient Paresis", "AQ": "BL CF CI CL CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Milk Fever, Animal|T047|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Parturient Pareses", "MN": "C22.695", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "animal only, exper or vet; in cows & ewes: check tags ANIMALS + FEMALE + PREGNANCY & don't forget CATTLE DISEASES (IM) + CATTLE (NIM) or SHEEP DISEASES (IM) + SHEEP (NIM)", "PI": "Hypocalcemia/veterinary (1966-1974)", "MS": "A disease of pregnant and lactating cows and ewes leading to generalized paresis and death. The disease, which is characterized by hypocalcemia, occurs at or shortly after parturition in cows and within weeks before or after parturition in ewes.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D010319"}, {"RECTYPE": "D", "MH": "Parvalbumins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Parvalbumin|T116|T123|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Parvalbumin B|T116|T123|NON|NRW|UNK (19XX)|840919|abbcdef", "MN": "D12.776.210.500.750", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "muscle proteins; /biosyn /physiol permitted", "PI": "Muscle Proteins (1973-1976)", "MS": "Low molecular weight, calcium binding muscle proteins. Their physiological function is possibly related to the contractile process.", "PM": "91; was see under MUSCLE PROTEINS 1977-90", "HN": "91(77); was see under MUSCLE PROTEINS 1977-90", "MR": "20200527", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D010320"}, {"RECTYPE": "D", "MH": "Parvoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Picodnaviruses|T005|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "B04.280.580", "MH_TH": "NLM (1974)", "ST": "T005", "RN": "txid10780", "MS": "A family of very small DNA viruses containing a single molecule of single-stranded DNA and consisting of two subfamilies: PARVOVIRINAE and DENSOVIRINAE. They infect both vertebrates and invertebrates.", "OL": "use PARVOVIRIDAE to search PARVOVIRUSES 1974-80", "PM": "81; was PARVOVIRUSES 1974-80", "HN": "81; was PARVOVIRUSES 1974-80", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010321"}, {"RECTYPE": "D", "MH": "Parvoviridae Infections", "DE": "PARVOVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Parvovirus Infections|T047|NON|NRW|NLM (1994)|930511|PARVOVIRUS INFECT|abcdefv", "ENTRY": "Parvovirus Infection", "MN": "C01.925.256.700", "MH_TH": "NLM (1984)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Virus Diseases (1966-1983)", "MS": "Virus infections caused by the PARVOVIRIDAE.", "OL": "use PARVOVIRIDAE INFECTIONS to search PARVOVIRUS INFECTIONS 1984-93", "PM": "94; was PARVOVIRUS INFECTIONS 1984-93", "HN": "94; was PARVOVIRUS INFECTIONS 1984-93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19830615", "DC": "1", "DX": "19840101", "UI": "D010322"}, {"RECTYPE": "D", "MH": "Passive Cutaneous Anaphylaxis", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "PCA|T059|ABB|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Cutaneous Anaphylaxis, Passive", "MN": "G12.122.754", "MH_TH": "NLM (1965)", "ST": "T059", "MS": "An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. PCA is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D010323"}, {"RECTYPE": "D", "MH": "Passive-Aggressive Personality Disorder", "DE": "PASSIVE AGGRESSIVE PERSONALITY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Personality Disorder, Passive-Aggressive|T048|NON|EQV|UNK (19XX)|800521|PERSONALITY DIS PASSIVE AGGRESSIVE|abcdefv", "ENTRY": "Personality, Passive-Aggressive", "MN": "F03.675.625", "MH_TH": "NLM (1975)", "ST": "T048", "MS": "A personality disorder characterized by an indirect resistance to demands for adequate social and occupational performance; anger and opposition to authority and the expectations of others that is expressed covertly by obstructionism, procrastination, stubbornness, dawdling, forgetfulness, and intentional inefficiency. (Dorland, 27th ed)", "OL": "use PASSIVE-AGGRESSIVE PERSONALITY DISORDER to search PASSIVE-AGGRESSIVE PERSONALITY 1975-80; use PERSONALITY DISORDERS 1968-74", "PM": "91; was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-AGGRESSIVE PERSONALITY see under PERSONALITY DISORDERS 1968-80", "HN": "91(81); was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-AGGRESSIVE PERSONALITY see under PERSONALITY DISORDERS 1968-80", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010324"}, {"RECTYPE": "D", "MH": "Pasteurella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.550.590", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid745", "MS": "The oldest recognized genus of the family PASTEURELLACEAE. It consists of several species. Its organisms occur most frequently as coccobacillus or rod-shaped and are gram-negative, nonmotile, facultative anaerobes. Species of this genus are found in both animals and humans.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010325"}, {"RECTYPE": "D", "MH": "Pasteurella Infections", "DE": "PASTEURELLA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pasteurellosis|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Pasteurelloses", "MN": "C01.150.252.400.700.662", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "Infections with bacteria of the genus PASTEURELLA.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D010326"}, {"RECTYPE": "D", "MH": "Pastoral Care", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Psychology, Pastoral|T091|NON|BRD|UNK (19XX)|780503|PSYCHOL PASTORAL|abcdefv", "ENTRY": "Care, Pastoral", "MN": "F02.880.410", "MH_TH": "BIOETHICS (1989)", "ST": "T058", "MS": "Counseling or comfort given by ministers, priests, rabbis, etc., to those in need of help with emotional problems or stressful situations.", "OL": "use PASTORAL CARE to search PSYCHOLOGY, PASTORAL 1966-78", "PM": "79; was PSYCHOLOGY, PASTORAL 1963-78", "HN": "79; was PSYCHOLOGY, PASTORAL 1963-78", "CATSH": "CAT LIST", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D010327"}, {"RECTYPE": "D", "MH": "Patch Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Patch Testing|T060|NON|REL|NLM (2021)|200115|abcdef", "ENTRY": "Tests, Patch", "MN": "E05.478.594.890.610", "MH_TH": "NLM (1975)", "ST": "T060", "MS": "Skin tests in which the sensitizer is applied to a patch of cotton cloth or gauze held in place for approximately 48-72 hours. It is used for the elicitation of a contact hypersensitivity reaction.", "OL": "search SKIN TESTS 1966-74", "PM": "91; was see under SKIN TESTS 1975-90", "HN": "91(75); was see under SKIN TESTS 1975-90", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010328"}, {"RECTYPE": "D", "MH": "Patella", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Patellas", "MN": "A02.835.232.730.500", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "/inj permitted: do not convert to KNEE INJURIES", "MS": "The flat, triangular bone situated at the anterior part of the KNEE.", "PM": "1966; for KNEE CAP see SESAMOID BONES 2016", "HN": "1966; for KNEE CAP use SESAMOID BONES 2016", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010329"}, {"RECTYPE": "D", "MH": "Patents as Topic", "AQ": "ES HI LJ SN", "PRINT ENTRY": "Trademarks|T089|NON|REL|NLM (1996)|941208|abcdef", "ENTRY": "Trademark", "MN": "N03.706.535.518.650", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with the Publication Type PATENT", "MS": "Works about exclusive legal rights or privileges applied to inventions, plants, etc.", "PM": "2008; see PATENTS 1963-2007", "HN": "2008(1963)", "MR": "20180713", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D010330"}, {"RECTYPE": "D", "MH": "Paternal Age", "ENTRY": "Paternal Ages", "MN": "G08.686.700", "MH_TH": "NLM (1977)", "ST": "T079", "MS": "Age of the biological father.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D010331"}, {"RECTYPE": "D", "MH": "Paternal Behavior", "AQ": "DE EH HI PH PX RE", "ENTRY": "Paternal Behaviors", "MN": "F01.829.263.370.330", "MH_TH": "NLM (1969)", "ST": "T054", "AN": "human & animal", "PI": "Parent-Child Relations (1966-1968)", "MS": "The behavior patterns associated with or characteristic of a father.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D010332"}, {"RECTYPE": "D", "MH": "Paternal Deprivation", "AQ": "EH", "ENTRY": "Paternal Deprivations", "MN": "F01.829.263.370.380", "MH_TH": "NLM (1969)", "ST": "T054", "AN": "human & animal", "MS": "Prolonged separation of the offspring from the father.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D010333"}, {"RECTYPE": "D", "MH": "Paternity", "ENTRY": "Paternities", "MN": "I01.198.780.937.766", "FX": "DNA Fingerprinting", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "human only", "MS": "Establishing the father relationship of a man and a child.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010334"}, {"RECTYPE": "D", "MH": "Pathologic Processes", "DE": "PATHOL PROCESSES", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Processes, Pathological", "MN": "C23.550", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "INDEXER: Do not use", "PI": "specific pathologic process (1966-1997)", "MS": "The abnormal mechanisms and forms involved in the dysfunctions of tissues and organs.", "PM": "98", "HN": "98; use explode 1971-97", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D010335"}, {"RECTYPE": "D", "MH": "Pathology", "DE": "PATHOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Pathologies", "MN": "H02.403.650", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use for the specialty only; use /pathol with organs & diseases", "MS": "A specialty concerned with the nature and cause of disease as expressed by changes in cellular or tissue structure and function caused by the disease process.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010336"}, {"RECTYPE": "D", "MH": "Pathology Department, Hospital", "DE": "PATHOL DEP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Pathology Department|T093|NON|EQV|UNK (19XX)|770519|HOSP PATHOL DEP|abcdefv", "ENTRY": "Hospital Pathology Departments", "MN": "N04.452.442.452.422.535", "MH_TH": "NLM (1977)", "ST": "T093", "MS": "Hospital department which administers and provides pathology services.", "PM": "91; was see under HOSPITAL DEPARTMENTS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90", "MR": "20190709", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D010337"}, {"RECTYPE": "D", "MH": "Pathology, Clinical", "DE": "PATHOL CLIN", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Clinical Pathology|T091|NON|EQV|NLM (1990)|890501|CLIN PATHOL|abcdefv", "MN": "H02.403.650.500", "MH_TH": "NLM (1980)", "ST": "T091", "AN": "specialty: do not use as a coordinate: use /pathol with organs and diseases", "PI": "Pathology (1966-1979)", "MS": "A subspecialty of pathology applied to the solution of clinical problems, especially the use of laboratory methods in clinical diagnosis. (Dorland, 28th ed.)", "PM": "80", "HN": "80", "MR": "20090706", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D010338"}, {"RECTYPE": "D", "MH": "Pathology, Oral", "DE": "PATHOL ORAL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Pathology, Maxillofacial|T091|NON|EQV|NLM (2016)|140801|abcdef", "MN": "H02.163.876.506", "MH_TH": "NLM (1970)", "ST": "T091", "AN": "use for the specialty only; not for MOUTH /pathol nor MOUTH DISEASES", "PI": "Pathology (1966-1969)", "MS": "A dental specialty concerned with pathology of the oral cavity.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20150305", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D010339"}, {"RECTYPE": "D", "MH": "Pathology, Surgical", "DE": "PATHOL SURG", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Surgical Pathology|T091|NON|EQV|UNK (19XX)|860101|SURG PATHOL|abcdefv", "MN": "H02.403.650.510", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "A field of anatomical pathology in which living tissue is surgically removed for the purpose of diagnosis and treatment.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010340"}, {"RECTYPE": "D", "MH": "Pathology, Veterinary", "DE": "PATHOL VET", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Veterinary Pathology|T091|NON|EQV|UNK (19XX)|860101|VET PATHOL|abcdefv", "MN": "H02.956.465", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use for the specialty only; not a substitute for /pathol of organs or diseases in veterinary animals nor for ANIMAL DISEASES or specific animal disease", "MS": "The field of veterinary medicine concerned with the causes of and changes produced in the body by disease.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010341"}, {"RECTYPE": "D", "MH": "Patient Acceptance of Health Care", "DE": "PATIENT ACCEPT", "AQ": "EH PX SN", "PRINT ENTRY": "Health Care Seeking Behavior|T055|NON|REL|UNK (19XX)|830606|abcdef", "ENTRY": "Utilization, Health Care", "MN": "N05.300.150.800.500", "MH_TH": "NLM (1975)", "ST": "T055", "PI": "Attitude to Health (1968-1974)", "MS": "Patients' willingness to receive health care.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D010342"}, {"RECTYPE": "D", "MH": "Patient Admission", "AQ": "EC LJ SN ST TD", "ENTRY": "Voluntary Admissions", "MN": "N02.421.585.400.600", "FX": "Patient Readmission", "MH_TH": "BIOETHICS (1985)", "ST": "T058", "PI": "Hospitalization (1966-1977)", "MS": "The process of accepting patients. The concept includes patients accepted for medical and nursing care in a hospital or other health care institution.", "PM": "78", "HN": "78", "MR": "20150629", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D010343"}, {"RECTYPE": "D", "MH": "Patient Advocacy", "AQ": "CL EC ED ES HI LJ PX SN ST TD", "PRINT ENTRY": "Patient Representatives|T097|NON|REL|UNK (19XX)|820426|abcdef", "ENTRY": "Representatives, Patient", "MN": "N03.706.678", "FX": "Patient Rights", "MH_TH": "NLM (1976)", "ST": "T058", "PI": "Human Rights (1973-1975)", "MS": "Promotion and protection of the rights of patients, frequently through a legal process.", "PM": "76", "HN": "76", "MR": "20030709", "DA": "19750723", "DC": "1", "DX": "19780101", "UI": "D010344"}, {"RECTYPE": "D", "MH": "Patient Care Management", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Management, Patient Care", "MN": "N04.590", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "general or unspecified; prefer specifics", "MS": "Generating, planning, organizing, and administering medical and nursing care and services for patients.", "PM": "98", "HN": "98; use explode 1970-97", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D010346"}, {"RECTYPE": "D", "MH": "Patient Care Planning", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Nursing Care Plans|T170|NON|REL|UNK (19XX)|850311|NURS CARE PLANS|abcdefv", "ENTRY": "Planning, Patient Care", "MN": "N04.590.233.624", "FX": "Community Participation", "MH_TH": "NLM (1968)", "ST": "T058", "AN": "for individual patient: do not confuse with PATIENT-CENTERED CARE which is institutional & administrative management", "MS": "Usually a written medical and nursing care program designed for a particular patient.", "PM": "68", "HN": "68", "MR": "20160718", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010347"}, {"RECTYPE": "D", "MH": "Patient Care Team", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Multidisciplinary Health Team|T058|NON|BRD|NLM (2022)|210426|abcdef", "ENTRY": "Teams, Interdisciplinary Health", "MN": "N04.590.715", "MH_TH": "BIOETHICS (1989)", "ST": "T058", "AN": "consider also NURSING, TEAM", "PI": "Progressive Patient Care (1966-1967)", "MS": "Care of patients by a multidisciplinary team usually organized under the leadership of a physician; each member of the team has specific responsibilities and the whole team contributes to the care of the patient.", "PM": "68", "HN": "68", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010348"}, {"RECTYPE": "D", "MH": "Patient Compliance", "AQ": "EH PX SN", "PRINT ENTRY": "Patient Noncompliance|T055|NON|REL|NLM (1991)|900417|abcdef", "ENTRY": "Treatment Compliances", "MN": "N05.300.150.800.500.600", "FX": "Treatment Refusal", "MH_TH": "BIOETHICS (1990)", "ST": "T055", "AN": "distinguish entry term PATIENT NON-COMPLIANCE from TREATMENT REFUSAL", "PI": "Cooperative Behavior (1971-1974)", "MS": "Voluntary cooperation of the patient in following a prescribed regimen.", "PM": "1975; for PATIENT NON-COMPLIANCE see TREATMENT REFUSAL 1997-2008, see PATIENT COMPLIANCE 1982-1990, see PATIENT DROPOUTS 1975-1981", "HN": "1975; for PATIENT NON-COMPLIANCE use TREATMENT REFUSAL 1997-2008, use PATIENT COMPLIANCE 1982-1990, use PATIENT DROPOUTS 1975-1981", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D010349"}, {"RECTYPE": "D", "MH": "Patient Credit and Collection", "DE": "PATIENT CREDIT COLLECTION", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Credit and Collection, Patient|T058|NON|EQV|UNK (19XX)|770511|CREDIT COLLECTION PATIENT|abcdefv", "ENTRY": "Patient Credits", "MN": "N03.219.463.030.320", "MH_TH": "NLM (1978)", "ST": "T058", "MS": "Accounting procedures for determining credit status and methods of obtaining payment.", "PM": "91; was see under ACCOUNTING 1978-90", "HN": "91(78); was see under ACCOUNTING 1978-90", "MR": "19930916", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D010350"}, {"RECTYPE": "D", "MH": "Patient Discharge", "AQ": "EC LJ SN ST TD", "PRINT ENTRY": "Discharge Planning|T058|NON|NRW|UNK (19XX)|780509|abcdef", "ENTRY": "Plannings, Discharge", "MN": "N04.590.233.727.210.125", "FX": "Patient Discharge Summaries", "MH_TH": "NLM (1978)", "ST": "T058", "PI": "Hospitalization (1966-1977)", "MS": "The administrative process of discharging the patient, alive or dead, from hospitals or other health facilities.", "PM": "78", "HN": "78", "MR": "20160531", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D010351"}, {"RECTYPE": "D", "MH": "Patient Dropouts", "AQ": "EH PX SN", "ENTRY": "Patient Dropout", "MN": "N05.300.150.800.500.610", "MH_TH": "NLM (1974)", "ST": "T055", "MS": "Discontinuance of care received by patient(s) due to reasons other than full recovery from the disease.", "PM": "74", "HN": "74", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010352"}, {"RECTYPE": "D", "MH": "Patient Education as Topic", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Education of Patients|T058|T065|NON|EQV|UNK (19XX)|790601|EDUC OF PATIENTS|abbcdefv", "ENTRY": "Patient Education", "MN": "N02.421.726.407.680", "MH_TH": "NLM (2008)", "ST": "T065", "AN": "do not confuse with the Publication Type PATIENT EDUCATION HANDOUT", "MS": "The teaching or training of patients concerning their own health needs.", "PM": "2008; see PATIENT EDUCATION 1980-2007, see PATIENTS/education 1963-1979", "HN": "2008(1963)", "MR": "20150626", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D010353"}, {"RECTYPE": "D", "MH": "Patient Escort Service", "DE": "PATIENT ESCORT SERV", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Services, Patient Escort", "MN": "N02.421.608", "MH_TH": "NLM (1977)", "ST": "T058", "MS": "A special service provided by volunteers to accompany patients who need help in moving about the health facility.", "PM": "91; was see under HOSPITAL VOLUNTEERS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL VOLUNTEERS 1977-90", "MR": "20160701", "DA": "19770511", "DC": "1", "DX": "19910101", "UI": "D010354"}, {"RECTYPE": "D", "MH": "Patient Identification Systems", "DE": "PATIENT ID SYSTEMS", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Trackings, Patient", "MN": "N04.452.653", "MH_TH": "NLM (1978)", "ST": "T170", "MS": "Organized procedures for establishing patient identity, including use of bracelets, etc.", "PM": "78", "HN": "78", "MR": "20120703", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D010355"}, {"RECTYPE": "D", "MH": "Patient Isolation", "DE": "PATIENT ISOL", "AQ": "CL EC ES HI IS LJ MT OG PX SN ST TD", "PRINT ENTRY": "Negative Pressure Patient Isolation|T061|NON|REL|NLM (2021)|200422|abcdef", "MN": "N06.850.780.200.450.650", "MH_TH": "NLM (1977)", "ST": "T061", "AN": "do not confuse with PATIENT ISOLATORS ", "PI": "Patient Isolators (1966-1976)", "MS": "The segregation of patients with communicable or other diseases for a specified time. Isolation may be strict, in which movement and social contacts are limited; modified, where an effort to control specified aspects of care is made in order to prevent cross infection; or reverse, where the patient is secluded in a controlled or germ-free environment in order to protect him or her from cross infection.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20200617", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D010356"}, {"RECTYPE": "D", "MH": "Patient Isolators", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Negative-Pressure Wards|T073|NON|REL|NLM (2021)|200422|abcdef", "ENTRY": "Ward, Negative-Pressure", "MN": "E07.325.755", "MH_TH": "NLM (1968)", "ST": "T074", "PI": "Germ-Free Life (1966-1967)", "MS": "Equipment used to prevent contamination of and by patients, especially those with infections. This includes plastic surgical isolators and specially designed spaces used to protect patients.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20200617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010357"}, {"RECTYPE": "D", "MH": "Patient Participation", "AQ": "EC HI LJ MT PX SN TD", "ENTRY": "Patient Participation Rate", "MN": "N05.300.150.800.500.620", "FX": "Refusal to Participate", "MH_TH": "BIOETHICS (1974)", "ST": "T058", "AN": "do not confuse with PATIENT COMPLIANCE", "MS": "Patient involvement in the decision-making process in matters pertaining to health.", "PM": "1978", "HN": "1978", "MR": "20180629", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D010358"}, {"RECTYPE": "D", "MH": "Patient Readmission", "AQ": "EC LJ SN ST TD", "PRINT ENTRY": "Unplanned Readmission|T058|NON|EQV|NLM (2022)|210430|abcdef", "ENTRY": "Unplanned Readmissions", "MN": "N02.421.585.400.620", "MH_TH": "NLM (1969)", "ST": "T058", "PI": "Hospitalization (1966-1969)", "MS": "Subsequent admissions of a patient to a hospital or other health care institution for treatment.", "OL": "use PATIENT READMISSION to search HOSPITAL READMISSION 1970-77 (as Prov 1970-71)", "PM": "78; was HOSPITAL READMISSION 1972-77; HOSPITAL READMISSIONS was see PATIENT READMISSION 1997", "HN": "78; was HOSPITAL READMISSION 1970-77 (Prov 1970-71); HOSPITAL READMISSIONS was see PATIENT READMISSION 1997", "MR": "20211202", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010359"}, {"RECTYPE": "D", "MH": "Patient Transfer", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Patient Dumping|T058|NON|NRW|UNK (19XX)|860530|abcdef", "ENTRY": "Turfings, Patient", "MN": "N04.590.233.727.210.624", "FX": "Transfer Agreement", "MH_TH": "BIOETHICS (1990)", "ST": "T058", "AN": "do not confuse with TRANSPORTATION OF PATIENTS or MOVING AND LIFTING PATIENTS", "MS": "Interfacility or intrahospital transfer of patients. Intrahospital transfer is usually to obtain a specific kind of care and interfacility transfer is usually for economic reasons as well as for the type of care provided.", "PM": "87", "HN": "87", "MR": "20170316", "DA": "19860530", "DC": "1", "DX": "19870101", "UI": "D010360"}, {"RECTYPE": "D", "MH": "Patients", "AQ": "CL HI LJ PX SN", "ENTRY": "Patient", "MN": "M01.643", "FX": "Outpatients", "EC": "education:Patient Education as Topic", "MH_TH": "BIOETHICS (1974)", "ST": "T101", "AN": "general only, irrespective of disease; patients as people or as a social, sociological, psychological, etc., group; do not confuse the patient with the disease: the \"tuberculotic patient\" equals TUBERCULOSIS and not also PATIENTS", "MS": "Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.", "OL": "search PATIENTS/ED under PATIENT EDUCATION 1966-79", "HN": "/education was used for indexing 1966-79; was in Cat G & M 1963-67", "MR": "20070711", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010361"}, {"RECTYPE": "D", "MH": "Patients' Rooms", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Wards, General|T073|NON|BRD|UNK (19XX)|790529|abcdef", "ENTRY": "Ward, General", "MN": "N02.278.220.640", "MH_TH": "NLM (1980)", "ST": "T073", "PI": "Hospital Units (1974-1979)", "MS": "Rooms occupied by one or more individuals during a stay in a health facility. The concept includes aspects of environment, design, care, or economics.", "PM": "91; was see under HEALTH FACILITIES 1980-90", "HN": "91(80); was see under HEALTH FACILITIES 1980-90", "MR": "19920515", "DA": "19790529", "DC": "1", "DX": "19910101", "UI": "D010362"}, {"RECTYPE": "D", "MH": "Pattern Recognition, Automated", "AQ": "CL EC ES HI LJ MT SD SN ST TD", "ENTRY": "Pattern Recognition Systems", "MN": "L01.399.750", "MH_TH": "NLM (2005)", "ST": "T041", "AN": "not physiological: physiol pattern recognition is PATTERN RECOGNITION, PHYSIOLOGICAL", "MS": "In INFORMATION RETRIEVAL, machine-sensing or identification of visible patterns (shapes, forms, and configurations). (Harrod's Librarians' Glossary, 7th ed)", "PM": "2005; see PATTERN RECOGNITION 1973-2004, see AUTOMATIC DATA PROCESSING 1968-1972", "HN": "2005; use PATTERN RECOGNITION 1973-2004, see AUTOMATIC DATA PROCESSING 1968-1972", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010363"}, {"RECTYPE": "D", "MH": "Pattern Recognition, Visual", "AQ": "CL DE ES PH RE", "ENTRY": "Visual Pattern Recognition", "MN": "F02.463.593.932.622", "MH_TH": "NLM (1975)", "ST": "T041", "MS": "Mental process to visually perceive a critical number of facts (the pattern), such as characters, shapes, displays, or designs.", "OL": "search FORM PERCEPTION 1968-74", "PM": "91; was see under FORM PERCEPTION 1975-90", "HN": "91(75); was see under FORM PERCEPTION 1975-90", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010364"}, {"RECTYPE": "D", "MH": "Patulin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.946.587.725", "PA": "Poisons", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "4H-Furo(3,2-c)pyran-2(6H)-one, 4-hydroxy-", "RN": "95X2BV4W8R", "RR": "149-29-1 (Patulin)", "PI": "Pyrans (1966-1974)", "MS": "4-Hydroxy-4H-furo(3,2-c)pyran-2(6H)-one. A mycotoxin produced by several species of Aspergillus and Penicillium. It is found in unfermented apple and grape juice and field crops. It has antibiotic properties and has been shown to be carcinogenic and mutagenic and causes chromosome damage in biological systems.", "PM": "91; was see under PYRANS 1975-90", "HN": "91(75); was see under PYRANS 1975-90", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010365"}, {"RECTYPE": "D", "MH": "Peak Expiratory Flow Rate", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Expiratory Peak Flow Rate|T034|T042|NON|EQV|UNK (19XX)|741205|abbcdef", "ENTRY": "PEFR|T034|T042|ABB|EQV|NLM (2004)|030514|abbcdef", "MN": "G09.772.650.300.790", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "usually NIM; do not confuse with MAXIMAL EXPIRATORY FLOW RATE; (MEFR)", "MS": "Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR.", "PM": "91; was see under FORCED EXPIRATORY FLOW RATES 1975-90", "HN": "91(75); was see under FORCED EXPIRATORY FLOW RATES 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D010366"}, {"RECTYPE": "D", "MH": "Arachis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Peanuts|T002|NON|NRW|NLM (1966)|990101|abcdef", "ENTRY": "Peanut", "MN": "B01.875.800.575.912.250.401.077", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid3817", "RR": "txid3818", "AN": "/adv eff: consider also PEANUT HYPERSENSITIVITY", "MS": "A plant genus of the family FABACEAE that includes peanuts.", "PM": "2016; see ARACHIS HYPOGAEA 2002-2015, PEANUTS 1963-2001", "HN": "2016; use ARACHIS HYPOGAEA 2002-2015, PEANUTS 1963-2001", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D010367"}, {"RECTYPE": "D", "MH": "Pectins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Pectinate, Zinc", "MN": "D20.215.784.500.618", "PA": "Food Additives", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "89NA02M4RX", "RR": "9000-69-5 (Pectin)", "MS": "High molecular weight polysaccharides present in the cell walls of all plants. Pectins cement cell walls together. They are used as emulsifiers and stabilizers in the food industry. They have been tried for a variety of therapeutic uses including as antidiarrheals, where they are now generally considered ineffective, and in the treatment of hypercholesterolemia.", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010368"}, {"RECTYPE": "D", "MH": "Pectoralis Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Pectoralis Minor Muscle|T023|NON|NRW|NLM (2021)|191129|abcdef", "ENTRY": "Pectoralis Muscle", "MN": "A02.633.567.775", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "/growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent", "MS": "The pectoralis major and pectoralis minor muscles that make up the upper and fore part of the chest in front of the AXILLA.", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010369"}, {"RECTYPE": "D", "MH": "Pediatric Assistants", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Pediatric Assistant", "MN": "N02.360.067.740.750", "FX": "Pediatric Nurse Practitioners", "MH_TH": "NLM (1975)", "ST": "T097", "MS": "Persons academically trained to provide medical care, under the supervision of a physician, to infants and children.", "OL": "search PHYSICIANS' ASSISTANTS 1971-74", "PM": "91; was see under PHYSICIANS' ASSISTANTS 1975-90", "HN": "91(75); was see under PHYSICIANS' ASSISTANTS 1975-90", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010370"}, {"RECTYPE": "D", "MH": "Pediatric Nursing", "DE": "PEDIATRIC NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Children and Young People's Nursing|T058|T091|NON|EQV|NLM (2023)|210811|abbcdef", "ENTRY": "Pediatric Nursings", "MN": "N02.421.533.691", "FX": "Maternal-Child Nursing", "MH_TH": "NLM (1967)", "ST": "T091", "AN": "check also the tag CHILD or specific", "PI": "Pediatrics (1966)", "MS": "The nursing specialty concerning care of children from birth to adolescence. It includes the clinical and psychological aspects of nursing care.", "PM": "67", "HN": "67", "MR": "20211202", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D010371"}, {"RECTYPE": "D", "MH": "Pediatrics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.670", "MH_TH": "BIOETHICS (1974)", "ST": "T091", "AN": "specialty", "MS": "A medical specialty concerned with maintaining health and providing medical care to children from birth to adolescence.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010372"}, {"RECTYPE": "D", "MH": "Lice Infestations", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pediculosis|T047|NON|EQV|NLM (1999)|980522|abcdef", "ENTRY": "Pediculoses", "MN": "C17.800.838.775.580", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific louse (IM); head lice: coord IM with SCALP DERMATOSES (IM) and PEDICULUS (IM)", "MS": "Parasitic attack or subsistence on the skin by members of the order Phthiraptera, especially on humans by Pediculus humanus of the family Pediculidae. The hair of the head, eyelashes, and pubis is a frequent site of infestation. (From Dorland, 28th ed; Stedman, 26th ed)", "PM": "1999; see PEDICULOSIS 1966-1998; for LICE INFESTATIONS see PEDICULOSIS 1998", "HN": "1999(1966)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D010373"}, {"RECTYPE": "D", "MH": "Pediculus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Head Lice|T204|NON|NRW|NLM (1999)|971027|abcdef", "ENTRY": "Louses, Head", "MN": "B01.050.500.131.617.690.060.716", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid121222", "AN": "infestation: coordinate IM with PEDICULOSIS see LICE INFESTATIONS (IM); for killing Pediculus with insecticides, see note at INSECTICIDES", "PI": "Lice (1966-1974)", "MS": "Lice of the genus Pediculus, family Pediculidae. Pediculus humanus corporus is the human body louse and Pediculus humanus capitis is the human head louse.", "OL": "search LICE 1966-74", "PM": "75; was see under LICE 1963-74", "HN": "75; was see under LICE 1963-74", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D010374"}, {"RECTYPE": "D", "MH": "Pedigree", "PRINT ENTRY": "Genealogical Tree|T170|NON|REL|NLM (1998)|960729|abcdef", "ENTRY": "Trees, Genealogical", "MN": "E05.393.673", "FX": "Genetic Privacy", "MH_TH": "NLM (1968)", "ST": "T170", "AN": "human & animal", "PI": "Genetics, Medical (1966-1967)", "MS": "The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20030725", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010375"}, {"RECTYPE": "D", "MH": "Pediococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.450.737", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1253", "MS": "A genus of gram-positive, facultatively anaerobic bacteria whose growth is dependent on the presence of a fermentable carbohydrate. No endospores are produced. Its organisms are found in fermenting plant products and are nonpathogenic to plants and animals, including humans.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010376"}, {"RECTYPE": "D", "MH": "Pediatric Dentistry", "DE": "PEDIATRIC DENT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Pedodontics|T091|NON|EQV|NLM (1993)|911121|abcdef", "MN": "H02.163.876.600", "FX": "Dental Care for Children", "MH_TH": "NLM (1965)", "ST": "T091", "AN": "Specialty", "MS": "The practice of dentistry concerned with the dental problems of children, proper maintenance, and treatment. The dental care may include the services provided by dental specialists.", "OL": "use PEDIATRIC DENTISTRY to search PEDODONTICS 1966-92", "PM": "93; was PEDODONTICS 1965-92; was PEDODONTIA 1963-64", "HN": "93; was PEDODONTICS 1965-92; was PEDODONTIA 1963-64", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010377"}, {"RECTYPE": "D", "MH": "Pedophilia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Pederasty|T048|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Pedophilias", "MN": "F03.657.600", "MH_TH": "NLM (1975)", "ST": "T048", "MS": "A sexual disorder occurring in a person 16 years or older and that is recurrent with intense sexually arousing fantasies, sexual urges, or behaviors involving sexual activity with a prepubescent child (generally age 13 or younger). (from APA, DSM-IV, 1994).", "OL": "search PARAPHILIAS 1969-74", "PM": "91; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1969-80", "HN": "91(75); was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1969-80", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010378"}, {"RECTYPE": "D", "MH": "Peer Group", "ENTRY": "Peer Groups", "MN": "F01.829.316.483", "MH_TH": "POPLINE (1978)", "ST": "T098", "PI": "Group Processes (1966-1967)", "MS": "Group composed of associates of same species, approximately the same age, and usually of similar rank or social status.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010379"}, {"RECTYPE": "D", "MH": "Peer Review", "DE": "PEER REV", "AQ": "ES LJ MT ST TD", "ENTRY": "Reviews, Peer", "MN": "N03.706.700", "FX": "Ethical Review", "MH_TH": "POPLINE (1978)", "ST": "T058", "AN": "professionals evaluating professionals", "PI": "Quality of Health Care (1968-1970)", "MS": "An organized procedure carried out by a select committee of professionals in evaluating the performance of other professionals in meeting the standards of their specialty. Review by peers is used by editors in the evaluation of articles and other papers submitted for publication. Peer review is used also in the evaluation of grant applications. It is applied also in evaluating the quality of health care provided to patients.", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20021031", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D010380"}, {"RECTYPE": "D", "MH": "Pelger-Huet Anomaly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pseudo Pelger Hu\u00ebt Anomaly", "MN": "C16.320.784", "FX": "Lamin Type B", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "in titles & translations, use diacritic: Hu\u00ebt", "MS": "Autosomal dominant anomaly characterized by abnormal ovoid shape GRANULOCYTE nuclei and their clumping chromatin. Mutations in the LAMIN B receptor gene that results in reduced protein levels are associated with the disorder. Heterozygote individuals are healthy with normal granulocyte function while homozygote individuals occasionally have skeletal anomalies, developmental delay, and seizures.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010381"}, {"RECTYPE": "D", "MH": "Peliosis Hepatis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hepatis, Peliosis", "MN": "C14.907.609", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Liver Diseases (1966-1980)", "MS": "A vascular disease of the LIVER characterized by the occurrence of multiple blood-filled CYSTS or cavities. The cysts are lined with ENDOTHELIAL CELLS; the cavities lined with hepatic parenchymal cells (HEPATOCYTES). Peliosis hepatis has been associated with use of anabolic steroids (ANABOLIC AGENTS) and certain drugs.", "PM": "91; was see under LIVER DISEASES 1981-90", "HN": "91(81); was see under LIVER DISEASES 1981-90", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19800409", "DC": "1", "DX": "19910101", "UI": "D010382"}, {"RECTYPE": "D", "MH": "Pellagra", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pellagras", "MN": "C18.654.521.500.133.699.529", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A disease due to deficiency of NIACIN, a B-complex vitamin, or its precursor TRYPTOPHAN. It is characterized by scaly DERMATITIS which is often associated with DIARRHEA and DEMENTIA (the three D's).", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010383"}, {"RECTYPE": "D", "MH": "Pelvic Bones", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Pelvic Bone", "MN": "A02.835.232.043.825", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "/anat: CEPHALOPELVIC PROPORTION see PELVIMETRY is also available", "MS": "Bones that constitute each half of the pelvic girdle in VERTEBRATES, formed by fusion of the ILIUM; ISCHIUM; and PUBIC BONE.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010384"}, {"RECTYPE": "D", "MH": "Pelvic Exenteration", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Pelvic Exenterations", "MN": "E04.584", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Removal of all of the organs and adjacent structures of the pelvis. It is usually performed to surgically remove cancer involving the bladder, uterine cervix, or rectum. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "19950313", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010385"}, {"RECTYPE": "D", "MH": "Pelvic Neoplasms", "DE": "PELVIC NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pelvic Cancer|T191|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Pelvis Neoplasm", "MN": "C04.588.699", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "internal pelvic organs and region, not bones; if referring to pelvic region as an external site (as in skin lesions) ignore; general or unspecified; prefer specific precoord; coord IM with histol type of neopl if possible (IM)", "MS": "Tumors or cancer of the pelvic region.", "CATSH": "CAT LIST", "MR": "19991105", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010386"}, {"RECTYPE": "D", "MH": "Pelvimetry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Cephalopelvimetry|T060|T081|NON|NRW|UNK (19XX)|880406|abbcdef", "ENTRY": "Proportions, Cephalopelvic", "MN": "E05.041.690", "FX": "Pelvis", "MH_TH": "NLM (1966)", "ST": "T081", "AN": "NIM", "MS": "Measurement of the dimensions and capacity of the pelvis. It includes cephalopelvimetry (measurement of fetal head size in relation to maternal pelvic capacity), a prognostic guide to the management of LABOR, OBSTETRIC associated with disproportion.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010387"}, {"RECTYPE": "D", "MH": "Pelvis", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Region, Pelvic", "MN": "A01.923.600", "FX": "Pelvimetry", "MH_TH": "NLM (1963)", "ST": "T029", "AN": "internal pelvic region, not PELVIC BONES; / surg: consider also PELVIC EXENTERATION; LESSER PELVIS is also available", "MS": "The space or compartment surrounded by the pelvic girdle (bony pelvis). It is subdivided into the greater pelvis and LESSER PELVIS. The pelvic girdle is formed by the PELVIC BONES and SACRUM.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010388"}, {"RECTYPE": "D", "MH": "Pemoline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenylisohydantoin|T109|T121|NON|EQV|UNK (19XX)|780208|abbcdef", "ENTRY": "Magnesium, Pemoline", "MN": "D03.383.129.462.673", "PA": "Central Nervous System Stimulants", "MH_TH": "USAN (1966)", "ST": "T121", "N1": "4(5H)-Oxazolone, 2-amino-5-phenyl-", "RN": "7GAQ2332NK", "RR": "2152-34-3 (Pemoline)", "MS": "A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children.", "OL": "use PEMOLINE to search PEMOLINE COMPOUNDS 1966-78 (as Prov 1966-69)", "PM": "79; was PEMOLINE COMPOUNDS 1970-78", "HN": "79; was PEMOLINE COMPOUNDS 1966-78 (Prov 1966-69)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D010389"}, {"RECTYPE": "D", "MH": "Pemphigoid, Benign Mucous Membrane", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pemphigoid, Cicatricial|T047|NON|EQV|UNK (19XX)|800513|abcdef", "ENTRY": "Pemphigoids, Ocular Cicatricial", "MN": "C17.800.865.670", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Skin Diseases, Bullous (1976-1980)", "MS": "A chronic blistering disease with predilection for mucous membranes and less frequently the skin, and with a tendency to scarring. It is sometimes called ocular pemphigoid because of conjunctival mucous membrane involvement.", "PM": "1991;see SKIN DISEASES, VESICULOBULLOUS 1981-1990", "HN": "1991(1981); use SKIN DISEASES, VESICULOBULLOUS 1981-1990", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19800513", "DC": "1", "DX": "19910101", "UI": "D010390"}, {"RECTYPE": "D", "MH": "Pemphigoid, Bullous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pemphigoid|T047|NON|EQV|NLM (1998)|960723|abcdef", "ENTRY": "Pemphigoids", "MN": "C20.111.730", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Skin Diseases, Bullous (1976-1980)", "MS": "A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.", "PM": "91; was see under SKIN DISEASES, VESICULOBULLOUS 1981-90", "HN": "91(81); was see under SKIN DISEASES, VESICULOBULLOUS 1981-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19800513", "DC": "1", "DX": "19910101", "UI": "D010391"}, {"RECTYPE": "D", "MH": "Pemphigus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pemphigus Vulgaris|T047|NON|NRW|NLM (1991)|ORD (2010)|891221|abcdeef", "ENTRY": "Foliaceus, Pemphigus", "MN": "C20.111.736", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with PEMPHIGOID; /genet: consider also PEMPHIGUS, BENIGN FAMILIAL", "MS": "Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010392"}, {"RECTYPE": "D", "MH": "Pempidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.621.610", "PA": "Nicotinic Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Piperidine, 1,2,2,6,6-pentamethyl-", "RN": "N5I18JI9D6", "RR": "79-55-0 (Pempidine)", "AN": "a nicotinic antag & ganglionic blocker", "MS": "A nicotinic antagonist most commonly used as an experimental tool. It has been used as a ganglionic blocker in the treatment of hypertension but has largely been supplanted for that purpose by more specific drugs.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010393"}, {"RECTYPE": "D", "MH": "Penbutolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Penbutolol", "MN": "D02.092.063.624.698.688", "PA": "Antihypertensive Agents", "MH_TH": "NLM (1979)", "ST": "T121", "N1": "2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-", "RN": "78W62V43DY", "RR": "US71433228", "PI": "Propanolamines (1974-1978)", "MS": "A nonselective beta-blocker used as an antihypertensive and an antianginal agent.", "PM": "91; was see under PROPANOLAMINES 1979-90", "HN": "91(79); was see under PROPANOLAMINES 1979-90", "MR": "20130708", "DA": "19780320", "DC": "1", "DX": "19910101", "UI": "D010394"}, {"RECTYPE": "D", "MH": "Penfluridol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R16341", "MN": "D03.383.621.620", "PA": "Dopamine Antagonists", "MH_TH": "USAN (1971)", "ST": "T121", "N1": "4-Piperidinol, 1-(4,4-bis(4-fluorophenyl)butyl)-4-(4-chloro-3-(trifluoromethyl)phenyl)-", "RN": "25TLU22Q8H", "RR": "26864-56-2 (Penfluridol)", "PI": "Toluene (1973-1974)", "MS": "One of the long-acting ANTIPSYCHOTIC AGENTS used for maintenance or long-term therapy of SCHIZOPHRENIA and other PSYCHOTIC DISORDERS.", "PM": "91; was see under PIPERIDINES 1975-90", "HN": "91(75); was see under PIPERIDINES 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010395"}, {"RECTYPE": "D", "MH": "Penicillamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta,beta-Dimethylcysteine|T116|T121|NON|EQV|NLM (1991)|900511|abbcdef", "ENTRY": "beta,beta Dimethylcysteine", "MN": "D12.125.166.786", "PA": "Chelating Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "D-Valine, 3-mercapto-", "RN": "GNN1DV99GX", "RR": "52-67-5 (Penicillamine)", "AN": "degradation product of the penicillin antibiotics", "MS": "3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.", "PM": "64", "HN": "64(63)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D010396"}, {"RECTYPE": "D", "MH": "Penicillanic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Penicillanic", "MN": "D03.633.100.300.750.687", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1971)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-, (2S-cis)-", "RN": "87-53-6", "AN": "do not confuse with PENICILLIC ACID", "PI": "Thiazoles (1966-1970)", "MS": "A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed)", "OL": "use PENICILLANIC ACID to search PENICILLANIC ACIDS 1975-93", "PM": "94,73-74; was PENICILLANIC ACIDS 1975-93", "HN": "94,73-74(71-72); was PENICILLANIC ACIDS 1975-93", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010397"}, {"RECTYPE": "D", "MH": "Penicillic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Penicillic", "MN": "D23.946.587.735", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1975)", "ST": "T195", "N1": "2,5-Hexadienoic acid, 3-methoxy-5-methyl-4-oxo-", "RN": "ONL14K3AFD", "RR": "90-65-3 (Penicillic Acid)", "AN": "do not confuse with PENICILLANIC ACID", "PI": "Lactones (1973-1974)", "MS": "A mycotoxin with antibiotic and carcinogenic activity produced by various strains of PENICILLIUM and ASPERGILLUS. It has been found in tobacco, sausages, and corn.", "PM": "91; was see under CAPROATES 1975-90", "HN": "91(75); was see under CAPROATES 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010398"}, {"RECTYPE": "D", "MH": "Penicillin Amidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Penicillin Amidohydrolase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Amidohydrolase, Penicillin", "MN": "D08.811.277.087.690", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Penicillin amidohydrolase", "RN": "EC 3.5.1.11", "PI": "Penicillins (1970-1974)", "MS": "An enzyme catalyzing the hydrolysis of penicillin to penicin and a carboxylic acid anion. EC 3.5.1.11.", "PM": "91; was see under AMIDOHYDROLASES 1975-90", "HN": "91(75); was see under AMIDOHYDROLASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010399"}, {"RECTYPE": "D", "MH": "Penicillin G", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzylpenicillin|T109|T195|NON|EQV|FDA SRS (2014)|INN (19XX)|UNK (19XX)|740330|abbcdeeef", "ENTRY": "Van-Pen-G|T109|T195|TRD|NRW|US|041208|abbcdef", "MN": "D03.633.100.300.750.750", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1966)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2S-(2alpha,5alpha,6beta))-", "RN": "Q42T66VG0C", "RR": "YS5LY7JF4N", "AN": "general or unspecified; prefer specifics", "MS": "A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010400"}, {"RECTYPE": "D", "MH": "Penicillin G Benzathine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzathine Penicillin|T109|T195|NON|EQV|BAN (19XX)|FDA SRS (2014)|750709|abbcdeef", "ENTRY": "Penicillin, Benzathine", "MN": "D03.633.100.300.750.750.685", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2S-(2alpha,5alpha,6beta))-, compd. with N,N'-bis(phenylmethyl)-1,2-ethanediamine (2:1)", "RN": "RIT82F58GK", "RR": "SSZ1S4I0US", "MS": "Semisynthetic antibiotic prepared by combining the sodium salt of penicillin G with N,N'-dibenzylethylenediamine.", "PM": "2010; see PENICILLIN G 1985-1990, see PENICILLIN G, BENZATHINE 1963-1984", "HN": "2010 (1963)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010401"}, {"RECTYPE": "D", "MH": "Penicillin G Procaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Procaine, Penicillin G", "MN": "D03.633.100.300.750.750.695", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2S-(2alpha,5alpha,6beta))-, compd. with 2-(diethylamino)ethyl 4-aminobenzoate (1:1), monohydrate", "RN": "17R794ESYN", "RR": "6130-64-9 (Penicillin G Procaine)", "MS": "Semisynthetic antibiotic prepared by combining penicillin G with PROCAINE.", "PM": "2010; see PENICILLIN G 1985-1990, see PENICILLIN G, PROCAINE 1963-1984", "HN": "2010 (1963)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010402"}, {"RECTYPE": "D", "MH": "Penicillin Resistance", "AQ": "DE EH GE IM PH RE", "ENTRY": "Resistances, Penicillin", "MN": "G07.690.773.984.269.347.500.600", "MH_TH": "NLM (1964)", "ST": "T032", "MS": "Nonsusceptibility of an organism to the action of penicillins.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D010403"}, {"RECTYPE": "D", "MH": "Penicillin V", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Penicillin, Phenoxymethyl|T109|T195|NON|EQV|NLM (1992)|910322|abbcdef", "ENTRY": "VCillin K", "MN": "D03.633.100.300.750.781", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenoxyacetyl)amino)-, (2S-(2alpha,5alpha,6beta))-", "RN": "Z61I075U2W", "RR": "87-08-1 (Penicillin V)", "MS": "A broad-spectrum penicillin antibiotic used orally in the treatment of mild to moderate infections by susceptible gram-positive organisms.", "OL": "use PENICILLIN V to search PENICILLIN, PHENOXYMETHYL 1966-91; use PENICILLIN V/AA to search PROPICILLIN 1966-84 (as Prov 1966-72)", "PM": "92; was PENICILLIN, PHENOXYMETHYL 1963-91; PENICILLIN V was see PENICILLIN, PHENOXYMETHYL 1963-91; PROPICILLIN was heading 1973-84", "HN": "92; was PENICILLIN, PHENOXYMETHYL 1963-91; PENICILLIN V was see PENICILLIN, PHENOXYMETHYL 1963-91; PROPICILLIN was heading 1964-84 (Prov 1964-72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D010404"}, {"RECTYPE": "D", "MH": "Penicillinase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Lactamase I|T116|T126|NON|NRW|UNK (1990)|770113|BETA LACTAMASE 01|abbcdefs", "ENTRY": "gamma Penicillinase", "MN": "D08.811.277.087.180.697", "EC": "antagonists & inhibitors:beta-Lactamase Inhibitors", "MH_TH": "NLM (1979)", "ST": "T126", "RN": "EC 3.5.2.-", "MS": "A beta-lactamase preferentially cleaving penicillins. (Dorland, 28th ed) EC 3.5.2.-.", "PM": "84,63-78; was see under BETA-LACTAMASES 1979-83", "HN": "84(79)63; was see under BETA-LACTAMASES 1979-83", "MR": "20140610", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D010405"}, {"RECTYPE": "D", "MH": "Penicillins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antibiotics, Penicillin|T109|T195|NON|EQV|NLM (1996)|940822|abbcdef", "ENTRY": "Penicillin Antibiotics", "MN": "D03.633.100.300.750", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1966)", "ST": "T195", "RN": "0", "MS": "A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)", "OL": "use PENICILLINS to search PENICILLIN 1966-74 & HETACILLIN 1974-84", "PM": "75; was PENICILLIN 1963-74; /adverse effects /poisoning /toxicity were PENICILLIN TOXICOLOGY 1963-65; HETACILLIN was heading 1974-84", "HN": "75; was PENICILLIN 1963-74; /adv eff-pois-tox was PENICILLIN TOXICOLOGY 1963-65; HETACILLIN was heading 1974-84", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010406"}, {"RECTYPE": "D", "MH": "Penicillium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Penicilliums", "MN": "B01.300.381.662", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid5073", "AN": "infection: coordinate IM with MYCOSES (IM) or specific mycosis (IM)", "MS": "A mitosporic Trichocomaceae fungal genus that develops fruiting organs resembling a broom. When identified, teleomorphs include EUPENICILLIUM and TALAROMYCES. Several species (but especially PENICILLIUM CHRYSOGENUM) are sources of the antibiotic penicillin.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010407"}, {"RECTYPE": "D", "MH": "Penicillium chrysogenum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Penicillium notatum|T004|NON|EQV|NLM (1999)|980302|abcdef", "MN": "B01.300.381.662.592", "MH_TH": "NLM (1972)", "ST": "T004", "RN": "txid5076", "PI": "Penicillium (1966-1971)", "MS": "A mitosporic fungal species used in the production of penicillin.", "PM": "91; see PENICILLIUM 1972-90", "HN": "91(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010408"}, {"RECTYPE": "D", "MH": "Penile Diseases", "DE": "PENILE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Penis Disease", "MN": "C12.200.294.494", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes involving the PENIS or its component tissues.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010409"}, {"RECTYPE": "D", "MH": "Penile Erection", "AQ": "DE GE IM PH PX RE", "PRINT ENTRY": "Tumescence, Penile|T042|NON|NRW|UNK (19XX)|850606|abcdef", "ENTRY": "Tumescence, Nocturnal Penile", "MN": "G08.686.784.717", "MH_TH": "NLM (1986)", "ST": "T042", "PI": "Penis (1966-1985)", "MS": "The state of the PENIS when the erectile tissue becomes filled or swollen (tumid) with BLOOD and causes the penis to become rigid and elevated. It is a complex process involving CENTRAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEMS; HORMONES; SMOOTH MUSCLES; and vascular functions.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D010410"}, {"RECTYPE": "D", "MH": "Penile Induration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Peyronie's Disease|T047|EPO|EQV|UNK (19XX)|740330|PEYRONIES DIS|abcdefv", "ENTRY": "Peyronies Disease", "MN": "C17.300.715", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A condition characterized by hardening of the PENIS due to the formation of fibrous plaques on the dorsolateral aspect of the PENIS, usually involving the membrane (tunica albuginea) surrounding the erectile tissue (corpus cavernosum penis). This may eventually cause a painful deformity of the shaft or constriction of the urethra, or both.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010411"}, {"RECTYPE": "D", "MH": "Penile Neoplasms", "DE": "PENILE NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Penile Cancer|T191|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Penis Neoplasm", "MN": "C12.900.619.500", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Cancers or tumors of the PENIS or of its component tissues.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010412"}, {"RECTYPE": "D", "MH": "Penis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Penis, Glans", "MN": "A05.360.444.492", "EC": "transplantation:Penile Transplantation", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at PENILE", "MS": "The external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra.", "MR": "20220408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010413"}, {"RECTYPE": "D", "MH": "Pennsylvania", "AQ": "EH EP", "MN": "Z01.107.567.875.500.550", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "PHILADELPHIA is also available", "MS": "State bounded on the north by New York and Lake Erie, on the east by Delaware and New Jersey, on the south by Delaware and Maryland, and on the west by Ohio and West Virginia.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D010414"}, {"RECTYPE": "D", "MH": "Pensions", "AQ": "CL HI SN", "PRINT ENTRY": "Retirement Benefits|T081|NON|EQV|UNK (19XX)|770425|abcdef", "ENTRY": "Retirement Benefit", "MN": "N01.824.417.510", "MH_TH": "NLM (1966)", "ST": "T081", "MS": "Fixed sums paid regularly to individuals.", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010415"}, {"RECTYPE": "D", "MH": "Pentachlorophenol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pentachlorophenate, Sodium", "MN": "D02.455.426.559.389.657.190.633", "PA": "Uncoupling Agents", "MH_TH": "NLM (1971)", "ST": "T131", "N1": "Phenol, pentachloro-", "RN": "D9BSU0SE4T", "RR": "87-86-5 (Pentachlorophenol)", "PI": "Phenols (1966-1970)", "MS": "An insecticide and herbicide that has also been used as a wood preservative. Pentachlorphenol is a widespread environmental pollutant. Both chronic and acute pentachlorophenol poisoning are medical concerns. The range of its biological actions is still being actively explored, but it is clearly a potent enzyme inhibitor and has been used as such as an experimental tool.", "PM": "91; was see under CHLOROPHENOLS 1977-90; was see under PHENOLS 1971-76", "HN": "91(71); was see under CHLOROPHENOLS 1977-90; was see under PHENOLS 1971-76", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010416"}, {"RECTYPE": "D", "MH": "Pentaerythritol Tetranitrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tetranitrate, Pentaerythritol", "MN": "D02.033.455.706.690", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,3-Propanediol, 2,2-bis((nitrooxy)methyl)-, dinitrate (ester)", "RN": "10L39TRG1Z", "RR": "78-11-5 (Pentaerythritol Tetranitrate)", "MS": "A vasodilator with general properties similar to NITROGLYCERIN but with a more prolonged duration of action. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1025)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010417"}, {"RECTYPE": "D", "MH": "Pentagastrin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pentapeptide, Gastrin", "MN": "D12.644.456.716", "FX": "Gastrointestinal Agents", "MH_TH": "USAN (1967)", "ST": "T125", "N1": "L-Phenylalaninamide, N-((1,1-dimethylethoxy)carbonyl)-beta-alanyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-", "RN": "EF0NX91490", "RR": "5534-95-2 (Pentagastrin)", "PI": "Peptides (1966-1971)", "MS": "A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid.", "PM": "73", "HN": "73(72)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010418"}, {"RECTYPE": "D", "MH": "Pentamidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pentamidine Isethionate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|USAN (19XX)|USP (19XX)|741111|abbcdeeeef", "ENTRY": "Pentamidine Mesylate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|820903|abbcdeef", "MN": "D02.078.100.700", "PA": "Trypanocidal Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenecarboximidamide, 4,4'-(1,5-pentanediylbis(oxy))bis-", "RN": "673LC5J4LQ", "RR": "V2P3K60DA2", "PI": "Phenyl Ethers (1974)", "MS": "Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.", "PM": "90; was see under AMIDINES 1975-89", "HN": "90(75); was see under AMIDINES 1975-89", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19900101", "UI": "D010419"}, {"RECTYPE": "D", "MH": "Pentanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isopentanes|T109|NON|NRW|UNK (19XX)|770520|abcdef", "MN": "D02.455.326.146.770", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "AN": "CYCLOPENTANES is also available", "PI": "Hydrocarbons (1966-1977)", "MS": "Five-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives.", "PM": "78", "HN": "78", "MR": "19970620", "DA": "19770520", "DC": "1", "DX": "19780101", "UI": "D010420"}, {"RECTYPE": "D", "MH": "Pentanoic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Pentanoic", "MN": "D10.251.400.895.593", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "Straight-chain CARBOXYLIC ACIDS with the general formula C5H10O2.", "OL": "search VALERATES 1966-74", "PM": "91; was see under VALERATES 1975-90", "HN": "91(75); was see under VALERATES 1975-90", "MR": "20161101", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010421"}, {"RECTYPE": "D", "MH": "Pentanones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methyl Propyl Ketones|T109|NON|NRW|UNK (19XX)|741111|abcdef", "ENTRY": "Propyl Ketones, Methyl", "MN": "D02.522.720", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Ketones (1966-1974)", "MS": "5-carbon straight-chain or branched-chain ketones.", "PM": "91; was see under KETONES 1975-90", "HN": "91(75); was see under KETONES 1975-90", "MR": "20000622", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010422"}, {"RECTYPE": "D", "MH": "Pentazocine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Lactate, Pentazocine", "MN": "D04.615.723.795.106.700", "PA": "Narcotics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2alpha,6alpha,11R*)-", "RN": "RP4A60D26L", "RR": "A36BXO4PPX", "MS": "The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)", "PM": "66", "HN": "66(64)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010423"}, {"RECTYPE": "D", "MH": "Pentobarbital", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mebumal|T109|T121|TRD|NRW|UNK (19XX)|761230|abbcdef", "ENTRY": "Monosodium Salt Pentobarbital", "MN": "D03.383.742.698.253.593", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-", "RN": "I4744080IR", "RR": "NJJ0475N0S", "MS": "A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010424"}, {"RECTYPE": "D", "MH": "Pentolinium Tartrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tartrate, Pentolonium", "MN": "D03.383.773.700", "PA": "Nicotinic Antagonists", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Pyrrolidinium, 1,1'-(1,5-pentanediyl)bis(1-methyl)-, salt with (R-(R*,R*))-2,3-dihydroxybutanedioic acid (1:2)", "RN": "953357GACY", "RR": "ULL76WPU5X", "MS": "A nicotinic antagonist that has been used as a ganglionic blocking agent in hypertension.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010425"}, {"RECTYPE": "D", "MH": "Pentosan Sulfuric Polyester", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polypentose Sulfate|T109|T121|NON|EQV|UNK (19XX)|771125|abbcdef", "ENTRY": "Xylan, Polysulfated", "MN": "D09.698.682", "PA": "Anticoagulants", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Xylan, hydrogen sulfate", "RN": "37300-21-3", "RR": "116001-96-8 (sodium salt)", "PI": "Sulfuric Acids (1972-1974)", "MS": "A sulfated pentosyl polysaccharide with heparin-like properties.", "PM": "1991; see POLYSACCHARIDES 1975-1990", "HN": "1991(1975)", "MR": "20160628", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010426"}, {"RECTYPE": "D", "MH": "Pentose Phosphate Pathway", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Pentosephosphate Pathway|T044|NON|EQV|NLM (1985)|990101|abcdef", "ENTRY": "Shunts, Pentosephosphate", "MN": "G03.493.695", "MH_TH": "UNK (19XX)", "ST": "T044", "PI": "Pentosephosphates (1966-1984)", "MS": "An oxidative decarboxylation process that converts GLUCOSE-6-PHOSPHATE to D-ribose-5-phosphate via 6-phosphogluconate. The pentose product is used in the biosynthesis of NUCLEIC ACIDS. The generated energy is stored in the form of NADPH. This pathway is prominent in tissues which are active in the synthesis of FATTY ACIDS and STEROIDS.", "PM": "2006; see PENTOSEPHOSPHATE PATHWAY 1985-2005", "HN": "2006 (1985)", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19840529", "DC": "1", "DX": "19850101", "UI": "D010427"}, {"RECTYPE": "D", "MH": "Pentosephosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.894.643", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "/metab: consider also PENTOSE PHOSPHATE PATHWAY", "MR": "20050701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010428"}, {"RECTYPE": "D", "MH": "Pentoses", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pentose|T109|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Ketopentoses|T109|NON|NRW|NLM (2018)|170118|abcdef", "MN": "D09.947.875.627", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified only; prefer specifics", "MS": "Monosaccharide sugar molecules that contain a five carbon backbone.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010429"}, {"RECTYPE": "D", "MH": "Pentosyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.913.400.725", "MH_TH": "NLM (1972)", "ST": "T126", "RN": "EC 2.4.2.-", "PI": "Transferases (1966-1971)", "MS": "Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another.", "PM": "72", "HN": "72", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010430"}, {"RECTYPE": "D", "MH": "Pentoxifylline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "BL191", "MN": "D03.633.100.759.758.824.651.700", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-", "RN": "SD6QCT3TSU", "RR": "6493-05-6 (Pentoxifylline)", "PI": "Xanthines (1972-1976)", "MS": "A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production.", "PM": "91; see THEOBROMINE 1977-90", "HN": "91(77)", "MR": "20160531", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D010431"}, {"RECTYPE": "D", "MH": "Pentoxyl", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.742.698.875.700", "MH_TH": "NLM (1980)", "ST": "T121", "N1": "2,4(1H,3H)-Pyrimidinedione, 5-(hydroxymethyl)-6-methyl-", "RN": "7LCS1FW4JV", "RR": "147-61-5 (Pentoxyl)", "PI": "Uracil (1966-1974) /AA (1975-1979)", "MS": "5-Hydroxymethyl-6-methyl- 2,4-(1H,3H)-pyrimidinedione. Uracil derivative used in combination with toxic antibiotics to lessen their toxicity; also to stimulate leukopoiesis and immunity. Synonyms: pentoksil; hydroxymethylmethyluracil.", "PM": "91; was see under URACIL 1980-90", "HN": "91(80); was see under URACIL 1980-90", "MR": "20160531", "DA": "19790302", "DC": "1", "DX": "19910101", "UI": "D010432"}, {"RECTYPE": "D", "MH": "Pentylenetetrazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pentetrazole|T109|T121|NON|EQV|BAN (19XX)|INN (19XX)|770429|abbcdeef", "ENTRY": "Pentylenetetrazol|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|811218|abbcdeef", "MN": "D03.383.066.600", "PA": "GABA Antagonists", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "5H-Tetrazolo(1,5-a)azepine, 6,7,8,9-tetrahydro-", "RN": "WM5Z385K7T", "RR": "54-95-5 (Pentylenetetrazole)", "MS": "A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010433"}, {"RECTYPE": "D", "MH": "Pepsin A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pepsin|T116|T121|T126|NON|EQV|NLM (1991)|900404|abbbcdef", "ENTRY": "Pepsin 3|T116|T121|T126|NON|NRW|UNK (19XX)|861007|abbbcdef", "MN": "D08.811.277.656.300.048.700", "PA": "Gastrointestinal Agents", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.4.23.1", "RR": "9001-75-6 (CAS RN)", "AN": "/biosyn /physiol permitted", "MS": "Formed from pig pepsinogen by cleavage of one peptide bond. The enzyme is a single polypeptide chain and is inhibited by methyl 2-diaazoacetamidohexanoate. It cleaves peptides preferentially at the carbonyl linkages of phenylalanine or leucine and acts as the principal digestive enzyme of gastric juice.", "OL": "use PEPSIN A to search PEPSIN 1966-90", "PM": "91; was PEPSIN 1964-90", "HN": "91; was PEPSIN 1964-90", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010434"}, {"RECTYPE": "D", "MH": "Pepsinogens", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pepsinogen B|T116|T123|NON|NRW|NLM (1999)|971212|abbcdef", "MN": "D12.776.811.243.509", "FX": "Gastric Juice", "MH_TH": "NLM (1972)", "ST": "T123", "RN": "0", "AN": "do not confuse with PEPSINOGEN see PEPSINOGEN A", "PI": "Pepsinogen (1972-1998)", "MS": "Proenzymes secreted by chief cells, mucous neck cells, and pyloric gland cells, which are converted into pepsin in the presence of gastric acid or pepsin itself. (Dorland, 28th ed) In humans there are 2 related pepsinogen systems: PEPSINOGEN A (formerly pepsinogen I or pepsinogen) and PEPSINOGEN C (formerly pepsinogen II or progastricsin). Pepsinogen B is the name of a pepsinogen from pigs.", "PM": "99; see Pepsinogen 1972-98", "HN": "99(72)", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010435"}, {"RECTYPE": "D", "MH": "Pepstatins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.644.456.724", "PA": "Protease Inhibitors", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "protease inhib", "PI": "Oligopeptides (1973-1974)", "MS": "N-acylated oligopeptides isolated from culture filtrates of Actinomycetes, which act specifically to inhibit acid proteases such as pepsin and renin.", "PM": "91; was see under OLIGOPEPTIDES 1975-90", "HN": "91(75); was see under OLIGOPEPTIDES 1975-90", "MR": "19950608", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010436"}, {"RECTYPE": "D", "MH": "Peptic Ulcer", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Marginal Ulcer|T020|T047|NON|NRW|NLM (1997)|960415|abbcdef", "ENTRY": "Ulcers, Peptic", "MN": "C06.405.748.586", "FX": "Zollinger-Ellison Syndrome", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "prefer specifics STOMACH ULCER or DUODENAL ULCER; stress ulcer: coordinate with STRESS, PHYSIOLOGICAL or STRESS, PSYCHOLOGICAL", "MS": "Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).", "PM": "MARGINAL ULCER was heading 1964-96 (see under PEPTIC ULCER 1964-90)", "HN": "MARGINAL ULCER was heading 1964-96 (see under PEPTIC ULCER 1964-90)", "CATSH": "CAT LIST", "MR": "20150625", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010437"}, {"RECTYPE": "D", "MH": "Peptic Ulcer Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Peptic Ulcer|T033|T046|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Ulcer Hemorrhage, Peptic", "MN": "C23.550.414.788.700", "FX": "Peptic Ulcer", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "coord IM with STOMACH ULCER (IM) or DUODENAL ULCER (IM) if appropriate", "MS": "Bleeding from a PEPTIC ULCER that can be located in any segment of the GASTROINTESTINAL TRACT.", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010438"}, {"RECTYPE": "D", "MH": "Peptic Ulcer Perforation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ulcer Perforations, Peptic", "MN": "C06.405.748.586.698", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with STOMACH ULCER /compl (IM) or DUODENAL ULCER /compl (IM) if pertinent", "MS": "Penetration of a PEPTIC ULCER through the wall of DUODENUM or STOMACH allowing the leakage of luminal contents into the PERITONEAL CAVITY.", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010439"}, {"RECTYPE": "D", "MH": "Peptichemio", "AQ": "AA AD AE AG AI AN BL CF CH CL CS DE EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D12.644.456.726", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Peptichemio", "RN": "9076-25-9", "PI": "Peptides (1974)", "MS": "A mixture of six synthetic oligopeptides, each containing MELPHALAN. It is used as a broad-spectrum antineoplastic due to its alkylating and antimetabolic actions but, is toxic to bone marrow, gastrointestinal system and vasculature.", "PM": "91; was see under MELPHALAN 1981-90; was see under NITROGEN MUSTARD COMPOUNDS 1975-80", "HN": "91(75); was see under MELPHALAN 1981-90; was see under NITROGEN MUSTARD COMPOUNDS 1975-80", "MR": "20000622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010440"}, {"RECTYPE": "D", "MH": "Peptide Chain Elongation, Translational", "AQ": "DE ES GE IM PH RE", "ENTRY": "Protein Translational Elongation", "MN": "G03.734.871.640", "FX": "Protein Synthesis Inhibitors", "MH_TH": "NLM (2005)", "ST": "T044", "AN": "coordinate with specific peptide; for protein biosynthesis on the ribosome only; for non-ribosomal biosynthesis use PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT", "PI": "Peptides/biosynthesis (1966-1970)", "MS": "A process of GENETIC TRANSLATION, when an amino acid is transferred from its cognate TRANSFER RNA to the lengthening chain of PEPTIDES.", "PM": "2005; see PEPTIDE CHAIN ELONGATION 1973-2004", "HN": "2005(1971)", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010441"}, {"RECTYPE": "D", "MH": "Peptide Chain Initiation, Translational", "AQ": "DE ES GE IM PH RE", "ENTRY": "Protein Translational Initiation", "MN": "G03.734.871.650", "FX": "Protein Synthesis Inhibitors", "MH_TH": "NLM (2005)", "ST": "T044", "AN": "coordinate with specific peptide; for protein biosynthesis on the ribosome only; for non-ribosomal biosynthesis use PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT", "PI": "Peptides/biosynthesis (1966-1970)", "MS": "A process of GENETIC TRANSLATION whereby the formation of a peptide chain is started. It includes assembly of the RIBOSOME components, the MESSENGER RNA coding for the polypeptide to be made, INITIATOR TRNA, and PEPTIDE INITIATION FACTORS; and placement of the first amino acid in the peptide chain. The details and components of this process are unique for prokaryotic protein biosynthesis and eukaryotic protein biosynthesis.", "PM": "2005; see PEPTIDE CHAIN INITIATION 1973-2004", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010442"}, {"RECTYPE": "D", "MH": "Peptide Chain Termination, Translational", "AQ": "DE ES GE IM PH RE", "ENTRY": "Termination, Protein Translational", "MN": "G03.734.871.720", "FX": "Peptide Termination Factors", "MH_TH": "NLM (2005)", "ST": "T044", "AN": "coordinate with specific peptide; for protein biosynthesis on the ribosome only; for non-ribosomal biosynthesis use PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT", "PI": "Peptides/biosynthesis (1966-1970)", "MS": "A process of GENETIC TRANSLATION whereby the terminal amino acid is added to a lengthening polypeptide. This termination process is signaled from the MESSENGER RNA, by one of three termination codons (CODON, TERMINATOR) that immediately follows the last amino acid-specifying CODON.", "PM": "2005; see PEPTIDE CHAIN TERMINATION 1973-2004", "HN": "2005(1971)", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010443"}, {"RECTYPE": "D", "MH": "Peptide Elongation Factor Tu", "DE": "EFTU", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Elongation Factor Tu|T116|T126|NON|EQV|UNK (19XX)|850606|abbcdef", "ENTRY": "eEF Tu", "MN": "D12.776.835.700.350.700", "MH_TH": "NLM (1986)", "ST": "T126", "RN": "EC 3.6.1.-", "AN": "coordinate with MITOCHONDRIAL PROTEINS or BACTERIAL PROTEINS if pertinent", "PI": "Proteins (1966-1972)", "MS": "A protein found in bacteria and eukaryotic mitochondria which delivers aminoacyl-tRNA's to the A site of the ribosome. The aminoacyl-tRNA is first bound to a complex of elongation factor Tu containing a molecule of bound GTP. The resulting complex is then bound to the 70S initiation complex. Simultaneously the GTP is hydrolyzed and a Tu-GDP complex is released from the 70S ribosome. The Tu-GTP complex is regenerated from the Tu-GDP complex by the Ts elongation factor and GTP.", "PM": "86", "HN": "86", "MR": "20210521", "DA": "19850606", "DC": "1", "DX": "19860101", "UI": "D010444"}, {"RECTYPE": "D", "MH": "Peptide Elongation Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Factors, Peptide Elongation", "MN": "D12.776.835.700", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "AN": "/drug eff /biosyn /physiol /ultrastruct permitted", "PI": "Proteins (1966-1972)", "MS": "Protein factors uniquely required during the elongation phase of protein synthesis.", "PM": "73", "HN": "73", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010445"}, {"RECTYPE": "D", "MH": "Peptide Fragments", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Fragment|T116|NON|EQV|NLM (2022)|201005|abcdef", "ENTRY": "Fragments, Peptide", "MN": "D12.644.541", "MH_TH": "NLM (1974)", "ST": "T116", "RN": "0", "MS": "Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.", "PM": "74", "HN": "74", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010446"}, {"RECTYPE": "D", "MH": "Peptide Hydrolases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proteolytic Enzymes|T116|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Hydrolase, Peptide", "MN": "D08.811.277.656", "EC": "antagonists & inhibitors:Protease Inhibitors", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.4.-", "MS": "Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES.", "PM": "1966; for PROTEINASES see ENDOPEPTIDASES 1979-2004; for PROTEASES see ENDOPEPTIDASES 1987-2004", "HN": "1966; for PROTEINASES use ENDOPEPTIDASES 1979-2000; for PROTEASES use ENDOPEPTIDASES 1987-2004", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010447"}, {"RECTYPE": "D", "MH": "Peptide Initiation Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Initiation Factors|T116|T123|NON|EQV|NLM (2003)|020411|abbcdef", "ENTRY": "Initiation Factors, Peptide", "MN": "D12.776.835.725", "FX": "Peptide Chain Initiation, Translational", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Proteins (1966-1972)", "MS": "Protein factors uniquely required during the initiation phase of protein synthesis in GENETIC TRANSLATION.", "PM": "73", "HN": "73", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010448"}, {"RECTYPE": "D", "MH": "Peptide Mapping", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Protein Fingerprinting|T059|NON|EQV|NLM (2001)|991222|abcdef", "ENTRY": "Protein Fingerprints", "MN": "E05.393.760.705.685", "FX": "Peptide Fragments", "MH_TH": "NLM (1987)", "ST": "T059", "PI": "Electrophoresis, Paper (1973-1986)", "MS": "Analysis of PEPTIDES that are generated from the digestion or fragmentation of a protein or mixture of PROTEINS, by ELECTROPHORESIS; CHROMATOGRAPHY; or MASS SPECTROMETRY. The resulting peptide fingerprints are analyzed for a variety of purposes including the identification of the proteins in a sample, GENETIC POLYMORPHISMS, patterns of gene expression, and patterns diagnostic for diseases.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19860624", "DC": "1", "DX": "19870101", "UI": "D010449"}, {"RECTYPE": "D", "MH": "Endopeptidases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Peptidohydrolases|T116|T126|NON|EQV|NLM (1966)|990101|abbcdef", "MN": "D08.811.277.656.300", "EC": "antagonists & inhibitors:Protease Inhibitors", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 3.4.-", "MS": "A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS.", "PM": "2000; see PEPTIDE PEPTIDOHYDROLASES 1963-1999; for ENDOPEPTIDASES see PEPTIDE PEPTIDOHYDROLASES 1980-1999", "HN": "2000(1963)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D010450"}, {"RECTYPE": "D", "MH": "Peptide PHI", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Peptide PHM|T116|T123|EQV|UNK (19XX)|860414|abbdef", "ENTRY": "Pro Vasoactive Intestinal Peptide", "MN": "D12.776.631.650.610", "MH_TH": "NLM (1987)", "ST": "T123", "RN": "0", "AN": "a neurotransmitter; entry term explains PHI", "PI": "Peptides (1966-1986)", "MS": "A 27-amino acid peptide with histidine at the N-terminal and isoleucine amide at the C-terminal. The exact amino acid composition of the peptide is species dependent. The peptide is secreted in the intestine, but is found in the nervous system, many organs, and in the majority of peripheral tissues. It has a wide range of biological actions, affecting the cardiovascular, gastrointestinal, respiratory, and central nervous systems.", "PM": "87", "HN": "87", "MR": "20151124", "DA": "19860414", "DC": "1", "DX": "19870101", "UI": "D010451"}, {"RECTYPE": "D", "MH": "Peptide Biosynthesis", "DE": "PEPTIDE BIOSYN", "AQ": "DE GE IM PH RE", "ENTRY": "Biosynthesis, Peptide", "MN": "G03.734", "FX": "Protein Biosynthesis", "MH_TH": "NLM (2005)", "ST": "T044", "AN": "general or unspecified; prefer specific peptide/biosyn; PROTEIN BIOSYNTHESIS and PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT are also available", "PI": "Peptides/biosynthesis (1966-1997)", "MS": "The production of PEPTIDES or PROTEINS by the constituents of a living organism. The biosynthesis of proteins on RIBOSOMES following an RNA template is termed translation (TRANSLATION, GENETIC). There are other, non-ribosomal peptide biosynthesis (PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT) mechanisms carried out by PEPTIDE SYNTHASES and PEPTIDYLTRANSFERASES. Further modifications of peptide chains yield functional peptide and protein molecules.", "PM": "2005; see PEPTIDE SYNTHESIS 1998-2004", "HN": "2005 (1998)", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D010452"}, {"RECTYPE": "D", "MH": "Peptide Synthases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Synthetases|T116|T126|NON|EQV|NLM (1998)|961120|abbcdef", "ENTRY": "Synthetases, Peptide", "MN": "D08.811.464.259.850", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 6.3.2.-", "PI": "Ligases (1966-1972)", "MS": "Ligases that catalyze the joining of adjacent AMINO ACIDS by the formation of carbon-nitrogen bonds between their carboxylic acid groups and amine groups.", "PM": "1998; see PEPTIDE SYNTHETASES 1973-1997", "HN": "1998(1973)", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010453"}, {"RECTYPE": "D", "MH": "Peptide Termination Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Termination Factors, Peptide", "MN": "D12.776.835.862", "FX": "Peptide Chain Termination, Translational", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "PI": "Proteins (1966-1972)", "MS": "Proteins that are involved in the peptide chain termination reaction (PEPTIDE CHAIN TERMINATION, TRANSLATIONAL) on RIBOSOMES. They include codon-specific class-I release factors, which recognize stop signals (TERMINATOR CODON) in the MESSENGER RNA; and codon-nonspecific class-II release factors.", "PM": "73", "HN": "73", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010454"}, {"RECTYPE": "D", "MH": "Peptides", "AQ": "AD AE AG AI AN BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polypeptides|T116|NON|NRW|UNK (19XX)|740330|abcdef", "MN": "D12.644", "FX": "Amino Acid Sequence", "EC": "biosynthesis:Peptide Biosynthesis", "MH_TH": "NLM (1966)", "ST": "T116", "RN": "0", "MS": "Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS.", "MR": "20210628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010455"}, {"RECTYPE": "D", "MH": "Peptides, Cyclic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Orbitide|T116|NON|NRW|NLM (2021)|191119|abcdef", "ENTRY": "Peptides, Circular", "MN": "D12.644.641", "MH_TH": "NLM (1971)", "ST": "T116", "RN": "0", "PI": "Peptides (1966-1970)", "MS": "Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL).", "PM": "1973", "HN": "1973 (1971)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010456"}, {"RECTYPE": "D", "MH": "Peptidoglycan", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PO RE TO TU UL UR", "PRINT ENTRY": "Murein|T109|T123|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Pseudomurein|T109|T123|NON|NRW|UNK (19XX)|831020|abbcdef", "MN": "D23.050.161.616.594", "MH_TH": "NLM (1971)", "ST": "T123", "RN": "0", "AN": "coordinate with specific bacterium", "PI": "Polysaccharides, Bacterial (1966-1970)", "MS": "A structural polymer of the bacterial cell envelope consisting of sugars and amino acids which is responsible for both shape determination and cellular integrity under osmotic stress in virtually all bacteria.", "PM": "73", "HN": "73(71)", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010457"}, {"RECTYPE": "D", "MH": "Peptidyl Transferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transpeptidases|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Translocases, Peptidyl", "MN": "D08.811.913.050.200.700", "FX": "Ribosomal Proteins", "MH_TH": "NLM (1998)", "ST": "T126", "N1": "Peptidyl-tRNA:aminoacyl-tRNA N-peptidyltransferase", "RN": "EC 2.3.2.12", "RR": "9059-29-4 (CAS RN)", "PI": "Peptides (1972-1974)", "MS": "Acyltransferases that use AMINO ACYL TRNA as the amino acid donor in formation of a peptide bond. There are ribosomal and non-ribosomal peptidyltransferases.", "PM": "2005; see PEPTIDYLTRANSFERASE 1998-2004, see PEPTIDYL TRANSFERASES 1991-1997, see ACYLTRANSFERASES 1975-1990", "HN": "2005(1975)", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010458"}, {"RECTYPE": "D", "MH": "Peptococcaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.562", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid186807", "PI": "Micrococcaceae (1975)", "MS": "A family of bacteria found in the mouth and intestinal and respiratory tracts of man and other animals as well as in the human female urogenital tract. Its organisms are also found in soil and on cereal grains.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750721", "DC": "1", "DX": "19760101", "UI": "D010459"}, {"RECTYPE": "D", "MH": "Peptococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.562.593", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid2740", "AN": "infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM)", "MS": "A genus of gram-positive, anaerobic, coccoid bacteria that is part of the normal flora of the mouth, upper respiratory tract, and large intestine in humans. Its organisms cause infections of soft tissues and bacteremias.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010460"}, {"RECTYPE": "D", "MH": "Peptones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peptone|T116|T130|NON|EQV|UNK (19XX)|840919|abbcdef", "MN": "D12.776.719", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "AN": "proteins", "MS": "Derived proteins or mixtures of cleavage products produced by the partial hydrolysis of a native protein either by an acid or by an enzyme. Peptones are readily soluble in water, and are not precipitable by heat, by alkalis, or by saturation with ammonium sulfate. (Dorland, 28th ed)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010461"}, {"RECTYPE": "D", "MH": "Peptostreptococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.625", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1257", "AN": "infection: coordinate with GRAM-POSITIVE BACTERIAL INFECTIONS", "MS": "A genus of gram-positive, anaerobic, coccoid bacteria that is part of the normal flora of humans. Its organisms are opportunistic pathogens causing bacteremias and soft tissue infections.", "OL": "use MICROCOCCUS to search GAFFKYA ANAEROBIA 1979-91", "PM": "GAFFKYA ANAEROBIA was see MICROCOCCUS 1979-91", "HN": "GAFFKYA ANAEROBIA was see MICROCOCCUS 1979-91", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010462"}, {"RECTYPE": "D", "MH": "Peracetic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Peroxyacetic Acid|T109|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abcdeef", "ENTRY": "Peracetate, Zinc", "MN": "D02.241.081.018.664", "PA": "Oxidants", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "Ethaneperoxoic acid", "RN": "I6KPI2E1HD", "RR": "79-21-0 (Peracetic Acid)", "PI": "Peroxides (1969-1974)", "MS": "A liquid that functions as a strong oxidizing agent. It has an acrid odor and is used as a disinfectant.", "PM": "91; was see under ACETIC ACIDS 1975-90", "HN": "91(75); was see under ACETIC ACIDS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010463"}, {"RECTYPE": "D", "MH": "Perazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Maleate, Perazine", "MN": "D03.633.300.783.575", "PA": "Dopamine Antagonists", "MH_TH": "NLM (1976)", "ST": "T121", "N1": "10H-Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-", "RN": "8915147A2B", "RR": "84-97-9 (Perazine)", "PI": "Piperazines (1972-1975)", "MS": "A phenothiazine antipsychotic with actions and uses similar to those of CHLORPROMAZINE. Extrapyramidal symptoms may be more common than other side effects.", "PM": "91; was see under PHENOTHIAZINE TRANQUILIZERS 1976-90", "HN": "91(76); was see under PHENOTHIAZINE TRANQUILIZERS 1976-90", "MR": "20180705", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D010464"}, {"RECTYPE": "D", "MH": "Perception", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Sensory Processing|T041|NON|EQV|NLM (2021)|200103|abcdef", "ENTRY": "Processing, Sensory", "MN": "F02.463.593", "FX": "Sensation", "MH_TH": "NLM (1963)", "ST": "T041", "AN": "general; prefer specifics", "MS": "The process by which the nature and meaning of sensory stimuli are recognized and interpreted.", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010465"}, {"RECTYPE": "D", "MH": "Perceptual Closure", "AQ": "PH", "PRINT ENTRY": "Perceptual Completion Phenomena|T041|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Phenomena, Perceptual Completion", "MN": "F02.463.593.932.677", "MH_TH": "NLM (1969)", "ST": "T041", "PI": "Visual Perception (1966-1968)", "MS": "The tendency to perceive an incomplete pattern or object as complete or whole. This includes the Gestalt Law of Closure.", "OL": "use PERCEPTUAL CLOSURE to search GESTALT LAW OF CLOSURE 1969-78", "PM": "69", "HN": "69; GESTALT LAW OF CLOSURE was see under PERCEPTUAL CLOSURE 1969-78", "CATSH": "CAT LIST", "MR": "20021024", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D010466"}, {"RECTYPE": "D", "MH": "Perceptual Defense", "ENTRY": "Defenses, Perceptual", "MN": "F01.393.628", "MH_TH": "NLM (1965)", "ST": "T041", "MS": "Selective perceiving such that the individual protects himself from becoming aware of something unpleasant or threatening, e.g., obscene words are not heard correctly, or violent acts are not seen accurately.", "PM": "70", "HN": "70(65)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D010467"}, {"RECTYPE": "D", "MH": "Perceptual Disorders", "DE": "PERCEPTUAL DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Hemispatial Neglect|T048|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Somatosensory Discrimination Disorders", "MN": "F01.700.750", "MH_TH": "NLM (1969)", "ST": "T048", "PI": "Phantom Limb (1966-1968)", "MS": "Cognitive disorders characterized by an impaired ability to perceive the nature of objects or concepts through use of the sense organs. These include spatial neglect syndromes, where an individual does not attend to visual, auditory, or sensory stimuli presented from one side of the body.", "PM": "1969", "HN": "1969", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D010468"}, {"RECTYPE": "D", "MH": "Perceptual Distortion", "AQ": "CL DE ES PH RE", "ENTRY": "Perceptual Distortions", "MN": "F02.463.593.603", "FX": "Perceptual Disorders", "MH_TH": "NLM (1967)", "ST": "T041", "PI": "Perception (1966)", "MS": "Lack of correspondence between the way a stimulus is commonly perceived and the way an individual perceives it under given conditions.", "PM": "69", "HN": "69(67)", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D010469"}, {"RECTYPE": "D", "MH": "Perceptual Masking", "AQ": "PH", "PRINT ENTRY": "Masking, Perceptual|T041|NON|EQV|UNK (19XX)|781214|abcdef", "ENTRY": "Perceptual Maskings", "MN": "G07.888.125.594", "MH_TH": "NLM (1972)", "ST": "T041", "PI": "Visual Perception (1966-1971)", "MS": "The interference of one perceptual stimulus with another causing a decrease or lessening in perceptual effectiveness.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010470"}, {"RECTYPE": "D", "MH": "Perches", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Percidae|T013|NON|EQV|NLM (2002)|000915|abcdef", "MN": "B01.050.150.900.493.602.600", "MH_TH": "NLM (2002)", "ST": "T013", "RN": "txid8165", "RR": "txid8168", "PI": "Fishes (1966-1986)", "MS": "A common name for fish of the family Percidae, belonging to the suborder Percoidei, order PERCIFORMES.", "PM": "91; was see under PERCIFORMES 1987-90", "HN": "91(87); was see under PERCIFORMES 1987-90", "MR": "20200813", "DA": "19860415", "DC": "1", "DX": "19910101", "UI": "D010471"}, {"RECTYPE": "D", "MH": "Perchlorates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Perchloric", "MN": "D01.210.675", "MH_TH": "UNK (19XX)", "ST": "T197", "RN": "0", "MS": "Compounds that contain the Cl(=O)(=O)(=O)O- structure. Included under this heading is perchloric acid and the salts and ester forms of perchlorate.", "PM": "2014; see PERCHLORIC ACIDS 1963-1993; see PERCHLORIC ACID 1994-2013", "HN": "1994(2014); was PERCHLORIC ACIDS 1963-1993; was PERCHLORIC ACID 1994-2013", "MR": "20141231", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D010472"}, {"RECTYPE": "D", "MH": "Perciformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Sunfishes|T013|NON|NRW|NLM (2002)|000804|abcdef", "ENTRY": "Mackerel", "MN": "B01.050.150.900.493.602", "MH_TH": "NLM (1987)", "ST": "T013", "RN": "txid8111", "RR": "txid8180", "AN": "general or unspecified; prefer specifics; do not confuse entry term DOLPHIN FISH with DOLPHINS which are mammals", "PI": "Fishes (1966-1986)", "MS": "The most diversified of all fish orders and the largest vertebrate order. It includes many of the commonly known fish such as porgies, croakers, sunfishes, dolphin fish, mackerels, TUNA, etc.", "PM": "87", "HN": "87", "MR": "20200902", "DA": "19860415", "DC": "1", "DX": "19870101", "UI": "D010473"}, {"RECTYPE": "D", "MH": "Percussion", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Percussions", "MN": "E01.370.600.610", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Act of striking a part with short, sharp blows as an aid in diagnosing the condition beneath the sound obtained.", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010474"}, {"RECTYPE": "D", "MH": "Perfume", "AQ": "AD AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO TU", "MN": "D27.720.269.700", "MH_TH": "NLM (1966)", "ST": "T120", "RN": "0", "MS": "A substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell, especially a fluid containing fragrant natural oils extracted from flowers, woods, etc., or similar synthetic oils. (Random House Unabridged Dictionary, 2d ed)", "MR": "20190501", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010476"}, {"RECTYPE": "D", "MH": "Perfusion", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Perfusions", "MN": "E05.680", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Treatment process involving the injection of fluid into an organ or tissue.", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010477"}, {"RECTYPE": "D", "MH": "Chemotherapy, Cancer, Regional Perfusion", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Regional Perfusion Antineoplastic Chemotherapy|T061|NON|EQV|NLM (2006)|050519|abcdef", "ENTRY": "Regional Perfusion Cancer Chemotherapy|T061|NON|EQV|NLM (2006)|050519|abcdef", "MN": "E04.292.425", "MH_TH": "NLM (2006)", "ST": "T061", "AN": "restricted to a special technique in cancer therapy; do not confuse with INFUSIONS, INTRA-ARTERIAL which is also used in cancer therapy", "MS": "Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part.", "PM": "2006; see PERFUSION, REGIONAL 1978-2005, see ISOLATION PERFUSION 1964-1977", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20150707", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D010478"}, {"RECTYPE": "D", "MH": "Pergolide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Mesylate, Pergolide", "MN": "D03.633.400.439.800", "PA": "Dopamine Agonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Ergoline, 8-((methylthio)methyl)-6-propyl-, (8beta)-", "RN": "24MJ822NZ9", "RR": "66104-23-2 (mesylate)", "PI": "Ergot Alkaloids (1966-1986)", "MS": "A long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES.", "PM": "87", "HN": "87", "MR": "20170524", "DA": "19860612", "DC": "1", "DX": "19870101", "UI": "D010479"}, {"RECTYPE": "D", "MH": "Perhexiline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Perhexilene|T109|T121|NON|EQV|UNK (19XX)|800515|abbcdef", "MN": "D03.383.621.644", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Piperidine, 2-(2,2-dicyclohexylethyl)-", "RN": "KU65374X44", "RR": "6621-47-2 (Perhexiline)", "AN": "a vasodilator calcium channel blocker", "PI": "Piperidines (1966-1974)", "MS": "2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.", "PM": "84; was see under PIPERIDINES 1975-83", "HN": "84(73); was see under PIPERIDINES 1975-83, was Prov 1973-74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D010480"}, {"RECTYPE": "D", "MH": "Perianal Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Circumanal Glands|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Perianal Gland", "MN": "A13.734", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "animal only", "PI": "Anus (1966-1967)", "MS": "A type of SEBACEOUS GLAND located in the area surrounding the ANUS of some mammals such as dogs, cats, opossums, and guinea pigs.", "PM": "68", "HN": "68", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010481"}, {"RECTYPE": "D", "MH": "Periapical Abscess", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Periodontitis, Apical, Suppurative|T047|NON|EQV|UNK (19XX)|790430|abcdef", "ENTRY": "Suppurative Periapical Periodontitis", "MN": "C07.465.714.533.487.700", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "do not confuse with PERIODONTAL ABSCESS: note X refs below; for coord read note on ABSCESS", "MS": "Acute or chronic inflammation of tissues surrounding the apical portion of a tooth, associated with the collection of pus, resulting from infection following pulp infection through a carious lesion or as a result of an injury causing pulp necrosis. (Dorland, 27th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010482"}, {"RECTYPE": "D", "MH": "Periapical Diseases", "DE": "PERIAPICAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Periapical Disease", "MN": "C07.465.714.306", "FX": "Dental Pulp Diseases", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Periodontal Diseases (1966-1979)", "MS": "Diseases of the PERIAPICAL TISSUE surrounding the root of the tooth, which is distinguished from DENTAL PULP DISEASES inside the TOOTH ROOT.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19790425", "DC": "1", "DX": "19800101", "UI": "D010483"}, {"RECTYPE": "D", "MH": "Periapical Granuloma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Periodontitis, Apical, Chronic Nonsuppurative|T047|NON|NRW|UNK (19XX)|790425|abcdef", "ENTRY": "Periapical Granulomas", "MN": "C07.465.714.533.487.740", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Chronic nonsuppurative inflammation of periapical tissue resulting from irritation following pulp disease or endodontic treatment.", "OL": "use PERIAPICAL GRANULOMA to search GRANULOMA, PERIAPICAL 1966-79", "PM": "80; was GRANULOMA, PERIAPICAL 1965-79", "HN": "80; was GRANULOMA, PERIAPICAL 1965-79", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010484"}, {"RECTYPE": "D", "MH": "Periapical Periodontitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Periodontitis, Apical|T047|NON|EQV|UNK (19XX)|790425|abcdef", "ENTRY": "Periodontitis, Periapical", "MN": "C07.465.714.533.487", "FX": "Pulpitis", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "general or unspecified", "PI": "Periodontitis (1966-1979)", "MS": "Inflammation of the PERIAPICAL TISSUE. It includes general, unspecified, or acute nonsuppurative inflammation. Chronic nonsuppurative inflammation is PERIAPICAL GRANULOMA. Suppurative inflammation is PERIAPICAL ABSCESS.", "PM": "1980", "HN": "1980", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19790425", "DC": "1", "DX": "19800101", "UI": "D010485"}, {"RECTYPE": "D", "MH": "Periapical Tissue", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Periodontium, Apical|T024|NON|EQV|UNK (19XX)|790430|abcdef", "ENTRY": "Tissues, Periapical", "MN": "A14.549.167.646.700", "MH_TH": "NLM (1972)", "ST": "T024", "PI": "Periodontium (1966-1971)", "MS": "Tissue surrounding the apex of a tooth, including the apical portion of the periodontal membrane and alveolar bone.", "PM": "73", "HN": "73(72)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010486"}, {"RECTYPE": "D", "MH": "Periaqueductal Gray", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Midbrain Central Gray|T023|NON|EQV|UNK (19XX)|820426|abcdef", "ENTRY": "Periaqueductal Grays, Central", "MN": "A08.186.211.132.659.413.875.595", "MH_TH": "NLM (1983)", "ST": "T023", "PI": "Mesencephalon (1966-1982)", "MS": "Central gray matter surrounding the CEREBRAL AQUEDUCT in the MESENCEPHALON. Physiologically it is probably involved in RAGE reactions, the LORDOSIS REFLEX; FEEDING responses, bladder tonus, and pain.", "PM": "83", "HN": "83", "MR": "20151124", "DA": "19820426", "DC": "1", "DX": "19830101", "UI": "D010487"}, {"RECTYPE": "D", "MH": "Polyarteritis Nodosa", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Periarteritis Nodosa|T047|NON|EQV|NLM (1995)|930831|abcdef", "ENTRY": "Polyarteritis, Essential", "MN": "C17.800.862.625", "FX": "Vasculitis, Central Nervous System", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A form of necrotizing non-granulomatous inflammation occurring primarily in medium-sized ARTERIES, often with microaneurysms. It is characterized by muscle, joint, and abdominal pain resulting from arterial infarction and scarring in affected organs. Polyarteritis nodosa with lung involvement is called CHURG-STRAUSS SYNDROME.", "OL": "use POLYARTERITIS NODOSA to search PERIARTERITIS NODOSA 1966-94;", "PM": "1995; was PERIARTERITIS NODOSA 1963-1994; for POLYARTERITIS NODOSA see PERIARTERITIS NODOSA 1968-1994", "HN": "1995; was PERIARTERITIS NODOSA 1963-1994; for POLYARTERITIS NODOSA use PERIARTERITIS NODOSA 1968-1994", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19950101", "UI": "D010488"}, {"RECTYPE": "D", "MH": "Periarthritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Periarthritides", "MN": "C05.550.251.595", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "\"inflamm of tissues around a joint\"", "MS": "Inflammation of the tissues around a joint. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19940524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010489"}, {"RECTYPE": "D", "MH": "Pericardial Effusion", "AQ": "BL CF CH CI CL CN CO CY DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemopericardium|T047|NON|NRW|UNK (19XX)|830503|abcdef", "ENTRY": "Pericardial Effusions", "MN": "C14.280.695", "FX": "Cardiac Tamponade", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Fluid accumulation within the PERICARDIUM. Serous effusions are associated with pericardial diseases. Hemopericardium is associated with trauma. Lipid-containing effusion (chylopericardium) results from leakage of THORACIC DUCT. Severe cases can lead to CARDIAC TAMPONADE.", "OL": "use PERICARDIAL EFFUSION to search HEMOPERICARDIUM 1969-83", "PM": "66; HEMOPERICARDIUM was see under PERICARDIAL EFFUSION 1969-83, was in Cat A & C 1969-83", "HN": "66; was in Cat A & C 1966-83", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010490"}, {"RECTYPE": "D", "MH": "Pericardial Window Techniques", "AQ": "AE CL EC ED ES HI IS LJ MO NU PX RH SN ST TD VE", "PRINT ENTRY": "Pericardiostomy|T061|NON|EQV|UNK (19XX)|870320|abcdef", "ENTRY": "Window Techniques, Pericardial", "MN": "E04.928.220.600", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Pericardium/surgery (1966-1987)", "MS": "Surgical construction of an opening or window in the pericardium. It is often called subxiphoid pericardial window technique.", "OL": "use PERICARDIAL WINDOW TECHNIQUES to search PERICARDIAL WINDOW TECHNICS 1988-90", "PM": "91; was PERICARDIAL WINDOW TECHNICS 1988-90", "HN": "91; was PERICARDIAL WINDOW TECHNICS 1988-90", "CATSH": "CAT LIST", "MR": "19970625", "DA": "19870320", "DC": "1", "DX": "19880101", "UI": "D010491"}, {"RECTYPE": "D", "MH": "Pericardiectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Pericardiotomy|T061|NON|REL|UNK (19XX)|870325|abcdef", "ENTRY": "Pericardotomies", "MN": "E04.928.220.605", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Pericardium/surgery (1966-1987)", "MS": "Surgical excision (total or partial) of a portion of the pericardium. Pericardiotomy refers to incision of the pericardium.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19870325", "DC": "1", "DX": "19880101", "UI": "D010492"}, {"RECTYPE": "D", "MH": "Pericarditis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pleuropericarditis|T047|NON|REL|NLM (2011)|090917|abcdef", "MN": "C14.280.720", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "note entry term PLEUROPERICARDITIS: coordinate with PLEURITIS see PLEURISY for pleuropericarditis", "MS": "Inflammation of the PERICARDIUM from various origins, such as infection, neoplasm, autoimmune process, injuries, or drug-induced. Pericarditis usually leads to PERICARDIAL EFFUSION, or CONSTRICTIVE PERICARDITIS.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010493"}, {"RECTYPE": "D", "MH": "Pericarditis, Constrictive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pick's Disease of Heart|T047|EPO|REL|UNK (19XX)|740330|PICKS DIS OF HEART|abcdefv", "ENTRY": "Picks Disease, Heart", "MN": "C14.280.720.595", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "Inflammation of the PERICARDIUM that is characterized by the fibrous scarring and adhesion of both serous layers, the VISCERAL PERICARDIUM and the PARIETAL PERICARDIUM leading to the loss of pericardial cavity. The thickened pericardium severely restricts cardiac filling. Clinical signs include FATIGUE, muscle wasting, and WEIGHT LOSS.", "PM": "64; PICK'S DISEASE OF HEART was see under PERICARDITIS 1963", "HN": "64; PICK'S DISEASE OF HEART was see under PERICARDITIS 1963", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D010494"}, {"RECTYPE": "D", "MH": "Pericarditis, Tuberculous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Tuberculous Pericarditis|T047|NON|EQV|NLM (2007)|060405|abcdef", "ENTRY": "Tuberculous Pericarditides", "MN": "C14.280.720.801", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "INFLAMMATION of the sac surrounding the heart (PERICARDIUM) due to MYCOBACTERIUM TUBERCULOSIS infection. Pericarditis can lead to swelling (PERICARDIAL EFFUSION), compression of the heart (CARDIAC TAMPONADE), and preventing normal beating of the heart.", "OL": "search TUBERCULOSIS, CARDIOVASCULAR 1966-74", "PM": "91; was see under TUBERCULOSIS, CARDIOVASCULAR 1975-90", "HN": "91(75); was see under TUBERCULOSIS, CARDIOVASCULAR 1975-90", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010495"}, {"RECTYPE": "D", "MH": "Pericardium", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Epicardium|T024|NON|NRW|NLM (1998)|960711|abcdef", "ENTRY": "Spaces, Pericardial", "MN": "A10.615.789.470", "FX": "Pericardiectomy", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "A conical fibro-serous sac surrounding the HEART and the roots of the great vessels (AORTA; VENAE CAVAE; PULMONARY ARTERY). Pericardium consists of two sacs: the outer fibrous pericardium and the inner serous pericardium. The latter consists of an outer parietal layer facing the fibrous pericardium, and an inner visceral layer (epicardium) resting next to the heart, and a pericardial cavity between these two layers.", "MR": "20150709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010496"}, {"RECTYPE": "D", "MH": "Pericoronitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pericoronitides", "MN": "C07.465.714.258.771", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "inflamm of gingiva surrounding crown of tooth", "MS": "Inflammation of the gingiva surrounding the crown of a tooth.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010497"}, {"RECTYPE": "D", "MH": "Perilymph", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Perilymphs", "MN": "A12.207.270.517.678", "MH_TH": "NLM (1975)", "ST": "T031", "AN": "a labyrinthine fluid", "MS": "The fluid separating the membranous labyrinth from the osseous labyrinth of the ear. It is entirely separate from the ENDOLYMPH which is contained in the membranous labyrinth. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1396, 642)", "OL": "search LABYRINTHINE FLUIDS 1966-74", "PM": "91; was see under LABYRINTHINE FLUIDS 1975-90", "HN": "91(75); was see under LABYRINTHINE FLUIDS 1975-90", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010498"}, {"RECTYPE": "D", "MH": "Perinatology", "DE": "PERINATOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Materno-Fetal Medicine|T091|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Medicine, Materno-Fetal", "MN": "H02.403.670.500", "FX": "Pregnancy Complications", "MH_TH": "NLM (1977)", "ST": "T091", "AN": "= fetus + newborn infant: differentiate from NEONATOLOGY, the newborn infant only", "PI": "Pediatrics (1966-1976)", "MS": "The branch of medicine dealing with the FETUS and NEWBORN during the perinatal period. The perinatal period begins with the twenty-eighth week of gestation and ends twenty-eight days after birth.", "PM": "77", "HN": "77", "MR": "20200116", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D010500"}, {"RECTYPE": "D", "MH": "Perinephritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Inflammation, Perinephrium|T047|NON|EQV|NLM (2007)|060127|abcdef", "ENTRY": "Perinephrium Inflammation", "MN": "C12.950.419.685", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the connective and adipose tissues surrounding the KIDNEY.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010501"}, {"RECTYPE": "D", "MH": "Perineum", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Perineums", "MN": "A01.719", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "The body region lying between the genital area and the ANUS on the surface of the trunk, and to the shallow compartment lying deep to this area that is inferior to the PELVIC DIAPHRAGM. The surface area is between the VULVA and the anus in the female, and between the SCROTUM and the anus in the male.", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010502"}, {"RECTYPE": "D", "MH": "Periodic Acid-Schiff Reaction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "PAS Reaction|T059|ACX|EQV|UNK (19XX)|760427|abcdef", "ENTRY": "Reactions, Periodic Acid-Schiff", "MN": "E05.200.750.551.790", "MH_TH": "NLM (1977)", "ST": "T059", "PI": "Staining (1966-1976)", "MS": "A histochemical technique for staining carbohydrates. It is based on PERIODIC ACID oxidation of a substance containing adjacent hydroxyl groups. The resulting aldehydes react with Schiff reagent to form a colored product.", "PM": "91; was see under HISTOCYTOCHEMISTRY 1979-90; was see under STAINS AND STAINING 1977-78", "HN": "91(77); was see under HISTOCYTOCHEMISTRY 1979-90; was see under STAINS AND STAINING 1977-78", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D010503"}, {"RECTYPE": "D", "MH": "Periodic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Periodic", "MN": "D01.475.705", "MH_TH": "NLM (1966)", "ST": "T197", "N1": "Periodic acid (H5IO6)", "RN": "10450-60-9", "RR": "13444-71-8 (HIO4)", "MS": "A strong oxidizing agent.", "OL": "use PERIODIC ACID to search PERIODIC ACIDS 1966-93", "PM": "94; was PERIODIC ACIDS 1963-93; PERIODIC ACID was indexed under PERIODIC ACIDS 1987-93", "HN": "94; was PERIODIC ACIDS 1963-93; PERIODIC ACID was NM 1987-93", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D010504"}, {"RECTYPE": "D", "MH": "Familial Mediterranean Fever", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wolff's Periodic Disease|T047|EPO|EQV|NLM (2000)|991103|WOLFFS PERIODIC DIS|abcdefv", "ENTRY": "Wolffs Periodic Disease", "MN": "C16.320.382.625", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "a specific disease entity: do not use entry term PERIODIC DISEASE for periodically occurring disease (= PERIODICITY (IM) + disease (IM))", "MS": "A group of HEREDITARY AUTOINFLAMMATION DISEASES, characterized by recurrent fever, abdominal pain, headache, rash, PLEURISY; and ARTHRITIS. ORCHITIS; benign MENINGITIS; and AMYLOIDOSIS may also occur. Homozygous or compound heterozygous mutations in marenostrin gene encoding PYRIN result in autosomal recessive transmission; simple heterozygous, autosomal dominant form of the disease also exists with mutations in the same gene.", "PM": "2000; see PERIODIC DISEASE 1966-1999; for FAMILIAL MEDITERRANEAN FEVER see PERIODIC DISEASE 1966-1999", "HN": "2000 (1966)", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D010505"}, {"RECTYPE": "D", "MH": "Periodicals as Topic", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Journals as Topic|T073|T170|NON|NRW|NLM (2008)|070626|abbcdef", "ENTRY": "Newsletter", "MN": "L01.462.500.682.829.678", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with the Publication Type PERIODICAL; medical periodicals, medical journals, medical newsletters: do not coordinate with MEDICINE; writing for periodicals goes here but see note on WRITING; note entry term NEWSLETTERS: for articles from newsletters, the Publication Type NEWSPAPER ARTICLE is available", "MS": "Works about publications issued at stated, more or less regular, intervals.", "PM": "2008; see PERIODICALS 1963-2007", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D010506"}, {"RECTYPE": "D", "MH": "Periodicity", "PRINT ENTRY": "Rhythmicity|T079|NON|EQV|UNK (19XX)|850619|abcdef", "ENTRY": "Rhythms, Biological", "MN": "G07.180.562", "MH_TH": "NLM (1966)", "ST": "T079", "AN": "coordinate with specific disease for periodically occurring disease; do not confuse with PERIODIC DISEASE see FAMILIAL MEDITERRANEAN FEVER", "MS": "The tendency of a phenomenon to recur at regular intervals; in biological systems, the recurrence of certain activities (including hormonal, cellular, neural) may be annual, seasonal, monthly, daily, or more frequently (ultradian).", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010507"}, {"RECTYPE": "D", "MH": "Periodontal Abscess", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Abscess, Periodontal|T047|NON|EQV|UNK (19XX)|790425|abcdef", "ENTRY": "Periodontal Abscesses", "MN": "C07.465.714.533.650", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "do not confuse with PERIAPICAL ABSCESS: see X refs there; for coord read note on ABSCESS", "MS": "Localized circumscribed purulent area of inflammation in the periodontal tissue. It is a derivative of marginal periodontitis and commonly associated with suprabony and infrabony pockets and interradicular involvements, in contrast to periapical abscess which is attributable to pulp necrosis.", "OL": "use PERIODONTAL ABSCESS to search ABSCESS, PERIODONTAL 1975-80; use PERIODONTITIS 1966-74", "PM": "91; was see under PERIODONTITIS 1980-90; was ABSCESS, PERIODONTAL see under PERIODONTITIS 1965-79", "HN": "91(80); was see under PERIODONTITIS 1980-90; was ABSCESS, PERIODONTAL see under PERIODONTITIS 1965-79", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010508"}, {"RECTYPE": "D", "MH": "Periodontal Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Lateral Cyst|T020|T047|NON|EQV|NLM (1991)|900208|abbcdef", "ENTRY": "Periodontal Cysts", "MN": "C07.465.714.470", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "non-neoplastic; coordinate with precoordinated organ/disease term", "MS": "An epithelium-lined sac containing fluid; usually found at the apex of a pulp-involved tooth. The lateral type occurs less frequently along the side of the root.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19900529", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010509"}, {"RECTYPE": "D", "MH": "Periodontal Diseases", "DE": "PERIODONTAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pyorrhea Alveolaris|T047|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Periodontal Disease", "MN": "C07.465.714", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Pathological processes involving the PERIODONTIUM including the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, and the PERIODONTAL LIGAMENT.", "PM": "65; was PERIODONTAL DISEASE 1963-64", "HN": "65; was PERIODONTAL DISEASE 1963-64", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010510"}, {"RECTYPE": "D", "MH": "Periodontal Dressings", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Dressings, Periodontal|T074|NON|EQV|NLM (1997)|960506|abcdef", "ENTRY": "Periodontal Dressing", "MN": "E06.721.595", "MH_TH": "NLM (1971)", "ST": "T074", "PI": "Dental Materials (1966-1970)", "MS": "Surgical dressings, after periodontal surgery, applied to the necks of teeth and the adjacent tissue to cover and protect the surgical wound. (Boucher's Clinical Dental Terminology, 4th ed, p218)", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010511"}, {"RECTYPE": "D", "MH": "Periodontal Index", "PRINT ENTRY": "Gingival Index|T034|NON|NRW|NLM (1990)|890525|abcdef", "ENTRY": "Periodontal Indices", "MN": "N06.890.160.215", "MH_TH": "NLM (1966)", "ST": "T034", "AN": "for gingival X refs do not coord with GINGIVA unless particularly discussed", "MS": "A numerical rating scale for classifying the periodontal status of a person or population with a single figure which takes into consideration prevalence as well as severity of the condition. It is based upon probe measurement of periodontal pockets and on gingival tissue status.", "PM": "70", "HN": "70(66)", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D010512"}, {"RECTYPE": "D", "MH": "Periodontal Ligament", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Gomphosis|T023|NON|REL|NLM (2020)|190502|abcdef", "ENTRY": "Periodontal Ligaments", "MN": "A14.549.167.646.771", "FX": "Periodontal Attachment Loss", "MH_TH": "NLM (1972)", "ST": "T024", "AN": "intraligamental anesthesia or periodontal ligament injection (PDLI): coordinate with ANESTHESIA, DENTAL ", "PI": "Periodontium (1966-1971)", "MS": "The fibrous CONNECTIVE TISSUE surrounding the TOOTH ROOT, separating it from and attaching it to the alveolar bone (ALVEOLAR PROCESS).", "PM": "73", "HN": "73(72)", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010513"}, {"RECTYPE": "D", "MH": "Periodontal Pocket", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pocket, Periodontal|T020|NON|EQV|UNK (19XX)|780228|abcdef", "ENTRY": "Pockets, Periodontal", "MN": "C07.465.714.533.750", "MH_TH": "NLM (1979)", "ST": "T020", "AN": "do not confuse with GINGIVAL POCKET: read MeSH definition", "PI": "Periodontitis (1966-1978)", "MS": "An abnormal extension of a gingival sulcus accompanied by the apical migration of the epithelial attachment and bone resorption.", "PM": "91; was see under PERIODONTITIS 1979-90", "HN": "91(79); was see under PERIODONTITIS 1979-90", "CATSH": "CAT LIST", "MR": "19910618", "DA": "19780228", "DC": "1", "DX": "19910101", "UI": "D010514"}, {"RECTYPE": "D", "MH": "Periodontal Prosthesis", "AQ": "AE CL EC ES HI IS MI MO MT NU PS PX SN ST TD VE VI", "ENTRY": "Prosthesis, Periodontal", "MN": "E07.695.190.610", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "Any restorative and replacement device that is used as a therapeutic aid in the treatment of periodontal disease. It is an adjunct to other forms of periodontal therapy and does not cure periodontal disease by itself. (Boucher's Clinical Dental Terminology, 3d ed)", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010515"}, {"RECTYPE": "D", "MH": "Periodontal Splints", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Splints, Periodontal|T074|NON|EQV|UNK (19XX)|790605|abcdef", "ENTRY": "Splint, Periodontal", "MN": "E06.721.721.680", "MH_TH": "NLM (1975)", "ST": "T074", "MS": "Fixed or removable devices that join teeth together. They are used to repair teeth that are mobile as a result of PERIODONTITIS.", "OL": "use PERIODONTAL SPLINTS to search SPLINTS, PERIODONTAL 1975-79; use PERIODONTAL PROSTHESIS 1966-74", "PM": "91; was see under PERIODONTAL PROSTHESIS 1980-90; was SPLINTS, PERIODONTAL see under PERIODONTAL PROSTHESIS 1966-79", "HN": "91(80); was see under PERIODONTAL PROSTHESIS 1980-90; was SPLINTS, PERIODONTAL see under PERIODONTAL PROSTHESIS 1966-79", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010516"}, {"RECTYPE": "D", "MH": "Periodontics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Periodontic", "MN": "H02.163.876.623", "MH_TH": "NLM (1965)", "ST": "T091", "MS": "A dental specialty concerned with the histology, physiology, and pathology of the tissues that support, attach, and surround the teeth.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010517"}, {"RECTYPE": "D", "MH": "Periodontitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pericementitis|T047|NON|NRW|UNK (19XX)|780227|abcdef", "ENTRY": "Periodontitides", "MN": "C07.465.714.533", "FX": "Subgingival Curettage", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "general; prefer specifics", "MS": "Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology)", "OL": "use PERIODONTITIS to search PERICEMENTITIS 1969-78", "PM": "65", "HN": "65; PERICEMENTITIS was see under PERIODONTITIS 1969-78", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010518"}, {"RECTYPE": "D", "MH": "Periodontium", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Tooth Supporting Structures|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Tooth Supporting Structure", "MN": "A14.549.167.646", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The structures surrounding and supporting the tooth. Periodontium includes the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, and the PERIODONTAL LIGAMENT.", "OL": "use PERIODONTIUM to search TOOTH SUPPORTING STRUCTURES 1966-67", "PM": "TOOTH SUPPORTING STRUCTURES was heading 1965-67", "HN": "TOOTH SUPPORTING STRUCTURES was heading 1965-67", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010519"}, {"RECTYPE": "D", "MH": "Aggressive Periodontitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Periodontosis|T047|NON|NRW|NLM (1997)|960304|abcdef", "ENTRY": "Periodontoses", "MN": "C07.465.714.533.161", "MH_TH": "NLM (2009)", "ST": "T047", "AN": "do not confuse entry term PERIODONTOSIS with \"periodontosis\" seen in foreign lit, meaning \"periodontal disease\" and indexed under PERIODONTAL DISEASES", "PI": "Periodontal Diseases (1966-1983)", "MS": "Inflammation and loss of PERIODONTIUM that is characterized by rapid attachment loss and bone destruction in the presence of little local factors such as DENTAL PLAQUE and DENTAL CALCULUS. This highly destructive form of periodontitis often occurs in young people and was called early-onset periodontitis, but this disease also appears in old people.", "PM": "2009; see PERIODONTITIS, JUVENILE 1997-2008, see PERIODONTOSIS 1984-1996, see PERIODONTAL DISEASES 1966-1983", "HN": "2009 (1997); use PERIODONTOSIS 1984-1996, use PERIODONTAL DISEASES 1966-1983", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19830421", "DC": "1", "DX": "19910101", "UI": "D010520"}, {"RECTYPE": "D", "MH": "Periosteum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A10.165.265.746", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "Thin outer membrane that surrounds a bone. It contains CONNECTIVE TISSUE, CAPILLARIES, nerves, and a number of cell types.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010521"}, {"RECTYPE": "D", "MH": "Periostitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Periostitides", "MN": "C05.116.165.595", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "inflamm of the periosteum", "MS": "Inflammation of the periosteum. The condition is generally chronic, and is marked by tenderness and swelling of the bone and an aching pain. Acute periostitis is due to infection, is characterized by diffuse suppuration, severe pain, and constitutional symptoms, and usually results in necrosis. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010522"}, {"RECTYPE": "D", "MH": "Peripheral Nervous System Diseases", "DE": "PERIPHERAL NERVOUS SYSTEM DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Peripheral Neuropathies|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Peripheral Neuropathy", "MN": "C10.668.829", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with specific nerve; \"diabetic peripheral neuropathy\": index only under DIABETIC NEUROPATHIES", "MS": "Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.", "PM": "1994; see PERIPHERAL NERVE DISEASES 1963-1993", "HN": "1994", "CATSH": "CAT LIST", "MR": "19991208", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D010523"}, {"RECTYPE": "D", "MH": "Peripheral Nervous System Neoplasms", "DE": "PNS NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Peripheral Nerve", "MN": "C10.668.829.725", "MH_TH": "NLM (2000)", "ST": "T191", "AN": "coordinate IM with specific peripheral nerve (IM) + histological type of neoplasm (IM)", "MS": "Neoplasms which arise from peripheral nerve tissue. This includes NEUROFIBROMAS; SCHWANNOMAS; GRANULAR CELL TUMORS; and malignant peripheral NERVE SHEATH NEOPLASMS. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp1750-1)", "PM": "2000; see PERIPHERAL NERVE NEOPLASMS 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20050701", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D010524"}, {"RECTYPE": "D", "MH": "Peripheral Nerves", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Perineurium|T024|NON|NRW|NLM (1994)|930112|abcdef", "ENTRY": "Peripheral Nerve", "MN": "A08.800.800", "FX": "Nerve Fibers", "EC": "injuries:Peripheral Nerve Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "general only; do not use as a coordinate for specific nerves indexed with organ /innerv", "MS": "The nerves outside of the brain and spinal cord, including the autonomic, cranial, and spinal nerves. Peripheral nerves contain non-neuronal cells and connective tissue as well as axons. The connective tissue layers include, from the outside to the inside, the epineurium, the perineurium, and the endoneurium.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010525"}, {"RECTYPE": "D", "MH": "Periplaneta", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Periplaneta americana|T204|NON|NRW|NLM (1999)|971022|abcdef", "ENTRY": "americana, Periplaneta", "MN": "B01.050.500.131.617.140.580", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid6977", "RR": "txid6978", "AN": "do not use /drug eff for insecticides: TN 111", "MS": "A genus in the family Blattidae containing several species, the most common being P. americana, the American cockroach.", "PM": "91; see COCKROACHES 1975-90", "HN": "91(75); for PERIPLANETA AMERICANA use COCKROACHES 1995-97", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D010526"}, {"RECTYPE": "D", "MH": "Perissodactyla", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Perissodactylas", "MN": "B01.050.150.900.649.313.984", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid9787", "MS": "An order of ungulates having an odd number of toes, including the horse, tapir, and rhinoceros. (Dorland, 27th ed)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010527"}, {"RECTYPE": "D", "MH": "Peristalsis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Peristalses", "MN": "G10.261.360.596", "MH_TH": "NLM (1975)", "ST": "T042", "MS": "A movement, caused by sequential muscle contraction, that pushes the contents of the intestines or other tubular organs in one direction.", "OL": "search GASTROINTESTINAL MOTILITY 1967-74", "PM": "91; was see under GASTROINTESTINAL MOTILITY 1975-90", "HN": "91(75); was see under GASTROINTESTINAL MOTILITY 1975-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010528"}, {"RECTYPE": "D", "MH": "Peritoneal Cavity", "AQ": "AB AH BS CY DG EM GD IN IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "Omental Bursa|T030|NON|NRW|NLM (2003)|011205|abcdef", "ENTRY": "Sac, Lesser", "MN": "A01.923.047.025.600.678", "FX": "Laparoscopy", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "The space enclosed by the peritoneum. It is divided into two portions, the greater sac and the lesser sac or omental bursa, which lies behind the STOMACH. The two sacs are connected by the foramen of Winslow, or epiploic foramen.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010529"}, {"RECTYPE": "D", "MH": "Peritoneal Dialysis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Peritoneal Dialyses", "MN": "E02.912.800.650", "FX": "Kidneys, Artificial", "MH_TH": "NLM (1964)", "ST": "T061", "MS": "Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20120705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010530"}, {"RECTYPE": "D", "MH": "Peritoneal Dialysis, Continuous Ambulatory", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "CAPD|T061|ABB|EQV|IOM (1990)|890414|abcdef", "ENTRY": "Continuous Ambulatory Peritoneal Dialysis|T061|NON|EQV|IOM (1990)|890414|abcdef", "MN": "N02.421.585.106.500", "MH_TH": "NLM (1982)", "ST": "T061", "PI": "Peritoneal Dialysis (1978-1981)", "MS": "Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution.", "PM": "86; was see under PERITONEAL DIALYSIS 1982-85", "HN": "86(82); was see under PERITONEAL DIALYSIS 1982-85", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19810302", "DC": "1", "DX": "19860101", "UI": "D010531"}, {"RECTYPE": "D", "MH": "Peritoneal Diseases", "DE": "PERITONEAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Peritoneal Disease", "MN": "C06.844", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Pathological processes involving the PERITONEUM.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010532"}, {"RECTYPE": "D", "MH": "Peritoneal Lavage", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Peritoneal Irrigation|T060|T061|NON|EQV|UNK (19XX)|870327|abbcdef", "MN": "E05.927.705", "FX": "Hyperthermic Intraperitoneal Chemotherapy", "MH_TH": "NLM (1988)", "ST": "T061", "CX": "following abdominal cancer surgery, also consider HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY", "PI": "Peritoneal Cavity (1966-1987)", "MS": "Washing out of the peritoneal cavity. The procedure is a diagnostic as well as a therapeutic technique following abdominal trauma or inflammation.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19870327", "DC": "1", "DX": "19880101", "UI": "D010533"}, {"RECTYPE": "D", "MH": "Peritoneal Neoplasms", "DE": "PERITONEAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Surface Malignancy, Peritoneal", "MN": "C06.844.620", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM)", "MS": "Tumors or cancer of the PERITONEUM.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010534"}, {"RECTYPE": "D", "MH": "Laparoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Laparoscopic|T060|T061|NON|NRW|NLM (1993)|990101|SURG PROCEDURES LAPAROSCOPIC|abbcdefv", "ENTRY": "Surgery, Laparoscopic Assisted", "MN": "E04.502.250.520", "FX": "Laparoscopes", "MH_TH": "NLM (1978)", "ST": "T061", "AN": "/ instrum permitted but consider also LAPAROSCOPES", "MS": "A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy.", "PM": "1993, 1973-1977; for SURGICAL PROCEDURES, LAPAROSCOPIC and LAPAROSCOPIC SURGICAL PROCEDURES see SURGICAL PROCEDURES, LAPROSCOPIC 1998-1999, see SURGERY, LAPAROSCOPIC 1993-1997; for PERITONEOSCOPY see PERITONEOSCOPY 1963-1992", "HN": "1993, 1971-1977; use PERITONEOSCOPY 1978-1992", "CATSH": "CAT LIST", "MR": "20160226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010535"}, {"RECTYPE": "D", "MH": "Peritoneovenous Shunt", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "LeVeen Shunt|T061|EPO|NRW|UNK (19XX)|800515|abcdef", "ENTRY": "Shunts, Peritoneovenous Ascites", "MN": "E04.210.790", "MH_TH": "NLM (1981)", "ST": "T061", "PI": "Vena Cava, Superior (1975-1980)", "MS": "An operation for the continuous emptying of ascitic fluid into the venous system. Fluid removal is based on intraperitoneal and intrathoracic superior vena cava pressure differentials and is performed via a pressure-sensitive one-way valve connected to a tube traversing the subcutaneous tissue of the chest wall to the neck where it enters the internal jugular vein and terminates in the superior vena cava. It is used in the treatment of intractable ascites.", "PM": "86; was see under VASCULAR SURGERY 1981-85", "HN": "86(81); was see under VASCULAR SURGERY 1981-85", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19800515", "DC": "1", "DX": "19860101", "UI": "D010536"}, {"RECTYPE": "D", "MH": "Peritoneum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Visceral Peritoneum|T024|NON|NRW|NLM (2003)|020116|abcdef", "ENTRY": "Parametriums", "MN": "A10.615.789.596", "FX": "Laparoscopy", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010537"}, {"RECTYPE": "D", "MH": "Peritonitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Peritonitis, Secondary", "MN": "C06.844.640", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010538"}, {"RECTYPE": "D", "MH": "Permeability", "AQ": "DE RE", "ENTRY": "Permeabilities", "MN": "G02.723", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "coordinate NIM with substance /pharmacokin (IM) or /metab (IM) or tissue /metab (IM); for nonbiological material coordinate with substance /chem (IM); note VASCULAR PERMEABILITY see CAPILLARY PERMEABILITY", "MS": "Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions.", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010539"}, {"RECTYPE": "D", "MH": "Permissiveness", "ENTRY": "Permissivenesses", "MN": "F01.145.813.546", "MH_TH": "NLM (1975)", "ST": "T055", "MS": "The attitude that grants freedom of expression and activity to another individual, but not necessarily with sanction or approval.", "PM": "91; was see under ATTITUDE 1975-90", "HN": "91(75); was see under ATTITUDE 1975-90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010541"}, {"RECTYPE": "D", "MH": "Peromyscus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Mice, White-Footed|T015|NON|REL|UNK (19XX)|810514|abcdef", "ENTRY": "White-Footed Mouse", "MN": "B01.050.150.900.649.313.992.635.075.500.510", "MH_TH": "NLM (1978)", "ST": "T015", "RN": "txid10040", "AN": "NIM when experimental animal", "PI": "Mice (1966-1977)", "MS": "A genus of the subfamily SIGMODONTINAE consisting of 49 species. Two of these are widely used in medical research. They are P. leucopus, or the white-footed mouse, and P. maniculatus, or the deer mouse.", "PM": "78", "HN": "78", "MR": "20200902", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D010542"}, {"RECTYPE": "D", "MH": "Peroneal Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Fibular Nerve|T023|NON|EQV|NLM (1994)|921118|abcdef", "ENTRY": "Peroneal Nerves", "MN": "A08.800.800.720.450.760.640", "FX": "Pudendal Nerve", "MH_TH": "NLM (1971)", "ST": "T023", "PI": "Spinal Nerves (1966-1970)", "MS": "The lateral of the two terminal branches of the sciatic nerve. The peroneal (or fibular) nerve provides motor and sensory innervation to parts of the leg and foot.", "PM": "72", "HN": "72(71)", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010543"}, {"RECTYPE": "D", "MH": "Peroxidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ovoperoxidase|T116|T126|NON|NRW|UNK (19XX)|830330|abbcdef", "MN": "D08.811.682.732", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 1.11.1.-", "AN": "a subclass of oxidoreductases: do not confuse with PEROXIDASE, a peroxiductase synthesized by leukocytes", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010544"}, {"RECTYPE": "D", "MH": "Peroxides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Peroxide|T197|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D02.389.593.374", "PA": "Oxidants", "FX": "Lipid Peroxides", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "MS": "A group of compounds that contain a bivalent O-O group, i.e., the oxygen atoms are univalent. They can either be inorganic or organic in nature. Such compounds release atomic (nascent) oxygen readily. Thus they are strong oxidizing agents and fire hazards when in contact with combustible materials, especially under high-temperature conditions. The chief industrial uses of peroxides are as oxidizing agents, bleaching agents, and initiators of polymerization. (From Hawley's Condensed Chemical Dictionary, 11th ed)", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010545"}, {"RECTYPE": "D", "MH": "Perphenazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trilafon|T109|T121|TRD|NRW|NLM (1992)|910226|abbcdef", "MN": "D03.633.300.783.593", "PA": "Dopamine Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1-Piperazineethanol, 4-(3-(2-chloro-10H-phenothiazin-10-yl)propyl)-", "RN": "FTA7XXY4EZ", "RR": "58-39-9 (Perphenazine)", "MS": "An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE.", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010546"}, {"RECTYPE": "D", "MH": "Persistent Fetal Circulation Syndrome", "DE": "PFC SYNDROME", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Persistent Pulmonary Hypertension of Newborn|T047|NON|EQV|UNK (19XX)|840608|PERSISTENT PULM HYPERTENSION OF NEWBORN|abcdefv", "ENTRY": "ACD MPV", "MN": "C16.614.694", "FX": "Ductus Arteriosus, Patent", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "also known as PPHN check the tags HUMANS & INFANT, NEWBORN", "PI": "Pulmonary Circulation (1966-1979)", "MS": "A syndrome of persistent PULMONARY HYPERTENSION in the newborn infant (INFANT, NEWBORN) without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction (reactive type), hypertrophy of pulmonary arterial muscle (hypertrophic type), or abnormally developed pulmonary arterioles (hypoplastic type). The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus (DUCTUS ARTERIOSUS, PATENT) and at times a patent foramen ovale (FORAMEN OVALE, PATENT).", "PM": "1980", "HN": "1980", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19790228", "DC": "1", "DX": "19800101", "UI": "D010547"}, {"RECTYPE": "D", "MH": "Personal Health Services", "DE": "PERSONAL HEALTH SERV", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Service, Personal Health", "MN": "N02.421.631", "MH_TH": "NLM (1968)", "ST": "T058", "PI": "specific service (1966-1967)", "MS": "Health care provided to individuals.", "PM": "68", "HN": "68", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010548"}, {"RECTYPE": "D", "MH": "Personal Satisfaction", "PRINT ENTRY": "Life Satisfaction|T080|NON|EQV|NLM (2024)|220905|abcdef", "ENTRY": "Satisfactions, Life", "MN": "F01.145.677", "MH_TH": "NLM (1970)", "ST": "T080", "PI": "Attitude (1966-1969)", "MS": "The individual's experience of a sense of fulfillment of a need or want and the quality or state of being satisfied.", "PM": "72", "HN": "72(70)", "CATSH": "CAT LIST", "MR": "20230615", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010549"}, {"RECTYPE": "D", "MH": "Personal Space", "PRINT ENTRY": "Privacy of Space|T078|NON|EQV|UNK (19XX)|790601|abcdef", "ENTRY": "Zones, Body Buffer", "MN": "F01.145.875.596", "MH_TH": "NLM (1975)", "ST": "T078", "MS": "Invisible boundaries surrounding the individual's body which are maintained in relation to others.", "OL": "use SPATIAL BEHAVIOR to search PERSONAL SPACE 1974; use PERSONAL SPACE to search BODY BUFFER ZONE 1975-78, use SPATIAL BEHAVIOR 1974", "PM": "91; was see under SPATIAL BEHAVIOR 1974-90; BODY BUFFER ZONE was see under SPATIAL BEHAVIOR 1974-78", "HN": "91(75); was see under SPATIAL BEHAVIOR 1974-90; BODY BUFFER ZONE was see under SPATIAL BEHAVIOR 1974-78", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010550"}, {"RECTYPE": "D", "MH": "Personality", "AQ": "CL DE GE PH RE", "ENTRY": "Personalities", "MN": "F01.752", "FX": "Human Characteristics", "MH_TH": "POPLINE (1984)", "ST": "T041", "MS": "Behavior-response patterns that characterize the individual.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010551"}, {"RECTYPE": "D", "MH": "Personality Assessment", "DE": "PERSONALITY ASSESS", "AQ": "HI SN ST", "ENTRY": "Personality Assessments", "MN": "F04.513", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "by a professional; differentiate from PERSONALITY INVENTORY (by the person himself)", "MS": "The determination and evaluation of personality attributes by interviews, observations, tests, or scales. Articles concerning personality measurement are considered to be within scope of this term.", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010552"}, {"RECTYPE": "D", "MH": "Personality Development", "ENTRY": "Development, Personality", "MN": "F01.752.747", "FX": "Socialization", "MH_TH": "POPLINE (1978)", "ST": "T055", "PI": "Personality (1966-1967)", "MS": "Growth of habitual patterns of behavior in childhood and adolescence.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010553"}, {"RECTYPE": "D", "MH": "Personality Disorders", "DE": "PERSONALITY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Inadequate Personality|T048|NON|NRW|UNK (19XX)|780428|abcdef", "ENTRY": "Personality, Inadequate", "MN": "F03.675", "MH_TH": "NLM (1968)", "ST": "T048", "PI": "Personality (1966-1967)", "MS": "A major deviation from normal patterns of behavior.", "OL": "use PERSONALITY DISORDERS to search AS IF PERSONALITY 1975-78 & IMPULSE-RIDDEN PERSONALITY & INADEQUATE PERSONALITY 1968-78", "PM": "68", "HN": "68; AS IF PERSONALITY was see under PERSONALITY DISORDERS 1975-78; IMPULSE-RIDDEN PERSONALITY & INADEQUATE PERSONALITY were see under PERSONALITY DISORDERS 1968-78", "CATSH": "CAT LIST", "MR": "20230615", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010554"}, {"RECTYPE": "D", "MH": "Personality Inventory", "AQ": "HI SN ST", "PRINT ENTRY": "Myers-Briggs Type Indicator|T060|T170|EPO|NRW|UNK (19XX)|830606|abbcdef", "ENTRY": "Personality Inventories", "MN": "F04.711.647.513", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "by the person himself: differentiate from PERSONALITY ASSESSMENT (by professionals)", "MS": "Check list, usually to be filled out by a person about himself, consisting of many statements about personal characteristics which the subject checks.", "OL": "use PERSONALITY INVENTORY to search EDWARDS PERSONAL PREFERENCE SCHEDULE 1975-96 & MYERS-BRIGGS TYPE INDICATOR 1969-78", "PM": "68; EDWARDS PERSONAL PREFERENCE SCHEDULE was heading 1975-96 (see under PERSONALITY INVENTORY 1975-90); MYERS-BRIGGS TYPE INDICATOR was see under PERSONALITY INVENTORY 1969-78", "HN": "68(66); EDWARDS PERSONAL PREFERENCE SCHEDULE was heading 1975-96 (see under PERSONALITY INVENTORY 1975-90); MYERS-BRIGGS TYPE INDICATOR was see under PERSONALITY INVENTORY 1969-78", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010555"}, {"RECTYPE": "D", "MH": "Personality Tests", "AQ": "HI SN ST", "ENTRY": "Tests, Personality", "MN": "F04.711.647", "MH_TH": "NLM (1976)", "ST": "T060", "MS": "Standardized objective tests designed to facilitate the evaluation of personality.", "OL": "search PSYCHOLOGICAL TESTS 1966-74", "PM": "76; was see under PSYCHOLOGICAL TESTS 1963-74", "HN": "76; was NON MESH 1975, was see under PSYCHOLOGICAL TESTS 1963-74", "CATSH": "CAT LIST", "MR": "19920515", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D010556"}, {"RECTYPE": "D", "MH": "Personnel Administration, Hospital", "DE": "PERSONNEL ADMIN HOSP", "AQ": "CL EC ED ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Personnel, Hospital, Organization and Administration|T058|NON|BRD|UNK (19XX)|770524|PERSONNEL HOSP ORGAN ADMIN|abcdefv", "ENTRY": "Management, Hospital Personnel", "MN": "N04.452.677.440", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "Management activities concerned with hospital employees.", "OL": "use PERSONNEL ADMINISTRATION, HOSPITAL to search HOSPITAL PERSONNEL ADMINISTRATION 1966-77", "PM": "78; was HOSPITAL PERSONNEL ADMINISTRATION 1963-77", "HN": "78; was HOSPITAL PERSONNEL ADMINISTRATION 1963-77", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D010557"}, {"RECTYPE": "D", "MH": "Personnel Loyalty", "ENTRY": "Personnel Loyalties", "MN": "N04.452.677.460", "MH_TH": "NLM (1984)", "ST": "T055", "MS": "Dedication or commitment shown by employees to organizations or institutions where they work.", "PM": "91; was see under PERSONNEL MANAGEMENT 1984-90", "HN": "91(84); was see under PERSONNEL MANAGEMENT 1984-90", "MR": "19900413", "DA": "19830606", "DC": "1", "DX": "19910101", "UI": "D010558"}, {"RECTYPE": "D", "MH": "Personnel Management", "AQ": "CL EC LJ MT SN ST TD", "ENTRY": "Ratios, Client-Staff", "MN": "N04.452.677", "FX": "Personnel Administration, Hospital", "MH_TH": "POPLINE (1981)", "ST": "T057", "MS": "Planning, organizing, and administering all activities related to personnel.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010559"}, {"RECTYPE": "D", "MH": "Personnel Selection", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Personnel Recruitment|T057|NON|BRD|UNK (19XX)|770512|abcdef", "ENTRY": "Selection, Personnel", "MN": "N04.452.677.500", "MH_TH": "NLM (1977)", "ST": "T057", "MS": "The process of choosing employees for specific types of employment. The concept includes recruitment.", "PM": "91; was see under PERSONNEL MANAGEMENT Aug 1977-90", "HN": "91(Aug 77); was see under PERSONNEL MANAGEMENT 1977-90", "MR": "20210512", "DA": "19770512", "DC": "1", "DX": "19910101", "UI": "D010560"}, {"RECTYPE": "D", "MH": "Personnel Staffing and Scheduling", "DE": "PERSONNEL STAFFING SCHEDULING", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Staffing and Scheduling|T057|NON|BRD|UNK (19XX)|741111|STAFFING SCHEDULING|abcdefv", "ENTRY": "Work Schedules", "MN": "N04.452.677.650", "MH_TH": "NLM (1975)", "ST": "T057", "AN": "med or non-med personnel", "MS": "The selection, appointing, and scheduling of personnel.", "PM": "91; was see under PERSONNEL MANAGEMENT 1975-90", "HN": "91(75); was see under PERSONNEL MANAGEMENT 1975-90", "MR": "20170620", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010561"}, {"RECTYPE": "D", "MH": "Personnel Staffing and Scheduling Information Systems", "DE": "PSIS", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Personnel Staffing Scheduling Information Systems|T170|NON|EQV|UNK (19XX)|860617|abcdef", "MN": "N04.452.515.800", "MH_TH": "NLM (1987)", "ST": "T170", "AN": "IM", "MS": "Computer-based systems for use in personnel management in a facility, e.g., distribution of caregivers with relation to patient needs.", "PM": "91; was see under MANAGEMENT INFORMATION SYSTEMS 1987-90", "HN": "91(87); was see under MANAGEMENT INFORMATION SYSTEMS 1987-90", "MR": "20180629", "DA": "19860617", "DC": "1", "DX": "19910101", "UI": "D010562"}, {"RECTYPE": "D", "MH": "Personnel Turnover", "AQ": "EC LJ SN TD", "PRINT ENTRY": "Personnel Retention|T081|NON|REL|NLM (2022)|210518|abcdef", "ENTRY": "Turnover, Personnel", "MN": "N04.452.677.680", "MH_TH": "NLM (1983)", "ST": "T081", "MS": "A change or shift in personnel due to reorganization, resignation, or discharge.", "PM": "91; was see under PERSONNEL MANAGEMENT 1983-90", "HN": "91(83); was see under PERSONNEL MANAGEMENT 1983-90", "MR": "20210630", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D010563"}, {"RECTYPE": "D", "MH": "Personnel, Hospital", "DE": "PERSONNEL HOSP", "AQ": "CL EC ED ES HI LJ PX SD SN ST TD", "PRINT ENTRY": "Hospital Personnel|T097|NON|EQV|POPLINE (1978)|770519|HOSP PERSONNEL|abcdefv", "MN": "N02.360.740", "EC": "organization & administration:Personnel Administration, Hospital", "MH_TH": "NLM (1968)", "ST": "T097", "PI": "Personnel Administration, Hospital (1966-1967)", "MS": "The individuals employed by the hospital.", "OL": "use PERSONNEL, HOSPITAL to search HOSPITAL PERSONNEL 1968-77", "PM": "78; was HOSPITAL PERSONNEL 1968-77", "HN": "78; was HOSPITAL PERSONNEL 1968-77", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010564"}, {"RECTYPE": "D", "MH": "Persuasive Communication", "PRINT ENTRY": "Persuasion|T078|T170|NON|EQV|POPLINE (1994)|UNK (19XX)|740330|abbcdeef", "ENTRY": "Communication, Persuasive", "MN": "L01.143.762", "FX": "Suggestion", "MH_TH": "NLM (1969)", "ST": "T170", "PI": "Suggestion (1966-1968)", "MS": "A mode of communication concerned with inducing or urging the adoption of certain beliefs, theories, or lines of action by others.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20230524", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D010565"}, {"RECTYPE": "D", "MH": "Virulence Factors, Bordetella", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bordetella Virulence Factors|T123|T131|NON|EQV|NLM (2003)|020129|abbcdef", "ENTRY": "Virulence Determinant, Bordetella", "MN": "D23.946.896.980", "MH_TH": "NLM (2003)", "ST": "T131", "RN": "0", "PI": "Toxins (1966-1976)", "MS": "A set of BACTERIAL ADHESINS and TOXINS, BIOLOGICAL produced by BORDETELLA organisms that determine the pathogenesis of BORDETELLA INFECTIONS, such as WHOOPING COUGH. They include filamentous hemagglutinin; FIMBRIAE PROTEINS; pertactin; PERTUSSIS TOXIN; ADENYLATE CYCLASE TOXIN; dermonecrotic toxin; tracheal cytotoxin; Bordetella LIPOPOLYSACCHARIDES; and tracheal colonization factor.", "PM": "2003 see PERTUSSIS TOXINS 1986-2002", "HN": "2003 (1986)", "MR": "20180629", "DA": "19850617", "DC": "1", "DX": "19860101", "UI": "D010566"}, {"RECTYPE": "D", "MH": "Pertussis Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccine, Pertussis", "MN": "D20.215.894.135.535", "FX": "Whooping Cough", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "AN": "DIPHTHERIA-TETANUS-PERTUSSIS VACCINE is also available", "MS": "A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed)", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010567"}, {"RECTYPE": "D", "MH": "Peru", "AQ": "EH EP", "MN": "Z01.107.757.702", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in western South America, bordering the South Pacific Ocean, and located between Chile and Ecuador.", "MR": "20160708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D010568"}, {"RECTYPE": "D", "MH": "Perylene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Perilene|T109|T121|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|780503|abbbcdeef", "ENTRY": "Peri Dinaphthalene", "MN": "D04.615.680.750", "MH_TH": "NLM (1979)", "ST": "T131", "N1": "Perylene", "RN": "5QD5427UN7", "RR": "198-55-0 (Perylene)", "PI": "Polycyclic Hydrocarbons (1974-1978)", "MS": "A 20-carbon dibenz(de,kl)anthracene that can be viewed as a naphthalene fused to a phenalene or as dinaphthalene. It is used as fluorescent lipid probe in the cytochemistry of membranes and is a polycyclic hydrocarbon pollutant in soil and water. Derivatives may be carcinogenic.", "PM": "91; was see under BENZANTHRACENES 1979-90", "HN": "91(79); was see under BENZANTHRACENES 1979-90", "MR": "20230725", "DA": "19780503", "DC": "1", "DX": "19910101", "UI": "D010569"}, {"RECTYPE": "D", "MH": "Pessaries", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Pessary", "MN": "E07.858.499", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "Devices worn in the vagina to provide support to displaced uterus or rectum. Pessaries are used in conditions such as UTERINE PROLAPSE; CYSTOCELE; or RECTOCELE.", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010570"}, {"RECTYPE": "D", "MH": "Pest Control", "AQ": "EC ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Pest Management|T057|T068|NON|EQV|NLM (2011)|091210|abbcdef", "ENTRY": "Management, Pest", "MN": "N06.850.780.200.650", "FX": "Weed Control", "MH_TH": "NLM (1976)", "ST": "T068", "AN": "general or unspecified; prefer specifics; coordinate with specific pest; WEED CONTROL is also available", "MS": "The reduction or regulation of the population of noxious, destructive, or dangerous plants, insects, or other animals.  This includes control of plants that serve as habitats or food sources for animal pests.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20150210", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D010571"}, {"RECTYPE": "D", "MH": "Pest Control, Biological", "DE": "PEST CONTROL BIOL", "AQ": "EC ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Biological Pest Control|T057|T068|NON|EQV|UNK (19XX)|740330|BIOL PEST CONTROL|abbcdefv", "ENTRY": "Pest Controls, Biological", "MN": "N06.850.780.200.650.650", "FX": "Chemosterilants", "MH_TH": "NLM (1973)", "ST": "T068", "AN": "coordinate IM with specific insect or other pest (IM) but do not coordinate with INSECT CONTROL & MOSQUITO CONTROL", "PI": "Rodent Control (1966-1972)", "MS": "Use of naturally-occuring or genetically-engineered organisms to reduce or eliminate populations of pests.", "PM": "73", "HN": "73", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010572"}, {"RECTYPE": "D", "MH": "Pesticide Residues", "AQ": "AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO UR", "ENTRY": "Residues, Pesticide", "MN": "N06.850.460.200.700", "MH_TH": "NLM (1973)", "ST": "T131", "RN": "0", "AN": "coordinate with specific pesticide or pesticide group", "PI": "Pesticides (1966-1972)", "MS": "Pesticides or their breakdown products remaining in the environment following their normal use or accidental contamination.", "PM": "73", "HN": "73", "MR": "20170602", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010573"}, {"RECTYPE": "D", "MH": "Pesticide Synergists", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Synergists, Pesticide", "MN": "D27.888.723.748", "MH_TH": "NLM (1972)", "ST": "T131", "RN": "0", "PI": "Pesticides (1966-1971)", "MS": "Chemicals that, while not possessing inherent pesticidal activity, nonetheless promote or enhance the effectiveness of other pesticides when combined.", "PM": "73", "HN": "73(72)", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010574"}, {"RECTYPE": "D", "MH": "Pesticides", "AQ": "AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO UR", "PRINT ENTRY": "Pesticide|T131|NON|EQV|NLM (2021)|191113|abcdef", "MN": "D27.888.723", "MH_TH": "POPLINE (1994)", "ST": "T131", "RN": "0", "AN": "general or unspecified only; prefer specific types", "MS": "Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010575"}, {"RECTYPE": "D", "MH": "Pestivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Pestiviruses", "MN": "B04.820.578.344.700", "MH_TH": "NLM (1981)", "ST": "T005", "RN": "txid11095", "MS": "A genus of FLAVIVIRIDAE, also known as mucosal disease virus group, which is not arthropod-borne. Transmission is by direct and indirect contact, and by transplacental and congenital transmission. Species include BORDER DISEASE VIRUS, bovine viral diarrhea virus (DIARRHEA VIRUS, BOVINE VIRAL), and CLASSICAL SWINE FEVER VIRUS.", "OL": "use PESTIVIRUS to search PESTIVIRUSES 1981-93", "PM": "94; was PESTIVIRUSES 1981-93", "HN": "94; was PESTIVIRUSES 1981-93", "MR": "20200813", "DA": "19800522", "DC": "1", "DX": "19810101", "UI": "D010576"}, {"RECTYPE": "D", "MH": "Petrolatum", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Petroleum Jelly|T109|T122|NON|EQV|UNK (19XX)|771125|abbcdef", "ENTRY": "White Petrolatum", "MN": "D02.455.699", "PA": "Ointment Bases", "MH_TH": "USP (19XX)", "ST": "T122", "N1": "Petrolatum", "RN": "8009-03-8", "RR": "8027-64-3 (hydrophilic)", "MS": "A colloidal system of semisolid hydrocarbons obtained from PETROLEUM. It is used as an ointment base, topical protectant, and lubricant.", "HN": "was in Cat D only 1963-82", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010577"}, {"RECTYPE": "D", "MH": "Petroleum", "AQ": "AE AN CL EC HI ME MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Crude Oil|T167|NON|EQV|NLM (1990)|890501|abcdef", "ENTRY": "Petroleums", "MN": "N06.230.132.258.630", "FX": "Oil and Gas Fields", "MH_TH": "NLM (1966)", "ST": "T167", "RN": "0", "MS": "Naturally occurring complex liquid hydrocarbons which, after distillation, yield combustible fuels, petrochemicals, and lubricants.", "HN": "was in Cat J only 1975-81, was in Cat D & J 1968-74, was in Cat D only 1963-67", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010578"}, {"RECTYPE": "D", "MH": "Petrous Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Petrous Pyramid|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Petrous Bones", "MN": "A02.835.232.781.885.681", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "fractures: coordinate PETROUS BONE /inj with SKULL FRACTURES; neoplasms: coordinate with SKULL NEOPLASMS ", "MS": "The dense rock-like part of temporal bone that contains the INNER EAR. Petrous bone is located at the base of the skull. Sometimes it is combined with the MASTOID PROCESS and called petromastoid part of temporal bone.", "MR": "20190521", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010579"}, {"RECTYPE": "D", "MH": "Peutz-Jeghers Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lentiginosis, Perioral|T191|NON|EQV|GHR (2014)|NLM (1993)|ORD (2010)|920406|abcdeeef", "ENTRY": "Syndromes, Polyps-and-Spots", "MN": "C17.800.621.430.530.550.625", "MH_TH": "ORD (2010)", "ST": "T191", "MS": "A hereditary disease caused by autosomal dominant mutations involving CHROMOSOME 19. It is characterized by the presence of INTESTINAL POLYPS, consistently in the JEJUNUM, and mucocutaneous pigmentation with MELANIN spots of the lips, buccal MUCOSA, and digits.", "PM": "65; was see under POLYPI (now POLYPS) 1963-64", "HN": "65; was see under POLYPI (now POLYPS) 1963-64", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010580"}, {"RECTYPE": "D", "MH": "Peyer's Patches", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Peyers Patches", "MN": "A15.382.520.604.600", "MH_TH": "NLM (1972)", "ST": "T023", "AN": "an area of lymphoid tissue on small intestine mucosa", "PI": "Lymphoid Tissue (1966-1971)", "MS": "Lymphoid tissue on the mucosa of the small intestine.", "PM": "85; was see under LYMPHOID TISSUE 1975-84", "HN": "85(72); was see under LYMPHOID TISSUE 1975-84", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D010581"}, {"RECTYPE": "D", "MH": "Bacteriophage lambda", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "lambda Phage|T005|NON|EQV|UNK (19XX)|790412|abcdef", "MN": "B04.280.090.800.230", "MH_TH": "NLM (1980)", "ST": "T005", "RN": "txid10710", "AN": "LAMBDA-LIKE PHAGES see SIPHOVIRIDAE is also available", "PI": "Coliphages (1966-1979)", "MS": "A temperate inducible phage and type species of the genus lambda-like viruses, in the family SIPHOVIRIDAE. Its natural host is E. coli K12. Its VIRION contains linear double-stranded DNA with single-stranded 12-base 5' sticky ends. The DNA circularizes on infection.", "OL": "use BACTERIOPHAGE LAMBDA to search PHAGE LAMBDA 1980-92; use COLIPHAGES to search BACTERIOPHAGE LAMBDA & LAMBDA PHAGE 1975-79", "PM": "93; was PHAGE LAMBDA 1980-92; BACTERIOPHAGE LAMBDA was see PHAGE LAMBDA 1980-92, was see COLIPHAGES 1975-79; LAMBDA PHAGE was see COLIPHAGES 1975-79", "HN": "93; was PHAGE LAMBDA 1980-92; BACTERIOPHAGE LAMBDA was see PHAGE LAMBDA 1980-92, was see COLIPHAGES 1975-79; LAMBDA PHAGE was see COLIPHAGES 1975-79", "MR": "20200813", "DA": "19790412", "DC": "1", "DX": "19800101", "UI": "D010582"}, {"RECTYPE": "D", "MH": "Bacteriophage mu", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "mu Phage|T005|NON|EQV|UNK (19XX)|790416|abcdef", "ENTRY": "mu Phages", "MN": "B04.280.090.500.260", "MH_TH": "NLM (1980)", "ST": "T005", "RN": "txid2681603", "PI": "Coliphages (1966-1979)", "MS": "A temperate coliphage, in the genus Mu-like viruses, family MYOVIRIDAE, composed of a linear, double-stranded molecule of DNA, which is able to insert itself randomly at any point on the host chromosome. It frequently causes a mutation by interrupting the continuity of the bacterial OPERON at the site of insertion.", "OL": "use BACTERIOPHAGE MU to search PHAGE MU 1990-92 & PHAGE MU 1 1980-89", "PM": "93; was PHAGE MU 1990-92; BACTERIOPHAGE MU was see PHAGE MU 1990-92, was see PHAGE MU 1 1980-89", "HN": "93; was PHAGE MU 1990-92; BACTERIOPHAGE MU was see PHAGE MU 1990-92, was see PHAGE MU 1 1980-89", "MR": "20200813", "DA": "19790416", "DC": "1", "DX": "19800101", "UI": "D010583"}, {"RECTYPE": "D", "MH": "Bacteriophage phi X 174", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "phi X 174 Phage|T005|NON|EQV|NLM (1994)|930119|abcdef", "ENTRY": "Phage phi X174|T005|NON|EQV|NLM (1993)|911015|abcdef", "MN": "B04.280.470.500.320", "MH_TH": "NLM (1980)", "ST": "T005", "RN": "txid10847", "PI": "Coliphages (1966-1979)", "MS": "The type species of the genus MICROVIRUS. A prototype of the small virulent DNA coliphages, it is composed of a single strand of supercoiled circular DNA, which on infection, is converted to a double-stranded replicative form by a host enzyme.", "OL": "use BACTERIOPHAGE PHI X 174 to search PHI X 174 1980-93 & PHAGE PHI X 174 1980-92", "PM": "93; was PHAGE PHI X 174 1980-92; PHI X 174 was see BACTERIOPHAGE PHI X 174 1980-93; BACTERIOPHAGE PHI X 174 was see PHAGE PHI X 174 1980-92", "HN": "93; was PHAGE PHI X 174 1980-92; PHI X 174 was see BACTERIOPHAGE PHI X 174 1980-93; BACTERIOPHAGE PHI X 174 was see PHAGE PHI X 174 1980-92", "MR": "20200813", "DA": "19790416", "DC": "1", "DX": "19800101", "UI": "D010584"}, {"RECTYPE": "D", "MH": "Phagocyte Bactericidal Dysfunction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Phagocyte Bactericidal Dysfunctions", "MN": "C20.673.774", "MH_TH": "NLM (1972)", "ST": "T047", "AN": "immunodefic syndrome where phagocytes cannot kill bacteria", "PI": "Phagocytosis (1966-1971)", "MS": "Disorders in which phagocytic cells cannot kill ingested bacteria; characterized by frequent recurring infection with formulation of granulomas.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010585"}, {"RECTYPE": "D", "MH": "Phagocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cells, Phagocytic", "MN": "A15.382.680", "MH_TH": "NLM (1973)", "ST": "T025", "PI": "Phagocytosis (1966-1972)", "MS": "Cells that can carry out the process of PHAGOCYTOSIS.", "PM": "73", "HN": "73", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010586"}, {"RECTYPE": "D", "MH": "Phagocytosis", "AQ": "DE GE IM PH RE", "ENTRY": "Phagocytoses", "MN": "G12.688", "FX": "Macrophages", "MH_TH": "NLM (1966)", "ST": "T043", "MS": "The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES).", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010587"}, {"RECTYPE": "D", "MH": "Phagosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Phagolysosomes|T026|NON|NRW|UNK (19XX)|850311|abcdef", "ENTRY": "Phagosome", "MN": "A11.284.430.214.190.875.190.700", "FX": "Phagocytosis", "MH_TH": "NLM (1986)", "ST": "T026", "PI": "Phagocytosis (1966-1985)", "MS": "Membrane-bound cytoplasmic vesicles formed by invagination of phagocytized material. They fuse with lysosomes to form phagolysosomes in which the hydrolytic enzymes of the lysosome digest the phagocytized material.", "PM": "86", "HN": "86", "MR": "20030709", "DA": "19850311", "DC": "1", "DX": "19860101", "UI": "D010588"}, {"RECTYPE": "D", "MH": "Phalloidine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phalloidin|T116|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D23.946.587.755", "PA": "Poisons", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "17466-45-4", "PI": "Peptides, Cyclic (1973-1974)", "MS": "Very toxic polypeptide isolated mainly from AMANITA phalloides (Agaricaceae) or death cup; causes fatal liver, kidney and CNS damage in mushroom poisoning; used in the study of liver damage.", "PM": "91; was see under OLIGOPEPTIDES 1975-90", "HN": "91(75); was see under OLIGOPEPTIDES 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010590"}, {"RECTYPE": "D", "MH": "Phantom Limb", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Pseudomelia|T048|NON|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Sensations, Phantom", "MN": "F01.700.750.700", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "Perception of painful and nonpainful phantom sensations that occur following the complete or partial loss of a limb. The majority of individuals with an amputated extremity will experience the impression that the limb is still present, and in many cases, painful. (From Neurol Clin 1998 Nov;16(4):919-36; Brain 1998 Sep;121(Pt 9):1603-30)", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010591"}, {"RECTYPE": "D", "MH": "Pharmaceutic Aids", "DE": "PHARM AIDS", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Pharmaceutical Aids|T120|NON|EQV|UNK (19XX)|780626|abcdef", "MN": "D27.720.744", "MH_TH": "NLM (1968)", "ST": "T120", "RN": "0", "PI": "specific aid (1966-1967)", "MS": "Substances which are of little or no therapeutic value, but are necessary in the manufacture, compounding, storage, etc., of pharmaceutical preparations or drug dosage forms. They include SOLVENTS, diluting agents, and suspending agents, and emulsifying agents. Also, ANTIOXIDANTS; PRESERVATIVES, PHARMACEUTICAL; COLORING AGENTS; FLAVORING AGENTS; VEHICLES; EXCIPIENTS; OINTMENT BASES.", "PM": "68", "HN": "68", "MR": "20050705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010592"}, {"RECTYPE": "D", "MH": "Pharmaceutical Services", "DE": "PHARM SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Service, Pharmacy", "MN": "N02.421.668", "MH_TH": "NLM (1968)", "ST": "T058", "PI": "Prescriptions (1966-1967)", "MS": "Total pharmaceutical services provided by qualified PHARMACISTS. In addition to the preparation and distribution of medical products, they may include consultative services provided to agencies and institutions which do not have a qualified pharmacist.", "PM": "68", "HN": "68", "MR": "20160302", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010593"}, {"RECTYPE": "D", "MH": "Pharmacies", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Community Pharmacies|T093|NON|NRW|UNK (19XX)|780508|abcdef", "ENTRY": "Pharmacy, Community", "MN": "N02.278.678", "MH_TH": "NLM (1966)", "ST": "T093", "AN": "the place: do not confuse with PHARMACY, the field", "MS": "Facilities for the preparation and dispensing of drugs.", "OL": "use PHARMACIES to search COMMUNITY PHARMACIES 1968-78", "HN": "COMMUNITY PHARMACIES was see under PHARMACIES 1968-78", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010594"}, {"RECTYPE": "D", "MH": "Pharmacists", "AQ": "CL EC ES HI LJ OG PX SD SN ST TD", "ENTRY": "Retail Pharmacist", "MN": "N02.360.780", "EC": "education:Education, Pharmacy", "MH_TH": "NLM (1968)", "ST": "T097", "PI": "Pharmacy (1966-1967)", "MS": "Those persons legally qualified by education and training to engage in the practice of pharmacy.", "PM": "68", "HN": "68", "MR": "20180711", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010595"}, {"RECTYPE": "D", "MH": "Pharmacy Technicians", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Pharmacists' Aides|T097|NON|EQV|NLM (1971)|990101|abcdef", "ENTRY": "Technicians, Pharmacy", "MN": "N02.360.067.730", "MH_TH": "NLM (2017)", "ST": "T097", "PI": "Pharmacy (1968-1970)", "MS": "Persons who perform certain functions under the supervision of a pharmacist.", "PM": "2017; see PHARMACISTS\u2019 AIDES 1971-2016", "HN": "2017; use PHARMACISTS' AIDES 1971-2016", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D010596"}, {"RECTYPE": "D", "MH": "Pharmacogenetics", "DE": "PHARMACOGENET", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Pharmacogenomics|T091|NON|REL|NLM (2003)|011004|abcdef", "MN": "H02.628.479", "FX": "Toxicology", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "the discipline (education, history, etc) only; for pharmacogenetic studies, index the specific drug and specific genetic aspect", "MS": "A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (BIOTRANSFORMATION).", "PM": "70", "HN": "70(66)", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D010597"}, {"RECTYPE": "D", "MH": "Pharmacognosy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Pharmacognosies", "MN": "H01.158.703.060", "FX": "Plants, Medicinal", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty", "MS": "The science of drugs prepared from natural-sources including preparations from PLANTS, animals, and other organisms as well as MINERALS and other substances included in MATERIA MEDICA. The therapeutic usage of plants is PHYTOTHERAPY.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010598"}, {"RECTYPE": "D", "MH": "Pharmacokinetics", "DE": "PHARMACOKIN", "PRINT ENTRY": "Liberation, Absorption, Distribution, Metabolism, Elimination, and Response|T039|NON|NRW|NLM (2021)|191113|abcdef", "MN": "G07.690.725", "MH_TH": "NLM (1988)", "ST": "T039", "AN": "general or unspecified; prefer /pharmacokin with drugs", "PI": "specific Category D heading/metabolism (1966-1987)", "MS": "Dynamic and kinetic mechanisms of exogenous chemical DRUG LIBERATION; ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and DRUG TOXICITY as a function of dosage, and rate of METABOLISM. LADMER, ADME and ADMET are abbreviations for liberation, absorption, distribution, metabolism, elimination, and toxicology.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20200722", "DA": "19870418", "DC": "1", "DX": "19880101", "UI": "D010599"}, {"RECTYPE": "D", "MH": "Pharmacology", "DE": "PHARMACOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Pharmacologies", "MN": "H02.628", "FX": "Pharmaceutical Preparations", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use PHARMACOLOGICAL AND TOXICOLOGICAL PHENOMENA or specifics treed under it for the properties of drugs and their metabolism and interactions; the qualifier /pharmacology is available for use with drugs and chemicals; methods: consider TECHNOLOGY, PHARMACEUTICAL", "MS": "The study of the origin, nature, properties, and actions of drugs and their effects on living organisms.", "MR": "20170713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010600"}, {"RECTYPE": "D", "MH": "Pharmacology, Clinical", "DE": "PHARMACOL CLIN", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Clinical Pharmacology|T091|NON|EQV|UNK (19XX)|790529|CLIN PHARMACOL|abcdefv", "MN": "H02.628.512", "MH_TH": "NLM (1980)", "ST": "T091", "PI": "Pharmacology (1966-1979)", "MS": "The branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans.", "PM": "80", "HN": "80", "MR": "20190524", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D010601"}, {"RECTYPE": "D", "MH": "Pharmacopoeias as Topic", "AQ": "CL HI ST", "PRINT ENTRY": "National Formulary|T170|NON|NRW|NLM (1996)|950117|abcdef", "ENTRY": "National Formularies", "MN": "L01.462.500.682.192.836.749", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with FORMULARIES AS TOPIC which, usually mere lists, are less complete; do not confuse with the Publication Type PHARMACOPOEIAS; specify country if pertinent", "MS": "Works about authoritative treatises on drugs and preparations, their description, formulation, analytic composition, physical constants, main chemical properties used in identification, standards for strength, purity, and dosage, chemical tests for determining identity and purity, etc.", "PM": "2008; see PHARMACOPOEIAS 1963-2007", "HN": "2008(1963)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D010602"}, {"RECTYPE": "D", "MH": "Pharmacopoeias, Homeopathic as Topic", "AQ": "HI ST", "ENTRY": "Homeopathic Pharmacopoeias as Topic|T073|T170|NON|EQV|NLM (2019)|180618|abbcdef", "MN": "L01.462.500.682.192.836.749.599", "FX": "Formularies, Homeopathic as Topic", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "do not confuse with the Publication Type PHARMACOPOEIA, HOMEOPATHIC ", "MS": "Works about authoritative resources describing the composition, properties, manufacture, and quality control of HOMEOPATHIC REMEDIES.", "HN": "2019(1966)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010603"}, {"RECTYPE": "D", "MH": "Pharmacy", "AQ": "CL IS MT OG SN ST TD", "ENTRY": "Practice Patterns, Pharmacy", "MN": "H02.646", "FX": "Pharmacy Service, Hospital", "EC": "legislation & jurisprudence:Legislation, Pharmacy", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty: do not confuse with PHARMACIES; /methods: consider TECHNOLOGY, PHARMACEUTICAL", "PI": "Pharmacy/History (1963-2018)", "MS": "The practice of compounding and dispensing medicinal preparations.", "MR": "20180615", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010604"}, {"RECTYPE": "D", "MH": "Pharmacy Administration", "DE": "PHARM ADMIN", "AQ": "CL EC ED ES HI IS LJ MT SN ST TD", "ENTRY": "Pharmacy Administrations|T057|NON|EQV|NLM (1994)|930122|abcdef", "MN": "N04.452.706", "FX": "Insurance, Pharmaceutical Services", "MH_TH": "NLM (1968)", "ST": "T057", "PI": "Pharmacy (1966-1967)", "MS": "The business and managerial aspects of pharmacy in its broadest sense.", "PM": "68", "HN": "68", "MR": "20170711", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010605"}, {"RECTYPE": "D", "MH": "Pharmacy and Therapeutics Committee", "DE": "PHARM THER COMM", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Therapeutics Committee|T093|NON|NRW|UNK (19XX)|740330|THER COMM|abcdefv", "ENTRY": "Therapeutics Committees|T093|NON|NRW|NLM (1994)|930122|abcdef", "MN": "N05.700.685.625", "FX": "Formularies, Hospital as Topic", "MH_TH": "NLM (1968)", "ST": "T093", "PI": "Pharmacy Service, Hospital (1966-1967)", "MS": "An advisory group composed primarily of staff physicians and the pharmacist which serves as the communication link between the medical staff and the pharmacy department.", "PM": "68", "HN": "68", "MR": "20180716", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010606"}, {"RECTYPE": "D", "MH": "Pharmacy Service, Hospital", "DE": "PHARM SERV HOSP", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Pharmacy Service, Clinical|T093|NON|BRD|UNK (19XX)|840411|PHARM SERV CLIN|abcdefv", "ENTRY": "Services, Hospital Pharmacy", "MN": "N04.452.442.452.422.603", "MH_TH": "NLM (1966)", "ST": "T093", "MS": "Hospital department responsible for the receiving, storing, and distribution of pharmaceutical supplies.", "OL": "use PHARMACY SERVICE, HOSPITAL to search HOSPITAL PHARMACY SERVICE 1966-77", "PM": "78; was HOSPITAL PHARMACY SERVICE 1963-77", "HN": "78; was HOSPITAL PHARMACY SERVICE 1963-77", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D010607"}, {"RECTYPE": "D", "MH": "Pharyngeal Diseases", "DE": "PHARYNGEAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pharynx Disease", "MN": "C09.775", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes involving the PHARYNX.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010608"}, {"RECTYPE": "D", "MH": "Pharyngeal Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Palatopharyngeus|T023|NON|NRW|NLM (2009)|071023|abcdef", "ENTRY": "Pharynx Muscles", "MN": "A14.724.617", "MH_TH": "NLM (1979)", "ST": "T023", "AN": "/growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent", "PI": "Pharynx (1966-1978)", "MS": "The muscles of the PHARYNX are voluntary muscles arranged in two layers. The external circular layer consists of three constrictors (superior, middle, and inferior). The internal longitudinal layer consists of the palatopharyngeus, the salpingopharyngeus, and the stylopharyngeus. During swallowing, the outer layer constricts the pharyngeal wall and the inner layer elevates pharynx and LARYNX.", "PM": "1991; see MUSCLES 1979-1990; for CRICOPHARYNGEUS MUSCLE see ESOPHAGEAL SPHINCTER, UPPER 2005-2008", "HN": "1991(1979); use MUSCLES 1979-1990; for CRICOPHARYNGEUS MUSCLE use ESOPHAGEAL SPHINCTER, UPPER 2005-2008", "MR": "20181005", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D010609"}, {"RECTYPE": "D", "MH": "Pharyngeal Neoplasms", "DE": "PHARYNGEAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pharyngeal Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Pharynx Neoplasm", "MN": "C09.775.549", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the PHARYNX.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010610"}, {"RECTYPE": "D", "MH": "Pharyngectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Pharyngectomies", "MN": "E04.580.515", "MH_TH": "NLM (1964)", "ST": "T061", "MS": "Surgical removal of a part of the pharynx. (Dorland, 28th ed)", "PM": "74", "HN": "74(64)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010611"}, {"RECTYPE": "D", "MH": "Pharyngitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sore Throat|T184|NON|REL|UNK (19XX)|771205|abcdef", "ENTRY": "Throat, Sore", "MN": "C09.775.649", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the throat (PHARYNX).", "OL": "use PHARYNGITIS to search SORE THROAT 1966-78", "HN": "SORE THROAT was see under PHARYNGITIS 1963-78", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010612"}, {"RECTYPE": "D", "MH": "Pharyngostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Pharyngostomies", "MN": "E04.580.540", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Pharynx/surgery (1966-1987)", "MS": "External surgical fistulization of the pharynx for feeding.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19870319", "DC": "1", "DX": "19880101", "UI": "D010613"}, {"RECTYPE": "D", "MH": "Pharynx", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Throat|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Throats", "MN": "A14.724", "FX": "Pharyngostomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A funnel-shaped fibromuscular tube that conducts food to the ESOPHAGUS, and air to the LARYNX and LUNGS. It is located posterior to the NASAL CAVITY; ORAL CAVITY; and LARYNX, and extends from the SKULL BASE to the inferior border of the CRICOID CARTILAGE anteriorly and to the inferior border of the C6 vertebra posteriorly. It is divided into the NASOPHARYNX; OROPHARYNX; and HYPOPHARYNX (laryngopharynx).", "MR": "20050718", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010614"}, {"RECTYPE": "D", "MH": "Phenacetin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acetophenetidin|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbcdeef", "MN": "D02.092.146.113.092.700", "PA": "Analgesics, Non-Narcotic", "MH_TH": "NLM (1965)", "ST": "T121", "N1": "Acetamide, N-(4-ethoxyphenyl)-", "RN": "ER0CTH01H9", "RR": "62-44-2 (Phenacetin)", "MS": "A phenylacetamide that was formerly used in ANALGESICS but nephropathy and METHEMOGLOBINEMIA led to its withdrawal from the market. (From Smith and Reynard, Textbook of Pharmacology,1991, p431)", "PM": "65; see ACETOPHENETIDIN 1963-64", "HN": "65(63)", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010615"}, {"RECTYPE": "D", "MH": "Phenanthrenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.723", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "POLYCYCLIC AROMATIC HYDROCARBONS composed of three fused BENZENE rings.", "PM": "GLAUCARUBIN was see under PYRANS 1975-80", "MR": "20161129", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010616"}, {"RECTYPE": "D", "MH": "Phenanthridines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.633", "MH_TH": "NLM (1969)", "ST": "T109", "RN": "0", "PM": "69", "HN": "69", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D010617"}, {"RECTYPE": "D", "MH": "Phenanthrolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenanthroline|T109|NON|EQV|NLM (2021)|200220|abcdef", "MN": "D03.633.300.669", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010618"}, {"RECTYPE": "D", "MH": "Phenazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.704", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010619"}, {"RECTYPE": "D", "MH": "Phenazocine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenethylazocine|T109|T121|NON|EQV|UNK (19XX)|770429|abbcdef", "ENTRY": "Hydrobromide, Phenazocine", "MN": "D04.615.723.795.106.715", "PA": "Narcotics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-phenylethyl)-", "RN": "J0ND6N0AQC", "RR": "C1749020IH", "MS": "An opioid analgesic with actions and uses similar to MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1095)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010620"}, {"RECTYPE": "D", "MH": "Phenazopyridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ReAzo", "MN": "D03.383.725.050.610", "MH_TH": "NLM (1965)", "ST": "T121", "N1": "2,6-Pyridinediamine, 3-(phenylazo)-", "RN": "K2J09EMJ52", "RR": "94-78-0 (Phenazopyridine)", "MS": "A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.", "PM": "91; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78", "HN": "91(65); was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78", "MR": "20170524", "DA": "19771207", "DC": "1", "DX": "19910101", "UI": "D010621"}, {"RECTYPE": "D", "MH": "Phencyclidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "GP121", "MN": "D03.383.621.699", "PA": "Hallucinogens", "FX": "Receptors, Phencyclidine", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Piperidine, 1-(1-phenylcyclohexyl)-", "RN": "J1DOI7UV76", "RR": "V1JZQ7GDTX", "PI": "Piperidines (1968-1972)", "MS": "A hallucinogen formerly used as a veterinary anesthetic, and briefly as a general anesthetic for humans. Phencyclidine is similar to KETAMINE in structure and in many of its effects. Like ketamine, it can produce a dissociative state. It exerts its pharmacological action through inhibition of NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE). As a drug of abuse, it is known as PCP and Angel Dust.", "PM": "73; was see under PIPERIDINES 1969-72; was see under PIPERIDINES & ANESTHETICS 1968; was see under ANESTHETICS 1967.", "HN": "73(64); was see under PIPERIDINES 1969-72; was see under PIPERIDINES & ANESTHETICS 1968; was see under ANESTHETICS 1967", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010622"}, {"RECTYPE": "D", "MH": "Phencyclidine Abuse", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Phencyclidine-Related Disorders|T048|NON|BRD|NLM (1998)|970515|PHENCYCLIDINE RELATED DIS|abcdefv", "ENTRY": "Phencyclidine-Related Disorder", "MN": "F03.900.700", "MH_TH": "NLM (1981)", "ST": "T048", "PI": "Substance Abuse (1968-1980)", "MS": "The misuse of phencyclidine with associated psychological symptoms and impairment in social or occupational functioning.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19800521", "DC": "1", "DX": "19810101", "UI": "D010623"}, {"RECTYPE": "D", "MH": "Phenelzine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fenelzin|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "beta Phenylethylhydrazine", "MN": "D02.442.700", "PA": "Monoamine Oxidase Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Hydrazine, (2-phenylethyl)-", "RN": "O408N561GF", "RR": "51-71-8 (Phenelzine)", "MS": "One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010624"}, {"RECTYPE": "D", "MH": "Phenylethanolamine N-Methyltransferase", "DS": "PHENYLETHANOLAMINE METHYLTRANSFERASE N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phenethanolamine N-Methyltransferase|T116|T126|NON|EQV|NLM (1998)|970513|PHENETHANOLAMINE METHYLTRANSFERASE N|abbcdefs", "ENTRY": "Phenylethanolamine N Methyltransferase", "MN": "D08.811.913.555.500.700", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "S-Adenosyl-L-methionine:phenylethanolamine N-methyltransferase", "RN": "EC 2.1.1.28", "RR": "9037-68-7 (CAS RN)", "PI": "Transferases (1966-1971)", "MS": "A methyltransferase that catalyzes the reaction of S-adenosyl-L-methionine and phenylethanolamine to yield S-adenosyl-L-homocysteine and N-methylphenylethanolamine. It can act on various phenylethanolamines and converts norepinephrine into epinephrine. (From Enzyme Nomenclature, 1992) EC 2.1.1.28.", "PM": "74", "HN": "74(72)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010625"}, {"RECTYPE": "D", "MH": "Phenylethyl Alcohol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenylethanol|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "beta Phenylethanol", "MN": "D02.033.375.650", "PA": "Preservatives, Pharmaceutical", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzeneethanol", "RN": "ML9LGA7468", "RR": "60-12-8 (Phenylethyl Alcohol)", "PI": "Benzene Derivatives (1972-1974)", "MS": "An antimicrobial, antiseptic, and disinfectant that is used also as an aromatic essence and preservative in pharmaceutics and perfumery.", "PM": "96; was PHENETHYL ALCOHOL 1975-95 (see under ALCOHOL, ETHYL 1975-90); PHENYLETHYL ALCOHOL was see PHENETHYL ALCOHOL 1975-95", "HN": "96; was PHENETHYL ALCOHOL 1975-95 (see under ALCOHOL, ETHYL 1975-90); PHENYLETHYL ALCOHOL was see PHENETHYL ALCOHOL 1975-95", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010626"}, {"RECTYPE": "D", "MH": "Phenethylamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenylethylamines|T109|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "D02.092.471.683", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed)", "OL": "use PHENETHYLAMINES to search PHENYLETHYLAMINES 1966-67", "PM": "68; was PHENYLETHYLAMINES 1963-67", "HN": "68; was PHENYLETHYLAMINES 1963-67", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010627"}, {"RECTYPE": "D", "MH": "Phenetidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethoxyaniline|T109|NON|EQV|UNK (19XX)|741111|abcdef", "MN": "D02.455.426.559.389.657.654.750", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "Benzenamine, 4-ethoxy-", "RN": "156-43-4", "PI": "Ethyl Ethers (1974)", "MS": "Used in the manufacture of acetophenetidin.", "PM": "91; was see under AMINOPHENOLS 1979-90; was see under ANILINE COMPOUNDS 1975-78", "HN": "91(75); was see under AMINOPHENOLS 1979-90; was see under ANILINE COMPOUNDS 1975-78", "MR": "20120703", "DA": "19771207", "DC": "1", "DX": "19910101", "UI": "D010628"}, {"RECTYPE": "D", "MH": "Phenformin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fenformin|T109|T131|NON|EQV|UNK (19XX)|761223|abbcdef", "ENTRY": "Phenylethylbiguanide|T109|T131|NON|EQV|UNK (19XX)|801120|abbcdef", "MN": "D02.078.370.141.700", "PA": "Hypoglycemic Agents", "MH_TH": "INN (19XX)", "ST": "T131", "N1": "Imidodicarbonimidic diamide, N-(2-phenylethyl)-", "RN": "DD5K7529CE", "RR": "114-86-3 (Phenformin)", "MS": "A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010629"}, {"RECTYPE": "D", "MH": "Phenindione", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "2 Phenyl 1,3 indandione", "MN": "D04.615.486.487.750", "PA": "Anticoagulants", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Indene-1,3(2H)-dione, 2-phenyl-", "RN": "5M7Y6274ZE", "RR": "83-12-5 (Phenindione)", "MS": "An indandione that has been used as an anticoagulant. Phenindione has actions similar to WARFARIN, but it is now rarely employed because of its higher incidence of severe adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p234)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010630"}, {"RECTYPE": "D", "MH": "Pheniramine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prophenpyridamine|T109|T121|NON|EQV|UNK (19XX)|760430|abbcdef", "ENTRY": "Maleate, Pheniramine", "MN": "D03.383.725.620", "PA": "Histamine H1 Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Pyridinepropanamine, N,N-dimethyl-gamma-phenyl-", "RN": "134FM9ZZ6M", "RR": "NYW905655B", "MS": "One of the HISTAMINE H1 ANTAGONISTS with little sedative action. It is used in treatment of hay fever, rhinitis, allergic dermatoses, and pruritus.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010632"}, {"RECTYPE": "D", "MH": "Phenmetrazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenmetraline|T109|T121|NON|EQV|UNK (19XX)|770516|abbcdef", "ENTRY": "Hydrochloride, Phenmetrazine", "MN": "D03.383.533.640.650", "PA": "Sympathomimetics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Morpholine, 3-methyl-2-phenyl-", "RN": "XA501VL3VR", "RR": "6U85YRT588", "MS": "A sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to DEXTROAMPHETAMINE.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010633"}, {"RECTYPE": "D", "MH": "Phenobarbital", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenylbarbital|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Sodium, Phenobarbital", "MN": "D03.383.742.698.253.650", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-phenyl-", "RN": "YQE403BP4D", "RR": "SW9M9BB5K3", "MS": "A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010634"}, {"RECTYPE": "D", "MH": "Phenolphthaleins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.657.625", "PA": "Indicators and Reagents", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "AN": "PHENOLPHTHALEIN is also available", "MS": "A family of 3,3-bis(p-hydroxyphenyl)phthalides. They are used as CATHARTICS, indicators, and COLORING AGENTS.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010635"}, {"RECTYPE": "D", "MH": "Phenols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.657", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010636"}, {"RECTYPE": "D", "MH": "Phenolsulfonphthalein", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Phenol Red|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|741018|abbcdeef", "ENTRY": "Sulphonthal|T109|T130|TRD|NRW|NLM (1992)|910221|abbcdef", "MN": "D02.455.426.559.389.657.625.560", "PA": "Indicators and Reagents", "MH_TH": "FDA SRS (2014)", "ST": "T130", "N1": "Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis-, S,S-dioxide", "RN": "I6G9Y0J1OJ", "RR": "143-74-8 (Phenolsulfonphthalein)", "PI": "Phenolphthaleins (1966-1974)", "MS": "Red dye, pH indicator, and diagnostic aid for determination of renal function. It is used also for studies of the gastrointestinal and other systems.", "OL": "search PHENOLPHTHALEINS 1966-74", "PM": "91; was see under PHENOLPHTHALEINS 1975-90", "HN": "91(75); was see under PHENOLPHTHALEINS 1975-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010637"}, {"RECTYPE": "D", "MH": "Phenoperidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R1406", "MN": "D03.383.621.349.683", "PA": "Narcotics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "4-Piperidinecarboxylic acid, 1-(3-hydroxy-3-phenylpropyl)-4-phenyl-, ethyl ester", "RN": "G9BH09J4JW", "RR": "562-26-5 (Phenoperidine)", "MS": "A narcotic analgesic partly metabolized to meperidine in the liver. It is similar to morphine in action and used for neuroleptanalgesia, usually with droperidol.", "PM": "74", "HN": "74(64)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010638"}, {"RECTYPE": "D", "MH": "Phenothiazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.783", "FX": "Antipsychotic Agents", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010640"}, {"RECTYPE": "D", "MH": "Phenotype", "ENTRY": "Phenotypes", "MN": "G05.695", "FX": "Somatotypes", "MH_TH": "NLM (1968)", "ST": "T032", "PI": "Genetics (1966-1967)", "MS": "The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010641"}, {"RECTYPE": "D", "MH": "Phenoxyacetates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.511.316.682", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "Derivatives of phenoxyacetic acid, including its salts and esters.", "OL": "search GLYCOLATES 1966-74", "PM": "91; was see under GLYCOLATES 1975-90", "HN": "91(75); was see under GLYCOLATES 1975-90", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010642"}, {"RECTYPE": "D", "MH": "Phenoxybenzamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Phenoxybenzamine", "MN": "D02.092.471.739", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenemethanamine, N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-", "RN": "0TTZ664R7Z", "RR": "X1IEG24OHL", "MS": "An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010643"}, {"RECTYPE": "D", "MH": "Phenprocoumon", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenylpropylhydroxycumarinum|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Phenprogramma|T109|T121|TRD|NRW|DE|041021|abbcdef", "MN": "D03.633.100.150.446.520.750", "PA": "Anticoagulants", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1-Benzopyran-2-one, 4-hydroxy-3-(1-phenylpropyl)-", "RN": "Q08SIO485D", "RR": "435-97-2 (Phenprocoumon)", "PI": "Coumarins (1966-1974)", "MS": "Coumarin derivative that acts as a long acting oral anticoagulant.", "PM": "91; was see under 4-HYDROXYCOUMARINS 1977-90; was see under COUMARINS 1975-76", "HN": "91(75); was see under 4-HYDROXYCOUMARINS 1977-90; was see under COUMARINS 1975-76", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010644"}, {"RECTYPE": "D", "MH": "Phentermine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Phentermine", "MN": "D02.092.471.683.152.766", "PA": "Sympathomimetics", "MH_TH": "USAN (1962)", "ST": "T121", "N1": "Benzeneethanamine, alpha,alpha-dimethyl-", "RN": "C045TQL4WP", "RR": "122-09-8 (Phentermine)", "MS": "A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.", "PM": "74", "HN": "74(66)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010645"}, {"RECTYPE": "D", "MH": "Phentolamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fentolamin|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Phentolamine Mono hydrochloride", "MN": "D03.383.129.308.754", "PA": "Antihypertensive Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Phenol, 3-(((4,5-dihydro-1H-imidazol-2-yl)methyl)(4-methylphenyl)amino)-", "RN": "Z468598HBV", "RR": "Y7543E5K9T", "MS": "A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.", "PM": "PHENTOLAMINE MESYLATE was indexed under PHENTOLAMINE/analogs & derivatives 1981-95", "HN": "PHENTOLAMINE MESYLATE was (NM) 1981-95", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D010646"}, {"RECTYPE": "D", "MH": "Phenyl Ethers", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diphenyl Oxides|T109|NON|NRW|UNK (19XX)|760324|abcdef", "ENTRY": "Oxides, Diphenyl", "MN": "D02.455.426.559.389.657.654", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Ethers that are linked to a benzene ring structure.", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010647"}, {"RECTYPE": "D", "MH": "Phenylacetates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Phenylacetic", "MN": "D02.241.223.601", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010648"}, {"RECTYPE": "D", "MH": "Phenylalanine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Phenylalanine, L Isomer", "MN": "D12.125.142.666", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "L-Phenylalanine", "RN": "47E5O17Y3R", "RR": "63-91-2 (Phenylalanine)", "MS": "An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010649"}, {"RECTYPE": "D", "MH": "Phenylalanine Ammonia-Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phenylalanine Tyrosine Ammonia lyase", "MN": "D08.811.520.232.400.700", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Phenylalanine ammonia-lyase", "RN": "EC 4.3.1.24", "RR": "EC 4.3.1.25", "PI": "Phenylalanine (1973-1974)", "MS": "An enzyme that catalyzes the deamination of PHENYLALANINE to form trans-cinnamate and ammonia.", "PM": "91; was see under AMMONIA-LYASES 1975-90", "HN": "91(75); was see under AMMONIA-LYASES 1975-90", "MR": "20090706", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010650"}, {"RECTYPE": "D", "MH": "Phenylalanine Hydroxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phenylalanine 4 Monooxygenase", "MN": "D08.811.682.690.708.601", "FX": "Phenylketonurias", "MH_TH": "NLM (1971)", "ST": "T126", "N1": "L-Phenylalanine,tetrahydrobiopterin:oxygen oxidoreductase (4-hydroxylating)", "RN": "EC 1.14.16.1", "AN": "/defic: consider also PHENYLKETONURIAS and PHENYLKETONURIA, MATERNAL", "PI": "Hydroxylases (1966-1970)", "MS": "An enzyme of the oxidoreductase class that catalyzes the formation of L-TYROSINE, dihydrobiopterin, and water from L-PHENYLALANINE, tetrahydrobiopterin, and oxygen. Deficiency of this enzyme may cause PHENYLKETONURIAS and PHENYLKETONURIA, MATERNAL. EC 1.14.16.1.", "PM": "73", "HN": "73(71)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010651"}, {"RECTYPE": "D", "MH": "Phenylalanine-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phenylalanyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961106|abbdef", "ENTRY": "Synthetase, Phenylalanyl-tRNA", "MN": "D08.811.464.263.200.650", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Phenylalanine:tRNA(Phe) ligase (AMP-forming)", "RN": "EC 6.1.1.20", "PI": "Phenylalanine (1973-1974)", "MS": "An enzyme that activates phenylalanine with its specific transfer RNA. EC 6.1.1.20.", "PM": "98; see PHENYLALANYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-1990", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010652"}, {"RECTYPE": "D", "MH": "Phenylbutazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fenilbutazon|T109|T121|NON|NRW|UNK (19XX)|770111|abbcdef", "ENTRY": "Butazolidin|T109|T121|TRD|NRW|UNK (19XX)|861113|abbcdef", "MN": "D03.383.129.539.850.777", "PA": "Anti-Inflammatory Agents, Non-Steroidal", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3,5-Pyrazolidinedione, 4-butyl-1,2-diphenyl-", "RN": "GN5P7K3T8S", "RR": "50-33-9 (Phenylbutazone)", "MS": "A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010653"}, {"RECTYPE": "D", "MH": "Phenylbutyrates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.223.651", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of 4-phenylbutyric acid, including its salts and esters.", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010654"}, {"RECTYPE": "D", "MH": "Phenylenediamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.092.782.258.651", "MH_TH": "NLM (1974)", "ST": "T129", "RN": "0", "MS": "Aniline compounds that contain two amino groups. They are used as a precursor in the synthesis of HETEROCYCLIC COMPOUNDS and POLYMERS. p-Phenylenediamine is used in the manufacture of HAIR DYES and is an ALLERGEN.", "PM": "74", "HN": "74", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010655"}, {"RECTYPE": "D", "MH": "Phenylephrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tannate, Phenylephrine", "MN": "D02.092.063.291.617", "PA": "Vasoconstrictor Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)-", "RN": "1WS297W6MV", "RR": "DU5ATO7HYP", "MS": "An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent.", "OL": "use PHENYLEPHRINE to search METASYMPATOL 1975-91", "PM": "METASYMPATOL was see PHENYLEPHRINE 1975-91", "HN": "METASYMPATOL was see PHENYLEPHRINE 1975-91", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010656"}, {"RECTYPE": "D", "MH": "Phenylethylmalonamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenylethylmalondiamide|T109|T121|NON|EQV|UNK (19XX)|800328|abbcdef", "ENTRY": "2 Ethyl 2 Phenylmalonamide", "MN": "D02.241.081.337.540.700", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Propanediamide, 2-ethyl-2-phenyl-", "RN": "7206-76-0", "PI": "Malonates (1972-1974)", "MS": "A metabolite of primidone.", "PM": "91; was see under MALONATES 1975-90", "HN": "91(75); was see under MALONATES 1975-90", "MR": "20000622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010657"}, {"RECTYPE": "D", "MH": "Phenylglyoxal", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D02.047.644.620", "PA": "Indicators and Reagents", "MH_TH": "NLM (1980)", "ST": "T130", "N1": "Benzeneacetaldehyde, alpha-oxo-", "RN": "N45G3015PA", "RR": "1074-12-0 (Phenylglyoxal)", "PI": "Glyoxal (1973-1974) /AA (1975-1979)", "MS": "A reagent that is highly selective for the modification of arginyl residues. It is used to selectively inhibit various enzymes and acts as an energy transfer inhibitor in photophosphorylation.", "PM": "91; was see under ALDEHYDES 1980-90", "HN": "91(80); was see under ALDEHYDES 1980-90", "MR": "20130708", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D010658"}, {"RECTYPE": "D", "MH": "Phenylhydrazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.442.726", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Diazo derivatives of aniline, used as a reagent for sugars, ketones, and aldehydes. (Dorland, 28th ed)", "OL": "use PHENYLHYDRAZINES to search PHENYLHYDRAZINE 1966-74", "PM": "75; was PHENYLHYDRAZINE 1963-74", "HN": "75; was PHENYLHYDRAZINE 1963-74", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D010659"}, {"RECTYPE": "D", "MH": "Phenylisopropyladenosine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isopropylphenyladenosine|T114|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "L Phenylisopropyladenosine", "MN": "D13.570.800.096.630", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Adenosine, N-(1-methylethyl)-N-phenyl-", "RN": "29193-86-0", "AN": "an antilipemic", "PI": "Propylamines (1972-1974)", "MS": "N-Isopropyl-N-phenyl-adenosine. Antilipemic agent. Synonym: TH 162.", "PM": "91; was see under ADENOSINE 1975-90", "HN": "91(75); was see under ADENOSINE 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010660"}, {"RECTYPE": "D", "MH": "Phenylketonurias", "DE": "PKU", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Phenylalanine Hydroxylase Deficiency Disease|T047|NON|NRW|GHR (2014)|NLM (2000)|991105|PHENYLALANINE HYDROXYLASE DEFIC DIS|abcdeefv", "ENTRY": "Non-Phenylketonuric Hyperphenylalaninemias", "MN": "C18.452.648.189.687", "FX": "Phenylalanine Hydroxylase", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952).", "PM": "2000; see PHENYLKETONURIA 1974-1999", "HN": "2000(1974)", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D010661"}, {"RECTYPE": "D", "MH": "Phenylmercuric Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acetoxyphenylmercury|T109|T131|NON|EQV|UNK (19XX)|760416|abbcdef", "ENTRY": "FalisanNassbeize", "MN": "D02.691.750.740.760", "PA": "Fungicides, Industrial", "MH_TH": "NLM (1977)", "ST": "T131", "N1": "Mercury, (acetato-O)phenyl-", "RN": "OSX88361UX", "RR": "62-38-4 (Phenylmercuric Acetate)", "PI": "Organometallic Compounds (1968-1976)", "MS": "A phenyl mercury compound used mainly as a fungicide. Has also been used as a herbicide, slimicide, and bacteriocide.", "PM": "91; was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79", "HN": "91(77); was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79", "MR": "20130708", "DA": "19760419", "DC": "1", "DX": "19910101", "UI": "D010662"}, {"RECTYPE": "D", "MH": "Phenylmercury Compounds", "DE": "PHENYLMERCURY CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenylmercurials|T109|NON|EQV|UNK (19XX)|760414|abcdef", "ENTRY": "Mercury Compounds, Phenyl", "MN": "D02.691.750.740", "PA": "Fungicides, Industrial", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "PI": "Organometallic Compounds (1968-1976)", "MS": "Organic mercury compounds in which the mercury is attached to a phenyl group. Often used as fungicides and seed treatment agents.", "OL": "use PHENYLMERCURY COMPOUNDS to search PHENYL MERCURY COMPOUNDS 1977-79", "PM": "80; was PHENYL MERCURY COMPOUNDS 1977-79; CHLOROMERCURIPHENYLSULFONATE was see under ORGANOMETALLIC COMPOUNDS 1975-76", "HN": "80; was PHENYL MERCURY COMPOUNDS 1977-79", "MR": "20110624", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D010663"}, {"RECTYPE": "D", "MH": "Phenylmethylsulfonyl Fluoride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzenemethanesulfonyl Fluoride|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Fluoride, Phenylmethylsulfonyl", "MN": "D02.886.590.625", "PA": "Protease Inhibitors", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Benzenemethanesulfonyl fluoride", "RN": "57KD15003I", "RR": "329-98-6 (Phenylmethylsulfonyl Fluoride)", "PI": "Sulfones (1973-1974)", "MS": "An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.", "PM": "91; was see under SULFONES 1975-90", "HN": "91(75); was see under SULFONES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010664"}, {"RECTYPE": "D", "MH": "Phenylpropanolamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Norephedrine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741018|abbcdeef", "ENTRY": "Hydrochloride, Phenylpropanolamine", "MN": "D02.092.063.624.706", "PA": "Sympathomimetics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenemethanol, alpha-(1-aminoethyl)-, (R*,S*)-(+-)-", "RN": "33RU150WUN", "RR": "8D5I63UE1Q", "MS": "A sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant.", "PM": "74; was see under SYMPATHOMIMETICS 1963-73", "HN": "74(63); was see under SYMPATHOMIMETICS 1963-73", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010665"}, {"RECTYPE": "D", "MH": "Phenylpropionates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.223.701", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Derivatives of 3-phenylpropionic acid, including its salts and esters.", "PM": "74; KETOPROFEN was see under BENZOPHENONES 1975-77", "HN": "74", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010666"}, {"RECTYPE": "D", "MH": "Phenylpyruvic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Phenylpyruvic", "MN": "D02.241.755.812.601", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A group of compounds that are derivatives of phenylpyruvic acid which has the general formula C6H5CH2COCOOH, and is a metabolite of phenylalanine. (From Dorland, 28th ed)", "OL": "use PHENYLPYRUVIC ACIDS to search PHENYLPYRUVIC ACID 1966-74", "PM": "75; was PHENYLPYRUVIC ACID 1963-74", "HN": "75; was PHENYLPYRUVIC ACID 1963-74", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D010667"}, {"RECTYPE": "D", "MH": "Phenylthiazolylthiourea", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "U14,624", "MN": "D02.886.904.601.600", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Thiourea, N-phenyl-N'-2-thiazolyl-", "RN": "14901-16-7", "PI": "Thiazoles (1972-1974)", "MS": "A dopamine-beta-hydroxylase inhibitor.", "PM": "91; was see under PHENYLTHIOUREA 1975-90", "HN": "91(75); was see under PHENYLTHIOUREA 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010668"}, {"RECTYPE": "D", "MH": "Phenylthiohydantoin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.308.432.555.868.650", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "4-Imidazolidinone, 3-phenyl-2-thioxo-", "RN": "2010-15-3", "PI": "Thiohydantoins (1973-1974)", "MS": "Thiohydantoin benzene derivative.", "PM": "91; was see under HYDANTOINS 1975-90", "HN": "91(75); was see under HYDANTOINS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010669"}, {"RECTYPE": "D", "MH": "Phenylthiourea", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenylthiocarbamide|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbcdeef", "MN": "D02.886.904.601", "MH_TH": "NLM (1964)", "ST": "T130", "N1": "Thiourea, phenyl-", "RN": "6F82C6Q54C", "RR": "103-85-5 (Phenylthiourea)", "MS": "Phenylthiourea is a THIOUREA derivative containing a phenyl ring. Depending on their genetic makeup, humans can find it either bitter-tasting or tasteless.", "PM": "66", "HN": "66(64)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010670"}, {"RECTYPE": "D", "MH": "Phenylurea Compounds", "DE": "PHENYLUREA CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenylcarbamides|T109|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Derivatives, Phenylurea", "MN": "D02.455.426.559.389.703", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Compounds that include the amino-N-phenylamide structure.", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010671"}, {"RECTYPE": "D", "MH": "Phenytoin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenhydan|T109|TRD|NRW|NLM (2022)|210505|abcdef", "ENTRY": "Diphenylhydantoinate, Sodium", "MN": "D03.383.129.308.432.555.730", "PA": "Voltage-Gated Sodium Channel Blockers", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4-Imidazolidinedione, 5,5-diphenyl-", "RN": "6158TKW0C5", "RR": "57-41-0 (Phenytoin)", "MS": "An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs.", "OL": "use PHENYTOIN to search DIPHENYLHYDANTOIN 1966-77", "PM": "78; was DIPHENYLHYDANTOIN 1963-77", "HN": "78; was DIPHENYLHYDANTOIN 1963-77", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010672"}, {"RECTYPE": "D", "MH": "Pheochromocytoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pheochromocytoma, Extra-Adrenal|T191|NON|NRW|NLM (2004)|030109|abcdef", "ENTRY": "Pheochromocytomas, Extra-Adrenal", "MN": "C04.557.580.625.650.700.725", "FX": "Multiple Endocrine Neoplasia Type 2b", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "benign or malignant; coord IM with usually ADRENAL GLAND NEOPLASMS (IM)", "MS": "A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010673"}, {"RECTYPE": "D", "MH": "Pheophytins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pheophytin|T109|T123|NON|EQV|NLM (2021)|191119|abbcdef", "MN": "D04.345.783.374.700", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "chlorophylls without magnesium", "PI": "Porphyrins (1971-1974)", "MS": "Chlorophylls from which the magnesium has been removed by treatment with weak acid.", "PM": "91; was see under CHLOROPHYLL 1975-90", "HN": "91(75); was see under CHLOROPHYLL 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010674"}, {"RECTYPE": "D", "MH": "Pheromones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Semiochemicals|T123|NON|BRD|UNK (19XX)|830613|SEMIOCHEM|abcdefv", "ENTRY": "Synomones|T123|NON|REL|NLM (2003)|011010|abcdef", "MN": "D23.641", "MH_TH": "NLM (1968)", "ST": "T123", "RN": "0", "PI": "Sex Behavior (1966-1967)", "MS": "Chemical substances, excreted by an organism into the environment, that elicit behavioral or physiological responses from other organisms of the same species. Perception of these chemical signals may be olfactory or by contact.", "PM": "1968", "HN": "1968", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010675"}, {"RECTYPE": "D", "MH": "Phialophora", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Phialophoras", "MN": "B01.300.381.706", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid1379869", "AN": "infection: coord IM with MYCOSES or specific mycosis (IM)", "MS": "A mitosporic fungal genus. Phialophora verrucosa is a cause of chromomycosis (CHROMOBLASTOMYCOSIS). Ophiobolus is the teleomorph of Phialophora.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010676"}, {"RECTYPE": "D", "MH": "Philadelphia Chromosome", "AQ": "DE RE", "PRINT ENTRY": "Ph1 Chromosome|T026|EQV|UNK (19XX)|850503|PHAA CHROMOSOME|abdefs", "ENTRY": "Ph1 Chromosomes", "MN": "G05.365.590.175.870.680", "FX": "Oncogene Proteins, Fusion", "MH_TH": "NLM (1986)", "ST": "T026", "PI": "Leukemia, Myelocytic/FG (1966-1985)", "MS": "An aberrant form of human CHROMOSOME 22 characterized by translocation of the distal end of chromosome 9 from 9q34, to the long arm of chromosome 22 at 22q11. It is present in the bone marrow cells of 80 to 90 per cent of patients with chronic myelocytic leukemia (LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE).", "OL": "search CHROMOSOMES, HUMAN, 21-22 1978-85", "PM": "86; was see CHROMOSOMES, HUMAN, 21-22 1978-85", "HN": "86; was see CHROMOSOMES, HUMAN, 21-22 1978-85", "CATSH": "CAT LIST", "MR": "20160628", "DA": "19850503", "DC": "1", "DX": "19860101", "UI": "D010677"}, {"RECTYPE": "D", "MH": "Philately", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Postage Stamps|T073|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Stamps, Postage", "MN": "K01.093.660", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "stamp collecting as a hobby: coordinate with HOBBIES ", "MS": "Study of stamps or postal markings. It usually refers to the design and commemorative aspects of the stamp.", "HN": "was in Cat I 1975-82, was in Cat E 1963-74", "MR": "19910108", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010678"}, {"RECTYPE": "D", "MH": "Philippines", "AQ": "EH EP", "ENTRY": "Phillippines|T083|NAM|EQV|NLM (1991)|891117|abcdef", "MN": "Z01.639.790", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in southeastern Asia, archipelago between the Philippine Sea and the South China Sea, and east of Vietnam. The capital is Manila.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D010679"}, {"RECTYPE": "D", "MH": "Philology", "DE": "PHILOL", "AQ": "HI", "MN": "K01.517.732", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "study of literature or language as used in literature; do not confuse with LITERATURE, literary works; general or unspecified; prefer specifics", "MS": "The study of literature in its widest sense, including grammar, etymology, criticism, literary history, language history, linguistic history, systems of writing, and anything else that is relevant to literature or language viewed as literature. Philology as a discipline has both philosophical and scientific overtones.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010680"}, {"RECTYPE": "D", "MH": "Philology, Classical", "DE": "PHILOL CLASSICAL", "AQ": "HI", "ENTRY": "Classical Philology|T170|NON|EQV|NLM (1994)|920827|CLASSICAL PHILOL|abcdefv", "MN": "K01.517.732.477", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "The study of ancient Greek and Roman literature, including grammar, etymology, criticism, literary history, and language and linguistic history.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010681"}, {"RECTYPE": "D", "MH": "Philology, Oriental", "DE": "PHILOL ORIENTAL", "AQ": "HI", "ENTRY": "Oriental Philology|T170|NON|EQV|NLM (1994)|920827|ORIENTAL PHILOL|abcdefv", "MN": "K01.517.732.602", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "The study of literature written in languages of Asia and the Far East, including grammar, etymology, criticism, literary history, and language and linguistic history.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010682"}, {"RECTYPE": "D", "MH": "Philology, Romance", "DE": "PHILOL ROMANCE", "AQ": "HI", "ENTRY": "Romance Philology|T170|NON|EQV|NLM (1994)|920827|ROMANCE PHILOL|abcdefv", "MN": "K01.517.732.727", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "The study of literature written in the Romance languages (French, Spanish, Italian, and others descended from Latin), including grammar, etymology, criticism, literary history, and language and linguistic history.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010683"}, {"RECTYPE": "D", "MH": "Philosophy", "AQ": "HI", "PRINT ENTRY": "Stoicism|T078|NON|NRW|UNK (19XX)|770317|abcdef", "ENTRY": "Philosophy, Pharmacy", "MN": "K01.752", "MH_TH": "BIOETHICS (1974)", "ST": "T090", "MS": "A love or pursuit of wisdom. A search for the underlying causes and principles of reality. (Webster, 3d ed)", "PM": "1963; for SECULARISM see RELIGION 1998-2001", "HN": "1963; for SECULARISM use RELIGION 1998-2001", "MR": "20170711", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D010684"}, {"RECTYPE": "D", "MH": "Philosophy, Dental", "DE": "PHILOSOPHY DENT", "AQ": "HI", "ENTRY": "Philosophies, Dental|T090|NON|EQV|NLM (1991)|900126|PHILOSOPHIES DENT|abcdefv", "MN": "K01.752.622", "MH_TH": "NLM (1971)", "ST": "T090", "PI": "appropriate dental heading", "MS": "The underlying rationale or theoretical basis for the principles of DENTISTRY.", "PM": "74", "HN": "74(71)", "MR": "20180201", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010685"}, {"RECTYPE": "D", "MH": "Philosophy, Medical", "DE": "PHILOSOPHY MED", "AQ": "HI", "ENTRY": "Medical Philosophy|T090|NON|EQV|NLM (1991)|891204|MED PHILOSOPHY|abcdefv", "MN": "K01.752.667", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "The underlying rationale or theoretical basis for the principles of MEDICINE.", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010686"}, {"RECTYPE": "D", "MH": "Philosophy, Nursing", "DE": "PHILOSOPHY NURS", "AQ": "HI", "ENTRY": "Philosophies, Nursing", "MN": "K01.752.712", "MH_TH": "NLM (1969)", "ST": "T078", "PI": "Philosophy (1966-1968)", "MS": "The underlying rationale or theoretical basis for the principles of NURSING.", "PM": "74", "HN": "74(69)", "MR": "20171211", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010687"}, {"RECTYPE": "D", "MH": "Phimosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Phimoses", "MN": "C12.200.294.494.684", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A condition in which the FORESKIN cannot be retracted to reveal the GLANS PENIS. It is due to tightness or narrowing of the foreskin opening.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010688"}, {"RECTYPE": "D", "MH": "Phlebitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Periphlebitis|T047|NON|NRW|UNK (19XX)|830504|abcdef", "ENTRY": "Phlebitides", "MN": "C14.907.940.740", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not coordinate with LEG; THROMBOPHLEBITIS is also available", "MS": "Inflammation of a vein, often a vein in the leg. Phlebitis associated with a blood clot is called (THROMBOPHLEBITIS).", "OL": "use PHLEBITIS to search PERIPHLEBITIS 1966-83", "PM": "PERIPHLEBITIS was heading 1963-83", "HN": "PERIPHLEBITIS was heading 1963-83", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010689"}, {"RECTYPE": "D", "MH": "Phlebography", "DE": "PHLEBOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Venography|T060|NON|EQV|UNK (19XX)|740330|VENOGR|abcdefv", "ENTRY": "Venographies", "MN": "E01.370.370.050.600", "MH_TH": "NLM (1963)", "ST": "T060", "MS": "Radiographic visualization or recording of a vein after the injection of contrast medium.", "PM": "66; was see under ANGIOGRAPHY 1963-65", "HN": "66(63); was see under ANGIOGRAPHY 1963-65", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010690"}, {"RECTYPE": "D", "MH": "Phlebotomus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.720.500.500.750.781.602", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid13203", "AN": "blood-sucking fly, the vector of PAPPATACI FEVER see PHLEBOTOMUS FEVER & other dis; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111", "MS": "A genus of PSYCHODIDAE which functions as the vector of a number of pathogenic organisms, including LEISHMANIA DONOVANI; LEISHMANIA TROPICA; Bartonella bacilliformis, and the Pappataci fever virus (SANDFLY FEVER NAPLES VIRUS).", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010691"}, {"RECTYPE": "D", "MH": "Phleomycins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phleomycin|T116|T195|NON|EQV|UNK (19XX)|800515|abbcdef", "MN": "D12.644.233.110.710", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "NLM (1975)", "ST": "T195", "RN": "0", "PI": "Peptides (1971-1974)", "MS": "Water-soluble, copper-containing low molecular weight polypeptides obtained from the culture medium of Streptomyces verticillus. They are specific inhibitors of DNA synthesis in bacteria and have been found to act as antitumor agents. They have also been used against rust fungi of plants.", "OL": "use PHLEOMYCINS to search PHLEOMYCIN 1975-80", "PM": "91; was see under BLEOMYCINS 1981-90; was PHLEOMYCIN see under ANTIBIOTICS 1975-80", "HN": "91(81); was see under BLEOMYCINS 1981-90; was PHLEOMYCIN see under ANTIBIOTICS 1975-80", "MR": "20040707", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010692"}, {"RECTYPE": "D", "MH": "Phloretin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.663.283.266.450.550", "MH_TH": "NLM (1963)", "ST": "T109", "N1": "1-Propanone, 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-", "RN": "S5J5OE47MK", "RR": "60-82-2 (Phloretin)", "MS": "A natural dihydrochalcone found in apples and many other fruits.", "PM": "73", "HN": "73(63)", "MR": "20161101", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010693"}, {"RECTYPE": "D", "MH": "Lactase-Phlorizin Hydrolase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phlorizin Hydrolase|T116|T126|NON|NRW|UNK (19XX)|770329|abbcdef", "ENTRY": "Phloretin Glucosidase", "MN": "D08.811.641.761", "FX": "Lactose Intolerance", "MH_TH": "NLM (1992)", "ST": "T126", "RN": "EC 3.2.1.62", "RR": "EC 3.2.1.108", "PI": "Glucosidases (1966-1977)", "MS": "A multifunctional protein that contains two enzyme domains. The first domain (EC 3.2.1.62) hydrolyzes glycosyl-N-acylsphingosine to a sugar and N-acylsphingosine. The second domain (EC 3.2.1.108) hydrolyzes LACTOSE and is found in the intestinal brush border membrane. Loss of activity for this enzyme in humans results in LACTOSE INTOLERANCE.", "PM": "2014; see GLYCOSYLCERAMIDASE 1992-2013, see PHLORETIN GLUCOSIDASE 1978-1991, see PHLORETIN GLUCOSIDASE 1978-1993", "HN": "2014 (1992)", "MR": "20180521", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D010694"}, {"RECTYPE": "D", "MH": "Phlorhizin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Phlorizin|T109|T121|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|820302|abbbcdeef", "MN": "D09.408.702", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "1-Propanone, 1-(2-(beta-D-glucopyranosyloxy)-4,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)-", "RN": "CU9S17279X", "RR": "60-81-1 (Phlorhizin)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010695"}, {"RECTYPE": "D", "MH": "Phloroglucinol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Spassirex|T109|T121|TRD|NRW|FR|041020|abbcdef", "MN": "D02.455.426.559.389.657.684", "PA": "Indicators and Reagents", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "1,3,5-Benzenetriol", "RN": "DHD7FFG6YS", "RR": "108-73-6 (Phloroglucinol)", "MS": "A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010696"}, {"RECTYPE": "D", "MH": "Eosine I Bluish", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Phloxine B|T109|T130|NON|EQV|NLM (1994)|921208|abbcdef", "ENTRY": "Bluish, Eosine I", "MN": "D04.711.347.300", "PA": "Fluorescent Dyes", "MH_TH": "NLM (1979)", "ST": "T130", "N1": "Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 2',4',5',7'-tetrabromo-4,5,6,7-tetrachloro-3',6'-dihydroxy-, disodium salt", "RN": "OMS4XQD1T0", "RR": "75888-73-2 (di-K salt)", "PI": "Fluoresceins (1966-1978)", "MS": "A red fluorescein dye used as a histologic stain. It may be cytotoxic, mutagenic, and inhibit certain mitochondrial functions.", "PM": "1994; see PHLOXINE B 1979-1993; EOSIN B was indexed under FLIOROSCEINS 1996-2013", "HN": "1994", "MR": "20160531", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D010697"}, {"RECTYPE": "D", "MH": "Phobic Disorders", "DE": "PHOBIC DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Scolionophobia|T048|NON|NRW|NLM (2023)|210920|abcdef", "ENTRY": "School Phobia", "MN": "F03.080.725", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.", "OL": "use PHOBIC DISORDERS to search PHOBIAS 1966-80, PHOBIC NEUROSES 1969-80, & CLAUSTROPHOBIA 1968-78", "PM": "81; was PHOBIAS 1963-80", "HN": "81; was PHOBIAS 1963-80; PHOBIC NEUROSES was see under PHOBIAS 1969-80; CLAUSTROPHOBIA was see under PHOBIAS 1968-78", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D010698"}, {"RECTYPE": "D", "MH": "Phonation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Phonations", "MN": "G09.772.585", "FX": "Voice Quality", "MH_TH": "NLM (1979)", "ST": "T042", "PI": "Voice (1966-1978)", "MS": "The process of producing vocal sounds by means of VOCAL CORDS vibrating in an expiratory blast of air.", "PM": "91; was see under VOICE 1979-90", "HN": "91(79); was see under VOICE 1979-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19780522", "DC": "1", "DX": "19910101", "UI": "D010699"}, {"RECTYPE": "D", "MH": "Phonetics", "PRINT ENTRY": "Speech Sounds|T068|NON|REL|UNK (19XX)|790409|abcdef", "ENTRY": "Speech Sound", "MN": "L01.559.598.518", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "The science or study of speech sounds and their production, transmission, and reception, and their analysis, classification, and transcription. (Random House Unabridged Dictionary, 2d ed)", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010700"}, {"RECTYPE": "D", "MH": "Phonocardiography", "DE": "PHONOCARDIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Phonocardiographies", "MN": "E01.370.370.380.400.500", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "usually NIM", "MS": "Graphic registration of the heart sounds picked up as vibrations and transformed by a piezoelectric crystal microphone into a varying electrical output according to the stresses imposed by the sound waves. The electrical output is amplified by a stethograph amplifier and recorded by a device incorporated into the electrocardiograph or by a multichannel recording machine.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010701"}, {"RECTYPE": "D", "MH": "Phorate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Thimet 10G", "MN": "D02.886.300.692.650", "PA": "Insecticides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Phosphorodithioic acid, O,O-diethyl S-((ethylthio)methyl) ester", "RN": "3W54X3W9IV", "RR": "298-02-2 (Phorate)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides (1966-1971)", "MS": "A cholinesterase inhibitor that is used as an insecticide.", "PM": "91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90", "HN": "91(72); was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010702"}, {"RECTYPE": "D", "MH": "Phorbol Esters", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Phorbol Ester|T109|T131|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Esters, Phorbol", "MN": "D02.455.849.291.500.510", "PA": "Carcinogens", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "PI": "Terpenes (1966-1973)", "MS": "Tumor-promoting compounds obtained from CROTON OIL (Croton tiglium). Some of these are used in cell biological experiments as activators of protein kinase C.", "PM": "86; was see under PHORBOLS 1975-85", "HN": "86(75); was see under PHORBOLS 1975-85", "MR": "20200527", "DA": "19741114", "DC": "1", "DX": "19860101", "UI": "D010703"}, {"RECTYPE": "D", "MH": "Phorbols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tigliane|T109|NON|NRW|NLM (2021)|191122|abcdef", "ENTRY": "Tiglianes|T109|NON|NRW|NLM (2020)|180820|abcdef", "MN": "D02.455.849.291.500", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Terpenes (1966-1973)", "MS": "The parent alcohol of the tumor promoting compounds from CROTON OIL (Croton tiglium).", "PM": "75", "HN": "75", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D010704"}, {"RECTYPE": "D", "MH": "Phosgene", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D02.522.741", "PA": "Chemical Warfare Agents", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Carbonic dichloride", "RN": "117K140075", "RR": "75-44-5 (Phosgene)", "MS": "A highly toxic gas that has been used as a chemical warfare agent. It is an insidious poison as it is not irritating immediately, even when fatal concentrations are inhaled. (From The Merck Index, 11th ed, p7304)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010705"}, {"RECTYPE": "D", "MH": "Phosmet", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "PRINT ENTRY": "Phthalophos|T109|T131|NON|EQV|UNK (19XX)|780309|abbcdef", "ENTRY": "Prolate|T109|T131|TRD|NRW|UNK (19XX)|820603|abbcdef", "MN": "D03.633.100.513.750.625", "PA": "Insecticides", "MH_TH": "FDA SRS (2014)", "ST": "T131", "N1": "Phosphorodithioic acid, S-((1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl) O,O-dimethyl ester", "RN": "VN04LI540Y", "RR": "732-11-6 (Phosmet)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides, Organothiophosphate (1974)", "MS": "An organothiophosphorus insecticide that has been used to control pig mange.", "OL": "use PHOSMET to search IMIDAN 1975-93", "PM": "91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1979-90, was IMIDAN see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-78; IMIDAN was see PHOSMET 1979-93", "HN": "91(75); was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1979-90, was IMIDAN see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-78; IMIDAN was see PHOSMET 1979-93", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010706"}, {"RECTYPE": "D", "MH": "Phosphamidon", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Dimecron|T109|T131|TRD|NRW|UNK (19XX)|871215|abbcdef", "MN": "D02.705.400.700", "PA": "Insecticides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Phosphoric acid, 2-chloro-3-(diethylamino)-1-methyl-3-oxo-1-propenyl dimethyl ester", "RN": "13171-21-6", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides (1966-1971)", "MS": "An organophosphate cholinesterase inhibitor that is used as an insecticide.", "PM": "91; was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90", "HN": "91(72); was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010707"}, {"RECTYPE": "D", "MH": "Phosphate Acetyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphotransacetylase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Acetyltransferase, Phosphate", "MN": "D08.811.913.050.134.700", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Acetyl-CoA:orthophosphate acetyltransferase", "RN": "EC 2.3.1.8", "RR": "9029-91-8 (CAS RN)", "PI": "Phosphates (1973-1974)", "MS": "An enzyme that catalyzes the synthesis of acetylphosphate from acetyl-CoA and inorganic phosphate. Acetylphosphate serves as a high-energy phosphate compound. EC 2.3.1.8.", "PM": "91; was see under ACETYLTRANSFERASES 1975-90", "HN": "91(75); was see under ACETYLTRANSFERASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010709"}, {"RECTYPE": "D", "MH": "Phosphates", "AQ": "AD AE AG AI AN BL CF CH CL CS DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphates, Inorganic|T197|NON|EQV|UNK (19XX)|760517|PHOSPHATES INORG|abcdefv", "ENTRY": "Phosphate, Inorganic", "MN": "D01.695.625.675.650", "FX": "Phosphorus", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "RR": "NK08V8K8HR", "AN": "PHOSPHATES, ORGANIC see ORGANOPHOSPHATES and POLYPHOSPHATES are also available; /blood: consider also HYPOPHOSPHATEMIA; HYPOPHOSPHATEMIA, FAMILIAL or HYPERPHOSPHATEMIA; /defic: consider also HYPOPHOSPHATEMIA or HYPOPHOSPHATEMIA, FAMILIAL", "MS": "Inorganic salts of phosphoric acid.", "OL": "use PHOSPHATES to search BLOOD PHOSPHATES 1966-67 & PHOSPHATES, INORGANIC 1974-76", "PM": "/blood was BLOOD PHOSPHATES 1963-67; PHOSPHATES, INORGANIC was see under PHOSPHATES 1974-76", "HN": "/blood was BLOOD PHOSPHATES 1963-67; PHOSPHATES, INORGANIC was see under PHOSPHATES 1974-76", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010710"}, {"RECTYPE": "D", "MH": "Phosphatidate Phosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphatidate Phosphohydrolase|T116|T126|NON|EQV|UNK (19XX)|780313|abbcdef", "ENTRY": "Phosphohydrolase, Phosphatidic Acid", "MN": "D08.811.277.352.650.620", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "3-sn-Phosphatidate phosphohydrolase", "RN": "EC 3.1.3.4", "PI": "Phosphomonoesterases (1975-1978)", "MS": "A phosphomonoesterase involved in the synthesis of triacylglycerols. It catalyzes the hydrolysis of phosphatidates with the formation of diacylglycerols and orthophosphate. EC 3.1.3.4.", "PM": "91; was see under PHOSPHOMONOESTERASES 1979-90", "HN": "91(79); was see under PHOSPHOMONOESTERASES 1979-90", "MR": "20030709", "DA": "19780313", "DC": "1", "DX": "19910101", "UI": "D010711"}, {"RECTYPE": "D", "MH": "Phosphatidic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Phosphatidate, Ammonium", "MN": "D10.570.755.375.760", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Phospholipids (1966-1974)", "MS": "Fatty acid derivatives of glycerophosphates. They are composed of glycerol bound in ester linkage with 1 mole of phosphoric acid at the terminal 3-hydroxyl group and with 2 moles of fatty acids at the other two hydroxyl groups.", "PM": "77; see PHOSPHOLIPIDS 1963-76", "HN": "77(63)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D010712"}, {"RECTYPE": "D", "MH": "Phosphatidylcholines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Choline Phosphoglycerides|T109|T123|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "Phosphoglycerides, Choline", "MN": "D10.570.755.375.760.400.800", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "MS": "Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety.", "PM": "1977; was PHOSPHATIDYL CHOLINE see LECITHINS 1963-1976", "HN": "1977; was PHOSPHATIDYL CHOLINE see LECITHINS 1963-1976", "MR": "20160616", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D010713"}, {"RECTYPE": "D", "MH": "Phosphatidylethanolamines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethanolamine Phosphoglycerides|T109|NON|EQV|UNK (19XX)|760517|abcdef", "ENTRY": "Phosphoglycerides, Ethanolamine", "MN": "D10.570.755.375.760.400.840", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "/biosyn /physiol permitted", "MS": "Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids.", "OL": "use PHOSPHATIDYLETHANOLAMINES to search PHOSPHATIDYL ETHANOLAMINE & CEPHALINS 1966-76", "PM": "77; was PHOSPHATIDYL ETHANOLAMINE see under CEPHALINS 1963-76; CEPHALINS was heading 1963-76", "HN": "77; was PHOSPHATIDYL ETHANOLAMINE see under CEPHALINS 1963-76; CEPHALINS was heading 1963-76", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D010714"}, {"RECTYPE": "D", "MH": "Phosphatidylglycerols", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphatidylglycerol|T109|T123|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Phosphoglycerides, Glycerol", "MN": "D10.570.755.375.760.400.885", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Phospholipids (1966-1974)", "MS": "A nitrogen-free class of lipids present in animal and particularly plant tissues and composed of one mole of glycerol and 1 or 2 moles of phosphatidic acid. Members of this group differ from one another in the nature of the fatty acids released on hydrolysis.", "OL": "use PHOSPHATIDYLGLYCEROLS to search PHOSPHATIDYL GLYCEROL 1975-76", "PM": "77; was PHOSPHATIDYL GLYCEROL see under PHOSPHOLIPIDS 1975-76", "HN": "77; was PHOSPHATIDYL GLYCEROL see under PHOSPHOLIPIDS 1975-76", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19770101", "UI": "D010715"}, {"RECTYPE": "D", "MH": "Phosphatidylinositols", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PtdIns|T109|T123|ABB|EQV|NLM (1994)|930222|abbcdef", "ENTRY": "Phospholipids, Inositol", "MN": "D10.570.755.375.760.400.942", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Phosphoinositides (1966-1974)", "MS": "Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to the hexahydroxy alcohol, myo-inositol. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid, myo-inositol, and 2 moles of fatty acids.", "OL": "use PHOSPHATIDYLINOSITOLS to search PHOSPHOINOSITIDES 1966-93 & PHOSPHATIDYL INOSITOL 1966-76", "PM": "77; was PHOSPHATIDYL INOSITOL see under PHOSPHOINOSITIDES 1963-76; PHOSPHOINOSITIDES was heading 1963-93", "HN": "77; was PHOSPHATIDYL INOSITOL see under PHOSPHOINOSITIDES 1963-76; PHOSPHOINOSITIDES was heading 1963-93", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D010716"}, {"RECTYPE": "D", "MH": "CDPdiacylglycerol-Serine O-Phosphatidyltransferase", "DS": "CDPDIACYLGLYCEROL SERINE PHOSPHATIDYLTRANSFERASE O", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphatidylserine Synthase|T116|T121|T126|NON|EQV|NLM (1994)|921015|abbbcdef", "ENTRY": "Synthetase, Phosphatidylserine", "MN": "D08.811.913.696.900.150", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "CDPdiacylglycerol:L-serine 3-O-phosphatidyltransferase", "RN": "EC 2.7.8.8", "RR": "9068-48-8 (CAS RN)", "PI": "Phosphotransferases (1972-1974)", "MS": "An enzyme that catalyzes the formation of phosphatidylserine and CMP from CDPdiglyceride plus serine. EC 2.7.8.8.", "PM": "98; see CDP DIACYLGLYCEROL-SERINE O-PHOSPHATIDYLTRANSFERASE 1994-97, PHOSPHATIDYLSERINE SYNTHETASE 1991-93, & PHOSPHOTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010717"}, {"RECTYPE": "D", "MH": "Phosphatidylserines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Serine Phosphoglycerides|T109|NON|EQV|UNK (19XX)|760517|abcdef", "ENTRY": "Serines, Phosphatidyl", "MN": "D10.570.755.375.760.400.971", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Phosphatidylethanolamines (1966-1974)", "MS": "Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a SERINE moiety.", "OL": "to search PHOSPHATIDYL SERINE use PHOSPHATIDYLSERINES 1975-76 & PHOSPHATIDYLETHANOLAMINES 1966-74", "PM": "77; was PHOSPHATIDYL SERINE see under CEPHALINS 1963-76", "HN": "77; was PHOSPHATIDYL SERINE see under CEPHALINS 1963-76", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D010718"}, {"RECTYPE": "D", "MH": "Phosphenes", "AQ": "DE GE IM PH RE", "ENTRY": "Phosphene", "MN": "G14.935.500", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "do not confuse with PHOSPHINES", "MS": "A subjective visual sensation with the eyes closed and in the absence of light. Phosphenes can be spontaneous, or induced by chemical, electrical, or mechanical (pressure) stimuli which cause the visual field to light up without optical inputs.", "PM": "91; was see under VISION 1975-90", "HN": "91(75); was see under VISION 1975-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010719"}, {"RECTYPE": "D", "MH": "Phosphines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.705.621", "MH_TH": "NLM (1963)", "ST": "T104", "RN": "0", "AN": "do not confuse with PHOSPHENES", "MS": "Inorganic or organic compounds derived from phosphine (PH3) by the replacement of H atoms. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "65", "HN": "65(63)", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010720"}, {"RECTYPE": "D", "MH": "Phosphinic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hypophosphorous Acids|T104|NON|EQV|NLM (1994)|930112|abcdef", "ENTRY": "Acids, Phosphinic", "MN": "D02.705.629", "MH_TH": "NLM (1965)", "ST": "T104", "RN": "0", "RR": "6303-21-5 (phosphinic acid)", "AN": "do not confuse with PHOSPHONIC ACIDS", "MS": "Inorganic or organic derivatives of phosphinic acid, H2PO(OH). They include phosphinates and phosphinic acid esters.", "PM": "65; was PHOSPHINIC ACID 1963-64", "HN": "65; was PHOSPHINIC ACID 1963-64", "MR": "20000621", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010721"}, {"RECTYPE": "D", "MH": "3-Deoxy-7-Phosphoheptulonate Synthase", "DS": "DEOXYPHOSPHOHEPTULONATE SYNTHASE 03 07", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phospho-2-Keto-3-Deoxyheptonate Aldolase|T116|T126|NON|EQV|NLM (1998)|961115|PHOSPHOKETO DEOXYHEPTONATE ALDOLASE 02 03|abbcdefs", "ENTRY": "Synthetase, 3-Deoxyarabinoheptulosonate-7-Phosphate", "MN": "D08.811.913.225.250", "MH_TH": "NLM (2007)", "ST": "T126", "N1": "2-Dehydro-3-deoxy-D-arabino-heptonate-7-phosphate D-erythrose-4-phosphate-lyase (pyruvate-phosphorylating)", "RN": "EC 2.5.1.54", "RR": "9026-94-2 (CAS RN)", "PI": "Tetroses (1972-1974)", "MS": "An enzyme that catalyzes the formation of 7-phospho-2-keto-3-deoxy-D-arabinoheptonate from phosphoenolpyruvate and D-erythrose-4-phosphate. It is one of the first enzymes in the biosynthesis of TYROSINE and PHENYLALANINE. This enzyme was formerly listed as EC 4.1.2.15.", "PM": "2007; see 2-Dehydro-3-Deoxyphosphoheptonate Aldolase 1998-2006, see PHOSPHO-2-KETO-3-DEOXYHEPTONATE ALDOLASE 1995-1997, see PHOSPHO-2-KETO-3-DEOXY-HEPTONATE ALDOLASE 1991-1994, see ALDEHYDE-LYASES 1975-1990; 3-DEOXY-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE was indexed under ALDEHYDE-LYASES 2003-2006", "HN": "2007(1975)", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010723"}, {"RECTYPE": "D", "MH": "Phosphoadenosine Phosphosulfate", "DE": "PAPS", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Phosphosulfate, Phosphoadenosine", "MN": "D13.695.827.068.850", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "3'-Adenylic acid, 5'-(dihydrogen phosphate), 5'-anhydride with sulfuric acid", "RN": "482-67-7", "PI": "Sulfuric Acids (1973-1974)", "MS": "3'-Phosphoadenosine-5'-phosphosulfate. Key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process of sulfur fixation in plants and microorganisms.", "PM": "91; was see under ADENINE NUCLEOTIDES 1975-90", "HN": "91(75); was see under ADENINE NUCLEOTIDES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010724"}, {"RECTYPE": "D", "MH": "Phosphocreatine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Creatine Phosphate|T116|T121|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|750717|abbbcdeef", "ENTRY": "Phosphate, Creatine", "MN": "D12.125.740.675", "PA": "Cardiotonic Agents", "MH_TH": "NLM (1963)", "ST": "T123", "N1": "Glycine, N-(imino(phosphonoamino)methyl)-N-methyl-", "RN": "020IUV4N33", "RR": "922-32-7 (di-Na salt)", "MS": "An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996)", "PM": "66; was see under COENZYMES 1963-65", "HN": "66(63); was see under COENZYMES 1963-65", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010725"}, {"RECTYPE": "D", "MH": "Phosphodiesterase Inhibitors", "DE": "PHOSPHODIESTERASE INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphoric Diester Hydrolase Inhibitors|T121|NON|EQV|NLM (1994)|921006|PHOSPHORIC DIESTER HYDROLASE INHIB|abcdefv", "ENTRY": "Inhibitor, Phosphodiesterase", "MN": "D27.505.519.389.735", "MH_TH": "NLM (1978)", "ST": "T121", "RN": "0", "PI": "Phosphodiesterases/antagonists & inhibitors (1972-1977)", "MS": "Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.", "PM": "78", "HN": "78", "MR": "20200527", "DA": "19770523", "DC": "1", "DX": "19780101", "UI": "D010726"}, {"RECTYPE": "D", "MH": "Phosphoric Diester Hydrolases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphodiesterases|T116|T126|NON|EQV|NLM (1994)|921006|abbcdef", "ENTRY": "Hydrolases, Phosphoric Diester", "MN": "D08.811.277.352.640", "EC": "antagonists & inhibitors:Phosphodiesterase Inhibitors", "MH_TH": "NLM (1972)", "ST": "T126", "RN": "EC 3.1.4.-", "PI": "Phosphatases (1966-1971)", "MS": "A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4.", "OL": "use PHOSPHORIC DIESTER HYDROLASES to search PHOSPHODIESTERASES 1972-93 (as Prov 1972-73)", "PM": "94; was PHOSPHODIESTERASES 1974-93", "HN": "94; was PHOSPHODIESTERASES 1972-93 (Prov 1972-73)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010727"}, {"RECTYPE": "D", "MH": "Phosphoenolpyruvate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.511.701", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "2-Propenoic acid, 2-(phosphonooxy)-, ion(1-)", "RN": "73-89-2", "PI": "Pyruvates (1966-1971)", "MS": "A monocarboxylic acid anion derived from selective deprotonation of the carboxy group of phosphoenolpyruvic acid. It is a metabolic intermediate in GLYCOLYSIS; GLUCONEOGENESIS; and other pathways.", "PM": "72", "HN": "72", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010728"}, {"RECTYPE": "D", "MH": "Phosphoenolpyruvate Carboxykinase (GTP)", "DE": "PEP CARBOXYKINASE GTP", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphoenolpyruvate Carboxykinase, GTP-Dependent", "MN": "D08.811.520.224.125.550", "MH_TH": "NLM (1973)", "ST": "T126", "N1": "GTP:oxaloacetate carboxy-lyase (transphosphorylating)", "RN": "EC 4.1.1.32", "RR": "9013-08-5 (CAS RN)", "AN": "do not confuse with PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP)", "PI": "Carboxy-Lyases (1966-1972)", "MS": "An enzyme of the lyase class that catalyzes the conversion of GTP and oxaloacetate to GDP, phosphoenolpyruvate, and carbon dioxide. This reaction is part of gluconeogenesis in the liver. The enzyme occurs in both the mitochondria and cytosol of mammalian liver. (From Dorland, 27th ed) EC 4.1.1.32.", "PM": "98; see PHOSPHOENOLPYRUVATE CARBOXYKINASES 1975-97, see PHOSPHOENOLPYRUVATE CARBOXYKINASE 1973-74", "HN": "98(73)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010729"}, {"RECTYPE": "D", "MH": "Phosphoenolpyruvate Carboxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Carboxylase, Phosphoenolpyruvate", "MN": "D08.811.520.224.125.650", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "Orthophosphate:oxaloacetate carboxy-lyase (phosphorylating)", "RN": "EC 4.1.1.31", "RR": "9067-77-0 (CAS RN)", "AN": "do not confuse with PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP) or PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP)", "PI": "Phosphoenolpyruvate (1972-1978)", "MS": "An enzyme with high affinity for carbon dioxide. It catalyzes irreversibly the formation of oxaloacetate from phosphoenolpyruvate and carbon dioxide. This fixation of carbon dioxide in several bacteria and some plants is the first step in the biosynthesis of glucose. EC 4.1.1.31.", "PM": "91; was see under CARBOXY-LYASES 1979-90", "HN": "91(79); was see under CARBOXY-LYASES 1979-90", "MR": "20030709", "DA": "19780313", "DC": "1", "DX": "19910101", "UI": "D010730"}, {"RECTYPE": "D", "MH": "Phosphoenolpyruvate Sugar Phosphotransferase System", "DE": "PEPPTS", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphoenolpyruvate Hexose Phosphotransferases|T116|NON|NRW|UNK (19XX)|790523|abcdef", "ENTRY": "System, Phosphoenolpyruvate-Glycose Phosphotransferase", "MN": "D08.811.913.696.620.650", "MH_TH": "NLM (1980)", "ST": "T126", "RN": "EC 2.7.1.-", "PI": "Phosphotransferases (1966-1979)", "MS": "The bacterial sugar phosphotransferase system (PTS) that catalyzes the transfer of the phosphoryl group from phosphoenolpyruvate to its sugar substrates (the PTS sugars) concomitant with the translocation of these sugars across the bacterial membrane. The phosphorylation of a given sugar requires four proteins, two general proteins, Enzyme I and HPr and a pair of sugar-specific proteins designated as the Enzyme II complex. The PTS has also been implicated in the induction of synthesis of some catabolic enzyme systems required for the utilization of sugars that are not substrates of the PTS as well as the regulation of the activity of ADENYLYL CYCLASES. EC 2.7.1.-.", "PM": "80", "HN": "80", "MR": "20150713", "DA": "19790523", "DC": "1", "DX": "19800101", "UI": "D010731"}, {"RECTYPE": "D", "MH": "Phosphofructokinase-1", "DS": "PHOSPHOFRUCTOKINASE 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "6-Phosphofructokinase|T116|T126|NON|EQV|NLM (1993)|990101|PHOSPHOFRUCTOKINASE 06|abbcdefs", "ENTRY": "Phosphofructokinase 1", "MN": "D08.811.913.696.620.225.850.500", "FX": "Phosphofructokinase-2", "MH_TH": "NLM (2002)", "ST": "T126", "N1": "ATP:D-fructose-6-phosphate 1-phosphotransferase", "RN": "EC 2.7.1.11", "RR": "9001-80-3 (CAS RN)", "AN": "general or unspecified; prefer specifics", "MS": "An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. D-tagatose- 6-phosphate and sedoheptulose-7-phosphate also are acceptors. UTP, CTP, and ITP also are donors. In human phosphofructokinase-1, three types of subunits have been identified. They are PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE; PHOSPHOFRUCTOKINASE-1, LIVER TYPE; and PHOSPHOFRUCTOKINASE-1, TYPE C; found in platelets, brain, and other tissues.", "PM": "2002; see 6-PHOSPHOFRUCTOKINASE 1993-2001, see PHOSPHOFRUCTOKINASE 1965-1992", "HN": "2002", "MR": "20090713", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010732"}, {"RECTYPE": "D", "MH": "Phosphoglucomutase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glucose Phosphomutase|T116|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Phosphomutase, Glucose", "MN": "D08.811.399.520.750.625", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "alpha-D-Glucose 1,6-phosphomutase", "RN": "EC 5.4.2.2", "RR": "9001-81-4 (CAS RN)", "MS": "An enzyme that catalyzes the conversion of alpha D-glucose 1-phosphate to alpha D-glucose 6-phosphate. EC 5.4.2.2.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010733"}, {"RECTYPE": "D", "MH": "Phosphogluconate Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, Phosphogluconate", "MN": "D08.811.682.047.150.600", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "6-Phospho-D-gluconate:NAD(P)+ 2-oxidoreductase", "RN": "EC 1.1.1.43", "MS": "An enzyme of the oxidoreductase class that catalyzes the reaction 6-phospho-D-gluconate and NADP+ to yield D-ribulose 5-phosphate, carbon dioxide, and NADPH. The reaction is a step in the pentose phosphate pathway of glucose metabolism. (From Dorland, 27th ed) EC 1.1.1.43.", "PM": "65", "HN": "65", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010734"}, {"RECTYPE": "D", "MH": "Phosphoglycerate Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kinase, Phosphoglycerate", "MN": "D08.811.913.696.630.700", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "ATP-3-phospho-D-glycerate 1-phosphotransferase", "RN": "EC 2.7.2.3", "RR": "9001-83-6 (CAS RN)", "MS": "An enzyme catalyzing the transfer of a phosphate group from 3-phospho-D-glycerate in the presence of ATP to yield 3-phospho-D-glyceroyl phosphate and ADP. EC 2.7.2.3.", "PM": "65", "HN": "65", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010735"}, {"RECTYPE": "D", "MH": "Phosphoglycerate Mutase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphoglyceromutase|T116|T126|NON|EQV|NLM (1994)|921019|abbcdef", "ENTRY": "Phosphomutase, Phosphoglycerate", "MN": "D08.811.399.520.750.700", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "D-Phosphoglycerate 2,3-phosphomutase", "RN": "EC 5.4.2.11", "RR": "9023-91-0 (CAS RN)", "PI": "Phosphotransferases (1973-1974)", "MS": "An enzyme that catalyzes the conversion of 2-phospho-D-glycerate to 3-phospho-D-glycerate.", "OL": "use PHOSPHOGLYCERATE MUTASE to search PHOSPHOGLYCEROMUTASE 1975-93; use PHOSPHOGLYCERATE MUTASE (NM) to search PHOSPHOGLYCERATE PHOSPHOMUTASE 1980-93", "PM": "94; was PHOSPHOGLYCEROMUTASE 1975-93 (see under PHOSPHOTRANSFERASES 1975-90); PHOSPHOGLYCERATE PHOSPHOMUTASE was indexed under ISOMERASES 1983-93, GLYCERIC ACIDS 1973-82 & ORGANOPHOSPHORUS COMPOUNDS 1973-82", "HN": "94; was PHOSPHOGLYCEROMUTASE 1975-93 (see under PHOSPHOTRANSFERASES 1975-90); PHOSPHOGLYCERATE PHOSPHOMUTASE was (NM) 1973-93", "MR": "20160602", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010736"}, {"RECTYPE": "D", "MH": "Type C Phospholipases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phospholipases, Type C|T116|T126|NON|EQV|NLM (2008)|070328|abbcdef", "ENTRY": "Phospholipases C|T116|T126|NON|EQV|NLM (2008)|070314|abbcdef", "MN": "D08.811.277.352.640.700.700", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.4.-", "RR": "EC 3.1.4.3", "AN": "general; many specifics are available", "PI": "Phospholipases (1966-1979)", "MS": "A subclass of phospholipases that hydrolyze the phosphoester bond found in the third position of GLYCEROPHOSPHOLIPIDS. Although the singular term phospholipase C specifically refers to an enzyme that catalyzes the hydrolysis of PHOSPHATIDYLCHOLINE (EC 3.1.4.3), it is commonly used in the literature to refer to broad variety of enzymes that specifically catalyze the hydrolysis of PHOSPHATIDYLINOSITOLS.", "PM": "2007; see PHOSPHOLIPASE C 1986-2007, see PHOSPHOLIPASES 1980-1985", "HN": "2007(1980)", "MR": "20070709", "DA": "19790222", "DC": "1", "DX": "19860101", "UI": "D010738"}, {"RECTYPE": "D", "MH": "Phospholipase D", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lecithinase D|T116|T126|NON|EQV|UNK (19XX)|790222|abbcdef", "ENTRY": "Phosphatidylcholine Phosphohydrolase|T116|T126|NON|EQV|UNK (19XX)|810917|abbcdef", "MN": "D08.811.277.352.640.700.710", "MH_TH": "NLM (1980)", "ST": "T126", "N1": "Phosphatidylcholine phosphatidohydrolase", "RN": "EC 3.1.4.4", "RR": "9001-87-0 (CAS RN)", "PI": "Phospholipases (1966-1979)", "MS": "An enzyme found mostly in plant tissue. It hydrolyzes glycerophosphatidates with the formation of a phosphatidic acid and a nitrogenous base such as choline. This enzyme also catalyzes transphosphatidylation reactions. EC 3.1.4.4.", "PM": "91; was see under PHOSPHOLIPASES 1980-90", "HN": "91(80); was see under PHOSPHOLIPASES 1980-90", "MR": "20030709", "DA": "19790222", "DC": "1", "DX": "19910101", "UI": "D010739"}, {"RECTYPE": "D", "MH": "Phospholipases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lecithinases|T116|T126|NON|EQV|UNK (19XX)|790221|abbcdef", "ENTRY": "Phospholipase|T116|T126|NON|EQV|UNK (19XX)|790221|abbcdef", "MN": "D08.811.277.352.640.700", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.1.-", "MS": "A class of enzymes that catalyze the hydrolysis of phosphoglycerides or glycerophosphatidates. EC 3.1.-.", "OL": "use PHOSPHOLIPASES to search PHOSPHOLIPASE & LECITHINASE 1966-79", "PM": "80; was PHOSPHOLIPASE 1963-79", "HN": "80; was PHOSPHOLIPASE 1963-79; LECITHINASES was LECITHINASE see under PHOSPHOLIPASE 1963-79", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D010740"}, {"RECTYPE": "D", "MH": "Phospholipases A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.352.100.680.750", "MH_TH": "NLM (1980)", "ST": "T126", "RN": "EC 3.1.1.32", "AN": "general; prefer specifics", "PI": "Phospholipases (1966-1979)", "MS": "Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.", "PM": "91; was see under PHOSPHOLIPASES 1980-90", "HN": "91(80); was see under PHOSPHOLIPASES 1980-90", "MR": "20160630", "DA": "19790222", "DC": "1", "DX": "19910101", "UI": "D010741"}, {"RECTYPE": "D", "MH": "Phospholipid Ethers", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycerophosphate Ethers|T109|NON|EQV|UNK (19XX)|870325|abcdef", "ENTRY": "Phospholipids, Ether", "MN": "D10.570.755.375.760.400.985", "MH_TH": "NLM (1988)", "ST": "T109", "RN": "0", "PI": "Phospholipids (1966-1987)", "MS": "Phospholipids which have an alcohol moiety in ethereal linkage with a saturated or unsaturated aliphatic alcohol. They are usually derivatives of phosphoglycerols or phosphatidates. The other two alcohol groups of the glycerol backbone are usually in ester linkage. These compounds are widely distributed in animal tissues.", "PM": "88", "HN": "88", "MR": "20170410", "DA": "19870325", "DC": "1", "DX": "19880101", "UI": "D010742"}, {"RECTYPE": "D", "MH": "Phospholipids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phospholipid|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D10.570.755", "FX": "Antiphospholipid Syndrome", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system.", "PM": "/metabolism was PHOSPHOLIPID METABOLISM 1965", "HN": "/metabolism was PHOSPHOLIPID METABOLISM 1965", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010743"}, {"RECTYPE": "D", "MH": "Phosphoric Monoester Hydrolases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphoric Monoester Hydrolase|T116|T126|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Monoester Hydrolase, Phosphoric", "MN": "D08.811.277.352.650", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.1.3.2", "RR": "EC 3.1.3.36", "PI": "Phosphatases (1966-1974)", "MS": "A group of hydrolases which catalyze the hydrolysis of monophosphoric esters with the production of one mole of orthophosphate.", "OL": "use PHOSPHORIC MONOESTER HYDROLASES to search PHOSPHOMONOESTERASES 1975-93 & PHOSPHATASES & PHOSPHOHYDROLASES 1966-93", "PM": "94; was PHOSPHOMONOESTERASES 1975-93; PHOSPHORIC MONOESTER HYDROLASES was see PHOSPHOMONOESTERASES 1975-93; PHOSPHATASES was heading 1963-93; PHOSPHOHYDROLASES was see PHOSPHATASES 1963-93", "HN": "94; was PHOSPHOMONOESTERASES 1975-93; PHOSPHORIC MONOESTER HYDROLASES was see PHOSPHOMONOESTERASES 1975-93; PHOSPHATASES was heading 1963-93; PHOSPHOHYDROLASES was see PHOSPHATASES 1963-93", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D010744"}, {"RECTYPE": "D", "MH": "Phosphonoacetic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphonoacetate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|770418|abbcdeef", "ENTRY": "Phosphonoacetate, Disodium", "MN": "D02.705.429.875", "PA": "Reverse Transcriptase Inhibitors", "MH_TH": "NLM (1978)", "ST": "T121", "N1": "Acetic acid, phosphono-", "RN": "N919E46723", "RR": "BY5RLE340B", "PI": "Organophosphorus Compounds (1972-1977)", "MS": "A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent.", "PM": "90; was see under ORGANOPHOSPHORUS COMPOUNDS 1978-89", "HN": "90(78); was see under ORGANOPHOSPHORUS COMPOUNDS 1978-89", "MR": "20160610", "DA": "19770422", "DC": "1", "DX": "19900101", "UI": "D010746"}, {"RECTYPE": "D", "MH": "Phosphopeptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphopeptide|T116|NON|EQV|NLM (2021)|200113|abcdef", "MN": "D12.644.717", "MH_TH": "NLM (1966)", "ST": "T116", "RN": "0", "MS": "PEPTIDES that incorporate a phosphate group via PHOSPHORYLATION.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010748"}, {"RECTYPE": "D", "MH": "Phosphoprotein Phosphatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Phosphatases|T116|T126|NON|EQV|UNK (19XX)|770329|abbcdef", "ENTRY": "Serine Threonine Phosphatase", "MN": "D12.776.476.559", "MH_TH": "NLM (1994)", "ST": "T126", "N1": "Phosphoprotein phosphohydrolase", "RN": "EC 3.1.3.16", "RR": "EC 3.1.3.16", "AN": "general; prefer specifics", "PI": "Phosphoproteins (1971-1977)", "MS": "A group of enzymes removing the SERINE- or THREONINE-bound phosphate groups from a wide range of phosphoproteins, including a number of enzymes which have been phosphorylated under the action of a kinase. (Enzyme Nomenclature, 1992)", "PM": "2008; see PHOSPHOPROTEIN PHOSPHATASE 1994-2007; see PHOSPHOPROTEIN PHOSPHATASES & PHOSPHOPROTEIN PHOSPHOHYDROLASES 1978-1993; PROTEIN-SERINE-THREONINE PHOSPHATASE was indexed under PHOSPHOPROTEIN PHOSPHATASES 1991-2007", "HN": "2008(1994)", "MR": "20210521", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D010749"}, {"RECTYPE": "D", "MH": "Phosphoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphoprotein|T116|T123|NON|EQV|NLM (2021)|191231|abbcdef", "MN": "D12.776.744", "MH_TH": "NLM (1971)", "ST": "T123", "RN": "0", "AN": "/physiol permitted", "PI": "Proteins (1966-1970)", "OL": "search PROTEINS 1966-70", "PM": "73; was see under PROTEINS 1963-72", "HN": "73(71); was see under PROTEINS 1963-72", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010750"}, {"RECTYPE": "D", "MH": "Phosphopyruvate Hydratase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neuron-Specific Enolase|T116|T123|T126|NON|NRW|UNK (19XX)|840406|abbbcdef", "ENTRY": "gamma Enolase", "MN": "D08.811.520.241.300.500", "MH_TH": "NLM (1964)", "ST": "T126", "N1": "2-Phospho-D-glycerate hydro-lyase", "RN": "EC 4.2.1.11", "RR": "EC 4.2.1.11", "MS": "A hydro-lyase that catalyzes the dehydration of 2-phosphoglycerate to form PHOSPHOENOLPYRUVATE. Several different isoforms of this enzyme exist, each with its own tissue specificity.", "PM": "73", "HN": "73(64)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010751"}, {"RECTYPE": "D", "MH": "Phosphoramide Mustards", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Mustards, Phosphoramide", "MN": "D02.705.672.500", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "NLM (1979)", "ST": "T121", "RN": "0", "AN": "nitrogen mustard cpds; alkylating antineoplastics", "PI": "Organophosphorus Compounds (1972-1974)", "MS": "A group of nitrogen mustard compounds which are substituted with a phosphoramide group or its derivatives. They are usually cytotoxic and used as antineoplastic agents.", "PM": "79", "HN": "79", "MR": "20120703", "DA": "19780208", "DC": "1", "DX": "19790101", "UI": "D010752"}, {"RECTYPE": "D", "MH": "Phosphoranes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.705.675", "MH_TH": "NLM (1968)", "ST": "T104", "RN": "0", "MS": "Inorganic or organic compounds that contain pentavalent phosphorus and the general formula R5P.", "PM": "68", "HN": "68", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010753"}, {"RECTYPE": "D", "MH": "Phosphoribosyl Pyrophosphate", "DE": "PRPP", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Pyrophosphate, Phosphoribosyl", "MN": "D09.894.643.650", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "alpha-D-Ribofuranose, 5-(dihydrogen phosphate) 1-(trihydrogen diphosphate)", "RN": "7540-64-9", "PI": "Pyrophosphoric Acids (1972-1974)", "MS": "The key substance in the biosynthesis of histidine, tryptophan, and purine and pyrimidine nucleotides.", "PM": "91; was see under PENTOSEPHOSPHATES 1975-90", "HN": "91(75); was see under PENTOSEPHOSPHATES 1975-90", "MR": "20040707", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010754"}, {"RECTYPE": "D", "MH": "Organophosphates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "PRINT ENTRY": "Phosphoric Acid Esters|T109|NON|NRW|NLM (1975)|990101|abcdef", "ENTRY": "Organic Phosphates", "MN": "D02.705.400", "EC": "poisoning:Organophosphate Poisoning", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "MS": "Carbon-containing phosphoric acid derivatives. Included under this heading are compounds that have CARBON atoms bound to one or more OXYGEN atoms of the P(=O)(O)3 structure. Note that several specific classes of endogenous phosphorus-containing compounds such as NUCLEOTIDES; PHOSPHOLIPIDS; and PHOSPHOPROTEINS are listed elsewhere.", "PM": "2013; see PHOSPHORIC ACID ESTERS 1991-2013, see ORGANOPHOSPHORUS COMPOUNDS 1972-1990; see PHOSPHORIC ACIDS 1968-1971; for PHOSPHATES, ORGANIC see ORGANOPHOSPHORUS COMPOUNDS 1976-1993", "HN": "2013(1975)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010755"}, {"RECTYPE": "D", "MH": "Phosphoric Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrophosphoric Acids|T197|NON|NRW|NLM (1994)|921217|abcdef", "ENTRY": "Acids, Pyrophosphoric", "MN": "D01.695.625.675", "MH_TH": "NLM (1968)", "ST": "T197", "RN": "0", "AN": "do not confuse with PHOSPHORUS ACIDS", "MS": "Inorganic derivatives of phosphoric acid (H3PO4). Note that organic derivatives of phosphoric acids are listed under ORGANOPHOSPHATES.", "OL": "use PHOSPHORIC ACIDS to search PYROPHOSPHORIC ACIDS 1968-93", "PM": "68; PYROPHOSPHORIC ACIDS was heading 1968-93", "HN": "68; PYROPHOSPHORIC ACIDS was heading 1968-93", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010756"}, {"RECTYPE": "D", "MH": "Phosphorous Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Phosphorous", "MN": "D01.695.625.700", "FX": "Phosphorus", "MH_TH": "NLM (1968)", "ST": "T104", "RN": "0", "AN": "do not confuse with PHOSPHORIC ACIDS", "MS": "Inorganic derivatives of phosphorus trihydroxide (P(OH)3) and its tautomeric form dihydroxyphosphine oxide (HP=O(OH)2). Note that organic derivatives of phosphonic acids are listed under are ORGANOPHOSPHONATES.", "PM": "1968; for PHOSPHONIC ACIDS see PHOSPHONIC ACIDS 2005-2012", "HN": "1968", "MR": "20171010", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010757"}, {"RECTYPE": "D", "MH": "Phosphorus", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Phosphorus, Yellow", "MN": "D01.268.666", "FX": "Phosphorus Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Phosphorus", "RN": "27YLU75U4W", "RR": "7723-14-0 (Phosphorus)", "AN": "PHOSPHORUS METABOLISM DISORDERS is available", "MS": "A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions.", "PM": "/metabolism was PHOSPHORUS METABOLISM 1965", "HN": "/metabolism was PHOSPHORUS METABOLISM 1965", "MR": "20171010", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010758"}, {"RECTYPE": "D", "MH": "Phosphorus Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Phosphorus", "MN": "D01.496.669", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable phosphorus atoms that have the same atomic number as the element phosphorus, but differ in atomic weight. P-31 is a stable phosphorus isotope.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010759"}, {"RECTYPE": "D", "MH": "Phosphorus Metabolism Disorders", "DE": "PHOSPHORUS METAB DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Phosphorus Metabolism Disorder", "MN": "C18.452.750", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "HYPOPHOSPHATEMIA is also available", "MS": "Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization.", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010760"}, {"RECTYPE": "D", "MH": "Phosphorus Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Phosphorus", "MN": "D01.496.749.658", "MH_TH": "NLM (1974)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "MS": "Unstable isotopes of phosphorus that decay or disintegrate emitting radiation. P atoms with atomic weights 28-34 except 31 are radioactive phosphorus isotopes.", "OL": "search PHOSPHORUS ISOTOPES 1966-73", "PM": "74", "HN": "74", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010761"}, {"RECTYPE": "D", "MH": "Phosphorylase a", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.913.400.450.460.400.280", "MH_TH": "NLM (1979)", "ST": "T126", "RN": "EC 2.4.1.-", "RR": "9032-10-4 (CAS RN)", "PI": "Glycogen Phosphorylase (1971-1978)", "MS": "The active form of GLYCOGEN PHOSPHORYLASE that is derived from the phosphorylation of PHOSPHORYLASE B. Phosphorylase a is deactivated via hydrolysis of phosphoserine by PHOSPHORYLASE PHOSPHATASE to form PHOSPHORYLASE B.", "OL": "search GLYCOGEN PHOSPHORYLASE 1975-78", "PM": "91; was see under GLYCOGEN PHOSPHORYLASE 1979-90; was see GLYCOGEN PHOSPHORYLASE 1975-78", "HN": "91(79); was see under GLYCOGEN PHOSPHORYLASE 1979-90; was see GLYCOGEN PHOSPHORYLASE 1975-78", "MR": "20030709", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D010762"}, {"RECTYPE": "D", "MH": "Phosphorylase b", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.913.400.450.460.400.327", "MH_TH": "NLM (1979)", "ST": "T126", "RN": "EC 2.4.1.-", "RR": "9012-69-5 (CAS RN)", "PI": "Glycogen Phosphorylase (1971-1978)", "MS": "The inactive form of GLYCOGEN PHOSPHORYLASE that is converted to the active form PHOSPHORYLASE A via phosphorylation by PHOSPHORYLASE KINASE and ATP.", "OL": "search GLYCOGEN PHOSPHORYLASE 1975-78", "PM": "91; was see under GLYCOGEN PHOSPHORYLASE 1979-90; was see GLYCOGEN PHOSPHORYLASE 1975-78", "HN": "91(79); was see under GLYCOGEN PHOSPHORYLASE 1979-90; was see GLYCOGEN PHOSPHORYLASE 1975-78", "MR": "20030709", "DA": "19780518", "DC": "1", "DX": "19910101", "UI": "D010763"}, {"RECTYPE": "D", "MH": "Phosphorylase Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "b Kinase, Phosphorylase", "MN": "D08.811.913.696.620.682.650", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "ATP:phosphorylase-b phosphotransferase", "RN": "EC 2.7.1.19", "RR": "9001-88-1 (CAS RN)", "MS": "An enzyme that catalyzes the conversion of ATP and PHOSPHORYLASE B to ADP and PHOSPHORYLASE A.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010764"}, {"RECTYPE": "D", "MH": "Phosphorylase Phosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphorylase Phosphatase, Glycogen", "MN": "D12.776.476.559.650", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "(Phosphorylase a) phosphohydrolase", "RN": "EC 3.1.3.17", "PI": "Phosphatases (1973-1974)", "MS": "An enzyme that deactivates glycogen phosphorylase a by releasing inorganic phosphate and phosphorylase b, the inactive form. EC 3.1.3.17.", "OL": "use PHOSPHORYLASE PHOSPHATASE to search PR-ENZYME 1975-93", "PM": "91; was see under PHOSPHOPROTEIN PHOSPHATASES 1979-90; was see under PHOSPHOMONOESTERASES 1975-78; PR-ENZYME was see PHOSPHORYLASE PHOSPHATASE 1975-93", "HN": "91(75); was see under PHOSPHOPROTEIN PHOSPHATASES 1979-90; was see under PHOSPHOMONOESTERASES 1975-78; PR-ENZYME was see PHOSPHORYLASE PHOSPHATASE 1975-93", "MR": "20210521", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010765"}, {"RECTYPE": "D", "MH": "Phosphorylation", "AQ": "DE GE IM PH RE", "ENTRY": "Phosphorylations", "MN": "G03.796", "MH_TH": "NLM (1979)", "ST": "T070", "AN": "almost never IM; enzymatic phosphorylation: coord NIM with PHOSPHOTRANSFERASES (IM) + substrate (NIM) or specific phosphotransferase (particularly KINASES or PROTEIN KINASES) (IM); OXIDATIVE PHOSPHORYLATION & PHOTOPHOSPHORYLATION are also available", "MS": "The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety.", "PM": "91; was see under CHEMISTRY, ORGANIC 1979-90", "HN": "91(79); was see under CHEMISTRY, ORGANIC 1979-90", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D010766"}, {"RECTYPE": "D", "MH": "Phosphorylcholine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphorylcholine Chloride|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Phosphate, Choline", "MN": "D02.675.276.232.700", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Ethanaminium, N,N,N-trimethyl-2-(phosphonooxy)-, chloride", "RN": "107-73-3", "PI": "Organophosphorus Compounds (1973-1974)", "MS": "Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.", "PM": "91; was see under CHOLINE 1975-90", "HN": "91(75); was see under CHOLINE 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010767"}, {"RECTYPE": "D", "MH": "Phosphoserine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Serine Phosphate|T116|T123|T130|NON|EQV|UNK (19XX)|790523|abbbcdef", "ENTRY": "Phosphate, Seryl", "MN": "D12.125.740.700", "MH_TH": "NLM (1980)", "ST": "T130", "N1": "DL-Serine, dihydrogen phosphate (ester)", "RN": "17885-08-4", "PI": "Serine (1966-1974) /analogs & derivatives (1975-1979)", "MS": "The phosphoric acid ester of serine.", "PM": "91; was see under SERINE 1980-90", "HN": "91(80); was see under SERINE 1980-90", "MR": "20150623", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D010768"}, {"RECTYPE": "D", "MH": "Phosphothreonine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Threonine Phosphate|T116|T130|NON|EQV|UNK (19XX)|790523|abbcdef", "ENTRY": "Phosphate, Threonine", "MN": "D12.125.740.725", "PA": "Indicators and Reagents", "MH_TH": "NLM (1980)", "ST": "T130", "N1": "L-Threonine, dihydrogen phosphate (ester)", "RN": "1114-81-4", "PI": "Threonine (1966-1974) /AA (1975-1979)", "MS": "The phosphoric acid ester of threonine. Used as an identifier in the analysis of peptides, proteins, and enzymes.", "PM": "91; was see under THREONINE 1980-90", "HN": "91(80); was see under THREONINE 1980-90", "MR": "20150623", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D010769"}, {"RECTYPE": "D", "MH": "Phosphotransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transphosphorylases|T116|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "ATP Phosphotransferases", "MN": "D08.811.913.696", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 2.7.-", "RR": "9031-09-8 (CAS RN)", "AN": "general or unspecified; prefer specific groups or specific phosphotransferases", "MS": "A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7.", "OL": "use PHOSPHOTRANSFERASES to search PHOSPHOTRANSFERASES, ATP 1974-93 & KINASES 1966-93", "PM": "PHOSPHOTRANSFERASES, ATP was heading 1974-93; KINASES was see PHOSPHOTRANSFERASES, ATP 1977-93, was see PHOSPHOTRANSFERASES 1963-76", "HN": "PHOSPHOTRANSFERASES, ATP was heading 1974-93; KINASES was see PHOSPHOTRANSFERASES, ATP 1977-93, was see PHOSPHOTRANSFERASES 1963-76", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D010770"}, {"RECTYPE": "D", "MH": "Phosphotungstic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Phosphotungstic", "MN": "D01.940.700", "MH_TH": "NLM (1964)", "ST": "T197", "N1": "Tungsten hydroxide oxide phosphate", "RN": "12067-99-1", "MS": "Tungsten hydroxide oxide phosphate. A white or slightly yellowish-green, slightly efflorescent crystal or crystalline powder. It is used as a reagent for alkaloids and many other nitrogen bases, for phenols, albumin, peptone, amino acids, uric acid, urea, blood, and carbohydrates. (From Merck Index, 11th ed)", "PM": "68", "HN": "68(64)", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010772"}, {"RECTYPE": "D", "MH": "Leptophos", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Phosvel|T109|T131|TRD|NRW|NLM (1996)|940719|abbcdef", "MN": "D02.886.300.846.500", "PA": "Insecticides", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Phosphonothioic acid, phenyl-, O-(4-bromo-2,5-dichlorophenyl) O-methyl ester", "RN": "C45E8FUG3Z", "RR": "21609-90-5 (Leptophos)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Insecticides, Organothiophosphate (1973-1974)", "MS": "An organothiophosphate insecticide.", "PM": "96; was PHOSVEL 1975-95 (see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-90); LEPTOPHOS was see PHOSVEL 1975-95", "HN": "96; was PHOSVEL 1975-95 (see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-90); LEPTOPHOS was see PHOSVEL 1975-95", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010773"}, {"RECTYPE": "D", "MH": "Phosvitin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphovitellin|T116|T123|NON|EQV|UNK (19XX)|880606|abbcdef", "MN": "D12.776.744.700", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Phosvitins", "RN": "9008-96-2", "AN": "an egg yolk protein", "PI": "Phosphoproteins (1973-1974)", "MS": "An egg yolk phosphoglycoprotein which contains about 90% of the yolk protein phosphorus. It is synthesized in the liver of the hen and transferred to the developing oocyte, where it is bound to lipoproteins within the yolk granules.", "PM": "91; was see under EGG PROTEINS 1975-90", "HN": "91(75); was see under EGG PROTEINS 1975-90", "MR": "20190708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010774"}, {"RECTYPE": "D", "MH": "Photic Stimulation", "AQ": "AE IS MT", "PRINT ENTRY": "Visual Stimulation|T060|NON|EQV|UNK (19XX)|860620|abcdef", "ENTRY": "Visual Stimulations", "MN": "E05.723.729", "MH_TH": "NLM (1972)", "ST": "T060", "PI": "Light (1966-1971)", "MS": "Investigative technique commonly used during ELECTROENCEPHALOGRAPHY in which a series of bright light flashes or visual patterns are used to elicit brain activity.", "PM": "73", "HN": "73(72)", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010775"}, {"RECTYPE": "D", "MH": "Photobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.830.590", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid657", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that are common in the marine environment and on the surfaces and in the intestinal contents of marine animals. Some species are bioluminescent and are found as symbionts in specialized luminous organs of fish.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010776"}, {"RECTYPE": "D", "MH": "Photochemistry", "DE": "PHOTOCHEM", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Photochemistries", "MN": "H01.181.529.711", "MH_TH": "NLM (1971)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use PHOTOCHEMICAL PROCESSES or specifics treed under it for photochemical principles and processes", "PI": "Light (1966-1970)", "MS": "A branch of physical chemistry which studies chemical reactions, isomerization and physical behavior that may occur under the influence of visible and/or ultraviolet light.", "PM": "71", "HN": "71", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D010777"}, {"RECTYPE": "D", "MH": "Photochemotherapy", "DE": "PHOTOCHEMOTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Red Light Photodynamic Therapy|T061|NON|NRW|NLM (2024)|221014|abcdef", "ENTRY": "Therapies, Photodynamic", "MN": "E02.774.722", "MH_TH": "NLM (1978)", "ST": "T061", "AN": "\"therapy using oral or topical photosensitizing agents with subsequent exposure to light\"; IM; coord with disease /drug ther (IM)", "PI": "Ultraviolet Therapy (1966-1977)", "MS": "Therapy using oral or topical photosensitizing agents with subsequent exposure to light.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20230828", "DA": "19770301", "DC": "1", "DX": "19780101", "UI": "D010778"}, {"RECTYPE": "D", "MH": "Photofluorography", "DE": "PHOTOFLUOROGR", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD VE", "ENTRY": "Photofluorographies", "MN": "E01.370.350.700.225.625", "MH_TH": "NLM (1975)", "ST": "T060", "AN": "usually NIM", "MS": "The photography of images produced on a fluorescent screen by X-rays.", "PM": "88; was see under FLUOROSCOPY 1975-87", "HN": "88(75); was see under FLUOROSCOPY 1975-87", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19880101", "UI": "D010779"}, {"RECTYPE": "D", "MH": "Photogrammetry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Stereophotogrammetry|T060|NON|NRW|UNK (19XX)|741205|abcdef", "ENTRY": "Stereophotogrammetries", "MN": "E01.370.350.600.630", "MH_TH": "NLM (1975)", "ST": "T060", "AN": "measurement by stereoscopic photographs", "MS": "Making measurements by the use of stereoscopic photographs.", "PM": "88; was see under PHOTOGRAPHY 1975-87", "HN": "88(75); was see under PHOTOGRAPHY 1975-87", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19880101", "UI": "D010780"}, {"RECTYPE": "D", "MH": "Photography", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD VE", "ENTRY": "Photographies", "MN": "E05.712", "FX": "Motion Pictures", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "Method of making images on a sensitized surface by exposure to light or other radiant energy.", "CATSH": "CAT LIST", "MR": "20170717", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010781"}, {"RECTYPE": "D", "MH": "Photolysis", "AQ": "DE RE", "ENTRY": "Photodegradation|T070|NON|NRW|NLM (2009)|080208|abcdef", "MN": "G02.740.685", "MH_TH": "NLM (1971)", "ST": "T070", "PI": "Ultraviolet Rays (1966-1970)", "MS": "Chemical bond cleavage reactions resulting from absorption of radiant energy.", "PM": "74", "HN": "74(71)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010782"}, {"RECTYPE": "D", "MH": "Photometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Photometries", "MN": "E05.196.712", "MH_TH": "NLM (1966)", "ST": "T081", "MS": "Measurement of the various properties of light.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010783"}, {"RECTYPE": "D", "MH": "Photomicrography", "DE": "PHOTOMICROGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Photomicrographies", "MN": "E05.595.799", "MH_TH": "NLM (1966)", "ST": "T059", "MS": "Photography of objects viewed under a microscope using ordinary photographic methods.", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010784"}, {"RECTYPE": "D", "MH": "Photophosphorylation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Photosynthetic Phosphorylations", "MN": "G15.568.750", "MH_TH": "NLM (1972)", "ST": "T044", "AN": "in plants: ATP formation in chloroplasts during photosynthesis", "PI": "Photosynthesis (1966-1971)", "MS": "The use of light to convert ADP to ATP without the concomitant reduction of dioxygen to water as occurs during OXIDATIVE PHOSPHORYLATION in MITOCHONDRIA.", "PM": "74", "HN": "74(72)", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010785"}, {"RECTYPE": "D", "MH": "Photoreceptor Cells", "DE": "PHOTORECEPT CELLS", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Rhabdomeric Photoreceptor Cell", "MN": "A11.671.650.915.937", "FX": "Retinal Pigments", "MH_TH": "NLM (2009)", "ST": "T025", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Sensory (1966-1970)", "MS": "Specialized cells that detect and transduce light. They are classified into two types based on their light reception structure, the ciliary photoreceptors and the rhabdomeric photoreceptors with MICROVILLI. Ciliary photoreceptor cells use OPSINS that activate a PHOSPHODIESTERASE phosphodiesterase cascade. Rhabdomeric photoreceptor cells use opsins that activate a PHOSPHOLIPASE C cascade.", "PM": "2009; see PHOTORECEPTORS 1971-2008", "HN": "2009 (1971)", "MR": "20090713", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D010786"}, {"RECTYPE": "D", "MH": "Photosensitivity Disorders", "DE": "PHOTOSENSITIVITY DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Photodermatitis|T047|NON|EQV|POPLINE (1978)|781219|abcdef", "ENTRY": "Syndromes, Actinic Reticuloid", "MN": "C17.800.600", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy.", "OL": "use PHOTOSENSITIVITY DISORDERS to search PHOTOSENSITIZATION 1966-79", "PM": "80; was PHOTOSENSITIZATION 1963-79", "HN": "80; was PHOTOSENSITIZATION 1963-79", "CATSH": "CAT LIST", "MR": "19950222", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D010787"}, {"RECTYPE": "D", "MH": "Photosynthesis", "DE": "PHOTOSYN", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Reductive Pentose Phosphate Cycle|T042|NON|NRW|NLM (2007)|050921|abcdef", "ENTRY": "Photosynthetic Carbon Fixation", "MN": "G15.568", "MH_TH": "NLM (1966)", "ST": "T039", "AN": "do not confuse REDUCTIVE PENTOSE PHOSPHATE CYCLE with PENTOSE PHOSPHATE PATHWAY", "MS": "The synthesis by organisms of organic chemical compounds, especially carbohydrates, from carbon dioxide using energy obtained from light rather than from the oxidation of chemical compounds. Photosynthesis comprises two separate processes: the light reactions and the dark reactions. In higher plants; GREEN ALGAE; and CYANOBACTERIA; NADPH and ATP formed by the light reactions drive the dark reactions which result in the fixation of carbon dioxide. (from Oxford Dictionary of Biochemistry and Molecular Biology, 2001)", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010788"}, {"RECTYPE": "D", "MH": "Phototherapy", "DE": "PHOTOTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Red Light Phototherapy|T061|NON|NRW|NLM (2024)|221014|abcdef", "ENTRY": "Therapy, Light", "MN": "E02.774", "MH_TH": "NLM (1981)", "ST": "T061", "AN": "coord disease with /ther, not /radiother; PHOTOCHEMOTHERAPY; COLOR THERAPY; & ULTRAVIOLET THERAPY are also available", "PI": "Light/therapeutic use (1967-1980)", "MS": "Treatment of disease by exposure to light, especially by variously concentrated light rays or specific wavelengths.", "OL": "to search LIGHT/TU use PHOTOTHERAPY 1966-80 (with no qualif)", "PM": "81; was LIGHT/therapeutic use 1966-80; HELIOTHERAPY was see under PHYSICAL THERAPY 1975-85 & SUNLIGHT 1963-74", "HN": "81; was LIGHT/therapeutic use 1966-80", "CATSH": "CAT LIST", "MR": "20230316", "DA": "19800409", "DC": "1", "DX": "19810101", "UI": "D010789"}, {"RECTYPE": "D", "MH": "Phrenic Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Phrenic Nerves", "MN": "A08.800.800.720.150.700", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES (IM); neopl: coord IM with PERIPHERAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "The motor nerve of the diaphragm. The phrenic nerve fibers originate in the cervical spinal column (mostly C4) and travel through the cervical plexus to the diaphragm.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010791"}, {"RECTYPE": "D", "MH": "Phrenology", "DE": "PHRENOL", "AQ": "HI IS", "MN": "K01.400.799", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "The study of the conformation of the skull as indicative of mental faculties and traits of character, especially according to the hypothesis of F. J. Gall (1758-1828). (Webster 3d ed)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010792"}, {"RECTYPE": "D", "MH": "Phthalazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.710.605", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "Bicyclic heterocyclic compounds containing a BENZENE ring fused to PYRIDAZINE.", "OL": "search HETEROCYCLIC COMPOUNDS 1966-74", "PM": "91; was see under PYRIDAZINES 1975-90; was see under HETEROCYCLIC COMPOUNDS 1966-74", "HN": "91(75); was see under PYRIDAZINES 1975-90; was see under HETEROCYCLIC COMPOUNDS 1966-74", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010793"}, {"RECTYPE": "D", "MH": "Phthalic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Phthalic", "MN": "D02.241.223.805", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A group of compounds that has the general structure of a dicarboxylic acid-substituted benzene ring. The ortho-isomer is used in dye manufacture. (Dorland, 28th ed)", "OL": "use PHTHALIC ACIDS to search PHTHALIC ACID 1966-74", "PM": "75; was PHTHALIC ACID 1963-74", "HN": "75; was PHTHALIC ACID 1963-74", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D010795"}, {"RECTYPE": "D", "MH": "Phthalic Anhydrides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Anhydrides, Phthalic", "MN": "D02.241.223.805.800", "MH_TH": "NLM (1979)", "ST": "T109", "RN": "0", "PI": "Phthalic Acids (1966-1978)", "MS": "Phthalic acid anhydrides. Can be substituted on any carbon atom. Used extensively in industry and as a reagent in the acylation of amino- and hydroxyl groups.", "PM": "91; was see under PHTHALIC ACIDS 1979-90", "HN": "91(79); was see under PHTHALIC ACIDS 1979-90", "MR": "20000621", "DA": "19771215", "DC": "1", "DX": "19910101", "UI": "D010796"}, {"RECTYPE": "D", "MH": "Phthalimides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.513.750", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Phthalic Acids (1966-1974)", "MS": "The imide of phthalic acids.", "PM": "75", "HN": "75", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D010797"}, {"RECTYPE": "D", "MH": "Phycocyanin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "C Phycocyanin", "MN": "D23.767.690", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Phycocyanins, C-", "RN": "11016-15-2", "AN": "plant pigment proteins", "PI": "Plant Proteins (1971-1974)", "MS": "The metal-free blue phycobilin pigment in a conjugated chromoprotein of blue-green algae. It functions as light-absorbing substance together with chlorophylls.", "PM": "91; was see under PIGMENTS 1975-90", "HN": "91(75); was see under PIGMENTS 1975-90", "MR": "20110624", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010798"}, {"RECTYPE": "D", "MH": "Phycoerythrin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "MN": "D23.767.705", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Phycoerythrins, R-", "RN": "11016-17-4", "AN": "a plant pigment protein", "PI": "Plant Proteins (1972-1974)", "MS": "The metal-free red phycobilin pigment in a conjugated chromoprotein of red algae. It functions as a light-absorbing substance together with chlorophylls.", "PM": "91; was see under PIGMENTS 1975-90", "HN": "91(75); was see under PIGMENTS 1975-90", "MR": "20110624", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010799"}, {"RECTYPE": "D", "MH": "Phycomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Phycomyce", "MN": "B01.300.300.500.750", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid4836", "MS": "A genus of zygomycetous fungi in the family Mucoraceae, order MUCORALES, forming mycelia having a metallic sheen. It has been used for research on phototropism.", "PM": "91; see MUCORALES 1986-90, see PHYCOMYCETES 1975-85", "HN": "91(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D010800"}, {"RECTYPE": "D", "MH": "Phylogeny", "PRINT ENTRY": "Phylogenetic Trees|T078|NON|REL|NLM (2021)|191122|abcdef", "ENTRY": "Tree, Phylogenetic", "MN": "L01.100.697", "FX": "Phylogeography", "MH_TH": "NLM (1975)", "ST": "T078", "PI": "Evolution (1966-1974)", "MS": "The relationships of groups of organisms as reflected by their genetic makeup.", "OL": "search EVOLUTION 1967-74", "PM": "78; was see under EVOLUTION 1967-77", "HN": "78(75); was see under EVOLUTION 1967-77", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D010802"}, {"RECTYPE": "D", "MH": "Physalaemin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Physalemin|T116|T123|T131|NON|EQV|NLM (2006)|050106|abbbcdef", "MN": "D23.946.833.033.728", "PA": "Neurotransmitter Agents", "MH_TH": "NLM (1977)", "ST": "T131", "RN": "2507-24-6", "PI": "Peptides (1969-1976)", "MS": "An oligopeptide isolated from the skin of Physalaemus fuscumaculatus, a South American frog. It is a typical kinin, resembling SUBSTANCE P in structure and action and has been proposed as a sialagogue, antihypertensive, and vasodilator.", "PM": "91; was see under TACHYKININS 1989-90; was see under KININS 1977-88", "HN": "91(77); was see under TACHYKININS 1989-90; was see under KININS 1977-88", "MR": "20151124", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D010803"}, {"RECTYPE": "D", "MH": "Physarum", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Physarums", "MN": "B01.046.550.550.600.700", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid5790", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Myxomycetes (1966-1974)", "MS": "A genus of protozoa, formerly also considered a fungus. Characteristics include the presence of violet to brown spores.", "PM": "79; see MYXOMYCETES 1975-78", "HN": "79(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19790101", "UI": "D010804"}, {"RECTYPE": "D", "MH": "Physical Conditioning, Animal", "AQ": "AE CL EC ES HI IS MO MT NU PH PX SN ST TD", "ENTRY": "Physical Conditionings, Animal", "MN": "G11.427.410.698.277.280", "FX": "Veterinary Sports Medicine", "MH_TH": "NLM (1976)", "ST": "T038", "AN": "check tag ANIMALS; exercising of animals goes here; animal running in exercise wheel is probably MOTOR ACTIVITY or PHYSICAL EXERTION", "MS": "Diet modification and physical exercise to improve the ability of animals to perform physical activities.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D010805"}, {"RECTYPE": "D", "MH": "Physical Education and Training", "DE": "PHYS ED", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Physical Education, Training|T065|T090|NON|EQV|UNK (19XX)|790329|PHYSICAL EDUC TRAINING|abbcdefv", "MN": "I02.233.543", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "\"instructional\" and \"often in schools\": differentiate from EXERCISE (see MeSH definition there), from GYMNASTICS (see note there) and from EXERCISE THERAPY (prescribed exercise and physical activity)", "MS": "Instructional programs in the care and development of the body, often in schools. The concept does not include prescribed exercises, which is EXERCISE THERAPY.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010806"}, {"RECTYPE": "D", "MH": "Physical Endurance", "AQ": "DE ES GE IM PH RE", "ENTRY": "Stamina, Physical|T201|NON|EQV|NLM (2019)|171019|abcdef", "MN": "I03.450.642.845.054.600", "FX": "Endurance Training", "MH_TH": "NLM (1977)", "ST": "T201", "AN": "differs from PHYSICAL FITNESS in that here the emphasis is on \"endurance\"", "PI": "Fatigue (1966-1976)", "MS": "The time span between the beginning of physical activity by an individual and the termination because of exhaustion.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20171213", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D010807"}, {"RECTYPE": "D", "MH": "Physical Examination", "DE": "PHYSICAL EXAM", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Physical Exam|T060|NON|EQV|NLM (2020)|190301|abcdef", "ENTRY": "Physical Exams", "MN": "E01.370.600", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "NEUROLOGIC EXAMINATION is also available", "MS": "Systematic and thorough inspection of the patient for physical signs of disease or abnormality.", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010808"}, {"RECTYPE": "D", "MH": "Physical Fitness", "AQ": "HI PH PX", "ENTRY": "Fitness, Physical", "MN": "N01.400.545", "FX": "Physical Endurance", "MH_TH": "NLM (1966)", "ST": "T078", "MS": "The ability to carry out daily tasks and perform physical activities in a highly functional state, often as a result of physical conditioning.", "MR": "20180116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010809"}, {"RECTYPE": "D", "MH": "Physical and Rehabilitation Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Physical Medicine|T091|NON|EQV|NLM (1966)|990101|PHYSICAL MED|abcdefv", "ENTRY": "Physical Medicine and Rehabilitation|T091|NON|EQV|NLM (2013)|120412|abcdef", "MN": "H02.403.680", "FX": "Biomechanical Phenomena", "MH_TH": "NLM (2013)", "ST": "T091", "AN": "the specialty; for therapy consider REHABILITATION or PHYSICAL THERAPY MODALITIES and their specifics and /rehabil with specific disease", "MS": "A medical specialty concerned with the use of physical agents, mechanical apparatus, and manipulation in rehabilitating physically diseased or injured patients.", "PM": "2013; see PHYSICAL MEDICINE 1966-2012", "HN": "2013 (1966)", "MR": "20130710", "DA": "19990101", "DC": "1", "DX": "20130101", "UI": "D010810"}, {"RECTYPE": "D", "MH": "Natural Science Disciplines", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Physical Sciences|T090|NON|NRW|NLM (2002)|010530|abcdef", "ENTRY": "Sciences, Physical", "MN": "H01", "RH": "H1 - NATURAL SCIENCE DISCIPLINES", "MH_TH": "NLM (2009)", "ST": "T090", "AN": "general or unspecified; prefer specifics", "PI": "Science (1966-1997)", "MS": "The sciences dealing with processes observable in nature.", "PM": "2009; see NATURAL SCIENCES 2002-2008; see PHYSICAL SCIENCES 1998-2001", "HN": "2009 (1998)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D010811"}, {"RECTYPE": "D", "MH": "Physical Stimulation", "AQ": "AE IS MT", "PRINT ENTRY": "Stimulation, Physical|T068|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Stimulations, Physical", "MN": "E05.723", "MH_TH": "NLM (1973)", "ST": "T068", "AN": "NIM", "MS": "Act of eliciting a response from a person or organism through physical contact.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010812"}, {"RECTYPE": "D", "MH": "Physical Therapy Department, Hospital", "DE": "PHYS THER DEP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Physical Therapy Department|T093|NON|EQV|UNK (19XX)|770519|HOSP PHYSICAL THER DEP|abcdefv", "ENTRY": "Physical Therapy Departments, Hospital|T093|NON|EQV|UNK (19XX)|790326|PHYSICAL THER DEP HOSP|abcdefv", "MN": "N04.452.442.452.422.615", "MH_TH": "NLM (1977)", "ST": "T093", "PI": "Physical Therapy (1966-Jul 1977)", "MS": "Hospital department which is responsible for the administration and provision of diagnostic and medical rehabilitation services to restore or improve the functional capacity of the patient.", "PM": "91; was see under HOSPITAL DEPARTMENTS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90", "MR": "20190709", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D010814"}, {"RECTYPE": "D", "MH": "Physician Impairment", "AQ": "CL EC LJ PX SN", "ENTRY": "Physician Impairments", "MN": "N03.706.535.606.528.500", "MH_TH": "NLM (1981)", "ST": "T080", "AN": "\"inability to practice medicine with reasonable skill & safety to patient\"; the causes may include alcohol & drug abuse, ment disord, phys disability, senility; coord IM with specific impairment (IM) + specialty if pertinent (IM)", "PI": "specific mental disorder", "MS": "The physician's inability to practice medicine with reasonable skill and safety to the patient due to the physician's disability. Common causes include alcohol and drug abuse, mental illness, physical disability, and senility.", "PM": "81", "HN": "81", "MR": "19920518", "DA": "19800513", "DC": "1", "DX": "19810101", "UI": "D010815"}, {"RECTYPE": "D", "MH": "Physician Incentive Plans", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Incentive Plans, Physician|T058|NON|EQV|UNK (19XX)|870504|abcdef", "ENTRY": "Plans, Physician Incentive", "MN": "N04.452.677.740", "MH_TH": "NLM (1988)", "ST": "T058", "PI": "Personnel Management (1966-1987)", "MS": "Compensatory plans designed to motivate physicians in relation to patient referral, physician recruitment, and efficient use of the health facility.", "PM": "91; was see under PERSONNEL MANAGEMENT 1988-90", "HN": "91(88); was see under PERSONNEL MANAGEMENT 1988-90", "MR": "19940505", "DA": "19870504", "DC": "1", "DX": "19910101", "UI": "D010816"}, {"RECTYPE": "D", "MH": "Physician-Patient Relations", "DE": "PHYSICIAN PATIENT RELAT", "AQ": "ES", "PRINT ENTRY": "Doctor-Patient Relations|T054|NON|EQV|UNK (19XX)|740330|DOCTOR PATIENT RELAT|abcdefv", "ENTRY": "Relationships, Physician Patient", "MN": "N05.300.660.625", "FX": "Truth Disclosure", "MH_TH": "POPLINE (1978)", "ST": "T054", "MS": "The interactions between physician and patient.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010817"}, {"RECTYPE": "D", "MH": "Practice Patterns, Physicians'", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Physician's Practice Patterns|T057|NON|EQV|NLM (1987)|990101|abcdef", "ENTRY": "Prescribing Pattern, Physician", "MN": "N05.300.625", "MH_TH": "NLM (2016)", "ST": "T057", "AN": "do not confuse with PROFESSIONAL PRACTICE where emphasis is on individual physicians & their practices", "PI": "Professional Practice (1968-1986)", "MS": "Patterns of practice related to diagnosis and treatment as especially influenced by cost of the service requested and provided.", "PM": "2016; see Physician's Practice Patterns 1987-2016", "HN": "2016 (1987)", "MR": "20150630", "DA": "19860530", "DC": "1", "DX": "19870101", "UI": "D010818"}, {"RECTYPE": "D", "MH": "Physician's Role", "AQ": "HI PX", "ENTRY": "Roles, Physicians'", "MN": "F01.829.316.616.625.600", "MH_TH": "BIOETHICS (1974)", "ST": "T054", "AN": "coord IM with area in which role is played (IM), as \"physician's role in reducing teenage pregnancy\"= PHYSICIAN'S ROLE (IM) + PREGNANCY IN ADOLESCENCE (IM)", "PI": "Role (1969-1977)", "MS": "The expected function of a member of the medical profession.", "PM": "91; was see under ROLE 1978-90", "HN": "91(78); was see under ROLE 1978-90", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D010819"}, {"RECTYPE": "D", "MH": "Physicians", "AQ": "CL EC ES HI LJ OG PX SD SN ST TD", "ENTRY": "Physician", "MN": "N02.360.810", "EC": "education:Education, Medical", "MH_TH": "POPLINE (1978)", "ST": "T097", "MS": "Individuals licensed to practice medicine.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010820"}, {"RECTYPE": "D", "MH": "Physicians, Family", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Physician, Family", "MN": "N02.360.810.770", "MH_TH": "NLM (1972)", "ST": "T097", "PI": "Physicians (1966-1971)", "MS": "Those physicians who have completed the education requirements specified by the American Academy of Family Physicians.", "PM": "74", "HN": "74(72)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010821"}, {"RECTYPE": "D", "MH": "Physicians, Women", "AQ": "CL EC ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Women Physicians|T097|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Woman Physicians", "MN": "N02.360.810.820", "EC": "education:Education, Medical", "MH_TH": "NLM (1966)", "ST": "T097", "MS": "Women licensed to practice medicine.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010822"}, {"RECTYPE": "D", "MH": "Physician Assistants", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Physicians' Extenders|T097|NON|EQV|UNK (19XX)|770421|abcdef", "ENTRY": "Physicians' Assistant", "MN": "N02.360.067.740", "MH_TH": "NLM (1971)", "ST": "T097", "AN": "coordinate IM with specialty (IM); PARAMEDICS see ALLIED HEALTH PERSONNEL is available", "PI": "Physicians (1968-1970)", "MS": "Health professionals who practice medicine as members of a team with their supervising physicians. They deliver a broad range of medical and surgical services to diverse populations in rural and urban settings. Duties may include physical exams, diagnosis and treatment of disease, interpretation of tests, assist in surgery, and prescribe medications. (from http://www.aapa.orglabout-pas accessed 2114/2011)", "OL": "use PHYSICIAN ASSISTANTS to search PHYSICIANS' ASSISTANTS 1971-94", "PM": "95; was PHYSICIANS' ASSISTANTS 1971-94", "HN": "95; was PHYSICIANS' ASSISTANTS 1971-94", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D010823"}, {"RECTYPE": "D", "MH": "Physicians' Offices", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Physicians' Office", "MN": "N02.278.692", "MH_TH": "NLM (1980)", "ST": "T093", "AN": "restrict to physical office: includes reception rooms, examining rooms, treatment rooms, office, labs, etc.; not for articles with title reading, e.g., \"office assessment of nutrition disord\" or \"office use of microscopes in otology\"", "MS": "The room or rooms in which the physician and staff provide patient care. The offices include all rooms in the physician's office suite.", "PM": "91; was see under HEALTH FACILITIES 1980-90", "HN": "91(80); was see under HEALTH FACILITIES 1980-90", "MR": "19991103", "DA": "19790411", "DC": "1", "DX": "19910101", "UI": "D010824"}, {"RECTYPE": "D", "MH": "Physics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Physic", "MN": "H01.671", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use PHYSICAL PHENOMENA or its specifics for physical processes and principles related to matter and energy", "MS": "The study of those aspects of energy and matter in terms of elementary principles and laws. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010825"}, {"RECTYPE": "D", "MH": "Physiognomy", "ENTRY": "Physiognomies", "MN": "E05.734", "FX": "Facial Expression", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "An assessment of a person's personality based on their facial and other external features.", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010826"}, {"RECTYPE": "D", "MH": "Physiology", "DE": "PHYSIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.158.782", "MH_TH": "POPLINE (1991)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use PHYSIOLOGICAL PHENOMENA or specifics treed under it for functions and processes of organisms, or the qualifier / physiology with specific anatomical terms, organisms, and physiological and psychological processes", "MS": "The biological science concerned with the life-supporting properties, functions, and processes of living organisms or their parts.", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010827"}, {"RECTYPE": "D", "MH": "Physiology, Comparative", "DE": "PHYSIOL COMPARATIVE", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Comparative Physiology|T091|NON|EQV|UNK (19XX)|860101|COMPARATIVE PHYSIOL|abcdefv", "MN": "H01.158.782.688", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "the discipline (education, history, etc) only; for comparative physiological studies, use the qualifier/ physiol with specific anatomical term, process or organism + the Publication Type COMPARATIVE STUDY", "MS": "The biological science concerned with similarities or differences in the life-supporting functions and processes of different species.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010828"}, {"RECTYPE": "D", "MH": "Physiological Phenomena", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Physiological Processes|T039|NON|NRW|NLM (2009)|080701|abcdef", "ENTRY": "Processes, Physiological", "MN": "G07", "RH": "G7 - PHYSIOLOGICAL PHENOMENA, GENERAL", "MH_TH": "NLM (2009)", "ST": "T039", "AN": "general or unspecified; prefer specifics; differentiate from PHYSIOLOGY, the specialty or discipline", "MS": "The functions and properties of living organisms, including both the physical and chemical factors and processes, supporting life in single- or multi-cell organisms from their origin through the progression of life.", "PM": "2009; see PHYSIOLOGICAL PROCESSES 1998-2008; for PHYSIOLOGICAL PROCESSES see PHYSIOLOGICAL PROCESSES 2009-2016", "HN": "2009 (1975)", "CATSH": "CAT LIST", "MR": "20160928", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D010829"}, {"RECTYPE": "D", "MH": "Physostigmine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Eserine|T109|T121|TRD|NRW|UNK (19XX)|740330|abbcdef", "MN": "D03.633.100.496.500.500.545", "PA": "Miotics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-", "RN": "9U1VM840SP", "RR": "57-47-6 (Physostigmine)", "MS": "A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010830"}, {"RECTYPE": "D", "MH": "Phytanic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Phytanic", "MN": "D02.455.849.291.515", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "Hexadecanoic acid, 3,7,11,15-tetramethyl-", "RN": "14721-66-5", "PI": "Fatty Acids (1970-1974)", "MS": "A 20-carbon branched chain fatty acid. In phytanic acid storage disease (REFSUM DISEASE) this lipid may comprise as much as 30% of the total fatty acids of the plasma. This is due to a phytanic acid alpha-hydroxylase deficiency.", "PM": "91; was see under EICOSANOIC ACIDS 1975-90", "HN": "91(75); was see under EICOSANOIC ACIDS 1975-90", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010831"}, {"RECTYPE": "D", "MH": "6-Phytase", "DS": "PHYTASE 06", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "6 Phytase", "MN": "D08.811.277.352.650.700", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "myo-Inositol-hexakisphosphate 6-phosphohydrolase", "RN": "EC 3.1.3.26", "RR": "9001-89-2 (CAS RN)", "MS": "An enzyme that catalyzes the conversion of myo-inositol hexakisphosphate and water to 1L-myo-inositol 1,2,3,4,5-pentakisphosphate and orthophosphate. EC 3.1.3.26.", "OL": "use 6-PHYTASE to search PHYTASE & INOSITOLHEXAPHOSPHATE PHOSPHOHYDROLASE 1966-93", "PM": "94; was PHYTASE 1966-93; INOSITOLHEXAPHOSPHATE PHOSPHOHYDROLASE was see PHYTASE 1966-93", "HN": "94; was PHYTASE 1966-93; INOSITOLHEXAPHOSPHATE PHOSPHOHYDROLASE was see PHYTASE 1966-93", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010832"}, {"RECTYPE": "D", "MH": "Phytic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phytin|T109|T121|T130|NON|NRW|FDA SRS (2014)|UNK (19XX)|770421|abbbcdeef", "ENTRY": "Phytate, Sodium", "MN": "D09.894.480.700", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "myo-Inositol, hexakis(dihydrogen phosphate)", "RN": "7IGF0S7R8I", "RR": "N1DEP08LNK", "PI": "Inositol (1966-1977)", "MS": "Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.", "OL": "search INOSITOL 1966-74; use PHYTIC ACID to search PHYTIN 1975-78 & use INOSITOL 1966-74", "PM": "78; was see under INOSITOL 1963-77; PHYTIN was see under INOSITOL 1963-77", "HN": "78(75); was see under INOSITOL 1963-77; PHYTIN was see under INOSITOL 1963-77", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D010833"}, {"RECTYPE": "D", "MH": "Phytochrome", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D23.767.712", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "11121-56-5", "AN": "a blue-green pigment of plants; a plant protein", "PI": "Plant Proteins (1972-1974)", "MS": "A blue-green biliprotein widely distributed in the plant kingdom.", "PM": "91; was see under PLANT PROTEINS 1975-90", "HN": "91(75); was see under PLANT PROTEINS 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010834"}, {"RECTYPE": "D", "MH": "Phytohemagglutinins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phytohemagglutinin|T116|T129|T130|NON|EQV|NLM (2021)|191120|abbbcdef", "ENTRY": "Plant Hemagglutinins", "MN": "D12.776.765.678.750", "PA": "Mitogens", "MH_TH": "NLM (1979)", "ST": "T130", "RN": "0", "PI": "Lectins (1966-1978)", "MS": "Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture.", "PM": "1979; see PLANT AGGLUTININS 1968-1978; for HEMAGGLUTININS, PLANT see PLANT LECTINS 2003-2021 and PLANT AGGLUTININS 1974-2002", "HN": "1979; use PLANT AGGLUTININS 1968-1978; for HEMAGGLUTININS, PLANT use PLANT LECTINS 2003-2021 and PLANT AGGLUTININS 1974-2002", "MR": "20230316", "DA": "19780503", "DC": "1", "DX": "19790101", "UI": "D010835"}, {"RECTYPE": "D", "MH": "Phytol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.849.291.523", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "2-Hexadecen-1-ol, 3,7,11,15-tetramethyl-, (R-(R*,R*-(E)))-", "RN": "150-86-7", "MS": "Acyclic diterpene used in making synthetic forms of vitamin E and vitamin K1.", "OL": "search TERPENES 1968-74", "PM": "91; was see under DITERPENES 1975-90; was see under TERPENES 1968-74", "HN": "91(75); was see under DITERPENES 1975-90; was see under TERPENES 1968-74", "MR": "20161101", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010836"}, {"RECTYPE": "D", "MH": "Vitamin K 1", "DS": "VITAMIN K A 01", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phytonadione|T109|T121|T127|NON|EQV|USP (19XX)|990101|abbbcdef", "ENTRY": "Vitamin K1|T109|T121|T127|NON|EQV|UNK (19XX)|880628|abbbcdef", "MN": "D04.615.638.721.374.689", "PA": "Vitamins", "MH_TH": "UNK (19XX)", "ST": "T127", "N1": "1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-, (R-(R*,R*-(E)))-", "RN": "84-80-0", "AN": "deficiency: coordinate VITAMIN K 1 (IM) with VITAMIN K DEFICIENCY (IM)", "PI": "Phytonadione (1964-2001)", "MS": "A family of phylloquinones that contains a ring of 2-methyl-1,4-naphthoquinone and an isoprenoid side chain. Members of this group of vitamin K 1 have only one double bond on the proximal isoprene unit. Rich sources of vitamin K 1 include green plants, algae, and photosynthetic bacteria. Vitamin K1 has antihemorrhagic and prothrombogenic activity.", "PM": "see PHYTONADIONE 1964-2001", "HN": "use PHYTONADIONE 1964-2001", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010837"}, {"RECTYPE": "D", "MH": "Phytophthora", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sudden Oak Death Agent|T204|NON|NRW|NLM (2024)|230412|abcdef", "ENTRY": "Phytophthora sojae|T204|NON|NRW|NLM (2009)|080404|abcdef", "MN": "B01.750.580.715", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid4783", "RR": "txid67593", "MS": "A genus of destructive parasitic OOMYCETES in the family Peronosporaceae, order Peronosporales, affecting numerous fruit, vegetable, and other crops. Differentiation of zoospores usually takes place in the sporangium and no vesicle is formed. It was previously considered a fungus.", "PM": "91; was see under MASTIGOMYCOTINA 1986-90; was see under PHYCOMYCETES 1975-85", "HN": "91(75); was see under MASTIGOMYCOTINA 1986-90; was see under PHYCOMYCETES 1975-85", "MR": "20230531", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D010838"}, {"RECTYPE": "D", "MH": "Phytoplankton", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B05.080.500.600", "FX": "Dinoflagellida", "MH_TH": "NLM (1971)", "ST": "T204", "AN": "coordinate with specific organism; phototrophic bacterioplankton: index PHYTOPLANKTON + BACTERIA or specific", "PI": "Plankton (1966-1970)", "MS": "Free-floating minute organisms that are photosynthetic. The term is non-taxonomic and refers to a lifestyle (energy utilization and motility), rather than a particular type of organism. Most, but not all, are unicellular algae. Important groups include DIATOMS; DINOFLAGELLATES; CYANOBACTERIA; CHLOROPHYTA; HAPTOPHYTA; CRYPTOMONADS; and silicoflagellates.", "PM": "91; was see under PLANKTON 1971-90", "HN": "91(71); was see under PLANKTON 1971-90", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010839"}, {"RECTYPE": "D", "MH": "Phytosterols", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Plant Sterols|T109|T123|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Sterols, Plant", "MN": "D23.704.500", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "PI": "Sterols (1968-1972)", "MS": "A class of organic compounds known as sterols or STEROIDS derived from plants.", "PM": "73", "HN": "73", "MR": "20161209", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010840"}, {"RECTYPE": "D", "MH": "Pia Mater", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Pia Maters", "MN": "A08.186.566.731", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The innermost layer of the three meninges covering the brain and spinal cord. It is the fine vascular membrane that lies under the ARACHNOID and the DURA MATER.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010841"}, {"RECTYPE": "D", "MH": "Pica", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Geophagia|T048|NON|NRW|NLM (2002)|000824|abcdef", "ENTRY": "Allotriophagy|T048|NON|REL|NLM (2015)|140515|abcdef", "MN": "F03.400.875", "MH_TH": "NLM (1968)", "ST": "T048", "PI": "Appetite Disorders (1966-1967)", "MS": "The persistent eating of non-nutritive substances for a period of at least one month.", "PM": "72", "HN": "72(68)", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010842"}, {"RECTYPE": "D", "MH": "Pichia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Hansenula|T004|NON|EQV|NLM (1999)|971113|abcdef", "ENTRY": "Pichias", "MN": "B01.300.930.600", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid4919", "MS": "Yeast-like ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES isolated from exuded tree sap.", "PM": "91; see ENDOMYCETALES 1986-90, see ASCOMYCETES 1975-85; for HANSENULA see HANSENULA 1991-98, see ENDOMYCETALES 1986-90, see ASCOMYCETES 1975-85", "HN": "91(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D010843"}, {"RECTYPE": "D", "MH": "Picibanil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Streptococcal Preparation OK432", "MN": "D20.215.659", "PA": "Antineoplastic Agents", "FX": "Streptococcus pyogenes", "MH_TH": "NLM (1978)", "ST": "T121", "N1": "Picibanil", "RN": "39325-01-4", "PI": "Streptococcus (1966-1977)", "MS": "A lyophilized preparation of a low-virulence strain (SU) of Streptococcus pyogenes (S. hemolyticus), inactivated by heating with penicillin G. It has been proposed as a noncytotoxic antineoplastic agent because of its immune system-stimulating activity.", "OL": "use PICIBANIL to search STREPTOCOCCAL PREPARATION OK-432 1978-82", "PM": "91; was see under BIOLOGICAL PRODUCTS 1983-90; was STREPTOCOCCAL PREPARATION OK-432 see under BIOLOGICAL PRODUCTS 1978-82", "HN": "91(83); was see under BIOLOGICAL PRODUCTS 1983-90; was STREPTOCOCCAL PREPARATION OK-432 see under BIOLOGICAL PRODUCTS 1978-82", "MR": "20050630", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D010844"}, {"RECTYPE": "D", "MH": "Obesity Hypoventilation Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pickwickian Syndrome|T047|EPO|EQV|NLM (1964)|OMIM (2013)|990101|abcdeef", "ENTRY": "Obesity-Hypoventilation Syndromes", "MN": "C18.654.726.750.500.600", "MH_TH": "NLM (2006)", "ST": "T047", "MS": "HYPOVENTILATION syndrome in very obese persons with excessive ADIPOSE TISSUE around the ABDOMEN and DIAPHRAGM. It is characterized by diminished to absent ventilatory chemoresponsiveness; chronic HYPOXIA; HYPERCAPNIA; POLYCYTHEMIA; and long periods of sleep during day and night (HYPERSOMNOLENCE). It is a condition often related to OBSTRUCTIVE SLEEP APNEA but can occur separately.", "PM": "2006 (1970); see PICKWICK SYNDROME 1964-1969", "HN": "2006 (1970); use PICKWICK SYNDROME 1964-1969", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D010845"}, {"RECTYPE": "D", "MH": "Picloram", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chloramp|T109|T131|NON|EQV|UNK (19XX)|810108|abbcdef", "MN": "D03.383.725.705.523", "PA": "Herbicides", "MH_TH": "NLM (1971)", "ST": "T131", "N1": "2-Pyridinecarboxylic acid, 4-amino-3,5,6-trichloro-", "RN": "O7437X49DW", "RR": "1918-02-1 (Picloram)", "PI": "Picolinic Acids (1968-1970)", "MS": "A picolinic acid derivative that is used as a herbicide.", "PM": "91; was see under PICOLINIC ACIDS 1971-90", "HN": "91(71); was see under PICOLINIC ACIDS 1971-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010846"}, {"RECTYPE": "D", "MH": "Picolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Picoline|T109|NON|NRW|UNK (19XX)|780516|abcdef", "MN": "D03.383.725.676", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A group of compounds that are monomethyl derivatives of pyridines. (From Dorland, 28th ed)", "OL": "use PICOLINES to search PICOLINE 1966-78", "PM": "79; was PICOLINE 1963-78", "HN": "79; was PICOLINE 1963-78", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D010847"}, {"RECTYPE": "D", "MH": "Picolinic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Picolinic", "MN": "D03.383.725.705", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Compounds with general formula C5H4N(CO2H) derived from PYRIDINE, having a carboxylic acid substituent at the 2-position.", "PM": "68", "HN": "68", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010848"}, {"RECTYPE": "D", "MH": "Picornaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Tremoviruses", "MN": "B04.820.578.750", "MH_TH": "NLM (1964)", "ST": "T005", "RN": "txid12058", "RR": "txid691955", "MS": "A family of small RNA viruses comprising some important pathogens of humans and animals. Transmission usually occurs mechanically. There are nine genera: APHTHOVIRUS; CARDIOVIRUS; ENTEROVIRUS; ERBOVIRUS; HEPATOVIRUS; KOBUVIRUS; PARECHOVIRUS; RHINOVIRUS; and TESCHOVIRUS.", "OL": "use PICORNAVIRIDAE to search PICORNAVIRUSES 1975-80 & PICORNAVIRUS 1966-74", "PM": "81; was PICORNAVIRUSES 1975-80, was PICORNAVIRUS 1964-74", "HN": "81; was PICORNAVIRUSES 1975-80, was PICORNAVIRUS 1964-74", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D010849"}, {"RECTYPE": "D", "MH": "Picornaviridae Infections", "DE": "PICORNAVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Picornavirus Infections|T047|NON|EQV|NLM (1994)|930525|PICORNAVIRUS INFECT|abcdefv", "ENTRY": "Picornavirus Infection", "MN": "C01.925.782.687", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Virus Diseases (1966-1979)", "MS": "Virus diseases caused by the PICORNAVIRIDAE.", "OL": "use PICORNAVIRIDAE INFECTIONS to search PICORNAVIRUS INFECTIONS 1980-93", "PM": "94; was PICORNAVIRUS INFECTIONS 1980-93", "HN": "94; was PICORNAVIRUS INFECTIONS 1980-93; was PICORNAVIRUS INFECTIONS (NON MESH) before 1980", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D010850"}, {"RECTYPE": "D", "MH": "Picrates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.640.743.690", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Salts or esters of PICRIC ACID.", "MR": "20161101", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010851"}, {"RECTYPE": "D", "MH": "Picrotoxin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cocculin|T109|T121|T131|NON|EQV|NLM (2023)|210817|abbbcdef", "MN": "D26.667.750", "PA": "Convulsants", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "ZLT174DL7U", "RR": "124-87-8", "MS": "A mixture of PICROTOXININ and PICROTIN that is a noncompetitive antagonist at GABA-A receptors acting as a convulsant. Picrotoxin blocks the GAMMA-AMINOBUTYRIC ACID-activated chloride ionophore. Although it is most often used as a research tool, it has been used as a CNS stimulant and an antidote in poisoning by CNS depressants, especially the barbiturates.", "PM": "1966", "HN": "1966", "MR": "20220408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010852"}, {"RECTYPE": "D", "MH": "Picryl Chloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2,4,6-Trinitro-1-chlorobenzene|T109|NON|EQV|FDA SRS (2014)|NLM (1993)|920324|TRINITROCHLOROBENZENE 02 04 06 01|TNCB|abcdeefsv", "ENTRY": "Chloride, Picryl", "MN": "D23.050.550.480.820", "MH_TH": "NLM (1965)", "ST": "T109", "N1": "Benzene, 2-chloro-1,3,5-trinitro-", "RN": "Z4ZG7O5SZ9", "RR": "88-88-0 (Picryl Chloride)", "MS": "A hapten that generates suppressor cells capable of down-regulating the efferent phase of trinitrophenol-specific contact hypersensitivity. (Arthritis Rheum 1991 Feb;34(2):180).", "PM": "65", "HN": "65", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010853"}, {"RECTYPE": "D", "MH": "Piedra", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "White Piedras", "MN": "C17.800.329.992", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Either of two diseases resulting from fungal infection of the hair shafts. Black piedra occurs mainly in and on the hairs of the scalp and is caused by Piedraia hortae; white piedra occurs in and on the hairs of the scalp, beard, moustache and genital areas and is caused by Trichosporon species.", "OL": "search MYCOSES 1966-74", "PM": "91; was see under MYCOSES 1975-90", "HN": "91(75); was see under MYCOSES 1975-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010854"}, {"RECTYPE": "D", "MH": "Pierre Robin Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Pierre-Robin", "MN": "C16.131.850.500.460.606", "FX": "SOX9 Transcription Factor", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "named for French dentist Pierre Robin: Robin is his surname; note: no hyphen", "MS": "Congenital malformation characterized by MICROGNATHIA or RETROGNATHIA; GLOSSOPTOSIS and CLEFT PALATE. The mandibular abnormalities often result in difficulties in sucking and swallowing. The syndrome may be isolated or associated with other syndromes (e.g., ANDERSEN SYNDROME; CAMPOMELIC DYSPLASIA). Developmental mis-expression of SOX9 TRANSCRIPTION FACTOR gene on chromosome 17q and its surrounding region is associated with the syndrome.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010855"}, {"RECTYPE": "D", "MH": "Columbidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Pigeons|T012|NON|EQV|NLM (1968)|990101|abcdef", "ENTRY": "Rock Pigeon", "MN": "B01.050.150.900.248.165.150", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid8930", "RR": "txid8932", "PI": "Poultry (1966-1967)", "MS": "Family in the order COLUMBIFORMES, comprised of pigeons or doves. They are BIRDS with short legs, stout bodies, small heads, and slender bills. Some sources call the smaller species doves and the larger pigeons, but the names are interchangeable.", "PM": "2005; see PIGEONS 1968-2004", "HN": "2005 (1968)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010856"}, {"RECTYPE": "D", "MH": "Pigment Epithelium of Eye", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Eye Pigment Epithelium", "MN": "A10.272.640", "MH_TH": "NLM (1976)", "ST": "T024", "PI": "Retinal Diseases (1972-1975)", "MS": "The layer of pigment-containing epithelial cells in the RETINA; the CILIARY BODY; and the IRIS in the eye.", "PM": "76", "HN": "76", "MR": "20080708", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D010857"}, {"RECTYPE": "D", "MH": "Pigmentation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Pigmentations", "MN": "G16.690", "FX": "Skin Pigmentation", "MH_TH": "NLM (1966)", "ST": "T201", "AN": "differentiate from COLOR in that PIGMENTATION is related to PIGMENTS, BIOLOGICAL", "MS": "Coloration or discoloration of a part by a pigment.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010858"}, {"RECTYPE": "D", "MH": "Pigmentation Disorders", "DE": "PIGMENTATION DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Schamberg's Disease|T047|EPO|NRW|UNK (19XX)|850325|SCHAMBERGS DIS|abcdefv", "ENTRY": "Syndrome, Ito", "MN": "C23.550.755", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not restrict to skin; do not confuse entry term INCONTINENTIA PIGMENTI ACHROMIANS with INCONTINENTIA PIGMENTI", "MS": "Diseases affecting PIGMENTATION, including SKIN PIGMENTATION.", "OL": "use PIGMENTATION DISORDERS to search SCHAMBERG'S DISEASE 1966-85", "PM": "SCHAMBERG'S DISEASE was see under PIGMENTATION DISORDERS 1965-85", "HN": "SCHAMBERG'S DISEASE was see under PIGMENTATION DISORDERS 1965-85", "CATSH": "CAT LIST", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010859"}, {"RECTYPE": "D", "MH": "Pigments, Biological", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Biological Pigments", "MN": "D23.767", "FX": "Pigmentation", "MH_TH": "NLM (2006)", "ST": "T120", "RN": "0", "AN": "differentiate from COLORING AGENTS", "MS": "Any normal or abnormal coloring matter in PLANTS; ANIMALS or micro-organisms.", "PM": "2006; see PIGMENTS 1963-2005", "HN": "2006(1963)", "MR": "20050701", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D010860"}, {"RECTYPE": "D", "MH": "Fimbriae, Bacterial", "DE": "FIMBRIAE BACT", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Pili, Common|T026|NON|EQV|NLM (1995)|941026|abcdef", "ENTRY": "Pilus, Common", "MN": "A20.843", "FX": "Adhesins, Bacterial", "MH_TH": "NLM (1980)", "ST": "T026", "PI": "specific bacterium (1966-1979)", "MS": "Thin, hairlike appendages, 1 to 20 microns in length and often occurring in large numbers, present on the cells of gram-negative bacteria, particularly Enterobacteriaceae and Neisseria. Unlike flagella, they do not possess motility, but being protein (pilin) in nature, they possess antigenic and hemagglutinating properties. They are of medical importance because some fimbriae mediate the attachment of bacteria to cells via adhesins (ADHESINS, BACTERIAL). Bacterial fimbriae refer to common pili, to be distinguished from the preferred use of \"pili\", which is confined to sex pili (PILI, SEX).", "PM": "95; was PILI, BACTERIAL 1980-94; FIMBRIAE, BACTERIAL was see PILI, BACTERIAL 1980-94", "HN": "95; was PILI, BACTERIAL 1980-94; FIMBRIAE, BACTERIAL was see PILI, BACTERIAL 1980-94", "MR": "20130709", "DA": "19790104", "DC": "1", "DX": "19800101", "UI": "D010861"}, {"RECTYPE": "D", "MH": "Pilocarpine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nitrate, Pilocarpine", "MN": "D03.132.672", "PA": "Muscarinic Agonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, (3S-cis)-", "RN": "01MI4Q9DI3", "RR": "M20T465H6J", "AN": "/biosyn permitted if by plant", "MS": "A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010862"}, {"RECTYPE": "D", "MH": "Piloerection", "AQ": "DE ES GE IM PH RE", "ENTRY": "Piloerections", "MN": "G13.750.622", "MH_TH": "NLM (1972)", "ST": "T042", "PI": "Reflex (1966-1971)", "MS": "Involuntary erection or bristling of hairs.", "PM": "91; was see under REFLEX 1972-90", "HN": "91(72); was see under REFLEX 1972-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010863"}, {"RECTYPE": "D", "MH": "Pilonidal Sinus", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Pilonidal Cyst|T019|NON|EQV|NLM (1997)|951102|abcdef", "ENTRY": "Sinus, Pilonidal", "MN": "C04.182.710", "MH_TH": "OMIM (2013)", "ST": "T019", "AN": "non-neoplastic; no organ coordinate needed", "MS": "A hair-containing cyst or sinus, occurring chiefly in the coccygeal region.", "PM": "97; was PILONIDAL CYST 1963-96; PILONIDAL SINUS was see PILONIDAL CYST 1978-96", "HN": "97; was PILONIDAL CYST 1963-96; PILONIDAL SINUS was see PILONIDAL CYST 1978-96", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19970101", "UI": "D010864"}, {"RECTYPE": "D", "MH": "Pilot Projects", "ENTRY": "Study, Pilot", "MN": "N06.850.520.450.720", "MH_TH": "POPLINE (1978)", "ST": "T062", "AN": "IM general only; coordinate NIM with specific subject (IM)", "PI": "Research (1966-1970)", "MS": "Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work.", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010865"}, {"RECTYPE": "D", "MH": "Natamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tennecetin|T109|T195|NON|EQV|UNK (19XX)|770216|abbcdef", "ENTRY": "Pimafucin|T109|T195|TRD|NRW|UNK (19XX)|801120|abbcdef", "MN": "D02.540.505.550", "PA": "Antifungal Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Pimaricin", "RN": "8O0C852CPO", "RR": "7681-93-8 (Natamycin)", "AN": "do not use /biosyn unless by living matter", "MS": "Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically.", "OL": "use NATAMYCIN to search PIMARICIN 1966-89", "PM": "90; was PIMARICIN 1973-89", "HN": "90(66); was PIMARICIN 1966-89", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010866"}, {"RECTYPE": "D", "MH": "Pimelic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Pimelic", "MN": "D02.241.081.337.699", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "RR": "BZQ96WX25F", "MS": "A group of compounds that are derivatives of heptanedioic acid with the general formula R-C7H11O4.", "OL": "use PIMELIC ACIDS to search PIMELIC ACID 1966-74", "PM": "75; was PIMELIC ACID 1963-74", "HN": "75; was PIMELIC ACID 1963-74", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D010867"}, {"RECTYPE": "D", "MH": "Pimozide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R6238", "MN": "D03.633.100.103.732", "PA": "Dopamine Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-Benzimidazol-2-one, 1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-", "RN": "1HIZ4DL86F", "RR": "2062-78-4 (Pimozide)", "PI": "Tranquilizing Agents (1966-1972)", "MS": "A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403)", "PM": "73", "HN": "73", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010868"}, {"RECTYPE": "D", "MH": "Pindolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prindolol|T109|T121|NON|EQV|UNK (19XX)|750708|abbcdef", "ENTRY": "LB46", "MN": "D02.092.063.624.698.699", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2-Propanol, 1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)-", "RN": "BJ4HF6IU1D", "RR": "13523-86-9 (Pindolol)", "PI": "Sympatholytics (1966-1972)", "MS": "A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)", "PM": "73", "HN": "73", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010869"}, {"RECTYPE": "D", "MH": "Pineal Gland", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Pineal Body|T023|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Pineal Glands", "MN": "A08.713.733", "FX": "Pinealectomy", "MH_TH": "NLM (1995)", "ST": "T023", "AN": "neoplasms: coordinate PINEAL GLAND (IM) with BRAIN NEOPLASMS (IM) + histological type of neoplasm (IM); consider PINEALOMA", "MS": "A light-sensitive neuroendocrine organ attached to the roof of the THIRD VENTRICLE of the brain. The pineal gland secretes MELATONIN, other BIOGENIC AMINES and NEUROPEPTIDES.", "MR": "20180622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010870"}, {"RECTYPE": "D", "MH": "Pinealoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pineocytoma|T191|NON|NRW|NLM (1994)|930527|abcdef", "ENTRY": "Tumors, Pineal Parenchymal", "MN": "C10.551.240.250.625", "FX": "Pinealectomy", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with BRAIN NEOPLASMS + PINEAL GLAND (IM) ", "MS": "Neoplasms which originate from pineal parenchymal cells that tend to enlarge the gland and be locally invasive. The two major forms are pineocytoma and the more malignant pineoblastoma. Pineocytomas have moderate cellularity and tend to form rosette patterns. Pineoblastomas are highly cellular tumors containing small, poorly differentiated cells. These tumors occasionally seed the neuroaxis or cause obstructive HYDROCEPHALUS or Parinaud's syndrome. GERMINOMA; CARCINOMA, EMBRYONAL; GLIOMA; and other neoplasms may arise in the pineal region with germinoma being the most common pineal region tumor. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2064; Adams et al., Principles of Neurology, 6th ed, p670)", "CATSH": "CAT LIST", "MR": "20180319", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010871"}, {"RECTYPE": "D", "MH": "Caniformia", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Pinnipedia|T015|NON|EQV|NLM (1968)|990101|abcdef", "ENTRY": "Pinnipeds|T015|NON|EQV|NLM (2005)|030808|abcdef", "MN": "B01.050.150.900.649.313.750.250", "MH_TH": "NLM (2018)", "ST": "T015", "RN": "txid379584", "AN": "general or unspecified only; prefer specifics", "PI": "Carnivora (1966-1967)", "MS": "Suborder of dog-like carnivores which include dogs, coyotes, skunks, mustelids, walruses, seals, bears, and procyonids.", "PM": "2018", "HN": "2018(1966)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010872"}, {"RECTYPE": "D", "MH": "Pinocytosis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Pinocytoses", "MN": "G04.417.370", "MH_TH": "NLM (1964)", "ST": "T043", "MS": "The engulfing of liquids by cells by a process of invagination and closure of the cell membrane to form fluid-filled vacuoles.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010873"}, {"RECTYPE": "D", "MH": "Pinta", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C17.800.838.765.630", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a nonvenereal treponemal skin infect", "MS": "An infectious disease of the skin caused by Treponema carateum that occurs only in the western hemisphere. Age of onset is between 10 and 20 years of age. This condition is characterized by marked changes in the skin color and is believed to be transmitted by direct person-to-person contact.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010874"}, {"RECTYPE": "D", "MH": "Pipecolic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Pipecolic", "MN": "D03.383.621.758", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010875"}, {"RECTYPE": "D", "MH": "Pipemidic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Piperamic Acid|T109|T121|NON|EQV|UNK (19XX)|771209|abbcdef", "ENTRY": "Acid, Piperamic", "MN": "D03.383.725.547.635", "PA": "Anti-Infective Agents, Urinary", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pyrido(2,3-d)pyrimidine-6-carboxylic acid, 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)-", "RN": "LT12J5HVR8", "RR": "51940-44-4 (Pipemidic Acid)", "PI": "Piperazines (1966-1970)", "MS": "Antimicrobial against Gram negative and some Gram positive bacteria. It is protein bound and concentrated in bile and urine and used for gastrointestinal, biliary, and urinary infections.", "PM": "91; was see under NICOTINIC ACIDS 1979-90", "HN": "91(79); was see under NICOTINIC ACIDS 1979-90", "MR": "20170524", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D010876"}, {"RECTYPE": "D", "MH": "Piperacillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "T 1220", "MN": "D03.633.100.300.750.750.050.650", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))-", "RN": "X00B0D5O0E", "RR": "M98T69Q7HP", "PI": "Penicillins (1966-1983)", "MS": "Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics.", "PM": "84", "HN": "84", "MR": "20170524", "DA": "19830311", "DC": "1", "DX": "19840101", "UI": "D010878"}, {"RECTYPE": "D", "MH": "Piperazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.606", "EC": "analogs & derivatives:Piperazine", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "PIPERAZINE is also available", "MS": "Compounds that are derived from PIPERAZINE.", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010879"}, {"RECTYPE": "D", "MH": "Piperidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.621", "FX": "Pyridines", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A family of hexahydropyridines.", "OL": "use PIPERIDINES to search AZACYCLONOL 1966-84", "PM": "AZACYCLONOL was heading 1963-84", "HN": "AZACYCLONOL was heading 1963-84", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010880"}, {"RECTYPE": "D", "MH": "Piperidones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Piperidone|T109|NON|EQV|NLM (2021)|191121|abcdef", "MN": "D03.383.621.808", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "Piperidines (1966-1970)", "MS": "A family of saturated heterocyclic organic compounds which contain one nitrogen atom and a carbonyl group in the ring structure.", "PM": "91; was see under PIPERIDINES 1971-90", "HN": "91(71); was see under PIPERIDINES 1971-90", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010881"}, {"RECTYPE": "D", "MH": "Piperonyl Butoxide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Butoxide, Piperonyl", "MN": "D03.633.100.115.600", "PA": "Pesticide Synergists", "MH_TH": "FDA SRS (2014)", "ST": "T131", "N1": "1,3-Benzodioxole, 5-((2-(2-butoxyethoxy)ethoxy)methyl)-6-propyl-", "RN": "LWK91TU9AH", "RR": "51-03-6 (Piperonyl Butoxide)", "PI": "Pesticides (1966-1971)", "MS": "An insecticide synergist, especially for pyrethroids and ROTENONE.", "PM": "74", "HN": "74(72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D010882"}, {"RECTYPE": "D", "MH": "Piperoxan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Piperoxane|T109|T121|NON|EQV|UNK (19XX)|760412|abbcdef", "MN": "D03.633.100.673", "PA": "Antihypertensive Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Piperidine, 1-((2,3-dihydro-1,4-benzodioxin-2-yl)methyl)-", "RN": "9ZCS27634Y", "RR": "59-39-2 (Piperoxan)", "PI": "Sympatholytics (1966-1974)", "MS": "A benzodioxane alpha-adrenergic blocking agent with considerable stimulatory action. It has been used to diagnose PHEOCHROMOCYTOMA and as an antihypertensive agent.", "OL": "search SYMPATHOLYTICS 1966-74", "PM": "91; was see under PIPERIDINES 1975-90; was see under SYMPATHOLYTICS 1963-74", "HN": "91(77); was see under PIPERIDINES 1975-90; was see under SYMPATHOLYTICS 1963-74", "MR": "20160701", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D010883"}, {"RECTYPE": "D", "MH": "Pipidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.090.180.610", "MH_TH": "NLM (1981)", "ST": "T011", "RN": "txid8352", "AN": "NIM when experimental animal", "MS": "A family of the order Anura, distinguished by the lack of a tongue. It includes four living genera of aquatic \"toads\". Two of the most familiar pipids are the popularly called Surinam \"toad\" (Pipa pipa) and XENOPUS LAEVIS.", "PM": "81", "HN": "81", "MR": "20200813", "DA": "19800512", "DC": "1", "DX": "19810101", "UI": "D010884"}, {"RECTYPE": "D", "MH": "Pipobroman", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vercyte|T109|T121|TRD|NRW|FR|041029|abbcdef", "MN": "D03.383.606.773", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Piperazine, 1,4-bis(3-bromo-1-oxopropyl)-", "RN": "6Q99RDT97R", "RR": "54-91-1 (Pipobroman)", "PI": "Propionates (1966)", "MS": "An antineoplastic agent that acts by alkylation.", "PM": "73", "HN": "73(67)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010885"}, {"RECTYPE": "D", "MH": "Piracetam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "UCB6215", "MN": "D03.383.773.812.555", "PA": "Nootropic Agents", "MH_TH": "USAN (1980)", "ST": "T121", "N1": "1-Pyrrolidineacetamide, 2-oxo-", "RN": "ZH516LNZ10", "RR": "7491-74-9 (Piracetam)", "PI": "Pyrrolidinones (1971-1974)", "MS": "A compound suggested to be both a nootropic and a neuroprotective agent.", "PM": "91; was see under PYRROLIDINONES 1975-90", "HN": "91(75); was see under PYRROLIDINONES 1975-90", "MR": "20170524", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010889"}, {"RECTYPE": "D", "MH": "Pirenzepine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Von Ct, Pirenzepin", "MN": "D03.633.100.079.080.070.750", "PA": "Muscarinic Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "6H-Pyrido(2,3-b)(1,4)benzodiazepin-6-one, 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)-", "RN": "3G0285N20N", "RR": "28797-61-7 (Pirenzepine)", "PI": "Benzodiazepinones (1974-1986)", "MS": "An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.", "PM": "87", "HN": "87", "MR": "20170524", "DA": "19860409", "DC": "1", "DX": "19870101", "UI": "D010890"}, {"RECTYPE": "D", "MH": "Piribedil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Piribendyl|T109|T121|NON|EQV|UNK (19XX)|771125|abbcdef", "ENTRY": "Piribedil Mono hydrochloride", "MN": "D03.383.606.790", "PA": "Dopamine Agonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pyrimidine, 2-(4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl)-", "RN": "DO22K1PRDJ", "RR": "78213-63-5 (mono-HCl)", "PI": "Pyrimidines (1971-1974)", "MS": "A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.", "PM": "91; was see under PIPERAZINES 1975-90", "HN": "91(75); was see under PIPERAZINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010891"}, {"RECTYPE": "D", "MH": "Pirinitramide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Piritramide|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|941121|abbcdeeef", "ENTRY": "Dipydolor|T109|T121|TRD|NRW|UNK (19XX)|850103|abbcdef", "MN": "D03.383.621.349.700", "PA": "Narcotics", "MH_TH": "NLM (1977)", "ST": "T121", "N1": "(1,4'-Bipiperidine)-4'-carboxamide, 1'-(3-cyano-3,3-diphenylpropyl)-", "RN": "4RP92LYZ2F", "RR": "302-41-0 (Pirinitramide)", "PI": "Piperidines (1971-1975)", "MS": "A diphenylpropylamine with intense narcotic analgesic activity of long duration. It is a derivative of MEPERIDINE with similar activity and usage.", "PM": "91; was see under ISONIPECOTIC ACIDS 1977-90", "HN": "91(77); was see under ISONIPECOTIC ACIDS 1977-90", "MR": "20170524", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D010892"}, {"RECTYPE": "D", "MH": "Piromidic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Piromidic", "MN": "D03.383.725.547.650", "PA": "Anti-Infective Agents, Urinary", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pyrido(2,3-d)pyrimidine-6-carboxylic acid, 8-ethyl-5,8-dihydro-5-oxo-2-(1-pyrrolidinyl)-", "RN": "3I12WH4EWF", "RR": "19562-30-2 (Piromidic Acid)", "PI": "Pyrrolidines (1966-1978)", "MS": "Antibacterial against mainly gram negative organisms. It is used for urinary tract and intestinal infections.", "PM": "91; was see under NICOTINIC ACIDS 1979-90", "HN": "91(79); was see under NICOTINIC ACIDS 1979-90", "MR": "20160531", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D010893"}, {"RECTYPE": "D", "MH": "Piroxicam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CP16171", "MN": "D03.383.855.500", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide", "RN": "13T4O6VMAM", "RR": "36322-90-4 (Piroxicam)", "PI": "Thiazines (1966-1986)", "MS": "A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.", "PM": "87", "HN": "87", "MR": "20160531", "DA": "19860602", "DC": "1", "DX": "19870101", "UI": "D010894"}, {"RECTYPE": "D", "MH": "Pit and Fissure Sealants", "DE": "PIT SEALANTS", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sealants, Tooth|T122|NON|NRW|UNK (19XX)|840501|abcdef", "ENTRY": "Tooth Sealants", "MN": "J01.637.051.339.773", "FX": "Dental Fissures", "MH_TH": "NLM (1972)", "ST": "T122", "RN": "0", "PI": "Dental Materials (1966-1971)", "MS": "Agents used to occlude dental enamel pits and fissures in the prevention of dental caries.", "PM": "80; was see under DENTAL MATERIALS 1975-79", "HN": "80(72); was see under DENTAL MATERIALS 1975-79", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D010895"}, {"RECTYPE": "D", "MH": "Pitcairn Island", "AQ": "EH EP", "MN": "Z01.639.760.815.700", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island in Polynesia, settled by the mutineers from the Bounty", "MS": "An island in Polynesia, in the south Pacific Ocean. It was discovered in 1767 by Philip Carteret, uninhabited until 1790 when settled by mutineers from the English ship, Bounty. The settlement was discovered in 1808; the population was removed temporarily to Tahiti in 1831 and to Norfolk Island (between New Caledonia and New Zealand) in 1856. Some later returned to Pitcairn and their descendents constitute the present population of this British colony. The island is named for the midshipman who first sighted it from the ship. (From Webster's New Geographical Dictionary, 1988, p958 & Room, Brewer's Dictionary of Names, 1992, p422)", "HN": "75", "MR": "20120703", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D010896"}, {"RECTYPE": "D", "MH": "Pitch Discrimination", "AQ": "CL DE ES PH RE", "ENTRY": "Pitch Discriminations", "MN": "G07.888.125.700.408", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "do not confuse with PITCH PERCEPTION", "MS": "The ability to differentiate sound frequency or pitch.", "CATSH": "CAT LIST", "MR": "20200221", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010897"}, {"RECTYPE": "D", "MH": "Pitch Perception", "AQ": "CL DE ES PH RE", "ENTRY": "Pitch Perceptions", "MN": "G07.888.125.700", "MH_TH": "NLM (1980)", "ST": "T041", "AN": "do not confuse with PITCH DISCRIMINATION", "PI": "Pitch Discrimination (1966-1979)", "MS": "A dimension of auditory sensation varying with cycles per second of the sound stimulus.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19781214", "DC": "1", "DX": "19800101", "UI": "D010898"}, {"RECTYPE": "D", "MH": "Pituitary Apoplexy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Apoplexy, Pituitary|T047|NON|EQV|UNK (19XX)|860418|abcdef", "MN": "C19.700.725", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Pituitary Neoplasms (1966-1986)", "MS": "The sudden loss of blood supply to the PITUITARY GLAND, leading to tissue NECROSIS and loss of function (PANHYPOPITUITARISM). The most common cause is hemorrhage or INFARCTION of a PITUITARY ADENOMA. It can also result from acute hemorrhage into SELLA TURCICA due to HEAD TRAUMA; INTRACRANIAL HYPERTENSION; or other acute effects of central nervous system hemorrhage. Clinical signs include severe HEADACHE; HYPOTENSION; bilateral visual disturbances; UNCONSCIOUSNESS; and COMA.", "PM": "1987", "HN": "1987", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D010899"}, {"RECTYPE": "D", "MH": "Pituitary Diseases", "DE": "PITUITARY DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neurohypophyseal Diseases|T047|NON|NRW|NLM (2000)|991103|NEUROHYPOPHYSEAL DIS|abcdefv", "ENTRY": "Posterior Pituitary Disease", "MN": "C19.700", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate IM with specific part of pituitary (IM) if pertinent", "MS": "Disorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010900"}, {"RECTYPE": "D", "MH": "Pituitary Function Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Pituitary Function", "MN": "E01.370.374.605", "MH_TH": "NLM (1968)", "ST": "T059", "AN": "test of pituitary function or hormonal secretion: do not confuse with PITUITARY-ADRENAL FUNCTION TESTS, test of pituitary function in relation to adrenal function or corticoid production", "MS": "Examinations that evaluate functions of the pituitary gland.", "OL": "use PITUITARY FUNCTION TESTS to search PITUITARY GLAND FUNCTION TESTS 1968-76", "PM": "77,66-67; was PITUITARY GLAND FUNCTION TESTS 1968-76", "HN": "77,66-67; was PITUITARY GLAND FUNCTION TESTS 1968-76", "CATSH": "CAT LIST", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010901"}, {"RECTYPE": "D", "MH": "Pituitary Gland", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Pituitary Stalk|T023|NON|REL|NLM (2000)|991103|abcdef", "ENTRY": "Stalks, Infundibular", "MN": "A08.713.357.750", "FX": "Hypophysectomy", "MH_TH": "NLM (1963)", "ST": "T023", "AN": "general or unspecified: prefer specific lobes; /rad eff: consider also PITUITARY IRRADIATION; /surg: probably HYPOPHYSECTOMY; consider also PITUITARY-ADRENAL SYSTEM & HYPOTHALAMO-HYPOPHYSEAL SYSTEM", "CX": "consider also terms at HYPOPHYS-", "MS": "A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010902"}, {"RECTYPE": "D", "MH": "Pituitary Gland, Anterior", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Adenohypophysis|T023|NON|EQV|UNK (19XX)|770210|abcdef", "ENTRY": "Pituitary Pars Distalis", "MN": "A08.713.357.750.500", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "diseases: coordinate IM with PITUITARY DISEASES (IM) or specifics (IM)", "PI": "Pituitary Gland (1966-1974)", "MS": "The anterior glandular lobe of the pituitary gland, also known as the adenohypophysis. It secretes the ADENOHYPOPHYSEAL HORMONES that regulate vital functions such as GROWTH; METABOLISM; and REPRODUCTION.", "OL": "search PITUITARY GLAND 1966-74", "PM": "78,63-67; was see under PITUITARY GLAND 1968-77", "HN": "78(75)63-67; was see under PITUITARY GLAND 1968-77", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D010903"}, {"RECTYPE": "D", "MH": "Pituitary Gland, Posterior", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Neurohypophysis|T023|NON|EQV|UNK (19XX)|770210|abcdef", "ENTRY": "Processes, Infundibular", "MN": "A08.713.357.750.875", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "diseases: coordinate IM with PITUITARY DISEASES (IM) or specifics (IM)", "MS": "Neural tissue of the pituitary gland, also known as the neurohypophysis. It consists of the distal AXONS of neurons that produce VASOPRESSIN and OXYTOCIN in the SUPRAOPTIC NUCLEUS and the PARAVENTRICULAR NUCLEUS. These axons travel down through the MEDIAN EMINENCE, the hypothalamic infundibulum of the PITUITARY STALK, to the posterior lobe of the pituitary gland.", "PM": "1963; for HYPOTHALAMUS, INFUNDIBULAR see HYPOTHALAMUS, MIDDLE 1983-1999; for INFUNDIBULAR STALK see PITUITARY GLAND 2000-2007", "HN": "1963; for HYPOTHALAMUS, INFUNDIBULAR use HYPOTHALAMUS, MIDDLE 1983-1999; for INFUNDIBULAR STALK use PITUITARY GLAND 2000-2007", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010904"}, {"RECTYPE": "D", "MH": "Pituitary Hormone Release Inhibiting Hormones", "DE": "PHRIH", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Pituitary Hormone-Release Inhibiting Hormones|T116|T125|NON|EQV|NLM (1990)|890905|PITUITARY HORMONE RELEASE INHIB HORMONES|abbcdefv", "MN": "D12.776.631.650.405.700", "FX": "Receptors, Pituitary Hormone-Regulating Hormone", "MH_TH": "NLM (1975)", "ST": "T125", "RN": "0", "PI": "Pituitary Hormone Releasing Hormones (1968-1974)", "MS": "Polypeptide hormones produced in the hypothalamus which inhibit the release of pituitary hormones. Used for PHRIH in general or for which there is no specific heading.", "PM": "75", "HN": "75", "MR": "20151124", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D010905"}, {"RECTYPE": "D", "MH": "Pituitary Hormone-Releasing Hormones", "DE": "PHRH", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Releasing Hormone, Hypothalamic", "MN": "D12.776.631.650.405.740", "FX": "Receptors, Pituitary Hormone-Regulating Hormone", "MH_TH": "NLM (1968)", "ST": "T125", "RN": "0", "AN": "general, prefer specifics", "PI": "Hypothalamo-Hypophyseal System/physiology (1966-1967)", "MS": "Peptides, natural or synthetic, that stimulate the release of PITUITARY HORMONES. They were first isolated from the extracts of the HYPOTHALAMUS; MEDIAN EMINENCE; PITUITARY STALK; and NEUROHYPOPHYSIS. In addition, some hypophysiotropic hormones control pituitary cell differentiation, cell proliferation, and hormone synthesis. Some can act on more than one pituitary hormone.", "OL": "use PITUITARY HORMONE-RELEASING HORMONES to search PITUITARY HORMONE RELEASING HORMONES 1974-90 & PITUITARY HORMONE RELEASING FACTORS 1968-73", "PM": "91; was PITUITARY HORMONE RELEASING HORMONES 1974-90; was PITUITARY HORMONE RELEASING FACTORS 1968-73", "HN": "91; was PITUITARY HORMONE RELEASING HORMONES 1974-90; was PITUITARY HORMONE RELEASING FACTORS 1968-73", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010906"}, {"RECTYPE": "D", "MH": "Pituitary Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Hormones, Pituitary", "MN": "D12.644.548.691", "FX": "Receptors, Pituitary Hormone", "MH_TH": "POPLINE (1978)", "ST": "T125", "RN": "0", "AN": "general or unspecified; prefer specifics; prefer specific groups or specific hormone; /defic: consider also HYPOPITUITARISM and its specifics", "MS": "Hormones secreted by the PITUITARY GLAND including those from the anterior lobe (adenohypophysis), the posterior lobe (neurohypophysis), and the ill-defined intermediate lobe. Structurally, they include small peptides, proteins, and glycoproteins. They are under the regulation of neural signals (NEUROTRANSMITTERS) or neuroendocrine signals (HYPOTHALAMIC HORMONES) from the hypothalamus as well as feedback from their targets such as ADRENAL CORTEX HORMONES; ANDROGENS; ESTROGENS.", "PM": "72", "HN": "72", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010907"}, {"RECTYPE": "D", "MH": "Pituitary Hormones, Anterior", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adenohypophyseal Hormones|T116|T125|NON|EQV|NLM (2003)|020123|abbcdef", "ENTRY": "Hormones, Anterior Pituitary", "MN": "D12.644.548.691.525", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Hormones secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Structurally, they include polypeptide, protein, and glycoprotein molecules.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010908"}, {"RECTYPE": "D", "MH": "Pituitary Hormones, Posterior", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pituitrin|T121|T123|TRD|NRW|NLM (1996)|950316|abbcdef", "ENTRY": "Posterior Pituitary Hormones", "MN": "D12.644.548.691.692", "FX": "Neurophysins", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Hormones released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). They include a number of peptides which are formed in the NEURONS in the HYPOTHALAMUS, bound to NEUROPHYSINS, and stored in the nerve terminals in the posterior pituitary. Upon stimulation, these peptides are released into the hypophysial portal vessel blood.", "PM": "PITUITRIN was heading 1975-95 (see under PITUITARY HORMONES, POSTERIOR 1975-90)", "HN": "PITUITRIN was heading 1975-95 (see under PITUITARY HORMONES, POSTERIOR 1975-90)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D010909"}, {"RECTYPE": "D", "MH": "Pituitary Irradiation", "DE": "PITUITARY IRRAD", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Pituitary Irradiations", "MN": "E02.815.190.600", "MH_TH": "NLM (1968)", "ST": "T061", "MS": "Radiation therapy used to treat the PITUITARY GLAND.", "OL": "use PITUITARY IRRADIATION to search PITUITARY GLAND IRRADIATION 1966-76", "PM": "77,63-67; was PITUITARY GLAND IRRADIATION 1968-76", "HN": "77,63-67; was PITUITARY GLAND IRRADIATION 1968-76", "CATSH": "CAT LIST", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010910"}, {"RECTYPE": "D", "MH": "Pituitary Neoplasms", "DE": "PITUITARY NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pituitary Cancer|T191|NON|NRW|NLM (2006)|040813|abcdef", "ENTRY": "Tumors, Pituitary", "MN": "C19.700.734", "FX": "Adenoma, Chromophobe", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM); pituitary adenoma: coordinate IM with ADENOMA (IM) in spite of entry term PITUITARY ADENOMA", "MS": "Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010911"}, {"RECTYPE": "D", "MH": "Pituitary-Adrenal Function Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Pituitary-Adrenal Function", "MN": "E01.370.374.600", "MH_TH": "NLM (1968)", "ST": "T059", "AN": "pituitary function in relation to adrenal function or corticoid production: differentiate from PITUITARY FUNCTION TESTS, test of pituitary function or hormonal secretion", "PI": "Pituitary Function Tests (1966-1967)", "MS": "Tests that evaluate the adrenal glands controlled by pituitary hormones.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010912"}, {"RECTYPE": "D", "MH": "Pituitary-Adrenal System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Systems, Pituitary-Adrenal", "MN": "A06.300.691", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "hypothalamo-pituitary-adrenal axis: coord HYPOTHALAMO-HYPOPHYSEAL SYSTEM + PITUITARY-ADRENAL SYSTEM", "MS": "The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary.", "PM": "68", "HN": "68(66); was in Cat G only 1966-74", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010913"}, {"RECTYPE": "D", "MH": "Pityriasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pityriases", "MN": "C17.800.859.600", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a papulosquamous skin dis", "MS": "A name originally applied to a group of skin diseases characterized by the formation of fine, branny scales, but now used only with a modifier. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010915"}, {"RECTYPE": "D", "MH": "Pityriasis Rubra Pilaris", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.859.600.685", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Dermatitis, Exfoliative (1966)", "MS": "A chronic skin disease characterized by small follicular papules, disseminated reddish-brown scaly patches, and often, palmoplantar hyperkeratosis. The papules are about the size of a pin and topped by a horny plug.", "OL": "use DERMATITIS EXFOLIATIVA to search PITYRIASIS RUBRA 1966", "PM": "67; was PITYRIASIS RUBRA see under DERMATITIS EXFOLIATIVA 1963-66", "HN": "67; was PITYRIASIS RUBRA see under DERMATITIS EXFOLIATIVA 1963-66", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D010916"}, {"RECTYPE": "D", "MH": "Pivampicillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ampicillin Pivaloyl Ester|T109|T195|NON|EQV|UNK (19XX)|840213|abbcdef", "ENTRY": "Monohydrochloride, Pivampicillin", "MN": "D03.633.100.300.750.750.050.700", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (2S-(2alpha,5alpha,6beta(S*)))-", "RN": "0HLM346LL7", "RR": "V9HOC53L7L", "PI": "Valerates (1973-1974)", "MS": "Pivalate ester analog of AMPICILLIN.", "PM": "91; was see under AMPICILLIN 1975-90", "HN": "91(75); was see under AMPICILLIN 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010917"}, {"RECTYPE": "D", "MH": "Pizotyline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pizotifen|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|741111|abbcdeeef", "ENTRY": "BC105", "MN": "D03.383.903.580", "PA": "Serotonin Antagonists", "MH_TH": "USAN (1970)", "ST": "T121", "N1": "Piperidine, 4-(9,10-dihydro-4H-benzo(4,5)cyclohepta(1,2-b)thien-4-ylidene)-1-methyl-", "RN": "0BY8440V3N", "RR": "15574-96-6 (Pizotyline)", "PI": "Thiophenes (1970-1974)", "MS": "Serotonin antagonist used against MIGRAINE DISORDERS and vascular headaches.", "PM": "91; was see under THIOPHENES 1975-90", "HN": "91(75); was see under THIOPHENES 1975-90", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010918"}, {"RECTYPE": "D", "MH": "Placebos", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Sham Treatment|T061|T074|NON|EQV|NLM (2002)|000816|abbcdef", "MN": "E02.785", "MH_TH": "BIOETHICS (1989)", "ST": "T074", "RN": "0", "AN": "usually NIM; do not index routinely for articles on CLINICAL TRIALS AS TOPIC; DOUBLE-BLIND METHOD; etc., unless particularly discussed; Manual 18.12.13", "MS": "Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol.", "MR": "20090713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010919"}, {"RECTYPE": "D", "MH": "Placenta", "AQ": "AB AH BS CH CY DE DG EM EN IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Placentome|T018|NON|EQV|UNK (19XX)|860618|abcdef", "ENTRY": "Placentomes", "MN": "A16.710", "FX": "Placental Circulation", "EC": "growth & development:Placentation", "MH_TH": "NLM (1966)", "ST": "T018", "MS": "A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES).", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010920"}, {"RECTYPE": "D", "MH": "Placenta Accreta", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Placenta Accreta Spectrum|T047|NON|BRD|NLM (2024)|230419|abcdef", "ENTRY": "Placenta, Morbidly Adherent", "MN": "C12.050.703.590.609", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY", "MS": "Abnormal placentation in which all or parts of the PLACENTA are attached directly to the MYOMETRIUM due to a complete or partial absence of DECIDUA. It is associated with POSTPARTUM HEMORRHAGE because of the failure of placental separation.", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010921"}, {"RECTYPE": "D", "MH": "Placenta Diseases", "DE": "PLACENTA DIS", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Placental Disease", "MN": "C12.050.703.590", "MH_TH": "NLM (1969)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY; FETAL MALNUTRITION is available", "PI": "Pregnancy Complications (1966-1968)", "MS": "Pathological processes or abnormal functions of the PLACENTA.", "OL": "use PLACENTA DISEASES to search PLACENTA DISORDERS 1969-79 (as Prov 1969-72)", "PM": "80; was PLACENTA DISORDERS 1973-79", "HN": "80; was PLACENTA DISORDERS 1969-79 (Prov 1969-72)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010922"}, {"RECTYPE": "D", "MH": "Placenta Previa", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Placenta Praevia|T047|NON|EQV|NLM (1963)|990101|abcdef", "MN": "C12.050.703.590.734", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY", "MS": "Abnormal placentation in which the PLACENTA implants in the lower segment of the UTERUS (the zone of dilation) and may cover part or all of the opening of the CERVIX. It is often associated with serious antepartum bleeding and PREMATURE LABOR.", "PM": "2006; see PLACENTA PRAEVIA 1963-2005", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D010923"}, {"RECTYPE": "D", "MH": "Placental Extracts", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Placental Extract|T123|NON|EQV|NLM (2021)|200617|abcdef", "ENTRY": "Extracts, Placental", "MN": "D20.777.608", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Extracts prepared from placental tissue; they may contain specific but uncharacterized factors or proteins with specific activities.", "MR": "20200618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010924"}, {"RECTYPE": "D", "MH": "Placental Function Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Fetoplacental Function Tests|T060|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Tests, Placental Function", "MN": "E01.370.378.610", "MH_TH": "NLM (1975)", "ST": "T060", "AN": "NIM", "PI": "Placenta Diseases (1969-1974)", "MS": "Methods used for the assessment of placental function.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D010925"}, {"RECTYPE": "D", "MH": "Placental Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Hormones, Placental", "MN": "D12.644.548.726", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "0", "MS": "Hormones produced by the placenta include CHORIONIC GONADOTROPIN, and PLACENTAL LACTOGEN as well as steroids (ESTROGENS; PROGESTERONE), and neuropeptide hormones similar to those found in the hypothalamus (HYPOTHALAMIC HORMONES).", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010926"}, {"RECTYPE": "D", "MH": "Placental Insufficiency", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Insufficiency, Placental", "MN": "C12.050.703.590.800", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY", "MS": "Failure of the PLACENTA to deliver an adequate supply of nutrients and OXYGEN to the FETUS.", "PM": "91; was see under PLACENTA DISEASES 1980-90; was see under PLACENTA DISORDERS 1975-79", "HN": "91(75); was see under PLACENTA DISEASES 1980-90; was see under PLACENTA DISORDERS 1975-79", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D010927"}, {"RECTYPE": "D", "MH": "Placental Lactogen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Somatomammotropin, Chorionic|T116|T125|NON|EQV|UNK (19XX)|750101|abbcdef", "ENTRY": "Pregnancy Associated Plasma Protein D", "MN": "D12.776.780.650", "FX": "Receptors, Somatotropin", "MH_TH": "NLM (1968)", "ST": "T125", "N1": "Lactogen, placental", "RN": "9035-54-5", "PI": "Placental Hormones (1966-1967)", "MS": "A polypeptide hormone of approximately 25 kDa that is produced by the SYNCYTIOTROPHOBLASTS of the PLACENTA, also known as chorionic somatomammotropin. It has both GROWTH HORMONE and PROLACTIN activities on growth, lactation, and luteal steroid production. In women, placental lactogen secretion begins soon after implantation and increases to 1 g or more a day in late pregnancy. Placental lactogen is also an insulin antagonist.", "PM": "72", "HN": "72(68)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010928"}, {"RECTYPE": "D", "MH": "Placentation", "AQ": "DE GE IM PH RE", "ENTRY": "Placentation, Hemochorial", "MN": "G08.686.784.769.491", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "check the tags FEMALE & PREGNANCY", "PI": "Placenta (1966-1974)", "MS": "The development of the PLACENTA, a highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products between mother and FETUS. The process begins at FERTILIZATION, through the development of CYTOTROPHOBLASTS and SYNCYTIOTROPHOBLASTS, the formation of CHORIONIC VILLI, to the progressive increase in BLOOD VESSELS to support the growing fetus.", "OL": "76; was see under PLACENTA 1975", "HN": "76(75); was see under PLACENTA 1975", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19760101", "UI": "D010929"}, {"RECTYPE": "D", "MH": "Plague", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pulmonic Plague|T047|NON|NRW|NLM (1998)|970106|abcdef", "ENTRY": "Yersinia pestis Infection|T047|NON|EQV|NLM (2018)|161007|abcdef", "MN": "C01.920.906", "MH_TH": "POPLINE (1981)", "ST": "T047", "MS": "An acute infectious disease caused by YERSINIA PESTIS that affects humans, wild rodents, and their ectoparasites. This condition persists due to its firm entrenchment in sylvatic rodent-flea ecosystems throughout the world. Bubonic plague is the most common form.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010930"}, {"RECTYPE": "D", "MH": "Plague Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccine, Plague", "MN": "D20.215.894.135.609", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "MS": "A suspension of killed Yersinia pestis used for immunizing people in enzootic plague areas.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010931"}, {"RECTYPE": "D", "MH": "Planarians", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Dugesia|T204|NON|NRW|UNK (19XX)|810515|abcdef", "ENTRY": "Planarian", "MN": "B01.050.500.500.736.847.610", "MH_TH": "NLM (1975)", "ST": "T204", "RR": "txid6160", "AN": "non-parasitic flatworms used in regeneration experiments", "MS": "Nonparasitic free-living flatworms of the class Turbellaria. The most common genera are Dugesia, formerly Planaria, which lives in water, and Bipalium, which lives on land. Geoplana occurs in South America and California.", "OL": "search TURBELLARIA 1966-74", "PM": "91; was see under TURBELLARIA 1975-90", "HN": "91(75); was see under TURBELLARIA 1975-90", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D010932"}, {"RECTYPE": "D", "MH": "Plankton", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B05.080.500", "FX": "Eutrophication", "MH_TH": "NLM (1966)", "ST": "T204", "AN": "coordinate with specific organism; PHYTOPLANKTON and ZOOPLANKTON are also available; non-phototrophic bacterioplankton: index PLANKTON + BACTERIA or specific; phototrophic bacterioplankton: index PHYTOPLANKTON + BACTERIA or specific", "MS": "Community of tiny aquatic PLANTS and ANIMALS, and photosynthetic BACTERIA, that are either free-floating or suspended in the water, with little or no power of locomotion. They are divided into PHYTOPLANKTON and ZOOPLANKTON.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010933"}, {"RECTYPE": "D", "MH": "Planning Techniques", "PRINT ENTRY": "Planning Theories|T170|NON|REL|UNK (19XX)|790601|abcdef", "ENTRY": "Theory, Planning", "MN": "N04.452.718", "FX": "Social Planning", "MH_TH": "NLM (1980)", "ST": "T170", "AN": "usually NIM", "MS": "Procedures, strategies, and theories of planning.", "OL": "use PLANNING TECHNIQUES to search PLANNING TECHNICS 1980-90", "PM": "91; was PLANNING TECHNICS 1980-90", "HN": "91; was PLANNING TECHNICS 1980-90", "MR": "20230531", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D010934"}, {"RECTYPE": "D", "MH": "Plant Diseases", "DE": "PLANT DIS", "AQ": "CI CL EC ET GE HI IM LJ MI PC PS SN TH VI", "ENTRY": "Plant Disease", "MN": "G15.610", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "coordinate with specific causative organism if pertinent but not with infection term ", "PI": "Plants (1966-1967)", "MS": "Diseases of plants.", "PM": "68", "HN": "68", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010935"}, {"RECTYPE": "D", "MH": "Plant Extracts", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Plant Extract|T123|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Medicines, Herbal", "MN": "D26.667", "FX": "Phytotherapy", "MH_TH": "NLM (1967)", "ST": "T123", "RN": "0", "PI": "Plants (1966)", "MS": "Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard.", "PM": "76; was see under PLANTS 1975", "HN": "76(67); was see under PLANTS 1975", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D010936"}, {"RECTYPE": "D", "MH": "Plant Growth Regulators", "DE": "PLANT GROWTH REG", "AQ": "AG AI AN BI CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO", "PRINT ENTRY": "Plant Hormones|T123|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Regulator, Plant Growth", "MN": "D27.505.696.377.760", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010937"}, {"RECTYPE": "D", "MH": "Plant Oils", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Vegetable Oils|T168|NON|NRW|UNK (19XX)|860603|abcdef", "ENTRY": "Oil, Vegetable", "MN": "D20.215.784.750", "MH_TH": "NLM (1987)", "ST": "T123", "RN": "0", "AN": "coordinate with specific plant source of oil; \"yusho poisoning\": see note on RICE", "PI": "Oils (1966-1986)", "MS": "Oils derived from plants or plant products.", "PM": "87; SESAME OIL was heading 1963-86", "HN": "87", "MR": "20200527", "DA": "19860603", "DC": "1", "DX": "19870101", "UI": "D010938"}, {"RECTYPE": "D", "MH": "Plant Poisoning", "DE": "PLANT POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Poisonings, Plant", "MN": "C25.723.756", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "human & animal; coord IM with specific plant (IM) + specific dis /etiol (IM); do not coord with food plants in Cat J: index under specific Cat J2 food plant /pois (IM), as FRUIT /pois or GARLIC /pois but not also here; Jamaican vomiting sickness: index PLANT POISONING + HYPOGLYCINS /pois", "MS": "Poisoning by the ingestion of plants or its leaves, berries, roots or stalks. The manifestations in both humans and animals vary in severity from mild to life threatening. In animals, especially domestic animals, it is usually the result of ingesting moldy or fermented forage.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010939"}, {"RECTYPE": "D", "MH": "Plant Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Plant Protein|T116|NON|EQV|NLM (2021)|191227|abcdef", "ENTRY": "Proteins, Plant", "MN": "D12.776.765", "FX": "Plants", "MH_TH": "NLM (1966)", "ST": "T116", "RN": "0", "AN": "PLANT PROTEINS, DIETARY is also available", "MS": "Proteins found in plants (flowers, herbs, shrubs, trees, etc.). The concept does not include proteins found in vegetables for which PLANT PROTEINS, DIETARY is available.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010940"}, {"RECTYPE": "D", "MH": "Plant Tumors", "AQ": "CI CL EC ET GE MI PS SN VI", "PRINT ENTRY": "Plant Galls|T191|NON|EQV|NLM (1995)|940520|abcdef", "ENTRY": "Tumors, Plant", "MN": "G15.610.700", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "A localized proliferation of plant tissue forming a swelling or outgrowth, commonly with a characteristic shape and unlike any organ of the normal plant. Plant tumors or galls usually form in response to the action of a pathogen or a pest. (Holliday, P., A Dictionary of Plant Pathology, 1989, p330)", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010941"}, {"RECTYPE": "D", "MH": "Plant Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Phytophagineae|T005|NON|EQV|UNK (19XX)|780310|abcdef", "ENTRY": "Viruses, Plant", "MN": "B04.715", "MH_TH": "NLM (1966)", "ST": "T005", "AN": "general or unspecified; prefer specifics; coordinate with specific plant /virol", "MS": "Viruses parasitic on plants.", "OL": "use PLANT VIRUSES to search PHYTOPHAGINEAE 1966-78", "PM": "PHYTOPHAGINEAE was see under PLANT VIRUSES 1963-78", "HN": "PHYTOPHAGINEAE was see under PLANT VIRUSES 1963-78", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D010942"}, {"RECTYPE": "D", "MH": "Plantago", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Plantain|T002|NON|EQV|UNK (19XX)|770329|abcdef", "ENTRY": "Plantains, Narrow-Leaved", "MN": "B01.875.800.575.912.250.583.700.700", "FX": "Psyllium", "MH_TH": "NLM (1978)", "ST": "T002", "RN": "txid26867", "RR": "txid39414", "AN": "note entry term  PLANTAIN: for the banana-like fruit or green plantain flour use MUSA", "PI": "Psyllium (1966-1977)", "MS": "A plant genus of the family Plantaginaceae. The small plants usually have a dense tuft of basal leaves and long, leafless stalks bearing a terminal spike of small flowers. The seeds, known as PSYLLIUM, swell in water and are used as laxatives. The leaves have been used medicinally.", "OL": "search PSYLLIUM 1966-77 (as Cat B & D heading)", "PM": "91; was see under PLANTS, MEDICINAL 1978-90; was see PSYLLIUM 1963-77 (Cat B & D heading)", "HN": "91(78); was see under PLANTS, MEDICINAL 1978-90; was see PSYLLIUM 1963-77 (Cat B & D heading)", "MR": "20210630", "DA": "19770329", "DC": "1", "DX": "19910101", "UI": "D010943"}, {"RECTYPE": "D", "MH": "Plants", "AQ": "AE AH CH CL DE EM EN GE IM ME MI PO PS RE TO UL VI", "ENTRY": "Plant", "MN": "B01.650", "FX": "Seeds", "EC": "physiology:Plant Physiological Phenomena", "MH_TH": "NLM (1966)", "ST": "T002", "MS": "Multicellular, eukaryotic life forms of kingdom Plantae. Plants acquired chloroplasts by direct endosymbiosis of CYANOBACTERIA. They are characterized by a mainly photosynthetic mode of nutrition; essentially unlimited growth at localized regions of cell divisions (MERISTEMS); cellulose within cells providing rigidity; the absence of organs of locomotion; absence of nervous and sensory systems; and an alternation of haploid and diploid generations. It is a non-taxonomical term most often referring to LAND PLANTS. In broad sense it includes RHODOPHYTA and GLAUCOPHYTA along with VIRIDIPLANTAE.", "OL": "use PLANTS to search PYRETHRUM 1966-85", "PM": "PYRETHRUM was heading 1963-85", "HN": "PYRETHRUM was heading 1963-85", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010944"}, {"RECTYPE": "D", "MH": "Plants, Edible", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Food Plants|T002|T168|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Plants, Food", "MN": "B01.650.510", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "note FRUIT and VEGETABLES are available", "MS": "An organism of the vegetable kingdom suitable by nature for use as a food, especially by human beings. Not all parts of any given plant are edible but all parts of edible plants have been known to figure as raw or cooked food: leaves, roots, tubers, stems, seeds, buds, fruits, and flowers. The most commonly edible parts of plants are FRUIT, usually sweet, fleshy, and succulent. Most edible plants are commonly cultivated for their nutritional value and are referred to as VEGETABLES.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010945"}, {"RECTYPE": "D", "MH": "Plants, Medicinal", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Medicinal Herbs|T002|NON|NRW|NLM (1993)|911002|abcdef", "ENTRY": "Plants, Pharmaceutical", "MN": "B01.650.560", "FX": "Plant Extracts", "MH_TH": "POPLINE (1978)", "ST": "T002", "AN": "IM general only; specify geographic term if pertinent", "MS": "Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals.", "OL": "use PLANTS, MEDICINAL to search AESCULUS, ASPIDIUM, CASTANEA, CHELIDONIUM, CHENOPODIUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX & TAMARIND 1966-85", "PM": "AESCULUS, ARECA, CASTANEA, CHELIDONIUM, CHENOPODIUM, COCA, COLCHICUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, ERYTHRINA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, PAPAVER, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX, TAMARIND & VALERIAN were headings 1963-85; ADONIS, ASPIDIUM & OLEANDER were see under PLANTS, MEDICINAL 1978-85 and headings 1963-77; AMMI was see under PLANTS, MEDICINAL 1977-85; ALOE & RHUBARB were headings 1963-77; PLANTAGO was see PSYLLIUM 1963-77", "HN": "AESCULUS, CASTANEA, CHELIDONIUM, CHENOPODIUM, COLCHICUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX & TAMARIND were headings 1963-85; ADONIS, ASPIDIUM & OLEANDER were see under PLANTS, MEDICINAL 1978-85 and headings 1963-77; AMMI was see under PLANTS, MEDICINAL 1977-85", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010946"}, {"RECTYPE": "D", "MH": "Plants, Toxic", "DE": "PLANTS TOX", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Toxic Plants", "MN": "B01.650.660", "PA": "Poisons", "FX": "Plant Poisoning", "MH_TH": "NLM (1976)", "ST": "T002", "AN": "IM general only", "PI": "Plants (1966-1975)", "MS": "Plants or plant parts which are harmful to man or other animals.", "PM": "1976", "HN": "1976; was NON MESH before 1976;", "MR": "20210630", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D010947"}, {"RECTYPE": "D", "MH": "Viral Plaque Assay", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Viral Plaque Assays", "MN": "E05.200.875.970.790", "MH_TH": "NLM (2012)", "ST": "T059", "AN": "for viruses; coord IM or NIM with specific virus /growth (IM); do not confuse with HEMOLYTIC PLAQUE TECHNIQUE in immunol", "PI": "Virus Cultivation (1966-1972)", "MS": "Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE.", "PM": "2012; see PLAQUE ASSAY 1973-2011", "HN": "2012 (1973)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010948"}, {"RECTYPE": "D", "MH": "Plasma", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Fresh Frozen Plasma|T031|NON|NRW|UNK (19XX)|850226|abcdef", "ENTRY": "Plasmas, Fresh Frozen", "MN": "A15.145.693", "FX": "Serum", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010949"}, {"RECTYPE": "D", "MH": "Plasma Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Plasmacytes|T025|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Plasmacyte", "MN": "A15.382.490.555.567.562.725", "MH_TH": "NLM (1966)", "ST": "T025", "AN": "not for BLOOD CELLS: they are antibody-producing cells", "MS": "Specialized forms of antibody-producing B-LYMPHOCYTES. They synthesize and secrete immunoglobulin. They are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. (Rosen et al., Dictionary of Immunology, 1989, p169 & Abbas et al., Cellular and Molecular Immunology, 2d ed, p20)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010950"}, {"RECTYPE": "D", "MH": "Plasma Exchange", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Plasma Exchanges", "MN": "E04.292.869.500", "MH_TH": "NLM (1981)", "ST": "T061", "AN": "/adv eff: coordinate with TRANSFUSION REACTION if pertinent", "PI": "Plasmapheresis (1968-1980)", "MS": "Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19800512", "DC": "1", "DX": "19810101", "UI": "D010951"}, {"RECTYPE": "D", "MH": "Plasma Substitutes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Plasma Volume Expanders|T121|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Volume Expanders, Plasma", "MN": "D27.505.954.502.140.500", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "BLOOD SUBSTITUTES is also available", "MS": "Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration.", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010952"}, {"RECTYPE": "D", "MH": "Plasma Volume", "AQ": "DE ES GE IM PH RE VE", "PRINT ENTRY": "Blood Plasma Volume|T034|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Volumes, Plasma", "MN": "G09.330.380.092.610", "FX": "Fluid Shifts", "MH_TH": "NLM (1966)", "ST": "T034", "AN": "coordinate IM with disease /physiopathol, not /blood", "MS": "Volume of PLASMA in the circulation. It is usually measured by INDICATOR DILUTION TECHNIQUES.", "PM": "70", "HN": "70(66)", "CATSH": "CAT LIST", "MR": "20150625", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D010953"}, {"RECTYPE": "D", "MH": "Plasmacytoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Plasma Cell Tumor|T191|NON|EQV|NLM (1998)|960815|abcdef", "ENTRY": "Tumors, Plasma Cell", "MN": "C20.683.515.880", "MH_TH": "ORD (2010)", "ST": "T191", "MS": "Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites.", "PM": "65; was PLASMOCYTOMA 1963-64", "HN": "65; was PLASMOCYTOMA 1963-64", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010954"}, {"RECTYPE": "D", "MH": "Plasmalogens", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Plasmalogen|T109|NON|EQV|NLM (2021)|200129|abcdef", "ENTRY": "Phospholipids, Alkenyl Ether", "MN": "D10.570.755.375.760.400.985.820", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse X ref here with specific phosphatidyl compounds in MeSH", "MS": "GLYCEROPHOSPHOLIPIDS in which one of the two acyl chains is attached to glycerol with an ether alkenyl linkage instead of an ester as with the other glycerophospholipids.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010955"}, {"RECTYPE": "D", "MH": "Plasmapheresis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Therapeutic Plasmapheresis|T061|NON|EQV|NLM (2020)|181106|abcdef", "ENTRY": "Therapeutic Plasmaphereses", "MN": "E04.292.869", "FX": "Blood Donation", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use.", "PM": "68", "HN": "68(65)", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010956"}, {"RECTYPE": "D", "MH": "Plasmids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Episomes|T114|T123|NON|REL|UNK (19XX)|770330|abbcdef", "ENTRY": "Plasmid|T114|T123|NON|EQV|NLM (2004)|030127|abbcdef", "MN": "G05.360.600", "FX": "Genetic Vectors", "MH_TH": "NLM (1975)", "ST": "T123", "AN": "general or unspecified; prefer specifics", "PI": "Genetics (1966-1967)", "MS": "Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.", "OL": "use PLASMIDS to search EPISOMES 1975-77", "PM": "78; was see under EXTRACHROMOSOMAL INHERITANCE 1975-77; EPISOMES was see under EXTRACHROMOSOMAL INHERITANCE 1975-77", "HN": "78(75); was see under EXTRACHROMOSOMAL INHERITANCE 1975-77; EPISOMES was see under EXTRACHROMOSOMAL INHERITANCE 1975-77", "MR": "20080708", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D010957"}, {"RECTYPE": "D", "MH": "Plasminogen", "AQ": "AD AE AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Profibrinolysin|T116|T121|T123|NON|EQV|UNK (19XX)|740330|abbbcdef", "ENTRY": "Plasminogen, Glutamyl", "MN": "D12.776.811.243.610", "PA": "Fibrinolytic Agents", "MH_TH": "BAN (19XX)", "ST": "T123", "N1": "Plasminogen", "RN": "9001-91-6", "AN": "an enzyme precursor & fibrinolytic agent; /antag: do not confuse with PLASMINOGEN INACTIVATORS which modulate PLASMINOGEN ACTIVATORS, not PLASMINOGEN", "MS": "Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent.", "PM": "65", "HN": "65(63)", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010958"}, {"RECTYPE": "D", "MH": "Tissue Plasminogen Activator", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tissue-Type Plasminogen Activator|T116|T121|T126|NON|EQV|UNK (19XX)|850612|abbbcdef", "ENTRY": "Tissue Type Plasminogen Activator", "MN": "D23.119.970", "PA": "Fibrinolytic Agents", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 3.4.21.68", "RR": "105857-23-6 (Alteplase)", "PI": "Plasminogen Activators (1976-1985)", "MS": "A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases.", "PM": "98; see ALTEPLASE 1992-97; see PLASMINOGEN ACTIVATOR, TISSUE-TYPE 1986-91", "HN": "98(86)", "MR": "20160701", "DA": "19850612", "DC": "1", "DX": "19860101", "UI": "D010959"}, {"RECTYPE": "D", "MH": "Plasminogen Activators", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Uterine Tissue Plasminogen Activator", "MN": "D12.776.124.125.662", "MH_TH": "NLM (1976)", "ST": "T126", "RN": "EC 3.4.21.-", "AN": "/antag: consider also PLASMINOGEN INACTIVATORS", "PI": "Plasminogen (1974-1975)", "MS": "A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation.", "PM": "76", "HN": "76", "MR": "20090706", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D010960"}, {"RECTYPE": "D", "MH": "Plasmodium", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Plasmodiums", "MN": "B01.043.075.380.611", "FX": "Antimalarials", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5820", "MS": "A genus of protozoa that comprise the malaria parasites of mammals. Four species infect humans (although occasional infections with primate malarias may occur). These are PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE, and PLASMODIUM VIVAX. Species causing infection in vertebrates other than man include: PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; P. vinckei, and PLASMODIUM YOELII in rodents; P. brasilianum, PLASMODIUM CYNOMOLGI; and PLASMODIUM KNOWLESI in monkeys; and PLASMODIUM GALLINACEUM in chickens.", "OL": "use PLASMODIUM to search HAEMAMOEBA 1976-91", "PM": "HAEMAMOEBA was see PLASMODIUM 1976-91", "HN": "HAEMAMOEBA was see PLASMODIUM 1976-91", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010961"}, {"RECTYPE": "D", "MH": "Plasmodium berghei", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "berghei, Plasmodium", "MN": "B01.043.075.380.611.461", "MH_TH": "NLM (1973)", "ST": "T204", "RN": "txid5821", "AN": "infection: coordinate IM with MALARIA (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Plasmodium (1966-1972)", "MS": "A protozoan parasite of rodents transmitted by the mosquito Anopheles dureni.", "PM": "73", "HN": "73", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010962"}, {"RECTYPE": "D", "MH": "Plasmodium falciparum", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "falciparums, Plasmodium", "MN": "B01.043.075.380.611.561", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5833", "MS": "A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010963"}, {"RECTYPE": "D", "MH": "Plasmodium gallinaceum", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "gallinaceums, Plasmodium", "MN": "B01.043.075.380.611.576", "MH_TH": "NLM (1986)", "ST": "T204", "RN": "txid5849", "PI": "Plasmodium (1966-1985)", "MS": "A protozoan parasite that causes avian malaria (MALARIA, AVIAN), primarily in chickens, and is transmitted by the Aedes mosquito.", "PM": "91; was see under PLASMODIUM 1986-90", "HN": "91(86); was see under PLASMODIUM 1986-90", "MR": "20200813", "DA": "19850311", "DC": "1", "DX": "19910101", "UI": "D010964"}, {"RECTYPE": "D", "MH": "Plasmodium malariae", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.043.075.380.611.661", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5858", "AN": "infection: coordinate IM with MALARIA (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A protozoan parasite that occurs primarily in subtropical and temperate areas. It is the causal agent of quartan malaria. As the parasite grows it exhibits little ameboid activity.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010965"}, {"RECTYPE": "D", "MH": "Plasmodium vivax", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "vivax, Plasmodium", "MN": "B01.043.075.380.611.761", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5855", "MS": "A protozoan parasite that causes vivax malaria (MALARIA, VIVAX). This species is found almost everywhere malaria is endemic and is the only one that has a range extending into the temperate regions.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010966"}, {"RECTYPE": "D", "MH": "Plasmodium yoelii", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "yoelius, Plasmodium", "MN": "B01.043.075.380.611.780", "MH_TH": "NLM (1988)", "ST": "T204", "RN": "txid5861", "AN": "infection: coordinate IM with MALARIA (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Plasmodium (1966-1987)", "MS": "A species of PLASMODIUM causing malaria in rodents.", "PM": "88", "HN": "88", "MR": "20200813", "DA": "19870310", "DC": "1", "DX": "19880101", "UI": "D010967"}, {"RECTYPE": "D", "MH": "Plasticizers", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Plasticizer|T122|NON|EQV|NLM (2021)|191129|abcdef", "MN": "D27.720.760", "MH_TH": "NLM (1977)", "ST": "T122", "RN": "0", "PI": "Phthalic Acids (1970-1976)", "MS": "Materials incorporated mechanically in plastics (usually PVC) to increase flexibility, workability or distensibility; due to the non-chemical inclusion, plasticizers leach out from the plastic and are found in body fluids and the general environment.", "PM": "77", "HN": "77", "MR": "20200527", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D010968"}, {"RECTYPE": "D", "MH": "Plastics", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Plastic", "MN": "J01.637.051.720.716", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "MS": "Polymeric materials (usually organic) of large molecular weight which can be shaped by flow. Plastic usually refers to the final product with fillers, plasticizers, pigments, and stabilizers included (versus the resin, the homogeneous polymeric starting material). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "HN": "was in Cat D & J 1967-82, was in Cat J only 1963-66", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D010969"}, {"RECTYPE": "D", "MH": "Plastocyanin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Plastocyanin, Silver", "MN": "D12.776.765.680", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Plastocyanins", "RN": "9014-09-9", "AN": "a plant protein", "PI": "Plant Proteins (1970-1974)", "MS": "A copper-containing plant protein that is a fundamental link in the electron transport chain of green plants during the photosynthetic conversion of light energy by photophosphorylation into the potential energy of chemical bonds.", "PM": "91; was see under PLANT PROTEINS 1975-90", "HN": "91(75); was see under PLANT PROTEINS 1975-90", "MR": "19920519", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010970"}, {"RECTYPE": "D", "MH": "Plastoquinone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Plastoquinone 9", "MN": "D02.806.250.700", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "2,5-Cyclohexadiene-1,4-dione, 2,3-dimethyl-5-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-, (all-E)-", "RN": "OAC30J69CN", "RR": "4299-57-4 (Plastoquinone)", "PI": "Quinones (1972-1974)", "MS": "Polyunsaturated side-chain quinone derivative which is an important link in the electron transport chain of green plants during the photosynthetic conversion of light energy by photophosphorylation into the potential energy of chemical bonds.", "PM": "91; was see under QUINONES 1975-90", "HN": "91(75); was see under QUINONES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010971"}, {"RECTYPE": "D", "MH": "Platelet Activating Factor", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphorylcholine, Acetyl Glyceryl Ether|T109|T129|NON|EQV|NLM (1992)|901001|abbcdef", "ENTRY": "Platelet Activating Substance", "MN": "D23.469.050.600", "MH_TH": "NLM (1983)", "ST": "T129", "RN": "0", "PI": "Lysophosphatidylcholines (1966-1980)", "MS": "A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION.", "PM": "1983; PLATELET AGGREGATING FACTOR was indexed under PLATLET ACTIVATING FACTOR 2002-2005 & BLOOD COAGULATION FACTORS 1979-2001", "HN": "1983(1979)", "MR": "20050630", "DA": "19820511", "DC": "1", "DX": "19830101", "UI": "D010972"}, {"RECTYPE": "D", "MH": "Platelet Adhesiveness", "AQ": "DE ES GE IM PH RE", "ENTRY": "Platelet Adhesivenesses", "MN": "G09.188.670", "FX": "Platelet Membrane Glycoproteins", "MH_TH": "NLM (1969)", "ST": "T043", "PI": "Blood Platelets (1966-1968)", "MS": "The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other \"foreign\" surfaces.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D010973"}, {"RECTYPE": "D", "MH": "Platelet Aggregation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Aggregation, Platelet", "MN": "G09.188.390.600.640", "FX": "Platelet Membrane Glycoproteins", "MH_TH": "POPLINE (1978)", "ST": "T043", "PI": "Platelet Adhesiveness (1969-1974)", "MS": "The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS.", "OL": "search PLATELET ADHESIVENESS 1974", "PM": "76; was see under PLATELET ADHESIVENESS 1974-75", "HN": "76(75); was see under PLATELET ADHESIVENESS 1974-75", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D010974"}, {"RECTYPE": "D", "MH": "Platelet Aggregation Inhibitors", "DE": "PLATELET AGGREGATION INHIB", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Protease-Activated Receptor-1 Antagonists|T121|NON|NRW|NLM (2024)|230405|abcdef", "ENTRY": "Protease Activated Receptor 1 Antagonists", "MN": "D27.505.954.502.780", "FX": "Dual Anti-Platelet Therapy", "MH_TH": "NLM (1988)", "ST": "T121", "RN": "0", "PI": "Platelet Aggregation (1976-1987)", "MS": "Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.", "PM": "88", "HN": "88", "MR": "20230531", "DA": "19870313", "DC": "1", "DX": "19880101", "UI": "D010975"}, {"RECTYPE": "D", "MH": "Platelet Count", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Platelet Number|T034|T081|NON|EQV|UNK (19XX)|790524|abbcdef", "ENTRY": "Platelet Numbers, Blood", "MN": "G09.188.105.700", "MH_TH": "NLM (1980)", "ST": "T081", "AN": "usually NIM; coord with disease /blood, not /physiopathol", "PI": "Blood Platelets (1966-1979)", "MS": "The number of PLATELETS per unit volume in a sample of venous BLOOD.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19790312", "DC": "1", "DX": "19800101", "UI": "D010976"}, {"RECTYPE": "D", "MH": "Platelet Factor 3", "DS": "PLATELET FACTOR 03", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PF 3|T109|T123|ABB|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Factor 3, Platelet", "MN": "D23.119.932", "PA": "Coagulants", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Blood platelet factor 3", "RN": "37270-93-2", "AN": "a coagulant", "PI": "Lipoproteins (1974)", "MS": "A phospholipid from the platelet membrane that contributes to the blood clotting cascade by forming a phospholipid-protein complex (THROMBOPLASTIN) which serves as a cofactor with FACTOR VIIA to activate FACTOR X in the extrinsic pathway of BLOOD COAGULATION.", "PM": "91; was see under BLOOD COAGULATION FACTORS 1975-90", "HN": "91(75); was see under BLOOD COAGULATION FACTORS 1975-90", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010977"}, {"RECTYPE": "D", "MH": "Platelet Factor 4", "DS": "PLATELET FACTOR 04", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chemokine CXCL4|T116|T123|ABX|EQV|NLM (2008)|061214|CHEMOKINE CXCL 004|abbcdefs", "ENTRY": "gamma Thromboglobulin", "MN": "D23.529.374.200.120.900", "PA": "Coagulants", "MH_TH": "NLM (1976)", "ST": "T123", "N1": "Blood platelet factor 4", "RN": "37270-94-3", "PI": "Glycoproteins (1974-1975)", "MS": "A CXC chemokine that is found in the alpha granules of PLATELETS. The protein has a molecular size of 7800 kDa and can occur as a monomer, a dimer or a tetramer depending upon its concentration in solution. Platelet factor 4 has a high affinity for HEPARIN and is often found complexed with GLYCOPROTEINS such as PROTEIN C.", "PM": "84; was see under BLOOD COAGULATION FACTORS 1976-83", "HN": "84(76); was see under BLOOD COAGULATION FACTORS 1976-83", "MR": "20070709", "DA": "19750725", "DC": "1", "DX": "19840101", "UI": "D010978"}, {"RECTYPE": "D", "MH": "Platelet Function Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Platelet Function", "MN": "E05.200.625.625", "MH_TH": "NLM (1980)", "ST": "T059", "AN": "NIM", "PI": "Platelet Aggregation (1975-1979)", "MS": "Laboratory examination used to monitor and evaluate platelet function in a patient's blood.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20150522", "DA": "19790307", "DC": "1", "DX": "19800101", "UI": "D010979"}, {"RECTYPE": "D", "MH": "Platelet Membrane Glycoproteins", "DE": "PM GPS", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Platelet Membrane Glycoprotein|T116|T129|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "PM GP", "MN": "D12.776.543.750.705.675", "MH_TH": "NLM (1987)", "ST": "T129", "RN": "0", "AN": "/biosyn /drug eff /physiol /ultrastruct permitted", "PI": "Membrane Proteins (1966-1986)", "MS": "Surface glycoproteins on platelets which have a key role in hemostasis and thrombosis such as platelet adhesion and aggregation. Many of these are receptors.", "PM": "87", "HN": "87", "MR": "20230316", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D010980"}, {"RECTYPE": "D", "MH": "Platelet Storage Pool Deficiency", "DE": "PLATELET STORAGE POOL DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Storage Pool Deficiency|T047|NON|EQV|UNK (19XX)|850311|STORAGE POOL DEFIC|abcdefv", "ENTRY": "Storage Pool Deficiencies", "MN": "C15.378.463.735", "MH_TH": "NLM (1986)", "ST": "T047", "PI": "Blood Platelet Disorders (1967-1985)", "MS": "Disorder characterized by a decrease or lack of platelet dense bodies in which the releasable pool of adenine nucleotides and 5HT are normally stored.", "PM": "91; was see under BLOOD PLATELET DISORDERS 1986-90", "HN": "91(86); was see under BLOOD PLATELET DISORDERS 1986-90", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19850311", "DC": "1", "DX": "19910101", "UI": "D010981"}, {"RECTYPE": "D", "MH": "Platelet-Derived Growth Factor", "DE": "PDGF", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Growth Factor, Platelet-Derived", "MN": "D23.529.910", "FX": "Receptors, Platelet-Derived Growth Factor", "MH_TH": "NLM (1984)", "ST": "T123", "RN": "0", "PI": "Peptides (1977-1983)", "MS": "Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication.", "PM": "84", "HN": "84", "MR": "20060705", "DA": "19830531", "DC": "1", "DX": "19840101", "UI": "D010982"}, {"RECTYPE": "D", "MH": "Plateletpheresis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Thrombocytapheresis|T061|NON|EQV|UNK (19XX)|850612|abcdef", "ENTRY": "Thrombocytophereses", "MN": "E05.242.363.171.790", "FX": "Blood Donation", "MH_TH": "NLM (1979)", "ST": "T061", "AN": "do not confuse with PLATELET TRANSFUSION", "PI": "Plasmapheresis (1978)", "MS": "The preparation of platelet concentrates with the return of red cells and platelet-poor plasma to the donor.", "OL": "search PLASMAPHERESIS 1978", "PM": "91; was see under BLOOD COMPONENT REMOVAL 1986-90; was see under CELL SEPARATION 1981-85; was see under BLOOD TRANSFUSION 1979-80; was see PLASMAPHERESIS 1978", "HN": "91(79); was see under BLOOD COMPONENT REMOVAL 1986-90; was see under CELL SEPARATION 1981-85; was see under BLOOD TRANSFUSION 1979-80; was see PLASMAPHERESIS 1978", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19780126", "DC": "1", "DX": "19910101", "UI": "D010983"}, {"RECTYPE": "D", "MH": "Platinum", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Platinum Black|T196|NON|EQV|FDA SRS (2014)|NLM (1992)|910621|abcdeef", "MN": "D01.552.544.690", "FX": "Organoplatinum Compounds", "MH_TH": "POPLINE (1978)", "ST": "T196", "N1": "Platinum", "RN": "49DFR088MY", "RR": "7440-06-4 (Platinum)", "MS": "A heavy, soft, whitish metal, resembling tin, with atomic number 78, atomic weight 195.084, symbol Pt. It is used in manufacturing equipment for laboratory and industrial use. It occurs as a black powder (platinum black) and as a spongy substance (spongy platinum) and may have been known in Pliny's time as \"alutiae\".", "MR": "20170704", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010984"}, {"RECTYPE": "D", "MH": "Platybasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Basilar Impression|T019|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Platybasias", "MN": "C16.131.621.207.720", "FX": "Arnold-Chiari Malformation", "MH_TH": "NLM (1967)", "ST": "T019", "AN": "occipital bone abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Occipital Bone/abnormalities (1966)", "MS": "A developmental deformity of the occipital bone and upper end of the cervical spine, in which the latter appears to have pushed the floor of the occipital bone upward. (Dorland, 27th ed)", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D010985"}, {"RECTYPE": "D", "MH": "Platyhelminths", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Flatworms|T204|NON|EQV|UNK (19XX)|741106|abcdef", "ENTRY": "Platyhelminth", "MN": "B01.050.500.500.736", "MH_TH": "NLM (1965)", "ST": "T204", "RN": "txid6157", "MS": "A phylum of acoelomate, bilaterally symmetrical flatworms, without a definite anus. It includes three classes: Cestoda, Turbellaria, and Trematoda.", "PM": "65", "HN": "65", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D010986"}, {"RECTYPE": "D", "MH": "Platypus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Duckbilled Platypus|T015|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Platypus, Duckbilled", "MN": "B01.050.150.900.649.627.600", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9258", "MS": "A small aquatic oviparous mammal of the order Monotremata found in Australia and Tasmania.", "OL": "use PLATYPUS to search DUCKMOLE 1975-95", "PM": "91; was see under MONOTREMATA 1975-95; DUCKMOLE was see PLATYPUS 1975-95", "HN": "91(75); was see under MONOTREMATA 1975-90; DUCKMOLE was see PLATYPUS 9175-95", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D010987"}, {"RECTYPE": "D", "MH": "Play and Playthings", "DE": "PLAY PLAYTHINGS", "AQ": "IN PX", "PRINT ENTRY": "Toys|T073|NON|NRW|UNK (19XX)|770421|abcdef", "ENTRY": "Toy", "MN": "I03.450.642.693", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "/psychol permitted but do not confuse with PLAY THERAPY", "MS": "Spontaneous or voluntary recreational activities pursued for enjoyment and accessories or equipment used in the activities; includes games, toys, etc.", "OL": "use PLAY AND PLAYTHINGS to search PLAY 1966-77", "PM": "78; was PLAY 1963-77", "HN": "78; was PLAY 1963-77", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D010988"}, {"RECTYPE": "D", "MH": "Play Therapy", "DE": "PLAY THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Play-based Mental Health Intervention|T061|NON|NRW|NLM (2023)|210913|abcdef", "ENTRY": "Therapy, Sandplay", "MN": "F04.754.664", "MH_TH": "NLM (1969)", "ST": "T061", "PI": "Psychotherapy, Group (1966-1968)", "MS": "A treatment technique utilizing play as a medium for expression and communication between patient and therapist.", "OL": "search ACTING OUT 1968 & PROJECTIVE TECHNIQUES 1966-67", "PM": "69; was see under ACTING OUT 1968, was see under PROJECTIVE TECHNIQUES 1963-67", "HN": "69; was see under ACTING OUT 1968, was see under PROJECTIVE TECHNIQUES 1963-67", "CATSH": "CAT LIST", "MR": "20211202", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D010989"}, {"RECTYPE": "D", "MH": "Pleasure-Pain Principle", "ENTRY": "Principles, Pleasure-Pain", "MN": "F02.739.794.746", "MH_TH": "NLM (1964)", "ST": "T170", "MS": "The psychoanalytic concept that man instinctively seeks to avoid pain and discomfort and strives for gratification and pleasure.", "PM": "73", "HN": "73(64)", "CATSH": "CAT LIST", "MR": "19910611", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010990"}, {"RECTYPE": "D", "MH": "Plethysmography", "DE": "PLETHYSMOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Plethysmographies", "MN": "E01.370.370.610", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "NIM; \"venous occlusion plethysmography\" & \"strain gauge plethysmography\" go here", "MS": "Recording of change in the size of a part as modified by the circulation in it.", "CATSH": "CAT LIST", "MR": "20150701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010991"}, {"RECTYPE": "D", "MH": "Plethysmography, Impedance", "DE": "PLETHYSMOGR IMPEDANCE", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Rheography|T060|NON|EQV|UNK (19XX)|740330|RHEOGR|abcdefv", "ENTRY": "Rheographies", "MN": "E01.370.405.610", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Recording changes in electrical impedance between electrodes placed on opposite sides of a part of the body, as a measure of volume changes in the path of the current. (Stedman, 25th ed)", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010992"}, {"RECTYPE": "D", "MH": "Plethysmography, Whole Body", "DE": "PLETHYSMOGR WHOLE BODY", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Whole Body Plethysmographies", "MN": "E01.370.386.700.615", "MH_TH": "NLM (1971)", "ST": "T060", "PI": "Respiratory Function Tests (1966-1970)", "MS": "Measurement of the volume of gas in the lungs, including that which is trapped in poorly communicating air spaces. It is of particular use in chronic obstructive pulmonary disease and emphysema. (Segen, Dictionary of Modern Medicine, 1992)", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D010993"}, {"RECTYPE": "D", "MH": "Pleura", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Pleura, Visceral", "MN": "A10.615.789.736", "FX": "Pneumonolysis", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "The thin serous membrane enveloping the lungs (LUNG) and lining the THORACIC CAVITY. Pleura consist of two layers, the inner visceral pleura lying next to the pulmonary parenchyma and the outer parietal pleura. Between the two layers is the PLEURAL CAVITY which contains a thin film of liquid.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010994"}, {"RECTYPE": "D", "MH": "Pleural Diseases", "DE": "PLEURAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pleural Disease", "MN": "C08.528", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases involving the PLEURA.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010995"}, {"RECTYPE": "D", "MH": "Pleural Effusion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pleural Effusions", "MN": "C08.528.652", "FX": "Yellow Nail Syndrome", "MH_TH": "NLM (1968)", "ST": "T184", "AN": "PLEURAL EFFUSION, MALIGNANT is also available", "MS": "Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.", "OL": "use PLEURAL EFFUSION to search PLEURAL EFFUSIONS 1966-1967", "PM": "1968; was PLEURAL EFFUSIONS 1963-1967", "HN": "1968; was in Cat A & C 1968-1983, was PLEURAL EFFUSIONS in Cat A & C 1963-1967", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D010996"}, {"RECTYPE": "D", "MH": "Pleural Neoplasms", "DE": "PLEURAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Pleural Neoplasm", "MN": "C08.785.640", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010997"}, {"RECTYPE": "D", "MH": "Pleurisy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pleuritides", "MN": "C08.730.582", "FX": "Pleura", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "pleuropericarditis: coordinate PLEUROPERICARDITIS see PERICARDITIS with PLEURITIS see PLEURISY", "MS": "INFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D010998"}, {"RECTYPE": "D", "MH": "Pleurodeles", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Pleurodele", "MN": "B01.050.150.900.090.608.700.540", "MH_TH": "NLM (1981)", "ST": "T011", "RN": "txid8317", "AN": "NIM when experimental animal", "PI": "Urodela (1966-1974)", "MS": "A genus of aquatic newts belonging to the family Salamandridae and sometimes referred to as \"spiny\" tritons. There are two species P. waltlii and P. poireti. P. waltlii is commonly used in the laboratory. Since this genus adapts to aquarium living, it is easy to maintain in laboratories.", "PM": "91; was see under SALAMANDRIDAE 1981-90", "HN": "91(81); was see under SALAMANDRIDAE 1981-90", "MR": "20200813", "DA": "19800512", "DC": "1", "DX": "19910101", "UI": "D010999"}, {"RECTYPE": "D", "MH": "Pleurodynia, Epidemic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Myalgia, Epidemic|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Pleurodynias, Epidemic", "MN": "C01.925.782.687.359.213.737", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An acute, febrile, infectious disease generally occurring in epidemics. It is usually caused by coxsackieviruses B and sometimes by coxsackieviruses A; echoviruses; or other enteroviruses.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011000"}, {"RECTYPE": "D", "MH": "Pleuropneumonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pleuropneumonias", "MN": "C08.730.610.473", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "in animals, consider also PLEUROPNEUMONIA, CONTAGIOUS", "MS": "Inflammation of the lung parenchyma that is associated with PLEURISY, inflammation of the PLEURA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011001"}, {"RECTYPE": "D", "MH": "Pleuropneumonia, Contagious", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Pleuropneumonias, Contagious", "MN": "C22.717", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "Mycoplasma infect; animal only; check tag ANIMALS; coord IM with precoord animal/dis term (IM) + animal (NIM) or with animal (IM) in absence of precoord", "MS": "A pleuropneumonia of cattle and goats caused by species of MYCOPLASMA.", "OL": "use MYCOPLASMA INFECTIONS to search PLEUROPNEUMONIA, CONTAGIOUS 1968-74", "PM": "91; was see under MYCOPLASMA INFECTIONS/veterinary 1979-90; was see under ANIMAL DISEASES 1978; was see under MYCOPLASMA INFECTIONS 1968-77", "HN": "91(75); was see under MYCOPLASMA INFECTIONS/veterinary 1979-90; was see under ANIMAL DISEASES 1978; was see under MYCOPLASMA INFECTIONS 1968-77", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011002"}, {"RECTYPE": "D", "MH": "Ploidies", "ENTRY": "Ploidy", "MN": "G05.700", "MH_TH": "NLM (1976)", "ST": "T081", "PI": "specific ploidies heading", "MS": "The degree of replication of the chromosome set in the karyotype.", "PM": "76", "HN": "76; was NON MESH before 1976", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D011003"}, {"RECTYPE": "D", "MH": "Plummer-Vinson Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Plummer Vinson", "MN": "C06.405.117.119.500.742", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A syndrome of DYSPHAGIA with IRON-DEFICIENCY ANEMIA that is due to congenital anomalies in the ESOPHAGUS (such as cervical esophageal webs). It is known as Patterson-Kelly syndrome in the United Kingdom.", "OL": "search DEGLUTITION DISORDERS 1966-74", "PM": "91; was see under DEGLUTITION DISORDERS 1975-90", "HN": "91(75); was see under DEGLUTITION DISORDERS 1975-90", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011004"}, {"RECTYPE": "D", "MH": "Plutonium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.700", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Plutonium", "RN": "53023GN24M", "RR": "7440-07-5 (Plutonium)", "MS": "A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, and atomic number 94. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011005"}, {"RECTYPE": "D", "MH": "Pneumatosis Cystoides Intestinalis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Intestinalis, Pneumatosis Cystoides", "MN": "C06.405.469.778", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A condition characterized by the presence of multiple gas-filled cysts in the intestinal wall, the submucosa and/or subserosa of the INTESTINE. The majority of the cysts are found in the JEJUNUM and the ILEUM.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011006"}, {"RECTYPE": "D", "MH": "Pneumocephalus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pneumocephalus, Tension|T047|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Traumatic Pneumocephalus", "MN": "C26.915.300.200.650", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "Presence of air or gas within the intracranial cavity (e.g., epidural space, subdural space, intracerebral, etc.) which may result from traumatic injuries, fistulous tract formation, erosions of the skull from NEOPLASMS or infection, NEUROSURGICAL PROCEDURES, and other conditions.", "PM": "68", "HN": "68(64)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011007"}, {"RECTYPE": "D", "MH": "Pneumococcal Infections", "DE": "PNEUMOCOCCAL INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Streptococcus pneumoniae Infections|T047|NON|EQV|NLM (1992)|910412|STREP PNEUMONIAE INFECT|abcdefv", "ENTRY": "Streptococcus pneumoniae Infection", "MN": "C01.150.252.410.890.670", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011008"}, {"RECTYPE": "D", "MH": "Pneumoconiosis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bagassosis|T047|NON|NRW|UNK (19XX)|830503|abcdef", "ENTRY": "Pneumoconioses", "MN": "C24.800", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "general or unspecified; prefer specifics; index specific pneumoconiosis for which there is no MeSH term here + substance yielding dust, as pneumoconiosis in gold mining: PNEUMOCONIOSIS (IM) + GOLD (IM) + MINING (IM); do not coordinate with OCCUPATIONAL DISEASES", "MS": "A diffuse parenchymal lung disease caused by inhalation of dust and by tissue reaction to their presence. These inorganic, organic, particulate, or vaporized matters usually are inhaled by workers in their occupational environment, leading to the various forms (ASBESTOSIS; BYSSINOSIS; and others). Similar air pollution can also have deleterious effects on the general population.", "OL": "use PNEUMOCONIOSIS to search BAGASSOSIS 1969-83", "PM": "66; BAGASSOSIS was see under PNEUMOCONIOSIS 1969-83", "HN": "66; BAGASSOSIS was see under PNEUMOCONIOSIS 1969-83", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011009"}, {"RECTYPE": "D", "MH": "Pneumocystis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Pneumocysti", "MN": "B01.300.107.730", "MH_TH": "NLM (2004)", "ST": "T004", "RN": "txid4753", "MS": "A genus of ascomycetous FUNGI, family Pneumocystidaceae, order Pneumocystidales. It includes various host-specific species causing PNEUMOCYSTIS PNEUMONIA in humans and other MAMMALS.", "PM": "2004; see PNEUMOCYSTIS CARINII 1974-2003", "HN": "2004 (1974)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011010"}, {"RECTYPE": "D", "MH": "Pneumoencephalography", "DE": "PNEUMOENCEPHALOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Cisternography, Pneumoencephalographic|T060|NON|NRW|UNK (19XX)|760512|CISTERNOGR PNEUMOENCEPHALOGR|abcdefv", "ENTRY": "Pneumoencephalographies", "MN": "E05.629.937.620", "MH_TH": "NLM (1969)", "ST": "T060", "PI": "Ventriculography, Cerebral (1966-1968)", "MS": "Radiographic visualization of the cerebral ventricles by injection of air or other gas.", "OL": "search VENTRICULOGRAPHY, CEREBRAL 1966-68", "PM": "72; was see under VENTRICULOGRAPHY 1963-71", "HN": "72(69); was see under VENTRICULOGRAPHY 1963-71", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011011"}, {"RECTYPE": "D", "MH": "Pneumomediastinum, Diagnostic", "DE": "PNEUMOMEDIASTINUM DIAG", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Pneumomediastinums, Diagnostic", "MN": "E01.370.388.600", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Deliberate introduction of air or gas into the mediastinum as an aid to examination and diagnosis.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011012"}, {"RECTYPE": "D", "MH": "Pneumonectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Lung Volume Reduction Surgery|T061|NON|NRW|NLM (2021)|191122|abcdef", "ENTRY": "Volume Reduction, Lung", "MN": "E04.928.600.600", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The excision of lung tissue including partial or total lung lobectomy.", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011013"}, {"RECTYPE": "D", "MH": "Pneumonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulmonary Inflammation|T047|NON|REL|NLM (2001)|991221|abcdef", "ENTRY": "Pulmonary Inflammations", "MN": "C08.730.610", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; PNEUMONIA, INTERSTITIAL see LUNG DISEASES, INTERSTITIAL and IDIOPATHIC INTERSTITIAL PNEUMONIAS and its specifics are also available", "MS": "Infection of the lung often accompanied by inflammation.", "PM": "1963; for LOBAR PNEUMONIA see PNEUMONIA, PNEUMOCOCCAL 1995-2008", "HN": "1963; for LOBAR PNEUMONIA use PNEUMONIA, PNEUMOCOCCAL 1995-2008", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D011014"}, {"RECTYPE": "D", "MH": "Pneumonia, Aspiration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aspiration Pneumonia|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Syndromes, Acid Aspiration", "MN": "C08.730.610.529", "FX": "Respiratory Aspiration of Gastric Contents", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "/congen: consider also RESPIRATORY DISTRESS SYNDROME, NEWBORN", "MS": "A type of lung inflammation resulting from the aspiration of food, liquid, or gastric contents into the upper RESPIRATORY TRACT.", "PM": "67", "HN": "67(66)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D011015"}, {"RECTYPE": "D", "MH": "Pneumonia, Atypical Interstitial, of Cattle", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Pulmonary Adenomatosis, Bovine|T047|NON|REL|UNK (19XX)|750711|PULM ADENOMATOSIS BOVINE|abcdefv", "ENTRY": "Fever, Fog", "MN": "C22.196.706", "MH_TH": "NLM (1976)", "ST": "T047", "AN": "don't forget also CATTLE (NIM) & check tag ANIMALS", "MS": "A cattle disease of uncertain cause, probably an allergic reaction.", "OL": "use PNEUMONIA, ATYPICAL INTERSTITIAL, OF CATTLE to search PULMONARY ADENOMATOSIS, BOVINE 1968-75", "PM": "76; was PULMONARY ADENOMATOSIS, BOVINE 1968-75", "HN": "76; was PULMONARY ADENOMATOSIS, BOVINE 1968-75", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D011016"}, {"RECTYPE": "D", "MH": "Pneumonia, Lipid", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lipoid Pneumonia|T047|NON|EQV|NLM (2023)|210831|abcdef", "ENTRY": "Pneumonia, Lipoid", "MN": "C08.730.610.529.612", "MH_TH": "NLM (1984)", "ST": "T047", "MS": "Pneumonia due to aspiration or inhalation of various oily or fatty substances or otherwise accumulation of endogenous lipid substances in the PULMONARY ALVEOLI.", "PM": "91; was see under PNEUMONIA, ASPIRATION 1984-90; was heading 1963-83", "HN": "91(84)63; was see under PNEUMONIA, ASPIRATION 1984-90; was heading 1963-83", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011017"}, {"RECTYPE": "D", "MH": "Pneumonia, Pneumococcal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Pneumonias, Pneumococcal", "MN": "C08.730.610.540.550", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.", "PM": "98; was PNEUMONIA, LOBAR 1963-97; PNEUMONIA, PNEUMOCOCCAL was see PNEUMONIA, LOBAR 1978-97", "HN": "98; was PNEUMONIA, LOBAR 1963-97; PNEUMONIA, PNEUMOCOCCAL was see PNEUMONIA, LOBAR 1978-97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D011018"}, {"RECTYPE": "D", "MH": "Pneumonia, Mycoplasma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pneumonia, Primary Atypical|T047|NON|EQV|NLM (1998)|960807|abcdef", "ENTRY": "Primary Atypical Pneumonias", "MN": "C08.730.610.540.545", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Pneumonia (1966-1979)", "MS": "Interstitial pneumonia caused by extensive infection of the lungs (LUNG) and BRONCHI, particularly the lower lobes of the lungs, by MYCOPLASMA PNEUMONIAE in humans. In SHEEP, it is caused by MYCOPLASMA OVIPNEUMONIAE. In CATTLE, it may be caused by MYCOPLASMA DISPAR.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19781221", "DC": "1", "DX": "19800101", "UI": "D011019"}, {"RECTYPE": "D", "MH": "Pneumonia, Pneumocystis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pneumonia, Interstitial Plasma Cell|T047|NON|EQV|UNK (19XX)|840608|abcdef", "ENTRY": "Pneumonias, PCP", "MN": "C08.730.610.675", "MH_TH": "NLM (2004)", "ST": "T047", "AN": "coordinate IM with species (IM) if pertinent", "MS": "A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.", "PM": "2004; see PNEUMONIA, PNEUMOCYSTIS CARINII 1985-2003, see PNEUMONIA, INTERSTITIAL PLASMA CELL 1963-1984", "HN": "2004 (1963)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D011020"}, {"RECTYPE": "D", "MH": "Pneumonia, Progressive Interstitial, of Sheep", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Progressive Interstitial Pneumonia of Sheep|T047|NON|EQV|UNK (19XX)|750701|abcdef", "MN": "C22.836.660", "MH_TH": "NLM (1976)", "ST": "T047", "AN": "caused by a lentivirus; don't forget also SHEEP (NIM) & check tag ANIMALS", "PI": "Pulmonary Adenomatosis, Ovine (1968-1975)", "MS": "Chronic respiratory disease caused by the VISNA-MAEDI VIRUS. It was formerly believed to be identical with jaagsiekte (PULMONARY ADENOMATOSIS, OVINE) but is now recognized as a separate entity.", "OL": "search PULMONARY ADENOMATOSIS, OVINE 1968-74", "PM": "76; MAEDI was see PULMONARY ADENOMATOSIS, OVINE 1968-74", "HN": "76; MAEDI was see PULMONARY ADENOMATOSIS, OVINE 1968-74", "CATSH": "CAT LIST", "MR": "20190529", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D011021"}, {"RECTYPE": "D", "MH": "Pneumonia, Rickettsial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Rickettsial Pneumonia|T047|NON|EQV|NLM (1995)|931208|abcdef", "ENTRY": "Rickettsial Pneumonias", "MN": "C08.730.610.540.600", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific rickettsial infection (IM)", "MS": "Pneumonia caused by infection with bacteria of the family RICKETTSIACEAE.", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011022"}, {"RECTYPE": "D", "MH": "Pneumonia, Staphylococcal", "DE": "PNEUMONIA STAPH", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Staphylococcal Pneumonia|T047|NON|EQV|UNK (19XX)|740330|STAPH PNEUMONIA|abcdefv", "ENTRY": "Staphylococcus Aureus Pneumonias", "MN": "C08.730.610.540.620", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "coordinate IM with Staphylococcus species (IM) if pertinent", "PI": "Staphylococcal Infections (1966-1967)", "MS": "Pneumonia caused by infections with bacteria of the genus STAPHYLOCOCCUS, usually with STAPHYLOCOCCUS AUREUS.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011023"}, {"RECTYPE": "D", "MH": "Pneumonia, Viral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Viral Pneumonias", "MN": "C08.730.610.763", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific viral disease (IM)", "MS": "Inflammation of the lung parenchyma that is caused by a viral infection.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011024"}, {"RECTYPE": "D", "MH": "Pneumonolysis", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Pneumonolyses", "MN": "E04.928.600.220.610", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Division of the tissues attaching the lung to the wall of the chest cavity, to permit collapse of the lung. It was formerly used to treat tuberculosis. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "20150701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011025"}, {"RECTYPE": "D", "MH": "Pneumopericardium", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pneumopericardiums", "MN": "C14.280.763", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Presence of air or gas in the space between the heart and the PERICARDIUM. The degree of respiratory distress depends on the amount of trapped air and circulation blocked in the systemic and pulmonary veins.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011026"}, {"RECTYPE": "D", "MH": "Pneumoperitoneum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C06.844.670", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "do not confuse with PNEUMOPERITONEUM, ARTIFICIAL, a technique; RETROPNEUMOPERITONEUM is also available", "MS": "A condition with trapped gas or air in the PERITONEAL CAVITY, usually secondary to perforation of the internal organs such as the LUNG and the GASTROINTESTINAL TRACT, or to recent surgery. Pneumoperitoneum may be purposely introduced to aid radiological examination.", "CATSH": "CAT LIST", "MR": "20160314", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011027"}, {"RECTYPE": "D", "MH": "Pneumoperitoneum, Artificial", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Artificial Pneumoperitoneum", "MN": "E01.370.388.605", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Deliberate introduction of air into the peritoneal cavity.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011028"}, {"RECTYPE": "D", "MH": "Pneumoradiography", "DE": "PNEUMORADIOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Radiography, Insufflation|T060|NON|EQV|UNK (19XX)|860620|RADIOGR INSUFFLATION|abcdefv", "ENTRY": "Radiographies, Negative Contrast", "MN": "E01.370.350.700.625", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "not related to radiographic imaging of the lung", "MS": "Radiography using air, oxygen, or some other gas as a contrast medium.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011029"}, {"RECTYPE": "D", "MH": "Pneumothorax", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spontaneous Pneumothorax, Primary", "MN": "C08.528.778", "FX": "Thoracentesis", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with PNEUMOTHORAX, ARTIFICIAL, a surgical procedure", "MS": "An accumulation of air or gas in the PLEURAL CAVITY, which may occur spontaneously or as a result of trauma or a pathological process. The gas may also be introduced deliberately during PNEUMOTHORAX, ARTIFICIAL.", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011030"}, {"RECTYPE": "D", "MH": "Pneumothorax, Artificial", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Pneumothoraxs, Artificial", "MN": "E04.928.600.220.620", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "coordinate with disease /surg; do not confuse with PNEUMOTHORAX, a disease", "MS": "Injection of air or a more slowly absorbed gas such as nitrogen, into the PLEURAL CAVITY to collapse the lung.", "CATSH": "CAT LIST", "MR": "20120927", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011031"}, {"RECTYPE": "D", "MH": "Podiatry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Chiropody|T091|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "H02.696", "FX": "Foot Diseases", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "for /educ, coordinate with medical education terms if pertinent", "MS": "A specialty concerned with the diagnosis and treatment of foot disorders and injuries and anatomic defects of the foot.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011032"}, {"RECTYPE": "D", "MH": "Podophyllin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Resin, Podophyllum", "MN": "D20.215.784.500.675", "PA": "Keratolytic Agents", "MH_TH": "NLM (1964)", "ST": "T123", "RN": "9000-55-9", "MS": "Caustic extract from the roots of Podophyllum peltatum and P. emodi. It contains PODOPHYLLOTOXIN and its congeners and is very irritating to mucous membranes and skin. Podophyllin is a violent purgative that may cause CNS damage and teratogenesis. It is used as a paint for warts, skin neoplasms, and senile keratoses.", "OL": "search PODOPHYLLUM 1966-71", "PM": "72; was see under PODOPHYLLUM 1963-71", "HN": "72(64); was see under PODOPHYLLUM 1963-71", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011033"}, {"RECTYPE": "D", "MH": "Podophyllotoxin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Epipodophyllotoxin|T109|T131|NON|REL|UNK (19XX)|750716|abbcdef", "ENTRY": "Warticon|T109|T121|TRD|NRW|IE|UK|041102|abbcdeef", "MN": "D04.615.638.960.675", "PA": "Tubulin Modulators", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R-(5alpha,5abeta,8aalpha,9alpha))-", "RN": "L36H50F353", "RR": "55568-79-1 ((5R-(5 alpha,5a alpha,8a beta,9 alpha))-isomer)", "AN": "/biosyn permitted if by plant", "PI": "Antineoplastic Agents (1966-1972)", "MS": "A lignan (LIGNANS) found in PODOPHYLLIN resin from the roots of PODOPHYLLUM plants. It is a potent spindle poison, toxic if taken internally, and has been used as a cathartic. It is very irritating to skin and mucous membranes, has keratolytic actions, has been used to treat warts and keratoses, and may have antineoplastic properties, as do some of its congeners and derivatives.", "OL": "use PODOPHYLLOTOXIN to search EPIPODOPHYLLOTOXIN 1975", "PM": "73; EPIPODOPHYLLOTOXIN was see under PODOPHYLLOTOXIN 1975", "HN": "73; EPIPODOPHYLLOTOXIN was see under PODOPHYLLOTOXIN 1975", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011034"}, {"RECTYPE": "D", "MH": "Podophyllum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Podophyllums", "MN": "B01.875.800.575.912.250.125.500", "FX": "Mandragora", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid35932", "MS": "A genus of poisonous American herbs, family BERBERIDACEAE. The roots yield PODOPHYLLOTOXIN and other pharmacologically important agents. The plant was formerly used as a cholagogue and cathartic. It is different from the European mandrake, MANDRAGORA.", "PM": "91; was see under PLANTS, TOXIC 1986-90; was heading 1963-85; was in Cat B & D 1963-77", "HN": "91(86)63; was see under PLANTS, TOXIC 1986-90; was heading 1963-85; was in Cat B & D 1963-77", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011035"}, {"RECTYPE": "D", "MH": "Poecilia", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Molly|T013|NON|NRW|UNK (19XX)|860415|abcdef", "ENTRY": "Poecilias", "MN": "B01.050.150.900.493.850.280.680", "MH_TH": "NLM (1987)", "ST": "T013", "RN": "txid8080", "RR": "txid69235", "AN": "NIM when experimental animal", "PI": "Fishes (1966-1986)", "MS": "A genus of livebearing cyprinodont fish comprising the guppy and molly. Some species are virtually all female and depend on sperm from other species to stimulate egg development. Poecilia is used in carcinogenicity studies as well as neurologic and physiologic research.", "PM": "91; was see under CYPRINODONTIFORMES 1987-90", "HN": "91(87); was see under CYPRINODONTIFORMES 1987-90", "MR": "20200902", "DA": "19860415", "DC": "1", "DX": "19910101", "UI": "D011036"}, {"RECTYPE": "D", "MH": "Poetry as Topic", "AQ": "HI", "MN": "K01.517.781", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "coordinate IM with LITERATURE, MEDIEVAL (IM) or LITERATURE, MODERN (IM) if pertinent; do not confuse with the Publication Type POETRY", "MS": "Works about the literary and oral genre expressing meaning via symbolism and following formal or informal patterns.", "PM": "2009; see Poetry 1966-2008", "HN": "2009(1966)", "MR": "20161216", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D011037"}, {"RECTYPE": "D", "MH": "Rothmund-Thomson Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Poikiloderma Congenitale|T047|NON|EQV|GHR (2014)|NLM (1964)|990101|POIKILODERMA CONGEN|abcdeefv", "ENTRY": "Syndrome, Rothmund-Thomson", "MN": "C18.452.284.760", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An autosomal recessive syndrome occurring principally in females, characterized by the presence of reticulated, atrophic, hyperpigmented, telangiectatic cutaneous plaques, often accompanied by juvenile cataracts, saddle nose, congenital bone defects, disturbances in the growth of HAIR; NAILS; and TEETH; and HYPOGONADISM.", "PM": "2006; see POIKILODERMA CONGENITALE 1991-2005, see SKIN DISEASES 1964-1990", "HN": "2006 (1964)", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011038"}, {"RECTYPE": "D", "MH": "Poison Control Centers", "DE": "POIS CONTROL CENTERS", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Poison Control Center", "MN": "N02.421.297.695", "MH_TH": "NLM (1964)", "ST": "T093", "AN": "specify geog if pertinent", "MS": "Facilities which provide information concerning poisons and treatment of poisoning in emergencies.", "PM": "66", "HN": "66(64)", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011039"}, {"RECTYPE": "D", "MH": "Dermatitis, Toxicodendron", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Toxicodendron Dermatitis|T047|NON|EQV|NLM (1993)|920331|abcdef", "ENTRY": "Toxicodendron Dermatitides", "MN": "C20.543.418.150.700", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "Toxicodendron or Rhus is the genus name for poison ivy; includes poison oak & poison sumac", "MS": "An allergic contact dermatitis caused by exposure to plants of the genus Toxicodendron (formerly Rhus). These include poison ivy, poison oak, and poison sumac, all plants that contain the substance urushiol, a potent skin sensitizing agent. (From Dorland, 27th ed)", "OL": "use DERMATITIS, TOXICODENDRON to search POISON IVY DERMATITIS 1966-92", "PM": "93; was POISON IVY DERMATITIS 1963-92", "HN": "93; was POISON IVY DERMATITIS 1963-92", "CATSH": "CAT LIST", "MR": "19920520", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D011040"}, {"RECTYPE": "D", "MH": "Poisoning", "DE": "POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Poisonings", "MN": "C25.723", "FX": "Antidotes", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011041"}, {"RECTYPE": "D", "MH": "Poisons", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "PRINT ENTRY": "Poison|T131|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D27.888.569.612", "EC": "antagonists & inhibitors:Antidotes", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "IM", "MS": "Substances which, when ingested, inhaled, or absorbed, or when applied to, injected into, or developed within the body in relatively small amounts may, by their chemical action, cause damage to structure or disturbance of function. (From Dorland, 27th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011042"}, {"RECTYPE": "D", "MH": "Pokeweed Mitogens", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pokeweed Mitogen|T129|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Mitogens, Pokeweed", "MN": "D12.776.765.678.875", "PA": "Mitogens", "MH_TH": "NLM (1979)", "ST": "T129", "RN": "0", "PI": "Mitogens (1966-1972)", "MS": "Proteins isolated from the roots of the pokeweed, Phytolacca americana, that agglutinate some erythrocytes, stimulate mitosis and antibody synthesis in lymphocytes, and induce activation of plasma cells.", "PM": "79", "HN": "79", "MR": "20200527", "DA": "19780503", "DC": "1", "DX": "19790101", "UI": "D011043"}, {"RECTYPE": "D", "MH": "Poland", "AQ": "EH EP", "ENTRY": "Republic of Poland|T083|NON|EQV|NLM (2018)|161223|abcdef", "MN": "Z01.542.248.679", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in central Europe, east of Germany. The capital is Warsaw.", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D011044"}, {"RECTYPE": "D", "MH": "Poland Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Poland", "MN": "C16.131.621.906.819.756", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "abnorm of pectoralis musc with syndactyly, named for A. Poland, 19th cent physician; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Syndactylia (1967-1984)", "MS": "A syndrome which is characterized by symbrachydactyly and aplasia of the sternal head of pectoralis major.", "PM": "91; was see under SYNDACTYLIA 1985-90", "HN": "91(85); was see under SYNDACTYLIA 1985-90", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19840405", "DC": "1", "DX": "19910101", "UI": "D011045"}, {"RECTYPE": "D", "MH": "Polarography", "DE": "POLAROGR", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Polarography, Pulse", "MN": "E05.301.700", "MH_TH": "NLM (1966)", "ST": "T059", "MS": "An electrochemical technique for measuring the current that flows in solution as a function of an applied voltage. The observed polarographic wave, resulting from the electrochemical response, depends on the way voltage is applied (linear sweep or differential pulse) and the type of electrode used. Usually a mercury drop electrode is used.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011048"}, {"RECTYPE": "D", "MH": "Social Control Policies", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Social Control Policy", "MN": "N03.623.500", "MH_TH": "NLM (1980)", "ST": "T089", "AN": "general or unspecified; prefer specifics; coordinate with subject of policy; specify state or country or other body if pertinent", "MS": "Decisions for determining and guiding present and future objectives from among alternatives.", "PM": "98", "HN": "98; use explode 1980-97", "MR": "20100625", "DA": "19790601", "DC": "1", "DX": "19980101", "UI": "D011049"}, {"RECTYPE": "D", "MH": "Policy Making", "ENTRY": "Policy Developments", "MN": "N03.706.742", "FX": "Public Policy", "MH_TH": "NLM (1980)", "ST": "T064", "MS": "The decision process by which individuals, groups or institutions establish policies pertaining to plans, programs or procedures.", "PM": "80", "HN": "80", "MR": "20020702", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D011050"}, {"RECTYPE": "D", "MH": "Poliomyelitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Poliomyelitis, Preparalytic|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Preparalytic Poliomyelitis", "MN": "C10.668.864", "FX": "Postpoliomyelitis Syndrome", "MH_TH": "POPLINE (1994)", "ST": "T047", "MS": "An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011051"}, {"RECTYPE": "D", "MH": "Poliomyelitis, Bulbar", "DE": "POLIO BULBAR", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Bulbar Poliomyelitis|T047|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Polio, Bulbar", "MN": "C10.668.864.250", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A form of paralytic poliomyelitis affecting neurons of the MEDULLA OBLONGATA of the brain stem. Clinical features include impaired respiration, HYPERTENSION, alterations of vasomotor control, and dysphagia. Weakness and atrophy of the limbs and trunk due to spinal cord involvement is usually associated. (From Adams et al., Principles of Neurology, 6th ed, p765)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011052"}, {"RECTYPE": "D", "MH": "Poliovirus Vaccine, Inactivated", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Salk Vaccine|T121|T129|EPO|NRW|UNK (19XX)|740330|abbcdef", "ENTRY": "Vaccine, Salk", "MN": "D20.215.894.899.623.500", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "MS": "A suspension of formalin-inactivated poliovirus grown in monkey kidney cell tissue culture and used to prevent POLIOMYELITIS.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011054"}, {"RECTYPE": "D", "MH": "Poliovirus Vaccine, Oral", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sabin Vaccine|T121|T129|EPO|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Vaccine, Sabin", "MN": "D20.215.894.899.623.750", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "AN": "SABIN VACCINE is attenuated (live)", "MS": "A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011055"}, {"RECTYPE": "D", "MH": "Political Systems", "AQ": "CL EC HI PX SN", "ENTRY": "Systems, Political", "MN": "I01.696", "MH_TH": "POPLINE (1978)", "ST": "T078", "AN": "specify geog", "PI": "Politics (1966-1979)", "MS": "The units based on political theory and chosen by countries under which their governmental power is organized and administered to their citizens.", "PM": "80", "HN": "80; was NON MESH before 1980", "MR": "20170708", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D011056"}, {"RECTYPE": "D", "MH": "Politics", "PRINT ENTRY": "Political Activity|T057|NON|NRW|BIOETHICS (1977)|770317|abcdef", "ENTRY": "Political Factor", "MN": "I01.738", "FX": "Dissent and Disputes", "MH_TH": "BIOETHICS (1975)", "ST": "T090", "AN": "specify geog if pertinent", "MS": "Activities concerned with governmental policies, functions, etc.", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011057"}, {"RECTYPE": "D", "MH": "Pollen", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Pollen Grain", "MN": "A18.024.249.500.249.500", "FX": "Rhinitis, Allergic, Seasonal", "MH_TH": "NLM (1966)", "ST": "T002", "AN": "coordinate with specific plant; pollen as an allergen: coordinate IM with ALLERGENS (IM); hypersensitivity: consider RESPIRATORY HYPERSENSITIVITY and its specifics particularly RHINITIS, ALLERGIC, SEASONAL", "MS": "The fertilizing element of plants that contains the male GAMETOPHYTES.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011058"}, {"RECTYPE": "D", "MH": "Polonium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.496.749.305.680", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Polonium", "RN": "DQY03U61EJ", "RR": "7440-08-6 (Polonium)", "MS": "A radioactive element that is a member of the chalcogen family. It has the atomic symbol Po, atomic number 84, and the atomic weight of the isotope with the longest half-life (209Po) is 208.98. It decays by alpha-emission.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011059"}, {"RECTYPE": "D", "MH": "Poloxalene", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polyoxyethylene Polyoxypropylene Polyoxyethylene Polymer|T109|T121|NON|EQV|UNK (19XX)|750211|abbcdef", "ENTRY": "SK&F18667", "MN": "J01.637.051.720.741.650", "PA": "Surface-Active Agents", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "Polyethylene-polypropylene glycol", "RN": "9003-11-6", "PI": "Polyethylene Glycols (1974)", "MS": "A copolymer of polyethylene and polypropylene ether glycol. It is a non-ionic polyol surface-active agent used medically as a fecal softener and in cattle for prevention of bloat.", "PM": "91; was see under POLYETHYLENE GLYCOLS 1975-90", "HN": "91(75); was see under POLYETHYLENE GLYCOLS 1975-90", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011060"}, {"RECTYPE": "D", "MH": "Poly A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyadenylic Acids|T114|NON|BRD|UNK (19XX)|750716|abcdef", "ENTRY": "Polynucleotides, Adenine", "MN": "D13.695.578.550.500", "MH_TH": "NLM (1976)", "ST": "T114", "N1": "5'-Adenylic acid, homopolymer", "RN": "24937-83-5", "AN": "do not confuse with POLY A-U", "PI": "Polynucleotides (1966-1975)", "MS": "A group of adenine ribonucleotides in which the phosphate residues of each adenine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.", "PM": "76", "HN": "76", "MR": "19970620", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D011061"}, {"RECTYPE": "D", "MH": "Polynucleotide Adenylyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polyadenylate Synthetase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Synthetase, Polyadenylate", "MN": "D08.811.913.696.445.650", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "ATP:polynucleotide adenylyltransferase", "RN": "EC 2.7.7.19", "RR": "9026-30-6 (CAS RN)", "PI": "Nucleotidyltransferases (1972-1974)", "MS": "An enzyme that catalyzes the synthesis of polyadenylic acid from ATP. May be due to the action of RNA polymerase (EC 2.7.7.6) or polynucleotide adenylyltransferase (EC 2.7.7.19). EC 2.7.7.19.", "PM": "98; see POLY A POLYMERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20160628", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011062"}, {"RECTYPE": "D", "MH": "Poly A-U", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyadenylic-Polyuridylic Acid|T114|T121|NON|EQV|NLM (1999)|980303|abbcdef", "ENTRY": "Polyadenylic Polyuridylic Acid", "MN": "D13.695.578.550.750.510", "PA": "Interferon Inducers", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "5'-Adenylic acid, homopolymer, complex with 5'-uridylic acid homopolymer (1:1)", "RN": "24936-38-7", "AN": "Do not confuse with POLY A", "PI": "Polynucleotides (1966-1971)", "MS": "A double-stranded polyribonucleotide comprising polyadenylic and polyuridylic acids.", "PM": "74", "HN": "74(72)", "MR": "19980610", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011063"}, {"RECTYPE": "D", "MH": "Poly Adenosine Diphosphate Ribose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Poly ADP Ribose|T109|T114|EQV|UNK (19XX)|760513|abbdef", "ENTRY": "Ribose, Poly ADP", "MN": "D13.695.827.708.070.125.600", "FX": "Poly(ADP-ribose) Polymerases", "MH_TH": "NLM (1975)", "ST": "T114", "N1": "Adenosine 5'-(trihydrogen diphosphate), P'-5-ester with D-ribose, homopolymer", "RN": "26656-46-2", "PI": "Polynucleotides (1973-1974)", "MS": "A polynucleotide formed from the ADP-RIBOSE moiety of nicotinamide-adenine dinucleotide (NAD) by POLY(ADP-RIBOSE) POLYMERASES.", "PM": "91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011064"}, {"RECTYPE": "D", "MH": "Poly(ADP-ribose) Polymerases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Poly(ADP-ribose) Polymerase|T116|T126|ACX|EQV|NLM (1999)|971224|abbcdef", "ENTRY": "Synthase, Poly ADP-Ribose", "MN": "D08.811.913.400.725.115.690", "FX": "Poly ADP Ribosylation", "EC": "antagonists & inhibitors:Poly(ADP-ribose) Polymerase Inhibitors", "MH_TH": "NLM (2003)", "ST": "T126", "N1": "NAD+:poly(adenosine diphosphate D-ribose)-acceptor ADP-D-ribosyltransferase", "RN": "EC 2.4.2.30", "RR": "58319-92-9 (CAS RN)", "PI": "Nucleosidases (1966-1974)", "MS": "Enzymes that catalyze the transfer of multiple ADP-RIBOSE groups from nicotinamide-adenine dinucleotide (NAD) onto protein targets, thus building up a linear or branched homopolymer of repeating ADP-ribose units i.e., POLY ADENOSINE DIPHOSPHATE RIBOSE.", "PM": "2003; see NAD+ ADP-RIBOSYLTRANSFERASE 1992-2002, see POLY ADP RIBOSE POLYMERASE 1977-1991, see NAD NUCLEOSIDASE 1975-1976", "HN": "2003 (1977); use NAD NUCLEOSIDASE 1975-1976", "MR": "20190701", "DA": "19760419", "DC": "1", "DX": "19860101", "UI": "D011065"}, {"RECTYPE": "D", "MH": "Poly C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polycytidylic Acids|T114|NON|EQV|UNK (19XX)|750731|abcdef", "ENTRY": "Polynucleotides, Cytosine", "MN": "D13.695.578.550.560", "MH_TH": "NLM (1976)", "ST": "T114", "N1": "5'-Cytidylic acid, homopolymer", "RN": "30811-80-4", "PI": "Polynucleotides (1966-1975)", "MS": "A group of cytosine ribonucleotides in which the phosphate residues of each cytosine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.", "PM": "91; was see under POLYRIBONUCLEOTIDES 1976-90", "HN": "91(76); was see under POLYRIBONUCLEOTIDES 1976-90", "MR": "20200527", "DA": "19750801", "DC": "1", "DX": "19910101", "UI": "D011066"}, {"RECTYPE": "D", "MH": "Poly dA-dT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polydeoxyadenine Nucleotides-Polythymine Nucleotides|T114|NON|EQV|UNK (19XX)|760414|abcdef", "ENTRY": "dT, Poly dA", "MN": "D13.695.578.500.300", "MH_TH": "NLM (1977)", "ST": "T114", "N1": "5'-Adenylic acid, thymidylyl-(5'-3')-2'-deoxy-, homopolymer", "RN": "26966-61-0", "AN": "used in DNA studies", "PI": "Thymine Nucleotides (1972-1976)", "MS": "Polydeoxyribonucleotides made up of deoxyadenine nucleotides and thymine nucleotides. Present in DNA preparations isolated from crab species. Synthetic preparations have been used extensively in the study of DNA.", "PM": "91; was see under POLYDEOXYRIBONUCLEOTIDES 1977-90", "HN": "91(77); was see under POLYDEOXYRIBONUCLEOTIDES 1977-90", "MR": "19950531", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D011067"}, {"RECTYPE": "D", "MH": "Poly G", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyguanylic Acids|T114|NON|EQV|UNK (19XX)|750731|abcdef", "ENTRY": "Polynucleotides, Guanine", "MN": "D13.695.578.550.600", "MH_TH": "NLM (1976)", "ST": "T114", "N1": "5'-Guanylic acid, homopolymer", "RN": "25191-14-4", "PI": "Polynucleotides (1966-1975)", "MS": "A group of guanine ribonucleotides in which the phosphate residues of each guanine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.", "PM": "91; was see under POLYRIBONUCLEOTIDES 1976-90", "HN": "91(76); was see under POLYRIBONUCLEOTIDES 1976-90", "MR": "20160628", "DA": "19750801", "DC": "1", "DX": "19910101", "UI": "D011068"}, {"RECTYPE": "D", "MH": "Poly I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyinosinic Acids|T114|NON|EQV|UNK (19XX)|750731|abcdef", "ENTRY": "Polynucleotides, Inosine", "MN": "D13.695.578.550.650", "MH_TH": "NLM (1976)", "ST": "T114", "RN": "25249-22-3", "AN": "do not confuse with POLY I-C", "PI": "Polynucleotides (1966-1975)", "MS": "A group of inosine ribonucleotides in which the phosphate residues of each inosine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.", "PM": "91; was see under POLYRIBONUCLEOTIDES 1976-90", "HN": "91(76); was see under POLYRIBONUCLEOTIDES 1976-90", "MR": "19920520", "DA": "19750801", "DC": "1", "DX": "19910101", "UI": "D011069"}, {"RECTYPE": "D", "MH": "Poly I-C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Polyribose Inosin Cytidil", "MN": "D13.695.578.550.650.600", "PA": "Interferon Inducers", "MH_TH": "NLM (1971)", "ST": "T121", "N1": "5'-Inosinic acid, homopolymer, complex with 5'-cytidylic acid homopolymer (1:1)", "RN": "O84C90HH2L", "RR": "24939-03-5", "AN": "do not confuse with POLY I", "PI": "Polynucleotides (1966-1970)", "MS": "Interferon inducer consisting of a synthetic, mismatched double-stranded RNA. The polymer is made of one strand each of polyinosinic acid and polycytidylic acid.", "PM": "73", "HN": "73(71)", "MR": "20170308", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011070"}, {"RECTYPE": "D", "MH": "Poly T", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thymine Polynucleotides|T114|NON|EQV|UNK (19XX)|750731|abcdef", "ENTRY": "dT, Poly", "MN": "D13.695.578.500.600", "MH_TH": "NLM (1976)", "ST": "T114", "N1": "5'-Thymidylic acid, homopolymer", "RN": "25086-81-1", "PI": "Polynucleotides (1966-1975)", "MS": "A group of thymine nucleotides in which the phosphate residues of each thymine nucleotide act as bridges in forming diester linkages between the deoxyribose moieties.", "PM": "91; was see under POLYDEOXYRIBONUCLEOTIDES 1976-90", "HN": "91(76); was see under POLYDEOXYRIBONUCLEOTIDES 1976-90", "MR": "19920520", "DA": "19750801", "DC": "1", "DX": "19910101", "UI": "D011071"}, {"RECTYPE": "D", "MH": "Poly U", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uracil Polynucleotides|T114|NON|EQV|UNK (19XX)|760520|abcdef", "ENTRY": "Polynucleotides, Uracil", "MN": "D13.695.578.550.750", "MH_TH": "NLM (1972)", "ST": "T114", "N1": "5'-Uridylic acid, homopolymer", "RN": "27416-86-0", "MS": "A group of uridine ribonucleotides in which the phosphate residues of each uridine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.", "PM": "74", "HN": "74(72)", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011072"}, {"RECTYPE": "D", "MH": "Polyamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyamine|T109|T123|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D02.092.782", "MH_TH": "NLM (1971)", "ST": "T123", "RN": "0", "PI": "Amines (1966-1970)", "MS": "Amine compounds that consist of carbon chains or rings containing two or more primary amino groups.", "PM": "72", "HN": "72(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011073"}, {"RECTYPE": "D", "MH": "Polyanetholesulfonate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polyanethol Sulfonate|T109|T121|T130|NON|EQV|NLM (1994)|921201|abbbcdef", "ENTRY": "Sulfonate, Polyanethol", "MN": "J01.637.051.720.722", "MH_TH": "NLM (1977)", "ST": "T130", "N1": "Benzene, 1-methoxy-4-(1-propenyl)-, (E)-, homopolymer, sulfonated, sodium salt", "RN": "55963-78-5", "RR": "52993-95-0 (cpd w/ unspecified locants, homopolymer)", "PI": "Sulfonic Acids (1966-1973)", "MS": "A compound originally developed as an anticoagulant, but possessing anticomplement action and lowering the bactericidal action of blood. It is used in vitro to inhibit blood coagulation and as a diagnostic reagent to encourage the growth of pathogens in the blood. It is also used to stabilize colloidal solutions such as milk and gelatin. (From Merck Index, 11th ed)", "OL": "use POLYANETHOLESULFONATE to search POLYANETHOL SULFONATE 1977-93", "PM": "94; was POLYANETHOL SULFONATE 1977-93 (see under BENZENESULFONATES 1977-90)", "HN": "94; was POLYANETHOL SULFONATE 1977-93 (see under BENZENESULFONATES 1977-90)", "MR": "20060705", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D011074"}, {"RECTYPE": "D", "MH": "Polybrominated Biphenyls", "DE": "PBBS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polybromobiphenyl Compounds|T109|NON|EQV|NLM (1994)|920812|POLYBROMOBIPHENYL CPDS|abcdefv", "ENTRY": "Compounds, Polybromobiphenyl", "MN": "D02.455.526.368.700", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "PI": "Hydrocarbons, Brominated (1974-1975)", "MS": "Biphenyl compounds which are extensively brominated. Many of these compounds are toxic environmental pollutants.", "OL": "use POLYBROMINATED BIPHENYLS to search POLYBROMOBIPHENYL COMPOUNDS 1977-93", "PM": "94; was POLYBROMOBIPHENYL COMPOUNDS 1977-93 (see under BIPHENYL COMPOUNDS 1977-83)", "HN": "94; was POLYBROMOBIPHENYL COMPOUNDS 1977-93 (see under BIPHENYL COMPOUNDS 1977-83)", "MR": "20000622", "DA": "19760427", "DC": "1", "DX": "19840101", "UI": "D011075"}, {"RECTYPE": "D", "MH": "Polycarboxylate Cement", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Polycarboxylate Cement, Zinc", "MN": "J01.637.051.339.291.700", "MH_TH": "NLM (1972)", "ST": "T122", "RN": "0", "PI": "Zinc (1966-1971)", "MS": "Water-soluble low-molecular-weight polymers of acrylic or methacrylic acid that form solid, insoluble products when mixed with specially prepared ZnO powder. The resulting cement adheres to dental enamel and is also used as a luting agent.", "PM": "91; was see under DENTAL CEMENTS 1982-90; was see under ACRYLIC RESINS 1977-81; was see under ACRYLATES 1975-76", "HN": "91(72); was see under DENTAL CEMENTS 1982-90; was see under ACRYLIC RESINS 1977-81; was see under ACRYLATES 1975-76", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011076"}, {"RECTYPE": "D", "MH": "Polychaeta", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Myxicola|T204|NON|NRW|UNK (19XX)|880321|abcdef", "ENTRY": "Polychaetas", "MN": "B01.050.500.091.700", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid6341", "RR": "txid76263", "AN": "marine worms; /microbiol /parasitol /virol permitted", "PI": "Annelida (1966-1974)", "MS": "A class of marine annelids including sandworms, tube worms, clamworms, and fire worms. It includes also the genus Myxicola infundibulum.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D011077"}, {"RECTYPE": "D", "MH": "Polychlorinated Biphenyls", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polychlorobiphenyl Compounds|T109|T131|NON|EQV|NLM (1992)|910325|POLYCHLOROBIPHENYL CPDS|abbcdefv", "ENTRY": "Compounds, Polychlorobiphenyl", "MN": "D02.455.526.439.773", "PA": "Environmental Pollutants", "MH_TH": "NLM (1971)", "ST": "T131", "RN": "DFC2HB4I0K", "AN": "\"yusho poisoning\": see note on RICE", "PI": "Biphenyl Compounds (1966-1970)", "MS": "Industrial products consisting of a mixture of chlorinated biphenyl congeners and isomers. These compounds are highly lipophilic and tend to accumulate in fat stores of animals. Many of these compounds are considered toxic and potential environmental pollutants.", "OL": "use POLYCHLORINATED BIPHENYLS to search POLYCHLOROBIPHENYL COMPOUNDS 1971-91 (as Prov 1971-72)", "PM": "92; was POLYCHLOROBIPHENYL COMPOUNDS 1973-91", "HN": "92; was POLYCHLOROBIPHENYL COMPOUNDS 1971-91 (Prov 1971-72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011078"}, {"RECTYPE": "D", "MH": "Polychloroterphenyl Compounds", "DE": "POLYCHLOROTERPHENYL CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polychlorotriphenyl Compounds|T109|NON|EQV|UNK (19XX)|770401|POLYCHLOROTRIPHENYL CPDS|abcdefv", "ENTRY": "Compounds, Polychlorotriphenyl", "MN": "D02.455.526.439.785", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Polycyclic Compounds (1974)", "MS": "Compounds consisting of three benzene rings linked to each other in either ortho, meta or para positions and substituted with chlorine atoms.", "PM": "91; was see under TERPHENYL COMPOUNDS 1975-90", "HN": "91(75); was see under TERPHENYL COMPOUNDS 1975-90", "MR": "19920520", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D011080"}, {"RECTYPE": "D", "MH": "Polychondritis, Relapsing", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polychondritis, Chronic Atrophic|T047|NON|EQV|NLM (1993)|920330|abcdef", "ENTRY": "Relapsing Polychondritis", "MN": "C17.300.182.531", "MH_TH": "NLM (1967)", "ST": "T047", "MS": "An acquired disease of unknown etiology, chronic course, and tendency to recur. It is characterized by inflammation and degeneration of cartilage and can result in deformities such as floppy ear and saddle nose. Loss of cartilage in the respiratory tract can lead to respiratory obstruction.", "PM": "72", "HN": "72(67)", "CATSH": "CAT LIST", "MR": "19920522", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011081"}, {"RECTYPE": "D", "MH": "Polycyclic Compounds", "DE": "POLYCYCLIC CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Polycyclic", "MN": "D04", "RH": "D4 - POLYCYCLIC COMPOUNDS", "FX": "Heterocyclic Compounds", "MH_TH": "NLM (1996)", "ST": "T109", "RN": "0", "MS": "Compounds which contain two or more rings in their structure.", "PM": "2005; POLYCYCLIC COMPOUNDS was heading 1966-1995; POLYCYCLIC HYDROCARBONS was heading 1966-1995", "HN": "2005(1974); POLYCYCLIC COMPOUNDS was heading 1966-1995; POLYCYCLIC HYDROCARBONS was heading 1966-1995", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011083"}, {"RECTYPE": "D", "MH": "Polycyclic Aromatic Hydrocarbons", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polynuclear Aromatic Hydrocarbons|T109|NON|EQV|NLM (1996)|950306|abcdef", "ENTRY": "Hydrocarbons, Polynuclear Aromatic", "MN": "D04.615", "FX": "Fused-Ring Compounds", "MH_TH": "NLM (1996)", "ST": "T109", "RN": "0", "MS": "Aromatic hydrocarbons that contain extended fused-ring structures.", "OL": "use POLYCYCLIC HYDROCARBONS to search POLYNUCLEAR AROMATIC HYDROCARBONS 1975-95", "PM": "2017; see POLYCYLCLIC HYDROCARBONS, AROMATIC 1995-2016;  POLYNUCLEAR AROMATIC HYDROCARBONS was see POLYCYCLIC HYDROCARBONS 1975-95", "HN": "2017(1996)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D011084"}, {"RECTYPE": "D", "MH": "Polycystic Ovary Syndrome", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Stein-Leventhal Syndrome|T047|EPO|EQV|OMIM (2013)|UNK (19XX)|840412|abcdeef", "ENTRY": "Syndrome, Stein-Leventhal", "MN": "C19.391.630.580.765", "FX": "Hyperandrogenism", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "non-neoplastic", "MS": "A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.", "OL": "use POLYCYSTIC OVARY SYNDROME to search STEIN-LEVENTHAL SYNDROME 1966-84", "PM": "85; was STEIN-LEVENTHAL SYNDROME 1963-84", "HN": "85; was STEIN-LEVENTHAL SYNDROME 1963-84", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D011085"}, {"RECTYPE": "D", "MH": "Polycythemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Erythrocytosis|T047|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Polycythemias", "MN": "C15.378.738", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "increase in total red cell mass", "MS": "An increase in the total red cell mass of the blood. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011086"}, {"RECTYPE": "D", "MH": "Polycythemia Vera", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Polycythemia Rubra Vera|T191|NON|EQV|NLM (2009)|OMIM (2013)|ORD (2010)|100331|abcdeeef", "ENTRY": "Veras, Polycythemia Rubra", "MN": "C15.378.400.200.500", "MH_TH": "ORD (2010)", "ST": "T191", "MS": "A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011087"}, {"RECTYPE": "D", "MH": "DNA Ligases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polydeoxyribonucleotide Synthetases|T116|T126|NON|EQV|NLM (1998)|961106|abbcdef", "ENTRY": "Synthetases, Polydeoxyribonucleotide", "MN": "D08.811.464.754.600", "MH_TH": "NLM (1978)", "ST": "T126", "RN": "EC 6.5.1.-", "AN": "do not confuse entry term POLYDEOXYRIBONUCLEOTIDE SYNTHETASES with entry term POLYRIBONUCLEOTIDE SYNTHETASE", "PI": "Polynucleotide Synthetases (1974-1977)", "MS": "Poly(deoxyribonucleotide):poly(deoxyribonucleotide)ligases. Enzymes that catalyze the joining of preformed deoxyribonucleotides in phosphodiester linkage during genetic processes during repair of a single-stranded break in duplex DNA. The class includes both EC 6.5.1.1 (ATP) and EC 6.5.1.2 (NAD).", "PM": "98; see POLYDEOXYRIBONUCLEOTIDE SYNTHETASES 1991-97, see POLYNUCLEOTIDE SYNTHETASES 1978-90; for DNA LIGASES see POLYNUCLEOTIDE SYNTHETASES 1974-77, & see DNA LIGASE 1973-76", "HN": "98(77); for DNA LIGASES use POLYNUCLEOTIDE SYNTHETASES 1973-76", "MR": "20200527", "DA": "19770523", "DC": "1", "DX": "19910101", "UI": "D011088"}, {"RECTYPE": "D", "MH": "Polydeoxyribonucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polydeoxyribonucleotide|T114|NON|EQV|NLM (2022)|201005|abcdef", "MN": "D13.695.578.500", "MH_TH": "NLM (1976)", "ST": "T114", "RN": "0", "AN": "13 or more nucleotides", "PI": "Polynucleotides (1966-1975)", "MS": "A group of 13 or more deoxyribonucleotides in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties.", "PM": "76", "HN": "76", "MR": "20210630", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D011089"}, {"RECTYPE": "D", "MH": "Polyenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Cumulenes|T109|NON|NRW|NLM (2007)|051201|abcdef", "MN": "D02.455.326.271.665", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Hydrocarbons with more than one double bond. They are a reduced form of POLYYNES.", "PM": "74", "HN": "74", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011090"}, {"RECTYPE": "D", "MH": "Polyesters", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Polyester", "MN": "J01.637.051.720.728", "MH_TH": "NLM (1977)", "ST": "T122", "RN": "0", "PI": "Polymers (1966-1976)", "MS": "Polymers of organic acids and alcohols, with ester linkages--usually polyethylene terephthalate; can be cured into hard plastic, films or tapes, or fibers which can be woven into fabrics, meshes or velours.", "PM": "77", "HN": "77", "MR": "20060705", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D011091"}, {"RECTYPE": "D", "MH": "Polyethylene Glycols", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polyoxyethylenes|T109|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Polyoxyethylene", "MN": "J01.637.051.720.741", "PA": "Surface-Active Agents", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "3WJQ0SDW1A", "MS": "Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.", "OL": "to search TRITONS use POLYETHYLENE GLYCOLS 1975-82 & SURFACE-ACTIVE AGENTS 1966-74", "PM": "74; TRITONS was heading 1975-82, was see under AMMONIUM COMPOUNDS 1975-78, was see under SURFACE-ACTIVE AGENTS 1963-74", "HN": "74; TRITONS was heading 1975-82, was see under AMMONIUM COMPOUNDS 1975-78, was see under SURFACE-ACTIVE AGENTS 1963-74", "MR": "20171010", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011092"}, {"RECTYPE": "D", "MH": "Polyethylene Terephthalates", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Terephthalates, Polyethylene", "MN": "J01.637.051.720.728.764", "MH_TH": "NLM (1973)", "ST": "T122", "RN": "0", "PI": "Polymers (1966-1972)", "MS": "Polyester polymers formed from terephthalic acid or its esters and ethylene glycol. They can be formed into tapes, films or pulled into fibers that are pressed into meshes or woven into fabrics.", "OL": "use POLYETHYLENE TEREPHTHALATES to search POLYETHYLENE TEREPHTHALATE 1973-92", "PM": "93; was POLYETHYLENE TEREPHTHALATE 1973-92", "HN": "93; was POLYETHYLENE TEREPHTHALATE 1973-92", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011093"}, {"RECTYPE": "D", "MH": "Polyethyleneimine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polyaziridine|T109|T130|NON|EQV|UNK (19XX)|800402|abbcdef", "ENTRY": "Polyethylenimines", "MN": "J01.637.051.720.716.507.600", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Aziridine, homopolymer", "RN": "9002-98-6", "PI": "Polyethylenes (1973-1974)", "MS": "Strongly cationic polymer that binds to certain proteins; used as a marker in immunology, to precipitate and purify enzymes and lipids. Synonyms: aziridine polymer; Epamine; Epomine; ethylenimine polymer; Montrek; PEI; Polymin(e).", "PM": "91; was see under POLYETHYLENES 1975-90", "HN": "91(75); was see under POLYETHYLENES 1975-90", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011094"}, {"RECTYPE": "D", "MH": "Polyethylenes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Ethylene Polymers|T109|T122|NON|EQV|UNK (19XX)|800523|abbcdef", "ENTRY": "Polymers, Ethylene", "MN": "J01.637.051.720.716.507", "EC": "analogs & derivatives:Polyethylene", "MH_TH": "NLM (1966)", "ST": "T122", "N1": "Ethylene Homopolymers", "RN": "0", "AN": "POLYETHYLENE is available", "MS": "Synthetic thermoplastics that are tough, flexible, inert, and resistant to chemicals and electrical current. They are often used as biocompatible materials for prostheses and implants.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011095"}, {"RECTYPE": "D", "MH": "Polygalacturonase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pectinase|T116|T126|NON|EQV|UNK (19XX)|760426|abbcdef", "ENTRY": "Depolymerase, Pectin", "MN": "D08.811.277.450.800", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "Poly(1,4-alpha-D-galacturonide)glycanhydrolase", "RN": "EC 3.2.1.15", "AN": "in microorganisms & higher plants", "PI": "Uronic Acids (1966-1976)", "MS": "A cell wall-degrading enzyme found in microorganisms and higher plants. It catalyzes the random hydrolysis of 1,4-alpha-D-galactosiduronic linkages in pectate and other galacturonans. EC 3.2.1.15.", "PM": "91; was see under GLYCOSIDE HYDROLASES 1977-90", "HN": "91(77); was see under GLYCOSIDE HYDROLASES 1977-90", "MR": "20030709", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D011096"}, {"RECTYPE": "D", "MH": "Polygeline", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Thomaegelins", "MN": "J01.637.051.720.780", "PA": "Plasma Substitutes", "MH_TH": "NLM (1975)", "ST": "T122", "RN": "9015-56-9", "PI": "Polymers (1972-1974)", "MS": "A 3.5 per cent colloidal solution containing urea-cross-linked polymerized peptides. It has a molecular weight of approximately 35,000 and is prepared from gelatin and electrolytes. The polymeric solution is used as a plasma expander.", "PM": "91; was see under POLYMERS 1975-90", "HN": "91(75); was see under POLYMERS 1975-90", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011097"}, {"RECTYPE": "D", "MH": "Polyglactin 910", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Poly(Lactide-Co-Glycoside)|T109|T121|T122|NON|BRD|UNK (19XX)|860325|abbbcdef", "ENTRY": "Polyester, Glycolic-Lactic Acid", "MN": "J01.637.051.720.728.772", "MH_TH": "NLM (1979)", "ST": "T122", "N1": "Propanoic acid, 2-hydroxy-, polymer with hydroxyacetic acid", "RN": "34346-01-5", "RR": "26780-50-7", "PI": "Polymers (1966-1978)", "MS": "A polyester used for absorbable sutures & surgical mesh, especially in ophthalmic surgery. 2-Hydroxy-propanoic acid polymer with polymerized hydroxyacetic acid, which forms 3,6-dimethyl-1,4-dioxane-dione polymer with 1,4-dioxane-2,5-dione copolymer of molecular weight about 80,000 daltons.", "PM": "91; was see under POLYMERS 1979-90", "HN": "91(79); was see under POLYMERS 1979-90", "MR": "20160628", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D011098"}, {"RECTYPE": "D", "MH": "Polyglutamic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Polyglutamate|T116|NON|NRW|UNK (19XX)|780519|abcdef", "MN": "D12.644.748", "MH_TH": "NLM (1979)", "ST": "T116", "N1": "L-Glutamic acid, homopolymer", "RN": "25513-46-6", "PI": "Peptides (1966-1978)", "MS": "A peptide that is a homopolymer of glutamic acid.", "PM": "91; was see under PEPTIDES 1979-90", "HN": "91(79); was see under PEPTIDES 1979-90", "MR": "20130708", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D011099"}, {"RECTYPE": "D", "MH": "Polyglycolic Acid", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polyglycolide|T109|T122|NON|EQV|NLM (1994)|920924|abbcdef", "ENTRY": "DexonS", "MN": "J01.637.051.720.728.780", "MH_TH": "NLM (1973)", "ST": "T122", "N1": "Poly(oxy(1-oxo-1,2-ethanediyl))", "RN": "26009-03-0", "PI": "Glycolates (1966-1972)", "MS": "A biocompatible polymer used as a surgical suture material.", "PM": "73", "HN": "73", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011100"}, {"RECTYPE": "D", "MH": "Polyhydroxyethyl Methacrylate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polyglycol Methacrylate|T109|T122|NON|EQV|UNK (19XX)|770426|abbcdef", "ENTRY": "Poly Hema", "MN": "J01.637.051.720.741.685", "MH_TH": "NLM (1978)", "ST": "T122", "N1": "2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, homopolymer", "RN": "25249-16-5", "PI": "Polymethacrylic Acids (1975-1977)", "MS": "A biocompatible, hydrophilic, inert gel that is permeable to tissue fluids. It is used as an embedding medium for microscopy, as a coating for implants and prostheses, for contact lenses, as microspheres in adsorption research, etc.", "PM": "91; was see under POLYMETHACRYLIC ACIDS 1981-90; was see under ACRYLIC RESINS 1978-80", "HN": "91(78); was see under POLYMETHACRYLIC ACIDS 1981-90; was see under ACRYLIC RESINS 1978-80", "MR": "20060705", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D011102"}, {"RECTYPE": "D", "MH": "Polyisoprenyl Phosphate Monosaccharides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isoprenoid Phosphate Monosaccharides|T109|T123|NON|EQV|UNK (19XX)|770517|abbcdef", "ENTRY": "Phosphate Monosaccharides, Polyisoprenyl", "MN": "D10.390.700.700", "MH_TH": "NLM (1978)", "ST": "T123", "RN": "0", "PI": "specific terpene or terpene group", "MS": "These compounds function as activated monosaccharide carriers in the biosynthesis of glycoproteins and oligosaccharide phospholipids. Obtained from a nucleoside diphosphate sugar and a polyisoprenyl phosphate.", "PM": "91; was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90", "HN": "91(78); was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90", "MR": "20040707", "DA": "19770517", "DC": "1", "DX": "19910101", "UI": "D011103"}, {"RECTYPE": "D", "MH": "Polyisoprenyl Phosphate Oligosaccharides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isoprenoid Phosphate Oligosaccharides|T109|NON|EQV|UNK (19XX)|770517|abcdef", "ENTRY": "Phosphate Oligosaccharides, Polyisoprenyl", "MN": "D10.390.700.710", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "specific terpene or terpene group (1966-1977)", "MS": "These compounds function as activated glycosyl carriers in the biosynthesis of glycoproteins and glycophospholipids. Include the pyrophosphates.", "PM": "91; was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90", "HN": "91(78); was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90", "MR": "20040707", "DA": "19770517", "DC": "1", "DX": "19910101", "UI": "D011104"}, {"RECTYPE": "D", "MH": "Polyisoprenyl Phosphate Sugars", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isoprenoid Phosphate Sugars|T109|NON|EQV|UNK (19XX)|770407|abcdef", "ENTRY": "Sugars, Polyisoprenyl Phosphate", "MN": "D10.390.700", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "specific terpene groups or specific terpene (1966-1977)", "MS": "Compounds functioning as activated glycosyl carriers in the biosynthesis of glycoproteins and glycophospholipids. They include the polyisoprenyl pyrophosphates.", "PM": "78", "HN": "78", "MR": "20040707", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D011105"}, {"RECTYPE": "D", "MH": "Polyisoprenyl Phosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Terpene Phosphates|T109|NON|NRW|UNK (19XX)|770407|abcdef", "ENTRY": "Phosphates, Terpene", "MN": "D02.705.400.725", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Terpenes (1966-1977)", "MS": "Phosphoric or pyrophosphoric acid esters of polyisoprenoids.", "PM": "78", "HN": "78", "MR": "20120703", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D011106"}, {"RECTYPE": "D", "MH": "Polylysine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Epsilon Polylysine", "MN": "D12.644.760", "MH_TH": "NLM (1975)", "ST": "T116", "N1": "L-Lysine, homopolymer", "RN": "25104-18-1", "PI": "Peptides (1973-1974)", "MS": "A peptide which is a homopolymer of lysine.", "PM": "86; was see under PEPTIDES 1975-85", "HN": "86(75); was see under PEPTIDES 1975-85", "MR": "20010725", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D011107"}, {"RECTYPE": "D", "MH": "Polymers", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Polymer", "MN": "J01.637.051.720", "MH_TH": "NLM (1984)", "ST": "T122", "RN": "0", "MS": "Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS).", "HN": "was in Cat D & J 1975-82, was in Cat D only 1963-74", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011108"}, {"RECTYPE": "D", "MH": "Polymethacrylic Acids", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Methacrylic Acid Polymers|T109|T122|T130|NON|EQV|UNK (19XX)|800523|abbbcdef", "ENTRY": "Polymers, Methacrylic Acid", "MN": "J01.637.051.720.716.822.111.650", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "0", "PI": "Polymers (1966-1974)", "MS": "Poly-2-methylpropenoic acids. Used in the manufacture of methacrylate resins and plastics in the form of pellets and granules, as absorbent for biological materials and as filters; also as biological membranes and as hydrogens. Synonyms: methylacrylate polymer; poly(methylacrylate); acrylic acid methyl ester polymer.", "PM": "81; was see under ACRYLIC RESINS 1975-80; POLYHYDROXYETHYL METHACRYLATE was see under ACRYLIC RESINS 1978-80", "HN": "81(75); was see under ACRYLIC RESINS 1975-80", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19810101", "UI": "D011109"}, {"RECTYPE": "D", "MH": "Polymorphism, Genetic", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Polymorphism (Genetics)|T045|NON|EQV|NLM (1968)|990101|POLYMORPHISM|POLYMORPHISM GENET|abcdefsv", "ENTRY": "Polymorphisms, Genetic", "MN": "G05.365.795", "MH_TH": "NLM (2005)", "ST": "T045", "PI": "Genetics, Population (1966-1967)", "MS": "The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.", "PM": "2005; see POLYMORPHISM (GENETICS) 1968-2004", "HN": "2005(1968)", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011110"}, {"RECTYPE": "D", "MH": "Polymyalgia Rheumatica", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rheumatism, Peri-Extra-Articular|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Syndrome, Forestier-Certonciny", "MN": "C17.300.775.720", "FX": "Giant Cell Arteritis", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "A syndrome in the elderly characterized by proximal joint and muscle pain, high erythrocyte sedimentation rate, and a self-limiting course. Pain is usually accompanied by evidence of an inflammatory reaction. Women are affected twice as commonly as men and Caucasians more frequently than other groups. The condition is frequently associated with GIANT CELL ARTERITIS and some theories pose the possibility that the two diseases arise from a single etiology or even that they are the same entity.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011111"}, {"RECTYPE": "D", "MH": "Polymyxin B", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Polymyxin B Sulfate|T116|T195|NON|REL|FDA SRS (2018)|USP (19XX)|861003|abbcdeef", "MN": "D12.776.543.695.054.600.750", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "Polymyxin B", "RN": "J2VZ07J96K", "RR": "19371312D4", "MS": "A mixture of polymyxins B1 and B2, obtained from BACILLUS POLYMYXA strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for treatment of infections with gram-negative bacteria, but may be neurotoxic and nephrotoxic.", "OL": "use POLYMYXIN B to search AEROSPORIN 1975-93; use POLYMYXINS 1966-74", "PM": "1991; was see under POLYMYXINS 1978-90; was AEROSPORIN see under POLYMYXIN 1971-77, see POLYMYXIN 1963-70; AEROSPORIN was see POLYMYXIN B 1978-93", "HN": "1991(1978); was see under POLYMYXINS 1978-90; was AEROSPORIN see under POLYMYXIN 1971-77, see POLYMYXIN 1963-70; AEROSPORIN was see POLYMYXIN B 1978-93", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011112"}, {"RECTYPE": "D", "MH": "Polymyxins", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polymyxin|T116|T195|NON|EQV|BAN (19XX)|990101|abbcdef", "ENTRY": "Polymyxin M|T116|T195|NON|NRW|UNK (19XX)|811202|abbcdef", "MN": "D12.776.543.695.054.600", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1994)", "ST": "T195", "RN": "0", "MS": "Basic lipopeptide antibiotic group obtained from Bacillus polymyxa. They affect the cell membrane by detergent action and may cause neuromuscular and kidney damage. At least eleven different members of the polymyxin group have been identified, each designated by a letter.", "PM": "1994,1963-1977; see POLYMYXIN 1994-2003; see POLYMYXINS 1978-93; see POLYMYXIN 1963-77", "HN": "1994,1963-1977", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D011113"}, {"RECTYPE": "D", "MH": "Polynesia", "AQ": "EH EP", "PRINT ENTRY": "Tahiti|T083|NAM|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Wallis and Futuna Islands|T083|NAM|NRW|POPLINE (1983)|861231|abcdef", "MN": "Z01.639.760.815", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "a group of islands in the central Pacific", "MS": "The collective name for the islands of the central Pacific Ocean, including the Austral Islands, Cook Islands, Easter Island, HAWAII; NEW ZEALAND; Phoenix Islands, PITCAIRN ISLAND; SAMOA; TONGA; Tuamotu Archipelago, Wake Island, and Wallis and Futuna Islands. Polynesians are of the Caucasoid race, but many are of mixed origin. Polynesia is from the Greek poly, many + nesos, island, with reference to the many islands in the group. (From Webster's New Geographical Dictionary, 1988, p966 & Room, Brewer's Dictionary of Names, 1992, p426)", "OL": "use CHILE to search EASTER ISLAND 1975-77", "HN": "68; EASTER ISLAND was see CHILE 1975-77", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19680101", "UI": "D011114"}, {"RECTYPE": "D", "MH": "Polyneuropathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polyneuropathy, Acquired|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Polyneuropathy", "MN": "C10.668.829.800", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance.", "PM": "2000; see POLYNEURITIS 1966-1999", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D011115"}, {"RECTYPE": "D", "MH": "Polynucleotide 5'-Hydroxyl-Kinase", "DS": "POLYNUCLEOTIDE HYDROXYLKINASE 05", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polynucleotide Kinase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Polynucleotide 5' Hydroxyl Kinase", "MN": "D08.811.913.696.620.680", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "ATP:5'-dephosphopolynucleotide 5'-phosphotransferase", "RN": "EC 2.7.1.78", "RR": "37211-65-7 (CAS RN)", "PI": "Polynucleotides (1974)", "MS": "An enzyme that catalyzes the transfer of a phosphate group to the 5'-terminal hydroxyl groups of DNA and RNA. EC 2.7.1.78.", "PM": "98; see POLYNUCLEOTIDE HYDROXYLKINASE 1991-97; see PHOSPHOTRANSFERASES, ATP 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011116"}, {"RECTYPE": "D", "MH": "Polyribonucleotide Nucleotidyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polynucleotide Phosphorylase|T116|T126|NON|EQV|NLM (1998)|961204|abbcdef", "ENTRY": "Phosphorylase, Polynucleotide", "MN": "D08.811.913.696.445.735.532", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "Polyribonucleotide:orthophosphate nucleotidyltransferase", "RN": "EC 2.7.7.8", "RR": "9014-12-4 (CAS RN)", "PI": "RNA Nucleotidyltransferases (1968-1971)", "MS": "An enzyme of the transferase class that catalyzes the reaction RNA(n+1) and orthophosphate to yield RNA(n) and a nucleoside diphosphate, or the reverse reaction. ADP, IDP, GDP, UDP, and CDP can act as donors in the latter case. (From Dorland, 27th ed) EC 2.7.7.8.", "PM": "98; see POLYNUCLEOTIDE PHOSPHORYLASE 1973-97, NUCLEOTIDYLTRANSFERASES 1968-72, & NUCLEOTIDYL TRANSFERASES 1963-67", "HN": "98(72); use NUCLEOTIDYLTRANSFERASES 1968-72, use NUCLEOTIDYL TRANSFERASES 1963-67", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011117"}, {"RECTYPE": "D", "MH": "Polynucleotide Ligases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polynucleotide Synthetases|T116|T126|NON|EQV|NLM (1998)|961106|abbcdef", "ENTRY": "Synthetases, Polynucleotide", "MN": "D08.811.464.754", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 6.5.1.-", "AN": "do not confuse entry term POLYNUCLEOTIDE SYNTHETASES with entry terms POLYRIBONUCLEOTIDE SYNTHETASE or POLYDEOXYRIBONUCLEOTIDE SYNTHETASES", "PI": "Ligases (1966-1973)", "MS": "Catalyze the joining of preformed ribonucleotides or deoxyribonucleotides in phosphodiester linkage during genetic processes. EC 6.5.1.", "PM": "98; see POLYNUCLEOTIDE SYNTHETASES 1974-97", "HN": "98(74)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D011118"}, {"RECTYPE": "D", "MH": "Polynucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polynucleotide|T114|NON|EQV|NLM (2021)|191120|abcdef", "MN": "D13.695.578", "MH_TH": "NLM (1966)", "ST": "T114", "RN": "0", "AN": "13 or more nucleotides", "MS": "BIOPOLYMERS composed of NUCLEOTIDES covalently bonded in a chain.  The most common examples are DNA and RNA chains.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011119"}, {"RECTYPE": "D", "MH": "Polyomavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Murine polyomavirus|T005|NON|NRW|NLM (2007)|060105|abcdef", "ENTRY": "polyomaviruses, Murine", "MN": "B04.613.204.670.615", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid36362", "RR": "txid1891754", "AN": "infection: coordinate IM with POLYOMAVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "MS": "A genus of potentially oncogenic viruses of the family POLYOMAVIRIDAE. These viruses are normally present in their natural hosts as latent infections. The virus is oncogenic in hosts different from the species of origin.", "OL": "use POLYOMAVIRUS to search POLYOMAVIRUSES 1978-93 & POLYOMA VIRUS 1966-77", "PM": "94; was POLYOMAVIRUSES 1978-93; was POLYOMA VIRUS 1963-77", "HN": "94; was POLYOMAVIRUSES 1978-93; was POLYOMA VIRUS 1963-77", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D011120"}, {"RECTYPE": "D", "MH": "Polyphloretin Phosphate", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Phosphate, Polyphloretin", "MN": "J01.637.051.720.795", "PA": "Prostaglandin Antagonists", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "1-Propanone, 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-, phosphate, homopolymer", "RN": "9014-72-6", "PI": "Polymers (1966-1974)", "MS": "A polymeric mixture of polyesters of phosphoric acid and phloretin. It blocks some cellular responses to prostaglandins.", "OL": "search PHLORETIN 1973-74", "PM": "91; was see under PHLORETIN 1975-90", "HN": "91(75); was see under PHLORETIN 1975-90", "MR": "20170711", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011121"}, {"RECTYPE": "D", "MH": "Polyphosphates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyphosphate|T197|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D01.695.625.675.650.775", "MH_TH": "NLM (1978)", "ST": "T197", "RN": "0", "PI": "Phosphates (1966-1977)", "MS": "Linear polymers in which orthophosphate residues are linked with energy-rich phosphoanhydride bonds. They are found in plants, animals, and microorganisms.", "PM": "78", "HN": "78", "MR": "20200527", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D011122"}, {"RECTYPE": "D", "MH": "Polyploidy", "ENTRY": "Polyploids", "MN": "G05.700.740", "FX": "Polytene Chromosomes", "MH_TH": "NLM (1968)", "ST": "T049", "PI": "Chromosomes (1966-1967)", "MS": "The chromosomal constitution of a cell containing multiples of the normal number of CHROMOSOMES; includes triploidy (symbol: 3N), tetraploidy (symbol: 4N), etc.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011123"}, {"RECTYPE": "D", "MH": "Polyporaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.179.120.760", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5317", "MS": "A family of bracket fungi, order POLYPORALES, living in decaying plant matter and timber.", "PM": "91; see BASIDIOMYCETES 1975-90", "HN": "91(75); use BASIDIOMYCOTA 1963-74", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011124"}, {"RECTYPE": "D", "MH": "Adenomatous Polyposis Coli", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Polyposis Syndrome, Familial|T191|NON|EQV|NLM (1994)|930329|abcdef", "ENTRY": "Polyposus, Familial Multiple", "MN": "C16.320.700.100", "FX": "Genes, APC", "MH_TH": "ORD (2010)", "ST": "T191", "MS": "A polyposis syndrome due to an autosomal dominant mutation of the APC genes (GENES, APC) on CHROMOSOME 5. The syndrome is characterized by the development of hundreds of ADENOMATOUS POLYPS in the COLON and RECTUM of affected individuals by early adulthood.", "PM": "1994; see POLYPOSIS SYNDROME, FAMILIAL 1987-1993; for ADENOMATOUS POLYPOSIS COLI, FAMILIALsee POLYPOSIS SYNDROME, FAMILIAL 1993", "HN": "1994; use POLYPOSIS SYNDROME, FAMILIAL 1987-1993; for ADENOMATOUS POLYPOSIS COLI, FAMILIAL use POLYPOSIS SYNDROME, FAMILIAL 1993", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19860623", "DC": "1", "DX": "19870101", "UI": "D011125"}, {"RECTYPE": "D", "MH": "Polypropylenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Propylene Polymers|T109|T122|NON|EQV|UNK (19XX)|800401|abbcdef", "ENTRY": "Polypropylene, Marlex", "MN": "J01.637.051.720.716.550", "MH_TH": "NLM (1975)", "ST": "T122", "RN": "0", "PI": "Polymers (1972-1974)", "MS": "Propylene or propene polymers. Thermoplastics that can be extruded into fibers, films or solid forms. They are used as a copolymer in plastics, especially polyethylene. The fibers are used for fabrics, filters and surgical sutures.", "PM": "1991; see PLASTICS 1975-1990; MARLEX was indexed under POLYETHYLENES & POLYPROPYLENES 1983-1999 & POLYMERS 1978-1982", "HN": "1991(1975); for MARLEX use PLASTIPORE (NM) 1978-1999", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011126"}, {"RECTYPE": "D", "MH": "Polyps", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Polyp", "MN": "C23.300.825", "MH_TH": "NLM (1965)", "ST": "T190", "AN": "if neoplastic, coord IM with precoord organ/neopl term (IM), otherwise coord with precoord organ/dis term (IM); COLONIC POLYPS; INTESTINAL POLYPS & NASAL POLYPS are also available", "MS": "Discrete abnormal tissue masses that protrude into the lumen of the DIGESTIVE TRACT or the RESPIRATORY TRACT. Polyps can be spheroidal, hemispheroidal, or irregular mound-shaped structures attached to the MUCOUS MEMBRANE of the lumen wall either by a stalk, pedunculus, or by a broad base.", "PM": "65; was POLYPI 1963-64", "HN": "65; was POLYPI 1963-64", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011127"}, {"RECTYPE": "D", "MH": "Polyradiculopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polyradiculopathy, Abdominal|T047|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Polyradiculopathies, Abdominal", "MN": "C10.668.829.800.750.700", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "do not confuse with POLYRADICULONEUROPATHY (dis of both spinal nerve roots & peripheral nerves) nor with RADICULOPATHY (dis of a single spinal nerve root)", "MS": "Disease or injury involving multiple SPINAL NERVE ROOTS. Polyradiculitis refers to inflammation of multiple spinal nerve roots.", "HN": "2000(1966)", "CATSH": "CAT LIST", "MR": "20180614", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D011128"}, {"RECTYPE": "D", "MH": "Polyradiculoneuropathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polyradiculoneuritis|T047|NON|NRW|NLM (1979)|990101|abcdef", "ENTRY": "Polyradiculoneuropathies", "MN": "C20.111.258.750", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "do not confuse with POLYRADICULOPATHY (dis of multiple nerve roots) nor with RADICULOPATHY (dis of a single nerve root)", "PI": "Polyradiculitis (1966-1978)", "MS": "Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy (GUILLAIN-BARRE SYNDROME) and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots.", "PM": "2000; see POLYRADICULONEURITIS 1979-1999", "HN": "2000(1979)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D011129"}, {"RECTYPE": "D", "MH": "RNA Ligase (ATP)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polyribonucleotide Synthetase|T116|T126|NON|EQV|NLM (1998)|961106|abbcdef", "ENTRY": "Synthetase, Polyribonucleotide", "MN": "D08.811.464.754.720", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "Poly(ribonucleotide):poly(ribonucleotide)ligase (AMP-forming)", "RN": "EC 6.5.1.3", "RR": "37353-39-2 (CAS RN)", "AN": "do not confuse entry term POLYRIBONUCLEOTIDE SYNTHETASE with entry terms POLYDEOXYRIBONUCLEOTIDE SYNTHETASES or POLYNUCLEOTIDE SYNTHETASES", "PI": "Polynucleotide Synthetases (1974-1977)", "MS": "An enzyme that catalyzes the conversion of linear RNA to a circular form by the transfer of the 5'-phosphate to the 3'-hydroxyl terminus. It also catalyzes the covalent joining of two polyribonucleotides in phosphodiester linkage. EC 6.5.1.3.", "PM": "98; see POLYRIBONUCLEOTIDE SYNTHETASE 1991-97; see POLYNUCLEOTIDE SYNTHETASES 1978-90", "HN": "98(78)", "MR": "20050727", "DA": "19770523", "DC": "1", "DX": "19910101", "UI": "D011130"}, {"RECTYPE": "D", "MH": "Polyribonucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D13.695.578.550", "MH_TH": "NLM (1976)", "ST": "T114", "RN": "0", "AN": "13 or more nucleotides", "PI": "Polynucleotides (1966-1975)", "MS": "A group of 13 or more ribonucleotides in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.", "PM": "76", "HN": "76", "MR": "19920520", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D011131"}, {"RECTYPE": "D", "MH": "Polyribosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Polysomes|T026|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Polysome", "MN": "A11.284.430.214.190.875.811.740", "MH_TH": "NLM (1964)", "ST": "T026", "MS": "A multiribosomal structure representing a linear array of RIBOSOMES held together by messenger RNA; (RNA, MESSENGER); They represent the active complexes in cellular protein synthesis and are able to incorporate amino acids into polypeptides both in vivo and in vitro. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)", "PM": "73", "HN": "73", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011132"}, {"RECTYPE": "D", "MH": "Polysaccharide-Lyases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polysaccharide-Lyase|T116|T126|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Polysaccharide Lyases", "MN": "D08.811.520.241.700", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 4.2.2.-", "PI": "Lyases (1966-1974)", "MS": "A group of carbon-oxygen lyases. These enzymes catalyze the breakage of a carbon-oxygen bond in polysaccharides leading to an unsaturated product and the elimination of an alcohol. EC 4.2.2.", "PM": "75", "HN": "75", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D011133"}, {"RECTYPE": "D", "MH": "Polysaccharides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polysaccharide|T109|T121|NON|EQV|NLM (2021)|191113|abbcdef", "MN": "D09.698", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "13 or more units; general or unspecified; prefer specifics", "MS": "Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds.", "PM": "XYLANS was XYLAN see under CELLULOSE 1963-74", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011134"}, {"RECTYPE": "D", "MH": "Polysaccharides, Bacterial", "DE": "POLYSACCHARIDES BACT", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Bacterial Polysaccharides|T109|T129|NON|EQV|UNK (19XX)|780516|BACT POLYSACCHARIDES|abbcdefv", "MN": "D23.050.161.616", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "AN": "general or unspecified; prefer specifics; coordinate with specific bacterium + specific polysaccahride if pertinent", "MS": "Polysaccharides found in bacteria and in capsules thereof.", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011135"}, {"RECTYPE": "D", "MH": "Polysorbates", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tweens|T109|T121|TRD|NRW|UNK (19XX)|741217|abbcdef", "ENTRY": "Tween 85s", "MN": "J01.637.051.720.741.700", "PA": "Surface-Active Agents", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "RR": "9005-65-6", "PI": "specific fatty acid (1966-1973)", "MS": "Sorbitan mono-9-octadecanoate poly(oxy-1,2-ethanediyl) derivatives; complex mixtures of polyoxyethylene ethers used as emulsifiers or dispersing agents in pharmaceuticals.", "OL": "to search TWEENS use SURFACE-ACTIVE AGENTS 1966-74", "PM": "81; was see under POLYETHYLENE GLYCOLS 1975-80; TWEENS was see under SURFACE-ACTIVE AGENTS 1963-74", "HN": "81(75); was see under POLYETHYLENE GLYCOLS 1975-80; TWEENS was see under SURFACE-ACTIVE AGENTS 1963-74", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19810101", "UI": "D011136"}, {"RECTYPE": "D", "MH": "Polystyrenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Polystyrols", "MN": "J01.637.051.720.716.579", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "AN": "STYRENES and STYRENE are available", "MS": "Polymerized forms of styrene used as a biocompatible material, especially in dentistry. They are thermoplastic and are used as insulators, for injection molding and casting, as sheets, plates, rods, rigid forms and beads.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011137"}, {"RECTYPE": "D", "MH": "Polytetrafluoroethylene", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Teflon|T109|T122|TRD|NRW|UNK (19XX)|740330|abbcdef", "ENTRY": "PTFE, Expanded", "MN": "J01.637.051.720.395.616", "MH_TH": "NLM (1973)", "ST": "T122", "N1": "Ethene, tetrafluoro-, homopolymer", "RN": "9002-84-0", "PI": "Fluorocarbon Polymers (1966-1972)", "MS": "Homopolymer of tetrafluoroethylene. Nonflammable, tough, inert plastic tubing or sheeting; used to line vessels, insulate, protect or lubricate apparatus; also as filter, coating for surgical implants or as prosthetic material. Synonyms: Fluoroflex; Fluoroplast; Ftoroplast; Halon; Polyfene; PTFE; Tetron.", "OL": "search FLUOROCARBON POLYMERS 1966-72", "PM": "73; was see under FLUOROCARBON POLYMERS 1966-72", "HN": "73; was see under FLUOROCARBON POLYMERS 1966-72", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011138"}, {"RECTYPE": "D", "MH": "Polythiazide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Renese|T109|T121|TRD|NRW|UNK (19XX)|861113|abbcdef", "MN": "D03.633.100.174.781", "PA": "Sodium Chloride Symporter Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-(((2,2,2-trifluoroethyl)thio)methyl)-, 1,1-dioxide", "RN": "36780APV5N", "RR": "346-18-9 (Polythiazide)", "MS": "A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p826)", "PM": "65", "HN": "65(64)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011139"}, {"RECTYPE": "D", "MH": "Polyurethanes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polyisocyanates|T109|T122|NON|EQV|UNK (19XX)|800515|abbcdef", "ENTRY": "Spandices", "MN": "J01.637.412.700", "MH_TH": "NLM (1968)", "ST": "T122", "RN": "0", "AN": "URETHANE is available", "PI": "Urethane (1966-1967)", "MS": "A group of thermoplastic or thermosetting polymers containing polyisocyanate. They are used as ELASTOMERS, as coatings, as fibers and as foams.", "PM": "1968; SPANDEX was indexed under POLYURETHANES 1975-1999", "HN": "1968; for SPANDEX use POLYURETHANES (NM) 1975-1999", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011140"}, {"RECTYPE": "D", "MH": "Polyuria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Polyurias", "MN": "C23.888.942.600", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Urination of a large volume of urine with an increase in urinary frequency, commonly seen in diabetes (DIABETES MELLITUS; DIABETES INSIPIDUS).", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011141"}, {"RECTYPE": "D", "MH": "Polyvinyl Alcohol", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Tears, Liquifilm", "MN": "J01.637.051.720.716.721.616", "MH_TH": "NLM (1971)", "ST": "T122", "N1": "Ethenol, homopolymer", "RN": "9002-89-5", "PI": "Polyvinyls (1966-1970)", "MS": "A polymer prepared from polyvinyl acetates by replacement of the acetate groups with hydroxyl groups. It is used as a pharmaceutic aid and ophthalmic lubricant as well as in the manufacture of surface coatings artificial sponges, cosmetics, and other products.", "PM": "74", "HN": "74(71)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011142"}, {"RECTYPE": "D", "MH": "Polyvinyl Chloride", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Vinyl Chloride Polymer|T109|T122|NON|EQV|UNK (19XX)|800523|abbcdef", "ENTRY": "Polymer, Vinyl Chloride", "MN": "J01.637.051.720.716.721.812", "MH_TH": "NLM (1975)", "ST": "T122", "N1": "Ethene, chloro-, homopolymer", "RN": "9002-86-2", "PI": "Polyvinyls (1966-1974)", "MS": "A polyvinyl resin used extensively in the manufacture of plastics, including medical devices, tubing, and other packaging. It is also used as a rubber substitute.", "PM": "91; was see under POLYVINYLS 1975-90", "HN": "91(75); was see under POLYVINYLS 1975-90", "MR": "20060705", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D011143"}, {"RECTYPE": "D", "MH": "Polyvinylpyridine N-Oxide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Polyvinylpyridine N Oxide", "MN": "D03.383.725.740", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Pyridine, 2-ethenyl-, 1-oxide, homopolymer", "RN": "9016-06-2", "PI": "Pyridines (1971-1974)", "MS": "Inhibits the cytotoxic action of quartz and is reported to have delayed the development of experimental silicosis in rats.", "PM": "91; was see under POLYVINYLS 1975-90", "HN": "91(75); was see under POLYVINYLS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011144"}, {"RECTYPE": "D", "MH": "Polyvinyls", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Polyvinyl", "MN": "J01.637.051.720.716.721", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "MS": "POLYMERS derived from the monomer VINYL COMPOUNDS.", "MR": "20151201", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011145"}, {"RECTYPE": "D", "MH": "Eczema, Dyshidrotic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vesicular Palmoplantar Eczema|T047|NON|EQV|NLM (1991)|900119|abcdef", "ENTRY": "Vesicular Palmoplantar Eczemas", "MN": "C17.800.865.385", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "eczema with hyperhidrosis", "MS": "A recurrent eczematous reaction characterized by the development of vesicular eruptions on the palms and soles, particularly along the sides and between the digits. It is accompanied by pruritus, a burning sensation, and hyperhidrosis. The disease is self-limiting, lasting only a few weeks. (Dorland, 27th ed)", "OL": "use ECZEMA, DYSHIDROTIC to search POMPHOLYX 1966-92", "PM": "93; was POMPHOLYX 1963-92; ECZEMA, DYSHIDROTIC was see POMPHOLYX 1991-92", "HN": "93; was POMPHOLYX 1963-92; ECZEMA, DYSHIDROTIC was see POMPHOLYX 1991-92", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D011146"}, {"RECTYPE": "D", "MH": "Pongo pygmaeus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Orangutan, Bornean|T015|EPO|EQV|NLM (2010)|090605|abcdef", "ENTRY": "Pongo pygmaeus pygmaeus|T015|NON|NRW|NLM (2010)|090403|abcdef", "MN": "B01.050.150.900.649.313.988.400.112.400.635.650", "MH_TH": "NLM (1981)", "ST": "T015", "RN": "txid9600", "RR": "txid9602", "AN": "diseases: coordinate with APE DISEASES + specific disease /vet", "PI": "Pongidae (1966-1980)", "MS": "A species of orangutan, family HOMINIDAE, found in the forests on the island of Borneo.", "PM": "91; was see under PONGIDAE 1981-90", "HN": "91(81); was see under PONGIDAE 1981-90", "MR": "20200813", "DA": "19800509", "DC": "1", "DX": "19910101", "UI": "D011148"}, {"RECTYPE": "D", "MH": "Pons", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Varolius, Pons", "MN": "A08.186.211.132.810.428.600", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The front part of the hindbrain (RHOMBENCEPHALON) that lies between the MEDULLA and the midbrain (MESENCEPHALON) ventral to the cerebellum. It is composed of two parts, the dorsal and the ventral. The pons serves as a relay station for neural pathways between the CEREBELLUM to the CEREBRUM.", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011149"}, {"RECTYPE": "D", "MH": "Popliteal Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Arteria Poplitea|T023|NON|EQV|NLM (2023)|220408|abcdef", "ENTRY": "Popliteal Arteries", "MN": "A07.015.114.681", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The continuation of the femoral artery coursing through the popliteal fossa; it divides into the anterior and posterior tibial arteries.", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011150"}, {"RECTYPE": "D", "MH": "Popliteal Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Baker's Cyst|T020|T047|EPO|EQV|UNK (19XX)|860623|abbcdef", "ENTRY": "Popliteal Cysts", "MN": "C04.182.867.500", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "non-neoplastic", "PI": "Synovial Cyst (1966-1986)", "MS": "A SYNOVIAL CYST located in the back of the knee, in the popliteal space arising from the semimembranous bursa or the knee joint.", "PM": "91; was see under SYNOVIAL CYST 1987-90", "HN": "91(87); was see under SYNOVIAL CYST 1987-90", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19860623", "DC": "1", "DX": "19910101", "UI": "D011151"}, {"RECTYPE": "D", "MH": "Popliteal Vein", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Popliteal", "MN": "A07.015.908.641", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The vein formed by the union of the anterior and posterior tibial veins; it courses through the popliteal space and becomes the femoral vein.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011152"}, {"RECTYPE": "D", "MH": "Population", "AQ": "GE", "ENTRY": "School-Age Populations", "MN": "N01.600", "MH_TH": "POPLINE (1978)", "ST": "T081", "AN": "IM human, NIM animal; /genet allowed; differentiate from DEMOGRAPHY (the statist study of population characteristics)", "MS": "The total number of individuals inhabiting a particular region or area.", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011153"}, {"RECTYPE": "D", "MH": "Population Characteristics", "ENTRY": "Statistics, Population", "MN": "N01", "RH": "N1 - HEALTH CARE-POPULATION CHARACTERISTICS", "MH_TH": "POPLINE (1978)", "ST": "T102", "AN": "INDEXER: Do not use", "PI": "Population (1971-1997)", "MS": "Qualities and characterization of various types of populations within a social or geographic group, with emphasis on demography, health status, and socioeconomic factors.", "PM": "98", "HN": "98; use explode 1970-97", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D011154"}, {"RECTYPE": "D", "MH": "Population Control", "AQ": "EC ES HI LJ MT SN TD", "ENTRY": "Programs, Population", "MN": "N06.850.505.400.700.650", "FX": "Sterilization, Reproductive", "MH_TH": "POPLINE (1978)", "ST": "T090", "AN": "IM human, NIM animal; specify geog; a broad plane: differentiate from FAMILY PLANNING, a personal level", "PI": "Sterilization, Sexual (1966-1967)", "MS": "Includes mechanisms or programs which control the numbers of individuals in a population of humans or animals.", "PM": "68", "HN": "68", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011155"}, {"RECTYPE": "D", "MH": "Population Density", "PRINT ENTRY": "Underpopulation|T081|NON|NRW|NLM (1990)|POPLINE (1981)|890502|abcdeef", "ENTRY": "Population Sizes", "MN": "N06.850.505.400.600", "FX": "Social Isolation", "MH_TH": "POPLINE (1978)", "ST": "T081", "AN": "IM human, NIM animal", "PI": "Population (1966-1967)", "MS": "Number of individuals in a population relative to space.", "PM": "68", "HN": "68", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011156"}, {"RECTYPE": "D", "MH": "Population Dynamics", "AQ": "HI SN TD", "PRINT ENTRY": "Neomalthusianism|T078|EPO|REL|NLM (1981)|890501|abcdef", "ENTRY": "Transitions, Demographic", "MN": "N06.850.505.400.700", "FX": "Life History Traits", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "IM human, NIM animal; specify geographic location", "MS": "The pattern of any process, or the interrelationship of phenomena, which affects growth or change within a population.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20160226", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D011157"}, {"RECTYPE": "D", "MH": "Population Growth", "PRINT ENTRY": "Population Explosion|T067|NON|NRW|UNK (19XX)|780509|abcdef", "ENTRY": "Trends, Past", "MN": "N06.850.505.400.700.660", "FX": "Population Forecast", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "IM human, NIM animal", "PI": "Population (1966-1967)", "MS": "Increase, over a specific period of time, in the number of individuals living in a country or region.", "OL": "use POPULATION GROWTH to search POPULATION EXPLOSION 1968-78", "PM": "68; POPULATION EXPLOSION was see under POPULATION GROWTH 1968-78", "HN": "68; POPULATION EXPLOSION was see under POPULATION GROWTH 1968-78", "MR": "20150625", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011158"}, {"RECTYPE": "D", "MH": "Population Surveillance", "AQ": "MT", "ENTRY": "Surveillance, Population", "MN": "N06.850.780.675", "MH_TH": "NLM (1965)", "ST": "T062", "AN": "IM human, NIM animal; specify geog", "MS": "Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D011159"}, {"RECTYPE": "D", "MH": "Porfiromycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylmitomycin C|T109|T195|NON|EQV|UNK (19XX)|810514|abbcdef", "MN": "D03.633.100.473.412.249.700", "PA": "Antibiotics, Antineoplastic", "MH_TH": "USAN (1965)", "ST": "T195", "N1": "Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-1,5-dimethyl-, (1aS-(1aalpha,8beta,8aalpha,8balpha))-", "RN": "H1WK901OA6", "RR": "801-52-5 (Porfiromycin)", "PI": "Antibiotics, Antineoplastic (1967-1972)", "MS": "Toxic antibiotic of the mitomycin group, obtained from MITOMYCIN and also from Streptomyces ardus and other species. It is proposed as an antineoplastic agent, with some antibiotic properties.", "PM": "91; was see under MITOMYCINS 1982-90; was heading 1973-81", "HN": "91(82)73; was see under MITOMYCINS 1982-90; was heading 1973-81", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011160"}, {"RECTYPE": "D", "MH": "Porifera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sponges (Zoology)|T204|NON|EQV|NLM (1995)|940224|SPONGES ZOOL|abcdefv", "ENTRY": "Sponge", "MN": "B01.050.500.802", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6040", "RR": "txid6042", "MS": "The phylum of sponges which are sessile, suspension-feeding, multicellular animals that utilize flagellated cells called choanocytes to circulate water. Most are hermaphroditic. They are probably an early evolutionary side branch that gave rise to no other group of animals. Except for about 150 freshwater species, sponges are marine animals. They are a source of ALKALOIDS; STEROLS; and other complex molecules useful in medicine and biological research.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011161"}, {"RECTYPE": "D", "MH": "Porphobilinogen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.578.617", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "1H-Pyrrole-3-propanoic acid, 5-(aminomethyl)-4-(carboxymethyl)-", "RN": "74KHC72QXK", "RR": "487-90-1 (Porphobilinogen)", "AN": "/biosyn /physiol permitted", "PI": "Pyrroles (1966-1971)", "PM": "74", "HN": "74(72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011162"}, {"RECTYPE": "D", "MH": "Hydroxymethylbilane Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Uroporphyrinogen I Synthase|T116|T126|NON|EQV|UNK (19XX)|840416|abbcdef", "ENTRY": "Synthetase, Preuroporphyrinogen", "MN": "D08.811.913.225.575", "FX": "Porphyrias", "EC": "deficiency:Porphyria, Acute Intermittent", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Porphobilinogen ammonia-lyase (polymerizing)", "RN": "EC 2.5.1.61", "RR": "9036-47-9 (CAS RN)", "PI": "Porphobilinogen (1973-1974)", "MS": "An enzyme that catalyzes the tetrapolymerization of the monopyrrole PORPHOBILINOGEN into the hydroxymethylbilane preuroporphyrinogen (UROPORPHYRINOGENS) in several discrete steps. It is the third enzyme in the 8-enzyme biosynthetic pathway of HEME. In humans, deficiency in this enzyme encoded by HMBS (or PBGD) gene results in a form of neurological porphyria (PORPHYRIA, ACUTE INTERMITTENT). This enzyme was formerly listed as EC 4.3.1.8", "PM": "98; see PORPHOBILINOGEN DEAMINASE 1991-97, see AMMONIA-LYASES 1975-90", "HN": "98(75)", "MR": "20090706", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011163"}, {"RECTYPE": "D", "MH": "Porphyrias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Porphyrin Disorders", "MN": "C18.452.811", "FX": "Porphobilinogen Synthase", "MH_TH": "NLM (2005)", "ST": "T047", "AN": "general or unspecified: prefer specifics", "MS": "A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.", "PM": "2005; see PORPHYRIA 1963-2004", "HN": "2005 (1963)", "CATSH": "CAT LIST", "MR": "20150602", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D011164"}, {"RECTYPE": "D", "MH": "Porphyrinogens", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D04.345.783.500.700", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Porphyrins (1968-1974)", "MS": "Colorless reduced precursors of porphyrins in which the pyrrole rings are linked by methylene (-CH2-) bridges.", "PM": "76; was see under PORPHYRINS 1975", "HN": "76(75); was see under PORPHYRINS 1975", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19760101", "UI": "D011165"}, {"RECTYPE": "D", "MH": "Porphyrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Porphyrin|T109|T123|NON|EQV|NLM (2021)|191121|abbcdef", "MN": "D23.767.727", "FX": "Porphobilinogen", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011166"}, {"RECTYPE": "D", "MH": "Portacaval Shunt, Surgical", "DE": "PORTACAVAL SHUNT SURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Eck Fistula|T061|EPO|EQV|UNK (19XX)|800523|abcdef", "ENTRY": "Surgical Portacaval Shunts", "MN": "E04.100.814.868.937.790", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Surgical portasystemic shunt between the portal vein and inferior vena cava.", "OL": "use PORTACAVAL SHUNT, SURGICAL to search PORTACAVAL ANASTOMOSIS 1966-80 & ECK FISTULA 1974-80", "PM": "81; was PORTACAVAL ANASTOMOSIS 1963-80", "HN": "81; was PORTACAVAL ANASTOMOSIS 1963-80; ECK FISTULA was see under PORTACAVAL ANASTOMOSIS 1974-80", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D011167"}, {"RECTYPE": "D", "MH": "Portal System", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Systems, Portal", "MN": "A07.015.908.670", "FX": "Portography", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A system of vessels in which blood, after passing through one CAPILLARY BED, is conveyed through a second set of capillaries before it returns to the systemic circulation. It pertains especially to the hepatic portal system.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011168"}, {"RECTYPE": "D", "MH": "Portal Vein", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Portal", "MN": "A07.015.908.670.567", "FX": "Portography", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A short thick vein formed by union of the superior mesenteric vein and the splenic vein.", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011169"}, {"RECTYPE": "D", "MH": "Portasystemic Shunt, Surgical", "DE": "PORTASYSTEMIC SHUNT SURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Portosystemic Shunt, Surgical|T061|NON|EQV|UNK (19XX)|800325|PORTOSYSTEMIC SHUNT SURG|abcdefv", "ENTRY": "Surgical Portosystemic Shunts", "MN": "E04.100.814.868.937", "MH_TH": "NLM (1981)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "PI": "specific portal system vein/surgery (1966-1980)", "MS": "Surgical venous shunt between the portal and systemic circulation to effect decompression of the portal circulation. It is performed primarily in the treatment of bleeding esophageal varices resulting from portal hypertension. Types of shunt include portacaval, splenorenal, mesocaval, splenocaval, left gastric-caval (coronary-caval), portarenal, umbilicorenal, and umbilicocaval.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19800325", "DC": "1", "DX": "19810101", "UI": "D011170"}, {"RECTYPE": "D", "MH": "Portoenterostomy, Hepatic", "DE": "PORTOENTEROSTOMY", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Hepatic Portoenterostomy|T061|NON|EQV|UNK (19XX)|870320|abcdef", "ENTRY": "Portoenterostomies, Hepatic", "MN": "E04.210.120.775", "FX": "Biliary Atresia", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Liver/surgery (1971-1987)", "MS": "Operation for BILIARY ATRESIA by anastomosis of the BILE DUCTS into the JEJUNUM or DUODENUM.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19870320", "DC": "1", "DX": "19880101", "UI": "D011171"}, {"RECTYPE": "D", "MH": "Portography", "DE": "PORTOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Splenoportography|T060|NON|NRW|UNK (19XX)|850617|SPLENOPORTOGR|abcdefv", "ENTRY": "Splenoportographies", "MN": "E01.370.372.610", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Examination of the portal circulation by the use of X-ray films after injection of radiopaque material.", "OL": "use PORTOGRAPHY to search SPLENOPORTOGRAPHY 1966-85", "PM": "86; was SPLENOPORTOGRAPHY 1963-85", "HN": "86; was SPLENOPORTOGRAPHY 1963-85", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D011172"}, {"RECTYPE": "D", "MH": "Portraits as Topic", "AQ": "CL ED ES HI PX SN TD", "MN": "K01.093.742", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "use only for portraits as a subject; for individual or group portraits in an article, use the Publication Type PORTRAIT", "MS": "Works about graphic representations, especially of the face, of real persons, usually posed, living or dead. (From Thesaurus for Graphic Materials II, p540, 1995)", "PM": "2008; see PORTRAITS 1963-2007", "HN": "2008(1963)", "MR": "20161216", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D011173"}, {"RECTYPE": "D", "MH": "Portugal", "AQ": "EH EP", "PRINT ENTRY": "Madeira Island|T083|NAM|NRW|UNK (19XX)|740501|abcdef", "ENTRY": "Portuguese Republic|T083|NON|EQV|NLM (2018)|161223|abcdef", "MN": "Z01.542.727", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in southwestern Europe, bordering the North Atlantic Ocean, west of Spain. The capital is Lisbon.", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D011174"}, {"RECTYPE": "D", "MH": "Positive-Pressure Respiration", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Positive End-Expiratory Pressure|T061|NON|NRW|NLM (1988)|881129|abcdef", "ENTRY": "Ventilations, Positive-Pressure", "MN": "E02.880.820.790", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "note category: a type of artificial respiration; do not confuse with POSITIVE-PRESSURE RESPIRATION, INTRINSIC, a type of respiratory insufficiency", "MS": "A method of mechanical ventilation in which pressure is maintained to increase the volume of gas remaining in the lungs at the end of expiration, thus reducing the shunting of blood through the lungs and improving gas exchange.", "OL": "use POSITIVE-PRESSURE RESPIRATION to search POSITIVE PRESSURE RESPIRATION 1979-90", "PM": "91; was POSITIVE PRESSURE RESPIRATION 1979-90; was heading 1963-78", "HN": "91; was POSITIVE PRESSURE RESPIRATION 1979-90; was heading 1963-78", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011175"}, {"RECTYPE": "D", "MH": "Post and Core Technique", "DE": "POST CORE TECHNIQUE", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "PRINT ENTRY": "Dental Dowels|T074|NON|REL|NLM (1998)|961108|DENT DOWELS|abcdefv", "ENTRY": "Techniques, Post", "MN": "E07.695.190.088.500", "MH_TH": "NLM (1975)", "ST": "T061", "MS": "Use of a metal casting, usually with a post in the pulp or root canal, designed to support and retain an artificial crown.", "OL": "use POST AND CORE TECHNIQUE to search POST AND CORE TECHNIC 1975-90; search CROWNS 1974", "PM": "91; was POST AND CORE TECHNIC see under CROWNS 1975-90", "HN": "91(75); was POST AND CORE TECHNIC see under CROWNS 1975-90", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011176"}, {"RECTYPE": "D", "MH": "Postal Service", "DE": "POSTAL SERV", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "ENTRY": "Services, Postal", "MN": "I01.451.617", "MH_TH": "NLM (1966)", "ST": "T064", "MS": "The functions and activities carried out by the U.S. Postal Service, foreign postal services, and private postal services such as Federal Express.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011177"}, {"RECTYPE": "D", "MH": "Postgastrectomy Syndromes", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Postgastrectomy", "MN": "C23.550.767.812", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Sequelae of gastrectomy from the second week after operation on. Include recurrent or anastomotic ulcer, postprandial syndromes (DUMPING SYNDROME and late postprandial hypoglycemia), disordered bowel action, and nutritional deficiencies.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011178"}, {"RECTYPE": "D", "MH": "Postmortem Changes", "PRINT ENTRY": "Livor Mortis|T033|NON|NRW|UNK (19XX)|780303|abcdef", "ENTRY": "Postmortem Change", "MN": "C23.550.260.224.617", "MH_TH": "NLM (1970)", "ST": "T046", "PI": "Death (1966-1969)", "MS": "Physiological changes that occur in bodies after death.", "OL": "use POSTMORTEM CHANGES to search ADIPOCERE, ALGOR MORTIS, CRUOR, LIVOR MORTIS & MUMMIFICATION 1970-78", "PM": "70", "HN": "70; ADIPOCERE, ALGOR MORTIS, CRUOR, LIVOR MORTIS & MUMMIFICATION were see under POSTMORTEM CHANGES 1970-78", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D011180"}, {"RECTYPE": "D", "MH": "Postnatal Care", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "ENTRY": "Programs, Postpartum", "MN": "N02.421.585.703.500", "MH_TH": "NLM (1971)", "ST": "T058", "PI": "Puerperium (1966-1970)", "MS": "The care provided to women and their NEWBORNS for the first few months following CHILDBIRTH.", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D011181"}, {"RECTYPE": "D", "MH": "Postoperative Care", "DE": "POSTOP CARE", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Care, Postoperative|T058|NON|EQV|NLM (1998)|961003|CARE POSTOP|abcdefv", "ENTRY": "Procedure, Postoperative", "MN": "N02.421.585.722.700", "FX": "Physical Therapy Modalities", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed)", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011182"}, {"RECTYPE": "D", "MH": "Postoperative Complications", "DE": "POSTOP COMPL", "AQ": "BL CF CI CL CN DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Postoperative Complication", "MN": "C23.550.767", "MH_TH": "NLM (1964)", "ST": "T046", "AN": "coordinate with specific postoperative complication (if not treed under POSTOPERATIVE COMPLICATIONS) and specific surgical procedure if pertinent;  effective 2017:  for postoperative complications that are a direct result of the surgical procedure, coordinate with specific postoperative complication(if not treed under POSTOPERATIVE COMPLICATIONS) and specific surgical procedure /adv eff", "MS": "Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20161110", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D011183"}, {"RECTYPE": "D", "MH": "Postoperative Period", "DE": "POSTOP PERIOD", "ENTRY": "Postoperative Periods", "MN": "N02.421.585.753.750", "MH_TH": "NLM (1979)", "ST": "T079", "AN": "usually NIM", "MS": "The period following a surgical operation.", "PM": "86; was see under SURGERY, OPERATIVE 1979-85", "HN": "86(79); was see under SURGERY, OPERATIVE 1979-85, was in Cat E & H 1979-81", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19780519", "DC": "1", "DX": "19860101", "UI": "D011184"}, {"RECTYPE": "D", "MH": "Postpericardiotomy Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Postcommissurotomy Syndrome|T047|NON|NRW|UNK (19XX)|850311|abcdef", "ENTRY": "Syndromes, Postpericardiotomy", "MN": "C23.550.767.863", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "A nonspecific hypersensitivity reaction caused by TRAUMA to the PERICARDIUM, often following PERICARDIOTOMY. It is characterized by PERICARDIAL EFFUSION; high titers of anti-heart antibodies; low-grade FEVER; LETHARGY; loss of APPETITE; or ABDOMINAL PAIN.", "PM": "91; was see under HEART DISEASES 1965-90", "HN": "91(65); was see under HEART DISEASES 1965-90", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011185"}, {"RECTYPE": "D", "MH": "Postphlebitic Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Postphlebitic Ulcer|T047|NON|NRW|UNK (19XX)|860326|abcdef", "ENTRY": "Ulcers, Postphlebitic", "MN": "C14.907.952.760", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Venous Insufficiency (1973-1986)", "MS": "A condition characterized by a chronically swollen limb, often a leg with stasis dermatitis and ulcerations. This syndrome can appear soon after phlebitis or years later. Postphlebitic syndrome is the result of damaged or incompetent venous valves in the limbs. Distended, tortuous VARICOSE VEINS are usually present. Leg pain may occur after long period of standing.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19860326", "DC": "1", "DX": "19870101", "UI": "D011186"}, {"RECTYPE": "D", "MH": "Posture", "AQ": "PH", "ENTRY": "Postures", "MN": "G11.427.695", "FX": "Patient Positioning", "MH_TH": "NLM (1966)", "ST": "T042", "MS": "The position or physical attitude of the body.", "CATSH": "CAT LIST", "MR": "20180601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011187"}, {"RECTYPE": "D", "MH": "Potassium", "AQ": "AD AE AG AN BL CF CH CL EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.547.650", "FX": "Potassium Radioisotopes", "EC": "deficiency:Potassium Deficiency", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Potassium", "RN": "RWP5GA015D", "RR": "7440-09-7 (Potassium)", "AN": "/blood: note also HYPERKALEMIA and HYPOKALEMIA; POTASSIUM, DIETARY is also available", "MS": "An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.", "MR": "20140612", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011188"}, {"RECTYPE": "D", "MH": "Potassium Chloride", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chloride, Potassium", "MN": "D01.745.625", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Potassium chloride (KCl)", "RN": "660YQ98I10", "RR": "7447-40-7 (Potassium Chloride)", "MS": "A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA.", "PM": "66", "HN": "66(64)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011189"}, {"RECTYPE": "D", "MH": "Potassium Cyanide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Cyanide, Potassium", "MN": "D01.745.635", "PA": "Poisons", "MH_TH": "NLM (1979)", "ST": "T197", "N1": "Potassium cyanide (K(CN))", "RN": "MQD255M2ZO", "RR": "5373-08-0 (K((14)CN))", "PI": "Potassium (1966-1978)", "MS": "A highly poisonous compound that is an inhibitor of many metabolic processes, but has been shown to be an especially potent inhibitor of heme enzymes and hemeproteins. It is used in many industrial processes.", "PM": "91; was see under CYANIDES 1979-90", "HN": "91(79); was see under CYANIDES 1979-90", "MR": "20130708", "DA": "19780313", "DC": "1", "DX": "19910101", "UI": "D011190"}, {"RECTYPE": "D", "MH": "Potassium Deficiency", "DE": "POTASSIUM DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Potassium Deficiencies", "MN": "C18.654.521.500.617", "FX": "Hypokalemia", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A condition due to decreased dietary intake of potassium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss in diarrhea, chronic laxative abuse, vomiting, gastric suction, or bowel diversion. Severe potassium deficiency may produce muscular weakness and lead to paralysis and respiratory failure. Muscular malfunction may result in hypoventilation, paralytic ileus, hypotension, muscle twitches, tetany, and rhabomyolysis. Nephropathy from potassium deficit impairs the concentrating mechanism, producing POLYURIA and decreased maximal urinary concentrating ability with secondary POLYDIPSIA. (Merck Manual, 16th ed)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011191"}, {"RECTYPE": "D", "MH": "Potassium Dichromate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Potassium Bichromate|T121|T131|T197|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbbcdeef", "ENTRY": "Dichromate, Potassium", "MN": "D01.745.650", "PA": "Coloring Agents", "MH_TH": "NLM (1975)", "ST": "T197", "N1": "Chromic acid (H2Cr2O7), dipotassium salt", "RN": "T4423S18FM", "RR": "7778-50-9 (Potassium Dichromate)", "AN": "an astringent, caustic, antiseptic & dye", "PI": "Chromates (1969-1974)", "MS": "Chromic acid (H2Cr2O7), dipotassium salt. A compound having bright orange-red crystals and used in dyeing, staining, tanning leather, as bleach, oxidizer, depolarizer for dry cells, etc. Medically it has been used externally as an astringent, antiseptic, and caustic. When taken internally, it is a corrosive poison.", "PM": "91; was see under CHROMATES 1975-90", "HN": "91(75); was see under CHROMATES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011192"}, {"RECTYPE": "D", "MH": "Potassium Iodide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Thyro Block", "MN": "D01.745.680", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Potassium iodide (KI)", "RN": "1C4QK22F9J", "RR": "7681-11-0 (Potassium Iodide)", "AN": "useful source of iodine in thyrotoxic crisis", "MS": "An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed)", "PM": "65", "HN": "65", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011193"}, {"RECTYPE": "D", "MH": "Potassium Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Potassium", "MN": "D01.552.547.650.500", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable potassium atoms that have the same atomic number as the element potassium, but differ in atomic weight. K-41 is a stable potassium isotope.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011194"}, {"RECTYPE": "D", "MH": "Potassium Magnesium Aspartate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Potassium Magnesium Asparaginate|T116|T121|NON|REL|UNK (19XX)|760412|abbcdef", "ENTRY": "Magnesium Aspartate, Potassium", "MN": "D12.125.119.170.700", "PA": "Cardiotonic Agents", "FX": "Electrolytes", "MH_TH": "NLM (1977)", "ST": "T121", "N1": "DL-Aspartic acid, monopotassium salt, mixt. with potassium hydrogen (T-4)-bis(DL-aspartato(2-)-N,O1)magnesate(2-)", "RN": "8076-65-1", "PI": "Potassium (1972-1975)", "MS": "An intra-extracellular electrolyte exchange agent with a variety of effects.", "PM": "91; was see under ASPARTIC ACID 1977-90", "HN": "91(77); was see under ASPARTIC ACID 1977-90", "MR": "20010725", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D011195"}, {"RECTYPE": "D", "MH": "Potassium Permanganate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Permanganate, Potassium", "MN": "D01.745.750", "PA": "Indicators and Reagents", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Permanganic acid (HMnO4), potassium salt", "RN": "00OT1QX5U4", "RR": "7722-64-7 (Potassium Permanganate)", "MS": "Permanganic acid (HMnO4), potassium salt. A highly oxidative, water-soluble compound with purple crystals, and a sweet taste. (From McGraw-Hill Dictionary of Scientific and Technical Information, 4th ed)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011196"}, {"RECTYPE": "D", "MH": "Potassium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Potassium", "MN": "D01.552.547.650.500.700", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Radioisotopes (1966-1974)", "MS": "Unstable isotopes of potassium that decay or disintegrate emitting radiation. K atoms with atomic weights 37, 38, 40, and 42-45 are radioactive potassium isotopes.", "OL": "search POTASSIUM ISOTOPES 1966-74", "PM": "75", "HN": "75", "MR": "20170425", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D011197"}, {"RECTYPE": "D", "MH": "Solanum tuberosum", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Potatoes|T168|NON|NRW|NLM (1986)|990101|abcdef", "ENTRY": "tuberosums, Solanum", "MN": "B01.875.800.575.912.250.908.500.725.777", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid4113", "AN": "SWEET POTATO see IPOMOEA BATAS is also available", "PI": "Vegetables (1966-1985)", "MS": "A plant species of the genus SOLANUM, family SOLANACEAE. The starchy roots are used as food. SOLANINE is found in green parts.", "PM": "2006; see POTATOES 1986-2005", "HN": "2006(1986)", "MR": "20210630", "DA": "19850503", "DC": "1", "DX": "19860101", "UI": "D011198"}, {"RECTYPE": "D", "MH": "Potentiometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "MN": "E05.301.710", "MH_TH": "NLM (1964)", "ST": "T081", "AN": "a type of titrimetry; NIM", "MS": "Solution titration in which the end point is read from the electrode-potential variations with the concentrations of potential determining ions. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D011199"}, {"RECTYPE": "D", "MH": "Poultry", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Fowls, Domestic|T012|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Poultries", "MN": "J02.500.600.750", "MH_TH": "NLM (1966)", "ST": "T012", "MS": "Domesticated birds raised for food. It typically includes CHICKENS; TURKEYS, DUCKS; GEESE; and others.", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011200"}, {"RECTYPE": "D", "MH": "Poultry Diseases", "DE": "POULTRY DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Poultry Disease", "MN": "C22.131.728", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific poultry (IM); for abnormalities or injuries, index under POULTRY /abnorm or POULTRY /inj; don't forget also POULTRY (NIM) if no specific fowl is indexed; also check tag ANIMALS; differentiate from BIRD DISEASES on basis of definition of BIRDS & POULTRY under POULTRY", "MS": "Diseases of birds which are raised as a source of meat or eggs for human consumption and are usually found in barnyards, hatcheries, etc. The concept is differentiated from BIRD DISEASES which is for diseases of birds not considered poultry and usually found in zoos, parks, and the wild.", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011201"}, {"RECTYPE": "D", "MH": "Poultry Products", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Products, Poultry", "MN": "J02.500.600.750.500", "FX": "Eggs", "MH_TH": "NLM (1968)", "ST": "T168", "AN": "coordinate IM with poultry source (NIM ): canned poultry meat: coordinate POULTRY or specific poultry (IM) with FOOD CANNED see FOOD, PRESERVED", "PI": "Poultry (1966-1967)", "MS": "Food products manufactured from poultry.", "PM": "68", "HN": "68", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011202"}, {"RECTYPE": "D", "MH": "Poverty", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Low-Income Population|T098|NON|REL|NLM (1990)|890502|abcdef", "ENTRY": "Poverty, Extreme", "MN": "N01.824.600", "FX": "Cultural Deprivation", "MH_TH": "POPLINE (1981)", "ST": "T102", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH; specify geographic location if pertinent", "MS": "A situation in which the level of living of an individual, family, or group is below the standard of the community. It is often related to a specific income level.", "PM": "68", "HN": "68", "MR": "20220713", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011203"}, {"RECTYPE": "D", "MH": "Poverty Areas", "PRINT ENTRY": "Slums|T080|NON|NRW|POPLINE (1986)|790531|abcdef", "ENTRY": "Slum", "MN": "N01.824.600.550", "MH_TH": "NLM (1980)", "ST": "T080", "PI": "Poverty (1968-1979)", "MS": "City, urban, rural, or suburban areas which are characterized by severe economic deprivation and by accompanying physical and social decay.", "PM": "91; was see under POVERTY 1980-90", "HN": "91(80); was see under POVERTY 1980-90", "MR": "19991103", "DA": "19790531", "DC": "1", "DX": "19910101", "UI": "D011204"}, {"RECTYPE": "D", "MH": "Povidone", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polyvinylpyrrolidone|T109|T121|T122|NON|EQV|UNK (19XX)|800523|abbbcdef", "ENTRY": "Unspecified Povidone", "MN": "J01.637.051.720.716.721.838", "PA": "Plasma Substitutes", "MH_TH": "USP (19XX)", "ST": "T122", "N1": "2-Pyrrolidinone, 1-ethenyl-, homopolymer", "RN": "FZ989GH94E", "RR": "9003-39-8", "MS": "A polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander.", "OL": "use POVIDONE to search POLYVINYLPYRROLIDONE 1966-80", "PM": "81; was POLYVINYLPYRROLIDONE 1963-80", "HN": "81; was POLYVINYLPYRROLIDONE 1963-80", "MR": "20180613", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D011205"}, {"RECTYPE": "D", "MH": "Povidone-Iodine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyvinylpyrrolidone Iodine|T109|T121|NON|EQV|UNK (19XX)|800523|abbcdef", "ENTRY": "Providines", "MN": "J01.637.051.720.716.721.838.745", "PA": "Anti-Infective Agents, Local", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2-Pyrrolidinone, 1-ethenyl-, homopolymer, compd. with iodine", "RN": "85H0HZU99M", "RR": "25655-41-8", "MS": "An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabeled for research purposes.", "PM": "91; was see under POVIDONE 1981-90; was see under POLYVINYLPYRROLIDONE 1975-80", "HN": "91(66); was see under POVIDONE 1981-90; was see under POLYVINYLPYRROLIDONE 1975-80", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011206"}, {"RECTYPE": "D", "MH": "Powders", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Powder|T122|NON|EQV|NLM (2021)|200106|abcdef", "MN": "D26.255.779", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "AN": "NIM (no qualifiers) with specific drug IM; /adv eff permitted but use only for the adverse effect of the powder itself and not the drug in powder form  ", "MS": "Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011208"}, {"RECTYPE": "D", "MH": "Power, Psychological", "PRINT ENTRY": "Power, Social|T068|NON|NRW|UNK (19XX)|870409|abcdef", "ENTRY": "Social Power", "MN": "F01.658.780", "FX": "Social Control, Informal", "MH_TH": "NLM (2020)", "ST": "T068", "MS": "The exertion of a strong influence or control over others in a variety of settings--administrative, social, academic, etc.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20181012", "DA": "19870409", "DC": "1", "DX": "19880101", "UI": "D011209"}, {"RECTYPE": "D", "MH": "Power Plants", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Thermoelectric Power Plants|T073|NON|NRW|UNK (19XX)|760516|abcdef", "ENTRY": "Thermoelectric Power Plant", "MN": "J03.540.680", "MH_TH": "NLM (1977)", "ST": "T073", "AN": "on an industrial & technology level: differentiate from POWER SOURCES; coordinate with source of power if pertinent", "PI": "Occupational Medicine (1966-1976)", "MS": "Units that convert some other form of energy into electrical energy.", "PM": "77", "HN": "77", "MR": "20160613", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D011210"}, {"RECTYPE": "D", "MH": "Electric Power Supplies", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Power Supplies|T073|NON|EQV|NLM (1992)|910506|abcdef", "ENTRY": "Supply, Electric Power", "MN": "E07.305.124", "FX": "Energy-Generating Resources", "MH_TH": "NLM (2006)", "ST": "T073", "AN": "do not confuse with POWER PLANTS which are on an industrial level", "MS": "Devices that control the supply of electric current for running electrical equipment.", "PM": "2006; see POWER SOURCES 1977-2005", "HN": "2006 (1977)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D011211"}, {"RECTYPE": "D", "MH": "Poxviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Poxviruses|T005|NON|EQV|UNK (19XX)|800515|abcdef", "MN": "B04.280.650", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid10240", "MS": "A family of double-stranded DNA viruses infecting mammals (including humans), birds and insects. There are two subfamilies: CHORDOPOXVIRINAE, poxviruses of vertebrates, and ENTOMOPOXVIRINAE, poxviruses of insects.", "OL": "use POXVIRIDAE to search POXVIRUSES 1975-80 & POXVIRUS 1966-74", "PM": "81; was POXVIRUSES 1975-80, was POXVIRUS 1963-74", "HN": "81; was POXVIRUSES 1975-80, was POXVIRUS 1963-74", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D011212"}, {"RECTYPE": "D", "MH": "Poxviridae Infections", "DE": "POXVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Poxvirus Infections|T047|NON|EQV|NLM (1994)|930511|POXVIRUS INFECT|abcdefv", "ENTRY": "Poxvirus Infection", "MN": "C01.925.256.743", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Virus diseases caused by the POXVIRIDAE.", "OL": "use POXVIRIDAE INFECTIONS to search MILKER'S NODES 1975-96 & POXVIRUS INFECTIONS 1966-93", "PM": "94; was POXVIRUS INFECTIONS 1963-93; MILKER'S NODES was heading 1975-96 (see under POXVIRUS INFECTIONS 1975-90)", "HN": "94; was POXVIRUS INFECTIONS 1963-93; MILKER'S NODES was heading 1975-96 (see under POXVIRUS INFECTIONS 1975-90)", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D011213"}, {"RECTYPE": "D", "MH": "Practice, Psychological", "PRINT ENTRY": "Practicing, Psychology|T041|T055|NON|EQV|NLM (2020)|190118|abbcdef", "ENTRY": "Psychology Practicing", "MN": "F02.463.425.674", "MH_TH": "NLM (2020)", "ST": "T055", "AN": "human & animal", "MS": "Performance of an act one or more times, with a view to its fixation or improvement; any performance of an act or behavior that leads to learning.", "PM": "2020; was PRACTICE (PSYCHOLOGY) 1966-2019", "HN": "2020 (1966); was PRACTICE (PSYCHOLOGY) 1966-2019", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011214"}, {"RECTYPE": "D", "MH": "Practice Management, Dental", "DE": "PRACTICE MANAGEMENT DENT", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Dental Practice Management Services|T057|NON|NRW|NLM (1999)|980310|DENT PRACTICE MANAGEMENT SERV|abcdefv", "ENTRY": "Practice Management Services, Dental|T057|NON|NRW|NLM (1999)|980406|PRACTICE MANAGEMENT SERV DENT|abcdefv", "MN": "N04.452.758.708.300", "MH_TH": "NLM (1968)", "ST": "T058", "PI": "Office Management (1966-1967)", "MS": "The organization and operation of the business aspects of a dental practice.", "PM": "2015; for DENTAL PRACTICE MANAGEMENT SERVICES see PRACTICE MANAGEMENT 1968-2014", "HN": "2015(1968); for DENTAL PRACTICE MANAGEMENT SERVICES use PRACTICE MANAGEMENT 1968-2014", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011215"}, {"RECTYPE": "D", "MH": "Practice Management, Medical", "DE": "PRACTICE MANAGEMENT MED", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Medical Practice Management Services|T058|NON|NRW|NLM (1999)|980310|MED PRACTICE MANAGEMENT SERV|abcdefv", "ENTRY": "Practice Managements, Medical", "MN": "N04.452.758.708.450", "MH_TH": "NLM (1968)", "ST": "T058", "PI": "Office Management (1966-1967)", "MS": "The organization and operation of the business aspects of a physician's practice.", "PM": "2015; for MEDICAL PRACTICE MANAGEMENT SERVICES see PRACTICE MANAGEMENT 1968-2014", "HN": "2015(1968); for MEDICAL PRACTICE MANAGEMENT SERVICES use PRACTICE MANAGEMENT 1968-2014", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011216"}, {"RECTYPE": "D", "MH": "Practolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Practolol, Eralzdin", "MN": "D02.092.146.113.092.800", "PA": "Anti-Arrhythmia Agents", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "Acetamide, N-(4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-", "RN": "SUG9176GRW", "RR": "6673-35-4 (Practolol)", "MS": "A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.", "PM": "74", "HN": "74", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011217"}, {"RECTYPE": "D", "MH": "Prader-Willi Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Royer Syndrome|T019|T047|EPO|REL|NLM (2000)|991103|abbcdef", "ENTRY": "Willi Prader Syndrome", "MN": "C18.654.726.750.500.740", "FX": "Intellectual Disability", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Obesity (1966-1976)", "MS": "An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229)", "PM": "1977", "HN": "1977", "CATSH": "CAT LIST", "MR": "20230414", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D011218"}, {"RECTYPE": "D", "MH": "Prajmaline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prajmalium|T109|T121|NON|EQV|UNK (19XX)|790302|abbcdef", "ENTRY": "NeoGilurytmal", "MN": "D03.633.100.496.500.500.681.077.650", "PA": "Anti-Arrhythmia Agents", "MH_TH": "NLM (1980)", "ST": "T121", "N1": "Ajmalanium, 17,21-dihydroxy-4-propyl-, (17R,21alpha)-", "RN": "75934UD4GJ", "RR": "H671L9190Z", "PI": "Rauwolfia (1966-1971)", "MS": "A derivative of the rauwolfia alkaloid AJMALINE. It is an anti-arrhythmia agent but may cause liver damage.", "PM": "91; was see under AJMALINE 1980-90", "HN": "91(80); was see under AJMALINE 1980-90", "MR": "20210630", "DA": "19790302", "DC": "1", "DX": "19910101", "UI": "D011219"}, {"RECTYPE": "D", "MH": "Pralidoxime Compounds", "DE": "PRALIDOXIME CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyridine Aldoxime Methyl Compounds|T109|NON|EQV|UNK (19XX)|820429|PYRIDINE ALDOXIME METHYL CPDS|abcdefv", "ENTRY": "Compounds, Pralidoxime", "MN": "D02.092.570.665.535", "MH_TH": "NLM (1963)", "ST": "T109", "RN": "0", "MS": "Various salts of a quaternary ammonium oxime that reconstitute inactivated acetylcholinesterase, especially at the neuromuscular junction, and may cause neuromuscular blockade. They are used as antidotes to organophosphorus poisoning as chlorides, iodides, methanesulfonates (mesylates), or other salts.", "PM": "65", "HN": "65(63)", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011220"}, {"RECTYPE": "D", "MH": "Praseodymium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.750", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Praseodymium", "RN": "NKN7EZA750", "RR": "7440-10-0 (Praseodymium)", "MS": "An element of the rare earth family of metals. It has the atomic symbol Pr, atomic number 59, and atomic weight 140.91.", "MR": "20170704", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011221"}, {"RECTYPE": "D", "MH": "Prazepam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Reapam|T109|T121|TRD|NRW|NL|041111|abbcdef", "MN": "D03.633.100.079.080.070.784", "PA": "GABA Modulators", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-", "RN": "Q30VCC064M", "RR": "2955-38-6 (Prazepam)", "PI": "Muscle Relaxants, Central (1970-1971)", "MS": "A benzodiazepine that is used in the treatment of ANXIETY DISORDERS.", "PM": "73", "HN": "73(72)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011222"}, {"RECTYPE": "D", "MH": "Praziquantel", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Traziquantel|T109|T121|TRD|NRW|UNK (19XX)|820302|abbcdef", "MN": "D03.633.100.531.690", "PA": "Anthelmintics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4H-Pyrazino(2,1-a)isoquinolin-4-one, 2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-", "RN": "6490C9U457", "RR": "57452-98-9 ((R)-isomer)", "PI": "Quinolines (1966-1968)", "MS": "An anthelmintic used in most schistosome and many cestode infestations.", "PM": "86; see ISOQUINOLINES 1980-85", "HN": "86(80)", "MR": "20170524", "DA": "19790530", "DC": "1", "DX": "19860101", "UI": "D011223"}, {"RECTYPE": "D", "MH": "Prazosin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Furazosin|T109|T121|NON|EQV|UNK (19XX)|760413|abbcdef", "ENTRY": "Hydrochloride, Prazosin", "MN": "D03.633.100.786.750", "PA": "Antihypertensive Agents", "MH_TH": "JAN (19XX)", "ST": "T121", "N1": "Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-", "RN": "XM03YJ541D", "RR": "X0Z7454B90", "PI": "Quinazolines (1974-1976)", "MS": "A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.", "PM": "86; was see under QUINAZOLINES 1977-85", "HN": "86(77); was see under QUINAZOLINES 1977-85", "MR": "20170524", "DA": "19760413", "DC": "1", "DX": "19860101", "UI": "D011224"}, {"RECTYPE": "D", "MH": "Pre-Eclampsia", "DS": "PREECLAMPSIA", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Toxemias, Pregnancy|T047|NON|EQV|NLM (2005)|031106|abcdef", "ENTRY": "Toxemias, EPH", "MN": "C12.050.703.395.249", "FX": "Toxemia", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "check tags FEMALE & PREGNANCY", "PI": "Pregnancy Toxemias (1966-1974)", "MS": "A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.", "PM": "1979; see PREGNANCY TOXEMIAS 1963-1978; for PREGNANCY TOXEMIAS see PREGNANCY TOXEMIAS 1963-2004; for EDEMA-PROTEINURIA-HYPERTENSION GESTOSIS see GESTOSIS, EPH 1989-2004", "HN": "1979(1963)", "CATSH": "CAT LIST", "MR": "20230426", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D011225"}, {"RECTYPE": "D", "MH": "Pre-Excitation Syndromes", "DS": "PREEXCITATION SYNDROMES", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Preexcitation Syndromes", "MN": "C14.280.123.750", "MH_TH": "NLM (1986)", "ST": "T047", "AN": "general, prefer specifics", "PI": "Tachycardia (1966-1985)", "MS": "A group of conditions in which HEART VENTRICLE activation by the atrial impulse is faster than the normal impulse conduction from the SINOATRIAL NODE. In these pre-excitation syndromes, atrial impulses often bypass the ATRIOVENTRICULAR NODE delay and travel via ACCESSORY CONDUCTING PATHWAYS connecting the atrium directly to the BUNDLE OF HIS.", "PM": "1986", "HN": "1986", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19850320", "DC": "1", "DX": "19860101", "UI": "D011226"}, {"RECTYPE": "D", "MH": "Pre-Excitation, Mahaim-Type", "DS": "PREEXCITATION MAHAIM TYPE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mahaim-Type Pre-Excitation|T047|EPO|EQV|UNK (19XX)|850320|abcdef", "ENTRY": "Preexcitation, Mahaim-Type", "MN": "C14.280.123.750.770", "MH_TH": "NLM (1986)", "ST": "T047", "AN": "SHORT PR NORMAL QRS COMPLEX SYNDROME see LOWN-GANONG-LEVINE SYNDROME is available", "MS": "A form of ventricular pre-excitation characterized by a normal PR interval and a long QRS interval with an initial slow deflection (delta wave). In this syndrome, the atrial impulse travel to the ventricle via the MAHAIM FIBERS which connect ATRIOVENTRICULAR NODE directly to the right ventricle wall (NODOVENTRICULAR ACCESSORY PATHWAY) or to the RIGHT BUNDLE BRANCH OF HIS (nodofascicular accessory pathway).", "OL": "use PRE-EXCITATION, MAHAIM-TYPE to search PRE-EXCITATION, MAHAIM TYPE 1986-91", "PM": "92; was PRE-EXCITATION, MAHAIM TYPE 1986-91 (see under PRE-EXCITATION SYNDROMES 1986-90)", "HN": "92; was PRE-EXCITATION, MAHAIM TYPE 1986-91 (see under PRE-EXCITATION SYNDROMES 1986-90)", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19850320", "DC": "1", "DX": "19910101", "UI": "D011227"}, {"RECTYPE": "D", "MH": "Prealbumin", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transthyretin|T116|T123|NON|EQV|NLM (1990)|890414|abbcdef", "MN": "D12.776.124.727.750", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "/biosyn /drug eff /physiol permitted", "PI": "Serum Albumin (1972-1974)", "MS": "A tetrameric protein, molecular weight between 50,000 and 70,000, consisting of 4 equal chains, and migrating on electrophoresis in 3 fractions more mobile than serum albumin. Its concentration ranges from 7 to 33 per cent in the serum, but levels decrease in liver disease.", "PM": "84; was see under SERUM ALBUMIN 1975-83", "HN": "84(75); was see under SERUM ALBUMIN 1975-83", "MR": "20150623", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D011228"}, {"RECTYPE": "D", "MH": "Preanesthetic Medication", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Preanesthetic Medications", "MN": "N02.421.585.722.775.750", "MH_TH": "POPLINE (1978)", "ST": "T061", "MS": "Drugs administered before an anesthetic to decrease a patient's anxiety and control the effects of that anesthetic.", "PM": "1966", "HN": "1966", "CATSH": "CAT LIST", "MR": "20220408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011229"}, {"RECTYPE": "D", "MH": "Precancerous Conditions", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Preneoplastic Conditions|T079|T191|NON|BRD|NLM (1996)|941208|PRENEOPL CONDITIONS|abbcdefv", "ENTRY": "Precancerous Condition", "MN": "C04.834", "MH_TH": "NLM (1968)", "ST": "T191", "AN": "IM; do not use /compl for develop into cancer: use /pathol; coord IM with organ/neopl term (IM); Manual 24.4.1.13", "MS": "Pathological conditions that tend eventually to become malignant.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20170707", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011230"}, {"RECTYPE": "D", "MH": "Preceptorship", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Clinical Supervision|T065|NON|REL|NLM (2022)|210416|abcdef", "ENTRY": "Work, Medical Field", "MN": "I02.358.968", "MH_TH": "NLM (1975)", "ST": "T065", "PI": "Education, Medical (1966-1974)", "MS": "Practical experience in medical and health-related services that occurs as part of an educational program wherein the professionally-trained student works outside the academic environment under the SUPERVISION of an established professional in the particular field.", "PM": "75", "HN": "75", "MR": "20210707", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D011231"}, {"RECTYPE": "D", "MH": "Chemical Precipitation", "AQ": "DE RE", "ENTRY": "Precipitation, Chemical", "MN": "G02.159", "MH_TH": "NLM (2010)", "ST": "T070", "AN": "do not use for precipitation as a weather phenomenon", "MS": "The formation of a solid in a solution as a result of a chemical reaction or the aggregation of soluble substances into complexes large enough to fall out of solution.", "PM": "2010; see PRECIPITATION 1966-2009", "HN": "2010 (1964)", "MR": "20160115", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011232"}, {"RECTYPE": "D", "MH": "Precipitin Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Precipitin", "MN": "E05.478.605.492", "MH_TH": "NLM (1966)", "ST": "T059", "MS": "Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011233"}, {"RECTYPE": "D", "MH": "Precipitins", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immune Precipitates|T129|NON|REL|UNK (19XX)|880323|abcdef", "ENTRY": "Precipitates, Immune", "MN": "D12.776.377.715.548.114.837", "PA": "Agglutinins", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "MS": "Antibodies which elicit IMMUNOPRECIPITATION when combined with antigen.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011234"}, {"RECTYPE": "D", "MH": "Predatory Behavior", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Predation|T054|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Predatory Behaviors", "MN": "F01.145.113.252.520", "MH_TH": "NLM (1975)", "ST": "T054", "AN": "animal only", "MS": "Instinctual behavior pattern in which food is obtained by killing and consuming other species.", "PM": "91; was see under APPETITIVE BEHAVIOR 1975-90", "HN": "91(75); was see under APPETITIVE BEHAVIOR 1975-90", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D011235"}, {"RECTYPE": "D", "MH": "Prediabetic State", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Prediabetes|T047|NON|EQV|NLM (2005)|040622|abcdef", "ENTRY": "States, Prediabetic", "MN": "C19.246.774", "FX": "Hyperglycemia", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "do not use /compl for development into diabetes mellitus; coordinate IM with specific type of diabetes mellitus (IM) if pertinent", "MS": "The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).", "PM": "68", "HN": "68(65)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011236"}, {"RECTYPE": "D", "MH": "Predictive Value of Tests", "PRINT ENTRY": "Predictive Values Of Tests|T081|NON|EQV|NLM (2021)|200113|abcdef", "ENTRY": "Predictive Value, Positive", "MN": "N06.850.520.445.800.650", "FX": "False Positive Reactions", "MH_TH": "NLM (1987)", "ST": "T081", "AN": "IM general only", "MS": "In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19860325", "DC": "1", "DX": "19870101", "UI": "D011237"}, {"RECTYPE": "D", "MH": "Prednimustine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NSC134087", "MN": "D04.210.500.745.432.769.795.700", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "USAN (1979)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 21-(4-(4-(bis(2-chloroethyl)amino)phenyl)-1-oxobutoxy)-11,17-dihydroxy-, (11beta)-", "RN": "9403SIO2S8", "RR": "29069-24-7 (Prednimustine)", "PI": "Prednisolone (1966-1974) /analogs & derivatives (1975-1979)", "MS": "Ester of CHLORAMBUCIL and PREDNISOLONE used as a combination alkylating agent and synthetic steroid to treat various leukemias and other neoplasms. It causes gastrointestinal and bone marrow toxicity.", "PM": "91; was see under CHLORAMBUCIL 1980-90", "HN": "91(80); was see under CHLORAMBUCIL 1980-90", "MR": "20170524", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D011238"}, {"RECTYPE": "D", "MH": "Prednisolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "DiAdresonF", "MN": "D04.210.500.745.432.769.795", "PA": "Glucocorticoids", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-", "RN": "9PHQ9Y1OLM", "RR": "50-24-8 (Prednisolone)", "MS": "A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.", "PM": "/therapeutic use was PREDNISOLONE, THERAPEUTIC 1965", "HN": "/therapeutic use was PREDNISOLONE, THERAPEUTIC 1965", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011239"}, {"RECTYPE": "D", "MH": "Prednisone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "delta-Cortisone|T109|T121|NON|EQV|NLM (1998)|961219|abbcdef", "ENTRY": "Acsis, Prednison", "MN": "D04.210.500.745.432.719.702", "PA": "Glucocorticoids", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,11,20-trione, 17,21-dihydroxy-", "RN": "VB0R961HZT", "RR": "53-03-2 (Prednisone)", "AN": "note entry term DECORTIN: DECORTIN (DESOXYCORTICOSTERONE) see DESOXYCORTICOSTERONE is also available", "MS": "A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.", "PM": "/adverse effects /poisoning /toxicity were PREDNISONE TOXICOLOGY 1963-65; /therapeutic use was PREDNISONE, THERAPEUTIC 1965", "HN": "/adv eff-pois-tox was PREDNISONE TOXICOLOGY 1963-65; /ther use was PREDNISONE, THERAPEUTIC 1965", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011241"}, {"RECTYPE": "D", "MH": "Preferred Provider Organizations", "DE": "PREFERRED PROVIDER ORGAN", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Organization, Preferred Provider", "MN": "N04.590.374.410.750", "MH_TH": "NLM (1985)", "ST": "T093", "AN": "specify geog if possible", "PI": "Insurance, Health (1966-1984)", "MS": "Arrangements negotiated between a third-party payer (often a self-insured company or union trust fund) and a group of health-care providers (hospitals and physicians) who furnish services at lower than usual fees, and, in return, receive prompt payment and an expectation of an increased volume of patients.", "OL": "use INSURANCE, HEALTH to search PREFERRED PROVIDER ORGANIZATIONS 1984", "PM": "91; was see under MANAGED CARE PROGRAMS 1990; was see under INSURANCE, HEALTH 1985-89; was see INSURANCE, HEALTH 1984", "HN": "91(85); was see under MANAGED CARE PROGRAMS 1990; was see under INSURANCE, HEALTH 1985-89; was see INSURANCE, HEALTH 1984", "MR": "20190524", "DA": "19840413", "DC": "1", "DX": "19910101", "UI": "D011243"}, {"RECTYPE": "D", "MH": "Pregnadienediols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dihydroxypregnadienes|T109|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "D04.210.500.745.432.719", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Doubly unsaturated pregnane derivatives with two hydroxy groups substituted anywhere on the rings or side chains.", "PM": "74", "HN": "74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011244"}, {"RECTYPE": "D", "MH": "Pregnadienes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.745.432", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "PI": "Pregnanes (1966-1972)", "MS": "Pregnane derivatives containing two double bonds anywhere within the ring structures.", "PM": "73", "HN": "73", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011245"}, {"RECTYPE": "D", "MH": "Pregnadienetriols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trihydroxypregnadienes|T109|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "D04.210.500.745.432.769", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Doubly unsaturated pregnane derivatives substituted with three hydroxy groups anywhere within the ring structure or side chains.", "PM": "74", "HN": "74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011246"}, {"RECTYPE": "D", "MH": "Pregnancy", "DE": "PREGN", "AQ": "BL CF DE EH ES GE IM ME PH PX RE SN UR", "PRINT ENTRY": "Gestation|T040|NON|EQV|NLM (2005)|040115|abcdef", "ENTRY": "Pregnancies", "MN": "G08.686.784.769", "FX": "Pseudopregnancy", "EC": "complications:Pregnancy Complications", "MH_TH": "NLM (1963)", "ST": "T040", "MS": "The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.", "PM": "1963", "HN": "1963", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011247"}, {"RECTYPE": "D", "MH": "Pregnancy Complications", "DE": "PREGN COMPL", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Adverse Birth Outcomes|T047|NON|NRW|NLM (2022)|210205|abcdef", "ENTRY": "Pregnancy Complication", "MN": "C12.050.703", "FX": "Pregnancy, Prolonged", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "coordinate with specific disease; / surg: consider also OBSTETRIC SURGICAL PROCEDURES", "MS": "Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases.", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011248"}, {"RECTYPE": "D", "MH": "Pregnancy Complications, Cardiovascular", "DE": "PREGN COMPL CARDIOVASC", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pregnancy Complication, Cardiovascular", "MN": "C14.583", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "coordinate IM with specific cardiovascular disease (IM); check the tags FEMALE & PREGNANCY; hemorrhage during pregnancy goes here, not PREGNANCY COMPLICATIONS, HEMATOLOGIC", "MS": "The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D011249"}, {"RECTYPE": "D", "MH": "Pregnancy Complications, Hematologic", "DE": "PREGN COMPL HEMATOL", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pregnancy Complication, Hematological", "MN": "C15.378.785", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "for disorders of formed elements or coagulation processes of blood in pregnancy, not for excess or deficiency of substances in the blood (as HYPOKALEMIA + PREGNANCY COMPLICATIONS not PREGNANCY COMPLICATIONS, HEMATOLOGIC); coordinate IM with specific hematologic disease (IM); check the tags FEMALE & PREGNANCY; hemorrhage during pregnancy goes under PREGNANCY COMPLICATIONS, CARDIOVASCULAR, not here", "MS": "The co-occurrence of pregnancy and a blood disease (HEMATOLOGIC DISEASES) which involves BLOOD CELLS or COAGULATION FACTORS. The hematologic disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D011250"}, {"RECTYPE": "D", "MH": "Pregnancy Complications, Infectious", "DE": "PREGN COMPL INFECT", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sepsis, Maternal", "MN": "C12.050.703.700", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "bacterial, fungal or viral infections: PREGNANCY COMPLICATIONS, PARASITIC is also available; coordinate  with specific infectious disease ", "MS": "The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D011251"}, {"RECTYPE": "D", "MH": "Pregnancy Complications, Neoplastic", "DE": "PREGN COMPL NEOPL", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pregnancy Complication, Neoplastic", "MN": "C12.050.703.720", "MH_TH": "NLM (1983)", "ST": "T191", "AN": "coordinate IM with specific histologic type (IM) + precoordinated organ/neopl term (IM); check the tags FEMALE & PREGNANCY; Manual 18.4.7; DF: PREGN COMPL NEOPL", "PI": "specific neoplasms (1966-1982)", "MS": "The co-occurrence of pregnancy and NEOPLASMS. The neoplastic disease may precede or follow FERTILIZATION.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19820426", "DC": "1", "DX": "19830101", "UI": "D011252"}, {"RECTYPE": "D", "MH": "Pregnancy in Adolescence", "DE": "PREGN IN ADOLESCENCE", "AQ": "BL CF DE EH ES GE IM ME PC PH PX RE SN UR", "PRINT ENTRY": "Teenage Pregnancy|T040|T054|NON|EQV|UNK (19XX)|780320|TEENAGE PREGN|abbcdefv", "ENTRY": "Teenage Pregnancies", "MN": "G08.686.784.769.494", "MH_TH": "NLM (1979)", "ST": "T054", "AN": "IM; use only for pregnancy as a social, cultural, or psychological problem in adolescents; for other aspects of PREGNANCY (IM) in adolescents, use PREGNANCY (IM) + ADOLESCENT (check tag); includes pregnancy in children under 13; check tags HUMAN; FEMALE; PREGNANCY & ADOLESCENT or CHILD if under 13", "PI": "Pregnancy (1966-1978)", "MS": "Pregnancy in human adolescent females under the age of 19.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19780320", "DC": "1", "DX": "19790101", "UI": "D011253"}, {"RECTYPE": "D", "MH": "Pregnancy in Diabetics", "DE": "PREGN IN DIABETICS", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pregnancy in Diabetic", "MN": "C12.050.703.726", "FX": "Diabetes, Gestational", "MH_TH": "NLM (2001)", "ST": "T047", "AN": "DIABETES MELLITUS, not DIABETES INSIPIDUS; coordinate IM with specific type of diabetes mellitus (IM) if pertinent", "MS": "The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy.", "PM": "2001; see PREGNANCY IN DIABETICS 1965-2000", "HN": "2001(1965)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20010101", "UI": "D011254"}, {"RECTYPE": "D", "MH": "Pregnancy Maintenance", "DE": "PREGN MAINTENANCE", "AQ": "DE GE IM PH RE", "ENTRY": "Pregnancy Maintenances", "MN": "G08.686.784.769.520", "MH_TH": "NLM (1975)", "ST": "T040", "MS": "Physiological mechanisms that sustain the state of PREGNANCY.", "PM": "80; was see under PREGNANCY 1975-79", "HN": "80(75); was see under PREGNANCY 1975-79", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D011255"}, {"RECTYPE": "D", "MH": "Pregnancy Outcome", "DE": "PREGN OUTCOME", "AQ": "EC EH EP GE PX VE", "ENTRY": "Pregnancy Outcomes|T080|NON|EQV|NLM (1988)|870427|PREGN OUTCOMES|abcdefv", "MN": "G08.686.784.769.496", "MH_TH": "NLM (1988)", "ST": "T080", "AN": "general or unspecified: prefer specific outcome", "PI": "Pregnancy Complications (1966-1987)", "MS": "Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19870323", "DC": "1", "DX": "19880101", "UI": "D011256"}, {"RECTYPE": "D", "MH": "Pregnancy Proteins", "DE": "PREGN PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Placental Proteins|T116|T123|NON|EQV|UNK (19XX)|790222|abbcdef", "ENTRY": "Proteins, Pregnancy", "MN": "D12.776.780", "MH_TH": "NLM (1980)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "specific protein", "MS": "Proteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific (present only during pregnancy) or pregnancy-associated (present during pregnancy or under other conditions such as hormone therapy or certain malignancies.)", "PM": "80", "HN": "80", "MR": "20050630", "DA": "19790222", "DC": "1", "DX": "19800101", "UI": "D011257"}, {"RECTYPE": "D", "MH": "Pregnancy Tests", "DE": "PREGN TESTS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Pregnancy|T060|NON|EQV|NLM (1994)|930503|TESTS PREGN|abcdefv", "MN": "E05.200.970", "MH_TH": "POPLINE (1978)", "ST": "T060", "AN": "human & animal; check tags FEMALE & PREGNANCY", "MS": "Tests to determine whether or not an individual is pregnant.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011258"}, {"RECTYPE": "D", "MH": "Pregnancy Tests, Immunologic", "DE": "PREGN TESTS IMMUNOL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Test, Immunological Pregnancy", "MN": "E05.478.594.662", "MH_TH": "POPLINE (1978)", "ST": "T060", "AN": "human & animal; check tags FEMALE & PREGNANCY", "PI": "Pregnancy Tests (1966-1972)", "MS": "Methods of detecting pregnancy by examining the levels of human chorionic gonadotropin (HCG) in plasma or urine.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011259"}, {"RECTYPE": "D", "MH": "Pregnancy Trimester, First", "DE": "PREGN TRIMESTER FIRST", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Trimester, First|T079|NON|EQV|UNK (19XX)|750725|abcdef", "ENTRY": "Trimesters, First", "MN": "G08.686.707.408", "MH_TH": "NLM (1975)", "ST": "T079", "AN": "human only", "PI": "Time Factors (1967-1974)", "MS": "The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation.", "OL": "use PREGNANCY TRIMESTER, FIRST to search PREGNANCY, FIRST TRIMESTER 1975", "PM": "76; was PREGNANCY, FIRST TRIMESTER 1975", "HN": "76; was PREGNANCY, FIRST TRIMESTER 1975", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19750725", "DC": "1", "DX": "19750101", "UI": "D011261"}, {"RECTYPE": "D", "MH": "Pregnancy Trimester, Second", "DE": "PREGN TRIMESTER SECOND", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Trimester, Second|T079|NON|EQV|UNK (19XX)|750725|abcdef", "ENTRY": "Trimesters, Second", "MN": "G08.686.707.490", "MH_TH": "NLM (1975)", "ST": "T079", "AN": "human only", "PI": "Time Factors (1967-1974)", "MS": "The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation.", "OL": "use PREGNANCY TRIMESTER, SECOND to search PREGNANCY, SECOND TRIMESTER 1975", "PM": "76; was PREGNANCY, SECOND TRIMESTER 1975", "HN": "76; was PREGNANCY, SECOND TRIMESTER 1975", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19750725", "DC": "1", "DX": "19750101", "UI": "D011262"}, {"RECTYPE": "D", "MH": "Pregnancy Trimester, Third", "DE": "PREGN TRIMESTER THIRD", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Trimester, Third|T079|NON|EQV|UNK (19XX)|750725|abcdef", "ENTRY": "Trimesters, Third", "MN": "G08.686.707.520", "MH_TH": "NLM (1975)", "ST": "T079", "AN": "human only; check tags HUMANS & FEMALE & PREGNANCY; \"at term\": consider better LABOR, OBSTETRIC", "PI": "Time Factors (1967-1974)", "MS": "The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation.", "OL": "use PREGNANCY TRIMESTER, THIRD to search PREGNANCY, THIRD TRIMESTER 1975", "PM": "76; was PREGNANCY, THIRD TRIMESTER 1975", "HN": "76; was PREGNANCY, THIRD TRIMESTER 1975", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19750725", "DC": "1", "DX": "19750101", "UI": "D011263"}, {"RECTYPE": "D", "MH": "Pregnancy Trimesters", "DE": "PREGN TRIMESTERS", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "ENTRY": "Trimester, Pregnancy", "MN": "G08.686.707", "MH_TH": "NLM (1974)", "ST": "T079", "AN": "human only; general or unspecified; prefer specifics; trimesters are indexed only when the point of the article or substantively discussed: they are not sought out routinely nor indexed when merely mentioned", "PI": "specific trimester (1975-1997)", "MS": "The three approximately equal periods of a normal human PREGNANCY. Each trimester is about three months or 13 to 14 weeks in duration depending on the designation of the first day of gestation.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D011264"}, {"RECTYPE": "D", "MH": "Pregnancy-Associated Plasma Protein-A", "DE": "PREGN ASSOCIATED PLASMA PROTEIN A", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PAPP-A|T116|T126|ABB|EQV|UNK (19XX)|790222|abbcdef", "ENTRY": "Protease, IGFBP-4", "MN": "D12.776.780.700", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.4.24.-", "PI": "Pregnancy (1966-1979)", "MS": "A product of the PLACENTA, and DECIDUA, secreted into the maternal circulation during PREGNANCY. It has been identified as an IGF binding protein (IGFBP)-4 protease that proteolyzes IGFBP-4 and thus increases IGF bioavailability. It is found also in human FIBROBLASTS, ovarian FOLLICULAR FLUID, and GRANULOSA CELLS. The enzyme is a heterotetramer of about 500-kDa.", "PM": "2004; for PREGNANCY-ASSOCIATED ALPHA-PLASMA PROTEIN see PREGNANCY-ASSOCIATED ALPHA-PLASMA PROTEIN 1991-2003, see PREGNANCY PROTEINS 1980-1990", "HN": "2004 (1996)", "MR": "20040713", "DA": "19790222", "DC": "1", "DX": "19910101", "UI": "D011266"}, {"RECTYPE": "D", "MH": "Pregnancy-Specific beta 1-Glycoproteins", "DE": "PREGN SPECIFIC BETA 1 GLYCOPROTEINS", "DS": "PREGNANCY SPECIFIC BETA GLYCOPROTEIN 01", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-1 Glycoprotein, Trophoblast-Specific|T116|T123|NON|EQV|NLM (1993)|920325|BETA GLYCOPROTEIN TROPHOBLAST SPECIFIC 01|abbcdefs", "ENTRY": "beta-Globulin, Trophoblastic", "MN": "D12.776.780.730", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Serum Globulins (1966-1979)", "MS": "Glycoproteins with the electrophoretic mobility of BETA-GLOBULINS, secreted by the placental TROPHOBLASTS into the maternal bloodstream during PREGNANCY. They can be detected 18 days after OVULATION and reach 200 mg/ml at the end of pregnancy. They are associated with fetal well-being.", "PM": "2005; see PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 1990-2004; see PREGNANCY PROTEINS 1980-1990; for PREGNANCY-ASSOCIATED BETA-PLASMA PROTEIN see PREGNANCY-ASSOCIATED BETA-PLASMA PROTEIN 1996-2003, see PREGNANCY-ASSOCIATED BETA PLASMA PROTEIN 1991-1995, see PREGNANCY PROTEINS 1980-1990", "HN": "2005(1980)", "MR": "20160628", "DA": "19790222", "DC": "1", "DX": "19910101", "UI": "D011268"}, {"RECTYPE": "D", "MH": "Pregnancy, Abdominal", "DE": "PREGN ABDOMINAL", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Abdominal Pregnancy|T047|NON|EQV|NLM (1994)|930503|ABDOMINAL PREGN|abcdefv", "ENTRY": "Pregnancies, Abdominal", "MN": "C12.050.703.733.536", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "A type of ectopic pregnancy in which the EMBRYO, MAMMALIAN implants in the ABDOMINAL CAVITY instead of in the ENDOMETRIUM of the UTERUS.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011269"}, {"RECTYPE": "D", "MH": "Pregnancy, Animal", "DE": "PREGN ANIMAL", "AQ": "BL CF DE GE IM ME PH PX RE UR", "ENTRY": "Pregnancies, Animal", "MN": "G08.686.784.769.498", "FX": "Animals, Newborn", "MH_TH": "NLM (1966)", "ST": "T040", "AN": "IM for articles on normal animal pregn but check also tag PREGNANCY; for NIM animal pregnancy do not index PREGNANCY, ANIMAL: merely check tag PREGNANCY; check tags ANIMALS & FEMALE also", "MS": "The process of bearing developing young (EMBRYOS or FETUSES) in utero in non-human mammals, beginning from FERTILIZATION to BIRTH.", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011270"}, {"RECTYPE": "D", "MH": "Pregnancy, Ectopic", "DE": "PREGN ECTOPIC", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ectopic Pregnancy|T047|NON|EQV|NLM (1992)|910618|ECTOPIC PREGN|abcdefv", "ENTRY": "Pregnancies, Extrauterine", "MN": "C12.050.703.733", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY; PREGNANCY, HETEROTOPIC is also available", "MS": "A potentially life-threatening condition in which EMBRYO IMPLANTATION occurs outside the cavity of the UTERUS. Most ectopic pregnancies (>96%) occur in the FALLOPIAN TUBES, known as TUBAL PREGNANCY. They can be in other locations, such as UTERINE CERVIX; OVARY; and abdominal cavity (PREGNANCY, ABDOMINAL).", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011271"}, {"RECTYPE": "D", "MH": "Pregnancy, Multiple", "DE": "PREGN MULTIPLE", "AQ": "BL CF DE EH GE IM ME PH PX RE SN UR", "ENTRY": "Pregnancies, Multiple", "MN": "G08.686.784.769.545", "FX": "Pregnancy Reduction, Multifetal", "MH_TH": "NLM (1991)", "ST": "T040", "AN": "human & animal; in reference to animals, do not use PREGNANCY, MULTIPLE for animals naturally having litters; consider LITTER SIZE; not for \"heterotopic pregnancy\": see note at PREGNANCY, ECTOPIC; check tags FEMALE & PREGNANCY", "MS": "The condition of carrying two or more FETUSES simultaneously.", "CATSH": "CAT LIST", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011272"}, {"RECTYPE": "D", "MH": "Pregnancy, Prolonged", "DE": "PREGN PROLONGED", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Prolonged Pregnancies", "MN": "C12.050.703.805", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "A term used to describe pregnancies that exceed the upper limit of a normal gestational period. In humans, a prolonged pregnancy is defined as one that extends beyond 42 weeks (294 days) after the first day of the last menstrual period (MENSTRUATION), or birth with gestational age of 41 weeks or more.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011273"}, {"RECTYPE": "D", "MH": "Pregnancy, Tubal", "DE": "PREGN TUBAL", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tubal Pregnancy|T047|NON|EQV|NLM (1994)|930503|TUBAL PREGN|abcdefv", "ENTRY": "Tubal Pregnancies", "MN": "C12.050.703.733.703", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY", "MS": "The most common (>96%) type of ectopic pregnancy in which the extrauterine EMBRYO IMPLANTATION occurs in the FALLOPIAN TUBE, usually in the ampullary region where FERTILIZATION takes place.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011274"}, {"RECTYPE": "D", "MH": "Pregnancy, Unwanted", "DE": "PREGN UNWANTED", "AQ": "BL CF DE EH ES GE IM ME PH PX RE UR", "ENTRY": "Unwanted Pregnancy", "MN": "G08.686.784.769.580", "FX": "Pregnancy, Unplanned", "MH_TH": "NLM (1991)", "ST": "T068", "AN": "PREGNANCY, UNPLANNED is also available", "PI": "Pregnancy (1966-1972)", "MS": "Pregnancy, usually accidental, that is not desired by the parent or parents.", "PM": "91; was see under PREGNANCY 1973-90", "HN": "91(73); was see under PREGNANCY 1973-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011275"}, {"RECTYPE": "D", "MH": "Pregnanediol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D06.472.334.851.687.750.739", "MH_TH": "NLM (1966)", "ST": "T109", "N1": "5-beta-Pregnane-3, 20-diol", "RN": "JR3JD1Y22C", "RR": "26445-07-8 (Pregnanediol)", "MS": "An inactive metabolite of PROGESTERONE by reduction at C5, C3, and C20 position. Pregnanediol has two hydroxyl groups, at 3-alpha and 20-alpha. It is detectable in URINE after OVULATION and is found in great quantities in the pregnancy urine.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011276"}, {"RECTYPE": "D", "MH": "Pregnanediones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diketopregnanes|T109|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Dioxopregnanes|T109|NON|EQV|NLM (1994)|930217|abcdef", "MN": "D04.210.500.745.558", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Pregnane derivatives in which two side-chain methyl groups or two methylene groups in the ring skeleton (or a combination thereof) have been oxidized to keto groups.", "PM": "74", "HN": "74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011277"}, {"RECTYPE": "D", "MH": "Pregnanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.745", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "do not confuse with PREGNENES", "MS": "Saturated derivatives of the steroid pregnane. The 5-beta series includes PROGESTERONE and related hormones; the 5-alpha series includes forms generally excreted in the urine.", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011278"}, {"RECTYPE": "D", "MH": "Pregnanetriol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "5beta-Pregnane-3alpha,17alpha,20alpha-triol|T109|NON|EQV|NLM (2004)|030205|abcdef", "MN": "D06.472.334.851.687.750.478.400.500", "MH_TH": "NLM (1964)", "ST": "T109", "N1": "Pregnanetriol", "RN": "27178-64-9", "MS": "A metabolite of 17-ALPHA-HYDROXYPROGESTERONE, normally produced in small quantities by the GONADS and the ADRENAL GLANDS, found in URINE. An elevated urinary pregnanetriol is associated with CONGENITAL ADRENAL HYPERPLASIA with a deficiency of STEROID 21-HYDROXYLASE.", "PM": "66", "HN": "66(64)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011279"}, {"RECTYPE": "D", "MH": "Pregnanolone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Eltanolone|T109|T121|T123|NON|EQV|FDA SRS (2014)|INN (19XX)|NLM (1998)|961114|abbbcdeeef", "ENTRY": "beta-pregnan-20-one, 3 alpha-Hydroxy-5", "MN": "D04.210.500.745.640", "PA": "Anesthetics", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Pregnan-20-one, 3-hydroxy-, (3alpha,5beta)-", "RN": "BXO86P3XXW", "RR": "S39XZ5QV8Y", "AN": "do not confuse with PREGNENOLONE", "PI": "Pregnanes (1969-1974)", "MS": "A pregnane found in the urine of pregnant women and sows. It has anesthetic, hypnotic, and sedative properties.", "PM": "91; was see under PREGNANES 1975-90", "HN": "91(75); was see under PREGNANES 1975-90", "MR": "20190617", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011280"}, {"RECTYPE": "D", "MH": "Pregnatrienes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.745.683", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "PI": "Pregnanes (1966-1972)", "MS": "Pregnane derivatives containing three double bonds in the ring structures.", "PM": "73", "HN": "73", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011281"}, {"RECTYPE": "D", "MH": "Pregnenediones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diketopregnenes|T109|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Dioxopregnenes|T109|NON|EQV|NLM (1994)|930217|abcdef", "MN": "D04.210.500.745.745.654", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Unsaturated pregnane derivatives containing two keto groups on side chains or ring structures.", "PM": "74", "HN": "74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011282"}, {"RECTYPE": "D", "MH": "Pregnenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.745.745", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "AN": "do not confuse with PREGNANES", "PI": "Pregnanes (1966-1972)", "MS": "Unsaturated derivatives of PREGNANES.", "PM": "73", "HN": "73", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011283"}, {"RECTYPE": "D", "MH": "Pregnenolone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "5 Pregnen 3 beta ol 20 one", "MN": "D06.472.334.851.687.500", "MH_TH": "NLM (1966)", "ST": "T125", "N1": "Pregn-5-en-20-one, 3-hydroxy-, (3beta)-", "RN": "73R90F7MQ8", "RR": "145-13-1 (Pregnenolone)", "AN": "do not confuse with PREGNANOLONE", "MS": "A 21-carbon steroid, derived from CHOLESTEROL and found in steroid hormone-producing tissues. Pregnenolone is the precursor to GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011284"}, {"RECTYPE": "D", "MH": "Pregnenolone Carbonitrile", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pregnenolone 16 alpha Carbonitrile", "MN": "D04.210.500.745.745.725.703", "MH_TH": "NLM (1974)", "ST": "T121", "N1": "Pregn-5-ene-16-carbonitrile, 3-hydroxy-20-oxo-, (3beta,16alpha)-", "RN": "1434-54-4", "RR": "95721-74-7 ((3 beta)-isomer)", "MS": "A catatoxic steroid and microsomal enzyme inducer having significant effects on the induction of cytochrome P450. It has also demonstrated the potential for protective capability against acetaminophen-induced liver damage.", "PM": "74", "HN": "74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011285"}, {"RECTYPE": "D", "MH": "Prejudice", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Islamophobia|T055|NON|NRW|NLM (2020)|181218|abcdef", "ENTRY": "Prejudices", "MN": "F01.829.595", "MH_TH": "NLM (1966)", "ST": "T055", "MS": "A preconceived judgment made without factual basis.", "PM": "1966; for SEGREGATION see PREJUDICE 1990-2012", "HN": "1966; for SEGREGATION use PREJUDICE 1990-2012", "CATSH": "CAT LIST", "MR": "20210119", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011287"}, {"RECTYPE": "D", "MH": "Prekallikrein", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Plasma Prokallikrein|T116|T123|NON|EQV|UNK (19XX)|880518|abbcdef", "ENTRY": "Prokallikrein, Plasma", "MN": "D23.119.597.712", "FX": "Coagulants", "MH_TH": "NLM (1976)", "ST": "T123", "N1": "Kallikreinogen", "RN": "9055-02-1", "PI": "Kallikrein (1973-1975)", "MS": "A plasma protein which is the precursor of kallikrein. Plasma that is deficient in prekallikrein has been found to be abnormal in thromboplastin formation, kinin generation, evolution of a permeability globulin, and plasmin formation. The absence of prekallikrein in plasma leads to Fletcher factor deficiency, a congenital disease.", "PM": "89; was see under KALLIKREIN 1976-88", "HN": "89(76); was see under KALLIKREINS 1976-88", "MR": "20190530", "DA": "19750725", "DC": "1", "DX": "19890101", "UI": "D011288"}, {"RECTYPE": "D", "MH": "Preleukemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Preleukemias", "MN": "C15.378.800", "MH_TH": "NLM (1977)", "ST": "T191", "AN": "do not use /compl for develop into leukemia", "MS": "Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20170707", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D011289"}, {"RECTYPE": "D", "MH": "Premarital Examinations", "DE": "PREMARITAL EXAM", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Premarital Examination", "MN": "E01.370.620", "MH_TH": "NLM (1966)", "ST": "T064", "MS": "Medical tests taken by couples planning to be married in order to determine presence of genetic and contagious diseases.", "CATSH": "CAT LIST", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011291"}, {"RECTYPE": "D", "MH": "Premedication", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Premedications", "MN": "E02.319.703", "FX": "Preanesthetic Medication", "MH_TH": "NLM (1969)", "ST": "T061", "PI": "specific drug/therapeutic use (1966-1968)", "MS": "Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION.", "PM": "73", "HN": "73(69)", "CATSH": "CAT LIST", "MR": "19950531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011292"}, {"RECTYPE": "D", "MH": "Premenstrual Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Premenstrual Tension|T048|NON|NRW|POPLINE (1978)|930503|abcdef", "ENTRY": "Tensions, Premenstrual", "MN": "C23.550.568.968", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.", "OL": "use PREMENSTRUAL SYNDROME to search PREMENSTRUAL TENSION 1966-85", "PM": "86; was PREMENSTRUAL TENSION 1963-85", "HN": "86; was PREMENSTRUAL TENSION 1963-85", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D011293"}, {"RECTYPE": "D", "MH": "Prenalterol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "KWD2033", "MN": "D02.092.063.624.698.708", "PA": "Sympathomimetics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, (S)-", "RN": "M4G34404CX", "RR": "U6VH18LCQ8", "PI": "Propylamines (1966-1974)", "MS": "A partial adrenergic agonist with functional beta 1-receptor specificity and inotropic effect. It is effective in the treatment of acute CARDIAC FAILURE, postmyocardial infarction low-output syndrome, SHOCK, and reducing ORTHOSTATIC HYPOTENSION in the SHY-RAGER SYNDROME.", "PM": "87", "HN": "87", "MR": "20130708", "DA": "19860612", "DC": "1", "DX": "19870101", "UI": "D011294"}, {"RECTYPE": "D", "MH": "Prenatal Care", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "ENTRY": "Care, Prenatal", "MN": "N02.421.585.786", "MH_TH": "POPLINE (1981)", "ST": "T058", "AN": "check tags FEMALE & PREGNANCY", "MS": "Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011295"}, {"RECTYPE": "D", "MH": "Prenatal Diagnosis", "DE": "PRENATAL DIAG", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Intrauterine Diagnosis|T060|NON|EQV|UNK (19XX)|740330|INTRAUTERINE DIAG|abcdefv", "ENTRY": "Screening, Prenatal", "MN": "E01.370.378.630", "FX": "Preimplantation Diagnosis", "MH_TH": "BIOETHICS (1989)", "ST": "T060", "AN": "check tags FEMALE & PREGNANCY; coordinate with FETAL DISEASES only if the article discusses the fetal aspect", "PI": "specific disease or abnormality/diagnosis (1966-1972)", "MS": "Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011296"}, {"RECTYPE": "D", "MH": "Prenatal Exposure Delayed Effects", "DE": "PRENATAL EXPOSURE DELAYED EFF", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Delayed Effects, Prenatal Exposure|T037|NON|EQV|NLM (1990)|881202|DELAYED EFF PRENATAL EXPOSURE|abcdefv", "ENTRY": "Late Effects, Prenatal Exposure|T037|NON|EQV|NLM (1990)|881202|LATE EFF PRENATAL EXPOSURE|abcdefv", "MN": "C12.050.703.824.500", "FX": "Paternal Exposure", "MH_TH": "NLM (1982)", "ST": "T037", "AN": "for mammals only; note PRECONCEPTION INJURIES; MATERNAL EXPOSURE & PATERNAL EXPOSURE are available for environmental exposure of mother or father; check tags FEMALE & PREGNANCY", "MS": "The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH.", "OL": "search PRENATAL INFLUENCES under PREGNANCY 1966-72", "PM": "82; PRENATAL INFLUENCES was heading 1963-72", "HN": "82; PRENATAL INFLUENCES was heading 1963-72", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19810519", "DC": "1", "DX": "19820101", "UI": "D011297"}, {"RECTYPE": "D", "MH": "Feprazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prenazone|T109|T121|NON|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "DA2370", "MN": "D03.383.129.539.850.777.670", "PA": "Anti-Inflammatory Agents, Non-Steroidal", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "3,5-Pyrazolidinedione, 4-(3-methyl-2-butenyl)-1,2-diphenyl-", "RN": "7BVX6J0CGR", "RR": "30748-29-9 (Feprazone)", "PI": "Terpenes (1972-1974)", "MS": "A pyrazole that has analgesic, anti-inflammatory, and antipyretic properties. It has been used in mild to moderate pain, fever, and inflammation associated with musculoskeletal and joint disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p15)", "PM": "2013; see PRENAZONE 1991-2012, see PHENYLBUTAZONE 1975-1990", "HN": "2013(1975)", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011298"}, {"RECTYPE": "D", "MH": "Prenylamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Segontin|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef", "MN": "D02.092.471.683.825", "PA": "Vasodilator Agents", "MH_TH": "USAN (1962)", "ST": "T121", "N1": "Benzenepropanamine, N-(1-methyl-2-phenylethyl)-gamma-phenyl-", "RN": "K2OH82Z000", "RR": "390-64-7 (Prenylamine)", "MS": "A drug formerly used in the treatment of angina pectoris but superseded by less hazardous drugs. Prenylamine depletes myocardial catecholamine stores and has some calcium channel blocking activity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1406)", "PM": "66; was SEGONTIN 1963-65", "HN": "66; was SEGONTIN 1963-65", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011299"}, {"RECTYPE": "D", "MH": "Preoperative Care", "DE": "PREOP CARE", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Procedures, Preoperative|T058|NON|NRW|NLM (1994)|930503|PROCEDURES PREOP|abcdefv", "MN": "N02.421.585.722.775", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "preoperative use of antibiotics for prevention of infection: index under ANTIBIOTIC PROPHYLAXIS & not here", "MS": "Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed)", "PM": "1966", "HN": "1966", "CATSH": "CAT LIST", "MR": "20220408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011300"}, {"RECTYPE": "D", "MH": "Preoptic Area", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Preopticas, Area", "MN": "A08.186.211.200.317.357.342.450", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "Region of hypothalamus between the ANTERIOR COMMISSURE and OPTIC CHIASM.", "PM": "83; was see under HYPOTHALAMUS 1975-82", "HN": "83(75); was see under HYPOTHALAMUS 1975-82", "MR": "20180630", "DA": "19741111", "DC": "1", "DX": "19830101", "UI": "D011301"}, {"RECTYPE": "D", "MH": "Prephenate Dehydratase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Prephenate Hydro-lyase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Prephenate Hydro lyase", "MN": "D08.811.520.241.300.600", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Prephenate hydro-lyase (decarboxylating)", "RN": "EC 4.2.1.51", "RR": "9044-88-6 (CAS RN)", "AN": "do not confuse with PREPHENATE DEHYDROGENASE", "PI": "Pyruvates (1970-1974)", "MS": "An enzyme that catalyzes the conversion of prephenate to phenylpyruvate with the elimination of water and carbon dioxide. In the enteric bacteria this enzyme also possesses chorismate mutase activity, thereby catalyzing the first two steps in the biosynthesis of phenylalanine. EC 4.2.1.51.", "PM": "91; was see under HYDRO-LYASES 1975-90", "HN": "91(75); was see under HYDRO-LYASES 1975-90", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D011302"}, {"RECTYPE": "D", "MH": "Prephenate Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chorismate Mutase-Prephenate Dehydrogenase|T116|T126|NON|NRW|UNK (19XX)|741111|abbcdef", "ENTRY": "Mutase-Prephenate Dehydrogenase, Chorismate", "MN": "D08.811.682.660.500", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Prephenate:NAD+ oxidoreductase (decarboxylating)", "RN": "EC 1.3.1.12", "RR": "9044-92-2 (CAS RN)", "AN": "do not confuse with PREPHENATE DEHYDRATASE", "PI": "Pyruvates (1972-1974)", "MS": "An enzyme that catalyzes the conversion of prephenate to p-hydroxyphenylpyruvate in the presence of NAD. In the enteric bacteria, this enzyme also possesses chorismate mutase activity, thereby catalyzing the first two steps in the biosynthesis of tyrosine. EC 1.3.1.12.", "PM": "91; was see under OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under OXIDOREDUCTASES 1975-90", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D011303"}, {"RECTYPE": "D", "MH": "Presbycusis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Presbycuses", "MN": "C23.888.592.763.393.341.887.772", "MH_TH": "NLM (1972)", "ST": "T184", "PI": "Deafness (1966-1971)", "MS": "Gradual bilateral hearing loss associated with aging that is due to progressive degeneration of cochlear structures and central auditory pathways. Hearing loss usually begins with the high frequencies then progresses to sounds of middle and low frequencies.", "PM": "91; was see under HEARING LOSS, SENSORINEURAL 1979-90; was see under DEAFNESS 1975-78", "HN": "91(72); was see under HEARING LOSS, SENSORINEURAL 1979-90; was see under DEAFNESS 1975-78", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011304"}, {"RECTYPE": "D", "MH": "Presbyopia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Presbyopias", "MN": "C11.744.786", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "The normal decreasing elasticity of the crystalline lens that leads to loss of accommodation.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011305"}, {"RECTYPE": "D", "MH": "Prescription Fees", "AQ": "CL ES HI LJ SN ST TD", "PRINT ENTRY": "Fees, Prescription|T081|NON|EQV|NLM (1992)|910104|abcdef", "ENTRY": "Prescription Fee", "MN": "N03.219.442.551.621", "MH_TH": "NLM (1975)", "ST": "T081", "AN": "for drug & non-drug prescriptions; costs to the patient or 3d-party payer: do not confuse with DRUG COSTS, which are costs to a health care facility or organization", "MS": "The charge levied on the consumer for drugs or therapy prescribed under written order of a physician or other health professional.", "OL": "search FEES, PHARMACEUTICAL 1968-74", "PM": "91; was see under FEES, PHARMACEUTICAL 1975-90", "HN": "91(75); was see under FEES, PHARMACEUTICAL 1975-90", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011306"}, {"RECTYPE": "D", "MH": "Drug Prescriptions", "AQ": "CL EC HI NU SN ST VE", "ENTRY": "Prescribings, Drug", "MN": "N02.421.668.778.500", "FX": "Legislation, Drug", "MH_TH": "NLM (2009)", "ST": "T170", "AN": "general; do not confuse the concept of \"prescription\" with the drug prescribed; do not index here routinely for every \"prescribed\" drug; do not confuse with DRUG COMPOUNDING: prescribing is by the MD, compounding is by the pharmacist or drug company; note category: do not confuse with PRESCRIPTION DRUGS; DRUG PRESCRIPTIONS are the written directions for obtaining drugs; PRESCRIPTION DRUGS are the drugs that are prescribed", "MS": "Directions written for the obtaining and use of DRUGS.", "PM": "2009; see PRESCRIPTIONS, DRUG 1978-2008; see PRESCRIPTIONS 1963-1977", "HN": "2009(1963)", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D011307"}, {"RECTYPE": "D", "MH": "Preservation, Biological", "DE": "PRESERVATION BIOL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Biologic Preservation", "MN": "E05.760", "FX": "Fixatives", "MH_TH": "NLM (1964)", "ST": "T059", "AN": "general; prefer specifics", "MS": "The process of protecting various samples of biological material.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D011309"}, {"RECTYPE": "D", "MH": "Preservatives, Pharmaceutical", "DE": "PRESERVATIVES PHARM", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Pharmaceutic Aids (Preservatives)|T120|NON|EQV|NLM (1996)|941202|PHARMACEUTIC AIDS PRESERVATIVES|abcdefv", "ENTRY": "Preservatives, Pharmaceutic|T120|NON|EQV|UNK (19XX)|780626|abcdef", "MN": "D27.720.744.771", "FX": "Antioxidants", "MH_TH": "NLM (1975)", "ST": "T120", "RN": "0", "PI": "Pharmacy (1966-1967)", "MS": "Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants.", "OL": "search PHARMACEUTIC AIDS 1968-74", "PM": "91; was see under PHARMACEUTIC AIDS 1975-90", "HN": "91(75); was see under PHARMACEUTIC AIDS 1975-90", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011310"}, {"RECTYPE": "D", "MH": "Pressoreceptors", "DE": "PRESSORECEPT", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Stretch Receptors, Vascular|T023|NON|EQV|NLM (1994)|921119|STRETCH RECEPT VASCULAR|abcdefv", "ENTRY": "Vascular Stretch Receptors", "MN": "A11.671.650.915.750.750", "FX": "Baroreflex", "MH_TH": "NLM (1965)", "ST": "T023", "MS": "Receptors in the vascular system, particularly the aorta and carotid sinus, which are sensitive to stretch of the vessel walls.", "PM": "65", "HN": "65", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011311"}, {"RECTYPE": "D", "MH": "Pressure", "AQ": "AE", "ENTRY": "Pressures", "MN": "G01.374.715", "FX": "Manometry", "MH_TH": "NLM (1964)", "ST": "T081", "MS": "A type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "68", "HN": "68(64)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011312"}, {"RECTYPE": "D", "MH": "Preventive Dentistry", "DE": "PREV DENT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Preventive Dentistries", "MN": "H02.163.721", "FX": "Primary Prevention", "MH_TH": "NLM (1965)", "ST": "T091", "AN": "specialty only; do not confuse with TOOTH DISEASES /prev or MOUTH DISEASES /prev; see note under DENTAL CARE; do not confuse with DENTAL PROPHYLAXIS or ORAL HYGIENE", "MS": "The branch of dentistry concerned with the prevention of disease and the maintenance and promotion of oral health.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011313"}, {"RECTYPE": "D", "MH": "Preventive Health Services", "DE": "PREV HEALTH SERV", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Service, Preventive Health", "MN": "N02.421.726", "FX": "Primary Prevention", "MH_TH": "NLM (1968)", "ST": "T058", "PI": "specific disease/PC (1966-1967)", "MS": "Services designed for HEALTH PROMOTION.", "PM": "68", "HN": "68", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011314"}, {"RECTYPE": "D", "MH": "Preventive Medicine", "DE": "PREV MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Preventative", "MN": "H02.403.720.750", "FX": "Public Health", "MH_TH": "BIOETHICS (1974)", "ST": "T091", "AN": "use for the specialty; for specific disease, use /prev;  PRIMARY PREVENTION, SECONDARY PREVENTION and TERTIARY PREVENTION are also available", "MS": "A medical specialty primarily concerned with prevention of disease (PRIMARY PREVENTION) and the promotion and preservation of health in the individual.", "MR": "20160503", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011315"}, {"RECTYPE": "D", "MH": "Preventive Psychiatry", "DE": "PREV PSYCHIATRY", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychiatry, Preventive|T091|NON|EQV|NLM (1990)|891114|PSYCHIATRY PREV|abcdefv", "MN": "H02.403.720.750.550", "FX": "Preventive Health Services", "MH_TH": "NLM (1975)", "ST": "T091", "AN": "specialty; do not confuse with MENTAL DISORDERS /prev or specific ment disord /prev or with MENTAL HEALTH", "MS": "A discipline concerned with the prevention of mental illness and the promotion of mental health.", "OL": "search COMMUNITY PSYCHIATRY 1973-74", "PM": "91; was see under COMMUNITY PSYCHIATRY 1980-90; was see under PSYCHIATRY, COMMUNITY 1973-79", "HN": "91(75); was see under COMMUNITY PSYCHIATRY 1980-90; was see under PSYCHIATRY, COMMUNITY 1973-79", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011316"}, {"RECTYPE": "D", "MH": "Priapism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Priapisms", "MN": "C12.200.294.494.786", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A prolonged painful erection that may lasts hours and is not associated with sexual activity. It is seen in patients with SICKLE CELL ANEMIA, advanced malignancy, spinal trauma; and certain drug treatments.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011317"}, {"RECTYPE": "D", "MH": "Prilocaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Propitocaine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbcdeef", "ENTRY": "Xylonest|T109|T121|TRD|NRW|DE|041119|abbcdef", "MN": "D02.092.146.113.750", "PA": "Anesthetics, Local", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Propanamide, N-(2-methylphenyl)-2-(propylamino)-", "RN": "046O35D44R", "RR": "MJW015BAPH", "PI": "Anesthetics, Local (1966)", "MS": "A local anesthetic that is similar pharmacologically to LIDOCAINE. Currently, it is used most often for infiltration anesthesia in dentistry.", "HN": "1968 (1967)", "MR": "20180301", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011318"}, {"RECTYPE": "D", "MH": "Primaquine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phosphate, Primaquine", "MN": "D03.633.100.810.050.650", "PA": "Antimalarials", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-", "RN": "MVR3634GX1", "RR": "H0982HF78B", "MS": "An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011319"}, {"RECTYPE": "D", "MH": "Primary Health Care", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Primary Care|T058|NON|EQV|NLM (1995)|940408|abcdef", "ENTRY": "Healthcare, Primary", "MN": "N04.590.233.727", "FX": "Access to Primary Care", "MH_TH": "POPLINE (1981)", "ST": "T058", "AN": "IM", "PI": "Comprehensive Health Care (1968-1971)", "MS": "Care which provides integrated, accessible health care services by clinicians who are accountable for addressing a large majority of personal health care needs, developing a sustained partnership with patients, and practicing in the context of family and community. (JAMA 1995;273(3):192)", "PM": "74; CONTINUITY OF PATIENT CARE was see under COMPREHENSIVE HEALTH CARE 1968-78", "HN": "74(72)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011320"}, {"RECTYPE": "D", "MH": "Primary Nursing", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Primary Nursing Care|T058|NON|EQV|NLM (1977)|990101|PRIMARY NURS CARE|abcdefv", "ENTRY": "Nursing, Primary", "MN": "N02.421.533.760", "MH_TH": "NLM (2011)", "ST": "T058", "AN": "do not confuse with PRIMARY CARE NURSING which refers to methods of patient care by nurses as primary care providers", "PI": "Primary Health Care (1974-1976)", "MS": "The primary responsibility of one nurse for the planning, evaluation, and care of a patient throughout the course of illness, convalescence, and recovery.", "PM": "77", "HN": "77", "MR": "20150629", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D011321"}, {"RECTYPE": "D", "MH": "Primary Prevention", "DE": "PRIMARY PREV", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Prevention, Primary|T061|NON|EQV|UNK (19XX)|780509|PREV PRIMARY|abcdefv", "ENTRY": "Primordial Preventions", "MN": "N06.850.780.680", "FX": "Prophylactic Surgical Procedures", "MH_TH": "NLM (1979)", "ST": "T061", "PI": "specific disease/prevention & control (1966-1978)", "MS": "Specific practices for the prevention of disease or mental disorders in susceptible individuals or populations. These include HEALTH PROMOTION, including mental health; protective procedures, such as COMMUNICABLE DISEASE CONTROL; and monitoring and regulation of ENVIRONMENTAL POLLUTANTS. Primary prevention is to be distinguished from SECONDARY PREVENTION and TERTIARY PREVENTION.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19780509", "DC": "1", "DX": "19790101", "UI": "D011322"}, {"RECTYPE": "D", "MH": "Primates", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Primate", "MN": "B01.050.150.900.649.313.988", "MH_TH": "BIOETHICS (1990)", "ST": "T015", "RN": "txid9443", "AN": "general or unspecified; prefer specifics", "MS": "An order of mammals consisting of more than 300 species that include LEMURS; LORISIDAE; TARSIERS; MONKEYS; and HOMINIDS. They are characterized by a relatively large brain when compared with other terrestrial mammals, forward-facing eyes, the presence of a CALCARINE SULCUS, and specialized MECHANORECEPTORS in the hands and feet which allow the perception of light touch.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011323"}, {"RECTYPE": "D", "MH": "Primidone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Primaclone|T109|T121|TRD|NRW|UNK (19XX)|770429|abbcdef", "ENTRY": "Apo Primidone", "MN": "D03.383.742.698.253.650.700", "PA": "Anticonvulsants", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4,6(1H,5H)-Pyrimidinedione, 5-ethyldihydro-5-phenyl-", "RN": "13AFD7670Q", "RR": "125-33-7 (Primidone)", "MS": "A barbiturate derivative that acts as a GABA modulator and anti-epileptic agent. It is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite.", "MR": "20180619", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011324"}, {"RECTYPE": "D", "MH": "Prince Edward Island", "AQ": "EH EP", "MN": "Z01.639.820", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a province of eastern Canada", "MS": "An island in the Gulf of St. Lawrence constituting a province of Canada in the eastern part of the country. It is very irregular in shape with many deep inlets. Its capital is Charlottetown. Discovered by the French in 1534 and originally named Ile Saint-Jean, it was renamed in 1799 in honor of Prince Edward, fourth son of George III and future father of Queen Victoria. (From Webster's New Geographical Dictionary, 1988, p981 & Room, Brewer's Dictionary of Names, 1992, p433)", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D011325"}, {"RECTYPE": "D", "MH": "Printers' Marks", "AQ": "HI", "ENTRY": "Printers' Mark", "MN": "L01.462.500.682.192.122.622", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Symbols or text that identifies a book as the work of a specific printer.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011326"}, {"RECTYPE": "D", "MH": "Printing", "AQ": "CL EC ES HI IS LJ MT OG SD SN ST TD", "MN": "L01.737.787", "FX": "Engraving and Engravings", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "IM", "MS": "Process of reproducing words or images on a physical media.", "PM": "LITHOGRAPHY was heading 1963-65", "HN": "LITHOGRAPHY was heading 1963-65", "MR": "20180124", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011327"}, {"RECTYPE": "D", "MH": "Prions", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO PY RE SD ST TO TU UL UR", "PRINT ENTRY": "Prion|T116|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Encephalopathy Virus, Mink", "MN": "D12.776.785", "MH_TH": "NLM (1986)", "ST": "T116", "RN": "0", "PI": "Viral Proteins (1966-1985)", "MS": "Small proteinaceous infectious particles which resist inactivation by procedures that modify NUCLEIC ACIDS and contain an abnormal isoform of a cellular protein which is a major and necessary component. The abnormal (scrapie) isoform is PrPSc (PRPSC PROTEINS) and the cellular isoform PrPC (PRPC PROTEINS). The primary amino acid sequence of the two isoforms is identical. Human diseases caused by prions include CREUTZFELDT-JAKOB SYNDROME; GERSTMANN-STRAUSSLER SYNDROME; and INSOMNIA, FATAL FAMILIAL.", "OL": "use PRIONS to search MINK ENCEPHALOPATHY VIRUS & TRANSMISSIBLE ENCEPHALOPATHY VIRUS OF MINK 1975-92", "PM": "86; MINK ENCEPHALOPATHY VIRUS was heading 1991-92, was see under VERTEBRATE VIRUSES, UNCLASSIFIED (now VIRUSES, UNCLASSIFIED) 1975-90; TRANSMISSIBLE ENCEPHALOPATHY VIRUS OF MINK was see MINK ENCEPHALOPATHY VIRUS 1975-92", "HN": "86; MINK ENCEPHALOPATHY VIRUS was heading 1991-92, was see under VERTEBRATE VIRUSES, UNCLASSIFIED (now VIRUSES, UNCLASSIFIED) 1975-90; TRANSMISSIBLE ENCEPHALOPATHY VIRUS OF MINK was see MINK ENCEPHALOPATHY VIRUS 1975-92", "MR": "20200527", "DA": "19850510", "DC": "1", "DX": "19860101", "UI": "D011328"}, {"RECTYPE": "D", "MH": "Prisoners", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Inmates|T098|NON|EQV|NLM (2024)|230526|abcdef", "ENTRY": "Prisoner", "MN": "M01.729", "MH_TH": "OBSSR (2022)", "ST": "T098", "AN": "differentiate from CRIMINAL PSYCHOLOGY; entry term HOSTAGES: coord with VIOLENCE only if particularly discussed", "PI": "Prisons (1966-1972)", "MS": "Persons deprived of their liberty; those held is against their will, or who are kept in confinement or custody.", "PM": "74", "HN": "74(73)", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011329"}, {"RECTYPE": "D", "MH": "Prisons", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Penitentiaries|T073|NON|EQV|NLM (2021)|200618|abcdef", "ENTRY": "Prison", "MN": "J03.220.500", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "specify geographic location if pertinent", "MS": "Penal institutions, or places of long-term confinement for prisoners.", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011330"}, {"RECTYPE": "D", "MH": "Private Practice", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Solo Practice|T058|T091|NON|NRW|NLM (1992)|910506|abbcdef", "ENTRY": "Solo Practices", "MN": "N04.452.758.745", "MH_TH": "NLM (1969)", "ST": "T091", "PI": "specific specialty (1966-1968)", "MS": "Practice of a health profession by an individual, offering services on a person-to-person basis, as opposed to group or partnership practice.", "PM": "73", "HN": "73(69)", "MR": "19940505", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011331"}, {"RECTYPE": "D", "MH": "Privatization", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Privatizations", "MN": "N04.452.633.780", "MH_TH": "NLM (1988)", "ST": "T064", "AN": "med or non-med services or facilities", "MS": "Process of shifting publicly controlled services and/or facilities to the private sector.", "PM": "91; was see under OWNERSHIP 1988-90", "HN": "91(88); was see under OWNERSHIP 1988-90", "MR": "19940505", "DA": "19870504", "DC": "1", "DX": "19910101", "UI": "D011332"}, {"RECTYPE": "D", "MH": "Pro-Opiomelanocortin", "DS": "PROOPIOMELANOCORTIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pro-Opiocortin|T116|T125|NON|EQV|UNK (19XX)|840530|PROOPIOCORTIN|abbcdefs", "ENTRY": "Pro Opiomelanocortin", "MN": "D12.776.811.800", "MH_TH": "NLM (1985)", "ST": "T125", "N1": "Opiomelanocortin, pro-", "RN": "66796-54-1", "RR": "78321-08-1", "PI": "Protein Precursors (1973-1984)", "MS": "A 30-kDa protein synthesized primarily in the ANTERIOR PITUITARY GLAND and the HYPOTHALAMUS. It is also found in the skin and other peripheral tissues. Depending on species and tissues, POMC is cleaved by PROHORMONE CONVERTASES yielding various active peptides including ACTH; BETA-LIPOTROPIN; ENDORPHINS; MELANOCYTE-STIMULATING HORMONES; and others (GAMMA-LPH; CORTICOTROPIN-LIKE INTERMEDIATE LOBE PEPTIDE; N-terminal peptide of POMC or NPP).", "PM": "1985; PRE-PRO-OPIOCORTIN was indexed under PRO-OPIOMELANOCORTIN & PROTEIN PRECURSORS 1980-2007; OPIOCORTIN was indexed under PRO-OPIOMELANOCORTIN 1987-2007", "HN": "1985", "MR": "20151124", "DA": "19840530", "DC": "1", "DX": "19850101", "UI": "D011333"}, {"RECTYPE": "D", "MH": "Proactive Inhibition", "DE": "PROACTIVE INHIB", "ENTRY": "Proactive Inhibitions", "MN": "F02.463.425.475.538", "MH_TH": "NLM (1975)", "ST": "T041", "AN": "no qualif", "MS": "The state or process hypothesized to account for poorer learning rate for elements later in a series as compared to the learning rate for elements coming earlier in a series.", "OL": "search INHIBITION (PSYCHOLOGY) 1971-74", "PM": "91; was see under INHIBITION (PSYCHOLOGY) 1975-90", "HN": "91(75); was see under INHIBITION (PSYCHOLOGY) 1975-90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011334"}, {"RECTYPE": "D", "MH": "Proadifen", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Propyladiphenin|T109|T121|NON|EQV|UNK (19XX)|770427|abbcdef", "ENTRY": "SKF525A", "MN": "D02.241.081.944.550", "PA": "Enzyme Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzeneacetic acid, alpha-phenyl-alpha-propyl-, 2-(diethylamino)ethyl ester", "RN": "A510CA4CBT", "RR": "62-68-0 (HCl)", "MS": "An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.", "PM": "66", "HN": "66(64)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011335"}, {"RECTYPE": "D", "MH": "Probability", "ENTRY": "Probabilities", "MN": "N06.850.520.830.600", "MH_TH": "NLM (2000)", "ST": "T081", "AN": "IM for probability as a statist concept; NIM as coord for relative frequency of occur of specific dis, physiol response, etc.; see note under RISK & RISK FACTORS; coord NIM with specific disease or other concept (IM)", "MS": "The study of chance processes or the relative frequency characterizing a chance process.", "PM": "68", "HN": "68(64)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011336"}, {"RECTYPE": "D", "MH": "Probability Learning", "ENTRY": "Probability Learnings", "MN": "F02.463.425.701", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "Usually refers to the use of mathematical models in the prediction of learning to perform tasks based on the theory of probability applied to responses; it may also refer to the frequency of occurrence of the responses observed in the particular study.", "PM": "69", "HN": "69(66)", "CATSH": "CAT LIST", "MR": "19890516", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D011337"}, {"RECTYPE": "D", "MH": "Probability Theory", "ENTRY": "Theory, Probability", "MN": "L01.906.394.622", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "The branch of mathematics dealing with the purely logical properties of probability. Its theorems underlie most statistical methods. (Last, A Dictionary of Epidemiology, 2d ed)", "OL": "search OPERATIONS RESEARCH 1966-74", "PM": "91; was see under OPERATIONS RESEARCH 1975-90", "HN": "91(75); was see under OPERATIONS RESEARCH 1975-90", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011338"}, {"RECTYPE": "D", "MH": "Probenecid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Probenecid Weimer|T109|T121|TRD|NRW|DE|041119|abbcdef", "MN": "D02.886.590.700.625", "PA": "Uricosuric Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzoic acid, 4-((dipropylamino)sulfonyl)-", "RN": "PO572Z7917", "RR": "57-66-9 (Probenecid)", "MS": "The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011339"}, {"RECTYPE": "D", "MH": "Problem Solving", "AQ": "CL DE ES PH RE", "MN": "F02.463.785.810", "FX": "Decision Making", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "human & animal", "MS": "A learning situation involving more than one alternative from which a selection is made in order to attain a specific goal.", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011340"}, {"RECTYPE": "D", "MH": "Probucol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "DH581", "MN": "D02.455.426.559.389.657.746", "PA": "Antioxidants", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Phenol, 4,4'-((1-methylethylidene)bis(thio))bis(2,6-bis(1,1-dimethylethyl))-", "RN": "P3CTH044XJ", "RR": "23288-49-5 (Probucol)", "PI": "Phenols (1966-1972)", "MS": "A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).", "PM": "91; was see under PHENOLS 1973-90", "HN": "91(73); was see under PHENOLS 1973-90", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011341"}, {"RECTYPE": "D", "MH": "Procainamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Procaine Amide|T109|T121|NON|EQV|UNK (19XX)|780503|abbcdef", "ENTRY": "Hydrochloride, Procainamide", "MN": "D02.455.426.559.389.127.085.650", "PA": "Voltage-Gated Sodium Channel Blockers", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-", "RN": "L39WTC366D", "RR": "SI4064O0LX", "MS": "A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.", "PM": "79; see PROCAINE AMIDE 1963-78", "HN": "79(63)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D011342"}, {"RECTYPE": "D", "MH": "Procaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Procaine", "MN": "D02.455.426.559.389.127.020.937.906", "PA": "Anesthetics, Local", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester", "RN": "4Z8Y51M438", "RR": "95URV01IDQ", "MS": "A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016).", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011343"}, {"RECTYPE": "D", "MH": "Procarbazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Procarbazine", "MN": "D02.455.426.559.389.127.085.655", "PA": "Antineoplastic Agents", "MH_TH": "UK", "ST": "T121", "N1": "Benzamide, N-(1-methylethyl)-4-((2-methylhydrazino)methyl)-", "RN": "35S93Y190K", "RR": "XH0NPH5ZX8", "PI": "Benzoates (1966-1970)", "MS": "An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.", "PM": "74", "HN": "74(71)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011344"}, {"RECTYPE": "D", "MH": "Fenofibrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Procetofen|T109|T121|NON|EQV|NLM (1980)|990101|abbcdef", "ENTRY": "Stada, Fenofibrat", "MN": "D02.522.223.750", "PA": "Hypolipidemic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Propanoic acid, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-, 1-methylethyl ester", "RN": "U202363UOS", "RR": "49562-28-9 (Fenofibrate)", "PI": "Propionates (1966-1979)", "MS": "An antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood.", "PM": "2011; see PROCETOFEN 1991-2010, see PROPIONATES 1980-1990", "HN": "2011(1980)", "MR": "20160701", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D011345"}, {"RECTYPE": "D", "MH": "Prochlorperazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Salt, Prochlorperazine Edisylate", "MN": "D03.633.300.783.639", "PA": "Dopamine Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "10H-Phenothiazine, 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)-", "RN": "YHP6YLT61T", "RR": "PG20W5VQZS", "MS": "A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612)", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011346"}, {"RECTYPE": "D", "MH": "Procollagen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protocollagen|T116|T123|NON|NRW|UNK (19XX)|760426|abbcdef", "ENTRY": "Procollagen Type M|T116|T123|NON|NRW|UNK (19XX)|850103|abbcdef", "MN": "D12.776.860.300.250.600", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "coord IM with specific collagen (IM) if pertinent", "PI": "Protein Precursors (1973-1976)", "MS": "A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains.", "PM": "77", "HN": "77", "MR": "20050630", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D011347"}, {"RECTYPE": "D", "MH": "Procollagen N-Endopeptidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Procollagen Peptidase|T116|T126|NON|EQV|NLM (1997)|951212|abbcdef", "ENTRY": "Procollagen N Proteinase", "MN": "D08.811.277.656.675.374.664", "MH_TH": "NLM (1977)", "ST": "T126", "RN": "EC 3.4.24.14", "PI": "Protein Precursors (1973-1976)", "MS": "An extracellular endopeptidase which excises a block of peptides at the amino terminal, nonhelical region of the procollagen molecule with the formation of collagen. Absence or deficiency of the enzyme causes accumulation of procollagen which results in the inherited connective tissue disorder--dermatosparaxis. EC 3.4.24.14.", "PM": "97; was PROCOLLAGEN PEPTIDASE 1977-96 (see under PEPTIDE PEPTIDOHYDROLASES 1977-90)", "HN": "97; was PROCOLLAGEN PEPTIDASE 1977-96 (see under ENDOPEPTIDASES 1977-90)", "MR": "20030709", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D011348"}, {"RECTYPE": "D", "MH": "Proctitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Proctitides", "MN": "C06.405.469.860.622", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "INFLAMMATION of the MUCOUS MEMBRANE of the RECTUM, the distal end of the large intestine (INTESTINE, LARGE).", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011349"}, {"RECTYPE": "D", "MH": "Proctocolitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rectosigmoiditis|T047|NON|NRW|UNK (19XX)|790530|abcdef", "ENTRY": "Ulcerative Rectocolitis", "MN": "C06.405.469.860.622.790", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Inflammation of the RECTUM and the distal portion of the COLON.", "PM": "1991; see COLITIS 1963-1990; for RECTOCOLITIS, HEMORRHAGIC & RECTOCOLITIS, ULCERATIVE see COLITIS, ULCERATIVE 1979-2003", "HN": "1991(1963); for RECTOCOLITIS, HEMORRHAGIC & RECTOCOLITIS, ULCERATIVE use COLITIS, ULCERATIVE 1979-2003", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011350"}, {"RECTYPE": "D", "MH": "Proctoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Proctoscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES PROCTOSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Proctoscopic", "MN": "E04.502.250.250.250.680", "FX": "Proctoscopes", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "/ instrum permitted but consider also PROCTOSCOPES", "MS": "Endoscopic examination, therapy or surgery of the RECTUM; ANAL CANAL; and ANUS.", "CATSH": "CAT LIST", "MR": "20221215", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011351"}, {"RECTYPE": "D", "MH": "Procyclidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Procyclidine", "MN": "D03.383.773.728", "PA": "Muscarinic Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Pyrrolidinepropanol, alpha-cyclohexyl-alpha-phenyl-", "RN": "C6QE1Q1TKR", "RR": "THH8Q65426", "AN": "a central muscle relaxant", "MS": "A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism.", "PM": "91; was see under PYRROLIDINES 1966-90", "HN": "91(66); was see under PYRROLIDINES 1966-90", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011352"}, {"RECTYPE": "D", "MH": "Prodigiosin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.767.778", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1963)", "ST": "T130", "N1": "2,2'-Bi-1H-pyrrole, 4-methoxy-5-((5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl)-", "RN": "OL369FU7CJ", "RR": "82-89-3 (Prodigiosin)", "AN": "an antibiotic from Serratia marcescens & others; do not confuse with PRODIGIOZAN, another antibiotic from same source; /biosyn permitted if by micro-organism", "MS": "4-Methoxy-5-((5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl)- 2,2'-bi-1H-pyrrole. A toxic, bright red tripyrrole pigment from Serratia marcescens and others. It has antibacterial, anticoccidial, antimalarial, and antifungal activities, but is used mainly as a biochemical tool.", "PM": "73", "HN": "73(63)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011353"}, {"RECTYPE": "D", "MH": "Prodigiozan", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Prodigiosan|T109|T121|T129|NON|EQV|UNK (19XX)|780313|abbbcdef", "MN": "D09.698.718.650", "PA": "Adjuvants, Immunologic", "MH_TH": "NLM (1979)", "ST": "T129", "N1": "Prodigiozan", "RN": "9057-00-5", "AN": "Do not confuse with PRODIGIOSIN, an antibiotic from same source", "PI": "Prodigiosin (1966-1978)", "MS": "A polysaccharide extracted from Serratia marcescens and other bacteria. It activates enzymatic activity of macrophages and stimulates phagocytic processes.", "PM": "91; was see under POLYSACCHARIDES, BACTERIAL 1979-90", "HN": "91(79); was see under POLYSACCHARIDES, BACTERIAL 1979-90", "MR": "20040707", "DA": "19780313", "DC": "1", "DX": "19910101", "UI": "D011354"}, {"RECTYPE": "D", "MH": "Prodrugs", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Prodrug|T120|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Pro Drugs", "MN": "D26.675", "MH_TH": "NLM (1988)", "ST": "T120", "RN": "0", "AN": "coordinate with specific drug ", "PI": "Delayed-Action Preparations (1966-1987)", "MS": "A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.", "PM": "89; was see under DRUGS 1988", "HN": "89(88); was see under DRUGS 1988", "MR": "20200527", "DA": "19870504", "DC": "1", "DX": "19890101", "UI": "D011355"}, {"RECTYPE": "D", "MH": "Product Labeling", "AQ": "CL EC ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Package Inserts|T073|NON|NRW|UNK (19XX)|780428|abcdef", "ENTRY": "Package Insert", "MN": "J01.576.761.700", "MH_TH": "NLM (1979)", "ST": "T057", "MS": "Use of written, printed, or graphic materials upon or accompanying a product or its container or wrapper. It includes purpose, effect, description, directions, hazards, warnings, and other relevant information.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19780428", "DC": "1", "DX": "19790101", "UI": "D011356"}, {"RECTYPE": "D", "MH": "Product Line Management", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Product Line Managements", "MN": "N04.590.374.600", "MH_TH": "NLM (1988)", "ST": "T058", "AN": "restrict to Cat N: not for drug industry: read MeSH definition", "MS": "Management control systems for structuring health care delivery strategies around case types, as in DRGs, or specific clinical services.", "PM": "91; was see under HOSPITAL ADMINISTRATION 1988-90", "HN": "91(88); was see under HOSPITAL ADMINISTRATION 1988-90", "MR": "20190709", "DA": "19870504", "DC": "1", "DX": "19910101", "UI": "D011357"}, {"RECTYPE": "D", "MH": "Product Surveillance, Postmarketing", "AQ": "EC MT SN ST TD", "PRINT ENTRY": "Postmarketing Product Surveillance|T062|NON|EQV|UNK (19XX)|820505|abcdef", "ENTRY": "Surveillances, Postmarketing Product", "MN": "E05.337.800", "MH_TH": "NLM (1983)", "ST": "T062", "AN": "not restricted to drugs; surveillance after release for general sale", "PI": "specific drug/AE (1966-1982)", "MS": "Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale.", "PM": "89; was see under EVALUATION STUDIES 1983-88", "HN": "89(83); was see under EVALUATION STUDIES 1983-88", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19820505", "DC": "1", "DX": "19890101", "UI": "D011358"}, {"RECTYPE": "D", "MH": "Proestrus", "AQ": "BL CF DE GE IM ME PH RE UR", "MN": "G08.686.195.875", "MH_TH": "NLM (1975)", "ST": "T079", "AN": "non-primate mammals only", "MS": "A phase of the ESTROUS CYCLE that precedes ESTRUS. During proestrus, the Graafian follicles undergo maturation.", "PM": "91; was see under ESTRUS 1975-90", "HN": "91(75); was see under ESTRUS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D011359"}, {"RECTYPE": "D", "MH": "Professional Competence", "AQ": "EC LJ SN ST", "PRINT ENTRY": "Competence, Professional|T080|NON|EQV|UNK (19XX)|780509|abcdef", "ENTRY": "Expertise, Technical", "MN": "I02.399.630", "MH_TH": "BIOETHICS (1989)", "ST": "T080", "AN": "competence in any profession or discipline: differentiate from CLINICAL COMPETENCE which is restricted to competence in professional activities directly related to patient care", "MS": "The capability to perform the duties of one's profession generally, or to perform a particular professional task, with skill of an acceptable quality.", "PM": "79", "HN": "79", "MR": "19921218", "DA": "19780509", "DC": "1", "DX": "19790101", "UI": "D011361"}, {"RECTYPE": "D", "MH": "Professional Corporations", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Corporate Practice|T058|NON|REL|UNK (19XX)|780509|abcdef", "ENTRY": "Professional Corporation", "MN": "N04.452.758.760", "MH_TH": "NLM (1979)", "ST": "T058", "AN": "coord IM with PRACTICE MANAGEMENT, MEDICAL or PRACTICE MANAGEMENT, DENTAL (IM) for med or dent profess corp", "PI": "Professional Practice (1968-1978)", "MS": "Legally authorized corporations owned and managed by one or more professionals (medical, dental, legal) in which the income is ascribed primarily to the professional activities of the owners or stockholders.", "PM": "91; was see under PROFESSIONAL PRACTICE 1979-90", "HN": "91(79); was see under PROFESSIONAL PRACTICE 1979-90", "MR": "19940505", "DA": "19780509", "DC": "1", "DX": "19910101", "UI": "D011362"}, {"RECTYPE": "D", "MH": "Professional Impairment", "AQ": "CL EC LJ PX SN", "ENTRY": "Professional Impairments", "MN": "N03.706.535.606.528", "MH_TH": "NLM (1986)", "ST": "T080", "AN": "for impairment see note on PHYSICIAN IMPAIRMENT; coord IM with specific impairment (IM) + specific profession (IM)", "PI": "Substance Dependence (1981-1985)", "MS": "The inability of a health professional to provide proper professional care of patients due to his or her physical and/or mental disability.", "PM": "86", "HN": "86", "MR": "19920518", "DA": "19850315", "DC": "1", "DX": "19860101", "UI": "D011363"}, {"RECTYPE": "D", "MH": "Professional Practice", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Professional Practices", "MN": "N04.452.758", "FX": "Practice Management, Medical", "MH_TH": "NLM (1968)", "ST": "T057", "AN": "/econ permitted but consider many specific economics terms available; do not confuse with PHYSICIAN'S PRACTICE PATTERNS: see note there", "PI": "Office Management (1966-1967)", "MS": "The use of one's knowledge in a particular profession. It includes, in the case of the field of biomedicine, professional activities related to health care and the actual performance of the duties related to the provision of health care.", "PM": "68", "HN": "68", "MR": "19940505", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011364"}, {"RECTYPE": "D", "MH": "Professional Practice Location", "AQ": "EC LJ SN ST TD", "ENTRY": "Professional Practice Locations", "MN": "N04.452.758.772", "MH_TH": "NLM (1983)", "ST": "T083", "MS": "Geographic area in which a professional person practices; includes primarily physicians and dentists.", "PM": "91; was see under PROFESSIONAL PRACTICE 1983-90", "HN": "91(83); was see under PROFESSIONAL PRACTICE 1983-90", "MR": "19920518", "DA": "19820427", "DC": "1", "DX": "19910101", "UI": "D011365"}, {"RECTYPE": "D", "MH": "Professional Review Organizations", "DE": "PROFESSIONAL REV ORGAN", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Utilization and Quality Control Peer Review Organizations|T093|NON|NRW|UNK (19XX)|850520|UTIL QUALITY CONTROL PEER REV ORGAN|abcdefv", "ENTRY": "Professional Review Organization", "MN": "N05.700.675", "MH_TH": "NLM (1974)", "ST": "T093", "MS": "Organizations representing designated geographic areas which have contracts under the PRO program to review the medical necessity, appropriateness, quality, and cost-effectiveness of care received by Medicare beneficiaries. Peer Review Improvement Act, PL 97-248, 1982.", "OL": "use PROFESSIONAL REVIEW ORGANIZATIONS to search PROFESSIONAL STANDARDS REVIEW ORGANIZATIONS 1974-85 & PSRO 1973 (as Prov)", "PM": "86; was PROFESSIONAL STANDARDS REVIEW ORGANIZATIONS 1974-85", "HN": "86; was PROFESSIONAL STANDARDS REVIEW ORGANIZATIONS 1974-85, was PSRO 1973 (Prov)", "MR": "19940505", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011366"}, {"RECTYPE": "D", "MH": "Professional Staff Committees", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Staff Committees, Professional", "MN": "N05.700.685", "FX": "Utilization Review", "MH_TH": "NLM (1968)", "ST": "T097", "PI": "Hospitals (1966-1967)", "MS": "Committees of professional personnel who have responsibility for determining policies, procedures, and controls related to professional matters in health facilities.", "PM": "68", "HN": "68", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011367"}, {"RECTYPE": "D", "MH": "Professional-Family Relations", "DE": "PROFESSIONAL FAMILY RELAT", "AQ": "ES", "ENTRY": "Relationships, Professional Family", "MN": "F01.829.401.550", "MH_TH": "NLM (1976)", "ST": "T054", "PI": "Family (1966-1975)", "MS": "The interactions between the professional person and the family.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D011368"}, {"RECTYPE": "D", "MH": "Professional-Patient Relations", "DE": "PROFESSIONAL PATIENT RELAT", "AQ": "ES", "ENTRY": "Relationships, Professional Patient", "MN": "N05.300.660", "FX": "Truth Disclosure", "MH_TH": "NLM (1968)", "ST": "T054", "PI": "Interpersonal Relations (1966-1967)", "MS": "Interactions between health personnel and patients.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20170711", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011369"}, {"RECTYPE": "D", "MH": "Proflavine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hemisulfate, Proflavine", "MN": "D03.633.300.046.250.720", "PA": "Anti-Infective Agents, Local", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "3,6-Acridinediamine", "RN": "CY3RNB3K4T", "RR": "92-62-6 (Proflavine)", "AN": "an anti-infective", "PI": "Diamines (1974)", "MS": "Topical antiseptic used mainly in wound dressings.", "PM": "1991; 3,6-DIAMINOACRIDINE was indexed under ACRIDINES 2006-2013, see ACRIDINES 1975-1990", "HN": "1991(1975)", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011370"}, {"RECTYPE": "D", "MH": "Progeria", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hutchinson-Gilford Syndrome|T047|EPO|EQV|GHR (2014)|ORD (2010)|UNK (19XX)|750101|abcdeeef", "ENTRY": "Progeria Syndromes, Hutchinson-Gilford", "MN": "C18.452.648.753", "FX": "Werner Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature graying; hair loss; hearing loss (DEAFNESS); cataracts (CATARACT); ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.", "CATSH": "CAT LIST", "MR": "20200221", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011371"}, {"RECTYPE": "D", "MH": "Progestins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Progestogens|T121|T125|NON|EQV|NLM (1993)|920502|abbcdef", "ENTRY": "Hormone, Progestational", "MN": "D27.505.696.399.472.858", "MH_TH": "UNK (19XX)", "ST": "T125", "RN": "0", "AN": "note entry term PROGESTIN EFFECT: use only for the progestin effect of a chemical substance", "MS": "Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.", "PM": "2004; see PROGESTATIONAL HORMONES 1963-2003", "HN": "2004 (1963)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D011372"}, {"RECTYPE": "D", "MH": "Progesterone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Progesterone, (9 beta,10 alpha)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef", "MN": "D06.472.334.851.687.750", "PA": "Progestins", "FX": "Receptors, Progesterone", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Pregn-4-ene-3,20-dione", "RN": "4G7DS2Q64Y", "RR": "59952-90-8 ((13 alpha,17 alpha)-(+-)-isomer)", "MS": "The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011374"}, {"RECTYPE": "D", "MH": "Progesterone Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "3 beta-Hydroxy-delta-5-Steroid Dehydrogenase|T116|T126|NON|EQV|UNK (19XX)|770107|BETA HYDROXY DELTA STEROID DEHYDROGENASE 03 05|abbcdefs", "ENTRY": "Reductase, Progesterone", "MN": "D08.811.682.047.820.500", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "3 beta-Hydroxy-delta(5)-steroid:NAD+ 3-oxidoreductase", "RN": "EC 1.1.1.145", "PI": "Hydroxysteroid Dehydrogenases (1972-1974)", "MS": "An enzyme that catalyzes the reduction of a 3 beta-hydroxy-delta(5)-steroid to 3-oxo-delta(4)-steroid in the presence of NAD. It converts pregnenolone to progesterone and dehydroepiandrosterone to androstenedione. EC 1.1.1.145.", "PM": "91; was see under 3-HYDROXYSTEROID DEHYDROGENASES 1975-90", "HN": "91(75); was see under 3-HYDROXYSTEROID DEHYDROGENASES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011375"}, {"RECTYPE": "D", "MH": "Progesterone-Binding Globulin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transprogestin|T116|T123|NON|EQV|UNK (19XX)|760414|abbcdef", "ENTRY": "Protein, Progesterone-Binding", "MN": "D12.776.377.715.085.740", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "an alpha-globulin; /biosyn /physiol permitted", "PI": "Serum Globulins (1974-1976)", "MS": "A glycoprotein migrating as alpha 1-globulin, molecular weight 70,000 to 120,000. The protein, which is present in increased amounts in the plasma during pregnancy, binds mainly progesterone, with other steroids including testosterone competing weakly.", "PM": "91; was see under ALPHA GLOBULINS 1977-90", "HN": "91(77); was see under ALPHA GLOBULINS 1977-90", "MR": "19950320", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D011376"}, {"RECTYPE": "D", "MH": "Proglumide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Xylamide|T116|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Xilamide|T116|T121|NON|EQV|UNK (19XX)|800917|abbcdef", "MN": "D12.125.095.461.700", "PA": "Anti-Ulcer Agents", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "Pentanoic acid, 4-(benzoylamino)-5-(dipropylamino)-5-oxo-, (+-)-", "RN": "EPL8W5565D", "RR": "6620-60-6 (Proglumide)", "PI": "Glutamine (1972-1974)", "MS": "A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.", "PM": "91; was see under GLUTAMINE 1975-90", "HN": "91(75); was see under GLUTAMINE 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D011377"}, {"RECTYPE": "D", "MH": "Prognathism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Prognathisms", "MN": "C16.131.850.500.460.655", "FX": "Malocclusion", "MH_TH": "NLM (1966)", "ST": "T019", "AN": "abnormal protrusion of mandible; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; consider also MALOCCLUSION, ANGLE CLASS III", "MS": "A condition marked by abnormal protrusion of the mandible. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011378"}, {"RECTYPE": "D", "MH": "Prognosis", "PRINT ENTRY": "Prognostic Factor|T080|NON|REL|NLM (2022)|201005|abcdef", "ENTRY": "Prognoses", "MN": "E01.789", "MH_TH": "BIOETHICS (1974)", "ST": "T058", "AN": "IM general only; coordinate NIM with specific disease /diag; despite category, do not restrict to diagnosis: prognosis after therapy is indexed disease /ther + PROGNOSIS (NIM)", "MS": "A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011379"}, {"RECTYPE": "D", "MH": "Programmed Instructions as Topic", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Textbooks, Programmed|T073|T170|NON|REL|UNK (19XX)|800519|abbcdef", "ENTRY": "Self Instruction Programs", "MN": "I02.903.771.500", "MH_TH": "NLM (2020)", "ST": "T065", "AN": "do not confuse with the Publication Type PROGRAMMED INSTRUCTION", "MS": "Works about instruction in which learners progress at their own rate using workbooks, textbooks, or electromechanical devices that provide information in discrete steps, test learning at each step, and provide immediate feedback about achievement. (ERIC, Thesaurus of ERIC Descriptors, 1996).", "PM": "2008; see PROGRAMMED INSTRUCTION 1966-2007", "HN": "2008(1966)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011380"}, {"RECTYPE": "D", "MH": "Programming Languages", "ENTRY": "Programming Language", "MN": "L01.224.900.780", "MH_TH": "NLM (1987)", "ST": "T170", "MS": "Specific languages used to prepare computer programs.", "PM": "87", "HN": "87", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D011381"}, {"RECTYPE": "D", "MH": "Programming, Linear", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Linear Programming", "MN": "L01.906.394.748", "MH_TH": "NLM (1975)", "ST": "T090", "AN": "IM", "MS": "A technique of operations research for solving certain kinds of problems involving many variables where a best value or set of best values is to be found. It is most likely to be feasible when the quantity to be optimized, sometimes called the objective function, can be stated as a mathematical expression in terms of the various activities within the system, and when this expression is simply proportional to the measure of the activities, i.e., is linear, and when all the restrictions are also linear. It is different from computer programming, although problems using linear programming techniques may be programmed on a computer.", "OL": "search OPERATIONS RESEARCH 1969-74 & OPERATIONS RESEARCH & PROGRAMMED INSTRUCTION 1966-68", "PM": "91; was see under OPERATIONS RESEARCH 1969-90; was see under OPERATIONS RESEARCH & PROGRAMMED INSTRUCTION 1966-68", "HN": "91(75); was see under OPERATIONS RESEARCH 1969-90; was see under OPERATIONS RESEARCH & PROGRAMMED INSTRUCTION 1966-68", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011382"}, {"RECTYPE": "D", "MH": "Progressive Patient Care", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Progressive Patient Cares", "MN": "N04.590.233.799", "MH_TH": "NLM (1964)", "ST": "T058", "AN": "IM", "MS": "Organization of medical and nursing care according to the degree of illness and care requirements in the hospital. The elements are intensive care, intermediate care, self-care, long-term care, and organized home care.", "PM": "66", "HN": "66(64)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011383"}, {"RECTYPE": "D", "MH": "Proinsulin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.811.706", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "Proinsulin", "RN": "9035-68-1", "PI": "Insulin (1966-1971)", "MS": "A pancreatic polypeptide of about 110 amino acids, depending on the species, that is the precursor of insulin. Proinsulin, produced by the PANCREATIC BETA CELLS, is comprised sequentially of the N-terminal B-chain, the proteolytically removable connecting C-peptide, and the C-terminal A-chain. It also contains three disulfide bonds, two between A-chain and B-chain. After cleavage at two locations, insulin and C-peptide are the secreted products. Intact proinsulin with low bioactivity also is secreted in small amounts.", "PM": "72", "HN": "72", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011384"}, {"RECTYPE": "D", "MH": "Projection", "MN": "F01.393.693", "MH_TH": "NLM (1969)", "ST": "T041", "PI": "Defense Mechanisms (1966-1968)", "MS": "A defense mechanism, operating unconsciously, whereby that which is emotionally unacceptable in the self is rejected and attributed (projected) to others.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D011385"}, {"RECTYPE": "D", "MH": "Projective Techniques", "AQ": "HI SN ST", "PRINT ENTRY": "Szondi Test|T060|T170|EPO|NRW|NLM (1975)|990101|abbcdef", "ENTRY": "Test, Szondi", "MN": "F04.711.647.622", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Techniques to reveal personality attributes by responses to relatively unstructured or ambiguous stimuli.", "PM": "1991; see PROJECTIVE TECHNICS 1963-1990; for ROSENZWEIG PICTURE-FRUSTRATION STUDY see ROSENZWEIG PICTURE-FRUSTRATION STUDY 1991-1999; see PROJECTIVE TECHNICS 1975-1980; for PICTURE FRUSTRATION STUDY see ROSENZWEIG PICTURE-FRUSTRATION STUDY 1979-1991; see PROJECTIVE TECHNIQUES 1975-1999; for SZONDI TEST see SZONDI TEST 1991-1999; see PROJECTIVE TECHNIQUES 1975-1900", "HN": "1991(1963)", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011386"}, {"RECTYPE": "D", "MH": "Prokaryotic Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Prokaryotic Cell", "MN": "A11.760", "MH_TH": "NLM (1978)", "ST": "T025", "AN": "general: prefer BACTERIA or ARCHAEA or specifics", "PI": "appropriate cell, organism, subcellular fraction, or process", "MS": "Cells lacking a nuclear membrane so that the nuclear material is either scattered in the cytoplasm or collected in a nucleoid region.", "PM": "91; was see under CELLS 1978-90", "HN": "91(78); was see under CELLS 1978-90", "MR": "20070709", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D011387"}, {"RECTYPE": "D", "MH": "Prolactin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mammotropin|T116|T125|NON|EQV|UNK (19XX)|741224|abbcdef", "ENTRY": "Pituitary Mammotropic Hormone", "MN": "D12.644.548.691.525.525", "FX": "Receptors, Prolactin", "MH_TH": "NLM (1964)", "ST": "T125", "N1": "Prolactin", "RN": "9002-62-4", "AN": "/blood: consider also HYPERPROLACTINEMIA", "MS": "A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011388"}, {"RECTYPE": "D", "MH": "Prolactin Release-Inhibiting Factors", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Prolactin Release Inhibitory Factor", "MN": "D12.776.631.650.405.700.750", "PA": "Hormones", "MH_TH": "NLM (2007)", "ST": "T125", "RN": "9034-47-3", "PI": "Prolactin (1968-1974)", "MS": "A number of peptides with inhibitory activities on PROLACTIN release have been isolated from the HYPOTHALAMUS, the peripheral nervous system, and the gut. These include SOMATOSTATIN, and peptides derived from POMC and precursor for VASOPRESSIN-ASSOCIATED NEUROPHYSIN. Biogenic amine DOPAMINE is also a potent PIF.", "PM": "2007; see PROLACTIN RELEASE-INHIBITING HORMONE 1975-2006", "HN": "2007 (1975)", "MR": "20151124", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D011389"}, {"RECTYPE": "D", "MH": "Prolapse", "ENTRY": "Prolapses", "MN": "C23.300.842", "FX": "Hernia", "MH_TH": "NLM (1977)", "ST": "T190", "AN": "general or unspecified; prefer specifics; coordinate with organ/disease term", "MS": "The protrusion of an organ or part of an organ into a natural or artificial orifice.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D011391"}, {"RECTYPE": "D", "MH": "Proline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L Proline", "MN": "D12.125.072.401.623", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "L-Proline", "RN": "9DLQ4CIU6V", "RR": "147-85-3 (Proline)", "AN": "/biosyn /defic /physiol permitted", "MS": "A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011392"}, {"RECTYPE": "D", "MH": "Procollagen-Proline Dioxygenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protocollagen Prolyl Hydroxylase|T116|T126|NON|EQV|UNK (19XX)|760520|abbcdef", "ENTRY": "Prolyl Hydroxylase, Protocollagen", "MN": "D08.811.682.690.708.694.750", "FX": "Protein Disulfide-Isomerases", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "Procollagen-L-proline,2-oxoglutarate:oxygen oxidoreductase", "RN": "EC 1.14.11.2", "RR": "9028-06-2 (CAS)", "PI": "Hydroxylases (1966-1971)", "MS": "A mixed-function oxygenase that catalyzes the hydroxylation of a prolyl-glycyl containing peptide, usually in PROTOCOLLAGEN, to a hydroxyprolylglycyl-containing-peptide. The enzyme utilizes molecular OXYGEN with a concomitant oxidative decarboxylation of 2-oxoglutarate to SUCCINATE. The enzyme occurs as a tetramer of two alpha and two beta subunits. The beta subunit of procollagen-proline dioxygenase is identical to the enzyme PROTEIN DISULFIDE-ISOMERASES.", "OL": "use PROCOLLAGEN-PROLINE DIOXYGENASE to search PROLINE HYDROXYLASE 1972-93 (as Prov 1972-73) & PROLINE,2-OXOGLUTARATE DIOXYGENASE 1977-93", "PM": "94; was PROLINE HYDROXYLASE 1974-93; PROLINE,2-OXOGLUTARATE 4-DIOXYGENASE was PROLINE,2-OXOGLUTARATE DIOXYGENASE see PROLINE HYDROXYLASE 1977-93", "HN": "94; was PROLINE HYDROXYLASE 1972-93 (Prov 1972-73); PROLINE,2-OXOGLUTARATE 4-DIOXYGENASE was PROLINE,2-OXOGLUTARATE DIOXYGENASE see PROLINE HYDROXYLASE 1977-93", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011393"}, {"RECTYPE": "D", "MH": "Proline Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proline Dehydrogenase|T116|T126|NON|EQV|UNK (19XX)|790523|abbcdef", "ENTRY": "Oxidase, Proline", "MN": "D08.811.682.664.500.810", "MH_TH": "NLM (1980)", "ST": "T126", "RN": "EC 1.5.3.-", "PI": "Oxygenases (1966-1979)", "MS": "The first enzyme of the proline degradative pathway. It catalyzes the oxidation of proline to pyrroline-5-carboxylic acid in the presence of oxygen and water. The action is not reversible. The specific activity of proline oxidase increases with age. EC 1.5.3.-.", "PM": "91; was see under AMINE OXIDOREDUCTASES 1980-90", "HN": "91(80); was see under AMINE OXIDOREDUCTASES 1980-90", "MR": "20050630", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D011394"}, {"RECTYPE": "D", "MH": "Promazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Promazine", "MN": "D03.633.300.783.661", "PA": "Dopamine Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "10H-Phenothiazine-10-propanamine, N,N-dimethyl-", "RN": "O9M39HTM5W", "RR": "U16EOR79U4", "MS": "A phenothiazine with actions similar to CHLORPROMAZINE but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic.", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011395"}, {"RECTYPE": "D", "MH": "Promedol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trimeperidine|T109|T121|NON|NRW|FDA SRS (2014)|INN (19XX)|UNK (19XX)|770418|abbcdeeef", "MN": "D03.383.621.349.450.700", "PA": "Narcotics", "MH_TH": "NLM (1978)", "ST": "T121", "N1": "4-Piperidinol, 1,2,5-trimethyl-4-phenyl-, propanoate (ester)", "RN": "64-39-1", "RR": "1M2IB31DTS", "PI": "Propionates (1966-1977)", "MS": "A narcotic analgesic similar to MEPERIDINE; it exists in four stereoisomers, two of which, the beta (isopromedol) and the gamma (trimeperidine) are active.", "PM": "91; was see under MEPERIDINE 1978-90", "HN": "91(78); was see under MEPERIDINE 1978-90", "MR": "20160531", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D011396"}, {"RECTYPE": "D", "MH": "Promegestone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Promestone|T109|T121|T125|NON|EQV|UNK (19XX)|770315|abbbcdef", "ENTRY": "RU 5020", "MN": "D04.210.500.668.651.443.680", "MH_TH": "INN (19XX)", "ST": "T125", "N1": "Estra-4,9-dien-3-one, 17-methyl-17-(1-oxopropyl)-, (17beta)-", "RN": "9XE0V2SQYX", "RR": "34184-77-5 (Promegestone)", "AN": "D25-26", "PI": "Progestational Hormones, Synthetic (1975-1978)", "MS": "A synthetic progestin which is useful for the study of progestin distribution and progestin tissue receptors, as it is not bound by transcortin and binds to progesterone receptors with a higher association constant than progesterone.", "OL": "use PROMEGESTONE to search R 5020 1979-85", "PM": "91; was see under NORPREGNADIENES 1986-90; was R 5020 see under NORPREGNADIENES 1979-85", "HN": "91(86); was see under NORPREGNADIENES 1986-90; was R 5020 see under NORPREGNADIENES 1979-85", "MR": "20170524", "DA": "19780315", "DC": "1", "DX": "19910101", "UI": "D011397"}, {"RECTYPE": "D", "MH": "Promethazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Proazamine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|760430|abbcdeef", "ENTRY": "Hydrochloride, Promethazine", "MN": "D03.633.300.783.670", "PA": "Histamine H1 Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl-", "RN": "FF28EJQ494", "RR": "R61ZEH7I1I", "MS": "A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals.", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011398"}, {"RECTYPE": "D", "MH": "Promethium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.550.399.875", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Promethium", "RN": "ZGV62C09KN", "RR": "7440-12-2 (Promethium)", "MS": "A radioactive element of the rare earth family of metals. It has the atomic symbol Pm, and atomic number 61. It has been used in the construction of atomic batteries, in the preparation of self-luminous compounds, and as a beta-particle source for thickness gauges.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011399"}, {"RECTYPE": "D", "MH": "Prometryne", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Prometryn|T109|T131|NON|EQV|UNK (19XX)|810318|abbcdef", "MN": "D03.383.931.674", "PA": "Herbicides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "1,3,5-Triazine-2,4-diamine, N,N'-bis(1-methylethyl)-6-(methylthio)-", "RN": "1K20TB75IL", "RR": "7287-19-6 (Prometryne)", "PI": "Triazines (1966-1971)", "MS": "A triazine used as a selective pre- and post-emergence herbicide. (From Merck Index, 11th ed)", "PM": "91; was see under HERBICIDES, TRIAZINE 1972-90", "HN": "91(72); was see under HERBICIDES, TRIAZINE 1972-90", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011400"}, {"RECTYPE": "D", "MH": "Promoter Regions, Genetic", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "rRNA Promoter|T114|T123|NRW|NLM (1999)|980410|abbdef", "ENTRY": "rRNA Promoters", "MN": "G05.360.340.024.340.137.750.680", "FX": "Genes, Reporter", "MH_TH": "NLM (2009)", "ST": "T123", "PI": "Transcription, Genetic (1973-1984)", "MS": "DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.", "PM": "2009; see PROMOTER REGIONS GENETICS 1985-2008; for PROMOTER (GENETICS) see OPERON 1980-1984; for rRNA PROMOTER see rRNA OPERON 1990-1998", "HN": "2009 (1985); for PROMOTER, GENETIC use OPERON 1980-1984; for rRNA PROMOTER use rRNA OPERON 1990-1998", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19840417", "DC": "1", "DX": "19850101", "UI": "D011401"}, {"RECTYPE": "D", "MH": "Pronase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "XIV, Protease", "MN": "D08.811.277.656.959.350.638", "MH_TH": "NLM (1971)", "ST": "T126", "RN": "EC 3.4.24.-", "PI": "Peptide Hydrolases (1966-1970)", "MS": "A proteolytic enzyme obtained from Streptomyces griseus.", "PM": "73", "HN": "73(71)", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011402"}, {"RECTYPE": "D", "MH": "Pronation", "AQ": "PH", "ENTRY": "Pronations", "MN": "G11.427.410.698.840", "MH_TH": "NLM (1988)", "ST": "T040", "AN": "refers to foot or forearm; do not confuse with PRONE POSITION", "PI": "Posture (1966-1987)", "MS": "Applies to movements of the forearm in turning the palm backward or downward. When referring to the foot, a combination of eversion and abduction movements in the tarsal and metatarsal joints (turning the foot up and in toward the midline of the body).", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19870402", "DC": "1", "DX": "19880101", "UI": "D011403"}, {"RECTYPE": "D", "MH": "Propafenone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SA79", "MN": "D02.522.818.830", "PA": "Voltage-Gated Sodium Channel Blockers", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Propanone, 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-", "RN": "68IQX3T69U", "RR": "54063-53-5 (Propafenone)", "PI": "Propiophenones (1966-1986)", "MS": "An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.", "PM": "87", "HN": "87", "MR": "20160701", "DA": "19860409", "DC": "1", "DX": "19870101", "UI": "D011405"}, {"RECTYPE": "D", "MH": "Propaganda", "MN": "L01.143.790", "MH_TH": "POPLINE (1978)", "ST": "T170", "MS": "The deliberate attempt to influence attitudes and beliefs for furthering one's cause or damaging an opponent's cause.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011406"}, {"RECTYPE": "D", "MH": "Propane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.326.146.800", "FX": "Cyclopropanes", "MH_TH": "NLM (1973)", "ST": "T109", "N1": "Propane", "RN": "T75W9911L6", "RR": "74-98-6 (Propane)", "PI": "Alkanes (1966-1972)", "MS": "A three carbon alkane with the formula H3CCH2CH3.", "PM": "73", "HN": "73", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011407"}, {"RECTYPE": "D", "MH": "Propanediol Dehydratase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Diol Dehydrase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Dehydratase, Propanediol", "MN": "D08.811.520.241.300.650", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Propane-1,2-diol hydro-lyase", "RN": "EC 4.2.1.28", "RR": "9026-90-8 (CAS RN)", "PI": "Propanediols (1972-1974)", "MS": "An enzyme that catalyzes the dehydration of 1,2-propanediol to propionaldehyde. EC 4.2.1.28.", "PM": "91; was see under HYDRO-LYASES 1975-90", "HN": "91(75); was see under HYDRO-LYASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011408"}, {"RECTYPE": "D", "MH": "Propylene Glycols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Propanediols|T109|NON|EQV|NLM (1998)|970221|abcdef", "ENTRY": "Glycols, Propylene", "MN": "D02.033.455.706", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "PROPYLENE GLYCOL is also available", "MS": "Derivatives of propylene glycol (1,2-propanediol). They are used as humectants and solvents in pharmaceutical preparations.", "PM": "98; see PROPANEDIOLS 1963-97", "HN": "98(63)", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D011409"}, {"RECTYPE": "D", "MH": "Propanidid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sombrevin|T109|T121|TRD|NRW|UNK (19XX)|800804|abbcdef", "MN": "D02.241.223.601.774", "PA": "Anesthetics, Intravenous", "MH_TH": "USAN (1963)", "ST": "T121", "N1": "Benzeneacetic acid, 4-(2-(diethylamino)-2-oxoethoxy)-3-methoxy-, propyl ester", "RN": "AO82L471NS", "RR": "1421-14-3 (Propanidid)", "PI": "Anesthetics (1966-1969)", "MS": "An intravenous anesthetic that has been used for rapid induction of anesthesia and for maintenance of anesthesia of short duration. (From Martindale, The Extra Pharmacopoeia, 30th ed, p918)", "PM": "70", "HN": "70", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D011410"}, {"RECTYPE": "D", "MH": "Propanil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Propanide|T109|T131|NON|EQV|UNK (19XX)|840919|abbcdef", "MN": "D02.092.146.113.789", "PA": "Herbicides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Propanamide, N-(3,4-dichlorophenyl)-", "RN": "709-98-8", "PI": "Herbicides (1966-1971)", "MS": "A chlorinated anilide that is used as an herbicide.", "PM": "91; was see under ANILIDES 1972-90", "HN": "91(72); was see under ANILIDES 1972-90", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011411"}, {"RECTYPE": "D", "MH": "Propanolamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aminopropanols|T109|NON|EQV|UNK (19XX)|770311|abcdef", "MN": "D02.092.063.624", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives.", "PM": "74", "HN": "74", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011412"}, {"RECTYPE": "D", "MH": "Propantheline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pro Banthine", "MN": "D03.633.300.953.558", "PA": "Muscarinic Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Propanaminium, N-methyl-N-(1-methylethyl)-N-(2-((9H-xanthen-9-ylcarbonyl)oxy)ethyl)-", "RN": "1306V2B0Q8", "RR": "UX9Z118X9F", "MS": "A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.", "OL": "use PROPANTHELINE & METHANTHELINE to search PROPANTHELINE 1966-67; use PROPANTHELINE to search PROPANTHELINE BROMIDE 1966-80 (as Prov 1966-71)", "PM": "81; was see under METHANTHELINE 1963-67; PROPANTHELINE BROMIDE was heading 1972-80", "HN": "81; was see under METHANTHELINE 1963-67; PROPANTHELINE BROMIDE was heading 1964-80 (Prov 1964-71)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011413"}, {"RECTYPE": "D", "MH": "Properdin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Complement Factor P|T116|T129|NON|EQV|NLM (1999)|970912|abbcdef", "ENTRY": "Factor P, Complement", "MN": "D12.776.377.715.182.624", "PA": "Immunologic Factors", "MH_TH": "NLM (1966)", "ST": "T129", "N1": "Complement factor P", "RN": "11016-39-0", "MS": "A 53-kDa protein that is a positive regulator of the alternate pathway of complement activation (COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE). It stabilizes the ALTERNATIVE PATHWAY C3 CONVERTASE (C3bBb) and protects it from rapid inactivation, thus facilitating the cascade of COMPLEMENT ACTIVATION and the formation of MEMBRANE ATTACK COMPLEX. Individuals with mutation in the PFC gene exhibit properdin deficiency and have a high susceptibility to infections.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011414"}, {"RECTYPE": "D", "MH": "Complement Factor B", "AQ": "AD AE AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Properdin Factor B|T116|T126|T129|NON|EQV|NLM (1999)|970912|abbbcdef", "ENTRY": "Protein B, Complement", "MN": "D12.776.811.243.200", "PA": "Immunologic Factors", "MH_TH": "NLM (1978)", "ST": "T129", "RN": "EC 3.4.21.47", "RR": "EC 3.4.21.47", "PI": "Glycoproteins (1966-1977)", "MS": "A glycine-rich, heat-labile serum glycoprotein that contains a component of the C3 CONVERTASE ALTERNATE PATHWAY (C3bBb). Bb, a serine protease, is generated when factor B is cleaved by COMPLEMENT FACTOR D into Ba and Bb.", "PM": "99; see PROPERDIN FACTOR B 1991-98, see ENZYME PRECURSORS 1978-90; for COMPLEMENT FACTOR B see PROPERDIN FACTOR B 1988-98", "HN": "99(78)", "MR": "20190530", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D011415"}, {"RECTYPE": "D", "MH": "Complement Factor D", "AQ": "AD AE AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Properdin Factor D|T116|T126|T129|NON|EQV|NLM (1999)|970912|abbbcdef", "ENTRY": "Protein D, Complement", "MN": "D12.776.124.486.274.045.450", "PA": "Immunologic Factors", "MH_TH": "NLM (1978)", "ST": "T129", "RN": "EC 3.4.21.46", "AN": "see SCR for organism-specific terms", "PI": "Serum Globulins (1970-1977)", "MS": "A serum protein which is important in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY. This enzyme cleaves the COMPLEMENT C3B-bound COMPLEMENT FACTOR B to form C3bBb which is ALTERNATIVE PATHWAY C3 CONVERTASE.", "PM": "1999; see PROPERDIN FACTOR D 1991-1998, see COMPLEMENT ACTIVATING ENZYMES 1978-1990; ADIPSIN was indexed under SERINE ENDOPEPTIDASES 1987-2005", "HN": "1999 (1978)", "MR": "20090706", "DA": "19770520", "DC": "1", "DX": "19910101", "UI": "D011416"}, {"RECTYPE": "D", "MH": "Prophase", "AQ": "DE GE IM PH RE", "ENTRY": "Prophases", "MN": "G05.113.220.781.906", "MH_TH": "NLM (1978)", "ST": "T079", "AN": "coordinate with specific cell /cytol; permitted with microorganisms", "PI": "Mitosis (1968-1977)", "MS": "The first phase of cell nucleus division, in which the CHROMOSOMES become visible, the CELL NUCLEUS starts to lose its identity, the SPINDLE APPARATUS appears, and the CENTRIOLES migrate toward opposite poles.", "PM": "81; was see under CELL CYCLE 1978-80", "HN": "81(78); was see under CELL CYCLE 1978-80", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19770510", "DC": "1", "DX": "19810101", "UI": "D011418"}, {"RECTYPE": "D", "MH": "Propidium", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Iodide, Propidium", "MN": "D03.633.300.633.700", "PA": "Intercalating Agents", "MH_TH": "NLM (1979)", "ST": "T130", "N1": "Phenanthridinium, 3,8-diamino-5-(3-(diethylmethylammonio)propyl)-6-phenyl-", "RN": "36015-30-2", "RR": "25535-16-4", "PI": "Phenanthridines (1969-1978)", "MS": "Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits.", "PM": "91; was see under PHENANTHRIDINES 1979-90", "HN": "91(79); was see under PHENANTHRIDINES 1979-90", "MR": "20160531", "DA": "19780208", "DC": "1", "DX": "19910101", "UI": "D011419"}, {"RECTYPE": "D", "MH": "Propiolactone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Propiolactone|T109|T121|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|800328|abbbcdeef", "ENTRY": "beta Propiolactone", "MN": "D02.540.600", "PA": "Disinfectants", "MH_TH": "USAN (1964)", "ST": "T131", "N1": "2-Oxetanone", "RN": "6RC3ZT4HB0", "RR": "57-57-8 (Propiolactone)", "PI": "Propionates (1972-1974)", "MS": "Disinfectant used in vapor form to sterilize vaccines, grafts, etc. The vapor is very irritating and the liquid form is carcinogenic.", "PM": "91; was see under LACTONES 1975-90", "HN": "91(75); was see under LACTONES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011420"}, {"RECTYPE": "D", "MH": "Propionates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Propionate|T109|NON|EQV|NLM (2021)|191219|abcdef", "ENTRY": "Derivatives, Propionic Acid", "MN": "D10.251.400.706", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "/blood: consider also PROPIONIC ACIDEMIA", "MS": "Derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure.", "PM": "1966; for PROPIONIC ACIDS see PROPIONIC ACIDS 1974-2012", "HN": "1966", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011422"}, {"RECTYPE": "D", "MH": "Propionibacteriaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.600", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid31957", "AN": "in dairy products or intestinal tracts of animals", "PI": "Bacteria (1966-1974)", "MS": "A family of gram-positive bacteria found in dairy products or in the intestinal tracts of animals.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D011423"}, {"RECTYPE": "D", "MH": "Propionibacterium", "DE": "PROPIONIBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.600.600", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1743", "AN": "do not confuse with PROPIONIGENIUM", "MS": "A genus of gram-positive, rod-shaped bacteria whose cells occur singly, in pairs or short chains, in V or Y configurations, or in clumps resembling letters of the Chinese alphabet. Its organisms are found in cheese and dairy products as well as on human skin and can occasionally cause soft tissue infections.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011424"}, {"RECTYPE": "D", "MH": "Propionibacterium acnes", "DE": "PROPIONIBACT ACNES", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Corynebacterium parvum|T007|NON|EQV|UNK (19XX)|750711|CORYNEBACT PARVUM|abcdefv", "MN": "B03.510.460.400.400.600.600.600", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid1747", "AN": "infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM)", "PI": "Corynebacterium (1966-1974)", "MS": "A bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses. It is a common contaminant of clinical specimens, presumably from the skin of patients or attendants.", "OL": "use PROPIONIBACTERIUM ACNES to search CORYNEBACTERIUM ACNES & CORYNEBACTERIUM PARVUM 1975; use CORYNEBACTERIUM 1972-74", "PM": "76; CORYNEBACTERIUM ACNES & CORYNEBACTERIUM PARVUM were see under CORYNEBACTERIUM 1975", "HN": "76; CORYNEBACTERIUM ACNES & CORYNEBACTERIUM PARVUM were see under CORYNEBACTERIUM 1972-75 (Provs 1972-74)", "MR": "20200813", "DA": "19750721", "DC": "1", "DX": "19760101", "UI": "D011425"}, {"RECTYPE": "D", "MH": "Propiophenones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.522.818", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Propiophenone (ethyl phenyl ketone, structural formula C6H5COCH2CH3) and its derivatives. They are commonly used in perfumes and pharmaceuticals.", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011427"}, {"RECTYPE": "D", "MH": "Proplast", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Proplast I|T109|T122|NON|EQV|UNK (19XX)|830223|abbcdef", "MN": "J01.637.051.720.395.616.755", "MH_TH": "NLM (1980)", "ST": "T122", "RN": "0", "PI": "Polytetrafluoroethylene (1973-1979)", "MS": "Polymer of polytetrafluoroethylene and carbon filaments; porous biocompatible material used in orofacial and middle ear reconstruction and as coating for metal implants.", "PM": "91; was see under POLYTETRAFLUOROETHYLENE 1980-90", "HN": "91(80); was see under POLYTETRAFLUOROETHYLENE 1980-90", "MR": "20160628", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D011428"}, {"RECTYPE": "D", "MH": "Propolis", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Glue, Bee", "MN": "D20.215.721.500.762", "PA": "Anti-Infective Agents", "MH_TH": "NLM (1979)", "ST": "T123", "N1": "Beebread", "RN": "9009-62-5", "AN": "/ther use: coordinate with APITHERAPY", "PI": "Resins (1966-1978)", "MS": "A resinous substance obtained from beehives that is used traditionally as an antimicrobial. It is a heterogeneous mixture of many substances.", "PM": "91; was see under RESINS 1979-90", "HN": "91(79); was see under RESINS 1979-90", "MR": "20180206", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D011429"}, {"RECTYPE": "D", "MH": "Propoxycaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Propoxyprocaine|T109|T121|NON|EQV|UNK (19XX)|770429|abbcdef", "ENTRY": "Hydrochloride, Propoxycaine", "MN": "D02.455.426.559.389.127.281.350.687", "PA": "Anesthetics, Local", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzoic acid, 4-amino-2-propoxy-, 2-(diethylamino)ethyl ester", "RN": "EPD1EH7F53", "RR": "K490D39G46", "MS": "A local anesthetic of the ester type that has a rapid onset of action and a longer duration of action than procaine hydrochloride. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1017)", "PM": "65", "HN": "65", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011430"}, {"RECTYPE": "D", "MH": "Dextropropoxyphene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "D-Propoxyphene|T109|T121|NON|EQV|UNK (19XX)|760517|PROPOXYPHENE D|abbcdefs", "ENTRY": "Hydrochloride, Propoxyphene", "MN": "D02.241.081.751.120", "PA": "Narcotics", "MH_TH": "UNK (19XX)", "ST": "T121", "N1": "Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), (S-(R*,S*))-", "RN": "S2F83W92TK", "RR": "CB2TL9PS0T", "MS": "A narcotic analgesic structurally related to METHADONE. Only the dextro-isomer has an analgesic effect; the levo-isomer appears to exert an antitussive effect.", "PM": "1965; see PROPOXYPHENE 1965-2008; DEXTRO PROPOXYPHENE was heading 1963-64", "HN": "2008(1965); DEXTRO PROPOXYPHENE was heading 1963-1964", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011431"}, {"RECTYPE": "D", "MH": "Propranolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dexpropranolol|T109|T121|NON|REL|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef", "ENTRY": "Hydrochloride, Propranolol", "MN": "D04.615.638.945", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-", "RN": "9Y8NXQ24VQ", "RR": "PG6KY07UD7", "MS": "A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.", "PM": "67", "HN": "67(65)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D011433"}, {"RECTYPE": "D", "MH": "Proprioception", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Vestibular Sense|T041|NON|NRW|NLM (2021)|200130|abcdef", "ENTRY": "Sense, Vestibular", "MN": "G11.561.790.541", "MH_TH": "NLM (1973)", "ST": "T042", "PI": "Kinesthesis (1966-1972)", "MS": "Sensory functions that transduce stimuli received by proprioceptive receptors in joints, tendons, muscles, and the INNER EAR into neural impulses to be transmitted to the CENTRAL NERVOUS SYSTEM. Proprioception provides sense of stationary positions and movements of one's body parts, and is important in maintaining KINESTHESIA and POSTURAL BALANCE.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011434"}, {"RECTYPE": "D", "MH": "Propyl Gallate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Gallate, Propyl", "MN": "D02.455.426.559.389.657.410.200.600", "PA": "Antioxidants", "MH_TH": "USAN (19XX)", "ST": "T130", "N1": "Benzoic acid, 3,4,5-trihydroxy-, propyl ester", "RN": "8D4SNN7V92", "RR": "121-79-9 (Propyl Gallate)", "PI": "Gallic Acid (1973-1974)", "MS": "Antioxidant for foods, fats, oils, ethers, emulsions, waxes, and transformer oils.", "PM": "91; was see under GALLIC ACID 1975-90", "HN": "91(75); was see under GALLIC ACID 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011435"}, {"RECTYPE": "D", "MH": "Spermidine Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Spermidine Synthetase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Transferase, Propylamine", "MN": "D08.811.913.225.825", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "S-Adenosylmethioninamine:putrescine 3-aminopropyltransferase", "RN": "EC 2.5.1.16", "RR": "37277-82-0 (CAS RN)", "AN": "do not confuse with SPERMINE SYNTHASE", "PI": "Transferases (1972-1974)", "MS": "An enzyme that catalyzes the transfer of the propylamine moiety from 5'-deoxy-5'-S-(3-methylthiopropylamine)sulfonium adenosine to putrescine in the biosynthesis of spermidine. The enzyme has a molecular weight of approximately 73,000 kDa and is composed of two subunits of equal size.", "PM": "97; was PROPYLAMINE TRANSFERASE 1975-96 (see under TRANSFERASES 1975-90); SPERMIDINE SYNTHASE was see PROPYLAMINE TRANSFERASE 1975-96", "HN": "97; was PROPYLAMINE TRANSFERASE 1975-96 (see under TRANSFERASES 1975-90); SPERMIDINE SYNTHASE was see PROPYLAMINE TRANSFERASE 1975-96", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011436"}, {"RECTYPE": "D", "MH": "Propylamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.092.831", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of propylamine (the structural formula NH2CH2CH2CH3).", "PM": "66", "HN": "66", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011437"}, {"RECTYPE": "D", "MH": "Propylbenzilylcholine Mustard", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Mustard, Propylbenzilylcholine", "MN": "D02.675.276.232.720", "PA": "Muscarinic Antagonists", "MH_TH": "NLM (1977)", "ST": "T130", "N1": "Benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 2-((2-chloroethyl)propylamino)ethyl ester", "RN": "36167-80-3", "PI": "Mustard Compounds (1974-1976)", "MS": "An analog of benzilylcholine mustard. It is an alkylating nitrogen mustard analog that binds specifically and irreversibly to cholinergic muscarinic receptors and is used as an affinity label to isolate and study the receptors.", "PM": "91; was see under CHOLINE 1977-90", "HN": "91(77); was see under CHOLINE 1977-90", "MR": "20050630", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D011438"}, {"RECTYPE": "D", "MH": "Propyliodone", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Propiodone|T109|T130|NON|EQV|UNK (19XX)|800401|abbcdef", "ENTRY": "Gastrotrast|T109|T130|TRD|NRW|UNK (19XX)|840305|abbcdef", "MN": "D03.383.725.791.496.750", "PA": "Contrast Media", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "1(4H)-Pyridineacetic acid, 3,5-diiodo-4-oxo-, propyl ester", "RN": "5NPJ6BPX36", "RR": "587-61-1 (Propyliodone)", "MS": "Radiopaque medium usually in oil; used in bronchography.", "OL": "search CONTRAST MEDIA 1966-74", "PM": "91; was see under IODOPYRIDONES 1975-90; was see under CONTRAST MEDIA 1963-74", "HN": "91(75); was see under IODOPYRIDONES 1975-90; was see under CONTRAST MEDIA 1963-74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011440"}, {"RECTYPE": "D", "MH": "Propylthiouracil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "6 Propyl 2 Thiouracil", "MN": "D03.383.742.698.875.842.708", "PA": "Antithyroid Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4(1H)-Pyrimidinone, 2,3-dihydro-6-propyl-2-thioxo-", "RN": "721M9407IY", "RR": "51-52-5 (Propylthiouracil)", "AN": "a thyroid antag", "MS": "A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011441"}, {"RECTYPE": "D", "MH": "Proscillaridin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Scillarenin Rhamnoside|T109|T121|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Rhamnoside, Scillarenin", "MN": "D09.408.180.660", "PA": "Enzyme Inhibitors", "MH_TH": "USAN (1967)", "ST": "T123", "N1": "Bufa-4,20,22-trienolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-14-hydroxy-, (3beta)-", "RN": "KC6BL281EN", "RR": "466-06-8 (Proscillaridin)", "PI": "Plants, Medicinal (1970-1974)", "MS": "A cardiotonic glycoside isolated from Scilla maritima var. alba (Squill).", "PM": "91; was see under BUFANOLIDES 1975-90", "HN": "91(75); was see under BUFANOLIDES 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011442"}, {"RECTYPE": "D", "MH": "Strepsirhini", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Sportive Lemurs|T015|NON|NRW|NLM (2020)|190327|abcdef", "ENTRY": "Sportive Lemur", "MN": "B01.050.150.900.649.313.988.700", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid376911", "RR": "txid9452", "PI": "Primates (1966-1974)", "MS": "A suborder of PRIMATES consisting of the following five families: CHEIROGALEIDAE; Daubentoniidae; Indriidae; LEMURIDAE; and LORISIDAE.", "OL": "use STREPSIRHINI to search PROSIMII 1981-91 & PROSIMIANS 1975-80", "PM": "1992; was PROSIMII 1981-1991; was PROSIMIANS 1975-1980; for SPORTIVE LEMURS see STREPSIRHINI 2020", "HN": "1992; was PROSIMII 1981-1991; was PROSIMIANS 1975-1980; for SPORTIVE LEMURS was STREPSIRHINI 2020", "MR": "20200902", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D011443"}, {"RECTYPE": "D", "MH": "Prospective Payment Assessment Commission", "DE": "PROSPECTIVE PAYMENT ASSESS COMMISSION", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "PROPAC|T097|NAM|EQV|UNK (19XX)|860530|abcdef", "ENTRY": "United States Prospective Payment Assessment Commission|T097|NON|EQV|NLM (2009)|080428|abcdef", "MN": "N03.219.521.710.305.200.605", "FX": "Medicare Payment Advisory Commission", "MH_TH": "NLM (1987)", "ST": "T097", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "PI": "Prospective Payment System (1986)", "MS": "The commission charged with evaluating issues and factors which affect the implementation of the PROSPECTIVE PAYMENT SYSTEM.", "PM": "91; was see under PROSPECTIVE PAYMENT SYSTEM 1987-90", "HN": "91(87); was see under PROSPECTIVE PAYMENT SYSTEM 1987-90", "MR": "20150605", "DA": "19860530", "DC": "1", "DX": "19910101", "UI": "D011444"}, {"RECTYPE": "D", "MH": "Prospective Payment System", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Reimbursement, Prospective|T170|NON|EQV|UNK (19XX)|850521|abcdef", "ENTRY": "Systems, Prospective Payment", "MN": "N03.219.521.710.305.200", "MH_TH": "NLM (1979)", "ST": "T170", "AN": "specify geog", "MS": "A system wherein reimbursement rates are set, for a given period of time, prior to the circumstances giving rise to actual reimbursement claims.", "OL": "use PROSPECTIVE PAYMENT SYSTEM to search REIMBURSEMENT, PROSPECTIVE 1979-85", "PM": "87; was see under REIMBURSEMENT MECHANISMS 1986; was REIMBURSEMENT, PROSPECTIVE see under REIMBURSEMENT MECHANISMS 1979-85", "HN": "87(86); was see under REIMBURSEMENT MECHANISMS 1986; was REIMBURSEMENT, PROSPECTIVE see under REIMBURSEMENT MECHANISMS 1979-85", "MR": "19991103", "DA": "19780510", "DC": "1", "DX": "19870101", "UI": "D011445"}, {"RECTYPE": "D", "MH": "Prospective Studies", "ENTRY": "Study, Prospective", "MN": "N06.850.520.450.500.750.650", "MH_TH": "POPLINE (1978)", "ST": "T081", "AN": "IM general only", "MS": "Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D011446"}, {"RECTYPE": "D", "MH": "Prospidium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prospidin|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Chloride, Prospidium", "MN": "D04.711.656", "PA": "Antirheumatic Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "3,12-Bis(3-chloro-2-hydroxypropyl)-3,12-diaza-6,9- diazoniadispiro(5.2.5.2)hexadecane", "RN": "7Y2M0915RZ", "RR": "7G733H6RES", "PI": "Spiro Compounds (1971-1974)", "MS": "An antineoplastic dispiropiperazine derivative.", "PM": "91; was see under PIPERAZINES 1975-90", "HN": "91(75); was see under PIPERAZINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011447"}, {"RECTYPE": "D", "MH": "Prostaglandin Antagonists", "DE": "PG ANTAG", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prostaglandin Inhibitors|T121|NON|EQV|UNK (19XX)|770401|PG INHIB|abcdefv", "ENTRY": "Inhibitor, Prostaglandin", "MN": "D27.505.696.399.450.710", "FX": "Cyclooxygenase Inhibitors", "MH_TH": "POPLINE (1981)", "ST": "T121", "RN": "0", "PI": "Prostaglandins/antagonists & inhibitors (1968-1974)", "MS": "Compounds that inhibit the action of prostaglandins.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D011448"}, {"RECTYPE": "D", "MH": "Prostaglandin Endoperoxides", "DE": "PG ENDOPEROXIDES", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Endoperoxides, Prostaglandin", "MN": "D23.469.050.175.725.025", "EC": "analogs & derivatives:Prostaglandin Endoperoxides, Synthetic", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "AN": "/chem syn permitted: do not convert to PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC", "PI": "Prostaglandins (1966-1977)", "MS": "Precursors in the biosynthesis of prostaglandins and thromboxanes from arachidonic acid. They are physiologically active compounds, having effect on vascular and airway smooth muscles, platelet aggregation, etc.", "PM": "78", "HN": "78", "MR": "20230226", "DA": "19770523", "DC": "1", "DX": "19780101", "UI": "D011449"}, {"RECTYPE": "D", "MH": "Prostaglandin Endoperoxides, Synthetic", "DE": "PG ENDOPEROXIDES SYN", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prostaglandin Endoperoxide Analogs|T109|NON|EQV|UNK (19XX)|770523|PG ENDOPEROXIDE ANALOGS|abcdefv", "ENTRY": "Endoperoxides, Synthetic Prostaglandin", "MN": "D23.469.700.630", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Prostaglandins, Synthetic (1977)", "MS": "Synthetic compounds that are analogs of the naturally occurring prostaglandin endoperoxides and that mimic their pharmacologic and physiologic activities. They are usually more stable than the naturally occurring compounds.", "PM": "78", "HN": "78", "MR": "20150608", "DA": "19770523", "DC": "1", "DX": "19780101", "UI": "D011450"}, {"RECTYPE": "D", "MH": "Prostaglandin-Endoperoxide Synthases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Prostaglandin-Endoperoxide Synthase|T116|T126|NON|EQV|NLM (1975)|990101|PROSTAGLANDIN ENDOPEROXIDE SYNTHASE|PG ENDOPEROXIDE SYNTHASE|abbcdefsv", "ENTRY": "Synthetase, Prostaglandin H2", "MN": "D08.811.682.690.708.715", "EC": "antagonists & inhibitors:Cyclooxygenase Inhibitors", "MH_TH": "NLM (2006)", "ST": "T126", "N1": "(5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenoate,hydrogen-donor:oxygen oxidoreductase", "RN": "EC 1.14.99.1", "PI": "Prostaglandins (1971-1974)", "MS": "Enzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor.", "PM": "2006; see PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1978-2005, see PROSTAGLANDIN SYNTHASE 1978-1991, see under HYDROXYLASES 1975-1977", "HN": "2006(1992);", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D011451"}, {"RECTYPE": "D", "MH": "15-Oxoprostaglandin 13-Reductase", "DE": "OXOPG REDUCTASE", "DS": "OXOPROSTAGLANDIN REDUCTASE 15 13", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Prostaglandin-13,14-Reductase|T116|T126|NON|EQV|NLM (1994)|930208|PROSTAGLANDIN REDUCTASE 13 14|PG REDUCTASE|abbcdefsv", "ENTRY": "delta-13-Reductase, Prostaglandin", "MN": "D08.811.682.660.490", "MH_TH": "NLM (1978)", "ST": "T126", "RN": "EC 1.3.1.48", "PI": "specific prostaglandin (1975-1977)", "MS": "(5Z)-(15S)-11 alpha-Hydroxy-9,15-dioxoprostanoate:NAD(P)+ delta(13)-oxidoreductase. An enzyme active in prostaglandin E and F catabolism. It catalyzes the reduction of the double bond at the 13-14 position of the 15-ketoprostaglandins and uses NADPH as cofactor. EC 1.3.1.48.", "OL": "use 15-OXOPROSTAGLANDIN 13-REDUCTASE to search PROSTAGLANDIN-13,14-REDUCTASE 1978-93; use 15-OXOPROSTAGLANDIN 13-REDUCTASE (NM) to search DELTA 13-15-KETOPROSTAGLANDIN REDUCTASE 1980-93 & PROSTAGLANDIN DELTA 13 REDUCTASE 1981-93", "PM": "94; was PROSTAGLANDIN-13,14-REDUCTASE 1978-93 (see under OXIDOREDUCTASES 1978-90); DELTA 13-15-KETOPROSTAGLANDIN REDUCTASE was indexed under PROSTAGLANDIN-13,14-REDUCTASE 1981-93 and OXIDOREDUCTASES & PROSTAGLANDINS 1976-80; PROSTAGLANDIN DELTA 13 REDUCTASE was indexed under OXIDOREDUCTASES 1981-93", "HN": "94; was PROSTAGLANDIN-13,14-REDUCTASE 1978-93 (see under OXIDOREDUCTASES 1978-90); DELTA 13-15-KETOPROSTAGLANDIN REDUCTASE was (NM) 1976-93; PROSTAGLANDIN DELTA 13 REDUCTASE was (NM) 1981-93", "MR": "20050630", "DA": "19770523", "DC": "1", "DX": "19910101", "UI": "D011452"}, {"RECTYPE": "D", "MH": "Prostaglandins", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prostanoid|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Prostanoids|T109|NON|EQV|UNK (19XX)|830330|abcdef", "MN": "D23.469.050.175.725", "FX": "Receptors, Prostaglandin", "EC": "antagonists & inhibitors:Prostaglandin Antagonists", "MH_TH": "POPLINE (1978)", "ST": "T109", "RN": "0", "AN": "general  or unspecified; prefer specifics; /chem syn: do not convert to PROSTAGLANDINS, SYNTHETIC", "MS": "A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes.", "PM": "66", "HN": "66(63)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011453"}, {"RECTYPE": "D", "MH": "Prostaglandins A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PGA|T109|EQV|NLM (1995)|940426|abdef", "MN": "D23.469.050.175.725.100", "EC": "analogs & derivatives:Prostaglandins A, Synthetic", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "/chem syn permitted: do not convert to PROSTAGLANDINS A, SYNTHETIC", "PI": "Prostaglandins (1966-1974)", "MS": "(13E,15S)-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid (PGA(1)); (5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic acid (PGA(2)); (5Z,13E,15S,17Z)-15-hydroxy-9-oxoprosta-5,10,13,17-tetraen-1-oic acid (PGA(3)). A group of naturally occurring secondary prostaglandins derived from PGE; PGA(1) and PGA(2) as well as their 19-hydroxy derivatives are found in many organs and tissues.", "PM": "75", "HN": "75", "MR": "20160628", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D011454"}, {"RECTYPE": "D", "MH": "Prostaglandins A, Synthetic", "DE": "PGA SYN", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prostaglandin A Analogs|T109|NON|EQV|UNK (19XX)|770523|PGA ANALOGS|abcdefv", "ENTRY": "Synthetic, PGA", "MN": "D23.469.700.645", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Prostaglandins, Synthetic (1977)", "MS": "Analogs or derivatives of prostaglandin A that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGA.", "PM": "78", "HN": "78", "MR": "20150608", "DA": "19770523", "DC": "1", "DX": "19780101", "UI": "D011455"}, {"RECTYPE": "D", "MH": "Prostaglandins B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PGB|T109|EQV|NLM (1995)|940426|abdef", "MN": "D23.469.050.175.725.150", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "AN": "/biosyn /physiol permitted; for analogs, coord NIM with PROSTAGLANDINS, SYNTHETIC (IM); /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC", "PI": "Prostaglandins (1966-1977)", "MS": "Physiologically active prostaglandins found in many tissues and organs. They are potent pressor substances and have many other physiological activities.", "PM": "91; was see under PROSTAGLANDINS 1978-90", "HN": "91(78); was see under PROSTAGLANDINS 1978-90", "MR": "20190524", "DA": "19770523", "DC": "1", "DX": "19910101", "UI": "D011456"}, {"RECTYPE": "D", "MH": "Prostaglandins D", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PGD|T109|EQV|NLM (1995)|940426|abdef", "MN": "D23.469.050.175.725.200", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "AN": "for analogs, coordinate with PROSTAGLANDINS, SYNTHETIC; /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC", "PI": "Prostaglandins (1966-1977)", "MS": "Physiologically active prostaglandins found in many tissues and organs. They show pressor activity, are mediators of inflammation, and have potential antithrombotic effects.", "PM": "84; was see under PROSTAGLANDINS 1978-83", "HN": "84(78); was see under PROSTAGLANDINS 1978-83", "MR": "20160628", "DA": "19770523", "DC": "1", "DX": "19840101", "UI": "D011457"}, {"RECTYPE": "D", "MH": "Prostaglandins E", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PGE|T109|EQV|NLM (1995)|940426|abdef", "MN": "D23.469.050.175.725.250", "EC": "analogs & derivatives:Prostaglandins E, Synthetic", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "/chem syn permitted: do not convert to PROSTAGLANDINS E, SYNTHETIC", "PI": "Prostaglandins (1966-1974)", "MS": "(11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities.", "PM": "75", "HN": "75", "MR": "20160628", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D011458"}, {"RECTYPE": "D", "MH": "Prostaglandins E, Synthetic", "DE": "PGE SYN", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prostaglandin E Analogs|T109|NON|EQV|UNK (19XX)|770523|PGE ANALOGS|abcdefv", "ENTRY": "Synthetic, PGE", "MN": "D23.469.700.660", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Prostaglandins, Synthetic (1977)", "MS": "Analogs or derivatives of prostaglandins E that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGE.", "PM": "78", "HN": "78", "MR": "20150608", "DA": "19770523", "DC": "1", "DX": "19780101", "UI": "D011459"}, {"RECTYPE": "D", "MH": "Prostaglandins F", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PGF|T109|EQV|NLM (1995)|940426|abdef", "MN": "D23.469.050.175.725.400", "EC": "analogs & derivatives:Prostaglandins F, Synthetic", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "/chem syn permitted: do not convert to PROSTAGLANDINS F, SYNTHETIC", "PI": "Prostaglandins (1966-1974)", "MS": "(9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics.", "PM": "75", "HN": "75", "MR": "20160628", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D011460"}, {"RECTYPE": "D", "MH": "Prostaglandins F, Synthetic", "DE": "PGF SYN", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prostaglandin F Analogs|T109|NON|EQV|UNK (19XX)|770523|PGF ANALOGS|abcdefv", "ENTRY": "Synthetic, PGF", "MN": "D23.469.700.670", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Prostaglandins, Synthetic (1977)", "MS": "Analogs or derivatives of prostaglandins F that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGF.", "PM": "78", "HN": "78", "MR": "20150608", "DA": "19770523", "DC": "1", "DX": "19780101", "UI": "D011461"}, {"RECTYPE": "D", "MH": "Prostaglandins G", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PGG|T109|EQV|NLM (1995)|940426|abdef", "MN": "D23.469.050.175.725.025.600", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "AN": "/biosyn /physiol permitted; for analogs, coord NIM with PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC (IM); /chem syn permitted: do not convert to PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; DF: PGG", "PI": "Prostaglandins (1966-1977)", "MS": "A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. Most frequently encountered member of this group is the prostaglandin G2.", "PM": "91; was see under PROSTAGLANDIN ENDOPEROXIDES 1978-90", "HN": "91(78); was see under PROSTAGLANDIN ENDOPEROXIDES 1978-90", "MR": "20230226", "DA": "19770523", "DC": "1", "DX": "19910101", "UI": "D011462"}, {"RECTYPE": "D", "MH": "Prostaglandins H", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.469.050.175.725.025.650", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "AN": "for analogs: coord with PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC if pertinant; /chem syn permitted: do not convert to PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; PROSTAGLANDIN H2 is also available; DF: PGH", "PI": "Prostaglandins (1966-1977)", "MS": "A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. The most frequently encountered member of this group is the prostaglandin H2.", "PM": "91; was see under PROSTAGLANDIN ENDOPEROXIDES 1978-90", "HN": "91(78); was see under PROSTAGLANDIN ENDOPEROXIDES 1978-90", "MR": "20230226", "DA": "19770523", "DC": "1", "DX": "19910101", "UI": "D011463"}, {"RECTYPE": "D", "MH": "Epoprostenol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prostaglandin I2|T109|T121|T123|NON|EQV|NLM (1994)|921215|PROSTAGLANDIN I 02|abbbcdefs", "ENTRY": "Veletri|T109|T121|TRD|NRW|NLM (2003)|030311|abbcdef", "MN": "D23.469.050.175.725.550.500", "PA": "Platelet Aggregation Inhibitors", "MH_TH": "USAN (1979)", "ST": "T123", "N1": "Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9alpha,11alpha,13E,15S)-", "RN": "DCR9Z582X0", "RR": "4K04IQ1OF4", "PI": "Prostaglandins (1966-1977)", "MS": "A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).", "PM": "1991; see PROSTAGLANDINS X 1978-1990; for PROSTACYCLIN see PROSTACYCLINS 1978-1993; for PROSTAGLANDIN I2 see PROSTAGLANDINS I2 1982-1993; for PROSTAGLANDIN X see PROSTAGLANDINS X 1991-1993", "HN": "1991 (1978); use PROSTAGLANDINS X 1978-1990; for PROSTACYCLIN use PROSTACYCLINS 1978-1993; for PROSTAGLANDIN I2 use PROSTAGLANDINS I2 1982-1993; for PROSTAGLANDIN X use PROSTAGLANDINS X 1991-1993", "MR": "20180301", "DA": "19770523", "DC": "1", "DX": "19840101", "UI": "D011464"}, {"RECTYPE": "D", "MH": "Prostaglandins, Synthetic", "DE": "PG SYN", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Synthetic Prostaglandin|T109|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Prostaglandin, Synthetic", "MN": "D23.469.700", "MH_TH": "POPLINE (1981)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics; for synthetic prostaglandins not precoord, coord specific non-synthetic (natural) prostaglandin term (NIM) and PROSTAGLANDINS, SYNTHETIC (IM)", "PI": "Prostaglandins (1966-1976)", "MS": "Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity.", "PM": "77", "HN": "77", "MR": "20200527", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D011465"}, {"RECTYPE": "D", "MH": "Prostanoic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Prostanoic", "MN": "D10.251.740", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with \"prostenoic acids\"; /biosyn /physiol permitted", "PI": "Prostaglandins (1971-1974)", "MS": "2-Octylcyclopentaneheptanoic acids. The family of saturated carbon-20 cyclic fatty acids that represent the parent compounds of the prostaglandins.", "PM": "91; was see under FATTY ACIDS 1975-90", "HN": "91(75); was see under FATTY ACIDS 1975-90", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D011466"}, {"RECTYPE": "D", "MH": "Prostate", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Prostates", "MN": "A10.336.707", "FX": "Prostatectomy", "MH_TH": "POPLINE (1978)", "ST": "T023", "MS": "A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM.", "MR": "20060707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011467"}, {"RECTYPE": "D", "MH": "Prostatectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Prostatectomy, Suprapubic|T061|NON|NRW|NLM (1999)|980522|abcdef", "ENTRY": "Suprapubic Prostatectomy", "MN": "E04.950.774.860.625", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE).", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011468"}, {"RECTYPE": "D", "MH": "Prostatic Diseases", "DE": "PROSTATIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Prostatic Disease", "MN": "C12.200.294.565", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes involving the PROSTATE or its component tissues.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011469"}, {"RECTYPE": "D", "MH": "Prostatic Hyperplasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Prostatic Hypertrophy, Benign|T046|NON|REL|NLM (1992)|910506|abcdef", "ENTRY": "Prostatic Hypertrophies", "MN": "C12.200.294.565.500", "FX": "Prostatism", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "note category: non-neoplastic despite entry terms ADENOMA, PROSTATIC, and PROSTATIC ADENOMA", "MS": "Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.", "PM": "96; was PROSTATIC HYPERTROPHY 1963-95; PROSTATIC HYPERPLASIA was see PROSTATIC HYPERTROPHY 1992-95", "HN": "96; was PROSTATIC HYPERTROPHY 1963-95; PROSTATIC HYPERPLASIA was see PROSTATIC HYPERTROPHY 1992-95", "CATSH": "CAT LIST", "MR": "20210607", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D011470"}, {"RECTYPE": "D", "MH": "Prostatic Neoplasms", "DE": "PROSTATIC NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Prostate Cancer|T191|NON|NRW|NLM (1997)|OMIM (2013)|960220|abcdeef", "ENTRY": "Prostatic Neoplasm", "MN": "C12.900.619.750", "FX": "Prostatic Hyperplasia", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM); note PROSTATIC ADENOMA see PROSTATIC HYPERPLASIA is also available", "MS": "Tumors or cancer of the PROSTATE.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011471"}, {"RECTYPE": "D", "MH": "Prostatitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Prostatitides, Chronic Bacterial", "MN": "C12.200.294.565.750", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with appropriate infection term if pertinent; do not confuse with PROSTATISM", "MS": "Infiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011472"}, {"RECTYPE": "D", "MH": "Prosthesis Design", "AQ": "AE CL EC ES HI IS MO MT PX SN ST TD VE", "ENTRY": "Prosthesis Designs", "MN": "E07.695.680", "FX": "Denture Design", "MH_TH": "NLM (1971)", "ST": "T058", "AN": "coordinate with specific prosthesis", "PI": "specific prosthesis (1966-1970)", "MS": "The plan and delineation of prostheses in general or a specific prosthesis.", "PM": "74", "HN": "74(71)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011474"}, {"RECTYPE": "D", "MH": "Prosthesis Failure", "AQ": "AE DE ET RE TD", "PRINT ENTRY": "Prosthesis Loosening|T067|NON|NRW|UNK (19XX)|850617|abcdef", "ENTRY": "Survivals, Prosthesis", "MN": "E05.325.771", "FX": "Prosthesis Retention", "MH_TH": "NLM (1986)", "ST": "T067", "PI": "Prosthesis Design (1971-1985)", "MS": "Malfunction of implantation shunts, valves, etc., and prosthesis loosening, migration, and breaking.", "PM": "91; was see under EQUIPMENT FAILURE 1986-90", "HN": "91(86); was see under EQUIPMENT FAILURE 1986-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19850617", "DC": "1", "DX": "19910101", "UI": "D011475"}, {"RECTYPE": "D", "MH": "Prosthodontics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Prosthetic Dentistry", "MN": "H02.163.876.708", "FX": "Oral Surgical Procedures, Preprosthetic", "MH_TH": "NLM (1965)", "ST": "T091", "MS": "A dental specialty concerned with the restoration and maintenance of oral function by the replacement of missing TEETH and related structures by artificial devices or DENTAL PROSTHESES.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20150210", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011476"}, {"RECTYPE": "D", "MH": "Sex Work", "AQ": "EH HI LJ PX SN", "PRINT ENTRY": "Prostitution|T054|NON|EQV|NLM (1963)|990101|abcdef", "ENTRY": "Work, Sex", "MN": "I01.880.735.679", "MH_TH": "NLM (2017)", "ST": "T054", "MS": "The act or practice of engaging in sexual relations for money or other benefit.", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011477"}, {"RECTYPE": "D", "MH": "Protactinium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.750", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Protactinium", "RN": "0S6855V29M", "RR": "7440-13-3 (Protactinium)", "MS": "A radioactive element of the actinide group of metals. It has the atomic symbol Pa, atomic number 91, and atomic weight 231. It decays by alpha-emission.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011478"}, {"RECTYPE": "D", "MH": "Protamines", "AQ": "AD AE AG AI AN BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protamine Sulfate|T116|T121|NON|NRW|UNK (19XX)|870409|abbcdef", "ENTRY": "Sulfate, Protamine", "MN": "D12.776.664.750", "PA": "Heparin Antagonists", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "heparin antag", "MS": "A group of simple proteins that yield basic amino acids on hydrolysis and that occur combined with nucleic acid in the sperm of fish. Protamines contain very few kinds of amino acids. Protamine sulfate combines with heparin to form a stable inactive complex; it is used to neutralize the anticoagulant action of heparin in the treatment of heparin overdose. (From Merck Index, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p692)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011479"}, {"RECTYPE": "D", "MH": "Protease Inhibitors", "DE": "PROTEASE INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Protease Antagonists|T121|T123|NON|EQV|UNK (19XX)|780519|PROTEASE ANTAG|abbcdefv", "ENTRY": "Peptidohydrolase Inhibitors, Peptide", "MN": "D27.505.519.389.745", "FX": "Proteinase Inhibitory Proteins, Secretory", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "AN": "PROTEASE INHIBITORY PROTEINS, SECRETORY is also available", "PI": "Peptide Peptidohydrolases/antagonists & inhibitors (1968-1978)", "MS": "Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES).", "PM": "79", "HN": "79", "MR": "20200527", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D011480"}, {"RECTYPE": "D", "MH": "Protective Clothing", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Clothing, Protective|T073|NON|EQV|NLM (2000)|991103|abcdef", "MN": "J01.637.708.560.875", "MH_TH": "NLM (1970)", "ST": "T073", "PI": "Clothing (1966-1969)", "MS": "Clothing designed to protect the individual against possible exposure to known hazards.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D011481"}, {"RECTYPE": "D", "MH": "Protective Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Safety Devices|T073|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Safety Device", "MN": "J01.637.708", "MH_TH": "NLM (1970)", "ST": "T073", "AN": "for personal protection", "PI": "Occupational Medicine (1966-1969)", "MS": "Devices designed to provide protection against injury.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20160302", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D011482"}, {"RECTYPE": "D", "MH": "Proteidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.090.608.630", "MH_TH": "NLM (1981)", "ST": "T011", "RN": "txid166053", "AN": "NIM with no qualifiers when experimental animal ", "MS": "The Proteidae family of permanently larval aquatic salamanders. It consists of two living genera - Necturus (mudpuppy) of the eastern United States and Proteus (the European olm).", "PM": "81", "HN": "81", "MR": "20200813", "DA": "19800512", "DC": "1", "DX": "19810101", "UI": "D011483"}, {"RECTYPE": "D", "MH": "Protein-Arginine N-Methyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein-Arginine N-Methyltransferase|T116|T126|NON|EQV|NLM (1977)|990101|PROTEIN ARGININE METHYLTRANSFERASE N|abbcdefs", "ENTRY": "Type I Protein Arginine N Methyltransferase", "MN": "D08.811.913.555.500.800.750", "MH_TH": "NLM (2010)", "ST": "T126", "N1": "S-Adenosyl-L-methionine:protein-L-arginine N-methyltransferase", "RN": "EC 2.1.1.319", "RR": "EC 2.1.1.321", "PI": "specific protein(1966-1976)", "MS": "Enzymes that catalyze the methylation of arginine residues of proteins to yield N-mono- and N,N-dimethylarginine. This enzyme is found in many organs, primarily brain and spleen.", "PM": "2010; see PROTEIN-ARGININE N-METHYLTRANSFERASE 1998-2009; see PROTEIN-ARGININE METHYLTRANSFERASE 1991-1997; see PROTEIN METHYLTRANSFERASES 1977-1990", "HN": "2010 (1977)", "MR": "20180110", "DA": "19760521", "DC": "1", "DX": "19910101", "UI": "D011484"}, {"RECTYPE": "D", "MH": "Protein Binding", "AQ": "DE ES GE IM PH RE", "ENTRY": "Binding, Protein", "MN": "G03.808", "FX": "Thyroxine-Binding Proteins", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "NIM; restrict to the chem or metab binding mechanism; coord NIM with substance being bound /metab (IM) + specific protein /metab (IM); do not use with receptors terms unless the substance bound to the receptor is a protein & the binding mechanism is discussed; do not confuse with BINDING PROTEINS see CARRIER PROTEINS", "MS": "The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.", "PM": "70", "HN": "70(66)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D011485"}, {"RECTYPE": "D", "MH": "Protein C", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D23.113.700", "PA": "Fibrinolytic Agents", "EC": "deficiency:Protein C Deficiency", "MH_TH": "NLM (1987)", "ST": "T123", "RN": "0", "PI": "Glycoproteins (1966-1986)", "MS": "A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.", "PM": "87", "HN": "87", "MR": "20230316", "DA": "19860602", "DC": "1", "DX": "19870101", "UI": "D011486"}, {"RECTYPE": "D", "MH": "Protein Conformation", "AQ": "DE RE", "ENTRY": "Protein Conformations", "MN": "G02.111.570.820.709", "MH_TH": "NLM (1972)", "ST": "T082", "PI": "Proteins (1966-1971)", "MS": "The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011487"}, {"RECTYPE": "D", "MH": "Protein Deficiency", "DE": "PROTEIN DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Protein Deficiencies", "MN": "C18.654.521.500.708", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "deficiency of dietary protein, not genetic defic of specific proteins; consider also PROTEIN-CALORIE MALNUTRITION", "MS": "A nutritional condition produced by a deficiency of proteins in the diet, characterized by adaptive enzyme changes in the liver, increase in amino acid synthetases, and diminution of urea formation, thus conserving nitrogen and reducing its loss in the urine. Growth, immune response, repair, and production of enzymes and hormones are all impaired in severe protein deficiency. Protein deficiency may also arise in the face of adequate protein intake if the protein is of poor quality (i.e., the content of one or more amino acids is inadequate and thus becomes the limiting factor in protein utilization). (From Merck Manual, 16th ed; Harrison's Principles of Internal Medicine, 12th ed, p406)", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011488"}, {"RECTYPE": "D", "MH": "Protein Denaturation", "AQ": "DE RE", "ENTRY": "Protein Denaturations", "MN": "G02.111.688.750.500", "MH_TH": "NLM (1964)", "ST": "T049", "MS": "Disruption of the non-covalent bonds and/or disulfide bonds responsible for maintaining the three-dimensional shape and activity of the native protein.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011489"}, {"RECTYPE": "D", "MH": "Protein Disulfide Reductase (Glutathione)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glutathione Protein Disulfide Oxidoreductase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Transhydrogenase, Glutathione Insulin", "MN": "D08.811.682.667.186", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Glutathione:protein-disulfide oxidoreductase", "RN": "EC 1.8.4.2", "PI": "Oxidoreductases (1972-1974)", "MS": "An enzyme that catalyzes the reduction of a protein-disulfide in the presence of glutathione, forming a protein-dithiol. Insulin is one of its substrates. EC 1.8.4.2.", "PM": "91; was see under OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under OXIDOREDUCTASES 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011490"}, {"RECTYPE": "D", "MH": "Protein Hydrolysates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Hydrolysate|T116|T121|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Hydrolysates, Protein", "MN": "D12.776.796", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "A complex mixture of OLIGOPEPTIDES, PEPTIDES, and free AMINO ACIDS that are produced by partial or extensive hydrolysis.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011492"}, {"RECTYPE": "D", "MH": "Protein Kinase C", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PKC Serine-Threonine Kinase|T116|T126|NON|EQV|NLM (2006)|050425|abbcdef", "ENTRY": "Serine-Threonine Kinase, PKC", "MN": "D12.776.476.563.725", "MH_TH": "NLM (1986)", "ST": "T126", "RN": "EC 2.7.11.13", "PI": "Protein Kinases (1973-1985)", "MS": "An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters.", "PM": "86; CALCIUM PHOSPHOLIPID-DEPENDENT PROTEIN KINASE was CALCIUM-PHOSPHOLIPID DEPENDENT PROTEIN KINASE 1986-93", "HN": "86; CALCIUM PHOSPHOLIPID-DEPENDENT PROTEIN KINASE was CALCIUM-PHOSPHOLIPID DEPENDENT PROTEIN KINASE 1986-93", "MR": "20210521", "DA": "19850517", "DC": "1", "DX": "19860101", "UI": "D011493"}, {"RECTYPE": "D", "MH": "Protein Kinases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kinases, Protein", "MN": "D08.811.913.696.620.682", "EC": "antagonists & inhibitors:Protein Kinase Inhibitors", "MH_TH": "NLM (1974)", "ST": "T126", "N1": "ATP-protein phosphotransferase", "RN": "EC 2.7.-", "MS": "A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein.", "OL": "use PROTEIN KINASES to search PROTEIN KINASE 1973-79 (as Prov 1973)", "PM": "80; was PROTEIN KINASE 1974-79", "HN": "80; was PROTEIN KINASE 1973-79 (Prov 1973)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011494"}, {"RECTYPE": "D", "MH": "Histone-Lysine N-Methyltransferase", "DS": "HISTONE LYSINE METHYLTRANSFERASE N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Methyltransferase III|T116|T126|NON|EQV|UNK (19XX)|760520|PROTEIN METHYLTRANSFERASE A 03|abbcdefs", "ENTRY": "N-Methyltransferase, Histone-Lysine", "MN": "D08.811.913.555.500.800.200.500", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "S-Adenosyl-L-methionine:histone-L-lysine N(6)-methyltransferase", "RN": "EC 2.1.1.43", "RR": "9055-08-7 (CAS RN)", "PI": "specific protein (1966-1976)", "MS": "An enzyme that catalyzes the methylation of the epsilon-amino group of lysine residues in proteins to yield epsilon mono-, di-, and trimethyllysine.", "PM": "1998; see HISTONE-LYSINE METHYLTRANSFERASE 1991-97; see METHYLTRANSFERASES 1977-90", "HN": "1998 (1977)", "MR": "20180116", "DA": "19760521", "DC": "1", "DX": "19910101", "UI": "D011495"}, {"RECTYPE": "D", "MH": "Protein Methyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Methyltransferase|T116|T126|NON|EQV|NLM (2021)|200617|abbcdef", "ENTRY": "Methyltransferases, Protein", "MN": "D08.811.913.555.500.800", "MH_TH": "NLM (1977)", "ST": "T126", "RN": "EC 2.1.1.-", "RR": "9068-28-4 (CAS RN)", "AN": "do not confuse with PROTEIN O-METHYLTRANSFERASE", "PI": "specific protein", "MS": "Enzymes that catalyze the methylation of amino acids after their incorporation into a polypeptide chain. S-Adenosyl-L-methionine acts as the methylating agent. EC 2.1.1.", "PM": "77", "HN": "77", "MR": "20200618", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D011496"}, {"RECTYPE": "D", "MH": "Protein O-Methyltransferase", "DS": "PROTEIN METHYLTRANSFERASE O", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Methyltransferase II|T126|NON|EQV|UNK (19XX)|760520|PROTEIN METHYLTRANSFERASE A 02|abcdefs", "ENTRY": "Transferase, S-Adenosylmethionine-Protein Carboxymethyl", "MN": "D08.811.913.555.500.800.800", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "S-Adenosylmethionine:protein O-methyltransferase", "RN": "EC 2.1.1.-", "RR": "9055-09-8 (CAS RN)", "AN": "do not confuse with PROTEIN METHYLTRANSFERASES", "PI": "S-Adenosylmethionine (1971-1976)", "MS": "An enzyme that catalyzes the transfer of methyl groups from S-adenosylmethionine to free carboxyl groups of a protein molecule forming methyl esters. EC 2.1.1.-.", "PM": "91; was see under PROTEIN METHYLTRANSFERASES 1977-90", "HN": "91(77); was see under PROTEIN METHYLTRANSFERASES 1977-90", "MR": "20030709", "DA": "19760521", "DC": "1", "DX": "19910101", "UI": "D011497"}, {"RECTYPE": "D", "MH": "Protein Precursors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Precursors, Protein", "MN": "D12.776.811", "FX": "Enzyme Precursors", "MH_TH": "NLM (1973)", "ST": "T123", "RN": "0", "AN": "IM; coord with specific protein (IM)", "PI": "specific protein (1966-1970)", "PM": "73", "HN": "73", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011498"}, {"RECTYPE": "D", "MH": "Protein Processing, Post-Translational", "DE": "PROTEIN PROC POST TRANSLATIONAL", "DS": "PROTEIN PROCESSING POSTTRANSLATIONAL", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Protein Modification, Post-Translational|T045|NON|EQV|NLM (2005)|030905|PROTEIN MODIFICATION POSTTRANSLATIONAL|abcdefs", "ENTRY": "Protein Modifications, Post-Translational", "MN": "G05.308.670.600", "FX": "Histone Code", "MH_TH": "NLM (1983)", "ST": "T045", "AN": "coord IM with specific protein /metab (IM) and with specific modification, for example, ACYLATION; AMINATION; DEAMINATION; PROTEIN ISOPRENYLATION; etc.; do not confuse with PROTEIN MODIFICATION, TRANSLATIONAL; DF: PROTEIN PROC POST", "PI": "Translation, Genetic (1973-1982)", "MS": "Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19820426", "DC": "1", "DX": "19830101", "UI": "D011499"}, {"RECTYPE": "D", "MH": "Protein Synthesis Inhibitors", "DE": "PROTEIN SYN INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Protein Synthesis Inhibitor|T121|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Synthesis Inhibitor, Protein", "MN": "D27.505.519.389.760", "MH_TH": "NLM (1988)", "ST": "T121", "RN": "0", "PI": "Proteins/biosynthesis (1966-1987)", "MS": "Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins.", "PM": "88", "HN": "88", "MR": "20200527", "DA": "19870409", "DC": "1", "DX": "19880101", "UI": "D011500"}, {"RECTYPE": "D", "MH": "Protein-Energy Malnutrition", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Protein-Calorie Malnutrition|T047|NON|EQV|NLM (1992)|910529|abcdef", "ENTRY": "Protein Energy Malnutrition", "MN": "C18.654.521.500.708.626", "FX": "Emaciation", "MH_TH": "NLM (1972)", "ST": "T047", "AN": "consider also KWASHIORKOR", "PI": "Nutrition Disorders (1966-1971)", "MS": "The lack of sufficient energy or protein to meet the body's metabolic demands, as a result of either an inadequate dietary intake of protein, intake of poor quality dietary protein, increased demands due to disease, or increased nutrient losses.", "OL": "use PROTEIN-ENERGY MALNUTRITION to search PROTEIN-CALORIE MALNUTRITION 1972-91 (as Prov 1972-73)", "PM": "92; was PROTEIN-CALORIE MALNUTRITION 1974-91", "HN": "92; was PROTEIN-CALORIE MALNUTRITION 1972-91 (Prov 1972-73)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011502"}, {"RECTYPE": "D", "MH": "Transglutaminases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transglutaminase|T116|T126|NON|EQV|NLM (2021)|191126|abbcdef", "ENTRY": "gamma-Glutamyltransferases, Protein-Glutamine", "MN": "D08.811.913.050.200.800", "MH_TH": "UNK (19XX)", "ST": "T126", "N1": "Protein-glutamine:amine gamma-glutamyltransferase", "RN": "EC 2.3.2.13", "RR": "80146-85-6 (CAS RN)", "AN": "distinguish entry terms GLUTAMINYL-PEPTIDE GAMMA-GLUTAMYLTRANSFERASES, and TRANSGLUTAMINASES from GAMMA-GLUTAMYL TRANSPEPTIDASE which is involved with glutathione metabolism; PLASMA TRANSGLUTAMINASE see FACTOR XIIIA is also available", "PI": "Acyltransferases (1966-1985)", "MS": "Transglutaminases catalyze cross-linking of proteins at a GLUTAMINE in one chain with LYSINE in another chain. They include keratinocyte transglutaminase (TGM1 or TGK), tissue transglutaminase (TGM2 or TGC), plasma transglutaminase involved with coagulation (FACTOR XIII and FACTOR XIIIa), hair follicle transglutaminase, and prostate transglutaminase. Although structures differ, they share an active site (YGQCW) and strict CALCIUM dependence.", "PM": "2002; see PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 1986-2002; for TRANSGLUTAMINASES see TRANSGLUTAMINASES 1986-2002", "HN": "2002(1986)", "MR": "20200527", "DA": "19850424", "DC": "1", "DX": "19860101", "UI": "D011503"}, {"RECTYPE": "D", "MH": "Protein-Losing Enteropathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Idiopathic Hypercatabolic Hypoproteinemia|T047|NON|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Protein Losing Enteropathy", "MN": "C06.405.469.818", "FX": "Lymphopenia", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011504"}, {"RECTYPE": "D", "MH": "Protein-Tyrosine Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tyrosine-Specific Protein Kinase|T116|T126|NON|EQV|UNK (19XX)|850425|abbcdef", "ENTRY": "Tyrosine Specific Protein Kinases", "MN": "D12.776.476.568", "FX": "src Homology Domains", "MH_TH": "NLM (2007)", "ST": "T126", "N1": "ATP:protein-tyrosine O-phosphotransferase", "RN": "EC 2.7.10.1", "RR": "EC 2.7.10.2", "PI": "Protein Kinases (1973-1985)", "MS": "Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors.", "PM": "2007; see PROTEIN-TYROSINE KINASE 1986-2006", "HN": "2007(1986)", "MR": "20210521", "DA": "19850425", "DC": "1", "DX": "19860101", "UI": "D011505"}, {"RECTYPE": "D", "MH": "Proteins", "AQ": "AD AE AG AI AN CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Protein|T116|T123|NON|EQV|NLM (2021)|191113|abbcdef", "ENTRY": "Proteins, Gene", "MN": "D12.776", "FX": "Protein Conformation", "EC": "urine:Proteinuria", "MH_TH": "NLM (1963)", "ST": "T123", "RN": "0", "MS": "Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.", "PM": "/metabolism was PROTEIN METABOLISM 1963-65; PROTEIN METABOLISM DISORDERS was heading 1963-64", "HN": "/metabolism was PROTEIN METABOLISM 1963-65; PROTEIN METABOLISM DISORDERS was heading 1963-64", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011506"}, {"RECTYPE": "D", "MH": "Proteinuria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Proteinurias", "MN": "C23.888.942.750", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "The presence of proteins in the urine, an indicator of KIDNEY DISEASES.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011507"}, {"RECTYPE": "D", "MH": "Chondroitin Sulfate Proteoglycans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proteochondroitin Sulfates|T116|T123|NON|EQV|NLM (1976)|990101|abbcdef", "ENTRY": "Sulfate Proteoglycans, Chondroitin", "MN": "D12.776.395.650.750", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "PI": "Mucoproteins (1973-1974)", "MS": "Proteoglycans consisting of proteins linked to one or more CHONDROITIN SULFATE-containing oligosaccharide chains.", "PM": "2011; see PROTEOCHONDROITIN SULFATES 1991-2010; see PROTEOGLYCANS 1977-1990, see MUCOPOLYSACCHARIDES 1976", "HN": "2011(1976)", "MR": "20230316", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D011508"}, {"RECTYPE": "D", "MH": "Proteoglycans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteoglycan Type H|T116|NON|NRW|UNK (19XX)|860930|abcdef", "MN": "D12.776.395.650", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "polysaccharides", "PI": "Mucopolysaccharides (1966-1974)", "MS": "Glycoproteins which have a very high polysaccharide content.", "OL": "search MUCOPOLYSACCHARIDES 1973-74", "PM": "77; was see under MUCOPOLYSACCHARIDES 1975-76; PROTEOCHONDROITIN SULFATES was see under MUCOPOLYSACCHARIDES 1976", "HN": "77(75); was see under MUCOPOLYSACCHARIDES 1975-76", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D011509"}, {"RECTYPE": "D", "MH": "Proteolipids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.816", "FX": "Lipoproteins", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "do not confuse with LIPOPROTEINS or LIPID-LINKED PROTEINS", "PI": "specific lipoprotein(1966-1976)", "MS": "Protein-lipid combinations abundant in brain tissue, but also present in a wide variety of animal and plant tissues. In contrast to lipoproteins, they are insoluble in water, but soluble in a chloroform-methanol mixture. The protein moiety has a high content of hydrophobic amino acids. The associated lipids consist of a mixture of GLYCEROPHOSPHATES; CEREBROSIDES; and SULFOGLYCOSPHINGOLIPIDS; while lipoproteins contain PHOSPHOLIPIDS; CHOLESTEROL; and TRIGLYCERIDES.", "PM": "77", "HN": "77", "MR": "20100625", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D011510"}, {"RECTYPE": "D", "MH": "Proteus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.590", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid583", "AN": "general or unspecified; prefer specifics; infection equals PROTEUS INFECTIONS", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the intestines of humans and a wide variety of animals, as well as in manure, soil, and polluted waters. Its species are pathogenic, causing urinary tract infections and are also considered secondary invaders, causing septic lesions at other sites of the body.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011511"}, {"RECTYPE": "D", "MH": "Proteus Infections", "DE": "PROTEUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Proteus Infection", "MN": "C01.150.252.400.310.708", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Infections with bacteria of the genus PROTEUS.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011512"}, {"RECTYPE": "D", "MH": "Proteus mirabilis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.590.500", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid584", "AN": "infection: coord IM with PROTEUS INFECTIONS (IM)", "PI": "Proteus (1966-1971)", "MS": "A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is frequently isolated from clinical specimens. Its most common site of infection is the urinary tract.", "PM": "74", "HN": "74(72)", "MR": "20200128", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011513"}, {"RECTYPE": "D", "MH": "Proteus vulgaris", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.590.840", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid585", "AN": "infection: coord IM with PROTEUS INFECTIONS (IM)", "PI": "Proteus (1966-1971)", "MS": "A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in soil, fecal matter, and sewage. It is an opportunistic pathogen and causes cystitis and pyelonephritis.", "PM": "74", "HN": "74(72)", "MR": "20200128", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011514"}, {"RECTYPE": "D", "MH": "Prothionamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Protionamide|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|741111|abbcdeef", "MN": "D03.383.725.394.675", "PA": "Antitubercular Agents", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "4-Pyridinecarbothioamide, 2-propyl-", "RN": "76YOO33643", "RR": "14222-60-7 (Prothionamide)", "PI": "Sulfides (1972-1974)", "MS": "Antitubercular agent similar in action and side effects to ETHIONAMIDE. It is used mostly in combination with other agents.", "PM": "91; was see under ISONICOTINIC ACIDS 1975-90", "HN": "91(75); was see under ISONICOTINIC ACIDS 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011515"}, {"RECTYPE": "D", "MH": "Prothrombin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Factor II|T116|T123|NON|EQV|UNK (19XX)|750101|abbcdef", "ENTRY": "II, Coagulation Factor", "MN": "D23.119.945", "FX": "Coagulants", "EC": "deficiency:Hypoprothrombinemias", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Blood-coagulation factor II", "RN": "9001-26-7", "AN": "a blood coag factor; an enzyme precursor", "MS": "A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia.", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011516"}, {"RECTYPE": "D", "MH": "Prothrombin Time", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Thrombotest|T059|TRD|REL|NLM (1992)|901011|abcdef", "ENTRY": "Times, Prothrombin", "MN": "G09.188.680", "FX": "Blood Coagulation", "MH_TH": "NLM (1966)", "ST": "T034", "MS": "Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011517"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-onc Proteins|T116|T123|EQV|UNK (19XX)|850425|abbdef", "ENTRY": "c onc Proteins", "MN": "D12.776.624.664.700", "MH_TH": "NLM (1986)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Proteins (1966-1985)", "MS": "Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity.", "OL": "use PROTO-ONCOGENE PROTEINS to search PROTO-ONCOGENE PROTEINS, CELLULAR 1986-90", "PM": "91; was PROTO-ONCOGENE PROTEINS, CELLULAR 1986-90", "HN": "91; was PROTO-ONCOGENE PROTEINS, CELLULAR 1986-90", "MR": "20050630", "DA": "19850425", "DC": "1", "DX": "19860101", "UI": "D011518"}, {"RECTYPE": "D", "MH": "Proto-Oncogenes", "AQ": "DE ES GE IM PH RE", "ENTRY": "Proto Oncogenes", "MN": "G05.360.340.024.340.375.500.791", "MH_TH": "NLM (1986)", "ST": "T028", "AN": "\"normal cellular genes homologous to viral oncogenes\"", "PI": "Oncogenes (1983-1985)", "MS": "Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc.", "OL": "search ONCOGENES 1983-85", "PM": "86; was see ONCOGENES 1983-85", "HN": "86; was see ONCOGENES 1983-85", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19850320", "DC": "1", "DX": "19860101", "UI": "D011519"}, {"RECTYPE": "D", "MH": "Protocatechuate-3,4-Dioxygenase", "DS": "PROTOCATECHUATE DIOXYGENASE 03 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protocatechuate 3,4 Dioxygenase", "MN": "D08.811.682.690.416.652", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Protocatechuate:oxygen 3,4-oxidoreductase (decyclizing)", "RN": "EC 1.13.11.3", "PI": "Oxygenases (1972-1974)", "MS": "An enzyme that catalyzes the oxidation of protocatechuate to 3-carboxy-cis-cis-muconate in the presence of molecular oxygen. It contains ferric ion. EC 1.13.11.3.", "PM": "91; was see under OXYGENASES 1975-90", "HN": "91(75); was see under OXYGENASES 1975-90", "MR": "20100625", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011520"}, {"RECTYPE": "D", "MH": "Protochlorophyllide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Protochlorophyllide A|T109|T123|NON|NRW|UNK (19XX)|741111|abbcdef", "ENTRY": "Protochlorophyllide, Monovinyl", "MN": "D04.345.783.374.725", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Magnesate(1-), (3,4-didehydro-9-ethenyl-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoato(3-)-N23,N24,N25,N26)-, hydrogen, (SP-4-2)-", "RN": "20369-67-9", "AN": "a chlorophyll", "PI": "Porphyrins (1972-1974)", "MS": "A photo-active pigment localized in prolamellar bodies occurring within the proplastids of dark-grown bean leaves. In the process of photoconversion, the highly fluorescent protochlorophyllide is converted to chlorophyll.", "PM": "91; was see under CHLOROPHYLL 1975-90", "HN": "91(75); was see under CHLOROPHYLL 1975-90", "MR": "20200221", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011521"}, {"RECTYPE": "D", "MH": "Protons", "AQ": "AE CL HI", "PRINT ENTRY": "Hydrogen Ions|T196|NON|EQV|UNK (19XX)|840302|abcdef", "ENTRY": "Proton", "MN": "G01.249.660.500", "EC": "therapeutic use:Proton Therapy", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion.", "PM": "66", "HN": "66", "MR": "20180117", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011522"}, {"RECTYPE": "D", "MH": "Protoplasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Protoplast", "MN": "A11.789", "MH_TH": "NLM (1964)", "ST": "T025", "MS": "The protoplasm and plasma membrane of plant, fungal, bacterial or archaeon cells without the CELL WALL.", "PM": "66", "HN": "66(64)", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011523"}, {"RECTYPE": "D", "MH": "Protoporphyrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.767.727.725", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "porphyrins", "PI": "Porphyrins (1968-1974)", "MS": "Porphyrins with four methyl, two vinyl, and two propionic acid side chains attached to the pyrrole rings. Protoporphyrin IX occurs in hemoglobin, myoglobin, and most of the cytochromes.", "PM": "91; was see under PORPHYRINS 1975-90", "HN": "91(75); was see under PORPHYRINS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011524"}, {"RECTYPE": "D", "MH": "Prototheca", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Protothecas", "MN": "B01.875.150.634", "MH_TH": "NLM (1980)", "ST": "T002", "RN": "txid3110", "AN": "infection: coordinate IM with INFECTION (IM)", "PI": "Algae, Green (1970-1979)", "MS": "A genus of achlorophyllic algae in the family Chlorellaceae, and closely related to CHLORELLA. It is found in decayed matter; WATER; SEWAGE; and SOIL; and produces cutaneous and disseminated infections in various VERTEBRATES including humans.", "PM": "80", "HN": "80", "MR": "20210630", "DA": "19781221", "DC": "1", "DX": "19800101", "UI": "D011525"}, {"RECTYPE": "D", "MH": "Protoveratrines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Veratetrin|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|790503|abbcdeef", "ENTRY": "Veralba|T109|T121|TRD|NRW|NLM (1991)|900605|abbcdef", "MN": "D03.633.400.256.543", "PA": "Antihypertensive Agents", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "RR": "XP343X1HJU", "MS": "Mixtures of closely related hypotensive alkaloids from Veratrum album (Liliaceae). They have been used in the treatment of hypertension but have largely been replaced by drugs with fewer adverse effects.", "OL": "use PROTOVERATRINES to search PROTOVERATRINE A 1966-75; use PROTOVERATRINES to search PROTOVERATRINE A DERIVATIVES 1978-80, use CEVANES 1969-77; use VERATRUM to search PROTOVERATRINE 1966-68; use PROTOVERATRINES to search CRYPTENAMINE 1975-79, use VERATRUM 1966-74", "PM": "91; was see under VERATRUM ALKALOIDS 1981-90; PROTOVERATRINE A was see under CEVANES 1975-79, was Prov 1966-74; PROTOVERATRINE A DERIVATIVES was see under CEVANES 1969-77; PROTOVERATRINE was see under VERATRUM 1966-68; CRYPTENAMINE was see under VERATRUM ALKALOIDS 1975-79, was see under VERATRUM 1963-74", "HN": "91(80); was see under VERATRUM ALKALOIDS 1981-90; PROTOVERATRINE A was see under CEVANES 1975-79, was Prov 1966-74; PROTOVERATRINE A DERIVATIVES was see under CEVANES 1969-77; PROTOVERATRINE was see under VERATRUM 1966-68; CRYPTENAMINE was see under VERATRUM ALKALOIDS 1975-79, was see under VERATRUM 1963-74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011526"}, {"RECTYPE": "D", "MH": "Protozoan Infections", "DE": "PROTOZOAN INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Histomoniasis|T047|NON|NRW|UNK (19XX)|850322|abcdef", "ENTRY": "Protozoan Infection", "MN": "C01.610.752", "FX": "Antiprotozoal Agents", "EC": "veterinary:Protozoan Infections, Animal", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Infections with unicellular organisms formerly members of the subkingdom Protozoa.", "OL": "use PROTOZOAN INFECTIONS to search HISTOMONIASIS 1968-85", "PM": "HISTOMONIASIS was heading 1968-85", "HN": "HISTOMONIASIS was heading 1968-85", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011528"}, {"RECTYPE": "D", "MH": "Protozoan Infections, Animal", "DE": "PROTOZOAN INFECT ANIMAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Protozoan Infection, Animal", "MN": "C22.674.710", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specific indentions or specific protozoan infecton /vet", "PI": "Protozoan Infections/veterinary (1966-1997)", "MS": "Infections with unicellular organisms formerly members of the subkingdom Protozoa. The infections may be experimental or veterinary.", "PM": "98", "HN": "98; use explode 1971-97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D011529"}, {"RECTYPE": "D", "MH": "Protriptyline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Protriptyline", "MN": "D04.615.181.384.650", "PA": "Antidepressive Agents, Tricyclic", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "5H-Dibenzo(a,d)cycloheptene-5-propanamine, N-methyl-", "RN": "4NDU154T12", "RR": "44665V00O8", "PI": "Propylamines (1969-1974)", "MS": "Tricyclic antidepressant similar in action and side effects to IMIPRAMINE. It may produce excitation.", "PM": "91; was see under DIBENZOCYCLOHEPTENES 1975-90", "HN": "91(75); was see under DIBENZOCYCLOHEPTENES 1975-90", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011530"}, {"RECTYPE": "D", "MH": "Proventriculus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A13.853.710", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "avian only; non-avian: use DIGESTIVE SYSTEM; dis: coord IM with STOMACH DISEASES /vet (IM); neopl: coord IM with STOMACH NEOPLASMS /vet (IM) + histol type (IM)", "PI": "Stomach (1966-1967)", "MS": "A thin-walled, glandular stomach found in birds. It precedes the gizzard.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011531"}, {"RECTYPE": "D", "MH": "Providencia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.600", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid586", "AN": "infection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)", "MS": "Gram-negative rods isolated from human urine and feces.", "OL": "use PROVIDENCIA to search PROTEUS INCONSTANS 1978-91; use PROTEUS to search PROVIDENCIA 1974", "PM": "91; was see under ENTEROBACTERIACEAE 1975-90; was see under PROTEUS 1975-89; PROTEUS INCONSTANS was see PROVIDENCIA 1978-91", "HN": "91(75); was see under ENTEROBACTERIACEAE 1975-90; was see under PROTEUS 1975-89; PROTEUS INCONSTANS was see PROVIDENCIA 1978-91", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011532"}, {"RECTYPE": "D", "MH": "Proviruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Provirus|T005|NON|EQV|NLM (1990)|891212|abcdef", "MN": "B04.725", "FX": "Virus Integration", "MH_TH": "NLM (1988)", "ST": "T005", "AN": "coord IM with specific virus (IM)", "PI": "Retroviridae or specific (1977-1987)", "MS": "Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology.", "PM": "88", "HN": "88", "MR": "20200902", "DA": "19870509", "DC": "1", "DX": "19880101", "UI": "D011533"}, {"RECTYPE": "D", "MH": "Prune Belly Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Prune-Belly", "MN": "C16.131.077.745", "MH_TH": "ORD (2010)", "ST": "T019", "AN": "a syndrome of multiple abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Urogenital System/AB (1966-1981)", "MS": "A syndrome characterized by abdominal wall musculature deficiency, cryptorchism, and urinary tract abnormalities. The syndrome derives its name from its characteristic distended abdomen with wrinkled skin.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19810223", "DC": "1", "DX": "19820101", "UI": "D011535"}, {"RECTYPE": "D", "MH": "Prurigo", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.674", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "itchy skin eruptions", "MS": "A name applied to several itchy skin eruptions of unknown cause. The characteristic course is the formation of a dome-shaped papule with a small transient vesicle on top, followed by crusting over or lichenification. (From Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011536"}, {"RECTYPE": "D", "MH": "Pruritus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Itching|T184|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Pruritis|T184|NON|EQV|UNK (19XX)|880628|abcdef", "MN": "C23.888.885.625", "FX": "Antipruritics", "MH_TH": "POPLINE (1978)", "ST": "T184", "AN": "/drug ther: consider also ANTIPRURITICS", "MS": "An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011537"}, {"RECTYPE": "D", "MH": "Pruritus Ani", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.685.544", "MH_TH": "NLM (1966)", "ST": "T033", "AN": "note spelling: -itus, not -itis", "MS": "Intense chronic itching in the anal area.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011538"}, {"RECTYPE": "D", "MH": "Pruritus Vulvae", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.685.710", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "note spelling: -itus, not -itis", "MS": "Intense itching of the external female genitals.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011539"}, {"RECTYPE": "D", "MH": "Prussian Blue Reaction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Ferrocyanide Reaction|T059|NON|EQV|NLM (1991)|900103|abcdef", "ENTRY": "Reactions, Prussian Blue", "MN": "E05.200.750.600.670.660", "MH_TH": "NLM (1979)", "ST": "T059", "PI": "Ferrocyanides (1966-1978)", "MS": "The reaction of potassium ferrocyanide with ferric iron to yield a dark blue precipitate at the sites of the ferric iron. Used to determine ferric iron in tissues, particularly in the diagnosis of disorders of iron metabolism.", "PM": "91; was see under HISTOCYTOCHEMISTRY 1979-90", "HN": "91(79); was see under HISTOCYTOCHEMISTRY 1979-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19780428", "DC": "1", "DX": "19910101", "UI": "D011540"}, {"RECTYPE": "D", "MH": "Pseudallescheria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Petriellidium|T004|NON|EQV|UNK (19XX)|850207|abcdef", "ENTRY": "Pseudallescherias", "MN": "B01.300.107.780", "MH_TH": "NLM (1986)", "ST": "T004", "RN": "txid5596", "AN": "infection: coordinate IM with MYCOSES (IM) or specific mycosis (IM)", "PI": "Mycoses (1966-1985)", "MS": "Ascomycetous fungi, family Microascaceae, order Microascales, commonly found in the soil. They are causative agents of mycetoma, maduromycosis, and other infections in humans.", "OL": "use PSEUDALLESCHERIA to search MONOSPORIUM 1966-85", "PM": "91; was see under ASCOMYCETES 1986-90; MONOSPORIUM was heading 1963-85", "HN": "91(86); was see under ASCOMYCETES 1986-90; MONOSPORIUM was heading 1963-85", "MR": "20200813", "DA": "19850207", "DC": "1", "DX": "19910101", "UI": "D011541"}, {"RECTYPE": "D", "MH": "Pseudarthrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pseudoarthroses", "MN": "C26.404.468.627", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a type of ununited fract; do not index under FRACTURES, UNUNITED unless particularly discussed", "MS": "A pathologic entity characterized by deossification of a weight-bearing long bone, followed by bending and pathologic fracture, with inability to form normal BONY CALLUS leading to existence of the \"false joint\" that gives the condition its name. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011542"}, {"RECTYPE": "D", "MH": "Pseudogenes", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Genes, Processed|T028|NON|NRW|UNK (19XX)|870509|abcdef", "ENTRY": "beta-Tubulin Pseudogenes", "MN": "G05.360.340.024.340.700", "MH_TH": "NLM (1988)", "ST": "T028", "PI": "Genes, Structural (1975-1987)", "MS": "Genes bearing close resemblance to known genes at different loci, but rendered non-functional by additions or deletions in structure that prevent normal transcription or translation. When lacking introns and containing a poly-A segment near the downstream end (as a result of reverse copying from processed nuclear RNA into double-stranded DNA), they are called processed genes.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19870509", "DC": "1", "DX": "19880101", "UI": "D011544"}, {"RECTYPE": "D", "MH": "Pseudohypoaldosteronism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pseudohypoaldosteronism, Type II|T047|NON|NRW|NLM (2005)|OMIM (2013)|040223|abcdeef", "ENTRY": "Type Is, Pseudohypoaldosteronism", "MN": "C16.320.831.770", "FX": "Receptors, Mineralocorticoid", "MH_TH": "NLM (1988)", "ST": "T047", "PI": "Renal Tubular Transport, Inborn Errors (1971-1987)", "MS": "A heterogeneous group of disorders characterized by renal electrolyte transport dysfunctions. Congenital forms are rare autosomal disorders characterized by neonatal hypertension, HYPERKALEMIA, increased RENIN activity and ALDOSTERONE concentration. The Type I features HYPERKALEMIA with sodium wasting; Type II, HYPERKALEMIA without sodium wasting. Pseudohypoaldosteronism can be the result of a defective renal electrolyte transport protein or acquired after KIDNEY TRANSPLANTATION.", "PM": "1991; see RENAL TUBULAR TRANSPORT, INBORN ERRORS 1988-90", "HN": "1991(1988); use RENAL TUBULAR TRANSPORT, INBORN ERRORS 1988-90", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19870313", "DC": "1", "DX": "19910101", "UI": "D011546"}, {"RECTYPE": "D", "MH": "Pseudohypoparathyroidism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "PHPIa|T047|NON|NRW|NLM (2021)|200309|abcdef", "ENTRY": "Type Ib Pseudohypoparathyroidisms", "MN": "C18.452.648.618.815", "FX": "GTP-Binding Protein alpha Subunits, Gs", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "do not confuse with PSEUDOPSEUDOHYPOPARATHYROIDISM", "MS": "A hereditary syndrome clinically similar to HYPOPARATHYROIDISM. It is characterized by HYPOCALCEMIA; HYPERPHOSPHATEMIA; and associated skeletal development impairment and caused by failure of response to PARATHYROID HORMONE rather than deficiencies. A severe form with resistance to multiple hormones is referred to as Type 1a and is associated with maternal mutant allele of the ALPHA CHAIN OF STIMULATORY G PROTEIN.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011547"}, {"RECTYPE": "D", "MH": "Pseudomonadaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Azotobacteraceae|T007|NON|NRW|NLM (1975)|990101|abcdef", "MN": "B03.660.250.580", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid135621", "RR": "txid69961", "PI": "Bacteria (1966-1974)", "MS": "A family of gram-negative bacteria usually found in soil or water and including many plant pathogens and a few animal pathogens.", "PM": "1975; for AZOTOBACTERACEAE see AZOTOBACTERACEAE 1975-2006; for AZOMONAS see AZOTOBACTERACEAE 1982-2006, see AZOMONAS 1976-1981; for AZOMONAS AGILIS see AZOTOBACTERACEAE 1982-2006, see AZOMONAS 1976-1981, see AZOTOBACTER 1975, see AZOTOBACTER AGILIS 1972-1974", "HN": "1975", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D011548"}, {"RECTYPE": "D", "MH": "Pseudomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pseudomona|T007|NON|EQV|NLM (2022)|201022|abcdef", "ENTRY": "Flavimonas|T007|NON|EQV|NLM (2004)|030108|abcdef", "MN": "B03.660.250.580.590", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid286", "MS": "A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011549"}, {"RECTYPE": "D", "MH": "Pseudomonas aeruginosa", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pseudomonas pyocyanea|T007|NON|EQV|NLM (1998)|960816|abcdef", "MN": "B03.660.250.580.590.050", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid287", "AN": "infections: coordinate IM with PSEUDOMONAS INFECTIONS (IM)", "MS": "A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.", "MR": "20200128", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011550"}, {"RECTYPE": "D", "MH": "Pseudomonas fluorescens", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Liquidomonas fluorescens|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.580.590.210", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid294", "PI": "Pseudomonas (1966-1971)", "MS": "A species of nonpathogenic fluorescent bacteria found in feces, sewage, soil, and water, and which liquefy gelatin.", "PM": "74", "HN": "74(72)", "MR": "20210209", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011551"}, {"RECTYPE": "D", "MH": "Pseudomonas Infections", "DE": "PSEUDOMONAS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Pseudomonas aeruginosa Infections", "MN": "C01.150.252.400.739", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "gram-neg bact infect; see note under PSEUDOMONAS AERUGINOSA", "MS": "Infections with bacteria of the genus PSEUDOMONAS.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011552"}, {"RECTYPE": "D", "MH": "Pseudomyxoma Peritonei", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Ascites, Gelatinous|T191|NON|EQV|UNK (19XX)|860418|abcdef", "ENTRY": "Pseudomyxoma Peritonei Syndromes", "MN": "C04.557.470.590.075.500", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "neoplastic", "PI": "Peritoneal Neoplasms (1966-1986)", "MS": "A peritoneal adenocarcinoma characterized by build-up of MUCUS in the PERITONEAL CAVITY. Mucus secreting cells may attach to the peritoneal lining and continue to secrete mucus. The majority of cases represent tumor spread from a primary low-grade mucinous neoplasm of the APPENDIX (NCI Thesaurus).", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D011553"}, {"RECTYPE": "D", "MH": "Pseudopodia", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Reticulopodia|T026|NON|REL|NLM (1999)|980331|abcdef", "ENTRY": "Surface Microspikes, Cell", "MN": "A11.284.180.700", "MH_TH": "NLM (1970)", "ST": "T026", "PI": "Organoids (1966-1969)", "MS": "A dynamic actin-rich extension of the surface of an animal cell used for locomotion or prehension of food.", "PM": "72", "HN": "72(70)", "MR": "20000621", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011554"}, {"RECTYPE": "D", "MH": "Pseudopregnancy", "DE": "PSEUDOPREGN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pseudocyesis|T046|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Pseudopregnancies", "MN": "G08.686.784.769.887", "MH_TH": "NLM (1963)", "ST": "T046", "AN": "do NOT check tag PREGNANCY", "MS": "An acyclic state that resembles PREGNANCY in that there is no ovarian cycle, ESTROUS CYCLE, or MENSTRUAL CYCLE. Unlike pregnancy, there is no EMBRYO IMPLANTATION. Pseudopregnancy can be experimentally induced to form DECIDUOMA in the UTERUS.", "HN": "was in Cat G only 1968-78, was in Cat F only 1963-67", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011555"}, {"RECTYPE": "D", "MH": "Pseudopseudohypoparathyroidism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pseudopseudohypoparathyroidisms", "MN": "C18.452.648.618.815.815", "FX": "GTP-Binding Protein alpha Subunits, Gs", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "do not confuse with PSEUDOHYPOPARATHYROIDISM of which it is an incomplete form", "MS": "A form of PSEUDOHYPOPARATHYROIDISM characterized by the same features except for the abnormal response to hormones such as PARATHYROID HORMONE. It is associated with paternally inherited mutant alleles of the ALPHA CHAIN OF STIMULATORY G PROTEIN.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011556"}, {"RECTYPE": "D", "MH": "Pseudorabies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Aujeszky's Disease|T047|EPO|EQV|UNK (19XX)|740330|AUJESZKYS DIS|abcdefv", "ENTRY": "Aujeszkys Disease", "MN": "C22.742", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A highly contagious herpesvirus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011557"}, {"RECTYPE": "D", "MH": "Herpesvirus 1, Suid", "DS": "HERPESVIRUS SUID 01", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Swine Herpesvirus 1|T005|NON|EQV|NLM (1994)|930302|SWINE HERPESVIRUS 01|abcdefs", "ENTRY": "Viruses, Pseudorabies", "MN": "B04.280.382.100.900.510", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid10345", "PI": "Herpesviridae (1966-1974)", "MS": "A species of VARICELLOVIRUS producing a respiratory infection (PSEUDORABIES) in swine, its natural host. It also produces an usually fatal ENCEPHALOMYELITIS in cattle, sheep, dogs, cats, foxes, and mink.", "OL": "use HERPESVIRUS 1, SUID to search HERPESVIRUS SUIS 1975-93 & PSEUDORABIES VIRUS 1966-93", "PM": "94; was PSEUDORABIES VIRUS 1963-93 (see under HERPESVIRUSES 1975-79, see under HERPESVIRUS 1963-74); HERPESVIRUS SUIS was see PSEUDORABIES VIRUS 1975-93", "HN": "94; was PSEUDORABIES VIRUS 1963-93 (see under HERPESVIRUSES 1975-79, see under HERPESVIRUS 1963-74); HERPESVIRUS SUIS was see PSEUDORABIES VIRUS 1975-93", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D011558"}, {"RECTYPE": "D", "MH": "Pseudotumor Cerebri", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Idiopathic Intracranial Hypertension|T047|NON|EQV|NLM (1994)|ORD (2010)|930304|abcdeef", "ENTRY": "Hypertension, Idiopathic Intracranial", "MN": "C10.228.140.631.750", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "note category: non-neopl", "MS": "A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).", "PM": "1973", "HN": "1973(1964)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011559"}, {"RECTYPE": "D", "MH": "Pseudouridine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D13.570.800.892.628", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "2,4(1H,3H)-Pyrimidinedione, 5-beta-D-ribofuranosyl-", "RN": "1445-07-4", "PI": "Uridine (1966-1971)", "MS": "A naturally-occurring isomer of URIDINE found in RNA, in which ribosyl is attached to a carbon instead of a nitrogen atom.", "PM": "91; was see under URIDINE 1972-90", "HN": "91(72); was see under URIDINE 1972-90", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011560"}, {"RECTYPE": "D", "MH": "Pseudoxanthoma Elasticum", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gronblad-Strandberg Syndrome|T019|T047|EPO|NRW|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|740330|abbcdeeeef", "ENTRY": "Syndrome, Gronblad-Strandberg", "MN": "C17.800.827.750", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "in titles & translations use diacritic: Gr\u00f6nblad", "MS": "An inherited disorder of connective tissue with extensive degeneration and calcification of ELASTIC TISSUE primarily in the skin, eye, and vasculature. At least two forms exist, autosomal recessive and autosomal dominant. This disorder is caused by mutations of one of the ATP-BINDING CASSETTE TRANSPORTERS. Patients are predisposed to MYOCARDIAL INFARCTION and GASTROINTESTINAL HEMORRHAGE.", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011561"}, {"RECTYPE": "D", "MH": "Psilocybin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Psilocybine|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|990101|abbcdeef", "ENTRY": "Psilocibin|T109|T121|NON|EQV|BAN (19XX)|941122|abbcdef", "MN": "D03.633.100.496.500.500.613", "PA": "Hallucinogens", "MH_TH": "NLM (2017)", "ST": "T121", "RN": "2RV7212BP0", "RR": "520-52-5 (Psilocybine)", "MS": "The major of two hallucinogenic components of the sacred Teonanacatl mushrooms (see PSILOCYBE), the other component being PSILOCIN.", "PM": "66", "HN": "66(63)", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011562"}, {"RECTYPE": "D", "MH": "Psittaciformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Psittacines|T012|NON|EQV|NLM (1968)|990101|abcdef", "MN": "B01.050.150.900.248.710", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid9223", "AN": "General or unspecified; prefer specifics", "PI": "Birds (1966-1967)", "MS": "An order of BIRDS comprised of several families and more than 300 species. It includes COCKATOOS; PARROTS; PARAKEETS; macaws; and BUDGERIGARS.", "PM": "2005; see PSITTACINES 1968-2004", "HN": "2005 (1968)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011563"}, {"RECTYPE": "D", "MH": "Furocoumarins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Psoralens|T109|NON|NRW|NLM (1979)|990101|abcdef", "ENTRY": "Angelicins|T109|NON|NRW|NLM (2015)|140207|abcdef", "MN": "D03.633.300.770", "PA": "Photosensitizing Agents", "MH_TH": "UNK (19XX)", "ST": "T123", "RN": "0", "AN": "do not confuse entry term PSORALENS with the specific drug PSORALEN see FICUSIN; do not index here for psoralens in PUVA THERAPY unless particularly discussed", "PI": "Furans (1966-1978)", "MS": "Polycyclic compounds consisting of a furan ring fused with coumarin. They commonly occur in PLANTS, especially UMBELLIFERAE and RUTACEAE, as well as PSORALEA.", "PM": "2015 see PSORALENS 1979-2014", "HN": "2015 (1979)", "MR": "20200527", "DA": "19780313", "DC": "1", "DX": "19790101", "UI": "D011564"}, {"RECTYPE": "D", "MH": "Psoriasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pustulosis of Palms and Soles|T047|NON|NRW|NLM (1990)|890407|PUSTULOSIS OF PALMS SOLES|abcdefv", "ENTRY": "Psoriases", "MN": "C17.800.859.675", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a papulosquamous skin dis; ARTHRITIS, PSORIATIC is also available", "MS": "A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011565"}, {"RECTYPE": "D", "MH": "Psychiatric Aides", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Psychiatric Ward Attendants|T097|NON|NRW|NLM (1998)|961010|abcdef", "ENTRY": "Ward Attendants, Psychiatric", "MN": "N02.360.067.652.628", "MH_TH": "NLM (1971)", "ST": "T097", "AN": "coord IM with HOSPITALS, PSYCHIATRIC or PSYCHIATRIC DEPARTMENT, HOSPITAL (IM or NIM) if pertinent", "PI": "Psychiatry (1968-1970)", "MS": "Persons who assist in the routine care of psychiatric persons, usually under the supervision of the nursing department.", "PM": "71", "HN": "71", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D011566"}, {"RECTYPE": "D", "MH": "Psychiatric Department, Hospital", "DE": "PSYCHIATR DEP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Psychiatric Department|T093|NON|EQV|UNK (19XX)|770519|HOSP PSYCHIATR DEP|abcdefv", "ENTRY": "Hospital Psychiatric Departments", "MN": "N04.452.442.452.422.641", "MH_TH": "NLM (1966)", "ST": "T093", "MS": "Hospital department responsible for the organization and administration of psychiatric services.", "OL": "use PSYCHIATRIC DEPARTMENT, HOSPITAL to search HOSPITAL PSYCHIATRIC DEPARTMENTS 1966-77", "PM": "78; was HOSPITAL PSYCHIATRIC DEPARTMENTS 1966-77", "HN": "78; was HOSPITAL PSYCHIATRIC DEPARTMENTS 1966-77", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011567"}, {"RECTYPE": "D", "MH": "Psychiatric Nursing", "DE": "PSYCHIATRIC NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Psychosocial", "MN": "N02.421.533.778", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "A specialty concerned with the application of psychiatric principles in caring for the mentally ill. It also includes the nursing care provided the mentally ill patient.", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011568"}, {"RECTYPE": "D", "MH": "Psychiatric Status Rating Scales", "DE": "PSR SCALES", "AQ": "HI SN ST", "PRINT ENTRY": "Wittenborn Scales|T170|NAM|NRW|NLM (1992)|910328|abcdef", "ENTRY": "Mini International Neuropsychiatric Interview|T170|NAM|NRW|NLM (2018)|160912|abcdef", "MN": "F04.711.513.653", "MH_TH": "NLM (1969)", "ST": "T170", "PI": "Psychological Tests (1966-1968)", "MS": "Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness.", "OL": "use PSYCHIATRIC STATUS RATING SCALES to search KATZ ADJUSTMENT SCALES 1975-96, LORR'S INPATIENT MULTIDIMENSIONAL PSYCHIATRIC RATING SCALE 1975-91, WITTENBORN SCALES 1979-91, WITTENBORN SCALE 1969-78, & FACTOR CONSTRUCT RATING SCALES 1973-78", "PM": "69; KATZ ADJUSTMENT SCALES was heading 1975-96 (see under PSYCHIATRIC STATUS RATING SCALES 1975-90); WITTENBORN SCALES was heading 1991, was see under PSYCHIATRIC STATUS RATING SCALES 1979-90, was WITTENBORN SCALE see under PSYCHIATRIC STATUS RATING SCALES 1969-78; LORR'S INPATIENT MULTIDIMENSIONAL PSYCHIATRIC RATING SCALE was heading 1991, see under PSYCHIATRIC STATUS RATING SCALES 1975-90", "HN": "69; KATZ ADJUSTMENT SCALES was heading 1975-96 (see under PSYCHIATRIC STATUS RATING SCALES 1975-90); WITTENBORN SCALES was heading 1979-91 (see under PSYCHIATRIC STATUS RATING SCALES 1979-90), was WITTENBORN SCALE see under PSYCHIATRIC STATUS RATING SCALES 1969-78; LORR'S INPATIENT MULTIDIMENSIONAL PSYCHIATRIC RATING SCALE was heading 1975-91 (see under PSYCHIATRIC STATUS RATING SCALES 1975-90); FACTOR CONSTRUCT RATING SCALES was see under PSYCHIATRIC STATUS RATING SCALES 1973-78", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D011569"}, {"RECTYPE": "D", "MH": "Psychiatry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.690", "MH_TH": "POPLINE (1994)", "ST": "T091", "AN": "specialty only; do not confuse with MENTAL DISORDERS", "MS": "The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders.", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011570"}, {"RECTYPE": "D", "MH": "Psychoacoustics", "ENTRY": "Psychoacoustic", "MN": "F04.096.753.628", "MH_TH": "NLM (1968)", "ST": "T091", "PI": "Auditory Perception (1967)", "MS": "The science pertaining to the interrelationship of psychologic phenomena and the individual's response to the physical properties of sound.", "PM": "72", "HN": "72(68)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011571"}, {"RECTYPE": "D", "MH": "Psychoanalysis", "DE": "PSYCHOANAL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychodynamic Analyses", "MN": "F04.096.544.779", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "specialty; for therapy use PSYCHOANALYTIC THERAPY or specifics", "MS": "The separation or resolution of the psyche into its constituent elements. The term has two separate meanings: 1. a procedure devised by Sigmund Freud, for investigating mental processes by means of free association, dream interpretation and interpretation of resistance and transference manifestations; and 2. a theory of psychology developed by Freud from his clinical experience with hysterical patients. (From Campbell, Psychiatric Dictionary, 1996).", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011572"}, {"RECTYPE": "D", "MH": "Psychoanalytic Interpretation", "DE": "PSYCHOANAL INTERPRETATION", "ENTRY": "Psychoanalytical Interpretations", "MN": "F04.628", "EC": "history:Psychoanalysis:history", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "PSYCHOANALYTIC THEORY is also available", "MS": "Utilization of Freudian theories to explain various psychologic aspects of art, literature, biographical material, etc.", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011573"}, {"RECTYPE": "D", "MH": "Psychoanalytic Theory", "DE": "PSYCHOANAL THEORY", "PRINT ENTRY": "Oral Character|T055|NON|REL|NLM (1997)|960416|abcdef", "ENTRY": "Theory, Psychoanalytical", "MN": "F02.739.794", "EC": "history:Psychoanalysis:history", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "PSYCHOANALYTIC INTERPRETATION is also available", "MS": "Conceptual system developed by Freud and his followers in which unconscious motivations are considered to shape normal and abnormal personality development and behavior.", "PM": "66; ORAL CHARACTER was heading 1975-96 (see under PSYCHOANALYTIC THEORY 1975-90)", "HN": "66; ORAL CHARACTER was heading 1975-96 (see under PSYCHOANALYTIC THEORY 1975-90)", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011574"}, {"RECTYPE": "D", "MH": "Psychoanalytic Therapy", "DE": "PSYCHOANAL THER", "AQ": "CL EC ED ES IS LJ MT OG SN ST TD", "PRINT ENTRY": "Balint Psychoanalytic Therapy|T061|EPO|NRW|UNK (19XX)|820427|BALINT PSYCHOANAL THER|abcdefv", "ENTRY": "Therapy, Psychoanalytical", "MN": "F04.754.709", "EC": "history:Psychoanalysis:history", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "A form of psychiatric treatment, based on Freudian principles, which seeks to eliminate or diminish the undesirable effects of unconscious conflicts by making the patient aware of their existence, origin, and inappropriate expression in current emotions and behavior.", "CATSH": "CAT LIST", "MR": "19950531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011575"}, {"RECTYPE": "D", "MH": "Psychodidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sergentomyia|T204|NON|NRW|UNK (19XX)|840417|abcdef", "ENTRY": "Sergentomyias", "MN": "B01.050.500.131.617.720.500.500.750.781", "MH_TH": "NLM (1973)", "ST": "T204", "RN": "txid7197", "RR": "txid7199", "AN": "do not use /drug eff for insecticides: TN 111", "PI": "Phlebotomus (1966-1972)", "MS": "Small, hairy, moth-like flies which are of considerable public health importance as vectors of certain pathogenic organisms. Important disease-related genera are PHLEBOTOMUS, Lutzomyia, and Sergentomyia.", "OL": "use PSYCHODIDAE to search SANDFLIES 1973-84; use PHLEBOTOMUS 1966-72", "PM": "85; was see SANDFLIES 1975-84; was SANDFLIES see PHLEBOTOMUS 1963-72", "HN": "85; was see SANDFLIES 1975-84; was SANDFLIES see PHLEBOTOMUS 1963-72", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011576"}, {"RECTYPE": "D", "MH": "Psychodrama", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapy, Drama", "MN": "F04.754.864.581.679", "FX": "Acting Out", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Primarily a technique of group psychotherapy which involves a structured, directed, and dramatized acting out of the patient's personal and emotional problems.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011577"}, {"RECTYPE": "D", "MH": "Psycholinguistics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psycholinguistic", "MN": "L01.559.598.628", "FX": "Language Development", "MH_TH": "NLM (1967)", "ST": "T090", "AN": "coordinate with specific linguistic & psychological concepts ", "PI": "Language (1966)", "MS": "A discipline concerned with relations between messages and the characteristics of individuals who select and interpret them; it deals directly with the processes of encoding (phonetics) and decoding (psychoacoustics) as they relate states of messages to states of communicators.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D011578"}, {"RECTYPE": "D", "MH": "Psychological Phenomena", "ENTRY": "Psychological Processe", "MN": "F02", "RH": "F2 - PSYCHOLOGICAL PHENOMENA AND PROCESSES", "MH_TH": "NLM (2018)", "ST": "T078", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Mechanisms and underlying psychological principles of mental processes and their applications.", "PM": "2018; see PSYCHOLOGICAL PHENOMENA AND PROCESSES 1998-2017", "HN": "2018 (1998)", "CATSH": "CAT LIST", "MR": "20170623", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D011579"}, {"RECTYPE": "D", "MH": "Psychological Techniques", "DE": "PSYCHOL TECHNIQUES", "AQ": "CL EC ED ES HI IS LJ OG SN ST TD", "PRINT ENTRY": "Theoretical Techniques|T060|T170|NON|EQV|NLM (1998)|970311|abbcdef", "ENTRY": "Theoretical Technique", "MN": "F04.669", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "general or unspecified; prefer specifics", "MS": "Methods used in the diagnosis and treatment of behavioral, personality, and mental disorders.", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "20150701", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D011580"}, {"RECTYPE": "D", "MH": "Psychological Tests", "DE": "PSYCHOL TESTS", "AQ": "HI SN ST", "PRINT ENTRY": "Trier Stress Test|T060|NON|NRW|NLM (2021)|200118|abcdef", "ENTRY": "Trier Stress Tests", "MN": "F04.711", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Standardized tests designed to measure abilities (as in intelligence, aptitude, and achievement tests) or to evaluate personality traits.", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011581"}, {"RECTYPE": "D", "MH": "Psychological Theory", "DE": "PSYCHOL THEORY", "PRINT ENTRY": "Social Cognitive Theory|T170|NON|NRW|NLM (2021)|200115|abcdef", "ENTRY": "Theory, Social Cognitive", "MN": "F02.739", "MH_TH": "NLM (1969)", "ST": "T170", "PI": "Psychology (1966-1968)", "MS": "Principles applied to the analysis and explanation of psychological or behavioral phenomena.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20200429", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D011582"}, {"RECTYPE": "D", "MH": "Psychological Warfare", "DE": "PSYCHOL WARFARE", "AQ": "HI", "ENTRY": "Warfare, Psychologic", "MN": "I01.880.735.950.500.711", "FX": "Propaganda", "MH_TH": "NLM (1966)", "ST": "T054", "MS": "The manipulation of psychological influences, primarily concerned with morale, to strengthen the ability of one's own country and weaken the enemy.", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011583"}, {"RECTYPE": "D", "MH": "Psychology", "DE": "PSYCHOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Side Effect, Psychological", "MN": "F04.096.628", "MH_TH": "POPLINE (1978)", "ST": "T091", "AN": "specialty; prefer /\u200cpsychol; may be used  NIM for \"psychological aspects of\" terms  which do not permit /psychol", "MS": "The science dealing with the study of mental processes and behavior in man and animals.", "CATSH": "CAT LIST", "MR": "20200526", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011584"}, {"RECTYPE": "D", "MH": "Psychology, Applied", "DE": "PSYCHOL APPLIED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychologies, Applied", "MN": "F02.784", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "specialty", "MS": "The science which utilizes psychologic principles to derive more effective means in dealing with practical problems.", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011585"}, {"RECTYPE": "D", "MH": "Psychology, Clinical", "DE": "PSYCHOL CLIN", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Clinical Psychology|T091|NON|EQV|UNK (19XX)|860101|CLIN PSYCHOL|abcdefv", "MN": "F04.096.628.579", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty", "MS": "The branch of psychology concerned with psychological methods of recognizing and treating behavior disorders.", "CATSH": "CAT LIST", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011586"}, {"RECTYPE": "D", "MH": "Psychology, Comparative", "DE": "PSYCHOL COMPARATIVE", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychologies, Comparative", "MN": "F04.096.628.629", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "The branch of psychology concerned with similarities or differences in the behavior of different animal species or of different races or peoples.", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011587"}, {"RECTYPE": "D", "MH": "Psychology, Educational", "DE": "PSYCHOL EDUC", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychologies, Educational", "MN": "F04.096.628.679", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty", "MS": "The branch of psychology concerned with psychological aspects of teaching and the formal learning process in school.", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011588"}, {"RECTYPE": "D", "MH": "Psychology, Experimental", "DE": "PSYCHOL EXPER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychologies, Experimental", "MN": "F04.096.628.729", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty", "MS": "The branch of psychology which seeks to learn more about the fundamental causes of behavior by studying various psychologic phenomena in controlled experimental situations.", "CATSH": "CAT LIST", "MR": "19910628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011589"}, {"RECTYPE": "D", "MH": "Psychology, Industrial", "DE": "PSYCHOL INDUST", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychologies, Industrial", "MN": "F04.096.628.779", "FX": "Ergonomics", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "The branch of applied psychology concerned with the application of psychologic principles and methods to industrial problems including selection and training of workers, working conditions, etc.", "CATSH": "CAT LIST", "MR": "20170717", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011590"}, {"RECTYPE": "D", "MH": "Psychology, Medical", "DE": "PSYCHOL MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Medical Psychology|T091|NON|EQV|UNK (19XX)|820426|MED PSYCHOL|abcdefv", "MN": "H02.720", "MH_TH": "NLM (1983)", "ST": "T091", "AN": "specialty", "MS": "A branch of psychology in which there is collaboration between psychologists and physicians in the management of medical problems. It differs from clinical psychology, which is concerned with the diagnosis and treatment of behavior disorders.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19820426", "DC": "1", "DX": "19830101", "UI": "D011591"}, {"RECTYPE": "D", "MH": "Psychology, Military", "DE": "PSYCHOL MILITARY", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Military Psychology|T090|NON|EQV|UNK (19XX)|740330|MILITARY PSYCHOL|abcdefv", "MN": "F02.784.754", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "specialty; consider also MILITARY PERSONNEL /psychol", "MS": "The branch of applied psychology concerned with psychological aspects of selection, assignment, training, morale, etc., of Armed Forces personnel.", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011592"}, {"RECTYPE": "D", "MH": "Psychology, Social", "DE": "PSYCHOL SOCIAL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Social Psychology|T091|NON|EQV|UNK (19XX)|740330|SOCIAL PSYCHOL|abcdefv", "ENTRY": "Perceptual Psychology", "MN": "F04.096.628.829", "FX": "Race Relations", "MH_TH": "POPLINE (1978)", "ST": "T091", "AN": "use for the field and as an NIM coordinate ", "MS": "The branch of psychology concerned with the effects of group membership upon the behavior, attitudes, and beliefs of an individual.", "CATSH": "CAT LIST", "MR": "20180406", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011593"}, {"RECTYPE": "D", "MH": "Psychometrics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychometric", "MN": "F04.711.780", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "includes statistical analysis of psychological tests, validation, application of statistical theory or formulae to psychology", "MS": "Assessment of psychological variables by the application of mathematical procedures.", "CATSH": "CAT LIST", "MR": "19780714", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011594"}, {"RECTYPE": "D", "MH": "Psychomotor Agitation", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Restlessness|T184|NON|EQV|UNK (19XX)|770513|abcdef", "ENTRY": "Restlessness, Psychomotor", "MN": "F01.700.875.700", "EC": "chemically induced:Akathisia, Drug-Induced", "MH_TH": "NLM (1978)", "ST": "T184", "AN": "do not confuse X ref AKATHISIA with AKATHISIA, DRUG-INDUCED: see note there", "PI": "Psychomotor Disorders (1969-1977)", "MS": "A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions.", "PM": "1978", "HN": "1978", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19770513", "DC": "1", "DX": "19780101", "UI": "D011595"}, {"RECTYPE": "D", "MH": "Psychomotor Disorders", "DE": "PSYCHOMOTOR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Psychomotor Impairment|T048|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Psychomotor Impairments", "MN": "F01.700.875", "FX": "Movement Disorders", "MH_TH": "NLM (1969)", "ST": "T048", "PI": "Movement Disorders (1966-1968)", "MS": "Abnormalities of motor function that are associated with organic and non-organic cognitive disorders.", "PM": "1969", "HN": "1969", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D011596"}, {"RECTYPE": "D", "MH": "Psychomotor Performance", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Visual Motor Coordination|T041|T055|NON|NRW|UNK (19XX)|820427|abbcdef", "ENTRY": "Visual Motor Coordinations", "MN": "G11.561.660", "FX": "Athletic Performance", "MH_TH": "NLM (1983)", "ST": "T055", "PI": "Visual Perception (1966-1982)", "MS": "The coordination of a sensory or ideational (cognitive) process and a motor activity.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19820427", "DC": "1", "DX": "19830101", "UI": "D011597"}, {"RECTYPE": "D", "MH": "Psychoneuroimmunology", "DE": "PSYCHONEUROIMMUNOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Psychoimmunology|T091|NON|REL|UNK (19XX)|870430|PSYCHOIMMUNOL|abcdefv", "MN": "H01.158.782.795.180", "FX": "Neuroimmunomodulation", "MH_TH": "NLM (1988)", "ST": "T091", "AN": "specialty; prefer specific terms with /physiol or /immunol; avoid as NIM coordinate", "MS": "The field concerned with the interrelationship between the brain, behavior and the immune system. Neuropsychologic, neuroanatomic and psychosocial studies have demonstrated their role in accentuating or diminishing immune/allergic responses.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19870430", "DC": "1", "DX": "19880101", "UI": "D011598"}, {"RECTYPE": "D", "MH": "Psychopathology", "DE": "PSYCHOPATHOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "F04.096.670", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty; used also as NIM coordinate, do not confuse with MENTAL DISORDERS", "MS": "The study of significant causes and processes in the development of mental illness.", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011599"}, {"RECTYPE": "D", "MH": "Psychopharmacology", "DE": "PSYCHOPHARMACOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.628.546", "FX": "Psychotropic Drugs", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty; used also as NIM coordinate", "MS": "The study of the effects of drugs on mental and behavioral activity.", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011600"}, {"RECTYPE": "D", "MH": "Psychophysics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychophysic", "MN": "F04.096.753", "FX": "Differential Threshold", "MH_TH": "NLM (1970)", "ST": "T091", "AN": "Specialty: IM, NIM coordinate, no qualification; PSYCHOACOUSTICS is also available", "PI": "Perception (1966-1969)", "MS": "The science dealing with the correlation of the physical characteristics of a stimulus, e.g., frequency or intensity, with the response to the stimulus, in order to assess the psychologic factors involved in the relationship.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D011601"}, {"RECTYPE": "D", "MH": "Psychophysiologic Disorders", "DE": "PSYCHOPHYSIOL DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Psychosomatic Disorders|T048|NON|EQV|UNK (19XX)|740330|PSYCHOSOMATIC DIS|abcdefv", "ENTRY": "Psychosomatic Disorder", "MN": "C23.888.592.700", "MH_TH": "NLM (1968)", "ST": "T048", "AN": "differentiate from PSYCHOSOMATIC MEDICINE which is the field; coord IM with specific dis /psychol (IM); Manual 27.12", "PI": "Psychosomatic Medicine (1966-1967)", "MS": "A group of disorders characterized by physical symptoms that are affected by emotional factors and involve a single organ system, usually under AUTONOMIC NERVOUS SYSTEM control. (American Psychiatric Glossary, 1988)", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011602"}, {"RECTYPE": "D", "MH": "Psychophysiology", "DE": "PSYCHOPHYSIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Psychology, Physiological|T091|NON|EQV|UNK (19XX)|740330|PSYCHOL PHYSIOL|abcdefv", "ENTRY": "Relationships, Mind-Body (Physiology)", "MN": "H01.158.782.795", "FX": "Psychosomatic Medicine", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "IM for the discipline (education, history, etc); NIM as a coordinate in psychophysiological studies; use / physiol with behavior and psychological phenomena terms & / psychol with diseases & mental disorder terms; do not confuse entry term MIND-BODY RELATIONS (PHYSIOLOGY) with MIND-BODY RELATIONS, METAPHYSICAL; Manual 27.12", "MS": "The study of the physiological basis of human and animal behavior.", "OL": "use PSYCHOPHYSIOLOGY to search MIND-BODY RELATIONS 1996", "PM": "MIND-BODY RELATIONS (PHYSIOLOGY) was MIND-BODY RELATIONS see PSYCHOPHYSIOLOGY 1996", "HN": "MIND-BODY RELATIONS (PHYSIOLOGY) was MIND-BODY RELATIONS see PSYCHOPHYSIOLOGY 1996", "CATSH": "CAT LIST", "MR": "20210706", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011603"}, {"RECTYPE": "D", "MH": "Psychoses, Alcoholic", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Alcoholic Psychoses", "MN": "F03.900.100.750", "FX": "Substance-Related Disorders", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "A group of mental disorders associated with organic brain damage and caused by poisoning from alcohol.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011604"}, {"RECTYPE": "D", "MH": "Psychoses, Substance-Induced", "DE": "PSYCHOSES SUBSTANCE IND", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Psychoses, Toxic|T048|NON|EQV|UNK (19XX)|800521|PSYCHOSES TOX|abcdefv", "ENTRY": "Substance Induced Psychoses", "MN": "F03.900.746", "MH_TH": "NLM (1966)", "ST": "T048", "AN": "PSYCHOSES, ALCOHOLIC is available", "MS": "Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.", "OL": "use PSYCHOSES, SUBSTANCE-INDUCED to search PSYCHOSES, TOXIC 1966-80", "PM": "81; was PSYCHOSES, TOXIC 1963-80", "HN": "81; was PSYCHOSES, TOXIC 1963-80", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D011605"}, {"RECTYPE": "D", "MH": "Psychosexual Development", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Phallic Stage|T079|NON|NRW|NLM (1997)|960416|abcdef", "ENTRY": "Stages, Phallic", "MN": "F02.739.794.793", "MH_TH": "NLM (1968)", "ST": "T041", "PI": "Sex Behavior (1966-1967)", "MS": "The stages of development of the psychological aspects of sexuality from birth to adulthood; i.e., oral, anal, genital, and latent periods.", "PM": "68; ANAL STAGE was heading 1975-96 (see under PSYCHOSEXUAL DEVELOPMENT 1975-90); was see under PSYCHOSEXUAL DEVELOPMENT 1968-74; PHALLIC STAGE was heading 1975-96 (see under PSYCHOSEXUAL DEVELOPMENT 1975-90)", "HN": "68; ANAL STAGE was heading 1975-96 (see under PSYCHOSEXUAL DEVELOPMENT 1975-90); was see under PSYCHOSEXUAL DEVELOPMENT 1968-74; PHALLIC STAGE was heading 1975-96 (see under PSYCHOSEXUAL DEVELOPMENT 1975-90)", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011606"}, {"RECTYPE": "D", "MH": "Psychosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sphingosine Galactoside|T109|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Galactoside, Sphingosine", "MN": "D10.570.877.360.806", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "beta-D-Galactopyranoside, 2-amino-3-hydroxy-4-octadecenyl, (R-(R*,S*-(E)))-", "RN": "2238-90-6", "PI": "Sphingosine (1972-1974)", "MS": "An intermediate in the biosynthesis of cerebrosides. It is formed by reaction of sphingosine with UDP-galactose and then itself reacts with fatty acid-Coenzyme A to form the cerebroside.", "PM": "91; was see under SPHINGOSINE 1975-90", "HN": "91(75); was see under SPHINGOSINE 1975-90", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011609"}, {"RECTYPE": "D", "MH": "Psychosocial Deprivation", "ENTRY": "Psychosocial Deprivations", "MN": "I01.880.853.748.877.750", "MH_TH": "NLM (1969)", "ST": "T054", "AN": "no qualif", "PI": "Cultural Deprivation (1968)", "MS": "The absence of appropriate stimuli in the physical or social environment which are necessary for the emotional, social, and intellectual development of the individual.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011610"}, {"RECTYPE": "D", "MH": "Psychosomatic Medicine", "DE": "PSYCHOSOMATIC MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Psychosomatic|T091|NON|EQV|NLM (1991)|891204|MED PSYCHOSOMATIC|abcdefv", "MN": "F04.096.544.830", "FX": "Psychophysiology", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty; differentiate from PSYCHOPHYSIOLOGIC DISORDERS; PSYCHOPHYSIOLOGY is also available", "MS": "A system of medicine which aims at discovering the exact nature of the relationship between the emotions and bodily function, affirming the principle that the mind and body are one.", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011611"}, {"RECTYPE": "D", "MH": "Psychosurgery", "DE": "PSYCHOSURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT OG PX RH SN ST TD", "PRINT ENTRY": "Topectomy|T061|NON|REL|UNK (19XX)|741209|abcdef", "ENTRY": "Topectomies", "MN": "F04.570.630", "MH_TH": "BIOETHICS (1974)", "ST": "T061", "AN": "coord IM with specific lobe /surg (NIM)", "MS": "Treatment of chronic, severe and intractable psychiatric disorders by surgical removal or interruption of certain areas or pathways in the brain, especially in the prefrontal lobes.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011612"}, {"RECTYPE": "D", "MH": "Psychotherapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychotherapies", "MN": "F04.754", "FX": "Psychology, Clinical", "MH_TH": "BIOETHICS (1974)", "ST": "T061", "MS": "A generic term for the treatment of mental illness or emotional disturbances primarily by verbal or nonverbal communication.", "CATSH": "CAT LIST", "MR": "20200706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011613"}, {"RECTYPE": "D", "MH": "Psychotherapy, Brief", "DE": "PSYCHOTHER BRIEF", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Short-Term Psychotherapy|T061|NON|EQV|UNK (19XX)|740330|SHORT TERM PSYCHOTHER|abcdefv", "ENTRY": "Therapy, Solution-Focused Brief", "MN": "F04.754.738", "MH_TH": "NLM (1973)", "ST": "T061", "PI": "Psychotherapy (1966-1972)", "MS": "Any form of psychotherapy designed to produce therapeutic change within a minimal amount of time, generally not more than 20 sessions.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20171211", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011614"}, {"RECTYPE": "D", "MH": "Psychotherapy, Group", "DE": "PSYCHOTHER GROUP", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Group Therapy|T061|NON|REL|BIOETHICS (1989)|770317|GROUP THER|abcdefv", "ENTRY": "Therapy, Group|T061|NON|REL|UNK (19XX)|770317|THER GROUP|abcdefv", "MN": "F04.754.864.581", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "A form of therapy in which two or more patients participate under the guidance of one or more psychotherapists for the purpose of treating emotional disturbances, social maladjustments, and psychotic states.", "CATSH": "CAT LIST", "MR": "19950531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011615"}, {"RECTYPE": "D", "MH": "Psychotherapy, Multiple", "DE": "PSYCHOTHER MULTIPLE", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychotherapies, Multiple", "MN": "F04.754.766", "MH_TH": "NLM (1973)", "ST": "T061", "PI": "Psychotherapy, Group (1966-1972)", "MS": "The use of more than one therapist at one time in individual or group psychotherapy.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "19950531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011616"}, {"RECTYPE": "D", "MH": "Psychotherapy, Rational-Emotive", "DE": "PSYCHOTHER RATIONAL EMOTIVE", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Rational-Emotive Psychotherapy|T061|NON|EQV|UNK (19XX)|760412|RATIONAL EMOTIVE PSYCHOTHER|abcdefv", "ENTRY": "Rational-Emotive Psychotherapies", "MN": "F04.754.785", "MH_TH": "NLM (1977)", "ST": "T061", "PI": "Psychotherapy (1966-1976)", "MS": "The replacement of illogical and unrealistic ideas with more realistic and adaptive ones through direct intervention and confrontation by the therapist.", "PM": "91; was see under PSYCHOTHERAPY 1977-90", "HN": "91(77); was see under PSYCHOTHERAPY 1977-90", "CATSH": "CAT LIST", "MR": "20050620", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D011617"}, {"RECTYPE": "D", "MH": "Psychotic Disorders", "DE": "PSYCHOTIC DIS", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Schizophreniform Disorders|T048|NON|NRW|UNK (19XX)|800521|SCHIZOPHRENIFORM DIS|abcdefv", "ENTRY": "Schizophreniform Disorder", "MN": "F03.700.675", "EC": "chemically induced:Psychoses, Substance-Induced", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)", "OL": "use PSYCHOTIC DISORDERS to search PSYCHOSES 1966-80", "PM": "81; was PSYCHOSES 1963-80", "HN": "81; was PSYCHOSES 1963-80", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D011618"}, {"RECTYPE": "D", "MH": "Psychotropic Drugs", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Psychotropic Drug|T121|NON|EQV|NLM (2021)|200317|abcdef", "ENTRY": "Drugs, Psychotropic", "MN": "D27.505.954.427.700", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).", "OL": "search ANTIDEPRESSIVE AGENTS & TRANQUILIZING AGENTS 1974", "PM": "75; was see under ANTIDEPRESSIVE AGENTS & TRANQUILIZING AGENTS 1974", "HN": "75; was see under ANTIDEPRESSIVE AGENTS & TRANQUILIZING AGENTS 1974", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D011619"}, {"RECTYPE": "D", "MH": "Psyllium", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Semen Plantaginis|T121|T123|NON|EQV|NLM (2022)|210222|abbcdef", "ENTRY": "Seed, Plantago", "MN": "D20.215.784.500.720", "PA": "Cathartics", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Psyllium gum", "RN": "8063-16-9", "RR": "9C60Y73166", "AN": "drug only; plant source is PLANTAGO", "MS": "Dried, ripe seeds of PLANTAGO PSYLLIUM; PLANTAGO INDICA; and PLANTAGO OVATA. Plantain seeds swell in water and are used as demulcents and bulk laxatives.", "HN": "was in Cat B & D 1963-77", "MR": "20210326", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011620"}, {"RECTYPE": "D", "MH": "Pteridines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrimido(4,5-b)pyrazine|T109|NON|NRW|NLM (2024)|221006|abcdef", "ENTRY": "Pteridinones|T109|NON|NRW|NLM (2004)|030128|abcdef", "MN": "D03.633.100.733", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds based on pyrazino[2,3-d]pyrimidine which is a pyrimidine fused to a pyrazine, containing four NITROGEN atoms.", "PM": "66", "HN": "66", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011621"}, {"RECTYPE": "D", "MH": "Pterins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pterin|T109|T123|NON|EQV|NLM (2021)|191119|abbcdef", "MN": "D23.767.831", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Compounds based on 2-amino-4-hydroxypteridine.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011622"}, {"RECTYPE": "D", "MH": "gamma-Glutamyl Hydrolase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pteroyl Polyglutamate Hydrolase|T116|T126|NON|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "gamma Glutamyl Hydrolase", "MN": "D08.811.277.656.350.245.280", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 3.4.19.9", "PI": "Glutamates (1972-1974)", "MS": "Catalyzes the hydrolysis of pteroylpolyglutamic acids in gamma linkage to pterolylmonoglutamic acid and free glutamic acid. EC 3.4.19.9.", "PM": "2000; see PTEROYL POLYGLUTAMATE HYDROLASE 1991-1999; for GAMMA-GLUTAMYL HYDROLASE see PTEROYL POLYGLUTAMATE HYDROLASE 1987-1999; see CYSTEINE PROTEINASES 1975-1990", "HN": "2000(1975)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011623"}, {"RECTYPE": "D", "MH": "Pteroylpolyglutamic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyglutamate Folates|T109|T127|NON|NRW|UNK (19XX)|780519|abbcdef", "ENTRY": "Polyglutamates, Folate", "MN": "D03.633.100.733.631.400.600", "PA": "Vitamin B Complex", "MH_TH": "NLM (1991)", "ST": "T127", "RN": "0", "AN": "deficiency: coordinate PTEROYLPOLYGLUTAMIC ACIDS /defic (IM) with FOLIC ACID DEFICIENCY (IM)", "PI": "Glutamates (1966-1978)", "MS": "Derivatives of folic acid (pteroylglutamic acid). In gamma-glutamyl linkage they are found in many tissues. They are converted to folic acid by the action of pteroylpolyglutamate hydrolase or synthesized from folic acid by the action of folate polyglutamate synthetase. Synthetic pteroylpolyglutamic acids, which are in alpha-glutamyl linkage, are active in bacterial growth assays.", "PM": "91; was see under FOLIC ACID 1979-90", "HN": "91(79); was see under FOLIC ACID 1979-90", "MR": "20160531", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D011624"}, {"RECTYPE": "D", "MH": "Pterygium", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pterygiums", "MN": "C11.187.781", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "a conjunctival dis, not a structure; pterygium of other organs: index under specific organ /abnorm", "MS": "An abnormal triangular fold of membrane in the interpalpebral fissure, extending from the conjunctiva to the cornea, being immovably united to the cornea at its apex, firmly attached to the sclera throughout its middle portion, and merged with the conjunctiva at its base. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011625"}, {"RECTYPE": "D", "MH": "Pterygoid Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Pterygoid Muscle", "MN": "A14.530.790", "MH_TH": "NLM (1980)", "ST": "T023", "AN": "/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent", "PI": "Muscles (1966-1979)", "MS": "Two of the masticatory muscles: the internal, or medial, pterygoid muscle and external, or lateral, pterygoid muscle. Action of the former is closing the jaws and that of the latter is opening the jaws, protruding the mandible, and moving the mandible from side to side.", "PM": "91; was see under MASTICATORY MUSCLES 1980-90", "HN": "91(80); was see under MASTICATORY MUSCLES 1980-90", "MR": "20080708", "DA": "19790312", "DC": "1", "DX": "19910101", "UI": "D011626"}, {"RECTYPE": "D", "MH": "Puberty", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "ENTRY": "Puberties", "MN": "G08.686.841.374", "FX": "Sexual Maturation", "MH_TH": "NLM (1963)", "ST": "T079", "AN": "human only: for animal use AGING; GROWTH or SEX MATURATION", "MS": "A period in the human life in which the development of the hypothalamic-pituitary-gonadal system takes place and reaches full maturity. The onset of synchronized endocrine events in puberty lead to the capacity for reproduction (FERTILITY), development of secondary SEX CHARACTERISTICS, and other changes seen in ADOLESCENT DEVELOPMENT.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011627"}, {"RECTYPE": "D", "MH": "Puberty, Delayed", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "ENTRY": "Delayed Puberty|T047|NON|EQV|NLM (2006)|040913|abcdef", "MN": "C19.391.690", "MH_TH": "NLM (1981)", "ST": "T047", "AN": "human only", "PI": "Puberty (1966-1980)", "MS": "The lack of development of SEXUAL MATURATION in boys and girls at a chronological age that is 2.5 standard deviations above the mean age at onset of PUBERTY in a population. Delayed puberty can be classified by defects in the hypothalamic LHRH pulse generator, the PITUITARY GLAND, or the GONADS. These patients will undergo spontaneous but delayed puberty whereas patients with SEXUAL INFANTILISM will not.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19800509", "DC": "1", "DX": "19810101", "UI": "D011628"}, {"RECTYPE": "D", "MH": "Puberty, Precocious", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "ENTRY": "Sexual Precocity, Idiopathic", "MN": "C19.391.693", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "human only", "MS": "Development of SEXUAL MATURATION in boys and girls at a chronological age that is 2.5 standard deviations below the mean age at onset of PUBERTY in the population. This early maturation of the hypothalamic-pituitary-gonadal axis results in sexual precocity, elevated serum levels of GONADOTROPINS and GONADAL STEROID HORMONES such as ESTRADIOL and TESTOSTERONE.", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011629"}, {"RECTYPE": "D", "MH": "Pubic Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Pubic Bones", "MN": "A02.835.232.043.825.781", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A bone that forms the lower and anterior part of each side of the hip bone.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011630"}, {"RECTYPE": "D", "MH": "Pubic Symphysis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Symphysis, Pubic", "MN": "A02.835.583.656", "FX": "Symphysiotomy", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "A slightly movable cartilaginous joint which occurs between the pubic bones.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011631"}, {"RECTYPE": "D", "MH": "Public Assistance", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Assistance, Public", "MN": "N03.219.521.346.506", "FX": "Social Welfare", "MH_TH": "POPLINE (1978)", "ST": "T064", "AN": "specify geog", "PI": "Social Welfare (1966-1967)", "MS": "Financial assistance to impoverished persons for the essentials of living through federal, state or local government programs.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011632"}, {"RECTYPE": "D", "MH": "Public Facilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Public Facility", "MN": "J03.720", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "do not add as a coordinate with a specific facility unless the public aspect is emphasized", "MS": "Any facility  owned, leased, or otherwise operated, or funded by a governmental body or public entity.", "PM": "98", "HN": "98; use explode 1970-97", "MR": "20160613", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D011633"}, {"RECTYPE": "D", "MH": "Public Health", "AQ": "CL EC ED ES HI IS LJ MT SN ST TD", "ENTRY": "Health, Public", "MN": "N06.850", "FX": "Zoonoses", "EC": "organization & administration:Public Health Administration", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty; do not confuse with NATIONAL HEALTH PROGRAMS", "MS": "Branch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state, or municipal level.", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011634"}, {"RECTYPE": "D", "MH": "Public Health Administration", "DE": "PUBLIC HEALTH ADMIN", "AQ": "CL EC ED ES HI IS LJ MT SN ST TD", "ENTRY": "Administration, Public Health|T058|T062|NON|EQV|UNK (19XX)|781226|ADMIN PUBLIC HEALTH|abbcdefv", "MN": "N04.452.794", "FX": "Community Health Services", "MH_TH": "NLM (1966)", "ST": "T062", "MS": "Management of public health organizations or agencies.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011635"}, {"RECTYPE": "D", "MH": "Public Health Dentistry", "DE": "PUBLIC HEALTH DENT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Dentistry, Public Health|T091|NON|EQV|NLM (1991)|900208|DENT PUBLIC HEALTH|abcdefv", "MN": "N06.890", "FX": "Health Education, Dental", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "A dental specialty concerned with the prevention of disease and the maintenance of oral health through promoting organized dental health programs at a community, state, or federal level.", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011636"}, {"RECTYPE": "D", "MH": "Public Health Nursing", "DE": "PUBLIC HEALTH NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Public Health|T058|T091|NON|EQV|UNK (19XX)|781226|NURS PUBLIC HEALTH|abbcdefv", "MN": "H02.478.676.755", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "do not confuse with COMMUNITY HEALTH NURSING", "MS": "A nursing specialty concerned with promoting and protecting the health of populations, using knowledge from nursing, social, and public health sciences to develop local, regional, state, and national health policy and research. It is population-focused and community-oriented, aimed at health promotion and disease prevention through educational, diagnostic, and preventive programs.", "MR": "20140616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011637"}, {"RECTYPE": "D", "MH": "Public Housing", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Housing, Public", "MN": "N06.230.150.360.650", "MH_TH": "NLM (1968)", "ST": "T064", "AN": "specify geog if pertinent", "PI": "Social Welfare (1966-1967)", "MS": "Housing subsidized by tax funds, usually intended for low income persons or families.", "PM": "68", "HN": "68", "MR": "20160608", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011638"}, {"RECTYPE": "D", "MH": "Public Opinion", "AQ": "HI", "ENTRY": "Public Opinion Poll", "MN": "I01.880.630.548", "FX": "Attitude to Health", "MH_TH": "POPLINE (1981)", "ST": "T081", "PI": "Attitude (1966-1967)", "MS": "The attitude of a significant portion of a population toward any given proposition, based upon a measurable amount of factual evidence, and involving some degree of reflection, analysis, and reasoning.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20091023", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011639"}, {"RECTYPE": "D", "MH": "Public Policy", "AQ": "EC HI LJ TD", "PRINT ENTRY": "Social Policy|T064|T170|NON|REL|POPLINE (1984)|770420|abbcdef", "ENTRY": "Social Policies", "MN": "N03.623.500.608", "FX": "Social Control, Formal", "MH_TH": "BIOETHICS (1974)", "ST": "T170", "MS": "A course or method of action selected, usually by a government, from among alternatives to guide and determine present and future decisions.", "PM": "78", "HN": "78", "MR": "20190304", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D011640"}, {"RECTYPE": "D", "MH": "Public Relations", "DE": "PUBLIC RELAT", "AQ": "EC SN TD", "ENTRY": "Relations, Client Staff", "MN": "N04.452.822", "MH_TH": "POPLINE (1978)", "ST": "T079", "MS": "Relations of an individual, association, organization, hospital, or corporation with the publics which it must take into consideration in carrying out its functions. Publics may include consumers, patients, pressure groups, departments, etc.", "OL": "use PUBLIC RELATIONS to search NEWS MEDIA RELATIONS 1978-93", "PM": "NEWS MEDIA RELATIONS was see PUBLIC RELATIONS 1978-93", "HN": "NEWS MEDIA RELATIONS was see PUBLIC RELATIONS 1978-93", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011641"}, {"RECTYPE": "D", "MH": "Publications", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Publication", "MN": "L01.462.500.682", "MH_TH": "NLM (1974)", "ST": "T170", "AN": "avoid: too general; prefer specifics; the published material itself: differentiate from PUBLISHING, the industry", "PI": "specific publication (1966-1997)", "MS": "Copies of a work or document distributed to the public by sale, rental, lease, or lending. (From ALA Glossary of Library and Information Science, 1983, p181)", "PM": "98", "HN": "98; use explode 1975-97", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D011642"}, {"RECTYPE": "D", "MH": "Publishing", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Publishing, Electronic|T057|NON|NRW|NLM (1998)|960723|abcdef", "ENTRY": "Publishings, Electronic", "MN": "L01.737", "FX": "Periodicals as Topic", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "the industry & the dissemination of knowledge & research; printing & disseminating textual material: do not confuse with WRITING (the act, profession or product) or with AUTHORSHIP (identity as author); med publishing: do not coord with MEDICINE; RETRACTION OF PUBLICATION AS TOPIC is also available", "MS": "\"The business or profession of the commercial production and issuance of literature\" (Webster's 3d). It includes the publisher, publication processes, editing and editors. Production may be by conventional printing methods or by electronic publishing.", "MR": "20190711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011643"}, {"RECTYPE": "D", "MH": "Puerperal Disorders", "DE": "PUERPERAL DIS", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Puerperal Disorder", "MN": "C12.050.703.844", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "check the tag FEMALE; puerperal psychoses: coordinate IM with PSYCHOTIC DISORDERS (IM)", "MS": "Disorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011644"}, {"RECTYPE": "D", "MH": "Puerperal Infection", "DE": "PUERPERAL INFECT", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sepsis, Postpartum", "MN": "C12.050.703.844.757", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; coordinate IM with specific infection (IM); check the tag FEMALE", "MS": "An infection occurring in PUERPERIUM, the period of 6-8 weeks after giving birth.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011645"}, {"RECTYPE": "D", "MH": "Puerto Rico", "AQ": "EH EP", "MN": "Z01.639.880.750", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island in the Greater Antilles in the West Indies; for Puerto Rico as a geog entity (as in epidemiol articles) & for Puerto Ricans in Puerto Rico; for Puerto Ricans living in the United States as an ethnic group, coord PUERTO RICO /ethnol (NIM) + HISPANIC OR LATINO (IM)", "MS": "An island in the Greater Antilles in the West Indies. Its capital is San Juan. It is a self-governing commonwealth in union with the United States. It was discovered by Columbus in 1493 but no colonization was attempted until 1508. It belonged to Spain until ceded to the United States in 1898. It became a commonwealth with autonomy in internal affairs in 1952. Columbus named the island San Juan for St. John's Day, the Monday he arrived, and the bay Puerto Rico, rich harbor. The island became Puerto Rico officially in 1932. (From Webster's New Geographical Dictionary, 1988, p987 & Room, Brewer's Dictionary of Names, 1992, p436)", "MR": "20210712", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D011647"}, {"RECTYPE": "D", "MH": "Pulmonary Adenomatosis, Ovine", "DE": "PULM ADENOMATOSIS OVINE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Jaagsiekte|T047|EPO|EQV|UNK (19XX)|750709|abcdef", "ENTRY": "Pulmonary Ovine Adenomatoses", "MN": "C22.836.715", "MH_TH": "NLM (1968)", "ST": "T047", "PI": "Sheep Diseases (1966-1967)", "MS": "A contagious, neoplastic, pulmonary disease of sheep characterized by hyperplasia and hypertrophy of pneumocytes and epithelial cells of the lung. It is caused by JAAGSIEKTE SHEEP RETROVIRUS.", "PM": "1968", "HN": "1968", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011648"}, {"RECTYPE": "D", "MH": "Pulmonary Alveolar Proteinosis", "DE": "PULM ALVEOLAR PROTEINOSIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pulmonary Alveolar Proteinoses|T047|NON|EQV|NLM (1992)|901107|PULM ALVEOLAR PROTEINOSES|abcdefv", "MN": "C08.381.719", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011649"}, {"RECTYPE": "D", "MH": "Pulmonary Alveoli", "DE": "PULM ALVEOLI", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Pulmonary Alveolus|T023|NON|EQV|NLM (1992)|901107|PULM ALVEOLUS|abcdefv", "MN": "A04.411.715", "MH_TH": "NLM (1964)", "ST": "T023", "MS": "Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place.", "PM": "66", "HN": "66(64)", "MR": "19910628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011650"}, {"RECTYPE": "D", "MH": "Pulmonary Artery", "DE": "PULM ARTERY", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Pulmonary Arteries|T023|NON|EQV|NLM (1992)|901107|PULM ARTERIES|abcdefv", "MN": "A07.015.114.715", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011651"}, {"RECTYPE": "D", "MH": "Pulmonary Circulation", "DE": "PULM CIRC", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Respiratory Circulation|T042|NON|EQV|NLM (1990)|990101|RESP CIRC|abcdefv", "ENTRY": "Pulmonary Blood Flows", "MN": "G09.772.593", "FX": "Ventilation-Perfusion Ratio", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "consider also LUNG /blood supply    ", "MS": "The circulation of the BLOOD through the LUNGS.", "PM": "1963; for RESPIRATORY CIRCULATION see RESPIRATORY CIRCULATION 1990-1999", "HN": "1963; for RESPIRATORY CIRCULATION use PULMONARY CIRCULATION 1990-1999", "CATSH": "CAT LIST", "MR": "20200221", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D011652"}, {"RECTYPE": "D", "MH": "Pulmonary Diffusing Capacity", "DE": "PULM DIFFUSING CAPAC", "AQ": "DE GE IM IS MT PH RE ST", "ENTRY": "Diffusing Capacity, Pulmonary|T042|T060|NON|EQV|NLM (1992)|901107|DIFFUSING CAPAC PULM|abbcdefv", "MN": "G09.772.600", "MH_TH": "NLM (1971)", "ST": "T060", "PI": "Respiratory Function Tests (1966-1970)", "MS": "The amount of a gas taken up, by the pulmonary capillary blood from the alveolar gas, per minute per unit of average pressure of the gradient of the gas across the BLOOD-AIR BARRIER.", "PM": "72", "HN": "72(71)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011653"}, {"RECTYPE": "D", "MH": "Pulmonary Edema", "DE": "PULM EDEMA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wet Lung|T047|T184|NON|EQV|NLM (1992)|901228|abbcdef", "ENTRY": "Wet Lungs", "MN": "C08.381.742", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "entry term WET LUNG: in shock, consider also SHOCK LUNG see RESPIRATORY DISTRESS SYNDROME", "MS": "Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.", "OL": "use RESPIRATORY DISTRESS SYNDROME, ADULT to search WET LUNG 1977-91; use PULMONARY EDEMA to search WET LUNG SYNDROME 1975-76", "PM": "WET LUNG was see RESPIRATORY DISTRESS SYNDROME, ADULT 1977-91; was WET LUNG SYNDROME see PULMONARY EDEMA 1975-76", "HN": "WET LUNG was see RESPIRATORY DISTRESS SYNDROME, ADULT 1977-91; was WET LUNG SYNDROME see PULMONARY EDEMA 1975-76", "CATSH": "CAT LIST", "MR": "20200709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011654"}, {"RECTYPE": "D", "MH": "Pulmonary Embolism", "DE": "PULM EMBOLISM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thromboembolism, Pulmonary|T047|NON|NRW|NLM (1998)|961213|abcdef", "ENTRY": "Thromboembolisms, Pulmonary|T047|NON|NRW|NLM (1998)|961213|THROMBOEMBOLISMS PULM|abcdefv", "MN": "C14.907.355.350.700", "MH_TH": "NLM (1978)", "ST": "T047", "MS": "Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011655"}, {"RECTYPE": "D", "MH": "Pulmonary Emphysema", "DE": "PULM EMPHYSEMA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Emphysema, Pulmonary|T047|NON|EQV|UNK (19XX)|760502|EMPHYSEMA PULM|abcdefv", "ENTRY": "Panlobular Emphysemas", "MN": "C23.550.291.500.875.875", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "in cattle, probably EMPHYSEMA, ACUTE BOVINE PULMONARY see PNEUMONIA, ATYPICAL INTERSTITIAL, OF CATTLE", "MS": "Enlargement of air spaces distal to the TERMINAL BRONCHIOLES where gas-exchange normally takes place. This is usually due to destruction of the alveolar wall. Pulmonary emphysema can be classified by the location and distribution of the lesions.", "CATSH": "CAT LIST", "MR": "20210312", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011656"}, {"RECTYPE": "D", "MH": "Pulmonary Eosinophilia", "DE": "PULM EOSINOPHILIA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pneumonia, Eosinophilic|T047|NON|NRW|UNK (19XX)|810519|abcdef", "ENTRY": "Tropical Eosinophilic Pneumonias", "MN": "C15.378.553.231.549.750", "MH_TH": "NLM (1982)", "ST": "T047", "AN": "do not confuse entry term LOEFFLER SYNDROME with LOEFFLER'S ENDOCARDITIS see HYPEREOSINOPHILIC SYNDROME", "PI": "Lung Diseases (1966-1981)", "MS": "A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.", "OL": "use PULMONARY EOSINOPHILIA to search LOEFFLER'S SYNDROME 1966-81", "PM": "82; LOEFFLER SYNDROME was heading LOEFFLER'S SYNDROME 1963-81", "HN": "82; LOEFFLER SYNDROME was heading LOEFFLER'S SYNDROME 1963-81", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19810519", "DC": "1", "DX": "19820101", "UI": "D011657"}, {"RECTYPE": "D", "MH": "Pulmonary Fibrosis", "DE": "PULM FIBROSIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Idiopathic Diffuse Interstitial Pulmonary Fibrosis|T047|NON|REL|NLM (2020)|190201|abcdef", "ENTRY": "Fibrosing Alveolitis", "MN": "C23.550.355.644", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "usually chronic so do not coordinate with CHRONIC DISEASE; IDIOPATHIC PULMONARY FIBROSIS is also available", "MS": "A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011658"}, {"RECTYPE": "D", "MH": "Pulmonary Gas Exchange", "DE": "PULM GAS EXCHANGE", "AQ": "DE ES GE IM PH RE", "ENTRY": "Gas Exchange, Pulmonary|T042|NON|EQV|NLM (1992)|901107|GAS EXCHANGE PULM|abcdefv", "MN": "G09.772.705.760.602", "FX": "Blood-Air Barrier", "MH_TH": "NLM (1983)", "ST": "T042", "AN": "do not coordinate with OXYGEN or CARBON DIOXIDE unless particularly discussed", "MS": "The exchange of OXYGEN and CARBON DIOXIDE between alveolar air and pulmonary capillary blood that occurs across the BLOOD-AIR BARRIER.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19820426", "DC": "1", "DX": "19830101", "UI": "D011659"}, {"RECTYPE": "D", "MH": "Pulmonary Heart Disease", "DE": "PULM HEART DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cor Pulmonale|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Pulmonary Heart Diseases|T047|NON|EQV|NLM (1992)|901107|PULM HEART DISEASES|abcdefv", "MN": "C14.280.832", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Hypertrophy and dilation of the RIGHT VENTRICLE of the heart that is caused by PULMONARY HYPERTENSION. This condition is often associated with pulmonary parenchymal or vascular diseases, such as CHRONIC OBSTRUCTIVE PULMONARY DISEASE and PULMONARY EMBOLISM.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011660"}, {"RECTYPE": "D", "MH": "Pulmonary Stretch Receptors", "DE": "PULM STRETCH RECEPT", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Stretch Receptors, Pulmonary|T023|NON|EQV|NLM (1994)|921119|STRETCH RECEPT PULM|abcdefv", "ENTRY": "Stretch Receptor, Pulmonary", "MN": "A11.671.650.915.750.780", "MH_TH": "NLM (1971)", "ST": "T023", "PI": "Lung/innervation (1966-1970)", "MS": "Stretch receptors found in the bronchi and bronchioles. Pulmonary stretch receptors are sensors for a reflex which stops inspiration. In humans, the reflex is protective and is probably not activated during normal respiration.", "PM": "91; was see under MECHANORECEPTORS 1971-90", "HN": "91(71); was see under MECHANORECEPTORS 1971-90", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011661"}, {"RECTYPE": "D", "MH": "Pulmonary Subvalvular Stenosis", "DE": "PULM SUBVALV STENOSIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulmonary Infundibular Stenosis|T047|NON|EQV|UNK (19XX)|860418|PULM INFUNDIBULAR STENOSIS|abcdefv", "ENTRY": "Subaortic Conus, Obstructive", "MN": "C14.280.955.750.762", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "do not confuse with PULMONARY VALVE STENOSIS; if secondary to idiopathic hypertrophic subaortic stenosis, coordinate with CARDIOMYOPATHY, HYPERTROPHIC", "MS": "Narrowing below the PULMONARY VALVE or well below it in the infundibuluar chamber where the pulmonary artery originates, usually caused by a defective VENTRICULAR SEPTUM or presence of fibrous tissues. It is characterized by restricted blood outflow from the RIGHT VENTRICLE into the PULMONARY ARTERY, exertional fatigue, DYSPNEA, and chest discomfort.", "OL": "search CARDIOMYOPATHY, HYPERTROPHIC 1967-74", "PM": "91; was see under CARDIOMYOPATHY, HYPERTROPHIC 1986-90; was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85", "HN": "91(75); was see under CARDIOMYOPATHY, HYPERTROPHIC 1986-90; was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011662"}, {"RECTYPE": "D", "MH": "Pulmonary Surfactants", "DE": "PULM SURFACTANTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Surfactants, Pulmonary|T121|T123|NON|EQV|UNK (19XX)|800521|SURFACTANTS PULM|abbcdefv", "ENTRY": "Surfactant, Pulmonary|T121|T123|NON|EQV|NLM (1992)|901107|SURFACTANT PULM|abbcdefv", "MN": "D27.505.954.796.600", "MH_TH": "NLM (1971)", "ST": "T123", "RN": "0", "PI": "Surface-Active Agents (1966-1970)", "MS": "Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI.", "OL": "use PULMONARY SURFACTANTS to search PULMONARY SURFACTANT 1971-86 (as Prov 1971-72)", "PM": "87; was PULMONARY SURFACTANT 1973-86", "HN": "87; was PULMONARY SURFACTANT 1971-86 (Prov 1971-72)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011663"}, {"RECTYPE": "D", "MH": "Pulmonary Valve", "DE": "PULM VALVE", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Valves, Pulmonary|T023|NON|EQV|NLM (1992)|901107|VALVES PULM|abcdefv", "MN": "A07.541.510.738", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "dis: coord IM with HEART VALVE DISEASES (NIM) but note specific pulm valve dis", "MS": "A valve situated at the entrance to the pulmonary trunk from the right ventricle.", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011664"}, {"RECTYPE": "D", "MH": "Pulmonary Valve Insufficiency", "DE": "PULM VALVE INSUFFICIENCY", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulmonary Valve Incompetence|T047|NON|EQV|NLM (1993)|911003|PULM VALVE INCOMPETENCE|abcdefv", "ENTRY": "Valve Regurgitation, Pulmonary|T047|NON|EQV|NLM (1993)|911003|VALVE REGURGITATION PULM|abcdefv", "MN": "C14.280.484.660", "MH_TH": "NLM (1967)", "ST": "T047", "PI": "Pulmonary Valve (1966)", "MS": "Backflow of blood from the PULMONARY ARTERY into the RIGHT VENTRICLE due to imperfect closure of the PULMONARY VALVE.", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D011665"}, {"RECTYPE": "D", "MH": "Pulmonary Valve Stenosis", "DE": "PULM VALVE STENOSIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulmonary Stenosis|T047|NON|BRD|UNK (19XX)|740330|PULM STENOSIS|abcdefv", "ENTRY": "Valvular Pulmonic Stenoses", "MN": "C14.280.955.750", "MH_TH": "NLM (1967)", "ST": "T190", "MS": "The pathologic narrowing of the orifice of the PULMONARY VALVE. This lesion restricts blood outflow from the RIGHT VENTRICLE to the PULMONARY ARTERY. When the trileaflet valve is fused into an imperforate membrane, the blockage is complete.", "OL": "use PULMONARY VALVE STENOSIS to search PULMONARY STENOSIS 1966", "PM": "67; was PULMONARY STENOSIS 1963-66", "HN": "67; was PULMONARY STENOSIS 1963-66", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D011666"}, {"RECTYPE": "D", "MH": "Pulmonary Veins", "DE": "PULM VEINS", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Pulmonary|T023|NON|EQV|NLM (1992)|901107|VEINS PULM|abcdefv", "MN": "A07.015.908.713", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The veins that return the oxygenated blood from the lungs to the left atrium of the heart.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011667"}, {"RECTYPE": "D", "MH": "Pulmonary Veno-Occlusive Disease", "DE": "PVOD", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Veno-Occlusive Disease, Pulmonary|T047|NON|EQV|NLM (1994)|921016|VENO OCCLUSIVE DIS PULM|abcdefv", "ENTRY": "Venoocclusive Diseases, Pulmonary", "MN": "C14.907.690", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Vascular Diseases (1966-1986)", "MS": "Pathological process resulting in the fibrous obstruction of the small- and medium-sized PULMONARY VEINS and PULMONARY HYPERTENSION. Veno-occlusion can arise from fibrous proliferation of the VASCULAR INTIMA and VASCULAR MEDIA; THROMBOSIS; or a combination of both.", "PM": "1987", "HN": "1987", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19860624", "DC": "1", "DX": "19870101", "UI": "D011668"}, {"RECTYPE": "D", "MH": "Pulmonary Wedge Pressure", "DE": "PULM WEDGE PRESSURE", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Wedge Pressure|T034|NON|BRD|UNK (19XX)|800509|abcdef", "ENTRY": "Wedge Pressures", "MN": "G09.330.380.076.695", "FX": "Pulmonary Circulation", "MH_TH": "NLM (1981)", "ST": "T033", "PI": "Pulmonary Circulation (1966-1980)", "MS": "The blood pressure as recorded after wedging a CATHETER in a small PULMONARY ARTERY; believed to reflect the PRESSURE in the pulmonary CAPILLARIES.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19800509", "DC": "1", "DX": "19810101", "UI": "D011669"}, {"RECTYPE": "D", "MH": "Pulpectomy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Pulpectomies", "MN": "E06.397.633", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "differentiate from PULPOTOMY", "MS": "Dental procedure in which the entire pulp chamber is removed from the crown and roots of a tooth.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011670"}, {"RECTYPE": "D", "MH": "Pulpitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Inflammation, Endodontic|T047|NON|EQV|NLM (2004)|030505|abcdef", "ENTRY": "Pulpitides", "MN": "C07.793.237.820", "FX": "Periapical Periodontitis", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Inflammation of the DENTAL PULP, usually due to bacterial infection in dental caries, tooth fracture, or other conditions causing exposure of the pulp to bacterial invasion. Chemical irritants, thermal factors, hyperemic changes, and other factors may also cause pulpitis.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011671"}, {"RECTYPE": "D", "MH": "Pulpotomy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Pulpotomies", "MN": "E06.397.695", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "differentiate from PULPECTOMY", "MS": "Dental procedure in which part of the pulp chamber is removed from the crown of a tooth.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011672"}, {"RECTYPE": "D", "MH": "Pulsatile Flow", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Perfusion, Pulsatile|T067|NON|EQV|UNK (19XX)|860620|abcdef", "ENTRY": "Pulsating Flows", "MN": "G09.330.380.630.555", "FX": "Blood Circulation", "MH_TH": "NLM (1987)", "ST": "T067", "AN": "hematologic or non-hematologic application", "PI": "Rheology (1966-1986)", "MS": "Rhythmic, intermittent propagation of a fluid through a BLOOD VESSEL or piping system, in contrast to constant, smooth propagation, which produces laminar flow.", "PM": "91; was see under RHEOLOGY 1987-90", "HN": "91(87); was see under RHEOLOGY 1987-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19860620", "DC": "1", "DX": "19910101", "UI": "D011673"}, {"RECTYPE": "D", "MH": "Pulse", "AQ": "DE GE IM PH RE", "ENTRY": "Pulses", "MN": "G09.330.380.750", "FX": "Traditional Pulse Diagnosis", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "do not add PULSE for PULSE PRESSURE see BLOOD PRESSURE unless particularly discussed; note TRADITIONAL PULSE DIAGNOSIS is available", "MS": "The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts.", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011674"}, {"RECTYPE": "D", "MH": "Pulse Radiolysis", "AQ": "AE CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Radiolysis, Pulse", "MN": "E05.196.867.660", "MH_TH": "NLM (1975)", "ST": "T059", "AN": "a type of spectrum anal; NIM", "MS": "Use of a pulse of X-rays or fast electrons to generate free radicals for spectroscopic examination.", "PM": "91; was see under SPECTRUM ANALYSIS 1975-90", "HN": "91(75); was see under SPECTRUM ANALYSIS 1975-90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D011675"}, {"RECTYPE": "D", "MH": "Punched-Card Systems", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "ENTRY": "Systems, Punched-Card", "MN": "L01.224.085.800", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Data processing using paper cards with punched holes that represent data.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011676"}, {"RECTYPE": "D", "MH": "Punctures", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Micropunctures|T060|T061|NON|NRW|UNK (19XX)|880321|abbcdef", "ENTRY": "Puncture", "MN": "E04.665", "FX": "Wounds, Stab", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Incision of tissues for injection of medication or for other diagnostic or therapeutic procedures. Punctures of the skin, for example may be used for diagnostic drainage; of blood vessels for diagnostic imaging procedures.", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011677"}, {"RECTYPE": "D", "MH": "Punishment", "AQ": "HI PX", "ENTRY": "Punishments", "MN": "I01.880.630.716", "MH_TH": "BIOETHICS (1976)", "ST": "T078", "AN": "human & animal", "MS": "The application of an unpleasant stimulus or penalty for the purpose of eliminating or correcting undesirable behavior.", "CATSH": "CAT LIST", "MR": "19950523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011678"}, {"RECTYPE": "D", "MH": "Pupa", "AQ": "AH CH CL CY DE EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Pupae|T204|NON|EQV|NLM (1999)|980515|abcdef", "MN": "G07.345.500.550.500.700", "MH_TH": "NLM (1970)", "ST": "T204", "AN": "do not use /embryol with reference to pupae", "PI": "specific insect(1966-1969)", "MS": "An inactive stage between the larval and adult stages in the life cycle of INSECTA.", "PM": "74", "HN": "74(70)", "MR": "20170713", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011679"}, {"RECTYPE": "D", "MH": "Pupil", "AQ": "DE PH RE", "ENTRY": "Pupils", "MN": "A09.371.894.513.780", "FX": "Reflex, Pupillary", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "of eye: do not use for STUDENTS; only contraction & dilation of pupil go here: everything else is probably IRIS; /drug eff: consider also MIOTICS & MYDRIATICS; /physiol: consider also MIOSIS (contraction of pupil) & MYDRIASIS (dilation of pupil)", "MS": "The aperture in the iris through which light passes.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011680"}, {"RECTYPE": "D", "MH": "Pupil Disorders", "DE": "PUPIL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pupillary Functions, Abnormal|T047|NON|NRW|NLM (1974)|990101|PUPILLARY FUNCTIONS ABNORM|abcdefv", "ENTRY": "Wernickes Hemianopic Pupil", "MN": "C23.888.592.708", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "see also IRIS DISEASES", "PI": "specific eye disease (1969-1989)", "MS": "Conditions which affect the structure or function of the pupil of the eye, including disorders of innervation to the pupillary constrictor or dilator muscles, and disorders of pupillary reflexes.", "PM": "2000; see PUPILLARY FUNCTIONS, ABNORMAL 1990-1999", "HN": "2000(1974)", "CATSH": "CAT LIST", "MR": "20050718", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D011681"}, {"RECTYPE": "D", "MH": "Purchasing, Hospital", "DE": "PURCHASING HOSP", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Hospital Purchasings|T093|NON|EQV|NLM (1997)|951004|HOSP PURCHASINGS|abcdefv", "ENTRY": "Purchasings, Hospital|T093|NON|EQV|NLM (1997)|951004|PURCHASINGS HOSP|abcdefv", "MN": "N04.452.442.452.422.679", "FX": "Equipment and Supplies, Hospital", "MH_TH": "NLM (1966)", "ST": "T093", "MS": "Hospital department responsible for the purchasing of supplies and equipment.", "OL": "use PURCHASING, HOSPITAL to search HOSPITAL PURCHASING 1966-77", "PM": "78; was HOSPITAL PURCHASING 1963-77", "HN": "78; was HOSPITAL PURCHASING 1963-77", "MR": "20190709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D011682"}, {"RECTYPE": "D", "MH": "Purine-Nucleoside Phosphorylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Inosine Phosphorylase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Riboside Phosphorylase, Nicotinamide", "MN": "D08.811.913.400.725.800", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Purine-nucleoside:orthophosphate ribosyltransferase", "RN": "EC 2.4.2.1", "RR": "9030-21-1 (CAS RN)", "PI": "Purine Nucleosides (1973-1974)", "MS": "An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1.", "OL": "use PURINE-NUCLEOSIDE PHOSPHORYLASE to search PURINE NUCLEOSIDE PHOSPHORYLASES 1975-91", "PM": "92; was PURINE NUCLEOSIDE PHOSPHORYLASES 1975-91 (see under PENTOSYLTRANSFERASES 1975-90)", "HN": "92; was PURINE NUCLEOSIDE PHOSPHORYLASES 1975-91 (see under PENTOSYLTRANSFERASES 1975-90)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011683"}, {"RECTYPE": "D", "MH": "Purine Nucleosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Purine Nucleoside|T114|T121|NON|EQV|NLM (2021)|200617|abbcdef", "ENTRY": "Nucleosides, Purine", "MN": "D13.570.583", "MH_TH": "NLM (1974)", "ST": "T121", "RN": "0", "MS": "Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES.", "PM": "74", "HN": "74", "MR": "20200618", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011684"}, {"RECTYPE": "D", "MH": "Purine Nucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Nucleotides, Purine", "MN": "D13.695.667", "MH_TH": "NLM (1972)", "ST": "T114", "RN": "0", "PI": "Nucleotides (1966-1971)", "MS": "Purines attached to a RIBOSE and a phosphate that can polymerize to form DNA and RNA.", "PM": "74", "HN": "74(72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011685"}, {"RECTYPE": "D", "MH": "Purine-Pyrimidine Metabolism, Inborn Errors", "DE": "PP METAB INBORN ERR", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Purine Pyrimidine Metabolism, Inborn Errors|T047|NON|EQV|UNK (19XX)|780109|PURINE PYRIMIDINE METAB INBORN ERR|abcdefv", "MN": "C18.452.648.798", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "coordinate with specific purine /metab or pyrimidine /metab", "MS": "Dysfunctions in the metabolism of PURINES or PYRIMIDINES resulting from inborn genetic mutations that are inherited or acquired in utero.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011686"}, {"RECTYPE": "D", "MH": "Purines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.759", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011687"}, {"RECTYPE": "D", "MH": "Purinones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxopurines|T109|NON|EQV|UNK (19XX)|840920|abcdef", "MN": "D03.633.100.759.758", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "PI": "Purines (1966-1967)", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011688"}, {"RECTYPE": "D", "MH": "Purkinje Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Purkyne Cells", "MN": "A11.671.784", "MH_TH": "NLM (1964)", "ST": "T025", "AN": "in cerebellum: do not confuse with PURKINJE FIBERS in heart", "MS": "The output neurons of the cerebellar cortex.", "PM": "65", "HN": "65(64)", "MR": "20150612", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011689"}, {"RECTYPE": "D", "MH": "Purkinje Fibers", "AQ": "AB AH CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Purkinje Fiber|T024|NON|EQV|NLM (2022)|201022|abcdef", "ENTRY": "Fibers, Purkinje", "MN": "A07.541.409.683", "MH_TH": "NLM (1975)", "ST": "T024", "AN": "in heart: do not confuse with PURKINJE CELLS in cerebellum; false tendons (free-running Purkinje fibers) go here but not with /abnorm", "MS": "Modified cardiac muscle fibers composing the terminal portion of the heart conduction system.", "OL": "search HEART CONDUCTION SYSTEM 1968-74", "PM": "91; was see under HEART CONDUCTION SYSTEM 1975-90", "HN": "91(75); was see under HEART CONDUCTION SYSTEM 1975-90", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011690"}, {"RECTYPE": "D", "MH": "Puromycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "P638", "MN": "D13.570.583.138.711", "PA": "Trypanocidal Agents", "MH_TH": "USAN (1965)", "ST": "T195", "N1": "Adenosine, 3'-((2-amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyl-, (S)-", "RN": "4A6ZS6Q2CL", "RR": "PGN54228S5", "MS": "A cinnamamido ADENOSINE found in STREPTOMYCES alboniger. It inhibits protein synthesis by binding to RNA. It is an antineoplastic and antitrypanosomal agent and is used in research as an inhibitor of protein synthesis.", "PM": "65", "HN": "65(63)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011691"}, {"RECTYPE": "D", "MH": "Puromycin Aminonucleoside", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Aminonucleoside, Puromycin", "MN": "D13.570.583.138.711.650", "PA": "Antimetabolites, Antineoplastic", "MH_TH": "NLM (1975)", "ST": "T195", "N1": "Adenosine, 3'-amino-3'-deoxy-N,N-dimethyl-", "RN": "58-60-6", "PI": "Deoxyadenosine (1972-1974)", "MS": "PUROMYCIN derivative that lacks the methoxyphenylalanyl group on the amine of the sugar ring. It is an antibiotic with antineoplastic properties and can cause nephrosis.", "PM": "91; was see under PUROMYCIN 1975-90", "HN": "91(75); was see under PUROMYCIN 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011692"}, {"RECTYPE": "D", "MH": "Purpura", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Petechiae|T047|NON|REL|UNK (19XX)|770428|abcdef", "ENTRY": "Purpuras", "MN": "C23.888.885.687", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "General or unspecified; prefer specifics", "MS": "Purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues. When the size of the discolorization is >2-3 cm it is generally called Ecchymoses (ECCHYMOSIS).", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011693"}, {"RECTYPE": "D", "MH": "Purpura, Hyperglobulinemic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Waldenstr\u00f6m Hyperglobulinemic Purpura", "MN": "C23.888.885.687.250", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Purplish or brownish red discoloration of the skin associated with increase in circulating polyclonal globulins, usually GAMMA-GLOBULINS. This syndrome often occurs on the legs of women aged 20 to 40 years.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011694"}, {"RECTYPE": "D", "MH": "IgA Vasculitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vasculitis, Hemorrhagic|T047|NON|REL|UNK (19XX)|850311|abcdef", "ENTRY": "Vasculitis, IgA", "MN": "C23.888.885.687.375", "MH_TH": "NLM (2022)", "ST": "T047", "PI": "Purpura (1966-1974)", "MS": "A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.", "PM": "2022; see HENOCH-SCHONLEIN PURPURA 1975-2021", "HN": "2022(1975)", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D011695"}, {"RECTYPE": "D", "MH": "Purpura, Thrombocytopenic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Purpura, Thrombopenic|T047|NON|EQV|UNK (19XX)|850325|abcdef", "ENTRY": "Thrombopenic Purpuras", "MN": "C23.888.885.687.687", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms.", "OL": "use PURPURA, THROMBOCYTOPENIC to search PURPURA, THROMBOPENIC 1966-85", "PM": "86; was PURPURA, THROMBOPENIC 1963-85", "HN": "86; was PURPURA, THROMBOPENIC 1963-85", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D011696"}, {"RECTYPE": "D", "MH": "Purpura, Thrombotic Thrombocytopenic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombotic Thrombocytopenic Purpura, Familial|T047|NON|NRW|NLM (2010)|OMIM (2013)|ORD (2010)|090501|abcdeeef", "ENTRY": "Upshaw Schulman Syndrome", "MN": "C23.888.885.687.687.680", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases.", "PM": "1986; see PURPURA, THROMBOTIC THROMBOPENIC 1965-1985", "HN": "1986; use PURPURA, THROMBOTIC THROMBOPENIC 1965-1985", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011697"}, {"RECTYPE": "D", "MH": "Pursuit, Smooth", "AQ": "DE ES GE IM PH RE", "ENTRY": "Smooth Pursuits", "MN": "G14.350.453", "MH_TH": "NLM (1984)", "ST": "T042", "AN": "refers to eye movements", "PI": "Eye Movements (1966-1983)", "MS": "Eye movements that are slow, continuous, and conjugate and occur when a fixed object is moved slowly.", "PM": "91; was see under EYE MOVEMENTS 1984-90", "HN": "91(84); was see under EYE MOVEMENTS 1984-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19830310", "DC": "1", "DX": "19910101", "UI": "D011698"}, {"RECTYPE": "D", "MH": "Putamen", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Putamens, Nucleus", "MN": "A08.186.211.200.885.287.249.487.550.784", "FX": "Putaminal Hemorrhage", "MH_TH": "NLM (1975)", "ST": "T023", "PI": "Corpus Striatum (1974)", "MS": "The largest and most lateral of the BASAL GANGLIA lying between the lateral medullary lamina of the GLOBUS PALLIDUS and the EXTERNAL CAPSULE. It is part of the neostriatum and forms part of the LENTIFORM NUCLEUS along with the GLOBUS PALLIDUS.", "OL": "search CORPUS STRIATUM 1974-78 & GANGLIA, BASAL 1963-73", "PM": "79; was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73", "HN": "79(75); was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D011699"}, {"RECTYPE": "D", "MH": "Putrescine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "1,4 Diaminobutane", "MN": "D02.092.782.258.784", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "1,4-Butanediamine", "RN": "V10TVZ52E4", "RR": "110-60-1 (Putrescine)", "PI": "Polyamines (1971)", "MS": "A toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine.", "PM": "73", "HN": "73(72)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011700"}, {"RECTYPE": "D", "MH": "PUVA Therapy", "DE": "PUVA THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Psoralen Ultraviolet A Therapy|T061|EQV|UNK (19XX)|801210|PSORALEN ULTRAVIOLET A THER|abdefv", "ENTRY": "Therapies, PUVA", "MN": "E02.774.945.500", "MH_TH": "NLM (1981)", "ST": "T061", "AN": "coordinate with disease /drug ther; do not index psoralen compound or ULTRAVIOLET LIGHT unless particularly discussed", "PI": "Ultraviolet Therapy (1966-Feb 81)", "MS": "Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA).", "PM": "86; was see under PHOTOCHEMOTHERAPY 1981-85", "HN": "86(Mar 81); was see under PHOTOCHEMOTHERAPY 1981-85", "CATSH": "CAT LIST", "MR": "20140606", "DA": "19801210", "DC": "1", "DX": "19860101", "UI": "D011701"}, {"RECTYPE": "D", "MH": "Pyelitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C12.950.419.570.821", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the KIDNEY PELVIS and KIDNEY CALICES where urine is collected before discharge, but does not involve the renal parenchyma (the NEPHRONS) where urine is processed.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011702"}, {"RECTYPE": "D", "MH": "Pyelonephritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pyelonephritis, Acute Necrotizing|T047|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Pyelonephritides", "MN": "C12.950.419.570.821.717", "FX": "Kidney Failure, Chronic", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Inflammation of the KIDNEY involving the renal parenchyma (the NEPHRONS); KIDNEY PELVIS; and KIDNEY CALICES. It is characterized by ABDOMINAL PAIN; FEVER; NAUSEA; VOMITING; and occasionally DIARRHEA.", "PM": "1963; for PYELONEPHRITIS, ACUTE NECROTIZING see KIDNEY PAPILLARY NECROSIS 1967-2006, see PYELONEPHRITIS, ACUTE NECROTIZING 1963-1966", "HN": "1963; for PYELONEPHRITIS, ACUTE NECROTIZING use KIDNEY PAPILLARY NECROSIS 1967-2006, use PYELONEPHRITIS, ACUTE NECROTIZING 1963-1966", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D011704"}, {"RECTYPE": "D", "MH": "Pyelonephritis, Xanthogranulomatous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Xanthogranulomatous Pyelonephritis|T047|NON|EQV|NLM (1993)|911010|abcdef", "ENTRY": "Xanthogranulomatous Pyelonephritides", "MN": "C12.950.419.570.821.717.810", "MH_TH": "NLM (1986)", "ST": "T047", "PI": "Xanthomatosis (1966-1985)", "MS": "A chronic inflammatory condition of the KIDNEY resulting in diffuse renal destruction, a grossly enlarged and nonfunctioning kidney associated with NEPHROLITHIASIS and KIDNEY STONES.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19850225", "DC": "1", "DX": "19860101", "UI": "D011705"}, {"RECTYPE": "D", "MH": "Pyloric Antrum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Gastric Antrum|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Pyloric Antrums", "MN": "A03.556.875.875.716", "MH_TH": "NLM (1973)", "ST": "T023", "PI": "Stomach (1966-1972)", "MS": "The region between the sharp indentation at the lower third of the STOMACH (incisura angularis) and the junction of the PYLORUS with the DUODENUM. Pyloric antral glands contain mucus-secreting cells and gastrin-secreting endocrine cells (G CELLS).", "PM": "73", "HN": "73", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011706"}, {"RECTYPE": "D", "MH": "Pyloric Stenosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pylorus Obstruction|T047|NON|REL|NLM (2022)|200902|abcdef", "ENTRY": "Pylorus Obstructions", "MN": "C06.405.748.340.690", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Narrowing of the pyloric canal with varied etiology. A common form is due to muscle hypertrophy (PYLORIC STENOSIS, HYPERTROPHIC) seen in infants.", "CATSH": "CAT LIST", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011707"}, {"RECTYPE": "D", "MH": "Pylorus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sphincters, Pyloric", "MN": "A03.556.875.875.799", "FX": "Gastric Emptying", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The region of the STOMACH at the junction with the DUODENUM. It is marked by the thickening of circular muscle layers forming the pyloric sphincter to control the opening and closure of the lumen.", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011708"}, {"RECTYPE": "D", "MH": "Pyocins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pyocin 1 4", "MN": "D12.776.097.151.785", "MH_TH": "NLM (1975)", "ST": "T195", "RN": "0", "PI": "Pyocin (1968-1978)", "MS": "Bacteriocins elaborated by mutant strains of Pseudomonas aeruginosa. They are protein or protein-lipopolysaccharide complexes lethal to other strains of the same or related species.", "OL": "use PYOCINS to search PYOCIN 1975-79; use BACTERIOCINS 1968-74 & ANTIBIOTICS 1966-67", "PM": "91; was see under BACTERIOCINS 1979-90; was PYOCIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67", "HN": "91(79); was see under BACTERIOCINS 1979-90; was PYOCIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011709"}, {"RECTYPE": "D", "MH": "Pyocyanine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pyocyanin|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "MN": "D23.767.860", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "1(5H)-Phenazinone, 5-methyl-", "RN": "9OQM399341", "RR": "85-66-5 (Pyocyanine)", "PI": "Phenazines (1969-1974)", "MS": "Antibiotic pigment produced by Pseudomonas aeruginosa.", "PM": "91; was see under PHENAZINES 1975-90", "HN": "91(75); was see under PHENAZINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011710"}, {"RECTYPE": "D", "MH": "Pyoderma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pyodermas", "MN": "C17.800.695", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "\"any purulent skin dis\" but do not make diagnoses: use term of text", "MS": "Any purulent skin disease (Dorland, 27th ed).", "CATSH": "CAT LIST", "MR": "19920522", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011711"}, {"RECTYPE": "D", "MH": "Pyramidal Tracts", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Decussation, Pyramidal|T023|NON|REL|UNK (19XX)|750101|abcdef", "ENTRY": "Tracts, Pyramidal", "MN": "A08.612.380.730", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Fibers that arise from cells within the cerebral cortex, pass through the medullary pyramid, and descend in the spinal cord. Many authorities say the pyramidal tracts include both the corticospinal and corticobulbar tracts.", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011712"}, {"RECTYPE": "D", "MH": "Pyran Copolymer", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Vinyl Ether Maleic Anhydride Polymer|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "NSC46015", "MN": "J01.637.051.720.830", "PA": "Interferon Inducers", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "2,5-Furandione, polymer with 1,1'-oxybis(ethene)", "RN": "27100-68-1", "AN": "D25-26 qualif", "PI": "Pyrans (1974)", "MS": "Copolymer of divinyl ether and maleic anhydride that acts as an immunostimulant with antineoplastic and anti-infective properties. It is used in combination with other antineoplastic agents.", "PM": "91; was see under POLYMERS 1975-90", "HN": "91(75); was see under POLYMERS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011713"}, {"RECTYPE": "D", "MH": "Pyrans", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyran|T109|NON|EQV|NLM (2021)|200117|abcdef", "MN": "D03.383.663", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with PYRENES or PYRONES", "PM": "AUROVERTINS was AUROVERTIN see under ANTIBIOTICS 1975-79", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011714"}, {"RECTYPE": "D", "MH": "Pyrantel", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.903.634", "PA": "Neuromuscular Depolarizing Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)-, (E)-", "RN": "4QIH0N49E7", "RR": "15686-83-6 (Pyrantel)", "AN": "an antinematodal agent", "MS": "A depolarizing neuromuscular-blocking agent, that causes persistent nicotinic activation resulting in spastic paralysis of susceptible nematodes. It is a drug of second-choice after benzimidazoles for treatment of ascariasis, hookworm, and pinworm infections, being effective after a single dose. (From Smith and Reynard, Textbook of Pharmacology, 1992, p920)", "PM": "74", "HN": "74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011715"}, {"RECTYPE": "D", "MH": "Pyrantel Pamoate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrantel Embonate|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Pamoate, Pyrantel", "MN": "D03.383.903.634.600", "PA": "Antinematodal Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2-Naphthalenecarboxylic acid, 4,4'-methylenebis(3-hydroxy), compd. with (E)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)pyrimidine (1:1)", "RN": "81BK194Z5M", "RR": "22204-24-6 (Pyrantel Pamoate)", "PI": "Pyrantel (1974)", "MS": "Broad spectrum antinematodal anthelmintic used also in veterinary medicine.", "PM": "91; was see under PYRANTEL 1975-90", "HN": "91(75); was see under PYRANTEL 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011716"}, {"RECTYPE": "D", "MH": "Pyrantel Tartrate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tartrate, Pyrantel", "MN": "D03.383.903.634.670", "PA": "Antinematodal Agents", "MH_TH": "USAN (1966)", "ST": "T121", "N1": "Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)-, (E)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)", "RN": "SC82VF0480", "RR": "33401-94-4 (Pyrantel Tartrate)", "PI": "Tartrates (1974)", "MS": "Broad spectrum anthelmintic for livestock.", "PM": "91; was see under PYRANTEL 1975-90", "HN": "91(75); was see under PYRANTEL 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011717"}, {"RECTYPE": "D", "MH": "Pyrazinamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tisamid|T109|T121|TRD|NRW|NLM (1998)|961114|abbcdef", "MN": "D03.383.679.750", "PA": "Antitubercular Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pyrazinecarboxamide", "RN": "2KNI5N06TI", "RR": "98-96-4 (Pyrazinamide)", "MS": "A pyrazine that is used therapeutically as an antitubercular agent.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011718"}, {"RECTYPE": "D", "MH": "Pyrazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrazine|T109|NON|EQV|NLM (2021)|191219|abcdef", "MN": "D03.383.679", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with PYRIDAZINES", "MS": "A heterocyclic aromatic organic compound with the chemical formula C4H4N2.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011719"}, {"RECTYPE": "D", "MH": "Pyrazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.539", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "includes pyrazolines & pyrazolidines", "MS": "Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011720"}, {"RECTYPE": "D", "MH": "Pyrenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.799", "MH_TH": "NLM (1974)", "ST": "T131", "RN": "0", "AN": "do not confuse with PYRANS or PYRONES", "MS": "A group of condensed ring hydrocarbons.", "PM": "74", "HN": "74", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011721"}, {"RECTYPE": "D", "MH": "Pyrethrins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrethroid|T109|NON|REL|NLM (2021)|191114|abcdef", "ENTRY": "Pyrethroids|T109|NON|REL|NLM (2005)|040304|abcdef", "MN": "D02.455.849.575.188.750", "PA": "Insecticides", "MH_TH": "NLM (1977)", "ST": "T131", "RN": "0", "AN": "for use as an insecticide, see note at INSECTICIDES", "PI": "Pyrethrum (1966-1976)", "MS": "The active insecticidal constituent of CHRYSANTHEMUM CINERARIIFOLIUM flowers. Pyrethrin I is the pyretholone ester of chrysanthemummonocarboxylic acid and pyrethrin II is the pyretholone ester of chrysanthemumdicarboxylic acid monomethyl ester.", "PM": "77", "HN": "77", "MR": "20200527", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D011722"}, {"RECTYPE": "D", "MH": "Chrysanthemum cinerariifolium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pyrethum Daisy|T002|NON|REL|NLM (2003)|010828|abcdef", "ENTRY": "coccineums, Tanacetum", "MN": "B01.875.800.575.912.250.100.206.222", "FX": "Pyrethrins", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid118510", "RR": "txid301880", "AN": "for insecticides from this plant use PYRETHRINS", "MS": "A plant species of the genus CHRYSANTHEMUM, family ASTERACEAE. The flowers contain PYRETHRINS, cinerolones, and chrysanthemines which are powerful contact insecticides. Most in the old Pyrethrum genus are reclassified to TANACETUM; some to other ASTERACEAE genera.", "PM": "2003; see PYRETHRUM 1992-2002, see PLANTS 1986-1990, see PYRETHRUM 1963-1985", "HN": "2003(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011723"}, {"RECTYPE": "D", "MH": "Pyridazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.710", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with PYRAZINES", "MS": "Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.", "PM": "PHTHALAZINES was see under HETEROCYCLIC COMPOUNDS 1966-74", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011724"}, {"RECTYPE": "D", "MH": "Pyridines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.725", "FX": "Piperidines", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "pyridine nucleotides will probably be NAD or NADP", "MS": "Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011725"}, {"RECTYPE": "D", "MH": "Pyridinium Compounds", "DE": "PYRIDINIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Pyridinium", "MN": "D03.383.725.762", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PI": "Pyridines (1966-1967)", "MS": "Derivatives of PYRIDINE containing a cation C5H5NH or radical C5H6N.", "PM": "68", "HN": "68", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011726"}, {"RECTYPE": "D", "MH": "Pyridinolcarbamate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyricarbate|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|941114|abbcdeef", "ENTRY": "P23", "MN": "D02.241.081.251.583.799", "PA": "Hypolipidemic Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "2,6-Pyridinedimethanol, bis(methylcarbamate) (ester)", "RN": "81R511UV73", "RR": "1882-26-4 (Pyridinolcarbamate)", "MS": "A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)", "PM": "91; was see under CARBAMATES 1973-90", "HN": "91(73); was see under CARBAMATES 1973-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011727"}, {"RECTYPE": "D", "MH": "Pyridones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyridinones|T109|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "D03.383.725.791", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Pyridine derivatives with one or more keto groups on the ring.", "OL": "use PYRIDONES to search PYRIDINONES 1966-67", "PM": "68; was PYRIDINONES 1966-67", "HN": "68; was PYRIDINONES 1966-67", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011728"}, {"RECTYPE": "D", "MH": "Pyridostigmine Bromide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Bromide, Pyridostigmine", "MN": "D03.383.725.762.740", "PA": "Cholinesterase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pyridinium, 3-(((dimethylamino)carbonyl)oxy)-1-methyl-, bromide", "RN": "KVI301NA53", "RR": "19QM69HH21", "AN": "a cholinesterase inhib", "MS": "A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.", "PM": "65; PYRIDOSTIGMINE was see under PARASYMPATHOMIMETICS 1963-64", "HN": "65; PYRIDOSTIGMINE was see under PARASYMPATHOMIMETICS 1963-64", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011729"}, {"RECTYPE": "D", "MH": "Pyridoxal", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.383.725.676.925.500", "PA": "Vitamin B Complex", "MH_TH": "NLM (1972)", "ST": "T127", "N1": "4-Pyridinecarboxaldehyde, 3-hydroxy-5-(hydroxymethyl)-2-methyl-", "RN": "3THM379K8A", "RR": "66-72-8 (Pyridoxal)", "AN": "deficiency: coordinate PYRIDOXAL /defic (IM) with VITAMIN B 6 DEFICIENCY (IM)", "PI": "Pyridoxine (1966-1971)", "MS": "The 4-carboxyaldehyde form of VITAMIN B 6 which is converted to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid.", "PM": "74", "HN": "74(72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011730"}, {"RECTYPE": "D", "MH": "Pyridoxal Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pyridoxine Kinase|T116|T126|NON|EQV|UNK (19XX)|771215|abbcdef", "ENTRY": "Phosphokinase, Pyridoxal", "MN": "D08.811.913.696.620.685", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "ATP:pyridoxal 5-phosphotransferase", "RN": "EC 2.7.1.35", "RR": "9026-42-0 (CAS RN)", "PI": "Pyridoxal (1972-1978)", "MS": "An enzyme that catalyzes reversibly the phosphorylation of pyridoxal in the presence of ATP with the formation of pyridoxal 5-phosphate and ADP. Pyridoxine, pyridoxamine and various derivatives can also act as acceptors. EC 2.7.1.35.", "PM": "91; was see under PHOSPHOTRANSFERASES, ATP 1979-90", "HN": "91(79); was see under PHOSPHOTRANSFERASES, ATP 1979-90", "MR": "20030709", "DA": "19771215", "DC": "1", "DX": "19910101", "UI": "D011731"}, {"RECTYPE": "D", "MH": "Pyridoxal Phosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Pyridoxal P", "MN": "D08.211.740", "PA": "Vitamin B Complex", "MH_TH": "NLM (1966)", "ST": "T127", "N1": "4-Pyridinecarboxaldehyde, 3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-", "RN": "5V5IOJ8338", "RR": "54-47-7 (Pyridoxal Phosphate)", "AN": "deficiency: coordinate PYRIDOXAL PHOSPHATE /defic (IM) with VITAMIN B 6 DEFICIENCY (IM)", "MS": "This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011732"}, {"RECTYPE": "D", "MH": "Pyridoxamine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.383.725.676.925.750", "PA": "Vitamin B Complex", "MH_TH": "NLM (1972)", "ST": "T127", "N1": "3-Pyridinemethanol, 4-(aminomethyl)-5-hydroxy-6-methyl-", "RN": "6466NM3W93", "RR": "85-87-0 (Pyridoxamine)", "AN": "deficiency: coordinate PYRIDOXAMINE /defic (IM) with VITAMIN B 6 DEFICIENCY (IM)", "PI": "Pyridoxine (1966-1971)", "MS": "The 4-aminomethyl form of VITAMIN B 6. During transamination of amino acids, PYRIDOXAL PHOSPHATE is transiently converted into pyridoxamine phosphate.", "PM": "74", "HN": "74(72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011733"}, {"RECTYPE": "D", "MH": "Pyridoxaminephosphate Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pyridoxinephosphate Oxidase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Pyridoxine 5 Phosphate Oxidase", "MN": "D08.811.682.662.680", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Pyridoxamine 5'-phosphate:oxygen oxidoreductase (deaminating)", "RN": "EC 1.4.3.5", "PI": "Pyridoxamine (1973-1974)", "MS": "An enzyme catalyzing the deamination of pyridoxaminephosphate to pyridoxal phosphate. It is a flavoprotein that also oxidizes pyridoxine-5-phosphate and pyridoxine. EC 1.4.3.5.", "PM": "91; was see under AMINE OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under AMINE OXIDOREDUCTASES 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011734"}, {"RECTYPE": "D", "MH": "Pyridoxic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyridoxinecarboxylic Acid|T109|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "4 Pyridoxylic Acid", "MN": "D03.383.725.705.645", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "4-Pyridinecarboxylic acid, 3-hydroxy-5-(hydroxymethyl)-2-methyl-", "RN": "5K18793O8D", "RR": "82-82-6 (Pyridoxic Acid)", "PI": "Isonicotinic Acids (1969-1974)", "MS": "The catabolic product of most of VITAMIN B 6; (PYRIDOXINE; PYRIDOXAL; and PYRIDOXAMINE) which is excreted in the urine.", "PM": "91; was see under ISONICOTINIC ACIDS 1975-90", "HN": "91(75); was see under ISONICOTINIC ACIDS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011735"}, {"RECTYPE": "D", "MH": "Pyridoxine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Rodex|T109|T127|TRD|NRW|UNK (19XX)|861117|abbcdef", "MN": "D03.383.725.676.925.875", "PA": "Vitamin B Complex", "MH_TH": "USAN (1999)", "ST": "T127", "N1": "3,4-Pyridinedimethanol, 5-hydroxy-6-methyl-", "RN": "KV2JZ1BI6Z", "RR": "68Y4CF58BV", "AN": "deficiency: coordinate PYRIDOXINE /defic (IM) with VITAMIN B 6 DEFICIENCY (IM)", "MS": "The 4-methanol form of VITAMIN B 6 which is converted to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. Although pyridoxine and Vitamin B 6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990).", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011736"}, {"RECTYPE": "D", "MH": "Pyrilamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyranisamine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Maleate, Pyrilamine", "MN": "D03.383.725.050.805", "PA": "Histamine H1 Antagonists", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "1,2-Ethanediamine, N-((4-methoxyphenyl)methyl)-N',N'-dimethyl-N-2-pyridinyl-", "RN": "HPE317O9TL", "RR": "R35D29L3ZA", "PI": "Pyridines (1970-1974)", "MS": "A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally. It is a common ingredient of cold remedies.", "PM": "91; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78", "HN": "91(75); was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011738"}, {"RECTYPE": "D", "MH": "Pyrimethamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tindurine|T109|T121|TRD|NRW|UNK (19XX)|810728|abbcdef", "MN": "D03.383.742.675", "PA": "Folic Acid Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4-Pyrimidinediamine, 5-(4-chlorophenyl)-6-ethyl-", "RN": "Z3614QOX8W", "RR": "58-14-0 (Pyrimethamine)", "MS": "One of the FOLIC ACID ANTAGONISTS that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011739"}, {"RECTYPE": "D", "MH": "Pyrimidine Dimers", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thymine Dimers|T114|NON|REL|UNK (19XX)|760414|abcdef", "ENTRY": "Thymine-Thymine Cyclobutane Dimers", "MN": "G05.200.615", "FX": "DNA Damage", "MH_TH": "NLM (1977)", "ST": "T114", "RN": "0", "PI": "Thymine Nucleotides (1972-1976)", "MS": "Dimers found in DNA chains damaged by ULTRAVIOLET RAYS. They consist of two adjacent PYRIMIDINE NUCLEOTIDES, usually THYMINE nucleotides, in which the pyrimidine residues are covalently joined by a cyclobutane ring. These dimers block DNA REPLICATION.", "PM": "77", "HN": "77", "MR": "20230526", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D011740"}, {"RECTYPE": "D", "MH": "Pyrimidine Nucleosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Nucleosides, Pyrimidine", "MN": "D13.570.685", "MH_TH": "NLM (1974)", "ST": "T114", "RN": "0", "MS": "Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES.", "PM": "74", "HN": "74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011741"}, {"RECTYPE": "D", "MH": "Pyrimidine Nucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Nucleotides, Pyrimidine", "MN": "D13.695.740", "MH_TH": "NLM (1972)", "ST": "T114", "RN": "0", "PI": "Nucleotides (1966-1971)", "MS": "Pyrimidines with a RIBOSE and phosphate attached that can polymerize to form DNA and RNA.", "PM": "74", "HN": "74(72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011742"}, {"RECTYPE": "D", "MH": "Pyrimidines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.742", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.", "OL": "use PYRIMIDINES to search THONZYLAMINE 1972-84 (as Prov 1972)", "PM": "THONZYLAMINE was heading 1973-84", "HN": "THONZYLAMINE was heading 1972-84 (Prov 1972)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011743"}, {"RECTYPE": "D", "MH": "Pyrimidinones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrimidones|T109|NON|REL|UNK (19XX)|810512|abcdef", "MN": "D03.383.742.698", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O.", "PM": "68", "HN": "68(66)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011744"}, {"RECTYPE": "D", "MH": "Pyrithiamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neopyrithiamine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|760412|abbcdeef", "ENTRY": "B 1, Heterovitamin", "MN": "D03.383.742.715", "PA": "Antimetabolites", "MH_TH": "NLM (1977)", "ST": "T121", "N1": "Pyridinium, 1-((4-amino-2-methyl-5-pyrimidinyl)methyl)-3-(2-hydroxyethyl)-2-methyl-, bromide, monohydrobromide", "RN": "5JB3029BJ7", "RR": "534-64-5 (Pyrithiamine)", "AN": "a thiamine antag", "PI": "Pyrimidines (1974-1976)", "MS": "A thiamine antagonist due to its inhibition of thiamine pyrophosphorylation. It is used to produce thiamine deficiency.", "PM": "91; was see under PYRIDINIUM COMPOUNDS 1977-90", "HN": "91(77); was see under PYRIDINIUM COMPOUNDS 1977-90", "MR": "20160531", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D011745"}, {"RECTYPE": "D", "MH": "Pyrithioxin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyritinol|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Hydrochloride, Pyritinol", "MN": "D03.383.725.812", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "4-Pyridinemethanol, 3,3'-(dithiobis(methylene))bis(5-hydroxy-6-methyl- )", "RN": "AK5Q5FZH2R", "RR": "1098-97-1 (Pyrithioxin)", "PI": "Pyridines (1974)", "MS": "A neurotropic agent which reduces permeability of blood-brain barrier to phosphate. It has no vitamin B6 activity.", "PM": "91; was see under PYRIDINES 1975-90", "HN": "91(75); was see under PYRIDINES 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011746"}, {"RECTYPE": "D", "MH": "Pyrogallol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "acid, Pyrogallic", "MN": "D02.455.426.559.389.657.800", "PA": "Antioxidants", "MH_TH": "NLM (1966)", "ST": "T109", "N1": "1,2,3-Benzenetriol", "RN": "01Y4A2QXY0", "RR": "87-66-1 (Pyrogallol)", "MS": "A trihydroxybenzene or dihydroxy phenol that can be prepared by heating GALLIC ACID.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011748"}, {"RECTYPE": "D", "MH": "Pyrogens", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrogen|T123|T131|NON|EQV|NLM (2022)|201005|abbcdef", "MN": "D27.888.569.673", "FX": "Endotoxins", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "MS": "Substances capable of increasing BODY TEMPERATURE and cause FEVER and may be used for FEVER THERAPY. They may be of microbial origin, often POLYSACCHARIDES, and may contaminate distilled water.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011749"}, {"RECTYPE": "D", "MH": "Pyroglobulins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.377.715.548.900.700", "PA": "Immunologic Factors", "MH_TH": "NLM (1976)", "ST": "T129", "RN": "0", "PI": "Precipitation (1972-1975)", "MS": "Atypical gamma immunoglobulins characterized by their irreversible heat denaturation at 56-degrees C. Pyroprecipitation is inhibited at pH below 3 and above 9. The presence of pyroglobulins in the serum is the cause of pyroglobulinemia. They are frequently present in multiple myeloma and the pyroglobulin precipitate binds complement, reacts with rheumatoid factor, produces passive cutaneous anaphylaxis, generalized passive anaphylaxis and passive Arthus-type phenomena.", "PM": "91; was see under PARAPROTEINS 1976-90", "HN": "91(76); was see under PARAPROTEINS 1976-90", "MR": "20050630", "DA": "19750801", "DC": "1", "DX": "19910101", "UI": "D011750"}, {"RECTYPE": "D", "MH": "Pyroglutamyl-Peptidase I", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pyrrolidonyl Peptidase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Pyroglutamyl Peptide Hydrolase", "MN": "D08.811.277.656.350.100.755", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.4.19.3", "PI": "Pyrrolidonecarboxylic Acid (1972-1974)", "MS": "An enzyme that catalyzes the release of a N-terminal pyroglutamyl group from a polypeptide provided the next residue is not proline. It is inhibited by thiol-blocking reagents and occurs in mammalian tissues, microorganisms, and plants. (From Enzyme Nomenclature, 1992) EC 3.4.19.3.", "OL": "use PYROGLUTAMYL-PEPTIDASE I to search 5-OXOPROLYL-PEPTIDASE 1991-94 & PYROGLUTAMATE AMINOPEPTIDASE 1975-90", "PM": "95: was 5-OXOPROLYL-PEPTIDASE 1991-94; was PYROGLUTAMATE AMINOPEPTIDASE see under AMINOPEPTIDASES 1975-90", "HN": "95: was 5-OXOPROLYL-PEPTIDASE 1991-94; was PYROGLUTAMATE AMINOPEPTIDASE see under AMINOPEPTIDASES 1975-90", "MR": "20160628", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011751"}, {"RECTYPE": "D", "MH": "Pyroglutamate Hydrolase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Oxoprolinase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Hydrolase, Pyroglutamate", "MN": "D08.811.277.087.760", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.5.2.-", "PI": "Pyrrolidonecarboxylic Acid (1974)", "MS": "Hydrolyzes pyroglutamic acid in the presence of ATP to glutamate plus ADP and inorganic phosphate. Deficiency leads to pyroglutamic acidurea.", "PM": "91; was see under AMIDOHYDROLASES 1975-90", "HN": "91(75); was see under AMIDOHYDROLASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011752"}, {"RECTYPE": "D", "MH": "Pyrones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.663.718", "FX": "Coumarins", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "1,2-BENZOPYRONES is available; pyran-2-ones: index PYRONES + LACTONES", "MS": "Keto-pyrans.", "OL": "search PYRANS 1966-74", "PM": "91; was see under PYRANS 1975-90", "HN": "91(75); was see under PYRANS 1975-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011753"}, {"RECTYPE": "D", "MH": "Pyronine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Pyronine G|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|821129|abbcdeef", "MN": "D03.633.300.953.570", "PA": "Coloring Agents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Xanthylium, 3,6-bis(dimethylamino)-, chloride", "RN": "W659G165T1", "RR": "92-32-0 (Pyronine)", "AN": "D25-26 qualif", "PI": "Xanthenes (1971-1974)", "MS": "Xanthene dye used as a bacterial and biological stain. Synonyms: Pyronin; Pyronine G; Pyronine Y. Use also for Pyronine B. which is diethyl-rather than dimethylamino-.", "PM": "91; was see under XANTHENES 1975-90", "HN": "91(75); was see under XANTHENES 1975-90", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011754"}, {"RECTYPE": "D", "MH": "Pyrophosphatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pyrophosphatase|T116|T126|NON|EQV|NLM (2021)|191118|abbcdef", "MN": "D08.811.277.040.600", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.6.1.-", "MS": "A group of enzymes within the class EC 3.6.1.- that catalyze the hydrolysis of diphosphate bonds, chiefly in nucleoside di- and triphosphates. They may liberate either a mono- or diphosphate. EC 3.6.1.-.", "OL": "use PYROPHOSPHATASES to search PYROPHOSPHATASE 1966-72", "PM": "73; was PYROPHOSPHATASE 1963-72", "HN": "73; was PYROPHOSPHATASE 1963-72", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011755"}, {"RECTYPE": "D", "MH": "Diphosphates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrophosphates|T197|NON|EQV|NLM (1994)|921028|abcdef", "ENTRY": "Analog, Pyrophosphate", "MN": "D01.695.625.675.650.775.150", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "MS": "Inorganic salts of phosphoric acid that contain two phosphate groups.", "OL": "use DIPHOSPHATES to search PYROPHOSPHATES 1966-93", "PM": "94; was PYROPHOSPHATES 1963-93", "HN": "94; was PYROPHOSPHATES 1963-93", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D011756"}, {"RECTYPE": "D", "MH": "Pyrroles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrrole|T109|NON|EQV|NLM (2021)|191219|abcdef", "MN": "D03.383.129.578", "MH_TH": "NLM (1966)", "ST": "T109", "N1": "1-aza-2,4-cyclopentadiene", "RN": "0", "MS": "Azoles of one NITROGEN and two double bonds that have aromatic chemical properties.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011758"}, {"RECTYPE": "D", "MH": "Pyrrolidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetrahydropyridine|T109|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Tetrahydropyridines|T109|NON|EQV|NLM (2018)|170227|abcdef", "MN": "D03.383.773", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with PYRROLIDONES or PYRROLIDINONES", "MS": "Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH.", "PM": "66", "HN": "66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011759"}, {"RECTYPE": "D", "MH": "Pyrrolidinones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrrolidones|T109|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "D03.383.773.812", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed)", "OL": "use PYRROLIDINONES to search PYRROLIDONES 1966-67", "PM": "68; was PYRROLIDONES 1963-67", "HN": "68; was PYRROLIDONES 1963-67", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011760"}, {"RECTYPE": "D", "MH": "Pyrrolidonecarboxylic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyroglutamic Acid|T116|T123|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|741209|abbbcdeef", "ENTRY": "Pidolate, Magnesium", "MN": "D12.125.072.401.761", "MH_TH": "NLM (1972)", "ST": "T130", "N1": "L-Proline, 5-oxo-", "RN": "SZB83O1W42", "RR": "V5PC588N7G", "PI": "Pyrrolidinones (1966-1971)", "MS": "A cyclized derivative of L-GLUTAMIC ACID. Elevated blood levels may be associated with problems of GLUTAMINE or GLUTATHIONE metabolism.", "PM": "91; see PYRROLIDINONES 1972-90; MAGNESIUM PIDOLATE was indexed under PYRROLIDONECARBOXYLIC ACID/analogs & derivatives 1995-97", "HN": "91(72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011761"}, {"RECTYPE": "D", "MH": "Pyrroline Carboxylate Reductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductases, Pyrroline Carboxylate", "MN": "D08.811.682.662.695", "MH_TH": "NLM (1977)", "ST": "T126", "RN": "EC 1.5.1.-", "PI": "Oxidoreductases (1966-1974)", "MS": "A group of enzymes that catalyze the reduction of 1-pyrroline carboxylate to proline in the presence of NAD(P)H. Includes both the 2-oxidoreductase (EC 1.5.1.1) and the 5-oxidoreductase (EC 1.5.1.2). The former also reduces 1-piperidine-2-carboxylate to pipecolate and the latter also reduces 1-pyrroline-3-hydroxy-5-carboxylate to hydroxyproline.", "PM": "91; was see under AMINE OXIDOREDUCTASES 1977-90", "HN": "91(77); was see under AMINE OXIDOREDUCTASES 1977-90", "MR": "20050630", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D011762"}, {"RECTYPE": "D", "MH": "Pyrrolizidine Alkaloids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Senecio Alkaloids|T109|T123|T131|NON|REL|UNK (19XX)|760305|abbbcdef", "ENTRY": "Alkaloids, Senecio", "MN": "D03.633.100.772", "MH_TH": "NLM (1971)", "ST": "T131", "RN": "0", "PI": "Heterocyclic Compounds (1966-1970)", "MS": "A group of ALKALOIDS, characterized by a nitrogen-containing necine, occurring mainly in plants of the BORAGINACEAE; COMPOSITAE; and LEGUMINOSAE plant families. They can be activated in the liver by hydrolysis of the ester and desaturation of the necine base to reactive electrophilic pyrrolic CYTOTOXINS.", "PM": "73", "HN": "73(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011763"}, {"RECTYPE": "D", "MH": "Pyrrolnitrin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.578.770", "PA": "Antifungal Agents", "MH_TH": "USAN (1968)", "ST": "T121", "N1": "1H-Pyrrole, 3-chloro-4-(3-chloro-2-nitrophenyl)-", "RN": "N0P24B6EDQ", "RR": "1018-71-9 (Pyrrolnitrin)", "AN": "an antifungal antibiotic", "PI": "Pyrroles (1969-1974)", "MS": "3-Chloro-4-(3-chloro-2-nitrophenyl)pyrrole. Antifungal antibiotic isolated from Pseudomonas pyrrocinia. It is effective mainly against Trichophyton, Microsporium, Epidermophyton, and Penicillium.", "PM": "91; was see under ANTIBIOTICS, ANTIFUNGAL 1975-90", "HN": "91(75); was see under ANTIBIOTICS, ANTIFUNGAL 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011764"}, {"RECTYPE": "D", "MH": "Pyruvaldehyde", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxopropanal|T109|NON|BRD|UNK (19XX)|741111|abcdef", "ENTRY": "Aldehyde, Pyruvic", "MN": "D02.047.644.650", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Propanal, 2-oxo-", "RN": "722KLD7415", "RR": "78-98-8 (Pyruvaldehyde)", "PI": "Glyoxal (1973-1974)", "MS": "An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.", "PM": "91; was see under ALDEHYDES 1975-90", "HN": "91(75); was see under ALDEHYDES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011765"}, {"RECTYPE": "D", "MH": "Pyruvate Carboxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Carboxylase, Pyruvate", "MN": "D08.811.464.257.500", "FX": "Pyruvate Carboxylase Deficiency Disease", "EC": "deficiency:Pyruvate Carboxylase Deficiency Disease", "MH_TH": "NLM (1974)", "ST": "T126", "N1": "Pyruvate:carbon-dioxide ligase (ADP-forming)", "RN": "EC 6.4.1.1", "RR": "9014-19-1 (CAS RN)", "MS": "A biotin-dependent enzyme belonging to the ligase family that catalyzes the addition of CARBON DIOXIDE to pyruvate. It is occurs in both plants and animals. Deficiency of this enzyme causes severe psychomotor retardation and ACIDOSIS, LACTIC in infants. EC 6.4.1.1.", "PM": "74", "HN": "74", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011766"}, {"RECTYPE": "D", "MH": "Pyruvate Decarboxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-Ketoacid Carboxylase|T116|T126|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "alpha Ketoacid Carboxylase", "MN": "D08.811.520.224.125.750", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 4.1.1.1", "RR": "9001-04-1 (CAS RN)", "PI": "Pyruvates (1973-1974)", "MS": "Catalyzes the decarboxylation of an alpha keto acid to an aldehyde and carbon dioxide. Thiamine pyrophosphate is an essential cofactor. In lower organisms, which ferment glucose to ethanol and carbon dioxide, the enzyme irreversibly decarboxylates pyruvate to acetaldehyde. EC 4.1.1.1.", "PM": "91; was see under CARBOXY-LYASES 1975-90", "HN": "91(75); was see under CARBOXY-LYASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011767"}, {"RECTYPE": "D", "MH": "Pyruvate Dehydrogenase Complex", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase Complex, Pyruvate", "MN": "D08.811.600.741", "EC": "deficiency:Pyruvate Dehydrogenase Complex Deficiency Disease", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "0", "PI": "Pyruvates (1966-1972)", "MS": "A multienzyme complex responsible for the formation of ACETYL COENZYME A from pyruvate. The enzyme components are PYRUVATE DEHYDROGENASE (LIPOAMIDE); dihydrolipoamide acetyltransferase; and LIPOAMIDE DEHYDROGENASE. Pyruvate dehydrogenase complex is subject to three types of control: inhibited by acetyl-CoA and NADH; influenced by the energy state of the cell; and inhibited when a specific serine residue in the pyruvate decarboxylase is phosphorylated by ATP. PYRUVATE DEHYDROGENASE (LIPOAMIDE)-PHOSPHATASE catalyzes reactivation of the complex. (From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed)", "PM": "74", "HN": "74(73)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011768"}, {"RECTYPE": "D", "MH": "Pyruvate Dehydrogenase (Lipoamide)-Phosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pyruvate Dehydrogenase Phosphatase|T116|T126|NON|EQV|NLM (1994)|921008|abbcdef", "ENTRY": "Phosphatase, Pyruvate Dehydrogenase", "MN": "D12.776.476.559.725", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.1.3.43", "PI": "Pyruvates (1973-1974)", "MS": "(Pyruvate dehydrogenase (lipoamide))-phosphate phosphohydrolase. A mitochondrial enzyme that catalyzes the hydrolytic removal of a phosphate on a specific seryl hydroxyl group of pyruvate dehydrogenase, reactivating the enzyme complex. EC 3.1.3.43.", "OL": "use PYRUVATE DEHYDROGENASE (LIPOAMIDE)-PHOSPHATASE to search PYRUVATE DEHYDROGENASE PHOSPHATASE 1975-93", "PM": "94; was PYRUVATE DEHYDROGENASE PHOSPHATASE 1975-93 (see under PHOSPHOPROTEIN PHOSPHATASES 1979-90, see under PHOSPHOMONOESTERASES 1975-78)", "HN": "94; was PYRUVATE DEHYDROGENASE PHOSPHATASE 1975-93 (see under PHOSPHOPROTEIN PHOSPHATASES 1979-90, see under PHOSPHOMONOESTERASES 1975-78)", "MR": "20210521", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011769"}, {"RECTYPE": "D", "MH": "Pyruvate Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "R Type Pyruvate Kinase", "MN": "D08.811.913.696.620.695", "FX": "Anemia, Hemolytic", "MH_TH": "NLM (1965)", "ST": "T126", "RN": "EC 2.7.1.40", "RR": "9001-59-6 (CAS RN)", "AN": "do not coord L-, R-, M-, M1- or M2-type pyruvate kinase with ISOENZYMES", "MS": "ATP:pyruvate 2-O-phosphotransferase. A phosphotransferase that catalyzes reversibly the phosphorylation of pyruvate to phosphoenolpyruvate in the presence of ATP. It has four isozymes (L, R, M1, and M2). Deficiency of the enzyme results in hemolytic anemia. EC 2.7.1.40.", "PM": "65", "HN": "65", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011770"}, {"RECTYPE": "D", "MH": "Pyruvate Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Pyruvate", "MN": "D08.811.682.657.350.937", "MH_TH": "NLM (1965)", "ST": "T126", "RN": "EC 1.2.3.3", "PM": "65", "HN": "65", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011771"}, {"RECTYPE": "D", "MH": "Pyruvate, Orthophosphate Dikinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pyruvate, Phosphate Dikinase|T116|T126|NON|EQV|NLM (1994)|930520|abbcdef", "ENTRY": "Pi Dikinase Pyruvate", "MN": "D08.811.913.696.645.700", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "ATP:pyruvate, orthophosphate phosphotransferase", "RN": "EC 2.7.9.1", "RR": "9027-40-1 (CAS RN)", "PI": "Pyruvates (1974)", "MS": "An enzyme that catalyzes the reaction of ATP, pyruvate, and orthophosphate to form AMP plus phosphoenolpyruvate plus pyrophosphate. EC 2.7.9.1.", "OL": "use PYRUVATE, ORTHOPHOSPHATE DIKINASE to search PYRUVATE, PHOSPHATE DIKINASE & PHOSPHOENOLPYRUVATE SYNTHETASE 1975-93", "PM": "94; was PYRUVATE, PHOSPHATE DIKINASE 1975-93 (see under PHOSPHOTRANSFERASES, ATP 1975-90); PHOSPHOENOLPYRUVATE SYNTHETASE was see PYRUVATE, PHOSPHATE DIKINASE 1975-93", "HN": "94; was PYRUVATE, PHOSPHATE DIKINASE 1975-93 (see under PHOSPHOTRANSFERASES, ATP 1975-90); PHOSPHOENOLPYRUVATE SYNTHETASE was see PYRUVATE, PHOSPHATE DIKINASE 1975-93", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011772"}, {"RECTYPE": "D", "MH": "Pyruvates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.755.812", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with PYRUVATE see PYRUVIC ACID", "MS": "Derivatives of PYRUVIC ACID, including its salts and esters.", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011773"}, {"RECTYPE": "D", "MH": "Pyrvinium Compounds", "DE": "PYRVINIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Viprynium|T109|NON|NRW|UNK (19XX)|770429|abcdef", "ENTRY": "Compounds, Pyrvinium", "MN": "D03.633.100.810.824.700", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011774"}, {"RECTYPE": "D", "MH": "Pythium", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Pythiums", "MN": "B01.750.580.750", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid4797", "MS": "A genus of destructive root-parasitic OOMYCETES in the family Pythiaceae, order Peronosporales, commonly found in cultivated soils all over the world. Differentiation of zoospores takes place in a vesicle.", "PM": "91; see MASTIGOMYCOTINA 1986-90, see PHYCOMYCETES 1975-85", "HN": "91(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D011775"}, {"RECTYPE": "D", "MH": "Pyuria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Pyurias", "MN": "C12.950.892.719", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "The presence of white blood cells (LEUKOCYTES) in the urine. It is often associated with bacterial infections of the urinary tract. Pyuria without BACTERIURIA can be caused by TUBERCULOSIS, stones, or cancer.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011776"}, {"RECTYPE": "D", "MH": "Q beta Replicase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Replicase, Q", "MN": "D08.811.913.696.445.735.630", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 2.7.7.-", "RR": "9026-28-2 (CAS RN)", "PI": "Virus Replication (1973-1974)", "MS": "An enzyme that catalyzes the replication of the RNA of coliphage Q beta. EC 2.7.7.-.", "PM": "91; was see under RNA NUCLEOTIDYLTRANSFERASES 1975-90", "HN": "91(75); was see under RNA NUCLEOTIDYLTRANSFERASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011777"}, {"RECTYPE": "D", "MH": "Q Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Query Fever|T047|NON|EQV|NLM (1966)|ORD (2010)|090608|abcdeef", "ENTRY": "Query Fevers", "MN": "C01.150.252.400.755", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An acute infectious disease caused by COXIELLA BURNETII. It is characterized by a sudden onset of FEVER; HEADACHE; malaise; and weakness. In humans, it is commonly contracted by inhalation of infected dusts derived from infected domestic animals (ANIMALS, DOMESTIC).", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011778"}, {"RECTYPE": "D", "MH": "Q-Sort", "AQ": "HI SN ST", "ENTRY": "Q-Sorts", "MN": "F04.513.636", "MH_TH": "NLM (1975)", "ST": "T060", "MS": "A personality assessment technique in which the subject or observer indicates the degree to which a standardized set of descriptive statements actually describes the subject. The term reflects \"sorting\" procedures occasionally used with this technique.", "OL": "search PERSONALITY ASSESSMENT 1970-74", "PM": "91; was see under PERSONALITY ASSESSMENT 1975-90", "HN": "91(75); was see under PERSONALITY ASSESSMENT 1975-90", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011779"}, {"RECTYPE": "D", "MH": "Qatar", "AQ": "EH EP", "PRINT ENTRY": "Katar|T083|NAM|EQV|NLM (1996)|950131|abcdef", "ENTRY": "State of Qatar|T083|NON|EQV|NLM (2018)|161223|abcdef", "MN": "Z01.252.245.500.690", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in the Middle East, a peninsula bordering the Persian Gulf and Saudi Arabia. The capital is Doha.", "HN": "75", "MR": "20161223", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D011780"}, {"RECTYPE": "D", "MH": "Quackery", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Quackeries", "MN": "I01.880.735.728", "FX": "Nostrums", "MH_TH": "NLM (1966)", "ST": "T058", "MS": "The fraudulent misrepresentation of the diagnosis and treatment of disease.", "MR": "19930605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011781"}, {"RECTYPE": "D", "MH": "Quadriplegia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tetraplegia|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Tetraplegias, Spastic", "MN": "C23.888.592.636.786", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "Severe or complete loss of motor function in all four limbs which may result from BRAIN DISEASES; SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; or rarely MUSCULAR DISEASES. The locked-in syndrome is characterized by quadriplegia in combination with cranial muscle paralysis. Consciousness is spared and the only retained voluntary motor activity may be limited eye movements. This condition is usually caused by a lesion in the upper BRAIN STEM which injures the descending cortico-spinal and cortico-bulbar tracts.", "PM": "1967", "HN": "1967(1964)", "CATSH": "CAT LIST", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D011782"}, {"RECTYPE": "D", "MH": "Quadruplets", "AQ": "CL ED GE HI LJ PX SN", "ENTRY": "Quadruplet", "MN": "M01.438.486", "MH_TH": "NLM (1966)", "ST": "T099", "AN": "human only: for animals use LITTER SIZE; PREGNANCY, QUADRUPLET is also available", "MS": "Four individuals derived from four FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011783"}, {"RECTYPE": "D", "MH": "Quail", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Quails", "MN": "B01.050.150.900.248.350.650", "MH_TH": "NLM (1973)", "ST": "T012", "AN": "general or unspecified; prefer COLINUS or COTURNIX; note JAPANESE QUAIL see COTURNIX; diseases: coordinate with BIRD DISEASES ", "PI": "Poultry (1966-1972)", "MS": "Common name for two distinct groups of BIRDS in the order GALLIFORMES: the New World or American quails of the family Odontophoridae and the Old World quails in the genus COTURNIX, family Phasianidae.", "PM": "73", "HN": "73", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011784"}, {"RECTYPE": "D", "MH": "Quality Assurance, Health Care", "DE": "QUAL ASSUR", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Quality Assessment, Health Care|T080|NON|NRW|NLM (1992)|910506|QUAL ASSESS HEALTH CARE|abcdefv", "ENTRY": "Quality Assurances, Healthcare", "MN": "N05.700", "MH_TH": "NLM (1980)", "ST": "T080", "PI": "Quality of Health Care (1968-1979)", "MS": "Activities and programs intended to assure or improve the quality of care in either a defined medical setting or a program. The concept includes the assessment or evaluation of the quality of care; identification of problems or shortcomings in the delivery of care; designing activities to overcome these deficiencies; and follow-up monitoring to ensure effectiveness of corrective steps.", "OL": "use QUALITY OF HEALTH CARE to search QUALITY ASSURANCE PROGRAM 1978-79", "PM": "80; QUALITY ASSURANCE PROGRAM was see QUALITY OF HEALTH CARE 1978-79", "HN": "80; QUALITY ASSURANCE PROGRAM was see QUALITY OF HEALTH CARE 1978-79", "MR": "20010725", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D011785"}, {"RECTYPE": "D", "MH": "Quality Control", "ENTRY": "Quality Controls", "MN": "J01.897.608", "FX": "Total Quality Management", "MH_TH": "POPLINE (1990)", "ST": "T057", "MS": "A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed)", "PM": "74", "HN": "74(71)", "MR": "20160113", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011786"}, {"RECTYPE": "D", "MH": "Quality of Health Care", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Pharmacy Audits", "MN": "N05.715", "FX": "Professional Staff Committees", "MH_TH": "NLM (1999)", "ST": "T080", "AN": "IM", "MS": "The levels of excellence which characterize the health service or health care provided based on accepted standards of quality.", "PM": "1968", "HN": "1968", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011787"}, {"RECTYPE": "D", "MH": "Quality of Life", "AQ": "LJ PX", "ENTRY": "Health Related Quality Of Life", "MN": "N06.850.505.400.425.837", "FX": "Value of Life", "MH_TH": "NLM (1986)", "ST": "T080", "MS": "A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease.", "PM": "77", "HN": "77(75)", "MR": "20210706", "DA": "19741111", "DC": "1", "DX": "19770101", "UI": "D011788"}, {"RECTYPE": "D", "MH": "Quantum Theory", "AQ": "HI", "ENTRY": "Theory, Quantum", "MN": "H01.671.579.800", "MH_TH": "NLM (1964)", "ST": "T170", "MS": "The theory that the radiation and absorption of energy take place in definite quantities called quanta (E) which vary in size and are defined by the equation E=hv in which h is Planck's constant and v is the frequency of the radiation.", "PM": "67", "HN": "67(64)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D011789"}, {"RECTYPE": "D", "MH": "Quarantine", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD VE", "PRINT ENTRY": "Travel Restrictions, Health-Related|T068|NON|REL|NLM (2023)|211015|abcdef", "ENTRY": "Travel Restrictions, Health Related", "MN": "N06.850.780.200.725", "FX": "Patient Isolation", "MH_TH": "BIOETHICS (1988)", "ST": "T068", "AN": "human or animal", "MS": "Limited freedom of movement of individuals to reduce the risk of spread of communicable disease by those who have been exposed to infectious or communicable disease in order to prevent its spread; a period of detention of vessels, vehicles, or travelers coming from infected or suspected places; and detention or isolation on account of suspected contagion. It includes government regulations on travel restrictions, border security measures to mitigate spread of a contagion and the detention of animals at frontiers or ports of entrance for the prevention of infectious disease. (From Black's Veterinary Dictionary, 17th ed)", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011790"}, {"RECTYPE": "D", "MH": "Quartz", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D01.837.725.600", "MH_TH": "NLM (1975)", "ST": "T197", "N1": "Quartz (SiO2)", "RN": "14808-60-7", "AN": "a form of silicon dioxide", "MS": "Quartz (SiO2). A glassy or crystalline form of silicon dioxide. Many colored varieties are semiprecious stones. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "OL": "use SILICA to search QUARTZ 1966-74", "PM": "91,63-64; was see under SILICA 1965-90; was heading 1963-64", "HN": "91(75)63-64; was see under SILICA 1965-90; was heading 1963-64", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011791"}, {"RECTYPE": "D", "MH": "Quebec", "AQ": "EH EP", "MN": "Z01.107.567.176.791", "MH_TH": "POPLINE (1993)", "ST": "T083", "AN": "a province of eastern Canada", "MS": "A province of eastern Canada. Its capital is Quebec. The region belonged to France from 1627 to 1763 when it was lost to the British. The name is from the Algonquian quilibek meaning the place where waters narrow, referring to the gradually narrowing channel of the St. Lawrence or to the narrows of the river at Cape Diamond. (From Webster's New Geographical Dictionary, 1988, p993 & Room, Brewer's Dictionary of Names, 1992, p440)", "MR": "19950221", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D011792"}, {"RECTYPE": "D", "MH": "Queensland", "AQ": "EH EP", "MN": "Z01.678.100.373.937", "MH_TH": "NLM (1988)", "ST": "T083", "AN": "a state of Australia", "PI": "Australia (1966-1987)", "MS": "A state in northeastern Australia. Its capital is Brisbane. Its coast was first visited by Captain Cook in 1770 and its first settlement (penal) was located on Moreton Bay in 1824. The name Cooksland was first proposed but honor to Queen Victoria prevailed. (From Webster's New Geographical Dictionary, 1988, p996 & Room, Brewer's Dictionary of Names, 1992, p441)", "HN": "88", "MR": "20150623", "DA": "19870309", "DC": "4", "DX": "19880101", "UI": "D011793"}, {"RECTYPE": "D", "MH": "Quercetin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Dikvertin|T109|T123|NON|EQV|NLM (2014)|130207|abbcdef", "MN": "D03.633.100.150.266.450.284.777", "PA": "Antioxidants", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-", "RN": "9IKM0I5T1E", "RR": "117-39-5 (Quercetin)", "MS": "A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin.", "PM": "1991; 3,3',4',5,7-PENTAHYDROXYFLAVONE was indexed under FLAVINOIDS 1999-2013, see FLAVONES 1975-1990, see BIOFLAVONOIDS 1963-1974", "HN": "1991(1975);", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011794"}, {"RECTYPE": "D", "MH": "Surveys and Questionnaires", "AQ": "CL EC SN ST", "PRINT ENTRY": "Surveys|T170|NON|NRW|BIOETHICS (1974)|NLM (1994)|POPLINE (1978)|921007|abcdeeef", "ENTRY": "Techniques, Randomized Response", "MN": "N06.850.520.308.980", "MH_TH": "NLM (2016)", "ST": "T062", "MS": "Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions.", "PM": "2016; for QUESTIONNAIRES see QUESTIONNAIRE 1968-2015 and QUESTIONNAIRE 1967-1972, for BASELINE SURVEY see DATA COLLECTION 1996-2015, for COMMUNITY SURVEYS see DATA COLLECTION 1980-2015, for NONRESPONDANTS see DATA COLLECTION 1992-2015, for RESPONDANTS see DATA COLLECTION 1995-2015, for SURVEY METHODS see DATA COLLECTION 1980-2015", "HN": "2016(1973); was QUESTIONNAIRE 1967-1972; for BASELINE SURVEY use DATA COLLECTION 1996-2015, for COMMUNITY SURVEYS use use DATA COLLECTION 1980-2015, for NONRESPONDANTS use DATA COLLECTION 1992-2015, for RESPONDANTS use DATA COLLECTION 1995-2015, for SURVEY METHODS use DATA COLLECTION 1980-2015", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011795"}, {"RECTYPE": "D", "MH": "Quinacrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mepacrine|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|740330|abbcdeeef", "ENTRY": "Monomesylate, Quinacrine", "MN": "D03.633.300.046.250.760", "PA": "Enzyme Inhibitors", "MH_TH": "POPLINE (1978)", "ST": "T121", "N1": "1,4-Pentanediamine, N4-(6-chloro-2-methoxy-9-acridinyl)-N1,N1-diethyl-", "RN": "H0C805XYDE", "RR": "G6242H2NAA", "MS": "An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.", "OL": "use QUINACRINE to search CHINACRIN 1977-93", "PM": "CHINACRIN was see QUINACRINE 1977-93", "HN": "CHINACRIN was see QUINACRINE 1977-93", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011796"}, {"RECTYPE": "D", "MH": "Quinacrine Mustard", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Yperite, Acrichine", "MN": "D03.633.300.046.250.760.750", "PA": "Fluorescent Dyes", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "1,4-Pentanediamine, N1,N1-bis(2-chloroethyl)-N4-(6-chloro-2-methoxy-9-acridinyl)-, dihydrochloride", "RN": "4213-45-0", "AN": "D25-26 qualif", "PI": "Quinacrine (1973-1974)", "MS": "Nitrogen mustard analog of quinacrine used primarily as a stain in the studies of chromosomes and chromatin. Fluoresces by reaction with nucleic acids in chromosomes.", "PM": "91; was see under QUINACRINE 1975-90", "HN": "91(75); was see under QUINACRINE 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011797"}, {"RECTYPE": "D", "MH": "Quinaldines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.810.637", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "OL": "search QUINOLINES 1969-74", "PM": "91; was see under QUINOLINES 1975-90", "HN": "91(75); was see under QUINOLINES 1975-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011798"}, {"RECTYPE": "D", "MH": "Quinazolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Quinazoline|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D03.633.100.786", "MH_TH": "NLM (1965)", "ST": "T109", "RN": "0", "MS": "A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring.", "PM": "66", "HN": "66(65)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011799"}, {"RECTYPE": "D", "MH": "Quinestrol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethinyl Estradiol 3-Cyclopentyl Ether|T109|T121|NON|EQV|UNK (19XX)|750101|ETHINYL ESTRADIOL CYCLOPENTYL ETHER 03|abbcdefs", "ENTRY": "Ethinyl Estradiol 3 Cyclopentyl Ether", "MN": "D06.472.334.851.437.968.500.750", "PA": "Estrogens", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "19-Norpregna-1,3,5(10)-trien-20-yn-17-ol, 3-(cyclopentyloxy)-, (17alpha)-", "RN": "JR0N7XD5GZ", "RR": "152-43-2 (Quinestrol)", "PI": "Estrogens (1966-1971)", "MS": "The 3-cyclopentyl ether of ETHINYL ESTRADIOL. After gastrointestinal absorption, it is stored in ADIPOSE TISSUE, slowly released, and metabolized principally to the parent compound. It has been used in ESTROGEN REPLACEMENT THERAPY. (From AMA Drug Evaluations Annual, 1992, p1011)", "PM": "91; was see under NORPREGNATRIENES 1972-90", "HN": "91(72); was see under NORPREGNATRIENES 1972-90", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011800"}, {"RECTYPE": "D", "MH": "Quinic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Quinic", "MN": "D02.241.511.764", "MH_TH": "NLM (1964)", "ST": "T109", "N1": "Cyclohexanecarboxylic acid, 1,3,4,5-tetrahydroxy-, (1R-(1alpha,3alpha,4alpha,5beta))-", "RN": "058C04BGYI", "RR": "77-95-2 (Quinic Acid)", "MS": "An acid which is found in cinchona bark and elsewhere in plants. (From Stedman, 26th ed)", "PM": "74", "HN": "74(64)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011801"}, {"RECTYPE": "D", "MH": "Quinidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Quinidine", "MN": "D03.633.100.810.699", "PA": "Voltage-Gated Sodium Channel Blockers", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "Cinchonan-9-ol, 6'-methoxy-, (9S)-", "RN": "ITX08688JL", "RR": "J13S2394HE", "MS": "An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011802"}, {"RECTYPE": "D", "MH": "Quinine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulphate, Quinine", "MN": "D03.633.100.810.762", "PA": "Muscle Relaxants, Central", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Cinchonan-9-ol, 6'-methoxy-, (8alpha,9R)-", "RN": "A7V27PHC7A", "RR": "M201HC068W", "AN": "/biosyn permitted if by plant", "MS": "An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011803"}, {"RECTYPE": "D", "MH": "Quinolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.810", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with QUINOLIZINES nor with QUINOLONES nor its X ref QUINOLINONES", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011804"}, {"RECTYPE": "D", "MH": "Quinolinic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Quinolinic", "MN": "D03.383.725.822", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "MS": "Dicarboxylic acids with a PYRIDINE backbone. Quinolinic Acids are downstream products of the KYNURENINE pathway which metabolize amino acid TRYPTOPHAN.", "OL": "search PYRIDINES 1966-74", "PM": "91; was see under PYRIDINES 1975-90", "HN": "91(75); was see under PYRIDINES 1975-90", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011805"}, {"RECTYPE": "D", "MH": "Quinolinium Compounds", "DE": "QUINOLINIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Quinolinium", "MN": "D03.633.100.810.824", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PI": "Quinolines (1966-1967)", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011806"}, {"RECTYPE": "D", "MH": "Quinolizines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.834", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with QUINOLINES", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011807"}, {"RECTYPE": "D", "MH": "Quinone Reductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductases, Quinone", "MN": "D08.811.682.608.800", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.6.99.-", "PI": "Vitamin K (1973-1974)", "MS": "NAD(P)H:(quinone acceptor) oxidoreductases. A family that includes three enzymes which are distinguished by their sensitivity to various inhibitors. EC 1.6.99.2 (NAD(P)H DEHYDROGENASE (QUINONE);) is a flavoprotein which reduces various quinones in the presence of NADH or NADPH and is inhibited by dicoumarol. EC 1.6.99.5 (NADH dehydrogenase (quinone)) requires NADH, is inhibited by AMP and 2,4-dinitrophenol but not by dicoumarol or folic acid derivatives. EC 1.6.99.6 (NADPH dehydrogenase (quinone)) requires NADPH and is inhibited by dicoumarol and folic acid derivatives but not by 2,4-dinitrophenol.", "PM": "86; was see under NADH, NADPH OXIDOREDUCTASES 1975-85", "HN": "86(75); was see under NADH, NADPH OXIDOREDUCTASES 1975-85", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D011808"}, {"RECTYPE": "D", "MH": "Quinones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.806", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "coord with specific hydrocarbon structure if pertinent", "MS": "Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011809"}, {"RECTYPE": "D", "MH": "Quinoxalines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Quinoxaline|T109|NON|EQV|NLM (2021)|191230|abcdef", "MN": "D03.633.100.857", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "PM": "66", "HN": "66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011810"}, {"RECTYPE": "D", "MH": "Quintuplets", "AQ": "CL ED GE HI LJ PX SN", "ENTRY": "Quintuplet", "MN": "M01.438.587", "MH_TH": "NLM (1966)", "ST": "T099", "AN": "human only: for animals use LITTER SIZE; PREGNANCY, QUINTUPLET is also available", "MS": "Five individuals derived from five FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011811"}, {"RECTYPE": "D", "MH": "Quinuclidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Quinuclidine|T109|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D03.605.687", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A class of organic compounds which contain two rings that share a pair of bridgehead carbon atoms and contains an amine group.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011812"}, {"RECTYPE": "D", "MH": "Quinuclidinyl Benzilate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Benzilate, Quinuclidinyl", "MN": "D03.605.687.800", "PA": "Muscarinic Antagonists", "MH_TH": "NLM (1980)", "ST": "T130", "N1": "Benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 1-azabicyclo(2.2.2)oct-3-yl ester", "RN": "6581-06-2", "PI": "Quinuclidines (1966-1979)", "MS": "A high-affinity muscarinic antagonist commonly used as a tool in animal and tissue studies.", "PM": "91; was see under QUINUCLIDINES 1980-90", "HN": "91(80); was see under QUINUCLIDINES 1980-90", "MR": "20000622", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D011813"}, {"RECTYPE": "D", "MH": "Quipazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MA1291", "MN": "D03.633.100.810.850", "PA": "Serotonin Receptor Agonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Quinoline, 2-(1-piperazinyl)-", "RN": "4WCY05C0SJ", "RR": "JY444CK9IG", "PI": "Quinolines (1966-1977)", "MS": "A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic.", "OL": "use QUIPAZINE (NM) to search QUIPAZINE MALEATE 1982-92", "PM": "91; was see under QUINOLINES 1978-90; QUIPAZINE MALEATE was indexed under QUIPAZINE/analogs & derivatives 1982-92", "HN": "91(78); was see under QUINOLINES 1978-90; QUIPAZINE MALEATE was NM 1982-92", "MR": "20160531", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D011814"}, {"RECTYPE": "D", "MH": "R Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Resistance Factors|T114|T123|EQV|UNK (19XX)|741111|abbdef", "ENTRY": "Plasmids, R", "MN": "G05.360.600.600", "MH_TH": "NLM (1975)", "ST": "T123", "AN": "bacterial", "PI": "Drug Resistance, Microbial (1967-1974)", "MS": "A class of plasmids that transfer antibiotic resistance from one bacterium to another by conjugation.", "PM": "78; was see under DRUG RESISTANCE, MICROBIAL 1975-77", "HN": "78(75); was see under DRUG RESISTANCE, MICROBIAL 1975-77", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D011815"}, {"RECTYPE": "D", "MH": "Rabbits", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rabbit, Domestic|T015|NON|NRW|NLM (2003)|011129|abcdef", "ENTRY": "cuniculus, Oryctolagus", "MN": "B01.050.150.900.649.313.968.700", "MH_TH": "NLM (1966)", "ST": "T015", "RR": "txid9986", "AN": "check tag: NIM no qualifiers; do not confuse entry term BELGIAN HARE with HARES", "MS": "A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011817"}, {"RECTYPE": "D", "MH": "Rabies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Paralytic Rabies|T047|NON|NRW|NLM (2023)|211013|abcdef", "ENTRY": "Raby, Furious", "MN": "C01.925.782.580.830.750", "MH_TH": "POPLINE (1994)", "ST": "T047", "AN": "human & animal; coordinate with NEGLECTED DISEASES if pertinent", "MS": "Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf.", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011818"}, {"RECTYPE": "D", "MH": "Rabies Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Rabies", "MN": "D20.215.894.899.700", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "MS": "Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis.", "PM": "2001; see RABIES VACCINE 1963-2000", "HN": "2001 (1963)", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "20010101", "UI": "D011819"}, {"RECTYPE": "D", "MH": "Rabies virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Rabies viruses", "MN": "B04.820.480.937.750.500.700", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid11292", "MS": "The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011820"}, {"RECTYPE": "D", "MH": "Raccoons", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Procyon|T015|NON|EQV|NLM (1998)|961028|abcdef", "ENTRY": "Raccoon", "MN": "B01.050.150.900.649.313.750.250.623.700", "MH_TH": "NLM (1968)", "ST": "T015", "RN": "txid9653", "AN": "do not confuse with RACCOON DOGS", "PI": "Carnivora (1966-1967)", "MS": "Carnivores of the genus Procyon of the family PROCYONIDAE. Two subgenera and seven species are currently recognized. They range from southern Canada to Panama and are found in several of the Caribbean Islands.", "PM": "68", "HN": "68", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011821"}, {"RECTYPE": "D", "MH": "Race Relations", "DE": "RACE RELAT", "AQ": "HI LJ PX TD", "ENTRY": "Relations, Racial", "MN": "I01.880.735.820.500", "FX": "Civil Rights", "MH_TH": "NLM (1978)", "ST": "T054", "PI": "Prejudice (1966-1967)", "MS": "Cultural contacts between people of different races.", "PM": "68", "HN": "68", "MR": "20180830", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011822"}, {"RECTYPE": "D", "MH": "Radar", "AQ": "HI IS SN", "MN": "L01.462.500.847.500", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "non-ionizing", "MS": "A system using beamed and reflected radio signals to and from an object in such a way that range, bearing, and other characteristics of the object may be determined.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011825"}, {"RECTYPE": "D", "MH": "Radial Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Radial Nerves", "MN": "A08.800.800.720.050.700", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A major nerve of the upper extremity. In humans the fibers of the radial nerve originate in the lower cervical and upper thoracic spinal cord (usually C5 to T1), travel via the posterior cord of the brachial plexus, and supply motor innervation to extensor muscles of the arm and cutaneous sensory fibers to extensor regions of the arm and hand.", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011826"}, {"RECTYPE": "D", "MH": "Radiation", "DE": "RAD", "AQ": "CL", "ENTRY": "Radiations", "MN": "G01.750", "FX": "Radioactivity", "EC": "therapeutic use:Radiotherapy", "MH_TH": "NLM (1975)", "ST": "T070", "MS": "Emission or propagation of acoustic waves (SOUND), ELECTROMAGNETIC ENERGY waves (such as LIGHT; RADIO WAVES; GAMMA RAYS; or X-RAYS), or a stream of subatomic particles (such as ELECTRONS; NEUTRONS; PROTONS; or ALPHA PARTICLES).", "OL": "search RADIATION IMMUNOLOGY under RADIATION EFFECTS 1966", "PM": "RADIATION IMMUNOLOGY was heading 1964-66", "HN": "RADIATION IMMUNOLOGY was heading 1964-66", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011827"}, {"RECTYPE": "D", "MH": "Radiation Chimera", "DE": "RAD CHIMERA", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Chimera, Radiation|T001|NON|EQV|UNK (19XX)|740330|CHIMERA RAD|abcdefv", "ENTRY": "Radiation Chimeras", "MN": "G12.470.500", "MH_TH": "NLM (1966)", "ST": "T001", "MS": "An organism whose body contains cell populations of different genotypes as a result of the TRANSPLANTATION of donor cells after sufficient ionizing radiation to destroy the mature recipient's cells which would otherwise reject the donor cells.", "PM": "70; was see under IMMUNITY /radiation effects 1967-69", "HN": "70(66); was see under IMMUNITY /radiation effects 1967-69", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D011828"}, {"RECTYPE": "D", "MH": "Radiation Dosage", "DE": "RAD DOSAGE", "PRINT ENTRY": "Sievert Units|T081|EPO|NRW|NLM (2008)|070129|abcdef", "ENTRY": "Units, Sievert", "MN": "N06.850.810.250", "FX": "Radiotherapy Dosage", "MH_TH": "NLM (1972)", "ST": "T081", "PI": "Radiometry (1966-1971)", "MS": "The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv).", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011829"}, {"RECTYPE": "D", "MH": "Radiation Effects", "DE": "RAD EFF", "ENTRY": "Radiation Effect", "MN": "N06.850.810.300", "FX": "Radiation Tolerance", "MH_TH": "NLM (1966)", "ST": "T038", "MS": "The effects of ionizing and nonionizing radiation upon living organisms, organs and tissues, and their constituents, and upon physiologic processes. It includes the effect of irradiation on food, drugs, and chemicals.", "OL": "use RADIATION EFFECTS to search RADIATION IMMUNOLOGY 1966", "PM": "RADIATION IMMUNOLOGY was heading 1964-66", "HN": "RADIATION IMMUNOLOGY was heading 1964-66", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011830"}, {"RECTYPE": "D", "MH": "Radiation Genetics", "DE": "RAD GENET", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Genetics, Radiation|T091|NON|EQV|UNK (19XX)|740330|GENET RAD|abcdefv", "MN": "N06.850.810.335", "FX": "Radiation Effects", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "A subdiscipline of genetics that studies RADIATION EFFECTS on the components and processes of biological inheritance.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011831"}, {"RECTYPE": "D", "MH": "Radiation Injuries", "DE": "RAD INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Radiation Syndrome|T037|T047|NON|REL|UNK (19XX)|740330|RAD SYNDROME|abbcdefv", "ENTRY": "Syndromes, Radiation", "MN": "N06.850.810.300.360", "FX": "Radioactive Hazard Release", "MH_TH": "NLM (1973)", "ST": "T037", "MS": "Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES.", "OL": "use RADIATION INJURIES to search RADIATION INJURY 1966-72", "PM": "73; was RADIATION INJURY 1963-72", "HN": "73; was RADIATION INJURY 1963-72", "CATSH": "CAT LIST", "MR": "20160317", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011832"}, {"RECTYPE": "D", "MH": "Radiation Injuries, Experimental", "DE": "RAD INJ EXPER", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Radiation Injury, Experimental", "MN": "N06.850.810.300.360.285", "MH_TH": "NLM (1973)", "ST": "T050", "MS": "Experimentally produced harmful effects of ionizing or non-ionizing RADIATION in CHORDATA animals.", "OL": "use RADIATION INJURIES, EXPERIMENTAL to search RADIATION INJURY, EXPERIMENTAL 1966-72", "PM": "73; was RADIATION INJURY, EXPERIMENTAL 1963-72", "HN": "73; was RADIATION INJURY, EXPERIMENTAL 1963-72", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011833"}, {"RECTYPE": "D", "MH": "Radiation Monitoring", "DE": "RAD MONITORING", "AQ": "EC ES HI IS LJ MT SN ST", "ENTRY": "Monitoring, Radiation|T059|NON|EQV|UNK (19XX)|860101|MONITORING RAD|abcdefv", "MN": "N06.850.810.370", "MH_TH": "NLM (1964)", "ST": "T059", "MS": "The observation, either continuously or at intervals, of the levels of radiation in a given area, generally for the purpose of assuring that they have not exceeded prescribed amounts or, in case of radiation already present in the area, assuring that the levels have returned to those meeting acceptable safety standards.", "PM": "64; was see under RADIOMETRY 1963", "HN": "64; was see under RADIOMETRY 1963", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D011834"}, {"RECTYPE": "D", "MH": "Radiation Protection", "DE": "RAD PROTECTION", "AQ": "EC HI IS LJ MT SN ST", "ENTRY": "Protection, Radiation|T067|NON|EQV|UNK (19XX)|860101|PROTECTION RAD|abcdefv", "MN": "N06.850.810.425", "MH_TH": "NLM (1966)", "ST": "T067", "AN": "includes \"shielding\"", "MS": "Methods and practices adopted to protect against RADIATION.", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011835"}, {"RECTYPE": "D", "MH": "Radiation Tolerance", "DE": "RAD TOLERANCE", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Radiosensitivity|T032|NON|EQV|UNK (19XX)|760412|abcdef", "ENTRY": "Tolerances, Radiation", "MN": "G07.738", "FX": "Radiation-Sensitizing Agents", "MH_TH": "NLM (1977)", "ST": "T032", "PI": "Radiotherapy Dosage (1966-1976)", "MS": "The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D011836"}, {"RECTYPE": "D", "MH": "Radiation-Protective Agents", "DE": "RAD PROTECTIVE AGENTS", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Radioprotective Drug|T121|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Radiation Protective Effects", "MN": "D27.720.799.763", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "SUNSCREENING AGENTS is also available; use RADIATION PROTECTION for shielding from diagnostic x-rays; note entry term RADIATION-PROTECTIVE EFFECT: use only for the radiation protective effect of a chemical substance", "MS": "Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011837"}, {"RECTYPE": "D", "MH": "Radiation-Sensitizing Agents", "DE": "RAD SENSITIZING AGENTS", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Radiosensitizing Agents|T121|NON|EQV|NLM (1996)|941122|abcdef", "ENTRY": "Sensitizing Agents, Radiation", "MN": "D27.505.954.600", "MH_TH": "NLM (1965)", "ST": "T121", "RN": "0", "AN": "note entry term RADIATION-SENSITIZING EFFECT: use only for the radiation sensitizing effect of a chemical substance", "MS": "Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.", "PM": "66", "HN": "66(65)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011838"}, {"RECTYPE": "D", "MH": "Radiation, Ionizing", "DE": "RAD IONIZING", "AQ": "CL", "ENTRY": "Radiations, Ionizing", "MN": "G01.750.750", "MH_TH": "NLM (1976)", "ST": "T070", "PI": "Radiation (1966-1975)", "MS": "ELECTROMAGNETIC RADIATION or particle radiation (high energy ELEMENTARY PARTICLES) capable of directly or indirectly producing IONS in its passage through matter. The wavelengths of ionizing electromagnetic radiation are equal to or smaller than those of short (far) ultraviolet radiation and include gamma and X-rays.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20110624", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D011839"}, {"RECTYPE": "D", "MH": "Radiation, Nonionizing", "DE": "RAD NONIONIZING", "AQ": "AE CL", "ENTRY": "Radiations, Nonionizing", "MN": "G01.750.770", "MH_TH": "NLM (1976)", "ST": "T070", "PI": "Radiation (1966-1975)", "MS": "ELECTROMAGNETIC RADIATION or sonic radiation (SOUND WAVES) which does not produce IONS in matter through which it passes. The wavelengths of non-ionizing electromagentic radiation are generally longer than those of far ultraviolet radiation and range through the longest RADIO WAVES.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20110624", "DA": "19750721", "DC": "1", "DX": "19760101", "UI": "D011840"}, {"RECTYPE": "D", "MH": "Radicular Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Periodontal Cyst, Apical|T047|NON|EQV|UNK (19XX)|790430|abcdef", "ENTRY": "Radicular Cysts", "MN": "C07.465.714.306.820", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "non-neoplastic periodontal cyst; coordinate with organ/disease, not organ/neoplasm", "MS": "Slow-growing fluid-filled epithelial sac at the apex of a tooth with a nonvital pulp or defective root canal filling.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011842"}, {"RECTYPE": "D", "MH": "Radiculopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Radiculitis|T047|NON|NRW|NLM (1971)|990101|abcdef", "ENTRY": "Radiculopathies, Cervical", "MN": "C10.668.829.820", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "disease of a single spinal nerve root; do not confuse with POLYRADICULOPATHY (disease of several spinal nerve roots) nor with POLYRADICULONEUROPATHY (disease of both spinal nerve roots & peripheral nerves)", "PI": "Polyradiculitis (1966-1970)", "MS": "Disease involving a spinal nerve root (see SPINAL NERVE ROOTS) which may result from compression related to INTERVERTEBRAL DISK DISPLACEMENT; SPINAL CORD INJURIES; SPINAL DISEASES; and other conditions. Clinical manifestations include radicular pain, weakness, and sensory loss referable to structures innervated by the involved nerve root.", "PM": "2000; see RADICULITIS 1971-1999", "HN": "2000(1971)", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D011843"}, {"RECTYPE": "D", "MH": "Radiesthesia", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E02.190.901.740", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Therapeutic cult concerned with intangible energies surrounding the living body and based on the detection of these intrinsic radiations by dowsing, or divining, or the use of more elaborate instruments (radionics).", "PM": "67,63-65", "HN": "67,63-65", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D011844"}, {"RECTYPE": "D", "MH": "Radio", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "ENTRY": "Radios", "MN": "L01.462.500.847.514", "MH_TH": "POPLINE (1978)", "ST": "T170", "MS": "The transmission and reception of electric impulses or signals by means of electric waves without a connecting wire, or the use of these waves for the wireless transmission of electric impulses into which sound is converted. (From Webster's 3d)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011845"}, {"RECTYPE": "D", "MH": "Radio Waves", "AQ": "AE CL HI", "PRINT ENTRY": "Very High Frequency Waves|T070|NON|NRW|NLM (1998)|961202|VHF WAVES|abcdefv", "ENTRY": "Waves, Short", "MN": "G01.750.770.721", "FX": "Radar", "EC": "therapeutic use:Radiofrequency Therapy", "MH_TH": "NLM (1966)", "ST": "T070", "MS": "Electromagnetic waves with frequencies between about 3 kilohertz (very low frequency - VLF) and 300,000 megahertz (extremely high frequency - EHF). They are used in television and radio broadcasting, land and satellite communications systems, radionavigation, radiolocation, and DIATHERMY. The highest frequency radio waves are MICROWAVES.", "MR": "20200618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011846"}, {"RECTYPE": "D", "MH": "Radioactive Fallout", "AQ": "AE AN EC HI LJ PC SN", "ENTRY": "Radioactive Fallouts", "MN": "N06.850.810.460", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "IM; specify geog if pertinent", "MS": "The material that descends to the earth or water well beyond the site of a surface or subsurface nuclear explosion. (McGraw-Hill Dictionary of Chemical and Technical Terms, 4th ed)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011847"}, {"RECTYPE": "D", "MH": "Radioactive Pollutants", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pollutants, Radioactive", "MN": "D20.693", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "specify radiopollutant if pertinent (IM or NIM)", "PI": "Radioactivity (1966-1974)", "MS": "Radioactive substances which act as pollutants. They include chemicals whose radiation is released via radioactive waste, nuclear accidents, fallout from nuclear explosions, and the like.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D011848"}, {"RECTYPE": "D", "MH": "Radioactive Tracers", "PRINT ENTRY": "Radionuclide Tracers|T130|T196|NON|EQV|NLM (2023)|210831|abbcdef", "ENTRY": "Tracers, Radionuclide", "MN": "D27.720.470.410.614", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "AN": "IM for general only", "MS": "Radioactive substances added in minute amounts to the reacting elements or compounds in a chemical process and traced through the process by appropriate detection methods, e.g., Geiger counter. Compounds containing tracers are often said to be tagged or labeled. (Hawley's Condensed Chemical Dictionary, 12th ed)", "OL": "search RADIOISOTOPES 1974", "PM": "91; was see under RADIOISOTOPES 1975-90", "HN": "91(75); was see under RADIOISOTOPES 1975-90", "MR": "20220408", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011849"}, {"RECTYPE": "D", "MH": "Radioactive Waste", "AQ": "AE AN CL EC ES LJ PC SN", "PRINT ENTRY": "Nuclear Waste|T069|T131|NON|EQV|NLM (1990)|890203|abbcdef", "ENTRY": "Wastes, Radioactive Hazardous", "MN": "N06.850.810.485", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "specify geog if pertinent", "MS": "Liquid, solid, or gaseous waste resulting from mining of radioactive ore, production of reactor fuel materials, reactor operation, processing of irradiated reactor fuels, and related operations, and from use of radioactive materials in research, industry, and medicine. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "OL": "use HAZARDOUS WASTE to search NUCLEAR WASTE 1988-89", "PM": "NUCLEAR WASTE was see HAZARDOUS WASTE 1988-89", "HN": "NUCLEAR WASTE was see HAZARDOUS WASTE 1988-89", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011850"}, {"RECTYPE": "D", "MH": "Radioactivity", "PRINT ENTRY": "Nuclear Decay|T070|NON|EQV|NLM (1998)|960724|abcdef", "ENTRY": "Radioactivities", "MN": "G01.828", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "IM general only for principle of emission of radiations; NIM as coordinate for degree of radioactivity of specific radioelements or radioisotopes (IM); do not use as routine coordinate for amount of radiation or degree of radioactivity of radioisotope tracers; entry term NUCLEAR DECAY: coordinate NIM with specific radioactive substance (IM) & do not add RADIOMETRY", "MS": "The spontaneous transformation of a nuclide into one or more different nuclides, accompanied by either the emission of particles from the nucleus, nuclear capture or ejection of orbital electrons, or fission. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011851"}, {"RECTYPE": "D", "MH": "Radioallergosorbent Test", "DE": "RAST", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Radioimmunosorbent Assay of Allergens|T059|NON|EQV|UNK (19XX)|760414|abcdef", "ENTRY": "Tests, Radioallergosorbent", "MN": "E05.601.470.639.810", "MH_TH": "NLM (1977)", "ST": "T059", "AN": "usually NIM; IMMUNOSORBENTS is also available", "PI": "Radioimmunoassay (1968-1976)", "MS": "An in vitro allergen radioimmunoassay in which allergens are coupled to an immunosorbent. The coupled allergens bind the IgE in the sera of patients which in turn binds radioisotope-labeled anti-IMMUNOGLOBULIN E antibodies.", "PM": "89; was see under RADIOIMMUNOASAY 1977-88", "HN": "89(77); was see under RADIOIMMUNOASSAY 1977-88", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19760416", "DC": "1", "DX": "19890101", "UI": "D011852"}, {"RECTYPE": "D", "MH": "Radiobiology", "DE": "RADIOBIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Radiation Biology|T091|NON|EQV|UNK (19XX)|740330|RAD BIOL|abcdefv", "ENTRY": "Biology, Radiation|T091|NON|EQV|UNK (19XX)|740330|BIOL RAD|abcdefv", "MN": "H01.158.273.789", "FX": "Nuclear Medicine", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty", "MS": "Study of the scientific principles, mechanisms, and effects of the interaction of ionizing radiation with living matter. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "66", "HN": "66", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011853"}, {"RECTYPE": "D", "MH": "Radiochemistry", "DE": "RADIOCHEM", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Radiochemistries", "MN": "H01.181.529.776", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "MS": "The study of the chemical and physical phenomena of radioactive substances.", "PM": "66", "HN": "66", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011854"}, {"RECTYPE": "D", "MH": "Radiodermatitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Radiation-Induced Dermatitis|T037|T047|NON|EQV|NLM (1993)|920402|RAD IND DERMATITIS|abbcdefv", "ENTRY": "Recall Reactions, Radiation", "MN": "G01.750.748.500.804", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "A cutaneous inflammatory reaction occurring as a result of exposure to ionizing radiation.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011855"}, {"RECTYPE": "D", "MH": "Radiographic Image Enhancement", "DE": "RADIOGR IMAGE ENHANCEMENT", "AQ": "EC IS MT ST TD", "PRINT ENTRY": "Digital Radiography|T060|NON|BRD|UNK (19XX)|860618|DIGITAL RADIOGR|abcdefv", "ENTRY": "Radiographic Image Enhancements", "MN": "L01.224.308.380.600", "FX": "X-Ray Intensifying Screens", "MH_TH": "NLM (1974)", "ST": "T060", "MS": "Improvement in the quality of an x-ray image by use of an intensifying screen, tube, or filter and by optimum exposure techniques. Digital processing methods are often employed.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011856"}, {"RECTYPE": "D", "MH": "Radiographic Image Interpretation, Computer-Assisted", "DE": "RADIOGR IMAGE INTERP", "AQ": "IS MT SN ST", "ENTRY": "Radiographic Image Interpretation, Computer Assisted|T060|T062|NON|EQV|NLM (1992)|901011|RADIOGR IMAGE INTERP COMPUTER ASSISTED|abbcdefv", "MN": "L01.313.500.750.100.158.600.680", "MH_TH": "NLM (1987)", "ST": "T062", "MS": "Computer systems or networks designed to provide radiographic interpretive information.", "PM": "91; was see under IMAGE INTERPRETATION, COMPUTER-ASSISTED 1987-90", "HN": "91(87); was see under IMAGE INTERPRETATION, COMPUTER-ASSISTED 1987-90", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19860617", "DC": "1", "DX": "19910101", "UI": "D011857"}, {"RECTYPE": "D", "MH": "Radiographic Magnification", "DE": "RADIOGR MAGNIFICATION", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Radiographic Magnifications", "MN": "E01.370.350.700.710", "MH_TH": "NLM (1973)", "ST": "T060", "PI": "specific radiography heading (1966-1971)", "MS": "Use of optic and geometric techniques to enhance radiographic image quality and interpretation. It includes use of microfocal X-ray tubes and intensifying fluoroscopic screens.", "PM": "73", "HN": "73(72)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011858"}, {"RECTYPE": "D", "MH": "Radiography", "DE": "RADIOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "X-Ray, Diagnostic|T060|NON|NRW|UNK (19XX)|760630|X RAY DIAG|abcdefv", "ENTRY": "X-Rays, Diagnostic", "MN": "E01.370.350.700", "FX": "Technology, Radiologic", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film).", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011859"}, {"RECTYPE": "D", "MH": "Radiography, Abdominal", "DE": "RADIOGR ABDOMINAL", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Radiographies, Abdominal", "MN": "E01.370.350.700.715", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "IM general only; avoid as NIM coordinate with ABDOMEN or specifics /diag image; instead prefer specific radiographic technique", "PI": "Abdomen/radiography (1967-1997)", "MS": "Radiographic visualization of the body between the thorax and the pelvis, i.e., within the peritoneal cavity.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D011860"}, {"RECTYPE": "D", "MH": "Radiography, Dental", "DE": "RADIOGR DENT", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Dental Radiography|T060|NON|EQV|UNK (19XX)|790529|DENT RADIOGR|abcdefv", "MN": "E06.342.764", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "IM general only; avoid as NIM coordinate with specific dental organs /diag image; instead prefer specific radiographic technique", "MS": "Radiographic techniques used in dentistry.", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011861"}, {"RECTYPE": "D", "MH": "Radiography, Panoramic", "DE": "RADIOGR PANORAMIC", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Pantomography|T060|NON|EQV|NLM (1992)|901011|PANTOMOGR|abcdefv", "ENTRY": "Radiographies, Panoramic", "MN": "E06.342.764.750", "MH_TH": "NLM (1974)", "ST": "T060", "MS": "Extraoral body-section radiography depicting an entire maxilla, or both maxilla and mandible, on a single film.", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "20160311", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011862"}, {"RECTYPE": "D", "MH": "Radioimmunoassay", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Radioimmunoassays", "MN": "E05.601.470.639", "MH_TH": "NLM (1968)", "ST": "T059", "AN": "NIM; coord with substance /anal or body fluid qualif but not /immunol; do not confuse with IMMUNORADIOMETRIC ASSAY", "PI": "Immunoassay (1966-1967)", "MS": "Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011863"}, {"RECTYPE": "D", "MH": "Radioimmunosorbent Test", "DE": "RIST", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Radioimmunosorbent", "MN": "E05.601.470.639.830", "FX": "Radioallergosorbent Test", "MH_TH": "NLM (1977)", "ST": "T059", "AN": "NIM; coord with substance /anal or body fluid qualif but not /immunol; IMMUNOSORBENTS is also available; DF: RIST", "PI": "Radioimmunoassay (1968-1976)", "MS": "Radioimmunoassay of proteins using antibody coupled to an immunosorbent.", "PM": "91; was see under RADIOIMMUNOASSAY 1977-90", "HN": "91(77); was see under RADIOIMMUNOASSAY 1977-90", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D011864"}, {"RECTYPE": "D", "MH": "Radioisotope Dilution Technique", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Radioisotope Dilution", "MN": "E05.484.650", "MH_TH": "NLM (1964)", "ST": "T060", "AN": "coordinate with specific radioisotope with no qualifiers", "MS": "Method for assessing flow through a system by injection of a known quantity of radionuclide into the system and monitoring its concentration over time at a specific point in the system. (From Dorland, 28th ed)", "OL": "use RADIOISOTOPE DILUTION TECHNIQUE to search RADIOISOTOPE DILUTION TECHNIC 1966-90", "PM": "91; was RADIOISOTOPE DILUTION TECHNIC 1967-90", "HN": "91(64); was RADIOISOTOPE DILUTION TECHNIC 1964-90 (Prov 1964-66)", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D011865"}, {"RECTYPE": "D", "MH": "Radioisotope Renography", "DE": "RADIOISOTOPE RENOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Renography|T060|NON|BRD|UNK (19XX)|740330|RENOGR|abcdefv", "ENTRY": "Renography, Radioisotope", "MN": "E01.370.390.400.700", "MH_TH": "NLM (1964)", "ST": "T060", "AN": "coordinate with disease /diag image", "MS": "Graphic tracing over a time period of radioactivity measured externally over the kidneys following intravenous injection of a radionuclide which is taken up and excreted by the kidneys.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011866"}, {"RECTYPE": "D", "MH": "Radioisotope Teletherapy", "DE": "RADIOISOTOPE TELETHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Teleradioisotope Therapy|T061|NON|EQV|UNK (19XX)|740330|TELERADIOISOTOPE THER|abcdefv", "ENTRY": "Therapy, Teleradioisotope|T061|NON|EQV|UNK (19XX)|740330|THER TELERADIOISOTOPE|abcdefv", "MN": "E02.815.722.820", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "coordinate with specific radioisotope /ther use ", "MS": "A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011867"}, {"RECTYPE": "D", "MH": "Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "PRINT ENTRY": "Radionuclides|T196|NON|EQV|UNK (19XX)|760324|abcdef", "ENTRY": "Nuclides, Daughter", "MN": "D01.496.749", "FX": "Isotopes", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011868"}, {"RECTYPE": "D", "MH": "Radioligand Assay", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Radioreceptor Assay|T059|T060|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Radioreceptor Assays", "MN": "E05.200.985", "MH_TH": "NLM (1973)", "ST": "T060", "AN": "coordinate with substance /anal ", "PI": "Protein Binding (1966-1972)", "MS": "Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders).", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011869"}, {"RECTYPE": "D", "MH": "Radiologic Health", "DE": "RADIOL HEALTH", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Health, Radiological", "MN": "N06.850.810", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "Health concerns associated with the effects of radiation on the environment and on public and personal health.", "PM": "98", "HN": "98; use explode 1970-97", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D011870"}, {"RECTYPE": "D", "MH": "Radiology", "DE": "RADIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.740", "MH_TH": "BIOETHICS (1974)", "ST": "T091", "AN": "specialty; /methods: probably better is TECHNOLOGY, RADIOLOGIC", "MS": "A specialty concerned with the use of x-ray and other forms of radiant energy in the diagnosis and treatment of disease.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011871"}, {"RECTYPE": "D", "MH": "Radiology Department, Hospital", "DE": "RADIOL DEP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "X-Ray Departments|T093|NON|NRW|UNK (19XX)|770519|X RAY DEP|abcdefv", "ENTRY": "X Ray Departments", "MN": "N04.452.442.452.422.695", "MH_TH": "NLM (1977)", "ST": "T093", "PI": "Radiology (1966-Jul 1977)", "MS": "Hospital department which is responsible for the administration and provision of x-ray diagnostic and therapeutic services.", "PM": "91; was see under HOSPITAL DEPARTMENTS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90", "MR": "20190709", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D011872"}, {"RECTYPE": "D", "MH": "Radiology Information Systems", "DE": "RADIOL INFORMATION SYSTEMS", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "X-Ray Information Systems|T170|NON|NRW|NLM (1991)|900522|abcdef", "ENTRY": "Xray Information System", "MN": "N04.452.515.825", "MH_TH": "NLM (1987)", "ST": "T170", "MS": "Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of radiology services and facilities.", "PM": "91; was see under HOSPITAL INFORMATION SYSTEMS 1987-90", "HN": "91(87); was see under HOSPITAL INFORMATION SYSTEMS 1987-90", "MR": "20200527", "DA": "19860617", "DC": "1", "DX": "19910101", "UI": "D011873"}, {"RECTYPE": "D", "MH": "Radiometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Radiation Dosimetry|T059|NON|EQV|NLM (1998)|960724|RAD DOSIMETRY|abcdefv", "ENTRY": "Tubes, Geiger-Mueller Counter", "MN": "E05.799", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "IM general only for measurement of radiation & techniques & equipment related to it; NIM as coordinate with specific radiation (IM) for measurement of its radiations; do not use with radioisotope tracers for measurement of amount of radiation emitted by the tracer: Manual 29.14; ionization chambers: index under RADIOMETRY / instrum", "MS": "The measurement of radiation by photography, as in x-ray film and film badge, by Geiger-Mueller tube, and by SCINTILLATION COUNTING.", "OL": "use RADIOMETRY to search GEIGER-MUELLER COUNTER 1966-77", "PM": "GEIGER-MUELLER COUNTER was see under RADIOMETRY 1963-77", "HN": "GEIGER-MUELLER COUNTER was see under RADIOMETRY 1963-77", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011874"}, {"RECTYPE": "D", "MH": "Radionuclide Angiography", "DE": "RADIONUCLIDE ANGIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Radioisotope Angiography|T060|NON|EQV|UNK (19XX)|860620|RADIOISOTOPE ANGIOGR|abcdefv", "ENTRY": "Radionuclide Angiographies", "MN": "E01.370.384.730.715", "MH_TH": "NLM (1987)", "ST": "T060", "AN": "coordinate with disease /diag image", "PI": "specific organ/radionuclide imaging (1978-1986)", "MS": "The measurement of visualization by radiation of any organ after a radionuclide has been injected into its blood supply. It is used to diagnose heart, liver, lung, and other diseases and to measure the function of those organs, except renography, for which RADIOISOTOPE RENOGRAPHY is available.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19860620", "DC": "1", "DX": "19870101", "UI": "D011875"}, {"RECTYPE": "D", "MH": "Radionuclide Generators", "AQ": "CL EC HI IS LJ SD SN ST", "PRINT ENTRY": "Radioisotope Generators|T073|NON|EQV|UNK (19XX)|780519|abcdef", "ENTRY": "Radionuclide Generator", "MN": "E07.710.770", "MH_TH": "NLM (1979)", "ST": "T073", "AN": "IM", "PI": "Radioisotopes (1966-1978)", "MS": "Separation systems containing a relatively long-lived parent radionuclide which produces a short-lived daughter in its decay scheme. The daughter can be periodically extracted (milked) by means of an appropriate eluting agent.", "PM": "79", "HN": "79", "MR": "20180629", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D011876"}, {"RECTYPE": "D", "MH": "Radionuclide Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Scintiphotography|T060|NON|NRW|IOM (1990)|890417|SCINTIPHOTOGR|abcdefv", "ENTRY": "Imaging, Radionuclide", "MN": "E01.370.384.730", "FX": "Scintillation Counting", "MH_TH": "NLM (1990)", "ST": "T060", "AN": "IM general only; coordinate NIM with anatomical term or disease term /diag image", "MS": "The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph.", "OL": "use RADIONUCLIDE IMAGING to search RADIOISOTOPE SCANNING 1966-76", "PM": "77; was RADIOISOTOPE SCANNING 1964-76; was RADIOISOTOPE SCANNING see under RADIOMETRY 1963", "HN": "77; was RADIOISOTOPE SCANNING 1964-76; was RADIOISOTOPE SCANNING see under RADIOMETRY 1963", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D011877"}, {"RECTYPE": "D", "MH": "Radiotherapy", "DE": "RADIOTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Targeted Radiotherapy|T061|NON|NRW|NLM (1994)|921221|TARGETED RADIOTHER|abcdefv", "ENTRY": "Treatment, Radiation", "MN": "E02.815", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general only: prefer /radiother with diseases; /adv eff: consider also RADIATION INJURIES or its specifics; many specific types of radiotherapy are available ", "MS": "The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions.", "CATSH": "CAT LIST", "MR": "20180226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011878"}, {"RECTYPE": "D", "MH": "Radiotherapy Dosage", "DE": "RADIOTHER DOSAGE", "AQ": "ST VE", "ENTRY": "Radiotherapy Dosages", "MN": "E02.815.639", "FX": "Radiotherapy, Conformal", "MH_TH": "NLM (1964)", "ST": "T081", "AN": "NIM", "MS": "The total amount of radiation absorbed by tissues as a result of radiotherapy.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D011879"}, {"RECTYPE": "D", "MH": "Radiotherapy Planning, Computer-Assisted", "DE": "RADIOTHER PLANNING COMPUTER ASSISTED", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Dosimetry Calculations, Computer-Assisted|T061|T062|NON|EQV|UNK (19XX)|860617|abbcdef", "ENTRY": "Radiotherapy Planning, Computer Assisted", "MN": "L01.313.500.750.100.710.600.608", "FX": "Radiotherapy, Conformal", "MH_TH": "NLM (1987)", "ST": "T062", "AN": "differentiate from RADIOTHERAPY, COMPUTER-ASSISTED in that in planning the emphasis is on theoretical principles of radiother rather than on the patient", "PI": "Radiotherapy Dosage (1966-1986)", "MS": "Computer-assisted mathematical calculations of beam angles, intensities of radiation, and duration of irradiation in radiotherapy.", "PM": "91; was see under RADIOTHERAPY, COMPUTER-ASSISTED 1987-90", "HN": "91(87); was see under RADIOTHERAPY, COMPUTER-ASSISTED 1987-90", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19860617", "DC": "1", "DX": "19910101", "UI": "D011880"}, {"RECTYPE": "D", "MH": "Radiotherapy, Computer-Assisted", "DE": "RADIOTHER COMPUTER ASSISTED", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Radiation Therapy, Computer-Assisted|T061|NON|EQV|UNK (19XX)|860617|RAD THER COMPUTER ASSISTED|abcdefv", "ENTRY": "Therapy, Computer-Assisted Radiation", "MN": "L01.313.500.750.100.710.600", "FX": "Radiotherapy, Conformal", "MH_TH": "NLM (1987)", "ST": "T061", "AN": "RADIOTHERAPY PLANNING, COMPUTER-ASSISTED is also available: see note there", "MS": "Computer systems or programs used in accurate computations for providing radiation dosage treatment to patients.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19860617", "DC": "1", "DX": "19870101", "UI": "D011881"}, {"RECTYPE": "D", "MH": "Radiotherapy, High-Energy", "DE": "RADIOTHER HIGH ENERGY", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Megavolt Radiotherapy|T061|NON|NRW|UNK (19XX)|740330|MEGAVOLT RADIOTHER|abcdefv", "ENTRY": "Radiotherapy, High Energy", "MN": "E02.815.722", "MH_TH": "NLM (1964)", "ST": "T061", "AN": "ionizing only", "MS": "Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D011882"}, {"RECTYPE": "D", "MH": "Radium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.775", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Radium", "RN": "W90AYD6R3Q", "RR": "7440-14-4 (Radium)", "AN": "/ther \u200cuse: consider CURIETHERAPY see BRACHYTHERAPY", "MS": "A radioactive element of the alkaline earth series of metals. It has the atomic symbol Ra and atomic number 88. Radium is the product of the disintegration of URANIUM and is present in pitchblende and all ores containing uranium. It is used clinically as a source of beta and gamma-rays in radiotherapy, particularly BRACHYTHERAPY.", "MR": "20170707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011883"}, {"RECTYPE": "D", "MH": "Radius", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tuberosity, Radial", "MN": "A02.835.232.087.090.700", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The outer shorter of the two bones of the FOREARM, lying parallel to the ULNA and partially revolving around it.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011884"}, {"RECTYPE": "D", "MH": "Radius Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Radial Fractures|T037|NON|EQV|NLM (2023)|210928|abcdef", "ENTRY": "Radius Fracture", "MN": "C26.404.562", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Fractures of the RADIUS.", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011885"}, {"RECTYPE": "D", "MH": "Radon", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Thoron (Element)|T196|NON|NRW|NLM (1994)|920806|THORON|abcdefv", "MN": "D01.496.749.305.800", "PA": "Carcinogens, Environmental", "FX": "Air Pollutants, Radioactive", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Radon", "RN": "Q74S4N8N1G", "RR": "10043-92-2 (Radon)", "AN": "RADON DAUGHTERS is also available", "MS": "A naturally radioactive element with atomic symbol Rn, and atomic number 86. It is a member of the noble gas family found in soil, and is released during the decay of RADIUM.", "OL": "use RADON to search ACTINON 1978-93; use RADON (NM) to search THORON (ELEMENT) 1980-93", "PM": "ACTINON was see RADON 1978-93; THORON (ELEMENT) was indexed under RADON 1983-93 & RADIOISOTOPES 1974-82", "HN": "ACTINON was see RADON 1978-93; THORON (ELEMENT) was (NM) 1974-93", "MR": "20170711", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D011886"}, {"RECTYPE": "D", "MH": "Raffinose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Melitriose|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "MN": "D09.698.629.802.700", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "alpha-D-Glucopyranoside, beta-D-fructofuranosyl O-alpha-D-galactopyranosyl-(1-6)-", "RN": "N5O3QU595M", "RR": "512-69-6 (Raffinose)", "PI": "Oligosaccharides (1970-1974)", "MS": "A trisaccharide occurring in Australian manna (from Eucalyptus spp, Myrtaceae) and in cottonseed meal.", "PM": "91; was see under OLIGOSACCHARIDES 1975-90", "HN": "91(75); was see under OLIGOSACCHARIDES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011887"}, {"RECTYPE": "D", "MH": "Rafoxanide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ranide|T109|T121|TRD|NRW|UNK (19XX)|800731|abbcdef", "MN": "D02.092.146.113.860.600", "PA": "Antiplatyhelmintic Agents", "MH_TH": "USAN (1970)", "ST": "T121", "N1": "Benzamide, N-(3-chloro-4-(4-chlorophenoxy)phenyl)-2-hydroxy-3,5-diiodo-", "RN": "22F4FLA7DH", "RR": "22662-39-1 (Rafoxanide)", "PI": "Salicylamides (1971-1974)", "MS": "Veterinary anthelmintic for grazing animals; used to treat fluke, hookworm and other infestations.", "PM": "91; was see under SALICYLAMIDES 1975-90", "HN": "91(75); was see under SALICYLAMIDES 1975-90", "MR": "20160705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011888"}, {"RECTYPE": "D", "MH": "Rage", "AQ": "CL DE ES PH RE", "ENTRY": "Rages", "MN": "F01.470.093.640", "MH_TH": "NLM (1975)", "ST": "T055", "AN": "human & animal", "MS": "Fury; violent, intense anger.", "OL": "search ANGER 1972-74", "PM": "91; was see under ANGER 1975-90", "HN": "91(75); was see under ANGER 1975-90", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011889"}, {"RECTYPE": "D", "MH": "Railroads", "AQ": "CL EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Subways|T073|NON|NRW|NLM (1998)|960724|abcdef", "ENTRY": "Subway", "MN": "J01.937.690", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Permanent roads having a line of rails fixed to ties and laid to gage, usually on a leveled or graded ballasted roadbed and providing a track for freight cars, passenger cars, and other rolling stock. Cars are designed to be drawn by locomotives or sometimes propelled by self-contained motors. (From Webster's 3d) The concept includes the organizational and administrative aspects of railroads as well.", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011890"}, {"RECTYPE": "D", "MH": "Rain", "AQ": "CH MI PS VI", "ENTRY": "Rains", "MN": "N06.230.520", "MH_TH": "NLM (1975)", "ST": "T070", "MS": "Water particles that fall from the ATMOSPHERE.", "OL": "search WEATHER 1969-74", "PM": "91; was see under WEATHER 1975-90", "HN": "91(75); was see under WEATHER 1975-90", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011891"}, {"RECTYPE": "D", "MH": "Rana catesbeiana", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Bullfrog|T011|NON|EQV|UNK (19XX)|741211|abcdef", "ENTRY": "catesbeiana, Rana", "MN": "B01.050.150.900.090.180.708.180", "MH_TH": "NLM (1972)", "ST": "T011", "RN": "txid8400", "AN": "bullfrog; NIM when exper animal: no qualif; when IM, qualif permitted", "PI": "Anura (1966-1971)", "MS": "A species of the family Ranidae (true frogs). The only anuran properly referred to by the common name \"bullfrog\", it is the largest native anuran in North America.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011892"}, {"RECTYPE": "D", "MH": "Rana esculenta", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Pelophylax esculentus|T011|NON|EQV|NLM (2013)|120319|abcdef", "MN": "B01.050.150.900.090.180.708.240", "MH_TH": "NLM (1972)", "ST": "T011", "RN": "txid8401", "AN": "NIM with no qualifiers when experimental animal", "PI": "Anura (1966-1971)", "MS": "An edible species of the family Ranidae, occurring in Europe and used extensively in biomedical research. Commonly referred to as \"edible frog\".", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011893"}, {"RECTYPE": "D", "MH": "Rana pipiens", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Leopard Frog|T011|NON|EQV|NLM (1990)|890621|abcdef", "ENTRY": "Leopard Frogs", "MN": "B01.050.150.900.090.180.708.310", "MH_TH": "NLM (1972)", "ST": "T011", "RN": "txid8404", "AN": "NIM when exper animal: no qualif; when IM, qualif permitted", "PI": "Anura (1966-1971)", "MS": "A highly variable species of the family Ranidae in Canada, the United States and Central America. It is the most widely used Anuran in biomedical research.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011894"}, {"RECTYPE": "D", "MH": "Rana ridibunda", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.090.180.708.360", "MH_TH": "NLM (1981)", "ST": "T011", "RN": "txid8406", "AN": "laughing frog; NIM when exper animal: no qualif; when IM, qualif permitted", "PI": "Ranidae (1972-1980)", "MS": "A species of the family Ranidae which occurs primarily in Europe and is used widely in biomedical research.", "PM": "91; was see under RANIDAE 1981-90", "HN": "91(81); was see under RANIDAE 1981-90", "MR": "20200813", "DA": "19800512", "DC": "1", "DX": "19910101", "UI": "D011895"}, {"RECTYPE": "D", "MH": "Rana temporaria", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Frog, Common European|T011|EPO|EQV|UNK (19XX)|800402|abcdef", "ENTRY": "Frog, European Common", "MN": "B01.050.150.900.090.180.708.420", "MH_TH": "NLM (1972)", "ST": "T011", "RN": "txid8407", "AN": "NIM when exper animal: no qualif; when IM, qualif permitted", "PI": "Anura (1966-1971)", "MS": "A species of the family Ranidae occurring in a wide variety of habitats from within the Arctic Circle to South Africa, Australia, etc.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011896"}, {"RECTYPE": "D", "MH": "Random Allocation", "PRINT ENTRY": "Randomization|T062|NON|EQV|UNK (19XX)|770420|abcdef", "ENTRY": "Allocation, Random", "MN": "N06.850.520.445.700", "MH_TH": "NLM (1978)", "ST": "T062", "AN": "IM general only; coordinate NIM with specific subject (IM); do not add as a coordinate with RANDOMIZED CONTROLLED TRIAL (PT) or other CLINICAL TRIAL (PT)", "PI": "Research Design (1973-1977)", "MS": "A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects.", "PM": "91; was see under RESEARCH DESIGN 1978-90", "HN": "91(78); was see under RESEARCH DESIGN 1978-90", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D011897"}, {"RECTYPE": "D", "MH": "Ranidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Rana|T011|NON|NRW|UNK (19XX)|800508|abcdef", "ENTRY": "True Frogs", "MN": "B01.050.150.900.090.180.708", "MH_TH": "NLM (1972)", "ST": "T011", "RN": "txid8397", "RR": "txid8399", "AN": "general or unspecified; prefer specific genera; NIM when experimental animal", "PI": "Anura (1966-1971)", "MS": "The family of true frogs of the order Anura. The family occurs worldwide except in Antarctica.", "OL": "use RANIDAE to search RANA 1972-80", "PM": "81; was RANA 1972-80", "HN": "81; was RANA 1972-80", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011898"}, {"RECTYPE": "D", "MH": "Ranitidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Ranitidine", "MN": "D03.383.312.750", "PA": "Histamine H2 Antagonists", "MH_TH": "USAN (1979)", "ST": "T121", "N1": "1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-", "RN": "884KT10YB7", "RR": "BK76465IHM", "PI": "Furans (1966-1983)", "MS": "A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.", "PM": "84", "HN": "84", "MR": "20160531", "DA": "19830613", "DC": "1", "DX": "19840101", "UI": "D011899"}, {"RECTYPE": "D", "MH": "Ranula", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Ranulas", "MN": "C07.465.780", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "non-neoplastic", "MS": "A form of retention cyst of the floor of the mouth, usually due to obstruction of the ducts of the submaxillary or sublingual glands, presenting a slowly enlarging painless deep burrowing mucocele of one side of the mouth. It is also called sublingual cyst and sublingual ptyalocele.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19940524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D011900"}, {"RECTYPE": "D", "MH": "Ranvier's Nodes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Nodes of Ranvier|T030|EPO|EQV|NLM (1994)|921201|abcdef", "ENTRY": "Ranviers Nodes", "MN": "A11.671.501.512.560.700", "MH_TH": "NLM (1965)", "ST": "T030", "AN": "regular gaps in myelin sheath; A 11 qualif except /cytol; /genet permitted", "MS": "Regularly spaced gaps in the myelin sheaths of peripheral axons. Ranvier's nodes allow saltatory conduction, that is, jumping of impulses from node to node, which is faster and more energetically favorable than continuous conduction.", "PM": "73", "HN": "73(65)", "MR": "20220603", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011901"}, {"RECTYPE": "D", "MH": "Rape", "AQ": "DI LJ PC PX RH SN", "MN": "I01.880.735.900.772", "MH_TH": "NLM (1980)", "ST": "T054", "MS": "Sexual intercourse without consent of the victim.", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011902"}, {"RECTYPE": "D", "MH": "Raphe Nuclei", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Raphe Nucleus", "MN": "A08.186.211.132.810.591.500.662", "MH_TH": "NLM (1978)", "ST": "T023", "PI": "Reticular Formation (1966-1977)", "MS": "Collections of small neurons centrally scattered among many fibers from the level of the TROCHLEAR NUCLEUS in the midbrain to the hypoglossal area in the MEDULLA OBLONGATA.", "PM": "85; was see under BRAIN STEM 1978-84", "HN": "85(78); was see under BRAIN STEM 1978-84", "MR": "20150623", "DA": "19770427", "DC": "1", "DX": "19850101", "UI": "D011903"}, {"RECTYPE": "D", "MH": "Rare Books", "AQ": "HI", "ENTRY": "Rare Book", "MN": "L01.462.500.682.192.779", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "Books that are limited in availability, have early printing dates or special characteristics that increase the value of an individual copy, print run, or edition.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011904"}, {"RECTYPE": "D", "MH": "Genes, ras", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "v-Ki-ras Genes|T028|NRW|NLM (1991)|900327|abdef", "ENTRY": "v-Ki-ras Oncogene", "MN": "G05.360.340.024.340.375.500.791.550", "FX": "ras Proteins", "MH_TH": "NLM (1988)", "ST": "T028", "PI": "Oncogenes (1983-1987)", "MS": "Family of retrovirus-associated DNA sequences (ras) originally isolated from Harvey (H-ras, Ha-ras, rasH) and Kirsten (K-ras, Ki-ras, rasK) murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both H-ras and K-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related N-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein.", "OL": "use GENES, RAS to search RAS GENES 1988-1990 & use ONCOGENES 1985-1987", "PM": "1991; was RAS GENES 1988-1990; was RAS GENES see ONCOGENES 1985-1987", "HN": "1991; was RAS GENES 1988-1990; was RAS GENES see ONCOGENES 1985-1987", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19870509", "DC": "1", "DX": "19880101", "UI": "D011905"}, {"RECTYPE": "D", "MH": "Rat-Bite Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Spirillum minus Infection|T047|NON|EQV|NLM (2021)|190822|abcdef", "ENTRY": "Streptobacillus moniliformis Infections", "MN": "C01.150.252.400.771", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A syndrome characterized by recurring fever, rash, and arthralgias occurring days to weeks after a rat bite. The causative agents are either Streptobacillus moniliformis or Spirillum minus.", "OL": "use RAT-BITE FEVER to search RAT-BITE FEVER, SPIRILLARY 1966-67", "PM": "RAT-BITE FEVER, SPIRILLARY was heading 1963-67", "HN": "RAT-BITE FEVER, SPIRILLARY was heading 1963-67", "CATSH": "CAT LIST", "MR": "20200128", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011906"}, {"RECTYPE": "D", "MH": "Rate Setting and Review", "DE": "RATE SETTING", "AQ": "CL ES HI LJ MT OG SN ST TD", "ENTRY": "Settings, Review Rate", "MN": "N03.219.463.060.800", "FX": "Relative Value Scales", "MH_TH": "NLM (1980)", "ST": "T058", "PI": "Fees and Charges (1968-1979)", "MS": "A method of examining and setting levels of payments.", "PM": "80", "HN": "80", "MR": "20180701", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D011907"}, {"RECTYPE": "D", "MH": "Rationalization", "MN": "F01.393.746", "MH_TH": "NLM (1975)", "ST": "T041", "AN": "no qualif", "MS": "A defense mechanism operating unconsciously, in which the individual attempts to justify or make consciously tolerable, by plausible means, feelings, behavior, and motives that would otherwise be intolerable.", "OL": "search DEFENSE MECHANISMS 1966-74", "PM": "91; was see under DEFENSE MECHANISMS 1975-90", "HN": "91(75); was see under DEFENSE MECHANISMS 1975-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011908"}, {"RECTYPE": "D", "MH": "Rats, Brattleboro", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Brattleboro Rats", "MN": "B01.050.150.900.649.313.992.635.505.700.550.110", "MH_TH": "NLM (1983)", "ST": "T015", "AN": "NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS", "PI": "Rats, Mutant Strains (1982)", "MS": "A mutant strain of Rattus norvegicus used in research on renal function and hypertension and as a disease model for diabetes insipidus.", "PM": "91; was see under RATS, MUTANT STRAINS 1983-90", "HN": "91(83); was see under RATS, MUTANT STRAINS 1983-90", "MR": "20200902", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D011910"}, {"RECTYPE": "D", "MH": "Rats, Gunn", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Gunn Rat|T015|NON|EQV|NLM (2022)|201016|abcdef", "ENTRY": "Rat, Gunn", "MN": "B01.050.150.900.649.313.992.635.505.700.550.308", "MH_TH": "NLM (1982)", "ST": "T015", "AN": "NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS", "PI": "Rats (1977-1981)", "MS": "Mutant strain of Rattus norvegicus which is used as a disease model of kernicterus.", "PM": "91; was see under RATS, MUTANT STRAINS 1982-90", "HN": "91(82); was see under RATS, MUTANT STRAINS 1982-90", "MR": "20210630", "DA": "19810515", "DC": "1", "DX": "19910101", "UI": "D011911"}, {"RECTYPE": "D", "MH": "Rats, Inbred ACI", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rats, Inbred A x C 9935 Irish|T015|EPO|EQV|UNK (19XX)|810515|abcdef", "ENTRY": "Rat, Inbred ACI", "MN": "B01.050.150.900.649.313.992.635.505.700.400.080", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Rats (1966-1971)", "MS": "An inbred strain of rat that is widely used in BIOMEDICAL RESEARCH. Applications include the study of spontaneous NEOPLASMS; CHRONIC KIDNEY DISEASES, and CONGENITAL ABNORMALITIES.", "PM": "91; was see under RATS, INBRED STRAINS 1972-90", "HN": "91(72); was see under RATS, INBRED STRAINS 1972-90", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011912"}, {"RECTYPE": "D", "MH": "Rats, Inbred BB", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Bio-Breeding Inbred Rats|T015|NON|EQV|UNK (19XX)|850315|BIOBREEDING INBRED RATS|abcdefs", "ENTRY": "Wistar Rats, BB", "MN": "B01.050.150.900.649.313.992.635.505.700.400.090", "MH_TH": "NLM (1986)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal; model for DIABETES MELLITUS, INSULIN-DEPENDENT; do not confuse with RATS, BRATTLEBORO", "PI": "Rats, Inbred Strains (1972-1985)", "MS": "A strain of Rattus norvegicus which is a model for spontaneous insulin-dependent diabetes mellitus (DIABETES MELLITUS, INSULIN-DEPENDENT).", "PM": "91; was see under RATS, INBRED STRAINS 1986-90", "HN": "91(86); was see under RATS, INBRED STRAINS 1986-90", "MR": "20200902", "DA": "19850315", "DC": "1", "DX": "19910101", "UI": "D011913"}, {"RECTYPE": "D", "MH": "Rats, Inbred BN", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rats, Inbred Brown Norway|T015|EPO|EQV|UNK (19XX)|810515|abcdef", "ENTRY": "Rat, Inbred BN", "MN": "B01.050.150.900.649.313.992.635.505.700.400.110", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Rats (1966-1971)", "MS": "An inbred strain of rat that is widely used in a variety of research areas such as the study of ASTHMA; CARCINOGENESIS; AGING; and LEUKEMIA.", "PM": "91; was see under RATS, INBRED STRAINS 1972-90", "HN": "91(72); was see under RATS, INBRED STRAINS 1972-90", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011914"}, {"RECTYPE": "D", "MH": "Rats, Inbred BUF", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rats, Inbred Buffalo|T015|EPO|EQV|UNK (19XX)|810515|abcdef", "ENTRY": "Rat, Inbred BUF", "MN": "B01.050.150.900.649.313.992.635.505.700.400.130", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Rats (1966-1971)", "MS": "An inbred strain of rat that is used for cancer research, particularly  the study of  CARCINOGENESIS", "PM": "91; was see under RATS, INBRED STRAINS 1972-90", "HN": "91(72); was see under RATS, INBRED STRAINS 1972-90", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011915"}, {"RECTYPE": "D", "MH": "Rats, Inbred F344", "DS": "RATS INBRED F 344", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rats, Inbred Fischer 344|T015|EPO|EQV|UNK (19XX)|810515|abcdef", "ENTRY": "Rats, Fischer", "MN": "B01.050.150.900.649.313.992.635.505.700.400.200", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Rats (1966-1971)", "MS": "An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes.", "PM": "91; was see under RATS, INBRED STRAINS 1972-90", "HN": "91(72); was see under RATS, INBRED STRAINS 1972-90", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011916"}, {"RECTYPE": "D", "MH": "Rats, Inbred Lew", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rats, Inbred Lewis|T015|EPO|EQV|UNK (19XX)|810515|abcdef", "ENTRY": "Rat, Lew", "MN": "B01.050.150.900.649.313.992.635.505.700.400.280", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Rats (1966-1971)", "MS": "An inbred strain of rat that is used in BIOMEDICAL RESEARCH.", "PM": "91; was see under RATS, INBRED STRAINS 1972-90", "HN": "91(72); was see under RATS, INBRED STRAINS 1972-90", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011917"}, {"RECTYPE": "D", "MH": "Rats, Inbred SHR", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rats, Spontaneously Hypertensive|T015|NON|EQV|UNK (19XX)|840406|abcdef", "ENTRY": "Spontaneously Hypertensive Rats", "MN": "B01.050.150.900.649.313.992.635.505.700.400.300", "MH_TH": "NLM (1985)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal ", "PI": "Rats, Inbred Strains (1972-1984)", "MS": "A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke.", "PM": "91; was see under RATS, INBRED STRAINS 1985-90", "HN": "91(85); was see under RATS, INBRED STRAINS 1985-90", "MR": "20200902", "DA": "19840406", "DC": "1", "DX": "19910101", "UI": "D011918"}, {"RECTYPE": "D", "MH": "Rats, Inbred Strains", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "August Rats|T015|NON|NRW|NLM (1998)|960724|abcdef", "ENTRY": "Strains, Inbred Rat", "MN": "B01.050.150.900.649.313.992.635.505.700.400", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "general or unspecified; prefer specifics; NIM with no qualifiers when experimental animal;  entry term  AUGUST RATS is seen often in Russian literature ", "PI": "Rats (1966-1971)", "MS": "Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding.", "PM": "72", "HN": "72", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D011919"}, {"RECTYPE": "D", "MH": "Rats, Inbred WF", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rats, Wistar Furth|T015|EPO|EQV|UNK (19XX)|810615|abcdef", "ENTRY": "Wistar Furth Rats", "MN": "B01.050.150.900.649.313.992.635.505.700.400.360", "MH_TH": "NLM (1972)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Rats (1966-1971)", "MS": "An inbred strain of rat that is used in BIOMEDICAL RESEARCH.", "PM": "91; was see under RATS, INBRED STRAINS 1972-90", "HN": "91(72); was see under RATS, INBRED STRAINS 1972-90", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011920"}, {"RECTYPE": "D", "MH": "Rats, Inbred WKY", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Wistar Kyoto Rat|T015|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Wistar Kyoto Rats", "MN": "B01.050.150.900.649.313.992.635.505.700.400.390", "MH_TH": "NLM (1985)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal ", "PI": "Rats, Inbred Strains (1972-1984)", "MS": "A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR).", "PM": "91; was see under RATS, INBRED STRAINS 1985-90", "HN": "91(85); was see under RATS, INBRED STRAINS 1985-90", "MR": "20200902", "DA": "19840406", "DC": "1", "DX": "19910101", "UI": "D011921"}, {"RECTYPE": "D", "MH": "Rats, Mutant Strains", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Strains Rats, Mutant", "MN": "B01.050.150.900.649.313.992.635.505.700.550", "MH_TH": "NLM (1982)", "ST": "T015", "AN": "general or unspecified; prefer specifics; NIM with no qualifiers when experimental animal ", "PI": "Rats (1977-1981)", "MS": "Rats bearing mutant genes which are phenotypically expressed in the animals.", "PM": "82; RATS, ZUCKER was see under RATS 1981", "HN": "82", "MR": "20200902", "DA": "19810515", "DC": "1", "DX": "19820101", "UI": "D011922"}, {"RECTYPE": "D", "MH": "Rats, Nude", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rats, Athymic|T015|NON|EQV|UNK (19XX)|860530|abcdef", "ENTRY": "Rat, Nude", "MN": "B01.050.150.900.649.313.992.635.505.700.550.508", "MH_TH": "NLM (1987)", "ST": "T015", "AN": "NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS", "PI": "Rat, Mutant Strains (1982-1986)", "MS": "A mutant strain of Rattus norvegicus without a thymus and with depressed or absent T-cell function. This strain of rats may have a small amount of hair at times, but then lose it.", "PM": "91; was see under RATS, MUTANT STRAINS 1987-90", "HN": "91(87); was see under RATS, MUTANT STRAINS 1987-90", "MR": "20200902", "DA": "19860530", "DC": "1", "DX": "19910101", "UI": "D011923"}, {"RECTYPE": "D", "MH": "Rats, Zucker", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Zucker Rats|T015|EPO|EQV|UNK (19XX)|800512|abcdef", "ENTRY": "Rat, Zucker", "MN": "B01.050.150.900.649.313.992.635.505.700.550.700", "MH_TH": "NLM (1981)", "ST": "T015", "AN": "NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS", "PI": "Rats (1966-1980)", "MS": "Two populations of Zucker rats have been cited in research--the \"fatty\" or obese and the lean. The \"fatty\" rat (Rattus norvegicus) appeared as a spontaneous mutant. The obese condition appears to be due to a single recessive gene.", "PM": "91; was see under RATS, MUTANT STRAINS 1982-90; was see under RATS 1981", "HN": "91(81); was see under RATS, MUTANT STRAINS 1982-90; was see under RATS 1981", "MR": "20200902", "DA": "19800512", "DC": "1", "DX": "19910101", "UI": "D011924"}, {"RECTYPE": "D", "MH": "Rauscher Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "leukemia viruses, Rauscher", "MN": "B04.820.650.375.525.770", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid11784", "AN": "infection: coordinate IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + LEUKEMIA, EXPERIMENTAL (IM) or LEUKEMIA (IM) (for spontaneous leukemia)", "MS": "A strain of MURINE LEUKEMIA VIRUS associated with mouse tumors similar to those caused by the FRIEND MURINE LEUKEMIA VIRUS. It is a replication-competent murine leukemia virus. It can act as a helper virus when complexing with a defective transforming component, RAUSCHER SPLEEN FOCUS-FORMING VIRUS.", "PM": "66", "HN": "66", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011925"}, {"RECTYPE": "D", "MH": "Rauwolfia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "serpentina, Rauwolfia", "MN": "B01.875.800.575.912.250.456.500.777", "FX": "Secologanin Tryptamine Alkaloids", "MH_TH": "NLM (1966)", "ST": "T002", "RN": "txid4059", "RR": "txid4060", "MS": "A plant genus of the APOCYNACEAE or dogbane family. Alkaloids from plants in this genus have been used as tranquilizers and antihypertensive agents. RESERPINE is derived from R. serpentina.", "HN": "was in Cat B & D 1963-77", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011926"}, {"RECTYPE": "D", "MH": "Raynaud Disease", "DE": "RAYNAUD DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Raynauds Disease", "MN": "C17.800.862.406.750", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.", "PM": "2004; use RAYNAUD'S DISEASE 1966-2003", "HN": "2004 (1966)", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D011928"}, {"RECTYPE": "D", "MH": "Razoxane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NSC129943", "MN": "D03.383.606.385.500", "PA": "Antimitotic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+-)-", "RN": "5AR83PR647", "RR": "79703-22-3 ((R)-isomer, mesylate)", "PI": "Propane (1973-1974)", "MS": "An antimitotic agent with immunosuppressive properties.", "OL": "use RAZOXANE to search ICRF 159 1975-78", "PM": "91; was see under PIPERAZINES 1979-90; was ICRF 159 see under PIPERAZINES 1975-78", "HN": "91(79); was see under PIPERAZINES 1979-90; was ICRF 159 see under PIPERAZINES 1975-78", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D011929"}, {"RECTYPE": "D", "MH": "Reaction Time", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Response Time|T079|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Speeds, Response", "MN": "G11.561.677", "MH_TH": "NLM (1966)", "ST": "T079", "AN": "physiological processes only", "MS": "The time from the onset of a stimulus until a response is observed.", "OL": "use REACTION TIME to search RESPONSE LATENCY 1970-76", "HN": "RESPONSE LATENCY was see under REACTION TIME 1970-76", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D011930"}, {"RECTYPE": "D", "MH": "Reactive Inhibition", "DE": "REACTIVE INHIB", "ENTRY": "Reactive Inhibitions", "MN": "F02.463.425.475.724", "MH_TH": "NLM (1975)", "ST": "T055", "AN": "no qualif", "MS": "Tendency toward a lessened strength of response due to practice or activity. It is independent of the effect of reward and is a direct function of time interval since the last response and the number of preceding responses.", "OL": "search INHIBITION (PSYCHOLOGY) 1971-74", "PM": "91; was see under INHIBITION (PSYCHOLOGY) 1975-90", "HN": "91(75); was see under INHIBITION (PSYCHOLOGY) 1975-90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011931"}, {"RECTYPE": "D", "MH": "Reading", "MN": "L01.559.423.557", "FX": "Dyslexia, Acquired", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "Braille: coordinate with VISION DISORDERS + SENSORY AIDS ", "MS": "Acquiring information from text.", "MR": "20180206", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011932"}, {"RECTYPE": "D", "MH": "Reagent Kits, Diagnostic", "DE": "REAGENT KITS DIAG", "AQ": "CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Diagnostic Reagent Kits|T074|T130|NON|EQV|UNK (19XX)|770418|DIAG REAGENT KITS|abbcdefv", "ENTRY": "Test Kits, Diagnostic", "MN": "E07.720", "FX": "Diagnostic Tests, Routine", "MH_TH": "NLM (1978)", "ST": "T130", "RN": "0", "MS": "Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20170531", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D011933"}, {"RECTYPE": "D", "MH": "Reagent Strips", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Strips, Reagent", "MN": "E07.720.720", "MH_TH": "NLM (1973)", "ST": "T130", "RN": "0", "AN": "D25-26 qualif with discretion", "PI": "Indicators and Reagents (1966-1972)", "MS": "Narrow pieces of material impregnated or covered with a substance used to produce a chemical reaction. The strips are used in detecting, measuring, producing, etc., other substances. (From Dorland, 28th ed)", "PM": "87; was see under INDICATORS AND REAGENTS 1975-86", "HN": "87(73); was see under INDICATORS AND REAGENTS 1975-86", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D011934"}, {"RECTYPE": "D", "MH": "Reagins", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Reagin|T116|T129|NON|EQV|NLM (2021)|191122|abbcdef", "MN": "D12.776.377.715.548.114.890", "PA": "Immunologic Factors", "MH_TH": "NLM (1975)", "ST": "T129", "RN": "0", "MS": "Antibodies, especially IGE, that bind to tissue of the same species so that ANTIGENS induce HISTAMINE RELEASE and other vasoactive agents. HYPERSENSITIVITY is the clinical manifestation.", "OL": "use IGE to search REAGINS 1966-74 (as Prov 1966-71)", "PM": "91,72; was see under ANTIBODIES 1975-90; was see under IGE 1973-74; was heading 1972", "HN": "91(75)72(66-71); was see under ANTIBODIES 1975-90; was see under IGE 1966-71, 1973-74 (Prov 1966-71); was heading 1972", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011935"}, {"RECTYPE": "D", "MH": "Reality Testing", "ENTRY": "Testings, Reality", "MN": "F02.739.794.206.508", "MH_TH": "NLM (1979)", "ST": "T041", "AN": "note category: not a diag test: \"ego function that consists of the objective evaluation & judgment of the external world\"; no qualif", "MS": "The individual's objective evaluation of the external world and the ability to differentiate adequately between it and the internal world; considered to be a primary ego function.", "PM": "91; was see under EGO 1979-90", "HN": "91(79); was see under EGO 1979-90", "CATSH": "CAT LIST", "MR": "19900413", "DA": "19780426", "DC": "1", "DX": "19910101", "UI": "D011936"}, {"RECTYPE": "D", "MH": "Reality Therapy", "DE": "REALITY THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapies, Reality", "MN": "F04.754.804", "MH_TH": "NLM (1974)", "ST": "T061", "MS": "Method of psychotherapeutic treatment based on assumption of patients' personal responsibility for their own behavior. The therapist actively guides patients to accurate self-perception for fulfillment of needs of self-worth and respect for others. (From APA, Thesaurus of Psychological Index Terms, 8th ed.)", "PM": "74", "HN": "74", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011937"}, {"RECTYPE": "D", "MH": "Rec A Recombinases", "DS": "RECA RECOMBINASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Rec A Protein|T116|T126|ABB|EQV|NLM (1984)|990101|RECA PROTEIN|abbcdefs", "ENTRY": "Recombinases, Rec A", "MN": "D08.811.913.696.445.692", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.7.7.-", "PI": "Bacterial Proteins (1966-1983)", "MS": "A family of recombinases initially identified in BACTERIA. They catalyze the ATP-driven exchange of DNA strands in GENETIC RECOMBINATION. The product of the reaction consists of a duplex and a displaced single-stranded loop, which has the shape of the letter D and is therefore called a D-loop structure.", "PM": "2004; see REC A PROTEIN 1984-2003, see REC A PROTEIN (NM) 1966-1983", "HN": "2004(1984)", "MR": "20050630", "DA": "19830615", "DC": "1", "DX": "19840101", "UI": "D011938"}, {"RECTYPE": "D", "MH": "Mental Recall", "AQ": "CL DE ES PH RE", "ENTRY": "Recall, Mental", "MN": "F02.463.425.540.641", "FX": "Comprehension", "MH_TH": "NLM (2003)", "ST": "T041", "MS": "The process whereby a representation of past experience is elicited.", "OL": "search MEMORY 1966-74", "PM": "2003; see RECALL 1991-2002, see MEMORY 1966-1990", "HN": "2003 (1966); use MEMORY 1966-1990", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011939"}, {"RECTYPE": "D", "MH": "Receptor Aggregation", "DE": "RECEPT AGGREGATION", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Capping, Receptor|T044|NON|EQV|UNK (19XX)|830224|CAPPING RECEPT|abcdefv", "ENTRY": "Receptor Capping|T044|NON|EQV|NLM (1992)|910522|RECEPT CAPPING|abcdefv", "MN": "G04.774", "FX": "Receptor Cross-Talk", "MH_TH": "NLM (1984)", "ST": "T044", "PI": "specific receptor (1968-1983)", "MS": "Chemically stimulated aggregation of cell surface receptors, which potentiates the action of the effector cell.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19830224", "DC": "1", "DX": "19840101", "UI": "D011940"}, {"RECTYPE": "D", "MH": "Receptors, Adrenergic", "DE": "RECEPT ADREN", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Norepinephrine|T116|T192|NON|NRW|NLM (1994)|930322|RECEPT NOREPINEPHRINE|abbcdefv", "ENTRY": "Receptor, Norepinephrine", "MN": "D12.776.543.750.720.330.300", "EC": "antagonists & inhibitors:Adrenergic Antagonists", "MH_TH": "NLM (1971)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics; coordinate with specific adrenergic agent ", "PI": "Receptors, Drug (1968-1970)", "MS": "Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of G-proteins with which they bind; this scheme does not respect the alpha-beta distinction.", "OL": "use RECEPTORS, ADRENERGIC to search RECEPTORS, NOREPINEPHRINE, NORADRENALINE RECEPTORS, NOREPINEPHRINE RECEPTORS & RECEPTORS NORADRENALINE 1993", "PM": "73; RECEPTORS, NOREPINEPHRINE was heading 1993; NORADRENALINE RECEPTORS, NOREPINEPHRINE RECEPTORS, & RECEPTORS, NORADRENALINE were see RECEPTORS, NOREPINEPHRINE 1993", "HN": "73(71); RECEPTORS, NOREPINEPHRINE was heading 1993; NORADRENALINE RECEPTORS, NOREPINEPHRINE RECEPTORS, & RECEPTORS, NORADRENALINE were see RECEPTORS, NOREPINEPHRINE 1993", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011941"}, {"RECTYPE": "D", "MH": "Receptors, Adrenergic, alpha", "DE": "RECEPT ADREN ALPHA", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "alpha-Adrenergic Receptors|T116|T192|NON|EQV|UNK (19XX)|760501|ALPHA ADREN RECEPT|abbcdefv", "ENTRY": "alpha-Receptors, Adrenergic", "MN": "D12.776.543.750.720.330.300.300", "EC": "antagonists & inhibitors:Adrenergic alpha-Antagonists", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "PI": "Receptors, Drug (1968-1976)", "MS": "One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation.", "PM": "84; was see under RECEPTORS, ADRENERGIC 1977-83", "HN": "84(77); was see under RECEPTORS, ADRENERGIC 1977-83", "MR": "20210630", "DA": "19760503", "DC": "1", "DX": "19840101", "UI": "D011942"}, {"RECTYPE": "D", "MH": "Receptors, Adrenergic, beta", "DE": "RECEPT ADREN BETA", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "beta-Adrenergic Receptors|T116|T192|NON|EQV|UNK (19XX)|760501|BETA ADREN RECEPT|abbcdefv", "ENTRY": "beta-Receptors, Adrenergic", "MN": "D12.776.543.750.720.330.300.340", "EC": "antagonists & inhibitors:Adrenergic beta-Antagonists", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "PI": "Receptors, Drug (1968-1972)", "MS": "One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS.", "PM": "84; was see under RECEPTORS, ADRENERGIC 1977-83", "HN": "84(77); was see under RECEPTORS, ADRENERGIC 1977-83", "MR": "20200527", "DA": "19760503", "DC": "1", "DX": "19840101", "UI": "D011943"}, {"RECTYPE": "D", "MH": "Receptors, Androgen", "DE": "RECEPT ANDROGEN", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Androgen Receptors|T116|T192|NON|EQV|UNK (19XX)|760505|ANDROGEN RECEPT|abbcdefv", "ENTRY": "alpha-Dihydrotestosterone Receptor, 5", "MN": "D12.776.826.750.150", "FX": "Prostatic Neoplasms, Castration-Resistant", "EC": "antagonists & inhibitors:Androgen Receptor Antagonists", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1973-1976)", "MS": "Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA.", "PM": "1986; see RECEPTORS, STEROID 1977-1985; STANOLONE RECEPTORS was indexed under RECEPTORS, ANDROGEN 1980-2008; TESTOSTERONE RECEPTOR was indexed under RECEPTORS, ANDROGEN 1990-2008, & under RECEPTORS, STEROID 1981-1989", "HN": "1986(1977)", "MR": "20150623", "DA": "19760505", "DC": "1", "DX": "19860101", "UI": "D011944"}, {"RECTYPE": "D", "MH": "Receptors, Angiotensin", "DE": "RECEPT ANGIOTENSIN", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Angiotensin Receptors|T116|T192|NON|EQV|UNK (19XX)|760429|ANGIOTENSIN RECEPT|abbcdefv", "ENTRY": "Receptor, Angiotensin", "MN": "D12.776.543.750.750.130", "EC": "antagonists & inhibitors:Angiotensin Receptor Antagonists", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "AN": "note specific subtypes; do not confuse receptors that bind to ANGIOTENSIN II and ANGIOTENSIN III with specific angiotensin receptor subtypes", "PI": "Receptors, Endogenous Substances (1973-1976)", "MS": "Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells.", "PM": "87; was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86", "HN": "87(77); was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86", "MR": "20200527", "DA": "19760503", "DC": "1", "DX": "19870101", "UI": "D011945"}, {"RECTYPE": "D", "MH": "Receptors, Antigen", "DE": "RECEPT ANTIGEN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Antigen Receptors|T116|T129|T192|NON|EQV|UNK (19XX)|790524|ANTIGEN RECEPT|abbbcdefv", "ENTRY": "Receptor, Antigen", "MN": "D12.776.543.750.705.816", "MH_TH": "NLM (1980)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "T Lymphocytes (1973-1979)", "MS": "Molecules on the surface of B- and T-lymphocytes that recognize and combine with specific antigens.", "PM": "80", "HN": "80", "MR": "20030709", "DA": "19790524", "DC": "1", "DX": "19800101", "UI": "D011946"}, {"RECTYPE": "D", "MH": "Receptors, Antigen, B-Cell", "DE": "RECEPT ANTIGEN B CELL", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Surface Immunoglobulin|T116|T129|T192|NON|EQV|NLM (2021)|191119|abbbcdef", "ENTRY": "Receptors, B-Cell Antigen", "MN": "D12.776.543.750.705.816.821", "PA": "Immunologic Factors", "MH_TH": "NLM (1980)", "ST": "T192", "RN": "0", "PI": "Lymphocytes (1966-1979)", "MS": "IMMUNOGLOBULINS on the surface of B-LYMPHOCYTES. Their MESSENGER RNA contains an EXON with a membrane spanning sequence, producing immunoglobulins in the form of type I transmembrane proteins as opposed to secreted immunoglobulins (ANTIBODIES) which do not contain the membrane spanning segment.", "PM": "1980; for IMMUNOGLOBULINS, SURFACE see IMMUNOGLOBULINS, SURFACE 1975-2005; for MEMBRANE-BOUND IMMUNOGLOBULINS see IMMUNOGLOBULINS, SURFACE 1975-2005", "HN": "1980 (1975)", "MR": "20200527", "DA": "19790524", "DC": "1", "DX": "19800101", "UI": "D011947"}, {"RECTYPE": "D", "MH": "Receptors, Antigen, T-Cell", "DE": "RECEPT ANTIGEN T CELL", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "T-Cell Receptors|T116|T129|T192|EQV|NLM (1992)|901115|T CELL RECEPT|abbbdefv", "ENTRY": "T-Cell Antigen Receptors", "MN": "D12.776.543.750.705.816.824", "FX": "Genes, T-Cell Receptor", "MH_TH": "NLM (1980)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics; do not confuse their gamma-delta chains with gamma and delta chains which are subunits of CD3 antigens (index under ANTIGENS, CD3)", "PI": "T Lymphocytes (1973-1979)", "MS": "Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.", "PM": "80", "HN": "80", "MR": "20170713", "DA": "19790524", "DC": "1", "DX": "19800101", "UI": "D011948"}, {"RECTYPE": "D", "MH": "Receptors, Cholecystokinin", "DE": "RECEPT CHOLECYSTOKININ", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Sincalide Receptors|T116|T192|NON|NRW|UNK (19XX)|860331|SINCALIDE RECEPT|abbcdefv", "ENTRY": "Receptors, CCK 8", "MN": "D12.776.543.750.750.555.270", "MH_TH": "NLM (1987)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1973-1986)", "MS": "Cell surface proteins that bind cholecystokinin (CCK) with high affinity and trigger intracellular changes influencing the behavior of cells. Cholecystokinin receptors are activated by GASTRIN as well as by CCK-4; CCK-8; and CCK-33. Activation of these receptors evokes secretion of AMYLASE by pancreatic acinar cells, acid and PEPSIN by stomach mucosal cells, and contraction of the PYLORUS and GALLBLADDER. The role of the widespread CCK receptors in the central nervous system is not well understood.", "PM": "87", "HN": "87", "MR": "20160617", "DA": "19860331", "DC": "1", "DX": "19870101", "UI": "D011949"}, {"RECTYPE": "D", "MH": "Receptors, Cholinergic", "DE": "RECEPT CHOLINERGIC", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Acetylcholine|T116|T192|NON|EQV|UNK (19XX)|810514|RECEPT ACETYLCHOLINE|abbcdefv", "ENTRY": "Sites, Cholinoceptive", "MN": "D12.776.543.750.720.360", "EC": "antagonists & inhibitors:Cholinergic Antagonists", "MH_TH": "NLM (1971)", "ST": "T192", "RN": "0", "PI": "specific agonist, tissue, or organ affected (1966-1970)", "MS": "Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology.", "PM": "74", "HN": "74(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D011950"}, {"RECTYPE": "D", "MH": "Receptors, Complement", "DE": "RECEPT COMPLEMENT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Complement Receptors|T116|T129|T192|NON|EQV|UNK (19XX)|790524|COMPLEMENT RECEPT|abbbcdefv", "ENTRY": "Receptor, Complement", "MN": "D12.776.543.750.705.833", "MH_TH": "NLM (1980)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Lymphocytes (1966-1979)", "MS": "Molecules on the surface of some B-lymphocytes and macrophages, that recognize and combine with the C3b, C3d, C1q, and C4b components of complement.", "PM": "80", "HN": "80", "MR": "20030709", "DA": "19790524", "DC": "1", "DX": "19800101", "UI": "D011951"}, {"RECTYPE": "D", "MH": "Receptors, Concanavalin A", "DE": "RECEPT CON A", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Concanavalin A Receptors|T116|T192|NON|EQV|UNK (19XX)|760429|CON A RECEPT|abbcdefv", "ENTRY": "Receptor, Concanavalin A|T116|T192|NON|EQV|UNK (19XX)|780509|RECEPT CONC A|abbcdefv", "MN": "D12.776.543.750.705.880.600", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "PI": "Receptors, Drug (1968-1976)", "MS": "Glycoprotein moieties on the surfaces of cell membranes that bind concanavalin A selectively; the number and location of the sites depends on the type and condition of the cell.", "PM": "80; was see under RECEPTORS, DRUG 1977-79", "HN": "80(77); was see under RECEPTORS, DRUG 1977-79", "MR": "20180701", "DA": "19760503", "DC": "1", "DX": "19800101", "UI": "D011952"}, {"RECTYPE": "D", "MH": "Receptors, Cyclic AMP", "DE": "RECEPT CYCL AMP", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "cAMP Receptors|T116|T192|EQV|NLM (1994)|930305|CAMP RECEPT|abbdefv", "ENTRY": "Receptor, cAMP", "MN": "D12.776.543.750.720.700.150", "FX": "Cyclic AMP-Dependent Protein Kinases", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "AN": "coord IM with specific cyclic AMP cpd (IM)", "PI": "Receptors, Endogenous Substances (1973-1976)", "MS": "Cell surface proteins that bind cyclic AMP with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized cyclic AMP receptors are those of the slime mold Dictyostelium discoideum. The transcription regulator CYCLIC AMP RECEPTOR PROTEIN of prokaryotes is not included nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins which are the regulatory subunits of CYCLIC AMP-DEPENDENT PROTEIN KINASES.", "PM": "77", "HN": "77", "MR": "20190524", "DA": "19760503", "DC": "1", "DX": "19770101", "UI": "D011953"}, {"RECTYPE": "D", "MH": "Receptors, Dopamine", "DE": "RECEPT DOPAMINE", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Dopamine Receptors|T116|T192|NON|EQV|UNK (19XX)|760501|DOPAMINE RECEPT|abbcdefv", "ENTRY": "Receptor, Dopamine", "MN": "D12.776.543.750.720.330.400", "EC": "antagonists & inhibitors:Dopamine Antagonists", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "PI": "Receptors, Drug (1968-1976)", "MS": "Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells.", "PM": "77", "HN": "77", "MR": "20160617", "DA": "19760503", "DC": "1", "DX": "19770101", "UI": "D011954"}, {"RECTYPE": "D", "MH": "Receptors, Drug", "DE": "RECEPT DRUG", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Drug Receptors|T116|T192|NON|EQV|UNK (19XX)|740330|DRUG RECEPT|abbcdefv", "ENTRY": "Receptor, Drug", "MN": "D12.776.827", "MH_TH": "NLM (1968)", "ST": "T192", "RN": "0", "AN": "do not confuse with CHEMORECEPTOR CELLS: TN 160; coord IM with specific drug or chemical (IM)", "PI": "Pharmacology (1966-1967)", "MS": "Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified.", "PM": "68", "HN": "68", "MR": "20090713", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011955"}, {"RECTYPE": "D", "MH": "Receptors, Cell Surface", "DE": "RECEPT CELL SURFACE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Endogenous Substances|T116|T192|NON|BRD|NLM (1994)|921207|RECEPT ENDOGENOUS SUBSTANCES|abbcdefv", "ENTRY": "Surface Receptor, Cell", "MN": "D12.776.543.750", "MH_TH": "NLM (1973)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics; coord IM with specific endogenous substance (IM); for hormone receptors in general coord HORMONES (IM) and RECEPTORS, CELL SURFACE (IM) or RECEPTORS, CYTOPLASMIC AND NUCLEAR (IM), for receptors of specific hormones, coord specific hormone or hormone group (IM) and precoord hormone receptor (e.g., RECEPTORS, ALDOSTERONE) (IM) or precoord hormone-group receptor (e.g., RECEPTORS, GLUCOCORTICOID) (IM)", "PI": "Receptors, Drug (1968-1972)", "MS": "Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands.", "OL": "use RECEPTORS, CELL SURFACE to search RECEPTORS, ENDOGENOUS SUBSTANCES 1983-93, CELL RECEPTORS 1985-93, HORMONE RECEPTORS 1975-93, RECEPTORS BIOLOGICAL 1985-93, & RECEPTORS, HORMONE 1973-93", "PM": "94; was RECEPTORS, ENDOGENOUS SUBSTANCES 1983-93; was RECEPTORS, HORMONE 1973-82; CELL RECEPTORS & RECEPTORS, BIOLOGIC were see RECEPTORS, ENDOGENOUS SUBSTANCES 1985-93; HORMONE RECEPTORS was see RECEPTORS, ENDOGENOUS SUBSTANCES 1975-93", "HN": "94; was RECEPTORS, ENDOGENOUS SUBSTANCES 1983-93; was RECEPTORS, HORMONE 1973-82; CELL RECEPTORS & RECEPTORS, BIOLOGIC were see RECEPTORS, ENDOGENOUS SUBSTANCES 1985-93; HORMONE RECEPTORS was see RECEPTORS, ENDOGENOUS SUBSTANCES 1975-93", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D011956"}, {"RECTYPE": "D", "MH": "Receptors, Opioid", "DE": "RECEPT OPIOID", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Opiate|T116|T192|NON|EQV|UNK (19XX)|790503|RECEPT OPIATE|abbcdefv", "ENTRY": "beta-Endorphin Receptors", "MN": "D12.776.543.750.750.555.610", "EC": "antagonists & inhibitors:Narcotic Antagonists", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "PI": "Receptors, Drug (1966-1976)", "MS": "Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known.", "OL": "use RECEPTORS, OPIOID to search RECEPTORS, ENDORPHIN 1980-93 & RECEPTORS, NARCOTIC 1977-79", "PM": "94; was RECEPTORS, ENDORPHIN 1980-93; was RECEPTORS, NARCOTIC 1977-79", "HN": "94; was RECEPTORS, ENDORPHIN 1980-93; was RECEPTORS, NARCOTIC 1977-79", "MR": "20160617", "DA": "19760503", "DC": "1", "DX": "19770101", "UI": "D011957"}, {"RECTYPE": "D", "MH": "Receptors, Estradiol", "DE": "RECEPT ESTRADIOL", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Estradiol Receptors|T116|T192|NON|EQV|UNK (19XX)|840424|ESTRADIOL RECEPT|abbcdefv", "ENTRY": "Receptor, Estradiol", "MN": "D12.776.826.750.350.350", "MH_TH": "NLM (1985)", "ST": "T192", "RN": "0", "PI": "Receptors, Estrogen (1977-1984)", "MS": "Cytoplasmic proteins that bind estradiol, migrate to the nucleus, and regulate DNA transcription.", "PM": "89; was see under RECEPTORS, ESTROGEN 1985-88", "HN": "89(85); was see under RECEPTORS, ESTROGEN 1985-88", "MR": "20150623", "DA": "19840524", "DC": "1", "DX": "19890101", "UI": "D011959"}, {"RECTYPE": "D", "MH": "Receptors, Estrogen", "DE": "RECEPT ESTROGEN", "AQ": "AD AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Estrogen Receptors|T116|T192|NON|EQV|UNK (19XX)|760429|ESTROGEN RECEPT|abbcdefv", "ENTRY": "Receptor, Estrogen", "MN": "D12.776.930.778.350", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "AN": "coord IM with specific estrogen (IM)", "PI": "Receptors, Endogenous Substances (1973-1976)", "MS": "Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.", "PM": "77", "HN": "77", "MR": "20200527", "DA": "19760503", "DC": "1", "DX": "19770101", "UI": "D011960"}, {"RECTYPE": "D", "MH": "Receptors, Fc", "DE": "RECEPT FC", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Fc Receptors|T116|T129|T192|EQV|UNK (19XX)|790524|FC RECEPT|abbbdefv", "ENTRY": "Receptor, Fc", "MN": "D12.776.543.750.705.871", "MH_TH": "NLM (1980)", "ST": "T192", "RN": "0", "PI": "Lymphocytes (1966-1979)", "MS": "Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules.", "PM": "80", "HN": "80", "MR": "20030709", "DA": "19790524", "DC": "1", "DX": "19800101", "UI": "D011961"}, {"RECTYPE": "D", "MH": "Receptors, FSH", "DE": "RECEPT FSH", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Follicle-Stimulating Hormone|T116|T192|NON|EQV|NLM (1993)|920429|RECEPT FOLLICLE STIMULATING HORMONE|abbcdefv", "ENTRY": "Receptors, Follicle Stimulating Hormone", "MN": "D12.776.543.750.750.660.350.300", "MH_TH": "NLM (1987)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1973-1986)", "MS": "Cell surface proteins that bind FOLLICLE STIMULATING HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells.", "OL": "use RECEPTORS, FSH to search FOLLITROPIN RECEPTORS 1987-92", "PM": "87; FOLLITROPIN RECEPTORS was see RECEPTORS, FSH 1987-92", "HN": "87; FOLLITROPIN RECEPTORS was see RECEPTORS, FSH 1987-92", "MR": "20160617", "DA": "19860331", "DC": "1", "DX": "19870101", "UI": "D011962"}, {"RECTYPE": "D", "MH": "Receptors, GABA-A", "DE": "RECEPT GABA A", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Muscimol|T116|T192|NON|EQV|UNK (19XX)|840531|RECEPT MUSCIMOL|abbcdefv", "ENTRY": "gamma Aminobutyric Acid Subtype A Receptors", "MN": "D12.776.543.750.720.200.300.300", "EC": "antagonists & inhibitors:GABA-A Receptor Antagonists", "MH_TH": "NLM (1985)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1973-1984)", "MS": "Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and contain an integral membrane chloride channel. Each receptor is assembled as a pentamer from a pool of at least 19 different possible subunits. The receptors belong to a superfamily that share a common CYSTEINE loop.", "PM": "1994; see RECEPTORS, GABA-BENZODIAZEPINE 1985-1993; DELTA SUBUNIT, GABA-A RECEPTOR was indexed under RECEPTORS, GABA-A 2006-2010; EPSILON SUBUNIT, GABA-A RECEPTOR was indexed under RECEPTORS, GABA-A 2002-2010", "HN": "1994; was RECEPTORS, GABA-BENZODIAZEPINE 1985-1993", "MR": "20160701", "DA": "19840531", "DC": "1", "DX": "19850101", "UI": "D011963"}, {"RECTYPE": "D", "MH": "Receptors, Gastrointestinal Hormone", "DE": "RECEPT GASTROINTESTINAL HORMONE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Gastrointestinal Peptides|T116|T192|NON|EQV|NLM (1994)|921215|RECEPT GASTROINTESTINAL PEPTIDES|abbcdefv", "ENTRY": "Receptor, Intestinal Hormone", "MN": "D12.776.543.750.750.360", "MH_TH": "NLM (1987)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics; coordinate with specific hormone ", "PI": "Receptors, Endogenous Substances (1973-1986)", "MS": "Cell surface proteins that bind gastrointestinal hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Most gastrointestinal hormones also act as neurotransmitters so these receptors are also present in the central and peripheral nervous systems.", "PM": "87", "HN": "87", "MR": "20190524", "DA": "19860331", "DC": "1", "DX": "19870101", "UI": "D011964"}, {"RECTYPE": "D", "MH": "Receptors, Glucocorticoid", "DE": "RECEPT GLUCOCORTICOID", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Glucocorticoids Receptor|T116|T192|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Receptor, Glucocorticoids", "MN": "D12.776.826.750.430", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "AN": "coord IM with specific glucocorticoid (IM)", "PI": "Receptors, Endogenous Substances (1973-1976)", "MS": "Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example.", "PM": "86; was see under RECEPTORS, STEROID 1977-85", "HN": "86(77); was see under RECEPTORS, STEROID 1977-85", "MR": "20200527", "DA": "19760505", "DC": "1", "DX": "19860101", "UI": "D011965"}, {"RECTYPE": "D", "MH": "Receptors, LHRH", "DE": "RECEPT LHRH", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Luliberin|T116|T192|NON|EQV|NLM (1993)|920512|RECEPT LULIBERIN|abbcdefv", "ENTRY": "Releasing-Hormone Receptors, Gonadotropin", "MN": "D12.776.543.750.750.700.460", "FX": "Inhibins", "MH_TH": "NLM (1987)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1973-1986)", "MS": "Receptors with a 6-kDa protein on the surfaces of cells that secrete LUTEINIZING HORMONE or FOLLICLE STIMULATING HORMONE, usually in the adenohypophysis. LUTEINIZING HORMONE-RELEASING HORMONE binds to these receptors, is endocytosed with the receptor and, in the cell, triggers the release of LUTEINIZING HORMONE or FOLLICLE STIMULATING HORMONE by the cell. These receptors are also found in rat gonads. INHIBINS prevent the binding of GnRH to its receptors.", "OL": "use RECEPTORS, LHRH to search RECEPTORS, GONADORELIN 1992-93 & RECEPTORS, GONADOLIBERIN & FOLIBERIN RECEPTORS 1987-91", "PM": "94; was RECEPTORS, GONADORELIN 1992-93; was RECEPTORS, GONADOLIBERIN 1987-91; FOLIBERIN RECEPTORS was see RECEPTORS, GONADOLIBERIN 1987-91", "HN": "94; was RECEPTORS, GONADORELIN 1992-93; was RECEPTORS, GONADOLIBERIN 1987-91; FOLIBERIN RECEPTORS was see RECEPTORS, GONADOLIBERIN 1987-91", "MR": "20160617", "DA": "19860325", "DC": "1", "DX": "19870101", "UI": "D011966"}, {"RECTYPE": "D", "MH": "Receptors, Gonadotropin", "DE": "RECEPT GONADOTROPIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Menotropin|T116|T192|NON|NRW|NLM (1993)|920429|RECEPT MENOTROPIN|abbcdefv", "ENTRY": "Receptor, Pituitary Gonadotropin", "MN": "D12.776.543.750.750.660.350", "MH_TH": "NLM (1987)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Endogenous Substances (1973-1986)", "MS": "Those protein complexes or molecular sites on the surfaces of gonadal and other sensitive cells that bind gonadotropins and thereby modify the functions of those cells; hCG, LH, and FOLLICLE STIMULATING HORMONE are the major specific gonadotropins.", "PM": "87", "HN": "87", "MR": "20190524", "DA": "19860325", "DC": "1", "DX": "19870101", "UI": "D011967"}, {"RECTYPE": "D", "MH": "Receptors, Histamine", "DE": "RECEPT HISTAMINE", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Histamine Receptors|T116|T192|NON|EQV|UNK (19XX)|760429|HISTAMINE RECEPT|abbcdefv", "ENTRY": "Sites, Histamine Binding", "MN": "D12.776.543.750.720.480", "EC": "antagonists & inhibitors:Histamine Antagonists", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Endogenous Substances (1973-1976)", "MS": "Cell-surface proteins that bind histamine and trigger intracellular changes influencing the behavior of cells. Histamine receptors are widespread in the central nervous system and in peripheral tissues. Three types have been recognized and designated H1, H2, and H3. They differ in pharmacology, distribution, and mode of action.", "PM": "77", "HN": "77", "MR": "20160617", "DA": "19760503", "DC": "1", "DX": "19770101", "UI": "D011968"}, {"RECTYPE": "D", "MH": "Receptors, Histamine H1", "DE": "RECEPT HISTAMINE H1", "DS": "RECEPTORS HISTAMINE H 001", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Histamine H1 Receptors|T116|T192|NON|EQV|UNK (19XX)|760505|HISTAMINE RECEPTORS H 001|HISTAMINE H1 RECEPT|abbcdefsv", "ENTRY": "Receptor, Histamine H1", "MN": "D12.776.543.750.720.480.300", "EC": "antagonists & inhibitors:Histamine H1 Antagonists", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "PI": "Receptors, Drug (1970-1976)", "MS": "A class of histamine receptors discriminated by their pharmacology and mode of action. Most histamine H1 receptors operate through the inositol phosphate/diacylglycerol second messenger system. Among the many responses mediated by these receptors are smooth muscle contraction, increased vascular permeability, hormone release, and cerebral glyconeogenesis. (From Biochem Soc Trans 1992 Feb;20(1):122-5)", "PM": "89; was see under RECEPTORS, HISTAMINE 1977-88", "HN": "89(77); was see under RECEPTORS, HISTAMINE 1977-88", "MR": "20200527", "DA": "19760505", "DC": "1", "DX": "19890101", "UI": "D011969"}, {"RECTYPE": "D", "MH": "Receptors, Histamine H2", "DE": "RECEPT HISTAMINE H2", "DS": "RECEPTORS HISTAMINE H 02", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Histamine H2 Receptors|T116|T192|NON|EQV|UNK (19XX)|760505|HISTAMINE RECEPTORS H 002|HISTAMINE H2 RECEPT|abbcdefsv", "ENTRY": "H2 Receptors, Histamine", "MN": "D12.776.543.750.720.480.400", "EC": "antagonists & inhibitors:Histamine H2 Antagonists", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "AN": "receptors for the non-classical antihistaminics (HISTAMINE H2 ANTAGONISTS)", "PI": "Receptors, Drug (1970-1976)", "MS": "A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H2 receptors act via G-proteins to stimulate ADENYLYL CYCLASES. Among the many responses mediated by these receptors are gastric acid secretion, smooth muscle relaxation, inotropic and chronotropic effects on heart muscle, and inhibition of lymphocyte function. (From Biochem Soc Trans 1992 Feb;20(1):122-5)", "PM": "87; was see under RECEPTORS, HISTAMINE 1977-86", "HN": "87(77); was see under RECEPTORS, HISTAMINE 1977-86", "MR": "20190524", "DA": "19760505", "DC": "1", "DX": "19870101", "UI": "D011970"}, {"RECTYPE": "D", "MH": "Receptors, Immunologic", "DE": "RECEPT IMMUNOL", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Immunologic Receptors|T116|T129|T192|NON|EQV|UNK (19XX)|790524|IMMUNOL RECEPT|abbbcdefv", "ENTRY": "Receptors, Immunological", "MN": "D12.776.543.750.705", "FX": "Immunologic Factors", "MH_TH": "NLM (1980)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "T Lymphocytes (1973-1979)", "MS": "Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere.", "PM": "80", "HN": "80", "MR": "20030709", "DA": "19790524", "DC": "1", "DX": "19800101", "UI": "D011971"}, {"RECTYPE": "D", "MH": "Receptor, Insulin", "DE": "RECEPT INSULIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Insulin Receptor beta Subunit|T116|T126|NON|NRW|NLM (2000)|991103|INSULIN RECEPT BETA SUBUNIT|abbcdefv", "ENTRY": "Insulin Receptors", "MN": "D12.776.543.750.750.580.300", "FX": "Donohue Syndrome", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptors, Endogenous Substances (1973-1976)", "MS": "A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE.", "PM": "2000; for INSULIN RECEPTOR PROTEIN-TYROSINE KINASE see INSULIN RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999; INSULIN-DEPENDENT PROTEIN TYROSINE KINASE was indexed under PROTEIN-TYROSINE KINASE 1986-1993 & PROTEIN KINASES 1983-1985", "HN": "2000(1977); for INSULIN RECEPTOR PROTEIN-TYROSINE KINASE use RECEPTOR, INSULIN (NM) 1983-1993", "MR": "20210521", "DA": "19760503", "DC": "1", "DX": "19770101", "UI": "D011972"}, {"RECTYPE": "D", "MH": "Receptors, LDL", "DE": "RECEPT LDL", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Low Density Lipoprotein|T116|T192|NON|EQV|UNK (19XX)|840525|RECEPT LOW DENSITY LIPOPROTEIN|abbcdefv", "ENTRY": "Receptors, Lipoprotein LDL", "MN": "D12.776.543.750.710.450", "FX": "Lipoproteins, LDL", "MH_TH": "NLM (1985)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1973-1984)", "MS": "Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking.", "OL": "use RECEPTORS, LDL to search LIPOPROTEINS, LDL RECEPTORS 1985-92", "PM": "85; LIPOPROTEINS, LDL RECEPTORS was see RECEPTORS, LDL 1985-92", "HN": "85; LIPOPROTEINS, LDL RECEPTORS was see RECEPTORS, LDL 1985-92", "MR": "20060705", "DA": "19840525", "DC": "1", "DX": "19850101", "UI": "D011973"}, {"RECTYPE": "D", "MH": "Receptors, LH", "DE": "RECEPT LH", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "hCG Receptors|T116|T192|EQV|UNK (19XX)|860331|HCG RECEPT|abbdefv", "ENTRY": "Receptors, LH hCG", "MN": "D12.776.543.750.750.660.350.450", "MH_TH": "NLM (1987)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1973-1986)", "MS": "Those protein complexes or molecular sites on the surfaces and cytoplasm of gonadal cells that bind luteinizing or chorionic gonadotropic hormones and thereby cause the gonadal cells to synthesize and secrete sex steroids. The hormone-receptor complex is internalized from the plasma membrane and initiates steroid synthesis.", "OL": "use RECEPTORS, GONADOTROPIN to search CHORIONIC GONADOTROPIN RECEPTORS 1986-93", "PM": "87; CHORIONIC GONADOTROPIN RECEPTORS was see RECEPTORS, GONADOTROPIN 1986-93", "HN": "87; CHORIONIC GONADOTROPIN RECEPTORS was see RECEPTORS, GONADOTROPIN 1986-93", "MR": "20210630", "DA": "19860331", "DC": "1", "DX": "19870101", "UI": "D011974"}, {"RECTYPE": "D", "MH": "Receptors, Mitogen", "DE": "RECEPT MITOGEN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Lectin|T109|T116|T192|NON|REL|UNK (19XX)|810514|RECEPT LECTIN|abbbcdefv", "ENTRY": "Receptor, Mitogen", "MN": "D12.776.543.750.705.880", "MH_TH": "NLM (1980)", "ST": "T192", "RN": "0", "PI": "T Lymphocytes (1973-1979)", "MS": "Glycoprotein molecules on the surface of B- and T-lymphocytes, that react with molecules of antilymphocyte sera, lectins, and other agents which induce blast transformation of lymphocytes.", "PM": "80", "HN": "80", "MR": "20030709", "DA": "19790524", "DC": "1", "DX": "19800101", "UI": "D011975"}, {"RECTYPE": "D", "MH": "Receptors, Muscarinic", "DE": "RECEPT MUSCARINIC", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Muscarinic Receptors|T116|T192|NON|EQV|UNK (19XX)|760429|MUSCARINIC RECEPT|abbcdefv", "ENTRY": "Receptors, Muscarinic Acetylcholine", "MN": "D12.776.543.750.720.360.500", "EC": "antagonists & inhibitors:Muscarinic Antagonists", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Drug (1968-1976)", "MS": "One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology.", "PM": "84; was see under RECEPTORS, CHOLINERGIC 1977-83", "HN": "84(77); was see under RECEPTORS, CHOLINERGIC 1977-83", "MR": "20160617", "DA": "19760503", "DC": "1", "DX": "19840101", "UI": "D011976"}, {"RECTYPE": "D", "MH": "Receptors, Nicotinic", "DE": "RECEPT NICOTINIC", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Nicotinic Receptors|T116|T192|NON|EQV|UNK (19XX)|760429|NICOTINIC RECEPT|abbcdefv", "ENTRY": "Receptors, Nicotinic Acetylcholine", "MN": "D12.776.543.750.720.360.550", "EC": "antagonists & inhibitors:Nicotinic Antagonists", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "PI": "Receptors, Drug (1968-1976)", "MS": "One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors.", "PM": "84; was see under RECEPTORS, CHOLINERGIC 1977-83", "HN": "84(77); was see under RECEPTORS, CHOLINERGIC 1977-83", "MR": "20160701", "DA": "19760503", "DC": "1", "DX": "19840101", "UI": "D011978"}, {"RECTYPE": "D", "MH": "Receptors, Pituitary Hormone", "DE": "RECEPT PITUITARY HORMONE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Pituitary Hormone Receptors|T116|T192|NON|EQV|UNK (19XX)|860331|PITUITARY HORMONE RECEPT|abbcdefv", "ENTRY": "Pituitary Hormones Receptors", "MN": "D12.776.543.750.750.660", "MH_TH": "NLM (1987)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics; coordinate with specific pituitary hormone ", "PI": "Receptors, Endogenous Substances (1973-1986)", "MS": "Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system.", "PM": "87", "HN": "87", "MR": "19950608", "DA": "19860331", "DC": "1", "DX": "19870101", "UI": "D011979"}, {"RECTYPE": "D", "MH": "Receptors, Progesterone", "DE": "RECEPT PROGESTERONE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Progestin|T116|T192|NON|EQV|UNK (19XX)|840411|RECEPT PROGESTIN|abbcdefv", "ENTRY": "Receptor, Progestin", "MN": "D12.776.826.750.765", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "AN": "coordinate with specific progesterone", "PI": "Receptors, Endogenous Substances (1973-1976)", "MS": "Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.", "PM": "77", "HN": "77", "MR": "20210630", "DA": "19760503", "DC": "1", "DX": "19770101", "UI": "D011980"}, {"RECTYPE": "D", "MH": "Receptors, Prolactin", "DE": "RECEPT PROLACTIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Prolactin Receptors|T116|T192|NON|EQV|UNK (19XX)|860331|PROLACTIN RECEPT|abbcdefv", "ENTRY": "Receptor, Prolactin", "MN": "D12.776.543.750.750.660.350.725", "MH_TH": "NLM (1987)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1973-1986)", "MS": "Labile proteins on or in prolactin-sensitive cells that bind prolactin initiating the cells' physiological response to that hormone. Mammary casein synthesis is one of the responses. The receptors are also found in placenta, liver, testes, kidneys, ovaries, and other organs and bind and respond to certain other hormones and their analogs and antagonists. This receptor is related to the growth hormone receptor.", "PM": "87", "HN": "87", "MR": "19950608", "DA": "19860331", "DC": "1", "DX": "19870101", "UI": "D011981"}, {"RECTYPE": "D", "MH": "Receptors, Prostaglandin", "DE": "RECEPT PG", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Prostaglandin Receptors|T116|T192|NON|EQV|UNK (19XX)|760429|PG RECEPT|abbcdefv", "ENTRY": "Prostaglandins Receptors", "MN": "D12.776.543.750.695.200.700", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "AN": "coord IM with specific natural or synthetic prostaglandin (IM); RECEPTORS, PROSTAGLANDIN E is available", "PI": "Receptors, Drug (1968-1976)", "MS": "Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors).", "PM": "87; was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86", "HN": "87(77); was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86", "MR": "20190524", "DA": "19760503", "DC": "1", "DX": "19870101", "UI": "D011982"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic", "DE": "RECEPT PURINERGIC", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Purinoceptors|T116|T192|NON|EQV|NLM (1994)|930104|abbcdef", "ENTRY": "Receptor, Purinergic", "MN": "D12.776.543.750.720.700", "EC": "antagonists & inhibitors:Purinergic Antagonists", "MH_TH": "NLM (1987)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Endogenous Substances (1973-1986)", "MS": "Cell surface proteins that bind PURINES with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized classes of purinergic receptors in mammals are the P1 receptors, which prefer ADENOSINE, and the P2 receptors, which prefer ATP or ADP.", "OL": "use RECEPTORS, PURINERGIC to search CAFFEINE RECEPTORS, METHYLXANTHINE RECEPTORS, & THEOPHYLLINE RECEPTORS 1987-93, & RECEPTORS, CAFFEINE & RECEPTORS, THEOPHYLLINE 1993", "PM": "87; CAFFEINE RECEPTORS, METHYLXANTHINE RECEPTORS, & THEOPHYLLINE RECEPTORS were see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, CAFFEINE & RECEPTORS, THEOPHYLLINE were see RECEPTORS, PURINERGIC 1993", "HN": "87; CAFFEINE RECEPTORS, METHYLXANTHINE RECEPTORS, & THEOPHYLLINE RECEPTORS were see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, CAFFEINE & RECEPTORS, THEOPHYLLINE were see RECEPTORS, PURINERGIC 1993", "MR": "20200527", "DA": "19860331", "DC": "1", "DX": "19870101", "UI": "D011983"}, {"RECTYPE": "D", "MH": "Sensory Receptor Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Receptors, Neural|T025|NON|EQV|NLM (1976)|890713|RECEPT NEURAL|abcdefv", "ENTRY": "Sensory Receptor Cell", "MN": "A11.671.650.915", "MH_TH": "NLM (2009)", "ST": "T025", "MS": "Specialized afferent neurons capable of transducing sensory stimuli into NERVE IMPULSES to be transmitted to the CENTRAL NERVOUS SYSTEM. Sometimes sensory receptors for external stimuli are called exteroceptors; for internal stimuli are called interoceptors and proprioceptors.", "PM": "2009; see RECEPTORS, SENSORY 1977-2008, see RECEPTORS, NEURAL 1963-1976; for SENSORY NEURONS see NEURONS, AFFERENT 2007-2008", "HN": "2009 (1963); for SENSORY NEURONS use NEURONS, AFFERENT 2007-2008", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011984"}, {"RECTYPE": "D", "MH": "Receptors, Serotonin", "DE": "RECEPT SEROTONIN", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Tryptamine Receptors|T116|T192|NON|REL|UNK (19XX)|760501|TRYPTAMINE RECEPT|abbcdefv", "ENTRY": "Receptors, 5 Hydroxytryptamine", "MN": "D12.776.543.750.720.850", "EC": "antagonists & inhibitors:Serotonin Antagonists", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Serotonin (1966-1976)", "MS": "Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action.", "PM": "77", "HN": "77", "MR": "20200527", "DA": "19760503", "DC": "1", "DX": "19770101", "UI": "D011985"}, {"RECTYPE": "D", "MH": "Receptors, Somatotropin", "DE": "RECEPT SOMATOTROPIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Somatotropin Receptors|T116|T192|NON|EQV|UNK (19XX)|860331|SOMATOTROPIN RECEPT|abbcdefv", "ENTRY": "Hormone Receptors, Growth", "MN": "D12.776.543.750.750.660.750", "MH_TH": "NLM (1987)", "ST": "T192", "RN": "0", "PI": "Somatotropin (1966-1986)", "MS": "Cell surface proteins that bind GROWTH HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells. Activation of growth hormone receptors regulates amino acid transport through cell membranes, RNA translation to protein, DNA transcription, and protein and amino acid catabolism in many cell types. Many of these effects are mediated indirectly through stimulation of the release of somatomedins.", "PM": "87", "HN": "87", "MR": "20130709", "DA": "19860331", "DC": "1", "DX": "19870101", "UI": "D011986"}, {"RECTYPE": "D", "MH": "Receptors, Steroid", "DE": "RECEPT STEROID", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Steroid Receptors|T116|T192|NON|EQV|UNK (19XX)|760429|STEROID RECEPT|abbcdefv", "ENTRY": "Steroids Receptors", "MN": "D12.776.930.778", "MH_TH": "NLM (1977)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Steroids (1966-1976)", "MS": "Proteins found usually in the cytoplasm or nucleus that specifically bind steroid hormones and trigger changes influencing the behavior of cells. The steroid receptor-steroid hormone complex regulates the transcription of specific genes.", "OL": "use RECEPTORS, GLUCOCORTICOID to search RECEPTORS, CORTICOSTEROID 1984-93 & CORTICOSTEROID RECEPTORS 1993", "PM": "77; RECEPTORS, CORTICOSTEROID was see RECEPTORS, GLUCOCORTICOID 1984-93; CORTICOSTEROID RECEPTORS was see RECEPTORS, GLUCOCORTICOID 1993", "HN": "77; RECEPTORS, CORTICOSTEROID was see RECEPTORS, GLUCOCORTICOID 1984-93; CORTICOSTEROID RECEPTORS was see RECEPTORS, GLUCOCORTICOID 1993", "MR": "20150623", "DA": "19760503", "DC": "1", "DX": "19770101", "UI": "D011987"}, {"RECTYPE": "D", "MH": "Receptors, Thyroid Hormone", "DE": "RECEPT THYROID HORMONE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Triiodothyronine Receptors|T116|T192|NON|NRW|UNK (19XX)|860331|TRIIODOTHYRONINE RECEPT|abbcdefv", "ENTRY": "Thyroxine Receptor|T116|T192|NON|NRW|NLM (1994)|930312|abbcdef", "MN": "D12.776.826.850", "FX": "Thyroid Hormone Resistance Syndrome", "MH_TH": "NLM (1987)", "ST": "T192", "RN": "0", "AN": "coordinate with specific thyroid hormone ", "PI": "Triiodothyronine (1966-1986)", "MS": "Specific high affinity binding proteins for THYROID HORMONES in target cells. They are usually found in the nucleus and regulate DNA transcription. These receptors are activated by hormones that leads to transcription, cell differentiation, and growth suppression. Thyroid hormone receptors are encoded by two genes (GENES, ERBA): erbA-alpha and erbA-beta for alpha and beta thyroid hormone receptors, respectively.", "OL": "use RECEPTORS, THYROID HORMONE (NM) to search PROTO-ONCOGENE PROTEIN ERBA 1987-93", "PM": "87; PROTO-ONCOGENE PROTEIN ERBA was indexed under PROTO-ONCOGENE PROTEINS 1987-93", "HN": "87; PROTO-ONCOGENE PROTEIN ERBA was (NM) 1987-93", "MR": "20150623", "DA": "19860331", "DC": "1", "DX": "19870101", "UI": "D011988"}, {"RECTYPE": "D", "MH": "Receptors, Thyrotropin", "DE": "RECEPT THYROTROPIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Thyrotropin Receptors|T116|T192|NON|EQV|UNK (19XX)|860331|THYROTROPIN RECEPT|abbcdefv", "ENTRY": "Receptors, Long Acting Thyroid Stimulator", "MN": "D12.776.543.750.750.660.825", "MH_TH": "NLM (1987)", "ST": "T192", "RN": "0", "PI": "Thyrotropin (1966-1986)", "MS": "Cell surface proteins that bind pituitary THYROTROPIN (also named thyroid stimulating hormone or TSH) and trigger intracellular changes of the target cells. TSH receptors are present in the nervous system and on target cells in the thyroid gland. Autoantibodies to TSH receptors are implicated in thyroid diseases such as GRAVES DISEASE and Hashimoto disease (THYROIDITIS, AUTOIMMUNE).", "PM": "1987; for RECEPTORS, LONG ACTING THYROID STIMULATOR see RECEPTORS, THYROID HORMONE 1993-2002", "HN": "1987; for RECEPTORS, LONG ACTING THYROID STIMULATOR use RECEPTORS, THYROID HORMONE 1993-2002", "MR": "20050701", "DA": "19860331", "DC": "1", "DX": "19870101", "UI": "D011989"}, {"RECTYPE": "D", "MH": "Receptors, Transferrin", "DE": "RECEPT TRANSFERRIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Transferrin Receptors|T116|T192|NON|EQV|UNK (19XX)|860331|TRANSFERRIN RECEPT|abbcdefv", "ENTRY": "Receptor, Transferrin", "MN": "D12.776.543.750.800", "FX": "Carrier Proteins", "MH_TH": "NLM (1987)", "ST": "T192", "RN": "0", "PI": "Transferrin (1966-1986)", "MS": "Membrane glycoproteins found in high concentrations on iron-utilizing cells. They specifically bind iron-bearing transferrin, are endocytosed with its ligand and then returned to the cell surface where transferrin without its iron is released.", "PM": "87", "HN": "87", "MR": "20160617", "DA": "19860331", "DC": "1", "DX": "19870101", "UI": "D011990"}, {"RECTYPE": "D", "MH": "Receptors, Virus", "AQ": "AD AG AI AN BI BL CH CL DE GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Virus Receptors|T109|T192|NON|EQV|UNK (19XX)|780519|abbcdef", "ENTRY": "Receptors, Virus Entry", "MN": "D12.776.543.750.830", "FX": "Virus Attachment", "MH_TH": "NLM (1979)", "ST": "T192", "RN": "0", "PI": "Binding Sites (1968-1978)", "MS": "Specific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response.", "PM": "1979", "HN": "1979", "MR": "20200622", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D011991"}, {"RECTYPE": "D", "MH": "Endosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Receptosomes|T026|NON|EQV|NLM (1995)|930915|abcdef", "ENTRY": "Receptosome", "MN": "A11.284.430.214.190.875.190.880.337", "FX": "Exosomes", "MH_TH": "NLM (1983)", "ST": "T026", "PI": "Endocytosis (1973-1982)", "MS": "Cytoplasmic vesicles formed when COATED VESICLES shed their CLATHRIN coat. Endosomes internalize macromolecules bound by receptors on the cell surface.", "OL": "use ENDOSOMES to search RECEPTOSOMES 1983-94", "PM": "95; was RECEPTOSOMES 1983-94", "HN": "95; was RECEPTOSOMES 1983-94", "MR": "20090706", "DA": "19820419", "DC": "1", "DX": "19830101", "UI": "D011992"}, {"RECTYPE": "D", "MH": "Recombinant Fusion Proteins", "AQ": "AD AE AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Recombinant Hybrid Protein|T116|T123|NON|NRW|NLM (2021)|191122|abbcdef", "ENTRY": "Proteins, Recombinant Hybrid", "MN": "D12.776.828.300", "FX": "Immunotoxins", "MH_TH": "NLM (1987)", "ST": "T116", "RN": "0", "AN": "do not confuse with MEMBRANE FUSION PROTEINS; VIRAL FUSION PROTEINS; MUTANT CHIMERIC PROTEINS; or ONCOGENE PROTEINS, FUSION", "MS": "Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes.", "PM": "1990; see RECOMBINANT PROTEINS 1987-1989; for CHIMERIC PROTEINS, RECOMBINANT see CHIMERIC PROTEINS 1993-2005", "HN": "1990(1987)", "MR": "20200527", "DA": "19860616", "DC": "1", "DX": "19900101", "UI": "D011993"}, {"RECTYPE": "D", "MH": "Recombinant Proteins", "AQ": "AD AE AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Recombinant Protein|T116|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Recombinant Proteins, DNA", "MN": "D12.776.828", "MH_TH": "NLM (1986)", "ST": "T116", "RN": "0", "AN": "IM general only; coordinate NIM with specific protein", "PI": "Proteins or specific protein (1966-1985)", "MS": "Proteins prepared by recombinant DNA technology.", "PM": "86", "HN": "86", "MR": "20200527", "DA": "19850308", "DC": "1", "DX": "19860101", "UI": "D011994"}, {"RECTYPE": "D", "MH": "Recombination, Genetic", "DE": "RECOMBINATION GENET", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Genetic Recombination|T045|NON|EQV|NLM (1990)|890501|GENET RECOMBINATION|abcdefv", "ENTRY": "Recombinations, Genetic", "MN": "G05.728", "FX": "Reassortant Viruses", "MH_TH": "NLM (1968)", "ST": "T045", "PI": "Genetics (1966-1967)", "MS": "Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011995"}, {"RECTYPE": "D", "MH": "Records", "AQ": "CL EC LJ SN ST VE", "PRINT ENTRY": "Records as Topic|T170|NON|EQV|NLM (2008)|070625|abcdef", "ENTRY": "Records as Topics", "MN": "N06.850.520.308.940", "MH_TH": "NLM (2019)", "ST": "T170", "PI": "Nursing Records (1967)", "MS": "Works on authentic evidence, of something having legal importance. The concept includes certificates of birth, death, etc., as well as hospital, medical, and other institutional records.", "PM": "2008; see RECORDS 1968-2007", "HN": "2008(1968)", "CATSH": "CAT LIST", "MR": "20180713", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D011996"}, {"RECTYPE": "D", "MH": "Recovery Room", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Recovery Rooms|T073|T093|NON|EQV|NLM (1997)|951004|HOSP RECOVERY ROOMS|abbcdefv", "ENTRY": "Rooms, Recovery|T073|T093|NON|EQV|NLM (1997)|951004|abbcdef", "MN": "N02.278.388.493.592", "MH_TH": "NLM (1975)", "ST": "T093", "PI": "Intensive Care Units (1966-1974)", "MS": "Hospital unit providing continuous monitoring of the patient following anesthesia.", "OL": "search INTENSIVE CARE UNITS 1966-74", "PM": "79; was see under INTENSIVE CARE UNITS 1966-78", "HN": "79(75); was see under INTENSIVE CARE UNITS 1966-78", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D011997"}, {"RECTYPE": "D", "MH": "Recreation", "AQ": "EC HI PH PX", "ENTRY": "Recreations", "MN": "I03.450.642", "MH_TH": "NLM (1966)", "ST": "T056", "MS": "Activity engaged in for pleasure.", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D011998"}, {"RECTYPE": "D", "MH": "Recruitment, Neurophysiological", "DE": "RECRUITMENT NEUROPHYSIOL", "AQ": "DE ES GE IM PH RE", "ENTRY": "Neurophysiological Recruitment", "MN": "G11.561.601.760", "FX": "Recruitment Detection, Audiologic", "MH_TH": "NLM (2007)", "ST": "T042", "PI": "Neural Transmission (1968-1971)", "MS": "The spread of response if stimulation is prolonged. (Campbell's Psychiatric Dictionary, 8th ed.)", "PM": "2007; see RECRUITMENT (NEUROLOGY) 1991-2006; see NEURAL CONDUCTION 1977-1990; see NEURAL TRANSMISSION 1975-1976", "HN": "2007 (1972)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D011999"}, {"RECTYPE": "D", "MH": "Recruitment Detection, Audiologic", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Short Increment Sensitivity Index|T081|NON|REL|UNK (19XX)|780522|abcdef", "ENTRY": "Recruitment Detection, Loudness", "MN": "E01.370.382.375.650", "FX": "Recruitment, Neurophysiological", "MH_TH": "NLM (2007)", "ST": "T060", "PI": "Auditory Threshold (1968-1978)", "MS": "Tests for measuring loudness recruitment.", "PM": "2007; see RECRUITMENT DETECTION (AUDIOLOGY) 1979-2006", "HN": "2007 (1979)", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D012000"}, {"RECTYPE": "D", "MH": "Hyperacusis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Recruitment, Loudness|T184|NON|EQV|NLM (1979)|990101|abcdef", "ENTRY": "Phonophobias", "MN": "C23.888.592.763.393.505", "MH_TH": "NLM (2000)", "ST": "T184", "PI": "Perception (1966-1967)", "MS": "An abnormally disproportionate increase in the sensation of loudness in response to auditory stimuli of normal volume. COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; FACIAL NERVE DISEASES; STAPES SURGERY; and other disorders may be associated with this condition.", "PM": "2000; see RECRUITMENT LOUDNESS 1979-1999", "HN": "2000(1979)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D012001"}, {"RECTYPE": "D", "MH": "Rectal Diseases", "DE": "RECTAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Rectal Disorder", "MN": "C06.405.469.860", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological developments in the RECTUM region of the large intestine (INTESTINE, LARGE).", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20160706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012002"}, {"RECTYPE": "D", "MH": "Rectal Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anal Fistula|T190|NON|NRW|NLM (1993)|911106|abcdef", "ENTRY": "Fistula, Rectal", "MN": "C23.300.575.185.550.600", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "do not confuse entry term ANAL FISTULA with FISSURE IN ANO; RECTOVAGINAL FISTULA is also available", "MS": "An abnormal anatomical passage connecting the RECTUM to the outside, with an orifice at the site of drainage.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012003"}, {"RECTYPE": "D", "MH": "Rectal Neoplasms", "DE": "RECTAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Rectal Tumors|T191|NON|EQV|NLM (2004)|030428|abcdef", "ENTRY": "Tumor, Rectal", "MN": "C06.405.469.860.180.500", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM); familial: consider also COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS", "MS": "Tumors or cancer of the RECTUM.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012004"}, {"RECTYPE": "D", "MH": "Rectal Prolapse", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anus Prolapse|T047|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Rectal Prolapses", "MN": "C23.300.842.624.500", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "Protrusion of the rectal mucous membrane through the anus. There are various degrees: incomplete with no displacement of the anal sphincter muscle; complete with displacement of the anal sphincter muscle; complete with no displacement of the anal sphincter muscle but with herniation of the bowel; and internal complete with rectosigmoid or upper rectum intussusception into the lower rectum.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012005"}, {"RECTYPE": "D", "MH": "Rectovaginal Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Rectovaginal Fistulas", "MN": "C23.300.575.925.558", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "fistula policy: Manual 23.19+", "MS": "An abnormal anatomical passage between the RECTUM and the VAGINA.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012006"}, {"RECTYPE": "D", "MH": "Rectum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Rectums", "MN": "A03.556.249.249.767", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at PROCT-", "MS": "The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL.", "MR": "20160503", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012007"}, {"RECTYPE": "D", "MH": "Recurrence", "PRINT ENTRY": "Relapse|T067|NON|NRW|NLM (1992)|910108|abcdef", "ENTRY": "Relapses", "MN": "C23.550.291.937", "FX": "Neoplasm Recurrence, Local", "EC": "prevention & control:Secondary Prevention", "MH_TH": "NLM (1971)", "ST": "T067", "AN": "coordinate NIM with specific disease", "MS": "The return of a sign, symptom, or disease after a remission.", "PM": "91; was see under DISEASE 1971-90", "HN": "91(71); was see under DISEASE 1971-90", "CATSH": "CAT LIST", "MR": "20140606", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012008"}, {"RECTYPE": "D", "MH": "Recurrent Laryngeal Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Laryngeal Nerve, Inferior|T023|NON|NRW|NLM (1994)|921006|abcdef", "ENTRY": "Recurrent Laryngeal Nerves", "MN": "A08.800.800.120.900.450.700", "EC": "injuries:Recurrent Laryngeal Nerve Injuries", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "Branches of the vagus (tenth cranial) nerve. The recurrent laryngeal nerves originate more caudally than the superior laryngeal nerves and follow different paths on the right and left sides. They carry efferents to all muscles of the larynx except the cricothyroid and carry sensory and autonomic fibers to the laryngeal, pharyngeal, tracheal, and cardiac regions.", "OL": "search LARYNGEAL NERVES 1966-74", "PM": "91; was see under LARYNGEAL NERVES 1975-90", "HN": "91(75); was see under LARYNGEAL NERVES 1975-90", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012009"}, {"RECTYPE": "D", "MH": "Red-Cell Aplasia, Pure", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pure Red-Cell Aplasia|T047|NON|EQV|UNK (19XX)|840529|abcdef", "ENTRY": "Red-Cell Aplasias, Pure", "MN": "C15.378.050.750", "MH_TH": "NLM (1985)", "ST": "T047", "AN": "a form of anemia", "PI": "Anemia, Aplastic (1966-1984)", "MS": "Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.", "OL": "use RED-CELL APLASIA, PURE to search RED CELL APLASIA, PURE 1985-91", "PM": "92; was RED CELL APLASIA, PURE 1985-91", "HN": "92; was RED CELL APLASIA, PURE 1985-91", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19840529", "DC": "1", "DX": "19850101", "UI": "D012010"}, {"RECTYPE": "D", "MH": "Red Cross", "AQ": "EC HI OG", "ENTRY": "Red Crescent|T095|NAM|EQV|NLM (2009)|080429|abcdef", "MN": "N03.540.630.780.608", "MH_TH": "NLM (1966)", "ST": "T095", "AN": "specify geographic location; CATALOGER: Coordinate with specific NAF entry if applicable", "MS": "International collective of humanitarian organizations led by volunteers and guided by its Congressional Charter and the Fundamental Principles of the International Red Cross Movement, to provide relief to victims of disaster and help people prevent, prepare for, and respond to emergencies.", "PM": "66", "HN": "66", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012011"}, {"RECTYPE": "D", "MH": "Red Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Nucleus Ruber|T023|NON|EQV|NLM (1998)|960815|abcdef", "ENTRY": "Nucleus, Red", "MN": "A08.186.211.132.659.413.875.642", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A pinkish-yellow portion of the midbrain situated in the rostral mesencephalic tegmentum. It receives a large projection from the contralateral half of the CEREBELLUM via the superior cerebellar peduncle and a projection from the ipsilateral MOTOR CORTEX.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012012"}, {"RECTYPE": "D", "MH": "Reference Books", "AQ": "ST", "ENTRY": "Reference Book", "MN": "L01.462.500.682.192.836", "FX": "Textbooks as Topic", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "IM", "MS": "Books designed by the arrangement and treatment of their subject matter to be consulted for definite terms of information rather than to be read consecutively. Reference books include DICTIONARIES; ENCYCLOPEDIAS; ATLASES; etc. (From the ALA Glossary of Library and Information Science, 1983)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012013"}, {"RECTYPE": "D", "MH": "Reference Books, Medical", "DE": "REFERENCE BOOKS MED", "ENTRY": "Medical Reference Books|T073|T170|NON|EQV|NLM (1991)|891204|MED REFERENCE BOOKS|abbcdefv", "MN": "L01.462.500.682.192.836.842", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "Books in the field of medicine intended primarily for consultation.", "PM": "75", "HN": "75", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D012014"}, {"RECTYPE": "D", "MH": "Reference Standards", "DE": "REFERENCE STAND", "PRINT ENTRY": "Standards, Reference|T081|T130|NON|EQV|UNK (19XX)|780324|STAND REFERENCE|abbcdefv", "ENTRY": "Standard, Reference", "MN": "E05.978.808", "MH_TH": "NLM (1979)", "ST": "T130", "MS": "A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy.", "PM": "79", "HN": "79", "MR": "20080708", "DA": "19780324", "DC": "1", "DX": "19790101", "UI": "D012015"}, {"RECTYPE": "D", "MH": "Reference Values", "PRINT ENTRY": "Reference Ranges|T081|NON|EQV|UNK (19XX)|781215|abcdef", "ENTRY": "Values, Reference", "MN": "E05.978.810", "FX": "Biological Variation, Population", "MH_TH": "NLM (1977)", "ST": "T081", "MS": "The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality.", "OL": "use REFERENCE VALUES to search NORMAL VALUES 1977-79", "PM": "80; was NORMAL VALUES 1977-79", "HN": "80; was NORMAL VALUES 1977-79", "MR": "20170623", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D012016"}, {"RECTYPE": "D", "MH": "Referral and Consultation", "DE": "REFERRAL CONSULTATION", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Second Opinion|T170|NON|REL|UNK (19XX)|790411|abcdef", "ENTRY": "Second Opinions", "MN": "N04.452.758.849", "FX": "Tertiary Care Centers", "MH_TH": "POPLINE (1990)", "ST": "T057", "PI": "Interprofessional Relations (1966-1967)", "MS": "The practice of sending a patient to another program or practitioner for services or advice which the referring source is not prepared to provide.", "PM": "68", "HN": "68", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012017"}, {"RECTYPE": "D", "MH": "Reflex", "AQ": "DE ES GE IM PH RE", "MN": "G11.561.731", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "areflexia, hyporeflexia, hyperreflexia, loss of reflex: index under REFLEX, ABNORMAL", "MS": "An involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.", "HN": "REFLEX, BABINSKI was BABINSKI REFLEX see under REFLEX, ABNORMAL 1968-89", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012018"}, {"RECTYPE": "D", "MH": "Reflex Sympathetic Dystrophy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sudek Atrophy|T047|EPO|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Type I, CRPS", "MN": "C10.668.829.250.800", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A syndrome characterized by severe burning pain in an extremity accompanied by sudomotor, vasomotor, and trophic changes in bone without an associated specific nerve injury. This condition is most often precipitated by trauma to soft tissue or nerve complexes. The skin over the affected region is usually erythematous and demonstrates hypersensitivity to tactile stimuli and erythema. (Adams et al., Principles of Neurology, 6th ed, p1360; Pain 1995 Oct;63(1):127-33)", "OL": "use REFLEX SYMPATHETIC DYSTROPHY to search HAND-SHOULDER SYNDROME 1992-95", "PM": "1965; HAND-SHOULDER SYNDROME was see REFLEX SYMPATHETIC DYSTROPHY 1992-95; SHOULDER-HAND SYNDROME & SUDECK'S ATROPHY were headings 1963-95; OSTEOPOROSIS, POST-TRAUMATIC was see SUDECK'S ATROPHY 1992-95", "HN": "1965; HAND-SHOULDER SYNDROME was see REFLEX SYMPATHETIC DYSTROPHY 1992-95; SHOULDER-HAND SYNDROME & SUDECK'S ATROPHY were headings 1963-95; OSTEOPOROSIS, POST-TRAUMATIC was see SUDECK'S ATROPHY 1992-95", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012019"}, {"RECTYPE": "D", "MH": "Reflex, Abdominal", "AQ": "DE ES GE IM PH RE", "ENTRY": "Abdominal Reflex", "MN": "G11.561.731.580", "MH_TH": "NLM (1970)", "ST": "T060", "AN": "reflex contraction of abdom wall: read MeSH definition; not for reflex responses of organs within abdom cavity", "PI": "Reflex (1966-1969)", "MS": "Contractions of the abdominal muscles upon stimulation of the skin (superficial abdominal reflex) or tapping neighboring bony structures (deep abdominal reflex). The superficial reflex may be weak or absent, for example, after a stroke, a sign of upper (suprasegmental) motor neuron lesions. (Stedman, 25th ed & Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p1073)", "PM": "91; was see under REFLEX 1970-90", "HN": "91(70); was see under REFLEX 1970-90", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012020"}, {"RECTYPE": "D", "MH": "Reflex, Abnormal", "DE": "REFLEX ABNORM", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Hyporeflexia|T033|NON|NRW|NLM (1998)|970116|abcdef", "ENTRY": "Reflex, Palmo-Mental", "MN": "G11.561.731.587", "FX": "Autonomic Dysreflexia", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "do not use Cat C or E qualif", "MS": "An abnormal response to a stimulus applied to the sensory components of the nervous system. This may take the form of increased, decreased, or absent reflexes.", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012021"}, {"RECTYPE": "D", "MH": "Reflex, Acoustic", "AQ": "DE ES GE IM PH RE", "ENTRY": "Acoustic Reflex", "MN": "G11.561.731.594", "MH_TH": "NLM (1980)", "ST": "T060", "PI": "Sound (1966-1971)", "MS": "Intra-aural contraction of tensor tympani and stapedius in response to sound.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19781214", "DC": "1", "DX": "19800101", "UI": "D012022"}, {"RECTYPE": "D", "MH": "Reflex, Monosynaptic", "AQ": "DE ES GE IM PH RE", "ENTRY": "Monosynaptic Reflex", "MN": "G11.561.731.643", "MH_TH": "NLM (1968)", "ST": "T042", "PI": "Reflex (1966-1967)", "MS": "A reflex in which the AFFERENT NEURONS synapse directly on the EFFERENT NEURONS, without any INTERCALATED NEURONS. (Lockard, Desk Reference for Neuroscience, 2nd ed.)", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D012023"}, {"RECTYPE": "D", "MH": "Reflex, Oculocardiac", "AQ": "DE ES GE IM PH RE", "ENTRY": "Oculocardiac Reflex", "MN": "G11.561.731.685", "MH_TH": "NLM (1976)", "ST": "T040", "PI": "Reflex (1966-1975)", "MS": "Change of heartbeat induced by pressure on the eyeball, manipulation of extraocular muscles, or pressure upon the tissue remaining in the orbital apex after enucleation.", "PM": "91; was see under REFLEX 1976-90", "HN": "91(76); was see under REFLEX 1976-90", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D012024"}, {"RECTYPE": "D", "MH": "Reflex, Pupillary", "AQ": "DE ES GE IM PH RE", "ENTRY": "Pupillary Reflex", "MN": "G11.561.731.705", "FX": "Adie Syndrome", "MH_TH": "NLM (1970)", "ST": "T060", "AN": "contraction of pupil on exposure to light", "PI": "Reflex (1966-1969)", "MS": "Constriction of the pupil in response to light stimulation of the retina. It refers also to any reflex involving the iris, with resultant alteration of the diameter of the pupil. (Cline et al., Dictionary of Visual Science, 4th ed)", "PM": "74", "HN": "74(70)", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012025"}, {"RECTYPE": "D", "MH": "Reflex, Stretch", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Reflex, Tendon|T042|NON|NRW|UNK (19XX)|810519|abcdef", "ENTRY": "Tendon Reflex", "MN": "G11.561.731.768", "MH_TH": "NLM (1965)", "ST": "T042", "MS": "Reflex contraction of a muscle in response to stretching, which stimulates muscle proprioceptors.", "OL": "use REFLEX, STRETCH to search REFLEX, TENDON 1966-81", "PM": "82; was REFLEX, TENDON 1965-81", "HN": "82; was REFLEX, TENDON 1965-81", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012026"}, {"RECTYPE": "D", "MH": "Reflex, Vestibulo-Ocular", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Vestibulo-Ocular Reflex|T040|NON|EQV|UNK (19XX)|860328|abcdef", "ENTRY": "Vestibuloocular Reflexes", "MN": "G11.561.731.795", "MH_TH": "NLM (1987)", "ST": "T040", "PI": "Vestibular Apparatus (1966-1986)", "MS": "A reflex wherein impulses are conveyed from the cupulas of the SEMICIRCULAR CANALS and from the OTOLITHIC MEMBRANE of the SACCULE AND UTRICLE via the VESTIBULAR NUCLEI of the BRAIN STEM and the median longitudinal fasciculus to the OCULOMOTOR NERVE nuclei. It functions to maintain a stable retinal image during head rotation by generating appropriate compensatory EYE MOVEMENTS.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19860328", "DC": "1", "DX": "19870101", "UI": "D012027"}, {"RECTYPE": "D", "MH": "Reflexotherapy", "DE": "REFLEXOTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Reflex Therapy|T061|NON|EQV|NLM (1994)|930319|REFLEX THER|abcdefv", "ENTRY": "Therapy, Reflex|T061|NON|EQV|NLM (1994)|930319|THER REFLEX|abcdefv", "MN": "E02.190.799", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "do not confuse with REFLEXOLOGY see MASSAGE", "MS": "Treatment of some morbid condition by producing a reflex action, as in the household treatment of nosebleed by a piece of ice applied to the cervical spine. (Stedman, 27th ed)", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012028"}, {"RECTYPE": "D", "MH": "Refraction, Ocular", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Ocular Refraction|T042|T060|NON|EQV|NLM (1991)|900103|abbcdef", "ENTRY": "Refractions, Ocular", "MN": "G14.760", "FX": "Retinoscopy", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Refraction of LIGHT effected by the media of the EYE.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012029"}, {"RECTYPE": "D", "MH": "Refractive Errors", "DE": "REFRACTIVE ERR", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT TH UR VE VI", "PRINT ENTRY": "Ametropia|T047|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Refractive Error", "MN": "C11.744", "EC": "surgery:Refractive Surgical Procedures", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Deviations from the average or standard indices of refraction of the eye through its dioptric or refractive apparatus.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012030"}, {"RECTYPE": "D", "MH": "Refractometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Refractive Index|T081|NON|REL|UNK (19XX)|780519|abcdef", "ENTRY": "Refractive Indices", "MN": "H01.671.617.755", "MH_TH": "NLM (1979)", "ST": "T090", "AN": "an anal chem technique; do not use for refractometry in REFRACTION, OCULAR", "MS": "Measurement of the index of refraction (the ratio of the velocity of light or other radiation in the first of two media to its velocity in the second as it passes from one into the other).", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D012031"}, {"RECTYPE": "D", "MH": "Refractory Period, Electrophysiological", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Wedensky Inhibition|T042|EPO|REL|NLM (1997)|960416|WEDENSKY INHIB|abcdefv", "ENTRY": "Transmission Fade, Neuromuscular", "MN": "G11.561.785", "FX": "Neural Inhibition", "MH_TH": "NLM (2007)", "ST": "T040", "PI": "Neural Conduction (1966-1971)", "MS": "The period of time following the triggering of an ACTION POTENTIAL when the CELL MEMBRANE has changed to an unexcitable state and is gradually restored to the resting (excitable) state. During the absolute refractory period no other stimulus can trigger a response. This is followed by the relative refractory period during which the cell gradually becomes more excitable and the stronger impulse that is required to illicit a response gradually lessens to that required during the resting state.", "PM": "2007; see REFRACTORY PERIOD, NEUROLOGIC 1991-2006; see NEURAL CONDUCTION 1972-1990; for WEDENSKY INHIBITION & VVEDENSKII'S INHIBITION see NEURAL CONDUCTION 1997-2006; WEDENSKY INHIBITION was heading 1977-1996; VVEDENSKII'S INHIBITION was heading 1975-1976", "HN": "2007 (1972); for WEDENSKY INHIBITION & VVEDENSKII'S INHIBITION use NEURAL CONDUCTION 1975-2006", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012032"}, {"RECTYPE": "D", "MH": "Refractory Period, Psychological", "DE": "REFRACTORY PERIOD PSYCHOL", "AQ": "CL DE ES PH RE", "ENTRY": "Refractory Periods, Psychologic", "MN": "F04.669.817.559", "MH_TH": "NLM (1972)", "ST": "T041", "AN": "human & animal", "PI": "Reaction Time (1966-1971)", "MS": "A delayed response interval occurring when two stimuli are presented in close succession.", "OL": "use REFRACTORY PERIOD, PSYCHOLOGICAL to search REFRACTORY PERIOD, PSYCHOLOGIC 1972-78 (as Prov 72-74)", "PM": "91; was see under REACTION TIME 1979-90; was REFRACTORY PERIOD, PSYCHOLOGIC see under REACTION TIME 1975-78", "HN": "91(79); was see under REACTION TIME 1979-90; was REFRACTORY PERIOD, PSYCHOLOGIC see under REACTION TIME 1975-78; was REFRACTORY PERIOD, PSYCHOLOGIC 1972-74 (Prov)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012033"}, {"RECTYPE": "D", "MH": "Refrigeration", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Cold Chain|T066|NON|NRW|POPLINE (1994)|950322|abcdef", "ENTRY": "Cold Chains", "MN": "E05.760.643", "FX": "Hypothermia, Induced", "MH_TH": "NLM (1966)", "ST": "T066", "MS": "The mechanical process of cooling.", "HN": "was in Cat E & J 1967-81, was in Cat G only 1963-66", "CATSH": "CAT LIST", "MR": "20150522", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012034"}, {"RECTYPE": "D", "MH": "Refsum Disease", "DE": "REFSUM DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Phytanic Acid Storage Disease|T047|NON|NRW|GHR (2014)|NLM (2000)|ORD (2010)|991110|PHYTANIC ACID STORAGE DIS|abcdeeefv", "ENTRY": "Syndromes, Refsum-Thiebaut", "MN": "C18.452.648.663.760", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with REFSUM DISEASE, INFANTILE", "MS": "An autosomal recessive familial disorder that usually presents in childhood with POLYNEUROPATHY; SENSORINEURAL HEARING LOSS; ICHTHYOSIS; ATAXIA; RETINITIS PIGMENTOSA; and CARDIOMYOPATHIES. (From Joynt, Clinical Neurology, 1991, Ch37, p58-9; Rev Med Interne 1996;17(5):391-8) This condition can be caused by mutation in the genes encoding peroxisomal phytanoyl-CoA hydroxylase or proteins associated peroxisomal membrane, leading to impaired catabolism of PHYTANIC ACID in PEROXISOMES.", "PM": "1996; see REFSUM'S SYNDROME 1991-1995, see REFSUM DISEASE 1964-1990", "HN": "1996 (1964)", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D012035"}, {"RECTYPE": "D", "MH": "Refugees", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Political Refugees|T098|NON|EQV|NLM (2020)|181210|abcdef", "ENTRY": "Seekers, Political Asylum", "MN": "M01.755", "MH_TH": "NLM (1986)", "ST": "T098", "AN": "specify geographic location if pertinent", "MS": "Persons fleeing to a place of safety, especially those who flee to a foreign country or power to escape danger, persecution, or economic distress in their own country or habitual residence.", "MR": "20190304", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012036"}, {"RECTYPE": "D", "MH": "Refuse Disposal", "AQ": "EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Waste Disposal, Solid|T057|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Waste Disposals, Solid", "MN": "N06.850.860.510.900.600", "FX": "Solid Waste", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "The discarding or destroying of garbage, sewage, or other waste matter or its transformation into something useful or innocuous.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012037"}, {"RECTYPE": "D", "MH": "Regeneration", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Endogenous Regeneration|T039|NON|EQV|NLM (2020)|190222|abcdef", "ENTRY": "Regenerations", "MN": "G16.762", "FX": "Wound Healing", "MH_TH": "NLM (1966)", "ST": "T039", "AN": "coordinate IM with organ / physiol (IM), not / growth; available also are BONE REGENERATION; LIVER REGENERATION; NERVE REGENERATION & SPINAL CORD REGENERATION", "MS": "The physiological renewal, repair, or replacement of tissue.", "CATSH": "CAT LIST", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012038"}, {"RECTYPE": "D", "MH": "Regional Blood Flow", "AQ": "DE GE IM PH RE", "ENTRY": "Regional Blood Flows", "MN": "G09.330.100.780", "MH_TH": "NLM (1964)", "ST": "T042", "AN": "coordinate with organ / blood supply or specific artery or vein / physiol; Manual 19.8.11; specifics available are CEREBROVASCULAR CIRCULATION; CORONARY CIRCULATION; LIVER CIRCULATION; PLACENTAL CIRCULATION; PULMONARY CIRCULATION; RENAL CIRCULATION; SPLANCHNIC CIRCULATION; also available are COLLATERAL CIRCULATION; MICROCIRCULATION & PORTAL SYSTEM; Manual 21.4.2, 21.6; taking of pulse at wrist is not REGIONAL BLOOD FLOW: it is PULSE", "MS": "The flow of BLOOD through or around an organ or region of the body.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D012039"}, {"RECTYPE": "D", "MH": "Regional Health Planning", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Comprehensive Health Planning|T058|NON|REL|UNK (19XX)|770509|abcdef", "ENTRY": "Reviews, Appropriateness", "MN": "N03.349.650", "MH_TH": "NLM (1977)", "ST": "T058", "AN": "specify geog", "PI": "Health Planning (1968-1974)", "MS": "Planning for health resources at a regional or multi-state level.", "OL": "use REGIONAL HEALTH PLANNING to search APPROPRIATENESS REVIEW (HEALTH CARE) 1980-85 & COMPREHENSIVE HEALTH PLANNING 1969-77 (as Prov 1969-71); use REGIONAL HEALTH PLANNING to search AREAWIDE PLANNING 1975-76 (use HEALTH AND WELFARE PLANNING 1968-74); use REGIONAL HEALTH PLANNING to search ANNUAL IMPLEMENTATION PLANS 1981-85 (use STATE HEALTH PLANS 1980)", "PM": "77; was AREAWIDE PLANNING see under HEALTH AND WELFARE PLANNING 1968-76; ANNUAL IMPLEMENTATION PLANS was see under REGIONAL HEALTH PLANNING 1981-85, was see under STATE HEALTH PLANS 1980; APPROPRIATENESS REVIEW was APPROPRIATENESS REVIEW (HEALTH CARE) see under REGIONAL HEALTH PLANNING 1980-85; COMPREHENSIVE HEALTH PLANNING was heading 1972-77", "HN": "77; was AREAWIDE PLANNING see under HEALTH AND WELFARE PLANNING 1968-76; ANNUAL IMPLEMENTATION PLANS was see under REGIONAL HEALTH PLANNING 1981-85, was see under STATE HEALTH PLANS 1980; APPROPRIATENESS REVIEW was APPROPRIATENESS REVIEW (HEALTH CARE) see under REGIONAL HEALTH PLANNING 1980-85; COMPREHENSIVE HEALTH PLANNING was heading 1969-77 (Prov 1969-71)", "MR": "19991103", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D012040"}, {"RECTYPE": "D", "MH": "Regional Medical Programs", "DE": "REGIONAL MED PROGRAMS", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Programs, Regional Medical|T064|NON|EQV|NLM (1991)|891205|PROGRAMS REGIONAL MED|abcdefv", "MN": "N03.349.650.400", "MH_TH": "NLM (1967)", "ST": "T064", "AN": "specify geog; TN 163: restricted definition and use", "PI": "United States Public Health Service (1966)", "MS": "Coordination of activities and programs among health care institutions within defined geographic areas for the purpose of improving delivery and quality of medical care to the patients. These programs are mandated under U.S. Public Law 89-239.", "PM": "68", "HN": "68(67)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012041"}, {"RECTYPE": "D", "MH": "Registries", "AQ": "CL ES SN ST", "ENTRY": "Registry", "MN": "N06.850.520.308.970", "MH_TH": "NLM (1969)", "ST": "T170", "AN": "IM; coord with specific population or disease registered (IM)", "PI": "specific heading/epidemiology (1966-1968)", "MS": "The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012042"}, {"RECTYPE": "D", "MH": "Regression, Psychology", "PRINT ENTRY": "Regression (Psychology)|T041|NON|EQV|NLM (1966)|990101|REGRESSION|REGRESSION PSYCHOL|abcdefsv", "ENTRY": "Psychology Regression", "MN": "F01.393.784", "MH_TH": "NLM (2020)", "ST": "T041", "AN": "do not confuse with REMISSION, SPONTANEOUS ", "MS": "A return to earlier, especially to infantile, patterns of thought or behavior, or stage of functioning, e.g., feelings of helplessness and dependency in a patient with a serious physical illness. (From APA, Thesaurus of Psychological Index Terms, 1994).", "PM": "2020; was REGRESSION (PSYCHOLOGY) 1980-2019; was REGRESSION 1963-1979", "HN": "2020 (1963); was REGRESSION (PSYCHOLOGY) 1980-2019; was REGRESSION 1963-1979", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D012043"}, {"RECTYPE": "D", "MH": "Regression Analysis", "DE": "REGRESSION ANAL", "PRINT ENTRY": "Statistical Regression|T081|NON|EQV|NLM (1990)|POPLINE (1978)|890502|STATIST REGRESSION|abcdeefv", "ENTRY": "Statistical Regressions", "MN": "N06.850.520.830.750", "MH_TH": "NLM (1973)", "ST": "T081", "AN": "IM GEN only; coord NIM with specific disease or other concept (IM); no qualif; specify geog if pertinent", "PI": "Statistics (1966-1972)", "MS": "Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable.", "PM": "80; was see under STATISTICS 1975-79", "HN": "80(73); was see under STATISTICS 1975-79", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D012044"}, {"RECTYPE": "D", "MH": "Regulatory Sequences, Nucleic Acid", "DE": "REG SEQ", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Regulatory Regions, Nucleic Acid (Genetics)|T114|T123|NON|EQV|UNK (19XX)|870509|REG REGIONS NUCLEIC ACID GENET|abbcdefv", "ENTRY": "Regulatory Regions|T114|T123|NON|EQV|NLM (1993)|911206|REG REGIONS|abbcdefv", "MN": "G05.360.080.689", "FX": "Nucleotide Motifs", "MH_TH": "NLM (1988)", "ST": "T123", "AN": "general or unspecified; prefer specifics", "PI": "DNA or specific (1977-1987)", "MS": "Nucleic acid sequences involved in regulating the expression of genes.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19870509", "DC": "1", "DX": "19880101", "UI": "D012045"}, {"RECTYPE": "D", "MH": "Rehabilitation", "DE": "REHABIL", "AQ": "CL EC ED ES HI IS LJ MT OG PX SN ST TD", "PRINT ENTRY": "Habilitation|T061|NON|BRD|UNK (19XX)|810519|abcdef", "MN": "N02.421.784", "FX": "Sports for Persons with Disabilities", "MH_TH": "BIOETHICS (1990)", "ST": "T061", "AN": "general only: prefer /rehabil with diseases: Manual 19.7+, 19.8.64; differentiate from AFTERCARE", "MS": "Restoration of human functions to the maximum degree possible in a person or persons suffering from disease or injury.", "CATSH": "CAT LIST", "MR": "20190711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012046"}, {"RECTYPE": "D", "MH": "Rehabilitation Centers", "DE": "REHABIL CENTERS", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Rehabilitation Center", "MN": "N02.278.808", "MH_TH": "NLM (1968)", "ST": "T093", "AN": "IM", "PI": "Rehabilitation (1966-1967)", "MS": "Facilities which provide programs for rehabilitating the mentally or physically disabled individuals.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012047"}, {"RECTYPE": "D", "MH": "Correction of Hearing Impairment", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Rehabilitation of Hearing Impaired|T058|NON|NRW|NLM (1974)|990101|REHABIL HEARING IMPAIRED|abcdefv", "ENTRY": "Rehabilitations, Aural", "MN": "N02.421.784.377", "MH_TH": "NLM (2013)", "ST": "T058", "AN": "general or unspecified; prefer specifics; coordinate IM with type of hearing disorder/ rehabil (IM)", "PI": "Hearing Disorders/rehabilitation (1966-1997)", "MS": "Procedures for correcting HEARING DISORDERS.", "PM": "2013; see Rehabilitation of Hearing Impaired 2000-2012", "HN": "2013; (1998); use Rehabilitation of Hearing Impaired 2000-2012", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012048"}, {"RECTYPE": "D", "MH": "Rehabilitation of Speech and Language Disorders", "AQ": "CL EC ED ES HI IS LJ MT NU OG PX SN ST TD", "PRINT ENTRY": "Speech and Language Disorder Rehabilitation|T058|NON|EQV|NLM (1998)|970224|SPEECH LANGUAGE DIS REHABIL|abcdefv", "MN": "E02.831.727", "MH_TH": "NLM (1974)", "ST": "T058", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "PI": "Speech Disorders/rehabilitation (1966-1997)", "MS": "Procedures for assisting a person with a speech or language disorder to communicate with maximum efficiency.", "PM": "98", "HN": "98; use explode 1975-79", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012049"}, {"RECTYPE": "D", "MH": "Rehabilitation, Vocational", "DE": "REHABIL VOCATIONAL", "AQ": "CL EC ES HI IS MO MT PX SN ST TD", "PRINT ENTRY": "Vocational Rehabilitation|T061|NON|EQV|UNK (19XX)|740330|VOCATIONAL REHABIL|abcdefv", "ENTRY": "Vocational Rehabilitations", "MN": "N02.421.784.644", "FX": "Sheltered Workshops", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Training of the mentally or physically disabled in work skills so they may be returned to regular employment utilizing these skills.", "PM": "67", "HN": "67(66)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D012050"}, {"RECTYPE": "D", "MH": "Reimbursement Mechanisms", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Reimbursement Mechanism", "MN": "N03.219.521.710.305", "MH_TH": "NLM (1979)", "ST": "T170", "PI": "Financing, Organized (1968-1978)", "MS": "Processes or methods of reimbursement for services rendered or equipment.", "PM": "79", "HN": "79", "MR": "19930916", "DA": "19780509", "DC": "1", "DX": "19790101", "UI": "D012051"}, {"RECTYPE": "D", "MH": "Reimbursement, Incentive", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Incentive Reimbursement|T170|NON|EQV|UNK (19XX)|780509|abcdef", "ENTRY": "Performance, Pay for", "MN": "N03.219.521.710.305.380", "MH_TH": "NLM (1979)", "ST": "T170", "MS": "A scheme which provides reimbursement for the health services rendered, generally by an institution, and which provides added financial rewards if certain conditions are met. Such a scheme is intended to promote and reward increased efficiency and cost containment, with better care, or at least without adverse effect on the quality of the care rendered.", "PM": "91; was see under REIMBURSEMENT MECHANISMS 1979-90", "HN": "91(79); was see under REIMBURSEMENT MECHANISMS 1979-90", "MR": "20090706", "DA": "19780509", "DC": "1", "DX": "19910101", "UI": "D012052"}, {"RECTYPE": "D", "MH": "Reindeer", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Caribou|T015|NON|EQV|NLM (1995)|940203|abcdef", "MN": "B01.050.150.900.649.313.500.380.373.644", "MH_TH": "NLM (1968)", "ST": "T015", "RN": "txid9870", "AN": "IM; qualif permitted", "PI": "Artiodactyla (1966-1967)", "MS": "A genus of deer, Rangifer, that inhabits the northern parts of Europe, Asia, and America. Caribou is the North American name; reindeer, the European. They are often domesticated and used, especially in Lapland, for drawing sleds and as a source of food. Rangifer is the only genus of the deer family in which both sexes are antlered. Most caribou inhabit arctic tundra and surrounding arboreal coniferous forests and most have seasonal shifts in migration. They are hunted extensively for their meat, skin, antlers, and other parts. (From Webster, 3d ed; Walker's Mammals of the World, 5th ed, p1397)", "OL": "use REINDEER to search CARIBOU 1975-94", "PM": "68; CARIBOU was heading 1975-94 (see under REINDEER 1975-90)", "HN": "68; CARIBOU was heading 1975-94 (see under REINDEER 1975-90)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012053"}, {"RECTYPE": "D", "MH": "Reinforcement, Psychology", "PRINT ENTRY": "Reinforcement (Psychology)|T041|T061|NON|EQV|NLM (1966)|990101|REINFORCEMENT PSYCHOL|abbcdefv", "ENTRY": "Reinforcements, Psychology", "MN": "F02.463.425.770", "MH_TH": "NLM (2020)", "ST": "T061", "AN": "human & animal", "MS": "The strengthening of a conditioned response.", "PM": "2020; was REINFORCEMENT (PSYCHOLOGY) 1965-2019; was REINFORCEMENT LEARNING 1963-1964", "HN": "2020 (1965); was REINFORCEMENT (PSYCHOLOGY) 1965-2019; was REINFORCEMENT LEARNING 1963-1964", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012054"}, {"RECTYPE": "D", "MH": "Reinforcement Schedule", "ENTRY": "Schedules, Reinforcement", "MN": "F02.463.425.770.644", "MH_TH": "NLM (1966)", "ST": "T062", "AN": "human & animal; no qualif", "MS": "A schedule prescribing when the subject is to be reinforced or rewarded in terms of temporal interval in psychological experiments. The schedule may be continuous or intermittent.", "PM": "69", "HN": "69(66)", "CATSH": "CAT LIST", "MR": "19890516", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012055"}, {"RECTYPE": "D", "MH": "Reinforcement, Social", "PRINT ENTRY": "Social Reinforcement|T054|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Social Reinforcements", "MN": "F02.463.425.770.706", "MH_TH": "NLM (1969)", "ST": "T054", "AN": "no qualif", "PI": "Reinforcement (Psychology) (1966-1968)", "MS": "The strengthening of a response with a social reward such as a nod of approval, a parent's love or attention.", "PM": "1969", "HN": "1969", "CATSH": "CAT LIST", "MR": "19991216", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012056"}, {"RECTYPE": "D", "MH": "Reinforcement, Verbal", "ENTRY": "Verbal Reinforcements", "MN": "F02.463.425.770.769", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "no qualif", "MS": "Use of word stimulus to strengthen a response during learning.", "PM": "69", "HN": "69(66)", "CATSH": "CAT LIST", "MR": "19890516", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012057"}, {"RECTYPE": "D", "MH": "Rejection, Psychology", "PRINT ENTRY": "Rejection (Psychology)|T054|NON|EQV|NLM (1975)|990101|REJECTION PSYCHOL|abcdefv", "ENTRY": "Rejection, Psychological", "MN": "F01.145.813.565", "MH_TH": "NLM (2020)", "ST": "T054", "PI": "Attitude (1966-1974)", "MS": "Non-acceptance, negative attitudes, hostility or excessive criticism of the individual which may precipitate feelings of rejection.", "PM": "2020; was REJECTION (PSYCHOLOGY) 1975-2019", "HN": "2020 (1975); was REJECTION (PSYCHOLOGY) 1975-2019", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19750204", "DC": "1", "DX": "19750901", "UI": "D012059"}, {"RECTYPE": "D", "MH": "Rejuvenation", "AQ": "PH PX", "MN": "E02.849", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The phenomenon of youthfulness, vitality, and freshness being restored. This can apply to appearance, TISSUES, organ functions, or other areas.", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012060"}, {"RECTYPE": "D", "MH": "Relapsing Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Tick-borne Relapsing Fever|T047|NON|NRW|NLM (2021)|190822|abcdef", "ENTRY": "Tick-borne Relapsing Fevers", "MN": "C01.920.930.775", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "not for \"recurrent fever\" [= FEVER + RECURRENCE (NIM)]; infections by Borrelia species other than B. burgdorferi or B. burgdorferi group (which cause LYME DISEASE) probably go here, otherwise index under BORRELIA INFECTIONS", "MS": "An acute infection characterized by recurrent episodes of PYREXIA alternating with asymptomatic intervals of apparent recovery. This condition is caused by SPIROCHETES of the genus BORRELIA. It is transmitted by the BITES of either the body louse (PEDICULUS humanus corporis), for which humans are the reservoir, or by soft ticks of the genus ORNITHODOROS, for which rodents and other animals are the principal reservoirs.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012061"}, {"RECTYPE": "D", "MH": "Relative Biological Effectiveness", "DE": "RBE", "ENTRY": "Relative Effectiveness, Biologic", "MN": "N06.850.810.250.275", "MH_TH": "NLM (1977)", "ST": "T081", "PI": "Dose-Response Relationship, Radiation (1973-1976)", "MS": "The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays.", "PM": "77", "HN": "77", "MR": "20080708", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D012062"}, {"RECTYPE": "D", "MH": "Relaxation", "AQ": "PH PX", "ENTRY": "Relaxations", "MN": "I03.450.769", "MH_TH": "NLM (1966)", "ST": "T056", "AN": "MUSCLE RELAXATION is also available", "MS": "Activity which reduces the feelings of tension and the effects of STRESS, PHYSIOLOGICAL.", "MR": "20080710", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012063"}, {"RECTYPE": "D", "MH": "Relaxation Therapy", "DE": "RELAXATION THER", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Therapeutic Relaxation|T061|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Therapy, Nature", "MN": "F04.754.137.750", "MH_TH": "OBSSR (2021)", "ST": "T061", "AN": "RELAXATION is also available; MUSCLE RELAXATION is available for the physiological relaxation of muscles", "PI": "Relaxation (1966-1975)", "MS": "Treatment to improve one's health condition by using techniques that can reduce PHYSIOLOGICAL STRESS; PSYCHOLOGICAL STRESS; or both.", "PM": "2009; see RELAXATION TECHNIQUES 1991-2008, see RELAXATION TECHNICS 1976-1990", "HN": "2009 (1991); use RELAXATION TECHNICS 1976-1990", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D012064"}, {"RECTYPE": "D", "MH": "Relaxin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Relaxin B|T116|T125|NON|NRW|UNK (19XX)|811209|abbcdef", "MN": "D12.644.548.762", "MH_TH": "NLM (1966)", "ST": "T125", "N1": "Relaxin", "RN": "9002-69-1", "AN": "/biosyn /physiol permitted", "MS": "A water-soluble polypeptide (molecular weight approximately 8,000) extractable from the corpus luteum of pregnancy. It produces relaxation of the pubic symphysis and dilation of the uterine cervix in certain animal species. Its role in the human pregnant female is uncertain. (Dorland, 28th ed)", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012065"}, {"RECTYPE": "D", "MH": "Relief Work", "AQ": "CL EC ES HI LJ OG SN ST", "ENTRY": "Works, Relief", "MN": "N06.230.100.300", "MH_TH": "NLM (1975)", "ST": "T057", "AN": "coord IM with agency supplying the relief (IM) if pertinent; specify geog if pertinent", "MS": "Assistance, such as money, food, or shelter, given to the needy, aged, or victims of disaster. It is usually granted on a temporary basis. (From The American Heritage Dictionary, 2d college ed)", "OL": "search DISASTERS 1968-74 & DISASTERS & INDIGENT CARE 1966-67", "PM": "91; was see under DISASTERS 1968-90; was see under DISASTERS & INDIGENT CARE 1963-67", "HN": "91(75); was see under DISASTERS 1968-90; was see under DISASTERS & INDIGENT CARE 1963-67", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012066"}, {"RECTYPE": "D", "MH": "Religion", "AQ": "HI", "PRINT ENTRY": "Religious Ethics|T078|NON|NRW|BIOETHICS (1975)|970227|abcdef", "ENTRY": "Religious Belief", "MN": "K01.844", "FX": "Secularism", "EC": "psychology:Religion and Psychology", "MH_TH": "POPLINE (1978)", "ST": "T078", "MS": "A set of beliefs concerning the nature, cause, and purpose of the universe, especially when considered as the creation of a superhuman agency. It usually involves devotional and ritual observances and often a moral code for the conduct of human affairs. (Random House Collegiate Dictionary, rev. ed.)", "PM": "RELIGION AND SOCIOLOGY was heading 1963-65", "HN": "RELIGION AND SOCIOLOGY was heading 1963-65", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012067"}, {"RECTYPE": "D", "MH": "Religion and Medicine", "DE": "RELIGION MED", "PRINT ENTRY": "Spiritual Coping|T041|NON|NRW|NLM (2023)|211109|abcdef", "ENTRY": "Religiosity Copings", "MN": "K01.844.619", "FX": "Parish Nursing", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "coordinate with medical aspect; FAITH HEALING is available", "MS": "The interrelationship of medicine and religion.", "MR": "20220719", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012068"}, {"RECTYPE": "D", "MH": "Religion and Psychology", "DE": "RELIGION PSYCHOL", "ENTRY": "Religion, Psychology|T078|NON|EQV|UNK (19XX)|790329|RELIGION PSYCHOLOGY|abcdefv", "MN": "K01.844.664", "MH_TH": "NLM (1966)", "ST": "T078", "MS": "The interrelationship of psychology and religion.", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012069"}, {"RECTYPE": "D", "MH": "Religion and Science", "DE": "RELIGION SCIENCE", "ENTRY": "Science and Religion", "MN": "K01.844.709", "MH_TH": "NLM (1966)", "ST": "T078", "MS": "The interrelationship of science and religion.", "MR": "20180201", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012070"}, {"RECTYPE": "D", "MH": "Religion and Sex", "DE": "RELIGION SEX", "ENTRY": "Sex and Religion", "MN": "K01.844.754", "MH_TH": "NLM (1966)", "ST": "T078", "MS": "The interrelationship of religion and sexual practices and beliefs.", "MR": "20180201", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012071"}, {"RECTYPE": "D", "MH": "Religious Philosophies", "AQ": "HI PX", "ENTRY": "Taoisms", "MN": "K01.844.799", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "general or unspecified; prefer specifics", "MS": "Sets of beliefs on the nature of the universe or Man.", "PM": "98", "HN": "98; use explode 1974-97", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012072"}, {"RECTYPE": "D", "MH": "Remedial Teaching", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Teachings, Remedial", "MN": "I02.903.694", "MH_TH": "NLM (1966)", "ST": "T065", "MS": "Specialized instruction for students deviating from the expected norm.", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012073"}, {"RECTYPE": "D", "MH": "Remission Induction", "AQ": "MT", "ENTRY": "Remission Inductions", "MN": "E02.860", "FX": "Disease-Free Survival", "MH_TH": "NLM (1987)", "ST": "T061", "AN": "coordinate NIM with disease /ther or specific ther qualifier ", "MS": "Therapeutic act or process that initiates a response to a complete or partial remission level.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19860624", "DC": "1", "DX": "19870101", "UI": "D012074"}, {"RECTYPE": "D", "MH": "Remission, Spontaneous", "PRINT ENTRY": "Spontaneous Remission|T070|NON|EQV|NLM (2024)|230206|abcdef", "ENTRY": "Spontaneous Regressions", "MN": "G16.767", "FX": "Remission Induction", "MH_TH": "NLM (1971)", "ST": "T070", "MS": "A spontaneous diminution or abatement of a disease over time, without formal treatment.", "OL": "use REMISSION, SPONTANEOUS to search REMISSION 1971-81 (as Prov 1971-74)", "PM": "91; was see under DISEASE 1982-90; was REMISSION see under DISEASE 1975-81", "HN": "91(82); was see under DISEASE 1982-90; was REMISSION see under DISEASE 1975-81; was REMISSION 1971-74 (Prov)", "CATSH": "CAT LIST", "MR": "20230414", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012075"}, {"RECTYPE": "D", "MH": "Renal Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Agents, Renal", "MN": "D27.505.954.493.250", "MH_TH": "NLM (1974)", "ST": "T121", "RN": "0", "MS": "Drugs used for their effects on the kidneys' regulation of body fluid composition and volume. The most commonly used are the diuretics. Also included are drugs used for their antidiuretic and uricosuric actions, for their effects on the kidneys' clearance of other drugs, and for diagnosis of renal function.", "PM": "96", "HN": "96; was NON MESH 1975-95", "MR": "20210708", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D012076"}, {"RECTYPE": "D", "MH": "Renal Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Renal Arteries", "MN": "A07.015.114.745", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "thrombosis: index under RENAL ARTERY OBSTRUCTION (IM) + THROMBOSIS (IM)", "MS": "A branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012077"}, {"RECTYPE": "D", "MH": "Renal Artery Obstruction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Renal Artery Stenosis|T047|NON|NRW|UNK (19XX)|830615|abcdef", "ENTRY": "Stenosis, Renal Artery", "MN": "C14.907.137.727", "FX": "Hypertension, Renovascular", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "renal artery thrombosis: coordinate IM with THROMBOSIS (IM); consider also HYPERTENSION, RENOVASCULAR (hypertension caused by renal artery obstruction or compression)", "MS": "Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR).", "OL": "use RENAL ARTERY OBSTRUCTION to search RENAL ARTERY STENOSIS 1966-83", "HN": "RENAL ARTERY STENOSIS was see under RENAL ARTERY OBSTRUCTION 1963-83", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D012078"}, {"RECTYPE": "D", "MH": "Renal Circulation", "DE": "RENAL CIRC", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Renal Blood Flow|T034|NON|REL|NLM (1994)|920807|abcdef", "ENTRY": "Flow, Renal Blood", "MN": "G09.330.100.812", "MH_TH": "NLM (1982)", "ST": "T042", "AN": "note specifics; consider also KIDNEY /blood supply", "PI": "Regional Blood Flow (1966-1981)", "MS": "The circulation of the BLOOD through the vessels of the KIDNEY.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19810519", "DC": "1", "DX": "19820101", "UI": "D012079"}, {"RECTYPE": "D", "MH": "Chronic Kidney Disease-Mineral and Bone Disorder", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rickets, Renal|T047|NON|NRW|UNK (19XX)|750708|abcdef", "ENTRY": "Renal Osteodystrophies", "MN": "C23.550.291.500.290", "MH_TH": "NLM (2017)", "ST": "T047", "MS": "Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.", "OL": "use RENAL OSTEODYSTROPHY to search RICKETS, RENAL 1966-71", "PM": "2017; see RENAL OSTEODYSTROPHY 1972-2016, see RICKETS, RENAL 1963-1971.", "HN": "2017(1963)", "CATSH": "CAT LIST", "MR": "20210607", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012080"}, {"RECTYPE": "D", "MH": "Renal Veins", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Renal", "MN": "A07.015.908.752", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Short thick veins which return blood from the kidneys to the vena cava.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012082"}, {"RECTYPE": "D", "MH": "Renin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Angiotensinogenase|T116|T126|NON|EQV|NLM (1991)|900405|abbcdef", "ENTRY": "Renin, Inactive", "MN": "D08.811.277.656.837.750", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.4.23.15", "RR": "80965-96-4 (CRN)", "AN": "do not confuse with RENNIN see CHYMOSIN", "MS": "A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19.", "PM": "1963; PRORENIN was listed under ENZYME PRECUSORS & RENIN 1977-2003; PREPRORENIN was listed under ENZYME PRECUSORS & RENIN 1980-2003", "HN": "1963; for PRORENIN use RENIN (NM) 1977-2003, for PREPRORENIN use RENIN (NM) 1980-2003", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D012083"}, {"RECTYPE": "D", "MH": "Renin-Angiotensin System", "DE": "RA SYSTEM", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Renin-Angiotensin-Aldosterone System|T022|NON|BRD|UNK (19XX)|810519|abcdef", "ENTRY": "System, Renin-Angiotensin-Aldosterone", "MN": "G09.330.380.813", "FX": "Kallikrein-Kinin System", "MH_TH": "NLM (1982)", "ST": "T022", "AN": "note entry term but do not index under ALDOSTERONE unless particularly discussed", "PI": "Renin (1966-1981)", "MS": "A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19810519", "DC": "1", "DX": "19820101", "UI": "D012084"}, {"RECTYPE": "D", "MH": "Chymosin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Rennin|T116|T121|T126|NON|EQV|NLM (1991)|900405|abbbcdef", "ENTRY": "Chymosin C|T116|T123|NON|NRW|UNK (19XX)|880912|abbcdef", "MN": "D08.811.277.656.300.048.200", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.4.23.4", "AN": "do not confuse entry term RENNIN with RENIN; /biosyn /physiol permitted", "MS": "The predominant milk-clotting enzyme from the true stomach or abomasum of the suckling calf. It is secreted as an inactive precursor called prorennin and converted in the acid environment of the stomach to the active enzyme. EC 3.4.23.4.", "OL": "use CHYMOSIN to search RENNIN 1966-90", "PM": "91; was RENNIN 1963-90", "HN": "91; was RENNIN 1963-90", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012085"}, {"RECTYPE": "D", "MH": "Reoperation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Revision|T061|NON|EQV|UNK (19XX)|860325|SURG REVISION|abcdefv", "ENTRY": "Surgery, Revision", "MN": "E04.690", "MH_TH": "NLM (1982)", "ST": "T061", "MS": "A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery.", "OL": "use REOPERATION to search REVISION ARTHROPLASTY 1987-92", "PM": "91; was see under SURGERY, OPERATIVE 1982-90; REVISION ARTHROPLASTY was see REOPERATION 1987-92", "HN": "91(82); was see under SURGERY, OPERATIVE 1982-90; REVISION ARTHROPLASTY was see REOPERATION 1987-92", "CATSH": "CAT LIST", "MR": "20160608", "DA": "19810515", "DC": "1", "DX": "19910101", "UI": "D012086"}, {"RECTYPE": "D", "MH": "Reoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Seadornavirus|T005|NON|NRW|NLM (2007)|050906|abcdef", "ENTRY": "Seadornaviruses", "MN": "B04.820.223.719", "MH_TH": "NLM (1964)", "ST": "T005", "RN": "txid10880", "RR": "txid311227", "MS": "A family of unenveloped RNA viruses with cubic symmetry. The twelve genera include ORTHOREOVIRUS; ORBIVIRUS; COLTIVIRUS; ROTAVIRUS; Aquareovirus, Cypovirus, Phytoreovirus, Fijivirus, Seadornavirus, Idnoreovirus, Mycoreovirus, and Oryzavirus.", "OL": "use REOVIRIDAE to search REOVIRUSES 1975-80; REOVIRUS 1966-74 and 1993; & RESPIRATORY ENTERIC ORPHAN VIRUS 1976-92; use INSECT VIRUSES to search CYTOPLASMIC POLYHEDROSIS VIRUSES 1975-90", "PM": "81; was REOVIRUSES 1975-80, was REOVIRUS 1966-74; RESPIRATORY ENTERIC ORPHAN VIRUSES was RESPIRATORY ENTERIC ORPHAN VIRUS 1976-92; CYTOPLASMIC POLYHEDROSIS VIRUSES was see POLYHEDROSIS VIRUSES 1975-90; REOVIRUS was see REOVIRIDAE 1993", "HN": "81; was REOVIRUSES 1975-80, was REOVIRUS 1964-74 (Prov 1964-65); RESPIRATORY ENTERIC ORPHAN VIRUSES was RESPIRATORY ENTERIC ORPHAN VIRUS 1976-92; CYTOPLASMIC POLYHEDROSIS VIRUSES was see POLYHEDROSIS VIRUSES 1975-90; REOVIRUS was see REOVIRIDAE 1993", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012087"}, {"RECTYPE": "D", "MH": "Reoviridae Infections", "DE": "REOVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Reovirus Infections|T047|NON|EQV|NLM (1994)|930524|REOVIRUS INFECT|abcdefv", "ENTRY": "Reovirus Infection", "MN": "C01.925.782.791", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Virus Diseases (1966-1967)", "MS": "Infections produced by reoviruses, general or unspecified.", "OL": "use REOVIRIDAE INFECTIONS to search REOVIRUS INFECTIONS 1968-93", "PM": "94; was REOVIRUS INFECTIONS 1968-93", "HN": "94; was REOVIRUS INFECTIONS 1968-93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012088"}, {"RECTYPE": "D", "MH": "Mammalian orthoreovirus 3", "DS": "MAMMALIAN ORTHOREOVIRUS 03", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Reovirus 3|T005|NON|EQV|NLM (1975)|990101|REOVIRUS 003|abcdefs", "ENTRY": "Reovirus 3, Mammalian", "MN": "B04.820.223.719.590.550.700", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid538123", "AN": "infection: coordinate IM with REOVIRIDAE INFECTIONS (IM)", "MS": "A serotype of ORTHOREOVIRUS, MAMMALIAN causing serious pathology in laboratory rodents, characterized by diarrhea, oily coat, jaundice, and multiple organ involvement.", "PM": "2007; see REOVIRUS 3 1997-2006, see REOVIRUS TYPE 3 1991-1996, see REOVIRIDAE 1981-1990, see REOVIRUSES 1975-1980", "HN": "2007 (1975)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012089"}, {"RECTYPE": "D", "MH": "Cumulative Trauma Disorders", "DE": "CUMULATIVE TRAUMA DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Trauma Disorders, Cumulative|T047|NON|EQV|NLM (1996)|950315|TRAUMA DIS CUMULATIVE|abcdefv", "ENTRY": "Trauma Disorder, Cumulative", "MN": "C26.844.150", "FX": "Microtrauma, Physical", "MH_TH": "NLM (1988)", "ST": "T047", "PI": "Sprains and Strains (1966-1987)", "MS": "Harmful and painful condition caused by overuse or overexertion of some part of the musculoskeletal system, often resulting from work-related physical activities. It is characterized by inflammation, pain, or dysfunction of the involved joints, bones, ligaments, and nerves.", "PM": "97; was REPETITION STRAIN INJURY 1988-96; CUMULATIVE TRAUMA DISORDERS was see REPETITION STRAIN INJURY 1996", "HN": "97; was REPETITION STRAIN INJURY 1988-96; CUMULATIVE TRAUMA DISORDERS was see REPETITION STRAIN INJURY 1996", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19870430", "DC": "1", "DX": "19880101", "UI": "D012090"}, {"RECTYPE": "D", "MH": "Repetitive Sequences, Nucleic Acid", "DE": "REPET SEQ NA", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Selfish Genes|T028|NON|REL|NLM (2001)|000120|abcdef", "ENTRY": "Selfish Gene", "MN": "G05.360.080.708", "FX": "Multigene Family", "MH_TH": "NLM (1981)", "ST": "T123", "AN": "coordinate with DNA, RNA, or specifics", "PI": "DNA (1968-1980)", "MS": "Sequences of DNA or RNA that occur in multiple copies. There are several types: INTERSPERSED REPETITIVE SEQUENCES are copies of transposable elements (DNA TRANSPOSABLE ELEMENTS or RETROELEMENTS) dispersed throughout the genome. TERMINAL REPEAT SEQUENCES flank both ends of another sequence, for example, the long terminal repeats (LTRs) on RETROVIRUSES. Variations may be direct repeats, those occurring in the same direction, or inverted repeats, those opposite to each other in direction. TANDEM REPEAT SEQUENCES are copies which lie adjacent to each other, direct or inverted (INVERTED REPEAT SEQUENCES).", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19800402", "DC": "1", "DX": "19810101", "UI": "D012091"}, {"RECTYPE": "D", "MH": "Replantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Replantation|T061|NON|EQV|UNK (19XX)|740330|SURG REPLANTATION|abcdefv", "ENTRY": "Surgical Replantations", "MN": "E04.936.494", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "differentiate from transplantation; coordinate with organ /surg", "MS": "Restoration of an organ or other structure to its original site.", "OL": "use REPLANTATION to search REIMPLANTATION 1966-81", "PM": "82; was REIMPLANTATION 1965-81", "HN": "82; was REIMPLANTATION 1965-81", "CATSH": "CAT LIST", "MR": "19940505", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012092"}, {"RECTYPE": "D", "MH": "Replicon", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Replication Unit|T114|T123|NON|EQV|UNK (19XX)|790523|abbcdef", "ENTRY": "Units, Replication", "MN": "G05.360.340.024.745", "MH_TH": "NLM (1980)", "ST": "T123", "PI": "DNA/biosynthesis (1966-1967)", "MS": "Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19790523", "DC": "1", "DX": "19800101", "UI": "D012093"}, {"RECTYPE": "D", "MH": "Repression, Psychology", "PRINT ENTRY": "Repression|T041|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Syndrome, False Memory", "MN": "F01.393.821", "MH_TH": "NLM (2011)", "ST": "T041", "MS": "The active mental process of keeping out and ejecting, banishing from consciousness, ideas or impulses that are unacceptable to it.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012094"}, {"RECTYPE": "D", "MH": "Repression-Sensitization", "PRINT ENTRY": "Repression-Sensitization Scales|T081|NON|REL|NLM (1997)|960416|abcdef", "ENTRY": "Scales, Repression-Sensitization", "MN": "F01.393.821.645", "MH_TH": "NLM (1973)", "ST": "T041", "PI": "Repression (1966-1970)", "MS": "Defense mechanisms involving approach and avoidance responses to threatening stimuli. The sensitizing process involves intellectualization in approaching or controlling the stimulus whereas repression involves unconscious denial in avoiding the stimulus.", "PM": "73; REPRESSION-SENSITIZATION SCALES was heading 1975-96 (see under REPRESSION-SENSITIZATION 1975-90)", "HN": "73(71); REPRESSION-SENSITIZATION SCALES was heading 1975-96 (see under REPRESSION-SENSITIZATION 1975-90)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012095"}, {"RECTYPE": "D", "MH": "Repressor Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Repressor Molecules|T116|T123|NON|BRD|UNK (19XX)|780519|abbcdef", "ENTRY": "Silencing Factors, Transcriptional", "MN": "D12.776.930.780", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "PI": "Transcription, Genetic (1973-1978)", "MS": "Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release.", "PM": "91; was see under TRANSCRIPTION FACTORS 1979-90", "HN": "91(79); was see under TRANSCRIPTION FACTORS 1979-90", "MR": "20150629", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D012097"}, {"RECTYPE": "D", "MH": "Reproduction", "AQ": "DE ES GE IM PH RE", "ENTRY": "Reproductive Periods", "MN": "G08.686.784", "MH_TH": "BIOETHICS (1974)", "ST": "T040", "AN": "IM for human, other mammals, birds & fish; NIM for other vertebrates, invertebrates & plants; REPRODUCTIVE BEHAVIOR is also available", "MS": "The total process by which organisms produce offspring. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012098"}, {"RECTYPE": "D", "MH": "Reproductive Techniques", "AQ": "AE CL EC ES HI IS LJ MO NU PX SN ST TD VE", "PRINT ENTRY": "Reproductive Technology|T061|T062|NON|BRD|NLM (1994)|920827|REPRODUCTIVE TECHNOL|abbcdefv", "ENTRY": "Technologies, Reproductive", "MN": "E05.820", "MH_TH": "NLM (2002)", "ST": "T062", "AN": "general or unspecified; prefer specifics ", "MS": "Methods pertaining to the generation of new individuals, including techniques used in selective BREEDING, cloning (CLONING, ORGANISM), and assisted reproduction (REPRODUCTIVE TECHNIQUES, ASSISTED).", "OL": "use REPRODUCTION TECHNIQUES to search REPRODUCTION TECHNICS 1988-90", "PM": "91; was REPRODUCTION TECHNICS 1988-90", "HN": "91; was REPRODUCTION TECHNICS 1988-90; was non-MeSH before 1988", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19741119", "DC": "1", "DX": "19880101", "UI": "D012099"}, {"RECTYPE": "D", "MH": "Reproduction, Asexual", "AQ": "DE ES GE IM PH RE", "ENTRY": "Reproductions, Asexual", "MN": "G08.686.784.830", "FX": "Cloning, Organism", "MH_TH": "NLM (1975)", "ST": "T040", "MS": "Reproduction without fusion of two types of cells, mostly found in ALGAE; FUNGI; and PLANTS. Asexual reproduction occurs in several ways, such as budding, fission, or splitting from \"parent\" cells. Only few groups of ANIMALS reproduce asexually or unisexually (PARTHENOGENESIS).", "PM": "91; was see under REPRODUCTION 1975-90", "HN": "91(75); was see under REPRODUCTION 1975-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D012100"}, {"RECTYPE": "D", "MH": "Reproductive and Urinary Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Reproductive and Urinary Physiology Phenomena|T040|NON|EQV|NLM (2009)|080701|abcdef", "ENTRY": "Reproductive and Urinary Tract Physiology|T040|NON|EQV|NLM (2009)|080430|abcdef", "MN": "G08", "RH": "G8 - PHYSIOLOGICAL PHENOMENA -REPRODUCTIVE AND URINARY", "MH_TH": "NLM (2009)", "ST": "T040", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "PI": "Urinary Tract/physiology (1969-1997)", "MS": "Physiology of the human and animal body, male or female, in the processes and characteristics of REPRODUCTION and the URINARY TRACT.", "PM": "2009; see REPRODUCTIVE AND URINARY PHYSIOLOGY 1998-2008", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012101"}, {"RECTYPE": "D", "MH": "Reproductive Control Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Control Agents, Reproductive", "MN": "D27.505.954.705", "MH_TH": "NLM (1974)", "ST": "T121", "RN": "0", "AN": "consider also REPRODUCTION /DE", "MS": "Substances used either in the prevention or facilitation of pregnancy.", "PM": "98", "HN": "98; use explode 1975-97", "MR": "20050815", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012102"}, {"RECTYPE": "D", "MH": "Batroxobin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hemocoagulase|T116|T126|T131|NON|NRW|UNK (19XX)|771125|abbbcdef", "ENTRY": "Reptilase DEF", "MN": "D23.946.833.850.960.200.105", "PA": "Hemostatics", "MH_TH": "UNK (19XX)", "ST": "T131", "RN": "EC 3.4.21.-", "RR": "9039-61-6 (CAS RN)", "PI": "Venoms (1969-1974)", "MS": "A proteolytic enzyme obtained from the venom of fer-de-lance (BOTHROPS ATROX). It is used as a plasma clotting agent for fibrinogen and for the detection of fibrinogen degradation products. The presence of heparin does not interfere with the clotting test. Hemocoagulase is a mixture containing batroxobin and factor X activator. EC 3.4.21.-.", "PM": "2000; see REPTILASE 1991-1999; see SERINE PROTEINASES 1975-1990; for BATROXOBIN see REPTILASE 1982-199; PLASMOCOAGULASE was indexed under COAGULASE 1979-1999", "HN": "2000(1975); for PLASMOCOAGULASE use BATROXOBIN (NM) 1979-1999", "MR": "20230405", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D012103"}, {"RECTYPE": "D", "MH": "Reptiles", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Reptilia|T014|NON|EQV|NLM (2009)|070716|abcdef", "ENTRY": "Reptile", "MN": "B01.050.150.900.833", "FX": "Reptilian Proteins", "MH_TH": "NLM (1966)", "ST": "T014", "AN": "general or unspecified; prefer specifics", "MS": "Cold-blooded, air-breathing VERTEBRATES belonging to the class Reptilia, usually covered with external scales or bony plates.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012104"}, {"RECTYPE": "D", "MH": "Research", "AQ": "CL EC ED HI IS LJ OG SN ST TD", "PRINT ENTRY": "Research Priorities|T062|NON|REL|NLM (1997)|960325|abcdef", "ENTRY": "Research, Laboratory", "MN": "H01.770.644", "FX": "Systems Analysis", "EC": "methods:Research Design", "MH_TH": "NLM (1966)", "ST": "T062", "AN": "general or unspecified; prefer specifics; research as a field or the progress or status of research in a particular field; do not add routinely for specific studies involving \"research\"", "MS": "Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012106"}, {"RECTYPE": "D", "MH": "Research Design", "AQ": "LJ SN ST TD", "PRINT ENTRY": "Experimental Design|T062|T169|NON|NRW|UNK (1994)|741105|EXPER DESIGN|abbcdefv", "ENTRY": "Techniques, Research", "MN": "H01.770.644.728", "FX": "Clinical Trials Data Monitoring Committees", "MH_TH": "BIOETHICS (1974)", "ST": "T062", "MS": "A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.", "PM": "73", "HN": "73", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012107"}, {"RECTYPE": "D", "MH": "Research Personnel", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Researchers|T097|NON|EQV|NLM (1996)|940711|abcdef", "ENTRY": "Researcher", "MN": "M01.526.839", "MH_TH": "NLM (1968)", "ST": "T097", "AN": "IM", "PI": "Research (1966-1967)", "MS": "Those individuals engaged in research.", "PM": "68", "HN": "68", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012108"}, {"RECTYPE": "D", "MH": "Research Support as Topic", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Subsidies, Research|T065|NON|NRW|UNK (19XX)|790601|abcdef", "ENTRY": "Research Subsidy", "MN": "N03.219.483.645", "MH_TH": "NLM (2008)", "ST": "T170", "MS": "Work about financial support of research activities.", "PM": "2008; see RESEARCH SUPPORT 1966-2007", "HN": "2008(1964)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012109"}, {"RECTYPE": "D", "MH": "Reserpine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "V Serp", "MN": "D03.633.100.496.500.500.681.933.500", "PA": "Antipsychotic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-", "RN": "8B1QWR724A", "RR": "50-55-5 (Reserpine)", "AN": "reserpine derivatives=RESERPINE /analogs", "MS": "An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.", "OL": "use RESERPINE to search RESERPINE DERIVATIVES 1975-77; use YOHIMBANS 1969-74", "PM": "RESERPINE DERIVATIVES was see under RESERPINE 1975-77, was see under YOHIMBANS 1969-74; /adverse effects /poisoning /toxicity were RESERPINE TOXICOLOGY 1963-65", "HN": "RESERPINE DERIVATIVES was see under RESERPINE 1975-77, was see under YOHIMBANS 1969-74; /adv eff-pois-tox was RESERPINE TOXICOLOGY 1963-65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012110"}, {"RECTYPE": "D", "MH": "Residence Characteristics", "AQ": "CL HI SN", "ENTRY": "Residence Characteristic", "MN": "N06.850.505.400.800", "FX": "Social Determinants of Health", "MH_TH": "NLM (1968)", "ST": "T081", "AN": "specify geographic location if pertinent", "PI": "Transients and Migrants (1966-1967)", "MS": "Elements of residence that characterize a population. They are applicable in determining need for and utilization of health services.", "PM": "68", "HN": "68", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012111"}, {"RECTYPE": "D", "MH": "Residential Facilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Residential Facility", "MN": "N02.278.825", "MH_TH": "BIOETHICS (1974)", "ST": "T093", "MS": "Long-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required.", "PM": "68", "HN": "68", "MR": "20160616", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012112"}, {"RECTYPE": "D", "MH": "Residential Treatment", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Treatments, Residential", "MN": "F04.754.864.696", "MH_TH": "NLM (1964)", "ST": "T061", "MS": "A specialized residential treatment program for behavior disorders including substance abuse. It may include therapeutically planned group living and learning situations including teaching of adaptive skills to help patient functioning in the community. (From Kahn, A. P. and Fawcett, J. Encyclopedia of Mental Health, 1993, p320.)", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012114"}, {"RECTYPE": "D", "MH": "Residual Volume", "AQ": "DE ES GE IM PH RE", "ENTRY": "Volumes, Residual", "MN": "G09.772.850.390.820", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "NIM; in texts as RV", "MS": "The volume of air remaining in the LUNGS at the end of a maximal expiration. Common abbreviation is RV.", "PM": "91; was see under LUNG VOLUME MEASUREMENTS 1975-90", "HN": "91(75); was see under LUNG VOLUME MEASUREMENTS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012115"}, {"RECTYPE": "D", "MH": "Resins, Plant", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Plant Resins", "MN": "D20.215.721.500", "MH_TH": "NLM (2003)", "ST": "T121", "RN": "0", "AN": "RESINS, SYNTHETIC is also available", "MS": "Flammable, amorphous, vegetable products of secretion or disintegration, usually formed in special cavities of plants. They are generally insoluble in water and soluble in alcohol, carbon tetrachloride, ether, or volatile oils. They are fusible and have a conchoidal fracture. They are the oxidation or polymerization products of the terpenes, and are mixtures of aromatic acids and esters. Most are soft and sticky, but harden after exposure to cold. (From Grant & Hackh's Chemical Dictionary, 5th ed & Dorland, 28th ed)", "PM": "2003; see RESINS 1963-2002", "HN": "2003 (1963)", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "20030101", "UI": "D012116"}, {"RECTYPE": "D", "MH": "Resins, Synthetic", "DE": "RESINS SYN", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Dental Resins|T122|NON|NRW|NLM (2009)|071017|abcdef", "ENTRY": "Synthetic Resins", "MN": "J01.637.051.720.716.822", "MH_TH": "NLM (1975)", "ST": "T122", "RN": "0", "PI": "Plastics (1966-1974)", "MS": "Polymers of high molecular weight which at some stage are capable of being molded and then harden to form useful components.", "PM": "75", "HN": "75", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D012117"}, {"RECTYPE": "D", "MH": "Resorcinols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "meta-Dihydroxybenzenes|T109|T121|NON|EQV|UNK (19XX)|770520|abbcdef", "ENTRY": "meta Dihydroxybenzenes", "MN": "D02.455.426.559.389.657.852", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "A water-soluble crystalline benzene-1,3-diol (resorcinol) and its derivatives.", "OL": "use RESORCINOLS to search RESORCINOL 1966-74", "PM": "75; was RESORCINOL 1963-74", "HN": "75; was RESORCINOL 1963-74", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D012118"}, {"RECTYPE": "D", "MH": "Respiration", "AQ": "DE ES GE IM RE", "PRINT ENTRY": "Breathing|T039|NON|EQV|NLM (1993)|920323|abcdef", "MN": "G09.772.705", "FX": "Oxygen Consumption", "MH_TH": "NLM (1966)", "ST": "T039", "AN": "lung only: does not refer to tissue respiration (= probably OXYGEN CONSUMPTION); CELL RESPIRATION is also available", "MS": "The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration (= OXYGEN CONSUMPTION) or cell respiration (= CELL RESPIRATION).", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012119"}, {"RECTYPE": "D", "MH": "Respiration Disorders", "DE": "RESPIRATION DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Respiration Disorder", "MN": "C08.618", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Respiratory Insufficiency (1966-1976)", "MS": "Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.", "PM": "77; RESPIRATORY DISEASES was a heading 1963-65 superseded by RESPIRATORY TRACT DISEASES in 1966; CHEYNE-STOKES RESPIRATION was see under RESPIRATION 1966-76", "HN": "77; was NON MESH before 1977; RESPIRATORY DISEASES was a heading 1963-65 superseded by RESPIRATORY TRACT DISEASES in 1966", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D012120"}, {"RECTYPE": "D", "MH": "Respiration, Artificial", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ventilation, Mechanical|T061|NON|NRW|UNK (19XX)|780313|abcdef", "ENTRY": "Ventilations, Mechanical", "MN": "E02.880.820", "FX": "Ventilators, Mechanical", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "/instrum: consider also VENTILATORS, MECHANICAL", "MS": "Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2).", "CATSH": "CAT LIST", "MR": "20150706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012121"}, {"RECTYPE": "D", "MH": "Ventilators, Mechanical", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Ventilators, Pulmonary|T074|NON|EQV|UNK (19XX)|780216|VENTILATORS PULM|abcdefv", "ENTRY": "Ventilator, Mechanical", "MN": "E07.950", "FX": "Ventilator-Induced Lung Injury", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "Mechanical devices used to produce or assist pulmonary ventilation.", "OL": "use VENTILATORS, MECHANICAL to search RESPIRATORS 1966-88", "PM": "89; was RESPIRATORS 1963-88", "HN": "89; was RESPIRATORS 1963-88", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19890101", "UI": "D012122"}, {"RECTYPE": "D", "MH": "Pulmonary Ventilation", "DE": "PULM VENTILATION", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Ventilation, Pulmonary|T034|T042|NON|EQV|NLM (1997)|950801|VENTILATION PULM|abbcdefv", "ENTRY": "Ventilation Test", "MN": "G09.772.650", "MH_TH": "NLM (1971)", "ST": "T042", "AN": "MAXIMAL VOLUNTARY VENTILATION & VENTILATION-PERFUSION RATIO are also available", "PI": "Respiration (1966-1970)", "MS": "The total volume of gas inspired or expired per unit of time, usually measured in liters per minute.", "OL": "use RESPIRATORY FUNCTION TESTS to search VENTILATION TESTS 1990-96", "PM": "97; was RESPIRATORY AIRFLOW 1972-96; VENTILATION TESTS was see RESPIRATORY FUNCTION TESTS 1990-96", "HN": "97; was RESPIRATORY AIRFLOW 1971-96 (Prov 1971); VENTILATION TESTS was see RESPIRATORY FUNCTION TESTS 1990-96", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012123"}, {"RECTYPE": "D", "MH": "Respiratory Care Units", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Units, Respiratory Care", "MN": "N02.278.388.493.696", "MH_TH": "NLM (1971)", "ST": "T093", "PI": "Respiratory Tract Diseases (1966-1970)", "MS": "The hospital unit in which patients with respiratory conditions requiring special attention receive intensive medical care and surveillance.", "PM": "73", "HN": "73(71)", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012124"}, {"RECTYPE": "D", "MH": "Respiratory Center", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Respiratory Centers", "MN": "A08.186.211.132.772.646", "MH_TH": "NLM (1968)", "ST": "T023", "PI": "Reticular Formation (1966-1967)", "MS": "Part of the brain located in the MEDULLA OBLONGATA and PONS. It receives neural, chemical and hormonal signals, and controls the rate and depth of respiratory movements of the DIAPHRAGM and other respiratory muscles.", "PM": "72", "HN": "72(68)", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012125"}, {"RECTYPE": "D", "MH": "Respiratory Dead Space", "AQ": "DE ES GE IM PH RE", "ENTRY": "Spaces, Respiratory Dead", "MN": "G09.772.760", "MH_TH": "NLM (1969)", "ST": "T042", "PI": "Respiration (1966-1968)", "MS": "That part of the RESPIRATORY TRACT or the air within the respiratory tract that does not exchange OXYGEN and CARBON DIOXIDE with pulmonary capillary blood.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012126"}, {"RECTYPE": "D", "MH": "Respiratory Distress Syndrome, Newborn", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Respiratory Distress Syndrome, Infant|T047|NON|EQV|NLM (2010)|ORD (2010)|090513|abcdeef", "MN": "C16.614.521.563", "MH_TH": "NLM (2004)", "ST": "T047", "AN": "for adults use RESPIRATORY DISTRESS SYNDROME, ADULT; do not confuse with \"respiratory distress\" which may be RESPIRATORY INSUFFICIENCY or a specific; do not confuse with SEVERE ACUTE RESPIRATORY SYNDROME", "MS": "A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.", "PM": "2004; see RESPIRATORY DISTRESS SYNDROME 1965-2003", "HN": "2004 (1965)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012127"}, {"RECTYPE": "D", "MH": "Respiratory Distress Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Shock Lung|T047|NON|EQV|UNK (19XX)|760518|abcdef", "ENTRY": "Syndrome, Respiratory Distress", "MN": "C08.618.840", "FX": "Acute Chest Syndrome", "MH_TH": "NLM (2021)", "ST": "T047", "AN": "RESPIRATORY DISTRESS SYNDROME, NEWBORN is also available; do not confuse with SEVERE ACUTE RESPIRATORY SYNDROME", "MS": "A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.", "PM": "2021; see RESPIRATORY DISTRESS SYNDROME, ADULT 1977-2020", "HN": "2021(1977)", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D012128"}, {"RECTYPE": "D", "MH": "Respiratory Function Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Pulmonary Function Tests|T060|NON|NRW|IOM (1990)|890417|PULM FUNCTION TESTS|abcdefv", "ENTRY": "Tests, Respiratory Function", "MN": "E01.370.386.700", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "general or unspecified; prefer specifics", "MS": "Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012129"}, {"RECTYPE": "D", "MH": "Respiratory Hypersensitivity", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypersensitivity, Respiratory|T046|NON|EQV|NLM (1993)|920203|abcdef", "ENTRY": "Respiratory Hypersensitivities", "MN": "C20.543.480.680", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "\"respiratory allergy\"", "MS": "A form of hypersensitivity affecting the respiratory tract. It includes ASTHMA and RHINITIS, ALLERGIC, SEASONAL.", "PM": "66; was RESPIRATORY ALLERGY 1963-65", "HN": "66; was RESPIRATORY ALLERGY 1963-65", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012130"}, {"RECTYPE": "D", "MH": "Respiratory Insufficiency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Respiratory Failure|T046|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Respiratory Failures", "MN": "C08.618.846", "MH_TH": "POPLINE (1978)", "ST": "T046", "AN": "do not confuse with RESPIRATORY DISTRESS SYNDROME, NEWBORN in newborn inf", "MS": "Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012131"}, {"RECTYPE": "D", "MH": "Respiratory Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Ventilatory Muscles|T023|NON|EQV|UNK (19XX)|860402|abcdef", "ENTRY": "Ventilatory Muscle", "MN": "A02.633.567.900", "MH_TH": "NLM (1987)", "ST": "T023", "AN": "/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent", "PI": "Respiration (1966-1986)", "MS": "These include the muscles of the DIAPHRAGM and the INTERCOSTAL MUSCLES.", "PM": "87", "HN": "87", "MR": "20080708", "DA": "19860402", "DC": "1", "DX": "19870101", "UI": "D012132"}, {"RECTYPE": "D", "MH": "Respiratory Paralysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paralysis, Respiratory Muscle|T033|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Respiratory Muscle Paralysis", "MN": "C23.888.592.636.812", "MH_TH": "NLM (1968)", "ST": "T033", "PI": "Respiratory Insufficiency (1966-1967)", "MS": "Complete or severe weakness of the muscles of respiration. This condition may be associated with MOTOR NEURON DISEASES; PERIPHERAL NERVE DISEASES; NEUROMUSCULAR JUNCTION DISEASES; SPINAL CORD DISEASES; injury to the PHRENIC NERVE; and other disorders.", "PM": "73", "HN": "73(68)", "CATSH": "CAT LIST", "MR": "20050722", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012133"}, {"RECTYPE": "D", "MH": "Respiratory Protective Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Respirators, Industrial|T073|NON|NRW|UNK (19XX)|780216|RESPIRATORS INDUST|abcdefv", "ENTRY": "Respiratory Protective Device", "MN": "J01.637.708.560.937", "MH_TH": "NLM (1975)", "ST": "T073", "MS": "Respirators to protect individuals from breathing air contaminated with harmful dusts, fogs, fumes, mists, gases, smokes, sprays, or vapors.", "PM": "91; see PROTECTIVE DEVICES 1975-90; for GAS MASKS see MASKS 1968-74, see GAS MASKS 1963-67", "HN": "91(63)", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012134"}, {"RECTYPE": "D", "MH": "Respiratory Sounds", "AQ": "CL DE DI ES ET GE IM PH PP RE VE", "PRINT ENTRY": "Wheezing|T184|NON|NRW|UNK (19XX)|790525|abcdef", "ENTRY": "Wheezings", "MN": "G09.772.775", "MH_TH": "NLM (1980)", "ST": "T184", "MS": "Noises, normal and abnormal, heard on auscultation over any part of the RESPIRATORY TRACT.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19790525", "DC": "1", "DX": "19800101", "UI": "D012135"}, {"RECTYPE": "D", "MH": "Respiratory Syncytial Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "RSV Respiratory Syncytial Virus|T005|ABX|EQV|NLM (2024)|221024|abcdef", "ENTRY": "Virus, Respiratory Syncytial", "MN": "B04.820.480.937.600.670.600.750", "MH_TH": "NLM (1964)", "ST": "T005", "RN": "txid1868215", "MS": "A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported.", "OL": "use RESPIRATORY SYNCYTIAL VIRUSES to search RESPIRATORY SYNCYTIAL VIRUS 1966-76", "PM": "77; was RESPIRATORY SYNCYTIAL VIRUS 1966-76", "HN": "77; was RESPIRATORY SYNCYTIAL VIRUS 1964-76 (Prov 1964-65)", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012136"}, {"RECTYPE": "D", "MH": "Respiratory System", "AQ": "AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PP PS RE SU UL VI", "ENTRY": "Tract, Respiratory", "MN": "A04", "RH": "A4 - ANATOMY-RESPIRATORY SYSTEM", "EC": "physiology:Respiratory Physiological Phenomena", "MH_TH": "NLM (1966)", "ST": "T022", "AN": "general or unspecified; prefer specifics; /abnorm: RESPIRATORY SYSTEM ABNORMALITIES is available but consider also specific part of respiratory system with /abnorm or specific abnormality", "MS": "The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012137"}, {"RECTYPE": "D", "MH": "Respiratory Therapy", "DE": "RESPIRATORY THER", "AQ": "AE CL EC ED ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Inhalation Therapy|T061|NON|REL|UNK (19XX)|770324|INHALATION THER|abcdefv", "ENTRY": "Therapies, Respiratory", "MN": "E02.880", "FX": "Breathing Exercises", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "do not confuse with ADMINISTRATION, INHALATION", "MS": "Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways.", "OL": "use RESPIRATORY THERAPY to search INHALATION THERAPY 1966-77", "PM": "78; was INHALATION THERAPY 1963-77", "HN": "78; was INHALATION THERAPY 1963-77", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D012138"}, {"RECTYPE": "D", "MH": "Respiratory Therapy Department, Hospital", "DE": "RESP THER DEP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Respiratory Therapy Department|T093|NON|EQV|UNK (19XX)|770519|HOSP RESPIRATORY THER DEP|abcdefv", "ENTRY": "Respiratory Therapy Departments, Hospital|T093|NON|EQV|UNK (19XX)|790326|RESPIRATORY THER DEP HOSP|abcdefv", "MN": "N04.452.442.452.422.712", "MH_TH": "NLM (1977)", "ST": "T093", "PI": "Respiratory Therapy (1966-Jul 1977)", "MS": "Hospital department which is responsible for the administration of diagnostic pulmonary function tests and of procedures to restore optimum pulmonary ventilation.", "PM": "91; was see under HOSPITAL DEPARTMENTS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90", "MR": "20190709", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D012139"}, {"RECTYPE": "D", "MH": "Respiratory Tract Diseases", "DE": "RESPIRATORY TRACT DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Respiratory System Diseases|T047|NON|EQV|NLM (2023)|220330|abcdef", "ENTRY": "Respiratory Tract Disease", "MN": "C08", "RH": "C8 - DISEASES-RESPIRATORY", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Diseases involving the RESPIRATORY SYSTEM.", "PM": "1966; was RESPIRATORY DISEASES 1963-65", "HN": "1966; was RESPIRATORY DISEASES 1963-65", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012140"}, {"RECTYPE": "D", "MH": "Respiratory Tract Infections", "DE": "RESPIRATORY TRACT INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Upper Respiratory Tract Infections|T047|NON|NRW|NLM (2009)|071025|abcdef", "ENTRY": "Respiratory Tract Infection", "MN": "C08.730", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general, prefer specifics", "MS": "Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012141"}, {"RECTYPE": "D", "MH": "Respiratory Tract Neoplasms", "DE": "RESPIRATORY TRACT NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Respiratory System Neoplasms|T191|NON|EQV|NLM (2023)|220330|abcdef", "ENTRY": "Respiratory Tract Neoplasm", "MN": "C08.785", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "general or unspecified; prefer specifics; coordinate with histological type of neoplasm ", "MS": "Tumors or cancer of the RESPIRATORY SYSTEM.", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012142"}, {"RECTYPE": "D", "MH": "Respiratory Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Respiratory Physiology|T042|NON|EQV|NLM (1966)|990101|RESPIRATORY PHYSIOL|abcdefv", "ENTRY": "Respiratory Physiological Phenomenons", "MN": "G09.772", "MH_TH": "NLM (2009)", "ST": "T042", "AN": "general or unspecified; prefer specifics", "PI": "Respiratory System/physiology (1966-1997)", "MS": "Physiological processes and properties of the RESPIRATORY SYSTEM as a whole or of any of its parts.", "PM": "2009; see RESPIRATORY PHYSIOLOGY 1998-2008; for RESPIRATORY PHYSIOLOGICAL PROCESSES see  RESPIRATORY PHYSIOLOGICAL PROCESSES 2009-2016; for  RESPIRATORY PHYSIOLOGIC PROCESSES see  RESPIRATORY PHYSIOLOGIC PROCESSES 2004-2008", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20160511", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012143"}, {"RECTYPE": "D", "MH": "Respite Care", "AQ": "CL EC ES HI LJ MT OG PX SD SN ST TD", "PRINT ENTRY": "In-Home Respite Care|T058|NON|NRW|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Respite, In-Home", "MN": "N02.421.533.320.610", "MH_TH": "NLM (1985)", "ST": "T058", "PI": "Home Nursing (1966-1984)", "MS": "Patient care provided in the home or institution intermittently in order to provide temporary relief to the family home care giver.", "PM": "85", "HN": "85", "MR": "20210512", "DA": "19840411", "DC": "1", "DX": "19850101", "UI": "D012144"}, {"RECTYPE": "D", "MH": "Rest", "AQ": "PH PX", "ENTRY": "Rests", "MN": "I03.450.769.647", "FX": "Post-Exercise Recovery", "MH_TH": "NLM (1966)", "ST": "T056", "AN": "do not confuse with IMMOBILIZATION; /physiol /psychol permitted", "MS": "Freedom from activity.", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012146"}, {"RECTYPE": "D", "MH": "Restaurants", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Restaurant", "MN": "J03.813", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "An establishment where meals are cooked, sold and served to customers.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012147"}, {"RECTYPE": "D", "MH": "Restless Legs Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Wittmaack-Ekbom", "MN": "F03.870.664.634", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "note entry terms containing \"Ekbom\": do not confuse with entry terms for DELUSIONAL PARASITOSIS which also contain \"Ekbom\"", "PI": "Paresthesia (1966-1972)", "MS": "A disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep.", "PM": "2000; see Restless Legs 1973-1999", "HN": "2000(1973)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012148"}, {"RECTYPE": "D", "MH": "Restraint, Physical", "AQ": "AE ES IS LJ MT PH PX SN ST VE", "ENTRY": "Restraints, Physical", "MN": "E05.472.760", "FX": "Protective Devices", "MH_TH": "NLM (1977)", "ST": "T061", "AN": "human and animal: NIM with no qualif for restraint of animals in experimental stress states; do not confuse with IMMOBILIZATION: if in doubt use word of text", "PI": "Stress (1966-1976)", "MS": "Use of a device for the purpose of controlling movement of all or part of the body. Splinting and casting are FRACTURE FIXATION.", "PM": "1977", "HN": "1977", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D012149"}, {"RECTYPE": "D", "MH": "Polymorphism, Restriction Fragment Length", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Restriction Fragment Length Polymorphism|T045|NON|EQV|NLM (1995)|940429|abcdef", "ENTRY": "Restriction Fragment Length Polymorphisms|T045|NON|EQV|NLM (2008)|070104|abcdef", "MN": "G05.365.795.595", "FX": "Mutation", "MH_TH": "NLM (1987)", "ST": "T045", "PI": "Polymorphism (Genetics) (1980-1986)", "MS": "Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment.", "OL": "use POLYMORPHISM, RESTRICTION FRAGMENT LENGTH to search for RESTRICTION FRAGMENT LENGTH POLYMORPHISMS 1987-94", "PM": "95; was RESTRICTION FRAGMENT LENGTH POLYMORPHISMS 1987-94 (see under POLYMORPHISM (GENETICS) 1987-89)", "HN": "95; was RESTRICTION FRAGMENT LENGTH POLYMORPHISMS 1987-94 (see under POLYMORPHISM (GENETICS) 1987-89)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19860618", "DC": "1", "DX": "19900101", "UI": "D012150"}, {"RECTYPE": "D", "MH": "Resuscitation", "AQ": "AE CL EC ED ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Resuscitations", "MN": "E02.365.647", "MH_TH": "BIOETHICS (1994)", "ST": "T061", "MS": "The restoration to life or consciousness of one apparently dead. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20150706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012151"}, {"RECTYPE": "D", "MH": "Rete Testis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Testis, Rete", "MN": "A05.360.444.849.600", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "The network of channels formed at the termination of the straight SEMINIFEROUS TUBULES in the mediastinum testis. Rete testis channels drain into the efferent ductules that pass into the caput EPIDIDYMIS.", "PM": "91; was see under TESTIS 1975-90", "HN": "91(75); was see under TESTIS 1975-90", "MR": "20020703", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D012152"}, {"RECTYPE": "D", "MH": "Retention, Psychology", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Retention (Psychology)|T041|NON|EQV|NLM (1975)|990101|RETENTION PSYCHOL|abcdefv", "ENTRY": "Retention, Psychological", "MN": "F02.463.425.540.772", "MH_TH": "NLM (2020)", "ST": "T041", "PI": "Memory (1966-1974)", "MS": "The persistence to perform a learned behavior (facts or experiences) after an interval has elapsed in which there has been no performance or practice of the behavior.", "PM": "2020; was RETENTION (PSYCHOLOGY) 1991-2019; see MEMORY 1963-1990", "HN": "2020 (1979); was RETENTION (PSYCHOLOGY) 1991-2019; use MEMORY 1963-1990", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012153"}, {"RECTYPE": "D", "MH": "Reticular Formation", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Reticular Formations", "MN": "A08.186.211.132.772", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A region extending from the PONS & MEDULLA OBLONGATA through the MESENCEPHALON, characterized by a diversity of neurons of various sizes and shapes, arranged in different aggregations and enmeshed in a complicated fiber network.", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012154"}, {"RECTYPE": "D", "MH": "Reticulin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fibrils, Reticulin", "MN": "D12.776.860.823", "FX": "Ehlers-Danlos Syndrome", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "A scleroprotein fibril consisting mostly of type III collagen. Reticulin fibrils are extremely thin, with a diameter of between 0.5 and 2 um. They are involved in maintaining the structural integrity in a variety of organs.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012155"}, {"RECTYPE": "D", "MH": "Reticulocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Reticulocyte", "MN": "A15.378.316.790", "MH_TH": "NLM (1966)", "ST": "T025", "MS": "Immature ERYTHROCYTES. In humans, these are ERYTHROID CELLS that have just undergone extrusion of their CELL NUCLEUS. They still contain some organelles that gradually decrease in number as the cells mature. RIBOSOMES are last to disappear. Certain staining techniques cause components of the ribosomes to precipitate into characteristic \"reticulum\" (not the same as the ENDOPLASMIC RETICULUM), hence the name reticulocytes.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012156"}, {"RECTYPE": "D", "MH": "Mononuclear Phagocyte System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Reticuloendothelial System|T022|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "System, Reticuloendothelial", "MN": "A15.382.670", "FX": "Phagocytes", "MH_TH": "NLM (2008)", "ST": "T022", "MS": "Mononuclear cells with pronounced phagocytic ability that are distributed extensively in lymphoid and other organs. It includes MACROPHAGES and their precursors; PHAGOCYTES; KUPFFER CELLS; HISTIOCYTES; DENDRITIC CELLS; LANGERHANS CELLS; and MICROGLIA. The term mononuclear phagocyte system has replaced the former reticuloendothelial system, which also included less active phagocytic cells such as fibroblasts and endothelial cells. (From Illustrated Dictionary of Immunology, 2d ed.)", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012157"}, {"RECTYPE": "D", "MH": "Reticulum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Reticulums", "MN": "A13.869.697", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "a ruminant's 2d stomach; note category: animal term; dis: coord IM with STOMACH DISEASES /vet (IM); neopl: coord IM with STOMACH NEOPLASMS /vet (IM) + histol type /vet (IM); ulcer: coord IM with STOMACH ULCER /vet (IM)", "PI": "Stomach (1966-1967)", "MS": "The second stomach of ruminants. It lies almost in the midline in the front of the abdomen, in contact with the liver and diaphragm and communicates freely with the RUMEN via the ruminoreticular orifice. The lining of the reticulum is raised into folds forming a honeycomb pattern over the surface. (From Concise Veterinary Dictionary, 1988)", "PM": "68", "HN": "68", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012159"}, {"RECTYPE": "D", "MH": "Retina", "AQ": "AB AH CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Ora Serrata|T024|NON|NRW|NLM (2020)|190215|abcdef", "MN": "A09.371.729", "FX": "Electroretinography", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent.", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012160"}, {"RECTYPE": "D", "MH": "Retinal Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Central Retinal Artery|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Retinal Artery, Central", "MN": "A07.015.611.647", "MH_TH": "NLM (1973)", "ST": "T023", "AN": "retinal artery dis: coord IM with RETINAL DISEASES (IM), not VASCULAR DISEASES", "PI": "Retinal Vessels (1966-1972)", "MS": "Central retinal artery and its branches. It arises from the ophthalmic artery, pierces the optic nerve and runs through its center, enters the eye through the porus opticus and branches to supply the retina.", "PM": "73", "HN": "73", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012161"}, {"RECTYPE": "D", "MH": "Retinal Degeneration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Retinal Degenerations", "MN": "C11.768.585", "MH_TH": "NLM (1968)", "ST": "T047", "PI": "Retina (1966-1967)", "MS": "A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20180615", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D012162"}, {"RECTYPE": "D", "MH": "Retinal Detachment", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Retinal Pigment Epithelial Detachment|T047|NON|NRW|NLM (1998)|960723|abcdef", "ENTRY": "Retinal Detachments", "MN": "C11.768.648", "FX": "Scleral Buckling", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "/surg: consider also SCLERAL BUCKLING", "MS": "Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12).", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012163"}, {"RECTYPE": "D", "MH": "Retinal Diseases", "DE": "RETINAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Retinal Disease", "MN": "C11.768", "MH_TH": "NLM (1972)", "ST": "T047", "PI": "Retina (1966-1971)", "MS": "Diseases involving the RETINA.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20151009", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012164"}, {"RECTYPE": "D", "MH": "Retinal Ganglion Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Retinal Ganglion Cell", "MN": "A11.671.650.850.875", "MH_TH": "NLM (1983)", "ST": "T025", "PI": "Retina (1966-1982)", "MS": "Neurons of the innermost layer of the retina, the internal plexiform layer. They are of variable sizes and shapes, and their axons project via the OPTIC NERVE to the brain. A small subset of these cells act as photoreceptors with projections to the SUPRACHIASMATIC NUCLEUS, the center for regulating CIRCADIAN RHYTHM.", "PM": "91; was see under RETINA 1983-90", "HN": "91(83); was see under RETINA 1983-90", "MR": "20080708", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D012165"}, {"RECTYPE": "D", "MH": "Retinal Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Retinal|T033|T046|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Retinal Hemorrhages", "MN": "C23.550.414.756.775", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Bleeding from the vessels of the retina.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012166"}, {"RECTYPE": "D", "MH": "Retinal Perforations", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Retinal Tears|T020|T047|NON|EQV|UNK (19XX)|830311|abbcdef", "ENTRY": "Tears, Retinal", "MN": "C11.768.740", "MH_TH": "NLM (1984)", "ST": "T047", "PI": "Retinal Detachment (1966-1983)", "MS": "Perforations through the whole thickness of the retina including the macula as the result of inflammation, trauma, degeneration, etc. The concept includes retinal breaks, tears, dialyses, and holes.", "OL": "use RETINAL DETACHMENT to search RETINAL TEARS 1977-83", "PM": "84; RETINAL TEARS was see RETINAL DETACHMENT 1977-83", "HN": "84; RETINAL TEARS was see RETINAL DETACHMENT 1977-83", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19830311", "DC": "1", "DX": "19840101", "UI": "D012167"}, {"RECTYPE": "D", "MH": "Retinal Pigments", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Visual Pigments|T109|T123|NON|EQV|NLM (1998)|960807|abbcdef", "ENTRY": "Pigments, Visual", "MN": "D23.767.930", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "not for deposition of pigments in the retina (= RETINITIS PIGMENTOSA)", "MS": "Photosensitive protein complexes of varied light absorption properties which are expressed in the PHOTORECEPTOR CELLS. They are OPSINS conjugated with VITAMIN A-based chromophores. Chromophores capture photons of light, leading to the activation of opsins and a biochemical cascade that ultimately excites the photoreceptor cells.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012168"}, {"RECTYPE": "D", "MH": "Retinal Vein", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Central Retinal Vein|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Veins, Retinal", "MN": "A07.015.908.783", "MH_TH": "NLM (1973)", "ST": "T023", "AN": "retinal vein dis: coord IM with RETINAL DISEASES (IM), not VASCULAR DISEASES", "PI": "Retinal Vessels (1966-1972)", "MS": "Central retinal vein and its tributaries. It runs a short course within the optic nerve and then leaves and empties into the superior ophthalmic vein or cavernous sinus.", "PM": "73", "HN": "73", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012169"}, {"RECTYPE": "D", "MH": "Retinal Vein Occlusion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombosis, Retinal Vein|T033|T047|NON|REL|UNK (19XX)|860418|abbcdef", "ENTRY": "Vein Thrombosis, Retinal", "MN": "C14.907.760", "FX": "Retinal Vasculitis", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Retinal Vein (1973-1986)", "MS": "Blockage of the RETINAL VEIN. Those at high risk for this condition include patients with HYPERTENSION; DIABETES MELLITUS; ATHEROSCLEROSIS; and other CARDIOVASCULAR DISEASES.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D012170"}, {"RECTYPE": "D", "MH": "Retinal Vessels", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Retinal Vasculature|T023|NON|REL|NLM (2020)|190212|abcdef", "ENTRY": "Vessel, Retinal Blood", "MN": "A07.015.611", "FX": "Retinal Vein Occlusion", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "general or unspecified: prefer RETINAL ARTERY or RETINAL VEIN; diseases of retinal vessels: coordinate with RETINAL DISEASES, not VASCULAR DISEASES ", "MS": "The blood vessels which supply and drain the RETINA.", "OL": "use RETINAL VESSELS to search PECTEN OCULI 1969-83", "HN": "PECTEN OCULI was see under RETINAL VESSELS 1969-83", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D012171"}, {"RECTYPE": "D", "MH": "Retinaldehyde", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "all-trans-Retinal|T109|NON|NRW|NLM (2022)|210210|abcdef", "ENTRY": "all trans Retinal", "MN": "D23.767.261.700.690", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "RR725D715M", "RR": "116-31-4 (Retinaldehyde)", "AN": "/biosyn /physiol permitted", "MS": "A diterpene derived from the carotenoid VITAMIN A which functions as the active component of the visual cycle. It is the prosthetic group of RHODOPSIN (i.e., covalently bonded to ROD OPSIN as 11-cis-retinal). When stimulated by visible light, rhodopsin transforms this cis-isomer of retinal to the trans-isomer (11-trans-retinal). This transformation straightens-out the bend of the retinal molecule and causes a change in the shape of rhodopsin triggering the visual process. A series of energy-requiring enzyme-catalyzed reactions convert the 11-trans-retinal back to the cis-isomer.", "OL": "search VITAMIN A 1968-74", "PM": "91; was see under RETINOIDS 1984-90; was see under VITAMIN A 1968-83", "HN": "91(75); was see under RETINOIDS 1984-90; was see under VITAMIN A 1968-83", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012172"}, {"RECTYPE": "D", "MH": "Retinitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neuroretinitis|T047|NON|REL|NLM (2002)|001220|abcdef", "MN": "C11.768.773", "FX": "Retinal Vasculitis", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the RETINA. It is rarely limited to the retina, but is commonly associated with diseases of the choroid (CHORIORETINITIS) and of the OPTIC DISK (neuroretinitis).", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012173"}, {"RECTYPE": "D", "MH": "Retinitis Pigmentosa", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tapetoretinal Degeneration|T047|NON|EQV|GHR (2014)|NLM (1990)|890328|abcdeef", "ENTRY": "Tapetoretinal Degenerations", "MN": "C16.320.290.684", "FX": "Tangier Disease", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "note entry term ROD CONE DYSTROPHIES: CONE-ROD DYSTROPHIES is also available", "MS": "Hereditary, progressive degeneration of the retina due to death of ROD PHOTORECEPTORS initially and subsequent death of CONE PHOTORECEPTORS. It is characterized by deposition of pigment in the retina.", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012174"}, {"RECTYPE": "D", "MH": "Retinoblastoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Neuroblastoma, Retinal|T191|NON|EQV|NLM (1998)|960917|abcdef", "ENTRY": "Sporadic Retinoblastomas", "MN": "C11.768.717.760", "FX": "Genes, Retinoblastoma", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with RETINAL NEOPLASMS (IM); /genetics: consider also GENES, RETINOBLASTOMA", "MS": "A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104)", "CATSH": "CAT LIST", "MR": "20180615", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012175"}, {"RECTYPE": "D", "MH": "Retinoids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Retinoid|T109|T121|T123|NON|EQV|NLM (2021)|191114|abbbcdef", "MN": "D23.767.261.700", "MH_TH": "NLM (1984)", "ST": "T123", "RN": "0", "PI": "Vitamin A/analogs & derivatives (1975-1983)", "MS": "A group of tetraterpenes, with four terpene units joined head-to-tail. Biologically active members of this class are used clinically in the treatment of severe cystic ACNE; PSORIASIS; and other disorders of keratinization.", "PM": "84; RETINALDEHYDE was see under VITAMIN A 1968-83", "HN": "84", "MR": "20200527", "DA": "19830616", "DC": "1", "DX": "19840101", "UI": "D012176"}, {"RECTYPE": "D", "MH": "Retinol-Binding Proteins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Retinol Binding Protein|T116|T123|NON|EQV|NLM (2021)|200227|abbcdef", "ENTRY": "Retinoid Binding Protein, F Type", "MN": "D12.776.157.700", "FX": "Receptors, Retinoic Acid", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "0", "AN": "specifics, RETINOL-BINDING PROTEINS, PLASMA and RETINOL-BINDING PROTEINS, CELLULAR are available; do not interpret the presence of retinol binding proteins in the blood as RETINOL-BINDING PROTEINS, PLASMA; check for appropriate term", "PI": "Vitamin A (1972-1974)", "MS": "Proteins which bind with RETINOL. The retinol-binding protein found in plasma has an alpha-1 mobility on electrophoresis and a molecular weight of about 21 kDa. The retinol-protein complex (MW=80-90 kDa) circulates in plasma in the form of a protein-protein complex with prealbumin. The retinol-binding protein found in tissue has a molecular weight of 14 kDa and carries retinol as a noncovalently bound ligand.", "PM": "76", "HN": "76", "MR": "20210630", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D012177"}, {"RECTYPE": "D", "MH": "Retinopathy of Prematurity", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Retrolental Fibroplasia|T047|NON|EQV|ORD (2010)|UNK (19XX)|860401|abcdeef", "ENTRY": "Retrolental Fibroplasias", "MN": "C16.614.521.731", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; caused by oxygen ther of premature inf but for this etiol, do not use /chem ind: use /etiol if this etiol is discussed at all (& then probably NIM): TN 167", "MS": "A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)", "OL": "use RETINOPATHY OF PREMATURITY to search RETROLENTAL FIBROPLASIA 1966-86", "PM": "87; was RETROLENTAL FIBROPLASIA 1963-86", "HN": "87; was RETROLENTAL FIBROPLASIA 1963-86", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D012178"}, {"RECTYPE": "D", "MH": "Retirement", "AQ": "CL EC ES HI LJ PX SN ST TD", "ENTRY": "Retirements", "MN": "I03.702", "MH_TH": "POPLINE (1982)", "ST": "T052", "MS": "The state of being retired from one's position or occupation.", "MR": "19950523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012179"}, {"RECTYPE": "D", "MH": "Retraction of Publication as Topic", "MN": "L01.737.840", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "for publication retraction as a subject; do not confuse with the Publication Type RETRACTION OF PUBLICATION; do not confuse with the Publication Type RETRACTED PUBLICATION which identifies an article or book cited in an NLM database as having been retracted; do not use for authors' or editors' errata", "MS": "Works about authors' withdrawal or disavowal of their participation in performing research or writing the results of their study.", "PM": "2008; see RETRACTION OF PUBLICATION 1984-2007", "HN": "2008(1984)", "MR": "20161216", "DA": "19840613", "DC": "1", "DX": "19840101", "UI": "D012180"}, {"RECTYPE": "D", "MH": "Retrocochlear Diseases", "DE": "RETROCOCHLEAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Retrocochlear Hearing Loss|T047|NON|NRW|NLM (2008)|070209|abcdef", "ENTRY": "Retrocochlear Disease", "MN": "C09.218.807", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Acoustic Nerve (1966-1997)", "MS": "Pathological processes involving the VESTIBULOCOCHLEAR NERVE; BRAINSTEM; or CENTRAL NERVOUS SYSTEM. When hearing loss is due to retrocochlear pathology, it is called retrocochlear hearing loss.", "PM": "98", "HN": "98; use explode 1980-97", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19781222", "DC": "1", "DX": "19980101", "UI": "D012181"}, {"RECTYPE": "D", "MH": "Retrograde Degeneration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Retrograde Degeneration, Transneuronal|T049|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Transneuronal Retrograde Degenerations", "MN": "C23.550.737.500", "MH_TH": "NLM (1975)", "ST": "T049", "MS": "Pathologic changes that occur in the axon and cell body of a neuron proximal to an axonal lesion. The process is characterized by central chromatolysis which features flattening and displacement of the nucleus, loss of Nissl bodies, and cellular edema. Central chromatolysis primarily occurs in lower motor neurons.", "OL": "use NERVE DEGENERATION to search NISSL DEGENERATION 1975-97 & RETROGRADE DEGENERATION 1967-74", "PM": "91; was see under NERVE DEGENERATION 1975-90; NISSL DEGENERATION was see NERVE DEGENERATION 1997, was heading 1975-96 (see under NERVE DEGENERATION 1975-90)", "HN": "91(75); was see under NERVE DEGENERATION 1975-90; NISSL DEGENERATION was see NERVE DEGENERATION 1997, was heading 1975-96 (see under NERVE DEGENERATION 1975-90)", "CATSH": "CAT LIST", "MR": "19991126", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012183"}, {"RECTYPE": "D", "MH": "Retrograde Obturation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Retrograde Obturations", "MN": "E06.397.778.778.648", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Procedure that involves the removal of infectious products from a root canal space through use of special instruments and fillings. This procedure is performed when root canal treatment fails.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012184"}, {"RECTYPE": "D", "MH": "Retroperitoneal Fibrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Periaortitis, Chronic|T033|T046|NON|NRW|UNK (19XX)|880414|abbcdef", "ENTRY": "Retroperitoneal Fibroses", "MN": "C23.550.355.700", "MH_TH": "ORD (2010)", "ST": "T046", "MS": "A slowly progressive condition of unknown etiology, characterized by deposition of fibrous tissue in the retroperitoneal space compressing the ureters, great vessels, bile duct, and other structures. When associated with abdominal aortic aneurysm, it may be called chronic periaortitis or inflammatory perianeurysmal fibrosis.", "PM": "66; for ORMOND DISEASE see ORMOND'S DISEASE 1966-97", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012185"}, {"RECTYPE": "D", "MH": "Retroperitoneal Neoplasms", "DE": "RETROPERITONEAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Retroperitoneal Neoplasm", "MN": "C04.588.033.731", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM)", "MS": "New abnormal growth of tissue in the RETROPERITONEAL SPACE.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012186"}, {"RECTYPE": "D", "MH": "Retroperitoneal Space", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Spaces, Retroperitoneal", "MN": "A01.923.047.025.750", "MH_TH": "NLM (1966)", "ST": "T030", "AN": "usually NIM as locational; diagnostic retropneumoperitoneum or pneumoretroperitoneum: index RETROPERITONEAL SPACE /diag image + PNEUMORADIOGRAPHY (do not confuse with  the pathological condition, RETROPNEUMOPERITONEUM)", "MS": "An area occupying the most posterior aspect of the ABDOMINAL CAVITY. It is bounded laterally by the borders of the quadratus lumborum muscles and extends from the DIAPHRAGM to the brim of the true PELVIS, where it continues as the pelvic extraperitoneal space.", "MR": "20160419", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012187"}, {"RECTYPE": "D", "MH": "Retropneumoperitoneum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pneumoretroperitoneum|T037|T046|NON|EQV|UNK (19XX)|741209|abbcdef", "MN": "C26.748", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "note category; diagnostic retropneumoperitoneum: index RETROPERITONEAL SPACE /diag image + PNEUMORADIOGRAPHY", "MS": "Pathological or accidental introduction of air into the retroperitoneal space.", "HN": "was in Cat E only 1963-85", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012188"}, {"RECTYPE": "D", "MH": "Retrospective Studies", "ENTRY": "Study, Retrospective", "MN": "N06.850.520.450.500.750.825", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "IM general only; coordinate NIM with specific disease (IM); specify geographic location if pertinent", "MS": "Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D012189"}, {"RECTYPE": "D", "MH": "Retroviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Type C Oncoviruses|T005|NON|REL|NLM (1994)|930312|abcdef", "ENTRY": "Viruses, RNA Tumor", "MN": "B04.820.650", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid11632", "MS": "Family of RNA viruses that infects birds and mammals and encodes the enzyme reverse transcriptase. The family contains seven genera: DELTARETROVIRUS; LENTIVIRUS; RETROVIRUSES TYPE B, MAMMALIAN; ALPHARETROVIRUS; GAMMARETROVIRUS; RETROVIRUSES TYPE D; and SPUMAVIRUS. A key feature of retrovirus biology is the synthesis of a DNA copy of the genome which is integrated into cellular DNA. After integration it is sometimes not expressed but maintained in a latent state (PROVIRUSES).", "OL": "use RETROVIRIDAE to search RETROVIRUSES, MLV-RELATED; MURINE LEUKEMIA VIRUS-RELATED RETROVIRUSES; & RETROVIRUSES, MURINE LEUKEMIA VIRUS-RELATED 1994-96; ONCOVIRINAE, TYPE C ONCORNAVIRUSES, TYPE C ONCOVIRUSES, & ONCOVIRUSES, TYPE C 1991-93; ONCOVIRUSES 1981-93; LEUKOVIRUSES, ONCORNAVIRUSES, & RNA TUMOR VIRUSES 1978-93; C-TYPE VIRUSES 1972-93 (as Prov 1972-73); use ONCOGENIC VIRUSES to search LEUKOVIRUSES & ONCORNAVIRUSES 1975-77", "PM": "81; was LEUKOVIRUSES 1978-80; was LEUKEMOGENIC VIRUSES 1966-77; RETROVIRUSES, MLV-RELATED was heading 1994-96; ONCOVIRINAE was heading 1992-93, was see RETROVIRIDAE 1991; MURINE LEUKEMIA VIRUS-RELATED RETROVIRUSES & RETROVIRUSES, MURINE LEUKEMIA VIRUS-RELATED were see RETROVIRUSES, MLV-RELATED 1994-96; ONCOVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91; RNA TUMOR VIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1978-91; ONCORNAVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91, was see LEUKOVIRUSES 1978-80, & was see ONCOGENIC VIRUSES 1975-77; ONCOVIRUSES, TYPE C was heading 1991-93, was C-TYPE VIRUSES 1974-90; C-TYPE VIRUSES was see ONCOVIRUSES, TYPE C 1991-93; LEUKOVIRUSES was see ONCOVIRUSES, TYPE C 1991-93, was see ONCOGENIC VIRUSES 1975-77, was heading 1978-90, was see RETROVIRIDAE 1981-90; TYPE C ONCOVIRUSES & TYPE C ONCORNAVIRUSES were see ONCOVIRUSES, TYPE C 1991-93", "HN": "81; was LEUKOVIRUSES 1978-80; was LEUKEMOGENIC VIRUSES 1966-77; RETROVIRUSES, MLV-RELATED was heading 1994-96; ONCOVIRINAE was heading 1992-93, was see RETROVIRIDAE 1991; MURINE LEUKEMIA VIRUS-RELATED RETROVIRUSES & RETROVIRUSES, MURINE LEUKEMIA VIRUS-RELATED were see RETROVIRUSES, MLV-RELATED 1994-96; ONCOVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91; RNA TUMOR VIRUSES was see ONCOVIRINAE 1992-3, was see RETROVIRIDAE 1978-91; ONCORNAVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91, was see LEUKOVIRUSES 1978-80, & was see ONCOGENIC VIRUSES 1975-77; ONCOVIRUSES, TYPE C was heading 1991-93, was C-TYPE VIRUSES 1974-90 (Prov 1972-73); C-TYPE VIRUSES was see ONCOVIRUSES, TYPE C 1991-93; LEUKOVIRUSES was see ONCOVIRUSES, TYPE C 1991-93, was see ONCOGENIC VIRUSES 1975-77, was heading 1978-90, was see RETROVIRIDAE 1981-90; TYPE C ONCOVIRUSES & TYPE C ONCORNAVIRUSES were see ONCOVIRUSES, TYPE C 1991-93", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012190"}, {"RECTYPE": "D", "MH": "Retroviridae Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Retrovirus Proteins|T116|T123|NON|NRW|UNK (19XX)|850425|abbcdef", "ENTRY": "Proteins, Retrovirus", "MN": "D12.776.964.775", "MH_TH": "NLM (1986)", "ST": "T123", "RN": "0", "AN": "IM; coord with specific virus (IM); /drug eff /ultrastruct permitted", "PI": "Viral Proteins (1966-1985)", "MS": "Proteins from the family Retroviridae. The most frequently encountered member of this family is the Rous sarcoma virus protein.", "PM": "86", "HN": "86", "MR": "20050630", "DA": "19850425", "DC": "1", "DX": "19860101", "UI": "D012191"}, {"RECTYPE": "D", "MH": "Retroviridae Infections", "DE": "RETROVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Retrovirus Infections|T047|NON|EQV|NLM (1994)|930525|RETROVIRUS INFECT|abcdefv", "ENTRY": "Xenotropic Murine Leukemia Virus related Virus Infection", "MN": "C01.925.782.815", "MH_TH": "NLM (1981)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Virus Diseases (1966-1980)", "MS": "Virus diseases caused by the RETROVIRIDAE.", "OL": "use RETROVIRIDAE INFECTIONS to search RETROVIRUS INFECTIONS 1981-93", "PM": "94; was RETROVIRUS INFECTIONS 1981-93", "HN": "94; was RETROVIRUS INFECTIONS 1981-93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19800513", "DC": "1", "DX": "19810101", "UI": "D012192"}, {"RECTYPE": "D", "MH": "Reversal Learning", "AQ": "CL DE ES PH RE", "ENTRY": "Reversal Learnings", "MN": "F02.463.425.798", "MH_TH": "NLM (1964)", "ST": "T062", "AN": "human & animal", "MS": "Any situation where an animal or human is trained to respond differentially to two stimuli (e.g., approach and avoidance) under reward and punishment conditions and subsequently trained under reversed reward values (i.e., the approach which was previously rewarded is punished and vice versa).", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012193"}, {"RECTYPE": "D", "MH": "RNA-Directed DNA Polymerase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Reverse Transcriptase|T116|T126|NON|EQV|NLM (1996)|950411|abbcdef", "ENTRY": "RNA Directed DNA Polymerase", "MN": "D12.776.964.970.600.850.375.750", "EC": "antagonists & inhibitors:Reverse Transcriptase Inhibitors", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "Deoxynucleotide-triphosphate:DNA deoxynucleotidyltransferase (RNA-directed)", "RN": "EC 2.7.7.49", "PI": "DNA Nucleotidyltransferases (1968-1971)", "MS": "An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49.", "PM": "96; was REVERSE TRANSCRIPTASE 1973-95", "HN": "96; was REVERSE TRANSCRIPTASE 1972-95 (Prov 1972)", "MR": "20200622", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012194"}, {"RECTYPE": "D", "MH": "Review Literature as Topic", "PRINT ENTRY": "State-of-the-Art Review|T170|NON|NRW|UNK (19XX)|870513|STATE OF THE ART|abcdefv", "ENTRY": "State of the Art Reviews", "MN": "L01.462.500.682.759", "FX": "Meta-Analysis as Topic", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "for review books or review articles as a form of literature; do not confuse with the Publication Type REVIEW", "MS": "Works about published materials which provide an examination of recent or current literature. These articles can cover a wide range of subject matter at various levels of completeness and comprehensiveness based on analyses of literature that may include research findings. The review may reflect the state of the art and may also include reviews as a literary form.", "PM": "2008; see REVIEW LITERATURE 1988-2007", "HN": "2008(1988)", "MR": "20220712", "DA": "19870513", "DC": "1", "DX": "19880101", "UI": "D012196"}, {"RECTYPE": "D", "MH": "Reward", "ENTRY": "Rewards", "MN": "F02.463.425.770.836", "FX": "Delay Discounting", "MH_TH": "NLM (1964)", "ST": "T078", "AN": "human & animal", "MS": "An object or a situation that can serve to reinforce a response, to satisfy a motive, or to afford pleasure.", "PM": "65; was see under MOTIVATION & REINFORCEMENT LEARNING 1963-64", "HN": "65(64); was see under MOTIVATION & REINFORCEMENT LEARNING 1963-64", "CATSH": "CAT LIST", "MR": "20140616", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012201"}, {"RECTYPE": "D", "MH": "Reye Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Reye's Like Syndrome", "MN": "C18.452.132.780", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Brain Diseases (1966-1972)", "MS": "A form of encephalopathy with fatty infiltration of the LIVER, characterized by brain EDEMA and VOMITING that may rapidly progress to SEIZURES; COMA; and DEATH. It is caused by a generalized loss of mitochondrial function leading to disturbances in fatty acid and CARNITINE metabolism.", "PM": "1998; see REYE'S SYNDROME 1977-97", "HN": "1998(1977)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D012202"}, {"RECTYPE": "D", "MH": "Rh Isoimmunization", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Isoimmunization, Rhesus|T047|NON|EQV|UNK (19XX)|840530|abcdef", "ENTRY": "Sensitizations, Rh", "MN": "G12.186.750", "FX": "Erythroblastosis, Fetal", "MH_TH": "NLM (1985)", "ST": "T047", "PI": "RH-HR Blood-Group System (1966-1984)", "MS": "The process by which fetal Rh+ erythrocytes enter the circulation of an Rh- mother, causing her to produce IMMUNOGLOBULIN G antibodies, which can cross the placenta and destroy the erythrocytes of Rh+ fetuses. Rh isoimmunization can also be caused by BLOOD TRANSFUSION with mismatched blood.", "PM": "1985; for RH SENSITIZATION see RH-HR BLOOD GROUP SYSTEM 1980-2009", "HN": "1985; for RH SENSITIZATION use RH-HR BLOOD GROUP SYSTEM 1980-2009", "CATSH": "CAT LIST", "MR": "20210304", "DA": "19840530", "DC": "1", "DX": "19850101", "UI": "D012203"}, {"RECTYPE": "D", "MH": "Rh-Hr Blood-Group System", "AQ": "AD AE AN BI BL CF CH CL EC GE HI IM IP ME PD PH PO TO TU UL UR", "PRINT ENTRY": "Rhesus Blood-Group System|T022|T129|T170|NON|EQV|UNK (19XX)|750722|abbbcdef", "ENTRY": "Systems, Rhesus Blood-Group", "MN": "D23.050.705.230.775", "FX": "Erythroblastosis, Fetal", "MH_TH": "NLM (1976)", "ST": "T170", "RN": "0", "AN": "coordinate IM with disease /blood (IM), not /immunol nor /genet", "MS": "Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis.", "OL": "use RH-HR BLOOD-GROUP SYSTEM to search RH FACTORS 1966-75", "PM": "76; was RH FACTORS 1963-75", "HN": "76; was RH FACTORS 1963-75", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D012204"}, {"RECTYPE": "D", "MH": "Rhabdiasoidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Rhabdiasoideas", "MN": "B01.050.500.500.294.400.875.640", "MH_TH": "NLM (1986)", "ST": "T204", "AN": "a superfamily of nematodes; infection: coord IM with RHABDITIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "MS": "A superfamily of intestinal nematode parasites containing one genus, STRONGYLOIDES, and several species. It is transmitted through fecal material onto the skin and occurs in animals and humans.", "PM": "86", "HN": "86", "MR": "20200902", "DA": "19850311", "DC": "1", "DX": "19860101", "UI": "D012205"}, {"RECTYPE": "D", "MH": "Rhabdomyolysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Rhabdomyolyses", "MN": "C05.651.807", "MH_TH": "NLM (1984)", "ST": "T046", "AN": "\"necrosis or disintegration of skeletal muscle often followed by myoglobinuria\": do not index under MYOGLOBINURIA unless this is particularly discussed & then probably NIM", "PI": "Myoglobinuria (1966-1983)", "MS": "Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.", "PM": "84; MYOGLOBINURIA was heading 1965-83", "HN": "84", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19830421", "DC": "1", "DX": "19840101", "UI": "D012206"}, {"RECTYPE": "D", "MH": "Rhabdomyoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Rhabdomyomas", "MN": "C04.557.450.590.540.700", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A benign tumor derived from striated muscle. It is extremely rare, generally occurring in the tongue, neck muscles, larynx, uvula, nasal cavity, axilla, vulva, and heart. These tumors are treated by simple excision. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1354)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012207"}, {"RECTYPE": "D", "MH": "Rhabdomyosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Rhabdomyosarcomas", "MN": "C04.557.450.795.550.660", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term ", "MS": "A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012208"}, {"RECTYPE": "D", "MH": "Rhabdoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Varicosaviruses", "MN": "B04.820.480.937.750", "MH_TH": "NLM (1978)", "ST": "T005", "RN": "txid11270", "RR": "txid140295", "PI": "RNA Viruses (1966-1977)", "MS": "A family of bullet-shaped viruses of the order MONONEGAVIRALES, infecting vertebrates, arthropods, protozoa, and plants. Genera include VESICULOVIRUS; LYSSAVIRUS; EPHEMEROVIRUS; NOVIRHABDOVIRUS; Cytorhabdovirus; and Nucleorhabdovirus.", "OL": "use RHABDOVIRIDAE to search RHABDOVIRUSES 1978-80", "PM": "81; was RHABDOVIRUSES 1978-80", "HN": "81; was RHABDOVIRUSES 1978-80", "MR": "20200813", "DA": "19770504", "DC": "1", "DX": "19780101", "UI": "D012209"}, {"RECTYPE": "D", "MH": "Rhamnose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Deoxymannose|T109|T123|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Rhamnose, L Isomer", "MN": "D09.254.799", "MH_TH": "NLM (1963)", "ST": "T123", "N1": "Mannose, 6-deoxy-", "RN": "QN34XC755A", "RR": "3615-41-6 (L-isomer)", "MS": "A methylpentose whose L- isomer is found naturally in many plant glycosides and some gram-negative bacterial lipopolysaccharides.", "PM": "66", "HN": "66(63)", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012210"}, {"RECTYPE": "D", "MH": "Rhenium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.787", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Rhenium", "RN": "7440-15-5", "MS": "A metal, atomic number 75, atomic weight 186.207, symbol Re.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012211"}, {"RECTYPE": "D", "MH": "Rheology", "DE": "RHEOL", "AQ": "CL DE EC ED ES HI IS LJ MT OG RE SN ST TD", "PRINT ENTRY": "Velocimetry|T059|NON|NRW|NLM (1993)|920511|abcdef", "ENTRY": "Velocimetries", "MN": "H01.671.808", "FX": "Microfluidics", "MH_TH": "NLM (1964)", "ST": "T057", "AN": "for non-plethysmographic rheography: for plethysmographic rheology, index under PLETHYSMOGRAPHY or its specifics", "MS": "The study of the deformation and flow of matter, usually liquids or fluids, and of the plastic flow of solids. The concept covers consistency, dilatancy, liquefaction, resistance to flow, shearing, thixotrophy, and VISCOSITY.", "PM": "1966", "HN": "1966(1964)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012212"}, {"RECTYPE": "D", "MH": "Rheumatic Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Rheumatism, Articular, Acute|T047|NON|EQV|NLM (1992)|910115|abcdef", "ENTRY": "Rheumatism, Inflammatory", "MN": "C17.300.775.860", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A febrile disease occurring as a delayed sequela of infections with STREPTOCOCCUS PYOGENES. It is characterized by multiple focal inflammatory lesions of the connective tissue structures, such as the heart, blood vessels, and joints (POLYARTHRITIS) and brain, and by the presence of ASCHOFF BODIES in the myocardium and skin.", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012213"}, {"RECTYPE": "D", "MH": "Rheumatic Heart Disease", "DE": "RHEUMATIC HEART DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Rheumatic Heart Diseases", "MN": "C14.280.874", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "coordinate with specific disease of the heart", "MS": "Cardiac manifestation of systemic rheumatological conditions, such as RHEUMATIC FEVER. Rheumatic heart disease can involve any part the heart, most often the HEART VALVES and the ENDOCARDIUM.", "PM": "1963; for BOUILLAUD'S DISEASE see RHEUMATIC FEVER 1964-1991", "HN": "1963; for BOUILLAUD'S DISEASE use RHEUMATIC FEVER 1964-1991", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D012214"}, {"RECTYPE": "D", "MH": "Rheumatic Nodule", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aschoff Bodies|T046|EPO|NRW|UNK (19XX)|780519|abcdef", "ENTRY": "Rheumatic Nodules", "MN": "C05.799.825.566", "MH_TH": "NLM (1967)", "ST": "T046", "AN": "in rheum fever; do not confuse with RHEUMATOID NODULE in rheum arthritis", "MS": "A small round or oval, mostly subcutaneous nodule made up chiefly of a mass of Aschoff bodies and seen in cases of rheumatic fever. It is differentiated from the RHEUMATOID NODULE which appears in rheumatoid arthritis, most frequently over bony prominences. (From Dorland, 27th ed)", "OL": "use RHEUMATIC NODULE to search ASCHOFF BODIES 1967-78", "PM": "67", "HN": "67; ASCHOFF BODIES was see under RHEUMATIC NODULE 1967-78", "CATSH": "CAT LIST", "MR": "19940524", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D012215"}, {"RECTYPE": "D", "MH": "Rheumatic Diseases", "DE": "RHEUMATIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rheumatism|T047|NON|EQV|NLM (1990)|890221|abcdef", "ENTRY": "Rheumatic Disease", "MN": "C17.300.775", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.", "OL": "90; use RHEUMATIC DISEASES to search RHEUMATISM 1966-89", "PM": "90; was RHEUMATISM 1966-89", "HN": "90; was RHEUMATISM 1966-89", "CATSH": "CAT LIST", "MR": "20160226", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D012216"}, {"RECTYPE": "D", "MH": "Rheumatoid Factor", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Factor, Rheumatoid", "MN": "D12.776.377.715.548.114.323.732", "PA": "Immunologic Factors", "MH_TH": "POPLINE (1978)", "ST": "T129", "RN": "9009-79-4", "MS": "Autoantibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS.", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012217"}, {"RECTYPE": "D", "MH": "Rheumatoid Nodule", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Rheumatoid Noduloses", "MN": "C17.300.775.099.683", "MH_TH": "NLM (1963)", "ST": "T046", "AN": "in rheum arthritis; do not confuse with RHEUMATIC NODULE in rheum fever", "MS": "Subcutaneous nodules seen in 20-30% of rheumatoid arthritis patients. They may arise anywhere on the body, but are most frequently found over the bony prominences. The nodules are characterized histologically by dense areas of fibrinoid necrosis with basophilic streaks and granules, surrounded by a palisade of cells, mainly fibroblasts and histiocytes.", "PM": "67", "HN": "67(63)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D012218"}, {"RECTYPE": "D", "MH": "Rheumatology", "DE": "RHEUMATOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.429.730", "FX": "Rheumatic Diseases", "MH_TH": "NLM (1980)", "ST": "T091", "PI": "Rheumatism (1966-1979)", "MS": "A subspecialty of internal medicine concerned with the study of inflammatory or degenerative processes and metabolic derangement of connective tissue structures which pertain to a variety of musculoskeletal disorders, such as arthritis.", "PM": "80", "HN": "80", "MR": "20090706", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D012219"}, {"RECTYPE": "D", "MH": "Rhinitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nasal Catarrh|T047|NON|EQV|NLM (2009)|080204|abcdef", "ENTRY": "Rhinitides", "MN": "C09.603.799", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; do not confuse NASAL CATARRH with CATARRH; rhinosinusitis: index RHINITIS + SINUSITIS", "MS": "Inflammation of the NASAL MUCOSA, the mucous membrane lining the NASAL CAVITIES.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012220"}, {"RECTYPE": "D", "MH": "Rhinitis, Allergic, Perennial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rhinitis, Allergic, Nonseasonal|T047|NON|EQV|UNK (19XX)|790228|abcdef", "MN": "C20.543.480.680.443.500", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "note X ref: do not confuse with RHINITIS, ALLERGIC, SEASONAL", "PI": "Rhinitis (1966-1979)", "MS": "Inflammation of the mucous membrane of the nose similar to that found in hay fever except that symptoms persist throughout the year. The causes are usually air-borne allergens, particularly dusts, feathers, molds, animal fur, etc.", "OL": "search RHINITIS, ALLERGIC under HAY FEVER 1966-79", "PM": "80; RHINITIS, ALLERGIC was see HAY FEVER 1963-79", "HN": "80; RHINITIS, ALLERGIC was see HAY FEVER 1963-79", "CATSH": "CAT LIST", "MR": "20050701", "DA": "19790228", "DC": "1", "DX": "19800101", "UI": "D012221"}, {"RECTYPE": "D", "MH": "Rhinitis, Atrophic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ozena|T047|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Rhinitides, Atrophic", "MN": "C09.603.799.649", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A chronic inflammation in which the NASAL MUCOSA gradually changes from a functional to a non-functional lining without mucociliary clearance. It is often accompanied by degradation of the bony TURBINATES, and the foul-smelling mucus which forms a greenish crust (ozena).", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012222"}, {"RECTYPE": "D", "MH": "Rhinitis, Vasomotor", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vasomotor Rhinitis|T047|NON|EQV|UNK (19XX)|790228|abcdef", "ENTRY": "Vasomotor Rhinitides", "MN": "C09.603.799.910", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Rhinitis (1966-1979)", "MS": "A form of non-allergic rhinitis that is characterized by nasal congestion and posterior pharyngeal drainage.", "OL": "use HAY FEVER to search VASOMOTOR RHINITIS 1973-79", "PM": "80; VASOMOTOR RHINITIS was see HAY FEVER 1973-79", "HN": "80; VASOMOTOR RHINITIS was see HAY FEVER 1973-79", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19790228", "DC": "1", "DX": "19800101", "UI": "D012223"}, {"RECTYPE": "D", "MH": "Rhinophyma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Rhinophymas", "MN": "C17.800.794.650", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "A manifestation of severe ROSACEA resulting in significant enlargement of the NOSE and occurring primarily in men. It is caused by hypertrophy of the SEBACEOUS GLANDS and surrounding CONNECTIVE TISSUE. The nose is reddened and marked with TELANGIECTASIS.", "OL": "search ROSACEA 1966-74", "PM": "91; was see under ROSACEA 1975-90", "HN": "91(75); was see under ROSACEA 1975-90", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012224"}, {"RECTYPE": "D", "MH": "Rhinoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Rhinoplasties", "MN": "E04.617.650", "FX": "Nose", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "A plastic surgical operation on the nose, either reconstructive, restorative, or cosmetic. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012225"}, {"RECTYPE": "D", "MH": "Rhinoscleroma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Scleroma, Nasal|T047|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "C17.800.838.765.705", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A granulomatous disease caused by KLEBSIELLA RHINOSCLEROMATIS infection. Despite its name, this disease is not limited to the nose and NASOPHARYNX but may affect any part of the RESPIRATORY TRACT, sometimes with extension to the lip and the skin.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012226"}, {"RECTYPE": "D", "MH": "Rhinosporidiosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Rhinosporidium seeberi Infection|T047|NON|EQV|NLM (2021)|200206|abcdef", "ENTRY": "Rhinosporidium seeberi Infections", "MN": "C01.610.600.700", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Chronic, localized granulomatous infection of mucocutaneous tissues, especially the NOSE, and characterized by HYPERPLASIA and the development of POLYPS. It is found in humans and other animals and is caused by the mesomycetozoean organism RHINOSPORIDIUM SEEBERI.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012227"}, {"RECTYPE": "D", "MH": "Rhinosporidium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Hyphochytrium|T204|NON|EQV|NLM (1999)|971113|abcdef", "ENTRY": "Rhinosporidium seeberi|T204|NON|NRW|NLM (2006)|041013|abcdef", "MN": "B01.500.700", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid90338", "RR": "txid90339", "MS": "A genus in the order Dermocystidium, class MESOMYCETOZOEA. It causes RHINOSPORIDIOSIS in MAMMALS and BIRDS.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012228"}, {"RECTYPE": "D", "MH": "Rhinovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Coryza Viruses|T005|NON|REL|UNK (19XX)|780602|abcdef", "ENTRY": "Rhinoviruses", "MN": "B04.820.578.750.775", "MH_TH": "NLM (1964)", "ST": "T005", "AN": "infection: coord IM with PICORNAVIRIDAE INFECTIONS (IM) but consider also COMMON COLD", "MS": "A genus of PICORNAVIRIDAE inhabiting primarily the respiratory tract of mammalian hosts. It includes over 100 human serotypes associated with the COMMON COLD.", "OL": "use RHINOVIRUS to search RHINOVIRUSES 1975-93 & COMMON COLD VIRUS 1966-78", "PM": "94, 64-74; was RHINOVIRUSES 1975-93; COMMON COLD VIRUS was see under RHINOVIRUSES 1975-78, was see under RHINOVIRUS 1964-74, was heading 1963", "HN": "94, 64-74; was RHINOVIRUSES 1975-93; COMMON COLD VIRUS was see under RHINOVIRUSES 1975-78, was see under RHINOVIRUS 1964-74, was heading 1963", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D012229"}, {"RECTYPE": "D", "MH": "Rhizobiaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rhizobium lupini|T007|NON|NRW|NLM (2004)|021022|abcdef", "MN": "B03.660.050.662", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid82115", "RR": "txid399", "AN": "in soil, water & plants", "PI": "Bacteria (1966-1974)", "MS": "A family of gram-negative bacteria which are saprophytes, symbionts, or plant pathogens.", "PM": "1975; for RHIZOBIUM GALEGAE see RHIZOBIUM 2014-2020", "HN": "1975", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D012230"}, {"RECTYPE": "D", "MH": "Rhizobium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.662.670", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid379", "MS": "A genus of gram-negative, aerobic, rod-shaped bacteria that activate PLANT ROOT NODULATION in leguminous plants. Members of this genus are nitrogen-fixing and common soil inhabitants.", "PM": "1963", "HN": "1963", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D012231"}, {"RECTYPE": "D", "MH": "Rhizoctonia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Rhizoctonias", "MN": "B01.300.381.740", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid1322061", "MS": "A mitosporic Ceratobasidiaceae fungal genus that is an important plant pathogen affecting potatoes and other plants. There are numerous teleomorphs.", "PM": "91; see HYPHOMYCETES 1986-90, see DEUTEROMYCETES 1975-85", "HN": "91(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012232"}, {"RECTYPE": "D", "MH": "Rhizopus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.300.500.800", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid4842", "AN": "infection: coord IM with MUCORMYCOSIS (IM)", "MS": "A genus of zygomycetous fungi of the family Mucoraceae, order MUCORALES, a common saprophyte and facultative parasite of mature fruits and vegetables. It may cause cerebral mycoses in diabetes and cutaneous infection in severely burned patients.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012233"}, {"RECTYPE": "D", "MH": "Rho Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Factor, Rho", "MN": "D12.776.930.785", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "in genetic transcription; do not confuse with blood RH FACTORS", "PI": "Transcription, Genetic (1973-1976)", "MS": "A protein which effects termination of RNA synthesis during the genetic transcription process by dissociating the ternary transcription complex RNA;-RNA POLYMERASE DNA at the termination of a gene.", "PM": "91; was see under TRANSCRIPTION FACTORS 1977-90", "HN": "91(77); was see under TRANSCRIPTION FACTORS 1977-90", "MR": "20150629", "DA": "19760419", "DC": "1", "DX": "19910101", "UI": "D012234"}, {"RECTYPE": "D", "MH": "Rhodamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Rhodamine|T109|T130|NON|NRW|UNK (19XX)|800401|abbcdef", "MN": "D03.633.300.953.600", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "0", "AN": "RHODAMINE 123 is available", "PI": "Xanthenes (1969-1974)", "MS": "A family of 3,6-di(substituted-amino)-9-benzoate derivatives of xanthene that are used as dyes and as indicators for various metals; also used as fluorescent tracers in histochemistry.", "OL": "use RHODAMINES to search TETRAETHYLRHODAMINE 1975-93", "PM": "91; was see under XANTHENES 1975-90; TETRAETHYLRHODAMINE was see RHODAMINES 1975-93", "HN": "91(75); was see under XANTHENES 1975-90; TETRAETHYLRHODAMINE was see RHODAMINES 1975-93", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012235"}, {"RECTYPE": "D", "MH": "Rhodanine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.708.649", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "4-Thiazolidinone, 2-thioxo-", "RN": "7O50LKL2G8", "RR": "141-84-4 (Rhodanine)", "AN": "do not confuse with RHODAMINES or rhodanide", "OL": "search THIAZOLES 1966-74", "PM": "91; was see under THIAZOLES 1975-90", "HN": "91(75); was see under THIAZOLES 1975-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012236"}, {"RECTYPE": "D", "MH": "Rhode Island", "AQ": "EH EP", "MN": "Z01.107.567.875.550.680", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded by Massachusetts, the Atlantic Ocean, and Connecticut. The capital is Providence.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D012237"}, {"RECTYPE": "D", "MH": "Rhodium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Rhodium 103", "MN": "D01.552.544.793", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Rhodium", "RN": "DMK383DSAC", "RR": "7440-16-6 (Rhodium)", "MS": "A hard and rare metal of the platinum group, atomic number 45, atomic weight 102.905, symbol Rh.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012238"}, {"RECTYPE": "D", "MH": "Rhodnius", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.412.420.700.850.700", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid13248", "AN": "vectors of Trypanosoma cruzi; do not use /drug eff for insecticides: TN 111;", "MS": "A genus of the subfamily TRIATOMINAE. Rhodnius prolixus is a vector for TRYPANOSOMA CRUZI.", "OL": "use TRIATOMINAE to search RHODNIUS 1973-74", "PM": "91; was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78", "HN": "91(75); was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012239"}, {"RECTYPE": "D", "MH": "Rhodococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.024.981.775", "MH_TH": "NLM (1987)", "ST": "T007", "RN": "txid1827", "AN": "infection: coord IM with ACTINOMYCETALES INFECTIONS (IM)", "PI": "Rhodospirillaceae (1976-1986)", "MS": "A bacterial genus of the order ACTINOMYCETALES.", "PM": "87", "HN": "87", "MR": "20200813", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D012240"}, {"RECTYPE": "D", "MH": "Rhodopseudomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.035.700", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1073", "AN": "in mud & stagnant water", "MS": "A genus of gram-negative, rod-shaped, phototrophic bacteria found in aquatic environments. Internal photosynthetic membranes are present as lamellae underlying the cytoplasmic membrane.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012241"}, {"RECTYPE": "D", "MH": "Rhodobacter sphaeroides", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rhodopseudomonas sphaeroides|T007|NON|EQV|NLM (1990)|890203|abcdef", "ENTRY": "Rhodopseudomonas spheroides|T007|NON|EQV|NLM (1991)|900423|abcdef", "MN": "B03.660.050.750.700.700", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid1063", "AN": "in mud & stagnant water", "PI": "Rhodopseudomonas (1966-1971)", "MS": "Spherical phototrophic bacteria found in mud and stagnant water exposed to light.", "OL": "use RHODOBACTER SPHAEROIDES to search RHODOPSEUDOMONAS SPHEROIDES 1972-89", "PM": "90; was RHODOPSEUDOMONAS SPHEROIDES 1972-89 (see under RHODOPSEUDOMONAS 1972-73)", "HN": "90(72); was RHODOPSEUDOMONAS SPHEROIDES 1972-89 (see under RHODOPSEUDOMONAS 1972-73)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012242"}, {"RECTYPE": "D", "MH": "Rhodopsin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Visual Purple|T116|T123|NON|EQV|UNK (19XX)|750708|abbcdef", "MN": "D23.767.930.750.500.500", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Rhodopsins", "RN": "9009-81-8", "AN": "do not confuse with ROD OPSINS or microbial rhodopsins (BACTERIORHODOPSINS)", "MS": "A purplish-red, light-sensitive pigment found in RETINAL ROD CELLS of most vertebrates. It is a complex consisting of a molecule of ROD OPSIN and a molecule of 11-cis retinal (RETINALDEHYDE). Rhodopsin exhibits peak absorption wavelength at about 500 nm.", "OL": "search RETINAL PIGMENTS 1966-74", "PM": "91; was see under RETINAL PIGMENTS 1975-90", "HN": "91(75); was see under RETINAL PIGMENTS 1975-90", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012243"}, {"RECTYPE": "D", "MH": "Rhodospirillaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Purple Nonsulfur Bacteria|T007|NON|EQV|NLM (2004)|021024|PURPLE NONSULFUR BACT|abcdefv", "MN": "B03.660.050.755.750", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid41295", "PI": "Bacteria (1966-1974)", "MS": "A family of phototrophic bacteria, in the order Rhodospirillales, isolated from stagnant water and mud.", "OL": "use RHODOSPIRILLACEAE to search ATHIORHODACEAE 1975", "PM": "76; was ATHIORHODACEAE 1975", "HN": "76; was ATHIORHODACEAE 1975", "MR": "20200813", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D012244"}, {"RECTYPE": "D", "MH": "Rhodospirillales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.755", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid204441", "AN": "in water", "PI": "Rhodospirillaceae (1975)", "MS": "An order of photosynthetic bacteria representing a physiological community of predominantly aquatic bacteria.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750721", "DC": "1", "DX": "19760101", "UI": "D012245"}, {"RECTYPE": "D", "MH": "Rhodospirillum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.755.750.733", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1081", "AN": "in mud & stagnant water", "MS": "A genus of gram-negative, spiral bacteria that possesses internal photosynthetic membranes. Its organisms divide by binary fission, are motile by means of polar flagella, and are found in aquatic environments.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012246"}, {"RECTYPE": "D", "MH": "Rhodospirillum rubrum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.755.750.733.650", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid1085", "AN": "in mud & stagnant water", "PI": "Rhodospirillum (1966-1971)", "MS": "Vibrio- to spiral-shaped phototrophic bacteria found in stagnant water and mud exposed to light.", "PM": "74", "HN": "74(72)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012247"}, {"RECTYPE": "D", "MH": "Rhodotorula", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Rhodotorulas", "MN": "B01.300.930.650", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5533", "MS": "A red yeast-like mitosporic fungal genus generally regarded as nonpathogenic. It is cultured from numerous sources in human patients.", "PM": "91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85", "HN": "91(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012248"}, {"RECTYPE": "D", "MH": "Rhombencephalon", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hindbrain|T023|NON|EQV|UNK (19XX)|860328|abcdef", "ENTRY": "Rhombencephalons", "MN": "A08.186.211.132.810", "MH_TH": "NLM (1987)", "ST": "T023", "PI": "Brain Stem (1966-1986)", "MS": "The posterior of the three primitive cerebral vesicles of an embryonic brain. It consists of myelencephalon, metencephalon, and isthmus rhombencephali from which develop the major BRAIN STEM components, such as MEDULLA OBLONGATA from the myelencephalon, CEREBELLUM and PONS from the metencephalon, with the expanded cavity forming the FOURTH VENTRICLE.", "PM": "87", "HN": "87", "MR": "20150623", "DA": "19860328", "DC": "1", "DX": "19870101", "UI": "D012249"}, {"RECTYPE": "D", "MH": "Rheum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rhubarb|T168|NON|REL|NLM (1964)|990101|abcdef", "ENTRY": "Rhubarb, Chinese", "MN": "B01.875.800.575.912.250.825.700", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid3620", "RR": "txid46087", "AN": "note entry term RHEUM RHAPONTICUM: RHAPONTICUM see LEUZEA is also available", "MS": "A plant genus of the family POLYGONACEAE. Members contain chrysophanic acid, rhein, EMODIN, and other ANTHRAQUINONES. The roots were formerly used as PURGATIVES.", "PM": "2004; see RHUBARB 1991-2003, see PLANTS, MEDICINAL 1978-1990, see RHUBARB 1963-1977", "HN": "2004(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D012250"}, {"RECTYPE": "D", "MH": "Toxicodendron", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sumac, Poison|T002|NON|NRW|NLM (2002)|010411|abcdef", "ENTRY": "toxicodendron, Rhus", "MN": "B01.875.800.575.912.250.044.744", "FX": "Dermatitis, Toxicodendron", "MH_TH": "NLM (1966)", "ST": "T002", "RN": "txid43852", "RR": "txid690247", "AN": "DERMATITIS, TOXICODENDRON is available", "MS": "A genus (formerly part of Rhus genus) of shrubs, vines, or trees that yields a highly allergenic oleoresin which causes a severe contact dermatitis (DERMATITIS, TOXICODENDRON). The most toxic species are Toxicodendron vernix (poison sumac), T. diversilobum (poison oak), and T. radicans (poison ivy). T. vernicifera yields a useful varnish from which certain enzymes (laccases) are obtained.", "OL": "use TOXICODENDRON to search RHUS 1966-92", "PM": "93; was RHUS 1963-92; TOXICODENDRON was see RHUS 1966-92", "HN": "93; was RHUS 1963-92; TOXICODENDRON was see RHUS 1986-92", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D012251"}, {"RECTYPE": "D", "MH": "Natural Family Planning Methods", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Periodic Abstinence|T061|NON|EQV|NLM (2004)|021023|abcdef", "ENTRY": "Family Planning, Natural", "MN": "E02.875.194.605", "FX": "Fertile Period", "MH_TH": "NLM (2004)", "ST": "T061", "PI": "Contraception (1966-1974)", "MS": "A class of natural contraceptive methods in which SEXUAL ABSTINENCE is practiced a few days before and after the estimated day of ovulation, during the fertile phase. Methods for determining the fertile period or OVULATION DETECTION are based on various physiological indicators, such as circulating hormones, changes in cervical mucus (CERVIX MUCUS), and the basal body temperature.", "PM": "2004; see RHYTHM METHOD 1975-2003; for NATURAL FAMILY PLANNING see FAMILY PLANNING 1988-2003", "HN": "2004 (1975); for NATURAL FAMILY PLANNING use FAMILY PLANNING 1988-2003", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D012252"}, {"RECTYPE": "D", "MH": "Rib Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Rib Fracture", "MN": "C26.891.733", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Fractures of any of the RIBS.", "CATSH": "CAT LIST", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012253"}, {"RECTYPE": "D", "MH": "Ribavirin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tribavirin|T114|T121|NON|EQV|BAN (19XX)|NLM (1992)|910227|abbcdeef", "ENTRY": "ICN1229", "MN": "D13.570.800.790", "PA": "Antiviral Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-", "RN": "49717AWG6K", "RR": "36791-04-5 (Ribavirin)", "PI": "Triazoles (1966-1974)", "MS": "A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.", "OL": "use RIBAVIRIN to search VIRAZOLE 1975-91", "PM": "91; was see under RIBONUCLEOSIDES 1978-90; was VIRAZOLE see under RIBONUCLEOSIDES 1975-77; VIRAZOLE was see RIBAVIRIN 1978-91", "HN": "91(78); was see under RIBONUCLEOSIDES 1978-90; was VIRAZOLE see under RIBONUCLEOSIDES 1975-77; VIRAZOLE was see RIBAVIRIN 1978-91", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012254"}, {"RECTYPE": "D", "MH": "Ribitol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Adonitol|T109|T123|NON|EQV|UNK (19XX)|830330|abbcdef", "MN": "D09.853.780", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Ribitol", "RN": "488-81-3", "PI": "Sugar Alcohols (1972-1977)", "MS": "A sugar alcohol formed by the reduction of ribose.", "PM": "91; was see under SUGAR ALCOHOLS 1978-90", "HN": "91(78); was see under SUGAR ALCOHOLS 1978-90", "MR": "20040707", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D012255"}, {"RECTYPE": "D", "MH": "Riboflavin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitamin G|T109|T127|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Vitamin B2|T109|T127|NON|EQV|FDA SRS (2014)|UNK (19XX)|880705|abbcdeef", "MN": "D23.767.405.650", "PA": "Vitamin B Complex", "EC": "deficiency:Riboflavin Deficiency", "MH_TH": "USP (19XX)", "ST": "T127", "RN": "TLM2976OFR", "RR": "83-88-5 (Riboflavin)", "MS": "Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. The richest natural source is yeast. It occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as FLAVIN MONONUCLEOTIDE and FLAVIN-ADENINE DINUCLEOTIDE.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012256"}, {"RECTYPE": "D", "MH": "Riboflavin Deficiency", "DE": "RIBOFLAVIN DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Riboflavin Deficiencies", "MN": "C18.654.521.500.133.699.713", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a vitamin B defic", "MS": "A dietary deficiency of riboflavin causing a syndrome chiefly marked by cheilitis, angular stomatitis, glossitis associated with a purplish red or magenta-colored tongue that may show fissures, corneal vascularization, dyssebacia, and anemia. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012257"}, {"RECTYPE": "D", "MH": "Riboflavin Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthase, Riboflavin", "MN": "D08.811.913.225.750", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "6,7-Dimethyl-8-(1-D-ribityl)lumazine:6,7-dimethyl-8-(1-D-ribityl)lumazine 2,3-butanediyltransferase", "RN": "EC 2.5.1.9", "RR": "9075-82-5 (CAS RN)", "PI": "Transferases (1973-1974)", "MS": "An enzyme that catalyzes the formation of riboflavin from two molecules of 6,7-dimethyl-8-ribityllumazine, utilizing a four-carbon fragment from one molecule which is transferred to the second molecule. EC 2.5.1.9.", "PM": "91; was see under TRANSFERASES 1975-90", "HN": "91(75); was see under TRANSFERASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012258"}, {"RECTYPE": "D", "MH": "Ribonuclease, Pancreatic", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ribonuclease A|T116|T126|NON|EQV|UNK (19XX)|830317|abbcdef", "ENTRY": "RNase, Pancreatic", "MN": "D08.811.277.352.700.350.715", "MH_TH": "NLM (1984)", "ST": "T126", "RN": "EC 3.1.27.5", "PI": "Ribonucleases (1979-1982)", "MS": "An enzyme that catalyzes the endonucleolytic cleavage of pancreatic ribonucleic acids to 3'-phosphomono- and oligonucleotides ending in cytidylic or uridylic acids with 2',3'-cyclic phosphate intermediates. EC 3.1.27.5.", "PM": "84", "HN": "84", "MR": "20030709", "DA": "19830317", "DC": "1", "DX": "19840101", "UI": "D012259"}, {"RECTYPE": "D", "MH": "Ribonucleases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RNase|T116|T126|EQV|UNK (19XX)|760513|abbdef", "ENTRY": "Ribonuclease, Alkaline", "MN": "D08.811.277.352.700", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.1.-", "MS": "Enzymes that catalyze the hydrolysis of ester bonds within RNA. EC 3.1.-.", "OL": "use RIBONUCLEASES to search RIBONUCLEASE 1986-82", "PM": "83; was RIBONUCLEASE 1963-82", "HN": "83; was RIBONUCLEASE 1963-82", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19830101", "UI": "D012260"}, {"RECTYPE": "D", "MH": "Ribonucleoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ribonucleoprotein|T116|T123|NON|EQV|UNK (19XX)|870509|abbcdef", "MN": "D12.776.664.962.500", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "0", "PI": "specific RNA(1966-1975)", "MS": "Complexes of RNA-binding proteins with ribonucleic acids (RNA).", "PM": "84; was see under NUCLEOPROTEINS 1976-83", "HN": "84(76); was see under NUCLEOPROTEINS 1976-83", "MR": "20050630", "DA": "19750725", "DC": "1", "DX": "19840101", "UI": "D012261"}, {"RECTYPE": "D", "MH": "Ribonucleoside Diphosphate Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase, UDP", "MN": "D08.811.682.810.567", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "2'-Deoxyribonucleoside-diphosphate:oxidized-thioredoxin 2'-oxidoreductase", "RN": "EC 1.17.4.1", "MS": "An enzyme of the oxidoreductase class that catalyzes the formation of 2'-deoxyribonucleotides from the corresponding ribonucleotides using NADPH as the ultimate electron donor. The deoxyribonucleoside diphosphates are used in DNA synthesis. (From Dorland, 27th ed) EC 1.17.4.1.", "OL": "search RIBONUCLEOTIDE REDUCTASES 1974", "PM": "91; was see under RIBONUCLEOTIDE REDUCTASES 1975-90", "HN": "91(75); was see under RIBONUCLEOTIDE REDUCTASES 1975-90", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012262"}, {"RECTYPE": "D", "MH": "Ribonucleosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D13.570.800", "MH_TH": "NLM (1971)", "ST": "T114", "RN": "0", "PI": "specific nucleoside (1966-1970)", "MS": "Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)", "PM": "73", "HN": "73(71)", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012263"}, {"RECTYPE": "D", "MH": "Ribonucleotide Reductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductases, Ribonucleotide", "MN": "D08.811.682.810", "MH_TH": "NLM (1974)", "ST": "T126", "RN": "EC 1.17.4.-", "PM": "74", "HN": "74", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012264"}, {"RECTYPE": "D", "MH": "Ribonucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ribonucleotide|T114|NON|EQV|NLM (2021)|200317|abcdef", "ENTRY": "Phosphates, Ribonucleoside", "MN": "D13.695.827", "MH_TH": "NLM (1971)", "ST": "T114", "RN": "0", "PI": "specific nucleotide (1966-1970)", "MS": "Nucleotides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)", "PM": "73", "HN": "73(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012265"}, {"RECTYPE": "D", "MH": "Ribose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "D Ribose", "MN": "D09.947.875.627.651", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Ribose", "RN": "681HV46001", "RR": "50-69-1 (Ribose)", "MS": "A pentose active in biological systems usually in its D-form.", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012266"}, {"RECTYPE": "D", "MH": "Ribosemonophosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.894.643.700", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Ribose (1968-1974)", "MS": "Ribose substituted in the 1-, 3-, or 5-position by a phosphoric acid moiety.", "PM": "91; was see under PENTOSEPHOSPHATES 1975-90", "HN": "91(75); was see under PENTOSEPHOSPHATES 1975-90", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012267"}, {"RECTYPE": "D", "MH": "Ribose-Phosphate Pyrophosphokinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphoribosyl Pyrophosphate Synthetase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Synthetase, Phosphoribosyl Pyrophosphate", "MN": "D08.811.913.696.175.650", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "ATP:ribose-5-phosphate pyrophosphotransferase", "RN": "EC 2.7.6.1", "RR": "9015-83-2 (CAS RN)", "PI": "Pyrophosphoric Acids (1974)", "MS": "An enzyme that catalyzes the formation of phosphoribosyl pyrophosphate from ATP and ribose-5-phosphate. EC 2.7.6.1.", "OL": "use RIBOSE-PHOSPHATE PYROPHOSPHOKINASE to search RIBOSEPHOSPHATE PYROPHOSPHOKINASE 1975-93", "PM": "94; was RIBOSEPHOSPHATE PYROPHOSPHOKINASE 1975-93 (see under PHOSPHOTRANSFERASES, ATP 1975-90)", "HN": "94; was RIBOSEPHOSPHATE PYROPHOSPHOKINASE 1975-93 (see under PHOSPHOTRANSFERASES, ATP 1975-90)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012268"}, {"RECTYPE": "D", "MH": "Ribosomal Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proteins, Ribosomal|T116|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Protein, Ribosomal", "MN": "D12.776.835", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "/biosyn /drug eff /physiol permitted", "PI": "Ribosomes (1966-1974)", "MS": "Proteins found in ribosomes. They are believed to have a catalytic function in reconstituting biologically active ribosomal subunits.", "PM": "75", "HN": "75", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D012269"}, {"RECTYPE": "D", "MH": "Ribosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Ribosome|T026|NON|EQV|NLM (2008)|070213|abcdef", "MN": "A11.284.430.214.190.875.811", "FX": "Ribosomal Proteins", "MH_TH": "NLM (1964)", "ST": "T026", "MS": "Multicomponent ribonucleoprotein structures found in the CYTOPLASM of all cells, and in MITOCHONDRIA, and PLASTIDS. They function in PROTEIN BIOSYNTHESIS via GENETIC TRANSLATION.", "PM": "65", "HN": "65(64)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012270"}, {"RECTYPE": "D", "MH": "Ribostamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SF733", "MN": "D09.408.051.623.800", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-2-deoxy-", "RN": "2Q5JOU7T53", "RR": "25546-65-0 (Ribostamycin)", "PI": "Antibiotics (1972-1974)", "MS": "A broad-spectrum antimicrobial isolated from Streptomyces ribosifidicus.", "PM": "91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90", "HN": "91(75); was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012271"}, {"RECTYPE": "D", "MH": "Ribs", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Rib", "MN": "A02.835.232.570.500", "FX": "Tietze's Syndrome", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "/inj permitted: do not coordinate with THORACIC INJURIES but note RIB FRACTURES is available", "MS": "A set of twelve curved bones which connect to the vertebral column posteriorly, and terminate anteriorly as costal cartilage. Together, they form a protective cage around the internal thoracic organs.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012272"}, {"RECTYPE": "D", "MH": "Ribulose-Bisphosphate Carboxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Rubisco|T116|T126|ACX|EQV|NLM (1998)|961127|abbcdef", "ENTRY": "Small-Subunit, Ribulose-1,5-Bisphosphate Carboxylase", "MN": "D12.776.765.199.499", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "3-Phospho-D-glycerate carboxy-lyase (dimerizing)", "RN": "EC 4.1.1.39", "RR": "EC 4.1.1.39", "PI": "Pentosephosphates (1973-1974)", "MS": "A carboxy-lyase that plays a key role in photosynthetic carbon assimilation in the CALVIN-BENSON CYCLE by catalyzing the formation of 3-phosphoglycerate from ribulose 1,5-biphosphate and CARBON DIOXIDE. It can also utilize OXYGEN as a substrate to catalyze the synthesis of 2-phosphoglycolate and 3-phosphoglycerate in a process referred to as photorespiration.", "PM": "1998; see RIBULOSEBIPHOSPHATE CARBOXYLASE 1984-1997, see CARBOXY-LYASES 1975-1983; RIBULOSE-1,5-BISPHOSPHOSPHATE CARBOXYLASE SMALL SUBUNIT was indexed under RIBULOSE-BISPHOSPHATE CARBOXYLASE 1994-2011", "HN": "1998(1975)", "MR": "20150623", "DA": "19741111", "DC": "1", "DX": "19840101", "UI": "D012273"}, {"RECTYPE": "D", "MH": "Ribulosephosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.894.643.720", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Pentosephosphates (1973-1974)", "MS": "Ribulose substituted by one or more phosphoric acid moieties.", "PM": "91; was see under PENTOSEPHOSPHATES 1975-90", "HN": "91(75); was see under PENTOSEPHOSPHATES 1975-90", "MR": "20040707", "DA": "19760628", "DC": "1", "DX": "19910101", "UI": "D012274"}, {"RECTYPE": "D", "MH": "Oryza", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rice|T002|T168|NON|REL|NLM (1966)|990101|abbcdef", "ENTRY": "Rices", "MN": "B01.875.800.575.912.250.822.616", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid4527", "RR": "txid4530", "AN": "\"yusho poisoning\": index under ORYZA /pois (IM) + PLANT OILS /pois (IM) + POLYCHLOROBIPHENYL COMPOUNDS /pois (IM) + FOOD CONTAMINATION (IM)", "MS": "A genus of grass family (Poaceae) that include several rice species.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012275"}, {"RECTYPE": "D", "MH": "Ricin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ricin Toxin|T131|NON|EQV|NLM (2021)|200128|abcdef", "ENTRY": "Toxin, Ricinus", "MN": "D12.776.765.678.906.750", "PA": "Chemical Warfare Agents", "MH_TH": "NLM (1964)", "ST": "T131", "N1": "Ricins", "RN": "9009-86-3", "AN": "/antag: consider also ANTITOXINS", "MS": "A protein phytotoxin from the seeds of Ricinus communis, the castor oil plant. It agglutinates cells, is proteolytic, and causes lethal inflammation and hemorrhage if taken internally.", "PM": "78; was see under PLANT PROTEINS 1975-77", "HN": "78(64); was see under PLANT PROTEINS 1975-77", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D012276"}, {"RECTYPE": "D", "MH": "Ricinoleic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oleic Acids, 12 hydroxy", "MN": "D10.251.355.325.600.780", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "12-hydroxyoctadec-9-enoic acids", "RN": "0", "MS": "Eighteen carbon fatty acids that comprise the great majority of CASTOR OIL, which is from the seed of RICINUS.", "OL": "use FATTY ACIDS to search RICINOLEIC ACID 1966-74; use RICINOLEIC ACIDS to search SODIUM RICINOLEATE 1975-80, use SCLEROSING SOLUTIONS 1966-74", "PM": "91; was see under OLEIC ACIDS 1988-90, was see under FATTY ACIDS, UNSATURATED 1975-87; was RICINOLEIC ACID see under FATTY ACIDS 1963-74; SODIUM RICINOLEATE was see under FATTY ACIDS, UNSATURATED 1975-80, was see under SCLEROSING SOLUTIONS 1963-74", "HN": "91(75); was see under OLEIC ACIDS 1988-90, was see under FATTY ACIDS, UNSATURATED 1975-87; was RICINOLEIC ACID see under FATTY ACIDS 1963-74; SODIUM RICINOLEATE was see under FATTY ACIDS, UNSATURATED 1975-80, was see under SCLEROSING SOLUTIONS 1963-74", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012277"}, {"RECTYPE": "D", "MH": "Ricinus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.797.438.650", "FX": "Ricin", "MH_TH": "NLM (1966)", "ST": "T002", "RN": "txid3987", "MS": "A plant genus of the family Euphorbiaceae. The seed of RICINUS COMMUNIS is the castor bean which is the source of CASTOR OIL; RICIN; and other LECTINS.", "PM": "2002; for CASTOR OIL PLANT see EUPHORBIACEAE 1998-2001", "HN": "2002; for CASTOR OIL PLANT use EUPHORBIACEAE 1998-2001", "MR": "20230526", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D012278"}, {"RECTYPE": "D", "MH": "Rickets", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rachitis|T037|T047|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Rachitides", "MN": "C18.654.521.500.133.770.734", "FX": "Genu Varum", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Disorders caused by interruption of BONE MINERALIZATION manifesting as OSTEOMALACIA in adults and characteristic deformities in infancy and childhood due to disturbances in normal BONE FORMATION. The mineralization process may be interrupted by disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis, resulting from dietary deficiencies, or acquired, or inherited metabolic, or hormonal disturbances.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012279"}, {"RECTYPE": "D", "MH": "Rickettsia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.875.650.650", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid780", "MS": "A genus of gram-negative, aerobic, rod-shaped bacteria often surrounded by a protein microcapsular layer and slime layer. The natural cycle of its organisms generally involves a vertebrate and an invertebrate host. Species of the genus are the etiological agents of human diseases, such as typhus.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012281"}, {"RECTYPE": "D", "MH": "Rickettsia Infections", "DE": "RICKETTSIA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Rickettsioses", "MN": "C01.920.914.725", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Rickettsial Infections (1977-1986)", "MS": "Infections by the genus RICKETTSIA.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19860407", "DC": "1", "DX": "19870101", "UI": "D012282"}, {"RECTYPE": "D", "MH": "Rickettsia prowazekii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.875.650.650.600", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid782", "MS": "A species of gram-negative, aerobic bacteria that is the etiologic agent of epidemic typhus fever acquired through contact with lice (TYPHUS, EPIDEMIC LOUSE-BORNE) as well as Brill's disease.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012283"}, {"RECTYPE": "D", "MH": "Rickettsia rickettsii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.875.650.650.650", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid783", "MS": "A species of gram-negative, aerobic bacteria that is the etiologic agent of ROCKY MOUNTAIN SPOTTED FEVER. Its cells are slightly smaller and more uniform in size than those of RICKETTSIA PROWAZEKII.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012284"}, {"RECTYPE": "D", "MH": "Orientia tsutsugamushi", "DE": "O TSUTSU", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rickettsia tsutsugamushi|T007|NON|EQV|NLM (1999)|980130|abcdef", "MN": "B03.660.050.783.875.650.450.500", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid784", "MS": "A gram-negative, rod-shaped to coccoid bacterium. It is the etiologic agent of SCRUB TYPHUS in humans and is transmitted by mites from rodent reservoirs.", "PM": "99; see RICKETTSIA TSUTSUGAMUSHI 1966-98", "HN": "99(66)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D012285"}, {"RECTYPE": "D", "MH": "Rickettsia typhi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.875.650.650.810", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid785", "MS": "The etiologic agent of murine typhus (see TYPHUS, ENDEMIC FLEA-BORNE).", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012286"}, {"RECTYPE": "D", "MH": "Rickettsiaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.875", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid775", "PI": "Bacteria (1966-1974)", "MS": "A family of gram-negative bacteria belonging to the order Rickettsiales.", "PM": "1975", "HN": "1975", "MR": "20200813", "DA": "19760525", "DC": "1", "DX": "19750101", "UI": "D012287"}, {"RECTYPE": "D", "MH": "Rickettsiaceae Infections", "DE": "RICKETTSIACEAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Rickettsiaceae Infection", "MN": "C01.920.914", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "do not confuse with RICKETTSIA INFECTIONS (infection by genus RICKETTSIA) ", "PI": "Rickettsial Diseases (1966-1976)", "MS": "Infections with bacteria of the family RICKETTSIACEAE.", "OL": "use RICKETTSIACEAE INFECTIONS/veterinary to search NEORICKETTSIOSIS HELMINTHOECA 1971-81; use RICKETTSIACEAE INFECTIONS to search RICKETTSIALPOX 1966-81", "PM": "77; NEORICKETTSIOSIS HELMINTHOECA was heading 1971-81; RICKETTSIALPOX was heading 1963-81", "HN": "77; NEORICKETTSIOSIS HELMINTHOECA was heading 1971-81; RICKETTSIALPOX was heading 1963-81", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D012288"}, {"RECTYPE": "D", "MH": "Rickettsial Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Rickettsial", "MN": "D20.215.894.135.650", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "AN": "coord IM with specific Rickettsia /immunol (IM)", "MS": "Vaccines for the prevention of diseases caused by various species of Rickettsia.", "PM": "91; was see under VACCINES 1973-90", "HN": "91(73); was see under VACCINES 1973-90", "MR": "20050630", "DA": "19760525", "DC": "1", "DX": "19910101", "UI": "D012290"}, {"RECTYPE": "D", "MH": "Rifampin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rifampicin|T109|T195|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbcdeef", "ENTRY": "Tubocin|T109|T195|TRD|NRW|UNK (19XX)|820519|abbcdef", "MN": "D04.345.295.750.700", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-", "RN": "VJT6J7R4TR", "RR": "13292-46-1 (Rifampin)", "PI": "Rifamycins (1966-1972)", "MS": "A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)", "PM": "73", "HN": "73", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012293"}, {"RECTYPE": "D", "MH": "Rifamycins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rifomycins|T109|T195|NON|EQV|UNK (19XX)|740330|abbcdef", "MN": "D04.345.295.750", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1973)", "ST": "T195", "RN": "0", "MS": "A group of ANTI-BACTERIAL AGENTS characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known ANTI-BACTERIAL AGENTS. They have been isolated from fermentation broths of Streptomyces mediterranei.", "OL": "use RIFAMYCINS to search RIFOMYCIN 1966-72", "PM": "73; was RIFOMYCIN 1963-72", "HN": "73; was RIFOMYCIN 1963-72", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012294"}, {"RECTYPE": "D", "MH": "Rift Valley Fever", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "ENTRY": "Fever, Rift Valley", "MN": "C22.467.435.812", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An acute infection caused by the RIFT VALLEY FEVER VIRUS, an RNA arthropod-borne virus, affecting domestic animals and humans. In animals, symptoms include HEPATITIS; abortion (ABORTION, VETERINARY); and DEATH. In humans, symptoms range from those of a flu-like disease to hemorrhagic fever, ENCEPHALITIS, or BLINDNESS.", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012295"}, {"RECTYPE": "D", "MH": "Rift Valley fever virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.480.750.710.700", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid11588", "MS": "A mosquito-borne species of the PHLEBOVIRUS genus found in eastern, central, and southern Africa, producing massive hepatitis, abortion, and death in sheep, goats, cattle, and other animals. It also has caused disease in humans.", "OL": "use ARBOVIRUSES to search RIFT VALLEY FEVER VIRUS 1966-74", "PM": "91; was see under BUNYAVIRIDAE 1981-90; was see under ARBOVIRUSES 1975-80; was see under ARBOVIRUS 1965-74; was see under ARBORVIRUSES 1963-64", "HN": "91(75); was see under BUNYAVIRIDAE 1981-90; was see under ARBOVIRUSES 1975-80; was see under ARBOVIRUS 1965-74; was see under ARBORVIRUSES 1963-64", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012296"}, {"RECTYPE": "D", "MH": "Right to Die", "AQ": "ES HI LJ", "PRINT ENTRY": "Death with Dignity|T080|NON|REL|UNK (19XX)|860530|abcdef", "ENTRY": "Dignity, Death with", "MN": "N03.706.437.650.750", "FX": "Suicide, Assisted", "MH_TH": "BIOETHICS (1991)", "ST": "T078", "AN": "differentiate from ALLOWING TO DIE see EUTHANASIA, PASSIVE", "PI": "Patient Advocacy (1976-1986)", "MS": "The right of the patient or the patient's representative to make decisions with regard to the patient's dying.", "PM": "87", "HN": "87", "MR": "20021031", "DA": "19860530", "DC": "1", "DX": "19870101", "UI": "D012297"}, {"RECTYPE": "D", "MH": "Rigor Mortis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mortis, Rigor", "MN": "C23.550.260.224.617.839", "MH_TH": "NLM (1970)", "ST": "T046", "PI": "Death (1966-1969)", "MS": "Muscular rigidity which develops in the cadaver usually from 4 to 10 hours after death and lasts 3 or 4 days.", "OL": "search DEATH 1966-69", "PM": "70; was see under DEATH 1963-69", "HN": "70; was see under DEATH 1963-69", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D012298"}, {"RECTYPE": "D", "MH": "Rimantadine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Remantadine|T109|T121|NON|EQV|UNK (19XX)|840406|abbcdef", "ENTRY": "Hydrochloride, Rimantadine", "MN": "D02.455.426.392.368.075.750", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Tricyclo(3.3.1.13,7)decane-1-methanamine, alpha-methyl-", "RN": "0T2EF4JQTU", "RR": "JEI07OOS8Y", "PI": "Ethylamines (1966-1975)", "MS": "An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.", "PM": "91; was see under ADAMANTANE 1980-90", "HN": "91(80); was see under ADAMANTANE 1980-90", "MR": "20160701", "DA": "19790302", "DC": "1", "DX": "19910101", "UI": "D012299"}, {"RECTYPE": "D", "MH": "Rinderpest", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Cattle Plague|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Plague, Cattle", "MN": "C22.780", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A viral disease of cloven-hoofed animals caused by MORBILLIVIRUS. It may be acute, subacute, or chronic with the major lesions characterized by inflammation and ulceration of the entire digestive tract. The disease was declared successfully eradicated worldwide in 2010.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012301"}, {"RECTYPE": "D", "MH": "Rinderpest virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.480.937.600.650.500.675", "MH_TH": "NLM (1964)", "ST": "T005", "RN": "txid11241", "MS": "A species of MORBILLIVIRUS causing cattle plague, a disease with high mortality. Sheep, goats, pigs, and other animals of the order Artiodactyla can also be infected.", "PM": "66", "HN": "66(64)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012302"}, {"RECTYPE": "D", "MH": "Ring Chromosomes", "PRINT ENTRY": "Chromosomes, Ring|T020|NON|EQV|UNK (19XX)|840405|abcdef", "ENTRY": "Ring Chromosome", "MN": "G05.365.590.175.760", "MH_TH": "NLM (1985)", "ST": "T020", "PI": "Chromosome Abnormalities (1966-1984)", "MS": "Aberrant chromosomes with no ends, i.e., circular.", "PM": "91; was see under CHROMOSOME ABERRATIONS 1985-90", "HN": "91(85); was see under CHROMOSOME ABERRATIONS 1985-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19840405", "DC": "1", "DX": "19910101", "UI": "D012303"}, {"RECTYPE": "D", "MH": "Riot Control Agents, Chemical", "DE": "RIOT CONTROL AGENTS CHEM", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chemical Riot Control Agents|T131|NON|EQV|NLM (1994)|930217|CHEM RIOT CONTROL AGENTS|abcdefv", "MN": "D27.888.569.734", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "PI": "Tear Gases (1968-1974)", "MS": "Chemical substances which are employed during a riot in order to control or disperse the rioting parties.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D012304"}, {"RECTYPE": "D", "MH": "Riots", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Riot", "MN": "I01.880.735.140.652", "FX": "Violence", "MH_TH": "NLM (1968)", "ST": "T054", "PI": "Social Problems (1968)", "MS": "A form of violent crowd behavior which expresses the emotional release of resentments and prejudices, usually relevant to grievances toward the social system.", "PM": "70", "HN": "70(69)", "MR": "19930605", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D012305"}, {"RECTYPE": "D", "MH": "Risk", "PRINT ENTRY": "Relative Risk|T080|T081|NON|NRW|NLM (1990)|890525|RELAT RISK|abbcdefv", "ENTRY": "Risks, Relative", "MN": "N06.850.520.830.600.800", "FX": "Risk Reduction Behavior", "MH_TH": "BIOETHICS (1994)", "ST": "T081", "AN": "IM GEN only; for risk as a statis concept; note other risk terms in MeSH", "MS": "The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome.", "OL": "search PROBABILITY 1973-74", "PM": "88; was see under PROBABILITY 1973-87", "HN": "88(75); was see under PROBABILITY 1973-87", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19880101", "UI": "D012306"}, {"RECTYPE": "D", "MH": "Risk Factors", "PRINT ENTRY": "Social Risk Factors|T081|NON|NRW|OBSSR (2022)|210519|abcdef", "ENTRY": "Social Risk Factor", "MN": "N06.850.520.830.600.800.725", "FX": "Organs at Risk", "MH_TH": "OBSSR (2021)", "ST": "T081", "AN": "human and animal; an epidemiologic concept for risk factors in disease, surgery, etc.: do not confuse with RISK, a statistical concept & aspect of probability; coordinate with specific disease or other concept; SOCIAL DETERMINANTS OF HEALTH is available", "PI": "Risk (1975-1987)", "MS": "An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent.", "PM": "1988; for POPULATION AT RISK see POPULATION CHARACTERISTICS 1983-2016", "HN": "1988; for POPULATION AT RISK use POPULATION CHARACTERISTICS 1983-2016", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19870501", "DC": "1", "DX": "19880101", "UI": "D012307"}, {"RECTYPE": "D", "MH": "Risk Management", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Incident Reporting, Hospital|T058|NON|NRW|UNK (19XX)|810226|INCIDENT REPORTING HOSP|abcdefv", "ENTRY": "Risks Management", "MN": "N04.452.871", "FX": "Patient Safety", "MH_TH": "NLM (1980)", "ST": "T057", "PI": "Malpractice (1966-1979)", "MS": "The process of minimizing risk to an organization by developing systems to identify and analyze potential hazards to prevent accidents, injuries, and other adverse occurrences, and by attempting to handle events and incidents which do occur in such a manner that their effect and cost are minimized. Effective risk management has its greatest benefits in application to insurance in order to avert or minimize financial liability. (From Slee & Slee: Health care terms, 2d ed)", "PM": "90; was see under FINANCIAL MANAGEMENT 1980-89", "HN": "90(80); was see under FINANCIAL MANAGEMENT 1980-89", "MR": "20190226", "DA": "19781222", "DC": "1", "DX": "19900101", "UI": "D012308"}, {"RECTYPE": "D", "MH": "Risk-Taking", "PRINT ENTRY": "Risk Behavior|T055|NON|NRW|NLM (1992)|POPLINE (1994)|910506|abcdeef", "ENTRY": "Risk Taking", "MN": "F01.145.722", "FX": "Dangerous Behavior", "MH_TH": "NLM (1975)", "ST": "T055", "PI": "Gambling (1969-1974)", "MS": "Undertaking a task involving a challenge for achievement or a desirable goal in which there is a lack of certainty or a fear of failure. It may also include the exhibiting of certain behaviors whose outcomes may present a risk to the individual or to those associated with him or her.", "PM": "79; was see under GAMBLING 1969-78; GAMBLING was heading 1968-78", "HN": "79(75); was see under GAMBLING 1969-78", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D012309"}, {"RECTYPE": "D", "MH": "Ristocetin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ristomycin|T116|T195|TRD|NRW|NLM (1994)|921202|abbcdef", "MN": "D12.644.233.697", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "Ristocetin", "RN": "1404-55-3", "MS": "An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro.", "OL": "use RISTOCETIN to search RISTOMYCIN 1966-93 (as Prov 1966-72)", "PM": "RISTOMYCIN was heading 1965-93", "HN": "RISTOMYCIN was heading 1965-93 (Prov 1965-72)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D012310"}, {"RECTYPE": "D", "MH": "Ritodrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "PrePar", "MN": "D02.092.471.683.870", "PA": "Tocolytic Agents", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "Benzenemethanol, 4-hydroxy-alpha-(1-((2-(4-hydroxyphenyl)ethyl)amino)ethyl)-, (R*,S*)-", "RN": "I0Q6O6740J", "RR": "ESJ56Q60GC", "PI": "Propanolamines (1974)", "MS": "An adrenergic beta-2 agonist used to control PREMATURE LABOR.", "PM": "86; was see under PROPANOLAMINES 1975-85", "HN": "86(75); was see under PROPANOLAMINES 1975-85", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D012312"}, {"RECTYPE": "D", "MH": "RNA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ribonucleic Acid|T114|T123|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "RNA, Non Polyadenylated", "MN": "D13.444.735", "FX": "Nissl Bodies", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Ribonucleic acids", "RN": "63231-63-0", "AN": "/immunol: consider also IMMUNE RNA MANIPULATION see IMMUNOTHERAPY, ACTIVE", "MS": "A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)", "OL": "use RNA (NM) to search RNA, NON-POLYADENYLATED 1981-94", "PM": "NON-POLYADENYLATED RNA was indexed under RNA, NEOPLASM 1981-94", "HN": "RNA, NON-POLYADENYLATED was NON-POLYADENYLATED RNA (NM) 1981-94", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D012313"}, {"RECTYPE": "D", "MH": "RNA Cap Analogs", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cap Analogues, RNA", "MN": "D13.695.827.426.700.710", "MH_TH": "NLM (1980)", "ST": "T121", "RN": "0", "AN": "IM; /drug eff /ultrastruct permitted", "PI": "Ribonucleotides (1971-1975)", "MS": "Analogs of RNA cap compounds which do not have a positive charge. These compounds inhibit the initiation of translation of both capped and uncapped messenger RNA.", "PM": "91; was see under RNA CAPS 1980-90", "HN": "91(80); was see under RNA CAPS 1980-90", "MR": "20160531", "DA": "19790525", "DC": "1", "DX": "19910101", "UI": "D012314"}, {"RECTYPE": "D", "MH": "RNA Caps", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RNA Cap|T114|T123|NON|EQV|NLM (2022)|201006|abbcdef", "ENTRY": "RNA, 5' Capped", "MN": "D13.695.827.426.700", "EC": "analogs & derivatives:RNA Cap Analogs", "MH_TH": "NLM (1980)", "ST": "T123", "RN": "0", "AN": "IM; /drug eff /ultrastruct permitted", "PI": "Ribonucleotides (1971-1975)", "MS": "Nucleic acid structures found on the 5' end of eukaryotic cellular and viral messenger RNA and some heterogeneous nuclear RNAs. These structures, which are positively charged, protect the above specified RNAs at their termini against attack by phosphatases and other nucleases and promote mRNA function at the level of initiation of translation. Analogs of the RNA caps (RNA CAP ANALOGS), which lack the positive charge, inhibit the initiation of protein synthesis.", "PM": "80", "HN": "80", "MR": "20210630", "DA": "19790523", "DC": "1", "DX": "19800101", "UI": "D012315"}, {"RECTYPE": "D", "MH": "RNA Nucleotidyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nucleotidyltransferases, RNA", "MN": "D08.811.913.696.445.735", "MH_TH": "NLM (1968)", "ST": "T126", "RN": "EC 2.7.7.-", "PI": "Nucleotidyltransferases (1966-1967)", "MS": "Enzymes that catalyze the template-directed incorporation of ribonucleotides into an RNA chain. EC 2.7.7.-.", "PM": "68", "HN": "68", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012316"}, {"RECTYPE": "D", "MH": "RNA Phages", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Phages, RNA|T005|EQV|UNK (19XX)|790416|abdef", "ENTRY": "RNA Phage", "MN": "B04.123.691", "MH_TH": "NLM (1980)", "ST": "T005", "AN": "coord with specific bacterium /virol", "PI": "Coliphages (1966-1979)", "MS": "Bacteriophages whose genetic material is RNA, which is single-stranded in all except the Pseudomonas phage phi 6 (BACTERIOPHAGE PHI 6). All RNA phages infect their host bacteria via the host's surface pili. Some frequently encountered RNA phages are: BF23, F2, R17, fr, PhiCb5, PhiCb12r, PhiCb8r, PhiCb23r, 7s, PP7, Q beta phage, MS2 phage, and BACTERIOPHAGE PHI 6.", "PM": "80", "HN": "80", "MR": "20200902", "DA": "19790416", "DC": "1", "DX": "19800101", "UI": "D012317"}, {"RECTYPE": "D", "MH": "RNA Polymerase I", "DS": "RNA POLYMERASE 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA-Dependent RNA Polymerase I|T116|T126|EQV|UNK (19XX)|760416|DNA DEPENDENT RNA POLYMERASE 01|abbdefs", "ENTRY": "Polymerase I, RNA", "MN": "D08.811.913.696.445.735.270.750", "MH_TH": "NLM (1977)", "ST": "T126", "RN": "EC 2.7.7.6", "PI": "RNA Polymerases (1973-1976)", "MS": "A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. The enzyme functions in the nucleolar structure and transcribes DNA into RNA. It has different requirements for cations and salts than RNA polymerase II and III and is not inhibited by alpha-amanitin.", "PM": "84; was see under RNA POLYMERASES 1977-83", "HN": "84(77); was see under RNA POLYMERASES 1977-83", "MR": "20160629", "DA": "19760419", "DC": "1", "DX": "19840101", "UI": "D012318"}, {"RECTYPE": "D", "MH": "RNA Polymerase II", "DS": "RNA POLYMERASE 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA-Dependent RNA Polymerase II|T116|T126|EQV|UNK (19XX)|760416|DNA DEPENDENT RNA POLYMERASE 02|abbdefs", "ENTRY": "DNA Dependent RNA Polymerase II", "MN": "D08.811.913.696.445.735.270.762", "MH_TH": "NLM (1977)", "ST": "T126", "RN": "EC 2.7.7.-", "PI": "RNA Polymerases (1973-1976)", "MS": "A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.", "PM": "84; was see under RNA POLYMERASES 1977-83", "HN": "84(77); was see under RNA POLYMERASES 1977-83", "MR": "20130708", "DA": "19760419", "DC": "1", "DX": "19840101", "UI": "D012319"}, {"RECTYPE": "D", "MH": "RNA Polymerase III", "DS": "RNA POLYMERASE 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA-Dependent RNA Polymerase III|T116|T126|EQV|UNK (19XX)|760416|DNA DEPENDENT RNA POLYMERASE 03|abbdefs", "ENTRY": "Polymerase III, RNA", "MN": "D08.811.913.696.445.735.270.775", "MH_TH": "NLM (1977)", "ST": "T126", "RN": "EC 2.7.7.6", "PI": "RNA Polymerases (1973-1976)", "MS": "A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure where it transcribes DNA into RNA. It has specific requirements for cations and salt and has shown an intermediate sensitivity to alpha-amanitin in comparison to RNA polymerase I and II.", "PM": "91; was see under RNA POLYMERASES 1977-90", "HN": "91(77); was see under RNA POLYMERASES 1977-90", "MR": "20160629", "DA": "19760419", "DC": "1", "DX": "19910101", "UI": "D012320"}, {"RECTYPE": "D", "MH": "DNA-Directed RNA Polymerases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transcriptases|T116|T126|NON|EQV|UNK (19XX)|760416|abbcdef", "ENTRY": "RNA Polymerases, DNA-Directed", "MN": "D08.811.913.696.445.735.270", "MH_TH": "NLM (2003)", "ST": "T126", "N1": "Nucleoside-triphosphate:RNA nucleotidyltransferase (DNA-directed)", "RN": "EC 2.7.7.6", "AN": "general or unspecified; prefer specifics ", "PI": "RNA Nucleotidyltransferases (1968-1972)", "MS": "Enzymes that catalyze DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992).", "PM": "2003; see DNA-DIRECTED RNA POLYMERASE 1998-2002, see RNA POLYMERASES 1977-1997, see RNA POLYMERASE 1973-1976", "HN": "2003(1973)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012321"}, {"RECTYPE": "D", "MH": "RNA Precursors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RNA, Transfer, Precursors|T114|T123|NRW|UNK (19XX)|870505|abbdef", "ENTRY": "Transcript, RNA Primary", "MN": "D13.444.735.640", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "AN": "coordinate with specific RNA", "PI": "Nucleic Acids (1966-1974)", "MS": "RNA transcripts of the DNA that are in some unfinished stage of post-transcriptional processing (RNA PROCESSING, POST-TRANSCRIPTIONAL) required for function. RNA precursors may undergo several steps of RNA SPLICING during which the phosphodiester bonds at exon-intron boundaries are cleaved and the introns are excised. Consequently a new bond is formed between the ends of the exons. Resulting mature RNAs can then be used; for example, mature mRNA (RNA, MESSENGER) is used as a template for protein production.", "PM": "88", "HN": "88", "MR": "20130709", "DA": "19870505", "DC": "1", "DX": "19880101", "UI": "D012322"}, {"RECTYPE": "D", "MH": "RNA Processing, Post-Transcriptional", "DE": "RNA PROC POST TRANSCRIPTIONAL", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "RNA Processing|T045|NON|EQV|NLM (2021)|200103|abcdef", "ENTRY": "RNA Modifications, Post-Transcriptional", "MN": "G05.308.700", "MH_TH": "NLM (1983)", "ST": "T045", "AN": "coordinate with specific RNA /metab ", "PI": "Transcription, Genetic (1973-1982)", "MS": "Post-transcriptional biological modification of messenger, transfer, or ribosomal RNAs or their precursors. It includes cleavage, methylation, thiolation, isopentenylation, pseudouridine formation, conformational changes, and association with ribosomal protein.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19820423", "DC": "1", "DX": "19830101", "UI": "D012323"}, {"RECTYPE": "D", "MH": "RNA-Dependent RNA Polymerase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RNA-Dependent RNA Replicase|T116|T126|NON|EQV|NLM (2021)|200430|abbcdef", "ENTRY": "Replicase, RNA-Dependent RNA", "MN": "D08.811.913.696.445.735.780", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 2.7.7.48", "PI": "RNA Nucleotidyltransferases (1969-1974)", "MS": "An enzyme that catalyses RNA-template-directed extension of the 3'- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. (Enzyme Nomenclature, 1992, p293)", "PM": "1991; see RNA NUCLEOTIDYLTRANSFERASES 1975-1990", "HN": "1991(1975)", "MR": "20200622", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012324"}, {"RECTYPE": "D", "MH": "RNA Splicing", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Splicing, RNA|T045|EQV|UNK (19XX)|810520|abdef", "ENTRY": "Splicings, RNA", "MN": "G05.308.700.700", "FX": "Spliceosomes", "MH_TH": "NLM (1982)", "ST": "T045", "AN": "note category: a physiologic process taking place within the cell nucleus; do not confuse with GENES, SPLICED see DNA, RECOMBINANT; CLONING, MOLECULAR or GENETIC ENGINEERING", "PI": "Transcription, Genetic (1976-1981)", "MS": "The ultimate exclusion of nonsense sequences or intervening sequences (introns) before the final RNA transcript is sent to the cytoplasm.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19810520", "DC": "1", "DX": "19820101", "UI": "D012326"}, {"RECTYPE": "D", "MH": "RNA Virus Infections", "DE": "RNA VIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Virus Infections, RNA", "MN": "C01.925.782", "MH_TH": "NLM (1974)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Virus Diseases (1975-1997)", "MS": "Diseases caused by RNA VIRUSES.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012327"}, {"RECTYPE": "D", "MH": "RNA Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "RNA Rodent Viruses|T005|NRW|NLM (1994)|930226|abdef", "ENTRY": "Viruses, RNA Rodent", "MN": "B04.820", "MH_TH": "NLM (1966)", "ST": "T005", "MS": "Viruses whose genetic material is RNA.", "OL": "use RNA VIRUSES to search RNA RODENT VIRUSES 1975-93", "PM": "66; RNA RODENT VIRUSES was heading 1975-93", "HN": "66; RNA RODENT VIRUSES was heading 1975-93", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012328"}, {"RECTYPE": "D", "MH": "RNA, Bacterial", "DE": "RNA BACT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Bacterial RNA|T114|EQV|NLM (1991)|900102|BACT RNA|abdefv", "MN": "D13.444.735.473", "MH_TH": "NLM (1966)", "ST": "T114", "RN": "0", "MS": "Ribonucleic acid in bacteria having regulatory and catalytic roles as well as involvement in protein synthesis.", "MR": "19950320", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012329"}, {"RECTYPE": "D", "MH": "RNA, Double-Stranded", "DE": "DSRNA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Double-Stranded RNA|T114|T123|EQV|NLM (1991)|900102|abbdef", "ENTRY": "RNA, Double Stranded", "MN": "G05.360.580.775", "MH_TH": "NLM (1980)", "ST": "T123", "RN": "0", "PI": "RNA (1966-1979)", "MS": "RNA consisting of two strands as opposed to the more prevalent single-stranded RNA. Most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop. Some double-stranded segments of RNA are normal in all organisms.", "PM": "80", "HN": "80", "MR": "20150623", "DA": "19790525", "DC": "1", "DX": "19800101", "UI": "D012330"}, {"RECTYPE": "D", "MH": "RNA, Fungal", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fungal RNA|T114|EQV|NLM (1991)|900102|abdef", "MN": "D13.444.735.500", "MH_TH": "NLM (1980)", "ST": "T114", "RN": "0", "AN": "IM; coord with specific fungus (IM); /drug eff /ultrastruct permitted", "PI": "RNA (1966-1979)", "MS": "Ribonucleic acid in fungi having regulatory and catalytic roles as well as involvement in protein synthesis.", "PM": "80", "HN": "80", "MR": "19950608", "DA": "19790525", "DC": "1", "DX": "19800101", "UI": "D012331"}, {"RECTYPE": "D", "MH": "RNA, Heterogeneous Nuclear", "DE": "HNRNA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "hnRNA|T114|T123|ABX|EQV|NLM (2020)|190228|abbcdef", "ENTRY": "Nuclear RNA, Heterogeneous", "MN": "D13.444.735.628.806", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "PI": "RNA (1966-1978)", "MS": "Nuclear nonribosomal RNA larger than about 1000 nucleotides, the mass of which is rapidly synthesized and degraded within the cell nucleus. Some heterogeneous nuclear RNA may be a precursor to mRNA. However, the great bulk of total hnRNA hybridizes with nuclear DNA rather than with mRNA.", "PM": "79", "HN": "79", "MR": "20190429", "DA": "19780315", "DC": "1", "DX": "19790101", "UI": "D012332"}, {"RECTYPE": "D", "MH": "RNA, Messenger", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "mRNA, Polyadenylated|T114|T123|NRW|NLM (1995)|940202|abbdef", "ENTRY": "mRNA, Non Polyadenylated", "MN": "D13.444.735.544", "MH_TH": "NLM (1964)", "ST": "T123", "RN": "0", "MS": "RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.", "OL": "use RNA, MESSENGER (NM) to search MRNA, NON-POLYADENYLATED 1981-94, MRNA, POLYADENYLATED 1980-94, & POLY(A)+ RNA 1980-94", "PM": "65; NON-POLYADENYLATED MRNA was indexed under RNA, MESSENGER 1981-94; POLYADENYLATED MRNA & POLY(A) RNA were indexed under POLY A & RNA, MESSENGER 1980-94", "HN": "65(64); MRNA, NON-POLYADENYLATED was NON-POLYADENYLATED MRNA (NM) 1981-94; MRNA, POLYADENYLATED was POLYADENYLATED MRNA (NM) 1980-94; POLY(A)+ RNA was SY to POLY(A) RNA (NM) 1980-94", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012333"}, {"RECTYPE": "D", "MH": "RNA, Neoplasm", "DE": "RNA NEOPL", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neoplasm RNA|T114|T123|EQV|NLM (1991)|900102|NEOPL RNA|abbdefv", "MN": "D13.444.735.615", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "IM; /drug eff /ultrastruct permitted; coord with required neopl term(s) (IM); Manual 24.4.4.2", "MS": "RNA present in neoplastic tissue.", "MR": "19950320", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012334"}, {"RECTYPE": "D", "MH": "RNA, Ribosomal", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ribosomal RNA|T114|T123|EQV|UNK (19XX)|870505|abbdef", "ENTRY": "RNA, 15S", "MN": "D13.444.735.686", "MH_TH": "NLM (1971)", "ST": "T123", "RN": "0", "AN": "IM; /drug eff /ultrastruct permitted; RRNA OPERON is also available", "PI": "Ribosomes (1966-1970)", "MS": "The most abundant form of RNA. Together with proteins, it forms the ribosomes, playing a structural role and also a role in ribosomal binding of mRNA and tRNAs. Individual chains are conventionally designated by their sedimentation coefficients. In eukaryotes, four large chains exist, synthesized in the nucleolus and constituting about 50% of the ribosome. (Dorland, 28th ed)", "PM": "72", "HN": "72(71)", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012335"}, {"RECTYPE": "D", "MH": "RNA, Ribosomal, 16S", "DE": "16S RRNA", "DS": "RNA RIBOSOMAL 16S", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "16S rRNA|T114|T123|NON|EQV|NLM (2020)|190225|abbcdef", "ENTRY": "rRNA, 16S", "MN": "D13.444.735.686.670", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Ribosomal (1971-1987)", "MS": "Constituent of 30S subunit prokaryotic ribosomes containing 1600 nucleotides and 21 proteins. 16S rRNA is involved in initiation of polypeptide synthesis.", "PM": "91; was see under RNA, RIBOSOMAL 1988-90", "HN": "91(88); was see under RNA, RIBOSOMAL 1988-90", "MR": "20190429", "DA": "19870509", "DC": "1", "DX": "19910101", "UI": "D012336"}, {"RECTYPE": "D", "MH": "RNA, Ribosomal, 18S", "DE": "18S RRNA", "DS": "RNA RIBOSOMAL 18S", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "18S Ribosomal RNA|T114|T123|EQV|UNK (19XX)|870507|RIBOSOMAL RNA 18S|abbdefs", "ENTRY": "Ribosomal RNA, 18S", "MN": "D13.444.735.686.675", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Ribosomal (1971-1987)", "MS": "Constituent of the 40S subunit of eukaryotic ribosomes. 18S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.", "PM": "91; was see under RNA, RIBOSOMAL 1988-90", "HN": "91(88); was see under RNA, RIBOSOMAL 1988-90", "MR": "20180612", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012337"}, {"RECTYPE": "D", "MH": "RNA, Ribosomal, 23S", "DE": "23S RRNA", "DS": "RNA RIBOSOMAL 23S", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "23S rRNA|T114|T123|NON|EQV|NLM (2020)|190226|abbcdef", "ENTRY": "rRNA, 23S", "MN": "D13.444.735.686.680", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Ribosomal (1971-1987)", "MS": "Constituent of 50S subunit of prokaryotic ribosomes containing about 3200 nucleotides. 23S rRNA is involved in the initiation of polypeptide synthesis.", "PM": "91; was see under RNA, RIBOSOMAL 1988-90", "HN": "91(88); was see under RNA, RIBOSOMAL 1988-90", "MR": "20190429", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012338"}, {"RECTYPE": "D", "MH": "RNA, Ribosomal, 28S", "DE": "28S RRNA", "DS": "RNA RIBOSOMAL 28S", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "28S rRNA|T114|T123|ABB|EQV|NLM (2020)|190226|abbcdef", "ENTRY": "Ribosomal RNA, 28S", "MN": "D13.444.735.686.690", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Ribosomal (1971-1987)", "MS": "Constituent of the 60S subunit of eukaryotic ribosomes. 28S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.", "PM": "91; was see under RNA, RIBOSOMAL 1988-90", "HN": "91(88); was see under RNA, RIBOSOMAL 1988-90", "MR": "20190503", "DA": "19870509", "DC": "1", "DX": "19910101", "UI": "D012339"}, {"RECTYPE": "D", "MH": "RNA, Ribosomal, 5.8S", "DS": "RNA RIBOSOMAL 06", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "5.8S Ribosomal RNA|T114|T123|EQV|UNK (19XX)|870507|RIBOSOMAL RNA 06|abbdefs", "ENTRY": "Ribosomal RNA, 5.8S", "MN": "D13.444.735.686.660", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Ribosomal (1971-1987)", "MS": "Constituent of the 60S subunit of eukaryotic ribosomes. 5.8S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.", "PM": "91; was see under RNA, RIBOSOMAL 1988-90", "HN": "91(88); was see under RNA, RIBOSOMAL 1988-90", "MR": "20180612", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012340"}, {"RECTYPE": "D", "MH": "RNA, Ribosomal, 5S", "DE": "5S RRNA", "DS": "RNA RIBOSOMAL 05S", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "5S rRNA|T114|T123|NON|EQV|NLM (2020)|190226|abbcdef", "ENTRY": "rRNA, 5S", "MN": "D13.444.735.686.650", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Ribosomal (1971-1987)", "MS": "Constituent of the 50S subunit of prokaryotic ribosomes containing about 120 nucleotides and 34 proteins. It is also a constituent of the 60S subunit of eukaryotic ribosomes. 5S rRNA is involved in initiation of polypeptide synthesis.", "PM": "91; was see under RNA, RIBOSOMAL 1988-90", "HN": "91(88); was see under RNA, RIBOSOMAL 1988-90", "MR": "20190429", "DA": "19870509", "DC": "1", "DX": "19910101", "UI": "D012341"}, {"RECTYPE": "D", "MH": "RNA, Small Nuclear", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "snRNA|T114|T123|NON|EQV|NLM (2001)|000322|abbcdef", "ENTRY": "RNA, Chromatin-Associated", "MN": "D13.444.735.790.552.937", "MH_TH": "NLM (1986)", "ST": "T123", "RN": "0", "PI": "RNA, Messenger (1966-1985)", "MS": "Short chains of RNA (100-300 nucleotides long) that are abundant in the nucleus and usually complexed with proteins in snRNPs (RIBONUCLEOPROTEINS, SMALL NUCLEAR). Many function in the processing of messenger RNA precursors. Others, the snoRNAs (RNA, SMALL NUCLEOLAR), are involved with the processing of ribosomal RNA precursors.", "PM": "86", "HN": "86", "MR": "20100625", "DA": "19850425", "DC": "1", "DX": "19860101", "UI": "D012342"}, {"RECTYPE": "D", "MH": "RNA, Transfer", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNA|T114|T123|ABB|EQV|NLM (1991)|900102|abbcdef", "ENTRY": "RNA, Suppressor Transfer", "MN": "D13.444.735.757", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "Ribonucleic acids, transfer", "RN": "9014-25-9", "AN": "general or unspecified; prefer specifics; for suppressor transfer RNA coordinate with GENES, SUPPRESSOR or SUPPRESSION, GENETIC", "MS": "The small RNA molecules, 73-80 nucleotides long, that function during translation (TRANSLATION, GENETIC) to align AMINO ACIDS at the RIBOSOMES in a sequence determined by the mRNA (RNA, MESSENGER). There are about 30 different transfer RNAs. Each recognizes a specific CODON set on the mRNA through its own ANTICODON and as aminoacyl tRNAs (RNA, TRANSFER, AMINO ACYL), each carries a specific amino acid to the ribosome to add to the elongating peptide chains.", "OL": "use RNA, TRANSFER to search RNA, SOLUBLE 1966-71", "PM": "72; was RNA, SOLUBLE 1965-71", "HN": "72; was RNA, SOLUBLE 1965-71", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012343"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Ala", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAAla|T114|T123|EQV|UNK (19XX)|870507|abbdef", "ENTRY": "tRNA, Alanine-Specific", "MN": "D13.444.735.757.700.050", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying alanine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012344"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Amino Acid-Specific", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNA-Amino Acid|T114|T123|EQV|UNK (19XX)|870505|TRNA AA|abbdefv", "ENTRY": "tRNA, Amino Acid-Specific", "MN": "D13.444.735.757.700", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics ", "PI": "RNA, Transfer (1972-1987)", "MS": "A group of transfer RNAs which are specific for carrying each one of the 20 amino acids to the ribosome in preparation for protein synthesis.", "PM": "88", "HN": "88", "MR": "19960610", "DA": "19870505", "DC": "1", "DX": "19880101", "UI": "D012345"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Amino Acyl", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNA-Amino Acyl|T114|T116|T123|EQV|UNK (19XX)|870505|abbbdef", "ENTRY": "tRNA, Amino Acyl", "MN": "D13.444.735.757.715", "MH_TH": "NLM (1978)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1977)", "MS": "Intermediates in protein biosynthesis. The compounds are formed from amino acids, ATP and transfer RNA, a reaction catalyzed by aminoacyl tRNA synthetase. They are key compounds in the genetic translation process.", "OL": "use RNA, TRANSFER, AMINO ACYL to search AMINO ACYL T RNA 1978-87", "PM": "88; was AMINO ACYL T RNA 1978-87", "HN": "88; was AMINO ACYL T RNA 1978-87", "MR": "19960610", "DA": "19770520", "DC": "1", "DX": "19780101", "UI": "D012346"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Arg", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAArg|T114|T123|EQV|UNK (19XX)|870506|abbdef", "ENTRY": "tRNA, Arginine-Specific", "MN": "D13.444.735.757.700.075", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying arginine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870506", "DC": "1", "DX": "19910101", "UI": "D012347"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Asn", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAAsn|T114|T123|EQV|UNK (19XX)|870507|abbdef", "ENTRY": "tRNA, Asparagine-Specific", "MN": "D13.444.735.757.700.085", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying asparagine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012348"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Asp", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAAsp|T114|T123|EQV|UNK (19XX)|870507|abbdef", "ENTRY": "tRNA, Aspartic Acid-Specific", "MN": "D13.444.735.757.700.090", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying aspartic acid to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012349"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Cys", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNACys|T114|T123|EQV|UNK (19XX)|870507|abbdef", "ENTRY": "tRNA, Cysteine-Specific", "MN": "D13.444.735.757.700.200", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying cysteine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012350"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Gln", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAGln|T114|T123|EQV|UNK (19XX)|870507|abbdef", "ENTRY": "tRNA, Glutamine-Specific", "MN": "D13.444.735.757.700.400", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying glutamine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012351"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Glu", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAGlu|T114|T123|EQV|UNK (19XX)|870507|abbdef", "ENTRY": "tRNA, Glutamic Acid-Specific", "MN": "D13.444.735.757.700.410", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying glutamic acid to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012352"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Gly", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAGly|T114|T123|EQV|UNK (19XX)|870507|abbdef", "ENTRY": "tRNA, Glycine-Specific", "MN": "D13.444.735.757.700.420", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "AN": "IM; /drug eff /ultrastruct permitted", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying glycine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "20190524", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012353"}, {"RECTYPE": "D", "MH": "RNA, Transfer, His", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAHis|T114|T123|EQV|UNK (19XX)|870507|abbdef", "ENTRY": "tRNA, Histidine-Specific", "MN": "D13.444.735.757.700.450", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying histidine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012354"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Ile", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAIle|T114|T123|EQV|UNK (19XX)|870507|abbdef", "ENTRY": "tRNA, Isoleucine-Specific", "MN": "D13.444.735.757.700.480", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying isoleucine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012355"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Leu", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNALeu|T114|T123|EQV|UNK (19XX)|870507|abbdef", "ENTRY": "tRNA, Leucine-Specific", "MN": "D13.444.735.757.700.500", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying leucine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012356"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Lys", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNALys|T114|T123|EQV|UNK (19XX)|870507|abbdef", "ENTRY": "tRNA, Lysine-Specific", "MN": "D13.444.735.757.700.510", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying lysine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012357"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Met", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAMet|T114|T123|EQV|UNK (19XX)|870507|abbdef", "ENTRY": "tRNAm, Methionine-Specific", "MN": "D13.444.735.757.700.525", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying methionine to sites on the ribosomes. During initiation of protein synthesis, tRNA(f)Met in prokaryotic cells and tRNA(i)Met in eukaryotic cells binds to the start codon (CODON, INITIATOR).", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "20000622", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012358"}, {"RECTYPE": "D", "MH": "tRNA Methyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNA Methyltransferase|T116|T126|NON|EQV|NLM (2021)|200317|abbcdef", "ENTRY": "RNA Methyltransferases, T", "MN": "D08.811.913.555.500.925", "MH_TH": "NLM (1974)", "ST": "T126", "RN": "EC 2.1.1.-", "MS": "Enzymes that catalyze the S-adenosyl-L-methionine-dependent methylation of ribonucleotide bases within a transfer RNA molecule. EC 2.1.1.", "PM": "98; see RNA, TRANSFER, METHYLTRANSFERASES 1974-97", "HN": "98(74)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012359"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Phe", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAPhe|T114|T123|EQV|UNK (19XX)|870514|abbdef", "ENTRY": "tRNA, Phenylalanine-Specific", "MN": "D13.444.735.757.700.650", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying phenylalanine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870514", "DC": "1", "DX": "19910101", "UI": "D012360"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Pro", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAPro|T114|T123|EQV|UNK (19XX)|870507|abbdef", "ENTRY": "tRNA, Proline-Specific", "MN": "D13.444.735.757.700.660", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying proline to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870507", "DC": "1", "DX": "19910101", "UI": "D012361"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Ser", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNASer|T114|T123|EQV|UNK (19XX)|870508|abbdef", "ENTRY": "tRNA, Serine-Specific", "MN": "D13.444.735.757.700.700", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying serine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870508", "DC": "1", "DX": "19910101", "UI": "D012362"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Thr", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAThr|T114|T123|EQV|UNK (19XX)|870508|abbdef", "ENTRY": "tRNA, Threonine-Specific", "MN": "D13.444.735.757.700.725", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying threonine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870508", "DC": "1", "DX": "19910101", "UI": "D012363"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Trp", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tryptophan-Specific tRNA|T114|T123|EQV|UNK (19XX)|870508|abbdef", "ENTRY": "tRNA, Tryptophan-Specific", "MN": "D13.444.735.757.700.740", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying tryptophan to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870508", "DC": "1", "DX": "19910101", "UI": "D012364"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Tyr", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNATyr|T114|T123|EQV|UNK (19XX)|870508|abbdef", "ENTRY": "tRNA, Tyrosine-Specific", "MN": "D13.444.735.757.700.750", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying tyrosine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870508", "DC": "1", "DX": "19910101", "UI": "D012365"}, {"RECTYPE": "D", "MH": "RNA, Transfer, Val", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tRNAVal|T114|T123|EQV|UNK (19XX)|870508|abbdef", "ENTRY": "tRNA, Valine-Specific", "MN": "D13.444.735.757.700.900", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "RNA, Transfer (1966-1987)", "MS": "A transfer RNA which is specific for carrying valine to sites on the ribosomes in preparation for protein synthesis.", "PM": "91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "HN": "91(88); was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90", "MR": "19960610", "DA": "19870508", "DC": "1", "DX": "19910101", "UI": "D012366"}, {"RECTYPE": "D", "MH": "RNA, Viral", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Viral RNA|T114|EQV|NLM (1991)|900103|abdef", "MN": "D13.444.735.828", "MH_TH": "NLM (1966)", "ST": "T114", "RN": "0", "AN": "IM; /drug eff /ultrastruct permitted; coord with specific virus (IM)", "MS": "Ribonucleic acid that makes up the genetic material of viruses.", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012367"}, {"RECTYPE": "D", "MH": "4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone", "DS": "BUTOXY 4 METHOXYBENZYL 2 IMIDAZOLIDINONE 4 3", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro 201724|T109|T121|LAB|EQV|UNK (19XX)|810608|abbcdef", "MN": "D03.383.129.308.100", "PA": "Phosphodiesterase Inhibitors", "MH_TH": "NLM (1989)", "ST": "T121", "N1": "2-Imidazolidinone, 4-((3-butoxy-4-methoxyphenyl)methyl)-", "RN": "29925-17-5", "PI": "Imidazoles (1972-1974)", "MS": "Inhibitor of phosphodiesterases.", "PM": "2005; see RO 21 1724 1991-2004;see IMIDAZOLES 1975-1990", "HN": "2005(1975)", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012368"}, {"RECTYPE": "D", "MH": "2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-", "DS": "BENZOQUINOLIZIN A OL ETHYL HEXAHYDRO ISOBUTYL DIMETHOXY 02H 02 02 01 03 04 06 07 11 03 09 10", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro4-1284|T109|T121|LAB|NRW|UNK (19XX)|741111|abbcdef", "MN": "D03.633.100.834.700", "MH_TH": "NLM (2005)", "ST": "T121", "N1": "2H-Benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-", "RN": "303-75-3", "PI": "Quinolizines (1970)", "MS": "Proposed catecholamine depletor.", "PM": "2005; see RO 4-1284 1991-2004; see QUINOLIZINES 1988-1990; see QUINOLIZINES 1975-1987", "HN": "2005(1988)", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012369"}, {"RECTYPE": "D", "MH": "Robenidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Robenzidine|T109|T121|NON|NRW|UNK (19XX)|800401|abbcdef", "ENTRY": "Hydrochloride, Robenidine", "MN": "D02.078.370.810", "PA": "Coccidiostats", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Carbonimidic dihydrazide, bis((4-chlorophenyl)methylene)-", "RN": "4888ME6C4E", "RR": "8STT15Y392", "PI": "Guanidines (1971-1974)", "MS": "An anticoccidial agent mainly for poultry.", "PM": "91; was see under GUANIDINES 1975-90", "HN": "91(75); was see under GUANIDINES 1975-90", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012370"}, {"RECTYPE": "D", "MH": "Robotics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Telerobotics|T090|NON|NRW|NLM (1997)|960305|abcdef", "ENTRY": "Soft Robotic", "MN": "L01.224.050.375.630", "FX": "Robotic Surgical Procedures", "MH_TH": "NLM (1987)", "ST": "T090", "PI": "Bionics (1966-1986)", "MS": "The application of electronic, computerized control systems to mechanical devices designed to perform human functions. Formerly restricted to industry, but nowadays applied to artificial organs controlled by bionic (bioelectronic) devices, like automated insulin pumps and other prostheses.", "OL": "search AUTOMATION 1966-86", "PM": "87; was see AUTOMATION 1963-86", "HN": "87; was see AUTOMATION 1963-86", "MR": "20230226", "DA": "19860408", "DC": "1", "DX": "19870101", "UI": "D012371"}, {"RECTYPE": "D", "MH": "ROC Curve", "PRINT ENTRY": "Receiver Operating Characteristic|T081|NON|BRD|UNK (19XX)|870406|abcdef", "ENTRY": "Receiver Operating Characteristics", "MN": "N06.850.520.445.800.750", "MH_TH": "NLM (1988)", "ST": "T081", "MS": "A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19870406", "DC": "1", "DX": "19880101", "UI": "D012372"}, {"RECTYPE": "D", "MH": "Rocky Mountain Spotted Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Typhus, Sao Paulo|T047|EPO|EQV|NLM (1992)|910228|abcdef", "ENTRY": "Spotted Fever, Brazilian", "MN": "C01.920.930.887.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by Rickettsia rickettsii; for X ref, in titles & translations use diacrit: S\u00e3o Paulo", "MS": "An acute febrile illness caused by RICKETTSIA RICKETTSII. It is transmitted to humans by bites of infected ticks and occurs only in North and South America. Characteristics include a sudden onset with headache and chills and fever lasting about two to three weeks. A cutaneous rash commonly appears on the extremities and trunk about the fourth day of illness.", "HN": "SAO PAULO TYPHUS was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-76", "CATSH": "CAT LIST", "MR": "20190613", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012373"}, {"RECTYPE": "D", "MH": "Rod Cell Outer Segment", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Rod Outer Segment|T026|NON|EQV|NLM (2009)|071115|abcdef", "ENTRY": "Outer Segments, Rod", "MN": "A11.671.650.915.937.670.650.650", "MH_TH": "NLM (2009)", "ST": "T026", "PI": "Rods and Cones (1966-1980)", "MS": "The portion of a retinal rod cell situated between the ROD INNER SEGMENT and the RETINAL PIGMENT EPITHELIUM. It contains a stack of photosensitive disk membranes laden with RHODOPSIN.", "PM": "2009; see ROD OUTER SEGMENTS 1991-2008, see RODS AND CONES 1981-1990", "HN": "2009(1981)", "MR": "20080708", "DA": "19800409", "DC": "1", "DX": "19910101", "UI": "D012374"}, {"RECTYPE": "D", "MH": "Rodent Control", "AQ": "EC ES HI IS LJ MT OG SN ST TD", "ENTRY": "Control, Rodent", "MN": "N06.850.780.200.650.700", "FX": "Rodenticides", "MH_TH": "NLM (1966)", "ST": "T068", "AN": "coord IM with specific rodent (IM)", "MS": "The reduction or regulation of the population of noxious, destructive, or dangerous rodents through chemical, biological, or other means.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012375"}, {"RECTYPE": "D", "MH": "Rodent Diseases", "DE": "RODENT DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Rodent Disease", "MN": "C22.795", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "IM GEN or unspecified; coord IM with specific dis /vet (IM) or specific rodent dis (IM); coord IM with specific rodent (IM); don't forget also RODENTIA (NIM) & check tag ANIMALS", "MS": "Diseases of rodents of the order RODENTIA. This term includes diseases of Sciuridae (squirrels), Geomyidae (gophers), Heteromyidae (pouched mice), Castoridae (beavers), Cricetidae (rats and mice), Muridae (Old World rats and mice), Erethizontidae (porcupines), and Caviidae (guinea pigs).", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012376"}, {"RECTYPE": "D", "MH": "Rodentia", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Jerboas|T015|NON|NRW|NLM (1998)|961011|abcdef", "ENTRY": "Rodentias", "MN": "B01.050.150.900.649.313.992", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid9989", "RR": "txid30648", "MS": "A mammalian order which consists of 29 families and many genera.", "PM": "1982; see RODENTS 1963-1981", "HN": "1982; use RODENTS 1963-1981", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19820101", "UI": "D012377"}, {"RECTYPE": "D", "MH": "Rodenticides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rodenticide|T131|NON|EQV|NLM (2021)|191118|abcdef", "MN": "D27.888.723.853", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "specify rodent if pertinent but not with /drug eff", "MS": "Substances used to destroy or inhibit the action of rats, mice, or other rodents.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012378"}, {"RECTYPE": "D", "MH": "Role", "PRINT ENTRY": "Role Concept|T078|NON|BRD|UNK (19XX)|780503|abcdef", "ENTRY": "Roles", "MN": "F01.829.316.616", "MH_TH": "NLM (1969)", "ST": "T054", "AN": "general or unspecified; prefer specifics", "PI": "Psychology, Social (1966-1968)", "MS": "The expected and characteristic pattern of behavior exhibited by an individual as a member of a particular social group.", "OL": "use ROLE to search ROLE CONCEPT 1969-78; use PSYCHOLOGY, SOCIAL 1966-68", "PM": "69; ROLE CONCEPT was see under PSYCHOLOGY, SOCIAL 1966-68", "HN": "69; ROLE CONCEPT was see under ROLE 1969-78, was see under PSYCHOLOGY, SOCIAL 1966-68", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012380"}, {"RECTYPE": "D", "MH": "Role Playing", "ENTRY": "Role Playings", "MN": "F04.754.864.581.679.653", "MH_TH": "NLM (1975)", "ST": "T061", "MS": "The adopting or performing the role of another significant individual in order to gain insight into the behavior of that person.", "OL": "search PSYCHODRAMA 1968-74", "PM": "91; was see under PSYCHODRAMA 1975-90", "HN": "91(75); was see under PSYCHODRAMA 1975-90", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012381"}, {"RECTYPE": "D", "MH": "Rolitetracycline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrrolidinomethyltetracycline|T109|T121|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Sesquihydrate Rolitetracycline Mononitrate", "MN": "D04.615.562.900.720", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-", "RN": "GH9IW85221", "RR": "TG72BS085Y", "MS": "A pyrrolidinylmethyl TETRACYCLINE.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012382"}, {"RECTYPE": "D", "MH": "Romania", "AQ": "EH EP", "PRINT ENTRY": "Rumania|T083|NAM|EQV|UNK (19XX)|780614|abcdef", "ENTRY": "Roumania|T083|NAM|EQV|UNK (19XX)|780324|abcdef", "MN": "Z01.542.248.764", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in southeastern Europe, bordering the Black Sea, between Bulgaria and Ukraine. The capital is Bucharest.", "OL": "use ROMANIA to search RUMANIA 1966-78", "HN": "79; was RUMANIA 1963-78", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19790101", "UI": "D012383"}, {"RECTYPE": "D", "MH": "Rome", "AQ": "EH EP", "MN": "Z01.542.489.569", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "the city, ancient or modern Rome: do not confuse with ROMAN WORLD or HOLY ROMAN EMPIRE", "MS": "The capital city of Italy.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D012384"}, {"RECTYPE": "D", "MH": "Ronidazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ronidazol|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D03.383.129.308.658.730", "PA": "Antiprotozoal Agents", "MH_TH": "USAN (1967)", "ST": "T121", "N1": "1H-Imidazole-2-methanol, 1-methyl-5-nitro-, carbamate (ester)", "RN": "E01R4M1063", "RR": "7681-76-7 (Ronidazole)", "PI": "Nitroimidazoles (1974)", "MS": "Antiprotozoal and antimicrobial agent used mainly in veterinary practice.", "PM": "91; was see under NITROIMIDAZOLES 1975-90", "HN": "91(75); was see under NITROIMIDAZOLES 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012385"}, {"RECTYPE": "D", "MH": "Rooming-in Care", "AQ": "CL EC ES HI LJ MT OG PX SD SN ST TD", "ENTRY": "Rooming-in Cares", "MN": "N02.421.088.120.240", "MH_TH": "NLM (1979)", "ST": "T058", "AN": "care of a neonate in a crib near the mother's bed in a hosp; check the tag INFANT, NEWBORN", "MS": "Care of the newborn infant in a crib near the mother's bed, instead of in a nursery, during the hospital stay.", "PM": "91; was see under INFANT CARE 1979-90", "HN": "91(79); was see under INFANT CARE 1979-90", "MR": "20150629", "DA": "19780510", "DC": "1", "DX": "19910101", "UI": "D012386"}, {"RECTYPE": "D", "MH": "Root Canal Filling Materials", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sealants, Root Canal|T122|NON|NRW|NLM (1997)|960118|abcdef", "ENTRY": "Sealant, Root Canal", "MN": "J01.637.051.339.859", "MH_TH": "NLM (1970)", "ST": "T122", "RN": "0", "PI": "Dental Materials (1966-1969)", "MS": "Materials placed inside a root canal for the purpose of obturating or sealing it. The materials may be gutta-percha, silver cones, paste mixtures, or other substances. (Dorland, 28th ed, p631 & Boucher's Clinical Dental Terminology, 4th ed, p187)", "PM": "72", "HN": "72(70)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012387"}, {"RECTYPE": "D", "MH": "Root Canal Irrigants", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Root Canal Medicaments|T121|NON|EQV|UNK (19XX)|830422|abcdef", "ENTRY": "Medicaments, Root Canal", "MN": "J01.637.051.800", "MH_TH": "NLM (1984)", "ST": "T121", "RN": "0", "PI": "Root Canal Therapy (1966-1983)", "MS": "Chemicals used mainly to disinfect root canals after pulpectomy and before obturation. The major ones are camphorated monochlorophenol, EDTA, formocresol, hydrogen peroxide, metacresylacetate, and sodium hypochlorite. Root canal irrigants include also rinsing solutions of distilled water, sodium chloride, etc.", "PM": "84", "HN": "84", "MR": "20200527", "DA": "19830422", "DC": "1", "DX": "19840101", "UI": "D012388"}, {"RECTYPE": "D", "MH": "Root Canal Obturation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Root Canal Obturations", "MN": "E06.397.778.778", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Phase of endodontic treatment in which a root canal system that has been cleaned is filled through use of special materials and techniques in order to prevent reinfection.", "PM": "66; was DENTAL PULP OBTURATION 1965", "HN": "66; was DENTAL PULP OBTURATION 1965", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012389"}, {"RECTYPE": "D", "MH": "Root Canal Therapy", "DE": "ROOT CANAL THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapies, Root Canal", "MN": "E06.397.778", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "the corresponding specialty is ENDODONTICS; reamers & broaches: index under ROOT CANAL PREPARATION /instrum", "MS": "A treatment modality in endodontics concerned with the therapy of diseases of the dental pulp. For preparatory procedures, ROOT CANAL PREPARATION is available.", "PM": "1965; see ENDODONTICS 1963-1964", "HN": "1965; use ENDODONTICS 1963-1964", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012390"}, {"RECTYPE": "D", "MH": "Root Resorption", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Root Resorptions", "MN": "G10.549.855.653", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Resorption in which cementum or dentin is lost from the root of a tooth owing to cementoclastic or osteoclastic activity in conditions such as trauma of occlusion or neoplasms. (Dorland, 27th ed)", "PM": "72", "HN": "72(63)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012391"}, {"RECTYPE": "D", "MH": "Rorschach Test", "AQ": "HI SN ST", "ENTRY": "Test, Rorschach", "MN": "F04.711.647.622.341.736", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "A projective test used to evaluate a broad range of personality variables including pathology of thought and perception. The subject's responses to inkblot prints are scored along with subjective interpretation by the test administrator.", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012392"}, {"RECTYPE": "D", "MH": "Rosacea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Rosacea, Phymatous", "MN": "C17.800.716", "MH_TH": "NLM (1993)", "ST": "T047", "MS": "A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).", "PM": "2005, 1963-1992; see ACNE ROSACEA 1993-2004", "HN": "2005, 1963-1992", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D012393"}, {"RECTYPE": "D", "MH": "Rosaniline Dyes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Magentas|T109|NON|EQV|UNK (19XX)|800521|abcdef", "ENTRY": "Dyes, Rosaniline", "MN": "D02.092.146.755", "PA": "Coloring Agents", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Compounds that contain the triphenylmethane aniline structure found in rosaniline. Many of them have a characteristic magenta color and are used as COLORING AGENTS.", "OL": "use ROSANILINE DYES to search FUCHSIN 1966-80", "HN": "FUCHSINS was FUCHSIN see under ROSANILINE DYES 1963-80", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012394"}, {"RECTYPE": "D", "MH": "Rose Bengal", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Bengal, Rose", "MN": "D04.711.347.700", "PA": "Fluorescent Dyes", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "Rose Bengal", "RN": "1ZPG1ELY14", "RR": "31S841PMN7", "MS": "A bright bluish pink compound that has been used as a dye, biological stain, and diagnostic aid.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012395"}, {"RECTYPE": "D", "MH": "Rosette Formation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Immunocytoadherence|T059|NON|EQV|UNK (19XX)|770223|abcdef", "ENTRY": "Rosette Formations", "MN": "E05.478.594.730", "MH_TH": "NLM (1978)", "ST": "T059", "AN": "an immunol technique", "PI": "Immune Adherence Reaction (1971-1977)", "MS": "The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19770301", "DC": "1", "DX": "19780101", "UI": "D012397"}, {"RECTYPE": "D", "MH": "Ross River virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.578.875.054.813", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid11029", "AN": "infection: coord IM with ALPHAVIRUS INFECTIONS (IM)", "MS": "A species of ALPHAVIRUS associated with epidemic EXANTHEMA and polyarthritis in Australia.", "PM": "91; was see under ALPHAVIRUSES 1981-90; was see under ARBOVIRUSES 1975-80", "HN": "91(75); was see under ALPHAVIRUSES 1981-90; was see under ARBOVIRUSES 1975-80", "MR": "20230405", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012398"}, {"RECTYPE": "D", "MH": "Rotation", "AQ": "AE", "PRINT ENTRY": "Clinorotation|T068|NON|NRW|NLM (1995)|940405|abcdef", "ENTRY": "Rotations", "MN": "G01.482.703", "FX": "Torsion, Mechanical", "MH_TH": "NLM (1968)", "ST": "T169", "AN": "TORSION ABNORMALITY and TORSION, MECHANICAL are also available", "PI": "Aerospace Medicine (1966-1967)", "MS": "Motion of an object in which either one or more points on a line are fixed. It is also the motion of a particle about a fixed point. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "68", "HN": "68", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012399"}, {"RECTYPE": "D", "MH": "Rotavirus Infections", "DE": "ROTAVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Rotavirus Infection", "MN": "C01.925.782.791.814", "MH_TH": "NLM (1983)", "ST": "T047", "AN": "caused by a reovirus", "PI": "Rotaviruses (1981-1982)", "MS": "Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19820428", "DC": "1", "DX": "19830101", "UI": "D012400"}, {"RECTYPE": "D", "MH": "Rotavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Neonatal Calf Diarrhea Virus|T005|NON|NRW|UNK (19XX)|770513|abcdef", "ENTRY": "Rotaviruses", "MN": "B04.820.223.719.790", "MH_TH": "NLM (1978)", "ST": "T005", "RN": "txid10912", "PI": "Reoviridae (1966-1977)", "MS": "A genus of REOVIRIDAE, causing acute gastroenteritis in BIRDS and MAMMALS, including humans. Transmission is horizontal and by environmental contamination. Seven species (Rotaviruses A thru G) are recognized.", "OL": "use ROTAVIRUS to search ROTAVIRUSES 1978-93", "PM": "94, 78-80; was ROTAVIRUSES 1981-93 (see under REOVIRIDAE 1981-82); was see under RNA VIRUSES 1978-80", "HN": "94, 78-80; was ROTAVIRUSES 1981-93 (see under REOVIRIDAE 1981-82); was see under RNA VIRUSES 1978-80", "MR": "20200902", "DA": "19770513", "DC": "1", "DX": "19830101", "UI": "D012401"}, {"RECTYPE": "D", "MH": "Rotenone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.400.825", "PA": "Uncoupling Agents", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "(1)Benzopyrano(3,4-b)furo(2,3-h)(1)benzopyran-6(6aH)-one, 1,2,12,12a-tetrahydro-8,9-dimethoxy-2-(1-methylethenyl)-, (2R-(2alpha,6aalpha,12aalpha))-", "RN": "03L9OT429T", "RR": "83-79-4 (Rotenone)", "MS": "A botanical insecticide that is an inhibitor of mitochondrial electron transport.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012402"}, {"RECTYPE": "D", "MH": "Rotifera", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Rotiferas", "MN": "B01.050.500.500.770", "MH_TH": "NLM (1977)", "ST": "T204", "RN": "txid10190", "AN": "an aschelminth", "PI": "Invertebrates (1966-1974)", "MS": "A class of minute animals of the phylum Aschelminthes.", "PM": "77", "HN": "77", "MR": "20200813", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D012403"}, {"RECTYPE": "D", "MH": "Round Ligament of Uterus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Uterus Round Ligaments", "MN": "A10.165.669.901.875", "MH_TH": "NLM (2016)", "ST": "T023", "MS": "A fibromuscular band that attaches to the UTERUS and then passes along the BROAD LIGAMENT, out through the INGUINAL RING, and into the labium majus.", "PM": "2016; see ADNEXA UTERI 1975-199, see ROUND LIGAMENT 1991-2015", "HN": "2016 (1975)", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012404"}, {"RECTYPE": "D", "MH": "Round Window, Ear", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Round Windows, Ear", "MN": "A09.246.300.246.814", "MH_TH": "NLM (2008)", "ST": "T030", "AN": "do not confuse with OVAL WINDOW, EAR in the VESTIBULE of INNER EAR", "PI": "Cochlea (1966-1978)", "MS": "Fenestra of the cochlea, an opening in the basal wall between the MIDDLE EAR and the INNER EAR, leading to the cochlea. It is closed by a secondary tympanic membrane.", "PM": "2008; see ROUND WINDOW 1991-2007, see COCHLEA 1979-1990", "HN": "2008 (1979)", "MR": "20180702", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D012405"}, {"RECTYPE": "D", "MH": "Roxarsone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, 3-Nitro-4-Hydroxyphenylarsonic", "MN": "D02.129.700", "PA": "Coccidiostats", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Arsonic acid, (4-hydroxy-3-nitrophenyl)-", "RN": "H5GU9YQL7L", "RR": "121-19-7 (Roxarsone)", "PI": "Nitrophenols (1972-1974)", "MS": "An arsenic derivative which has anticoccidial action and promotes growth in animals.", "PM": "91; was see under ARSENICALS 1975-90", "HN": "91(75); was see under ARSENICALS 1975-90", "MR": "20190701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012406"}, {"RECTYPE": "D", "MH": "rRNA Operon", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Operon, rRNA|T028|EQV|UNK (19XX)|870509|abdef", "ENTRY": "rrnB Operons", "MN": "G05.360.340.358.207.500.817", "FX": "Genes, rRNA", "MH_TH": "NLM (1988)", "ST": "T028", "PI": "RNA, Ribosomal (1977-1987)", "MS": "Genetic loci which direct transcription of ribosomal RNA in bacterial operons. They are designated rrnB, rrnC, rrnD, etc. according to the structural position of the transcription unit in the DNA sequence.", "PM": "91; was see under OPERON 1988-90", "HN": "91(88); was see under OPERON 1988-90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19870509", "DC": "1", "DX": "19910101", "UI": "D012407"}, {"RECTYPE": "D", "MH": "Rubber", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Latex Rubber|T073|T109|NON|EQV|UNK (19XX)|800515|abbcdef", "ENTRY": "Rubbers, Plant", "MN": "J01.637.412.767", "FX": "Latex Hypersensitivity", "MH_TH": "NLM (1966)", "ST": "T109", "N1": "Rubber, natural", "RN": "9006-04-6", "MS": "A high-molecular-weight polymeric elastomer derived from the milk juice (LATEX) of HEVEA brasiliensis and other trees and plants. It is a substance that can be stretched at room temperature to at least twice its original length and after releasing the stress, retract rapidly, and recover its original dimensions fully.", "OL": "use RUBBER to search LATEX RUBBER 1968-80", "HN": "LATEX RUBBER was see under RUBBER 1968-80", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012408"}, {"RECTYPE": "D", "MH": "Rubella", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Measles, German|T047|EPO|EQV|ORD (2010)|UNK (19XX)|740330|abcdeef", "ENTRY": "Three Day Measle", "MN": "C01.925.782.930.700.700", "MH_TH": "POPLINE (1994)", "ST": "T047", "MS": "An acute infectious disease caused by the RUBELLA VIRUS. The virus enters the respiratory tract via airborne droplet and spreads to the LYMPHATIC SYSTEM.", "CATSH": "CAT LIST", "MR": "20190529", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012409"}, {"RECTYPE": "D", "MH": "Rubella Syndrome, Congenital", "DE": "RUBELLA SYNDROME CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Syndromes, Congenital Rubella", "MN": "C16.131.077.790", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "caused by a rubivirus; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; restrict to syndrome: see MeSH definition; otherwise RUBELLA /congen permitted", "PI": "Syndrome (1972-1986)", "MS": "Transplacental infection of the fetus with rubella usually in the first trimester of pregnancy, as a consequence of maternal infection, resulting in various developmental abnormalities in the newborn infant. They include cardiac and ocular lesions, deafness, microcephaly, mental retardation, and generalized growth retardation. (From Dorland, 27th ed)", "PM": "91; was see under RUBELLA 1987-90", "HN": "91(87); was see under RUBELLA 1987-90", "CATSH": "CAT LIST", "MR": "20190529", "DA": "19860617", "DC": "1", "DX": "19910101", "UI": "D012410"}, {"RECTYPE": "D", "MH": "Rubella Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccine, Rubella", "MN": "D20.215.894.899.779", "MH_TH": "NLM (1969)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1966-1968)", "MS": "A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunized and do not have serum antibodies to rubella. Children are usually immunized with measles-mumps-rubella combination vaccine. (Dorland, 28th ed)", "PM": "73", "HN": "73(69)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012411"}, {"RECTYPE": "D", "MH": "Rubella virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Measles Virus, German|T005|EPO|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "German Measles Virus", "MN": "B04.820.578.875.700.700", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid11041", "MS": "The type (and only) species of RUBIVIRUS causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis.", "PM": "66", "HN": "66", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012412"}, {"RECTYPE": "D", "MH": "Rubidium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.800", "FX": "Rubidium Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Rubidium", "RN": "MLT4718TJW", "RR": "7440-17-7 (Rubidium)", "MS": "An element that is an alkali metal. It has an atomic symbol Rb, atomic number 37, and atomic weight 85.47. It is used as a chemical reagent and in the manufacture of photoelectric cells.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012413"}, {"RECTYPE": "D", "MH": "Rubidium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Rubidium", "MN": "D01.496.749.740", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Rubidium (1966-1987)", "MS": "Unstable isotopes of rubidium that decay or disintegrate emitting radiation. Rb atoms with atomic weights 79-84, and 86-95 are radioactive rubidium isotopes.", "PM": "88", "HN": "88", "MR": "20170705", "DA": "19870408", "DC": "1", "DX": "19880101", "UI": "D012414"}, {"RECTYPE": "D", "MH": "Rubinstein-Taybi Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Broad Thumb-Hallux Syndrome|T019|NON|EQV|GHR (2014)|NLM (2000)|OMIM (2013)|ORD (2010)|991103|abcdeeeef", "ENTRY": "Syndromes, Broad Thumb-Hallux", "MN": "C16.320.180.790", "FX": "Intellectual Disability", "MH_TH": "ORD (2010)", "ST": "T019", "PI": "Mental Retardation (1966-1971)", "MS": "A chromosomal disorder characterized by MENTAL RETARDATION, broad thumbs, webbing of fingers and toes, beaked nose, short upper lip, pouting lower lip, agenesis of corpus callosum, large foramen magnum, keloid formation, pulmonary stenosis, vertebral anomalies, chest wall anomalies, sleep apnea, and megacolon. The disease has an autosomal dominant pattern of inheritance and is associated with deletions of the short arm of chromosome 16 (16p13.3).", "PM": "91; was see under ABNORMALITIES, MULTIPLE 1972-90", "HN": "91(72); was see under ABNORMALITIES, MULTIPLE 1972-90", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012415"}, {"RECTYPE": "D", "MH": "Rubredoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Rubredoxin|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "MN": "D12.776.556.579.374.375.275.725", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "a ferredoxin", "MS": "A class of iron-sulfur proteins that contains one iron coordinated to the sulfur atom of four cysteine residues. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "PM": "91; was see under FERREDOXINS 1973-90", "HN": "91(73); was see under FERREDOXINS 1973-90", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012416"}, {"RECTYPE": "D", "MH": "Rumen", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Rumens", "MN": "A13.869.804", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "a ruminant's 1st stomach; dis: coord IM with STOMACH DISEASES /vet (IM); neopl: coord IM with STOMACH NEOPLASMS /vet (IM) + histol type /vet (IM); ulcer: coord IM with STOMACH ULCER /vet (IM)", "MS": "The first stomach of ruminants. It lies on the left side of the body, occupying the whole of the left side of the abdomen and even stretching across the median plane of the body to the right side. It is capacious, divided into an upper and a lower sac, each of which has a blind sac at its posterior extremity. The rumen is lined by mucous membrane containing no digestive glands, but mucus-secreting glands are present in large numbers. Coarse, partially chewed food is stored and churned in the rumen until the animal finds circumstances convenient for rumination. When this occurs, little balls of food are regurgitated through the esophagus into the mouth, and are subjected to a second more thorough mastication, swallowed, and passed on into other parts of the compound stomach. (From Black's Veterinary Dictionary, 17th ed)", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012417"}, {"RECTYPE": "D", "MH": "Ruminants", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Ruminantia|T015|NON|EQV|UNK (19XX)|860418|abcdef", "ENTRY": "Ruminant", "MN": "B01.050.150.900.649.313.500.380", "MH_TH": "NLM (1987)", "ST": "T015", "RN": "txid9845", "RR": "txid34873", "AN": "general or unspecified; prefer specifics", "PI": "Artiodactyla (1966-1986)", "MS": "A suborder of the order ARTIODACTYLA whose members have the distinguishing feature of a four-chambered stomach, including the capacious RUMEN. Horns or antlers are usually present, at least in males.", "PM": "87", "HN": "87", "MR": "20200813", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D012418"}, {"RECTYPE": "D", "MH": "Runaway Behavior", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Behavior, Runaway", "MN": "I01.880.735.779", "MH_TH": "NLM (1969)", "ST": "T055", "PI": "Child Behavior Disorders (1966-1968)", "MS": "A behavioral response manifested by leaving home in order to escape from threatening situations. Children or adolescents leaving home without permission is usually implied.", "PM": "98; use RUNAWAY REACTION 1969-97", "HN": "98; see RUNAWAY REACTION 1969-97", "CATSH": "CAT LIST", "MR": "19980611", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012419"}, {"RECTYPE": "D", "MH": "Running", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Runnings", "MN": "I03.450.642.845.610", "MH_TH": "NLM (1976)", "ST": "T056", "AN": "human & animal; / inj: coordinate IM with specific injury (IM); JOGGING and TRACK AND FIELD are also available; animals running in exercise wheel is probably MOTOR ACTIVITY or PHYSICAL EXERTION", "PI": "Sports (1966-1975)", "MS": "An activity in which the body is propelled by moving the legs rapidly. Running is performed at a moderate to rapid pace and should be differentiated from JOGGING, which is performed at a much slower pace.", "PM": "76", "HN": "76", "MR": "20160701", "DA": "19750721", "DC": "1", "DX": "19760101", "UI": "D012420"}, {"RECTYPE": "D", "MH": "Rupture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ruptures", "MN": "C26.761", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "traumatic only: differentiate from RUPTURE, SPONTANEOUS; coordinate with organ /inj or precoordinated injury term", "MS": "Forcible or traumatic tear or break of an organ or other soft part of the body.", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "20160505", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012421"}, {"RECTYPE": "D", "MH": "Rupture, Spontaneous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spontaneous Ruptures", "MN": "C23.300.909", "MH_TH": "NLM (1965)", "ST": "T046", "AN": "includes spontan rupt unexplained or as a result of dis: differentiate from RUPTURE, traumatic only; never IM: coord NIM with organ/diseases term (IM)", "MS": "Tear or break of an organ, vessel or other soft part of the body, occurring in the absence of external force.", "PM": "68", "HN": "68(65)", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012422"}, {"RECTYPE": "D", "MH": "Rural Health", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "ENTRY": "Health, Rural", "MN": "N01.400.548.750", "FX": "Agricultural Workers' Diseases", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "specify geog", "MS": "The status of health in rural populations.", "MR": "20180623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012423"}, {"RECTYPE": "D", "MH": "Rural Population", "AQ": "CL HI SN TD", "PRINT ENTRY": "Rural Residence|T073|NON|REL|NLM (2023)|211027|abcdef", "ENTRY": "Rural Spatial Distributions", "MN": "N01.600.725", "MH_TH": "POPLINE (1978)", "ST": "T098", "AN": "specify geog; RURAL HEALTH & RURAL HEALTH SERVICES are also available", "MS": "The inhabitants of rural areas or of small towns classified as rural.", "PM": "68", "HN": "68(65)", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012424"}, {"RECTYPE": "D", "MH": "Russia (Pre-1917)", "AQ": "EH EP", "ENTRY": "Russia (Pre 1917)|T083|NAM|EQV|UNK (19XX)|780203|abcdef", "MN": "Z01.586.800", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "MOSCOW is also available", "MS": "A monarchy located in north Asia bordering the Arctic Ocean, extending from Europe (the portion west of the Urals) to the North Pacific Ocean. St Petersburg was the capital 1712\u20131918. Moscow was the capital before St. Petersburg and following it.", "OL": "use RUSSIA (PRE-1917) to search RUSSIA 1966; search RUSSIAN FEDERATION under RUSSIA & SIBERIA 1966", "HN": "67; RUSSIAN FEDERATION was heading 1966; RUSSIA was heading 1963-66", "MR": "20161222", "DA": "19990101", "DC": "4", "DX": "19670101", "UI": "D012425"}, {"RECTYPE": "D", "MH": "Russia", "AQ": "EH EP", "PRINT ENTRY": "Russian S.F.S.R.|T083|NAM|EQV|NLM (1993)|920422|abcdef", "ENTRY": "Russian SFSR|T083|NAM|EQV|UNK (19XX)|810302|RSFSR|abcdefv", "MN": "Z01.542.248.775", "MH_TH": "NLM (1981)", "ST": "T083", "AN": "MOSCOW is also available; consider also RUSSIA (PRE-1917); in historical articles when part of the former Soviet Union, it may be called Russian S.F.S.R. or RSFSR (see other names in history note)", "MS": "A country located in north Asia bordering the Arctic Ocean, extending from Europe (the portion west of the Urals) to the North Pacific Ocean. The capital is Moscow.", "OL": "use RUSSIA to search RUSSIAN S.F.S.R. 1982-92 & RUSSIAN FEDERATION (EUROPE) 1967-81; use RUSSIA & SIBERIA to search RUSSIAN FEDERATION 1966; search RUSSIA under RUSSIA (PRE-1917) 1966", "HN": "93; was RUSSIAN S.F.S.R. 1982-92, was RUSSIAN FEDERATION (EUROPE) 1967-81, was RUSSIAN FEDERATION 1966; RUSSIA was heading 1963-66", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "19930101", "UI": "D012426"}, {"RECTYPE": "D", "MH": "Rutamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oligomycin D|T109|T195|NON|EQV|FDA SRS (2014)|UNK (19XX)|770304|abbcdeef", "ENTRY": "RR32705", "MN": "D02.540.505.620.750", "PA": "Uncoupling Agents", "MH_TH": "USAN (1963)", "ST": "T195", "N1": "Oligomycin A, 26-demethyl-", "RN": "4736R46V0G", "RR": "1404-59-7 (Rutamycin)", "PI": "Antibiotics, Antifungal (1969-1974)", "MS": "A macrolide antibiotic of the oligomycin group, obtained from Streptomyces rutgersensis. It is used in cytochemistry as a tool to inhibit various ATPases and to uncouple oxidative phosphorylation from electron transport and also clinically as an antifungal agent.", "PM": "91; was see under OLIGOMYCINS 1982-90; was see under ANTIBIOTICS, ANTIFUNGAL 1975-81", "HN": "91(75); was see under OLIGOMYCINS 1982-90; was see under ANTIBIOTICS, ANTIFUNGAL 1975-81", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012427"}, {"RECTYPE": "D", "MH": "Ruthenium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.805", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Ruthenium", "RN": "7UI0TKC3U5", "RR": "7440-18-8 (Ruthenium)", "MS": "A hard, brittle, grayish-white rare earth metal with an atomic symbol Ru, atomic number 44, and atomic weight 101.07. It is used as a catalyst and hardener for PLATINUM and PALLADIUM.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012428"}, {"RECTYPE": "D", "MH": "Ruthenium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Ruthenium", "MN": "D01.496.749.745", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Ruthenium (1966-1987)", "MS": "Unstable isotopes of ruthenium that decay or disintegrate emitting radiation. Ru atoms with atomic weights 93-95, 97, 103, and 105-108 are radioactive ruthenium isotopes.", "PM": "88", "HN": "88", "MR": "20170705", "DA": "19870408", "DC": "1", "DX": "19880101", "UI": "D012429"}, {"RECTYPE": "D", "MH": "Ruthenium Red", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ammoniated Ruthenium Oxychloride|T130|T197|NON|EQV|NLM (1999)|980219|abbcdef", "ENTRY": "Ruthenium Oxychloride, Ammoniated", "MN": "D01.765.765", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T197", "N1": "Ruthenium red", "RN": "11103-72-3", "PI": "Ruthenium (1972-1974)", "MS": "An inorganic dye used in microscopy for differential staining and as a diagnostic reagent. In research this compound is used to study changes in cytoplasmic concentrations of calcium. Ruthenium red inhibits calcium transport through membrane channels.", "PM": "91; was see under RUTHENIUM 1975-90", "HN": "91(75); was see under RUTHENIUM 1975-90", "MR": "20050706", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012430"}, {"RECTYPE": "D", "MH": "Rutin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Quercetin, 3-Rhamnosyl-Glucosyl", "MN": "D03.633.100.150.266.450.284.888", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "4H-1-Benzopyran-4-one, 3-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-", "RN": "5G06TVY3R7", "RR": "153-18-4 (Rutin)", "MS": "A flavonol glycoside found in many plants, including BUCKWHEAT; TOBACCO; FORSYTHIA; HYDRANGEA; VIOLA, etc. It has been used therapeutically to decrease capillary fragility.", "PM": "2007; RUTINOSIDE was indexed under RUTIN 1988-2006", "HN": "2007(1963); for RUTINOSIDE use RUTIN SULFATE (NM) 1988-2006", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D012431"}, {"RECTYPE": "D", "MH": "Rwanda", "AQ": "EH EP", "PRINT ENTRY": "Ruanda|T083|NAM|EQV|NLM (1998)|960816|abcdef", "ENTRY": "Republic of Rwanda|T083|NON|EQV|NLM (2009)|080325|abcdef", "MN": "Z01.058.290.100.535", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in eastern Africa, south of UGANDA, east of DEMOCRATIC REPUBLIC OF THE CONGO, west of TANZANIA. Its capital is Kigali. It was formerly part of the Belgian trust territory of Ruanda-Urund.", "MR": "20230226", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D012432"}, {"RECTYPE": "D", "MH": "Ryanodine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.578.805", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Ryanodol, 3-(1H-pyrrole-2-carboxylate)", "RN": "15662-33-6", "PI": "Alkaloids (1970-1974)", "MS": "A methylpyrrole-carboxylate from RYANIA that disrupts the RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL to modify CALCIUM release from SARCOPLASMIC RETICULUM resulting in alteration of MUSCLE CONTRACTION. It was previously used in INSECTICIDES. It is used experimentally in conjunction with THAPSIGARGIN and other inhibitors of CALCIUM ATPASE uptake of calcium into SARCOPLASMIC RETICULUM.", "PM": "91; was see under ALKALOIDS 1975-90", "HN": "91(75); was see under ALKALOIDS 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012433"}, {"RECTYPE": "D", "MH": "Secale", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Secale cereale|T002|T168|NON|NRW|NLM (2003)|011011|abbcdef", "ENTRY": "Ryes", "MN": "B01.875.800.575.912.250.822.857", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid4549", "RR": "txid4550", "MS": "Genus in the grass family (Poaceae) including well known species Secale cereale (rye).", "PM": "2016; see SECALE CEREALE 2003-1015, see RYE 1991-2002, see CEREALS 1985-1990, see GRAIN 1963-1984", "HN": "2016 (1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012434"}, {"RECTYPE": "D", "MH": "S-Adenosylhomocysteine", "DS": "ADENOSYLHOMOCYSTEINE S", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Adenosylhomocysteine, S", "MN": "D13.570.800.096.262", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "L-Homocysteine, S-(5'-deoxyadenosin-5'-yl)-", "RN": "979-92-0", "PI": "Homocysteine (1972-1974)", "MS": "5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.", "PM": "91; was see under HOMOCYSTEINE 1975-90", "HN": "91(75); was see under HOMOCYSTEINE 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012435"}, {"RECTYPE": "D", "MH": "S-Adenosylmethionine", "DS": "ADENOSYLMETHIONINE A S", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "AdoMet|T116|T123|ABB|EQV|FDA SRS (2014)|NLM (1997)|951121|abbcdeef", "ENTRY": "S Adenosylmethionine Sulfate Tosylate", "MN": "D13.570.800.096.264", "MH_TH": "NLM (1971)", "ST": "T123", "N1": "Adenosine, 5'-((3-amino-3-carboxypropyl)methylsulfonio)-5'-deoxy-, inner salt, (3S)-", "RN": "7LP2MPO46S", "RR": "564ROC9U09", "PI": "Methionine (1966-1970)", "MS": "Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed)", "PM": "73", "HN": "73(71)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012436"}, {"RECTYPE": "D", "MH": "Adenosylmethionine Decarboxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "S-Adenosylmethionine Decarboxylase|T116|T126|NON|EQV|NLM (1998)|961115|ADENOSYLMETHIONINE DECARBOXYLASE S|abbcdefs", "ENTRY": "S Adenosylmethionine Decarboxylase", "MN": "D08.811.520.224.125.050", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "S-Adenosyl-L-methionine carboxy-lyase", "RN": "EC 4.1.1.50", "RR": "9036-20-8 (CAS RN)", "PI": "S-Adenosylmethionine (1972-1974)", "MS": "An enzyme that catalyzes the decarboxylation of S-adenosyl-L-methionine to yield 5'-deoxy-(5'-),3-aminopropyl-(1), methylsulfonium salt. It is one of the enzymes responsible for the synthesis of spermidine from putrescine. EC 4.1.1.50.", "PM": "98; see S-ADENOSYLMETHIONINE DECARBOXYLASE 1991-97, see CARBOXY-LYASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012437"}, {"RECTYPE": "D", "MH": "Saccades", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Saccadic Eye Movements|T042|T184|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Saccadic Pursuits", "MN": "G14.350.500", "MH_TH": "NLM (1975)", "ST": "T184", "MS": "An abrupt voluntary shift in ocular fixation from one point to another, as occurs in reading.", "PM": "91; was see under EYE MOVEMENTS 1975-90", "HN": "91(75); was see under EYE MOVEMENTS 1975-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D012438"}, {"RECTYPE": "D", "MH": "Saccharin", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Calcium, Saccharin", "MN": "D03.633.100.185.708", "PA": "Sweetening Agents", "MH_TH": "NLM (1970)", "ST": "T121", "N1": "1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide", "RN": "FST467XS7D", "RR": "SB8ZUX40TY", "PI": "Sweetening Agents (1966-1969)", "MS": "Flavoring agent and non-nutritive sweetener.", "OL": "search SWEETENING AGENTS 1966-69", "PM": "71; was see under SWEETENING AGENTS 1963-70", "HN": "71(70); was see under SWEETENING AGENTS 1963-70", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D012439"}, {"RECTYPE": "D", "MH": "Saccharomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Saccharomyce", "MN": "B01.300.930.705", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid4930", "AN": "there are many species but check Dorland for those wrongly called Saccharomyces", "MS": "A genus of ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES.", "PM": "64; was see under YEASTS 1963", "HN": "64; was see under YEASTS 1963", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D012440"}, {"RECTYPE": "D", "MH": "Saccharomyces cerevisiae", "DE": "SACCH CEREV", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Yeast, Brewer's|T004|NON|EQV|NLM (1993)|911209|abcdef", "ENTRY": "Yeast, Baker", "MN": "B01.300.930.705.655", "FX": "Yeast, Dried", "MH_TH": "NLM (1972)", "ST": "T004", "RN": "txid4932", "AN": "use YEAST, DRIED for brewer's yeast or baker's yeast used as a nutritional supplement or therapeutically", "PI": "Saccharomyces (1966-1971)", "MS": "A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" yeast. The dried form is used as a dietary supplement.", "PM": "73", "HN": "73(72)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012441"}, {"RECTYPE": "D", "MH": "Saccharomycopsis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Saccharomycopses", "MN": "B01.300.930.710", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid4943", "MS": "Yeast-like ascomycetous fungi of the family Saccharomycopsidaceae, order SACCHAROMYCETALES, isolated from the stomach of rabbits and some other animals.", "PM": "91; see ENDOMYCETALES 1986-90, see ASCOMYCETES 1975-85", "HN": "91(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012442"}, {"RECTYPE": "D", "MH": "Saccharopine Dehydrogenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Saccharopine Dehydrogenase|T116|T126|NON|EQV|NLM (2022)|201006|abbcdef", "ENTRY": "Reductase, Lysine-Ketoglutarate", "MN": "D08.811.682.662.750", "FX": "Hyperlysinemias", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.5.1.-", "RR": "EC 1.5.1.9", "AN": "/defic: consider also HYPERLYSINEMIAS", "PI": "Oxidoreductases (1970-1974)", "MS": "Amine oxidoreductases that use either NAD+ (EC 1.5.1.7) or NADP+ (EC 1.5.1.8) as an acceptor to form L-LYSINE or NAD+ (EC 1.5.1.9) or NADP+ (EC 1.5.1.10) as an acceptor to form L-GLUTAMATE. Deficiency of this enzyme causes HYPERLYSINEMIAS.", "PM": "91; was see under AMINE OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under AMINE OXIDOREDUCTASES 1975-90", "MR": "20210630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012443"}, {"RECTYPE": "D", "MH": "Saccule and Utricle", "DE": "SACCULE UTRICLE", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Utricle|T023|NON|NRW|UNK (19XX)|820423|abcdef", "ENTRY": "Utricles", "MN": "A09.923.500.625", "MH_TH": "NLM (1983)", "ST": "T023", "PI": "Utricle (1975-1982)", "MS": "Two membranous sacs within the vestibular labyrinth of the INNER EAR. The saccule communicates with COCHLEAR DUCT through the ductus reuniens, and communicates with utricle through the utriculosaccular duct from which the ENDOLYMPHATIC DUCT arises. The utricle and saccule have sensory areas (acoustic maculae) which are innervated by the VESTIBULAR NERVE.", "OL": "to search SACCULE & UTRICLE use SACCULE AND UTRICLE 1975-82; LABYRINTH 1966-74", "PM": "83; SACCULE & UTRICLE were see under LABYRINTH 1966-82; MACULAE, ACOUSTIC was see under LABYRINTH 1979-82", "HN": "83; SACCULE & UTRICLE were see under LABYRINTH 1966-82", "MR": "20210630", "DA": "19820422", "DC": "1", "DX": "19830101", "UI": "D012444"}, {"RECTYPE": "D", "MH": "Sacrococcygeal Region", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "Sacral Region|T029|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Sacrococcygeal Regions", "MN": "A01.923.176.780", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "NIM when merely locational", "MS": "The body region between (and flanking) the SACRUM and COCCYX.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012445"}, {"RECTYPE": "D", "MH": "Sacroiliac Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Sacroiliac Joints", "MN": "A02.835.583.707", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "The immovable joint formed by the lateral surfaces of the SACRUM and ILIUM.", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012446"}, {"RECTYPE": "D", "MH": "Sacrum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sacral Vertebrae|T023|NON|REL|NLM (2021)|200114|abcdef", "ENTRY": "Vertebrae, Sacral", "MN": "A02.835.232.834.717", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "do not confuse with LUMBOSACRAL REGION or SACROCOCCYGEAL REGION", "MS": "Five fused VERTEBRAE forming a triangle-shaped structure at the back of the PELVIS. It articulates superiorly with the LUMBAR VERTEBRAE, inferiorly with the COCCYX, and anteriorly with the ILIUM of the PELVIS. The sacrum strengthens and stabilizes the PELVIS.", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012447"}, {"RECTYPE": "D", "MH": "Sadism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Sexual Sadism|T048|NON|NRW|NLM (1998)|970319|abcdef", "ENTRY": "Sexual Sadisms", "MN": "F03.657.700", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "A condition in which there is a derivation of pleasure from inflicting pain, discomfort or humiliation on another person or persons. The sexual significance of sadistic wishes or behavior may be conscious or unconscious.", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012448"}, {"RECTYPE": "D", "MH": "Safety", "AQ": "EC HI LJ SN ST", "ENTRY": "Safeties", "MN": "N06.850.135.060.075", "MH_TH": "POPLINE (1994)", "ST": "T068", "MS": "Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property.", "OL": "search ACCIDENT PREVENTION 1966-74", "PM": "91; was see under ACCIDENT PREVENTION 1975-90", "HN": "91(75); was see under ACCIDENT PREVENTION 1975-90", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012449"}, {"RECTYPE": "D", "MH": "Safflower Oil", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Safflower Oils", "MN": "J02.500.375.400.700", "MH_TH": "NLM (1975)", "ST": "T168", "N1": "Safflower oil", "RN": "8001-23-8", "AN": "an unsaturated fat", "MS": "An oily liquid extracted from the seeds of the safflower, Carthamus tinctorius. It is used as a dietary supplement in the management of HYPERCHOLESTEROLEMIA. It is used also in cooking, as a salad oil, and as a vehicle for medicines, paints, varnishes, etc. (Dorland, 28th ed & Random House Unabridged Dictionary, 2d ed)", "OL": "search FATTY ACIDS, ESSENTIAL 1966-74", "PM": "91; was see under PLANT OILS 1975-90; was see under FATTY ACIDS, ESSENTIAL 1963-74", "HN": "91(75); was see under PLANT OILS 1975-90; was see under FATTY ACIDS, ESSENTIAL 1963-74", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012450"}, {"RECTYPE": "D", "MH": "Safrole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Shikimol|T109|T123|T131|NON|REL|UNK (19XX)|760306|abbbcdef", "ENTRY": "Shikimols", "MN": "D03.633.100.115.750", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "1,3-Benzodioxole, 5-(2-propenyl)-", "RN": "RSB34337V9", "RR": "94-59-7 (Safrole)", "PI": "Dioxoles (1969-1974)", "MS": "A member of the BENZODIOXOLES that is a constituent of several VOLATILE OILS, notably SASSAFRAS oil. It is a precursor in the synthesis of the insecticide PIPERONYL BUTOXIDE and the drug N-methyl-3,4-methylenedioxyamphetamine (MDMA).", "PM": "91; was see under DIOXOLES 1975-90", "HN": "91(75); was see under DIOXOLES 1975-90", "MR": "20190705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012451"}, {"RECTYPE": "D", "MH": "Saguinus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Tamarins, Long-tusked|T015|NON|EQV|NLM (2006)|050107|abcdef", "ENTRY": "Tamarins, Long tusked", "MN": "B01.050.150.900.649.313.988.400.600.150.150.710", "MH_TH": "NLM (1981)", "ST": "T015", "RN": "txid9486", "RR": "txid9490", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "PI": "Callithricidae (1975-1980)", "MS": "A genus in the subfamily CALLITRICHINAE consisting of 12 species and found in Panama as well as South America. Species seen most frequently in the literature are S. oedipus (cotton-top marmoset), S. nigricollis, and S. fusicollis.", "PM": "91; was see under CALLITHRICIDAE 1981-90", "HN": "91(81); was see under CALLITHRICIDAE 1981-90", "MR": "20200813", "DA": "19800507", "DC": "1", "DX": "19910101", "UI": "D012452"}, {"RECTYPE": "D", "MH": "Saimiri", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Squirrel Monkey|T015|NON|EQV|NLM (1992)|901128|abcdef", "ENTRY": "Squirrel Monkeys", "MN": "B01.050.150.900.649.313.988.400.600.150.710.710", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9520", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "MS": "A genus of the family CEBIDAE consisting of four species: S. boliviensis, S. orstedii (red-backed squirrel monkey), S. sciureus (common squirrel monkey), and S. ustus. They inhabit tropical rain forests in Central and South America. S. sciureus is used extensively in research studies.", "OL": "use SAIMIRI to search SQUIRREL MONKEYS 1975-80", "PM": "91; was see under CEBIDAE 1981-90; was SQUIRREL MONKEYS see under MONKEYS 1975-80", "HN": "91(81); was see under CEBIDAE 1981-90; was SQUIRREL MONKEYS see under MONKEYS 1975-80", "MR": "20200813", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D012453"}, {"RECTYPE": "D", "MH": "Salamandra", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.090.608.700.610", "MH_TH": "NLM (1972)", "ST": "T011", "RN": "txid57569", "AN": "NIM when experimental animal", "PI": "Urodela (1966-1971)", "MS": "A genus of European newts in the Salamandridae family. The two species of this genus are Salamandra salamandra (European \"fire\" salamander) and Salamandra atra (European alpine salamander).", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012454"}, {"RECTYPE": "D", "MH": "Salamandridae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Taricha|T011|NON|NRW|UNK (19XX)|800512|abcdef", "ENTRY": "Tarichas", "MN": "B01.050.150.900.090.608.700", "MH_TH": "NLM (1975)", "ST": "T011", "RN": "txid8314", "RR": "txid8320", "AN": "general or unspecified; prefer specifics; NIM with no qualifiers when experimental animal", "MS": "A family of Urodela consisting of 15 living genera and about 42 species and occurring in North America, Europe, Asia, and North Africa.", "OL": "use SALAMANDRIDAE to search NEWTS 1975-80; use URODELA 1972-74", "PM": "81; was NEWTS see under SALAMANDERS 1972-80", "HN": "81; was NEWTS see under SALAMANDERS 1972-80", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D012455"}, {"RECTYPE": "D", "MH": "Salaries and Fringe Benefits", "DE": "SALARIES FRINGE BENEFITS", "AQ": "CL EC HI LJ SN TD", "PRINT ENTRY": "Wages|T081|NON|NRW|POPLINE (1978)|770512|abcdef", "ENTRY": "Wage", "MN": "N04.452.677.800", "MH_TH": "NLM (1978)", "ST": "T081", "PI": "Income (1968-1977)", "MS": "The remuneration paid or benefits granted to an employee.", "PM": "78", "HN": "78", "MR": "19950523", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D012456"}, {"RECTYPE": "D", "MH": "Salicylamides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.065.793", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Amides of salicylic acid.", "MR": "19940524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012457"}, {"RECTYPE": "D", "MH": "Salicylanilides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "N-Phenylsalicylamides|T109|NON|EQV|UNK (19XX)|760426|PHENYLSALICYLAMIDES N|abcdefs", "ENTRY": "N Phenylsalicylamides", "MN": "D02.092.146.113.860", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "AN": "antifungals", "PI": "Salicylamides (1966-1976)", "MS": "2-Hydroxy-N-phenylbenzamides. N-phenyl substituted salicylamides. Derivatives have been used as fungicides, anti-mildew agents and topical antifungal agents. In concentrated form may cause irritation of skin and mucous membranes.", "PM": "91; was see under SALICYLAMIDES 1977-90", "HN": "91(77); was see under SALICYLAMIDES 1977-90", "MR": "20151124", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D012458"}, {"RECTYPE": "D", "MH": "Salicylates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Salicylate|T109|T121|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Acids, Salicylic", "MN": "D02.455.426.559.389.657.410.595", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis.", "PM": "1963; for SALICYLIC ACIDS see SALICYCLIC ACIDS 1966-2012", "HN": "1963", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D012459"}, {"RECTYPE": "D", "MH": "Sulfasalazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Salicylazosulfapyridine|T109|T121|NON|EQV|NLM (1995)|940421|abbcdef", "ENTRY": "ratio Sulfasalazine", "MN": "D02.886.590.700.730", "PA": "Gastrointestinal Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzoic acid, 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)-", "RN": "3XC8GUZ6CB", "RR": "599-79-1 (Sulfasalazine)", "MS": "A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)", "PM": "1995; see SALICYLAZOSULFAPYRIDINE 1963-1994; for SULFASALAZINE see SALICYLAZOSULFAPYRIDINE 1975-1994", "HN": "1995 (1963)", "MR": "20180301", "DA": "19990101", "DC": "1", "DX": "19950101", "UI": "D012460"}, {"RECTYPE": "D", "MH": "Saline Solution, Hypertonic", "DE": "SALINE SOL HYPERTONIC", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sodium Chloride Solution, Hypertonic|T121|T197|NON|EQV|UNK (19XX)|741111|SODIUM CHLORIDE SOL HYPERTONIC|abbcdefv", "ENTRY": "Solutions, Saline Hypertonic", "MN": "D26.776.314.890", "MH_TH": "POPLINE (1984)", "ST": "T197", "RN": "0", "AN": "usually NIM with no qualifiers", "PI": "Sodium Chloride (1966-1974)", "MS": "Hypertonic sodium chloride solution. A solution having an osmotic pressure greater than that of physiologic salt solution (0.9 g NaCl in 100 ml purified water).", "PM": "90; was see under SODIUM CHLORIDE 1975-89", "HN": "90(75); was see under SODIUM CHLORIDE 1975-89", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19900101", "UI": "D012462"}, {"RECTYPE": "D", "MH": "Saliva", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Salivas", "MN": "A12.200.666", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "SALIVATION and SALIVARY GLANDS are also available; \"salivary IMMUNOGLOBULIN A\": index SALIVA/immunol (IM) + IMMUNOGLOBULIN A, SECRETORY (IM)", "MS": "The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012463"}, {"RECTYPE": "D", "MH": "Saliva, Artificial", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Artificial Saliva", "MN": "J01.637.051.583.820", "MH_TH": "NLM (1984)", "ST": "T121", "RN": "0", "PI": "Saliva (1966-1983)", "MS": "A solution used for irrigating the mouth in xerostomia and as a substitute for saliva.", "PM": "91; was see under MOUTHWASHES 1984-90", "HN": "91(84); was see under MOUTHWASHES 1984-90", "MR": "20060705", "DA": "19830422", "DC": "1", "DX": "19910101", "UI": "D012464"}, {"RECTYPE": "D", "MH": "Salivary Duct Calculi", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Sialolithiasis, Ductal|T031|T046|NON|EQV|UNK (19XX)|880607|abbcdef", "ENTRY": "Stones, Salivary Duct", "MN": "C23.300.175.700.325", "MH_TH": "OMIM (2013)", "ST": "T046", "AN": "chem composition of calculi: use /chem; /ultrastruct permitted; coord IM with specific precoord salivary gland dis term (IM); do not confuse with SALIVARY GLAND CALCULI", "MS": "Presence of small calculi in the terminal salivary ducts (salivary sand), or stones (larger calculi) found in the larger ducts.", "OL": "use SALIVARY DUCT CALCULI to search SIALOLITHIASIS 1966-88; to search for chem composition of salivary duct calculi, use SALIVARY DUCT CALCULI/anal 1987-90 & SALIVARY DUCT CALCULI/metab 1966-86", "PM": "66; SIALOLITHIASIS was see SALIVARY DUCT CALCULI 1966-88", "HN": "66; SIALOLITHIASIS was see SALIVARY DUCT CALCULI 1966-88", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012465"}, {"RECTYPE": "D", "MH": "Salivary Gland Diseases", "DE": "SALIVARY GLAND DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Salivary Gland Disease", "MN": "C07.465.815", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Diseases involving the SALIVARY GLANDS.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012466"}, {"RECTYPE": "D", "MH": "Salivary Gland Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Salivary Gland Fistulas", "MN": "C23.300.575.500.775", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "fistula policy: Manual 23.19+; coord IM with specific salivary gland or precoord salivary gland dis (IM)", "MS": "A fistula between a salivary duct or gland and the cutaneous surface of the oral cavity.", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012467"}, {"RECTYPE": "D", "MH": "Salivary Gland Neoplasms", "DE": "SALIVARY GLAND NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Sebaceous Lymphadenomas|T191|NON|NRW|NLM (2022)|210428|abcdef", "ENTRY": "Sebaceous Lymphadenoma", "MN": "C07.465.815.718", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "general or unspecified; prefer specifics; coordinate with histological type of neoplasm", "MS": "Tumors or cancer of the SALIVARY GLANDS.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012468"}, {"RECTYPE": "D", "MH": "Salivary Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Salivary Gland", "MN": "A14.549.760", "FX": "Sialography", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at SIAL-", "MS": "Glands that secrete SALIVA in the MOUTH. There are three pairs of salivary glands (PAROTID GLAND; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND).", "MR": "20160809", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012469"}, {"RECTYPE": "D", "MH": "Salivary Glands, Minor", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Salivary Gland, Minor", "MN": "A14.549.760.650", "MH_TH": "NLM (1979)", "ST": "T023", "AN": "diseases: coord NIM with SALIVARY GLAND DISEASES (IM)", "PI": "Salivary Glands (1966-1978)", "MS": "Accessory salivary glands located in the lip, cheek, tongue, floor of mouth, palate and intramaxillary.", "PM": "91; was see under SALIVARY GLANDS 1979-90", "HN": "91(79); was see under SALIVARY GLANDS 1979-90", "MR": "20030709", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D012470"}, {"RECTYPE": "D", "MH": "Salivary Proteins and Peptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Salivary Proteins|T116|T123|NON|NRW|NLM (1977)|990101|abbcdef", "ENTRY": "Protein, Salivary Gland", "MN": "D12.776.850", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics; do not confuse entry term SALIVARY PROTEINS with SIALOPROTEINS, a type of glycoprotein", "PI": "Salivary Glands (1966-1976)", "MS": "Proteins and peptides found in SALIVA and the SALIVARY GLANDS. Some salivary proteins such as ALPHA-AMYLASES are enzymes, but their composition varies in different individuals.", "PM": "2009; see SALIVARY PROTEINS (1977-2008)", "HN": "2009(1977)", "MR": "20200527", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D012471"}, {"RECTYPE": "D", "MH": "Salivation", "AQ": "DE EH GE IM PH RE", "MN": "G10.261.190.800", "FX": "Xerostomia", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "SALIVA and SALIVARY GLANDS are also available; distinguish from SALIVARY ELIMINATION, the discharge of substances from the blood supply by diffusion into the saliva", "MS": "The discharge of saliva from the SALIVARY GLANDS that keeps the mouth tissues moist and aids in digestion.", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012472"}, {"RECTYPE": "D", "MH": "Salmine", "AQ": "AD AE AG AI AN BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "MN": "D12.776.664.750.739", "MH_TH": "NLM (1975)", "ST": "T116", "N1": "Salmine", "RN": "9014-82-8", "OL": "search PROTAMINES 1966-74", "PM": "91; was see under PROTAMINES 1975-90", "HN": "91(75); was see under PROTAMINES 1975-90", "MR": "19920520", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012473"}, {"RECTYPE": "D", "MH": "Salmon", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Salmon, Sockeye|T013|NON|NRW|NLM (1994)|920805|abcdef", "ENTRY": "Sockeye Salmon", "MN": "B01.050.150.900.493.817.750.705", "MH_TH": "NLM (1972)", "ST": "T013", "RR": "txid8023", "PI": "Salmonidae (1968-1971)", "MS": "Fish of the genera ONCORHYNCHUS and Salmo in the family SALMONIDAE. They are anadromous game fish, frequenting the coastal waters of both the North Atlantic and Pacific. They are known for their gameness as a sport fish and for the quality of their flesh as a table fish. (Webster, 3d ed).", "PM": "72", "HN": "72", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012474"}, {"RECTYPE": "D", "MH": "Salmonella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.710", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid590", "AN": "general or unspecified; prefer specifics; infection equals SALMONELLA INFECTIONS or its specifics: see notes on species terms for various infections", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that utilizes citrate as a sole carbon source. It is pathogenic for humans, causing enteric fevers, gastroenteritis, and bacteremia. Food poisoning is the most common clinical manifestation. Organisms within this genus are separated on the basis of antigenic characteristics, sugar fermentation patterns, and bacteriophage susceptibility.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012475"}, {"RECTYPE": "D", "MH": "Salmonella arizonae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Arizona Bacteria|T007|NON|EQV|UNK (19XX)|770127|ARIZONA BACT|abcdefv", "ENTRY": "Salmonella enterica serovar arizonae|T007|NON|EQV|NLM (2004)|030429|abcdef", "MN": "B03.660.250.150.710.050", "MH_TH": "NLM (1978)", "ST": "T007", "RN": "txid59203", "AN": "infection: coord IM with SALMONELLA INFECTIONS (IM)", "PI": "Salmonella (1966-1977)", "MS": "Gram-negative rods widely distributed in LIZARDS and SNAKES, and implicated in enteric, bone (BONE DISEASES), and joint infections (JOINT DISEASES) in humans.", "PM": "91; was see under SALMONELLA 1978-90", "HN": "91(78); was see under SALMONELLA 1978-90", "MR": "20200813", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D012476"}, {"RECTYPE": "D", "MH": "Salmonella enteritidis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Salmonella enterica serovar enteritidis|T007|NON|EQV|NLM (2000)|991103|abcdef", "MN": "B03.660.250.150.710.160.160", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid149539", "AN": "infection: coord IM with SALMONELLA INFECTIONS (IM)", "PI": "Salmonella (1966-1971)", "MS": "A serotype of Salmonella enterica which is an etiologic agent of gastroenteritis in man and other animals.", "PM": "74", "HN": "74(72)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012477"}, {"RECTYPE": "D", "MH": "Salmonella Food Poisoning", "DE": "SALMONELLA FOOD POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Salmonella Food Poisonings", "MN": "C25.723.415.738", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Poisoning caused by ingestion of food harboring species of SALMONELLA. Conditions of raising, shipping, slaughtering, and marketing of domestic animals contribute to the spread of this bacterium in the food supply.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012478"}, {"RECTYPE": "D", "MH": "Salmonella paratyphi C", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Salmonella hirschfeldii|T007|NON|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Salmonella enterica serovar Paratyphi C|T007|NON|EQV|NLM (2003)|010821|abcdef", "MN": "B03.660.250.150.710.160.711", "MH_TH": "UNK (19XX)", "ST": "T007", "RN": "txid57046", "AN": "infection: coord IM with PARATYPHOID FEVER (IM)", "PI": "Salmonella paratyphi A (1966-1974)", "MS": "A serotype of SALMONELLA ENTERICA which is an agent of PARATYPHOID FEVER in Asia, Africa, and southern Europe.", "PM": "2003, 1975; see SALMONELLA HIRSCHFELDII 1991-2002, see SALMONELLA 1976-1990, see SALMONELLA PARATYPHI 1966-1974", "HN": "2003, 1975", "MR": "20200813", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D012479"}, {"RECTYPE": "D", "MH": "Salmonella Infections", "DE": "SALMONELLA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Salmonellosis|T047|NON|EQV|NLM (1992)|910320|abcdef", "ENTRY": "Salmonelloses", "MN": "C01.150.252.400.310.821", "EC": "veterinary:Salmonella Infections, Animal", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Infections with bacteria of the genus SALMONELLA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012480"}, {"RECTYPE": "D", "MH": "Salmonella Infections, Animal", "DE": "SALMONELLA INFECT ANIMAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Salmonella Infection, Animal", "MN": "C22.812", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "exper or vet; don't forget to check tag ANIMALS", "MS": "Infections in animals with bacteria of the genus SALMONELLA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012481"}, {"RECTYPE": "D", "MH": "Salmonella paratyphi A", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Salmonella paratyphi|T007|NON|EQV|UNK (19XX)|750716|abcdef", "ENTRY": "Salmonella enterica serovar Paratyphi A|T007|NON|EQV|NLM (2003)|010821|abcdef", "MN": "B03.660.250.150.710.160.580", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid54388", "AN": "infection: coord IM with PARATYPHOID FEVER (IM)", "MS": "A serotype of SALMONELLA ENTERICA that causes mild PARATYPHOID FEVER in humans.", "PM": "1976; for SALMONELLA PARATYPHI see SALMONELLA PARATYPHI 1963-1975", "HN": "1976; for SALMONELLA PARATYPHI use SALMONELLA PARATYPHI 1963-1975", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D012482"}, {"RECTYPE": "D", "MH": "Salmonella Phages", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Salmonella Phage", "MN": "B04.123.706", "MH_TH": "NLM (1966)", "ST": "T005", "AN": "coord IM with specific Salmonella (NIM)", "MS": "Viruses whose host is Salmonella. A frequently encountered Salmonella phage is BACTERIOPHAGE P22.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012483"}, {"RECTYPE": "D", "MH": "Salmonella paratyphi B", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Salmonella schottmuelleri|T007|NON|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Salmonella enterica serovar Paratyphi B|T007|NON|EQV|NLM (2003)|010821|abcdef", "MN": "B03.660.250.150.710.160.710", "MH_TH": "UNK (19XX)", "ST": "T007", "RN": "txid57045", "AN": "infection: coord IM with PARATYPHOID FEVER (IM)", "PI": "Salmonella paratyphi A (1966-1974)", "MS": "A serotype of SALMONELLA ENTERICA which is an agent of PARATYPHOID FEVER in humans.", "PM": "2003, 1975; see SALMONELLA SCHOTTMUELLERI 1991-2002, see SALMONELLA 1976-1990, see SALMONELLA PARATYPHI 1966-1974", "HN": "2003, 1975", "MR": "20200813", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D012484"}, {"RECTYPE": "D", "MH": "Salmonella typhi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Salmonella typhosa|T007|NON|EQV|UNK (19XX)|750711|abcdef", "MN": "B03.660.250.150.710.160.750", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid90370", "MS": "A serotype of SALMONELLA ENTERICA which is the etiologic agent of TYPHOID FEVER.", "OL": "use SALMONELLA TYPHI to search SALMONELLA TYPHOSA 1966-75", "PM": "76; was SALMONELLA TYPHOSA 1963-75", "HN": "76; was SALMONELLA TYPHOSA 1963-75", "MR": "20200813", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D012485"}, {"RECTYPE": "D", "MH": "Salmonella typhimurium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Salmonella typhimurium LT2|T007|NON|NRW|NLM (2005)|040212|abcdef", "MN": "B03.660.250.150.710.160.760", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid90371", "RR": "txid99287", "AN": "infection: coordinate IM with SALMONELLA INFECTIONS (IM) or SALMONELLA FOOD POISONING (IM) if pertinent", "MS": "A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012486"}, {"RECTYPE": "D", "MH": "Salmonidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Whitefish|T013|NON|NRW|UNK (19XX)|860415|abcdef", "ENTRY": "Salmonid", "MN": "B01.050.150.900.493.817.750", "MH_TH": "NLM (1968)", "ST": "T013", "RN": "txid8015", "RR": "txid504569", "AN": "general or unspecified; prefer SALMON or TROUT or specifics", "PI": "Fishes (1966-1967)", "MS": "A family of anadromous fish comprising SALMON; TROUT; whitefish; and graylings. They are the most important food and game fishes. Their habitat is the northern Atlantic and Pacific, both marine and inland, and the Great Lakes. (Nelson: Fishes of the World, 1976, p97)", "PM": "1968", "HN": "1968", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012487"}, {"RECTYPE": "D", "MH": "Salpingitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Salpingitides", "MN": "C12.100.250.056.750.875", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the uterine salpinx, the trumpet-shaped FALLOPIAN TUBES, usually caused by ascending infections of organisms from the lower reproductive tract. Salpingitis can lead to tubal scarring, hydrosalpinx, tubal occlusion, INFERTILITY, and ectopic pregnancy (PREGNANCY, ECTOPIC)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012488"}, {"RECTYPE": "D", "MH": "Salpingostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Salpingostomies", "MN": "E04.950.300.750", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Fallopian Tubes/surgery (1966-1987)", "MS": "Formation of an artificial opening in a fallopian tube.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19870320", "DC": "1", "DX": "19880101", "UI": "D012489"}, {"RECTYPE": "D", "MH": "Salsoline Alkaloids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Alkaloids, Salsoline", "MN": "D03.633.100.531.820.500", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "PI": "Quinolines (1966-1968)", "MS": "Tetrahydroisoquinolinol alkaloids in both dextro and levo forms, originally found in SALSOLA plants.", "PM": "91; was see under ISOQUINOLINES 1979-90", "HN": "91(79); was see under ISOQUINOLINES 1979-90", "MR": "20160531", "DA": "19780208", "DC": "1", "DX": "19910101", "UI": "D012490"}, {"RECTYPE": "D", "MH": "Salt Gland", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Rectal Gland|T023|NON|EQV|NLM (1994)|920730|abcdef", "ENTRY": "Salt Glands", "MN": "A13.811", "MH_TH": "NLM (1964)", "ST": "T023", "AN": "in marine animals and birds only; entry term RECTAL GLAND is found in sharks, rays and skates and is used often in marine electrolyte studies", "MS": "A compound tubular gland, located around the eyes and nasal passages in marine animals and birds, the physiology of which figures in water-electrolyte balance. The Pekin duck serves as a common research animal in salt gland studies. A rectal gland or rectal salt gland in the dogfish shark is attached at the junction of the intestine and cloaca and aids the kidneys in removing excess salts from the blood. (Storer, Usinger, Stebbins & Nybakken: General Zoology, 6th ed, p658)", "PM": "70", "HN": "70(64)", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D012491"}, {"RECTYPE": "D", "MH": "Salts", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Salt|T104|NON|EQV|NLM (2021)|191121|abcdef", "MN": "D01.786", "MH_TH": "NLM (1966)", "ST": "T104", "RN": "0", "AN": "note plural: not for \"salt\" referring to common salt (SODIUM CHLORIDE) or TABLE SALT see SODIUM CHLORIDE, DIETARY; GEN; NIM; Manual 25.5.5.2", "MS": "Substances produced from the reaction between acids and bases; compounds consisting of a metal (positive) and nonmetal (negative) radical. (Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012492"}, {"RECTYPE": "D", "MH": "Samarium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.937", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Samarium", "RN": "42OD65L39F", "RR": "7440-19-9 (Samarium)", "MS": "An element of the rare earth family of metals. It has the atomic symbol Sm, atomic number 62, and atomic weight 150.36. The oxide is used in the control rods of some nuclear reactors.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012493"}, {"RECTYPE": "D", "MH": "Sampling Studies", "ENTRY": "Study, Sampling", "MN": "N06.850.520.450.875", "MH_TH": "POPLINE (1978)", "ST": "T170", "AN": "NIM with specific study IM; epidemiological & statistical only: not for blood samples, soil samples, water samples, air samples, etc.", "MS": "Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D012494"}, {"RECTYPE": "D", "MH": "San Francisco", "AQ": "EH EP", "MN": "Z01.433.875", "MH_TH": "NLM (1988)", "ST": "T083", "MS": "A city in northern California.", "HN": "88", "MR": "20161219", "DA": "19870227", "DC": "4", "DX": "19880101", "UI": "D012495"}, {"RECTYPE": "D", "MH": "San Marino", "AQ": "EH EP", "ENTRY": "Republic of San Marino|T083|NON|EQV|NLM (2018)|161223|abcdef", "MN": "Z01.542.786", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "An enclave in central Italy.", "MR": "20161223", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D012496"}, {"RECTYPE": "D", "MH": "Sandhoff Disease", "DE": "SANDHOFF DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hexosaminidase A and B Deficiency Disease|T047|NON|EQV|GHR (2014)|NLM (2000)|ORD (2010)|991103|HEXOSAMINIDASE A AND B DEFIC DIS|abcdeeefv", "ENTRY": "beta-Hexosaminidase-beta-Subunit Deficiencies", "MN": "C18.452.648.595.554.825.300.300.800", "FX": "beta-N-Acetylhexosaminidases", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Sphingolipidosis (1974-1978)", "MS": "An autosomal recessive neurodegenerative disorder characterized by an accumulation of G(M2) GANGLIOSIDE in neurons and other tissues. It is caused by mutation in the common beta subunit of HEXOSAMINIDASE A and HEXOSAMINIDASE B. Thus this disease is also known as the O variant since both hexosaminidase A and B are missing. Clinically, it is indistinguishable from TAY-SACHS DISEASE.", "PM": "1979", "HN": "1979", "CATSH": "CAT LIST", "MR": "20210602", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D012497"}, {"RECTYPE": "D", "MH": "Sanitary Engineering", "AQ": "EC ED ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Plumbing|T090|NON|NRW|UNK (19XX)|810519|abcdef", "ENTRY": "Engineering, Sanitary", "MN": "N06.850.860.510", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "A branch of engineering concerned with the design, construction, and maintenance of environmental facilities conducive to public health, such as water supply and waste disposal.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012498"}, {"RECTYPE": "D", "MH": "Sanitation", "AQ": "CL EC ES HI IS LJ MT SN ST TD", "MN": "N06.850.860", "MH_TH": "POPLINE (1978)", "ST": "T090", "MS": "The development and establishment of environmental conditions favorable to the health of the public.", "OL": "search SANITARY SURVEYS under HEALTH SURVEYS 1966", "PM": "SANITARY SURVEYS was heading 1963-66", "HN": "SANITARY SURVEYS was heading 1963-66", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012499"}, {"RECTYPE": "D", "MH": "Santonin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.663.500.500", "PA": "Antinematodal Agents", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Naphtho(1,2-b)furan-2,8(3H,4H)-dione, 3a,5,5a,9b-tetrahydro-3,5a,9-trimethyl-, (3S-(3alpha,3aalpha,5abeta,9bbeta))-", "RN": "1VL8J38ERO", "RR": "481-06-1 (Santonin)", "MS": "Anthelmintic isolated from the dried unexpanded flower heads of Artemisia maritima and other species of Artemisia found principally in Russian and Chinese Turkestan and the Southern Ural region. (From Merck, 11th ed.)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012500"}, {"RECTYPE": "D", "MH": "Saphenous Vein", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Saphenous", "MN": "A07.015.908.819", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The vein which drains the foot and leg.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012501"}, {"RECTYPE": "D", "MH": "Sapogenins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.795", "MH_TH": "NLM (1979)", "ST": "T109", "RN": "0", "PI": "Triterpenes (1974-1978)", "MS": "The aglucon moiety of a saponin molecule. It may be triterpenoid or steroid, usually spirostan, in nature.", "PM": "79; OLEANOLIC ACID was see under TRITERPENES 1975-78", "HN": "79", "MR": "20160531", "DA": "19771216", "DC": "1", "DX": "19790101", "UI": "D012502"}, {"RECTYPE": "D", "MH": "Saponins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Saponin|T109|NON|NRW|UNK (19XX)|841002|abcdef", "MN": "D09.408.782", "FX": "Saporins", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A type of glycoside widely distributed in plants. Each consists of a sapogenin as the aglycone moiety, and a sugar. The sapogenin may be a steroid or a triterpene and the sugar may be glucose, galactose, a pentose, or a methylpentose.", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012503"}, {"RECTYPE": "D", "MH": "Saralasin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "1-Sarcosine-8-Alanine Angiotensin II|T116|T121|NON|EQV|UNK (19XX)|770428|SARCOSINEALANINEANGIOTENSIN 02 01 08|abbcdefs", "ENTRY": "Hydrated Saralasin Acetate", "MN": "D23.469.050.050.050.700", "PA": "Angiotensin II Type 1 Receptor Blockers", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Angiotensin II, 1-(N-methylglycine)-5-L-valine-8-L-alanine-", "RN": "H2AFV2HE66", "RR": "U603K01682", "PI": "Sarcosine (1974)", "MS": "An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION.", "PM": "1984; see ANGIOTENSIN II 1978-83; 1-SARCOSINE-8-ALANINE ANGIOTENSIN II was indexed under ANGIOTENSIN II 1975-77", "HN": "1984(1978)", "MR": "20140624", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D012504"}, {"RECTYPE": "D", "MH": "Sarcina", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.750", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1266", "MS": "A genus of gram-positive, anaerobic bacteria whose organisms divide in three perpendicular planes and occur in packets of eight or more cells. It has been isolated from soil, grains, and clinical specimens.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012505"}, {"RECTYPE": "D", "MH": "Sarcoidosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Boeck's Sarcoid|T047|EPO|EQV|ORD (2010)|UNK (19XX)|740330|abcdeef", "ENTRY": "Syndrome, Schaumann's", "MN": "C20.543.418.575", "FX": "Kveim Test", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coordinate with precoordinated organ disease term; sarcoidosis of heart: coordinate with CARDIOMYOPATHIES, not HEART DISEASES", "MS": "An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.", "PM": "PSEUDOTUBERCULOSIS see SARCOIDOSIS 1963-1992", "HN": "PSEUDOTUBERCULOSIS use SARCOIDOSIS 1963-1992", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012507"}, {"RECTYPE": "D", "MH": "Sarcolemma", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Sarcolemmas", "MN": "A11.284.149.707", "MH_TH": "NLM (1967)", "ST": "T026", "PI": "Muscles (1966)", "MS": "The excitable plasma membrane of a muscle cell. (Glick, Glossary of Biochemistry and Molecular Biology, 1990)", "PM": "72", "HN": "72(67)", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012508"}, {"RECTYPE": "D", "MH": "Sarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Sarcoma, Spindle Cell|T191|NON|REL|NLM (1994)|930326|abcdef", "ENTRY": "Spindle Cell Sarcomas", "MN": "C04.557.450.795", "FX": "Avian Sarcoma Viruses", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term; SARCOMA, EXPERIMENTAL is also available", "MS": "A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012509"}, {"RECTYPE": "D", "MH": "Sarcoma 180", "DS": "SARCOMA A 180", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "PRINT ENTRY": "Sarcoma 180, Crocker|T050|T191|EPO|EQV|UNK (19XX)|820505|SARCOMA A 180 CROCKER|abbcdefs", "ENTRY": "Crocker Sarcoma 180", "MN": "C04.619.857.656", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "An experimental sarcoma of mice.", "OL": "use SARCOMA 180 to search SARCOMA 180, CROCKER 1966-82", "PM": "83; was SARCOMA 180, CROCKER 1963-82", "HN": "83; was SARCOMA 180, CROCKER 1963-82", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19830101", "UI": "D012510"}, {"RECTYPE": "D", "MH": "Sarcoma 37", "DS": "SARCOMA A 037", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "MN": "C04.619.857.573", "MH_TH": "NLM (1984)", "ST": "T191", "MS": "An experimental sarcoma of mice.", "PM": "91,63-83; was see under SARCOMA, EXPERIMENTAL 1984-90; was heading 1963-83", "HN": "91(84)63; was see under SARCOMA, EXPERIMENTAL 1984-90; was heading 1963-83", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012511"}, {"RECTYPE": "D", "MH": "Sarcoma, Ewing", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Sarcoma, Ewing's|T191|EPO|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Tumor, Ewing's", "MN": "C04.557.450.795.620.800", "FX": "Neuroectodermal Tumors, Primitive, Peripheral", "MH_TH": "NLM (2012)", "ST": "T191", "AN": "coordinate IM with BONE NEOPLASMS (IM) or specific bone/neoplasm term (IM) or specific bone (IM) + BONE NEOPLASMS (IM)", "MS": "A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.", "PM": "2012; use SARCOMA, EWING'S 1963-2011", "HN": "2012 (1963)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "20120101", "UI": "D012512"}, {"RECTYPE": "D", "MH": "Sarcoma, Experimental", "DE": "SARCOMA EXPER", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "PRINT ENTRY": "Sarcoma, Jensen|T050|T191|EPO|NRW|UNK (19XX)|810519|abbcdef", "ENTRY": "Tumor, EHS", "MN": "E05.598.500.496.968", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with pre-coordinated organ/neoplasm term (IM or NIM)", "MS": "Experimentally induced neoplasms of CONNECTIVE TISSUE in animals to provide a model for studying human SARCOMA.", "OL": "use SARCOMA, EXPERIMENTAL to search SARCOMA, JENSEN 1966-81", "PM": "SARCOMA, JENSEN was heading 1963-81", "HN": "SARCOMA, JENSEN was heading 1963-81", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D012513"}, {"RECTYPE": "D", "MH": "Sarcoma, Kaposi", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Kaposi Sarcoma|T191|EPO|EQV|OMIM (2013)|ORD (2010)|UNK (19XX)|740330|abcdeeef", "ENTRY": "Sarcoma, Kaposi's", "MN": "C04.557.645.750", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/ neoplasm term (IM)", "MS": "A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.", "PM": "98; was SARCOMA, KAPOSI'S 1963-97; KAPOSI SARCOMA was KAPOSI'S SARCOMA 1963-97", "HN": "98; was SARCOMA, KAPOSI'S 1963-97; KAPOSI SARCOMA was KAPOSI'S SARCOMA 1963-97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012514"}, {"RECTYPE": "D", "MH": "Mast-Cell Sarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Sarcoma, Mast-Cell|T191|NON|EQV|NLM (1968)|990101|abcdef", "ENTRY": "Sarcomas, Mast-Cell", "MN": "C20.762.750.375", "MH_TH": "UNK (19XX)", "ST": "T191", "PI": "Sarcoma (1966-1967)", "MS": "A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.", "OL": "use SARCOMA, MAST-CELL to search SARCOMA, MAST CELL 1968-91", "PM": "92; was SARCOMA, MAST CELL 1968-91", "HN": "92; was SARCOMA, MAST CELL 1968-91", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012515"}, {"RECTYPE": "D", "MH": "Osteosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Sarcoma, Osteogenic|T191|NON|EQV|ORD (2010)|UNK (19XX)|880421|abcdeef", "ENTRY": "Tumors, Osteosarcoma", "MN": "C04.557.450.795.620", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate with BONE NEOPLASMS or specific precoordinated bone/neoplasm term or specific bone + BONE NEOPLASMS ", "MS": "A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)", "OL": "use OSTEOSARCOMA to search SARCOMA, OSTEOGENIC 1966-88", "PM": "89; was SARCOMA, OSTEOGENIC 1963-88", "HN": "89; was SARCOMA, OSTEOGENIC 1963-88", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19890101", "UI": "D012516"}, {"RECTYPE": "D", "MH": "Sarcoma, Yoshida", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "PRINT ENTRY": "Reticulum Cell-Like Sarcoma, Yoshida|T050|T191|EPO|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Yoshida Sarcoma", "MN": "C04.619.857.822", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "An experimental sarcoma of rats.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012517"}, {"RECTYPE": "D", "MH": "Sarcomeres", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Sarcomere|T026|NON|EQV|NLM (2009)|070726|abcdef", "MN": "A11.620.500.500.700", "MH_TH": "NLM (1984)", "ST": "T026", "PI": "Myofibrils (1966-1983)", "MS": "The repeating contractile units of the MYOFIBRIL, delimited by Z bands along its length.", "PM": "91; was see under MYOFIBRILS 1984-90", "HN": "91(84); was see under MYOFIBRILS 1984-90", "MR": "20080708", "DA": "19830615", "DC": "1", "DX": "19910101", "UI": "D012518"}, {"RECTYPE": "D", "MH": "Sarcoplasmic Reticulum", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Sarcoplasmic Reticulums", "MN": "A11.284.430.214.190.875.248.310.800", "MH_TH": "NLM (1972)", "ST": "T026", "PI": "Endoplasmic Reticulum (1966-1971)", "MS": "A network of tubules and sacs in the cytoplasm of SKELETAL MUSCLE FIBERS that assist with muscle contraction and relaxation by releasing and storing calcium ions.", "PM": "72", "HN": "72", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012519"}, {"RECTYPE": "D", "MH": "Sarcoptes scabiei", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "scabieus, Sarcoptes", "MN": "B01.050.500.131.166.132.419.750.800", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid52283", "MS": "A species of mite that causes SCABIES in humans and sarcoptic mange in other animals. Specific variants of S. scabiei exist for humans and animals, but many have the ability to cross species and cause disease.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012520"}, {"RECTYPE": "D", "MH": "Sarcosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylglycine|T116|T123|NON|EQV|NLM (1996)|941207|abbcdef", "ENTRY": "Sarcosylate, Magnesium", "MN": "D12.125.481.700.374", "MH_TH": "NLM (1968)", "ST": "T123", "N1": "Glycine, N-methyl-", "RN": "Z711V88R5F", "RR": "W50V8R1ZE9", "PI": "Glycine (1966-1967)", "MS": "An amino acid intermediate in the metabolism of choline.", "OL": "search GLYCINE 1966-67", "PM": "68; was see under GLYCINE 1963-67; METHYLGLYCINE was heading 1963-95 (see under GLYCINE 1963-67)", "HN": "68; was see under GLYCINE 1963-67; METHYLGLYCINE was heading 1963-95 (see under GLYCINE 1963-67)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012521"}, {"RECTYPE": "D", "MH": "Sarcocystis", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sarcosporidia|T204|NON|EQV|NLM (1992)|910313|abcdef", "ENTRY": "Sarcosporidias", "MN": "B01.043.075.189.250.750.750", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5812", "MS": "A genus of protozoa found in reptiles, birds, and mammals, including humans. This heteroxenous parasite produces muscle cysts in intermediate hosts such as domestic herbivores (cattle, sheep, pigs) and rodents. Final hosts are predators such as dogs, cats, and man.", "OL": "use SARCOCYSTIS to search SARCOSPORIDIA 1966-91", "PM": "92; was SARCOSPORIDIA 1963-91; SARCOCYSTIS was see SARCOSPORIDIA 1979-91, was see under SARCOSPORIDIA 1963-78", "HN": "92; was SARCOSPORIDIA 1963-91; SARCOCYSTIS was see SARCOSPORIDIA 1979-91, was see under SARCOSPORIDIA 1963-78", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D012522"}, {"RECTYPE": "D", "MH": "Sarcocystosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Sarcosporidiosis|T047|NON|EQV|NLM (1992)|910206|abcdef", "ENTRY": "Sarcosporidioses", "MN": "C01.610.752.250.634", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "/drug ther: consider also COCCIDIOSTATS", "MS": "Infection of the striated muscle of mammals by parasites of the genus SARCOCYSTIS. Disease symptoms such as vomiting, diarrhea, muscle weakness, and paralysis are produced by sarcocystin, a toxin produced by the organism.", "PM": "1992; see SARCOSPORIDIOSIS 1963-1991", "HN": "1992 (1963)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D012523"}, {"RECTYPE": "D", "MH": "Sarin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ortho Isopropylmethyl Phosphonofluoridate", "MN": "D02.705.429.750.500", "PA": "Cholinesterase Inhibitors", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Phosphonofluoridic acid, methyl-, 1-methylethyl ester", "RN": "B4XG72QGFM", "RR": "107-44-8 (Sarin)", "PI": "Organophosphorus Compounds (1971)", "MS": "An organophosphorus ester compound that produces potent and irreversible inhibition of cholinesterase. It is toxic to the nervous system and is a chemical warfare agent.", "PM": "91; was see under ORGANOPHOSPHORUS COMPOUNDS 1972-90", "HN": "91(72); was see under ORGANOPHOSPHORUS COMPOUNDS 1972-90", "MR": "20141202", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012524"}, {"RECTYPE": "D", "MH": "Saskatchewan", "AQ": "EH EP", "MN": "Z01.107.567.176.858", "MH_TH": "NLM (1966)", "ST": "T083", "MS": "A province of Canada, lying between the provinces of Alberta and Manitoba. Its capital is Regina. It is entirely a plains region with prairie in the south and wooded country with many lakes and swamps in the north. The name was taken from the Saskatchewan River from the Cree name Kisiskatchewani Sipi, meaning rapid-flowing river. (From Webster's New Geographical Dictionary, 1988, p1083 & Room, Brewer's Dictionary of Names, 1992, p486)", "MR": "19950221", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D012525"}, {"RECTYPE": "D", "MH": "Satellite Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Associated Viruses|T005|NON|EQV|UNK (19XX)|771205|ASSOC VIRUSES|abcdefv", "ENTRY": "Viruses, Satellite", "MN": "B04.265.658", "FX": "RNA, Satellite", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid198600", "AN": "defective viruses able to multiply only with a helper virus; coord IM with specific virus (IM)", "PI": "Viruses (1966)", "MS": "Defective viruses which can multiply only by association with a helper virus which complements the defective gene. Satellite viruses may be associated with certain plant viruses, animal viruses, or bacteriophages. They differ from satellite RNA; (RNA, SATELLITE) in that satellite viruses encode their own coat protein.", "OL": "use SATELLITE VIRUSES to search ASSOCIATED VIRUSES 1975-78 & ASSOCIATED VIRUS 1967-74 (as Prov 1967-72)", "PM": "79; was see under ASSOCIATED VIRUSES 1975-78, was SATELLITE VIRUS see under ASSOCIATED VIRUS 1974; ASSOCIATED VIRUSES was heading 1975-78, was ASSOCIATED VIRUS 1973-74", "HN": "79(75); was see under ASSOCIATED VIRUSES 1975-78, was SATELLITE VIRUS see under ASSOCIATED VIRUS 1974; ASSOCIATED VIRUSES was heading 1975-78, was ASSOCIATED VIRUS 1967-74 (Prov 1967-72)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D012526"}, {"RECTYPE": "D", "MH": "Satiation", "AQ": "CL DE ES PH RE", "ENTRY": "Satiations", "MN": "F02.830.749", "MH_TH": "NLM (1973)", "ST": "T041", "AN": "human & animal", "MS": "Full gratification of a need or desire followed by a state of relative insensitivity to that particular need or desire.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012527"}, {"RECTYPE": "D", "MH": "Satiety Response", "AQ": "CL DE ES PH RE", "ENTRY": "Satiety Responses", "MN": "F02.830.749.658", "MH_TH": "NLM (1975)", "ST": "T055", "AN": "human & animal", "MS": "Behavioral response associated with the achieving of gratification.", "OL": "search SATIATION 1973-74", "PM": "91; was see under SATIATION 1975-90", "HN": "91(75); was see under SATIATION 1975-90", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012528"}, {"RECTYPE": "D", "MH": "Saudi Arabia", "AQ": "EH EP", "ENTRY": "Kingdom of Saudi Arabia|T083|NON|EQV|NLM (2018)|161223|abcdef", "MN": "Z01.252.245.500.750", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country located in the Middle East, bordering the Persian Gulf and the Red Sea, north of Yemen. The capital is Riyadh.", "HN": "75", "MR": "20161223", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D012529"}, {"RECTYPE": "D", "MH": "Saxitoxin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gonyaulax Toxin|T109|T123|T131|NON|EQV|UNK (19XX)|770414|abbbcdef", "ENTRY": "Toxin, Gonyaulax", "MN": "D23.946.833.590.662", "PA": "Poisons", "MH_TH": "NLM (1974)", "ST": "T131", "N1": "1H,10H-Pyrrolo(1,2-c)purine-10,10-diol, 2,6-diamino-4-(((aminocarbonyl)oxy)methyl)-3a,4,8,9-tetrahydro-, (3aS-(3aalpha,4alpha,10aR*))-", "RN": "35523-89-8", "AN": "/antag permitted but consider also ANTITOXINS", "MS": "A compound that contains a reduced purine ring system but is not biosynthetically related to the purine alkaloids. It is a poison found in certain edible mollusks at certain times; elaborated by GONYAULAX and consumed by mollusks, fishes, etc. without ill effects. It is neurotoxic and causes RESPIRATORY PARALYSIS and other effects in MAMMALS, known as paralytic SHELLFISH poisoning.", "PM": "74", "HN": "74", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012530"}, {"RECTYPE": "D", "MH": "Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide", "DS": "DIBENZOXAZEPINE CARBOXYLIC ACID CHLOROACETYLHYDRAZIDE B F 01 04 10 11H 08 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SC-19220|T109|T121|LAB|NRW|NLM (1975)|990101|abbcdef", "MN": "D03.633.300.347.200", "PA": "Prostaglandin Antagonists", "MH_TH": "NLM (2005)", "ST": "T121", "N1": "Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide", "RN": "19395-87-0", "PI": "Hydrazines (1972-1974)", "MS": "Inhibits the activity of prostaglandins.", "PM": "2005; see SC-19220 1991-2005; see DIBENZOXAZEPINES 1975-1990", "HN": "2005(1975)", "MR": "20160529", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D012531"}, {"RECTYPE": "D", "MH": "Scabies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Mange, Sarcoptic|T047|NON|REL|UNK (19XX)|760517|abcdef", "ENTRY": "Sarcoptic Mange", "MN": "C17.800.838.775.800", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "mite infest caused by Sarcoptes scabiei", "MS": "A contagious cutaneous inflammation caused by the bite of the mite SARCOPTES SCABIEI. It is characterized by pruritic papular eruptions and burrows and affects primarily the axillae, elbows, wrists, and genitalia, although it can spread to cover the entire body.", "OL": "use SCABIES to search MANGE, SARCOPTIC 1968-76", "HN": "MANGE, SARCOPTIC was see under SCABIES 1968-76", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012532"}, {"RECTYPE": "D", "MH": "Scala Tympani", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tympanus, Scala", "MN": "A09.246.300.246.848", "MH_TH": "NLM (1979)", "ST": "T023", "AN": "SCALA VESTIBULI is also available", "PI": "Cochlea (1966-1978)", "MS": "The lower chamber of the COCHLEA, extending from the round window to the helicotrema (the opening at the apex that connects the PERILYMPH-filled spaces of scala tympani and SCALA VESTIBULI).", "PM": "91; was see under COCHLEA 1979-90", "HN": "91(79); was see under COCHLEA 1979-90", "MR": "20180702", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D012533"}, {"RECTYPE": "D", "MH": "Dental Scaling", "DE": "DENT SCALING", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Scaling, Supragingival|T061|NON|NRW|NLM (1992)|910111|abcdef", "ENTRY": "Supragingival Scaling", "MN": "E06.761.227.350", "MH_TH": "NLM (1972)", "ST": "T061", "AN": "do not confuse entry term ROOT SCALING with ROOT PLANING", "PI": "Dental Prophylaxis (1966-1971)", "MS": "Removal of dental plaque and dental calculus from the surface of a tooth, from the surface of a tooth apical to the gingival margin accumulated in periodontal pockets, or from the surface coronal to the gingival margin.", "OL": "use DENTAL SCALING to search SCALING, DENTAL 1972-90 (as Prov 1972-74)", "PM": "91; was SCALING, DENTAL see under DENTAL PROPHYLAXIS 1975-90", "HN": "91(72); was SCALING, DENTAL see under DENTAL PROPHYLAXIS 1972-90 (Prov 1972-74)", "CATSH": "CAT LIST", "MR": "19910429", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012534"}, {"RECTYPE": "D", "MH": "Scalp", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Scalps", "MN": "A01.456.810", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012535"}, {"RECTYPE": "D", "MH": "Scalp Dermatoses", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dermatosis, Scalp", "MN": "C17.800.738", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "consider synonym for dermatitis of scalp & do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH; does not include neoplasms of scalp: see note on SCALP", "MS": "Skin diseases involving the SCALP.", "CATSH": "CAT LIST", "MR": "20160217", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012536"}, {"RECTYPE": "D", "MH": "Scandinavian and Nordic Countries", "AQ": "EH EP", "PRINT ENTRY": "Scandinavia|T083|NAM|NRW|POPLINE (1983)|990101|abcdef", "ENTRY": "Nordic Countries|T083|NON|NRW|NLM (2015)|140506|abcdef", "MN": "Z01.542.816", "MH_TH": "NLM (2015)", "ST": "T083", "MS": "NORWAY; SWEDEN; DENMARK; ICELAND; and FINLAND.", "HN": "use SCANDINAVIA 1983-2014", "MR": "20140613", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D012537"}, {"RECTYPE": "D", "MH": "Scandium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.800", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Scandium", "RN": "YUJ4U1EW7R", "RR": "7440-20-2 (Scandium)", "MS": "An element of the rare earth family of metals. It has the atomic symbol Sc, atomic number 21, and atomic weight 45.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012538"}, {"RECTYPE": "D", "MH": "Scapegoating", "MN": "F01.393.693.500", "MH_TH": "NLM (1976)", "ST": "T055", "PI": "Schizophrenia (1966-1975)", "MS": "Process in which the mechanisms of projection or displacement are utilized in focusing feelings of aggression, hostility, frustration, etc., upon another individual or group; the amount of blame being unwarranted.", "PM": "91; was see under DISPLACEMENT (PSYCHOLOGY) 1976-90", "HN": "91(76); was see under DISPLACEMENT (PSYCHOLOGY) 1976-90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D012539"}, {"RECTYPE": "D", "MH": "Scapula", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Shoulder Blades", "MN": "A02.835.232.087.783", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Also called the shoulder blade, it is a flat triangular bone, a pair of which form the back part of the shoulder girdle.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012540"}, {"RECTYPE": "D", "MH": "Scarlet Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Scarlet Fevers", "MN": "C01.150.252.410.890.823", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "strep infect; also called scarlatina", "MS": "Infection with group A streptococci that is characterized by tonsillitis and pharyngitis. An erythematous rash is commonly present.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012541"}, {"RECTYPE": "D", "MH": "Scattering, Radiation", "DE": "SCATTERING RAD", "ENTRY": "Scatterings, Radiation", "MN": "G01.867", "FX": "Nephelometry and Turbidimetry", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "light scattering: coordinate with LIGHT", "PI": "specific radiation (1966-1970)", "MS": "The diversion of RADIATION (thermal, electromagnetic, or nuclear) from its original path as a result of interactions or collisions with atoms, molecules, or larger particles in the atmosphere or other media. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "OL": "use SCATTERING, RADIATION to search SCATTERING 1971-73 (as Prov)", "PM": "74", "HN": "74; was SCATTERING 1971-73 (Prov)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012542"}, {"RECTYPE": "D", "MH": "Scent Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Scent Gland", "MN": "A13.820", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "animal only; includes skunk perianal glands, weasel anal glands, fox musk glands, wood rat ventral glands, peccary dorsal glands", "MS": "Exocrine glands in animals which secrete scents which either repel or attract other animals, e.g. perianal glands of skunks, anal glands of weasels, musk glands of foxes, ventral glands of wood rats, and dorsal glands of peccaries.", "PM": "91; was see under EXOCRINE GLANDS 1975-90", "HN": "91(75); was see under EXOCRINE GLANDS 1975-90", "MR": "19900413", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D012543"}, {"RECTYPE": "D", "MH": "Scheuermann Disease", "DE": "SCHEUERMANN DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Adolescent Hyperkyphosis|T047|NON|EQV|NLM (2020)|190118|abcdef", "ENTRY": "Spine Juvenile Osteochondrosis", "MN": "C05.116.900.808.500", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "A type of juvenile osteochondrosis affecting the fibrocartilaginous disc (INTERVERTEBRAL DISC) in the thoracic or thoracolumbar region of the SPINE. It is characterized by a forward concave SPINAL CURVATURE or KYPHOSIS.", "PM": "2009; see SCHEUERMANN'S DISEASE 1963-2008", "HN": "2009(1963)", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D012544"}, {"RECTYPE": "D", "MH": "Schiff Bases", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Bases, Schiff", "MN": "D02.491.784", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "AN": "IM general only; an imine: do not confuse with Schiff reagent nor PERIODIC ACID-SCHIFF REACTION", "PI": "Amines (1966-1970)", "MS": "Condensation products of aromatic amines and aldehydes forming azomethines substituted on the N atom, containing the general formula R-N:CHR. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "OL": "use SCHIFF BASES to search SCHIFF BASE 1971-72 (as Prov 1971-72)", "PM": "73", "HN": "73; was SCHIFF BASE 1971-72 (Prov)", "MR": "19950522", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012545"}, {"RECTYPE": "D", "MH": "Schilling Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Test, Schilling", "MN": "E05.200.625.750", "MH_TH": "NLM (1963)", "ST": "T060", "MS": "A diagnostic test in which vitamin B12 is tagged with radioactive cobalt, taken orally, and gastrointestinal absorption is determined via measurement of the amount of radioactivity in a 24-hour urine collection.", "PM": "66", "HN": "66(63)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012546"}, {"RECTYPE": "D", "MH": "Schistosoma", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Bilharzia|T204|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Schistosomas", "MN": "B01.050.500.500.736.715.770.680", "FX": "Schistosomicides", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6181", "AN": "general or unspecified; prefer specifics; infection equals SCHISTOSOMIASIS; coordinate with specific precoordinated helminth terms (ANTIGENS, HELMINTH, etc.) if pertinent", "MS": "A genus of trematode flukes belonging to the family Schistosomatidae. There are over a dozen species. These parasites are found in man and other mammals. Snails are the intermediate hosts.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012547"}, {"RECTYPE": "D", "MH": "Schistosoma haematobium", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "haematobiums, Schistosoma", "MN": "B01.050.500.500.736.715.770.680.510", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid6185", "PI": "Schistosoma (1966-1971)", "MS": "A species of trematode blood flukes of the family Schistosomatidae which occurs at different stages in development in veins of the pulmonary and hepatic system and finally the bladder lumen. This parasite causes urinary schistosomiasis.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012548"}, {"RECTYPE": "D", "MH": "Schistosoma japonicum", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "japonicum, Schistosoma", "MN": "B01.050.500.500.736.715.770.680.570", "MH_TH": "NLM (1979)", "ST": "T204", "RN": "txid6182", "PI": "Schistosoma (1966-1978)", "MS": "A species of trematode blood flukes belonging to the family Schistosomatidae whose distribution is confined to areas of the ASIA, EASTERN. The intermediate host is a snail. It occurs in man and other mammals.", "PM": "79", "HN": "79", "MR": "20220715", "DA": "19780306", "DC": "1", "DX": "19790101", "UI": "D012549"}, {"RECTYPE": "D", "MH": "Schistosoma mansoni", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "mansonus, Schistosoma", "MN": "B01.050.500.500.736.715.770.680.700", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid6183", "PI": "Schistosoma (1966-1971)", "MS": "A species of trematode blood flukes of the family Schistosomatidae. It is common in the Nile delta. The intermediate host is the planorbid snail. This parasite causes schistosomiasis mansoni and intestinal bilharziasis.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012550"}, {"RECTYPE": "D", "MH": "Schistosomatidae", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.736.715.770", "MH_TH": "NLM (1982)", "ST": "T204", "RN": "txid31245", "AN": "a family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Trematoda (1966-1981)", "MS": "A family of blood flukes of the class Trematoda which is found in animals and man. It Includes the genera Heterobilharzia, Schistosomatium, Schistosoma, Ornithobilharzia, Bilharziella, Trichobilharzia, Pseudobilharzia, and Austrobilharzia.", "PM": "82", "HN": "82", "MR": "20200813", "DA": "19810515", "DC": "1", "DX": "19820101", "UI": "D012551"}, {"RECTYPE": "D", "MH": "Schistosomiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Bilharziasis|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Schistosomiases", "MN": "C01.920.922", "FX": "Schistosomicides", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with NEGLECTED DISEASES if pertinent", "MS": "Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States.", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012552"}, {"RECTYPE": "D", "MH": "Schistosomiasis haematobia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Schistosomiasis, Urinary|T047|NON|NRW|UNK (19XX)|850507|abcdef", "ENTRY": "Urogenital Schistosomiases", "MN": "C12.950.892.775", "MH_TH": "NLM (1986)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent; in titles & translations do not capitalize haematobia", "PI": "Schistosomiasis (1966-1985)", "MS": "A human disease caused by the infection of parasitic worms SCHISTOSOMA HAEMATOBIUM. It is endemic in AFRICA and parts of the MIDDLE EAST. Tissue damages most often occur in the URINARY TRACT, specifically the URINARY BLADDER.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19850507", "DC": "1", "DX": "19860101", "UI": "D012553"}, {"RECTYPE": "D", "MH": "Schistosomiasis japonica", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Schistosoma japonicum Infections", "MN": "C01.920.922.521", "MH_TH": "NLM (1986)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent; in titles & translations do not capitalize japonica", "PI": "Schistosomiasis (1966-1985)", "MS": "Schistosomiasis caused by Schistosoma japonicum. It is endemic in the ASIA, EASTERN and affects the bowel, liver, and spleen.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20220715", "DA": "19850507", "DC": "1", "DX": "19860101", "UI": "D012554"}, {"RECTYPE": "D", "MH": "Schistosomiasis mansoni", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Schistosomiasis, Intestinal|T047|NON|REL|UNK (19XX)|860530|abcdef", "ENTRY": "Schistosomiases, Intestinal", "MN": "C01.920.922.576", "MH_TH": "NLM (1986)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent; for entry term SCHISTOSOMIASIS, INTESTINAL do not coordinate with INTESTINAL DISEASES, PARASITIC; in titles & translations do not capitalize mansoni", "PI": "Schistosomiasis (1966-1985)", "MS": "Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19850509", "DC": "1", "DX": "19860101", "UI": "D012555"}, {"RECTYPE": "D", "MH": "Schistosomicides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Schistosomicide|T121|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Agents, Antischistosomal", "MN": "D27.505.954.122.250.075.100.750", "MH_TH": "NLM (1973)", "ST": "T121", "RN": "0", "AN": "-cidal or -static; consider also SCHISTOSOMA /drug eff & SCHISTOSOMIASIS /drug ther or pertinent specifics", "PI": "Schistosomiasis/drug therapy (1966-1972)", "MS": "Agents that act systemically to kill adult schistosomes.", "PM": "75", "HN": "75(73)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D012556"}, {"RECTYPE": "D", "MH": "Schizoid Personality Disorder", "DE": "SCHIZOID PERSONALITY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Personality Disorder, Schizoid|T048|NON|EQV|UNK (19XX)|800521|PERSONALITY DIS SCHIZOID|abcdefv", "ENTRY": "Schizoid Personality Disorders", "MN": "F03.675.700", "MH_TH": "NLM (1972)", "ST": "T048", "PI": "Personality Disorders (1968-1971)", "MS": "A personality disorder manifested by a profound defect in the ability to form social relationships, no desire for social involvement, and an indifference to praise or criticism.", "OL": "use SCHIZOID PERSONALITY DISORDER to search SCHIZOID PERSONALITY 1972-80 (as Prov 1972); use PERSONALITY DISORDERS 1969-71", "PM": "81; was SCHIZOID PERSONALITY 1973-80, was SCHIZOID PERSONALITY see under PERSONALITY DISORDERS 1969-72", "HN": "81; was SCHIZOID PERSONALITY 1972-80 (Prov 1972), was SCHIZOID PERSONALITY see under PERSONALITY DISORDERS 1969-72", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012557"}, {"RECTYPE": "D", "MH": "Schizophrenia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS RH SU TH UR VI", "PRINT ENTRY": "Schizophrenic Disorders|T048|NON|EQV|UNK (19XX)|800521|SCHIZOPHRENIC DIS|abcdefv", "ENTRY": "Schizophrenic Disorder", "MN": "F03.700.750", "EC": "psychology:Schizophrenic Psychology", "MH_TH": "OMIM (2013)", "ST": "T048", "AN": "general or unspecified; prefer specifics", "MS": "A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012559"}, {"RECTYPE": "D", "MH": "Schizophrenia, Catatonic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Catatonic Schizophrenia|T048|NON|EQV|UNK (19XX)|800520|abcdef", "ENTRY": "Schizophrenias, Catatonic", "MN": "F03.700.750.300", "MH_TH": "NLM (1975)", "ST": "T048", "AN": "/psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY (IM) if catatonic aspect is less relevant (NIM)", "PI": "Schizophrenia (1966-1974)", "MS": "A type of schizophrenia characterized by abnormality of motor behavior which may involve particular forms of stupor, rigidity, excitement or inappropriate posture.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D012560"}, {"RECTYPE": "D", "MH": "Schizophrenia, Childhood", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Childhood Schizophrenia|T048|NON|EQV|ORD (2010)|UNK (19XX)|800520|abcdeef", "ENTRY": "Schizophrenia, Childhood-Onset", "MN": "F03.625.968", "MH_TH": "NLM (1966)", "ST": "T048", "AN": "obsolete concept, historical; do not use for schizophrenia in a child; see scope note", "MS": "An obsolete concept, historically used for childhood mental disorders thought to be a form of schizophrenia. It was in earlier versions of DSM but is now included within the broad concept of PERVASIVE DEVELOPMENT DISORDERS.", "CATSH": "CAT LIST", "MR": "20150624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012561"}, {"RECTYPE": "D", "MH": "Schizophrenia, Disorganized", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Schizophrenia, Hebephrenic|T048|NON|EQV|UNK (19XX)|800521|abcdef", "ENTRY": "Schizophrenias, Hebephrenic", "MN": "F03.700.750.350", "MH_TH": "NLM (1972)", "ST": "T048", "AN": "/psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY (IM) if hebephrenic aspect is less relevant (NIM)", "PI": "Schizophrenia (1966-1971)", "MS": "A type of schizophrenia characterized by frequent incoherence; marked loosening of associations, or grossly disorganized behavior and flat or grossly inappropriate affect that does not meet the criteria for the catatonic type; associated features include extreme social withdrawal, grimacing, mannerisms, mirror gazing, inappropriate giggling, and other odd behavior. (Dorland, 27th ed)", "OL": "use SCHIZOPHRENIA, DISORGANIZED to search SCHIZOPHRENIA, HEBEPHRENIC 1972-80 (as Prov 1972)", "PM": "81; was SCHIZOPHRENIA, HEBEPHRENIC 1973-80", "HN": "81; was SCHIZOPHRENIA, HEBEPHRENIC 1972-80 (Prov 1972)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012562"}, {"RECTYPE": "D", "MH": "Schizophrenia, Paranoid", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Paranoid Schizophrenia|T048|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Schizophrenias, Paranoid", "MN": "F03.700.750.600", "MH_TH": "NLM (1973)", "ST": "T048", "AN": "/psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY (IM) if paranoid aspect is less relevant (NIM)", "PI": "Schizophrenia (1966-1972)", "MS": "A chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012563"}, {"RECTYPE": "D", "MH": "Schizophrenic Language", "ENTRY": "Language, Schizophrenic", "MN": "F01.145.126.975", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "any language concept in schizophrenia; coordinate with specific language term + specific type of schizophrenia if relevant ", "MS": "The artificial language of schizophrenic patients - neologisms (words of the patient's own making with new meanings).", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012564"}, {"RECTYPE": "D", "MH": "Schizophrenic Psychology", "DE": "SCHIZOPHRENIC PSYCHOL", "PRINT ENTRY": "Psychology, Schizophrenic|T057|NON|EQV|UNK (19XX)|740330|PSYCHOL SCHIZOPHRENIC|abcdefv", "MN": "F04.824", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "any mental process in schizophrenia; coordinate with specific psychological term + specific type of schizophrenia if relevant", "MS": "Study of mental processes and behavior of schizophrenics.", "CATSH": "CAT LIST", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012565"}, {"RECTYPE": "D", "MH": "Sizofiran", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Schizophyllan|T109|T121|NON|NRW|NLM (1992)|901214|abbcdef", "ENTRY": "Sonifilan|T109|T121|TRD|NRW|NLM (1992)|901214|abbcdef", "MN": "D09.698.365.089.625", "PA": "Antineoplastic Agents, Phytogenic", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "beta-D-Glucopyranosyl-(1->3)-(beta-D-glucopyranosyl-(1->6))-beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranose", "RN": "7F763NNC9X", "RR": "9050-67-3", "PI": "Mucopolysaccharides (1973-1975)", "MS": "A beta-D-glucan obtained from the Aphyllophoral fungus Schizophyllum commune. It is used as an immunoadjuvant in the treatment of neoplasms, especially tumors found in the stomach.", "PM": "1992; see SCHIZOPHYLLAN 1976-1991; SIZOFIRAN was indexed under MUCOPOLYSACCHARIDES 1976-1990", "HN": "1992 (1976); use SCHIZOPHYLLAN 1976-1991", "MR": "20180521", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D012566"}, {"RECTYPE": "D", "MH": "Schizophyllum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Schizophyllum commune|T004|NON|NRW|NLM (2005)|040212|abcdef", "ENTRY": "Schizophyllums", "MN": "B01.300.179.100.750", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5333", "RR": "txid5334", "AN": "infection: coordiante with MYCOSES or specific mycosis ", "MS": "A genus of fleshy shelf basidiomycetous fungi, family Schizophyllaceae, order AGARICALES, growing on woody substrata. It is pathogenic in humans.", "PM": "91; see BASIDIOMYCETES 1986-90, see AGARICACEAE 1975-85", "HN": "91(75)", "MR": "20200527", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012567"}, {"RECTYPE": "D", "MH": "Schizosaccharomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Yeast, Fission|T004|NON|NRW|NLM (1993)|911209|abcdef", "ENTRY": "Fission Yeasts", "MN": "B01.300.930.720", "FX": "Schizosaccharomyces pombe Proteins", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid4895", "RR": "txid4896", "MS": "A genus of ascomycetous fungi of the family Schizosaccharomycetaceae, order Schizosaccharomycetales.", "PM": "91; see ENDOMYCETALES 1986-90, see ASCOMYCETES 1975-85", "HN": "91(75)", "MR": "20200527", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012568"}, {"RECTYPE": "D", "MH": "Schizotypal Personality Disorder", "DE": "SCHIZOTYPAL PERSONALITY DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Schizophrenia, Pseudoneurotic|T048|NON|NRW|UNK (19XX)|800521|abcdef", "ENTRY": "Schizotypal Personality Disorders", "MN": "F03.675.725", "MH_TH": "NLM (1972)", "ST": "T048", "PI": "Schizophrenia (1966-1971)", "MS": "A personality disorder in which there are oddities of thought (magical thinking, paranoid ideation, suspiciousness), perception (illusions, depersonalization), speech (digressive, vague, overelaborate), and behavior (inappropriate affect in social interactions, frequently social isolation) that are not severe enough to characterize schizophrenia.", "OL": "use SCHIZOTYPAL PERSONALITY DISORDER to search SCHIZOPHRENIA, LATENT 1972-80 (as Prov 1972)", "PM": "81; was SCHIZOPHRENIA, LATENT 1973-80", "HN": "81; was SCHIZOPHRENIA, LATENT 1972-80 (Prov 1972)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012569"}, {"RECTYPE": "D", "MH": "School Admission Criteria", "AQ": "SN TD", "PRINT ENTRY": "Student Selection|T065|NON|NRW|UNK (19XX)|780112|abcdef", "ENTRY": "Student Selections", "MN": "I02.399.750", "MH_TH": "NLM (1975)", "ST": "T080", "MS": "Requirements for the selection of students for admission to academic institutions.", "PM": "91; was see under EDUCATIONAL MEASUREMENT 1975-90", "HN": "91(75); was see under EDUCATIONAL MEASUREMENT 1975-90", "MR": "20021024", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D012570"}, {"RECTYPE": "D", "MH": "School Dentistry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "School Dentistries", "MN": "N02.421.726.809.576", "MH_TH": "NLM (1972)", "ST": "T091", "PI": "School Health Services (1966-1971)", "MS": "Preventive dental services provided for students in primary and secondary schools.", "PM": "74", "HN": "74(72)", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012571"}, {"RECTYPE": "D", "MH": "School Health Services", "DE": "SCHOOL HEALTH SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Services, School-Based Health", "MN": "N02.421.726.809", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "for high schools & under; do not confuse with STUDENT HEALTH SERVICES for universities", "MS": "Preventive health services provided for students. It excludes college or university students.", "PM": "1979; see SCHOOL HEALTH 1963-1978", "HN": "1979; use SCHOOL HEALTH 1963-1978", "MR": "20181213", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D012572"}, {"RECTYPE": "D", "MH": "School Nursing", "DE": "SCHOOL NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "School Nursings", "MN": "N02.421.726.809.742", "MH_TH": "NLM (1967)", "ST": "T091", "AN": "do not confuse with SCHOOLS, NURSING", "PI": "School Health Services (1966)", "MS": "A nursing specialty concerned with health and nursing care given to primary and secondary school students by a registered nurse.", "PM": "67", "HN": "67", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D012573"}, {"RECTYPE": "D", "MH": "Schools", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Secondary School", "MN": "J03.832", "MH_TH": "POPLINE (1978)", "ST": "T092", "AN": "specify geographic location if pertinent", "MS": "Educational institutions.", "MR": "20160613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012574"}, {"RECTYPE": "D", "MH": "Schools, Dental", "DE": "SCHOOLS DENT", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Dental Schools|T073|T093|NON|EQV|NLM (1991)|900105|DENT SCHOOLS|abbcdefv", "ENTRY": "School, Dental|T073|T093|NON|EQV|NLM (1991)|900105|SCHOOL DENT|abbcdefv", "MN": "I02.783.495.481", "MH_TH": "NLM (1966)", "ST": "T093", "AN": "Manual 30.7.3, 30.8; specify geog if pertinent", "MS": "Educational institutions for individuals specializing in the field of dentistry.", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012575"}, {"RECTYPE": "D", "MH": "Schools, Health Occupations", "DE": "SCHOOLS HEALTH OCCUP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Health Occupations Schools|T073|T093|NON|EQV|NLM (1991)|900105|HEALTH OCCUP SCHOOLS|abbcdefv", "ENTRY": "School, Health Occupations", "MN": "I02.783.495", "MH_TH": "NLM (1968)", "ST": "T093", "AN": "specify geographic term if pertinent", "PI": "Universities (1966-1967)", "MS": "Schools which offer training in the area of health.", "PM": "68", "HN": "68", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012576"}, {"RECTYPE": "D", "MH": "Schools, Medical", "DE": "SCHOOLS MED", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Medical Schools|T073|T093|NON|EQV|BIOETHICS (1998)|NLM (1991)|900105|MED SCHOOLS|abbcdeefv", "ENTRY": "School, Medical|T073|T093|NON|EQV|NLM (1991)|900105|SCHOOL MED|abbcdefv", "MN": "N02.278.020.578", "MH_TH": "POPLINE (1978)", "ST": "T093", "MS": "Educational institutions for individuals specializing in the field of medicine.", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012577"}, {"RECTYPE": "D", "MH": "Schools, Nursery", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Nursery Schools|T092|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "School, Nursery", "MN": "J03.832.660", "FX": "Child Day Care Centers", "MH_TH": "NLM (1966)", "ST": "T092", "AN": "IM", "MS": "Schools for children usually under five years of age.", "MR": "20160608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012578"}, {"RECTYPE": "D", "MH": "Schools, Nursing", "DE": "SCHOOLS NURS", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Nursing Schools|T073|T093|NON|EQV|NLM (1990)|890502|NURS SCHOOLS|abbcdefv", "ENTRY": "Training Schools, Nurse", "MN": "I02.783.495.623", "MH_TH": "POPLINE (1978)", "ST": "T093", "AN": "do not confuse with SCHOOL NURSING; Manual 30.7.3, 30.8; specify geog if pertinent", "MS": "Educational institutions for individuals specializing in the field of nursing.", "MR": "20210611", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012579"}, {"RECTYPE": "D", "MH": "Schools, Pharmacy", "DE": "SCHOOLS PHARM", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Pharmacy Schools|T073|T093|NON|EQV|NLM (1991)|900105|PHARM SCHOOLS|abbcdefv", "ENTRY": "School, Pharmacy|T073|T093|NON|EQV|NLM (1991)|900105|SCHOOL PHARM|abbcdefv", "MN": "I02.783.495.694", "MH_TH": "NLM (1968)", "ST": "T093", "AN": "specify geog term if pertinent", "PI": "Education, Pharmacy (1966-1967)", "MS": "Educational institutions for individuals specializing in the field of pharmacy.", "PM": "68", "HN": "68", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012580"}, {"RECTYPE": "D", "MH": "Schools, Public Health", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Public Health Schools|T073|T093|NON|EQV|NLM (1991)|900105|abbcdef", "ENTRY": "School, Public Health", "MN": "I02.783.495.765", "MH_TH": "POPLINE (1978)", "ST": "T093", "AN": "Manual 30.7.3, 30.8; specify geog if pertinent", "MS": "Educational institutions for individuals specializing in the field of public health.", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012581"}, {"RECTYPE": "D", "MH": "Schools, Veterinary", "DE": "SCHOOLS VET", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Veterinary Schools|T073|T093|NON|EQV|NLM (1990)|890502|VET SCHOOLS|abbcdefv", "ENTRY": "Veterinary School|T073|T093|NON|EQV|NLM (1991)|900105|VET SCHOOL|abbcdefv", "MN": "I02.783.495.836", "MH_TH": "NLM (1966)", "ST": "T093", "AN": "Manual 30.7.3, 30.8; specify geog if pertinent", "MS": "Educational institutions for individuals specializing in the field of veterinary medicine.", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012582"}, {"RECTYPE": "D", "MH": "Schwann Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Schwann Cell|T025|NON|EQV|NLM (2021)|191126|abcdef", "ENTRY": "Cells, Schwann", "MN": "A11.650.800", "MH_TH": "NLM (1963)", "ST": "T025", "MS": "Neuroglial cells of the peripheral nervous system which form the insulating myelin sheaths of peripheral axons.", "PM": "68", "HN": "68(63)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012583"}, {"RECTYPE": "D", "MH": "Sciatic Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sciatic Nerves", "MN": "A08.800.800.720.450.760", "FX": "Sciatica", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A nerve which originates in the lumbar and sacral spinal cord (L4 to S3) and supplies motor and sensory innervation to the lower extremity. The sciatic nerve, which is the main continuation of the sacral plexus, is the largest nerve in the body. It has two major branches, the TIBIAL NERVE and the PERONEAL NERVE.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012584"}, {"RECTYPE": "D", "MH": "Sciatica", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sciatic Neuralgia|T184|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Sciatic Neuralgias", "MN": "C23.888.592.612.664.800", "FX": "Low Back Pain", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "do not confuse with BACK PAIN or LUMBAGO see LOW BACK PAIN: use term of text; \"lombo-sciatique\" in French texts is indexed here (IM) + LOW BACK PAIN (IM)", "MS": "A condition characterized by pain radiating from the back into the buttock and posterior/lateral aspects of the leg. Sciatica may be a manifestation of SCIATIC NEUROPATHY; RADICULOPATHY (involving the SPINAL NERVE ROOTS; L4, L5, S1, or S2, often associated with INTERVERTEBRAL DISK DISPLACEMENT); or lesions of the CAUDA EQUINA.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012585"}, {"RECTYPE": "D", "MH": "Science", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sciences", "MN": "H01.770", "FX": "Religion and Science", "MH_TH": "BIOETHICS (1976)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "MS": "The study of natural phenomena by observation, measurement, and experimentation.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012586"}, {"RECTYPE": "D", "MH": "Scimitar Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Anomaly, Scimitar", "MN": "C16.131.740.815", "MH_TH": "ORD (2010)", "ST": "T019", "PI": "Pulmonary Veins/abnormalities (1966-1984)", "MS": "An anomalous pulmonary venous return in which the right PULMONARY VEIN is not connected to the LEFT ATRIUM but to the INFERIOR VENA CAVA. Scimitar syndrome is named for the crescent- or Turkish sword-like shadow in the chest radiography and is often associated with hypoplasia of the right lung and right pulmonary artery, and dextroposition of the heart.", "PM": "85", "HN": "85", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19840529", "DC": "1", "DX": "19850101", "UI": "D012587"}, {"RECTYPE": "D", "MH": "Scintillation Counting", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Scintillation Counter", "MN": "E05.799.700", "FX": "Gamma Cameras", "MH_TH": "NLM (1973)", "ST": "T081", "PI": "Radiometry (1966-1972)", "MS": "Detection and counting of scintillations produced in a fluorescent material by ionizing radiation.", "OL": "use SCINTILLATION COUNTING to search SCINTILLATION COUNTERS 1973-78; use RADIOMETRY to search SCINITLLATION COUNTER 1966-72", "PM": "79; was SCINTILLATION COUNTERS 1973-78; was SCINTILLATION COUNTER see under RADIOMETRY 1963-72", "HN": "79; was SCINTILLATION COUNTERS 1973-78; was SCINTILLATION COUNTER see under RADIOMETRY 1963-72", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012588"}, {"RECTYPE": "D", "MH": "Sciuridae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Tamias|T015|NON|NRW|UNK (19XX)|810515|abcdef", "ENTRY": "Suslik", "MN": "B01.050.150.900.649.313.992.750", "MH_TH": "NLM (1968)", "ST": "T015", "RN": "txid55153", "RR": "txid9996", "PI": "Rodentia (1966-1967)", "MS": "A family of the order Rodentia which contains 49 genera. Some of the more common genera are MARMOTA, which includes the marmot and woodchuck; Sciurus, the gray squirrel, S. carolinensis, and the fox squirrel, S. niger; Tamias, the eastern and western chipmunk; and Tamiasciurus, the red squirrel. The flying squirrels, except the scaly-tailed Anomaluridae, also belong to this family.", "OL": "use SCIURIDAE to search SQUIRRELS 1968-81 & CHIPMUNKS & GROUND SQUIRRELS 1975-81", "PM": "82; was SQUIRRELS 1968-81; CHIPMUNKS was see under RODENTS 1975-81; GROUND SQUIRRELS was see SQUIRRELS 1981, was indexed under RODENTS or SQUIRRELS 1975-80; MARMOTA was MARMOTS see under RODENTS 1975-81", "HN": "82; was SQUIRRELS 1968-81; CHIPMUNKS was see under RODENTS 1975-81; GROUND SQUIRRELS was see SQUIRRELS 1981, was see under CHIPMUNKS 1975-80", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012589"}, {"RECTYPE": "D", "MH": "Sclera", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Scleral Spur|T023|NON|NRW|NLM (2020)|190211|abcdef", "ENTRY": "Scleras", "MN": "A09.371.784", "FX": "Sclerostomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The white, opaque, fibrous, outer tunic of the eyeball, covering it entirely excepting the segment covered anteriorly by the cornea. It is essentially avascular but contains apertures for vessels, lymphatics, and nerves. It receives the tendons of insertion of the extraocular muscles and at the corneoscleral junction contains the CANAL OF SCHLEMM. (From Cline et al., Dictionary of Visual Science, 4th ed)", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012590"}, {"RECTYPE": "D", "MH": "Scleral Buckling", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Scleral Bucklings", "MN": "E04.540.890", "FX": "Retinal Detachment", "MH_TH": "NLM (1975)", "ST": "T061", "PI": "Sclera (1966-1974)", "MS": "An operation for retinal detachment which reduces the size of the globe by indenting the sclera so that it approximates the retina.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D012591"}, {"RECTYPE": "D", "MH": "Scleredema Adultorum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Scleredemas", "MN": "C17.800.751", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "induration of skin in diabetes", "MS": "A diffuse, non-pitting induration of the skin of unknown etiology that occurs most commonly in association with diabetes mellitus, predominantly in females. It typically begins on the face or head and spreads to other areas of the body, sometimes involving noncutaneous tissues. Often it is preceded by any of various infections, notably staphylococcal infections. The condition resolves spontaneously, usually within two years of onset. (From Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012592"}, {"RECTYPE": "D", "MH": "Sclerema Neonatorum", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.804.812", "MH_TH": "NLM (1966)", "ST": "T019", "AN": "a skin abnorm; adipose tissue dis in preterm or debilitated inf; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "A severe, sometimes fatal, disorder of adipose tissue occurring chiefly in preterm or debilitated infants suffering from an underlying illness and manifested by a diffuse, nonpitting induration of the affected tissue. The skin becomes cold, yellowish, mottled, and inflexible.", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012593"}, {"RECTYPE": "D", "MH": "Scleroderma, Localized", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Scleroderma, Circumscribed|T047|NON|EQV|NLM (1971)|990101|abcdef", "ENTRY": "Sclerodermas, Localized", "MN": "C17.800.767", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with SCLERODERMA, LIMITED", "PI": "Scleroderma, Systemic (1966-1970)", "MS": "A term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques (morphea), bands (linear), or nodules.", "PM": "2004; see SCLERODERMA, CIRCUMSCRIBED 1971-2003", "HN": "2004 (1971)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D012594"}, {"RECTYPE": "D", "MH": "Scleroderma, Systemic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sclerosis, Systemic|T047|NON|EQV|NLM (1997)|960227|abcdef", "ENTRY": "Systemic Sclerosis|T047|NON|EQV|GHR (2014)|NLM (2004)|030509|abcdeef", "MN": "C17.800.784", "MH_TH": "NLM (1971)", "ST": "T047", "AN": "note specific indentations and SCLERODERMA, LOCALIZED", "MS": "A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.", "PM": "1971; SCLERODERMA was heading 1963-70", "HN": "1971", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D012595"}, {"RECTYPE": "D", "MH": "Scleroproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Scleroprotein|T116|T123|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Protein, Fibrous", "MN": "D12.776.860", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Simple proteins characterized by their insolubility and fibrous structure. Within the body, they perform a supportive or protective function.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012596"}, {"RECTYPE": "D", "MH": "Sclerosing Solutions", "DE": "SCLEROSING SOL", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sclerosing Solution|T121|NON|EQV|NLM (2021)|200330|abcdef", "ENTRY": "Solutions, Sclerosing", "MN": "D27.720.752.822", "FX": "Sclerotherapy", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "coordinate /ther use with disease /ther, not disease /drug ther", "MS": "Chemical agents injected into blood vessels and lymphatic sinuses to shrink or cause localized THROMBOSIS; FIBROSIS, and obliteration of the vessels. This treatment is applied in a number of conditions such as VARICOSE VEINS; HEMORRHOIDS; GASTRIC VARICES; ESOPHAGEAL VARICES; PEPTIC ULCER HEMORRHAGE.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012597"}, {"RECTYPE": "D", "MH": "Sclerosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Scleroses", "MN": "C23.550.823", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "NIM as pathol process with no qualif: coord with Cat A term /pathol (IM)", "MS": "A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012598"}, {"RECTYPE": "D", "MH": "Sclerostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Sclerostomies", "MN": "E04.579.895", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Sclera/surgery (1971-1987)", "MS": "Surgical formation of an external opening in the sclera, primarily in the treatment of glaucoma.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19870323", "DC": "1", "DX": "19880101", "UI": "D012599"}, {"RECTYPE": "D", "MH": "Scoliosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Scolioses", "MN": "C05.116.900.800.875", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "a type of spinal curvature", "MS": "An appreciable lateral deviation in the normally straight vertical line of the spine. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19940411", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012600"}, {"RECTYPE": "D", "MH": "Scopolamine", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Scopolamine Hydrobromide|T109|T121|NRW|FDA SRS (2014)|NLM (2012)|USP (19XX)|821206|abbdeeef", "ENTRY": "Transderm V", "MN": "D03.605.869.822.775", "PA": "Mydriatics", "EC": "analogs & derivatives:Scopolamine Derivatives", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "DL48G20X8X", "RR": "451IFR0GXB", "MS": "An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics like ATROPINE, but may have more central nervous system effects. Its many uses include an anesthetic premedication, the treatment of URINARY INCONTINENCE and MOTION SICKNESS, an antispasmodic, and a mydriatic and cycloplegic.", "PM": "2019; see SCOPOLAMINE HYDROBROMIDE 1982-2018", "HN": "2019 (1966)", "MR": "20180619", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012601"}, {"RECTYPE": "D", "MH": "Scopolamine Derivatives", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Derivatives, Scopolamine", "MN": "D03.605.869.822", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Tropanes (1966-1974)", "MS": "Analogs or derivatives of scopolamine.", "OL": "search SCOPOLAMINE 1966-74 & TROPANES 1969-74", "PM": "78; was see under SCOPOLAMINE 1975-77, was see under TROPANES 1969-74; BUTYLSCOPOLAMMONIUM BROMIDE was see under SCOPOLAMINE 1976-77", "HN": "78(75); was see under SCOPOLAMINE 1975-77, was see under TROPANES 1969-74", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D012602"}, {"RECTYPE": "D", "MH": "Scopoletin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylesculetin|T109|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Acid, Gelseminic", "MN": "D03.633.100.150.446.912.850", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-", "RN": "KLF1HS0SXJ", "RR": "92-61-5 (Scopoletin)", "PI": "Coumarins (1969-1974)", "MS": "Plant growth factor derived from the root of Scopolia carniolica or Scopolia japonica.", "PM": "91; was see under UMBELLIFERONES 1977-90; was see under COUMARINS 1975-76", "HN": "91(75); was see under UMBELLIFERONES 1977-90; was see under COUMARINS 1975-76", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012603"}, {"RECTYPE": "D", "MH": "Scorpion Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE TO TU UR", "PRINT ENTRY": "Tityus serrulatus Venom|T123|T131|NON|NRW|NLM (2021)|200131|abbcdef", "ENTRY": "gamma Scorpion Toxin", "MN": "D23.946.833.065.830", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTIVENINS; /enzymol permitted", "PI": "Venoms (1966-1977)", "MS": "Venoms from animals of the order Scorpionida of the class Arachnida. They contain neuro- and hemotoxins, enzymes, and various other factors that may release acetylcholine and catecholamines from nerve endings. Of the several protein toxins that have been characterized, most are immunogenic.", "PM": "78", "HN": "78", "MR": "20200527", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D012604"}, {"RECTYPE": "D", "MH": "Scorpions", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Scorpion", "MN": "B01.050.500.131.166.661", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6855", "AN": "includes the genera Androctonus, Buthus, Centruoides, Leiurus, Nebo, Tityus; SCORPION STINGS is available", "MS": "Arthropods of the order Scorpiones, of which 1500 to 2000 species have been described. The most common live in tropical or subtropical areas. They are nocturnal and feed principally on insects and other arthropods. They are large arachnids but do not attack man spontaneously. They have a venomous sting. Their medical significance varies considerably and is dependent on their habits and venom potency rather than on their size. At most, the sting is equivalent to that of a hornet but certain species possess a highly toxic venom potentially fatal to humans. (From Dorland, 27th ed; Smith, Insects and Other Arthropods of Medical Importance, 1973, p417; Barnes, Invertebrate Zoology, 5th ed, p503)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012605"}, {"RECTYPE": "D", "MH": "Scotland", "AQ": "EH EP", "MN": "Z01.542.363.766", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "The most northerly of the four countries of the United Kingdom, occupying about one-third of the island of Great Britain. The capital is Edinburgh.", "MR": "20171211", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D012606"}, {"RECTYPE": "D", "MH": "Scotoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Scotoma, Centrocecal|T033|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Sector Scotomas", "MN": "C23.888.592.763.941.811", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES (e.g., RETINAL DISEASES and GLAUCOMA); OPTIC NERVE DISEASES, and other conditions.", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012607"}, {"RECTYPE": "D", "MH": "Scrapie", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Rida|T047|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "C22.836.799", "FX": "Prions", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a prion dis; usually animal: check tag ANIMAL; if in sheep, coord IM with SHEEP (NIM) but do not index under SHEEP DISEASES; if in goats, coord IM with GOAT DISEASES (IM) & GOATS (NIM)", "MS": "A fatal disease of the nervous system in sheep and goats, characterized by pruritus, debility, and locomotor incoordination. It is caused by proteinaceous infectious particles called PRIONS.", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012608"}, {"RECTYPE": "D", "MH": "Screw Worm Infection", "DE": "SCREW WORM INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Screw Worm Myiases", "MN": "C01.610.858.211.503.744", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Infection with larvae of the blow fly Cochliomyia hominivorax (Callitroga americanum), a common cause of disease in livestock in the southern and southwestern U.S.A.", "OL": "search MYIASIS 1968-74", "PM": "91; was see under MYIASIS 1975-90", "HN": "91(75); was see under MYIASIS 1975-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012610"}, {"RECTYPE": "D", "MH": "Scrotum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Scrotums", "MN": "A05.360.444.661", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A cutaneous pouch of skin containing the testicles and spermatic cords.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012611"}, {"RECTYPE": "D", "MH": "Scrub Typhus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Typhus, Scrub|T047|NON|EQV|UNK (19XX)|860618|abcdef", "ENTRY": "Tsutsugamushi Fevers", "MN": "C01.920.914.850", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by ORIENTIA TSUTSUGAMUSHI", "MS": "An acute infectious disease caused by ORIENTIA TSUTSUGAMUSHI. It is limited to eastern and southeastern Asia, India, northern Australia, and the adjacent islands. Characteristics include the formation of a primary cutaneous lesion at the site of the bite of an infected mite, fever lasting about two weeks, and a maculopapular rash.", "OL": "use SCRUB TYPHUS to search TSUTSUGAMUSHI 1966-91", "PM": "TSUTSUGAMUSHI DISEASE was TSUTSUGAMUSHI see SCRUB TYPHUS 1963-91", "HN": "TSUTSUGAMUSHI DISEASE was TSUTSUGAMUSHI see SCRUB TYPHUS 1963-91", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012612"}, {"RECTYPE": "D", "MH": "Sculpture", "AQ": "CL ED ES HI PX SN TD", "ENTRY": "Sculptures", "MN": "K01.093.849", "MH_TH": "NLM (1975)", "ST": "T170", "OL": "search ART 1966-74", "PM": "91; was see under ART 1975-90", "HN": "91(75); was see under ART 1975-90", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012613"}, {"RECTYPE": "D", "MH": "Scurvy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Scorbutus|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Scurvies", "MN": "C18.654.521.500.133.115.661", "FX": "Ascorbic Acid Deficiency", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "An acquired blood vessel disorder caused by severe deficiency of vitamin C (ASCORBIC ACID) in the diet leading to defective collagen formation in small blood vessels. Scurvy is characterized by bleeding in any tissue, weakness, ANEMIA, spongy gums, and a brawny induration of the muscles of the calves and legs.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012614"}, {"RECTYPE": "D", "MH": "Sea Anemones", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Actiniaria|T204|NON|EQV|NLM (2003)|020130|abcdef", "ENTRY": "Sea Anemone", "MN": "B01.050.500.308.237.750", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid6103", "MS": "The order Actiniaria, in the class ANTHOZOA, comprised of large, solitary polyps. All species are carnivorous.", "PM": "91; was see under COELENTERATA 1975-90", "HN": "91(75); was see under COELENTERATA 1975-90", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012615"}, {"RECTYPE": "D", "MH": "Sea Cucumbers", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Holothuroidea|T204|NON|EQV|UNK (19XX)|770127|abcdef", "ENTRY": "Sea Cucumber", "MN": "B01.050.500.408.560", "MH_TH": "NLM (1978)", "ST": "T204", "RN": "txid7705", "AN": "note specifics", "PI": "Echinodermata (1966-1977)", "MS": "A class of Echinodermata characterized by long, slender bodies.", "PM": "91; was see under ECHINODERMATA 1978-90", "HN": "91(78); was see under ECHINODERMATA 1978-90", "MR": "20200813", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D012616"}, {"RECTYPE": "D", "MH": "Sea Urchins", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sand-Dollar|T204|NON|NRW|UNK (19XX)|750211|abcdef", "ENTRY": "Urchins, Sea", "MN": "B01.050.500.408.578", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid7625", "RR": "txid31186", "PI": "Echinodermata (1966-1971)", "MS": "Somewhat flattened, globular echinoderms, having thin, brittle shells of calcareous plates. They are useful models for studying FERTILIZATION and EMBRYO DEVELOPMENT.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012617"}, {"RECTYPE": "D", "MH": "Sea-Blue Histiocyte Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Histiocytosis, Sea-Blue|T047|NON|EQV|NLM (1990)|OMIM (2013)|ORD (2010)|890119|abcdeeef", "ENTRY": "Syndromes, Sea-Blue Histiocyte", "MN": "C18.452.648.595.554.825.775", "FX": "Niemann-Pick Diseases", "MH_TH": "NLM (1984)", "ST": "T047", "PI": "Histiocytes (1966-1983)", "MS": "A congenital disease caused by an inborn error involving APOLIPOPROTEINS E leading to abnormal LIPID METABOLISM and the accumulation of GLYCOSPHINGOLIPIDS, particularly SPHINGOMYELINS in the HISTIOCYTES. This disorder is characterized by SPLENOMEGALY and the sea-blue histiocytes in the spleen and bone marrow after May Grunwald staining.", "PM": "1984", "HN": "1984", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19830531", "DC": "1", "DX": "19840101", "UI": "D012618"}, {"RECTYPE": "D", "MH": "Seasons", "ENTRY": "Variations, Seasonal", "MN": "N06.230.300.100.250.525", "MH_TH": "NLM (1966)", "ST": "T079", "MS": "Divisions of the year according to some regularly recurrent phenomena usually astronomical or climatic. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012621"}, {"RECTYPE": "D", "MH": "Seat Belts", "AQ": "AE CL EC ES HI LJ MI PS SD SN ST TD VE VI", "ENTRY": "Seat Belt", "MN": "E07.700.800", "FX": "Child Restraint Systems", "MH_TH": "NLM (1970)", "ST": "T073", "PI": "Automobiles (1966-1969)", "MS": "Restraining belts fastened to the frame of automobiles, aircraft, or other vehicles, and strapped around the person occupying the seat in the car or plane, intended to prevent the person from being thrown forward or out of the vehicle in case of sudden deceleration.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D012622"}, {"RECTYPE": "D", "MH": "Seawater", "AQ": "AE AN CH MI PS VI", "ENTRY": "Waters, Sea", "MN": "G16.500.275.725.500", "FX": "Geologic Sediments", "MH_TH": "NLM (1969)", "ST": "T167", "PI": "Water (1966-1968)", "MS": "The salinated water of OCEANS AND SEAS that provides habitat for marine organisms.", "PM": "74", "HN": "74(69)", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012623"}, {"RECTYPE": "D", "MH": "Seaweed", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Macroalgae|T002|NON|EQV|NLM (2011)|091112|abcdef", "MN": "B05.080.750", "FX": "Rhodophyta", "MH_TH": "NLM (1966)", "ST": "T002", "AN": "coordinate with specific alga if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29", "MS": "Multicellular marine macroalgae including some members of red (RHODOPHYTA), green (CHLOROPHYTA), and brown (PHAEOPHYCEAE) algae. They are widely distributed in the ocean, occurring from the tide level to considerable depths, free-floating (planktonic) or anchored to the substratum (benthic). They lack a specialized vascular system but take up fluids, nutrients, and gases directly from the water. They contain CHLOROPHYLL and are photosynthetic, but some also contain other light-absorbing pigments. Many are of economic importance as FOOD, fertilizer, AGAR, potash, or source of IODINE.", "MR": "20230727", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012624"}, {"RECTYPE": "D", "MH": "Sebaceous Gland Diseases", "DE": "SEBACEOUS GLAND DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sebaceous Gland Disease", "MN": "C17.800.794", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Skin Appendage Diseases (1966-1997)", "MS": "Diseases of the sebaceous glands such as sebaceous hyperplasia and sebaceous cell carcinoma (SEBACEOUS GLAND NEOPLASMS).", "PM": "98", "HN": "98; use explode 1976-97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012625"}, {"RECTYPE": "D", "MH": "Sebaceous Gland Neoplasms", "DE": "SEBACEOUS GLAND NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Sebaceous Gland Neoplasm", "MN": "C17.800.882.712", "MH_TH": "NLM (1968)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM)", "PI": "Skin Neoplasms (1966-1967)", "MS": "New abnormal growth of tissue in the SEBACEOUS GLANDS.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012626"}, {"RECTYPE": "D", "MH": "Sebaceous Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sebaceous Gland", "MN": "A17.815.805", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Small, sacculated organs found within the DERMIS. Each gland has a single duct that emerges from a cluster of oval alveoli. Each alveolus consists of a transparent BASEMENT MEMBRANE enclosing epithelial cells. The ducts from most sebaceous glands open into a HAIR FOLLICLE, but some open on the general surface of the SKIN. Sebaceous glands secrete SEBUM.", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012627"}, {"RECTYPE": "D", "MH": "Dermatitis, Seborrheic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Seborrhea|T033|T047|NON|EQV|NLM (1993)|920402|abbcdef", "ENTRY": "Seborrheic Dermatitides", "MN": "C17.800.859.350", "FX": "Dandruff", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A chronic inflammatory disease of the skin with unknown etiology. It is characterized by moderate ERYTHEMA, dry, moist, or greasy (SEBACEOUS GLAND) scaling and yellow crusted patches on various areas, especially the scalp, that exfoliate as dandruff. Seborrheic dermatitis is common in children and adolescents with HIV INFECTIONS.", "OL": "use DERMATITIS, SEBORRHEIC to search SEBORRHEA 1966-92", "PM": "93; was SEBORRHEA 1963-92", "HN": "93; was SEBORRHEA 1963-92", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D012628"}, {"RECTYPE": "D", "MH": "Sebum", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Sebums", "MN": "A12.200.702", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "The oily substance secreted by SEBACEOUS GLANDS. It is composed of KERATIN, fat, and cellular debris.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012629"}, {"RECTYPE": "D", "MH": "Secobarbital", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Quinalbarbitone|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Sodium, Secobarbital", "MN": "D03.383.742.698.253.762", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-", "RN": "1P7H87IN75", "RR": "XBP604F6UM", "MS": "A barbiturate that is used as a sedative. Secobarbital is reported to have no anti-anxiety activity.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012631"}, {"RECTYPE": "D", "MH": "Secosteroids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.210.500.812", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Steroids in which fission of one or more ring structures and concomitant addition of a hydrogen atom at each terminal group has occurred.", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012632"}, {"RECTYPE": "D", "MH": "Secretin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "SecretinKABI", "MN": "D12.776.631.650.705", "PA": "Hormones", "MH_TH": "JAN (19XX)", "ST": "T125", "RN": "1393-25-5", "RR": "67307-60-2 (pig, citrate (salt))", "MS": "A peptide hormone of about 27 amino acids from the duodenal mucosa that activates pancreatic secretion and lowers the blood sugar level. (USAN and the USP Dictionary of Drug Names, 1994, p597)", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012633"}, {"RECTYPE": "D", "MH": "Bodily Secretions", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Secretions|T031|NON|EQV|NLM (1998)|970224|abcdef", "ENTRY": "Secretions, Bodily", "MN": "A12.200", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "general or unspecified; prefer specifics ", "PI": "specific substance/secretion (1966-1997)", "MS": "Endogenous substances produced through the activity of intact cells of glands, tissues, or organs.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012634"}, {"RECTYPE": "D", "MH": "Secretory Component", "DE": "SECRET COMPONENT", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Secretory Piece|T116|T129|T192|NON|EQV|UNK (19XX)|750701|SECRET PIECE|abbbcdefv", "MN": "D12.776.377.715.548.705.875", "PA": "Immunologic Factors", "MH_TH": "NLM (1976)", "ST": "T192", "RN": "0", "PI": "Immunoglobulin Fragments (1973-1975)", "MS": "The extracellular moiety of the POLYMERIC IMMUNOGLOBULIN RECEPTOR found alone or complexed with IGA or IGM, in a variety of external secretions (tears, bile, colostrum.) Secretory component is derived by proteolytic cleavage of the receptor during transcytosis. When immunoglobulins IgA and IgM are bound to the receptor, during their transcytosis secretory component becomes covalently attached to them generating SECRETORY IMMUNOGLOBULIN A or secretory IMMUNOGLOBULIN M.", "PM": "91; was see under IMMUNOGLOBULIN FRAGMENTS 1976-90", "HN": "91(76); was see under IMMUNOGLOBULIN FRAGMENTS 1976-90", "MR": "20050630", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D012635"}, {"RECTYPE": "D", "MH": "Secretory Rate", "DE": "SECRET RATE", "AQ": "DE ES GE IM PH RE", "ENTRY": "Secretory Rates", "MN": "G03.857", "MH_TH": "NLM (1966)", "ST": "T081", "AN": "usually NIM; restrict to secretion of endogenous substances ", "MS": "The amount of a substance secreted by cells or by a specific organ or organism over a given period of time; usually applies to those substances which are formed by glandular tissues and are released by them into biological fluids, e.g., secretory rate of corticosteroids by the adrenal cortex, secretory rate of gastric acid by the gastric mucosa.", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012636"}, {"RECTYPE": "D", "MH": "Security Measures", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Security, National", "MN": "N04.452.910", "MH_TH": "NLM (1978)", "ST": "T089", "AN": "med or non-med contexts", "MS": "Regulations to assure protection of property and equipment.", "PM": "78", "HN": "78", "MR": "20020703", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D012637"}, {"RECTYPE": "D", "MH": "Seeds", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Zygotes, Plant|T002|T168|NON|EQV|NLM (1998)|960823|abbcdef", "ENTRY": "Zygote, Plant", "MN": "J02.500.775", "FX": "Nuts", "MH_TH": "NLM (1966)", "ST": "T168", "MS": "The encapsulated embryos of flowering plants. They are used as is or for animal feed because of the high content of concentrated nutrients like starches, proteins, and fats. Rapeseed, cottonseed, and sunflower seed are also produced for the oils (fats) they yield.", "OL": "use EMBRYO, PLANT to search EMBRYOS, PLANT 1986-94", "PM": "63; EMBRYO, PLANT was EMBRYOS, PLANT see SEEDS 1986-94", "HN": "63; EMBRYO, PLANT was EMBRYOS, PLANT see SEEDS 1986-94", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D012639"}, {"RECTYPE": "D", "MH": "Seizures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tonic-Clonic Seizure|T184|NON|NRW|NLM (2021)|191122|abcdef", "ENTRY": "Visual Seizures", "MN": "C23.888.592.742", "FX": "Kindling, Neurologic", "MH_TH": "NLM (1979)", "ST": "T184", "AN": "specific seizure terms are also available", "PI": "specific epilepsy heading (1966-1978)", "MS": "Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or \"seizure disorder.\"", "PM": "1979; for CONVULSIVE SEIZURES & SEIZURES, CONVULSIVE see CONVULSIONS 1998-1999; for JACKSONIAN SEIZURE see EPILEPSY, PARTIAL 1992-1999; for SINGLE SEIZURE see EPILEPSY 2000-2017; for EPILEPTIC SEIZURES see EPILEPSY 1998-2017; for ABSENCE SEIZURES see EPILEPSY, ABSENCE 1992-2017", "HN": "1979; for CONVULSIVE SEIZURES & SEIZURES, CONVULSIVE use CONVULSIONS 1998-1999; for JACKSONIAN SEIZURE use EPILEPSY, PARTIAL 1992-1999; for SINGLE SEIZURE use EPILEPSY 2000-2017; for EPILEPTIC SEIZURES use EPILEPSY 1998-2017; for ABSENCE SEIZURES use EPILEPSY, ABSENCE 1992-2017", "CATSH": "CAT LIST", "MR": "20200225", "DA": "19780517", "DC": "1", "DX": "19790101", "UI": "D012640"}, {"RECTYPE": "D", "MH": "Selection, Genetic", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Natural Selection|T045|NON|NRW|UNK (19XX)|780322|abcdef", "ENTRY": "Selection, Natural", "MN": "G05.783", "FX": "Genetic Fitness", "MH_TH": "NLM (2010)", "ST": "T045", "PI": "Genetics, Population (1966-1967)", "MS": "Differential and non-random reproduction of different genotypes, operating to alter the gene frequencies within a population.", "OL": "use EVOLUTION & SELECTION (GENETICS) to search NATURAL SELECTION 1978", "PM": "2010; see SELECTION (GENETICS) 1979-2009; NATURAL SELECTION was indexed under EVOLUTION 1978", "HN": "68; NATURAL SELECTION was indexed under EVOLUTION 1978", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012641"}, {"RECTYPE": "D", "MH": "Selegiline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Deprenyl|T109|T121|TRD|NRW|UNK (19XX)|830404|abbcdef", "ENTRY": "E250", "MN": "D02.092.471.683.915", "PA": "Neuroprotective Agents", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, (R)-", "RN": "2K1V7GP655", "RR": "6W731X367Q", "PI": "Phenethylamines (1966-1978)", "MS": "A selective, irreversible inhibitor of Type B monoamine oxidase that is used for the treatment of newly diagnosed patients with PARKINSON DISEASE, and for the treatment of depressive disorders. The compound without isomeric designation is Deprenyl.", "OL": "use SELEGILINE to search DEPRENYL 1979-83", "PM": "91; was see under PHENETHYLAMINES 1984-90; was DEPRENYL see under PHENETHYLAMINES 1979-83", "HN": "91(84); was see under PHENETHYLAMINES 1984-90; was DEPRENYL see under PHENETHYLAMINES 1979-83", "MR": "20180702", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D012642"}, {"RECTYPE": "D", "MH": "Selenium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Selenium 80", "MN": "D01.578.700", "PA": "Trace Elements", "FX": "Selenium Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "H6241UJ22B", "RR": "7782-49-2 (Selenium)", "MS": "An element with the atomic symbol Se, atomic number 34, and atomic weight 78.97. It is an essential micronutrient for mammals and other animals but is toxic in large amounts. Selenium protects intracellular structures against oxidative damage. It is an essential component of GLUTATHIONE PEROXIDASE.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012643"}, {"RECTYPE": "D", "MH": "Selenium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Selenium", "MN": "D01.496.749.780", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Selenium (1966-1987)", "MS": "Unstable isotopes of selenium that decay or disintegrate emitting radiation. Se atoms with atomic weights 70-73, 75, 79, 81, and 83-85 are radioactive selenium isotopes.", "PM": "88", "HN": "88", "MR": "20170705", "DA": "19870408", "DC": "1", "DX": "19880101", "UI": "D012644"}, {"RECTYPE": "D", "MH": "Selenomethionine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Selenomethionine Se 75|T116|T121|T130|NON|NRW|FDA SRS (2014)|UNK (19XX)|USAN (19XX)|741111|abbbcdeeef", "ENTRY": "Se 75, Selenomethionine", "MN": "D12.125.166.676.900", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "964MRK2PEL", "RR": "P6708E7555", "AN": "for radiolabeled selenomethionine, coordinate with SELENIUM RADIOISOTOPES or see Supplementary Concept Records for  specific radiolabeled selnomethionine terms", "PI": "Selenium (1969-1974)", "MS": "Diagnostic aid in pancreas function determination.", "PM": "91; was see under SELENIUM 1975-90", "HN": "91(75); was see under SELENIUM 1975-90", "MR": "20190701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012645"}, {"RECTYPE": "D", "MH": "Self Administration", "DE": "SELF ADMIN", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Self Administrations", "MN": "E02.900.890", "MH_TH": "NLM (1977)", "ST": "T061", "AN": "NIM; differentiate from SELF MEDICATION & SELF CARE (see note there)", "PI": "specific heading/administration & dosage (1966-1976)", "MS": "Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D012646"}, {"RECTYPE": "D", "MH": "Self-Assessment", "PRINT ENTRY": "Self Assessment (Psychology)|T041|NON|EQV|NLM (1975)|990101|SELF ASSESS PSYCHOL|abcdefv", "ENTRY": "Self-Criticisms", "MN": "F01.752.747.792.537", "FX": "Metacognition", "MH_TH": "NLM (2011)", "ST": "T041", "AN": "do not confuse with DIAGNOSTIC SELF EVALUATION, used in the context of disease diagnosis", "PI": "Self Concept (1969-1974)", "MS": "Appraisal of one's own personal qualities or traits.", "PM": "2011; see SELF ASSESSMENT (PSYCHOLOGY) 1979-2010, see SELF CONCEPT 1969-1978", "HN": "2011 (1969)", "CATSH": "CAT LIST", "MR": "20150109", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D012647"}, {"RECTYPE": "D", "MH": "Self Care", "AQ": "AE CL EC ES HI IS MO MT PX SN ST TD VE", "ENTRY": "Care, Self", "MN": "N02.421.784.680", "MH_TH": "POPLINE (1986)", "ST": "T058", "AN": "= care prescribed by MD or generated by person himself & includes care for self, family or friends; differentiate from SELF MEDICATION (medication not prescribed by MD) and SELF ADMINISTRATION (admin of medication prescribed by MD or self admin of substances by exper animals)", "PI": "Patient Participation (1978)", "MS": "Caring for self when ill or positive actions and adopting behaviors to prevent illness.", "PM": "81; was see ACTIVITIES OF DAILY LIVING 1979-80", "HN": "81; was see ACTIVITIES OF DAILY LIVING 1979-80", "CATSH": "CAT LIST", "MR": "20180601", "DA": "19800519", "DC": "1", "DX": "19810101", "UI": "D012648"}, {"RECTYPE": "D", "MH": "Self Concept", "PRINT ENTRY": "Self Perception|T041|NON|REL|NLM (1984)|780503|abcdef", "ENTRY": "Self-Perceptions", "MN": "F01.752.747.792", "FX": "Personal Autonomy", "MH_TH": "NLM (2019)", "ST": "T041", "AN": "do not confuse with SELF PSYCHOLOGY", "MS": "Persons' view of themselves.", "OL": "use SELF CONCEPT to search SELF PERCEPTION 1969-78", "PM": "69", "HN": "69; SELF PERCEPTION was see under SELF CONCEPT 1969-78", "CATSH": "CAT LIST", "MR": "20200429", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012649"}, {"RECTYPE": "D", "MH": "Self Disclosure", "ENTRY": "Self Disclosures", "MN": "F01.752.747.792.662", "MH_TH": "NLM (1975)", "ST": "T055", "PI": "Self Concept (1969-1974)", "MS": "A willingness to reveal information about oneself to others.", "OL": "search SELF CONCEPT 1969-74", "PM": "79; was see under SELF CONCEPT 1969-78", "HN": "79(75); was see under SELF CONCEPT 1969-78", "CATSH": "CAT LIST", "MR": "19890516", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D012650"}, {"RECTYPE": "D", "MH": "Self Medication", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Self Medications", "MN": "E02.900.900", "MH_TH": "NLM (1965)", "ST": "T055", "AN": "differentiate from SELF ADMINISTRATION & SELF CARE (see note there)", "MS": "The self administration of medication not prescribed by a physician or in a manner not directed by a physician.", "PM": "68", "HN": "68(65)", "CATSH": "CAT LIST", "MR": "19950523", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012651"}, {"RECTYPE": "D", "MH": "Self Mutilation", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Self Mutilating Behavior|T037|T048|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abbcdeef", "ENTRY": "Self Mutilating Behaviors", "MN": "F01.145.126.980.750", "MH_TH": "NLM (1966)", "ST": "T048", "AN": "SELF-INJURIOUS BEHAVIOR is also available", "MS": "The act of injuring one's own body to the extent of cutting off or permanently destroying a limb or other essential part of a body.", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012652"}, {"RECTYPE": "D", "MH": "Self Stimulation", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Self-Stimulation|T041|T055|NON|EQV|NLM (2022)|201230|abbcdef", "ENTRY": "Stimulations, Self", "MN": "F02.830.784", "MH_TH": "NLM (1964)", "ST": "T055", "AN": "human & animal", "MS": "The act or process of inducing or increasing the level of arousal in oneself. It can be observed in various situations; for example, infants who are understimulated may explore their surroundings or babble to themselves.(https://dictionary.apa.org/self-stimulation accessed 12/30/2020)", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "20211202", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012653"}, {"RECTYPE": "D", "MH": "Self-Care Units", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Minimal Care Units|T073|NON|NRW|UNK (19XX)|770519|abcdef", "ENTRY": "Units, Self-Care", "MN": "N02.278.388.740", "MH_TH": "NLM (1977)", "ST": "T093", "MS": "Rooms in health care facilities for patients who require a minimal level of care.", "PM": "91; was see under HOSPITAL UNITS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL UNITS 1977-90", "MR": "19920518", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D012654"}, {"RECTYPE": "D", "MH": "Self-Evaluation Programs", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Self-Evaluation Program", "MN": "I02.399.780", "MH_TH": "NLM (1979)", "ST": "T065", "PI": "Educational Measurement (1974-1978)", "MS": "Educational programs structured in such a manner that the participating professionals, physicians, or students develop an increased awareness of their performance, usually on the basis of self-evaluation questionnaires.", "PM": "91; was see under EDUCATIONAL MEASUREMENT 1979-90", "HN": "91(79); was see under EDUCATIONAL MEASUREMENT 1979-90", "MR": "19920518", "DA": "19780510", "DC": "1", "DX": "19910101", "UI": "D012655"}, {"RECTYPE": "D", "MH": "Self-Help Devices", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Assistive Technology|T074|NON|EQV|NLM (1999)|980306|abcdef", "ENTRY": "Technology, Assistive", "MN": "E07.796", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "Devices, not affixed to the body, designed to help persons having musculoskeletal or neuromuscular disabilities to perform activities involving movement.", "CATSH": "CAT LIST", "MR": "19980611", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012656"}, {"RECTYPE": "D", "MH": "Self-Help Groups", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Support Groups|T095|NON|EQV|NLM (1995)|940124|abcdef", "ENTRY": "Therapeutic Social Club", "MN": "N03.540.782", "MH_TH": "NLM (1975)", "ST": "T095", "PI": "Organizations (1968-1972)", "MS": "Organizations which provide an environment encouraging social interactions through group activities or individual relationships especially for the purpose of rehabilitating or supporting patients, individuals with common health problems, or the elderly. They include therapeutic social clubs.", "OL": "use SELF-HELP GROUPS to search SOCIAL CLUBS (now SOCIAL CLUBS, THERAPEUTIC see SELF-HELP GROUPS) 1973-78 (as Prov 1973-74)", "PM": "79; was SOCIAL CLUBS see under ORGANIZATIONS 1975-78", "HN": "79; was SOCIAL CLUBS see under ORGANIZATIONS 1975-78, was SOCIAL CLUBS 1973-74 (Prov)", "MR": "19940523", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D012657"}, {"RECTYPE": "D", "MH": "Sella Turcica", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Turcicas, Sella", "MN": "A02.835.232.781.802.662", "FX": "Empty Sella Syndrome", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "A bony prominence situated on the upper surface of the body of the sphenoid bone. It houses the PITUITARY GLAND.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012658"}, {"RECTYPE": "D", "MH": "Semantic Differential", "DE": "SEMANTIC DIFFER", "AQ": "HI SN ST", "ENTRY": "Semantic Differentials", "MN": "F04.711.647.745", "MH_TH": "NLM (1968)", "ST": "T170", "AN": "a type of psychological test: do not confuse with SEMANTICS", "PI": "Semantics (1966-1967)", "MS": "Analysis of word concepts by the association of polar adjectives, e.g., good-bad, with the concept, father. The adjectives are usually scaled in 7 steps. The subject's placement of the concept on the adjectival scale indicates the connotative meaning of the concept.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012659"}, {"RECTYPE": "D", "MH": "Semantics", "ENTRY": "Semantic", "MN": "L01.559.598.745", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "do not confuse with LINGUISTICS or TERMINOLOGY AS TOPIC ", "MS": "The relationships between symbols and their meanings.", "MR": "20170707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012660"}, {"RECTYPE": "D", "MH": "Semen", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Seminal Plasma|T031|NON|NRW|NLM (1995)|940309|abcdef", "ENTRY": "Plasma, Seminal", "MN": "A12.200.732", "FX": "Spermatozoa", "MH_TH": "POPLINE (1978)", "ST": "T031", "AN": "semen donors: coord SEMEN (IM) + TISSUE DONORS (IM); consider also INSEMINATION, ARTIFICIAL, HOMOLOGOUS (husband) (IM) or INSEMINATION, ARTIFICIAL, HETEROLOGOUS (non-husband) (IM) if pertinent; HEMOSPERMIA is available", "MS": "The thick, yellowish-white, viscid fluid secretion of male reproductive organs discharged upon ejaculation. In addition to reproductive organ secretions, it contains SPERMATOZOA and their nutrient plasma.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012661"}, {"RECTYPE": "D", "MH": "Semen Preservation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Sperm Preservation|T058|NON|NRW|NLM (1995)|940309|abcdef", "ENTRY": "Semen, Frozen", "MN": "E05.760.833.890", "FX": "Tissue and Organ Harvesting", "MH_TH": "NLM (1978)", "ST": "T058", "AN": "cryopreservation of semen: coord IM with CRYOPRESERVATION (IM)", "PI": "Semen (1966-1977)", "MS": "The process by which semen is kept viable outside of the organism from which it was derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism).", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D012662"}, {"RECTYPE": "D", "MH": "Semicarbazides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.845", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of UREA where one of the amino groups is replaced with hydrazine.", "PM": "66", "HN": "66", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012663"}, {"RECTYPE": "D", "MH": "Semicarbazones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Semicarbazone|T109|NON|EQV|NLM (2021)|191118|abcdef", "MN": "D02.845.746", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Thiosemicarbazones (1966-1971)", "MS": "A class of organic compounds that are derivatives of imines formed by condensation reactions between KETONES or ALDEHYDES and SEMICARBAZIDES.", "PM": "74", "HN": "74(72)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012664"}, {"RECTYPE": "D", "MH": "Semicircular Canals", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Semi-Circular Canals|T023|NON|EQV|NLM (2023)|211012|abcdef", "ENTRY": "Semicircular Canal", "MN": "A09.246.300.663", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Three long canals (anterior, posterior, and lateral) of the bony labyrinth. They are set at right angles to each other and are situated posterosuperior to the vestibule of the bony labyrinth (VESTIBULAR LABYRINTH). The semicircular canals have five openings into the vestibule with one shared by the anterior and the posterior canals. Within the canals are the SEMICIRCULAR DUCTS.", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012665"}, {"RECTYPE": "D", "MH": "Semiconductors", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Semiconductor", "MN": "E07.305.625", "FX": "Quantum Dots", "MH_TH": "NLM (1967)", "ST": "T073", "PI": "Electronics (1966)", "MS": "Materials that have a limited and usually variable electrical conductivity. They are particularly useful for the production of solid-state electronic devices.", "PM": "73", "HN": "73(67); was in Cat H & J 1967-82", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012666"}, {"RECTYPE": "D", "MH": "Lunate Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Semilunar Bone|T023|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Semilunar Bones", "MN": "A02.835.232.087.319.150.500", "MH_TH": "NLM (2001)", "ST": "T023", "MS": "A moon-shaped carpal bone which is located between the SCAPHOID BONE and TRIQUETRUM BONE.", "PM": "2006; see SEMILUNAR BONE 1963-2005", "HN": "2006 (1963)", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D012667"}, {"RECTYPE": "D", "MH": "Trigeminal Ganglion", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Semilunar Ganglion|T023|NON|EQV|NLM (1990)|881202|abcdef", "ENTRY": "Trigeminal Ganglions", "MN": "A08.800.800.120.760.825", "MH_TH": "NLM (1975)", "ST": "T023", "AN": "neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "The semilunar-shaped ganglion containing the cells of origin of most of the sensory fibers of the trigeminal nerve. It is situated within the dural cleft on the cerebral surface of the petrous portion of the temporal bone and gives off the ophthalmic, maxillary, and part of the mandibular nerves.", "OL": "use TRIGEMINAL NERVE to search SEMILUNAR GANGLION 1966-74; use TRIGEMINAL GANGLION 1975-89", "PM": "90; was SEMILUNAR GANGLION see under TRIGEMINAL NERVE 1963-89", "HN": "90(75); was SEMILUNAR GANGLION see under TRIGEMINAL NERVE 1963-89", "MR": "19940411", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D012668"}, {"RECTYPE": "D", "MH": "Seminal Vesicles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vesicles, Seminal", "MN": "A05.360.444.713", "MH_TH": "POPLINE (1978)", "ST": "T023", "MS": "A saclike, glandular diverticulum on each ductus deferens in male vertebrates. It is united with the excretory duct and serves for temporary storage of semen. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "MR": "19950523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012669"}, {"RECTYPE": "D", "MH": "Seminiferous Epithelium", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Seminiferous Epitheliums", "MN": "A10.272.700", "MH_TH": "NLM (1975)", "ST": "T024", "MS": "The epithelium lining the seminiferous tubules composed of primary male germ cells (SPERMATOGONIA) and supporting SERTOLI CELLS. As SPERMATOGENESIS proceeds, the developing germ cells migrate toward the lumen. The adluminal compartment, the inner two thirds of the tubules, contains SPERMATOCYTES and the more advanced germ cells.", "PM": "91; was see under TESTIS 1975-90", "HN": "91(75); was see under TESTIS 1975-90", "MR": "20130709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D012670"}, {"RECTYPE": "D", "MH": "Seminiferous Tubules", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tubules, Seminiferous", "MN": "A05.360.444.849.700", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "The convoluted tubules in the TESTIS where sperm are produced (SPERMATOGENESIS) and conveyed to the RETE TESTIS. Spermatogenic tubules are composed of developing germ cells and the supporting SERTOLI CELLS.", "PM": "91; was see under TESTIS 1975-90", "HN": "91(75); was see under TESTIS 1975-90", "MR": "20020703", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D012671"}, {"RECTYPE": "D", "MH": "Semliki forest virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.578.875.054.840", "MH_TH": "NLM (1964)", "ST": "T005", "RN": "txid11033", "AN": "infection: coord IM with ALPHAVIRUS INFECTIONS (IM)", "MS": "A species of ALPHAVIRUS isolated in central, eastern, and southern Africa.", "PM": "66", "HN": "66(64)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012672"}, {"RECTYPE": "D", "MH": "Semustine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methyl-CCNU|T109|T121|EQV|UNK (19XX)|741111|abbdef", "ENTRY": "NSC95441", "MN": "D02.654.692.440.700", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "USAN (1972)", "ST": "T121", "N1": "Urea, N-(2-chloroethyl)-N'-(4-methylcyclohexyl)-N-nitroso-", "RN": "13909-09-6", "PI": "Urea (1966-1972)", "MS": "4-Methyl derivative of LOMUSTINE; (CCNU). An antineoplastic agent which functions as an alkylating agent.", "PM": "91; was see under NITROSOUREA COMPOUNDS 1975-90", "HN": "91(75); was see under NITROSOUREA COMPOUNDS 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012673"}, {"RECTYPE": "D", "MH": "Senecio", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ragwort|T002|NON|NRW|UNK (19XX)|850516|abcdef", "ENTRY": "Senecios", "MN": "B01.875.800.575.912.250.100.800", "FX": "Pyrrolizidine Alkaloids", "MH_TH": "NLM (1966)", "ST": "T002", "RN": "txid18794", "AN": "poisonous to livestock", "MS": "A species of toxic plants of the Compositae. The poisonous compounds are alkaloids which cause cattle diseases, neoplasms, and liver damage and are used to produce cancers in experimental animals.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012674"}, {"RECTYPE": "D", "MH": "Senegal", "AQ": "EH EP", "ENTRY": "Republic of Senegal|T083|NAM|EQV|NLM (2009)|080401|abcdef", "MN": "Z01.058.290.190.710", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in western Africa, southwest of MAURITANIA and east of MALI. Its capital is Dakar.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D012675"}, {"RECTYPE": "D", "MH": "Senna Extract", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sennae Fructus|T123|NON|REL|NLM (2022)|210223|abcdef", "ENTRY": "Pods, Senna", "MN": "D20.215.784.500.860", "PA": "Cathartics", "MH_TH": "JAN (19XX)", "ST": "T123", "RN": "8013-11-4", "RR": "S8SJ19N2NX", "AN": "SENNA PLANT is also available", "MS": "Preparations of SENNA PLANT. They contain sennosides, which are anthraquinone type CATHARTICS and are used in many different preparations as laxatives.", "PM": "2002; see SENNA 1963-2001", "HN": "2002(1963)", "MR": "20230607", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D012676"}, {"RECTYPE": "D", "MH": "Sensation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Sensory Function|T041|T042|NON|EQV|NLM (2009)|080305|abbcdef", "ENTRY": "Sensory Functions", "MN": "G11.561.790", "FX": "Perception", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "SENSATION DISORDERS is available but burning, tingling or prickling sensations go under PARESTHESIA", "MS": "The process in which specialized SENSORY RECEPTOR CELLS transduce peripheral stimuli (physical or chemical) into NERVE IMPULSES which are then transmitted to the various sensory centers in the CENTRAL NERVOUS SYSTEM.", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012677"}, {"RECTYPE": "D", "MH": "Sensation Disorders", "DE": "SENSATION DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Special Senses Disorders|T047|NON|NRW|NLM (2000)|991108|SPECIAL SENSES DIS|abcdefv", "ENTRY": "Special Senses Disorder", "MN": "C23.888.592.763", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Sensation (1969-1992)", "MS": "Disorders of the special senses (i.e., VISION; HEARING; TASTE; and SMELL) or somatosensory system (i.e., afferent components of the PERIPHERAL NERVOUS SYSTEM).", "PM": "1993", "HN": "1993; was SENSATION DISORDERS (NON MESH) 1967-92", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D012678"}, {"RECTYPE": "D", "MH": "Sense Organs", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sensory System|T023|NON|BRD|NLM (2022)|210514|abcdef", "ENTRY": "System, Sensory", "MN": "A09", "RH": "A9 - ANATOMY-SENSE ORGANS", "FX": "Sensory Receptor Cells", "MH_TH": "NLM (1972)", "ST": "T023", "AN": "general: prefer specifics", "PI": "Sensation (1966-1971)", "MS": "Specialized organs adapted for the reception of stimuli by the NERVOUS SYSTEM.", "PM": "72", "HN": "72", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012679"}, {"RECTYPE": "D", "MH": "Sensitivity and Specificity", "DE": "SENSITIVITY SPECIFICITY", "PRINT ENTRY": "Specificity|T081|NON|NRW|UNK (19XX)|860325|abcdef", "ENTRY": "Specificity and Sensitivity", "MN": "N06.850.520.830.872", "FX": "Diagnostic Techniques and Procedures", "MH_TH": "NLM (1987)", "ST": "T081", "AN": "IM general only; coordinate (NIM) with specific concept (IM)", "MS": "Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)", "OL": "use SENSITIVITY AND SPECIFICITY to search SENSITIVITY AND SPECIFICITY (EPIDEMIOLOGY) 1987-90", "PM": "91; was SENSITIVITY AND SPECIFICITY (EPIDEMIOLOGY) 1987-90", "HN": "91; was SENSITIVITY AND SPECIFICITY (EPIDEMIOLOGY) 1987-90", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19860325", "DC": "1", "DX": "19870101", "UI": "D012680"}, {"RECTYPE": "D", "MH": "Sensitivity Training Groups", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "T-Groups|T065|EQV|UNK (19XX)|740330|abdef", "ENTRY": "Training Groups, Sensitivity", "MN": "F04.754.864.581.813", "MH_TH": "NLM (1969)", "ST": "T065", "PI": "Group Processes (1966-1968)", "MS": "A group of people who meet in an unstructured setting to learn about themselves, interpersonal relationships, and group processes and about larger social systems.", "PM": "72; ENCOUNTER GROUPS was heading 1975-96 (see under SENSITIVITY TRAINING GROUPS 1975-90)", "HN": "72(69); ENCOUNTER GROUPS was heading 1975-96 (see under SENSITIVITY TRAINING GROUPS 1975-90)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012681"}, {"RECTYPE": "D", "MH": "Sensory Aids", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Sensory Aid", "MN": "E07.814", "MH_TH": "NLM (1973)", "ST": "T074", "AN": "for hearing loss consider HEARING AIDS; for Braille coordinate with VISION DISORDERS  + READING", "PI": "Deafness/rehabilitation (1966-1972)", "MS": "Devices and materials used to extend the functioning of the senses, most often including materials adapted for those  having visual or hearing impairments and also includes materials that have been translated from one sensory mode to another. (ERIC https://eric.ed.gov/?qt=braille&ti=Sensory+Aids accessed 12/31/2020)", "PM": "74", "HN": "74(73)", "CATSH": "CAT LIST", "MR": "20210706", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012682"}, {"RECTYPE": "D", "MH": "Sensory Deprivation", "AQ": "PH", "ENTRY": "Sensory Deprivations", "MN": "F02.463.593.696", "MH_TH": "NLM (1966)", "ST": "T068", "AN": "human & animal", "MS": "The absence or restriction of the usual external sensory stimuli to which the individual responds.", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012683"}, {"RECTYPE": "D", "MH": "Sensory Thresholds", "AQ": "CL DE ES PH RE", "ENTRY": "Thresholds, Sensory", "MN": "F02.463.593.710", "FX": "Signal Detection, Psychological", "MH_TH": "NLM (1979)", "ST": "T081", "MS": "The minimum amount of stimulus energy necessary to elicit a sensory response.", "PM": "79", "HN": "79; was THRESHOLD (NON MESH) before 1979", "CATSH": "CAT LIST", "MR": "20080710", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D012684"}, {"RECTYPE": "D", "MH": "Sepharose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Agarose|T109|T122|NON|EQV|UNK (19XX)|741209|abbcdef", "ENTRY": "C1 4B, Sepharose", "MN": "D09.698.813", "MH_TH": "NLM (1975)", "ST": "T122", "N1": "Agarose", "RN": "9012-36-6", "OL": "search POLYSACCHARIDES 1974", "PM": "84; was see under POLYSACCHARIDES 1975-83", "HN": "84(75); was see under POLYSACCHARIDES 1975-83", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D012685"}, {"RECTYPE": "D", "MH": "Septal Nuclei", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Septofimbrial Nucleus|T023|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Triangularis Septus, Nucleus", "MN": "A08.186.211.200.885.750.800", "MH_TH": "NLM (1972)", "ST": "T023", "PI": "Limbic System (1966-1971)", "MS": "Neural nuclei situated in the septal region. They have afferent and cholinergic efferent connections with a variety of FOREBRAIN and BRAIN STEM areas including the HIPPOCAMPAL FORMATION, the LATERAL HYPOTHALAMUS, the tegmentum, and the AMYGDALA. Included are the dorsal, lateral, medial, and triangular septal nuclei, septofimbrial nucleus, nucleus of diagonal band, nucleus of anterior commissure, and the nucleus of stria terminalis.", "PM": "78; was see under SEPTUM PELLUCIDUM 1975-77", "HN": "78(72); was see under SEPTUM PELLUCIDUM 1975-77", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D012686"}, {"RECTYPE": "D", "MH": "Septum Pellucidum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Supracommissural Septums", "MN": "A08.186.211.200.885.750.814", "MH_TH": "NLM (1973)", "ST": "T023", "PI": "Cerebral Ventricles (1966-1972)", "MS": "A triangular double membrane separating the anterior horns of the LATERAL VENTRICLES of the brain. It is situated in the median plane and bounded by the CORPUS CALLOSUM and the body and columns of the FORNIX (BRAIN).", "PM": "73", "HN": "73", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012688"}, {"RECTYPE": "D", "MH": "Sequence Homology, Nucleic Acid", "DE": "SEQ HOMOL NUCLEIC ACID", "PRINT ENTRY": "Homologous Sequences, Nucleic Acid|T086|NON|REL|UNK (19XX)|850503|HOMOL SEQ NUCLEIC ACID|abcdefv", "ENTRY": "Sequence Homologies, Base", "MN": "G05.810.550", "FX": "Sequence Alignment", "MH_TH": "NLM (1986)", "ST": "T081", "AN": "coordinate with specific nucleic acid", "PI": "Nucleic Acid Hybridization (1971-1985)", "MS": "The sequential correspondence of nucleotides in one nucleic acid molecule with those of another nucleic acid molecule. Sequence homology is an indication of the genetic relatedness of different organisms and gene function.", "PM": "91; was see under BASE SEQUENCE 1986-90", "HN": "91(86); was see under BASE SEQUENCE 1986-90", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19850503", "DC": "1", "DX": "19910101", "UI": "D012689"}, {"RECTYPE": "D", "MH": "Serial Extraction", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Serial Extractions", "MN": "E06.658.641.890", "MH_TH": "NLM (1971)", "ST": "T061", "PI": "Tooth Extraction (1966-1970)", "MS": "The selective extraction of deciduous teeth during the stage of mixed dentition in accordance with the shedding and eruption of the teeth. It is done over an extended period to allow autonomous adjustment to relieve crowding of the dental arches during the eruption of the lateral incisors, canines, and premolars, eventually involving the extraction of the first premolar teeth. (Dorland, 28th ed)", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012690"}, {"RECTYPE": "D", "MH": "Serial Learning", "AQ": "CL DE ES PH RE", "ENTRY": "Serial Learnings", "MN": "F02.463.425.952.747", "MH_TH": "NLM (1964)", "ST": "T041", "MS": "Learning to make a series of responses in exact order.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D012691"}, {"RECTYPE": "D", "MH": "Serial Passage", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Serial Passages", "MN": "E05.200.875.837", "MH_TH": "NLM (1988)", "ST": "T062", "AN": "restrict to in vivo or in vitro passage of infectious organisms or develop of vaccines: do not use for passage of cultured cells, cell lines, etc.; NIM; coord with organism or vaccine (IM)", "PI": "Virus Cultivation (1966-1987)", "MS": "Inoculation of a series of animals or in vitro tissue with an infectious bacterium or virus, as in VIRULENCE studies and the development of vaccines.", "PM": "91; was see under MICROBIOLOGICAL TECHNIQUES 1988-90", "HN": "91(88); was see under MICROBIOLOGICAL TECHNIQUES 1988-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19870509", "DC": "1", "DX": "19910101", "UI": "D012692"}, {"RECTYPE": "D", "MH": "Serial Publications", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Serial Publication", "MN": "L01.462.500.682.829", "MH_TH": "NLM (1974)", "ST": "T170", "AN": "general or unspecified; prefer specifics; coordinate with subject of the publication", "PI": "specific publication (1966-1997)", "MS": "Publications in any medium issued in successive parts bearing numerical or chronological designations and intended to be continued indefinitely. (ALA Glossary of Library and Information Science, 1983, p203)", "PM": "98", "HN": "98; use explode 1975-97", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012693"}, {"RECTYPE": "D", "MH": "Serine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L Serine", "MN": "D12.125.154.800", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "L-Serine", "RN": "452VLY9402", "RR": "56-45-1 (Serine)", "MS": "A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012694"}, {"RECTYPE": "D", "MH": "L-Serine Dehydratase", "DS": "SERINE DEHYDRATASE L", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serine Dehydratase|T116|T126|NON|EQV|NLM (1998)|961127|abbcdef", "ENTRY": "Serine Threonine Dehydratase", "MN": "D08.811.520.232.400.600", "MH_TH": "NLM (1967)", "ST": "T126", "N1": "L-Serine hydro-lyase (deaminating)", "RN": "EC 4.3.1.17", "RR": "9014-27-1 (CAS RN)", "AN": "specific for L-serine", "PI": "Hydro-Lyases (1966)", "MS": "A PYRIDOXAL-phosphate containing enzyme that catalyzes the dehydration and deamination of L-serine to form pyruvate. This enzyme was formerly listed as EC 4.2.1.13.", "PM": "98; see SERINE DEHYDRATASE 1972-97; for SERINE DEAMINASE see HYDRO-LYASES 1963-71", "HN": "98(67); for SERINE DEAMINASE use HYDRO-LYASES 1963-71", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012695"}, {"RECTYPE": "D", "MH": "Glycine Hydroxymethyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Threonine Aldolase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Transhydroxymethylase, Serine", "MN": "D08.811.913.555.400.500", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "5,10-Methylenetetrahydrofolate:glycine hydroxymethyltransferase", "RN": "EC 2.1.2.1", "RR": "9029-83-8 (CAS RN)", "PI": "Transferases (1973-1974)", "MS": "A pyridoxal phosphate enzyme that catalyzes the reaction of glycine and 5,10-methylene-tetrahydrofolate to form serine. It also catalyzes the reaction of glycine with acetaldehyde to form L-threonine. EC 2.1.2.1.", "PM": "98; see SERINE HYDROXYMETHYLTRANSFERASE 1991-97, see TRANSFERASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012696"}, {"RECTYPE": "D", "MH": "Serine Endopeptidases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serine Endopeptidase|T116|T126|NON|EQV|NLM (2024)|230508|abbcdef", "ENTRY": "Endopeptidases, Serine", "MN": "D08.811.277.656.959.350", "EC": "antagonists & inhibitors:Serine Proteinase Inhibitors", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.4.21.-", "RR": "EC 3.4.99.-", "AN": "do not confuse with SERINE PROTEASES", "PI": "Peptide Peptidohydrolases (1966-1987)", "MS": "Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis.", "PM": "2000; see SERINE PROTEINASES 1988-1999", "HN": "2000(1988)", "MR": "20230612", "DA": "19870504", "DC": "1", "DX": "19880101", "UI": "D012697"}, {"RECTYPE": "D", "MH": "Serologic Tests", "DE": "SEROL TESTS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Serodiagnosis|T059|NON|REL|NLM (1998)|970410|SERODIAG|abcdefv", "ENTRY": "Tests, Serological", "MN": "E05.478.594.760", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "general or unspecified; prefer specifics; do not confuse with SEROLOGY, the specialty", "MS": "Diagnostic procedures involving immunoglobulin reactions.", "PM": "98; see SERODIAGNOSIS 1963-97", "HN": "98(63)", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012698"}, {"RECTYPE": "D", "MH": "Serology", "DE": "SEROL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.781", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "do not confuse with SEROLOGIC TESTS", "MS": "The study of serum, especially of antigen-antibody reactions in vitro.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012699"}, {"RECTYPE": "D", "MH": "Serositis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Serositides", "MN": "C23.550.470.646", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Inflammation of a serous membrane.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012700"}, {"RECTYPE": "D", "MH": "Serotonin", "AQ": "AA AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "5-Hydroxytryptamine|T109|T123|NON|EQV|FDA SRS (2014)|NLM (1993)|920405|HYDROXYTRYPTAMINE A 05|abbcdeefs", "ENTRY": "5 Hydroxytryptamine", "MN": "D23.469.050.650", "PA": "Serotonin Receptor Agonists", "FX": "Serotonin Syndrome", "EC": "antagonists & inhibitors:Serotonin Antagonists", "MH_TH": "POPLINE (1978)", "ST": "T123", "N1": "1H-Indol-5-ol, 3-(2-aminoethyl)-", "RN": "333DO1RDJY", "RR": "50-67-9 (Serotonin)", "MS": "A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator.", "OL": "use SEROTONIN to search HYDROXYTRYPTAMINE 1975-92", "PM": "HYDROXYTRYPTAMINE was see SEROTONIN 1975-92", "HN": "HYDROXYTRYPTAMINE was see SEROTONIN 1975-92", "MR": "20220715", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012701"}, {"RECTYPE": "D", "MH": "Serotonin Antagonists", "DE": "SEROTONIN ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Serotonin Receptor Blocker|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Receptor Blockers, Serotonin", "MN": "D27.505.696.577.850.850", "FX": "Selective Serotonin Reuptake Inhibitors", "MH_TH": "NLM (1978)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; differentiate from SEROTONIN UPTAKE INHIBITORS: do not confuse with SEROTONIN AGONISTS", "PI": "Serotonin/antagonists & inhibitors (1968-1977)", "MS": "Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS.", "PM": "1978, 1964-1967", "HN": "1978(1964)", "MR": "20220718", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D012702"}, {"RECTYPE": "D", "MH": "Serotyping", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Serotypings", "MN": "E05.478.594.780", "FX": "Serogroup", "MH_TH": "NLM (1968)", "ST": "T059", "PI": "Bacteriological Techniques (1966-1967)", "MS": "Process of determining and distinguishing species of bacteria or viruses based on antigens they share.", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20150522", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D012703"}, {"RECTYPE": "D", "MH": "Serous Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Serosa|T024|NON|EQV|NLM (2006)|041022|abcdef", "ENTRY": "Membranes, Serous", "MN": "A10.615.789", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "A thin lining of closed cavities of the body, consisting of a single layer of squamous epithelial cells (MESOTHELIUM) resting on a thin layer of CONNECTIVE TISSUE, and covered with secreted clear fluid from blood and lymph vessels. Major serous membranes in the body include PERICARDIUM; PERITONEUM; and PLEURA.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012704"}, {"RECTYPE": "D", "MH": "Serratia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.720", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid613", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the natural environment (soil, water, and plant surfaces) or as an opportunistic human pathogen.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012705"}, {"RECTYPE": "D", "MH": "Serratia marcescens", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.720.500", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid615", "AN": "in water, soil, dairy products, insects; do not use /blood-csf-urine; opportunistic; infection: coord IM with SERRATIA INFECTIONS (IM)", "MS": "A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in soil, water, food, and clinical specimens. It is a prominent opportunistic pathogen for hospitalized patients.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012706"}, {"RECTYPE": "D", "MH": "Sertoli Cell Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumor, Sertoli Cell", "MN": "C19.391.829.782.500.500", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with TESTICULAR NEOPLASMS (IM) in male or OVARIAN NEOPLASMS (IM) if in female", "MS": "Gonadal neoplasm composed entirely of SERTOLI CELLS or may have a component of GRANULOSA CELLS. Some of the Sertoli cell tumors produce ESTROGEN or ANDROGENS, but seldom in sufficient quantity to cause clinical symptoms such as FEMINIZATION or masculinization (VIRILISM).", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012707"}, {"RECTYPE": "D", "MH": "Sertoli Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Sertoli Cell|T025|NON|EQV|NLM (2021)|191129|abcdef", "ENTRY": "Cells, Sertoli", "MN": "A11.436.837", "MH_TH": "NLM (1964)", "ST": "T025", "MS": "Supporting cells projecting inward from the basement membrane of SEMINIFEROUS TUBULES. They surround and nourish the developing male germ cells and secrete the ANDROGEN-BINDING PROTEIN and hormones such as ANTI-MULLERIAN HORMONE. The tight junctions of Sertoli cells with the SPERMATOGONIA and SPERMATOCYTES provide a BLOOD-TESTIS BARRIER.", "PM": "68", "HN": "68(64)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012708"}, {"RECTYPE": "D", "MH": "Serum Albumin", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Plasma Albumin|T116|T123|NON|BRD|NLM (2004)|030313|abbcdef", "ENTRY": "Albumin, Serum", "MN": "D12.776.124.727", "FX": "Receptors, Albumin", "EC": "urine:Albuminuria", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules.", "MR": "20150602", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012709"}, {"RECTYPE": "D", "MH": "Serum Albumin, Bovine", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fetal Calf Serum|T116|NON|NRW|NLM (2021)|191122|abcdef", "ENTRY": "Serum, Fetal Calf", "MN": "D12.776.124.727.875", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "27432CM55Q", "MS": "Serum albumin from cows, commonly used in in vitro biological studies. (From Stedman, 25th ed)", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012710"}, {"RECTYPE": "D", "MH": "Serum Albumin, Radio-Iodinated", "DE": "RISA", "AQ": "AA AD AE AG AI AN BL CF CH CL CS DE EC HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Serum Albumin, Radio Iodinated", "MN": "D12.776.124.727.906.750", "PA": "Radiopharmaceuticals", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "MS": "Normal human serum albumin mildly iodinated with radioactive iodine (131-I) which has a half-life of 8 days, and emits beta and gamma rays. It is used as a diagnostic aid in blood volume determination. (from Merck Index, 11th ed)", "MR": "20170629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012711"}, {"RECTYPE": "D", "MH": "Serum Globulins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serum Globulin|T116|T123|NON|EQV|NLM (2022)|201023|abbcdef", "ENTRY": "Globulins, Serum", "MN": "D12.776.377.715", "MH_TH": "NLM (1970)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "OL": "use SERUM GLOBULINS to search SERUM GLOBULIN 1966-69", "PM": "70; was SERUM GLOBULIN 1963-69", "HN": "70; was SERUM GLOBULIN 1963-69", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D012712"}, {"RECTYPE": "D", "MH": "Serum Sickness", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sicknesses, Serum", "MN": "C25.100.468.380.800", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Immune complex disease caused by the administration of foreign serum or serum proteins and characterized by fever, lymphadenopathy, arthralgia, and urticaria. When they are complexed to protein carriers, some drugs can also cause serum sickness when they act as haptens inducing antibody responses.", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012713"}, {"RECTYPE": "D", "MH": "Serine-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Seryl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961106|abbdef", "ENTRY": "Synthetase, Seryl-tRNA", "MN": "D08.811.464.263.200.750", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Serine:tRNA(Ser) ligase (AMP-forming)", "RN": "EC 6.1.1.11", "PI": "Serine (1973-1974)", "MS": "An enzyme that activates serine with its specific transfer RNA. EC 6.1.1.11.", "PM": "98; see SERYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012714"}, {"RECTYPE": "D", "MH": "Sesame Oil", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sesame Oils", "MN": "J02.500.375.400.725", "MH_TH": "NLM (1987)", "ST": "T168", "N1": "Fats and Glyceridic oils, sesame", "RN": "8008-74-0", "AN": "an unsaturated fat", "MS": "The refined fixed oil obtained from the seed of one or more cultivated varieties of Sesamum indicum. It is used as a solvent and oleaginous vehicle for drugs and has been used internally as a laxative and externally as a skin softener. It is used also in the manufacture of margarine, soap, and cosmetics. (Dorland, 28th ed & Random House Unabridged Dictionary, 2d ed)", "PM": "91; was see under PLANT OILS 1987-90; was heading 1966-86", "HN": "91(87)66; was see under PLANT OILS 1987-90; was heading 1966-86", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012715"}, {"RECTYPE": "D", "MH": "Sesamoid Bones", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sesamoid Bone", "MN": "A02.835.232.730", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Nodular bones which lie within a tendon and slide over another bony surface. The kneecap (see PATELLA) is a sesamoid bone.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012716"}, {"RECTYPE": "D", "MH": "Sesquiterpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sesquiterpenoid|T109|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Derivatives, Sesquiterpene", "MN": "D02.455.849.765", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Fifteen-carbon compounds formed from three isoprenoid units with general formula C15H24.", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012717"}, {"RECTYPE": "D", "MH": "Set, Psychology", "PRINT ENTRY": "Set (Psychology)|T041|NON|EQV|NLM (1965)|990101|SET PSYCHOL|abcdefv", "ENTRY": "Set, Psychological", "MN": "F02.463.425.838", "MH_TH": "NLM (2020)", "ST": "T041", "MS": "Readiness to think or respond in a predetermined way when confronted with a problem or stimulus situation.", "PM": "2020; was SET (PSYCHOLOGY) 1965-2019", "HN": "2020 (1965); was SET (PSYCHOLOGY) 1965-2019", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012718"}, {"RECTYPE": "D", "MH": "Setariasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Setariases", "MN": "C22.674.377.820", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "/drug ther: consider FILARICIDES", "MS": "Infection with nematodes of the genus Setaria. This condition is usually seen in cattle and equines and is of little pathogenic significance, although migration of the worm to the eye may lead to blindness.", "OL": "search FILARIASIS 1968-74", "PM": "91; was see under FILARIASIS 1975-90", "HN": "91(75); was see under FILARIASIS 1975-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012719"}, {"RECTYPE": "D", "MH": "Severity of Illness Index", "ENTRY": "Illness Index Severity", "MN": "N06.850.520.308.980.438.475.364.500", "MH_TH": "NLM (1986)", "ST": "T081", "AN": "TRAUMA SEVERITY INDICES is also available but do not confuse with TRIAGE, emergency selection of patients by priority of need", "MS": "Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.", "OL": "search DIAGNOSTIC RELATED GROUPS 1984-85", "PM": "89; was see under DIAGNOSTIC RELATED GROUPS 1986-88; was SEVERITY OF ILLNESS CLASSIFICATION see CASE MIX 1984-85", "HN": "89(86); was see under DIAGNOSTIC RELATED GROUPS 1986-88; was SEVERITY OF ILLNESS CLASSIFICATION see CASE MIX 1984-85", "MR": "20211202", "DA": "19850523", "DC": "1", "DX": "19890101", "UI": "D012720"}, {"RECTYPE": "D", "MH": "Carbaryl", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "insecticide Vetoquinol, Poudre", "MN": "D04.615.638.162", "PA": "Insecticides", "MH_TH": "FDA SRS (2014)", "ST": "T131", "N1": "1-Naphthalenol, methylcarbamate", "RN": "R890C8J3N1", "RR": "63-25-2 (Carbaryl)", "PI": "Insecticides (1966-1970)", "MS": "A carbamate insecticide and parasiticide. It is a potent anticholinesterase agent belonging to the carbamate group of reversible cholinesterase inhibitors. It has a particularly low toxicity from dermal absorption and is used for control of head lice in some countries.", "OL": "use CARBARYL to search SEVIN 1971-91 (as Prov 1971-73)", "PM": "92; was SEVIN 1974-91; CARBARYL was see SEVIN 1976-91; SEVIN was see CARBARYL 1991-95", "HN": "92; was SEVIN 1971-91 (Prov 1971-73); CARBARYL was see SEVIN 1976-91; SEVIN was see CARBARYL 1991-95", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012721"}, {"RECTYPE": "D", "MH": "Sewage", "AQ": "AE AN CH LJ MI PS SN VI", "PRINT ENTRY": "Sludge|T069|NON|NRW|NLM (1996)|950109|abcdef", "ENTRY": "Sludge Flocs|T069|NON|REL|NLM (2019)|180228|abcdef", "MN": "D20.944.932.500", "MH_TH": "NLM (1966)", "ST": "T069", "RN": "0", "AN": "entry term SLUDGE: usually mudlike ooze in sewage but non-sewage sludge is indexed under other specific waste term", "MS": "Refuse liquid or waste matter carried off by sewers.", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012722"}, {"RECTYPE": "D", "MH": "Sex", "ENTRY": "Sex, Phenotypic", "MN": "G08.686.810", "FX": "Sexual Behavior", "EC": "education:Sex Education", "MH_TH": "NLM (1966)", "ST": "T032", "AN": "differentiate from SEX FACTORS, largely statist in concept; sex therapy: coord PSYCHOTHERAPY (IM) + SEXUAL DYSFUNCTION, PHYSIOLOGICAL /ther or PSYCHOSEXUAL DYSFUNCTIONS /ther or their indentions /ther (IM)", "MS": "The totality of characteristics of reproductive structure, functions, PHENOTYPE, and GENOTYPE, differentiating the MALE from the FEMALE organism.", "CATSH": "CAT LIST", "MR": "20100628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012723"}, {"RECTYPE": "D", "MH": "Sex Attractants", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sexual Pheromone|T123|NON|EQV|NLM (2022)|201023|abcdef", "ENTRY": "Sexual Pheromones", "MN": "D23.641.800", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "human & animal pheromones", "PI": "Sex Behavior (1966-1967)", "MS": "Pheromones that elicit sexual attraction or mating behavior usually in members of the opposite sex in the same species.", "OL": "search PHEROMONES 1968-74", "PM": "91; was see under PHEROMONES 1975-90", "HN": "91(75); was see under PHEROMONES 1975-90", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012724"}, {"RECTYPE": "D", "MH": "Sexual Behavior", "AQ": "CL DE EH ES HI PH PX RE SN", "PRINT ENTRY": "Sexual Orientation|T041|NON|NRW|NLM (1994)|920810|abcdef", "ENTRY": "Sex, Oral", "MN": "F01.145.802", "FX": "Sexual Partners", "MH_TH": "NLM (2004)", "ST": "T055", "AN": "human only: SEXUAL BEHAVIOR, ANIMAL is available; do not confuse entry term SEXUAL ORIENTATION with GENDER IDENTITY (see note there)", "MS": "Sexual activities of humans.", "PM": "2004; see SEX BEHAVIOR 1966-2003", "HN": "2004 (1966)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D012725"}, {"RECTYPE": "D", "MH": "Sexual Behavior, Animal", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Mating Behavior, Animal|T054|NON|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Sexual Behaviors, Animal", "MN": "F01.145.113.252.748", "MH_TH": "NLM (2007)", "ST": "T054", "PI": "Sex Behavior (1966-1967)", "MS": "Sexual activities of animals.", "PM": "2007; see SEX BEHAVIOR, ANIMAL 1968-2006", "HN": "2007 (1968)", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012726"}, {"RECTYPE": "D", "MH": "Sex Characteristics", "PRINT ENTRY": "Sexual Dichromatism|T032|NON|NRW|NLM (2021)|191129|abcdef", "ENTRY": "Sexual Dimorphisms", "MN": "G08.686.815", "FX": "Sexual Selection", "MH_TH": "NLM (1966)", "ST": "T032", "AN": "note SEX DETERMINATION PROCESSES; SEX DIFFERENTIATION; SEX DISTRIBUTION; and SEX FACTORS are also available", "MS": "Those characteristics that distinguish one SEX from the other. The primary sex characteristics are the OVARIES and TESTES and their related hormones. Secondary sex characteristics are those which are masculine or feminine but not directly related to reproduction.", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012727"}, {"RECTYPE": "D", "MH": "Sex Chromatin", "AQ": "CH CL DE EN GE IM IP ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Chromatin, Sex|T026|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Sex Chromatins", "MN": "G05.360.162.865.800", "FX": "Sex Determination Analysis", "MH_TH": "NLM (1966)", "ST": "T026", "MS": "In the interphase nucleus, a condensed mass of chromatin representing an inactivated X chromosome. Each X CHROMOSOME, in excess of one, forms sex chromatin (Barr body) in the mammalian nucleus. (from King & Stansfield, A Dictionary of Genetics, 4th ed)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012728"}, {"RECTYPE": "D", "MH": "Sex Chromosome Aberrations", "AQ": "CI CL DE EM RE SN VE", "PRINT ENTRY": "Sex Chromosome Abnormalities|T019|T047|NON|EQV|NLM (1968)|990101|SEX CHROMOSOME ABNORM|abbcdefv", "ENTRY": "Sex Chromosome Abnormality", "MN": "G05.365.590.175.815", "FX": "Sex Chromosome Disorders of Sex Development", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "coordinate with specific sex chromosome (IM)", "PI": "Sex (1966-1967)", "MS": "Abnormal number or structure of the SEX CHROMOSOMES. Some sex chromosome aberrations are associated with SEX CHROMOSOME DISORDERS and SEX CHROMOSOME DISORDERS OF SEX DEVELOPMENT.", "PM": "1968; see SEX CHROMOSOME ABNORMALITIES 1968-2001", "HN": "1968", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012729"}, {"RECTYPE": "D", "MH": "Sex Chromosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Gonosomes|T026|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Sex Chromosome", "MN": "G05.360.162.865", "EC": "abnormalities:Sex Chromosome Aberrations", "MH_TH": "NLM (1968)", "ST": "T026", "PI": "Sex Chromatin (1966-1967)", "MS": "The homologous chromosomes that are dissimilar in the heterogametic sex. There are the X CHROMOSOME, the Y CHROMOSOME, and the W, Z chromosomes (in animals in which the female is the heterogametic sex (the silkworm moth Bombyx mori, for example)). In such cases the W chromosome is the female-determining and the male is ZZ. (From King & Stansfield, A Dictionary of Genetics, 4th ed)", "PM": "68", "HN": "68", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012730"}, {"RECTYPE": "D", "MH": "Sex Counseling", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Counseling, Sex|T058|NON|EQV|UNK (19XX)|870302|abcdef", "ENTRY": "Sex Counselings", "MN": "N02.421.461.363.700", "MH_TH": "NLM (1988)", "ST": "T058", "PI": "Psychotherapy (1966-1987)", "MS": "Advice and support given to individuals to help them understand and resolve their sexual adjustment problems. It excludes treatment for PSYCHOSEXUAL DISORDERS or PSYCHOSEXUAL DYSFUNCTION.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19870226", "DC": "1", "DX": "19880101", "UI": "D012731"}, {"RECTYPE": "D", "MH": "Sex Determination Analysis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Sex Determination Techniques|T059|T063|NON|EQV|NLM (1998)|970408|abbcdef", "ENTRY": "Techniques, Sex Determination", "MN": "E05.393.285.830", "FX": "Sex", "MH_TH": "NLM (2011)", "ST": "T063", "AN": "do not confuse with SEX DETERMINATION PROCESSES which is establishment of sex at fertilization; SEX DETERMINATION BY SKELETON is also available", "MS": "Validation of the SEX of an individual by inspection of the GONADS and/or by genetic tests.", "PM": "2011; see SEX DETERMINATION (ANALYSIS) 1998-2010, see SEX DETERMINATION 1963-1997", "HN": "2011(1963)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "20110101", "UI": "D012732"}, {"RECTYPE": "D", "MH": "Sex Differentiation", "DE": "SEX DIFFER", "AQ": "DE GE IM PH RE", "ENTRY": "Differentiation, Sexual", "MN": "G08.686.841.500", "FX": "Sex Determination Processes", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "note SEX DETERMINATION PROCESSES; SEX CHARACTERISTICS; SEX DISTRIBUTION; and SEX FACTORS are also available", "PI": "Gonads/embryology (1966-1974)", "MS": "The process in developing sex- or gender-specific tissue, organ, or function after SEX DETERMINATION PROCESSES have set the sex of the GONADS. Major areas of sex differentiation occur in the reproductive tract (GENITALIA) and the brain.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D012733"}, {"RECTYPE": "D", "MH": "Disorders of Sex Development", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sex Differentiation Disorders|T019|T047|NON|NRW|NLM (1966)|990101|SEX DIFFER DIS|abbcdefv", "ENTRY": "Sexual Differentiation Disorder", "MN": "C19.391.119", "FX": "Transsexualism", "MH_TH": "NLM (2010)", "ST": "T047", "AN": "differentiate from SEXUAL DYSFUNCTION, PHYSIOLOGICAL; note entry term HERMAPHRODITISM: HERMAPHRODITISM, TRUE see OVOTESTICULAR DISORDERS OF SEX DEVELOPMENT is also available", "MS": "In gonochoristic organisms, congenital conditions in which development of chromosomal, gonadal, or anatomical sex is atypical. Effects from exposure to abnormal levels of GONADAL HORMONES in the maternal environment, or disruption of the function of those hormones by ENDOCRINE DISRUPTORS are included.", "PM": "2011; see SEX DIFFERENTIATION DISORDERS 1966-2010; for HERMAPHRODITISM and INTERSEXUALITY see HERMAPHRODITISM 1966-2010; for PSEUDOHERMAPHRODITISM see PSEUDOHERMAPHRODITISM 1973-2010", "HN": "2011(1966)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20110101", "UI": "D012734"}, {"RECTYPE": "D", "MH": "Sexual Dysfunction, Physiological", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sexual Disorder, Physiological", "MN": "C12.100.875", "MH_TH": "NLM (2006)", "ST": "T047", "AN": "differentiate from DISORDERS OF SEX DEVELOPMENT", "MS": "Physiological disturbances in normal sexual performance in either the male or the female.", "PM": "2006; see SEX DISORDERS 1963-2005", "HN": "2006 (1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20060101", "UI": "D012735"}, {"RECTYPE": "D", "MH": "Sex Education", "DE": "SEX EDUC", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Sexuality Education|T058|T065|NON|EQV|NLM (2022)|210122|abbcdef", "ENTRY": "Training, Family Planning", "MN": "I02.233.332.749", "FX": "Sexual Health", "MH_TH": "NLM (1963)", "ST": "T065", "MS": "Education which increases the knowledge of the functional, structural, and behavioral aspects of human reproduction.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012736"}, {"RECTYPE": "D", "MH": "Sex Factors", "ENTRY": "Sex Factor", "MN": "N06.850.490.875", "MH_TH": "NLM (1968)", "ST": "T102", "AN": "usually NIM; human & animal; do not confuse with SEX DISTRIBUTION or SEX CHARACTERISTICS", "MS": "Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances.", "PM": "68", "HN": "68", "MR": "20160119", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012737"}, {"RECTYPE": "D", "MH": "Sex Hormone-Binding Globulin", "DE": "SHBG", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Testosterone-Estradiol Binding Globulin|T116|T123|NON|EQV|UNK (19XX)|760416|abbcdef", "ENTRY": "Testosterone Estradiol Binding Globulin", "MN": "D12.776.377.715.182.800", "FX": "Androgen-Binding Protein", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "does not refer to all sex hormones: refers to a specific protein in the blood binding only testosterone or estradiol; for other sex hormone-binding globulins consider ANDROGEN-BINDING PROTEIN & PROGESTERONE-BINDING GLOBULIN", "PI": "Sex Hormones (1974-1976)", "MS": "A glycoprotein migrating as a beta-globulin. Its molecular weight, 52,000 or 95,000-115,000, indicates that it exists as a dimer. The protein binds testosterone, dihydrotestosterone, and estradiol in the plasma. Sex hormone-binding protein has the same amino acid sequence as ANDROGEN-BINDING PROTEIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications.", "OL": "use SEX HORMONE-BINDING GLOBULIN (NM) to search SEX-STEROID-BINDING PROTEIN 1981-91; use SEX HORMONE-BINDING GLOBULIN to search ESTRADIOL-BINDING GLOBULIN & TESTOSTERONE-BINDING GLOBULIN 1977-92", "PM": "77; SEX-STEROID-BINDING PROTEIN was indexed under CARRIER PROTEINS 1981-91; ESTRADIOL-BINDING GLOBULIN & TESTOSTERONE-BINDING GLOBULIN were see SEX HORMONE-BINDING GLOBULIN 1977-92", "HN": "77; SEX STEROID-BINDING PROTEIN was SEX-STEROID-BINDING PROTEIN (NM) 1981-91; ESTRADIOL-BINDING GLOBULIN & TESTOSTERONE-BINDING GLOBULIN were see SEX HORMONE-BINDING GLOBULIN 1977-92", "MR": "20190524", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D012738"}, {"RECTYPE": "D", "MH": "Gonadal Steroid Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sex Steroid Hormones|T125|NON|EQV|NLM (2004)|021108|abcdef", "ENTRY": "Steroid Hormones, Sex", "MN": "D06.472.334.851", "MH_TH": "NLM (2004)", "ST": "T125", "RN": "0", "AN": "general or unspecified; prefer specific groups or specific hormone", "MS": "Steroid hormones produced by the GONADS. They stimulate reproductive organs, germ cell maturation, and the secondary sex characteristics in the males and the females. The major sex steroid hormones include ESTRADIOL; PROGESTERONE; and TESTOSTERONE.", "PM": "2004; see SEX HORMONES 1963-2003", "HN": "2004 (1963)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D012739"}, {"RECTYPE": "D", "MH": "Sex Manuals", "ENTRY": "Sex Manual", "MN": "L01.462.500.820.500.666", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "Books used for sex education and procedural instruction.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012740"}, {"RECTYPE": "D", "MH": "Sexual Maturation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Sex Maturation|T040|NON|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Maturation, Sexual", "MN": "G08.686.841.750", "FX": "Puberty", "MH_TH": "NLM (2005)", "ST": "T040", "AN": "human & animal", "PI": "Puberty (1966-1974)", "MS": "Achievement of full sexual capacity in animals and in humans.", "PM": "2005; see SEX MATURATION 1975-2004", "HN": "2005 (1975)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D012741"}, {"RECTYPE": "D", "MH": "Sex Offenses", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Sexual Assault|T055|NON|NRW|NLM (2022)|210126|abcdef", "ENTRY": "Violences, Sexual", "MN": "I01.198.240.748", "FX": "Domestic Violence", "MH_TH": "NLM (1974)", "ST": "T055", "PI": "Paraphilias (1966-1967)", "MS": "Any violation of established legal or moral codes in respect to sexual behavior.", "PM": "68", "HN": "68", "MR": "20210312", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012742"}, {"RECTYPE": "D", "MH": "Sex Preselection", "AQ": "ES HI LJ MT PX SN VE", "PRINT ENTRY": "Sex Selection|T061|T062|NON|EQV|NLM (1990)|890216|abbcdef", "ENTRY": "Selection, Sex", "MN": "E05.393.420.890", "FX": "Sex Determination Processes", "MH_TH": "NLM (1975)", "ST": "T062", "AN": "do not confuse with SEX DETERMINATION ANALYSIS: analysis of sex genotype", "MS": "Methods for controlling genetic SEX of offspring.", "PM": "91; was see under GENETIC ENGINEERING 1975-90", "HN": "91(75); was see under GENETIC ENGINEERING 1975-90", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012743"}, {"RECTYPE": "D", "MH": "Sex Ratio", "ENTRY": "Sex Ratios", "MN": "N06.850.505.400.850.815", "MH_TH": "POPLINE (1978)", "ST": "T081", "PI": "Sex (1966-1967)", "MS": "The number of males per 100 females.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012744"}, {"RECTYPE": "D", "MH": "Sexual Abstinence", "AQ": "DE EH ES HI PH PX RE SN", "PRINT ENTRY": "Virginity|T055|NON|NRW|NLM (1998)|970106|abcdef", "ENTRY": "Abstinence, Sexual", "MN": "F01.145.802.900", "MH_TH": "NLM (1976)", "ST": "T055", "MS": "Refraining from SEXUAL INTERCOURSE.", "PM": "91; was see under SEX BEHAVIOR 1975-90; CELIBACY was heading 1963-67", "HN": "91(75); was see under SEX BEHAVIOR 1975-90; CELIBACY was heading 1963-67", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D012746"}, {"RECTYPE": "D", "MH": "Sexual Partners", "AQ": "CL PX", "PRINT ENTRY": "Sex Partners|T098|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Sexual Partner, Multiple", "MN": "M01.778", "MH_TH": "POPLINE (1993)", "ST": "T098", "PI": "Sex Behavior (1966-1987)", "MS": "Married or single individuals who share sexual relations.", "PM": "88", "HN": "88", "MR": "20210512", "DA": "19870226", "DC": "1", "DX": "19880101", "UI": "D012747"}, {"RECTYPE": "D", "MH": "Sexually Transmitted Diseases", "DE": "SEX TRANSM DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Venereal Diseases|T047|NON|EQV|UNK (19XX)|860327|VENEREAL DIS|abcdefv", "ENTRY": "Venereal Disease", "MN": "C23.550.291.531.937", "MH_TH": "POPLINE (1990)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Diseases due to or propagated by sexual contact.", "OL": "use SEXUALLY TRANSMITTED DISEASES to search VENEREAL DISEASES 1966-86", "PM": "87; was VENEREAL DISEASES 1963-86", "HN": "87; was VENEREAL DISEASES 1963-86", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D012749"}, {"RECTYPE": "D", "MH": "Seychelles", "AQ": "EH EP", "MN": "Z01.639.520.750", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "a group of Indian Ocean Islands east of Tanzania", "MS": "A group of Indian Ocean Islands, east of Tanzania. Their capital is Victoria. They were first claimed by the French in 1744 but taken by the English in 1794 and made a dependency of MAURITIUS in 1810. They became a crown colony in 1903 and a republic within the Commonwealth in 1976. They were named for the French finance minister, Jean Moreau de Sechelles, but respelled by the English in 1794. (From Webster's New Geographical Dictionary, 1988, p1102 & Room, Brewer's Dictionary of Names, 1992, p496)", "MR": "20220708", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D012750"}, {"RECTYPE": "D", "MH": "Sezary Syndrome", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Erythroderma, Sezary|T191|EPO|EQV|NLM (1991)|900514|abcdef", "ENTRY": "Syndrome, Sezary", "MN": "C20.683.515.920", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with SKIN NEOPLASMS (IM); spell in titles & translations with accent: S\u00e9zary", "PI": "Reticuloendotheliosis (1966-1978)", "MS": "A form of cutaneous T-cell lymphoma manifested by generalized exfoliative ERYTHRODERMA; PRURITUS; peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear (cerebriform) cells in the skin, LYMPH NODES, and peripheral blood (Sezary cells).", "PM": "1979", "HN": "1979", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D012751"}, {"RECTYPE": "D", "MH": "Shame", "ENTRY": "Shames", "MN": "F01.470.483.666", "MH_TH": "NLM (1975)", "ST": "T041", "MS": "An emotional attitude excited by realization of a shortcoming or impropriety.", "OL": "search GUILT 1966-74", "PM": "91; was see under GUILT 1975-90", "HN": "91(75); was see under GUILT 1975-90", "CATSH": "CAT LIST", "MR": "19900413", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012752"}, {"RECTYPE": "D", "MH": "Shared Paranoid Disorder", "DE": "SHARED PARANOID DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Shared Psychotic Disorder|T048|NON|EQV|NLM (1998)|970319|abcdef", "ENTRY": "Shared Psychotic Disorders", "MN": "F03.700.750.700", "MH_TH": "NLM (1968)", "ST": "T048", "AN": "spell FOLIE A DEUX as folie \u00e1 deux (with accent) in translations", "PI": "Psychotic Disorders (1966-1967)", "MS": "A condition in which closely related persons, usually in the same family, share the same delusions.", "OL": "use SHARED PARANOID DISORDER to search FOLIE A DEUX 1968-80", "PM": "81; was FOLIE A DEUX 1968-80", "HN": "81; was FOLIE A DEUX 1968-80", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012753"}, {"RECTYPE": "D", "MH": "Sharks", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Shark", "MN": "B01.050.150.900.493.370.853", "MH_TH": "NLM (1966)", "ST": "T013", "RN": "txid119203", "MS": "A group of elongate elasmobranchs. Sharks are mostly marine fish, with certain species large and voracious.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012754"}, {"RECTYPE": "D", "MH": "Sheep", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Sheep, Dall|T015|NON|NRW|NLM (2003)|011128|abcdef", "ENTRY": "Ovis dalli|T015|NON|NRW|NLM (2003)|011128|abcdef", "MN": "B01.050.150.900.649.313.500.380.791", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid9935", "RR": "txid9943", "AN": "SHEEP, DOMESTIC and SHEEP, BIGHORN are also available; SHEEP unspecified goes here", "MS": "Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012756"}, {"RECTYPE": "D", "MH": "Sheep Diseases", "DE": "SHEEP DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Sheep Disease", "MN": "C22.836", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "IM GEN or unspecified; coord IM with specific dis /vet (IM) or specific sheep dis (IM); for abnormalities or injuries, index under SHEEP /abnorm or SHEEP /inj; don't forget also SHEEP (NIM) & check tag ANIMALS; DF: SHEEP DIS", "MS": "Diseases of domestic and mountain sheep of the genus Ovis.", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012757"}, {"RECTYPE": "D", "MH": "Shellfish", "AQ": "AE AN CL EC HI MI PS RE SD SN ST TO VI", "MN": "J02.500.600.875.700", "FX": "Nephropidae", "EC": "poisoning:Shellfish Poisoning", "MH_TH": "NLM (1966)", "ST": "T168", "MS": "Aquatic invertebrates belonging to the phylum MOLLUSCA or the subphylum CRUSTACEA, and used as food.", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012758"}, {"RECTYPE": "D", "MH": "Sheltered Workshops", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Workshops, Sheltered", "MN": "N02.278.808.860", "FX": "Employment, Supported", "MH_TH": "NLM (1965)", "ST": "T093", "AN": "do not confuse with EMPLOYMENT, SUPPORTED which takes place in normal or regular work setting: a sheltered workshop is work in a controlled working environment", "MS": "Protective places of employment for disabled persons which provide training and employment on a temporary or permanent basis.", "PM": "67", "HN": "67(65)", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D012759"}, {"RECTYPE": "D", "MH": "Shigella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.730", "FX": "Dysentery, Bacillary", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid620", "AN": "general or unspecified; prefer specifics; infection equals DYSENTERY, BACILLARY and specify species if pertinent ", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that ferments sugar without gas production. Its organisms are intestinal pathogens of man and other primates and cause bacillary dysentery (DYSENTERY, BACILLARY).", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012760"}, {"RECTYPE": "D", "MH": "Shigella boydii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.730.050", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid621", "AN": "infection: coord IM with DYSENTERY, BACILLARY (IM)", "PI": "Shigella (1966-1971)", "MS": "One of the SHIGELLA species that produces bacillary dysentery (DYSENTERY, BACILLARY).", "PM": "91; was see under SHIGELLA 1972-90", "HN": "91(72); was see under SHIGELLA 1972-90", "MR": "20200128", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012761"}, {"RECTYPE": "D", "MH": "Shigella dysenteriae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Shigella shigae|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.150.730.125", "FX": "Shigella Vaccines", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid622", "AN": "infection: coord IM with DYSENTERY, BACILLARY (IM)", "MS": "A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is extremely pathogenic and causes severe dysentery. Infection with this organism often leads to ulceration of the intestinal epithelium.", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012762"}, {"RECTYPE": "D", "MH": "Shigella flexneri", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.730.210", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid623", "AN": "infection: coord IM with DYSENTERY, BACILLARY (IM)", "PI": "Shigella (1966-1971)", "MS": "A bacterium which is one of the etiologic agents of bacillary dysentery (DYSENTERY, BACILLARY) and sometimes of infantile gastroenteritis.", "PM": "74", "HN": "74(72)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012763"}, {"RECTYPE": "D", "MH": "Shigella sonnei", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Bacterium sonnei|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.150.730.710", "MH_TH": "NLM (1963)", "ST": "T007", "RN": "txid624", "AN": "infection: coord IM with DYSENTERY, BACILLARY (IM)", "MS": "A lactose-fermenting bacterium causing dysentery.", "PM": "66", "HN": "66(63)", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012764"}, {"RECTYPE": "D", "MH": "Shikimic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Shikimic Acid Derivatives|T109|NON|REL|NLM (2024)|220907|abcdef", "ENTRY": "Acid, Shikimic", "MN": "D02.455.426.392.368.367.379.750", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "29MS2WI2NU", "RR": "138-59-0 (Shikimic Acid)", "MS": "A tri-hydroxy cyclohexene carboxylic acid metabolite of the shikimate pathway. It is important in the biosynthesis of aromatic amino acids, flavonoids and alkaloids in plants and microorganisms.", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012765"}, {"RECTYPE": "D", "MH": "Pasteurellosis, Pneumonic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Shipping Fever|T047|NON|EQV|NLM (1991)|890824|abcdef", "ENTRY": "Pneumonic Pasteurellosis", "MN": "C22.196.090.600", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "infection: coordinate with PASTEURELLA MULTOCIDA (IM), MANNHEIMIA HAEMOLYTICA (IM) or HAEMOPHILUS SOMNUS (IM) only if particularly discussed; if in cows, check the tag CATTLE; if in other animas, coordinate with precoordinated animal/disease term (IM) + specific animal (NIM) or specific animal (IM) if there is no precoordinated animal/disease term", "MS": "Bovine respiratory disease found in animals that have been shipped or exposed to CATTLE recently transported. The major agent responsible for the disease is MANNHEIMIA HAEMOLYTICA and less commonly, PASTEURELLA MULTOCIDA or HAEMOPHILUS SOMNUS. All three agents are normal inhabitants of the bovine nasal pharyngeal mucosa but not the LUNG. They are considered opportunistic pathogens following STRESS, PHYSIOLOGICAL and/or a viral infection. The resulting bacterial fibrinous BRONCHOPNEUMONIA is often fatal.", "OL": "Use PASTEURELLOSIS, PNEUMONIC to search SHIPPING FEVER 1975-90; use PASTEURELLA INFECTIONS 1966-74", "PM": "91; was SHIPPING FEVER see under PASTEURELLA INFECTIONS 1963-90", "HN": "91; was SHIPPING FEVER see under PASTEURELLA INFECTIONS 1963-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012766"}, {"RECTYPE": "D", "MH": "Ships", "AQ": "CL EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Boats|T073|NON|REL|NLM (1992)|901004|abcdef", "ENTRY": "Ships, Hospital", "MN": "J01.937.817", "FX": "Hospital Units", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "use as a coordinate for non-medical aspects of sailors; for physiology, psychology, and diseases of sailors use NAVAL MEDICINE but see note there", "MS": "Large vessels propelled by power or sail used for transportation on rivers, seas, oceans, or other navigable waters. Boats are smaller vessels propelled by oars, paddles, sail, or power; they may or may not have a deck.", "MR": "20150713", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012767"}, {"RECTYPE": "D", "MH": "Shivering", "AQ": "DE ES GE IM PH RE", "ENTRY": "Shiverings", "MN": "G16.012.500.535.778.500", "MH_TH": "NLM (1964)", "ST": "T184", "MS": "Involuntary contraction or twitching of the muscles. It is a physiologic method of heat production in man and other mammals.", "PM": "70", "HN": "70(64)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D012768"}, {"RECTYPE": "D", "MH": "Shock", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypovolemic Shock|T033|T046|NON|REL|UNK (19XX)|750101|abbcdef", "ENTRY": "Shock, Hypovolemic", "MN": "C23.550.835", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "A pathological condition manifested by failure to perfuse or oxygenate vital organs.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012769"}, {"RECTYPE": "D", "MH": "Shock, Cardiogenic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cardiogenic Shock", "MN": "C23.550.835.550", "MH_TH": "NLM (1971)", "ST": "T046", "PI": "Shock (1966-1970)", "MS": "Shock resulting from diminution of cardiac output in heart disease.", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D012770"}, {"RECTYPE": "D", "MH": "Shock, Hemorrhagic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhagic Shock|T033|T046|NON|EQV|NLM (2000)|991104|abbcdef", "MN": "C23.550.835.650", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "HYPOVOLEMIC SHOCK does not go here: it is a see ref to SHOCK", "MS": "Acute hemorrhage or excessive fluid loss resulting in HYPOVOLEMIA.", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012771"}, {"RECTYPE": "D", "MH": "Shock, Septic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Toxic Shock Syndrome|T047|NON|NRW|POPLINE (1986)|830603|TOX SHOCK SYNDROME|abcdefv", "ENTRY": "Toxic Shock Syndromes", "MN": "C23.550.835.900.712", "MH_TH": "NLM (1977)", "ST": "T047", "AN": "coordinate (IM) with specific infection (IM)", "MS": "Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.", "OL": "use SHOCK, SEPTIC to search SHOCK, TOXIC 1966-76 & SHOCK, ENDOTOXIC 1968-76", "PM": "77; was SHOCK, TOXIC 1963-76; SHOCK, ENDOTOXIC was heading 1968-76", "HN": "77; was SHOCK, TOXIC 1963-76; SHOCK, ENDOTOXIC was heading 1968-76", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D012772"}, {"RECTYPE": "D", "MH": "Shock, Surgical", "DE": "SHOCK SURG", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Surgical Shocks", "MN": "C23.550.835.775", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "A type of shock that occurs as a result of a surgical procedure.", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012773"}, {"RECTYPE": "D", "MH": "Shock, Traumatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Traumatic Shock", "MN": "C26.797", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Shock produced as a result of trauma.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012774"}, {"RECTYPE": "D", "MH": "Shoes", "AQ": "AE CL EC ES HI LJ SN ST", "ENTRY": "Shoe", "MN": "J01.637.215.800", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "horseshoes may be indexed here but only as NIM", "MS": "Footwear made of a flat sole shaped to the contour of the foot, connected to an upper portion which may or may not completely cover or wrap around the foot.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012775"}, {"RECTYPE": "D", "MH": "Fibroma Virus, Rabbit", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Shope Fibroma Virus|T005|EPO|EQV|NLM (1994)|930309|abcdef", "ENTRY": "Rabbits Fibromatosis Viruses", "MN": "B04.613.204.600.250", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid10271", "AN": "entry term SHOPE FIBROMA VIRUS, described by Shope in 1932: do not confuse with SHOPE PAPILLOMA VIRUS; infection: coord IM with POXVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "MS": "A species of LEPORIPOXVIRUS causing subcutaneous localized swellings in rabbits, usually on the feet.", "OL": "use FIBROMA VIRUS, RABBIT to search SHOPE FIBROMA VIRUS 1975-93", "PM": "94; was SHOPE FIBROMA VIRUS 1975-93 (see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80)", "HN": "94; was SHOPE FIBROMA VIRUS 1975-93 (see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012776"}, {"RECTYPE": "D", "MH": "Cottontail rabbit papillomavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Shope Papilloma Virus|T005|EPO|EQV|NLM (1994)|930304|abcdef", "ENTRY": "papillomaviruses, Cottontail rabbit", "MN": "B04.613.204.655.500.150", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid10623", "AN": "do not confuse entry term SHOPE PAPILLOMA VIRUS with SHOPE FIBROMA VIRUS; infection: coordinate IM with PAPILLOMAVIRUS INFECTIONS (IM)", "MS": "The type species of KAPPAPAPILLOMAVIRUS. It is reported to occur naturally in cottontail rabbits in North America.", "PM": "2007; see PAPILLOMAVIRUS, COTTONTAIL RABBIT 1997-2006, see PAPILLOMAVIRUS SYLVILAGI 1994-1996, see SHOPE PAPILLOMA VIRUS 1991-1993, see PAPILLOMAVIRUSES 1978-1990, see PAPILLOMA VIRUSES 1975-1977", "HN": "2007 (1975)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012777"}, {"RECTYPE": "D", "MH": "Short Bowel Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Short Bowel", "MN": "C23.550.767.882", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Syndrome (1972-1980)", "MS": "A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.", "PM": "91; was see under MALABSORPTION SYNDROMES 1981-90", "HN": "91(81); was see under MALABSORPTION SYNDROMES 1981-90", "CATSH": "CAT LIST", "MR": "20050714", "DA": "19800409", "DC": "1", "DX": "19910101", "UI": "D012778"}, {"RECTYPE": "D", "MH": "Short Rib-Polydactyly Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Saldino-Noonan Syndrome|T019|T047|EPO|NRW|OMIM (2013)|UNK (19XX)|840406|abbcdeef", "ENTRY": "Short Rib-Polydactyly Syndromes", "MN": "C16.131.621.585.600.750", "MH_TH": "NLM (1985)", "ST": "T047", "AN": "do not confuse entry term SALDINO-NOONAN SYNDROME with NOONAN SYNDROME", "PI": "Ribs (1966-1984)", "MS": "A syndrome inherited as an autosomal recessive trait and incompatible with life. The main features are narrow thorax, short ribs, scapular and pelvic dysplasia, and polydactyly.", "PM": "1991; see OSTEOCHONDRODYSPLASIAS 1985-1990", "HN": "1991(1985);use OSTEOCHONDRODYSPLASIAS 1985-1990", "CATSH": "CAT LIST", "MR": "20150701", "DA": "19840406", "DC": "1", "DX": "19910101", "UI": "D012779"}, {"RECTYPE": "D", "MH": "Short-Wave Therapy", "DE": "SHORT WAVE THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Short Wave", "MN": "E02.808.875", "MH_TH": "NLM (1975)", "ST": "T061", "MS": "The use of focused short radio waves to produce local hyperthermia in an injured person or diseased body area.", "OL": "search DIATHERMY 1966-74", "PM": "91; was see under DIATHERMY 1975-90", "HN": "91(75); was see under DIATHERMY 1975-90", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012780"}, {"RECTYPE": "D", "MH": "Shorthand", "MN": "L01.559.423.906.539.750", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "Rapid handwriting using simple strokes, abbreviations, or symbols that designate letters, words, or phrases.", "MR": "20180201", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012781"}, {"RECTYPE": "D", "MH": "Shoulder", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "ENTRY": "Shoulders", "MN": "A01.378.800.750", "EC": "injuries:Shoulder Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "use for humans and other vertebrates; differentiate from SHOULDER JOINT", "MS": "Part of the body in humans and primates where the arms connect to the trunk. The shoulder has five joints; ACROMIOCLAVICULAR joint, CORACOCLAVICULAR joint, GLENOHUMERAL joint, scapulathoracic joint, and STERNOCLAVICULAR joint.", "PM": "SHOULDER ARTHROSES was heading 1963-64", "HN": "SHOULDER ARTHROSES was heading 1963-64", "MR": "20160120", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012782"}, {"RECTYPE": "D", "MH": "Shoulder Dislocation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Glenohumeral Dislocation|T037|NON|EQV|NLM (2007)|060308|abcdef", "ENTRY": "Subluxations, Glenohumeral", "MN": "C26.803.125", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Displacement of the HUMERUS from the SCAPULA.", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012783"}, {"RECTYPE": "D", "MH": "Shoulder Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Humeral Head Fracture Dislocation|T037|NON|NRW|NLM (2023)|210929|abcdef", "ENTRY": "Shoulder Fracture", "MN": "C26.803.250", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "refers to SHOULDER, not SHOULDER JOINT; restricted to fractures of proximal humerus (head, neck, tuberosities): do not confuse with HUMERAL FRACTURES", "MS": "Fractures of the proximal humerus, including the head, anatomic and surgical necks, and tuberosities.", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012784"}, {"RECTYPE": "D", "MH": "Shoulder Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Glenohumeral Joint|T030|NON|EQV|NLM (2007)|060308|abcdef", "ENTRY": "Shoulder Joints", "MN": "A02.835.583.748", "EC": "injuries:Shoulder Injuries", "MH_TH": "NLM (1965)", "ST": "T030", "AN": "use for humans and other vertebrates; differentiate from SHOULDER", "MS": "The articulation between the head of the HUMERUS and the glenoid cavity of the SCAPULA.", "PM": "65; SHOULDER ARTHROSES was heading 1963-64", "HN": "65; SHOULDER ARTHROSES was heading 1963-64", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012785"}, {"RECTYPE": "D", "MH": "Showdomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D13.570.800.810", "PA": "Sulfhydryl Reagents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "1H-Pyrrole-2,5-dione, 3-beta-D-ribofuranosyl-", "RN": "E1V8315QHY", "RR": "16755-07-0 (Showdomycin)", "AN": "an antineoplastic antibiotic", "PI": "Ribonucleosides (1973-1974)", "MS": "3-beta-D-Ribofuranosylmaleimide. Antineoplastic antibiotic isolated from Streptomyces showdoensis. It is possibly active also as a sulfhydryl reagent.", "PM": "91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90", "HN": "91(75); was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012787"}, {"RECTYPE": "D", "MH": "Shrews", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Shrew", "MN": "B01.050.150.900.649.313.961.751", "MH_TH": "NLM (1972)", "ST": "T015", "RN": "txid9376", "AN": "do not confuse SHREWS (insectivore) with TREE SHREWS see TUPAIIDAE", "PI": "Insectivora (1966-1971)", "MS": "Small mammals in the family Soricidae, order Soricomorpha (formerly Insectivora). They resemble moles and are characterized by a mobile snout, sharp INCISOR teeth, and are found in tropical and temperate regions worldwide.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012788"}, {"RECTYPE": "D", "MH": "Shwartzman Phenomenon", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Shwartzman Reaction|T047|EPO|EQV|NLM (1999)|971222|abcdef", "ENTRY": "Schwartzman Reactions", "MN": "C15.378.463.515.810", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Hemorrhagic necrosis that was first demonstrated in rabbits with a two-step reaction, an initial local (intradermal) or general (intravenous) injection of a priming endotoxin (ENDOTOXINS) followed by a second intravenous endotoxin injection (provoking agent) 24 h later. The acute inflammation damages the small blood vessels. The following intravascular coagulation leads to capillary and venous THROMBOSIS and NECROSIS. Shwartzman phenomenon can also occur in other species with a single injection of a provoking agent, and during infections or pregnancy. Its susceptibility depends on the status of IMMUNE SYSTEM, coagulation, FIBRINOLYSIS, and blood flow.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012790"}, {"RECTYPE": "D", "MH": "Shy-Drager Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Orthostatic Hypotension, Dysautonomic|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Syndromes, Dysautonomia-Orthostatic Hypotension", "MN": "C14.907.514.741", "FX": "Multiple System Atrophy", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Nervous System Diseases (1966-1980)", "MS": "A progressive neurodegenerative condition of the central and autonomic nervous systems characterized by atrophy of the preganglionic lateral horn neurons of the thoracic spinal cord. This disease is generally considered a clinical variant of MULTIPLE SYSTEM ATROPHY. Affected individuals present in the fifth or sixth decade with ORTHOSTASIS and bladder dysfunction; and later develop FECAL INCONTINENCE; anhidrosis; ATAXIA; IMPOTENCE; and alterations of tone suggestive of basal ganglia dysfunction. (From Adams et al., Principles of Neurology, 6th ed, p536)", "PM": "1991; see AUTONOMIC NERVOUS SYSTEM DISEASES 1981-1990", "HN": "1991(1981)", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19800512", "DC": "1", "DX": "19910101", "UI": "D012791"}, {"RECTYPE": "D", "MH": "Shyness", "PRINT ENTRY": "Timidity|T054|T055|NON|REL|UNK (19XX)|860325|abbcdef", "MN": "F01.145.813.617", "MH_TH": "NLM (1987)", "ST": "T054", "MS": "Discomfort and partial inhibition of the usual forms of behavior when in the presence of others.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19860325", "DC": "1", "DX": "19870101", "UI": "D012792"}, {"RECTYPE": "D", "MH": "Sialadenitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sialitis|T047|NON|EQV|NLM (2006)|050414|abcdef", "ENTRY": "Sialoadenitides", "MN": "C07.465.815.793", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "tuberculous sialitis: coordinate IM with TUBERCULOSIS, ORAL (IM)", "MS": "INFLAMMATION of salivary tissue (SALIVARY GLANDS), usually due to INFECTION or injuries.", "OL": "search SALIVARY GLAND DISEASES 1966-74", "PM": "91; was see under SALIVARY GLAND DISEASES 1975-90", "HN": "91(75); was see under SALIVARY GLAND DISEASES 1975-90", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012793"}, {"RECTYPE": "D", "MH": "Sialic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "N-Acetylneuraminic Acids|T109|NON|EQV|UNK (19XX)|760526|ACETYLNEURAMINIC ACIDS N|abcdefs", "ENTRY": "N Acetylneuraminic Acids", "MN": "D09.811.589.668", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Neuraminic Acids (1966-1974)", "MS": "A group of naturally occurring N-and O-acyl derivatives of the deoxyamino sugar neuraminic acid. They are ubiquitously distributed in many tissues.", "OL": "search NEURAMINIC ACIDS 1966-74", "PM": "75; was see under NEURAMINIC ACIDS 1963-74", "HN": "75; was see under NEURAMINIC ACIDS 1963-74", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D012794"}, {"RECTYPE": "D", "MH": "Sialoglycoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sialoproteins|T116|T123|NON|BRD|UNK (19XX)|760427|abbcdef", "ENTRY": "Polysialoglycoproteins|T116|T123|NON|NRW|UNK (19XX)|830916|abbcdef", "MN": "D12.776.395.700", "FX": "Asialoglycoproteins", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "glycoproteins containing sialic acid: do not confuse with SALIVARY PROTEINS, proteins found in saliva; /biosyn /physiol permitted", "PI": "Sialic Acids (1975-1976)", "MS": "Glycoproteins which contain sialic acid as one of their carbohydrates. They are often found on or in the cell or tissue membranes and participate in a variety of biological activities.", "PM": "77", "HN": "77", "MR": "20230316", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D012795"}, {"RECTYPE": "D", "MH": "Sialography", "DE": "SIALOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Sialographies", "MN": "E06.342.764.793", "MH_TH": "NLM (1965)", "ST": "T060", "MS": "Radiography of the SALIVARY GLANDS or ducts following injection of contrast medium.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012796"}, {"RECTYPE": "D", "MH": "Sialometaplasia, Necrotizing", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Necrotizing Sialometaplasia|T047|NON|EQV|UNK (19XX)|820426|abcdef", "ENTRY": "Sialometaplasias, Necrotizing", "MN": "C07.465.815.802", "MH_TH": "NLM (1983)", "ST": "T047", "AN": "benign inflamm self-healing lesions of minor salivary glands", "PI": "Salivary Glands, Minor (1979-1982)", "MS": "A benign, inflammatory, variably ulcerated, occasionally bilateral, self-healing lesion of the minor salivary glands that is often confused clinically and histologically with carcinoma.", "PM": "91; was see under SALIVARY GLAND DISEASES 1983-90", "HN": "91(83); was see under SALIVARY GLAND DISEASES 1983-90", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19820426", "DC": "1", "DX": "19910101", "UI": "D012797"}, {"RECTYPE": "D", "MH": "Sialorrhea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypersalivation|T047|T184|NON|EQV|UNK (19XX)|760426|abbcdef", "MN": "C07.465.815.815", "MH_TH": "NLM (1977)", "ST": "T184", "AN": "\"increased salivary flow\"", "PI": "Salivation (1966-1976)", "MS": "Increased salivary flow.", "OL": "search SALIVARY GLAND DISEASES 1966-74", "PM": "77; was see under SALIVARY GLAND DISEASES 1965-74", "HN": "77; was see under SALIVARY GLAND DISEASES 1965-74", "CATSH": "CAT LIST", "MR": "19910619", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D012798"}, {"RECTYPE": "D", "MH": "Sialyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sialyltransferase|T116|T126|NON|EQV|NLM (2021)|191227|abbcdef", "ENTRY": "Sialyltransferases, Glycoprotein", "MN": "D08.811.913.400.800", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 2.4.99.-", "PI": "Transferases (1972-1974)", "MS": "A group of enzymes with the general activity CMP-N-acetylneuraminate:acceptor N-acetylneuraminyl transferase. They catalyze the transfer of N-ACETYLNEURAMINIC ACID from CMP-N-ACETYLNEURAMINIC ACID to an acceptor, which is usually the terminal sugar residue of an oligosaccharide, a glycoprotein, or a glycolipid.", "OL": "use SIALYLTRANSFERASES to search SIALYLTRANSFERASE 1975-78", "PM": "87; was see under TRANSFERASES 1979-86; was SIALYLTRANSFERASE see under TRANSFERASES 1975-78", "HN": "87(79); was see under TRANSFERASES 1979-86; was SIALYLTRANSFERASE see under TRANSFERASES 1975-78", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D012799"}, {"RECTYPE": "D", "MH": "Siberia", "AQ": "EH EP", "PRINT ENTRY": "Russian S.F.S.R., Asian|T083|NAM|EQV|UNK (19XX)|810302|RSFSR ASIAN|abcdefv", "ENTRY": "Russian Federation (Asia)|T083|NAM|EQV|UNK (19XX)|810302|abcdef", "MN": "Z01.252.122.500.500", "MH_TH": "NLM (1966)", "ST": "T083", "MS": "A region, north-central Asia, largely in Russia. It extends from the Ural Mountains to the Pacific Ocean and from the Arctic Ocean to central Kazakhstan and the borders of China and Mongolia.", "OL": "use SIBERIA to search RUSSIAN FEDERATION (ASIA) 1967-81; use SIBERIA & RUSSIAN S.F.S.R. to search RUSSIAN FEDERATION 1966; search RUSSIA under RUSSIA (PRE-1917) 1966", "HN": "82; was RUSSIAN FEDERATION (ASIA) 1967-81; RUSSIAN FEDERATION was heading 1966; RUSSIA was heading 1963-66", "MR": "20161226", "DA": "19990101", "DC": "4", "DX": "19820101", "UI": "D012800"}, {"RECTYPE": "D", "MH": "Sibling Relations", "DE": "SIBLING RELAT", "AQ": "EH", "ENTRY": "Sibling Relation", "MN": "F01.829.263.370.450", "MH_TH": "NLM (1968)", "ST": "T054", "AN": "human & animal", "PI": "Parent-Child Relations (1966-1967)", "MS": "Interactions and relationships between sisters and/or brothers. The concept also applies to animal studies.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19950523", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012801"}, {"RECTYPE": "D", "MH": "Sicily", "AQ": "EH EP", "MN": "Z01.639.640.751", "MH_TH": "NLM (1970)", "ST": "T083", "PI": "Italy (1966-1969)", "MS": "An island located in the Mediterranean Sea and governed by Italy,", "HN": "70", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19700101", "UI": "D012802"}, {"RECTYPE": "D", "MH": "Sick Role", "AQ": "CL DE ES PH RE", "ENTRY": "Sick Roles", "MN": "F01.829.316.616.751", "FX": "Illness Behavior", "MH_TH": "NLM (1971)", "ST": "T054", "PI": "Role (1969-1970)", "MS": "Set of expectations that exempt persons from responsibility for their illness and exempt them from usual responsibilities.", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D012803"}, {"RECTYPE": "D", "MH": "Sick Sinus Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sinus Node Dysfunction|T047|NON|REL|NLM (2009)|080130|abcdef", "ENTRY": "Syndrome, Sick Sinus", "MN": "C23.550.073.425.440", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Arrhythmia, Sinus (1966-1979)", "MS": "A condition caused by dysfunctions related to the SINOATRIAL NODE including impulse generation (CARDIAC SINUS ARREST) and impulse conduction (SINOATRIAL EXIT BLOCK). It is characterized by persistent BRADYCARDIA, chronic ATRIAL FIBRILLATION, and failure to resume sinus rhythm following CARDIOVERSION. This syndrome can be congenital or acquired, particularly after surgical correction for heart defects.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19781220", "DC": "1", "DX": "19800101", "UI": "D012804"}, {"RECTYPE": "D", "MH": "Sickle Cell Trait", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Traits, Sickle Cell", "MN": "C16.320.365.155.668", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "The condition of being heterozygous for hemoglobin S.", "OL": "search ANEMIA, SICKLE CELL 1966-74", "PM": "91; was see under ANEMIA, SICKLE CELL 1975-90", "HN": "91(75); was see under ANEMIA, SICKLE CELL 1975-90", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012805"}, {"RECTYPE": "D", "MH": "Siderosis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sideroses", "MN": "C24.800.773", "FX": "Hemosiderosis", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not coordinate with OCCUPATIONAL DISEASES", "MS": "A form of pneumoconiosis resulting from inhalation of iron in the mining dust or welding fumes.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012806"}, {"RECTYPE": "D", "MH": "Sierra Leone", "AQ": "EH EP", "ENTRY": "Republic of Sierra Leone|T083|NAM|EQV|NLM (2009)|080401|abcdef", "MN": "Z01.058.290.190.725", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in western Africa, south of GUINEA and west of LIBERIA. Its capital is Freetown.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D012807"}, {"RECTYPE": "D", "MH": "Sigma Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sigma Subunit|T116|T123|NON|EQV|UNK (19XX)|760416|abbcdef", "ENTRY": "Subunit, Sigma", "MN": "D12.776.930.800", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "a transcription factor; /biosyn /physiol permitted", "PI": "Transcription, Genetic (1973-1976)", "MS": "A protein which is a subunit of RNA polymerase. It effects initiation of specific RNA chains from DNA.", "PM": "91; was see under TRANSCRIPTION FACTORS 1977-90", "HN": "91(77); was see under TRANSCRIPTION FACTORS 1977-90", "MR": "20050630", "DA": "19760419", "DC": "1", "DX": "19910101", "UI": "D012808"}, {"RECTYPE": "D", "MH": "Colon, Sigmoid", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sigmoid|T023|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Sigmoid Colon|T023|NON|EQV|NLM (2004)|021218|abcdef", "MN": "A03.556.249.249.356.668", "FX": "Sigmoidoscopy", "MH_TH": "NLM (2004)", "ST": "T023", "MS": "A segment of the COLON between the RECTUM and the descending colon.", "PM": "2004; see SIGMOID 1966-2003", "HN": "2004 (1966)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D012809"}, {"RECTYPE": "D", "MH": "Sigmoid Diseases", "DE": "SIGMOID DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sigmoid Disease", "MN": "C06.405.469.158.850", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "inflamm dis: coord IM with COLITIS (NIM) but note PROCTOSIGMOIDITIS see PROCTOCOLITIS & RECTOSIGMOIDITIS see PROCTOCOLITIS; diverticula & diverticulosis: coord IM with DIVERTICULUM, COLON (IM); diverticulitis: coord IM with DIVERTICULITIS, COLONIC (IM)", "PI": "specific intestinal disease", "MS": "Pathological processes in the SIGMOID COLON region of the large intestine (INTESTINE, LARGE).", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D012810"}, {"RECTYPE": "D", "MH": "Sigmoid Neoplasms", "DE": "SIGMOID NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Sigmoid Cancer|T191|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Sigmoid Neoplasm", "MN": "C06.405.469.491.307.180.800", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the SIGMOID COLON.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012811"}, {"RECTYPE": "D", "MH": "Sigmoidoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Sigmoidoscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES SIGMOIDOSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Sigmoidoscopic", "MN": "E04.502.250.250.250.160.800", "FX": "Sigmoidoscopes", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "/ instrum permitted but consider also SIGMOIDOSCOPES", "MS": "Endoscopic examination, therapy or surgery of the sigmoid flexure.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012812"}, {"RECTYPE": "D", "MH": "Sign Language", "ENTRY": "Sign Languages", "MN": "L01.143.649.526.668", "MH_TH": "NLM (1975)", "ST": "T171", "MS": "A system of hand gestures used for communication by those with HEARING LOSS or by people speaking different languages.", "OL": "use MANUAL COMMUNICATION to search SIGN LANGUAGE 1974", "PM": "91; was see under MANUAL COMMUNICATION 1974-90; was heading 1963-65", "HN": "91(75)63-65; was see under MANUAL COMMUNICATION 1974-90; was heading 1963-65", "CATSH": "CAT LIST", "MR": "20220531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012813"}, {"RECTYPE": "D", "MH": "Signal Processing, Computer-Assisted", "AQ": "IS", "PRINT ENTRY": "Signal Processing, Digital|T066|NON|NRW|UNK (19XX)|860618|abcdef", "ENTRY": "Signal Processing, Computer Assisted", "MN": "L01.224.800", "MH_TH": "NLM (1987)", "ST": "T066", "AN": "IM", "MS": "Computer-assisted processing of electric, ultrasonic, or electronic signals to interpret function and activity.", "OL": "use DIAGNOSIS, COMPUTER-ASSISTED to search SIGNAL INTERPRETATION, COMPUTER-ASSISTED 1986-88", "PM": "87; SIGNAL INTERPRETATION, COMPUTER-ASSISTED was see DIAGNOSIS, COMPUTER-ASSISTED 1986-88", "HN": "87; SIGNAL INTERPRETATION, COMPUTER-ASSISTED was see DIAGNOSIS, COMPUTER-ASSISTED 1986-88", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D012815"}, {"RECTYPE": "D", "MH": "Signs and Symptoms", "DE": "SIGNS SYMPTOMS", "ENTRY": "Symptoms and Signs", "MN": "C23.888", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "INDEXER: Do not use", "MS": "Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.", "PM": "1998", "HN": "1998", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012816"}, {"RECTYPE": "D", "MH": "Signs and Symptoms, Digestive", "DE": "SIGNS SYMPTOMS DIGESTIVE", "MN": "C23.888.821", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "INDEXER: Do not use", "PI": "specific sign or symptom (1966-1997)", "MS": "Digestive system manifestations of diseases of the gastrointestinal system or of other organs.", "OL": "consider also specific digestive diseases in C6", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012817"}, {"RECTYPE": "D", "MH": "Signs and Symptoms, Respiratory", "DE": "SIGNS SYMPTOMS RESPIRATORY", "MN": "C23.888.852", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "INDEXER: Do not use", "PI": "specific sign or symptom (1966-1997)", "MS": "Respiratory system manifestations of diseases of the respiratory tract or of other organs.", "OL": "consider also RESPIRATORY TRACT DISEASES & all specifics in C8", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012818"}, {"RECTYPE": "D", "MH": "Sikkim", "AQ": "EH EP", "MN": "Z01.252.245.782.875.750", "MH_TH": "NLM (1975)", "ST": "T083", "MS": "A state within northeast India in the Eastern Himalayas. The capital is Gangtok.", "HN": "75", "MR": "20220708", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D012819"}, {"RECTYPE": "D", "MH": "Silage", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "MN": "J02.500.300.100.800", "MH_TH": "NLM (1964)", "ST": "T168", "AN": "\"fodder converted into succulent feed for livestock\"", "MS": "Fodder converted into succulent feed for livestock through processes of anaerobic fermentation (as in a silo).", "PM": "91; was see under ANIMAL FEED 1964-90", "HN": "91(64); was see under ANIMAL FEED 1964-90", "MR": "20170414", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012820"}, {"RECTYPE": "D", "MH": "Silanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Silane|T104|NON|EQV|NLM (2021)|191227|abcdef", "MN": "D01.837.700", "MH_TH": "NLM (1975)", "ST": "T104", "RN": "0", "PI": "Silicon (1966-1974)", "MS": "Compounds similar to hydrocarbons in which a tetravalent silicon atom replaces the carbon atom. They are very reactive, ignite in air, and form useful derivatives.", "OL": "use SILANES to search HYDROSILICONS, SILICANS & SILICOHYDRIDES 1975-93", "PM": "91; was see under SILICON 1975-90; HYDROSILICONS, SILICANS & SILICOHYDRIDES were see SILANES 1975-93", "HN": "91(75); was see under SILICON 1975-90; HYDROSILICONS, SILICANS & SILICOHYDRIDES were see SILANES 1975-93", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012821"}, {"RECTYPE": "D", "MH": "Silicon Dioxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Silica|T197|NON|EQV|NLM (1994)|920718|abcdef", "ENTRY": "Quso G 32", "MN": "D01.837.725", "MH_TH": "NLM (1966)", "ST": "T197", "N1": "Silica", "RN": "7631-86-9", "AN": "note entry term: do not confuse with SILICON; TN 172: differentiation among silic- terms; see MeSH definition for names of common forms of silicon dioxide", "MS": "Transparent, tasteless crystals found in nature as agate, amethyst, chalcedony, cristobalite, flint, sand, QUARTZ, and tridymite. The compound is insoluble in water or acids except hydrofluoric acid.", "OL": "use SILICON DIOXIDE to search SILICA 1966-93", "PM": "94; was SILICA 1963-93", "HN": "94; was SILICA 1963-93", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012822"}, {"RECTYPE": "D", "MH": "Silicate Cement", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Cement, Silicate", "MN": "J01.637.051.339.291.800", "MH_TH": "NLM (1965)", "ST": "T122", "N1": "Silicic acid, aluminum calcium salt", "RN": "1327-39-5", "MS": "A relatively hard, translucent, restorative material used primarily in anterior teeth. (From Boucher's Clinical Dental Terminology, 4th ed, p50)", "PM": "65", "HN": "65", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012823"}, {"RECTYPE": "D", "MH": "Silicic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Silica Gel, Hydrated", "MN": "D01.837.725.700", "MH_TH": "NLM (1975)", "ST": "T197", "N1": "Silicic acid", "RN": "1343-98-2", "MS": "A hydrated form of silicon dioxide. It is commonly used in the manufacture of TOOTHPASTES and as a stationary phase for CHROMATOGRAPHY.", "PM": "1991; see SILICA 1975-1990, for SILICATE HYDRATE see SILICATES 1993-2010", "HN": "1991(1975) use SILICA 1975-1990, for SILICATE HYDRATE use SILICATES 1993-2010", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012824"}, {"RECTYPE": "D", "MH": "Silicon", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Silicon 28", "MN": "D01.268.513.937", "PA": "Trace Elements", "FX": "Organosilicon Compounds", "MH_TH": "POPLINE (1984)", "ST": "T196", "RN": "Z4152N8IUI", "RR": "7440-21-3 (Silicon)", "MS": "A trace element that constitutes about 27.6% of the earth's crust in the form of SILICON DIOXIDE. It does not occur free in nature. Silicon has the atomic symbol Si, atomic number 14, and atomic weight [28.084; 28.086].", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012825"}, {"RECTYPE": "D", "MH": "Silicone Elastomers", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Silicone Rubber|T109|T122|NON|EQV|NLM (1994)|921013|abbcdef", "ENTRY": "Silicone Elastomer", "MN": "J01.637.412.900", "FX": "Breast Implants", "MH_TH": "NLM (1972)", "ST": "T122", "RN": "0", "AN": "silicones in breast implants probably goes under SILICONE GELS or here if specified as elastomers; for prosthetic implants do not use /ther use; ELASTOMERS is available", "MS": "Polymers of silicone that are formed by crosslinking and treatment with amorphous silica to increase strength. They have properties similar to vulcanized natural rubber, in that they stretch under tension, retract rapidly, and fully recover to their original dimensions upon release. They are used in the encapsulation of surgical membranes and implants.", "OL": "use SILICONE ELASTOMERS to search SILASTICS 1975-93; use SILICONE ELASTOMERS (NM) to search SILASTIC 1988-93", "PM": "72; SILASTICS was see SILICONE ELASTOMERS 1975-93; SILASTIC was indexed under SILICONES 1988-93", "HN": "72; SILASTICS was see SILICONE ELASTOMERS 1975-93; SILASTIC was (NM) 1988-93", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012826"}, {"RECTYPE": "D", "MH": "Silicone Oils", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Silicone Oil|T109|T122|NON|EQV|NLM (2021)|191219|abbcdef", "ENTRY": "Oil, Silicone", "MN": "J01.637.051.720.900.850.950", "MH_TH": "NLM (1987)", "ST": "T122", "RN": "0", "PI": "Silicones (1966-1986)", "MS": "Organic siloxanes which are polymerized to the oily stage. The oils have low surface tension and density less than 1. They are used in industrial applications and in the treatment of retinal detachment, complicated by proliferative vitreoretinopathy.", "PM": "87", "HN": "87", "MR": "20200527", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D012827"}, {"RECTYPE": "D", "MH": "Silicones", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Silicone|T109|T122|T131|NON|EQV|NLM (1994)|POPLINE (1978)|921013|abbbcdeef", "MN": "J01.637.051.720.900.850", "MH_TH": "POPLINE (1978)", "ST": "T131", "RN": "0", "AN": "in breast implants use SILICONE GELS or SILICONE ELASTOMERS; do not confuse with SILICON", "MS": "A broad family of synthetic organosiloxane polymers containing a repeating silicon-oxygen backbone with organic side groups attached via carbon-silicon bonds. Depending on their structure, they are classified as liquids, gels, and elastomers. (From Merck Index, 12th ed)", "MR": "20190627", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012828"}, {"RECTYPE": "D", "MH": "Silicosis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Silicoses", "MN": "C24.800.834", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "ANTHRACOSILICOSIS & SILICOTUBERCULOSIS are also available; do not coordinate with OCCUPATIONAL DISEASES", "MS": "A form of pneumoconiosis resulting from inhalation of dust containing crystalline form of SILICON DIOXIDE, usually in the form of quartz. Amorphous silica is relatively nontoxic.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012829"}, {"RECTYPE": "D", "MH": "Silicotuberculosis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Silicotuberculoses", "MN": "C24.800.834.752", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not coordinate with OCCUPATIONAL DISEASES", "MS": "Pulmonary or extrapulmonary infection caused by MYCOBACTERIUM TUBERCULOSIS or nontuberculous mycobacteria in a patient with silicosis.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012830"}, {"RECTYPE": "D", "MH": "Bombyx", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Silkworms|T204|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "mori, Bombyx", "MN": "B01.050.500.131.617.720.500.500.937.650.100", "MH_TH": "UNK (19XX)", "ST": "T204", "RN": "txid7090", "RR": "txid7091", "MS": "A genus of silkworm MOTHS in the family Bombycidae of the order LEPIDOPTERA. The family contains a single species, Bombyx mori from the Greek for silkworm + mulberry tree (on which it feeds). A native of Asia, it is sometimes reared in this country. It has long been raised for its SILK and after centuries of domestication it probably does not exist in nature. It is used extensively in experimental GENETICS. (From Borror et al., An Introduction to the Study of Insects, 4th ed, p519)", "PM": "2005; use SILKWORMS 1963-2004", "HN": "2005 (1963)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D012831"}, {"RECTYPE": "D", "MH": "Silo Filler's Disease", "DE": "SILO FILLERS DIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Disease, Silo Fillers'", "MN": "C24.080.752", "MH_TH": "NLM (1964)", "ST": "T047", "MS": "A form of alveolitis or PNEUMONITIS caused by hypersensitivity to high level of inhaled nitrogen oxides, decomposition products of silage.", "PM": "91; was see under LUNG DISEASES 1964-90", "HN": "91(64); was see under LUNG DISEASES 1964-90", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012832"}, {"RECTYPE": "D", "MH": "Siloxanes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Siloxane", "MN": "J01.637.051.720.900", "MH_TH": "NLM (1975)", "ST": "T104", "RN": "0", "PI": "Silicones (1968-1974)", "MS": "Silicon polymers that contain alternate silicon and oxygen atoms in linear or cyclic molecular structures.", "PM": "91; was see under SILICONES 1975-90", "HN": "91(75); was see under SILICONES 1975-90", "MR": "20190627", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D012833"}, {"RECTYPE": "D", "MH": "Silver", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK RE SD ST TO TU UR", "MN": "D01.552.544.812", "EC": "poisoning:Argyria", "MH_TH": "POPLINE (1978)", "ST": "T196", "N1": "Silver", "RN": "3M4G523W1G", "RR": "7440-22-4 (Silver)", "MS": "An element with the atomic symbol Ag, atomic number 47, and atomic weight 107.87. It is a soft metal that is used medically in surgical instruments, dental prostheses, and alloys. Long-continued use of silver salts can lead to a form of poisoning known as ARGYRIA.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012834"}, {"RECTYPE": "D", "MH": "Silver Nitrate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Silver Nitrate, Alcoholic", "MN": "D01.847.900", "PA": "Anti-Infective Agents, Local", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Nitric acid silver(1+) salt", "RN": "95IT3W8JZE", "RR": "7761-88-8 (Silver Nitrate)", "AN": "SILVER NITRATE STAINING  see SILVER STAINING is also available", "MS": "A silver salt with powerful germicidal activity. It has been used topically to prevent OPHTHALMIA NEONATORUM.", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012835"}, {"RECTYPE": "D", "MH": "Silver Proteins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Proteins, Silver", "MN": "D12.776.884", "PA": "Anti-Infective Agents, Local", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "anti-infective agents", "MS": "Compounds of silver and proteins used as topical anti-infective agents.", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012836"}, {"RECTYPE": "D", "MH": "Silver Sulfadiazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfadiazine, Silver", "MN": "D02.886.590.700.725.755.800", "PA": "Anti-Infective Agents, Local", "MH_TH": "NLM (1977)", "ST": "T121", "N1": "Silver, (4-amino-N-2-pyrimidinylbenzenesulfonamidato-NN,O1)-", "RN": "W46JY43EJR", "RR": "22199-08-2 (Silver Sulfadiazine)", "PI": "Sulfadiazine (1966-1976)", "MS": "Antibacterial used topically in burn therapy.", "PM": "91; was see under SULFADIAZINE 1977-90", "HN": "91(77); was see under SULFADIAZINE 1977-90", "MR": "20230608", "DA": "19760503", "DC": "1", "DX": "19910101", "UI": "D012837"}, {"RECTYPE": "D", "MH": "Silymarin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Silimarin|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D03.633.100.150.266.450.268.777", "PA": "Protective Agents", "FX": "Silybum marianum", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Flavones (1971-1974)", "MS": "A mixture of flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum. It consists primarily of silybin and its isomers, silicristin and silidianin. Silymarin displays antioxidant and membrane stabilizing activity. It protects various tissues and organs against chemical injury, and shows potential as an antihepatoxic agent.", "PM": "91; was see under FLAVONES 1975-90", "HN": "91(75); was see under FLAVONES 1975-90", "MR": "20230731", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012838"}, {"RECTYPE": "D", "MH": "Simazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Herbazin50", "MN": "D03.383.931.819", "PA": "Herbicides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "1,3,5-Triazine-2,4-diamine, 6-chloro-N,N'-diethyl-", "RN": "SG0C34SMY3", "RR": "122-34-9 (Simazine)", "PI": "Triazines (1966-1971)", "MS": "A triazine herbicide.", "PM": "91; was see under HERBICIDES, TRIAZINE 1972-90", "HN": "91(72); was see under HERBICIDES, TRIAZINE 1972-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012839"}, {"RECTYPE": "D", "MH": "Simbu virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Simbu Group Viruses|T005|EPO|BRD|NLM (1975)|990101|abcdef", "MN": "B04.820.480.750.640.855", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid35306", "AN": "infection: coord IM with BUNYAVIRIDAE INFECTIONS (IM)", "MS": "A species in the ORTHOBUNYAVIRUS genus of the family BUNYAVIRIDAE family. Previously a large group of serotypes, most are now considered separate species.", "PM": "2002; see SIMBU VIRUS GROUP 1991-2001, see BUNYAVIRIDAE 1981-1990, see ARBOVIRUSES 1975-1980", "HN": "2002 (1975)", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012840"}, {"RECTYPE": "D", "MH": "Simethicone", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Phazyme 125|T109|T121|T122|TRD|NRW|UNK (19XX)|880423|abbbcdef", "MN": "J01.637.051.720.900.850.150.750", "PA": "Emollients", "MH_TH": "USP (19XX)", "ST": "T122", "RN": "8050-81-5", "PI": "Silicones (1972-1974)", "MS": "A poly(dimethylsiloxane) which is a polymer of 200-350 units of dimethylsiloxane, along with added silica gel. It is used as an antiflatulent, surfactant, and ointment base.", "PM": "1991; see SILICONES 1975-1990", "HN": "1991(1975)", "MR": "20190627", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012841"}, {"RECTYPE": "D", "MH": "Sarcoma Virus, Woolly Monkey", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Wooley monkey sarcoma virus|T005|NON|EQV|NLM (2002)|010503|abcdef", "ENTRY": "Simian Sarcoma Virus", "MN": "B04.820.650.805.601", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11970", "AN": "infection: coordinate  with RETROVIRIDAE INFECTIONS + TUMOR VIRUS INFECTIONS ", "PI": "Retroviridae (1972-1977)", "MS": "A species of GAMMARETROVIRUS producing tumors in primates. Originally isolated from a fibrosarcoma in a woolly monkey, WMSV is a replication-defective v-onc virus which carries the sis oncogene. In order to propagate, WMSV requires a replication-competent helper virus.", "PM": "2002; see SARCOMA VIRUSES, SIMIAN 1994-2001, see SIMIAN SARCOMA VIRUSES 1991-1993, see BUNYAVIRIDAE 1989-1990, see RETROVIRIDAE 1981-1988, see LEUKOVIRUSES 1978-1980", "HN": "2002 (1978); was SIMIAN SARCOMA VIRUSES 1978-93 (see under BUNYAVIRIDAE 1989-90, see under RETROVIRIDAE 1981-88, see under LEUKOVIRUSES 1978-80)", "MR": "20200813", "DA": "19770513", "DC": "1", "DX": "19910101", "UI": "D012842"}, {"RECTYPE": "D", "MH": "Simuliidae", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Simulium|T204|NON|NRW|UNK (19XX)|830606|abcdef", "ENTRY": "Simuliums", "MN": "B01.050.500.131.617.720.500.500.750.712.500.937", "MH_TH": "NLM (1984)", "ST": "T204", "RN": "txid7190", "RR": "txid7191", "AN": "for killing Simuliidae with insecticides, see note at INSECTICIDES; buffalo gnats are indexed here", "PI": "Diptera (1966-1983)", "MS": "A family of insects in the order DIPTERA, which include black flies, buffalo gnats and simulies. Several species are intermediate hosts (vectors) for the parasitic disease ONCHOCERCIASIS.", "PM": "84", "HN": "84", "MR": "20200813", "DA": "19830606", "DC": "1", "DX": "19840101", "UI": "D012843"}, {"RECTYPE": "D", "MH": "Sincalide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cholecystokinin Octapeptide|T116|T121|T125|NON|EQV|UNK (19XX)|830613|abbbcdef", "ENTRY": "SQ19844", "MN": "D12.644.120.500", "FX": "Gastrointestinal Agents", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Caerulein, 1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine-", "RN": "M03GIQ7Z6P", "RR": "25126-32-3 (Sincalide)", "PI": "Peptides (1966-1972)", "MS": "An octapeptide hormone present in the intestine and brain. When secreted from the gastric mucosa, it stimulates the release of bile from the gallbladder and digestive enzymes from the pancreas.", "PM": "84", "HN": "84", "MR": "20160701", "DA": "19830613", "DC": "1", "DX": "19840101", "UI": "D012844"}, {"RECTYPE": "D", "MH": "Sindbis Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Ockelbo Virus|T005|EPO|NRW|NLM (1994)|930223|abcdef", "MN": "B04.820.578.875.054.860", "MH_TH": "NLM (1971)", "ST": "T005", "RN": "txid11034", "RR": "txid48542", "AN": "infection: coord IM with ALPHAVIRUS INFECTIONS (IM)", "PI": "Arboviruses (1966-1970)", "MS": "The type species of ALPHAVIRUS normally transmitted to birds by CULEX mosquitoes in Egypt, South Africa, India, Malaya, the Philippines, and Australia. It may be associated with fever in humans. Serotypes (differing by less than 17% in nucleotide sequence) include Babanki, Kyzylagach, and Ockelbo viruses.", "PM": "1973; for OCKLEBO VIRUS see ALPHAVIRUS 1994-2001", "HN": "1973 (1971); for OCKELBO VIRUS use ALPHAVIRUS 1994-2001", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012845"}, {"RECTYPE": "D", "MH": "Singapore", "AQ": "EH EP", "MN": "Z01.252.145.774", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "Country of islands in Southeastern Asia, islands between Malaysia and Indonesia. The capital is Singapore.", "MR": "20171211", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D012846"}, {"RECTYPE": "D", "MH": "Single Person", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Single Persons", "MN": "N01.824.308.500.725", "FX": "Widowhood", "MH_TH": "BIOETHICS (1975)", "ST": "T098", "PI": "Marriage (1966-1967)", "MS": "The unmarried man or woman.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012847"}, {"RECTYPE": "D", "MH": "Sinoatrial Block", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sinoatrial Exit Blocks", "MN": "C23.550.073.425.780", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "Disturbance in the atrial activation that is caused by transient failure of impulse conduction from the SINOATRIAL NODE to the HEART ATRIA. It is characterized by a delayed in heartbeat and pauses between P waves in an ELECTROCARDIOGRAM.", "PM": "91; was see under HEART BLOCK 1975-90", "HN": "91(75); was see under HEART BLOCK 1975-90", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D012848"}, {"RECTYPE": "D", "MH": "Sinoatrial Node", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sinus Node|T023|NON|EQV|NLM (2006)|050112|abcdef", "ENTRY": "Sinus Nodes", "MN": "A07.541.409.819", "MH_TH": "NLM (1964)", "ST": "T023", "MS": "The small mass of modified cardiac muscle fibers located at the junction of the superior vena cava (VENA CAVA, SUPERIOR) and right atrium. Contraction impulses probably start in this node, spread over the atrium (HEART ATRIUM) and are then transmitted by the atrioventricular bundle (BUNDLE OF HIS) to the ventricle (HEART VENTRICLE).", "OL": "use SINOATRIAL NODE to search SINO-ATRIAL NODE 1966-77 (as Prov 1966-69)", "PM": "78; was SINO-ATRIAL NODE 1970-77", "HN": "78; was SINO-ATRIAL NODE 1964-77 (Prov 1964-69)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D012849"}, {"RECTYPE": "D", "MH": "Sinus of Valsalva", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Aortic Sinus|T023|NON|EQV|UNK (19XX)|780519|abcdef", "ENTRY": "Valsalva Sinus", "MN": "A07.015.114.056.847", "MH_TH": "NLM (1979)", "ST": "T023", "AN": "aneurysm: coord IM with AORTIC ANEURYSM (IM); ruptured aneurysm of sinus: coord IM with AORTIC RUPTURE (IM)", "MS": "The dilatation of the aortic wall behind each of the cusps of the aortic valve.", "PM": "79", "HN": "79", "MR": "20180701", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D012850"}, {"RECTYPE": "D", "MH": "Sinus Thrombosis, Intracranial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Venous Sinus Thrombosis, Cranial|T047|NON|EQV|NLM (2008)|060811|abcdef", "ENTRY": "Thrombosis, Sinus", "MN": "C14.907.355.590.213.350.500", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "Formation or presence of a blood clot (THROMBUS) in the CRANIAL SINUSES, large endothelium-lined venous channels situated within the SKULL. Intracranial sinuses, also called cranial venous sinuses, include the superior sagittal, cavernous, lateral, petrous sinuses, and many others. Cranial sinus thrombosis can lead to severe HEADACHE; SEIZURE; and other neurological defects.", "PM": "2000; see SINUS THROMBOSIS 1964-1999", "HN": "2000(1964)", "CATSH": "CAT LIST", "MR": "20150608", "DA": "19990101", "DC": "1", "DX": "20000101", "UI": "D012851"}, {"RECTYPE": "D", "MH": "Sinusitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sinusitides", "MN": "C09.603.692.752", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; rhinosinusitis: index RHINITIS + SINUSITIS", "MS": "Inflammation of the NASAL MUCOSA in one or more of the PARANASAL SINUSES.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012852"}, {"RECTYPE": "D", "MH": "Sisomicin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sissomicin|T109|T195|NON|EQV|BAN (19XX)|FDA SRS (2014)|800523|abbcdeef", "ENTRY": "Sch13475", "MN": "D09.408.051.374.785", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USAN (1972)", "ST": "T195", "N1": "D-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-4))-2-deoxy-", "RN": "X55XSL74YQ", "RR": "K14444371C", "PI": "Glycosides (1966-1973)", "MS": "Antibiotic produced by Micromonospora inyoensis. It is closely related to gentamicin C1A, one of the components of the gentamicin complex (GENTAMICINS).", "PM": "84; was see under GENTAMICINS 1978-83, was see under ANTIBIOTICS 1975-77", "HN": "84(75); was see under GENTAMICINS 1978-83, was see under ANTIBIOTICS 1975-77", "MR": "20160628", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D012853"}, {"RECTYPE": "D", "MH": "Sister Chromatid Exchange", "AQ": "DE ES GE IM PH RE", "ENTRY": "Sister Chromatid Exchanges", "MN": "G05.728.615.750", "FX": "Crossing Over, Genetic", "MH_TH": "NLM (1980)", "ST": "T045", "PI": "Genetics (1966)", "MS": "An exchange of segments between the sister chromatids of a chromosome, either between the sister chromatids of a meiotic tetrad or between the sister chromatids of a duplicated somatic chromosome. Its frequency is increased by ultraviolet and ionizing radiation and other mutagenic agents and is particularly high in BLOOM SYNDROME.", "PM": "85; was see under CROSSING OVER (GENETICS) 1980-84", "HN": "85(80); was see under CROSSING OVER (GENETICS) 1980-84", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19781221", "DC": "1", "DX": "19850101", "UI": "D012854"}, {"RECTYPE": "D", "MH": "Sitosterols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.704.500.669", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "AN": "plant sterols", "PI": "Sterols (1966-1971)", "MS": "A family of sterols commonly found in plants and plant oils. Alpha-, beta-, and gamma-isomers have been characterized.", "PM": "74", "HN": "74(72)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012855"}, {"RECTYPE": "D", "MH": "4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid", "DS": "ACETAMIDOISOTHIOCYANATOSTILBENEDISULFONIC ACID 04 04 02 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Disodium Salt, SITS", "MN": "D02.886.250.050", "MH_TH": "UNK (19XX)", "ST": "T130", "N1": "Benzenesulfonic acid, 5-(acetylamino)-2-(2-(4-isothiocyanato-2-sulfophenyl)ethenyl)-", "RN": "27816-59-7", "RR": "51023-76-8 (di-Na salt)", "PI": "Thiocyanates (1966-1975)", "MS": "A non-penetrating amino reagent (commonly called SITS) which acts as an inhibitor of anion transport in erythrocytes and other cells.", "PM": "2001; see SITS 1991-2000 & STILBENES 1980-90", "HN": "2001(1980);", "MR": "20000621", "DA": "19790222", "DC": "1", "DX": "19910101", "UI": "D012856"}, {"RECTYPE": "D", "MH": "Situs Inversus", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Inversus, Situs", "MN": "C16.131.810", "MH_TH": "NLM (1966)", "ST": "T019", "MS": "A congenital abnormality in which organs in the THORAX and the ABDOMEN are opposite to their normal positions (situs solitus) due to lateral transposition. Normally the STOMACH and SPLEEN are on the left, LIVER on the right, the three-lobed right lung is on the right, and the two-lobed left lung on the left. Situs inversus has a familial pattern and has been associated with a number of genes related to microtubule-associated proteins.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012857"}, {"RECTYPE": "D", "MH": "Size Perception", "AQ": "CL DE ES PH RE", "ENTRY": "Size Perceptions", "MN": "F02.463.593.778.794", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "The sensory interpretation of the dimensions of objects.", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012858"}, {"RECTYPE": "D", "MH": "Sjogren's Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sicca Syndrome|T047|NON|REL|NLM (1991)|OMIM (2013)|891219|abcdeef", "ENTRY": "Syndrome, Sjogren's", "MN": "C20.111.199.774", "FX": "Keratoconjunctivitis Sicca", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a form of rheum arthritis; do not confuse with SJOGREN-LARSSON SYNDROME, a form of ichthyosis; in titles & translations, use diacrit: Sjogren", "MS": "Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012859"}, {"RECTYPE": "D", "MH": "Skates, Fish", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Skates (Fish)|T013|NON|EQV|NLM (1987)|990101|SKATES|abcdefv", "ENTRY": "Skate, Fish", "MN": "B01.050.150.900.493.378.682", "MH_TH": "NLM (2020)", "ST": "T013", "RN": "txid30475", "RR": "txid7858", "AN": "do not confuse entry term RAYS (FISH) with ELECTRIC RAYS see TORPEDO", "PI": "Fishes (1966-1986)", "MS": "The common name for all members of the Rajidae family. Skates and rays are members of the same order (Rajiformes). Skates have weak electric organs.", "PM": "2020; was SKATES (FISH) 1987-2019; RAYS, FISH was RAYS (FISH) 1992-2019; see ELECTRIC FISH 1987-1990", "HN": "2020 (1987); was SKATES (FISH) 1987-2019; RAYS, FISH was RAYS (FISH) 1992-2019; use ELECTRIC FISH 1987-1990", "MR": "20200813", "DA": "19860415", "DC": "1", "DX": "19910101", "UI": "D012860"}, {"RECTYPE": "D", "MH": "Skating", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Skateboarding|T056|NON|NRW|UNK (19XX)|780508|abcdef", "ENTRY": "Skatings, Ice", "MN": "I03.450.642.845.700", "MH_TH": "NLM (1976)", "ST": "T056", "AN": "/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1", "PI": "Sports (1966-1975)", "MS": "Using ice skates, roller skates, or skateboards in racing or other competition or for recreation.", "PM": "90; was see under SPORTS 1976-89", "HN": "90(76); was see under SPORTS 1976-89", "MR": "19960610", "DA": "19750723", "DC": "1", "DX": "19900101", "UI": "D012861"}, {"RECTYPE": "D", "MH": "Skatole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "3-Methylindole|T109|T123|NON|EQV|UNK (19XX)|760324|METHYLINDOLE 03|abbcdefs", "ENTRY": "3 Methylindole", "MN": "D03.633.100.473.808", "MH_TH": "NLM (1964)", "ST": "T123", "N1": "1H-Indole, 3-methyl-", "RN": "9W945B5H7R", "RR": "83-34-1 (Skatole)", "PM": "91; was see under INDOLES 1964-90", "HN": "91(64); was see under INDOLES 1964-90", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012862"}, {"RECTYPE": "D", "MH": "Skeleton", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Skeletons", "MN": "A02.835", "FX": "Bone and Bones", "MH_TH": "NLM (1966)", "ST": "T022", "MS": "The rigid framework of connected bones that gives form to the body, protects and supports its soft organs and tissues, and provides attachments for MUSCLES.", "MR": "20150615", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012863"}, {"RECTYPE": "D", "MH": "Skiing", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Snowboarding|T056|NON|NRW|NLM (2003)|020220|abcdef", "ENTRY": "Snow Skiings", "MN": "I03.450.642.845.787.500", "MH_TH": "NLM (1966)", "ST": "T056", "AN": "/inj: coord IM with specific inj (IM); /physiol permitted; does not include water-skiing (index under SPORTS)", "MS": "A snow sport which uses skis to glide over the snow. It does not include water-skiing.", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012865"}, {"RECTYPE": "D", "MH": "Skilled Nursing Facilities", "DE": "SKILLED NURS FACILITIES", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Extended Care Facilities|T073|T093|NON|EQV|UNK (19XX)|780508|abbcdef", "ENTRY": "Skilled Nursing Facility", "MN": "N02.278.825.610.770", "MH_TH": "NLM (1968)", "ST": "T093", "PI": "Hospitals (1966-1967)", "MS": "Extended care facilities which provide skilled nursing care or rehabilitation services for inpatients on a daily basis.", "OL": "use SKILLED NURSING FACILITIES to search EXTENDED CARE FACILITIES 1968-78", "PM": "79; was EXTENDED CARE FACILITIES 1968-78", "HN": "79; was EXTENDED CARE FACILITIES 1968-78", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012866"}, {"RECTYPE": "D", "MH": "Skin", "AQ": "AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PP PS RE UL VI", "MN": "A17.815", "FX": "Skin Manifestations", "EC": "transplantation:Skin Transplantation", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at CUTANEOUS, CUTIS, and DERMAT-", "MS": "The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.", "PM": "/transplantation was SKIN TRANSPLANTATION 1963-65; was SKIN/transplantation 1966-89", "HN": "/transplantation was SKIN TRANSPLANTATION 1963-65; was SKIN/transplantation 1966-89", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012867"}, {"RECTYPE": "D", "MH": "Skin Abnormalities", "DE": "SKIN ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Skin Abnormality", "MN": "C17.800.804", "MH_TH": "NLM (1985)", "ST": "T047", "AN": "for congenital structural abnormalities only; general or unspecified; prefer specifics", "PI": "Skin/abnormalities (1966-1997)", "MS": "Congenital structural abnormalities of the skin.", "PM": "98", "HN": "98; use explode 1985-97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19840502", "DC": "1", "DX": "19980101", "UI": "D012868"}, {"RECTYPE": "D", "MH": "Skin Absorption", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Absorption, Skin|T042|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Transdermal Absorptions", "MN": "G13.750.778", "FX": "Administration, Cutaneous", "MH_TH": "NLM (1965)", "ST": "T042", "MS": "Uptake of substances through the SKIN.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012869"}, {"RECTYPE": "D", "MH": "Skin Diseases", "DE": "SKIN DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Skin and Subcutaneous Tissue Disorders|T047|NON|BRD|NLM (2020)|190507|abcdef", "ENTRY": "Skin Disease", "MN": "C17.800", "FX": "Skin Manifestations", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Diseases involving the DERMIS or EPIDERMIS.", "PM": "1965; was see under DERMATOLOGY 1963-64", "HN": "1965; was see under DERMATOLOGY 1963-64", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012871"}, {"RECTYPE": "D", "MH": "Skin Diseases, Vesiculobullous", "DE": "SKIN DIS VESICULOBULLOUS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vesiculobullous Skin Diseases|T047|NON|EQV|NLM (1991)|891221|VESICULOBULLOUS SKIN DIS|abcdefv", "ENTRY": "Vesiculobullous Skin Disease", "MN": "C17.800.865", "MH_TH": "NLM (1976)", "ST": "T047", "AN": "general or unspecified; prefer specifics; do not confuse entry term SNEDDON-WILKINSON DISEASE with SNEDDON SYNDROME", "PI": "specific skin disease (1966-1975)", "MS": "Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990)", "OL": "use SKIN DISEASES, VESICULOBULLOUS to search SKIN DISEASES, BULLOUS 1976-90; use ICHTHYOSIS & SKIN DISEASES, VESICULOBULLOUS to search ERYTHRODERMA ICHTHYOSIFORME 1975-78 & use ICHTHYOSIS 1966-74", "PM": "91; SKIN DISEASES, BULLOUS was heading 1976-90; ERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78", "HN": "91; SKIN DISEASES, BULLOUS was heading 1976-90 & was NON MESH before 1976; ERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19750721", "DC": "1", "DX": "19760101", "UI": "D012872"}, {"RECTYPE": "D", "MH": "Skin Diseases, Genetic", "DE": "SKIN DIS GENET", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Skin Disease, Genetic", "MN": "C17.800.827", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Skin Diseases (1975-1997)", "MS": "Diseases of the skin with a genetic component, usually the result of various inborn errors of metabolism.", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012873"}, {"RECTYPE": "D", "MH": "Skin Diseases, Infectious", "DE": "SKIN DIS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Skin Disease, Infectious", "MN": "C17.800.838", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with specific infectious  disease  + site  or with precoordinated  site terms ", "PI": "specific skin disease (1966-1967)", "MS": "Skin diseases caused by bacteria, fungi, parasites, or viruses.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012874"}, {"RECTYPE": "D", "MH": "Skin Diseases, Metabolic", "DE": "SKIN DIS METAB", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Skin Disease, Metabolic", "MN": "C18.452.880", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics  ", "PI": "Skin Diseases (1972-1997)", "MS": "Diseases of the skin associated with underlying metabolic disorders.", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012875"}, {"RECTYPE": "D", "MH": "Skin Diseases, Parasitic", "DE": "SKIN DIS PARASITIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Parasitic Skin Diseases|T047|NON|EQV|NLM (1993)|920422|PARASITIC SKIN DIS|abcdefv", "ENTRY": "Skin Disease, Parasitic", "MN": "C17.800.838.775", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "general or unspecified; coordinate with specific parasitic disease + site or with precoordinated site terms; ECTOPARASITIC INFESTATIONS is available for parasites on or within the skin ", "PI": "Skin Diseases (1966-1967)", "MS": "Skin diseases caused by ARTHROPODS; HELMINTHS; or other parasites.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012876"}, {"RECTYPE": "D", "MH": "Skin Manifestations", "ENTRY": "Skin Manifestation", "MN": "C23.888.885", "MH_TH": "NLM (1965)", "ST": "T184", "AN": "not used for indexing since 1989; prior to 1989 used for skin manifest of non-skin diseases", "MS": "Dermatologic disorders attendant upon non-dermatologic disease or injury.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012877"}, {"RECTYPE": "D", "MH": "Skin Neoplasms", "DE": "SKIN NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Skin Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Skin Neoplasm", "MN": "C17.800.882", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neoplasm (IM); coord also with site (NIM) if merely locational but for neoplasms of the head or neck, coord IM with HEAD AND NECK NEOPLASMS or specifics (IM)", "MS": "Tumors or cancer of the SKIN.", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012878"}, {"RECTYPE": "D", "MH": "Skin Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Skin Physiology|T042|NON|EQV|NLM (1966)|990101|SKIN PHYSIOL|abcdefv", "ENTRY": "Skin Physiological Phenomenons", "MN": "G13.750", "MH_TH": "NLM (2009)", "ST": "T042", "AN": "general or unspecified; prefer specifics", "PI": "Skin/physiology (1966-1997)", "MS": "The functions of the skin in the human and animal body. It includes the pigmentation of the skin.", "PM": "2009; see SKIN PHYSIOLOGY 1998-2008; for SKIN  PHYSIOLOGICAL PROCESSES see SKIN  PHYSIOLOGICAL PROCESSES 2009-2016", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D012879"}, {"RECTYPE": "D", "MH": "Skin Pigmentation", "AQ": "DE GE IM PH RE", "ENTRY": "Tones, Skin", "MN": "G16.690.890", "MH_TH": "NLM (1975)", "ST": "T184", "PI": "Pigmentation (1966-1974)", "MS": "Coloration of the skin.", "OL": "search PIGMENTATION 1966-74", "PM": "76; was see under PIGMENTATION 1963-75", "HN": "76(75); was see under PIGMENTATION 1963-75", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D012880"}, {"RECTYPE": "D", "MH": "Skin Temperature", "AQ": "DE GE IM PH RE", "ENTRY": "Temperatures, Skin", "MN": "G13.750.844", "MH_TH": "NLM (1970)", "ST": "T032", "PI": "Skin (1966-1969)", "MS": "The TEMPERATURE at the outer surface of the body.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D012881"}, {"RECTYPE": "D", "MH": "Skin Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Skin", "MN": "E05.478.594.890", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "NIM", "MS": "Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012882"}, {"RECTYPE": "D", "MH": "Skin Ulcer", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ulcers, Skin", "MN": "C17.800.893", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An ULCER of the skin and underlying tissues.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012883"}, {"RECTYPE": "D", "MH": "Skin Window Technique", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Techniques, Skin Window", "MN": "E05.478.594.890.705", "MH_TH": "NLM (1967)", "ST": "T059", "PI": "Inflammation (1966)", "MS": "A technique to study CELL MIGRATION in the INFLAMMATION process or during immune reactions. After an area on the skin is abraded, the movement of cells in the area is followed via microscopic observation of the exudate through a coverslip or tissue culture chamber placed over the area.", "OL": "use SKIN WINDOW TECHNIQUE to search SKIN WINDOW TECHNIC 1967-90", "PM": "91; was SKIN WINDOW TECHNIC 1970-90", "HN": "91(67); was SKIN WINDOW TECHNIC 1967-90 (Prov 1967-69)", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D012884"}, {"RECTYPE": "D", "MH": "Skinfold Thickness", "ENTRY": "Thicknesses, Skinfold", "MN": "G07.100.100.803", "MH_TH": "NLM (1968)", "ST": "T060", "PI": "Skin (1966-1967)", "MS": "The measurement of subcutaneous fat located directly beneath the skin by grasping a fold of skin and subcutaneous fat between the thumb and forefinger and pulling it away from the underlying muscle tissue. The thickness of the double layer of skin and subcutaneous tissue is then read with a caliper. The five most frequently measured sites are the upper arm, below the scapula, above the hip bone, the abdomen, and the thigh. Its application is the determination of relative fatness, of changes in physical conditioning programs, and of the percentage of body fat in desirable body weight. (From McArdle, et al., Exercise Physiology, 2d ed, p496-8)", "PM": "73", "HN": "73(68)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012885"}, {"RECTYPE": "D", "MH": "Skull", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cranium|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Skulls", "MN": "A02.835.232.781", "FX": "Trephining", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "bony part of head only; differentiate from HEAD & FACE; \"cranial\" is SKULL; /abnorm: consider also CRANIOFACIAL ABNORMALITIES; /anat: consider also CEPHALOMETRY; /inj \"cranio-cerebral inj\" is CRANIOCEREBRAL TRAUMA (or its specifics) only & not also here unless particularly discussed; /surg: consider also CRANIOTOMY & TREPHINING; \"craniofacial dysmorphism\" or \"craniofacial fibrous dysplasia\": index under FACIAL BONES (IM) + SKULL (IM) + FIBROUS DYSPLASIA, POLYOSTOTIC (IM)", "CX": "consider also terms at CRANI-", "MS": "The SKELETON of the HEAD including the FACIAL BONES and the bones enclosing the BRAIN.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012886"}, {"RECTYPE": "D", "MH": "Skull Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Skull Fracture, Non-Depressed|T037|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Skull Fractures, Non-Depressed", "MN": "C26.915.300.745", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "fractures of specific bones of the skull: coordinate with specific bone/inj", "MS": "Fractures of the skull which may result from penetrating or nonpenetrating head injuries or rarely BONE DISEASES (see also FRACTURES, SPONTANEOUS). Skull fractures may be classified by location (e.g., SKULL FRACTURE, BASILAR), radiographic appearance (e.g., linear), or based upon cranial integrity (e.g., SKULL FRACTURE, DEPRESSED).", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012887"}, {"RECTYPE": "D", "MH": "Skull Neoplasms", "DE": "SKULL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Skull Neoplasm", "MN": "C05.116.231.754", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "of bony part of skull only: do not confuse with HEAD AND NECK NEOPLASMS or FACIAL NEOPLASMS; \"intracranial tumors\" is probably BRAIN NEOPLASMS, not SKULL NEOPLASMS; general or unspecified; prefer specifics; coordinate with histological type of neoplasm; SKULL BASE NEOPLASMS is also available", "MS": "Neoplasms of the bony part of the skull.", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012888"}, {"RECTYPE": "D", "MH": "Mephitidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Striped Skunks|T015|NON|NRW|NLM (1998)|961028|abcdef", "ENTRY": "Striped Skunk", "MN": "B01.050.150.900.649.313.750.250.479", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid119825", "RR": "txid30550", "MS": "The family of omnivorous New World skunks, showing typical warning coloration of patterned black and white and able to eject a malodorous secretion when the animal is startled or in danger.", "PM": "2005; see SKUNKS 1991-2004, see CARNIVORA 1975-1990", "HN": "2005 (1975)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012889"}, {"RECTYPE": "D", "MH": "Sleep", "AQ": "DE ES GE IM PH RE", "ENTRY": "Sleep Habit", "MN": "G11.561.803", "FX": "Polysomnography", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility.", "CATSH": "CAT LIST", "MR": "20181012", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012890"}, {"RECTYPE": "D", "MH": "Sleep Apnea Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sleep-Disordered Breathing|T047|NON|REL|NLM (1997)|950926|abcdef", "ENTRY": "Sleep Hypopneas", "MN": "C10.886.425.800.750", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Sleep Disorders (1966-1979)", "MS": "Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19790525", "DC": "1", "DX": "19800101", "UI": "D012891"}, {"RECTYPE": "D", "MH": "Sleep Deprivation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sleep Insufficiency|T067|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Syndrome, Insufficient Sleep", "MN": "F03.870.400.099", "MH_TH": "NLM (1964)", "ST": "T067", "AN": "do not confuse with SLEEP INITIATION AND MAINTENANCE DISORDERS, inability to fall asleep or sleep", "MS": "The state of being deprived of sleep under experimental conditions, due to life events, or from a wide variety of pathophysiologic causes such as medication effect, chronic illness, psychiatric illness, or sleep disorder.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19991108", "DC": "1", "DX": "19670101", "UI": "D012892"}, {"RECTYPE": "D", "MH": "Sleep Wake Disorders", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sleep Disorders|T047|T184|NON|BRD|NLM (1966)|990101|SLEEP DIS|abbcdefv", "ENTRY": "Wake Disorders, Sleep", "MN": "F03.870", "MH_TH": "NLM (2016)", "ST": "T048", "MS": "Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle.", "CATSH": "CAT LIST", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012893"}, {"RECTYPE": "D", "MH": "Sleep Stages", "AQ": "DE GE IM PH RE", "ENTRY": "Stages, Sleep", "MN": "G11.561.803.754", "MH_TH": "NLM (1969)", "ST": "T040", "PI": "Sleep (1966-1968)", "MS": "Periods of sleep manifested by changes in EEG activity and certain behavioral correlates; they formerly included Stage 1: sleep onset, drowsy sleep; Stage 2: light sleep; Stages 3 and 4: delta sleep, light sleep, deep sleep, telencephalic sleep. In 2007, sleep stages were redefined by The American Academy of Sleep Medicine (AASM) as: N1-N2 (sleep onset - light sleep), N3 (SLOW-WAVE SLEEP), and REM SLEEP.", "PM": "1972", "HN": "1972 (1969)", "CATSH": "CAT LIST", "MR": "20180409", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012894"}, {"RECTYPE": "D", "MH": "Sleep, REM", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Sleep, Fast-Wave|T041|NON|EQV|NLM (1998)|960711|abcdef", "ENTRY": "Sleep, Rhombencephalic", "MN": "G11.561.803.754.671", "MH_TH": "NLM (1969)", "ST": "T041", "PI": "Sleep (1966-1968)", "MS": "A stage of sleep characterized by rapid movements of the eye and low voltage fast pattern EEG. It is usually associated with dreaming.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012895"}, {"RECTYPE": "D", "MH": "Sloths", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Sloth", "MN": "B01.050.150.900.649.313.999.750", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid948953", "MS": "Slow-moving exclusively arboreal mammals that inhabit the tropical forests of South and Central America.", "PM": "91; was see under EDENTATA 1975-90", "HN": "91(75); was see under EDENTATA 1975-90", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D012896"}, {"RECTYPE": "D", "MH": "Slow Virus Diseases", "DE": "SLOW VIRUS DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Virus Diseases, Slow", "MN": "C01.925.839", "FX": "Prion Diseases", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Virus Diseases (1966-1967)", "MS": "Diseases of viral origin, characterized by incubation periods of months to years, insidious onset of clinical manifestations, and protracted clinical course. Though the disease process is protracted, viral multiplication may not be unusually slow. Conventional viruses produce slow virus diseases such as SUBACUTE SCLEROSING PANENCEPHALITIS, progressive multifocal leukoencephalopathy (LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL), and AIDS. Diseases produced by unconventional agents were originally considered part of this group. They are now called PRION DISEASES.", "PM": "72", "HN": "72(68)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D012897"}, {"RECTYPE": "D", "MH": "Autacoids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Slow-Reacting Substances|T123|NON|EQV|NLM (1995)|931124|abcdef", "ENTRY": "Substances, Slow-Reacting", "MN": "D23.469.050", "MH_TH": "NLM (1967)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "specific tissue (1966)", "MS": "A chemically diverse group of substances produced by various tissues in the body that cause slow contraction of smooth muscle; they have other intense but varied pharmacologic activities.", "OL": "use AUTACOIDS to search SLOW-REACTING SUBSTANCES 1967-94 (as Prov 1967-73)", "PM": "95; was SLOW-REACTING SUBSTANCES 1974-94; AUTACOIDS was see SLOW-REACTING SUBSTANCES 1978-94", "HN": "95; was SLOW-REACTING SUBSTANCES 1967-94 (Prov 1967-73); AUTACOIDS was see SLOW-REACTING SUBSTANCES 1978-94", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012898"}, {"RECTYPE": "D", "MH": "Smallpox", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Variola Minor|T047|NON|REL|NLM (1997)|960411|abcdef", "ENTRY": "Variolas", "MN": "C01.925.256.743.826", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by a poxvirus", "MS": "An acute, highly contagious, often fatal infectious disease caused by an orthopoxvirus characterized by a biphasic febrile course and distinctive progressive skin eruptions. Vaccination has succeeded in eradicating smallpox worldwide. (Dorland, 28th ed)", "PM": "ALASTRIM was heading 1975-96 (see under SMALLPOX 1975-90); VARIOLA MINOR was see ALASTRIM 1979-96", "HN": "ALASTRIM was heading 1975-96 (see under SMALLPOX 1975-90); VARIOLA MINOR was see ALASTRIM 1979-96", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012899"}, {"RECTYPE": "D", "MH": "Smallpox Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaccinia Vaccine|T121|NON|REL|NLM (2023)|220811|abcdef", "ENTRY": "Vaccine, Vaccinia", "MN": "D20.215.894.899.859", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "MS": "A VACCINIA VIRUS vaccine used for immunization against SMALLPOX. It is now recommended only for laboratory workers exposed to SMALLPOX VIRUS. Certain countries continue to vaccinate those in the military service. Rare complications most often associated with older generation smallpox vaccines include VACCINIA, secondary bacterial infections, and ENCEPHALOMYELITIS. Because MONKEYPOX VIRUS and SMALLPOX VIRUS are both ORTHOPOXVIRUS and are closely related smallpox vaccines provide effective CROSS-PROTECTION against MPOX (MONKEYPOX) (https://www.cdc.gov/poxvirus/monkeypox/clinicians/smallpox-vaccine.html).", "MR": "20230727", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012900"}, {"RECTYPE": "D", "MH": "Variola virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Smallpox Virus|T005|NON|EQV|NLM (1994)|930309|abcdef", "ENTRY": "Variola viruses", "MN": "B04.280.650.160.650.930", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid10255", "MS": "A species of ORTHOPOXVIRUS causing infections in humans. No infections have been reported since 1977 and the virus is now believed to be virtually extinct.", "OL": "use VARIOLA VIRUS to search SMALLPOX VIRUS 1966-93", "PM": "94; was SMALLPOX VIRUS 1963-93; VARIOLA VIRUS was see SMALLPOX VIRUS 1975-93", "HN": "94; was SMALLPOX VIRUS 1963-93; VARIOLA VIRUS was see SMALLPOX VIRUS 1975-93", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D012901"}, {"RECTYPE": "D", "MH": "Smegma", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Smegmas", "MN": "A12.200.769", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "A foul-smelling accumulation of SEBUM and desquaminated epidermal cells, especially the cheesy substance found under the foreskin of the penis and at the base of the labia minor near the clitoris.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012902"}, {"RECTYPE": "D", "MH": "Smell", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Olfaction|T042|NON|EQV|NLM (1991)|900426|abcdef", "ENTRY": "Smell Sense", "MN": "G11.561.790.643", "FX": "Olfaction Disorders", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "differentiate from OLFACTORY PERCEPTION: SMELL takes place in the nose, OLFACTORY PERCEPTION takes place in the brain", "MS": "The ability to detect scents or odors, such as the function of OLFACTORY RECEPTOR NEURONS.", "CATSH": "CAT LIST", "MR": "20170709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012903"}, {"RECTYPE": "D", "MH": "Smiling", "AQ": "PH PX", "ENTRY": "Smilings", "MN": "F01.145.209.530.385.671", "MH_TH": "NLM (1975)", "ST": "T054", "MS": "A facial expression which may denote feelings of pleasure, affection, amusement, etc.", "OL": "search FACIAL EXPRESSION 1969-74", "PM": "91; was see under FACIAL EXPRESSION 1975-90", "HN": "91(75); was see under FACIAL EXPRESSION 1975-90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012904"}, {"RECTYPE": "D", "MH": "Smog", "AQ": "AE AN PC", "MN": "D20.633.875", "MH_TH": "NLM (1971)", "ST": "T070", "RN": "0", "AN": "IM", "PI": "Air Pollution (1966-1970)", "MS": "A mixture of smoke and fog polluting the atmosphere. (Dorland, 27th ed)", "OL": "search AIR POLLUTION 1966-70", "PM": "74; was see under AIR POLLUTION 1969-73", "HN": "74(71); was see under AIR POLLUTION 1969-73", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012905"}, {"RECTYPE": "D", "MH": "Smoke", "AQ": "AE AN PC", "MN": "D20.633.937", "MH_TH": "NLM (1971)", "ST": "T131", "RN": "0", "PI": "Air Pollution (1966-1970)", "MS": "Visible gaseous suspension of carbon and other particulate matter emitted from burning substances.", "OL": "search AIR POLLUTION 1966-70", "PM": "74; was see under AIR POLLUTION 1963-73", "HN": "74(71); was see under AIR POLLUTION 1963-73", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012906"}, {"RECTYPE": "D", "MH": "Smoking", "AQ": "AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PP PX TD TH UR", "ENTRY": "Smoking Habits", "MN": "F01.145.805", "FX": "Tobacco Use Disorder", "EC": "prevention & control:Smoking Prevention", "MH_TH": "POPLINE (1978)", "ST": "T055", "MS": "Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand.", "CATSH": "CAT LIST", "MR": "20170712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012907"}, {"RECTYPE": "D", "MH": "Snails", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Snail", "MN": "B01.050.500.644.400.750", "MH_TH": "NLM (1966)", "ST": "T204", "AN": "as animal and food; general or unspecified; prefer specifics; as food, coordinate with SHELLFISH ", "MS": "Marine, freshwater, or terrestrial mollusks of the class Gastropoda. Most have an enclosing spiral shell, and several genera harbor parasites pathogenic to man.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012908"}, {"RECTYPE": "D", "MH": "Snake Bites", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Snakebite Envenoming|T037|NON|NRW|NLM (2024)|230301|abcdef", "ENTRY": "Snakebite Envenomings", "MN": "C26.176.724", "FX": "Snake Venoms", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "Coordinate IM with specific snake family or genus (IM); therapy with antivenins is /ther, not /drug ther", "MS": "Bites by snakes. Bite by a venomous snake is characterized by stinging pain at the wound puncture. The venom injected at the site of the bite is capable of producing a deleterious effect on the blood or on the nervous system. (Webster's 3d ed; from Dorland, 27th ed, at snake, venomous)", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012909"}, {"RECTYPE": "D", "MH": "Snake Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE TO TU UR", "PRINT ENTRY": "Snake Toxins|T123|T131|NON|NRW|NLM (2021)|200128|abbcdef", "ENTRY": "Venom, Snake", "MN": "D23.946.833.850", "FX": "Antivenins", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "general or unspecified; prefer specifics; coordinate with specific available snake family or genus; /antag permitted but consider also ANTIVENINS; do not use qualifers when coordinating with ANTIVENINS", "PI": "Venoms (1968-1974)", "MS": "Solutions or mixtures of toxic and nontoxic substances elaborated by snake (Ophidia) salivary glands (Duvernoy's gland) for the purpose of killing prey or disabling predators and delivered by grooved or hollow fangs. They usually contain enzymes, toxins, and other factors.", "PM": "76; was see under VENOMS 1975", "HN": "76(75); was see under VENOMS 1975", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D012910"}, {"RECTYPE": "D", "MH": "Snakes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Serpentes|T014|NON|EQV|NLM (2007)|050929|abcdef", "ENTRY": "Snake", "MN": "B01.050.150.900.833.672", "FX": "Snake Venoms", "MH_TH": "NLM (1966)", "ST": "T014", "RN": "txid8570", "AN": "general or unspecified; prefer specific families or genera", "MS": "Limbless REPTILES of the suborder Serpentes.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012911"}, {"RECTYPE": "D", "MH": "Sneezing", "AQ": "DE ES GE IM PH RE", "ENTRY": "Sneezings", "MN": "G09.772.832", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "The sudden, forceful, involuntary expulsion of air from the NOSE and MOUTH caused by irritation to the MUCOUS MEMBRANES of the upper RESPIRATORY TRACT.", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012912"}, {"RECTYPE": "D", "MH": "Snoring", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Snorings", "MN": "C23.888.852.779.850", "MH_TH": "NLM (1979)", "ST": "T184", "AN": "note category", "MS": "Rough, noisy breathing during sleep, due to vibration of the uvula and soft palate.", "PM": "85; was see under RESPIRATORY SOUNDS 1980-84 & MOUTH BREATHING 1979", "HN": "85(79); was see under RESPIRATORY SOUNDS 1980-84 & MOUTH BREATHING 1979", "CATSH": "CAT LIST", "MR": "19900529", "DA": "19780519", "DC": "1", "DX": "19850101", "UI": "D012913"}, {"RECTYPE": "D", "MH": "Snow", "AQ": "CH MI PS VI", "ENTRY": "Snows", "MN": "N06.230.300.100.725.480", "MH_TH": "NLM (1975)", "ST": "T167", "MS": "Frozen water crystals that fall from the ATMOSPHERE.", "OL": "search WEATHER 1969-74", "PM": "91; was see under WEATHER 1975-90", "HN": "91(75); was see under WEATHER 1975-90", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012914"}, {"RECTYPE": "D", "MH": "Soaps", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Solutions, Soap", "MN": "J01.516.872", "MH_TH": "NLM (1963)", "ST": "T120", "RN": "0", "MS": "Sodium or potassium salts of long chain fatty acids. These detergent substances are obtained by boiling natural oils or fats with caustic alkali. Sodium soaps are harder and are used as topical anti-infectives and vehicles in pills and liniments; potassium soaps are soft, used as vehicles for ointments and also as topical antimicrobials.", "PM": "91,63-80; was see under SURFACE-ACTIVE AGENTS 1981-90; was heading 1963-80", "HN": "91(81)63; was see under SURFACE-ACTIVE AGENTS 1981-90; was heading 1963-80", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D012915"}, {"RECTYPE": "D", "MH": "Soccer", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Football European|T056|NON|EQV|NLM (2022)|210118|abcdef", "ENTRY": "Football, European", "MN": "I03.450.642.845.800", "MH_TH": "NLM (1976)", "ST": "T056", "AN": "/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1; includes non-North American \"football\"; does not include rugby (RUGBY see FOOTBALL)", "PI": "Sports (1966-1975)", "MS": "A game in which a round inflated ball is advanced by kicking or propelling with any part of the body except the hands or arms. The object of the game is to place the ball in opposite goals.", "PM": "90; was see under SPORTS 1976-89", "HN": "90(76); was see under SPORTS 1976-89", "MR": "20210118", "DA": "19750723", "DC": "1", "DX": "19900101", "UI": "D012916"}, {"RECTYPE": "D", "MH": "Social Adjustment", "PRINT ENTRY": "Adjustment, Social|T054|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Social Adjustments", "MN": "F01.145.813.621", "MH_TH": "POPLINE (1986)", "ST": "T054", "PI": "Behavior (1966-1968)", "MS": "Adaptation of the person to the social environment. Adjustment may take place by adapting the self to the environment or by changing the environment. (From Campbell, Psychiatric Dictionary, 1996).", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012917"}, {"RECTYPE": "D", "MH": "Social Alienation", "AQ": "PX", "PRINT ENTRY": "Social Breakdown Syndrome|T054|NON|REL|NLM (1975)|970714|abcdef", "ENTRY": "Syndromes, Social Breakdown", "MN": "I01.880.853.748.755", "MH_TH": "NLM (1973)", "ST": "T054", "PI": "Sociology (1966-1967)", "MS": "The state of estrangement individuals feel in cultural settings that they view as foreign, unpredictable, or unacceptable.", "PM": "73; SOCIAL BREAKDOWN was heading 1975-97", "HN": "73", "CATSH": "CAT LIST", "MR": "20230615", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012918"}, {"RECTYPE": "D", "MH": "Social Behavior", "AQ": "HI", "PRINT ENTRY": "Sociality|T054|NON|NRW|NLM (2021)|200115|abcdef", "ENTRY": "Social Behaviors", "MN": "F01.145.813", "FX": "Interpersonal Relations", "MH_TH": "NLM (2017)", "ST": "T054", "AN": "human & animal", "PI": "Psychology, Social (1966-1968)", "MS": "Any behavior caused by or affecting another individual or group usually of the same species.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20200708", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012919"}, {"RECTYPE": "D", "MH": "Social Behavior Disorders", "DE": "SOCIAL BEHAVIOR DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Disorders, Social Behavior", "MN": "I01.880.735.784", "FX": "Antisocial Personality Disorder", "MH_TH": "NLM (1969)", "ST": "T054", "AN": "human only", "PI": "Child Behavior Disorders (1966-1968)", "MS": "Behaviors which are at variance with the expected social norm and which affect other individuals.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012920"}, {"RECTYPE": "D", "MH": "Social Change", "AQ": "HI", "ENTRY": "Social Impacts", "MN": "N01.824.737", "MH_TH": "POPLINE (1978)", "ST": "T054", "AN": "specify geographic term if pertinent", "PI": "Sociology (1966-1967)", "MS": "A shift, alteration, modification, or evolution of human behavior and culture, which over time, results in measurable consequences on societal values and norms.", "PM": "68", "HN": "68", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012922"}, {"RECTYPE": "D", "MH": "Social Class", "AQ": "HI", "PRINT ENTRY": "Socioeconomic Status|T080|NON|REL|NLM (1990)|890502|SOCIOECON STATUS|abcdefv", "ENTRY": "Status, Socioeconomic", "MN": "N01.824.782", "MH_TH": "POPLINE (1978)", "ST": "T080", "PI": "Sociology (1966-1967)", "MS": "A stratum of people with similar position and prestige; includes social stratification. Social class is measured by criteria such as education, occupation, and income.", "PM": "68", "HN": "68", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012923"}, {"RECTYPE": "D", "MH": "Social Conditions", "AQ": "CL EC HI LJ SN TD", "ENTRY": "Social Condition", "MN": "N01.824.827", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "specify geographic term if pertinent", "MS": "The state of society as it exists or in flux. While it usually refers to society as a whole in a specified geographical or political region, it is applicable also to restricted strata of a society.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012924"}, {"RECTYPE": "D", "MH": "Social Conformity", "PRINT ENTRY": "Conformity, Social|T054|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Social Conformities", "MN": "F01.145.813.625", "FX": "Social Norms", "MH_TH": "NLM (1968)", "ST": "T054", "PI": "Interpersonal Relations (1966-1967)", "MS": "Behavioral or attitudinal compliance with recognized social patterns or standards.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012925"}, {"RECTYPE": "D", "MH": "Social Control, Formal", "AQ": "CL MT", "ENTRY": "Social Controls", "MN": "N03.706", "FX": "Public Policy", "MH_TH": "NLM (1968)", "ST": "T064", "AN": "entry term REGULATION: not for regulation in biological processes", "PI": "specific subject controlled (1966-1967)", "MS": "Control which is exerted by the more stable organizations of society, such as established institutions and the law. They are ordinarily embodied in definite codes, usually written.", "PM": "68", "HN": "68", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012926"}, {"RECTYPE": "D", "MH": "Social Control, Informal", "AQ": "CL HI MT", "ENTRY": "Social Controls, Informal", "MN": "I01.880.630", "MH_TH": "NLM (1968)", "ST": "T068", "MS": "Those forms of control which are exerted in less concrete and tangible ways, as through folkways, mores, conventions, and public sentiment.", "PM": "68", "HN": "68", "MR": "20150615", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012927"}, {"RECTYPE": "D", "MH": "Social Desirability", "ENTRY": "Worth, Social", "MN": "F01.145.813.628", "MH_TH": "NLM (1965)", "ST": "T054", "MS": "A personality trait rendering the individual acceptable in social or interpersonal relations. It is related to social acceptance, social approval, popularity, social status, leadership qualities, or any quality making him a socially desirable companion.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012928"}, {"RECTYPE": "D", "MH": "Psychological Distance", "ENTRY": "Psychological Distances", "MN": "F01.829.316.777", "MH_TH": "NLM (2021)", "ST": "T054", "PI": "Psychology, Social (1966-1968)", "MS": "The degree of a person's detachment from emotional involvement with people or situations.(APA Thesaurus of Psychological Index Terms accessed 12/29/2020)", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20210705", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012929"}, {"RECTYPE": "D", "MH": "Social Dominance", "AQ": "HI", "PRINT ENTRY": "Dominance, Social|T054|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Hierarchy, Dominance", "MN": "F01.145.813.650", "MH_TH": "BIOETHICS (1974)", "ST": "T054", "AN": "human & animal", "MS": "Social structure of a group as it relates to the relative social rank of dominance status of its members. (APA, Thesaurus of Psychological Index Terms, 8th ed.)", "OL": "use SOCIAL DOMINANCE to search DOMINANCE, SOCIAL 1968", "PM": "69; was DOMINANCE, SOCIAL 1968", "HN": "69; was DOMINANCE, SOCIAL 1968", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012930"}, {"RECTYPE": "D", "MH": "Social Environment", "PRINT ENTRY": "Social Context|T078|NON|EQV|NLM (2021)|200115|abcdef", "ENTRY": "Social Environments", "MN": "I01.880.853.500", "FX": "Life Style", "MH_TH": "NLM (1972)", "ST": "T078", "AN": "human & animal", "PI": "Socioeconomic Factors (1968-1971)", "MS": "The aggregate of social and cultural institutions, forms, patterns, and processes that influence the life of an individual or community.", "PM": "73", "HN": "73(72)", "MR": "20200429", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012931"}, {"RECTYPE": "D", "MH": "Social Facilitation", "ENTRY": "Social Facilitations", "MN": "F01.145.813.655", "MH_TH": "NLM (1968)", "ST": "T054", "AN": "human & animal", "MS": "Any enhancement of a motivated behavior in which individuals do the same thing with some degree of mutual stimulation and consequent coordination.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012932"}, {"RECTYPE": "D", "MH": "Social Identification", "PRINT ENTRY": "Professional Identity Formation|T054|NON|BRD|NLM (2023)|211128|abcdef", "ENTRY": "Social Identities", "MN": "F01.145.813.708", "MH_TH": "NLM (1978)", "ST": "T055", "PI": "Social Behavior (1969-1977)", "MS": "The process by which an aspect of self image is developed based on in-group preference or ethnocentrism and a perception of belonging to a social or cultural group. (From APA, Thesaurus of Psychological Index Terms, 8th ed.)", "PM": "91; was see under SOCIAL BEHAVIOR 1978-90", "HN": "91(78); was see under SOCIAL BEHAVIOR 1978-90", "CATSH": "CAT LIST", "MR": "20211202", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D012933"}, {"RECTYPE": "D", "MH": "Social Isolation", "AQ": "PX", "PRINT ENTRY": "Social Exclusion|T054|NON|REL|OBSSR (2021)|210520|abcdef", "ENTRY": "Social Exclusions", "MN": "I01.880.853.748", "MH_TH": "OBSSR (2022)", "ST": "T054", "AN": "human & animal; for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "The separation of individuals or groups resulting in the lack of or minimizing of social contact and/or communication. This separation may be accomplished by physical separation, by social barriers and by psychological mechanisms. In the latter, there may be interaction but no real communication.", "OL": "use SOCIAL ISOLATION to search ISOLATION, SOCIAL 1968", "PM": "69; was ISOLATION, SOCIAL 1968", "HN": "69; was ISOLATION, SOCIAL 1968", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012934"}, {"RECTYPE": "D", "MH": "Social Justice", "AQ": "CL EC ED ES HI IN LJ PX SN ST TD", "PRINT ENTRY": "Food Justice|T080|NON|REL|NLM (2022)|200819|abcdef", "ENTRY": "Justice, Social", "MN": "N05.350.958.750", "FX": "Human Rights", "MH_TH": "NLM (1978)", "ST": "T080", "AN": "specify geographic term if pertinent", "MS": "An interactive process whereby members of a community are concerned for the equality and rights of all.", "PM": "91; was see under HUMAN RIGHTS 1978-90", "HN": "91(78); was see under HUMAN RIGHTS 1978-90", "MR": "20210118", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D012935"}, {"RECTYPE": "D", "MH": "Social Medicine", "DE": "SOCIAL MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Social|T091|NON|EQV|NLM (1991)|891204|MED SOCIAL|abcdefv", "MN": "H02.403.800", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "A branch of medicine concerned with the role of socio-environmental factors in the occurrence, prevention and treatment of disease.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012936"}, {"RECTYPE": "D", "MH": "Social Mobility", "AQ": "EC HI SN TD", "ENTRY": "Social Mobilities", "MN": "N01.824.782.673", "MH_TH": "POPLINE (1990)", "ST": "T068", "PI": "Sociology (1966-1967)", "MS": "The movement or shifting of membership between or within social classes by individuals or by groups.", "PM": "68", "HN": "68", "MR": "19900830", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012937"}, {"RECTYPE": "D", "MH": "Social Perception", "AQ": "DE EH ES PX", "PRINT ENTRY": "Perception, Social|T041|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Social Perceptions", "MN": "F02.463.593.752", "FX": "Stereotyping", "MH_TH": "NLM (1969)", "ST": "T041", "PI": "Perception (1966-1968)", "MS": "The perceiving of attributes, characteristics, and behaviors of one's associates or social groups.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20200618", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012938"}, {"RECTYPE": "D", "MH": "Social Planning", "ENTRY": "Social Plannings", "MN": "I01.880.709", "MH_TH": "POPLINE (1978)", "ST": "T052", "PI": "Sociology (1966-1967)", "MS": "A systematic process for evaluating and identifying specific needs in the community and the implementation of practical steps for meeting those needs and improving quality of life.", "PM": "68", "HN": "68", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012939"}, {"RECTYPE": "D", "MH": "Social Problems", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Social Exploitation|T054|NON|NRW|NLM (2020)|181218|abcdef", "ENTRY": "Social Problem", "MN": "I01.880.735", "FX": "Substance-Related Disorders", "MH_TH": "POPLINE (1978)", "ST": "T054", "AN": "specify geographic location if pertinent", "PI": "Prostitution (1966-1967)", "MS": "Situations affecting a significant number of people, that are believed to be sources of difficulty or threaten the stability of the community, and that require programs of amelioration.", "PM": "68", "HN": "68", "MR": "20190307", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012940"}, {"RECTYPE": "D", "MH": "Social Responsibility", "PRINT ENTRY": "Responsibility, Social|T078|NON|EQV|UNK (19XX)|770420|abcdef", "ENTRY": "Society, Obligations to", "MN": "K01.752.566.869", "MH_TH": "NLM (1978)", "ST": "T078", "MS": "The obligations and accountability assumed in carrying out actions or ideas on behalf of others.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D012941"}, {"RECTYPE": "D", "MH": "Social Sciences", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Social Science", "MN": "I01", "RH": "I1 - SOCIAL SCIENCES", "MH_TH": "POPLINE (1981)", "ST": "T090", "MS": "Disciplines concerned with the interrelationships of individuals in a social environment including social organizations and institutions. Includes Sociology and Anthropology.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012942"}, {"RECTYPE": "D", "MH": "Social Security", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Social Insurance|T064|NON|EQV|UNK (19XX)|750708|abcdef", "ENTRY": "Security, Social", "MN": "N03.219.521.576.823", "MH_TH": "NLM (1978)", "ST": "T064", "AN": "specify country, including U.S.", "MS": "Government sponsored social insurance programs.", "PM": "AID TO THE BLIND & AID TO THE TOTALLY DISABLED were see under PUBLIC ASSISTANCE 1968-77", "HN": "AID TO THE BLIND & AID TO THE TOTALLY DISABLED were see under PUBLIC ASSISTANCE 1968-77", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012943"}, {"RECTYPE": "D", "MH": "Social Support", "AQ": "EC HI LJ MT PX SN TD", "PRINT ENTRY": "Social Care|T054|NON|EQV|NLM (2021)|200118|abcdef", "ENTRY": "Supports, Perceived Social", "MN": "I01.880.853.500.600", "FX": "Self-Help Groups", "MH_TH": "NLM (1983)", "ST": "T054", "AN": "human only", "PI": "Social Environment (1973-1982)", "MS": "Support systems that provide assistance and encouragement to individuals with physical or emotional disabilities in order that they may better cope. Informal social support is usually provided by friends, relatives, or peers, while formal assistance such as COMMUNITY SUPPORT is provided by churches, groups, etc.", "PM": "91; was see under SOCIAL ENVIRONMENT 1983-90", "HN": "91(83); was see under SOCIAL ENVIRONMENT 1983-90", "MR": "20210708", "DA": "19820427", "DC": "1", "DX": "19910101", "UI": "D012944"}, {"RECTYPE": "D", "MH": "Social Values", "AQ": "EH HI", "ENTRY": "Value Orientations", "MN": "F01.829.873", "FX": "Virtues", "MH_TH": "NLM (1969)", "ST": "T078", "PI": "Psychology, Social (1966-1968)", "MS": "Abstract standards or empirical variables in social life which are believed to be important and/or desirable.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "20140616", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D012945"}, {"RECTYPE": "D", "MH": "Social Welfare", "AQ": "CL EC EH ES HI LJ PX SN TD", "ENTRY": "Welfare, Social", "MN": "I01.880.787", "MH_TH": "POPLINE (1978)", "ST": "T095", "AN": "specify geog if pertinent", "MS": "Organized institutions which provide services to ameliorate conditions of need or social pathology in the community.", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012946"}, {"RECTYPE": "D", "MH": "Social Work", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Social Work Intervention|T057|NON|REL|NLM (2023)|211027|abcdef", "ENTRY": "Work Intervention, Social", "MN": "N02.421.849", "FX": "Relief Work", "MH_TH": "POPLINE (1978)", "ST": "T090", "MS": "The use of community resources, individual case work, or group work to promote the adaptive capacities of individuals in relation to their social and economic environments. It includes social service agencies.", "OL": "use SOCIAL WORK to search SOCIAL SERVICE 1966-77", "PM": "78; was SOCIAL SERVICE 1963-77", "HN": "78; was SOCIAL SERVICE 1963-77", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D012947"}, {"RECTYPE": "D", "MH": "Social Work Department, Hospital", "DE": "SOCIAL WORK DEP HOSP", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Hospital Social Work Department|T093|NON|EQV|UNK (19XX)|830610|HOSP SOCIAL WORK DEP|abcdefv", "MN": "N04.452.442.452.422.730", "MH_TH": "NLM (1984)", "ST": "T093", "PI": "Social Work (1978-1983)", "MS": "Hospital department responsible for administering and providing social services to patients and their families.", "PM": "91; was see under HOSPITAL DEPARTMENTS 1984-90", "HN": "91(84); was see under HOSPITAL DEPARTMENTS 1984-90", "MR": "20190709", "DA": "19830610", "DC": "1", "DX": "19910101", "UI": "D012948"}, {"RECTYPE": "D", "MH": "Social Work, Psychiatric", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Social Service, Psychiatric|T058|T091|NON|EQV|UNK (19XX)|770426|SOCIAL SERV PSYCHIATRIC|abbcdefv", "ENTRY": "Works, Psychiatric Social", "MN": "N02.421.849.673", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "Use of all social work processes in the treatment of patients in a psychiatric or mental health setting.", "OL": "use SOCIAL WORK, PSYCHIATRIC to search SOCIAL SERVICE, PSYCHIATRIC 1966-77", "PM": "78; was SOCIAL SERVICE, PSYCHIATRIC 1963-77", "HN": "78; was SOCIAL SERVICE, PSYCHIATRIC 1963-77", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D012949"}, {"RECTYPE": "D", "MH": "Socialism", "AQ": "CL EC HI SN TD", "ENTRY": "Socialisms", "MN": "I01.696.798", "MH_TH": "POPLINE (1978)", "ST": "T078", "AN": "specify country; do not confuse with NATIONAL SOCIALISM", "MS": "A system of government in which means of production and distribution of goods are controlled by the state.", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012950"}, {"RECTYPE": "D", "MH": "Socialization", "ENTRY": "Socializations", "MN": "I01.880.853.934", "MH_TH": "NLM (1968)", "ST": "T065", "PI": "Parent-Child Relations (1966-1967)", "MS": "The training or molding of an individual through various relationships, educational agencies, and social controls, which enables him to become a member of a particular society.", "PM": "68", "HN": "68", "MR": "19900322", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012951"}, {"RECTYPE": "D", "MH": "Societies", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Professional Organization", "MN": "N03.540.828", "FX": "Library Associations", "MH_TH": "NLM (1966)", "ST": "T092", "AN": "general or unspecified; prefer specific types of societies; do not confuse with ORGANIZATIONS; specify geographic location if pertinent", "MS": "Organizations composed of members with common interests and whose professions may be similar.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012952"}, {"RECTYPE": "D", "MH": "Societies, Dental", "DE": "SOCIETIES DENT", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Society, Dental|T094|NON|EQV|NLM (1991)|900105|SOCIETY DENT|abcdefv", "MN": "N03.540.828.506", "MH_TH": "NLM (1965)", "ST": "T094", "AN": "specify geographic term if pertinent", "MS": "Societies whose membership is limited to dentists.", "PM": "65", "HN": "65", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012953"}, {"RECTYPE": "D", "MH": "Societies, Hospital", "DE": "SOCIETIES HOSP", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Society, Hospital|T094|NON|EQV|NLM (1991)|891205|SOCIETY HOSP|abcdefv", "MN": "N03.540.828.540", "MH_TH": "NLM (1977)", "ST": "T094", "AN": "specify geographic term if pertinent ", "PI": "Societies (1966-Jul 1977)", "MS": "Societies having institutional membership limited to hospitals and other health care institutions.", "PM": "91; was see under SOCIETIES Aug 1977-90", "HN": "91(Aug 77); was see under SOCIETIES 1977-90", "MR": "20190524", "DA": "19770512", "DC": "1", "DX": "19910101", "UI": "D012954"}, {"RECTYPE": "D", "MH": "Societies, Medical", "DE": "SOCIETIES MED", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Society, Medical|T094|NON|EQV|NLM (1991)|891205|SOCIETY MED|abcdefv", "MN": "N03.540.828.589", "MH_TH": "NLM (1966)", "ST": "T094", "AN": "for conventional medical societies & soc of med specialties indented under spec in Cat G2; Manual 35.9.1; TN 174: scope; specify geog; \"College of Physicians\" goes here", "MS": "Societies whose membership is limited to physicians.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012955"}, {"RECTYPE": "D", "MH": "Societies, Nursing", "DE": "SOCIETIES NURS", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Society, Nursing|T094|NON|EQV|NLM (1991)|891205|SOCIETY NURS|abcdefv", "MN": "N03.540.828.672", "MH_TH": "NLM (1966)", "ST": "T094", "MS": "Societies whose membership is limited to nurses.", "PM": "66", "HN": "66", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012956"}, {"RECTYPE": "D", "MH": "Societies, Pharmaceutical", "DE": "SOCIETIES PHARM", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Society, Pharmacy|T094|NON|EQV|NLM (1994)|930121|abcdef", "MN": "N03.540.828.755", "MH_TH": "NLM (1968)", "ST": "T094", "PI": "Pharmacy (1966-1967)", "MS": "Societies whose membership is limited to pharmacists.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012957"}, {"RECTYPE": "D", "MH": "Societies, Scientific", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Scientific Societies|T094|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Society, Scientific", "MN": "N03.540.828.838", "MH_TH": "NLM (1966)", "ST": "T094", "AN": "for societies of scientists & professionals in disciplines not covered under SOCIETIES, MEDICAL; Manual 35.9.1; specify geog", "MS": "Societies whose membership is limited to scientists.", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012958"}, {"RECTYPE": "D", "MH": "Socioeconomic Factors", "AQ": "HI", "PRINT ENTRY": "Socioeconomic Characteristics|T102|NON|EQV|NLM (2023)|211028|abcdef", "ENTRY": "Tenure, Land", "MN": "N01.824", "MH_TH": "POPLINE (1978)", "ST": "T102", "PI": "Sociology (1966-1967)", "MS": "Social and economic factors that characterize the individual or group within the social structure.", "PM": "68", "HN": "68", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012959"}, {"RECTYPE": "D", "MH": "Socioenvironmental Therapy", "DE": "SOCIOENVIR THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapies, Socioenvironmental", "MN": "F04.754.864", "MH_TH": "NLM (1973)", "ST": "T061", "PI": "Psychotherapy (1966-1972)", "MS": "Therapy whose primary emphasis is on the physical and social structuring of the environment to promote interpersonal relationships which will be influential in reducing behavioral disturbances of patients.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "19950519", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012960"}, {"RECTYPE": "D", "MH": "Sociology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "General Social Development and Population|T054|NON|NRW|UNK (19XX)|810826|abcdef", "MN": "I01.880", "FX": "Group Processes", "MH_TH": "POPLINE (1978)", "ST": "T090", "AN": "specialty; use SOCIOLOGICAL FACTORS or specifics treed under it for sociological characteristics and phenomena; /methods: probably SOCIOMETRIC TECHNIQUES", "MS": "A social science dealing with group relationships, patterns of collective behavior, and social organization.", "PM": "RELIGION AND SOCIOLOGY was heading 1963-65", "HN": "RELIGION AND SOCIOLOGY was heading 1963-65", "CATSH": "CAT LIST", "MR": "20200618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012961"}, {"RECTYPE": "D", "MH": "Sociology, Medical", "DE": "SOCIOL MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Medical Sociology|T091|NON|EQV|UNK (19XX)|770420|MED SOCIOL|abcdefv", "ENTRY": "Sociology of Medicine|T091|NON|EQV|BIOETHICS (1974)|770420|abcdef", "MN": "I01.880.859", "MH_TH": "NLM (1978)", "ST": "T091", "AN": "use for the specialty only", "PI": "Sociology (1966-1977)", "MS": "The study of the social determinants and social effects of health and disease, and of the social structure of medical institutions or professions.", "PM": "80; was see under SOCIOLOGY 1978-79", "HN": "80(78); was see under SOCIOLOGY 1978-79", "CATSH": "CAT LIST", "MR": "20140616", "DA": "19770422", "DC": "1", "DX": "19800101", "UI": "D012962"}, {"RECTYPE": "D", "MH": "Sociometric Techniques", "ENTRY": "Techniques, Sociometric", "MN": "I01.880.866", "MH_TH": "NLM (1968)", "ST": "T081", "PI": "Sociology (1966-1967)", "MS": "Methods for quantitatively assessing and measuring interpersonal and group relationships.", "OL": "use SOCIOMETRIC TECHNIQUES to search SOCIOMETRIC TECHNICS 1968-90", "PM": "91; was SOCIOMETRIC TECHNICS 1968-90", "HN": "91; was SOCIOMETRIC TECHNICS 1968-90", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D012963"}, {"RECTYPE": "D", "MH": "Sodium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Sodium 23", "MN": "D01.552.547.725", "FX": "Sodium Radioisotopes", "MH_TH": "POPLINE (1984)", "ST": "T196", "N1": "Sodium", "RN": "9NEZ333N27", "RR": "7440-23-5 (Sodium)", "AN": "/blood: note also HYPERNATREMIA& HYPONATREMIA; /defic: consider also HYPONATREMIA; /urine: consider also NATRIURESIS; SODIUM, DIETARY is also available", "MS": "A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23.", "MR": "20170414", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012964"}, {"RECTYPE": "D", "MH": "Sodium Chloride", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium Chloride, (24)NaCl|T130|T196|NON|NRW|NLM (1999)|990913|abbcdef", "MN": "D01.857.650", "FX": "Diet, Sodium-Restricted", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Sodium chloride (NaCl)", "RN": "451W47IQ8X", "RR": "7647-14-5", "AN": "for intake of table salt use SODIUM CHLORIDE, DIETARY", "MS": "A ubiquitous sodium salt that is commonly used to season food.", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012965"}, {"RECTYPE": "D", "MH": "Sodium Cyanide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Cyanide, Sodium", "MN": "D01.857.660", "PA": "Poisons", "MH_TH": "NLM (1979)", "ST": "T197", "N1": "Sodium cyanide (Na(CN))", "RN": "O5DDB9Z95G", "RR": "143-33-9 (Sodium Cyanide)", "PI": "Sodium (1966-1978)", "MS": "A highly poisonous compound that is an inhibitor of many metabolic processes and is used as a test reagent for the function of chemoreceptors. It is also used in many industrial processes.", "PM": "91; was see under CYANIDES 1979-90", "HN": "91(79); was see under CYANIDES 1979-90", "MR": "20130708", "DA": "19780315", "DC": "1", "DX": "19910101", "UI": "D012966"}, {"RECTYPE": "D", "MH": "Sodium Dodecyl Sulfate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sodium Lauryl Sulfate|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbcdeef", "ENTRY": "Sulfate, Sodium Lauryl", "MN": "D10.289.220.720", "PA": "Surface-Active Agents", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "Sulfuric acid monododecyl ester sodium salt", "RN": "368GB5141J", "RR": "151-21-3 (Sodium Dodecyl Sulfate)", "PI": "Surface-Active Agents (1966-1971)", "MS": "An anionic surfactant, usually a mixture of sodium alkyl sulfates, mainly the lauryl; lowers surface tension of aqueous solutions; used as fat emulsifier, wetting agent, detergent in cosmetics, pharmaceuticals and toothpastes; also as research tool in protein biochemistry.", "PM": "74", "HN": "74(72)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D012967"}, {"RECTYPE": "D", "MH": "Etidronic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sodium Etidronate|T109|T121|NON|NRW|NLM (1992)|901001|abbcdef", "ENTRY": "Tetrapotassium Salt Etidronate", "MN": "D02.705.429.500.830", "PA": "Bone Density Conservation Agents", "MH_TH": "USAN (1970)", "ST": "T121", "RN": "M2F465ROXU", "RR": "M16PXG993G", "PI": "Organophosphorus Compounds (1972)", "MS": "A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.", "PM": "2001; see ETIDRONATE DISODIUM 1993-2000, see SODIUM ETIDRONATE 1977-1991, see DIPHOSPHONATES 1973-1976; (1-HYDROXYETHYLENE)DIPHOSPHONIC ACID was indexed under DIPHOSPHONATES 1987-2000", "HN": "2001(1973); for (1-HYDROXYETHLENE)DIPHOSPHONIC ACID use ETIDRONAT DISODIUM (NM) 1987-2000", "MR": "20160610", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D012968"}, {"RECTYPE": "D", "MH": "Sodium Fluoride", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Zymafluors", "MN": "J01.637.051.223.716", "PA": "Cariostatic Agents", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Sodium fluoride (NaF)", "RN": "8ZYQ1474W7", "RR": "7681-49-4 (Sodium Fluoride)", "PI": "Fluorides, Topical (1966-1976)", "MS": "A source of inorganic fluoride which is used topically to prevent dental caries.", "PM": "84; was see under FLUORIDES 1977-83; ACIDULATED PHOSPHATE FLUORIDE was see under FLUORIDES 1977-83", "HN": "84(77); was see under FLUORIDES 1977-83", "MR": "20160701", "DA": "19760416", "DC": "1", "DX": "19840101", "UI": "D012969"}, {"RECTYPE": "D", "MH": "Sodium Glutamate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vestin|T116|T168|TRD|NRW|NLM (1994)|220111|abbcdef", "ENTRY": "Glutamate, Sodium", "MN": "D12.125.119.409.349.575", "PA": "Flavoring Agents", "MH_TH": "NLM (1975)", "ST": "T168", "N1": "L-Glutamic acid, monosodium salt", "RN": "W81N5U6R6U", "RR": "142-47-2 (Sodium Glutamate)", "PI": "Glutamates (1966-1974)", "MS": "One of the FLAVORING AGENTS used to impart a meat-like flavor.", "PM": "91; was see under GLUTAMATES 1975-90", "HN": "91(75); was see under GLUTAMATES 1975-90", "MR": "20220111", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012970"}, {"RECTYPE": "D", "MH": "Gold Sodium Thiosulfate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sodium Gold Thiosulfate|T121|T197|NON|EQV|NLM (1992)|910325|abbcdef", "ENTRY": "Thiosulfate, Sodium Gold", "MN": "D01.875.800.800.850.900.250", "PA": "Antirheumatic Agents", "MH_TH": "NLM (1975)", "ST": "T197", "N1": "Aurate(3-), bis(monothiosulfato(2-)-O,S)-, trisodium, (T-4)-", "RN": "CKS1YQ9W1J", "RR": "15283-45-1 (Gold Sodium Thiosulfate)", "MS": "A sodium salt of gold thiosulfate. It has uses like the ORGANOGOLD COMPOUNDS.", "OL": "use GOLD SODIUM THIOSULFATE to search SODIUM GOLD THIOSULFATE 1975-91; search GOLD 1966-74", "PM": "92; was SODIUM GOLD THIOSULFATE 1975-91 (see under GOLD 1975-90)", "HN": "92; was SODIUM GOLD THIOSULFATE 1975-91 (see under GOLD 1975-90)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012971"}, {"RECTYPE": "D", "MH": "Sodium Hydroxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Soda, Caustic", "MN": "D01.857.745", "PA": "Caustics", "MH_TH": "NLM (1964)", "ST": "T197", "N1": "Sodium hydroxide (Na(OH))", "RN": "55X04QC32I", "RR": "1310-73-2 (Sodium Hydroxide)", "AN": "a caustic", "MS": "A highly caustic substance that is used to neutralize acids and make sodium salts. (From Merck Index, 11th ed)", "PM": "65", "HN": "65(64)", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012972"}, {"RECTYPE": "D", "MH": "Sodium Hypochlorite", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hypochlorite, Sodium", "MN": "D01.857.750", "PA": "Oxidants", "MH_TH": "NLM (1965)", "ST": "T197", "N1": "Hypochlorous acid, sodium salt", "RN": "DY38VHM5OD", "RR": "7681-52-9 (Sodium Hypochlorite)", "AN": "needle bleaching (as by intravenous drug users) is indexed under SODIUM HYPOCHLORITE + DISINFECTION + NEEDLES", "MS": "It is used as an oxidizing and bleaching agent and as a disinfectant. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "65", "HN": "65", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012973"}, {"RECTYPE": "D", "MH": "Sodium Iodide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D01.857.760", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Sodium iodide (NaI)", "RN": "F5WR8N145C", "RR": "7681-82-5 (Sodium Iodide)", "PI": "Sodium (1966-1978)", "MS": "A compound forming white, odorless deliquescent crystals and used as iodine supplement, expectorant or in its radioactive (I-131) form as an diagnostic aid, particularly for thyroid function tests.", "PM": "91; was see under IODIDES 1979-90", "HN": "91(79); was see under IODIDES 1979-90", "MR": "20130708", "DA": "19780315", "DC": "1", "DX": "19910101", "UI": "D012974"}, {"RECTYPE": "D", "MH": "Sodium Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Sodium", "MN": "D01.552.547.725.500", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable sodium atoms that have the same atomic number as the element sodium, but differ in atomic weight. Na-23 is a stable sodium isotope.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012975"}, {"RECTYPE": "D", "MH": "Sodium Morrhuate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Morrhuate Sodium|T109|T121|NON|EQV|UNK (19XX)|800402|abbcdef", "ENTRY": "Sodium, Morrhuate", "MN": "D10.251.860", "PA": "Sclerosing Solutions", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Sodium morrhuate", "RN": "8031-09-2", "MS": "The sodium salts of the fatty acids in cod liver oil; an irritant and sclerosing agent used to treat varicose veins and arthritic joints.", "OL": "search SCLEROSING SOLUTIONS 1966-74", "PM": "91; was see under FATTY ACIDS 1975-90; was see under SCLEROSING SOLUTIONS 1963-74", "HN": "91(75); was see under FATTY ACIDS 1975-90; was see under SCLEROSING SOLUTIONS 1963-74", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012976"}, {"RECTYPE": "D", "MH": "Sodium Nitrite", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nitrite, Sodium", "MN": "D01.857.775", "PA": "Indicators and Reagents", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Nitrous acid, sodium salt", "RN": "M0KG633D4F", "RR": "7632-00-0 (Sodium Nitrite)", "PI": "Sodium (1966-1978)", "MS": "Nitrous acid sodium salt. Used in many industrial processes, in meat curing, coloring, and preserving, and as a reagent in ANALYTICAL CHEMISTRY TECHNIQUES. It is used therapeutically as an antidote in cyanide poisoning. The compound is toxic and mutagenic and will react in vivo with secondary or tertiary amines thereby producing highly carcinogenic nitrosamines.", "PM": "91; was see under NITRITES 1979-90", "HN": "91(79); was see under NITRITES 1979-90", "MR": "20130708", "DA": "19780315", "DC": "1", "DX": "19910101", "UI": "D012977"}, {"RECTYPE": "D", "MH": "Sodium Oxybate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "gamma-Hydroxybutyrate|T109|T121|T123|NON|BRD|UNK (19XX)|820505|abbbcdef", "ENTRY": "gamma Hydroxybutyrate", "MN": "D02.241.511.429.700", "PA": "Anesthetics, Intravenous", "MH_TH": "USAN (1966)", "ST": "T121", "N1": "Butanoic acid, 4-hydroxy-, monosodium salt", "RN": "7G33012534", "RR": "502-85-2", "PI": "Hydroxybutyrates (1969-1974)", "MS": "The sodium salt of 4-hydroxybutyric acid. It is used for both induction and maintenance of ANESTHESIA.", "PM": "91; was see under HYDROXYBUTYRATES 1975-90", "HN": "91(75); was see under HYDROXYBUTYRATES 1975-90", "MR": "20141014", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D012978"}, {"RECTYPE": "D", "MH": "Sodium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Sodium", "MN": "D01.552.547.725.500.800", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Sodium Isotopes (1966-1974)", "MS": "Unstable isotopes of sodium that decay or disintegrate emitting radiation. Na atoms with atomic weights 20-22 and 24-26 are radioactive sodium isotopes.", "OL": "search SODIUM ISOTOPES 1966-74", "PM": "75", "HN": "75", "MR": "20170425", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D012979"}, {"RECTYPE": "D", "MH": "Sodium Salicylate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Salicylate, Sodium", "MN": "D02.455.426.559.389.657.410.595.608.500", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzoic acid, 2-hydroxy-, monosodium salt", "RN": "WIQ1H85SYP", "RR": "54-21-7 (Sodium Salicylate)", "MS": "A non-steroidal anti-inflammatory agent that is less effective than equal doses of ASPIRIN in relieving pain and reducing fever. However, individuals who are hypersensitive to ASPIRIN may tolerate sodium salicylate. In general, this salicylate produces the same adverse reactions as ASPIRIN, but there is less occult gastrointestinal bleeding. (From AMA Drug Evaluations Annual, 1992, p120)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012980"}, {"RECTYPE": "D", "MH": "Sodium Tetradecyl Sulfate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Tetradecyl Sulfate, Sodium", "MN": "D10.289.900", "PA": "Surface-Active Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Tetradecanol, hydrogen sulfate, sodium salt", "RN": "Q1SUG5KBD6", "RR": "1191-50-0 (Sodium Tetradecyl Sulfate)", "PI": "Sclerosing Solutions (1966-1974)", "MS": "An anionic surface-active agent used for its wetting properties in industry and used in medicine as an irritant and sclerosing agent for hemorrhoids and varicose veins.", "OL": "use SODIUM TETRADECYL SULFATE to search SODIUM TETRADECYL SULFATES 1975-80; use SCLEROSING SOLUTIONS 1966-74", "PM": "91; was see under FATTY ALCOHOLS 1981-90; was SODIUM TETRADECYL SULFATES see under FATTY ALCOHOLS 1975-80, see under SCLEROSING SOLUTIONS 1963-74", "HN": "91(81); was see under FATTY ALCOHOLS 1981-90; was SODIUM TETRADECYL SULFATES see under FATTY ALCOHOLS 1975-80, see under SCLEROSING SOLUTIONS 1963-74", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012981"}, {"RECTYPE": "D", "MH": "Sodium, Dietary", "AQ": "AD AE AG AI AN BL CF CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dietary Sodium|T168|T197|NON|EQV|UNK (19XX)|870323|abbcdef", "MN": "D01.857.875", "EC": "chemistry:Sodium:chemistry", "MH_TH": "NLM (1988)", "ST": "T197", "RN": "0", "PI": "Sodium Glutamate (1975-1987)", "MS": "Sodium or sodium compounds used in foods or as a food. The most frequently used compounds are sodium chloride or sodium glutamate.", "PM": "88", "HN": "88", "MR": "20180702", "DA": "19870323", "DC": "1", "DX": "19880101", "UI": "D012982"}, {"RECTYPE": "D", "MH": "Soft Tissue Neoplasms", "DE": "SOFT TISSUE NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Soft Tissue Neoplasm", "MN": "C04.588.839", "MH_TH": "NLM (1976)", "ST": "T191", "AN": "neoplasms located in soft (connective) tissue, NOT neoplasms composed of soft tissue; coordinate with precoordinated organ/neoplasm term or site ", "MS": "Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19750721", "DC": "1", "DX": "19760101", "UI": "D012983"}, {"RECTYPE": "D", "MH": "Software", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Software Tools|T170|NON|NRW|UNK (19XX)|860618|abcdef", "ENTRY": "Tools, Software", "MN": "L01.224.900", "FX": "Search Engine", "MH_TH": "NLM (1983)", "ST": "T170", "PI": "Computers (1966-1982)", "MS": "Sequential operating programs and data which instruct the functioning of a digital computer.", "PM": "87; was COMPUTER PROGRAMS see under COMPUTERS 1983-86, was PROGRAMS, COMPUTER see COMPUTERS 1979-82, was PROGRAMMING, COMPUTER see under COMPUTERS 1966-74", "HN": "87(83); was COMPUTER PROGRAMS see under COMPUTERS 1983-86, was PROGRAMS, COMPUTER see COMPUTERS 1979-82, was PROGRAMMIMG, COMPUTER see under COMPUTERS 1966-74", "MR": "20210119", "DA": "19820430", "DC": "1", "DX": "19870101", "UI": "D012984"}, {"RECTYPE": "D", "MH": "Software Design", "PRINT ENTRY": "Flowcharts (Computer)|T073|T170|NON|NRW|UNK (19XX)|860618|abbcdef", "ENTRY": "Software Designs", "MN": "L01.224.900.820", "MH_TH": "NLM (1987)", "ST": "T090", "MS": "Specifications and instructions applied to the software.", "PM": "91; was see under SOFTWARE 1987-90", "HN": "91(87); was see under SOFTWARE 1987-90", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19910101", "UI": "D012985"}, {"RECTYPE": "D", "MH": "Software Validation", "PRINT ENTRY": "Software Verification|T090|NON|EQV|UNK (19XX)|860618|abcdef", "ENTRY": "Verifications, Software", "MN": "L01.224.900.868", "MH_TH": "NLM (1987)", "ST": "T090", "MS": "The act of testing the software for compliance with a standard.", "PM": "91; was see under SOFTWARE 1987-90", "HN": "91(87); was see under SOFTWARE 1987-90", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19910101", "UI": "D012986"}, {"RECTYPE": "D", "MH": "Soil", "AQ": "CH CL PS ST", "PRINT ENTRY": "Peat|T167|NON|NRW|UNK (19XX)|810519|abcdef", "ENTRY": "Soils|T167|NON|EQV|NLM (2004)|030508|abcdef", "MN": "N06.230.600", "FX": "Soil Erosion", "EC": "virology:Soil Microbiology", "MH_TH": "NLM (1966)", "ST": "T167", "RN": "0", "MS": "The unconsolidated mineral or organic matter on the surface of the earth that serves as a natural medium for the growth of land plants.", "OL": "use SOIL to search PEAT 1966-81", "PM": "PEAT was heading 1963-81", "HN": "PEAT was heading 1963-81", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D012987"}, {"RECTYPE": "D", "MH": "Soil Microbiology", "DE": "SOIL MICROBIOL", "AQ": "ST", "ENTRY": "Microbiology, Soil|T067|NON|EQV|UNK (19XX)|860101|MICROBIOL SOIL|abcdefv", "MN": "N06.850.425.300", "MH_TH": "NLM (1966)", "ST": "T067", "AN": "coordinate with specific bacterium, virus or fungus ", "MS": "The presence of bacteria, viruses, and fungi in the soil. This term is not restricted to pathogenic organisms.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012988"}, {"RECTYPE": "D", "MH": "Soil Pollutants", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Soil Pollutant|T131|NON|EQV|NLM (2022)|201023|abcdef", "ENTRY": "Pollutants, Soil", "MN": "D27.888.284.756", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "specify pollutant if pertinent (IM or NIM)", "PI": "Soil (1966-1974)", "MS": "Substances which pollute the soil. Use for soil pollutants in general or for which there is no specific heading.", "PM": "75", "HN": "75", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D012989"}, {"RECTYPE": "D", "MH": "Soil Pollutants, Radioactive", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Radioactive Soil Pollutants", "MN": "D27.888.284.756.674", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "specify radiopollutant if pertinent (IM or NIM)", "MS": "Pollutants, present in soil, which exhibit radioactivity.", "PM": "91; was see under SOIL POLLUTANTS 1975-90", "HN": "91(75); was see under SOIL POLLUTANTS 1975-90", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D012990"}, {"RECTYPE": "D", "MH": "Solanaceous Alkaloids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Solanum Alkaloids|T109|NON|EQV|UNK (19XX)|780208|abcdef", "ENTRY": "Alkaloids, Solanum", "MN": "D03.132.760", "FX": "Parasympatholytics", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "PI": "Solanum Alkaloids (1977-1978)", "MS": "Alkaloids, mainly tropanes, elaborated by plants of the family Solanaceae, including Atropa, Hyoscyamus, Mandragora, Nicotiana, Solanum, etc. Some act as cholinergic antagonists; most are very toxic; many are used medicinally.", "OL": "use SOLANACEOUS ALKALOIDS to search SOLANUM ALKALOIDS 1977-78", "PM": "79; was SOLANUM ALKALOIDS 1977-78", "HN": "79; was SOLANUM ALKALOIDS 1977-78", "MR": "19970620", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D012991"}, {"RECTYPE": "D", "MH": "Solanine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D10.570.938.897", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "beta-D-Galactopyranoside, (3beta)-solanid-5-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-(beta-D-glucopyranosyl-(1-3))-", "RN": "20562-02-1", "MS": "A mixture of alpha-chaconine and alpha-solanine, found in SOLANACEAE plants.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012992"}, {"RECTYPE": "D", "MH": "Solar Energy", "AQ": "EC HI LJ SN ST", "ENTRY": "Solar Energies", "MN": "N06.230.132.644.500", "FX": "Solar Activity", "MH_TH": "NLM (1982)", "ST": "T070", "PI": "Sunlight (1966-1981)", "MS": "Energy transmitted from the sun in the form of electromagnetic radiation.", "PM": "91; was see under ENERGY-GENERATING RESOURCES 1982-90", "HN": "91(82); was see under ENERGY-GENERATING RESOURCES 1982-90", "MR": "20180629", "DA": "19810519", "DC": "1", "DX": "19910101", "UI": "D012993"}, {"RECTYPE": "D", "MH": "Dental Soldering", "DE": "DENT SOLDERING", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Soldering, Dental|T059|NON|EQV|NLM (1991)|900126|SOLDERING DENT|abcdefv", "MN": "E06.912.190", "MH_TH": "NLM (1973)", "ST": "T059", "AN": "includes solders", "PI": "Welding (1966-1972)", "MS": "The joining of pieces of metal through the use of an alloy which has a lower melting point, usually at least 100 degrees Celsius below the fusion temperature of the parts being soldered. In dentistry, soldering is used for joining components of a dental appliance, as in assembling a bridge, joining metals to orthodontic bands, or adding to the bulk of certain structures, such as the establishment of proper contact areas on inlays and crowns with adjacent teeth. (Illustrated Dictionary of Dentistry, 1982)", "OL": "use DENTAL SOLDERING to search SOLDERING, DENTAL 1973-94", "PM": "95; was SOLDERING, DENTAL 1973-94", "HN": "95; was SOLDERING, DENTAL 1973-94", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D012994"}, {"RECTYPE": "D", "MH": "Solubility", "AQ": "DE RE", "ENTRY": "Solubilities", "MN": "G02.805", "MH_TH": "NLM (1964)", "ST": "T081", "AN": "NIM", "MS": "The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "65", "HN": "65(64)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D012995"}, {"RECTYPE": "D", "MH": "Solutions", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Solution|T122|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D26.776", "FX": "Pharmaceutical Solutions", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "AN": "IM for general only, qualif permitted; NIM (no qualif) when substance in solution is IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the substance in solution, not the \"solution\"", "MS": "The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012996"}, {"RECTYPE": "D", "MH": "Solvents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Solvent|T130|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D27.720.844", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "MS": "Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant & Hackh's Chemical Dictionary, 5th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D012997"}, {"RECTYPE": "D", "MH": "Somalia", "AQ": "EH EP", "MN": "Z01.058.290.120.730", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "Somalia is located on the east coast of Africa on and north of the Equator and, with Ethiopia, Eritrea, Djibouti, and Kenya, is often referred to as the Horn of Africa. It comprises Italy's former Trust Territory of Somalia and the former British Protectorate of Somaliland. The capital is Mogadishu.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D012998"}, {"RECTYPE": "D", "MH": "Soman", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Methylphosphonofluoridate, Pinacolyl", "MN": "D02.705.429.750.750", "PA": "Convulsants", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Phosphonofluoridic acid, methyl-, 1,2,2-trimethylpropyl ester", "RN": "96-64-0", "PI": "Organophosphorus Compounds (1971)", "MS": "An organophosphorus compound that inhibits cholinesterase. It causes seizures and has been used as a chemical warfare agent.", "PM": "86; was see under ORGANOPHOSPHORUS COMPOUNDS 1972-85", "HN": "86(72); was see under ORGANOPHOSPHORUS COMPOUNDS 1975-85, was Prov 1972-74", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D012999"}, {"RECTYPE": "D", "MH": "Psychiatric Somatic Therapies", "DE": "PSYCHIATRIC SOMATIC THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapy, Psychiatric Somatic", "MN": "F04.570", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "PI": "specific somatic therapy (1969-1997)", "MS": "The biologic treatment of mental disorders (e.g., ELECTROCONVULSIVE THERAPY), in contrast with psychotherapy. (Stone, American Psychiatric Glossary, 1988, p159)", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013000"}, {"RECTYPE": "D", "MH": "Somatoform Disorders", "DE": "SOMATOFORM DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Somatization Disorder|T048|NON|REL|OBSSR (2021)|UNK (19XX)|800521|SOMATIZATION DIS|abcdeefv", "ENTRY": "Unexplained Syndrome, Medically", "MN": "F03.875", "MH_TH": "NLM (1981)", "ST": "T048", "AN": "differentiate from FACTITIOUS DISORDERS and PSYCHOPHYSIOLOGIC DISORDERS", "MS": "Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19800521", "DC": "1", "DX": "19810101", "UI": "D013001"}, {"RECTYPE": "D", "MH": "Somatomedins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sulfation Factor|T116|T123|T125|NON|EQV|UNK (19XX)|740330|abbbcdef", "ENTRY": "Factor, Sulfation", "MN": "D23.529.742.500", "FX": "Receptors, Somatomedin", "MH_TH": "NLM (1973)", "ST": "T125", "RN": "0", "PI": "Sulfates/metabolism (1966-1970)", "MS": "Insulin-like polypeptides made by the liver and some fibroblasts and released into the blood when stimulated by SOMATOTROPIN. They cause sulfate incorporation into collagen, RNA, and DNA synthesis, which are prerequisites to cell division and growth of the organism.", "OL": "use SOMATOMEDINS to search SOMATOMEDIN 1973-81 & SULFATION FACTOR 1971-72 (as Prov 1971-72)", "PM": "82; was SOMATOMEDIN 1973-81", "HN": "82; was SOMATOMEDIN 1973-81, was SULFATION FACTOR 1971-72 (Prov)", "MR": "20230517", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013002"}, {"RECTYPE": "D", "MH": "Somatosensory Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "SII Cortex|T023|ABX|NRW|NLM (2022)|201009|abcdef", "ENTRY": "Somesthetic Areas, Primary", "MN": "A08.186.211.200.885.287.500.814.906", "MH_TH": "NLM (1971)", "ST": "T023", "PI": "Cerebral Cortex (1966-1970)", "MS": "Area of the parietal lobe concerned with receiving sensations such as movement, pain, pressure, position, temperature, touch, and vibration. It lies posterior to the central sulcus.", "PM": "71", "HN": "71", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D013003"}, {"RECTYPE": "D", "MH": "Somatostatin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Somatotropin Release-Inhibiting Hormone|T116|T121|T125|NON|EQV|UNK (19XX)|840608|SOMATOTROPIN RELEASE INHIB HORMONE|abbbcdefv", "ENTRY": "Somatotropin Release Inhibiting Hormone", "MN": "D12.776.631.650.405.700.875", "PA": "Hormones", "FX": "Receptors, Somatostatin", "MH_TH": "INN (19XX)", "ST": "T125", "RN": "51110-01-1", "PI": "Somatotropin/antagonists & inhibitors (1973-1974)", "MS": "A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal.", "OL": "use SOMATOSTATIN to search SOMATOTROPIN RELEASE INHIBITING HORMONE 1975-84", "PM": "99", "HN": "99", "MR": "20151124", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D013004"}, {"RECTYPE": "D", "MH": "Somatostatinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Somatostatinomas", "MN": "C19.344.421.500.500", "MH_TH": "NLM (1982)", "ST": "T191", "AN": "coord IM with PANCREATIC NEOPLASMS (IM) or other precoord organ/neopl term (IM) if primary; this is a delta cell tumor", "PI": "Islet Cell Tumor (1966-1981)", "MS": "A SOMATOSTATIN-secreting tumor derived from the pancreatic delta cells (SOMATOSTATIN-SECRETING CELLS). It is also found in the INTESTINE. Somatostatinomas are associated with DIABETES MELLITUS; CHOLELITHIASIS; STEATORRHEA; and HYPOCHLORHYDRIA. The majority of somatostatinomas have the potential for METASTASIS.", "PM": "91; was see under ISLET CELL TUMOR 1982-90", "HN": "91(82); was see under ISLET CELL TUMOR 1982-90", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19810520", "DC": "1", "DX": "19910101", "UI": "D013005"}, {"RECTYPE": "D", "MH": "Growth Hormone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Somatotropin, Recombinant|T116|T121|NON|NRW|NLM (2003)|020219|abbcdef", "ENTRY": "Recombinant Somatotropin", "MN": "D12.644.548.691.525.425", "FX": "Receptors, Somatotropin", "MH_TH": "UNK (19XX)", "ST": "T125", "N1": "Somatotropin", "RN": "9002-72-6", "AN": "despite X ref, coord with RECOMBINANT PROTEINS for recombinant somatotropin; HUMAN GROWTH HORMONE is also available", "MS": "A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized.", "PM": "2003; see SOMATOTROPIN 1966-2002; for GROWTH HORMONE, RECOMBINANT see SOMATOTROPINS, RECOMBINANT 1997-2002", "HN": "2003 (1966)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "20030101", "UI": "D013006"}, {"RECTYPE": "D", "MH": "Growth Hormone-Releasing Hormone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Somatotropin-Releasing Hormone|T116|T121|T125|NON|EQV|NLM (1974)|990101|SRH|abbbcdefv", "ENTRY": "Somatotropin Releasing Hormone", "MN": "D12.776.631.650.405.740.860", "PA": "Hormones", "MH_TH": "UNK (19XX)", "ST": "T125", "N1": "Somatoliberin", "RN": "9034-39-3", "MS": "A peptide of 44 amino acids in most species that stimulates the release and synthesis of GROWTH HORMONE. GHRF (or GRF) is synthesized by neurons in the ARCUATE NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, GHRF stimulates GH release by the SOMATOTROPHS in the PITUITARY GLAND.", "PM": "2007; see SOMATOTROPIN-RELEASING HORMONE 1991-2006, see SOMATOTROPIN RELEASING HORMONE 1974-1990", "HN": "2007 (1974)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013007"}, {"RECTYPE": "D", "MH": "Somatotypes", "AQ": "GE PH PX", "PRINT ENTRY": "Mesomorph|T032|NON|NRW|NLM (1998)|961213|abcdef", "ENTRY": "Somatotype", "MN": "G07.100.175.750", "MH_TH": "NLM (1966)", "ST": "T032", "MS": "Body builds determined on the basis of certain physical characteristics of body shape and BODY COMPOSITION. A somatotyping appraisal is a composite rating of the three basic body types: ectomorph (thin physique), endomorph (rounded physique), and mesomorph (athletic physique).", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013008"}, {"RECTYPE": "D", "MH": "Somnambulism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sleepwalking|T047|NON|EQV|NLM (1994)|921207|abcdef", "ENTRY": "Wandering, Nocturnal", "MN": "F03.870.664.635.700", "MH_TH": "NLM (1969)", "ST": "T047", "PI": "Sleep Disorders (1966-1968)", "MS": "A parasomnia characterized by a partial arousal that occurs during stage IV of non-REM sleep. Affected individuals exhibit semipurposeful behaviors such as ambulation and are difficult to fully awaken. Children are primarily affected, with a peak age range of 4-6 years.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D013009"}, {"RECTYPE": "D", "MH": "Sonication", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Sonications", "MN": "E05.848", "MH_TH": "NLM (1975)", "ST": "T062", "MS": "The application of high intensity ultrasound to liquids.", "OL": "search ULTRASONICS 1974 & VIBRATION 1969-73", "PM": "91; was see under ULTRASONICS 1974-90; was see under VIBRATION 1969-73", "HN": "91(75); was see under ULTRASONICS 1974-90; was see under VIBRATION 1969-73", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013010"}, {"RECTYPE": "D", "MH": "Sorbic Acid", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Propenylacrylic Acid|T109|T121|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Sorbate, Sodium", "MN": "D10.251.355.840", "PA": "Food Preservatives", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "2,4-Hexadienoic acid, (E,E)-", "RN": "X045WJ989B", "RR": "TGW6Q2CCVM", "AN": "POLYSORBATES is available", "PI": "Fatty Acids, Unsaturated (1974)", "MS": "Mold and yeast inhibitor. Used as a fungistatic agent for foods, especially cheeses.", "PM": "91; was see under FATTY ACIDS, UNSATURATED 1975-90", "HN": "91(75); was see under FATTY ACIDS, UNSATURATED 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013011"}, {"RECTYPE": "D", "MH": "Sorbitol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glucitol|T109|T121|NON|EQV|UNK (19XX)|770107|abbcdef", "ENTRY": "klysma Sorbit|T109|T121|TRD|NRW|DE|041119|abbcdef", "MN": "D09.853.813", "PA": "Sweetening Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "D-Glucitol", "RN": "506T60A25R", "RR": "50-70-4 (Sorbitol)", "MS": "A polyhydric alcohol with about half the sweetness of sucrose. Sorbitol occurs naturally and is also produced synthetically from glucose. It was formerly used as a diuretic and may still be used as a laxative and in irrigating solutions for some surgical procedures. It is also used in many manufacturing processes, as a pharmaceutical aid, and in several research applications.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013012"}, {"RECTYPE": "D", "MH": "Sorbose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L Sorbose", "MN": "D09.947.875.465.758", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Sorbose", "RN": "NV2001607Y", "RR": "3615-39-2 (Sorbose)", "MS": "A ketose sugar that is commonly used in the commercial synthesis of ASCORBIC ACID.", "MR": "20180301", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013013"}, {"RECTYPE": "D", "MH": "SOS Response, Genetics", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "SOS Response (Genetics)|T045|ACX|EQV|NLM (1987)|990101|SOS RESPONSE GENET|abcdefv", "ENTRY": "Systems, SOS", "MN": "G05.219.830", "MH_TH": "NLM (2020)", "ST": "T045", "PI": "DNA, Bacterial (1975-1986)", "MS": "An error-prone mechanism or set of functions for repairing damaged microbial DNA. SOS functions (a concept reputedly derived from the SOS of the international distress signal) are involved in DNA repair and mutagenesis, in cell division inhibition, in recovery of normal physiological conditions after DNA repair, and possibly in cell death when DNA damage is extensive.", "PM": "2020; was SOS RESPONSE (GENETICS) 1991-2019; see DNA REPAIR 1987-1990", "HN": "2020 (1991); was SOS RESPONSE (GENETICS) 1991-2019; use DNA REPAIR 1987-1990", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19860619", "DC": "1", "DX": "19910101", "UI": "D013014"}, {"RECTYPE": "D", "MH": "Sotalol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MJ1999", "MN": "D02.092.063.291.805", "PA": "Sympatholytics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-", "RN": "A6D97U294I", "RR": "HEC37C70XX", "PI": "Sympatholytics (1966-1971)", "MS": "An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.", "PM": "73", "HN": "73(72)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013015"}, {"RECTYPE": "D", "MH": "Sound", "AQ": "AE", "ENTRY": "Waves, Sound", "MN": "G01.750.770.776", "FX": "Noise", "MH_TH": "NLM (1966)", "ST": "T070", "CX": "consider also terms at PHON-", "MS": "A type of non-ionizing radiation in which energy is transmitted through solid, liquid, or gas as compression waves. Sound (acoustic or sonic) radiation with frequencies above the audible range is classified as ultrasonic. Sound radiation below the audible range is classified as infrasonic.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013016"}, {"RECTYPE": "D", "MH": "Sound Localization", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Auditory Localization|T041|NON|EQV|UNK (19XX)|781214|abcdef", "ENTRY": "Sound Localizations", "MN": "G07.888.125.869", "FX": "Echolocation", "MH_TH": "NLM (1980)", "ST": "T041", "AN": "do not confuse with ECHOLOCATION (animal only)", "PI": "Perception (1966)", "MS": "Ability to determine the specific location of a sound source.", "PM": "91; was see under AUDITORY PERCEPTION 1980-90", "HN": "91(80); was see under AUDITORY PERCEPTION 1980-90", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19781214", "DC": "1", "DX": "19910101", "UI": "D013017"}, {"RECTYPE": "D", "MH": "Sound Spectrography", "DE": "SOUND SPECTROGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Sonography, Speech|T060|NON|NRW|UNK (19XX)|781214|SONOGR SPEECH|abcdefv", "ENTRY": "Spectrography, Sound", "MN": "E05.855", "MH_TH": "NLM (1980)", "ST": "T059", "AN": "usually NIM    ", "MS": "The graphic registration of the frequency and intensity of sounds, such as speech, infant crying, and animal vocalizations.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19781214", "DC": "1", "DX": "19800101", "UI": "D013018"}, {"RECTYPE": "D", "MH": "South Africa", "AQ": "EH EP", "PRINT ENTRY": "Union of South Africa|T083|NAM|EQV|NLM (1998)|960815|abcdef", "MN": "Z01.058.290.175.735", "MH_TH": "NLM (1979)", "ST": "T083", "AN": "do not confuse with geographic designation AFRICA, SOUTHERN", "MS": "A republic in southern Africa, the southernmost part of Africa. It has three capitals: Pretoria (administrative), Cape Town (legislative), and Bloemfontein (judicial). Officially the Republic of South Africa since 1960, it was called the Union of South Africa 1910-1960.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013019"}, {"RECTYPE": "D", "MH": "South America", "AQ": "EH EP", "MN": "Z01.107.757", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "each South American country is available as a heading", "MS": "The southern continent of the Western Hemisphere, extending southward from the Colombia-Panama border.", "MR": "20160707", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013020"}, {"RECTYPE": "D", "MH": "South Australia", "AQ": "EH EP", "MN": "Z01.678.100.373.968", "MH_TH": "NLM (1988)", "ST": "T083", "AN": "a state of Australia", "PI": "Australia (1966-1987)", "MS": "A state in south central Australia. Its capital is Adelaide. It was probably first visited by F. Thyssen in 1627. Later discoveries in 1802 and 1830 opened up the southern part. It became a British province in 1836 with this self-descriptive name and became a state in 1901. (From Webster's New Geographical Dictionary, 1988, p1135)", "HN": "88", "MR": "20150623", "DA": "19870309", "DC": "4", "DX": "19880101", "UI": "D013021"}, {"RECTYPE": "D", "MH": "South Carolina", "AQ": "EH EP", "MN": "Z01.107.567.875.750.700", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by North Carolina, on the east and south by the Atlantic Ocean, and on the west by Georgia.", "MR": "20160707", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013022"}, {"RECTYPE": "D", "MH": "South Dakota", "AQ": "EH EP", "MN": "Z01.107.567.875.510.700", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by North Dakota, on the east by Minnesota, on the south by Nebraska, and on the west by Montana and Wyoming.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013023"}, {"RECTYPE": "D", "MH": "Soybean Oil", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Soya Oil|T168|NON|EQV|UNK (19XX)|860603|abcdef", "ENTRY": "Soybean Oils", "MN": "J02.500.375.400.750", "MH_TH": "NLM (1987)", "ST": "T168", "N1": "Soybean oil", "RN": "8001-22-7", "PI": "Oils (1966-1986)", "MS": "Oil from soybean or soybean plant.", "PM": "91; was see under PLANT OILS 1987-90", "HN": "91(87); was see under PLANT OILS 1987-90", "MR": "20141014", "DA": "19860603", "DC": "1", "DX": "19910101", "UI": "D013024"}, {"RECTYPE": "D", "MH": "Glycine max", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Soybeans|T002|T168|NON|EQV|NLM (1966)|990101|abbcdef", "ENTRY": "Soybean", "MN": "B01.875.800.575.912.250.401.750", "MH_TH": "UNK (19XX)", "ST": "T168", "RN": "txid3847", "MS": "An annual legume. The SEEDS of this plant are edible and used to produce a variety of SOY FOODS.", "OL": "use SOYBEANS to search SOY BEANS 1966-85", "PM": "1986; was SOY BEANS 1963-1985; use SOYBEANS 1986-2023", "HN": "1986; was SOY BEANS 1963-1985; was in Cat J only 1963-1980; use SOYBEANS 1986-2023", "MR": "20230526", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D013025"}, {"RECTYPE": "D", "MH": "Space Flight", "AQ": "CL EC ED ES HI IS LJ MT OG PX SN ST TD", "PRINT ENTRY": "Space Exploration|T057|T066|NON|REL|NLM (1995)|940112|abbcdef", "ENTRY": "Travels, Space", "MN": "J01.937.285.850", "FX": "Weightlessness", "MH_TH": "NLM (1966)", "ST": "T066", "MS": "Travel beyond the earth's atmosphere.", "MR": "20191121", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013026"}, {"RECTYPE": "D", "MH": "Space Maintenance, Orthodontic", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Space Maintenance|T061|NON|EQV|NLM (1965)|990101|abcdef", "ENTRY": "Space Maintenances, Orthodontic", "MN": "E06.658.703.675", "MH_TH": "NLM (2016)", "ST": "T061", "AN": "note category: dental (mouth & teeth) context only", "MS": "Common treatment method used in pediatric dentistry that involves the use of fixed or removable space maintainers in order to keep the space left by a baby tooth safe in the event it is lost early. Space maintainers also help permanent teeth to grow safely.", "PM": "72", "HN": "72(65)", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013027"}, {"RECTYPE": "D", "MH": "Space Perception", "AQ": "CL DE ES PH RE", "ENTRY": "Space Perceptions", "MN": "F02.463.593.778", "FX": "Spatial Learning", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "The awareness of the spatial properties of objects; includes physical space.", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013028"}, {"RECTYPE": "D", "MH": "Space-Time Clustering", "ENTRY": "Space-Time Clusterings", "MN": "N06.850.520.830.933.500.500", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "usually NIM", "PI": "Statistics (1966-1977)", "MS": "A statistically significant excess of cases of a disease, occurring within a limited space-time continuum.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19770301", "DC": "1", "DX": "19780101", "UI": "D013029"}, {"RECTYPE": "D", "MH": "Spain", "AQ": "EH EP", "ENTRY": "Canary Islands|T083|NAM|NRW|NLM (2009)|080131|abcdef", "MN": "Z01.542.846", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "Country located between France on the northeast and Portugal on the west and bordered by the Atlantic Ocean and the Mediterranean Sea. The capital is Madrid.", "MR": "20160707", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013030"}, {"RECTYPE": "D", "MH": "Sparganosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Sparganoses", "MN": "C01.610.335.190.304.780", "FX": "Diphyllobothriasis", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "tapeworm infect; see note under SPARGANUM; infect at larval stage: DIPHYLLOBOTHRIASIS is infect by adult", "MS": "Infection of animals, including fish and man, with a developmental stage of Diphyllobothrium. This stage has recently been referred to as a plerocercoid but the name sparganum has persisted. Therefore, infection of fish or other animals with the plerocercoid larvae is sparganosis. Fish-eating mammals, including man, are the final hosts.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013031"}, {"RECTYPE": "D", "MH": "Sparganum", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Plerocercoid Larvae|T204|NON|EQV|NLM (1990)|881201|abcdef", "ENTRY": "Sparganums", "MN": "B01.050.500.500.736.215.800.810", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid64605", "PI": "Diphyllobothrium (1966-1974)", "MS": "The larval form of the diphyllobothriid tapeworms of the genus DIPHYLLOBOTHRIUM and SPIROMETRA. Fish-eating mammals and man are the final hosts.", "OL": "search CESTODA 1966-74", "PM": "79; was see under CESTODA 1965-78; was see under TAPEWORMS 1963-64", "HN": "79(75); was see under CESTODA 1965-78; was see under TAPEWORMS 1963-64", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D013032"}, {"RECTYPE": "D", "MH": "Sparsomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.742.698.715", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USAN (1962)", "ST": "T195", "N1": "2-Propenamide, N-(1-(hydroxymethyl)-2-(((methylthio)methyl)sulfinyl)ethyl)-3-(1,2,3,4-tetrahydro-6-methyl-2,4-dioxo-5-pyrimidinyl)-, (R-(R*,S*-(E)))-", "RN": "6C940P63E7", "RR": "1404-64-4 (Sparsomycin)", "AN": "an antineoplastic antibiotic", "PI": "Ribonucleosides (1974)", "MS": "An antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems.", "PM": "91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90", "HN": "91(75); was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013033"}, {"RECTYPE": "D", "MH": "Sparteine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pachycarpine|T109|T121|NON|REL|NLM (2002)|abbcde", "ENTRY": "beta Isosparteine", "MN": "D03.132.722.750", "PA": "Oxytocics", "MH_TH": "INN (19XX)", "ST": "T121", "RN": "298897D62S", "RR": "GQ3J2TLZ7E", "MS": "A quinolizidine alkaloid isolated from several FABACEAE including LUPINUS; SPARTIUM; and CYTISUS. It has been used as an oxytocic and an anti-arrhythmia agent. It has also been of interest as an indicator of CYP2D6 genotype.", "PM": "1963; PACHYCARPINE was indexed under SPARTEINE 1973-2001", "HN": "1963; for PACHYCARPINE use SPARTEINE(NM) 1973-2001", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D013034"}, {"RECTYPE": "D", "MH": "Spasm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Muscle Spasm|T184|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Spasms, Muscular", "MN": "C23.888.592.608.750", "FX": "Muscle Spasticity", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "general or unspecified; prefer specifics; coordinate with specific organ/disease; spasms in infants: index SPASMS, INFANTILE if an epileptic seizure or SPASM and INFANT if non-epileptic such as in tetany or vitamin deficiency; \"facial spasm\" equals SPASM and FACIAL MUSCLES but \"hemifacial spasm\" equals HEMIFACIAL SPASM; also available are BRONCHIAL SPASM and ESOPHAGEAL SPASM, DIFFUSE", "MS": "An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013035"}, {"RECTYPE": "D", "MH": "Spasms, Infantile", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "West Syndrome|T047|EPO|EQV|ORD (2010)|UNK (19XX)|760505|abcdeef", "ENTRY": "West Syndrome, Symptomatic", "MN": "C10.228.140.490.493.875", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "epileptic seizures only: do not confuse with SPASM + INFANT for non-epileptic seizures in infants", "PI": "Myoclonus (1966-1976)", "MS": "An epileptic syndrome characterized by the triad of infantile spasms, hypsarrhythmia, and arrest of psychomotor development at seizure onset. The majority present between 3-12 months of age, with spasms consisting of combinations of brief flexor or extensor movements of the head, trunk, and limbs. The condition is divided into two forms: cryptogenic (idiopathic) and symptomatic (secondary to a known disease process such as intrauterine infections; nervous system abnormalities; BRAIN DISEASES, METABOLIC, INBORN; prematurity; perinatal asphyxia; TUBEROUS SCLEROSIS; etc.). (From Menkes, Textbook of Child Neurology, 5th ed, pp744-8)", "PM": "1977; see HYPSARRHYTHMIA 1963-76", "HN": "1977(1963)", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19760505", "DC": "1", "DX": "19770101", "UI": "D013036"}, {"RECTYPE": "D", "MH": "Spatial Behavior", "AQ": "DE PH RE", "ENTRY": "Spatial Behaviors", "MN": "F01.145.875", "MH_TH": "NLM (1968)", "ST": "T055", "AN": "human & animal", "PI": "Psychotherapy (1966-1967)", "MS": "Reactions of an individual or groups of individuals with relation to the immediate surrounding area including the animate or inanimate objects within that area.", "PM": "1968", "HN": "1968", "CATSH": "CAT LIST", "MR": "20140616", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013037"}, {"RECTYPE": "D", "MH": "Specialization", "AQ": "EC HI LJ SN ST TD", "PRINT ENTRY": "Specialism|T078|NON|REL|NLM (1966)|990101|abcdef", "ENTRY": "Specialist", "MN": "H02.811", "MH_TH": "NLM (2010)", "ST": "T090", "AN": "coordinate IM with field or subject (IM)", "MS": "An occupation limited in scope to a subsection of a broader field.", "PM": "2010; see SPECIALISM 1966-2009", "HN": "2010 (1966)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "20100101", "UI": "D013038"}, {"RECTYPE": "D", "MH": "Specialties, Dental", "DE": "SPECIALTIES DENT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Specialty, Dental|T091|NON|EQV|NLM (1991)|900126|SPECIALTY DENT|abcdefv", "MN": "H02.163.876", "MH_TH": "NLM (1968)", "ST": "T091", "AN": "coordinate with field or subject but note specifics ", "PI": "Specialism (1966-1967)", "MS": "Various branches of dental practice limited to specialized areas.", "PM": "68", "HN": "68", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013039"}, {"RECTYPE": "D", "MH": "Specialties, Nursing", "DE": "SPECIALTIES NURS", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Specialty, Nursing|T091|NON|EQV|NLM (1992)|910522|SPECIALTY NURS|abcdefv", "MN": "H02.478.676", "MH_TH": "NLM (1971)", "ST": "T091", "AN": "general or unspecified; prefer specifics", "PI": "Nursing (1966-1970)", "MS": "Various branches of nursing practice limited to specialized areas.", "PM": "73", "HN": "73(71)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013041"}, {"RECTYPE": "D", "MH": "Specialties, Surgical", "DE": "SPECIALTIES SURG", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Surgical Specialties|T091|NON|EQV|UNK (19XX)|860101|SURG SPECIALTIES|abcdefv", "MN": "H02.403.810", "MH_TH": "NLM (1980)", "ST": "T091", "PI": "Surgery (1966-1979)", "MS": "Various branches of surgical practice limited to specialized areas.", "PM": "80", "HN": "80", "MR": "20130709", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D013043"}, {"RECTYPE": "D", "MH": "Specialty Boards", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Specialty Board", "MN": "N05.700.200.190.750", "MH_TH": "NLM (1977)", "ST": "T097", "AN": "specify specialty (IM) + geog", "PI": "specific specialty (1968-Jul 1977)", "MS": "Organizations which certify physicians and dentists as specialists in various fields of medical and dental practice.", "PM": "91; was see under CERTIFICATION Aug 1977-90", "HN": "91(Aug 77); was see under CERTIFICATION 1977-90", "MR": "19930916", "DA": "19770512", "DC": "1", "DX": "19910101", "UI": "D013044"}, {"RECTYPE": "D", "MH": "Species Specificity", "ENTRY": "Specificity, Species", "MN": "G16.824", "MH_TH": "NLM (1964)", "ST": "T070", "AN": "NIM; may refer to phylum, class, order, family, genus or strain as well as species", "MS": "The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013045"}, {"RECTYPE": "D", "MH": "Specific Gravity", "AQ": "DE RE", "ENTRY": "Specific Gravities", "MN": "G02.819", "MH_TH": "NLM (1968)", "ST": "T081", "AN": "NIM", "PI": "Chemistry, Physical (1966-1967)", "MS": "The ratio of the density of a material to the density of some standard material, such as water or air, at a specified temperature.", "PM": "68", "HN": "68", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013046"}, {"RECTYPE": "D", "MH": "Specific Pathogen-Free Organisms", "DE": "SPF ORGANISMS", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Pathogen-Free Organisms|T001|NON|EQV|NLM (1993)|911101|abcdef", "ENTRY": "Specific Pathogen-Free Organism", "MN": "G06.320.676", "MH_TH": "NLM (1975)", "ST": "T001", "AN": "organism may be human, animal or plant free of specific pathogens; usually NIM; when IM, coord IM with specific pathogenic microorganism discussed (IM); do not confuse with GERM-FREE LIFE which refers to freedom from any microorganism, unspecified", "MS": "Animals or humans raised in the absence of a particular disease-causing virus or other microorganism. Less frequently plants are cultivated pathogen-free.", "OL": "use SPECIFIC PATHOGEN-FREE ORGANISMS to search SPECIFIC PATHOGEN FREE 1975-92; search GERM-FREE LIFE 1969-74", "PM": "93; was SPECIFIC PATHOGEN FREE 1975-92 (see under GERM-FREE LIFE 1975-90)", "HN": "93; was SPECIFIC PATHOGEN FREE 1975-92 (see under GERM-FREE LIFE 1975-90)", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013047"}, {"RECTYPE": "D", "MH": "Specimen Handling", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Specimen Handlings", "MN": "E05.200.998", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Procedures for collecting, preserving, and transporting of specimens sufficiently stable to provide accurate and precise results suitable for clinical interpretation.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013048"}, {"RECTYPE": "D", "MH": "Spectrin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Spectrin", "MN": "D12.776.543.850", "MH_TH": "NLM (1977)", "ST": "T123", "N1": "Spectrins", "RN": "12634-43-4", "PI": "Erythrocytes (1966-1975)", "MS": "A high molecular weight (220-250 kDa) water-soluble protein which can be extracted from erythrocyte ghosts in low ionic strength buffers. The protein contains no lipids or carbohydrates, is the predominant species of peripheral erythrocyte membrane proteins, and exists as a fibrous coating on the inner, cytoplasmic surface of the membrane.", "PM": "84; was see under MEMBRANE PROTEINS 1978-83, was see under BLOOD PROTEINS 1977", "HN": "84(77); was see under MEMBRANE PROTEINS 1978-83, was see under BLOOD PROTEINS 1977", "MR": "20170703", "DA": "19760416", "DC": "1", "DX": "19840101", "UI": "D013049"}, {"RECTYPE": "D", "MH": "Spectrometry, Fluorescence", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Spectrofluorometry|T059|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Spectroscopy, Fluorescence", "MN": "E05.196.867.726", "MH_TH": "NLM (1972)", "ST": "T059", "AN": "a type of spectrum anal; NIM; do not confuse with SPECTROMETRY, X-RAY FLUORESCENCE see SPECTROMETRY, X-RAY EMISSION", "PI": "Spectrum Analysis (1966-1971)", "MS": "Measurement of the intensity and quality of fluorescence.", "OL": "use SPECTROMETRY, FLUORESCENCE to search FLUORESCENCE SPECTROPHOTOMETRY 1972-73 (as Prov 1972-73)", "PM": "74", "HN": "74; was FLUORESCENCE SPECTROPHOTOMETRY (Prov 1972-73)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013050"}, {"RECTYPE": "D", "MH": "Spectrometry, Gamma", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Gamma Spectrophotometry|T059|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Spectrophotometry, Gamma", "MN": "E05.799.801", "MH_TH": "NLM (1969)", "ST": "T059", "AN": "a type of spectrum anal; NIM", "PI": "Spectrum Analysis (1966-1968)", "MS": "Determination of the energy distribution of gamma rays emitted by nuclei. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "OL": "use SPECTROMETRY, GAMMA to search GAMMA SPECTROMETRY 1969-73 (as Prov 1969-73)", "PM": "74", "HN": "74; was GAMMA SPECTROMETRY (Prov 1969-73)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013051"}, {"RECTYPE": "D", "MH": "Spectrometry, X-Ray Emission", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "X-Ray Fluorescence Spectrometry|T059|T062|NON|EQV|UNK (19XX)|770329|abbcdef", "ENTRY": "Xray Emission Spectrometry", "MN": "E05.799.830", "MH_TH": "NLM (1978)", "ST": "T062", "AN": "do not confuse with entry terms at ELECTRON PROBE MICROANALYSIS; do not confuse entry term SPECTROMETRY, X-RAY FLUORESCENCE with SPECTROMETRY, FLUORESCENCE", "PI": "X-Rays (1975-1977)", "MS": "The spectrometric analysis of fluorescent X-RAYS, i.e. X-rays emitted after bombarding matter with high energy particles such as PROTONS; ELECTRONS; or higher energy X-rays. Identification of ELEMENTS by this technique is based on the specific type of X-rays that are emitted which are characteristic of the specific elements in the material being analyzed. The characteristic X-rays are distinguished and/or quantified by either wavelength dispersive or energy dispersive methods.", "PM": "1978", "HN": "1978", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19770329", "DC": "1", "DX": "19780101", "UI": "D013052"}, {"RECTYPE": "D", "MH": "Spectrophotometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "MN": "E05.196.867.826", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "a type of spectrum anal; NIM", "MS": "The art or process of comparing photometrically the relative intensities of the light in different parts of the spectrum.", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013053"}, {"RECTYPE": "D", "MH": "Spectrophotometry, Atomic", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Spectrophotometry, Atomic Absorption|T059|NON|NRW|NLM (1972)|990101|abcdef", "ENTRY": "Spectrophotometry, AE", "MN": "E05.196.867.826.551", "FX": "Absorption, Radiation", "MH_TH": "NLM (2004)", "ST": "T059", "PI": "Spectrophotometry (1966-1971)", "MS": "Spectrophotometric techniques by which the absorption or emmision spectra of radiation from atoms are produced and analyzed.", "PM": "2004; see SPECTROPHOTOMETRY, ATOMIC ABSORPTION 1972-2003", "HN": "2004 (1972)", "CATSH": "CAT LIST", "MR": "20140606", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013054"}, {"RECTYPE": "D", "MH": "Spectrophotometry, Infrared", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Infrared Spectrophotometry|T059|NON|EQV|NLM (1995)|940411|abcdef", "ENTRY": "Spectra, IR", "MN": "E05.196.867.826.676", "MH_TH": "NLM (1973)", "ST": "T059", "AN": "a type of spectrum anal; NIM; 770-1500 millimus", "PI": "Spectrophotometry (1966-1972)", "MS": "Spectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013055"}, {"RECTYPE": "D", "MH": "Spectrophotometry, Ultraviolet", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Ultraviolet Spectrophotometry|T059|NON|EQV|NLM (1995)|940411|abcdef", "MN": "E05.196.867.826.802", "MH_TH": "NLM (1973)", "ST": "T059", "AN": "a type of spectrum anal; NIM; 180-390 millimus", "PI": "Spectrophotometry (1966-1972)", "MS": "Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013056"}, {"RECTYPE": "D", "MH": "Spectrum Analysis", "DE": "SPECTRUM ANAL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Spectroscopy|T090|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Spectrometry|T059|NON|NRW|NLM (2010)|090213|abcdef", "MN": "E05.196.867", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "general or unspecified; prefer specifics", "MS": "The measurement of the amplitude of the components of a complex waveform throughout the frequency range of the waveform. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013057"}, {"RECTYPE": "D", "MH": "Mass Spectrometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Spectrum Analysis, Mass|T059|NON|EQV|NLM (1971)|990101|SPECTRUM ANAL MASS|abcdefv", "ENTRY": "Spectrum Analyses, Mass", "MN": "E05.196.566", "MH_TH": "UNK (19XX)", "ST": "T059", "PI": "Spectrum Analysis (1966-1970)", "MS": "An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers.", "PM": "2007; see SPECTRUM ANALYSIS, MASS 1974-2006", "HN": "2007 (1971)", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013058"}, {"RECTYPE": "D", "MH": "Spectrum Analysis, Raman", "DE": "SPECTRUM ANAL RAMAN", "AQ": "HI IS MT ST", "PRINT ENTRY": "Raman Spectroscopy|T059|EPO|EQV|UNK (19XX)|760414|abcdef", "ENTRY": "Spectroscopy, Raman", "MN": "E05.196.867.890", "MH_TH": "NLM (1977)", "ST": "T059", "PI": "Spectrum Analysis (1966-1976)", "MS": "Analysis of the intensity of Raman scattering of monochromatic light as a function of frequency of the scattered light.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D013059"}, {"RECTYPE": "D", "MH": "Speech", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Public Speaking|T054|NON|REL|NLM (1998)|970408|abcdef", "ENTRY": "Speaking, Public", "MN": "L01.559.423.676", "FX": "Verbal Behavior", "MH_TH": "NLM (1966)", "ST": "T054", "AN": "= LANGUAGE as it comes out of the mouth; VERBAL BEHAVIOR is how it comes out; PHONETICS is the sounds making up SPEECH; AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION is also available", "MS": "Communication through a system of conventional vocal symbols.", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013060"}, {"RECTYPE": "D", "MH": "Speech Acoustics", "PRINT ENTRY": "Acoustics, Speech|T081|NON|EQV|UNK (19XX)|790221|abcdef", "ENTRY": "Speech Acoustic", "MN": "G11.561.820", "MH_TH": "NLM (1980)", "ST": "T081", "PI": "Voice (1966-1979)", "MS": "The acoustic aspects of speech in terms of frequency, intensity, and time.", "PM": "91; was see under SPEECH 1980-90", "HN": "91(80); was see under SPEECH 1980-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19790221", "DC": "1", "DX": "19910101", "UI": "D013061"}, {"RECTYPE": "D", "MH": "Speech Articulation Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Speech Articulation", "MN": "E01.370.760.760", "MH_TH": "NLM (1979)", "ST": "T060", "MS": "Tests of accuracy in pronouncing speech sounds, e.g., Iowa Pressure Articulation Test, Deep Test of Articulation, Templin-Darley Tests of Articulation, Goldman-Fristoe Test of Articulation, Screening Speech Articulation Test, Arizona Articulation Proficiency Scale.", "PM": "91; was see under SPEECH PRODUCTION MEASUREMENT 1979-90", "HN": "91(79); was see under SPEECH PRODUCTION MEASUREMENT 1979-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19780522", "DC": "1", "DX": "19910101", "UI": "D013062"}, {"RECTYPE": "D", "MH": "Speech Discrimination Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Speech Discrimination", "MN": "E01.370.382.375.060.060.750", "MH_TH": "NLM (1979)", "ST": "T060", "AN": "the examinee hears & understands the examiner's speech; do not confuse with SPEECH INTELLIGIBILITY (the speaker speaks in such a way that the hearer understands him)", "PI": "Speech (1966-1978)", "MS": "Tests of the ability to hear and understand speech as determined by scoring the number of words in a word list repeated correctly.", "PM": "1979", "HN": "1979", "CATSH": "CAT LIST", "MR": "19991216", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D013063"}, {"RECTYPE": "D", "MH": "Speech Disorders", "DE": "SPEECH DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Aprosodia|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Verbal Fluency Disorder", "MN": "C23.888.592.604.150.500.800", "FX": "Language Disorders", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "/ther: consider also SPEECH THERAPY; do not confuse with LANGUAGE DISORDERS: read differentiation of SPEECH & LANGUAGE under SPEECH", "MS": "Acquired or developmental conditions marked by an impaired ability to comprehend or generate spoken forms of language.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013064"}, {"RECTYPE": "D", "MH": "Speech Intelligibility", "AQ": "CL DE ES PH RE", "ENTRY": "Speech Intelligibilities", "MN": "G11.561.812.686", "FX": "Speech Production Measurement", "MH_TH": "NLM (1979)", "ST": "T080", "AN": "the speaker's speech is understood or not understood by the hearer; do not confuse with SPEECH DISCRIMINATION TESTS (the examinee hears & understands the examiner's speech)", "PI": "Speech (1966-1978)", "MS": "Ability to make speech sounds that are recognizable.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D013065"}, {"RECTYPE": "D", "MH": "Speech-Language Pathology", "DE": "SPEECH LANGUAGE PATHOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Speech Pathology|T091|NON|NRW|NLM (1991)|900213|SPEECH PATHOL|abcdefv", "ENTRY": "Speech Language Pathology", "MN": "H02.010.750", "MH_TH": "NLM (1980)", "ST": "T091", "PI": "Speech Therapy (1966-1979)", "MS": "The study of speech or language disorders and their diagnosis and correction.", "OL": "use SPEECH-LANGUAGE PATHOLOGY to search SPEECH PATHOLOGY 1980-90; search SPEECH THERAPY 1966-79", "PM": "91; was SPEECH PATHOLOGY 1980-90; was included in SPEECH THERAPY 1966-79", "HN": "91; was SPEECH PATHOLOGY 1980-90; was included in SPEECH THERAPY 1964-79 (Prov 1964-65)", "MR": "20080708", "DA": "19781214", "DC": "1", "DX": "19800101", "UI": "D013066"}, {"RECTYPE": "D", "MH": "Speech Perception", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Speech Discrimination|T041|NON|NRW|UNK (19XX)|780522|abcdef", "ENTRY": "Perception, Speech", "MN": "G07.888.125.875", "FX": "Voice Recognition", "MH_TH": "NLM (1979)", "ST": "T041", "PI": "Speech (1966-1978)", "MS": "The process whereby an utterance is decoded into a representation in terms of linguistic units (sequences of phonetic segments which combine to form lexical and grammatical morphemes).", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20200622", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D013067"}, {"RECTYPE": "D", "MH": "Speech Production Measurement", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Speech Production Measurements", "MN": "E01.370.760", "MH_TH": "NLM (1979)", "ST": "T060", "PI": "Speech (1966-1978)", "MS": "Measurement of parameters of the speech product such as vocal tone, loudness, pitch, voice quality, articulation, resonance, phonation, phonetic structure and prosody.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D013068"}, {"RECTYPE": "D", "MH": "Speech Reception Threshold Test", "DE": "SRT TEST", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Test, Speech Reception Threshold|T060|NON|EQV|NLM (1998)|961007|TEST SRT|abcdefv", "MN": "E01.370.382.375.060.060.760", "MH_TH": "NLM (1979)", "ST": "T060", "PI": "Speech (1966-1978)", "MS": "A test to determine the lowest sound intensity level at which fifty percent or more of the spondaic test words (words of two syllables having equal stress) are repeated correctly.", "PM": "91; was see under SPEECH DISCRIMINATION TESTS 1979-90", "HN": "91(79); was see under SPEECH DISCRIMINATION TESTS 1979-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19780522", "DC": "1", "DX": "19910101", "UI": "D013069"}, {"RECTYPE": "D", "MH": "Speech Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG PX SN ST TD", "ENTRY": "Therapies, Speech", "MN": "E02.831.727.552", "FX": "Voice Training", "MH_TH": "NLM (1964)", "ST": "T061", "AN": "do not confuse with LANGUAGE THERAPY; coordinate IM with specific speech disorder / ther (IM), not / rehabil", "MS": "Treatment for individuals with speech defects and disorders that involves counseling and use of various exercises and aids to help the development of new speech habits.", "PM": "66", "HN": "66(64); was in Cat E & G 1973-79, was in Cat G only 1968-72, was in Cat E only 1964-67", "CATSH": "CAT LIST", "MR": "20200618", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013070"}, {"RECTYPE": "D", "MH": "Speech, Alaryngeal", "AQ": "IS MT PX", "ENTRY": "Voice Productions, Alaryngeal", "MN": "E02.831.727.541", "FX": "Larynx, Artificial", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Methods of enabling a patient without a larynx or with a non-functional larynx to produce voice or speech. The methods may be pneumatic or electronic.", "OL": "use SPEECH, ALARYNGEAL to search VOICE PRODUCTION, ALARYNGEAL 1968-79", "PM": "80; was VOICE PRODUCTION, ALARYNGEAL 1968-79", "HN": "80; was VOICE PRODUCTION, ALARYNGEAL 1968-79", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D013071"}, {"RECTYPE": "D", "MH": "Speech, Esophageal", "AQ": "IS MT PX", "ENTRY": "Speechs, Esophageal", "MN": "E02.831.727.541.677", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "post-laryngectomy speech", "MS": "A method of speech used after laryngectomy, with sound produced by vibration of the column of air in the esophagus against the contracting cricopharyngeal sphincter. (Dorland, 27th ed)", "OL": "use SPEECH, ALARYNGEAL to search SPEECH, ESOPHAGEAL 1966-74 (as Prov 1966-67)", "PM": "91; was see under SPEECH, ALARYNGEAL 1979-90; was see under VOICE PRODUCTION, ALARYNGEAL 1968-79", "HN": "91(75)(65-67); was see under SPEECH, ALARYNGEAL 1979-90; was see under VOICE PRODUCTION, ALARYNGEAL 1965-79 (Prov 1965-67)", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013072"}, {"RECTYPE": "D", "MH": "Sperm Agglutination", "AQ": "DE ES GE IM PH RE", "ENTRY": "Sperm Agglutinations", "MN": "G12.122.100.700", "MH_TH": "POPLINE (1984)", "ST": "T043", "PI": "Spermatozoa (1966-1974)", "MS": "Agglutination of spermatozoa by antibodies or autoantibodies.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D013073"}, {"RECTYPE": "D", "MH": "Sperm Banks", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Sperm Bank", "MN": "N02.278.065.700", "MH_TH": "POPLINE (1978)", "ST": "T093", "PI": "Tissue Banks (1978-1981)", "MS": "Centers for acquiring and storing semen.", "PM": "91; was see under TISSUE BANKS 1982-90", "HN": "91(82); was see under TISSUE BANKS 1982-90", "MR": "19950523", "DA": "19810302", "DC": "1", "DX": "19910101", "UI": "D013074"}, {"RECTYPE": "D", "MH": "Sperm Capacitation", "AQ": "DE GE IM PH RE", "ENTRY": "Spermatozoa Capacitation", "MN": "G08.686.784.277.760", "MH_TH": "NLM (1974)", "ST": "T042", "PI": "Spermatozoa (1966-1971)", "MS": "The structural and functional changes by which SPERMATOZOA become capable of oocyte FERTILIZATION. It normally requires exposing the sperm to the female genital tract for a period of time to bring about increased SPERM MOTILITY and the ACROSOME REACTION before fertilization in the FALLOPIAN TUBES can take place.", "PM": "73", "HN": "73(72)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013075"}, {"RECTYPE": "D", "MH": "Sperm Count", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Sperm Number|T081|NON|REL|UNK (19XX)|790312|abcdef", "ENTRY": "Sperm Numbers", "MN": "G04.140.870", "FX": "Oligospermia", "MH_TH": "NLM (1980)", "ST": "T059", "PI": "Spermatozoa (1966-1979)", "MS": "A count of SPERM in the ejaculum, expressed as number per milliliter.", "PM": "1980", "HN": "1980", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19790312", "DC": "1", "DX": "19800101", "UI": "D013076"}, {"RECTYPE": "D", "MH": "Sperm Head", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Sperm Heads", "MN": "A11.497.760.400", "MH_TH": "NLM (1975)", "ST": "T026", "MS": "The anterior portion of the spermatozoon (SPERMATOZOA) that contains mainly the nucleus with highly compact CHROMATIN material.", "PM": "91; was see under SPERMATOZOA 1975-90", "HN": "91(75); was see under SPERMATOZOA 1975-90", "MR": "20020703", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013077"}, {"RECTYPE": "D", "MH": "Sperm Immobilizing Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sperm Immobilizing Effects", "MN": "D27.888.569.071.379", "MH_TH": "POPLINE (1981)", "ST": "T121", "RN": "0", "AN": "note entry term SPERM-IMMOBILIZING EFFECT: use only for the sperm immobilizing effect of a chemical substance", "PI": "Spermatozoa/drug effects (1966-1974)", "MS": "Chemical substances with sperm immobilizing activity used as topically administered vaginal contraceptives.", "PM": "75", "HN": "75", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D013078"}, {"RECTYPE": "D", "MH": "Sperm Maturation", "AQ": "DE GE IM PH RE", "ENTRY": "Spermatozoa Maturation", "MN": "G08.686.784.310.760.700", "FX": "Antispermatogenic Agents", "MH_TH": "NLM (1976)", "ST": "T042", "PI": "Spermatozoa (1966-1974)", "MS": "The maturing process of SPERMATOZOA after leaving the testicular SEMINIFEROUS TUBULES. Maturation in SPERM MOTILITY and FERTILITY takes place in the EPIDIDYMIS as the sperm migrate from caput epididymis to cauda epididymis.", "PM": "76; was see under SPERMATOZOA 1975", "HN": "76(75); was see under SPERMATOZOA 1975", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19760101", "UI": "D013079"}, {"RECTYPE": "D", "MH": "Sperm Motility", "AQ": "DE GE IM PH RE", "ENTRY": "Sperm Motilities", "MN": "G04.198.750", "FX": "Sperm Transport", "MH_TH": "NLM (1975)", "ST": "T043", "PI": "Spermatozoa (1966-1974)", "MS": "Movement characteristics of SPERMATOZOA in a fresh specimen. It is measured as the percentage of sperms that are moving, and as the percentage of sperms with productive flagellar motion such as rapid, linear, and forward progression.", "PM": "1976; see SPERMATOZOA 1975", "HN": "1976(1975); use SPERMATOZOA 1975", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19760101", "UI": "D013081"}, {"RECTYPE": "D", "MH": "Sperm Tail", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Sperm Flagellum|T026|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Tails, Sperm", "MN": "A11.497.760.500", "MH_TH": "NLM (1975)", "ST": "T026", "MS": "The posterior filiform portion of the spermatozoon (SPERMATOZOA) that provides sperm motility.", "PM": "91; was see under SPERMATOZOA 1975-90", "HN": "91(75); was see under SPERMATOZOA 1975-90", "MR": "20020703", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013082"}, {"RECTYPE": "D", "MH": "Sperm Transport", "AQ": "DE GE IM PH RE", "ENTRY": "Transport, Sperm", "MN": "G08.686.784.277.820", "FX": "Sperm Motility", "MH_TH": "NLM (1976)", "ST": "T042", "PI": "Spermatozoa (1966-1974)", "MS": "Passive or active movement of SPERMATOZOA from the testicular SEMINIFEROUS TUBULES through the male reproductive tract as well as within the female reproductive tract.", "PM": "76; was see under SPERMATOZOA 1975", "HN": "76(75); was see under SPERMATOZOA 1975", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19760101", "UI": "D013083"}, {"RECTYPE": "D", "MH": "Sperm-Ovum Interactions", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Sperm Penetration|T043|NON|NRW|UNK (19XX)|840531|abcdef", "ENTRY": "Sperm-Zona Pellucida Penetrations", "MN": "G08.686.784.277.800", "MH_TH": "NLM (1975)", "ST": "T042", "MS": "Interactive processes between the oocyte (OVUM) and the sperm (SPERMATOZOA) including sperm adhesion, ACROSOME REACTION, sperm penetration of the ZONA PELLUCIDA, and events leading to FERTILIZATION.", "PM": "85; was see under FERTILIZATION 1975-84", "HN": "85(75); was see under FERTILIZATION 1975-84", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19850101", "UI": "D013084"}, {"RECTYPE": "D", "MH": "Spermatic Cord", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Spermatic Cords", "MN": "A05.360.444.777", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "diseases: coord IM with GENITAL DISEASES, MALE (IM)", "MS": "Either of a pair of tubular structures formed by DUCTUS DEFERENS; ARTERIES; VEINS; LYMPHATIC VESSELS; and nerves. The spermatic cord extends from the deep inguinal ring through the INGUINAL CANAL to the TESTIS in the SCROTUM.", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013085"}, {"RECTYPE": "D", "MH": "Spermatic Cord Torsion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Testicular Torsion|T047|NON|EQV|OMIM (2013)|UNK (19XX)|740330|abcdeef", "ENTRY": "Torsions, Testicular", "MN": "C12.200.294.693", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "The twisting of the SPERMATIC CORD due to an anatomical abnormality that left the TESTIS mobile and dangling in the SCROTUM. The initial effect of testicular torsion is obstruction of venous return. Depending on the duration and degree of cord rotation, testicular symptoms range from EDEMA to interrupted arterial flow and testicular pain. If blood flow to testis is absent for 4 to 6 h, SPERMATOGENESIS may be permanently lost.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013086"}, {"RECTYPE": "D", "MH": "Spermatids", "AQ": "CH CL CY DE EN GD IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Spermatoblasts|T025|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Spermatoblast", "MN": "A11.497.760.600", "MH_TH": "NLM (1975)", "ST": "T025", "PI": "Spermatozoa (1966-1974)", "MS": "Male germ cells derived from the haploid secondary SPERMATOCYTES. Without further division, spermatids undergo structural changes and give rise to SPERMATOZOA.", "PM": "85; was see under SPERMATOZOA 1975-84", "HN": "85(75); was see under SPERMATOZOA 1975-84", "MR": "20020703", "DA": "19741111", "DC": "1", "DX": "19850101", "UI": "D013087"}, {"RECTYPE": "D", "MH": "Spermatocele", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Epididymal Cyst|T047|NON|EQV|NLM (2007)|050927|abcdef", "ENTRY": "Spermatoceles", "MN": "C23.300.306.750", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A cystic dilation of the EPIDIDYMIS, usually in the head portion (caput epididymis). The cyst fluid contains dead SPERMATOZOA and can be easily differentiated from TESTICULAR HYDROCELE and other testicular lesions.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013088"}, {"RECTYPE": "D", "MH": "Spermatocidal Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Spermicidal Agents|T121|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Spermicides, Vaginal", "MN": "D27.888.569.071.569", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "consider also SPERMATOZOA /drug eff", "PI": "Spermatozoa/drug effects (1966-1974)", "MS": "Chemical substances that are destructive to spermatozoa used as topically administered vaginal contraceptives.", "PM": "75", "HN": "75", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D013089"}, {"RECTYPE": "D", "MH": "Spermatocytes", "AQ": "CH CL CY DE EN GD IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Spermiocytes|T025|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Spermiocyte", "MN": "A11.497.760.700", "FX": "Sperm Maturation", "MH_TH": "NLM (1975)", "ST": "T025", "PI": "Spermatozoa (1966-1974)", "MS": "Male germ cells derived from SPERMATOGONIA. The euploid primary spermatocytes undergo MEIOSIS and give rise to the haploid secondary spermatocytes which in turn give rise to SPERMATIDS.", "PM": "85; was see under SPERMATOZOA 1975-84", "HN": "85(75); was see under SPERMATOZOA 1975-84", "MR": "20020703", "DA": "19741111", "DC": "1", "DX": "19850101", "UI": "D013090"}, {"RECTYPE": "D", "MH": "Spermatogenesis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Spermiogenesis|T043|NON|NRW|NLM (1998)|961213|abcdef", "MN": "G08.686.784.310.760", "FX": "Spermatogenesis-Blocking Agents", "MH_TH": "POPLINE (1978)", "ST": "T043", "PI": "Spermatozoa (1966-1970)", "MS": "The process of germ cell development in the male from the primordial germ cells, through SPERMATOGONIA; SPERMATOCYTES; SPERMATIDS; to the mature haploid SPERMATOZOA.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013091"}, {"RECTYPE": "D", "MH": "Spermatogenesis-Blocking Agents", "DE": "SPERMATOGENESIS BLOCK AGENTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Agents, Spermatogenesis-Blocking", "MN": "D27.888.569.071.760", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "consider also SPERMATOGENESIS /drug eff & ANTISPERMATOGENIC AGENTS", "PI": "Spermatogenesis/drug effects (1971-1974)", "MS": "Chemical substances which inhibit the process of spermatozoa formation at either the first stage, in which spermatogonia develop into spermatocytes and then into spermatids, or the second stage, in which spermatids transform into spermatozoa.", "OL": "use SPERMATOGENESIS-BLOCKING AGENTS to search SPERMATOGENESIS BLOCKING AGENTS 1975-93", "PM": "94; was SPERMATOGENESIS BLOCKING AGENTS 1975-93", "HN": "94; was SPERMATOGENESIS BLOCKING AGENTS 1975-93", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D013092"}, {"RECTYPE": "D", "MH": "Spermatogonia", "AQ": "CH CL CY DE EN GD IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Spermatophores|T025|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Spermatophore", "MN": "A11.497.760.800", "MH_TH": "NLM (1975)", "ST": "T025", "MS": "Euploid male germ cells of an early stage of SPERMATOGENESIS, derived from prespermatogonia. With the onset of puberty, spermatogonia at the basement membrane of the seminiferous tubule proliferate by mitotic then meiotic divisions and give rise to the haploid SPERMATOCYTES.", "PM": "91; was see under SPERMATOZOA 1975-90", "HN": "91(75); was see under SPERMATOZOA 1975-90", "MR": "20020703", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013093"}, {"RECTYPE": "D", "MH": "Spermatozoa", "AQ": "AB CH CL CY DE EN GD IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Sperm|T025|NON|EQV|BIOETHICS (19XX)|UNK (19XX)|761231|abcdeef", "ENTRY": "Y-Chromosome-Bearing Sperms", "MN": "A11.497.760", "FX": "Spermatocidal Agents", "MH_TH": "NLM (1966)", "ST": "T025", "MS": "Mature male germ cells derived from SPERMATIDS. As spermatids move toward the lumen of the SEMINIFEROUS TUBULES, they undergo extensive structural changes including the loss of cytoplasm, condensation of CHROMATIN into the SPERM HEAD, formation of the ACROSOME cap, the SPERM MIDPIECE and the SPERM TAIL that provides motility.", "PM": "1963; for X-BEARING SPERM see X CHROMOSOME 1980-2005; for Y-BEARING SPERM see Y CHROMOSOME 1980-2005", "HN": "1963; for X-BEARING SPERM use X CHROMOSOME 1980-2005; for Y-BEARING SPERM use Y CHROMOSOME 1980-2005", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D013094"}, {"RECTYPE": "D", "MH": "Spermidine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D02.092.782.677", "MH_TH": "NLM (1971)", "ST": "T123", "N1": "1,4-Butanediamine, N-(3-aminopropyl)-", "RN": "U87FK77H25", "RR": "124-20-9 (Spermidine)", "PI": "Amines (1966-1970)", "MS": "A polyamine formed from putrescine. It is found in almost all tissues in association with nucleic acids. It is found as a cation at all pH values, and is thought to help stabilize some membranes and nucleic acid structures. It is a precursor of spermine.", "PM": "73", "HN": "73(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013095"}, {"RECTYPE": "D", "MH": "Spermine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D02.092.782.802", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "1,4-Butanediamine, N,N'-bis(3-aminopropyl)-", "RN": "2FZ7Y3VOQX", "RR": "71-44-3 (Spermine)", "MS": "A biogenic polyamine formed from spermidine. It is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria. It is found as a polycation at all pH values. Spermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013096"}, {"RECTYPE": "D", "MH": "Spermine Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Spermine Synthetase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Synthetase, Spermine", "MN": "D08.811.913.225.912", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "S-Adenosylmethioninamine:spermidine 3-aminopropyltransferase", "RN": "EC 2.5.1.22", "RR": "74812-43-4 (CAS RN)", "AN": "do not confuse with SPERMIDINE SYNTHASE", "PI": "Transferases (1972-1974)", "MS": "An enzyme that catalyzes the transfer of the propylamine moiety from 5'-deoxy-5'-S-(3-methylthiopropylamine)sulfonium adenosine to spermidine in the biosynthesis of spermine. It has an acidic isoelectric point at pH 5.0. EC 2.5.1.22.", "PM": "91; was see under TRANSFERASES 1975-90", "HN": "91(75); was see under TRANSFERASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013097"}, {"RECTYPE": "D", "MH": "Xylariales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Sphaeriales|T004|NON|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Xylariale", "MN": "B01.300.107.950", "MH_TH": "NLM (2006)", "ST": "T004", "RN": "txid37989", "MS": "An order of ascomycetous FUNGI which includes many economically important plant parasites as well as saprophytes.", "PM": "2006; see SPHAERIALES 1991-2005, see ASCOMYCETES 1975-1990", "HN": "2006 (1975)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013098"}, {"RECTYPE": "D", "MH": "Sphenoid Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Greater Sphenoid Wing|T030|NON|NRW|NLM (2020)|190412|abcdef", "ENTRY": "Sphenoid Wing, Greater", "MN": "A02.835.232.781.802", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "fractures: coordinate SPHENOID BONE /inj (IM) + SKULL FRACTURES (IM); neoplasms: coordinate IM with SKULL NEOPLASMS (IM)", "MS": "An irregular unpaired bone situated at the SKULL BASE and wedged between the frontal, temporal, and occipital bones (FRONTAL BONE; TEMPORAL BONE; OCCIPITAL BONE). Sphenoid bone consists of a median body and three pairs of processes resembling a bat with spread wings. The body is hollowed out in its inferior to form two large cavities (SPHENOID SINUS).", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013100"}, {"RECTYPE": "D", "MH": "Sphenoid Sinus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Sinus, Sphenoid", "MN": "A04.531.621.827", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "One of the paired air spaces located in the body of the SPHENOID BONE behind the ETHMOID BONE in the middle of the skull. Sphenoid sinus communicates with the posterosuperior part of NASAL CAVITY on the same side.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013101"}, {"RECTYPE": "D", "MH": "Spherocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Spherocyte", "MN": "A15.145.229.334.330.802", "MH_TH": "NLM (1975)", "ST": "T025", "MS": "Small, abnormal spherical red blood cells with more than the normal amount of hemoglobin.", "OL": "use ERYTHROCYTES, ABNORMAL to search SPHEROCYTES 1966-74 (as Prov 1966-67)", "PM": "91; was see under ERYTHROCYTES, ABNORMAL 1968-90", "HN": "91(75)(63-67); was see under ERYTHROCYTES, ABNORMAL 1963-90 (Prov 1963-67)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013102"}, {"RECTYPE": "D", "MH": "Spherocytosis, Hereditary", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spherocytoses, Hereditary", "MN": "C16.320.070.785", "FX": "Anion Exchange Protein 1, Erythrocyte", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "A group of familial congenital hemolytic anemias characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. The erythrocytes have increased osmotic fragility and are abnormally permeable to sodium ions.", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013103"}, {"RECTYPE": "D", "MH": "Spheroplasts", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Spheroplast", "MN": "B05.110.761", "MH_TH": "NLM (1972)", "ST": "T025", "AN": "in micro-organisms only; coord IM with specific micro-organism (IM)", "PI": "L Forms (1966-1971)", "MS": "Cells, usually bacteria or yeast, which have partially lost their cell wall, lost their characteristic shape and become round.", "PM": "74", "HN": "74(72)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013104"}, {"RECTYPE": "D", "MH": "Sphincterotomy, Transduodenal", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Sphincterotomy, Transhepatic|T061|NON|EQV|NLM (1988)|990101|abcdef", "ENTRY": "Transhepatic Sphincterotomy", "MN": "E04.515.750.750", "MH_TH": "UNK (19XX)", "ST": "T061", "AN": "refers to SPHINCTER OF ODDI only", "PI": "Vater's Ampulla/surgery (1966-1987)", "MS": "Surgical incision of the SPHINCTER OF ODDI in the management of COMMON BILE DUCT DISEASES (e.g., CHOLEDOCHOLITHIASIS; and SPHINCTER OF ODDI DYSFUNCTION).", "PM": "2018; see Sphincterotomy, Transhepatic", "HN": "2018(1988)", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19870325", "DC": "1", "DX": "19880101", "UI": "D013105"}, {"RECTYPE": "D", "MH": "Sphingolipidoses", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Storage Diseases, Sphingolipid", "MN": "C18.452.648.595.554.825", "MH_TH": "NLM (1974)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "A group of inherited metabolic disorders characterized by the intralysosomal accumulation of SPHINGOLIPIDS primarily in the CENTRAL NERVOUS SYSTEM and to a variable degree in the visceral organs. They are classified by the enzyme defect in the degradation pathway and the substrate accumulation (or storage). Clinical features vary in subtypes but neurodegeneration is a common sign.", "PM": "1992; see SPHINGOLIPIDOSIS 1974-91", "HN": "1992(1974)", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013106"}, {"RECTYPE": "D", "MH": "Sphingolipids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sphingolipid|T109|NON|EQV|NLM (2021)|191126|abcdef", "MN": "D10.570.877", "FX": "Sphingosine", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "Lipids (1966-1970)", "MS": "A class of membrane lipids that have a polar head and two nonpolar tails. They are composed of one molecule of the long-chain amino alcohol sphingosine (4-sphingenine) or one of its derivatives, one molecule of a long-chain acid, a polar head alcohol and sometimes phosphoric acid in diester linkage at the polar head group. (Lehninger et al, Principles of Biochemistry, 2nd ed)", "OL": "search LIPIDS 1966-70", "PM": "72; was see under LIPIDS 1963-71", "HN": "72(71); was see under LIPIDS 1963-71", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013107"}, {"RECTYPE": "D", "MH": "Sphingomyelin Phosphodiesterase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sphingomyelinase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Sphingomyelinase C|T116|T126|NON|EQV|UNK (19XX)|830629|abbcdef", "MN": "D08.811.277.352.640.750", "FX": "Niemann-Pick Diseases", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Sphingomyelin cholinephosphohydrolase", "RN": "EC 3.1.4.12", "AN": "/defic: consider also NIEMANN-PICK DISEASE", "PI": "Sphingomyelins (1973-1974)", "MS": "An enzyme that catalyzes the hydrolysis of sphingomyelin to ceramide (N-acylsphingosine) plus choline phosphate. A defect in this enzyme leads to NIEMANN-PICK DISEASE. EC 3.1.4.12.", "PM": "91; was see under PHOSPHODIESTERASES 1975-90", "HN": "91(75); was see under PHOSPHODIESTERASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013108"}, {"RECTYPE": "D", "MH": "Sphingomyelins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sphingomyelin|T109|T123|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D10.570.877.360.612.870", "MH_TH": "NLM (1963)", "ST": "T123", "RN": "0", "MS": "A class of sphingolipids found largely in the brain and other nervous tissue. They contain phosphocholine or phosphoethanolamine as their polar head group so therefore are the only sphingolipids classified as PHOSPHOLIPIDS.", "PM": "66; was see under PHOSPHOLIPIDS 1963-65", "HN": "66(63); was see under PHOSPHOLIPIDS 1963-65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013109"}, {"RECTYPE": "D", "MH": "Sphingosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "4 Sphingenine", "MN": "D02.092.063.700", "FX": "Sphingolipids", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "4-Octadecene-1,3-diol, 2-amino-, (R-(R*,S*-(E)))-", "RN": "NGZ37HRE42", "RR": "123-78-4 (Sphingosine)", "PI": "Glycols (1966-1971)", "MS": "An amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. (Dorland, 28th ed)", "PM": "72", "HN": "72", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013110"}, {"RECTYPE": "D", "MH": "Spider Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE TO TU UR", "PRINT ENTRY": "Tarantula Venom|T123|T131|NON|NRW|NLM (2021)|200129|abbcdef", "ENTRY": "Venoms, Tarantula", "MN": "D23.946.833.065.870", "FX": "Spider Bites", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTIVENINS; /enzymol permitted", "PI": "Venoms (1966-1977)", "MS": "Venoms of arthropods of the order Araneida of the ARACHNIDA. The venoms usually contain several protein fractions, including ENZYMES, hemolytic, neurolytic, and other TOXINS, BIOLOGICAL.", "PM": "91; was see under ARTHROPOD VENOMS 1978-90", "HN": "91(78); was see under ARTHROPOD VENOMS 1978-90", "MR": "20200527", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D013111"}, {"RECTYPE": "D", "MH": "Spiders", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Spider", "MN": "B01.050.500.131.166.803", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6893", "AN": "SPIDER BITES is available; venomous genera include: Latrodectus (BLACK WIDOW SPIDER), Loxosceles (BROWN RECLUSE SPIDER), Tarantula", "MS": "Arthropods of the class ARACHNIDA, order Araneae. Except for mites and ticks, spiders constitute the largest order of arachnids, with approximately 37,000 species having been described. The majority of spiders are harmless, although some species can be regarded as moderately harmful since their bites can lead to quite severe local symptoms. (From Barnes, Invertebrate Zoology, 5th ed, p508; Smith, Insects and Other Arthropods of Medical Importance, 1973, pp424-430)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013112"}, {"RECTYPE": "D", "MH": "Spin Labels", "AQ": "CS", "PRINT ENTRY": "Spin Label|T130|NON|EQV|NLM (2021)|200129|abcdef", "ENTRY": "Labels, Spin", "MN": "D02.389.678", "FX": "Spin Trapping", "MH_TH": "NLM (1974)", "ST": "T130", "RN": "0", "AN": "/chem syn permitted", "MS": "Molecules which contain an atom or a group of atoms exhibiting an unpaired electron spin that can be detected by electron spin resonance spectroscopy and can be bonded to another molecule. (McGraw-Hill Dictionary of Chemical and Technical Terms, 4th ed)", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013113"}, {"RECTYPE": "D", "MH": "Spinal Canal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Vertebral Foramina|T030|NON|REL|NLM (2021)|200114|abcdef", "ENTRY": "Vertebral Foramens", "MN": "A02.835.232.834.803", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "The cavity within the SPINAL COLUMN through which the SPINAL CORD passes.", "MR": "20200317", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013115"}, {"RECTYPE": "D", "MH": "Spinal Cord", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Thoracic Cords", "MN": "A08.186.854", "FX": "Myelography", "EC": "injuries:Spinal Cord Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at MYEL-", "MS": "A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER.", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013116"}, {"RECTYPE": "D", "MH": "Spinal Cord Compression", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myelopathy, Compressive|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Syndromes, Conus Medullaris", "MN": "C26.819.678", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific vertebrae (NIM) to locate site on spinal cord; not for \"cauda equina syndrome\": use CAUDA EQUINA (IM) + NERVE COMPRESSION SYNDROMES (IM)", "MS": "Acute and chronic conditions characterized by external mechanical compression of the SPINAL CORD due to extramedullary neoplasm; EPIDURAL ABSCESS; SPINAL FRACTURES; bony deformities of the vertebral bodies; and other conditions. Clinical manifestations vary with the anatomic site of the lesion and may include localized pain, weakness, sensory loss, incontinence, and impotence.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013117"}, {"RECTYPE": "D", "MH": "Spinal Cord Diseases", "DE": "SPINAL CORD DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myelopathy|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Spinal Cord Disorder", "MN": "C10.228.854", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific vertebrae (NIM) to locate site on spinal cord; inflamm dis of spinal cord= MYELITIS", "MS": "Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.", "PM": "1966", "HN": "1966", "CATSH": "CAT LIST", "MR": "19991208", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013118"}, {"RECTYPE": "D", "MH": "Spinal Cord Injuries", "DE": "SPINAL CORD INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myelopathy, Traumatic|T037|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Traumatic Myelopathy", "MN": "C26.819", "FX": "Spinal Cord Regeneration", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "coordinate IM with specific vertebra (NIM) to locate site on spinal cord", "MS": "Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.).", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013119"}, {"RECTYPE": "D", "MH": "Spinal Cord Neoplasms", "DE": "SPINAL CORD NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Intramedullary Spinal Cord Neoplasms|T191|NON|NRW|NLM (2000)|991103|INTRAMEDULLARY SPINAL CORD NEOPL|abcdefv", "ENTRY": "Tumor, Spinal Cord", "MN": "C10.551.240.750", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM); coord IM with specific vertebrae (NIM) to locate site on spinal cord", "MS": "Benign and malignant neoplasms which occur within the substance of the spinal cord (intramedullary neoplasms) or in the space between the dura and spinal cord (intradural extramedullary neoplasms). The majority of intramedullary spinal tumors are primary CNS neoplasms including ASTROCYTOMA; EPENDYMOMA; and LIPOMA. Intramedullary neoplasms are often associated with SYRINGOMYELIA. The most frequent histologic types of intradural-extramedullary tumors are MENINGIOMA and NEUROFIBROMA.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013120"}, {"RECTYPE": "D", "MH": "Spinal Curvatures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spinal Curvature", "MN": "C05.116.900.800", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Scoliosis (1966-1997)", "MS": "Deformities of the SPINE characterized by abnormal bending or flexure in the vertebral column. They may be bending forward (KYPHOSIS), backward (LORDOSIS), or sideway (SCOLIOSIS).", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013121"}, {"RECTYPE": "D", "MH": "Spinal Diseases", "DE": "SPINAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spinal Disease", "MN": "C05.116.900", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific vertebrae (IM)", "MS": "Diseases involving the SPINE.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013122"}, {"RECTYPE": "D", "MH": "Spinal Fusion", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Spondylosyndesis|T061|NON|NRW|NLM (1997)|950928|abcdef", "ENTRY": "Spondylosyndeses", "MN": "E04.555.100.700", "FX": "Laminectomy", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Operative immobilization or ankylosis of two or more vertebrae by fusion of the vertebral bodies with a short bone graft or often with diskectomy or laminectomy. (From Blauvelt & Nelson, A Manual of Orthopaedic Terminology, 5th ed, p236; Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013123"}, {"RECTYPE": "D", "MH": "Spinal Injuries", "DE": "SPINAL INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spinal Injury", "MN": "C26.117.500", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "do not confuse with SPINAL CORD INJURIES", "MS": "Injuries involving the vertebral column.", "CATSH": "CAT LIST", "MR": "20150701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013124"}, {"RECTYPE": "D", "MH": "Spinal Neoplasms", "DE": "SPINAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Spinal Neoplasm", "MN": "C05.116.900.801", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "do not confuse with SPINAL CORD NEOPLASMS; coordinate IM with specific vertebrae (IM) + histological type of neoplasm (IM)", "MS": "New abnormal growth of tissue in the SPINE.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013125"}, {"RECTYPE": "D", "MH": "Spinal Nerve Roots", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Ventral Roots|T023|NON|REL|NLM (1994)|921009|abcdef", "ENTRY": "Ventral Root", "MN": "A08.800.800.720.725", "FX": "Rhizotomy", "MH_TH": "NLM (1970)", "ST": "T023", "PI": "Spinal Nerves (1966-1969)", "MS": "Paired bundles of NERVE FIBERS entering and leaving the SPINAL CORD at each segment. The dorsal and ventral nerve roots join to form the mixed segmental spinal nerves. The dorsal roots are generally afferent, formed by the central projections of the spinal (dorsal root) ganglia sensory cells, and the ventral roots are efferent, comprising the axons of spinal motor and PREGANGLIONIC AUTONOMIC FIBERS.", "PM": "73", "HN": "73(70)", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013126"}, {"RECTYPE": "D", "MH": "Spinal Nerves", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Spinal Nerve", "MN": "A08.800.800.720", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "peripheral nerves; do not use vertebra headings to locate area of spinal nerves", "MS": "The 31 paired peripheral nerves formed by the union of the dorsal and ventral spinal roots from each spinal cord segment. The spinal nerve plexuses and the spinal roots are also included.", "MR": "19930621", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013127"}, {"RECTYPE": "D", "MH": "Spinal Osteophytosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Osteophytosis, Spinal|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Spinal Osteophytoses", "MN": "C05.116.900.815", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "coordinate with specific vertebra", "MS": "Outgrowth of immature bony processes or bone spurs (OSTEOPHYTE) from the VERTEBRAE, reflecting the presence of degenerative disease and calcification. It commonly occurs in cervical and lumbar SPONDYLOSIS.", "PM": "1965", "HN": "1965", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013128"}, {"RECTYPE": "D", "MH": "Spinal Puncture", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Lumbar Puncture|T060|NON|EQV|UNK (19XX)|741224|abcdef", "ENTRY": "Taps, Spinal", "MN": "E05.200.998.054.790", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Tapping fluid from the subarachnoid space in the lumbar region, usually between the third and fourth lumbar vertebrae.", "CATSH": "CAT LIST", "MR": "20150701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013129"}, {"RECTYPE": "D", "MH": "Spinal Stenosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stenosis, Spinal", "MN": "C05.116.900.825", "MH_TH": "NLM (1983)", "ST": "T047", "AN": "coordinate with vertebrae headings if appropriate", "PI": "Spinal Diseases (1966-1982)", "MS": "Narrowing of the spinal canal.", "PM": "83", "HN": "83", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19820422", "DC": "1", "DX": "19830101", "UI": "D013130"}, {"RECTYPE": "D", "MH": "Spine", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Vertebral Column|T023|NON|EQV|NLM (2000)|991109|abcdef", "ENTRY": "Vertebral Columns", "MN": "A02.835.232.834", "FX": "Laminectomy", "EC": "injuries:Spinal Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at SPONDYL- and VERTEBRAL", "MS": "The spinal or vertebral column.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013131"}, {"RECTYPE": "D", "MH": "Spinocerebellar Degenerations", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spinocerebellar Degeneration|T047|NON|EQV|NLM (1987)|990101|abcdef", "ENTRY": "Syndrome-Myopathy, Marinesco-Sjogren", "MN": "C16.320.400.780", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Spinal Cord Diseases (1966-1986)", "MS": "A heterogenous group of degenerative syndromes marked by progressive cerebellar dysfunction either in isolation or combined with other neurologic manifestations. Sporadic and inherited subtypes occur. Inheritance patterns include autosomal dominant, autosomal recessive, and X-linked.", "PM": "2000; see SPINOCEREBELLAR DEGENERATION 1989-1999, see SPINOCEREBELLAR DEGENERATIONS 1987-1988", "HN": "2000(1987)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19860331", "DC": "1", "DX": "19870101", "UI": "D013132"}, {"RECTYPE": "D", "MH": "Spinothalamic Tracts", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Tracts, Spinothalamic", "MN": "A08.612.220.735", "MH_TH": "NLM (1971)", "ST": "T023", "PI": "Thalamus (1966-1970)", "MS": "A bundle of NERVE FIBERS connecting each posterior horn of the spinal cord to the opposite side of the THALAMUS, carrying information about pain, temperature, and touch. It is one of two major routes by which afferent spinal NERVE FIBERS carrying sensations of somaesthesis are transmitted to the THALAMUS.", "PM": "71", "HN": "71", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D013133"}, {"RECTYPE": "D", "MH": "Spiperone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Spiroperone|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D04.711.800", "PA": "Dopamine Antagonists", "MH_TH": "USAN (1966)", "ST": "T121", "N1": "1,3,8-Triazaspiro(4.5)decan-4-one, 8-(4-(4-fluorophenyl)-4-oxobutyl)-1-phenyl-", "RN": "4X6E73CJ0Q", "RR": "749-02-0 (Spiperone)", "PI": "Spiro Compounds (1966-1974)", "MS": "A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.", "PM": "87; was see under BUTYROPHENONES 1975-86", "HN": "87(75); was see under BUTYROPHENONES 1975-86", "MR": "20160531", "DA": "19741119", "DC": "1", "DX": "19870101", "UI": "D013134"}, {"RECTYPE": "D", "MH": "Spiral Ganglion", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Ganglion of Corti|T023|EPO|EQV|UNK (19XX)|780519|abcdef", "ENTRY": "Ganglions, Auditory", "MN": "A09.246.300.246.900", "MH_TH": "NLM (1979)", "ST": "T023", "PI": "Organ of Corti (1968-1978)", "MS": "The sensory ganglion of the COCHLEAR NERVE. The cells of the spiral ganglion send fibers peripherally to the cochlear hair cells and centrally to the COCHLEAR NUCLEI of the BRAIN STEM.", "PM": "91; was see under COCHLEA 1979-90", "HN": "91(79); was see under COCHLEA 1979-90", "MR": "20210630", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D013136"}, {"RECTYPE": "D", "MH": "Spiral Lamina", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Spiral Laminas", "MN": "A09.246.300.246.930", "MH_TH": "NLM (1979)", "ST": "T023", "PI": "Cochlea (1966-1978)", "MS": "The bony plate which extends outwards from the modiolus into the spiral canal of the cochlea, forming part of the structure that divides the upper SCALA VESTIBULI and the lower SCALA TYMPANI.", "PM": "91; was see under COCHLEA 1979-90", "HN": "91(79); was see under COCHLEA 1979-90", "MR": "20180702", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D013137"}, {"RECTYPE": "D", "MH": "Spirillum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.710.750", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid967", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM) or RAT-BITE FEVER (IM)", "MS": "A genus of gram-negative, curved and spiral-shaped bacteria found in stagnant, freshwater environments. These organisms are motile by bipolar tufts of flagella having a long wavelength and about one helical turn. Some species of Spirillum cause a form of RAT-BITE FEVER.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013139"}, {"RECTYPE": "D", "MH": "Spiritualism", "AQ": "HI PX", "MN": "K01.844.799.679", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "IM; specify geog if pertinent; do not confuse with SPIRITUAL HEALING see MENTAL HEALING", "MS": "Religious philosophy expressing the fundamental belief that departed spirits may be contacted by the living through a medium.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013140"}, {"RECTYPE": "D", "MH": "Spiro Compounds", "DE": "SPIRO CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Spiro", "MN": "D04.711", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Cyclic compounds that include two rings which share a single atom (usually a carbon). The simplest example of this type of compound is Spiro[2.2]pentane, which looks like a bow tie.", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013141"}, {"RECTYPE": "D", "MH": "Spirochaeta", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.851.595.679", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid146", "AN": "a genus of the family SPIROCHAETACEAE of the order SPIROCHAETALES; do not confuse with SPIROCHETES see SPIROCHAETALES; found in mud & slime", "MS": "A genus of flexible, spiral rods found in hydrogen sulfide-containing mud, sewage, and polluted water. None of the species properly referred to in this genus are pathogenic.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013142"}, {"RECTYPE": "D", "MH": "Spirochaetaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.851.595", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid137", "AN": "a family in the order SPIROCHAETALES; in stagnant water & in bivalve mollusks", "PI": "Bacteria (1966-1974)", "MS": "A family of spiral bacteria of the order SPIROCHAETALES.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D013143"}, {"RECTYPE": "D", "MH": "Spirochaetales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Spirochetes|T007|NON|EQV|NLM (1998)|960711|abcdef", "ENTRY": "Spirochete|T007|NON|EQV|NLM (1998)|960711|abcdef", "MN": "B03.851", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid136", "MS": "An order of slender, flexuous, helically coiled bacteria, with one or more complete turns in the helix.", "PM": "76; was see under SCHIZOMYCETES 1975, was see under BACTERIA 1966-74", "HN": "76(66); was see under SCHIZOMYCETES 1975, was see under BACTERIA 1966-74", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D013144"}, {"RECTYPE": "D", "MH": "Spirochaetales Infections", "DE": "SPIROCHAETALES INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Spirochete Infections|T047|NON|EQV|UNK (19XX)|780322|SPIROCHETE INFECT|abcdefv", "ENTRY": "Spirochete Infection", "MN": "C01.150.252.400.794", "MH_TH": "NLM (1972)", "ST": "T047", "PI": "Spirochaeta (1966-1971)", "MS": "Infections with bacteria of the order SPIROCHAETALES.", "OL": "use SPIROCHAETALES INFECTIONS to search SPIROCHETE INFECTIONS 1972-78", "PM": "79; was SPIROCHETE INFECTIONS 1972-78", "HN": "79; was SPIROCHETE INFECTIONS 1972-78", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013145"}, {"RECTYPE": "D", "MH": "Spirometra", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Spirometras", "MN": "B01.050.500.500.736.215.800", "MH_TH": "NLM (1979)", "ST": "T204", "RN": "txid46580", "AN": "a genus of tapeworm of Diphyllobothriidae; found in fish; larval form is SPARGANUM; infection: coord IM with CESTODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Sparganum (1975-1978)", "MS": "A genus of tapeworms of the family Diphyllobothriidae, which are parasites of fish-eating cats, dogs, and birds. Infection in man is caused by eating undercooked fish. The larval form is called SPARGANUM.", "OL": "use SPARGANUM to search SPIROMETRA 1975-78", "PM": "91,79-85; was see under CESTODA 1986-90; was heading 1979-85; was see SPARGANUM 1975-78", "HN": "91(86)79; was see under CESTODA 1986-90; was heading 1979-85; was see SPARGANUM 1975-78", "MR": "20200813", "DA": "19780130", "DC": "1", "DX": "19790101", "UI": "D013146"}, {"RECTYPE": "D", "MH": "Spirometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Spirometries", "MN": "E01.370.386.700.750", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "BRONCHOSPIROMETRY is also available", "MS": "Measurement of volume of air inhaled or exhaled by the lung.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013147"}, {"RECTYPE": "D", "MH": "Spironolactone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Spirolactone|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Von Ct, Spiro", "MN": "D04.210.500.745.745.855", "PA": "Mineralocorticoid Receptor Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo-, gamma-lactone, (7alpha,17alpha)-", "RN": "27O7W4T232", "RR": "52-01-7 (Spironolactone)", "MS": "A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013148"}, {"RECTYPE": "D", "MH": "Spiroplasma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.300.750.625", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid2132", "PI": "Mycoplasmatales (1975)", "MS": "A genus of gram-negative, helical bacteria, in the family SPIROPLASMATACEAE, order Entomoplasmatales, causing disease in PLANTS. It has been isolated from TICKS; INSECTS; and PLANTS.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D013149"}, {"RECTYPE": "D", "MH": "Spirostans", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Spirostenes|T109|NON|NRW|NLM (2007)|051017|abcdef", "MN": "D04.210.500.247.515", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Cholestane derivatives containing a fused lactone ring at the 16,17-position and a spiroglycosidic linkage at C-22. Members include sarsaponin, DIOSGENIN and yamogenin.", "PM": "68", "HN": "68", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013150"}, {"RECTYPE": "D", "MH": "Spiruroidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Tetrameres|T204|NON|NRW|UNK (19XX)|850321|abcdef", "ENTRY": "Tetramere", "MN": "B01.050.500.500.294.400.937.700.680", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid214002", "RR": "txid75558", "AN": "a superfamily of nematodes; do not confuse with the order SPIRURIDA or the suborder SPIRURINA; infection: coord IM with SPIRURIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "MS": "A superfamily of parasitic nematodes which requires one or two intermediate arthropod hosts before finally being eaten by the final host. Its organisms occur rarely in man.", "OL": "use SPIRUROIDEA to search GONGYLONEMA & PHYSALOPTERA 1966-85 & FILARIA LABIALIS 1966-78", "PM": "GONGYLONEMA & PHYSALOPTERA were see under SPIRUROIDEA 1963-85; FILARIA LABIALIS was see under SPIRUROIDEA 1963-78", "HN": "GONGYLONEMA & PHYSALOPTERA were see under SPIRUROIDEA 1963-85; FILARIA LABIALIS was see under SPIRUROIDEA 1963-78", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013151"}, {"RECTYPE": "D", "MH": "Splanchnic Circulation", "DE": "SPLANCHNIC CIRC", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Mesenteric Circulation|T042|NON|EQV|UNK (19XX)|800515|MESENTERIC CIRC|abcdefv", "ENTRY": "Splanchnic Circulations", "MN": "G09.330.100.881", "MH_TH": "NLM (1981)", "ST": "T042", "MS": "The circulation of blood through the BLOOD VESSELS supplying the abdominal VISCERA.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19800515", "DC": "1", "DX": "19810101", "UI": "D013152"}, {"RECTYPE": "D", "MH": "Splanchnic Nerves", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Splanchnic Nerve", "MN": "A08.800.800.060.800", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "major nerves of sympath innerv of abdomen", "MS": "The major nerves supplying sympathetic innervation to the abdomen. The greater, lesser, and lowest (or smallest) splanchnic nerves are formed by preganglionic fibers from the spinal cord which pass through the paravertebral ganglia and then to the celiac ganglia and plexuses. The lumbar splanchnic nerves carry fibers which pass through the lumbar paravertebral ganglia to the mesenteric and hypogastric ganglia.", "MR": "19930621", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013153"}, {"RECTYPE": "D", "MH": "Spleen", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A15.382.520.604.700", "FX": "Splenectomy", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "/inj: consider also SPLENIC RUPTURE but traumatic spleen perforation is indexed under SPLEEN /inj; accessory spleen: index under SPLEEN /abnorm", "MS": "An encapsulated lymphatic organ through which venous blood filters.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013154"}, {"RECTYPE": "D", "MH": "Spleen Focus-Forming Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Rauscher Spleen Focus-Forming Virus|T005|EPO|NRW|NLM (2007)|051129|abcdef", "ENTRY": "Spleen Focus-Forming Virus", "MN": "B04.820.650.375.525.850", "MH_TH": "NLM (1986)", "ST": "T005", "RN": "txid11819", "RR": "txid11821", "AN": "infection: coordinate IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + LEUKEMIA, EXPERIMENTAL (IM) or LEUKEMIA, ERYTHROBLASTIC, ACUTE (IM) (for spontaneous erythroleukemia)", "PI": "Mouse Leukemia Viruses (1966-1985)", "MS": "Strains of MURINE LEUKEMIA VIRUS that are replication-defective and rapidly transforming. The envelope gene plays an essential role in initiating erythroleukemia (LEUKEMIA, ERYTHROBLASTIC, ACUTE), manifested by splenic foci, SPLENOMEGALY, and POLYCYTHEMIA. Spleen focus-forming viruses are generated by recombination with endogenous retroviral sequences.", "PM": "91; was see under MOUSE LEUKEMIA VIRUSES 1986-90", "HN": "91(86); was see under MOUSE LEUKEMIA VIRUSES 1986-90", "MR": "20200813", "DA": "19850509", "DC": "1", "DX": "19910101", "UI": "D013155"}, {"RECTYPE": "D", "MH": "Splenectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Splenectomies", "MN": "E04.726", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "coordinate IM with non-splenic disease / surg (IM), not / ther", "MS": "Surgical procedure involving either partial or entire removal of the spleen.", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013156"}, {"RECTYPE": "D", "MH": "Splenic Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Splenic Arteries", "MN": "A07.015.114.814", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The largest branch of the celiac trunk with distribution to the spleen, pancreas, stomach and greater omentum.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013157"}, {"RECTYPE": "D", "MH": "Splenic Diseases", "DE": "SPLENIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Splenic Disease", "MN": "C15.604.744", "FX": "Splenosis", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases involving the SPLEEN.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013158"}, {"RECTYPE": "D", "MH": "Splenic Infarction", "DE": "SPLENIC INFARCT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Splenic Infarct|T047|NON|EQV|NLM (2020)|190301|abcdef", "ENTRY": "Splenic Infarctions", "MN": "C23.550.717.489.937", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Insufficiency of arterial or venous blood supply to the spleen due to emboli, thrombi, vascular torsion, or pressure that produces a macroscopic area of necrosis. (From Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013159"}, {"RECTYPE": "D", "MH": "Splenic Neoplasms", "DE": "SPLENIC NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Spleen Cancer|T191|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Splenic Neoplasm", "MN": "C15.604.744.680", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the SPLEEN.", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013160"}, {"RECTYPE": "D", "MH": "Splenic Rupture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Splenic Ruptures", "MN": "C26.761.555", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Rupture of the SPLEEN due to trauma or disease.", "CATSH": "CAT LIST", "MR": "20160708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013161"}, {"RECTYPE": "D", "MH": "Splenic Vein", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Splenic", "MN": "A07.015.908.670.730", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Vein formed by the union (at the hilus of the spleen) of several small veins from the stomach, pancreas, spleen and mesentery.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013162"}, {"RECTYPE": "D", "MH": "Splenomegaly", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Enlarged Spleen|T033|T046|NON|EQV|NLM (2000)|991104|abbcdef", "ENTRY": "Spleen, Enlarged", "MN": "C23.300.775.750", "FX": "Hypersplenism", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "do not confuse with HYPERSPLENISM, increase in splenic hemolytic function; IM only if point of article; do not index at all if the usual symptom of a disease; NIM if merely one of many symptoms in article", "MS": "Enlargement of the spleen.", "CATSH": "CAT LIST", "MR": "19991104", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013163"}, {"RECTYPE": "D", "MH": "Splenorenal Shunt, Surgical", "DE": "SPLENORENAL SHUNT SURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Splenorenal Shunts", "MN": "E04.100.814.868.937.870", "MH_TH": "NLM (1981)", "ST": "T061", "PI": "Splenic Vein/surgery (1966-1980)", "MS": "Anastomosis of splenic vein to renal vein to relieve portal hypertension.", "PM": "88; was see under PORTASYSTEMIC SHUNT, SURGICAL 1981-87", "HN": "88(81); was see under PORTASYSTEMIC SHUNT, SURGICAL 1981-87", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19800409", "DC": "1", "DX": "19880101", "UI": "D013164"}, {"RECTYPE": "D", "MH": "Splints", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Static Orthose", "MN": "E07.858.690.725.430.750", "FX": "Stents", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "Rigid or flexible appliances that are used to maintain a displaced or movable part in position, or to maintain the position of and protect an injured part.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013165"}, {"RECTYPE": "D", "MH": "Spondylitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spondylitides", "MN": "C05.116.900.853", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with specific vertebra; do not confuse with SPONDYLOSIS or SPONDYLOLYSIS", "MS": "Inflammation of the SPINE. This includes both arthritic and non-arthritic conditions.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013166"}, {"RECTYPE": "D", "MH": "Spondylitis, Ankylosing", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spondylarthritis Ankylopoietica|T047|NON|EQV|GHR (2014)|UNK (19XX)|740330|abcdeef", "ENTRY": "Spondyloarthritis, Ankylosing", "MN": "C05.550.114.865.800.744.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with specific vertebra", "MS": "A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.", "CATSH": "CAT LIST", "MR": "20210326", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013167"}, {"RECTYPE": "D", "MH": "Spondylolisthesis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Olisthesis|T047|NON|BRD|NLM (2022)|201203|abcdef", "ENTRY": "Spondylolistheses", "MN": "C05.116.900.938.500.500", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "coordinate with specific vertebra", "MS": "Forward displacement of a superior vertebral body over the vertebral body below.", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013168"}, {"RECTYPE": "D", "MH": "Spondylolysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spondylolyses", "MN": "C05.116.900.938.500", "FX": "Spondylosis", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "coordinate with specific vertebra; do not confuse with SPONDYLOSIS or SPONDYLITIS", "MS": "Deficient development or degeneration of a portion of the VERTEBRA, usually in the pars interarticularis (the bone bridge between the superior and inferior facet joints of the LUMBAR VERTEBRAE) leading to SPONDYLOLISTHESIS.", "OL": "search SPONDYLOLISTHESIS 1968-74", "PM": "91; was see under SPONDYLOLISTHESIS 1975-90", "HN": "91(75); was see under SPONDYLOLISTHESIS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013169"}, {"RECTYPE": "D", "MH": "Spores", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Spore", "MN": "B05.775", "MH_TH": "NLM (1964)", "ST": "T001", "AN": "general or unspecified; prefer specifics; sporulation: coordinate organism /physiol and SPORES ", "MS": "The reproductive elements of lower organisms, such as BACTERIA; FUNGI; and cryptogamic plants.", "PM": "68", "HN": "68(64)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013170"}, {"RECTYPE": "D", "MH": "Spores, Bacterial", "DE": "SPORES BACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Bacterial Spores|T026|NON|EQV|UNK (19XX)|870507|BACT SPORES|abcdefv", "ENTRY": "Spore, Bacterial|T026|NON|EQV|NLM (1994)|930212|SPORE BACT|abcdefv", "MN": "B05.775.700", "MH_TH": "NLM (1971)", "ST": "T026", "AN": "sporulation: index specific bacterium /physiol  + SPORES, BACTERIAL", "PI": "specific bacterium", "MS": "Heat and stain resistant, metabolically inactive bodies formed within the vegetative cells of bacteria of the genera Bacillus and Clostridium.", "PM": "74", "HN": "74(71)", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013171"}, {"RECTYPE": "D", "MH": "Spores, Fungal", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Fungal Spores|T004|NON|EQV|UNK (19XX)|870507|abcdef", "ENTRY": "Spore, Fungal", "MN": "B05.775.710", "MH_TH": "NLM (1971)", "ST": "T004", "AN": "coordinate with specific fungus; sporulation: coordinate specific fungus /physiol; Manual 22.31", "PI": "specific fungus", "MS": "Reproductive bodies produced by fungi.", "PM": "74", "HN": "74(71)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013172"}, {"RECTYPE": "D", "MH": "Sporidesmins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.946.587.800", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "/antag permitted but consider also ANTITOXINS", "PI": "Pyrroles (1966-1974)", "MS": "A group of related mycotoxins produced by the pasture fungus Pithomyces chartarum (formerly Sporidesmium bakeri); causes liver damage and facial eczema in cattle and sheep.", "PM": "91; was see under INDOLES 1975-90", "HN": "91(75); was see under INDOLES 1975-90", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013173"}, {"RECTYPE": "D", "MH": "Sporotrichosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Sporothrix brasiliensis Infection|T047|NON|NRW|NLM (2021)|200207|abcdef", "ENTRY": "Sporotrichoses", "MN": "C17.800.838.208.675", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "The commonest and least serious of the deep mycoses, characterized by nodular lesions of the cutaneous and subcutaneous tissues. It is caused by inhalation of contaminated dust or by infection of a wound with SPOROTHRIX.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013174"}, {"RECTYPE": "D", "MH": "Sporothrix", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Sporotrichum|T004|NON|EQV|NLM (1999)|980115|abcdef", "ENTRY": "Sporotrichums", "MN": "B01.300.381.820", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid29907", "MS": "A mitosporic Ophiostomataceae fungal genus, whose species Sporothrix schenckii is a well-known animal pathogen. The conidia of this soil fungus may be inhaled causing a primary lung infection, or may infect independently via skin punctures.", "PM": "99; see SPOROTRICHUM 1963-98; for SPOROTHRIX see SPOROTRICHUM 1974-98", "HN": "99(63)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19990101", "UI": "D013175"}, {"RECTYPE": "D", "MH": "Sports", "AQ": "CL EC ED ES HI LJ PH PX SN ST TD", "PRINT ENTRY": "Athletics|T056|NON|NRW|UNK (19XX)|750716|abcdef", "ENTRY": "Sport", "MN": "I03.450.642.845", "FX": "Exercise Therapy", "EC": "injuries:Athletic Injuries", "MH_TH": "NLM (1966)", "ST": "T056", "AN": "SPORTS is the activity, SPORTS MEDICINE is the specialty", "MS": "Activities or games, usually involving physical effort or skill. Reasons for engagement in sports include pleasure, competition, and/or financial reward.", "OL": "use SPORTS to search ATHLETICS 1966-75", "HN": "ATHLETICS was see under SPORTS 1963-75", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013177"}, {"RECTYPE": "D", "MH": "Sports Medicine", "DE": "SPORTS MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sport Medicine|T091|NON|EQV|UNK (19XX)|790529|SPORT MED|abcdefv", "MN": "H02.403.830", "FX": "Protective Devices", "MH_TH": "BIOETHICS (1986)", "ST": "T091", "AN": "use for the discipline (education, history, etc) only; SPORTS is available for the activity; policy Manual 30.15", "MS": "The field of medicine concerned with physical fitness and the diagnosis and treatment of injuries sustained in exercise and sports activities.", "OL": "use SPORTS MEDICINE to search SPORT MEDICINE 1966-79", "PM": "80; was SPORT MEDICINE 1963-79", "HN": "80; was SPORT MEDICINE 1963-79", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D013178"}, {"RECTYPE": "D", "MH": "Spouse Abuse", "AQ": "CL DI EC EH ES HI LJ MO PC PX RH SN TD TH", "PRINT ENTRY": "Wife Abuse|T054|T055|NON|NRW|UNK (19XX)|760516|abbcdef", "ENTRY": "Abuse, Wife", "MN": "I01.880.735.900.688.500", "MH_TH": "NLM (1977)", "ST": "T055", "AN": "wife or husband abused or abuser", "MS": "Deliberate severe and repeated injury to one domestic partner by the other.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D013179"}, {"RECTYPE": "D", "MH": "Sprains and Strains", "DE": "SPRAINS STRAINS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Strains and Sprains", "MN": "C26.844", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "coordinate sprain with specific joint /inj or ligament /inj  & strain with specific muscle /inj; CUMULATIVE TRAUMA DISORDERS and SPRAIN FRACTURE see FRACTURES, AVULSION are also available", "MS": "A collective term for muscle and ligament injuries without dislocation or fracture. A sprain is a joint injury in which some of the fibers of a supporting ligament are ruptured but the continuity of the ligament remains intact. A strain is an overstretching or overexertion of some part of the musculature.", "CATSH": "CAT LIST", "MR": "20160421", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013180"}, {"RECTYPE": "D", "MH": "Cortical Spreading Depression", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Spreading Cortical Depression|T034|T042|NON|EQV|NLM (1964)|990101|abbcdef", "ENTRY": "Spreading Depressions, Cortical", "MN": "G11.561.200.500.300", "MH_TH": "NLM (2010)", "ST": "T042", "MS": "The decrease in neuronal activity (related to a decrease in metabolic demand) extending from the site of cortical stimulation. It is believed to be responsible for the decrease in cerebral blood flow that accompanies the aura of MIGRAINE WITH AURA. (Campbell's Psychiatric Dictionary, 8th ed.)", "PM": "2010; see SPREADING CORTICAL DEPRESSION 1967-2009", "HN": "2010(1964)", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D013181"}, {"RECTYPE": "D", "MH": "Sprue, Tropical", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tropical Sprue", "MN": "C18.452.603.850", "FX": "Celiac Disease", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "note \"tropical\": do not confuse with non-tropical sprue which is CELIAC DISEASE", "MS": "A chronic malabsorption syndrome, occurring mainly in residents of or visitors to the tropics or subtropics. The failed INTESTINAL ABSORPTION of nutrients from the SMALL INTESTINE results in MALNUTRITION and ANEMIA that is due to FOLIC ACID deficiency.", "CATSH": "CAT LIST", "MR": "20121204", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013182"}, {"RECTYPE": "D", "MH": "Sputum", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Sputums, Induced", "MN": "A12.200.808", "FX": "Drainage, Postural", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013183"}, {"RECTYPE": "D", "MH": "5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole", "DS": "AMINONITROFURYLVINYL OXADIAZOLE 05 03 05 02 01 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SQ 18506", "MN": "D03.383.312.649.200", "PA": "Trypanocidal Agents", "MH_TH": "UNK (19XX)", "ST": "T121", "N1": "1,2,4-Oxadiazol-5-amine, 3-(2-(5-nitro-2-furanyl)ethenyl)-, (E)-", "RN": "28754-68-9", "PI": "Vinyl Compounds (1972-1974)", "MS": "A nitrovinyl furan used as a schistosomicidal agent and proposed for trypanosomiasis, especially Chagas disease.", "PM": "2005; see SQ-19506 1991-2004; see NITROFURANS 1975-1990", "HN": "2005(1975)", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013184"}, {"RECTYPE": "D", "MH": "Squalene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.849.919.681", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-, (all-E)-", "RN": "7QWM220FJH", "RR": "111-02-4 (Squalene)", "MS": "A natural 30-carbon triterpene.", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013185"}, {"RECTYPE": "D", "MH": "Farnesyl-Diphosphate Farnesyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Squalene Synthetase|T116|T126|NON|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "Transferase, FPP-FPP Farnesyl", "MN": "D08.811.913.225.431", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.5.1.21", "PI": "Squalene (1972-1974)", "MS": "The first committed enzyme of the biosynthesis pathway that leads to the production of STEROLS. it catalyzes the synthesis of SQUALENE from farnesyl pyrophosphate via the intermediate PRESQUALENE PYROPHOSPHATE. This enzyme is also a critical branch point enzyme in the biosynthesis of ISOPRENOIDS that is thought to regulate the flux of isoprene intermediates through the sterol pathway.", "PM": "2006; see OXIDOREDUCTASES 1975-1990; FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE was indexed under OXIDOREDUCTASES & SQUALENE SYNTHETASE 1998-2001", "HN": "2006(1975)", "MR": "20090713", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013186"}, {"RECTYPE": "D", "MH": "Sri Lanka", "AQ": "EH EP", "PRINT ENTRY": "Ceylon|T083|NAM|EQV|POPLINE (1986)|760414|abcdef", "MN": "Z01.639.520.875", "MH_TH": "POPLINE (1986)", "ST": "T083", "MS": "Country in southern Asia, an island in the Indian Ocean, south of India. The capital is Colombo.", "OL": "use SRI LANKA to search CEYLON 1966-76", "HN": "77; was CEYLON 1963-76", "MR": "20220708", "DA": "19760416", "DC": "4", "DX": "19770101", "UI": "D013188"}, {"RECTYPE": "D", "MH": "SRS-A", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Slow Reacting Substance of Anaphylaxis|T109|T123|NON|EQV|UNK (19XX)|740330|abbcdef", "MN": "D23.469.050.175.450.725", "MH_TH": "NLM (1967)", "ST": "T123", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Muscle, Smooth/physiology (1966)", "MS": "A group of LEUKOTRIENES; (LTC4; LTD4; and LTE4) that is the major mediator of BRONCHOCONSTRICTION; HYPERSENSITIVITY; and other allergic reactions. Earlier studies described a \"slow-reacting substance of ANAPHYLAXIS\" released from lung by cobra venom or after anaphylactic shock. The relationship between SRS-A leukotrienes was established by UV which showed the presence of the conjugated triene. (From Merck Index, 11th ed)", "PM": "73", "HN": "73(67)", "MR": "20150608", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013189"}, {"RECTYPE": "D", "MH": "SSPE Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Subacute Sclerosing Panenceph Virus|T005|NON|EQV|UNK (19XX)|770127|abcdef", "ENTRY": "Viruses, SSPE", "MN": "B04.820.480.937.600.650.500.500.890", "MH_TH": "NLM (1978)", "ST": "T005", "PI": "Subacute Sclerosing Panencephalitis (1971-1977)", "MS": "A defective variant of MEASLES VIRUS that has been isolated from the brain tissue of patients with subacute sclerosing panencephalitis.", "PM": "78", "HN": "78", "MR": "20200902", "DA": "19770301", "DC": "1", "DX": "19780101", "UI": "D013190"}, {"RECTYPE": "D", "MH": "Stachybotrys", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Stachybotry", "MN": "B01.300.381.840", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid74721", "MS": "A mitosporic fungal genus including one species which forms a toxin in moldy hay that may cause a serious illness in horses.", "PM": "91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85", "HN": "91(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D013191"}, {"RECTYPE": "D", "MH": "Staff Development", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Human Resources Development|T057|NON|BRD|UNK (19XX)|850311|abcdef", "ENTRY": "Resources Development, Human", "MN": "N04.452.677.822", "MH_TH": "NLM (1986)", "ST": "T057", "PI": "Nursing Staff, Hospital/education (1968-1985)", "MS": "The process by which the employer promotes staff performance and efficiency consistent with management goals and objectives.", "PM": "91; was see under PERSONNEL MANAGEMENT 1986-90", "HN": "91(86); was see under PERSONNEL MANAGEMENT 1986-90", "MR": "20070709", "DA": "19850311", "DC": "1", "DX": "19910101", "UI": "D013192"}, {"RECTYPE": "D", "MH": "Stainless Steel", "AQ": "AE AN CH CL EC HI IP PD PK PO RE SD ST TO", "ENTRY": "Steels, Stainless", "MN": "J01.637.051.058.807.681", "MH_TH": "POPLINE (1978)", "ST": "T197", "N1": "Stainless steel", "RN": "12597-68-1", "MS": "Stainless steel. A steel containing Ni, Cr, or both. It does not tarnish on exposure and is used in corrosive environments. (Grant & Hack's Chemical Dictionary, 5th ed)", "PM": "68", "HN": "68(65)", "MR": "20170602", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013193"}, {"RECTYPE": "D", "MH": "Staining and Labeling", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Staining|T059|NON|NRW|NLM (1966)|990101|abcdef", "ENTRY": "Stainings", "MN": "E05.200.750.600.670", "FX": "Coloring Agents", "MH_TH": "NLM (2001)", "ST": "T059", "MS": "The marking of biological material with a dye or other reagent for the purpose of identifying and quantitating components of tissues, cells or their extracts.", "PM": "2001; see STAINING 1996-2000, see STAINS AND STAINING 1963-1995", "HN": "2001(1963)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "20010101", "UI": "D013194"}, {"RECTYPE": "D", "MH": "Stanford-Binet Test", "AQ": "HI SN ST", "PRINT ENTRY": "Binet Test|T060|T170|EPO|EQV|UNK (19XX)|780517|abbcdef", "ENTRY": "Test, Stanford-Binet", "MN": "F04.711.141.493.225", "MH_TH": "NLM (1975)", "ST": "T170", "PI": "Intelligence Tests (1966-1974)", "MS": "An individual intelligence test designed primarily for school children to predict school performance and the ability to adjust to everyday demands.", "OL": "use STANFORD-BINET TEST to search BINET TESTS 1975-78; use INTELLIGENCE TESTS 1966-74", "PM": "91; was see under INTELLIGENCE TESTS 1979-90; was BINET TESTS see under INTELLIGENCE TESTS 1963-78", "HN": "91(79); was see under INTELLIGENCE TESTS 1979-90; was BINET TESTS see under INTELLIGENCE TESTS 1963-78", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013195"}, {"RECTYPE": "D", "MH": "Dihydrotestosterone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Stanolone|T109|T121|T125|NON|EQV|FDA SRS (2014)|NLM (1963)|990101|abbbcdeef", "ENTRY": "beta-Hydroxy-5 beta-Androstan-3-One, 17", "MN": "D06.472.334.851.968.964", "PA": "Androgens", "MH_TH": "UNK (19XX)", "ST": "T125", "N1": "Androstan-3-one, 17-hydroxy-, (5alpha,17beta)-", "RN": "08J2K08A3Y", "RR": "521-18-6 (Dihydrotestosterone)", "MS": "A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE.", "PM": "2004; see STANOLONE 1963-2003", "HN": "2004 (1963)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D013196"}, {"RECTYPE": "D", "MH": "Stanozolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylstanazol|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Winstrol|T109|T121|TRD|NRW|ES|US|041119|abbcdeef", "MN": "D04.210.500.054.040.881", "PA": "Androgens", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2'H-Androst-2-eno(3,2-c)pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-", "RN": "4R1VB9P8V3", "RR": "10418-03-8 (Stanozolol)", "AN": "an anabolic steroid", "MS": "A synthetic steroid that has anabolic and androgenic properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1194)", "PM": "65", "HN": "65(64)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013197"}, {"RECTYPE": "D", "MH": "Stapedius", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A09.246.397.727", "MH_TH": "NLM (1979)", "ST": "T023", "AN": "/growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent", "PI": "Stapes (1975-1978)", "MS": "A tiny muscle that arises from the posterior wall of the TYMPANIC CAVITY of MIDDLE EAR with its tendon inserted onto the neck of the STAPES. Stapedius pulls the stapes posteriorly and controls its movement.", "PM": "91; was see under MUSCLES 1979-90", "HN": "91(79); was see under MUSCLES 1979-90", "MR": "20080708", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D013198"}, {"RECTYPE": "D", "MH": "Stapes", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE TR UL VI", "MN": "A09.246.397.247.806", "EC": "surgery:Stapes Surgery", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "One of the three ossicles of the middle ear. It transmits sound vibrations from the INCUS to the internal ear (Ear, Internal see LABYRINTH).", "OL": "search EAR OSSICLES 1966-74", "PM": "91; was see under EAR OSSICLES 1975-90", "HN": "91(75); was see under EAR OSSICLES 1975-90", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013199"}, {"RECTYPE": "D", "MH": "Stapes Mobilization", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Stapes Mobilizations", "MN": "E04.580.450.731.681", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "An operation to remobilize the footplate of the stapes to relieve conductive hearing impairment caused by its immobilization through otosclerosis or middle ear disease. (Stedman, 26th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013200"}, {"RECTYPE": "D", "MH": "Stapes Surgery", "DE": "STAPES SURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Stapedectomy|T061|NON|NRW|IOM (1990)|890417|abcdef", "ENTRY": "Surgeries, Stapes", "MN": "E04.580.450.731", "MH_TH": "NLM (1964)", "ST": "T061", "AN": "STAPES MOBILIZATION is also available", "MS": "Surgery performed in which part of the STAPES, a bone in the middle ear, is removed and a prosthesis is placed to help transmit sound between the middle ear and inner ear.", "PM": "64", "HN": "64", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D013201"}, {"RECTYPE": "D", "MH": "Staphylococcal Food Poisoning", "DE": "STAPH FOOD POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Staphylococcal Food Poisonings", "MN": "C25.723.415.846", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Poisoning by staphylococcal toxins present in contaminated food.", "PM": "68", "HN": "68(66)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013202"}, {"RECTYPE": "D", "MH": "Staphylococcal Infections", "DE": "STAPH INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Staphylococcus aureus Infections", "MN": "C01.150.252.410.868", "FX": "Cross Infection", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "gram-pos bact infect; STAPHYLOCOCCAL FOOD POISONING is also available", "MS": "Infections with bacteria of the genus STAPHYLOCOCCUS.", "OL": "use STAPHYLOCOCCAL INFECTIONS to search STAPHYLOCOCCAL INFECTIONS, GASTROINTESTINAL & STAPHYLOCOCCAL INFECTIONS, RESPIRATORY 1966-67", "PM": "STAPHYLOCOCCAL INFECTIONS, GASTROINTESTINAL & STAPHYLOCOCCAL INFECTIONS, RESPIRATORY were headings 1963-67", "HN": "STAPHYLOCOCCAL INFECTIONS, GASTROINTESTINAL & STAPHYLOCOCCAL INFECTIONS, RESPIRATORY were headings 1963-67", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013203"}, {"RECTYPE": "D", "MH": "Staphylococcus Phages", "DE": "STAPH PHAGES", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Staphylococcal Phages|T005|NON|EQV|NLM (1993)|911118|abcdef", "ENTRY": "Staphylococcal Phage", "MN": "B04.123.831", "MH_TH": "NLM (1966)", "ST": "T005", "AN": "coord IM with specific Staph (NIM)", "MS": "Viruses whose host is Staphylococcus.", "PM": "1993; was STAPHYLOCOCCAL PHAGES 1966-1992", "HN": "1993(1966)", "MR": "20210304", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D013204"}, {"RECTYPE": "D", "MH": "Staphylococcal Protein A", "DE": "STAPH PROTEIN A", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PO RE TO TU UL UR", "PRINT ENTRY": "Protein A|T116|T123|T129|T130|NON|EQV|UNK (19XX)|770524|abbbbcdef", "ENTRY": "Protein A, Staphylococcal", "MN": "D23.050.161.821", "MH_TH": "NLM (1978)", "ST": "T130", "RN": "0", "PI": "Staphylococcus aureus (1976-1977)", "MS": "A protein present in the cell wall of most Staphylococcus aureus strains. The protein selectively binds to the Fc region of human normal and myeloma-derived IMMUNOGLOBULIN G. It elicits antibody activity and may cause hypersensitivity reactions due to histamine release; has also been used as cell surface antigen marker and in the clinical assessment of B lymphocyte function.", "PM": "78", "HN": "78", "MR": "20220523", "DA": "19770524", "DC": "1", "DX": "19780101", "UI": "D013205"}, {"RECTYPE": "D", "MH": "Staphylococcal Scalded Skin Syndrome", "DE": "SSSS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Scalded Skin Syndrome, Staphylococcal|T047|NON|EQV|NLM (1993)|920421|SCALDED SKIN SYNDROME STAPH|abcdefv", "ENTRY": "Syndromes, Staphylococcal Scalded-Skin", "MN": "C17.800.838.765.770.770", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "in inf; do not confuse with another epidermolytic disease: NONSTAPHYLOCOCCAL SCALDED SKIN SYNDROME see EPIDERMAL NECROLYSIS, TOXIC", "PI": "Staphylococcal Infections (1966-1985)", "MS": "A disease of infants due to group 2 phage type 17 staphylococci that produce an epidermolytic exotoxin. Superficial fine vesicles and bullae form and rupture easily, resulting in loss of large sheets of epidermis.", "PM": "1991; see STAPHYLOCOCCAL SKIN INFECTIONS 1986-1990; RITTER'S DISEASE see DERMATITIS EXFOLIATIVA 1968-1985, was heading 1966-1967", "HN": "1991(1986); use STAPHYLOCOCCAL SKIN INFECTIONS 1986-1990; RITTER'S DISEASE use DERMATITIS EXFOLIATIVA 1968-1985, was heading 1966-1967", "CATSH": "CAT LIST", "MR": "20190613", "DA": "19850507", "DC": "1", "DX": "19910101", "UI": "D013206"}, {"RECTYPE": "D", "MH": "Staphylococcal Skin Infections", "DE": "STAPH SKIN INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Skin Diseases, Staphylococcal|T047|NON|EQV|UNK (19XX)|850507|SKIN DIS STAPH|abcdefv", "ENTRY": "Staphylococcal Skin Diseases|T047|NON|EQV|NLM (1992)|910301|STAPH SKIN DIS|abcdefv", "MN": "C17.800.838.765.770", "MH_TH": "NLM (1986)", "ST": "T047", "AN": "coord IM with specific STAPHYLOCOCCUS (IM)", "PI": "Staphylococcal Infections (1966-1985)", "MS": "Infections to the skin caused by bacteria of the genus STAPHYLOCOCCUS.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19850507", "DC": "1", "DX": "19860101", "UI": "D013207"}, {"RECTYPE": "D", "MH": "Staphylococcal Toxoid", "DE": "STAPH TOXOID", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Toxoid, Staphylococcal", "MN": "D20.215.894.691.681", "MH_TH": "NLM (1965)", "ST": "T129", "RN": "0", "PM": "65", "HN": "65", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013208"}, {"RECTYPE": "D", "MH": "Staphylococcal Vaccines", "DE": "STAPH VACCINES", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Staphylococcal", "MN": "D20.215.894.135.744", "MH_TH": "NLM (1965)", "ST": "T129", "RN": "0", "AN": "coord IM with specific Staphylococcus", "PM": "65", "HN": "65", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013209"}, {"RECTYPE": "D", "MH": "Staphylococcus", "DE": "STAPH", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.790.750", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1279", "MS": "A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013210"}, {"RECTYPE": "D", "MH": "Staphylococcus aureus", "DE": "STAPH AUREUS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.790.750.100", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid1280", "AN": "infection: coordinate with STAPHYLOCOCCAL INFECTIONS", "PI": "Staphylococcus (1966-1974)", "MS": "Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.", "OL": "use STAPHYLOCOCCUS AUREUS to search MICROCOCCUS PYOGENES 1975-91; use STAPHYLOCOCCUS 1966-74", "PM": "76; was MICROCOCCUS PYOGENES see under STAPHYLOCOCCUS 1963-75; MICROCOCCUS PYOGENES was see STAPHYLOCOCCUS AUREUS 1976-91", "HN": "76; was MICROCOCCUS PYOGENES see under STAPHYLOCOCCUS 1963-75; MICROCOCCUS PYOGENES was see STAPHYLOCOCCUS AUREUS 1976-91", "MR": "20200813", "DA": "19750721", "DC": "1", "DX": "19760101", "UI": "D013211"}, {"RECTYPE": "D", "MH": "Staphylococcus epidermidis", "DE": "STAPH EPIDERMIDIS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.790.750.343", "MH_TH": "NLM (1984)", "ST": "T007", "RN": "txid1282", "AN": "infection: coordinate with STAPHYLOCOCCAL INFECTIONS", "PI": "Staphylococcus (1966-1983)", "MS": "A species of STAPHYLOCOCCUS that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals, it can be primary pathogen or secondary invader.", "PM": "84", "HN": "84", "MR": "20200813", "DA": "19830615", "DC": "1", "DX": "19840101", "UI": "D013212"}, {"RECTYPE": "D", "MH": "Starch", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Starch, Amylomaize", "MN": "D09.698.365.855", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Starch", "RN": "9005-25-8", "MS": "Any of a group of polysaccharides of the general formula (C6-H10-O5)n, composed of a long-chain polymer of glucose in the form of amylose and amylopectin. It is the chief storage form of energy reserve (carbohydrates) in plants.", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013213"}, {"RECTYPE": "D", "MH": "Starch Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Starch (Bacterial Glycogen) Synthase|T116|T126|NON|EQV|NLM (1998)|961216|STARCH BACTERIAL GLYCOGEN SYNTHASE|abbcdefs", "ENTRY": "Synthase, Starch", "MN": "D08.811.913.400.450.460.750", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "ADPglucose:1,4-alpha-D-glucan 4-alpha-D-glucosyltransferase", "RN": "EC 2.4.1.21", "RR": "9030-10-8 (CAS RN)", "AN": "do not confuse with GLYCOGEN (STARCH) SYNTHASE see GLYCOGEN SYNTHASE", "PI": "Nucleoside Diphosphate Sugars (1973-1974)", "MS": "An enzyme that catalyzes the transfer of glucose from ADPglucose to glucose-containing polysaccharides in 1,4-alpha-linkages. EC 2.4.1.21.", "PM": "98; see STARCH (BACTERIAL GLYCOGEN) SYNTHASE 1991-97; see GLUCOSYLTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013214"}, {"RECTYPE": "D", "MH": "Starfish", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Seastars", "MN": "B01.050.500.408.765", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid7588", "AN": "note specifics", "PI": "Echinodermata (1966-1971)", "MS": "Echinoderms having bodies of usually five radially disposed arms coalescing at the center.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013215"}, {"RECTYPE": "D", "MH": "Reflex, Startle", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Startle Reaction|T040|T184|NON|EQV|NLM (1965)|990101|abbcdef", "ENTRY": "Startle Responses", "MN": "G11.561.731.869", "FX": "Prepulse Inhibition", "MH_TH": "NLM (2015)", "ST": "T184", "AN": "human & animal", "MS": "A complex involuntary response to an unexpected strong stimulus. The reaction involves physical movement away from the stimulus, MUSCLE CONTRACTION and limb flexion, BLINKING, and changes in HEART RATE, BLOOD PRESSURE, and RESPIRATION.", "PM": "2015; STARTLE REFLEX was indexed under STARTLE REACTION 1966-2014; ACOUSTIC STARTLE REFLEX was indexed under STARTLE REACTION 1973-2014; REFLEX, MORO was indexed under REFLEX 1952-2014", "HN": "2015(1954); use STARTLE REACTION 1966-2014, use REFLEX 1954-1965", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D013216"}, {"RECTYPE": "D", "MH": "Starvation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C18.654.521.750", "FX": "Hunger", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "refeeding after starvation: index refeeding under FOOD if pertinent", "MS": "Lengthy and continuous deprivation of food. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20190307", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013217"}, {"RECTYPE": "D", "MH": "State Dentistry", "DE": "STATE DENT", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Socialized Dentistry|T058|T064|NON|EQV|UNK (19XX)|740330|SOCIALIZED DENT|abbcdefv", "ENTRY": "State Dentistries", "MN": "N03.787", "MH_TH": "NLM (1965)", "ST": "T064", "PI": "State Medicine", "MS": "Control, direction and financing of the total dental care of the population by a national government.", "PM": "65", "HN": "65", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013218"}, {"RECTYPE": "D", "MH": "State Government", "PRINT ENTRY": "Provincial Government|T092|NON|EQV|NLM (1999)|980519|abcdef", "ENTRY": "State Governments", "MN": "N03.540.348.875", "MH_TH": "NLM (1984)", "ST": "T092", "AN": "not restricted to the U.S.; specify state or province", "MS": "The level of governmental organization and function below that of the national or country-wide government.", "PM": "90; was see under GOVERNMENT 1984-89", "HN": "90(84); was see under GOVERNMENT 1984-89", "MR": "20070709", "DA": "19830620", "DC": "1", "DX": "19900101", "UI": "D013219"}, {"RECTYPE": "D", "MH": "State Health Planning and Development Agencies", "DE": "SHPDA", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "State Health Planning, Development Agencies|T093|NON|EQV|UNK (19XX)|790531|STATE HEALTH PLANNING DEVELOPMENT AGENCIES|abcdefv", "MN": "N03.540.452.508", "MH_TH": "NLM (1980)", "ST": "T093", "AN": "U.S. only; Public Law 93-641; specify geog & add UNITED STATES also", "PI": "Regional Health Planning (1977-1979)", "MS": "Agencies established under PL93-641 to coordinate, conduct, and implement state health planning activities. Two primary responsibilities are the preparation of an annual State Health Plan and giving assistance to the Statewide Health Coordinating Council.", "OL": "use STATE HEALTH PLANNING AND DEVELOPMENT AGENCIES to search HEALTH PLANNING AGENCIES, UNITED STATES 1980; use HEALTH SYSTEMS AGENCIES to search STATE HEALTH PLANNING AGENCIES, UNITED STATES 1979", "PM": "91; was see under HEALTH PLANNING ORGANIZATIONS 1980-90; STATE HEALTH PLANNING AGENCIES, UNITED STATES was see HEALTH SYSTEMS AGENCIES 1979", "HN": "91(80); was see under HEALTH PLANNING ORGANIZATIONS 1980-90; STATE HEALTH PLANNING AGENCIES, UNITED STATES was see HEALTH SYSTEMS AGENCIES 1979", "MR": "20190524", "DA": "19790531", "DC": "1", "DX": "19910101", "UI": "D013220"}, {"RECTYPE": "D", "MH": "State Health Plans", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Comprehensive Health Plans, State|T058|T064|NON|NRW|UNK (19XX)|790601|abbcdef", "ENTRY": "State Health Plan", "MN": "N03.349.650.480", "MH_TH": "NLM (1980)", "ST": "T064", "AN": "Public Law 93-641; specify geog & add UNITED STATES also", "MS": "State plans prepared by the State Health Planning and Development Agencies which are made up from plans submitted by the Health Systems Agencies and subject to review and revision by the Statewide Health Coordinating Council.", "PM": "80", "HN": "80", "MR": "19991103", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D013221"}, {"RECTYPE": "D", "MH": "State Medicine", "DE": "STATE MED", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Socialized Medicine|T058|T064|NON|EQV|UNK (19XX)|740330|SOCIALIZED MED|abbcdefv", "ENTRY": "Service, British National Health|T058|T064|NON|NRW|NLM (1996)|950308|SERV BRITISH NATIONAL HEALTH|abbcdefv", "MN": "N03.858", "MH_TH": "BIOETHICS (1975)", "ST": "T064", "AN": "not for medical programs of individual states; compulsory system of personal medical care under control of a national government paying physicians out of public funds; compulsory: do not confuse with NATIONAL HEALTH PROGRAMS; specify country, even GREAT BRITAIN despite entry term NATIONAL HEALTH SERVICE, BRITISH", "MS": "A system of medical care regulated, controlled and financed by the government, in which the government assumes responsibility for the health needs of the population.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013222"}, {"RECTYPE": "D", "MH": "Statistics as Topic", "AQ": "CL EC ED ES HI IS LJ MT OG ST TD", "ENTRY": "Techniques, Indirect Estimation", "MN": "N06.850.520.830", "FX": "Sociometric Techniques", "MH_TH": "NLM (2008)", "ST": "T090", "MS": "Works about the science and art of collecting, summarizing, and analyzing data that are subject to random variation.", "PM": "2008; see STATISTICS 1963-2007", "HN": "2008(1963)", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D013223"}, {"RECTYPE": "D", "MH": "Status Asthmaticus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Asthmatic Shock|T047|NON|EQV|UNK (19XX)|840529|abcdef", "ENTRY": "Shocks, Asthmatic", "MN": "C20.543.480.680.095.880", "MH_TH": "NLM (1985)", "ST": "T047", "AN": "sudden intense aggravation of asthma", "PI": "Asthma (1966-1984)", "MS": "A sudden intense and continuous aggravation of a state of asthma, marked by dyspnea to the point of exhaustion and collapse and not responding to the usual therapeutic efforts.", "PM": "91; was see under ASTHMA 1985-90", "HN": "91(85); was see under ASTHMA 1985-90", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19840529", "DC": "1", "DX": "19910101", "UI": "D013224"}, {"RECTYPE": "D", "MH": "Status Epilepticus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Simple Partial Status Epilepticus|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Subclinical Status Epilepticus", "MN": "C23.888.592.742.785", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "note entry term PETIT MAL STATUS: do not confuse with PETIT MAL EPILEPSY see EPILEPSY, ABSENCE", "PI": "Epilepsy (1966-1976)", "MS": "A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30)", "PM": "1977", "HN": "1977", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D013226"}, {"RECTYPE": "D", "MH": "Steam", "AQ": "AE AN", "ENTRY": "Water Vapors", "MN": "N06.230.650", "FX": "Water", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "MS": "Water in its gaseous state. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013227"}, {"RECTYPE": "D", "MH": "Stearates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Stearate|T109|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D10.251.882.800", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Stearic Acids (1966-1974)", "MS": "Salts and esters of the 18-carbon saturated, monocarboxylic acid--stearic acid.", "PM": "91; was see under STEARIC ACIDS 1975-90", "HN": "91(75); was see under STEARIC ACIDS 1975-90", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013228"}, {"RECTYPE": "D", "MH": "Stearic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetrahydrolinoleic Acids|T109|NON|EQV|UNK (19XX)|770520|abcdef", "ENTRY": "Acids, Tetrahydrolinoleic", "MN": "D10.251.882", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse entry term OCTADECANOIC ACIDS with OCTADECENOIC ACIDS see OLEIC ACIDS", "MS": "A group of compounds that are derivatives of octadecanoic acid which is one of the most abundant fatty acids found in animal lipids. (Stedman, 25th ed)", "OL": "use STEARIC ACIDS to search STEARIC ACID 1966-74", "PM": "75; was STEARIC ACID 1963-74", "HN": "75; was STEARIC ACID 1963-74", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D013229"}, {"RECTYPE": "D", "MH": "Stearoyl-CoA Desaturase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stearyl-CoA Desaturase|T116|T126|NON|EQV|NLM (1995)|940112|abbcdef", "ENTRY": "delta 9 Desaturase", "MN": "D08.811.682.690.708.392.625", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Stearoyl-CoA,hydrogen-donor:oxygen oxidoreductase", "RN": "EC 1.14.19.1", "PI": "Stearic Acids (1973-1974)", "MS": "An enzyme that catalyzes the formation of oleoyl-CoA, A, and water from stearoyl-CoA, AH2, and oxygen where AH2 is an unspecified hydrogen donor.", "OL": "use STEAROYL-COA DESATURASE to search STEARYL-COA DESATURASE 1975-94", "PM": "95; was STEARYL-COA DESATURASE 1975-94 (see under FATTY ACID DESATURASES 1975-90)", "HN": "95; was STEARYL-COA DESATURASE 1975-94 (see under FATTY ACID DESATURASES 1975-90)", "MR": "20090706", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013230"}, {"RECTYPE": "D", "MH": "Steatitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Steatitides", "MN": "C22.880", "MH_TH": "NLM (1971)", "ST": "T047", "AN": "inflamm of adipose tissue in cats & minks; coord IM with CAT DISEASES (IM) or MINKS (IM); check tags CATS if cat & ANIMALS for cat or mink", "PI": "Vitamin E Deficiency/VE (1966-1970)", "MS": "A disease of cats and mink characterized by a marked inflammation of adipose tissue and the deposition of \"ceroid\" pigment in the interstices of the adipose cells. It is believed to be caused by feeding diets containing too much unsaturated fatty acid and too little vitamin E. (Merck Veterinary Manual, 5th ed; Stedman, 25th ed)", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D013231"}, {"RECTYPE": "D", "MH": "Steel", "AQ": "AE AN CH CL EC HI IP PD PK PO RE SD ST TO", "ENTRY": "Steels", "MN": "J01.637.051.058.807", "MH_TH": "NLM (1975)", "ST": "T197", "N1": "Steel", "RN": "12597-69-2", "MS": "A tough, malleable, iron-based alloy containing up to, but no more than, two percent carbon and often other metals. It is used in medicine and dentistry in implants and instrumentation.", "OL": "use ALLOYS to search STEEL 1968-74 & METALS 1966-67", "PM": "91; was see under ALLOYS 1968-90; was see under METALS 1963-67", "HN": "91(75); was see under ALLOYS 1968-90; was see under METALS 1963-67", "MR": "20170712", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013232"}, {"RECTYPE": "D", "MH": "Stellate Ganglion", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cervicothoracic Ganglion|T023|NON|EQV|NLM (1994)|921005|abcdef", "ENTRY": "Stellate Ganglias", "MN": "A08.800.050.800.300.800", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "a sympath ganglion", "MS": "A paravertebral sympathetic ganglion formed by the fusion of the inferior cervical and first thoracic ganglia.", "MR": "19940411", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013233"}, {"RECTYPE": "D", "MH": "Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Progenitor Cells|T025|NON|EQV|UNK (19XX)|830224|abcdef", "ENTRY": "Stem Cell", "MN": "A11.872", "FX": "Stem Cell Research", "EC": "transplantation:Stem Cell Transplantation", "MH_TH": "NLM (1963)", "ST": "T025", "PI": "Colony-Forming Units Assay (1979-1983)", "MS": "Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.", "PM": "1984; for Oogonial Stem Cells see Adult Stem Cells 2014-2016", "HN": "1984; for Oogonial Stem Cells use Adult Stem Cells 2014-2016", "MR": "20160706", "DA": "19830224", "DC": "1", "DX": "19840101", "UI": "D013234"}, {"RECTYPE": "D", "MH": "Stereognosis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Tactile Gnosis|T041|NON|EQV|NLM (2022)|210510|abcdef", "ENTRY": "Tactile Gnoses", "MN": "F02.463.593.894.500", "MH_TH": "NLM (1973)", "ST": "T041", "PI": "Touch (1966-1972)", "MS": "Perception of shape and form of objects by TOUCH and KINESTHESIS, via tactile stimuli.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013236"}, {"RECTYPE": "D", "MH": "Stereoisomerism", "PRINT ENTRY": "Stereoisomers|T104|NON|REL|NLM (1997)|950801|abcdef", "ENTRY": "Stereoisomer", "MN": "G02.607.445.682", "MH_TH": "NLM (1968)", "ST": "T070", "AN": "NIM; policy: Manual 25.5.5.1", "MS": "The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "PM": "1997; was STEREOISOMERS 1974-1996; for MOLECULAR STEREOCHEMISTRY see MOLECULAR CONFORMATION 1993-2008", "HN": "1997 (1968); for MOLECULAR STEREOCHEMISTRY use MOLECULAR CONFORMATION 1993-2008", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013237"}, {"RECTYPE": "D", "MH": "Stereotaxic Techniques", "AQ": "AE CL EC ED ES HI IS LJ MO NU PX RH SN ST TD VE", "ENTRY": "Techniques, Stereotaxic", "MN": "E05.873", "FX": "Brain Mapping", "MH_TH": "NLM (1964)", "ST": "T061", "MS": "Techniques used mostly during brain surgery which use a system of three-dimensional coordinates to locate the site to be operated on.", "OL": "use STEREOTAXIC TECHNIQUES to search STEREOTAXIC TECHNICS 1966-90", "PM": "91; was STEREOTAXIC TECHNICS 1965-90", "HN": "91; was STEREOTAXIC TECHNICS 1965-90", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013238"}, {"RECTYPE": "D", "MH": "Stereotyped Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Stereotyped Behaviors", "MN": "F01.145.896", "FX": "Stereotypic Movement Disorder", "MH_TH": "NLM (1973)", "ST": "T055", "AN": "human & animal", "PI": "Behavior, Animal (1966-1972)", "MS": "Relatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive.", "PM": "81; was see under BEHAVIOR 1975-80", "HN": "81(73); was see under BEHAVIOR 1975-80", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D013239"}, {"RECTYPE": "D", "MH": "Stereotyping", "ENTRY": "Stigmatization|T041|NON|REL|NLM (2019)|180523|abcdef", "MN": "F01.145.813.854", "MH_TH": "NLM (1981)", "ST": "T041", "AN": "includes both person using stereotypic thinking & person or group being stereotyped; do not confuse with STEREOTYPED BEHAVIOR", "PI": "Stereotyped Behavior (1973-1980)", "MS": "An oversimplified perception or conception especially of persons, social groups, etc.", "OL": "1981", "PM": "1981", "HN": "1981", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19800514", "DC": "1", "DX": "19810101", "UI": "D013240"}, {"RECTYPE": "D", "MH": "Sterigmatocystin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.946.587.850", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "7H-Furo(3',2':4,5)furo(2,3-c)xanthen-7-one, 3a,12c-dihydro-8-hydroxy-6-methoxy-, (3aR-cis)-", "RN": "10048-13-2", "AN": "/antag permitted but consider also ANTITOXINS;", "PI": "Xanthenes (1969-1974)", "MS": "A carcinogenic mycotoxin produced in high yields by strains of the common molds, Aspergillus versicolor, A. nidulans, and an unidentified species of Bipolaris. It causes necrosis of the liver and kidney and has an inhibitory effect on orotic acid incorporation into nuclear RNA.", "PM": "91; was see under XANTHENES 1975-90", "HN": "91(75); was see under XANTHENES 1975-90", "MR": "20160531", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013241"}, {"RECTYPE": "D", "MH": "Sterilization", "AQ": "CL EC ES HI IS LJ MT OG SN ST TD", "MN": "N06.850.780.200.450.850", "FX": "Pasteurization", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "of the environment, not sexual; differentiate from DISINFECTION: DISINFECTION renders matter free of pathogens, STERILIZATION destroys all microbes; if in doubt, use the word of the text", "MS": "The destroying of all forms of life, especially microorganisms, by heat, chemical, or other means.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013242"}, {"RECTYPE": "D", "MH": "Sterilization Reversal", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Vas Deferens Reanastomoses", "MN": "E04.950.599.500", "MH_TH": "NLM (1975)", "ST": "T061", "PI": "Vasectomy (1973-1974)", "MS": "Procedures to reverse the effect of REPRODUCTIVE STERILIZATION and to regain fertility. Reversal procedures include those used to restore the flow in the FALLOPIAN TUBE or the VAS DEFERENS.", "PM": "1975", "HN": "1975", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19750901", "UI": "D013243"}, {"RECTYPE": "D", "MH": "Sterilization, Involuntary", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Sterilizations, Involuntary", "MN": "I01.880.604.528.750", "MH_TH": "NLM (1978)", "ST": "T061", "PI": "Sterilization, Sexual (1966-1977)", "MS": "Interference of a person's reproductive ability without the consent of the person or guardian.", "PM": "91; was see under STERILIZATION, SEXUAL 1978-90", "HN": "91(78); was see under STERILIZATION, SEXUAL 1978-90", "CATSH": "CAT LIST", "MR": "20170709", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D013244"}, {"RECTYPE": "D", "MH": "Sterilization, Reproductive", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Voluntary Sterilization|T061|NON|NRW|BIOETHICS (1974)|770317|abcdef", "ENTRY": "Voluntary Sterilizations", "MN": "E04.950.599", "FX": "Population Control", "MH_TH": "NLM (2004)", "ST": "T061", "AN": "restrict to humans and vertebrates; for invertebrates, consider PEST CONTROL, BIOLOGICAL", "MS": "Procedures to block or remove all or part of the genital tract for the purpose of rendering individuals sterile, incapable of reproduction. Surgical sterilization procedures are the most commonly used. There are also sterilization procedures involving chemical or physical means.", "PM": "2004; see STERILIZATION, SEXUAL 1963-2003", "HN": "2004 (1963)", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D013245"}, {"RECTYPE": "D", "MH": "Sterilization, Tubal", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Tubal Ligation|T061|NON|NRW|NLM (1976)|750117|abcdef", "ENTRY": "Tubal Sterilizations", "MN": "E04.950.599.683", "FX": "Sterilization Reversal", "MH_TH": "NLM (1973)", "ST": "T061", "PI": "Sterilization, Sexual (1966-1972)", "MS": "Procedures that render the female sterile by interrupting the flow in the FALLOPIAN TUBE. These procedures generally are surgical, and may also use chemicals or physical means.", "PM": "1973", "HN": "1973", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013246"}, {"RECTYPE": "D", "MH": "Sternoclavicular Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Sternoclavicular Joints", "MN": "A02.835.583.781", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "A double gliding joint formed by the CLAVICLE, superior and lateral parts of the manubrium sterni at the clavicular notch, and the cartilage of the first rib.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013247"}, {"RECTYPE": "D", "MH": "Sternocostal Joints", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Sternocostal Joint", "MN": "A02.835.583.790", "MH_TH": "NLM (1975)", "ST": "T030", "MS": "An articulation where the costal cartilage of each rib fit with slight concavities along the lateral borders of the STERNUM.", "OL": "search RIBS 1966-74", "PM": "91; was see under JOINTS 1979-90; was see under RIBS 1963-78", "HN": "91(75); was see under JOINTS 1979-90; was see under RIBS 1963-78", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013248"}, {"RECTYPE": "D", "MH": "Sternum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A02.835.232.570.750", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A long, narrow, and flat bone commonly known as BREASTBONE occurring in the midsection of the anterior thoracic segment or chest region, which stabilizes the rib cage and serves as the point of origin for several muscles that move the arms, head, and neck.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013249"}, {"RECTYPE": "D", "MH": "Steroid Hydroxylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Steroid Monooxygenases|T116|T126|NON|EQV|UNK (19XX)|770205|abbcdef", "ENTRY": "Monooxygenases, Steroid", "MN": "D12.776.422.220.453.915", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 1.14.-", "AN": "general; prefer specifics", "PI": "Hydroxylases (1966-1972)", "MS": "Cytochrome P-450 monooxygenases (MIXED FUNCTION OXYGENASES) that are important in steroid biosynthesis and metabolism.", "PM": "73", "HN": "73", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013250"}, {"RECTYPE": "D", "MH": "Steroid Isomerases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "3-Oxosteroid Isomerases|T116|T126|NON|EQV|UNK (19XX)|750227|OXOSTEROID ISOMERASES 03|abbcdefs", "ENTRY": "Isomerases, Steroid", "MN": "D08.811.399.475.400.700", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 5.3.3.-", "PI": "Ketosteroids (1972-1974)", "MS": "Enzymes that catalyze the transposition of double bond(s) in a steroid molecule. EC 5.3.3.", "PM": "91; was see under ISOMERASES 1975-90", "HN": "91(75); was see under ISOMERASES 1975-90", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013251"}, {"RECTYPE": "D", "MH": "Steroid 11-beta-Hydroxylase", "DS": "STEROID HYDROXYLASE BETA 011", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Steroid 11-beta-Monooxygenase|T116|T126|NON|EQV|NLM (1978)|990101|STEROID MONOOXYGENASE BETA 011|abbcdefs", "ENTRY": "Steroid 11 beta Monooxygenase", "MN": "D12.776.422.220.453.915.750", "FX": "Adrenal Hyperplasia, Congenital", "EC": "deficiency:Adrenal Hyperplasia, Congenital", "MH_TH": "UNK (19XX)", "ST": "T126", "N1": "Steroid, reduced-adrenal-ferredoxin:oxygen oxidoreductase (11 beta-hydroxylating)", "RN": "EC 1.14.15.4", "PI": "Steroid Hydroxylases (1973-1977)", "MS": "A mitochondrial cytochrome P450 enzyme that catalyzes the 11-beta-hydroxylation of steroids in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP11B1 gene, is important in the synthesis of CORTICOSTERONE and HYDROCORTISONE. Defects in CYP11B1 cause congenital adrenal hyperplasia (ADRENAL HYPERPLASIA, CONGENITAL).", "PM": "2003; see STEROID 11 BETA-MONOOXYGENASE 1997-2002, see STEROID 11-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1990, see STEROID-11-HYDROXYLASE 1978-1989", "HN": "2003 (1978)", "MR": "20160527", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D013252"}, {"RECTYPE": "D", "MH": "Steroid 12-alpha-Hydroxylase", "DS": "STEROID HYDROXYLASE ALPHA 012", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sterol 12-alpha-Hydroxylase|T116|T126|NON|EQV|NLM (2003)|020325|STEROL HYDROXYLASE ALPHA 12|abbcdefs", "ENTRY": "alpha-Hydroxylase, Sterol 12", "MN": "D12.776.422.220.453.915.730", "MH_TH": "UNK (19XX)", "ST": "T126", "N1": "Steroid, hydrogen-donor:oxygen oxidoreductase (12-alpha-hydroxylating)", "RN": "EC 1.14.18.8", "PI": "Steroid Hydroxylases (1973-1977)", "MS": "A liver microsomal cytochrome P450 enzyme that catalyzes the 12-alpha-hydroxylation of a broad spectrum of sterols in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP8B1gene, converts 7-alpha-hydroxy-4-cholesten-3-one to 7-alpha-12-alpha-dihydroxy-4-cholesten-3-one and is required in the synthesis of BILE ACIDS from cholesterol.", "PM": "2003; see STEROID 12-MONOOXYGENASE 1997-2002, see STEROID 12-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1978-1990; for STEROID 12-MONOOXYGENASE see STEROID 12-HYDROXYLASE 1978-1996", "HN": "2003 (1978)", "MR": "20160628", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D013253"}, {"RECTYPE": "D", "MH": "Steroid 17-alpha-Hydroxylase", "DS": "STEROID HYDROXYLASE ALPHA 017", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Steroid 17-Monooxygenase|T116|T126|NON|EQV|UNK (19XX)|770405|STEROID MONOOXYGENASE 017|abbcdefs", "ENTRY": "alpha-Monooxygenase, Steroid 17", "MN": "D12.776.422.220.453.915.748", "FX": "Adrenal Hyperplasia, Congenital", "EC": "deficiency:Adrenal Hyperplasia, Congenital", "MH_TH": "NLM (2003)", "ST": "T126", "N1": "Steroid, hydrogen-donor:oxygen oxidoreductase (17 alpha-hydroxylating)", "RN": "EC 1.14.14.19", "RR": "9029-67-8 (CAS RN)", "PI": "Steroid Hydroxylases (1973-1977)", "MS": "A microsomal cytochrome P450 enzyme that catalyzes the 17-alpha-hydroxylation of progesterone or pregnenolone and subsequent cleavage of the residual two carbons at C17 in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP17 gene, generates precursors for glucocorticoid, androgen, and estrogen synthesis. Defects in CYP17 gene cause congenital adrenal hyperplasia (ADRENAL HYPERPLASIA, CONGENITAL) and abnormal sexual differentiation.", "PM": "2003; see STEROID 17 ALPHA-MONOOXYGENASE 1997-2002, see STEROID 17-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1990; for STEROID-17-HYDROXYLASE see STEROID HYDROXYLASES 1978-1989; for 17,20-LYASE see 17 ALPHA-HYDROXYPROGESTERONE ALDOLASE 1996-1997", "HN": "2003 (1978)", "MR": "20160601", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D013254"}, {"RECTYPE": "D", "MH": "Steroid 21-Hydroxylase", "DS": "STEROID HYDROXYLASE 021", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Steroid 21-Monooxygenase|T116|T126|NON|EQV|NLM (1978)|990101|STEROID MONOOXYGENASE 021|abbcdefs", "ENTRY": "Steroid 21 Monooxygenase", "MN": "D12.776.422.220.453.915.760", "EC": "deficiency:Adrenal Hyperplasia, Congenital", "MH_TH": "NLM (1997)", "ST": "T126", "N1": "Steroid,hydrogen-donor:oxygen oxidoreductase (21-hydroxylating)", "RN": "EC 1.14.14.16", "PI": "Steroid Hydroxylases (1973-1977)", "MS": "An adrenal microsomal cytochrome P450 enzyme that catalyzes the 21-hydroxylation of steroids in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP21 gene, converts progesterones to precursors of adrenal steroid hormones (CORTICOSTERONE; HYDROCORTISONE). Defects in CYP21 cause congenital adrenal hyperplasia (ADRENAL HYPERPLASIA, CONGENITAL).", "PM": "2003; see STE see STEROID 21-MONOOXYGENASE 1997-2002, see STEROID 21-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1978-1990; for STEROID 21-MONOOXYGENASE see STEROID 21-HYDROXYLASE 1978-1996; CYTOCHROME P-450 C21 was indexed under STEROID 21-HYDROXYLASE 2004 & under CYTOCHROME P-450 ENZYME SYSTEM 1996-2003", "HN": "2003 (1978)", "MR": "20160601", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D013255"}, {"RECTYPE": "D", "MH": "Steroids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Steroid|T109|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Steroids, Catatoxic", "MN": "D04.210.500", "FX": "Receptors, Steroid", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specific steroid groups or specific steroids; PLANT STEROIDS see PHYTOSTEROLS is also available", "MS": "A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed)", "PM": "1963; CATATOXIC STEROIDS was heading 1974-95", "HN": "1963; CATATOXIC STEROIDS was heading 1974-95", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D013256"}, {"RECTYPE": "D", "MH": "Steroids, Brominated", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Brominated Steroids|T109|NON|EQV|UNK (19XX)|760325|abcdef", "MN": "D04.210.500.875", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Steroids (1966-1974)", "MS": "Steroids which are substituted with one or more bromine atoms in any position.", "PM": "77; was see under STEROIDS 1975-76", "HN": "77(75); was see under STEROIDS 1975-76", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19770101", "UI": "D013257"}, {"RECTYPE": "D", "MH": "Steroids, Chlorinated", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Chlorinated Steroids|T109|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "D04.210.500.883", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Steroids which are substituted with one or more chlorine atoms in any position.", "PM": "74", "HN": "74", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013258"}, {"RECTYPE": "D", "MH": "Steroids, Fluorinated", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluorinated Steroids|T109|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "D04.210.500.908", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Steroids which are substituted with one or more fluorine atoms in any position.", "PM": "74", "HN": "74", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013259"}, {"RECTYPE": "D", "MH": "Steroids, Heterocyclic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Heterocyclic Steroids", "MN": "D04.210.500.925", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "specific steroid class compound (1968-1974)", "MS": "Steroidal compounds in which one or more carbon atoms in the steroid ring system have been substituted with non-carbon atoms.", "PM": "75", "HN": "75", "MR": "20160601", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D013260"}, {"RECTYPE": "D", "MH": "Sterols", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sterol|T109|NON|EQV|NLM (2021)|191219|abcdef", "MN": "D10.570.938", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Steroids with a hydroxyl group at C-3 and most of the skeleton of cholestane. Additional carbon atoms may be present in the side chain. (IUPAC Steroid Nomenclature, 1987)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013261"}, {"RECTYPE": "D", "MH": "Stevens-Johnson Syndrome", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Toxic Epidermal Necrolyses", "MN": "C25.100.468.380.900", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013262"}, {"RECTYPE": "D", "MH": "Stifle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Stifles", "MN": "A13.473.683", "MH_TH": "NLM (1975)", "ST": "T030", "AN": "in quadrupeds, corresponds to the human knee", "MS": "In horses, cattle, and other quadrupeds, the joint between the femur and the tibia, corresponding to the human knee.", "OL": "search HINDLIMB 1968-74", "PM": "91; was see under HINDLIMB 1975-90", "HN": "91(75); was see under HINDLIMB 1975-90", "MR": "20040713", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013264"}, {"RECTYPE": "D", "MH": "Stigmasterol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Poriferasterol|T109|T123|NON|EQV|UNK (19XX)|831014|abbcdef", "MN": "D23.704.500.808", "MH_TH": "NLM (1972)", "ST": "T123", "N1": "Stigmasta-5,22-dien-3-ol, (3beta,22E)-", "RN": "99WUK5D0Y8", "RR": "83-48-7 (Stigmasterol)", "AN": "called \"anti-stiffness factor\"", "PI": "Sterols (1966-1971)", "PM": "91; was see under PHYTOSTEROLS 1972-90", "HN": "91(72); was see under PHYTOSTEROLS 1972-90", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013265"}, {"RECTYPE": "D", "MH": "Stilbamidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.150.700.550", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "STILBENES with AMIDINES attached.", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013266"}, {"RECTYPE": "D", "MH": "Stilbenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Stilbenoids|T109|NON|EQV|NLM (2020)|190506|abcdef", "ENTRY": "Derivatives, Stilbene", "MN": "D02.455.426.559.389.150.700", "FX": "Allylbenzene Derivatives", "MH_TH": "POPLINE (1978)", "ST": "T109", "RN": "0", "MS": "Organic compounds that contain 1,2-diphenylethylene as a functional group.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013267"}, {"RECTYPE": "D", "MH": "Stimulation, Chemical", "DE": "STIMULATION CHEM", "ENTRY": "Stimulations, Chemical", "MN": "G07.690.773.996", "FX": "Enzyme Induction", "MH_TH": "NLM (1968)", "ST": "T044", "AN": "NIM", "MS": "The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013268"}, {"RECTYPE": "D", "MH": "Stochastic Processes", "ENTRY": "Processes, Stochastic", "MN": "N06.850.520.830.996", "MH_TH": "NLM (1975)", "ST": "T081", "AN": "IM general only; coordinate NIM with specific disease or other concept (IM)", "MS": "Processes that incorporate some element of randomness, used particularly to refer to a time series of random variables.", "OL": "search PROBABILITY 1968-74", "PM": "91; was see under STATISTICS 1990-90; was see under PROBABILITY 1968-89", "HN": "91(75); was see under STATISTICS 1990-90; was see under PROBABILITY 1968-89", "CATSH": "CAT LIST", "MR": "20080714", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013269"}, {"RECTYPE": "D", "MH": "Stomach", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Stomachs", "MN": "A03.556.875.875", "FX": "Gastrostomy", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at GASTR-", "MS": "An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013270"}, {"RECTYPE": "D", "MH": "Gastric Dilatation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stomach Dilatation|T047|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Dilation, Stomach", "MN": "C06.405.748.300", "MH_TH": "NLM (2005)", "ST": "T047", "MS": "Abnormal distention of the STOMACH due to accumulation of gastric contents that may reach 10 to 15 liters. Gastric dilatation may be the result of GASTRIC OUTLET OBSTRUCTION; ILEUS; GASTROPARESIS; or denervation.", "PM": "2005; see STOMACH DILATATION 1966-2004", "HN": "2005 (1966)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D013271"}, {"RECTYPE": "D", "MH": "Stomach Diseases", "DE": "STOMACH DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stomach Disease", "MN": "C06.405.748", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; inflammatory disease equals GASTRITIS", "MS": "Pathological processes involving the STOMACH.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013272"}, {"RECTYPE": "D", "MH": "Diverticulum, Stomach", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stomach Diverticulum|T190|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Stomach Diverticula", "MN": "C23.300.415.687", "FX": "Diverticulosis, Stomach", "MH_TH": "NLM (2001)", "ST": "T190", "AN": "inflamm divertic or diverticulitis: coord IM with DIVERTICULITIS (IM)", "MS": "Saccular, outward protrusion of all or a portion of the wall of the STOMACH.", "OL": "use STOMACH DIVERTICULUM to search STOMACH DIVERTICULA 1966-91", "PM": "92; was STOMACH DIVERTICULA 1963-91", "HN": "92; was STOMACH DIVERTICULA 1963-91", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D013273"}, {"RECTYPE": "D", "MH": "Stomach Neoplasms", "DE": "STOMACH NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Stomach Cancer|T191|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Stomach Neoplasm", "MN": "C06.405.748.789", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM); neopl of ruminant stomach or its parts: coord STOMACH, RUMINANT or indention (IM) with STOMACH NEOPLASMS /vet (IM) + histol type of neopl /vet (IM)", "MS": "Tumors or cancer of the STOMACH.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013274"}, {"RECTYPE": "D", "MH": "Stomach Rupture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stomach Ruptures", "MN": "C26.761.684", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Bursting of the STOMACH.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013275"}, {"RECTYPE": "D", "MH": "Stomach Ulcer", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gastric Ulcer|T047|NON|EQV|NLM (2005)|030911|abcdef", "ENTRY": "Ulcers, Stomach", "MN": "C06.405.748.586.849", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Ulceration of the GASTRIC MUCOSA due to contact with GASTRIC JUICE. It is often associated with HELICOBACTER PYLORI infection or consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013276"}, {"RECTYPE": "D", "MH": "Stomach Volvulus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Volvulus, Stomach|T020|T047|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Volvulus, Gastric", "MN": "C06.405.748.895", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Twisting of the STOMACH that may result in gastric ISCHEMIA and GASTRIC OUTLET OBSTRUCTION. It is often associated with DIAPHRAGMATIC HERNIA.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013277"}, {"RECTYPE": "D", "MH": "Stomach, Avian", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Stomachs, Avian", "MN": "A13.853", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "diseases: coordinate IM with STOMACH DISEASES /vet (IM); neoplasms: coordinate IM with STOMACH NEOPLASMS /vet (IM) + histological type of neoplasm (IM)", "PI": "Stomach (1966-1967)", "MS": "A component of the digestive system of birds which consists of the GIZZARD and PROVENTRICULUS.", "PM": "68", "HN": "68", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013278"}, {"RECTYPE": "D", "MH": "Stomach, Ruminant", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Stomachs, Ruminant", "MN": "A13.869", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "diseases: coordinate IM with STOMACH DISEASES /vet (IM); neoplasms: coordinate IM with STOMACH NEOPLASMS /vet (IM) + histological type of neoplasm (IM); ulcer: coordinate IM with STOMACH ULCER /vet (IM)", "PI": "Stomach (1966-1967)", "MS": "A component of the DIGESTIVE SYSTEM of RUMINANTS which consists of the ABOMASUM; OMASUM; RETICULUM; and RUMEN.", "PM": "68", "HN": "68", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013279"}, {"RECTYPE": "D", "MH": "Stomatitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Oral Mucositis|T047|NON|NRW|NLM (2006)|050511|abcdef", "ENTRY": "Stomatitides", "MN": "C07.465.864", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013280"}, {"RECTYPE": "D", "MH": "Stomatitis, Aphthous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ulcer, Aphthous|T047|NON|EQV|UNK (19XX)|781215|abcdef", "ENTRY": "Ulcers, Aphthous", "MN": "C07.465.864.750", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "A recurrent disease of the oral mucosa of unknown etiology. It is characterized by small white ulcerative lesions, single or multiple, round or oval. Two to eight crops of lesions occur per year, lasting for 7 to 14 days and then heal without scarring. (From Jablonski's Dictionary of Dentistry, 1992, p742)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013281"}, {"RECTYPE": "D", "MH": "Stomatitis, Denture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stomatitides, Denture", "MN": "C07.465.864.875", "MH_TH": "NLM (1972)", "ST": "T047", "AN": "coord with specific denture /adv eff; unspecified mycotic denture-sore mouth: coord IM with CANDIDIASIS, ORAL (IM)", "PI": "specific dental prosthesis/AE (1966-1971)", "MS": "Inflammation of the mouth due to denture irritation.", "PM": "91; was see under STOMATITIS 1972-90", "HN": "91(72); was see under STOMATITIS 1972-90", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013282"}, {"RECTYPE": "D", "MH": "Stomatitis, Herpetic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Herpes Simplex, Oral|T047|NON|EQV|UNK (19XX)|781219|abcdef", "ENTRY": "Stomatitides, Herpetic", "MN": "C07.465.864.937", "MH_TH": "NLM (1980)", "ST": "T047", "PI": "Stomatitis, Aphthous (1966-1979)", "MS": "Stomatitis caused by Herpesvirus hominis. It usually occurs as acute herpetic stomatitis (or gingivostomatitis), an oral manifestation of primary herpes simplex seen primarily in children and adolescents.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19781219", "DC": "1", "DX": "19800101", "UI": "D013283"}, {"RECTYPE": "D", "MH": "Stomatognathic System", "AQ": "AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Masticatory System|T022|NON|NRW|UNK (19XX)|850507|abcdef", "ENTRY": "Systems, Stomatognathic", "MN": "A14", "RH": "A14 - ANATOMY-STOMATOGNATHIC SYSTEM", "FX": "Dental Arch", "EC": "abnormalities:Stomatognathic System Abnormalities", "MH_TH": "NLM (1974)", "ST": "T022", "AN": "general or unspecified; prefer specifics", "MS": "The mouth, teeth, jaws, pharynx, and related structures as they relate to mastication, deglutition, and speech.", "PM": "1986", "HN": "1986; was MOUTH AND TEETH (NON MESH) 1975-1985", "MR": "20180612", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D013284"}, {"RECTYPE": "D", "MH": "Strabismus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Strabismus, Noncomitant|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Strabismus, Nonconcomitant", "MN": "C11.590.810", "FX": "Orthoptics", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Misalignment of the visual axes of the eyes. In comitant strabismus the degree of ocular misalignment does not vary with the direction of gaze. In noncomitant strabismus the degree of misalignment varies depending on direction of gaze or which eye is fixating on the target. (Miller, Walsh & Hoyt's Clinical Neuro-Ophthalmology, 4th ed, p641)", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013285"}, {"RECTYPE": "D", "MH": "Datura stramonium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thornapple|T002|NON|EQV|UNK (19XX)|850430|abcdef", "ENTRY": "stramoniums, Datura", "MN": "B01.875.800.575.912.250.908.500.188.800", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4076", "MS": "A plant species of the genus DATURA, family SOLANACEAE, that contains TROPANES and other SOLANACEOUS ALKALOIDS.", "PM": "2003; see STRAMONIUM 1963-2002", "HN": "2003(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20030101", "UI": "D013286"}, {"RECTYPE": "D", "MH": "Illicit Drugs", "AQ": "AE AG AN BL CF CH CL CS EC HI IM IP LJ ME PD PK PO RE SD ST TO UR", "PRINT ENTRY": "Street Drugs|T121|T131|NON|NRW|NLM (1977)|990101|abbcdef", "ENTRY": "Drugs, Street", "MN": "D26.878", "FX": "Substance-Related Disorders", "MH_TH": "UNK (19XX)", "ST": "T131", "RN": "0", "AN": "coordinate with specific drug or chemical", "PI": "Substance Abuse (1968-1976)", "MS": "Drugs that are manufactured, obtained, or sold illegally. They include prescription drugs obtained or sold without prescription and non-prescription drugs. Illicit drugs are widely distributed, tend to be grossly impure and may cause unexpected toxicity.", "PM": "2020 (1977); see DRUGS 1977-1986; STREET DRUGS 1987-2018", "HN": "2020 (1977); use DRUGS 1977-1986", "MR": "20210701", "DA": "19760416", "DC": "1", "DX": "19870101", "UI": "D013287"}, {"RECTYPE": "D", "MH": "Streptobacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.450.700", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid34104", "AN": "infection: coord IM with FUSOBACTERIUM INFECTIONS (IM) or RAT-BITE FEVER (IM) (see MeSH definition)", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that require SERUM; ASCITIC FLUID; or BLOOD for growth. Its organisms inhabit the THROAT; and NASOPHARYNX of wild and laboratory rats and cause one form of RAT-BITE FEVER in man.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013288"}, {"RECTYPE": "D", "MH": "Streptococcaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Gaffkya homari|T007|NON|NRW|UNK (19XX)|780526|abcdef", "MN": "B03.510.550.737", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid1300", "RR": "txid1377", "PI": "Micrococcaceae (1975)", "MS": "A family of gram-positive non-sporing bacteria including many parasitic, pathogenic, and saprophytic forms.", "OL": "use STREPTOCOCCACEAE & MICROCOCCUS to search GAFFKYA (all species) 1966-78", "PM": "76; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75", "HN": "76; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75", "MR": "20200813", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D013289"}, {"RECTYPE": "D", "MH": "Streptococcal Infections", "DE": "STREP INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Streptococcal Infection", "MN": "C01.150.252.410.890", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "gram-pos bact infect; coord IM with species (IM)", "MS": "Infections with bacteria of the genus STREPTOCOCCUS.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013290"}, {"RECTYPE": "D", "MH": "Streptococcus", "DE": "STREP", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1301", "AN": "general or unspecified; prefer specifics; hemolytic streptococci equals STREPTOCOCCUS unless specified in text as S. pyogenes, S. agalactiae, etc.; group A equals STREPTOCOCCUS PYOGENES; B equals STREPTOCOCCUS AGALACTIAE; D equals ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; STREPTOCOCCUS BOVIS; S. equinus (index under STREPTOCOCCUS); N equals LACTOCOCCUS LACTIS; groups E, L, M, O, R, S go under STREPTOCOCCUS; infection equals STREPTOCOCCAL INFECTIONS", "MS": "A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013291"}, {"RECTYPE": "D", "MH": "Streptococcus agalactiae", "DE": "STREP AGALACTIAE", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Streptococcus Group B|T007|NON|EQV|UNK (19XX)|760508|STREP GROUP B|abcdefv", "MN": "B03.510.550.737.872.100", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid1311", "AN": "infection: coord IM with STREPTOCOCCAL INFECTIONS (IM)", "PI": "Streptococcus (1966-1971)", "MS": "A bacterium which causes mastitis in cattle and occasionally in man.", "PM": "74", "HN": "74(72)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013292"}, {"RECTYPE": "D", "MH": "Enterococcus faecalis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Streptococcus faecalis|T007|NON|EQV|NLM (1992)|910329|STREP FAECALIS|abcdefv", "MN": "B03.510.550.250.250.280", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1351", "AN": "infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM); do not confuse with ENTEROCOCCUS FAECIUM", "MS": "A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic.", "OL": "use ENTEROCOCCUS FAECALIS to search STREPTOCOCCUS FAECALIS 1966-91", "PM": "92; was STREPTOCOCCUS FAECALIS 1963-91", "HN": "92; was STREPTOCOCCUS FAECALIS 1963-91", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D013293"}, {"RECTYPE": "D", "MH": "Lactococcus lactis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Streptococcus lactis|T007|NON|EQV|NLM (1992)|910418|STREP LACTIS|abcdefv", "ENTRY": "Lactococcus lactis subsp. lactis|T007|NON|NRW|NLM (2005)|040227|abcdef", "MN": "B03.510.550.737.500.400", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid1358", "RR": "txid1360", "PI": "Streptococcus (1966-1971)", "MS": "A non-pathogenic species of LACTOCOCCUS found in DAIRY PRODUCTS and responsible for the souring of MILK and the production of LACTIC ACID.", "OL": "use LACTOCOCCUS LACTIS to search STREPTOCOCCUS LACTIS 1972-91 (as Prov 1972-73)", "PM": "92; was STREPTOCOCCUS LACTIS 1974-91", "HN": "92(72); was STREPTOCOCCUS LACTIS 1972-91 (Prov 1972-73)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013294"}, {"RECTYPE": "D", "MH": "Streptococcus mutans", "DE": "STREP MUTANS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872.875.520", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid1309", "PI": "Streptococcus (1966-1975)", "MS": "A polysaccharide-producing species of STREPTOCOCCUS isolated from human dental plaque.", "PM": "78; was see under STREPTOCOCCUS 1976-77", "HN": "78(76); was see under STREPTOCOCCUS 1976-77", "MR": "20200813", "DA": "19750721", "DC": "1", "DX": "19780101", "UI": "D013295"}, {"RECTYPE": "D", "MH": "Streptococcus pneumoniae", "DE": "STREP PNEUMONIAE", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pneumococcus|T007|NON|EQV|UNK (19XX)|750711|abcdef", "MN": "B03.510.550.737.872.550", "FX": "Pneumococcal Infections", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid1313", "MS": "A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.", "OL": "use STREPTOCOCCUS PNEUMONIAE to search DIPLOCOCCUS PNEUMONIAE 1966-75", "PM": "76; was DIPLOCOCCUS PNEUMONIAE 1963-75", "HN": "76; was DIPLOCOCCUS PNEUMONIAE 1963-75", "MR": "20200813", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D013296"}, {"RECTYPE": "D", "MH": "Streptococcus pyogenes", "DE": "STREP PYOGENES", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Streptococcus Group A|T007|NON|EQV|UNK (19XX)|760508|STREP GROUP A|abcdefv", "ENTRY": "Bacteria, Flesh-Eating|T007|NON|NRW|NLM (1996)|950331|BACT FLESH EATING|abcdefv", "MN": "B03.510.550.737.872.575", "FX": "Streptolysins", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1314", "AN": "infection: coordinate with STREPTOCOCCAL INFECTIONS; note entry term BACTERIA, FLESH-EATING: consider also FASCIITIS, NECROTIZING", "MS": "A species of gram-positive, coccoid bacteria isolated from skin lesions, blood, inflammatory exudates, and the upper respiratory tract of humans. It is a group A hemolytic Streptococcus that can cause SCARLET FEVER and RHEUMATIC FEVER.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013297"}, {"RECTYPE": "D", "MH": "Streptococcus sanguis", "DE": "STREP SANGUIS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Streptococcus sanguinis|T007|NON|EQV|NLM (2021)|200305|abcdef", "MN": "B03.510.550.737.872.875.700", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid1305", "AN": "infection: coordinate with STREPTOCOCCAL INFECTIONS", "PI": "Streptococcus (1966-1975)", "MS": "A gram-positive organism found in dental plaque, in blood, on heart valves in subacute endocarditis, and infrequently in saliva and throat specimens. L-forms are associated with recurrent aphthous stomatitis.", "PM": "76", "HN": "76", "MR": "20200527", "DA": "19750721", "DC": "1", "DX": "19760101", "UI": "D013298"}, {"RECTYPE": "D", "MH": "Streptodornase and Streptokinase", "DE": "STREPTODORNASE STREPTOKINASE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Streptokinase and Streptodornase", "MN": "D12.776.124.125.662.537.900", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.-", "AN": "a pharm prep as ther agent combining both enzymes in a single dosage form; do not confuse with STREPTODORNASE see DEOXYRIBONUCLEASE I nor with STREPTOKINASE", "MS": "A mixture of the enzymes (streptokinase and streptodornase) produced by hemolytic streptococci. It is used topically on surface lesions and by instillation in closed body cavities to remove clotted blood or fibrinous or purulent accumulations. It is also used as a skin test antigen in evaluating generalized cell-mediated immunodeficiency. (Dorland, 27th ed) EC 3.-.", "OL": "use STREPTODORNASE AND STREPTOKINASE to search FIBRINOKINASE & PLASMINOKINASE 1963-93", "PM": "FIBRINOKINASE & PLASMINOKINASE were see STREPTODORNASE AND STREPTOKINASE 1963-93", "HN": "FIBRINOKINASE & PLASMINOKINASE were see STREPTODORNASE AND STREPTOKINASE 1963-93", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013299"}, {"RECTYPE": "D", "MH": "Streptokinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Streptodecase|T116|T121|T126|TRD|NRW|UNK (19XX)|811209|abbbcdef", "MN": "D12.776.124.125.662.537", "PA": "Fibrinolytic Agents", "FX": "Streptodornase and Streptokinase", "MH_TH": "INN (19XX)", "ST": "T126", "RN": "EC 3.4.-", "AN": "an enzyme; see note on STREPTODORNASE AND STREPTOKINASE", "MS": "Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-.", "PM": "66", "HN": "66", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013300"}, {"RECTYPE": "D", "MH": "Streptolysins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Streptolysin|T116|T123|NON|EQV|UNK (19XX)|770425|abbcdef", "MN": "D23.946.350.750", "FX": "Antistreptolysin", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "/antag permitted but consider also ANTISTREPTOLYSIN", "MS": "Exotoxins produced by certain strains of streptococci, particularly those of group A (STREPTOCOCCUS PYOGENES), that cause HEMOLYSIS.", "OL": "use STREPTOLYSINS to search STREPTOLYSIN 1966-77", "PM": "78; was STREPTOLYSIN 1963-77", "HN": "78; was STREPTOLYSIN 1963-77", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D013301"}, {"RECTYPE": "D", "MH": "Streptomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.810.768", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid1883", "AN": "the bacterium that produces many antibiotics", "MS": "A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013302"}, {"RECTYPE": "D", "MH": "Streptomyces antibioticus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.810.768.100", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid1890", "AN": "yields oleandomycin", "PI": "Streptomyces (1966-1971)", "MS": "An actinomycete from which the antibiotic OLEANDOMYCIN is obtained.", "PM": "91; was see under STREPTOMYCES 1972-90", "HN": "91(72); was see under STREPTOMYCES 1972-90", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013303"}, {"RECTYPE": "D", "MH": "Streptomyces aureofaciens", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.810.768.125", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid1894", "AN": "yields chlortetracycline", "PI": "Streptomyces (1966-1971)", "MS": "An actinomycete from which the antibiotic CHLORTETRACYCLINE is obtained.", "PM": "74", "HN": "74(72)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013304"}, {"RECTYPE": "D", "MH": "Streptomyces griseus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.810.768.375", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid1911", "AN": "yields streptomycin, candicidin & grisein", "PI": "Streptomyces (1966-1971)", "MS": "An actinomycete from which the antibiotics STREPTOMYCIN, grisein, and CANDICIDIN are obtained.", "PM": "74", "HN": "74(72)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013305"}, {"RECTYPE": "D", "MH": "Streptomycetaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.810", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid2062", "AN": "soil bacteria", "PI": "Bacteria (1966-1974)", "MS": "A family of soil bacteria. It also includes some parasitic forms.", "PM": "75", "HN": "75", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D013306"}, {"RECTYPE": "D", "MH": "Streptomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Strepto Hefa", "MN": "D09.408.051.885", "PA": "Protein Synthesis Inhibitors", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "D-Streptamine, O-2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl-(1-2)-O-5-deoxy-3-C-formyl-alpha-L-lyxofuranosyl-(1-4)-N,N'-bis(aminoiminomethyl)-", "RN": "Y45QSO73OB", "RR": "CW25IKJ202", "MS": "An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis.", "PM": "/adverse effects /poisoning /toxicity were STREPTOMYCIN TOXICOLOGY 1963-65", "HN": "/adv eff-pois-tox was STREPTOMYCIN TOXICOLOGY 1963-65", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013307"}, {"RECTYPE": "D", "MH": "Streptonigrin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rufocromomycin|T109|T195|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|750708|abbcdeeef", "ENTRY": "NSC45383", "MN": "D03.383.725.705.768", "PA": "Antibiotics, Antineoplastic", "MH_TH": "USAN (1962)", "ST": "T195", "N1": "2-Pyridinecarboxylic acid, 5-amino-6-(7-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolinyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl-", "RN": "261Q3JB310", "RR": "3930-19-6 (Streptonigrin)", "MS": "Complex cytotoxic antibiotic obtained from Streptomyces flocculus or S. rufochronmogenus. It is used in advanced carcinoma and causes leukopenia.", "PM": "73", "HN": "73(65)", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013308"}, {"RECTYPE": "D", "MH": "Streptothricins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Yazumycins|T109|T116|NON|EQV|NLM (2004)|021104|abbcdef", "ENTRY": "Streptothricin|T109|T116|NON|EQV|UNK (19XX)|760526|abbcdef", "MN": "D09.408.051.892", "MH_TH": "NLM (1975)", "ST": "T116", "N1": "Streptothricin", "RN": "54003-27-9", "RR": "56089-12-4 (nourseothricin)", "PI": "Peptides (1972-1974)", "MS": "A group of antibiotic aminoglycosides differing only in the number of repeating residues in the peptide side chain. They are produced by Streptomyces and Actinomyces and may have broad spectrum antimicrobial and some antiviral properties.", "PM": "1991; see ANTIBIOTICS, AMINOGLYCOSIDE 1978-1990; was STREPTOTHRICIN see ANTIBIOTICS 1975-77; NOURSEOTHRICIN was indexed under STREPTOTHRICINS 1975-1993; RACEMOMYCINS was indexed under RACEMOMYCIN (NM) 2000-2003", "HN": "1991(1978); use ANTIBIOTICS, AMINOGLYCOSIDE 1978-1990; was STREPTOTHRICIN use ANTIBIOTICS 1975-1977; NOURSEOTHRICIN was (NM) 1975-1993; for RACEMOMYCINS use RACEMOMYCIN (NM) 2000-2003", "MR": "20130709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013309"}, {"RECTYPE": "D", "MH": "Streptovaricin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Streptovaricins|T109|T195|NON|EQV|NLM (1995)|931118|abbcdef", "MN": "D04.345.295.750.650.700", "PA": "Antiviral Agents", "MH_TH": "INN (19XX)", "ST": "T195", "RN": "1404-74-6", "MS": "A complex of ansamycin antibiotics consisting of streptovaricins A, B, C, D, E, F, G, J, and K of which streptovaricin C is the major component. (From Merck Index, 11th ed)", "OL": "use STREPTOVARICIN to search STREPTOVARICINS 1966-94", "PM": "95; was STREPTOVARICINS 1973-94; was STREPTOVARICIN 1963-72", "HN": "95; was STREPTOVARICINS 1973-94; was STREPTOVARICIN 1963-72", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19950101", "UI": "D013310"}, {"RECTYPE": "D", "MH": "Streptozocin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Streptozotocin|T109|T195|NON|EQV|NLM (1993)|920312|abbcdef", "ENTRY": "Zanosar|T109|T195|TRD|NRW|CA|FR|US|041120|abbcdeeef", "MN": "D09.408.051.900", "PA": "Antibiotics, Antineoplastic", "MH_TH": "USAN (1975)", "ST": "T195", "N1": "D-Glucose, 2-deoxy-2-(((methylnitrosoamino)carbonyl)amino)-", "RN": "5W494URQ81", "RR": "18883-66-4 (Streptozocin)", "PI": "Nitroso Compounds (1966-1971)", "MS": "An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals.", "OL": "use STREPTOZOCIN to search STREPTOZOTOCIN 1972-92 (as Prov 1972)", "PM": "93; was STREPTOZOTOCIN 1973-92; STREPTOZOCIN was see STREPTOZOTOCIN 1977-92", "HN": "93; was STREPTOZOTOCIN 1972-92 (Prov 1972); STREPTOZOCIN was see STREPTOZOTOCIN 1977-92", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013311"}, {"RECTYPE": "D", "MH": "Stress, Physiological", "DE": "STRESS PHYSIOL", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Physiological Stress|T032|NON|EQV|NLM (2009)|080124|PHYSIOL STRESS|abcdefv", "ENTRY": "Stress, Metabolic", "MN": "G07.775", "FX": "General Adaptation Syndrome", "MH_TH": "NLM (2009)", "ST": "T032", "AN": "note category: may be used with microorganisms, plants and invertebrates", "MS": "The unfavorable effect of environmental factors (stressors) on the physiological functions of an organism. Prolonged unresolved physiological stress can affect HOMEOSTASIS of the organism, and may lead to damaging or pathological conditions.", "PM": "2009; see STRESS 1963-2008", "HN": "2009 (1963)", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D013312"}, {"RECTYPE": "D", "MH": "Stress Disorders, Post-Traumatic", "DE": "STRESS DIS POST TRAUMATIC", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Post-Traumatic Stress Disorders|T048|NON|EQV|UNK (19XX)|840621|POSTTRAUMATIC STRESS DISORDERS|POST TRAUMATIC STRESS DIS|abcdefsv", "ENTRY": "Stress Disorder, Posttraumatic", "MN": "F03.950.750.500", "FX": "Combat Disorders", "MH_TH": "NLM (1966)", "ST": "T048", "AN": "COMBAT DISORDERS is also available; SOCIAL DETERMINANTS OF HEALTH is available", "MS": "A class of traumatic stress disorders with symptoms that last more than one month.", "OL": "use STRESS DISORDERS, POST-TRAUMATIC to search NEUROSES, POST-TRAUMATIC 1966-80", "PM": "81; was NEUROSES, POST-TRAUMATIC 1963-80", "HN": "81; was NEUROSES, POST-TRAUMATIC 1963-80", "CATSH": "CAT LIST", "MR": "20210709", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D013313"}, {"RECTYPE": "D", "MH": "Stress, Mechanical", "ENTRY": "Stresses, Mechanical", "MN": "G01.374.835", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "note category: does not refer to stress response to mechanical stimuli such as vibration (= STRESS, PHYSIOLOGICAL + VIBRATION)", "PI": "Physics (1966-1970)", "MS": "A purely physical condition which exists within any material because of strain or deformation by external forces or by non-uniform thermal expansion; expressed quantitatively in units of force per unit area.", "PM": "1973", "HN": "1973 (1971)", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013314"}, {"RECTYPE": "D", "MH": "Stress, Psychological", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Stressful Conditions, Psychological|T048|NON|REL|NLM (2024)|230510|abcdef", "ENTRY": "Stressor, Individual", "MN": "F02.830.900", "FX": "Life Change Events", "MH_TH": "NLM (1969)", "ST": "T048", "AN": "human & animal; coordinate with type of stress if relevant; stress ulcer: index PEPTIC ULCER or specific + STRESS, PSYCHOLOGICAL or STRESS, PHYSIOLOGICAL ", "MS": "Stress wherein emotional factors predominate.", "PM": "1973; was STRESS, PSYCHOLOGIC 1969-1972; for EMOTIONAL STRESS see PHYCOLOGICAL DISTRESS 2023", "HN": "1973; was STRESS, PSYCHOLOGIC 1969-1972; for EMOTIONAL STRESS use 1975-2022 and PHYCOLOGICAL DISTRESS 2023", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D013315"}, {"RECTYPE": "D", "MH": "Stria Vascularis", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Vascularis, Stria", "MN": "A09.246.300.246.292.876", "MH_TH": "NLM (1979)", "ST": "T023", "PI": "Organ of Corti (1968-1978)", "MS": "A layer of stratified EPITHELIUM forming the endolymphatic border of the cochlear duct at the lateral wall of the cochlea. Stria vascularis contains primarily three cell types (marginal, intermediate, and basal), and capillaries. The marginal cells directly facing the ENDOLYMPH are important in producing ion gradients and endochoclear potential.", "PM": "91; was see under COCHLEA 1979-90", "HN": "91(79); was see under COCHLEA 1979-90", "MR": "20180702", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D013316"}, {"RECTYPE": "D", "MH": "Strikes, Employee", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Employee Strikes|T057|NON|EQV|BIOETHICS (1977)|790411|abcdef", "ENTRY": "Strike, Employee", "MN": "N04.452.677.842", "MH_TH": "NLM (1980)", "ST": "T057", "PI": "Labor Unions (1966-1970)", "MS": "Work-related situations in which the employees as a group refuse to work until certain conditions of employment are granted by the employer.", "PM": "80", "HN": "80", "MR": "19950523", "DA": "19790411", "DC": "1", "DX": "19800101", "UI": "D013317"}, {"RECTYPE": "D", "MH": "Stroke Volume", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Ventricular End-Systolic Volume|T034|T042|NON|NRW|NLM (1991)|900411|abbcdef", "ENTRY": "Volumes, Ventricular End-Systolic", "MN": "G09.330.380.124.882", "MH_TH": "NLM (1979)", "ST": "T033", "PI": "Cardiac Output (1966-1978)", "MS": "The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume.", "OL": "search CARDIAC OUTPUT 1974-78", "PM": "86; was see under CARDIAC OUTPUT 1979-85; was see CARDIAC OUTPUT 1974-78", "HN": "86(79); was see under CARDIAC OUTPUT 1979-85; was see CARDIAC OUTPUT 1974-78", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19780310", "DC": "1", "DX": "19860101", "UI": "D013318"}, {"RECTYPE": "D", "MH": "Strongyle Infections, Equine", "DE": "STRONGYLE INFECT EQUINE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Strongylosis, Equine|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Strongyloses, Equine", "MN": "C22.674.377.840", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "nematode infect; don't forget also HORSES (NIM) & check tag ANIMALS; for organism coord IM with STRONGYLUS (NIM) or other genus of superfamily STRONGYLOIDEA & its taxonomic families (NIM)", "PI": "Nematode Infections (1966-1967)", "MS": "Infection of horses with parasitic nematodes of the superfamily STRONGYLOIDEA. Characteristics include the development of hemorrhagic nodules on the abdominal peritoneum.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013319"}, {"RECTYPE": "D", "MH": "Strongyloidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Strongyloideas", "MN": "B01.050.500.500.294.400.968.710", "MH_TH": "NLM (1973)", "ST": "T204", "RN": "txid27829", "AN": "a superfamily of nematodes: do not confuse with STRONGYLIDA, an order; infection: coord IM with STRONGYLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Nematoda (1967-1972)", "MS": "A superfamily of strongyles or roundworms which are parasites in the intestinal tract of equines, pigs, rodents, and primates (including man). It includes the genera Cyasthostomum, Ransomus, Globocephalus, OESOPHAGOSTOMUM, and STRONGYLUS.", "OL": "search HOOKWORMS 1966", "PM": "73; was see under HOOKWORMS 1963-66", "HN": "73; was see under HOOKWORMS 1963-66", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013320"}, {"RECTYPE": "D", "MH": "Strongyloides", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Strongyloide", "MN": "B01.050.500.500.294.400.875.640.680", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6247", "MS": "A genus of parasitic nematodes widely distributed as intestinal parasites of mammals.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013321"}, {"RECTYPE": "D", "MH": "Strongyloidiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Anguilluliasis|T047|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Strongyloidiases", "MN": "C01.610.335.508.700.700.799", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "nematode infect caused by STRONGYLOIDES, not STRONGYLOIDEA", "MS": "Infection with nematodes of the genus STRONGYLOIDES. The presence of larvae may produce pneumonitis and the presence of adult worms in the intestine could lead to moderate to severe diarrhea.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013322"}, {"RECTYPE": "D", "MH": "Strongylus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.294.400.968.710.700", "MH_TH": "NLM (1986)", "ST": "T204", "RN": "txid40345", "AN": "a genus of nematodes; infection: coord IM with STRONGYLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Strongyloidea (1973-1985)", "MS": "A genus of intestinal parasitic nematodes occurring in animals and man.", "PM": "91; was see under STRONGYLOIDEA 1986-90", "HN": "91(86); was see under STRONGYLOIDEA 1986-90", "MR": "20200813", "DA": "19850311", "DC": "1", "DX": "19910101", "UI": "D013323"}, {"RECTYPE": "D", "MH": "Strontium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.825", "FX": "Strontium Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Strontium", "RN": "YZS2RPE8LE", "RR": "7440-24-6 (Strontium)", "MS": "An element of the alkaline earth family of metals. It has the atomic symbol Sr, atomic number 38, and atomic weight 87.62.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013324"}, {"RECTYPE": "D", "MH": "Strontium Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Strontium", "MN": "D01.552.544.825.500", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable strontium atoms that have the same atomic number as the element strontium, but differ in the atomic weight. Sr-84, 86, 87, and 88 are the stable strontium isotopes.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013325"}, {"RECTYPE": "D", "MH": "Strontium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Strontium", "MN": "D01.552.544.825.500.685", "MH_TH": "NLM (1974)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "MS": "Unstable isotopes of strontium that decay or disintegrate spontaneously emitting radiation. Sr 80-83, 85, and 89-95 are radioactive strontium isotopes.", "OL": "search STRONTIUM ISOTOPES 1966-73", "PM": "74", "HN": "74", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013326"}, {"RECTYPE": "D", "MH": "Strophanthidin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cymarigenin|T109|T123|T131|NON|EQV|UNK (19XX)|770310|abbbcdef", "ENTRY": "KStrophanthidin", "MN": "D04.210.500.155.580.130.750.800", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Card-20(22)-enolide, 3,5,14-trihydroxy-19-oxo-, (3beta,5beta)-", "RN": "66-28-4", "AN": "a cardioactive agent", "PI": "Cardanolides (1968-1974)", "MS": "3 beta,5,14-Trihydroxy-19-oxo-5 beta-card-20(22)-enolide. The aglycone cardioactive agent isolated from Strophanthus Kombe, S. gratus and other species; it is a very toxic material formerly used as digitalis. Synonyms: Apocymarin; Corchorin; Cynotoxin; Corchorgenin.", "OL": "search CARDANOLIDES 1968-74", "PM": "77; was see under STROPHANTHINS 1975-76, was see under CARDANOLIDES 1968-74", "HN": "77(75); was see under STROPHANTHINS 1975-76, was see under CARDANOLIDES 1968-74", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D013327"}, {"RECTYPE": "D", "MH": "Strophanthins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Strophanthin|T109|T121|T123|NON|NRW|UNK (19XX)|760905|abbbcdef", "MN": "D09.408.180.810", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "cardiac glycosides", "MS": "A number of different cardioactive glycosides obtained from Strophanthus species. OUABAIN is from S. gratus and CYMARINE from S. kombe. They are used like the digitalis glycosides.", "OL": "use STROPHANTHINS to search STROPHANTHIN 1972-74", "PM": "75; was STROPHANTHIN 1963-74", "HN": "75; was STROPHANTHIN 1963-74", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D013328"}, {"RECTYPE": "D", "MH": "Structure-Activity Relationship", "DE": "STRUCT ACTIV RELAT", "ENTRY": "Structure-Activity Relationships", "MN": "G07.690.773.997", "MH_TH": "NLM (1972)", "ST": "T080", "AN": "usually NIM ", "MS": "The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.", "PM": "72", "HN": "72", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013329"}, {"RECTYPE": "D", "MH": "Struma Ovarii", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "MN": "C04.557.465.910.850", "MH_TH": "NLM (1963)", "ST": "T191", "MS": "A rare teratoid tumor of the ovary composed almost entirely of thyroid tissue, with large follicles containing abundant colloid. Occasionally there are symptoms of hyperthyroidism. 5-10% of struma ovarii become malignant, the only absolute criterion for which is the presence of metastasis. (Dorland, 27th ed; Segen, Dictionary of Modern Medicine, 1992)", "PM": "67", "HN": "67(63)", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D013330"}, {"RECTYPE": "D", "MH": "Strychnine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Nitrate, Strychnine", "MN": "D03.633.100.496.500.500.681.722", "PA": "Poisons", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Strychnidin-10-one", "RN": "H9Y79VD43J", "RR": "O642E96711", "MS": "An alkaloid found in the seeds of STRYCHNOS NUX-VOMICA. It is a competitive antagonist at glycine receptors and thus a convulsant. It has been used as an analeptic, in the treatment of nonketotic hyperglycinemia and sleep apnea, and as a rat poison.", "OL": "use STRYCHNINE to search NUX VOMICA 1966-78", "PM": "NUX VOMICA was heading 1963-78", "HN": "NUX VOMICA was heading 1963-78", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013331"}, {"RECTYPE": "D", "MH": "Student Dropouts", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "School Dropouts|T098|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Student Dropout", "MN": "M01.848.602", "MH_TH": "NLM (1964)", "ST": "T098", "MS": "Individuals who leave school, secondary or college, prior to completion of specified curriculum requirements.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D013332"}, {"RECTYPE": "D", "MH": "Student Health Services", "DE": "STUDENT HEALTH SERV", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "University Health Services|T058|NON|NRW|UNK (19XX)|780426|UNIV HEALTH SERV|abcdefv", "ENTRY": "University Health Service", "MN": "N02.421.897", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "do not confuse with SCHOOL HEALTH SERVICES for high school and under; specify geog", "MS": "Health services for college and university students usually provided by the educational institution.", "OL": "use STUDENT HEALTH SERVICES to search UNIVERSITY HEALTH SERVICES 1966-78", "HN": "UNIVERSITY HEALTH SERVICES was see under STUDENT HEALTH SERVICES 1963-78", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D013333"}, {"RECTYPE": "D", "MH": "Students", "AQ": "CL HI LJ PX SN", "ENTRY": "Student", "MN": "M01.848", "EC": "education:Education", "MH_TH": "POPLINE (1978)", "ST": "T097", "MS": "Individuals enrolled in a school or formal educational program.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013334"}, {"RECTYPE": "D", "MH": "Students, Dental", "DE": "STUDENTS DENT", "AQ": "CL HI LJ PX SN", "ENTRY": "Student, Dental|T097|NON|EQV|NLM (1991)|900105|STUDENT DENT|abcdefv", "MN": "M01.848.769.519", "EC": "education:Education, Dental", "MH_TH": "NLM (1966)", "ST": "T097", "MS": "Individuals enrolled a school of dentistry or a formal educational program in leading to a degree in dentistry.", "PM": "66", "HN": "66", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013335"}, {"RECTYPE": "D", "MH": "Students, Health Occupations", "DE": "STUDENTS HEALTH OCCUP", "AQ": "CL HI LJ PX SN", "ENTRY": "Student, Health Occupations", "MN": "M01.848.769", "EC": "education:Health Occupations:education", "MH_TH": "NLM (1968)", "ST": "T097", "PI": "Students (1966-1967)", "MS": "Individuals enrolled in a school or formal educational program in the health occupations.", "PM": "68", "HN": "68", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013336"}, {"RECTYPE": "D", "MH": "Students, Medical", "DE": "STUDENTS MED", "AQ": "CL HI LJ PX SN", "ENTRY": "Student, Medical|T097|NON|EQV|NLM (1991)|891204|STUDENT MED|abcdefv", "MN": "M01.848.769.602", "EC": "education:Education, Medical", "MH_TH": "NLM (1966)", "ST": "T097", "MS": "Individuals enrolled in a school of medicine or a formal educational program in medicine.", "PM": "66", "HN": "66", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013337"}, {"RECTYPE": "D", "MH": "Students, Nursing", "DE": "STUDENTS NURS", "AQ": "CL HI LJ PX SN", "PRINT ENTRY": "Pupil Nurses|T097|NON|EQV|NLM (1998)|961022|abcdef", "ENTRY": "Pupil Nurse", "MN": "M01.848.769.685", "EC": "education:Education, Nursing", "MH_TH": "NLM (1966)", "ST": "T097", "MS": "Individuals enrolled in a school of nursing or a formal educational program leading to a degree in nursing.", "PM": "66", "HN": "66", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013338"}, {"RECTYPE": "D", "MH": "Students, Pharmacy", "DE": "STUDENTS PHARM", "AQ": "CL HI LJ PX SN", "ENTRY": "Student, Pharmacy|T097|NON|EQV|NLM (1991)|900105|STUDENT PHARM|abcdefv", "MN": "M01.848.769.768", "EC": "education:Education, Pharmacy", "MH_TH": "NLM (1968)", "ST": "T097", "PI": "Students (1966-1967)", "MS": "Individuals enrolled in a school of pharmacy or a formal educational program leading to a degree in pharmacy.", "PM": "68", "HN": "68", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013339"}, {"RECTYPE": "D", "MH": "Students, Premedical", "DE": "STUDENTS PREMED", "AQ": "CL HI LJ PX SN", "ENTRY": "Student, Premedical|T097|NON|EQV|NLM (1991)|891204|STUDENT PREMED|abcdefv", "MN": "M01.848.769.851", "EC": "education:Education, Premedical", "MH_TH": "NLM (1966)", "ST": "T097", "MS": "Individuals enrolled in a preparatory course for medical school.", "PM": "66", "HN": "66", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013340"}, {"RECTYPE": "D", "MH": "Sturge-Weber Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Phakomatosis, Sturge-Weber|T047|EPO|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Syndrome, Sturge-Weber-Krabbe", "MN": "C14.907.077.850", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A non-inherited congenital condition with vascular and neurological abnormalities. It is characterized by facial vascular nevi (PORT-WINE STAIN), and capillary angiomatosis of intracranial membranes (MENINGES; CHOROID). Neurological features include EPILEPSY; cognitive deficits; GLAUCOMA; and visual defects.", "OL": "search ANGIOMATOSIS 1966-74; use STURGE-WEBER SYNDROME to search DIMITRI DISEASE 1989-93", "PM": "91; was see under ANGIOMATOSIS 1975-90; DIMITRI DISEASE was see STURGE-WEBER SYNDROME 1989-93", "HN": "91(75); was see under ANGIOMATOSIS 1975-90; DIMITRI DISEASE was see STURGE-WEBER SYNDROME 1989-93", "CATSH": "CAT LIST", "MR": "20230426", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013341"}, {"RECTYPE": "D", "MH": "Stuttering", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Stammering|T047|NON|REL|OMIM (2013)|UNK (19XX)|740330|abcdeef", "ENTRY": "Developmental Stuttering", "MN": "C23.888.592.604.150.500.800.750", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A disturbance in the normal fluency and time patterning of speech that is inappropriate for the individual's age. This disturbance is characterized by frequent repetitions or prolongations of sounds or syllables. Various other types of speech dysfluencies may also be involved including interjections, broken words, audible or silent blocking, circumlocutions, words produced with an excess of physical tension, and monosyllabic whole word repetitions. Stuttering may occur as a developmental condition in childhood or as an acquired disorder which may be associated with BRAIN INFARCTIONS and other BRAIN DISEASES. (From DSM-IV, 1994)", "CATSH": "CAT LIST", "MR": "20141202", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013342"}, {"RECTYPE": "D", "MH": "Styrenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.150.750", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "AN": "STYRENE and POLYSTYRENES are also available", "MS": "Derivatives and polymers of styrene. They are used in the manufacturing of synthetic rubber, plastics, and resins. Some of the polymers form the skeletal structures for ion exchange resin beads.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013343"}, {"RECTYPE": "D", "MH": "Subacute Sclerosing Panencephalitis", "DE": "SUBACUTE SCLEROSING PANENCEPH", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Van Bogaert's Leukoencephalitis|T047|EPO|EQV|UNK (19XX)|780522|VAN BOGAERTS LEUKOENCEPH|abcdefv", "ENTRY": "Van Bogaerts Leukoencephalitis", "MN": "C10.586.250.520.750.600", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Cerebral Sclerosis, Diffuse (1966-1970)", "MS": "A rare, slowly progressive encephalitis caused by chronic infection with the MEASLES VIRUS. The condition occurs primarily in children and young adults, approximately 2-8 years after the initial infection. A gradual decline in intellectual abilities and behavioral alterations are followed by progressive MYOCLONUS; MUSCLE SPASTICITY; SEIZURES; DEMENTIA; autonomic dysfunction; and ATAXIA. DEATH usually occurs 1-3 years after disease onset. Pathologic features include perivascular cuffing, eosinophilic cytoplasmic inclusions, neurophagia, and fibrous gliosis. It is caused by the SSPE virus, which is a defective variant of MEASLES VIRUS. (From Adams et al., Principles of Neurology, 6th ed, pp767-8)", "OL": "use SUBACUTE SCLEROSING PANENCEPHALITIS to search VAN BOGAERT'S LEUKOENCEPHALITIS 1971-78; use CEREBRAL SCLEROSIS, DIFFUSE 1966-70", "PM": "71; VAN BOGAERT'S LEUKOENCEPHALITIS was see under SUBACUTE SCLEROSING PANENCEPHALITIS 1971-78; was see under CEREBRAL SCLEROSIS, DIFFUSE 1963-70", "HN": "71; VAN BOGAERT'S LEUKOENCEPHALITIS was see under SUBACUTE SCLEROSING PANENCEPHALITIS 1971-78; was see under CEREBRAL SCLEROSIS, DIFFUSE 1963-70", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D013344"}, {"RECTYPE": "D", "MH": "Subarachnoid Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subarachnoid Hemorrhage, Spontaneous|T046|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Subarachnoid Hemorrhages, Spontaneous", "MN": "C23.550.414.913.850", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013345"}, {"RECTYPE": "D", "MH": "Subarachnoid Space", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Subarachnoid Spaces", "MN": "A08.186.566.166.686", "MH_TH": "NLM (1966)", "ST": "T030", "AN": "NIM when merely locational", "MS": "The space between the arachnoid membrane and PIA MATER, filled with CEREBROSPINAL FLUID. It contains large blood vessels that supply the BRAIN and SPINAL CORD.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013346"}, {"RECTYPE": "D", "MH": "Subcellular Fractions", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Subcellular Fraction", "MN": "A11.284.835", "FX": "Cell Fractionation", "MH_TH": "NLM (1972)", "ST": "T026", "PI": "Microsomes (1966-1971)", "MS": "Components of a cell produced by various separation techniques which, though they disrupt the delicate anatomy of a cell, preserve the structure and physiology of its functioning constituents for biochemical and ultrastructural analysis. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p163)", "OL": "use SUBCELLULAR FRACTIONS to search HOMOGENATES 1966", "PM": "72", "HN": "72; HOMOGENATES was Prov 1964-66", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013347"}, {"RECTYPE": "D", "MH": "Subclavian Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Subclavian Arteries", "MN": "A07.015.114.839", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Artery arising from the brachiocephalic trunk on the right side and from the arch of the aorta on the left side. It distributes to the neck, thoracic wall, spinal cord, brain, meninges, and upper limb.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013348"}, {"RECTYPE": "D", "MH": "Subclavian Steal Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subclavian Artery Stenosis|T047|NON|EQV|NLM (2003)|011026|abcdef", "ENTRY": "Syndromes, Brachial-Basilar Insufficiency", "MN": "C14.907.253.092.956.700", "FX": "Coronary-Subclavian Steal Syndrome", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "do not confuse with CORONARY-SUBCLAVIAN STEAL SYNDROME", "MS": "A clinically significant reduction in blood supply to the BRAIN STEM and CEREBELLUM (i.e., VERTEBROBASILAR INSUFFICIENCY) resulting from reversal of blood flow through the VERTEBRAL ARTERY from occlusion or stenosis of the proximal subclavian or brachiocephalic artery. Common symptoms include VERTIGO; SYNCOPE; and INTERMITTENT CLAUDICATION of the involved upper extremity. Subclavian steal may also occur in asymptomatic individuals. (From J Cardiovasc Surg 1994;35(1):11-4; Acta Neurol Scand 1994;90(3):174-8)", "PM": "1965", "HN": "1965(1964)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013349"}, {"RECTYPE": "D", "MH": "Subclavian Vein", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Subclavian", "MN": "A07.015.908.877", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The continuation of the axillary vein which follows the subclavian artery and then joins the internal jugular vein to form the brachiocephalic vein.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013350"}, {"RECTYPE": "D", "MH": "Subcommissural Organ", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Subcommissural Organs", "MN": "A08.713.049.937", "MH_TH": "NLM (1977)", "ST": "T023", "PI": "Neurosecretory Systems (1970-1976)", "MS": "Ependymal derivative located at the junction of the THIRD VENTRICLE and the CEREBRAL AQUEDUCT; and the SOMATOSTATIN SECRETING CELLS.", "PM": "91; was see under NEUROSECRETORY SYSTEMS 1977-90", "HN": "91(77); was see under NEUROSECRETORY SYSTEMS 1977-90", "MR": "20150622", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D013351"}, {"RECTYPE": "D", "MH": "Subcutaneous Emphysema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Emphysema, Subcutaneous|T046|NON|EQV|UNK (19XX)|760426|abcdef", "ENTRY": "Subcutaneous Emphysemas", "MN": "C23.550.325.500", "MH_TH": "NLM (1977)", "ST": "T046", "PI": "Emphysema (1966-1976)", "MS": "Presence of air or gas in the subcutaneous tissues of the body.", "PM": "91; was see under EMPHYSEMA 1977-90", "HN": "91(77); was see under EMPHYSEMA 1977-90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D013352"}, {"RECTYPE": "D", "MH": "Subdural Effusion", "AQ": "BL CF CH CI CL CN CO CY DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subdural Cerebrospinal Fluid Effusion|T020|NON|EQV|NLM (2000)|991103|SUBDURAL CSF EFFUSION|abcdefv", "ENTRY": "Subdural Hygroma", "MN": "C10.228.228.709.675", "FX": "Meningitis", "MH_TH": "NLM (1972)", "ST": "T020", "AN": "Coord IM with specific infection (IM)", "PI": "specific meningitis/complications (1966-1971)", "MS": "Leakage and accumulation of CEREBROSPINAL FLUID in the subdural space which may be associated with an infectious process; CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; INTRACRANIAL HYPOTENSION; and other conditions.", "PM": "1991; see MENINGITIS 1972-1990", "HN": "1991(1972)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013353"}, {"RECTYPE": "D", "MH": "Empyema, Subdural", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Subdural Empyema|T047|NON|EQV|NLM (1995)|940426|abcdef", "ENTRY": "Subdural Empyemas", "MN": "C23.550.470.756.305.500", "FX": "Brain Abscess", "MH_TH": "NLM (1984)", "ST": "T047", "AN": "coordinate IM with specific infection (IM) and specific CNS infection term (IM)", "PI": "Brain Abscess (1966-1983)", "MS": "An intracranial or rarely intraspinal suppurative process invading the space between the inner surface of the DURA MATER and the outer surface of the ARACHNOID.", "PM": "1995; see SUBDURAL EMPYEMA 1984-94; for EMPYEMA, SUBDURAL see SUBDURAL EMPYEMA 1984-94", "HN": "1995(1984)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19830421", "DC": "1", "DX": "19840101", "UI": "D013354"}, {"RECTYPE": "D", "MH": "Subdural Space", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Subdural Spaces", "MN": "A08.186.566.395.687", "MH_TH": "NLM (1972)", "ST": "T030", "AN": "NIM when merely locational", "PI": "Meninges (1966-1971)", "MS": "Potential cavity which separates the ARACHNOID MATER from the DURA MATER.", "PM": "91; was see under MENINGES 1972-90", "HN": "91(72); was see under MENINGES 1972-90", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013355"}, {"RECTYPE": "D", "MH": "Subfornical Organ", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Subfornicales, Organum", "MN": "A08.713.049.968", "MH_TH": "NLM (1977)", "ST": "T023", "PI": "Neurosecretory Systems (1970-1976)", "MS": "A structure, situated close to the intraventricular foramen, which induces DRINKING BEHAVIOR after stimulation with ANGIOTENSIN II.", "PM": "91; was see under NEUROSECRETORY SYSTEMS 1977-90", "HN": "91(77); was see under NEUROSECRETORY SYSTEMS 1977-90", "MR": "20140611", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D013356"}, {"RECTYPE": "D", "MH": "Subgingival Curettage", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Periodontal Epithelial Debridement|T061|NON|EQV|NLM (2011)|091030|abcdef", "ENTRY": "Subgingival Curettages", "MN": "E06.721.874", "FX": "Periodontal Debridement", "MH_TH": "NLM (1965)", "ST": "T061", "MS": "Removal of degenerated and necrotic epithelium and underlying connective tissue of a periodontal pocket in an effort to convert a chronic ulcerated wound to an acute surgical wound, thereby insuring wound healing and attachment or epithelial adhesion, and shrinkage of the marginal gingiva. The term is sometimes used in connection with smoothing of a root surface or ROOT PLANING. (Jablonski; Illustrated Dictionary of Dentistry, 1982)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013357"}, {"RECTYPE": "D", "MH": "Subject Headings", "PRINT ENTRY": "Descriptors|T170|NON|NRW|NLM (1996)|940714|abcdef", "ENTRY": "Subject Heading", "MN": "L01.462.750.245.945.700", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "VOCABULARY, CONTROLLED is also available", "MS": "Terms or expressions which provide the major means of access by subject to the bibliographic unit.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013358"}, {"RECTYPE": "D", "MH": "Sublimation, Psychological", "ENTRY": "Psychological Sublimation", "MN": "F01.393.898", "MH_TH": "NLM (2018)", "ST": "T041", "PI": "Psychoanalytic Theory (1966-1967)", "MS": "A defense mechanism through which unacceptable impulses and instinctive urges are diverted into personally and socially acceptable channels; e.g., aggression may be diverted through sports activities.", "PM": "2018; see SUBLIMATION 1968-2017", "HN": "2018 (1968)", "CATSH": "CAT LIST", "MR": "20170428", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013359"}, {"RECTYPE": "D", "MH": "Subliminal Stimulation", "PRINT ENTRY": "Subliminal Stimulus|T068|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Subliminal Stimulations", "MN": "F02.463.593.710.750", "MH_TH": "NLM (1964)", "ST": "T068", "MS": "Stimulation at an intensity below that where a differentiated response can be elicited.", "OL": "use SUBLIMINAL STIMULATION to search SUBLIMINAL PERCEPTION 1969-78", "PM": "69", "HN": "69(64); SUBLIMINAL PERCEPTION was see under SUBLIMINAL STIMULATION 1969-78", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D013360"}, {"RECTYPE": "D", "MH": "Sublingual Gland", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sublingual Glands", "MN": "A14.549.760.687", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "diseases: coordinate with SALIVARY GLAND DISEASES", "MS": "A salivary gland on each side of the mouth below the TONGUE.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013361"}, {"RECTYPE": "D", "MH": "Sublingual Gland Neoplasms", "DE": "SUBLINGUAL GLAND NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Sublingual Gland Neoplasm", "MN": "C07.465.815.718.870", "MH_TH": "NLM (1986)", "ST": "T191", "AN": "coordinate with histological type of neoplasm", "PI": "Salivary Gland Neoplasms (1966-1985)", "MS": "Neoplasms of the sublingual glands.", "PM": "91; was see under SALIVARY GLAND NEOPLASMS 1986-90", "HN": "91(86); was see under SALIVARY GLAND NEOPLASMS 1986-90", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19850311", "DC": "1", "DX": "19910101", "UI": "D013362"}, {"RECTYPE": "D", "MH": "Submandibular Gland", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Submaxillary Gland|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Submaxillary Glands", "MN": "A14.549.760.812", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "One of two salivary glands in the neck, located in the space bound by the two bellies of the digastric muscle and the angle of the mandible. It discharges through the submandibular duct. The secretory units are predominantly serous although a few mucous alveoli, some with serous demilunes, occur. (Stedman, 25th ed)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013363"}, {"RECTYPE": "D", "MH": "Submandibular Gland Diseases", "DE": "SUBMANDIBULAR GLAND DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Submandibular Gland Disease", "MN": "C07.465.815.882", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Submandibular Gland (1966-1980)", "MS": "Diseases involving the SUBMANDIBULAR GLAND.", "PM": "91; was see under SALIVARY GLAND DISEASES 1981-90", "HN": "91(81); was see under SALIVARY GLAND DISEASES 1981-90", "CATSH": "CAT LIST", "MR": "20151009", "DA": "19800409", "DC": "1", "DX": "19910101", "UI": "D013364"}, {"RECTYPE": "D", "MH": "Submandibular Gland Neoplasms", "DE": "SUBMANDIBULAR GLAND NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Submandibular Gland Neoplasm", "MN": "C07.465.815.882.500", "MH_TH": "NLM (1981)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM)", "PI": "Submandibular Gland (1966-1980)", "MS": "New abnormal growth of tissue in the SUBMANDIBULAR GLAND.", "PM": "91; was see under SALIVARY GLAND NEOPLASMS 1981-90", "HN": "91(81); was see under SALIVARY GLAND NEOPLASMS 1981-90", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19800409", "DC": "1", "DX": "19910101", "UI": "D013365"}, {"RECTYPE": "D", "MH": "Submarine Medicine", "DE": "SUBMARINE MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Submarine|T091|NON|EQV|NLM (1991)|891205|MED SUBMARINE|abcdefv", "MN": "H02.403.560.508", "FX": "Ecological Systems, Closed", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "for medical & physiological aspects of activities of submarine personnel coordinate with SUBMARINERS see MILITARY PERSONNEL", "MS": "The field of medicine concerned with conditions affecting the health of people in submarines or sealabs.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013366"}, {"RECTYPE": "D", "MH": "Submitochondrial Particles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Submitochondrial Particle", "MN": "A11.284.835.626.882", "MH_TH": "NLM (1979)", "ST": "T026", "PI": "specific mitochondria heading", "MS": "The various filaments, granules, tubules or other inclusions within mitochondria.", "PM": "85; was see under MITOCHONDRIA 1979-84", "HN": "85(79); was see under MITOCHONDRIA 1979-84", "MR": "20030709", "DA": "19780310", "DC": "1", "DX": "19850101", "UI": "D013367"}, {"RECTYPE": "D", "MH": "Submucous Plexus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Submucosal Plexus|T023|NON|EQV|NLM (1994)|921116|abcdef", "ENTRY": "Plexus, Submucous", "MN": "A08.800.800.060.840", "MH_TH": "NLM (1965)", "ST": "T023", "AN": "a neural network of the enteric nerv syst", "MS": "One of two ganglionated neural networks which together form the enteric nervous system. The submucous (Meissner's) plexus is in the connective tissue of the submucosa. Its neurons innervate the epithelium, blood vessels, endocrine cells, other submucosal ganglia, and myenteric ganglia, and play an important role in regulating ion and water transport. (From FASEB J 1989;3:127-38)", "PM": "65", "HN": "65", "MR": "19930621", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013368"}, {"RECTYPE": "D", "MH": "Subphrenic Abscess", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Subdiaphragmatic Abscess|T047|NON|EQV|NLM (1998)|960726|abcdef", "ENTRY": "Subphrenic Abscesses", "MN": "C06.844.640.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific organism/infection term (IM) but not with BACTERIAL INFECTIONS for unspecified bacterial abscess", "MS": "Accumulation of purulent EXUDATES beneath the DIAPHRAGM, also known as upper abdominal abscess. It is usually associated with PERITONITIS or postoperative infections.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013369"}, {"RECTYPE": "D", "MH": "Subrenal Capsule Assay", "DE": "SRCA", "AQ": "EC HI IS MT SN ST VE", "PRINT ENTRY": "Subrenal Capsule Xenograft Assay|T059|NON|EQV|UNK (19XX)|870508|abcdef", "ENTRY": "Subrenal Capsule Assays", "MN": "E05.624.850.830", "MH_TH": "NLM (1988)", "ST": "T059", "PI": "Tumor Stem Cell Assay (1984-1987)", "MS": "In vivo method of screening investigative anticancer drugs and biologic response modifiers for individual cancer patients. Fresh tumor tissue is implanted under the kidney capsule of immunocompetent mice or rats; gross and histological assessments follow several days after tumor treatment in situ.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19870508", "DC": "1", "DX": "19880101", "UI": "D013370"}, {"RECTYPE": "D", "MH": "Substance P", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Substance P, Hypothalamic", "MN": "D23.529.812.900.866", "PA": "Neurotransmitter Agents", "FX": "Receptors, Neurokinin-1", "MH_TH": "NLM (1965)", "ST": "T123", "RN": "33507-63-0", "MS": "An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses.", "OL": "use SUBSTANCE P to search EULER-GADDUM SUBSTANCE P 1973-92 & HYPOTHALAMIC SUBSTANCE P 1977-92", "PM": "73; was see under PEPTIDES 1963-72; EULER-GADDUM SUBSTANCE P was see SUBSTANCE P 1973-92; HYPOTHALAMIC SUBSTANCE P was see SUBSTANCE P 1977-92", "HN": "73(65); was see under PEPTIDES 1963-72; EULER-GADDUM SUBSTANCE P was see SUBSTANCE P 1973-92; HYPOTHALAMIC SUBSTANCE P was see SUBSTANCE P 1977-92", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013373"}, {"RECTYPE": "D", "MH": "Substance Withdrawal Syndrome", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Withdrawal Symptoms|T184|NON|BRD|UNK (19XX)|740329|abcdef", "ENTRY": "Withdrawal Syndromes, Substance", "MN": "F03.900.825", "MH_TH": "NLM (1964)", "ST": "T048", "MS": "Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.", "OL": "use SUBSTANCE WITHDRAWAL SYNDROME to search DRUG WITHDRAWAL SYMPTOMS 1966-80 (as Prov 1966)", "PM": "81; was DRUG WITHDRAWAL SYMPTOMS 1967-80", "HN": "81; was DRUG WITHDRAWAL SYMPTOMS 1964-80 (Prov 1964-66)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D013375"}, {"RECTYPE": "D", "MH": "Substantia Gelatinosa", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Substantia Gelatinosas", "MN": "A11.671.650.675.800", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "Gelatinous-appearing material in the dorsal horn of the spinal cord, consisting chiefly of Golgi type II neurons and some larger nerve cells.", "OL": "use SPINAL CORD to search SUBSTANTIA GELATINOSA 1966-74 (as Prov 1966-67)", "PM": "91; was see under SPINAL CORD 1968-90", "HN": "91(75)(64-67); was see under SPINAL CORD 1964-90 (Prov 1964-67)", "MR": "20140611", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013376"}, {"RECTYPE": "D", "MH": "Substantia Innominata", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Innominata, Substantia", "MN": "A08.186.211.200.885.287.249.880", "MH_TH": "NLM (1984)", "ST": "T023", "PI": "Telencephalon (1966-1983)", "MS": "Tissue in the BASAL FOREBRAIN inferior to the anterior perforated substance, and anterior to the GLOBUS PALLIDUS and ansa lenticularis. It contains the BASAL NUCLEUS OF MEYNERT.", "PM": "91; was see under BASAL GANGLIA 1984-90", "HN": "91(84); was see under BASAL GANGLIA 1984-90", "MR": "20180630", "DA": "19830615", "DC": "1", "DX": "19910101", "UI": "D013377"}, {"RECTYPE": "D", "MH": "Substantia Nigra", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Substantia Nigras", "MN": "A08.186.211.132.659.413.656", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis.", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013378"}, {"RECTYPE": "D", "MH": "Substrate Specificity", "AQ": "DE ES GE IM PH RE", "ENTRY": "Substrate Specificities", "MN": "G02.111.835", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "almost never IM; coord NIM with specific enzyme or catalytic molecule (IM)", "MS": "A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D013379"}, {"RECTYPE": "D", "MH": "Subtalar Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Talocalcaneal Joint|T030|NON|EQV|UNK (19XX)|870402|abcdef", "ENTRY": "Talocalcaneal Joints", "MN": "A02.835.583.378.831.780", "MH_TH": "NLM (1988)", "ST": "T030", "AN": "human & animal", "MS": "Formed by the articulation of the talus with the calcaneus.", "PM": "88", "HN": "88", "MR": "20020703", "DA": "19870402", "DC": "1", "DX": "19880101", "UI": "D013380"}, {"RECTYPE": "D", "MH": "Subtilisins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Subtilisin, Carlsberg", "MN": "D08.811.277.656.959.350.787", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 3.4.21.-", "AN": "SUBTILISIN is available", "PI": "Peptide Peptidohydrolases (1966-1972)", "MS": "A family of SERINE ENDOPEPTIDASES isolated from Bacillus subtilis. EC 3.4.21.-", "PM": "74", "HN": "74(73)", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013381"}, {"RECTYPE": "D", "MH": "Subtraction Technique", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Subtraction", "MN": "E01.370.350.760", "MH_TH": "NLM (1964)", "ST": "T060", "AN": "coordinate with RADIOGRAPHY or RADIONUCLIDE IMAGING", "MS": "Combination or superimposition of two images for demonstrating differences between them (e.g., radiograph with contrast vs. one without, radionuclide images using different radionuclides, radiograph vs. radionuclide image) and in the preparation of audiovisual materials (e.g., offsetting identical images, coloring of vessels in angiograms).", "OL": "use SUBTRACTION TECHNIQUE to search SUBTRACTION TECHNIC 1966-90", "PM": "91; was SUBTRACTION TECHNIC 1973-90", "HN": "91(64); was SUBTRACTION TECHNIC 1964-90 (Prov 1964-72)", "CATSH": "CAT LIST", "MR": "20160317", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013382"}, {"RECTYPE": "D", "MH": "Suburban Population", "AQ": "CL HI SN TD", "PRINT ENTRY": "Suburban Residence|T073|NON|REL|NLM (2023)|211027|abcdef", "ENTRY": "Suburban Residences", "MN": "N01.600.775", "MH_TH": "NLM (1980)", "ST": "T098", "AN": "specify geog; SUBURBAN HEALTH & SUBURBAN HEALTH SERVICES are also available", "PI": "Urban Population (1968-1979)", "MS": "The inhabitants of peripheral or adjacent areas of a city or town.", "PM": "80", "HN": "80", "MR": "20220413", "DA": "19781222", "DC": "1", "DX": "19800101", "UI": "D013383"}, {"RECTYPE": "D", "MH": "Succinate Cytochrome c Oxidoreductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Succinate Cytochrome c Reductase|T116|T126|NON|EQV|UNK (19XX)|810713|abbcdef", "MN": "D12.776.543.277.875", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 1.-", "AN": "spell in titles & translations with lowercase c: succinate cytochrome c oxidoreductase", "PI": "Succinates (1973-1974)", "MS": "An electron transport chain complex that catalyzes the transfer of electrons from SUCCINATE to CYTOCHROME C. It includes ELECTRON TRANSPORT COMPLEX II and ELECTRON TRANSPORT COMPLEX III.", "PM": "91; was see under OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under OXIDOREDUCTASES 1975-90", "MR": "20110624", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013384"}, {"RECTYPE": "D", "MH": "Succinate Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Succinic Oxidase|T116|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Reductase, Fumarate", "MN": "D12.776.556.579.374.375.141.500", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 1.3.99.1", "MS": "A flavoprotein containing oxidoreductase that catalyzes the dehydrogenation of SUCCINATE to fumarate. In most eukaryotic organisms this enzyme is a component of mitochondrial electron transport complex II.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013385"}, {"RECTYPE": "D", "MH": "Succinates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Succinic", "MN": "D02.241.081.337.759", "FX": "Succinimides", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of SUCCINIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a 1,4-carboxy terminated aliphatic structure.", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013386"}, {"RECTYPE": "D", "MH": "Succinic Anhydrides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Anhydrides, Succinic", "MN": "D02.241.081.337.759.750", "MH_TH": "NLM (1979)", "ST": "T109", "RN": "0", "PI": "Succinates (1966-1978)", "MS": "A subclass of anhydrides with the general structure of dihydrofurandione. They can be substituted on any carbon atom. They modify and inhibit proteins and enzymes and are used in the acylation of amino- and hydroxyl groups.", "PM": "91; was see under SUCCINATES 1979-90", "HN": "91(79); was see under SUCCINATES 1979-90", "MR": "20120703", "DA": "19771222", "DC": "1", "DX": "19910101", "UI": "D013387"}, {"RECTYPE": "D", "MH": "Succinimides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pyrrolidinediones|T109|T121|NON|EQV|NLM (1998)|970422|abbcdef", "MN": "D03.383.773.812.852", "FX": "Succinates", "MH_TH": "NLM (1972)", "ST": "T121", "RN": "0", "PI": "Succinates (1966-1971)", "MS": "A subclass of IMIDES with the general structure of pyrrolidinedione. They are prepared by the distillation of ammonium succinate. They are sweet-tasting compounds that are used as chemical intermediates and plant growth stimulants.", "OL": "use SUCCINIMIDES to search PHENSUXIMIDE 1966-84 (as Prov 1966-72)", "PM": "74; PHENSUXIMIDE was heading 1973-84", "HN": "74(72); PHENSUXIMIDE was heading l963-84 (Prov l963-72)", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013388"}, {"RECTYPE": "D", "MH": "Succinate-CoA Ligases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Succinyl Coenzyme A Synthetases|T116|T126|NON|EQV|NLM (1998)|961105|abbcdef", "ENTRY": "Thiokinases, Succinic", "MN": "D08.811.464.267.500.600", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "Succinate:CoA ligase (GDP- or ADP-forming)", "RN": "EC 6.2.1.-", "PI": "Succinates (1973)", "MS": "Enzymes that catalyze the first step leading to the oxidation of succinic acid by the reversible formation of succinyl-CoA from succinate and CoA with the concomitant cleavage of ATP to ADP (EC 6.2.1.5) or GTP to GDP (EC 6.2.1.4) and orthophosphate. Itaconate can act instead of succinate and ITP instead of GTP.EC 6.2.1.-.", "PM": "98; see SUCCINYL COENZYME A SYNTHETASES 1991-97; see COENZYME A SYNTHETASES 1976-90", "HN": "98(76)", "MR": "20200527", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D013389"}, {"RECTYPE": "D", "MH": "Succinylcholine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Suxamethonium|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|760324|abbcdeef", "ENTRY": "Succinylcholine Dichloride, Di H2O", "MN": "D02.675.276.232.780", "PA": "Neuromuscular Depolarizing Agents", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Ethanaminium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy))bis(N,N,N-trimethyl)-", "RN": "J2R869A8YF", "RR": "I9L0DDD30I", "MS": "A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.", "MR": "20180614", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013390"}, {"RECTYPE": "D", "MH": "Sucking Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Sucking Behaviors", "MN": "F01.145.916", "MH_TH": "NLM (1965)", "ST": "T055", "AN": "human & animal", "MS": "Any suction exerted by the mouth; response of the mammalian infant to draw milk from the breast. Includes sucking on inanimate objects. Not to be used for thumb sucking, which is indexed under fingersucking.", "PM": "68", "HN": "68(65)", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013391"}, {"RECTYPE": "D", "MH": "Sucralfate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aluminum Sucrose Sulfate|T109|T121|NON|EQV|UNK (19XX)|860409|abbcdef", "ENTRY": "Sulfate, Aluminum Sucrose", "MN": "D09.947.750.770.850", "PA": "Anti-Ulcer Agents", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "Aluminum, hexadeca-mu-hydroxytetracosahydroxy(mu8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-)))hexadeca-", "RN": "54182-58-0", "PI": "Sucrose/analogs & derivatives (1977-1981)", "MS": "A basic aluminum complex of sulfated sucrose.", "PM": "87", "HN": "87", "MR": "20190701", "DA": "19860409", "DC": "1", "DX": "19870101", "UI": "D013392"}, {"RECTYPE": "D", "MH": "Sucrase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha-D-Glucohydrolase, Sucrose", "MN": "D08.811.277.450.329.738", "MH_TH": "NLM (1963)", "ST": "T126", "RN": "EC 3.2.1.48", "AN": "do not confuse with SUCROSE; /defic: consider also SUCROSE /metab  + CARBOHYDRATE METABOLISM, INBORN ERRORS", "MS": "Digestive enzyme secreted in the INTESTINES. It catalyzes hydrolysis of SUCROSE to FRUCTOSE and GLUCOSE.", "PM": "72", "HN": "72(63)", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013393"}, {"RECTYPE": "D", "MH": "Sucrase-Isomaltase Complex", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Isomaltase Complex, Sucrase", "MN": "D08.811.600.850", "MH_TH": "NLM (1978)", "ST": "T126", "RN": "EC 3.2.1.-", "AN": "/defic: consider also SUCROSE /metab (IM) + CARBOHYDRATE METABOLISM, INBORN ERRORS (IM)", "PI": "Sucrase (1972-1977)", "MS": "An enzyme complex found in the brush border membranes of the small intestine. It is believed to be an enzyme complex with different catalytic sites. Its absence is manifested by an inherited disease called sucrase-isomaltase deficiency.", "PM": "91; was see under MULTIENZYME COMPLEXES 1978-90", "HN": "91(78); was see under MULTIENZYME COMPLEXES 1978-90", "MR": "20040707", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D013394"}, {"RECTYPE": "D", "MH": "Sucrose", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Saccharose|T109|T123|NON|EQV|UNK (19XX)|810728|abbcdef", "MN": "D09.947.750.770", "PA": "Sweetening Agents", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "alpha-D-Glucopyranoside, beta-D-fructofuranosyl", "RN": "57-50-1", "AN": "do not confuse with SUCRASE; table sugar is DIETARY SUCROSE; sucrose density gradient is CENTRIFUGATION, DENSITY GRADIENT & ignore sucrose", "MS": "A nonreducing disaccharide composed of GLUCOSE and FRUCTOSE linked via their anomeric carbons. It is obtained commercially from SUGARCANE, sugar beet (BETA VULGARIS), and other plants and used extensively as a food and a sweetener.", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013395"}, {"RECTYPE": "D", "MH": "Suction", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Drainage, Suction|T061|NON|EQV|UNK (19XX)|760516|abcdef", "ENTRY": "Suctions", "MN": "E04.237.890", "MH_TH": "NLM (1977)", "ST": "T061", "AN": "usually NIM; note entry term DRAINAGE, SUCTION: differentiate from DRAINAGE; SUCTION LIPECTOMY see LIPECTOMY is available", "MS": "The removal of secretions, gas or fluid from hollow or tubular organs or cavities by means of a tube and a device that acts on negative pressure.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20050713", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D013396"}, {"RECTYPE": "D", "MH": "Sudan", "AQ": "EH EP", "ENTRY": "Republic of the Sudan|T083|NAM|EQV|NLM (2009)|080325|abcdef", "MN": "Z01.058.290.120.760", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "formerly the Anglo-Egyptian Sudan", "MS": "A country in northeastern Africa. The capital is Khartoum.", "MR": "20150629", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013397"}, {"RECTYPE": "D", "MH": "Sudden Infant Death", "AQ": "BL CF CL DI EH EP ET GE IM PA PC", "PRINT ENTRY": "SIDS|T033|T046|ABB|EQV|NLM (1994)|OMIM (2013)|ORD (2010)|921021|abbcdeeef", "ENTRY": "Infant Death, Sudden", "MN": "C23.550.260.657.500", "MH_TH": "NLM (1975)", "ST": "T046", "PI": "Death, Sudden (1966-1974)", "MS": "The abrupt and unexplained death of an apparently healthy infant under one year of age, remaining unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of the clinical history. (Pediatr Pathol 1991 Sep-Oct;11(5):677-84)", "OL": "use SUDDEN INFANT DEATH to search SID 1993", "PM": "75; SID was see SUDDEN INFANT DEATH 1993", "HN": "75; SID was see SUDDEN INFANT DEATH 1993", "CATSH": "CAT LIST", "MR": "20140616", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D013398"}, {"RECTYPE": "D", "MH": "Sugar Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Sugar", "MN": "D09.811", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "PI": "Carbohydrates (1966-1972)", "MS": "MONOSACCHARIDES and other sugars that contain one or more carboxylic acid moieties.", "PM": "73", "HN": "73", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013400"}, {"RECTYPE": "D", "MH": "Sugar Alcohol Dehydrogenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sugar Alcohol Oxidoreductases|T116|T126|NON|EQV|UNK (19XX)|770329|abbcdef", "ENTRY": "Oxidoreductases, Sugar Alcohol", "MN": "D08.811.682.047.150.700", "MH_TH": "NLM (1978)", "ST": "T126", "RN": "EC 1.1.-", "PI": "Alcohol Oxidoreductases (1966-1977)", "MS": "Reversibly catalyzes the oxidation of a hydroxyl group of sugar alcohols to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.; EC 1.1.2. and EC 1.1.99.", "PM": "78; ALDOSE REDUCTASE was see under ALCOHOL OXIDOREDUCTASES 1976-77; IDITOL DEHYDROGENASE was see under ALCOHOL OXIDOREDUCTASES 1977", "HN": "78", "MR": "20060705", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D013401"}, {"RECTYPE": "D", "MH": "Sugar Alcohols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sugar Alcohol|T109|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Alcohol, Sugar", "MN": "D09.853", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Alcohols (1966-1971)", "MS": "Polyhydric alcohols having no more than one hydroxy group attached to each carbon atom. They are formed by the reduction of the carbonyl group of a sugar to a hydroxyl group. (From Dorland, 28th ed)", "PM": "72", "HN": "72", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013402"}, {"RECTYPE": "D", "MH": "Sugar Phosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Phosphates, Sugar", "MN": "D09.894", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "PM": "74", "HN": "74", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013403"}, {"RECTYPE": "D", "MH": "Suggestion", "ENTRY": "Suggestions", "MN": "F04.754.424.771", "FX": "Persuasive Communication", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The uncritical acceptance of an idea or plan of action.", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013404"}, {"RECTYPE": "D", "MH": "Suicide", "AQ": "CL EC EH ES HI LJ PX SN TD", "ENTRY": "Suicides", "MN": "I01.880.735.856", "EC": "prevention & control:Suicide Prevention", "MH_TH": "NLM (1981)", "ST": "T054", "AN": "SUICIDE, ATTEMPTED and SUICIDE, COMPLETED are also available", "MS": "The act of killing oneself.", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013405"}, {"RECTYPE": "D", "MH": "Suicide, Attempted", "AQ": "CL EC EH ES HI LJ PX SN TD", "PRINT ENTRY": "Suicide Attempt|T033|NON|EQV|NLM (2022)|210122|abcdef", "ENTRY": "Parasuicides", "MN": "I01.880.735.856.600", "MH_TH": "NLM (1975)", "ST": "T033", "PI": "Suicide (1966-1974)", "MS": "The unsuccessful attempt to kill oneself.", "PM": "2019; was Self-Injurious Behavior 1975-2018", "HN": "2019; see Self-Injurious Behavior 1975-2018", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D013406"}, {"RECTYPE": "D", "MH": "Sulbactam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfone, Penicillanic Acid", "MN": "D03.633.100.300.750.812", "PA": "beta-Lactamase Inhibitors", "MH_TH": "NLM (1988)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-, 4,4-dioxide, (2S-cis)-", "RN": "S4TF6I2330", "RR": "DKQ4T82YE6", "PI": "Penicillanic Acids (1971-1987)", "MS": "A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone.", "PM": "88", "HN": "88", "MR": "20170524", "DA": "19870409", "DC": "1", "DX": "19880101", "UI": "D013407"}, {"RECTYPE": "D", "MH": "Sulbenicillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfobenzylpenicillin|T109|T195|NON|EQV|UNK (19XX)|750701|abbcdef", "ENTRY": "alpha-Sulfobenzylpenicillin, Disodium", "MN": "D03.633.100.300.750.750.875", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylsulfoacetyl)amino)-, (2S-(2alpha,5alpha,6beta(S*)))-", "RN": "Q2VYF0562D", "RR": "41744-40-5 (Sulbenicillin)", "PI": "Sulfonic Acids (1973-1975)", "MS": "Semisynthetic penicillin-type antibiotic.", "PM": "91; was see under PENICILLIN G 1976-90", "HN": "91(76); was see under PENICILLIN G 1976-90", "MR": "20170524", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D013408"}, {"RECTYPE": "D", "MH": "Sulfacetamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfacetamida, Colircusi", "MN": "D02.886.590.700.725.650", "PA": "Anti-Infective Agents, Urinary", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Acetamide, N-((4-aminophenyl)sulfonyl)-", "RN": "4965G3J0F5", "RR": "6209-17-2 (mono-Na salt)", "MS": "An anti-bacterial agent that is used topically to treat skin infections and orally for urinary tract infections.", "MR": "20180521", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013409"}, {"RECTYPE": "D", "MH": "Sulfachlorpyridazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monosodium Salt Sulfachlorpyridazine", "MN": "D02.886.590.700.725.700", "PA": "Anti-Infective Agents, Urinary", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(6-chloro-3-pyridazinyl)-", "RN": "P78D9P90C0", "RR": "80-32-0 (Sulfachlorpyridazine)", "PI": "Sulfanilamides (1974)", "MS": "A sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine.", "PM": "91; was see under SULFANILAMIDES 1975-90", "HN": "91(75); was see under SULFANILAMIDES 1975-90", "MR": "20230608", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013410"}, {"RECTYPE": "D", "MH": "Sulfadiazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfadiazine, Zinc", "MN": "D02.886.590.700.725.755", "PA": "Coccidiostats", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-", "RN": "0N7609K889", "RR": "68-35-9 (Sulfadiazine)", "AN": "METHYLSULFADIAZINE see SULFAMERAZINE is also available", "MS": "One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013411"}, {"RECTYPE": "D", "MH": "Sulfadimethoxine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulphadimethoxine|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|940728|abbcdeef", "MN": "D02.886.590.700.725.760", "PA": "Anti-Infective Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(2,6-dimethoxy-4-pyrimidinyl)-", "RN": "30CPC5LDEX", "RR": "122-11-2 (Sulfadimethoxine)", "MS": "A sulfanilamide that is used as an anti-infective agent.", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013412"}, {"RECTYPE": "D", "MH": "Sulfadoxine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulforthomidine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Ro 44393", "MN": "D02.886.590.700.725.765", "PA": "Antimalarials", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(5,6-dimethoxy-4-pyrimidinyl)-", "RN": "88463U4SM5", "RR": "2447-57-6 (Sulfadoxine)", "PI": "Sulfonamides (1971-1974)", "MS": "A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.", "PM": "91; was see under SULFANILAMIDES 1975-90", "HN": "91(75); was see under SULFANILAMIDES 1975-90", "MR": "20230608", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013413"}, {"RECTYPE": "D", "MH": "Sulfaguanidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Veto centre", "MN": "D02.886.590.700.725.810", "PA": "Anti-Infective Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(aminoiminomethyl)-", "RN": "15XQ8043FN", "RR": "57-67-0 (Sulfaguanidine)", "MS": "A sulfanilamide antimicrobial agent that is used to treat enteric infections.", "PM": "91; was see under GUANIDINES 1963-90", "HN": "91(63); was see under GUANIDINES 1963-90", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013414"}, {"RECTYPE": "D", "MH": "Sulfalene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfapyrazinmethoxine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Sulphametopyrazine|T109|T121|NON|EQV|NLM (1992)|910227|abbcdef", "MN": "D02.886.590.700.725.850", "PA": "Antimalarials", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(3-methoxypyrazinyl)-", "RN": "T6BL4ZC15G", "RR": "152-47-6 (Sulfalene)", "PI": "Sulfonamides (1971-1974)", "MS": "Long-acting plasma-bound sulfonamide used for respiratory and urinary tract infections and also for malaria.", "PM": "91; was see under SULFANILAMIDES 1975-90", "HN": "91(75); was see under SULFANILAMIDES 1975-90", "MR": "20230608", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013415"}, {"RECTYPE": "D", "MH": "Sulfamerazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylsulfadiazine|T109|T121|NON|EQV|UNK (19XX)|760324|abbcdef", "ENTRY": "Trimetox|T109|TRD|NRW|DE|060410|abcdef", "MN": "D02.886.590.700.725.853", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-", "RN": "UR1SAB295F", "RR": "127-79-7 (Sulfamerazine)", "MS": "A sulfanilamide that is used as an antibacterial agent.", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013416"}, {"RECTYPE": "D", "MH": "Sulfameter", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfametorinum|T109|T121|NON|EQV|UNK (19XX)|741211|abbcdef", "ENTRY": "Sulphamethoxydiazine|T109|T121|NON|EQV|BAN (19XX)|940728|abbcdef", "MN": "D02.886.590.700.725.857", "PA": "Leprostatic Agents", "MH_TH": "USAN (1967)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(5-methoxy-2-pyrimidinyl)-", "RN": "3L179F09D6", "RR": "651-06-9 (Sulfameter)", "PI": "Sulfanilamides (1973-1974)", "MS": "Long acting sulfonamide used in leprosy, urinary, and respiratory tract infections.", "PM": "91; was see under SULFANILAMIDES 1975-90", "HN": "91(75); was see under SULFANILAMIDES 1975-90", "MR": "20230608", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D013417"}, {"RECTYPE": "D", "MH": "Sulfamethazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulphamethazine|T109|T121|NON|EQV|NLM (2022)|210414|abbcdef", "ENTRY": "Sulphamezathine|T109|T121|NON|EQV|UNK (19XX)|810728|abbcdef", "MN": "D02.886.590.700.725.862", "PA": "Anti-Infective Agents", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "48U51W007F", "RR": "57-68-1 (Sulfamethazine)", "MS": "A sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides.", "PM": "1963; SULFAMETHOMIDINE was indexed under SULFANILAMIDES 1984-2013", "HN": "1963", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D013418"}, {"RECTYPE": "D", "MH": "Sulfamethizole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "FNA, Sulfamethizol", "MN": "D02.886.590.700.725.935.813", "PA": "Anti-Infective Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)-", "RN": "25W8454H16", "RR": "144-82-1 (Sulfamethizole)", "MS": "A sulfathiazole antibacterial agent.", "PM": "91; was see under SULFATHIAZOLES 1963-90", "HN": "91(63); was see under SULFATHIAZOLES 1963-90", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013419"}, {"RECTYPE": "D", "MH": "Sulfamethoxazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfamethylisoxazole|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Sulphamethoxazole|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|811218|abbcdeef", "MN": "D02.886.590.700.725.867", "PA": "Anti-Infective Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-", "RN": "JE42381TNV", "RR": "723-46-6 (Sulfamethoxazole)", "AN": "a sulfanilamide anti-infective", "MS": "A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)", "PM": "68", "HN": "68(63)", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013420"}, {"RECTYPE": "D", "MH": "Sulfamethoxypyridazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulphamethoxypyridazine|T109|T121|NON|EQV|BAN (19XX)|940825|abbcdef", "MN": "D02.886.590.700.725.872", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(6-methoxy-3-pyridazinyl)-", "RN": "T034E4NS2Z", "RR": "80-35-3 (Sulfamethoxypyridazine)", "MS": "A sulfanilamide antibacterial agent.", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013421"}, {"RECTYPE": "D", "MH": "Sulfamonomethoxine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.886.590.700.725.877", "PA": "Anti-Infective Agents", "MH_TH": "USAN (1963)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(6-methoxy-4-pyrimidinyl)-", "RN": "U700P169W2", "RR": "1220-83-3 (Sulfamonomethoxine)", "PI": "Sulfonamides (1969-1974)", "MS": "Long acting sulfonamide antibacterial agent.", "PM": "91; was see under SULFANILAMIDES 1975-90", "HN": "91(75); was see under SULFANILAMIDES 1975-90", "MR": "20230608", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013422"}, {"RECTYPE": "D", "MH": "Sulfamoxole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulphamoxole|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|940825|abbcdeef", "MN": "D02.886.590.700.725.882", "PA": "Anti-Infective Agents", "MH_TH": "USAN (1968)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(4,5-dimethyl-2-oxazolyl)-", "RN": "HGG82XE020", "RR": "729-99-7 (Sulfamoxole)", "MS": "A sulfanilamide antibacterial agent.", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013423"}, {"RECTYPE": "D", "MH": "Sulfanilamides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulphanilamides|T109|T121|NON|EQV|NLM (2022)|210414|abbcdef", "MN": "D02.886.590.700.725", "PA": "Anti-Infective Agents", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Compounds based on 4-aminobenzenesulfonamide. The '-anil-' part of the name refers to aniline.", "OL": "use SULFANILAMIDES to search SULFANILAMIDE 1966-74", "PM": "75; was SULFANILAMIDE 1963-74", "HN": "75; was SULFANILAMIDE 1963-74", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D013424"}, {"RECTYPE": "D", "MH": "Sulfanilic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Anilinesulfonic Acids|T109|NON|EQV|UNK (19XX)|820514|abcdef", "ENTRY": "Acids, Sulfanilic", "MN": "D02.886.645.600.080.850", "FX": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Benzenesulfonates (1974)", "MS": "Aminobenzenesulfonic acids. Organic acids that are used in the manufacture of dyes and organic chemicals and as reagents.", "OL": "use SULFANILIC ACIDS to search SULFANILIC ACID 1975-82", "PM": "91; was see under BENZENESULFONATES 1983-90; was SULFANILIC ACID see under BENZENESULFONATES 1975-82", "HN": "91(83); was see under BENZENESULFONATES 1983-90; was SULFANILIC ACID see under BENZENESULFONATES 1975-82", "MR": "20000621", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013425"}, {"RECTYPE": "D", "MH": "Sulfaphenazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfaphenylpyrazol|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Sulphaphenazole|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|940825|abbcdeef", "MN": "D03.383.129.539.925", "PA": "Anti-Infective Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(1-phenyl-1H-pyrazol-5-yl)-", "RN": "0J8L4V3F81", "RR": "526-08-9 (Sulfaphenazole)", "MS": "A sulfonilamide anti-infective agent.", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013426"}, {"RECTYPE": "D", "MH": "Sulfapyridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulphapyridine|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|940808|abbcdeef", "MN": "D02.886.590.700.725.900", "PA": "Dermatologic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-2-pyridinyl-", "RN": "Y5V2N1KE8U", "RR": "144-83-2 (Sulfapyridine)", "PI": "Sulfanilamides (1974)", "MS": "Antibacterial, potentially toxic, used to treat certain skin diseases.", "PM": "91; was see under SULFANILAMIDES 1975-90", "HN": "91(75); was see under SULFANILAMIDES 1975-90", "MR": "20230608", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013427"}, {"RECTYPE": "D", "MH": "Sulfaquinoxaline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfachinoxalin|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "MN": "D02.886.590.700.725.925", "PA": "Antiprotozoal Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-2-quinoxalinyl-", "RN": "WNW8115TM9", "RR": "59-40-5 (Sulfaquinoxaline)", "PI": "Sulfanilamides (1974)", "MS": "An antiprotozoal agent used to combat coccidial infections of swine, cattle, fowl, and other veterinary animals. Also used in controlling outbreaks of fowl typhoid and fowl cholera and in treatment of infectious enteritis.", "PM": "91; was see under SULFANILAMIDES 1975-90", "HN": "91(75); was see under SULFANILAMIDES 1975-90", "MR": "20230608", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013428"}, {"RECTYPE": "D", "MH": "Sulfatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sulfatase|T116|T126|NON|EQV|NLM (2021)|191115|abbcdef", "MN": "D08.811.277.352.827", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.1.6.-", "MS": "A class of enzymes that catalyze the hydrolysis of sulfate ESTERS.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013429"}, {"RECTYPE": "D", "MH": "Sulfate Adenylyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sulfurylase|T116|T126|NON|EQV|UNK (19XX)|780316|abbcdef", "ENTRY": "Sulfurylase, ATP", "MN": "D08.811.913.696.445.800", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "ATP:sulfate adenylyltransferase", "RN": "EC 2.7.7.4", "RR": "9012-39-9 (CAS RN)", "PI": "Transferases (1966-1967)", "MS": "An enzyme that catalyzes the activation of sulfate ions by ATP to form adenosine-5'-phosphosulfate and pyrophosphate. This reaction constitutes the first enzymatic step in sulfate utilization following the uptake of sulfate. EC 2.7.7.4.", "PM": "91; was see under NUCLEOTIDYLTRANSFERASES 1979-90", "HN": "91(79); was see under NUCLEOTIDYLTRANSFERASES 1979-90", "MR": "20030709", "DA": "19780316", "DC": "1", "DX": "19910101", "UI": "D013430"}, {"RECTYPE": "D", "MH": "Sulfates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfates, Inorganic|T197|NON|EQV|UNK (19XX)|760905|SULFATES INORG|abcdefv", "ENTRY": "Inorganic Sulfates|T197|NON|EQV|UNK (19XX)|880606|INORG SULFATES|abcdefv", "MN": "D01.875.800.800.850", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "MS": "Inorganic salts of sulfuric acid.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013431"}, {"RECTYPE": "D", "MH": "Sulfathiazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.708.725", "PA": "Anti-Infective Agents", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Sulfanilamides consisting of  a 4-aminobenzenesulfonamido group at the 2-position of 1,3-thiazole. They are often used as ANTI-INFECTIVE AGENTS.", "MR": "20160426", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013432"}, {"RECTYPE": "D", "MH": "Sulfoglycosphingolipids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfatoglycosphingolipids|T109|T123|NON|EQV|NLM (1999)|980306|abbcdef", "MN": "D10.570.877.360.025.837", "MH_TH": "NLM (1971)", "ST": "T123", "RN": "0", "PI": "Cerebrosides (1966-1970)", "MS": "GLYCOSPHINGOLIPIDS with a sulfate group esterified to one of the sugar groups.", "PM": "99; see SULFATIDES 1971-98", "HN": "99(71)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013433"}, {"RECTYPE": "D", "MH": "Sulfenic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfenic Acid|T109|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Acids, Sulfenic", "MN": "D02.886.645.575", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "MS": "Oxy acids of sulfur with the general formula RSOH, where R is an alkyl or aryl group such as CH3. They are often encountered as esters and halides. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "68", "HN": "68", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013434"}, {"RECTYPE": "D", "MH": "Sulfhemoglobin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "MN": "D12.776.422.316.762.865", "EC": "blood:Sulfhemoglobinemia", "MH_TH": "NLM (1963)", "ST": "T123", "N1": "Hemoglobins, sulf-", "RN": "9010-20-2", "PM": "65", "HN": "65(63)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013435"}, {"RECTYPE": "D", "MH": "Sulfhemoglobinemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sulfhemoglobinemias", "MN": "C15.378.896", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "sulfmethemoglobin (see Dorland) in the blood", "MS": "A morbid condition due to the presence of sulfmethemoglobin in the blood. It is marked by persistent cyanosis, but the blood count does not reveal any special abnormality in the blood. It is thought to be caused by the action of hydrogen sulfide absorbed from the intestine. (Stedman, 25th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013436"}, {"RECTYPE": "D", "MH": "Carbon-Sulfur Lyases", "DE": "C S LYASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sulfhydrases|T116|T126|NON|EQV|NLM (1998)|961127|abbcdef", "ENTRY": "Lyases, Carbon-Sulfur", "MN": "D08.811.520.300", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 4.4.-", "MS": "Enzymes that catalyze the cleavage of a carbon-sulfur bond by means other than hydrolysis or oxidation. EC 4.4.", "PM": "98; see SULFHYDRASES 1991-97, see LYASES 1975-90", "HN": "98(75)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013437"}, {"RECTYPE": "D", "MH": "Sulfhydryl Compounds", "DE": "SULFHYDRYL CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiols|T109|NON|EQV|UNK (19XX)|770520|abcdef", "ENTRY": "Compounds, Sulfhydryl", "MN": "D02.886.489", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with SULFHYDRYL REAGENTS", "MS": "Compounds containing the -SH radical.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013438"}, {"RECTYPE": "D", "MH": "Sulfhydryl Reagents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiol Reagents|T121|T130|NON|EQV|NLM (1996)|940727|abbcdef", "ENTRY": "SH Reagents", "MN": "D27.720.470.410.700", "FX": "Enzyme Inhibitors", "MH_TH": "NLM (1971)", "ST": "T130", "RN": "0", "AN": "do not confuse with SULFHYDRYL COMPOUNDS", "PI": "Sulfhydryl Compounds/antagonists & inhibitors (1968-1970)", "MS": "Chemical agents that react with SH groups. This is a chemically diverse group that is used for a variety of purposes. Among these are enzyme inhibition, enzyme reactivation or protection, and labelling.", "PM": "99; for SULFHYDRYL COMPOUND ANTAGONISTS see SULFHYDRYL COMPOUNDS ANTAGONISTS 1978-98; for SULFHYDRYL COMPOUND INHIBITORS see SULFHYDRYL COMPOUNDS INHIBITORS 1978-98", "HN": "99(72)", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013439"}, {"RECTYPE": "D", "MH": "Sulfides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thioethers|T109|NON|NRW|UNK (19XX)|780516|abcdef", "ENTRY": "Ethers, Sulfur", "MN": "D02.886.520", "MH_TH": "NLM (1966)", "ST": "T104", "RN": "0", "MS": "Chemical groups containing the covalent sulfur bonds -S-. The sulfur atom can be bound to inorganic or organic moieties.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013440"}, {"RECTYPE": "D", "MH": "Sulfinic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Sulfinic", "MN": "D02.886.645.585", "MH_TH": "NLM (1965)", "ST": "T104", "RN": "0", "AN": "do not confuse with SULFONIC ACIDS", "MS": "Any of the monobasic inorganic or organic acids of sulfur with the general formula RSO(OH). (From McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "65", "HN": "65", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013441"}, {"RECTYPE": "D", "MH": "Sulfinpyrazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfoxyphenylpyrazolidin|T109|T121|NON|EQV|UNK (19XX)|770505|abbcdef", "ENTRY": "Nu Sulfinpyrazone", "MN": "D03.383.129.539.850.777.800", "PA": "Uricosuric Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3,5-Pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)-", "RN": "V6OFU47K3W", "RR": "57-96-5 (Sulfinpyrazone)", "AN": "a uricosuric", "MS": "A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.", "PM": "65", "HN": "65(64)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013442"}, {"RECTYPE": "D", "MH": "Sulfisomidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Sulfisomidine", "MN": "D02.886.590.700.725.940", "PA": "Anti-Infective Agents", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(2,6-dimethyl-4-pyrimidinyl)-", "RN": "W03L3ODK6E", "RR": "515-64-0 (Sulfisomidine)", "MS": "A sulfanilamide antibacterial agent.", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013443"}, {"RECTYPE": "D", "MH": "Sulfisoxazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfafurazole|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|UNK (19XX)|741224|abbcdeeef", "ENTRY": "V Sul", "MN": "D02.886.590.700.725.945", "PA": "Anti-Infective Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, 4-amino-N-(3,4-dimethyl-5-isoxazolyl)-", "RN": "740T4C525W", "RR": "76849-50-8 (mono-NH4 salt)", "MS": "A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013444"}, {"RECTYPE": "D", "MH": "Sulfites", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfites, Inorganic|T197|NON|EQV|UNK (19XX)|760905|SULFITES INORG|abcdefv", "ENTRY": "Inorganic Sulfites|T197|NON|EQV|UNK (19XX)|880606|INORG SULFITES|abcdefv", "MN": "D01.875.750", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "MS": "Inorganic salts of sulfurous acid.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013447"}, {"RECTYPE": "D", "MH": "Sulfobromophthalein", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Bromsulphalein|T109|T121|T130|TRD|NRW|UNK (19XX)|740330|abbbcdef", "ENTRY": "Sodium, Sulfobromophthalein", "MN": "D02.455.426.559.389.657.625.617", "PA": "Indicators and Reagents", "MH_TH": "FDA SRS (2014)", "ST": "T130", "N1": "Benzenesulfonic acid, 3,3'-(4,5,6,7-tetrabromo-3-oxo-1(3H)-isobenzofuranylidene)bis(6-hydroxy-), disodium salt", "RN": "0C2P5QKL36", "RR": "71-67-0 (di-Na salt)", "MS": "A phenolphthalein that is used as a diagnostic aid in hepatic function determination.", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013448"}, {"RECTYPE": "D", "MH": "Sulfonamides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfonamide Mixture|T109|T121|NON|REL|NLM (2021)|191126|abbcdef", "ENTRY": "Mixtures, Sulfonamide", "MN": "D02.886.590.700", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "A group of compounds that contain the structure SO2NH2.", "OL": "use SULFONAMIDES to search SULFONAMIDE MIXTURES 1966-79", "PM": "SULFONAMIDE MIXTURES was heading 1963-79", "HN": "SULFONAMIDE MIXTURES was heading 1963-79", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013449"}, {"RECTYPE": "D", "MH": "Sulfones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfone|T109|NON|EQV|NLM (2021)|200203|abcdef", "MN": "D02.886.590", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013450"}, {"RECTYPE": "D", "MH": "Sulfonic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfonic Acid|T104|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Acids, Sulfonic", "MN": "D02.886.645.600", "MH_TH": "NLM (1966)", "ST": "T104", "RN": "0", "AN": "do not confuse with SULFINIC ACIDS", "MS": "Inorganic or organic oxy acids of sulfur which contain the RSO2(OH) radical.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013451"}, {"RECTYPE": "D", "MH": "Sulfonium Compounds", "DE": "SULFONIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfine Compounds|T109|NON|REL|UNK (19XX)|770401|SULFINE CPDS|abcdefv", "ENTRY": "Compounds, Sulfonium", "MN": "D02.886.620", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Onium Compounds (1968-1974)", "MS": "Sulfur compounds in which the sulfur atom is attached to three organic radicals and an electronegative element or radical.", "PM": "91; was see under ONIUM COMPOUNDS 1975-90", "HN": "91(75); was see under ONIUM COMPOUNDS 1975-90", "MR": "19920520", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013452"}, {"RECTYPE": "D", "MH": "Sulfonylurea Compounds", "DE": "SULFONYLUREA CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Sulfonylurea", "MN": "D02.886.590.795", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Hypoglycemic Agents (1966-1971)", "MS": "A class of compounds in which a sulfone functional group is attached to UREA.", "PM": "72", "HN": "72", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013453"}, {"RECTYPE": "D", "MH": "Sulfoxides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.886.640", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Organic compounds that have the general formula R-SO-R. They are obtained by oxidation of mercaptans (analogous to the ketones). (From Hackh's Chemical Dictionary, 4th ed)", "PM": "66", "HN": "66", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013454"}, {"RECTYPE": "D", "MH": "Sulfur", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Sulfur 16", "MN": "D01.268.185.900", "FX": "Sulfur Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Sulfur", "RN": "70FD1KFU70", "RR": "7704-34-9 (Sulfur)", "MS": "An element that is a member of the chalcogen family. It has an atomic symbol S, atomic number 16, and atomic weight [32.059; 32.076]. It is found in the amino acids cysteine and methionine.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013455"}, {"RECTYPE": "D", "MH": "Sulfur Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfurous Acids|T104|NON|NRW|NLM (1994)|921217|abcdef", "ENTRY": "Acids, Sulfurous", "MN": "D02.886.645", "MH_TH": "NLM (1994)", "ST": "T104", "RN": "0", "AN": "do not confuse with SULFURIC ACIDS", "MS": "Inorganic or organic acids that contain sulfur as an integral part of the molecule.", "OL": "use SULFUR ACIDS to search SULFUROUS ACIDS 1968-93", "PM": "94; SULFUROUS ACIDS was heading 1968-93", "HN": "94; was NON MESH 1971-93; SULFUROUS ACIDS was heading 1968-93", "MR": "19950629", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D013456"}, {"RECTYPE": "D", "MH": "Sulfur Compounds", "DE": "SULFUR CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sulfur Compound|T104|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Compounds, Sulfur", "MN": "D02.886", "MH_TH": "NLM (1966)", "ST": "T104", "RN": "0", "MS": "Inorganic or organic compounds that contain sulfur as an integral part of the molecule.", "PM": "98", "HN": "98; use explode 1968-97", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013457"}, {"RECTYPE": "D", "MH": "Sulfur Dioxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfurous Anhydride|T131|T197|NON|EQV|UNK (19XX)|821123|abbcdef", "MN": "D01.875.825.925", "PA": "Air Pollutants", "MH_TH": "NLM (1964)", "ST": "T197", "RN": "0UZA3422Q4", "RR": "7446-09-5 (Sulfur Dioxide)", "MS": "A highly toxic, colorless, nonflammable gas. It is used as a pharmaceutical aid and antioxidant. It is also an environmental air pollutant.", "PM": "66", "HN": "66(64)", "MR": "20170913", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013458"}, {"RECTYPE": "D", "MH": "Sulfur Hexafluoride", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hexafluoride, Sulfur", "MN": "D01.875.812", "MH_TH": "USAN (19XX)", "ST": "T197", "N1": "Sulfur fluoride (SF6), (OC-6-11)-", "RN": "WS7LR3I1D6", "RR": "2551-62-4 (Sulfur Hexafluoride)", "AN": "an inert gas used in resp physiol studies", "PI": "Sulfur (1966-1979)", "MS": "Sulfur hexafluoride. An inert gas used mainly as a test gas in respiratory physiology. Other uses include its injection in vitreoretinal surgery to restore the vitreous chamber and as a tracer in monitoring the dispersion and deposition of air pollutants.", "PM": "91; was see under FLUORIDES 1980-90", "HN": "91(80); was see under FLUORIDES 1980-90", "MR": "20130708", "DA": "19790525", "DC": "1", "DX": "19910101", "UI": "D013459"}, {"RECTYPE": "D", "MH": "Sulfur Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Sulfur", "MN": "D01.496.868", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable sulfur atoms that have the same atomic number as the element sulfur, but differ in atomic weight. S-33, 34, and 36 are stable sulfur isotopes.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013460"}, {"RECTYPE": "D", "MH": "Sulfur Oxides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxides, Sulfur", "MN": "D01.875.825", "MH_TH": "NLM (1975)", "ST": "T197", "RN": "0", "AN": "inorganic; SULFUR DIOXIDE is available", "PI": "Sulfur (1966-1974)", "MS": "Inorganic oxides of sulfur.", "PM": "75", "HN": "75", "MR": "19930603", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D013461"}, {"RECTYPE": "D", "MH": "Sulfur Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Sulfur", "MN": "D01.496.868.690", "MH_TH": "NLM (1974)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "MS": "Unstable isotopes of sulfur that decay or disintegrate spontaneously emitting radiation. S 29-31, 35, 37, and 38 are radioactive sulfur isotopes.", "OL": "search SULFUR ISOTOPES 1966-73", "PM": "74", "HN": "74", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013462"}, {"RECTYPE": "D", "MH": "Sulfuric Acid Esters", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiosulfuric Acid Esters|T109|NON|NRW|NLM (1994)|930210|abcdef", "ENTRY": "Esters, Thiosulfuric Acid", "MN": "D02.886.645.655.850", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "Organic esters of sulfuric acid.", "OL": "search SULFURIC ACIDS 1968-74; use SULFURIC ACIDS to search SULFATES, ORGANIC 1977-93; use SULFURIC ACID ESTERS to search THIOSULFURIC ACID ESTERS 1975-93", "PM": "91; was see under SULFURIC ACIDS 1975-90; SULFATES, ORGANIC was see SULFURIC ACIDS 1977-93; THIOSULFURIC ACID ESTERS was heading 1975-93 (see under SULFURIC ACIDS 1975-90)", "HN": "91(75); was see under SULFURIC ACIDS 1975-90; SULFATES, ORGANIC was see SULFURIC ACIDS 1977-93; THIOSULFURIC ACID ESTERS was heading 1975-93 (see under SULFURIC ACIDS 1975-90)", "MR": "19930625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013463"}, {"RECTYPE": "D", "MH": "Sulfuric Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Sulfuric", "MN": "D02.886.645.655", "MH_TH": "NLM (1968)", "ST": "T104", "RN": "0", "AN": "do not confuse with SULFUR ACIDS", "MS": "Inorganic and organic derivatives of sulfuric acid (H2SO4). The salts and esters of sulfuric acid are known as SULFATES and SULFURIC ACID ESTERS respectively.", "OL": "use SULFURIC ACIDS to search SULFURIC ACID 1966-68", "PM": "68; was SULFURIC ACID 1963-67", "HN": "68; was SULFURIC ACID 1963-67", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013464"}, {"RECTYPE": "D", "MH": "Sulfurtransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sulfurtransferase|T116|T126|NON|EQV|NLM (2022)|201006|abbcdef", "MN": "D08.811.913.817.500", "MH_TH": "NLM (1972)", "ST": "T126", "RN": "EC 2.8.1.-", "AN": "do not confuse with SULFOTRANSFERASES", "PI": "Transferases (1966-1971)", "MS": "Enzymes which transfer sulfur atoms to various acceptor molecules. EC 2.8.1.", "PM": "72", "HN": "72", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013466"}, {"RECTYPE": "D", "MH": "Sulindac", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nu Sulindac", "MN": "D04.615.486.875", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-, (Z)-", "RN": "184SNS8VUH", "RR": "38194-50-2 (Sulindac)", "PI": "Indenes (1966-1978)", "MS": "A sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects.", "PM": "90; was see under INDENES 1979-89", "HN": "90(79); was see under INDENES 1979-89", "MR": "20160701", "DA": "19780208", "DC": "1", "DX": "19900101", "UI": "D013467"}, {"RECTYPE": "D", "MH": "Suloctidil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Suloctidil Hydrochloride|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef", "MN": "D02.092.471.683.934", "PA": "Vasodilator Agents", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Benzenemethanol, 4-((1-methylethyl)thio)-alpha-(1-(octylamino)ethyl)-, (R*,S*)-", "RN": "XV1N1XY17K", "RR": "60175-02-2 (HCl)", "PI": "Propanolamines (1974-1979)", "MS": "A peripheral vasodilator that was formerly used in the management of peripheral and cerebral vascular disorders. It is hepatotoxic and fatalities have occurred. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)", "PM": "91; was see under PROPANOLAMINES 1980-90", "HN": "91(80); was see under PROPANOLAMINES 1980-90", "MR": "20130708", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D013468"}, {"RECTYPE": "D", "MH": "Sulpiride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "vertigo neogama", "MN": "D02.455.426.559.389.127.085.866", "PA": "Dopamine Antagonists", "MH_TH": "USAN (1968)", "ST": "T121", "N1": "Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-", "RN": "7MNE9M8287", "RR": "15676-16-1 (Sulpiride)", "MS": "A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)", "PM": "74", "HN": "74", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013469"}, {"RECTYPE": "D", "MH": "Sunburn", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sunburns", "MN": "C26.200.855", "FX": "Sunstroke", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "/prev: consider also SUNSCREENING AGENTS", "MS": "An injury to the skin causing erythema, tenderness, and sometimes blistering and resulting from excessive exposure to the sun. The reaction is produced by the ultraviolet radiation in sunlight.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013471"}, {"RECTYPE": "D", "MH": "Sunlight", "AQ": "AE", "ENTRY": "Sunshine|T070|NON|EQV|NLM (2010)|080826|abcdef", "MN": "N06.230.300.100.725.525", "FX": "Heliotherapy", "MH_TH": "NLM (1966)", "ST": "T070", "MS": "Irradiation directly from the sun.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013472"}, {"RECTYPE": "D", "MH": "Sunscreening Agents", "AQ": "AD AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sunscreen|T121|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Agents, Sunscreening", "MN": "D27.720.799.763.764", "FX": "Sun Protection Factor", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation.", "PM": "72", "HN": "72(66)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013473"}, {"RECTYPE": "D", "MH": "Sunstroke", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sunstrokes", "MN": "C26.522.500.500", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "HEAT STROKE is also available", "MS": "Heat stroke caused by exposure to the sun. It is characterized by dangerously high BODY TEMPERATURE; red, hot skin; DELUSIONS; CONVULSIONS; or COMA. It can be a life-threatening emergency and is most common in infants and the elderly.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013474"}, {"RECTYPE": "D", "MH": "Superego", "ENTRY": "Superegos", "MN": "F02.739.794.881", "MH_TH": "NLM (1968)", "ST": "T078", "MS": "The component of the personality associated with ethics, standards, and self-criticism - the \"conscience\". It is derived mainly from identification with parents and parent substitutes.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19890516", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013475"}, {"RECTYPE": "D", "MH": "Superfetation", "AQ": "DE GE IM PH RE", "ENTRY": "Superfetations", "MN": "G08.686.784.769.545.608", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "The FERTILIZATION of an OVUM that takes place when a FETUS is already present in the UTERUS. Superfetation results in an unusual PREGNANCY with fetuses of different ages and sizes developing in utero simultaneously.", "CATSH": "CAT LIST", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013476"}, {"RECTYPE": "D", "MH": "Superior Colliculi", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Optic Tectum|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Tectums, Optic", "MN": "A08.186.211.132.659.800.816", "MH_TH": "NLM (2008)", "ST": "T023", "AN": "note entry term OPTIC LOBE, MAMMALIAN: OPTIC LOBE, NONMAMMALIAN is also available", "PI": "Corpora Quadrigemina (1966-1970)", "MS": "The anterior pair of the quadrigeminal bodies which coordinate the general behavioral orienting responses to visual stimuli, such as whole-body turning, and reaching.", "PM": "2008; see SUPERIOR COLLICULUS 1971-2007; for OPTIC LOBE, HUMAN see CORPORA QUADRIGEMINA 2004-2007", "HN": "2008 (1971); for OPTIC LOBE, HUMAN use CORPORA QUADRIGEMINA 2004-2007", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D013477"}, {"RECTYPE": "D", "MH": "Superior Mesenteric Artery Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mesenteric Duodenal Compression Syndrome|T047|NON|EQV|UNK (19XX)|790530|abcdef", "ENTRY": "Syndrome, Wilkie", "MN": "C06.405.469.275.395.890", "FX": "Renal Nutcracker Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Mesenteric Arteries (1966-1979)", "MS": "DUODENAL OBSTRUCTION by the superior mesenteric artery (MESENTERIC ARTERY, SUPERIOR) which travels in the root of the MESENTERY and crosses over the DUODENUM. The syndrome is characterized by the dilated proximal duodenum and STOMACH, bloating, ABDOMINAL CRAMPS, and VOMITING. Often it is observed in patient with body casts after spinal surgery.", "PM": "91; was see under DUODENAL OBSTRUCTION 1980-90", "HN": "91(80); was see under DUODENAL OBSTRUCTION 1980-90", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D013478"}, {"RECTYPE": "D", "MH": "Superior Vena Cava Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Superior Vena Cava Thrombosis|T047|NON|NRW|UNK (19XX)|850320|abcdef", "ENTRY": "Thrombosis, SVC", "MN": "C14.907.800", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coordinate with the cause of the obstruction", "PI": "Vena Cava, Superior (1966-1985)", "MS": "A condition that occurs when the obstruction of the thin-walled SUPERIOR VENA CAVA interrupts blood flow from the head, upper extremities, and thorax to the RIGHT ATRIUM. Obstruction can be caused by NEOPLASMS; THROMBOSIS; ANEURYSM; or external compression. The syndrome is characterized by swelling and/or CYANOSIS of the face, neck, and upper arms which is called Pemberton's sign. Classification of SVC obstruction is often based on COLLATERAL CIRCULATION.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19850320", "DC": "1", "DX": "19860101", "UI": "D013479"}, {"RECTYPE": "D", "MH": "Superovulation", "AQ": "BL CF DE EH ES GE IM ME PH PX RE UR", "ENTRY": "Superovulations", "MN": "G08.686.784.690.768", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "note categories; qualif permitted as for PREGNANCY", "MS": "Occurrence or induction of release of more ova than are normally released at the same time in a given species. The term applies to both animals and humans.", "PM": "91; was see under OVULATION 1975-90", "HN": "91(75); was see under OVULATION 1975-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013480"}, {"RECTYPE": "D", "MH": "Superoxides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Superoxide Radical|T196|NON|EQV|UNK (19XX)|820830|abcdef", "ENTRY": "Superoxide Anion|T196|NON|EQV|UNK (19XX)|810713|abcdef", "MN": "D02.389.593.374.850", "PA": "Oxidants", "FX": "Superoxide Dismutase", "MH_TH": "NLM (1975)", "ST": "T196", "N1": "Superoxide", "RN": "11062-77-4", "PI": "Oxygen (1974)", "MS": "Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to METHEMOGLOBIN. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxides.", "OL": "use SUPEROXIDES to search SUPEROXIDE 1975-1993", "PM": "1994; was SUPEROXIDE 1975-1993 (see under OXYGEN 1975-1983)", "HN": "1994; was SUPEROXIDE 1975-1993 (see under OXYGEN 1975-1983)", "MR": "20230226", "DA": "19741111", "DC": "1", "DX": "19840101", "UI": "D013481"}, {"RECTYPE": "D", "MH": "Superoxide Dismutase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hemocuprein|T116|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Superoxide Dismutase, Manganese", "MN": "D08.811.682.881", "PA": "Free Radical Scavengers", "MH_TH": "NLM (1973)", "ST": "T126", "N1": "Superoxide:superoxide oxidoreductase", "RN": "EC 1.15.1.1", "PI": "Oxidoreductases (1966-1972)", "MS": "An oxidoreductase that catalyzes the reaction between SUPEROXIDES and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide.", "PM": "74", "HN": "74(73)", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013482"}, {"RECTYPE": "D", "MH": "Superstitions", "AQ": "HI PX", "ENTRY": "Superstition", "MN": "I01.076.201.450.897", "MH_TH": "NLM (1966)", "ST": "T078", "MS": "A belief or practice which lacks adequate basis for proof; an embodiment of fear of the unknown, magic, and ignorance.", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013483"}, {"RECTYPE": "D", "MH": "Supination", "AQ": "PH", "ENTRY": "Supinations", "MN": "G11.427.410.698.920", "MH_TH": "NLM (1988)", "ST": "T040", "AN": "refers to foot or forearm; do not confuse with SUPINE POSITION", "PI": "Posture (1966-1987)", "MS": "Applies to movements of the forearm in turning the palm forward or upward. When referring to the foot, a combination of adduction and inversion movements of the foot.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19870406", "DC": "1", "DX": "19880101", "UI": "D013484"}, {"RECTYPE": "D", "MH": "Research Support, Non-U.S. Gov't", "DE": "SUP NON GOVT", "ENTRY": "Support, Non-U.S. Govt|T052|NON|EQV|UNK (19XX)|810326|abcdef", "MN": "V04.124", "MH_TH": "NLM (1981)", "ST": "T052", "AN": "for all articles noted as supported by American sources (societies, institutes, state governments, universities, private organizations, etc.) or by foreign sources (national, departmental, provincial, academic & private organizations, etc); CATALOGER: Used by collaborating partners only", "MS": "Acknowledgement that funding support is from any non-US government agency, for example state and local governments, foreign governments, and private organizations.", "HN": "2005 (1981)", "MR": "20171211", "DA": "19800307", "DC": "2", "DX": "19810101", "UI": "D013485"}, {"RECTYPE": "D", "MH": "Research Support, U.S. Gov't, Non-P.H.S.", "PRINT ENTRY": "United States Gov't Supported, Non-P.H.S.|T064|NON|REL|UNK (19XX)|800513|NON PHS SUP|abcdefv", "ENTRY": "Support, U.S. Govt, Non-P.H.S.|T064|NON|REL|UNK (19XX)|810326|abcdef", "MN": "V04.750.249", "MH_TH": "NLM (2005)", "ST": "T064", "AN": "for all articles noted as supported by U.S. Government agencies (DOD, DOE, etc.) other than PHS (which is RESEARCH SUPPORT, U.S. GOV'T, P.H.S.) & NIH (which is RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL); National Science Foundation support is checked here, National Academy of Sciences & National Research Council support are checked RESEARCH SUPPORT, NON-U.S. GOV'T; CATALOGER: Used by collaborating partners only", "MS": "Acknowledgment that funding support is from any US government agency other than the Public Health Service, such as the National Science Foundation, NASA, Department of Energy, etc.", "HN": "2005; was SUPPORT, U.S. Gov't, Non-P.H.S. 1981-2004; was UNITED STATES GOV'T SUPPORTED (used for U.S. gov't agencies other than P.H.S.) 1979-1980; UNITED STATES GOV'T SUPPORTED, N.I.H. & UNITED STATES GOV'T SUPPORTED, NON-N.I.H. were headings 1978, were headings having slightly different forms 1975-77 (UNITED STATES was U.S. 1977; GOV'T WAS GOVERNMENT 1975-1976)", "MR": "20171211", "DA": "19750204", "DC": "2", "DX": "19790101", "UI": "D013486"}, {"RECTYPE": "D", "MH": "Research Support, U.S. Gov't, P.H.S.", "PRINT ENTRY": "United States Gov't Supported, P.H.S.|T064|NON|REL|UNK (19XX)|800513|GOVT SUP PHS|abcdefv", "ENTRY": "Support, U.S. Govt, P.H.S.|T064|REL|UNK (19XX)|810326|abdef", "MN": "V04.750.500", "MH_TH": "NLM (2005)", "ST": "T064", "AN": "for all articles noted as supported by PHS & its bureaus & services but support by NIH is either RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; support by BRSG (Biomedical Research Support Grants) goes here; CATALOGER: Used by collaborating partners only", "MS": "Acknowledgement that funding support is from any component of the Public Health Service.", "HN": "2005; was SUPPORT, U.S. Gov't P.H.S 1981-2004; was UNITED STATES GOV'T SUPPORTED, P.H.S. 1979-1980; UNITED STATES GOV'T SUPPORTED, N.I.H. & UNITED STATES GOV'T SUPPORTED, NON-N.I.H. were headings 1978, were headings having slightly different forms 1975-1977 (UNITED STATES was U.S. 1977; GOV'T was GOVERNMENT 1975-1976)", "MR": "20171211", "DA": "19750204", "DC": "2", "DX": "19790101", "UI": "D013487"}, {"RECTYPE": "D", "MH": "Suppositories", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Vaginal Suppositories|T122|NON|NRW|UNK (19XX)|860604|abcdef", "ENTRY": "Suppository, Vaginal", "MN": "D26.255.785", "FX": "Rectal Absorption", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "AN": "IM GEN only; coord NIM (no qualif) with specific drug IM", "MS": "Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature.", "MR": "20140606", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013488"}, {"RECTYPE": "D", "MH": "Suppression, Genetic", "DE": "SUPPRESSION GENET", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Suppressor Mutation|T045|NON|NRW|UNK (19XX)|781222|abcdef", "ENTRY": "Suppressor Mutations", "MN": "G05.558.835", "MH_TH": "NLM (1968)", "ST": "T045", "PI": "Genes, Suppressor (1968-1979)", "MS": "Mutation process that restores the wild-type PHENOTYPE in an organism possessing a mutationally altered GENOTYPE. The second \"suppressor\" mutation may be on a different gene, on the same gene but located at a distance from the site of the primary mutation, or in extrachromosomal genes (EXTRACHROMOSOMAL INHERITANCE).", "PM": "80; was GENES, SUPPRESSOR 1970-79", "HN": "80; was GENES, SUPPRESSOR 1968-79 (Prov 1968-69)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D013489"}, {"RECTYPE": "D", "MH": "Suppressor Factors, Immunologic", "DE": "SUPPRESSOR FACTORS IMMUNOL", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "T-Suppressor Factors|T116|T129|NON|EQV|UNK (19XX)|850614|abbcdef", "ENTRY": "T-Cell Factors, Suppressor", "MN": "D23.529.374.480.700", "MH_TH": "NLM (1986)", "ST": "T129", "RN": "0", "PI": "Suppressor Cells (1979-1985)", "MS": "Proteins, protein complexes, or glycoproteins secreted by suppressor T-cells that inhibit either subsequent T-cells, B-cells, or other immunologic phenomena. Some of these factors have both histocompatibility (I-J) and antigen-specific domains which may be linked by disulfide bridges. They can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory.", "PM": "86", "HN": "86", "MR": "20060705", "DA": "19850614", "DC": "1", "DX": "19860101", "UI": "D013491"}, {"RECTYPE": "D", "MH": "Suppuration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pus|T031|T184|NON|REL|UNK (19XX)|740330|abbcdef", "MN": "C23.550.470.756", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "NIM; TN 178: for suppurative dis & coord", "MS": "A pathologic process consisting in the formation of pus.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013492"}, {"RECTYPE": "D", "MH": "Suprachiasmatic Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Suprachiasmatic Nucleus, Hypothalamic", "MN": "A08.186.211.200.317.357.342.625", "MH_TH": "NLM (1983)", "ST": "T023", "PI": "Hypothalamus (1966-1982)", "MS": "An ovoid densely packed collection of small cells of the anterior hypothalamus lying close to the midline in a shallow impression of the OPTIC CHIASM.", "PM": "83", "HN": "83", "MR": "20180630", "DA": "19820428", "DC": "1", "DX": "19830101", "UI": "D013493"}, {"RECTYPE": "D", "MH": "Supranuclear Palsy, Progressive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Steele-Richardson-Olszewski Syndrome|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|860401|abcdeeeef", "ENTRY": "Supranuclear Palsies, Progressive", "MN": "C23.888.592.636.447.690", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Paralysis, Bulbar (1966-1986)", "MS": "A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)", "PM": "1987", "HN": "1987", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19860401", "DC": "1", "DX": "19870101", "UI": "D013494"}, {"RECTYPE": "D", "MH": "Supraoptic Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Supraopticus, Nucleus", "MN": "A08.186.211.200.317.357.342.650", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "Hypothalamic nucleus overlying the beginning of the OPTIC TRACT.", "PM": "83; was see under HYPOTHALAMUS 1975-82", "HN": "83(75); was see under HYPOTHALAMUS 1975-82", "MR": "20180630", "DA": "19741111", "DC": "1", "DX": "19830101", "UI": "D013495"}, {"RECTYPE": "D", "MH": "Suprofen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TN762", "MN": "D02.241.223.701.700", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzeneacetic acid, alpha-methyl-4-(2-thienylcarbonyl)-", "RN": "988GU2F9PE", "RR": "40828-46-4 (Suprofen)", "PI": "Thiophenes (1966-1977)", "MS": "An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It inhibits prostaglandin synthesis and has been proposed as an anti-arthritic.", "PM": "90; was see under PHENYLPROPIONATES 1978-89", "HN": "90(78); was see under PHENYLPROPIONATES 1978-89", "MR": "20130708", "DA": "19770422", "DC": "1", "DX": "19900101", "UI": "D013496"}, {"RECTYPE": "D", "MH": "Sural Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sural Nerves", "MN": "A08.800.800.720.450.760.820.820", "MH_TH": "NLM (1971)", "ST": "T023", "AN": "dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES (IM); neopl: coord IM with PERIPHERAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "PI": "Spinal Nerves (1966-1970)", "MS": "A branch of the tibial nerve which supplies sensory innervation to parts of the lower leg and foot.", "PM": "91; was see under SPINAL NERVES 1971-90", "HN": "91(71); was see under SPINAL NERVES 1971-90", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013497"}, {"RECTYPE": "D", "MH": "Suramin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Suramin", "MN": "D04.615.638.555.750", "PA": "Trypanocidal Agents", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "1,3,5-Naphthalenetrisulfonic acid, 8,8'-(carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bis-", "RN": "6032D45BEM", "RR": "89521262IH", "MS": "A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013498"}, {"RECTYPE": "D", "MH": "Surface Properties", "AQ": "DE RE", "ENTRY": "Surface Property", "MN": "G02.860", "MH_TH": "NLM (1968)", "ST": "T070", "AN": "NIM", "MS": "Characteristics or attributes of the outer boundaries of objects, including molecules.", "PM": "70", "HN": "70(68)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D013499"}, {"RECTYPE": "D", "MH": "Surface Tension", "AQ": "DE RE", "ENTRY": "Tensions, Surface", "MN": "G02.860.816", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "NIM", "MS": "The force acting on the surface of a liquid, tending to minimize the area of the surface. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013500"}, {"RECTYPE": "D", "MH": "Surface-Active Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tenside|T121|NON|NRW|NLM (2021)|191115|abcdef", "ENTRY": "Agents, Surface-Active", "MN": "D27.720.877", "FX": "Pulmonary Surfactants", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "MS": "Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics.", "PM": "1963; TENSIDES was indexed under SURFACE ACTIVE AGENTS 1973-2004", "HN": "1963", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D013501"}, {"RECTYPE": "D", "MH": "General Surgery", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Surgery|T091|NON|EQV|BIOETHICS (1974)|POPLINE (1978)|990101|SURG|abcdeefv", "ENTRY": "Surgery, General", "MN": "H02.403.810.300", "FX": "Surgical Procedures, Operative", "MH_TH": "NLM (2009)", "ST": "T091", "AN": "use for the specialty only; prefer /surg with organs and diseases; use SURGICAL PROCEDURES, OPERATIVE or specifics for the surgery patient or surgical procedures", "MS": "A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.", "PM": "2009; see SURGERY 1974-2008", "HN": "2009 (1974)", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013502"}, {"RECTYPE": "D", "MH": "Surgery Department, Hospital", "DE": "SURG DEP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Surgery Department|T093|NON|EQV|UNK (19XX)|770519|HOSP SURG DEP|abcdefv", "ENTRY": "Hospital Surgery Departments", "MN": "N04.452.442.452.422.750", "MH_TH": "NLM (1977)", "ST": "T093", "MS": "Hospital department which administers all departmental functions and the provision of surgical diagnostic and therapeutic services.", "PM": "91; was see under HOSPITAL DEPARTMENTS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90", "MR": "20190709", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D013503"}, {"RECTYPE": "D", "MH": "Cardiovascular Surgical Procedures", "DE": "CARDIOVASC SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Cardiovascular|T061|NON|EQV|NLM (1998)|961021|SURG PROCEDURES CARDIOVASC|abcdefv", "MN": "E04.100", "FX": "Thoracic Surgery", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general or unspecified; prefer specifics; consider also /surg with specific parts of the cardiovascular system; also CARDIOVASCULAR DISEASES /surg or /surg with specific cardiovascular disease", "MS": "Surgery performed on the heart or blood vessels.", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013504"}, {"RECTYPE": "D", "MH": "Digestive System Surgical Procedures", "DE": "DIGESTIVE SYSTEM SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Gastrointestinal Surgical Procedures|T061|NON|NRW|NLM (1998)|970210|GASTROINTESTINAL SURG PROCEDURES|abcdefv", "ENTRY": "Surgical Procedures, Gastrointestinal|T061|NON|NRW|NLM (1998)|970210|SURG PROCEDURES GASTROINTESTINAL|abcdefv", "MN": "E04.210", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "general or unspecified; prefer specifics; consider also /surg with specific parts of the digestive system; also /surg with specific digestive disease", "MS": "Surgery performed on the digestive system or its parts.", "PM": "98", "HN": "98; use explode 1970-74", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013505"}, {"RECTYPE": "D", "MH": "Otologic Surgical Procedures", "DE": "OTOL SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Otologic|T061|NON|EQV|NLM (1998)|961016|SURG PROCEDURES OTOL|abcdefv", "MN": "E04.580.450", "FX": "Otolaryngology", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "general or unspecified; prefer specifics; consider also EAR /surg or /surg with specific ear terms; also EAR DISEASES /surg or /surg with specific ear disease", "MS": "Surgery performed on the external, middle, or internal ear.", "PM": "98", "HN": "98; use explode 1976-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013506"}, {"RECTYPE": "D", "MH": "Endocrine Surgical Procedures", "DE": "ENDOCRINE SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Endocrine|T061|NON|EQV|NLM (1998)|961016|SURG PROCEDURES ENDOCRINE|abcdefv", "MN": "E04.270", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "general or unspecified; prefer specifics; consider also ENDOCRINE GLANDS /surg or /surg with specific endocrine glands; also ENDOCRINE SYSTEM DISEASES /surg or /surg with specific endocrine diseases", "MS": "Surgery performed on any endocrine gland.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013507"}, {"RECTYPE": "D", "MH": "Ophthalmologic Surgical Procedures", "DE": "OPHTHALMOL SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Ophthalmological", "MN": "E04.540", "FX": "Ophthalmology", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "general or unspecified; prefer specifics; consider also /surg with specific parts of the eye or EYE DISEASES /surg or /surg with specific eye disease", "MS": "Surgery performed on the eye or any of its parts.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013508"}, {"RECTYPE": "D", "MH": "Gynecologic Surgical Procedures", "DE": "GYNECOL SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Gynecological", "MN": "E04.950.300", "FX": "Gynecology", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general or unspecified; prefer specifics; consider also GENITALIA, FEMALE /surg or /surg with specific genital terms; also GENITAL DISEASES, FEMALE /surg or /surg with specific gynecologic disease; check the tag FEMALE", "MS": "Surgery performed on the female genitalia.", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013509"}, {"RECTYPE": "D", "MH": "Pulmonary Surgical Procedures", "DE": "PULM SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Pulmonary|T061|NON|EQV|NLM (1998)|961018|SURG PROCEDURES PULM|abcdefv", "MN": "E04.928.600", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "general or unspecified; prefer specifics; consider also LUNG /surg and LUNG DISEASES /surg or /surg with specific lung disease", "MS": "Surgery performed on the lung.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013510"}, {"RECTYPE": "D", "MH": "Minor Surgical Procedures", "DE": "MINOR SURG PROCEDURES", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Minor|T061|NON|EQV|NLM (1966)|990101|SURG PROCEDURES MINOR|abcdefv", "ENTRY": "Surgeries, Minor", "MN": "E04.506", "MH_TH": "NLM (1998)", "ST": "T061", "AN": "IM general only", "MS": "Surgery for problems and injuries that are of relatively slight extent, and with a low risk for life threatening complications.", "PM": "2015; see SURGICAL PROCEDURES, MINOR 1998-2014; see SURGERY, MINOR 1963-1997", "HN": "2015(1963)", "CATSH": "CAT LIST", "MR": "20140616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013511"}, {"RECTYPE": "D", "MH": "Obstetric Surgical Procedures", "DE": "OBSTET SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Obstetrical", "MN": "E04.520", "FX": "Obstetrics", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general or unspecified; prefer specifics; consider also PREGNANCY COMPLICATIONS /surg; and OBSTETRIC LABOR COMPLICATIONS /surg or /surg with specific pregnancy and labor complications; check the tags FEMALE and PREGNANCY", "MS": "Surgery performed on the pregnant woman for conditions associated with pregnancy, labor, or the puerperium. It does not include surgery of the newborn infant.", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013513"}, {"RECTYPE": "D", "MH": "Surgical Procedures, Operative", "DE": "SURG PROCEDURES OPERATIVE", "AQ": "AE CL EC ED ES LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures|T061|NON|EQV|NLM (2021)|191231|abcdef", "ENTRY": "Surgical Procedure", "MN": "E04", "RH": "E4 - PROCEDURES AND TECHNIQUES-SURGICAL", "FX": "Reoperation", "EC": "history:General Surgery:history", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Operations carried out for the correction of deformities and defects, repair of injuries, and diagnosis and cure of certain diseases. (Taber, 18th ed.).", "PM": "1998; see SURGERY, OPERATIVE 1963-97", "HN": "1998(1963)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013514"}, {"RECTYPE": "D", "MH": "Surgery, Oral", "DE": "SURG ORAL", "AQ": "CL EC ED ES HI IS LJ MT NU OG PX RH SN ST TD", "PRINT ENTRY": "Surgery, Maxillofacial|T091|NON|EQV|NLM (1995)|930920|SURG MAXILLOFACIAL|abcdefv", "ENTRY": "Oral Surgery|T091|NON|EQV|UNK (19XX)|860101|ORAL SURG|abcdefv", "MN": "H02.163.876.886", "FX": "Oral Surgical Procedures", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty of surgical therapy of diseases, injuries & defects of soft tissue of mouth & jaws; do not confuse with DENTISTRY, OPERATIVE: to restore tooth function; cranio-maxillo-facial surgery does not go here; use instead SPECIALTIES, SURGICAL; see also note at ORAL SURGICAL PROCEDURES", "MS": "A dental specialty concerned with the diagnosis and surgical treatment of disease, injuries, and defects of the human oral and maxillofacial region.", "PM": "EXODONTICS was see TOOTH EXTRACTION 1965-97; was EXODONTIA see TEETH EXTRACTION 1963-64", "HN": "EXODONTICS was see TOOTH EXTRACTION 1965-97; was EXODONTIA see TEETH EXTRACTION 1963-64", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013515"}, {"RECTYPE": "D", "MH": "Oral Surgical Procedures, Preprosthetic", "DE": "ORAL SURG PROCEDURES PREPROSTHETIC", "AQ": "AE CL EC ES HI IS MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Preprosthetic Oral Surgical Procedures|T061|NON|EQV|UNK (19XX)|790427|PREPROSTHETIC ORAL SURG PROCEDURES|abcdefv", "ENTRY": "Surgical Procedures, Oral, Preprosthetic|T061|NON|EQV|NLM (1998)|961015|SURG PROCEDURES ORAL PREPROSTHETIC|abcdefv", "MN": "E06.645.550", "MH_TH": "NLM (1980)", "ST": "T061", "PI": "specific oral surgery heading (1966-1979)", "MS": "Surgery necessary for a denture to rest on a firm base, free from marked osseous protuberances or undercuts, and devoid of interfering muscle attachments, excess mucoperiosteum, hyperplasias, and fibrous or papillary growths.", "PM": "98; was SURGERY, ORAL, PREPROSTHETIC 1980-97; PREPROSTHETIC ORAL SURGICAL PROCEDURES was PREPROSTHETIC ORAL SURGERY 1980-97", "HN": "98; was SURGERY, ORAL, PREPROSTHETIC 1980-97; PREPROSTHETIC ORAL SURGICAL PROCEDURES was PREPROSTHETIC ORAL SURGERY 1980-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19790427", "DC": "1", "DX": "19800101", "UI": "D013516"}, {"RECTYPE": "D", "MH": "Otorhinolaryngologic Surgical Procedures", "DE": "ORL SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Otorhinolaryngological", "MN": "E04.580", "FX": "Otolaryngology", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "general or unspecified; prefer specifics; consider also EAR /surg, NOSE /surg, LARYNX /surg and /surg with specific parts of these organs; also OTORHINOLARYNGOLOGIC DISEASES /surg and /surg with specific ORL disease", "MS": "Surgery performed on the ear and its parts, the nose and nasal cavity, or the throat, including surgery of the adenoids, tonsils, pharynx, and trachea.", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013517"}, {"RECTYPE": "D", "MH": "Surgery, Plastic", "DE": "SURG PLASTIC", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX RH SN ST TD VE", "PRINT ENTRY": "Surgery, Esthetic|T091|NON|REL|NLM (1993)|911107|SURG ESTHETIC|abcdefv", "ENTRY": "Surgery, Reconstructive", "MN": "H02.403.810.788", "FX": "Plastic Surgery Procedures", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use for the specialty only; do not confuse with RECONSTRUCTIVE SURGICAL PROCEDURES, the technique", "MS": "The branch of surgery concerned with restoration, reconstruction, or improvement of defective, damaged, or missing structures.", "PM": "1966; for RECONSTRUCTIVE SURGERY see RECONSTRUCTIVE SURGICAL PROCEDURES 2017-2022", "HN": "1966; for RECONSTRUCTIVE SURGERY use RECONSTRUCTIVE SURGICAL PROCEDURES 2017-2022", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013518"}, {"RECTYPE": "D", "MH": "Urogenital Surgical Procedures", "DE": "UROGENITAL SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Urogenital Surgical Procedure|T061|NON|EQV|NLM (1998)|961015|UROGENITAL SURG PROCEDURE|abcdefv", "MN": "E04.950", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "avoid: too inclusive; prefer GYNECOLOGIC SURGICAL PROCEDURES & specifics or UROLOGIC SURGICAL PROCEDURES & specifics or UROLOGIC SURGICAL PROCEDURES, MALE & specifics; consider also UROGENITAL SYSTEM /surg or /surg with specific urogenital syst terms; also UROLOGIC DISEASES /surg or /surg with specific urol dis; DF: UROGENITAL SURG PROCEDURES", "MS": "Surgery performed on the urinary tract or its organs and on the male or female genitalia.", "PM": "98", "HN": "98; use explode 1975-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013519"}, {"RECTYPE": "D", "MH": "Urologic Surgical Procedures", "DE": "UROL SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Urological Surgical Procedure", "MN": "E04.950.774", "FX": "Urology", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general or unspecified; prefer specifics;", "MS": "Surgery performed on the urinary tract or its parts in the male or female. For surgery of the male genitalia, UROLOGIC SURGICAL PROCEDURES, MALE is available.", "PM": "98", "HN": "98; use explode 1970-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013520"}, {"RECTYPE": "D", "MH": "Urologic Surgical Procedures, Male", "DE": "UROL SURG PROCEDURES MALE", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgery, Male Urological", "MN": "E04.950.774.860", "MH_TH": "NLM (1974)", "ST": "T061", "AN": "general or unspecified; prefer specifics; consider also GENITALIA, MALE /surg or /surg with specific genital terms; also GENITAL DISEASES, MALE /surg or /surg with specific male genital disease; check the tag MALE", "MS": "Surgery performed on the male genitalia.", "PM": "98", "HN": "98; use explode 1974-97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013521"}, {"RECTYPE": "D", "MH": "Surgery, Veterinary", "DE": "SURG VET", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Veterinary Surgeries", "MN": "H02.956.692", "MH_TH": "NLM (1975)", "ST": "T091", "AN": "use for the specialty only", "MS": "A board-certified specialty of VETERINARY MEDICINE, requiring at least four years of special education, training, and practice of veterinary surgery after graduation from veterinary school. In the written, oral, and practical examinations candidates may choose either large or small animal surgery. (From AVMA Directory, 43d ed, p278)", "OL": "search VETERINARY MEDICINE 1966-74", "PM": "91; was see under VETERINARY MEDICINE 1975-90", "HN": "91(75); was see under VETERINARY MEDICINE 1975-90", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013522"}, {"RECTYPE": "D", "MH": "Surgical Equipment", "DE": "SURG EQUIPMENT", "AQ": "AE CL EC ES HI LJ MI PS SD SN ST TD VE VI", "ENTRY": "Surgical Equipments", "MN": "E07.858", "MH_TH": "NLM (1981)", "ST": "T073", "AN": "differentiate from SURGICAL INSTRUMENTS in that the instrument is for use in the immediate operative field, usually held in the hand", "MS": "Nonexpendable apparatus used during surgical procedures. They are differentiated from SURGICAL INSTRUMENTS, usually hand-held and used in the immediate operative field.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013523"}, {"RECTYPE": "D", "MH": "Surgical Flaps", "DE": "SURG FLAPS", "AQ": "AE BS CL EC ES HI IM IR MI PA PH PS SD SN ST SU TD TR VE VI", "PRINT ENTRY": "Island Flaps|T023|NON|NRW|UNK (19XX)|830201|abcdef", "ENTRY": "Pedicled Flaps", "MN": "E07.862.710", "MH_TH": "NLM (1980)", "ST": "T023", "AN": "includes skin & muscle tissue but do not specify site or tissue unless particularly discussed; do not coordinate with TRANSPLANTATION, AUTOLOGOUS", "PI": "Transplantation, Autologous (1966-1979)", "MS": "Tongues of skin and subcutaneous tissue, sometimes including muscle, cut away from the underlying parts but often still attached at one end. They retain their own microvasculature which is also transferred to the new site. They are often used in plastic surgery for filling a defect in a neighboring region.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19781214", "DC": "1", "DX": "19800101", "UI": "D013524"}, {"RECTYPE": "D", "MH": "Surgical Instruments", "DE": "SURG INSTRUM", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Valves, Surgical|T074|NON|NRW|NLM (1998)|970227|VALVES SURG|abcdefv", "ENTRY": "Trocars", "MN": "E07.858.700", "MH_TH": "NLM (1965)", "ST": "T074", "AN": "general or unspecified; prefer specifics or /instrum with specialty or with surgical technique; differentiate from SURGICAL EQUIPMENT on basis of size (instruments are holdable in the hand); surgical instrument left in the operative field: coordinate with FOREIGN BODIES ", "MS": "Hand-held tools or implements used by health professionals for the performance of surgical tasks.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013525"}, {"RECTYPE": "D", "MH": "Surgical Mesh", "DE": "SURG MESH", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Surgical Meshes|T074|NON|EQV|UNK (19XX)|860101|SURG MESHES|abcdefv", "MN": "E07.858.708", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "Any woven or knit material of open texture used in surgery for the repair, reconstruction, or substitution of tissue. The mesh is usually a synthetic fabric made of various polymers. It is occasionally made of metal.", "CATSH": "CAT LIST", "MR": "20021023", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013526"}, {"RECTYPE": "D", "MH": "Perioperative Nursing", "DE": "PERIOP NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Surgical Nursing|T058|T091|NON|EQV|NLM (1996)|940713|SURG NURS|abbcdefv", "ENTRY": "Nursing, Perianesthesia", "MN": "N02.421.585.722.500", "FX": "Postanesthesia Nursing", "MH_TH": "NLM (1968)", "ST": "T091", "AN": "OPERATING ROOM NURSING is also available", "PI": "Surgical Procedures, Operative (1966-1967)", "MS": "Nursing care of the surgical patient before, during, and after surgery.", "PM": "1996; see SURGICAL NURSING 1968-1995; for PERIOPERATIVE NURSING see OPERATING ROOM NURSING 1988-1995", "HN": "1996 (1968); for PERIOPERATIVE NURSING use OPERATING ROOM NURSING 1988-1995", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013527"}, {"RECTYPE": "D", "MH": "Surgical Staplers", "DE": "SURG STAPLERS", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Surgical Stapler|T074|NON|EQV|NLM (1992)|910515|SURG STAPLER|abcdefv", "MN": "E07.858.700.750", "MH_TH": "NLM (1964)", "ST": "T074", "MS": "Fastening devices composed of steel-tantalum alloys used to close operative wounds, especially of the skin, which minimizes infection by not introducing a foreign body that would connect external and internal regions of the body. (From Segen, Current Med Talk, 1995)", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013528"}, {"RECTYPE": "D", "MH": "Surgical Wound Dehiscence", "DE": "SURG WOUND DEHISCENCE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Wound Dehiscence, Surgical|T046|NON|EQV|UNK (19XX)|860101|WOUND DEHISCENCE SURG|abcdefv", "MN": "C23.550.767.887", "MH_TH": "NLM (1964)", "ST": "T046", "MS": "Pathologic process consisting of a partial or complete disruption of the layers of a surgical wound.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013529"}, {"RECTYPE": "D", "MH": "Surgical Wound Infection", "DE": "SURG WOUND INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Postoperative Wound Infection|T046|NON|EQV|UNK (19XX)|830505|POSTOP WOUND INFECT|abcdefv", "ENTRY": "Wound Infections, Surgical", "MN": "C23.550.767.925", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "coordinate IM with specific infection term (IM); do not coordinate with POSTOPERATIVE COMPLICATIONS", "MS": "Infection occurring at the site of a surgical incision.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013530"}, {"RECTYPE": "D", "MH": "Surgicenters", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Surgicenter", "MN": "N02.278.421.556.868", "MH_TH": "NLM (1972)", "ST": "T093", "PI": "Surgery, Minor (1966-1971)", "MS": "Facilities designed to serve patients who require surgical treatment exceeding the capabilities of usual physician's office yet not of such proportion as to require hospitalization.", "PM": "78; was see under HOSPITALS, SPECIAL 1975-77", "HN": "78(72); was see under HOSPITALS, SPECIAL 1975-77", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D013531"}, {"RECTYPE": "D", "MH": "Suriname", "AQ": "EH EP", "PRINT ENTRY": "Netherlands Guiana|T083|NAM|EQV|NLM (1996)|950217|abcdef", "ENTRY": "Surinam|T083|NAM|EQV|NLM (1992)|910611|abcdef", "MN": "Z01.107.757.833", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "in So. Amer; entry terms NETHERLANDS GUIANA, and DUTCH GUIANA were former names; in translations use American spelling Suriname, not Surinam", "MS": "A republic in the north of South America, bordered on the west by GUYANA (British Guiana) and on the east by FRENCH GUIANA. Its capital is Paramaribo. It was formerly called Netherlands Guiana or Dutch Guiana or Surinam. Suriname was first settled by the English in 1651 but was ceded to the Dutch by treaty in 1667. It became an autonomous territory under the Dutch crown in 1954 and gained independence in 1975. The country was named for the Surinam River but the meaning of that name is uncertain. (From Webster's New Geographical Dictionary, 1988, p1167 & Room, Brewer's Dictionary of Names, 1992, p526)", "OL": "use SURINAME to search SURINAM 1966-80", "HN": "81; was SURINAM 1963-80", "MR": "19970620", "DA": "19990101", "DC": "4", "DX": "19810101", "UI": "D013532"}, {"RECTYPE": "D", "MH": "Surrogate Mothers", "AQ": "ED LJ PX SN", "PRINT ENTRY": "Mothers, Surrogate|T099|NON|EQV|UNK (19XX)|850320|abcdef", "ENTRY": "Surrogate Mother", "MN": "M01.620.892", "MH_TH": "POPLINE (1993)", "ST": "T099", "AN": "human only; check tags HUMAN; FEMALE & PREGNANCY", "PI": "Insemination, Artificial, Heterologous (1975-1985)", "MS": "Women who allow themselves to be impregnated with the understanding that the offspring are to be given over to the parents who have commissioned the surrogate.", "PM": "90; was see under MOTHERS 1986-89", "HN": "90(86); was see under MOTHERS 1986-89", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19850320", "DC": "1", "DX": "19900101", "UI": "D013533"}, {"RECTYPE": "D", "MH": "Survival", "AQ": "PH PX", "MN": "I03.784", "MH_TH": "NLM (1966)", "ST": "T052", "AN": "use for survival after adverse events such as disasters, plane crashes, shipwrecks", "MS": "Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013534"}, {"RECTYPE": "D", "MH": "Suspensions", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Suspension|T122|NON|EQV|NLM (2021)|191219|abcdef", "MN": "D26.255.165.810", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "AN": "IM for general only, qualif permitted; NIM (no qualif) with specific drug IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in suspension, not the \"suspension\"", "MS": "Colloids with liquid continuous phase and solid dispersed phase; the term is used loosely also for solid-in-gas (AEROSOLS) and other colloidal systems; water-insoluble drugs may be given as suspensions.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013535"}, {"RECTYPE": "D", "MH": "Suture Techniques", "AQ": "AE CL EC ED ES HI IS LJ MO NU PX RH SN ST TD VE", "ENTRY": "Techniques, Suture", "MN": "E04.987.775", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Techniques for securing together the edges of a wound, with loops of thread or similar materials (SUTURES).", "OL": "use SUTURE TECHNIQUES to search SUTURE TECHNICS 1966-90", "PM": "91; was SUTURE TECHNICS 1963-90", "HN": "91; was SUTURE TECHNICS 1963-90", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013536"}, {"RECTYPE": "D", "MH": "Sutures", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Surgical Staples|T074|NON|NRW|NLM (1998)|970516|SURG STAPLES|abcdefv", "ENTRY": "Suture", "MN": "E07.858.690.820", "EC": "methods:Suture Techniques", "MH_TH": "NLM (1966)", "ST": "T074", "AN": "/adv eff permitted but do not confuse adv eff of the suture with the adv eff of the material of which suture is made or the adv eff of the suture method", "MS": "Materials used in closing a surgical or traumatic wound. (From Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013537"}, {"RECTYPE": "D", "MH": "Svalbard", "AQ": "EH EP", "PRINT ENTRY": "Spitsbergen|T083|NAM|NRW|UNK (19XX)|741111|abcdef", "MN": "Z01.639.835", "MH_TH": "NLM (1975)", "ST": "T083", "MS": "Norwegian islands located in the Arctic Ocean, halfway between Norway and the North Pole", "HN": "75", "MR": "20160707", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D013538"}, {"RECTYPE": "D", "MH": "Simian virus 40", "DS": "SIMIAN VIRUS 040", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Vacuolating Agent|T005|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Vacuolating Agents", "MN": "B04.613.204.670.615.700", "MH_TH": "UNK (19XX)", "ST": "T005", "RN": "txid1891767", "AN": "entry term SV40 VIRUS is from Simian Vacuolating virus; infection: coord IM with POLYOMAVIRUS INFECTIONS (IM) and TUMOR VIRUS INFECTIONS (IM)", "MS": "A species of POLYOMAVIRUS originally isolated from Rhesus monkey kidney tissue. It produces malignancy in human and newborn hamster kidney cell cultures.", "PM": "2001; see POLYOMAVIRUS MACACAE 1994-2001, see SV40 VIRUS 1965-1993", "HN": "2001 (1965)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013539"}, {"RECTYPE": "D", "MH": "Swayback", "AQ": "BL CF CI CL CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Enzootic Ataxia|T047|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Enzootic Ataxias", "MN": "C22.836.886", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "animal only: disease of sheep; check tag ANIMAL; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES", "PI": "Sheep Diseases (1966-1967)", "MS": "Congenital locomotor ataxia of lambs, thought to be associated with copper deficiency. It is characterized clinically by progressive incoordination of the hind limbs and pathologically by disruption of neuron and myelin development in the central nervous system. It is caused by a deficiency of metabolizable copper in the ewe during the last half of her pregnancy. (Dorland, 28th ed; Stedman, 26th ed)", "PM": "91; was see under SHEEP DISEASES 1968-90", "HN": "91(68); was see under SHEEP DISEASES 1968-90", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013540"}, {"RECTYPE": "D", "MH": "Eswatini", "AQ": "EH EP", "PRINT ENTRY": "Swaziland|T083|NAM|EQV|NLM (1996)|990101|abcdef", "MN": "Z01.058.290.175.300", "MH_TH": "NLM (2020)", "ST": "T083", "MS": "A kingdom in southern Africa, west of MOZAMBIQUE. Its capital is Mbabane. It became independent from Britain in 1968. The former country name Swaziland was changed in 2018. (from CIA World Factbook, 2019)", "HN": "2020(1975)", "MR": "20190506", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D013541"}, {"RECTYPE": "D", "MH": "Sweat", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Sweats", "MN": "A12.200.849", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "TN 181: relation to SWEAT GLANDS & SWEATING", "MS": "The fluid excreted by the SWEAT GLANDS. It consists of water containing sodium chloride, phosphate, urea, ammonia, and other waste products.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013542"}, {"RECTYPE": "D", "MH": "Sweat Gland Diseases", "DE": "SWEAT GLAND DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sweat Gland Disease", "MN": "C17.800.946", "MH_TH": "NLM (1976)", "ST": "T047", "PI": "specific sweat gland disease (1966-1975)", "MS": "Diseases of the SWEAT GLANDS.", "PM": "76", "HN": "76; was NON MESH before 1976", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D013543"}, {"RECTYPE": "D", "MH": "Sweat Gland Neoplasms", "DE": "SWEAT GLAND NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Sweat Gland Neoplasm", "MN": "C17.800.946.743", "MH_TH": "NLM (1968)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM)", "PI": "Sweat Glands (1966-1967)", "MS": "New abnormal growth of tissue in the SWEAT GLANDS.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013544"}, {"RECTYPE": "D", "MH": "Sweat Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sweat Gland", "MN": "A17.815.830", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Sweat-producing structures that are embedded in the DERMIS. Each gland consists of a single tube, a coiled body, and a superficial duct.", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013545"}, {"RECTYPE": "D", "MH": "Sweating", "AQ": "DE ES GE IM PH RE", "MN": "G16.012.500.535.693", "FX": "Hypohidrosis", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "do not confuse with CUTANEOUS ELIMINATION; PRICKLY HEAT see MILIARIA is also available", "MS": "The process of exocrine secretion of the SWEAT GLANDS, including the aqueous sweat from the ECCRINE GLANDS and the complex viscous fluids of the APOCRINE GLANDS.", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013546"}, {"RECTYPE": "D", "MH": "Sweating, Gustatory", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperhidrosis, Gustatory|T047|NON|EQV|NLM (1993)|OMIM (2013)|920407|abcdeef", "ENTRY": "von Freys Syndrome", "MN": "C17.800.946.350.843", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An autonomic disorder characterized by excessive sweating of the forehead, upper lip, perioral region, or sternum subsequent to gustatory stimuli. The auriculotemporal syndrome features facial flushing or sweating limited to the distribution of the auriculotemporal nerve and may develop after trauma to the parotid gland, in association with PAROTID NEOPLASMS, or following their surgical removal. (From Ann Neurol 1997 Dec;42(6):973-5)", "OL": "use SWEATING, GUSTATORY to search FREY'S SYNDROME 1966-73 (as Prov)", "PM": "74", "HN": "74; was FREY'S SYNDROME 1965-73 (Prov)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013547"}, {"RECTYPE": "D", "MH": "Sweden", "AQ": "EH EP", "MN": "Z01.542.816.500", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "Country in northern Europe, bordering the Baltic Sea, between Finland and Norway. The capital is Stockholm.", "MR": "20170308", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013548"}, {"RECTYPE": "D", "MH": "Sweetening Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sugar Substitutes|T120|NON|NRW|NLM (1990)|881206|abcdef", "ENTRY": "Sweetening Agent", "MN": "J02.500.514.500.400.700", "MH_TH": "NLM (1966)", "ST": "T120", "RN": "0", "MS": "Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed)", "MR": "20170623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013549"}, {"RECTYPE": "D", "MH": "Swimming", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "MN": "I03.450.642.845.945.500", "MH_TH": "NLM (1966)", "ST": "T056", "AN": "human & animal; /inj: coordinate with specific  injury; consider also DIVING; index NIM for swimming in animal experiments on PHYSICAL EXERTION", "MS": "An activity in which the body is propelled through water by specific movement of the arms and/or the legs. Swimming as propulsion through water by the movement of limbs, tail, or fins of animals is often studied as a form of PHYSICAL EXERTION or endurance.", "MR": "20170414", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013550"}, {"RECTYPE": "D", "MH": "Swimming Pools", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Swimming Pool", "MN": "J03.925.830", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Excavations or containment structures filled with water and used for swimming.", "MR": "20160705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013551"}, {"RECTYPE": "D", "MH": "Swine", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Warthogs|T010|NON|NRW|NLM (2003)|020114|abcdef", "ENTRY": "Wart Hog", "MN": "B01.050.150.900.649.313.500.880", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid9821", "RR": "txid41425", "AN": "unspecified swine or pigs goes here; PIG, DOMESTIC see SUS SCROFA is available", "CX": "consider also terms at HOG and PORCINE", "MS": "Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA).", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013552"}, {"RECTYPE": "D", "MH": "Swine Diseases", "DE": "SWINE DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Swine Disease", "MN": "C22.905", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Diseases of domestic swine and of the wild boar of the genus Sus.", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013553"}, {"RECTYPE": "D", "MH": "Swine Erysipelas", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "MN": "C22.905.832", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "Erysipelothrix infect; don't forget also SWINE (NIM) & check tag ANIMALS", "MS": "An acute and chronic contagious disease of young pigs caused by Erysipelothrix insidiosa.", "OL": "search ERYSIPELOTHRIX INFECTIONS 1968-74 & ERYSIPELOID 1966-67", "PM": "91; was see under ERYSIPELOTHRIX INFECTIONS 1968-90; was see under ERYSIPELOID 1963-67", "HN": "91(75); was see under ERYSIPELOTHRIX INFECTIONS 1968-90; was see under ERYSIPELOID 1963-67", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013554"}, {"RECTYPE": "D", "MH": "Swine Vesicular Disease", "DE": "SWINE VESICULAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Vesicular Diseases, Swine", "MN": "C22.905.850", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "An enterovirus infection of swine clinically indistinguishable from FOOT-AND-MOUTH DISEASE, vesicular stomatitis, and VESICULAR EXANTHEMA OF SWINE. It is caused by a strain of HUMAN ENTEROVIRUS B.", "PM": "91; was see under ENTEROVIRUS INFECTIONS 1975-90", "HN": "91(75); was see under ENTEROVIRUS INFECTIONS 1975-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013555"}, {"RECTYPE": "D", "MH": "Swine, Miniature", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Minipigs|T015|NON|EQV|UNK (19XX)|820426|abcdef", "ENTRY": "Swines, Miniature", "MN": "B01.050.150.900.649.313.500.880.399.800", "MH_TH": "NLM (1983)", "ST": "T015", "PI": "Swine (1966-1982)", "MS": "Genetically developed small pigs for use in biomedical research. There are several strains - Yucatan miniature, Sinclair miniature, and Minnesota miniature.", "PM": "83", "HN": "83", "MR": "20200902", "DA": "19820426", "DC": "1", "DX": "19830101", "UI": "D013556"}, {"RECTYPE": "D", "MH": "Switzerland", "AQ": "EH EP", "MN": "Z01.542.883", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "A country in Europe. It is bordered by Austria, France, Italy, Liechtenstein, and Germany. The capital is Bern.", "MR": "20160707", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013557"}, {"RECTYPE": "D", "MH": "Sydnones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.462.580.693", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "OXADIAZOLES bearing an oxygen at the 5-position. They are mesoionic, with delocalized positive and negative charges.", "OL": "search OXADIAZOLES 1968-74", "PM": "91; was see under OXADIAZOLES 1975-90", "HN": "91(75); was see under OXADIAZOLES 1975-90", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013558"}, {"RECTYPE": "D", "MH": "Symbiosis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Endosymbiosis|T070|NON|NRW|NLM (2010)|081217|abcdef", "ENTRY": "Mutualism|T070|NON|NRW|NLM (2014)|130507|abcdef", "MN": "G16.840", "FX": "Mycorrhizae", "MH_TH": "NLM (1966)", "ST": "T070", "MS": "The relationship between two different species of organisms that are interdependent; each gains benefits from the other or a relationship between different species where both of the organisms in question benefit from the presence of the other.", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013559"}, {"RECTYPE": "D", "MH": "Symbolism", "ENTRY": "Symbolisms (Psychology)", "MN": "K01.752.798", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "symbolism in art, music, literature, etc. goes here; graphic symbols go in a variety of places where pertinent (EMBLEMS AND INSIGNIA; LANGUAGE; COMMUNICATION; WRITING; etc.); coordinate with the object or concept symbolized ", "MS": "A concept that stands for or suggests something else by reason of its relationship, association, convention, or resemblance. The symbolism may be mental or a visible sign or representation. (From Webster, 3d ed)", "PM": "96; was SYMBOLISM (PSYCHOLOGY) 1979-95; was heading 1963-78", "HN": "96; was SYMBOLISM (PSYCHOLOGY) 1979-95; was heading 1963-78", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D013561"}, {"RECTYPE": "D", "MH": "Sympathectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Sympathetic Denervation|T061|NON|EQV|NLM (1994)|921015|abcdef", "ENTRY": "Sympathetic Denervations", "MN": "E04.525.210.105.800", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "coordinate with nerve /surg or plexus /surg but note that GANGLIONECTOMY is also available; lumbar sympathectomy: coordinate with LUMBOSACRAL PLEXUS /surg; coordinate with disease /surg ", "MS": "The removal or interruption of some part of the sympathetic nervous system for therapeutic or research purposes.", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013562"}, {"RECTYPE": "D", "MH": "Sympathectomy, Chemical", "DE": "SYMPATHECTOMY CHEM", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Denervation, Sympathetic, Chemical|T061|T062|NON|EQV|UNK (19XX)|810227|DENERVATION SYMPATHETIC CHEM|abbcdefv", "ENTRY": "Sympathetic Denervations, Chemical", "MN": "E04.525.210.105.800.800", "MH_TH": "NLM (1982)", "ST": "T062", "AN": "coordinate with specific chemical with no qualifiers + disease /ther; do not confuse with SYMPATHETIC NERVE BLOCK see AUTONOMIC NERVE BLOCK", "PI": "specific sympathetic nervous system term (1966-1981)", "MS": "Sympathectomy using chemicals (e.g., 6-hydroxydopamine or guanethidine) which selectively and reversibly destroy adrenergic nerve endings while leaving cholinergic nerve endings intact.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19810227", "DC": "1", "DX": "19820101", "UI": "D013563"}, {"RECTYPE": "D", "MH": "Sympathetic Nervous System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Systems, Sympathetic Nervous", "MN": "A08.800.050.800", "FX": "Sympathomimetics", "MH_TH": "NLM (1966)", "ST": "T022", "AN": "/drug eff: consider also SYMPATHOLYTICS & SYMPATHOMIMETICS; /surg: probably SYMPATHECTOMY", "MS": "The thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body's response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system.", "MR": "19930811", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013564"}, {"RECTYPE": "D", "MH": "Sympatholytics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sympatholytic Drug|T121|NON|EQV|NLM (2022)|201023|abcdef", "ENTRY": "Sympathetic Blocking Agents", "MN": "D27.505.696.663.050.850", "FX": "Adrenergic Antagonists", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "note entry term SYMPATHOLYTIC EFFECT: use only for the sympatholytic effect of a chemical substance", "MS": "Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.", "OL": "use SYMPATHOLYTICS to search ADRENERGIC FALSE TRANSMITTERS 1973-81", "PM": "ADRENERGIC FALSE TRANSMITTERS was heading 1973-81", "HN": "ADRENERGIC FALSE TRANSMITTERS was heading 1973-81", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013565"}, {"RECTYPE": "D", "MH": "Sympathomimetics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sympathomimetic Drug|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Sympathomimetic Amines", "MN": "D27.505.696.663.050.870", "FX": "Receptors, Adrenergic", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "note entry term SYMPATHOMIMETIC EFFECT: use only for the sympathomimetic effect of a chemical substance", "MS": "Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013566"}, {"RECTYPE": "D", "MH": "Symphysiotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Symphysiotomies", "MN": "E04.910", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Surgical procedure to widen a woman's pelvis during childbirth.", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013567"}, {"RECTYPE": "D", "MH": "Pathological Conditions, Signs and Symptoms", "DE": "PATHOL CONDITIONS SIGNS SYMPTOMS", "PRINT ENTRY": "Symptoms and General Pathology|T046|T184|NON|EQV|NLM (1966)|990101|SYMPTOMS GENERAL PATHOL|abbcdefv", "MN": "C23", "RH": "C23 - PATHOLOGICAL CONDITIONS, SIGNS AND SYMPTOMS", "MH_TH": "NLM (2000)", "ST": "T184", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Abnormal anatomical or physiological conditions and objective or subjective manifestations of disease, not classified as disease or syndrome.", "PM": "2000; see SYMPTOMS AND GENERAL PATHOLOGY 1998-1999", "HN": "2000(1998); use explode 1970-1997", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013568"}, {"RECTYPE": "D", "MH": "Synapses", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "ENTRY": "Synapse|T030|NON|EQV|NLM (2008)|061211|abcdef", "MN": "A11.284.149.165.420.780", "FX": "Synaptosomes", "MH_TH": "NLM (1966)", "ST": "T030", "AN": "note specifics; IMMUNOLOGICAL SYNAPSES is also available; / physiol: consider also SYNAPTIC TRANSMISSION; do not confuse with SYNAPSIS see CHROMOSOME PAIRING", "MS": "Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013569"}, {"RECTYPE": "D", "MH": "Synaptic Membranes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Synaptic Membrane", "MN": "A11.284.149.844", "FX": "Synaptosomes", "MH_TH": "NLM (1970)", "ST": "T026", "PI": "Synapses (1966-1969)", "MS": "Cell membranes associated with synapses. Both presynaptic and postsynaptic membranes are included along with their integral or tightly associated specializations for the release or reception of transmitters.", "PM": "73", "HN": "73(70)", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013570"}, {"RECTYPE": "D", "MH": "Synaptic Vesicles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Vesicles, Synaptic", "MN": "A11.284.430.214.190.875.190.880.810.750", "MH_TH": "NLM (1970)", "ST": "T026", "PI": "Synapses (1966-1969)", "MS": "Membrane-bound compartments which contain transmitter molecules. Synaptic vesicles are concentrated at presynaptic terminals. They actively sequester transmitter molecules from the cytoplasm. In at least some synapses, transmitter release occurs by fusion of these vesicles with the presynaptic membrane, followed by exocytosis of their contents.", "PM": "72", "HN": "72(70)", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013572"}, {"RECTYPE": "D", "MH": "Synaptonemal Complex", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Complex, Synaptonemal", "MN": "G05.360.160.830", "MH_TH": "NLM (1986)", "ST": "T026", "PI": "Meiosis (1968-1985)", "MS": "The three-part structure of ribbon-like proteinaceous material that serves to align and join the paired homologous CHROMOSOMES. It is formed during the ZYGOTENE STAGE of the first meiotic division. It is a prerequisite for CROSSING OVER.", "PM": "91; was see under MEIOSIS 1986-90", "HN": "91(86); was see under MEIOSIS 1986-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19850523", "DC": "1", "DX": "19910101", "UI": "D013573"}, {"RECTYPE": "D", "MH": "Synaptosomes", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Synaptosome", "MN": "A11.284.835.859", "MH_TH": "NLM (1972)", "ST": "T026", "PI": "Synaptic Vesicles (1970-1971)", "MS": "Pinched-off nerve endings and their contents of vesicles and cytoplasm together with the attached subsynaptic area of the membrane of the post-synaptic cell. They are largely artificial structures produced by fractionation after selective centrifugation of nervous tissue homogenates.", "PM": "74", "HN": "74(72)", "MR": "20000622", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013574"}, {"RECTYPE": "D", "MH": "Syncope", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Syncope, Postural|T047|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Vertigos, Syncopal", "MN": "C23.888.592.604.359.800.600", "FX": "Unconsciousness", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)", "CATSH": "CAT LIST", "MR": "19991126", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013575"}, {"RECTYPE": "D", "MH": "Syndactyly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polysyndactyly|T019|NON|NRW|NLM (2003)|011114|abcdef", "ENTRY": "Syndactylies", "MN": "C16.131.621.906.819", "FX": "Polydactyly", "MH_TH": "NLM (1967)", "ST": "T019", "AN": "do not confuse with POLYDACTYLY; coord IM with FINGERS /abnorm (IM) or TOES /abnorm (IM); ACROCEPHALOSYNDACTYLIA is also available", "PI": "Fingers/abnormalities (1966)", "MS": "A congenital anomaly of the hand or foot, marked by the webbing between adjacent fingers or toes. Syndactylies are classified as complete or incomplete by the degree of joining. Syndactylies can also be simple or complex. Simple syndactyly indicates joining of only skin or soft tissue; complex syndactyly marks joining of bony elements.", "OL": "use SYNDACTYLY to search SYNDACTYLIA 1967-93", "PM": "94; was SYNDACTYLIA 1967-93", "HN": "94; was SYNDACTYLIA 1967-93", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D013576"}, {"RECTYPE": "D", "MH": "Syndrome", "ENTRY": "Syndromes", "MN": "C23.550.288.500", "MH_TH": "NLM (1972)", "ST": "T047", "AN": "NIM; policy: Manual 23.20.2.1, 23.26+", "MS": "A characteristic symptom complex.", "PM": "91; was see under DISEASE 1972-90", "HN": "91(72); was see under DISEASE 1972-90", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013577"}, {"RECTYPE": "D", "MH": "Synephrine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sympaethamin|T109|T121|TRD|NRW|UNK (19XX)|770428|abbcdef", "ENTRY": "Synephrin|T109|T121|TRD|NRW|UNK (19XX)|790227|abbcdef", "MN": "D02.092.211.215.811.875", "PA": "Vasoconstrictor Agents", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Benzenemethanol, 4-hydroxy-alpha-((methylamino)methyl)-", "RN": "PEG5DP7434", "RR": "94-07-5 (Synephrine)", "MS": "Sympathetic alpha-adrenergic agonist with actions like PHENYLEPHRINE. It is used as a vasoconstrictor in circulatory failure, asthma, nasal congestion, and glaucoma.", "OL": "use SYNEPHRINE to search OXEDRINE 1966-79", "PM": "80; was OXEDRINE 1963-79", "HN": "80; was OXEDRINE 1963-79", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D013578"}, {"RECTYPE": "D", "MH": "Synostosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Synostoses", "MN": "C16.131.621.906", "MH_TH": "NLM (1966)", "ST": "T019", "AN": "abnorm union between bones or parts of bones; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "A union between adjacent bones or parts of a single bone formed by osseous material, such as ossified connecting cartilage or fibrous tissue. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013580"}, {"RECTYPE": "D", "MH": "Synovial Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Cysts, Synovial", "MN": "C04.182.867", "MH_TH": "NLM (1966)", "ST": "T020", "AN": "non-neoplastic; also available GANGLION CYSTS", "MS": "Non-neoplastic tumor-like lesions at joints, developed from the SYNOVIAL MEMBRANE of a joint through the JOINT CAPSULE into the periarticular tissues. They are filled with SYNOVIAL FLUID with a smooth and translucent appearance. A synovial cyst can develop from any joint, but most commonly at the back of the knee, where it is known as POPLITEAL CYST.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013581"}, {"RECTYPE": "D", "MH": "Synovial Fluid", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Synovia|T031|NON|EQV|NLM (1994)|921102|abcdef", "ENTRY": "Synovial Fluids", "MN": "A12.207.270.847", "MH_TH": "NLM (1966)", "ST": "T031", "MS": "The clear, viscous fluid secreted by the SYNOVIAL MEMBRANE. It contains mucin, albumin, fat, and mineral salts and serves to lubricate joints.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013582"}, {"RECTYPE": "D", "MH": "Synovial Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE TR UL VI", "PRINT ENTRY": "Synovium|T023|NON|EQV|NLM (1994)|921228|abcdef", "ENTRY": "Synovial Membranes", "MN": "A02.835.583.443.800", "EC": "surgery:Synovectomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The inner membrane of a joint capsule surrounding a freely movable joint. It is loosely attached to the external fibrous capsule and secretes SYNOVIAL FLUID.", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013583"}, {"RECTYPE": "D", "MH": "Sarcoma, Synovial", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Synovioma|T191|NON|EQV|NLM (1994)|930326|abcdef", "ENTRY": "Synoviomas", "MN": "C04.557.450.795.875", "MH_TH": "OMIM (2013)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1363)", "OL": "use SARCOMA, SYNOVIAL to search SYNOVIOMA 1966-93", "PM": "94; was SYNOVIOMA 1963-93", "HN": "94; was SYNOVIOMA 1963-93", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D013584"}, {"RECTYPE": "D", "MH": "Synovitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Synovial Plica Syndrome|T046|NON|REL|NLM (2020)|190121|abcdef", "ENTRY": "Thickenings, Synovial", "MN": "C05.550.870", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with TENOSYNOVITIS, inflammation of tendon sheath", "MS": "Inflammation of the SYNOVIAL MEMBRANE.", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013585"}, {"RECTYPE": "D", "MH": "Synovitis, Pigmented Villonodular", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Villonodular Synovitis, Pigmented", "MN": "C05.651.869.762.500", "MH_TH": "NLM (1978)", "ST": "T191", "PI": "Synovitis (1966-1977)", "MS": "Diffuse outgrowth arising from the SYNOVIAL MEMBRANE; SYNOVIAL BURSA; or TENDON sheath around the joint cavity, with extension to surrounding soft tissue. It is characterized by pigmented HEMOSIDERIN-containing MACROPHAGES; FOAM CELLS; and multinucleated GIANT CELLS. It usually occurs in the hands and feet, and around large joints, such as in the ankle and knee joints.", "PM": "91; was see under SYNOVITIS 1978-90", "HN": "91(78); was see under SYNOVITIS 1978-90", "CATSH": "CAT LIST", "MR": "20170316", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D013586"}, {"RECTYPE": "D", "MH": "Syphilis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Great Pox|T047|NON|EQV|NLM (2006)|050114|abcdef", "MN": "C12.100.937.281.859", "EC": "congenital:Syphilis, Congenital", "MH_TH": "BIOETHICS (1990)", "ST": "T047", "AN": "/diag: consider also SYPHILIS SERODIAGNOSIS; note terms for specific types of syphilis", "MS": "A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013587"}, {"RECTYPE": "D", "MH": "Syphilis Serodiagnosis", "DE": "SYPHILIS SERODIAG", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Wassermann Reaction|T060|EPO|REL|NLM (1997)|960416|abcdef", "ENTRY": "Test, Kahn", "MN": "E05.478.594.760.850", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Serologic tests for syphilis.", "OL": "use SYPHILIS SERODIAGNOSIS to search WASSERMANN REACTION 1966-96 & KAHN TEST 1966-91", "PM": "WASSERMANN REACTION was heading 1963-96; KAHN TEST was heading 1963-91", "HN": "WASSERMANN REACTION was heading 1963-96; KAHN TEST was heading 1963-91", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D013588"}, {"RECTYPE": "D", "MH": "Syphilis, Cardiovascular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Cardiovascular Syphilis|T047|NON|EQV|NLM (2007)|060405|abcdef", "ENTRY": "Syphilitic Aortitides", "MN": "C14.260.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific cardiovascular term (IM) or specific cardiovascular disease (IM); note entry term AORTITIS, SYPHILITIC", "MS": "Cardiovascular manifestations of SYPHILIS, an infection of TREPONEMA PALLIDUM. In the late stage of syphilis, sometimes 20-30 years after the initial infection, damages are often seen in the blood vessels including the AORTA and the AORTIC VALVE. Clinical signs include syphilitic aortitis, aortic insufficiency, or aortic ANEURYSM.", "OL": "use SYPHILIS, CARDIOVASCULAR to search AORTITIS, SYPHILITIC 1966-83 (as Prov 1966-74)", "HN": "AORTITIS, SYPHILITIC was see under SYPHILIS, CARDIOVASCULAR 1963-83 (Prov 1963-74)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013589"}, {"RECTYPE": "D", "MH": "Syphilis, Congenital", "DE": "SYPHILIS CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Hutchinson's Teeth|T019|T184|EPO|REL|NLM (1992)|910328|abbcdef", "ENTRY": "Teeth, Hutchinson's", "MN": "C16.614.868", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "Syphilis acquired in utero and manifested by any of several characteristic tooth (Hutchinson's teeth) or bone malformations and by active mucocutaneous syphilis at birth or shortly thereafter. Ocular and neurologic changes may also occur.", "OL": "use SYPHILIS, CONGENITAL to search HUTCHINSON'S TEETH 1966-91", "PM": "HUTCHINSON'S TEETH was heading 1965-91", "HN": "HUTCHINSON'S TEETH was heading 1965-91", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013590"}, {"RECTYPE": "D", "MH": "Syphilis, Cutaneous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Syphilids|T184|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Syphilis, Skin", "MN": "C17.800.838.765.790", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Cutaneous lesions arising from infection with Treponema pallidum. In the primary stage, 18-21 days following infection, one or more chancres appear. If untreated, the subsequent stages of the disease appear as syphilids. These eruptions are superficial, nondestructive, exanthematic, transient, macular roseolas that may later be maculopapular or papular polymorphous or scaly, pustular, pigmented eruptions.(Arnold, Odom, and James, Andrew's Diseases of the Skin, 8th ed, p409)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013591"}, {"RECTYPE": "D", "MH": "Syphilis, Latent", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Syphilis, Latent Stage|T047|NON|EQV|NLM (2011)|ORD (2010)|100331|abcdeef", "MN": "C01.550.750", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "The stage of syphilis that occurs following the primary (CHANCRE) and secondary stages. The patient is asymptomatic at the latent stage but remains seropositive for the SPIROCHETE.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013592"}, {"RECTYPE": "D", "MH": "Syria", "AQ": "EH EP", "MN": "Z01.252.245.500.795", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "Country in the Middle East, bordering the Mediterranean Sea, between Lebanon and Turkey. The capital is Damascus.", "MR": "20171212", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013593"}, {"RECTYPE": "D", "MH": "Syringes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Syringes, Hypodermic", "MN": "E07.877", "MH_TH": "POPLINE (1978)", "ST": "T074", "MS": "Instruments used for injecting or withdrawing fluids. (Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013594"}, {"RECTYPE": "D", "MH": "Syringomyelia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Morvan Disease|T047|NON|REL|GHR (2014)|NLM (2000)|OMIM (2013)|ORD (2010)|991103|MORVAN DIS|abcdeeeefv", "ENTRY": "Syringomyelias", "MN": "C10.228.854.833", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Longitudinal cavities in the spinal cord, most often in the cervical region, which may extend for multiple spinal levels. The cavities are lined by dense, gliogenous tissue and may be associated with SPINAL CORD NEOPLASMS; spinal cord traumatic injuries; and vascular malformations. Syringomyelia is marked clinically by pain and PARESTHESIA, muscular atrophy of the hands, and analgesia with thermoanesthesia of the hands and arms, but with the tactile sense preserved (sensory dissociation). Lower extremity spasticity and incontinence may also develop. (From Adams et al., Principles of Neurology, 6th ed, p1269)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013595"}, {"RECTYPE": "D", "MH": "Systems Analysis", "DE": "SYSTEMS ANAL", "ENTRY": "Thinkings, Systems", "MN": "L01.906", "FX": "Task Performance and Analysis", "MH_TH": "POPLINE (1978)", "ST": "T090", "MS": "The analysis of an activity, procedure, method, technique, or business to determine what must be accomplished and how the necessary operations may best be accomplished.", "PM": "66; was see under HUMAN ENGINEERING 1963-65", "HN": "66(65); was see under HUMAN ENGINEERING 1963-65", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013597"}, {"RECTYPE": "D", "MH": "Systems Theory", "PRINT ENTRY": "Queuing Theory|T170|NON|NRW|UNK (19XX)|790531|abcdef", "ENTRY": "Theory, Systems", "MN": "H01.770.808", "FX": "Systems Biology", "MH_TH": "NLM (1980)", "ST": "T170", "PI": "Systems Analysis (1966-1979)", "MS": "Principles, models, and laws that apply to complex interrelationships and interdependencies of sets of linked components which form a functioning whole, a system. Any system may be composed of components which are systems in their own right (sub-systems), such as several organs within an individual organism.", "OL": "search SYSTEMS ANALYSIS 1976-79", "PM": "80; was see SYSTEMS ANALYSIS 1976-79", "HN": "80; was see SYSTEMS ANALYSIS 1976-79", "MR": "20040707", "DA": "19790531", "DC": "1", "DX": "19800101", "UI": "D013598"}, {"RECTYPE": "D", "MH": "Systole", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Systolic Time Interval|T079|NON|REL|UNK (19XX)|771206|abcdef", "ENTRY": "Time Intervals, Systolic", "MN": "G11.427.494.570.880", "MH_TH": "NLM (1979)", "ST": "T079", "AN": "SYSTOLIC PRESSURE see BLOOD PRESSURE & do not add SYSTOLE (NIM) unless particularly discussed", "PI": "Myocardial Contraction (1975-1978)", "MS": "Period of contraction of the HEART, especially of the HEART VENTRICLES.", "PM": "91; was see under MYOCARDIAL CONTRACTION 1979-90", "HN": "91(79); was see under MYOCARDIAL CONTRACTION 1979-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19771206", "DC": "1", "DX": "19910101", "UI": "D013599"}, {"RECTYPE": "D", "MH": "T-Lymphocytes", "DS": "LYMPHOCYTES J", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Thymus-Dependent Lymphocytes|T025|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Thymus-Dependent Lymphocyte", "MN": "A15.382.490.555.567.569", "FX": "Lymphocyte Cooperation", "MH_TH": "NLM (1973)", "ST": "T025", "AN": "general; prefer specifics; subpopulations: coordinate T-LYMPHOCYTE SUBSETS (IM) with specific T-LYMPHOCYTE (IM)", "PI": "Lymphocytes (1966-1972)", "MS": "Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.", "PM": "1990; see T LYMPHOCYTES 1973-1989", "HN": "1990 (1973)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013601"}, {"RECTYPE": "D", "MH": "T-Lymphocytes, Cytotoxic", "DE": "T LYMPHOCYTES CYTOTOX", "DS": "LYMPHOCYTES J CYTOTOXIC", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "TC2 Cells|T025|ABX|NRW|NLM (2002)|001121|TC A 002 CELLS|abcdefs", "ENTRY": "T-Lymphocyte, Cytotoxic", "MN": "A15.382.490.555.567.569.500.200", "MH_TH": "NLM (1983)", "ST": "T025", "AN": "if subpopulations are discussed, coordinate IM with T-LYMPHOCYTE SUBSETS (IM)", "PI": "T Lymphocytes (1973-1982)", "MS": "Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2.", "OL": "use T-LYMPHOCYTES, CYTOTOXIC to search T LYMPHOCYTES, CYTOTOXIC 1983-89", "PM": "90; was T LYMPHOCYTES, CYTOTOXIC 1983-89", "HN": "90; was T LYMPHOCYTES, CYTOTOXIC 1983-89", "MR": "20220413", "DA": "19820429", "DC": "1", "DX": "19830101", "UI": "D013602"}, {"RECTYPE": "D", "MH": "T-Phages", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Phages T|T005|NON|EQV|UNK (19XX)|790416|abcdef", "ENTRY": "T-Phage", "MN": "B04.123.205.891", "MH_TH": "NLM (1980)", "ST": "T005", "AN": "general or unspecified; prefer specifics; do not confuse with T VIRUS see RETICULOENDOTHELIOSIS VIRUS", "PI": "Coliphages (1966-1979)", "MS": "A series of 7 virulent phages which infect E. coli. The T-even phages T2, T4; (BACTERIOPHAGE T4), and T6, and the phage T5 are called \"autonomously virulent\" because they cause cessation of all bacterial metabolism on infection. Phages T1, T3; (BACTERIOPHAGE T3), and T7; (BACTERIOPHAGE T7) are called \"dependent virulent\" because they depend on continued bacterial metabolism during the lytic cycle. The T-even phages contain 5-hydroxymethylcytosine in place of ordinary cytosine in their DNA.", "PM": "80", "HN": "80", "MR": "20200902", "DA": "19790416", "DC": "1", "DX": "19800101", "UI": "D013604"}, {"RECTYPE": "D", "MH": "T-2 Toxin", "DS": "T AA TOXIN 02", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fusaritoxin|T109|T131|NON|EQV|UNK (19XX)|800520|abbcdef", "ENTRY": "Toxin, T2", "MN": "D23.946.587.933.950.500", "MH_TH": "NLM (1977)", "ST": "T131", "N1": "Trichothec-9-ene-3,4,8,15-tetrol, 12,13-epoxy-, 4,15-diacetate 8-(3-methylbutanoate), (3alpha,4beta,8alpha)-", "RN": "I3FL5NM3MO", "RR": "42461-85-8 (cpd without stereochemical designation)", "PI": "Trichothecenes (1975-1976)", "MS": "A potent mycotoxin produced in feedstuffs by several species of the genus FUSARIUM. It elicits a severe inflammatory reaction in animals and has teratogenic effects.", "PM": "91; was see under SESQUITERPENES 1977-90", "HN": "91(77); was see under SESQUITERPENES 1977-90", "MR": "20190705", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D013605"}, {"RECTYPE": "D", "MH": "Tabes Dorsalis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Syphilis, Spinal Cord|T047|NON|REL|NLM (1992)|910412|abcdef", "ENTRY": "Syphilitic Meningomyelitides", "MN": "C10.228.854.889", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Parenchymatous NEUROSYPHILIS marked by slowly progressive degeneration of the posterior columns, posterior roots, and ganglia of the spinal cord. The condition tends to present 15 to 20 years after the initial infection and is characterized by lightening-like pains in the lower extremities, URINARY INCONTINENCE; ATAXIA; severely impaired position and vibratory sense, abnormal gait (see GAIT DISORDERS, NEUROLOGIC), OPTIC ATROPHY; Argyll-Robertson pupils, hypotonia, hyperreflexia, and trophic joint degeneration (Charcot's Joint; see ARTHROPATHY, NEUROGENIC). (From Adams et al., Principles of Neurology, 6th ed, p726)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013606"}, {"RECTYPE": "D", "MH": "Tablets", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tablet|T122|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D26.255.830", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "AN": "IM for general only, qualif permitted; NIM (no qualif) when drug in tablet form is IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in the tablet, not the \"tablet\"", "MS": "Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013607"}, {"RECTYPE": "D", "MH": "Tablets, Enteric-Coated", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Tablets, Enteric Coated", "MN": "D26.255.830.860", "MH_TH": "NLM (1966)", "ST": "T122", "RN": "0", "AN": "IM for general only, qualif permitted; NIM (no qualif) when drug in tablet form is IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in the tablet, not the \"tablet\"", "MS": "Tablets coated with material that delays release of the medication until after they leave the stomach. (Dorland, 28th ed)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013608"}, {"RECTYPE": "D", "MH": "Taboo", "AQ": "CL HI PX", "ENTRY": "Taboos", "MN": "I01.076.201.450.948", "MH_TH": "POPLINE (1978)", "ST": "T078", "MS": "Any negative tradition or behavior that is generally regarded as harmful to social welfare and forbidden within a cultural or social group.", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013609"}, {"RECTYPE": "D", "MH": "Tachycardia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tachyarrhythmia|T033|T046|NON|REL|NLM (1991)|900404|abbcdef", "ENTRY": "Tachycardias", "MN": "C23.550.073.845", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013610"}, {"RECTYPE": "D", "MH": "Tachycardia, Atrioventricular Nodal Reentry", "DE": "AVNRT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tachycardia, AV Nodal Reentrant|T047|ACX|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Tachycardia, Atrioventricular Reentrant", "MN": "C23.550.073.845.787.500", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Tachycardia, Paroxysmal (1966-1986)", "MS": "Abnormally rapid heartbeats caused by reentry of atrial impulse into the dual (fast and slow) pathways of ATRIOVENTRICULAR NODE. The common type involves a blocked atrial impulse in the slow pathway which reenters the fast pathway in a retrograde direction and simultaneously conducts to the atria and the ventricles leading to rapid HEART RATE of 150-250 beats per minute.", "PM": "1991; see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90", "HN": "1991(1987)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19860623", "DC": "1", "DX": "19910101", "UI": "D013611"}, {"RECTYPE": "D", "MH": "Tachycardia, Ectopic Atrial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ectopic Atrial Tachycardia|T047|NON|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Tachycardias, Ectopic Atrial", "MN": "C23.550.073.845.880.315", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Tachycardia (1966-1986)", "MS": "Abnormally rapid heartbeats originating from one or more automatic foci (nonsinus pacemakers) in the HEART ATRIUM but away from the SINOATRIAL NODE. Unlike the reentry mechanism, automatic tachycardia speeds up and slows down gradually. The episode is characterized by a HEART RATE between 135 to less than 200 beats per minute and lasting 30 seconds or longer.", "PM": "91; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90", "HN": "91(87); was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19860623", "DC": "1", "DX": "19910101", "UI": "D013612"}, {"RECTYPE": "D", "MH": "Tachycardia, Ectopic Junctional", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Junctional Ectopic Tachycardia|T047|NON|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Tachycardias, Junctional Ectopic", "MN": "C23.550.073.845.880.320", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Tachycardia (1966-1986)", "MS": "A rare form of supraventricular tachycardia caused by automatic, not reentrant, conduction initiated from sites at the atrioventricular junction, but not the ATRIOVENTRICULAR NODE. It usually occurs during myocardial infarction, after heart surgery, or in digitalis intoxication with a HEART RATE ranging from 140 to 250 beats per minute.", "PM": "91; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90", "HN": "91(87); was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19860623", "DC": "1", "DX": "19910101", "UI": "D013613"}, {"RECTYPE": "D", "MH": "Tachycardia, Paroxysmal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tachycardias, Paroxysmal Reciprocal", "MN": "C23.550.073.845.695", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Abnormally rapid heartbeats with sudden onset and cessation.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013614"}, {"RECTYPE": "D", "MH": "Tachycardia, Sinoatrial Nodal Reentry", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tachycardia, SA Nodal Reentrant|T047|ACX|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Sinus Node Reentrant Tachycardia|T047|NON|EQV|NLM (2008)|060922|abcdef", "MN": "C23.550.073.845.787.750", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Tachycardia (1966-1986)", "MS": "Abnormally rapid heartbeats caused by reentry circuit in or around the SINOATRIAL NODE. It is characterized by sudden onset and offset episodes of tachycardia with a HEART RATE of 100-150 beats per minute. The P wave is identical to the sinus P wave but with a longer PR interval.", "PM": "91; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90", "HN": "91(87); was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19860623", "DC": "1", "DX": "19910101", "UI": "D013615"}, {"RECTYPE": "D", "MH": "Tachycardia, Sinus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sinus Tachycardia|T047|NON|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Tachycardias, Sinus", "MN": "C23.550.073.845.880.845", "MH_TH": "NLM (1987)", "ST": "T047", "PI": "Tachycardia (1966-1986)", "MS": "Simple rapid heartbeats caused by rapid discharge of impulses from the SINOATRIAL NODE, usually between 100 and 180 beats/min in adults. It is characterized by a gradual onset and termination. Sinus tachycardia is common in infants, young children, and adults during strenuous physical activities.", "PM": "91; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90", "HN": "91(87); was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19860623", "DC": "1", "DX": "19910101", "UI": "D013616"}, {"RECTYPE": "D", "MH": "Tachycardia, Supraventricular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tachycardias, Supraventricular", "MN": "C23.550.073.845.880", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "general: prefer specific types of supraventric tachycardia; do not confuse with TACHYCARDIA, VENTRICULAR which originates below the bundle of His", "PI": "Tachycardia, Paroxysmal (1966-1986)", "MS": "A generic expression for any tachycardia that originates above the BUNDLE OF HIS.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19860623", "DC": "1", "DX": "19870101", "UI": "D013617"}, {"RECTYPE": "D", "MH": "Tachyphylaxis", "AQ": "EH GE IM PH RE", "MN": "G12.535.425.910", "MH_TH": "NLM (1963)", "ST": "T040", "AN": "\"rapidly decreasing response to a drug or physiol active agent after admin of a few doses\"", "MS": "Rapidly decreasing response to a drug or physiologically active agent after administration of a few doses. In immunology, it is the rapid immunization against the effect of toxic doses of an extract or serum by previous injection of small doses. (Dorland, 28th ed)", "PM": "66", "HN": "66(63)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013618"}, {"RECTYPE": "D", "MH": "Tacrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetrahydroaminoacridine|T109|T121|NON|EQV|UNK (19XX)|870504|abbcdef", "ENTRY": "Tenakrin|T109|T121|TRD|NRW|NLM (1990)|890331|abbcdef", "MN": "D03.633.300.046.250.900", "PA": "Parasympathomimetics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "9-Acridinamine, 1,2,3,4-tetrahydro-", "RN": "4VX7YNB537", "RR": "4966RNG0BU", "PI": "Amines (1972-1974)", "MS": "A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.", "PM": "91; was see under AMINOACRIDINES 1984-90; was see under ACRIDINES 1975-83", "HN": "91(75); was see under AMINOACRIDINES 1984-90; was see under ACRIDINES 1975-83", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013619"}, {"RECTYPE": "D", "MH": "Tajikistan", "AQ": "EH EP", "PRINT ENTRY": "Tadzhikistan|T083|NAM|EQV|NLM (1993)|920422|abcdef", "ENTRY": "Tadzhik SSR|T083|NAM|EQV|UNK (19XX)|810302|abcdef", "MN": "Z01.252.100.900", "MH_TH": "POPLINE (1993)", "ST": "T083", "MS": "Country in central Asia, west of China, south of Kyrgyzstan. The capital is Dushanbe.", "OL": "use TAJIKISTAN to search TADZHIK S.S.R. 1982-92 & TADZHIKISTAN 1966-81", "HN": "93; was TADZHIK S.S.R. 1982-92; was TADZHIKISTAN 1963-81", "MR": "20180201", "DA": "19990101", "DC": "4", "DX": "19930101", "UI": "D013620"}, {"RECTYPE": "D", "MH": "Taenia", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Taeniarhynchus|T204|NON|EQV|UNK (19XX)|771205|abcdef", "ENTRY": "Taenias", "MN": "B01.050.500.500.736.215.895", "FX": "Neurocysticercosis", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6202", "MS": "A genus of large tapeworms.", "OL": "use TAENIA to search TAENIARHYNCHUS 1966-78", "PM": "TAENIARHYNCHUS was see under TAENIA 1966-78", "HN": "TAENIARHYNCHUS was see under TAENIA 1966-78", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013621"}, {"RECTYPE": "D", "MH": "Taeniasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Taenia solium Infection|T047|NON|NRW|NLM (2021)|200506|abcdef", "ENTRY": "Taeniases", "MN": "C01.610.335.190.902", "FX": "Neurocysticercosis", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Cestode Infections (1966-1967)", "MS": "Infection with tapeworms of the genus Taenia.", "PM": "1968", "HN": "1968", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013622"}, {"RECTYPE": "D", "MH": "Tail", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tails", "MN": "A13.895", "FX": "Coccyx", "MH_TH": "NLM (1968)", "ST": "T023", "AN": "avoid subheadings when tail is test tissue", "PI": "specific animal (1966-1967)", "MS": "An extension of the posterior of an animal body beyond the TORSO.", "PM": "68", "HN": "68", "MR": "20200221", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013623"}, {"RECTYPE": "D", "MH": "Taiwan", "AQ": "EH EP", "PRINT ENTRY": "Republic of China|T083|NAM|EQV|UNK (19XX)|750101|abcdef", "MN": "Z01.639.850", "MH_TH": "NLM (1986)", "ST": "T083", "MS": "Country in eastern Asia, islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China. The capital is Taipei. The alternate country name is Republic of China.", "MR": "20171208", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013624"}, {"RECTYPE": "D", "MH": "Takayasu Arteritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulseless Disease|T047|NON|EQV|NLM (1995)|OMIM (2013)|ORD (2010)|930831|PULSELESS DIS|abcdeeefv", "ENTRY": "Young Female Arteritides", "MN": "C17.800.862.875", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A chronic inflammatory process that affects the AORTA and its primary branches, such as the brachiocephalic artery (BRACHIOCEPHALIC TRUNK) and CAROTID ARTERIES. It results in progressive arterial stenosis, occlusion, and aneurysm formation. The pulse in the arm is hard to detect. Patients with aortitis syndrome often exhibit retinopathy.", "PM": "2008; see TAKAYASU'S ARTERITIS 1995-2007,see PULSELESS DISEASE 1993-1994, see TAKAYASU SYNDROME 1991-1992, see AORTIC ARCH SYNDROMES 1965-1990, see AORTIC DISEASES 1963-1964; for AORTITIS SYNDROME see AORTIC ARCH SYNDROMES 1987-2007", "HN": "2008 (1963)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013625"}, {"RECTYPE": "D", "MH": "Talampicillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phthalidyl Ampicillin|T109|T195|NON|EQV|UNK (19XX)|770224|abbcdef", "ENTRY": "Hydrochloride, Talampicillin", "MN": "D03.633.100.300.750.750.050.900", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1,3-dihydro-3-oxo-1-isobenzofuranyl ester, (2S-(2alpha,5alpha,6beta(S*)))-", "RN": "29OJI73DPC", "RR": "4C5O3X072I", "PI": "Benzofurans (1966-1976)", "MS": "An ester of AMPICILLIN which is readily hydrolyzed on absorption to release ampicillin. It is well absorbed from the gastrointestinal tract resulting in a greater bioavailability of ampicillin than can be achieved with equivalent doses of ampicillin.", "PM": "91; was see under AMPICILLIN 1978-90", "HN": "91(78); was see under AMPICILLIN 1978-90", "MR": "20160601", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D013626"}, {"RECTYPE": "D", "MH": "Talc", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Talcum Powder|T197|NON|EQV|NLM (2008)|061024|abcdef", "MN": "D01.837.725.700.760.535.800", "PA": "Antiperspirants", "MH_TH": "NLM (1966)", "ST": "T197", "N1": "Talc (Mg3H2(SiO3)4)", "RN": "14807-96-6", "MS": "Finely powdered native hydrous magnesium silicate. It is used as a dusting powder, either alone or with starch or boric acid, for medicinal and toilet preparations. It is also an excipient and filler for pills, tablets, and for dusting tablet molds. (From Merck Index, 11th ed)", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013627"}, {"RECTYPE": "D", "MH": "Talus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Os Trigonum|T023|NON|REL|UNK (19XX)|750101|abcdef", "ENTRY": "Bones, Astragalus", "MN": "A02.835.232.043.300.710.780", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The second largest of the TARSAL BONES. It articulates with the TIBIA and FIBULA to form the ANKLE JOINT.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013628"}, {"RECTYPE": "D", "MH": "Tamoxifen", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ICI47699", "MN": "D02.455.426.559.389.150.700.900", "PA": "Selective Estrogen Receptor Modulators", "MH_TH": "NLM (1978)", "ST": "T121", "N1": "Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-", "RN": "094ZI81Y45", "RR": "7FRV7310N6", "PI": "Stilbenes (1966-1974)", "MS": "One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.", "PM": "78; was see under STILBENES 1975-77", "HN": "78(75); was see under STILBENES 1975-77", "MR": "20160701", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D013629"}, {"RECTYPE": "D", "MH": "Tampons, Surgical", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Tampon, Surgical", "MN": "E07.858.826", "MH_TH": "NLM (2007)", "ST": "T073", "AN": "VAGINAL TAMPONS is also available", "MS": "Plugs or cylinders made of cotton, sponge, or other absorbent material. They are used in surgery to absorb fluids such as blood or drainage.", "PM": "2007; see TAMPONS 1963-2006", "HN": "2007 (1963)", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D013630"}, {"RECTYPE": "D", "MH": "Tangier Disease", "DE": "TANGIER DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tangier Disease Neuropathy|T047|NAM|NRW|GHR (2014)|NLM (2000)|991104|TANGIER DIS NEUROPATHY|abcdeefv", "ENTRY": "Thesaurismosis, Cholesterol", "MN": "C18.452.648.398.500.330.750", "FX": "Retinitis Pigmentosa", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Lipoproteins, HDL (1972-1977)", "MS": "An autosomal recessively inherited disorder caused by mutation of ATP-BINDING CASSETTE TRANSPORTERS involved in cellular cholesterol removal (reverse-cholesterol transport). It is characterized by near absence of ALPHA-LIPOPROTEINS (high-density lipoproteins) in blood. The massive tissue deposition of cholesterol esters results in HEPATOMEGALY; SPLENOMEGALY; RETINITIS PIGMENTOSA; large orange tonsils; and often sensory POLYNEUROPATHY. The disorder was first found among inhabitants of Tangier Island in the Chesapeake Bay, MD.", "PM": "1991; see HYPOLIPOPROTEINEMIA 1980-1990, see HYPOLIPOPROTEINEMIAS 1978-1979", "HN": "1991(1978)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19770429", "DC": "1", "DX": "19910101", "UI": "D013631"}, {"RECTYPE": "D", "MH": "Tanning", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Tannings", "MN": "J01.576.852", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "do not confuse with SUNTANNING see SUNBATHING ", "MS": "A process of preserving animal hides by chemical treatment (using vegetable tannins, metallic sulfates, and sulfurized phenol compounds, or syntans) to make them immune to bacterial attack, and subsequent treatments with fats and greases to make them pliable. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013633"}, {"RECTYPE": "D", "MH": "Tannins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tannin|T109|NON|EQV|NLM (2021)|191129|abcdef", "MN": "D05.750.078.937", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "HYDROLYZABLE TANNINS is also available", "MS": "Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS). The two main types are HYDROLYZABLE TANNINS and CONDENSED TANNINS. Historically, the term has applied to many compounds and plant extracts able to render skin COLLAGEN impervious to degradation. The word tannin derives from the Celtic word for OAK TREE which was used for leather processing.", "HN": "2022 (1966)", "MR": "20230522", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013634"}, {"RECTYPE": "D", "MH": "Tantalum", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Tantalum 181", "MN": "D01.552.544.837", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Tantalum", "RN": "6424HBN274", "RR": "7440-25-7 (Tantalum)", "MS": "A rare metallic element, atomic number 73, atomic weight 180.948, symbol Ta. It is a noncorrosive and malleable metal that has been used for plates or disks to replace cranial defects, for wire sutures, and for making prosthetic devices.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013635"}, {"RECTYPE": "D", "MH": "Tanzania", "AQ": "EH EP", "PRINT ENTRY": "Zanzibar|T083|NAM|NRW|NLM (1994)|920820|abcdef", "ENTRY": "United Republic of Tanzania|T083|NAM|EQV|NLM (2009)|080325|abcdef", "MN": "Z01.058.290.120.840", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in eastern Africa, south of UGANDA and north of MOZAMBIQUE. Its capital is Dar es Salaam. It was formed in 1964 by a merger of the countries of TANGANYIKA and ZANZIBAR.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013636"}, {"RECTYPE": "D", "MH": "Tape Recording", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Recording, Tape", "MN": "L01.462.500.820.090.846", "MH_TH": "NLM (1964)", "ST": "T073", "AN": "IM", "MS": "Recording of information on magnetic or punched paper tape.", "PM": "67", "HN": "67(64)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D013637"}, {"RECTYPE": "D", "MH": "Tars", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D20.749", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Viscous materials composed of complex, high-molecular-weight compounds derived from the distillation of petroleum or the destructive distillation of wood or coal. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013638"}, {"RECTYPE": "D", "MH": "Tarsal Bones", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Tarsus Osseus|T023|NON|EQV|NLM (1997)|950718|abcdef", "ENTRY": "Tarsal Bone", "MN": "A02.835.232.043.300.710", "FX": "Ankle", "MH_TH": "NLM (1972)", "ST": "T023", "AN": "note entry terms; TALUS & CALCANEUS are available; do not confuse with TARSUS see ANKLE or TARSAL JOINTS", "PI": "Ankle Joint (1966-1971)", "MS": "The seven bones which form the tarsus - namely, CALCANEUS; TALUS; cuboid, navicular, and the internal, middle, and external cuneiforms.", "OL": "use TARSUS to search TARSUS OSSEUS 1988-96", "PM": "72; TARSUS OSSEUS was see TARSUS 1988-96", "HN": "72; TARSUS OSSEUS was see TARSUS 1988-96", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013639"}, {"RECTYPE": "D", "MH": "Tarsal Joints", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Tarsal Joint|T030|NON|EQV|NLM (1965)|990101|abcdef", "ENTRY": "Joints, Tarsal", "MN": "A02.835.583.378.831", "MH_TH": "NLM (2002)", "ST": "T030", "AN": "do not confuse with TARSUS see ANKLE; tarsal joints of animals goes here not under TARSUS, ANIMAL", "MS": "The articulations between the various TARSAL BONES. This does not include the ANKLE JOINT which consists of the articulations between the TIBIA; FIBULA; and TALUS.", "PM": "2002; see TARSAL JOINT 1965-2001", "HN": "2002 (1965)", "MR": "20050802", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013640"}, {"RECTYPE": "D", "MH": "Tarsal Tunnel Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tibial Neuropathy, Tarsal Tunnel|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Tunnel Syndromes, Tarsal", "MN": "C10.668.829.550.800", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Entrapment of the distal branches of the posterior TIBIAL NERVE (which divides into the medial plantar, lateral plantar, and calcanial nerves) in the tarsal tunnel, which lies posterior to the internal malleolus and beneath the retinaculum of the flexor muscles of the foot. Symptoms include ankle pain radiating into the foot which tends to be aggravated by walking. Examination may reveal Tinel's sign (radiating pain following nerve percussion) over the tibial nerve at the ankle, weakness and atrophy of the small foot muscles, or loss of sensation in the foot. (From Foot Ankle 1990;11(1):47-52)", "PM": "1972", "HN": "1972(1964)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013641"}, {"RECTYPE": "D", "MH": "Tarsus, Animal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hock|T029|NON|EQV|NLM (1997)|951205|abcdef", "ENTRY": "Hocks", "MN": "A13.473.821", "MH_TH": "NLM (1975)", "ST": "T029", "AN": "use for ankle of non-primate vertebrates; tarsal joints of animals does not go here: use TARSAL JOINTS", "MS": "The region in the hindlimb of a quadruped, corresponding to the human ANKLE.", "PM": "1988; see HINDLIMB 1968-87; for HOCK see HINDLIMB 1997-2001, see HOCK 1991-1996, see HINDLIMB 1975-1990", "HN": "1988(1968); for HOCK see HINDLIMB 1975-2001", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19880101", "UI": "D013643"}, {"RECTYPE": "D", "MH": "Tartrates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D09.811.779", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of tartronic acid (the structural formula (COOH)CHOH(COOH)) including its salts and esters.", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013644"}, {"RECTYPE": "D", "MH": "Tartrazine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Barium, Tartrazine", "MN": "D02.172.950", "PA": "Food Coloring Agents", "MH_TH": "NLM (1977)", "ST": "T130", "N1": "1H-Pyrazole-3-carboxylic acid, 4,5-dihydro-5-oxo-1-(4-sulfophenyl)-4-((4-sulfophenyl)azo)-, trisodium salt", "RN": "I753WB2F1M", "RR": "84681-80-1 (barium salt (2:3))", "PI": "Pyrazoles (1969-1976)", "MS": "An anionic, hydrophilic azo dye with an orange-yellow color used in fabrics, foods and cosmetics, and as a biological stain.", "PM": "91; was see under AZO COMPOUNDS 1977-90", "HN": "91(77); was see under AZO COMPOUNDS 1977-90", "MR": "20130708", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D013645"}, {"RECTYPE": "D", "MH": "Tartronates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Hydroxymalonic", "MN": "D09.811.835", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of tartronic acid (the structural formula (COOH)CHOH(COOH)) including its salts and esters.", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013646"}, {"RECTYPE": "D", "MH": "Task Performance and Analysis", "DE": "TASK PERFORMANCE ANAL", "PRINT ENTRY": "Critical Incident Technique|T057|NON|NRW|NLM (1997)|951204|abcdef", "ENTRY": "Techniques, Critical Incident", "MN": "F02.808.600", "FX": "Workload", "MH_TH": "NLM (1972)", "ST": "T057", "AN": "do not use for analysis of performance on individual tasks in learning experiments", "MS": "The detailed examination of observable activity or behavior associated with the execution or completion of a required function or unit of work.", "PM": "73", "HN": "73(72)", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013647"}, {"RECTYPE": "D", "MH": "Tasmania", "AQ": "EH EP", "MN": "Z01.678.100.373.984", "MH_TH": "NLM (1988)", "ST": "T083", "AN": "an island state of Australia", "PI": "Australia (1966-1987)", "MS": "An island south of Australia and the smallest state of the Commonwealth. Its capital is Hobart. It was discovered and named Van Diemen's Island in 1642 by Abel Tasman, a Dutch navigator, in honor of the Dutch governor-general of the Dutch East Indian colonies. It was renamed for the discoverer in 1853. In 1803 it was taken over by Great Britain and was used as a penal colony. It was granted government in 1856 and federated as a state in 1901. (From Webster's New Geographical Dictionary, 1988, p1190 & Room, Brewer's Dictionary of Names, p535)", "HN": "88", "MR": "20150623", "DA": "19870309", "DC": "4", "DX": "19880101", "UI": "D013648"}, {"RECTYPE": "D", "MH": "Taste", "AQ": "DE GE IM PH RE", "ENTRY": "Tastes", "MN": "G11.561.790.724", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "differentiate from TASTE PERCEPTION: TASTE takes place in the mouth, TASTE PERCEPTION takes place in the brain", "MS": "The ability to detect chemicals through gustatory receptors in the mouth, including those on the TONGUE; the PALATE; the PHARYNX; and the EPIGLOTTIS.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013649"}, {"RECTYPE": "D", "MH": "Taste Buds", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Taste Bud", "MN": "A14.549.885.779", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "chemoreceptors on the tongue, palate & pharynx", "MS": "Small sensory organs which contain gustatory receptor cells, basal cells, and supporting cells. Taste buds in humans are found in the epithelia of the tongue, palate, and pharynx. They are innervated by the CHORDA TYMPANI NERVE (a branch of the facial nerve) and the GLOSSOPHARYNGEAL NERVE.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013650"}, {"RECTYPE": "D", "MH": "Taste Disorders", "DE": "TASTE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Taste, Metallic|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Tastes, Metallic", "MN": "C23.888.592.763.861", "MH_TH": "NLM (1971)", "ST": "T047", "PI": "Taste (1966-1970)", "MS": "Conditions characterized by an alteration in gustatory function or perception. Taste disorders are frequently associated with OLFACTION DISORDERS. Additional potential etiologies include METABOLIC DISEASES; DRUG TOXICITY; and taste pathway disorders (e.g., TASTE BUD diseases; FACIAL NERVE DISEASES; GLOSSOPHARYNGEAL NERVE DISEASES; and BRAIN STEM diseases).", "PM": "1973", "HN": "1973(1971)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013651"}, {"RECTYPE": "D", "MH": "Taste Threshold", "AQ": "CL DE GE PH RE", "ENTRY": "Thresholds, Taste", "MN": "G11.561.840", "MH_TH": "NLM (1976)", "ST": "T081", "PI": "Taste (1966-1975)", "MS": "The minimum concentration at which taste sensitivity to a particular substance or food can be perceived.", "PM": "91; was see under TASTE 1976-90", "HN": "91(76); was see under TASTE 1976-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D013652"}, {"RECTYPE": "D", "MH": "Tattooing", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Tattoos", "MN": "E04.085.840", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "includes tattooing as body decoration among various cultures and as an aid in endoscopic procedures", "MS": "The indelible marking of TISSUES, primarily SKIN, by pricking it with NEEDLES to imbed various COLORING AGENTS. Tattooing of the CORNEA is done to colorize LEUKOMA spots.", "CATSH": "CAT LIST", "MR": "20181011", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013653"}, {"RECTYPE": "D", "MH": "Taurine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Taurine, Monopotassium Salt|T116|T121|NON|NRW|FDA SRS (2014)|NLM (1999)|990913|abbcdeef", "MN": "D02.886.645.600.055.850", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "Ethanesulfonic acid, 2-amino-", "RN": "1EQV5MLY3D", "RR": "73328-73-1 (HCl)", "AN": "/biosyn /physiol permitted", "MS": "A conditionally essential nutrient, important during mammalian development. It is present in milk but is isolated mostly from ox bile and strongly conjugates bile acids.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013654"}, {"RECTYPE": "D", "MH": "Taurochenodeoxycholic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Taurochenodeoxycholate|T109|T121|T123|NON|NRW|UNK (19XX)|770303|abbbcdef", "ENTRY": "Chenodeoxycholate, Taurine", "MN": "D04.210.500.221.430.873.920.900", "PA": "Detergents", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha)-3,7-dihydroxy-24-oxocholan-24-yl)amino)-", "RN": "516-35-8", "AN": "/biosyn /physiol permitted", "PI": "Taurocholic Acid (1973-1977)", "MS": "A bile salt formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. It acts as detergent to solubilize fats in the small intestine and is itself absorbed. It is used as a cholagogue and choleretic.", "PM": "91; was see under CHENODEOXYCHOLIC ACID 1978-90", "HN": "91(78); was see under CHENODEOXYCHOLIC ACID 1978-90", "MR": "20160601", "DA": "19770304", "DC": "1", "DX": "19910101", "UI": "D013655"}, {"RECTYPE": "D", "MH": "Taurocholic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Taurocholate|T109|T121|T123|NON|NRW|UNK (19XX)|770210|abbbcdef", "ENTRY": "Taurocholate, Sodium", "MN": "D04.210.500.221.430.873", "PA": "Detergents", "MH_TH": "NLM (1973)", "ST": "T123", "N1": "Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-", "RN": "5E090O0G3Z", "RR": "M6N3TH81NO", "AN": "/biosyn /physiol permitted", "PI": "Taurine (1966-1972)", "MS": "The product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and cholerectic.", "PM": "74", "HN": "74(73)", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013656"}, {"RECTYPE": "D", "MH": "Taurodeoxycholic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Taurodeoxycholate|T109|T121|T123|NON|NRW|UNK (19XX)|770602|abbbcdef", "ENTRY": "Taurodeoxycholate, Sodium", "MN": "D04.210.500.221.430.873.920", "PA": "Detergents", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Ethanesulfonic acid, 2-(((3alpha,5beta,12alpha)-3,12-dihydroxy-24-oxocholan-24-yl)amino)-", "RN": "516-50-7", "RR": "5PE424S83L", "AN": "a bile acid; /biosyn /physiol permitted", "PI": "Taurocholic Acid (1973-1977)", "MS": "A bile salt formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. It is used as a cholagogue and choleretic, also industrially as a fat emulsifier.", "PM": "91; was see under DEOXYCHOLIC ACID 1978-90", "HN": "91(78); was see under DEOXYCHOLIC ACID 1978-90", "MR": "20160601", "DA": "19770602", "DC": "1", "DX": "19910101", "UI": "D013657"}, {"RECTYPE": "D", "MH": "Taurolithocholic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Taurolithocholate|T109|T121|T123|NON|NRW|UNK (19XX)|770601|abbbcdef", "ENTRY": "Lithocholate, Taurine", "MN": "D04.210.500.221.430.873.940", "PA": "Detergents", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Ethanesulfonic acid, 2-(((3alpha,5beta)-3-hydroxy-24-oxocholan-24-yl)amino)-", "RN": "516-90-5", "RR": "6042-32-6 (mono-Na salt)", "AN": "/biosyn /physiol permitted", "PI": "Taurocholic Acid (1973-1977)", "MS": "A bile salt formed in the liver from lithocholic acid conjugation with taurine, usually as the sodium salt. It solubilizes fats for absorption and is itself absorbed. It is a cholagogue and choleretic.", "PM": "91; was see under LITHOCHOLIC ACID 1978-90", "HN": "91(78); was see under LITHOCHOLIC ACID 1978-90", "MR": "20160601", "DA": "19770601", "DC": "1", "DX": "19910101", "UI": "D013658"}, {"RECTYPE": "D", "MH": "Tax Equity and Fiscal Responsibility Act", "DE": "TAX EQUITY FISCAL RESPONSIBILITY ACT", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "United States Tax Equity and Fiscal Responsibility Act|T089|NON|EQV|NLM (2002)|001205|abcdef", "ENTRY": "Act, Tax Equity", "MN": "N03.706.615.889", "MH_TH": "NLM (1985)", "ST": "T089", "AN": "specify state if given CATALOGER: Use NAF entry", "MS": "PL97-248. Title II of the Act specifies \"provisions relating to savings in health and income security programs.\" This includes changes in payment for services, benefits and premiums of Medicare as well as changes in provisions under Medicaid and other specific programs covered by Social Security. Title II includes various revenue measures.", "PM": "91; was see under TAXES 1985-90", "HN": "91(85); was see under TAXES 1985-90", "MR": "20150605", "DA": "19840411", "DC": "1", "DX": "19910101", "UI": "D013659"}, {"RECTYPE": "D", "MH": "Taxes", "AQ": "CL EC HI LJ SN TD", "PRINT ENTRY": "Institutional Tax|T081|NON|NRW|UNK (19XX)|820429|abcdef", "ENTRY": "Taxes, Institutional", "MN": "N03.219.900", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "coord IM with subject of tax (IM); specify geog; INCOME TAX is also available", "MS": "Governmental levies on property, inheritance, gifts, etc.", "OL": "use TAXES to search INSTITUTIONAL TAXES 1978-82", "PM": "78", "HN": "INSTITUTIONAL TAX was see under TAXES 1978-82", "MR": "19991103", "DA": "19770511", "DC": "1", "DX": "19780101", "UI": "D013660"}, {"RECTYPE": "D", "MH": "Tay-Sachs Disease", "DE": "TAY SACHS DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tay-Sachs Disease, B Variant|T047|EPO|EQV|NLM (2007)|050726|abcdef", "ENTRY": "Type I GM2-Gangliosidosis", "MN": "C18.452.648.595.554.825.300.300.840", "FX": "beta-N-Acetylhexosaminidases", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "TAY-SACHS DISEASE, AB VARIANT is also available", "PI": "Lipoidosis (1966-1978)", "MS": "An autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the HEXOSAMINIDASE A resulting in lipid-laden ganglion cells. It is also known as the B variant (with increased HEXOSAMINIDASE B but absence of hexosaminidase A) and is strongly associated with Ashkenazic Jewish ancestry.", "PM": "1979; see AMAUROTIC FAMILIAL IDIOCY 1963-1978; for AMAUROTIC FAMILIAL IDIOCY see LIPOIDOSIS 1985-2006, see AMAUROTIC FAMILIAL IDIOCY 1963-1978", "HN": "1979; for AMAUROTIC FAMILIAL IDIOCY use LIPOIDOSIS 1985-2006", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D013661"}, {"RECTYPE": "D", "MH": "Tea", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM LJ ME MI PH PO PS RE SD ST TO UL VI", "ENTRY": "Teas, Green", "MN": "J02.200.831", "FX": "Theophylline", "MH_TH": "NLM (1966)", "ST": "T168", "RN": "0", "AN": "restrict to drink prepared from tea plant, CAMELLIA SINENSIS (formerly Thea sinensis);  TEAS, HERBAL and TEAS, MEDICINAL are also available", "MS": "The infusion of leaves of CAMELLIA SINENSIS (formerly Thea sinensis) as a beverage, the familiar Asian tea, which contains CATECHIN (especially epigallocatechin gallate) and CAFFEINE.", "HN": "66", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013662"}, {"RECTYPE": "D", "MH": "Teaching", "AQ": "CL ED ES HI LJ OG PX SN ST TD", "PRINT ENTRY": "Training Technique|T065|NON|NRW|NLM (2021)|200220|abcdef", "ENTRY": "Training, Academic", "MN": "I02.903", "FX": "Faculty", "MH_TH": "NLM (1966)", "ST": "T065", "MS": "A formal and organized process of transmitting knowledge to a person or group.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013663"}, {"RECTYPE": "D", "MH": "Teaching Materials", "AQ": "EC SD ST", "ENTRY": "Teaching Material", "MN": "L01.462.500.820", "FX": "Audiovisual Aids", "MH_TH": "POPLINE (1986)", "ST": "T073", "MS": "Instructional materials used in teaching.", "PM": "74", "HN": "74", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013664"}, {"RECTYPE": "D", "MH": "Tear Gases", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO", "ENTRY": "Gas, Tear", "MN": "J01.637.870.800", "MH_TH": "NLM (1968)", "ST": "T131", "RN": "0", "MS": "Gases that irritate the eyes, throat, or skin. Severe lacrimation develops upon irritation of the eyes.", "PM": "73", "HN": "73(68)", "MR": "20170531", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013665"}, {"RECTYPE": "D", "MH": "Tears", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Meibum|T031|NON|NRW|NLM (2020)|190212|abcdef", "ENTRY": "Tear", "MN": "A12.200.882", "MH_TH": "NLM (1966)", "ST": "T031", "CX": "consider also terms at DACRYO- and LACRIMAL", "MS": "The fluid secreted by the lacrimal glands. This fluid moistens the CONJUNCTIVA and CORNEA.", "MR": "20190408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013666"}, {"RECTYPE": "D", "MH": "Technetium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "PRINT ENTRY": "Technetium 99m|T196|NON|NRW|FDA SRS (2014)|NLM (1998)|960724|TECHNETIUM A 099M|abcdeefs", "ENTRY": "99m, Technetium", "MN": "D01.552.544.843", "FX": "Organotechnetium Compounds", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Technetium", "RN": "7440-26-8", "RR": "6EW75241VU", "AN": "note entry term: many specific Technetium Tc 99m terms are available", "MS": "The first artificially produced element and a radioactive fission product of URANIUM. Technetium has the atomic symbol Tc, and atomic number 43. All technetium isotopes are radioactive. Technetium 99m (m=metastable) which is the decay product of Molybdenum 99, has a half-life of about 6 hours and is used diagnostically as a radioactive imaging agent. Technetium 99 which is a decay product of technetium 99m, has a half-life of 210,000 years.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013667"}, {"RECTYPE": "D", "MH": "Technetium Tc 99m Aggregated Albumin", "DE": "TC HSA", "DS": "TECHNETIUM TC AGGREGATED ALBUMIN 099M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS DE EC HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tc 99m-Albumin Colloid|T116|T121|T130|NON|EQV|UNK (19XX)|860611|TC ALBUMIN COLLOID 099M|abbbcdefs", "ENTRY": "Technetium 99m Albumin Colloid", "MN": "D12.776.034.900", "PA": "Radiopharmaceuticals", "MH_TH": "NLM (1985)", "ST": "T130", "RN": "0", "AN": "for routine use as label, use no qualifiers", "PI": "Technetium (1966-1984)", "MS": "A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in cardiovascular and cerebral circulation.", "PM": "85", "HN": "85", "MR": "20150605", "DA": "19840611", "DC": "1", "DX": "19850101", "UI": "D013668"}, {"RECTYPE": "D", "MH": "Technetium Tc 99m Medronate", "DE": "TC MEDRONATE", "DS": "TECHNETIUM TC MEDRONATE 099M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Technetium Methylene Diphosphonate|T109|T130|NON|EQV|UNK (19XX)|850308|abbcdef", "ENTRY": "Tc 99m Methylene Diphosphonate", "MN": "D02.705.429.500.885", "PA": "Radiopharmaceuticals", "MH_TH": "USP (19XX)", "ST": "T130", "RN": "X89XV46R07", "RR": "63347-66-0 (Technetium Tc 99m Medronate)", "AN": "for routine use as label, use no qualifiers", "PI": "Technetium (1966-1985)", "MS": "A gamma-emitting radionuclide imaging agent used primarily in skeletal scintigraphy. Because of its absorption by a variety of tumors, it is useful for the detection of neoplasms.", "PM": "1986", "HN": "1986", "MR": "20170629", "DA": "19850308", "DC": "1", "DX": "19860101", "UI": "D013669"}, {"RECTYPE": "D", "MH": "Sodium Pertechnetate Tc 99m", "DE": "SODIUM PERTECHNETATE", "DS": "SODIUM PERTECHNETATE TC 099M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Technetium Tc 99m Pertechnetate|T130|T197|NON|BRD|NLM (1994)|921207|TECHNETIUM TC PERTECHNETATE 099 M|TC PERTECHNETATE|abbcdefsv", "ENTRY": "Technetium 99mTc pertechnetate", "MN": "D01.925.800", "PA": "Radiopharmaceuticals", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Technetate (99TcO41-), sodium, (T-4)-", "RN": "A0730CX801", "RR": "23288-61-1 (parent)", "AN": "for routine use as label, use no qualifiers", "PI": "Technetium (1966-1984)", "MS": "A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints.", "PM": "1994; see TECHNETIUM TC 99M PERTECHNETATE 1985-1993; TECHNETIUM TC 99M O(4) was indexed under TECHNETIUM COMPOUNDS 2001-2002", "HN": "1994; use TECHNETIUM TC 99M PERTECHNETATE 1985-1993; for TECHNETIUM TC 99M O(4) use TECHNETIUM TC 99M O(4) (NM) 2001-2002", "MR": "20180702", "DA": "19840611", "DC": "1", "DX": "19850101", "UI": "D013670"}, {"RECTYPE": "D", "MH": "Technetium Tc 99m Sulfur Colloid", "DE": "TC SULFUR COLLOID", "DS": "TECHNETIUM TC SULFUR COLLOID 099M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Technetium Sulfur Colloid|T130|T197|NON|EQV|UNK (19XX)|840611|abbcdef", "ENTRY": "Colloid, Technetium Sulfur", "MN": "D01.925.950", "PA": "Radiopharmaceuticals", "MH_TH": "USP (19XX)", "ST": "T197", "RN": "556Q0P6PB1", "AN": "for routine use as label, use no qualifiers", "PI": "Technetium (1966-1984)", "MS": "A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, liver, and spleen.", "PM": "85", "HN": "85", "MR": "20150605", "DA": "19840611", "DC": "1", "DX": "19850101", "UI": "D013671"}, {"RECTYPE": "D", "MH": "Technology", "DE": "TECHNOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Industrial Arts|T090|NON|NRW|UNK (19XX)|780310|INDUST ARTS|abcdefv", "ENTRY": "Arts, Industrial|T090|NON|NRW|NLM (1996)|950316|ARTS INDUST|abcdefv", "MN": "J01.897", "MH_TH": "POPLINE (1978)", "ST": "T090", "MS": "The application of scientific knowledge to practical purposes in any field. It includes methods, techniques, and instrumentation.", "OL": "search INDUSTRIAL ARTS under TECHNOLOGY 1967-present & under OCCUPATIONS 1966", "PM": "INDUSTRIAL ARTS was see under TECHNOLOGY 1967-78; was see under OCCUPATIONS AND PROFESSIONS 1963-66", "HN": "INDUSTRIAL ARTS was see under TECHNOLOGY 1967-78; was see under OCCUPATIONS AND PROFESSIONS 1963-66", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013672"}, {"RECTYPE": "D", "MH": "Technology Assessment, Biomedical", "DE": "TECHNOL ASSESS BIOMED", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Technology Assessments, Health", "MN": "N05.715.360.825", "MH_TH": "NLM (1980)", "ST": "T058", "AN": "restrict to MeSH definition: do not use as routine coordinate for \"evaluation\" of a specific technique or technology", "MS": "Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems.", "PM": "80", "HN": "80", "MR": "20150701", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D013673"}, {"RECTYPE": "D", "MH": "Technology, Dental", "DE": "TECHNOL DENT", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Dental Technology|T091|NON|EQV|NLM (1991)|900111|DENT TECHNOL|abcdefv", "MN": "J01.897.724", "MH_TH": "NLM (1966)", "ST": "T091", "MS": "The field of dentistry involved in procedures for designing and constructing dental appliances. It includes also the application of any technology to the field of dentistry.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013674"}, {"RECTYPE": "D", "MH": "Technology, High-Cost", "DE": "TECHNOL HIGH COST", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "High-Cost Technology|T090|NON|EQV|UNK (19XX)|790601|HIGH COST TECHNOL|abcdefv", "ENTRY": "Technology, High Cost", "MN": "N03.880.502", "MH_TH": "NLM (1980)", "ST": "T090", "MS": "Advanced technology that is costly, requires highly skilled personnel, and is unique in its particular application. Includes innovative, specialized medical/surgical procedures as well as advanced diagnostic and therapeutic equipment.", "PM": "80", "HN": "80", "MR": "19930916", "DA": "19790601", "DC": "1", "DX": "19800101", "UI": "D013675"}, {"RECTYPE": "D", "MH": "Technology, Industry, and Agriculture", "MN": "J01", "RH": "J1 - TECHNOLOGY, INDUSTRY, AND AGRICULTURE", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "The science and application of techniques for the extraction of raw materials, provision of services, manufacture of goods, cultivation of crops, and raising of livestock.", "PM": "98", "HN": "98; use explode", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013676"}, {"RECTYPE": "D", "MH": "Medical Laboratory Science", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Technology, Medical Laboratory|T058|T091|NON|EQV|NLM (2000)|990101|TECHNOL MED LABORATORY|abbcdefv", "ENTRY": "Technologies, Medical Laboratory", "MN": "J01.897.480", "FX": "Medical Laboratory Personnel", "MH_TH": "NLM (2012)", "ST": "T091", "MS": "The specialty related to the performance of techniques in clinical pathology such as those in hematology, microbiology, and other general clinical laboratory applications.", "PM": "2012; see TECHNOLOGY, MEDICAL 1966-2012", "HN": "2012 (1966)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "20120101", "UI": "D013677"}, {"RECTYPE": "D", "MH": "Technology, Pharmaceutical", "DE": "TECHNOL PHARM", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Technology, Pharmacy|T091|NON|EQV|NLM (1998)|970107|abcdef", "ENTRY": "Technology, Pharmaceutic|T091|NON|EQV|NLM (1994)|930121|abcdef", "MN": "J01.897.836", "MH_TH": "NLM (1968)", "ST": "T091", "PI": "Pharmacy (1966-1967)", "MS": "The application of scientific knowledge or technology to pharmacy and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures, and in the treatment of patients.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160302", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013678"}, {"RECTYPE": "D", "MH": "Technology, Radiologic", "DE": "TECHNOL RADIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD VE", "ENTRY": "Radiological Technology", "MN": "J01.897.891", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "do not confuse with RADIOGRAPHY", "MS": "The application of scientific knowledge or technology to the field of radiology. The applications center mostly around x-ray or radioisotopes for diagnostic and therapeutic purposes but the technological applications of any radiation or radiologic procedure is within the scope of radiologic technology.", "CATSH": "CAT LIST", "MR": "20160321", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013679"}, {"RECTYPE": "D", "MH": "Tectorial Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tectorial Membranes", "MN": "A09.246.300.246.292.938", "MH_TH": "NLM (1979)", "ST": "T023", "PI": "Cochlea (1966-1978)", "MS": "A membrane, attached to the bony SPIRAL LAMINA, overlying and coupling with the hair cells of the ORGAN OF CORTI in the inner ear. It is a glycoprotein-rich keratin-like layer containing fibrils embedded in a dense amorphous substance.", "PM": "91; was see under COCHLEA 1979-90", "HN": "91(79); was see under COCHLEA 1979-90", "MR": "20180702", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D013680"}, {"RECTYPE": "D", "MH": "Tegmentum Mesencephali", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Trochlearis, Nucleus Nervi", "MN": "A08.186.211.132.659.413.875", "MH_TH": "NLM (1971)", "ST": "T023", "AN": "do not confuse with TECTUM MESENCEPHALI", "PI": "Mesencephalon (1966-1970)", "MS": "Portion of midbrain situated under the dorsal TECTUM MESENCEPHALI. The two ventrolateral cylindrical masses or peduncles are large nerve fiber bundles providing a tract of passage between the FOREBRAIN with the HINDBRAIN. Ventral MIDBRAIN also contains three colorful structures: the GRAY MATTER (PERIAQUEDUCTAL GRAY), the black substance (SUBSTANTIA NIGRA), and the RED NUCLEUS.", "PM": "1974; for CEREBRAL PEDUNCLES see MESENCEPHALON 1976-2007", "HN": "1974(1971); for CEREBRAL PEDUNCLES use MESENCEPHALON 1976-2007", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013681"}, {"RECTYPE": "D", "MH": "Teichoic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Acids, Teichoic", "MN": "D23.050.161.616.797", "MH_TH": "NLM (1971)", "ST": "T123", "RN": "0", "PI": "Phosphoric Acids (1966-1970)", "MS": "Bacterial polysaccharides that are rich in phosphodiester linkages. They are the major components of the cell walls and membranes of many bacteria.", "PM": "74", "HN": "74(71)", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013682"}, {"RECTYPE": "D", "MH": "Telangiectasia, Hereditary Hemorrhagic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Weber-Osler Syndrome|T047|EPO|EQV|NLM (2020)|190430|abcdef", "ENTRY": "Weber Osler Syndrome", "MN": "C16.131.240.850.968", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA.", "PM": "1968; for OSLER-RENDU DISEASE see ANGIOMATOSIS 1963-1967", "HN": "1968(1966); for OSLER-RENDU DISEASE use ANGIOMATOSIS 1963-1967", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013683"}, {"RECTYPE": "D", "MH": "Telangiectasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spider Veins|T047|NON|NRW|NLM (2003)|020318|abcdef", "ENTRY": "Veins, Spider", "MN": "C14.907.823", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "note specifics; CAPILLARY TELANGIECTASIA, BRAIN and PONTINE CAPILLARY TELANGIECTASIAS see CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS are also available", "MS": "Permanent dilation of preexisting blood vessels (CAPILLARIES; ARTERIOLES; VENULES) creating small focal red lesions, most commonly in the skin or mucous membranes. It is characterized by the prominence of skin blood vessels, such as vascular spiders.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013684"}, {"RECTYPE": "D", "MH": "Telecommunications", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Telegraphy|T066|NON|NRW|NLM (1998)|960715|TELEGR|abcdefv", "ENTRY": "Telegraphies", "MN": "L01.462.500.847", "FX": "Computer Communication Networks", "MH_TH": "POPLINE (1990)", "ST": "T066", "PI": "Television (1966-1975)", "MS": "Transmission of information over distances via electronic means.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20220712", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D013685"}, {"RECTYPE": "D", "MH": "Telemetry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Telemetries", "MN": "L01.462.500.847.675", "FX": "Telemedicine", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "coordinate with specific procedure if relevant", "MS": "Transmission of the readings of instruments to a remote location by means of wires, radio waves, or other means. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013686"}, {"RECTYPE": "D", "MH": "Telencephalon", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Endbrains", "MN": "A08.186.211.200.885", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The anterior subdivision of the embryonic PROSENCEPHALON or the corresponding part of the adult prosencephalon that includes the cerebrum and associated structures.", "PM": "1963", "HN": "1963", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013687"}, {"RECTYPE": "D", "MH": "Telepathy", "AQ": "CL DE ES PH RE", "MN": "F02.550.847", "FX": "Parapsychology", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "The knowledge or communication by one person with the mental processes of another through channels other than known physical or perceptual processes.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013688"}, {"RECTYPE": "D", "MH": "Telephone", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "PRINT ENTRY": "Switchboard Service|T057|NON|NRW|UNK (19XX)|770426|SWITCHBOARD SERV|abcdefv", "ENTRY": "Telephones", "MN": "L01.462.500.847.698", "MH_TH": "NLM (1971)", "ST": "T073", "PI": "Communication (1966-1970)", "MS": "An instrument for reproducing sounds especially articulate speech at a distance. (Webster, 3rd ed)", "PM": "74", "HN": "74(71)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013689"}, {"RECTYPE": "D", "MH": "Television", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "ENTRY": "Televisions", "MN": "L01.462.500.847.823", "MH_TH": "POPLINE (1975)", "ST": "T073", "AN": "for color TV do not coord with COLOR unless specifically emphasized & then NIM only", "MS": "The transmission and reproduction of transient images of fixed or moving objects. An electronic system of transmitting such images together with sound over a wire or through space by apparatus that converts light and sound into electrical waves and reconverts them into visible light rays and audible sound. (From Webster, 3rd ed)", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013690"}, {"RECTYPE": "D", "MH": "Tellurium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.268.513.968", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Tellurium", "RN": "NQA0O090ZJ", "RR": "13494-80-9 (Tellurium)", "MS": "An element that is a member of the chalcogen family. It has the atomic symbol Te, atomic number 52, and atomic weight 127.60. It has been used as a coloring agent and in the manufacture of electrical equipment. Exposure may cause nausea, vomiting, and CNS depression.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013691"}, {"RECTYPE": "D", "MH": "Telophase", "AQ": "DE GE IM PH RE", "ENTRY": "Telophases", "MN": "G05.113.220.781.953", "MH_TH": "NLM (1978)", "ST": "T079", "AN": "coordinate with specific cell /cytol; permitted with microorganisms", "PI": "Mitosis (1968-1977)", "MS": "The final phase of cell nucleus division following ANAPHASE, in which two daughter nuclei are formed, the CYTOPLASM completes division, and the CHROMOSOMES lose their distinctness and are transformed into CHROMATIN threads.", "PM": "81; was see under CELL CYCLE 1978-80", "HN": "81(78); was see under CELL CYCLE 1978-80", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19770510", "DC": "1", "DX": "19810101", "UI": "D013692"}, {"RECTYPE": "D", "MH": "Temazepam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Norkotral Tema|T109|T121|TRD|NRW|DE|041123|abbcdef", "ENTRY": "WY3917", "MN": "D03.633.100.079.080.070.880", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-", "RN": "CHB1QD2QSS", "RR": "846-50-4 (Temazepam)", "PI": "Benzodiazepinones (1974-1978)", "MS": "A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.", "PM": "91; was see under BENZODIAZEPINE TRANQUILIZERS 1979-90", "HN": "91(79); was see under BENZODIAZEPINE TRANQUILIZERS 1979-90", "MR": "20170524", "DA": "19780320", "DC": "1", "DX": "19910101", "UI": "D013693"}, {"RECTYPE": "D", "MH": "Temperament", "AQ": "CL DE ES PH RE", "ENTRY": "Temperaments", "MN": "F01.752.898", "MH_TH": "NLM (1975)", "ST": "T041", "MS": "Predisposition to react to one's environment in a certain way; usually refers to mood changes.", "OL": "search PERSONALITY 1968-74", "PM": "91; was see under PERSONALITY 1975-90", "HN": "91(75); was see under PERSONALITY 1975-90", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013694"}, {"RECTYPE": "D", "MH": "Temperance", "AQ": "CL EC ES HI LJ PX SN TD", "ENTRY": "Temperances", "MN": "F01.914", "MH_TH": "NLM (1966)", "ST": "T055", "AN": "ALCOHOL ABSTINENCE is also available", "MS": "Habitual moderation in the indulgence of a natural appetite, especially but not exclusively the consumption of alcohol.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013695"}, {"RECTYPE": "D", "MH": "Temperature", "ENTRY": "Temperatures", "MN": "N06.230.300.100.725.710", "FX": "Thermometers", "MH_TH": "NLM (1966)", "ST": "T081", "AN": "prefer specifics HOT TEMPERATURE or COLD TEMPERATURE", "MS": "The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013696"}, {"RECTYPE": "D", "MH": "Thermosensing", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Temperature Sense|T041|T042|NON|EQV|NLM (1966)|990101|abbcdef", "ENTRY": "Thermosensings", "MN": "G11.561.790.781", "MH_TH": "NLM (2011)", "ST": "T042", "MS": "The sensation of cold, heat, coolness, and warmth as detected by THERMORECEPTORS.", "PM": "2011; see TEMPERATURE SENSE 1963-2010", "HN": "2011 (1963)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "20110101", "UI": "D013697"}, {"RECTYPE": "D", "MH": "Templates, Genetic", "ENTRY": "Template, Genetic", "MN": "G05.360.840", "MH_TH": "NLM (2003)", "ST": "T028", "AN": "biol context only: not for metal templates or patterns or gauges; NIM", "PI": "RNA (1966-1967)", "MS": "Macromolecular molds for the synthesis of complementary macromolecules, as in DNA REPLICATION; GENETIC TRANSCRIPTION of DNA to RNA, and GENETIC TRANSLATION of RNA into POLYPEPTIDES.", "PM": "2003; TEMPLATES was heading 1968-2002", "HN": "2003", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013698"}, {"RECTYPE": "D", "MH": "Temporal Arteries", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Temporal Artery", "MN": "A07.015.114.228.868", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Arteries arising from the external carotid or the maxillary artery and distributing to the temporal region.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013699"}, {"RECTYPE": "D", "MH": "Giant Cell Arteritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Temporal Arteritis|T047|NON|NRW|NLM (1963)|OMIM (2013)|ORD (2010)|990101|abcdeeef", "ENTRY": "Temporal Arteritis, Juvenile", "MN": "C20.111.258.962.800", "FX": "Polymyalgia Rheumatica", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "A systemic autoimmune disorder that typically affects medium and large ARTERIES, usually leading to occlusive granulomatous vasculitis with transmural infiltrate containing multinucleated GIANT CELLS. The TEMPORAL ARTERY is commonly involved. This disorder appears primarily in people over the age of 50. Symptoms include FEVER; FATIGUE; HEADACHE; visual impairment; pain in the jaw and tongue; and aggravation of pain by cold temperatures. (From Adams et al., Principles of Neurology, 6th ed)", "PM": "2008; see TEMPORAL ARTERITIS 1963-2007", "HN": "2008 (1963)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D013700"}, {"RECTYPE": "D", "MH": "Temporal Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Stylomastoid Foramen|T023|NON|NRW|NLM (2020)|190220|abcdef", "ENTRY": "Temporal Bones", "MN": "A02.835.232.781.885", "FX": "Ear, Inner", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "fractures: index TEMPORAL BONE  /inj + SKULL FRACTURES; neoplasms: coordinate with SKULL NEOPLASMS ", "MS": "Either of a pair of compound bones forming the lateral (left and right) surfaces and base of the skull which contains the organs of hearing. It is a large bone formed by the fusion of parts: the squamous (the flattened anterior-superior part), the tympanic (the curved anterior-inferior part), the mastoid (the irregular posterior portion), and the petrous (the part at the base of the skull).", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013701"}, {"RECTYPE": "D", "MH": "Temporal Lobe", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Parainsular Area|T023|NON|NRW|NLM (2022)|201009|abcdef", "ENTRY": "Temporal Regions", "MN": "A08.186.211.200.885.287.500.863", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "diseases: coordinate with BRAIN DISEASES; neoplasms: coordinate with BRAIN NEOPLASMS ", "MS": "Lower lateral part of the cerebral hemisphere responsible for auditory, olfactory, and semantic processing. It is located inferior to the lateral fissure and anterior to the OCCIPITAL LOBE.", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013702"}, {"RECTYPE": "D", "MH": "Temporal Muscle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Temporal Muscles", "MN": "A14.530.940", "MH_TH": "NLM (1980)", "ST": "T023", "AN": "/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent", "PI": "Muscles (1966-1979)", "MS": "A masticatory muscle whose action is closing the jaws; its posterior portion retracts the mandible.", "PM": "91; was see under MASTICATORY MUSCLES 1980-90", "HN": "91(80); was see under MASTICATORY MUSCLES 1980-90", "MR": "20080708", "DA": "19790312", "DC": "1", "DX": "19910101", "UI": "D013703"}, {"RECTYPE": "D", "MH": "Temporomandibular Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "TMJ|T030|ACR|EQV|NLM (2002)|000928|abcdef", "ENTRY": "Temporomandibular Joints", "MN": "A14.907", "FX": "Centric Relation", "MH_TH": "NLM (1966)", "ST": "T030", "MS": "An articulation between the condyle of the mandible and the articular tubercle of the temporal bone.", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013704"}, {"RECTYPE": "D", "MH": "Temporomandibular Joint Disorders", "DE": "TEMPOROMANDIBULAR JOINT DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "TMJ Disorders|T047|EQV|NLM (1997)|960607|TMJ DIS|abdefv", "ENTRY": "Temporomandibular Joint Disorder", "MN": "C07.678", "MH_TH": "NLM (1982)", "ST": "T047", "AN": "TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME is also available", "PI": "Temporomandibular Joint (1966-1981)", "MS": "A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. (From Thoma's Oral Pathology, 6th ed, pp577-600)", "PM": "97; was TEMPOROMANDIBULAR JOINT DISEASES 1982-96", "HN": "97; was TEMPOROMANDIBULAR JOINT DISEASES 1982-96", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19810224", "DC": "1", "DX": "19820101", "UI": "D013705"}, {"RECTYPE": "D", "MH": "Temporomandibular Joint Dysfunction Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Temporomandibular Joint Syndrome|T047|NON|EQV|NLM (1997)|950913|abcdef", "ENTRY": "Syndrome, Temporomandibular Joint", "MN": "C07.678.949", "MH_TH": "NLM (1973)", "ST": "T047", "MS": "A symptom complex consisting of pain, muscle tenderness, clicking in the joint, and limitation or alteration of mandibular movement. The symptoms are subjective and manifested primarily in the masticatory muscles rather than the temporomandibular joint itself. Etiologic factors are uncertain but include occlusal dysharmony and psychophysiologic factors.", "OL": "use TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME to search TEMPOROMANDIBULAR JOINT SYNDROME 1973-96 & COSTEN'S SYNDROME 1966-96", "PM": "97; was TEMPOROMANDIBULAR JOINT SYNDROME 1973-96, was COSTEN'S SYNDROME 1966-72; COSTEN'S SYNDROME was see TEMPOROMANDIBULAR JOINT SYNDROME 1973-96", "HN": "97; was TEMPOROMANDIBULAR JOINT SYNDROME 1973-96, was COSTEN'S SYNDROME 1966-72; COSTEN'S SYNDROME was see TEMPOROMANDIBULAR JOINT SYNDROME 1973-96", "CATSH": "CAT LIST", "MR": "19960613", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013706"}, {"RECTYPE": "D", "MH": "Tendon Injuries", "DE": "TENDON INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tendon Injury", "MN": "C26.874", "MH_TH": "NLM (1973)", "ST": "T037", "MS": "Injuries to the fibrous cords of connective tissue which attach muscles to bones or other structures.", "OL": "use TENDON INJURIES to search TENDON INJURY 1966-72", "PM": "73; was TENDON INJURY 1963-72", "HN": "73; was TENDON INJURY 1963-72", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013708"}, {"RECTYPE": "D", "MH": "Tendon Transfer", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Transfers, Tendon", "MN": "E04.555.700", "MH_TH": "NLM (1969)", "ST": "T061", "PI": "Tendons/surgery (1966-1968)", "MS": "Surgical procedure by which a tendon is incised at its insertion and placed at an anatomical site distant from the original insertion. The tendon remains attached at the point of origin and takes over the function of a muscle inactivated by trauma or disease.", "PM": "73", "HN": "73(69)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013709"}, {"RECTYPE": "D", "MH": "Tendons", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tendons, Para Articular", "MN": "A02.880", "FX": "Tendon Transfer", "EC": "injuries:Tendon Injuries", "MH_TH": "NLM (1966)", "ST": "T024", "MS": "Fibrous bands or cords of CONNECTIVE TISSUE at the ends of SKELETAL MUSCLE FIBERS that serve to attach the MUSCLES to bones and other structures.", "PM": "1963; /transplantation was TENDON TRANSPLANTATION 1963-65; for TENDONS, PARA-ARTICULAR see TENDONS, PARA-ARTICULAR 1965-2006", "HN": "1963; /transplantation was TENDON TRANSPLANTATION 1963-65", "MR": "20160505", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D013710"}, {"RECTYPE": "D", "MH": "Tenebrio", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Mealworm|T204|NON|EQV|UNK (19XX)|750211|abcdef", "ENTRY": "Tenebrios", "MN": "B01.050.500.131.617.720.500.500.375.615", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid7066", "AN": "beetle; /microbiol /parasitol /virol permitted", "PI": "Beetles (1966-1971)", "MS": "A genus of beetles which infests grain products. Its larva is called mealworm.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013712"}, {"RECTYPE": "D", "MH": "Teniposide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Demethyl Epipodophyllotoxin Thenylidine Glucoside|T109|T121|NON|EQV|UNK (19XX)|750703|abbcdef", "ENTRY": "VM26", "MN": "D09.408.348.800", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USAN (1978)", "ST": "T121", "N1": "Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-((4,6-O-(2-thienylmethylene)-beta-D-glucopyranosyl)oxy)-, (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-", "RN": "957E6438QA", "RR": "89301-94-0 ((5a alpha,9 alpha(S*))-isomer)", "PI": "Podophyllotoxin (1973-1974)", "MS": "A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Teniposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent cells from entering into the mitotic phase of the cell cycle, and lead to cell death. Teniposide acts primarily in the G2 and S phases of the cycle.", "OL": "use TENIPOSIDE to search VM 26 1976-80", "PM": "91; was see under PODOPHYLLOTOXIN 1981-90; was VM 26 see under PODOPHYLLOTOXIN 1976-80", "HN": "91(81); was see under PODOPHYLLOTOXIN 1981-90; was VM 26 see under PODOPHYLLOTOXIN 1976-80", "MR": "20160701", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D013713"}, {"RECTYPE": "D", "MH": "Tennessee", "AQ": "EH EP", "MN": "Z01.107.567.875.075.775", "MH_TH": "NLM (1998)", "ST": "T083", "MS": "State bounded on the north by Kentucky and Virginia, on the east by North Carolina, on the south by Georgia, Alabama and Mississippi, and on the west by Arkansas and Missouri.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013714"}, {"RECTYPE": "D", "MH": "Tennis", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "MN": "I03.450.642.845.600.900", "MH_TH": "NLM (1976)", "ST": "T056", "AN": "/inj: coord IM with specific inj (IM); /physiol permitted", "PI": "Sports (1966-1975)", "MS": "A game played by two or four players with rackets and an elastic ball on a level court divided by a low net.", "PM": "90; was see under SPORTS 1976-89", "HN": "90(76); was see under SPORTS 1976-89", "MR": "19960610", "DA": "19750721", "DC": "1", "DX": "19900101", "UI": "D013715"}, {"RECTYPE": "D", "MH": "Tennis Elbow", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Epicondylitis, Lateral Humeral|T037|T047|NON|EQV|UNK (19XX)|810302|abbcdef", "ENTRY": "Tennis Elbows", "MN": "C26.874.800.500.500", "MH_TH": "NLM (1982)", "ST": "T047", "AN": "do not coordinate with TENNIS unless the sport is particularly discussed; do not coordinate with ATHLETIC INJURIES unless discussed as an athletic injury", "PI": "Tennis (1976-1981)", "MS": "A condition characterized by pain in or near the lateral humeral epicondyle or in the forearm extensor muscle mass as a result of unusual strain. It occurs due repetitive stresses on the elbow from activities such as tennis playing.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19810302", "DC": "1", "DX": "19820101", "UI": "D013716"}, {"RECTYPE": "D", "MH": "Tenosynovitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tenosynovitides", "MN": "C05.651.869.870", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with TENDINITIS (inflammation of tendon) or SYNOVITIS (inflammation of synovial membrane); STENOSING TENOSYNOVITIS see TENDON ENTRAPMENT is available", "MS": "Inflammation of the synovial lining of a tendon sheath. Causes include trauma, tendon stress, bacterial disease (gonorrhea, tuberculosis), rheumatic disease, and gout. Common sites are the hand, wrist, shoulder capsule, hip capsule, hamstring muscles, and Achilles tendon. The tendon sheaths become inflamed and painful, and accumulate fluid. Joint mobility is usually reduced.", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013717"}, {"RECTYPE": "D", "MH": "Tensile Strength", "AQ": "DE PH RE", "ENTRY": "Tensile Strengths", "MN": "G01.374.850", "MH_TH": "NLM (1977)", "ST": "T081", "AN": "do not confuse with COMPRESSIVE STRENGTH", "PI": "Stress, Mechanical (1973-1976)", "MS": "The maximum stress a material subjected to a stretching load can withstand without tearing. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed, p2001)", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D013718"}, {"RECTYPE": "D", "MH": "Tensor Tympani", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tympanus, Tensor", "MN": "A09.246.397.749", "MH_TH": "NLM (1963)", "ST": "T023", "AN": "/growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent", "MS": "A short muscle that arises from the pharyngotympanic tube (EUSTACHIAN TUBE) and inserts into the handle of the MALLEUS. This muscle pulls the handle medially thus controlling the tension and movement of TYMPANIC MEMBRANE.", "PM": "91; was see under TYMPANIC MEMBRANE 1963-90", "HN": "91(63); was see under TYMPANIC MEMBRANE 1963-90", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013719"}, {"RECTYPE": "D", "MH": "Tenuazonic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Tenuazonic", "MN": "D23.946.587.915", "PA": "Antiviral Agents", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "2H-Pyrrol-2-one, 3-acetyl-1,5-dihydro-4-hydroxy-5-(1-methylpropyl)-, (S-(R*,R*))-", "RN": "610-88-8", "AN": "an antineoplastic antibiotic", "PI": "Pyrrolidinones (1971-1974)", "MS": "3-Acetyl-5-sec-butyl-4-hydroxy-3-pyrrolin-2-one. A metabolite found in a strain of the fungus Alternaria tenuis Auct. which functions as an antibiotic with antiviral and antineoplastic properties, and may also act as a mycotoxin.", "PM": "91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90", "HN": "91(75); was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013720"}, {"RECTYPE": "D", "MH": "Triethylenephosphoramide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "TEPA|T109|T121|T131|ABB|EQV|FDA SRS (2014)|NLM (1996)|940715|abbbcdeef", "MN": "D03.383.097.217.935", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Aziridine, 1,1',1''-phosphinylidynetris-", "RN": "GL19M2KE52", "RR": "545-55-1 (Triethylenephosphoramide)", "AN": "a chemosterilant & alkylating antineoplastic", "PI": "Chemosterilants (1966-1971)", "MS": "An insect chemosterilant and an antineoplastic agent.", "PM": "96; was TEPA 1972-95 (see under AZIRINES 1972-90)", "HN": "96; was TEPA 1972-95 (see under AZIRINES 1972-90)", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013721"}, {"RECTYPE": "D", "MH": "Teprotide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Peptide 9a, Bradykinin-Potentiating", "MN": "D12.644.456.810", "PA": "Antihypertensive Agents", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "Bradykinin potentiator B, 2-L-tryptophan-3-de-L-leucine-4-de-L-proline-8-L-glutamine-", "RN": "C3E5QBF1R6", "RR": "35115-60-7 (Teprotide)", "PI": "Snakes (1966-1972)", "MS": "A synthetic nonapeptide (Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) which is identical to the peptide from the venom of the snake, Bothrops jararaca. It inhibits kininase II and ANGIOTENSIN I and has been proposed as an antihypertensive agent.", "OL": "use TEPROTIDE to search SQ 20881 1975-93; use TEPROTIDE (NM) to search NONAPEPTIDE CONVERTING-ENZYME INHIBITOR 1980-93", "PM": "91; was see under OLIGOPEPTIDES 1981-90, was SQ 20881 see under OLIGOPEPTIDES 1975-80; SQ 20881 was see TEPROTIDE 1981-93; NONAPEPTIDE CONVERTING-ENZYME INHIBITOR was indexed under OLIGOPEPTIDES 1975-93", "HN": "91(81); was see under OLIGOPEPTIDES 1981-90, was SQ 20881 see under OLIGOPEPTIDES 1975-80; SQ 20881 was see TEPROTIDE 1981-93; NONAPEPTIDE CONVERTING-ENZYME INHIBITOR was (NM) 1975-93", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013722"}, {"RECTYPE": "D", "MH": "Teratogens", "AQ": "AN CH CL CS EC HI IP ME PD PK RE SD ST TO", "PRINT ENTRY": "Teratogen|T131|NON|EQV|NLM (2021)|191227|abcdef", "MN": "D27.888.569.864", "FX": "Teratogenesis", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "PI": "Abnormalities, Drug-Induced (1966-1974)", "MS": "An agent that causes the production of physical defects in the developing embryo.", "PM": "75", "HN": "75", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D013723"}, {"RECTYPE": "D", "MH": "Teratoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Teratoma, Mature|T191|NON|NRW|NLM (1994)|930329|abcdef", "ENTRY": "Tumors, Teratoid", "MN": "C04.557.465.910", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642)", "OL": "use TERATOMA to search TERATOID TUMOR 1966-81 & DYSEMBRYOMA 1966-84; use DERMOID CYST to search TERATOMA, CYSTIC & TERATOMA, MATURE 1985-93", "PM": "82; was TERATOID TUMOR 1963-81; TERATOMA, CYSTIC & TERATOMA, MATURE were see DERMOID CYST 1985-93; DYSEMBRYOMA was heading 1963-84", "HN": "82; was TERATOID TUMOR 1963-81; TERATOMA, CYSTIC & TERATOMA, MATURE were see DERMOID CYST 1985-93; DYSEMBRYOMA was heading 1963-84", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19820101", "UI": "D013724"}, {"RECTYPE": "D", "MH": "Terbium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.968", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Terbium", "RN": "06SSF7P179", "RR": "7440-27-9 (Terbium)", "MS": "An element of the rare earth family of metals. It has the atomic symbol Tb, atomic number 65, and atomic weight 158.92.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013725"}, {"RECTYPE": "D", "MH": "Terbutaline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Terbutalin ratiopharm", "MN": "D02.092.063.291.905", "PA": "Tocolytic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-", "RN": "N8ONU3L3PG", "RR": "576PU70Y8E", "MS": "A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.", "PM": "74", "HN": "74", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013726"}, {"RECTYPE": "D", "MH": "Terminal Care", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "PRINT ENTRY": "End-Of-Life Care|T058|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "End-Of-Life Cares", "MN": "N02.421.585.905", "FX": "Palliative Care", "MH_TH": "BIOETHICS (1974)", "ST": "T058", "AN": "medical & nursing care for the patient; TERMINALLY ILL refers to the patient; also available is HOSPICE CARE (palliative & supportive care for the patient & family)", "MS": "Medical and nursing care of patients in the terminal stage of an illness.", "PM": "68", "HN": "68(64)", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013727"}, {"RECTYPE": "D", "MH": "Terminator Regions, Genetic", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Transcriptional Terminator Regions|T114|T123|NON|EQV|NLM (2003)|020530|abbcdef", "ENTRY": "Transcriptional Terminator Region", "MN": "G05.360.340.024.340.137.750.830", "MH_TH": "NLM (2009)", "ST": "T123", "PI": "Transcription, Genetic (1973-1984)", "MS": "DNA sequences recognized as signals to end GENETIC TRANSCRIPTION.", "PM": "2009; see TERMINATOR REGIONS (GENETICS) 1991-2008, see GENES, REGULATOR 1985-1990", "HN": "2009 (1985)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19840405", "DC": "1", "DX": "19910101", "UI": "D013728"}, {"RECTYPE": "D", "MH": "Terpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Terpenoid|T109|NON|EQV|NLM (2021)|191219|abcdef", "ENTRY": "Terpenoids|T109|NON|EQV|NLM (2004)|030512|abcdef", "MN": "D02.455.849", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A class of compounds composed of repeating 5-carbon units of HEMITERPENES.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013729"}, {"RECTYPE": "D", "MH": "Terphenyl Compounds", "DE": "TERPHENYL CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Triphenyl Compounds|T109|NON|REL|UNK (19XX)|770401|TRIPHENYL CPDS|abcdefv", "ENTRY": "Compounds, Triphenyl", "MN": "D02.455.426.559.389.805", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Benzene Derivatives (1973-1974)", "MS": "Compounds consisting of benzene rings linked to each other in either ortho, meta or para positions. Permitted are any substitutions, but ring fusion to any of the benzene rings is not allowed.", "PM": "75", "HN": "75", "MR": "19920520", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D013730"}, {"RECTYPE": "D", "MH": "Territoriality", "ENTRY": "Territorialities", "MN": "F01.145.875.864", "MH_TH": "NLM (1968)", "ST": "T054", "PI": "Behavior, Animal (1966-1967)", "MS": "Behavior in defense of an area against another individual or individuals primarily of the same species.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013731"}, {"RECTYPE": "D", "MH": "Test Anxiety Scale", "AQ": "HI SN ST", "ENTRY": "Test Anxiety Scales", "MN": "F04.711.647.513.886", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "A self-reporting test consisting of items concerning fear and worry about taking tests and physiological activity, such as heart rate, sweating, etc., before, during, and after tests.", "OL": "search PERSONALITY INVENTORY 1968-74", "PM": "91; was see under PERSONALITY INVENTORY 1975-90", "HN": "91(75); was see under PERSONALITY INVENTORY 1975-90", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013732"}, {"RECTYPE": "D", "MH": "Testicular Diseases", "DE": "TESTICULAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Testicular Disease", "MN": "C19.391.829", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes of the TESTIS.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013733"}, {"RECTYPE": "D", "MH": "Androgen-Insensitivity Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Testicular Feminization|T047|NON|NRW|GHR (2014)|NLM (1968)|ORD (2010)|990101|abcdeeef", "ENTRY": "Testicular Feminizations", "MN": "C19.391.119.096.500", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "check the tag MALE", "PI": "Sex Differentiation Disorders (1966-1967)", "MS": "A disorder of sexual development transmitted as an X-linked recessive trait. These patients have a karyotype of 46,XY with end-organ resistance to androgen due to mutations in the androgen receptor (RECEPTORS, ANDROGEN) gene. Severity of the defect in receptor quantity or quality correlates with their phenotypes. In these genetic males, the phenotypic spectrum ranges from those with normal female external genitalia, through those with genital ambiguity as in Reifenstein Syndrome, to that of a normal male with INFERTILITY.", "PM": "2002; see TESTICULAR FEMINIZATION (1970-2001)", "HN": "2002(1968)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D013734"}, {"RECTYPE": "D", "MH": "Testicular Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Hormones, Testicular", "MN": "D06.472.334.984", "MH_TH": "NLM (1975)", "ST": "T125", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Sex Hormones (1966-1974)", "MS": "Hormones produced in the testis.", "PM": "75", "HN": "75", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D013735"}, {"RECTYPE": "D", "MH": "Testicular Neoplasms", "DE": "TESTICULAR NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Testis Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Tumors, Testicular", "MN": "C19.391.829.782", "FX": "Germinoma", "MH_TH": "NLM (1963)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM)", "MS": "Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.", "PM": "1963; for TUMOR OF RETE TESTIS see TESTICULAR NEOPLASMS 1984-2006, see RETE CELL TUMOR 1963-1983", "HN": "1963", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D013736"}, {"RECTYPE": "D", "MH": "Testis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Testicles|T023|NON|EQV|NLM (2003)|011212|abcdef", "ENTRY": "Testicle", "MN": "A06.300.312.782", "FX": "Orchiectomy", "MH_TH": "NLM (1963)", "ST": "T023", "CX": "consider also terms at ORCHI-", "MS": "The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013737"}, {"RECTYPE": "D", "MH": "Testolactone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "1 Dehydrotestolactone", "MN": "D04.210.500.496.699", "PA": "Antineoplastic Agents, Hormonal", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione", "RN": "6J9BLA949Q", "RR": "968-93-4 (Testolactone)", "MS": "An antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer.", "PM": "73", "HN": "73(64)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013738"}, {"RECTYPE": "D", "MH": "Testosterone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "8 Isotestosterone", "MN": "D06.472.334.851.968.984", "PA": "Androgens", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Androst-4-en-17beta-ol-3-one", "RN": "3XMK78S47O", "RR": "58-22-0 (Testosterone)", "AN": "TESTOSTERONE PROPIONATE is also available", "MS": "A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.", "PM": "1963; SUSTANON was indexed under TESTOSTERONE/AA 1976-2003; /therapeutic use was TESTOSTERONE, THERAPEUTIC 1965", "HN": "1963; for SUSTANON use TESTOSTERONE (NM) 1976-2003; /therapeutic use was TESTOSTERONE, THERAPEUTIC 1965", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D013739"}, {"RECTYPE": "D", "MH": "3-Oxo-5-alpha-Steroid 4-Dehydrogenase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Testosterone delta-4-5-alpha-Reductase|T116|T126|NON|EQV|UNK (19XX)|760517|TESTOSTERONE DELTA ALPHA REDUCTASE 04 05|abbcdefs", "ENTRY": "delta4 3 ketosteroid 5alpha Oxidoreductase", "MN": "D08.811.682.660.465", "EC": "antagonists & inhibitors:5-alpha Reductase Inhibitors", "MH_TH": "NLM (2011)", "ST": "T126", "N1": "3-Oxo-5 alpha-steroid:(acceptor) delta(4)-oxidoreductase", "RN": "EC 1.3.99.5", "PI": "Testosterone (1972-1974)", "MS": "An enzyme that catalyzes the reduction of TESTOSTERONE to 5-ALPHA DIHYDROTESTOSTERONE.", "PM": "2010; see TESTOSTERONE 5-ALPHA REDUCTASE 1986-2010, see OXIDOREDUCTASES 1975-1985", "HN": "2010(1975)", "MR": "20141121", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D013741"}, {"RECTYPE": "D", "MH": "Tetanus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Clostridium tetani", "MN": "C01.150.252.410.222.864", "FX": "Trismus", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013742"}, {"RECTYPE": "D", "MH": "Tetanus Antitoxin", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Antitoxin, Tetanus", "MN": "D20.215.401.601.824", "PA": "Immunologic Factors", "FX": "Tetanus Toxoid", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "AN": "for therapy: for prevention index under TETANUS TOXOID", "MS": "An antitoxin used for the treatment of TETANUS.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013743"}, {"RECTYPE": "D", "MH": "Tetanus Toxin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Clostridium tetani Toxin|T131|NON|EQV|UNK (19XX)|850617|abcdef", "ENTRY": "Toxins, Tetanus", "MN": "D23.946.123.893", "PA": "Neurotoxins", "FX": "Tetanus Antitoxin", "MH_TH": "NLM (1965)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also TETANUS ANTITOXIN", "MS": "Protein synthesized by CLOSTRIDIUM TETANI as a single chain of ~150 kDa with 35% sequence identity to BOTULINUM TOXIN that is cleaved to a light and a heavy chain that are linked by a single disulfide bond. Tetanolysin is the hemolytic and tetanospasmin is the neurotoxic principle. The toxin causes disruption of the inhibitory mechanisms of the CNS, thus permitting uncontrolled nervous activity, leading to fatal CONVULSIONS.", "PM": "65", "HN": "65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013744"}, {"RECTYPE": "D", "MH": "Tetanus Toxoid", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetanus Vaccine|T121|T129|NON|REL|UNK (19XX)|790606|abbcdef", "ENTRY": "Vaccine, Tetanus", "MN": "D20.215.894.691.824", "FX": "Tetanus Antitoxin", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "AN": "note specific indentions", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013745"}, {"RECTYPE": "D", "MH": "Tetany", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tetany, Neonatal|T047|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Tetanillas", "MN": "C23.888.592.608.875", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A disorder characterized by muscle twitches, cramps, and carpopedal spasm, and when severe, laryngospasm and seizures. This condition is associated with unstable depolarization of axonal membranes, primarily in the peripheral nervous system. Tetany usually results from HYPOCALCEMIA or reduced serum levels of MAGNESIUM that may be associated with HYPERVENTILATION; HYPOPARATHYROIDISM; RICKETS; UREMIA; or other conditions. (From Adams et al., Principles of Neurology, 6th ed, p1490)", "OL": "use TETANY to search SPASMOPHILIA 1966-76", "PM": "SPASMOPHILIA was heading 1963-76", "HN": "SPASMOPHILIA was heading 1963-76", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013746"}, {"RECTYPE": "D", "MH": "Tetrabenazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Xenazine|T109|T121|TRD|NRW|UK|041124|abbcdef", "MN": "D03.633.100.834.850", "PA": "Adrenergic Uptake Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-", "RN": "Z9O08YRN8O", "RR": "58-46-8 (Tetrabenazine)", "MS": "A drug formerly used as an antipsychotic and treatment of various movement disorders. Tetrabenazine blocks neurotransmitter uptake into adrenergic storage vesicles and has been used as a high affinity label for the vesicle transport system.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013747"}, {"RECTYPE": "D", "MH": "Tetracaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetrakain|T109|T121|NON|EQV|UNK (19XX)|770429|abbcdef", "ENTRY": "Hydrochloride, Tetrracaine", "MN": "D02.455.426.559.389.127.020.937.968", "PA": "Anesthetics, Local", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester", "RN": "0619F35CGV", "RR": "94-24-6 (Tetracaine)", "MS": "A potent local anesthetic of the ester type used for surface and spinal anesthesia.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013748"}, {"RECTYPE": "D", "MH": "Tetrachloroethylene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Perchloroethylene|T109|T121|T131|NON|EQV|UNK (19XX)|771129|abbbcdef", "ENTRY": "Tetrachloroethene|T109|T121|T131|NON|EQV|NLM (2002)|001212|abbbcdef", "MN": "D02.455.526.439.880", "PA": "Solvents", "MH_TH": "USP (19XX)", "ST": "T131", "N1": "Ethene, tetrachloro-", "RN": "TJ904HH8SN", "RR": "127-18-4 (Tetrachloroethylene)", "MS": "A chlorinated hydrocarbon used as an industrial solvent and cooling liquid in electrical transformers. It is a potential carcinogen.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013750"}, {"RECTYPE": "D", "MH": "Tetrachlorvinphos", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Stirofos|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|USAN (19XX)|800801|abbcdeeef", "MN": "D02.705.400.750", "PA": "Insecticides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Phosphoric acid, 2-chloro-1-(2,4,5-trichlorophenyl)ethenyl dimethyl ester, (Z)-", "RN": "DM33MW89QU", "RR": "22248-79-9 (Tetrachlorvinphos)", "AN": "for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING", "PI": "Organophosphorus Compounds (1971)", "MS": "An organophosphate cholinesterase inhibitor that is used as an insecticide. It has low mammalian toxicity. (From Merck Index, 11th ed)", "OL": "use TETRACHLORVINPHOS to search GARDONA 1972-78 (as Prov 1972-73)", "PM": "79; was GARDONA 1974-78", "HN": "79; was GARDONA 1972-78 (Prov 1972-73)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013751"}, {"RECTYPE": "D", "MH": "Tetracycline", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "4 Epitetracycline", "MN": "D04.615.562.900.875", "PA": "Protein Synthesis Inhibitors", "EC": "analogs & derivatives:Tetracyclines", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-", "RN": "F8VB5M810T", "RR": "P6R62377KV", "MS": "A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013752"}, {"RECTYPE": "D", "MH": "Tetracycline Resistance", "AQ": "DE EH GE IM PH RE", "MN": "G07.690.773.984.269.347.937", "MH_TH": "NLM (1988)", "ST": "T032", "PI": "Tetracycline (1966-1987)", "MS": "Nonsusceptibility of bacteria to the action of TETRACYCLINE which inhibits aminoacyl-tRNA binding to the 30S ribosomal subunit during protein synthesis.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19870508", "DC": "1", "DX": "19880101", "UI": "D013753"}, {"RECTYPE": "D", "MH": "Tetracyclines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.562.900", "MH_TH": "NLM (1976)", "ST": "T195", "RN": "0", "AN": "TETRACYCLINE is also available", "MS": "Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. (Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1117)", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20060705", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D013754"}, {"RECTYPE": "D", "MH": "Tetradecanoylphorbol Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phorbol Myristate Acetate|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|830613|abbcdeef", "ENTRY": "Tetradecanoylphorbol Acetate, 4a alpha Isomer", "MN": "D02.455.849.291.500.510.850", "PA": "Carcinogens", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Tetradecanoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester, (1aR-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha))-", "RN": "NI40JAQ945", "RR": "63597-44-4 (4a alpha-isomer)", "PI": "Terpenes (1966-1973)", "MS": "A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA.", "PM": "87; was see under PHORBOLS 1975-86", "HN": "87(75); was see under PHORBOLS 1975-86", "MR": "20130708", "DA": "19741114", "DC": "1", "DX": "19870101", "UI": "D013755"}, {"RECTYPE": "D", "MH": "Tetraethyl Lead", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Lead, Tetraethyl", "MN": "D02.691.950", "MH_TH": "NLM (1976)", "ST": "T131", "N1": "Plumbane, tetraethyl-", "RN": "13426ZWT6A", "RR": "78-00-2 (Tetraethyl Lead)", "PI": "Organometallic Compounds (1969-1975)", "MS": "A highly toxic compound used as a gasoline additive. It causes acute toxic psychosis or chronic poisoning if inhaled or absorbed through the skin.", "PM": "91; was see under ORGANOMETALLIC COMPOUNDS 1976-90", "HN": "91(76); was see under ORGANOMETALLIC COMPOUNDS 1976-90", "MR": "20130708", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D013756"}, {"RECTYPE": "D", "MH": "Tetraethylammonium Compounds", "DE": "TETRAETHYLAMMONIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetrylammonium|T109|NON|EQV|UNK (19XX)|761230|abcdef", "ENTRY": "Compounds, Tetraethylammonium", "MN": "D02.675.276.787", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Quaternary ammonium compounds that consist of an ammonium cation where the central nitrogen atom is bonded to four ethyl groups.", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013757"}, {"RECTYPE": "D", "MH": "Tetragastrin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gastrin Tetrapeptide|T116|T121|NON|EQV|NLM (1998)|960729|abbcdef", "ENTRY": "Tetrapeptide, Gastrin", "MN": "D12.644.456.830", "FX": "Gastrointestinal Agents", "MH_TH": "NLM (1979)", "ST": "T121", "N1": "L-Phenylalaninamide, L-tryptophyl-L-methionyl-L-alpha-aspartyl-", "RN": "0OL293AV80", "RR": "1947-37-1 (Tetragastrin)", "AN": "\"smallest peptide fragment of gastrin\"", "PI": "Peptides (1966-1972)", "MS": "L-Tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide. The C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin.", "PM": "91; was see under GASTRINS 1979-90", "HN": "91(79); was see under GASTRINS 1979-90", "MR": "20160628", "DA": "19780316", "DC": "1", "DX": "19910101", "UI": "D013758"}, {"RECTYPE": "D", "MH": "Dronabinol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "delta(9)-THC|T109|T121|NON|EQV|UNK (19XX)|830531|DELTA THC 09|abbcdefs", "ENTRY": "Tetrahydrocannabinol, Trans Isomer", "MN": "D02.455.849.090.810", "PA": "Psychotropic Drugs", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-", "RN": "7J8897W37S", "RR": "69855-10-3", "PI": "Cannabis (1966-1970)", "MS": "A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound.", "PM": "2014; seeTETRAHDYROCANNABINOL 1971-2013", "HN": "2014(1971);", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D013759"}, {"RECTYPE": "D", "MH": "Tetrahydrocortisol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D06.472.040.585.478.782", "MH_TH": "NLM (1973)", "ST": "T125", "N1": "Pregnan-20-one, 3,11,17,21-tetrahydroxy-, (3alpha,5beta,11beta)-", "RN": "7P2O6MFN8O", "RR": "53-02-1 (Tetrahydrocortisol)", "AN": "do not confuse with TETRAHYDROCORTISONE", "PI": "Hydrocortisone (1966-1972)", "PM": "91; was see under HYDROCORTISONE 1973-90", "HN": "91(73); was see under HYDROCORTISONE 1973-90", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013760"}, {"RECTYPE": "D", "MH": "Tetrahydrocortisone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D06.472.040.585.478.865", "MH_TH": "NLM (1973)", "ST": "T125", "N1": "Pregnane-11,20-dione, 3,17,21-trihydroxy-, (3alpha,5beta)-", "RN": "5HF9TM2D15", "RR": "53-05-4 (Tetrahydrocortisone)", "AN": "do not confuse with TETRAHYDROCORTISOL", "PI": "Cortisone (1966-1972)", "PM": "91; was see under CORTISONE 1973-90", "HN": "91(73); was see under CORTISONE 1973-90", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013761"}, {"RECTYPE": "D", "MH": "Tetrahydrofolate Dehydrogenase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Folic Acid Reductase|T116|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Reductase, Folic Acid", "MN": "D08.811.682.662.825", "EC": "antagonists & inhibitors:Folic Acid Antagonists", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "5,6,7,8-Tetrahydrofolate:NADP+ oxidoreductase", "RN": "EC 1.5.1.3", "MS": "An enzyme of the oxidoreductase class that catalyzes the reaction 7,8-dihyrofolate and NADPH to yield 5,6,7,8-tetrahydrofolate and NADPH+, producing reduced folate for amino acid metabolism, purine ring synthesis, and the formation of deoxythymidine monophosphate. Methotrexate and other folic acid antagonists used as chemotherapeutic drugs act by inhibiting this enzyme. (Dorland, 27th ed) EC 1.5.1.3.", "OL": "use TETRAHYDROFOLATE DEHYDROGENASE to search DIHYDROFOLATE DEHYDROGENASE 1966-88", "PM": "66; DIHYDROFOLATE DEHYDROGENASE was heading 1966-88", "HN": "66; DIHYDROFOLATE DEHYDROGENASE was heading 1966-88", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013762"}, {"RECTYPE": "D", "MH": "Tetrahydrofolates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D08.211.840", "PA": "Vitamin B Complex", "MH_TH": "NLM (1972)", "ST": "T127", "RN": "0", "AN": "deficiency: coordinate TETRAHYDROFOLATES /defic (IM) with FOLIC ACID DEFICIENCY (IM)", "PI": "Folic Acid (1966-1971)", "MS": "Compounds based on 5,6,7,8-tetrahydrofolate.", "PM": "74", "HN": "74(72)", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013763"}, {"RECTYPE": "D", "MH": "Tetrahydronaphthalenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetralins|T109|NON|EQV|UNK (19XX)|770517|abcdef", "MN": "D04.615.638.960", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Naphthalenes (1966-1977)", "MS": "Partially saturated 1,2,3,4-tetrahydronaphthalene compounds.", "PM": "91; was see under NAPHTHALENES 1978-90", "HN": "91(78); was see under NAPHTHALENES 1978-90", "MR": "20060705", "DA": "19770517", "DC": "1", "DX": "19910101", "UI": "D013764"}, {"RECTYPE": "D", "MH": "Tetrahydropapaveroline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetrahydroxypapaveroline|T109|T123|NON|EQV|UNK (19XX)|770224|abbcdef", "MN": "D03.633.100.531.085.666.850", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "6,7-Isoquinolinediol, 1-((3,4-dihydroxyphenyl)methyl)-1,2,3,4-tetrahydro-", "RN": "4747-99-3", "AN": "/biosyn /physiol permitted", "PI": "Quinolines (1966-1973)", "MS": "A leukomaine (animal alkaloid) formed in brain and liver from dopamine and L-dopa; it may be implicated in psychiatric problems.", "PM": "91; was see under PAPAVERINE 1978-90", "HN": "91(78); was see under PAPAVERINE 1978-90", "MR": "20160531", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D013765"}, {"RECTYPE": "D", "MH": "5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase", "DS": "METHYLTETRAHYDROFOLATE Z", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tetrahydropteroylglutamate Methyltransferase|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef", "ENTRY": "Synthetase, Methionine", "MN": "D08.811.913.555.500.645", "FX": "Homocystinuria", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "5-Methyltetrahydropteroyltri-L-glutamate:L-homocysteine S-methyltransferase", "RN": "EC 2.1.1.13", "RR": "9033-23-2 (CAS RN)", "AN": "/defic: consider also HOMOCYSTINURIA", "PI": "Tetrahydrofolates (1973-1974)", "MS": "An enzyme that catalyzes the formation of methionine by transfer of a methyl group from 5-methyltetrahydrofolate to homocysteine. It requires a cobamide coenzyme. The enzyme can act on mono- or triglutamate derivatives. EC 2.1.1.13.", "PM": "98; see TETRAHYDROPTEROYLGLUTAMATE METHYLTRANSFERASE 1991-97; see METHYLTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013766"}, {"RECTYPE": "D", "MH": "Tetrahydrouridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NSC112907", "MN": "D13.570.800.892.800", "PA": "Antimetabolites", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "2(1H)-Pyrimidinone, tetrahydro-4-hydroxy-1-beta-D-ribofuranosyl-", "RN": "18771-50-1", "PI": "Uridine (1971-1974)", "MS": "An inhibitor of nucleotide metabolism.", "PM": "91; was see under URIDINE 1975-90", "HN": "91(75); was see under URIDINE 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013767"}, {"RECTYPE": "D", "MH": "Tetrahymena", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Tetrahymenas", "MN": "B01.043.185.650.375.750.850", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5890", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A genus of ciliate protozoa commonly used in genetic, cytological, and other research.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013768"}, {"RECTYPE": "D", "MH": "Tetrahymena pyriformis", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "pyriformi, Tetrahymena", "MN": "B01.043.185.650.375.750.850.700", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid5908", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Tetrahymena (1966-1971)", "MS": "A species of ciliate protozoa used extensively in genetic research.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013769"}, {"RECTYPE": "D", "MH": "Tetraisopropylpyrophosphamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Iso-OMPA|T109|T121|EQV|UNK (19XX)|741111|abbdef", "ENTRY": "Iso OMPA", "MN": "D02.705.672.750", "PA": "Cholinesterase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Diphosphoramide, N,N',N'',N'''-tetrakis(1-methylethyl)-", "RN": "513-00-8", "AN": "a cholinesterase inhib", "PI": "Organophosphorus Compounds (1972-1974)", "MS": "N,N',N'',N'''-Tetraisopropylpyrophosphamide. A specific inhibitor of pseudocholinesterases. It is commonly used experimentally to determine whether pseudo- or acetylcholinesterases are involved in an enzymatic process.", "PM": "91; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90", "HN": "91(75); was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90", "MR": "20120703", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013770"}, {"RECTYPE": "D", "MH": "Tetralogy of Fallot", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fallot's Tetralogy|T019|EPO|EQV|ORD (2010)|UNK (19XX)|740330|abcdeef", "ENTRY": "Tetralogy, Fallots", "MN": "C16.131.240.400.849", "FX": "Pentalogy of Cantrell", "MH_TH": "ORD (2010)", "ST": "T019", "AN": "do not confuse with TRILOGY OF FALLOT", "MS": "A combination of congenital heart defects consisting of four key features including VENTRICULAR SEPTAL DEFECTS; PULMONARY STENOSIS; RIGHT VENTRICULAR HYPERTROPHY; and a dextro-positioned AORTA. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing CYANOSIS.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013771"}, {"RECTYPE": "D", "MH": "Tetramethylphenylenediamine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Wursters Reagent", "MN": "D02.092.782.258.651.900", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Benzenediamine, N,N,N',N'-tetramethyl-", "RN": "P4P3AC32ZB", "RR": "27215-51-6 (Tetramethylphenylenediamine)", "PI": "Phenylenediamines (1974)", "MS": "Used in the form of the hydrochloride as a reagent in ANALYTICAL CHEMISTRY TECHNIQUES.", "PM": "91; was see under PHENYLENEDIAMINES 1975-90", "HN": "91(75); was see under PHENYLENEDIAMINES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013772"}, {"RECTYPE": "D", "MH": "Tetramisole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nilverm|T109|T121|TRD|NRW|UNK (19XX)|800801|abbcdef", "MN": "D03.383.129.708.782", "MH_TH": "NLM (1974)", "ST": "T121", "N1": "Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (+-)-", "RN": "C8M7RFE4NO", "RR": "5036-02-2 (Tetramisole)", "PM": "74", "HN": "74", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013773"}, {"RECTYPE": "D", "MH": "Tetranitromethane", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D02.640.720.800", "PA": "Oxidants", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Methane, tetranitro-", "RN": "K1G7CKU98F", "RR": "509-14-8 (Tetranitromethane)", "PI": "Nitro Compounds (1972-1974)", "MS": "Corrosive oxidant, explosive; additive to diesel and rocket fuels; causes skin and lung irritation; proposed war gas. A useful reagent for studying the modification of specific amino acids, particularly tyrosine residues in proteins. Has also been used for studying carbanion formation and for detecting the presence of double bonds in organic compounds.", "PM": "91; was see under METHANE 1975-90", "HN": "91(75); was see under METHANE 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013774"}, {"RECTYPE": "D", "MH": "Tetraphenylborate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tetraphenylboron Sodium|T109|T130|NON|NRW|UNK (19XX)|741111|abbcdef", "ENTRY": "Tetraphenylborate, Sodium", "MN": "D02.203.087.050.750", "PA": "Uncoupling Agents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Borate(1-), tetraphenyl-", "RN": "4358-26-3", "RR": "3244-41-5 (potassium)", "PI": "Boron Compounds (1973-1974)", "MS": "An anionic compound that is used as a reagent for determination of potassium, ammonium, rubidium, and cesium ions. It also uncouples oxidative phosphorylation and forms complexes with biological materials, and is used in biological assays.", "PM": "91; was see under BORON COMPOUNDS 1975-90", "HN": "91(75); was see under BORON COMPOUNDS 1975-90", "MR": "20000621", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013775"}, {"RECTYPE": "D", "MH": "Tetrathionic Acid", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sodium Tetrathionate|T197|NON|NRW|UNK (19XX)|741111|abcdef", "ENTRY": "Tetrathionate, Sodium", "MN": "D01.875.800.800.900", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T197", "N1": "Tetrathionic acid", "RN": "8V1L8R19JH", "RR": "8X6V5C8FZ9", "PI": "Thiosulfates (1970-1974)", "MS": "A sulfuric acid dimer, formed by disulfide linkage. This compound has been used to prolong coagulation time and as an antidote in cyanide poisoning.", "PM": "91; was see under THIOSULFATES 1975-90", "HN": "91(75); was see under THIOSULFATES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013776"}, {"RECTYPE": "D", "MH": "Tetrazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.129.617", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "PI": "Azoles (1966-1972)", "OL": "search AZOLES 1966-72", "PM": "91; was see under AZOLES 1973-90", "HN": "91(73); was see under AZOLES 1973-90", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013777"}, {"RECTYPE": "D", "MH": "Tetrazolium Salts", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tetrazolium Salt|T109|T130|NON|EQV|NLM (2021)|191122|abbcdef", "ENTRY": "Salts, Tetrazolium", "MN": "D03.383.129.617.700", "PA": "Indicators and Reagents", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "MS": "Quaternary salts derived from tetrazoles. They are used in tests to distinguish between reducing sugars and simple aldehydes, for detection of dehydrogenase in tissues, cells, and bacteria, for determination of corticosteroids, and in color photography. (From Mall's Dictionary of Chemistry, 5th ed, p455)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013778"}, {"RECTYPE": "D", "MH": "Tetrodotoxin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tarichatoxin|T109|T131|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Toxin, Fugu", "MN": "D23.946.580.910", "PA": "Sodium Channel Blockers", "MH_TH": "NLM (1964)", "ST": "T131", "RN": "4368-28-9", "AN": "/antag permitted but consider also ANTITOXINS", "MS": "An aminoperhydroquinazoline poison found mainly in the liver and ovaries of fishes in the order TETRAODONTIFORMES, which are eaten. The toxin causes paresthesia and paralysis through interference with neuromuscular conduction.", "PM": "68", "HN": "68(64)", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013779"}, {"RECTYPE": "D", "MH": "Tetroses", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ketotetroses|T109|NON|NRW|NLM (2018)|170118|abcdef", "MN": "D09.947.875.805", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Monosaccharide sugar molecules that contain a four carbon backbone.", "PM": "1966; ALDOTETROSE was indexed under TETROSES 1966-2017", "HN": "1966", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013780"}, {"RECTYPE": "D", "MH": "Texas", "AQ": "EH EP", "MN": "Z01.107.567.875.760.750", "MH_TH": "NLM (1998)", "ST": "T083", "MS": "State bounded on the north by Oklahoma, on the east by Arkansas and Louisiana, on the south by Mexico, and on the west by New Mexico.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013781"}, {"RECTYPE": "D", "MH": "Textbooks as Topic", "AQ": "HI ST", "MN": "L01.462.500.820.900", "FX": "Reference Books", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with the Publication Type TEXTBOOK", "PI": "Teaching Materials (1974-1980)", "MS": "Works about books used in the study of a subject that contain a systematic presentation of the principles and vocabulary of a subject.", "PM": "2008; see TEXTBOOKS 1991-2007, see under BOOKS 1981-1990", "HN": "2008(1981)", "MR": "20220712", "DA": "19800519", "DC": "1", "DX": "19910101", "UI": "D013782"}, {"RECTYPE": "D", "MH": "Textile Industry", "DE": "TEXTILE INDUST", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Textile Industries", "MN": "J01.576.655.937", "MH_TH": "NLM (1966)", "ST": "T092", "MS": "The aggregate business enterprise of manufacturing textiles. (From Random House Unabridged Dictionary, 2d ed)", "MR": "20140612", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013783"}, {"RECTYPE": "D", "MH": "Textiles", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Textile", "MN": "J01.637.836", "MH_TH": "NLM (1966)", "ST": "T073", "AN": "textile mesh is probably SURGICAL MESH", "MS": "Filament or fiber, or the materials generated from them by weaving, embroidery, knitting, crocheting, tufting, or felting such as yarn, thread, cording, rope, netting, lace, or sheets of cloth or fabric.", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013784"}, {"RECTYPE": "D", "MH": "Thailand", "AQ": "EH EP", "ENTRY": "Siam|T083|NAM|EQV|NLM (2016)|150116|abcdef", "MN": "Z01.252.145.841", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "Formerly known as Siam, this is a Southeast Asian nation at the center of the Indochina peninsula. Bangkok is the capital city.", "MR": "20150629", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D013785"}, {"RECTYPE": "D", "MH": "Thalamic Diseases", "DE": "THALAMIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dejerine-Roussy Syndrome|T047|EPO|NRW|NLM (2000)|ORD (2010)|991103|abcdeef", "ENTRY": "Thalamic Syndromes", "MN": "C10.228.140.915", "MH_TH": "NLM (1981)", "ST": "T047", "PI": "Thalamus (1966-1980)", "MS": "Disorders of the centrally located thalamus, which integrates a wide range of cortical and subcortical information. Manifestations include sensory loss, MOVEMENT DISORDERS; ATAXIA, pain syndromes, visual disorders, a variety of neuropsychological conditions, and COMA. Relatively common etiologies include CEREBROVASCULAR DISORDERS; CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; BRAIN HYPOXIA; INTRACRANIAL HEMORRHAGES; and infectious processes.", "PM": "1981", "HN": "1981", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19800409", "DC": "1", "DX": "19810101", "UI": "D013786"}, {"RECTYPE": "D", "MH": "Thalamic Nuclei", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Nuclei, Thalamic", "MN": "A08.186.211.200.317.826.701", "MH_TH": "NLM (1971)", "ST": "T023", "PI": "Thalamus (1966-1970)", "MS": "Several groups of nuclei in the thalamus that serve as the major relay centers for sensory impulses in the brain.", "PM": "71", "HN": "71", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D013787"}, {"RECTYPE": "D", "MH": "Thalamus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Thalamencephalons", "MN": "A08.186.211.200.317.826", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Paired bodies containing mostly GRAY MATTER and forming part of the lateral wall of the THIRD VENTRICLE of the brain.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013788"}, {"RECTYPE": "D", "MH": "Thalassemia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thalassemias|T047|NON|EQV|OMIM (2013)|111115|abcdef", "MN": "C16.320.365.826", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.", "OL": "use THALASSEMIA to search ANEMIA, TARGET-CELL 1966-92", "PM": "65; was ANEMIA, ERYTHROBLASTIC 1963-64; ANEMIA, TARGET-CELL was see THALASSEMIA 1965-92", "HN": "65; was ANEMIA, ERYTHROBLASTIC 1963-64; ANEMIA, TARGET-CELL was see THALASSEMIA 1965-92", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013789"}, {"RECTYPE": "D", "MH": "Climatotherapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Thalassotherapy|T061|NON|REL|NLM (1966)|990101|THALASSOTHER|abcdefv", "ENTRY": "Therapy, Climate", "MN": "E02.175", "MH_TH": "NLM (2008)", "ST": "T061", "MS": "Relocating a patient to a CLIMATE more suitable for health or for management of a health condition.", "PM": "2007; see THALASSOTHERAPY 1963-2007", "HN": "2007(1963)", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "20070101", "UI": "D013790"}, {"RECTYPE": "D", "MH": "Thalidomide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Thalomid|T109|T121|TRD|NRW|US|041129|abbcdef", "MN": "D03.633.100.513.750.750", "PA": "Teratogens", "MH_TH": "USP (19XX)", "ST": "T131", "N1": "1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-", "RN": "4Z8R6ORS6L", "RR": "50-35-1 (Thalidomide)", "MS": "A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013792"}, {"RECTYPE": "D", "MH": "Thallium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Thallium 205", "MN": "D01.552.544.847", "FX": "Thallium Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Thallium", "RN": "AD84R52XLF", "RR": "7440-28-0 (Thallium)", "MS": "A heavy, bluish white metal, atomic number 81, atomic weight [204.382; 204.385], symbol Tl.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013793"}, {"RECTYPE": "D", "MH": "Thallium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Thallium", "MN": "D01.496.749.900", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Thallium (1966-1987)", "MS": "Unstable isotopes of thallium that decay or disintegrate emitting radiation. Tl atoms with atomic weights 198-202, 204, and 206-210 are thallium radioisotopes.", "PM": "88", "HN": "88", "MR": "20170705", "DA": "19870408", "DC": "1", "DX": "19880101", "UI": "D013794"}, {"RECTYPE": "D", "MH": "Thanatology", "DE": "THANATOL", "AQ": "HI", "MN": "K01.752.827", "FX": "Death", "MH_TH": "NLM (1975)", "ST": "T170", "AN": "\"the study of the theory, philosophy & doctrine of death\"; do not confuse with DEATH, the physiol concept", "PI": "Death (1966-1974)", "MS": "The study of the theory, philosophy, and doctrine of death.", "OL": "search DEATH 1974", "PM": "90; was see under DEATH 1974-89", "HN": "90(75); was see under DEATH 1974-89", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D013795"}, {"RECTYPE": "D", "MH": "Thanatophoric Dysplasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thanatophoric Dwarfism|T019|NON|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|840605|abcdeeeef", "ENTRY": "Thanatophoric Dysplasias", "MN": "C16.614.890", "MH_TH": "OMIM (2013)", "ST": "T019", "PI": "Skull (1966-1984)", "MS": "A severe form of neonatal dwarfism with very short limbs. All cases have died at birth or later in the neonatal period.", "PM": "91; was see under OSTEOCHONDRODYSPLASIAS 1985-90", "HN": "91(85); was see under OSTEOCHONDRODYSPLASIAS 1985-90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19840406", "DC": "1", "DX": "19910101", "UI": "D013796"}, {"RECTYPE": "D", "MH": "Thebaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.723.795.576.856", "PA": "Narcotics", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Morphinan, 6,7,8,14-tetradehydro-4,5-epoxy-3,6-dimethoxy-17-methyl-, (5alpha)-", "RN": "2P9MKG8GX7", "RR": "115-37-7 (Thebaine)", "MS": "A drug that is derived from opium, which contains from 0.3-1.5% thebaine depending on its origin. It produces strychnine-like convulsions rather than narcosis. It may be habit-forming and is a controlled substance (opiate) listed in the U.S. Code of Federal Regulations, Title 21 Part 1308.12 (1985). (From Merck Index, 11th ed)", "OL": "use THEBAINE/analogs & derivatives to search THEBAINE DERIVATIVES 1975-77; use MORPHINANS 1969-74", "PM": "THEBAINE DERIVATIVES was see under THEBAINE 1975-77; was see under MORPHINANS 1969-74", "HN": "THEBAINE DERIVATIVES was see under THEBAINE 1975-77; was see under MORPHINANS 1969-74", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013797"}, {"RECTYPE": "D", "MH": "Thecoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Theca Cell Tumor|T191|NON|EQV|NLM (1994)|930331|abcdef", "ENTRY": "Tumors, Theca Cell", "MN": "C19.391.630.705.765", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with OVARIAN NEOPLASMS (IM)", "MS": "A gonadal stromal neoplasm composed only of THECA CELLS, occurring mostly in the postmenopausal OVARY. It is filled with lipid-containing spindle cells and produces ESTROGENS that can lead to ENDOMETRIAL HYPERPLASIA; UTERINE HEMORRHAGE; or other malignancies in postmenopausal women and sexual precocity in girls. When tumors containing theca cells also contain FIBROBLASTS, they are identified as thecoma-fibroma tumors with less active hormone production.", "OL": "use THECOMA to search THECA CELL TUMOR 1966-93", "PM": "94; was THECA CELL TUMOR 1963-93; THECOMA was see THECA CELL TUMOR 1981-93", "HN": "94; was THECA CELL TUMOR 1963-93; THECOMA was see THECA CELL TUMOR 1981-93", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D013798"}, {"RECTYPE": "D", "MH": "Theca Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Ovarian Interstitial Cells|T025|NON|EQV|UNK (19XX)|770509|abcdef", "ENTRY": "Theca Cell", "MN": "A11.329.850", "FX": "Ovarian Follicle", "MH_TH": "NLM (1975)", "ST": "T025", "MS": "The flattened stroma cells forming a sheath or theca outside the basal lamina lining the mature OVARIAN FOLLICLE. Thecal interstitial or stromal cells are steroidogenic, and produce primarily ANDROGENS which serve as precusors of ESTROGENS in the GRANULOSA CELLS.", "OL": "use THECA CELLS to search OVARIAN INTERSTITIAL CELLS 1975-77", "PM": "78; was see under GRAAFIAN FOLLICLE 1975-77; OVARIAN INTERSTITIAL CELLS was see under OVARY 1975-77", "HN": "78(75); was see under GRAAFIAN FOLLICLE 1975-77; OVARIAN INTERSTITIAL CELLS was see under OVARY 1975-77", "MR": "20180630", "DA": "19770509", "DC": "1", "DX": "19780101", "UI": "D013799"}, {"RECTYPE": "D", "MH": "Theft", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Stealing|T055|NON|EQV|UNK (19XX)|770512|abcdef", "ENTRY": "Thefts", "MN": "I01.880.735.191.410", "MH_TH": "NLM (1978)", "ST": "T055", "MS": "Unlawful act of taking property.", "PM": "78", "HN": "78", "MR": "19930605", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D013800"}, {"RECTYPE": "D", "MH": "Theileriasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "East Coast Fever|T047|EPO|NRW|UNK (19XX)|810518|abcdef", "ENTRY": "Theilerioses", "MN": "C22.674.710.735", "MH_TH": "NLM (1968)", "ST": "T047", "PI": "Protozoan Infections (1966-1967)", "MS": "Infection of cattle, sheep, or goats with protozoa of the genus THEILERIA. This infection results in an acute or chronic febrile condition.", "OL": "use THEILERIASIS to search GONDERIASIS 1975-91, CORRIDOR DISEASE 1968-78, and EAST COAST FEVER 1968-81", "PM": "68; GONDERIASIS was see THEILERIASIS 1975-91", "HN": "68; GONDERIASIS was see THEILERIASIS 1975-91; CORRIDOR DISEASE was see under THEILERIASIS 1968-78; EAST COAST FEVER was see under THEILERIASIS 1968-81", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013801"}, {"RECTYPE": "D", "MH": "Thelazioidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Thelazia|T204|NON|NRW|UNK (19XX)|850321|abcdef", "ENTRY": "Thelazioideas", "MN": "B01.050.500.500.294.400.937.700.722", "MH_TH": "NLM (1986)", "ST": "T204", "RN": "txid103829", "RR": "txid304460", "AN": "a superfamily of nematodes; infection: coord IM with SPIRURIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "MS": "A superfamily of parasitic nematodes which includes three genera: Thelazia, Spirocerca, and GNATHOSTOMA. Only Thelazia and GNATHOSTOMA occasionally occur in man.", "OL": "use THELAZIOIDEA to search THELAZIA 1975-85; use SPIRUROIDEA 1966-74", "PM": "86; GNATHOSTOMA & THELAZIA were see under SPIRUROIDEA 1963-85", "HN": "86; GNATHOSTOMA & THELAZIA were see under SPIRUROIDEA 1963-85", "MR": "20200813", "DA": "19850321", "DC": "1", "DX": "19860101", "UI": "D013802"}, {"RECTYPE": "D", "MH": "Thematic Apperception Test", "AQ": "HI SN ST", "ENTRY": "Thematic Apperception Tests", "MN": "F04.711.647.622.851", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "A projective technique which focuses primarily on the dynamics of interpersonal relationships. It consists of a series of 31 pictures that depict various social situations and interpersonal relations. A subset is selected by the examiner and presented to the subject who is asked to tell a story about each picture. The stories are interpreted in terms of the subject's relations to authority figures, to contemporaries of both sexes, and in terms of the compromises between external demands and the needs of the id, the ego, and the superego. (From Campbell, Psychiatric Dictionary, 1996)", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013803"}, {"RECTYPE": "D", "MH": "Thenoyltrifluoroacetone", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Trifluorothienylacetone|T109|T121|NON|EQV|UNK (19XX)|800821|abbcdef", "MN": "D03.383.903.820", "PA": "Chelating Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "1,3-Butanedione, 4,4,4-trifluoro-1-(2-thienyl)-", "RN": "326-91-0", "PI": "Thiophenes (1971-1974)", "MS": "Chelating agent and inhibitor of cellular respiration.", "PM": "1991; 4,4,4-TRIFLUORO-1-(2-THIENYL)-1,3-BUTANEDIONE was indexed under THENOYLFLUOROACETONE 2005-2008, & under THIOPHENES & BUTANONES 2005", "HN": "1991(1975)", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013804"}, {"RECTYPE": "D", "MH": "Theobromine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.633.100.759.758.824.651", "PA": "Vasodilator Agents", "MH_TH": "FDA SRS (2014)", "ST": "T123", "N1": "1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-", "RN": "OBD445WZ5P", "RR": "83-67-0 (Theobromine)", "AN": "a bronchodilator & vasodilator alkaloid", "MS": "3,7-Dimethylxanthine. The principle alkaloid in Theobroma cacao (the cacao bean) and other plants. A xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than THEOPHYLLINE and is also a less powerful stimulant of smooth muscle. It has practically no stimulant effect on the central nervous system. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, pp1318-9)", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013805"}, {"RECTYPE": "D", "MH": "Theophylline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Von Ct, Theo", "MN": "D03.633.100.759.758.824.751", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-", "RN": "C137DTR5RG", "RR": "58-55-9 (Theophylline)", "MS": "A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013806"}, {"RECTYPE": "D", "MH": "Therapeutic Community", "DE": "THER COMMUNITY", "ENTRY": "Therapeutic Communities", "MN": "F04.754.864.392.701", "MH_TH": "NLM (1967)", "ST": "T061", "PI": "Psychotherapy, Group (1966)", "MS": "Psychotherapeutic technique which emphasizes socioenvironmental and interpersonal influences in the resocialization and rehabilitation of the patient. The setting is usually a hospital unit or ward in which professional and nonprofessional staff interact with the patients.", "PM": "69", "HN": "69(67)", "CATSH": "CAT LIST", "MR": "19900216", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D013808"}, {"RECTYPE": "D", "MH": "Therapeutic Equivalency", "DE": "THER EQUIVALENCY", "PRINT ENTRY": "Generic Equivalency|T169|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Generic Equivalencies", "MN": "G07.690.725.898", "MH_TH": "NLM (1970)", "ST": "T169", "AN": "coordinate NIM with specific drug / pharmacokin (IM)", "PI": "Pharmacology (1966-1969)", "MS": "The relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D013810"}, {"RECTYPE": "D", "MH": "Psychotherapeutic Processes", "DE": "PSYCHOTHER PROCESSES", "ENTRY": "Psychotherapeutic Process", "MN": "F04.754.720", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "PI": "Psychotherapy (1966-1997)", "MS": "Experiential, attitudinal, emotional, or behavioral phenomena occurring during the course of treatment. They apply to the patient or therapist (i.e., nurse, doctor, etc.) individually or to their interaction. (American Psychological Association: Thesaurus of Psychological Index Terms, 1994)", "PM": "98", "HN": "98; use explode 1971-97", "CATSH": "CAT LIST", "MR": "20080714", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013811"}, {"RECTYPE": "D", "MH": "Therapeutics", "DE": "THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Treatments", "MN": "E02", "RH": "E2 - PROCEDURES AND TECHNIQUES-THERAPEUTIC", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "avoid: too general: prefer /ther with diseases", "MS": "Procedures concerned with the remedial treatment or prevention of diseases.", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013812"}, {"RECTYPE": "D", "MH": "Therapy, Computer-Assisted", "DE": "THER COMPUTER ASSISTED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Protocol-Directed Therapy, Computer-Assisted|T061|NON|EQV|UNK (19XX)|860617|PROTOCOL DIRECTED THER COMPUTER ASSISTED|abcdefv", "ENTRY": "Therapy, Computer Assisted Protocol Directed", "MN": "L01.313.500.750.100.710", "MH_TH": "NLM (1987)", "ST": "T061", "AN": "DRUG THERAPY, COMPUTER-ASSISTED, and RADIOTHERAPY, COMPUTER-ASSISTED are also available", "MS": "Computer systems utilized as adjuncts in the treatment of disease.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19860617", "DC": "1", "DX": "19870101", "UI": "D013813"}, {"RECTYPE": "D", "MH": "Thermal Conductivity", "ENTRY": "Conductivity, Thermal", "MN": "G01.906.730", "MH_TH": "NLM (1971)", "ST": "T081", "PI": "Physics (1966-1970)", "MS": "The heat flow across a surface per unit area per unit time, divided by the negative of the rate of change of temperature with distance in a direction perpendicular to the surface. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "74", "HN": "74(71)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013814"}, {"RECTYPE": "D", "MH": "Thermodilution", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Thermodilutions", "MN": "E05.484.750", "MH_TH": "NLM (1977)", "ST": "T059", "AN": "NIM", "PI": "Indicator Dilution Techniques (1967-1976)", "MS": "Measurement of blood flow based on induction at one point of the circulation of a known change in the intravascular heat content of flowing blood and detection of the resultant change in temperature at a point downstream.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D013815"}, {"RECTYPE": "D", "MH": "Thermodynamics", "ENTRY": "Thermodynamic", "MN": "G01.906", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "A rigorously mathematical analysis of energy relationships (heat, work, temperature, and equilibrium). It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. (From Hawley's Condensed Chemical Dictionary, 12th ed)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013816"}, {"RECTYPE": "D", "MH": "Thermography", "DE": "THERMOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Temperature Mappings", "MN": "E05.933.500", "MH_TH": "NLM (1965)", "ST": "T057", "AN": "coordinate with disease /diag", "MS": "Imaging the temperatures in a material, or in the body or an organ. Imaging is based on self-emanating infrared radiation (HEAT WAVES), or on changes in properties of the material or tissue that vary with temperature, such as ELASTICITY; MAGNETIC FIELD; or LUMINESCENCE.", "PM": "67", "HN": "67(65)", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D013817"}, {"RECTYPE": "D", "MH": "Thermogravimetry", "AQ": "IS MT", "ENTRY": "Thermogravimetries", "MN": "E05.196.904", "MH_TH": "NLM (1977)", "ST": "T059", "AN": "NIM", "PI": "Heat (1966-1976)", "MS": "Technique whereby the weight of a sample can be followed over a period of time while its temperature is being changed (usually increased at a constant rate).", "PM": "91; was see under CHEMISTRY, ANALYTICAL 1977-90", "HN": "91(77); was see under CHEMISTRY, ANALYTICAL 1977-90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D013818"}, {"RECTYPE": "D", "MH": "Thermoluminescent Dosimetry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Thermoluminescent Dosimetries", "MN": "N06.850.810.370.420", "MH_TH": "NLM (1971)", "ST": "T058", "PI": "Radiometry (1966-1970)", "MS": "The use of a device composed of thermoluminescent material for measuring exposure to IONIZING RADIATION. The thermoluminescent material emits light when heated. The amount of light emitted is proportional to the amount of ionizing radiation to which the material has been exposed.", "PM": "73", "HN": "73(71)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013819"}, {"RECTYPE": "D", "MH": "Thermolysin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Thermolysin S|T116|T123|NON|NRW|UNK (19XX)|861001|abbcdef", "MN": "D08.811.277.656.675.374.827", "MH_TH": "NLM (1971)", "ST": "T126", "N1": "Bacillus thermoproteolyticus neutral proteinase", "RN": "EC 3.4.24.27", "PI": "Peptide Peptidohydrolases (1966-1970)", "MS": "A thermostable extracellular metalloendopeptidase containing four calcium ions. (Enzyme Nomenclature, 1992) 3.4.24.27.", "PM": "73", "HN": "73(71)", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013820"}, {"RECTYPE": "D", "MH": "Thermometers", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Thermometer", "MN": "E07.900", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Measuring instruments for determining the temperature of matter. Most thermometers used in the field of medicine are designed for measuring body temperature or for use in the clinical laboratory. (From UMDNS, 1999)", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013821"}, {"RECTYPE": "D", "MH": "Thermoplasma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.850.800", "MH_TH": "NLM (1976)", "ST": "T194", "RN": "txid2302", "AN": "a genus of archaea found in burning slag & hot springs", "PI": "Mycoplasmatales (1975)", "MS": "A genus of facultatively anaerobic heterotrophic archaea, in the order THERMOPLASMALES, isolated from self-heating coal refuse piles and acid hot springs. They are thermophilic and can grow both with and without sulfur.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750721", "DC": "1", "DX": "19760101", "UI": "D013822"}, {"RECTYPE": "D", "MH": "Thermoreceptors", "DE": "THERMORECEPT", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Thermoreceptor", "MN": "A11.671.650.915.968", "FX": "Body Temperature Regulation", "MH_TH": "NLM (1971)", "ST": "T026", "PI": "Temperature Sense (1966-1970)", "MS": "Cellular receptors which mediate the sense of temperature. Thermoreceptors in vertebrates are mostly located under the skin. In mammals there are separate types of thermoreceptors for cold and for warmth and NOCICEPTORS which detect cold or heat extreme enough to cause pain.", "PM": "74", "HN": "74(71)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013823"}, {"RECTYPE": "D", "MH": "Thermus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.400.425.875", "MH_TH": "NLM (1978)", "ST": "T007", "RN": "txid270", "AN": "in hot springs, hot-water tanks, thermally polluted waters", "PI": "Gram-Negative Aerobic Bacteria (1976-1977)", "MS": "Gram-negative aerobic rods found in warm water (40-79 degrees C) such as hot springs, hot water tanks, and thermally polluted rivers.", "PM": "78", "HN": "78", "MR": "20200813", "DA": "19770301", "DC": "1", "DX": "19780101", "UI": "D013824"}, {"RECTYPE": "D", "MH": "Theta Rhythm", "AQ": "DE GE IM PH RE", "ENTRY": "Theta Rhythms", "MN": "G11.561.127.937", "MH_TH": "NLM (1975)", "ST": "T042", "MS": "Brain waves characterized by a frequency of 4-7 Hz, usually observed in the temporal lobes when the individual is awake, but relaxed and sleepy.", "PM": "91; was see under ELECTROENCEPHALOGRAPHY 1975-90", "HN": "91(75); was see under ELECTROENCEPHALOGRAPHY 1975-90", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D013826"}, {"RECTYPE": "D", "MH": "Thiabendazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tiabendazol|T109|T121|NON|EQV|UNK (19XX)|770429|abbcdef", "ENTRY": "Thibendole|T109|T121|NON|EQV|UNK (19XX)|800731|abbcdef", "MN": "D03.633.100.103.850", "PA": "Anthelmintics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Benzimidazole, 2-(4-thiazolyl)-", "RN": "N1Q45E87DT", "RR": "148-79-8 (Thiabendazole)", "MS": "2-Substituted benzimidazole first introduced in 1962. It is active against a variety of nematodes and is the drug of choice for STRONGYLOIDIASIS. It has CENTRAL NERVOUS SYSTEM side effects and hepatototoxic potential. (From Smith and Reynard, Textbook of Pharmacology, 1992, p919)", "PM": "65", "HN": "65(63)", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013827"}, {"RECTYPE": "D", "MH": "Thioacetazone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amithiozone|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1996)|950309|abbcdeef", "ENTRY": "TBI698", "MN": "D02.886.803.702", "PA": "Antitubercular Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Acetamide, N-(4-(((aminothioxomethyl)hydrazono)methyl)phenyl)-", "RN": "MMG78X7SSR", "RR": "104-06-3 (Thioacetazone)", "MS": "A thiosemicarbazone that is used in association with other antimycobacterial agents in the initial and continuation phases of antituberculosis regimens. Thiacetazone containing regimens are less effective than the short-course regimen recommended by the International Union Against Tuberculosis and are used in some developing countries to reduce drug costs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p217)", "PM": "96; was THIACETAZONE 1968-95; THIOACETAZON was see THIACETAZONE 1977-95", "HN": "96; was THIACETAZONE 1963-95 (Prov 1963-67); THIOACETAZON was see THIACETAZONE 1977-95", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013828"}, {"RECTYPE": "D", "MH": "Thiadiazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.855.785", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "Heterocyclic Compounds (1966-1970)", "PM": "91; was see under THIAZINES 1971-90", "HN": "91(71); was see under THIAZINES 1971-90", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013829"}, {"RECTYPE": "D", "MH": "Thiadiazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiadiazole|T109|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D03.383.129.708.867", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "AN": "includes thiadiazolines, thiadiazolidines", "PI": "Heterocyclic Compounds (1966-1970)", "MS": "Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms.", "PM": "73; METHAZOLAMIDE was see under CARBONIC ANHYDRASE INHIBITORS 1965-74", "HN": "73(71)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013830"}, {"RECTYPE": "D", "MH": "Thiamine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitamin B 1|T109|T121|T127|NON|EQV|UNK (19XX)|740701|VITAMIN B A 01|abbbcdefs", "ENTRY": "Mononitrate, Thiamine", "MN": "D03.383.742.795", "PA": "Vitamin B Complex", "EC": "deficiency:Thiamine Deficiency", "MH_TH": "NLM (1966)", "ST": "T127", "N1": "Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl- chloride", "RN": "X66NSO3N35", "RR": "8K0I04919X", "MS": "3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2- hydroxyethyl)-4-methylthiazolium chloride.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013831"}, {"RECTYPE": "D", "MH": "Thiamine Deficiency", "DE": "THIAMINE DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thiamine Deficiencies", "MN": "C18.654.521.500.133.699.827", "FX": "Beriberi", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A nutritional condition produced by a deficiency of THIAMINE in the diet, characterized by anorexia, irritability, and weight loss. Later, patients experience weakness, peripheral neuropathy, headache, and tachycardia. In addition to being caused by a poor diet, thiamine deficiency in the United States most commonly occurs as a result of alcoholism, since ethanol interferes with thiamine absorption. In countries relying on polished rice as a dietary staple, BERIBERI prevalence is very high. (From Cecil Textbook of Medicine, 19th ed, p1171)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013832"}, {"RECTYPE": "D", "MH": "Thiamine Monophosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Phosphoester, Thiamine", "MN": "D03.383.742.795.600", "PA": "Vitamin B Complex", "MH_TH": "NLM (1979)", "ST": "T127", "N1": "Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(2-(phosphonooxy)ethyl)-, chloride", "RN": "532-40-1", "AN": "deficiency: coordinate THIAMINE MONOPHOSPHATE /defic (IM) with THIAMINE DEFICIENCY (IM)", "PI": "Thiamine (1966-1978)", "MS": "Thiamine dihydrogen phosphate ester. The monophosphate ester of thiamine. Synonyms: monophosphothiamine; vitamin B1 monophosphate.", "PM": "91; was see under THIAMINE 1979-90", "HN": "91(79); was see under THIAMINE 1979-90", "MR": "20160601", "DA": "19771222", "DC": "1", "DX": "19910101", "UI": "D013833"}, {"RECTYPE": "D", "MH": "Thiamine Pyrophosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TPPase|T116|T126|EQV|UNK (19XX)|820517|abbdef", "ENTRY": "Pyrophosphate Phosphohydrolase, Thiamine", "MN": "D08.811.277.040.600.600.500", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.6.1.-", "AN": "do not confuse with THIAMINE PYROPHOSPHATE", "PI": "Thiamine Pyrophosphate (1973-1974)", "MS": "An enzyme that hydrolyzes thiamine pyrophosphate to thiamine monophosphate plus inorganic phosphate. EC 3.6.1.-.", "PM": "91; was see under PYROPHOSPHATASES 1975-90", "HN": "91(75); was see under PYROPHOSPHATASES 1975-90", "MR": "20230405", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013834"}, {"RECTYPE": "D", "MH": "Thiamine Pyrophosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiamine Diphosphate|T109|T121|T127|NON|EQV|UNK (19XX)|760515|abbbcdef", "ENTRY": "Pyrophosphate, Thiamine", "MN": "D08.211.878", "PA": "Vitamin B Complex", "MH_TH": "NLM (1966)", "ST": "T127", "N1": "Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(4,6,6-trihydroxy-3,5-dioxa-4,6-diphosphahex-1-yl)-, chloride, P,P'-dioxide", "RN": "Q57971654Y", "RR": "154-87-0 (Thiamine Pyrophosphate)", "AN": "do not confuse with THIAMINE PYROPHOSPHATASE; deficiency: coordinate THIAMINE PYROPHOSPHATE /defic (IM) with THIAMINE DEFICIENCY (IM)", "MS": "The coenzyme form of Vitamin B1 present in many animal tissues. It is a required intermediate in the PYRUVATE DEHYDROGENASE COMPLEX and the KETOGLUTARATE DEHYDROGENASE COMPLEX.", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013835"}, {"RECTYPE": "D", "MH": "Thiamin Pyrophosphokinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thiamine Pyrophosphokinase|T116|T126|NON|EQV|NLM (1994)|930520|abbcdef", "ENTRY": "Pyrophosphokinase, Thiamine", "MN": "D08.811.913.696.175.825", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "ATP:thiamine pyrophosphotransferase", "RN": "EC 2.7.6.2", "RR": "9026-24-8 (CAS RN)", "AN": "do not confuse with THIAMINE PYROPHOSPHATASE nor with thiamine diphosphate kinase", "PI": "Thiamine (1966-1978)", "MS": "An enzyme that catalyzes the formation of thiamine pyrophosphate from ATP and thiamine. EC 2.7.6.2.", "OL": "use THIAMIN PYROPHOSPHOKINASE to search THIAMINE PYROPHOSPHOKINASE 1979-93", "PM": "94; was THIAMINE PYROPHOSPHOKINASE 1979-93 (see under PHOSPHOTRANSFERASES, ATP 1979-90)", "HN": "94; was THIAMINE PYROPHOSPHOKINASE 1979-93 (see under PHOSPHOTRANSFERASES, ATP 1979-90)", "MR": "20030709", "DA": "19771222", "DC": "1", "DX": "19910101", "UI": "D013836"}, {"RECTYPE": "D", "MH": "Thiamin-Triphosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thiamine Triphosphatase|T116|T126|NON|EQV|NLM (1994)|921006|abbcdef", "ENTRY": "Thiamin Triphosphatase", "MN": "D08.811.277.040.850", "MH_TH": "NLM (1979)", "ST": "T126", "N1": "Thiamin-triphosphate phosphohydrolase", "RN": "EC 3.6.1.28", "AN": "do not confuse with THIAMINE TRIPHOSPHATE", "PI": "Thiamine Pyrophosphate (1977-1978)", "MS": "An enzyme present in nerve tissue. It catalyzes reversibly the formation of thiamine diphosphate and orthophosphate from thiamine triphosphate. EC 3.6.1.28.", "OL": "use THIAMIN-TRIPHOSPHATASE to search THIAMINE TRIPHOSPHATASE 1979-93", "PM": "94; was THIAMINE TRIPHOSPHATASE 1979-93 (see under PHOSPHATASES 1979-90)", "HN": "94; was THIAMINE TRIPHOSPHATASE 1979-93 (see under PHOSPHATASES 1979-90)", "MR": "20030709", "DA": "19771222", "DC": "1", "DX": "19910101", "UI": "D013837"}, {"RECTYPE": "D", "MH": "Thiamine Triphosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Triphosphate, Thiamine", "MN": "D03.383.742.795.900", "PA": "Vitamin B Complex", "MH_TH": "NLM (1979)", "ST": "T127", "N1": "Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(4,6,8,8-tetrahydroxy-3,5,7-trioxa-4,6,8-triphosphaoct-1-yl)-, inner salt, P,P',P''-trioxide", "RN": "3475-65-8", "AN": "do not confuse with THIAMIN TRIPHOSPHATASE; deficiency: coordinate THIAMINE TRIPHOSPHATE /defic (IM) with THIAMINE DEFICIENCY (IM)", "PI": "Thiamine (1966-1978)", "MS": "3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(4,6,8,8-tetrahydroxy-3,5,7-trioxa-4,6,8-triphosphaoct-1-yl)thiazolium hydroxide, inner salt, P,P',P''-trioxide. The triphosphate ester of thiamine. In Leigh's disease, this compound is present in decreased amounts in the brain due to a metabolic block in its formation.", "PM": "91; was see under THIAMINE 1979-90", "HN": "91(79); was see under THIAMINE 1979-90", "MR": "20160601", "DA": "19771222", "DC": "1", "DX": "19910101", "UI": "D013838"}, {"RECTYPE": "D", "MH": "Thiamphenicol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiophenicol|T109|T195|TRD|NRW|FR|UNK (19XX)|741111|abbcdeef", "ENTRY": "Vicemycetin|T109|T195|TRD|NRW|NLM (1990)|891122|abbcdef", "MN": "D02.640.529.175.850", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1968)", "ST": "T195", "N1": "Acetamide, 2,2-dichloro-N-(2-hydroxy-1-(hydroxymethyl)-2-(4-(methylsulfonyl)phenyl)ethyl)-, (R-(R*,R*))-", "RN": "FLQ7571NPM", "RR": "15318-45-3 (Thiamphenicol)", "PI": "Sulfones (1966-1974)", "MS": "A methylsulfonyl analog of CHLORAMPHENICOL. It is an antibiotic and immunosuppressive agent.", "PM": "79; was see under ANTIBIOTICS 1975-78", "HN": "79(75); was see under ANTIBIOTICS 1975-78", "MR": "20160701", "DA": "19741111", "DC": "1", "DX": "19790101", "UI": "D013839"}, {"RECTYPE": "D", "MH": "Thiamylal", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thioquinalbarbitone|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Sodium, Thiamylal", "MN": "D03.383.742.698.253.800.750", "PA": "Hypnotics and Sedatives", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4,6(1H,5H)-Pyrimidinedione, dihydro-5-(1-methylbutyl)-5-(2-propenyl)-2-thioxo-", "RN": "01T23W89FR", "RR": "T4L2P3KH7K", "MS": "A barbiturate that is administered intravenously for the production of complete anesthesia of short duration, for the induction of general anesthesia, or for inducing a hypnotic state. (From Martindale, The Extra Pharmacopoeia, 30th ed, p919)", "PM": "65", "HN": "65", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013840"}, {"RECTYPE": "D", "MH": "Thiazepines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiazepine|T109|NON|EQV|NLM (2021)|191121|abcdef", "MN": "D03.383.886.702", "MH_TH": "NLM (1973)", "ST": "T109", "RN": "0", "PI": "Dibenzazepines (1968-1972)", "MS": "Compounds that are derivatives of THIEPINS, with a nitrogen replacing a carbon in the seven-membered heterocyclic compound.", "PM": "74", "HN": "74(73)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013841"}, {"RECTYPE": "D", "MH": "Thiazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.855", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "OL": "use THIAZINES to search PYRIDOBENZOTHIAZINES 1966-84", "PM": "PYRIDOBENZOTHIAZINES was heading 1963-84", "HN": "PYRIDOBENZOTHIAZINES was heading 1963-84", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D013843"}, {"RECTYPE": "D", "MH": "Thiazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiazole|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D03.383.129.708", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "includes thiazolines, thiazolidines", "MS": "Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms.", "PM": "ETHOXZOLAMIDE was see under CARBONIC ANHYDRASE INHIBITORS 1965-74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013844"}, {"RECTYPE": "D", "MH": "Thienamycins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antibiotics, Thienamycin|T109|T195|NON|EQV|NLM (1996)|940822|abbcdef", "ENTRY": "Thienamycin Antibiotics", "MN": "D03.633.100.300.124.300", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1983)", "ST": "T195", "RN": "0", "PI": "Lactams (1974-1982)", "MS": "Beta-lactam antibiotics that differ from PENICILLINS in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors.", "PM": "83", "HN": "83", "MR": "20160601", "DA": "19820505", "DC": "1", "DX": "19830101", "UI": "D013845"}, {"RECTYPE": "D", "MH": "Thiepins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.886", "MH_TH": "NLM (1968)", "ST": "T109", "RN": "0", "PM": "68", "HN": "68", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013846"}, {"RECTYPE": "D", "MH": "Thiethylperazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Torecan|T109|T121|TRD|NRW|ES|MX|US|060404|abbcdeeef", "MN": "D03.633.300.783.780", "PA": "Dopamine Antagonists", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "10H-Phenothiazine, 2-(ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)-", "RN": "8ETK1WAF6R", "RR": "HP46XK89XB", "MS": "A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457)", "PM": "65", "HN": "65(63)", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013847"}, {"RECTYPE": "D", "MH": "Thigh", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Thighs", "MN": "A01.378.610.750", "FX": "Femur", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "for humans & other vertebrates; for bone index FEMUR; NIM when merely locational ", "MS": "The superior part of the lower extremity between the HIP and the KNEE.", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013848"}, {"RECTYPE": "D", "MH": "Thimerosal", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiomersalate|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Ethylmercurithiosalicylate, Sodium", "MN": "D02.691.750.100.347.850", "PA": "Preservatives, Pharmaceutical", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Mercurate(1-), ethyl(2-mercaptobenzoato(2-)-O,S)-, sodium", "RN": "2225PI3MOV", "RR": "54-64-8 (Thimerosal)", "PI": "Sulfides (1974)", "MS": "An ethylmercury-sulfidobenzoate that has been used as a preservative in VACCINES; ANTIVENINS; and OINTMENTS. It was formerly used as a topical antiseptic. It degrades to ethylmercury and thiosalicylate.", "PM": "91; was see under ETHYLMERCURY COMPOUNDS 1980-90; was see under ETHYL MERCURY COMPOUNDS 1975-79", "HN": "91(75); was see under ETHYLMERCURY COMPOUNDS 1980-90; was see under ETHYL MERCURY COMPOUNDS 1975-79", "MR": "20160701", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013849"}, {"RECTYPE": "D", "MH": "Thinking", "AQ": "CL DE ES PH RE", "ENTRY": "Thoughts", "MN": "F02.463.785", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "differentiate from MEDITATION and COGNITION", "MS": "Mental activity that is not predominantly perceptual by which one apprehends some aspect of an object or situation based on past learning and experience.", "CATSH": "CAT LIST", "MR": "20170711", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013850"}, {"RECTYPE": "D", "MH": "Thinness", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Leanness|T184|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Underweight|T184|NON|REL|NLM (2005)|040623|abcdef", "MN": "G07.100.175.313.828", "FX": "Emaciation", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A state of insufficient flesh on the body usually defined as having a body weight less than skeletal and physical standards, such as  BODY MASS INDEX, and dependent on age, sex, and genetic background.", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013851"}, {"RECTYPE": "D", "MH": "Thiotepa", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Triethylenethiophosphoramide|T109|T121|T131|NON|EQV|NLM (1992)|910404|abbbcdef", "ENTRY": "Thio Tepa", "MN": "D03.383.097.217.935.960", "PA": "Myeloablative Agonists", "MH_TH": "USP (19XX)", "ST": "T131", "N1": "Aziridine, 1,1',1''-phosphinothioylidynetris-", "RN": "905Z5W3GKH", "RR": "52-24-4 (Thiotepa)", "MS": "A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).", "OL": "use THIOTEPA to search THIO-TEPA 1966-91", "PM": "92; was THIO-TEPA 1963-91; THIOTEPA was see THIO-TEPA 1977-91", "HN": "92; was THIO-TEPA 1963-91; THIOTEPA was see THIO-TEPA 1977-91", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D013852"}, {"RECTYPE": "D", "MH": "Thioacetamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiacetamid|T109|T131|NON|EQV|UNK (19XX)|760305|abbcdef", "ENTRY": "Thioacetamid|T109|T131|NON|EQV|UNK (19XX)|760305|abbcdef", "MN": "D02.886.685.800", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Ethanethioamide", "RN": "075T165X8M", "RR": "62-55-5 (Thioacetamide)", "MS": "A crystalline compound used as a laboratory reagent in place of HYDROGEN SULFIDE. It is a potent hepatocarcinogen.", "PM": "91; was see under ACETAMIDES 1973-90", "HN": "91(73); was see under ACETAMIDES 1973-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013853"}, {"RECTYPE": "D", "MH": "Thioamides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thioamide|T109|NON|EQV|NLM (2021)|200129|abcdef", "MN": "D02.886.685", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Amides (1966-1974)", "MS": "Organic compounds containing the radical -CSNH2.", "PM": "91; was see under AMIDES 1975-90", "HN": "91(75); was see under AMIDES 1975-90", "MR": "20200527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013854"}, {"RECTYPE": "D", "MH": "Thiobacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Thiobacillus thioparus|T007|NON|NRW|NLM (2004)|021112|abcdef", "MN": "B03.660.075.400.800", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid919", "RR": "txid931", "MS": "A genus of gram-negative, rod-shaped bacteria that derives energy from the oxidation of one or more reduced sulfur compounds. Many former species have been reclassified to other classes of PROTEOBACTERIA.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013855"}, {"RECTYPE": "D", "MH": "Acidithiobacillus thiooxidans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Thiobacillus thiooxidans|T007|NON|EQV|NLM (1972)|990101|abcdef", "MN": "B03.660.250.015.800", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid930", "AN": "THIOBACILLUS is also available", "PI": "Thiobacillus (1966-1971)", "MS": "A strictly autotrophic species of bacteria that oxidizes sulfur and thiosulfate to sulfuric acid. It was formerly called Thiobacillus thiooxidans.", "PM": "2004; see THIOBACILLUS THIOOXIDANS 1991-2003, see THIOBACILLUS 1972-1990", "HN": "2004 (1972)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013856"}, {"RECTYPE": "D", "MH": "Thiobarbiturates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.742.698.253.800", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Barbiturates (1966-1974)", "MS": "Compounds in which one or more of the ketone groups on the pyrimidine ring of barbituric acid are replaced by thione groups.", "PM": "75", "HN": "75", "MR": "20160601", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D013858"}, {"RECTYPE": "D", "MH": "Thiocarbamates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiocarbamate|T109|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D02.886.706", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Carbamates in which the -CO- group has been replaced by a -CS- group.", "PM": "66", "HN": "66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013859"}, {"RECTYPE": "D", "MH": "Thiocholine", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D02.886.489.789", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Ethanaminium, 2-mercapto-N,N,N-trimethyl-", "RN": "625-00-3", "PI": "Sulfhydryl Compounds (1966-1974)", "MS": "A mercaptocholine used as a reagent for the determination of CHOLINESTERASES. It also serves as a highly selective nerve stain.", "PM": "91; was see under CHOLINE 1975-90", "HN": "91(75); was see under CHOLINE 1975-90", "MR": "20070709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D013860"}, {"RECTYPE": "D", "MH": "Thiocyanates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rhodanates|T109|NON|EQV|UNK (19XX)|770425|abcdef", "MN": "D02.886.728", "FX": "Isothiocyanates", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Organic derivatives of thiocyanic acid which contain the general formula R-SCN.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013861"}, {"RECTYPE": "D", "MH": "Thiogalactosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiogalactopyranosides|T109|NON|EQV|UNK (19XX)|760324|abcdef", "MN": "D09.408.903.600", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Thioglycosides (1974)", "MS": "Galactosides in which the oxygen atom linking the sugar and aglycone is replaced by a sulfur atom.", "PM": "91; was see under THIOGLYCOSIDES 1975-90", "HN": "91(75); was see under THIOGLYCOSIDES 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013862"}, {"RECTYPE": "D", "MH": "Thioglucosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thioglucopyranosides|T109|NON|EQV|UNK (19XX)|760324|abcdef", "MN": "D09.408.903.703", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "AN": "do not confuse with THIOGLYCOSIDES", "OL": "search THIOGLYCOSIDES 1974", "PM": "91; was see under THIOGLYCOSIDES 1975-90", "HN": "91(75); was see under THIOGLYCOSIDES 1975-90", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013863"}, {"RECTYPE": "D", "MH": "Thioglycolates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Thioglycollates|T109|NON|EQV|UNK (19XX)|800731|abcdef", "MN": "D02.886.489.828", "MH_TH": "NLM (1964)", "ST": "T109", "RN": "0", "MS": "Organic esters of thioglycolic acid (HS-CH2COOH).", "PM": "70", "HN": "70(64)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D013864"}, {"RECTYPE": "D", "MH": "Thioglycosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.408.903", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "do not confuse with THIOGLUCOSIDES", "PM": "74", "HN": "74", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013865"}, {"RECTYPE": "D", "MH": "Thioguanine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "6-Thioguanine|T109|T121|NON|EQV|UNK (19XX)|830531|THIOGUANINE 06|abbcdefs", "ENTRY": "ThioguaninGSK", "MN": "D03.633.100.759.854", "PA": "Antimetabolites, Antineoplastic", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "6H-Purine-6-thione, 2-amino-1,7-dihydro-", "RN": "FTK8U1GZNX", "RR": "WIX31ZPX66", "MS": "An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.", "PM": "1966; 2-AMINO-6-PURINETHIOL was indexed under 6-MERCAPTOPURINE 2007-2009", "HN": "1966(1964)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013866"}, {"RECTYPE": "D", "MH": "Thiohydantoins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiohydantoin|T109|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D03.383.129.308.432.555.868", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "Sulfur analogs of hydantoins with one or both carbonyl groups replaced by thiocarbonyl groups.", "PM": "91; was see under HYDANTOINS 1973-90", "HN": "91(73); was see under HYDANTOINS 1973-90", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013867"}, {"RECTYPE": "D", "MH": "Thioinosine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "6-Mercaptopurine Riboside|T114|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|761223|MERCAPTOPURINE RIBOSIDE 06|abbcdeefs", "ENTRY": "Ribosyl 6 mercaptopurine", "MN": "D13.570.900.800", "PA": "Immunosuppressive Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Inosine, 6-thio-", "RN": "46S541971T", "RR": "574-25-4 (Thioinosine)", "PI": "Mercaptopurine (1973-1974)", "MS": "Sulfhydryl analog of INOSINE that inhibits nucleoside transport across erythrocyte plasma membranes, and has immunosuppressive properties. It has been used similarly to MERCAPTOPURINE in the treatment of leukemia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p503)", "PM": "91; was see under INOSINE 1975-90", "HN": "91(75); was see under INOSINE 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013868"}, {"RECTYPE": "D", "MH": "Thiolester Hydrolases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hydrolases, Thiolester", "MN": "D08.811.277.352.897", "MH_TH": "NLM (1973)", "ST": "T126", "RN": "EC 3.1.2.-", "PI": "Esterases (1966-1972)", "PM": "73", "HN": "73", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013869"}, {"RECTYPE": "D", "MH": "Thiomalates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.886.489.891", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of thiomalic acid (the structural formula (COOH)CHSH(COOH)), including its salts and esters.", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013870"}, {"RECTYPE": "D", "MH": "Thiones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thione|T109|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Thioketones|T109|NON|EQV|NLM (2018)|161019|abcdef", "MN": "D02.886.753", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "AN": "also \"thions\"", "MS": "Sulfur-containing compounds also known as thioketones of general formula R2C=S.", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013871"}, {"RECTYPE": "D", "MH": "Thionucleosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D13.570.900", "MH_TH": "NLM (1977)", "ST": "T114", "RN": "0", "PI": "specific nucleoside (1966-1976)", "MS": "Nucleosides in which the base moiety is substituted with one or more sulfur atoms.", "PM": "77", "HN": "77", "MR": "20050630", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D013872"}, {"RECTYPE": "D", "MH": "Thionucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D13.695.900", "MH_TH": "NLM (1977)", "ST": "T114", "RN": "0", "PI": "specific nucleotide (1966-1976)", "MS": "Nucleotides in which the base moiety is substituted with one or more sulfur atoms.", "PM": "77", "HN": "77", "MR": "20050630", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D013873"}, {"RECTYPE": "D", "MH": "Thiopental", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiopentobarbital|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Trapanal|T109|T121|TRD|NRW|DE|NLM (1996)|950522|abbcdeef", "MN": "D03.383.742.698.253.800.810", "PA": "Hypnotics and Sedatives", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "4,6(1H,5H)-Pyrimidinedione, 5-ethyldihydro-5-(1-methylbutyl)-2-thioxo-", "RN": "JI8Z5M7NA3", "RR": "76-75-5 (Thiopental)", "MS": "A barbiturate that is administered intravenously for the induction of general anesthesia or for the production of complete anesthesia of short duration.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013874"}, {"RECTYPE": "D", "MH": "Thiophanate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiophanate-Methyl|T109|T121|T131|NON|NRW|UNK (19XX)|780509|abbbcdef", "ENTRY": "Thiophanate Methyl", "MN": "D02.886.904.601.900", "PA": "Fungicides, Industrial", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Carbamic acid, (1,2-phenylenebis(iminocarbonothioyl))bis-, dimethyl ester", "RN": "5Q0Y96D5I8", "RR": "23564-05-8 (Thiophanate)", "PI": "Phenylthiourea (1966-1974)", "MS": "Nematocide used in livestock; also has fungicidal properties.", "OL": "use THIOPHANATE to search THIOPHANATE-METHYL 1975-78", "PM": "91; was see under CARBAMATES 1979-90; was THIOPHANATE-METHYL see under CARBAMATES 1975-78", "HN": "91(79); was see under CARBAMATES 1979-90; was THIOPHANATE-METHYL see under CARBAMATES 1975-78", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013875"}, {"RECTYPE": "D", "MH": "Thiophenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiophene|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D03.383.903", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013876"}, {"RECTYPE": "D", "MH": "Thioredoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Thioredoxin-2|T116|T123|NON|NRW|NLM (2008)|040730|abbcdef", "MN": "D12.776.915", "MH_TH": "NLM (2008)", "ST": "T123", "N1": "Thioredoxins", "RN": "52500-60-4", "PI": "Bacterial Proteins (1968-1974)", "MS": "Hydrogen-donating proteins that participates in a variety of biochemical reactions including ribonucleotide reduction and reduction of PEROXIREDOXINS. Thioredoxin is oxidized from a dithiol to a disulfide when acting as a reducing cofactor. The disulfide form is then reduced by NADPH in a reaction catalyzed by THIOREDOXIN REDUCTASE.", "PM": "2008; see THIOREDOXIN 1991, see BACTERIAL PROTEINS 1975-1990; THIOREDOXIN 2 was indexed under THIOREDOXIN & MEMBRANE PROTEINS 1997-2006", "HN": "2008(1975)", "MR": "20070709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013879"}, {"RECTYPE": "D", "MH": "Thioredoxin-Disulfide Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thioredoxin Reductase (NADPH)|T116|T126|ACX|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "Thioredoxin Disulfide Reductase", "MN": "D12.776.331.971", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.8.1.9", "PI": "Oxidoreductases (1972-1974)", "MS": "A FLAVOPROTEIN enzyme that catalyzes the oxidation of THIOREDOXINS to thioredoxin disulfide in the presence of NADP+. It was formerly listed as EC 1.6.4.5", "PM": "2008; see THIOREDOXIN REDUCTASE (NADPH) 1991-2007, see NADH, NADPH OXIDOREDUCTASES 1975-1990", "HN": "2008(1975)", "MR": "20070711", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013880"}, {"RECTYPE": "D", "MH": "Thioridazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ThioridazineNeurazpharm", "MN": "D03.633.300.783.843", "PA": "Dopamine Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "10H-Phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylthio)-", "RN": "N3D6TG58NI", "RR": "50-52-2 (Thioridazine)", "MS": "A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013881"}, {"RECTYPE": "D", "MH": "Thiosemicarbazones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiosemicarbazone|T109|NON|EQV|NLM (2021)|191219|abcdef", "MN": "D02.886.803", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "antituberc agents", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013882"}, {"RECTYPE": "D", "MH": "Thiostrepton", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Thiactin|T116|T195|TRD|NRW|NLM (1990)|891108|abbcdef", "MN": "D12.644.641.825", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Thiostrepton", "RN": "HR4S203Y18", "RR": "1393-48-2 (Thiostrepton)", "PI": "Peptides (1971-1974)", "MS": "One of the CYCLIC PEPTIDES from Streptomyces that is active against gram-positive bacteria. In veterinary medicine, it has been used in mastitis caused by gram-negative organisms and in dermatologic disorders.", "PM": "91; was see under ANTIBIOTICS 1975-90", "HN": "91(75); was see under ANTIBIOTICS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013883"}, {"RECTYPE": "D", "MH": "Thiosulfate Sulfurtransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thiosulfate Cyanide Transsulphurase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Transsulphurase, Thiosulfate Cyanide", "MN": "D08.811.913.817.500.500", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Thiosulfate:cyanide sulfurtransferase", "RN": "EC 2.8.1.1", "RR": "9026-04-4 (CAS RN)", "PI": "Thiosulfates (1972-1974)", "MS": "An enzyme that catalyzes the transfer of the planetary sulfur atom of thiosulfate ion to cyanide ion to form thiocyanate ion. EC 2.8.1.1.", "PM": "91; was see under SULFURTRANSFERASES 1975-90", "HN": "91(75); was see under SULFURTRANSFERASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013884"}, {"RECTYPE": "D", "MH": "Thiosulfates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiosulfate|T197|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D01.875.800.800.850.900", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "MS": "Inorganic salts of thiosulfuric acid possessing the general formula R2S2O3.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013885"}, {"RECTYPE": "D", "MH": "Thiosulfonic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Thiosulfonic", "MN": "D02.886.645.600.925", "MH_TH": "NLM (1975)", "ST": "T104", "RN": "0", "MS": "Inorganic or organic oxy acids of sulfur which contain the general formula RS2O2H.", "OL": "use SULFONIC ACIDS to search THIOSULFONIC ACIDS 1968-74", "PM": "91; was see under SULFONIC ACIDS 1975-90", "HN": "91(75); was see under SULFONIC ACIDS 1975-90", "MR": "19930604", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013886"}, {"RECTYPE": "D", "MH": "Thiothixene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tiotixene|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|890627|abbcdeef", "ENTRY": "Navane|T109|T121|TRD|NRW|AU|US|861117|abbcdeef", "MN": "D03.633.300.953.704.787", "PA": "Dopamine Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "9H-Thioxanthene-2-sulfonamide, N,N-dimethyl-9-(3-(4-methyl-1-piperazinyl)propylidene)-", "RN": "7318FJ13YJ", "RR": "5591-45-7 (Thiothixene)", "PI": "Xanthenes (1966-1969)", "MS": "A thioxanthine used as an antipsychotic agent. Its effects are similar to the phenothiazine antipsychotics.", "PM": "73", "HN": "73(70)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013888"}, {"RECTYPE": "D", "MH": "Thiouracil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.742.698.875.842", "PA": "Vasodilator Agents", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-", "RN": "59X161SCYL", "RR": "141-90-2 (Thiouracil)", "AN": "a thyroid antag", "MS": "Occurs in seeds of Brassica and Crucifera species. Thiouracil has been used as antithyroid, coronary vasodilator, and in congestive heart failure although its use has been largely supplanted by other drugs. It is known to cause blood dyscrasias and suspected of terato- and carcinogenesis.", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013889"}, {"RECTYPE": "D", "MH": "Thiourea", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.886.904", "PA": "Indicators and Reagents", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "Thiourea", "RN": "GYV9AM2QAG", "RR": "62-56-6 (Thiourea)", "AN": "a thyroid antag", "MS": "A photographic fixative used also in the manufacture of resins. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance may reasonably be anticipated to be a carcinogen (Merck Index, 9th ed). Many of its derivatives are ANTITHYROID AGENTS and/or FREE RADICAL SCAVENGERS.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013890"}, {"RECTYPE": "D", "MH": "Thiouridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "4 Thiouridine", "MN": "D13.570.900.829", "PA": "Antimetabolites", "MH_TH": "NLM (1972)", "ST": "T121", "N1": "Uridine, 4-thio-", "RN": "13957-31-8", "AN": "an antimetabolite", "PI": "Uridine (1966-1971)", "MS": "A photoactivable URIDINE analog that is used as an affinity label.", "PM": "74", "HN": "74(72)", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013891"}, {"RECTYPE": "D", "MH": "Thioxanthenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.953.704", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Compounds with three aromatic rings in linear arrangement with a SULFUR in the center ring.", "PM": "74; CLOPENTHIXOL was see under TRANQUILIZING AGENTS 1967-74", "HN": "74", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013892"}, {"RECTYPE": "D", "MH": "Thiram", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Disulfide, Tetramethylthiuram", "MN": "D02.886.706.175.900", "PA": "Mutagens", "MH_TH": "USAN (1962)", "ST": "T131", "N1": "Thioperoxydicarbonic diamide (((H2N)C(S))2S2), tetramethyl-", "RN": "0D771IS0FH", "RR": "137-26-8 (Thiram)", "MS": "A dithiocarbamate chemical, used commercially in the rubber processing industry and as a fungicide. In vivo studies indicate that it inactivates the enzyme GLUTATHIONE REDUCTASE. It has mutagenic activity and may induce chromosomal aberrations.", "PM": "91; was see under THIOCARBAMATES 1966-90", "HN": "91(66); was see under THIOCARBAMATES 1966-90", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013893"}, {"RECTYPE": "D", "MH": "Thirst", "AQ": "CL DE ES PH RE", "ENTRY": "Thirsts", "MN": "F01.658.293.787", "FX": "Water Deprivation", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A drive stemming from a physiological need for WATER.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013894"}, {"RECTYPE": "D", "MH": "Thoracic Arteries", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Thoracic Artery", "MN": "A07.015.114.891", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Arteries originating from the subclavian or axillary arteries and distributing to the anterior thoracic wall, mediastinal structures, diaphragm, pectoral muscles, mammary gland and the axillary aspect of the chest wall.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013895"}, {"RECTYPE": "D", "MH": "Thoracic Diseases", "DE": "THORACIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thoracic Disease", "MN": "C08.846", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; CHEST PAIN is available", "MS": "Disorders affecting the organs of the thorax.", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013896"}, {"RECTYPE": "D", "MH": "Thoracic Duct", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cisterna Chyli|T023|NON|REL|UNK (19XX)|780310|abcdef", "ENTRY": "Thoracic Ducts", "MN": "A15.382.520.301.750", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The largest lymphatic vessel that passes through the chest and drains into the SUBCLAVIAN VEIN.", "OL": "use THORACIC DUCT to search CISTERNA CHYLI 1966-78", "HN": "CISTERNA CHYLI was see under THORACIC DUCT 1963-78", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013897"}, {"RECTYPE": "D", "MH": "Thoracic Injuries", "DE": "THORACIC INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chest Injuries|T037|NON|EQV|NLM (1992)|901005|CHEST INJ|abcdefv", "ENTRY": "Thoracic Injury", "MN": "C26.891", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "general or unspecified only: prefer specifics like HEART INJURIES; LUNG INJURIES, etc.; consider also / inj with specific parts of the chest", "MS": "General or unspecified injuries to the chest area.", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013898"}, {"RECTYPE": "D", "MH": "Thoracic Neoplasms", "DE": "THORACIC NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Thoracic Neoplasm", "MN": "C04.588.894", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "general or unspecified; prefer specifics; coordinate IM with histological type of neoplasm (IM)", "MS": "New abnormal growth of tissue in the THORAX.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013899"}, {"RECTYPE": "D", "MH": "Thoracic Nerves", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Pectoral Nerves|T023|NON|NRW|UNK (19XX)|780519|abcdef", "ENTRY": "Thoracic Nerve", "MN": "A08.800.800.720.800", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES (IM); neopl: coord IM with PERIPHERAL NERVOUS SYSTEM NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "The twelve spinal nerves on each side of the thorax. They include eleven INTERCOSTAL NERVES and one subcostal nerve. Both sensory and motor, they supply the muscles and skin of the thoracic and abdominal walls.", "OL": "use THORACIC NERVES to search PECTORAL NERVES 1966-78", "HN": "PECTORAL NERVES was see under THORACIC NERVES 1963-78", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013900"}, {"RECTYPE": "D", "MH": "Thoracic Outlet Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thoracic Outlet Nerve Compression Syndrome|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Thoracic Outlet Syndromes", "MN": "C14.907.863", "FX": "Cervical Rib", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A neurovascular syndrome associated with compression of the BRACHIAL PLEXUS; SUBCLAVIAN ARTERY; and SUBCLAVIAN VEIN at the superior thoracic outlet. This may result from a variety of anomalies such as a CERVICAL RIB, anomalous fascial bands, and abnormalities of the origin or insertion of the anterior or medial scalene muscles. Clinical features may include pain in the shoulder and neck region which radiates into the arm, PARESIS or PARALYSIS of brachial plexus innervated muscles, PARESTHESIA, loss of sensation, reduction of arterial pulses in the affected extremity, ISCHEMIA, and EDEMA. (Adams et al., Principles of Neurology, 6th ed, pp214-5).", "PM": "1983; see SCALENUS ANTICUS SYNDROME 1963-1982", "HN": "1983(1963)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19830101", "UI": "D013901"}, {"RECTYPE": "D", "MH": "Radiography, Thoracic", "DE": "RADIOGR THORACIC", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Thoracic Radiographies", "MN": "E01.370.350.700.730", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "IM general only; use for \"thoracic\" only when the enclosed organs are not specified or are irrelevant; avoid as NIM coordinate with specific region /diag image; instead prefer specific radiographic technique; MASS CHEST X-RAY is also available", "MS": "X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs.", "PM": "98; see THORACIC RADIOGRAPHY 1963-97", "HN": "98(63)", "CATSH": "CAT LIST", "MR": "20160321", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013902"}, {"RECTYPE": "D", "MH": "Thoracic Surgery", "DE": "THORACIC SURG", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Heart Surgery|T091|NON|NRW|NLM (1998)|970613|HEART SURG|abcdefv", "ENTRY": "Surgery, Thoracic|T091|NON|EQV|UNK (19XX)|860101|SURG THORACIC|abcdefv", "MN": "H02.403.810.803", "FX": "Thoracic Surgical Procedures", "MH_TH": "NLM (1980)", "ST": "T091", "AN": "a surgical specialty: do not confuse with THORACIC SURGICAL PROCEDURES", "MS": "A surgical specialty concerned with diagnosis and treatment of disorders of the heart, lungs, and esophagus. Two major types of thoracic surgery are classified as pulmonary and cardiovascular.", "OL": "use THORACIC SURGERY to search THORAX /surgery 1966-79 (with no qualif 1966-79)", "PM": "80; was THORAX /surgery 1966-79", "HN": "80; was THORAX /surgery 1966-79 & SURGERY, THORACIC (NON MESH) before 1980", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19800101", "UI": "D013903"}, {"RECTYPE": "D", "MH": "Thoracic Vertebrae", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vertebrae, Thoracic", "MN": "A02.835.232.834.892", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A group of twelve VERTEBRAE connected to the ribs that support the upper trunk region.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013904"}, {"RECTYPE": "D", "MH": "Thoracoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Thoracoplasties", "MN": "E04.928.750", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Surgical removal of ribs, allowing the chest wall to move inward and collapse a diseased lung. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013905"}, {"RECTYPE": "D", "MH": "Thoracoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Thoracoscopic Surgical Procedures|T060|T061|NON|NRW|NLM (2000)|991103|THORACOSCOPIC SURG PROCEDURES|abbcdefv", "ENTRY": "Thoracoscopies", "MN": "E04.928.752", "FX": "Thoracoscopes", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "/ instrum permitted but consider also THORACOSCOPES", "MS": "Endoscopic examination, therapy or surgery of the pleural cavity.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013906"}, {"RECTYPE": "D", "MH": "Thoracostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Thoracostomy, Needle", "MN": "E04.928.755", "FX": "Chest Tubes", "MH_TH": "NLM (1988)", "ST": "T061", "AN": "do not confuse with THORACOTOMY", "PI": "Thoracic Surgery (1966-1987)", "MS": "Surgical procedure involving the creation of an opening (stoma) into the chest cavity for drainage; used in the treatment of PLEURAL EFFUSION; PNEUMOTHORAX; HEMOTHORAX; and EMPYEMA.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19870325", "DC": "1", "DX": "19880101", "UI": "D013907"}, {"RECTYPE": "D", "MH": "Thoracotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Thoracotomies", "MN": "E04.928.760", "MH_TH": "NLM (1988)", "ST": "T061", "AN": "do not confuse with THORACOSTOMY", "PI": "Thorax/surgery (1966-1979)", "MS": "Surgical incision into the chest wall.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19870323", "DC": "1", "DX": "19880101", "UI": "D013908"}, {"RECTYPE": "D", "MH": "Thorax", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE TR UL VI", "PRINT ENTRY": "Chest|T029|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Thorace", "MN": "A01.923.761", "FX": "Thoracotomy", "EC": "injuries:Thoracic Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "The upper part of the trunk between the NECK and the ABDOMEN. It contains the chief organs of the circulatory and respiratory systems. (From Stedman, 25th ed)", "OL": "search THORAX/SU under THORACIC SURGERY 1966-79", "HN": "/surgery was used for indexing 1966-79", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013909"}, {"RECTYPE": "D", "MH": "Thorium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.850", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Thorium", "RN": "60YU5MIG9W", "RR": "7440-29-1 (Thorium)", "MS": "A radioactive element of the actinide series of metals. It has an atomic symbol Th, atomic number 90, and atomic weight 232.04. It is used as fuel in nuclear reactors to produce fissionable uranium isotopes. Because of its radioopacity, various thorium compounds are used to facilitate visualization in roentgenography.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013910"}, {"RECTYPE": "D", "MH": "Thorium Dioxide", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Thorium Oxide|T131|T197|NON|EQV|UNK (19XX)|761223|abbcdef", "ENTRY": "Oxide, Thorium", "MN": "D01.930.930", "PA": "Carcinogens", "MH_TH": "NLM (1965)", "ST": "T197", "N1": "Thorium oxide (ThO2)", "RN": "9XA7X17UQC", "RR": "1314-20-1 (Thorium Dioxide)", "MS": "Thorium oxide (ThO2). A radiographic contrast agent that was used in the early 1930s through about 1954. High rates of mortality have been linked to its use and it has been shown to cause liver cancer.", "PM": "65", "HN": "65", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013911"}, {"RECTYPE": "D", "MH": "Threonine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L Threonine", "MN": "D12.125.154.900", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "L-Threonine", "RN": "2ZD004190S", "RR": "72-19-5 (Threonine)", "MS": "An essential amino acid occurring naturally in the L-form, which is the active form. It is found in eggs, milk, gelatin, and other proteins.", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013912"}, {"RECTYPE": "D", "MH": "Threonine Dehydratase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Threonine Dehydrase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Threonine Ammonia Lyase", "MN": "D08.811.520.232.400.850", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Threonine hydro-lyase (deaminating)", "RN": "EC 4.3.1.19", "RR": "9024-34-4 (CAS RN)", "PI": "Threonine (1966-1974)", "MS": "A pyridoxal-phosphate protein that catalyzes the deamination of THREONINE to 2-ketobutyrate and AMMONIA. The role of this enzyme can be biosynthetic or biodegradative. In the former role it supplies 2-ketobutyrate required for ISOLEUCINE biosynthesis, while in the latter it is only involved in the breakdown of threonine to supply energy. This enzyme was formerly listed as EC 4.2.1.16.", "PM": "78; was see under HYDRO-LYASES 1975-77", "HN": "78(75); was see under HYDRO-LYASES 1975-77", "MR": "20050630", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D013913"}, {"RECTYPE": "D", "MH": "Threonine-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Threonyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961106|abbdef", "ENTRY": "Threonyl tRNA Synthetase", "MN": "D08.811.464.263.200.800", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Threonine:tRNA(Thr) ligase (AMP-forming)", "RN": "EC 6.1.1.3", "PI": "Threonine (1973-1974)", "MS": "An enzyme that activates threonine with its specific transfer RNA. EC 6.1.1.3.", "PM": "98; see THREONYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013914"}, {"RECTYPE": "D", "MH": "Thrombasthenia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Glanzmann Thrombasthenia|T047|EPO|EQV|OMIM (2013)|ORD (2010)|UNK (19XX)|850311|abcdeeef", "ENTRY": "Thrombasthenias", "MN": "C16.320.099.820", "FX": "Platelet Glycoprotein GPIIb-IIIa Complex", "MH_TH": "NLM (1986)", "ST": "T047", "PI": "Blood Platelet Disorders (1967-1985)", "MS": "A congenital bleeding disorder with prolonged bleeding time, absence of aggregation of platelets in response to most agents, especially ADP, and impaired or absent clot retraction. Platelet membranes are deficient in or have a defect in the glycoprotein IIb-IIIa complex (PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX).", "PM": "1991; see BLOOD PLATELET DISORDERS 1986-1990", "HN": "1991(1986); use BLOOD PLATELET DISORDERS 1986-1990", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19850311", "DC": "1", "DX": "19910101", "UI": "D013915"}, {"RECTYPE": "D", "MH": "Thrombelastography", "DE": "THROMBELASTOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Thromboelastography|T060|NON|EQV|UNK (19XX)|750731|THROMBOELASTOGR|abcdefv", "ENTRY": "Thromboelastometry|T060|NON|REL|NLM (2014)|130207|abcdef", "MN": "E05.200.625.115.830", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Use of a thrombelastograph, which provides a continuous graphic record of the physical shape of a clot during fibrin formation and subsequent lysis.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013916"}, {"RECTYPE": "D", "MH": "Thrombin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thrombase|T116|T121|T126|NON|EQV|UNK (19XX)|740330|abbbcdef", "ENTRY": "JMI, Thrombin", "MN": "D23.119.960", "PA": "Hemostatics", "FX": "Coagulants", "MH_TH": "USP (19XX)", "ST": "T126", "RN": "EC 3.4.21.5", "AN": "/antag permitted: not same as ANTITHROMBINS", "MS": "An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013917"}, {"RECTYPE": "D", "MH": "Thrombin Time", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Reptilase Time|T034|NON|EQV|UNK (19XX)|790307|abcdef", "ENTRY": "Times, Thrombin", "MN": "G09.188.840", "FX": "Blood Coagulation", "MH_TH": "NLM (1980)", "ST": "T034", "AN": "usually NIM", "PI": "Thrombin (1966-1979)", "MS": "Clotting time of PLASMA mixed with a THROMBIN solution. It is a measure of the conversion of FIBRINOGEN to FIBRIN, which is prolonged by AFIBRINOGENEMIA, abnormal fibrinogen, or the presence of inhibitory substances, e.g., fibrin-fibrinogen degradation products, or HEPARIN. BATROXOBIN, a thrombin-like enzyme unaffected by the presence of heparin, may be used in place of thrombin.", "PM": "91; was see under BLOOD COAGULATION TESTS 1980-90", "HN": "91(80); was see under BLOOD COAGULATION TESTS 1980-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19790307", "DC": "1", "DX": "19910101", "UI": "D013918"}, {"RECTYPE": "D", "MH": "Thromboangiitis Obliterans", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Buerger Disease|T047|EPO|EQV|OMIM (2013)|UNK (19XX)|840615|BUERGER DIS|abcdeefv", "ENTRY": "Disease, Buerger's", "MN": "C14.907.940.905", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "A non-atherosclerotic, inflammatory thrombotic disease that commonly involves small and medium-sized arteries or veins in the extremities. It is characterized by occlusive THROMBOSIS and FIBROSIS in the vascular wall leading to digital and limb ISCHEMIA and ulcerations. Thromboangiitis obliterans is highly associated with tobacco smoking.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013919"}, {"RECTYPE": "D", "MH": "Thrombocythemia, Essential", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombocythemia, Primary|T047|NON|EQV|UNK (19XX)|850325|abcdef", "ENTRY": "Thrombocytoses, Primary", "MN": "C15.378.463.825", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.", "PM": "2009; see THROMBOCYTHEMIA, HEMORRHAGIC 1986-2008, see HEMORRHAGIC THROMBOCYTHEMIA 1967-1985", "HN": "2009 (1963)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D013920"}, {"RECTYPE": "D", "MH": "Thrombocytopenia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombopenia|T047|NON|EQV|UNK (19XX)|840608|abcdef", "ENTRY": "Thrombopenias", "MN": "C15.378.243.937", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A subnormal level of BLOOD PLATELETS.", "OL": "use THROMBOCYTOPENIA to search THROMBOPENIA 1966-84", "PM": "85; was THROMBOPENIA 1963-84", "HN": "85; was THROMBOPENIA 1963-84", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D013921"}, {"RECTYPE": "D", "MH": "Thrombocytosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombocythemia|T047|NON|EQV|NLM (1994)|921103|abcdef", "ENTRY": "Thrombocytoses", "MN": "C15.378.190.636.860", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Increased numbers of platelets in the peripheral blood. (Dorland, 27th ed)", "PM": "67", "HN": "67(63)", "CATSH": "CAT LIST", "MR": "20080710", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D013922"}, {"RECTYPE": "D", "MH": "Thromboembolism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thromboembolisms", "MN": "C14.907.355.590", "MH_TH": "NLM (1963)", "ST": "T046", "MS": "Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.", "CATSH": "CAT LIST", "MR": "20150608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013923"}, {"RECTYPE": "D", "MH": "Thrombophlebitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Phlegmasia Alba Dolens|T047|NON|NRW|UNK (19XX)|780310|abcdef", "ENTRY": "Thrombophlebitides", "MN": "C14.907.940.740.910", "FX": "Vena Cava Filters", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "assume to be of the legs so do not coordinate with LEG", "MS": "Inflammation of a vein associated with a blood clot (THROMBUS).", "OL": "use THROMBOPHLEBITIS to search PHLEGMASIA ALBA DOLENS 1966-78", "HN": "PHLEGMASIA ALBA DOLENS was see under THROMBOPHLEBITIS 1963-78", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D013924"}, {"RECTYPE": "D", "MH": "Thromboplastin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tissue Thromboplastin|T116|T129|NON|EQV|NLM (1990)|890419|abbcdef", "ENTRY": "Thromboplastin, Tissue", "MN": "D23.119.965", "PA": "Hemostatics", "FX": "Coagulants", "MH_TH": "NLM (1966)", "ST": "T129", "N1": "Blood-coagulation factor III", "RN": "9035-58-9", "MS": "Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013925"}, {"RECTYPE": "D", "MH": "Thrombopoietin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-mpl Ligand|T116|T123|EQV|NLM (1998)|970226|abbdef", "ENTRY": "Thrombocytopoiesis Stimulating Factor", "MN": "D23.529.374.410.240.750", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Thrombopoietin", "RN": "9014-42-0", "MS": "A humoral factor that stimulates the production of thrombocytes (BLOOD PLATELETS). Thrombopoietin stimulates the proliferation of bone marrow MEGAKARYOCYTES and their release of blood platelets. The process is called THROMBOPOIESIS.", "PM": "91; was see under GLYCOPROTEINS 1976-90; was see under BLOOD PLATELETS 1975", "HN": "91(66); was see under GLYCOPROTEINS 1976-90; was see under BLOOD PLATELETS 1975", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013926"}, {"RECTYPE": "D", "MH": "Thrombosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombus|T031|NON|REL|NLM (1992)|910412|abcdef", "ENTRY": "Thromboses", "MN": "C14.907.355.830", "FX": "Thrombectomy", "MH_TH": "NLM (1963)", "ST": "T046", "AN": "general; prefer specifics; mural thrombus: if in the heart wall, coordinate IM with HEART DISEASES (IM); if in the wall of a blood vessel, coordinate IM with specific blood vessel (IM) or precoordinated blood vessel disease term (IM)", "MS": "Formation and development of a thrombus or blood clot in BLOOD VESSELS.", "CATSH": "CAT LIST", "MR": "20230612", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013927"}, {"RECTYPE": "D", "MH": "Thromboxane A2", "DS": "THROMBOXANE A 002", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rabbit Aorta Contracting Substance|T109|NON|BRD|UNK (19XX)|770523|abcdef", "ENTRY": "A2, Thromboxane", "MN": "D10.251.355.310.166.971.800", "MH_TH": "NLM (1978)", "ST": "T109", "N1": "Thromboxa-5,13-dien-1-oic acid, 9,11-epoxy-15-hydroxy-, (5Z,9alpha,11alpha,13E,15S)-", "RN": "57576-52-0", "AN": "/biosyn /physiol permitted", "PI": "Pyrans (1966-1977)", "MS": "An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS).", "PM": "86; was see under THROMBOXANES 1978-85", "HN": "86(78); was see under THROMBOXANES 1978-85", "MR": "20150623", "DA": "19770523", "DC": "1", "DX": "19860101", "UI": "D013928"}, {"RECTYPE": "D", "MH": "Thromboxane B2", "DS": "THROMBOXANE B 002", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "B2, Thromboxane", "MN": "D10.251.355.310.166.971.810", "MH_TH": "NLM (1978)", "ST": "T109", "N1": "Thromboxa-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,13E,15S)-", "RN": "54397-85-2", "AN": "/biosyn /physiol permitted", "PI": "Pyrans (1966-1977)", "MS": "A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin).", "PM": "86; was see under THROMBOXANES 1978-85", "HN": "86(78); was see under THROMBOXANES 1978-85", "MR": "20150623", "DA": "19770524", "DC": "1", "DX": "19860101", "UI": "D013929"}, {"RECTYPE": "D", "MH": "Thromboxane-A Synthase", "DS": "THROMBOXANE A 000 SYNTHASE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thromboxane Synthetase|T116|T126|NON|EQV|NLM (1998)|961108|abbcdef", "ENTRY": "Synthetase, Thromboxane A2", "MN": "D08.811.399.475.900", "MH_TH": "NLM (1978)", "ST": "T126", "N1": "(5Z,13E)-(15S)-9alpha,11alpha-Epidioxy-15-hydroxyprosta-5,13-dienoate thromboxane-A(2)-isomerase", "RN": "EC 5.3.99.5", "RR": "60832-04-4 (CAS RN)", "AN": "found in platelet microsomes", "PI": "Pyrans (1966-1977)", "MS": "An enzyme found predominantly in platelet microsomes. It catalyzes the conversion of PGG(2) and PGH(2) (prostaglandin endoperoxides) to thromboxane A2. EC 5.3.99.5.", "PM": "98; see THROMBOXANE SYNTHETASE 1986-97; see OXIDOREDUCTASES 1978-85", "HN": "98(78)", "MR": "20030709", "DA": "19770524", "DC": "1", "DX": "19860101", "UI": "D013930"}, {"RECTYPE": "D", "MH": "Thromboxanes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thromboxane|T109|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D10.251.355.310.166.971", "FX": "Receptors, Thromboxane", "MH_TH": "NLM (1978)", "ST": "T109", "RN": "0", "PI": "Pyrans (1966-1977)", "MS": "Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase.", "PM": "78", "HN": "78", "MR": "20200527", "DA": "19770523", "DC": "1", "DX": "19780101", "UI": "D013931"}, {"RECTYPE": "D", "MH": "Thulium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.984", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Thulium", "RN": "8RKC5ATI4P", "RR": "7440-30-4 (Thulium)", "MS": "An element of the rare earth family of metals. It has the atomic symbol Tm, atomic number 69, and atomic weight 168.93.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013932"}, {"RECTYPE": "D", "MH": "Thumb", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU TR VI", "ENTRY": "Thumbs", "MN": "A01.378.800.667.430.705", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "use for primates only", "MS": "The first digit on the radial side of the hand which in humans lies opposite the other four.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013933"}, {"RECTYPE": "D", "MH": "Thymectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Thymectomies", "MN": "E04.928.770", "MH_TH": "NLM (1964)", "ST": "T061", "MS": "Surgical removal of the thymus gland. (Dorland, 28th ed)", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013934"}, {"RECTYPE": "D", "MH": "Thymic Factor, Circulating", "DE": "THYMIC FACTOR CIRC", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Serum Thymic Factor|T116|T125|NON|EQV|UNK (19XX)|790523|abbcdef", "ENTRY": "Thymique Serique, Facteur", "MN": "D12.644.456.835", "MH_TH": "NLM (1980)", "ST": "T125", "N1": "Thymulin", "RN": "9H198D04WL", "RR": "78922-62-0 (Thymic Factor, Circulating)", "PI": "Thymus Hormones (1977-1979)", "MS": "A thymus-dependent nonapeptide found in normal blood. Stimulates the formation of E rosettes and is believed to be involved in T-cell differentiation.", "PM": "91; was see under THYMUS HORMONES 1980-90", "HN": "91(80); was see under THYMUS HORMONES 1980-90", "MR": "20130708", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D013935"}, {"RECTYPE": "D", "MH": "Thymidine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "2' Deoxythymidine", "MN": "D13.570.685.705", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Thymidine", "RN": "VC2W18DGKR", "RR": "50-89-5 (Thymidine)", "AN": "\"tritiated thymidine\" as a research tool is probably NIM if indexed at all", "MS": "A nucleoside in which THYMINE is linked to DEOXYRIBOSE.", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013936"}, {"RECTYPE": "D", "MH": "Thymidine Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Deoxythymidine Kinase|T116|T126|NON|EQV|UNK (19XX)|770425|abbcdef", "ENTRY": "Kinase, Thymidine", "MN": "D08.811.913.696.620.750", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "ATP:thymidine 5'-phosphotransferase", "RN": "EC 2.7.1.21", "RR": "9002-06-6 (CAS RN)", "MS": "An enzyme that catalyzes the conversion of ATP and thymidine to ADP and thymidine 5'-phosphate. Deoxyuridine can also act as an acceptor and dGTP as a donor. (From Enzyme Nomenclature, 1992) EC 2.7.1.21.", "PM": "65", "HN": "65", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013937"}, {"RECTYPE": "D", "MH": "Thymidine Monophosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thymidylic Acid|T114|T123|NON|EQV|UNK (19XX)|770401|abbcdef", "ENTRY": "Monophosphate, Thymidine", "MN": "D13.695.740.706.788", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "5'-Thymidylic acid", "RN": "365-07-1", "AN": "/biosyn /physiol permitted", "PI": "Thymine Nucleotides (1972-1974)", "MS": "5-Thymidylic acid. A thymine nucleotide containing one phosphate group esterified to the deoxyribose moiety.", "OL": "use THYMIDINE MONOPHOSPHATE to search THYMIDYLIC ACIDS 1975-78, use THYMINE NUCLEOTIDES 1972-74 & NUCLEOTIDES 1966-71", "PM": "91; was see under THYMINE NUCLEOTIDES 1978-90; was THYMIDYLIC ACIDS see under THYMINE NUCLEOTIDES 1972-77, see under NUCLEOTIDES 1963-71", "HN": "91(78); was see under THYMINE NUCLEOTIDES 1978-90; was THYMIDYLIC ACIDS see under THYMINE NUCLEOTIDES 1972-77, see under NUCLEOTIDES 1963-71", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013938"}, {"RECTYPE": "D", "MH": "Thymidine Phosphorylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Platelet-Derived Endothelial Cell Growth Factor|T116|T126|NON|EQV|NLM (1998)|970303|abbcdef", "ENTRY": "Platelet Derived Endothelial Cell Growth Factor", "MN": "D23.050.705.552.600.850", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Thymidine:orthophosphate deoxy-D-ribosyltransferase", "RN": "EC 2.4.2.4", "PI": "Thymidine (1973-1974)", "MS": "An enzyme that catalyzes the transfer of 2-deoxy-D-ribose from THYMIDINE to orthophosphate, thereby liberating thymidine.", "PM": "91; see PENTOSYLTRANSFERASES 1975-90; GLIOSTATIN was indexed under NERVE TISSUE PROTEINS 1992-98", "HN": "91(75); for GLIOSTATIN use THYMIDINE PHOSPHORYLASE (NM) 1992-98", "MR": "20160226", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013939"}, {"RECTYPE": "D", "MH": "Thymidylate Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, Thymidylate", "MN": "D08.811.913.555.500.862", "MH_TH": "NLM (1973)", "ST": "T126", "N1": "5,10-Methylenetetrahydrofolate:dUMP C-methyltransferase", "RN": "EC 2.1.1.45", "RR": "9031-61-2 (CAS RN)", "PI": "Transferases (1969-1972)", "MS": "An enzyme of the transferase class that catalyzes the reaction 5,10-methylenetetrahydrofolate and dUMP to dihydrofolate and dTMP in the synthesis of thymidine triphosphate. (From Dorland, 27th ed) EC 2.1.1.45.", "PM": "1998; see METHYLTRANSFERASES 1975-1985, see THYMIDYLATE SYNTHETASE 1985-1997", "HN": "1998; see METHYLTRANSFERASES 1975-1985", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D013940"}, {"RECTYPE": "D", "MH": "Thymine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "5 Methyluracil", "MN": "D03.383.742.698.875.899", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "2,4(1H,3H)-Pyrimidinedione, 5-methyl-", "RN": "QR26YLT7LT", "RR": "65-71-4 (Thymine)", "MS": "One of four constituent bases of DNA.", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013941"}, {"RECTYPE": "D", "MH": "Thymine Nucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thymidine Phosphates|T114|NON|EQV|UNK (19XX)|741105|abcdef", "ENTRY": "Phosphates, Thymidine", "MN": "D13.695.740.706", "MH_TH": "NLM (1971)", "ST": "T114", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Thymine (1966-1970)", "MS": "Phosphate esters of THYMIDINE in N-glycosidic linkage with ribose or deoxyribose, as occurs in nucleic acids. (From Dorland, 28th ed, p1154)", "OL": "to search THYMIDINE PHOSPHATES use NUCLEOTIDES 1966-71", "PM": "72; THYMIDINE PHOSPHATES was see under NUCLEOTIDES 1963-71", "HN": "72(71); THYMIDINE PHOSPHATES was see under NUCLEOTIDES 1963-71", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013942"}, {"RECTYPE": "D", "MH": "Thymol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phenol, 5-methyl-2-(1-methylethyl)-|T109|T121|NON|EQV|NLM (2024)|221110|abbcdef", "ENTRY": "2 Isopropyl 5 Methylphenol", "MN": "D02.455.849.575.875", "PA": "Antifungal Agents", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "3J50XA376E", "RR": "89-83-8 (Thymol)", "MS": "A phenol obtained from thyme oil or other volatile oils used as a stabilizer in pharmaceutical preparations, and as an antiseptic (antibacterial or antifungal) agent.", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013943"}, {"RECTYPE": "D", "MH": "Thymolphthalein", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D02.455.426.559.389.657.625.808", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "1(3H)-Isobenzofuranone, 3,3-bis(4-hydroxy-2-methyl-5-(1-methylethyl)phenyl)-", "RN": "YG5I28WSQP", "RR": "125-20-2 (Thymolphthalein)", "PI": "Phenolphthaleins (1969-1974)", "MS": "Used as a pH indicator and as a reagent for blood after decolorizing the alkaline solution by boiling with zinc dust.", "PM": "91; was see under PHENOLPHTHALEINS 1975-90", "HN": "91(75); was see under PHENOLPHTHALEINS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013944"}, {"RECTYPE": "D", "MH": "Thymoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Carcinoma, Thymic|T191|NON|REL|NLM (1994)|930415|abcdef", "ENTRY": "Thymomas", "MN": "C15.604.861.800", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with THYMUS NEOPLASMS (IM)", "MS": "A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed)", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013945"}, {"RECTYPE": "D", "MH": "Thymopoietins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thymopoietin|T116|T125|T129|NON|EQV|NLM (2021)|191119|abbbcdef", "ENTRY": "TP 49", "MN": "D06.472.910.800", "MH_TH": "NLM (1977)", "ST": "T129", "RN": "0", "AN": "do not confuse entry term THYMINS with THYMINE", "PI": "Thymus Gland (1966-1976)", "MS": "Two closely related polypeptides (molecular weight 7,000) isolated from the thymus gland. These hormones induce the differentiation of prothymocytes to thymocytes within the thymus. They also cause a delayed impairment of neuromuscular transmission in vivo and are therefore believed to be the agent responsible for myasthenia gravis.", "PM": "91; was see under THYMUS HORMONES 1977-90", "HN": "91(77); was see under THYMUS HORMONES 1977-90", "MR": "20200527", "DA": "19760419", "DC": "1", "DX": "19910101", "UI": "D013946"}, {"RECTYPE": "D", "MH": "Thymosin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Thymosins|T116|T125|NON|EQV|NLM (1994)|930203|abbcdef", "MN": "D12.776.922", "MH_TH": "NLM (1975)", "ST": "T125", "N1": "Thymosin", "RN": "61512-21-8", "AN": "/biosyn /physiol permitted", "PI": "Tissue Extracts (1973-1974)", "MS": "Thymosin. A family of heat-stable, polypeptide hormones secreted by the thymus gland. Their biological activities include lymphocytopoiesis, restoration of immunological competence and enhancement of expression of T-cell characteristics and function. They have therapeutic potential in patients having primary or secondary immunodeficiency diseases, cancer or diseases related to aging.", "PM": "84; was see under THYMUS HORMONES 1977-83, was see under THYMUS EXTRACTS 1975-76", "HN": "84(75); was see under THYMUS HORMONES 1977-83, was see under THYMUS EXTRACTS 1975-76", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D013947"}, {"RECTYPE": "D", "MH": "Moxisylyte", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thymoxyalcylamine|T109|T121|NON|EQV|UNK (19XX)|750708|abbcdef", "ENTRY": "Hydrochloride, Moxisylyte", "MN": "D02.092.668.387.500", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester)", "RN": "PW8QYA7KI0", "RR": "WK2KZM9V6X", "PI": "Sympatholytics (1966-1971)", "MS": "An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)", "OL": "use MOXISYLYTE to search THYMOXAMINE 1972-92 (as Prov 1972)", "PM": "93; was THYMOXAMINE 1972-92; MOXISYLYTE was see THYMOXAMINE 1976-92", "HN": "93; was THYMOXAMINE 1972-92 (Prov 1972); MOXISYLYTE was see THYMOXAMINE 1976-92", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013948"}, {"RECTYPE": "D", "MH": "Thymus Extracts", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Extracts, Thymus", "MN": "D20.777.871", "MH_TH": "NLM (1974)", "ST": "T123", "RN": "0", "AN": "do not confuse with chemical substances \"extracted\" from the thymus, as \"peptides extracted from the thymus\" (= PEPTIDES /anal +THYMUS GLAND /chem)", "MS": "Extracts of the THYMUS GLAND that contain specific factors, peptides, and proteins with specific biological activities.", "PM": "74", "HN": "74", "MR": "20160707", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D013949"}, {"RECTYPE": "D", "MH": "Thymus Gland", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Thymus Glands", "MN": "A15.382.520.604.750", "FX": "Thymectomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013950"}, {"RECTYPE": "D", "MH": "Thymus Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thymic Hormones|T125|NON|EQV|UNK (19XX)|760414|abcdef", "ENTRY": "Hormones, Thymus", "MN": "D06.472.910", "MH_TH": "NLM (1977)", "ST": "T125", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Thymus Gland (1966-1976)", "MS": "Humoral factors secreted by the thymus gland. They participate in the development of the lymphoid system and the maturation of the cellular immune response.", "PM": "77", "HN": "77", "MR": "19920520", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D013951"}, {"RECTYPE": "D", "MH": "Thymus Hyperplasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thymus Gland Hyperplasias", "MN": "C15.604.816", "FX": "Myasthenia Gravis", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Enlargement of the thymus. A condition described in the late 1940's and 1950's as pathological thymic hypertrophy was status thymolymphaticus and was treated with radiotherapy. Unnecessary removal of the thymus was also practiced. It later became apparent that the thymus undergoes normal physiological hypertrophy, reaching a maximum at puberty and involuting thereafter. The concept of status thymolymphaticus has been abandoned. Thymus hyperplasia is present in two thirds of all patients with myasthenia gravis. (From Segen, Dictionary of Modern Medicine, 1992; Cecil Textbook of Medicine, 19th ed, p1486)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013952"}, {"RECTYPE": "D", "MH": "Thymus Neoplasms", "DE": "THYMUS NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Thymus Tumors|T191|NON|EQV|NLM (2005)|040622|abcdef", "ENTRY": "Tumors, Thymus", "MN": "C15.604.861", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the THYMUS GLAND.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013953"}, {"RECTYPE": "D", "MH": "Thyroglobulin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.486.706", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Thyroglobulins", "RN": "9010-34-8", "AN": "/biosyn /physiol permitted", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013954"}, {"RECTYPE": "D", "MH": "Thyroglossal Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Thyrolingual Cyst|T047|NON|EQV|NLM (1998)|970113|abcdef", "ENTRY": "Thyrolingual Cysts", "MN": "C04.182.902", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "non-neoplastic; \"thyroglossal duct\" probably goes here", "MS": "A cyst in the neck caused by persistence of portions of, or by lack of closure of, the primitive thyroglossal duct. (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013955"}, {"RECTYPE": "D", "MH": "Antithyroid Agents", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thyroid Antagonists|T121|NON|EQV|NLM (1996)|941130|THYROID ANTAG|abcdefv", "ENTRY": "Effects, Antithyroid", "MN": "D27.505.696.399.450.100", "FX": "Hyperthyroidism", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "note entry term ANTITHYROID EFFECT: use only for the antithyroid effect of a chemical substance", "MS": "Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.", "OL": "use ANTITHYROID AGENTS to search GOITROGENS 1966", "PM": "96; was THYROID ANTAGONISTS 1963-95; GOITROGENS was heading 1963-66; ANTITHYROID DRUGS was see THYROID ANTAGONISTS 1975-95", "HN": "96; was THYROID ANTAGONISTS 1963-95; GOITROGENS was heading 1963-66; ANTITHYROID DRUGS was see THYROID ANTAGONISTS 1975-95", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19960101", "UI": "D013956"}, {"RECTYPE": "D", "MH": "Thyroid Cartilage", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Thyroid Cartilages", "MN": "A04.329.591.870", "MH_TH": "NLM (1979)", "ST": "T023", "AN": "a laryngeal cartilage: nothing to do with THYROID GLAND", "PI": "Laryngeal Cartilages (1966-1978)", "MS": "The largest cartilage of the larynx consisting of two laminae fusing anteriorly at an acute angle in the midline of the neck. The point of fusion forms a subcutaneous projection known as the Adam's apple.", "PM": "91; was see under LARYNGEAL CARTILAGES 1979-90", "HN": "91(79); was see under LARYNGEAL CARTILAGES 1979-90", "MR": "20050630", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D013957"}, {"RECTYPE": "D", "MH": "Thyroid Crisis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thyrotoxic Storm|T033|T047|NON|EQV|UNK (19XX)|860326|THYROTOX STORM|abbcdefv", "ENTRY": "Storm, Thyrotoxic", "MN": "C19.874.397.685.905", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A dangerous life-threatening hypermetabolic condition characterized by high FEVER and dysfunction of the cardiovascular, the nervous, and the gastrointestinal systems.", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013958"}, {"RECTYPE": "D", "MH": "Thyroid Diseases", "DE": "THYROID DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thyroid Disease", "MN": "C19.874", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes involving the THYROID GLAND.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013959"}, {"RECTYPE": "D", "MH": "Thyroid Function Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Thyrotroph Thyroid Hormone Sensitivity Index|T059|NON|NRW|NLM (2020)|190508|abcdef", "ENTRY": "Thyrotropin Index, Jostel's", "MN": "E01.370.374.750", "MH_TH": "NLM (1968)", "ST": "T060", "MS": "Blood tests used to evaluate the functioning of the thyroid gland.", "PM": "77,63-67; was THYROID GLAND FUNCTION TESTS 1968-76; PROTEIN-BOUND IODINE TEST was heading 1963-95", "HN": "77,63-67; was THYROID GLAND FUNCTION TESTS 1968-76; PROTEIN-BOUND IODINE TEST was heading 1963-95", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013960"}, {"RECTYPE": "D", "MH": "Thyroid Gland", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Thyroids", "MN": "A06.300.900", "FX": "Ultimobranchial Body", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013961"}, {"RECTYPE": "D", "MH": "Thyroid (USP)", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thyroid Gland, Desiccated|T121|T123|NON|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "Thyroid, Dried", "MN": "D06.472.931.669", "MH_TH": "USAN (2010)", "ST": "T123", "RN": "0", "AN": "note category: do not confuse with THYROID GLAND", "MS": "A dehydrated extract of thyroid glands from domesticated animals. After the removal of fat and connective tissue, the extract is dried or lyophilized to yield a yellowish to buff-colored amorphous powder containing 0.17-0.23% of iodine.", "PM": "2011; see THYROID EXTRACT, DESICCATED 2009-2010, see THYROID GLAND, DESICATED 1991-2008, see THYROID HORMONES 1975-1990", "HN": "2011 (1975)", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013962"}, {"RECTYPE": "D", "MH": "Thyroid Hormones", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thyroid Hormone|T116|T125|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Hormones, Thyroid", "MN": "D06.472.931", "FX": "Thyroglobulin", "EC": "antagonists & inhibitors:Antithyroid Agents", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "0", "MS": "Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013963"}, {"RECTYPE": "D", "MH": "Thyroid Neoplasms", "DE": "THYROID NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Thyroid Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Thyroid Neoplasm", "MN": "C19.874.788", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM); THYROID NODULE is also available", "MS": "Tumors or cancer of the THYROID GLAND.", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013964"}, {"RECTYPE": "D", "MH": "Thyroidectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Thyroidectomies", "MN": "E04.270.856", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Surgical removal of the thyroid gland. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013965"}, {"RECTYPE": "D", "MH": "Thyroiditis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thyroiditides", "MN": "C19.874.871", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified: prefer specifics", "MS": "Inflammatory diseases of the THYROID GLAND. Thyroiditis can be classified into acute (THYROIDITIS, SUPPURATIVE), subacute (granulomatous and lymphocytic), chronic fibrous (Riedel's), chronic lymphocytic (HASHIMOTO DISEASE), transient (POSTPARTUM THYROIDITIS), and other AUTOIMMUNE THYROIDITIS subtypes.", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013966"}, {"RECTYPE": "D", "MH": "Thyroiditis, Autoimmune", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thyroiditis, Lymphomatous|T047|NON|EQV|UNK (19XX)|860407|abcdef", "ENTRY": "Thyroiditides, Lymphomatous", "MN": "C20.111.809", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammatory disease of the THYROID GLAND due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-CELLS and thyroid AUTOANTIBODIES. The clinical signs can range from HYPOTHYROIDISM to THYROTOXICOSIS depending on the type of autoimmune thyroiditis.", "OL": "use THYROIDITIS, AUTOIMMUNE to search THYROIDITIS, LYMPHOMATOUS 1966-86", "PM": "87; was THYROIDITIS, LYMPHOMATOUS 1963-86", "HN": "87; was THYROIDITIS, LYMPHOMATOUS 1963-86", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19870101", "UI": "D013967"}, {"RECTYPE": "D", "MH": "Thyroiditis, Subacute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "De Quervain Thyroiditis|T047|EPO|EQV|UNK (19XX)|860326|abcdef", "ENTRY": "Thyroiditis, Subacute Painful", "MN": "C19.874.871.900", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "do not confuse entry term DE QUERVAIN THYROIDITIS with DE QUERVAIN DISEASE", "PI": "Thyroiditis (1966-1986)", "MS": "Spontaneously remitting inflammatory condition of the THYROID GLAND, characterized by FEVER; MUSCLE WEAKNESS; SORE THROAT; severe thyroid PAIN; and an enlarged damaged gland containing GIANT CELLS. The disease frequently follows a viral infection.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19860326", "DC": "1", "DX": "19870101", "UI": "D013968"}, {"RECTYPE": "D", "MH": "Thyroiditis, Suppurative", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Thyroiditis, Infectious|T047|NON|EQV|UNK (19XX)|860326|THYROIDITIS INFECT|abcdefv", "ENTRY": "Thyroiditis, Acute Suppurative", "MN": "C19.874.871.910", "MH_TH": "NLM (1987)", "ST": "T047", "AN": "coordinate IM with specific infection (IM)", "PI": "Thyroiditis (1966-1986)", "MS": "Acute inflammatory disease of the THYROID GLAND due to infections by BACTERIA; FUNGI; or other microorganisms. Symptoms include tender swelling, FEVER, and often with LEUKOCYTOSIS.", "PM": "91; was see under THYROIDITIS 1987-90", "HN": "91(87); was see under THYROIDITIS 1987-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19860326", "DC": "1", "DX": "19910101", "UI": "D013969"}, {"RECTYPE": "D", "MH": "Thyronines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Thyronine|T116|T123|NON|NRW|UNK (19XX)|790516|abbcdef", "MN": "D12.125.072.050.767.741", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "A group of metabolites derived from THYROXINE and TRIIODOTHYRONINE via the peripheral enzymatic removal of iodines from the thyroxine nucleus. Thyronine is the thyroxine nucleus devoid of its four iodine atoms.", "OL": "use THYRONINES to search THYRONINE 1966-78", "PM": "79; was THYRONINE 1963-78", "HN": "79; was THYRONINE 1963-78", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D013970"}, {"RECTYPE": "D", "MH": "Thyrotoxicosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thyrotoxicoses", "MN": "C19.874.397.685", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Hyperthyroidism (1966-1986)", "MS": "A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.", "OL": "search HYPERTHYROIDISM 1974-86", "PM": "87; was see HYPERTHYROIDISM 1974-86", "HN": "87; was see HYPERTHYROIDISM 1974-86", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19860407", "DC": "1", "DX": "19870101", "UI": "D013971"}, {"RECTYPE": "D", "MH": "Thyrotropin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thyroid-Stimulating Hormone|T116|T125|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Thyroid Stimulating Hormone", "MN": "D12.644.548.691.525.883", "FX": "Receptors, Thyrotropin", "MH_TH": "NLM (1966)", "ST": "T125", "N1": "Thyrotropin", "RN": "9002-71-5", "AN": "for alpha subunit, coord with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; THYROTROPIN, BETA SUBUNIT is also available", "MS": "A glycoprotein hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Thyrotropin stimulates THYROID GLAND by increasing the iodide transport, synthesis and release of thyroid hormones (THYROXINE and TRIIODOTHYRONINE). Thyrotropin consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the pituitary glycoprotein hormones (TSH; LUTEINIZING HORMONE and FSH), but the beta subunit is unique and confers its biological specificity.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013972"}, {"RECTYPE": "D", "MH": "Thyrotropin-Releasing Hormone", "DE": "TRH", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thyroliberin|T116|T121|TRD|NRW|UNK (19XX)|770425|abbcdef", "ENTRY": "Thyrotropin Releasing Hormone Tartrate", "MN": "D12.776.631.650.810", "PA": "Hormones", "FX": "Receptors, Thyrotropin-Releasing Hormone", "MH_TH": "NLM (1992)", "ST": "T125", "N1": "pyroGlu-His-Pro-NH2 (or 5-oxo-L-prolyl-L-histidyl-L-prolinamide)", "RN": "5Y5F15120W", "RR": "SYW8T997EQ", "PI": "Thyrotropin/metabolism (1966-1967)", "MS": "A tripeptide that stimulates the release of THYROTROPIN and PROLACTIN. It is synthesized by the neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, TRH (was called TRF) stimulates the release of TSH and PRL from the ANTERIOR PITUITARY GLAND.", "PM": "2006; see PROTIRELIN 1992-2005, see THYROTROPIN-RELEASING HORMONE 1991, see THYROTROPIN RELEASING HORMONE 1974-1990, see THYROTROPIN RELEASING FACTOR 1968-1973", "HN": "2006(1968)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013973"}, {"RECTYPE": "D", "MH": "Thyroxine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "T4 Thyroid Hormone|T116|T121|T125|NON|EQV|UNK (19XX)|810519|T AAB THYROID HORMONE 004|abbbcdefs", "ENTRY": "Thyroid Hormone, T4", "MN": "D12.125.072.050.767", "FX": "Receptors, Thyroid Hormone", "MH_TH": "NLM (1965)", "ST": "T125", "N1": "Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-", "RN": "Q51BO43MG4", "RR": "7488-70-2 (Thyroxine)", "AN": "/blood: consider also HYPERTHYROXINEMIA", "MS": "The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.", "PM": "1965; see THYROXIN 1963-1964; for LEVOTHYROXINE see LEVOTHYROXINE 1991-2001, see THYROXINE 1966-1990, see LEVOTHYROXINE 1963-1965", "HN": "1965; use THYROXIN 1963-1964; for LEVOTHYROXINE use LEVOTHYROXINE 1991-2001, use THYROXINE 1966-1990", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D013974"}, {"RECTYPE": "D", "MH": "Thyroxine-Binding Proteins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Thyroxine Binding Proteins", "MN": "D12.776.395.832", "FX": "Thyroid Hormone-Binding Proteins", "MH_TH": "NLM (1965)", "ST": "T123", "RN": "0", "MS": "Blood proteins that bind to THYROID HORMONES such as THYROXINE and transport them throughout the circulatory system.", "OL": "use THYROXINE-BINDING PROTEINS to search THYROXINE-BINDING PROTEIN 1966-91", "PM": "92; was THYROXINE-BINDING PROTEIN 1966-91", "HN": "92; was THYROXINE-BINDING PROTEIN 1965-91 (Prov 1965)", "MR": "20230822", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013975"}, {"RECTYPE": "D", "MH": "Tiapamil Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro 111781", "MN": "D02.355.726.825", "PA": "Calcium Channel Blockers", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1,3-Dithiane-2-propanamine, 2-(3,4-dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-, 1,1,3,3-tetraoxide, hydrochloride", "RN": "V824N2T753", "RR": "57010-32-9 (HCl)", "PI": "Benzoates (1966-1972)", "MS": "A phenylethylamine derivative that acts as a calcium antagonist showing hemodynamic effects in patients with acute myocardial infarction.", "PM": "2012; see TIAPRIDE 1991-2011, see BENZAMIDES 1980-1990", "HN": "2012; DIMEDITIAPRAMINE was indexed under PROLAMINES 1982-2011, under HETEROCYCLIC COMPOUNDS, CALCIUM, and PHENYL ETHERS 1977-1981", "MR": "20130708", "DA": "19790501", "DC": "1", "DX": "19910101", "UI": "D013976"}, {"RECTYPE": "D", "MH": "Tibia", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tibias", "MN": "A02.835.232.043.650.883", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "/blood supply: consider also TIBIAL ARTERIES; /inj: consider also TIBIAL FRACTURES; avoid TIBIA /metab, TIBIA /chem, etc. when BONE AND BONES /metab, etc. is meant; tibia vara: index under TIBIA (IM) + BONE DISEASES, DEVELOPMENTAL (IM)", "MS": "The second longest bone of the skeleton. It is located on the medial side of the lower leg, articulating with the FIBULA laterally, the TALUS distally, and the FEMUR proximally.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013977"}, {"RECTYPE": "D", "MH": "Tibial Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Toddlers Fracture", "MN": "C26.558.857", "MH_TH": "NLM (1966)", "ST": "T037", "MS": "Fractures of the TIBIA.", "CATSH": "CAT LIST", "MR": "20160708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013978"}, {"RECTYPE": "D", "MH": "Tibial Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Posterior Tibial Nerve|T023|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Tibial Nerves, Posterior", "MN": "A08.800.800.720.450.760.820", "FX": "Tarsal Tunnel Syndrome", "MH_TH": "NLM (1971)", "ST": "T023", "PI": "Spinal Nerves (1966-1970)", "MS": "The medial terminal branch of the sciatic nerve. The tibial nerve fibers originate in lumbar and sacral spinal segments (L4 to S2). They supply motor and sensory innervation to parts of the calf and foot.", "PM": "72", "HN": "72(71)", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D013979"}, {"RECTYPE": "D", "MH": "Tic Disorders", "DE": "TIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vocal Tic Disorders|T047|NON|NRW|NLM (2000)|991108|VOCAL TIC DIS|abcdefv", "ENTRY": "Vocal Tic Disorder", "MN": "F03.625.992", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "TICS is available; TIC DOULOUREUX see TRIGEMINAL NEURALGIA is also available", "MS": "Disorders characterized by recurrent TICS that may interfere with speech and other activities. Tics are sudden, rapid, nonrhythmic, stereotyped motor movements or vocalizations which may be exacerbated by stress and are generally attenuated during absorbing activities. Tic disorders are distinguished from conditions which feature other types of abnormal movements that may accompany another another condition. (From DSM-IV, 1994)", "PM": "1998; see Tic 1966-1997", "HN": "1998(1966)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D013981"}, {"RECTYPE": "D", "MH": "Ticarcillin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Disodium, Ticarcillin", "MN": "D03.633.100.300.750.875", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxy-3-thienylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))-", "RN": "F93UJX4SWT", "RR": "G8TVV6DSYG", "PI": "Thiophenes (1973-1974)", "MS": "An antibiotic derived from penicillin similar to CARBENICILLIN in action.", "PM": "91; was see under PENICILLINS 1975-90", "HN": "91(75); was see under PENICILLINS 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013982"}, {"RECTYPE": "D", "MH": "Tick Control", "AQ": "EC ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Mite Control|T058|NON|REL|UNK (19XX)|880414|abcdef", "ENTRY": "Controls, Mite", "MN": "N06.850.780.200.650.850", "MH_TH": "NLM (1973)", "ST": "T068", "AN": "chemicals killing or controlling ticks are indexed under acaricides; mite control can go here as MITES (IM) + TICK CONTROL (IM)", "PI": "Ticks (1966-1972)", "MS": "Chemical, biological, or medical measures designed to prevent the spread of ticks or the concomitant infestations which result in tick-borne diseases. It includes the veterinary as well as the public health aspects of tick and mite control.", "PM": "73", "HN": "73", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D013983"}, {"RECTYPE": "D", "MH": "Tick Infestations", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Tick Infestation", "MN": "C01.610.858.211.857", "MH_TH": "NLM (1968)", "ST": "T047", "PI": "Ticks (1966-1967)", "MS": "Infestations with soft-bodied (Argasidae) or hard-bodied (Ixodidae) ticks.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013984"}, {"RECTYPE": "D", "MH": "Tick Paralysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tick Paralyses", "MN": "C25.723.127.789.500.707", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "paralysis caused by tick bite; see note under TICKS", "MS": "Paralysis caused by a neurotropic toxin secreted by the salivary glands of ticks.", "OL": "search TICK TOXICOSES 1968-74", "PM": "91; was see under TICK TOXICOSES 1975-90", "HN": "91(75); was see under TICK TOXICOSES 1975-90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013985"}, {"RECTYPE": "D", "MH": "Tick Toxicoses", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Toxicoses, Tick", "MN": "C25.723.127.789.500", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "see note under TICKS", "PI": "Ticks (1966-1967)", "MS": "Toxicoses caused by toxic substances secreted by the salivary glands of ticks; include tick paralysis (neurotropic toxin), sweating sickness (dermotropic toxin), and Rhipicephalus appendiculatus toxicosis (leukotropic toxin).", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D013986"}, {"RECTYPE": "D", "MH": "Ticks", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Ixodida|T204|NON|EQV|NLM (2002)|010607|abcdef", "ENTRY": "Tick", "MN": "B01.050.500.131.166.132.832", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6935", "MS": "Blood-sucking acarid parasites of the order Ixodida comprising two families: the softbacked ticks (ARGASIDAE) and hardbacked ticks (IXODIDAE). Ticks are larger than their relatives, the MITES. They penetrate the skin of their host by means of highly specialized, hooked mouth parts and feed on its blood. Ticks attack all groups of terrestrial vertebrates. In humans they are responsible for many TICK-BORNE DISEASES, including the transmission of ROCKY MOUNTAIN SPOTTED FEVER; TULAREMIA; BABESIOSIS; AFRICAN SWINE FEVER; and RELAPSING FEVER. (From Barnes, Invertebrate Zoology, 5th ed, pp543-44)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013987"}, {"RECTYPE": "D", "MH": "Ticlopidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Ticlopidine", "MN": "D03.633.100.928.500", "PA": "Purinergic P2Y Receptor Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Thieno(3,2-c)pyridine, 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydro-", "RN": "OM90ZUW7M1", "RR": "A1L4914FMF", "PI": "Thiophenes (1966-1986)", "MS": "An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.", "PM": "87", "HN": "87", "MR": "20170524", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D013988"}, {"RECTYPE": "D", "MH": "Ticrynafen", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tienilic Acid|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|790302|abbcdeeef", "ENTRY": "SKF62698", "MN": "D03.383.903.840", "PA": "Uricosuric Agents", "MH_TH": "USAN (1975)", "ST": "T121", "N1": "Acetic acid, (2,3-dichloro-4-(2-thienylcarbonyl)phenoxy)-", "RN": "HC95205SY4", "RR": "40180-04-9 (Ticrynafen)", "PI": "Thiophenes (1966-1979)", "MS": "A novel diuretic with uricosuric action. It has been proposed as an antihypertensive agent.", "PM": "91; was see under GLYCOLATES 1980-90", "HN": "91(80); was see under GLYCOLATES 1980-90", "MR": "20160601", "DA": "19790302", "DC": "1", "DX": "19910101", "UI": "D013989"}, {"RECTYPE": "D", "MH": "Tidal Volume", "AQ": "DE ES GE IM PH RE", "ENTRY": "Volumes, Tidal", "MN": "G09.772.850.970.500.700", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "NIM; in texts as TV or Vt", "MS": "The volume of air inspired or expired during each normal, quiet respiratory cycle. Common abbreviations are TV or V with subscript T.", "PM": "91; was see under LUNG VOLUME MEASUREMENTS 1975-90", "HN": "91(75); was see under LUNG VOLUME MEASUREMENTS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D013990"}, {"RECTYPE": "D", "MH": "Tietze's Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Costal Chondritis|T047|NON|EQV|NLM (1992)|901010|abcdef", "ENTRY": "Tietzes Syndrome", "MN": "C17.300.182.790", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "painful swelling of rib cartilage", "MS": "Idiopathic painful nonsuppurative swellings of one or more costal cartilages, especially of the second rib. The anterior chest pain may mimic that of coronary artery disease. (Dorland, 27th ed.)", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013991"}, {"RECTYPE": "D", "MH": "Tiletamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Tiletamine", "MN": "D03.383.903.850", "PA": "Anticonvulsants", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Cyclohexanone, 2-(ethylamino)-2-(2-thienyl)-", "RN": "2YFC543249", "RR": "99TAQ2QWJI", "PI": "Thiophenes (1972-1974)", "MS": "Proposed anesthetic with possible anticonvulsant and sedative properties.", "PM": "91; was see under CYCLOHEXANES 1975-90", "HN": "91(75); was see under CYCLOHEXANES 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013992"}, {"RECTYPE": "D", "MH": "Tilidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tilidate|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|741111|abbcdeef", "ENTRY": "Hydrochloride, Tilidine", "MN": "D02.241.223.268.825", "PA": "Narcotics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "3-Cyclohexene-1-carboxylic acid, 2-(dimethylamino)-1-phenyl-, ethyl ester, trans-(+-)-", "RN": "GY33N31E9Y", "RR": "4YI72J28N9", "PI": "Dimethylamines (1974)", "MS": "An opioid analgesic used similarly to MORPHINE in the control of moderate to severe pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1097)", "PM": "91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90", "HN": "91(75); was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013993"}, {"RECTYPE": "D", "MH": "Tilorone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bis-DEAE-Fluorenone|T109|T121|EQV|UNK (19XX)|741111|BISDEAEFLUORENONE|abbdefs", "ENTRY": "Hydrochloride, Tilorone", "MN": "D04.615.389.850", "PA": "Interferon Inducers", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "9H-Fluoren-9-one, 2,7-bis(2-(diethylamino)ethoxy)-", "RN": "O6W7VEW6KS", "RR": "BJ507J4LKY", "PI": "Fluorenes (1971-1974)", "MS": "An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.", "OL": "use TILORONE (NM) to search AMYXIN (NM) 1988-91", "PM": "91; was see under FLUORENES 1975-90; AMYXIN was indexed under TILORONE/analogs & derivatives 1988-91", "HN": "91(75); was see under FLUORENES 1975-90; AMYXIN was AMYXIN (NM) 1988-91", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D013994"}, {"RECTYPE": "D", "MH": "Time", "ENTRY": "Longterm Effect", "MN": "G01.910", "MH_TH": "NLM (1966)", "ST": "T079", "AN": "IM as the abstraction; do not confuse with TIME FACTORS, the NIM coordinate with a given subject; \"diurnal\" & \"nocturnal\": consider preferably CIRCADIAN RHYTHM", "MS": "The dimension of the physical universe which, at a given place, orders the sequence of events. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013995"}, {"RECTYPE": "D", "MH": "Time and Motion Studies", "DE": "TIME MOTION STUDIES", "ENTRY": "Time Study", "MN": "F02.784.692.746.707", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "The observation and analysis of movements in a task with an emphasis on the amount of time required to perform the task.", "OL": "search TASK PERFORMANCE AND ANALYSIS 1973-74", "PM": "91; was see under TASK PERFORMANCE AND ANALYSIS 1975-90", "HN": "91(75); was see under TASK PERFORMANCE AND ANALYSIS 1975-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013996"}, {"RECTYPE": "D", "MH": "Time Factors", "PRINT ENTRY": "Time Series|T079|NON|REL|NLM (2022)|210125|abcdef", "ENTRY": "Time Factor", "MN": "G01.910.857", "MH_TH": "POPLINE (1978)", "ST": "T079", "AN": "NIM coordinate of a given subject; do not confuse with TIME, the abstraction; differentiate from AGE FACTORS", "MS": "Elements of limited time intervals, contributing to particular results or situations.", "PM": "91; was see under TIME 1967-90", "HN": "91(67); was see under TIME 1967-90", "MR": "20210326", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D013997"}, {"RECTYPE": "D", "MH": "Time Perception", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Time Processing|T041|NON|EQV|NLM (2021)|200116|abcdef", "ENTRY": "Processing, Time", "MN": "F02.463.593.857", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "The ability to estimate periods of time lapsed or duration of time.", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D013998"}, {"RECTYPE": "D", "MH": "Timolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MK950", "MN": "D03.383.533.640.775", "PA": "Antihypertensive Agents", "MH_TH": "USAN (1985)", "ST": "T121", "RN": "817W3C6175", "RR": "P8Y54F701R", "PI": "Thiadiazoles (1972-1976)", "MS": "A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.", "PM": "1984; TIMOLOL was indexed under PROPANOLAMINES 1977-1983", "HN": "1984 (1977)", "MR": "20180619", "DA": "19760413", "DC": "1", "DX": "19840101", "UI": "D013999"}, {"RECTYPE": "D", "MH": "Tin", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Stannum|T123|T196|NON|EQV|UNK (19XX)|740330|abbcdef", "MN": "D01.552.544.875", "PA": "Trace Elements", "FX": "Tin Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Tin", "RN": "7440-31-5", "MS": "A trace element that is required in bone formation. It has the atomic symbol Sn, atomic number 50, and atomic weight 118.71.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014001"}, {"RECTYPE": "D", "MH": "Tin Fluorides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tin Tetrafluoride|T197|NON|NRW|FDA SRS (2014)|UNK (19XX)|760414|abcdeef", "ENTRY": "Tin Tetrafluorides", "MN": "J01.637.051.223.800", "PA": "Cariostatic Agents", "MH_TH": "NLM (1977)", "ST": "T197", "RN": "0", "RR": "HNZ2XMR1ZF", "PI": "Tin (1966-1976)", "MS": "Inorganic fluorides of tin. They include both stannic fluoride (tin tetrafluoride) and stannous fluoride (tin difluoride). The latter is used in the prevention of dental caries.", "PM": "91; was see under FLUORIDES 1977-90", "HN": "91(77); was see under FLUORIDES 1977-90", "MR": "20160701", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D014002"}, {"RECTYPE": "D", "MH": "Tin Polyphosphates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tin Pyrophosphates|T130|T197|NON|NRW|UNK (19XX)|760414|abbcdef", "ENTRY": "Pyrophosphates, Tin", "MN": "D01.935.950", "MH_TH": "NLM (1977)", "ST": "T197", "RN": "0", "PI": "Tin (1966-1976)", "MS": "Poly or pyrophosphates of tin. In conjunction with radioactive technetium these compounds are used as bone-scanning agents and in scintigraphy to diagnose myocardial and cerebral infarction.", "PM": "91; was see under POLYPHOSPHATES 1978-90; was see under PHOSPHATES 1977", "HN": "91(77); was see under POLYPHOSPHATES 1978-90; was see under PHOSPHATES 1977", "MR": "20130708", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D014003"}, {"RECTYPE": "D", "MH": "Tin Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Tin", "MN": "D01.496.749.910", "MH_TH": "NLM (1988)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Tin (1966-1987)", "MS": "Unstable isotopes of tin that decay or disintegrate emitting radiation. Sn atoms with atomic weights 108-111, 113, 120-121, 123 and 125-128 are tin radioisotopes.", "PM": "88", "HN": "88", "MR": "20170705", "DA": "19870408", "DC": "1", "DX": "19880101", "UI": "D014004"}, {"RECTYPE": "D", "MH": "Tinea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Trichophytosis|T047|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Trichophytoses", "MN": "C17.800.838.208.883", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "the disease ringworm: do not confuse with TAENIA, tapeworm; GEN or unspecified: prefer specifics", "MS": "Fungal infection of keratinized tissues such as hair, skin and nails. The main causative fungi include MICROSPORUM; TRICHOPHYTON; and EPIDERMOPHYTON.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014005"}, {"RECTYPE": "D", "MH": "Tinea Capitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Kerion Celsi|T047|T184|NON|NRW|NLM (2012)|ORD (2010)|110218|abbcdeef", "ENTRY": "Trichophytia Profunda Capitides", "MN": "C17.800.838.208.883.558", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Ringworm of the scalp and associated hair mainly caused by species of MICROSPORUM; TRICHOPHYTON; and EPIDERMOPHYTON, which may occasionally involve the eyebrows and eyelashes.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014006"}, {"RECTYPE": "D", "MH": "Tinea Favosa", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Favus|T047|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "C17.800.838.208.883.558.708", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "ringworm of the scalp; caused by Trichophyton schoenleini", "MS": "A disease of the scalp that may affect the glabrous skin and the nails and is recognized by the concave sulfur-yellow crusts that form around loose, wiry hairs. Atrophy ensues, leaving a smooth, glossy, thin, paper-white patch. This type of disease is rare in the United States and more frequently seen in the Middle East, Africa, Southeastern Europe, and other countries bordering the Mediterranean Sea. (Arnold, Odom, and James, Andrew's Diseases of the Skin, 8th ed, p319)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014007"}, {"RECTYPE": "D", "MH": "Tinea Pedis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Athlete's Foot|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Athletes Foot", "MN": "C23.888.885.625.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not coord with FOOT or FOOT DERMATOSES", "MS": "Dermatological pruritic lesion in the feet, caused by Trichophyton rubrum, T. mentagrophytes, or Epidermophyton floccosum.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014008"}, {"RECTYPE": "D", "MH": "Onychomycosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Tinea Unguium|T047|NON|EQV|NLM (1993)|920406|abcdef", "ENTRY": "Onychomycoses", "MN": "C17.800.838.208.883.458", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with FOOT DERMATOSES (IM) or HAND DERMATOSES (IM); do not coordinate with NAILS", "MS": "A fungal infection of the nail, usually caused by DERMATOPHYTES; YEASTS; or nondermatophyte MOLDS.", "OL": "use ONYCHOMYCOSIS to search TINEA UNGUIUM 1966-92", "PM": "93; was TINEA UNGUIUM 1963-92; ONYCHOMYCOSIS was see TINEA UNGUIUM 1963-92", "HN": "93; was TINEA UNGUIUM 1963-92; ONYCHOMYCOSIS was see TINEA UNGUIUM 1963-92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D014009"}, {"RECTYPE": "D", "MH": "Tinea Versicolor", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pityrosporum orbiculare Infection|T047|NON|EQV|NLM (2021)|200210|abcdef", "ENTRY": "Pityrosporum orbiculare Infections", "MN": "C17.800.838.208.941", "FX": "Malassezia", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A common chronic, noninflammatory and usually symptomless disorder, characterized by the occurrence of multiple macular patches of all sizes and shapes, and varying in pigmentation from fawn-colored to brown. It is seen most frequently in hot, humid, tropical regions and is mostly caused by MALASSEZIA FURFUR (formerly Pityrosporum orbiculare).", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014010"}, {"RECTYPE": "D", "MH": "Tinidazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "CP12574", "MN": "D03.383.129.308.658.900", "PA": "Antitrichomonal Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Imidazole, 1-(2-(ethylsulfonyl)ethyl)-2-methyl-5-nitro-", "RN": "033KF7V46H", "RR": "19387-91-8 (Tinidazole)", "PI": "Sulfones (1971-1974)", "MS": "A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections.", "PM": "1991; was see under NITROIMIDAZOLES 1975-1990", "HN": "1991 (1975); was see under NITROIMIDAZOLES 1975-1990", "MR": "20180521", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014011"}, {"RECTYPE": "D", "MH": "Tinnitus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulsatile Tinnitus|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Tinnitus, Vascular Origin", "MN": "C23.888.592.763.393.670", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A nonspecific symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, and other noises in the ear. Objective tinnitus refers to noises generated from within the ear or adjacent structures that can be heard by other individuals. The term subjective tinnitus is used when the sound is audible only to the affected individual. Tinnitus may occur as a manifestation of COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; and other conditions.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014012"}, {"RECTYPE": "D", "MH": "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tiron|T109|T130|TRD|NRW|NLM (1975)|990101|abbcdef", "MN": "D02.886.645.600.080.050.100.150", "PA": "Indicators and Reagents", "MH_TH": "NLM (2009)", "ST": "T130", "N1": "1,3-Benzenedisulfonic acid, 4,5-dihydroxy-, disodium salt", "RN": "4X87R5T106", "RR": "149-45-1 (1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt)", "PI": "Catechols (1974)", "MS": "A colorimetric reagent for iron, manganese, titanium, molybdenum, and complexes of zirconium. (From Merck Index, 11th ed)", "PM": "2009; see TIRON 1991-2008, see BENZENESULFONATES 1975-1990", "HN": "2009(1975)", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014013"}, {"RECTYPE": "D", "MH": "Tissue Adhesives", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Tissue Adhesive", "MN": "J01.637.051.919", "FX": "Sutureless Surgical Procedures", "MH_TH": "NLM (1963)", "ST": "T122", "RN": "0", "MS": "Substances used to cause adherence of tissue to tissue or tissue to non-tissue surfaces, as for prostheses.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014014"}, {"RECTYPE": "D", "MH": "Tissue Banks", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Tissue Bank", "MN": "N02.278.065.900", "MH_TH": "BIOETHICS (1994)", "ST": "T093", "AN": "general or unspecified for tissues or organs: prefer specifics; coordinate with specific organ or tissue ", "MS": "Centers for acquiring, characterizing, and storing organs or tissue for future use.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014015"}, {"RECTYPE": "D", "MH": "Tissue Conditioning, Dental", "DE": "TISSUE CONDITIONING DENT", "AQ": "AE CL EC ES HI IS MT NU PX SN ST TD VE", "PRINT ENTRY": "Tissue Conditioning (Dental)|T061|NON|EQV|NLM (1968)|990101|TISSUE CONDITIONING|abcdefv", "ENTRY": "Conditioning, Tissue (Dental)", "MN": "E06.780.895", "MH_TH": "NLM (1991)", "ST": "T061", "PI": "Prosthodontics (1966-1967)", "MS": "The use of a treatment material (tissue conditioner) to re-establish tone and health to irritated oral soft tissue, usually applied to the edentulous alveolar ridge.", "PM": "2019; see Tissue Conditioning (Dental) 1968-2018", "HN": "2019(1968); was Tissue Conditioning (Dental) 1968-2018", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014016"}, {"RECTYPE": "D", "MH": "Tissue Distribution", "AQ": "DE ES GE IM PH RE", "ENTRY": "Tissue Distributions", "MN": "G07.690.725.949", "MH_TH": "NLM (1978)", "ST": "T081", "AN": "general only: not a substitute for organ /metab or organ /chem; usually NIM; coordinate with substance /pharmacokin or /metab ", "PI": "Organ Specificity (1966-1977)", "MS": "Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D014018"}, {"RECTYPE": "D", "MH": "Tissue Donors", "AQ": "CL ED ES HI LJ PX SD SN", "PRINT ENTRY": "Organ Donors|T098|NON|BRD|UNK (19XX)|860530|abcdef", "ENTRY": "Transplant Donor", "MN": "M01.898", "FX": "Transplant Donor Site", "MH_TH": "NLM (1964)", "ST": "T098", "AN": "semen or sperm donors: coord IM with SEMEN (IM) or SPERMATOZOA (IM); consider also INSEMINATION, ARTIFICIAL, HOMOLOGOUS (husband) (IM) or INSEMINATION, ARTIFICIAL, HETEROLOGOUS (non-husband) (IM)", "MS": "Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients.", "PM": "1967", "HN": "1967(1964)", "MR": "20140616", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014019"}, {"RECTYPE": "D", "MH": "Tissue Extracts", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Extracts, Tissue", "MN": "D20.777", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "not for chemical substances \"extracted\" from tissues (= specific chemical + organ or tissue /chem)", "MS": "Preparations made from animal tissues or organs (ANIMAL STRUCTURES). They usually contain many components, any one of which may be pharmacologically or physiologically active. Tissue extracts may contain specific, but uncharacterized factors or proteins with specific actions.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014020"}, {"RECTYPE": "D", "MH": "Tissue Preservation", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Tissue Preservations", "MN": "E05.760.833", "FX": "Tissue and Organ Harvesting", "MH_TH": "NLM (1967)", "ST": "T061", "AN": "general or unspecified; prefer specifics; cryopreservation of tissue: coordinate specific tissue heading and CRYOPRESERVATION", "PI": "Tissue Banks (1966)", "MS": "The process by which a tissue or aggregate of cells is kept alive outside of the organism from which it was derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism).", "PM": "67", "HN": "67", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014021"}, {"RECTYPE": "D", "MH": "Tissue Survival", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Organ Survival|T042|T079|NON|BRD|UNK (19XX)|750620|abbcdef", "ENTRY": "Viability, Tissue", "MN": "G16.920", "MH_TH": "NLM (1971)", "ST": "T079", "PI": "specific organ or tissue", "MS": "The span of viability of a tissue or an organ.", "PM": "76; was see under CYTOLOGY 1975", "HN": "76(71); was see under CYTOLOGY 1975", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D014022"}, {"RECTYPE": "D", "MH": "Tissue Therapy, Historical", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Biogenic Stimulators|T061|NON|REL|NLM (1998)|961010|abcdef", "ENTRY": "Therapy, Historical Tissue", "MN": "E02.190.701.884", "FX": "Cell- and Tissue-Based Therapy", "MH_TH": "NLM (2014)", "ST": "T061", "MS": "Historically, tissue transplantation, especially of refrigerated tissue (after Filatov). It was theorized that nonspecific substances, capable of initiating restorative processes, formed in tissues when refrigerated. Cell therapy (after Niehans) refers to implantation of tissue by injection. Originally this involved fresh cells but later frozen or lyophilized cells.", "PM": "2014; see TISSUE THERAPY 1966-2013", "HN": "2014; use TISSUE THERAPY 1966-2013", "CATSH": "CAT LIST", "MR": "20130903", "DA": "19990101", "DC": "1", "DX": "20140101", "UI": "D014023"}, {"RECTYPE": "D", "MH": "Tissues", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Tissue", "MN": "A10", "RH": "A10 - ANATOMY-TISSUES", "EC": "transplantation:Tissue Transplantation", "MH_TH": "NLM (1974)", "ST": "T024", "AN": "used for searching; INDEXER: Do not use", "PI": "specific tissue/anatomy & histology (1967-1997)", "MS": "Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.", "PM": "98", "HN": "98; use explode 1967-97", "MR": "20160219", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D014024"}, {"RECTYPE": "D", "MH": "Titanium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.547.800", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Titanium", "RN": "D1JT611TNE", "RR": "7440-32-6 (Titanium)", "MS": "A dark-gray, metallic element of widespread distribution but occurring in small amounts with atomic number, 22, atomic weight, 47.867 and symbol, Ti; specific gravity, 4.5; used for fixation of fractures.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014025"}, {"RECTYPE": "D", "MH": "Nicotiana", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tobacco Plant|T002|NON|EQV|NLM (2024)|230426|abcdef", "ENTRY": "Tobacco Plants", "MN": "B01.875.800.575.912.250.908.500.900", "FX": "Tobacco Use Disorder", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid4085", "RR": "txid4097", "MS": "A plant genus of the family SOLANACEAE. Members contain NICOTINE and other biologically active chemicals; the dried leaves of Nicotiana tabacum are used for SMOKING.", "PM": "1966; for plant, use TOBACCO 1966-2023", "HN": "1966; for plant, use TOBACCO 1966-2023", "MR": "20230526", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014026"}, {"RECTYPE": "D", "MH": "Tobacco Mosaic Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, Tobacco Mosaic", "MN": "B04.820.578.844.800", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid12242", "AN": "a species of plant virus; coord IM with NICOTIANA /virol (IM or NIM)", "MS": "The type species of TOBAMOVIRUS which causes mosaic disease of NICOTIANA. Transmission occurs by mechanical inoculation.", "MR": "20230727", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014027"}, {"RECTYPE": "D", "MH": "Tobacco Smoke Pollution", "AQ": "AE AN EC ES HI LJ PC SN", "PRINT ENTRY": "Smoking, Passive|T069|NON|NRW|UNK (19XX)|810519|abcdef", "ENTRY": "Tobacco Smoke Pollutions", "MN": "N06.850.460.100.555", "MH_TH": "NLM (1982)", "ST": "T069", "RN": "0", "PI": "Ventilation (1972-1981)", "MS": "Contamination of the air by tobacco smoke.", "PM": "82", "HN": "82", "MR": "20130708", "DA": "19810519", "DC": "1", "DX": "19820101", "UI": "D014028"}, {"RECTYPE": "D", "MH": "Tobacco Use Disorder", "DE": "TOBACCO USE DIS", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Tobacco Dependence|T048|NON|NRW|OBSSR (2021)|UNK (19XX)|800521|abcdeef", "ENTRY": "Tobacco Use Disorders", "MN": "F03.900.912", "FX": "Tobacco Use Cessation", "MH_TH": "NLM (1981)", "ST": "T048", "AN": "includes cigarettes, cigars, chewing tobacco & snuff; a psychiatric diagnosis: do not confuse with SMOKING /\u200cadv eff; note entry term NICOTINE DEPENDENCE: do not coordinate with NICOTINE unless nicotine is substantially discussed as a chemical", "PI": "Smoking (1966-1980)", "MS": "Tobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19800521", "DC": "1", "DX": "19810101", "UI": "D014029"}, {"RECTYPE": "D", "MH": "Tobacco, Smokeless", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Snuff|T121|NON|NRW|UNK (19XX)|850516|abcdef", "ENTRY": "Tobaccos, Smokeless", "MN": "J01.637.767.844.500", "MH_TH": "NLM (1975)", "ST": "T073", "MS": "Any product of NICOTIANA TABACUM that is not smoked but is either inhaled through the nose, chewed, or stored in cheek pouches.", "OL": "to search SNUFF use TOBACCO, SMOKELESS 1975-85 & TOBACCO 1966-74", "PM": "91; was see under TOBACCO 1986-90; was SNUFF see under TOBACCO 1963-85", "HN": "91(86); was see under TOBACCO 1986-90; was SNUFF see under TOBACCO 1963-85", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014030"}, {"RECTYPE": "D", "MH": "Tobramycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nebramycin Factor 6|T109|T195|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Sulfate, Tobramycin", "MN": "D09.408.051.476.600.800", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-4))-2-deoxy-", "RN": "VZ8RRZ51VK", "RR": "HJT0RXD7JK", "PI": "Glycosides (1966-1973)", "MS": "An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.", "PM": "84; was see under ANTIBIOTICS 1975-83", "HN": "84(75); was see under ANTIBIOTICS 1975-83", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19840101", "UI": "D014031"}, {"RECTYPE": "D", "MH": "Todralazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Todrazoline|T109|T121|NON|EQV|UNK (19XX)|790226|abbcdef", "ENTRY": "Ecarazine|T109|T121|NON|EQV|UNK (19XX)|800918|abbcdef", "MN": "D03.383.710.605.925", "PA": "Antihypertensive Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, monohydrochloride", "RN": "WEN3K83YKD", "RR": "3778-76-5 (Todralazine)", "PI": "Hydrazines (1971-1974)", "MS": "An antihypertensive agent with both central and peripheral action; it has some central nervous system depressant effects.", "OL": "use TODRALAZINE to search BINAZINE 1975-79", "PM": "91; was see under HYDRAZINES 1980-90; was BINAZINE see under HYDRAZINES 1975-79", "HN": "91(80); was see under HYDRAZINES 1980-90; was BINAZINE see under HYDRAZINES 1975-79", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014032"}, {"RECTYPE": "D", "MH": "Toe Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Interphalangeal Joint of Foot|T030|NON|EQV|NLM (2003)|011009|abcdef", "ENTRY": "Toe Joints", "MN": "A02.835.583.378.900", "MH_TH": "NLM (1965)", "ST": "T030", "AN": "restrict to humans and other vertebrates; differentiate from TOES", "MS": "The articulation between the head of one phalanx and the base of the one distal to it, in each toe.", "PM": "65", "HN": "65", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014033"}, {"RECTYPE": "D", "MH": "Toes", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU TR VI", "ENTRY": "Toe", "MN": "A01.378.610.250.300.792", "MH_TH": "NLM (1966)", "ST": "T029", "AN": "use for humans and other vertebrates; differentiate from TOE JOINT; NIM when merely locational", "MS": "Any one of five terminal digits of the vertebrate FOOT.", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014034"}, {"RECTYPE": "D", "MH": "Togaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Togavirus", "MN": "B04.820.578.875", "MH_TH": "NLM (1981)", "ST": "T005", "RN": "txid11018", "PI": "Arboviruses (1966-1980)", "MS": "A family of RNA viruses, mainly arboviruses, consisting of two genera: ALPHAVIRUS (group A arboviruses), and RUBIVIRUS. Virions are spherical, 60-70 nm in diameter, with a lipoprotein envelope tightly applied to the icosahedral nucleocapsid.", "OL": "use ARBOVIRUSES to search TOGAVIRUSES 1978-80", "PM": "81; was TOGAVIRUSES see ARBOVIRUSES 1978-80", "HN": "81; was TOGAVIRUSES see ARBOVIRUSES 1978-80", "MR": "20200813", "DA": "19800522", "DC": "1", "DX": "19810101", "UI": "D014035"}, {"RECTYPE": "D", "MH": "Togaviridae Infections", "DE": "TOGAVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Togavirus Infections|T047|NON|EQV|NLM (1994)|ORD (2010)|930525|TOGAVIRUS INFECT|abcdeefv", "ENTRY": "Togavirus Infection", "MN": "C01.925.782.930", "MH_TH": "NLM (1981)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Arbovirus Infections (1966-1980)", "MS": "Virus diseases caused by the TOGAVIRIDAE.", "OL": "use TOGAVIRIDAE INFECTIONS to search TOGAVIRUS INFECTIONS 1981-93", "PM": "94; was TOGAVIRUS INFECTIONS 1981-93", "HN": "94; was TOGAVIRUS INFECTIONS 1981-93", "CATSH": "CAT LIST", "MR": "20190529", "DA": "19800513", "DC": "1", "DX": "19810101", "UI": "D014036"}, {"RECTYPE": "D", "MH": "Togo", "AQ": "EH EP", "ENTRY": "Togolese Republic|T083|NAM|EQV|NLM (2009)|080401|abcdef", "MN": "Z01.058.290.190.800", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in western Africa, lying between GHANA on its west and BENIN on its east. Its capital is Lome.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014037"}, {"RECTYPE": "D", "MH": "Toilet Facilities", "AQ": "CL EC HI LJ SN ST", "PRINT ENTRY": "Latrines|T073|NON|NRW|UNK (19XX)|760526|abcdef", "ENTRY": "Toilet Facility", "MN": "N06.850.860.510.490", "FX": "Bathroom Equipment", "MH_TH": "NLM (1975)", "ST": "T073", "MS": "Facilities containing equipment for disposal of human excrement, often with an accompanying hand-washing station.", "OL": "use TOILET FACILITIES to search LATRINES 1966-76", "PM": "77; was LATRINES 1963-76", "HN": "77; was LATRINES 1963-76", "MR": "20171213", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D014038"}, {"RECTYPE": "D", "MH": "Toilet Training", "ENTRY": "Trainings, Toilet", "MN": "F01.318.709", "MH_TH": "NLM (1968)", "ST": "T065", "PI": "Child Care (1966-1967)", "MS": "Conditioning to defecate and urinate in culturally acceptable places.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19890516", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014039"}, {"RECTYPE": "D", "MH": "Token Economy", "DE": "TOKEN ECON", "PRINT ENTRY": "Token Reinforcement|T061|NON|EQV|UNK (19XX)|741211|abcdef", "ENTRY": "Token Reinforcements", "MN": "F02.463.425.770.836.500", "MH_TH": "NLM (1975)", "ST": "T061", "PI": "Reward (1966-1974)", "MS": "A practice whereby tokens representing money, toys, candy, etc., are given as secondary reinforcers contingent upon certain desired behaviors or performances.", "PM": "79; was see under REWARD 1975-78", "HN": "79(75); was see under REWARD 1975-78", "CATSH": "CAT LIST", "MR": "19910611", "DA": "19741212", "DC": "1", "DX": "19790101", "UI": "D014040"}, {"RECTYPE": "D", "MH": "Tokyo", "AQ": "EH EP", "MN": "Z01.433.900", "MH_TH": "NLM (1966)", "ST": "T083", "MS": "Capital of the country of JAPAN.", "OL": "use JAPAN to search BONIN ISLANDS 1975-83", "HN": "BONIN ISLANDS was see JAPAN 1975-83", "MR": "20190222", "DA": "19990101", "DC": "4", "DX": "19750101", "UI": "D014041"}, {"RECTYPE": "D", "MH": "Tolazamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tolinase|T109|T121|TRD|NRW|US|041201|abbcdef", "MN": "D02.886.590.795.834", "PA": "Hypoglycemic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, N-(((hexahydro-1H-azepin-1-yl)amino)carbonyl)-4-methyl-", "RN": "9LT1BRO48Q", "RR": "1156-19-0 (Tolazamide)", "MS": "A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE.", "PM": "73", "HN": "73(64)", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014042"}, {"RECTYPE": "D", "MH": "Tolazoline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzalolin|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Tolazoline Monohydrochloride|T109|T121|NRW|NLM (1999)|990913|abbdef", "MN": "D03.383.129.308.436.750", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)-", "RN": "CHH9H12AQ3", "RR": "E669Z6S1JG", "MS": "A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014043"}, {"RECTYPE": "D", "MH": "Tolbutamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tolbutamid R.A.N.|T109|T121|TRD|NRW|DE|041201|abbcdef", "MN": "D02.886.590.795.896", "PA": "Hypoglycemic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzenesulfonamide, N-((butylamino)carbonyl)-4-methyl-", "RN": "982XCM1FOI", "RR": "64-77-7 (Tolbutamide)", "MS": "A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)", "MR": "20230608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014044"}, {"RECTYPE": "D", "MH": "Tolmetin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Tolmetin", "MN": "D03.383.129.578.910", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USAN (1971)", "ST": "T121", "N1": "1H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)-", "RN": "D8K2JPN18B", "RR": "WL259637KX", "PI": "Pyrroles (1973-1975)", "MS": "A non-steroidal anti-inflammatory agent (ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL) similar in mode of action to INDOMETHACIN.", "PM": "90; was see under PYRROLES 1976-89", "HN": "90(76); was see under PYRROLES 1976-89", "MR": "20160601", "DA": "19750725", "DC": "1", "DX": "19900101", "UI": "D014046"}, {"RECTYPE": "D", "MH": "Tolnaftate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Purder N, Tolnaftat", "MN": "D04.615.638.975", "PA": "Antifungal Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Carbamothioic acid, methyl(3-methylphenyl)-, O-2-naphthalenyl ester", "RN": "06KB629TKV", "RR": "2398-96-1 (Tolnaftate)", "PI": "Thiocarbamates (1966-1971)", "MS": "A synthetic antifungal agent.", "PM": "73", "HN": "73(72)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014047"}, {"RECTYPE": "D", "MH": "Tolonium Chloride", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Toluidine Blue O|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740330|abbcdeef", "ENTRY": "Chloride, Tolonium", "MN": "D03.633.300.783.869", "PA": "Heparin Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Phenothiazin-5-ium, 3-amino-7-(dimethylamino)-2-methyl-, chloride", "RN": "15XUH0X66N", "RR": "92-31-9 (Tolonium Chloride)", "MS": "A phenothiazine that has been used as a hemostatic, a biological stain, and a dye for wool and silk. Tolonium chloride has also been used as a diagnostic aid for oral and gastric neoplasms and in the identification of the parathyroid gland in thyroid surgery.", "OL": "use TOLONIUM CHLORIDE to search TOLUIDINE BLUE O 1972-73 (as Prov 1972-73); search HEMOSTATICS 1966-71", "PM": "74; was see under HEMOSTATICS 1963-73", "HN": "74; was see under HEMOSTATICS 1963-73, was TOLUIDINE BLUE O 1972-73 (Prov)", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014048"}, {"RECTYPE": "D", "MH": "Tolperisone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Tolperisone", "MN": "D03.383.725.877", "PA": "Muscle Relaxants, Central", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Propanone, 2-methyl-1-(4-methylphenyl)-3-(1-piperidinyl)-", "RN": "F5EOM0LD8E", "RR": "8Z075K2TIG", "PI": "Propiophenones (1966-1978)", "MS": "A centrally acting muscle relaxant that has been used for the symptomatic treatment of spasticity and muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1211)", "PM": "91; was see under PROPIOPHENONES 1979-90", "HN": "91(79); was see under PROPIOPHENONES 1979-90", "MR": "20170524", "DA": "19780320", "DC": "1", "DX": "19910101", "UI": "D014049"}, {"RECTYPE": "D", "MH": "Toluene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.559.389.832", "PA": "Solvents", "MH_TH": "NLM (1966)", "ST": "T109", "N1": "Benzene, methyl-", "RN": "3FPU23BG52", "RR": "108-88-3 (Toluene)", "MS": "A widely used industrial solvent.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014050"}, {"RECTYPE": "D", "MH": "Toluene 2,4-Diisocyanate", "DS": "TOLUENE DIISOCYANATE 02 04", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tolylene Diisocyanate|T109|T131|NON|BRD|UNK (19XX)|741111|abbcdef", "ENTRY": "Toluene 2,4 Diisocyanate", "MN": "D02.500.800", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Benzene, 2,4-diisocyanato-1-methyl-", "RN": "17X7AFZ1GH", "RR": "584-84-9 (Toluene 2,4-Diisocyanate)", "PI": "Toluene (1973-1974)", "MS": "Skin irritant and allergen used in the manufacture of polyurethane foams and other elastomers.", "OL": "use TOLUENE 2,4-DIISOCYANATE to search TOLUENE DIISOCYANATE 1975-93", "PM": "94; was TOLUENE DIISOCYANATE 1975-93 (see under CYANATES 1975-90)", "HN": "94; was TOLUENE DIISOCYANATE 1975-93 (see under CYANATES 1975-90)", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014051"}, {"RECTYPE": "D", "MH": "Toluidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Aminotoluene|T109|T130|NON|NRW|UNK (19XX)|801120|abbcdef", "MN": "D02.455.426.559.389.832.559", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Toluene (1966-1971)", "MS": "Any of three isomeric compounds (ortho-, meta-, and para-) containing a benzene ring with a methyl and amino group attached to it. They are suspected CARCINOGENS.", "PM": "73", "HN": "73(72)", "MR": "20151008", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014052"}, {"RECTYPE": "D", "MH": "Tomatine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D09.408.934", "PA": "Indicators and Reagents", "MH_TH": "NLM (1964)", "ST": "T130", "N1": "beta-D-Galactopyranoside, (3beta,5alpha,22beta,25S)-spirosolan-3-yl O-beta-D-glucopyranosyl-(1-2)-O-(beta-D-xylopyranosyl-(1-3))-O-beta-D-glucopyranosyl-(1-4)-", "RN": "31U6547O08", "RR": "17406-45-0 (Tomatine)", "MS": "An alkaloid that occurs in the extract of leaves of wild tomato plants. It has been found to inhibit the growth of various fungi and bacteria. It is used as a precipitating agent for steroids. (From The Merck Index, 11th ed)", "PM": "91; was see under ALKALOIDS 1964-90", "HN": "91(64); was see under ALKALOIDS 1964-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014053"}, {"RECTYPE": "D", "MH": "Tomography", "DE": "TOMOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tomographies", "MN": "E01.370.350.825", "FX": "Anatomy, Cross-Sectional", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "used for non-x-ray and non-radionuclide tomographies; echotomography seen in foreign literature is probably ULTRASONOGRAPHY and if so use \"ultrasonics\" or \"ultrasonic diagnosis\" or \"ultrasonography\" in translations and not \"echotomography\"", "MS": "Imaging methods that result in sharp images of objects located on a chosen plane and blurred images located above or below the plane.", "CATSH": "CAT LIST", "MR": "20160317", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014054"}, {"RECTYPE": "D", "MH": "Tomography, Emission-Computed", "DE": "TOMOGR EMISS COMPUTED", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tomography, Radionuclide-Computed|T060|NON|EQV|UNK (19XX)|790529|TOMOGR RADIONUCLIDE COMPUTED|abcdefv", "ENTRY": "Tomography, Radionuclide-Emission Computed", "MN": "E01.370.384.730.800", "FX": "Gamma Cameras", "MH_TH": "NLM (1980)", "ST": "T060", "AN": "uses radionuclides & computer: do not confuse with TOMOGRAPHY, X-RAY COMPUTED using x-rays & computer; \"computed tomography\" unspecified is probably TOMOGRAPHY, X-RAY COMPUTED;", "PI": "Tomography, X-Ray Computed (1977-1979)", "MS": "Tomography using radioactive emissions from injected RADIONUCLIDES and computer ALGORITHMS to reconstruct an image.", "OL": "use TOMOGRAPHY, EMISSION-COMPUTED to search TOMOGRAPHY, EMISSION COMPUTED 1980-89", "PM": "90; was TOMOGRAPHY, EMISSION COMPUTED 1980-89", "HN": "90; was TOMOGRAPHY, EMISSION COMPUTED 1980-89", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19790529", "DC": "1", "DX": "19800101", "UI": "D014055"}, {"RECTYPE": "D", "MH": "Tomography, X-Ray", "DE": "TOMOGR X RAY", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Zonography|T060|NON|EQV|UNK (19XX)|740330|ZONOGR|abcdefv", "ENTRY": "Xray Tomography|T060|NON|EQV|NLM (1995)|931015|XRAY TOMOGR|abcdefv", "MN": "E01.370.350.825.810", "MH_TH": "NLM (1973)", "ST": "T060", "AN": "x-ray tomography in the literature is more likely TOMOGRAPHY, X-RAY COMPUTED or specifics", "PI": "Tomography (1966-1972)", "MS": "Tomography using x-ray transmission.", "OL": "use TOMOGRAPHY, X-RAY to search TOMOGRAPHY, RADIOGRAPHIC 1973-79; LAMINAGRAPHY X-RAY, PLANIGRAPHY, X-RAY & STRATIGRAPHY, X-RAY 1980-96; RADIOGRAPHY, BODY-SECTION 1973-96; LAMINAGRAPHY, RADIOGRAPHIC 1975-79; PLANIGRAPHY, RADIOGRAPHIC & STRATIGRAPHY, RADIOGRAPHIC 1973-79", "PM": "80; was TOMOGRAPHY, RADIOGRAPHIC 1973-79; LAMINAGRAPHY, X-RAY was see TOMOGRAPHY, X-RAY 1980-96, was LAMINAGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1975-96; PLANIGRAPHY, X-RAY & STRATIGRAPHY, X-RAY were see TOMOGRAPHY, X-RAY 1980-96, were PLANIGRAPHY, RADIOGRAPHIC & STRATIGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1973-79; RADIOGRAPHY, BODY-SECTION was see TOMOGRAPHY, X-RAY 1973-96", "HN": "80; was TOMOGRAPHY, RADIOGRAPHIC 1973-79; LAMINAGRAPHY, X-RAY was see TOMOGRAPHY, X-RAY 1980-96, was LAMINAGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1975-79; PLANIGRAPHY, X-RAY & STRATIGRAPHY, X-RAY were see TOMOGRAPHY, X-RAY 1980-96, were PLANIGRAPHY, RADIOGRAPHIC & STRATIGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1973-79; RADIOGRAPHY, BODY-SECTION was see TOMOGRAPHY, X-RAY 1973-96", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014056"}, {"RECTYPE": "D", "MH": "Tomography, X-Ray Computed", "DE": "CT XRAY", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "X-Ray Tomography, Computed|T060|NON|EQV|UNK (19XX)|790529|abcdef", "ENTRY": "Xray Computed Tomography", "MN": "E01.370.350.825.810.810", "MH_TH": "NLM (1977)", "ST": "T060", "AN": "uses x-rays & computer: do not confuse with TOMOGRAPHY, EMISSION-COMPUTED using radionuclides & computer; \"computed tomography\" unspecified probably goes here; /instrum: consider also TOMOGRAPHY SCANNERS, X-RAY COMPUTED; do not confuse entry term ELECTRON BEAM TOMOGRAPHY with ELECTRON TOMOGRAPHY see ELECTRON MICROSCOPE TOMOGRAPHY", "PI": "Tomography, X-Ray (1973-1976)", "MS": "Tomography using x-ray transmission and a computer algorithm to reconstruct the image.", "OL": "use TOMOGRAPHY, X-RAY COMPUTED to search TOMOGRAPHY, COMPUTERIZED AXIAL 1977-79", "PM": "80; was TOMOGRAPHY, COMPUTERIZED AXIAL 1977-79", "HN": "80; was TOMOGRAPHY, COMPUTERIZED AXIAL 1977-79", "CATSH": "CAT LIST", "MR": "20160317", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D014057"}, {"RECTYPE": "D", "MH": "Tonga", "AQ": "EH EP", "MN": "Z01.639.760.815.890", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island group in Polynesia", "MS": "An archipelago in Polynesia in the southwest Pacific Ocean, comprising about 150 islands. It is a kingdom whose capital is Nukualofa. It was discovered by the Dutch in 1616, visited by Tasman in 1643, and by Captain Cook in 1773 and 1777. The modern kingdom was established during the reign of King George Tupou I, 1845-93. It became a British protectorate in 1900 and gained independence in 1970. The name Tonga may be of local origin, meaning either island or holy. Its other name, Friendly Islands, was given by Captain Cook from the welcome given him by the natives. (From Webster's New Geographical Dictionary, 1988, p1219 & Room, Brewer's Dictionary of Names, 1992, p549)", "HN": "75", "MR": "20120703", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D014058"}, {"RECTYPE": "D", "MH": "Tongue", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tongues", "MN": "A14.549.885", "FX": "Glossectomy", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at GLOSS- and LINGUAL", "MS": "A muscular organ in the mouth that is covered with pink tissue called mucosa, tiny bumps called papillae, and thousands of taste buds. The tongue is anchored to the mouth and is vital for chewing, swallowing, and for speech.", "PM": "/abnormalities was TONGUE ABNORMALITIES 1965", "HN": "/abnormalities was TONGUE ABNORMALITIES 1965", "MR": "20150616", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D014059"}, {"RECTYPE": "D", "MH": "Tongue Diseases", "DE": "TONGUE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tongue Disease", "MN": "C07.465.910", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Diseases involving the TONGUE.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014060"}, {"RECTYPE": "D", "MH": "Tongue Habits", "AQ": "AE PX TH", "ENTRY": "Habits, Tongue", "MN": "F01.145.466.874", "MH_TH": "NLM (1965)", "ST": "T055", "MS": "Acquired responses regularly manifested by tongue movement or positioning.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014061"}, {"RECTYPE": "D", "MH": "Tongue Neoplasms", "DE": "TONGUE NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Tongue Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Tongue Neoplasm", "MN": "C07.465.910.470", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the TONGUE.", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014062"}, {"RECTYPE": "D", "MH": "Tongue, Fissured", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tongue, Furrowed|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Tongues, Scrotal", "MN": "C07.465.910.708", "FX": "Melkersson-Rosenthal Syndrome", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "The occurrence of of breaks or slits in the tissue of the dorsal surface of the TONGUE.", "CATSH": "CAT LIST", "MR": "20151009", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014063"}, {"RECTYPE": "D", "MH": "Tongue, Hairy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tongues, Hairy", "MN": "C07.465.910.791", "FX": "Leukoplakia, Hairy", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "hairy refers to appearance of hypertrophied papillae on tongue", "MS": "A benign condition of the tongue characterized by hypertrophy of the filiform papillae that give the dorsum of the tongue a furry appearance. The color of the elongated papillae varies from yellowish white to brown or black, depending upon staining by substances such as tobacco, food, or drugs. (Dorland, 27th ed)", "OL": "search TONGUE DISEASES 1966-74", "PM": "91; was see under TONGUE DISEASES 1975-90", "HN": "91(75); was see under TONGUE DISEASES 1975-90", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014064"}, {"RECTYPE": "D", "MH": "Tonometry, Ocular", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Ocular Tonometry|T060|NON|EQV|NLM (2004)|030325|abcdef", "MN": "E01.370.380.750", "MH_TH": "NLM (2004)", "ST": "T060", "AN": "TONOMETRY see MANOMETRY is available for non-ocular tension or pressure", "MS": "Measurement of ocular tension (INTRAOCULAR PRESSURE) with a tonometer. (Cline, et al., Dictionary of Visual Science, 4th ed)", "PM": "2004; see TONOMETRY 1966-2003", "HN": "2004; use TONOMETRY 1966-2003", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D014065"}, {"RECTYPE": "D", "MH": "Palatine Tonsil", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Tonsil, Palatine|T023|NON|EQV|NLM (1993)|920212|abcdef", "ENTRY": "Tonsils, Palatine", "MN": "A15.382.520.604.580", "FX": "Tonsillectomy", "MH_TH": "NLM (1993)", "ST": "T023", "MS": "A round-to-oval mass of lymphoid tissue embedded in the lateral wall of the PHARYNX. There is one on each side of the oropharynx in the fauces between the anterior and posterior pillars of the SOFT PALATE.", "PM": "2009; use TONSIL 1963-2008", "HN": "2009 (1963)", "MR": "20110701", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D014066"}, {"RECTYPE": "D", "MH": "Tonsillar Neoplasms", "DE": "TONSILLAR NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Tonsillar Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Tonsillar Neoplasm", "MN": "C09.775.549.685.800", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "MS": "Tumors or cancer of the PALATINE TONSIL.", "CATSH": "CAT LIST", "MR": "20080710", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014067"}, {"RECTYPE": "D", "MH": "Tonsillectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Tonsillectomies", "MN": "E04.580.848", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "Surgical removal of a tonsil or tonsils. (Dorland, 28th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014068"}, {"RECTYPE": "D", "MH": "Tonsillitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tonsillitides", "MN": "C09.775.649.750", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "coordinate IM with infection (IM) if specified; lingual tonsillitis: coordinate IM with TONGUE (NIM)", "MS": "Inflammation of the tonsils, especially the PALATINE TONSILS but the ADENOIDS (pharyngeal tonsils) and lingual tonsils may also be involved. Tonsillitis usually is caused by bacterial infection. Tonsillitis may be acute, chronic, or recurrent.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014069"}, {"RECTYPE": "D", "MH": "Tooth", "AQ": "AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Teeth|T023|NON|EQV|JAN (19XX)|UNK (19XX)|881119|abcdeef", "MN": "A14.549.167.860", "FX": "Paleodontology", "EC": "injuries:Tooth Injuries", "MH_TH": "NLM (1965)", "ST": "T023", "CX": "consider also terms at DENT- and ODONTO-", "MS": "One of a set of bone-like structures in the mouth used for biting and chewing.", "PM": "65; was TEETH 1963-64; /transplantation was TOOTH TRANSPLANTATION 1965", "HN": "65; was TEETH 1963-64; /transplantation was TOOTH TRANSPLANTATION 1965", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014070"}, {"RECTYPE": "D", "MH": "Tooth Abnormalities", "DE": "TOOTH ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Odontome|T019|NON|NRW|NLM (1998)|960724|abcdef", "ENTRY": "Tooth Abnormality", "MN": "C16.131.850.800", "MH_TH": "NLM (1965)", "ST": "T019", "MS": "Congenital absence of or defects in structures of the teeth.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014071"}, {"RECTYPE": "D", "MH": "Tooth Abrasion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dental Abrasion|T037|NON|EQV|NLM (1991)|900427|DENT ABRASION|abcdefv", "ENTRY": "Abrasion, Tooth", "MN": "C07.793.818.124", "MH_TH": "NLM (1965)", "ST": "T037", "AN": "do not confuse with TOOTH ATTRITION or TOOTH EROSION", "MS": "The pathologic wearing away of the tooth substance by brushing, bruxism, clenching, and other mechanical causes. It is differentiated from TOOTH ATTRITION in that this type of wearing away is the result of tooth-to-tooth contact, as in mastication, occurring only on the occlusal, incisal, and proximal surfaces. It differs also from TOOTH EROSION, the progressive loss of the hard substance of a tooth by chemical processes not involving bacterial action. (From Jablonski, Dictionary of Dentistry, 1992, p2)", "PM": "1965", "HN": "1965", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014072"}, {"RECTYPE": "D", "MH": "Tooth Bleaching", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Whitening, Tooth", "MN": "E06.420.750", "FX": "Tooth Bleaching Agents", "MH_TH": "NLM (1971)", "ST": "T061", "PI": "Tooth Discoloration/therapy (1966-1970)", "MS": "The use of a chemical oxidizing agent to whiten TEETH. In some procedures the oxidation process is activated by the use of heat or light.", "PM": "72", "HN": "72(71)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014073"}, {"RECTYPE": "D", "MH": "Tooth Calcification", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Calcification, Tooth|T042|NON|EQV|NLM (1997)|960422|abcdef", "ENTRY": "Tooth Calcifications", "MN": "G10.549.800", "MH_TH": "NLM (1965)", "ST": "T042", "AN": "the physiol process; hypocalcification is probably indexed under AMELOGENESIS IMPERFECTA or DENTAL ENAMEL HYPOPLASIA", "MS": "The process whereby calcium salts are deposited in the dental enamel. The process is normal in the development of bones and teeth. (Boucher's Clinical Dental Terminology, 4th ed, p43)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20180206", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014074"}, {"RECTYPE": "D", "MH": "Tooth Discoloration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tooth Discolorations", "MN": "C07.793.735", "FX": "Tooth Bleaching", "MH_TH": "NLM (1965)", "ST": "T184", "AN": "external staining or staining within pulp; from any cause; coord IM with cause if pertinent (IM or NIM); do not confuse with FLUOROSIS, DENTAL (occurring during tooth calcification)", "MS": "Any change in the hue, color, or translucency of a tooth due to any cause. Restorative filling materials, drugs (both topical and systemic), pulpal necrosis, or hemorrhage may be responsible. (Jablonski, Dictionary of Dentistry, 1992, p253)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20050714", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014075"}, {"RECTYPE": "D", "MH": "Tooth Diseases", "DE": "TOOTH DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tooth Disease", "MN": "C07.793", "FX": "Mouth Rehabilitation", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Diseases involving the TEETH.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014076"}, {"RECTYPE": "D", "MH": "Tooth Erosion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dental Erosion|T047|NON|EQV|NLM (2023)|220406|abcdef", "ENTRY": "Tooth Erosions", "MN": "C07.793.818.500", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "loss of substance caused by chem action without bact action: differentiate from TOOTH ABRASION (loss of substance caused by friction) & TOOTH ATTRITION (wearing away through tooth-to-tooth contact)", "MS": "Progressive loss of the hard substance of a tooth by chemical processes that do not involve bacterial action. (Jablonski, Dictionary of Dentistry, 1992, p296)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014077"}, {"RECTYPE": "D", "MH": "Tooth Eruption", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Teething|T042|NON|BRD|NLM (1998)|960722|abcdef", "ENTRY": "Tooth Eruptions", "MN": "G10.549.810", "FX": "Tooth Eruption, Ectopic", "MH_TH": "NLM (1965)", "ST": "T042", "MS": "The emergence of a tooth from within its follicle in the ALVEOLAR PROCESS of the MAXILLA or MANDIBLE into the ORAL CAVITY. (Boucher's Clinical Dental Terminology, 4th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014078"}, {"RECTYPE": "D", "MH": "Tooth Eruption, Ectopic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tooth Eruptions, Ectopic", "MN": "C07.793.790", "FX": "Tooth Eruption", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "note category", "MS": "An abnormality in the direction of a TOOTH ERUPTION.", "PM": "66", "HN": "66(65)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014079"}, {"RECTYPE": "D", "MH": "Tooth Exfoliation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tooth Exfoliations", "MN": "G10.549.820", "MH_TH": "NLM (1968)", "ST": "T042", "PI": "Tooth, Deciduous (1966-1967)", "MS": "Physiologic loss of the primary dentition. (Zwemer, Boucher's Clinical Dental Terminology, 4th ed)", "PM": "72", "HN": "72(68)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014080"}, {"RECTYPE": "D", "MH": "Tooth Extraction", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tooth Extractions", "MN": "E06.645.700", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "SERIAL EXTRACTION is available as orthodontic proced for sequential removal of teeth over a period of years", "MS": "The surgical removal of a tooth. (Dorland, 28th ed)", "PM": "65; was TEETH EXTRACTION 1963-64", "HN": "65; was TEETH EXTRACTION 1963-64", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014081"}, {"RECTYPE": "D", "MH": "Tooth Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tooth Fracture", "MN": "C26.900.750", "MH_TH": "NLM (1965)", "ST": "T037", "AN": "coord IM with specific tooth /inj (IM)", "MS": "Break or rupture of a tooth or tooth root.", "PM": "66", "HN": "66(65)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014082"}, {"RECTYPE": "D", "MH": "Tooth Germ", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tooth Germs", "MN": "A14.549.167.900.720", "FX": "Odontogenesis", "MH_TH": "NLM (1966)", "ST": "T024", "AN": "/embryol: consider also ODONTOGENESIS", "MS": "The collective tissues from which an entire tooth is formed, including the DENTAL SAC; ENAMEL ORGAN; and DENTAL PAPILLA. (From Jablonski, Dictionary of Dentistry, 1992)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014083"}, {"RECTYPE": "D", "MH": "Tooth Avulsion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tooth Luxation|T037|NON|REL|UNK (19XX)|830615|abcdef", "ENTRY": "Tooth, Avulsed", "MN": "C26.900.725", "MH_TH": "NLM (1970)", "ST": "T037", "AN": "partial or complete displacement of tooth from socket; coord IM with specific tooth /inj (IM)", "PI": "specific tooth (1966-1969)", "MS": "Partial or complete displacement of a tooth from its alveolar support. It is commonly the result of trauma. (From Boucher's Clinical Dental Terminology, 4th ed, p312)", "PM": "97; was TOOTH LUXATION 1970-96; TOOTH AVULSION was see TOOTH LUXATION 1984-96", "HN": "97; was TOOTH LUXATION 1970-96; TOOTH AVULSION was see TOOTH LUXATION 1984-96", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D014084"}, {"RECTYPE": "D", "MH": "Tooth Migration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Migration, Tooth", "MN": "G10.549.830", "MH_TH": "NLM (1965)", "ST": "T042", "AN": "do not confuse with TOOTH MOBILITY", "MS": "The movement of teeth into altered positions in relationship to the basal bone of the ALVEOLAR PROCESS and to adjoining and opposing teeth as a result of loss of approximating or opposing teeth, occlusal interferences, habits, inflammatory and dystrophic disease of the attaching and supporting structures of the teeth. (From Boucher's Clinical Dental Terminology, 4th ed)", "PM": "66", "HN": "66(65)", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014085"}, {"RECTYPE": "D", "MH": "Tooth Mobility", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tooth Mobilities", "MN": "G10.549.840", "MH_TH": "NLM (1965)", "ST": "T042", "AN": "do not confuse with TOOTH MOVEMENT TECHNIQUES (an orthodontic procedure)", "MS": "Horizontal and, to a lesser degree, axial movement of a tooth in response to normal forces, as in occlusion. It refers also to the movability of a tooth resulting from loss of all or a portion of its attachment and supportive apparatus, as seen in periodontitis, occlusal trauma, and periodontosis. (From Jablonski, Dictionary of Dentistry, 1992, p507 & Boucher's Clinical Dental Terminology, 4th ed, p313)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160712", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014086"}, {"RECTYPE": "D", "MH": "Tooth Movement Techniques", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tooth Uprighting|T061|NON|NRW|NLM (1998)|961011|abcdef", "ENTRY": "Uprightings, Tooth", "MN": "E06.658.578.836", "MH_TH": "NLM (2017)", "ST": "T061", "AN": "note TOOTH MIGRATION and TOOTH MOBILITY are also available", "PI": "Orthodontics, Corrective (1966-1972)", "MS": "Orthodontic techniques used to correct the malposition of a tooth or teeth.", "PM": "2017; see TOOTH MOVEMENT 1997-2016;was TOOTH MOVEMENT, MINOR 1973-1996", "HN": "2017 (1973)", "CATSH": "CAT LIST", "MR": "20170428", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014087"}, {"RECTYPE": "D", "MH": "Tooth Permeability", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Permeability, Tooth|T042|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Tooth Permeabilities", "MN": "G10.549.845", "MH_TH": "NLM (1965)", "ST": "T042", "MS": "The property of TEETH to permit passage of light, heat, gases, liquids, metabolites, mineral ions and other substances. It does not include the penetration of the teeth by microorganisms.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014088"}, {"RECTYPE": "D", "MH": "Tooth Remineralization", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Remineralization, Tooth", "MN": "E06.950", "MH_TH": "NLM (1985)", "ST": "T061", "AN": "note category: replacement of minerals in partially decalcified teeth", "PI": "Tooth Calcification (1966-1984)", "MS": "Therapeutic technique for replacement of minerals in partially decalcified teeth.", "OL": "search TOOTH CALCIFICATION 1966-84", "PM": "85; was see TOOTH CALCIFICATION 1975-84; was see under TOOTH CALCIFICATION 1969-74", "HN": "85; was see TOOTH CALCIFICATION 1975-84; was see under TOOTH CALCIFICATION 1969-74", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19840430", "DC": "1", "DX": "19850101", "UI": "D014089"}, {"RECTYPE": "D", "MH": "Tooth Replantation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tooth Reimplantation|T061|NON|EQV|UNK (19XX)|810520|abcdef", "ENTRY": "Tooth Replantations", "MN": "E06.645.710", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "differentiate from DENTAL IMPLANTATION: see note there", "MS": "Reinsertion of a tooth into the alveolus from which it was removed or otherwise lost.", "OL": "use TOOTH REPLANTATION to search TOOTH REIMPLANTATION 1966-81", "PM": "82; was TOOTH REIMPLANTATION 1965-81", "HN": "82; was TOOTH REIMPLANTATION 1965-81", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014090"}, {"RECTYPE": "D", "MH": "Tooth Resorption", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tooth Resorptions", "MN": "G10.549.855", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "Resorption of calcified dental tissue, involving demineralization due to reversal of the cation exchange and lacunar resorption by osteoclasts. There are two types: external (as a result of tooth pathology) and internal (apparently initiated by a peculiar inflammatory hyperplasia of the pulp). (From Jablonski, Dictionary of Dentistry, 1992, p676)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014091"}, {"RECTYPE": "D", "MH": "Tooth Root", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tooth Roots", "MN": "A14.549.167.900.750", "FX": "Root Resorption", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "dis: coord IM with TOOTH DISEASES (IM); root fract or radicular fract: index under TOOTH ROOT /inj (IM) + TOOTH FRACTURES (IM); dilaceration of root: index under TOOTH ROOT /abnorm; TOOTH APEX is available", "MS": "The part of a tooth from the neck to the apex, embedded in the alveolar process and covered with cementum. A root may be single or divided into several branches, usually identified by their relative position, e.g., lingual root or buccal root. Single-rooted teeth include mandibular first and second premolars and the maxillary second premolar teeth. The maxillary first premolar has two roots in most cases. Maxillary molars have three roots. (Jablonski, Dictionary of Dentistry, 1992, p690)", "PM": "65", "HN": "65", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014092"}, {"RECTYPE": "D", "MH": "Tooth, Artificial", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Teeth, Artificial", "MN": "E07.695.190.800", "FX": "Dental Porcelain", "MH_TH": "NLM (1965)", "ST": "T074", "MS": "A fabricated tooth substituting for a natural tooth in a prosthesis. It is usually made of porcelain or plastic.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014093"}, {"RECTYPE": "D", "MH": "Tooth, Deciduous", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Tooth, Primary|T023|NON|EQV|NLM (1997)|960530|abcdef", "ENTRY": "Tooth, Milk", "MN": "A14.549.167.860.700", "MH_TH": "NLM (1965)", "ST": "T023", "MS": "The teeth of the first dentition, which are shed and replaced by the permanent teeth.", "PM": "65; was TEETH, DECIDUOUS 1963-64", "HN": "65; was TEETH, DECIDUOUS 1963-64", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014094"}, {"RECTYPE": "D", "MH": "Tooth, Impacted", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Impacted Tooth", "MN": "C07.793.905", "MH_TH": "NLM (1965)", "ST": "T190", "AN": "do not confuse with TOOTH, UNERUPTED", "MS": "A tooth that is prevented from erupting by a physical barrier, usually other teeth. Impaction may also result from orientation of the tooth in an other than vertical position in the periodontal structures.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014095"}, {"RECTYPE": "D", "MH": "Tooth, Supernumerary", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Molar, Fourth|T019|NON|REL|UNK (19XX)|780303|abcdef", "ENTRY": "Supernumerary Tooth", "MN": "C16.131.850.800.850", "MH_TH": "NLM (1965)", "ST": "T023", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; may refer to erupted or unerupted tooth: if erupted do not use TOOTH ERUPTION; if unerupted coord IM with TOOTH, UNERUPTED (NIM)", "MS": "An extra tooth, erupted or unerupted, resembling or unlike the other teeth in the group to which it belongs. Its presence may cause malposition of adjacent teeth or prevent their eruption.", "OL": "use TOOTH, SUPERNUMERARY to search MOLAR, FOURTH 1966-78", "PM": "65", "HN": "65; MOLAR, FOURTH was see under TOOTH, SUPERNUMERARY 1965-78", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014096"}, {"RECTYPE": "D", "MH": "Tooth, Unerupted", "AQ": "AH BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RE RH RT SU TH TR UL UR VE VI", "ENTRY": "Unerupted Tooth", "MN": "C07.793.915", "FX": "Tooth, Impacted", "MH_TH": "NLM (1973)", "ST": "T023", "AN": "note categories; do not confuse with TOOTH, IMPACTED", "PI": "Tooth Eruption (1966-1972)", "MS": "A normal developing tooth which has not yet perforated the oral mucosa or one that fails to erupt in the normal sequence or time interval expected for the type of tooth in a given gender, age, or population group.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014097"}, {"RECTYPE": "D", "MH": "Toothache", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Odontalgia|T184|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Toothaches", "MN": "C23.888.592.612.330.500", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Pain in the adjacent areas of the teeth.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014098"}, {"RECTYPE": "D", "MH": "Toothbrushing", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Toothbrushings", "MN": "E06.761.726.794", "MH_TH": "NLM (1970)", "ST": "T061", "AN": "restrict to brushing with a toothbrush: see note at DENTAL DEVICES, HOME CARE", "MS": "The act of cleaning teeth with a brush to remove plaque and prevent tooth decay. (From Webster, 3d ed)", "OL": "use TOOTHBRUSHING to search TOOTHBRUSHES 1966-69", "PM": "70; was TOOTHBRUSHES 1963-69", "HN": "70; was TOOTHBRUSHES 1963-69", "CATSH": "CAT LIST", "MR": "19950518", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D014099"}, {"RECTYPE": "D", "MH": "Toothpastes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Toothpaste|T122|NON|EQV|NLM (1975)|990101|abcdef", "MN": "J01.637.051.376.711", "PA": "Dentifrices", "MH_TH": "NLM (2011)", "ST": "T122", "RN": "0", "MS": "Dentifrices that are formulated into a paste form. They typically contain abrasives, HUMECTANTS; DETERGENTS; FLAVORING AGENTS; and CARIOSTATIC AGENTS.", "PM": "2011; see TOOTHPASTE 1991-2020, see DENTIFRICES 1975-1990", "HN": "2011(1975); use DENTIFRICES 1975-1990", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014100"}, {"RECTYPE": "D", "MH": "Torpedo", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Electric Rays|T013|NON|BRD|NLM (2002)|000815|abcdef", "ENTRY": "Rays, Electric", "MN": "B01.050.150.900.493.378.722", "MH_TH": "NLM (1982)", "ST": "T013", "RN": "txid7786", "RR": "txid30480", "AN": "do not confuse entry term ELECTRIC RAYS with RAYS (FISH) see SKATES (FISH)", "PI": "Fishes (1968-1981)", "MS": "A genus of the Torpedinidae family consisting of several species. Members of this family have powerful electric organs and are commonly called electric rays.", "PM": "1982", "HN": "1982", "MR": "20200813", "DA": "19810519", "DC": "1", "DX": "19820101", "UI": "D014101"}, {"RECTYPE": "D", "MH": "Torsion Abnormality", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Abnormality, Torsion|T046|NON|EQV|NLM (2008)|060919|abcdef", "ENTRY": "Torsion Abnormalities", "MN": "C23.300.970", "FX": "Dystonia", "MH_TH": "NLM (2008)", "ST": "T046", "AN": "coordinate with organ/disease term; TORSION, MECHANICAL is also available", "MS": "An abnormal twisting or rotation of a bodily part or member on its axis.", "PM": "2008; was TORSION 1968-2007", "HN": "2008 (1968,1963)", "CATSH": "CAT LIST", "MR": "20090713", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014102"}, {"RECTYPE": "D", "MH": "Torticollis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wryneck|T184|NON|EQV|UNK (19XX)|770817|abcdef", "ENTRY": "Torticollis, Spasmodic", "MN": "C23.888.592.350.300.800", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "A symptom, not a disease, of a twisted neck. In most instances, the head is tipped toward one side and the chin rotated toward the other. The involuntary muscle contractions in the neck region of patients with torticollis can be due to congenital defects, trauma, inflammation, tumors, and neurological or other factors.", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014103"}, {"RECTYPE": "D", "MH": "Torture", "AQ": "CL ES HI LJ PX SN", "MN": "I01.880.735.900.825", "FX": "Human Rights Abuses", "MH_TH": "BIOETHICS (1974)", "ST": "T068", "AN": "of humans or animals; physical or mental torture", "MS": "The intentional infliction of physical or mental suffering upon an individual or individuals, including the torture of animals.", "PM": "84; was see under AGGRESSION 1975-83", "HN": "84(75); was see under AGGRESSION 1975-83", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19840101", "UI": "D014104"}, {"RECTYPE": "D", "MH": "Tosyl Compounds", "DE": "TOSYL CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Toluenesulfonyl Compounds|T109|NON|EQV|UNK (19XX)|770401|TOLUENESULFONYL CPDS|abcdefv", "ENTRY": "Compounds, Tosyl", "MN": "D02.886.590.887", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Toluene (1966-1971)", "MS": "Toluenesulfonyl compounds with general formula CH3C6H4S(O2)R\u201d widely used to block amino groups in the course of syntheses of drugs and other biologically active compounds.", "PM": "73", "HN": "73(72)", "MR": "20161129", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014105"}, {"RECTYPE": "D", "MH": "Tosylarginine Methyl Ester", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "N-alpha-Tosyl-L-Arginate, Methyl", "MN": "D12.125.095.104.900", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "L-Arginine, N2-((4-methylphenyl)sulfonyl)-, methyl ester", "RN": "901-47-3", "PI": "Tosyl Compounds (1972-1974)", "MS": "Arginine derivative which is a substrate for many proteolytic enzymes. As a substrate for the esterase from the first component of complement, it inhibits the action of C(l) on C(4).", "PM": "91; was see under ARGININE 1975-90", "HN": "91(75); was see under ARGININE 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014106"}, {"RECTYPE": "D", "MH": "Tosyllysine Chloromethyl Ketone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tosyllysyl Chloromethane|T116|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Ketone, Tosyllysine Chloromethyl", "MN": "D12.125.065.850", "PA": "Serine Proteinase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Benzenesulfonamide, N-(5-amino-1-(chloroacetyl)pentyl)-4-methyl-", "RN": "2104-86-1", "PI": "Tosyl Compounds (1974)", "MS": "An inhibitor of SERINE ENDOPEPTIDASES. Acts as an alkylating agent and is known to interfere with the translation process.", "PM": "91; was see under AMINO ACID CHLOROMETHYL KETONES 1977-90; was see under LYSINE 1975-76", "HN": "91(75); was see under AMINO ACID CHLOROMETHYL KETONES 1977-90; was see under LYSINE 1975-76", "MR": "20230608", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014107"}, {"RECTYPE": "D", "MH": "Tosylphenylalanyl Chloromethyl Ketone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tosylphenylalanyl Chloromethane|T116|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Ketone, Tosylphenylalanyl Chloromethyl", "MN": "D12.125.065.930", "PA": "Serine Proteinase Inhibitors", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Benzenesulfonamide, N-(3-chloro-2-oxo-1-(phenylmethyl)propyl)-4-methyl-, (S)-", "RN": "402-71-1", "PI": "Tosyl Compounds (1973-1974)", "MS": "An inhibitor of Serine Endopeptidases. Acts as alkylating agent and is known to interfere with the translation process.", "PM": "91; was see under AMINO ACID CHLOROMETHYL KETONES 1977-90; was see under PHENYLALANINE 1975-76", "HN": "91(75); was see under AMINO ACID CHLOROMETHYL KETONES 1977-90; was see under PHENYLALANINE 1975-76", "MR": "20230608", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014108"}, {"RECTYPE": "D", "MH": "Total Lung Capacity", "DE": "TOTAL LUNG CAPAC", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Lung Capacity, Total|T034|T042|NON|EQV|NLM (1991)|900125|LUNG CAPAC TOTAL|abbcdefv", "ENTRY": "Total Lung Capacities", "MN": "G09.772.850", "MH_TH": "NLM (1975)", "ST": "T042", "AN": "usually NIM", "MS": "The volume of air contained in the lungs at the end of a maximal inspiration. It is the equivalent to each of the following sums: VITAL CAPACITY plus RESIDUAL VOLUME; INSPIRATORY CAPACITY plus FUNCTIONAL RESIDUAL CAPACITY; TIDAL VOLUME plus INSPIRATORY RESERVE VOLUME plus functional residual capacity; or tidal volume plus inspiratory reserve volume plus EXPIRATORY RESERVE VOLUME plus residual volume.", "PM": "91; was see under LUNG VOLUME MEASUREMENTS 1975-90", "HN": "91(75); was see under LUNG VOLUME MEASUREMENTS 1975-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D014109"}, {"RECTYPE": "D", "MH": "Touch", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Tactile Sense|T042|NON|EQV|NLM (2009)|080320|abcdef", "ENTRY": "Touch Senses", "MN": "G11.561.790.850", "MH_TH": "NLM (1966)", "ST": "T042", "AN": "differentiate from TOUCH PERCEPTION: TOUCH takes place in the skin and mucous membranes, TOUCH PERCEPTION takes place in the brain", "MS": "Sensation of making physical contact with objects, animate or inanimate. Tactile stimuli are detected by MECHANORECEPTORS in the skin and mucous membranes.", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014110"}, {"RECTYPE": "D", "MH": "Tourniquets", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Tourniquet", "MN": "E07.926", "MH_TH": "NLM (1963)", "ST": "T074", "MS": "Devices for the compression of a blood vessel by application around an extremity to control the circulation and prevent the flow of blood to or from the distal area. (From Dorland, 28th ed)", "PM": "66", "HN": "66(63)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014111"}, {"RECTYPE": "D", "MH": "Toxaphene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Polychlorocamphene|T109|T131|NON|EQV|UNK (19XX)|800825|abbcdef", "MN": "D04.075.080.500.795", "PA": "Insecticides", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Toxaphene", "RN": "8001-35-2", "PI": "Insecticides (1966-1972)", "MS": "A very complex, but reproducible mixture of at least 177 C10 polychloro derivatives, having an approximate overall empirical formula of C10-H10-Cl8. It is used as an insecticide and may reasonably be anticipated to be a carcinogen: Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)", "PM": "91; was see under INSECTICIDES, ORGANOCHLORINE 1972-90", "HN": "91(72); was see under INSECTICIDES, ORGANOCHLORINE 1972-90", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014112"}, {"RECTYPE": "D", "MH": "Toxascaris", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Toxascari", "MN": "B01.050.500.500.294.400.500.100.700", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid59263", "PI": "Nematoda (1966-1971)", "MS": "An ascarid nematode found primarily in the small intestine of the larger Felidae as well as dogs and cats. It differs from TOXOCARA in that the larvae do not migrate through the lungs. It does occasionally produce visceral larva migrans (LARVA MIGRANS, VISCERAL) in man, although more rarely than does Toxocara.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014114"}, {"RECTYPE": "D", "MH": "Toxemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Toxemias", "MN": "C01.861", "FX": "Pre-Eclampsia", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A condition produced by the presence of toxins or other harmful substances in the BLOOD.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014115"}, {"RECTYPE": "D", "MH": "Toxicology", "DE": "TOXICOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Toxinology|T091|NON|REL|NLM (2002)|001122|abcdef", "ENTRY": "Toxicology, Evidence-Based", "MN": "H02.884", "FX": "Poisons", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use DRUG TOXICITY or specifics or specific drug with /adv eff /pois or/tox for studies of the adverse effects of drugs", "MS": "The science concerned with the detection, chemical composition, and biological action of toxic substances or poisons and the treatment and prevention of toxic manifestations.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014116"}, {"RECTYPE": "D", "MH": "Toxiferine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.531.820.687", "PA": "Nicotinic Antagonists", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Toxiferine I, 2,2',16,16'-tetradehydro-16,16',17,17'-tetrahydro-", "RN": "9M7D9K3OJI", "RR": "302-30-7 (Toxiferine)", "AN": "a neuromusc nondepolarizing agent", "MS": "A curare alkaloid that is a very potent competitive nicotinic antagonist at the neuromuscular junction.", "OL": "use TOXIFERINE to search CALABASH CURARE 1966-94", "PM": "63; CALABASH CURARE was see TOXIFERINE 1966-94", "HN": "63; CALABASH CURARE was see TOXIFERINE 1966-94", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D014117"}, {"RECTYPE": "D", "MH": "Toxins, Biological", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Biological Toxins", "MN": "D23.946", "FX": "Toxoids", "MH_TH": "NLM (2006)", "ST": "T131", "RN": "0", "AN": "general or unspecified; prefer specifics; /antag permitted but consider also ANTITOXINS", "MS": "Specific, characterizable, poisonous chemicals, often PROTEINS, with specific biological properties, including immunogenicity, produced by microbes, higher plants (PLANTS, TOXIC), or ANIMALS.", "PM": "2006; see TOXINS 1966-2005, see TOXINS AND ANTITOXINS 1963-1965", "HN": "2006(1966)", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014118"}, {"RECTYPE": "D", "MH": "Toxocara", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Toxocaras", "MN": "B01.050.500.500.294.400.500.100.780", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6264", "MS": "A genus of ascarid nematodes commonly parasitic in the intestines of cats and dogs.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014119"}, {"RECTYPE": "D", "MH": "Toxocariasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Toxocariases", "MN": "C22.674.377.868", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "an Ascaridida infect but differentiate from TOXASCARIASIS, also an Ascaridida infect; coord IM with species (IM); in animals but check tag ANIMAL; in man, probably is LARVA MIGRANS, VISCERAL", "MS": "Infection by round worms of the genus TOXOCARA, usually found in wild and domesticated cats and dogs and foxes, except for the larvae, which may produce visceral and ocular larva migrans in man.", "OL": "search ASCARIASIS 1967-74", "PM": "89; was see under ASCARIASIS 1967-88", "HN": "89(75); was see under ASCARIASIS 1967-88", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19890101", "UI": "D014120"}, {"RECTYPE": "D", "MH": "Toxoids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Toxoid|T121|T129|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Toxoids, Anatoxin", "MN": "D20.215.894.691", "FX": "Toxins, Biological", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "AN": "entry term ANATOXIN TOXOIDS: do not confuse with anatoxins found in CYANOBACTERIA; coordinate IM with specific organism /immunol (IM)", "MS": "Preparations of pathogenic organisms or their derivatives made nontoxic and intended for active immunologic prophylaxis. They include deactivated toxins. Anatoxin toxoids are distinct from anatoxins that are TROPANES found in CYANOBACTERIA.", "PM": "66; TOXINS AND ANTITOXINS was heading 1963-65", "HN": "66; TOXINS AND ANTITOXINS was heading 1963-65", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014121"}, {"RECTYPE": "D", "MH": "Toxoplasma", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Toxoplasma gondii|T204|NON|NRW|NLM (1990)|890703|abcdef", "ENTRY": "gondius, Toxoplasma", "MN": "B01.043.075.189.250.750.800", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5810", "RR": "txid5811", "MS": "A genus of protozoa parasitic to birds and mammals. T. gondii is one of the most common infectious pathogenic animal parasites of man.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014122"}, {"RECTYPE": "D", "MH": "Toxoplasmosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Toxoplasma gondii Infection|T047|NON|EQV|NLM (1990)|890703|TOXOPLASMA GONDII INFECT|abcdefv", "ENTRY": "Infection, Toxoplasma gondii|T047|NON|EQV|NLM (1990)|890703|INFECT TOXOPLASMA GONDII|abcdefv", "MN": "C01.610.752.250.800", "EC": "veterinary:Toxoplasmosis, Animal", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "The acquired form of infection by Toxoplasma gondii in animals and man.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014123"}, {"RECTYPE": "D", "MH": "Toxoplasmosis, Animal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Toxoplasmoses, Animal", "MN": "C22.674.710.817", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "exper or vet; /congen permitted: do not coord with TOXOPLASMOSIS, CONGENITAL", "MS": "Acquired infection of non-human animals by organisms of the genus TOXOPLASMA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014124"}, {"RECTYPE": "D", "MH": "Toxoplasmosis, Congenital", "DE": "TOXOPLASMOSIS CONGEN", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Toxoplasmosis, Prenatal|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Toxoplasmoses, Prenatal", "MN": "C16.614.909", "EC": "veterinary:Toxoplasmosis, Animal:congenital", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Prenatal protozoal infection with TOXOPLASMA gondii which is associated with injury to the developing fetal nervous system. The severity of this condition is related to the stage of pregnancy during which the infection occurs; first trimester infections are associated with a greater degree of neurologic dysfunction. Clinical features include HYDROCEPHALUS; MICROCEPHALY; deafness; cerebral calcifications; SEIZURES; and psychomotor retardation. Signs of a systemic infection may also be present at birth, including fever, rash, and hepatosplenomegaly. (From Adams et al., Principles of Neurology, 6th ed, p735)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014125"}, {"RECTYPE": "D", "MH": "Toxoplasmosis, Ocular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Ocular Toxoplasmosis|T047|NON|EQV|NLM (1990)|890519|abcdef", "ENTRY": "Toxoplasmoses, Ocular", "MN": "C11.294.725.781", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "/congen permitted: do not coord with TOXOPLASMOSIS, CONGENITAL", "MS": "Infection caused by the protozoan parasite TOXOPLASMA in which there is extensive connective tissue proliferation, the retina surrounding the lesions remains normal, and the ocular media remain clear. Chorioretinitis may be associated with all forms of toxoplasmosis, but is usually a late sequel of congenital toxoplasmosis. The severe ocular lesions in infants may lead to blindness.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014126"}, {"RECTYPE": "D", "MH": "Toyocamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Toyokamycin|T114|T121|NON|EQV|UNK (19XX)|800523|abbcdef", "MN": "D13.570.800.840", "PA": "Antimetabolites, Antineoplastic", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "7H-Pyrrolo(2,3-d)pyrimidine-5-carbonitrile, 4-amino-7-beta-D-ribofuranosyl-", "RN": "L7995C4D7F", "RR": "606-58-6 (Toyocamycin)", "AN": "an antineoplastic antibiotic & antimetabolite", "PI": "Ribonucleosides (1973-1974)", "MS": "4-Amino-5-cyano-7-(D-ribofuranosyl)-7H- pyrrolo(2,3-d)pyrimidine. Antibiotic antimetabolite isolated from Streptomyces toyocaensis cultures. It is an analog of adenosine, blocks RNA synthesis and ribosome function, and is used mainly as a tool in biochemistry.", "PM": "91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1981-90; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-80", "HN": "91(75); was see under ANTIBIOTICS, AMINOGLYCOSIDE 1981-90; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-80", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014127"}, {"RECTYPE": "D", "MH": "Chromomycin A3", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Toyomycin|T109|T195|TRD|NRW|NLM (1991)|900329|abbcdef", "MN": "D09.408.210.209", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "NLM (1975)", "ST": "T195", "N1": "Olivomycin D, 3D-O-(4-O-acetyl-2,6-dideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-7-methyl-", "RN": "DVW027E7NL", "RR": "7059-24-7 (Chromomycin A3)", "MS": "Glycosidic antibiotic from Streptomyces griseus used as a fluorescent stain of DNA and as an antineoplastic agent.", "OL": "use CHROMOMYCINS to search TOYOMICIN 1973-90", "PM": "91; was TOYOMICIN see under CHROMOMYCINS 1975-90", "HN": "91(75); was TOYOMICIN see under CHROMOMYCINS 1975-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014128"}, {"RECTYPE": "D", "MH": "Trabecular Meshwork", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Trabecular Meshworks", "MN": "A09.371.060.750", "MH_TH": "NLM (1977)", "ST": "T023", "AN": "in the eye: do not confuse with other trabeculae", "PI": "Uvea (1966-1976)", "MS": "A porelike structure surrounding the entire circumference of the anterior chamber through which aqueous humor circulates to the SCHLEMM'S CANAL.", "PM": "77", "HN": "77", "MR": "20220708", "DA": "19760427", "DC": "1", "DX": "19770101", "UI": "D014129"}, {"RECTYPE": "D", "MH": "Trabeculectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Trabeculoplasty|T061|NON|EQV|UNK (19XX)|870325|abcdef", "ENTRY": "Trabeculotomies", "MN": "E04.540.450.700", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Trabecular Meshwork/surgery (1977-1987)", "MS": "Any surgical procedure for treatment of glaucoma by means of puncture or reshaping of the trabecular meshwork. It includes goniotomy, trabeculectomy, and laser perforation.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20040802", "DA": "19870325", "DC": "1", "DX": "19880101", "UI": "D014130"}, {"RECTYPE": "D", "MH": "Trace Elements", "AQ": "AD AE AG AI AN BL CF CH CL CS DF EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Minerals, Trace", "MN": "J02.500.681.500.555", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "AN": "do not confuse with \"tracers\" used for detection or with trace amounts of substances in tissue, food, etc.", "MS": "A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014131"}, {"RECTYPE": "D", "MH": "Trachea", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tracheas", "MN": "A04.889", "FX": "Tracheotomy", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi.", "MR": "20150714", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014132"}, {"RECTYPE": "D", "MH": "Tracheal Diseases", "DE": "TRACHEAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tracheal Disease", "MN": "C08.907", "MH_TH": "NLM (1968)", "ST": "T047", "PI": "Trachea (1966-1967)", "MS": "Diseases involving the TRACHEA.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014133"}, {"RECTYPE": "D", "MH": "Tracheal Neoplasms", "DE": "TRACHEAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tracheal Neoplasm", "MN": "C08.907.563", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM)", "MS": "New abnormal growth of tissue in the TRACHEA.", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014134"}, {"RECTYPE": "D", "MH": "Tracheal Stenosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tracheal Stenoses", "MN": "C08.907.663", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A pathological narrowing of the TRACHEA.", "CATSH": "CAT LIST", "MR": "20151009", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014135"}, {"RECTYPE": "D", "MH": "Tracheitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tracheitides", "MN": "C08.907.763", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "INFLAMMATION of the TRACHEA that is usually associated with RESPIRATORY TRACT INFECTIONS.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014136"}, {"RECTYPE": "D", "MH": "Tracheobronchomegaly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mounier-Kuhn Syndrome|T019|EPO|EQV|ORD (2010)|UNK (19XX)|860623|abcdeef", "ENTRY": "Tracheobronchomegaly, Congenital", "MN": "C16.131.740.830", "MH_TH": "OMIM (2013)", "ST": "T019", "AN": "enlarged trachea lumen & larger bronchi; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Trachea/abnormalities (1966-1986)", "MS": "A rare and probably congenital condition characterized by great enlargement of the lumen of the trachea and the larger bronchi.", "PM": "1991; see TRACHEAL DISEASES 1987-1990", "HN": "1991(1987); use TRACHEAL DISEASES 1987-1990", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19860623", "DC": "1", "DX": "19910101", "UI": "D014137"}, {"RECTYPE": "D", "MH": "Tracheoesophageal Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Esophagotracheal Fistula|T046|T190|NON|EQV|NLM (1991)|900131|abbcdef", "ENTRY": "Tracheoesophageal Fistulas", "MN": "C23.300.575.185.250.725", "MH_TH": "ORD (2010)", "ST": "T190", "AN": "fistula policy: Manual 23.19+", "MS": "Abnormal passage between the ESOPHAGUS and the TRACHEA, acquired or congenital, often associated with ESOPHAGEAL ATRESIA.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014138"}, {"RECTYPE": "D", "MH": "Tracheostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Tracheostomies", "MN": "E04.928.780", "MH_TH": "NLM (1988)", "ST": "T061", "AN": "do not confuse with TRACHEOTOMY", "PI": "Tracheotomy (1966-1987)", "MS": "Surgical formation of an opening into the trachea through the neck, or the opening so created.", "OL": "search TRACHEOTOMY 1966-87", "PM": "88,63-66; was see TRACHEOTOMY 1967-87", "HN": "88,63-66; was see TRACHEOTOMY 1967-87", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19870325", "DC": "1", "DX": "19880101", "UI": "D014139"}, {"RECTYPE": "D", "MH": "Tracheotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Tracheotomies", "MN": "E04.928.790", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "do not confuse with TRACHEOSTOMY", "MS": "Surgical incision of the trachea.", "OL": "use TRACHEOTOMY to search TRACHEOSTOMY 1966", "PM": "TRACHEOSTOMY was heading 1963-66", "HN": "TRACHEOSTOMY was heading 1963-66", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D014140"}, {"RECTYPE": "D", "MH": "Trachoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Egyptian Ophthalmia|T047|EPO|EQV|NLM (2009)|070823|abcdef", "ENTRY": "Trachomas", "MN": "C11.294.354.220.800", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "MS": "A chronic infection of the CONJUNCTIVA and CORNEA caused by CHLAMYDIA TRACHOMATIS.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014141"}, {"RECTYPE": "D", "MH": "Track and Field", "DE": "TRACK FIELD", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Tracks", "MN": "I03.450.642.845.925", "FX": "Running", "MH_TH": "NLM (1976)", "ST": "T056", "PI": "Sports (1966-1975)", "MS": "Sports performed on a track, field, or arena and including running events and other competitions, such as the pole vault, shot put, etc.", "PM": "76", "HN": "76", "MR": "20200128", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D014142"}, {"RECTYPE": "D", "MH": "Traction", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Tractions", "MN": "E04.555.720", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "The pull on a limb or a part thereof. Skin traction (indirect traction) is applied by using a bandage to pull on the skin and fascia where light traction is required. Skeletal traction (direct traction), however, uses pins or wires inserted through bone and is attached to weights, pulleys, and ropes. (From Blauvelt & Nelson, A Manual of Orthopaedic Terminology, 5th ed)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014143"}, {"RECTYPE": "D", "MH": "Tragacanth", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gum Tragacanth|T109|T121|T123|NON|EQV|UNK (19XX)|770224|abbbcdef", "ENTRY": "Tragacanth, Gum", "MN": "D20.215.721.249.750", "PA": "Excipients", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Gum tragacanth", "RN": "9000-65-1", "AN": "/biosyn permitted if by plant", "PI": "Resins (1966-1977)", "MS": "Powdered exudate from Astragalus gummifer and related plants. It forms gelatinous mass in water. Tragacanth is used as suspending agent, excipient or emulsifier in foods, cosmetics and pharmaceuticals. It has also been used as a bulk-forming laxative.", "PM": "91; was see under POLYSACCHARIDES 1978-90", "HN": "91(78); was see under POLYSACCHARIDES 1978-90", "MR": "20060705", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D014144"}, {"RECTYPE": "D", "MH": "Trail Making Test", "AQ": "HI SN ST", "ENTRY": "Tactual Performance Test|T170|NAM|REL|NLM (2018)|160830|abcdef", "MN": "F04.711.513.838", "MH_TH": "NLM (1971)", "ST": "T170", "PI": "Psychological Tests (1966-1970)", "MS": "The subject's ability to connect 25 numbered and lettered circles in sequence in a specific length of time. A score of 12 or below is suggestive of organic brain damage.", "PM": "91; was see under NEUROPSYCHOLOGICAL TESTS 1985-90; was see under PSYCHOLOGICAL TESTS 1971-84", "HN": "91(71); was see under NEUROPSYCHOLOGICAL TESTS 1985-90; was see under PSYCHOLOGICAL TESTS 1971-84", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014145"}, {"RECTYPE": "D", "MH": "Training Support", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Subsidies, Educational|T065|NON|NRW|UNK (19XX)|790601|SUBSIDIES EDUC|abcdefv", "ENTRY": "Training Supports", "MN": "N03.219.483.838", "MH_TH": "NLM (1966)", "ST": "T065", "AN": "specify agency or government & geographic term if possible", "MS": "Financial support for training including both student stipends and loans and training grants to institutions.", "OL": "use TRAINING SUPPORT to search STUDENT LOANS 1966-77", "PM": "66", "HN": "66; STUDENT LOANS was see under TRAINING SUPPORT 1966-77", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014146"}, {"RECTYPE": "D", "MH": "Tramadol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tramadolratiopharm", "MN": "D10.289.510.500.802", "PA": "Narcotics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Cyclohexanol, 2-((dimethylamino)methyl)-1-(3-methoxyphenyl)-, cis-(+-)-", "RN": "39J1LGJ30J", "RR": "9N7R477WCK", "PI": "Dimethylamines (1974)", "MS": "A narcotic analgesic proposed for severe pain. It may be habituating.", "PM": "91; was see under CYCLOHEXANOLS 1975-90", "HN": "91(75); was see under CYCLOHEXANOLS 1975-90", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014147"}, {"RECTYPE": "D", "MH": "Tranexamic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "AMCHA|T109|T121|ABB|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "trans-4-(Aminomethyl)cyclohexanecarboxylic Acid|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|821123|abbcdeef", "MN": "D02.241.223.268.860", "PA": "Antifibrinolytic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Cyclohexanecarboxylic acid, 4-(aminomethyl)-, trans-", "RN": "6T84R30KC1", "RR": "1197-18-8 (Tranexamic Acid)", "PI": "Methylamines (1973-1974)", "MS": "Antifibrinolytic hemostatic used in severe hemorrhage.", "PM": "91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90", "HN": "91(75); was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90", "MR": "20160701", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014148"}, {"RECTYPE": "D", "MH": "Tranquilizing Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ataractics|T121|NON|EQV|UNK (19XX)|750228|abcdef", "ENTRY": "Effects, Tranquilizing", "MN": "D27.505.954.427.700.872", "FX": "Hypnotics and Sedatives", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; note entry term TRANQUILIZING EFFECT: use only for the tranquilizing effect of a chemical substance", "MS": "A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014149"}, {"RECTYPE": "D", "MH": "Antipsychotic Agents", "AQ": "AD AE AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tranquilizing Agents, Major|T121|NON|EQV|NLM (1995)|940126|abcdef", "ENTRY": "Tranquilizer, Major", "MN": "D27.505.954.427.700.872.331", "FX": "Dopamine Antagonists", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "note entry term ANTIPSYCHOTIC EFFECT: use only for the antipsychotic effect of a chemical substance", "PI": "Tranquilizing Agents (1966-1974)", "MS": "Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.", "OL": "use ANTIPSYCHOTIC AGENTS to search TRANQUILIZING AGENTS, MAJOR 1975-94; use TRANQUILIZING AGENTS to search NEUROLEPTICS 1969-94", "PM": "95; was TRANQUILIZING AGENTS, MAJOR 1975-94; ANTIPSYCHOTIC AGENTS was see TRANQUILIZING AGENTS, MAJOR 1975-94; NEUROLEPTICS was see TRANQUILIZING AGENTS 1975-78, was see under TRANQUILIZING AGENTS 1969-74", "HN": "95; was TRANQUILIZING AGENTS, MAJOR 1975-94; ANTIPSYCHOTIC AGENTS was see TRANQUILIZING AGENTS, MAJOR 1975-94; NEUROLEPTICS was see TRANQUILIZING AGENTS 1975-78, was see under TRANQUILIZING AGENTS 1969-74", "MR": "20210312", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D014150"}, {"RECTYPE": "D", "MH": "Anti-Anxiety Agents", "DS": "ANTIANXIETY AGENTS", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tranquilizing Agents, Minor|T121|NON|EQV|NLM (1995)|940126|abcdef", "ENTRY": "Minor Tranquillizing Agents", "MN": "D27.505.954.427.700.872.015", "FX": "Anxiety Disorders", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "note entry term ANTI-ANXIETY EFFECT: use only for the anti-anxiety effect of a chemical substance", "PI": "Tranquilizing Agents (1966-1974)", "MS": "Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.", "OL": "use ANTI-ANXIETY AGENTS to search TRANQUILIZING AGENTS, MINOR 1975-94", "PM": "95; was TRANQUILIZING AGENTS, MINOR 1975-94; ANTI-ANXIETY AGENTS was see TRANQUILIZING AGENTS, MINOR 1975-94", "HN": "95; was TRANQUILIZING AGENTS, MINOR 1975-94; ANTI-ANXIETY AGENTS was see TRANQUILIZING AGENTS, MINOR 1975-94", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D014151"}, {"RECTYPE": "D", "MH": "Transactional Analysis", "DE": "TRANSACTIONAL ANAL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Transactional Analyses", "MN": "F04.754.709.838", "MH_TH": "NLM (1975)", "ST": "T061", "PI": "Psychoanalytic Therapy (1973-1978)", "MS": "A psychoanalytic therapy wherein each social transaction is analyzed to determine the involved ego state (whether parent-like, child-like, or adult-like) as a basis for understanding behavior.", "PM": "79; was see under PSYCHOANALYTIC THERAPY 1975-78", "HN": "79(73); was see under PSYCHOANALYTIC THERAPY 1975-78", "CATSH": "CAT LIST", "MR": "19950531", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D014152"}, {"RECTYPE": "D", "MH": "Transaldolase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transaldolase B|T116|T126|NRW|NLM (1998)|970303|abbdef", "MN": "D08.811.913.200.650", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "Sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase", "RN": "EC 2.2.1.2", "RR": "9014-46-4 (CAS RN)", "PI": "Transferases (1966-1971)", "MS": "An enzyme of the transferase class that catalyzes the reaction sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate to yield D-erythrose 4-phosphate and D-fructose phosphate in the PENTOSE PHOSPHATE PATHWAY. (Dorland, 27th ed) EC 2.2.1.2.", "PM": "91; was see under TRANSFERASES 1972-90", "HN": "91(72); was see under TRANSFERASES 1972-90", "MR": "20050701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014153"}, {"RECTYPE": "D", "MH": "Transcaucasia", "AQ": "EH EP", "MN": "Z01.542.900", "MH_TH": "NLM (1982)", "ST": "T083", "MS": "Area of Europe that includes ARMENIA,; AZERBAIJAN; and the Republic of GEORGIA.", "HN": "82", "MR": "20010725", "DA": "19810227", "DC": "4", "DX": "19820101", "UI": "D014154"}, {"RECTYPE": "D", "MH": "Transcobalamins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vitamin B12-Binding Protein|T116|T127|NON|EQV|NLM (2021)|200317|abbcdef", "ENTRY": "Vitamin B12 Binding Proteins", "MN": "D12.776.377.715.900", "MH_TH": "NLM (1975)", "ST": "T127", "RN": "0", "PI": "Vitamin B 12 (1973-1974)", "MS": "A group of carrier proteins which bind with VITAMIN B12 in the BLOOD and aid in its transport. Transcobalamin I migrates electrophoretically as a beta-globulin, while transcobalamins II and III migrate as alpha-globulins.", "PM": "84; was see under BLOOD PROTEINS 1975-83", "HN": "84(75); was see under BLOOD PROTEINS 1975-83", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D014155"}, {"RECTYPE": "D", "MH": "Transcortin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Corticosteroid-Binding Globulin|T116|T123|NON|EQV|UNK (19XX)|760630|abbcdef", "ENTRY": "Corticosteroid Binding Globulin", "MN": "D12.776.872.923", "MH_TH": "NLM (1964)", "ST": "T123", "N1": "Transcortins", "RN": "9010-38-2", "MS": "A serpin family member that binds to and transports GLUCOCORTICOIDS in the BLOOD.", "PM": "65", "HN": "65(64)", "MR": "20230316", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014156"}, {"RECTYPE": "D", "MH": "Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Factors, Transcription", "MN": "D12.776.930", "FX": "Trans-Activators", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "in genetic transcription; /biosyn /physiol permitted; regulatory proteins go here or under REPRESSOR PROTEINS or VIRAL REGULATORY PROTEINS", "PI": "Transcription, Genetic (1973-1976)", "MS": "Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.", "PM": "77", "HN": "77", "MR": "20050630", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D014157"}, {"RECTYPE": "D", "MH": "Transcription, Genetic", "DE": "TRANSCRIPTION GENET", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Genetic Transcription|T045|NON|EQV|UNK (19XX)|860101|GENET TRANSCRIPTION|abcdefv", "MN": "G05.297.700", "FX": "Transcription Factors", "MH_TH": "NLM (1973)", "ST": "T045", "PI": "RNA, Messenger (1966-1972)", "MS": "The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION.", "PM": "1973", "HN": "1973", "CATSH": "CAT LIST", "MR": "20200622", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014158"}, {"RECTYPE": "D", "MH": "Transducers", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Transducer", "MN": "E07.305.812", "MH_TH": "NLM (1966)", "ST": "T073", "MS": "Any device or element which converts an input signal into an output signal of a different form. Examples include the microphone, phonographic pickup, loudspeaker, barometer, photoelectric cell, automobile horn, doorbell, and underwater sound transducer. (McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed)", "OL": "use TRANSDUCERS to search TRANSDUCER 1966-72 (as Prov 1966-67)", "PM": "73; was TRANSDUCER 1968-72", "HN": "73; was TRANSDUCER 1966-72 (Prov 1966-67)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014159"}, {"RECTYPE": "D", "MH": "Transducers, Pressure", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Transducer, Pressure", "MN": "E07.305.812.901", "MH_TH": "NLM (1980)", "ST": "T073", "AN": "NIM", "PI": "Transducers (1966-1979)", "MS": "Transducers that are activated by pressure changes, e.g., blood pressure.", "PM": "91; was see under TRANSDUCERS 1980-90", "HN": "91(80); was see under TRANSDUCERS 1980-90", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19781214", "DC": "1", "DX": "19910101", "UI": "D014160"}, {"RECTYPE": "D", "MH": "Transduction, Genetic", "DE": "TRANSDUCTION GENET", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Transductions, Genetic", "MN": "G05.728.850", "FX": "Transformation, Genetic", "MH_TH": "NLM (1968)", "ST": "T063", "PI": "Genetics (1966-1967)", "MS": "The transfer of bacterial DNA by phages from an infected bacterium to another bacterium. This also refers to the transfer of genes into eukaryotic cells by viruses. This naturally occurring process is routinely employed as a GENE TRANSFER TECHNIQUE.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014161"}, {"RECTYPE": "D", "MH": "Transfection", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Transfections", "MN": "G05.728.860", "FX": "Transformation, Genetic", "MH_TH": "NLM (1978)", "ST": "T063", "AN": "coordinate with recipient/genet if permitted + specific donor/genet; do not confuse with genetic transvection, an epigenetic phenomenon (index under EPIGENESIS, GENETIC)", "PI": "Transformation, Genetic (1968-1974)", "MS": "The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES.", "PM": "78; was see under TRANSFORMATION, GENETIC 1975-77", "HN": "78(75); was see under TRANSFORMATION, GENETIC 1975-77", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19770504", "DC": "1", "DX": "19780101", "UI": "D014162"}, {"RECTYPE": "D", "MH": "Transfer, Psychology", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Transfer of Training|T041|NON|EQV|NLM (1998)|960717|abcdef", "ENTRY": "Transfers, Psychology", "MN": "F02.463.425.910", "MH_TH": "NLM (2020)", "ST": "T041", "AN": "human & animal", "MS": "Change in learning in one situation due to prior learning in another situation. The transfer can be positive (with second learning improved by first) or negative (where the reverse holds).", "PM": "2020; was TRANSFER (PSYCHOLOGY) 1965-2019", "HN": "2020 (1965); was TRANSFER (PSYCHOLOGY) 1965-2019", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014163"}, {"RECTYPE": "D", "MH": "Transfer Agreement", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Transfer Agreements", "MN": "N04.452.602.713", "MH_TH": "NLM (1968)", "ST": "T170", "AN": "\"transfer of patients & their med records from onehealth care institution to another\"", "PI": "specific organization", "MS": "A written agreement for the transfer of patients and their medical records from one health care institution to another.", "PM": "68", "HN": "68", "MR": "19940505", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014164"}, {"RECTYPE": "D", "MH": "Transfer Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Leukocyte Extract, Dialyzable", "MN": "D23.529.374.480.750", "MH_TH": "NLM (1975)", "ST": "T129", "RN": "0", "AN": "derived from leukocytes; /biosyn /drug eff /physiol /ultrastruct permitted", "PI": "Lymphokines (1974)", "MS": "Factor derived from leukocyte lysates of immune donors which can transfer both local and systemic cellular immunity to nonimmune recipients.", "PM": "75", "HN": "75", "MR": "20060705", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D014165"}, {"RECTYPE": "D", "MH": "Transferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transferase|T116|T126|NON|EQV|NLM (1988)|870505|abbcdef", "MN": "D08.811.913", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 2.-", "RR": "9047-61-4 (CAS RN)", "MS": "Transferases are enzymes transferring a group, for example, the methyl group or a glycosyl group, from one compound (generally regarded as donor) to another compound (generally regarded as acceptor). The classification is based on the scheme \"donor:acceptor group transferase\". (Enzyme Nomenclature, 1992) EC 2.", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014166"}, {"RECTYPE": "D", "MH": "Transference, Psychology", "PRINT ENTRY": "Transference (Psychology)|T041|NON|EQV|NLM (1963)|990101|TRANSFERENCE PSYCHOL|abcdefv", "ENTRY": "Transferences, Psychology", "MN": "F04.754.720.864", "MH_TH": "NLM (2020)", "ST": "T041", "AN": "human only", "MS": "The unconscious transfer to others (including psychotherapists) of feelings and attitudes which were originally associated with important figures (parents, siblings, etc.) in one's early life.", "PM": "2020; was TRANSFERENCE (PSYCHOLOGY) 1965-2019", "HN": "2020 (1965); was TRANSFERENCE (PSYCHOLOGY) 1965-2019", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014167"}, {"RECTYPE": "D", "MH": "Transferrin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Siderophilin|T116|T123|NON|EQV|UNK (19XX)|750101|abbcdef", "ENTRY": "tau Transferrin", "MN": "D12.776.556.579.750.500", "FX": "Receptors, Transferrin", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "TRANSFERRINS is also available", "MS": "An iron-binding beta1-globulin that is synthesized in the LIVER and secreted into the blood. It plays a central role in the transport of IRON throughout the circulation. A variety of transferrin isoforms exist in humans, including some that are considered markers for specific disease states.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014168"}, {"RECTYPE": "D", "MH": "Transformation, Bacterial", "DE": "TRANSFORM BACT", "AQ": "DE ES GE IM PH RE", "ENTRY": "Bacterial Transformation|T045|T063|NON|EQV|NLM (1992)|901105|BACT TRANSFORM|abbcdefv", "MN": "G06.099.850", "FX": "Transfection", "MH_TH": "NLM (1978)", "ST": "T063", "AN": "coordinate with specific bacterium transformed /genet", "PI": "Transformation, Genetic (1968-1977)", "MS": "The heritable modification of the properties of a competent bacterium by naked DNA from another source. The uptake of naked DNA is a naturally occuring phenomenon in some bacteria. It is often used as a GENE TRANSFER TECHNIQUE.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19770513", "DC": "1", "DX": "19780101", "UI": "D014169"}, {"RECTYPE": "D", "MH": "Transformation, Genetic", "DE": "TRANSFORM GENET", "AQ": "DE ES GE IM PH RE", "ENTRY": "Transformations, Genetic", "MN": "G05.728.865", "FX": "Transfection", "MH_TH": "NLM (1968)", "ST": "T045", "PI": "Genetics (1966-1967)", "MS": "Change brought about to an organisms genetic composition by unidirectional transfer (TRANSFECTION; TRANSDUCTION, GENETIC; CONJUGATION, GENETIC, etc.) and incorporation of foreign DNA into prokaryotic or eukaryotic cells by recombination of part or all of that DNA into the cell's genome.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014170"}, {"RECTYPE": "D", "MH": "Transients and Migrants", "DE": "TRANSIENTS MIGRANTS", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Migrants|T098|NON|NRW|NLM (1966)|740330|abcdef", "ENTRY": "Workers, Migrant", "MN": "M01.920", "FX": "Ill-Housed Persons", "MH_TH": "NLM (1966)", "ST": "T098", "AN": "specify geographic term if pertinent", "MS": "People who frequently change their place of residence.", "MR": "20220718", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014171"}, {"RECTYPE": "D", "MH": "Transillumination", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Diaphanoscopy|T060|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Transilluminations", "MN": "E05.642.500", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Passage of light through body tissues or cavities for examination of internal structures.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014172"}, {"RECTYPE": "D", "MH": "Transistors, Electronic", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Transistor, Electronic", "MN": "E07.305.625.714", "MH_TH": "NLM (2010)", "ST": "T073", "MS": "Electrical devices that are composed of semiconductor material, with at least three connections to an external electronic circuit. They are used to amplify electrical signals, detect signals, or as switches.", "PM": "2010; see TRANSISTORS 1991-2009, see SEMICONDUCTORS 1975-1990", "HN": "2010 (1975)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014173"}, {"RECTYPE": "D", "MH": "Transketolase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glycolaldehydetransferase|T116|T126|NON|EQV|NLM (1998)|970425|abbcdef", "MN": "D08.811.913.200.825", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "Sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glycolaldehydetransferase", "RN": "EC 2.2.1.1", "RR": "9014-48-6 (CAS RN)", "PI": "Transferases (1966-1971)", "MS": "An enzyme of the transferase class that catalyzes the conversion of sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate to D-ribose 5-phosphate and D-xylulose 5-phosphate in the PENTOSE PHOSPHATE PATHWAY. (Dorland, 27th ed) EC 2.2.1.1.", "PM": "73", "HN": "73(72)", "MR": "20050701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014174"}, {"RECTYPE": "D", "MH": "Translating", "PRINT ENTRY": "Written Materials Translation|T057|T090|NON|EQV|NLM (2024)|230403|abbcdef", "ENTRY": "Written Materials Translations", "MN": "L01.559.423.796", "MH_TH": "NLM (1966)", "ST": "T090", "MS": "Conversion of written materials from one language to another language.", "MR": "20230427", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014175"}, {"RECTYPE": "D", "MH": "Protein Biosynthesis", "DE": "PROTEIN BIOSYN", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Translation, Genetic|T044|NON|EQV|NLM (1973)|990101|TRANSLATION GENET|abcdefv", "ENTRY": "mRNA Translations", "MN": "G05.297.670", "FX": "Genetic Code", "MH_TH": "NLM (2005)", "ST": "T044", "AN": "do not confuse the ribosome translocation step of PROTEIN BIOSYNTHESIS with TRANSLOCATION, GENETIC a chromosome aberration; coordinate with the specific protein/biosyn only when genetic translation is discussed; PEPTIDE BIOSYNTHESIS and PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT are also available; for \"protein anabolism\" and \"protein catabolism\" use PROTEINS/metab", "PI": "Ribosomes (1966-1972)", "MS": "The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS.", "PM": "2005; see TRANSLATION, GENETIC 1973-2004", "HN": "2005 (1973)", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014176"}, {"RECTYPE": "D", "MH": "Translations", "MN": "L01.462.500.682.920", "MH_TH": "NLM (1966)", "ST": "T170", "MS": "Products resulting from the conversion of one language to another.", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014177"}, {"RECTYPE": "D", "MH": "Translocation, Genetic", "DE": "TRANSLOCATION GENET", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Translocation, Chromosomal|T045|NON|EQV|UNK (19XX)|870509|abcdef", "ENTRY": "Translocations, Genetic", "MN": "G05.558.860", "MH_TH": "NLM (2005)", "ST": "T045", "PI": "Chromosome Abnormalities (1966-1967)", "MS": "A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome.", "PM": "2005; see TRANSLOCATION (GENETICS) 1978-2005; see CHROMOSOME ABERRATIONS 1968-1977", "HN": "2005(1968)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D014178"}, {"RECTYPE": "D", "MH": "Neurotransmitter Uptake Inhibitors", "DE": "NEUROTRANSM UPTAKE INHIB", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Transmitter Uptake Inhibitors, Neuronal|T121|NON|EQV|NLM (1993)|920414|TRANSM UPTAKE INHIB NEURONAL|abcdefv", "ENTRY": "Neurotransmitter Reuptake Inhibitors", "MN": "D27.505.696.577.600", "MH_TH": "NLM (1985)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specific groups or specific drugs; coordinate with specific neurotransmitters /physiol ", "PI": "Synaptosomes (1974-1984)", "MS": "Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects.", "OL": "use NEUROTRANSMITTER UPTAKE INHIBITORS to search TRANSMITTER UPTAKE INHIBITORS, NEURONAL; INHIBITORS OF NEUROTRANSMITTER UPTAKE & UPTAKE INHIBITORS, NEUROTRANSMITTER 1985-92", "PM": "93; was TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92; NEUROTRANSMITTER UPTAKE INHIBITORS, INHIBITORS OF NEUROTRANSMITTER UPTAKE & UPTAKE INHIBITORS, NEUROTRANSMITTER were see TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92", "HN": "93; WAS TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92; NEUROTRANSMITTER UPTAKE INHIBITORS, INHIBITORS OF NEUROTRANSMITTER UPTAKE & UPTAKE INHIBITORS, NEUROTRANSMITTER were see TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92", "MR": "20190524", "DA": "19840501", "DC": "1", "DX": "19850101", "UI": "D014179"}, {"RECTYPE": "D", "MH": "Transplantation", "DE": "TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Transplantations", "MN": "E04.936", "FX": "Transplantation Immunology", "MH_TH": "BIOETHICS (1977)", "ST": "T061", "AN": "use for the surgical procedure; use TRANSPLANTS or specifics for the transplant itself; general or unspecified only; prefer /transpl with specific organ, tissue or cell terms or precoordinated transplantation terms (ORGAN TRANSPLANTATION, HEART TRANSPLANTATION, etc.)", "MS": "Transference of a tissue or organ from either an alive or deceased donor, within an individual, between individuals of the same species, or between individuals of different species.", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014180"}, {"RECTYPE": "D", "MH": "Transplantation Immunology", "DE": "TRANSPL IMMUNOL", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Immunology, Transplantation|T040|NON|EQV|NLM (1990)|890501|IMMUNOL TRANSPL|abcdefv", "MN": "G12.875", "FX": "Transplantation", "MH_TH": "NLM (1964)", "ST": "T040", "MS": "A general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20210713", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014181"}, {"RECTYPE": "D", "MH": "Transplantation, Autologous", "DE": "TRANSPL AUTOL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Transplantations, Autologous", "MN": "E04.936.664", "FX": "Autografts", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "add as NIM coordinate only if discussed: Manual 19.8.75; for skin or muscle flaps in plastic surgery index under SKIN TRANSPLANTATION or SURGICAL FLAPS & not also here", "MS": "Transplantation of an individual's own tissue from one site to another site.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20160125", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014182"}, {"RECTYPE": "D", "MH": "Transplantation, Heterologous", "DE": "TRANSPL HETEROL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Xenotransplantation|T061|NON|EQV|NLM (1996)|950117|XENOTRANSPL|abcdefv", "ENTRY": "Transplantation, Xenograft", "MN": "E04.936.764", "FX": "Heterografts", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "coordinate with specific transplantation terms; do not coordinate with BIOPROSTHESIS or BIOLOGICAL DRESSINGS; do not confuse with TRANSPLANTATION, HETEROTOPIC; Manual 19.8.75; use for the surgical procedure; use HETEROGRAFTS for the graft itself", "MS": "Transplantation between animals of different species.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014183"}, {"RECTYPE": "D", "MH": "Transplantation, Homologous", "DE": "TRANSPL HOMOL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Allogeneic|T061|NON|EQV|UNK (19XX)|781215|TRANSPL ALLOGENEIC|abcdefv", "ENTRY": "Grafting, Allogeneic", "MN": "E04.936.864", "FX": "Allografts", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "add as an NIM coordinate with specific transplantation terms only if particularly discussed; use for the surgical procedure; use HOMOGRAFTS see ALLOGRAFTS for the graft itself", "MS": "Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.", "OL": "use TRANSPLANTATION, HOMOLOGOUS to search TRANSPLANTATION, ALLOGENEIC 1975-79", "PM": "65", "HN": "65; TRANSPLANTATION, ALLOGENEIC was see under TRANSPLANTATION, HOMOLOGOUS 1975-79", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014184"}, {"RECTYPE": "D", "MH": "Transplantation, Isogeneic", "DE": "TRANSPL ISOGEN", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Syngeneic|T061|NON|EQV|UNK (19XX)|771221|TRANSPL SYNGENEIC|abcdefv", "ENTRY": "Transplantation, Isograft", "MN": "E04.936.864.700", "FX": "Isografts", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "add as an NIM coordinate with specific transplantation terms only if particularly discussed; use for the surgical procedure; use ISOGRAFTS for the graft itself", "PI": "Transplantation, Homologous (1966-1974)", "MS": "Transplantation between genetically identical individuals, i.e., members of the same species with identical histocompatibility antigens, such as monozygotic twins, members of the same inbred strain, or members of a hybrid population produced by crossing certain inbred strains.", "PM": "80; was see under TRANSPLANTATION, HOMOLOGOUS 1975-79", "HN": "80(75); was see under TRANSPLANTATION, HOMOLOGOUS 1975-79", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19750204", "DC": "1", "DX": "19800101", "UI": "D014185"}, {"RECTYPE": "D", "MH": "Transportation", "AQ": "CL EC ES HI IS LJ MT SN ST", "ENTRY": "Commuting|T056|NON|NRW|POPLINE (1981)|861231|abcdef", "MN": "J01.937", "MH_TH": "POPLINE (1978)", "ST": "T066", "AN": "specify industry or geog if pertinent", "MS": "The means of moving persons, animals, goods, or materials from one place to another.", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "19991103", "DA": "19750721", "DC": "1", "DX": "19760101", "UI": "D014186"}, {"RECTYPE": "D", "MH": "Transportation of Patients", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Transportation Accessibility|T058|NON|REL|NLM (2023)|220207|abcdef", "ENTRY": "Transportation, Accessible", "MN": "N05.300.430.750", "FX": "Stretchers", "MH_TH": "NLM (1964)", "ST": "T058", "AN": "includes transport inside (e.g., bed to bed) & outside the hosp or elsewhere but do not confuse with PATIENT TRANSFER (interfacility or intrahospital transfer for admin reasons with regard to special care or economics)", "MS": "Conveying ill or injured individuals from one place to another.", "OL": "use TRANSPORTATION OF PATIENTS to search TRANSPORT OF WOUNDED AND SICK 1966-77", "PM": "78; was TRANSPORT OF WOUNDED AND SICK 1964-77, was TRANSPORT OF WOUNDED 1963", "HN": "78; was TRANSPORT OF WOUNDED AND SICK 1964-77, was TRANSPORT OF WOUNDED 1963", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D014187"}, {"RECTYPE": "D", "MH": "Transposition of Great Vessels", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Levotransposition of Great Vessels|T019|NON|NRW|NLM (2023)|220209|abcdef", "ENTRY": "Levo-TGAs", "MN": "C16.131.240.400.915", "FX": "Arterial Switch Operation", "MH_TH": "NLM (1965)", "ST": "T019", "MS": "A congenital cardiovascular malformation in which the AORTA arises entirely from the RIGHT VENTRICLE, and the PULMONARY ARTERY arises from the LEFT VENTRICLE. Consequently, the pulmonary and the systemic circulations are parallel and not sequential, so that the venous return from the peripheral circulation is re-circulated by the right ventricle via aorta to the systemic circulation without being oxygenated in the lungs. This is a potentially lethal form of heart disease in newborns and infants.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014188"}, {"RECTYPE": "D", "MH": "Transsexualism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Transexualism|T054|NON|EQV|NLM (2024)|230419|abcdef", "ENTRY": "Transexualisms", "MN": "F02.739.794.793.200.500", "FX": "Transgender Persons", "MH_TH": "NLM (1978)", "ST": "T054", "AN": "index both MALE and FEMALE check tags", "PI": "Transvestism (1966-1967)", "MS": "Expression of a GENDER IDENTITY inconsistent with, or not culturally-associated with the gender assigned to an individual at birth, combined with the desire to permanently transition to the gender with which they identify.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014189"}, {"RECTYPE": "D", "MH": "Transvestism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Transvestic Fetishism|T048|NON|EQV|NLM (1998)|970319|abcdef", "ENTRY": "Transvestisms", "MN": "F03.657.800", "MH_TH": "NLM (1966)", "ST": "T048", "MS": "Disorder characterized by recurrent, intense sexually arousing fantasies, sexual urges, or behaviors involving cross-dressing in a heterosexual male. The fantasies, urges, or behaviors cause clinically significant distress or impairment in social, occupational or other areas of functioning. (from APA, DSM-IV, 1994)", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014190"}, {"RECTYPE": "D", "MH": "Tranylcypromine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "trans 2 Phenylcyclopropylamine", "MN": "D02.092.831.845", "PA": "Monoamine Oxidase Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Cyclopropanamine, 2-phenyl-, trans-(+-)-", "RN": "3E3V44J4Z9", "RR": "7ZAT6ES870", "MS": "A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, 1994, p311)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014191"}, {"RECTYPE": "D", "MH": "Trapidil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trapymin|T109|T121|NON|EQV|UNK (19XX)|830614|abbcdef", "ENTRY": "Rocornal|T109|T121|TRD|NRW|DE|NLM (1996)|940822|abbcdeef", "MN": "D03.383.742.875", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "(1,2,4)Triazolo(1,5-a)pyrimidin-7-amine, N,N-diethyl-5-methyl-", "RN": "EYG5Y6355E", "RR": "15421-84-8 (Trapidil)", "PI": "Triazoles (1966-1974)", "MS": "A coronary vasodilator agent.", "OL": "use TRAPIDIL to search TRAPYMIN 1975-83", "PM": "91; was see under PYRIMIDINES 1984-90; was TRAPYMIN see under PYRIMIDINES 1975-83", "HN": "91(84); was see under PYRIMIDINES 1984-90; was TRAPYMIN see under PYRIMIDINES 1975-83", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014192"}, {"RECTYPE": "D", "MH": "Trauma Centers", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Trauma Units|T073|T093|NON|NRW|UNK (19XX)|741111|abbcdef", "ENTRY": "Units, Trauma", "MN": "N04.452.442.452.422.336.400", "MH_TH": "NLM (1975)", "ST": "T093", "PI": "Emergency Service, Hospital (1966-1974)", "MS": "Specialized hospital facilities which provide diagnostic and therapeutic services for trauma patients.", "PM": "75", "HN": "75", "MR": "20190709", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D014193"}, {"RECTYPE": "D", "MH": "Traumatology", "DE": "TRAUMATOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Traumatology, Surgical", "MN": "H02.403.810.104.500", "FX": "Wounds and Injuries", "MH_TH": "NLM (1987)", "ST": "T091", "AN": "use for the specialty dealing with physical trauma, not psychological trauma", "MS": "The medical specialty which deals with WOUNDS and INJURIES as well as resulting disability and disorders from physical traumas.", "PM": "87", "HN": "87", "MR": "20230414", "DA": "19860325", "DC": "1", "DX": "19870101", "UI": "D014194"}, {"RECTYPE": "D", "MH": "Travel", "AQ": "CL EC ES HI LJ PX SN TD", "ENTRY": "Travels, Sea", "MN": "I03.883", "MH_TH": "NLM (1990)", "ST": "T056", "AN": "coordinate with specific type of travel (AUTOMOBILES, SHIPS, etc. if pertinent); not for study tours to various countries: index object of study + geographic location (for example HOSPITALS + GHANA; PEDIATRICS + CHINA); consider also MEDICAL MISSIONS  or RELIGIOUS MISSIONS; TRAVEL-RELATED ILLNESS and TRAVEL MEDICINE are also available", "MS": "MOVEMENT across different GEOGRAPHIC LOCATIONS.", "MR": "20181011", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014195"}, {"RECTYPE": "D", "MH": "Trazodone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TrazodonNeuraxpharm", "MN": "D03.383.725.791.900", "PA": "Selective Serotonin Reuptake Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1,2,4-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-", "RN": "YBK48BXK30", "RR": "6E8ZO8LRNM", "PI": "Triazoles (1971-1974)", "MS": "A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)", "PM": "86; was see under PIPERAZINES 1975-85", "HN": "86(75); was see under PIPERAZINES 1975-85", "MR": "20220718", "DA": "19741119", "DC": "1", "DX": "19860101", "UI": "D014196"}, {"RECTYPE": "D", "MH": "Trees", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Tree", "MN": "B01.650.915", "FX": "Forests", "MH_TH": "NLM (1966)", "ST": "T002", "MS": "Woody, usually tall, perennial higher plants (Angiosperms, Gymnosperms, and some Pterophyta) having usually a main stem and numerous branches.", "PM": "ACACIA & EUCALYPTUS were headings 1963-85", "HN": "ACACIA & EUCALYPTUS were headings 1963-85", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014197"}, {"RECTYPE": "D", "MH": "Trehalase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.450.329.865", "MH_TH": "NLM (1971)", "ST": "T126", "N1": "alpha,alpha-Trehalose glucohydrolase", "RN": "EC 3.2.1.28", "AN": "do not confuse with TREHALOSE", "PI": "Glycoside Hydrolases (1966-1970)", "MS": "An enzyme that catalyzes the conversion of alpha,alpha-trehalose and water to D-glucose. EC 3.2.1.28.", "PM": "73", "HN": "73(71)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014198"}, {"RECTYPE": "D", "MH": "Trehalose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.947.750.880", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "alpha-D-Glucopyranoside, alpha-D-glucopyranosyl", "RN": "B8WCK70T7I", "RR": "99-20-7 (Trehalose)", "AN": "called ergot sugar & mycose; do not confuse with TREHALASE", "PM": "91; was see under DISACCHARIDES 1973-90", "HN": "91(73); was see under DISACCHARIDES 1973-90", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014199"}, {"RECTYPE": "D", "MH": "Trematoda", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Petasiger|T204|NON|NRW|NLM (2023)|211216|abcdef", "ENTRY": "Troglotremas", "MN": "B01.050.500.500.736.715", "FX": "Antiplatyhelmintic Agents", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6178", "RR": "txid6179", "MS": "Class of parasitic flukes consisting of subclasses Aspidogastrea and Digenea. The digenetic trematodes are the only ones found in man. They are endoparasites and require two hosts to complete their life cycle.", "MR": "20220708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014200"}, {"RECTYPE": "D", "MH": "Trematode Infections", "DE": "TREMATODE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Metagonimiasis|T047|NON|NRW|UNK (19XX)|810519|abcdef", "ENTRY": "Trematode Infection", "MN": "C01.610.335.865", "FX": "Antiplatyhelmintic Agents", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specific trematode infections or coordinate specific trematode in MeSH with infection term as directed under name of trematode", "MS": "Infections caused by infestation with worms of the class Trematoda.", "OL": "use TREMATODE INFECTIONS to search FASCIOLOPSIASIS & METAGONIMIASIS 1967-81", "HN": "FASCIOLOPSIASIS & METAGONIMIASIS were see under TREMATODE INFECTIONS 1967-81", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D014201"}, {"RECTYPE": "D", "MH": "Tremor", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Resting Tremor|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Tremors", "MN": "C23.888.592.350.850", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.", "CATSH": "CAT LIST", "MR": "20220808", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014202"}, {"RECTYPE": "D", "MH": "Tremorine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.773.906", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Pyrrolidine, 1,1'-(2-butyne-1,4-diyl)bis-", "RN": "U817VZ1URQ", "RR": "51-73-0 (Tremorine)", "PM": "66", "HN": "66", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014203"}, {"RECTYPE": "D", "MH": "Trenbolone Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trienbolone|T109|T121|NON|REL|FDA SRS (2015)|UNK (19XX)|771222|abbcdeef", "ENTRY": "Progro TS", "MN": "D04.210.500.365.415.930", "PA": "Anabolic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "RUD5Y4SV0S", "RR": "P53R4420TR", "PI": "Estrenes (1975-1978)", "MS": "An anabolic steroid used mainly as an anabolic agent in veterinary practice.", "PM": "91; was see under ESTRENES 1979-90", "HN": "91(79); was see under ESTRENES 1979-90", "MR": "20160601", "DA": "19771222", "DC": "1", "DX": "19910101", "UI": "D014204"}, {"RECTYPE": "D", "MH": "Trench Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Bartonella quintana", "MN": "C01.150.252.400.126.100.800", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by Bartonella quintana; do not confuse with TRENCH FOOT", "MS": "An intermittent fever characterized by intervals of chills, fever, and splenomegaly each of which may last as long as 40 hours. It is caused by BARTONELLA QUINTANA and transmitted by the human louse.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014205"}, {"RECTYPE": "D", "MH": "Trephining", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Trepannings", "MN": "E04.525.190.840", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "restrict to skull: do not use for other tissues", "MS": "The removal of a circular disk of the cranium.", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014207"}, {"RECTYPE": "D", "MH": "Treponema", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.851.595.795", "FX": "Digital Dermatitis", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid157", "MS": "A genus of microorganisms of the order SPIROCHAETALES, many of which are pathogenic and parasitic for man and animals.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014208"}, {"RECTYPE": "D", "MH": "Treponema Immobilization Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Treponema Immobilization Tests", "MN": "E05.478.594.760.850.800", "MH_TH": "NLM (1966)", "ST": "T059", "AN": "also called Treponema Pallidum Immobilization & TPI", "MS": "Syphilis serodiagnosis employing as the antigen Treponema pallidum obtained from rabbit syphilis orchitis. Treponemes are kept alive for a few hours in a special medium. When syphilitic serum and complement are added and incubated, the treponemes are immobilized, i.e., stop moving.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014209"}, {"RECTYPE": "D", "MH": "Treponema pallidum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.851.595.795.840", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid160", "MS": "The causative agent of venereal and non-venereal syphilis as well as yaws.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014210"}, {"RECTYPE": "D", "MH": "Treponemal Infections", "DE": "TREPONEMAL INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Bejel|T047|NON|NRW|NLM (1997)|ORD (2010)|960411|abcdeef", "ENTRY": "Treponemal Infection", "MN": "C01.150.252.400.840", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Infections with bacteria of the genus TREPONEMA.", "PM": "BEJEL was heading 1963-67, 75-96 (see under TREPONEMAL INFECTIONS 1975-90); was see under TREPONEMAL INFECTIONS 1968-74", "HN": "BEJEL was heading 1963-67, 75-96 (see under TREPONEMAL INFECTIONS 1975-90); was see under TREPONEMAL INFECTIONS 1968-74", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D014211"}, {"RECTYPE": "D", "MH": "Tretinoin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitamin A Acid|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "trans Retinoic Acid", "MN": "D23.767.261.700.780", "PA": "Keratolytic Agents", "FX": "Receptors, Retinoic Acid", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Retinoic acid", "RN": "5688UTC01R", "RR": "75980-27-7 (Zn salt)", "PI": "Vitamin A (1966-1974)", "MS": "An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).", "PM": "80; was see under VITAMIN A 1975-79", "HN": "80(75); was see under VITAMIN A 1975-79", "MR": "20200609", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D014212"}, {"RECTYPE": "D", "MH": "Tretoquinol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trimethoquinol|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "CV705", "MN": "D03.633.100.531.085.888", "PA": "Sympathomimetics", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((3,4,5-trimethoxyphenyl)methyl)-, (S)-", "RN": "JIO3275WGI", "RR": "SS28YGI1ZQ", "PI": "Isoquinolines (1971-1974)", "MS": "An adrenergic beta-agonist used as a bronchodilator agent in asthma therapy.", "PM": "91; was see under ISOQUINOLINES 1975-90", "HN": "91(75); was see under ISOQUINOLINES 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014213"}, {"RECTYPE": "D", "MH": "Triallate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tri allate", "MN": "D02.886.706.850", "PA": "Herbicides", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Carbamothioic acid, bis(1-methylethyl)-, S-(2,3,3-trichloro-2-propenyl) ester", "RN": "A9S097HS99", "RR": "2303-17-5 (Triallate)", "PI": "Thiocarbamates (1970-1974)", "MS": "A pre-emergence, selective herbicide for the control of wild oats in various crops.", "OL": "use TRIALLATE to search TRI-ALLATE 1975-93", "PM": "94; was TRI-ALLATE 1975-93 (see under THIOCARBAMATES 1975-90)", "HN": "94; was TRI-ALLATE 1975-93 (see under THIOCARBAMATES 1975-90)", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D014214"}, {"RECTYPE": "D", "MH": "Triacetin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Triacetylglycerol|T109|T121|NON|EQV|NLM (2008)|060830|abbcdef", "ENTRY": "Triacetyl glycerol", "MN": "D10.351.801.632", "PA": "Solvents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,2,3-Propanetriol, triacetate", "RN": "XHX3C3X673", "RR": "102-76-1 (Triacetin)", "MS": "A triglyceride that is used as an antifungal agent.", "PM": "91; was see under TRIGLYCERIDES 1966-90", "HN": "91(66); was see under TRIGLYCERIDES 1966-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014215"}, {"RECTYPE": "D", "MH": "Triacetoneamine-N-Oxyl", "DS": "TRIACETONEAMINEOXYL N", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "TAN|T109|T121|T130|ABB|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Triacetoneamine N Oxyl", "MN": "D03.661.243.930", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "1-Piperidinyloxy, 2,2,6,6-tetramethyl-4-oxo-", "RN": "2896-70-0", "PI": "Piperidones (1973-1974)", "MS": "Cyclic N-oxide radical functioning as a spin label and radiation-sensitizing agent.", "PM": "91; was see under CYCLIC N-OXIDES 1975-90", "HN": "91(75); was see under CYCLIC N-OXIDES 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014216"}, {"RECTYPE": "D", "MH": "Troleandomycin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Triacetyloleandomycin|T109|T195|NON|EQV|BAN (19XX)|FDA SRS (2014)|890328|abbcdeef", "ENTRY": "TAO|T109|T195|TRD|NRW|US|041203|abbcdef", "MN": "D02.540.505.600.800", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Oleandomycin, triacetate (ester)", "RN": "C4DZ64560D", "RR": "2751-09-9 (Troleandomycin)", "MS": "A macrolide antibiotic that is similar to ERYTHROMYCIN.", "OL": "use TROLEANDOMYCIN to search TRIACETYLOLEANDOMYCIN 1966-89", "PM": "90; was TRIACETYLOLEANDOMYCIN 1964-89", "HN": "90; was TRIACETYLOLEANDOMYCIN 1964-89", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D014217"}, {"RECTYPE": "D", "MH": "Triage", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Triages", "MN": "N02.421.297.900", "MH_TH": "NLM (1976)", "ST": "T061", "PI": "Emergency Service, Hospital (1966-1975)", "MS": "The sorting out and classification of patients or casualties to determine priority of need and proper place of treatment.", "PM": "91; was see under EMERGENCY MEDICAL SERVICES 1980-90; was see under EMERGENCY HEALTH SERVICES 1976-79", "HN": "91(76); was see under EMERGENCY MEDICAL SERVICES 1980-90; was see under EMERGENCY HEALTH SERVICES 1976-79", "MR": "20150629", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D014218"}, {"RECTYPE": "D", "MH": "Trial of Labor", "ENTRY": "Labor Trials", "MN": "G08.686.784.769.326.660", "FX": "Delivery, Obstetric", "MH_TH": "NLM (1988)", "ST": "T060", "MS": "Allowing a woman to be in LABOR, OBSTETRIC long enough to determine if vaginal birth may be anticipated.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19870314", "DC": "1", "DX": "19880101", "UI": "D014219"}, {"RECTYPE": "D", "MH": "Trialkyltin Compounds", "DE": "TRIALKYLTIN CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Trialkyltin", "MN": "D02.691.850.900", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Tin (1968-1974)", "MS": "Organometallic compounds which contain tin and three alkyl groups.", "PM": "75", "HN": "75", "MR": "20110624", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D014220"}, {"RECTYPE": "D", "MH": "Triamcinolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Volon|T109|T121|TRD|NRW|UNK (19XX)|861110|abbcdef", "MN": "D04.210.500.908.891", "PA": "Glucocorticoids", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)-", "RN": "1ZK20VI6TY", "RR": "124-94-7 (Triamcinolone)", "MS": "A glucocorticoid given, as the free alcohol or in esterified form, orally, intramuscularly, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. (From Martindale, The Extra Pharmacopoeia, 30th ed, p739)", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014221"}, {"RECTYPE": "D", "MH": "Triamcinolone Acetonide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tricort40", "MN": "D04.210.500.908.891.927", "PA": "Immunosuppressive Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-", "RN": "F446C597KA", "RR": "76-25-5 (Triamcinolone Acetonide)", "MS": "An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014222"}, {"RECTYPE": "D", "MH": "Triamterene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Urocaudal|T109|T121|TRD|NRW|ES|041203|abbcdef", "MN": "D03.633.100.733.900", "PA": "Epithelial Sodium Channel Blockers", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4,7-Pteridinetriamine, 6-phenyl-", "RN": "WS821Z52LQ", "RR": "396-01-0 (Triamterene)", "MS": "A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.", "PM": "65", "HN": "65(63)", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014223"}, {"RECTYPE": "D", "MH": "Triatoma", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Triatomas", "MN": "B01.050.500.131.617.412.420.700.850.800", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid30075", "AN": "vector of Trypanosoma cruzi; do not use /drug eff for insecticides: TN 111", "MS": "A genus of the subfamily TRIATOMINAE. Several species are vectors of TRYPANOSOMA CRUZI.", "OL": "use TRIATOMINAE to search TRIATOMA 1973-74", "PM": "91; was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78", "HN": "91(75); was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014224"}, {"RECTYPE": "D", "MH": "Triatominae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.412.420.700.850", "MH_TH": "NLM (1967)", "ST": "T204", "RN": "txid70999", "AN": "vectors of Trypanosoma cruzi; do not use /drug eff for insecticides: TN 111", "PI": "Insects (1966)", "MS": "A subfamily of assassin bugs (REDUVIIDAE) that are obligate blood-suckers of vertebrates. Included are the genera TRIATOMA; RHODNIUS; and PANSTRONGYLUS, which are vectors of TRYPANOSOMA CRUZI, the agent of CHAGAS DISEASE in humans.", "PM": "91; see TRIATOMIDAE 1979-90, see TRIATOMINAE 1973-78; for TRIATOMIDAE see TRIATOMINAE 1991-98", "HN": "91(67)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014225"}, {"RECTYPE": "D", "MH": "Triazenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Diazoamino", "MN": "D02.925", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "AN": "do not confuse with TRIAZINES", "PI": "Azo Compounds (1966-1971)", "MS": "Compounds with three contiguous nitrogen atoms in linear format, H2N-N=NH, and hydrocarbyl derivatives.", "PM": "73", "HN": "73(72)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014226"}, {"RECTYPE": "D", "MH": "Triazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Triazine|T109|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Benzotriazines|T109|NON|NRW|NLM (2005)|040224|abcdef", "MN": "D03.383.931", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with TRIAZENES", "MS": "Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014227"}, {"RECTYPE": "D", "MH": "Triaziquone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trenimon|T109|T121|TRD|NRW|UNK (19XX)|800825|abbcdef", "MN": "D03.383.097.217.900", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2,5-Cyclohexadiene-1,4-dione, 2,3,5-tris(1-aziridinyl)-", "RN": "F3D5D9P25I", "RR": "68-76-8 (Triaziquone)", "MS": "Alkylating antineoplastic agent used mainly for ovarian tumors. It is toxic to skin, gastrointestinal tract, bone marrow and kidneys.", "PM": "67", "HN": "67(64)", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014228"}, {"RECTYPE": "D", "MH": "Triazolam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "U33,030", "MN": "D03.633.100.079.080.900", "PA": "GABA Modulators", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-methyl-", "RN": "1HM943223R", "RR": "28911-01-5 (Triazolam)", "PI": "Triazoles (1974-1976)", "MS": "A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.", "PM": "86; was see under BENZODIAZEPINE TRANQUILIZERS 1977-85", "HN": "86(77); was see under BENZODIAZEPINE TRANQUILIZERS 1977-85", "MR": "20170524", "DA": "19760416", "DC": "1", "DX": "19860101", "UI": "D014229"}, {"RECTYPE": "D", "MH": "Triazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Triazole|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D03.383.129.799", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "includes triazolines, triazolidines", "MS": "Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014230"}, {"RECTYPE": "D", "MH": "Tribolium", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Triboliums", "MN": "B01.050.500.131.617.720.500.500.375.799", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid7069", "AN": "\"confused flour beetle\"; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111", "PI": "Beetles (1966-1971)", "MS": "A genus of small beetles of the family Tenebrionidae; T. confusum is the \"confused flour beetle\".", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014231"}, {"RECTYPE": "D", "MH": "Tricarboxylic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tricarboxylic Acid|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Acids, Tricarboxylic", "MN": "D02.241.081.901", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "AN": "/metab is probably TRICARBOXYLIC ACID CYCLE", "PI": "Acids (1966-1970)", "MS": "Organic compounds that are acyclic and contain three acid groups. A member of this class is citric acid which is the first product formed by reaction of pyruvate and oxaloacetate. (From Lehninger, Principles of Biochemistry, 1982, p443)", "OL": "use TRICARBOXYLIC ACIDS to search ACIDS, TRICARBOXYLIC 1971", "PM": "72; was ACIDS, TRICARBOXYLIC 1971", "HN": "72; was ACIDS, TRICARBOXYLIC 1971", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014233"}, {"RECTYPE": "D", "MH": "Trichinella", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Trichina|T204|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Trichinellas", "MN": "B01.050.500.500.294.100.275.780.608", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6333", "AN": "a genus of nematodes; infection =TRICHINELLOSIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "MS": "A genus of parasitic nematodes that causes TRICHINELLOSIS in man and other animal.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014234"}, {"RECTYPE": "D", "MH": "Trichinellosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Trichinosis|T047|NON|EQV|NLM (1966)|ORD (2010)|990101|abcdeef", "ENTRY": "Trichinoses", "MN": "C01.610.335.508.100.275.882", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "nematode infect caused by Trichina or Trichinella: do not confuse with TRICHURIASIS, caused by Trichuris", "MS": "An infection with TRICHINELLA. It is caused by eating raw or undercooked meat that is infected with larvae of nematode worms TRICHINELLA genus. All members of the TRICHINELLA genus can infect human in addition to TRICHINELLA SPIRALIS, the traditional etiological agent. It is distributed throughout much of the world and is re-emerging in some parts as a public health hazard and a food safety problem.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014235"}, {"RECTYPE": "D", "MH": "Trichlorfon", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "PRINT ENTRY": "Metrifonate|T109|T121|T131|NON|EQV|FDA SRS (2014)|INN (19XX)|USP (19XX)|750717|abbbcdeeef", "ENTRY": "Trichlorphon|T109|T121|T131|NON|EQV|UNK (19XX)|800801|abbbcdef", "MN": "D02.705.429.937", "PA": "Insecticides", "MH_TH": "USAN (1995)", "ST": "T131", "N1": "Phosphonic acid, (2,2,2-trichloro-1-hydroxyethyl)-, dimethyl ester", "RN": "DBF2DG4G2K", "RR": "52-68-6 (Trichlorfon)", "AN": "TN 111 for eff on insects, for POIS consider ORGANOPHOSPHATE POISONING", "PI": "Insecticides (1966-1971)", "MS": "An organochlorophosphate cholinesterase inhibitor that is used as an insecticide for the control of flies and roaches. It is also used in anthelmintic compositions for animals. (From Merck, 11th ed)", "PM": "74", "HN": "74(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014236"}, {"RECTYPE": "D", "MH": "Trichlormethiazide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trichloromethiazide|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1996)|950522|abbcdeef", "MN": "D03.633.100.174.261.476.716", "PA": "Sodium Chloride Symporter Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-, 1,1-dioxide", "RN": "Q58C92TUN0", "RR": "133-67-5 (Trichlormethiazide)", "MS": "A thiazide diuretic with properties similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p830)", "MR": "20180116", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014237"}, {"RECTYPE": "D", "MH": "Trichloroacetic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "trichloracetique, Acide", "MN": "D02.455.526.439.196.750", "PA": "Caustics", "EC": "analogs & derivatives:Chloroacetates", "MH_TH": "USP (19XX)", "ST": "T109", "N1": "Acetic acid, trichloro-", "RN": "5V2JDO056X", "RR": "76-03-9 (Trichloroacetic Acid)", "MS": "A strong acid used as a protein precipitant in clinical chemistry and also as a caustic for removing warts.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014238"}, {"RECTYPE": "D", "MH": "Trichloroepoxypropane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trichloropropene Oxide|T109|T121|NON|EQV|UNK (19XX)|790221|abbcdef", "ENTRY": "Oxide, Trichloropropylene", "MN": "D02.455.526.439.920", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1980)", "ST": "T121", "N1": "Oxirane, (trichloromethyl)-", "RN": "3083-23-6", "PI": "Hydrocarbons, Halogenated (1966-1973)", "MS": "A potent epoxide hydrase and aryl hydrocarbon hydroxylase inhibitor. It enhances the tumor-initiating ability of certain carcinogens.", "PM": "91; was see under HYDROCARBONS, CHLORINATED 1980-90", "HN": "91(80); was see under HYDROCARBONS, CHLORINATED 1980-90", "MR": "20040707", "DA": "19790221", "DC": "1", "DX": "19910101", "UI": "D014239"}, {"RECTYPE": "D", "MH": "Trichloroethanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.526.439.927", "MH_TH": "NLM (1977)", "ST": "T131", "RN": "0", "PI": "Hydrocarbons, Chlorinated (1974-1976)", "MS": "Chlorinated ethanes which are used extensively as industrial solvents. They have been utilized in numerous home-use products including spot remover preparations and inhalant decongestant sprays. These compounds cause central nervous system and cardiovascular depression and are hepatotoxic. Include 1,1,1- and 1,1,2-isomers.", "PM": "91; was see under HYDROCARBONS, CHLORINATED 1977-90", "HN": "91(77); was see under HYDROCARBONS, CHLORINATED 1977-90", "MR": "19920520", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D014240"}, {"RECTYPE": "D", "MH": "Trichloroethylene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethinyl Trichloride|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef", "ENTRY": "Trichloride, Ethinyl", "MN": "D02.455.526.439.939", "PA": "Solvents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Ethene, trichloro-", "RN": "290YE8AR51", "RR": "79-01-6 (Trichloroethylene)", "MS": "A highly volatile inhalation anesthetic used mainly in short surgical procedures where light anesthesia with good analgesia is required. It is also used as an industrial solvent. Prolonged exposure to high concentrations of the vapor can lead to cardiotoxicity and neurological impairment.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014241"}, {"RECTYPE": "D", "MH": "Trichoderma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Trichodermas", "MN": "B01.300.381.910", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5543", "AN": "infection: coord IM with MYCOSES or specifics", "MS": "A mitosporic fungal genus frequently found in soil and on wood. It is sometimes used for controlling pathogenic fungi. Its teleomorph is HYPOCREA.", "PM": "91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85", "HN": "91(75)", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D014242"}, {"RECTYPE": "D", "MH": "Trichodermin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trichodermol|T109|T121|NON|REL|UNK (19XX)|800520|abbcdef", "MN": "D23.946.587.933.900", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Trichothec-9-en-4-ol, 12,13-epoxy-, acetate, (4beta)-", "RN": "4682-50-2", "PI": "Sesquiterpenes (1974)", "MS": "Antifungal metabolite from several fungi, mainly Trichoderma viride; inhibits protein synthesis by binding to ribosomes; proposed as antifungal and antineoplastic; used as tool in cellular biochemistry.", "PM": "91; was see under SESQUITERPENES 1975-90", "HN": "91(75); was see under SESQUITERPENES 1975-90", "MR": "20190705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014243"}, {"RECTYPE": "D", "MH": "Trichomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Trichomona", "MN": "B01.630.800.808", "FX": "Antitrichomonal Agents", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5721", "MS": "A genus of parasitic flagellate EUKARYOTES distinguished by the presence of four anterior flagella, an undulating membrane, and a trailing flagellum.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014244"}, {"RECTYPE": "D", "MH": "Trichomonas Infections", "DE": "TRICHOMONAS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Trichomoniases", "MN": "C01.610.752.890", "FX": "Antitrichomonal Agents", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "protozoan infect; /drug ther: consider also ANTITRICHOMONAL AGENTS", "MS": "Infections in birds and mammals produced by various species of Trichomonas.", "OL": "use TRICHOMONAS INFECTIONS to search TRICHOMONAS CYSTITIS, TRICHOMONAS PROSTATO-SEMINO-VESICULITIS & TRICHOMONAS URETHRITIS 1966-71", "PM": "TRICHOMONAS CYSTITIS, TRICHOMONAS PROSTATO-SEMINO-VESICULITIS & TRICHOMONAS URETHRITIS were headings 1963-71", "HN": "TRICHOMONAS CYSTITIS, TRICHOMONAS PROSTATO-SEMINO-VESICULITIS & TRICHOMONAS URETHRITIS were headings 1963-71", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D014245"}, {"RECTYPE": "D", "MH": "Trichomonas vaginalis", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "vaginali, Trichomonas", "MN": "B01.630.800.808.717", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid5722", "PI": "Trichomonas (1966-1971)", "MS": "A species of TRICHOMONAS that produces a refractory vaginal discharge in females, as well as bladder and urethral infections in males.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014246"}, {"RECTYPE": "D", "MH": "Trichomonas Vaginitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Vaginitis, Trichomonas", "MN": "C12.100.250.894.906.633", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with the organism TRICHOMONAS VAGINALIS", "MS": "Inflammation of the vagina, marked by a purulent discharge. This disease is caused by the protozoan TRICHOMONAS VAGINALIS.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014247"}, {"RECTYPE": "D", "MH": "Trichophytin", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "MN": "D23.050.202.800", "MH_TH": "NLM (1986)", "ST": "T129", "N1": "Trichophytin", "RN": "1404-86-0", "AN": "do not confuse with TRICHOPHYTON, an organism", "MS": "Antigens from the genus TRICHOPHYTON. Trichophytin has been used in studies of immunological responses to these dermatophytes.", "PM": "91; was see under ANTIGENS, FUNGAL 1986-90; was heading 1963-85", "HN": "91(86)63; was see under ANTIGENS, FUNGAL 1986-90; was heading 1963-85", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014248"}, {"RECTYPE": "D", "MH": "Trichophyton", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Endodermophyton|T004|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Trychophytons", "MN": "B01.300.381.928", "MH_TH": "NLM (1966)", "ST": "T004", "RN": "txid5550", "MS": "A mitosporic fungal genus and an anamorphic form of Arthroderma. Various species attack the skin, nails, and hair.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014249"}, {"RECTYPE": "D", "MH": "Trichosporon", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Trichosporons", "MN": "B01.300.930.930", "MH_TH": "NLM (1986)", "ST": "T004", "RN": "txid5552", "PI": "Hyphomycetes (1966-1985)", "MS": "A mitosporic fungal genus causing opportunistic infections, endocarditis, fungemia, a hypersensitivity pneumonitis (see TRICHOSPORONOSIS) and white PIEDRA.", "PM": "91; see HYPHOMYCETES 1986-90", "HN": "91(86)", "MR": "20200813", "DA": "19850212", "DC": "1", "DX": "19910101", "UI": "D014250"}, {"RECTYPE": "D", "MH": "Trichostrongyloidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Trichostrongyloideas", "MN": "B01.050.500.500.294.400.968.746", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6314", "MS": "A superfamily of nematodes. Most are intestinal parasites of ruminants and accidentally in humans. This superfamily includes seven genera: DICTYOCAULUS; HAEMONCHUS; Cooperia, OSTERTAGIA; Nematodirus, TRICHOSTRONGYLUS; and Hyostrongylus.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014251"}, {"RECTYPE": "D", "MH": "Trichostrongyloidiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Trichostrongyloidiases", "MN": "C01.610.335.508.700.775.825", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "roundworm infect; caused by various genera of the superfamily TRICHOSTRONGYLOIDEA: do not confuse with TRICHOSTRONGYLOSIS, caused by the genus TRICHOSTRONGYLUS", "PI": "Nematode Infections (1966-1967)", "MS": "Infection by roundworms of the superfamily TRICHOSTRONGYLOIDEA, including the genera TRICHOSTRONGYLUS; OSTERTAGIA; Cooperia, HAEMONCHUS; Nematodirus, Hyostrongylus, and DICTYOCAULUS.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014252"}, {"RECTYPE": "D", "MH": "Trichostrongylosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Trichostrongyloses", "MN": "C01.610.335.508.700.775.825.842", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "nematode infect caused by TRICHOSTRONGYLUS, a genus: do not confuse with TRICHOSTRONGYLOIDIASIS, caused by genera of the superfamily TRICHOSTRONGYLOIDEA", "MS": "Infestation with nematode worms of the genus TRICHOSTRONGYLUS. Man and animals become infected by swallowing larvae, usually with contaminated food or drink, although the larvae may penetrate human skin.", "OL": "use TRICHOSTRONGYLOIDIASIS to search TRICHOSTRONGYLOSIS 1966-74", "PM": "91,63-67; was see under TRICHOSTRONGYLOIDIASIS 1968-90; was heading 1963-67", "HN": "91(75)63-67; was see under TRICHOSTRONGYLOIDIASIS 1968-90; was heading 1963-67", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014253"}, {"RECTYPE": "D", "MH": "Trichostrongylus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.294.400.968.746.610", "MH_TH": "NLM (1986)", "ST": "T204", "RN": "txid6318", "PI": "Trichostrongyloidea (1966-1985)", "MS": "A genus of parasitic nematodes found in the digestive tract of herbivorous animals. They cause incidental infections in humans from the following species: Trichostrongylus colubriformis, T. orientalis, T. axei, and T. probolurus.", "PM": "86", "HN": "86", "MR": "20200813", "DA": "19850311", "DC": "1", "DX": "19860101", "UI": "D014254"}, {"RECTYPE": "D", "MH": "Trichothecenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trichothecene Epoxides|T109|T123|NON|NRW|UNK (19XX)|741220|abbcdef", "ENTRY": "Epoxides, Trichothecene", "MN": "D23.946.587.933", "PA": "Poisons", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "PI": "Terpenes (1966-1973)", "MS": "Usually 12,13-epoxytrichothecenes, produced by Fusaria, Stachybotrys, Trichoderma and other fungi, and some higher plants. They may contaminate food or feed grains, induce emesis and hemorrhage in lungs and brain, and damage bone marrow due to protein and DNA synthesis inhibition.", "OL": "use TRICHOTHECENES to search EPOXYTRICHOTHECENES 1975-80", "PM": "91; was see under SESQUITERPENES 1981-90; was EPOXYTRICHOTHECENES see under SESQUITERPENES 1975-80", "HN": "91(81); was see under SESQUITERPENES 1981-90; was EPOXYTRICHOTHECENES see under SESQUITERPENES 1975-80", "MR": "20190705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014255"}, {"RECTYPE": "D", "MH": "Trichotillomania", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Hair Pulling Disorder|T048|NON|EQV|NLM (2024)|230201|abcdef", "ENTRY": "Trichotillomanias", "MN": "F03.250.800", "MH_TH": "OMIM (2013)", "ST": "T048", "MS": "Compulsion to pull out one's hair.", "OL": "use OBSESSIVE-COMPULSIVE DISORDER to search TRICHOTILLOMANIA 1966-74", "PM": "91; was see under OBSESSIVE-COMPULSIVE DISORDER 1981-90; was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; was in Cat F only 1975-79", "HN": "91(75); was see under OBSESSIVE-COMPULSIVE DISORDER 1981-90; was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; was in Cat F only 1975-79", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014256"}, {"RECTYPE": "D", "MH": "Trichuriasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Trichocephaliasis|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Whipworm Infections", "MN": "C01.610.335.508.100.275.895", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with TRICHINELLOSIS, caused by TRICHINA or TRICHINELLA", "MS": "Infection with nematodes of the genus TRICHURIS, formerly called Trichocephalus.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014257"}, {"RECTYPE": "D", "MH": "Trichuris", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Trichuris trichiura|T204|NON|NRW|NLM (1993)|911107|abcdef", "ENTRY": "trichiura, Trichuris", "MN": "B01.050.500.500.294.100.275.780.628", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid36086", "RR": "txid36087", "MS": "A genus of nematode worms comprising the whipworms.", "OL": "search TRICHUROIDEA 1966-71; use TRICHUROIDEA to search TRICHOCEPHALUS 1966-73", "PM": "72; was see under TRICHUROIDEA 1967-71, was see under TRICHINELLOIDEA 1963-66; TRICHOCEPHALUS was see under TRICHUROIDEA 1967-73, was see under TRICHINELLOIDEA 1963-66", "HN": "72; was see under TRICHUROIDEA 1967-71, was see under TRICHINELLOIDEA 1963-66; TRICHOCEPHALUS was see under TRICHURIS 1974-78, was see under TRICHUROIDEA 1967-73, was see under TRICHINELLOIDEA 1963-66", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014258"}, {"RECTYPE": "D", "MH": "Trichuroidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Trichuroideas", "MN": "B01.050.500.500.294.100.275.780", "MH_TH": "NLM (1967)", "ST": "T204", "AN": "a superfamily of nematodes; infection: coord IM with ENOPLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "MS": "A superfamily of nematodes of the order ENOPLIDA. Its organisms have a well developed intestine and rectum.", "OL": "use TRICHUROIDEA to search TRICHINELLOIDEA 1966-92", "PM": "67; was TRICHINELLOIDEA 1963-66; TRICHINELLOIDEA was see TRICHUROIDEA 1967-92", "HN": "67; was TRICHINELLOIDEA 1963-66; TRICHINELLOIDEA was see TRICHUROIDEA 1967-92", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014259"}, {"RECTYPE": "D", "MH": "Triclosan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SterZac Bath Concentrate", "MN": "D02.455.426.559.389.657.654.900", "PA": "Fatty Acid Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Phenol, 5-chloro-2-(2,4-dichlorophenoxy)-", "RN": "4NM5039Y5X", "RR": "3380-34-5 (Triclosan)", "PI": "Phenyl Ethers (1974-1975)", "MS": "A diphenyl ether derivative used in cosmetics and toilet soaps as an antiseptic. It has some bacteriostatic and fungistatic action.", "PM": "1991; see PHENYL ETHERS 1976-1990; for IRGASAN DP 300 see TRICLOSAN 1976-1995, 2,4,4'-TRICHLORO-2'-HYDROXYDIPHENYL ETHER was indexed under TRICLOSAN 1998-2013", "HN": "1991(1976)", "MR": "20160701", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D014260"}, {"RECTYPE": "D", "MH": "Tricuspid Valve", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Valves, Tricuspid", "MN": "A07.541.510.893", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The valve consisting of three cusps situated between the right atrium and right ventricle of the heart.", "MR": "19980611", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014261"}, {"RECTYPE": "D", "MH": "Tricuspid Valve Insufficiency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tricuspid Valve Incompetence|T047|NON|EQV|NLM (1993)|911008|abcdef", "ENTRY": "Valve Regurgitation, Tricuspid", "MN": "C14.280.484.856", "MH_TH": "NLM (1967)", "ST": "T047", "MS": "Backflow of blood from the RIGHT VENTRICLE into the RIGHT ATRIUM due to imperfect closure of the TRICUSPID VALVE.", "OL": "use TRICUSPID VALVE INSUFFICIENCY to search TRICUSPID INSUFFICIENCY 1966", "PM": "67; was TRICUSPID INSUFFICIENCY 1963-66", "HN": "67; was TRICUSPID INSUFFICIENCY 1963-66", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014262"}, {"RECTYPE": "D", "MH": "Tricuspid Valve Prolapse", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Valve Prolapses, Tricuspid", "MN": "C14.280.484.400.875", "MH_TH": "NLM (1983)", "ST": "T047", "PI": "Tricuspid Valve (1966-1982)", "MS": "Abnormal protrusion of one or more of the leaflets of TRICUSPID VALVE into the RIGHT ATRIUM during SYSTOLE. This allows the backflow of blood into right atrium leading to TRICUSPID VALVE INSUFFICIENCY; SYSTOLIC MURMURS. Its most common cause is not primary valve abnormality but rather the dilation of the RIGHT VENTRICLE and the tricuspid annulus.", "PM": "91; was see under HEART VALVE DISEASES 1983-90", "HN": "91(83); was see under HEART VALVE DISEASES 1983-90", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19820426", "DC": "1", "DX": "19910101", "UI": "D014263"}, {"RECTYPE": "D", "MH": "Tricuspid Valve Stenosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Valve Stenosis, Tricuspid", "MN": "C14.280.484.911", "MH_TH": "NLM (1967)", "ST": "T190", "MS": "The pathologic narrowing of the orifice of the TRICUSPID VALVE. This hinders the emptying of RIGHT ATRIUM leading to elevated right atrial pressure and systemic venous congestion. Tricuspid valve stenosis is almost always due to RHEUMATIC FEVER.", "OL": "use TRICUSPID VALVE STENOSIS to search TRICUSPID STENOSIS 1966", "PM": "67; was TRICUSPID STENOSIS 1963-66", "HN": "67; was TRICUSPID STENOSIS 1963-66", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014264"}, {"RECTYPE": "D", "MH": "Triethylenemelamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tretamine|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|800404|abbcdeeef", "ENTRY": "Melamine, Triethylene", "MN": "D03.383.931.915", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "1,3,5-Triazine, 2,4,6-tris(1-aziridinyl)-", "RN": "F7IY6HZG9D", "RR": "51-18-3 (Triethylenemelamine)", "MS": "Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.", "OL": "use TRIETHYLENEMELAMINE to search TRIETHYLENE MELAMINE 1966-80", "PM": "81; was TRIETHYLENE MELAMINE 1963-80", "HN": "81; was TRIETHYLENE MELAMINE 1963-80", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D014265"}, {"RECTYPE": "D", "MH": "Trientine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Triethylenetetramine|T109|T121|T130|NON|EQV|FDA SRS (2014)|NLM (1978)|990101|abbbcdeef", "ENTRY": "Trientine Hydrochloride|T109|T121|T130|NON|NRW|FDA SRS (2014)|NLM (2011)|USAN (19XX)|USP (19XX)|090923|abbbcdeeeef", "MN": "D02.092.782.258.368.880", "PA": "Chelating Agents", "MH_TH": "UNK (19XX)", "ST": "T130", "N1": "1,2-Ethanediamine, N,N'-bis(2-aminoethyl)-", "RN": "SJ76Y07H5F", "RR": "HC3NX54582", "PI": "Piperidines (1966-1974)", "MS": "An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.", "PM": "2011; see TRIETHYLENETETRAMINE 1991-2010, see ETHYLENEDIAMINES 1978-1990", "HN": "2011(1978)", "MR": "20160701", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D014266"}, {"RECTYPE": "D", "MH": "Triethyltin Compounds", "DE": "TRIETHYLTIN CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Triethyltin", "MN": "D02.691.850.900.910", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Tin (1972-1974)", "MS": "Organic compounds composed of tin and three ethyl groups. Affect mitochondrial metabolism and inhibit oxidative phosphorylation by acting directly on the energy conserving processes.", "PM": "91; was see under TRIALKYLTIN COMPOUNDS 1975-90", "HN": "91(75); was see under TRIALKYLTIN COMPOUNDS 1975-90", "MR": "20110624", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D014267"}, {"RECTYPE": "D", "MH": "Trifluoperazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Triftazin|T109|T121|NON|NRW|UNK (19XX)|770111|abbcdef", "ENTRY": "ApoTrifluoperazine", "MN": "D03.633.300.783.898", "PA": "Dopamine Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "10H-Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-", "RN": "214IZI85K3", "RR": "6P1Y2SNF5V", "MS": "A phenothiazine with actions similar to CHLORPROMAZINE. It is used as an antipsychotic and an antiemetic.", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014268"}, {"RECTYPE": "D", "MH": "Trifluoroacetic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trifluoroacetate|T109|NON|NRW|UNK (19XX)|741125|abcdef", "ENTRY": "Trifluoroacetate, Cesium", "MN": "D02.455.526.510.286.500", "EC": "analogs & derivatives:Fluoroacetates", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Acetic acid, trifluoro-", "RN": "E5R8Z4G708", "RR": "76-05-1 (Trifluoroacetic Acid)", "PI": "Fluoroacetates (1972-1974)", "MS": "A very strong halogenated derivative of acetic acid. It is used in acid catalyzed reactions, especially those where an ester is cleaved in peptide synthesis.", "PM": "91; was see under FLUOROACETATES 1975-90", "HN": "91(75); was see under FLUOROACETATES 1975-90", "MR": "20130708", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D014269"}, {"RECTYPE": "D", "MH": "Trifluoroethanol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trifluoroethyl Alcohol|T109|NON|EQV|UNK (19XX)|741125|abcdef", "ENTRY": "Alcohol, Trifluoroethyl", "MN": "D02.033.375.880", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "Ethanol, 2,2,2-trifluoro-", "RN": "75-89-8", "PI": "Fluorine (1972-1974)", "MS": "A non-aqueous co-solvent that serves as tool to study protein folding. It is also used in various pharmaceutical, chemical and engineering applications.", "PM": "91; was see under ALCOHOL, ETHYL 1975-90", "HN": "91(75); was see under ALCOHOL, ETHYL 1975-90", "MR": "20000621", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D014270"}, {"RECTYPE": "D", "MH": "Trifluridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trifluorothymidine|T114|T121|NON|EQV|FDA SRS (2014)|NLM (1992)|901029|abbcdeef", "ENTRY": "5 Trifluoromethyl 2' deoxyuridine", "MN": "D13.570.685.705.900", "PA": "Antiviral Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Thymidine, alpha,alpha,alpha-trifluoro-", "RN": "RMW9V5RW38", "RR": "70-00-8 (Trifluridine)", "PI": "Thymidine (1972-1974)", "MS": "An antiviral derivative of THYMIDINE used mainly in the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to HERPES SIMPLEX virus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p557)", "PM": "1974; see TRIFLUOROTHYMIDINE 1975-1991, see THYMIDINE 1975-1990, 2'-DEOXY-5-(TRIFLUOROMETHYL)URIDINE was indexed under DEOXYURIDINE", "HN": "1974(1992)", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014271"}, {"RECTYPE": "D", "MH": "Trifluperidol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trisedil|T109|T121|TRD|NRW|UNK (19XX)|850103|abbcdef", "MN": "D02.522.352.867", "PA": "Dopamine Antagonists", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "1-Butanone, 1-(4-fluorophenyl)-4-(4-hydroxy-4-(3-(trifluoromethyl)phenyl)-1-piperidinyl)-", "RN": "R8869Q7R8I", "RR": "749-13-3 (Trifluperidol)", "MS": "A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p621)", "PM": "72", "HN": "72(65)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014272"}, {"RECTYPE": "D", "MH": "Triflupromazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluopromazine|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|761230|abbcdeef", "ENTRY": "Trifluopromazine|T109|T121|NON|EQV|NLM (1998)|970226|abbcdef", "MN": "D03.633.300.783.918", "PA": "Dopamine Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "10H-Phenothiazine-10-propanamine, N,N-dimethyl-2-(trifluoromethyl)-", "RN": "RO16TQF95Y", "RR": "146-54-3 (Triflupromazine)", "MS": "A phenothiazine used as an antipsychotic agent and as an antiemetic.", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014273"}, {"RECTYPE": "D", "MH": "Trifluralin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Treflan|T109|T131|TRD|NRW|UNK (19XX)|801120|abbcdef", "MN": "D02.455.426.559.389.832.767", "PA": "Tubulin Modulators", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Benzenamine, 2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)-", "RN": "C8BX46QL7K", "RR": "1582-09-8 (Trifluralin)", "PI": "Toluene (1966-1971)", "MS": "A microtubule-disrupting pre-emergence herbicide.", "PM": "91; was see under TOLUIDINES 1972-90", "HN": "91(72); was see under TOLUIDINES 1972-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014274"}, {"RECTYPE": "D", "MH": "Trigeminal Caudal Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Caudal Nucleus, Trigeminal|T023|NON|EQV|UNK (19XX)|781222|abcdef", "ENTRY": "Nucleus, Trigeminal Caudal", "MN": "A08.186.211.132.931.920.927", "MH_TH": "NLM (1980)", "ST": "T023", "AN": "do not confuse with CAUDATE NUCLEUS (corpus striatum)", "PI": "Trigeminal Nerve (1966-1979)", "MS": "The caudal portion of the nucleus of the spinal trigeminal tract (TRIGEMINAL NUCLEUS, SPINAL), a nucleus involved with pain and temperature sensation.", "PM": "91; was see under TRIGEMINAL NUCLEUS, SPINAL 1982-90; was see under TRIGEMINAL NUCLEI 1980-81", "HN": "91(80); was see under TRIGEMINAL NUCLEUS, SPINAL 1982-90; was see under TRIGEMINAL NUCLEI 1980-81", "MR": "20150623", "DA": "19781222", "DC": "1", "DX": "19910101", "UI": "D014275"}, {"RECTYPE": "D", "MH": "Trigeminal Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Fifth Cranial Nerve|T023|NON|EQV|NLM (1998)|960731|abcdef", "ENTRY": "Trigeminus, Nervus", "MN": "A08.800.800.120.760", "FX": "Trigeminal Neuralgia", "EC": "injuries:Trigeminal Nerve Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The 5th and largest cranial nerve. The trigeminal nerve is a mixed motor and sensory nerve. The larger sensory part forms the ophthalmic, mandibular, and maxillary nerves which carry afferents sensitive to external or internal stimuli from the skin, muscles, and joints of the face and mouth and from the teeth. Most of these fibers originate from cells of the TRIGEMINAL GANGLION and project to the TRIGEMINAL NUCLEUS of the brain stem. The smaller motor part arises from the brain stem trigeminal motor nucleus and innervates the muscles of mastication.", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014276"}, {"RECTYPE": "D", "MH": "Trigeminal Neuralgia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tic Douloureux|T047|NON|EQV|OMIM (2013)|UNK (19XX)|850507|abcdeef", "ENTRY": "Trigeminal Neuralgias", "MN": "C10.292.319.625.700.700", "FX": "Trigeminal Nerve", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "A syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the TRIGEMINAL NERVE. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. (Adams et al., Principles of Neurology, 6th ed, p187)", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014277"}, {"RECTYPE": "D", "MH": "Trigeminal Nuclei", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Trigeminal Nucleus", "MN": "A08.186.211.132.931", "MH_TH": "NLM (1980)", "ST": "T023", "PI": "Trigeminal Nerve (1966-1979)", "MS": "Nuclei of the trigeminal nerve situated in the brain stem. They include the nucleus of the spinal trigeminal tract (TRIGEMINAL NUCLEUS, SPINAL), the principal sensory nucleus, the mesencephalic nucleus, and the motor nucleus.", "PM": "80", "HN": "80", "MR": "20140613", "DA": "19781219", "DC": "1", "DX": "19800101", "UI": "D014278"}, {"RECTYPE": "D", "MH": "Trigeminal Nucleus, Spinal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Spinal Trigeminal Nucleus", "MN": "A08.186.211.132.931.920", "MH_TH": "NLM (1982)", "ST": "T023", "PI": "Trigeminal Nuclei (1980-1981)", "MS": "Nucleus of the spinal tract of the trigeminal nerve. It is divided cytoarchitectonically into three parts: oralis, caudalis (TRIGEMINAL CAUDAL NUCLEUS), and interpolaris.", "PM": "82; TRIGEMINAL CAUDAL NUCLEUS was see under TRIGEMINAL NUCLEI 1980-81", "HN": "82", "MR": "20150623", "DA": "19810520", "DC": "1", "DX": "19820101", "UI": "D014279"}, {"RECTYPE": "D", "MH": "Triglycerides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Triglyceride|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D10.351.801", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "/blood: consider also HYPERTRIGLYCERIDEMIA & the hypertriglyceridemias in HYPERLIPOPROTEINEMIA TYPE I; HYPERLIPOPROTEINEMIA TYPE IV & HYPERLIPOPROTEINEMIA TYPE V", "MS": "An ester formed from GLYCEROL and three fatty acid groups.", "PM": "2001; TRIACYLGLYCEROL was indexed under TRIGLYCERIDES 1976-2000", "HN": "2001(1966); for TRIACYLGLYCEROL use TRIGLYCERIDES (NM) 1976-2000", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014280"}, {"RECTYPE": "D", "MH": "Trihexosylceramides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trihexosyl Ceramides|T109|T123|NON|EQV|UNK (19XX)|780516|abbcdef", "ENTRY": "Trihexosides, Ceramide", "MN": "D10.570.877.360.612.200.906", "MH_TH": "NLM (1979)", "ST": "T123", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Glycosphingolipids (1975-1978)", "MS": "Glycosphingolipids which contain as their polar head group a trisaccharide (galactose-galactose-glucose) moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in ceramide trihexosidase, is the cause of angiokeratoma corporis diffusum (FABRY DISEASE).", "PM": "91; was see under GLYCOSPHINGOLIPIDS 1979-90", "HN": "91(79); was see under GLYCOSPHINGOLIPIDS 1979-90", "MR": "20060705", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D014281"}, {"RECTYPE": "D", "MH": "Trihexyphenidyl", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzhexol|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|750708|abbcdeef", "ENTRY": "ApoTrihex", "MN": "D03.383.621.900", "PA": "Muscarinic Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Piperidinepropanol, alpha-cyclohexyl-alpha-phenyl-", "RN": "6RC5V8B7PO", "RR": "AO61G82577", "MS": "One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.", "MR": "20170502", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014282"}, {"RECTYPE": "D", "MH": "Triiodobenzoic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Triiodobenzoic", "MN": "D02.455.426.559.389.127.375.880", "PA": "Plant Growth Regulators", "MH_TH": "NLM (1972)", "ST": "T109", "RN": "0", "PI": "Plant Growth Regulators (1966-1971)", "MS": "Triiodo-substituted derivatives of BENZOIC ACID.", "OL": "use TRIIODOBENZOIC ACIDS to search TRIIODOBENZOIC ACID 1972-77 (as Prov 1972-74)", "PM": "91; was see under IODOBENZOATES 1978-90; was TRIIODOBENZOIC ACID see under IODOBENZOATES 1975-77", "HN": "91(78); was see under IODOBENZOATES 1978-90; was TRIIODOBENZOIC ACID see under IODOBENZOATES 1972-77 (Prov 1972-74)", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014283"}, {"RECTYPE": "D", "MH": "Triiodothyronine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "T3 Thyroid Hormone|T116|T121|T125|NON|EQV|NLM (2002)|001122|T AAA THYROID HORMONE 003|abbbcdefs", "ENTRY": "Thyroid Hormone, T3", "MN": "D12.125.072.050.767.741.894", "FX": "Receptors, Thyroid Hormone", "MH_TH": "NLM (1966)", "ST": "T125", "N1": "L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-", "RN": "06LU7C9H1V", "RR": "GCA9VV7D2N", "MS": "A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.", "OL": "use TRIIODOTHYRONINE to search LIOTHYRONINE 1966", "PM": "LIOTHYRONINE was heading 1963-66", "HN": "LIOTHYRONINE was heading 1963-66", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D014284"}, {"RECTYPE": "D", "MH": "Triiodothyronine, Reverse", "DE": "REVERSE T3", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Reverse Triiodothyronine|T116|T121|T125|NON|EQV|UNK (19XX)|780315|abbbcdef", "ENTRY": "3,3,5-Triiodothyronine|T116|T121|T125|NON|EQV|UNK (19XX)|840727|abbbcdef", "MN": "D12.125.072.050.767.741.947", "MH_TH": "NLM (1979)", "ST": "T125", "N1": "L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3-iodo-", "RN": "5817-39-0", "PI": "Triiodothyronine (1966-1978)", "MS": "A metabolite of THYROXINE, formed by the peripheral enzymatic monodeiodination of T4 at the 5 position of the inner ring of the iodothyronine nucleus.", "PM": "85; was see under TRIIODOTHYRONINE 1979-84", "HN": "85(79); was see under TRIIODOTHYRONINE 1979-84", "MR": "20010725", "DA": "19780315", "DC": "1", "DX": "19850101", "UI": "D014285"}, {"RECTYPE": "D", "MH": "Trilogy of Fallot", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fallot's Trilogy|T019|EPO|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "Trilogy, Fallot's", "MN": "C16.131.240.400.960", "MH_TH": "NLM (1975)", "ST": "T019", "AN": "do not confuse with TETRALOGY OF FALLOT", "MS": "A combination of congenital heart defects consisting of three key features including ATRIAL SEPTAL DEFECTS; PULMONARY STENOSIS; and RIGHT VENTRICULAR HYPERTROPHY.", "PM": "91; was see under HEART SEPTAL DEFECTS, ATRIAL 1975-90", "HN": "91(75); was see under HEART SEPTAL DEFECTS, ATRIAL 1975-90", "CATSH": "CAT LIST", "MR": "20090819", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D014286"}, {"RECTYPE": "D", "MH": "Trimebutine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TM906", "MN": "D02.455.426.559.389.657.654.638.750", "PA": "Parasympatholytics", "MH_TH": "NLM (1977)", "ST": "T121", "N1": "Benzoic acid, 3,4,5-trimethoxy-, 2-(dimethylamino)-2-phenylbutyl ester", "RN": "QZ1OJ92E5R", "RR": "39133-31-8 (Trimebutine)", "PI": "Butylamines (1966-1976)", "MS": "Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.", "PM": "91; was see under BENZOATES 1977-90", "HN": "91(77); was see under BENZOATES 1977-90", "MR": "20160701", "DA": "19760503", "DC": "1", "DX": "19910101", "UI": "D014287"}, {"RECTYPE": "D", "MH": "Trimecaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Trimecaine", "MN": "D02.092.146.113.092.900", "PA": "Anesthetics, Local", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Acetamide, 2-(diethylamino)-N-(2,4,6-trimethylphenyl)-", "RN": "IN1233R0JO", "RR": "616-68-2 (Trimecaine)", "PI": "Diethylamines (1974)", "MS": "Acetanilide derivative used as a local anesthetic.", "PM": "91; was see under ACETANILIDES 1975-90", "HN": "91(75); was see under ACETANILIDES 1975-90", "MR": "20151124", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014288"}, {"RECTYPE": "D", "MH": "Trimedoxime", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Bromide, Trimedoxime", "MN": "D03.383.725.762.900", "PA": "Cholinesterase Reactivators", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Pyridinium, 1,1'-(1,3-propanediyl)bis(4-(hydroxyimino)methyl)-, dibromide", "RN": "56-97-3", "RR": "ED0GXI9825", "PI": "Pyridinium Compounds (1969-1974)", "MS": "Cholinesterase reactivator used as an antidote in alkyl phosphate poisoning.", "PM": "91; was see under OXIMES 1975-90", "HN": "91(75); was see under OXIMES 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014289"}, {"RECTYPE": "D", "MH": "Metipranolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trimepranol|T109|T121|NON|EQV|NLM (1995)|940424|abbcdef", "ENTRY": "Methypranol|T109|T121|NON|EQV|UNK (19XX)|800813|abbcdef", "MN": "D02.092.063.624.698.542", "PA": "Sympatholytics", "MH_TH": "USAN (1990)", "ST": "T121", "N1": "Phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-2,3,6-trimethyl-, 1-acetate", "RN": "X39AL81KEB", "RR": "22664-55-7 (Metipranolol)", "PI": "Propanolamines (1974-1978)", "MS": "A beta-adrenergic antagonist effective for both beta-1 and beta-2 receptors. It is used as an antiarrhythmic, antihypertensive, and antiglaucoma agent.", "OL": "use METIPRANOLOL to search TRIMEPRANOL 1979-94", "PM": "95; was TRIMEPRANOL 1979-94 (see under PROPANOLAMINES 1979-90); METIPRANOLOL was see TRIMEPRANOL 1986-94", "HN": "95; was TRIMEPRANOL 1979-94 (see under PROPANOLAMINES 1979-90); METIPRANOLOL was see TRIMEPRANOL 1986-94", "MR": "20130708", "DA": "19780208", "DC": "1", "DX": "19910101", "UI": "D014290"}, {"RECTYPE": "D", "MH": "Trimeprazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylpromazine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef", "ENTRY": "Variargil|T109|T121|TRD|NRW|ES|020723|abbcdef", "MN": "D03.633.300.783.939", "PA": "Antipruritics", "MH_TH": "FDA SRS (2014)", "ST": "T121", "N1": "10H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-", "RN": "76H78MJJ52", "RR": "84-96-8 (Trimeprazine)", "MS": "A phenothiazine derivative that is used as an antipruritic.", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014291"}, {"RECTYPE": "D", "MH": "Trimetazidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dihydrochloride, Trimetazidine", "MN": "D03.383.606.920", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Piperazine, 1-((2,3,4-trimethoxyphenyl)methyl)-", "RN": "N9A0A0R9S8", "RR": "5011-34-7 (Trimetazidine)", "PI": "Piperazines (1969-1975)", "MS": "A vasodilator used in angina of effort or ischemic heart disease.", "PM": "91; was see under PIPERAZINES 1976-90", "HN": "91(76); was see under PIPERAZINES 1976-90", "MR": "20170524", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D014292"}, {"RECTYPE": "D", "MH": "Trimethadione", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Troxidone|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|NLM (1995)|940406|abbcdeeef", "MN": "D03.383.129.462.883", "PA": "Anticonvulsants", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4-Oxazolidinedione, 3,5,5-trimethyl-", "RN": "R7GV3H6FQ4", "RR": "127-48-0 (Trimethadione)", "MS": "An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378)", "PM": "91; was see under OXAZOLES 1975-90; see under ANTICONVULSANTS 1963-74", "HN": "91(64); was see under OXAZOLES 1975-90; see under ANTICONVULSANTS 1963-74", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014293"}, {"RECTYPE": "D", "MH": "Trimethaphan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trimetaphan|T109|T121|NON|EQV|UNK (19XX)|770506|abbcdef", "MN": "D03.383.129.308.935", "PA": "Nicotinic Antagonists", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Thieno(1',2':1,2)thieno(3,4-d)imidazol-5-ium, decahydro-2-oxo-1,3-bis(phenylmethyl)-", "RN": "6G8X656T45", "RR": "7187-66-8 (Trimethaphan)", "MS": "A nicotinic antagonist that has been used as a ganglionic blocker in hypertension, as an adjunct to anesthesia, and to induce hypotension during surgery.", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014294"}, {"RECTYPE": "D", "MH": "Trimethoprim", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trimpex|T109|T121|TRD|NRW|UNK (19XX)|861118|abbcdef", "MN": "D03.383.742.906", "PA": "Folic Acid Antagonists", "FX": "Trimethoprim Resistance", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4-Pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)methyl)-", "RN": "AN164J8Y0X", "RR": "738-70-5 (Trimethoprim)", "AN": "consider TRIMETHOPRIM RESISTANCE for nonsusceptibility of bacteria", "PI": "Pyrimidines (1966-1971)", "MS": "A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.", "PM": "1974", "HN": "1974 (1972)", "MR": "20180521", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014295"}, {"RECTYPE": "D", "MH": "Trimethoprim Resistance", "AQ": "DE EH GE IM PH RE", "MN": "G07.690.773.984.269.347.968", "FX": "Trimethoprim", "MH_TH": "NLM (1988)", "ST": "T032", "PI": "Trimethoprim (1972-1987)", "MS": "Nonsusceptibility of bacteria to the action of TRIMETHOPRIM.", "PM": "1988", "HN": "1988", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19870511", "DC": "1", "DX": "19880101", "UI": "D014296"}, {"RECTYPE": "D", "MH": "Trimethylsilyl Compounds", "DE": "TRIMETHYLSILYL CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Trimethylsilyl", "MN": "D02.756.715", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Silicon (1974)", "MS": "Organic silicon derivatives used to characterize hydroxysteroids, nucleosides, and related compounds. Trimethylsilyl esters of amino acids are used in peptide synthesis.", "PM": "91; was see under SILICON 1975-90", "HN": "91(75); was see under SILICON 1975-90", "MR": "20190627", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D014297"}, {"RECTYPE": "D", "MH": "Trimethyltin Compounds", "DE": "TRIMETHYLTIN CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Trimethyltin", "MN": "D02.691.850.900.950", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Tin (1972-1974)", "MS": "Organic compounds composed of tin and three methyl groups. Affect mitochondrial metabolism and inhibit oxidative phosphorylation by acting directly on the energy conserving processes.", "PM": "91; was see under TRIALKYLTIN COMPOUNDS 1975-90", "HN": "91(75); was see under TRIALKYLTIN COMPOUNDS 1975-90", "MR": "20110624", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D014298"}, {"RECTYPE": "D", "MH": "Trimipramine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trimeprimine|T109|T121|NON|EQV|UNK (19XX)|800521|abbcdef", "ENTRY": "TrimipraminNeurazpharm", "MN": "D03.633.300.240.918", "PA": "Antidepressive Agents, Tricyclic", "MH_TH": "USAN (1966)", "ST": "T121", "N1": "5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-", "RN": "6S082C9NDT", "RR": "Y62G268P6X", "MS": "Tricyclic antidepressant similar to IMIPRAMINE, but with more antihistaminic and sedative properties.", "OL": "search DIBENZAZEPINES 1968-74", "PM": "91; was see under DIBENZAZEPINES 1975-90", "HN": "91(75); was see under DIBENZAZEPINES 1975-90", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014299"}, {"RECTYPE": "D", "MH": "Trinidad and Tobago", "DE": "TRINIDAD TOBAGO", "AQ": "EH EP", "PRINT ENTRY": "Tobago|T083|NAM|NRW|UNK (19XX)|780523|abcdef", "ENTRY": "Trinidad|T083|NAM|NRW|UNK (19XX)|780504|abcdef", "MN": "Z01.639.880.900", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "An independent state in the Lesser Antilles in the West Indies, north of Venezuela, comprising the islands of Trinidad and Tobago. Its capital is Port of Spain. Both islands were discovered by Columbus in 1498. The Spanish, English, Dutch, and French figure in their history over four centuries. Trinidad and Tobago united in 1898 and were made part of the British colony of Trinidad and Tobago in 1899. The colony became an independent state in 1962. Trinidad was so named by Columbus either because he arrived on Trinity Sunday or because three mountain peaks suggested the Holy Trinity. Tobago was given the name by Columbus from the Haitian tambaku, pipe, from the natives' habit of smoking tobacco leaves. (Webster's New Geographical Dictionary, 1988, p1228, 1216 & Room, Brewer's Dictionary of Names, 1992, p555, 547)", "OL": "use TRINIDAD AND TOBAGO to search TRINIDAD 1966-78", "HN": "79; was TRINIDAD 1966-78", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19790101", "UI": "D014300"}, {"RECTYPE": "D", "MH": "Trinitrobenzenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trinitrophenyl Compounds|T109|NON|EQV|UNK (19XX)|770401|TRINITROPHENYL CPDS|abcdefv", "ENTRY": "Compounds, Trinitrophenyl", "MN": "D02.640.529.880", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "PI": "Nitrophenols (1966-1976)", "MS": "Benzene derivatives which are substituted with three nitro groups in any position.", "PM": "91; was see under NITROBENZENES 1977-90", "HN": "91(77); was see under NITROBENZENES 1977-90", "MR": "19920520", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D014301"}, {"RECTYPE": "D", "MH": "Trinitrobenzenesulfonic Acid", "DE": "TNBS", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trinitrobenzene Sulfonate|T109|T130|NON|NRW|UNK (19XX)|741111|abbcdef", "ENTRY": "Sulfonate, Trinitrobenzene", "MN": "D02.886.645.600.080.900", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Benzenesulfonic acid, 2,4,6-trinitro-", "RN": "8T3HQG2ZC4", "RR": "5400-70-4 (Na salt)", "PI": "Nitrobenzenes (1971-1974)", "MS": "A reagent that is used to neutralize peptide terminal amino groups.", "PM": "91; was see under NITROBENZENES 1975-90", "HN": "91(75); was see under NITROBENZENES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014302"}, {"RECTYPE": "D", "MH": "Trinitrotoluene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "TNT|T109|T131|ABB|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "2,4,6-Trinitrotoluene|T109|T131|NON|EQV|NLM (2018)|160902|abbcdef", "MN": "D02.455.426.559.389.832.868", "PA": "Explosive Agents", "MH_TH": "NLM (1966)", "ST": "T131", "N1": "Benzene, 2-methyl-1,3,5-trinitro-", "RN": "118-96-7", "MS": "A 2,4,6-trinitrotoluene, which is an explosive chemical that can cause skin irritation and other toxic consequences.", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014303"}, {"RECTYPE": "D", "MH": "Triolein", "AQ": "AA AD AE AG AI AN CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Trioleate, Glycerol", "MN": "D10.351.801.801", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "9-Octadecenoic acid (Z)-, 1,2,3-propanetriyl ester", "RN": "122-32-7", "AN": "a triglyceride", "MS": "(Z)-9-Octadecenoic acid 1,2,3-propanetriyl ester.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014304"}, {"RECTYPE": "D", "MH": "Triose-Phosphate Isomerase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Triosephosphate Mutase|T116|T126|NON|EQV|UNK (19XX)|741125|abbcdef", "ENTRY": "Triose Phosphate Isomerase", "MN": "D08.811.399.475.200.775", "FX": "Anemia, Hemolytic, Congenital Nonspherocytic", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "D-Glyceraldehyde-3-phosphate ketol isomerase", "RN": "EC 5.3.1.1", "RR": "9023-78-3 (CAS RN)", "AN": "/defic: consider also ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC", "PI": "Trioses (1973-1974)", "MS": "An enzyme that catalyzes reversibly the conversion of D-glyceraldehyde 3-phosphate to dihydroxyacetone phosphate. A deficiency in humans causes nonspherocytic hemolytic disease (ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC). EC 5.3.1.1.", "PM": "98; see TRIOSEPHOSPHATE ISOMERASE 1991-97, see CARBOHYDRATE ISOMERASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D014305"}, {"RECTYPE": "D", "MH": "Trioses", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sugars, Three Carbon", "MN": "D09.947.875.894", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Monosaccharide molecules that contain a three carbon backbone.", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014306"}, {"RECTYPE": "D", "MH": "Trioxsalen", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Trioxysalen|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|741111|abbcdeeef", "ENTRY": "NSC71047", "MN": "D03.633.300.770.875", "PA": "Photosensitizing Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "7H-Furo(3,2-g)(1)benzopyran-7-one, 2,5,9-trimethyl-", "RN": "Y6UY8OV51T", "RR": "3902-71-4 (Trioxsalen)", "PI": "Furans (1966-1974)", "MS": "Pigmenting photosensitizing agent obtained from several plants, mainly Psoralea corylifolia. It is administered either topically or orally in conjunction with ultraviolet light in the treatment of vitiligo.", "OL": "use TRIOXSALEN to search TRIOXISALENUM 1982-92", "PM": "91; was see under PSORALENS 1979-90; was see under COUMARINS 1975-78; TRIOXISALENUM was see TRIOXSALEN 1975-92", "HN": "91(75); was see under PSORALENS 1979-90; was see under COUMARINS 1975-78; TRIOXISALENUM was see TRIOXSALEN 1975-92", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014307"}, {"RECTYPE": "D", "MH": "Triparanol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MER29", "MN": "D02.455.426.559.389.875", "PA": "Hypolipidemic Agents", "MH_TH": "INN (19XX)", "ST": "T131", "N1": "Benzeneethanol, 4-chloro-alpha-(4-(2-(diethylamino)ethoxy)phenyl)-alpha-(4-methylphenyl)-", "RN": "63S8C3RXGS", "RR": "78-41-1 (Triparanol)", "MS": "Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts.", "PM": "64", "HN": "64(63)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D014308"}, {"RECTYPE": "D", "MH": "Tripelennamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vetibenzamin|T109|T121|TRD|NRW|DE|060328|abbcdef", "MN": "D03.383.725.050.920", "PA": "Histamine H1 Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1,2-Ethanediamine, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-", "RN": "3C5ORO99TY", "RR": "FWV8GJ56ZN", "MS": "A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.", "MR": "20180301", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014309"}, {"RECTYPE": "D", "MH": "Triplets", "AQ": "CL ED GE HI LJ PX SN", "ENTRY": "Triplet", "MN": "M01.438.768", "MH_TH": "NLM (1966)", "ST": "T099", "AN": "human only: for animals use LITTER SIZE; PREGNANCY, TRIPLET is also available", "MS": "Three individuals derived from three FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014310"}, {"RECTYPE": "D", "MH": "Triprolidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Triprolidine", "MN": "D03.383.725.932", "PA": "Histamine H1 Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pyridine, 2-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, (E)-", "RN": "2L8T9S52QM", "RR": "YAN7R5L890", "MS": "Histamine H1 antagonist used in allergic rhinitis; ASTHMA; and URTICARIA. It is a component of COUGH and COLD medicines. It may cause drowsiness.", "PM": "91; was see under PYRIDINES 1966-90", "HN": "91(66); was see under PYRIDINES 1966-90", "MR": "20170524", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014311"}, {"RECTYPE": "D", "MH": "Trisaccharides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trisaccharide|T109|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D09.698.629.802", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "MS": "Oligosaccharides containing three monosaccharide units linked by glycosidic bonds.", "OL": "search OLIGOSACCHARIDES 1966-74", "PM": "86; was see under OLIGOSACCHARIDES 1966-85", "HN": "86(75); was see under OLIGOSACCHARIDES 1966-85", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D014312"}, {"RECTYPE": "D", "MH": "Trismus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Masseter Muscle Spasm|T033|NON|BRD|NLM (2000)|991103|abcdef", "ENTRY": "Spasms, Masseter Muscle", "MN": "C23.888.592.608.750.700", "FX": "Tetanus", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Spasmodic contraction of the masseter muscle resulting in forceful jaw closure. This may be seen with a variety of diseases, including TETANUS, as a complication of radiation therapy, trauma, or in association with neoplastic conditions.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014313"}, {"RECTYPE": "D", "MH": "Trisomy", "AQ": "DI GE IM PA PP", "PRINT ENTRY": "Partial Trisomy|T019|NON|NRW|NLM (2011)|100301|abcdef", "ENTRY": "Trisomy, Partial", "MN": "G05.700.131.750", "MH_TH": "NLM (1963)", "ST": "T019", "AN": "coordinate IM with specific chromosome number (IM); TRISOMY 21 see DOWN SYNDROME is also available", "MS": "The possession of a third chromosome of any one type in an otherwise diploid cell.", "PM": "64", "HN": "64(63)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D014314"}, {"RECTYPE": "D", "MH": "Triterpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Triterpenoid|T109|NON|EQV|NLM (2021)|191129|abcdef", "ENTRY": "Triterpenoids|T109|NON|EQV|NLM (2020)|180917|abcdef", "MN": "D02.455.849.919", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units.", "PM": "74", "HN": "74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014315"}, {"RECTYPE": "D", "MH": "Tritium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Hydrogen 3", "MN": "D01.496.749.925", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Tritium", "RN": "10028-17-8", "MS": "The radioactive isotope of hydrogen also known as hydrogen-3. It contains two NEUTRONS and one PROTON in its nucleus and decays to produce low energy BETA PARTICLES.", "MR": "20170414", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014316"}, {"RECTYPE": "D", "MH": "Tritolyl Phosphates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tricresyl Phosphates|T109|NON|EQV|UNK (19XX)|780519|abcdef", "ENTRY": "Phosphates, Tritolyl", "MN": "D02.705.400.875", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Organophosphorus Compounds (1972-1974)", "MS": "A mixture of isomeric tritolyl phosphates. Used in the sterilization of certain surgical instruments and in many industrial processes.", "OL": "use TRITOLYL PHOSPHATES to search TRITOLYL PHOSPHATE 1975-78", "PM": "91; was see under CRESOLS 1979-90; was TRITOLYL PHOSPHATE see under CRESOLS 1975-78", "HN": "91(79); was see under CRESOLS 1979-90; was TRITOLYL PHOSPHATE see under CRESOLS 1975-78", "MR": "20120703", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014317"}, {"RECTYPE": "D", "MH": "Tritrichomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Tritrichomona", "MN": "B01.630.800.849", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid5723", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Mastigophora (1966-1971)", "MS": "A genus of flagellate EUKARYOTES possessing three long anterior flagella.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014318"}, {"RECTYPE": "D", "MH": "Triturus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.090.608.700.670", "MH_TH": "NLM (1972)", "ST": "T011", "RN": "txid8322", "AN": "NIM when experimental animal", "PI": "Urodela (1966-1971)", "MS": "A genus of aquatic newts in the Salamandridae family. During breeding season many Triturus males have a dorsal crest which also serves as an accessory respiratory organ. One of the common Triturus species is Triturus cristatus (crested newt).", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014319"}, {"RECTYPE": "D", "MH": "Trityl Compounds", "DE": "TRITYL CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Triphenylmethyl Compounds|T109|NON|EQV|UNK (19XX)|770401|TRIPHENYLMETHYL CPDS|abcdefv", "ENTRY": "Compounds, Trityl", "MN": "D02.455.426.559.389.884", "MH_TH": "NLM (1974)", "ST": "T109", "RN": "0", "MS": "Derivatives of triphenylmethane.", "PM": "74", "HN": "74", "MR": "20161129", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014320"}, {"RECTYPE": "D", "MH": "Trochlear Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Fourth Cranial Nerve|T023|NON|EQV|NLM (1998)|960731|abcdef", "ENTRY": "Trochlear Nerves", "MN": "A08.800.800.120.800", "EC": "injuries:Trochlear Nerve Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The 4th cranial nerve. The trochlear nerve carries the motor innervation of the superior oblique muscles of the eye.", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014321"}, {"RECTYPE": "D", "MH": "Troglotrematidae", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.736.715.800", "MH_TH": "NLM (1982)", "ST": "T204", "RN": "txid34502", "AN": "a family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Trematoda (1966-1997)", "MS": "A family of flukes (TREMATODA) usually under 10 mm in length, some being only 1 or 2 mm long. In general they are thick, spinous, or scaly flukes having an oval outline and living in various organs and sinuses of birds and mammals. The genus with the greatest interest is PARAGONIMUS. (From Noble et al., Parasitology: the Biology of Animal Parasites, 6th ed, p191)", "PM": "98", "HN": "98; use explode 1982-97", "MR": "20200813", "DA": "19810515", "DC": "1", "DX": "19980101", "UI": "D014322"}, {"RECTYPE": "D", "MH": "Trombiculiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Trombiculiases", "MN": "C01.610.858.211.480.869", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "mite infestation", "MS": "Infestation with mites of the genus Trombicula, whose larvae carry the rickettsial agent of scrub typhus.", "OL": "search MITE INFESTATIONS 1968-74", "PM": "91; was see under MITE INFESTATIONS 1975-90", "HN": "91(75); was see under MITE INFESTATIONS 1975-90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014323"}, {"RECTYPE": "D", "MH": "Trombiculidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Trombiculid Mites|T204|NON|EQV|NLM (1975)|990101|abcdef", "ENTRY": "Trombiculid Mite", "MN": "B01.050.500.131.166.132.419.875", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid92251", "RR": "txid279271", "MS": "Family of MITES in the superfamily Trombiculoidea, suborder Prostigmata, which attack humans and other vertebrates, causing DERMATITIS and severe allergic reactions. Chiggers, red bugs, and harvest mites commonly refer to the larval stage of Trombiculid mites, the only parasitic stage of the mite's life cycle.", "PM": "91; was see under MITES 1975-90", "HN": "91(75); was see under MITES 1975-90", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D014324"}, {"RECTYPE": "D", "MH": "Tromethamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trometamol|T109|T121|T130|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|770429|abbbcdeeef", "ENTRY": "Trizma|T109|T121|T130|TRD|NRW|NLM (1998)|961120|abbbcdef", "MN": "D02.033.455.706.900", "PA": "Excipients", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "1,3-Propanediol, 2-amino-2-(hydroxymethyl)-", "RN": "023C2WHX2V", "RR": "77-86-1 (Tromethamine)", "MS": "An organic amine proton acceptor. It is used in the synthesis of surface-active agents and pharmaceuticals; as an emulsifying agent for cosmetic creams and lotions, mineral oil and paraffin wax emulsions, as a biological buffer, and used as an alkalizer. (From Merck, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p1424)", "PM": "65", "HN": "65", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014325"}, {"RECTYPE": "D", "MH": "Tropanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Azabicyclo(3.2.1)Octanes|T109|NON|BRD|NLM (2008)|060711|abcdef", "MN": "D03.605.869", "MH_TH": "NLM (1969)", "ST": "T109", "RN": "0", "PI": "Scopolamine (1966-1968)", "MS": "N-methyl-8-azabicyclo[3.2.1]octanes best known for the ones found in PLANTS.", "OL": "search NORTROPANES 1966-68", "PM": "69; was see under NORTROPANES 1963-68; HOMATROPINE was see under BELLADONNA 1963-68", "HN": "69; was see under NORTROPANES 1963-68", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D014326"}, {"RECTYPE": "D", "MH": "Trophoblasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Syncytiotrophoblasts|T018|NON|NRW|NLM (2003)|011011|abcdef", "ENTRY": "Syncytiotrophoblast", "MN": "A16.710.802", "MH_TH": "NLM (2003)", "ST": "T018", "MS": "Cells lining the outside of the BLASTOCYST. After binding to the ENDOMETRIUM, trophoblasts develop into two distinct layers, an inner layer of mononuclear cytotrophoblasts and an outer layer of continuous multinuclear cytoplasm, the syncytiotrophoblasts, which form the early fetal-maternal interface (PLACENTA).", "PM": "68", "HN": "68(64)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014327"}, {"RECTYPE": "D", "MH": "Trophoblastic Neoplasms", "DE": "TROPHOBLASTIC NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Trophoblastic Tumor|T191|NON|EQV|NLM (1994)|930329|abcdef", "ENTRY": "Tumors, Trophoblastic", "MN": "C12.050.703.720.949", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "= \"trophoblastic disease\"; coord IM with UTERINE NEOPLASMS (IM); check the tags FEMALE & PREGNANCY if needed", "MS": "Trophoblastic growth, which may be gestational or nongestational in origin. Trophoblastic neoplasia resulting from pregnancy is often described as gestational trophoblastic disease to distinguish it from germ cell tumors which frequently show trophoblastic elements, and from the trophoblastic differentiation which sometimes occurs in a wide variety of epithelial cancers. Gestational trophoblastic growth has several forms, including HYDATIDIFORM MOLE and CHORIOCARCINOMA. (From Holland et al., Cancer Medicine, 3d ed, p1691)", "OL": "use TROPHOBLASTIC NEOPLASMS to search TROPHOBLASTIC TUMOR 1966-93", "PM": "94; was TROPHOBLASTIC TUMOR 1963-93", "HN": "94; was TROPHOBLASTIC TUMOR 1963-93", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D014328"}, {"RECTYPE": "D", "MH": "Tropical Climate", "AQ": "AE", "ENTRY": "Tropical Climates", "MN": "N06.230.300.100.250.600", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "specify geog if pertinent", "MS": "A climate which is typical of equatorial and tropical regions, i.e., one with continually high temperatures with considerable precipitation, at least during part of the year. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014329"}, {"RECTYPE": "D", "MH": "Tropical Medicine", "DE": "TROPICAL MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Tropical|T091|NON|EQV|NLM (1991)|891205|MED TROPICAL|abcdefv", "MN": "H02.403.879", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use for the specialty only; \"tropical diseases\" when very general but avoid: prefer specific diseases", "MS": "The branch of medicine concerned with diseases, mainly of parasitic origin, common in tropical and subtropical regions.", "MR": "20121210", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014330"}, {"RECTYPE": "D", "MH": "Tropicamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "OcuTropic", "MN": "D03.383.725.942", "PA": "Mydriatics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzeneacetamide, N-ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)-", "RN": "N0A3Z5XTC6", "RR": "92934-64-0", "PI": "Pyridines (1966-1978)", "MS": "One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.", "PM": "91; was see under PYRIDINES 1979-90", "HN": "91(79); was see under PYRIDINES 1979-90", "MR": "20170524", "DA": "19780208", "DC": "1", "DX": "19910101", "UI": "D014331"}, {"RECTYPE": "D", "MH": "Tropocollagen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.860.300.250.700", "MH_TH": "NLM (1972)", "ST": "T123", "RN": "0", "PI": "Collagen (1966-1971)", "MS": "The molecular unit of collagen fibrils that consist of repeating three-stranded polypeptide units arranged head to tail in parallel bundles. It is a right-handed triple helix composed of 2 polypeptide chains. It is rich in glycine, proline, hydroxyproline, and hydroxylysine.", "PM": "72", "HN": "72", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014332"}, {"RECTYPE": "D", "MH": "Tropoelastin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tropoelastin b|T116|T123|NON|NRW|UNK (19XX)|810728|abbcdef", "MN": "D12.776.860.300.350.700", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "a protein precursor; /biosyn /physiol permitted", "PI": "Protein Precursors (1973-1976)", "MS": "A salt-soluble precursor of elastin. Lysyl oxidase is instrumental in converting it to elastin in connective tissue.", "PM": "91; was see under ELASTIN 1977-90", "HN": "91(77); was see under ELASTIN 1977-90", "MR": "20040707", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D014333"}, {"RECTYPE": "D", "MH": "Tropolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.392.368.284.900", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "2,4,6-Cycloheptatrien-1-one, 2-hydroxy-", "RN": "7L6DL16P1T", "RR": "533-75-5 (Tropolone)", "PI": "Cycloheptanes (1970-1974)", "MS": "A seven-membered aromatic ring compound. It is structurally related to a number of naturally occurring antifungal compounds (ANTIFUNGAL AGENTS).", "PM": "91; was see under CYCLOHEPTANES 1975-90", "HN": "91(75); was see under CYCLOHEPTANES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014334"}, {"RECTYPE": "D", "MH": "Tropomyosin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Paramyosin|T116|NON|NRW|UNK (19XX)|760324|abcdef", "ENTRY": "gamma Tropomyosin", "MN": "D12.776.220.525.800", "FX": "Cardiomyopathy, Hypertrophic, Familial", "MH_TH": "NLM (1971)", "ST": "T123", "RN": "0", "AN": "a muscle protein; /biosyn /physiol permitted", "PI": "Muscle Proteins (1966-1970)", "MS": "A protein found in the thin filaments of muscle fibers. It inhibits contraction of the muscle unless its position is modified by TROPONIN.", "PM": "74", "HN": "74(71)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014335"}, {"RECTYPE": "D", "MH": "Troponin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Troponins|T116|T123|NON|EQV|NLM (2017)|160519|abbcdef", "MN": "D12.776.220.525.825", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "AN": "TROPONIN C; TROPONIN I; & TROPONIN T are also available", "PI": "Muscle Proteins (1973-1974)", "MS": "One of the minor protein components of skeletal and cardiac muscles. It functions as the calcium-binding component in a complex with BETA-TROPOMYOSIN; ACTIN; and MYOSIN and confers calcium sensitivity to the cross-linked actin and myosin filaments. Troponin itself is a complex of three regulatory proteins (TROPONIN C; TROPONIN I; and TROPONIN T).", "PM": "84; was see under MUSCLE PROTEINS 1975-83", "HN": "84(75); was see under MUSCLE PROTEINS 1975-83", "MR": "20181102", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D014336"}, {"RECTYPE": "D", "MH": "Trout", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Salvelinus|T013|NON|NRW|UNK (19XX)|860415|abcdef", "ENTRY": "Char", "MN": "B01.050.150.900.493.817.750.825", "MH_TH": "NLM (1975)", "ST": "T013", "RR": "txid8033", "AN": "genera Oncorhynchus and Salmo may be either salmon or trout; check text", "MS": "Various fish of the family SALMONIDAE, usually smaller than salmon. They are mostly restricted to cool clear freshwater. Some are anadromous. They are highly regarded for their handsome colors, rich well-flavored flesh, and gameness as an angling fish. The genera Salvelinus, Salmo, and ONCORHYNCHUS have been introduced virtually throughout the world.", "PM": "1991; see SALMONIDAE 1968-1990", "HN": "1991(1975); use SALMONIDAE 1968-1974", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014337"}, {"RECTYPE": "D", "MH": "Truncus Arteriosus", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Arteriosus, Truncus", "MN": "A16.378.303.930", "MH_TH": "NLM (1977)", "ST": "T018", "PI": "Pulmonary Artery (1966-1976)", "MS": "The arterial trunk arising from the fetal heart. During development, it divides into AORTA and the PULMONARY ARTERY.", "PM": "77", "HN": "77", "MR": "20070709", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D014338"}, {"RECTYPE": "D", "MH": "Truncus Arteriosus, Persistent", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Truncus Arteriosus Communis|T019|NON|EQV|OMIM (2013)|ORD (2010)|210308|abcdeef", "ENTRY": "Truncus Arteriosus Communi", "MN": "C16.131.240.400.560.098.500", "MH_TH": "NLM (1977)", "ST": "T019", "PI": "Heart Defects, Congenital (1966-1976)", "MS": "A congenital anomaly caused by the failed development of TRUNCUS ARTERIOSUS into separate AORTA and PULMONARY ARTERY. It is characterized by a single arterial trunk that forms the outlet for both HEART VENTRICLES and gives rise to the systemic, pulmonary, and coronary arteries. It is always accompanied by a ventricular septal defect.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19760519", "DC": "1", "DX": "19770101", "UI": "D014339"}, {"RECTYPE": "D", "MH": "Trusses", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "MN": "E07.858.925", "MH_TH": "NLM (1966)", "ST": "T074", "MS": "A surgical device designed for retaining a hernia in a reduced state within the abdominal cavity.", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014340"}, {"RECTYPE": "D", "MH": "Trustees", "AQ": "CL EC ES HI LJ OG PX SD SN ST TD", "ENTRY": "Trustee", "MN": "N04.452.394.600", "MH_TH": "NLM (1980)", "ST": "T097", "PI": "Governing Board (1968-1979)", "MS": "Board members of an institution or organization who are entrusted with the administering of funds and the directing of policy.", "OL": "search GOVERNING BOARD 1968-79", "PM": "91; was see under GOVERNING BOARD 1980-90; was see GOVERNING BOARD 1968-79", "HN": "91(80); was see under GOVERNING BOARD 1980-90; was see GOVERNING BOARD 1968-79", "MR": "20180629", "DA": "19790529", "DC": "1", "DX": "19910101", "UI": "D014341"}, {"RECTYPE": "D", "MH": "Truth Disclosure", "AQ": "ES", "PRINT ENTRY": "Disclosure, Truth|T055|NON|EQV|UNK (19XX)|770420|abcdef", "ENTRY": "Truth Disclosures", "MN": "I01.880.604.583.080.134.800", "FX": "Risk Management", "MH_TH": "BIOETHICS (1974)", "ST": "T055", "AN": "DISCLOSURE is also available", "PI": "Truth Disclosure (1974-2001)", "MS": "Truthful revelation of information, specifically when the information disclosed is likely to be psychologically painful (\"bad news\") to the recipient (e.g., revelation to a patient or a patient's family of the patient's DIAGNOSIS or PROGNOSIS) or embarrassing to the teller (e.g., revelation of medical errors).", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20150109", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D014342"}, {"RECTYPE": "D", "MH": "Trypan Blue", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Blue, Trypan", "MN": "D04.615.638.555.875", "PA": "Coloring Agents", "MH_TH": "NLM (1966)", "ST": "T130", "N1": "2,7-Naphthalenedisulfonic acid, 3,3'-((3,3'-dimethyl(1,1'-biphenyl)-4,4'-diyl)bis(azo))bis(5-amino-4-hydroxy-), tetrasodium salt", "RN": "I2ZWO3LS3M", "RR": "72-57-1 (Trypan Blue)", "MS": "A diazo-naphthalene sulfonate that is widely used as a stain.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014343"}, {"RECTYPE": "D", "MH": "Trypanocidal Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Drugs, Trypanocidal", "MN": "D27.505.954.122.250.100.875", "MH_TH": "NLM (1972)", "ST": "T121", "RN": "0", "AN": "consider also TRYPANOSOMA /drug eff & TRYPANOSOMIASIS /drug ther or pertinent specifics", "PI": "specific disease (1966-1971)", "MS": "Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA.", "PM": "74", "HN": "74(72)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014344"}, {"RECTYPE": "D", "MH": "Trypanosoma", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Nannomonas|T204|NON|NRW|NLM (1997)|960531|abcdef", "ENTRY": "Trypanosome", "MN": "B01.268.475.868.887", "FX": "Trypanocidal Agents", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid5690", "RR": "txid47569", "MS": "A genus of flagellate protozoans found in the BLOOD and LYMPH of vertebrates and invertebrates, both hosts being required to complete the life cycle.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014345"}, {"RECTYPE": "D", "MH": "Trypanosoma brucei brucei", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Trypanosoma brucei|T204|NON|EQV|UNK (19XX)|830620|abcdef", "ENTRY": "bruceus, Trypanosoma brucei", "MN": "B01.268.475.868.887.080", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid5702", "AN": "causes nagana and also TRYPANOSOMIASIS, BOVINE in African cattle or TRYPANOSOMIASIS, AFRICAN /vet in African game animals; infection: coord IM with TRYPANOSOMIASIS, AFRICAN (IM) but see note there for entry term NAGANA see TRYPANOSOMIASIS, AFRICAN; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN", "PI": "Trypanosoma (1966-1971)", "MS": "A hemoflagellate subspecies of parasitic protozoa that causes nagana in domestic and game animals in Africa. It apparently does not infect humans. It is transmitted by bites of tsetse flies (Glossina).", "OL": "use TRYPANOSOMA BRUCEI BRUCEI to search TRYPANOSOMA BRUCEI 1972-83", "PM": "84; was TRYPANOSOMA BRUCEI 1972-83", "HN": "84; was TRYPANOSOMA BRUCEI 1972-83", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014346"}, {"RECTYPE": "D", "MH": "Trypanosoma brucei gambiense", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Trypanosoma gambiense|T204|NON|EQV|UNK (19XX)|830620|abcdef", "ENTRY": "gambienses, Trypanosoma", "MN": "B01.268.475.868.887.110", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid31285", "AN": "causes Gambian or West African sleeping sickness in several parts of Africa; infection: coord IM with TRYPANOSOMIASIS, AFRICAN (IM); for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN", "PI": "Trypanosoma (1966-1971)", "MS": "A hemoflagellate subspecies of parasitic protozoa that causes Gambian or West African sleeping sickness in humans. The vector host is usually the tsetse fly (Glossina).", "OL": "use TRYPANOSOMA BRUCEI GAMBIENSE to search TRYPANOSOMA GAMBIENSE 1972-83", "PM": "84; was TRYPANOSOMA GAMBIENSE 1972-83", "HN": "84; was TRYPANOSOMA GAMBIENSE 1972-83", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014347"}, {"RECTYPE": "D", "MH": "Trypanosoma congolense", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Trypanosoma (Nannomonas) congolense|T204|NON|EQV|NLM (1997)|960531|abcdef", "ENTRY": "congolense, Trypanosoma", "MN": "B01.268.475.868.887.128", "MH_TH": "NLM (1984)", "ST": "T204", "RN": "txid5692", "AN": "infection: coord IM with TRYPANOSOMIASIS, AFRICAN (IM); for antigens, coord with ANTIGENS, PROTOZOAN for antibodies, coord with ANTIBODIES, PROTOZOAN", "PI": "Trypanosoma (1966-1983)", "MS": "A species of Trypanosome hemoflagellates that is carried by tsetse flies and causes severe anemia in cattle. These parasites are also found in horses, sheep, goats, and camels.", "PM": "84", "HN": "84", "MR": "20200813", "DA": "19830606", "DC": "1", "DX": "19840101", "UI": "D014348"}, {"RECTYPE": "D", "MH": "Trypanosoma cruzi", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "cruzi, Trypanosoma", "MN": "B01.268.475.868.887.140", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid5693", "PI": "Trypanosoma (1966-1971)", "MS": "The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014349"}, {"RECTYPE": "D", "MH": "Trypanosoma lewisi", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "lewisus, Trypanosoma", "MN": "B01.268.475.868.887.410", "MH_TH": "NLM (1972)", "ST": "T204", "RN": "txid5695", "AN": "in rats; infection: coord IM with TRYPANOSOMIASIS (IM); for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN", "PI": "Trypanosoma (1966-1971)", "MS": "A trypanosome found in the blood of adult rats and transmitted by the rat flea. It is generally non-pathogenic in adult rats but can cause lethal infection in suckling rats.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014350"}, {"RECTYPE": "D", "MH": "Trypanosomatina", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Trypanosomatidae|T204|NON|EQV|NLM (1992)|910305|abcdef", "ENTRY": "Trypanosomatinas", "MN": "B01.268.475.868", "MH_TH": "NLM (1986)", "ST": "T204", "RR": "txid5714", "AN": "infection: coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Trypanosoma (1966-1985)", "MS": "A suborder of monoflagellate parasitic protozoa that lives in the blood and tissues of man and animals. Representative genera include: Blastocrithidia, Leptomonas, CRITHIDIA, Herpetomonas, LEISHMANIA, Phytomonas, and TRYPANOSOMA. Species of this suborder may exist in two or more morphologic stages formerly named after genera exemplifying these forms - amastigote (LEISHMANIA), choanomastigote (CRITHIDIA), promastigote (Leptomonas), opisthomastigote (Herpetomonas), epimastigote (Blastocrithidia), and trypomastigote (TRYPANOSOMA).", "OL": "use TRYPANOSOMATINA to search TRYPANOSOMATIDAE 1986-91", "PM": "92; was TRYPANOSOMATIDAE 1986-91", "HN": "92; was TRYPANOSOMATIDAE 1986-91", "MR": "20200902", "DA": "19850311", "DC": "1", "DX": "19860101", "UI": "D014351"}, {"RECTYPE": "D", "MH": "Trypanosomiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Trypanosomiases", "MN": "C01.610.752.300.900", "FX": "Trypanocidal Agents", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with NEGLECTED DISEASES if pertinent", "MS": "Infection with protozoa of the genus TRYPANOSOMA.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014352"}, {"RECTYPE": "D", "MH": "Trypanosomiasis, African", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Nagana|T047|NON|NRW|NLM (1995)|940324|abcdef", "ENTRY": "Trypanosomiases, African", "MN": "C01.920.937", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "for trypanosomiasis in tropical Africa caused by any species of Trypanosoma; coordinate with NEGLECTED DISEASES if pertinent; coordinate IM with TRYPANOSOMA BRUCEI GAMBIENSE (IM) for Gambian trypanosomiasis; entry term NAGANA: coordinate TRYPANOSOMIASIS, AFRICAN /vet (IM) with specific Trypanosoma species (IM) + animal disease term (IM) + specific animal (IM or NIM) + check tag ANIMALS; specify geographic term pertinent", "MS": "A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces \"African sleeping sickness.\" Nagana is a rapidly fatal trypanosomiasis of horses and other animals.", "OL": "use TRYPANOSOMIASIS, AFRICAN to search NAGANA 1975-94; use TRYPANOSOMIASIS, AFRICAN/VE 1972-74; use TRYPANOSOMIASIS, BOVINE 1968-72", "PM": "NAGANA was heading 1991-94; was see under TRYPANOSOMIASIS, AFRICAN 1973-90; was see under TRYPANOSOMIASIS, BOVINE 1968-mid 72", "HN": "NAGANA was heading 1991-94; was see under TRYPANOSOMIASIS, AFRICAN 1973-90; was see under TRYPANOSOMIASIS, BOVINE 1968-mid 72", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D014353"}, {"RECTYPE": "D", "MH": "Trypanosomiasis, Bovine", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Trypanosomiases, Bovine", "MN": "C22.674.710.896", "MH_TH": "NLM (1968)", "ST": "T047", "AN": "don't forget also CATTLE (NIM) & check tag ANIMALS; coord IM with specific type of trypanosomiasis /vet (NIM)", "PI": "Trypanosomiasis, African (1966-1967)", "MS": "Infection in cattle caused by various species of trypanosomes.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014354"}, {"RECTYPE": "D", "MH": "Chagas Disease", "DE": "CHAGAS DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Trypanosomiasis, South American|T047|EPO|EQV|NLM (1992)|910204|abcdef", "ENTRY": "Trypanosomiasis, American", "MN": "C01.920.625", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent; CHAGAS CARDIOMYOPATHY is also available.", "MS": "Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.", "OL": "use CHAGAS DISEASE to search TRYPANOSOMIASIS, SOUTH AMERICAN 1966-91", "PM": "92; was TRYPANOSOMIASIS, SOUTH AMERICAN 1966-91; CHAGAS DISEASE was see TRYPANOSOMIASIS, SOUTH AMERICAN 1981-91", "HN": "92; was TRYPANOSOMIASIS, SOUTH AMERICAN 1966-91; CHAGAS DISEASE was see TRYPANOSOMIASIS, SOUTH AMERICAN 1981-91", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19920101", "UI": "D014355"}, {"RECTYPE": "D", "MH": "Trypsin", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Trypsin", "MN": "D08.811.277.656.959.350.895", "EC": "antagonists & inhibitors:Trypsin Inhibitors", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.4.21.4", "MS": "A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014357"}, {"RECTYPE": "D", "MH": "Trypsin Inhibitor, Bowman-Birk Soybean", "DE": "TRYPSIN INHIB BOWMAN", "AQ": "AD AE AG AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Bowman-Birk Soybean Trypsin Inhibitor|T116|T121|T123|EPO|EQV|UNK (19XX)|770401|BOWMAN BIRK SOYBEAN TRYPSIN INHIB|abbbcdefv", "ENTRY": "Bowman Birk Soybean Trypsin Inhibitor", "MN": "D12.776.765.741.500", "PA": "Trypsin Inhibitors", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Soy Beans (1972-1974)", "MS": "A low-molecular-weight protein (minimum molecular weight 8000) which has the ability to inhibit trypsin as well as chymotrypsin at independent binding sites. It is characterized by a high cystine content and the absence of glycine.", "PM": "91; was see under TRYPSIN INHIBITORS 1975-90", "HN": "91(75); was see under TRYPSIN INHIBITORS 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014358"}, {"RECTYPE": "D", "MH": "Trypsin Inhibitor, Kazal Pancreatic", "DE": "TRYPSIN INHIB KAZAL", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Trypsin Inhibitor, Pancreatic Secretory|T116|T121|T123|NON|EQV|NLM (2020)|190429|abbbcdef", "ENTRY": "Tumor Associated Trypsin Inhibitor", "MN": "D12.776.815.688.500", "FX": "Kazal Motifs", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "50936-63-5", "PI": "Trypsin Inhibitors (1972-1974)", "MS": "A secreted KAZAL MOTIF-containing serine peptidase inhibitor that inhibits TRYPSIN. It is a protein composed of 56 amino acid residues and is different in amino acid composition and physiological activity from the Kunitz bovine pancreatic trypsin inhibitor (APROTININ). It protects against the trypsin-mediated premature activation of ENZYME PRECURSORS in the PANCREAS. Mutations in the SPINK1 gene are associated with CHRONIC PANCREATITIS.", "PM": "91; was see under TRYPSIN INHIBITORS 1975-90", "HN": "91(75); was see under TRYPSIN INHIBITORS 1975-90", "MR": "20220712", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014359"}, {"RECTYPE": "D", "MH": "Trypsin Inhibitor, Kunitz Soybean", "DE": "TRYPSIN INHIB KUNITZ", "AQ": "AD AE AG AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Kunitz Soybean Trypsin Inhibitor|T116|T121|T123|EPO|EQV|UNK (19XX)|770401|KUNITZ SOYBEAN TRYPSIN INHIB|abbbcdefv", "ENTRY": "Trypsin Inhibitor DE 3", "MN": "D12.776.765.741.750", "PA": "Trypsin Inhibitors", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Trypsin inhibitor, Kunitz soybean", "RN": "9088-41-9", "PI": "Soybeans (1972-1974)", "MS": "A high-molecular-weight protein (approximately 22,500) containing 198 amino acid residues. It is a strong inhibitor of trypsin and human plasmin.", "PM": "91; was see under TRYPSIN INHIBITORS 1975-90", "HN": "91(75); was see under TRYPSIN INHIBITORS 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014360"}, {"RECTYPE": "D", "MH": "Trypsin Inhibitors", "DE": "TRYPSIN INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trypsin Inhibitor|T121|T123|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Inhibitors, Trypsin", "MN": "D27.505.519.389.745.800.900", "MH_TH": "NLM (1965)", "ST": "T123", "RN": "0", "MS": "Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds.", "PM": "65", "HN": "65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014361"}, {"RECTYPE": "D", "MH": "Trypsinogen", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Trypsinogen 1|T116|T123|NON|NRW|UNK (19XX)|840918|abbcdef", "MN": "D12.776.811.243.885", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Trypsinogen", "RN": "9002-08-8", "AN": "an enzyme precursor; /defic: consider also MALABSORPTION SYNDROMES (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM)", "MS": "The inactive proenzyme of trypsin secreted by the pancreas, activated in the duodenum via cleavage by enteropeptidase. (Stedman, 25th ed)", "MR": "20190530", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014362"}, {"RECTYPE": "D", "MH": "Tryptamines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Triptan|T109|T121|NON|NRW|NLM (2021)|191115|abbcdef", "ENTRY": "Triptans|T109|T121|NON|NRW|NLM (2006)|050418|abbcdef", "MN": "D03.633.100.473.914", "FX": "Receptors, Serotonin", "MH_TH": "NLM (1964)", "ST": "T123", "RN": "0", "MS": "Decarboxylated monoamine derivatives of TRYPTOPHAN.", "PM": "66; METHOXYDIMETHYLTRYPTAMINES was see under SEROTONIN 1980-88", "HN": "66(64)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014363"}, {"RECTYPE": "D", "MH": "Tryptophan", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "ratio Tryptophan", "MN": "D12.125.142.875", "PA": "Antidepressive Agents, Second-Generation", "FX": "Eosinophilia-Myalgia Syndrome", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "Tryptophan", "RN": "8DUH1N11BX", "RR": "73-22-3 (Tryptophan)", "MS": "An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014364"}, {"RECTYPE": "D", "MH": "Tryptophan Hydroxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tryptophan Monooxygenase|T116|T126|NON|EQV|UNK (19XX)|770205|abbcdef", "ENTRY": "Monooxygenase, Tryptophan", "MN": "D08.811.682.690.708.870", "FX": "Tryptophan Oxygenase", "MH_TH": "NLM (1973)", "ST": "T126", "N1": "L-tryptophan,tetrahydropteridine:oxygen oxidoreductase (5-hydroxylating)", "RN": "EC 1.14.16.4", "PI": "Hydroxylases (1966-1972)", "MS": "An enzyme that catalyzes the hydroxylation of TRYPTOPHAN to 5-HYDROXYTRYPTOPHAN in the presence of NADPH and molecular oxygen. It is important in the biosynthesis of SEROTONIN.", "PM": "78; was see under HYDROXYLASES 1975-77", "HN": "78(73); was see under HYDROXYLASES 1975-77", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D014365"}, {"RECTYPE": "D", "MH": "Tryptophan Oxygenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tryptophan Pyrrolase|T116|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Tryptophan 2,3 Dioxygenase", "MN": "D08.811.682.690.416.722", "FX": "Tryptophan Hydroxylase", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "L-Tryptophan:oxygen 2,3-oxidoreductase (decyclizing)", "RN": "EC 1.13.11.11", "MS": "A dioxygenase with specificity for the oxidation of the indoleamine ring of TRYPTOPHAN. It is a LIVER-specific enzyme that is the first and rate limiting enzyme in the kynurenine pathway of TRYPTOPHAN catabolism.", "PM": "68", "HN": "68(65)", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014366"}, {"RECTYPE": "D", "MH": "Tryptophan Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tryptophan Synthetase|T116|T126|NON|EQV|UNK (19XX)|790525|abbcdef", "ENTRY": "Synthetase, Tryptophan", "MN": "D08.811.600.896", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "L-Serine hydro-lyase (adding indoleglycerol-phosphate)", "RN": "EC 4.2.1.20", "RR": "9014-52-2 (CAS RN)", "PI": "Hydro-Lyases (1966-1971)", "MS": "An enzyme that catalyzes the conversion of L-serine and 1-(indol-3-yl)glycerol 3-phosphate to L-tryptophan and glyceraldehyde 3-phosphate. It is a pyridoxal phosphate protein that also catalyzes the conversion of serine and indole into tryptophan and water and of indoleglycerol phosphate into indole and glyceraldehyde phosphate. (From Enzyme Nomenclature, 1992) EC 4.2.1.20.", "OL": "use TRYPTOPHAN SYNTHASE to search TRYPTOPHAN SYNTHETASE 1972-79 (as Prov 1972-73)", "PM": "80; was TRYPTOPHAN SYNTHETASE 1974-79", "HN": "80; was TRYPTOPHAN SYNTHETASE 1972-79 (Prov 1972-73)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014367"}, {"RECTYPE": "D", "MH": "Tryptophanase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tryptophan Indole-Lyase|T116|T126|NON|EQV|NLM (1998)|970423|abbcdef", "ENTRY": "Tryptophan Indole Lyase", "MN": "D08.811.520.224.800", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "L-Tryptophan indole-lyase (deaminating)", "RN": "EC 4.1.99.1", "RR": "9024-00-4 (CAS RN)", "PI": "Hydro-Lyases (1966-1971)", "MS": "An enzyme that catalyzes the conversion of L-tryptophan and water to indole, pyruvate, and ammonia. It is a pyridoxal-phosphate protein, requiring K+. It also catalyzes 2,3-elimination and beta-replacement reactions of some indole-substituted tryptophan analogs of L-cysteine, L-serine, and other 3-substituted amino acids. (From Enzyme Nomenclature, 1992) EC 4.1.99.1.", "PM": "91; was see under LYASES 1972-90", "HN": "91(72); was see under LYASES 1972-90", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014368"}, {"RECTYPE": "D", "MH": "Tryptophan-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tryptophanyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961106|abbdef", "ENTRY": "Tryptophanyl tRNA Synthetase", "MN": "D08.811.464.263.200.850", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Tryptophan:tRNA(Trp) ligase (AMP-forming)", "RN": "EC 6.1.1.2", "PI": "Tryptophan (1974)", "MS": "An enzyme that activates tryptophan with its specific transfer RNA. EC 6.1.1.2.", "PM": "98; see TRYPTOPHANYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014369"}, {"RECTYPE": "D", "MH": "Tsetse Flies", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Glossina|T204|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Tsetse Fly", "MN": "B01.050.500.131.617.720.500.500.750.400.700", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid7393", "AN": "vectors of various species of Trypanosoma; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111", "MS": "Bloodsucking flies of the genus Glossina, found primarily in equatorial Africa. Several species are intermediate hosts of trypanosomes.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014370"}, {"RECTYPE": "D", "MH": "Tuber Cinereum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tuber Cinereums", "MN": "A08.186.211.200.317.357.352.870", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "Layer of GRAY MATTER in the HYPOTHALAMUS that also forms part of the floor of the THIRD VENTRICLE and merges anteriorly into the infundibulum (see PITUITARY GLAND, POSTERIOR).", "OL": "search HYPOTHALAMUS 1969-74", "PM": "91; was see under HYPOTHALAMUS 1975-90", "HN": "91(75); was see under HYPOTHALAMUS 1975-90", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014371"}, {"RECTYPE": "D", "MH": "Tubercidin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "7-Deazaadenosine|T114|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|DEAZAADENOSINE 7|abbcdeefs", "ENTRY": "7 Deazaadenosine", "MN": "D13.570.800.850", "PA": "Antimetabolites, Antineoplastic", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "7H-Pyrrolo(2,3-d)pyrimidin-4-amine, 7-beta-D-ribofuranosyl-", "RN": "M351LCX45Y", "RR": "69-33-0 (Tubercidin)", "AN": "an antineoplastic antimetabolite", "PI": "Ribonucleosides (1973-1974)", "MS": "An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids.", "PM": "91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90", "HN": "91(75); was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90", "MR": "20160601", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D014372"}, {"RECTYPE": "D", "MH": "Tuberculin", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "PPD L", "MN": "D23.050.161.845", "PA": "Indicators and Reagents", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "AN": "TUBERCULIN TEST is also available", "MS": "A protein extracted from boiled culture of tubercle bacilli (MYCOBACTERIUM TUBERCULOSIS). It is used in the tuberculin skin test (TUBERCULIN TEST) for the diagnosis of tuberculosis infection in asymptomatic persons.", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014373"}, {"RECTYPE": "D", "MH": "Tuberculin Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tuberculin Tests", "MN": "E05.478.594.890.800", "FX": "Tuberculosis", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "One of several skin tests to determine past or present tuberculosis infection. A purified protein derivative of the tubercle bacilli, called tuberculin, is introduced into the skin by scratch, puncture, or interdermal injection.", "PM": "66; was TUBERCULIN REACTION 1963-65", "HN": "66; was TUBERCULIN REACTION 1963-65", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014374"}, {"RECTYPE": "D", "MH": "Tuberculoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Tuberculomas", "MN": "C01.150.252.410.040.552.846.493", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "not a neoplasm; coord IM with precoord tuberculosis term (IM) or organ/dis precoord (IM) if tuberc term is not available", "MS": "A tumor-like mass resulting from the enlargement of a tuberculous lesion.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014375"}, {"RECTYPE": "D", "MH": "Tuberculosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Tuberculoses", "MN": "C01.150.252.410.040.552.846", "FX": "Tuberculin Test", "MH_TH": "POPLINE (1986)", "ST": "T047", "AN": "general or unspecified; prefer specifics; if unspecified as just \"tuberculosis\", TUBERCULOSIS, PULMONARY is probably the correct heading but check text carefully; tuberculid: index under TUBERCULOSIS, CUTANEOUS; ", "MS": "Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.", "OL": "use TUBERCULOSIS to search TUBERCULOSIS IMMUNITY 1966", "PM": "TUBERCULOSIS IMMUNITY was heading 1963-66", "HN": "TUBERCULOSIS IMMUNITY was heading 1963-66", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D014376"}, {"RECTYPE": "D", "MH": "Tuberculosis Societies", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Tuberculosis Society", "MN": "N03.540.630.780.850", "MH_TH": "NLM (1975)", "ST": "T095", "MS": "Voluntary agencies concerned with prevention and treatment of tuberculosis.", "OL": "use VOLUNTARY HEALTH AGENCIES to search TUBERCULOSIS SOCIETIES 1966-74", "PM": "91; was see under VOLUNTARY HEALTH AGENCIES 1967-90; was heading 1963-66", "HN": "91(75)63-66; was see under VOLUNTARY HEALTH AGENCIES 1967-90; was heading 1963-66", "MR": "19930916", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014378"}, {"RECTYPE": "D", "MH": "Tuberculosis, Avian", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Tuberculoses, Avian", "MN": "C22.131.921", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with BIRDS (NIM) or specific bird (IM)", "MS": "A variety of TUBERCULOSIS affecting various birds, including chickens and ducks. It is caused by MYCOBACTERIUM AVIUM and characterized by tubercles consisting principally of epithelioid cells.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014379"}, {"RECTYPE": "D", "MH": "Tuberculosis, Bovine", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Tuberculoses, Bovine", "MN": "C22.196.927", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by Mycobacterium bovis; don't forget also CATTLE (NIM) & check tag ANIMALS", "MS": "An infection of cattle caused by MYCOBACTERIUM BOVIS. It is transmissible to man and other animals.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014380"}, {"RECTYPE": "D", "MH": "Tuberculosis, Cardiovascular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Cardiovascular Tuberculosis|T047|NON|EQV|NLM (2007)|060405|abcdef", "ENTRY": "Tuberculoses, Cardiovascular", "MN": "C14.260.750", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific cardiovascular term (IM) or specific cardiovascular disease (IM)", "MS": "Pathological conditions of the CARDIOVASCULAR SYSTEM caused by infection of MYCOBACTERIUM TUBERCULOSIS. Tuberculosis involvement may include the HEART; the BLOOD VESSELS; or the PERICARDIUM.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014381"}, {"RECTYPE": "D", "MH": "Tuberculosis, Cutaneous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Tuberculid|T047|NON|NRW|NLM (1998)|960722|abcdef", "MN": "C17.800.838.765.820", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Tuberculosis of the skin. It includes scrofuloderma and tuberculid, but not LUPUS VULGARIS.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014382"}, {"RECTYPE": "D", "MH": "Tuberculosis, Endocrine", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Tuberculoses, Endocrine", "MN": "C19.927", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific endocrine system disease (IM)", "MS": "Infection of the ENDOCRINE GLANDS with species of MYCOBACTERIUM, most often MYCOBACTERIUM TUBERCULOSIS.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014383"}, {"RECTYPE": "D", "MH": "Tuberculosis, Female Genital", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Tuberculoses, Female Genital", "MN": "C12.600.940", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "coordinate IM with specific organ (IM) or organ/disease (IM)", "MS": "MYCOBACTERIUM infections of the female reproductive tract (GENITALIA, FEMALE).", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014384"}, {"RECTYPE": "D", "MH": "Tuberculosis, Gastrointestinal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Gastrointestinal Tuberculosis|T047|NON|EQV|NLM (2004)|021223|abcdef", "MN": "C06.405.874", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific organ or organ /dis (IM)", "MS": "TUBERCULOSIS that involves any region of the GASTROINTESTINAL TRACT, mostly in the distal ILEUM and the CECUM. In most cases, MYCOBACTERIUM TUBERCULOSIS is the pathogen. Clinical features include ABDOMINAL PAIN; FEVER; and palpable mass in the ileocecal area.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014385"}, {"RECTYPE": "D", "MH": "Tuberculosis, Hepatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Tuberculoses, Hepatic", "MN": "C06.552.933", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Infection of the LIVER with species of MYCOBACTERIUM, most often MYCOBACTERIUM TUBERCULOSIS. It is characterized by localized small tuberculous miliary lesions or tumor-like mass (TUBERCULOMA), and abnormalities in liver function tests.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014386"}, {"RECTYPE": "D", "MH": "Tuberculosis, Laryngeal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Tuberculoses, Laryngeal", "MN": "C09.400.860", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Tuberculosis involving the larynx, producing ulceration of the VOCAL CORDS and the LARYNGEAL MUCOSA.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014387"}, {"RECTYPE": "D", "MH": "Tuberculosis, Lymph Node", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Scrofula|T047|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Tuberculous Lymphadenitis, Cervical", "MN": "C01.150.252.410.040.552.846.617.475", "FX": "King's Evil", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Infection of the lymph nodes by tuberculosis. Tuberculous infection of the cervical lymph nodes is scrofula.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014388"}, {"RECTYPE": "D", "MH": "Tuberculosis, Male Genital", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Male Genital Tuberculosis|T047|NON|EQV|NLM (2007)|050927|abcdef", "ENTRY": "Tuberculoses, Male Genital", "MN": "C12.600.955", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific organ or organ /dis (IM)", "MS": "MYCOBACTERIUM infections of the male reproductive tract (GENITALIA, MALE).", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014389"}, {"RECTYPE": "D", "MH": "Tuberculosis, Meningeal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Meningitis, Tuberculous|T047|NON|EQV|ORD (2010)|UNK (19XX)|740330|abcdeef", "ENTRY": "Tuberculous Meningitis", "MN": "C10.586.625.280.915", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A form of bacterial meningitis caused by MYCOBACTERIUM TUBERCULOSIS or rarely MYCOBACTERIUM BOVIS. The organism seeds the meninges and forms microtuberculomas which subsequently rupture. The clinical course tends to be subacute, with progressions occurring over a period of several days or longer. Headache and meningeal irritation may be followed by SEIZURES, cranial neuropathies, focal neurologic deficits, somnolence, and eventually COMA. The illness may occur in immunocompetent individuals or as an OPPORTUNISTIC INFECTION in the ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunodeficiency syndromes. (From Adams et al., Principles of Neurology, 6th ed, pp717-9)", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014390"}, {"RECTYPE": "D", "MH": "Tuberculosis, Miliary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Tuberculoses, Miliary", "MN": "C01.150.252.410.040.552.846.764", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An acute form of TUBERCULOSIS in which minute tubercles are formed in a number of organs of the body due to dissemination of the bacilli through the blood stream.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014391"}, {"RECTYPE": "D", "MH": "Tuberculosis, Ocular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Ocular Tuberculosis|T047|NON|EQV|NLM (1990)|890519|abcdef", "ENTRY": "Tuberculoses, Ocular", "MN": "C11.294.354.800", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "IM; coord IM with specific eye heading (IM) or eye dis heading (IM)", "MS": "Tuberculous infection of the eye, primarily the iris, ciliary body, and choroid.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014392"}, {"RECTYPE": "D", "MH": "Tuberculosis, Oral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Tuberculoses, Oral", "MN": "C07.465.943", "MH_TH": "NLM (1972)", "ST": "T047", "AN": "\"tuberc of the mouth, tongue & salivary glands\"; IM; coord IM with specific mouth, tongue or salivary gland heading (IM) or mouth, tongue or salivary dis heading (IM)", "PI": "specific oral disease (1966-1971)", "MS": "Tuberculosis of the mouth, tongue, and salivary glands.", "PM": "91; was see under TUBERCULOSIS 1972-90", "HN": "91(72); was see under TUBERCULOSIS 1972-90", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014393"}, {"RECTYPE": "D", "MH": "Tuberculosis, Osteoarticular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Joint Tuberculosis|T047|NON|REL|UNK (19XX)|740330|abcdef", "ENTRY": "Tuberculosis, Joint", "MN": "C05.116.165.886", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "IM; may be osteo- or artic; coord IM with specific bone or joint (IM) or bone or joint dis (IM)", "MS": "Tuberculosis of the bones or joints.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014394"}, {"RECTYPE": "D", "MH": "Peritonitis, Tuberculous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Tuberculosis, Peritoneal|T047|NON|EQV|NLM (1966)|990101|abcdef", "MN": "C06.844.640.249", "MH_TH": "NLM (1993)", "ST": "T047", "MS": "A form of PERITONITIS seen in patients with TUBERCULOSIS, characterized by lesion either as a miliary form or as a pelvic mass on the peritoneal surfaces. Most patients have ASCITES, abdominal swelling, ABDOMINAL PAIN, and other systemic symptoms such as FEVER; WEIGHT LOSS; and ANEMIA.", "PM": "2005; see TUBERCULOSIS, PERITONEAL 1966-2004", "HN": "2005 (1966)", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "20050101", "UI": "D014395"}, {"RECTYPE": "D", "MH": "Tuberculosis, Pleural", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pleurisy, Tuberculous|T047|NON|EQV|NLM (1992)|910412|abcdef", "ENTRY": "Tuberculous Pleurisy", "MN": "C08.730.912", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Tuberculosis of the serous membrane lining the thoracic cavity and surrounding the lungs.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014396"}, {"RECTYPE": "D", "MH": "Tuberculosis, Pulmonary", "DE": "TUBERCULOSIS PULM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pulmonary Phthisis|T047|NON|EQV|NLM (2009)|080408|abcdef", "ENTRY": "Pulmonary Phthises", "MN": "C08.730.939", "FX": "Pneumonectomy", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "MYCOBACTERIUM infections of the lung.", "OL": "use TUBERCULOSIS, PULMONARY to search TUBERCULOSIS IN CHILDHOOD 1966-89", "PM": "TUBERCULOSIS IN CHILDHOOD was heading 1963-89", "HN": "TUBERCULOSIS IN CHILDHOOD was heading 1963-89", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D014397"}, {"RECTYPE": "D", "MH": "Tuberculosis, Renal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Tuberculoses, Renal", "MN": "C12.950.419.912", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Infection of the KIDNEY with species of MYCOBACTERIUM.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014398"}, {"RECTYPE": "D", "MH": "Tuberculosis, Spinal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pott's Disease|T047|EPO|EQV|UNK (19XX)|740330|POTTS DIS|abcdefv", "ENTRY": "Tuberculoses, Spinal", "MN": "C05.116.900.853.850", "FX": "Pott Puffy Tumor", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coordinate IM with specific vertebra (IM); do not confuse entry term POTT DISEASE with POTT-PUFFY TUMOR", "MS": "Osteitis or caries of the vertebrae, usually occurring as a complication of tuberculosis of the lungs.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014399"}, {"RECTYPE": "D", "MH": "Tuberculosis, Splenic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Tuberculoses, Splenic", "MN": "C15.604.744.909", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Infection of the spleen with species of MYCOBACTERIUM.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014400"}, {"RECTYPE": "D", "MH": "Tuberculosis, Urogenital", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Urogenital Tuberculoses", "MN": "C12.600", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general; prefer TUBERCULOSIS, FEMALE GENITAL; TUBERCULOSIS, MALE GENITAL; or TUBERCULOSIS, RENAL", "MS": "A general term for MYCOBACTERIUM infections of any part of the UROGENITAL SYSTEM in either the male or the female.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014401"}, {"RECTYPE": "D", "MH": "Tuberous Sclerosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Phakomatosis, Bourneville|T191|EPO|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Syndrome, Bourneville's", "MN": "C16.320.700.700", "MH_TH": "ORD (2010)", "ST": "T191", "MS": "Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014402"}, {"RECTYPE": "D", "MH": "Tubocurarine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "d-Tubocurarine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|810728|abbcdeef", "MN": "D03.633.100.531.820.875", "PA": "Nicotinic Antagonists", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Tubocuraranium, 7',12'-dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyl-", "RN": "W9YXS298BM", "RR": "900961Z8VR", "MS": "A neuromuscular blocker and active ingredient in CURARE; plant based alkaloid of Menispermaceae.", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014403"}, {"RECTYPE": "D", "MH": "Tubulin", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "gamma Tubulin", "MN": "D12.776.631.920", "EC": "antagonists & inhibitors:Tubulin Modulators", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1966-1974)", "MS": "A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE.", "PM": "80; was see under GLYCOPROTEINS 1975-79", "HN": "80(75); was see under GLYCOPROTEINS 1975-79", "MR": "20151124", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D014404"}, {"RECTYPE": "D", "MH": "Tuftsin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Taftsin|T116|T129|NON|EQV|UNK (19XX)|850103|abbcdef", "MN": "D12.776.377.715.548.680.650.750", "PA": "Immunologic Factors", "MH_TH": "NLM (1975)", "ST": "T129", "N1": "L-Arginine, N2-(1-(N2-L-threonyl-L-lysyl)-L-prolyl)-", "RN": "QF5336J16C", "RR": "9063-57-4 (Tuftsin)", "PI": "Oligopeptides (1973-1974)", "MS": "N(2)-((1-(N(2)-L-Threonyl)-L-lysyl)-L-prolyl)-L-arginine. A tetrapeptide produced in the spleen by enzymatic cleavage of a leukophilic gamma-globulin. It stimulates the phagocytic activity of blood polymorphonuclear leukocytes and neutrophils in particular. The peptide is located in the Fd fragment of the gamma-globulin molecule.", "OL": "use TUFTSIN to search LEUKOKININ & LEUCOKININ 1975-93", "PM": "84; was see under IMMUNOGLOBULINS, FD 1975-83; LEUKOKININ (with LEUCOKININ a see ref to it) was see under GAMMA GLOBULINS 1975-83; LEUKOKININ & LEUCOKININ were see TUFTSIN 1984-93", "HN": "84(75); was see under IMMUNOGLOBULINS, FD 1975-83; LEUKOKININ (with LEUCOKININ a see ref to it) was see under GAMMA GLOBULINS 1975-83; LEUKOKININ & LEUCOKININ were see TUFTSIN 1984-93", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19840101", "UI": "D014405"}, {"RECTYPE": "D", "MH": "Tularemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Francisella tularensis Infection|T047|NON|EQV|NLM (2011)|ORD (2010)|100401|abcdeef", "ENTRY": "Tularemias", "MN": "C01.920.930.943", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A plague-like disease of rodents, transmissible to man. It is caused by FRANCISELLA TULARENSIS and is characterized by fever, chills, headache, backache, and weakness.", "CATSH": "CAT LIST", "MR": "20190613", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014406"}, {"RECTYPE": "D", "MH": "Tumor Cells, Cultured", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Neoplastic Cells, Cultured|T025|NON|EQV|UNK (19XX)|870508|NEOPL CELLS CULTURED|abcdefv", "ENTRY": "Tumor Cell, Cultured", "MN": "A11.251.860", "FX": "Drug Screening Assays, Antitumor", "MH_TH": "NLM (1988)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMALS or HUMAN; do not routinely add neoplasm term; policy: Manual 21.57, 22.26.1, 24.4.5+", "PI": "Tissue Culture (1966-1982)", "MS": "Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.", "PM": "88", "HN": "88", "MR": "20040802", "DA": "19870508", "DC": "1", "DX": "19880101", "UI": "D014407"}, {"RECTYPE": "D", "MH": "Biomarkers, Tumor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tumor Markers, Biological|T123|NON|EQV|NLM (1988)|990101|TUMOR MARKERS BIOL|abcdefv", "ENTRY": "Tumor Metabolite Markers", "MN": "D23.101.140", "MH_TH": "NLM (2016)", "ST": "T123", "RN": "0", "MS": "Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.", "PM": "2016; See TUMOR MARKERS, BIOLOGICAL 1988-2015", "HN": "2016(1988)", "MR": "20200527", "DA": "19870327", "DC": "1", "DX": "19880101", "UI": "D014408"}, {"RECTYPE": "D", "MH": "Tumor Necrosis Factor-alpha", "DS": "TUMOR NECROSIS FACTOR ALPHA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Ligand Superfamily Member 2|T116|T129|NON|EQV|NLM (2007)|051207|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 002|abbcdefs", "ENTRY": "Tumor Necrosis Factor alpha", "MN": "D23.529.374.750.626", "FX": "Infliximab", "MH_TH": "UNK (19XX)", "ST": "T129", "RN": "0", "PI": "Necrosis (1975-1987)", "MS": "Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS.", "PM": "2005; see TUMOR NECROSIS FACTOR 1988-2005", "HN": "2005(1988)", "MR": "20230316", "DA": "19870508", "DC": "1", "DX": "19880101", "UI": "D014409"}, {"RECTYPE": "D", "MH": "Tumor Stem Cell Assay", "DE": "TCFU ASSAY", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Stem Cell Assay, Tumor|T059|NON|EQV|UNK (19XX)|830404|abcdef", "ENTRY": "Colony Forming Units Assay, Tumor|T059|NON|EQV|UNK (19XX)|840501|abcdef", "MN": "E05.337.550.200.800", "MH_TH": "NLM (1984)", "ST": "T059", "AN": "coord IM with histol type of neopl + precoord organ/neopl term (IM or NIM) if pertinent", "PI": "specific neoplasm (1972-1983)", "MS": "A cytologic technique for measuring the functional capacity of tumor stem cells by assaying their activity. It is used primarily for the in vitro testing of antineoplastic agents.", "PM": "91; was see under COLONY-FORMING UNITS ASSAY 1984-90", "HN": "91(84); was see under COLONY-FORMING UNITS ASSAY 1984-90", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19830404", "DC": "1", "DX": "19910101", "UI": "D014410"}, {"RECTYPE": "D", "MH": "Neoplastic Stem Cells", "DE": "NEOPL STEM CELLS", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Tumor Stem Cells|T025|NON|EQV|NLM (1984)|990101|abcdef", "ENTRY": "Units, Neoplastic Colony-Forming", "MN": "A11.872.650", "MH_TH": "NLM (1992)", "ST": "T025", "PI": "specific neoplasm/PA (1975-1983)", "MS": "Highly proliferative, self-renewing, and colony-forming stem cells which give rise to NEOPLASMS.", "PM": "2008; see TUMOR STEM CELLS 1986-2007; see STEM CELLS 1984-1985", "HN": "2008 (1984)", "MR": "20160701", "DA": "19830224", "DC": "1", "DX": "19860101", "UI": "D014411"}, {"RECTYPE": "D", "MH": "Tumor Virus Infections", "DE": "TUMOR VIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Papilloma, Shope|T191|EPO|NRW|UNK (19XX)|810519|abcdef", "ENTRY": "Tumor Virus Infection", "MN": "C01.925.928", "MH_TH": "NLM (1972)", "ST": "T191", "AN": "coordinate IM with specific oncogenic virus (IM) and neoplasm term (IM) if pertinent, but note specifics", "PI": "Virus Diseases (1966-1971)", "MS": "Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses.", "OL": "use TUMOR VIRUS INFECTIONS to search FIBROMA, SHOPE 1968-81 & PAPILLOMA, SHOPE 1966-81", "PM": "72; FIBROMA, SHOPE was heading 1968-81; PAPILLOMA, SHOPE was heading 1963-81", "HN": "72; FIBROMA, SHOPE was heading 1968-81; PAPILLOMA, SHOPE was heading 1963-81", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014412"}, {"RECTYPE": "D", "MH": "Tuna", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Tunas", "MN": "B01.050.150.900.493.602.825", "MH_TH": "NLM (1975)", "ST": "T013", "MS": "Common name for various species of large, vigorous ocean fishes in the family Scombridae.", "PM": "91; was see under FISHES 1975-90", "HN": "91(75); was see under FISHES 1975-90", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D014413"}, {"RECTYPE": "D", "MH": "Tungsten", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Wolfram|T196|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "D01.552.544.887", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Tungsten", "RN": "V9306CXO6G", "RR": "7440-33-7 (Tungsten)", "MS": "A metallic element with the atomic symbol W, atomic number 74, and atomic weight 183.85. It is used in many manufacturing applications, including increasing the hardness, toughness, and tensile strength of steel; manufacture of filaments for incandescent light bulbs; and in contact points for automotive and electrical apparatus.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014414"}, {"RECTYPE": "D", "MH": "Tunicamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D13.570.685.725", "PA": "Antiviral Agents", "MH_TH": "NLM (1979)", "ST": "T195", "N1": "Tunicamycin", "RN": "11089-65-9", "AN": "an antibiotic; do not use /biosyn unless by living matter", "PI": "Glucosamine (1966-1978)", "MS": "An N-acetylglycosamine containing antiviral antibiotic obtained from Streptomyces lysosuperificus. It is also active against some bacteria and fungi, because it inhibits the glucosylation of proteins. Tunicamycin is used as tool in the study of microbial biosynthetic mechanisms.", "PM": "87; was see under GLUCOSAMINE 1979-86", "HN": "87(79); was see under GLUCOSAMINE 1979-86", "MR": "20160601", "DA": "19780208", "DC": "1", "DX": "19870101", "UI": "D014415"}, {"RECTYPE": "D", "MH": "Tunisia", "AQ": "EH EP", "MN": "Z01.058.266.887", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in northern Africa between ALGERIA and LIBYA. Its capital is Tunis.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014416"}, {"RECTYPE": "D", "MH": "Tupaia", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "MN": "B01.050.150.900.649.313.996.770.770", "MH_TH": "NLM (1981)", "ST": "T015", "RN": "txid9394", "PI": "Tupaiidae (1975-1980)", "MS": "A genus of tree shrews of the family TUPAIIDAE which consists of about 12 species. One of the most frequently encountered species is T. glis. Members of this genus inhabit rain forests and secondary growth areas in southeast Asia.", "PM": "91; was see under TUPAIIDAE 1981-90", "HN": "91(81); was see under TUPAIIDAE 1981-90", "MR": "20200813", "DA": "19800509", "DC": "1", "DX": "19910101", "UI": "D014417"}, {"RECTYPE": "D", "MH": "Tupaiidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Tupaiinae|T015|NON|NRW|UNK (19XX)|800509|abcdef", "ENTRY": "Treeshrew", "MN": "B01.050.150.900.649.313.996.770", "MH_TH": "NLM (1975)", "ST": "T015", "RN": "txid9393", "RR": "txid320337", "AN": "do not confuse entry term TREE SHREWS with SHREWS (insectivore)", "MS": "The only family of the order SCANDENTIA, variously included in the order Insectivora or in the order Primates, and often in the order Microscelidea, consisting of five genera. They are TUPAIA, Ananthana (Indian tree shrew), Dendrogale (small smooth-tailed tree shrew), Urogale (Mindanao tree shrew), and Ptilocercus (pen-tailed tree shrew). The tree shrews inhabit the forest areas of eastern Asia from India and southwestern China to Borneo and the Philippines.", "OL": "use TUPAIIDAE to search TREE SHREWS 1975-80; use PRIMATES 1972-74", "PM": "81; was TREE SHREWS see under PROSIMIANS 1975-80, see under PRIMATES 1972-74", "HN": "81; was TREE SHREWS see under PROSIMIANS 1975-80, see under PRIMATES 1972-74", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D014418"}, {"RECTYPE": "D", "MH": "Turbellaria", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Turbellarias", "MN": "B01.050.500.500.736.847", "MH_TH": "NLM (1965)", "ST": "T204", "RN": "txid166384", "AN": "a class of platyhelminths not usually parasitic", "MS": "A class of free-living freshwater flatworms of North America.", "PM": "65", "HN": "65", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014419"}, {"RECTYPE": "D", "MH": "Turbinates", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Nasal Concha|T023|NON|EQV|NLM (2009)|071129|abcdef", "ENTRY": "Turbinate", "MN": "A04.531.898", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "fractures: coordinate TURBINATES /inj (IM) + SKULL FRACTURES (IM)", "MS": "The scroll-like bony plates with curved margins on the lateral wall of the NASAL CAVITY. Turbinates, also called nasal concha, increase the surface area of nasal cavity thus providing a mechanism for rapid warming and humidification of air as it passes to the lung.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014420"}, {"RECTYPE": "D", "MH": "Turkey", "AQ": "EH EP", "PRINT ENTRY": "Turkiye|T083|NAM|EQV|NLM (2024)|220812|abcdef", "MN": "Z01.252.245.500.850", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "the country, not TURKEYS", "MS": "Country in Southeastern Europe and Southwestern Asia bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria. The capital is Ankara.", "MR": "20230226", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014421"}, {"RECTYPE": "D", "MH": "Turkeys", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Meleagridinae|T012|NON|EQV|NLM (2005)|031028|abcdef", "ENTRY": "Meleagrididae|T012|NON|EQV|NLM (2005)|030813|abcdef", "MN": "B01.050.150.900.248.690.800", "MH_TH": "NLM (1968)", "ST": "T012", "RN": "txid9005", "AN": "diseases: coord IM with POULTRY DISEASES (IM)", "PI": "Poultry (1966-1967)", "MS": "Large woodland game BIRDS in the subfamily Meleagridinae, family Phasianidae, order GALLIFORMES. Formerly they were considered a distinct family, Melegrididae.", "PM": "1968", "HN": "1968", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014422"}, {"RECTYPE": "D", "MH": "Turkmenistan", "AQ": "EH EP", "PRINT ENTRY": "Turkmen S.S.R.|T083|NAM|EQV|NLM (1993)|920422|abcdef", "ENTRY": "Turkmen SSR|T083|NAM|EQV|UNK (19XX)|810302|abcdef", "MN": "Z01.586.200.940", "MH_TH": "POPLINE (1993)", "ST": "T083", "OL": "use TURKMENISTAN to search TURKMEN S.S.R. 1982-92", "HN": "93; was TURKMEN S.S.R. l982-92; was heading 1963-81", "MR": "20170717", "DA": "19990101", "DC": "4", "DX": "19930101", "UI": "D014423"}, {"RECTYPE": "D", "MH": "Turner Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gonadal Dysgenesis, XO|T019|T047|NON|REL|UNK (19XX)|781219|GONADAL DYSGENESIS AA|abbcdefs", "ENTRY": "XO Gonadal Dysgenesis", "MN": "C19.391.119.795.750", "FX": "Noonan Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "in females; TURNER SYNDROME, MALE see NOONAN SYNDROME is also available", "MS": "A syndrome of defective gonadal development in phenotypic females associated with the karyotype 45,X (or 45,XO). Patients generally are of short stature with undifferentiated GONADS (streak gonads), SEXUAL INFANTILISM, HYPOGONADISM, webbing of the neck, cubitus valgus, elevated GONADOTROPINS, decreased ESTRADIOL level in blood, and CONGENITAL HEART DEFECTS. NOONAN SYNDROME (also called Pseudo-Turner Syndrome and Male Turner Syndrome) resembles this disorder; however, it occurs in males and females with a normal karyotype and is inherited as an autosomal dominant.", "PM": "2002; see TURNER'S SYNDROME 1963-2001; for BONNEVIE-ULLRICH SYNDROME see SEX CHROMOSOME ABNORMALITIES 1997-2001, see BONNEVIE-ULLRICH SYNDROME 1963-1996", "HN": "2002(1963); for BONNEVIE-ULLRICH SYNDROME use SEX CHROMOSOME ABNORMALITIES 1963-2001", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D014424"}, {"RECTYPE": "D", "MH": "Turpentine", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Oil Turpentine", "MN": "D20.215.721.500.881", "PA": "Solvents", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "XJ6RUH0O4G", "RR": "C5H0QJ6V7F", "MS": "The concrete oleoresin obtained from PINACEAE such as longleaf pine (Pinus palustris). It contains a volatile oil, to which its properties are due, and to which form it is generally used. Turpentine is used as a solvent and an experimental irritant in biomedical research.", "MR": "20180301", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014425"}, {"RECTYPE": "D", "MH": "Turtles", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Turtles, Sea", "MN": "B01.050.150.900.833.848", "MH_TH": "NLM (1968)", "ST": "T014", "RN": "txid8459", "RR": "txid8487", "PI": "Reptiles (1966-1967)", "MS": "Any reptile including tortoises, fresh water, and marine species of the order Testudines with a body encased in a bony or cartilaginous shell consisting of a top (carapace) and a bottom (plastron) derived from the ribs.", "PM": "68", "HN": "68", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014426"}, {"RECTYPE": "D", "MH": "Twins", "AQ": "CL ED GE HI LJ PX SN", "ENTRY": "Twin", "MN": "M01.438.873", "FX": "Diseases in Twins", "MH_TH": "BIOETHICS (1991)", "ST": "T099", "AN": "human only: for animals use LITTER SIZE; PREGNANCY, TWIN is also available", "MS": "Two individuals derived from two FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother. Twins are either monozygotic (TWINS, MONOZYGOTIC) or dizygotic (TWINS, DIZYGOTIC).", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014427"}, {"RECTYPE": "D", "MH": "Twins, Conjoined", "AQ": "CL EM PA PP PX SU", "PRINT ENTRY": "Twins, Siamese|T019|NON|EQV|NLM (1998)|960722|abcdef", "ENTRY": "Twin, Siamese", "MN": "C16.131.085.806", "MH_TH": "NLM (1966)", "ST": "T019", "MS": "MONOZYGOTIC TWINS who are joined in utero. They may be well developed and share only a superficial connection, often in the frontal, transverse or sagittal body plane, or they may share a partial duplication of a body structure. Alternatively, there may be a small and incompletely developed twin conjoined to a larger, more fully developed twin.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20151216", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014428"}, {"RECTYPE": "D", "MH": "Twins, Dizygotic", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Twins, Fraternal|T099|NON|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "Twin, Fraternal", "MN": "M01.438.873.920", "MH_TH": "NLM (1975)", "ST": "T099", "MS": "Two offspring from the same PREGNANCY. They are from two OVA, fertilized at about the same time by two SPERMATOZOA. Such twins are genetically distinct and can be of different sexes.", "PM": "91; was see under TWINS 1975-90", "HN": "91(75); was see under TWINS 1975-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D014429"}, {"RECTYPE": "D", "MH": "Twins, Monozygotic", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Twins, Identical|T099|NON|EQV|UNK (19XX)|741205|abcdef", "ENTRY": "Twin, Monozygotic", "MN": "M01.438.873.940", "MH_TH": "NLM (1975)", "ST": "T099", "AN": "TWINNING, MONOZYGOTIC is also available", "MS": "Two off-spring from the same PREGNANCY. They are from a single fertilized OVUM that split into two EMBRYOS. Such twins are usually genetically identical and of the same sex.", "PM": "91; was see under TWINS 1975-90", "HN": "91(75); was see under TWINS 1975-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D014430"}, {"RECTYPE": "D", "MH": "Tylenchoidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Meloidogyne|T204|NON|NRW|UNK (19XX)|850321|abcdef", "ENTRY": "Tylenchoideas", "MN": "B01.050.500.500.294.400.984.825", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid33284", "RR": "txid189290", "AN": "a superfamily of nematodes in plants & in man after ingestion of infected plants; infection: coord IM with SECERNENTEA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "MS": "A superfamily of nematodes whose members are free-living saprophytes or parasites of plants. Ova are sometimes found in human feces after ingestion of infected plants.", "OL": "search NEMATODA 1966-74", "PM": "91; was see under NEMATODA 1975-90", "HN": "91(75); was see under NEMATODA 1975-90", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014431"}, {"RECTYPE": "D", "MH": "Tympanic Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tympanic Membranes", "MN": "A09.246.272.702", "FX": "Tympanoplasty", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "do not confuse with TYMPANUM; /surg: consider MYRINGOPLASTY & TYMPANOPLASTY", "MS": "An oval semitransparent membrane separating the external EAR CANAL from the tympanic cavity (EAR, MIDDLE). It contains three layers: the skin of the external ear canal; the core of radially and circularly arranged collagen fibers; and the MUCOSA of the middle ear.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014432"}, {"RECTYPE": "D", "MH": "Tympanoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Tympanoplasties", "MN": "E04.580.450.873", "FX": "Myringoplasty", "MH_TH": "NLM (1964)", "ST": "T061", "MS": "Surgical reconstruction of the hearing mechanism of the middle ear, with restoration of the drum membrane to protect the round window from sound pressure, and establishment of ossicular continuity between the tympanic membrane and the oval window. (Dorland, 28th ed.)", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014433"}, {"RECTYPE": "D", "MH": "Type A Personality", "PRINT ENTRY": "Personality Type A|T041|NON|EQV|UNK (19XX)|840406|abcdef", "ENTRY": "Type A, Personality", "MN": "F01.752.747.880", "MH_TH": "NLM (1985)", "ST": "T041", "PI": "Personality (1966-1984)", "MS": "Established behavior pattern characterized by excessive drive and ambition, impatience, competitiveness, sense of time urgency, and poorly contained aggression.", "PM": "85", "HN": "85", "CATSH": "CAT LIST", "MR": "19910611", "DA": "19840406", "DC": "1", "DX": "19850101", "UI": "D014434"}, {"RECTYPE": "D", "MH": "Typhoid Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Typhus, Abdominal|T047|NON|EQV|NLM (1992)|900920|abcdef", "ENTRY": "Typhoids", "MN": "C01.150.252.400.310.821.873", "MH_TH": "NLM (2001)", "ST": "T047", "MS": "An acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA.", "PM": "2001; see TYPHOID 1963-2000", "HN": "2001(1963)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "20010101", "UI": "D014435"}, {"RECTYPE": "D", "MH": "Typhoid-Paratyphoid Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Typhoid Vaccine|T121|T129|NON|NRW|UNK (19XX)|840920|abbcdef", "ENTRY": "Vaccines, Typhoid-Paratyphoid", "MN": "D20.215.894.135.685.910", "MH_TH": "NLM (1966)", "ST": "T129", "RN": "0", "MS": "Vaccines used to prevent TYPHOID FEVER and/or PARATYPHOID FEVER which are caused by various species of SALMONELLA. Attenuated, subunit, and inactivated forms of the vaccines exist.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014436"}, {"RECTYPE": "D", "MH": "Typhus, Endemic Flea-Borne", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Typhus, Murine|T047|NON|EQV|ORD (2010)|UNK (19XX)|760508|abcdeef", "ENTRY": "Typhus, Endemic Flea Borne", "MN": "C01.920.914.725.800", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "An infectious disease clinically similar to epidemic louse-borne typhus (TYPHUS, EPIDEMIC LOUSE-BORNE), but caused by RICKETTSIA TYPHI, which is transmitted from rat to man by the rat flea, XENOPSYLLA CHEOPIS.", "OL": "use TYPHUS, ENDEMIC FLEA-BORNE to search TYPHUS, MURINE 1966-76", "PM": "77; was TYPHUS, MURINE 1963-76", "HN": "77; was TYPHUS, MURINE 1963-76", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D014437"}, {"RECTYPE": "D", "MH": "Typhus, Epidemic Louse-Borne", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Typhus|T047|NON|REL|ORD (2010)|UNK (19XX)|760508|abcdeef", "ENTRY": "Typhus, Louse-Borne", "MN": "C01.920.914.725.805", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "The classic form of typhus, caused by RICKETTSIA PROWAZEKII, which is transmitted from man to man by the louse Pediculus humanus corporis. This disease is characterized by the sudden onset of intense headache, malaise, and generalized myalgia followed by the formation of a macular skin eruption and vascular and neurologic disturbances.", "OL": "use TYPHUS, EPIDEMIC LOUSE-BORNE to search BRILL-ZINSSER DISEASE 1992-96, BRILL'S DISEASE 1966-96, & TYPHUS 1966-76", "PM": "77; was TYPHUS 1963-76; BRILL'S DISEASE was heading 1975-96 (see under TYPHUS, EPIDEMIC LOUSE-BORNE 1977-90, see under TYPHUS 1975-76), was see under TYPHUS 1963-74; BRILL-ZINSSER DISEASE was see BRILL'S DISEASE 1992-96", "HN": "77; was TYPHUS 1963-76; BRILL'S DISEASE was heading 1975-96 (see under TYPHUS, EPIDEMIC LOUSE-BORNE 1977-90, see under TYPHUS 1975-76), was see under TYPHUS 1963-74; BRILL-ZINSSER DISEASE was see BRILL'S DISEASE 1992-96", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D014438"}, {"RECTYPE": "D", "MH": "Tyramine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "4 Hydroxyphenethylamine", "MN": "D02.092.211.215.811", "PA": "Sympathomimetics", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Phenol, 4-(2-aminoethyl)-", "RN": "X8ZC7V0OX3", "RR": "51-67-2 (Tyramine)", "MS": "An indirect sympathomimetic that occurs naturally in cheese and other foods. Tyramine does not directly activate adrenergic receptors, but it can serve as a substrate for adrenergic uptake systems and  MONOAMINE OXIDASE to prolong the actions of adrenergic transmitters. It also provokes transmitter release from adrenergic terminals and may be a neurotransmitter in some invertebrate nervous systems.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014439"}, {"RECTYPE": "D", "MH": "Tyrocidine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tyrocidines|T116|T121|NON|EQV|NLM (1994)|921203|abbcdef", "MN": "D12.644.641.850.920", "PA": "Anti-Infective Agents, Local", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Tyrothricin (1966-1974)", "MS": "An antibiotic mixture produced by Bacillus brevis which may be separated into three components, tyrocidines A, B, and C. It is the major constituent (40-60 per cent) of tyrothricin, gramicidin accounting for the remaining 10-20 per cent active material. It is a topical antimicrobial agent, that is very toxic parenterally.", "OL": "use TYROCIDINE to search TYROCIDINES 1975-93", "PM": "94; was TYROCIDINES 1975-93 (see under TYROTHRICIN 1975-90)", "HN": "94; was TYROCIDINES 1975-93 (see under TYROTHRICIN 1975-90)", "MR": "20150623", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014440"}, {"RECTYPE": "D", "MH": "Tyropanoate", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sodium Tyropanoate|T109|T130|NON|NRW|BAN (19XX)|FDA SRS (2014)|INN (19XX)|741111|abbcdeeef", "ENTRY": "WIN88512", "MN": "D02.455.526.581.496.950", "PA": "Contrast Media", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Benzenepropanoic acid, alpha-ethyl-2,4,6-triiodo-3-((1-oxobutyl)amino)-", "RN": "4F05V145YR", "RR": "XRJ0P5FAYO", "PI": "Iodobenzoates (1974)", "MS": "A diagnostic aid as a radiopaque medium in cholecystography.", "PM": "91; was see under IODOBENZENES 1975-90", "HN": "91(75); was see under IODOBENZENES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014441"}, {"RECTYPE": "D", "MH": "Monophenol Monooxygenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tyrosinase|T116|T126|NON|EQV|NLM (1992)|910314|abbcdef", "ENTRY": "Oxidase, Phenol", "MN": "D08.811.682.690.708.125.500", "FX": "Albinism", "MH_TH": "NLM (1977)", "ST": "T126", "N1": "Monophenol,L-dopa:oxygen oxidoreductase", "RN": "EC 1.14.18.1", "AN": "/defic: consider also ALBINISM", "PI": "Tyrosine Decarboxylase (1966-1967)", "MS": "An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1.", "OL": "use MONOPHENOL MONOOXYGENASE to search TYROSINASE 1977-91, use CATECHOL OXIDASE 1968-76 & use TYROSINE DECARBOXYLASE 1966-67; use CATECHOL OXIDASE to search DOPA OXIDASE 1968-75 (as Prov 1973-74), use TYROSINE DECARBOXYLASE 1963-67", "PM": "92; was TYROSINASE 1977-91 (see under DIPHENOL OXIDASES 1977-90); TYROSINASE was see DIPHENOL OXIDASES 1975-76, see under DIPHENOL OXIDASES 1968-74 & see TYROSINE DECARBOXYLASE 1963-67; DOPA OXIDASE was heading 1991, was see under DIPHENOL OXIDASES 1968-72 & 1975-90, was see under TYROSINE DECARBOXYLASE 1963-67", "HN": "92; was TYROSINASE 1977-91 (see under DIPHENOL OXIDASES 1977-90); TYROSINASE was see DIPHENOL OXIDASES 1975-76, see under DIPHENOL OXIDASES 1968-74 & see TYROSINE DECARBOXYLASE 1963-67; DOPA OXIDASE was heading 1973-91 (see under DIPHENOL OXIDASES 1968-90 (Prov 1973-74)), was see under TYROSINE DECARBOXYLASE 1963-67", "MR": "20040707", "DA": "19760419", "DC": "1", "DX": "19910101", "UI": "D014442"}, {"RECTYPE": "D", "MH": "Tyrosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "para Tyrosine", "MN": "D12.125.072.050.875", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "Tyrosine", "RN": "42HK56048U", "RR": "60-18-4 (L-isomer)", "AN": "/blood: consider also TYROSINEMIAS", "MS": "A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014443"}, {"RECTYPE": "D", "MH": "Tyrosine Transaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tyrosine Aminotransferase|T116|T126|NON|EQV|NLM (1995)|940303|abbcdef", "ENTRY": "Transaminase, Tyrosine", "MN": "D08.811.913.477.700.900", "FX": "Tyrosinemias", "MH_TH": "NLM (1964)", "ST": "T126", "N1": "L-Tyrosine:2-oxoglutarate aminotransferase", "RN": "EC 2.6.1.5", "RR": "9014-55-5 (CAS RN)", "AN": "/defic: consider also TYROSINEMIAS", "MS": "An enzyme that catalyzes the conversion of L-TYROSINE and 2-oxoglutarate to 4-hydroxyphenylpyruvate and L-GLUTAMATE. It is a pyridoxal-phosphate protein. L-PHENYLALANINE is hydroxylated to L-tyrosine. The mitochondrial enzyme may be identical with ASPARTATE AMINOTRANSFERASES (EC 2.6.1.1.). Deficiency of this enzyme may cause type II Tyrosinemia (see TYROSINEMIAS). EC 2.6.1.5.", "OL": "use TYROSINE TRANSAMINASE to search TYROSINE AMINOTRANSFERASE 1966-94 (as Prov 1966-68)", "PM": "95; was TYROSINE AMINOTRANSFERASE 1964-94", "HN": "95; was TYROSINE AMINOTRANSFERASE 1964-94 (Prov 1964-68)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014444"}, {"RECTYPE": "D", "MH": "Tyrosine Decarboxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Decarboxylase, Tyrosine", "MN": "D08.811.520.224.125.875", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "L-Tyrosine carboxy-lyase", "RN": "EC 4.1.1.25", "MS": "A pyridoxal-phosphate protein that catalyzes the conversion of L-tyrosine to tyramine and carbon dioxide. The bacterial enzyme also acts on 3-hydroxytyrosine and, more slowly, on 3-hydroxyphenylalanine. (From Enzyme Nomenclature, 1992) EC 4.1.1.25.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014445"}, {"RECTYPE": "D", "MH": "Tyrosine 3-Monooxygenase", "DS": "TYROSINE MONOOXYGENASE 003", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tyrosine Hydroxylase|T116|T126|NON|EQV|NLM (1995)|940303|abbcdef", "ENTRY": "Tyrosine 3 Monooxygenase", "MN": "D12.776.556.579.374.925", "MH_TH": "NLM (1971)", "ST": "T126", "N1": "L-Tyrosine,tetrahydrobiopterin:oxygen oxidoreductase (3-hydroxylating)", "RN": "EC 1.14.16.2", "PI": "Hydroxylases (1966-1970)", "MS": "An enzyme that catalyzes the conversion of L-tyrosine, tetrahydrobiopterin, and oxygen to 3,4-dihydroxy-L-phenylalanine, dihydrobiopterin, and water. EC 1.14.16.2.", "OL": "use TYROSINE 3-MONOOXYGENASE to search TYROSINE HYDROXYLASE 1971-94 (as Prov 1971-73)", "PM": "95; was TYROSINE HYDROXYLASE 1971-94", "HN": "95; was TYROSINE HYDROXYLASE 1971-94 (Prov 1971-73)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014446"}, {"RECTYPE": "D", "MH": "Tyrosine Phenol-Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Tyrosinase|T116|T126|NON|EQV|UNK (19XX)|760518|abbcdef", "ENTRY": "beta Tyrosinase", "MN": "D08.811.520.224.900", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Tyrosine phenol-lyase (deaminating)", "RN": "EC 4.1.99.2", "RR": "9059-31-8 (CAS RN)", "PI": "Tyrosine (1972-1974)", "MS": "An enzyme that catalyzes the cleavage of tyrosine to phenol, pyruvate, and ammonia. It is a pyridoxal phosphate protein. The enzyme also forms pyruvate from D-tyrosine, L-cysteine, S-methyl-L-cysteine, L-serine, and D-serine, although at a slower rate. EC 4.1.99.2.", "PM": "91; was see under LYASES 1975-90", "HN": "91(75); was see under LYASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014447"}, {"RECTYPE": "D", "MH": "Tyrosine-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tyrosyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961106|abbdef", "ENTRY": "Tyrosyl tRNA Synthetase", "MN": "D08.811.464.263.200.900", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Tyrosine:tRNA-(Tyr) ligase (AMP-forming)", "RN": "EC 6.1.1.1", "PI": "Tyrosine (1972-1974)", "MS": "An enzyme that activates tyrosine with its specific transfer RNA. EC 6.1.1.1.", "PM": "98; see TYROSYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014448"}, {"RECTYPE": "D", "MH": "Tyrothricin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tyrosur|T116|T195|TRD|NRW|DE|041207|abbcdef", "MN": "D12.644.641.850", "PA": "Anti-Infective Agents, Local", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Tyrothricin", "RN": "1404-88-2", "MS": "A polypeptide antibiotic mixture obtained from Bacillus brevis. It consists of a mixture of three tyrocidines (60%) and several gramicidins (20%) and is very toxic to blood, liver, kidneys, meninges, and the olfactory apparatus. It is used topically.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014449"}, {"RECTYPE": "D", "MH": "Electron Transport Complex III", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ubiquinol-Cytochrome-c Reductase|T116|T126|NON|EQV|NLM (1987)|990101|abbcdef", "ENTRY": "Ubiquinone Cytochrome b c2 Oxidoreductase", "MN": "D12.776.556.579.374.375.142", "MH_TH": "NLM (2004)", "ST": "T126", "N1": "Ubiquinol-ferricytochrome-c oxidoreductase", "RN": "EC 7.1.1.8", "RR": "EC 1.10.2.2", "PI": "Quinone Reductases (1975-1986)", "MS": "A multisubunit enzyme complex that contains CYTOCHROME B GROUP; CYTOCHROME C1; and iron-sulfur centers. It catalyzes the oxidation of ubiquinol to UBIQUINONE, and transfers the electrons to CYTOCHROME C. In MITOCHONDRIA the redox reaction is coupled to the transport of PROTONS across the inner mitochondrial membrane.", "PM": "2004; see UBIQUINOL-CYTOCHROME-C REDUCTASE 1994-2003, see UBIQUINOL-CYTOCHROME C REDUCTASE 1987-1993; CORE I PROTEIN, UBIQUINOL-CYTOCHROME C REDUCTASE & CORE II PROTEIN, UBIQUINOL-CYTOCHROME C REDUCTASE were indexed under NUCLEAR PROTEINS 1991-2003", "HN": "2004(1994); for CORE I PROTEIN, UBIQUINOL-CYTOCHROME C REDUCTASE & CORE II PROTEIN, UBIQUINOL-CYTOCHROME C REDUCTASE use ELECTRON TRANSPORT COMPLEX III (NM) 1991-2004", "MR": "20190705", "DA": "19860612", "DC": "1", "DX": "19870101", "UI": "D014450"}, {"RECTYPE": "D", "MH": "Ubiquinone", "AQ": "AA AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Coenzyme Q|T109|T123|NON|EQV|UNK (19XX)|740330|abbcdef", "MN": "D08.211.935", "PA": "Micronutrients", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "1339-63-5", "MS": "A lipid-soluble benzoquinone which is involved in ELECTRON TRANSPORT in mitochondrial preparations. The compound occurs in the majority of aerobic organisms, from bacteria to higher plants and animals.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014451"}, {"RECTYPE": "D", "MH": "Ubiquitins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ubiquitin-Like Proteins|T116|T123|NON|REL|NLM (2002)|000918|abbcdef", "ENTRY": "Ubiquitin Like Proteins", "MN": "D12.776.947", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "UBIQUITIN is available", "PI": "Peptides (1975-1980)", "MS": "A family of proteins that are structurally-related to Ubiquitin. Ubiquitins and ubiquitin-like proteins participate in diverse cellular functions, such as protein degradation and HEAT-SHOCK RESPONSE, by conjugation to other proteins.", "PM": "2002; see UBIQUITIN 1987-2001, see HIGH MOBILITY GROUP PROTEINS 1985-1986; for HIGH MOBILITY PROTEIN 20 & HMG-20 see UBIQUITIN 1985-1993", "HN": "2002(1985);", "MR": "20200527", "DA": "19840530", "DC": "1", "DX": "19870101", "UI": "D014452"}, {"RECTYPE": "D", "MH": "Glucuronosyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "UDP Glucuronosyltransferase|T116|T126|EQV|NLM (1992)|910212|abbdef", "ENTRY": "p Nitrophenyl UDP Glucuronosyltransferase", "MN": "D08.811.913.400.450.480", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "UDPglucuronate beta-D-glucuronosyltransferase (acceptor-unspecific)", "RN": "EC 2.4.1.17", "RR": "9030-08-4 (CAS RN)", "AN": "/defic: consider also CRIGLER-NAJJAR SYNDROME & coord with BILIRUBIN /metab (NIM)", "PI": "Transferases (1966-1971)", "MS": "A family of enzymes accepting a wide range of substrates, including phenols, alcohols, amines, and fatty acids. They function as drug-metabolizing enzymes that catalyze the conjugation of UDPglucuronic acid to a variety of endogenous and exogenous compounds. EC 2.4.1.17.", "OL": "use GLUCURONOSYLTRANSFERASE to search UDP GLUCURONOSYLTRANSFERASE 1973-91 (as Prov 1973-74)", "PM": "92; was UDP GLUCURONOSYLTRANSFERASE 1975-91 (see under HEXOSYLTRANSFERASES 1975-76)", "HN": "92; was UDP GLUCURONOSYLTRANSFERASE 1973-91 (see under HEXOSYLTRANSFERASES 1975-76, Prov 1973-74)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19770101", "UI": "D014453"}, {"RECTYPE": "D", "MH": "Uganda", "AQ": "EH EP", "ENTRY": "Republic of Uganda|T083|NAM|EQV|NLM (2009)|080701|abcdef", "MN": "Z01.058.290.120.880", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A republic in eastern Africa, south of SUDAN and west of KENYA. Its capital is Kampala.", "MR": "20090706", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014454"}, {"RECTYPE": "D", "MH": "Ukraine", "AQ": "EH EP", "MN": "Z01.542.248.960", "MH_TH": "POPLINE (1993)", "ST": "T083", "AN": "no change in English spelling in pre-Soviet, Soviet or post- Soviet translations", "MS": "Country in Europe, bordering the Black Sea, between Poland, Romania, and Moldova in the west and Russia in the east. The capital is Kyiv.", "MR": "20230531", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014455"}, {"RECTYPE": "D", "MH": "Ulcer", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ulcers", "MN": "C23.550.891", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "coord IM with organ/dis precoord (IM) but note specific precoord ulcer terms; RODENT ULCER see CARCINOMA, BASAL CELL is available; stress ulcer: index under PEPTIC ULCER or specific (IM) + STRESS, PHYSIOLOGICAL or STRESS, PSYCHOLOGICAL (IM)", "MS": "A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.", "CATSH": "CAT LIST", "MR": "20080710", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014456"}, {"RECTYPE": "D", "MH": "Ulna", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ulnas", "MN": "A02.835.232.087.090.850", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The inner and longer bone of the FOREARM.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014457"}, {"RECTYPE": "D", "MH": "Ulna Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ulna Fracture", "MN": "C26.404.937", "MH_TH": "NLM (1973)", "ST": "T037", "PI": "Ulna (1966-1972)", "MS": "Fractures of the larger bone of the forearm.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014458"}, {"RECTYPE": "D", "MH": "Ulnar Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ulnar Nerves", "MN": "A08.800.800.720.050.850", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A major nerve of the upper extremity. In humans, the fibers of the ulnar nerve originate in the lower cervical and upper thoracic spinal cord (usually C7 to T1), travel via the medial cord of the brachial plexus, and supply sensory and motor innervation to parts of the hand and forearm.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014459"}, {"RECTYPE": "D", "MH": "Ultimobranchial Body", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ultimobranchial Bodies", "MN": "A13.939", "FX": "Calcitonin", "MH_TH": "NLM (1973)", "ST": "T018", "AN": "embryonic structure in animals; /embryol permitted but consider other qualif", "PI": "Thyroid Gland (1966-1972)", "MS": "A diverticulum from the fourth pharyngeal pouch of an embryo, regarded by some as a rudimentary fifth pharyngeal pouch and by others as a lateral thyroid primordium. The ultimobranchial bodies of lower vertebrates contain large amounts of calcitonin. In mammals the bodies fuse with the thyroid gland and are thought to develop into the parafollicular cells. (Stedman, 25th ed)", "PM": "73", "HN": "73", "MR": "19950313", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014460"}, {"RECTYPE": "D", "MH": "Ultracentrifugation", "AQ": "CL EC ES HI IS MT SN ST TD VE", "MN": "E05.196.941", "MH_TH": "NLM (1965)", "ST": "T059", "AN": "general or unspecified; prefer specifics", "MS": "Centrifugation with a centrifuge that develops centrifugal fields of more than 100,000 times gravity. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014461"}, {"RECTYPE": "D", "MH": "Ultrafiltration", "AQ": "AE CL EC ES HI IS MT SN ST TD VE", "MN": "G02.263.807", "FX": "Micropore Filters", "MH_TH": "NLM (1973)", "ST": "T061", "AN": "NIM; ultrafilt of blood is indexed under HEMOFILTRATION or HEMODIAFILTRATION if combined with hemodialysis", "PI": "Filtration (1970-1972)", "MS": "The separation of particles from a suspension by passage through a filter with very fine pores. In ultrafiltration the separation is accomplished by convective transport; in DIALYSIS separation relies instead upon differential diffusion. Ultrafiltration occurs naturally and is a laboratory procedure. Artificial ultrafiltration of the blood is referred to as HEMOFILTRATION or HEMODIAFILTRATION (if combined with HEMODIALYSIS).", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014462"}, {"RECTYPE": "D", "MH": "Ultrasonography", "DE": "ULTRASONOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Ultrasonographic Imaging|T060|NON|EQV|NLM (2020)|190430|abcdef", "ENTRY": "Ultrasounds, Diagnostic", "MN": "E01.370.350.850", "FX": "Anatomy, Cross-Sectional", "MH_TH": "NLM (1974)", "ST": "T060", "AN": "IM general only; coordinate NIM with anatomical term or disease term \u200c/\u200cdiag \u200cimage; note many specific ultrasonographic techniques are available ", "MS": "The visualization of deep structures of the body by recording the reflections or echoes of ultrasonic pulses directed into the tissues. Use of ultrasound for imaging or diagnostic purposes employs frequencies ranging from 1.6 to 10 megahertz.", "OL": "use ULTRASONOGRAPHY to search ULTRASONIC DIAGNOSIS 1985-90; use ULTRASONICS/DU to search DIAGNOSIS, ULTRASONIC 1974-84", "PM": "91; was ULTRASONIC DIAGNOSIS 1985-90", "HN": "91; was ULTRASONIC DIAGNOSIS 1985-90; was DIAGNOSIS, ULTRASONIC (NON MESH) 1974-84", "CATSH": "CAT LIST", "MR": "20190708", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D014463"}, {"RECTYPE": "D", "MH": "Ultrasonic Therapy", "DE": "ULTRASONIC THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ultrasound Therapy|T061|NON|EQV|NLM (2023)|210902|abcdef", "ENTRY": "Ultrasound, Therapeutic", "MN": "E02.565.280.945", "FX": "Ultrasonic Surgical Procedures", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "coordinate with disease /ther, not disease /radiother", "MS": "The use of focused, high-frequency sound waves to produce local hyperthermia in certain diseased or injured parts of the body or to destroy the diseased tissue.", "PM": "1966", "HN": "1966", "CATSH": "CAT LIST", "MR": "20220408", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014464"}, {"RECTYPE": "D", "MH": "Ultrasonics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Ultrasonic", "MN": "H01.671.031.849", "FX": "Ultrasonic Waves", "EC": "therapeutic use:Ultrasonic Therapy", "MH_TH": "NLM (1978)", "ST": "T090", "AN": "the discipline (education, history, etc.) only; use ULTRASONOGRAPHY or ULTRASONIC THERAPY or specifics for diagnostic or therapeutic use of ULTRASONIC WAVES", "MS": "A subfield of acoustics dealing in the radio frequency range higher than acoustic SOUND waves (approximately above 20 kilohertz). Ultrasonic radiation is used therapeutically (DIATHERMY and ULTRASONIC THERAPY) to generate HEAT and to selectively destroy tissues. It is also used in diagnostics, for example, ULTRASONOGRAPHY; ECHOENCEPHALOGRAPHY; and ECHOCARDIOGRAPHY, to visually display echoes received from irradiated tissues.", "MR": "20160317", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014465"}, {"RECTYPE": "D", "MH": "Ultraviolet Rays", "AQ": "AE CL HI", "PRINT ENTRY": "Actinic Rays|T070|NON|EQV|UNK (19XX)|800520|abcdef", "ENTRY": "Ultraviolet Ray", "MN": "N06.230.300.100.725.525.600", "EC": "therapeutic use:Ultraviolet Therapy", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "non-ionizing but short-wave UV is ionizing", "MS": "That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants.", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014466"}, {"RECTYPE": "D", "MH": "Ultraviolet Therapy", "DE": "ULTRAVIOLET THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Actinotherapy|T061|NON|EQV|UNK (19XX)|740330|ACTINOTHER|abcdefv", "ENTRY": "Ultraviolet Therapies", "MN": "E02.774.945", "FX": "Photochemotherapy", "MH_TH": "NLM (1965)", "ST": "T061", "AN": "coordinate with disease /radiother, not disease /ther", "MS": "The use of ultraviolet electromagnetic radiation in the treatment of disease, usually of the skin. This is the part of the sun's spectrum that causes sunburn and tanning. Ultraviolet A, used in PUVA, is closer to visible light and less damaging than Ultraviolet B, which is ionizing.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014467"}, {"RECTYPE": "D", "MH": "Umbelliferones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Skimmetin|T109|T121|NON|NRW|UNK (19XX)|760413|abbcdef", "ENTRY": "7 Hydroxycoumarins", "MN": "D03.633.100.150.446.912", "MH_TH": "NLM (1977)", "ST": "T109", "RN": "0", "AN": "/biosyn permitted if by plant", "PI": "Coumarins (1969-1976)", "MS": "7-Hydroxycoumarins. Substances present in many plants, especially umbelliferae. Umbelliferones are used in sunscreen preparations and may be mutagenic. Their derivatives are used in liver therapy, as reagents, plant growth factors, sunscreens, insecticides, parasiticides, choleretics, spasmolytics, etc.", "PM": "77; HYMECROMONE & SCOPOLETIN were see under COUMARINS 1975-76", "HN": "77", "MR": "20160601", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D014468"}, {"RECTYPE": "D", "MH": "Umbilical Arteries", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Umbilical Artery", "MN": "A16.378.693.641", "MH_TH": "NLM (1964)", "ST": "T018", "PI": "Umbilical Cord/BS (1966-1967)", "MS": "Specialized arterial vessels in the umbilical cord. They carry waste and deoxygenated blood from the FETUS to the mother via the PLACENTA. In humans, there are usually two umbilical arteries but sometimes one.", "PM": "68", "HN": "68(64)", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014469"}, {"RECTYPE": "D", "MH": "Umbilical Cord", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Umbilical Cords", "MN": "A16.378.693", "MH_TH": "NLM (1966)", "ST": "T018", "AN": "CORD BLOOD see FETAL BLOOD is available", "MS": "The flexible rope-like structure that connects a developing FETUS to the PLACENTA in mammals. The cord contains blood vessels which carry oxygen and nutrients from the mother to the fetus and waste products away from the fetus.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014470"}, {"RECTYPE": "D", "MH": "Umbilical Veins", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Veins, Umbilical", "MN": "A16.378.693.807", "MH_TH": "NLM (1964)", "ST": "T018", "MS": "Venous vessels in the umbilical cord. They carry oxygenated, nutrient-rich blood from the mother to the FETUS via the PLACENTA. In humans, there is normally one umbilical vein.", "OL": "use UMBILICAL VEINS to search UMBILICAL VEIN 1966-67 (as Prov)", "PM": "68", "HN": "68; was UMBILICAL VEIN 1964-67 (Prov)", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014471"}, {"RECTYPE": "D", "MH": "Umbilicus", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU TR VI", "MN": "A01.923.047.849", "MH_TH": "NLM (1966)", "ST": "T029", "CX": "consider also terms at OMPHALO- (navel)", "MS": "The pit in the center of the ABDOMINAL WALL marking the point where the UMBILICAL CORD entered in the FETUS.", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014472"}, {"RECTYPE": "D", "MH": "Unconscious, Psychology", "PRINT ENTRY": "Unconscious (Psychology)|T041|NON|EQV|NLM (1969)|990101|UNCONSCIOUS PSYCHOL|abcdefv", "ENTRY": "Unconscious, Psychological", "MN": "F02.739.794.942", "MH_TH": "NLM (2020)", "ST": "T041", "AN": "\"the unconscious\" or unconscious behavior: do not confuse with UNCONSCIOUSNESS, the physiologic loss of consciousness", "MS": "Those forces and content of the mind which are not ordinarily available to conscious awareness or to immediate recall.", "PM": "2020; was UNCONCSCIOUS (PSYCHOLOGY) 1969-2019; was SUBCONSCIOUS 1963-1968", "HN": "2020 (1969); was UNCONCSCIOUS (PSYCHOLOGY) 1969-2019; was SUBCONSCIOUS 1963-1968", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D014473"}, {"RECTYPE": "D", "MH": "Unconsciousness", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Unconscious State|T033|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Unconscious States", "MN": "C23.888.592.604.359.800", "FX": "Syncope", "MH_TH": "NLM (1966)", "ST": "T033", "AN": "do not confuse with UNCONSCIOUS (PSYCHOLOGY), unconscious behavior or \"the unconscious\" in psychol", "MS": "Loss of the ability to maintain awareness of self and environment combined with markedly reduced responsiveness to environmental stimuli. (From Adams et al., Principles of Neurology, 6th ed, pp344-5)", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014474"}, {"RECTYPE": "D", "MH": "Uncoupling Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Agents, Uncoupling", "MN": "D27.505.519.389.936", "FX": "Ionophores", "MH_TH": "NLM (1969)", "ST": "T121", "RN": "0", "AN": "enzyme inhib", "PI": "Oxidoreductases/antagonists & inhibitors (1968)", "MS": "Chemical agents that uncouple oxidation from phosphorylation in the metabolic cycle so that ATP synthesis does not occur. Included here are those IONOPHORES that disrupt electron transfer by short-circuiting the proton gradient across mitochondrial membranes.", "PM": "72; DIO-9 was see under ANTIBIOTICS 1975-81", "HN": "72(69)", "MR": "20140625", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014475"}, {"RECTYPE": "D", "MH": "Undecylenic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Undecylenic Acid Dervatives|T109|T121|T123|NON|EQV|NLM (2014)|130613|abbbcdef", "MN": "D10.251.355.325.919", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Salts and derivatives of undecylenic acid.", "PM": "1963; see UNDECYLENIC ACID 1963-1974", "HN": "1963(1975)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D014476"}, {"RECTYPE": "D", "MH": "Underachievement", "ENTRY": "Underachievements", "MN": "F02.784.629.880", "MH_TH": "NLM (1968)", "ST": "T055", "PI": "Learning Disorders (1966-1967)", "MS": "Performance, usually in school work, poorer than that predicted from aptitude and/or intelligence testing.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "19890516", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014477"}, {"RECTYPE": "D", "MH": "Unemployment", "AQ": "CL HI PX SN TD", "MN": "N01.824.245.850", "MH_TH": "POPLINE (1978)", "ST": "T068", "MS": "The state of not being engaged in a gainful occupation.", "MR": "19950523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014478"}, {"RECTYPE": "D", "MH": "United Arab Emirates", "AQ": "EH EP", "PRINT ENTRY": "Trucial States|T083|NAM|EQV|UNK (19XX)|800513|abcdef", "MN": "Z01.252.245.500.900", "MH_TH": "POPLINE (1986)", "ST": "T083", "AN": "7 states on the southeast Arabian peninsula", "MS": "A federation of seven states on the southeast portion of the Arabian peninsula: Abu Dhabi, Ajman, Dubai, Fujairah, Ras al-Khaimah, Sharjah and Umm al-Qaiwain. In 1820 a treaty of peace was concluded between Great Britain and native rulers. During the 19th century the rulers agreed to suppression of the slave trade and restriction of foreign relations to Great Britain. The Trucial Council was established in 1952 and defense treaties with Great Britain terminated. In 1971 an independent six-member federation was formed, with Ras al-Khaimah joining the federation in 1972. (From Webster's New Geographical Dictionary, 1988, p1250)", "OL": "use UNITED ARAB EMIRATES to search TRUCIAL STATES 1975-80", "HN": "81; was TRUCIAL STATES 1975-80", "MR": "20150629", "DA": "19741111", "DC": "4", "DX": "19750101", "UI": "D014479"}, {"RECTYPE": "D", "MH": "United Nations", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "UNICEF|T092|NAM|NRW|POPLINE (1978)|790411|abcdef", "ENTRY": "United Nations High Commissioner for Refugees (UNHCR)|T092|NON|NRW|NLM (2012)|110405|abcdef", "MN": "N03.540.514.718", "MH_TH": "NLM (1980)", "ST": "T092", "AN": "CATALOGER: Use NAF entry", "PI": "International Agencies (1966-1979)", "MS": "An international organization whose members include most of the sovereign nations of the world with headquarters in New York City. The primary objectives of the organization are to maintain peace and security and to achieve international cooperation in solving international economic, social, cultural, or humanitarian problems.", "PM": "80", "HN": "80", "MR": "20180629", "DA": "19790411", "DC": "1", "DX": "19800101", "UI": "D014480"}, {"RECTYPE": "D", "MH": "United States", "AQ": "EH EP", "MN": "Z01.107.567.875", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "do not abbreviate; each state is available as a heading as are several cities; \"American\" in the literature refers probably to UNITED STATES, not AMERICAS", "MS": "A country in NORTH AMERICA between CANADA and MEXICO.", "MR": "20180228", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014481"}, {"RECTYPE": "D", "MH": "United States Substance Abuse and Mental Health Services Administration", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "United States Alcohol, Drug Abuse, and Mental Health Administration|T093|NAM|NRW|NLM (1994)|930510|UNITED STATES ALCOHOL DRUG ABUSE MENTAL HEALTH ADMIN|abcdefv", "ENTRY": "United States Health Services and Mental Health Administration|T093|NAM|NRW|NLM (1994)|930510|UNITED STATES HEALTH SERV MENTAL HEALTH ADMIN|abcdefv", "MN": "N03.540.348.500.500.600.650.920", "MH_TH": "NLM (1975)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; CATALOGER: Use NAF entry", "MS": "An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to substance abuse and mental health. It is commonly referred to by the acronym SAMHSA. On 1 October 1992, the United States Alcohol, Drug Abuse, and Mental Health Administration (ADAMHA) became SAMHSA.", "PM": "1994; see UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1978-1993; see ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1975-1977, see UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-1974", "HN": "1994", "MR": "20150629", "DA": "19750203", "DC": "1", "DX": "19750901", "UI": "D014482"}, {"RECTYPE": "D", "MH": "United States Dept. of Health and Human Services", "DE": "HHS", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "United States Department of Health, Education, and Welfare|T093|NAM|BRD|UNK (19XX)|800527|HEW|abcdefv", "ENTRY": "United States. Dept. of Health and Human Services|T093|NAM|EQV|NLM (2008)|070223|abcdef", "MN": "N03.540.348.500.500.600", "MH_TH": "NLM (1976)", "ST": "T093", "AN": "add UNITED STATES;  research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.; CATALOGER: Use NAF entry", "PI": "specific agency (1968-1975)", "MS": "A cabinet department in the Executive Branch of the United States Government concerned with administering those agencies and offices having programs pertaining to health and human services.", "PM": "1982; see UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES 1981, see UNITED STATES DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE 1976-1880", "HN": "1882(1976)", "MR": "20150629", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D014483"}, {"RECTYPE": "D", "MH": "United States Environmental Protection Agency", "DE": "EPA", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Environmental Protection Agency (U.S.)|T092|NAM|EQV|UNK (19XX)|810226|abcdef", "ENTRY": "USEPA|T092|ACR|EQV|NLM (2008)|070707|abcdef", "MN": "N03.540.348.500.500.937", "MH_TH": "NLM (1982)", "ST": "T092", "AN": "add UNITED STATES;  research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.; CATALOGER: Use NAF entry", "PI": "Government Agencies (1968-1981)", "MS": "An agency in the Executive Branch of the Federal Government. It was created as an independent regulatory agency responsible for the implementation of federal laws designed to protect the environment. Its mission is to protect human health and the ENVIRONMENT.", "PM": "1991; was see under GOVERNMENT AGENCIES 1982-90", "HN": "1991(1982)", "MR": "20150629", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D014484"}, {"RECTYPE": "D", "MH": "United States Federal Trade Commission", "DE": "FTC", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "USFTC|T092|ACR|EQV|NLM (2008)|070707|abcdef", "ENTRY": "Federal Trade Commission|T092|NAM|EQV|UNK (19XX)|810605|abcdef", "MN": "N03.540.348.500.500.968", "MH_TH": "NLM (1982)", "ST": "T092", "AN": "add UNITED STATES;  research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.; CATALOGER: Use NAF entry", "PI": "Government Agencies (1968-1981)", "MS": "An independent administrative agency concerned with maintaining competitive free enterprise by prohibiting unfair methods of competition and unfair deceptive acts or practices.", "PM": "91; was see under GOVERNMENT AGENCIES 1982-90", "HN": "91(82); was see under GOVERNMENT AGENCIES 1982-90", "MR": "20150629", "DA": "19810226", "DC": "1", "DX": "19910101", "UI": "D014485"}, {"RECTYPE": "D", "MH": "United States Food and Drug Administration", "DE": "FDA", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "USFDA|T093|NAM|EQV|NLM (1996)|950324|abcdef", "ENTRY": "United States Food, Drug Administration|T093|NAM|EQV|UNK (19XX)|790329|UNITED STATES FOOD DRUG ADMIN|abcdefv", "MN": "N03.540.348.500.500.600.650.760", "MH_TH": "NLM (1964)", "ST": "T093", "AN": "add UNITED STATES;  research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; CATALOGER: Use NAF entry", "MS": "An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.", "PM": "66", "HN": "66(64)", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014486"}, {"RECTYPE": "D", "MH": "Centers for Medicare and Medicaid Services, U.S.", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "United States Health Care Financing Administration|T093|NAM|EQV|NLM (1982)|990101|abcdef", "ENTRY": "Health Care Financing Administration, U.S.|T093|NAM|EQV|NLM (2020)|180827|abcdef", "MN": "N03.540.348.500.500.600.550", "MH_TH": "NLM (2020)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.; CATALOGER: Use NAF entry", "MS": "A component of the Department of Health and Human Services to oversee and direct the Medicare and Medicaid programs and related Federal medical care quality control staffs. Name was changed effective June 14, 2001.", "PM": "2020; see CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.) 2002-2019; see UNITED STATES HEALTH CARE FINANCING ADMINISTRATION 1992-2001; see UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES 1982-1990", "HN": "2020 (1982); was CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.) 2002-2019; was UNITED STATES HEALTH CARE FINANCING ADMINISTRATION 1992-2001; was UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES 1982-1990", "MR": "20181010", "DA": "19810519", "DC": "1", "DX": "19910101", "UI": "D014487"}, {"RECTYPE": "D", "MH": "United States Health Resources and Services Administration", "DE": "HRSA", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "United States Health Resources Administration|T093|NAM|NRW|UNK (19XX)|830614|UNITED STATES HEALTH RESOURCES ADMIN|abcdefv", "ENTRY": "Health Resources and Services Administration (U.S.)|T093|NAM|EQV|UNK (19XX)|830614|HEALTH RESOURCES SERV ADMIN|abcdefv", "MN": "N03.540.348.500.500.600.650.790", "MH_TH": "NLM (1979)", "ST": "T093", "AN": "add UNITED STATES;  research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; CATALOGER: Use NAF entry", "MS": "A component of the PUBLIC HEALTH SERVICE that provides leadership related to the delivery of health services and the requirements for and distribution of health resources, including manpower training.", "OL": "use UNITED STATES HEALTH RESOURCES AND SERVICES ADMINISTRATION to search UNITED STATES HEALTH RESOURCES ADMINISTRATION 1979-83", "PM": "84; was UNITED STATES HEALTH RESOURCES ADMINISTRATION 1980-83; was see under UNITED STATES PUBLIC HEALTH SERVICE 1979", "HN": "84; was UNITED STATES HEALTH RESOURCES ADMINISTRATION 1980-83; was see under UNITED STATES PUBLIC HEALTH SERVICE 1979", "MR": "20150629", "DA": "19780510", "DC": "1", "DX": "19800101", "UI": "D014488"}, {"RECTYPE": "D", "MH": "United States Occupational Safety and Health Administration", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Occupational Safety and Health Administration (U.S.)|T093|NAM|EQV|UNK (19XX)|810226|OCCUP SAFETY HEALTH ADMIN|abcdefv", "ENTRY": "United States Occupational Safety, Health Administration|T093|NAM|EQV|UNK (19XX)|810605|UNITED STATES OCCUP SAFETY HEALTH ADMIN|abcdefv", "MN": "N03.540.348.500.500.992", "MH_TH": "NLM (1982)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.; CATALOGER: Use NAF entry", "PI": "Government Agencies (1968-1981)", "MS": "An office in the Department of Labor responsible for developing and establishing occupational safety and health standards.", "PM": "82", "HN": "82", "MR": "20150629", "DA": "19810226", "DC": "1", "DX": "19820101", "UI": "D014489"}, {"RECTYPE": "D", "MH": "United States Office of Economic Opportunity", "DE": "UNITED STATES OFFICE ECON OPPORTUNITY", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Office of Economic Opportunity (U.S.)|T092|NAM|EQV|UNK (19XX)|800527|OFFICE OF ECON OPPORTUNITY|abcdefv", "ENTRY": "Office of Economic Opportunity|T092|NAM|EQV|UNK (19XX)|810605|OEO|abcdefv", "MN": "N03.540.348.500.500.996", "MH_TH": "NLM (1968)", "ST": "T092", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.; CATALOGER: Use NAF entry", "PI": "Government (1966-1967)", "MS": "A division of the Executive Branch of the United States government concerned with overall planning, promoting, and administering programs relative to the provision of opportunities for economic advancement.", "PM": "68", "HN": "68", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014490"}, {"RECTYPE": "D", "MH": "United States Office of Technology Assessment", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Office of Technology Assessment (U.S.)|T092|NAM|EQV|UNK (19XX)|870504|OFFICE TECHNOL ASSESS|abcdefv", "ENTRY": "United States Congress Office of Technology Assessment|T092|NON|EQV|NLM (2002)|001214|abcdef", "MN": "N03.540.348.500.500.998", "MH_TH": "NLM (1988)", "ST": "T092", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.; CATALOGER: Use NAF entry", "PI": "Technology Assessment, Biomedical (1980-1987)", "MS": "An office established to help Congress participate and plan for the consequences of uses of technology. It provided information on both the beneficial and adverse effects of technological applications. The Office of Technology Assessment closed on September 29, 1995.", "PM": "88", "HN": "88", "MR": "20150629", "DA": "19870504", "DC": "1", "DX": "19880101", "UI": "D014491"}, {"RECTYPE": "D", "MH": "United States Public Health Service", "DE": "PHS", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "USPHS|T093|ACR|EQV|POPLINE (1978)|781226|abcdef", "ENTRY": "United States. Public Health Service|T093|NON|EQV|NLM (2008)|070223|abcdef", "MN": "N03.540.348.500.500.600.650", "MH_TH": "NLM (1966)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; CATALOGER: Use NAF entry", "MS": "A constituent organization of the DEPARTMENT OF HEALTH AND HUMAN SERVICES concerned with protecting and improving the health of the nation.", "PM": "66", "HN": "66", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014492"}, {"RECTYPE": "D", "MH": "United States Department of Veterans Affairs", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Veterans Affairs (U.S.)|T092|NAM|EQV|NLM (1998)|970121|abcdef", "ENTRY": "Veterans Administration|T092|NAM|EQV|UNK (19XX)|810605|abcdef", "MN": "N03.540.348.500.500.700", "MH_TH": "NLM (1966)", "ST": "T092", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.; CATALOGER: Use NAF entry", "MS": "A cabinet department in the Executive Branch of the United States Government concerned with overall planning, promoting, and administering programs pertaining to VETERANS. It was established March 15, 1989 as a Cabinet-level position.", "PM": "1991; was UNITED STATES VETERANS ADMINISTRATION 1966-90", "HN": "1991; was UNITED STATES VETERANS ADMINISTRATION 1966-90", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014493"}, {"RECTYPE": "D", "MH": "Unithiol", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "DMPS Heyl", "MN": "D02.886.489.180.900", "PA": "Chelating Agents", "MH_TH": "NLM (1976)", "ST": "T130", "N1": "1-Propanesulfonic acid, 2,3-dimercapto-, monosodium salt", "RN": "4076-02-2", "RR": "74-61-3 (parent cpd)", "PI": "Sulfhydryl Compounds (1974-1975)", "MS": "A chelating agent used as an antidote to heavy metal poisoning.", "PM": "91; was see under DIMERCAPROL 1976-90", "HN": "91(76); was see under DIMERCAPROL 1976-90", "MR": "20160701", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D014494"}, {"RECTYPE": "D", "MH": "Universities", "DE": "UNIV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "University", "MN": "J03.832.830", "MH_TH": "POPLINE (1978)", "ST": "T092", "AN": "IM; Manual 30.8, 36.18; specify locale if pertinent; colleges as educ institutions go here: do not confuse with bodies such as \"College of Physicians\" which are indexed under SOCIETIES, MEDICAL; Uniformed Services University of the Health Sciences (USUHS), under US Dept of Defense, goes under SCHOOLS, MEDICAL + UNITED STATES; DF: UNIV", "MS": "Educational institutions providing facilities for teaching and research and authorized to grant academic degrees.", "MR": "20160608", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014495"}, {"RECTYPE": "D", "MH": "Urachal Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Umbilical Cyst|T047|NON|REL|UNK (19XX)|800509|abcdef", "ENTRY": "Urachal Cysts", "MN": "C04.182.946", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "non-neoplastic; do not confuse with patent urachus (= URACHUS /abnorm)", "MS": "Cyst occurring in a persistent portion of the urachus, presenting as an extraperitoneal mass in the umbilical region. It is characterized by abdominal pain, and fever if infected. It may rupture, leading to peritonitis, or it may drain through the umbilicus.", "OL": "use URACHAL CYST to search UMBILICAL CYST 1966-80", "PM": "81; was UMBILICAL CYST 1963-80", "HN": "81; was UMBILICAL CYST 1963-80", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D014496"}, {"RECTYPE": "D", "MH": "Urachus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A16.890", "MH_TH": "NLM (1963)", "ST": "T018", "AN": "patent urachus: index under URACHUS /abnorm: do not confuse with URACHAL CYST", "MS": "An embryonic structure originating from the ALLANTOIS. It is a canal connecting the fetal URINARY BLADDER and the UMBILICUS. It is normally converted into a fibrous cord postnatally. When the canal fails to be filled and remains open (patent urachus), urine leaks through the umbilicus.", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014497"}, {"RECTYPE": "D", "MH": "Uracil", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.383.742.698.875", "MH_TH": "USAN (19XX)", "ST": "T123", "N1": "2,4(1H,3H)-Pyrimidinedione", "RN": "56HH86ZVCT", "RR": "66-22-8 (Uracil)", "MS": "One of four nucleotide bases in the nucleic acid RNA.", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014498"}, {"RECTYPE": "D", "MH": "Uracil Mustard", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uramustine|T114|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|800404|abbcdeeef", "ENTRY": "Mustard, Uracil", "MN": "D03.383.742.698.875.949", "PA": "Antineoplastic Agents, Alkylating", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4(1H,3H)-Pyrimidinedione, 5-(bis(2-chloroethyl)amino)-", "RN": "W7KQ46GJ8U", "RR": "66-75-1 (Uracil Mustard)", "MS": "Nitrogen mustard derivative of URACIL. It is a alkylating antineoplastic agent that is used in lymphatic malignancies, and causes mainly gastrointestinal and bone marrow damage.", "PM": "66", "HN": "66(63)", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014499"}, {"RECTYPE": "D", "MH": "Uracil Nucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uridine Phosphates|T114|NON|EQV|UNK (19XX)|741105|abcdef", "ENTRY": "Phosphates, Uridine", "MN": "D13.695.827.919", "MH_TH": "NLM (1963)", "ST": "T114", "RN": "0", "MS": "A group of pyrimidine NUCLEOTIDES which contain URACIL.", "MR": "20170308", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D014500"}, {"RECTYPE": "D", "MH": "Uranium", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "MN": "D01.552.544.900", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Uranium", "RN": "4OC371KSTK", "RR": "7440-61-1 (Uranium)", "MS": "A radioactive element of the actinide series of metals. It has an atomic symbol U, atomic number 92, and atomic weight 238.03. U-235 is used as the fissionable fuel in nuclear weapons and as fuel in nuclear power reactors.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014501"}, {"RECTYPE": "D", "MH": "Uranyl Nitrate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nitrate, Uranyl", "MN": "D01.950.950", "MH_TH": "NLM (1976)", "ST": "T197", "N1": "Uranium, bis(nitrato-O)dioxo-, (T-4)-", "RN": "0C0WI17JYF", "RR": "10102-06-4 (Uranyl Nitrate)", "AN": "used in photography & porcelain indust", "PI": "Uranium (1973-1975)", "MS": "Bis(nitrato-O)dioxouranium. A compound used in photography and the porcelain industry. It causes severe renal insufficiency and renal tubular necrosis in mammals and is an effective lymphocyte mitogen.", "PM": "91; was see under URANIUM 1976-90", "HN": "91(76); was see under URANIUM 1976-90", "MR": "20130708", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D014502"}, {"RECTYPE": "D", "MH": "Urate Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Uricase|T116|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Oxidase, Urate", "MN": "D08.811.682.943", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Urate:oxygen oxidoreductase", "RN": "EC 1.7.3.3", "MS": "An enzyme that catalyzes the conversion of urate and unidentified products. It is a copper protein. The initial products decompose to form allantoin. EC 1.7.3.3.", "PM": "66", "HN": "66", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014503"}, {"RECTYPE": "D", "MH": "Urban Health", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "ENTRY": "Health, Urban", "MN": "N01.400.548.875", "MH_TH": "NLM (1979)", "ST": "T078", "AN": "specify geog", "PI": "Health (1966-1978)", "MS": "The status of health in urban populations.", "PM": "90; was see under HEALTH 1979-89", "HN": "90(79); was see under HEALTH 1979-89", "MR": "20180623", "DA": "19780510", "DC": "1", "DX": "19900101", "UI": "D014504"}, {"RECTYPE": "D", "MH": "Urban Population", "AQ": "CL HI SN TD", "PRINT ENTRY": "Urban Residence|T073|NON|REL|NLM (2023)|211027|abcdef", "ENTRY": "Urban Spatial Distributions", "MN": "N01.600.900", "FX": "Urbanization", "MH_TH": "POPLINE (1978)", "ST": "T098", "AN": "specify geog; URBAN HEALTH & URBAN HEALTH SERVICES are also available", "PI": "Population (1966-1967)", "MS": "The inhabitants of a city or town, including metropolitan areas and suburban areas.", "PM": "68", "HN": "68", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014505"}, {"RECTYPE": "D", "MH": "Urban Renewal", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Urban Development|T068|NON|BRD|UNK (19XX)|740330|abcdef", "ENTRY": "Urban Renewals", "MN": "I01.880.709.876", "FX": "Housing", "MH_TH": "NLM (1968)", "ST": "T068", "AN": "Public Law 89-754; specify locale", "PI": "Social Conditions (1966-1967)", "MS": "The planned upgrading of a deteriorating urban area, involving rebuilding, renovation, or restoration. It frequently refers to programs of major demolition and rebuilding of blighted areas.", "PM": "68", "HN": "68", "MR": "19991105", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014506"}, {"RECTYPE": "D", "MH": "Urbanization", "AQ": "HI LJ TD", "ENTRY": "Urbanizations", "MN": "I01.880.853.400.726", "FX": "Cities", "MH_TH": "POPLINE (1986)", "ST": "T068", "AN": "specify geog if pertinent", "PI": "Sociology (1966-1967)", "MS": "The process whereby a society changes from a rural to an urban way of life. It refers also to the gradual increase in the proportion of people living in urban areas.", "PM": "68", "HN": "68", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014507"}, {"RECTYPE": "D", "MH": "Urea", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Carmol|T109|T121|T123|TRD|NRW|UNK (19XX)|861118|abbbcdef", "MN": "D02.065.950", "FX": "Blood Urea Nitrogen", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "Urea", "RN": "8W8T17847W", "RR": "57-13-6 (Urea)", "MS": "A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014508"}, {"RECTYPE": "D", "MH": "Ureaplasma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Ureaplasma parvum|T007|NON|NRW|NLM (2003)|020305|abcdef", "ENTRY": "Ureaplasma urealyticum biovar 1|T007|NON|NRW|NLM (2003)|020305|abcdef", "MN": "B03.440.860.580.553.900", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid2129", "RR": "txid134821", "PI": "Mycoplasma (1966-1975)", "MS": "A genus of gram-negative, nonmotile bacteria which are common parasitic inhabitants of the urogenital tracts of humans, cattle, dogs, and monkeys.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750718", "DC": "1", "DX": "19760101", "UI": "D014509"}, {"RECTYPE": "D", "MH": "Urease", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Amidohydrolase, Urea", "MN": "D08.811.277.087.902", "MH_TH": "NLM (1966)", "ST": "T126", "N1": "Urea amidohydrolase", "RN": "EC 3.5.1.5", "MS": "An enzyme that catalyzes the conversion of urea and water to carbon dioxide and ammonia. EC 3.5.1.5.", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014510"}, {"RECTYPE": "D", "MH": "Uremia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Uremias", "MN": "C12.950.419.936", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014511"}, {"RECTYPE": "D", "MH": "Ureohydrolases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ureohydrolase|T116|T126|NON|EQV|NLM (2022)|201007|abbcdef", "MN": "D08.811.277.913", "MH_TH": "NLM (1966)", "ST": "T126", "RN": "EC 3.5.3.-", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014512"}, {"RECTYPE": "D", "MH": "Ureter", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ureters|T023|NON|EQV|NLM (2007)|051122|abcdef", "MN": "A05.810.776", "FX": "Urinary Diversion", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "One of a pair of thick-walled tubes that transports urine from the KIDNEY PELVIS to the URINARY BLADDER.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014513"}, {"RECTYPE": "D", "MH": "Ureteral Calculi", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Calculus, Ureteral", "MN": "C23.300.175.850.750", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "chem composition of caclculi use /chem; /ultrastruct permitted", "MS": "Stones in the URETER that are formed in the KIDNEY. They are rarely more than 5 mm in diameter for larger renal stones cannot enter ureters. They are often lodged at the ureteral narrowing and can cause excruciating renal colic.", "OL": "to search for chem composition of ureteral calculi, use URETERAL CALCULI/anal 1987-90 & URETERAL CALCULI/metab 1966-86", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014514"}, {"RECTYPE": "D", "MH": "Ureteral Diseases", "DE": "URETERAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ureteral Disease", "MN": "C12.950.725", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes involving the URETERS.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014515"}, {"RECTYPE": "D", "MH": "Ureteral Neoplasms", "DE": "URETERAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Ureteral Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Ureteral Neoplasm", "MN": "C12.950.983.875", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "do not confuse with URETHRAL NEOPLASMS, especially in Romance language: see note on \"ureteral\" & \"urethral\" under URETERAL DISEASES; coordinate IM with histological type of neoplasm (IM)", "MS": "Cancer or tumors of the URETER which may cause obstruction leading to hydroureter, HYDRONEPHROSIS, and PYELONEPHRITIS. HEMATURIA is a common symptom.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014516"}, {"RECTYPE": "D", "MH": "Ureteral Obstruction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ureteral Obstructions", "MN": "C12.950.725.776", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "do not confuse with URETHRAL OBSTRUCTION, especially in Romance languages: see note on \"ureteral\" & \"urethral\" under URETERAL DISEASES", "MS": "Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014517"}, {"RECTYPE": "D", "MH": "Ureterocele", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ureteroceles", "MN": "C12.950.725.876", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "A cystic dilatation of the end of a URETER as it enters into the URINARY BLADDER. It is characterized by the ballooning of the ureteral orifice into the lumen of the bladder and may obstruct urine flow.", "PM": "68", "HN": "68(63)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014518"}, {"RECTYPE": "D", "MH": "Ureterostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Ureterostomies", "MN": "E04.950.774.852.947", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Urinary Diversion (1966-1987)", "MS": "Surgical formation of an opening in the ureter for external drainage of the urine; cutaneous route utilizes a ureteral orifice emerging through the skin.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19870320", "DC": "1", "DX": "19880101", "UI": "D014519"}, {"RECTYPE": "D", "MH": "Urethane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethyl Carbamate|T109|T121|NON|EQV|NLM (1993)|920204|abbcdef", "ENTRY": "Carbamate, Ethyl", "MN": "D02.241.081.251.944", "PA": "Carcinogens", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Carbamic acid, ethyl ester", "RN": "3IN71E75Z5", "RR": "51-79-6 (Urethane)", "AN": "POLYURETHANES is available", "MS": "Antineoplastic agent that is also used as a veterinary anesthetic. It has also been used as an intermediate in organic synthesis. Urethane is suspected to be a carcinogen.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014520"}, {"RECTYPE": "D", "MH": "Urethra", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vesical Sphincter, Internal", "MN": "A05.810.876", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A tube that transports URINE from the URINARY BLADDER to the outside of the body in both the sexes. It also has a reproductive function in the male by providing a passage for SPERM.", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014521"}, {"RECTYPE": "D", "MH": "Urethral Diseases", "DE": "URETHRAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Urethral Disease", "MN": "C12.950.767", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes involving the URETHRA.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014522"}, {"RECTYPE": "D", "MH": "Urethral Neoplasms", "DE": "URETHRAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Urethral Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Urethral Neoplasm", "MN": "C12.950.983.890", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "do not confuse with URETERAL NEOPLASMS, especially in Romance language: see note on \"ureteral\" & \"urethral\" under URETERAL DISEASES; coordinate IM with histological type of neoplasm (IM)", "MS": "Cancer or tumors of the URETHRA. Benign epithelial tumors of the urethra usually consist of squamous and transitional cells. Primary urethral carcinomas are rare and typically of squamous cells. Urethral carcinoma is the only urological malignancy that is more common in females than in males.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014523"}, {"RECTYPE": "D", "MH": "Urethral Obstruction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Urethral Obstructions", "MN": "C12.950.767.700", "MH_TH": "NLM (1979)", "ST": "T047", "AN": "do not confuse with URETERAL OBSTRUCTION, especially in Romance languages: see note on \"ureteral\" & \"urethral\" under URETERAL DISEASES; URETHRAL STRICTURE is also available", "PI": "Urethral Stricture (1966-1978)", "MS": "Partial or complete blockage in any part of the URETHRA that can lead to difficulty or inability to empty the URINARY BLADDER. It is characterized by an enlarged, often damaged, bladder with frequent urges to void.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19771123", "DC": "1", "DX": "19790101", "UI": "D014524"}, {"RECTYPE": "D", "MH": "Urethral Stricture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Urethral Stenosis|T047|T190|NON|EQV|NLM (1993)|911003|abbcdef", "ENTRY": "Urethral Strictures, Posterior", "MN": "C12.950.767.700.700", "MH_TH": "NLM (1963)", "ST": "T190", "AN": "do not confuse with URETHRAL OBSTRUCTION", "MS": "Narrowing of any part of the URETHRA. It is characterized by decreased urinary stream and often other obstructive voiding symptoms.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014525"}, {"RECTYPE": "D", "MH": "Urethritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Urethritides", "MN": "C12.950.767.851", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Inflammation involving the URETHRA. Similar to CYSTITIS, clinical symptoms range from vague discomfort to painful urination (DYSURIA), urethral discharge, or both.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014526"}, {"RECTYPE": "D", "MH": "Uric Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Urate, Sodium Acid", "MN": "D03.633.100.759.758.824.877", "PA": "Antioxidants", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-", "RN": "268B43MJ25", "RR": "69-93-2 (Uric Acid)", "MS": "An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.", "MR": "20160622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014527"}, {"RECTYPE": "D", "MH": "Uricosuric Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uricosuric Agent|T121|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Agents, Uricosuric", "MN": "D27.505.954.329.337.900", "MH_TH": "NLM (1964)", "ST": "T121", "RN": "0", "MS": "Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma.", "PM": "64", "HN": "64", "MR": "20210708", "DA": "19990101", "DC": "1", "DX": "19640101", "UI": "D014528"}, {"RECTYPE": "D", "MH": "Uridine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Allo Uridine", "MN": "D13.570.800.892", "MH_TH": "NLM (1964)", "ST": "T123", "N1": "Uridine", "RN": "WHI7HQ7H85", "RR": "58-96-8 (Uridine)", "MS": "A ribonucleoside in which RIBOSE is linked to URACIL.", "PM": "66; was see under NUCLEOSIDES 1963-65; ARABINOFURANOSYLURACIL was see under PYRIMIDINE NUCLEOSIDES 1976-77", "HN": "66(64); was see under NUCLEOSIDES 1963-65", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014529"}, {"RECTYPE": "D", "MH": "Uridine Diphosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "UDP|T109|T114|T123|ABB|EQV|UNK (19XX)|770420|abbbcdef", "ENTRY": "Pyrophosphate, Uridine", "MN": "D13.695.827.919.600", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Uridine 5'-(trihydrogen diphosphate)", "RN": "58-98-0", "PI": "Uracil Nucleotides (1966-1977)", "MS": "A uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety.", "PM": "91; was see under URACIL NUCLEOTIDES 1978-90", "HN": "91(78); was see under URACIL NUCLEOTIDES 1978-90", "MR": "20160601", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D014530"}, {"RECTYPE": "D", "MH": "Uridine Diphosphate Galactose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uridine Pyrophosphogalactose|T109|T114|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Pyrophosphogalactose, Uridine", "MN": "D13.695.827.919.600.677.300", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Uridine 5'-(trihydrogen diphosphate), P'-alpha-D-galactopyranosyl ester", "RN": "2956-16-3", "PI": "Uridine Diphosphate Sugars (1973-1974)", "MS": "A nucleoside diphosphate sugar which can be epimerized into UDPglucose for entry into the mainstream of carbohydrate metabolism. Serves as a source of galactose in the synthesis of lipopolysaccharides, cerebrosides, and lactose.", "PM": "91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014531"}, {"RECTYPE": "D", "MH": "Uridine Diphosphate Glucose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uridine Diphosphoglucose|T109|T114|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Glucose, Uridine Diphosphate", "MN": "D13.695.827.919.600.677.350", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Uridine 5'-(trihydrogen diphosphate), P'-alpha-D-glucopyranosyl ester", "RN": "V50K1D7P4Y", "RR": "133-89-1 (Uridine Diphosphate Glucose)", "PI": "Uridine Diphosphate Sugars (1973-1974)", "MS": "A key intermediate in carbohydrate metabolism. Serves as a precursor of glycogen, can be metabolized into UDPgalactose and UDPglucuronic acid which can then be incorporated into polysaccharides as galactose and glucuronic acid. Also serves as a precursor of sucrose lipopolysaccharides, and glycosphingolipids.", "PM": "91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014532"}, {"RECTYPE": "D", "MH": "Uridine Diphosphate Glucose Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "UDPG Dehydrogenase|T109|T116|T126|EQV|UNK (19XX)|741111|abbbdef", "ENTRY": "Glucose Dehydrogenase, UDP", "MN": "D08.811.682.047.150.900", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "UDPglucose:NAD+ 6-oxidoreductase", "RN": "EC 1.1.1.22", "PI": "Uridine Diphosphate Sugars (1973-1974)", "MS": "An enzyme that catalyzes the oxidation of UDPglucose to UDPglucuronate in the presence of NAD+. EC 1.1.1.22.", "PM": "91; was see under CARBOHYDRATE DEHYDROGENASES 1978-90; was see under ALCOHOL OXIDOREDUCTASES 1975-77", "HN": "91(75); was see under CARBOHYDRATE DEHYDROGENASES 1978-90; was see under ALCOHOL OXIDOREDUCTASES 1975-77", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014533"}, {"RECTYPE": "D", "MH": "UDPglucose 4-Epimerase", "DS": "UDPGLUCOSE EPIMERASE 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Uridine Diphosphate Glucose Epimerase|T116|T126|NON|EQV|NLM (1998)|961108|abbcdef", "ENTRY": "UDPglucose 4 Epimerase", "MN": "D08.811.399.894.500.700", "FX": "Galactosemias", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "UDPglucose 4-epimerase", "RN": "EC 5.1.3.2", "RR": "9032-89-7 (CAS RN)", "PI": "Uridine Diphosphate Sugars (1973-1974)", "MS": "A necessary enzyme in the metabolism of galactose. It reversibly catalyzes the conversion of UDPglucose to UDPgalactose. NAD+ is an essential component for enzymatic activity. EC 5.1.3.2.", "PM": "98; see URIDINE DIPHOSPHATE GLUCOSE EPIMERASE 1991-97, see CARBOHYDRATE ISOMERASES 1975-90; UDPGALACTOSE 4-EPIMERASE & UPD-GALACTOSE 4-EPIMERASE were indexed under CARBOHYDRATE ISOMERASES 1977-96, GALACTOSE 1977-82, and UDPGLUCOSE 4-EPIMERASE 1977-98,", "HN": "98(75); for UDPGALACTOSE 4-EPIMERASE use GALACTOSE EPIMERASE (NM) 1977-98; for UDP-GALACTOSE 4-EPIPMERASE use GALACTOSE EPIMERASE (NM) 1977-98", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D014534"}, {"RECTYPE": "D", "MH": "Uridine Diphosphate Glucuronic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uridine Diphosphoglucuronic Acid|T109|T114|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Glucuronic Acid, UDP", "MN": "D13.695.827.919.600.677.375", "FX": "Glucuronides", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "alpha-D-Glucopyranuronic acid, 1-P'-ester with uridine 5'-(trihydrogen diphosphate)", "RN": "2616-64-0", "PI": "Uridine Diphosphate Sugars (1973-1974)", "MS": "A nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP iduronic acid, which donates iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones.", "PM": "91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014535"}, {"RECTYPE": "D", "MH": "Uridine Diphosphate N-Acetylgalactosamine", "DS": "URIDINE DIPHOSPHATE ACETYLGALACTOSAMINE N", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "UDP Acetylgalactosamine|T109|T114|T123|EQV|UNK (19XX)|760513|abbbdef", "ENTRY": "N-Acetylgalactosamine, Uridine Diphosphate", "MN": "D13.695.827.919.600.677.100", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Uridine 5'-(trihydrogen diphosphate), P'-(2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl) ester", "RN": "7277-98-7", "PI": "Uridine Diphosphate Sugars (1973-1974)", "MS": "A nucleoside diphosphate sugar which serves as a source of N-acetylgalactosamine for glycoproteins, sulfatides and cerebrosides.", "PM": "91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014536"}, {"RECTYPE": "D", "MH": "Uridine Diphosphate N-Acetylglucosamine", "DS": "URIDINE DIPHOSPHATE ACETYLGLUCOSAMINE N", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uridine Pyrophosphoacetylglucosamine|T109|T114|T123|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Uridine Diphospho N Acetylglucosamine", "MN": "D13.695.827.919.600.677.120", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Uridine 5'-(trihydrogen diphosphate), P'-(2-(acetylamino)-2-deoxy-alpha-D-glucopyranosyl) ester", "RN": "528-04-1", "PI": "Uridine Diphosphate Sugars (1974)", "MS": "Serves as the biological precursor of insect chitin, of muramic acid in bacterial cell walls, and of sialic acids in mammalian glycoproteins.", "PM": "91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014537"}, {"RECTYPE": "D", "MH": "Uridine Diphosphate N-Acetylmuramic Acid", "DS": "URIDINE DIPHOSPHATE ACETYLMURAMIC ACID N", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "UDP Acetylmuramic Acid|T109|T114|T123|EQV|UNK (19XX)|760513|abbbdef", "ENTRY": "Acid, UDP Acetylmuramic", "MN": "D13.695.827.919.600.677.150", "MH_TH": "NLM (1975)", "ST": "T123", "RN": "0", "PI": "Uridine Diphosphate Sugars (1973-1974)", "MS": "A nucleoside diphosphate sugar which is formed from UDP-N-acetylglucosamine and phosphoenolpyruvate. It serves as the building block upon which peptidoglycan is formed.", "PM": "91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014538"}, {"RECTYPE": "D", "MH": "Uridine Diphosphate Sugars", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "UDP Sugars|T109|T114|EQV|UNK (19XX)|760507|abbdef", "ENTRY": "Sugars, Uridine Diphosphate", "MN": "D13.695.827.919.600.677", "MH_TH": "NLM (1973)", "ST": "T114", "RN": "0", "PI": "specific carbohydrate (1966-1972)", "MS": "Nucleotide-sugars such as uridine-diphosphate glucose or UDP-glucose.", "PM": "73", "HN": "73", "MR": "20170619", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014539"}, {"RECTYPE": "D", "MH": "Uridine Diphosphate Xylose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "UDP Xylose|T109|T114|T123|EQV|UNK (19XX)|760513|abbbdef", "ENTRY": "Xylose, Uridine Diphosphate", "MN": "D13.695.827.919.600.677.800", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Uridine 5'-(trihydrogen diphosphate), P'-alpha-D-xylopyranosyl ester", "RN": "3616-06-6", "PI": "Xylose (1973-1974)", "MS": "The decarboxylation product of UDPglucuronic acid, which is used for formation of the xylosides of seryl hydroxyl groups in mucoprotein synthesis. Also forms plant xylans.", "PM": "91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "HN": "91(75); was see under URIDINE DIPHOSPHATE SUGARS 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014540"}, {"RECTYPE": "D", "MH": "Uridine Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Uridine Cytidine Kinase", "MN": "D08.811.913.696.620.800", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "ATP:uridine 5'-phosphotransferase", "RN": "EC 2.7.1.48", "RR": "9026-39-5 (CAS RN)", "PI": "Uridine (1974)", "MS": "An enzyme that catalyzes the phosphorylation of uridine and cytidine to uridine 5'-phosphate and cytidine 5'-phosphate, respectively. ATP, dUTP, dGTP, and dATP are effective phosphate donors. EC 2.7.1.48.", "PM": "91; was see under PHOSPHOTRANSFERASES, ATP 1975-90", "HN": "91(75); was see under PHOSPHOTRANSFERASES, ATP 1975-90", "MR": "20030709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D014541"}, {"RECTYPE": "D", "MH": "Uridine Monophosphate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uridylic Acid|T114|T123|NON|EQV|UNK (19XX)|770401|abbcdef", "ENTRY": "Uridine 5' Monophosphate", "MN": "D13.695.827.919.877", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "5'-Uridylic acid", "RN": "E2OU15WN0N", "RR": "58-97-9 (Uridine Monophosphate)", "PI": "Uracil Nucleotides (1966-1974)", "MS": "5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position.", "OL": "to search URIDYLIC ACIDS use URIDINE MONOPHOSPHATE 1975-77 & URACIL NUCLEOTIDES 1966-74", "PM": "91; was see under URACIL NUCLEOTIDES 1978-90; was URIDYLIC ACIDS see under URACIL NUCLEOTIDES 1963-77", "HN": "91(78); was see under URACIL NUCLEOTIDES 1978-90; was URIDYLIC ACIDS see under URACIL NUCLEOTIDES 1963-77", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014542"}, {"RECTYPE": "D", "MH": "Uridine Phosphorylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphorylase, Uridine", "MN": "D08.811.913.400.725.850.750", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Uridine:orthophosphate alpha-D-ribosyltransferase", "RN": "EC 2.4.2.3", "PI": "Uridine (1973-1974)", "MS": "An enzyme that catalyzes the transfer of ribose from uridine to orthophosphate, forming uracil and ribose 1-phosphate.", "PM": "91; was see under PENTOSYLTRANSFERASES 1975-90", "HN": "91(75); was see under PENTOSYLTRANSFERASES 1975-90", "MR": "20100625", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014543"}, {"RECTYPE": "D", "MH": "Uridine Triphosphate", "DE": "URPPP", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "UTP|T114|T123|ABB|EQV|UNK (19XX)|770421|abbcdef", "ENTRY": "UTP, Magnesium", "MN": "D13.695.827.919.950", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Uridine 5'-(tetrahydrogen triphosphate)", "RN": "UT0S826Z60", "RR": "63-39-8 (Uridine Triphosphate)", "PI": "Uracil Nucleotides (1966-1977)", "MS": "Uridine 5'-(tetrahydrogen triphosphate). A uracil nucleotide containing three phosphate groups esterified to the sugar moiety.", "PM": "90; was see under URACIL NUCLEOTIDES 1978-89", "HN": "90(78); was see under URACIL NUCLEOTIDES 1978-89", "MR": "20160601", "DA": "19770422", "DC": "1", "DX": "19900101", "UI": "D014544"}, {"RECTYPE": "D", "MH": "Urinary Calculi", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Urinary Stones|T031|NON|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Urinary Tract Stone", "MN": "C23.300.175.850", "FX": "Crystalluria", "MH_TH": "NLM (1963)", "ST": "T031", "AN": "general or unspecified; consider URINARY BLADDER CALCULI; KIDNEY CALCULI; URETERAL CALCULI; chemical composition of calculi: use /chem; /ultrastruct permitted", "MS": "Low-density crystals or stones in any part of the URINARY TRACT. Their chemical compositions often include CALCIUM OXALATE, magnesium ammonium phosphate (struvite), CYSTINE, or URIC ACID.", "PM": "1963", "HN": "1963", "CATSH": "CAT LIST", "MR": "20220209", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D014545"}, {"RECTYPE": "D", "MH": "Urinary Catheterization", "DE": "URINARY CATH", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Catheterization, Urinary|T060|T061|NON|EQV|UNK (19XX)|740330|CATH URINARY|abbcdefv", "ENTRY": "Urinary Catheterizations", "MN": "E05.157.500", "FX": "Urinary Catheters", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "coordinate IM with specific site (NIM) if pertinent", "MS": "Passage of a CATHETER into the URINARY BLADDER or kidney.", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014546"}, {"RECTYPE": "D", "MH": "Urinary Diversion", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Ileal Conduit|T061|NON|NRW|NLM (1997)|960307|abcdef", "ENTRY": "Urinary Diversions", "MN": "E04.950.774.852", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general or unspecified; prefer specifics; if specifics not available, coordinate with organ /surg ", "MS": "Temporary or permanent diversion of the flow of urine through the ureter away from the URINARY BLADDER in the presence of a bladder disease or after cystectomy. There is a variety of techniques: direct anastomosis of ureter and bowel, cutaneous ureterostomy, ileal, jejunal or colon conduit, ureterosigmoidostomy, etc. (From Campbell's Urology, 6th ed, p2654)", "CATSH": "CAT LIST", "MR": "20060707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014547"}, {"RECTYPE": "D", "MH": "Urinary Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Urinary Fistulas", "MN": "C23.300.575.825", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "general or unspecified; coordinate IM with pre-coordinated urinary organ/diseases (IM); fistula policy: Manual 23.19+; URINARY BLADDER FISTULA & VESICOVAGINAL FISTULA are available", "MS": "An abnormal passage in any part of the URINARY TRACT between itself or with other organs.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014548"}, {"RECTYPE": "D", "MH": "Urinary Incontinence", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Incontinence, Urinary", "MN": "C23.888.942.343.800", "FX": "Urinary Sphincter, Artificial", "MH_TH": "NLM (1966)", "ST": "T184", "MS": "Involuntary loss of URINE, such as leaking of urine. It is a symptom of various underlying pathological processes. Major types of incontinence include URINARY URGE INCONTINENCE and URINARY STRESS INCONTINENCE.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014549"}, {"RECTYPE": "D", "MH": "Urinary Incontinence, Stress", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stress Incontinence, Urinary", "MN": "C23.888.942.343.800.500", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "stress refers to coughing, sneezing & other forces", "MS": "Involuntary discharge of URINE as a result of physical activities that increase abdominal pressure on the URINARY BLADDER without detrusor contraction or overdistended bladder. The subtypes are classified by the degree of leakage, descent and opening of the bladder neck and URETHRA without bladder contraction, and sphincter deficiency.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014550"}, {"RECTYPE": "D", "MH": "Urinary Tract", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PP PS RE SU UL VI", "ENTRY": "Urinary Tracts", "MN": "A05.810", "FX": "Urography", "EC": "physiology:Urinary Tract Physiological Phenomena", "MH_TH": "NLM (1972)", "ST": "T023", "PI": "Urogenital System (1966-1971)", "MS": "The duct which coveys URINE from the pelvis of the KIDNEY through the URETERS, BLADDER, and URETHRA.", "PM": "72", "HN": "72", "MR": "20160809", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014551"}, {"RECTYPE": "D", "MH": "Urinary Tract Infections", "DE": "URINARY TRACT INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Urinary Tract Infection", "MN": "C12.950.892", "FX": "Anti-Infective Agents, Urinary", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "general or unspecified; prefer specific organ/disease term coordinated with specific infection term", "MS": "Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014552"}, {"RECTYPE": "D", "MH": "Urinary Tract Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Urinary Tract Physiology|T042|NON|EQV|NLM (1966)|990101|URINARY TRACT PHYSIOL|abcdefv", "ENTRY": "Urinary Physiology Concept", "MN": "G08.852", "MH_TH": "NLM (2009)", "ST": "T042", "AN": "general or unspecified; prefer specifics", "PI": "Urinary Tract/physiology (1969-1997)", "MS": "Properties, functions, and processes of the URINARY TRACT as a whole or of any of its parts.", "PM": "2009; see URINARY TRACT PHYSIOLOGY 1998-2008", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D014553"}, {"RECTYPE": "D", "MH": "Urination", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Micturition|T040|NON|EQV|NLM (2008)|060726|abcdef", "MN": "G08.852.880", "MH_TH": "NLM (1966)", "ST": "T040", "AN": "urine volume: index under URINE probably NIM", "MS": "Discharge of URINE, liquid waste processed by the KIDNEY, from the body.", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014554"}, {"RECTYPE": "D", "MH": "Urination Disorders", "DE": "URINATION DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Urination Disorder", "MN": "C12.950.934", "FX": "Urological Manifestations", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Abnormalities in the process of URINE voiding, including bladder control, frequency of URINATION, as well as the volume and composition of URINE.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014555"}, {"RECTYPE": "D", "MH": "Urine", "AQ": "CH CY MI PH PS VI", "MN": "A12.207.927", "FX": "Renal Aminoacidurias", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "general only; prefer / urine with higher animals, substances & diseases; urine volume: index URINE probably NIM; /microbiol: consider also BACTERIURIA", "MS": "Liquid by-product of excretion produced in the kidneys, temporarily stored in the bladder until discharge through the URETHRA.", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014556"}, {"RECTYPE": "D", "MH": "Urobilin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.767.193.727", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "21H-Biline-8,12-dipropanoic acid, 3,18-diethyl-1,4,5,15,16,19,22,24-octahydro-2,7,13,17-tetramethyl-1,19-dioxo-", "RN": "1856-98-0", "AN": "a bile pigment; /biosyn /physiol permitted", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014557"}, {"RECTYPE": "D", "MH": "Urobilinogen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.767.193.852", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "21H-Biline-8,12-dipropanoic acid, 2,17-diethyl-1,4,5,10,15,16,19,22,23,24-decahydro-3,7,13,18-tetramethyl-1,19-dioxo-", "RN": "14684-37-8", "AN": "a bile pigment; /biosyn /physiol permitted", "MS": "A colorless compound formed in the intestines by the reduction of bilirubin. Some is excreted in the feces where it is oxidized to urobilin. Some is reabsorbed and re-excreted in the bile as bilirubin. At times, it is re-excreted in the urine, where it may be later oxidized to urobilin.", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014558"}, {"RECTYPE": "D", "MH": "Urocanate Hydratase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Urocanase|T116|T126|NON|EQV|NLM (1995)|940303|abbcdef", "ENTRY": "Hydratase, Urocanate", "MN": "D08.811.520.241.300.900", "MH_TH": "NLM (1972)", "ST": "T126", "N1": "4,5-Dihydro-4-oxo-5-imidazolepropanoate hydro-lyase", "RN": "EC 4.2.1.49", "RR": "9014-58-8 (CAS RN)", "PI": "Hydro-Lyases (1966-1971)", "MS": "An enzyme that catalyzes the conversion of 4,5-dihydro-4-oxo-5-imidazolepropanoate to urocanate and water. EC 4.2.1.49.", "OL": "use UROCANATE HYDRATASE to search UROCANASE 1972-94", "PM": "95; was UROCANASE 1972-94, see under HYDRO-LYASES 1972-90", "HN": "95; was UROCANASE 1972-94, see under HYDRO-LYASES 1972-90", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014559"}, {"RECTYPE": "D", "MH": "Urocanic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glyoxalinylacrylic Acid|T109|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Acid, Urocanic", "MN": "D03.383.129.308.960", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "2-Propenoic acid, 3-(1H-imidazol-4-yl)-", "RN": "G8D26XJJ3B", "RR": "104-98-3 (Urocanic Acid)", "PI": "Imidazoles (1969-1974)", "MS": "4-Imidazoleacrylic acid.", "PM": "91; was see under IMIDAZOLES 1975-90", "HN": "91(75); was see under IMIDAZOLES 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014560"}, {"RECTYPE": "D", "MH": "Urochordata", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Tunicata|T008|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Urochordate", "MN": "B01.050.500.272.727", "MH_TH": "NLM (1973)", "ST": "T008", "RN": "txid7712", "RR": "txid7713", "PI": "Chordata (1966-1972)", "MS": "A subphylum of chordates intermediate between the invertebrates and the true vertebrates. It includes the Ascidians.", "PM": "2020; see UROCHORDATA 1999-2019", "HN": "2020(1973); was UROCHORDATA 1999-2019", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014561"}, {"RECTYPE": "D", "MH": "Urodela", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Salamanders|T011|NON|REL|UNK (19XX)|800512|abcdef", "ENTRY": "Salamander", "MN": "B01.050.150.900.090.608", "MH_TH": "NLM (1966)", "ST": "T011", "RN": "txid8293", "RR": "txid8311", "AN": "NIM with no qualifiers when experimental animal", "MS": "An order of the Amphibia class which includes salamanders and newts. They are characterized by usually having slim bodies and tails, four limbs of about equal size (except in Sirenidae), and a reduction in skull bones.", "OL": "use URODELA to search SALAMANDERS 1966-80", "PM": "81; was SALAMANDERS 1963-80", "HN": "81; was SALAMANDERS 1963-80", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19810101", "UI": "D014562"}, {"RECTYPE": "D", "MH": "Urodynamics", "AQ": "DE GE IM PH RE", "ENTRY": "Urodynamic", "MN": "G08.852.898", "MH_TH": "NLM (1978)", "ST": "T042", "AN": "same relation to URINARY TRACT that HEMODYNAMICS is to CARDIOVASCULAR SYSTEM; urine volume: index under URINE probably NIM", "PI": "specific urologic disease", "MS": "The mechanical laws of fluid dynamics as they apply to urine transport.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D014563"}, {"RECTYPE": "D", "MH": "Urogenital Abnormalities", "DE": "UROGENITAL ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Genitourinary Abnormalities|T019|T047|NON|EQV|NLM (2006)|050510|abbcdef", "ENTRY": "Urogenital Abnormality", "MN": "C16.131.939", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics or specific parts of urogenital system /abnorm", "PI": "Urogenital System/abnormalities (1966-1997)", "MS": "Congenital structural abnormalities of the UROGENITAL SYSTEM in either the male or the female.", "PM": "98", "HN": "98; use explode 1972-97", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D014564"}, {"RECTYPE": "D", "MH": "Urogenital Neoplasms", "DE": "UROGENITAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Urogenital Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Urogenital Neoplasm", "MN": "C12.900", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "general or unspecified; prefer specifics; coordinate IM with histological type of neoplasm (IM)", "MS": "Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014565"}, {"RECTYPE": "D", "MH": "Urogenital System", "AQ": "AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Genitourinary System|T022|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Urogenital Systems", "MN": "A05", "RH": "A5 - ANATOMY-UROGENITAL SYSTEM", "FX": "Urography", "EC": "abnormalities:Urogenital Abnormalities", "MH_TH": "NLM (1975)", "ST": "T022", "AN": "general or unspecified; prefer specifics; /surg: UROGENITAL SURGICAL PROCEDURES is available", "MS": "All the organs involved in reproduction and the formation and release of URINE. It includes the kidneys, ureters, BLADDER; URETHRA, and the organs of reproduction - ovaries, UTERUS; FALLOPIAN TUBES; VAGINA; and CLITORIS in women and the testes; SEMINAL VESICLES; PROSTATE; seminal ducts; and PENIS in men.", "MR": "20160809", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014566"}, {"RECTYPE": "D", "MH": "Urography", "DE": "UROGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Pyelography|T060|NON|NRW|UNK (19XX)|741224|PYELOGR|abcdefv", "ENTRY": "Urographies", "MN": "E01.370.390.830", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "coordinate with specific part of urinary tract /diag image; CYSTOGRAPHY is also available", "MS": "Radiography of any part of the URINARY TRACT.", "CATSH": "CAT LIST", "MR": "20180521", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014567"}, {"RECTYPE": "D", "MH": "Urokinase-Type Plasminogen Activator", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Urokinase|T116|T121|T126|NON|EQV|BAN (19XX)|INN (19XX)|JAN (19XX)|USAN (1965)|990101|abbbcdeeeef", "ENTRY": "Urokinase Type Plasminogen Activator", "MN": "D12.776.124.125.662.884", "MH_TH": "NLM (1992)", "ST": "T126", "RN": "EC 3.4.21.73", "RR": "9039-53-6 (CAS RN)", "PI": "Fibrinolytic Agents (1966-1974)", "MS": "A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES.", "PM": "2009; see URINARY PLASMINOGEN ACTIVATOR 2000-2008, see UROKINASE 1984-1999, see PEPTIDE PEPTIDOHYDROLASES 1975-1983, see FIBRINOLYTIC AGENTS 1966-1974, see STREPTODORNASE AND STREPTOKINASE 1963-1965; UROKINASE-TYPE PLASMINOGEN ACTIVATOR was indexed under PLASMINOGEN ACTIVATORS & UROKINASE 1984-1999", "HN": "2009(1963)", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19840101", "UI": "D014568"}, {"RECTYPE": "D", "MH": "Urologic Diseases", "DE": "UROL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Urinary Tract Diseases|T047|NON|EQV|NLM (1992)|901001|URINARY TRACT DIS|abcdefv", "ENTRY": "Urological Disease", "MN": "C12.950", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "general or unspecified: prefer specifics", "MS": "Pathological processes of the URINARY TRACT in both males and females.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014570"}, {"RECTYPE": "D", "MH": "Urologic Neoplasms", "DE": "UROL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Urologic Cancer|T191|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Urological Neoplasm", "MN": "C12.950.983", "MH_TH": "NLM (1978)", "ST": "T191", "AN": "general or unspecified: prefer specifics; coordinate with histological type of neoplasm ", "PI": "Urogenital Neoplasms (1966-1977)", "MS": "Tumors or cancer of the URINARY TRACT in either the male or the female.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19770329", "DC": "1", "DX": "19780101", "UI": "D014571"}, {"RECTYPE": "D", "MH": "Urology", "DE": "UROL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.810.860", "FX": "Urologic Surgical Procedures", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specialty", "MS": "A surgical specialty concerned with the study, diagnosis, and treatment of diseases of the urinary tract in both sexes, and the genital tract in the male. Common urological problems include urinary obstruction, URINARY INCONTINENCE, infections, and UROGENITAL NEOPLASMS.", "MR": "20190524", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014572"}, {"RECTYPE": "D", "MH": "Urology Department, Hospital", "DE": "UROL DEP", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital Urology Department|T093|NON|EQV|UNK (19XX)|770519|HOSP UROL DEP|abcdefv", "ENTRY": "Hospital Urology Departments", "MN": "N04.452.442.452.422.790", "MH_TH": "NLM (1977)", "ST": "T093", "PI": "Urology (1966-Jul 1977)", "MS": "Hospital department responsible for the administration and provision of diagnostic and therapeutic services for the urologic patient.", "PM": "91; was see under HOSPITAL DEPARTMENTS Aug 1977-90", "HN": "91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90", "MR": "20190709", "DA": "19770519", "DC": "1", "DX": "19910101", "UI": "D014573"}, {"RECTYPE": "D", "MH": "Uronic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Uronic Acid|T109|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Acids, Uronic", "MN": "D09.811.922", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "MS": "Acids derived from monosaccharides by the oxidation of the terminal (-CH2OH) group farthest removed from the carbonyl group to a (-COOH) group. (From Stedmans, 26th ed)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014574"}, {"RECTYPE": "D", "MH": "Uroporphyrinogen Decarboxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Uroporphyrinogen Carboxy-Lyase|T116|T126|NON|EQV|UNK (19XX)|750725|abbcdef", "ENTRY": "Uroporphyrinogen Carboxy Lyase", "MN": "D08.811.520.224.125.900", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "Uroporphyrinogen-III carboxy-lyase", "RN": "EC 4.1.1.37", "RR": "9024-70-8 (CAS RN)", "AN": "/defic permitted but consider also PORPHYRIA CUTANEA TARDA and HEPATOERYTHROPOIETIC PORPHYRIA", "PI": "Porphyrins (1974)", "MS": "An enzyme that catalyzes the decarboxylation of UROPORPHYRINOGEN III to coproporphyrinogen III by the conversion of four acetate groups to four methyl groups. It is the fifth enzyme in the 8-enzyme biosynthetic pathway of HEME. Several forms of cutaneous PORPHYRIAS are results of this enzyme deficiency as in PORPHYRIA CUTANEA TARDA; and HEPATOERYTHROPOIETIC PORPHYRIA.", "PM": "91; was see under CARBOXY-LYASES 1976-90", "HN": "91(76); was see under CARBOXY-LYASES 1976-90", "MR": "20130709", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D014575"}, {"RECTYPE": "D", "MH": "Uroporphyrinogen III Synthetase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Uroporphyrinogen-III Synthase|T116|T126|NON|EQV|NLM (1975)|990101|abbcdef", "ENTRY": "Uroporphyrinogen III Synthase", "MN": "D08.811.520.241.300.950", "FX": "Porphyria, Erythropoietic", "EC": "deficiency:Porphyria, Erythropoietic", "MH_TH": "UNK (19XX)", "ST": "T126", "N1": "Hydroxymethylbilane hydro-lyase (cyclizing)", "RN": "EC 4.2.1.75", "RR": "37340-55-9 (CAS RN)", "PI": "Porphobilinogen (1973-1974)", "MS": "An enzyme that catalyzes the cyclization of hydroxymethylbilane to yield UROPORPHYRINOGEN III and water. It is the fourth enzyme in the 8-enzyme biosynthetic pathway of HEME, and is encoded by UROS gene. Mutations of UROS gene result in CONGENITAL ERYTHROPOIETIC PORPHYRIA.", "PM": "2005; see UROPORPHYRINOGEN-III SYNTHASE 1998-2004, see UROPORPHYRINOGEN III SYNTHASE 1991-1997, see HYDRO-LYASES 1985-1990, see ISOMERASES 1975-1984", "HN": "2005 (1975)", "MR": "20090706", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014576"}, {"RECTYPE": "D", "MH": "Uroporphyrinogens", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Uroporphyrinogen III|T109|T123|NON|NRW|UNK (19XX)|840305|abbcdef", "MN": "D04.345.783.500.700.900", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "0", "AN": "porphyrins", "PI": "Porphyrins (1971-1974)", "MS": "Porphyrinogens which are intermediates in heme biosynthesis. They have four acetic acid and four propionic acid side chains attached to the pyrrole rings. Uroporphyrinogen I and III are formed from polypyrryl methane in the presence of uroporphyrinogen III cosynthetase and uroporphyrin I synthetase, respectively. They can yield uroporphyrins by autooxidation or coproporphyrinogens by decarboxylation.", "PM": "91; was see under PORPHYRINOGENS 1976-90", "HN": "91(76); was see under PORPHYRINOGENS 1976-90", "MR": "20160601", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D014577"}, {"RECTYPE": "D", "MH": "Uroporphyrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.767.727.880", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "0", "AN": "porphyrins", "PI": "Porphyrins (1968-1974)", "MS": "Porphyrins with four acetic acid and four propionic acid side chains attached to the pyrrole rings.", "PM": "91; was see under PORPHYRINS 1975-90", "HN": "91(75); was see under PORPHYRINS 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014578"}, {"RECTYPE": "D", "MH": "Urotensins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Urotensin|T116|T125|NON|EQV|NLM (2022)|201007|abbcdef", "MN": "D23.469.050.375.925", "MH_TH": "NLM (1979)", "ST": "T125", "RN": "0", "AN": "antihypertensives; from urophyses of fish; /biosyn /physiol permitted", "PI": "Peptides (1966-1978)", "MS": "Teleost hormones. A family of small peptides isolated from urophyses of bony fishes. They have many different physiological effects, including long-lasting hypotensive activity and have been proposed as antihypertensives. There are at least four different compounds: urotensin I, urotensin II, urotensin III, and urotensin IV.", "PM": "91; was see under PEPTIDES 1979-90", "HN": "91(79); was see under PEPTIDES 1979-90", "MR": "20210630", "DA": "19771209", "DC": "1", "DX": "19910101", "UI": "D014579"}, {"RECTYPE": "D", "MH": "Ursodeoxycholic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Deoxyursocholic Acid|T109|T121|T123|NON|EQV|UNK (19XX)|790530|abbbcdef", "ENTRY": "Ursodeoxycholate, Sodium", "MN": "D04.210.500.221.430.342.925", "PA": "Cholagogues and Choleretics", "MH_TH": "INN (19XX)", "ST": "T123", "N1": "Cholan-24-oic acid, 3,7-dihydroxy-, (3alpha,5beta,7beta)-", "RN": "724L30Y2QR", "RR": "128-13-2 (Ursodeoxycholic Acid)", "AN": "/biosyn /defic /physiol permitted; urso- refers to its first isol from URSIDAE (Latin ursus)", "PI": "Deoxycholic Acid (1973-1974) /analogs & derivatives (1975-1979)", "MS": "An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.", "PM": "91; was see under DEOXYCHOLIC ACID 1980-90", "HN": "91(80); was see under DEOXYCHOLIC ACID 1980-90", "MR": "20170524", "DA": "19790530", "DC": "1", "DX": "19910101", "UI": "D014580"}, {"RECTYPE": "D", "MH": "Urticaria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Urticarial Wheals|T047|NON|EQV|NLM (2024)|230414|abcdef", "ENTRY": "Wheals, Urticarial", "MN": "C20.543.480.904", "MH_TH": "POPLINE (1978)", "ST": "T047", "MS": "A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.", "CATSH": "CAT LIST", "MR": "20230414", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014581"}, {"RECTYPE": "D", "MH": "Urticaria Pigmentosa", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Maculopapular Cutaneous Mastocytosis|T047|NON|EQV|NLM (2003)|011130|abcdef", "ENTRY": "Maculopapular Cutaneous Mastocytoses", "MN": "C20.762.750.563.850", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "entry term MACULOPAPULAR CUTANEOUS MASTOCYTOSIS: MASTOCYTOSIS, CUTANEOUS is also available", "MS": "The most common form of cutaneous mastocytosis (MASTOCYTOSIS, CUTANEOUS) that occurs primarily in children. It is characterized by the multiple small reddish-brown pigmented pruritic macules and papules.", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014582"}, {"RECTYPE": "D", "MH": "Uruguay", "AQ": "EH EP", "MN": "Z01.107.757.904", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in southern South America, bordering the South Atlantic Ocean, located between Argentina and Brazil.", "MR": "20160707", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014583"}, {"RECTYPE": "D", "MH": "User-Computer Interface", "PRINT ENTRY": "Virtual Systems|T170|NON|NRW|NLM (1997)|960326|abcdef", "ENTRY": "Virtual System", "MN": "L01.224.900.910", "FX": "Speech Recognition Software", "MH_TH": "NLM (1987)", "ST": "T170", "MS": "The portion of an interactive computer program that issues messages to and receives commands from a user.", "PM": "91; was see under SOFTWARE 1987-90", "HN": "91(87); was see under SOFTWARE 1987-90", "MR": "20170703", "DA": "19860618", "DC": "1", "DX": "19910101", "UI": "D014584"}, {"RECTYPE": "D", "MH": "USSR", "AQ": "EH EP", "PRINT ENTRY": "Union of Soviet Socialist Republics|T083|NAM|EQV|UNK (19XX)|750717|abcdef", "MN": "Z01.586.950", "MH_TH": "NLM (1986)", "ST": "T083", "AN": "each former Soviet republic is available as a heading; MOSCOW is also available", "MS": "A country located from the Baltic and Black seas to the Pacific Ocean and, for a time including 15 Soviet Socialist Republics. The capital was Moscow.", "MR": "20170717", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014586"}, {"RECTYPE": "D", "MH": "Ustilaginales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Ustilaginale", "MN": "B01.300.179.853", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5267", "AN": "an order of basidiomycetes; parasitic on POACEAE & corn", "MS": "An order of basidiomycetous fungi; some species are parasitic on grasses (POACEAE) and maize.", "OL": "search BASIDIOMYCETES 1966-74", "PM": "91; was see under BASIDIOMYCETES 1975-90", "HN": "91(75); was see under BASIDIOMYCETES 1975-90", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014587"}, {"RECTYPE": "D", "MH": "Ustilago", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Ustilagos", "MN": "B01.300.179.853.800", "MH_TH": "NLM (1975)", "ST": "T004", "RN": "txid5269", "AN": "a basidiomycete representing the smuts", "MS": "A genus of basidiomycetous smut fungi comprising the loose smuts.", "PM": "91; was see under BASIDIOMYCETES 1975-90", "HN": "91(75); was see under BASIDIOMYCETES 1975-90", "MR": "20200813", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D014588"}, {"RECTYPE": "D", "MH": "Utah", "AQ": "EH EP", "MN": "Z01.107.567.875.760.800", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Idaho and Wyoming, on the east by Wyoming and Colorado, on the south by Arizona, and on the west by Nevada.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014589"}, {"RECTYPE": "D", "MH": "Uterine Contraction", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Myometrial Contraction|T042|NON|EQV|NLM (1998)|960801|abcdef", "ENTRY": "Uterine Contractions", "MN": "G11.427.494.890", "FX": "Uterine Monitoring", "MH_TH": "NLM (1975)", "ST": "T042", "PI": "Uterus (1966-1974)", "MS": "Contraction of the UTERINE MUSCLE.", "PM": "75", "HN": "75", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D014590"}, {"RECTYPE": "D", "MH": "Uterine Diseases", "DE": "UTERINE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Endometrial Diseases|T047|NON|NRW|NLM (2007)|060412|abcdef", "ENTRY": "Uterine Disease", "MN": "C12.100.250.852", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes involving any part of the UTERUS.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014591"}, {"RECTYPE": "D", "MH": "Uterine Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vaginal Bleeding|T033|T046|NON|REL|NLM (2012)|100908|abbcdef", "ENTRY": "Vaginal Bleedings", "MN": "C23.550.414.993", "FX": "Metrorrhagia", "MH_TH": "NLM (1966)", "ST": "T046", "MS": "Bleeding from blood vessels in the UTERUS, sometimes manifested as vaginal bleeding.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014592"}, {"RECTYPE": "D", "MH": "Uterine Inertia", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Inertia, Uterine", "MN": "C12.050.703.420.288.728", "MH_TH": "NLM (1964)", "ST": "T046", "AN": "check tags FEMALE and PREGNANCY", "MS": "Failure of the UTERUS to contract with normal strength, duration, and intervals during childbirth (LABOR, OBSTETRIC). It is also called uterine atony.", "PM": "67", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014593"}, {"RECTYPE": "D", "MH": "Uterine Neoplasms", "DE": "UTERINE NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Uterine Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Uterus Neoplasm", "MN": "C12.900.418.875", "MH_TH": "NLM (1966)", "ST": "T191", "MS": "Tumors or cancer of the UTERUS.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014594"}, {"RECTYPE": "D", "MH": "Uterine Perforation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Uterine Perforations", "MN": "C26.761.853.500", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "A hole or break through the wall of the UTERUS, usually made by the placement of an instrument or INTRAUTERINE DEVICES.", "PM": "91; was see under UTERINE RUPTURE 1975-90", "HN": "91(75); was see under UTERINE RUPTURE 1975-90", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D014595"}, {"RECTYPE": "D", "MH": "Uterine Prolapse", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vaginal Prolapse|T047|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Vaginal Prolapses", "MN": "C23.300.842.624.750", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with UTERINE INVERSION", "MS": "Downward displacement of the UTERUS. It is classified in various degrees: in the first degree the UTERINE CERVIX is within the vaginal orifice; in the second degree the cervix is outside the orifice; in the third degree the entire uterus is outside the orifice.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014596"}, {"RECTYPE": "D", "MH": "Uterine Rupture", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Uterine Ruptures", "MN": "C26.761.853", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "spontaneous or traumatic but do not coordinate with RUPTURE or RUPTURE, SPONTANEOUS", "MS": "A complete separation or tear in the wall of the UTERUS with or without expulsion of the FETUS. It may be due to injuries, multiple pregnancies, large fetus, previous scarring, or obstruction.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014597"}, {"RECTYPE": "D", "MH": "Uteroglobin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Blastokinin|T116|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Clara Cell Specific Protein", "MN": "D12.776.861.500", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Blastokinin", "RN": "9060-09-7", "PI": "Glycoproteins (1971-1974)", "MS": "A steroid-inducible protein that was originally identified in uterine fluid. It is a secreted homodimeric protein with identical 70-amino acid subunits that are joined in an antiparallel orientation by two disulfide bridges. A variety of activities are associated with uteroglobin including the sequestering of hydrophobic ligands and the inhibition of SECRETORY PHOSPHOLIPASE A2.", "PM": "1991; CLARA CELL SECRETORY PROTEIN was indexed under UTEROGLOBIN 2005-2011 and under PROTEINS 1986-2004, see GLYCOPROTEINS 1975-1990", "HN": "1991(1975)", "MR": "20110624", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014598"}, {"RECTYPE": "D", "MH": "Uterus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Wombs", "MN": "A05.360.319.679", "FX": "Hysteroscopy", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at HYSTER-", "MS": "The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.", "MR": "20180206", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014599"}, {"RECTYPE": "D", "MH": "Utilization Review", "DE": "UTIL REV", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Utilization Reviews", "MN": "N05.700.900", "FX": "Insurance Claim Review", "MH_TH": "POPLINE (1978)", "ST": "T058", "MS": "An organized procedure carried out through committees to review admissions, duration of stay, professional services furnished, and to evaluate the medical necessity of those services and promote their most efficient use.", "PM": "68", "HN": "68", "MR": "19950523", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014600"}, {"RECTYPE": "D", "MH": "Utopias", "AQ": "HI", "ENTRY": "Utopia", "MN": "K01.752.884", "MH_TH": "NLM (1966)", "ST": "T080", "MS": "Ideal perfection especially in laws, government, and social conditions.", "MR": "20171212", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014601"}, {"RECTYPE": "D", "MH": "Uvea", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Uveas", "MN": "A09.371.894", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The pigmented vascular coat of the eyeball, consisting of the CHOROID; CILIARY BODY; and IRIS, which are continuous with each other. (Cline et al., Dictionary of Visual Science, 4th ed)", "MR": "20010725", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014602"}, {"RECTYPE": "D", "MH": "Uveal Diseases", "DE": "UVEAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Uveal Disease", "MN": "C11.941", "MH_TH": "NLM (1976)", "ST": "T047", "PI": "specific uveal disease", "MS": "Diseases of the uvea.", "PM": "76", "HN": "76; was NON MESH before 1976", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D014603"}, {"RECTYPE": "D", "MH": "Uveal Neoplasms", "DE": "UVEAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Uveal Neoplasm", "MN": "C11.941.855", "MH_TH": "NLM (1981)", "ST": "T191", "AN": "coordinate with histological type of neoplasm; CHOROID NEOPLASMS and IRIS NEOPLASMS are also available", "PI": "Uveal Diseases (1976-1980)", "MS": "Tumors or cancer of the UVEA.", "PM": "81", "HN": "81", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19800409", "DC": "1", "DX": "19810101", "UI": "D014604"}, {"RECTYPE": "D", "MH": "Uveitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Uveitides", "MN": "C11.941.879", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014605"}, {"RECTYPE": "D", "MH": "Uveitis, Anterior", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Uveitides, Anterior", "MN": "C11.941.879.780.880", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the anterior uvea comprising the iris, angle structures, and the ciliary body. Manifestations of this disorder include ciliary injection, exudation into the anterior chamber, iris changes, and adhesions between the iris and lens (posterior synechiae). Intraocular pressure may be increased or reduced.", "PM": "86; was IRIDOCYCLITIS 1963-85", "HN": "86; was IRIDOCYCLITIS 1963-85", "CATSH": "CAT LIST", "MR": "19900529", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D014606"}, {"RECTYPE": "D", "MH": "Uveomeningoencephalitic Syndrome", "DE": "UVEOMENINGOENCEPH SYNDROME", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vogt-Koyanagi-Harada Syndrome|T047|EPO|EQV|ORD (2010)|UNK (19XX)|850507|abcdeef", "ENTRY": "Vogt Koyanagi Harada Syndrome", "MN": "C20.111.258.925", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "A syndrome characterized by bilateral granulomatous UVEITIS with IRITIS and secondary GLAUCOMA, premature ALOPECIA, symmetrical VITILIGO, poliosis circumscripta (a strand of depigmented hair), HEARING DISORDERS, and meningeal signs (neck stiffness and headache). Examination of the cerebrospinal fluid reveals a pattern consistent with MENINGITIS, ASEPTIC. (Adams et al., Principles of Neurology, 6th ed, p748; Surv Ophthalmol 1995 Jan;39(4):265-292)", "PM": "1991; was see under UVEITIS 1965-1990", "HN": "1991(1965); was see under UVEITIS 1965-1990", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014607"}, {"RECTYPE": "D", "MH": "Uveoparotid Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Uveoparotitis|T047|NON|EQV|NLM (1998)|960806|abcdef", "ENTRY": "Uveoparotitides", "MN": "C20.543.418.575.865", "MH_TH": "NLM (1975)", "ST": "T047", "MS": "A manifestation of sarcoidosis marked by chronic inflammation of the parotid gland and the uvea.", "OL": "search SARCOIDOSIS 1966-74", "PM": "91; was see under SARCOIDOSIS 1975-90", "HN": "91(75); was see under SARCOIDOSIS 1975-90", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014608"}, {"RECTYPE": "D", "MH": "Uvula", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A14.549.617.780.729", "MH_TH": "NLM (1963)", "ST": "T023", "MS": "A fleshy extension at the back of the soft palate that hangs above the opening of the throat.", "PM": "65; was see under PALATE 1963-64", "HN": "65(63); was see under PALATE 1963-64", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014609"}, {"RECTYPE": "D", "MH": "Uzbekistan", "AQ": "EH EP", "PRINT ENTRY": "Uzbek S.S.R.|T083|NAM|EQV|NLM (1993)|920422|abcdef", "ENTRY": "Uzbek SSR|T083|NAM|EQV|UNK (19XX)|810302|abcdef", "MN": "Z01.586.950.975", "MH_TH": "NLM (1993)", "ST": "T083", "MS": "A country in Central Asia, north of Turkmenistan, south of Kazakhstan. The capital is Tashkent.", "OL": "use UZBEKISTAN to search UZBEK S.S.R. 1982-92", "HN": "93; was UZBEK S.S.R. 1982-92; was heading 1963-81", "MR": "20170717", "DA": "19990101", "DC": "4", "DX": "19930101", "UI": "D014610"}, {"RECTYPE": "D", "MH": "Vaccination", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Immunization, Active|T061|NON|REL|NLM (1991)|900312|abcdef", "ENTRY": "Vaccinations", "MN": "N06.850.780.680.310.890", "MH_TH": "POPLINE (1978)", "ST": "T061", "AN": "Manual 26.22.2.2+; coordinate IM with disease /prev (IM); REVACCINATION see IMMUNIZATION, SECONDARY is also available", "MS": "Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014611"}, {"RECTYPE": "D", "MH": "Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaccine|T121|T129|NON|EQV|NLM (2021)|191113|abbcdef", "MN": "D20.215.894", "MH_TH": "POPLINE (1991)", "ST": "T129", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins,  synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014612"}, {"RECTYPE": "D", "MH": "Vaccines, Attenuated", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Attenuated Vaccine|T121|T129|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Vaccine, Attenuated", "MN": "D20.215.894.811", "MH_TH": "NLM (1973)", "ST": "T129", "RN": "0", "AN": "live vaccine; coord NIM with specific vaccine (IM)", "PI": "specific vaccine (1966-1972)", "MS": "Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity.", "PM": "74", "HN": "74(73)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014613"}, {"RECTYPE": "D", "MH": "Vaccines, Synthetic", "DE": "VACCINES SYN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME MI PD PO RE SD ST TO TU UL UR VI", "PRINT ENTRY": "Vaccines, Recombinant|T116|T121|T129|NON|NRW|UNK (19XX)|860325|abbbcdef", "ENTRY": "Vaccine, Synthetic", "MN": "D23.050.865", "MH_TH": "NLM (1987)", "ST": "T129", "RN": "0", "AN": "IM general only; coord NIM with specific vaccine (IM)", "PI": "Antigens (1966-1986)", "MS": "Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.", "PM": "91; was see under VACCINES 1989-90; was see under ANTIGENS 1987-88", "HN": "91(87); was see under VACCINES 1989-90; was see under ANTIGENS 1987-88", "MR": "20200623", "DA": "19860325", "DC": "1", "DX": "19910101", "UI": "D014614"}, {"RECTYPE": "D", "MH": "Vaccinia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Vaccinias", "MN": "C01.925.256.743.929", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "caused by a poxvirus after smallpox vaccination", "MS": "The cutaneous and occasional systemic reactions associated with vaccination using smallpox (variola) vaccine.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014615"}, {"RECTYPE": "D", "MH": "Vaccinia virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Rabbitpox virus|T005|NON|NRW|NLM (1994)|930309|abcdef", "ENTRY": "virus, Buffalopox", "MN": "B04.280.650.160.650.900", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid10245", "RR": "txid32606", "MS": "The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS.", "OL": "use VACCINIA VIRUS to search RABBIT POX VIRUS & RABBIT PLAGUE VIRUS 1975-93", "PM": "63; RABBIT POX VIRUS was heading 1975-93 (see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80); RABBIT PLAGUE VIRUS was see RABBIT POX VIRUS 1975-93", "HN": "63; RABBIT POX VIRUS was heading 1975-93 (see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80); RABBIT PLAGUE VIRUS was see RABBIT POX VIRUS 1975-93", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D014616"}, {"RECTYPE": "D", "MH": "Vacuoles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Vacuole", "MN": "A11.284.430.214.190.875.190.920", "MH_TH": "NLM (1975)", "ST": "T026", "MS": "Any spaces or cavities within a cell. They may function in digestion, storage, secretion, or excretion.", "OL": "search CELLULAR INCLUSIONS 1974 & CYTOPLASM 1966-73", "PM": "89; was see under ORGANOIDS 1977-88; was see under CELLULAR INCLUSIONS 1974-76; was see under CYTOPLASM 1966-73", "HN": "89(75); was see under ORGANOIDS 1977-88; was see under CELLULAR INCLUSIONS 1974-76; was see under CYTOPLASM 1966-73", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19890101", "UI": "D014617"}, {"RECTYPE": "D", "MH": "Vacuum", "ENTRY": "Vacuums", "MN": "N06.230.300.100.185.902", "MH_TH": "NLM (1978)", "ST": "T070", "AN": "usually NIM", "MS": "A space in which the pressure is far below atmospheric pressure so that the remaining gases do not affect processes being carried on in the space.", "PM": "91; was see under ATMOSPHERIC PRESSURE 1978-90", "HN": "91(78); was see under ATMOSPHERIC PRESSURE 1978-90", "MR": "20080708", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D014618"}, {"RECTYPE": "D", "MH": "Vacuum Curettage", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Suction Curettage|T061|T074|NON|EQV|UNK (19XX)|750116|abbcdef", "ENTRY": "Vacuum Curettages", "MN": "E04.950.300.299.970", "MH_TH": "NLM (1975)", "ST": "T074", "MS": "Aspiration of the contents of the uterus with a vacuum curette.", "PM": "91; was see under DILATATION AND CURETTAGE 1975-90", "HN": "91(75); was see under DILATATION AND CURETTAGE 1975-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19750204", "DC": "1", "DX": "19910101", "UI": "D014619"}, {"RECTYPE": "D", "MH": "Vacuum Extraction, Obstetrical", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Delivery, Vacuum Extraction|T061|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Vacuum Extractions, Obstetrical", "MN": "E04.520.252.875.970", "MH_TH": "NLM (1975)", "ST": "T061", "MS": "Removal of the fetus from the uterus or vagina at or near the end of pregnancy with a metal traction cup that is attached to the fetus' head. Negative pressure is applied and traction is made on a chain passed through the suction tube. (From Stedman, 26th ed & Dorland, 28th ed)", "OL": "search EXTRACTION, OBSTETRICAL 1966-74", "PM": "91; was see under EXTRACTION, OBSTETRICAL 1975-90", "HN": "91(75); was see under EXTRACTION, OBSTETRICAL 1975-90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014620"}, {"RECTYPE": "D", "MH": "Vagina", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Vaginas", "MN": "A05.360.319.779", "FX": "Colposcopy", "MH_TH": "NLM (1963)", "ST": "T023", "CX": "consider also terms at COLPO-", "MS": "The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014621"}, {"RECTYPE": "D", "MH": "Vaginal Creams, Foams, and Jellies", "AQ": "AD AE AN CH CL EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Vaginal Creams, Foams and Jellies|T121|T122|NON|EQV|NLM (1975)|990101|VAGINAL CREAMS FOAMS JELLIES|abbcdefv", "ENTRY": "Vaginal Gels", "MN": "E07.357.750", "FX": "Spermatocidal Agents", "MH_TH": "NLM (2007)", "ST": "T122", "RN": "0", "AN": "IM general only; coordinate NIM with specific drug (IM)", "PI": "Dosage Forms (1966-1974)", "MS": "Medicated dosage forms for topical application in the vagina. A cream is a semisolid emulsion containing suspended or dissolved medication; a foam is a dispersion of a gas in a medicated liquid resulting in a light, frothy mass; a jelly is a colloidal semisolid mass of a water soluble medicated material, usually translucent.", "PM": "2007; see VAGINAL CREAMS, FOAMS AND JELLIES 1975-2006", "HN": "2007 (1975)", "MR": "20150623", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D014622"}, {"RECTYPE": "D", "MH": "Vaginal Diseases", "DE": "VAGINAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vaginal Disease", "MN": "C12.100.250.894", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Pathological processes of the VAGINA.", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014623"}, {"RECTYPE": "D", "MH": "Vaginal Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vaginal Fistulas", "MN": "C23.300.575.925", "MH_TH": "NLM (1966)", "ST": "T190", "AN": "fistula policy: Manual 23.19+; RECTOVAGINAL FISTULA & VESICOVAGINAL FISTULA are available", "MS": "An abnormal anatomical passage that connects the VAGINA to other organs, such as the bladder (VESICOVAGINAL FISTULA) or the rectum (RECTOVAGINAL FISTULA).", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014624"}, {"RECTYPE": "D", "MH": "Vaginal Neoplasms", "DE": "VAGINAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Vaginal Cancer|T191|NON|NRW|NLM (1980)|ORD (2010)|781226|abcdeef", "ENTRY": "Vaginal Neoplasm", "MN": "C12.900.418.937", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate IM with histologic type of neoplasm (IM)", "MS": "Tumors or cancer of the VAGINA.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014625"}, {"RECTYPE": "D", "MH": "Vaginal Smears", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Cervical Smears|T060|NON|EQV|NLM (1991)|900308|abcdef", "ENTRY": "Vaginal Smear", "MN": "E05.242.384.100.800", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "note entry term CERVICAL SMEARS: do not coordinate with CERVIX UTERI; Pap smear: coordinate VAGINAL SMEARS with PAPANICOLAOU TEST", "MS": "Collection of pooled secretions of the posterior vaginal fornix for cytologic examination.", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014626"}, {"RECTYPE": "D", "MH": "Vaginitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vaginitides", "MN": "C12.100.250.894.906", "MH_TH": "POPLINE (1986)", "ST": "T047", "AN": "general or unspecified; prefer specifics; TRICHOMONAS VAGINITIS is also available", "MS": "Inflammation of the vagina characterized by pain and a purulent discharge.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014627"}, {"RECTYPE": "D", "MH": "Vagotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Vagotomies", "MN": "E04.525.210.105.600.850", "MH_TH": "NLM (1966)", "ST": "T062", "AN": "also called \"hyperselective,\" \"superselective,\" \"supraselective,\" \"ultraselective\" vagotomy", "MS": "The interruption or removal of any part of the vagus (10th cranial) nerve. Vagotomy may be performed for research or for therapeutic purposes.", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014628"}, {"RECTYPE": "D", "MH": "Vagotomy, Proximal Gastric", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Vagotomy, Selective Proximal|T061|T062|NON|NRW|UNK (19XX)|800409|abbcdef", "ENTRY": "Vagotomies, Selective Proximal", "MN": "E04.525.210.105.600.850.850", "MH_TH": "NLM (1981)", "ST": "T062", "AN": "also called \"hyperselective\", \"superselective\", \"supraselective\", \"ultraselective\"", "PI": "Vagotomy (1966-1980)", "MS": "Vagal denervation of that part of the STOMACH lined with acid-secreting mucosa (GASTRIC MUCOSA) containing the GASTRIC PARIETAL CELLS. Since the procedure leaves the vagal branches to the antrum and PYLORUS intact, it circumvents gastric drainage required with truncal vagotomy techniques.", "PM": "86; was see under VAGOTOMY 1981-85", "HN": "86(81); was see under VAGOTOMY 1981-85", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19800409", "DC": "1", "DX": "19860101", "UI": "D014629"}, {"RECTYPE": "D", "MH": "Vagus Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Tenth Cranial Nerve|T023|NON|EQV|NLM (1998)|960731|abcdef", "ENTRY": "Vagus, Nervus", "MN": "A08.800.800.120.900", "FX": "Vagotomy", "EC": "injuries:Vagus Nerve Injuries", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The 10th cranial nerve. The vagus is a mixed nerve which contains somatic afferents (from skin in back of the ear and the external auditory meatus), visceral afferents (from the pharynx, larynx, thorax, and abdomen), parasympathetic efferents (to the thorax and abdomen), and efferents to striated muscle (of the larynx and pharynx).", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014630"}, {"RECTYPE": "D", "MH": "Valerates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Valerate|T109|NON|EQV|NLM (2021)|191121|abcdef", "MN": "D10.251.400.895", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "Derivatives of valeric acid, including its salts and esters.", "PM": "66", "HN": "66", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014631"}, {"RECTYPE": "D", "MH": "Valerian", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Valeriana officinalis|T002|NON|NRW|NLM (2002)|010321|abcdef", "ENTRY": "officinalis, Valeriana", "MN": "B01.875.800.575.912.250.328.937.888", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid19952", "RR": "txid19953", "AN": "do not confuse entry term HELIOTROPE, GARDEN with HELIOTROPIUM", "MS": "A plant genus of the family VALERIANACEAE, order Dipsacales, subclass Asteridae, class Magnoliopsida. It is best known for the sedative use and valepotriate content of the roots. It is sometimes called Garden Heliotrope but is unrelated to true Heliotrope (HELIOTROPIUM).", "PM": "91,63-85; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85", "HN": "91(86)63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014632"}, {"RECTYPE": "D", "MH": "Valine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "L Valine", "MN": "D12.125.142.930", "MH_TH": "USP (19XX)", "ST": "T123", "N1": "Valine", "RN": "HG18B9YRS7", "RR": "72-18-4 (L-isomer)", "AN": "/biosyn /defic /physiol permitted", "MS": "A branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014633"}, {"RECTYPE": "D", "MH": "Valinomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D12.644.641.297.500", "PA": "Ionophores", "MH_TH": "NLM (1971)", "ST": "T195", "N1": "Valinomycin", "RN": "2001-95-8", "PI": "Antibiotics (1966-1970)", "MS": "A cyclododecadepsipeptide ionophore antibiotic produced by Streptomyces fulvissimus and related to the enniatins. It is composed of 3 moles each of L-valine, D-alpha-hydroxyisovaleric acid, D-valine, and L-lactic acid linked alternately to form a 36-membered ring. (From Merck Index, 11th ed) Valinomycin is a potassium selective ionophore and is commonly used as a tool in biochemical studies.", "PM": "73", "HN": "73(71)", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014634"}, {"RECTYPE": "D", "MH": "Valproic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sodium Valproate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|760317|abbcdeef", "ENTRY": "2 Propylpentanoic Acid", "MN": "D10.251.400.895.593.900", "PA": "GABA Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pentanoic acid, 2-propyl-", "RN": "614OI1Z5WI", "RR": "Q400352CM2", "PI": "Valerates (1966-1974)", "MS": "A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.", "OL": "use VALPROIC ACID to search VALPROATE 1979-90 & DIPROPYL ACETATE 1975-90", "PM": "1991; was VALPROATE 1979-1990; was DIPROPYL ACETATE see under VALERATES 1975-1978", "HN": "1991; was VALPROATE 1979-1990; was DIPROPYL ACETATE see under VALERATES 1975-1978", "MR": "20180619", "DA": "19741111", "DC": "1", "DX": "19790101", "UI": "D014635"}, {"RECTYPE": "D", "MH": "Valsalva Maneuver", "AQ": "DE ES GE IM PH RE", "ENTRY": "Valsalva Maneuvers", "MN": "G09.772.910", "MH_TH": "NLM (2004)", "ST": "T060", "AN": "for Valsalva Maneuver headache coordinate with PRIMARY COUGH HEADACHE (see HEADACHE DISORDERS, PRIMARY)", "MS": "Forced expiratory effort against a closed GLOTTIS.", "PM": "2004; see VALSALVA'S MANEUVER 1963-2003", "HN": "2004(1963)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014636"}, {"RECTYPE": "D", "MH": "Valine-tRNA Ligase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Valyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961106|abbdef", "ENTRY": "Valyl tRNA Synthetase", "MN": "D08.811.464.263.200.950", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "L-Valine:tRNA(Val) ligase (AMP-forming)", "RN": "EC 6.1.1.9", "PI": "Valine (1972-1974)", "MS": "An enzyme that activates valine with its specific transfer RNA. EC 6.1.1.9", "PM": "98; see VALYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90", "HN": "98(75)", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014637"}, {"RECTYPE": "D", "MH": "Vanadates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vanadyl|T197|NON|NRW|NLM (1990)|890330|abcdef", "ENTRY": "Vanadate, Sodium", "MN": "D01.960.960", "MH_TH": "NLM (1988)", "ST": "T197", "RN": "3WHH0066W5", "RR": "252S9L5606", "AN": "enzyme inhib", "PI": "Vanadium (1966-1987)", "MS": "Oxyvanadium ions in various states of oxidation. They act primarily as ion transport inhibitors due to their inhibition of Na(+)-, K(+)-, and Ca(+)-ATPase transport systems. They also have insulin-like action, positive inotropic action on cardiac ventricular muscle, and other metabolic effects.", "PM": "88", "HN": "88", "MR": "20160701", "DA": "19870504", "DC": "1", "DX": "19880101", "UI": "D014638"}, {"RECTYPE": "D", "MH": "Vanadium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Vanadium 51", "MN": "D01.552.544.920", "PA": "Trace Elements", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Vanadium", "RN": "00J9J9XKDE", "RR": "7440-62-2 (Vanadium)", "MS": "A metallic element with the atomic symbol V, atomic number 23, and atomic weight 50.94. It is used in the manufacture of vanadium steel. Prolonged exposure can lead to chronic intoxication caused by absorption usually via the lungs.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014639"}, {"RECTYPE": "D", "MH": "Vancomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Vancomycin", "MN": "D12.644.233.925", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "Vancomycin", "RN": "6Q205EH1VU", "RR": "98301-28-1 (phosphate (1:2) (salt), decahydrate)", "AN": "do not confuse with trade name Vancomin, a vitamin B12 deriv", "MS": "Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014640"}, {"RECTYPE": "D", "MH": "Vanillic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "p Hydroxy m methoxy benzoic Acid", "MN": "D02.455.426.559.389.657.654.638.875", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Benzoic acid, 4-hydroxy-3-methoxy-", "RN": "GM8Q3JM2Y8", "RR": "121-34-6 (Vanillic Acid)", "MS": "A flavoring agent. It is the intermediate product in the two-step bioconversion of ferulic acid to vanillin. (J Biotechnol 1996;50(2-3):107-13).", "OL": "search BENZOATES 1968-74", "PM": "91; was see under HYDROXYBENZOIC ACIDS 1975-90; was see under BENZOATES 1968-74", "HN": "91(75); was see under HYDROXYBENZOIC ACIDS 1975-90; was see under BENZOATES 1968-74", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014641"}, {"RECTYPE": "D", "MH": "Vanilmandelic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methoxyhydroxymandelic Acid|T109|T123|NON|EQV|UNK (19XX)|741224|abbcdef", "ENTRY": "Acid, Vanilmandelic", "MN": "D02.241.511.536.730", "MH_TH": "NLM (1968)", "ST": "T123", "N1": "Benzeneacetic acid, alpha,4-dihydroxy-3-methoxy-", "RN": "55-10-7", "PI": "Mandelic Acids (1966-1967)", "MS": "A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.", "PM": "72", "HN": "72(68)", "MR": "20151123", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014642"}, {"RECTYPE": "D", "MH": "Variant Surface Glycoproteins, Trypanosoma", "DE": "VSG TRYPAN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Trypanosoma Variant Surface Coat Glycoproteins|T116|T123|NON|EQV|UNK (19XX)|870505|abbcdef", "ENTRY": "VSG 221|T116|T123|ABB|NRW|UNK (19XX)|870505|abbcdef", "MN": "D23.050.301.900", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1977-1987)", "MS": "Glycoproteins attached to the surface coat of the trypanosome. Many of these glycoproteins show amino acid sequence diversity expressed as antigenic variations. This continuous development of antigenically distinct variants in the course of infection ensures that some trypanosomes always survive the development of immune response to propagate the infection.", "PM": "88", "HN": "88", "MR": "20230316", "DA": "19870505", "DC": "1", "DX": "19880101", "UI": "D014643"}, {"RECTYPE": "D", "MH": "Genetic Variation", "DE": "GENET VARIATION", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Variation, Genetic|T070|NON|EQV|NLM (2009)|080416|abcdef", "ENTRY": "Variations, Genetic", "MN": "G05.365", "MH_TH": "NLM (1999)", "ST": "T070", "PI": "Genetics, Population (1966-1967)", "MS": "Genotypic differences observed among individuals in a population.", "PM": "2009; see VARIATION (GENETICS) 1968-2008", "HN": "2009 (1968)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014644"}, {"RECTYPE": "D", "MH": "Herpesvirus 3, Human", "DE": "HHV 3", "DS": "HERPESVIRUS HUMAN 03", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Varicella-Zoster Virus|T005|NON|EQV|NLM (1994)|930302|abcdef", "ENTRY": "Varicellae, Herpesvirus", "MN": "B04.280.382.100.900.460", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid10335", "MS": "The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans.", "OL": "use HERPESVIRUS 3, HUMAN to search VARICELLA-ZOSTER VIRUS 1966-93", "PM": "94; was VARICELLA-ZOSTER VIRUS 1963-93", "HN": "94; was VARICELLA-ZOSTER VIRUS 1963-93", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D014645"}, {"RECTYPE": "D", "MH": "Varicocele", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Varicoceles", "MN": "C14.907.903", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A condition characterized by the dilated tortuous veins of the SPERMATIC CORD with a marked left-sided predominance. Adverse effect on male fertility occurs when varicocele leads to an increased scrotal (and testicular) temperature and reduced testicular volume.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014646"}, {"RECTYPE": "D", "MH": "Varicose Ulcer", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Venous Ulcer|T047|NON|EQV|NLM (1993)|920422|abcdef", "ENTRY": "Venous Ulcers", "MN": "C17.800.893.592.730", "FX": "Postthrombotic Syndrome", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Skin breakdown or ulceration in the drainage area of a VARICOSE VEIN, usually in the leg.", "CATSH": "CAT LIST", "MR": "20160606", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014647"}, {"RECTYPE": "D", "MH": "Varicose Veins", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Varices|T020|T184|NON|EQV|NLM (1990)|890512|abbcdef", "ENTRY": "Veins, Varicose", "MN": "C14.907.927", "FX": "Sclerotherapy", "MH_TH": "OMIM (2013)", "ST": "T184", "MS": "Enlarged and tortuous VEINS.", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014648"}, {"RECTYPE": "D", "MH": "Vas Deferens", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Ductus Deferens|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Deferens, Vas", "MN": "A05.360.444.930", "FX": "Vasovasostomy", "MH_TH": "POPLINE (1984)", "ST": "T023", "AN": "/surg: consider also VASECTOMY", "MS": "The excretory duct of the testes that carries SPERMATOZOA. It rises from the SCROTUM and joins the SEMINAL VESICLES to form the ejaculatory duct.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014649"}, {"RECTYPE": "D", "MH": "Vasa Nervorum", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vasa Nervorums", "MN": "A07.015.765", "MH_TH": "NLM (1964)", "ST": "T023", "MS": "Blood vessels supplying the nerves.", "PM": "91; was see under BLOOD VESSELS 1964-90", "HN": "91(64); was see under BLOOD VESSELS 1964-90", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014650"}, {"RECTYPE": "D", "MH": "Vasa Vasorum", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vasorums, Vasa", "MN": "A07.015.836", "MH_TH": "NLM (1965)", "ST": "T023", "MS": "Nutrient blood vessels which supply the walls of large arteries or veins.", "PM": "74", "HN": "74(65)", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014651"}, {"RECTYPE": "D", "MH": "Vascular Diseases", "DE": "VASCULAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vascular Disease", "MN": "C14.907", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014652"}, {"RECTYPE": "D", "MH": "Vascular Headaches", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Headache, Vascular|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Vascular Cephalgias", "MN": "C14.907.253.937", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "general: prefer specifics", "MS": "Secondary headache disorders attributed to a variety of cranial or cervical vascular disorders, such as BRAIN ISCHEMIA; INTRACRANIAL HEMORRHAGES; and CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS.", "PM": "2000; see VASCULAR HEADACHE 1978-1999; see HEADACHE 1975-1977", "HN": "2000(1964); use HEADACHE 1975-1977", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D014653"}, {"RECTYPE": "D", "MH": "Vascular Patency", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Patency, Vascular|T042|NON|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Vascular Patencies", "MN": "G09.330.920", "FX": "Graft Occlusion, Vascular", "MH_TH": "NLM (1987)", "ST": "T042", "PI": "Graft Occlusion, Vascular (1985-1986)", "MS": "The degree to which BLOOD VESSELS are not blocked or obstructed.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19860623", "DC": "1", "DX": "19870101", "UI": "D014654"}, {"RECTYPE": "D", "MH": "Vascular Resistance", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Total Peripheral Resistance|T039|NON|NRW|NLM (2004)|030515|abcdef", "ENTRY": "Vascular Resistance, Systemic", "MN": "G09.330.380.921", "FX": "Vasoconstriction", "MH_TH": "NLM (1964)", "ST": "T039", "AN": "do not confuse with VASCULAR CAPACITANCE, blood volume within a vessel", "MS": "The force that opposes the flow of BLOOD through a vascular bed. It is equal to the difference in BLOOD PRESSURE across the vascular bed divided by the CARDIAC OUTPUT.", "PM": "67; CAPILLARY RESISTANCE was heading 1963-85", "HN": "67(64)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014655"}, {"RECTYPE": "D", "MH": "Vascular Surgical Procedures", "DE": "VASCULAR SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT OG PX RH SN ST TD", "PRINT ENTRY": "Vascular Surgery|T061|NON|EQV|OBSSR (2022)|210204|abcdef", "ENTRY": "Vascular Surgeries", "MN": "E04.100.814", "MH_TH": "NLM (1966)", "ST": "T061", "AN": "general only: prefer specific blood vessel /surg", "MS": "Operative procedures for the treatment of vascular disorders.", "PM": "98; was VASCULAR SURGERY 1963-97", "HN": "98; was VASCULAR SURGERY 1963-97", "CATSH": "CAT LIST", "MR": "20210326", "DA": "19990101", "DC": "1", "DX": "19980101", "UI": "D014656"}, {"RECTYPE": "D", "MH": "Vasculitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Angiitis|T033|T047|NON|EQV|UNK (19XX)|770426|abbcdef", "ENTRY": "Vasculitides", "MN": "C14.907.940", "MH_TH": "NLM (1978)", "ST": "T047", "AN": "general or unspecified; consider SYSTEMIC VASCULITIS; ARTERITIS; or PHLEBITIS & their indentions; VASCULITIS, HEMORRHAGIC see PURPURA, SCHOENLEIN-HENOCH is also available", "PI": "Periarteritis Nodosa (1966-1977)", "MS": "Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.", "PM": "1978", "HN": "1978", "CATSH": "CAT LIST", "MR": "20090713", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D014657"}, {"RECTYPE": "D", "MH": "Vasectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Vasectomy Seeker, Refused", "MN": "E04.950.774.860.856", "FX": "Sterilization Reversal", "MH_TH": "POPLINE (1978)", "ST": "T061", "PI": "Vas Deferens/surgery (1966-1972)", "MS": "Surgical removal of the ductus deferens, or a portion of it. It is done in association with prostatectomy, or to induce infertility. (Dorland, 28th ed)", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014659"}, {"RECTYPE": "D", "MH": "Vasoactive Intestinal Peptide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Polypeptide, Vasoactive Intestinal", "MN": "D12.776.631.650.875", "PA": "Vasodilator Agents", "MH_TH": "NLM (1977)", "ST": "T125", "N1": "His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn", "RN": "37221-79-7", "PI": "Peptides (1974-1976)", "MS": "A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE).", "PM": "84; was see under GASTROINTESTINAL HORMONES 1977-83", "HN": "84(77); was see under GASTROINTESTINAL HORMONES 1977-83", "MR": "20151124", "DA": "19760413", "DC": "1", "DX": "19840101", "UI": "D014660"}, {"RECTYPE": "D", "MH": "Vasoconstriction", "AQ": "DE ES GE IM PH RE", "ENTRY": "Vasoconstrictions", "MN": "G09.330.380.925", "FX": "Vasoconstrictor Agents", "MH_TH": "NLM (1978)", "ST": "T042", "PI": "specific blood vessel/physiology (1966-1977)", "MS": "The physiological narrowing of BLOOD VESSELS by contraction of the VASCULAR SMOOTH MUSCLE.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D014661"}, {"RECTYPE": "D", "MH": "Vasoconstrictor Agents", "AQ": "AD AE AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vasopressor Agents|T121|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Drugs, Vasoconstrictor", "MN": "D27.505.954.411.793", "MH_TH": "NLM (1965)", "ST": "T121", "RN": "0", "AN": "consider also VASOMOTOR SYSTEM /drug eff", "MS": "Drugs used to cause constriction of the blood vessels.", "PM": "67", "HN": "67(65)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014662"}, {"RECTYPE": "D", "MH": "Nasal Decongestants", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vasoconstrictor Agents, Nasal|T121|NON|NRW|NLM (1996)|941018|abcdef", "ENTRY": "Nasal Vasoconstrictors", "MN": "D27.505.954.796.560", "MH_TH": "NLM (1967)", "ST": "T121", "RN": "0", "AN": "Nasal Decongestants - do not use entry term VASOCONSTRICTOR AGENTS, NASAL for the nasal administration of systemic vasoconstrictor agents; use instead the specific vasoconstrictor agent / admin + ADMINISTRATION, INTRANASAL", "PI": "Sympathomimetics (1966)", "MS": "Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)", "PM": "96; was VASOCONSTRICTOR AGENTS, NASAL 1967-95; NASAL DECONGESTANTS was see VASOCONSTRICTOR AGENTS, NASAL 1967-95", "HN": "96; was VASOCONSTRICTOR AGENTS, NASAL 1967-95; NASAL DECONGESTANTS was see VASOCONSTRICTOR AGENTS, NASAL 1967-95", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014663"}, {"RECTYPE": "D", "MH": "Vasodilation", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Vasorelaxation|T033|T042|NON|EQV|NLM (1998)|960709|abbcdef", "ENTRY": "Vascular Endothelium Dependent Relaxation", "MN": "G09.330.380.928", "FX": "Vasodilator Agents", "MH_TH": "NLM (1978)", "ST": "T042", "PI": "tissue or organ/blood supply (1966-1977)", "MS": "The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19770427", "DC": "1", "DX": "19780101", "UI": "D014664"}, {"RECTYPE": "D", "MH": "Vasodilator Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vasorelaxant|T121|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Drugs, Vasodilator", "MN": "D27.505.954.411.918", "MH_TH": "NLM (1966)", "ST": "T121", "RN": "0", "MS": "Drugs used to cause dilation of the blood vessels.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014665"}, {"RECTYPE": "D", "MH": "Vasomotor System", "AQ": "AB AH CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Vasomotor Systems", "MN": "A08.800.050.800.900", "FX": "Vasodilator Agents", "MH_TH": "NLM (1966)", "ST": "T022", "AN": "/drug eff: consider also VASOCONSTRICTOR AGENTS & VASODILATOR AGENTS", "MS": "The neural systems which act on VASCULAR SMOOTH MUSCLE to control blood vessel diameter. The major neural control is through the sympathetic nervous system.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014666"}, {"RECTYPE": "D", "MH": "Vasopressins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Hypophamine|T116|T121|T125|NON|EQV|UNK (19XX)|761230|abbbcdef", "ENTRY": "beta Hypophamine", "MN": "D12.776.631.650.937", "PA": "Vasoconstrictor Agents", "FX": "Receptors, Vasopressin", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "11000-17-2", "AN": "general or unspecified; prefer specifics", "MS": "Antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure.", "OL": "use VASOPRESSINS to search VASOPRESSIN 1966-78", "PM": "79; was VASOPRESSIN 1963-78", "HN": "79; was VASOPRESSIN 1963-78", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D014667"}, {"RECTYPE": "D", "MH": "Vasotocin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vasopressin, Non-Mammalian|T116|T123|T125|NON|EQV|UNK (19XX)|750101|abbbcdef", "ENTRY": "Vasotocin, Arginine", "MN": "D12.644.548.691.692.881", "PA": "Vasoconstrictor Agents", "MH_TH": "NLM (1963)", "ST": "T125", "N1": "Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly, cyclic 1-6 disulfide", "RN": "W6S6URY8OF", "RR": "9034-50-8 (Vasotocin)", "MS": "A nonapeptide that contains the ring of OXYTOCIN and the side chain of ARG-VASOPRESSIN with the latter determining the specific recognition of hormone receptors. Vasotocin is the non-mammalian vasopressin-like hormone or antidiuretic hormone regulating water and salt metabolism.", "PM": "73", "HN": "73(63)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014668"}, {"RECTYPE": "D", "MH": "Vasovasostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Vasostomy|T061|NON|REL|UNK (19XX)|870323|abcdef", "ENTRY": "Vasovasostomies", "MN": "E04.950.774.860.956", "MH_TH": "NLM (1988)", "ST": "T061", "PI": "Vas Deferens/surgery (1966-1987)", "MS": "Surgical anastomosis or fistulization of the spermatic ducts to restore fertility in a previously vasectomized male.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19870323", "DC": "1", "DX": "19880101", "UI": "D014669"}, {"RECTYPE": "D", "MH": "Ampulla of Vater", "DE": "AMPULLA VATER", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Vater's Ampulla|T023|EPO|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Vaters Ampulla", "MN": "A03.734.667.500", "FX": "Sphincterotomy, Transduodenal", "MH_TH": "NLM (1992)", "ST": "T023", "AN": "diseases: coordinate IM with COMMON BILE DUCT DISEASES (IM); inflammation: coordinate IM with CHOLANGITIS (IM); neoplasms: coordinate IM with probably COMMON BILE DUCT NEOPLASMS (IM) but consider also DUODENAL NEOPLASMS or CARCINOMA, PANCREATIC DUCTAL depending on text; note entry term DUODENAL PAPILLA, MAJOR: do not confuse with DUODENAL PAPILLA, MINOR see PANCREATIC DUCTS; \"duodenal papilla\" unspecified is probably DUODENAL PAPILLA, MAJOR", "MS": "A dilation of the duodenal papilla that is the opening of the juncture of the COMMON BILE DUCT and the MAIN PANCREATIC DUCT, also known as the hepatopancreatic ampulla.", "PM": "2004; see VATER'S AMPULLA 1963-2003", "HN": "2004 (1963)", "MR": "20170501", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D014670"}, {"RECTYPE": "D", "MH": "Vatican City", "AQ": "EH EP", "ENTRY": "Holy See|T083|NAM|EQV|NLM (2017)|160126|abcdef", "MN": "Z01.542.961", "MH_TH": "POPLINE (1994)", "ST": "T083", "MS": "Enclave of Rome.", "MR": "20160707", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014671"}, {"RECTYPE": "D", "MH": "Vectorcardiography", "DE": "VECTORCARDIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Polarcardiography|T060|NON|NRW|NLM (1997)|960416|POLARCARDIOGR|abcdefv", "ENTRY": "Vectorcardiographies", "MN": "E01.370.405.240.850", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "Recording of the moment-to-moment electromotive forces of the heart on a plane of the body surface delineated as a vector function of time.", "PM": "POLARCARDIOGRAPHY was heading 1975-96 (see under VECTORCARDIOGRAPHY 1975-90); was see under VECTORCARDIOGRAPHY 1965-74 (Prov 1965-73)", "HN": "POLARCARDIOGRAPHY was heading 1975-96 (see under VECTORCARDIOGRAPHY 1975-90); was see under VECTORCARDIOGRAPHY 1965-74 (Prov 1965-73)", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D014672"}, {"RECTYPE": "D", "MH": "Vecuronium Bromide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phosphate, Vecuronium", "MN": "D04.210.500.054.040.920", "PA": "Nicotinic Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Piperidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl)-1-methyl-, bromide", "RN": "7E4PHP5N1D", "RR": "86029-43-8 (quaternary ion)", "PI": "Pancuronium/analogs & derivatives (1972-1986)", "MS": "Monoquaternary homolog of PANCURONIUM. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents.", "OL": "use VECURONIUM BROMIDE to search VECURONIUM 1987-94", "PM": "95; was VECURONIUM 1987-94; VECURONIUM BROMIDE was see VECURONIUM 1987-94", "HN": "95; was VECURONIUM 1987-94; VECURONIUM BROMIDE was see VECURONIUM 1987-94", "MR": "20160601", "DA": "19860602", "DC": "1", "DX": "19870101", "UI": "D014673"}, {"RECTYPE": "D", "MH": "Plant Proteins, Dietary", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vegetable Proteins|T116|NON|NRW|NLM (1975)|990101|abcdef", "ENTRY": "Vegetable Protein", "MN": "J02.500.428.920", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "AN": "note specifics; coordinate with plant term if pertinent", "PI": "Plant Proteins (1966-1974)", "MS": "Proteins which are present in or isolated from vegetables or vegetable products used as food. The concept is distinguished from PLANT PROTEINS which refers to non-dietary proteins from plants.", "OL": "search PLANT PROTEINS 1966-74", "PM": "2019; see PLANT PROTEINS 1963-1974", "HN": "2019(1975)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D014674"}, {"RECTYPE": "D", "MH": "Vegetables", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "ENTRY": "Vegetable", "MN": "J02.500.850", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "coordinate with specific plant if pertinent; therapeutic use of vegetables: index VEGETABLES + specific plant  if pertinent + disease /diet ther; PHYTOTHERAPY is also available", "MS": "A food group comprised of EDIBLE PLANTS or their parts.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014675"}, {"RECTYPE": "D", "MH": "Diet, Vegetarian", "AQ": "AE CL EC EH ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Vegetarianism|T078|NON|REL|NLM (1966)|990101|abcdef", "ENTRY": "Vegetarian Diets, Lacto-Ovo", "MN": "G07.203.650.240.278.500", "FX": "Vegetarians", "MH_TH": "NLM (2003)", "ST": "T061", "MS": "The dietary practice of completely avoiding meat or fish products in the DIET, consuming VEGETABLES, CEREALS, and NUTS. Some vegetarian diets called lacto-ovo also include milk and egg products.", "PM": "2003; see VEGETARIANISM 1963-2003", "HN": "2003(1963)", "CATSH": "CAT LIST", "MR": "20221215", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014676"}, {"RECTYPE": "D", "MH": "Pharmaceutical Vehicles", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Vehicles, Pharmaceutical", "MN": "E02.319.300.754", "MH_TH": "NLM (2011)", "ST": "T120", "RN": "0", "PI": "Vehicles (1960-2010)", "MS": "A carrier or inert medium used as a solvent (or diluent) in which the medicinally active agent is formulated and or administered. (Dictionary of Pharmacy, 1986)", "PM": "2011; see VEHICLES 1963-2010", "HN": "2011 (1963)", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "20110101", "UI": "D014677"}, {"RECTYPE": "D", "MH": "Veillonella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.800.938", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid29465", "AN": "in mouth, intestines & resp tract of man & other animals", "MS": "A genus of gram-negative, anaerobic cocci parasitic in the mouth and in the intestinal and respiratory tracts of man and other animals.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014678"}, {"RECTYPE": "D", "MH": "Veins", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vein", "MN": "A07.015.908", "FX": "Phlebography", "MH_TH": "NLM (1966)", "ST": "T023", "CX": "consider also terms at PHLEB-", "MS": "The vessels carrying blood away from the CAPILLARY BEDS.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014680"}, {"RECTYPE": "D", "MH": "Velopharyngeal Insufficiency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Palatopharyngeal Incompetence|T019|T020|NON|EQV|OMIM (2013)|UNK (19XX)|770513|abbcdeef", "ENTRY": "Velopharyngeal Closures, Inadequate", "MN": "C16.131.850.525.955", "FX": "Speech Disorders", "MH_TH": "OMIM (2013)", "ST": "T020", "PI": "Pharynx (1966-1977)", "MS": "Failure of the SOFT PALATE to reach the posterior pharyngeal wall to close the opening between the oral and nasal cavities. Incomplete velopharyngeal closure is primarily related to surgeries (ADENOIDECTOMY; CLEFT PALATE) or an incompetent PALATOPHARYNGEAL SPHINCTER. It is characterized by hypernasal speech.", "PM": "78", "HN": "78", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19770513", "DC": "1", "DX": "19780101", "UI": "D014681"}, {"RECTYPE": "D", "MH": "Vena Cava, Inferior", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vena Cavas, Inferior", "MN": "A07.015.908.949.648", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The venous trunk which receives blood from the lower extremities and from the pelvic and abdominal organs.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014682"}, {"RECTYPE": "D", "MH": "Vena Cava, Superior", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vena Cavas, Superior", "MN": "A07.015.908.949.815", "FX": "Superior Vena Cava Syndrome", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The venous trunk which returns blood from the head, neck, upper extremities and chest.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014683"}, {"RECTYPE": "D", "MH": "Venae Cavae", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cavae, Venae", "MN": "A07.015.908.949", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "try to specify VENA CAVA, INFERIOR or VENA CAVA, SUPERIOR", "MS": "The inferior and superior venae cavae.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014684"}, {"RECTYPE": "D", "MH": "Venereal Tumors, Veterinary", "DE": "VENEREAL TUMORS VET", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "PRINT ENTRY": "Venereal Tumors, Transmissible|T191|NON|EQV|UNK (19XX)|780519|VENEREAL TUMORS TRANSM|abcdefv", "ENTRY": "Veterinary Venereal Tumor", "MN": "C22.950", "MH_TH": "NLM (1979)", "ST": "T191", "AN": "do not coordinate with GENITALIA or specific genital term unless especially discussed; coordinate with precoordinated animal/disease term + animal (NIM)", "PI": "Venereal Diseases (1966-1978)", "MS": "Tumors most commonly seen on or near the genitalia. They are venereal, most likely transmitted through transplantation of cells by contact. Metastases have been reported. Spontaneous regression may occur.", "PM": "79", "HN": "79", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19780519", "DC": "1", "DX": "19790101", "UI": "D014685"}, {"RECTYPE": "D", "MH": "Venereology", "DE": "VENEREOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.909", "FX": "Sexually Transmitted Diseases", "MH_TH": "NLM (1983)", "ST": "T091", "PI": "Venereal Diseases (1966-1982)", "MS": "A branch of medicine which deals with sexually transmitted disease.", "PM": "83", "HN": "83", "MR": "20090706", "DA": "19820430", "DC": "1", "DX": "19830101", "UI": "D014686"}, {"RECTYPE": "D", "MH": "Venezuela", "AQ": "EH EP", "MN": "Z01.107.757.943", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "A country in northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, located between Colombia and Guyana.", "MR": "20160707", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014687"}, {"RECTYPE": "D", "MH": "Venoms", "AQ": "AD AE AG AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE TO TU UR", "ENTRY": "Venom|T123|T131|NON|EQV|NLM (1999)|980217|abbcdef", "MN": "D23.946.833", "PA": "Poisons", "FX": "Antivenins", "EC": "antagonists & inhibitors:Antivenins", "MH_TH": "NLM (1966)", "ST": "T131", "RN": "0", "AN": "general or unspecified only: prefer specifics; coordinate with the animal producing the venom but many specific precoordinated venom terms are available (AMPHIBIAN VENOMS; ARTHROPOD VENOMS; SNAKE VENOMS & its indentions, etc.)", "MS": "Poisonous animal secretions forming fluid mixtures of many different enzymes, toxins, and other substances. These substances are produced in specialized glands and secreted through specialized delivery systems (nematocysts, spines, fangs, etc.) for disabling prey or predator.", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014688"}, {"RECTYPE": "D", "MH": "Venous Insufficiency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Venous Insufficiencies", "MN": "C14.907.952", "MH_TH": "NLM (1973)", "ST": "T047", "AN": "general or unspecified but usually of the legs; coordinate IM with specific vein (IM) or organ /blood supply (IM) if pertinent", "PI": "Vascular Diseases (1966-1972)", "MS": "Impaired venous blood flow or venous return (venous stasis), usually caused by inadequate venous valves. Venous insufficiency often occurs in the legs, and is associated with EDEMA and sometimes with VENOUS STASIS ULCERS at the ankle.", "PM": "73", "HN": "73", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014689"}, {"RECTYPE": "D", "MH": "Venous Pressure", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Blood Pressure, Venous|T033|T040|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Venous Pressures", "MN": "G09.330.380.076.732", "MH_TH": "NLM (1970)", "ST": "T040", "AN": "IM GEN only; NIM for pressure within a specific vessel; CENTRAL VENOUS PRESSURE & PORTAL PRESSURE are also available; venous hypertension: index under VENOUS PRESSURE (IM) & do not coord with HYPERTENSION", "PI": "Veins (1966-1969)", "MS": "The blood pressure in the VEINS. It is usually measured to assess the filling PRESSURE to the HEART VENTRICLE.", "PM": "70", "HN": "70", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D014690"}, {"RECTYPE": "D", "MH": "Ventilation", "AQ": "EC IS LJ MT SN ST", "ENTRY": "Ventilations", "MN": "N06.230.150.520", "FX": "Confined Spaces", "MH_TH": "NLM (1966)", "ST": "T069", "MS": "Supplying a building or house, their rooms and corridors, with fresh air. The controlling of the environment thus may be in public or domestic sites and in medical or non-medical locales. (From Dorland, 28th ed)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014691"}, {"RECTYPE": "D", "MH": "Ventilation-Perfusion Ratio", "AQ": "DE ES GE IM PH RE", "ENTRY": "Ventilation-Perfusion Ratios", "MN": "G09.772.920", "MH_TH": "NLM (1968)", "ST": "T042", "AN": "a resp funct test", "PI": "Respiratory Function Tests (1966-1967)", "MS": "The ratio of alveolar ventilation to simultaneous alveolar capillary blood flow in any part of the lung. (Stedman, 25th ed)", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D014692"}, {"RECTYPE": "D", "MH": "Ventricular Fibrillation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ventricular Fibrillations", "MN": "C23.550.073.922", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "does not confuse with VENTRICULAR FLUTTER", "MS": "A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014693"}, {"RECTYPE": "D", "MH": "Ventricular Outflow Obstruction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ventricular Outflow Obstructions", "MN": "C14.280.955", "MH_TH": "NLM (1988)", "ST": "T047", "PI": "Heart Ventricle (1966-1987)", "MS": "Occlusion of the outflow tract in either the LEFT VENTRICLE or the RIGHT VENTRICLE of the heart. This may result from CONGENITAL HEART DEFECTS, predisposing heart diseases, complications of surgery, or HEART NEOPLASMS.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19870402", "DC": "1", "DX": "19880101", "UI": "D014694"}, {"RECTYPE": "D", "MH": "Cerebral Ventriculography", "DE": "CEREBRAL VENTRICULOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Ventriculography, Cerebral|T060|NON|EQV|NLM (1990)|890321|VENTRICULOGR CEREBRAL|abcdefv", "ENTRY": "Ventriculographies, Cerebral", "MN": "E05.629.937.190", "FX": "Cerebral Ventricles", "MH_TH": "NLM (1977)", "ST": "T060", "MS": "Radiography of the ventricular system of the brain after injection of air or other contrast medium directly into the cerebral ventricles. It is used also for x-ray computed tomography of the cerebral ventricles.", "OL": "use CEREBRAL VENTRICULOGRAPHY to search VENTRICULOGRAPHY, CEREBRAL 1977-89 & VENTRICULOGRAPHY 1966-76", "PM": "90; was VENTRICULOGRAPHY, CEREBRAL 1977-89; was VENTRICULOGRAPHY 1963-76", "HN": "90; was VENTRICULOGRAPHY, CEREBRAL 1977-89; was VENTRICULOGRAPHY 1963-76", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D014695"}, {"RECTYPE": "D", "MH": "Ventriculostomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Ventriculocisternostomy|T061|NON|NRW|UNK (19XX)|870318|abcdef", "ENTRY": "Ventriculostomies", "MN": "E04.525.170.860", "FX": "Cerebral Ventricles", "MH_TH": "NLM (1988)", "ST": "T061", "AN": "refers to cerebral ventricles only, not heart nor stomach", "PI": "Cerebrospinal Fluid Shunts (1972-1987)", "MS": "Surgical creation of an opening in a cerebral ventricle.", "PM": "91; was see under CEREBROSPINAL FLUID SHUNTS 1988-90", "HN": "91(88); was see under CEREBROSPINAL FLUID SHUNTS 1988-90", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19870318", "DC": "1", "DX": "19910101", "UI": "D014696"}, {"RECTYPE": "D", "MH": "Ventromedial Hypothalamic Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hypothalamic Nucleus, Ventromedial|T023|NON|EQV|UNK (19XX)|820428|abcdef", "ENTRY": "Nucleus, Ventromedial Hypothalamic", "MN": "A08.186.211.200.317.357.352.953", "MH_TH": "NLM (1983)", "ST": "T023", "PI": "Hypothalamus, Middle (1975-1982)", "MS": "A nucleus of the middle hypothalamus, the largest cell group of the tuberal region with small-to-medium size cells.", "PM": "83", "HN": "83", "MR": "20180630", "DA": "19820428", "DC": "1", "DX": "19830101", "UI": "D014697"}, {"RECTYPE": "D", "MH": "Venturicidins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.540.800", "PA": "Uncoupling Agents", "MH_TH": "NLM (1977)", "ST": "T123", "RN": "0", "AN": "uncoupling agents & antifungal antibiotics; from Streptomyces", "PI": "Rhamnose (1973-1974)", "MS": "Toxic substances isolated from various strains of Streptomyces. They are 20-membered macrolides that inhibit oxidative phosphorylation and mitochondrial ATPases. Venturicidins A and B are glycosides. Used mainly as tools in the study of mitochondrial function.", "PM": "91; was see under LACTONES 1977-90", "HN": "91(77); was see under LACTONES 1977-90", "MR": "20090706", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D014698"}, {"RECTYPE": "D", "MH": "Venules", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Venule", "MN": "A07.015.908.952", "MH_TH": "NLM (1978)", "ST": "T023", "AN": "restrict to blood vessels: not for \"lymphatic venules\" or \"postcapillary venules\": see note on LYMPHATIC SYSTEM; IM GEN only; NIM as coord with specific organ /blood supply (IM)", "PI": "Veins (1966-1977)", "MS": "The minute vessels that collect blood from the capillary plexuses and join together to form veins.", "OL": "search VEINS 1966-74", "PM": "91; was see under VEINS 1975-90; was see under VEINS 1964-74", "HN": "91(78); was see under VEINS 1975-90; was see under VEINS 1964-74", "MR": "20180630", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D014699"}, {"RECTYPE": "D", "MH": "Verapamil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Iproveratril|T109|T121|NON|EQV|UNK (19XX)|830614|abbcdef", "ENTRY": "Hydrochloride, Verapamil", "MN": "D02.092.471.683.953", "PA": "Vasodilator Agents", "MH_TH": "USAN (1968)", "ST": "T121", "N1": "Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-", "RN": "CJ0O37KU29", "RR": "V3888OEY5R", "MS": "A calcium channel blocker that is a class IV anti-arrhythmia agent.", "OL": "use VERAPAMIL to search IPROVERATRIL 1966-83 (as Prov 1966-71)", "PM": "84; was IPROVERATRIL 1972-83", "HN": "84; was IPROVERATRIL 1964-83 (Prov 1964-71)", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014700"}, {"RECTYPE": "D", "MH": "Veratridine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.400.256.679", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Cevane-3,4,12,14,16,17,20-heptol, 4,9-epoxy-, 3-(3,4-dimethoxybenzoate), (3beta,4alpha,16beta)-", "RN": "71-62-5", "PI": "Veratrine (1973-1974)", "MS": "A benzoate-cevane found in VERATRUM and Schoenocaulon. It activates SODIUM CHANNELS to stay open longer than normal.", "PM": "91; was see under VERATRINE 1975-90", "HN": "91(75); was see under VERATRINE 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014701"}, {"RECTYPE": "D", "MH": "Veratrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cevane-3,4,12,14,16,17,20-heptol, 4,9-epoxy-, 3-(2-methyl-2-butenoate), (3beta(Z),4alpha,16beta)-|T109|T121|T123|NON|EQV|NLM (2020)|190408|abbbcdef", "ENTRY": "Cevadine|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|810318|abbcdeef", "MN": "D03.633.400.256.815", "MH_TH": "NLM (1963)", "ST": "T123", "RN": "ERQ7M6C50B", "RR": "62-59-9 (Veratrine)", "AN": "do not confuse with VERATRIDINE", "MS": "A voltage-gated sodium channel activator.", "HN": "1973 (1963)", "MR": "20190429", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014702"}, {"RECTYPE": "D", "MH": "Veratrum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hellebore, False|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Hellebores, False", "MN": "B01.875.800.575.912.250.618.875.625.920", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid50241", "RR": "txid203100", "AN": "VERATRUM ALKALOIDS is also available", "MS": "A plant genus of the family Melanthiaceae with roots that contain VERATRUM ALKALOIDS used as emetics, parasiticides, antihypertensives. The common name \"black hellebore\" is used for both Veratrum nigrum and HELLEBORUS NIGER.", "PM": "91,63-85; was see under PLANTS, TOXIC 1986-90; was heading 1963-85; was in Cat B & D 1963-77", "HN": "91(86)63; was see under PLANTS, TOXIC 1986-90; was heading 1963-85; was in Cat B & D 1963-77", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014703"}, {"RECTYPE": "D", "MH": "Veratrum Alkaloids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Alkaloids, Veratrum", "MN": "D03.132.920", "PA": "Antihypertensive Agents", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "AN": "antihypertensives", "PI": "Veratrum (1966-1974)", "MS": "Alkaloids with powerful hypotensive effects isolated from American or European Hellebore (Veratrum viride Ait. Liliaceae and Veratrum album L. Liliaceae). They increase cholinergic and decrease adrenergic tone with appropriate side effects and at higher doses depress respiration and produce cardiac arrhythmias; only the ester alkaloids have been used as hypotensive agents in specific instances. They have been generally replaced by drugs with fewer adverse effects.", "PM": "75; PROTOVERATRINE A was see under CEVANES 1975-79; PROTOVERATRINE A DERIVATIVES was see under CEVANES 1969-77; PROTOVERATRINE was see under VERATRUM 1963-68; CRYPTENAMINE (now see PROTOVERATRINES) was see under VERATRUM ALKALOIDS 1975-79, was see under VERATRUM 1963-74", "HN": "75", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D014704"}, {"RECTYPE": "D", "MH": "Verbal Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Verbal Behaviors", "MN": "F01.145.209.908", "FX": "Speech Disorders", "MH_TH": "NLM (1964)", "ST": "T055", "MS": "Includes both producing and responding to words, either written or spoken.", "PM": "66", "HN": "66(64)", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014705"}, {"RECTYPE": "D", "MH": "Verbal Learning", "AQ": "CL DE ES PH RE", "ENTRY": "Verbal Learnings", "MN": "F02.463.425.952", "FX": "Language Disorders", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "Learning to respond verbally to a verbal stimulus cue.", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014706"}, {"RECTYPE": "D", "MH": "Vermont", "AQ": "EH EP", "MN": "Z01.107.567.875.550.880", "MH_TH": "NLM (1997)", "ST": "T083", "MS": "State bounded on the north by Canada, on the east by New Hampshire, on the south by Massachusetts, and on the west by New York.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014707"}, {"RECTYPE": "D", "MH": "Vernix Caseosa", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Vernix Caseosas", "MN": "A16.378.857", "MH_TH": "NLM (1966)", "ST": "T031", "AN": "check the tag INFANT, NEWBORN", "MS": "An unctuous substance composed of sebum and desquamated epithelial cells, which covers the skin of the fetus.", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014708"}, {"RECTYPE": "D", "MH": "Vero Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Vero Cell", "MN": "A11.436.955", "FX": "COS Cells", "MH_TH": "NLM (1987)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMALS & add CHLOROCEBUS AETHIOPS (NIM); do not routinely add KIDNEY", "PI": "Kidney (1966-1986)", "MS": "A CELL LINE derived from the kidney of the African green (vervet) monkey, (CHLOROCEBUS AETHIOPS) used primarily in virus replication studies and plaque assays.", "PM": "87", "HN": "87", "MR": "20190710", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D014709"}, {"RECTYPE": "D", "MH": "Version, Fetal", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Version, External Cephalic|T061|NON|NRW|NLM (2001)|000424|abcdef", "ENTRY": "Versions, Fetal", "MN": "E04.520.252.996", "MH_TH": "NLM (1975)", "ST": "T061", "MS": "The artificial alteration of the fetal position to facilitate birth.", "OL": "to search VERSION use VERSION, FETAL 1975-80 & DELIVERY 1966-74", "PM": "91; was see under DELIVERY 1981-90; was VERSION see under DELIVERY 1963-80", "HN": "91(81); was see under DELIVERY 1981-90; was VERSION see under DELIVERY 1963-80", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014710"}, {"RECTYPE": "D", "MH": "Vertebral Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Artery, Vertebral", "MN": "A07.015.114.955", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The first branch of the SUBCLAVIAN ARTERY with distribution to muscles of the NECK; VERTEBRAE; SPINAL CORD; CEREBELLUM; and interior of the CEREBRUM.", "MR": "20180630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014711"}, {"RECTYPE": "D", "MH": "Viruses, Unclassified", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Unclassified Viruses", "MN": "B04.970", "MH_TH": "NLM (1966)", "ST": "T005", "MS": "Viruses whose taxonomic relationships have not been established.", "OL": "use VIRUSES, UNCLASSIFIED to search VERTEBRATE VIRUSES, UNCLASSIFIED 1966-91", "PM": "92; was VERTEBRATE VIRUSES, UNCLASSIFIED 1966-91", "HN": "92; was VERTEBRATE VIRUSES, UNCLASSIFIED 1966-91", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014713"}, {"RECTYPE": "D", "MH": "Vertebrates", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Vertebrate", "MN": "B01.050.150.900", "MH_TH": "NLM (1966)", "ST": "T010", "RN": "txid7742", "AN": "avoid: too general; prefer specific classes, orders, families & genera", "MS": "Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014714"}, {"RECTYPE": "D", "MH": "Vertebrobasilar Insufficiency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vertebral Artery Stenosis|T047|NON|REL|NLM (2000)|991103|abcdef", "ENTRY": "Vertebrobasilar Ischemias", "MN": "C14.907.253.092.956", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "BRACHIAL-BASILAR INSUFFICIENCY SYNDROME see SUBCLAVIAN STEAL SYNDROME is available", "PI": "Vertebral Artery (1966-1979)", "MS": "Localized or diffuse reduction in blood flow through the vertebrobasilar arterial system, which supplies the BRAIN STEM; CEREBELLUM; OCCIPITAL LOBE; medial TEMPORAL LOBE; and THALAMUS. Characteristic clinical features include SYNCOPE; lightheadedness; visual disturbances; and VERTIGO. BRAIN STEM INFARCTIONS or other BRAIN INFARCTION may be associated.", "PM": "1980", "HN": "1980", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19790425", "DC": "1", "DX": "19800101", "UI": "D014715"}, {"RECTYPE": "D", "MH": "Vertical Dimension", "PRINT ENTRY": "Rest Vertical Dimension|T082|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Vertical Dimensions, Rest", "MN": "E06.276.459.733", "MH_TH": "NLM (1966)", "ST": "T082", "MS": "The length of the face determined by the distance of separation of jaws. Occlusal vertical dimension (OVD or VDO) or contact vertical dimension is the lower face height with the teeth in centric occlusion. Rest vertical dimension (VDR) is the lower face height measured from a chin point to a point just below the nose, with the mandible in rest position. (From Jablonski, Dictionary of Dentistry, 1992, p250)", "PM": "66", "HN": "66", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014716"}, {"RECTYPE": "D", "MH": "Vertigo", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vertigos, Subjective", "MN": "C23.888.592.958", "FX": "Dizziness", "MH_TH": "POPLINE (1978)", "ST": "T184", "AN": "differentiate from DIZZINESS, \"sensation of unsteadiness or lightheadedness\", but use word of text", "MS": "An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)", "CATSH": "CAT LIST", "MR": "20140620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014717"}, {"RECTYPE": "D", "MH": "Vesico-Ureteral Reflux", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vesicoureteral Reflux1|T047|NON|REL|NLM (2023)|210910|abcdef", "ENTRY": "Vesicoureteral Reflux1s", "MN": "C12.950.829.920", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Retrograde flow of urine from the URINARY BLADDER into the URETER. This is often due to incompetence of the vesicoureteral valve.", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014718"}, {"RECTYPE": "D", "MH": "Vesicovaginal Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vesicovaginal Fistulas", "MN": "C23.300.575.925.816", "MH_TH": "NLM (1966)", "ST": "T190", "MS": "An abnormal anatomical passage between the URINARY BLADDER and the VAGINA.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014719"}, {"RECTYPE": "D", "MH": "Vesicular Exanthema of Swine", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Swine Vesicular Exanthemas", "MN": "C22.905.927", "MH_TH": "NLM (1971)", "ST": "T047", "AN": "caused by a calicivirus; don't forget also SWINE (NIM) & check tag ANIMALS", "PI": "Virus Diseases/veterinary (1966-1970)", "MS": "A calicivirus infection of swine characterized by hydropic degeneration of the oral and cutaneous epithelia.", "PM": "71", "HN": "71", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19710101", "UI": "D014720"}, {"RECTYPE": "D", "MH": "Vesicular stomatitis Indiana virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Vesicular stomatitis-Indiana virus|T005|EPO|EQV|NLM (1966)|990101|abcdef", "MN": "B04.820.480.937.750.900.900", "MH_TH": "NLM (2008)", "ST": "T005", "RN": "txid11277", "AN": "infection: coordinate IM with probably VESICULAR STOMATITIS (IM); otherwise coordinate with RHABDOVIRIDAE INFECTIONS (IM)", "MS": "The type species of VESICULOVIRUS causing a disease symptomatically similar to FOOT-AND-MOUTH DISEASE in cattle, horses, and pigs. It may be transmitted to other species including humans, where it causes influenza-like symptoms.", "PM": "2008; see VESICULAR STOMATITIS-INDIANA VIRUS 1994-2007, see VESICULAR STOMATITIS VIRUS 1963-1993", "HN": "2008 (1963)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D014721"}, {"RECTYPE": "D", "MH": "Vestibule, Labyrinth", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Vestibular Apparatus|T030|NON|EQV|NLM (1990)|890328|abcdef", "ENTRY": "Vestibules, Labyrinth", "MN": "A09.923.500", "MH_TH": "NLM (2008)", "ST": "T030", "MS": "An oval, bony chamber of the inner ear, part of the bony labyrinth. It is continuous with bony COCHLEA anteriorly, and SEMICIRCULAR CANALS posteriorly. The vestibule contains two communicating sacs (utricle and saccule) of the balancing apparatus. The oval window on its lateral wall is occupied by the base of the STAPES of the MIDDLE EAR.", "PM": "2008; see VESTIBULE 1990-2007, see VESTIBULAR APPARATUS 1963-1989", "HN": "2008 (1979)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D014722"}, {"RECTYPE": "D", "MH": "Vestibular Aqueduct", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vestibule Aqueducts", "MN": "A09.923.500.957", "MH_TH": "NLM (1979)", "ST": "T023", "PI": "Vestibular Apparatus (1966-1978)", "MS": "A small bony canal linking the vestibule of the inner ear to the posterior part of the internal surface of the petrous TEMPORAL BONE. It transmits the endolymphatic duct and two small blood vessels.", "PM": "91; was see under VESTIBULE 1990-90; was see under VESTIBULAR APPARATUS 1979-89", "HN": "91(79); was see under VESTIBULE 1990-90; was see under VESTIBULAR APPARATUS 1979-89", "MR": "20210630", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D014723"}, {"RECTYPE": "D", "MH": "Vestibular Function Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Vestibular Function Test", "MN": "E01.370.382.900", "FX": "Vestibular Evoked Myogenic Potentials", "MH_TH": "NLM (1966)", "ST": "T060", "MS": "A number of tests used to determine if the brain or balance portion of the inner ear are causing dizziness.", "CATSH": "CAT LIST", "MR": "20150522", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014724"}, {"RECTYPE": "D", "MH": "Vestibular Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Scarpa's Ganglion|T023|EPO|REL|UNK (19XX)|780522|abcdef", "ENTRY": "Vestibular Nerves", "MN": "A09.923.250", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "dis: coord IM with VESTIBULOCOCHLEAR NERVE DISEASES (IM); neopl: coord IM with VESTIBULOCOCHLEAR NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "MS": "The vestibular part of the 8th cranial nerve (VESTIBULOCOCHLEAR NERVE). The vestibular nerve fibers arise from neurons of Scarpa's ganglion and project peripherally to vestibular hair cells and centrally to the VESTIBULAR NUCLEI of the BRAIN STEM. These fibers mediate the sense of balance and head position.", "OL": "use VESTIBULAR NERVE to search SCARPA'S GANGLION 1966-78", "HN": "SCARPA'S GANGLION was see under VESTIBULAR NERVE 1963-78", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D014725"}, {"RECTYPE": "D", "MH": "Vestibular Nuclei", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Vestibular Nucleus, Medial|T023|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Schwalbes Nucleus", "MN": "A09.923.375", "MH_TH": "NLM (1965)", "ST": "T023", "MS": "The four cellular masses in the floor of the fourth ventricle giving rise to a widely dispersed special sensory system. Included is the superior, medial, inferior, and LATERAL VESTIBULAR NUCLEUS. (From Dorland, 27th ed)", "PM": "1967", "HN": "1967(1965)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014726"}, {"RECTYPE": "D", "MH": "Vestibuloplasty", "AQ": "AE CL EC ED ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Vestibuloplasties", "MN": "E06.645.550.800", "MH_TH": "NLM (1968)", "ST": "T061", "AN": "refers to the oral cavity, not to the vestibular apparatus", "PI": "Surgery, Oral (1966-1967)", "MS": "Those procedures designed to widen the zone of attached gingiva and deepen the vestibular depth which will facilitate the clearance of the area for natural food passage, and provide access for toothbrushing and interdental stimulation.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "20200221", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014727"}, {"RECTYPE": "D", "MH": "Veterans", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Veteran", "MN": "M01.930", "FX": "Veterans Health", "MH_TH": "NLM (1966)", "ST": "T098", "MS": "Former members of the armed services.", "PM": "81; was VETERANS AFFAIRS 1963-80", "HN": "81; was VETERANS AFFAIRS 1963-80", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014728"}, {"RECTYPE": "D", "MH": "Veterans Disability Claims", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Veterans Disability Claim", "MN": "N03.219.521.346.733", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "specify country", "MS": "Disorders claimed as a result of military service.", "MR": "19930916", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014729"}, {"RECTYPE": "D", "MH": "Veterinary Medicine", "DE": "VET MED", "AQ": "CL EC ES HI IS MT OG SN ST TD", "PRINT ENTRY": "Medicine, Veterinary|T091|NON|EQV|NLM (1990)|890501|MED VET|abcdefv", "MN": "H02.956", "FX": "Laboratory Animal Science", "EC": "legislation & jurisprudence:Legislation, Veterinary", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use for the specialty only; use /vet with diseases & techniques", "MS": "The medical science concerned with the prevention, diagnosis, and treatment of diseases in animals.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014730"}, {"RECTYPE": "D", "MH": "Veterinary Service, Military", "DE": "VET SERV MILITARY", "AQ": "CL EC ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Military Veterinary Service|T091|NON|EQV|NLM (1990)|890501|MILITARY VET SERV|abcdefv", "ENTRY": "Veterinary Services, Military", "MN": "H02.956.858", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "specify country", "MS": "A corps of the armed services concerned with animal medicine, the chief interest of which is the care of government-owned working dogs (as in the military police units), working horses (as in state funerals), and working military dolphins (as in undersea exploration and other activities). In the United States Army Veterinary Corps animal medicine overlaps and interconnects with biomedical research using laboratory research animals. A related activity is laboratory animal care. The Corps provides limited care for privately owned animals of military personnel through non-appropriated funds. Military service veterinarians in the United States Army must be graduates of accredited veterinary schools and must have a state license. (Telephone communication with Lt. Col. William Inskeep II, U.S. Army Veterinary Corps, October 4, 1994)", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014731"}, {"RECTYPE": "D", "MH": "Vibration", "AQ": "AE TU", "ENTRY": "Vibrations", "MN": "G01.374.930", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "biological and non-biological application", "MS": "A continuing periodic change in displacement with respect to a fixed reference. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014732"}, {"RECTYPE": "D", "MH": "Vibrio", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Beneckea|T007|NON|NRW|UNK (1989)|890206|abcdef", "MN": "B03.660.250.830.830", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid662", "AN": "general or unspecified; prefer specifics; VIBRIO MARINUS and VIBRIO VISCOSUS see MORITELLA are also available; infection equals VIBRIO INFECTIONS", "MS": "A genus of VIBRIONACEAE, made up of short, slightly curved, motile, gram-negative rods. Various species produce cholera and other gastrointestinal disorders as well as abortion in sheep and cattle.", "OL": "use VIBRIONACEAE to search BENECKEA 1978-89", "PM": "90; BENECKEA was see under VIBRIONACEAE 1978-89, was heading 1963-65", "HN": "90; BENECKEA was see under VIBRIONACEAE l978-89, was heading 1963-65", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19900101", "UI": "D014733"}, {"RECTYPE": "D", "MH": "Vibrio cholerae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Vibrio comma|T007|NON|EQV|UNK (19XX)|750711|abcdef", "MN": "B03.660.250.830.830.100", "FX": "Cholera Toxin", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid666", "PI": "Vibrio (1966-1971)", "MS": "The etiologic agent of CHOLERA.", "OL": "use VIBRIO CHOLERAE to search VIBRIO COMMA 1972-75 (as Prov 1972-73)", "PM": "76; was VIBRIO COMMA 1974-75", "HN": "76; was VIBRIO COMMA 1972-75 (Prov 1972-73)", "MR": "20200206", "DA": "19750718", "DC": "1", "DX": "19760101", "UI": "D014734"}, {"RECTYPE": "D", "MH": "Vibrio Infections", "DE": "VIBRIO INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Vibrioses", "MN": "C01.150.252.400.959", "MH_TH": "NLM (1968)", "ST": "T047", "PI": "Vibrio (1966-1967)", "MS": "Infections with bacteria of the genus VIBRIO.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014735"}, {"RECTYPE": "D", "MH": "Vibrio parahaemolyticus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pasteurella parahaemolytica|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.830.830.590", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid670", "AN": "infection: coord IM with VIBRIO INFECTIONS (IM)", "PI": "Vibrio (1966-1975)", "MS": "A species of bacteria found in the marine environment, sea foods, and the feces of patients with acute enteritis.", "PM": "76", "HN": "76", "MR": "20200206", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D014736"}, {"RECTYPE": "D", "MH": "Vibrionaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.830", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid641", "AN": "infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Spirillaceae (1975)", "MS": "A family of gram-negative bacteria whose members predominate in the bacterial flora of PLANKTON; FISHES; and SEAWATER. Some members are important pathogens for humans and animals.", "PM": "76", "HN": "76", "MR": "20200813", "DA": "19750718", "DC": "1", "DX": "19760101", "UI": "D014737"}, {"RECTYPE": "D", "MH": "Vibrissae", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Whiskers|T023|NON|EQV|UNK (19XX)|840405|abcdef", "ENTRY": "Whisker", "MN": "A13.950", "MH_TH": "NLM (1985)", "ST": "T023", "PI": "Mechanoreceptors (1971-1984)", "MS": "Stiff hairs projecting from the face around the nose of most mammals, acting as touch receptors.", "PM": "85", "HN": "85", "MR": "20180629", "DA": "19840406", "DC": "1", "DX": "19850101", "UI": "D014738"}, {"RECTYPE": "D", "MH": "Victoria", "AQ": "EH EP", "MN": "Z01.678.100.373.992", "MH_TH": "NLM (1988)", "ST": "T083", "AN": "a state of Australia", "PI": "Australia (1966-1987)", "MS": "A state in southeastern Australia, the southernmost state. Its capital is Melbourne. It was discovered in 1770 by Captain Cook and first settled by immigrants from Tasmania. In 1851 it was separated from New South Wales as a separate colony. Self-government was introduced in 1851; it became a state in 1901. It was named for Queen Victoria in 1851. (From Webster's New Geographical Dictionary, 1988, p1295 & Room, Brewer's Dictionary of Names, p574)", "HN": "88", "MR": "20150623", "DA": "19870309", "DC": "4", "DX": "19880101", "UI": "D014739"}, {"RECTYPE": "D", "MH": "Vidarabine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Arabinosyladenine|T114|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "beta Ara A", "MN": "D13.570.583.138.900", "PA": "Antiviral Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-", "RN": "FA2DM6879K", "RR": "5536-17-4 (Vidarabine)", "AN": "an antiviral & antimetabolite", "PI": "Purines (1966-1973)", "MS": "A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus.", "OL": "use VIDARABINE to search ARABINOFURANOSYLADENINE 1975-78", "PM": "79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76", "HN": "79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19770101", "UI": "D014740"}, {"RECTYPE": "D", "MH": "Video Recording", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Videorecordings", "MN": "L01.280.960", "FX": "Video-Assisted Surgery", "MH_TH": "NLM (1984)", "ST": "T073", "AN": "VIDEODISC RECORDING & VIDEOTAPE RECORDING are also available", "PI": "Videotape Recording (1974-1983)", "MS": "The storing or preserving of video signals to be played back later via a transmitter or receiver.", "PM": "84", "HN": "84", "MR": "20170703", "DA": "19830613", "DC": "1", "DX": "19840101", "UI": "D014741"}, {"RECTYPE": "D", "MH": "Videodisc Recording", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Videodisk Recordings", "MN": "L01.462.500.820.090.898.800", "MH_TH": "NLM (1984)", "ST": "T073", "AN": "IM; do not confuse with VIDEO RECORDING or VIDEOTAPE RECORDING", "PI": "Videotape Recording (1974-1983)", "MS": "The storing of visual and usually sound signals on discs for later reproduction on a television screen or monitor.", "PM": "91; was see under VIDEO RECORDING 1984-90", "HN": "91(84); was see under VIDEO RECORDING 1984-90", "MR": "20220712", "DA": "19830613", "DC": "1", "DX": "19910101", "UI": "D014742"}, {"RECTYPE": "D", "MH": "Videotape Recording", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "PRINT ENTRY": "Tape Recording, Video|T068|T073|NON|EQV|UNK (19XX)|810224|abbcdef", "ENTRY": "Videotape Recordings", "MN": "L01.462.500.820.090.898.840", "MH_TH": "NLM (1974)", "ST": "T073", "AN": "IM; do not confuse with VIDEO RECORDING or VIDEODISC RECORDING", "MS": "Recording of visual and sometimes sound signals on magnetic tape.", "PM": "74", "HN": "74", "MR": "20220712", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014743"}, {"RECTYPE": "D", "MH": "Vietnam", "AQ": "EH EP", "ENTRY": "Vietnam, Republic of|T083|NAM|EQV|UNK (19XX)|781226|abcdef", "MN": "Z01.252.145.945", "MH_TH": "NLM (1983)", "ST": "T083", "MS": "A country in southeastern Asia, bordering the Gulf of Thailand, Gulf of Tonkin, and South China Sea, as well as China, Laos, and Cambodia. The capital is Hanoi.", "MR": "20161219", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014744"}, {"RECTYPE": "D", "MH": "Viloxazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ICI58,834", "MN": "D03.383.533.640.900", "PA": "Antidepressive Agents, Second-Generation", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Morpholine, 2-((2-ethoxyphenoxy)methyl)-", "RN": "5I5Y2789ZF", "RR": "OQW30I1332", "PI": "Oxazines (1972-1975)", "MS": "A morpholine derivative used as an antidepressant. It is similar in action to IMIPRAMINE.", "PM": "91; was see under MORPHOLINES 1977-90", "HN": "91(77); was see under MORPHOLINES 1977-90", "MR": "20170524", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D014745"}, {"RECTYPE": "D", "MH": "Vimentin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.220.475.900", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "AN": "an intermediate filament protein; /biosyn /physiol permitted", "PI": "Muscle Proteins (1966-1982)", "MS": "An intermediate filament protein found in most differentiating cells, in cells grown in tissue culture, and in certain fully differentiated cells. Its insolubility suggests that it serves a structural function in the cytoplasm. MW 52,000.", "PM": "85", "HN": "85", "MR": "20040707", "DA": "19840406", "DC": "1", "DX": "19850101", "UI": "D014746"}, {"RECTYPE": "D", "MH": "Vinblastine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vincaleukoblastine|T109|T121|T123|NON|EQV|UNK (19XX)|740330|abbbcdef", "ENTRY": "Sulfate, Vinblastine", "MN": "D03.633.100.496.500.500.681.827.650", "PA": "Tubulin Modulators", "MH_TH": "INN (19XX)", "ST": "T123", "RN": "5V9KLZ54CY", "RR": "N00W22YO2B", "AN": "/biosyn permitted if by plant", "MS": "Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014747"}, {"RECTYPE": "D", "MH": "Vinca Alkaloids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Alkaloids, Vinca", "MN": "D03.633.100.496.500.500.681.827", "PA": "Tubulin Modulators", "MH_TH": "NLM (1973)", "ST": "T121", "RN": "0", "PI": "Alkaloids (1966-1972)", "MS": "A group of indole-indoline dimers which are ALKALOIDS obtained from the VINCA genus of plants. They inhibit polymerization of TUBULIN into MICROTUBULES thus blocking spindle formation and arresting cells in METAPHASE. They are some of the most useful ANTINEOPLASTIC AGENTS.", "PM": "73", "HN": "73", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014748"}, {"RECTYPE": "D", "MH": "Vincamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vincimax|T109|T121|TRD|NRW|UNK (19XX)|830330|abbcdef", "MN": "D03.633.100.496.500.500.681.827.750", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3alpha,14beta,16alpha)-", "RN": "996XVD0JHT", "RR": "1617-90-9 (Vincamine)", "AN": "/biosyn permitted if by plant", "PI": "Vinca Alkaloids (1973-1978)", "MS": "A major alkaloid of Vinca minor L., Apocynaceae. It has been used therapeutically as a vasodilator and antihypertensive agent, particularly in cerebrovascular disorders.", "PM": "91; was see under VINCA ALKALOIDS 1979-90", "HN": "91(79); was see under VINCA ALKALOIDS 1979-90", "MR": "20200527", "DA": "19780519", "DC": "1", "DX": "19910101", "UI": "D014749"}, {"RECTYPE": "D", "MH": "Vincristine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Leurocristine|T109|T121|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Sulfate, Vincristine", "MN": "D03.633.100.496.500.500.681.827.817", "PA": "Tubulin Modulators", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Vincaleukoblastine, 22-oxo-", "RN": "5J49Q6B70F", "RR": "T5IRO3534A", "MS": "An antitumor alkaloid isolated from VINCA ROSEA. (Merck, 11th ed.)", "PM": "66", "HN": "66(63)", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014750"}, {"RECTYPE": "D", "MH": "Vindesine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Vindesine", "MN": "D03.633.100.496.500.500.681.827.830", "PA": "Tubulin Modulators", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "Vincaleukoblastine, 3-(aminocarbonyl)-O4-deacetyl-3-de(methoxycarbonyl)-", "RN": "RSA8KO39WH", "RR": "CPH2U7DNDY", "PI": "Vinca Alkaloids (1973-1979)", "MS": "Vinblastine derivative with antineoplastic activity against CANCER. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS).", "PM": "86", "HN": "86", "MR": "20200527", "DA": "19850424", "DC": "1", "DX": "19860101", "UI": "D014751"}, {"RECTYPE": "D", "MH": "Vinyl Chloride", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Chloroethylene|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef", "ENTRY": "Chloride, Vinyl", "MN": "D02.455.526.439.975", "PA": "Carcinogens", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Ethene, chloro-", "RN": "WD06X94M2D", "RR": "75-01-4 (Vinyl Chloride)", "AN": "POLYVINYL CHLORIDE is available", "PI": "Vinyl Compounds (1974)", "MS": "A gas that has been used as an aerosol propellant and is the starting material for polyvinyl resins. Toxicity studies have shown various adverse effects, particularly the occurrence of liver neoplasms.", "PM": "91; was see under VINYL COMPOUNDS 1975-90; was in Cat D & J 1975-79", "HN": "91(75); was see under VINYL COMPOUNDS 1975-90; was in Cat D & J 1975-79", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D014752"}, {"RECTYPE": "D", "MH": "Vinyl Compounds", "DE": "VINYL CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Vinyl", "MN": "D02.455.326.271.884", "MH_TH": "NLM (1971)", "ST": "T109", "RN": "0", "PI": "specific component in the molecule (1971-1973)", "MS": "Compounds containing the vinyl (-C=CH2) functional group.", "PM": "73", "HN": "73(71)", "MR": "20151201", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014753"}, {"RECTYPE": "D", "MH": "Violence", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Violent Crime|T048|T054|NON|EQV|NLM (2023)|211026|abbcdef", "ENTRY": "Violent Crimes", "MN": "I01.880.735.900", "FX": "Warfare", "MH_TH": "BIOETHICS (1974)", "ST": "T054", "PI": "Psychology, Social (1966-1967)", "MS": "Use of physical force causing or intent to cause harm, injury or abuse.", "PM": "70; ATROCITIES was heading 1963-67", "HN": "70(68); ATROCITIES was heading 1963-67", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D014754"}, {"RECTYPE": "D", "MH": "Viologens", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Viologen|T109|T130|NON|EQV|NLM (2021)|191118|abbcdef", "MN": "D03.383.725.762.925", "MH_TH": "NLM (1975)", "ST": "T130", "RN": "0", "AN": "oxidation-reduction indicators", "PI": "Pyridinium Compounds (1968-1974)", "PM": "91; was see under PYRIDINIUM COMPOUNDS 1975-90", "HN": "91(75); was see under PYRIDINIUM COMPOUNDS 1975-90", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014755"}, {"RECTYPE": "D", "MH": "Viomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tuberactinomycin B|T116|T195|NON|EQV|FDA SRS (2014)|UNK (19XX)|800523|abbcdeef", "ENTRY": "Viomycins|T116|T195|NON|BRD|NLM (1994)|921120|abbcdef", "MN": "D12.644.641.875", "PA": "Protein Synthesis Inhibitors", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "Viomycin", "RN": "YVU35998K5", "RR": "32988-50-4 (Viomycin)", "MS": "A strongly basic peptide, antibiotic complex from several strains of Streptomyces. It is allergenic and toxic to kidneys and the labyrinth. Viomycin is used in tuberculosis as several different salts and in combination with other agents.", "OL": "use VIOMYCIN to search VIOMYCINS 1981-93", "PM": "94,63-80; was VIOMYCINS 1981-93; was VIOMYCIN 1963-80", "HN": "94,63-80; was VIOMYCINS 1981-93; was VIOMYCIN 1963-80", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19940101", "UI": "D014756"}, {"RECTYPE": "D", "MH": "Viper Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE ST TO TU UR", "PRINT ENTRY": "Viperidae Venoms|T123|NON|BRD|NLM (2021)|200131|abcdef", "ENTRY": "Viper Venoms, Russell's", "MN": "D23.946.833.850.960", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTIVENINS; /enzymol permitted; includes adder venoms & viperotoxin; TN 241: common & scientific names of various viperids; note PIT VIPER VENOMS see CROTALID VENOMS", "PI": "Venoms (1966-1974)", "MS": "Venoms from SNAKES of the viperid family. They tend to be less toxic than elapid or hydrophid venoms and act mainly on the vascular system, interfering with coagulation and capillary membrane integrity and are highly cytotoxic. They contain large amounts of several enzymes, other factors, and some toxins.", "OL": "use VIPER VENOMS to search CERASTES VENOM 1986-93", "PM": "78; CERASTES VENOM was indexed under VIPER VENOMS 1986-93", "HN": "78; CERASTES VENOM was (NM) 1986-93", "MR": "20200527", "DA": "19770422", "DC": "1", "DX": "19780101", "UI": "D014757"}, {"RECTYPE": "D", "MH": "Viral Core Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Major Core Proteins, Viral|T116|T123|NON|NRW|UNK (19XX)|870511|abbcdef", "ENTRY": "Proteins, Virus Core", "MN": "D12.776.964.970.600.850", "MH_TH": "NLM (1986)", "ST": "T123", "RN": "0", "AN": "IM; coord with specific virus (IM); /drug eff /ultrastruct permitted", "PI": "Viral Proteins (1966-1985)", "MS": "Proteins found mainly in icosahedral DNA and RNA viruses. They consist of proteins directly associated with the nucleic acid inside the NUCLEOCAPSID.", "PM": "86", "HN": "86", "MR": "20060705", "DA": "19850425", "DC": "1", "DX": "19860101", "UI": "D014758"}, {"RECTYPE": "D", "MH": "Viral Envelope Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Virus Peplomer Proteins|T116|T123|NON|NRW|NLM (1990)|890525|abbcdef", "ENTRY": "Proteins, Virus Peplomer", "MN": "D12.776.964.970.880", "MH_TH": "NLM (1984)", "ST": "T123", "RN": "0", "AN": "IM; coord with specific virus (IM); /drug eff /ultrastruct permitted", "PI": "Viral Proteins (1966-1983)", "MS": "Integral membrane proteins that are incorporated into the VIRAL ENVELOPE. They are glycosylated during VIRAL ASSEMBLY.", "PM": "84", "HN": "84", "MR": "20230316", "DA": "19830616", "DC": "1", "DX": "19840101", "UI": "D014759"}, {"RECTYPE": "D", "MH": "Viral Fusion Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Viral Fusion Glycoproteins|T116|T123|NRW|UNK (19XX)|860616|abbdef", "ENTRY": "Viral Fusion Glycoprotein", "MN": "D12.776.964.970.880.910", "MH_TH": "NLM (1987)", "ST": "T123", "RN": "0", "AN": "coord with specific virus; do not confuse with RECOMBINANT FUSION PROTEINS", "PI": "Viral Proteins (1966-1983)", "MS": "Proteins, usually glycoproteins, found in the viral envelopes of a variety of viruses. They promote cell membrane fusion and thereby may function in the uptake of the virus by cells.", "PM": "87", "HN": "87", "MR": "20060705", "DA": "19860616", "DC": "1", "DX": "19870101", "UI": "D014760"}, {"RECTYPE": "D", "MH": "Viral Hepatitis Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hepatitis, Viral, Vaccines|T121|T129|NON|EQV|UNK (19XX)|840620|abbcdef", "ENTRY": "Vaccines, Viral Hepatitis", "MN": "D20.215.894.899.955", "MH_TH": "NLM (1985)", "ST": "T129", "RN": "0", "AN": "coord IM with specific hepatitis virus or viral hepatitis (IM or NIM) if pertinent", "PI": "Viral Vaccines (1966-1984)", "MS": "Any vaccine raised against any virus or viral derivative that causes hepatitis.", "PM": "85", "HN": "85", "MR": "20050630", "DA": "19840502", "DC": "1", "DX": "19850101", "UI": "D014761"}, {"RECTYPE": "D", "MH": "Viral Interference", "AQ": "DE ES GE IM PH RE", "ENTRY": "Viral Interferences", "MN": "G06.920.800", "FX": "Superinfection", "MH_TH": "NLM (1965)", "ST": "T070", "MS": "A phenomenon in which infection by a first virus results in resistance of cells or tissues to infection by a second, unrelated virus.", "PM": "66", "HN": "66(65)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014762"}, {"RECTYPE": "D", "MH": "Viral Matrix Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Viral M Proteins|T116|T123|NRW|UNK (19XX)|870505|abbdef", "ENTRY": "Viral Membrane Proteins|T116|T123|NON|REL|UNK (19XX)|870505|abbcdef", "MN": "D12.776.964.970.880.940", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "PI": "Viral Proteins (1966-1987)", "MS": "Proteins associated with the inner surface of the lipid bilayer of the viral envelope. These proteins have been implicated in control of viral transcription and may possibly serve as the \"glue\" that binds the nucleocapsid to the appropriate membrane site during viral budding from the host cell.", "PM": "88", "HN": "88", "MR": "20180201", "DA": "19870505", "DC": "1", "DX": "19880101", "UI": "D014763"}, {"RECTYPE": "D", "MH": "Viral Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Viral Protein|T116|T123|NON|EQV|NLM (2021)|191230|abbcdef", "ENTRY": "Proteins, Viral", "MN": "D12.776.964", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "AN": "/drug eff /ultrastruct permitted; /physiol permitted for function with the virus; IM; coord with specific protein (IM) + specific virus (IM)", "MS": "Proteins found in any species of virus.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014764"}, {"RECTYPE": "D", "MH": "Viral Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Viral Vaccine|T121|T129|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Vaccines, Viral", "MN": "D20.215.894.899", "MH_TH": "NLM (1965)", "ST": "T129", "RN": "0", "AN": "for specifics not indented here coord IM with specific virus /immunol (IM)", "MS": "Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease.", "PM": "65", "HN": "65", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014765"}, {"RECTYPE": "D", "MH": "Viremia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Viremias", "MN": "C23.550.470.790.500.900", "MH_TH": "NLM (1980)", "ST": "T047", "AN": "coord with specific virus disease or specific virus if specific virus dis is not in MeSH (do not use /blood to indicate -emia)", "PI": "specific virus disease/blood (1967-1979)", "MS": "The presence of viruses in the blood.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19790223", "DC": "1", "DX": "19800101", "UI": "D014766"}, {"RECTYPE": "D", "MH": "United States Virgin Islands", "AQ": "EH EP", "PRINT ENTRY": "Virgin Islands of the United States|T083|NAM|EQV|NLM (1982)|990101|VIRGIN ISLANDS|abcdefv", "MN": "Z01.639.880.970", "MH_TH": "NLM (1978)", "ST": "T083", "PI": "West Indies (1966-1981)", "MS": "A group of islands in the Lesser Antilles in the West Indies, the three main islands being St. Croix, St. Thomas, and St. John. The capital is Charlotte Amalie. Before 1917 the U.S. Virgin Islands were held by the Danish and called the Danish West Indies but the name was changed when the United States acquired them by purchase.", "HN": "2014(1982)", "MR": "20190524", "DA": "19810515", "DC": "4", "DX": "19820101", "UI": "D014767"}, {"RECTYPE": "D", "MH": "Virginia", "AQ": "EH EP", "MN": "Z01.107.567.875.750.870", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Maryland and West Virginia, on the east by the Atlantic Ocean, the Chesapeake Bay and Maryland, and on the south by North Carolina and Tennessee, and on the west by Kentucky and West Virginia.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014768"}, {"RECTYPE": "D", "MH": "Virginiamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Staphylomycin|T116|T195|TRD|REL|UNK (19XX)|740330|abbcdef", "ENTRY": "Virgimycine|T116|T195|NON|EQV|NLM (1991)|900501|abbcdef", "MN": "D12.644.641.802.875", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USAN (1973)", "ST": "T195", "N1": "Virginiamycin", "RN": "11006-76-1", "MS": "A cyclic polypeptide antibiotic complex from Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. It consists of 2 major components, VIRGINIAMYCIN FACTOR M1 and virginiamycin Factor S1. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.", "PM": "1991; see VIRGINIAMYCINS 1974-1990", "HN": "1991(1974);", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014769"}, {"RECTYPE": "D", "MH": "Virilism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Virilization|T184|NON|EQV|NLM (2005)|040622|abcdef", "MN": "C23.888.971", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "check the tag FEMALE", "MS": "Development of male secondary SEX CHARACTERISTICS in the FEMALE. It is due to the effects of androgenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs.", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014770"}, {"RECTYPE": "D", "MH": "Virion", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Virus Particle|T005|NON|EQV|NLM (1992)|900911|abcdef", "ENTRY": "Virus Particles", "MN": "A21.249", "MH_TH": "NLM (1978)", "ST": "T005", "PI": "specific virus", "MS": "The infective system of a virus, composed of the viral genome, a protein core, and a protein coat called a capsid, which may be naked or enclosed in a lipoprotein envelope called the peplos.", "PM": "78", "HN": "78", "MR": "20200622", "DA": "19770504", "DC": "1", "DX": "19780101", "UI": "D014771"}, {"RECTYPE": "D", "MH": "Viroids", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viroid", "MN": "B04.956", "MH_TH": "NLM (1981)", "ST": "T005", "AN": "\"smallest known agents of infect dis\"; read MeSH definition", "PI": "RNA, Viral (1971-1980)", "MS": "A group of pathogens comprising the smallest known agents of infectious disease. They are unencapsulated and are capable of replicating autonomously in susceptible cells. Positively identified viroids composed of single-stranded RNA have been isolated from higher plants, but the existence of DNA viroids pathogenic to animals is suspected.", "PM": "81", "HN": "81", "MR": "20200902", "DA": "19800402", "DC": "1", "DX": "19810101", "UI": "D014772"}, {"RECTYPE": "D", "MH": "Virology", "DE": "VIROL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.158.273.540.859", "FX": "Infectious Disease Medicine", "MH_TH": "NLM (1967)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use VIRUS PHYSIOLOGICAL PHENOMENA or specifics treed under it for biological processes and properties of viruses, or the qualifier /virology with specific anatomical terms, organisms & diseases", "PI": "Viruses (1966)", "MS": "The study of the structure, growth, function, genetics, and reproduction of viruses, and VIRUS DISEASES.", "PM": "67", "HN": "67", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014773"}, {"RECTYPE": "D", "MH": "Virulence", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Pathogenicity|T032|T080|NON|REL|NLM (2003)|020131|abbcdef", "MN": "G06.930", "FX": "Virulence Factors", "MH_TH": "NLM (1965)", "ST": "T081", "AN": "coord NIM with micro-organism or parasite /pathogen (IM)", "MS": "The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS.", "PM": "66", "HN": "66(65)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014774"}, {"RECTYPE": "D", "MH": "Virus Activation", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Virus Induction|T040|NON|EQV|UNK (19XX)|781221|abcdef", "ENTRY": "Virus Inductions", "MN": "G06.920.925.940", "FX": "Lysogeny", "MH_TH": "NLM (1980)", "ST": "T040", "AN": "coord with specific virus /physiol (IM or NIM)", "PI": "specific virus (1966-1967)", "MS": "The mechanism by which latent viruses, such as genetically transmitted tumor viruses (PROVIRUSES) or PROPHAGES of lysogenic bacteria, are induced to replicate and then released as infectious viruses. It may be effected by various endogenous and exogenous stimuli, including B-cell LIPOPOLYSACCHARIDES, glucocorticoid hormones, halogenated pyrimidines, IONIZING RADIATION, ultraviolet light, and superinfecting viruses.", "PM": "80", "HN": "80", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19781221", "DC": "1", "DX": "19800101", "UI": "D014775"}, {"RECTYPE": "D", "MH": "Virus Cultivation", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Virus Cultivations", "MN": "E05.200.875.970", "MH_TH": "NLM (1966)", "ST": "T062", "MS": "Process of growing viruses in live animals, plants, or cultured cells.", "CATSH": "CAT LIST", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014776"}, {"RECTYPE": "D", "MH": "Virus Diseases", "DE": "VIRUS DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Virus Infection", "MN": "C01.925", "RH": "C2 - DISEASES-VIRAL", "FX": "Antiviral Agents", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "general; prefer specifics", "MS": "A general term for diseases caused by viruses.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014777"}, {"RECTYPE": "D", "MH": "Virus Replication", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Viral Replication|T040|NON|EQV|NLM (2021)|200618|abcdef", "ENTRY": "Virus Replications", "MN": "G06.920.925", "FX": "Viral Replication Compartments", "MH_TH": "NLM (1968)", "ST": "T040", "AN": "coord with specific virus /physiol", "PI": "specific virus (1966-1967)", "MS": "The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20200622", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014779"}, {"RECTYPE": "D", "MH": "Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PY RE UL", "PRINT ENTRY": "Zoophaginae|T005|NON|NRW|NLM (1992)|901228|abcdef", "ENTRY": "Viruses, Animal", "MN": "B04", "RH": "B4 - ORGANISMS-VIRUSES", "FX": "Receptors, Virus", "EC": "physiology:Virus Physiological Phenomena", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid10239", "MS": "Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.", "PM": "1963; for ZOOPHAGINAE see VERTEBRATE VIRUSES 1975-1991; for ANIMAL VIRUSES see ANIMAL VIRUSES 1963-1965, see VERTEBRATE VIRUSES 1975-1991", "HN": "1963; for ANIMAL VIRUSES & ZOOPHAGINAE use VERTEBRATE VIRUSES 1975-1991", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D014780"}, {"RECTYPE": "D", "MH": "Viscera", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A01.960", "MH_TH": "NLM (1987)", "ST": "T029", "AN": "general or unspecified; prefer specific organ term", "CX": "consider also terms at SPLANCHN-", "MS": "Any of the large interior organs in any one of the three great cavities of the body, especially in the abdomen.", "PM": "87", "HN": "87", "MR": "20021024", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D014781"}, {"RECTYPE": "D", "MH": "Visceral Prolapse", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Visceroptosis|T047|NON|EQV|NLM (1966)|990101|abcdef", "ENTRY": "Prolapse, Visceral", "MN": "C23.300.842.624.875", "MH_TH": "NLM (2004)", "ST": "T047", "MS": "The prolapse or downward displacement of the VISCERA.", "PM": "2004; see VISCEROPTOSIS 1966-2003", "HN": "2004 (1966)", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "20040101", "UI": "D014782"}, {"RECTYPE": "D", "MH": "Viscosity", "AQ": "DE RE", "ENTRY": "Viscosities", "MN": "G02.930", "FX": "Blood Viscosity", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "NIM", "MS": "The resistance that a gaseous or liquid system offers to flow when it is subjected to shear stress. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014783"}, {"RECTYPE": "D", "MH": "Mistletoe", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Mistletoes", "MN": "B01.875.800.575.912.250.735", "MH_TH": "UNK (19XX)", "ST": "T002", "MS": "Parasitic plants that form a bushy growth on branches of host trees which are in the order Santalales. It includes the Christmas mistletoe family (VISCACEAE), the showy mistletoe family (LORANTHACEAE) and the catkin mistletoe family (Eremolepidaceae). The composition of toxins, lectins, tyramine, phenethylamines, and other compounds may be affected by the host.", "PM": "2002(1963)", "HN": "2002(1963)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "20020101", "UI": "D014784"}, {"RECTYPE": "D", "MH": "Vision, Ocular", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Vision|T042|NON|EQV|NLM (1963)|990101|abcdef", "ENTRY": "Transduction, Visual", "MN": "G14.935", "FX": "Visual Perception", "MH_TH": "NLM (2009)", "ST": "T042", "AN": "differentiate from VISUAL PERCEPTION which takes place in the brain, vision takes place in the eye; visual stimulation: probably PHOTIC STIMULATION but check text for possible non-light (non-photic) stimulation", "MS": "The process in which light signals are transformed by the PHOTORECEPTOR CELLS into electrical signals which can then be transmitted to the brain.", "PM": "2009; see VISION 1963-2008", "HN": "2009 (1963)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "20090101", "UI": "D014785"}, {"RECTYPE": "D", "MH": "Vision Disorders", "DE": "VISION DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Micropsia|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Visual Impairments", "MN": "C23.888.592.763.941", "FX": "Visually Impaired Persons", "MH_TH": "NLM (1967)", "ST": "T047", "AN": "general or unspecified: prefer specifics; / diag: consider also DlAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; for Braille coordinate with SENSORY AIDS + READING", "PI": "Vision (1966)", "MS": "Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. These may result from EYE DISEASES; OPTIC NERVE DISEASES; VISUAL PATHWAY diseases; OCCIPITAL LOBE diseases; OCULAR MOTILITY DISORDERS; and other conditions (From Newell, Ophthalmology: Principles and Concepts, 7th ed, p132).", "PM": "1967; for HEMERALOPIA see HEMERALOPIA 1963-1989", "HN": "1967", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014786"}, {"RECTYPE": "D", "MH": "Vision Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Vision Test", "MN": "E01.370.380.850", "MH_TH": "NLM (1966)", "ST": "T060", "AN": "for an individual: differentiate from VISION SCREENING on a given population", "MS": "A series of tests used to assess various functions of the eyes.", "CATSH": "CAT LIST", "MR": "20150522", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014787"}, {"RECTYPE": "D", "MH": "Vision, Entoptic", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Entoptic Vision|T042|NON|EQV|UNK (19XX)|741111|abcdef", "ENTRY": "Phenomenon, Entoptic", "MN": "G14.935.730", "MH_TH": "NLM (1975)", "ST": "T042", "MS": "Visual sensation derived from sensory stimulation by objects or shadows inside the eye itself, such as floating vitreous fibers, tissues, or blood.", "PM": "91; was see under VISION 1975-90", "HN": "91(75); was see under VISION 1975-90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014788"}, {"RECTYPE": "D", "MH": "Visitors to Patients", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Patients' Visitors|T098|NON|EQV|UNK (19XX)|770512|abcdef", "ENTRY": "Visitors, Patients'", "MN": "M01.935", "MH_TH": "NLM (1978)", "ST": "T098", "MS": "Patients' guests and rules for visiting.", "PM": "78", "HN": "78", "MR": "19920518", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D014789"}, {"RECTYPE": "D", "MH": "Visna-maedi virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Visna Virus|T005|NON|EQV|NLM (1994)|930427|abcdef", "ENTRY": "Visna Maedi Virus", "MN": "B04.820.650.589.600.900", "MH_TH": "NLM (1975)", "ST": "T005", "RN": "txid2169971", "PI": "Scrapie (1968-1972)", "MS": "A species of LENTIVIRUS, subgenus ovine-caprine lentiviruses (LENTIVIRUSES, OVINE-CAPRINE), that can cause chronic pneumonia (maedi), mastitis, arthritis, and encephalomyelitis (visna) in sheep. Maedi is a progressive pneumonia of sheep which is similar to but not the same as jaagsiekte (PULMONARY ADENOMATOSIS, OVINE). Visna is a demyelinating leukoencephalomyelitis of sheep which is similar to but not the same as SCRAPIE.", "OL": "use VISNA-MAEDI VIRUS to search VISNA VIRUS 1991-93 & VISNA-MAEDI VIRUSES 1978-90", "PM": "94; was VISNA VIRUS 1991-93; was VISNA-MAEDI VIRUSES 1975-90 (see under RNA VIRUSES 1975-77); VISNA-MAEDI VIRUS was see VISNA VIRUS 1991-93", "HN": "94; was VISNA VIRUS 1991-93; was VISNA-MAEDI VIRUSES 1975-90 (see under RNA VIRUSES 1975-77); VISNA-MAEDI VIRUS was see VISNA VIRUS 1991-93", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19780101", "UI": "D014790"}, {"RECTYPE": "D", "MH": "Visual Acuity", "AQ": "DE GE IM PH RE", "ENTRY": "Visual Acuities", "MN": "G14.940", "FX": "Refractive Errors", "MH_TH": "NLM (1968)", "ST": "T041", "PI": "Vision (1966-1967)", "MS": "Clarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast.", "PM": "70", "HN": "70(68)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D014792"}, {"RECTYPE": "D", "MH": "Visual Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Visual Motion Area|T023|NON|NRW|NLM (2022)|201008|abcdef", "ENTRY": "Visual Motion Areas", "MN": "A08.186.211.200.885.287.500.814.953", "MH_TH": "NLM (1968)", "ST": "T023", "PI": "Vision (1966-1967)", "MS": "Area of the OCCIPITAL LOBE concerned with the processing of visual information relayed via VISUAL PATHWAYS.", "PM": "70", "HN": "70(68)", "MR": "20210305", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D014793"}, {"RECTYPE": "D", "MH": "Visual Fields", "AQ": "DE GE IM PH RE", "ENTRY": "Visual Field", "MN": "G14.950", "FX": "Visual Field Tests", "MH_TH": "NLM (1966)", "ST": "T082", "AN": "VISUAL FIELD TESTS is also available", "MS": "The total area or space visible in a person's peripheral vision with the eye looking straightforward.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014794"}, {"RECTYPE": "D", "MH": "Visual Pathways", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Visual Pathway", "MN": "A08.612.220.860", "MH_TH": "NLM (1971)", "ST": "T023", "PI": "Vision (1966-1970)", "MS": "Set of cell bodies and nerve fibers conducting impulses from the eyes to the cerebral cortex. It includes the RETINA; OPTIC NERVE; optic tract; and geniculocalcarine tract.", "PM": "72", "HN": "72(71)", "MR": "20140613", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014795"}, {"RECTYPE": "D", "MH": "Visual Perception", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Visual Processing|T041|NON|EQV|NLM (2021)|200103|abcdef", "ENTRY": "Processing, Visual", "MN": "F02.463.593.932", "FX": "Vision, Ocular", "MH_TH": "NLM (1966)", "ST": "T041", "AN": "differentiate from VISION, OCULAR; visual perception takes place in the brain, ocular vision takes place in the eye", "MS": "The selecting and organizing of visual stimuli based on the individual's past experience.", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014796"}, {"RECTYPE": "D", "MH": "Vital Capacity", "DE": "VITAL CAPAC", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Forced Vital Capacity|T034|T042|NON|REL|UNK (19XX)|741210|FORCED VITAL CAPAC|abbcdefv", "ENTRY": "Vital Capacity, Forced", "MN": "G09.772.850.970", "MH_TH": "NLM (1969)", "ST": "T042", "AN": "usually NIM; TIMED VITAL CAPACITY see FORCED EXPIRATORY VOLUME is also available", "PI": "Spirometry (1966-1968)", "MS": "The volume of air that is exhaled by a maximal expiration following a maximal inspiration.", "PM": "72", "HN": "72(69)", "CATSH": "CAT LIST", "MR": "20160520", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014797"}, {"RECTYPE": "D", "MH": "Vital Statistics", "DE": "VITAL STATIST", "ENTRY": "Vital Statistics Registrations", "MN": "N06.850.520.308.985", "MH_TH": "POPLINE (1978)", "ST": "T081", "AN": "general or unspecified; prefer specifics; specify geographic location if pertinent", "MS": "Used for general articles concerning statistics of births, deaths, marriages, etc.", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014798"}, {"RECTYPE": "D", "MH": "Vitalism", "AQ": "HI PX", "ENTRY": "Vitalisms", "MN": "K01.752.935", "MH_TH": "NLM (1966)", "ST": "T078", "MS": "The metaphysical doctrine that the functions and processes of life are due to a vital principle distinct from physicochemical forces and that the laws of physics and chemistry alone cannot explain life functions and processes. Vitalism is opposed to mechanistic materialism. The belief was that matter was divided into two classes based on behavior with respect to heat: organic and inorganic. Inorganic material could be melted but could always be recovered by removing the heat source. Organic compounds changed form upon heating and could not be recovered by removing the heat source. The proposed explanation for the difference between organic and inorganic compounds was the Vitalism Theory, which stated that inorganic materials did not contain the \"vital force\" of life.", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014799"}, {"RECTYPE": "D", "MH": "Vitallium", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Cobalt Chromium Molybdenum Alloy", "MN": "J01.637.051.339.208.224.959", "MH_TH": "NLM (1975)", "ST": "T197", "N1": "Cobalt alloy, base, Co 56-68,Cr 25.00-29.00,Mo 5.00-6.00,Ni 1.75-3.75,Fe 0-3.00,Mn 0-1.00,Si 0-1.00,C 0.20-0.30,B 0-0.007 (UNS R30021)", "RN": "12629-02-6", "MS": "An alloy of 60% cobalt, 20% chromium, 5% molybdenum, and traces of other substances. It is used in dentures, certain surgical appliances, prostheses, implants, and instruments.", "OL": "use CHROMIUM ALLOYS to search VITALLIUM 1966-74", "PM": "91,63-64; was see under CHROMIUM ALLOYS 1982-90; was see under CHROMIUM-COBALT ALLOYS 1965-81; was heading 1963-64", "HN": "91(75)63-64; was see under CHROMIUM ALLOYS 1982-90; was see under CHROMIUM-COBALT ALLOYS 1965-81; was heading 1963-64", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014800"}, {"RECTYPE": "D", "MH": "Vitamin A", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK RE SD ST TO TU UR", "PRINT ENTRY": "Retinol|T109|T127|NON|NRW|FDA SRS (2014)|INN (19XX)|UNK (19XX)|760630|abbcdeeef", "ENTRY": "All Trans Retinol", "MN": "D23.767.261.700.860", "PA": "Vitamins", "EC": "poisoning:Hypervitaminosis A", "MH_TH": "POPLINE (1978)", "ST": "T127", "N1": "Vitamin A", "RN": "11103-57-4", "RR": "G2SH0XKK91", "AN": "/ther use: coordinate disease with /drug ther, not /diet ther", "MS": "Retinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of CAROTENOIDS found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products.", "OL": "use VITAMIN A to search RETINOL 1969-76", "HN": "RETINOL was see under VITAMIN A 1971-76, was see VITAMIN A 1969-70", "MR": "20200609", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D014801"}, {"RECTYPE": "D", "MH": "Vitamin A Deficiency", "DE": "VITAMIN A DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vitamin A Deficiencies", "MN": "C18.654.521.500.133.628", "FX": "Xerophthalmia", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A nutritional condition produced by a deficiency of VITAMIN A in the diet, characterized by NIGHT BLINDNESS and other ocular manifestations such as dryness of the conjunctiva and later of the cornea (XEROPHTHALMIA). Vitamin A deficiency is a very common problem worldwide, particularly in developing countries as a consequence of famine or shortages of vitamin A-rich foods. In the United States it is found among the urban poor, the elderly, alcoholics, and patients with malabsorption. (From Cecil Textbook of Medicine, 19th ed, p1179)", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014802"}, {"RECTYPE": "D", "MH": "Vitamin B Complex", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "B Vitamin|T109|T127|NON|NRW|NLM (2021)|191121|abbcdef", "ENTRY": "Vitamin, B", "MN": "D27.505.696.494.600.708", "EC": "deficiency:Vitamin B Deficiency", "MH_TH": "POPLINE (1978)", "ST": "T127", "RN": "12001-76-2", "AN": " \u200c/\u200cther \u200cuse: coordinate disease with /\u200cdrug \u200cther, not /\u200cdiet \u200cther ", "MS": "A group of water-soluble vitamins, some of which are COENZYMES.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014803"}, {"RECTYPE": "D", "MH": "Vitamin B Deficiency", "DE": "VITAMIN B DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vitamin B Deficiencies", "MN": "C18.654.521.500.133.699", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A condition due to deficiency in any member of the VITAMIN B COMPLEX. These B vitamins are water-soluble and must be obtained from the diet because they are easily lost in the urine. Unlike the lipid-soluble vitamins, they cannot be stored in the body fat.", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014804"}, {"RECTYPE": "D", "MH": "Vitamin B 12", "DS": "VITAMIN B A 12", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyanocobalamin|T109|T121|T127|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|USP (19XX)|740408|abbbcdeeeef", "ENTRY": "B12, Vitamin", "MN": "D04.345.783.437.777", "PA": "Vitamin B Complex", "FX": "Schilling Test", "EC": "deficiency:Vitamin B 12 Deficiency", "MH_TH": "NLM (1966)", "ST": "T127", "N1": "Vitamin B12", "RN": "P6YC3EG204", "RR": "8406EY2OQA", "AN": "therapeutic use: coordinate disease with /drug ther, not /diet ther", "MS": "A cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin B 12 from the soil and so are a poor source of the substance as compared with animal tissues. INTRINSIC FACTOR is important for the assimilation of vitamin B 12.", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014805"}, {"RECTYPE": "D", "MH": "Vitamin B 12 Deficiency", "DE": "VITAMIN B 12 DEFIC", "DS": "VITAMIN B A 12 DEFICIENCY", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vitamin B12 Deficiencies", "MN": "C18.654.521.500.133.699.923", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "coord IM with specific B 12 vitamin /defic (IM)", "MS": "A nutritional condition produced by a deficiency of VITAMIN B 12 in the diet, characterized by megaloblastic anemia. Since vitamin B 12 is not present in plants, humans have obtained their supply from animal products, from multivitamin supplements in the form of pills, and as additives to food preparations. A wide variety of neuropsychiatric abnormalities is also seen in vitamin B 12 deficiency and appears to be due to an undefined defect involving myelin synthesis. (From Cecil Textbook of Medicine, 19th ed, p848)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014806"}, {"RECTYPE": "D", "MH": "Vitamin D", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D04.210.500.812.768", "PA": "Vitamins", "FX": "Receptors, Calcitriol", "EC": "deficiency:Vitamin D Deficiency", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "1406-16-2", "MS": "A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014807"}, {"RECTYPE": "D", "MH": "Vitamin D Deficiency", "DE": "VITAMIN D DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vitamin D Deficiencies", "MN": "C18.654.521.500.133.770", "FX": "Rickets", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A nutritional condition produced by a deficiency of VITAMIN D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as RICKETS in children and OSTEOMALACIA in adults. (From Cecil Textbook of Medicine, 19th ed, p1406)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014808"}, {"RECTYPE": "D", "MH": "Vitamin D-Binding Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vitamin D-Binding Globulin|T116|T123|NON|EQV|UNK (19XX)|840530|abbcdef", "ENTRY": "Vitamin D Binding Protein", "MN": "D12.776.157.920", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "PI": "Vitamin D (1966-1984)", "MS": "An alpha-globulin found in the plasma of man and other vertebrates. It is apparently synthesized in the liver and carries vitamin D and its metabolites through the circulation and mediates the response of tissue. It is also known as group-specific component (Gc). Gc subtypes are used to determine specific phenotypes and gene frequencies. These data are employed in the classification of population groups, paternity investigations, and in forensic medicine.", "PM": "85", "HN": "85", "MR": "20040707", "DA": "19840530", "DC": "1", "DX": "19850101", "UI": "D014809"}, {"RECTYPE": "D", "MH": "Vitamin E", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.633.100.150.909", "PA": "Vitamins", "EC": "deficiency:Vitamin E Deficiency", "MH_TH": "USP (19XX)", "ST": "T127", "RN": "1406-18-4", "AN": "/ther use: coordinate disease with /drug ther, not /diet ther", "MS": "A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014810"}, {"RECTYPE": "D", "MH": "Vitamin E Deficiency", "DE": "VITAMIN E DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vitamin E Deficiencies", "MN": "C18.654.521.500.133.841", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A nutritional condition produced by a deficiency of VITAMIN E in the diet, characterized by posterior column and spinocerebellar tract abnormalities, areflexia, ophthalmoplegia, and disturbances of gait, proprioception, and vibration. In premature infants vitamin E deficiency is associated with hemolytic anemia, thrombocytosis, edema, intraventricular hemorrhage, and increasing risk of retrolental fibroplasia and bronchopulmonary dysplasia. An apparent inborn error of vitamin E metabolism, named familial isolated vitamin E deficiency, has recently been identified. (Cecil Textbook of Medicine, 19th ed, p1181)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014811"}, {"RECTYPE": "D", "MH": "Vitamin K", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D04.615.638.721.374", "PA": "Vitamins", "EC": "deficiency:Vitamin K Deficiency", "MH_TH": "NLM (1966)", "ST": "T127", "N1": "Vitamin K", "RN": "12001-79-5", "AN": "/ther use: coordinate disease with /drug ther, not /diet ther", "MS": "A lipid cofactor that is required for normal blood clotting. Several forms of vitamin K have been identified: VITAMIN K 1 (phytomenadione) derived from plants, VITAMIN K 2 (menaquinone) from bacteria, and synthetic naphthoquinone provitamins, VITAMIN K 3 (menadione). Vitamin K 3 provitamins, after being alkylated in vivo, exhibit the antifibrinolytic activity of vitamin K. Green leafy vegetables, liver, cheese, butter, and egg yolk are good sources of vitamin K.", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014812"}, {"RECTYPE": "D", "MH": "Vitamin K Deficiency", "DE": "VITAMIN K DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vitamin K Deficiencies", "MN": "C18.654.521.500.133.912", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A nutritional condition produced by a deficiency of VITAMIN K in the diet, characterized by an increased tendency to hemorrhage (HEMORRHAGIC DISORDERS). Such bleeding episodes may be particularly severe in newborn infants. (From Cecil Textbook of Medicine, 19th ed, p1182)", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014813"}, {"RECTYPE": "D", "MH": "Vitamin U", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylmethioninesulfonium Chloride|T116|T121|T127|NON|NRW|UNK (19XX)|760413|abbbcdef", "ENTRY": "S Methylmethionine", "MN": "D12.125.166.676.950", "PA": "Vitamins", "MH_TH": "NLM (1977)", "ST": "T127", "N1": "Sulfonium, (3-amino-3-carboxypropyl)dimethyl-, chloride, (S)-", "RN": "3485Y39925", "RR": "G9CUR2204U", "AN": "/ther use: coordinate disease with /drug ther, not /diet ther", "PI": "Vitamins (1973-1976)", "MS": "A vitamin found in green vegetables. It is used in the treatment of peptic ulcers, colitis, and gastritis and has an effect on secretory, acid-forming, and enzymatic functions of the intestinal tract.", "PM": "91; was see under VITAMINS 1977-90", "HN": "91(77); was see under VITAMINS 1977-90", "MR": "20130708", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D014814"}, {"RECTYPE": "D", "MH": "Vitamins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Vitamin", "MN": "J02.500.681.500.600", "EC": "deficiency:Avitaminosis", "MH_TH": "NLM (1963)", "ST": "T127", "RN": "0", "MS": "Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body.", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014815"}, {"RECTYPE": "D", "MH": "Vitelline Duct", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Omphalomesenteric Duct|T018|NON|EQV|UNK (19XX)|770818|abcdef", "ENTRY": "Vitelline Ducts", "MN": "A16.920", "FX": "Meckel Diverticulum", "MH_TH": "NLM (1966)", "ST": "T018", "MS": "The narrow tube connecting the YOLK SAC with the midgut of the EMBRYO; persistence of all or part of it in post-fetal life produces abnormalities, of which the commonest is MECKEL DIVERTICULUM.", "OL": "use VITELLINE DUCT to search VITELLINE DUCTS 1966-78", "PM": "79; was VITELLINE DUCTS 1963-78", "HN": "79; was VITELLINE DUCTS 1963-78", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D014816"}, {"RECTYPE": "D", "MH": "Vitelline Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vitelline Membranes", "MN": "A16.690.886", "MH_TH": "NLM (1963)", "ST": "T018", "MS": "The plasma membrane of the egg.", "PM": "73", "HN": "73(63)", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014817"}, {"RECTYPE": "D", "MH": "Vitellogenesis", "AQ": "DE GE IM PH RE", "ENTRY": "Vitellogeneses", "MN": "G08.686.784.310.500.880", "MH_TH": "NLM (1984)", "ST": "T042", "MS": "The active production and accumulation of VITELLINS (egg yolk proteins) in the non-mammalian OOCYTES from circulating precursors, VITELLOGENINS. Vitellogenesis usually begins after the first MEIOSIS and is regulated by estrogenic hormones.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19830606", "DC": "1", "DX": "19840101", "UI": "D014818"}, {"RECTYPE": "D", "MH": "Vitellogenins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Vitellogenin II|T116|T123|NON|NRW|UNK (19XX)|821129|abbcdef", "MN": "D12.776.744.925", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Phosphoproteins (1973-1974)", "MS": "Phospholipoglycoproteins produced in the fat body of egg-laying animals such as non-mammalian VERTEBRATES; ARTHROPODS; and others. Vitellogenins are secreted into the HEMOLYMPH, and taken into the OOCYTES by receptor-mediated ENDOCYTOSIS to form the major yolk proteins, VITELLINS. Vitellogenin production is under the regulation of steroid hormones, such as ESTRADIOL and JUVENILE HORMONES in insects.", "PM": "2005; see VITELLOGENIN 1986-2004; see LIPOPROTEINS 1975-1985; for YOLK PROTEIN 2, DROSOPHILA see EGG PROTEINS 1990-2004", "HN": "2005 (1986); use LIPOPROTEINS 1975-1985; for YOLK PROTEIN 2, DROSOPHILA use EGG PROTEINS 1990-2004", "MR": "20150618", "DA": "19741111", "DC": "1", "DX": "19860101", "UI": "D014819"}, {"RECTYPE": "D", "MH": "Vitiligo", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.621.440.895", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "macular depigmentation", "MS": "A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014820"}, {"RECTYPE": "D", "MH": "Vitrectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Vitrectomies", "MN": "E04.540.960", "MH_TH": "NLM (1984)", "ST": "T061", "PI": "Vitreous Body/surgery (1966-1983)", "MS": "Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma.", "PM": "84", "HN": "84", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19830209", "DC": "1", "DX": "19840101", "UI": "D014821"}, {"RECTYPE": "D", "MH": "Vitreous Body", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vitreous Humors", "MN": "A09.371.714.500", "FX": "Vitrectomy", "MH_TH": "NLM (1966)", "ST": "T023", "AN": "/surg: consider also VITRECTOMY; VITREOUS DETACHMENT is available; opacities, muscae volitantes & other diseases are indexed VITREOUS BODY (IM) and EYE DISEASES (IM)", "MS": "The transparent, semigelatinous substance that fills the cavity behind the CRYSTALLINE LENS of the EYE and in front of the RETINA. It is contained in a thin hyaloid membrane and forms about four fifths of the optic globe.", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014822"}, {"RECTYPE": "D", "MH": "Vitreous Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Vitreous|T033|T046|NON|EQV|NLM (1990)|890314|abbcdef", "ENTRY": "Vitreous Hemorrhages", "MN": "C23.550.414.756.887", "MH_TH": "NLM (1987)", "ST": "T046", "PI": "Vitreous Body (1966-1986)", "MS": "Hemorrhage into the VITREOUS BODY.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19860408", "DC": "1", "DX": "19870101", "UI": "D014823"}, {"RECTYPE": "D", "MH": "Vivisection", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Vivisections", "MN": "E05.017.900", "FX": "Animal Welfare", "MH_TH": "NLM (1966)", "ST": "T062", "MS": "The cutting of or surgical operation on a living animal, usually for physiological or pathological investigation. (from Merriam-Webster's Collegiate Dict, 10th ed)", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014824"}, {"RECTYPE": "D", "MH": "Vocabulary", "ENTRY": "Vocabularies", "MN": "L01.559.598.901", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "do not confuse with NOMENCLATURE or THESAURUS (VOCABULARY,CONTROLLED)", "MS": "The sum or the stock of words used by a language, a group, or an individual. (From Webster, 3d ed)", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014825"}, {"RECTYPE": "D", "MH": "Vocal Cord Paralysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Laryngeal Paralysis|T047|T184|NON|BRD|UNK (19XX)|740330|abbcdef", "ENTRY": "Vocal Fold Palsies", "MN": "C23.888.592.636.943", "MH_TH": "NLM (1966)", "ST": "T184", "AN": "coordinate with RECURRENT LARYNGEAL NERVE if pertinent", "MS": "Congenital or acquired paralysis of one or both VOCAL CORDS. This condition is caused by defects in the CENTRAL NERVOUS SYSTEM, the VAGUS NERVE and branches of LARYNGEAL NERVES. Common symptoms are VOICE DISORDERS including HOARSENESS or APHONIA.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014826"}, {"RECTYPE": "D", "MH": "Vocal Cords", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Vocal Fold|T023|NON|EQV|UNK (19XX)|860418|abcdef", "ENTRY": "Vocal Ligaments", "MN": "A04.329.364.737", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "A pair of cone-shaped elastic mucous membrane projecting from the laryngeal wall and forming a narrow slit between them. Each contains a thickened free edge (vocal ligament) extending from the THYROID CARTILAGE to the ARYTENOID CARTILAGE, and a VOCAL MUSCLE that shortens or relaxes the vocal cord to control sound production.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014827"}, {"RECTYPE": "D", "MH": "Vocalization, Animal", "AQ": "CL DE ES PH RE", "ENTRY": "Vocalizations, Animal", "MN": "F01.145.113.055.800", "MH_TH": "NLM (1968)", "ST": "T055", "PI": "Voice (1966-1967)", "MS": "Sounds used in animal communication.", "PM": "68", "HN": "68", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014828"}, {"RECTYPE": "D", "MH": "Vocational Education", "DE": "VOCATIONAL EDUC", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Training, Vocational", "MN": "I02.233.862", "MH_TH": "NLM (1966)", "ST": "T065", "MS": "EDUCATION that prepares the student for a specific trade such as plumbing, masonry, and carpentry.", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014829"}, {"RECTYPE": "D", "MH": "Vocational Guidance", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Career Counseling|T065|NON|EQV|NLM (1992)|910307|abcdef", "ENTRY": "Guidance, Vocational", "MN": "F02.784.692.887", "MH_TH": "NLM (1966)", "ST": "T065", "AN": "consider also APTITUDE or APTITUDE TESTS", "MS": "Systematic efforts to assist individuals in selecting an occupation or suitable employment on the basis of aptitude, education, etc.", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014830"}, {"RECTYPE": "D", "MH": "Voice", "AQ": "DE ES GE IM PH RE", "ENTRY": "Voices", "MN": "G09.772.925", "FX": "Speech", "MH_TH": "NLM (1966)", "ST": "T040", "AN": "human only: for animal use VOCALIZATION, ANIMAL", "MS": "The sounds produced by humans by the passage of air through the LARYNX and over the VOCAL CORDS, and then modified by the resonance organs, the NASOPHARYNX, and the MOUTH.", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014831"}, {"RECTYPE": "D", "MH": "Voice Disorders", "DE": "VOICE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Voice Fatigues", "MN": "C23.888.592.979", "MH_TH": "NLM (1979)", "ST": "T047", "PI": "Voice (1966-1978)", "MS": "Pathological processes that affect voice production, usually involving VOCAL CORDS and the LARYNGEAL MUCOSA. Voice disorders can be caused by organic (anatomical), or functional (emotional or psychological) factors leading to DYSPHONIA; APHONIA; and defects in VOICE QUALITY, loudness, and pitch.", "PM": "1979", "HN": "1979", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19780522", "DC": "1", "DX": "19790101", "UI": "D014832"}, {"RECTYPE": "D", "MH": "Voice Quality", "AQ": "DE ES GE IM PH RE", "ENTRY": "Voice Qualities", "MN": "G09.772.925.960", "FX": "Phonation", "MH_TH": "NLM (1979)", "ST": "T080", "PI": "Voice (1966-1978)", "MS": "That component of SPEECH which gives the primary distinction to a given speaker's VOICE when pitch and loudness are excluded. It involves both phonatory and resonatory characteristics. Some of the descriptions of voice quality are harshness, breathiness and nasality.", "PM": "91; was see under VOICE 1979-90", "HN": "91(79); was see under VOICE 1979-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19780522", "DC": "1", "DX": "19910101", "UI": "D014833"}, {"RECTYPE": "D", "MH": "Voice Training", "ENTRY": "Voice Trainings", "MN": "E02.831.727.862", "MH_TH": "NLM (1966)", "ST": "T061", "MS": "A variety of techniques used to help individuals utilize their voice for various purposes and with minimal use of muscle energy.", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014834"}, {"RECTYPE": "D", "MH": "Volatilization", "AQ": "DE RE", "PRINT ENTRY": "Vaporization|T070|NON|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Volatility|T070|NON|REL|NLM (2008)|061004|abcdef", "MN": "G02.734.933", "EC": "instrumentation:Nebulizers and Vaporizers", "MH_TH": "NLM (1971)", "ST": "T070", "AN": "NIM", "PI": "appropriate chemical heading", "MS": "A phase transition from liquid state to gas state, which is affected by Raoult's law. It can be accomplished by fractional distillation.", "PM": "74", "HN": "74(71)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014835"}, {"RECTYPE": "D", "MH": "Volition", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Will|T041|NON|EQV|UNK (19XX)|740330|abcdef", "MN": "F02.463.902", "MH_TH": "NLM (1966)", "ST": "T041", "MS": "Voluntary activity without external compulsion.", "CATSH": "CAT LIST", "MR": "19950523", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014836"}, {"RECTYPE": "D", "MH": "Voluntary Health Agencies", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Voluntary Health Agency", "MN": "N03.540.630.780", "MH_TH": "NLM (1978)", "ST": "T058", "MS": "Non-profit organizations concerned with various aspects of health, e.g., education, promotion, treatment, services, etc.", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014837"}, {"RECTYPE": "D", "MH": "Volunteers", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Volunteer Personnel|T098|NON|EQV|NLM (2021)|OBSSR (2021)|200528|abcdeef", "ENTRY": "Worker, Volunteer", "MN": "M01.955", "MH_TH": "NLM (2014)", "ST": "T098", "PI": "specific service (1966-1967)", "MS": "Persons who donate their services.", "PM": "68", "HN": "68", "MR": "20210512", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014838"}, {"RECTYPE": "D", "MH": "Vomiting", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Emesis|T184|NON|EQV|NLM (1999)|980602|abcdef", "MN": "C23.888.821.937", "FX": "Emetics", "MH_TH": "NLM (1963)", "ST": "T184", "AN": "/chem ind: EMETICS is also available; /drug ther: ANTIEMETICS is also available", "MS": "The forcible expulsion of the contents of the STOMACH through the MOUTH.", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014839"}, {"RECTYPE": "D", "MH": "Vomiting, Anticipatory", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anticipatory Vomiting|T184|NON|EQV|UNK (19XX)|870501|abcdef", "MN": "C23.888.821.937.080", "MH_TH": "NLM (1988)", "ST": "T184", "AN": "do not use /chem ind in cancer chemother: prefer /etiol, /psychol, etc.", "PI": "Vomiting (1966-1987)", "MS": "Vomiting caused by expectation of discomfort or unpleasantness.", "PM": "88", "HN": "88", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19870501", "DC": "1", "DX": "19880101", "UI": "D014840"}, {"RECTYPE": "D", "MH": "von Willebrand Factor", "DE": "VWF", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Factor VIII-Related Antigen|T116|T123|NON|EQV|NLM (1990)|890420|FACTOR VIII RELAT ANTIGEN|abbcdefv", "ENTRY": "Ristocetin Willebrand Factor", "MN": "D23.119.985", "FX": "von Willebrand Diseases", "MH_TH": "NLM (1976)", "ST": "T123", "RN": "0", "PI": "von Willebrand's Disease (1966-1975)", "MS": "A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor.", "OL": "use FACTOR VIII & ANTIGENS to search FACTOR VIII RELATED ANTIGEN 1977-89", "PM": "86; was see under BLOOD COAGULATION FACTORS 1976-85", "HN": "86(76); was see under BLOOD COAGULATION FACTORS 1976-85; FACTOR VIII RELATED ANTIGEN, previously in the Supplementary Chemical File, was mapped to both FACTOR VIII & ANTIGENS 1977-89", "MR": "20090706", "DA": "19750725", "DC": "1", "DX": "19860101", "UI": "D014841"}, {"RECTYPE": "D", "MH": "von Willebrand Diseases", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "von Willebrand Disease|T047|EPO|EQV|GHR (2014)|NLM (1964)|ORD (2010)|990101|VON WILLEBRAND DIS|abcdeeefv", "ENTRY": "Vascular Pseudohemophilias", "MN": "C16.320.099.920", "MH_TH": "NLM (2010)", "ST": "T047", "AN": "note specific types of Von Willebrand Disease are available", "MS": "Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.", "PM": "2010; see VON WILLEBRAND DISEASE 1999-2009; see VON WILLEBRAND'S DISEASE 1968-1998, see HEMORRHAGIC DIATHESIS 1967, see THROMBOCYTOPATHY 1963-1966", "HN": "2010(1963)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014842"}, {"RECTYPE": "D", "MH": "Voyeurism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Voyeurisms", "MN": "F03.657.900", "MH_TH": "NLM (1975)", "ST": "T048", "MS": "A paraphilia characterized by repetitive looking at unsuspecting people, usually strangers, who are either naked, in the act of disrobing, or engaging in sexual activity, as the method for achieving sexual excitement.", "OL": "search PARAPHILIAS 1968-74", "PM": "91; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80", "HN": "91(75); was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014843"}, {"RECTYPE": "D", "MH": "Vulva", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vulvas", "MN": "A05.360.319.887", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "The external genitalia of the female. It includes the CLITORIS, the labia, the vestibule, and its glands.", "MR": "20040707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014844"}, {"RECTYPE": "D", "MH": "Vulvar Diseases", "DE": "VULVAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vulvar Disease", "MN": "C12.100.250.944", "MH_TH": "NLM (1976)", "ST": "T047", "PI": "specific vulvar disease", "MS": "Pathological processes of the VULVA.", "PM": "76", "HN": "76; was NON MESH before 1976", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D014845"}, {"RECTYPE": "D", "MH": "Vulvar Neoplasms", "DE": "VULVAR NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Vulvar Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Vulvar Neoplasm", "MN": "C12.900.418.968", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "coordinate with histological type of neoplasm", "MS": "Tumors or cancer of the VULVA.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014846"}, {"RECTYPE": "D", "MH": "Vulvitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vulvitides", "MN": "C12.100.250.944.902", "MH_TH": "NLM (1963)", "ST": "T047", "MS": "Inflammation of the VULVA. It is characterized by PRURITUS and painful urination.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014847"}, {"RECTYPE": "D", "MH": "Vulvovaginitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vulvovaginitides", "MN": "C12.100.250.944.902.737", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "Inflammation of the VULVA and the VAGINA, characterized by discharge, burning, and PRURITUS.", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014848"}, {"RECTYPE": "D", "MH": "Waardenburg Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Waardenburg's Syndrome|T019|T047|EPO|EQV|GHR (2014)|NLM (1964)|ORD (2010)|990101|abbcdeeef", "ENTRY": "Waardenburgs Syndrome", "MN": "C16.131.077.938", "FX": "Piebaldism", "MH_TH": "NLM (2013)", "ST": "T047", "MS": "Rare, autosomal dominant disease with variable penetrance and several known clinical types. Characteristics may include depigmentation of the hair and skin, congenital deafness, heterochromia iridis, medial eyebrow hyperplasia, hypertrophy of the nasal root, and especially dystopia canthorum. The underlying cause may be defective development of the neural crest (neurocristopathy). Waardenburg's syndrome may be closely related to piebaldism. Klein-Waardenburg Syndrome refers to a disorder that also includes upper limb abnormalities.", "PM": "2013; see ABNORMALITIES, MULTIPLE 1975-1990; Waardenburg's Syndrome 1991-2012", "HN": "2013 (1966); use ABNORMALITIES, MULTIPLE 1975-1990; Waardenburg's Syndrome 1991-2012", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014849"}, {"RECTYPE": "D", "MH": "Waiting Lists", "AQ": "MO", "ENTRY": "Waiting List", "MN": "N04.452.095.738", "MH_TH": "NLM (1975)", "ST": "T170", "MS": "Prospective patient listings for appointments or treatments.", "PM": "91; was see under APPOINTMENTS AND SCHEDULES 1975-90", "HN": "91(75); was see under APPOINTMENTS AND SCHEDULES 1975-90", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014850"}, {"RECTYPE": "D", "MH": "Wakefulness", "AQ": "CL DE ES GE PH RE", "ENTRY": "Wakefulnesses", "MN": "G11.561.035.738", "FX": "Sleep Initiation and Maintenance Disorders", "MH_TH": "NLM (1967)", "ST": "T040", "PI": "Consciousness (1966)", "MS": "A state in which there is an enhanced potential for sensitivity and an efficient responsiveness to external stimuli.", "PM": "69", "HN": "69(67)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D014851"}, {"RECTYPE": "D", "MH": "Wales", "AQ": "EH EP", "MN": "Z01.542.363.914", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "A region of the United Kingdom, in the southwestern area of Great Britain.", "MR": "20160707", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014852"}, {"RECTYPE": "D", "MH": "Walkers", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Walker", "MN": "E07.858.442.980", "MH_TH": "NLM (1975)", "ST": "T074", "MS": "Walking aids generally having two handgrips and four legs.", "PM": "91; was see under ORTHOPEDIC EQUIPMENT 1975-90", "HN": "91(75); was see under ORTHOPEDIC EQUIPMENT 1975-90", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D014853"}, {"RECTYPE": "D", "MH": "Lateral Medullary Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wallenberg Syndrome|T047|EPO|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Wallenbergs Syndrome", "MN": "C23.550.717.489.250.100.500", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "INFARCTION of the dorsolateral aspect of MEDULLA OBLONGATA in the BRAIN STEM. It is caused by occlusion of the VERTEBRAL ARTERY and/or the posterior inferior cerebellar artery. Clinical manifestations vary with the size of infarction, but may include loss of pain and temperature sensation in the ipsilateral face and contralateral body below the chin; ipsilateral HORNER SYNDROME; ipsilateral ATAXIA; DYSARTHRIA; VERTIGO; nausea, hiccup; dysphagia; and VOCAL CORD PARALYSIS. (From Adams et al., Principles of Neurology, 6th ed, p801)", "PM": "2000; see WALLENBERG'S SYNDROME 1991-1999, see CEREBRAL EMBOLISM AND THROMBOSIS 1964-1990", "HN": "2000 (1964)", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014854"}, {"RECTYPE": "D", "MH": "Wallerian Degeneration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Degeneration, Wallerian", "MN": "C23.550.737.750", "MH_TH": "ORD (2010)", "ST": "T049", "MS": "Degeneration of distal aspects of a nerve axon following injury to the cell body or proximal portion of the axon. The process is characterized by fragmentation of the axon and its MYELIN SHEATH.", "OL": "search NERVE DEGENERATION 1967-74", "PM": "91; was see under NERVE DEGENERATION 1975-90", "HN": "91(75); was see under NERVE DEGENERATION 1975-90", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014855"}, {"RECTYPE": "D", "MH": "Walruses", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Odobenidae|T015|NON|EQV|NLM (2005)|030811|abcdef", "ENTRY": "Walrus|T015|NON|NRW|NLM (1975)|990101|abcdef", "MN": "B01.050.150.900.649.313.750.250.821", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid9705", "RR": "txid9707", "MS": "The family Odobenidae, suborder PINNIPEDIA, order CARNIVORA. It is represented by a single species of large, nearly hairless mammal found on Arctic shorelines, whose upper canines are modified into tusks.", "PM": "2005; see WALRUS 1991-2004, see PINNIPEDIA 1975-1990", "HN": "2005 (1975)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014856"}, {"RECTYPE": "D", "MH": "Warfare", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "MN": "I01.880.735.950.500", "FX": "Violence", "MH_TH": "NLM (2016)", "ST": "T052", "MS": "Methods of conducting ARMED CONFLICTS.", "PM": "2016", "HN": "2016(1973)", "MR": "20190705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014857"}, {"RECTYPE": "D", "MH": "War Crimes", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "War Crime", "MN": "I01.880.735.950.500.903", "FX": "Human Rights Abuses", "MH_TH": "NLM (1966)", "ST": "T052", "MS": "Criminal acts committed during, or in connection with, war, e.g., maltreatment of prisoners, willful killing of civilians, etc.", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014858"}, {"RECTYPE": "D", "MH": "Warfarin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Warfarin", "MN": "D03.633.100.150.446.520.914", "PA": "Rodenticides", "MH_TH": "INN (19XX)", "ST": "T131", "N1": "2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-", "RN": "5Q7ZVV76EI", "RR": "I47IU4FOCO", "AN": "an anticoagulant & rodenticide", "MS": "An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.", "MR": "20160624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014859"}, {"RECTYPE": "D", "MH": "Warts", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Verruca|T047|NON|EQV|UNK (19XX)|770819|abcdef", "ENTRY": "Wart", "MN": "C17.800.838.790.810", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "a non-neoplastic tumor virus infect; coord IM with precoord organ/dis term (IM)", "MS": "Benign epidermal proliferations or tumors; some are viral in origin.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014860"}, {"RECTYPE": "D", "MH": "Washington", "AQ": "EH EP", "MN": "Z01.107.567.875.580.900", "MH_TH": "NLM (1978)", "ST": "T083", "AN": "the state; for Washington, D. C. use DISTRICT OF COLUMBIA", "MS": "State bounded by on the north by Canada, on the east by Idaho, on the south by Oregon, and on the west by the Pacific Ocean.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014861"}, {"RECTYPE": "D", "MH": "Wasp Venoms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE TO TU UR", "PRINT ENTRY": "Vespid Venoms|T123|T131|NON|EQV|UNK (19XX)|770426|abbcdef", "ENTRY": "Venoms, Wasp", "MN": "D23.946.833.065.970", "MH_TH": "NLM (1978)", "ST": "T131", "RN": "0", "AN": "/antag permitted but consider also ANTIVENINS; /enzymol permitted", "PI": "Wasps (1975-1977)", "MS": "Venoms produced by the wasp (Vespid) family of stinging insects, including hornets; the venoms contain enzymes, biogenic amines, histamine releasing factors, kinins, toxic polypeptides, etc., and are similar to bee venoms.", "PM": "91; was see under BEE VENOMS 1978-90", "HN": "91(78); was see under BEE VENOMS 1978-90", "MR": "20050630", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D014862"}, {"RECTYPE": "D", "MH": "Wasps", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Yellow Jackets|T204|NON|NRW|UNK (19XX)|741205|abcdef", "ENTRY": "Yellow Jacket", "MN": "B01.050.500.131.617.720.500.500.875.900", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid7438", "AN": "/microbiol /parasitol /virol permitted; wasp stings: coord IM with INSECT BITES AND STINGS (IM)", "MS": "Any of numerous winged hymenopterous insects of social as well as solitary habits and having formidable stings.", "PM": "91; was see under HYMENOPTERA 1975-90", "HN": "91(75); was see under HYMENOPTERA 1975-90", "MR": "20200902", "DA": "19741212", "DC": "1", "DX": "19910101", "UI": "D014863"}, {"RECTYPE": "D", "MH": "Waste Disposal, Fluid", "AQ": "EC ES HI IS LJ MT SN ST", "ENTRY": "Waste Disposals, Fluid", "MN": "N06.850.860.510.900.600.900", "MH_TH": "NLM (1975)", "ST": "T057", "MS": "The discarding or destroying of liquid waste products or their transformation into something useful or innocuous.", "OL": "search SEWAGE 1969-74", "PM": "91; was see under SEWAGE 1975-90", "HN": "91(75); was see under SEWAGE 1975-90", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014865"}, {"RECTYPE": "D", "MH": "Waste Products", "AQ": "AE AN CL EC SN", "ENTRY": "Waste Product", "MN": "N06.850.460.710", "MH_TH": "NLM (1978)", "ST": "T167", "RN": "0", "AN": "MEDICAL WASTE & DENTAL WASTE are also available", "MS": "Debris resulting from a process that is of no further use to the system producing it. The concept includes materials discharged from or stored in a system in inert form as a by-product of vital activities. (From Webster's New Collegiate Dictionary, 1981)", "PM": "76", "HN": "76; was NON MESH before 1976", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19760101", "UI": "D014866"}, {"RECTYPE": "D", "MH": "Water", "AQ": "AD AE AN CH ME PD PH PS ST", "ENTRY": "Hydrogen Oxide|T197|NON|EQV|NLM (1994)|920730|abcdef", "MN": "D01.650.550.925", "FX": "Steam", "EC": "urine:Urine", "MH_TH": "NLM (1966)", "ST": "T197", "N1": "Water", "RN": "059QF0KO0R", "RR": "7732-18-5 (Water)", "MS": "A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014867"}, {"RECTYPE": "D", "MH": "Water Deprivation", "AQ": "PH", "ENTRY": "Water Deprivations", "MN": "F01.658.938", "FX": "Thirst", "MH_TH": "NLM (1969)", "ST": "T061", "AN": "human & animal; /physiol permitted for physiol & metab eff", "PI": "Thirst (1966-1968)", "MS": "The withholding of water in a structured experimental situation.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "19910620", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D014868"}, {"RECTYPE": "D", "MH": "Water Intoxication", "DE": "WATER INTOX", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Overhydration|T047|NON|EQV|NLM (2023)|220325|abcdef", "MN": "C25.723.932", "FX": "Water-Electrolyte Imbalance", "MH_TH": "NLM (1965)", "ST": "T047", "MS": "A condition resulting from the excessive retention of water with sodium depletion.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014869"}, {"RECTYPE": "D", "MH": "Water Loss, Insensible", "AQ": "DE ES GE IM PH RE", "ENTRY": "Insensible Water Losses", "MN": "G07.410.810.500.750", "MH_TH": "NLM (1972)", "ST": "T040", "PI": "Sweating (1966-1971)", "MS": "Loss of water by diffusion through the skin and by evaporation from the respiratory tract.", "PM": "74", "HN": "74(72)", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014870"}, {"RECTYPE": "D", "MH": "Water Microbiology", "DE": "WATER MICROBIOL", "AQ": "ST", "ENTRY": "Microbiology, Water|T067|NON|EQV|UNK (19XX)|860101|MICROBIOL WATER|abcdefv", "MN": "N06.850.425.450", "MH_TH": "NLM (1966)", "ST": "T067", "AN": "coordinate with specific bacterium, virus or fungus ", "MS": "The presence of bacteria, viruses, and fungi in water. This term is not restricted to pathogenic organisms.", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014871"}, {"RECTYPE": "D", "MH": "Water Movements", "ENTRY": "Water Movement", "MN": "N06.230.850", "MH_TH": "NLM (1972)", "ST": "T070", "AN": "FLOODS is also available", "PI": "Water (1966-1971)", "MS": "The flow of water in enviromental bodies of water such as rivers, oceans, water supplies, aquariums, etc. It includes currents, tides, and waves.", "PM": "74", "HN": "74(72)", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D014872"}, {"RECTYPE": "D", "MH": "Water Pollutants", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Water Pollutant|T131|NON|EQV|NLM (2022)|201023|abcdef", "ENTRY": "Pollutants, Water", "MN": "D27.888.284.903", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "specify pollutant if pertinent (IM or NIM)", "PI": "Water Pollution (1966-1974)", "MS": "Substances or organisms which pollute the water or bodies of water. Use for water pollutants in general or those for which there is no specific heading.", "PM": "75", "HN": "75", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19750901", "UI": "D014873"}, {"RECTYPE": "D", "MH": "Water Pollutants, Chemical", "DE": "WATER POLLUTANTS CHEM", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Landfill Leachate|T131|NON|NRW|NLM (2007)|060310|abcdef", "ENTRY": "Pollutants, Chemical Water", "MN": "D27.888.284.903.655", "FX": "Water Pollution, Chemical", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "restrict to water in rivers, reservoirs, streams, lakes, sea, etc; specify pollutant if pertinent", "MS": "Chemical compounds which pollute the water of rivers, streams, lakes, the sea, reservoirs, or other bodies of water.", "PM": "91; was see under WATER POLLUTANTS 1975-90", "HN": "91(75); was see under WATER POLLUTANTS 1975-90", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014874"}, {"RECTYPE": "D", "MH": "Water Pollutants, Radioactive", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Radioactive Water Pollutants", "MN": "D27.888.284.903.821", "MH_TH": "NLM (1975)", "ST": "T131", "RN": "0", "AN": "specify radiopollutant if pertinent (IM or NIM)", "MS": "Pollutants, present in water or bodies of water, which exhibit radioactivity.", "PM": "91; was see under WATER POLLUTANTS 1975-90", "HN": "91(75); was see under WATER POLLUTANTS 1975-90", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014875"}, {"RECTYPE": "D", "MH": "Water Pollution", "AQ": "AE AN EC ES HI LJ PC SN", "PRINT ENTRY": "Water Pollution, Thermal|T069|NON|NRW|NLM (1997)|960416|abcdef", "ENTRY": "Water Pollutions, Thermal", "MN": "N06.850.460.790", "MH_TH": "NLM (1966)", "ST": "T069", "AN": "IM; coord with source of pollution (IM); note entry term THERMAL WATER POLLUTION: coord with HOT TEMPERATURE (IM) only if heat is particularly discussed; specify geog if pertinent", "MS": "Contamination of bodies of water (such as LAKES; RIVERS; SEAS; and GROUNDWATER.)", "PM": "WATER POLLUTION, THERMAL was heading 1973-96; THERMAL WATER POLLUTION was see WATER POLLUTION, THERMAL 1973-96", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014876"}, {"RECTYPE": "D", "MH": "Water Pollution, Chemical", "DE": "WATER POLLUTION CHEM", "AQ": "AE AN EC ES HI LJ PC SN", "PRINT ENTRY": "Chemical Water Pollution|T069|NON|EQV|UNK (19XX)|740330|CHEM WATER POLLUTION|abcdefv", "ENTRY": "Water Pollutions, Chemical", "MN": "N06.850.460.790.410", "FX": "Water Pollutants, Chemical", "MH_TH": "NLM (1971)", "ST": "T069", "AN": "specify pollutant if pertinent", "PI": "specific chemical (1966-1970)", "MS": "Adverse effect upon bodies of water (LAKES; RIVERS; seas; groundwater etc.) caused by CHEMICAL WATER POLLUTANTS.", "PM": "73", "HN": "73(71)", "MR": "20110624", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014877"}, {"RECTYPE": "D", "MH": "Water Pollution, Radioactive", "AQ": "AE AN EC ES HI LJ PC SN", "ENTRY": "Radioactive Water Pollution", "MN": "N06.850.810.530", "MH_TH": "NLM (1966)", "ST": "T069", "AN": "coordinate with specific source of pollution", "MS": "Contamination of water with radioactive materials and/or substances.", "PM": "66", "HN": "66", "MR": "20151130", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014878"}, {"RECTYPE": "D", "MH": "Water Softening", "AQ": "AE EC IS LJ MT SN ST", "ENTRY": "Softening, Water", "MN": "N06.850.860.510.910", "MH_TH": "NLM (1966)", "ST": "T068", "MS": "Processes by which minerals such as calcium, magnesium, and certain metal cations are removed from hard water, making it more compatible with soap and safer on appliances and  plumbing.", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014880"}, {"RECTYPE": "D", "MH": "Water Supply", "AQ": "EC HI LJ MT SN ST", "ENTRY": "Water Supplies", "MN": "J01.293.821.500", "FX": "Water Resources", "MH_TH": "POPLINE (1981)", "ST": "T081", "AN": "do not use WATER SUPPLY with regard to FLUORIDATION: assume to be of the water supply", "MS": "Means or process of supplying water (as for a community) usually including reservoirs, tunnels, and pipelines and often the watershed from which the water is ultimately drawn. (Webster, 3d ed)", "MR": "20150629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014881"}, {"RECTYPE": "D", "MH": "Water-Electrolyte Balance", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Fluid Balance|T040|NON|BRD|NLM (1978)|740330|abcdef", "ENTRY": "Water Electrolyte Balance", "MN": "G07.410.810.500", "FX": "Water-Electrolyte Imbalance", "MH_TH": "NLM (1966)", "ST": "T040", "MS": "The balance of fluid in the BODY FLUID COMPARTMENTS; total BODY WATER; BLOOD VOLUME; EXTRACELLULAR SPACE; INTRACELLULAR SPACE, maintained by processes in the body that regulate the intake and excretion of WATER and ELECTROLYTES, particularly SODIUM and POTASSIUM.", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014882"}, {"RECTYPE": "D", "MH": "Water-Electrolyte Imbalance", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Water-Electrolyte Imbalances", "MN": "C18.452.950", "FX": "Water-Electrolyte Balance", "MH_TH": "NLM (1976)", "ST": "T046", "AN": "note category", "PI": "Water-Electrolyte Balance (1966-1975)", "MS": "Disturbances in the body's WATER-ELECTROLYTE BALANCE.", "PM": "76", "HN": "76; was NON MESH before 1976", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D014883"}, {"RECTYPE": "D", "MH": "Waterhouse-Friderichsen Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Purpura Fulminans (Waterhouse-Friderichsen Syndrome)|T047|EPO|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Waterhouse-Friderichsen Syndrome, Meningococcal", "MN": "C23.888.885.687.843", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not coordinate with NEISSERIA MENINGITIDIS unless particularly discussed; if caused by another organism, coordinate IM with precoordinated organism/infection term (IM)", "MS": "A condition of HEMORRHAGE and NECROSIS of the ADRENAL GLAND. It is characterized by rapidly developing ADRENAL INSUFFICIENCY; HYPOTENSION; and widespread cutaneous PURPURA.", "PM": "1991, 1963-1983; see MENINGOCOCCAL INFECTIONS 1984-1990, see WATERHOUSE-FRIDERICHSEN SYNDROME 1963-1983", "HN": "1991, 1963-1983; use MENINGOCOCCAL INFECTIONS 1984-1990", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014884"}, {"RECTYPE": "D", "MH": "Waxes", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D10.945", "FX": "Inlay Casting Wax", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MS": "A plastic substance deposited by insects or obtained from plants. Waxes are esters of various fatty acids with higher, usually monohydric alcohols. The wax of pharmacy is principally yellow wax (beeswax), the material of which honeycomb is made. It consists chiefly of cerotic acid and myricin and is used in making ointments, cerates, etc. (Dorland, 27th ed)", "MR": "20030709", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014885"}, {"RECTYPE": "D", "MH": "Weaning", "AQ": "EH", "ENTRY": "Weanings", "MN": "G07.203.650.915", "MH_TH": "POPLINE (1983)", "ST": "T040", "AN": "human & animal; NIM when merely an aspect of growth (as \"in newborn, suckling & weaned\")", "MS": "Permanent deprivation of breast milk and commencement of nourishment with other food. (From Stedman, 25th ed)", "PM": "66", "HN": "66(63)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014886"}, {"RECTYPE": "D", "MH": "Weather", "PRINT ENTRY": "Fog|T070|NON|NRW|NLM (1998)|961011|abcdef", "ENTRY": "Fogs", "MN": "N06.230.300.100.725", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "do not confuse entry term FOG with SMOG, a mixture of smoke & fog", "MS": "The state of the ATMOSPHERE over minutes to months.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014887"}, {"RECTYPE": "D", "MH": "Wechsler Scales", "AQ": "HI SN ST", "ENTRY": "Intelligence Scales, Wechsler", "MN": "F04.711.141.493.822", "MH_TH": "NLM (1975)", "ST": "T170", "PI": "Intelligence Tests ( 66-1974)", "MS": "Tests designed to measure intellectual functioning in children and adults.", "OL": "search INTELLIGENCE TESTS 1966-74", "PM": "79; was see under INTELLIGENCE TESTS 1963-78", "HN": "79(75); was see under INTELLIGENCE TESTS 1963-78", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19990101", "DC": "1", "DX": "19790101", "UI": "D014888"}, {"RECTYPE": "D", "MH": "Granulomatosis with Polyangiitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wegener Granulomatosis|T047|EPO|EQV|NLM (2007)|OMIM (2013)|ORD (2010)|051117|abcdeeef", "ENTRY": "with Polyangiitis, Granulomatosis", "MN": "C20.111.193.875", "FX": "Vasculitis, Central Nervous System", "MH_TH": "NLM (2015)", "ST": "T047", "MS": "A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN.", "PM": "2015; see Wegener Granulomatosis 2007-20014", "HN": "2015(1963)", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014890"}, {"RECTYPE": "D", "MH": "Weight Lifting", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Weight Liftings", "MN": "I03.450.642.845.950", "MH_TH": "NLM (1976)", "ST": "T056", "AN": "/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15+; includes body building if restricted to weight lifting, otherwise index under EXERCISE", "PI": "Sports (1966-1975)", "MS": "A sport in which weights are lifted competitively or as an exercise.", "PM": "90; was see under SPORTS 1976-89", "HN": "90(76); was see under SPORTS 1976-89", "MR": "19970620", "DA": "19750723", "DC": "1", "DX": "19900101", "UI": "D014891"}, {"RECTYPE": "D", "MH": "Weight Perception", "AQ": "CL DE ES PH RE", "ENTRY": "Weight Perceptions", "MN": "F02.463.593.959", "MH_TH": "NLM (1964)", "ST": "T041", "MS": "Recognition and discrimination of the heaviness of a lifted object.", "PM": "70", "HN": "70(64)", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D014892"}, {"RECTYPE": "D", "MH": "Weightlessness", "AQ": "AE", "PRINT ENTRY": "Zero Gravity|T070|NON|EQV|NLM (1995)|931119|abcdef", "ENTRY": "Gravity, Zero", "MN": "G01.060.350.369.400.900", "FX": "Hypogravity", "MH_TH": "NLM (1966)", "ST": "T070", "AN": "natural only: WEIGHTLESSNESS SIMULATION and WEIGHTLESSNESS COUNTERMEASURES are also available", "MS": "Condition in which no acceleration, whether due to gravity or any other force, can be detected by an observer within a system. It also means the absence of weight or the absence of the force of gravity acting on a body. Microgravity, gravitational force between 0 and 10 -6 g, is included here. (From NASA Thesaurus, 1988)", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014893"}, {"RECTYPE": "D", "MH": "Weights and Measures", "DE": "WEIGHTS MEASURES", "AQ": "HI IS ST", "ENTRY": "Measures and Weights", "MN": "E05.978", "MH_TH": "NLM (1966)", "ST": "T081", "AN": "types and systems of measurement: not for \"weight\" ; METRIC SYSTEM is available", "MS": "Measuring and weighing systems and processes.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014894"}, {"RECTYPE": "D", "MH": "Weil Disease", "DE": "WEIL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Leptospirosis, Icterohemorrhagic|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Weils Disease", "MN": "C01.150.252.400.794.511.739", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "if not caused by LEPTOSPIRA INTERROGANS SEROVAR ICTEROHAEMORRHAGIAE, coord IM with specific Leptospira interrogans serovar (IM) or LEPTOSPIRA INTERROGANS (IM)", "MS": "A severe form of LEPTOSPIROSIS, usually caused by LEPTOSPIRA INTERROGANS SEROVAR ICTEROHAEMORRHAGIAE and occasionally other serovars. It is transmitted to humans by the rat and is characterized by hemorrhagic and renal symptoms with accompanying JAUNDICE.", "PM": "2003; see WEIL'S DISEASE 1963-2002", "HN": "2003 (1963)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "20030101", "UI": "D014895"}, {"RECTYPE": "D", "MH": "Welding", "AQ": "CL EC ES HI IS LJ MT SN ST", "MN": "J01.576.655.875.400.900", "MH_TH": "NLM (1966)", "ST": "T057", "MS": "Joining metal pieces or parts together by melting the adjoining surfaces with heat, using a heat source such as a blowtorch or electric arc. The melted surfaces are then pressed together by hammering.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014896"}, {"RECTYPE": "D", "MH": "Spinal Muscular Atrophies of Childhood", "DE": "SPINAL MUSCULAR ATROPHIES CHILDHOOD", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Werdnig-Hoffmann Disease|T047|EPO|NRW|NLM (1988)|OMIM (2013)|ORD (2010)|990101|WERDNIG HOFFMANN DIS|abcdeeefv", "ENTRY": "Werdnig Hoffmann Disease", "MN": "C16.320.400.765", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "infantile, childhood or adolescent: for other, MUSCULAR ATROPHY, SPINAL is available", "PI": "Spinal Cord Diseases (1966-1987)", "MS": "A group of recessive inherited diseases that feature progressive muscular atrophy and hypotonia. They are classified as type I (Werdnig-Hoffman disease), type II (intermediate form), and type III (Kugelberg-Welander disease). Type I is fatal in infancy, type II has a late infantile onset and is associated with survival into the second or third decade. Type III has its onset in childhood, and is slowly progressive. (J Med Genet 1996 Apr:33(4):281-3)", "PM": "2000; see WERDNIG-HOFFMAN DISEASE 1991-1999, see MUSCULAR ATROPHY, SPINAL 1988-90", "HN": "2000(1988)", "CATSH": "CAT LIST", "MR": "20160208", "DA": "19870428", "DC": "1", "DX": "19910101", "UI": "D014897"}, {"RECTYPE": "D", "MH": "Werner Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Progeria, Adult|T047|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Syndrome, Werners", "MN": "C18.452.284.960", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "An autosomal recessive disorder that causes premature aging in adults, characterized by sclerodermal skin changes, cataracts, subcutaneous calcification, muscular atrophy, a tendency to diabetes mellitus, aged appearance of the face, baldness, and a high incidence of neoplastic disease.", "PM": "98; was WERNER'S SYNDROME 1967-97", "HN": "98; was WERNER'S SYNDROME 1964-97 (Prov 1964-67)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014898"}, {"RECTYPE": "D", "MH": "Wernicke Encephalopathy", "DE": "WERNICKE ENCEPH", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Encephalopathy, Wernicke|T047|EPO|EQV|NLM (2000)|991104|ENCEPH WERNICKE|abcdefv", "ENTRY": "Wernicke Encephalopathies", "MN": "F03.900.100.875", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "An acute neurological disorder characterized by the triad of ophthalmoplegia, ataxia, and disturbances of mental activity or consciousness. Eye movement abnormalities include nystagmus, external rectus palsies, and reduced conjugate gaze. THIAMINE DEFICIENCY and chronic ALCOHOLISM are associated conditions. Pathologic features include periventricular petechial hemorrhages and neuropil breakdown in the diencephalon and brainstem. Chronic thiamine deficiency may lead to KORSAKOFF SYNDROME. (Adams et al., Principles of Neurology, 6th ed, pp1139-42; Davis & Robertson, Textbook of Neuropathology, 2nd ed, pp452-3)", "PM": "2000; see WERNICKE'S ENCEPHALOPATHY 1970-1999, see VITAMIN B DEFICIENCY 1963-1969", "HN": "2000(1964)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19700101", "UI": "D014899"}, {"RECTYPE": "D", "MH": "West Indies", "AQ": "EH EP", "PRINT ENTRY": "Caribbean Islands|T083|NAM|EQV|NLM (1994)|921116|abcdef", "ENTRY": "Turks and Caicos Islands|T083|NAM|NRW|NLM (1983)|861231|abcdef", "MN": "Z01.639.880", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "the indentions can be grouped as the Greater Antilles, the Lesser Antilles & the Bahamas: see MeSH definition", "MS": "Islands lying between southeastern North America and northern South America, enclosing the Caribbean Sea. They comprise the Greater Antilles (CUBA; DOMINICAN REPUBLIC; HAITI; JAMAICA; and PUERTO RICO), the Lesser Antilles (ANTIGUA AND BARBUDA and the other Leeward Islands, BARBADOS; MARTINIQUE and the other Windward Islands, NETHERLANDS ANTILLES; VIRGIN ISLANDS OF THE UNITED STATES, BRITISH VIRGINI ISLANDS, and the islands north of Venezuela which include TRINIDAD AND TOBAGO), and the BAHAMAS. (From Webster's New Geographical Dictionary, 1988, p1330)", "MR": "20150629", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014900"}, {"RECTYPE": "D", "MH": "West Nile Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Kunjin virus Infection|T047|NON|REL|NLM (2024)|230203|abcdef", "ENTRY": "WNV Infections", "MN": "C10.586.250.520.750.300.887", "MH_TH": "NLM (1966)", "ST": "T047", "MS": "A mosquito-borne viral illness caused by the WEST NILE VIRUS, a FLAVIVIRUS and endemic to regions of Africa, Asia, and Europe. Common clinical features include HEADACHE; FEVER; maculopapular rash; gastrointestinal symptoms; and lymphadenopathy. MENINGITIS; ENCEPHALITIS; and MYELITIS may also occur. The disease may occasionally be fatal or leave survivors with residual neurologic deficits. (From Joynt, Clinical Neurology, 1996, Ch26, p13; Lancet 1998 Sep 5;352(9130):767-71)", "PM": "1991; see TOGAVIRUS INFECTIONS 1981-1990, see ARBOVIRUS INFECTIONS 1966-80", "HN": "1991(1966)", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014901"}, {"RECTYPE": "D", "MH": "West Nile virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Kunjin virus|T005|EPO|NRW|NLM (1994)|930506|abcdef", "MN": "B04.820.578.344.350.300.950", "FX": "West Nile Fever", "MH_TH": "NLM (1965)", "ST": "T005", "RN": "txid11082", "RR": "txid11077", "MS": "A species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE). It can infect birds and mammals. In humans, it is seen most frequently in Africa, Asia, and Europe presenting as a silent infection or undifferentiated fever (WEST NILE FEVER). The virus appeared in North America for the first time in 1999. It is transmitted mainly by CULEX spp mosquitoes which feed primarily on birds, but it can also be carried by the Asian Tiger mosquito, AEDES albopictus, which feeds mainly on mammals.", "PM": "1973; for KUNJIN VIRUS see ENCEPHALITIS VIRUSES, JAPANESE 1994-2001", "HN": "1973 (1965); for KUNJIN VIRUS use ENCEPHALITIS VIRUSES, JAPANESE 1994-2001", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014902"}, {"RECTYPE": "D", "MH": "West Virginia", "AQ": "EH EP", "MN": "Z01.107.567.875.750.900", "MH_TH": "NLM (1998)", "ST": "T083", "MS": "State bounded on the north by Ohio, Maryland, and Pennsylvania, bounded on the west by Ohio and Kentucky, on the east and south by Virginia.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014903"}, {"RECTYPE": "D", "MH": "Western Australia", "AQ": "EH EP", "MN": "Z01.678.100.373.996", "MH_TH": "NLM (1988)", "ST": "T083", "AN": "a state of Australia", "PI": "Australia (1966-1987)", "MS": "A state in western Australia. Its capital is Perth. It was first visited by the Dutch in 1616 but the English took possession in 1791 and permanent colonization began in 1829. It was a penal settlement 1850-1888, became part of the colonial government in 1886, and was granted self government in 1890. (From Webster's New Geographical Dictionary, 1988, p1329)", "HN": "88", "MR": "20150623", "DA": "19870309", "DC": "4", "DX": "19880101", "UI": "D014904"}, {"RECTYPE": "D", "MH": "Independent State of Samoa", "AQ": "EH EP", "PRINT ENTRY": "Western Samoa|T083|NON|EQV|NLM (1999)|980323|abcdef", "MN": "Z01.639.760.815.800.400", "MH_TH": "NLM (1966)", "ST": "T083", "AN": "a monarchy; do not confuse with SAMOA, the island group in Polynesia; AMERICAN SAMOA is also available", "MS": "An island group and constitutional monarchy in the southwest central Pacific Ocean. The capital is Apia. The islands were jointly administered by England, the United States, and Germany 1889-99, with the chief islands of Savai'i and Upolu recognized as German until 1919. Western Samoa gained independence in 1962 and assumed its present formal name in 1997.", "HN": "99; was WESTERN SAMOA 1975-98", "MR": "20120703", "DA": "19990101", "DC": "4", "DX": "19990101", "UI": "D014905"}, {"RECTYPE": "D", "MH": "Wetting Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Wetting Agent|T122|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Agents, Wetting", "MN": "D27.720.877.974", "MH_TH": "NLM (1975)", "ST": "T122", "RN": "0", "AN": "for electrowetting agents coordinate with ELECTROWETTING", "MS": "A surfactant that renders a surface wettable by water or enhances the spreading of water over the surface.", "OL": "search SURFACE-ACTIVE AGENTS 1966-74", "PM": "91; was see under SURFACE-ACTIVE AGENTS 1975-90", "HN": "91(75); was see under SURFACE-ACTIVE AGENTS 1975-90", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014906"}, {"RECTYPE": "D", "MH": "Whales", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Ziphius|T015|NON|NRW|NLM (1998)|961025|abcdef", "ENTRY": "Whales, Southern Right", "MN": "B01.050.150.900.649.313.875.865", "FX": "Ambergris", "MH_TH": "NLM (1975)", "ST": "T015", "RR": "txid9764", "AN": "some dolphins are misnamed \"whales\": note FALSE KILLER WHALE; PYGMY KILLER WHALE; and MELON-HEADED WHALE; are entry terms to DOLPHINS; PILOT WHALES; and KILLER WHALE; both types of dolphin, are also available", "MS": "Large marine mammals of the order CETACEA. In the past, they were commercially valued for whale oil, for their flesh as human food and in ANIMAL FEED and FERTILIZERS, and for baleen. Today, there is a moratorium on most commercial whaling, as all species are either listed as endangered or threatened.", "OL": "search CETACEA 1966-74", "PM": "91; was see under CETACEA 1975-90", "HN": "91(75); was see under CETACEA 1975-90", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014907"}, {"RECTYPE": "D", "MH": "Triticum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Wheat|T002|T168|NON|REL|NLM (1966)|990101|abbcdef", "ENTRY": "Wheat, Durum", "MN": "B01.875.800.575.912.250.822.918", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid4564", "RR": "txid58933", "AN": "wheat germ: index under TRITICUM, not TRITICUM / embryol; the rye-wheat hybrid TRITICALE is also available", "MS": "A plant genus of the family POACEAE that is the source of EDIBLE GRAIN. A hybrid with rye (SECALE CEREALE) is called TRITICALE. The seed is ground into FLOUR and used to make BREAD, and is the source of WHEAT GERM AGGLUTININS.", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014908"}, {"RECTYPE": "D", "MH": "Wheat Germ Agglutinins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Wheat Germ Lectins|T129|T130|NON|EQV|UNK (19XX)|860625|abbcdef", "ENTRY": "Vulgare Lectin, Triticum", "MN": "D12.776.765.678.968", "MH_TH": "NLM (1987)", "ST": "T130", "RN": "0", "PI": "Lectins (1966-1986)", "MS": "Lectins purified from the germinating seeds of common wheat (Triticum vulgare); these bind to certain carbohydrate moieties on cell surface glycoproteins and are used to identify certain cell populations and inhibit or promote some immunological or physiological activities. There are at least two isoforms of this lectin.", "PM": "87", "HN": "87", "MR": "20200527", "DA": "19860625", "DC": "1", "DX": "19870101", "UI": "D014909"}, {"RECTYPE": "D", "MH": "Wheelchairs", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Wheelchair", "MN": "E07.796.980", "MH_TH": "NLM (1976)", "ST": "T074", "MS": "Chairs or seating mounted on wheels and designed to be controlled or propelled by the occupant. Medicare Part B (Medical Insurance) covers power-operated vehicles (scooters), walkers, and wheelchairs as durable medical equipment.", "OL": "use WHEELCHAIRS to search WHEEL CHAIRS 1966-75", "PM": "76; was WHEEL CHAIRS 1963-75", "HN": "76; was WHEEL CHAIRS 1963-75", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19750718", "DC": "1", "DX": "19760101", "UI": "D014910"}, {"RECTYPE": "D", "MH": "Whiplash Injuries", "DE": "WHIPLASH INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Whiplash Injury", "MN": "C26.700.500", "MH_TH": "NLM (1973)", "ST": "T037", "MS": "Hyperextension injury to the neck, often the result of being struck from behind by a fast-moving vehicle, in an automobile accident. (From Segen, The Dictionary of Modern Medicine, 1992)", "OL": "use WHIPLASH INJURIES to search WHIPLASH INJURY 1966-72", "PM": "73; was WHIPLASH INJURY 1963-72", "HN": "73; was WHIPLASH INJURY 1963-72", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014911"}, {"RECTYPE": "D", "MH": "White Muscle Disease", "DE": "WHITE MUSCLE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "White Muscle Diseases", "MN": "C22.595.740", "MH_TH": "NLM (1975)", "ST": "T047", "AN": "a form of musc dystrophy usually in calves & lambs; manifest of selenium defic; check tag ANIMALS; coord IM with precoord animal/dis term (IM) + animal (NIM) or with animal (IM) in absence of precoord", "MS": "A myodegeneration most frequent in calves and lambs whose dams have been fed during gestation or longer on feeds, especially legumes (FABACEAE), grown in certain areas where selenium is either deficient or unavailable in the soil. It has been recorded in many countries. It has been produced experimentally in several species of animals on low-selenium intake. A similar myopathy occurs naturally in goats, deer, foals, and dogs but proof of the etiology is lacking. (Merck Veterinary Manual, 5th ed)", "OL": "search MUSCULAR DYSTROPHY, ANIMAL 1970-74", "PM": "91; was see under MUSCULAR DYSTROPHY, ANIMAL 1975-90", "HN": "91(75); was see under MUSCULAR DYSTROPHY, ANIMAL 1975-90", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014912"}, {"RECTYPE": "D", "MH": "Whole Blood Coagulation Time", "DE": "WHOLE BLOOD COAG TIME", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Coagulation Time, Whole Blood|T034|NON|EQV|UNK (19XX)|790308|COAG TIME WHOLE BLOOD|abcdefv", "MN": "G09.188.960", "FX": "Blood Coagulation", "MH_TH": "NLM (1980)", "ST": "T034", "AN": "usually NIM ", "PI": "Blood Coagulation Tests (1966-1979)", "MS": "The time required by whole blood to produce a visible clot.", "PM": "91; was see under BLOOD COAGULATION TESTS 1980-90", "HN": "91(80); was see under BLOOD COAGULATION TESTS 1980-90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19790308", "DC": "1", "DX": "19910101", "UI": "D014914"}, {"RECTYPE": "D", "MH": "Whole-Body Counting", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Whole Body Counter|T074|NON|REL|NLM (2022)|201023|abcdef", "ENTRY": "Whole-Body Counter", "MN": "E05.799.950", "MH_TH": "NLM (1971)", "ST": "T081", "PI": "Radiometry (1966-1970)", "MS": "Measurement of radioactivity in the entire human body.", "OL": "use WHOLE-BODY COUNTING to search WHOLE BODY COUNTING 1979-91, WHOLE BODY COUNTERS 1973-78, & WHOLE BODY COUNTER 1971-72 (as Prov)", "PM": "91; was WHOLE BODY COUNTING 1979-91; was WHOLE BODY COUNTERS 1973-78", "HN": "92; was WHOLE BODY COUNTING 1979-91; was WHOLE BODY COUNTERS 1973-78; was WHOLE BODY COUNTER 1971-72 (Prov)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014915"}, {"RECTYPE": "D", "MH": "Whole-Body Irradiation", "DE": "WHOLE BODY IRRAD", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Total Body Irradiation|T061|NON|EQV|UNK (19XX)|810227|TOTAL BODY IRRAD|abcdefv", "ENTRY": "Whole-Body Radiations", "MN": "E05.980", "FX": "Lymphatic Irradiation", "MH_TH": "NLM (1982)", "ST": "T061", "AN": "in rad experiments IM when point of article is irrad of entire animal & coord with organ or process /rad eff (IM or NIM); no qualif when NIM; in radiother coord IM with disease /radiother (IM)", "MS": "Irradiation of the whole body with ionizing or non-ionizing radiation. It is applicable to humans or animals but not to microorganisms.", "OL": "use WHOLE-BODY IRRADIATION to search WHOLE BODY IRRADIATION 1982-90", "PM": "91; was WHOLE BODY IRRADIATION 1982-90", "HN": "91; was WHOLE BODY IRRADIATION 1982-90", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19810227", "DC": "1", "DX": "19820101", "UI": "D014916"}, {"RECTYPE": "D", "MH": "Whooping Cough", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pertussis|T047|NON|EQV|POPLINE (1994)|UNK (19XX)|740330|abcdeef", "ENTRY": "Pertusses", "MN": "C08.730.969", "FX": "Pertussis Vaccine", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "caused by Bordetella pertussis", "MS": "A respiratory infection caused by BORDETELLA PERTUSSIS and characterized by paroxysmal coughing ending in a prolonged crowing intake of breath.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014917"}, {"RECTYPE": "D", "MH": "Wills", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Inheritance, Legal|T081|NON|REL|NLM (2023)|210819|abcdef", "ENTRY": "Legal Inheritance", "MN": "I01.880.604.583.927", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "do not confuse entry term INHERITANCE with HEREDITY", "MS": "Legal documents that are declarations of individuals' wishes regarding the disposal of their property or estate after death; esp: written instruments, legally executed, by which dispositions are made of estates. LIVING WILLS are written declarations regarding prolongation of life by extraordinary means.", "MR": "20211202", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014918"}, {"RECTYPE": "D", "MH": "Wind", "ENTRY": "Winds", "MN": "N06.230.300.100.725.780", "MH_TH": "NLM (1975)", "ST": "T070", "AN": "CYCLONIC STORMS and entry terms TYPHOONS and HURRICANES are also available", "MS": "The motion of air relative to the earth's surface.", "OL": "search AIR MOVEMENTS 1974 & WEATHER 1969-73", "PM": "91; was see under AIR MOVEMENTS 1974-90; was see under WEATHER 1969-73", "HN": "91(75); was see under AIR MOVEMENTS 1974-90; was see under WEATHER 1969-73", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014919"}, {"RECTYPE": "D", "MH": "Wine", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "ENTRY": "Wines", "MN": "J02.350.594.968", "MH_TH": "NLM (1966)", "ST": "T168", "MS": "Fermented juice of fresh grapes or of other fruit or plant products used as a beverage.", "MR": "20210707", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014920"}, {"RECTYPE": "D", "MH": "Wings, Animal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Wing, Animal", "MN": "A13.395.823", "MH_TH": "NLM (2016)", "ST": "T017", "PI": "Birds (1966-1967)", "MS": "Movable feathered or membranous paired appendages by means of which certain animals such as birds, bats, or insects are able to fly.", "PM": "2016; see WING 1989-2015", "HN": "2016 (1989)", "MR": "20150701", "DA": "19990101", "DC": "1", "DX": "19680101", "UI": "D014921"}, {"RECTYPE": "D", "MH": "Wisconsin", "AQ": "EH EP", "MN": "Z01.107.567.875.510.900", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Lake Superior and Michigan, on the east by Lake Michigan, on the south by Illinois and Iowa, and on the west by Minnesota and Iowa.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014922"}, {"RECTYPE": "D", "MH": "Wiskott-Aldrich Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aldrich Syndrome|T047|EPO|EQV|OMIM (2013)|ORD (2010)|UNK (19XX)|840210|abcdeeef", "ENTRY": "Wiskott Syndromes", "MN": "C20.673.795.875", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A rare, X-linked immunodeficiency syndrome characterized by ECZEMA; LYMPHOPENIA; and, recurrent pyogenic infection. It is seen exclusively in young boys. Typically, IMMUNOGLOBULIN M levels are low and IMMUNOGLOBULIN A and IMMUNOGLOBULIN E levels are elevated. Lymphoreticular malignancies are common.", "OL": "use WISKOTT-ALDRICH SYNDROME to search ALDRICH SYNDROME 1966-84", "PM": "85; was ALDRICH SYNDROME 1963-84", "HN": "85; was ALDRICH SYNDROME 1963-84", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D014923"}, {"RECTYPE": "D", "MH": "Wissler's Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wissler-Fanconi Syndrome|T047|EPO|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Wisslers Syndrome", "MN": "C20.543.928", "MH_TH": "NLM (1964)", "ST": "T047", "AN": "a form of rheumatic fever", "MS": "A rheumatic syndrome of possibly allergic origin, usually affecting children and adolescents, and characterized by high fever, exanthema, arthralgia, leukocytosis, and increased sedimentation rate.", "PM": "65", "HN": "65(64)", "CATSH": "CAT LIST", "MR": "19920522", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014924"}, {"RECTYPE": "D", "MH": "Wit and Humor as Topic", "AQ": "HI PX", "ENTRY": "Wits", "MN": "K01.517.946", "FX": "Laughter Therapy", "EC": "therapeutic use:Laughter Therapy", "MH_TH": "NLM (2008)", "ST": "T078", "AN": "do not confuse with the Publication Type WIT AND HUMOR", "MS": "The comical expression of connections between ideas that awaken amusement and pleasure.", "PM": "2008; see WIT AND HUMOR 1963-2007", "HN": "2008(1963)", "MR": "20180713", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D014925"}, {"RECTYPE": "D", "MH": "Wolff-Parkinson-White Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "WPW Syndrome|T047|EPO|EQV|GHR (2014)|NLM (1992)|OMIM (2013)|ORD (2010)|910619|abcdeeeef", "ENTRY": "Wolff Parkinson White Syndrome", "MN": "C16.131.240.400.980", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014927"}, {"RECTYPE": "D", "MH": "Wolffian Ducts", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Gartner Ducts|T018|EPO|REL|NLM (2008)|061024|abcdef", "ENTRY": "Mesonephric Duct", "MN": "A16.935", "MH_TH": "NLM (2008)", "ST": "T018", "MS": "A pair of excretory ducts of the middle kidneys (MESONEPHROI) of an embryo, also called mesonephric ducts. In higher vertebrates, Wolffian ducts persist in the male forming VAS DEFERENS, but atrophy into vestigial structures in the female.", "PM": "2008; see WOLFFIAN DUCT 1963-2007", "HN": "2008 (1963)", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "20080101", "UI": "D014928"}, {"RECTYPE": "D", "MH": "Wolfram Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "DIDMOAD Syndrome|T047|ABB|EQV|GHR (2014)|NLM (2010)|ORD (2010)|090504|abcdeeef", "ENTRY": "Syndrome, Wolfram", "MN": "C19.700.159.875", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Optic Atrophy (1966-1985)", "MS": "A hereditary condition characterized by multiple symptoms including those of DIABETES INSIPIDUS; DIABETES MELLITUS; OPTIC ATROPHY; and DEAFNESS. This syndrome is also known as DIDMOAD (first letter of each word) and is usually associated with VASOPRESSIN deficiency. It is caused by mutations in gene WFS1 encoding wolframin, a 100-kDa transmembrane protein.", "PM": "86", "HN": "86", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19850311", "DC": "1", "DX": "19860101", "UI": "D014929"}, {"RECTYPE": "D", "MH": "Women", "AQ": "ED HI PX", "ENTRY": "Women's Group", "MN": "M01.975", "MH_TH": "NLM (1978)", "ST": "T098", "AN": "for women or girls only as a cultural, social, sociological, political, economic force; distinguish from the check tag FEMALE; when indexing WOMEN, check the tags HUMANS & FEMALE; CATALOGER: Coordinate with age group if appropriate", "MS": "Human females as cultural, psychological, sociological, political, and economic entities.", "MR": "20151124", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014930"}, {"RECTYPE": "D", "MH": "Women, Working", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Working Women|T098|NON|EQV|UNK (19XX)|830606|abcdef", "ENTRY": "Working Woman", "MN": "M01.975.825", "MH_TH": "NLM (1984)", "ST": "T098", "PI": "Women (1966-1983)", "MS": "Women who are engaged in gainful activities usually outside the home.", "PM": "91; was see under WOMEN 1984-90", "HN": "91(84); was see under WOMEN 1984-90", "MR": "19950609", "DA": "19830606", "DC": "1", "DX": "19910101", "UI": "D014931"}, {"RECTYPE": "D", "MH": "Women's Health Services", "DE": "WOMENS HEALTH SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Health Services, Women's|T058|NON|EQV|UNK (19XX)|870504|HEALTH SERV WOMENS|abcdefv", "ENTRY": "Women's Health Service", "MN": "N02.421.920", "MH_TH": "BIOETHICS (1994)", "ST": "T058", "AN": "does not include maternal care services: index MATERNAL HEALTH SERVICES; check also tags HUMANS and FEMALE", "MS": "Organized services to provide health care to women. It excludes maternal care services for which MATERNAL HEALTH SERVICES is available.", "PM": "89; was see under HEALTH SERVICES 1988", "HN": "89(88); was see under HEALTH SERVICES 1988", "MR": "20150626", "DA": "19870504", "DC": "1", "DX": "19890101", "UI": "D014932"}, {"RECTYPE": "D", "MH": "Women's Rights", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Women's Liberation|T054|NON|NRW|UNK (19XX)|760505|abcdef", "ENTRY": "Women's Right", "MN": "N03.706.437.850", "FX": "Feminism", "MH_TH": "BIOETHICS (1974)", "ST": "T064", "AN": "specify geog", "PI": "Human Rights (1973-1976)", "MS": "The rights of women to equal status pertaining to social, economic, and educational opportunities afforded by society.", "PM": "77", "HN": "77", "MR": "19991103", "DA": "19760505", "DC": "1", "DX": "19770101", "UI": "D014933"}, {"RECTYPE": "D", "MH": "Wood", "AQ": "AE AH AN CH CL CY DE EC EN GD GE HI IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Woods", "MN": "J01.637.241.900", "FX": "Forests", "MH_TH": "NLM (1966)", "ST": "T167", "MS": "A product of hard secondary xylem composed of CELLULOSE, hemicellulose, and LIGNANS, that is under the bark of trees and shrubs. It is used in construction and as a source of CHARCOAL and many other products.", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014934"}, {"RECTYPE": "D", "MH": "Wool", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE TR UL VI", "MN": "A17.360.855", "FX": "Wool Fiber", "MH_TH": "NLM (1966)", "ST": "T167", "AN": "WOOL FIBER is also available", "MS": "The hair of SHEEP or other animals that is used for weaving or felting.", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014935"}, {"RECTYPE": "D", "MH": "Word Association Tests", "DE": "WORD ASSOC TESTS", "AQ": "HI SN ST", "ENTRY": "Word Association Test", "MN": "F04.711.647.905", "MH_TH": "NLM (1969)", "ST": "T060", "PI": "Association (1966-1968)", "MS": "Lists of words to which individuals are asked to respond ascertaining the conceptual meaning held by the individual.", "PM": "69", "HN": "69", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19990101", "DC": "1", "DX": "19690101", "UI": "D014936"}, {"RECTYPE": "D", "MH": "Work", "AQ": "CL EC ES HI LJ PH PX SN ST TD", "MN": "I03.946", "FX": "Employment", "MH_TH": "NLM (1966)", "ST": "T057", "AN": "purposeful activity: differentiate from PHYSICAL EXERTION; EMPLOYMENT; and ENERGY EXPENDITURE; BURNOUT, PROFESSIONAL is available", "MS": "Productive or purposeful activities.", "PM": "66; was see under EXERTION 1963-65", "HN": "66; was see under EXERTION 1963-65", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014937"}, {"RECTYPE": "D", "MH": "Work Capacity Evaluation", "DE": "WORK CAPAC EVALUATION", "ENTRY": "Work Capacity Evaluations", "MN": "E01.370.400.925", "MH_TH": "NLM (1975)", "ST": "T060", "PI": "Disability Evaluation (1966-1974)", "MS": "Assessment of physiological capacities in relation to job requirements. It is usually done by measuring certain physiological (e.g., circulatory and respiratory) variables during a gradually increasing workload until specific limitations occur with respect to those variables.", "OL": "search DISABILITY EVALUATION 1966-74", "PM": "86; was see under DISABILITY EVALUATION 1966-85", "HN": "86(75); was see under DISABILITY EVALUATION 1966-85", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19860101", "UI": "D014938"}, {"RECTYPE": "D", "MH": "Work of Breathing", "AQ": "DE ES GE IM PH RE", "ENTRY": "Breathing Works", "MN": "G09.772.965", "MH_TH": "NLM (1971)", "ST": "T060", "PI": "Respiration (1966-1970)", "MS": "RESPIRATORY MUSCLE contraction during INHALATION. The work is accomplished in three phases: LUNG COMPLIANCE work, that required to expand the LUNGS against its elastic forces; tissue resistance work, that required to overcome the viscosity of the lung and chest wall structures; and AIRWAY RESISTANCE work, that required to overcome airway resistance during the movement of air into the lungs. Work of breathing does not refer to expiration, which is entirely a passive process caused by elastic recoil of the lung and chest cage. (Guyton, Textbook of Medical Physiology, 8th ed, p406)", "PM": "72", "HN": "72(71)", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014939"}, {"RECTYPE": "D", "MH": "Work Schedule Tolerance", "AQ": "PH PX", "ENTRY": "Work Schedule Tolerances", "MN": "N04.452.677.650.375", "FX": "Sleep Disorders, Circadian Rhythm", "MH_TH": "NLM (1983)", "ST": "T078", "AN": "/physiol /psychol permitted", "PI": "Work (1966-1982)", "MS": "Physiological or psychological effects of periods of work which may be fixed or flexible such as flexitime, work shifts, and rotating shifts.", "PM": "91; was see under WORK 1983-90", "HN": "91(83); was see under WORK 1983-90", "MR": "20170224", "DA": "19820428", "DC": "1", "DX": "19910101", "UI": "D014940"}, {"RECTYPE": "D", "MH": "Work Simplification", "ENTRY": "Work Simplifications", "MN": "F02.784.692.746.853", "MH_TH": "NLM (1975)", "ST": "T057", "PI": "Task Performance and Analysis (1972-1974)", "MS": "The construction or arrangement of a task so that it may be done with the greatest possible efficiency.", "OL": "search EFFICIENCY & TASK PERFORMANCE AND ANALYSIS 1974 & EFFICIENCY 1970-73", "PM": "75; was see under EFFICIENCY 1970-73, was see under EFFICIENCY & TASK PERFORMANCE AND ANALYSIS 1974", "HN": "75; was see under EFFICIENCY 1970-73, was see under EFFICIENCY & TASK PERFORMANCE AND ANALYSIS 1974", "MR": "19970620", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D014941"}, {"RECTYPE": "D", "MH": "Workers' Compensation", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Workmen's Compensation|T058|NON|EQV|NLM (1993)|911023|abcdef", "ENTRY": "Workmens Compensation", "MN": "N03.219.521.576.300.900", "FX": "Disability Evaluation", "MH_TH": "NLM (1966)", "ST": "T058", "AN": "specify country or state", "MS": "Insurance coverage providing compensation and medical benefits to individuals because of work-connected injuries or disease.", "OL": "use WORKERS' COMPENSATION to search WORKMEN'S COMPENSATION 1966-92", "PM": "93; was WORKMEN'S COMPENSATION 1963-92", "HN": "93; was WORKMEN'S COMPENSATION 1963-92", "MR": "20020703", "DA": "19990101", "DC": "1", "DX": "19930101", "UI": "D014942"}, {"RECTYPE": "D", "MH": "Global Health", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "PRINT ENTRY": "World Health|T078|NON|REL|NLM (1978)|990101|abcdef", "ENTRY": "Problems, International Health", "MN": "N01.400.337", "FX": "World Health Organization", "MH_TH": "NLM (2015)", "ST": "T078", "PI": "World Health (1978-2014)", "MS": "A multi- and interdisciplinary field concerned with improving health and achieving equity in health for all people. It transcends national boundaries, promotes cooperation and collaboration within and beyond health science fields, and combines population-based disease prevention with individually-based patient care.", "PM": "2015; for WORLD HEALTH see WORLD HEALTH 1978-2014; for INTERNATIONAL HEALTH PROBLEMS see WORLD HEALTH 1978-2014.", "HN": "2015 (1978)", "MR": "20180629", "DA": "19770512", "DC": "1", "DX": "19780101", "UI": "D014943"}, {"RECTYPE": "D", "MH": "World Health Organization", "DE": "WORLD HEALTH ORGAN", "AQ": "EC HI OG", "ENTRY": "WHO|T093|NAM|EQV|POPLINE (1978)|781226|abcdef", "MN": "N03.540.514.718.800", "FX": "Global Health", "MH_TH": "NLM (1965)", "ST": "T093", "AN": "CATALOGER: Use NAF entry", "MS": "A specialized agency of the United Nations designed as a coordinating authority on international health work; its aim is to promote the attainment of the highest possible level of health by all peoples.", "PM": "66", "HN": "66(65)", "MR": "20150605", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014944"}, {"RECTYPE": "D", "MH": "Wound Healing", "AQ": "DE ES GE IM PH RE", "ENTRY": "Wound Healings", "MN": "G16.762.891", "FX": "Regeneration", "MH_TH": "NLM (1966)", "ST": "T040", "AN": "also available is FRACTURE HEALING; not for invertebrates or plants", "MS": "Restoration of integrity to traumatized tissue.", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014945"}, {"RECTYPE": "D", "MH": "Wound Infection", "DE": "WOUND INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Wound Infections", "MN": "C01.947", "MH_TH": "NLM (1966)", "ST": "T046", "AN": "coordinate with specific infection term", "MS": "Invasion of a wound by pathogenic microorganisms.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014946"}, {"RECTYPE": "D", "MH": "Wounds and Injuries", "DE": "WOUNDS INJURIES", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Trauma|T033|T037|NON|REL|UNK (19XX)|740330|abbcdef", "ENTRY": "Wound", "MN": "C26", "RH": "C26 - WOUNDS AND INJURIES", "FX": "Transportation of Patients", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "general or unspecified; prefer / inj with organs or specific organ / injury terms", "MS": "Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014947"}, {"RECTYPE": "D", "MH": "Wounds, Gunshot", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Wound, Gunshot", "MN": "C26.986.900", "FX": "Forensic Ballistics", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "coord IM with organ /inj (IM) or precoord inj term (IM); FORENSIC BALLISTICS is also available", "MS": "Disruption of structural continuity of the body as a result of the discharge of firearms.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014948"}, {"RECTYPE": "D", "MH": "Wounds, Nonpenetrating", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Injuries, Nonpenetrating|T037|NON|EQV|UNK (19XX)|750701|INJ NONPENETRATING|abcdefv", "ENTRY": "Wound, Nonpenetrating", "MN": "C26.974", "MH_TH": "NLM (1976)", "ST": "T037", "AN": "IM; coord with organ /inj or precoord inj term (IM)", "PI": "Thoracic Injuries (1966-1975)", "MS": "Injuries caused by impact with a blunt object where there is no penetration of the skin.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D014949"}, {"RECTYPE": "D", "MH": "Wounds, Penetrating", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Wound, Penetrating", "MN": "C26.986", "MH_TH": "NLM (1976)", "ST": "T037", "AN": "note WOUNDS, GUNSHOT & WOUNDS, STAB; IM; coord with organ /inj or precoord inj term (IM)", "PI": "specific heading/injuries (1966-1975)", "MS": "Wounds caused by objects penetrating the skin.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D014950"}, {"RECTYPE": "D", "MH": "Wounds, Stab", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Wound, Stab", "MN": "C26.986.950", "FX": "Punctures", "MH_TH": "NLM (1976)", "ST": "T037", "AN": "coordinate with organ /inj or precoordinated injury term", "PI": "specific heading/injuries (1966-1975)", "MS": "Penetrating wounds caused by a pointed object.", "PM": "76", "HN": "76", "CATSH": "CAT LIST", "MR": "20160705", "DA": "19750725", "DC": "1", "DX": "19760101", "UI": "D014951"}, {"RECTYPE": "D", "MH": "Wrestling", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Wrestlings", "MN": "I03.450.642.845.975", "FX": "Martial Arts", "MH_TH": "NLM (1976)", "ST": "T056", "AN": "/inj: coord IM with specific inj (IM); /physiol permitted", "PI": "Sports (1966-1975)", "MS": "A sport consisting of hand-to-hand combat between two unarmed contestants seeking to pin or press each other's shoulders to the ground.", "PM": "90; was see under SPORTS 1976-89", "HN": "90(76); was see under SPORTS 1976-89", "MR": "19970620", "DA": "19750723", "DC": "1", "DX": "19900101", "UI": "D014952"}, {"RECTYPE": "D", "MH": "Wrist", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "ENTRY": "Wrists", "MN": "A01.378.800.875", "EC": "injuries:Wrist Injuries", "MH_TH": "NLM (1966)", "ST": "T029", "MS": "The region of the upper limb between the metacarpus and the FOREARM.", "MR": "20190517", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014953"}, {"RECTYPE": "D", "MH": "Wrist Injuries", "DE": "WRIST INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Wrist Injury", "MN": "C26.088.906", "MH_TH": "NLM (1966)", "ST": "T037", "AN": "consider also CARPAL BONES /inj", "MS": "Injuries to the wrist or the wrist joint.", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014954"}, {"RECTYPE": "D", "MH": "Wrist Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Wrist Joints", "MN": "A02.835.583.405.930", "EC": "injuries:Wrist Injuries", "MH_TH": "NLM (1965)", "ST": "T030", "AN": "primates only; use CARPUS, ANIMAL for non-primate vertebrates; differentiate from wrist; wrist ganglion is indexed under WRIST (IM) + SYNOVIAL CYST (IM)", "MS": "The joint that is formed by the distal end of the RADIUS, the articular disc of the distal radioulnar joint, and the proximal row of CARPAL BONES; (SCAPHOID BONE; LUNATE BONE; triquetral bone).", "PM": "65", "HN": "65", "MR": "20050630", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014955"}, {"RECTYPE": "D", "MH": "Writing", "AQ": "HI ST", "MN": "L01.559.423.906", "MH_TH": "NLM (1966)", "ST": "T090", "AN": "the act or profession of writing or its product; do not confuse with PUBLISHING or LITERATURE or AUTHORSHIP or JOURNALISM; style of writing goes here; includes typewriting; editing for publication is indexed as PUBLISHING; writing for periodicals is indexed as PERIODICALS AS TOPIC; letters & correspondence of biographees & famous persons are indexed as CORRESPONDENCE AS TOPIC (IM); HANDWRITING and MEDICAL WRITING are also available", "MS": "The act or practice of literary composition, the occupation of writer, or producing or engaging in literary work as a profession.", "MR": "20170703", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014956"}, {"RECTYPE": "D", "MH": "Wuchereria", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Wuchererias", "MN": "B01.050.500.500.294.400.937.463.708", "MH_TH": "NLM (1966)", "ST": "T204", "RN": "txid6292", "AN": "infection: coord IM with FILARIASIS (IM); coord with specific helminth term (ANTIGENS, HELMINTH, etc) if pertinent; /drug eff: consider FILARICIDES", "MS": "A genus of filarial nematodes.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014957"}, {"RECTYPE": "D", "MH": "Wuchereria bancrofti", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Filaria sanguinis hominis|T204|NON|EQV|UNK (19XX)|780302|abcdef", "MN": "B01.050.500.500.294.400.937.463.708.150", "MH_TH": "NLM (1975)", "ST": "T204", "RN": "txid6293", "AN": "infection: coord IM with probably ELEPHANTIASIS, FILARIAL (IM) but if elephantiasis is not present, coord with FILARIASIS (IM) instead; coord with specific helminth term (ANTIGENS, HELMINTH, etc) if pertinent; /drug eff: consider FILARICIDES", "MS": "A white threadlike worm which causes elephantiasis, lymphangitis, and chyluria by interfering with the lymphatic circulation. The microfilaria are found in the circulating blood and are carried by mosquitoes.", "OL": "use WUCHERERIA BANCROFTI to search FILARIA BANCROFTI & FILARIA SANGUINIS HOMINIS 1975-78; use WUCHERERIA 1966-74", "PM": "91; was see under WUCHERERIA 1979-90; was FILARIA BANCROFTI see under WUCHERERIA 1963-78; FILARIA SANGUINIS HOMINIS was see under WUCHERERIA 1963-78", "HN": "91(79); was see under WUCHERERIA 1979-90; was FILARIA BANCROFTI see under WUCHERERIA 1963-78; FILARIA SANGUINIS HOMINIS was see under WUCHERERIA 1963-78", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014958"}, {"RECTYPE": "D", "MH": "Wyoming", "AQ": "EH EP", "MN": "Z01.107.567.875.560.925", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "State bounded on the north by Montana, on the east by South Dakota and Nebraska, on the south by Utah and Colorado, and on the west by Idaho and Utah.", "MR": "20160602", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D014959"}, {"RECTYPE": "D", "MH": "X Chromosome", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "ENTRY": "X Chromosomes", "MN": "G05.360.162.865.982", "MH_TH": "NLM (1978)", "ST": "T026", "PI": "Sex Chromosomes (1968-1977)", "MS": "The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in human and other male-heterogametic species.", "OL": "search SEX CHROMOSOMES 1968-77", "PM": "84; was see under SEX CHROMOSOMES 1968-83", "HN": "84(78); was see under SEX CHROMOSOMES 1968-83", "MR": "20130709", "DA": "19770429", "DC": "1", "DX": "19840101", "UI": "D014960"}, {"RECTYPE": "D", "MH": "X-Ray Diffraction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Xray Diffractions", "MN": "G02.965", "MH_TH": "NLM (1963)", "ST": "T070", "MS": "The scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays (CRYSTALLOGRAPHY, X-RAY). (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "65", "HN": "65(63)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014961"}, {"RECTYPE": "D", "MH": "X-Ray Film", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Radiographic Film|T073|NON|EQV|UNK (19XX)|810518|RADIOGR FILM|abcdefv", "ENTRY": "Xray Films", "MN": "E07.960", "MH_TH": "NLM (1982)", "ST": "T073", "AN": "do not confuse with x-ray technique", "PI": "specific radiography heading (1966-1981)", "MS": "A film base coated with an emulsion designed for use with x-rays.", "PM": "82", "HN": "82", "CATSH": "CAT LIST", "MR": "20160318", "DA": "19810518", "DC": "1", "DX": "19820101", "UI": "D014962"}, {"RECTYPE": "D", "MH": "X-Ray Intensifying Screens", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "X-Ray Film-Screen Systems|T074|NON|EQV|UNK (19XX)|810519|abcdef", "ENTRY": "Xray Intensifying Screen", "MN": "E07.970", "MH_TH": "NLM (1982)", "ST": "T074", "PI": "Technology, Radiologic (1977-1981)", "MS": "Screens which absorb the energy in the x-ray beam that has penetrated the patient and convert this energy into a light pattern which has as nearly as possible the same information as the original x-ray beam. The more light a screen produces for a given input of x-radiation, the less x-ray exposure and thus shorter exposure time are needed to expose the film. In most film-screen systems, the film is sandwiched between two screens in a cassette so that the emulsion on each side is exposed to the light from its contiguous screen.", "PM": "89; was see under RADIOGRAPHIC IMAGE ENHANCEMENT 1982-88", "HN": "89(82); was see under RADIOGRAPHIC IMAGE ENHANCEMENT 1982-88", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19810519", "DC": "1", "DX": "19890101", "UI": "D014963"}, {"RECTYPE": "D", "MH": "X-Ray Therapy", "DE": "X RAY THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Roentgenotherapy|T061|NON|EQV|UNK (19XX)|741217|ROENTGENOTHER|abcdefv", "ENTRY": "Xray Therapies", "MN": "E02.815.907", "MH_TH": "NLM (1975)", "ST": "T061", "AN": "general; prefer / radiother with specific disease and do not add as a coordinate; assume all / radiother is X-RAY THERAPY unless otherwise specified", "MS": "Medical treatment involving the use of controlled amounts of X-Rays.", "OL": "search RADIOTHERAPY 1966-74", "PM": "91; was see under RADIOTHERAPY 1975-90", "HN": "91(75); was see under RADIOTHERAPY 1975-90", "CATSH": "CAT LIST", "MR": "20150617", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014964"}, {"RECTYPE": "D", "MH": "X-Rays", "AQ": "AE", "PRINT ENTRY": "Xray|T070|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "X-Radiations", "MN": "G01.750.750.918", "EC": "therapeutic use:X-Ray Therapy", "MH_TH": "NLM (1975)", "ST": "T070", "MS": "Penetrating electromagnetic radiation emitted when the inner orbital electrons of an atom are excited and release radiant energy. X-ray wavelengths range from 1 pm to 10 nm. Hard X-rays are the higher energy, shorter wavelength X-rays. Soft x-rays or Grenz rays are less energetic and longer in wavelength. The short wavelength end of the X-ray spectrum overlaps the GAMMA RAYS wavelength range. The distinction between gamma rays and X-rays is based on their radiation source.", "OL": "search RADIATION 1966-74", "PM": "91; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1965-75", "HN": "91(75); was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1965-75", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014965"}, {"RECTYPE": "D", "MH": "Xanthenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Xanthene|T109|NON|EQV|NLM (2021)|191121|abcdef", "MN": "D03.633.300.953", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with XANTHINES", "MS": "Compounds with three aromatic rings in linear arrangement with an OXYGEN in the center ring.", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014966"}, {"RECTYPE": "D", "MH": "Xanthine Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidoreductase, Xanthine", "MN": "D08.811.682.047.892", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Xanthine:NAD+ oxidoreductase", "RN": "EC 1.17.1.4", "PI": "Xanthines (1973-1974)", "MS": "An enzyme that catalyzes the oxidation of XANTHINE in the presence of NAD+ to form URIC ACID and NADH. It acts also on a variety of other purines and aldehydes.", "PM": "91; was see under KETONE OXIDOREDUCTASES 1975-90", "HN": "91(75); was see under KETONE OXIDOREDUCTASES 1975-90", "MR": "20070709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D014968"}, {"RECTYPE": "D", "MH": "Xanthine Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hypoxanthine Oxidase|T116|T126|NON|EQV|NLM (1992)|910326|abbcdef", "ENTRY": "Purine Xanthine Oxidase", "MN": "D08.811.682.047.928", "MH_TH": "NLM (1965)", "ST": "T126", "N1": "Xanthine:oxygen oxidoreductase", "RN": "EC 1.17.3.2", "AN": "/defic: consider also XANTHINES /urine (IM) + PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS (IM)", "MS": "An iron-molybdenum flavoprotein containing FLAVIN-ADENINE DINUCLEOTIDE that oxidizes hypoxanthine, some other purines and pterins, and aldehydes. Deficiency of the enzyme, an autosomal recessive trait, causes xanthinuria.", "PM": "65", "HN": "65", "MR": "20070709", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D014969"}, {"RECTYPE": "D", "MH": "Xanthines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.759.758.824", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "AN": "do not confuse with XANTHENES; XANTHINE is also available", "MS": "Purine bases found in body tissues and fluids and in some plants.", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014970"}, {"RECTYPE": "D", "MH": "Xanthinol Niacinate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Xantinol Nicotinate|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|890627|abbcdeef", "ENTRY": "Nicotinate, Xantinol", "MN": "D03.633.100.759.758.824.751.950", "PA": "Vasodilator Agents", "MH_TH": "USAN (1963)", "ST": "T121", "N1": "3-Pyridinecarboxylic acid, compd. with 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)-1,3-dimethyl-1H-purine-2,6-dione (1:1)", "RN": "8G60H12X2D", "RR": "437-74-1 (Xanthinol Niacinate)", "PI": "Theophylline (1969-1974)", "MS": "A vasodilator used in peripheral vascular disorders and insufficiency. It may cause gastric discomfort and hypotension.", "PM": "91; was see under THEOPHYLLINE 1975-90", "HN": "91(75); was see under THEOPHYLLINE 1975-90", "MR": "20170524", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014971"}, {"RECTYPE": "D", "MH": "Xanthogranuloma, Juvenile", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Xanthoma, Juvenile|T047|NON|EQV|NLM (1992)|900905|abcdef", "ENTRY": "Xanthomas, Juvenile", "MN": "C17.800.973", "MH_TH": "NLM (1963)", "ST": "T047", "AN": "non-neoplastic", "MS": "Benign disorder of infants and children caused by proliferation of HISTIOCYTES, macrophages found in tissues. These histiocytes, usually lipid-laden non-Langerhans cells, form multiple yellow-red nodules most often in the skin, the eye, and sometimes in the viscera. Patients appear to have normal lipid metabolism and are classified as a normolipemic non-Langerhans cell histiocytosis.", "OL": "use XANTHOGRANULOMA, JUVENILE to search XANTHOMA, JUVENILE 1966-91", "PM": "92; was XANTHOMA, JUVENILE 1967-91; XANTHOGRANULOMA, JUVENILE was see XANTHOMA, JUVENILE 1979-91", "HN": "92; was XANTHOMA, JUVENILE 1963-91 (Prov 1963-66); XANTHOGRANULOMA, JUVENILE was see XANTHOMA, JUVENILE 1979-91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19990101", "DC": "1", "DX": "19670101", "UI": "D014972"}, {"RECTYPE": "D", "MH": "Xanthomatosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Xanthoma|T047|NON|NRW|NLM (1998)|960711|abcdef", "ENTRY": "Xanthomatoses", "MN": "C18.452.584.750", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "non-neoplastic; coordinate IM with organ/disease term (IM); xanthogranuloma goes here (IM) + GRANULOMA (IM) but note XANTHOGRANULOMA, JUVENILE is available", "MS": "A condition marked by the development of widespread xanthomas, yellow tumor-like structures filled with lipid deposits. Xanthomas can be found in a variety of tissues including the SKIN; TENDONS; joints of KNEES and ELBOWS. Xanthomatosis is associated with disturbance of LIPID METABOLISM and formation of FOAM CELLS.", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014973"}, {"RECTYPE": "D", "MH": "Xanthomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Xanthomonas albilineans|T007|NON|NRW|NLM (2004)|030110|abcdef", "MN": "B03.660.250.915.930", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid338", "RR": "txid29447", "MS": "A genus in the family XANTHOMONADACEAE whose cells produce a yellow pigment (Gr. xanthos - yellow). It is pathogenic to plants.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014974"}, {"RECTYPE": "D", "MH": "Lutein", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Lutein, gamma", "MN": "D23.767.261.887.500", "MH_TH": "UNK (19XX)", "ST": "T123", "N1": "beta,epsilon-Carotene-3,3'-diol, (3R,3'R,6'R)-", "RN": "X72A60C9MT", "RR": "127-40-2 (Lutein)", "MS": "A xanthophyll found in the major LIGHT-HARVESTING PROTEIN COMPLEXES of plants. Dietary lutein accumulates in the MACULA LUTEA.", "PM": "2002; see XANTHOPHYLL 1966-2001", "HN": "2002(1966)", "MR": "20140606", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014975"}, {"RECTYPE": "D", "MH": "Xanthopterin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.767.831.742", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "4,6-Pteridinedione, 2-amino-1,5-dihydro-", "RN": "V66551EU1R", "RR": "119-44-8 (Xanthopterin)", "AN": "a pigment", "MS": "2-Amino-1,5-dihydro-4,6-pteridinedione. Pigment first discovered in butterfly wings and widely distributed in plants and animals.", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014976"}, {"RECTYPE": "D", "MH": "Xanthurenates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.066.942", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "MR": "19920520", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014977"}, {"RECTYPE": "D", "MH": "Xenon", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.362.641.918", "PA": "Anesthetics, Inhalation", "FX": "Xenon Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Xenon", "RN": "3H3U766W84", "RR": "7440-63-3 (Xenon)", "MS": "A noble gas with the atomic symbol Xe, atomic number 54, and atomic weight 131.30. It is found in the earth's atmosphere and has been used as an anesthetic.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014978"}, {"RECTYPE": "D", "MH": "Xenon Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Xenon", "MN": "D01.496.920", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "PI": "Xenon (1966-1974)", "MS": "Stable xenon atoms that have the same atomic number as the element xenon, but differ in atomic weight. Xe-124, 126, 128-131, 134, and 136 are stable xenon isotopes.", "PM": "75", "HN": "75", "MR": "20170425", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D014979"}, {"RECTYPE": "D", "MH": "Xenon Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Xenon", "MN": "D01.496.920.700", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Xenon (1966-1974)", "MS": "Unstable isotopes of xenon that decay or disintegrate emitting radiation. Xe atoms with atomic weights 121-123, 125, 127, 133, 135, 137-145 are radioactive xenon isotopes.", "PM": "75", "HN": "75", "MR": "20170425", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D014980"}, {"RECTYPE": "D", "MH": "Xenopus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.090.180.610.500", "FX": "Xenopus Proteins", "MH_TH": "NLM (1972)", "ST": "T011", "RN": "txid8353", "AN": "NIM when experimental animal", "PI": "Anura (1966-1971)", "MS": "An aquatic genus of the family, Pipidae, occurring in Africa and distinguished by having black horny claws on three inner hind toes.", "PM": "72", "HN": "72", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014981"}, {"RECTYPE": "D", "MH": "Xenopus laevis", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Platanna|T011|NON|EQV|UNK (19XX)|800513|abcdef", "ENTRY": "X. laevi", "MN": "B01.050.150.900.090.180.610.500.562", "FX": "Xenopus Proteins", "MH_TH": "NLM (1981)", "ST": "T011", "RN": "txid8355", "AN": "NIM with no qualifiers when an experimental animal", "PI": "Xenopus (1972-1980)", "MS": "The commonest and widest ranging species of the clawed \"frog\" (Xenopus) in Africa. This species is used extensively in research. There is now a significant population in California derived from escaped laboratory animals.", "PM": "81", "HN": "81", "MR": "20200813", "DA": "19800513", "DC": "1", "DX": "19810101", "UI": "D014982"}, {"RECTYPE": "D", "MH": "Xeroderma Pigmentosum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Kaposi Disease|T191|EPO|EQV|UNK (19XX)|740330|KAPOSI DIS|abcdefv", "ENTRY": "Kaposis Disease", "MN": "C18.452.284.975", "MH_TH": "NLM (1966)", "ST": "T191", "AN": "if non-neoplastic, coordinate IM with precoordinated organ/disease term (IM); if neoplastic, coordinate IM with organ/neoplasm term (IM); do not confuse KAPOSI DISEASE with SARCOMA, KAPOSI", "MS": "A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.", "PM": "63; KAPOSI DISEASE was KAPOSI'S DISEASE 1963-97", "HN": "63; KAPOSI DISEASE was KAPOSI'S DISEASE 1963-97", "CATSH": "CAT LIST", "MR": "20170707", "DA": "19990101", "DC": "1", "DX": "19630101", "UI": "D014983"}, {"RECTYPE": "D", "MH": "Xeromammography", "DE": "XEROMAMMOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Xeroradiography, Breast|T060|NON|EQV|UNK (19XX)|760427|XERORADIOGR BREAST|abcdefv", "MN": "E01.370.350.700.975.975", "MH_TH": "NLM (1977)", "ST": "T060", "PI": "Xeroradiography (1968-1976)", "MS": "Xeroradiography of the breast.", "PM": "91; was see under MAMMOGRAPHY 1977-90", "HN": "91(77); was see under MAMMOGRAPHY 1977-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19760427", "DC": "1", "DX": "19910101", "UI": "D014984"}, {"RECTYPE": "D", "MH": "Xerophthalmia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Xerophthalmias", "MN": "C11.496.260.892", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "dryness of the eyes; do not restrict to the xerosis of vit A defic: use for any cause; do not confuse with DRY EYE SYNDROMES", "MS": "Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014985"}, {"RECTYPE": "D", "MH": "Xeroradiography", "DE": "XERORADIOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Xeroradiographies", "MN": "E01.370.350.700.975", "MH_TH": "NLM (1967)", "ST": "T060", "PI": "specific radiography heading (1966)", "MS": "A photoelectric method of recording an X-ray image on a coated metal plate, using low-energy photon beams, long exposure time and dry chemical developers.", "PM": "73", "HN": "73(67)", "CATSH": "CAT LIST", "MR": "20160311", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D014986"}, {"RECTYPE": "D", "MH": "Xerostomia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mouth Dryness|T047|NON|EQV|UNK (19XX)|760422|abcdef", "ENTRY": "Xerostomias", "MN": "C07.465.815.929", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "decreased saliva flow", "MS": "Decreased salivary flow.", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014987"}, {"RECTYPE": "D", "MH": "Xipamide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Xipamid|T109|T121|NON|EQV|UNK (19XX)|760414|abbcdef", "MN": "D02.886.590.700.975", "PA": "Diuretics", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "Benzamide, 5-(aminosulfonyl)-4-chloro-N-(2,6-dimethylphenyl)-2-hydroxy-", "RN": "4S9EY0NUEC", "RR": "14293-44-8 (Xipamide)", "PI": "Xylenes (1974-1975)", "MS": "A sulfamoylbenzamide analog of CLOPAMIDE. It is diuretic and saluretic with antihypertensive activity. It is bound to PLASMA PROTEINS, thus has a delayed onset and prolonged action.", "PM": "91; was see under DIURETICS, SULFAMYL 1977-90", "HN": "91(77); was see under DIURETICS, SULFAMYL 1977-90", "MR": "20130708", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D014988"}, {"RECTYPE": "D", "MH": "Xiphoid Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Xiphoid Processes", "MN": "A02.835.232.570.750.825", "MH_TH": "NLM (1975)", "ST": "T023", "MS": "The smallest and most inferior triangular protrusion of the STERNUM or breastbone that extends into the center of the RIBCAGE.", "OL": "search STERNUM 1966-74", "PM": "91; was see under STERNUM 1975-90", "HN": "91(75); was see under STERNUM 1975-90", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D014989"}, {"RECTYPE": "D", "MH": "Xylans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Xylan|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D09.698.925", "MH_TH": "NLM (1975)", "ST": "T109", "RN": "0", "PI": "Polysaccharides (1966-1974)", "MS": "Polysaccharides consisting of xylose units.", "OL": "to search XYLAN use CELLULOSE 1966-74", "PM": "91; was see under POLYSACCHARIDES 1975-90; was XYLAN see under CELLULOSE 1963-74", "HN": "91(75); was see under POLYSACCHARIDES 1975-90; was XYLAN see under CELLULOSE 1963-74", "MR": "20200527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014990"}, {"RECTYPE": "D", "MH": "Xylazine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "BAYVa 1470", "MN": "D03.383.855.985", "PA": "Muscle Relaxants, Central", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4H-1,3-Thiazin-2-amine, N-(2,6-dimethylphenyl)-5,6-dihydro-", "RN": "2KFG9TP5V8", "RR": "NGC3S0882S", "PI": "Xylene (1971-1974)", "MS": "An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.", "PM": "91; see THIAZINES 1975-90", "HN": "91(75)", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014991"}, {"RECTYPE": "D", "MH": "Xylenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Xylene|T109|T130|NON|NRW|UNK (19XX)|760905|abbcdef", "MN": "D02.455.426.559.389.948", "MH_TH": "NLM (1966)", "ST": "T130", "RN": "0", "MS": "A family of isomeric, colorless aromatic hydrocarbon liquids, that contain the general formula C6H4(CH3)2. They are produced by the destructive distillation of coal or by the catalytic reforming of petroleum naphthenic fractions. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "OL": "use XYLENES to search XYLENE 1966-74", "PM": "75; was XYLENE 1963-74", "HN": "75; was XYLENE 1963-74", "MR": "20040803", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D014992"}, {"RECTYPE": "D", "MH": "Xylitol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.853.936", "PA": "Sweetening Agents", "MH_TH": "NLM (1963)", "ST": "T121", "N1": "Xylitol", "RN": "VCQ006KQ1E", "RR": "87-99-0 (Xylitol)", "MS": "A five-carbon sugar alcohol derived from XYLOSE by reduction of the carbonyl group. It is as sweet as sucrose and used as a noncariogenic sweetener.", "PM": "72", "HN": "72(63)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D014993"}, {"RECTYPE": "D", "MH": "Xylose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "D Xylose", "MN": "D09.947.875.627.867", "MH_TH": "USP (19XX)", "ST": "T123", "RN": "A1TA934AKO", "MR": "20170410", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014994"}, {"RECTYPE": "D", "MH": "Xylosidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Xylobiases|T116|T126|NON|EQV|UNK (19XX)|770329|abbcdef", "ENTRY": "Hydrolases, Xylan", "MN": "D08.811.277.450.950", "MH_TH": "NLM (1978)", "ST": "T126", "RN": "EC 3.2.1.-", "PI": "Glycoside Hydrolases (1966-1977)", "MS": "A group of enzymes that catalyze the hydrolysis of alpha- or beta-xylosidic linkages. EC 3.2.1.8 catalyzes the endo-hydrolysis of 1,4-beta-D-xylosidic linkages; EC 3.2.1.32 catalyzes the endo-hydrolysis of 1,3-beta-D-xylosidic linkages; EC 3.2.1.37 catalyzes the exo-hydrolysis of 1,4-beta-D-linkages from the non-reducing termini of xylans; and EC 3.2.1.72 catalyzes the exo-hydrolysis of 1,3-beta-D-linkages from the non-reducing termini of xylans. Other xylosidases have been identified that catalyze the hydrolysis of alpha-xylosidic bonds.", "PM": "91; was see under GLYCOSIDE HYDROLASES 1978-90", "HN": "91(78); was see under GLYCOSIDE HYDROLASES 1978-90", "MR": "20030709", "DA": "19770415", "DC": "1", "DX": "19910101", "UI": "D014995"}, {"RECTYPE": "D", "MH": "Xylulose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lyxulose|T109|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Xylulose, (L-threo)-Isomer|T109|NON|REL|NLM (1999)|990913|abcdef", "MN": "D09.947.875.627.885", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "threo-2-Pentulose", "RN": "5962-29-8", "RR": "551-84-8 ((D-threo)-isomer)", "PI": "Xylose (1974)", "MS": "A 5-carbon keto sugar.", "PM": "91; was see under PENTOSES 1975-90", "HN": "91(75); was see under PENTOSES 1975-90", "MR": "20170410", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D014996"}, {"RECTYPE": "D", "MH": "XYY Karyotype", "AQ": "BL CF CI CL DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT UR VE VI", "ENTRY": "XYY Karyotypes", "MN": "G05.365.590.175.815.970", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; check the tags HUMANS & MALE", "PI": "Sex Chromosome Abnormalities (1968-1977)", "MS": "Abnormal genetic constitution in males characterized by an extra Y chromosome.", "PM": "91; was see under SEX CHROMOSOME ABNORMALITIES 1978-90", "HN": "91(78); was see under SEX CHROMOSOME ABNORMALITIES 1978-90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D014997"}, {"RECTYPE": "D", "MH": "Y Chromosome", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "ENTRY": "Y Chromosomes", "MN": "G05.360.162.865.983", "MH_TH": "NLM (1978)", "ST": "T026", "AN": "abnormalities; coordinate IM with SEX CHROMOSOME ABERRATIONS (IM) or specific disease (IM) + SEX CHROMOSOME ABERRATIONS (NIM); Y CHROMOSOME, HUMAN is also available", "PI": "Sex Chromosomes (1968-1977)", "MS": "The male sex chromosome, being the differential sex chromosome carried by half the male gametes and none of the female gametes in humans and in some other male-heterogametic species in which the homologue of the X chromosome has been retained.", "OL": "search SEX CHROMOSOMES 1968-77", "PM": "84; was see under SEX CHROMOSOMES 1968-83", "HN": "84(78); was see under SEX CHROMOSOMES 1968-83", "MR": "20080708", "DA": "19770429", "DC": "1", "DX": "19840101", "UI": "D014998"}, {"RECTYPE": "D", "MH": "Yaba monkey tumor virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Yaba Virus|T005|EPO|EQV|NLM (1994)|930309|abcdef", "MN": "B04.613.204.950.950", "MH_TH": "NLM (1964)", "ST": "T005", "RN": "txid38804", "AN": "infection: coord IM with POXVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "MS": "The type species of YATAPOXVIRUS, a tumor-producing DNA virus discovered in monkeys in Yaba, Nigeria. It has been found to produce histiocytomas in monkeys and humans.", "OL": "use YABA MONKEY TUMOR VIRUS to search YABA VIRUS 1966-93", "PM": "94; was YABA VIRUS 1966-93 (see under POXVIRIDAE 1990)", "HN": "94; was YABA VIRUS 1964-93 (see under POXVIRIDAE 1990, Prov 1964-65)", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D014999"}, {"RECTYPE": "D", "MH": "Yawning", "AQ": "DE ES GE IM PH RE", "ENTRY": "Yawnings", "MN": "G09.772.982", "MH_TH": "NLM (1987)", "ST": "T184", "MS": "An involuntary deep INHALATION with the MOUTH open, often accompanied by the act of stretching.", "PM": "87", "HN": "87", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19860418", "DC": "1", "DX": "19870101", "UI": "D015000"}, {"RECTYPE": "D", "MH": "Yaws", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Frambesia|T047|NON|EQV|ORD (2010)|UNK (19XX)|740330|abcdeef", "ENTRY": "Frambesias", "MN": "C17.800.838.765.910", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "MS": "A systemic non-venereal infection of the tropics caused by TREPONEMA PALLIDUM subspecies pertenue.", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015001"}, {"RECTYPE": "D", "MH": "Yeast, Dried", "AQ": "AD AE AG AI AN BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Yeast, Nutritional|T123|T168|NON|EQV|NLM (2003)|020612|abbcdef", "ENTRY": "Nutritional Yeast", "MN": "J02.500.456.933", "MH_TH": "NLM (1966)", "ST": "T168", "AN": "when brewer's or baker's yeast is given as therapy, index here; when the yeast is the source of matter in enzyme or other metab studies, index as SACCHAROMYCES CEREVISIAE", "MS": "The dry cells of any suitable strain of SACCHAROMYCES CEREVISIAE or CANDIDA. It can be obtained as a by-product from the brewing of beer or by growing on media not suitable for beer production. Dried yeast serves as a source of protein and VITAMIN B COMPLEX.", "MR": "20141014", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015002"}, {"RECTYPE": "D", "MH": "Yeasts", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Yeast", "MN": "B01.300.930", "FX": "Fungal Proteins", "MH_TH": "NLM (1966)", "ST": "T004", "MS": "A general term for single-celled rounded fungi that reproduce by budding. Brewers' and bakers' yeasts are SACCHAROMYCES CEREVISIAE; therapeutic dried yeast is YEAST, DRIED.", "MR": "20200902", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015003"}, {"RECTYPE": "D", "MH": "Yellow Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Yellow Fevers", "MN": "C01.925.782.417.881", "MH_TH": "POPLINE (1994)", "ST": "T047", "MS": "An acute infectious disease primarily of the tropics, caused by a virus and transmitted to man by mosquitoes of the genera Aedes and Haemagogus. The severe form is characterized by fever, HEMOLYTIC JAUNDICE, and renal damage.", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015004"}, {"RECTYPE": "D", "MH": "Yellow fever virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.578.344.350.990", "MH_TH": "NLM (1966)", "ST": "T005", "RN": "txid11089", "MS": "The type species of the FLAVIVIRUS genus. Principal vector transmission to humans is by AEDES spp. mosquitoes.", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015005"}, {"RECTYPE": "D", "MH": "Yemen", "AQ": "EH EP", "PRINT ENTRY": "South Yemen|T083|NAM|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Republic of Yemen|T083|NON|EQV|NLM (2018)|161223|abcdef", "MN": "Z01.252.245.500.950", "MH_TH": "NLM (1996)", "ST": "T083", "MS": "A country in the Middle East, bordering the Arabian Sea, Gulf of Aden, and Red Sea, between Oman and Saudi Arabia. The capital is Sanaa.", "MR": "20161226", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D015006"}, {"RECTYPE": "D", "MH": "Yersinia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.950", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid629", "MS": "A genus of gram-negative, facultatively anaerobic rod- to coccobacillus-shaped bacteria that occurs in a broad spectrum of habitats.", "OL": "search PASTEURELLA 1972-74", "PM": "75; was see under PASTEURELLA 1972-74", "HN": "75; was see under PASTEURELLA 1972-74", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19750101", "UI": "D015007"}, {"RECTYPE": "D", "MH": "Yersinia enterocolitica", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Bacterium enterocoliticum|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.150.950.160", "MH_TH": "NLM (1983)", "ST": "T007", "RN": "txid630", "AN": "infection: coord IM with YERSINIA INFECTIONS (IM)", "PI": "Yersinia (1975-1982)", "MS": "A species of the genus YERSINIA, isolated from both man and animal. It is a frequent cause of bacterial gastroenteritis in children.", "PM": "83", "HN": "83", "MR": "20200206", "DA": "19820428", "DC": "1", "DX": "19830101", "UI": "D015008"}, {"RECTYPE": "D", "MH": "Yersinia Infections", "DE": "YERSINIA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Yersinia Infection|T047|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Yersinioses", "MN": "C01.150.252.400.310.980", "FX": "Arthritis, Reactive", "MH_TH": "NLM (1977)", "ST": "T047", "PI": "Pasteurella Infections (1966-1976)", "MS": "Infections with bacteria of the genus YERSINIA.", "PM": "77", "HN": "77", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19760416", "DC": "1", "DX": "19770101", "UI": "D015009"}, {"RECTYPE": "D", "MH": "Yersinia pestis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Yersinia pseudotuberculosis subsp. pestis|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.150.950.580", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid632", "MS": "The etiologic agent of PLAGUE in man, rats, ground squirrels, and other rodents.", "OL": "use YERSINIA PESTIS to search PASTEURELLA PESTIS 1966-75", "PM": "76; was PASTEURELLA PESTIS 1963-75", "HN": "76; was PASTEURELLA PESTIS 1963-75", "MR": "20200206", "DA": "19750723", "DC": "1", "DX": "19760101", "UI": "D015010"}, {"RECTYPE": "D", "MH": "Yersinia pseudotuberculosis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.950.590", "MH_TH": "NLM (1987)", "ST": "T007", "RN": "txid633", "PI": "Yersinia (1975-1986)", "MS": "A human and animal pathogen causing mesenteric lymphadenitis, diarrhea, and bacteremia.", "PM": "87", "HN": "87", "MR": "20200813", "DA": "19860618", "DC": "1", "DX": "19870101", "UI": "D015011"}, {"RECTYPE": "D", "MH": "Yersinia pseudotuberculosis Infections", "DE": "YERSINIA PSEUDOTUBERCULOSIS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pseudotuberculosis, Pasteurella|T047|NON|EQV|UNK (19XX)|760416|abcdef", "ENTRY": "Pseudotuberculoses, Pasteurella", "MN": "C01.150.252.400.310.980.780", "MH_TH": "NLM (1977)", "ST": "T047", "PI": "Pasteurella Infections (1966-1974)", "MS": "Infections with bacteria of the species YERSINIA PSEUDOTUBERCULOSIS.", "OL": "use YERSINIA PSEUDOTUBERCPLOSIS INFECTIONS to search PSEUDOTUBERCULOSIS, YERSINIA 1977-86 & PSEUDOTUBERCULOSIS INFECTIONS, YERSINIA 1987-93; use YERSINIA PSEUDOTUBERCULOSIS INFECTIONS to search PSEUDOTUBERCULOSIS, PASTEURELLA 1975-76, use PASTEURELLA INFECTIONS 1966-74", "PM": "91; was see under YERSINIA INFECTIONS 1987-90; was PSEUDOTUBERCULOSIS, YERSINIA 1977-86; was PSEUDOTUBERCULOSIS, PASTEURELLA see under PASTEURELLA INFECTIONS 1964-76, was see under PASTEURELLA 1963; TUBERCULOSIS INFECTIONS, YERSINIA was see YERSINIA PSEUDOTUBERCULOSIS INFECTIONS 1987-93", "HN": "91(87); was see under YERSINIA INFECTIONS 1987-90; was PSEUDOTUBERCULOSIS, YERSINIA 1977-86; was PSEUDOTUBERCULOSIS, PASTEURELLA see under PASTEURELLA INFECTIONS 1964-76, was see under PASTEURELLA 1963; PSEUDOTUBERCULOSIS INFECTIONS, YERSINIA was see YERSINIA PSEUDOTUBERCULOSIS INFECTIONS 1987-93", "CATSH": "CAT LIST", "MR": "20200128", "DA": "19760419", "DC": "1", "DX": "19910101", "UI": "D015012"}, {"RECTYPE": "D", "MH": "Yoga", "AQ": "HI PX", "MN": "K01.844.799.867", "FX": "Muscle Stretching Exercises", "MH_TH": "NLM (1966)", "ST": "T078", "AN": "IM; specify geog if pertinent", "MS": "A major orthodox system of Hindu philosophy based on Sankhya (metaphysical dualism) but differing from it in being theistic and characterized by the teaching of raja-yoga as a practical method of liberating the self. It includes a system of exercises for attaining bodily or mental control and well-being with liberation of the self and union with the universal spirit. (From Webster, 3d ed)", "MR": "20160531", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015013"}, {"RECTYPE": "D", "MH": "Yogurt", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Yoghurt|T168|NON|EQV|NLM (1998)|970220|abcdef", "MN": "J02.500.350.300.888", "MH_TH": "NLM (1978)", "ST": "T168", "PI": "Dairy Products (1966-1977)", "MS": "A slightly acid milk food produced by fermentation due to the combined action of Lactobacillus acidophilus and Streptococcus thermophilus.", "PM": "91; was see under DAIRY PRODUCTS 1978-90", "HN": "91(78); was see under DAIRY PRODUCTS 1978-90", "MR": "20210707", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D015014"}, {"RECTYPE": "D", "MH": "Yohimbine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rauwolscine|T109|T121|NON|REL|UNK (19XX)|850605|abbcdef", "ENTRY": "Tartrate, Corynanthine", "MN": "D03.633.100.496.500.500.681.933", "PA": "Urological Agents", "MH_TH": "NLM (1966)", "ST": "T121", "N1": "Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16alpha,17alpha)-", "RN": "2Y49VWD90Q", "RR": "NB2E1YP49F", "MS": "A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION.", "OL": "use YOHIMBINE /analogs & derivatives to search YOHIMBINE DERIVATIVES, CORYNANTHINE, & RAUWOLSCINE 1975-77; use YOHIMBANS 1969-74", "PM": "CORYNANTHIDINE, RAUWOLSCINE & YOHIMBINE DERIVATIVES were see under YOHIMBINE 1975-77, were see under YOHIMBANS 1969-74", "HN": "YOHIMBINE DERIVATIVES was see under YOHIMBINE 1975-77, was see under YOHIMBANS 1969-74", "MR": "20200527", "DA": "19990101", "DC": "1", "DX": "19600101", "UI": "D015016"}, {"RECTYPE": "D", "MH": "Yolk Sac", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Yolk Sacs", "MN": "A16.331.800", "MH_TH": "NLM (1978)", "ST": "T018", "PI": "Vitelline Membrane (1966-1974)", "MS": "The first of four extra-embryonic membranes to form during EMBRYOGENESIS. In REPTILES and BIRDS, it arises from endoderm and mesoderm to incorporate the EGG YOLK into the DIGESTIVE TRACT for nourishing the embryo. In placental MAMMALS, its nutritional function is vestigial; however, it is the source of INTESTINAL MUCOSA; BLOOD CELLS; and GERM CELLS. It is sometimes called the vitelline sac, which should not be confused with the VITELLINE MEMBRANE of the egg.", "OL": "search VITELLINE MEMBRANE 1973-77", "PM": "78; was see VITELLINE MEMBRANE 1973-77", "HN": "78; was see VITELLINE MEMBRANE 1973-77", "MR": "20070711", "DA": "19770513", "DC": "1", "DX": "19780101", "UI": "D015017"}, {"RECTYPE": "D", "MH": "Ytterbium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.399.992", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Ytterbium", "RN": "MNQ4O4WSI1", "RR": "7440-64-4 (Ytterbium)", "MS": "An element of the rare earth family of metals. It has the atomic symbol Yb, atomic number 70, and atomic weight 173. Ytterbium has been used in lasers and as a portable x-ray source.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015018"}, {"RECTYPE": "D", "MH": "Yttrium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.550.975", "FX": "Yttrium Radioisotopes", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Yttrium", "RN": "58784XQC3Y", "RR": "7440-65-5 (Yttrium)", "MS": "An element of the rare earth family of metals. It has the atomic symbol Y, atomic number 39, and atomic weight 88.91. In conjunction with other rare earths, yttrium is used as a phosphor in television receivers and is a component of the yttrium-aluminum garnet (YAG) lasers.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015019"}, {"RECTYPE": "D", "MH": "Yttrium Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Yttrium", "MN": "D01.552.550.975.500", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable yttrium atoms that have the same atomic number as the element yttrium, but differ in atomic weight. Y-89 is the only naturally occurring stable isotope of yttrium.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015020"}, {"RECTYPE": "D", "MH": "Yttrium Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Yttrium", "MN": "D01.552.550.975.500.800", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Yttrium Isotopes (1966-1974)", "MS": "Unstable isotopes of yttrium that decay or disintegrate emitting radiation. Y atoms with atomic weights 82-88 and 90-96 are radioactive yttrium isotopes.", "OL": "search YTTRIUM ISOTOPES 1966-74", "PM": "75", "HN": "75", "MR": "20170425", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D015021"}, {"RECTYPE": "D", "MH": "Yugoslavia", "AQ": "EH EP", "PRINT ENTRY": "Vojvodina|T083|NAM|NRW|NLM (1994)|930310|abcdef", "MN": "Z01.586.980", "MH_TH": "NLM (1978)", "ST": "T083", "MS": "Created as the Kingdom of Serbs, Croats, and Slovenes in 1918. Yugoslavia became the official name in 1929. BOSNIA-HERZEGOVINA; CROATIA; and SLOVENIA formed independent countries 7 April 1992. Macedonia became independent 8 February 1994 as the Former Yugoslav Republic of Macedonia (MACEDONIA REPUBLIC).", "MR": "20130708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D015022"}, {"RECTYPE": "D", "MH": "Democratic Republic of the Congo", "AQ": "EH EP", "PRINT ENTRY": "Zaire|T083|NAM|EQV|NLM (1998)|970527|abcdef", "MN": "Z01.058.290.100.220", "MH_TH": "NLM (1998)", "ST": "T083", "MS": "A republic in central Africa, east of the REPUBLIC OF THE CONGO, south of the CENTRAL AFRICAN REPUBLIC and north of ANGOLA and ZAMBIA. The capital is Kinshasa.", "HN": "98(74)", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19980101", "UI": "D015023"}, {"RECTYPE": "D", "MH": "Zambia", "AQ": "EH EP", "PRINT ENTRY": "Rhodesia, Northern|T083|NAM|EQV|NLM (1994)|920911|abcdef", "ENTRY": "Republic of Zambia|T083|NAM|EQV|NLM (2009)|080701|abcdef", "MN": "Z01.058.290.175.920", "MH_TH": "POPLINE (1978)", "ST": "T083", "MS": "A republic in southern Africa, south of DEMOCRATIC REPUBLIC OF THE CONGO and TANZANIA, and north of ZIMBABWE. Its capital is Lusaka. It was formerly called Northern Rhodesia.", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19660101", "UI": "D015024"}, {"RECTYPE": "D", "MH": "Zearalenone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "F-2 Toxin|T109|T125|T131|NON|EQV|UNK (19XX)|800520|F A 02 TOXIN|abbbcdefs", "ENTRY": "Toxin, F2", "MN": "D23.946.587.989", "PA": "Estrogens, Non-Steroidal", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-, (S-(E))-", "RN": "5W827M159J", "RR": "17924-92-4 (Zearalenone)", "AN": "a mycotoxin & non-steroidal estrogen; do not confuse with zearalanone (index under ZEARALENONE /analogs)", "PI": "Resorcinols (1966-1974)", "MS": "(S-(E))-3,4,5,6,8,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione. One of a group of compounds known under the general designation of resorcylic acid lactones. Cis, trans, dextro and levo forms have been isolated from the fungus Gibberella zeae (formerly Fusarium graminearum). They have estrogenic activity, cause toxicity in livestock as feed contaminant, and have been used as anabolic or estrogen substitutes.", "PM": "91; was see under RESORCINOLS 1975-90", "HN": "91(75); was see under RESORCINOLS 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D015025"}, {"RECTYPE": "D", "MH": "Zeatin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.633.100.759.138.525.700", "PA": "Plant Growth Regulators", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "2-Buten-1-ol, 2-methyl-4-(1H-purin-6-ylamino)-, (E)-", "RN": "7I6OOJ9GR6", "RR": "1637-39-4 (Zeatin)", "PI": "Purines (1973-1974)", "MS": "An aminopurine factor in plant extracts that induces cell division. (Grant & Hackh's Chemical Dict, 5th ed)", "PM": "91; was see under PURINES 1975-90", "HN": "91(75); was see under PURINES 1975-90", "MR": "20160601", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015026"}, {"RECTYPE": "D", "MH": "Zebrafish", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Danio rerio|T013|NON|EQV|NLM (2002)|000807|abcdef", "ENTRY": "danio, Zebra", "MN": "B01.050.150.900.493.200.244.828", "FX": "Zebrafish Proteins", "MH_TH": "NLM (1987)", "ST": "T013", "RN": "txid7955", "PI": "Fishes (1966-1986)", "MS": "An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. Zebrafish is a model organism for drug assay and cancer research.", "OL": "use ZEBRAFISH to search BRACHYDANIO 1987-93", "PM": "91; was see under CYPRINIDAE 1987-90; BRACHYDANIO was see ZEBRAFISH 1987-93", "HN": "91(87); was see under CYPRINIDAE 1987-90; BRACHYDANIO was see ZEBRAFISH 1987-93", "MR": "20200813", "DA": "19860415", "DC": "1", "DX": "19910101", "UI": "D015027"}, {"RECTYPE": "D", "MH": "Zein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.765.725.500.750", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Zeins", "RN": "9010-66-6", "MS": "A group of alcohol-soluble seed storage proteins from the endosperm of corn.", "MR": "20180702", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015028"}, {"RECTYPE": "D", "MH": "Zeranol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Zearalanol|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "P 1496", "MN": "D02.540.950.975", "PA": "Estrogens, Non-Steroidal", "MH_TH": "USAN (1969)", "ST": "T121", "N1": "1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-, (3S-(3R*,7S*))-", "RN": "76LO2L2V39", "RR": "26538-44-3 (Zeranol)", "PI": "Resorcinols (1973-1974)", "MS": "A non-steroidal estrogen analog.", "PM": "91; was see under RESORCINOLS 1975-90", "HN": "91(75); was see under RESORCINOLS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015029"}, {"RECTYPE": "D", "MH": "Zimbabwe", "AQ": "EH EP", "PRINT ENTRY": "Southern Rhodesia|T083|NAM|EQV|NLM (1998)|970113|abcdef", "ENTRY": "Zimbabwe Rhodesia|T083|NAM|EQV|UNK (19XX)|800513|abcdef", "MN": "Z01.058.290.175.960", "MH_TH": "NLM (1981)", "ST": "T083", "MS": "A republic in southern Africa, east of ZAMBIA and BOTSWANA and west of MOZAMBIQUE. Its capital is Harare. It was formerly called Rhodesia and Southern Rhodesia.", "HN": "1981; was ZIMBABWE RHODESIA 1980, was RHODESIA 1967-1979, was RHODESIA-NYASALAND 1963-1966", "MR": "20080708", "DA": "19990101", "DC": "4", "DX": "19810101", "UI": "D015030"}, {"RECTYPE": "D", "MH": "Zimeldine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Zimelidine|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1993)|920309|abbcdeef", "ENTRY": "Hydrochloride, Zimelidine", "MN": "D03.383.725.620.129.960", "PA": "Selective Serotonin Reuptake Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Propen-1-amine, 3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridinyl)-, (Z)-", "RN": "3J928617DW", "RR": "56775-88-3 (Zimeldine)", "PI": "Pyridines (1966-1983)", "MS": "One of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS formerly used for depression but was withdrawn worldwide in September 1983 because of the risk of GUILLAIN-BARRE SYNDROME associated with its use. (From Martindale, The Extra Pharmacopoeia, 29th ed, p385)", "OL": "use ZIMELDINE to search ZIMELIDINE 1984-92", "PM": "93; was ZIMELIDINE 1984-92", "HN": "93; was ZIMELIDINE 1984-92", "MR": "20220715", "DA": "19830311", "DC": "1", "DX": "19840101", "UI": "D015031"}, {"RECTYPE": "D", "MH": "Zinc", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.940", "PA": "Trace Elements", "FX": "Zinc Radioisotopes", "MH_TH": "POPLINE (1978)", "ST": "T196", "RN": "J41CSQ7QDS", "RR": "7440-66-6 (Zinc)", "MS": "A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with ANEMIA, short stature, HYPOGONADISM, impaired WOUND HEALING, and geophagia. It is known by the symbol Zn.", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015032"}, {"RECTYPE": "D", "MH": "Zinc Isotopes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Isotopes, Zinc", "MN": "D01.552.544.940.500", "MH_TH": "NLM (1966)", "ST": "T196", "RN": "0", "MS": "Stable zinc atoms that have the same atomic number as the element zinc, but differ in atomic weight. Zn-66-68, and 70 are stable zinc isotopes.", "MR": "20170425", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015033"}, {"RECTYPE": "D", "MH": "Zinc Oxide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Paste, Lassar's", "MN": "D01.975.975", "PA": "Sunscreening Agents", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Zinc oxide (ZnO)", "RN": "SOI2LOH54Z", "RR": "1314-13-2 (Zinc Oxide)", "AN": "a dermatol agent", "PI": "Zinc (1966-1974)", "MS": "A mild astringent and topical protectant with some antiseptic action. It is also used in bandages, pastes, ointments, dental cements, and as a sunblock.", "PM": "91; was see under ZINC 1975-90", "HN": "91(75); was see under ZINC 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015034"}, {"RECTYPE": "D", "MH": "Zinc Oxide-Eugenol Cement", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Zinc Oxide Eugenol Cement", "MN": "J01.637.051.339.291.925", "MH_TH": "NLM (1965)", "ST": "T122", "RN": "0", "MS": "Used as a dental cement this is mainly zinc oxide (with strengtheners and accelerators) and eugenol. (Boucher's Clinical Dental Terminology, 4th ed, p50)", "PM": "65", "HN": "65", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D015035"}, {"RECTYPE": "D", "MH": "Zinc Phosphate Cement", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Cement, Zinc Phosphate", "MN": "J01.637.051.339.291.950", "MH_TH": "NLM (1965)", "ST": "T197", "N1": "Phosphoric acid, zinc salt (2:3)", "RN": "7779-90-0", "MS": "A material used for cementation of inlays, crowns, bridges, and orthodontic appliances and occasionally as a temporary restoration. It is prepared by mixing zinc oxide and magnesium oxide powders with a liquid consisting principally of phosphoric acid, water, and buffers. (From Bouchers' Clinical Dental Terminology, 3d ed)", "PM": "65", "HN": "65", "MR": "20060705", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D015036"}, {"RECTYPE": "D", "MH": "Zinc Radioisotopes", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Radioisotopes, Zinc", "MN": "D01.552.544.940.500.800", "MH_TH": "NLM (1975)", "ST": "T196", "RN": "0", "AN": "for routine use as tracer, use no qualifiers", "PI": "Zinc Isotopes (1966-1974)", "MS": "Unstable isotopes of zinc that decay or disintegrate emitting radiation. Zn atoms with atomic weights 60-63, 65, 69, 71, and 72 are radioactive zinc isotopes.", "OL": "search ZINC ISOTOPES 1966-74", "PM": "75", "HN": "75", "MR": "20170425", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D015037"}, {"RECTYPE": "D", "MH": "Zineb", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dithane Z78", "MN": "D02.886.706.250.950", "PA": "Fungicides, Industrial", "MH_TH": "NLM (1972)", "ST": "T131", "N1": "Zinc, ((1,2-ethanediylbis(carbamodithioato))(2-))-", "RN": "X1FSB1OZPT", "RR": "12122-67-7 (Zineb)", "PI": "Zinc (1966-1971)", "MS": "An agricultural fungicide of the dithiocarbamate class. It has relatively low toxicity and there is little evidence of human injury from exposure.", "PM": "91; was see under THIOCARBAMATES 1972-90", "HN": "91(72); was see under THIOCARBAMATES 1972-90", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D015038"}, {"RECTYPE": "D", "MH": "Ziram", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dimethyldithiocarbamate, Zinc", "MN": "D02.886.706.175.950", "PA": "Fungicides, Industrial", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Zinc, bis(dimethylcarbamodithioato-S,S')-, (T-4)-", "RN": "73D8UA974J", "RR": "137-30-4 (Ziram)", "PI": "Zinc (1969-1974)", "MS": "An industrial fungicide with low mammalian toxicity, although it does possess an irritant capacity for skin and mucous membranes.", "PM": "91; was see under THIOCARBAMATES 1975-90", "HN": "91(75); was see under THIOCARBAMATES 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015039"}, {"RECTYPE": "D", "MH": "Zirconium", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D01.552.544.950", "MH_TH": "NLM (1966)", "ST": "T196", "N1": "Zirconium", "RN": "C6V6S92N3C", "RR": "7440-67-7 (Zirconium)", "MS": "A rather rare metallic element with atomic number 40, atomic weight 91.224, and symbol Zr.", "MR": "20170705", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015040"}, {"RECTYPE": "D", "MH": "Zolazepam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Flupyrazapon|T109|T121|NON|NRW|UNK (19XX)|760414|abbcdef", "ENTRY": "Hydrochloride, Zolazepam", "MN": "D03.633.100.964", "PA": "GABA Modulators", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Pyrazolo(3,4-e)(1,4)diazepin-7(1H)-one, 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethyl-", "RN": "G1R474U58U", "RR": "45SJ093Q1N", "PI": "Pyrazoles (1974-1975)", "MS": "A pyrazolodiazepinone with pharmacological actions similar to ANTI-ANXIETY AGENTS. It is commonly used in combination with TILETAMINE to obtain immobilization and anesthesia in animals.", "PM": "91; was see under AZEPINES 1977-90", "HN": "91(77); was see under AZEPINES 1977-90", "MR": "20160601", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D015041"}, {"RECTYPE": "D", "MH": "Zollinger-Ellison Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Zollinger Ellison Syndrome", "MN": "C06.405.748.947", "FX": "Multiple Endocrine Neoplasia Type 1", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A syndrome that is characterized by the triad of severe PEPTIC ULCER, hypersecretion of GASTRIC ACID, and GASTRIN-producing tumors of the PANCREAS or other tissue (GASTRINOMA). This syndrome may be sporadic or be associated with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1.", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015043"}, {"RECTYPE": "D", "MH": "Zona Pellucida", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "MN": "A16.690.900", "MH_TH": "NLM (1975)", "ST": "T030", "MS": "A tough transparent membrane surrounding the OVUM. It is penetrated by the sperm during FERTILIZATION.", "PM": "91; was see under OVUM 1975-90", "HN": "91(75); was see under OVUM 1975-90", "MR": "20070709", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D015044"}, {"RECTYPE": "D", "MH": "Zoogloea", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Zooglea|T007|NON|EQV|UNK (19XX)|770819|abcdef", "MN": "B03.660.075.655.975", "MH_TH": "NLM (1972)", "ST": "T007", "RN": "txid349", "PI": "Bacteria (1966-1971)", "MS": "A genus of RHODOCYCLACEAE occurring as rod-shaped cells embedded in a gelatinous matrix. It includes Z. filipendula.", "OL": "use ZOOGLOEA to search ZOOGLEA 1972-78", "PM": "79,63-65; was ZOOGLEA 1972-78", "HN": "79,63-65; was ZOOGLEA 1972-78", "MR": "20200813", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D015045"}, {"RECTYPE": "D", "MH": "Zoology", "DE": "ZOOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.158.273.943", "FX": "Animal Population Groups", "MH_TH": "NLM (1966)", "ST": "T091", "AN": "use for the discipline (education, history, etc) only", "MS": "The study of animals - their morphology, growth, distribution, classification, and behavior.", "MR": "20090706", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015046"}, {"RECTYPE": "D", "MH": "Zoonoses", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Zoonotic Spillover|T047|NON|NRW|NLM (2021)|200616|abcdef", "ENTRY": "Zoonotic Spillovers", "MN": "C22.969", "FX": "Disease Reservoirs", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "not a routine coordinate for every zoonotic disease; index only when discussed; coordinate with specific infection term and with animal disease term if pertinent", "MS": "Diseases of non-human animals that may be transmitted to HUMANS or may be transmitted from humans to non-human animals.", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015047"}, {"RECTYPE": "D", "MH": "Zooplankton", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B05.080.500.980", "MH_TH": "NLM (1971)", "ST": "T204", "AN": "live in almost all natural waters", "PI": "Plankton (1966-1970)", "MS": "Minute free-floating animal organisms which live in practically all natural waters.", "PM": "91; was see under PLANKTON 1971-90", "HN": "91(71); was see under PLANKTON 1971-90", "MR": "20120703", "DA": "19990101", "DC": "1", "DX": "19910101", "UI": "D015048"}, {"RECTYPE": "D", "MH": "Zoxazolamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.221.950", "PA": "Uricosuric Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Benzoxazolamine, 5-chloro-", "RN": "9DOW362Q29", "RR": "61-80-3 (Zoxazolamine)", "AN": "a uricosuric & central muscle relaxant", "MS": "A uricosuric and muscle relaxant. Zoxazolamine acts centrally as a muscle relaxant, but the mechanism of its action is not understood.", "MR": "20160601", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015049"}, {"RECTYPE": "D", "MH": "Zygoma", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Zygomatic Arch|T021|NON|REL|NLM (1993)|911010|abcdef", "ENTRY": "Zygomas", "MN": "A02.835.232.781.324.995", "MH_TH": "NLM (1966)", "ST": "T023", "MS": "Either of a pair of bones that form the prominent part of the CHEEK and contribute to the ORBIT on each side of the SKULL.", "MR": "20180629", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015050"}, {"RECTYPE": "D", "MH": "Zygomatic Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Zygomatic Fracture", "MN": "C26.915.300.425.500.950", "MH_TH": "NLM (1971)", "ST": "T037", "PI": "Fractures (1966-1970)", "MS": "Fractures of the zygoma.", "PM": "72", "HN": "72(71)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D015051"}, {"RECTYPE": "D", "MH": "Zygote", "AQ": "CH CL CY DE EN GD IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Ovum, Fertilized|T018|NON|EQV|NLM (1998)|970113|abcdef", "ENTRY": "Zygotes", "MN": "A16.950", "MH_TH": "NLM (1975)", "ST": "T018", "PI": "Ovum (1966-1974)", "MS": "The fertilized OVUM resulting from the fusion of a male and a female gamete.", "PM": "75", "HN": "75", "MR": "20020703", "DA": "19741111", "DC": "1", "DX": "19750901", "UI": "D015053"}, {"RECTYPE": "D", "MH": "Zymosan", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Zymosan A|T109|T123|NON|NRW|UNK (19XX)|831209|abbcdef", "MN": "D09.698.365.089.750", "MH_TH": "NLM (1966)", "ST": "T123", "N1": "Zymosans", "RN": "9010-72-4", "MR": "20160628", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015054"}, {"RECTYPE": "D", "MH": "1-Carboxyglutamic Acid", "DS": "CARBOXYGLUTAMIC ACID 01", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "gamma-Carboxyglutamic Acid|T116|T123|NON|EQV|NLM (1979)|780518|abbcdef", "ENTRY": "gamma Carboxyglutamic Acid", "MN": "D12.125.119.409.174", "MH_TH": "NLM (1979)", "ST": "T123", "N1": "1,1,3-Propanetricarboxylic acid, 3-amino-", "RN": "53445-96-8", "AN": "/biosyn /physiol permitted", "PI": "Glutamates (1966-1978)", "MS": "Found in various tissues, particularly in four blood-clotting proteins including prothrombin, in kidney protein, in bone protein, and in the protein present in various ectopic calcifications.", "PM": "87; was see under GLUTAMATES 1979-86", "HN": "87(79); was see under GLUTAMATES 1979-86", "MR": "20130708", "DA": "19780518", "DC": "1", "DX": "19870101", "UI": "D015055"}, {"RECTYPE": "D", "MH": "1-Methyl-3-isobutylxanthine", "DE": "MIBX", "DS": "METHYLISOBUTYLXANTHINE 01 03", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isobutyltheophylline|T109|T121|NON|EQV|UNK (19XX)|780309|abbcdef", "ENTRY": "3 Isobutyl 1 methylxanthine", "MN": "D03.633.100.759.758.824.751.500", "PA": "Phosphodiesterase Inhibitors", "MH_TH": "NLM (1979)", "ST": "T121", "N1": "1H-Purine-2,6-dione, 3,7-dihydro-1-methyl-3-(2-methylpropyl)-", "RN": "TBT296U68M", "RR": "28822-58-4 (1-Methyl-3-isobutylxanthine)", "PI": "Xanthines (1966-1978)", "MS": "A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES", "PM": "91; was see under THEOPHYLLINE 1979-90", "HN": "91(79); was see under THEOPHYLLINE 1979-90", "MR": "20160527", "DA": "19780309", "DC": "1", "DX": "19910101", "UI": "D015056"}, {"RECTYPE": "D", "MH": "1-Naphthylamine", "DS": "NAPHTHYLAMINE 01", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "alpha-Naphthylamine|T109|T131|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "alpha Naphthylamine", "MN": "D04.615.638.845", "PA": "Carcinogens", "MH_TH": "NLM (1976)", "ST": "T131", "N1": "1-Naphthalenamine", "RN": "9753I242R5", "RR": "134-32-7 (1-Naphthylamine)", "PI": "Naphthalenes (1969-1975)", "MS": "A suspected industrial carcinogen (and listed as such by OSHA). Its N-hydroxy metabolite is strongly carcinogenic and mutagenic.", "PM": "91; was see under NAPHTHALENES 1976-90", "HN": "91(76); was see under NAPHTHALENES 1976-90", "MR": "20130708", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D015057"}, {"RECTYPE": "D", "MH": "1-Naphthylisothiocyanate", "DS": "NAPHTHYLISOTHIOCYANATE 01", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "alpha-Naphthylisothiocyanate|T109|T130|T131|NON|EQV|UNK (19XX)|760517|abbbcdef", "ENTRY": "alpha Naphthylisothiocyanate", "MN": "D04.615.638.870", "MH_TH": "NLM (1976)", "ST": "T131", "N1": "Naphthalene, 1-isothiocyanato-", "RN": "551-06-4", "PI": "Thiocyanates (1972-1975)", "MS": "A tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. It may cause skin and kidney damage.", "OL": "use 1-NAPHTHYLISOTHIOCYANATE to search ALPHA-NAPHTHYLISOTHIOCYANATE 1976 & ANIT 1976-93", "PM": "91; was see under THIOCYANATES 1977-90; was ALPHA-NAPHTHYLISOTHIOCYANATE (see under THIOCYANATES 1976); ANIT was see 1-NAPHTHYLISOTHIOCYANATE 1976-93", "HN": "91(77); was see under THIOCYANATES 1977-90; was ALPHA-NAPHTHYLISOTHIOCYANATE (see under THIOCYANATES 1976); ANIT was see 1-NAPHTHYLISOTHIOCYANATE 1976-93", "MR": "20130709", "DA": "19750725", "DC": "1", "DX": "19910101", "UI": "D015058"}, {"RECTYPE": "D", "MH": "1-Sarcosine-8-Isoleucine Angiotensin II", "DE": "SAR ISO ANG", "DS": "SARCOSINEISOLEUCINEANGIOTENSIN 02 01 08", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "1-Sar-8-Ile Angiotensin II|T116|T121|EQV|UNK (19XX)|790628|SAR ILE ANGIOTENSIN 02 01 08|abbdefs", "ENTRY": "Angiotensin II, 1-Sarcosine-8-Isoleucine", "MN": "D23.469.050.050.050.725", "PA": "Antihypertensive Agents", "MH_TH": "NLM (1980)", "ST": "T121", "N1": "Angiotensin II, 1-(N-methylglycine)-8-L-isoleucine-", "RN": "9088-01-1", "PI": "Sarcosine (1968-1974)/analogs & derivatives (1975-1979)", "MS": "An ANGIOTENSIN II analog which acts as a highly specific inhibitor of ANGIOTENSIN TYPE 1 RECEPTOR.", "PM": "91; was see under ANGIOTENSIN II 1980-90", "HN": "91(80); was see under ANGIOTENSIN II 1980-90", "MR": "20140617", "DA": "19790525", "DC": "1", "DX": "19910101", "UI": "D015059"}, {"RECTYPE": "D", "MH": "1,2-Dipalmitoylphosphatidylcholine", "DE": "DPPC", "DS": "DIPALMITOYLPHOSPHATIDYLCHOLINE 0102", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dipalmitoyllecithin|T109|T121|NON|EQV|UNK (19XX)|860612|abbcdef", "ENTRY": "Phosphatidylcholine, Dipalmitoyl", "MN": "D10.570.755.375.760.400.800.224", "MH_TH": "NLM (1987)", "ST": "T121", "N1": "3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-((1-oxohexadecyl)oxy)-, inner salt, 4-oxide", "RN": "2644-64-6", "AN": "\"a major constituent of pulmonary surfactants\"; /biosyn /physiol permitted", "PI": "Surface-Active Agents (1966-1970)", "MS": "Synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of PULMONARY SURFACTANTS.", "OL": "search PULMONARY SURFACTANTS 1977-86", "PM": "87; was DIPALMITOYL PHOSPHATIDYLCHOLINE see PULMONARY SURFACTANT 1977-86", "HN": "87", "MR": "20170410", "DA": "19860612", "DC": "1", "DX": "19870101", "UI": "D015060"}, {"RECTYPE": "D", "MH": "1,4-alpha-Glucan Branching Enzyme", "DE": "GLUCAN BRANCHING ENZYME", "DS": "ALPHA GLUCAN BRANCHING ENZYME 01 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Q-Enzyme|T116|T126|NON|NRW|UNK (19XX)|750630|abbcdef", "ENTRY": "Q Enzyme", "MN": "D08.811.913.400.450.460.100", "MH_TH": "NLM (1976)", "ST": "T126", "N1": "1,4-alpha-D-Glucan:1,4-alpha-D-glucan 6-alpha-D-(1,4-alpha-D-glucano)-transferase", "RN": "EC 2.4.1.18", "RR": "9001-97-2 (CAS RN)", "PI": "specific polysaccharide (1973-1975)", "MS": "In glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. EC 2.4.1.18.", "PM": "91; was see under GLUCOSYLTRANSFERASES 1976-90", "HN": "91(76); was see under GLUCOSYLTRANSFERASES 1976-90", "MR": "20170410", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D015061"}, {"RECTYPE": "D", "MH": "11-Hydroxycorticosteroids", "DS": "HYDROXYCORTICOSTEROIDS A 11", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "11 Hydroxycorticosteroids", "MN": "D06.472.040.585.353", "MH_TH": "NLM (1973)", "ST": "T125", "RN": "0", "PI": "Glucocorticoids (1967-1971)", "MS": "A group of corticosteroids bearing a hydroxy group at the 11-position.", "PM": "73", "HN": "73(72)", "MR": "20050711", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D015062"}, {"RECTYPE": "D", "MH": "16,16-Dimethylprostaglandin E2", "DE": "DIMETHYLPGE2", "DS": "DIMETHYLPROSTAGLANDIN E 02 16 16", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "E2, 16,16-Dimethylprostaglandin", "MN": "D23.469.700.660.200", "PA": "Anti-Ulcer Agents", "MH_TH": "NLM (1980)", "ST": "T121", "N1": "Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-16,16-dimethyl-9-oxo-, (5Z,11alpha,13E,15R)-", "RN": "M790V82VAC", "RR": "39746-25-3 (16,16-Dimethylprostaglandin E2)", "PI": "Prostaglandins, Synthetic (1977)", "MS": "A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes the healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and growth of experimental tumors.", "OL": "use 16,16-DIMETHYLPROSTAGLANDIN E2 to search DIMETHYLDINOPROSTONE & 16,16-DIMETHYLPROSTAGLANDIN E2 METHYL ESTER 1980-93", "PM": "91; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; DIMETHYLDINOPROSTONE & 16,16-DIMETHYLPROSTAGLANDIN E2 METHYL ESTER were see 16,16-DIMETHYLPROSTAGLANDIN E2 1980-93", "HN": "91(80); was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; DIMETHYLDINOPROSTONE & 16,16-DIMETHYLPROSTAGLANDIN E2 METHYL ESTER were see 16,16-DIMETHYLPROSTAGLANDIN E2 1980-93", "MR": "20150608", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D015064"}, {"RECTYPE": "D", "MH": "17-Hydroxycorticosteroids", "DS": "HYDROXYCORTICOSTEROIDS A 17", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "17 Hydroxycorticosteroids", "MN": "D06.472.040.585.478", "MH_TH": "NLM (1965)", "ST": "T125", "RN": "0", "MS": "A group of hydroxycorticosteroids bearing a hydroxy group at the 17-position. Urinary excretion of these compounds is used as an index of adrenal function. They are used systemically in the free alcohol form, but with esterification of the hydroxy groups, topical effectiveness is increased.", "PM": "65", "HN": "65", "MR": "20050711", "DA": "19990101", "DC": "1", "DX": "19650101", "UI": "D015065"}, {"RECTYPE": "D", "MH": "17-Hydroxysteroid Dehydrogenases", "DS": "HYDROXYSTEROID DEHYDROGENASES 17", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Testosterone Dehydrogenases|T116|T126|NON|NRW|NLM (1994)|930218|abbcdef", "ENTRY": "Reductases, 17-Ketosteroid", "MN": "D08.811.682.047.436.375", "MH_TH": "NLM (1978)", "ST": "T126", "RN": "EC 1.1.-", "PI": "Hydroxysteroid Dehydrogenases (1966-1977)", "MS": "A class of enzymes that catalyzes the oxidation of 17-hydroxysteroids to 17-ketosteroids. EC 1.1.-.", "OL": "use 17-HYDROXYSTEROID DEHYDROGENASES to search TESTOSTERONE DEHYDROGENASES 1978-93", "PM": "78; TESTOSTERONE DEHYDROGENASES was heading 1978-93 (see under 17-HYDROXYSTEROID DEHYDROGENASES 1978-90)", "HN": "78; TESTOSTERONE DEHYDROGENASES was heading 1978-93 (see under 17-HYDROXYSTEROID DEHYDROGENASES 1978-90)", "MR": "20030709", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D015067"}, {"RECTYPE": "D", "MH": "17-Ketosteroids", "DS": "KETOSTEROIDS 17", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "17-Oxosteroids|T109|T121|T125|NON|EQV|UNK (19XX)|750101|OXOSTEROIDS 17|abbbcdefs", "ENTRY": "17 Oxosteroids", "MN": "D06.472.040.502", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "0", "AN": "adrenal cortex hormones", "MS": "Steroids that contain a ketone group at position 17.", "MR": "20160527", "DA": "19990101", "DC": "1", "DX": "19660101", "UI": "D015068"}, {"RECTYPE": "D", "MH": "18-Hydroxycorticosterone", "DS": "HYDROXYCORTICOSTERONE 18", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "18-Hydrocorticosterone|T109|T121|NON|EQV|UNK (19XX)|741111|HYDROCORTICOSTERONE 18|abbcdefs", "ENTRY": "Hydroxycorticosterone, 18", "MN": "D06.472.040.585.353.500", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "Pregn-4-ene-3,20-dione, 11,18,21-trihydroxy-, (11beta)-", "RN": "561-65-9", "PI": "Hydrocortisone (1973-1974)", "MS": "11 beta,18,21-Trihydroxypregn-4-ene-3,20-dione.", "PM": "91; was see under CORTICOSTERONE 1975-90", "HN": "91(75); was see under CORTICOSTERONE 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015069"}, {"RECTYPE": "D", "MH": "18-Hydroxydesoxycorticosterone", "DS": "HYDROXYDESOXYCORTICOSTERONE 18", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydroxydesoxycorticosterone, 18", "MN": "D06.472.040.585.611.400", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "PI": "Desoxycorticosterone (1973-1974)", "MS": "An analog of desoxycorticosterone which is substituted by a hydroxyl group at the C-18 position.", "PM": "1991; see DESOXYCORTICOSTERONE 1975-1990; 18-HYDROXY-11-DEOXYCORTICOSTERONE was indexed under 18-HYDROXYCORTICOSTERONE 2003-2004", "HN": "1991(1975); for 18-HYDROXY-11-DEOXYCORTICOSTERONE use 18-HYDROXYDESOXYCORTICOSTERONE (NM) 2003-2004", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015070"}, {"RECTYPE": "D", "MH": "19-Iodocholesterol", "DS": "IODOCHOLESTEROL 19", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "19 Iodocholesterol|T109|T130|NON|EQV|UNK (19XX)|780516|abbcdef", "MN": "D10.570.938.208.627", "MH_TH": "NLM (1979)", "ST": "T130", "N1": "Cholest-5-en-3-ol, 19-(iodo-125I)-, (3beta)-", "RN": "30461-91-7", "PI": "Iodine Radioisotopes (1966-1978)", "MS": "19-Iodocholest-5-en-3 beta-ol. A cholesterol derivative usually substituted with radioactive iodine in the 19 position. The compound is an adrenal cortex scanning agent used in the assessment of patients suspected of having Cushing's syndrome, hyperaldosteronism, pheochromocytoma and adrenal remnants following total adrenalectomy.", "PM": "91; was see under CHOLESTEROL 1979-90", "HN": "91(79); was see under CHOLESTEROL 1979-90", "MR": "20160527", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D015071"}, {"RECTYPE": "D", "MH": "2-Acetolactate Mutase", "DS": "ACETOLACTATE MUTASE 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Acetohydroxy Acid Reductoisomerase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Reductoisomerase, Acetohydroxy Acid", "MN": "D08.811.399.520.100", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "2-Acetolactate methylmutase", "RN": "EC 5.4.99.3", "PI": "Lactates (1973-1974)", "MS": "An enzyme involved in the biosynthesis of isoleucine and valine. It converts 2-acetolactate into 3-hydroxy-2-oxo-isovalerate. Also acts on 2-hydroxy-2-acetobutyrate to form 2-hydroxy-2-oxo-3-methylvalerate. EC 5.4.99.3.", "PM": "91; was see under ISOMERASES 1975-90", "HN": "91(75); was see under ISOMERASES 1975-90", "MR": "20030709", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015072"}, {"RECTYPE": "D", "MH": "2-Acetylaminofluorene", "DS": "ACETYLAMINOFLUORENE 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluoren-2-ylacetamide|T109|T130|T131|NON|EQV|UNK (19XX)|820518|FLUORENYLACETAMIDE 02|abbbcdefs", "ENTRY": "N Acetyl 2 Aminofluorene", "MN": "D04.615.389.050", "PA": "Carcinogens", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Acetamide, N-9H-fluoren-2-yl-", "RN": "9M98QLJ2DL", "RR": "53-96-3 (2-Acetylaminofluorene)", "PI": "Fluorenes (1966-1974)", "MS": "A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.", "OL": "use 2-ACETYLAMINOFLUORENE to search ACETYLAMINOFLUORENE 1975-82", "PM": "83; was ACETYLAMINOFLUORENE 1980-82; was ACETYLAMINOFLUORENE see under FLUORENES 1975-79", "HN": "83; was ACETYLAMINOFLUORENE 1980-82; was ACETYLAMINOFLUORENE see under FLUORENES 1975-79", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19800101", "UI": "D015073"}, {"RECTYPE": "D", "MH": "2-Aminoadipic Acid", "DS": "AMINOADIPIC ACID 02", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "alpha-Aminoadipic Acid|T116|T123|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "alpha Aminoadipic Acid", "MN": "D12.125.119.075", "PA": "Excitatory Amino Acid Antagonists", "MH_TH": "NLM (1976)", "ST": "T123", "N1": "Hexanedioic acid, 2-amino-", "RN": "1K7B1OED4N", "RR": "542-32-5 (2-Aminoadipic Acid)", "PI": "Amino Acids, Dicarboxylic (1974-1975)", "MS": "A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; (NMDA).", "PM": "91; was see under AMINO ACIDS, DICARBOXYLIC 1976-90", "HN": "91(76); was see under AMINO ACIDS, DICARBOXYLIC 1976-90", "MR": "20130708", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D015074"}, {"RECTYPE": "D", "MH": "2-Aminopurine", "DS": "AMINOPURINE 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "2 Aminopurine", "MN": "D03.633.100.759.138.050", "PA": "Antimetabolites", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "1H-Purin-2-amine", "RN": "452-06-2", "PI": "Purines (1972-1974)", "MS": "A purine that is an isomer of ADENINE (6-aminopurine).", "PM": "91; was see under ADENINE 1975-90", "HN": "91(75); was see under ADENINE 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015075"}, {"RECTYPE": "D", "MH": "2-Hydroxy-5-nitrobenzyl Bromide", "DS": "HYDROXYNITROBENZYL BROMIDE 02 05", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Koshland's Reagent I|T109|T130|EPO|EQV|UNK (19XX)|880606|KOSHLANDS REAGENT 01|abbcdefs", "ENTRY": "Reagent, Koshlands", "MN": "D02.640.743.400", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "Phenol, 2-(bromomethyl)-4-nitro-", "RN": "772-33-8", "PI": "Nitrophenols (1973-1974)", "MS": "A chemical reagent that reacts with and modifies chemically the tryptophan portion of protein molecules. Used for 'active site' enzyme studies and other protein studies. Sometimes referred to as Koshland's reagent.", "PM": "91; was see under NITROPHENOLS 1975-90", "HN": "91(75); was see under NITROPHENOLS 1975-90", "MR": "20120703", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015077"}, {"RECTYPE": "D", "MH": "2-Hydroxyphenethylamine", "DS": "HYDROXYPHENETHYLAMINE 02", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Phenylethanolamine|T109|T121|T123|NON|EQV|UNK (19XX)|770418|abbbcdef", "ENTRY": "beta Phenylethanolamine", "MN": "D02.092.471.683.545", "MH_TH": "NLM (1978)", "ST": "T123", "N1": "Benzenemethanol, alpha-(aminomethyl)-", "RN": "7568-93-6", "PI": "Phenethylamines (1966-1973)", "MS": "Simple amine found in the brain. It may be modulator of sympathetic functions. Its derivatives are adrenergic agonists and antagonists. It is also used in chemical industry.", "PM": "91; was see under PHENETHYLAMINES 1978-90", "HN": "91(78); was see under PHENETHYLAMINES 1978-90", "MR": "20000622", "DA": "19770422", "DC": "1", "DX": "19910101", "UI": "D015078"}, {"RECTYPE": "D", "MH": "2-Isopropylmalate Synthase", "DS": "ISOPROPYLMALATE SYNTHASE 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Isopropylmalate Synthase", "MN": "D08.811.913.050.614", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "3-Carboxy-3-hydroxy-4-methylpentanoate 3-methyl-2-oxobutanoate-lyase (CoA-acetylating)", "RN": "EC 2.3.3.13", "RR": "9030-98-2 (CAS RN)", "PI": "Malates (1973-1974)", "MS": "An enzyme that catalyzes the first step in the biosynthetic pathway to LEUCINE, forming isopropyl malate from acetyl-CoA and alpha-ketoisovaleric acid. This enzyme was formerly listed as EC 4.1.3.12.", "PM": "91; was see under KETOACID-LYASES 1975-90", "HN": "91(75); was see under KETOACID-LYASES 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015079"}, {"RECTYPE": "D", "MH": "Mesna", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethanesulfonic acid, 2-mercapto-, monosodium salt|T109|T121|NON|EQV|NLM (2021)|200520|abbcdef", "ENTRY": "UCB3983", "MN": "D02.886.645.600.055.050.500", "PA": "Protective Agents", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "NR7O1405Q9", "RR": "3375-50-6 (parent cpd)", "PI": "Mercaptoethanol (1974-1976)", "MS": "A sulfhydryl compound used to prevent urothelial toxicity by inactivating metabolites from ANTINEOPLASTIC AGENTS, such as IFOSFAMIDE or CYCLOPHOSPHAMIDE.", "OL": "use MESNA to search 2-MERCAPTOETHANESULFONATE 1977-91", "PM": "92; was 2-MERCAPTOETHANESULFONATE 1977-91 (see under MERCAPTOETHANOL 1977-90); MESNA was see 2-MERCAPTOETHANESULFONATE 1978-91", "HN": "92; was 2-MERCAPTOETHANESULFONATE 1977-91 (see under MERCAPTOETHANOL 1977-90); MESNA was see 2-MERCAPTOETHANESULFONATE 1978-91", "MR": "20200527", "DA": "19760416", "DC": "1", "DX": "19910101", "UI": "D015080"}, {"RECTYPE": "D", "MH": "2-Naphthylamine", "DS": "NAPHTHYLAMINE 02", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "beta-Naphthylamine|T109|T131|NON|EQV|UNK (19XX)|760518|abbcdef", "ENTRY": "beta Naphthylamine", "MN": "D04.615.638.850", "PA": "Carcinogens", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "2-Naphthalenamine", "RN": "CKR7XL41N4", "RR": "91-59-8 (2-Naphthylamine)", "PI": "Naphthalenes (1971-1974)", "MS": "A naphthalene derivative with carcinogenic action.", "PM": "91; was see under NAPHTHALENES 1975-90", "HN": "91(75); was see under NAPHTHALENES 1975-90", "MR": "20130708", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D015081"}, {"RECTYPE": "D", "MH": "2,2'-Dipyridyl", "DE": "DIPYRIDYL", "DS": "DIPYRIDYL 02 02", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "alpha,alpha-Dipyridyl|T109|T130|NON|EQV|UNK (19XX)|760517|abbcdef", "ENTRY": "alpha,alpha Dipyridyl", "MN": "D03.383.725.220", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "2,2'-Bipyridine", "RN": "551W113ZEP", "RR": "366-18-7 (2,2'-Dipyridyl)", "PI": "Pyridines (1969-1974)", "MS": "A reagent used for the determination of iron.", "OL": "use 2,2'-DIPYRIDYL to search ALPHA,ALPHA-DIPYRIDYL 1975-76", "PM": "91; was see under PYRIDINES 1977-90; was ALPHA,ALPHA-DIPYRIDYL see under PYRIDINES 1975-76", "HN": "91(77); was see under PYRIDINES 1977-90; was ALPHA,ALPHA-DIPYRIDYL see under PYRIDINES 1975-76", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015082"}, {"RECTYPE": "D", "MH": "2,3-Diketogulonic Acid", "DS": "DIKETOGULONIC ACID 02 03", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, 2,3-Diketogulonic", "MN": "D09.811.200", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "threo-2,3-Hexodiulosonic acid", "RN": "3409-57-2", "PI": "Sugar Acids (1973-1974)", "MS": "Metabolite of ASCORBIC ACID and the oxidized form of the lactone DEHYDROASCORBIC ACID.", "PM": "91; was see under SUGAR ACIDS 1975-90", "HN": "91(75); was see under SUGAR ACIDS 1975-90", "MR": "20040707", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D015083"}, {"RECTYPE": "D", "MH": "2,4-Dichlorophenoxyacetic Acid", "DS": "DICHLOROPHENOXYACETIC ACID 0204", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2,4-D|T109|T131|ABB|EQV|FDA SRS (2014)|UNK (19XX)|741020|D A 002 004|abbcdeefs", "ENTRY": "2,4 Dichlorophenoxyacetic Acid", "MN": "D02.241.511.316.682.149", "PA": "Herbicides", "MH_TH": "NLM (1971)", "ST": "T131", "N1": "Acetic acid, (2,4-dichlorophenoxy)-", "RN": "2577AQ9262", "RR": "94-75-7 (2,4-Dichlorophenoxyacetic Acid)", "PI": "Phenols (1966-1970)", "MS": "An herbicide with irritant effects on the eye and the gastrointestinal system.", "PM": "73", "HN": "73(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19730101", "UI": "D015084"}, {"RECTYPE": "D", "MH": "2,4,5-Trichlorophenoxyacetic Acid", "DS": "TRICHLOROPHENOXYACETIC ACID 020405", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2,4,5-T|T109|T131|ABB|EQV|FDA SRS (2014)|UNK (19XX)|760630|T A 02 04 05|abbcdeefs", "MN": "D02.241.511.316.682.800", "PA": "Herbicides", "MH_TH": "NLM (1971)", "ST": "T131", "N1": "Acetic acid, (2,4,5-trichlorophenoxy)-", "RN": "9Q963S4YMX", "RR": "93-76-5 (2,4,5-Trichlorophenoxyacetic Acid)", "PI": "Phenols (1966-1970)", "MS": "An herbicide with strong irritant properties. Use of this compound on rice fields, orchards, sugarcane, rangeland, and other noncrop sites was terminated by the EPA in 1985. (From Merck Index, 11th ed)", "PM": "74", "HN": "74(71)", "MR": "20130708", "DA": "19990101", "DC": "1", "DX": "19740101", "UI": "D015085"}, {"RECTYPE": "D", "MH": "2,6-Dichloroindophenol", "DS": "DICHLOROINDOPHENOL 02 06", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tillmans' Reagent|T109|T130|EPO|NRW|UNK (19XX)|741111|abbcdef", "ENTRY": "Tillman's Reagent", "MN": "D02.455.426.559.389.657.446.250", "PA": "Indicators and Reagents", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "2,5-Cyclohexadien-1-one, 2,6-dichloro-4-((4-hydroxyphenyl)imino)-", "RN": "C35QN2Z58B", "RR": "KAD7Q8XO1Y", "PI": "Indophenol (1972-1974)", "MS": "A dye used as a reagent in the determination of vitamin C.", "PM": "91; was see under INDOPHENOL 1975-90", "HN": "91(75); was see under INDOPHENOL 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015086"}, {"RECTYPE": "D", "MH": "2',3'-Cyclic-Nucleotide Phosphodiesterases", "DE": "2 3 CYCL NPD", "DS": "CYCLIC NUCLEOTIDE PHOSPHODIESTERASES 02 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphodiesterases, 2,3-Cyclic Nucleotide", "MN": "D08.811.277.352.640.160", "MH_TH": "NLM (1975)", "ST": "T126", "RN": "EC 3.1.4.-", "PI": "Phosphodiesterases (1973-1974)", "MS": "Nucleoside-2',3'-cyclic phosphate nucleotidohydrolase. Enzymes that catalyze the hydrolysis of the 2'- or 3'- phosphate bonds of 2',3'-cyclic nucleotides. Also hydrolyzes nucleoside monophosphates. Includes EC 3.1.4.16 and EC 3.1.4.37. EC 3.1.4.-.", "OL": "use 2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES to search 2',3'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASES 1985-93 & 2',3'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 1975-84", "PM": "94; was 2',3'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASES 1985-93; was 2',3'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE see under PHOSPHODIESTERASES 1975-84", "HN": "94; was 2',3'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASES 1985-93; was 2',3'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE see under PHOSPHODIESTERASES 1975-84", "MR": "20030709", "DA": "19741127", "DC": "1", "DX": "19850101", "UI": "D015087"}, {"RECTYPE": "D", "MH": "2',5'-Oligoadenylate Synthetase", "DS": "OLIGOADENYLATE SYNTHETASE 02 05", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "2-5A Synthetase|T116|T126|NON|EQV|UNK (19XX)|820504|SYNTHETASE 02 05A|abbcdefs", "ENTRY": "Synthetase, 2,5 Oligoadenylate", "MN": "D08.811.913.696.445.625", "MH_TH": "NLM (1983)", "ST": "T126", "RN": "EC 2.7.7.84", "PI": "Nucleotidyltransferases (1966-1982)", "MS": "An enzyme that catalyzes the conversion of ATP into a series of (2'-5') linked oligoadenylates and pyrophosphate in the presence of double-stranded RNA. These oligonucleotides activate an endoribonuclease (RNase L) which cleaves single-stranded RNA. Interferons can act as inducers of these reactions.", "PM": "83", "HN": "83", "MR": "20160629", "DA": "19820504", "DC": "1", "DX": "19830101", "UI": "D015088"}, {"RECTYPE": "D", "MH": "20-Hydroxysteroid Dehydrogenases", "DS": "HYDROXYSTEROID DEHYDROGENASES 20", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hydroxysteroid Dehydrogenases, 20", "MN": "D08.811.682.047.820.125", "MH_TH": "NLM (1978)", "ST": "T126", "RN": "EC 1.1.1.-", "AN": "do not confuse with 20-BETA-HYDROXYSTEROID DEHYDROGENASE (see CORTISONE REDUCTASE)", "PI": "Hydroxysteroid Dehydrogenases (1966-1977)", "MS": "A group of enzymes that catalyze the reversible reduction-oxidation reaction of 20-hydroxysteroids, such as from a 20-ketosteroid to a 20-alpha-hydroxysteroid (EC 1.1.1.149) or to a 20-beta-hydroxysteroid (EC 1.1.1.53).", "PM": "78", "HN": "78", "MR": "20130708", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D015089"}, {"RECTYPE": "D", "MH": "25-Hydroxyvitamin D3 1-alpha-Hydroxylase", "DS": "HYDROXYVITAMIN D 03 25 HYDROXYLASE 01 ALPHA", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochrome P-450 CYP27B1|T116|T126|NON|EQV|NLM (2001)|991220|CYTOCHROME P 450 CYP 027 B 001|abbcdefs", "ENTRY": "Cytochrome P 450 CYP27B1", "MN": "D12.776.422.220.453.915.400", "MH_TH": "NLM (2003)", "ST": "T126", "N1": "Calcidiol,NADPH:oxygen oxidoreductase (1-hydroxylating)", "RN": "EC 1.14.15.18", "PI": "Steroid Hydroxylases (1973-1974)", "MS": "A mitochondrial cytochrome P450 enzyme that catalyzes the 1-alpha-hydroxylation of 25-hydroxyvitamin D3 (also known as 25-hydroxycholecalciferol) in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP27B1 gene, converts 25-hydroxyvitamin D3 to 1-alpha,25-dihydroxyvitamin D3 which is the active form of VITAMIN D in regulating bone growth and calcium metabolism. This enzyme is also active on plant 25-hydroxyvitamin D2 (ergocalciferol).", "PM": "2003; see 25-HYDROXYCHOLECALCIFEROL 1-HYDROXYLASE 1991-2002, see STEROID HYDROXYLASES 1975-1990; 25-HYDROXYVITAMIN D2 1-HYDROXYLASE was indexed under STEROID HYDROXYLASES 1976-2002", "HN": "2003 (1975); for 25-HYDROXYVITAMIN D2 1-HYDROXYLASE use STEROID HYDROXYLASES (NM) 1976-2002", "MR": "20190429", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015090"}, {"RECTYPE": "D", "MH": "beta-Alanine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "3-Aminopropionic Acid|T116|T123|NON|EQV|FDA SRS (2014)|NLM (1992)|910308|AMINOPROPIONIC ACID 03|abbcdeefs", "ENTRY": "beta Alanine, Monosodium Salt", "MN": "D12.125.042.070", "MH_TH": "NLM (1979)", "ST": "T123", "N1": "beta-Alanine", "RN": "11P2JDE17B", "RR": "6057-90-5 (HCl)", "PI": "Amino Acids (1966-1978)", "MS": "An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported.", "OL": "use BETA-ALANINE to search 3-AMINOPROPIONIC ACID 1979-90", "PM": "92; was 3-AMINOPROPIONIC ACID 1979-91 (see under ALANINE 1979-90); BETA-ALANINE was see 3-AMINOPROPIONIC ACID 1979-91", "HN": "92; was 3-AMINOPROPIONIC ACID 1979-91 (see under ALANINE 1979-90); BETA-ALANINE was see 3-AMINOPROPIONIC ACID 1979-91", "MR": "20130708", "DA": "19780516", "DC": "1", "DX": "19910101", "UI": "D015091"}, {"RECTYPE": "D", "MH": "3-Deazauridine", "DS": "DEAZAURIDINE 03", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "3 Deazauridine", "MN": "D13.570.800.892.250", "PA": "Antimetabolites, Antineoplastic", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "2(1H)-Pyridinone, 4-hydroxy-1-beta-D-ribofuranosyl-", "RN": "263CU738ZY", "RR": "23205-42-7 (3-Deazauridine)", "AN": "an antineoplastic antimetabolite", "PI": "Uridine (1972-1974)", "MS": "4-Hydroxy-1-(beta-D-ribofuranosyl)-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent.", "PM": "91; was see under URIDINE 1975-90", "HN": "91(75); was see under URIDINE 1975-90", "MR": "20160527", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015092"}, {"RECTYPE": "D", "MH": "Meglutol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "3-Hydroxy-3-methylglutaric Acid|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1996)|941201|HYDROXYMETHYLGLUTARIC ACID 03 03|abbcdeefs", "ENTRY": "beta Hydroxy beta Methylglutarate", "MN": "D02.241.081.337.351.550", "PA": "Hypolipidemic Agents", "MH_TH": "USAN (1978)", "ST": "T121", "N1": "Pentanedioic acid, 3-hydroxy-3-methyl-", "RN": "CLA99KCD53", "RR": "503-49-1 (Meglutol)", "PI": "Hydroxy Acids (1975-1979)", "MS": "An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate limiting enzyme in the biosynthesis of cholesterol.", "PM": "96; was 3-HYDROXY-3-METHYLGLUTARIC ACID 1980-95 (see under GLUTARATES 1980-90)", "HN": "96; was 3-HYDROXY-3-METHYLGLUTARIC ACID 1980-95 (see under GLUTARATES 1980-90)", "MR": "20130708", "DA": "19790523", "DC": "1", "DX": "19910101", "UI": "D015093"}, {"RECTYPE": "D", "MH": "3-Hydroxyacyl CoA Dehydrogenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Hydroxyacyl Dehydrogenases|T116|T126|NON|EQV|UNK (19XX)|770523|abbcdef", "ENTRY": "beta Hydroxyacyl Dehydrogenases", "MN": "D08.811.682.047.820.150", "MH_TH": "NLM (1978)", "ST": "T126", "RN": "EC 1.1.1.-", "PI": "Coenzyme A (1966-1977)", "MS": "Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis.", "PM": "78", "HN": "78", "MR": "20130708", "DA": "19770523", "DC": "1", "DX": "19780101", "UI": "D015094"}, {"RECTYPE": "D", "MH": "3-Hydroxyanthranilic Acid", "DS": "HYDROXYANTHRANILIC ACID 03", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Acid, 3-Hydroxyanthranilic", "MN": "D02.455.426.559.389.127.020.906.249", "PA": "Free Radical Scavengers", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Benzoic acid, 2-amino-3-hydroxy-", "RN": "1UQB1BT4OT", "RR": "548-93-6 (3-Hydroxyanthranilic Acid)", "PI": "Phenols (1972-1974)", "MS": "An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen.", "PM": "91; was see under ANTHRANILIC ACIDS 1975-90", "HN": "91(75); was see under ANTHRANILIC ACIDS 1975-90", "MR": "20130708", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015095"}, {"RECTYPE": "D", "MH": "3-Hydroxysteroid Dehydrogenases", "DS": "HYDROXYSTEROID DEHYDROGENASES 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "3-beta-Hydroxysteroid Dehydrogenase|T116|T126|NON|EQV|UNK (19XX)|770426|BETA HYDROXYSTEROID DEHYDROGENASE A 03|abbcdefs", "ENTRY": "Hydroxysteroid Dehydrogenases, 3", "MN": "D08.811.682.047.436.350", "MH_TH": "NLM (1978)", "ST": "T126", "RN": "EC 1.1.-", "PI": "Hydroxysteroid Dehydrogenases (1966-1977)", "MS": "Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids.", "PM": "78", "HN": "78", "MR": "20030709", "DA": "19770415", "DC": "1", "DX": "19780101", "UI": "D015096"}, {"RECTYPE": "D", "MH": "3-Mercaptopropionic Acid", "DS": "MERCAPTOPROPIONIC ACID 03", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Mercaptopropionate|T109|T121|NON|NRW|UNK (19XX)|770223|abbcdef", "ENTRY": "beta Mercaptopropionate", "MN": "D02.886.489.520", "PA": "GABA Agents", "MH_TH": "NLM (1978)", "ST": "T121", "N1": "Propanoic acid, 3-mercapto-", "RN": "B03TJ3QU9M", "RR": "107-96-0 (3-Mercaptopropionic Acid)", "PI": "Sulfhydryl Compounds (1966-1977)", "MS": "An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions.", "PM": "91; was see under SULFHYDRYL COMPOUNDS 1978-90", "HN": "91(78); was see under SULFHYDRYL COMPOUNDS 1978-90", "MR": "20130708", "DA": "19770301", "DC": "1", "DX": "19910101", "UI": "D015097"}, {"RECTYPE": "D", "MH": "3-Methoxy-4-hydroxyphenylethanol", "DS": "METHOXYHYDROXYPHENYLETHANOL 03 04", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methoxyhydroxyphenylethanol|T109|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "Alcohol, Hydroxymethoxyphenethyl", "MN": "D02.455.426.559.389.657.166.500", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Benzeneethanol, 4-hydroxy-3-methoxy-", "RN": "2380-78-1", "PI": "Catechols (1972-1974)", "MS": "Metabolite of serotonin and norepinephrine.", "PM": "91; was see under CATECHOLS 1975-90", "HN": "91(75); was see under CATECHOLS 1975-90", "MR": "20120703", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015098"}, {"RECTYPE": "D", "MH": "3-Oxoacyl-(Acyl-Carrier-Protein) Synthase", "DE": "OXOACYL ACP SYNTHASE", "DS": "OXOACYL ACYL CARRIER PROTEIN SYNTHASE 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Keto Acyl Carrier Protein Synthase II", "MN": "D08.811.913.050.622", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "Acyl-(acyl carrier protein):malonyl-(acyl-carrier-protein) C-acyltransferase (decarboxylating)", "RN": "EC 2.3.1.41", "RR": "9077-10-5 (CAS RN)", "PI": "Malonates (1970-1974)", "MS": "An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41.", "PM": "98; see 3-OXOACYL (ACYL CARRIER PROTEIN) SYNTHASE 1991-97; see ACYLTRANSFERASES 1975-90", "HN": "98(75)", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015099"}, {"RECTYPE": "D", "MH": "3,3'-Diaminobenzidine", "DS": "DIAMINOBENZIDINE 03 03", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Diaminobenzidine, 3,3'", "MN": "D02.455.426.559.389.185.100.500", "MH_TH": "NLM (1975)", "ST": "T130", "N1": "(1,1'-Biphenyl)-3,3',4,4'-tetramine", "RN": "2RV4T6KHQI", "RR": "91-95-2 (3,3'-Diaminobenzidine)", "PI": "Phenylenediamines (1974)", "MS": "A chemically and thermodynamically stable derivative of BENZIDINE.", "PM": "91; was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76", "HN": "91(75); was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76", "MR": "20161101", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015100"}, {"RECTYPE": "D", "MH": "3,3'-Dichlorobenzidine", "DS": "DICHLOROBENZIDINE 03 03", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "3,3' Dichlorobenzidine", "MN": "D02.455.426.559.389.185.100.750", "PA": "Carcinogens", "MH_TH": "NLM (1977)", "ST": "T131", "N1": "(1,1'-Biphenyl)-4,4'-diamine, 3,3'-dichloro-", "RN": "1SDI2328UX", "RR": "91-94-1 (3,3'-Dichlorobenzidine)", "PI": "Biphenyl Compounds (1969-1974)", "MS": "A material used in the manufacture of azo dyes that is toxic to skin and carcinogenic in several species.", "PM": "91; was see under BENZIDINES 1977-90", "HN": "91(77); was see under BENZIDINES 1977-90", "MR": "20190705", "DA": "19760421", "DC": "1", "DX": "19910101", "UI": "D015101"}, {"RECTYPE": "D", "MH": "3,4-Dihydroxyphenylacetic Acid", "DS": "DIHYDROXYPHENYLACETIC ACID 03 04", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Homoprotocatechuic Acid|T109|T123|NON|EQV|UNK (19XX)|741111|abbcdef", "ENTRY": "3,4 Dihydroxyphenylacetic Acid", "MN": "D02.241.223.601.220", "MH_TH": "NLM (1975)", "ST": "T123", "N1": "Benzeneacetic acid, 3,4-dihydroxy-", "RN": "102-32-9", "RR": "79428-07-2 (mono-Na salt)", "PI": "Phenylacetates (1972-1974)", "MS": "A deaminated metabolite of LEVODOPA.", "OL": "use 3,4-DIHYDROXYPHENYLACETIC ACID to search DOPACETIC ACID 1975-93", "PM": "91; was see under PHENYLACETATES 1975-90; DOPACETIC ACID was see 3,4-DIHYDROXYPHENYLACETIC ACID 1975-93", "HN": "91(75); was see under PHENYLACETATES 1975-90; DOPACETIC ACID was see 3,4-DIHYDROXYPHENYLACETIC ACID 1975-93", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015102"}, {"RECTYPE": "D", "MH": "Droxidopa", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "3,4-Dihydroxyphenylserine|T116|T121|NON|BRD|NLM (1997)|951212|DIHYDROXYPHENYLSERINE 03 04|abbcdefs", "ENTRY": "threo DOPS", "MN": "D12.125.154.800.875", "PA": "Antiparkinson Agents", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "L-Tyrosine, beta,3-dihydroxy-, threo-", "RN": "J7A92W69L7", "RR": "23651-95-8 (Droxidopa)", "PI": "Serine (1971-1974)", "MS": "A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION.", "PM": "1997; see 3,4-DIHYDROXYPHENYLSERINE 1975-96", "HN": "1997 (1975);  use 3,4-DIHYDROXYPHENYLSERINE 1975-1996", "MR": "20180529", "DA": "19741127", "DC": "1", "DX": "19910101", "UI": "D015103"}, {"RECTYPE": "D", "MH": "3,4-Methylenedioxyamphetamine", "DS": "METHYLENEDIOXYAMPHETAMINE 03 04", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "3,4 Methylenedioxyamphetamine", "MN": "D02.092.471.683.152.660", "PA": "Serotonin Agents", "MH_TH": "NLM (1977)", "ST": "T121", "N1": "1,3-Benzodioxole-5-ethanamine, alpha-methyl-", "RN": "4764-17-4", "PI": "Methyl Ethers (1973)", "MS": "An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.", "PM": "91; was see under AMPHETAMINES 1977-90", "HN": "91(77); was see under AMPHETAMINES 1977-90", "MR": "20000622", "DA": "19760413", "DC": "1", "DX": "19910101", "UI": "D015104"}, {"RECTYPE": "D", "MH": "3',5'-Cyclic-AMP Phosphodiesterases", "DS": "CYCLIC AMP PHOSPHODIESTERASE 03 05", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CAMP Phosphodiesterase|T116|T126|EQV|NLM (1994)|921006|abbdef", "ENTRY": "Phosphodiesterases, 3',5'-Cyclic-AMP", "MN": "D12.776.476.008", "MH_TH": "NLM (2008)", "ST": "T126", "N1": "3',5'-Cyclic-nucleotide 5'-nucleotidohydrolase", "RN": "EC 3.1.4.17", "AN": "general or unspecified; prefer specifics", "PI": "Phosphodiesterases (1973-1974)", "MS": "Enzymes that catalyze the hydrolysis of CYCLIC AMP to form adenosine 5'-phosphate. The enzymes are widely distributed in animal tissue and control the level of intracellular cyclic AMP. Many specific enzymes classified under this heading demonstrate additional spcificity for 3',5'-cyclic IMP and CYCLIC GMP.", "PM": "2008; see 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE 1994-2007, see 3',5'-CYCLIC AMP PHOSPHODIESTERASE 1975-1993, see PHOSPHODIESTERASES 1975-1977", "HN": "2008(1975)", "MR": "20210520", "DA": "19741111", "DC": "1", "DX": "19780101", "UI": "D015105"}, {"RECTYPE": "D", "MH": "3',5'-Cyclic-GMP Phosphodiesterases", "DS": "CYCLIC GMP PHOSPHODIESTERASES 03 05", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "3',5'-Cyclic GMP 5'-Nucleotidohydrolase|T116|T126|EQV|UNK (19XX)|770520|CYCLIC GMP NUCLEOTIDOHYDROLASE 03 05 05|abbdefs", "ENTRY": "Phosphodiesterases, 3',5'-Cyclic-GMP", "MN": "D12.776.476.009", "MH_TH": "NLM (2008)", "ST": "T126", "N1": "3',5'-Cyclic-GMP 5'-nucleotidohydrolase", "RN": "EC 3.1.4.35", "PI": "Phosphodiesterases (1972-1977)", "MS": "Enzymes that catalyze the hydrolysis of cyclic GMP to yield guanosine-5'-phosphate.", "PM": "2008; see 3',5'-CYCLIC-GMP-PHOSPHODIESTERASE 1994-2007, see 3',5'-CYCLIC GMP PHOSPHODIESTERASE 1978-1993", "HN": "2008(1994)", "MR": "20210520", "DA": "19770520", "DC": "1", "DX": "19780101", "UI": "D015106"}, {"RECTYPE": "D", "MH": "4-Butyrolactone", "DS": "BUTYROLACTONE 04", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "gamma-Butyrolactone|T109|T121|T123|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|760517|abbbbcdeef", "ENTRY": "gamma Butyrolactone", "MN": "D03.383.312.150", "PA": "Solvents", "MH_TH": "NLM (1976)", "ST": "T130", "N1": "2(3H)-Furanone, dihydro-", "RN": "OL659KIY4X", "RR": "96-48-0 (4-Butyrolactone)", "PI": "Lactones (1969-1975)", "MS": "One of the FURANS with a carbonyl thereby forming a cyclic lactone. It is an endogenous compound made from gamma-aminobutyrate and is the precursor of gamma-hydroxybutyrate. It is also used as a pharmacological agent and solvent.", "OL": "use 4-BUTYROLACTONE to search GAMMA BUTYROLACTONE 1976", "PM": "91; was see under FURANS 1977-90; was GAMMA BUTYROLACTONE see under FURANS 1976", "HN": "91(77); was see under FURANS 1977-90; was GAMMA BUTYROLACTONE see under FURANS 1976", "MR": "20160527", "DA": "19750723", "DC": "1", "DX": "19910101", "UI": "D015107"}, {"RECTYPE": "D", "MH": "4-Hydroxyaminoquinoline-1-oxide", "DS": "HYDROXYAMINOQUINOLINE A OXIDE 04 01", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "4-Hydroxyaminoquinoline-N-oxide|T109|T131|NON|EQV|UNK (19XX)|741111|HYDROXYAMINOQUINOLINE N OXIDE 04|abbcdefs", "ENTRY": "4 Hydroxyaminoquinoline N oxide", "MN": "D03.661.243.320", "PA": "Mutagens", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "4-Quinolinamine, N-hydroxy-, 1-oxide", "RN": "4637-56-3", "PI": "Quinolines (1972-1974)", "MS": "A potent mutagen and carcinogen. It is a reduction product of 4-NITROQUINOLINE-1-OXIDE. It binds with nucleic acids and inactivates both bacteria and bacteriophage.", "PM": "91; was see under AMINOQUINOLINES 1975-90", "HN": "91(75); was see under AMINOQUINOLINES 1975-90", "MR": "20160527", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D015108"}, {"RECTYPE": "D", "MH": "4-Hydroxybenzoate-3-Monooxygenase", "DS": "HYDROXYBENZOATE MONOOXYGENASE 04 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "para-Hydroxybenzoate Hydroxylase|T116|T126|NON|EQV|UNK (19XX)|760515|abbcdef", "ENTRY": "para Hydroxybenzoate Hydroxylase", "MN": "D08.811.682.690.708.425", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "4-Hydroxybenzoate,NADPH:oxygen oxidoreductase (3-hydroxylating)", "RN": "EC 1.14.13.2", "PI": "Phenols (1971-1974)", "MS": "A flavoprotein that catalyzes the synthesis of protocatechuic acid from 4-hydroxybenzoate in the presence of molecular oxygen. EC 1.14.13.2.", "PM": "91; was see under HYDROXYLASES 1975-90", "HN": "91(75); was see under HYDROXYLASES 1975-90", "MR": "20040707", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015109"}, {"RECTYPE": "D", "MH": "4-Hydroxycoumarins", "DS": "HYDROXYCOUMARINS 04", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "4 Hydroxycoumarins", "MN": "D03.633.100.150.446.520", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1977)", "ST": "T121", "RN": "0", "AN": "/biosyn permitted if by plant", "PI": "Coumarins (1972-1976)", "MS": "Substances found in many plants, containing the 4-hydroxycoumarin radical. They interfere with vitamin K and the blood clotting mechanism, are tightly protein-bound, inhibit mitochondrial and microsomal enzymes, and are used as oral anticoagulants.", "PM": "77; PHENPROCOUMON was see under COUMARINS 1975-76", "HN": "77", "MR": "20160527", "DA": "19760413", "DC": "1", "DX": "19770101", "UI": "D015110"}, {"RECTYPE": "D", "MH": "4-Hydroxyphenylpyruvate Dioxygenase", "DS": "HYDROXYPHENYLPYRUVATE DIOXYGENASE 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "para-Hydroxyphenylpyruvate Oxidase|T116|T126|NON|EQV|UNK (19XX)|760515|abbcdef", "ENTRY": "para Hydroxyphenylpyruvate Oxidase", "MN": "D08.811.682.690.416.330", "MH_TH": "NLM (1975)", "ST": "T126", "N1": "4-Hydroxyphenylpyruvate:oxygen oxidoreductase (hydroxylating, decarboxylating)", "RN": "EC 1.13.11.27", "AN": "/defic: consider also TYROSINE /blood (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM)", "PI": "Phenylpyruvic Acids (1974)", "MS": "An enzyme that catalyzes the conversion of 4-hydroxyphenylpyruvate plus oxygen to homogentisic acid and carbon dioxide. EC 1.13.11.27.", "PM": "91; was see under OXYGENASES 1975-90", "HN": "91(75); was see under OXYGENASES 1975-90", "MR": "20050630", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015111"}, {"RECTYPE": "D", "MH": "4-Nitroquinoline-1-oxide", "DS": "NITROQUINOLINE A OXIDE 04 01", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "4-Nitroquinoline-N-oxide|T109|T131|NON|EQV|UNK (19XX)|741111|NITROQUINOLINE N OXIDE 04|abbcdefs", "ENTRY": "4 Nitroquinoline N oxide", "MN": "D03.661.243.500", "PA": "Mutagens", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Quinoline, 4-nitro-, 1-oxide", "RN": "56-57-5", "PI": "Quinolines (1970-1974)", "MS": "A potent mutagen and carcinogen. This compound and its metabolite 4-HYDROXYAMINOQUINOLINE-1-OXIDE bind to nucleic acids. It inactivates bacteria but not bacteriophage.", "PM": "91; was see under NITROQUINOLINES 1975-90", "HN": "91(75); was see under NITROQUINOLINES 1975-90", "MR": "20160527", "DA": "19741114", "DC": "1", "DX": "19910101", "UI": "D015112"}, {"RECTYPE": "D", "MH": "Androstane-3,17-diol", "DS": "ANDROSTANEDIOL 03 17", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Androstane 3,17 diol", "MN": "D06.472.334.851.968.500", "PA": "Anabolic Agents", "MH_TH": "NLM (1975)", "ST": "T125", "N1": "Androstane-3,17-diol", "RN": "25126-76-5", "PI": "Hydroxysteroids (1973-1974)", "MS": "The unspecified form of the steroid, normally a major metabolite of TESTOSTERONE with androgenic activity. It has been implicated as a regulator of gonadotropin secretion.", "OL": "use 5-ANDROSTANE-3,17-DIOL to search ANDROSTANEDIOL 1975-79", "PM": "98; was 5-ANDROSTANE-3,17-DIOL 1975-97; 91; see ANDROSTANOLS 1980-90; was ANDROSTANEDIOL see ANDROSTANES 1975-79", "HN": "98(75); was 5-ANDROSTANE-3,17-DIOL 1975-97; see ANDROSTANOLS 1980-90; was ANDROSTANEDIOL see ANDROSTANES 1975-79", "MR": "20160527", "DA": "19741111", "DC": "1", "DX": "19910101", "UI": "D015113"}, {"RECTYPE": "D", "MH": "Androstenediol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "delta 5 Androstene 3 beta,17 beta Diol", "MN": "D06.472.334.851.968.750", "PA": "Anabolic Agents", "MH_TH": "NLM (1998)", "ST": "T123", "N1": "Androst-5-ene-3,17-diol, (3beta,17beta)-", "RN": "95PS51EMXY", "RR": "521-17-5 (Androstenediol)", "PI": "Androstenediols (1975)", "MS": "An intermediate in TESTOSTERONE biosynthesis, found in the TESTIS or the ADRENAL GLANDS. Androstenediol, derived from DEHYDROEPIANDROSTERONE by the reduction of the 17-keto group (17-HYDROXYSTEROID DEHYDROGENASES), is converted to TESTOSTERONE by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-HYDROXYSTEROID DEHYDROGENASES).", "PM": "2004; see ANDROST-5-ENE-3 BETA,17 BETA-DIOL 1998-2003, see 5-ANDROSTENE-3,17-DIOL 1991-1997, see ANDROSTENEDIOLS 1976-1990", "HN": "2004 (1976); use 5-ANDROSTENE-3,17-DIOL 1991-1997, use ANDROSTENEDIOLS 1976-1990", "MR": "20170524", "DA": "19750718", "DC": "1", "DX": "19910101", "UI": "D015114"}, {"RECTYPE": "D", "MH": "5,6-Dihydroxytryptamine", "DS": "DIHYDROXYTRYPTAMINE 05 06", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "5,6 Dihydroxytryptamine", "MN": "D03.633.100.473.914.201.259", "PA": "Serotonin Agents", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "1H-Indole-5,6-diol, 3-(2-aminoethyl)-", "RN": "W2QY253O8S", "RR": "5090-36-8 (5,6-Dihydroxytryptamine)", "PI": "Tryptamines (1966-1974)", "MS": "Tryptamine substituted with two hydroxyl groups in positions 5 and 6. It is a neurotoxic serotonin analog that destroys serotonergic neurons preferentially and is used in neuropharmacologic research.", "PM": "78; was see under TRYPTAMINES 1975-77", "HN": "78(75); was see under TRYPTAMINES 1975-77", "MR": "20160527", "DA": "19741127", "DC": "1", "DX": "19780101", "UI": "D015115"}, {"RECTYPE": "D", "MH": "5,7-Dihydroxytryptamine", "DS": "DIHYDROXYTRYPTAMINE 05 07", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, 5,7-Dihydroxytryptamine Creatine", "MN": "D03.633.100.473.914.201.263", "PA": "Serotonin Agents", "MH_TH": "NLM (1978)", "ST": "T121", "N1": "1H-Indole-5,7-diol, 3-(2-aminoethyl)-", "RN": "31363-74-3", "PI": "Tryptamines (1966-1977)", "MS": "Tryptamine substituted with two hydroxyl groups in positions 5 and 7. It is a neurotoxic serotonin analog that destroys serotonergic neurons preferentially and is used in neuropharmacology as a tool.", "PM": "91; was see under DIHYDROXYTRYPTAMINES 1978-90", "HN": "91(78); was see under DIHYDROXYTRYPTAMINES 1978-90", "MR": "20160527", "DA": "19770427", "DC": "1", "DX": "19910101", "UI": "D015116"}, {"RECTYPE": "D", "MH": "5,8,11,14-Eicosatetraynoic Acid", "DS": "EICOSATETRAYNOIC ACID 05 08 11 14", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ETYA|T109|T121|ABB|EQV|UNK (19XX)|850605|abbcdef", "ENTRY": "Ro 31428", "MN": "D10.251.355.255.205", "MH_TH": "NLM (1975)", "ST": "T121", "N1": "5,8,11,14-Eicosatetraynoic acid", "RN": "1191-85-1", "PI": "Fatty Acids, Unsaturated (1973-1974)", "MS": "A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).", "PM": "91; was see under FATTY ACIDS, UNSATURATED 1975-90", "HN": "91(75); was see under FATTY ACIDS, UNSATURATED 1975-90", "MR": "20060705", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015117"}, {"RECTYPE": "D", "MH": "Eicosapentaenoic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Icosapent|T109|T123|NON|EQV|INN (19XX)|NLM (2021)|200115|abbcdeef", "ENTRY": "omega 3 Eicosapentaenoic Acid", "MN": "D10.627.430.450.390", "MH_TH": "NLM (2004)", "ST": "T123", "N1": "5,8,11,14,17-Eicosapentaenoic acid", "RN": "AAN7QOV9EA", "RR": "1553-41-9 (Eicosapentaenoic Acid)", "PI": "Fatty Acids, Unsaturated (1973-1985)", "MS": "Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.", "PM": "1986; see 5,8,11,14,17-EICOSAPENTAENOIC ACID 1986-2003; EICOSAPENTANOIC ACID was indexed under FATTY ACIDS, UNSATURATED 2002-2010", "HN": "2003(1986);", "MR": "20200622", "DA": "19850605", "DC": "1", "DX": "19860101", "UI": "D015118"}, {"RECTYPE": "D", "MH": "Aminocaproic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "epsilon-Aminocaproic Acid|T116|T121|NON|EQV|UNK (19XX)|760512|abbcdef", "ENTRY": "epsilon Aminocaproic Acid", "MN": "D12.125.213.075", "PA": "Antifibrinolytic Agents", "EC": "analogs & derivatives:Aminocaproates", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Hexanoic acid, 6-amino-", "RN": "U6F3787206", "RR": "60-32-2 (Aminocaproic Acid)", "PI": "Aminocaproic Acids (1966-1976)", "MS": "An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.", "PM": "2014; see AMINOCAPROIC ACIDS 1977-90; for EPSILON-AMINOCAPROIC ACID was see AMINOCAPROIC ACIDS 1975-1976, see AMINOCAPROIC ACID 1964-1974, for AMINOCAPROIC ACID see AMINOCAPROIC ACIDS 1975-2013", "HN": "2014(1977); for AMINOCAPROIC ACID use AMINOCAPROIC ACIDS 1975-2013", "MR": "20160701", "DA": "19760519", "DC": "1", "DX": "19910101", "UI": "D015119"}, {"RECTYPE": "D", "MH": "6-Aminonicotinamide", "DS": "AMINONICOTINAMIDE 06", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "6 Aminonicotinamide", "MN": "D03.383.725.547.530.248", "PA": "Teratogens", "MH_TH": "NLM (1976)", "ST": "T131", "N1": "3-Pyridinecarboxamide, 6-amino-", "RN": "329-89-5", "PI": "Nicotinamide (1968-1974) /analogs & derivatives (1975)", "MS": "A vitamin antagonist which has teratogenic effects.", "PM": "91; was see under NICOTINAMIDE 1976-90", "HN": "91(76); was see under NICOTINAMIDE 1976-90", "MR": "20160527", "DA": "19750721", "DC": "1", "DX": "19910101", "UI": "D015120"}, {"RECTYPE": "D", "MH": "6-Ketoprostaglandin F1 alpha", "DS": "KETOPROSTAGLANDIN F 01 06 ALPHA", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "6-Oxoprostaglandin F1 alpha|T109|NON|EQV|UNK (19XX)|810512|OXOPROSTAGLANDIN F 01 06 ALPHA|abcdefs", "ENTRY": "alpha, 6-Oxoprostaglandin F1", "MN": "D23.469.050.175.725.400.350", "MH_TH": "NLM (1982)", "ST": "T109", "N1": "Prost-13-en-1-oic acid, 9,11,15-trihydroxy-6-oxo-, (9alpha,11alpha,13E,15S)-", "RN": "58962-34-8", "PI": "Prostaglandins F (1975-1981)", "MS": "The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.", "PM": "82", "HN": "82", "MR": "20150608", "DA": "19810512", "DC": "1", "DX": "19820101", "UI": "D015121"}, {"RECTYPE": "D", "MH": "Mercaptopurine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "6-Mercaptopurine|T114|T121|NON|EQV|NLM (1966)|990101|MERCAPTOPURINE A 06|abbcdefs", "ENTRY": "BW 57323H", "MN": "D03.633.100.759.570", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "E7WED276I5", "RR": "PKK6MUZ20G", "MS": "An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.", "PM": "2018; see 6-Mecaptopurine 1985-2017; see MERCAPTOPURINE 1963-1984; see ARABINOSYL-6-MERCAPTOPURINE 1975-1991; MERCAPTOPURINE was indexed under 6-MERCAPTOPURINE 1975-1990", "HN": "2018(1985)", "MR": "20180705", "DA": "19990101", "DC": "1", "DX": "19850101", "UI": "D015122"}, {"RECTYPE": "D", "MH": "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide", "DE": "7 8 DDBP", "DS": "DIHYDRODIHYDROXYBENZOAPYRENEOXIDE 07 08 07 08 09 10", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Benzo(a)pyrene 7,8-Dihydrodiol 9,10-Epoxide|T109|T131|NON|EQV|UNK (19XX)|860409|BENZOPYRENE A DIHYDRODIOL EPOXIDE 07 08 09 10|abbcdefs", "ENTRY": "Anti BaPDE", "MN": "D04.615.799.306.400.350", "PA": "Mutagens", "MH_TH": "NLM (1987)", "ST": "T131", "N1": "Benzo(10,11)chryseno(3,4-b)oxirene-7,8-diol, 7,8,8a,9a-tetrahydro-", "RN": "55097-80-8", "PI": "Benzopyrenes (1966-1986)", "MS": "7,8,8a,9a-Tetrahydrobenzo(10,11)chryseno (3,4-b)oxirene-7,8-diol. A benzopyrene derivative with carcinogenic and mutagenic activity.", "PM": "91; was see under DIHYDROXYDIHYDROBENZOPYRENES 1987-90", "HN": "91(87); was see under DIHYDROXYDIHYDROBENZOPYRENES 1987-90", "MR": "20060705", "DA": "19860409", "DC": "1", "DX": "19910101", "UI": "D015123"}, {"RECTYPE": "D", "MH": "8-Bromo Cyclic Adenosine Monophosphate", "DE": "BR CAMP", "DS": "BROMO CYCLIC ADENOSINE MONOPHOSPHATE 08", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "8-Bromo-cAMP|T114|T121|NON|EQV|UNK (19XX)|830531|BROMO CAMP 08|abbcdefs", "ENTRY": "Cyclic AMP, 8-Bromo", "MN": "D13.695.827.068.395.225", "MH_TH": "NLM (1984)", "ST": "T121", "N1": "Adenosine, 8-bromo-, cyclic 3',5'-(hydrogen phosphate)", "RN": "23583-48-4", "RR": "76939-46-3 (mono-Na salt)", "PI": "Adenosine Cyclic Monophosphate (1968-1983)", "MS": "A long-acting derivative of cyclic AMP. It is an activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase.", "PM": "84", "HN": "84", "MR": "20160527", "DA": "19830531", "DC": "1", "DX": "19840101", "UI": "D015124"}, {"RECTYPE": "D", "MH": "Oxyquinoline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxyquinol|T109|T121|T130|NON|EQV|UNK (19XX)|741111|abbbcdef", "ENTRY": "Sulfate, Oxyquinoline", "MN": "D03.633.100.810.350.625", "MH_TH": "USAN (19XX)", "ST": "T130", "N1": "8-Quinolinol", "RN": "5UTX5635HP", "RR": "61VUG75Y3P", "PI": "Quinolines (1971-1974)", "MS": "An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics.", "OL": "use OXYQUINOLINE to search 8-HYDROXYQUINOLINE 1975-91", "PM": "92; was 8-HYDROXYQUINOLINE 1975-91 (see under HYDROXYQUINOLINES 1975-90); OXYQUINOLINE was see 8-HYDROXYQUINOLINE 1975-91", "HN": "92; was 8-HYDROXYQUINOLINE 1975-91 (see under HYDROXYQUINOLINES 1975-90); OXYQUINOLINE was see 8-HYDROXYQUINOLINE 1975-91", "MR": "20170502", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015125"}, {"RECTYPE": "D", "MH": "8,11,14-Eicosatrienoic Acid", "DS": "EICOSATRIENOIC ACID 08 11 14", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Homo-gamma Linolenic Acid|T109|NON|EQV|UNK (19XX)|741220|HOMOGAMMA LINOLENIC ACID|abcdefs", "ENTRY": "Ro 121989", "MN": "D10.251.355.255.207", "MH_TH": "NLM (1975)", "ST": "T109", "N1": "8,11,14-Eicosatrienoic acid", "RN": "FC398RK06S", "RR": "7324-41-6 (8,11,14-Eicosatrienoic Acid)", "PI": "Fatty Acids, Unsaturated (1973-1974)", "MS": "A 20-carbon-chain fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5.", "PM": "91; was see under FATTY ACIDS, UNSATURATED 1975-90", "HN": "91(75); was see under FATTY ACIDS, UNSATURATED 1975-90", "MR": "20180521", "DA": "19741119", "DC": "1", "DX": "19910101", "UI": "D015126"}, {"RECTYPE": "D", "MH": "9,10-Dimethyl-1,2-benzanthracene", "DS": "DIMETHYLBENZANTHRACENE 09 10 01 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "7,12-Dimethylbenzanthracene|T109|T131|NON|EQV|UNK (19XX)|741024|DIMETHYLBENZANTHRACENE 07 12|abbcdefs", "ENTRY": "7,12 Dimethylbenzanthracene", "MN": "D04.615.149.301", "PA": "Carcinogens", "MH_TH": "NLM (1975)", "ST": "T131", "N1": "Benz(a)anthracene, 7,12-dimethyl-", "RN": "57-97-6", "PI": "Benzanthracenes (1966-1974)", "MS": "Polycyclic aromatic hydrocarbon found in tobacco smoke that is a potent carcinogen.", "PM": "85; was see under BENZANTHRACENES 1975-84", "HN": "85(75); was see under BENZANTHRACENES 1975-84", "MR": "20180702", "DA": "19741024", "DC": "1", "DX": "19850101", "UI": "D015127"}, {"RECTYPE": "D", "MH": "RNA, Nuclear", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RNA, Chromosomal|T114|T123|NRW|UNK (19XX)|880318|abbdef", "MN": "D13.444.735.628", "MH_TH": "NLM (1989)", "ST": "T123", "RN": "0", "AN": "IM; /drug eff /ultrastruct permitted", "PI": "RNA (1966-1988)", "MS": "RNA molecules found in the nucleus either associated with chromosomes or in the nucleoplasm.", "PM": "89", "HN": "89", "MR": "19950608", "DA": "19880318", "DC": "1", "DX": "19890101", "UI": "D015138"}, {"RECTYPE": "D", "MH": "Blotting, Southern", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Southern Blotting|T059|T063|EPO|EQV|UNK (19XX)|880318|abbcdef", "ENTRY": "Southern Blot|T034|EPO|REL|NLM (2002)|010313|abcdef", "MN": "E05.601.150", "MH_TH": "NLM (1989)", "ST": "T063", "AN": "\"Southern\" (developed by E.M. Southern) is capitalized in titles & translations", "PI": "Nucleic Acid Hybridization (1980-1988)", "MS": "A method (first developed by E.M. Southern) for detection of DNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19880318", "DC": "1", "DX": "19890101", "UI": "D015139"}, {"RECTYPE": "D", "MH": "Dementia, Vascular", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Vascular Dementia|T047|NON|EQV|UNK (19XX)|880414|abcdef", "ENTRY": "Vascular Dementias, Subcortical", "MN": "F03.615.400.350", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Dementia (1981-1988)", "MS": "An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)", "PM": "1989", "HN": "1989", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19880318", "DC": "1", "DX": "19890101", "UI": "D015140"}, {"RECTYPE": "D", "MH": "Los Angeles", "AQ": "EH EP", "MN": "Z01.433.565", "MH_TH": "NLM (1989)", "ST": "T083", "MS": "City in California.", "HN": "89", "MR": "20160628", "DA": "19880318", "DC": "4", "DX": "19890101", "UI": "D015141"}, {"RECTYPE": "D", "MH": "Baltimore", "DE": "BALT", "AQ": "EH EP", "MN": "Z01.433.100", "MH_TH": "NLM (1989)", "ST": "T083", "MS": "A city located in Maryland.", "HN": "89", "MR": "20160628", "DA": "19880318", "DC": "4", "DX": "19890101", "UI": "D015142"}, {"RECTYPE": "D", "MH": "Philadelphia", "DE": "PHILA", "AQ": "EH EP", "MN": "Z01.433.820", "MH_TH": "NLM (1989)", "ST": "T083", "MS": "City located in Pennsylvania.", "HN": "89", "MR": "20160708", "DA": "19880318", "DC": "4", "DX": "19890101", "UI": "D015143"}, {"RECTYPE": "D", "MH": "Southeastern United States", "AQ": "EH EP", "PRINT ENTRY": "Southeast U.S.|T083|NAM|EQV|UNK (19XX)|880318|abcdef", "ENTRY": "Southeast US|T083|NAM|EQV|UNK (19XX)|880318|abcdef", "MN": "Z01.107.567.875.750", "MH_TH": "NLM (1989)", "ST": "T083", "AN": "index specific states as needed but use SOUTHEASTERN UNITED STATES when text uses the term & when the region is the intent of the author; CATALOGER: Use for 4 or more states", "MS": "The geographic area of the southeastern region of the United States in general or when the specific state or states are not included. The states usually included in this region are Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, West Virginia, and Virginia.", "HN": "89", "MR": "20150605", "DA": "19880318", "DC": "4", "DX": "19890101", "UI": "D015144"}, {"RECTYPE": "D", "MH": "Tocolysis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tocolytic Therapy|T061|NON|EQV|UNK (19XX)|880321|TOCOLYTIC THER|abcdefv", "ENTRY": "Treatments, Tocolytic", "MN": "E02.875.900", "MH_TH": "NLM (1989)", "ST": "T061", "AN": "check tags FEMALE & PREGNANCY; \"tokolysis\": translate as \"tocolysis\"; TOCOLYTIC AGENTS is available", "PI": "Uterus (1966-1974)", "MS": "Any drug treatment modality designed to inhibit UTERINE CONTRACTION. It is used in pregnant women to arrest PREMATURE LABOR.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19880321", "DC": "1", "DX": "19890101", "UI": "D015145"}, {"RECTYPE": "D", "MH": "Midwestern United States", "AQ": "EH EP", "PRINT ENTRY": "Midwest U.S.|T083|NAM|EQV|UNK (19XX)|880325|abcdef", "ENTRY": "Midwest US|T083|NAM|EQV|UNK (19XX)|880325|abcdef", "MN": "Z01.107.567.875.510", "MH_TH": "NLM (1989)", "ST": "T083", "AN": "index specific states as needed but use MIDWESTERN UNITED STATES when text uses the term & when the region is the intent of the author; CATALOGER: Use for 4 or more states", "MS": "The geographic area of the midwestern region of the United States in general or when the specific state or states are not indicated. The states usually included in this region are Illinois, Indiana, Iowa, Kansas, Kentucky, Michigan, Minnesota, Missouri, Nebraska, Ohio, Oklahoma, North Dakota, South Dakota and Wisconsin.", "HN": "89", "MR": "20150605", "DA": "19880321", "DC": "4", "DX": "19890101", "UI": "D015146"}, {"RECTYPE": "D", "MH": "Cardiotocography", "DE": "CARDIOTOCOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "CTG, Antepartum|T060|EQV|UNK (19XX)|880321|abdef", "ENTRY": "Monitoring, Internal Fetal", "MN": "E01.370.520.230.150", "MH_TH": "NLM (1989)", "ST": "T060", "PI": "Uterine Contraction (1974-1988)", "MS": "Monitoring of FETAL HEART frequency before birth in order to assess impending prematurity in relation to the pattern or intensity of antepartum UTERINE CONTRACTION.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19880321", "DC": "1", "DX": "19890101", "UI": "D015148"}, {"RECTYPE": "D", "MH": "Tocolytic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tocolytic Agent|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Effects, Tocolytic", "MN": "D27.505.954.705.825", "MH_TH": "NLM (1989)", "ST": "T121", "RN": "0", "AN": "note entry term TOCOLYTIC EFFECT: use only for the tocolytic effect of a chemical substance", "PI": "Uterus (1966-1974)", "MS": "Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete.", "PM": "89", "HN": "89", "MR": "20200527", "DA": "19880321", "DC": "1", "DX": "19890101", "UI": "D015149"}, {"RECTYPE": "D", "MH": "Echocardiography, Doppler", "DE": "ECHOCARDIOGR DOPPLER", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Echocardiography, Two-Dimensional Doppler|T060|EPO|NRW|UNK (19XX)|880321|ECHOCARDIOGR TWO DIMENSIONAL DOPPLER|abcdefv", "ENTRY": "Two Dimensional Doppler Echocardiography", "MN": "E01.370.370.380.220.220", "MH_TH": "NLM (1989)", "ST": "T060", "PI": "Ultrasonics (1966-1988)", "MS": "Measurement of intracardiac blood flow using an M-mode and/or two-dimensional (2-D) echocardiogram while simultaneously recording the spectrum of the audible Doppler signal (e.g., velocity, direction, amplitude, intensity, timing) reflected from the moving column of red blood cells.", "OL": "use ECHOCARDIOGRAPHY to search DOPPLER ECHOCARDIOGRAPHY 1985-88", "PM": "89; was DOPPLER ECHOCARDIOGRAPHY see ECHOCARDIOGRAPHY 1985-88", "HN": "89; was DOPPLER ECHOCARDIOGRAPHY see ECHOCARDIOGRAPHY 1985-88", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19880321", "DC": "1", "DX": "19890101", "UI": "D015150"}, {"RECTYPE": "D", "MH": "Immunoblotting", "DE": "IMMUNOBLOT", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Reverse Immunoblotting|T059|NON|NRW|UNK (19XX)|880322|REVERSE IMMUNOBLOT|abcdefv", "ENTRY": "Reverse Immunoblottings", "MN": "E05.601.470.320", "FX": "Immunochemistry", "MH_TH": "NLM (1989)", "ST": "T059", "PI": "Isoelectric Focusing (1984-1988)", "MS": "Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19880322", "DC": "1", "DX": "19890101", "UI": "D015151"}, {"RECTYPE": "D", "MH": "Blotting, Northern", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Northern Blotting|T059|T063|NON|EQV|NLM (1989)|880322|abbcdef", "ENTRY": "Northern Blottings", "MN": "E05.601.100", "MH_TH": "NLM (1989)", "ST": "T063", "AN": "\"northern\" is not capitalized in titles or translations", "PI": "RNA or specific (1979-1988)", "MS": "Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES.", "PM": "91; was see under MOLECULAR PROBE TECHNIQUES 1989-90", "HN": "91(89); was see under MOLECULAR PROBE TECHNIQUES 1989-90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19880322", "DC": "1", "DX": "19910101", "UI": "D015152"}, {"RECTYPE": "D", "MH": "Blotting, Western", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Western Immunoblotting|T059|T063|NON|EQV|NLM (1989)|880322|abbcdef", "ENTRY": "Western Immunoblottings", "MN": "E05.601.470.320.200", "MH_TH": "NLM (1989)", "ST": "T063", "AN": "\"western\" is not capitalized in titles or translations", "PI": "Immunologic Techniques (1981-1988)", "MS": "Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19880322", "DC": "1", "DX": "19890101", "UI": "D015153"}, {"RECTYPE": "D", "MH": "Esophageal Motility Disorders", "DE": "ESOPHAGEAL MOTILITY DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nutcracker Esophagus|T047|NON|NRW|UNK (19XX)|880322|abcdef", "ENTRY": "Motility Disorders, Esophageal", "MN": "C06.405.117.119.500", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Peristalsis (1975-1988)", "MS": "Disorders affecting the motor function of the UPPER ESOPHAGEAL SPHINCTER; LOWER ESOPHAGEAL SPHINCTER; the ESOPHAGUS body, or a combination of these parts. The failure of the sphincters to maintain a tonic pressure may result in gastric reflux of food and acid into the esophagus (GASTROESOPHAGEAL REFLUX). Other disorders include hypermotility (spastic disorders) and markedly increased amplitude in contraction (nutcracker esophagus).", "PM": "1989", "HN": "1989", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19880322", "DC": "1", "DX": "19890101", "UI": "D015154"}, {"RECTYPE": "D", "MH": "Esophageal Spasm, Diffuse", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spasm, Esophageal|T047|NON|EQV|UNK (19XX)|880322|abcdef", "ENTRY": "Spasms, Esophageal", "MN": "C06.405.117.119.500.450", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "\"diffuse\" need not be used by author: note X ref", "PI": "Spasm (1966-1988)", "MS": "A hypermotility disorder of the ESOPHAGUS that is characterized by spastic non-peristaltic responses to SWALLOWING; CHEST PAIN; and DYSPHAGIA.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19880322", "DC": "1", "DX": "19890101", "UI": "D015155"}, {"RECTYPE": "D", "MH": "Hydrops Fetalis", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fetal Hydrops|T184|NON|EQV|UNK (19XX)|880328|abcdef", "ENTRY": "Nonimmunes, Hydrops Fetalis", "MN": "C23.888.277.395", "MH_TH": "ORD (2010)", "ST": "T184", "PI": "Fetal Diseases (1966-1988)", "MS": "Abnormal accumulation of serous fluid in two or more fetal compartments, such as SKIN; PLEURA; PERICARDIUM; PLACENTA; PERITONEUM; AMNIOTIC FLUID. General fetal EDEMA may be of non-immunologic origin, or of immunologic origin as in the case of ERYTHROBLASTOSIS FETALIS.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19880328", "DC": "1", "DX": "19890101", "UI": "D015160"}, {"RECTYPE": "D", "MH": "Dementia, Multi-Infarct", "DS": "DEMENTIA MULTIINFARCT", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Multi-Infarct Dementia|T047|NON|EQV|GHR (2014)|ORD (2010)|UNK (19XX)|880414|MULTIINFARCT DEMENTIA|abcdeeefs", "ENTRY": "Multiinfarct Dementias", "MN": "F03.615.400.350.400", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Dementia (1981-1988)", "MS": "Loss of higher cortical functions with retained awareness due to multiple cortical or subcortical CEREBRAL INFARCTION. Memory, judgment, attention span, and impulse control are often impaired, and may be accompanied by PSEUDOBULBAR PALSY; HEMIPARESIS; reflex abnormalities, and other signs of localized neurologic dysfunction. (From Adams et al., Principles of Neurology, 6th ed, p1060)", "PM": "1989", "HN": "1989", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19880406", "DC": "1", "DX": "19890101", "UI": "D015161"}, {"RECTYPE": "D", "MH": "Micronucleus Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Micronucleus Assays|T059|T063|NON|EQV|UNK (19XX)|880406|abbcdef", "ENTRY": "Tests, Micronucleus", "MN": "E05.393.560.598", "FX": "Micronuclei, Chromosome-Defective", "MH_TH": "NLM (1989)", "ST": "T063", "AN": "NIM", "PI": "Mutagenicity Tests (1981-1988)", "MS": "Induction and quantitative measurement of chromosomal damage leading to the formation of micronuclei (MICRONUCLEI, CHROMOSOME-DEFECTIVE) in cells which have been exposed to genotoxic agents or IONIZING RADIATION.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19880406", "DC": "1", "DX": "19890101", "UI": "D015162"}, {"RECTYPE": "D", "MH": "Superinfection", "DE": "SUPERINFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Superinvasion, Microbial|T046|NON|EQV|UNK (19XX)|880414|abcdef", "ENTRY": "Superinvasions, Microbial", "MN": "C01.597.880", "FX": "Viral Interference", "MH_TH": "NLM (1989)", "ST": "T046", "AN": "opportunistic infect; IM; coord with specific infect (IM)", "PI": "Tissue Culture (1967-1980)", "MS": "A frequent complication of drug therapy for microbial infection. It may result from opportunistic colonization following immunosuppression by the primary pathogen and can be influenced by the time interval between infections, microbial physiology, or host resistance. Experimental challenge and in vitro models are sometimes used in virulence and infectivity studies.", "PM": "1989", "HN": "1989", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19880406", "DC": "1", "DX": "19890101", "UI": "D015163"}, {"RECTYPE": "D", "MH": "Vaccines, Inactivated", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaccines, Killed|T121|T129|NON|EQV|UNK (19XX)|880406|abbcdef", "ENTRY": "Vaccine, Killed", "MN": "D20.215.894.830", "MH_TH": "NLM (1989)", "ST": "T129", "RN": "0", "AN": "coord NIM with specific vaccine (IM)", "PI": "Vaccines, Attenuated (1973-1988)", "MS": "Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins.", "PM": "89", "HN": "89", "MR": "20200527", "DA": "19880406", "DC": "1", "DX": "19890101", "UI": "D015164"}, {"RECTYPE": "D", "MH": "Monitoring, Immunologic", "DE": "MONITORING IMMUNOL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Monitoring, Radioimmunologic|T058|NON|NRW|UNK (19XX)|880408|MONITORING RADIOIMMUNOL|abcdefv", "ENTRY": "Radioimmunological Monitoring", "MN": "E05.478.594.550", "MH_TH": "NLM (1989)", "ST": "T058", "AN": "determ of immune status of patient in diag, and ther: do not confuse entry term IMMUNOSURVEILLANCE with IMMUNOLOGIC SURVEILLANCE, a function of T-lymphocytes; IM GEN only; avoid indexing routinely every word \"monitoring\" as \"monitoring\": read MeSH definition", "PI": "Monitoring, Physiologic (1976-1988)", "MS": "Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumor antigen and other markers (often by RADIOIMMUNOASSAY), studies of cellular or humoral immunity in cancer etiology, IMMUNOTHERAPY trials, etc.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19880408", "DC": "1", "DX": "19890101", "UI": "D015166"}, {"RECTYPE": "D", "MH": "Vagotomy, Truncal", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Truncal Vagotomy|T061|T062|NON|EQV|UNK (19XX)|880408|abbcdef", "ENTRY": "Vagotomies, Truncal", "MN": "E04.525.210.105.600.850.860", "MH_TH": "NLM (1989)", "ST": "T062", "PI": "Vagotomy (1966-1988)", "MS": "Bilateral dissection of the abdominal branches of the vagus nerve. It is used frequently in the surgical management of duodenal and gastric ulcers, as well as in physiologic studies of gastrointestinal secretion and motility.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19880408", "DC": "1", "DX": "19890101", "UI": "D015167"}, {"RECTYPE": "D", "MH": "Lightning Injuries", "DE": "LIGHTNING INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lightning Stroke|T070|NON|NRW|UNK (19XX)|880408|abcdef", "ENTRY": "Strokes, Lightning", "MN": "C26.324.550", "MH_TH": "NLM (1989)", "ST": "T037", "PI": "Lightning (1966-1988)", "MS": "Accidental injuries caused by brief high-voltage electrical discharges during thunderstorms. Cardiopulmonary arrest, coma and other neurologic symptoms, myocardial necrosis, and dermal burns are common. Prompt treatment of the acute sequelae, including cardiopulmonary resuscitation, is indicated for survival.", "PM": "91; was see under ELECTRIC INJURIES 1989-90", "HN": "91(89); was see under ELECTRIC INJURIES 1989-90", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19880408", "DC": "1", "DX": "19910101", "UI": "D015168"}, {"RECTYPE": "D", "MH": "Colony Count, Microbial", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Streak Plate Count|T059|NON|NRW|UNK (19XX)|880408|abcdef", "ENTRY": "Streak Plate Counts", "MN": "E05.200.875.220", "FX": "Parasite Load", "MH_TH": "NLM (1989)", "ST": "T059", "AN": "coordinate NIM with organism /growth or /isol (IM) as appropriate", "PI": "Microbiological Techniques (1978-1988)", "MS": "Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19880408", "DC": "1", "DX": "19890101", "UI": "D015169"}, {"RECTYPE": "D", "MH": "Cerebrospinal Fluid Pressure", "DE": "CSF PRESSURE", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Spinal Fluid Pressure|T034|NON|NRW|UNK (19XX)|880412|abcdef", "ENTRY": "Spinal Fluid Pressures", "MN": "G11.561.170", "FX": "Intracranial Pressure", "MH_TH": "NLM (1989)", "ST": "T034", "PI": "Pressure (1966-1988)", "MS": "Manometric pressure of the CEREBROSPINAL FLUID as measured by lumbar, cerebroventricular, or cisternal puncture. Within the cranial cavity it is called INTRACRANIAL PRESSURE.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19880412", "DC": "1", "DX": "19890101", "UI": "D015170"}, {"RECTYPE": "D", "MH": "Ganglionectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Ganglionectomies", "MN": "E04.525.210.105.800.380", "MH_TH": "NLM (1989)", "ST": "T062", "AN": "coordinate with specific ganglion; coordinate with disease /surg ", "PI": "Sympathectomy, Chemical (1984-1988)", "MS": "Removal of an autonomic or sensory ganglion by any means.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19880413", "DC": "1", "DX": "19890101", "UI": "D015171"}, {"RECTYPE": "D", "MH": "Supratentorial Neoplasms", "DE": "SUPRATENTORIAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cancer, Supratentorial|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Tumors, Supratentorial", "MN": "C10.551.240.250.700", "MH_TH": "NLM (1989)", "ST": "T191", "AN": "general or unspecified; prefer specifics; coordinate with histological type of neoplasm", "PI": "Brain Neoplasms (1966-1988)", "MS": "Primary and metastatic (secondary) tumors of the brain located above the tentorium cerebelli, a fold of dura mater separating the CEREBELLUM and BRAIN STEM from the cerebral hemispheres and DIENCEPHALON (i.e., THALAMUS and HYPOTHALAMUS and related structures). In adults, primary neoplasms tend to arise in the supratentorial compartment, whereas in children they occur more frequently in the infratentorial space. Clinical manifestations vary with the location of the lesion, but SEIZURES; APHASIA; HEMIANOPSIA; hemiparesis; and sensory deficits are relatively common features. Metastatic supratentorial neoplasms are frequently multiple at the time of presentation.", "PM": "1989", "HN": "1989", "CATSH": "CAT LIST", "MR": "19991208", "DA": "19880413", "DC": "1", "DX": "19890101", "UI": "D015173"}, {"RECTYPE": "D", "MH": "Epidural Neoplasms", "DE": "EPIDURAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Malignant Epidural Neoplasms", "MN": "C10.551.240.750.200", "MH_TH": "NLM (1989)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM); coord IM with specific vertebrae (NIM) to locate site on spinal cord", "PI": "Spinal Neoplasms (1966-1988)", "MS": "Neoplasms located in the space between the vertebral PERIOSTEUM and DURA MATER surrounding the SPINAL CORD. Tumors in this location are most often metastatic in origin and may cause neurologic deficits by mass effect on the spinal cord or nerve roots or by interfering with blood supply to the spinal cord.", "PM": "1989", "HN": "1989", "CATSH": "CAT LIST", "MR": "19991208", "DA": "19880413", "DC": "1", "DX": "19890101", "UI": "D015174"}, {"RECTYPE": "D", "MH": "Prolactinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pituitary Adenoma, Prolactin-Secreting|T191|NON|EQV|OMIM (2013)|UNK (19XX)|880413|abcdeef", "ENTRY": "Prolactinomas", "MN": "C19.700.734.792", "FX": "Hyperprolactinemia", "MH_TH": "NLM (1989)", "ST": "T191", "AN": "coordinate IM with PITUITARY NEOPLASMS (IM)", "PI": "Prolactin (1966-1988)", "MS": "A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.", "PM": "1989", "HN": "1989", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19880413", "DC": "1", "DX": "19890101", "UI": "D015175"}, {"RECTYPE": "D", "MH": "Colorectal Neoplasms", "DE": "COLORECTAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Colorectal Cancer|T191|NON|NRW|OMIM (2013)|UNK (19XX)|880414|abcdeef", "ENTRY": "Tumors, Colorectal", "MN": "C06.405.469.860.180", "FX": "Genes, MCC", "MH_TH": "NLM (1989)", "ST": "T191", "AN": "COLONIC NEOPLASMS and RECTAL NEOPLASMS are also available; coordinate with histological type of neoplasm if given;  GENES, DCC (for \"Deleted in Colorectal Cancer\") & GENES, MCC (for \"Mutated in Colorectal Cancer\") are available", "PI": "Rectal Neoplasms (1966-1988)", "MS": "Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20200303", "DA": "19880414", "DC": "1", "DX": "19890101", "UI": "D015179"}, {"RECTYPE": "D", "MH": "Electrophoresis, Gel, Two-Dimensional", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Polyacrylamide Gel Electrophoresis, Two-Dimensional|T059|NON|NRW|UNK (19XX)|880416|abcdef", "ENTRY": "Two-Dimensional Gel Electrophoresis", "MN": "E05.301.300.230", "MH_TH": "NLM (1989)", "ST": "T059", "AN": "usually performed on polyacrylamide gel but agarose is also used", "PI": "Electrophoresis, Polyacrylamide Gel (1975-1988)", "MS": "Electrophoresis in which a second perpendicular electrophoretic transport is performed on the separate components resulting from the first electrophoresis. This technique is usually performed on polyacrylamide gels.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19880416", "DC": "1", "DX": "19890101", "UI": "D015180"}, {"RECTYPE": "D", "MH": "Gamete Intrafallopian Transfer", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Transfer, Gamete Intrafallopian", "MN": "E05.820.800.875", "MH_TH": "NLM (1989)", "ST": "T061", "PI": "Insemination, Artificial (1985-1988)", "MS": "A technique that came into use in the mid-1980's for assisted conception in infertile women with normal fallopian tubes. The protocol consists of hormonal stimulation of the ovaries, followed by laparoscopic follicular aspiration of oocytes, and then the transfer of sperm and oocytes by catheterization into the fallopian tubes.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19880418", "DC": "1", "DX": "19890101", "UI": "D015181"}, {"RECTYPE": "D", "MH": "Lymphatic Irradiation", "DE": "LYMPHATIC IRRAD", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Radiotherapy, Lymphatic|T061|NON|NRW|UNK (19XX)|880418|RADIOTHER LYMPHATIC|abcdefv", "ENTRY": "Therapies, Lymphatic Radiation", "MN": "E02.815.350", "MH_TH": "NLM (1989)", "ST": "T061", "PI": "Radiotherapy, High Energy (1966-1988)", "MS": "External or interstitial irradiation to treat lymphomas (e.g., Hodgkin's and non-Hodgkin's lymphomas) and lymph node metastases and also some autoimmune diseases, such as rheumatoid arthritis.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19880418", "DC": "1", "DX": "19890101", "UI": "D015182"}, {"RECTYPE": "D", "MH": "Restriction Mapping", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Site Mapping, Restriction|T059|T063|NON|EQV|UNK (19XX)|880418|abbcdef", "ENTRY": "Site Mappings, Restriction", "MN": "E05.393.712", "MH_TH": "NLM (1989)", "ST": "T063", "PI": "Endonucleases (1971-1975)", "MS": "Use of restriction endonucleases to analyze and generate a physical map of genomes, genes, or other segments of DNA.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "19980611", "DA": "19880418", "DC": "1", "DX": "19890101", "UI": "D015183"}, {"RECTYPE": "D", "MH": "Hominidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Homo|T015|NON|NRW|NLM (2005)|040204|abcdef", "ENTRY": "Homininus", "MN": "B01.050.150.900.649.313.988.400.112.400", "MH_TH": "NLM (1989)", "ST": "T015", "RN": "txid9604", "RR": "txid9605", "AN": "diseases: coordinate with PRIMATE DISEASES ; note entry term APES: diseases in an unspecified ape, index APE DISEASES  + HOMINIDAE (NIM); extinct humans (Homo species other than Homo sapiens) go here; NEANDERTHALS is also available ", "PI": "Primates (1968-1988)", "MS": "Family of the suborder HAPLORHINI (Anthropoidea) comprising bipedal primate MAMMALS. It includes modern man (HOMO SAPIENS) and the great apes: gorillas (GORILLA GORILLA), chimpanzees (PAN PANISCUS and PAN TROGLODYTES), and orangutans (PONGO PYGMAEUS).", "PM": "89", "HN": "89", "MR": "20200902", "DA": "19880419", "DC": "1", "DX": "19890101", "UI": "D015186"}, {"RECTYPE": "D", "MH": "Lipectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Suction Lipectomy|T061|NON|NRW|UNK (19XX)|880419|abcdef", "ENTRY": "Suction Lipolysis", "MN": "E04.617.450", "MH_TH": "NLM (1989)", "ST": "T061", "PI": "Surgery, Plastic (1967-1988)", "MS": "Removal of localized SUBCUTANEOUS FAT deposits by SUCTION CURETTAGE or blunt CANNULATION in the cosmetic correction of OBESITY and other esthetic contour defects.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19880419", "DC": "1", "DX": "19890101", "UI": "D015187"}, {"RECTYPE": "D", "MH": "Blood Glucose Self-Monitoring", "DE": "BGSM", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Self-Monitoring, Blood Glucose|T060|NON|EQV|UNK (19XX)|880420|abcdef", "ENTRY": "Sugar Self-Monitorings, Blood", "MN": "E05.200.124.100.105", "MH_TH": "NLM (1989)", "ST": "T060", "AN": "usually NIM; coordinate with disease /blood, not /physiopathol", "PI": "Self Care (1981-1988)", "MS": "Self evaluation of whole blood glucose levels outside the clinical laboratory. A digital or battery-operated reflectance meter may be used. It has wide application in controlling unstable insulin-dependent diabetes.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20200618", "DA": "19880420", "DC": "1", "DX": "19890101", "UI": "D015190"}, {"RECTYPE": "D", "MH": "Infratentorial Neoplasms", "DE": "INFRATENTORIAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Posterior Fossa Neoplasms|T191|NON|EQV|NLM (2000)|991103|POSTERIOR FOSSA NEOPL|abcdefv", "ENTRY": "Tumor, Posterior Fossa", "MN": "C10.551.240.250.400", "MH_TH": "NLM (1989)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "PI": "Cerebellar Neoplasms (1971-1988)", "MS": "Intracranial tumors originating in the region of the brain inferior to the TENTORIUM CEREBELLI, which contains the cerebellum, FOURTH VENTRICLE; CEREBELLOPONTINE ANGLE; BRAIN STEM, and related structures. Primary tumors of this region are more frequent in children, and may present with ATAXIA; CRANIAL NERVE DISEASES; vomiting; HEADACHE; HYDROCEPHALUS; or other signs of neurologic dysfunction. Relatively frequent histologic subtypes include TERATOMA; MEDULLOBLASTOMA; GLIOBLASTOMA; ASTROCYTOMA; EPENDYMOMA; CRANIOPHARYNGIOMA; and choroid plexus papilloma (PAPILLOMA, CHOROID PLEXUS).", "PM": "1989", "HN": "1989", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19880421", "DC": "1", "DX": "19890101", "UI": "D015192"}, {"RECTYPE": "D", "MH": "Chorionic Villi Sampling", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Biopsy, Chorionic Villi|T060|NON|EQV|UNK (19XX)|880421|abcdef", "ENTRY": "Samplings, Chorionic Villus", "MN": "E05.242.384.100.149", "MH_TH": "BIOETHICS (1991)", "ST": "T060", "PI": "Prenatal Diagnosis (1983-1988)", "MS": "A method for diagnosis of fetal diseases by sampling the cells of the placental chorionic villi for DNA analysis, presence of bacteria, concentration of metabolites, etc. The advantage over amniocentesis is that the procedure can be carried out in the first trimester.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19880421", "DC": "1", "DX": "19890101", "UI": "D015193"}, {"RECTYPE": "D", "MH": "Diffusion Chambers, Culture", "AQ": "CL EC HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Tissue Cages|T075|NON|NRW|UNK (19XX)|880421|abcdef", "ENTRY": "Tissue Cage", "MN": "E07.241", "FX": "Culture Techniques", "MH_TH": "NLM (1989)", "ST": "T075", "PI": "Tissue Culture (1966-1988)", "MS": "Devices used in a technique by which cells or tissues are grown in vitro or, by implantation, in vivo within chambers permeable to diffusion of solutes across the chamber walls. The chambers are used for studies of drug effects, osmotic responses, cytogenic and immunologic phenomena, metabolism, etc., and include tissue cages.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20170602", "DA": "19880421", "DC": "1", "DX": "19890101", "UI": "D015194"}, {"RECTYPE": "D", "MH": "Drug Design", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Pharmaceutical Design|T090|NON|EQV|NLM (2020)|190404|abcdef", "ENTRY": "Pharmaceutical Designs", "MN": "E05.290.563.250", "FX": "Designer Drugs", "MH_TH": "NLM (1989)", "ST": "T090", "AN": "do not confuse with DESIGNER DRUGS", "PI": "Drugs (1966-1988)", "MS": "The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19880421", "DC": "1", "DX": "19890101", "UI": "D015195"}, {"RECTYPE": "D", "MH": "Carcinogenicity Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tumorigenicity Tests|T060|T062|NON|EQV|UNK (19XX)|880423|abbcdef", "ENTRY": "Tumorigenicity Test", "MN": "E05.940.150", "FX": "Mutagenicity Tests", "MH_TH": "NLM (1989)", "ST": "T062", "AN": "NIM; Manual 24.5.6.2+", "PI": "Mutagenicity Tests (1981-1988)", "MS": "Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "19940512", "DA": "19880423", "DC": "1", "DX": "19890101", "UI": "D015197"}, {"RECTYPE": "D", "MH": "Designer Drugs", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Designer Drug|T121|T131|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Drugs, Designer", "MN": "D26.909.500", "FX": "Substance-Related Disorders", "MH_TH": "NLM (1989)", "ST": "T131", "RN": "0", "AN": "coordinate with specific drug or chemical; do not confuse with DRUG DESIGN ", "PI": "Street Drugs (1985-1988)", "MS": "Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.", "PM": "1989", "HN": "1989", "MR": "20200527", "DA": "19880423", "DC": "1", "DX": "19890101", "UI": "D015198"}, {"RECTYPE": "D", "MH": "Extracorporeal Membrane Oxygenation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Venovenous Extracorporeal Membrane Oxygenation|T061|NON|NRW|NLM (2021)|200415|abcdef", "ENTRY": "Venovenous ECMOs", "MN": "E04.292.451", "FX": "Oxygenators, Membrane", "MH_TH": "NLM (1989)", "ST": "T061", "PI": "Oxygenators, Membrane (1971-1988)", "MS": "Application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of SMOKE INHALATION INJURY; RESPIRATORY FAILURE; and CARDIAC FAILURE.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19880423", "DC": "1", "DX": "19890101", "UI": "D015199"}, {"RECTYPE": "D", "MH": "Fluoroimmunoassay", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Time-Resolved Immunofluorometric Assay|T059|NON|NRW|UNK (19XX)|880430|abcdef", "ENTRY": "Time-Resolved Immunofluorometric Assays", "MN": "E05.478.583.375.655", "MH_TH": "NLM (1989)", "ST": "T059", "AN": "used with reference to the FLUORESCENT ANTIBODY TECHNIQUE where it is indented; NIM", "PI": "Spectrometry, Fluorescence (1975-1988)", "MS": "The use of fluorescence spectrometry to obtain quantitative results for the FLUORESCENT ANTIBODY TECHNIQUE. One advantage over the other methods (e.g., radioimmunoassay) is its extreme sensitivity, with a detection limit on the order of tenths of microgram/liter.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19880430", "DC": "1", "DX": "19890101", "UI": "D015200"}, {"RECTYPE": "D", "MH": "Meta-Analysis as Topic", "PRINT ENTRY": "Data Pooling|T170|NON|EQV|NLM (1990)|890510|abcdef", "ENTRY": "Overview, Clinical Trial", "MN": "N06.850.520.445.500", "FX": "Review Literature as Topic", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "for general design, methodology, economics, etc. of meta-analysis studies; a different heading META-ANALYSIS is used for reports of a specific meta-analysis study", "PI": "Statistics (1980-1988)", "MS": "A quantitative method of combining the results of independent studies (usually drawn from the published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc., with application chiefly in the areas of research and medicine.", "PM": "2008; see META-ANALYSIS 1989-2007", "HN": "2008(1989)", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19880430", "DC": "1", "DX": "19890101", "UI": "D015201"}, {"RECTYPE": "D", "MH": "Protein Engineering", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "PRINT ENTRY": "Genetic Engineering of Proteins|T059|T063|NON|EQV|UNK (19XX)|880430|GENET ENGINEERING OF PROTEINS|abbcdefv", "ENTRY": "Protein Genetic Engineering", "MN": "E05.393.420.601", "FX": "Mutagenesis, Site-Directed", "MH_TH": "NLM (1989)", "ST": "T063", "PI": "Mutation (1983-1988)", "MS": "Procedures by which protein structure and function are changed or created in vitro by altering existing or synthesizing new structural genes that direct the synthesis of proteins with sought-after properties. Such procedures may include the design of MOLECULAR MODELS of proteins using COMPUTER GRAPHICS or other molecular modeling techniques; site-specific mutagenesis (MUTAGENESIS, SITE-SPECIFIC) of existing genes; and DIRECTED MOLECULAR EVOLUTION techniques to create new genes.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20040730", "DA": "19880430", "DC": "1", "DX": "19890101", "UI": "D015202"}, {"RECTYPE": "D", "MH": "Reproducibility of Results", "PRINT ENTRY": "Validity of Results|T080|NON|REL|NLM (1990)|890510|abcdef", "ENTRY": "Validity, Face", "MN": "N06.850.520.445.725", "MH_TH": "NLM (1989)", "ST": "T081", "AN": "IM general only; coordinate NIM with specific subject (IM)", "MS": "The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19880430", "DC": "1", "DX": "19890101", "UI": "D015203"}, {"RECTYPE": "D", "MH": "Spectroscopy, Mossbauer", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Nuclear Gamma Resonance Spectroscopy|T059|NON|EQV|UNK (19XX)|880430|abcdef", "MN": "E05.196.867.776.751", "MH_TH": "NLM (1989)", "ST": "T059", "AN": "a type of spectrum anal; NIM", "PI": "Spectrum Analysis (1966-1988)", "MS": "A spectroscopic technique which uses the Mossbauer effect (inelastic scattering of gamma radiation resulting from interaction with heavy nuclei) to monitor the small variations in the interaction between an atomic nucleus and its environment. Such variations may be induced by changes in temperature, pressure, chemical state, molecular conformation, molecular interaction, or physical site. It is particularly useful for studies of structure-activity relationship in metalloproteins, mobility of heavy metals, and the state of whole tissue and cell membranes.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19880430", "DC": "1", "DX": "19890101", "UI": "D015204"}, {"RECTYPE": "D", "MH": "Northwestern United States", "AQ": "EH EP", "PRINT ENTRY": "Pacific Northwest|T083|NAM|NRW|UNK (19XX)|880430|abcdef", "ENTRY": "Northwest US|T083|NAM|EQV|UNK (19XX)|880430|abcdef", "MN": "Z01.107.567.875.560", "MH_TH": "NLM (1989)", "ST": "T083", "AN": "index specific states as needed but use NORTHWESTERN UNITED STATES when text uses the term & when the region is the intent of the author; CATALOGER: Use for 4 or more states", "MS": "The geographic area of the northwestern region of the United States. The states usually included in this region are Idaho, Montana, Oregon, Washington, and Wyoming.", "HN": "89", "MR": "20150605", "DA": "19880430", "DC": "4", "DX": "19890101", "UI": "D015205"}, {"RECTYPE": "D", "MH": "Southwestern United States", "AQ": "EH EP", "PRINT ENTRY": "Southwest U.S.|T083|NAM|EQV|UNK (19XX)|880430|abcdef", "ENTRY": "Southwest US|T083|NAM|EQV|UNK (19XX)|880430|abcdef", "MN": "Z01.107.567.875.760", "MH_TH": "NLM (1989)", "ST": "T083", "AN": "index specific states as needed but use SOUTHWESTERN UNITED STATES when text uses the term & when the region is the intent of the author; CATALOGER: Use for 4 or more states", "MS": "The geographic area of the southwestern region of the United States. The states usually included in this region are Arizona, California, Colorado, Nevada, New Mexico, Texas, and Utah.", "HN": "89", "MR": "20150605", "DA": "19880430", "DC": "4", "DX": "19890101", "UI": "D015206"}, {"RECTYPE": "D", "MH": "Osteoarthritis, Hip", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Osteoarthritis of the Hip|T047|NON|EQV|NLM (2020)|190124|abcdef", "ENTRY": "Osteoarthritis Of Hips", "MN": "C05.799.613.400", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Osteoarthritis (1966-1988)", "MS": "Noninflammatory degenerative disease of the hip joint which usually appears in late middle or old age. It is characterized by growth or maturational disturbances in the femoral neck and head, as well as acetabular dysplasia. A dominant symptom is pain on weight-bearing or motion.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19880502", "DC": "1", "DX": "19890101", "UI": "D015207"}, {"RECTYPE": "D", "MH": "Smoke Inhalation Injury", "DE": "SMOKE INHAL INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Inhalation Injury, Smoke|T037|NON|EQV|UNK (19XX)|880502|INHAL INJ SMOKE|abcdefv", "ENTRY": "Smoke Inhalation Injuries", "MN": "C26.200.322.800", "MH_TH": "NLM (1989)", "ST": "T037", "AN": "BURNS, INHALATION is also available", "PI": "Burns, Inhalation (1966-1988)", "MS": "Pulmonary injury following the breathing in of toxic smoke from burning materials such as plastics, synthetics, building materials, etc. This injury is the most frequent cause of death in burn patients.", "OL": "search SMOKE INHALATION under BURNS, INHALATION 1966-88", "PM": "89; was SMOKE INHALATION see BURNS, INHALATION 1963-88", "HN": "89; was SMOKE INHALATION see BURNS, INHALATION 1963-88", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19880502", "DC": "1", "DX": "19890101", "UI": "D015208"}, {"RECTYPE": "D", "MH": "Cholangitis, Sclerosing", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sclerosing Cholangitis, Primary", "MN": "C06.130.120.200.110", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Sclerosis (1966-1988)", "MS": "Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19880504", "DC": "1", "DX": "19890101", "UI": "D015209"}, {"RECTYPE": "D", "MH": "Arthritis, Gouty", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gouty Arthritis|T047|NON|EQV|NLM (1990)|881220|abcdef", "ENTRY": "Gouty Arthritides", "MN": "C18.452.648.798.368.410", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Gout (1966-1988)", "MS": "Arthritis, especially of the great toe, as a result of gout. Acute gouty arthritis often is precipitated by trauma, infection, surgery, etc. The initial attacks are usually monoarticular but later attacks are often polyarticular. Acute and chronic gouty arthritis are associated with accumulation of MONOSODIUM URATE in and around affected joints.", "OL": "use ARTHRITIS, GOUTY to search GOUTY ARTHRITIS 1989", "PM": "90; was GOUTY ARTHRITIS 1989", "HN": "90; was GOUTY ARTHRITIS 1989", "CATSH": "CAT LIST", "MR": "20160303", "DA": "19880504", "DC": "1", "DX": "19890101", "UI": "D015210"}, {"RECTYPE": "D", "MH": "Zellweger Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Zellweger-Like Syndrome|T047|EPO|REL|NLM (2000)|991103|abcdef", "ENTRY": "Zellweger Like Syndrome", "MN": "C18.452.648.663.970", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Liver Diseases (1966-1988)", "MS": "An autosomal recessive disorder due to defects in PEROXISOME biogenesis which involves more than 13 genes encoding peroxin proteins of the peroxisomal membrane and matrix. Zellweger syndrome is typically seen in the neonatal period with features such as dysmorphic skull; MUSCLE HYPOTONIA; SENSORINEURAL HEARING LOSS; visual compromise; SEIZURES; progressive degeneration of the KIDNEYS and the LIVER. Zellweger-like syndrome refers to phenotypes resembling the neonatal Zellweger syndrome but seen in children or adults with apparently intact peroxisome biogenesis.", "PM": "1989", "HN": "1989", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19880504", "DC": "1", "DX": "19890101", "UI": "D015211"}, {"RECTYPE": "D", "MH": "Inflammatory Bowel Diseases", "DE": "INFLAMM BOWEL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Inflammatory Bowel Disease", "MN": "C06.405.469.432", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Crohn Disease (1980-1988)", "MS": "Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19880504", "DC": "1", "DX": "19890101", "UI": "D015212"}, {"RECTYPE": "D", "MH": "Neuroimmunomodulation", "DE": "NEUROIMMUNOMOD", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Vagal-immune Interactions|T023|NON|REL|NLM (2020)|190214|abcdef", "ENTRY": "Vagal-immune Interaction", "MN": "G12.535.575", "FX": "Neurogenic Inflammation", "MH_TH": "NLM (1989)", "ST": "T040", "PI": "Neurosecretory Systems (1987-1988)", "MS": "The biochemical and electrophysiological interactions between the NERVOUS SYSTEM and IMMUNE SYSTEM.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20190429", "DA": "19880504", "DC": "1", "DX": "19890101", "UI": "D015213"}, {"RECTYPE": "D", "MH": "Antigens, Differentiation, Myelomonocytic", "DE": "ANTIGENS DIFFER MM", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Myelomonocytic Differentiation Antigens|T116|T129|NON|EQV|UNK (19XX)|880504|MM DIFFER ANTIGENS|abbcdefv", "ENTRY": "Antigens, Myelomonocytic Differentiation", "MN": "D23.101.100.900", "MH_TH": "NLM (1989)", "ST": "T129", "RN": "0", "PI": "Monocytes (1976-1988)", "MS": "Surface antigens expressed on myeloid cells of the granulocyte-monocyte-histiocyte series during differentiation. Analysis of their reactivity in normal and malignant myelomonocytic cells is useful in identifying and classifying human leukemias and lymphomas.", "OL": "use ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC to search LEU ANTIGENS, MYELOMONOCYTIC, LEU-M1 ANTIGENS, LEU-M2 ANTIGENS, & LEU-M4 ANTIGENS 1989-94", "PM": "89; LEU ANTIGENS, MYELOMONOCYTIC, LEU-M1 ANTIGENS, LEU-M2 ANTIGENS, & LEU-M4 ANTIGENS were see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94", "HN": "89; LEU ANTIGENS, MYELOMONOCYTIC, LEU-M1 ANTIGENS, LEU-M2 ANTIGENS, & LEU-M4 ANTIGENS were see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94", "MR": "20050630", "DA": "19880504", "DC": "1", "DX": "19890101", "UI": "D015214"}, {"RECTYPE": "D", "MH": "Zidovudine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Azidothymidine|T114|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|880509|abbcdeef", "ENTRY": "BWA509U", "MN": "D13.570.685.705.950", "PA": "Reverse Transcriptase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Thymidine, 3'-azido-3'-deoxy-", "RN": "4B9XT59T7S", "RR": "30516-87-1 (Zidovudine)", "PI": "Thymidine/analogs & derivatives (1975-1988)", "MS": "A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia.", "PM": "89", "HN": "89", "MR": "20160601", "DA": "19880509", "DC": "1", "DX": "19890101", "UI": "D015215"}, {"RECTYPE": "D", "MH": "Cholesterol Ester Storage Disease", "DE": "CHOLESTEROL ESTER STORAGE DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cholesteryl Ester Storage Disease|T047|NON|EQV|GHR (2014)|UNK (19XX)|880511|CHOLESTERYL ESTER STORAGE DIS|abcdeefv", "MN": "C18.452.648.595.201", "FX": "Sterol Esterase", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Lipoidosis (1966-1988)", "MS": "An autosomal recessive disorder caused by mutations in the gene for acid lipase (STEROL ESTERASE). It is characterized by the accumulation of neutral lipids, particularly CHOLESTEROL ESTERS in leukocytes, fibroblasts, and hepatocytes.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19880511", "DC": "1", "DX": "19890101", "UI": "D015217"}, {"RECTYPE": "D", "MH": "Hyperostosis, Sternocostoclavicular", "DE": "SCCH", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sternocostoclavicular Hyperostosis|T047|NON|EQV|NLM (1990)|890323|abcdef", "ENTRY": "Sternocostoclavicular Hyperostoses", "MN": "C17.300.775.440", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Sternum (1975-1988)", "MS": "A rare, benign rheumatologic disorder or syndrome characterized by hyperostosis and soft tissue ossification between the clavicles and the anterior part of the upper ribs. It is often associated with the dermatologic disorder palmoplantar pustulosis, particularly in Japan. Careful diagnosis is required to distinguish it from psoriatic arthritis, OSTEITIS DEFORMANS, and other diseases. Spondylitis of pustulosis palmaris et plantaris is one of the possible causes; also, evidence suggests one origin may be bone infection. Bone imaging is especially useful for diagnosis. It was originally described by Sonozaki in 1974.", "OL": "use HYPEROSTOSIS, STERNOCOSTOCLAVICULAR to search STERNOCOSTOCLAVICULAR HYPEROSTOSIS 1989", "PM": "90; was STERNOCOSTOCLAVICULAR HYPEROSTOSIS 1989", "HN": "90; was STERNOCOSTOCLAVICULAR HYPEROSTOSIS 1989", "CATSH": "CAT LIST", "MR": "19920520", "DA": "19880511", "DC": "1", "DX": "19890101", "UI": "D015218"}, {"RECTYPE": "D", "MH": "Substrate Cycling", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Futile Cycling|T044|NON|NRW|UNK (19XX)|880511|abcdef", "ENTRY": "Substrate Cyclings, Futile", "MN": "G03.295.835", "MH_TH": "NLM (1989)", "ST": "T044", "AN": "restricted to enzyme activity; almost never IM; coord NIM with specific enzyme (IM)", "PI": "specific substance/metabolism (1975-1988)", "MS": "A set of opposing, nonequilibrium reactions catalyzed by different enzymes which act simultaneously, with at least one of the reactions driven by ATP hydrolysis. The results of the cycle are that ATP energy is depleted, heat is produced and no net substrate-to-product conversion is achieved. Examples of substrate cycling are cycling of gluconeogenesis and glycolysis pathways and cycling of the triglycerides and fatty acid pathways. Rates of substrate cycling may be increased many-fold in association with hypermetabolic states resulting from severe burns, cold exposure, hyperthyroidism, or acute exercise.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19880511", "DC": "1", "DX": "19890101", "UI": "D015219"}, {"RECTYPE": "D", "MH": "Calcium Channels", "DE": "CA CHANNELS", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Voltage-Dependent Calcium Channel|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Voltage Dependent Calcium Channels", "MN": "D12.776.543.585.400.150", "FX": "Calcium-Transporting ATPases", "EC": "antagonists & inhibitors:Calcium Channel Blockers", "MH_TH": "NLM (1989)", "ST": "T123", "RN": "0", "AN": "L-, N-, P-, Q-, R-, and T-Type CALCIUM CHANNELS are available", "PI": "Ion Channels (1979-1988)", "MS": "Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, & R-types are located in neuronal tissue.", "OL": "use CALCIUM CHANNELS to search RECEPTORS, CALCIUM CHANNEL BLOCKER, CALCIUM CHANNEL ANTAGONIST RECEPTORS, CALCIUM CHANNEL BLOCKER RECEPTORS & RECEPTORS, CALCIUM CHANNEL ANTAGONIST 1993; use CALCIUM CHANNELS (NM) to search RECEPTORS, CALCIUM CHANNEL BLOCKER 1983-93", "PM": "89; RECEPTORS, CALCIUM CHANNEL BLOCKER was heading 1993 (was CALCIUM CHANNEL BLOCKER RECEPTOR (NM) 1983-92, was indexed under RECEPTORS, NICOTINIC 1983-92); CALCIUM CHANNEL ANTAGONIST RECEPTORS, CALCIUM CHANNEL BLOCKER RECEPTORS & RECEPTORS, CALCIUM CHANNEL ANTAGONIST were see RECEPTORS, CALCIUM CHANNEL BLOCKER 1993", "HN": "89; RECEPTORS, CALCIUM CHANNEL BLOCKER was heading 1993 (was CALCIUM CHANNEL BLOCKER RECEPTOR (NM) 1983-92); CALCIUM CHANNEL ANTAGONIST RECEPTORS, CALCIUM CHANNEL BLOCKER RECEPTORS & RECEPTORS, CALCIUM CHANNEL ANTAGONIST were see RECEPTORS, CALCIUM CHANNEL BLOCKER 1993", "MR": "20200527", "DA": "19880512", "DC": "1", "DX": "19890101", "UI": "D015220"}, {"RECTYPE": "D", "MH": "Potassium Channels", "DE": "K CHANNELS", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ion Channels, Potassium|T116|T123|NON|EQV|UNK (19XX)|880512|ION CHANNELS K|abbcdefv", "ENTRY": "Potassium Ion Channel", "MN": "D12.776.543.585.400.750", "FX": "Sodium-Potassium-Exchanging ATPase", "EC": "antagonists & inhibitors:Potassium Channel Blockers", "MH_TH": "NLM (1989)", "ST": "T123", "RN": "0", "PI": "Potassium (1979-1988)", "MS": "Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits.", "PM": "89", "HN": "89", "MR": "20160701", "DA": "19880512", "DC": "1", "DX": "19890101", "UI": "D015221"}, {"RECTYPE": "D", "MH": "Sodium Channels", "DE": "NA CHANNELS", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ion Channels, Sodium|T116|T123|NON|EQV|UNK (19XX)|880512|ION CHANNELS NA|abbcdefv", "ENTRY": "Sodium Ion Channel", "MN": "D12.776.543.585.400.875", "FX": "Sodium-Potassium-Exchanging ATPase", "EC": "antagonists & inhibitors:Sodium Channel Blockers", "MH_TH": "NLM (1989)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Sodium (1979-1988)", "MS": "Ion channels that specifically allow the passage of SODIUM ions. A variety of specific sodium channel subtypes are involved in serving specialized functions such as neuronal signaling, CARDIAC MUSCLE contraction, and KIDNEY function.", "PM": "89", "HN": "89", "MR": "20160701", "DA": "19880512", "DC": "1", "DX": "19890101", "UI": "D015222"}, {"RECTYPE": "D", "MH": "Wolman Disease", "DE": "WOLMAN DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Xanthomatosis, Wolman's|T047|EPO|EQV|UNK (19XX)|880512|abcdef", "ENTRY": "Xanthomatosis, Wolmans", "MN": "C18.452.648.595.201.500", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Xanthomatosis (1966-1988)", "MS": "The severe infantile form of inherited lysosomal lipid storage diseases due to deficiency of acid lipase (STEROL ESTERASE). It is characterized by the accumulation of neutral lipids, particularly CHOLESTEROL ESTERS in leukocytes, fibroblasts, and hepatocytes. It is also known as Wolman's xanthomatosis and is an allelic variant of CHOLESTEROL ESTER STORAGE DISEASE.", "PM": "1989", "HN": "1989", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880512", "DC": "1", "DX": "19890101", "UI": "D015223"}, {"RECTYPE": "D", "MH": "Dideoxynucleosides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dideoxyribonucleosides|T114|NON|NRW|UNK (19XX)|880512|abcdef", "ENTRY": "2',3' Dideoxynucleosides", "MN": "D13.570.230.500", "PA": "Reverse Transcriptase Inhibitors", "MH_TH": "NLM (1989)", "ST": "T114", "RN": "0", "AN": "antivirals & antimetabolites", "PI": "Deoxyribonucleosides (1971-1988)", "MS": "Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription.", "PM": "89", "HN": "89", "MR": "19950608", "DA": "19880512", "DC": "1", "DX": "19890101", "UI": "D015224"}, {"RECTYPE": "D", "MH": "Magnetoencephalography", "DE": "MAGNETOENCEPHALOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Magnetoencephalogram|T060|NON|EQV|NLM (2023)|220324|abcdef", "ENTRY": "Magnetoencephalograms", "MN": "E05.540.500", "FX": "Transcranial Magnetic Stimulation", "MH_TH": "NLM (1989)", "ST": "T060", "PI": "Magnetics (1983-1988)", "MS": "The measurement of magnetic fields over the head generated by electric currents in the brain. As in any electrical conductor, electric fields in the brain are accompanied by orthogonal magnetic fields. The measurement of these fields provides information about the localization of brain activity which is complementary to that provided by ELECTROENCEPHALOGRAPHY. Magnetoencephalography may be used alone or together with electroencephalography, for measurement of spontaneous or evoked activity, and for research or clinical purposes.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19880512", "DC": "1", "DX": "19890101", "UI": "D015225"}, {"RECTYPE": "D", "MH": "Dinucleoside Phosphates", "DE": "DN PH", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dinucleoside Triphosphates|T114|NON|NRW|UNK (19XX)|880512|abcdef", "ENTRY": "Triphosphates, Dinucleoside", "MN": "D13.695.250", "MH_TH": "NLM (1989)", "ST": "T114", "RN": "0", "PI": "Oligonucleotides (1972-1988)", "MS": "A group of compounds which consist of a nucleotide molecule to which an additional nucleoside is attached through the phosphate molecule(s). The nucleotide can contain any number of phosphates.", "PM": "89", "HN": "89", "MR": "19920513", "DA": "19880512", "DC": "1", "DX": "19890101", "UI": "D015226"}, {"RECTYPE": "D", "MH": "Lipid Peroxidation", "AQ": "DE GE IM PH RE", "ENTRY": "Peroxidations, Lipid", "MN": "G03.295.531.587", "MH_TH": "NLM (1989)", "ST": "T044", "PI": "Lipids/metabolism (1966-1988)", "MS": "Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19880512", "DC": "1", "DX": "19890101", "UI": "D015227"}, {"RECTYPE": "D", "MH": "Hypertriglyceridemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypertriglyceridemias", "MN": "C18.452.584.500.500.851", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "consider also HYPERLIPOPROTEINEMIA TYPE I; HYPERLIPOPROTEINEMIA TYPE IV; & HYPERLIPOPROTEINEMIA TYPE V", "PI": "Triglycerides (1966-1988)", "MS": "A condition of elevated levels of TRIGLYCERIDES in the blood.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19880512", "DC": "1", "DX": "19890101", "UI": "D015228"}, {"RECTYPE": "D", "MH": "Sexually Transmitted Diseases, Viral", "DE": "SEX TRANSM DIS VIRAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Venereal Diseases, Viral|T047|NON|EQV|UNK (19XX)|880512|VENEREAL DIS VIRAL|abcdefv", "ENTRY": "Viral Venereal Disease", "MN": "C23.550.291.531.937.640", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Venereal Diseases (1966-1986)", "MS": "Viral diseases which are transmitted or propagated by sexual conduct.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19880512", "DC": "1", "DX": "19890101", "UI": "D015229"}, {"RECTYPE": "D", "MH": "Prostaglandin D2", "DS": "PROSTAGLANDIN D 02", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PGD2|T109|T123|EQV|FDA SRS (2014)|NLM (1995)|940426|abbdeef", "ENTRY": "alpha, 11-Dehydroprostaglandin F2", "MN": "D23.469.050.175.725.200.200", "MH_TH": "NLM (1989)", "ST": "T123", "N1": "Prosta-5,13-dien-1-oic acid, 9,15-dihydroxy-11-oxo-, (5Z,9alpha,13E,15S)-", "RN": "RXY07S6CZ2", "RR": "41598-07-6 (Prostaglandin D2)", "PI": "Prostaglandins D (1978-1988)", "MS": "The principal cyclooxygenase metabolite of arachidonic acid. It is released upon activation of mast cells and is also synthesized by alveolar macrophages. Among its many biological actions, the most important are its bronchoconstrictor, platelet-activating-factor-inhibitory, and cytotoxic effects.", "PM": "89", "HN": "89", "MR": "20150608", "DA": "19880512", "DC": "1", "DX": "19890101", "UI": "D015230"}, {"RECTYPE": "D", "MH": "Sexually Transmitted Diseases, Bacterial", "DE": "SEX TRANSM DIS BACT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Venereal Diseases, Bacterial|T047|NON|EQV|UNK (19XX)|880512|VENEREAL DIS BACT|abcdefv", "ENTRY": "Venereal Disease, Bacterial", "MN": "C23.550.291.531.937.281", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Venereal Diseases (1966-1986)", "MS": "Bacterial diseases transmitted or propagated by sexual conduct.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19880512", "DC": "1", "DX": "19890101", "UI": "D015231"}, {"RECTYPE": "D", "MH": "Dinoprostone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prostaglandin E2alpha|T109|T121|T125|NON|EQV|UNK (19XX)|880512|PROSTAGLANDIN E 02 ALPHA|abbbcdefs", "ENTRY": "alpha, Prostaglandin E2", "MN": "D23.469.050.175.725.250.200", "PA": "Oxytocics", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)-", "RN": "K7Q1JQR04M", "RR": "363-24-6 (Dinoprostone)", "AN": "do not confuse with DINOPROST; /biosyn /physiol permitted", "PI": "Prostaglandins E (1975-1988)", "MS": "The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa.", "PM": "89", "HN": "89", "MR": "20150608", "DA": "19880512", "DC": "1", "DX": "19890101", "UI": "D015232"}, {"RECTYPE": "D", "MH": "Models, Statistical", "DE": "MODELS STATIST", "PRINT ENTRY": "Two-Parameter Models|T081|NON|NRW|NLM (1990)|890525|abcdef", "ENTRY": "Two-Parameter Model", "MN": "N06.850.520.830.500", "FX": "Meta-Analysis as Topic", "MH_TH": "NLM (1989)", "ST": "T170", "PI": "Statistics (1966-1988)", "MS": "Statistical formulations or analyses which, when applied to data and found to fit the data, are then used to verify the assumptions and parameters used in the analysis. Examples of statistical models are the linear model, binomial model, polynomial model, two-parameter model, etc.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19880513", "DC": "1", "DX": "19890101", "UI": "D015233"}, {"RECTYPE": "D", "MH": "HLA-A Antigens", "DS": "HLA A 01 ANTIGENS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Antigens, HLA-A|T116|T129|EQV|UNK (19XX)|880514|abbdef", "ENTRY": "HLA A Antigens", "MN": "D23.050.705.552.450.370", "MH_TH": "NLM (1989)", "ST": "T129", "RN": "0", "AN": "general; prefer specifics", "PI": "Histocompatibility Antigens (1975-1980)", "MS": "Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts.", "PM": "89", "HN": "89", "MR": "20230316", "DA": "19880514", "DC": "1", "DX": "19890101", "UI": "D015234"}, {"RECTYPE": "D", "MH": "HLA-B Antigens", "DS": "HLA B 00 ANTIGENS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "HLA-B Antigen|T129|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "HLA B Antigens", "MN": "D23.050.705.552.450.380", "MH_TH": "NLM (1989)", "ST": "T129", "RN": "0", "AN": "general; prefer specifics", "PI": "Histocompatibility Antigens (1975-1981)", "MS": "Class I human histocompatibility (HLA) surface antigens encoded by more than 30 detectable alleles on locus B of the HLA complex, the most polymorphic of all the HLA specificities. Several of these antigens (e.g., HLA-B27, -B7, -B8) are strongly associated with predisposition to rheumatoid and other autoimmune disorders. Like other class I HLA determinants, they are involved in the cellular immune reactivity of cytolytic T lymphocytes.", "PM": "89", "HN": "89", "MR": "20230316", "DA": "19880514", "DC": "1", "DX": "19890101", "UI": "D015235"}, {"RECTYPE": "D", "MH": "HLA-C Antigens", "DS": "HLA C 00 ANTIGENS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Antigens, HLA-C|T116|T129|EQV|UNK (19XX)|880514|abbdef", "ENTRY": "HLA C Antigens", "MN": "D23.050.705.552.450.390", "MH_TH": "NLM (1989)", "ST": "T129", "RN": "0", "PI": "HLA Antigens (1977-1988)", "MS": "Class I human histocompatibility (HLA) antigens encoded by a small cluster of structural genes at the C locus on chromosome 6. They have significantly lower immunogenicity than the HLA-A and -B determinants and are therefore of minor importance in donor/recipient crossmatching. Their primary role is their high-risk association with certain disease manifestations (e.g., spondylarthritis, psoriasis, multiple myeloma).", "PM": "89", "HN": "89", "MR": "20230316", "DA": "19880514", "DC": "1", "DX": "19890101", "UI": "D015236"}, {"RECTYPE": "D", "MH": "Dinoprost", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prostaglandin F2alpha|T109|T121|T125|EQV|UNK (19XX)|880514|PROSTAGLANDIN F 02 ALPHA|abbbdefs", "ENTRY": "alpha, PGF2", "MN": "D23.469.050.175.725.400.200", "PA": "Oxytocics", "FX": "F2-Isoprostanes", "MH_TH": "USAN (1971)", "ST": "T125", "N1": "Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,11alpha,13E,15S)-", "RN": "B7IN85G1HY", "RR": "551-11-1 (Dinoprost)", "AN": "do not confuse with DINOPROSTONE; /biosyn /physiol permitted", "PI": "Prostaglandins F (1975-1988)", "MS": "A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions.", "PM": "89", "HN": "89", "MR": "20150608", "DA": "19880514", "DC": "1", "DX": "19890101", "UI": "D015237"}, {"RECTYPE": "D", "MH": "Sulfotransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sulfotransferase|T116|T126|NON|EQV|NLM (2021)|191230|abbcdef", "MN": "D08.811.913.817.400", "MH_TH": "NLM (1989)", "ST": "T126", "RN": "EC 2.8.2.-", "AN": "do not confuse with SULFURTRANSFERASES", "PI": "Sulfurtransferases (1966-1988)", "MS": "Enzymes which transfer sulfate groups to various acceptor molecules. They are involved in posttranslational sulfation of proteins and sulfate conjugation of exogenous chemicals and bile acids. EC 2.8.2.", "PM": "89", "HN": "89", "MR": "20200527", "DA": "19880514", "DC": "1", "DX": "19890101", "UI": "D015238"}, {"RECTYPE": "D", "MH": "Arylsulfotransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phenol Sulfotransferase|T116|T126|NON|EQV|UNK (19XX)|880514|abbcdef", "ENTRY": "Sulphotransferase, Acetaminophen", "MN": "D08.811.913.817.400.300", "MH_TH": "NLM (1989)", "ST": "T126", "N1": "3'-Phosphoadenylylsulfate:phenol sulfotransferase", "RN": "EC 2.8.2.1", "RR": "9026-09-9 (CAS RN)", "PI": "Transferases (1966-1971)", "MS": "A sulfotransferase that catalyzes the sulfation of a phenol in the presence of 3'-phosphoadenylylsulfate as sulfate donor to yield an aryl sulfate and adenosine 3',5'-bisphosphate. A number of aromatic compounds can act as acceptors; however, organic hydroxylamines are not substrates. Sulfate conjugation by this enzyme is a major pathway for the biotransformation of phenolic and catechol drugs as well as neurotransmitters. EC 2.8.2.1.", "PM": "89", "HN": "89", "MR": "20030709", "DA": "19880514", "DC": "1", "DX": "19890101", "UI": "D015239"}, {"RECTYPE": "D", "MH": "Phorbol 12,13-Dibutyrate", "DE": "PDBU", "DS": "PHORBOL DIBUTYRATE 12 13", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Phorbol 12,13 Dibutyrate", "MN": "D02.455.849.291.500.510.700", "PA": "Carcinogens", "MH_TH": "NLM (1989)", "ST": "T131", "N1": "Butanoic acid, 1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-9aH-cyclopropa(3,4)benz(1,2-e)azulene-9,9a-diyl ester, (1aR-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha))-", "RN": "37558-16-0", "PI": "Phorbol Esters (1979-1988)", "MS": "A phorbol ester found in CROTON OIL which, in addition to being a potent skin tumor promoter, is also an effective activator of calcium-activated, phospholipid-dependent protein kinase (protein kinase C). Due to its activation of this enzyme, phorbol 12,13-dibutyrate profoundly affects many different biological systems.", "PM": "89", "HN": "89", "MR": "20040730", "DA": "19880514", "DC": "1", "DX": "19890101", "UI": "D015240"}, {"RECTYPE": "D", "MH": "Fibrinogens, Abnormal", "DE": "FIBRINOGENS ABNORM", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Abnormal Fibrinogens|T116|T123|NON|EQV|UNK (19XX)|880516|ABNORM FIBRINOGENS|abbcdefv", "MN": "D23.119.490.265", "MH_TH": "NLM (1989)", "ST": "T123", "RN": "0", "PI": "Fibrinogen (1966-1988)", "MS": "Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilized fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing.", "PM": "89", "HN": "89", "MR": "20180630", "DA": "19880516", "DC": "1", "DX": "19890101", "UI": "D015241"}, {"RECTYPE": "D", "MH": "Ofloxacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ru43280", "MN": "D03.633.100.810.835.322.500", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7- -oxo-7H-pyrido(1,2,3-de)- -1,4-benzoxazine-6-carboxylic acid", "RN": "A4P49JAZ9H", "RR": "I2UWV315WA", "PI": "Oxazines (1981-1988)", "MS": "A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.", "PM": "89", "HN": "89", "MR": "20160531", "DA": "19880516", "DC": "1", "DX": "19890101", "UI": "D015242"}, {"RECTYPE": "D", "MH": "Cholesterol, VLDL", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "VLDL Cholesterol|T109|T123|EQV|UNK (19XX)|880516|abbdef", "ENTRY": "Pre beta Lipoprotein Cholesterol", "MN": "D12.776.521.622.700", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Lipoproteins, VLDL (1972-1988)", "MS": "Cholesterol which is contained in or bound to very low density lipoproteins (VLDL). High circulating levels of VLDL cholesterol are found in HYPERLIPOPROTEINEMIA TYPE IIB. The cholesterol on the VLDL is eventually delivered by LOW-DENSITY LIPOPROTEINS to the tissues after the catabolism of VLDL to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LDL.", "PM": "2007; see LIPOPROTEINS, VLDL CHOLESTEROL 1989-2006", "HN": "2007 (1989)", "MR": "20160528", "DA": "19880516", "DC": "1", "DX": "19890101", "UI": "D015243"}, {"RECTYPE": "D", "MH": "Thiorphan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tiorphan|T109|T121|NON|EQV|UNK (19XX)|880516|abbcdef", "MN": "D12.125.481.700.750", "PA": "Protease Inhibitors", "MH_TH": "NLM (1989)", "ST": "T121", "N1": "Glycine, N-(2-(mercaptomethyl)-1-oxo-3-phenylpropyl)-, (+-)-", "RN": "B79L7B5X3Z", "RR": "95909-00-5", "PI": "Mercaptopropionylglycine/analogs & derivatives (1980-1988)", "MS": "A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.", "PM": "89", "HN": "89", "MR": "20130708", "DA": "19880516", "DC": "1", "DX": "19890101", "UI": "D015244"}, {"RECTYPE": "D", "MH": "Deoxyribonuclease BamHI", "DE": "BAMHI", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endonuclease BamHI|T116|T126|EQV|UNK (19XX)|880516|abbdef", "ENTRY": "SolI, Endonuclease", "MN": "D08.811.277.352.355.325.300.260.240", "MH_TH": "NLM (1989)", "ST": "T126", "RN": "EC 3.1.21.-", "PI": "DNA Restriction Enzymes (1975-1988)", "MS": "One of the Type II site-specific deoxyribonucleases (EC 3.1.21.4). It recognizes and cleaves the sequence G/GATCC at the slash. BamHI is from Bacillus amyloliquefaciens N. Numerous isoschizomers have been identified. EC 3.1.21.-.", "PM": "89", "HN": "89", "MR": "20030709", "DA": "19880516", "DC": "1", "DX": "19890101", "UI": "D015245"}, {"RECTYPE": "D", "MH": "Deoxyribonuclease EcoRI", "DE": "ECORI", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endonuclease EcoRI|T116|T126|EQV|UNK (19XX)|880516|abbdef", "ENTRY": "Restriction Endonuclease RsrI|T116|T126|REL|UNK (19XX)|881102|abbdef", "MN": "D08.811.277.352.355.325.300.260.250", "MH_TH": "NLM (1989)", "ST": "T126", "RN": "EC 3.1.21.-", "PI": "DNA Restriction Enzymes (1975-1988)", "MS": "One of the Type II site-specific deoxyribonucleases (EC 3.1.21.4). It recognizes and cleaves the sequence G/AATTC at the slash. EcoRI is from E coliRY13. Several isoschizomers have been identified. EC 3.1.21.-.", "PM": "89", "HN": "89", "MR": "20030709", "DA": "19880516", "DC": "1", "DX": "19890101", "UI": "D015246"}, {"RECTYPE": "D", "MH": "Deoxyribonuclease HindIII", "DE": "HINDIII", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endonuclease HindIII|T116|T126|EQV|UNK (19XX)|880516|abbdef", "ENTRY": "LlaCI, Endonuclease", "MN": "D08.811.277.352.355.325.300.260.260", "MH_TH": "NLM (1989)", "ST": "T126", "RN": "EC 3.1.21.-", "PI": "DNA Restriction Enzymes (1975-1988)", "MS": "One of the Type II site-specific deoxyribonucleases (EC 3.1.21.4). It recognizes and cleaves the sequence A/AGCTT at the slash. HindIII is from Haemophilus influenzae R(d). Numerous isoschizomers have been identified. EC 3.1.21.-.", "PM": "89", "HN": "89", "MR": "20030709", "DA": "19880516", "DC": "1", "DX": "19890101", "UI": "D015247"}, {"RECTYPE": "D", "MH": "Gemfibrozil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "PMS Gemfibrozil", "MN": "D10.251.400.895.593.350", "PA": "Hypolipidemic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pentanoic acid, 5-(2,5-dimethylphenoxy)-2,2-dimethyl-", "RN": "Q8X02027X3", "RR": "25812-30-0 (Gemfibrozil)", "PI": "Valerates (1966-1974)", "MS": "A lipid-regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol.", "PM": "89", "HN": "89", "MR": "20160701", "DA": "19880516", "DC": "1", "DX": "19890101", "UI": "D015248"}, {"RECTYPE": "D", "MH": "Aclarubicin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aclacinomycin A|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|880516|abbcdeef", "ENTRY": "NSC208734", "MN": "D09.408.051.059.050", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USAN (1981)", "ST": "T121", "N1": "1-Naphthacenecarboxylic acid,(2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, methyl ester, (1R-(1alpha,2beta,4beta))-", "RN": "74KXF8I502", "RR": "57576-44-0 (Aclarubicin)", "PI": "Naphthacenes (1966-1988)", "MS": "An anthracycline produced by Streptomyces galilaeus. It has potent antineoplastic activity.", "PM": "89", "HN": "89", "MR": "20160701", "DA": "19880516", "DC": "1", "DX": "19890101", "UI": "D015250"}, {"RECTYPE": "D", "MH": "Epirubicin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "4'-Epidoxorubicin|T109|T121|NON|EQV|UNK (19XX)|880516|EPIDOXORUBICIN 04|abbcdefs", "ENTRY": "NSC256942", "MN": "D09.408.051.059.200.175.200", "PA": "Topoisomerase II Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-", "RN": "3Z8479ZZ5X", "RR": "56420-45-2 (Epirubicin)", "PI": "Doxorubicin (1973-1988)", "MS": "An anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.", "PM": "89", "HN": "89", "MR": "20160701", "DA": "19880516", "DC": "1", "DX": "19890101", "UI": "D015251"}, {"RECTYPE": "D", "MH": "Deoxyribonucleases, Type II Site-Specific", "DE": "DNASE SS II", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Type II Restriction Enzymes|T116|T126|NON|EQV|UNK (19XX)|880517|abbcdef", "ENTRY": "Site Specific DNase, Type II", "MN": "D08.811.277.352.355.325.300.260", "MH_TH": "NLM (1989)", "ST": "T126", "RN": "EC 3.1.21.4", "PI": "DNA Restriction Enzymes (1978-1988)", "MS": "Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognize specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.4.", "PM": "89", "HN": "89", "MR": "20030709", "DA": "19880517", "DC": "1", "DX": "19890101", "UI": "D015252"}, {"RECTYPE": "D", "MH": "Deoxyribonucleases, Type I Site-Specific", "DE": "DNASE SS I", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Type I Restriction Enzymes|T116|T126|NON|EQV|UNK (19XX)|880517|abbcdef", "ENTRY": "Site Specific DNase, Type I", "MN": "D08.811.277.352.355.325.300.250", "MH_TH": "NLM (1989)", "ST": "T126", "RN": "EC 3.1.21.3", "PI": "DNA Restriction Enzymes (1978-1988)", "MS": "Enzyme systems containing three different subunits and requiring ATP, S-adenosylmethionine, and magnesium for endonucleolytic activity to give random double-stranded fragments with terminal 5'-phosphates. They function also as DNA-dependent ATPases and modification methylases, catalyzing the reactions of EC 2.1.1.72 and EC 2.1.1.73 with similar site-specificity. The systems recognize specific short DNA sequences and cleave at sites remote from the recognition sequence. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.3.", "PM": "89", "HN": "89", "MR": "20030709", "DA": "19880517", "DC": "1", "DX": "19890101", "UI": "D015253"}, {"RECTYPE": "D", "MH": "DNA Modification Methylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Modification Methylases|T116|T126|NON|EQV|UNK (19XX)|880517|abbcdef", "ENTRY": "Modification Methyltransferases, DNA", "MN": "D08.811.913.555.500.350", "MH_TH": "NLM (1989)", "ST": "T126", "RN": "EC 2.1.1.-", "PI": "Methyltransferases (1971-1988)", "MS": "Enzymes that are part of the restriction-modification systems. They are responsible for producing a species-characteristic methylation pattern, on either adenine or cytosine residues, in a specific short base sequence in the host cell's own DNA. This methylated sequence will occur many times in the host-cell DNA and remain intact for the lifetime of the cell. Any DNA from another species which gains entry into a living cell and lacks the characteristic methylation pattern will be recognized by the restriction endonucleases of similar specificity and destroyed by cleavage. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms.", "PM": "1989", "HN": "1989", "MR": "20030709", "DA": "19880517", "DC": "1", "DX": "19890101", "UI": "D015254"}, {"RECTYPE": "D", "MH": "Idarubicin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "4-Demethoxydaunorubicin|T109|T121|NON|EQV|UNK (19XX)|880517|DEMETHOXYDAUNORUBICIN 04|abbcdefs", "ENTRY": "NSC256439", "MN": "D09.408.051.059.200.300", "PA": "Topoisomerase II Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-", "RN": "ZRP63D75JW", "RR": "5VV3MDU5IE", "PI": "Daunorubicin/analogs & derivatives (1975-1988)", "MS": "An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA.", "PM": "89", "HN": "89", "MR": "20130708", "DA": "19880517", "DC": "1", "DX": "19890101", "UI": "D015255"}, {"RECTYPE": "D", "MH": "Coenzyme A-Transferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CoA-Transferases|T116|T126|EQV|UNK (19XX)|880517|abbdef", "ENTRY": "Transferases, Coenzyme A", "MN": "D08.811.913.817.200", "MH_TH": "NLM (1989)", "ST": "T126", "RN": "EC 2.8.3.-", "PI": "Transferases (1966-1971)", "MS": "Enzymes which transfer coenzyme A moieties from acyl- or acetyl-CoA to various carboxylic acceptors forming a thiol ester. Enzymes in this group are instrumental in ketone body metabolism and utilization of acetoacetate in mitochondria. EC 2.8.3.", "PM": "89", "HN": "89", "MR": "20160628", "DA": "19880517", "DC": "1", "DX": "19890101", "UI": "D015256"}, {"RECTYPE": "D", "MH": "DNA-Cytosine Methylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Site-Specific Methyltransferases (Cytosine-Specific)|T116|T126|NON|NRW|UNK (19XX)|880517|SITE SPECIFIC METHYLTRANSFERASES CYTOSINE SPECIFIC|abbcdefs", "ENTRY": "Methylases, Cytosine-Specific DNA", "MN": "D08.811.913.555.500.350.100", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 2.1.1.-", "AN": "note specifics: DNA (CYTOSINE-5-)-METHYLTRANSFERASE and SITE-SPECIFIC DNA-METHYLTRANSFERASE (CYTOSINE-N(4)-SPECIFIC)", "PI": "Methyltransferases (1971-1988)", "MS": "Methylases that are specific for CYTOSINE residues found on DNA.", "PM": "2010; see SITE-SPECIFIC DNA METHYLTRANSFERASE (CYTOSINE-SPECIFIC) 1998-2009, see DNA MODIFICATION METHYLASES (CYTOSINE-SPECIFIC) 1989-1997", "HN": "2010(1989)", "MR": "20200527", "DA": "19880517", "DC": "1", "DX": "19890101", "UI": "D015257"}, {"RECTYPE": "D", "MH": "Acid Rain", "AQ": "AE AN EC LJ PC PO SN TO", "PRINT ENTRY": "Rain, Acid|T069|T131|NON|EQV|UNK (19XX)|880517|abbcdef", "ENTRY": "Rains, Acid", "MN": "N06.850.460.790.410.050", "MH_TH": "NLM (1989)", "ST": "T131", "RN": "0", "AN": "specify geog if pertinent", "PI": "Weather (1975-1988)", "MS": "Acidic water usually pH 2.5 to 4.5, which poisons the ecosystem and adversely affects plants, fishes, and mammals. It is caused by industrial pollutants, mainly sulfur oxides and nitrogen oxides, emitted into the atmosphere and returning to earth in the form of acidic rain water.", "PM": "89", "HN": "89", "MR": "20160602", "DA": "19880517", "DC": "1", "DX": "19890101", "UI": "D015258"}, {"RECTYPE": "D", "MH": "Dopamine Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Dopaminergic", "MN": "D27.505.696.577.150", "MH_TH": "NLM (1989)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; note entry term DOPAMINE EFFECT: use only for the dopamine effect of a chemical substance", "PI": "Receptors, Dopamine (1977-1988)", "MS": "Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.", "OL": "use DOPAMINE AGENTS to search DOPAMINERGIC AGENTS 1989-94", "PM": "95; was DOPAMINERGIC AGENTS 1989-94", "HN": "95; was DOPAMINERGIC AGENTS 1989-94; DOPAMINE NEURON AGENTS (NON MESH) was heading 1995", "MR": "20110624", "DA": "19880517", "DC": "1", "DX": "19890101", "UI": "D015259"}, {"RECTYPE": "D", "MH": "Neprilysin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Membrane Metallo-Endopeptidase|T116|T126|T129|NON|EQV|NLM (1997)|951212|abbbcdef", "ENTRY": "YGG Forming Enzyme", "MN": "D23.101.140.500", "MH_TH": "NLM (1989)", "ST": "T129", "RN": "EC 3.4.24.11", "PI": "Peptide Peptidohydrolases (1966-1987)", "MS": "Enzyme that is a major constituent of kidney brush-border membranes and is also present to a lesser degree in the brain and other tissues. It preferentially catalyzes cleavage at the amino group of hydrophobic residues of the B-chain of insulin as well as opioid peptides and other biologically active peptides. The enzyme is inhibited primarily by EDTA, phosphoramidon, and thiorphan and is reactivated by zinc. Neprilysin is identical to common acute lymphoblastic leukemia antigen (CALLA Antigen), an important marker in the diagnosis of human acute lymphocytic leukemia. There is no relationship with CALLA PLANT.", "OL": "use NEPRILYSIN (NM) to search COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGENS 1983-92", "PM": "1997; was MEMBRANE METALLO-ENDOPEPTIDASE 1989-96; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGENS was indexed under ANTIGENS, NEOPLASM & ANTIGENS, DIFFERENTIATION 1983-92; for CALLA ANTIGEN see CALLA 1993-2002", "HN": "1997; was MEMBRANE METALLO-ENDOPEPTIDASE 1989-96; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGENS was COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGENS (NM) 1983-92", "MR": "20170524", "DA": "19880518", "DC": "1", "DX": "19890101", "UI": "D015260"}, {"RECTYPE": "D", "MH": "Xenobiotics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Xenobiotic|T103|T123|T131|NON|EQV|NLM (2021)|191114|abbbcdef", "MN": "D26.969", "MH_TH": "NLM (1989)", "ST": "T131", "RN": "0", "AN": "general or unspecified; prefer specifics; do not interpret: use the term if used by the author", "MS": "Chemical substances that are foreign to the biological system. They include naturally occurring compounds, drugs, environmental agents, carcinogens, insecticides, etc.", "PM": "89", "HN": "89", "MR": "20200527", "DA": "19880518", "DC": "1", "DX": "19890101", "UI": "D015262"}, {"RECTYPE": "D", "MH": "Deoxyribonucleases, Type III Site-Specific", "DE": "DNASE SS III", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Type III Restriction Enzymes|T116|T126|NON|EQV|UNK (19XX)|880518|abbcdef", "ENTRY": "Site Specific DNase, Type III", "MN": "D08.811.277.352.355.325.300.270", "MH_TH": "NLM (1989)", "ST": "T126", "RN": "EC 3.1.21.5", "PI": "DNA Restriction Enzymes (1975-1988)", "MS": "Enzyme systems composed of two subunits and requiring ATP and magnesium for endonucleolytic activity; they do not function as ATPases. They exist as complexes with modification methylases of similar specificity listed under EC 2.1.1.72 or EC 2.1.1.73. The systems recognize specific short DNA sequences and cleave a short distance, about 24 to 27 bases, away from the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.5.", "PM": "89", "HN": "89", "MR": "20030709", "DA": "19880518", "DC": "1", "DX": "19890101", "UI": "D015263"}, {"RECTYPE": "D", "MH": "Site-Specific DNA-Methyltransferase (Adenine-Specific)", "DS": "SITE SPECIFIC DNA A METHYLTRANSFERASE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Site-Specific Methyltransferases (Adenine-Specific)|T116|T126|NON|EQV|UNK (19XX)|880518|SITE SPECIFIC METHYLTRANSFERASES ADENINE SPECIFIC|abbcdefs", "ENTRY": "Methylases, DNA-Adenine", "MN": "D08.811.913.555.500.350.700", "MH_TH": "NLM (1989)", "ST": "T126", "RN": "EC 2.1.1.72", "RR": "69553-52-2 (CAS RN)", "PI": "Methyltransferases (1971-1988)", "MS": "An enzyme responsible for producing a species-characteristic methylation pattern on adenine residues in a specific short base sequence in the host cell DNA. The enzyme catalyzes the methylation of DNA adenine in the presence of S-adenosyl-L-methionine to form DNA containing 6-methylaminopurine and S-adenosyl-L-homocysteine. EC 2.1.1.72.", "PM": "98; see DNA MODIFICATION METHYLASES (ADENINE-SPECIFIC) 1989-97", "HN": "98(89)", "MR": "20030709", "DA": "19880518", "DC": "1", "DX": "19890101", "UI": "D015265"}, {"RECTYPE": "D", "MH": "Carcinoma, Merkel Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Merkel Cell Tumor|T191|EPO|EQV|UNK (19XX)|880518|abcdef", "ENTRY": "Tumors, Merkle", "MN": "C04.557.580.625.650.240.325", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with SKIN NEOPLASMS (IM)", "PI": "Skin Neoplasms (1966-1988)", "MS": "A carcinoma arising from MERKEL CELLS located in the basal layer of the epidermis and occurring most commonly as a primary neuroendocrine carcinoma of the skin. Merkel cells are tactile cells of neuroectodermal origin and histologically show neurosecretory granules. The skin of the head and neck are a common site of Merkel cell carcinoma, occurring generally in elderly patients. (Holland et al., Cancer Medicine, 3d ed, p1245)", "OL": "use CARCINOMA, MERKEL CELL to search CARCINOMA, TRABECULAR 1992-93", "PM": "89; CARCINOMA, TRABECULAR was see CARCINOMA, MERKEL CELL 1992-93", "HN": "89; CARCINOMA, TRABECULAR was see CARCINOMA, MERKEL CELL 1992-93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19880518", "DC": "1", "DX": "19890101", "UI": "D015266"}, {"RECTYPE": "D", "MH": "Churg-Strauss Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vasculitis, Churg-Strauss|T047|EPO|EQV|UNK (19XX)|880518|abcdef", "ENTRY": "Vasculitis, Eosinophilic Granulomatous", "MN": "C20.111.193.500", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Vasculitis (1966-1988)", "MS": "Widespread necrotizing angiitis with granulomas. Pulmonary involvement is frequent. Asthma or other respiratory infection may precede evidence of vasculitis. Eosinophilia and lung involvement differentiate this disease from POLYARTERITIS NODOSA.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20230426", "DA": "19880518", "DC": "1", "DX": "19890101", "UI": "D015267"}, {"RECTYPE": "D", "MH": "Mycobacterium avium Complex", "DE": "MYCOBACT AVIUM COMPLEX", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Nocardia intracellularis|T007|NON|NRW|NLM (2021)|190918|abcdef", "MN": "B03.510.460.400.410.552.552.720.100", "FX": "Mycobacterium avium", "MH_TH": "NLM (1989)", "ST": "T007", "RN": "txid37162", "RR": "txid1767", "PI": "Mycobacterium avium (1975-1988)", "MS": "A complex that includes several strains of M. avium. M. intracellulare is not easily distinguished from M. avium and therefore is included in the complex. These organisms are most frequently found in pulmonary secretions from persons with a tuberculous-like mycobacteriosis. Strains of this complex have also been associated with childhood lymphadenitis and AIDS; M. avium alone causes tuberculosis in a variety of birds and other animals, including pigs.", "OL": "use MYCOBACTERIUM AVIUM to search MAIC, MYCOBACTERIUM AVIUM-INTRACELLULARE & MYCOBACTERIUM INTRACELLULARE 1987-88", "PM": "89; MAIC, MYCOBACTERIUM AVIUM-INTRACELLULARE & MYCOBACTERIUM INTRACELLULARE were see MYCOBACTERIUM AVIUM 1987-88", "HN": "89; MAIC, MYCOBACTERIUM AVIUM-INTRACELLULARE & MYCOBACTERIUM INTRACELLULARE were see MYCOBACTERIUM AVIUM 1987-88", "MR": "20200804", "DA": "19880519", "DC": "1", "DX": "19890101", "UI": "D015269"}, {"RECTYPE": "D", "MH": "Mycobacterium avium-intracellulare Infection", "DE": "MAI INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Mycobacterium intracellulare Infection|T047|NON|EQV|UNK (19XX)|880519|MYCOBACT INTRACELLULARE INFECT|abcdefv", "ENTRY": "Mycobacterium intracellulare Infections", "MN": "C01.150.252.410.040.552.475.495", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Mycobacterium avium (1975-1988)", "MS": "A nontuberculous infection when occurring in humans. It is characterized by pulmonary disease, lymphadenitis in children, and systemic disease in AIDS patients. Mycobacterium avium-intracellulare infection of birds and swine results in tuberculosis.", "PM": "1989", "HN": "1989", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19880519", "DC": "1", "DX": "19890101", "UI": "D015270"}, {"RECTYPE": "D", "MH": "Insurance Pools", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Health Alliances|T093|NON|NRW|NLM (1996)|940712|abcdef", "ENTRY": "Pools, Insurance", "MN": "N03.219.521.576.570", "MH_TH": "NLM (1989)", "ST": "T093", "AN": "specify geog if possible", "PI": "Insurance, Liability (1971-1988)", "MS": "An organization of insurers or reinsurers through which particular types of risk are shared or pooled. The risk of high loss by a particular insurance company is transferred to the group as a whole (the insurance pool) with premiums, losses, and expenses shared in agreed amounts.", "PM": "89", "HN": "89", "MR": "19991103", "DA": "19880519", "DC": "1", "DX": "19890101", "UI": "D015271"}, {"RECTYPE": "D", "MH": "Pulmonary Medicine", "DE": "PULM MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Pulmonology|T091|NON|EQV|UNK (19XX)|880519|PULMONOL|abcdefv", "ENTRY": "Medicine, Respiratory", "MN": "H02.403.429.675", "MH_TH": "UNK (19XX)", "ST": "T091", "AN": "specialty only; do not confuse with LUNG DISEASES", "PI": "Lung Diseases (1966-1988)", "MS": "A subspecialty of internal medicine concerned with the study of the RESPIRATORY SYSTEM. It is especially concerned with diagnosis and treatment of diseases and defects of the lungs and bronchial tree.", "PM": "2009; see PULMONARY DISEASE (SPECIALTY) 1989-2008", "HN": "2009 (1989)", "MR": "20210312", "DA": "19880519", "DC": "1", "DX": "19890101", "UI": "D015272"}, {"RECTYPE": "D", "MH": "Insurance Selection Bias", "ENTRY": "Selection Bias, Insurance", "MN": "N03.219.521.576.585", "MH_TH": "NLM (1989)", "ST": "T080", "PI": "Insurance, Health/utilization (1976-1988)", "MS": "Adverse or favorable selection bias exhibited by insurers or enrollees resulting in disproportionate enrollment of certain groups of people.", "PM": "91; was see under INSURANCE 1989-90", "HN": "91(89); was see under INSURANCE 1989-90", "MR": "20100922", "DA": "19880519", "DC": "1", "DX": "19910101", "UI": "D015273"}, {"RECTYPE": "D", "MH": "Interdepartmental Relations", "DE": "INTERDEP RELAT", "ENTRY": "Relations, Interdepartmental", "MN": "N04.452.822.388", "MH_TH": "NLM (1989)", "ST": "T054", "PI": "Interprofessional Relations (1966-1988)", "MS": "The interactions between representatives of institutional departments.", "PM": "91; was see under PUBLIC RELATIONS 1989-90", "HN": "91(89); was see under PUBLIC RELATIONS 1989-90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19880519", "DC": "1", "DX": "19910101", "UI": "D015274"}, {"RECTYPE": "D", "MH": "Tumor Lysis Syndrome", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tumour Lysis Syndromes", "MN": "C20.683.515.950", "FX": "Tumor Necrosis Factor-alpha", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "lymphoproliferative disord caused by anticancer drugs; coord IM with /etiol (not /chem ind) + anticancer drug /adv eff (IM) + required neopl coords /drug ther (IM or NIM) if pertinent", "PI": "Burkitt's Lymphoma/complications (1980-1988)", "MS": "A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20040720", "DA": "19880519", "DC": "1", "DX": "19890101", "UI": "D015275"}, {"RECTYPE": "D", "MH": "Health Care Rationing", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Rationing, Health Care|T058|NON|EQV|UNK (19XX)|880519|abcdef", "ENTRY": "Resources Allocation, Healthcare", "MN": "N05.300.430.375", "FX": "Patient Selection", "MH_TH": "NLM (1989)", "ST": "T058", "PI": "Health Services/supply & distribution (1974-1988)", "MS": "Planning for the equitable allocation, apportionment, or distribution of available health resources.", "PM": "89", "HN": "89", "MR": "20210312", "DA": "19880519", "DC": "1", "DX": "19890101", "UI": "D015276"}, {"RECTYPE": "D", "MH": "Hotlines", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Telephone Hotlines|T064|NON|EQV|UNK (19XX)|880519|abcdef", "ENTRY": "Telephone Hotline", "MN": "N02.421.297.448", "MH_TH": "NLM (1989)", "ST": "T064", "MS": "A direct communication system, usually telephone, established for instant contact. It is designed to provide special information and assistance through trained personnel and is used for counseling, referrals, and emergencies such as poisonings and threatened suicides.", "PM": "89", "HN": "89", "MR": "20170630", "DA": "19880519", "DC": "1", "DX": "19890101", "UI": "D015277"}, {"RECTYPE": "D", "MH": "Intensive Care Units, Pediatric", "DE": "ICU PEDIATRIC", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Pediatric Intensive Care Units|T073|T093|NON|EQV|UNK (19XX)|880519|PEDIATRIC ICU|abbcdefv", "ENTRY": "Pediatric ICUs", "MN": "N02.278.388.493.390", "MH_TH": "NLM (1989)", "ST": "T093", "AN": "check also tags HUMANS & CHILD", "PI": "Intensive Care Units (1966-1988)", "MS": "Hospital units providing continuous surveillance and care to acutely ill infants and children. Neonates are excluded since INTENSIVE CARE UNITS, NEONATAL is available.", "PM": "89", "HN": "89", "MR": "20200527", "DA": "19880519", "DC": "1", "DX": "19890101", "UI": "D015278"}, {"RECTYPE": "D", "MH": "Organizational Culture", "PRINT ENTRY": "Corporate Culture|T080|NON|EQV|UNK (19XX)|880520|abcdef", "ENTRY": "Organizational Cultures", "MN": "N04.452.606", "FX": "Safety Management", "MH_TH": "NLM (1989)", "ST": "T080", "PI": "Organization and Administration (1968-1988)", "MS": "Beliefs and values shared by all members of the organization. These shared values, which are subject to change, are reflected in the day to day management of the organization.", "PM": "91; was see under ORGANIZATION AND ADMINISTRATION 1989-90", "HN": "91(89); was see under ORGANIZATION AND ADMINISTRATION 1989-90", "MR": "20150605", "DA": "19880520", "DC": "1", "DX": "19910101", "UI": "D015279"}, {"RECTYPE": "D", "MH": "DNA Restriction-Modification Enzymes", "DE": "RESTRICT MOD ENZYMES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Restriction-Modification Systems|T116|T126|NON|EQV|UNK (19XX)|880523|abbcdef", "ENTRY": "Systems, Restriction-Modification", "MN": "D08.811.150", "MH_TH": "NLM (1989)", "ST": "T126", "RN": "0", "PI": "Methyltransferases (1971-1988)", "MS": "Systems consisting of two enzymes, a modification methylase and a restriction endonuclease. They are closely related in their specificity and protect the DNA of a given bacterial species. The methylase adds methyl groups to adenine or cytosine residues in the same target sequence that constitutes the restriction enzyme binding site. The methylation renders the target site resistant to restriction, thereby protecting DNA against cleavage.", "PM": "89", "HN": "89", "MR": "20200527", "DA": "19880523", "DC": "1", "DX": "19890101", "UI": "D015280"}, {"RECTYPE": "D", "MH": "Cefmenoxime", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SCE1365", "MN": "D03.633.100.300.249.190.190.125", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(Z)))-", "RN": "KBZ4844CXN", "RR": "NON736D32W", "PI": "Cephalosporins (1979-1981)", "MS": "A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.", "PM": "89", "HN": "89", "MR": "20160528", "DA": "19880523", "DC": "1", "DX": "19890101", "UI": "D015281"}, {"RECTYPE": "D", "MH": "Octreotide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Octreotide Acetate|T116|T121|T125|NON|NRW|JAN (19XX)|NLM (2000)|USAN (19XX)|991104|abbbcdeeef", "ENTRY": "Sandoz 201995", "MN": "D12.644.641.650", "PA": "Gastrointestinal Agents", "MH_TH": "USAN (1987)", "ST": "T125", "N1": "L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2-7)-disulfide, (R-(R*,R*))-", "RN": "RWM8CCW8GP", "RR": "83150-76-9 (Octreotide)", "PI": "Somatostatin/analogs & derivatives (1982-1988)", "MS": "A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula.", "PM": "89", "HN": "89", "MR": "20130708", "DA": "19880523", "DC": "1", "DX": "19890101", "UI": "D015282"}, {"RECTYPE": "D", "MH": "Citalopram", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Lu10171", "MN": "D03.633.100.127.187", "PA": "Selective Serotonin Reuptake Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-", "RN": "0DHU5B8D6V", "RR": "59729-33-8 (Citalopram)", "PI": "Serotonin Antagonists (1978-1988)", "MS": "A furancarbonitrile that is one of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.", "PM": "1989; for ESCITALOPRAM was indexed under CITALOPRAM 2001-2002", "HN": "1989; for ESCITALOPRAM use CITALOPRAM (NM) 2001-2002", "MR": "20220715", "DA": "19880523", "DC": "1", "DX": "19890101", "UI": "D015283"}, {"RECTYPE": "D", "MH": "Physician Payment Review Commission", "DE": "PPRC", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "United States Physician Payment Review Commission|T093|NON|EQV|NLM (2009)|080428|abcdef", "MN": "N03.219.521.710.305.180", "FX": "Medicare Payment Advisory Commission", "MH_TH": "NLM (1989)", "ST": "T093", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "MS": "A commission created by the Consolidated Omnibus Reconciliation Act of 1985, enacted in 1986, and given the mandate to advise Congress on Medicare-physician payment. The commission members are appointed by the U.S. Office of Technology Assessment.", "PM": "91; was see under REIMBURSEMENT MECHANISMS 1989-90", "HN": "91(89); was see under REIMBURSEMENT MECHANISMS 1989-90", "MR": "20150622", "DA": "19880523", "DC": "1", "DX": "19910101", "UI": "D015284"}, {"RECTYPE": "D", "MH": "Hospital-Patient Relations", "DE": "HOSP PATIENT RELAT", "PRINT ENTRY": "Guest Relations|T054|NON|NRW|UNK (19XX)|880523|GUEST RELAT|abcdefv", "ENTRY": "Relations, Hospital-Patient", "MN": "N04.452.822.370", "MH_TH": "NLM (1989)", "ST": "T058", "PI": "Consumer Satisfaction (1983-1988)", "MS": "Interactions between hospital staff or administrators and patients. Includes guest relations programs designed to improve the image of the hospital and attract patients.", "PM": "91; was see under PUBLIC RELATIONS 1989-90", "HN": "91(89); was see under PUBLIC RELATIONS 1989-90", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19880523", "DC": "1", "DX": "19910101", "UI": "D015285"}, {"RECTYPE": "D", "MH": "Kassinin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.529.812.900.475", "PA": "Neurotransmitter Agents", "MH_TH": "NLM (1989)", "ST": "T123", "RN": "63968-82-1", "PI": "Oligopeptides (1977-1988)", "MS": "Dodecapeptide tachykinin found in the central nervous system of the amphibian Kassina senegalensis. It is similar in structure and action to other tachykinins, but is especially effective in contracting smooth muscle tissue and stimulating the micturition reflex.", "PM": "89", "HN": "89", "MR": "20151124", "DA": "19880523", "DC": "1", "DX": "19890101", "UI": "D015286"}, {"RECTYPE": "D", "MH": "Neurokinin B", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neuromedin K|T116|T123|NON|EQV|NLM (2003)|020110|abbcdef", "ENTRY": "Neurokinin beta|T116|T123|NON|EQV|UNK (19XX)|880523|abbcdef", "MN": "D23.529.812.900.550", "PA": "Neurotransmitter Agents", "FX": "Receptors, Neurokinin-3", "MH_TH": "UNK (19XX)", "ST": "T123", "N1": "Kassinin, 2-L-methionine-3-L-histidine-4-de-L-lysine-5-de-L-serine-7-L-phenylalanine-", "RN": "86933-75-7", "PI": "Oligopeptides (1983-1986)", "MS": "A mammalian neuropeptide of 10 amino acids that belongs to the tachykinin family. It is similar in structure and action to SUBSTANCE P and NEUROKININ A with the ability to excite neurons, dilate blood vessels, and contract smooth muscles, such as those in the URINARY BLADDER and UTERUS.", "PM": "2003: see NEUROKININ K (1989-2002)", "HN": "2003 (1989)", "MR": "20151124", "DA": "19880523", "DC": "1", "DX": "19890101", "UI": "D015287"}, {"RECTYPE": "D", "MH": "Neurokinin A", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Substance K|T116|T123|NON|EQV|NLM (1994)|930416|abbcdef", "ENTRY": "Neuromedin L|T116|T123|NON|EQV|UNK (19XX)|880524|abbcdef", "MN": "D23.529.812.900.500", "PA": "Neurotransmitter Agents", "FX": "Receptors, Neurokinin-2", "MH_TH": "NLM (1989)", "ST": "T123", "N1": "Kassinin, 1-de-L-aspartic acid-2-de-L-valine-3-L-histidine-5-L-threonine-7-L-serine-", "RN": "86933-74-6", "PI": "Oligopeptides (1980-1986)", "MS": "A mammalian neuropeptide of 10 amino acids that belongs to the tachykinin family. It is similar in structure and action to SUBSTANCE P and NEUROKININ B with the ability to excite neurons, dilate blood vessels, and contract smooth muscles, such as those in the BRONCHI.", "OL": "use NEUROKININ A to search SUBSTANCE K 1989-93", "PM": "94; was SUBSTANCE K 1989-93; NEUROKININ A was see SUBSTANCE K 1989-93", "HN": "94; was SUBSTANCE K 1989-93; NEUROKININ A was see SUBSTANCE K 1989-93", "MR": "20151124", "DA": "19880524", "DC": "1", "DX": "19890101", "UI": "D015288"}, {"RECTYPE": "D", "MH": "Leukotrienes", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Leukotriene|T109|T123|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D23.469.050.175.450", "FX": "Receptors, Leukotriene", "EC": "antagonists & inhibitors:Leukotriene Antagonists", "MH_TH": "NLM (1989)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "SRS-A (1979-1988)", "MS": "A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system.", "PM": "89", "HN": "89", "MR": "20200527", "DA": "19880524", "DC": "1", "DX": "19890101", "UI": "D015289"}, {"RECTYPE": "D", "MH": "Second Messenger Systems", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Intracellular Second Messengers|T044|T123|NON|EQV|UNK (19XX)|880524|abbcdef", "ENTRY": "Systems, Second Messenger", "MN": "G04.835.800", "MH_TH": "NLM (1989)", "ST": "T123", "AN": "a metab concept; IM; coord with substance acting as the second messenger (IM) with /physiol or /antag as applicable", "MS": "Systems in which an intracellular signal is generated in response to an intercellular primary messenger such as a hormone or neurotransmitter. They are intermediate signals in cellular processes such as metabolism, secretion, contraction, phototransduction, and cell growth. Examples of second messenger systems are the adenyl cyclase-cyclic AMP system, the phosphatidylinositol diphosphate-inositol triphosphate system, and the cyclic GMP system.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19880524", "DC": "1", "DX": "19890101", "UI": "D015290"}, {"RECTYPE": "D", "MH": "Transforming Growth Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Growth Factors, Transforming", "MN": "D23.529.960", "MH_TH": "NLM (1989)", "ST": "T123", "N1": "Animal growth regulators, transforming growth factors", "RN": "76057-06-2", "AN": "general or unspecified; prefer specifics", "PI": "Peptides (1966-1988)", "MS": "Hormonally active polypeptides that can induce the transformed phenotype when added to normal, non-transformed cells. They have been found in culture fluids from retrovirally transformed cells and in tumor-derived cells as well as in non-neoplastic sources. Their transforming activities are due to the simultaneous action of two otherwise unrelated factors, TRANSFORMING GROWTH FACTOR ALPHA and TRANSFORMING GROWTH FACTOR BETA.", "PM": "89", "HN": "89", "MR": "20150602", "DA": "19880524", "DC": "1", "DX": "19890101", "UI": "D015291"}, {"RECTYPE": "D", "MH": "Glycoprotein Hormones, alpha Subunit", "DE": "GPHAS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thyrotropin alpha Subunit|T116|T125|NON|EQV|UNK (19XX)|880524|abbcdef", "ENTRY": "Thyroid Stimulating Hormone, alpha Subunit", "MN": "D12.644.548.726.367.562", "MH_TH": "NLM (1989)", "ST": "T125", "RN": "0", "AN": "coord with THYROTROPIN; FOLLICLE STIMULATING HORMONE; LUTEINIZING HORMONE; or CHORIONIC GONADOTROPIN if particularly discussed", "PI": "Thyrotropin (1972-1988)", "MS": "The alpha chain of pituitary glycoprotein hormones (THYROTROPIN; FOLLICLE STIMULATING HORMONE; LUTEINIZING HORMONE) and the placental CHORIONIC GONADOTROPIN. Within a species, the alpha subunits of these four hormones are identical; the distinct functional characteristics of these glycoprotein hormones are determined by the unique beta subunits. Both subunits, the non-covalently bound heterodimers, are required for full biologic activity.", "PM": "1989", "HN": "1989", "MR": "20110624", "DA": "19880524", "DC": "1", "DX": "19890101", "UI": "D015292"}, {"RECTYPE": "D", "MH": "Transducin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gamma-Transducin|T116|T123|NON|NRW|UNK (19XX)|880524|abbcdef", "ENTRY": "gamma Transducin", "MN": "D12.776.543.325.800", "MH_TH": "NLM (1989)", "ST": "T126", "RN": "EC 3.6.5.1", "AN": "alpha, beta and gamma transducins refer to its subunits", "PI": "Membrane Proteins (1980-1988)", "MS": "A heterotrimeric GTP-binding protein that mediates the light activation signal from photolyzed rhodopsin to cyclic GMP phosphodiesterase and is pivotal in the visual excitation process. Activation of rhodopsin on the outer membrane of rod and cone cells causes GTP to bind to transducin followed by dissociation of the alpha subunit-GTP complex from the beta/gamma subunits of transducin. The alpha subunit-GTP complex activates the cyclic GMP phosphodiesterase which catalyzes the hydrolysis of cyclic GMP to 5'-GMP. This leads to closure of the sodium and calcium channels and therefore hyperpolarization of the rod cells.", "PM": "89", "HN": "89", "MR": "20210521", "DA": "19880524", "DC": "1", "DX": "19890101", "UI": "D015293"}, {"RECTYPE": "D", "MH": "Antigens, Tumor-Associated, Carbohydrate", "DE": "ANTIGENS TUMOR ASSOC CARBOHYDRATE", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Tumor-Associated Carbohydrate Antigens|T109|T129|NON|EQV|UNK (19XX)|880524|TUMOR ASSOC CARBOHYDRATE ANTIGENS|abbcdefv", "ENTRY": "Tumor Associated Carbohydrate Antigens", "MN": "D23.101.140.075", "MH_TH": "NLM (1989)", "ST": "T129", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Antigens, Neoplasm (1973-1988)", "MS": "Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies.", "PM": "89", "HN": "89", "MR": "20150619", "DA": "19880524", "DC": "1", "DX": "19890101", "UI": "D015295"}, {"RECTYPE": "D", "MH": "Ceftizoxime", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ceftizoxime Sodium|T109|T195|NON|NRW|FDA SRS (2014)|JAN (19XX)|USAN (1980)|USP (19XX)|941114|abbcdeeeef", "ENTRY": "Sodium, Ceftizoxime", "MN": "D03.633.100.300.249.190.190.145", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))-", "RN": "C43C467DPE", "RR": "68401-82-1 (mono NA salt)", "PI": "Cephalosporins (1979-1981)", "MS": "A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.", "PM": "89", "HN": "89", "MR": "20170524", "DA": "19880524", "DC": "1", "DX": "19890101", "UI": "D015296"}, {"RECTYPE": "D", "MH": "Discitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spondylodiscitis|T047|NON|EQV|UNK (19XX)|880526|abcdef", "ENTRY": "Spondylodiskitides", "MN": "C05.116.900.853.500", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "coord IM with specific vertebrae (IM)", "PI": "Spondylitis (1966-1988)", "MS": "Inflammation of an INTERVERTEBRAL DISC or disk space which may lead to disk erosion. Until recently, discitis has been defined as a nonbacterial inflammation and has been attributed to aseptic processes (e.g., chemical reaction to an injected substance). However, recent studies provide evidence that infection may be the initial cause, but perhaps not the promoter, of most cases of discitis. Discitis has been diagnosed in patients following discography, myelography, lumbar puncture, paravertebral injection, and obstetrical epidural anesthesia. Discitis following chemonucleolysis (especially with chymopapain) is attributed to chemical reaction by some and to introduction of microorganisms by others.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19880526", "DC": "1", "DX": "19890101", "UI": "D015299"}, {"RECTYPE": "D", "MH": "Ventilator Weaning", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Respirator Weaning|T061|NON|EQV|UNK (19XX)|880526|abcdef", "ENTRY": "Weaning, Ventilator", "MN": "E02.880.820.950", "MH_TH": "NLM (1989)", "ST": "T061", "PI": "Respiration, Artificial (1966-1988)", "MS": "Techniques for effecting the transition of the respiratory-failure patient from mechanical ventilation to spontaneous ventilation, while meeting the criteria that tidal volume be above a given threshold (greater than 5 ml/kg), respiratory frequency be below a given count (less than 30 breaths/min), and oxygen partial pressure be above a given threshold (PaO2 greater than 50mm Hg). Weaning studies focus on finding methods to monitor and predict the outcome of mechanical ventilator weaning as well as finding ventilatory support techniques which will facilitate successful weaning. Present methods include intermittent mandatory ventilation, intermittent positive pressure ventilation, and mandatory minute volume ventilation.", "OL": "use VENTILATOR WEANING to search VENTILATORS, MECHANICAL, WEANING & VENTILATORS, PULMONARY, WEANING 1989-92", "PM": "89; VENTILATORS, MECHANICAL, WEANING & VENTILATORS, PULMONARY, WEANING were see VENTILATOR WEANING 1989-92", "HN": "89; VENTILATORS, MECHANICAL, WEANING & VENTILATORS, PULMONARY, WEANING were see VENTILATOR WEANING 1989-92", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19880526", "DC": "1", "DX": "19890101", "UI": "D015300"}, {"RECTYPE": "D", "MH": "Retroviruses, Simian", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Simian Retroviruses|T005|NON|EQV|NLM (1994)|930223|abcdef", "ENTRY": "Simian Retrovirus", "MN": "B04.820.650.805", "MH_TH": "NLM (1989)", "ST": "T005", "AN": "a group of the family Retroviridae; infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "PI": "Retroviridae (1978-1988)", "MS": "Classes of retroviruses for which monkeys or apes are hosts. Those isolated from the West African green monkey and the Asian rhesus macaque monkey are of particular interest because of their similarities to viruses causing cancer and acquired immunodeficiency syndrome (AIDS) in humans.", "OL": "use RETROVIRUSES, SIMIAN to search SIMIAN RETROVIRUSES 1989-93", "PM": "94; was SIMIAN RETROVIRUSES 1989-93", "HN": "94; was SIMIAN RETROVIRUSES 1989-93", "MR": "20200902", "DA": "19880526", "DC": "1", "DX": "19890101", "UI": "D015301"}, {"RECTYPE": "D", "MH": "Simian Immunodeficiency Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "SIV (Simian immunodeficiency virus)|T005|NON|EQV|NLM (2006)|050218|abcdef", "ENTRY": "Immunodeficiency Virus, Simian", "MN": "B04.820.650.805.700", "MH_TH": "NLM (2016)", "ST": "T005", "RN": "txid11723", "PI": "Retroviridae (1978-1988)", "MS": "Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV.", "PM": "2006; see SIV 1989-2005", "HN": "2006 (1989)", "MR": "20200813", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015302"}, {"RECTYPE": "D", "MH": "Simian T-lymphotropic virus 1", "DS": "SIMIAN LYMPHOTROPIC VIRUS T 001", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "T-Lymphotropic Virus, Type I, Simian|T005|NON|EQV|UNK (19XX)|880531|LYMPHOTROPIC VIRUS TYPE I SIMIAN T|abcdefs", "ENTRY": "Simian T lymphotropic virus 1", "MN": "B04.820.650.805.851", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid33747", "AN": "infection: coord IM with DELTARETROVIRUS INFECTIONS (IM)", "PI": "Retroviridae (1978-1988)", "MS": "A strain of PRIMATE T-LYMPHOTROPIC VIRUS 2, closely related to the human HTLV-1 virus. The clinical, hematological, and histopathological characteristics of the disease in STLV-infected monkeys are very similar to those of human adult T-cell leukemia. Subgroups include the African green monkey subtype (STLV-I-AGM), for which the nucleotide sequence is 95% homologous with that of HUMAN T-LYMPHOTROPIC VIRUS 1, and the Asian rhesus macaque subtype (STLV-I-MM), for which the nucleotide sequence is 90% homologous with that of HUMAN T-LYMPHOTROPIC VIRUS 1.", "PM": "2002; see STLV 1994-2001, see STLV-I 1991-1993, see SIMIAN RETROVIRUSES 1989-1990", "HN": "2002 (1989); was STLV-I 1989-93 (see under SIMIAN RETROVIRUSES 1989-90)", "MR": "20200813", "DA": "19880531", "DC": "1", "DX": "19910101", "UI": "D015303"}, {"RECTYPE": "D", "MH": "Biogenic Monoamines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Monoamines, Biogenic|T109|T123|NON|EQV|UNK (19XX)|880531|abbcdef", "MN": "D02.092.211.215", "MH_TH": "NLM (1989)", "ST": "T123", "RN": "0", "AN": "general: prefer specifics", "PI": "Norepinephrine (1966-1988)", "MS": "Biogenic amines having only one amine moiety. Included in this group are all natural monoamines formed by the enzymatic decarboxylation of natural amino acids.", "PM": "89", "HN": "89", "MR": "20050630", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015306"}, {"RECTYPE": "D", "MH": "Anaerobic Threshold", "AQ": "DE ES GE IM PH RE", "ENTRY": "Thresholds, Anaerobic", "MN": "G11.427.680.134", "MH_TH": "NLM (1989)", "ST": "T081", "PI": "Oxygen Consumption (1966-1988)", "MS": "The oxygen consumption level above which aerobic energy production is supplemented by anaerobic mechanisms during exercise, resulting in a sustained increase in lactate concentration and metabolic acidosis. The anaerobic threshold is affected by factors that modify oxygen delivery to the tissues; it is low in patients with heart disease. Methods of measurement include direct measure of lactate concentration, direct measurement of bicarbonate concentration, and gas exchange measurements.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015308"}, {"RECTYPE": "D", "MH": "Glucose Clamp Technique", "AQ": "AE CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Glucose Clamping|T060|T062|NON|BRD|UNK (19XX)|880531|abbcdef", "ENTRY": "Techniques, Glucose Clamp", "MN": "E05.200.124.100.350", "MH_TH": "NLM (1989)", "ST": "T062", "PI": "Blood Glucose/metabolism (1975-1988)", "MS": "Maintenance of a constant blood glucose level by perfusion or infusion with glucose or insulin. It is used for the study of metabolic rates (e.g., in glucose, lipid, amino acid metabolism) at constant glucose concentration.", "OL": "use GLUCOSE CLAMP TECHNIQUE to search GLUCOSE CLAMP TECHNIC 1989-90", "PM": "91; was GLUCOSE CLAMP TECHNIC 1989-90", "HN": "91; was GLUCOSE CLAMP TECHNIC 1989-90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015309"}, {"RECTYPE": "D", "MH": "Cefotiam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SCE963", "MN": "D03.633.100.300.249.190.190.135", "PA": "Anti-Bacterial Agents", "MH_TH": "INN (19XX)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)acetyl)amino)-3-(((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-trans)-", "RN": "91W6Z2N718", "RR": "H7V12WDZ93", "PI": "Cephalosporins (1979-1981)", "MS": "One of the CEPHALOSPORINS that has a broad spectrum of activity against both gram-positive and gram-negative microorganisms.", "PM": "89", "HN": "89", "MR": "20160528", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015310"}, {"RECTYPE": "D", "MH": "Cefmetazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "U72791A", "MN": "D03.633.100.300.249.250.177", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1992)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-cis)-", "RN": "3J962UJT8H", "RR": "56796-39-5 (mono-Na salt)", "PI": "Cephamycins (1979-1988)", "MS": "A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.", "PM": "89", "HN": "89", "MR": "20170524", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015311"}, {"RECTYPE": "D", "MH": "Hemodialysis Solutions", "DE": "HEMODIALYSIS SOL", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Solutions, Hemodialysis|T121|NON|EQV|UNK (19XX)|880531|SOL HEMODIALYSIS|abcdefv", "ENTRY": "Solutions, Hemodialysis Dialysis", "MN": "D27.720.752.483.651", "MH_TH": "NLM (1989)", "ST": "T121", "RN": "0", "PI": "Hemodialysis (1967-1988)", "MS": "Solutions prepared for hemodialysis. The composition of the pre-dialysis solution may be varied in order to determine the effect of solvated metabolites on anoxia, malnutrition, acid-base balance, etc. Of principal interest are the effect of the choice of buffers (e.g., acetate or carbonate), the addition of cations (Na+, K+, Ca2+), and addition of carbohydrates (glucose).", "PM": "91; was see under DIALYSIS SOLUTIONS 1989-90", "HN": "91(89); was see under DIALYSIS SOLUTIONS 1989-90", "MR": "20130708", "DA": "19880531", "DC": "1", "DX": "19910101", "UI": "D015312"}, {"RECTYPE": "D", "MH": "Cefotetan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "YM09330", "MN": "D03.633.100.300.249.250.199", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1983)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7alpha))-", "RN": "48SPP0PA9Q", "RR": "74356-00-6 (di-Na salt)", "PI": "Cephamycins (1982-1988)", "MS": "A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms.", "PM": "89", "HN": "89", "MR": "20170524", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015313"}, {"RECTYPE": "D", "MH": "Dialysis Solutions", "DE": "DIALYSIS SOL", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Dialyzate|T121|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Solutions, Dialysis", "MN": "D27.720.752.483", "MH_TH": "NLM (1989)", "ST": "T121", "RN": "0", "PI": "Peritoneal Dialysis, Continuous Ambulatory (1982-1988)", "MS": "Solutions prepared for exchange across a semipermeable membrane of solutes below a molecular size determined by the cutoff threshold of the membrane material.", "PM": "89", "HN": "89", "MR": "20200527", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015314"}, {"RECTYPE": "D", "MH": "Genetic Therapy", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Somatic Gene Therapy|T061|T062|NON|NRW|UNK (19XX)|880531|SOMATIC GENE THER|abbcdefv", "ENTRY": "Therapy, Somatic Genetic", "MN": "E05.393.420.301", "FX": "Genetic Services", "MH_TH": "NLM (2013)", "ST": "T061", "PI": "Genetic Intervention (1973-1988)", "MS": "Techniques and strategies which include the use of coding sequences and other conventional or radical means to transform or modify cells for the purpose of treating or reversing disease conditions.", "PM": "2012; see Gene Therapy 1988-2011", "HN": "2012; use Gene Therapy 1988-2011", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015316"}, {"RECTYPE": "D", "MH": "Biogenic Polyamines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyamines, Biogenic|T109|T123|NON|EQV|UNK (19XX)|880531|abbcdef", "MN": "D02.092.211.415", "MH_TH": "NLM (1989)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Biogenic Amines (1971-1988)", "MS": "Biogenic amines having more than one amine group. These are long-chain aliphatic compounds that contain multiple amino and/or imino groups. Because of the linear arrangement of positive charge on these molecules, polyamines bind electrostatically to ribosomes, DNA, and RNA.", "PM": "89", "HN": "89", "MR": "19920508", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015317"}, {"RECTYPE": "D", "MH": "Fructose Metabolism, Inborn Errors", "DE": "FRUCTOSE METAB INBORN ERR", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C18.452.648.202.251", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Fructose (1966-1988)", "MS": "Inherited abnormalities of fructose metabolism, which include three known autosomal recessive types: hepatic fructokinase deficiency (essential fructosuria), hereditary fructose intolerance, and hereditary fructose-1,6-diphosphatase deficiency. Essential fructosuria is a benign asymptomatic metabolic disorder caused by deficiency in fructokinase, leading to decreased conversion of fructose to fructose-1-phosphate and alimentary hyperfructosemia, but with no clinical dysfunction; may produce a false-positive diabetes test.", "OL": "use CARBOHYDRATE METABOLISM, INBORN ERRORS to search FRUCTOSE METABOLISM, INBORN ERRORS 1966-74", "PM": "89; FRUCTOSE INTOLERANCE was see under CARBOHYDRATE METABOLISM, INBORN ERRORS 1967-88 (Prov 1964-66)", "HN": "89; FRUCTOSE INTOLERANCE was see under CARBOHYDRATE METABOLISM, INBORN ERRORS 1967-88 (Prov 1964-66)", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015318"}, {"RECTYPE": "D", "MH": "Fructose-1,6-Diphosphatase Deficiency", "DE": "FDP DEFIC", "DS": "FRUCTOSE DIPHOSPHATASE DEFICIENCY 01 06", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hexosediphosphatase Deficiency|T047|NON|BRD|UNK (19XX)|880531|HEXOSEDIPHOSPHATASE DEFIC|abcdefv", "ENTRY": "Hexosediphosphatase Deficiencies", "MN": "C18.452.648.202.251.221", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Hexosediphosphatase/deficiency (1970-1988)", "MS": "An autosomal recessive fructose metabolism disorder due to absent or deficient fructose-1,6-diphosphatase activity. Gluconeogenesis is impaired, resulting in accumulation of gluconeogenic precursors (e.g., amino acids, lactate, ketones) and manifested as hypoglycemia, ketosis, and lactic acidosis. Episodes in the newborn infant are often lethal. Later episodes are often brought on by fasting and febrile infections. As patients age through early childhood, tolerance to fasting improves and development becomes normal.", "PM": "91; was see under FRUCTOSE METABOLISM, INBORN ERRORS 1989-90", "HN": "91(89); was see under FRUCTOSE METABOLISM, INBORN ERRORS 1989-90", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19880531", "DC": "1", "DX": "19910101", "UI": "D015319"}, {"RECTYPE": "D", "MH": "Tachykinins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Tachykinin|T116|T123|T125|NON|EQV|UNK (19XX)|880531|abbbcdef", "MN": "D23.529.812.900", "PA": "Neurotransmitter Agents", "FX": "Receptors, Tachykinin", "MH_TH": "NLM (1989)", "ST": "T125", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Peptides (1966-1988)", "MS": "A family of biologically active peptides sharing a common conserved C-terminal sequence, -Phe-X-Gly-Leu-Met-NH2, where X is either an aromatic or a branched aliphatic amino acid. Members of this family have been found in mammals, amphibians, and mollusks. Tachykinins have diverse pharmacological actions in the central nervous system and the cardiovascular, genitourinary, respiratory, and gastrointestinal systems, as well as in glandular tissues. This diversity of activity is due to the existence of three or more subtypes of tachykinin receptors.", "PM": "89; PHYSALAEMIN was see under KININS 1977-88", "HN": "89; PHYSALAEMIN was see under KININS 1977-88", "MR": "20151124", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015320"}, {"RECTYPE": "D", "MH": "Gene Rearrangement", "DE": "GENE REARR", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "DNA Rearrangement|T045|EQV|UNK (19XX)|880531|DNA REARR|abdefv", "ENTRY": "Rearrangements, Gene", "MN": "G05.344", "FX": "VDJ Recombinases", "MH_TH": "NLM (1989)", "ST": "T045", "PI": "Genes or specific gene (1977-1988)", "MS": "The ordered rearrangement of gene regions by DNA recombination such as that which occurs normally during development.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015321"}, {"RECTYPE": "D", "MH": "Gene Rearrangement, B-Lymphocyte", "DE": "GENE REARR B LYMPHOCYTE", "DS": "GENE REARRANGEMENT LYMPHOCYTE B", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "B-Lymphocyte Gene Rearrangement|T045|EQV|UNK (19XX)|880531|LYMPHOCYTE GENE REARRANGEMENT B|B LYMPHOCYTE GENE REARR|abdefsv", "ENTRY": "Rearrangements, B-Lymphocyte Gene", "MN": "G12.500.274", "FX": "Somatic Hypermutation, Immunoglobulin", "MH_TH": "NLM (1989)", "ST": "T045", "PI": "Genes, Immunoglobulin (1977-1988)", "MS": "Ordered rearrangement of B-lymphocyte variable gene regions coding for the IMMUNOGLOBULIN CHAINS, thereby contributing to antibody diversity. It occurs during the differentiation of the IMMATURE B-LYMPHOCYTES.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015322"}, {"RECTYPE": "D", "MH": "Pyruvate Metabolism, Inborn Errors", "DE": "PYRUVATE METAB INBORN ERR", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C18.452.648.202.810", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Pyruvates (1966-1988)", "MS": "Hereditary disorders of pyruvate metabolism. They are difficult to diagnose and describe because pyruvate is a key intermediate in glycolysis, gluconeogenesis, and the tricarboxylic acid cycle. Some inherited metabolic disorders may alter pyruvate metabolism indirectly. Disorders in pyruvate metabolism appear to lead to deficiencies in neurotransmitter synthesis and, consequently, to nervous system disorders.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19880531", "DC": "1", "DX": "19890101", "UI": "D015323"}, {"RECTYPE": "D", "MH": "Pyruvate Carboxylase Deficiency Disease", "DE": "PYRUVATE CARBOXYLASE DEFIC DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lactic Acidosis with Ataxia, Type II|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Deficiency, Pyruvate Carboxylase", "MN": "C18.452.660.705", "FX": "Pyruvate Carboxylase", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Pyruvate Carboxylase/deficiency (1974-1988)", "MS": "An autosomal recessive metabolic disorder caused by absent or decreased PYRUVATE CARBOXYLASE activity, the enzyme that regulates gluconeogenesis, lipogenesis, and neurotransmitter synthesis. Clinical manifestations include lactic acidosis, seizures, respiratory distress, marked psychomotor delay, periodic HYPOGLYCEMIA, and hypotonia. The clinical course may be similar to LEIGH DISEASE. (From Am J Hum Genet 1998 Jun;62(6):1312-9)", "PM": "2000; see PYRUVATE CARBOXYLASE DEFICIENCY 1991-1999; see PYRUVATE METABOLISM, INBORN ERRORS 1989-1990", "HN": "2000(1989); use PYRUVATE METABOLISM, INBORN ERRORS 1989-1990", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19880601", "DC": "1", "DX": "19910101", "UI": "D015324"}, {"RECTYPE": "D", "MH": "Pyruvate Dehydrogenase Complex Deficiency Disease", "DE": "PYRUVATE DEHYDROGENASE COMPLEX DEFIC DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lactic Acidosis with Ataxia, Type I|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Deficiency, Pyruvate Dehydrogenase", "MN": "C18.452.660.710", "FX": "Pyruvate Dehydrogenase Complex", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Pyruvate Dehydrogenase Complex/deficiency (1974-1988)", "MS": "An inherited metabolic disorder caused by deficient enzyme activity in the PYRUVATE DEHYDROGENASE COMPLEX, resulting in deficiency of acetyl CoA and reduced synthesis of acetylcholine. Two clinical forms are recognized: neonatal and juvenile. The neonatal form is a relatively common cause of lactic acidosis in the first weeks of life and may also feature an erythematous rash. The juvenile form presents with lactic acidosis, alopecia, intermittent ATAXIA; SEIZURES; and an erythematous rash. (From J Inherit Metab Dis 1996;19(4):452-62) Autosomal recessive and X-linked forms are caused by mutations in the genes for the three different enzyme components of this multisubunit pyruvate dehydrogenase complex. One of the mutations at Xp22.2-p22.1 in the gene for the E1 alpha component of the complex leads to LEIGH DISEASE.", "PM": "2000; see PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY 1991-1999; see PYRUVATE METABOLISM, INBORN ERRORS 1989-1990", "HN": "2000(1989); use PYRUVATE METABOLISM, INBORN ERRORS 1989-1990", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19880601", "DC": "1", "DX": "19910101", "UI": "D015325"}, {"RECTYPE": "D", "MH": "Gene Rearrangement, B-Lymphocyte, Heavy Chain", "DE": "GENE REARR HEAVY CHAIN", "DS": "GENE REARRANGEMENT LYMPHOCYTE HEAVY CHAIN B", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "B-Lymphocyte Mu Chain Gene Rearrangement|T045|NRW|UNK (19XX)|880601|LYMPHOCYTE MU CHAIN GENE REARRANGEMENT B|B LYMPHOCYTE M CHAIN GENE REARR|abdefsv", "ENTRY": "B Lymphocyte Mu Chain Gene Rearrangement", "MN": "G12.500.274.501", "MH_TH": "NLM (1989)", "ST": "T045", "PI": "Immunoglobulins, Heavy Chain/genetics (1977-1988)", "MS": "Ordered rearrangement of B-lymphocyte variable gene regions of the IMMUNOGLOBULIN HEAVY CHAINS, thereby contributing to antibody diversity. It occurs during the first stage of differentiation of the IMMATURE B-LYMPHOCYTES.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19880601", "DC": "1", "DX": "19890101", "UI": "D015326"}, {"RECTYPE": "D", "MH": "Gene Rearrangement, B-Lymphocyte, Light Chain", "DE": "GENE REARR LIGHT CHAIN", "DS": "GENE REARRANGEMENT LYMPHOCYTE LIGHT CHAIN B", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "B-Lymphocyte lambda-Chain Gene Rearrangement|T045|NRW|UNK (19XX)|880601|LYMPHOCYTE LAMBDA CHAIN GENE REARRANGEMENT B|B LYMPHOCYTE L CHAIN GENE REARR|abdefsv", "ENTRY": "B Lymphocyte lambda Chain Gene Rearrangement", "MN": "G12.500.274.601", "MH_TH": "NLM (1989)", "ST": "T045", "PI": "Immunoglobulins, Light Chain/genetics (1977-1988)", "MS": "Ordered rearrangement of B-lymphocyte variable gene regions coding for the kappa or lambda IMMUNOGLOBULIN LIGHT CHAINS, thereby contributing to antibody diversity. It occurs during the second stage of differentiation of the IMMATURE B-LYMPHOCYTES.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19880601", "DC": "1", "DX": "19890101", "UI": "D015328"}, {"RECTYPE": "D", "MH": "Gene Rearrangement, T-Lymphocyte", "DE": "GENE REARR T LYMPHOCYTE", "DS": "GENE REARRANGEMENT LYMPHOCYTE T", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "T-Lymphocyte Gene Rearrangement|T045|EQV|UNK (19XX)|880601|LYMPHOCYTE GENE REARRANGEMENT T|T LYMPHOCYTE GENE REARR|abdefsv", "ENTRY": "T-Lymphocyte Gene Rearrangements", "MN": "G12.500.287", "FX": "Genes, T-Cell Receptor", "MH_TH": "NLM (1989)", "ST": "T045", "PI": "T Lymphocytes/immunology (1977-1988)", "MS": "Ordered rearrangement of T-cell variable gene regions coding for the antigen receptors.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19880601", "DC": "1", "DX": "19890101", "UI": "D015329"}, {"RECTYPE": "D", "MH": "Cohort Studies", "PRINT ENTRY": "Incidence Studies|T081|NON|NRW|NLM (1990)|890525|abcdef", "ENTRY": "Study, Incidence", "MN": "N06.850.520.450.500.750", "FX": "Birth Cohort", "MH_TH": "NLM (1989)", "ST": "T081", "AN": "IM general only; coordinate NIM with specific disease (IM); add geographic term if pertinent", "PI": "Prospective Studies (1966-1988)", "MS": "Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.", "OL": "use COHORT STUDIES to search INCIDENCE STUDIES 1989", "PM": "89; INCIDENCE STUDIES was heading 1989", "HN": "89; INCIDENCE STUDIES was heading 1989", "CATSH": "CAT LIST", "MR": "20210312", "DA": "19880601", "DC": "1", "DX": "19890101", "UI": "D015331"}, {"RECTYPE": "D", "MH": "Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor", "DE": "GENE REARR ALPHA CHAIN", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "T-Lymphocyte Antigen Receptor alpha-Chain Gene Rearrangement|T045|EQV|UNK (19XX)|880601|LYMPHOCYTE ANTIGEN RECEPTOR ALPHA CHAIN GENE REARRANGEMENT T|T LYMPHOCYTE ANTIGEN RECEPT A CHAIN GENE REARR|abdefsv", "ENTRY": "T Lymphocyte alpha Chain Gene Rearrangement", "MN": "G12.500.287.111", "MH_TH": "NLM (1988)", "ST": "T045", "PI": "T Lymphocytes/immunology (1977-1988)", "MS": "Ordered rearrangement of T-cell variable gene regions coding for the alpha-chain of antigen receptors.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19880601", "DC": "1", "DX": "19880101", "UI": "D015332"}, {"RECTYPE": "D", "MH": "Gene Rearrangement, beta-Chain T-Cell Antigen Receptor", "DE": "GENE REARR BETA CHAIN", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "T-Lymphocyte Antigen Receptor beta-Chain Gene Rearrangement|T045|EQV|UNK (19XX)|880601|LYMPHOCYTE ANTIGEN RECEPTOR BETA CHAIN GENE REARRANGEMENT T|T LYMPHOCYTE ANTIGEN RECEPT B CHAIN GENE REARR|abdefsv", "ENTRY": "T Lymphocyte beta Chain Gene Rearrangement", "MN": "G12.500.287.211", "MH_TH": "NLM (1988)", "ST": "T045", "PI": "T Lymphocytes/immunology (1977-1988)", "MS": "Ordered rearrangement of T-cell variable gene regions coding for the beta-chain of antigen receptors.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19880601", "DC": "1", "DX": "19880101", "UI": "D015333"}, {"RECTYPE": "D", "MH": "Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor", "DE": "GENE REARR GAMMA CHAIN", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "T-Lymphocyte Antigen Receptor gamma-Chain Gene Rearrangement|T045|EQV|UNK (19XX)|880601|LYMPHOCYTE ANTIGEN RECEPTOR GAMMA CHAIN GENE REARRANGEMENT T|T LYMPHOCYTE ANTIGEN RECEPT G CHAIN GENE REARR|abdefsv", "ENTRY": "T Lymphocyte gamma Chain Gene Rearrangement", "MN": "G12.500.287.311", "MH_TH": "NLM (1988)", "ST": "T045", "PI": "T Lymphocytes/immunology (1977-1988)", "MS": "Ordered rearrangement of T-cell variable gene regions coding for the gamma-chain of antigen receptors.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19880601", "DC": "1", "DX": "19880101", "UI": "D015334"}, {"RECTYPE": "D", "MH": "Molecular Probes", "DE": "MOL PROBES", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Probes, Molecular|T130|NON|EQV|NLM (1994)|920827|PROBES MOL|abcdefv", "MN": "D27.720.470.530", "FX": "Biomarkers", "MH_TH": "NLM (1989)", "ST": "T130", "RN": "0", "AN": "MOLECULAR PROBE TECHNIQUES is also available", "MS": "A group of atoms or molecules attached to other molecules or cellular structures and used in studying the properties of these molecules and structures. Radioactive DNA or RNA sequences are used in MOLECULAR GENETICS to detect the presence of a complementary sequence by NUCLEIC ACID HYBRIDIZATION.", "PM": "89", "HN": "89", "MR": "20150714", "DA": "19880601", "DC": "1", "DX": "19890101", "UI": "D015335"}, {"RECTYPE": "D", "MH": "Molecular Probe Techniques", "DE": "MOL PROBE TECHNIQUES", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Probe Techniques, Molecular", "MN": "E05.601", "MH_TH": "NLM (1989)", "ST": "T059", "AN": "specific probes are indented under MOLECULAR PROBES", "MS": "The use of devices which use detector molecules to detect, investigate, or analyze other molecules, macromolecules, molecular aggregates, or organisms.", "OL": "use MOLECULAR PROBE TECHNIQUES to search MOLECULAR PROBE TECHNICS 1989-90", "PM": "91; was MOLECULAR PROBE TECHNICS 1989-90", "HN": "91; was MOLECULAR PROBE TECHNICS 1989-90", "CATSH": "CAT LIST", "MR": "20150701", "DA": "19880601", "DC": "1", "DX": "19890101", "UI": "D015336"}, {"RECTYPE": "D", "MH": "Multicenter Studies as Topic", "AQ": "CL EC ES HI IS LJ MT PX SN ST VE", "PRINT ENTRY": "Multicenter Trials|T062|NON|NRW|NLM (1990)|890510|abcdef", "ENTRY": "Trials, Multicentre", "MN": "N06.850.520.450.643", "FX": "Clinical Trials, Phase IV as Topic", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "for general design, methodology, economics, etc. of multicenter studies; a different heading MULTICENTER STUDIES is used for reports of a specific multicenter study; specify geographic term if pertinent", "MS": "Works about controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.", "PM": "2008; see MULTICENTER STUDIES 1989-2007", "HN": "2008(1989)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19880601", "DC": "1", "DX": "19890101", "UI": "D015337"}, {"RECTYPE": "D", "MH": "Epidemiologic Research Design", "DE": "EPIDEMIOL RESEARCH DESIGN", "AQ": "VE", "ENTRY": "Research Designs, Epidemiological", "MN": "N06.850.520.445", "MH_TH": "NLM (1989)", "ST": "T062", "AN": "general or unspecified; prefer specifics; coordinate with subject of research ", "PI": "Research Design (1971-1997)", "MS": "The form and structure of analytic studies in epidemiologic research.", "OL": "restrict to study design of EPIDEMIOLOGIC METHODS", "PM": "98", "HN": "98; use explode 1989-97", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19880601", "DC": "1", "DX": "19980101", "UI": "D015340"}, {"RECTYPE": "D", "MH": "Nucleic Acid Probes", "AQ": "AD AE AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Probes, Nucleic Acid", "MN": "D27.720.470.530.600", "FX": "Nucleic Acid Hybridization", "MH_TH": "NLM (1989)", "ST": "T130", "RN": "0", "AN": "general or unspecified; prefer specific DNA & RNA probes", "PI": "Nucleic Acids or specific nucleic acid (1972-1988)", "MS": "Nucleic acid which complements a specific mRNA or DNA molecule, or fragment thereof; used for hybridization studies in order to identify microorganisms and for genetic studies.", "PM": "89", "HN": "89", "MR": "20140625", "DA": "19880601", "DC": "1", "DX": "19890101", "UI": "D015341"}, {"RECTYPE": "D", "MH": "DNA Probes", "AQ": "AD AE AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gene Probes, DNA|T114|T130|NON|NRW|UNK (19XX)|880601|abbcdef", "ENTRY": "Probes, Whole Chromosomal", "MN": "D27.720.470.530.600.223", "FX": "Chromosome Walking", "MH_TH": "NLM (1989)", "ST": "T130", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Nucleic Acid Hybridization (1972-1988)", "MS": "Species- or subspecies-specific DNA (including COMPLEMENTARY DNA; conserved genes, whole chromosomes, or whole genomes) used in hybridization studies in order to identify microorganisms, to measure DNA-DNA homologies, to group subspecies, etc. The DNA probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the DNA probe include the radioisotope labels 32P and 125I and the chemical label biotin. The use of DNA probes provides a specific, sensitive, rapid, and inexpensive replacement for cell culture techniques for diagnosing infections.", "PM": "89", "HN": "89", "MR": "20200527", "DA": "19880601", "DC": "1", "DX": "19890101", "UI": "D015342"}, {"RECTYPE": "D", "MH": "DNA Probes, HLA", "DE": "HLA PROBES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Human Leukocyte Antigen DNA Probes|T114|T130|EQV|UNK (19XX)|880601|abbdef", "ENTRY": "Probes, HLA-Dw DNA", "MN": "D27.720.470.530.600.223.615", "MH_TH": "NLM (1989)", "ST": "T130", "RN": "0", "PI": "Nucleic Acid Hybridization (1972-1988)", "MS": "DNA probes specific for the human leukocyte antigen genes, which represent the major histocompatibility determinants in humans. The four known loci are designated as A, B, C, and D. Specific antigens are identified by a locus notation and number, e.g., HLA-A11. The inheritance of certain HLA alleles is associated with increased risk for certain diseases (e.g., insulin-dependent diabetes mellitus).", "PM": "91; was see under DNA PROBES 1989-90", "HN": "91(89); was see under DNA PROBES 1989-90", "MR": "20140617", "DA": "19880601", "DC": "1", "DX": "19910101", "UI": "D015343"}, {"RECTYPE": "D", "MH": "DNA Probes, HPV", "DE": "HPV PROBES", "AQ": "AD AE AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Papilloma Virus DNA Probes|T114|T130|EQV|UNK (19XX)|880601|abbdef", "ENTRY": "Probes, HPV DNA", "MN": "D27.720.470.530.600.223.620", "MH_TH": "NLM (1989)", "ST": "T130", "RN": "0", "PI": "Papilloma Viruses (1972-1988)", "MS": "DNA probes specific for the identification of human papilloma virus.", "PM": "91; was see under DNA PROBES 1989-90", "HN": "91(89); was see under DNA PROBES 1989-90", "MR": "20140625", "DA": "19880601", "DC": "1", "DX": "19910101", "UI": "D015344"}, {"RECTYPE": "D", "MH": "Oligonucleotide Probes", "AQ": "AD AE AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Oligoribonucleotide Probes|T114|T130|NON|NRW|UNK (19XX)|880601|abbcdef", "ENTRY": "Probes, Oligoribonucleotide", "MN": "D27.720.470.530.600.650", "FX": "Oligonucleotide Array Sequence Analysis", "MH_TH": "NLM (1989)", "ST": "T130", "RN": "0", "PI": "Oligonucleotides (1972-1988)", "MS": "Synthetic or natural oligonucleotides used in hybridization studies in order to identify and study specific nucleic acid fragments, e.g., DNA segments near or within a specific gene locus or gene. The probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the probe include the radioisotope labels 32P and 125I and the chemical label biotin.", "PM": "89", "HN": "89", "MR": "20200617", "DA": "19880601", "DC": "1", "DX": "19890101", "UI": "D015345"}, {"RECTYPE": "D", "MH": "RNA Probes", "AQ": "AD AE AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RNA Probe|T114|T130|NON|EQV|NLM (2021)|200623|abbcdef", "ENTRY": "RNA Gene Probes", "MN": "D27.720.470.530.600.825", "MH_TH": "NLM (1989)", "ST": "T130", "RN": "0", "AN": "usually no qualif: /drug eff /ultrastruct permitted", "PI": "RNA, Messenger (1972-1988)", "MS": "RNA, usually prepared by transcription from cloned DNA, which complements a specific mRNA or DNA and is generally used for studies of virus genes, distribution of specific RNA in tissues and cells, integration of viral DNA into genomes, transcription, etc. Whereas DNA PROBES are preferred for use at a more macroscopic level for detection of the presence of DNA/RNA from specific species or subspecies, RNA probes are preferred for genetic studies. Conventional labels for the RNA probe include radioisotope labels 32P and 125I and the chemical label biotin. RNA probes may be further divided by category into plus-sense RNA probes, minus-sense RNA probes, and antisense RNA probes.", "PM": "89", "HN": "89", "MR": "20200625", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015347"}, {"RECTYPE": "D", "MH": "Vision, Binocular", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Binocular Vision|T041|NON|EQV|UNK (19XX)|880602|abcdef", "MN": "F02.463.593.932.885", "MH_TH": "NLM (1989)", "ST": "T041", "PI": "Visual Perception (1966-1988)", "MS": "The blending of separate images seen by each eye into one composite image.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015348"}, {"RECTYPE": "D", "MH": "Vision, Monocular", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Monovision|T041|NON|EQV|NLM (2020)|190214|abcdef", "MN": "F02.463.593.932.893", "MH_TH": "NLM (1989)", "ST": "T041", "PI": "Vision (1966-1988)", "MS": "Images seen by one eye.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20190429", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015349"}, {"RECTYPE": "D", "MH": "Contrast Sensitivity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Visual Contrast Sensitivity|T041|T042|NON|EQV|UNK (19XX)|880602|abbcdef", "ENTRY": "Sensitivity, Visual Contrast", "MN": "G14.940.500", "MH_TH": "NLM (1989)", "ST": "T042", "PI": "Visual Perception (1972-1988)", "MS": "The ability to detect sharp boundaries (stimuli) and to detect slight changes in luminance at regions without distinct contours. Psychophysical measurements of this visual function are used to evaluate VISUAL ACUITY and to detect eye disease.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015350"}, {"RECTYPE": "D", "MH": "Vision Screening", "AQ": "AE CL EC ES HI IS LJ MO MT NU OG PX ST TD VE", "ENTRY": "Vision Screenings", "MN": "N06.850.780.500.950", "MH_TH": "NLM (1989)", "ST": "T060", "AN": "on an epidemiol or population level: do not confuse with VISION TESTS on a personal level; coord with disease /diag or /epidemiol or /prev", "PI": "Vision Tests (1966-1988)", "MS": "Application of tests and examinations to identify visual defects or vision disorders occurring in specific populations, as in school children, the elderly, etc. It is differentiated from VISION TESTS, which are given to evaluate/measure individual visual performance not related to a specific population.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015351"}, {"RECTYPE": "D", "MH": "Dry Eye Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Evaporative Dry Eye Syndrome|T047|NON|NRW|NLM (2020)|190212|abcdef", "ENTRY": "Evaporative Dry Eyes", "MN": "C11.496.260", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "general or unspecified: prefer specifics; do not confuse with XEROPHTHALMIA", "MS": "Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20190429", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015352"}, {"RECTYPE": "D", "MH": "Eye Enucleation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Enucleation Technique|T061|NON|EQV|NLM (2020)|190208|abcdef", "ENTRY": "Surgery, Enucleation", "MN": "E04.540.429", "MH_TH": "NLM (1989)", "ST": "T061", "AN": "do not confuse with EYE EVISCERATION ", "PI": "Eye/surgery (1966-1988)", "MS": "The surgical removal of the eyeball leaving the eye muscles and remaining orbital contents intact.", "OL": "use EYE ENUCLEATON to search ENUCLEATION, EYE 1989-92", "PM": "89; ENUCLEATION, EYE was see EYE ENUCLEATION 1989-92", "HN": "89; ENUCLEATION, EYE was see EYE ENUCLEATION 1989-92", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015353"}, {"RECTYPE": "D", "MH": "Vision, Low", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vision, Subnormal|T033|T047|NON|EQV|NLM (1989)|990101|abbcdef", "ENTRY": "Subnormal Vision", "MN": "C23.888.592.763.941.848", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "do not make a diagnosis: use term of author", "PI": "Visual Acuity (1969-1988)", "MS": "Vision considered to be inferior to normal vision as represented by accepted standards of acuity, field of vision, or motility. Low vision generally refers to visual disorders that are caused by diseases that cannot be corrected by refraction (e.g., MACULAR DEGENERATION; RETINITIS PIGMENTOSA; DIABETIC RETINOPATHY, etc.).", "PM": "2000; see VISION, SUBNORMAL 1990-1999, see VISION, LOW 1989; for VISION, LOW see VISION, SUBNORMAL 1990-1999", "HN": "2000(1989)", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015354"}, {"RECTYPE": "D", "MH": "Glaucoma, Neovascular", "DE": "GLAUCOMA NEOVASC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neovascular Glaucomas", "MN": "C11.525.381.348", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Neovascularization (1979-1988)", "MS": "A form of secondary glaucoma which develops as a consequence of another ocular disease and is attributed to the forming of new vessels in the angle of the anterior chamber.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015355"}, {"RECTYPE": "D", "MH": "Retinal Artery Occlusion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Central Retinal Artery Occlusion|T047|NON|NRW|UNK (19XX)|880602|CRAO|abcdefv", "ENTRY": "Retinal Artery Occlusions", "MN": "C14.907.137.780", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Retinal Diseases (1972-1988)", "MS": "Sudden ISCHEMIA in the RETINA due to blocked blood flow through the CENTRAL RETINAL ARTERY or its branches leading to sudden complete or partial loss of vision, respectively, in the eye.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015356"}, {"RECTYPE": "D", "MH": "Vision Disparity", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Retinal Disparity|T081|NON|EQV|UNK (19XX)|880602|abcdef", "ENTRY": "Visual Disparities", "MN": "G14.930", "MH_TH": "NLM (1989)", "ST": "T081", "MS": "The difference between two images on the retina when looking at a visual stimulus. This occurs since the two retinas do not have the same view of the stimulus because of the location of our eyes. Thus the left eye does not get exactly the same view as the right eye.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015357"}, {"RECTYPE": "D", "MH": "Mycobacterium scrofulaceum", "DE": "MYCOBACT SCROFULACEUM", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.552.552.720.625", "MH_TH": "NLM (1989)", "ST": "T007", "RN": "txid1783", "AN": "infection: coordinate with MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS", "PI": "Mycobacterium, Atypical (1966-1988)", "MS": "A non-tuberculous mycobacterium causing cervical lymphadenitis in children. It very rarely causes pulmonary disease, and is believed to be non-pathogenic in animals.", "PM": "89", "HN": "89", "MR": "20200813", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015359"}, {"RECTYPE": "D", "MH": "Analgesia, Epidural", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Epidural Analgesia|T061|NON|EQV|UNK (19XX)|880602|abcdef", "MN": "E03.091.080", "MH_TH": "NLM (1989)", "ST": "T061", "AN": "for relief of pain: do not confuse with ANESTHESIA, EPIDURAL", "PI": "Pain/drug therapy (1966-1988)", "MS": "The relief of pain without loss of consciousness through the introduction of an analgesic agent into the epidural space of the vertebral canal. It is differentiated from ANESTHESIA, EPIDURAL which refers to the state of insensitivity to sensation.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "19910512", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015360"}, {"RECTYPE": "D", "MH": "Rhytidoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Rhytidectomy|T061|NON|NRW|UNK (19XX)|880602|abcdef", "ENTRY": "Rhytidoplasties", "MN": "E04.617.275.700", "FX": "Superficial Musculoaponeurotic System", "MH_TH": "NLM (1989)", "ST": "T061", "AN": "if of the face, do not coordinate with FACE or SKIN", "PI": "Surgery, Plastic (1966-1988)", "MS": "Plastic surgery performed, usually by excision of skin, for the elimination of wrinkles from the skin.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015361"}, {"RECTYPE": "D", "MH": "Child Nutrition Disorders", "DE": "CHILD NUTRITION DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nutrition Disorders, Child|T047|NON|EQV|UNK (19XX)|880602|NUTRITION DIS CHILD|abcdefv", "ENTRY": "Overnutrition, Child", "MN": "C18.654.180", "FX": "Infant Nutrition Disorders", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "general or unspecified; prefer specifics disease with appropriate age check tag", "PI": "Nutrition Disorders (1966-1988)", "MS": "Disorders caused by nutritional imbalance, either overnutrition or undernutrition, occurring in children ages 2 to 12 years.", "PM": "1989", "HN": "1989", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015362"}, {"RECTYPE": "D", "MH": "Quinolones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Quinolone|T109|T121|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D03.633.100.810.835", "MH_TH": "NLM (1989)", "ST": "T121", "RN": "0", "AN": "do not confuse with QUINOLINES", "PI": "Quinolines (1966-1988)", "MS": "A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.", "OL": "use QUINOLONES to search QUINOLINONES 1989-93", "PM": "94; was QUINOLINONES 1989-93; QUINOLONES was see QUINOLINONES 1989-93", "HN": "94; was QUINOLINONES 1989-93; QUINOLONES was see QUINOLINONES 1989-93", "MR": "20200527", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015363"}, {"RECTYPE": "D", "MH": "Enoxacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sesquihydrate, Enoxacin", "MN": "D03.633.100.810.835.322.280", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USAN (1984)", "ST": "T121", "N1": "1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-", "RN": "325OGW249P", "RR": "I9CD31N8WB", "PI": "Naphthyridines (1983-1988)", "MS": "A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.", "PM": "89", "HN": "89", "MR": "20190429", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015365"}, {"RECTYPE": "D", "MH": "Pefloxacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R.B., 2589", "MN": "D03.633.100.810.835.322.750", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USAN (1981)", "ST": "T121", "N1": "3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-", "RN": "2H52Z9F2Q5", "RR": "CX28QC6FU0", "PI": "Quinolines (1981-1983)", "MS": "A synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria.", "PM": "89", "HN": "89", "MR": "20230601", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015366"}, {"RECTYPE": "D", "MH": "Human T-lymphotropic virus 2", "DS": "HUMAN LYMPHOTROPIC VIRUS 002", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "T-Cell Leukemia Virus II, Human|T005|EQV|UNK (19XX)|880602|T CELL LEUKEMIA VIRUS II HUMAN|abdefs", "ENTRY": "Human T lymphotropic virus 2", "MN": "B04.820.650.200.730.404", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11909", "PI": "Retroviridae (1981-1983)", "MS": "A strain of PRIMATE T-LYMPHOTROPIC VIRUS 2 that can transform normal T-lymphocytes and can replicate in both T- and B-cell lines. The virus is related to but distinct from HTLV-1.", "PM": "2002; see HTLV-II 1989-2001", "HN": "2002 (1989)", "MR": "20200813", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015367"}, {"RECTYPE": "D", "MH": "Human T-lymphotropic virus 1", "DS": "HUMAN LYMPHOTROPIC VIRUS 001", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "T-Cell Leukemia Virus I, Human|T005|EQV|UNK (19XX)|880602|T CELL LEUKEMIA VIRUS I HUMAN|abdefs", "ENTRY": "Human T lymphotropic virus 1", "MN": "B04.820.650.200.725.400", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11908", "PI": "Retroviridae (1981-1983)", "MS": "A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC).", "PM": "2001; see HTLV-I 1989-2001", "HN": "2001 (1989)", "MR": "20200813", "DA": "19880602", "DC": "1", "DX": "19890101", "UI": "D015368"}, {"RECTYPE": "D", "MH": "Infant Equipment", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Infant Walkers|T073|NON|NRW|UNK (19XX)|880603|abcdef", "ENTRY": "Walkers, Infant", "MN": "E07.490", "MH_TH": "NLM (1989)", "ST": "T073", "PI": "Equipment and Supplies (1966-1988)", "MS": "Equipment and furniture used by infants and babies in the home, car, and play area.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19880603", "DC": "1", "DX": "19890101", "UI": "D015370"}, {"RECTYPE": "D", "MH": "Bacterial Typing Techniques", "DE": "BACT TYPING TECHNIQUES", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Typing, Bacterial|T059|NON|BRD|UNK (19XX)|880603|TYPING BACT|abcdefv", "ENTRY": "Typing, Bacteriocin", "MN": "E05.200.875.150.125", "MH_TH": "NLM (1989)", "ST": "T059", "AN": "coordinate with bacterium /class", "PI": "Serotyping (1966-1988)", "MS": "Procedures for identifying types and strains of bacteria. The most frequently employed typing systems are BACTERIOPHAGE TYPING and SEROTYPING as well as bacteriocin typing and biotyping.", "OL": "use BACTERIAL TYPING TECHNIQUES to search BACTERIAL TYPING TECHNICS 1989-90 & BIOTYPING 1989-91; use BACTERIOPHAGE TYPING to search BACTERIOCIN TYPING 1986-88", "PM": "91; was BACTERIAL TYPING TECHNICS 1989-90; BIOTYPING was see BACTERIAL TYPING TECHNICS 1989-90 & BACTERIAL TYPING TECHNIQUES 1991; BACTERIOCIN TYPING was see BACTERIOPHAGE TYPING 1986-88", "HN": "91; was BACTERIAL TYPING TECHNICS 1989-90; BIOTYPING was see BACTERIAL TYPING TECHNICS 1989-90 & BACTERIAL TYPING TECHNIQUES 1991; BACTERIOCIN TYPING was see BACTERIOPHAGE TYPING 1986-88", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19880603", "DC": "1", "DX": "19890101", "UI": "D015373"}, {"RECTYPE": "D", "MH": "Biosensing Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Electrodes, Enzyme|T075|NON|REL|UNK (19XX)|880603|abcdef", "ENTRY": "Techniques, Biosensing", "MN": "E05.601.043", "FX": "Microchemistry", "MH_TH": "NLM (1989)", "ST": "T059", "PI": "Monitoring, Physiologic/instrumentation (1980-1988)", "MS": "Any of a variety of procedures which use biomolecular probes to measure the presence or concentration of biological molecules, biological structures, microorganisms, etc., by translating a biochemical interaction at the probe surface into a quantifiable physical signal.", "PM": "99; see BIOSENSORS 1989-98", "HN": "99(89)", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19880603", "DC": "1", "DX": "19890101", "UI": "D015374"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-2", "DE": "RECEPT IL 2", "DS": "RECEPTORS INTERLEUKIN 002", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "T-Cell Growth Factor Receptors|T116|T192|NON|EQV|UNK (19XX)|880603|T CELL GROWTH FACTOR RECEPT|abbcdefv", "ENTRY": "T Cell Growth Factor Receptors", "MN": "D12.776.543.750.705.852.420.320", "MH_TH": "NLM (1989)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1980-1988)", "MS": "Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN.", "PM": "1990; see RECEPTORS, INTERLEUKIN 2 1989", "HN": "1990(1989)", "MR": "20200527", "DA": "19880603", "DC": "1", "DX": "19890101", "UI": "D015375"}, {"RECTYPE": "D", "MH": "Nimustine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ACNU|T109|T121|ABB|EQV|FDA SRS (2014)|UNK (19XX)|880603|abbcdeef", "ENTRY": "NSC 245382|T109|T121|LAB|NRW|UNK (19XX)|880603|abbcdef", "MN": "D02.654.692.550", "PA": "Antineoplastic Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Urea, N'-((4-amino-2-methyl-5-pyrimidinyl)methyl)-N-(2-chloroethyl)-N-nitroso-", "RN": "0S726V972K", "RR": "42471-28-3 (Nimustine)", "PI": "Nitrosourea Compounds (1975-1988)", "MS": "Antineoplastic agent especially effective against malignant brain tumors. The resistance which brain tumor cells acquire to the initial effectiveness of this drug can be partially overcome by the simultaneous use of membrane-modifying agents such as reserpine, calcium antagonists such as nicardipine or verapamil, or the calmodulin inhibitor, trifluoperazine. The drug has also been used in combination with other antineoplastic agents or with radiotherapy for the treatment of various neoplasms.", "PM": "89", "HN": "89", "MR": "20200527", "DA": "19880603", "DC": "1", "DX": "19890101", "UI": "D015376"}, {"RECTYPE": "D", "MH": "Cilastatin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Cilastatin", "MN": "D10.251.355.325.200", "PA": "Protease Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "2-Heptenoic acid, 7-((2-amino-2-carboxyethyl)thio)-2-(((2,2-dimethylcyclopropyl)carbonyl)amino)-, (R-(R*,S*-(Z)))-", "RN": "141A6AMN38", "RR": "82009-34-5 (Cilastatin)", "PI": "Protease Inhibitors (1983-1988)", "MS": "A renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4.", "PM": "89", "HN": "89", "MR": "20160628", "DA": "19880603", "DC": "1", "DX": "19890101", "UI": "D015377"}, {"RECTYPE": "D", "MH": "Imipenem", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "N-Formimidoylthienamycin|T109|T195|NON|EQV|UNK (19XX)|880603|FORMIMIDOYLTHIENAMYCIN N|abbcdefs", "ENTRY": "N Formimidoylthienamycin", "MN": "D03.633.100.300.124.300.500", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R-(5alpha,6alpha(R*)))-", "RN": "71OTZ9ZE0A", "RR": "Q20IM7HE75", "PI": "Thienamycins (1983-1988)", "MS": "Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.", "PM": "89", "HN": "89", "MR": "20160531", "DA": "19880603", "DC": "1", "DX": "19890101", "UI": "D015378"}, {"RECTYPE": "D", "MH": "Zona Fasciculata", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Adrenal Fasciculata|T023|NON|EQV|UNK (19XX)|880606|abcdef", "ENTRY": "Fasciculata, Zona", "MN": "A06.300.071.140.950", "MH_TH": "NLM (1989)", "ST": "T023", "PI": "Adrenal Glands (1966-1988)", "MS": "The wide middle zone of the adrenal cortex. This zone produces a series of enzymes that convert PREGNENOLONE to cortisol (HYDROCORTISONE) via 17-ALPHA-HYDROXYPROGESTERONE.", "PM": "89", "HN": "89", "MR": "20180630", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015383"}, {"RECTYPE": "D", "MH": "Zona Glomerulosa", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Adrenal Glomerulosa|T023|NON|EQV|UNK (19XX)|880606|abcdef", "ENTRY": "Glomerulosa, Zona", "MN": "A06.300.071.140.960", "MH_TH": "NLM (1989)", "ST": "T023", "PI": "Adrenal Glands (1966-1988)", "MS": "The narrow subcapsular outer zone of the adrenal cortex. This zone produces a series of enzymes that convert PREGNENOLONE to ALDOSTERONE. The final steps involve three successive oxidations by CYTOCHROME P-450 CYP11B2.", "PM": "89", "HN": "89", "MR": "20180630", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015384"}, {"RECTYPE": "D", "MH": "Zona Reticularis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Adrenal Reticularis|T023|NON|EQV|UNK (19XX)|880606|abcdef", "ENTRY": "Reticularis, Zona", "MN": "A06.300.071.140.970", "MH_TH": "NLM (1989)", "ST": "T023", "PI": "Adrenal Glands (1966-1988)", "MS": "The inner zone of the adrenal cortex. This zone produces the enzymes that convert PREGNENOLONE, a 21-carbon steroid, to 19-carbon steroids (DEHYDROEPIANDROSTERONE; and ANDROSTENEDIONE) via 17-ALPHA-HYDROXYPREGNENOLONE.", "PM": "89", "HN": "89", "MR": "20180630", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015385"}, {"RECTYPE": "D", "MH": "Hazardous Substances", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Toxic Substances, Environmental|T131|NON|NRW|UNK (19XX)|880606|TOXIC SUBSTANCES ENVIR|abcdefv", "ENTRY": "Substances, Toxic Environmental", "MN": "D27.888.426", "MH_TH": "NLM (1989)", "ST": "T131", "RN": "0", "AN": "HAZARDOUS WASTE is also available", "PI": "Environmental Pollution (1971-1988)", "MS": "Elements, compounds, mixtures, or solutions that are considered severely harmful to human health and the environment. They include substances that are toxic, corrosive, flammable, or explosive.", "PM": "89", "HN": "89", "MR": "20200527", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015386"}, {"RECTYPE": "D", "MH": "Egg Proteins, Dietary", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Yolk Proteins, Dietary|T116|T168|NON|NRW|UNK (19XX)|880606|abbcdef", "ENTRY": "Yolk Protein, Dietary", "MN": "J02.500.470.349", "MH_TH": "NLM (1989)", "ST": "T168", "RN": "0", "AN": "specifically, \"proteins in eggs consumed as food\", otherwise EGG PROTEINS is available", "PI": "Egg Proteins (1966-1988)", "MS": "Proteins found in eggs which are consumed as a food.", "PM": "89", "HN": "89", "MR": "20190708", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015387"}, {"RECTYPE": "D", "MH": "Organelles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Organelle", "MN": "A11.284.430.214.190.875", "MH_TH": "NLM (1989)", "ST": "T026", "AN": "do not confuse with ORGANOIDS: read MeSH definitions & follow text", "PI": "Organoids (1966-1988)", "MS": "Specific particles of membrane-bound organized living substances present in eukaryotic cells, such as the MITOCHONDRIA; the GOLGI APPARATUS; ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES.", "PM": "89", "HN": "89", "MR": "20040729", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015388"}, {"RECTYPE": "D", "MH": "Gastric Bypass", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Gastroileal Bypass|T061|NON|NRW|IOM (1990)|890417|abcdef", "ENTRY": "Roux en Y Gastric Bypass", "MN": "E04.210.457.430", "MH_TH": "NLM (1989)", "ST": "T061", "AN": "do not routinely add ANASTOMOSIS, ROUX-EN-Y", "PI": "Stomach/surgery (1966-1988)", "MS": "Surgical procedure in which the STOMACH is transected high on the body. The resulting small proximal gastric pouch is joined to any parts of the SMALL INTESTINE by an end-to-side SURGICAL ANASTOMOSIS, depending on the amounts of intestinal surface being bypasses. This procedure is used frequently in the treatment of MORBID OBESITY by limiting the size of functional STOMACH, food intake, and food absorption.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20200221", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015390"}, {"RECTYPE": "D", "MH": "Gastroplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Vertical-Banded Gastroplasties", "MN": "E04.210.485", "MH_TH": "NLM (1989)", "ST": "T061", "PI": "Stomach/surgery (1966-1988)", "MS": "Surgical procedures involving the STOMACH and sometimes the lower ESOPHAGUS to correct anatomical defects, or to treat MORBID OBESITY by reducing the size of the stomach. There are several subtypes of bariatric gastroplasty, such as vertical banded gastroplasty, silicone ring vertical gastroplasty, and horizontal banded gastroplasty.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20200221", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015391"}, {"RECTYPE": "D", "MH": "Chemistry, Inorganic", "DE": "CHEM INORG", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Inorganic Chemistry|T090|NON|EQV|UNK (19XX)|880606|INORG CHEM|abcdefv", "ENTRY": "Inorganic Chemistries", "MN": "H01.181.370", "MH_TH": "NLM (1989)", "ST": "T090", "PI": "Chemistry (1966-1988)", "MS": "A field of chemistry which pertains to chemical compounds or ions that do not contain the element carbon (with the exception of carbon dioxide and compounds containing a carbonate radical, e.g., calcium carbonate).", "PM": "89", "HN": "89", "MR": "19930602", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015392"}, {"RECTYPE": "D", "MH": "Chemistry, Bioinorganic", "DE": "CHEM BIOINORG", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Bioinorganic Chemistry|T090|NON|EQV|UNK (19XX)|880606|BIOINORG CHEM|abcdefv", "ENTRY": "Inorganic Chemistry, Biological", "MN": "H01.181.370.310", "MH_TH": "NLM (1989)", "ST": "T090", "AN": "The discipline (education, history, etc) only; use CHEMICAL PHENOMENA or BIOCHEMICAL PHENOMENA or specifics treed under them for characteristics of inorganic substances interacting with biological substances.", "PI": "Metalloproteins (1982-1993)", "MS": "Field of chemistry pertaining to the study of inorganic compounds or ions and their interactions with biological ligands at the molecular level.", "PM": "89", "HN": "89", "MR": "20130709", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015393"}, {"RECTYPE": "D", "MH": "Molecular Structure", "DE": "MOL STRUCT", "PRINT ENTRY": "Structure, Molecular|T085|NON|EQV|UNK (19XX)|880606|STRUCT MOL|abcdefv", "ENTRY": "Structures, Molecular", "MN": "G02.466", "FX": "Models, Molecular", "MH_TH": "NLM (1989)", "ST": "T085", "PI": "Models, Molecular (1975-1988)", "MS": "The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds.", "PM": "89", "HN": "89", "MR": "20190524", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015394"}, {"RECTYPE": "D", "MH": "Histocompatibility Antigens Class I", "DS": "HISTOCOMPATIBILITY ANTIGENS CLASS 01", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "MHC-I Peptide|T116|T129|NON|EQV|NLM (2021)|200312|abbcdef", "ENTRY": "Peptides, MHC-I", "MN": "D23.050.705.552.100", "FX": "Genes, MHC Class I", "MH_TH": "NLM (1988)", "ST": "T129", "RN": "0", "AN": "human & animal", "PI": "Histocompatibility Antigens (1973-1988)", "MS": "Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells.", "PM": "89", "HN": "89", "MR": "20230316", "DA": "19880606", "DC": "1", "DX": "19880101", "UI": "D015395"}, {"RECTYPE": "D", "MH": "Program Evaluation", "AQ": "EC MT SN ST TD", "PRINT ENTRY": "Evaluation, Program|T057|NON|EQV|UNK (19XX)|880606|abcdef", "ENTRY": "Sustainability, Program", "MN": "N05.715.360.650", "FX": "Social Validity, Research", "MH_TH": "POPLINE (1978)", "ST": "T057", "AN": "do not confuse with terms indented under QUALITY OF HEALTH CARE", "PI": "Evaluation Studies (1971-1988)", "MS": "Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015397"}, {"RECTYPE": "D", "MH": "Signal Transduction", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Signal Pathways|T043|T044|NON|NRW|UNK (19XX)|880606|abbcdef", "ENTRY": "Transductions, Signal", "MN": "G04.835", "FX": "Ion Channels", "MH_TH": "NLM (1989)", "ST": "T044", "PI": "specific compounds/physiology (1977-1988)", "MS": "The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015398"}, {"RECTYPE": "D", "MH": "Nursing Research", "DE": "NURS RESEARCH", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Research, Nursing|T062|NON|EQV|UNK (19XX)|880606|RESEARCH NURS|abcdefv", "MN": "N04.590.233.508.613", "MH_TH": "NLM (1989)", "ST": "T062", "PI": "Research (1966-1988)", "MS": "Research carried out by nurses, generally in clinical settings, in the areas of clinical practice, evaluation, nursing education, nursing administration, and methodology.", "PM": "89", "HN": "89", "MR": "20100625", "DA": "19880606", "DC": "1", "DX": "19890101", "UI": "D015399"}, {"RECTYPE": "D", "MH": "Clinical Nursing Research", "DE": "CLIN NURS RESEARCH", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Research, Clinical Nursing|T062|NON|EQV|UNK (19XX)|880606|RESEARCH CLIN NURS|abcdefv", "ENTRY": "Research, Nursing Clinical|T062|NON|EQV|NLM (1994)|920817|RESEARCH NURS CLIN|abcdefv", "MN": "N04.590.233.508.613.234", "MH_TH": "NLM (1989)", "ST": "T062", "PI": "Research (1966-1988)", "MS": "Research carried out by nurses in the clinical setting and designed to provide information that will help improve patient care. Other professional staff may also participate in the research.", "PM": "91; was see under NURSING RESEARCH 1989-90", "HN": "91(89); was see under NURSING RESEARCH 1989-90", "MR": "20100625", "DA": "19880606", "DC": "1", "DX": "19910101", "UI": "D015400"}, {"RECTYPE": "D", "MH": "Nursing Administration Research", "DE": "NURS ADMIN RESEARCH", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Research, Nursing Administration|T062|NON|EQV|UNK (19XX)|880606|RESEARCH NURS ADMIN|abcdefv", "ENTRY": "Researchs, Nursing Administration", "MN": "N04.590.233.508.613.385", "MH_TH": "NLM (1989)", "ST": "T062", "PI": "Research (1966-1988)", "MS": "Research concerned with establishing costs of nursing care, examining the relationships between nursing services and quality patient care, and viewing problems of nursing service delivery within the broader context of policy analysis and delivery of health services (from a national study, presented at the 1985 Council on Graduate Education for Administration in Nursing (CGEAN) meeting).", "PM": "91; was see under NURSING RESEARCH 1989-90", "HN": "91(89); was see under NURSING RESEARCH 1989-90", "MR": "20100625", "DA": "19880606", "DC": "1", "DX": "19910101", "UI": "D015401"}, {"RECTYPE": "D", "MH": "Nursing Education Research", "DE": "NURS EDUC RESEARCH", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Research, Nursing Education|T062|NON|EQV|UNK (19XX)|880606|RESEARCH NURS EDUC|abcdefv", "ENTRY": "Researchs, Nursing Education", "MN": "N04.590.233.508.613.413", "MH_TH": "NLM (1989)", "ST": "T062", "PI": "Research (1966-1988)", "MS": "Investigations into the problems of integrating research findings into nursing curricula, developing problem solving skills, finding approaches to clinical teaching, determining the level of practice by graduates from different basic preparations, etc.", "PM": "91; was see under NURSING RESEARCH 1989-90", "HN": "91(89); was see under NURSING RESEARCH 1989-90", "MR": "20100625", "DA": "19880606", "DC": "1", "DX": "19910101", "UI": "D015402"}, {"RECTYPE": "D", "MH": "Nursing Evaluation Research", "DE": "NURS EVALUATION RESEARCH", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Research, Nursing Evaluation|T062|EQV|UNK (19XX)|880606|RESEARCH NURS EVALUATION|abdefv", "ENTRY": "Study, Nursing Evaluation", "MN": "N04.590.233.508.613.432", "MH_TH": "NLM (1989)", "ST": "T062", "PI": "Research (1966-1988)", "MS": "Research carried out by nurses that uses interviews, data collection, observation, surveys, etc., to evaluate nursing, health, clinical, and nursing education programs and curricula, and which also demonstrates the value of such evaluation.", "PM": "91; was see under NURSING RESEARCH 1989-90", "HN": "91(89); was see under NURSING RESEARCH 1989-90", "MR": "20100625", "DA": "19880606", "DC": "1", "DX": "19910101", "UI": "D015403"}, {"RECTYPE": "D", "MH": "Nursing Methodology Research", "DE": "NURS METHODOL RESEARCH", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Research, Nursing Methodology|T062|NON|EQV|UNK (19XX)|880606|RESEARCH NURS METHODOL|abcdefv", "ENTRY": "Nursing Methodological Issues Research|T062|NON|NRW|UNK (19XX)|880606|NURS METHODOL ISSUES RESEARCH|abcdefv", "MN": "N04.590.233.508.613.634", "MH_TH": "NLM (1989)", "ST": "T062", "PI": "Research (1966-1988)", "MS": "Research carried out by nurses concerning techniques and methods to implement projects and to document information, including methods of interviewing patients, collecting data, and forming inferences. The concept includes exploration of methodological issues such as human subjectivity and human experience.", "PM": "91; was see under NURSING RESEARCH 1989-90", "HN": "91(89); was see under NURSING RESEARCH 1989-90", "MR": "20100625", "DA": "19880606", "DC": "1", "DX": "19910101", "UI": "D015404"}, {"RECTYPE": "D", "MH": "Single Parent", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Parent, Single|T099|NON|EQV|UNK (19XX)|880607|abcdef", "ENTRY": "Stepparents, Single", "MN": "N01.824.308.500.725.700", "FX": "Single-Parent Family", "MH_TH": "NLM (1989)", "ST": "T099", "AN": "never-married, divorced or widowed: read MeSH definition", "PI": "Single Person (1968-1988)", "MS": "A natural, adoptive, or substitute parent of a dependent child, who lives with only one parent. The single parent may live with or visit the child. The concept includes the never-married, as well as the divorced and widowed.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015406"}, {"RECTYPE": "D", "MH": "Gastrinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Islet Cell Tumor, Ulcerogenic|T191|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Tumors, Gastrin-Producing", "MN": "C19.344.421.500.124", "FX": "Zollinger-Ellison Syndrome", "MH_TH": "NLM (1989)", "ST": "T191", "AN": "coord IM with PANCREATIC NEOPLASMS (IM) or other precoord organ/neopl term (IM) if not in pancreas", "PI": "Zollinger-Ellison Syndrome (1982-1988)", "MS": "A GASTRIN-secreting neuroendocrine tumor of the non-beta ISLET CELLS, the GASTRIN-SECRETING CELLS. This type of tumor is primarily located in the PANCREAS or the DUODENUM. Majority of gastrinomas are malignant. They metastasize to the LIVER; LYMPH NODES; and BONE but rarely elsewhere. The presence of gastrinoma is one of three requirements to be met for identification of ZOLLINGER-ELLISON SYNDROME, which sometimes occurs in families with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; (MEN 1).", "OL": "use ZOLLINGER-ELLISON SYNDROME to search GASTRINOMA 1982-88; use ADENOMA, ISLET CELL 1981", "PM": "89; was see ZOLLINGER-ELLISON SYNDROME 1982-88; was see ISLET CELL TUMOR 1981", "HN": "89; was see ZOLLINGER-ELLISON SYNDROME 1982-88; was see ISLET CELL TUMOR 1981", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015408"}, {"RECTYPE": "D", "MH": "Mastectomy, Radical", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Halsted Mastectomy|T061|EPO|NRW|UNK (19XX)|880607|abcdef", "ENTRY": "Radical Mastectomy", "MN": "E04.466.678", "MH_TH": "NLM (1989)", "ST": "T061", "AN": "MASTECTOMY, EXTENDED RADICAL & MASTECTOMY, MODIFIED RADICAL are also available", "PI": "Mastectomy (1966-1988)", "MS": "Removal of the breast, pectoral muscles, axillary lymph nodes, and associated skin and subcutaneous tissue.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015409"}, {"RECTYPE": "D", "MH": "Mastectomy, Extended Radical", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Radical Mastectomy, Extended", "MN": "E04.466.678.354", "MH_TH": "NLM (1989)", "ST": "T061", "PI": "Mastectomy (1966-1988)", "MS": "Radical mastectomy with removal of the ipsilateral half of the sternum and a portion of ribs two through five with the underlying pleura and the internal mammary lymph nodes.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015410"}, {"RECTYPE": "D", "MH": "Mastectomy, Modified Radical", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Patey Mastectomy|T061|EPO|NRW|NLM (1994)|930219|abcdef", "ENTRY": "Radical Mastectomy, Modified", "MN": "E04.466.678.476", "MH_TH": "NLM (1989)", "ST": "T061", "PI": "Mastectomy (1966-1988)", "MS": "Total mastectomy with axillary node dissection, but with preservation of the pectoral muscles.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015411"}, {"RECTYPE": "D", "MH": "Mastectomy, Segmental", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Partial Mastectomy|T061|NON|EQV|UNK (19XX)|880607|abcdef", "ENTRY": "Surgery, Breast-Sparing", "MN": "E04.466.701", "MH_TH": "NLM (1989)", "ST": "T061", "PI": "Mastectomy (1966-1988)", "MS": "Removal of only enough breast tissue to ensure that the margins of the resected surgical specimen are free of tumor.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015412"}, {"RECTYPE": "D", "MH": "Mastectomy, Simple", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Total Mastectomy|T061|NON|EQV|UNK (19XX)|880607|abcdef", "ENTRY": "Total Mastectomies", "MN": "E04.466.754", "MH_TH": "NLM (1989)", "ST": "T061", "PI": "Mastectomy (1966-1988)", "MS": "Removal of only the breast tissue and nipple and a small portion of the overlying skin.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "19910515", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015413"}, {"RECTYPE": "D", "MH": "Mastectomy, Subcutaneous", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Subcutaneous Mastectomy", "MN": "E04.466.823", "MH_TH": "NLM (1989)", "ST": "T061", "PI": "Mastectomy (1966-1988)", "MS": "Excision of breast tissue with preservation of overlying skin, nipple, and areola so that breast form may be reconstructed.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015414"}, {"RECTYPE": "D", "MH": "Biomarkers", "AQ": "AN BL CF CH ME UR", "PRINT ENTRY": "Viral Markers|T080|NON|NRW|NLM (1993)|911115|abcdef", "ENTRY": "Markers, Immune", "MN": "D23.101", "FX": "Molecular Probes", "MH_TH": "NLM (2008)", "ST": "T081", "RN": "0", "AN": "IM general only; coordinate with specific substance; note that many specific markers are available ", "MS": "Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc.", "PM": "2016; See BIOLOGICAL MARKERS 1989-2015", "HN": "2016(1989)", "MR": "20200514", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015415"}, {"RECTYPE": "D", "MH": "Maillard Reaction", "AQ": "DE RE", "PRINT ENTRY": "Ribation|T070|NON|NRW|NLM (2023)|211217|abcdef", "ENTRY": "Reactions, Browning", "MN": "G02.607.522", "FX": "Glycation End Products, Advanced", "MH_TH": "NLM (1989)", "ST": "T070", "PI": "Chemistry (1966-1988)", "MS": "A group of nonenzymatic reactions in which ALDEHYDES; KETONES; or reducing sugars react with the amino groups of AMINO ACIDS; PEPTIDES; PROTEINS; LIPIDS; or NUCLEIC ACIDS.The reaction with reducing sugars (glycation) results in formation of Schiff bases which undergo Amadori rearrangement and other reactions that result in the irreversible formation of ADVANCED GLYCATION END PRODUCTS (AGEs). Food browning, such as occurs when cooking with high heat (grilling, frying, roasting, etc.) is attributed to the Maillard reaction. Non-enzymatic glycation and subsequent formation of AGEs also occurs in vivo and is accelerated under hyperglycemic and inflammatory conditions, and OXIDATIVE STRESS.", "PM": "89", "HN": "89", "MR": "20220408", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015416"}, {"RECTYPE": "D", "MH": "Hereditary Sensory and Motor Neuropathy", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuropathies, Hereditary Motor and Sensory|T047|NON|EQV|NLM (1988)|990101|NEUROPATHIES HEREDITARY MOTOR SENSORY|abcdefv", "ENTRY": "Type VII, HMSN", "MN": "C16.320.400.375", "MH_TH": "NLM (2010)", "ST": "T047", "AN": "do not confuse with HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES", "PI": "Neuromuscular Diseases (1979-1988)", "MS": "A group of slowly progressive inherited disorders affecting motor and sensory peripheral nerves. Subtypes include HMSNs I-VII. HMSN I and II both refer to CHARCOT-MARIE-TOOTH DISEASE. HMSN III refers to hypertrophic neuropathy of infancy. HMSN IV refers to REFSUM DISEASE. HMSN V refers to a condition marked by a hereditary motor and sensory neuropathy associated with spastic paraplegia (see SPASTIC PARAPLEGIA, HEREDITARY). HMSN VI refers to HMSN associated with an inherited optic atrophy (OPTIC ATROPHIES, HEREDITARY), and HMSN VII refers to HMSN associated with retinitis pigmentosa. (From Adams et al., Principles of Neurology, 6th ed, p1343)", "PM": "2000; see NEUROPATHIES, HEREDITARY MOTOR AND SENSORY 1988-1999", "HN": "2000(1989)", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19991108", "DC": "1", "DX": "19880101", "UI": "D015417"}, {"RECTYPE": "D", "MH": "Optic Atrophies, Hereditary", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hereditary Optic Atrophy|T019|NON|EQV|NLM (1989)|880607|abcdef", "ENTRY": "Hereditary Optic Atrophies", "MN": "C16.320.400.630", "MH_TH": "NLM (2000)", "ST": "T019", "PI": "Optic Atrophy/genetics (1966-1988)", "MS": "Hereditary conditions that feature progressive visual loss in association with optic atrophy. Relatively common forms include autosomal dominant optic atrophy (OPTIC ATROPHY, AUTOSOMAL DOMINANT) and Leber hereditary optic atrophy (OPTIC ATROPHY, HEREDITARY, LEBER).", "PM": "2000; see OPTIC ATROPHY, HEREDITARY 1991-1999, see NEUROPATHIES, HEREDITARY MOTOR AND SENSORY 1989-1990", "HN": "2000(1989)", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19880607", "DC": "1", "DX": "19910101", "UI": "D015418"}, {"RECTYPE": "D", "MH": "Spastic Paraplegia, Hereditary", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "X-Linked, Spastic Paraplegia, Hereditary|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Type V, HMSN", "MN": "C16.320.400.375.820", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "coordinate with GENES, DOMINANT or GENES, RECESSIVE if discussed", "PI": "Paraplegia/genetics (1966-1988)", "MS": "A group of inherited diseases that share similar phenotypes but are genetically diverse. Different genetic loci for autosomal recessive, autosomal dominant, and x-linked forms of hereditary spastic paraplegia have been identified. Clinically, patients present with slowly progressive distal limb weakness and lower extremity spasticity. Peripheral sensory neurons may be affected in the later stages of the disease. (J Neurol Neurosurg Psychiatry 1998 Jan;64(1):61-6; Curr Opin Neurol 1997 Aug;10(4):313-8)", "PM": "1991; see NEUROPATHIES, HEREDITARY MOTOR AND SENSORY 1989-1990", "HN": "1991(1989)", "CATSH": "CAT LIST", "MR": "20190521", "DA": "19880607", "DC": "1", "DX": "19910101", "UI": "D015419"}, {"RECTYPE": "D", "MH": "Scleral Diseases", "DE": "SCLERAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Scleral Disease", "MN": "C11.790", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Sclera (1966-1988)", "MS": "General disorders of the sclera or white of the eye. They may include anatomic, embryologic, degenerative, or pigmentation defects.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "19910619", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015422"}, {"RECTYPE": "D", "MH": "Scleritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Necrotizing Scleritis|T047|NON|NRW|UNK (19XX)|880607|abcdef", "ENTRY": "Scleritis, Necrotizing", "MN": "C11.790.500", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "note entry term EPISCLERITIS", "PI": "Sclera (1966-1988)", "MS": "Refers to any inflammation of the sclera including episcleritis, a benign condition affecting only the episclera, which is generally short-lived and easily treated. Classic scleritis, on the other hand, affects deeper tissue and is characterized by higher rates of visual acuity loss and even mortality, particularly in necrotizing form. Its characteristic symptom is severe and general head pain. Scleritis has also been associated with systemic collagen disease. Etiology is unknown but is thought to involve a local immune response. Treatment is difficult and includes administration of anti-inflammatory and immunosuppressive agents such as corticosteroids. Inflammation of the sclera may also be secondary to inflammation of adjacent tissues, such as the conjunctiva.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015423"}, {"RECTYPE": "D", "MH": "Reperfusion", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Reperfusions", "MN": "E05.680.730", "FX": "Reperfusion Injury", "MH_TH": "NLM (1989)", "ST": "T061", "AN": "note category: a technique; /adv eff permitted but consider also REPERFUSION INJURY; MYOCARDIAL REPERFUSION is also available", "PI": "specific organ/blood supply (1976-1988)", "MS": "Restoration of blood supply to tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. It is primarily a procedure for treating infarction or other ischemia, by enabling viable ischemic tissue to recover, thus limiting further necrosis. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing REPERFUSION INJURY.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015424"}, {"RECTYPE": "D", "MH": "Myocardial Reperfusion", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Reperfusion, Myocardial|T061|NON|EQV|UNK (19XX)|880607|abcdef", "ENTRY": "Reperfusions, Myocardial", "MN": "E05.680.730.600", "FX": "Myocardial Stunning", "MH_TH": "NLM (1989)", "ST": "T061", "AN": "note category: a technique; /adv eff permitted but consider also MYOCARDIAL REPERFUSION INJURY", "PI": "Perfusion (1968-1988)", "MS": "Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing MYOCARDIAL REPERFUSION INJURY.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19880607", "DC": "1", "DX": "19890101", "UI": "D015425"}, {"RECTYPE": "D", "MH": "Reperfusion Injury", "DE": "REPERFUSION INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ischemia-Reperfusion Injury|T037|NON|EQV|UNK (19XX)|880608|ISCHEMIA REPERFUSION INJ|abcdefv", "ENTRY": "Reperfusion Injuries", "MN": "C23.550.767.877", "FX": "Reperfusion", "MH_TH": "NLM (1989)", "ST": "T037", "PI": "Perfusion (1971-1988)", "MS": "Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015427"}, {"RECTYPE": "D", "MH": "Myocardial Reperfusion Injury", "DE": "MYOCARDIAL REPERFUSION INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Reperfusion Injury, Myocardial|T037|NON|EQV|UNK (19XX)|880608|REPERFUSION INJ MYOCARDIAL|abcdefv", "ENTRY": "Reperfusion Injuries, Myocardial", "MN": "C23.550.767.877.500", "FX": "Myocardial Stunning", "MH_TH": "NLM (1989)", "ST": "T037", "PI": "Perfusion (1971-1988)", "MS": "Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20141121", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015428"}, {"RECTYPE": "D", "MH": "Weight Gain", "AQ": "DE EH GE IM PH RE", "ENTRY": "Weight Gains", "MN": "G07.345.249.314.120.200.926", "FX": "Obesity", "MH_TH": "NLM (1989)", "ST": "T184", "PI": "Body Weight (1966-1988)", "MS": "Increase in BODY WEIGHT over existing weight.", "OL": "search BODY WEIGHT 1966-88", "PM": "89; was see BODY WEIGHT 1966-88", "HN": "89; was see BODY WEIGHT 1966-88", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015430"}, {"RECTYPE": "D", "MH": "Weight Loss", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Weight Reduction|T040|T184|NON|EQV|UNK (19XX)|880608|abbcdef", "ENTRY": "Weight Reductions", "MN": "G07.345.249.314.120.200.963", "FX": "Thinness", "MH_TH": "NLM (1989)", "ST": "T184", "PI": "Body Weight (1966-1988)", "MS": "Decrease in existing BODY WEIGHT.", "OL": "search BODY WEIGHT 1966-88", "PM": "89; was see BODY WEIGHT 1966-88", "HN": "89; was see BODY WEIGHT 1966-88", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015431"}, {"RECTYPE": "D", "MH": "Glomerulonephritis, Membranoproliferative", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mesangiocapillary Glomerulonephritis|T047|NON|EQV|UNK (19XX)|880608|MCGN|abcdefv", "ENTRY": "Type II MPGNs", "MN": "C20.425", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "do not confuse with GLOMERULONEPHRITIS, MEMBRANOUS; do not make diagnoses: use the term used by the author", "PI": "Glomerulonephritis (1969-1988)", "MS": "Chronic glomerulonephritis characterized histologically by proliferation of MESANGIAL CELLS, increase in the MESANGIAL EXTRACELLULAR MATRIX, and a thickening of the glomerular capillary walls. This may appear as a primary disorder or secondary to other diseases including infections and autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Various subtypes are classified by their abnormal ultrastructures and immune deposits. Hypocomplementemia is a characteristic feature of all types of MPGN.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015432"}, {"RECTYPE": "D", "MH": "Glomerulonephritis, Membranous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nephropathy, Membranous|T047|NON|EQV|UNK (19XX)|880608|abcdef", "ENTRY": "Nephropathy, Idiopathic Membranous", "MN": "C20.111.535", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "do not confuse with GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; do not make diagnoses: use the term used by the author", "PI": "Glomerulonephritis (1966-1988)", "MS": "A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.", "PM": "1989; for HEYMANN NEPHRITIS see GLOMERULONEPHRITIS 1987-2006", "HN": "1989; for HEYMANN NEPHRITIS use GLOMERULONEPHRITIS 1987-2006", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015433"}, {"RECTYPE": "D", "MH": "Panniculitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Panniculitis, Subacute Nodular Migratory|T047|NON|NRW|UNK (19XX)|880608|abcdef", "ENTRY": "Panniculitis, Cold", "MN": "C17.800.566", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Panniculitis, Nodular Nonsuppurative (1966-1988)", "MS": "General term for inflammation of adipose tissue, usually of the skin, characterized by reddened subcutaneous nodules.", "PM": "89; was heading 1963-64", "HN": "89; was heading 1963-64", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015434"}, {"RECTYPE": "D", "MH": "Panniculitis, Lupus Erythematosus", "DE": "PANNICULITIS LE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lupus Panniculitis|T047|NON|EQV|UNK (19XX)|880608|abcdef", "ENTRY": "Panniculitis, Lupus", "MN": "C17.800.566.400", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Panniculitis, Nodular Nonsuppurative (1966-1988)", "MS": "A type of lupus erythematosus characterized by deep dermal or subcutaneous nodules, most often on the head, face, or upper arms. It is generally chronic and occurs most often in women between the ages of 20 and 45.", "PM": "91; was see under PANNICULITIS 1989-90", "HN": "91(89); was see under PANNICULITIS 1989-90", "CATSH": "CAT LIST", "MR": "19920522", "DA": "19880608", "DC": "1", "DX": "19910101", "UI": "D015435"}, {"RECTYPE": "D", "MH": "Panniculitis, Peritoneal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mesenteric Panniculitis|T047|NON|NRW|ORD (2010)|UNK (19XX)|880608|abcdeef", "ENTRY": "Peritoneal Panniculitis", "MN": "C17.300.710.600", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Peritoneal Diseases (1966-1988)", "MS": "INFLAMMATION of the underlying layer of ADIPOSE TISSUE (panniculus) of the PERITONEUM, usually of the MESENTERY or the OMENTUM. There are several forms with various names and are usually characterized by infiltration of LYMPHOCYTES and NEUTROPHILS, fat NECROSIS, and FIBROSIS.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015436"}, {"RECTYPE": "D", "MH": "Health Behavior", "AQ": "CL DE EH ES PH RE", "ENTRY": "Health-Related Behaviors", "MN": "F01.145.488", "FX": "Healthy Lifestyle", "MH_TH": "NLM (1989)", "ST": "T055", "PI": "Attitude to Health (1969-1988)", "MS": "Combination of HEALTH KNOWLEDGE, ATTITUDES, PRACTICE which underlie actions taken by individuals regarding their health.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20181012", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015438"}, {"RECTYPE": "D", "MH": "Leprosy, Borderline", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Leprosy, Dimorphous|T047|NON|EQV|UNK (19XX)|880608|abcdef", "ENTRY": "Leprosies, Dimorphous", "MN": "C01.150.252.410.040.552.475.371.850.249", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "PI": "Leprosy (1966-1988)", "MS": "A form of LEPROSY in which there are clinical manifestations of both principal types (lepromatous and tuberculoid). The disease may shift toward one of these two polar or principal forms.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015439"}, {"RECTYPE": "D", "MH": "Leprosy, Lepromatous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Leprosy, Nodular|T047|NON|NRW|UNK (19XX)|880608|abcdef", "ENTRY": "Nodular Leprosy", "MN": "C01.150.252.410.040.552.475.371.775.500", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent; erythema nodosum leprosum (ENL): index under LEPROSY, LEPROMATOUS (IM) + ERYTHEMA NODOSUM (IM)", "PI": "Leprosy (1966-1988)", "MS": "A chronic communicable infection which is a principal or polar form of LEPROSY. This disorder is caused by MYCOBACTERIUM LEPRAE and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage.", "OL": "use LEPROSY, LEPROMATOUS to search CUTANEOUS LEPROSY & NODULAR LEPROSY 1989-91", "PM": "89; CUTANEOUS LEPROSY & NODULAR LEPROSY were see LEPROSY, LEPROMATOUS 1989-91", "HN": "89; CUTANEOUS LEPROSY & NODULAR LEPROSY were see LEPROSY, LEPROMATOUS 1989-91", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015440"}, {"RECTYPE": "D", "MH": "Leprosy, Tuberculoid", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Tuberculoid Leprosy|T047|NON|EQV|UNK (19XX)|880608|abcdef", "ENTRY": "Tuberculoid Leprosies", "MN": "C01.150.252.410.040.552.475.371.850.500", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "PI": "Leprosy (1966-1988)", "MS": "A principal or polar form of LEPROSY in which the skin lesions are few and are sharply demarcated. Peripheral nerve involvement is pronounced and may be severe. Unlike lepromatous leprosy (LEPROSY, LEPROMATOUS), the lepromin test is positive. Tuberculoid leprosy is rarely a source of infection to others.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015441"}, {"RECTYPE": "D", "MH": "Medicare Assignment", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Physician Assignment Acceptance|T078|NON|NRW|UNK (19XX)|880608|abcdef", "ENTRY": "Physician Assignment Acceptances", "MN": "N03.219.521.576.343.840.508", "MH_TH": "NLM (1989)", "ST": "T058", "AN": "specify geog if possible", "PI": "Insurance, Physician Services (1981-1988)", "MS": "Concept referring to the standardized fees for services rendered by health care providers, e.g., laboratories and physicians, and reimbursement for those services under Medicare Part B. It includes acceptance by the physician.", "PM": "91; was see under HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1989-90", "HN": "91(89); was see under HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1989-90", "MR": "19991103", "DA": "19880608", "DC": "1", "DX": "19910101", "UI": "D015442"}, {"RECTYPE": "D", "MH": "Word Processing", "AQ": "CL EC ED ES HI IS LJ MT SD SN ST TD", "ENTRY": "Word Processings", "MN": "N04.452.515.708.950", "MH_TH": "NLM (1989)", "ST": "T066", "PI": "Software (1983-1988)", "MS": "Text editing and storage functions using computer software.", "PM": "1989", "HN": "1989", "MR": "20180629", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015443"}, {"RECTYPE": "D", "MH": "Exercise", "AQ": "AE CL GE HI IM PH PX SN ST TD", "PRINT ENTRY": "Physical Activity|T040|T056|NON|EQV|NLM (2003)|020128|abbcdef", "ENTRY": "Trainings, Exercise", "MN": "I03.350", "FX": "Sports", "MH_TH": "NLM (1989)", "ST": "T056", "AN": "restrict to humans: for animals use PHYSICAL CONDITIONING, ANIMAL; EXERCISE THERAPY & EXERCISE TEST are also available; includes body building unless article specifies WEIGHT LIFTING; do not confuse with PHYSICAL EXERTION", "PI": "Physical Fitness (1966-1988)", "MS": "Physical activity which is usually regular and done with the intention of improving or maintaining PHYSICAL FITNESS or HEALTH. Contrast with PHYSICAL EXERTION which is concerned largely with the physiologic and metabolic response to energy expenditure.", "OL": "search EXERTION & SPORTS 1966-74; use EXERTION to search EXERCISE, PHYSICAL 1976-88; use ISOMETRIC CONTRACTION to search EXERCISE, ISOMETRIC 1984-88", "PM": "89; was see under EXERTION & SPORTS 1963-74; EXERCISE, ISOMETRIC was see under EXERTION 1977-83, was see ISOMETRIC CONTRACTION 1984-88; EXERCISE, PHYSICAL was see EXERTION 1976-88", "HN": "89; was see under EXERTION & SPORTS 1963-74; EXERCISE, ISOMETRIC was see under EXERTION 1977-83, was see ISOMETRIC CONTRACTION 1984-88; EXERCISE, PHYSICAL was see EXERTION 1976-88", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19880608", "DC": "1", "DX": "19890101", "UI": "D015444"}, {"RECTYPE": "D", "MH": "Leukemia, B-Cell", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lymphocytic Leukemia, B-Cell|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Lymphocytic Leukemias, B-Cell", "MN": "C20.683.515.528.080", "MH_TH": "NLM (1989)", "ST": "T191", "AN": "general or unspecified: prefer specifics", "PI": "Leukemia, Lymphocytic (1966-1988)", "MS": "A malignant disease of the B-LYMPHOCYTES in the bone marrow and/or blood.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015448"}, {"RECTYPE": "D", "MH": "Leukemia, Lymphocytic, Chronic, B-Cell", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lymphoma, Small Lymphocytic|T191|NON|EQV|NLM (1991)|990101|abcdef", "ENTRY": "Well-Differentiated Lymphocytic Lymphomas", "MN": "C23.550.291.500.483", "MH_TH": "UNK (19XX)", "ST": "T191", "PI": "Leukemia, Lymphocytic (1977-1988)", "MS": "A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.", "PM": "2008; see LEUKEMIA, B-CELL, CHRONIC 1989-2007; for LYMPHOMA, SMALL LYMPHOCYTIC see LYMPHOMA, SMALL LYMPHOCYTIC 1991-2007; for LYMPHOMA, SMALL-CELL see LYMPHOMA, SMALL CELL 1991-2007, see LYMPHOMA, LYMPHOCYTIC 1987-1990; for LEUKEMIA, LYMPHOCYTIC, CHRONIC, see LEUKEMIA, LYMPHOCYTIC, CHRONIC 1989-2007, see LEUKEMIA, LYMPHOCYTIC 1974-1988", "HN": "2008 (1989)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015451"}, {"RECTYPE": "D", "MH": "Precursor B-Cell Lymphoblastic Leukemia-Lymphoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pre-B-Cell Leukemia|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Precursor B Cell Lymphoblastic Lymphoma", "MN": "C20.683.515.528.600.600", "MH_TH": "NLM (2008)", "ST": "T191", "PI": "Leukemia, Lymphocytic (1977-1988)", "MS": "A leukemia/lymphoma found predominately in children and adolescents and characterized by a high number of lymphoblasts and solid tumor lesions. Frequent sites involve LYMPH NODES, skin, and bones. It most commonly presents as leukemia.", "PM": "2008; see LEUKEMIA, PRE-B-CELL 1989-2007", "HN": "2008 (1989)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015452"}, {"RECTYPE": "D", "MH": "Leukemia, Biphenotypic, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lymphocytic Leukemia, Acute, B- and T-Cell|T191|NON|EQV|UNK (19XX)|880609|LYMPHOCYTIC LEUKEMIA ACUTE B AND T CELL|abcdefs", "ENTRY": "Mixed-Lineage Acute Leukemia", "MN": "C20.683.515.528.100", "MH_TH": "NLM (2008)", "ST": "T191", "PI": "T Lymphocytes (1977-1988)", "MS": "An acute leukemia exhibiting cell features characteristic of both the myeloid and lymphoid lineages and probably arising from MULTIPOTENT STEM CELLS.", "PM": "2008; see LEUKEMIA, MIXED-CELL 1989-2007", "HN": "2008 (1989)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015456"}, {"RECTYPE": "D", "MH": "Leukemia, T-Cell", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "T-Lymphocytic Leukemia|T191|EQV|UNK (19XX)|880609|LYMPHOCYTIC LEUKEMIA A T|abdefs", "ENTRY": "T-Lymphocytic Leukemias", "MN": "C20.683.515.528.582", "MH_TH": "NLM (1989)", "ST": "T191", "AN": "general or unspecified: prefer specifics", "PI": "T Lymphocytes (1975-1988)", "MS": "A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.", "PM": "1989; see HTLV INFECTIONS 1987-88; for LEUKEMIA, ADULT T-CELL & T-CELL LEUKEMIA, ADULT see HTLV INFECTIONS 1987-88", "HN": "1989; use HTLV INFECTIONS 1987-1988", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015458"}, {"RECTYPE": "D", "MH": "Leukemia-Lymphoma, Adult T-Cell", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "T-Cell Leukemias, Adult", "MN": "C20.683.515.528.582.100", "MH_TH": "UNK (19XX)", "ST": "T191", "PI": "T Lymphocytes (1975-1988)", "MS": "Aggressive T-Cell malignancy with adult onset, caused by HUMAN T-LYMPHOTROPIC VIRUS 1. It is endemic in Japan, the Caribbean basin, Southeastern United States, Hawaii, and parts of Central and South America and sub-Saharan Africa.", "PM": "2008; see LEUKEMIA, T-CELL, ACUTE 1989-2007", "HN": "2008 (1989)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015459"}, {"RECTYPE": "D", "MH": "Leukemia, Prolymphocytic, T-Cell", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "T-Cell Prolymphocytic Leukemia|T191|NON|EQV|NLM (2008)|061207|abcdef", "ENTRY": "T-Cell Prolymphocytic Leukemias", "MN": "C20.683.515.528.582.125", "MH_TH": "NLM (2008)", "ST": "T191", "PI": "T Lymphocytes (1977-1988)", "MS": "A lymphoid leukemia characterized by a profound LYMPHOCYTOSIS with or without LYMPHADENOPATHY, hepatosplenomegaly, frequently rapid progression, and short survival. It was formerly called T-cell chronic lymphocytic leukemia.", "PM": "2008; see LEUKEMIA, T-CELL, CHRONIC 1989-2007", "HN": "2008 (1989)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015461"}, {"RECTYPE": "D", "MH": "Leukemia, Prolymphocytic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Prolymphocytic Leukemia|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Prolymphocytic Leukemias", "MN": "C20.683.515.528.565", "MH_TH": "NLM (1989)", "ST": "T191", "PI": "Leukemia, Lymphocytic (1966-1988)", "MS": "A chronic leukemia characterized by a large number of circulating prolymphocytes. It can arise spontaneously or as a consequence of transformation of CHRONIC LYMPHOCYTIC LEUKEMIA.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015463"}, {"RECTYPE": "D", "MH": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myeloid Leukemia, Chronic|T191|NON|EQV|ORD (2010)|UNK (19XX)|880609|abcdeef", "ENTRY": "Philadelphia-Positive Myeloid Leukemias", "MN": "C23.550.291.500.485", "MH_TH": "NLM (2008)", "ST": "T191", "PI": "Leukemia, Myeloid (1966-1988)", "MS": "Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.", "PM": "2008; see LEUKEMIA, MYELOID, CHRONIC 1989-2007; for LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE see LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE 1989-2007; for LEUKEMIA, MYELOCYTIC, CHRONIC & LEUKEMIA, MYELOGENOUS, CHRONIC see LEUKEMIA, MYELOCYTIC 1974-1988", "HN": "2008 (1989); for LEUKEMIA, MYELOCYTIC, CHRONIC & LEUKEMIA, MYELOGENOUS, CHRONIC use LEUKEMIA, MYELOID 1974-1988", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015464"}, {"RECTYPE": "D", "MH": "Leukemia, Myeloid, Accelerated Phase", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myeloid Leukemia, Chronic, Aggressive Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Myeloid Leukemia, Chronic, Aggressive-Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef", "MN": "C23.550.291.500.485.300", "MH_TH": "UNK (19XX)", "ST": "T191", "PI": "Leukemia, Myeloid (1972-1988)", "MS": "The phase of chronic myeloid leukemia following the chronic phase (LEUKEMIA, MYELOID, CHRONIC-PHASE), where there are increased systemic symptoms, worsening cytopenias, and refractory LEUKOCYTOSIS.", "PM": "2008; see LEUKEMIA, MYELOID, AGGRESSIVE-PHASE 1989-2007", "HN": "2008 (1989)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015465"}, {"RECTYPE": "D", "MH": "Leukemia, Myeloid, Chronic-Phase", "DE": "CML CHRONIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myeloid Leukemia, Chronic, Stable-Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Myeloid Leukemia, Chronic, Chronic Phase|T191|NON|EQV|UNK (19XX)|880609|abcdef", "MN": "C23.550.291.500.485.400", "MH_TH": "NLM (1989)", "ST": "T191", "PI": "Leukemia, Myeloid (1972-1988)", "MS": "The initial phase of chronic myeloid leukemia consisting of an relatively indolent period lasting from 4 to 7 years. Patients range from asymptomatic to those exhibiting ANEMIA; SPLENOMEGALY; and increased cell turnover. There are 5% or fewer blast cells in the blood and bone marrow in this phase.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015466"}, {"RECTYPE": "D", "MH": "Leukemia, Neutrophilic, Chronic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neutrophilic Leukemia, Chronic|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Neutrophilic Leukemias, Chronic", "MN": "C23.550.291.500.497", "MH_TH": "NLM (1989)", "ST": "T191", "PI": "Neutrophils (1966-1988)", "MS": "A rare myeloproliferative disorder that is characterized by a sustained, mature neutrophilic leukocytosis. No monocytosis, EOSINOPHILIA, or basophilia is present, nor is there a PHILADELPHIA CHROMOSOME or bcr-abl fusion gene (GENES, ABL).", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20210312", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015467"}, {"RECTYPE": "D", "MH": "Leukemia, Myeloid, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nonlymphocytic Leukemia, Acute|T191|NON|EQV|ORD (2010)|UNK (19XX)|880609|abcdeef", "ENTRY": "Nonlymphocytic Leukemias, Acute", "MN": "C15.378.508.539.275", "MH_TH": "NLM (2008)", "ST": "T191", "AN": "general or unspecified: prefer specifics", "PI": "Leukemia, Myeloblastic (1966-1988)", "MS": "Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.", "PM": "2008; see LEUKEMIA, NONLYMPHOCYTIC, ACUTE 1989-2007", "HN": "2008 (1989)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015470"}, {"RECTYPE": "D", "MH": "Leukemia, Basophilic, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Basophilic Leukemia, Acute|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Leukemias, Acute Basophilic", "MN": "C15.378.508.539.275.125", "MH_TH": "NLM (1989)", "ST": "T191", "PI": "Leukemia, Myeloblastic (1966-1988)", "MS": "A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015471"}, {"RECTYPE": "D", "MH": "Leukemia, Eosinophilic, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Eosinophilic Leukemia, Acute|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Leukemias, Acute Eosinophilic", "MN": "C15.378.508.539.275.300", "MH_TH": "NLM (1989)", "ST": "T191", "PI": "Leukemia, Myeloblastic (1966-1988)", "MS": "A rare acute myeloid leukemia characterized by abnormal EOSINOPHILS in the bone marrow.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015472"}, {"RECTYPE": "D", "MH": "Leukemia, Promyelocytic, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Promyelocytic Leukemia, Acute|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Acute Promyelocytic Leukemias", "MN": "C15.378.508.539.275.700", "MH_TH": "NLM (1989)", "ST": "T191", "PI": "Leukemia, Myeloid (1966-1988)", "MS": "An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015473"}, {"RECTYPE": "D", "MH": "Isotretinoin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "13-cis-Retinoic Acid|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1992)|910115|RETINOIC ACID A CIS 013|abbcdeefs", "ENTRY": "Ro 43780", "MN": "D23.767.261.700.325", "PA": "Teratogens", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Retinoic acid, 13-cis-", "RN": "EH28UP18IF", "RR": "4759-48-2 (Isotretinoin)", "PI": "Tretinoin (1975-1988)", "MS": "A topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The drug has teratogenic and other adverse effects.", "PM": "89", "HN": "89", "MR": "20130708", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015474"}, {"RECTYPE": "D", "MH": "Leukemia, Myelomonocytic, Chronic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myelomonocytic Leukemia, Chronic|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Myelomonocytic Leukemias, Chronic", "MN": "C23.550.291.500.495", "MH_TH": "NLM (1989)", "ST": "T191", "PI": "Leukemia, Myeloid (1980-1988)", "MS": "A myelodysplastic-myeloproliferative disease characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood.", "OL": "use LEUKEMIA, MYELOID to search LEUKEMIA, MYELOMONOCYTIC 1981-88", "PM": "89; was see LEUKEMIA, MYELOCYTIC 1981-88", "HN": "89; was see LEUKEMIA, MYELOCYTIC 1981-88", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015477"}, {"RECTYPE": "D", "MH": "Antigens, Heterophile", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Xenoantigens|T129|NON|EQV|NLM (1990)|890110|abcdef", "ENTRY": "Xenogenic Antigens", "MN": "D23.050.244", "MH_TH": "NLM (1972)", "ST": "T129", "RN": "0", "AN": "coord IM with specific antigen/organism heading (IM)", "MS": "Antigens stimulating the formation of, or combining with heterophile antibodies. They are cross-reacting antigens found in phylogenetically unrelated species.", "OL": "use ANTIGENS, HETEROPHILE to search ANTIGENS, HETEROGENETIC 1966-89 (Prov 1966-71)", "PM": "90; was ANTIGENS, HETEROGENETIC 1972-89", "HN": "90; was ANTIGENS, HETEROGENETIC 1972-89 (Prov 1966-71)", "MR": "20210630", "DA": "19990101", "DC": "1", "DX": "19720101", "UI": "D015478"}, {"RECTYPE": "D", "MH": "Leukemia, Myelomonocytic, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myelomonocytic Leukemia, Acute|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Naegeli-Type Myeloid Leukemia", "MN": "C15.378.508.539.520", "MH_TH": "NLM (1989)", "ST": "T191", "PI": "Leukemia, Myelocytic (1981-1988)", "MS": "A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.", "OL": "use LEUKEMIA, MYELOID to search LEUKEMIA, MYELOMONOCYTIC 1981-88 & LEUKEMIA, NAEGELI-TYPE 1981-88", "PM": "89; LEUKEMIA, MYELOMONOCYTIC was see LEUKEMIA, MYELOCYTIC 1981-88; LEUKEMIA, NAEGELI-TYPE was see LEUKEMIA, MYELOCYTIC 1975-88", "HN": "89; LEUKEMIA, MYELOMONOCYTIC was see LEUKEMIA, MYELOCYTIC 1981-88; LEUKEMIA, NAEGELI-TYPE was see LEUKEMIA, MYELOCYTIC 1975-88", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19880609", "DC": "1", "DX": "19890101", "UI": "D015479"}, {"RECTYPE": "D", "MH": "Deltaretrovirus Antibodies", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "T-Cell Leukemia-Lymphoma Virus Antibodies, Human|T116|T129|NRW|UNK (19XX)|880610|abbdef", "ENTRY": "HTLV BLV Antibodies", "MN": "D12.776.377.715.548.114.254.150", "PA": "Immunologic Factors", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "AN": "general or unspecified: prefer specifics; do not coordinate with specific delta retrovirus /immunol; do not coordinate with ANTIBODY FORMATION for /biosyn", "PI": "Human T-Cell Leukemia Virus/immunology (1984-1988)", "MS": "Antibodies reactive with various types of human T-cell leukemia/lymphoma antigens or bovine leukemia virus antigens.", "PM": "2003; see HTLV-BLV ANTIBODIES 1995-2002, see HTLV ANTIBODIES 1989-1994", "HN": "2003 (1989)", "MR": "20050630", "DA": "19880610", "DC": "1", "DX": "19880101", "UI": "D015480"}, {"RECTYPE": "D", "MH": "HTLV-I Antibodies", "DS": "HTLV WI ANTIBODIES", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "T-Cell Leukemia Virus I Antibodies, Human|T129|EQV|UNK (19XX)|880610|abdef", "ENTRY": "I Antibodies, HTLV", "MN": "D12.776.377.715.548.114.254.150.500", "PA": "Immunologic Factors", "MH_TH": "NLM (1988)", "ST": "T129", "RN": "0", "AN": "do not coordinate with ANTIBODY FORMATION for /biosyn", "PI": "Human T-Cell Leukemia Virus/immunology (1984-1988)", "MS": "Antibodies reactive with the HTLV-I ANTIGENS.", "PM": "89", "HN": "89", "MR": "20050630", "DA": "19880610", "DC": "1", "DX": "19880101", "UI": "D015481"}, {"RECTYPE": "D", "MH": "HTLV-II Antibodies", "DS": "HTLV WII ANTIBODIES", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "T-Cell Leukemia Virus II Antibodies, Human|T129|EQV|UNK (19XX)|880610|abdef", "ENTRY": "II Antibodies, HTLV", "MN": "D12.776.377.715.548.114.254.150.510", "PA": "Immunologic Factors", "MH_TH": "NLM (1989)", "ST": "T129", "RN": "0", "AN": "do not coordinate with ANTIBODY FORMATION for /biosyn", "PI": "Human T-Cell Leukemia Virus/immunology (1984-1988)", "MS": "Antibodies reactive with the HTLV-II ANTIGENS.", "PM": "89", "HN": "89", "MR": "20050630", "DA": "19880610", "DC": "1", "DX": "19890101", "UI": "D015482"}, {"RECTYPE": "D", "MH": "HIV Antibodies", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "T-Lymphotropic Virus Type III Antibodies, Human|T129|EQV|UNK (19XX)|880610|LYMPHOTROPIC VIRUS TYPE III ANTIBODIES HUMAN T|abdefs", "ENTRY": "Antibodies, Lymphadenopathy-Associated", "MN": "D12.776.377.715.548.114.254.150.440", "PA": "Immunologic Factors", "FX": "AIDS Serodiagnosis", "MH_TH": "NLM (1988)", "ST": "T129", "RN": "0", "AN": "coordinate IM with HIV-1/ immunol (IM) or HIV-2/ immunol (IM) if pertinent; do not coordinate with ANTIBODY FORMATION for /biosyn", "PI": "Human T-Cell Leukemia Virus/immunology (1986-1987)", "MS": "Antibodies reactive with HIV ANTIGENS.", "PM": "89", "HN": "89", "MR": "20060705", "DA": "19880610", "DC": "1", "DX": "19880101", "UI": "D015483"}, {"RECTYPE": "D", "MH": "Deltaretrovirus Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "T-Cell Leukemia-Lymphoma Virus Antigens, Human|T116|T129|NRW|UNK (19XX)|880610|abbdef", "ENTRY": "HTLV BLV Antigens", "MN": "D23.050.327.150", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Human T-Cell Leukemia Virus/immunology (1984-1987)", "MS": "Antigens associated with the DELTARETROVIRUS; HTLV-I ANTIGENS and HTLV-II ANTIGENS belong to this group.", "PM": "2003; see HTLV-BLV ANTIGENS 1995-2002, see HTLV ANTIGENS 1989-1994", "HN": "2003 (1989)", "MR": "20220413", "DA": "19880610", "DC": "1", "DX": "19880101", "UI": "D015485"}, {"RECTYPE": "D", "MH": "HTLV-I Antigens", "DS": "HTLV WI ANTIGENS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "T-Cell Leukemia Virus I Antigens, Human|T129|EQV|UNK (19XX)|880610|abdef", "ENTRY": "I Antigens, HTLV", "MN": "D23.050.327.150.500", "MH_TH": "NLM (1988)", "ST": "T129", "RN": "0", "PI": "Human T-Cell Leukemia Virus/immunology (1984-1988)", "MS": "Antigens associated with HUMAN T-LYMPHOTROPIC VIRUS 1.", "PM": "89", "HN": "89", "MR": "20220413", "DA": "19880610", "DC": "1", "DX": "19880101", "UI": "D015486"}, {"RECTYPE": "D", "MH": "HTLV-II Antigens", "DS": "HTLV WII ANTIGENS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "T-Cell Leukemia Virus II Antigens, Human|T129|EQV|UNK (19XX)|880610|abdef", "ENTRY": "II Antigens, HTLV", "MN": "D23.050.327.150.510", "MH_TH": "NLM (1989)", "ST": "T129", "RN": "0", "PI": "Human T-Cell Leukemia Virus/immunology (1984-1988)", "MS": "Antigens associated with HUMAN T-LYMPHOTROPIC VIRUS 2.", "PM": "89", "HN": "89", "MR": "20220413", "DA": "19880610", "DC": "1", "DX": "19890101", "UI": "D015487"}, {"RECTYPE": "D", "MH": "HIV Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "T-Lymphotropic Virus Type III Antigens, Human|T116|EQV|UNK (19XX)|880610|LYMPHOTROPIC VIRUS TYPE III ANTIGENS HUMAN T|abdefs", "ENTRY": "III Antigens, HTLV", "MN": "D23.050.327.520", "MH_TH": "NLM (1988)", "ST": "T116", "RN": "0", "PI": "Human T-Cell Leukemia Virus/immunology (1984-1987)", "MS": "Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (LAV) antigens.", "PM": "89", "HN": "89", "MR": "20220413", "DA": "19880610", "DC": "1", "DX": "19880101", "UI": "D015488"}, {"RECTYPE": "D", "MH": "HTLV-I Infections", "DE": "HTLV I INFECT", "DS": "HTLV WI INFECTIONS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, HTLV I", "MN": "C20.673.483.470", "FX": "Paraparesis, Tropical Spastic", "MH_TH": "NLM (1989)", "ST": "T047", "AN": "consider also LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED & PARAPARESIS, TROPICAL SPASTIC", "PI": "Retrovirus Infections (1985-1986)", "MS": "Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19880610", "DC": "1", "DX": "19890101", "UI": "D015490"}, {"RECTYPE": "D", "MH": "HTLV-II Infections", "DE": "HTLV II INFECT", "DS": "HTLV WII INFECTIONS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, HTLV II", "MN": "C20.673.483.480", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Leukemia, Hairy Cell (1986-1988)", "MS": "Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 2.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19880610", "DC": "1", "DX": "19890101", "UI": "D015491"}, {"RECTYPE": "D", "MH": "AIDS Serodiagnosis", "DE": "AIDS SERODIAG", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "HTLV-III Serology|T059|EQV|UNK (19XX)|880610|HTLV WIII SEROLOGY|HTLV III SEROL|abdefsv", "ENTRY": "Serology, HTLV III", "MN": "E05.478.594.760.060", "FX": "HIV Seroprevalence", "MH_TH": "NLM (1991)", "ST": "T059", "AN": "coordinate with specific technique (FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; RADIOIMMUNOPRECIPITATION ASSAY, ETC)", "PI": "Human T-Cell Leukemia Virus/immunology (1984-1987)", "MS": "Immunologic tests for identification of HIV (HTLV-III/LAV) antibodies. They include assays for HIV SEROPOSITIVITY and HIV SERONEGATIVITY that have been developed for screening persons carrying the viral antibody from patients with overt symptoms of AIDS or AIDS-RELATED COMPLEX.", "PM": "89", "HN": "89", "CATSH": "CAT LIST", "MR": "20200721", "DA": "19880610", "DC": "1", "DX": "19890101", "UI": "D015492"}, {"RECTYPE": "D", "MH": "Paraparesis, Tropical Spastic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Tropical Spastic Paraparesis|T047|NON|EQV|UNK (19XX)|880610|abcdef", "ENTRY": "Tropical Spastic Paraplegias", "MN": "C10.586.750.700", "MH_TH": "NLM (1989)", "ST": "T047", "PI": "Retrovirus Infections (1985-1986)", "MS": "A subacute paralytic myeloneuropathy occurring endemically in tropical areas such as the Caribbean, Colombia, India, and Africa, as well as in the southwestern region of Japan; associated with infection by HUMAN T-CELL LEUKEMIA VIRUS I. Clinical manifestations include a slowly progressive spastic weakness of the legs, increased reflexes, Babinski signs, incontinence, and loss of vibratory and position sensation. On pathologic examination inflammatory, demyelination, and necrotic lesions may be found in the spinal cord. (Adams et al., Principles of Neurology, 6th ed, p1239)", "PM": "1989", "HN": "1989", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19880610", "DC": "1", "DX": "19890101", "UI": "D015493"}, {"RECTYPE": "D", "MH": "Salivary Gland Calculi", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Sialolithiasis|T031|T046|NON|EQV|UNK (19XX)|880610|abbcdef", "ENTRY": "Stones, Salivary Gland", "MN": "C23.300.175.700.500", "MH_TH": "NLM (1989)", "ST": "T046", "AN": "chem composition of calculi: use /chem; /ultrastruct permitted; coord IM with specific precoord salivary gland dis term (IM); do not confuse with SALIVARY DUCT CALCULI", "PI": "Salivary Gland Diseases (1966-1988)", "MS": "Calculi occurring in a salivary gland. Most salivary gland calculi occur in the submandibular gland, but can also occur in the parotid gland and in the sublingual and minor salivary glands.", "OL": "use SALIVARY DUCT CALCULI to search SIALOLITHIASIS 1966-88; to search for chem composition of salivary duct calculi, use SALIVARY DUCT CALCULI/anal 1987-90 & SALIVARY DUCT CALCULI/metab 1966-86", "PM": "89; SIALOLITHIASIS was see SALIVARY DUCT CALCULI 1966-88", "HN": "89; SIALOLITHIASIS was see SALIVARY DUCT CALCULI 1966-88", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19880610", "DC": "1", "DX": "19890101", "UI": "D015494"}, {"RECTYPE": "D", "MH": "CD4-Positive T-Lymphocytes", "DS": "CD 004 POSITIVE LYMPHOCYTES T", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "T4 Lymphocytes|T025|EQV|NLM (1995)|940412|LYMPHOCYTES J 04|abdefs", "ENTRY": "T4 Lymphocyte", "MN": "A15.382.490.555.567.569.200", "FX": "T-Lymphocytopenia, Idiopathic CD4-Positive", "MH_TH": "NLM (1989)", "ST": "T025", "AN": "subpopulations: index specifics if available or coordinate CD4-POSITIVE T-LYMPHOCYTES with T-LYMPHOCYTE SUBSETS; count: coordinate IM with CD4 LYMPHOCYTE COUNT (NIM)", "PI": "T Lymphocytes (1986-1988)", "MS": "A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.", "OL": "use CD4-POSITIVE T-LYMPHOCYTES to search T4 LYMPHOCYTES 1989-94", "PM": "95; was T4 LYMPHOCYTES 1989-94", "HN": "95; was T4 LYMPHOCYTES 1989-94", "MR": "20170717", "DA": "19880701", "DC": "1", "DX": "19890101", "UI": "D015496"}, {"RECTYPE": "D", "MH": "HIV-1", "DS": "HIV 01", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human immunodeficiency virus 1|T005|NON|EQV|NLM (2002)|010511|HUMAN IMMUNODEFICIENCY VIRUS 001|HUMAN IMMUNODEFIC VIRUS 1|abcdefsv", "ENTRY": "Immunodeficiency Virus Type 1, Human|T005|NON|EQV|NLM (1994)|930416|IMMUNODEFIC VIRUS TYPE 1 HUMAN|abcdefv", "MN": "B04.820.650.589.650.350.400", "FX": "Acquired Immunodeficiency Syndrome", "MH_TH": "NLM (1989)", "ST": "T005", "RN": "txid11676", "AN": "infection: coord IM with HIV INFECTIONS (IM) or AIDS (IM) or their specifics (IM)", "PI": "HIV (1987-1988)", "MS": "The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.", "PM": "89", "HN": "89", "MR": "20200813", "DA": "19880701", "DC": "1", "DX": "19890101", "UI": "D015497"}, {"RECTYPE": "D", "MH": "HIV-2", "DS": "HIV 02", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "LAV-2|T005|ABB|EQV|UNK (19XX)|880701|LAV AA 02|abcdefs", "ENTRY": "SBL-6669|T005|LAB|NRW|UNK (19XX)|880701|abcdef", "MN": "B04.820.650.589.650.350.410", "MH_TH": "NLM (1989)", "ST": "T005", "RN": "txid11709", "AN": "infection: coord IM with HIV INFECTIONS (IM) or AIDS (IM) or their specifics (IM)", "PI": "HIV (1987-1988)", "MS": "An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker.", "PM": "89", "HN": "89", "MR": "20200902", "DA": "19880701", "DC": "1", "DX": "19890101", "UI": "D015498"}, {"RECTYPE": "D", "MH": "Renal Tubular Transport, Inborn Errors", "DE": "RENAL TUB TRANSP INBORN ERR", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Kidney Tubular Transport, Inborn Errors|T047|NON|EQV|UNK (19XX)|740330|KIDNEY TUB TRANSP INBORN ERR|abcdefv", "ENTRY": "Renal Tubular Transport, Inborn Error|T047|NON|EQV|UNK (19XX)|830727|RENAL TUBULAR TRANSPORT INBORN ERR|abcdefv", "MN": "C18.452.648.893", "MH_TH": "NLM (1965)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with specific metabolite /metab ", "MS": "Genetic defects in the selective or non-selective transport functions of the KIDNEY TUBULES.", "PM": "65", "HN": "65", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19640701", "DC": "1", "DX": "19650101", "UI": "D015499"}, {"RECTYPE": "D", "MH": "Chloramphenicol O-Acetyltransferase", "DS": "CHLORAMPHENICOL ACETYLTRANSFERASE O", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chloramphenicol Acetyltransferase|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef", "ENTRY": "Transacetylase, Chloramphenicol", "MN": "D08.811.913.050.134.170", "FX": "Chloramphenicol Resistance", "MH_TH": "NLM (1989)", "ST": "T126", "N1": "Acetyl-CoA-chloramphenicol 3-O-acetyltransferase", "RN": "EC 2.3.1.28", "RR": "9040-07-7 (CAS RN)", "PI": "Transferases (1966-1972)", "MS": "An enzyme that catalyzes the acetylation of chloramphenicol to yield chloramphenicol 3-acetate. Since chloramphenicol 3-acetate does not bind to bacterial ribosomes and is not an inhibitor of peptidyltransferase, the enzyme is responsible for the naturally occurring chloramphenicol resistance in bacteria. The enzyme, for which variants are known, is found in both gram-negative and gram-positive bacteria. EC 2.3.1.28.", "PM": "1998; see CHLORAMPHENICOL ACETYLTRANSFERASE 1989-1997", "HN": "1998(1989)", "MR": "20190701", "DA": "19880713", "DC": "1", "DX": "19890101", "UI": "D015500"}, {"RECTYPE": "D", "MH": "Absorptiometry, Photon", "AQ": "AE CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "X-Ray Absorptiometry|T060|NON|NRW|NLM (2008)|070504|abcdef", "ENTRY": "Xray Densitometry", "MN": "E05.196.712.224.187", "MH_TH": "NLM (1990)", "ST": "T060", "PI": "Tomography, Emission Computed (1980-1989)", "MS": "A noninvasive method for assessing BODY COMPOSITION. It is based on the differential absorption of X-RAYS (or GAMMA RAYS) by different tissues such as bone, fat and other soft tissues. The source of (X-ray or gamma-ray) photon beam is generated either from radioisotopes such as GADOLINIUM 153, IODINE 125, or Americanium 241 which emit GAMMA RAYS in the appropriate range; or from an X-ray tube which produces X-RAYS in the desired range. It is primarily used for quantitating BONE MINERAL CONTENT, especially for the diagnosis of OSTEOPOROSIS, and also in measuring BONE MINERALIZATION.", "OL": "use RADIONUCLIDE IMAGING to search ABSORPTIOMETRY, PHOTON 1985-89", "PM": "90; was see RADIONUCLIDE IMAGING 1985-89", "HN": "90; was see RADIONUCLIDE IMAGING 1985-1989; for DUAL-ENERGY RADIOGRAPHIC ABSORPTIOMETRY use DENSITOMETRY, X-RAY", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19891004", "DC": "1", "DX": "19900101", "UI": "D015502"}, {"RECTYPE": "D", "MH": "Surgical Sponges", "DE": "SURG SPONGES", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Surgical Sponge|T074|NON|EQV|NLM (1998)|970516|SURG SPONGE|abcdefv", "MN": "E07.858.740", "MH_TH": "NLM (1990)", "ST": "T074", "AN": "surgical sponge accidentally left in the surgical field: coordinate with GOSSYPIBOMA see FOREIGN BODIES", "PI": "Surgical Instruments (1974-1989)", "MS": "Gauze material used to absorb body fluids during surgery. Referred to as GOSSYPIBOMA if accidentally retained in the body following surgery.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015503"}, {"RECTYPE": "D", "MH": "Chest Tubes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Tubes, Chest", "MN": "E07.858.150", "MH_TH": "NLM (1990)", "ST": "T074", "AN": "\"used for drainage of air or fluid from the pleural space\"", "PI": "Suction (1977-1989)", "MS": "Plastic tubes used for drainage of air or fluid from the pleural space. Their surgical insertion is called tube thoracostomy.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19890413", "DC": "1", "DX": "19900101", "UI": "D015505"}, {"RECTYPE": "D", "MH": "Drugs, Investigational", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Investigational New Drugs|T121|NON|EQV|NLM (1990)|881130|IND|abcdefv", "ENTRY": "New Drugs, Investigational", "MN": "D26.371", "FX": "Investigational New Drug Application", "MH_TH": "NLM (1990)", "ST": "T121", "RN": "0", "AN": "coordinate with specific drug; not restricted to FDA studies: may be used for investigational drugs in other countries", "PI": "Drugs (1966-1989)", "MS": "Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (Treatment IND). The main heading includes drugs under investigation in foreign countries.", "PM": "90", "HN": "90", "MR": "20200527", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015507"}, {"RECTYPE": "D", "MH": "Nasal Obstruction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Obstructions, Nasal", "MN": "C09.603.525", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Nose Diseases (1966-1989)", "MS": "Any hindrance to the passage of air into and out of the nose. The obstruction may be unilateral or bilateral, and may involve any part of the NASAL CAVITY.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015508"}, {"RECTYPE": "D", "MH": "Developmental Biology", "DE": "DEVELOPMENTAL BIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Auxology|T090|NON|REL|NLM (2020)|190414|abcdef", "ENTRY": "Biology, Developmental|T090|NON|EQV|NLM (1990)|890901|BIOL DEVELOPMENTAL|abcdefv", "MN": "H01.158.273.200", "FX": "Growth and Development", "MH_TH": "NLM (1990)", "ST": "T090", "PI": "Models, Biological (1968-1972)", "MS": "The field of BIOLOGY which deals with the process of the GROWTH AND DEVELOPMENT of an organism.", "PM": "90", "HN": "90", "MR": "20210707", "DA": "19890901", "DC": "1", "DX": "19900101", "UI": "D015509"}, {"RECTYPE": "D", "MH": "Clinical Medicine", "DE": "CLIN MED", "AQ": "CL EC ED HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Clinical|T091|NON|EQV|NLM (1991)|891129|MED CLIN|abcdefv", "MN": "H02.403.200", "FX": "Evidence-Based Medicine", "EC": "ethics:Ethics, Clinical", "MH_TH": "NLM (1990)", "ST": "T091", "PI": "Medicine (1966-1989)", "MS": "The study and practice of medicine by direct examination of the patient.", "OL": "search MEDICINE 1986-89", "PM": "90; was see MEDICINE 1986-89", "HN": "90; was see MEDICINE 1986-89", "MR": "20080708", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015510"}, {"RECTYPE": "D", "MH": "Goat Diseases", "DE": "GOAT DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Goat Disease", "MN": "C22.405", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "IM GEN or unspecified; coord IM with specific dis /vet (IM); for abnormalities or injuries, index under GOATS /abnorm or GOATS /inj; don't forget also GOATS (NIM) & check tag ANIMALS", "PI": "Goats (1966-1989)", "MS": "Diseases of the domestic or wild goat of the genus Capra.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015511"}, {"RECTYPE": "D", "MH": "Oncogene Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Oncoproteins|T116|T123|NON|EQV|NLM (1990)|881201|abbcdef", "ENTRY": "Proteins, Oncogene", "MN": "D12.776.624.664", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Viral Proteins (1983-1989)", "MS": "Proteins coded by oncogenes. They include proteins resulting from the fusion of an oncogene and another gene (ONCOGENE PROTEINS, FUSION).", "OL": "use ONCOGENE PROTEINS to search ONCOGENE PRODUCTS 1990-92", "PM": "93; was ONCOGENE PRODUCTS 1990-92; ONCOGENE PROTEINS was see ONCOGENE PRODUCTS 1990-92", "HN": "93; was ONCOGENE PRODUCTS 1990-92; ONCOGENE PROTEINS was see ONCOGENE PRODUCTS 1990-92", "MR": "20200527", "DA": "19890619", "DC": "1", "DX": "19900101", "UI": "D015513"}, {"RECTYPE": "D", "MH": "Oncogene Proteins, Fusion", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Oncogene Fusion", "MN": "D12.776.624.664.500", "MH_TH": "NLM (1990)", "ST": "T116", "RN": "0", "AN": "do not confuse with CHIMERIC PROTEINS, RECOMBINANT see RECOMBINANT FUSION PROTEINS or MUTANT CHIMERIC PROTEINS", "PI": "Viral Proteins (1980-1985)", "MS": "The GENETIC TRANSLATION products of the fusion between an ONCOGENE and another gene. The latter may be of viral or cellular origin.", "PM": "90", "HN": "90", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015514"}, {"RECTYPE": "D", "MH": "Rett Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cerebroatrophic Hyperammonemia|T047|NON|EQV|GHR (2014)|NLM (2000)|991103|abcdeef", "ENTRY": "Syndrome, Rett's", "MN": "C16.320.400.525.937", "FX": "Intellectual Disability", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Movement Disorders (1986-1989)", "MS": "An inherited neurological developmental disorder that is associated with X-LINKED INHERITANCE and may be lethal in utero to hemizygous males. The affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ATAXIA; SEIZURES; autistic behavior; intermittent HYPERVENTILATION; and HYPERAMMONEMIA appear. (From Menkes, Textbook of Child Neurology, 5th ed, p199)", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015518"}, {"RECTYPE": "D", "MH": "Bone Density", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Bone Mineral Density|T034|NON|EQV|NLM (1990)|881205|abcdef", "ENTRY": "Density, Bone Mineral", "MN": "G11.427.100", "FX": "Absorptiometry, Photon", "MH_TH": "NLM (1990)", "ST": "T034", "PI": "Bone and Bones (1966-1989)", "MS": "The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19891004", "DC": "1", "DX": "19900101", "UI": "D015519"}, {"RECTYPE": "D", "MH": "Ethmoid Sinusitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sinusitis, Ethmoid|T047|NON|EQV|NLM (1990)|890306|abcdef", "ENTRY": "Sinusitis, Ethmoidal", "MN": "C09.603.692.752.267", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Sinusitis (1966-1989)", "MS": "Inflammation of the NASAL MUCOSA in the ETHMOID SINUS. It may present itself as an acute (infectious) or chronic (allergic) condition.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015521"}, {"RECTYPE": "D", "MH": "Frontal Sinusitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sinusitis, Frontal|T047|NON|EQV|NLM (1990)|890306|abcdef", "ENTRY": "Sinusitides, Frontal", "MN": "C09.603.692.752.387", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Sinusitis (1966-1989)", "MS": "Inflammation of the NASAL MUCOSA in the FRONTAL SINUS. In many cases, it is caused by an infection of the bacteria STREPTOCOCCUS PNEUMONIAE or HAEMOPHILUS INFLUENZAE.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19890621", "DC": "1", "DX": "19900101", "UI": "D015522"}, {"RECTYPE": "D", "MH": "Maxillary Sinusitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sinusitis, Maxillary|T047|NON|EQV|NLM (1990)|890306|abcdef", "ENTRY": "Sinusitides, Maxillary", "MN": "C09.603.692.752.578", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Sinusitis (1966-1989)", "MS": "Inflammation of the NASAL MUCOSA in the MAXILLARY SINUS. In many cases, it is caused by an infection of the bacteria HAEMOPHILUS INFLUENZAE; STREPTOCOCCUS PNEUMONIAE; or STAPHYLOCOCCUS AUREUS.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015523"}, {"RECTYPE": "D", "MH": "Sphenoid Sinusitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sinusitis, Sphenoid|T047|NON|EQV|NLM (1990)|890306|abcdef", "ENTRY": "Sphenoidal Sinusitides", "MN": "C09.603.692.752.827", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Sinusitis (1966-1989)", "MS": "Inflammation of the NASAL MUCOSA in the SPHENOID SINUS. Isolated sphenoid sinusitis is uncommon. It usually occurs in conjunction with other paranasal sinusitis.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015524"}, {"RECTYPE": "D", "MH": "Fatty Acids, Omega-3", "DS": "FATTY ACIDS OMEGA 03", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "n3 Oil|T109|T123|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "n 3 Polyunsaturated Fatty Acid", "MN": "D10.627.430.450", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "specify source if pertinent", "PI": "Fish Oils (1966-1989)", "MS": "A group of unsaturated fatty acids occurring mainly in fish oils, with three double bonds at particular positions in the hydrocarbon chain.", "PM": "1990; N-3 POLYUNSATURATED FATTY ACID was indexed under FATTY ACIDS, UNSATURATED 2000-2005", "HN": "1990; for n-3 POLYUNSATURATED FATTY ACID use PIKASOL (NM) 2000-2005", "MR": "20200527", "DA": "19890608", "DC": "1", "DX": "19900101", "UI": "D015525"}, {"RECTYPE": "D", "MH": "AIDS Dementia Complex", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "HIV-Associated Cognitive Motor Complex|T047|EQV|NLM (1997)|960311|HIV ASSOC COGNITIVE MOTOR COMPLEX|abdefv", "ENTRY": "HIV Encephalopathies", "MN": "F03.615.400.050", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "coord IM with HIV-1 or HIV-2 (IM or NIM) if pertinent", "PI": "Dementia (1983-1989)", "MS": "A neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. (From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332(14):934-40)", "PM": "1990", "HN": "1990", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19890721", "DC": "1", "DX": "19900101", "UI": "D015526"}, {"RECTYPE": "D", "MH": "HIV Seroprevalence", "AQ": "TD", "ENTRY": "Seroprevalence, HIV", "MN": "N06.850.520.450.500.950.375", "MH_TH": "NLM (1990)", "ST": "T058", "AN": "IM; an epidemiol concept: do not confuse with HIV SEROPOSITIVITY, a diag finding; specify geog if pertinent", "PI": "HIV Seropositivity/epidemiology (1988-1989)", "MS": "Studies of the number of cases where human immunodeficiency virus (HIV) is present in a specific population at a designated time. The presence in a given individual is determined by the finding of HIV antibodies in the serum (HIV SEROPOSITIVITY).", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015528"}, {"RECTYPE": "D", "MH": "Choledochal Cyst", "AQ": "BL BS CF CH CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Congenital Choledochal Cyst|T019|T047|NON|EQV|NLM (2010)|ORD (2010)|090512|abbcdeef", "ENTRY": "Multiple Choledochal Cyst", "MN": "C16.131.314.184", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "non-neoplastic", "PI": "Cysts (1966-1989)", "MS": "A congenital anatomic malformation of a bile duct, including cystic dilatation of the extrahepatic bile duct or the large intrahepatic bile duct. Classification is based on the site and type of dilatation. Type I is most common.", "PM": "1990", "HN": "1990", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015529"}, {"RECTYPE": "D", "MH": "Nuclear Matrix", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Nuclear Scaffold|T026|NON|EQV|NLM (2004)|030422|abcdef", "ENTRY": "Scaffolds, Nuclear", "MN": "A11.284.430.106.279.345.700", "MH_TH": "NLM (1990)", "ST": "T026", "PI": "Cell Nucleus (1972-1989)", "MS": "The residual framework structure of the CELL NUCLEUS that maintains many of the overall architectural features of the cell nucleus including the nuclear lamina with NUCLEAR PORE complex structures, residual CELL NUCLEOLI and an extensive fibrogranular structure in the nuclear interior. (Advan. Enzyme Regul. 2002; 42:39-52)", "PM": "90", "HN": "90", "MR": "20120703", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015530"}, {"RECTYPE": "D", "MH": "Radioimmunoprecipitation Assay", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Radioimmunoprecipitation Analysis|T059|NON|EQV|NLM (1990)|881214|RADIOIMMUNOPRECIPITATION ANAL|abcdefv", "ENTRY": "Radioimmunoprecipitation Assays", "MN": "E05.601.470.639.825", "MH_TH": "NLM (1990)", "ST": "T059", "PI": "Radioimmunoassay (1966-1989)", "MS": "Sensitive assay using radiolabeled ANTIGENS to detect specific ANTIBODIES in SERUM. The antigens are allowed to react with the serum and then precipitated using a special reagent such as PROTEIN A sepharose beads. The bound radiolabeled immunoprecipitate is then commonly analyzed by gel electrophoresis.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015531"}, {"RECTYPE": "D", "MH": "Rehydration Solutions", "DE": "REHYDRATION SOL", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Rehydration Solution|T121|NON|EQV|NLM (2022)|201006|abcdef", "ENTRY": "Solution, Rehydration", "MN": "D26.776.741", "MH_TH": "NLM (1990)", "ST": "T121", "RN": "0", "PI": "Solutions (1972-1978)", "MS": "Fluids restored to the body in order to maintain normal water-electrolyte balance.", "PM": "90", "HN": "90", "MR": "20210630", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015532"}, {"RECTYPE": "D", "MH": "Transcriptional Activation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Transactivation|T045|NON|NRW|NLM (1990)|890224|abcdef", "ENTRY": "Trans Activation, Genetic", "MN": "G05.308.800", "MH_TH": "NLM (1993)", "ST": "T045", "PI": "Virus Activation (1983-1987)", "MS": "Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes.", "PM": "2009; see TRANS-ACTIVATION (GENETICS) 1990-2008; for GENE ACTIVATION and INDUCTION, GENETIC see GENE EXPRESSION REGULATION 1988-2008", "HN": "2009 (1990); for GENE ACTIVATION and INDUCTION, GENETIC use GENE EXPRESSION REGULATION 1988-2008", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19890619", "DC": "1", "DX": "19900101", "UI": "D015533"}, {"RECTYPE": "D", "MH": "Trans-Activators", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Trans-Acting Factors|T116|T123|NON|EQV|NLM (1990)|881219|abbcdef", "ENTRY": "Trans-Acting Factor, Nuclear", "MN": "D12.776.964.925.984", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Viral Proteins (1986-1989)", "MS": "Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.", "OL": "use TRANS-ACTIVATORS to search EPSTEIN-BARR VIRUS TRANS-ACTING FACTOR 1990-92 and LOR PROTEINS & PX PROTEINS 1990", "PM": "90; EPSTEIN-BARR VIRUS TRANS-ACTING FACTOR was see TRANSACTIVATORS 1990-92; LOR PROTEINS & PX PROTEINS were see TRANS-ACTIVATORS 1990", "HN": "90; EPSTEIN-BARR VIRUS TRANS-ACTING FACTOR was see TRANSACTIVATORS 1990-92; LOR PROTEINS & PX PROTEINS were see TRANS-ACTIVATORS 1990", "MR": "20070709", "DA": "19890706", "DC": "1", "DX": "19900101", "UI": "D015534"}, {"RECTYPE": "D", "MH": "Arthritis, Psoriatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Psoriasis, Arthritic|T047|NON|EQV|NLM (1990)|881220|abcdef", "ENTRY": "Psoriatic Arthropathies", "MN": "C17.800.859.675.175", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Psoriasis (1966-1989)", "MS": "A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015535"}, {"RECTYPE": "D", "MH": "Down-Regulation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Receptor Down-Regulation|T043|T044|NON|NRW|NLM (2002)|001211|RECEPT DOWN REG|abbcdefv", "ENTRY": "Down-Regulation, Receptor", "MN": "G07.690.773.937", "FX": "Up-Regulation", "MH_TH": "NLM (1990)", "ST": "T044", "MS": "A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins.", "PM": "2002; see Down-Regulation (Physiology) 1990-2001", "HN": "2002 (1990)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015536"}, {"RECTYPE": "D", "MH": "Nitrosation", "AQ": "DE GE IM PH RE", "ENTRY": "Nitrosations", "MN": "G03.558", "MH_TH": "NLM (1990)", "ST": "T044", "AN": "almost never IM; enzymatic nitrosation: coord NIM with NITRATES (IM) + substrate (NIM)", "PI": "Nitroso Compounds (1966-1989)", "MS": "Conversion into nitroso compounds. An example is the reaction of nitrites with amino compounds to form carcinogenic N-nitrosamines.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19890619", "DC": "1", "DX": "19900101", "UI": "D015538"}, {"RECTYPE": "D", "MH": "Platelet Activation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Platelet Activations", "MN": "G09.188.390.600", "FX": "Bleeding Time", "MH_TH": "NLM (1990)", "ST": "T042", "PI": "Platelet Aggregation (1977-1989)", "MS": "A series of progressive, overlapping events, triggered by exposure of the PLATELETS to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015539"}, {"RECTYPE": "D", "MH": "Off-Road Motor Vehicles", "AQ": "CL EC ES HI LJ SD SN ST", "PRINT ENTRY": "Three-Wheeler Vehicle|T073|NON|NRW|NLM (2021)|191121|abcdef", "ENTRY": "Vehicles, Three-Wheeler", "MN": "J01.937.500.600", "MH_TH": "NLM (1990)", "ST": "T073", "AN": "do not confuse with MOTORCYCLES which are public-road vehicles", "PI": "Motorcycles (1966-1989)", "MS": "Motorized, recreational vehicles used on non-public roads. They include all-terrain vehicles, dirt-bikes, minibikes, motorbikes, trailbikes, and snowmobiles. Excludes MOTORCYCLES, which are considered public road vehicles.", "PM": "90", "HN": "90", "MR": "20200527", "DA": "19890619", "DC": "1", "DX": "19900101", "UI": "D015541"}, {"RECTYPE": "D", "MH": "Inositol 1,4,5-Trisphosphate", "DS": "INOSITOL TRISPHOSPHATE 01 04 05", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Myo-Inositol 1,4,5-Trisphosphate|T109|T123|NON|EQV|NLM (1990)|881227|MYO INOSITOL TRISPHOSPHATE 01 04 05|MYO INOSITOL 1 4 5 TRISPHOSPHATE|abbcdefsv", "ENTRY": "Myoinositol 1,4,5-Triphosphate|T109|T123|NON|EQV|NLM (1990)|890404|MYOINOSITOL 1 4 5 TRIPHOSPHATE|abbcdefv", "MN": "D09.894.480.350", "MH_TH": "NLM (1990)", "ST": "T123", "N1": "D-myo-Inositol, 1,4,5-tris(dihydrogen phosphate)", "RN": "85166-31-0", "PI": "Sugar Phosphates (1974-1977)", "MS": "Intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane. Inositol 1,4,5-trisphosphate is released into the cytoplasm where it releases calcium ions from internal stores within the cell's endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin.", "PM": "90", "HN": "90", "MR": "20040707", "DA": "19890705", "DC": "1", "DX": "19900101", "UI": "D015544"}, {"RECTYPE": "D", "MH": "Basophil Degranulation Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Basophil Activation Test|T059|NON|EQV|NLM (2022)|210423|abcdef", "ENTRY": "Tests, Basophil Activation", "MN": "E05.478.594.100", "MH_TH": "NLM (1990)", "ST": "T059", "PI": "Basophils (1966-1989)", "MS": "An in vitro test used in the diagnosis of allergies including drug hypersensitivity. The allergen is added to the patient's white blood cells and the subsequent histamine release is measured.", "PM": "91; was see under IMMUNOLOGIC TESTS 1990", "HN": "91(90); was see under IMMUNOLOGIC TESTS 1990", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19890407", "DC": "1", "DX": "19910101", "UI": "D015549"}, {"RECTYPE": "D", "MH": "Cell Degranulation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Degranulation, Cell", "MN": "G04.468.160", "FX": "Secretory Vesicles", "MH_TH": "NLM (1990)", "ST": "T043", "AN": "IM; coord with specific cell /physiol (IM)", "MS": "The process of losing secretory granules (SECRETORY VESICLES). This occurs, for example, in mast cells, basophils, neutrophils, eosinophils, and platelets when secretory products are released from the granules by EXOCYTOSIS.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19890329", "DC": "1", "DX": "19900101", "UI": "D015550"}, {"RECTYPE": "D", "MH": "Autoimmunity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Autoimmune Response|T046|NON|REL|NLM (1978)|950105|abcdef", "ENTRY": "Autoimmunities", "MN": "G12.450.192", "FX": "Autoimmune Diseases", "MH_TH": "NLM (1990)", "ST": "T046", "PI": "Autoimmune Diseases (1966-1989)", "MS": "Process whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890502", "DC": "1", "DX": "19900101", "UI": "D015551"}, {"RECTYPE": "D", "MH": "Injections, Intralesional", "DE": "INJECT INTRALESIONAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Intralesional Injection", "MN": "E02.319.267.530.430", "MH_TH": "NLM (1990)", "ST": "T061", "PI": "Injections (1966-1989)", "MS": "Injections introduced directly into localized lesions.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015552"}, {"RECTYPE": "D", "MH": "Josamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "EN141", "MN": "D02.540.576.500.998", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1976)", "ST": "T195", "N1": "Leucomycin V, 3-acetate 4B-(3-methylbutanoate)", "RN": "HV13HFS217", "RR": "16846-24-5 (Josamycin)", "AN": "do not use /biosyn unless by living matter", "PI": "Leucomycins (1981-1989)", "MS": "A macrolide antibiotic from Streptomyces narbonensis. The drug has antimicrobial activity against a wide spectrum of pathogens.", "OL": "use ANTIBIOTICS to search JOSAMYCIN 1975-80; use LEUCOMYCINS 1981-89", "PM": "90; was see LEUCOMYCINS 1981-89; was see under ANTIBIOTICS 1975-80", "HN": "90; was see LEUCOMYCINS 1981-89; was see under ANTIBIOTICS 1975-80", "MR": "20150622", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015570"}, {"RECTYPE": "D", "MH": "Follicular Fluid", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Folliculi, Liquor", "MN": "A12.207.270.340", "MH_TH": "NLM (1990)", "ST": "T031", "PI": "Graafian Follicle (1966-1989)", "MS": "The fluid surrounding the OVUM and GRANULOSA CELLS in the Graafian follicle (OVARIAN FOLLICLE). The follicular fluid contains sex steroids, glycoprotein hormones, plasma proteins, mucopolysaccharides, and enzymes.", "PM": "90", "HN": "90", "MR": "20180630", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015571"}, {"RECTYPE": "D", "MH": "Spiramycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Spiramycin Adipate|T109|T195|NON|NRW|NLM (1990)|890512|abbcdef", "ENTRY": "NSC64393", "MN": "D02.540.576.500.999.725", "PA": "Coccidiostats", "MH_TH": "USAN (1962)", "ST": "T195", "N1": "Spiramycin", "RN": "8025-81-8", "AN": "do not use /biosyn unless by living matter", "PI": "Leucomycins (1981-1989)", "MS": "A macrolide antibiotic produced by Streptomyces ambofaciens. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii.", "OL": "use LEUCOMYCINS to search SPIRAMYCIN 1981-89", "PM": "90; was see LEUCOMYCINS 1981-89; was heading 1963-80", "HN": "90; was see LEUCOMYCINS 1981-89; was heading 1963-80", "MR": "20160701", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015572"}, {"RECTYPE": "D", "MH": "Roxithromycin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RU965", "MN": "D02.540.576.500.992.630", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1986)", "ST": "T195", "N1": "Erythromycin, 9-(O-((2-methoxyethoxy)methyl)oxime), (9E)-", "RN": "21KOF230FA", "RR": "80214-83-1 (Roxithromycin)", "PI": "Leucomycins (1981-1989)", "MS": "Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is particularly effective in the treatment of respiratory and genital tract infections.", "OL": "use LEUCOMYCINS to search ROXITHROMYCIN 1981-89", "PM": "90; was see LEUCOMYCINS 1981-89", "HN": "90; was see LEUCOMYCINS 1981-89", "MR": "20160701", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015575"}, {"RECTYPE": "D", "MH": "Hyperostosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bone Hypertrophy|T047|NON|EQV|NLM (1990)|890109|abcdef", "ENTRY": "Hypertrophy, Bone", "MN": "C05.116.540", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Spondylitis, Ankylosing (1966-1989)", "MS": "Increase in the mass of bone per unit volume.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015576"}, {"RECTYPE": "D", "MH": "Geriatric Assessment", "DE": "GERIATRIC ASSESS", "AQ": "CL HI MT SN", "ENTRY": "Geriatric Assessments", "MN": "N06.850.520.308.225", "MH_TH": "NLM (1990)", "ST": "T058", "PI": "Health Status (1980-1989)", "MS": "Evaluation of the level of physical, physiological, or mental functioning in the older population group.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19890620", "DC": "1", "DX": "19900101", "UI": "D015577"}, {"RECTYPE": "D", "MH": "Mohs Surgery", "DE": "MOHS SURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Micrographic Surgery, Mohs|T061|EPO|EQV|NLM (1991)|900116|MICROGRAPHIC SURG MOHS|abcdefv", "ENTRY": "Surgery, Mohs' Micrographic", "MN": "E04.617.275.580", "MH_TH": "NLM (1991)", "ST": "T061", "AN": "note spelling: no apostrophe; named for Dr. F.E. Mohs", "PI": "Skin Neoplasms/surgery (1975-1990)", "MS": "A surgical technique used primarily in the treatment of skin neoplasms, especially basal cell or squamous cell carcinoma of the skin. This procedure is a microscopically controlled excision of cutaneous tumors either after fixation in vivo or after freezing the tissue. Serial examinations of fresh tissue specimens are most frequently done.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D015580"}, {"RECTYPE": "D", "MH": "Observer Variation", "PRINT ENTRY": "Observer Bias|T080|T081|NON|EQV|NLM (1990)|890110|abbcdef", "ENTRY": "Variations, Observer", "MN": "N06.850.490.500.250", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "IM general only", "MS": "The failure by the observer to measure or identify a phenomenon accurately, which results in an error. Sources for this may be due to the observer's missing an abnormality, or to faulty technique resulting in incorrect test measurement, or to misinterpretation of the data. Two varieties are inter-observer variation (the amount observers vary from one another when reporting on the same material) and intra-observer variation (the amount one observer varies between observations when reporting more than once on the same material).", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20150701", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015588"}, {"RECTYPE": "D", "MH": "Fluorophotometry", "AQ": "AE CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Vitreous Fluorophotometry|T060|NON|EQV|NLM (1990)|890110|abcdef", "ENTRY": "Fluorophotometry, Vitreous", "MN": "E05.196.712.516.600.410", "MH_TH": "NLM (1990)", "ST": "T060", "AN": "NIM; note X refs & read MeSH definition: restrict to ophthalmology", "PI": "Photometry (1966-1989)", "MS": "Measurement of light given off by fluorescein in order to assess the integrity of various ocular barriers. The method is used to investigate the blood-aqueous barrier, blood-retinal barrier, aqueous flow measurements, corneal endothelial permeability, and tear flow dynamics.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015590"}, {"RECTYPE": "D", "MH": "Microspectrophotometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Microspectrophotometries", "MN": "E05.196.867.826.300", "MH_TH": "NLM (1990)", "ST": "T062", "AN": "a type of spectrum anal; NIM", "PI": "Spectrophotometry (1966-1989)", "MS": "Analytical technique for studying substances present at enzyme concentrations in single cells, in situ, by measuring light absorption. Light from a tungsten strip lamp or xenon arc dispersed by a grating monochromator illuminates the optical system of a microscope. The absorbance of light is measured (in nanometers) by comparing the difference between the image of the sample and a reference image.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015591"}, {"RECTYPE": "D", "MH": "Immunoradiometric Assay", "DE": "IRMA", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Immunoradiometric Assays", "MN": "E05.601.470.639.405", "MH_TH": "NLM (1990)", "ST": "T059", "AN": "usually NIM; do not confuse with RADIOIMMUNOASSAY", "PI": "Radioimmunoassay (1966-1989)", "MS": "Form of radioimmunoassay in which excess specific labeled antibody is added directly to the test antigen being measured.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015592"}, {"RECTYPE": "D", "MH": "Retinal Drusen", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Drusen, Retinal|T047|NON|EQV|NLM (1990)|890405|abcdef", "MN": "C11.768.585.585", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "colloid or hyalin bodies under retinal pigment; do not confuse with OPTIC DISK DRUSEN, hyalin bodies in optic nerve", "PI": "Pigment Epithelium of Eye (1966-1989)", "MS": "Colloid or hyaline bodies lying beneath the retinal pigment epithelium. They may occur either secondary to changes in the choroid that affect the pigment epithelium or as an autosomal dominant disorder of the retinal pigment epithelium.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015593"}, {"RECTYPE": "D", "MH": "Optic Disk Drusen", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Drusen, Optic Nerve|T047|NON|EQV|NLM (1990)|890111|abcdef", "ENTRY": "Optic Nerve Drusen", "MN": "C11.640.513", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "do not confuse with RETINAL DRUSEN", "PI": "Optic Nerve Diseases (1975-1989)", "MS": "Optic disk bodies composed primarily of acid mucopolysaccharides that may produce pseudopapilledema (elevation of the optic disk without associated INTRACRANIAL HYPERTENSION) and visual field deficits. Drusen may also occur in the retina (see RETINAL DRUSEN). (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p355)", "PM": "91; was see under OPTIC NERVE DISEASES 1990", "HN": "91(90); was see under OPTIC NERVE DISEASES 1990", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19890526", "DC": "1", "DX": "19910101", "UI": "D015594"}, {"RECTYPE": "D", "MH": "Skin Aging", "AQ": "DE EH ES GE IM PA PH RE", "PRINT ENTRY": "Solar Aging of Skin|T042|NON|EQV|NLM (1990)|890111|abcdef", "ENTRY": "Wrinkling, Skin", "MN": "G13.750.804", "MH_TH": "NLM (1990)", "ST": "T042", "PI": "Sunlight (1966-1989)", "MS": "The process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015595"}, {"RECTYPE": "D", "MH": "Nutrition Assessment", "DE": "NUTRITION ASSESS", "PRINT ENTRY": "Prognostic Nutritional Index (PNI)|T081|REL|NLM (1990)|890111|abdef", "ENTRY": "Prognostic Nutritional Indices (PNI)", "MN": "N06.850.520.308.585", "MH_TH": "NLM (1990)", "ST": "T060", "AN": "do not confuse with NUTRITION SURVEYS: survey refers to a population in a given geographic area, assessment refers to an individual; coordinate with GERIATRIC ASSESSMENT if relevant", "PI": "Nutritional Status (1987-1989)", "MS": "Evaluation and measurement of nutritional variables in order to assess the level of nutrition or the NUTRITIONAL STATUS of the individual. NUTRITION SURVEYS may be used in making the assessment.", "PM": "1990; for NUTRITION INDEXES see NUTRITION 1992-2006", "HN": "1990; for NUTRITION INDEXES use NUTRITION PHYSIOLOGY 1992-2006", "CATSH": "CAT LIST", "MR": "20140606", "DA": "19890706", "DC": "1", "DX": "19900101", "UI": "D015596"}, {"RECTYPE": "D", "MH": "Pregnancy Complications, Parasitic", "DE": "PREGN COMPL PARASITIC", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Parasitic Pregnancy Complications|T047|NON|EQV|NLM (1995)|940105|PARASITIC PREGN COMPL|abcdefv", "ENTRY": "Pregnancy Complication, Parasitic", "MN": "C12.050.703.700.680", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "coordinate IM with specific parasitic disease (IM); check the tags FEMALE & PREGNANCY", "PI": "Pregnancy Complications, Infectious (1966-1992)", "MS": "The co-occurrence of pregnancy and parasitic diseases. The parasitic infection may precede or follow FERTILIZATION.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D015597"}, {"RECTYPE": "D", "MH": "Trauma Severity Indices", "ENTRY": "Severity Indices, Trauma", "MN": "N06.850.520.308.940.968.875", "MH_TH": "NLM (1990)", "ST": "T170", "AN": "do not confuse with TRIAGE, emergency selection of patients by priority of need; SEVERITY OF ILLNESS INDEX is also available", "PI": "Wounds and Injuries/classification (1966-1989)", "MS": "Systems for assessing, classifying, and coding injuries. These systems are used in medical records, surveillance systems, and state and national registries to aid in the collection and reporting of trauma.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015599"}, {"RECTYPE": "D", "MH": "Glasgow Coma Scale", "AQ": "EC HI SN ST TD VE", "ENTRY": "Scale, Glasgow Coma", "MN": "N05.715.360.300.715.500.800.325", "MH_TH": "NLM (1990)", "ST": "T170", "PI": "Severity of Illness Index (1986-1989)", "MS": "A scale that assesses the response to stimuli in patients with craniocerebral injuries. The parameters are eye opening, motor response, and verbal response.", "PM": "91; was see under TRAUMA SEVERITY INDICES 1990", "HN": "91(90); was see under TRAUMA SEVERITY INDICES 1990", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19890525", "DC": "1", "DX": "19910101", "UI": "D015600"}, {"RECTYPE": "D", "MH": "Injury Severity Score", "DE": "INJ SEVERITY SCORE", "PRINT ENTRY": "ISS Score|T081|T170|ABB|EQV|NLM (1990)|890111|abbcdef", "ENTRY": "Scores, Injury Severity", "MN": "N05.715.360.300.715.500.800.400", "MH_TH": "NLM (1990)", "ST": "T170", "PI": "Wounds and Injuries (1974-1989)", "MS": "An anatomic severity scale based on the Abbreviated Injury Scale (AIS) and developed specifically to score multiple traumatic injuries. It has been used as a predictor of mortality.", "PM": "91; was see under TRAUMA SEVERITY INDICES 1990", "HN": "91(90); was see under TRAUMA SEVERITY INDICES 1990", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19890525", "DC": "1", "DX": "19910101", "UI": "D015601"}, {"RECTYPE": "D", "MH": "Keratinocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Keratinocyte", "MN": "A11.436.397", "MH_TH": "NLM (1990)", "ST": "T025", "PI": "Skin/cytology (1968-1989)", "MS": "Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell.", "PM": "90", "HN": "90", "MR": "20180630", "DA": "19890703", "DC": "1", "DX": "19900101", "UI": "D015603"}, {"RECTYPE": "D", "MH": "Cowpox", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Pox, Cow", "MN": "C01.925.256.743.175", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "caused by a poxvirus; in man or animal; in animal use /vet and check tag ANIMALS", "PI": "Vaccinia (1966-1989)", "MS": "A mild, eruptive skin disease of milk cows caused by COWPOX VIRUS, with lesions occurring principally on the udder and teats. Human infection may occur while milking an infected animal.", "OL": "search VACCINIA 1974-89", "PM": "91; was see under POXVIRUS INFECTIONS 1990; was see VACCINIA 1974-89", "HN": "91(90); was see under POXVIRUS INFECTIONS 1990; was see VACCINIA 1974-89", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19890407", "DC": "1", "DX": "19910101", "UI": "D015605"}, {"RECTYPE": "D", "MH": "Stents", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Stent", "MN": "E07.695.750", "MH_TH": "NLM (1990)", "ST": "T074", "PI": "Splints (1966-1989)", "MS": "Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19890413", "DC": "1", "DX": "19900101", "UI": "D015607"}, {"RECTYPE": "D", "MH": "Cowpox virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Cowpox viruses", "MN": "B04.280.650.160.650.150", "MH_TH": "NLM (1990)", "ST": "T005", "RN": "txid10243", "PI": "Vaccinia Virus (1967-1989)", "MS": "A species of ORTHOPOXVIRUS that is the etiologic agent of COWPOX. It is closely related to but antigenically different from VACCINIA VIRUS.", "PM": "90", "HN": "90", "MR": "20200813", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015608"}, {"RECTYPE": "D", "MH": "Organotechnetium Compounds", "DE": "ORGANOTECHNETIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Organotechnetium", "MN": "D02.691.825", "MH_TH": "NLM (1990)", "ST": "T109", "RN": "0", "PI": "Technetium (1966-1989)", "MS": "Organic compounds that contain technetium as an integral part of the molecule. These compounds are often used as radionuclide imaging agents.", "PM": "90", "HN": "90", "MR": "20110624", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015609"}, {"RECTYPE": "D", "MH": "Serum Bactericidal Test", "DE": "SBT", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Schlichter Test|T059|EPO|EQV|NLM (1990)|890301|abcdef", "ENTRY": "Tests, Serum Bactericidal", "MN": "E05.337.550.400.800", "FX": "Blood Bactericidal Activity", "MH_TH": "NLM (1990)", "ST": "T059", "AN": "do not confuse with BLOOD BACTERICIDAL ACTIVITY (natural bactericidal property of blood) or SERUM BACTERICIDAL ANTIBODY ASSAY (measurement of IMMUNOGLOBULINS in blood that initiate lysis of bacteria)", "PI": "Microbial Sensitivity Tests (1972-1989)", "MS": "Method of measuring the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy. It is used to monitor the therapy in BACTERIAL ENDOCARDITIS; OSTEOMYELITIS and other serious bacterial infections. As commonly performed, the test is a variation of the broth dilution test. This test needs to be distinguished from testing of the naturally occurring BLOOD BACTERICIDAL ACTIVITY.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015610"}, {"RECTYPE": "D", "MH": "Hepatitis B Virus, Duck", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Duck hepatitis B virus|T005|NON|EQV|NLM (1991)|900328|abcdef", "ENTRY": "Hepatitis B Viruses, Duck|T005|NON|EQV|NLM (1990)|890119|abcdef", "MN": "B04.450.390.100.450", "MH_TH": "NLM (1990)", "ST": "T005", "RN": "txid12639", "AN": "do not confuse with HEPATITIS VIRUS, DUCK, an enterovirus; infection: coord IM with HEPADNAVIRIDAE INFECTIONS (IM) + HEPATITIS, VIRAL, ANIMAL (IM)", "PI": "Hepatitis B Virus (1981-1989)", "MS": "A DNA virus that closely resembles human hepatitis B virus. It has been recovered from naturally infected ducks.", "PM": "90", "HN": "90", "MR": "20200813", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015611"}, {"RECTYPE": "D", "MH": "Phonophoresis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Phonophoreses", "MN": "E02.319.267.700", "MH_TH": "NLM (1990)", "ST": "T061", "PI": "Ultrasonics (1966-1989)", "MS": "Use of ultrasound to increase the percutaneous adsorption of drugs.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015612"}, {"RECTYPE": "D", "MH": "Hepadnaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Hepadnavirus", "MN": "B04.450.390", "MH_TH": "NLM (1990)", "ST": "T005", "RN": "txid10404", "PI": "Hepatitis B Virus (1982-1989)", "MS": "A family of hepatotropic DNA viruses which contains double-stranded DNA genomes and causes hepatitis in humans and animals. There are two genera: AVIHEPADNAVIRUS and ORTHOHEPADNAVIRUS. Hepadnaviruses include HEPATITIS B VIRUS, duck hepatitis B virus (HEPATITIS B VIRUS, DUCK), heron hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis B virus (HEPATITIS B VIRUS, WOODCHUCK).", "PM": "90", "HN": "90", "MR": "20200813", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015613"}, {"RECTYPE": "D", "MH": "Histiocytosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Histiocytoses", "MN": "C15.604.250", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "general or unspecified; prefer specifics; do not confuse with HISTIOCYTOSIS X see HISTIOCYTOSIS, LANGERHANS-CELL", "MS": "General term for the abnormal appearance of histiocytes in the blood. Based on the pathological features of the cells involved rather than on clinical findings, the histiocytic diseases are subdivided into three groups: HISTIOCYTOSIS, LANGERHANS CELL; HISTIOCYTOSIS, NON-LANGERHANS-CELL; and HISTIOCYTIC DISORDERS, MALIGNANT.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20090714", "DA": "19890620", "DC": "1", "DX": "19900101", "UI": "D015614"}, {"RECTYPE": "D", "MH": "Cystic Adenomatoid Malformation of Lung, Congenital", "DE": "CCAM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Congenital Cystic Adenomatoid Malformation|T019|NON|EQV|NLM (2009)|080228|abcdef", "ENTRY": "Lung Malformation, Cystic Adenomatoid, Congenital|T019|NON|EQV|NLM (1990)|890124|LUNG MALFORMATION CYSTIC ADENOMATOID CONGEN|abcdefv", "MN": "C16.131.740.290", "MH_TH": "NLM (1990)", "ST": "T019", "AN": "do not use / congen & do not coordinate with INFANT, NEWBORN, DISEASES", "PI": "Lung/abnormalities (1966-1989)", "MS": "An abnormality in lung development that is characterized by a multicystic mass resulting from an adenomatous overgrowth of the terminal BRONCHIOLES with a consequent reduction of PULMONARY ALVEOLI. This anomaly is classified into three types by the cyst size.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015615"}, {"RECTYPE": "D", "MH": "Histiocytosis, Non-Langerhans-Cell", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Xanthoma Disseminatum|T047|NON|NRW|NLM (1990)|890119|abcdef", "ENTRY": "Reticulohistiocytomas", "MN": "C15.604.250.410", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Reticuloendotheliosis (1966-1989)", "MS": "Group of disorders which feature accumulations of active HISTIOCYTES and LYMPHOCYTES, but where the histiocytes are not LANGERHANS CELLS. The group includes HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; SINUS HISTIOCYTOSIS; xanthogranuloma; reticulohistiocytoma; JUVENILE XANTHOGRANULOMA; xanthoma disseminatum; as well as the lipid storage diseases (SEA-BLUE HISTIOCYTE SYNDROME; and NIEMANN-PICK DISEASES).", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015616"}, {"RECTYPE": "D", "MH": "Histiocytosis, Sinus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rosai-Dorfman Disease|T047|EPO|EQV|NLM (1990)|ORD (2010)|890123|ROSAI DORFMAN DIS|abcdeefv", "ENTRY": "Syndrome, Destombes-Rosai-Dorfman", "MN": "C15.604.250.410.450", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "a non-Langerhans cell histiocytosis; sinus refers to the lymphatic sinuses", "PI": "Reticuloendotheliosis (1966-1989)", "MS": "Benign, non-Langerhans-cell, histiocytic proliferative disorder that primarily affects the lymph nodes. It is often referred to as sinus histiocytosis with massive lymphadenopathy.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015618"}, {"RECTYPE": "D", "MH": "Respiratory System Abnormalities", "DE": "RESPIRATORY SYSTEM ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "System Abnormality, Respiratory", "MN": "C16.131.740", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "for congenital structural abnormalities only; general or unspecified; prefer specifics or specific organ /abnorm", "PI": "Respiratory System/abnormalities (1966-1997)", "MS": "Congenital structural abnormalities of the respiratory system.", "PM": "98", "HN": "98; use explode 1990-97", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19890407", "DC": "1", "DX": "19980101", "UI": "D015619"}, {"RECTYPE": "D", "MH": "Histiocytic Disorders, Malignant", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Malignant Histiocytic Disorders", "MN": "C15.604.250.390", "MH_TH": "NLM (1990)", "ST": "T191", "AN": "general or unspecified; prefer specifics", "MS": "Distinctive neoplastic disorders of histiocytes. Included are malignant neoplasms of MACROPHAGES and DENDRITIC CELLS.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19890620", "DC": "1", "DX": "19900101", "UI": "D015620"}, {"RECTYPE": "D", "MH": "Epithelioid Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Epithelioid Cell", "MN": "A15.382.680.397.300", "FX": "Giant Cells", "MH_TH": "NLM (1990)", "ST": "T025", "AN": "a type of macrophage; do not confuse with EPITHELIAL CELLS", "PI": "Macrophages (1966-1989)", "MS": "Characteristic cells of granulomatous hypersensitivity. They appear as large, flattened cells with increased endoplasmic reticulum. They are believed to be activated macrophages that have differentiated as a result of prolonged antigenic stimulation. Further differentiation or fusion of epithelioid cells is thought to produce multinucleated giant cells (GIANT CELLS).", "PM": "90", "HN": "90", "MR": "20180630", "DA": "19890329", "DC": "1", "DX": "19900101", "UI": "D015622"}, {"RECTYPE": "D", "MH": "Diet, Macrobiotic", "AQ": "AE EC EH HI PX SN", "ENTRY": "Macrobiotic Diets", "MN": "G07.203.650.240.278.500.375", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "coord with specific disease /diet ther", "PI": "Diet Fads (1966-1989)", "MS": "An approach to nutrition based on whole cereal grains, beans, cooked vegetables and the Chinese YIN-YANG principle. It advocates a diet consisting of organic and locally grown foods, seasonal vegetables, complex carbohydrates, and fewer fats, sugars, and chemically processed foods.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20221215", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015623"}, {"RECTYPE": "D", "MH": "Lambert-Eaton Myasthenic Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myasthenic Syndrome, Lambert-Eaton|T047|EPO|EQV|NLM (1999)|980217|abcdef", "ENTRY": "Syndrome, Lambert-Eaton Myasthenic", "MN": "C20.111.258.500.150", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Neuromuscular Junction (1980-1986)", "MS": "An autoimmune disease characterized by weakness and fatigability of proximal muscles, particularly of the pelvic girdle, lower extremities, trunk, and shoulder girdle. There is relative sparing of extraocular and bulbar muscles. CARCINOMA, SMALL CELL of the lung is a frequently associated condition, although other malignancies and autoimmune diseases may be associated. Muscular weakness results from impaired impulse transmission at the NEUROMUSCULAR JUNCTION. Presynaptic calcium channel dysfunction leads to a reduced amount of acetylcholine being released in response to stimulation of the nerve. (From Adams et al., Principles of Neurology, 6th ed, pp 1471)", "PM": "1990", "HN": "1990", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015624"}, {"RECTYPE": "D", "MH": "Tissue Expansion Devices", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Vacuum Tissue Expanders|T074|NON|NRW|NLM (2008)|070306|abcdef", "ENTRY": "Vacuum Tissue Expander", "MN": "E07.858.886", "FX": "Tissue Expansion", "MH_TH": "NLM (2008)", "ST": "T074", "PI": "Implants, Artificial (1983-1989)", "MS": "Devices used to generate extra soft tissue in vivo to be used in surgical reconstructions. They exert stretching forces on the tissue and thus stimulate new growth and result in TISSUE EXPANSION. They are commonly inflatable reservoirs, usually made of silicone, which are implanted under the tissue and gradually inflated. Other tissue expanders exert stretching forces by attaching to outside of the body, for example, vacuum tissue expanders. Once the tissue has grown, the expander is removed and the expanded tissue is used to cover the area being reconstructed.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080229", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015625"}, {"RECTYPE": "D", "MH": "Tissue Expansion", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Tissue Expansions", "MN": "E04.617.800", "FX": "Tissue Expansion Devices", "MH_TH": "NLM (1990)", "ST": "T061", "PI": "Surgical Flaps (1983-1989)", "MS": "A procedure whereby the body is stimulated to generate extra soft tissue by the application of stretching forces that stimulate new growth of tissue which, over a period of time, results in a 2-dimensional expansion of the tissue. The procedure is used in reconstructive surgery for injuries caused by trauma, burns, or ablative surgery. Various types of TISSUE EXPANSION DEVICES have been developed that exert stretching forces.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015626"}, {"RECTYPE": "D", "MH": "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "DS": "METHYLPHENYLTETRAHYDROPYRIDINE 01 04 01 02 03 06", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TU UR", "PRINT ENTRY": "MPTP|T109|T131|ABB|EQV|FDA SRS (2014)|NLM (1990)|890130|abbcdeef", "ENTRY": "N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine|T109|T131|NON|EQV|NLM (1990)|890214|abbcdef", "MN": "D03.383.725.450", "PA": "Neurotoxins", "EC": "toxicity:MPTP Poisoning", "MH_TH": "NLM (1990)", "ST": "T131", "N1": "Pyridine, 1,2,3,6-tetrahydro-1-methyl-4-phenyl-", "RN": "9P21XSP91P", "RR": "28289-54-5 (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine)", "PI": "Pyridines (1966-1989)", "MS": "A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.", "PM": "90", "HN": "90", "MR": "20160527", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015632"}, {"RECTYPE": "D", "MH": "Extravascular Lung Water", "DE": "EVLW", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Lung Water, Extravascular|T031|NON|EQV|NLM (1990)|890306|abcdef", "ENTRY": "Water, Extravascular Lung", "MN": "A12.207.270.300", "MH_TH": "NLM (1990)", "ST": "T031", "PI": "Lung (1969-1989)", "MS": "Water content outside of the lung vasculature. About 80% of a normal lung is made up of water, including intracellular, interstitial, and blood water. Failure to maintain the normal homeostatic fluid exchange between the vascular space and the interstitium of the lungs can result in PULMONARY EDEMA and flooding of the alveolar space.", "PM": "90", "HN": "90", "MR": "20180630", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015633"}, {"RECTYPE": "D", "MH": "Radionuclide Ventriculography", "DE": "RADIONUCLIDE VENTRICULOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Ventriculography, Radionuclide|T060|NON|EQV|NLM (1990)|890131|VENTRICULOGR RADIONUCLIDE|abcdefv", "MN": "E01.370.384.730.715.710", "MH_TH": "NLM (1990)", "ST": "T060", "AN": "\"ventriculo-\" refers to the heart, not the cerebral ventricles", "PI": "Heart/radionuclide imaging (1977-1989)", "MS": "Imaging of a ventricle of the heart after the injection of a radioactive contrast medium. The technique is less invasive than cardiac catheterization and is used to assess ventricular function.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160317", "DA": "19890619", "DC": "1", "DX": "19900101", "UI": "D015635"}, {"RECTYPE": "D", "MH": "Magnesium Chloride", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chloride, Magnesium", "MN": "D01.524.475", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Magnesium chloride (MgCl2)", "RN": "02F3473H9O", "RR": "7786-30-3 (Magnesium Chloride)", "AN": "used as a source of magnesium ions", "PI": "Magnesium (1966-1989)", "MS": "Magnesium chloride. An inorganic compound consisting of one magnesium and two chloride ions. The compound is used in medicine as a source of magnesium ions, which are essential for many cellular activities. It has also been used as a cathartic and in alloys.", "PM": "90", "HN": "90", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015636"}, {"RECTYPE": "D", "MH": "Gated Blood-Pool Imaging", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Ventriculography, Gated Radionuclide|T060|NON|EQV|NLM (1990)|890130|VENTRICULOGR GATED RADIONUCLIDE|abcdefv", "ENTRY": "Ventriculographies, Gated Radionuclide", "MN": "E01.370.384.730.715.710.350", "MH_TH": "NLM (1990)", "ST": "T060", "MS": "Radionuclide ventriculography where scintigraphic data is acquired during repeated cardiac cycles at specific times in the cycle, using an electrocardiographic synchronizer or gating device. Analysis of right ventricular function is difficult with this technique; that is best evaluated by first-pass ventriculography (VENTRICULOGRAPHY, FIRST-PASS).", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19890502", "DC": "1", "DX": "19900101", "UI": "D015637"}, {"RECTYPE": "D", "MH": "Cytochalasin D", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.946.587.370.450", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "NLM (1990)", "ST": "T123", "N1": "(11)Cytochalasa-6(12),13,19-triene-1,17-dione, 21-(acetyloxy)-7,18-dihydroxy-16,18-dimethyl-10-phenyl-, (7S,13E,16S,18R,19E,21R)-", "RN": "22144-77-0", "PI": "Cytochalasins (1973-1989)", "MS": "A fungal metabolite that blocks cytoplasmic cleavage by blocking formation of contractile microfilament structures resulting in multinucleated cell formation, reversible inhibition of cell movement, and the induction of cellular extrusion. Additional reported effects include the inhibition of actin polymerization, DNA synthesis, sperm motility, glucose transport, thyroid secretion, and growth hormone release.", "PM": "90", "HN": "90", "MR": "20160528", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015638"}, {"RECTYPE": "D", "MH": "Ion Channel Gating", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Gating, Ion Channel|T043|NON|EQV|NLM (1990)|890327|abcdef", "ENTRY": "Ion Channel Gatings", "MN": "G07.265.625", "MH_TH": "NLM (1990)", "ST": "T043", "AN": "do not confuse with SENSORY GATING", "PI": "Membrane Potentials (1966-1989)", "MS": "The opening and closing of ion channels due to a stimulus. The stimulus can be a change in membrane potential (voltage-gated), drugs or chemical transmitters (ligand-gated), or a mechanical deformation. Gating is thought to involve conformational changes of the ion channel which alters selective permeability.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19890619", "DC": "1", "DX": "19900101", "UI": "D015640"}, {"RECTYPE": "D", "MH": "Radiography, Interventional", "DE": "RADIOGR INTERVENTIONAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Interventional Radiography|T060|NON|EQV|NLM (1990)|891106|INTERVENTIONAL RADIOGR|abcdefv", "MN": "E04.502.780", "MH_TH": "NLM (1990)", "ST": "T060", "AN": "coordinate with specific minimally invasive procedure if pertinent", "PI": "Technology, Radiologic (1972-1989)", "MS": "Diagnostic and therapeutic procedures that are invasive or surgical in nature, and require the expertise of a specially trained radiologist. In general, they are more invasive than diagnostic imaging but less invasive than major surgery. They often involve catheterization, fluoroscopy, or computed tomography. Some examples include percutaneous transhepatic cholangiography, percutaneous transthoracic biopsy, balloon angioplasty, and arterial embolization.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015641"}, {"RECTYPE": "D", "MH": "Radiology, Interventional", "DE": "RADIOL INTERVENTIONAL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Interventional Radiology|T091|NON|EQV|NLM (1992)|900927|INTERVENTIONAL RADIOL|abcdefv", "MN": "H02.403.740.675", "MH_TH": "NLM (1990)", "ST": "T091", "AN": "specialty; RADIOGRAPHY, INTERVENTIONAL is available for the diagnostic and therapeutic procedures", "PI": "Radiology (1977-1989)", "MS": "Subspecialty of radiology that combines organ system radiography, catheter techniques and sectional imaging.", "PM": "90", "HN": "90", "MR": "20160321", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015642"}, {"RECTYPE": "D", "MH": "Erythromycin Ethylsuccinate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Monomycin|T109|T195|TRD|NRW|UNK (1990)|900405|abbcdef", "ENTRY": "Succinate, Eyrthromycin Ethyl", "MN": "D02.540.576.500.992.260", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Erythromycin, 2'-(ethyl butanedioate)", "RN": "1014KSJ86F", "RR": "1264-62-6 (Erythromycin Ethylsuccinate)", "PI": "Erythromycin (1966-1989)", "MS": "A macrolide antibiotic, produced by Streptomyces erythreus. This compound is an ester of erythromycin base and succinic acid. It acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.", "PM": "90", "HN": "90", "MR": "20150622", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015643"}, {"RECTYPE": "D", "MH": "Miocamycin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ponsinomycin|T109|T195|NON|EQV|FDA SRS (2014)|NLM (1992)|910226|abbcdeef", "ENTRY": "PM88908", "MN": "D02.540.505.500", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1990)", "ST": "T195", "N1": "Leucomycin V, 3B,9-diacetate 3,4B-dipropanoate", "RN": "3T48CPS7U2", "RR": "55881-07-7 (Miocamycin)", "AN": "do not use /biosyn unless by living matter", "PI": "Leucomycins (1981-1989)", "MS": "A macrolide antibiotic that has a wide antimicrobial spectrum and is particularly effective in respiratory and genital infections.", "PM": "90", "HN": "90", "MR": "20130708", "DA": "19891017", "DC": "1", "DX": "19900101", "UI": "D015644"}, {"RECTYPE": "D", "MH": "Tylosin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tartrate, Tylosin", "MN": "D02.540.505.905", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Tylosin", "RN": "YEF4JXN031", "RR": "5P4625C51T", "AN": "do not use /biosyn unless by living matter", "PI": "Leucomycins (1981-1989)", "MS": "Macrolide antibiotic obtained from cultures of Streptomyces fradiae. The drug is effective against many microorganisms in animals but not in humans.", "OL": "use ANTIBIOTICS to search TYLOSIN 1966-80; use LEUCOMYCINS 1981-89", "PM": "90; was see LEUCOMYCINS 1981-89; was see under ANTIBIOTICS 1964-80", "HN": "90; was see LEUCOMYCINS 1981-89; was see under ANTIBIOTICS 1964-80", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015645"}, {"RECTYPE": "D", "MH": "Ventriculography, First-Pass", "DE": "VENTRICULOGR FIRST PASS", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Radionuclide Ventriculography, First-Pass|T060|NON|EQV|NLM (1990)|890228|RADIONUCLIDE VENTRICULOGR FIRST PASS|abcdefv", "ENTRY": "Ventriculography, First-Pass Radionuclide", "MN": "E01.370.384.730.715.710.950", "FX": "Gated Blood-Pool Imaging", "MH_TH": "NLM (1990)", "ST": "T060", "AN": "\"ventriculo-\" refers to the heart, not the cerebral ventricles", "PI": "Radionuclide Angiography (1983-1989)", "MS": "Radionuclide ventriculography where a bolus of radionuclide is injected and data are recorded from one pass through the heart ventricle. Left and right ventricular function can be analyzed independently during this technique. First-pass ventriculography is preferred over GATED BLOOD-POOL IMAGING for assessing right ventricular function.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19890619", "DC": "1", "DX": "19900101", "UI": "D015646"}, {"RECTYPE": "D", "MH": "2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine", "DS": "TETRAHYDRODIHYDROXYPHENYLBENZAZEPINE 02 03 04 05 07 08 01 01H 03", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SKF 38393A", "MN": "D03.633.100.079.838", "PA": "Dopamine Agonists", "MH_TH": "NLM (1990)", "ST": "T121", "RN": "67287-49-4", "PI": "Dopaminergic Agents (1989)", "MS": "A selective D1 dopamine receptor agonist used primarily as a research tool.", "PM": "2005; see SK&F-38393 1989-2004", "HN": "2005(1990)", "MR": "20180620", "DA": "19890901", "DC": "1", "DX": "19900101", "UI": "D015647"}, {"RECTYPE": "D", "MH": "Pentostatin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2'-Deoxycoformycin|T109|T121|NON|REL|NLM (1990)|890131|DEOXYCOFORMYCIN 02|abbcdefs", "ENTRY": "NSC218321", "MN": "D13.570.685.350.200.700", "PA": "Antineoplastic Agents", "MH_TH": "USAN (1977)", "ST": "T121", "N1": "Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-", "RN": "395575MZO7", "RR": "53910-25-1 (Pentostatin)", "PI": "Deoxyribonucleosides (1971-1978)", "MS": "A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.", "PM": "1997; CO-VIDARABINE (now PENTOSTATIN) was indexed under VIDARABINE/*analogs & derivatives 1976-97", "HN": "1997 (1990); for CO-VIDARABINE use PENTOSTATIN 1982-1997", "MR": "20190701", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015649"}, {"RECTYPE": "D", "MH": "24,25-Dihydroxyvitamin D 3", "DE": "24 25 DIHYDROXYVITAMIN D 3", "DS": "DIHYDROXYVITAMIN D3 24 25", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "24,25-Dihydroxycholecalciferol|T109|T127|NON|EQV|NLM (1990)|890201|DIHYDROXYCHOLECALCIFEROL 024 025|abbcdefs", "ENTRY": "Dihydroxyvitamin D3, 24,25", "MN": "D10.570.938.146.478.387.400", "PA": "Vitamins", "MH_TH": "NLM (1990)", "ST": "T127", "N1": "9,10-Secocholesta-5,7,10(19)-triene-3,24,25-triol, (3beta,5Z,7E)-", "RN": "40013-87-4", "RR": "55721-11-4 ((3beta,5Z,7E,24R)-isomer)", "AN": "deficiency: coordinate 24,25-DIHYDROXYVITAMIN D 3 /defic (IM) with RICKETS (IM) or with VITAMIN D DEFICIENCY (IM)", "PI": "Dihydroxycholecalciferols (1973-1989)", "MS": "A physiologically active metabolite of VITAMIN D. The compound is involved in the regulation of calcium metabolism, alkaline phosphatase activity, and enhancing the calcemic effect of CALCITRIOL.", "PM": "90", "HN": "90", "MR": "20180522", "DA": "19890721", "DC": "1", "DX": "19900101", "UI": "D015650"}, {"RECTYPE": "D", "MH": "Mycotoxicosis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fungus Poisoning|T037|NON|EQV|NLM (1990)|890201|FUNGUS POIS|abcdefv", "ENTRY": "Poisonings, Fungus", "MN": "C25.723.680", "MH_TH": "NLM (1990)", "ST": "T037", "AN": "\"caused by ingestion of mycotoxins (toxins of fungal origin)\"", "PI": "Toxins (1966)", "MS": "Poisoning caused by the ingestion of mycotoxins (toxins of fungal origin).", "OL": "use MUSHROOM POISONING to search MYCOTOXICOSIS 1985-89", "PM": "90; was see MUSHROOM POISONING 1985-89", "HN": "90; was see MUSHROOM POISONING 1985-89", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015651"}, {"RECTYPE": "D", "MH": "25-Hydroxyvitamin D 2", "DS": "HYDROXYVITAMIN D 02 25", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "25-Hydroxyergocalciferol|T109|T127|NON|EQV|NLM (1990)|890201|HYDROXYERGOCALCIFEROL 025|abbcdefs", "ENTRY": "25 Hydroxyvitamin D2", "MN": "D10.570.938.439.500", "PA": "Vitamins", "MH_TH": "NLM (1990)", "ST": "T127", "N1": "9,10-Secoergosta-5,7,10(19),22-tetraene-3,25-diol, (3beta,5Z,7E,22E)-", "RN": "21343-40-8", "AN": "deficiency: coordinate 25-HYDROXYVITAMIN D 2 /defic (IM) with RICKETS (IM) or with VITAMIN D DEFICIENCY (IM)", "PI": "Ergocalciferols (1966-1989)", "MS": "9,10-Secoergosta-5,7,10(19),22-tetraene-3,25-diol. Biologically active metabolite of vitamin D2 which is more active in curing rickets than its parent. The compound is believed to attach to the same receptor as vitamin D2 and 25-hydroxyvitamin D3.", "PM": "90", "HN": "90", "MR": "20160527", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015652"}, {"RECTYPE": "D", "MH": "Cystectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Radical Cystectomy|T061|NON|NRW|NLM (2023)|220329|abcdef", "ENTRY": "Radical Cystectomies", "MN": "E04.950.774.150", "FX": "Urinary Diversion", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "\"cyst-\" refers to the bladder, not to \"cyst\"", "PI": "Bladder Neoplasms (1966-1989)", "MS": "Surgical removal of the full or partial removal of the URINARY BLADDER.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19890619", "DC": "1", "DX": "19900101", "UI": "D015653"}, {"RECTYPE": "D", "MH": "Herpesvirus 6, Human", "DE": "HHV 6", "DS": "HERPESVIRUS HUMAN 06", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human B-Lymphotropic Virus|T005|EQV|NLM (1990)|890202|HUMAN LYMPHOTROPIC VIRUS AB|abdefs", "ENTRY": "Human betaherpesvirus 6s", "MN": "B04.280.382.150.750.400", "FX": "Exanthema Subitum", "MH_TH": "NLM (1990)", "ST": "T005", "RN": "txid10368", "AN": "infection: coordinate IM with ROSEOLOVIRUS INFECTIONS (IM) but consider also EXANTHEMA SUBITUM", "PI": "Herpesviridae (1986-1989)", "MS": "Members of the ROSEOLOVIRUS genus of the Betaherpesvirales subfamily isolated from patients with AIDS and other LYMPHOPROLIFERATIVE DISORDERS. It infects and replicates in fresh and established lines of hematopoietic cells and cells of neural origin. It also appears to alter the activity of NK CELLS. HHV-6; (HBLV) antibodies are elevated in patients with AIDS; SJOGREN'S SYNDROME; SARCOIDOSIS; CHRONIC FATIGUE SYNDROME, and certain malignancies. HHV-6A is the most common cause of EXANTHEMA SUBITUM and has been implicated in encephalitis. When HHV-6 integrates into the host genome it is referred to as ciHVH-6. When such VIRUS INTEGRATION occurs into the germline it is referred to as iciHHV-6.", "OL": "use HERPESVIRUS 6, HUMAN to search HERPESVIRUS-6, HUMAN & HUMAN HERPESVIRUS-6 1990-93", "PM": "94; was HERPESVIRUS-6, HUMAN 1990-93; HUMAN HERPESVIRUS-6 was see HERPESVIRUS-6, HUMAN 1990-93", "HN": "94; was HERPESVIRUS-6, HUMAN 1990-93; HUMAN HERPESVIRUS-6 was see HERPESVIRUS-6, HUMAN 1990-93", "MR": "20200902", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015654"}, {"RECTYPE": "D", "MH": "1-Methyl-4-phenylpyridinium", "DS": "METHYLPHENYLPYRIDINIUM 01 04", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyperquat|T109|T131|NON|EQV|FDA SRS (2014)|NLM (1990)|890202|abbcdeef", "ENTRY": "N Methyl 4 phenylpyridine", "MN": "D03.383.725.762.550", "PA": "Herbicides", "FX": "MPTP Poisoning", "MH_TH": "NLM (1990)", "ST": "T131", "N1": "Pyridinium, 1-methyl-4-phenyl-", "RN": "R865A5OY8J", "RR": "MRP3DNB9K9", "PI": "Pyridinium Compounds (1968-1989)", "MS": "An active neurotoxic metabolite of 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE. The compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. These and other toxic effects lead to cessation of oxidative phosphorylation, ATP depletion, and cell death. The compound, which is related to PARAQUAT, has also been used as an herbicide.", "PM": "90", "HN": "90", "MR": "20160527", "DA": "19890516", "DC": "1", "DX": "19900101", "UI": "D015655"}, {"RECTYPE": "D", "MH": "Respiratory Mechanics", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Breathing Mechanics|T042|NON|EQV|NLM (2004)|030514|abcdef", "ENTRY": "Respiratory Mechanic", "MN": "G09.772.705.700", "FX": "Lung Compliance", "MH_TH": "NLM (1990)", "ST": "T042", "PI": "Respiration (1966-1989)", "MS": "The physical or mechanical action of the LUNGS; DIAPHRAGM; RIBS; and CHEST WALL during respiration. It includes airflow, lung volume, neural and reflex controls, mechanoreceptors, breathing patterns, etc.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19890516", "DC": "1", "DX": "19900101", "UI": "D015656"}, {"RECTYPE": "D", "MH": "Respiratory Transport", "AQ": "DE ES GE IM PH RE", "ENTRY": "Transports, Respiratory", "MN": "G09.772.705.760", "MH_TH": "NLM (1990)", "ST": "T042", "PI": "Respiration (1966-1989)", "MS": "The processes of diffusion across the BLOOD-AIR BARRIER, and the chemical reactions coupled with diffusion that effect the rate of PULMONARY GAS EXCHANGE, generally at the alveolar level.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19890516", "DC": "1", "DX": "19900101", "UI": "D015657"}, {"RECTYPE": "D", "MH": "HIV Infections", "DE": "HIV INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "T-Lymphotropic Virus Type III Infections, Human|T047|EQV|NLM (1990)|890203|LYMPHOTROPIC VIRUS TYPE III INFECTIONS HUMAN T|T LYMPHOTROPIC VIRUS TYPE III INFECT HUMAN|abdefsv", "ENTRY": "T Lymphotropic Virus Type III Infections, Human", "MN": "C20.673.480", "FX": "Lymphoma, AIDS-Related", "MH_TH": "POPLINE (1988)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with HIV-1 or HIV-2 ", "PI": "HIV Seropositivity (1988-1989)", "MS": "Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).", "OL": "use ACQUIRED IMMUNODEFICIENCY SYNDROME to search HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION 1989; HIV INFECTION 1988-89; HTLV-III INFECTION & HTLV-III LAV INFECTION 1987-89", "PM": "90; T-LYMPHOTROPIC VIRUS TYPE III INFECTION, HUMAN was HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION see ACQUIRED IMMUNODEFICIENCY SYNDROME 1989; HIV INFECTION was see ACQUIRED IMMUNODEFICIENCY SYNDROME 1988-89; HTLV-III INFECTION & HTLV-III-LAV INFECTION were see ACQUIRED IMMUNODEFICIENCY SYNDROME 1987-89", "HN": "90; T-LYMPHOTROPIC VIRUS TYPE III INFECTION, HUMAN was HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION see ACQUIRED IMMUNODEFICIENCY SYNDROME 1989; HIV INFECTION was see ACQUIRED IMMUNODEFICIENCY SYNDROME 1988-89; HTLV-III INFECTION & HTLV-III-LAV INFECTION were see ACQUIRED IMMUNODEFICIENCY SYNDROME 1987-89", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015658"}, {"RECTYPE": "D", "MH": "7-Alkoxycoumarin O-Dealkylase", "DS": "ALKOXYCOUMARIN DEALKYLASE O 07", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "7-Ethoxycoumarin O-Deethylase|T116|T126|NON|EQV|NLM (1990)|890203|ETHOXYCOUMARIN DEETHYLASE O 07|abbcdefs", "ENTRY": "P-450-Dependent O-Dealkylase, Cytochrome", "MN": "D08.811.682.690.708.170.010.024", "MH_TH": "NLM (1990)", "ST": "T126", "RN": "EC 1.14.13.-", "PI": "Oxygenases (1966-1989)", "MS": "A drug-metabolizing enzyme found in the hepatic, placental and intestinal microsomes that metabolizes 7-alkoxycoumarin to 7-hydroxycoumarin. The enzyme is cytochrome P-450- dependent.", "PM": "90", "HN": "90", "MR": "20160527", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015660"}, {"RECTYPE": "D", "MH": "Pasteurellaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Histophilus|T007|NON|NRW|NLM (2004)|030107|abcdef", "MN": "B03.660.250.550", "MH_TH": "NLM (1990)", "ST": "T007", "RN": "txid712", "RR": "txid214906", "PI": "Pasteurella (1974-1989)", "MS": "A family of coccoid to rod-shaped nonsporeforming, gram-negative, nonmotile, facultatively anaerobic bacteria that includes the genera ACTINOBACILLUS; HAEMOPHILUS; MANNHEIMIA; and PASTEURELLA.", "PM": "90", "HN": "90", "MR": "20200813", "DA": "19890703", "DC": "1", "DX": "19900101", "UI": "D015661"}, {"RECTYPE": "D", "MH": "Trimethoprim, Sulfamethoxazole Drug Combination", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trimethoprim-Sulfamethoxazole Combination|T109|T121|NON|EQV|NLM (1990)|990101|abbcdef", "ENTRY": "Trimethoprim Sulfamethoxazole Combination", "MN": "D26.310.875", "PA": "Antimalarials", "MH_TH": "NLM (2016)", "ST": "T121", "N1": "Benzenesulfonamide, 4-a)mino-N-(5-methyl-3-isoxazolyl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl-2,4-pyrimidinediamine", "RN": "8064-90-2", "PI": "Trimethoprim (1972-1989)", "MS": "A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.", "PM": "2016", "HN": "2016 (1990)", "MR": "20230608", "DA": "19890901", "DC": "1", "DX": "19900101", "UI": "D015662"}, {"RECTYPE": "D", "MH": "Osteoporosis, Postmenopausal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Postmenopausal Osteoporosis|T047|NON|EQV|NLM (1990)|890511|abcdef", "ENTRY": "Postmenopausal Osteoporoses", "MN": "C18.452.104.579.610", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "in females; don't forget also check tags HUMANS + FEMALE; corresponding age-related osteoporosis in men goes under OSTEOPOROSIS", "PI": "Osteoporosis (1966-1989)", "MS": "Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.", "OL": "use OSTEOPOROSIS to search BONE LOSS, PERIMENOPAUSAL; BONE LOSS, POSTMENOPAUSAL; PERIMENOPAUSAL BONE LOSS; & POSTMENOPAUSAL BONE LOSS 1987-89", "PM": "90; BONE LOSS, PERIMENOPAUSAL; BONE LOSS, POSTMENOPAUSAL; PERIMENOPAUSAL BONE LOSS; & POSTMENOPAUSAL BONE LOSS were see OSTEOPOROSIS 1987-89", "HN": "90; BONE LOSS, PERIMENOPAUSAL; BONE LOSS, POSTMENOPAUSAL; PERIMENOPAUSAL BONE LOSS; & POSTMENOPAUSAL BONE LOSS were see OSTEOPOROSIS 1987-89", "CATSH": "CAT LIST", "MR": "20151124", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015663"}, {"RECTYPE": "D", "MH": "Acupuncture Analgesia", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Analgesia, Acupuncture|T061|NON|EQV|NLM (1994)|930510|abcdef", "ENTRY": "Anesthesia, Acupuncture|T061|NON|NRW|NLM (1994)|930510|abcdef", "MN": "E03.091.048", "MH_TH": "NLM (1990)", "ST": "T061", "PI": "Analgesia (1972-1989)", "MS": "Analgesia produced by the insertion of ACUPUNCTURE needles at certain ACUPUNCTURE POINTS on the body. This activates small myelinated nerve fibers in the muscle which transmit impulses to the spinal cord and then activate three centers - the spinal cord, midbrain and pituitary/hypothalamus - to produce analgesia.", "PM": "1990; for ACUPUNCTURE ANESTHESIA see ACUPUNCTURE ANESTHESIA 1990-2001; see ACUPUNCTURE 1990", "HN": "1990; for ACUPUNCTURE ANESTHESIA use ACUPUNCTURE ANESTHESIA 1991-2001; use ACUPUNCTURE 1990", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015667"}, {"RECTYPE": "D", "MH": "Acupuncture Points", "AQ": "CL", "PRINT ENTRY": "Acupoints|T029|NON|EQV|NLM (1990)|890206|abcdef", "ENTRY": "Points, Acupuncture", "MN": "E02.190.044.555.035", "FX": "Trigger Points", "MH_TH": "NLM (1990)", "ST": "T029", "PI": "Acupuncture (1966-1989)", "MS": "Designated locations along nerves or organ meridians for inserting acupuncture needles.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015669"}, {"RECTYPE": "D", "MH": "Acupuncture Therapy", "DE": "ACUPUNCTURE THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Treatment, Pharmacoacupuncture", "MN": "E02.190.044", "FX": "Medicine, Chinese Traditional", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "do not confuse with ACUPUNCTURE, the specialty; ACUPUNCTURE, EAR is also available", "PI": "Acupuncture (1966-1989)", "MS": "Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. It is sometimes used in conjunction with heat, moxibustion, acupressure, or electric stimulation.", "PM": "1990", "HN": "1990", "CATSH": "CAT LIST", "MR": "20170428", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015670"}, {"RECTYPE": "D", "MH": "Electroacupuncture", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E03.155.519", "MH_TH": "NLM (1990)", "ST": "T061", "PI": "Acupuncture (1966-1989)", "MS": "A form of acupuncture with electrical impulses passing through the needles to stimulate NERVE TISSUE. It can be used for ANALGESIA; ANESTHESIA; REHABILITATION; and treatment for diseases.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015671"}, {"RECTYPE": "D", "MH": "Erythroid Precursor Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Stem Cells, Erythroid|T025|NON|NRW|NLM (1990)|890427|abcdef", "ENTRY": "Units, Erythroid Colony-Forming", "MN": "A15.378.316.378.590.837.250", "MH_TH": "NLM (1990)", "ST": "T025", "PI": "Hematopoietic Stem Cells (1977-1989)", "MS": "The cells in the erythroid series derived from MYELOID PROGENITOR CELLS or from the bi-potential MEGAKARYOCYTE-ERYTHROID PROGENITOR CELLS which eventually give rise to mature RED BLOOD CELLS. The erythroid progenitor cells develop in two phases: erythroid burst-forming units (BFU-E) followed by erythroid colony-forming units (CFU-E); BFU-E differentiate into CFU-E on stimulation by ERYTHROPOIETIN, and then further differentiate into ERYTHROBLASTS when stimulated by other factors.", "PM": "2009; see ERYTHROID PROGENITOR CELLS 1990-2008", "HN": "2009 (1990)", "MR": "20160610", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015672"}, {"RECTYPE": "D", "MH": "Fatigue Syndrome, Chronic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Postviral Fatigue Syndrome|T047|NON|EQV|NLM (1990)|890207|abcdef", "ENTRY": "Syndrome, Postviral Fatigue", "MN": "C23.550.291.500.392", "FX": "Fibromyalgia", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "a clinical entity: do not confuse with \"chronic fatigue\" (= FATIGUE + CHRONIC DISEASE (NIM))", "PI": "Virus Diseases (1986-1989)", "MS": "A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015673"}, {"RECTYPE": "D", "MH": "Mammary Neoplasms, Animal", "DE": "MAMMARY NEOPL ANIMAL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "ENTRY": "Neoplasms, Animal Mammary", "MN": "C22.520", "MH_TH": "NLM (2004)", "ST": "T191", "AN": "animal only but MAMMARY NEOPLASMS, EXPERIMENTAL is also available; coord IM with histol type of neopl (IM) + precoord animal/dis term (IM) + specific animal (NIM); do not coord with NEOPLASMS, EXPERIMENTAL; check tag ANIMALS", "PI": "Neoplasms/veterinary (1967-1989)", "MS": "Tumors or cancer of the MAMMARY GLAND in animals (MAMMARY GLANDS, ANIMAL).", "PM": "2004; see MAMMARY NEOPLASMS 1990-2003", "HN": "2004 (1990)", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015674"}, {"RECTYPE": "D", "MH": "Osteocalcin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vitamin K-Dependent Bone Protein|T116|T123|NON|EQV|NLM (1990)|890208|abbcdef", "ENTRY": "Vitamin K Dependent Bone Protein", "MN": "D12.776.157.125.700", "MH_TH": "NLM (1990)", "ST": "T123", "N1": "Osteocalcin (human reduced), 3-de-L-tyrosine-4-de-L-glutamine-5-de-L-tryptophan-6-de-L-leucine-9-L-serine-12-L-serine-19-L-threonine-22-L-glutamine-28-L-alanine-33-L-serine-35-L-glutamine-36-L-tyrosine-38-L-leucine-39-L-lysine-40-L-threonine-43-L-lysine-45-L-isoleucine-48-L-isoleucine-49-L-threonine-49a-L-isoleucine-", "RN": "104982-03-8", "PI": "Proteins (1980-1981)", "MS": "Vitamin K-dependent calcium-binding protein synthesized by OSTEOBLASTS and found primarily in BONES. Serum osteocalcin measurements provide a noninvasive specific marker of bone metabolism. The protein contains three residues of the amino acid gamma-carboxyglutamic acid (Gla), which, in the presence of CALCIUM, promotes binding to HYDROXYAPATITE and subsequent accumulation in BONE MATRIX.", "OL": "use OSTEOCALCIN to search GLA-PROTEIN 1990-96", "PM": "90; GLA-PROTEIN was see OSTEOCALCIN 1990-96", "HN": "90; GLA-PROTEIN was see OSTEOCACLIN 1990-96", "MR": "20040707", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015675"}, {"RECTYPE": "D", "MH": "Osteonectin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SPARC Glycoprotein|T116|T123|ACX|EQV|NLM (1992)|901105|abbcdef", "ENTRY": "Basement Membrane Tumor Protein|T116|T123|NON|EQV|NLM (1990)|890208|abbcdef", "MN": "D12.776.395.600", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1980-1989)", "MS": "Non-collagenous, calcium-binding glycoprotein of developing bone. It links collagen to mineral in the bone matrix. In the synonym SPARC glycoprotein, the acronym stands for Secreted Protein, Acidic and Rich in Cysteine.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015676"}, {"RECTYPE": "D", "MH": "Viral Structural Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "VP1, Structural Polypeptide", "MN": "D12.776.964.970", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "coordinate IM with specific protein (IM) + specific virus (IM)", "PI": "Viral Proteins (1973-1989)", "MS": "Viral proteins that are components of the mature assembled VIRUS PARTICLES. They may include nucleocapsid core proteins (gag proteins), enzymes packaged within the virus particle (pol proteins), and membrane components (env proteins). These do not include the proteins encoded in the VIRAL GENOME that are produced in infected cells but which are not packaged in the mature virus particle,i.e. the so called non-structural proteins (VIRAL NONSTRUCTURAL PROTEINS).", "PM": "90", "HN": "90", "MR": "20200622", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015678"}, {"RECTYPE": "D", "MH": "Fusion Proteins, gag-onc", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gag-onc Fusion Proteins|T116|EQV|NLM (1991)|900514|abdef", "ENTRY": "v-fes, Oncogene Protein", "MN": "D12.776.964.775.750.320", "MH_TH": "NLM (1990)", "ST": "T116", "RN": "0", "AN": "IM; coord with specific virus (IM); /drug eff /ultrastruct permitted", "PI": "Viral Proteins (1980-1985)", "MS": "General name for the translation products of a fusion mRNA consisting of a gag gene and a viral oncogene (v-onc). These products are thought to have the ability to transform cells.", "OL": "use FUSION PROTEINS, GAG-ONC to search GAG-ONC FUSION PROTEINS 1990", "PM": "91; was GAG-ONC FUSION PROTEINS 1990", "HN": "91; was GAG-ONC FUSION PROTEINS 1990", "MR": "20050630", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015681"}, {"RECTYPE": "D", "MH": "Retroviridae Proteins, Oncogenic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Oncogenic Retroviridae", "MN": "D12.776.964.775.750", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "IM; coord with specific virus (IM); /drug eff /ultrastruct permitted", "PI": "Viral Proteins (1980-1985)", "MS": "Retroviral proteins that have the ability to transform cells. They can induce sarcomas, leukemias, lymphomas, and mammary carcinomas. Not all retroviral proteins are oncogenic.", "PM": "90", "HN": "90", "MR": "20050630", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015682"}, {"RECTYPE": "D", "MH": "Gene Products, gag", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gag Viral Proteins|T116|T123|EQV|NLM (1990)|890209|abbdef", "ENTRY": "gag Proteins, Viral", "MN": "D12.776.964.970.600.850.350", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "coordinate with specific virus ", "PI": "Viral Proteins (1972-1989)", "MS": "Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen.", "PM": "90", "HN": "90", "MR": "20210630", "DA": "19890706", "DC": "1", "DX": "19900101", "UI": "D015683"}, {"RECTYPE": "D", "MH": "Gene Products, pol", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "pol Protein|T116|T123|EQV|NLM (1991)|900514|abbdef", "ENTRY": "pol Gene Product", "MN": "D12.776.964.970.600.850.375", "FX": "RNA-Directed DNA Polymerase", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "coord with specific virus (IM)", "PI": "Viral Proteins (1977-1989)", "MS": "Retroviral proteins coded by the pol gene. They are usually synthesized as a protein precursor (POLYPROTEINS) and later cleaved into final products that include reverse transcriptase, endonuclease/integrase, and viral protease. Sometimes they are synthesized as a gag-pol fusion protein (FUSION PROTEINS, GAG-POL). Pol is short for polymerase, the enzyme class of reverse transcriptase.", "PM": "90", "HN": "90", "MR": "20210630", "DA": "19891012", "DC": "1", "DX": "19900101", "UI": "D015684"}, {"RECTYPE": "D", "MH": "Fusion Proteins, gag-pol", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gag-pol Protein|T116|EQV|NLM (1991)|900514|abdef", "ENTRY": "gag pol Protein", "MN": "D12.776.964.970.600.850.375.325", "MH_TH": "NLM (1990)", "ST": "T116", "RN": "0", "AN": "coord with specific virus (IM)", "PI": "Viral Proteins (1980-1985)", "MS": "Polyprotein products of a fused portion of retroviral mRNA containing the gag and pol genes. The polyprotein is synthesized only five percent of the time since pol is out of frame with gag, and is generated by ribosomal frameshifting.", "OL": "use GENE PRODUCTS, GAG to search GAG-POL FUSION PROTEINS 1990", "PM": "91; was GAG-POL FUSION PROTEINS see under GENE PRODUCTS, GAG 1990", "HN": "91(90); was GAG-POL FUSION PROTEINS see under GENE PRODUCTS, GAG 1990", "MR": "20200622", "DA": "19890707", "DC": "1", "DX": "19910101", "UI": "D015685"}, {"RECTYPE": "D", "MH": "Gene Products, env", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "env Protein|T116|T123|ABX|EQV|NLM (1991)|900514|abbcdef", "ENTRY": "Polyproteins, env", "MN": "D12.776.964.970.880.325", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Viral Proteins (1977-1985)", "MS": "Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesized as protein precursors (POLYPROTEINS) and later cleaved into the final viral envelope glycoproteins by a viral protease.", "PM": "90", "HN": "90", "MR": "20070709", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015686"}, {"RECTYPE": "D", "MH": "Cell Hypoxia", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Hypoxia, Cellular|T043|NON|EQV|NLM (1990)|890417|abcdef", "ENTRY": "Hypoxias, Cellular", "MN": "G04.270.300", "MH_TH": "NLM (1990)", "ST": "T043", "AN": "not for micro-organisms", "PI": "Oxygen (1985-1989)", "MS": "A condition of decreased oxygen content at the cellular level.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20200622", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015687"}, {"RECTYPE": "D", "MH": "Oncogene Protein pp60(v-src)", "DS": "ONCOGENE PROTEIN PP 060 V SRC", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-src Protein pp60|T116|T126|EQV|NLM (1991)|900502|V SRC PROTEIN PP 060|abbdefs", "ENTRY": "v-src, pp60", "MN": "D12.776.964.775.750.760", "MH_TH": "NLM (1990)", "ST": "T126", "N1": "Kinase (phosphorylating), protein pp60src", "RN": "EC 2.7.10.2", "PI": "Viral Proteins (1981-1985)", "MS": "A tyrosine-specific protein kinase encoded by the v-src oncogene of ROUS SARCOMA VIRUS. The transforming activity of pp60(v-src) depends on both the lack of a critical carboxy-terminal tyrosine phosphorylation site at position 527, and the attachment of pp60(v-src) to the plasma membrane which is accomplished by myristylation of its N-terminal glycine.", "OL": "use ONCOGENE PROTEIN PP60(V-SRC) to search ONCOGENE PROTEIN PP60(SRC) & PP60(SRC) 1990", "PM": "91; was ONCOGENE PROTEIN PP60(SRC) 1990; PP60(SRC) was see ONCOGENE PROTEIN PP60(SRC) 1990", "HN": "91; was ONCOGENE PROTEIN PP60(SRC) 1990; PP60(SRC) was see ONCOGENE PROTEIN PP60(SRC) 1990", "MR": "20210521", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015688"}, {"RECTYPE": "D", "MH": "Oncogene Protein p21(ras)", "DS": "ONCOGENE PROTEIN P 021 RAS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ras Oncogene Protein p21|T116|T126|EQV|NLM (1990)|890508|RAS ONCOGENE PROTEIN P A 021|abbdefs", "ENTRY": "v-ras, p21", "MN": "D12.776.964.775.750.710", "MH_TH": "NLM (1990)", "ST": "T126", "RN": "EC 3.6.5.2", "AN": "coord with specific virus", "PI": "Oncogene Proteins, Viral (1986-1989)", "MS": "Transforming protein encoded by ras oncogenes. Point mutations in the cellular ras gene (c-ras) can also result in a mutant p21 protein that can transform mammalian cells. Oncogene protein p21(ras) has been directly implicated in human neoplasms, perhaps accounting for as much as 15-20% of all human tumors. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "1990", "HN": "1990", "MR": "20210521", "DA": "19890719", "DC": "1", "DX": "19900101", "UI": "D015689"}, {"RECTYPE": "D", "MH": "Gene Products, nef", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "nef Protein|T116|T123|ABX|EQV|NLM (1991)|900514|abbcdef", "ENTRY": "nef Gene Product", "MN": "D12.776.964.925.500", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Viral Proteins (1987-1988)", "MS": "Products of the retroviral NEF GENE. They play a role as accessory proteins that influence the rate of viral infectivity and the destruction of the host immune system. nef gene products were originally found as factors that trans-suppress viral replication and function as negative regulators of transcription. nef stands for negative factor.", "PM": "91; was see under VIRAL REGULATORY PROTEINS 1990", "HN": "91(90); was see under VIRAL REGULATORY PROTEINS 1990", "MR": "20070709", "DA": "19891020", "DC": "1", "DX": "19910101", "UI": "D015693"}, {"RECTYPE": "D", "MH": "Gene Products, rev", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rev Protein|T116|T123|ABX|EQV|NLM (1991)|900514|abbcdef", "ENTRY": "rev Gene Product", "MN": "D12.776.964.925.984.385", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Viral Proteins (1986-1989)", "MS": "Trans-acting nuclear proteins whose functional expression are required for retroviral replication. Specifically, the rev gene products are required for processing and translation of the gag and env mRNAs, and thus rev regulates the expression of the viral structural proteins. rev can also regulate viral regulatory proteins. A cis-acting antirepression sequence (CAR) in env, also known as the rev-responsive element (RRE), is responsive to the rev gene product. Rev is short for regulator of virion.", "PM": "91; was see under TRANS-ACTIVATORS 1990", "HN": "91(90); was see under TRANS-ACTIVATORS 1990", "MR": "20210630", "DA": "19890706", "DC": "1", "DX": "19910101", "UI": "D015694"}, {"RECTYPE": "D", "MH": "Gene Products, tat", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tat Protein|T116|T123|ABX|EQV|NLM (1991)|900514|abbcdef", "ENTRY": "tat Gene Product", "MN": "D12.776.964.925.984.400", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1988-1989)", "MS": "Trans-acting transcription factors produced by retroviruses such as HIV. They are nuclear proteins whose expression is required for viral replication. The tat protein stimulates LONG TERMINAL REPEAT-driven RNA synthesis for both viral regulatory and viral structural proteins. Tat stands for trans-activation of transcription.", "PM": "91; was see under TRANS-ACTIVATORS 1990", "HN": "91(90); was see under TRANS-ACTIVATORS 1990", "MR": "20210630", "DA": "19890707", "DC": "1", "DX": "19910101", "UI": "D015696"}, {"RECTYPE": "D", "MH": "Genomic Library", "ENTRY": "Library, Genomic", "MN": "G05.360.340.425", "FX": "Human Genome Project", "MH_TH": "NLM (1990)", "ST": "T130", "PI": "Nucleic Acid Hybridization (1980-1989)", "MS": "A form of GENE LIBRARY containing the complete DNA sequences present in the genome of a given organism. It contrasts with a cDNA library which contains only sequences utilized in protein coding (lacking introns).", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890606", "DC": "1", "DX": "19900101", "UI": "D015698"}, {"RECTYPE": "D", "MH": "HIV Envelope Protein gp120", "DS": "HIV ENVELOPE PROTEIN GP 120", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gp120(HIV)|T116|T123|EQV|NLM (1990)|890525|GP 120 HIV|abbdefs", "ENTRY": "gp120, HTLV-III", "MN": "D23.050.327.520.350", "FX": "Peptide T", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Viral Envelope Proteins (1983-1989)", "MS": "External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120 kDa and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably T4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV.", "PM": "90", "HN": "90", "MR": "20220413", "DA": "19890619", "DC": "1", "DX": "19900101", "UI": "D015699"}, {"RECTYPE": "D", "MH": "HIV Envelope Protein gp41", "DS": "HIV ENVELOPE PROTEIN GP 041", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gp41(HIV)|T116|T123|ABB|EQV|NLM (1990)|890525|GP 041 HIV|abbcdefs", "ENTRY": "gp41 Envelope Protein, HIV|T116|T123|ABX|EQV|NLM (1990)|890214|GP41 ENV PROTEIN HIV|abbcdefv", "MN": "D23.050.327.520.330", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Viral Envelope Proteins (1983-1989)", "MS": "Transmembrane envelope protein of the HUMAN IMMUNODEFICIENCY VIRUS which is encoded by the HIV env gene. It has a molecular weight of 41,000 and is glycosylated. The N-terminal part of gp41 is thought to be involved in CELL FUSION with the CD4 ANTIGENS of T4 LYMPHOCYTES, leading to syncytial formation. Gp41 is one of the most common HIV antigens detected by IMMUNOBLOTTING.", "PM": "90", "HN": "90", "MR": "20220413", "DA": "19890619", "DC": "1", "DX": "19900101", "UI": "D015700"}, {"RECTYPE": "D", "MH": "Near Drowning", "AQ": "BL CF CL CO DG DI EC EN EP ET HI IM ME MI NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Near-Drownings", "MN": "N06.850.135.696.500", "MH_TH": "NLM (1990)", "ST": "T037", "PI": "Drowning (1966-1989)", "MS": "Non-fatal immersion or submersion in water. The subject is resuscitable.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015701"}, {"RECTYPE": "D", "MH": "Antigens, CD", "DS": "ANTIGENS CD", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Leukocyte Differentiation Antigens, Human|T129|NON|NRW|NLM (1990)|890228|abcdef", "ENTRY": "Marker Cluster, Differentiation", "MN": "D23.101.100.110", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "Antigens, Differentiation, T-Lymphocyte (1988-1989)", "MS": "Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.", "PM": "90", "HN": "90", "MR": "20200527", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015703"}, {"RECTYPE": "D", "MH": "CD4 Antigens", "DS": "CD 004 ANTIGENS", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "T4 Antigens, T-Cell|T116|T129|T192|EQV|NLM (1990)|890427|T AAB ANTIGENS T CELL 04|abbbdefs", "ENTRY": "T4 Antigens, T Cell", "MN": "D23.101.100.894.100", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (1990)", "ST": "T192", "RN": "0", "AN": "for hematodermic CD4/CD56 neoplasm use LYMPHOMA, NON-HODGKIN", "PI": "Receptors, Virus (1979-1989)", "MS": "55-kDa antigens found on HELPER-INDUCER T-LYMPHOCYTES and on a variety of other immune cell types. They are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MAJOR HISTOCOMPATIBILITY COMPLEX class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. T4 antigens also serve as INTERLEUKIN-15 receptors and bind to the HIV receptors, binding directly to the HIV ENVELOPE PROTEIN GP120.", "PM": "2018; see ANTIGENS, CD4 1990-2017 and ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989", "HN": "2018 (1989); use ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989", "MR": "20210630", "DA": "19890619", "DC": "1", "DX": "19900101", "UI": "D015704"}, {"RECTYPE": "D", "MH": "Bibliometrics", "AQ": "HI", "PRINT ENTRY": "Bibliography, Statistical|T062|NON|EQV|NLM (1990)|890216|BIBLIOG STATIST|abcdefv", "ENTRY": "Bibliometric Analyses", "MN": "L01.462.750.183.291", "MH_TH": "NLM (1990)", "ST": "T062", "AN": "IM; coord with subject (IM); med bibliometrics: do not coordinate with MEDICINE", "PI": "Bibliography (1966-1989)", "MS": "The use of statistical methods in the analysis of a body of literature to reveal the historical development of subject fields and patterns of authorship, publication, and use. Formerly called statistical bibliography. (from The ALA Glossary of Library and Information Science, 1983)", "OL": "90", "PM": "90", "HN": "90", "MR": "20220712", "DA": "19890619", "DC": "1", "DX": "19900101", "UI": "D015706"}, {"RECTYPE": "D", "MH": "HN Protein", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Hemagglutinin-Neuraminidase Glycoprotein|T116|T123|NON|EQV|NLM (1990)|890216|HEMAGGLUTININ NEURAMINIDASE GLYCOPROTEIN|HN GLYCOPROTEIN|abbcdefsv", "ENTRY": "Protein, HN", "MN": "D23.050.327.461.350", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "IM; coord with specific virus (IM); /drug eff /ultrastruct permitted", "PI": "Viral Proteins (1972-1985)", "MS": "Glycoprotein from Sendai, para-influenza, Newcastle Disease, and other viruses that participates in binding the virus to cell-surface receptors. The HN protein possesses both hemagglutinin and neuraminidase activity.", "PM": "90", "HN": "90", "MR": "20220413", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015707"}, {"RECTYPE": "D", "MH": "Correspondence as Topic", "AQ": "HI", "ENTRY": "Letters as Topics", "MN": "L01.559.423.906.377", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "do not confuse with the Publication Types LETTER or COLLECTED CORRESPONDENCE", "MS": "Works on written communication between persons or between institutions or organizations.", "PM": "2008; CORRESPONDENCE 1990-2007, see WRITING 1966-1989", "HN": "2008(1990)", "MR": "20170630", "DA": "19890622", "DC": "1", "DX": "19900101", "UI": "D015709"}, {"RECTYPE": "D", "MH": "Duplicate Publications as Topic", "PRINT ENTRY": "Duplicate Publication as Topic|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "L01.737.471", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "IM only for duplicate publication as a publishing or bibliothecal problem & for notices that an article has been published in duplicate; do not confuse with Publication Type DUPLICATE PUBLICATION used for an individual item identified as a duplicate publication; do not confuse with PLAGIARISM", "PI": "Publishing (1966-1989)", "MS": "Work about simultaneous or successive publishing of identical or near- identical material in two or more different sources without acknowledgment. It differs from reprinted publication in that a reprint cites sources. It differs from PLAGIARISM in that duplicate publication is the product of the same authorship while plagiarism publishes a work or parts of a work of another as one's own.", "PM": "2008; see DUPLICATE PUBLICATION 1990-2007", "HN": "2008(1990)", "MR": "20190705", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015713"}, {"RECTYPE": "D", "MH": "Plagiarism", "MN": "L01.737.684", "MH_TH": "NLM (1990)", "ST": "T055", "AN": "do not confuse with DUPLICATE PUBLICATIONS AS TOPIC", "PI": "Fraud (1977-1989)", "MS": "Passing off as one's own the work of another without credit.", "PM": "90", "HN": "90", "MR": "20190710", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015714"}, {"RECTYPE": "D", "MH": "Corneal Edema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Edemas, Corneal", "MN": "C11.204.267", "MH_TH": "NLM (1990)", "ST": "T184", "PI": "Edema (1966-1989)", "MS": "An excessive amount of fluid in the cornea due to damage of the epithelium or endothelium causing decreased visual acuity.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015715"}, {"RECTYPE": "D", "MH": "Electrocardiography, Ambulatory", "DE": "ECG AMBULATORY", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Monitoring, Holter|T060|EPO|NRW|NLM (1990)|890217|abcdef", "ENTRY": "Monitoring, Ambulatory Electrocardiography", "MN": "E01.370.520.500.230", "MH_TH": "NLM (1990)", "ST": "T060", "PI": "Monitoring, Physiologic (1966-1989)", "MS": "Method in which prolonged electrocardiographic recordings are made on a portable tape recorder (Holter-type system) or solid-state device (\"real-time\" system), while the patient undergoes normal daily activities. It is useful in the diagnosis and management of intermittent cardiac arrhythmias and transient myocardial ischemia.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19890705", "DC": "1", "DX": "19900101", "UI": "D015716"}, {"RECTYPE": "D", "MH": "Peptide T", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "HIV Peptide T|T116|T121|NON|EQV|NLM (1990)|890510|abbcdef", "ENTRY": "Peptide T, HIV", "MN": "D12.644.456.729", "MH_TH": "NLM (1990)", "ST": "T121", "N1": "L-Threonine, N-(N-(N2-(N-(N-(N-(N-D-alanyl-L-seryl)-L-threonyl)-L-threonyl)-L-threonyl)-L-asparaginyl)-L-tyrosyl)-", "RN": "106362-33-8", "AN": "/biosyn /drug eff /physiol permitted", "PI": "Peptide Fragments (1987-1989)", "MS": "N-(N-(N(2)-(N-(N-(N-(N-D-Alanyl L-seryl)-L-threonyl)-L-threonyl) L-threonyl)-L-asparaginyl)-L-tyrosyl) L-threonine. Octapeptide sharing sequence homology with HIV envelope protein gp120. It is potentially useful as antiviral agent in AIDS therapy. The core pentapeptide sequence, TTNYT, consisting of amino acids 4-8 in peptide T, is the HIV envelope sequence required for attachment to the CD4 receptor.", "PM": "90", "HN": "90", "MR": "19900629", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015717"}, {"RECTYPE": "D", "MH": "Fibrin Tissue Adhesive", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fibrinogen Adhesive|T116|T121|NON|EQV|NLM (1990)|890217|abbcdef", "ENTRY": "Tissue Adhesive, Fibrin", "MN": "D12.776.124.270.305", "PA": "Tissue Adhesives", "FX": "Platelet-Rich Fibrin", "MH_TH": "NLM (1990)", "ST": "T121", "RN": "0", "PI": "Thrombin (1966-1989)", "MS": "An autologous or commercial tissue adhesive containing FIBRINOGEN and THROMBIN. The commercial product is a two component system from human plasma that contains more than fibrinogen and thrombin. The first component contains highly concentrated fibrinogen, FACTOR VIII, fibronectin, and traces of other plasma proteins. The second component contains thrombin, calcium chloride, and antifibrinolytic agents such as APROTININ. Mixing of the two components promotes BLOOD CLOTTING and the formation and cross-linking of fibrin. The tissue adhesive is used for tissue sealing, HEMOSTASIS, and WOUND HEALING.", "PM": "90", "HN": "90", "MR": "20161014", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015718"}, {"RECTYPE": "D", "MH": "Single-Strand Specific DNA and RNA Endonucleases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Single Strand Specific DNA and RNA Endonucleases", "MN": "D08.811.277.352.700.350.850", "MH_TH": "NLM (2009)", "ST": "T126", "RN": "EC 3.1.30.1", "PI": "Phosphodiesterases (1972)", "MS": "Enzymes that catalyze the endonucleolytic cleavage of single-stranded regions of DNA or RNA molecules while leaving the double-stranded regions intact. They are particularly useful in the laboratory for producing \"blunt-ended\" DNA molecules from DNA with single-stranded ends and for sensitive GENETIC TECHNIQUES such as NUCLEASE PROTECTION ASSAYS that involve the detection of single-stranded DNA and RNA.", "PM": "2008; see ASPERGILLUS NUCLEASE S1 1990-2008", "HN": "2009(1990)", "MR": "20100625", "DA": "19890714", "DC": "1", "DX": "19900101", "UI": "D015719"}, {"RECTYPE": "D", "MH": "5'-Nucleotidase", "DS": "NUCLEOTIDASE 05", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Uridylate 5'-Nucleotidase|T116|T126|T129|NON|EQV|NLM (1990)|890328|URIDYLATE NUCLEOTIDASE 05|abbbcdefs", "ENTRY": "Uridylate 5' Nucleotidase", "MN": "D08.811.277.352.650.600.600", "MH_TH": "NLM (1990)", "ST": "T129", "N1": "5'-Ribonucleotide phosphohydrolase", "RN": "EC 3.1.3.5", "PI": "Nucleotidases (1966-1989)", "MS": "A glycoprotein enzyme present in various organs and in many cells. The enzyme catalyzes the hydrolysis of a 5'-ribonucleotide to a ribonucleoside and orthophosphate in the presence of water. It is cation-dependent and exists in a membrane-bound and soluble form. EC 3.1.3.5.", "PM": "1990; for CD73 ANTIGENS see CD73 ANTIGEN 1992-93", "HN": "1990; for CD73 ANTIGENS use CD73 ANTIGEN 1992-93", "MR": "20170524", "DA": "19890516", "DC": "1", "DX": "19900101", "UI": "D015720"}, {"RECTYPE": "D", "MH": "Diphtheria-Tetanus-Pertussis Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diphtheria-Pertussis-Tetanus Vaccine|T121|T129|NON|EQV|NLM (1990)|890404|abbcdef", "ENTRY": "Vaccine, Diphtheria-Tetanus-Pertussis", "MN": "D20.215.894.815.300", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "AN": "DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES and DIPHTHERIA-TETANUS VACCINE are also available", "PI": "Tetanus Toxoid (1966-1989)", "MS": "A vaccine consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and whole-cell PERTUSSIS VACCINE. The vaccine protects against diphtheria, tetanus, and whooping cough.", "PM": "1990", "HN": "1990", "MR": "20150622", "DA": "19890714", "DC": "1", "DX": "19900101", "UI": "D015721"}, {"RECTYPE": "D", "MH": "Gene Library", "PRINT ENTRY": "cDNA Library|T028|T114|T130|NON|REL|NLM (2000)|991103|abbbcdef", "ENTRY": "cDNA Libraries", "MN": "G05.360.325", "FX": "Databases, Nucleic Acid", "MH_TH": "NLM (1990)", "ST": "T130", "AN": "do not confuse with GENOMIC LIBRARY", "PI": "Plasmids (1978-1985)", "MS": "A large collection of DNA fragments cloned (CLONING, MOLECULAR) from a given organism, tissue, organ, or cell type. It may contain complete genomic sequences (GENOMIC LIBRARY) or complementary DNA sequences, the latter being formed from messenger RNA and lacking intron sequences.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190708", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015723"}, {"RECTYPE": "D", "MH": "Fluconazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "UK49858", "MN": "D03.383.129.799.450", "PA": "Cytochrome P-450 CYP2C9 Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-1,2,4-Triazole-1-ethanol, alpha-(2,4-difluorophenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl)-", "RN": "8VZV102JFY", "RR": "86386-73-4 (Fluconazole)", "PI": "Triazoles (1985-1989)", "MS": "Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.", "PM": "90", "HN": "90", "MR": "20170117", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015725"}, {"RECTYPE": "D", "MH": "Giant Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Syncytium|T025|NON|EQV|NLM (1990)|890221|abcdef", "ENTRY": "Polykaryocyte", "MN": "A11.500", "MH_TH": "NLM (1990)", "ST": "T025", "PI": "Cell Fusion (1972-1989)", "MS": "Multinucleated masses produced by the fusion of many cells; often associated with viral infections. In AIDS, they are induced when the envelope glycoprotein of the HIV virus binds to the CD4 antigen of uninfected neighboring T4 cells. The resulting syncytium leads to cell death and thus may account for the cytopathic effect of the virus.", "PM": "90", "HN": "90", "MR": "20110624", "DA": "19890407", "DC": "1", "DX": "19900101", "UI": "D015726"}, {"RECTYPE": "D", "MH": "Receptors, HIV", "DE": "RECEPT HIV", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "HTLV-III Receptors|T116|T192|EQV|NLM (1990)|890222|HTLV WIII RECEPTORS|HTLV III RECEPT|abbdefsv", "ENTRY": "Virus Receptors, AIDS", "MN": "D12.776.543.750.830.700", "FX": "HIV Envelope Protein gp120", "MH_TH": "NLM (1990)", "ST": "T192", "RN": "0", "AN": "includes HIV-1 and HIV-2 receptors", "PI": "Receptors, Virus (1987-1989)", "MS": "Cellular receptors that bind the human immunodeficiency virus that causes AIDS. Included are CD4 ANTIGENS, found on T4 lymphocytes, and monocytes/macrophages, which bind to the HIV ENVELOPE PROTEIN GP120.", "PM": "90", "HN": "90", "MR": "20160617", "DA": "19890619", "DC": "1", "DX": "19900101", "UI": "D015728"}, {"RECTYPE": "D", "MH": "Djibouti", "AQ": "EH EP", "PRINT ENTRY": "Somaliland, French|T083|NAM|EQV|NLM (1996)|950217|abcdef", "ENTRY": "Republic of Djibouti|T083|NAM|EQV|NLM (2009)|080304|abcdef", "MN": "Z01.058.290.120.275", "MH_TH": "NLM (1990)", "ST": "T083", "AN": "a republic in eastern Africa; the name of the country & the capital", "PI": "Africa, Eastern (1966-1989)", "MS": "A republic in eastern Africa, on the Gulf of Aden at the entrance to the Red Sea. Djibouti is also the name of its capital.", "HN": "90", "MR": "20080708", "DA": "19891013", "DC": "4", "DX": "19900101", "UI": "D015730"}, {"RECTYPE": "D", "MH": "Mifepristone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ZK 98296", "MN": "D04.210.500.365.415.580", "PA": "Menstruation-Inducing Agents", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Estra-4,9-dien-3-one, 11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-, (11beta,17beta)-", "RN": "320T6RNW1F", "RR": "84371-65-3 (Mifepristone)", "PI": "Glucocorticoids/antagonists & inhibitors (1967-1989)", "MS": "A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.", "PM": "90", "HN": "90", "MR": "20170524", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015735"}, {"RECTYPE": "D", "MH": "Felodipine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Von Ct, Felodipin", "MN": "D03.383.725.203.250", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, ethyl methyl ester", "RN": "OL961R6O2C", "RR": "72509-76-3 (Felodipine)", "PI": "Pyridines (1966-1980)", "MS": "A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.", "PM": "90", "HN": "90", "MR": "20170524", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015736"}, {"RECTYPE": "D", "MH": "Nisoldipine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Bay K 5552|T109|T121|LAB|NRW|NLM (1990)|890225|abbcdef", "MN": "D03.383.725.203.580", "PA": "Vasodilator Agents", "MH_TH": "USAN (1981)", "ST": "T121", "N1": "3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-methylpropyl ester", "RN": "4I8HAB65SZ", "RR": "63675-72-9 (Nisoldipine)", "PI": "Pyridines (1966-1980)", "MS": "A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.", "PM": "90", "HN": "90", "MR": "20160531", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015737"}, {"RECTYPE": "D", "MH": "Famotidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "YM11170", "MN": "D03.383.129.708.215", "PA": "Histamine H2 Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Propanimidamide, 3-(((2-((aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)-", "RN": "5QZO15J2Z8", "RR": "76824-35-6 (Famotidine)", "PI": "Thiazoles (1966-1989)", "MS": "A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.", "PM": "90", "HN": "90", "MR": "20160531", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015738"}, {"RECTYPE": "D", "MH": "Nocodazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R 17934", "MN": "D03.633.100.103.637", "PA": "Tubulin Modulators", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "Carbamic acid, (5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl)-, methyl ester", "RN": "SH1WY3R615", "RR": "31430-18-9 (Nocodazole)", "PI": "Benzimidazoles (1966-1989)", "MS": "Nocodazole is an antineoplastic agent which exerts its effect by depolymerizing microtubules.", "PM": "90", "HN": "90", "MR": "20160531", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015739"}, {"RECTYPE": "D", "MH": "Calcitonin Gene-Related Peptide", "DE": "CGRP", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "beta Calcitonin Gene Related Peptide", "MN": "D12.776.631.650.097", "PA": "Vasodilator Agents", "FX": "Receptors, Calcitonin Gene-Related Peptide", "MH_TH": "NLM (1990)", "ST": "T125", "RN": "JHB2QIZ69Z", "RR": "83652-28-2", "PI": "Neuropeptides (1987-1989)", "MS": "A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.", "PM": "1990", "HN": "1990", "MR": "20180228", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015740"}, {"RECTYPE": "D", "MH": "Metribolone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methyltrienolone|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1990)|890227|abbcdeef", "ENTRY": "Ru1881", "MN": "D04.210.500.365.415.550", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Estra-4,9,11-trien-3-one, 17-hydroxy-17-methyl-, (17beta)-", "RN": "2C323EGI97", "RR": "965-93-5 (Metribolone)", "PI": "Estrenes (1973-1989)", "MS": "A synthetic non-aromatizable androgen and anabolic steroid. It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors.", "PM": "90", "HN": "90", "MR": "20160531", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015741"}, {"RECTYPE": "D", "MH": "Propofol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Disoprofol|T109|T121|NON|EQV|NLM (1990)|890227|abbcdef", "ENTRY": "ICI35868", "MN": "D02.455.426.559.389.657.773", "PA": "Hypnotics and Sedatives", "FX": "Propofol Infusion Syndrome", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Phenol, 2,6-bis(1-methylethyl)-", "RN": "YI7VU623SF", "RR": "2078-54-8 (Propofol)", "PI": "Sedatives, Nonbarbiturate (1975-1989)", "MS": "An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.", "PM": "90", "HN": "90", "MR": "20170524", "DA": "19890608", "DC": "1", "DX": "19900101", "UI": "D015742"}, {"RECTYPE": "D", "MH": "Giant Cells, Foreign-Body", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Giant Cells, Foreign Body", "MN": "A15.382.680.397.376", "MH_TH": "NLM (1990)", "ST": "T025", "PI": "Macrophages (1966-1989)", "MS": "Multinucleated cells (fused macrophages), characteristic of granulomatous inflammation, which form around exogenous material in the skin. They are similar in appearance to Langhans giant cells (GIANT CELLS, LANGHANS), but foreign-body giant cells have more abundant chromatin and their nuclei are scattered in an irregular pattern in the cytoplasm.", "PM": "91; was see under GIANT CELLS 1990", "HN": "91(90); was see under GIANT CELLS 1990", "MR": "20180630", "DA": "19890407", "DC": "1", "DX": "19910101", "UI": "D015743"}, {"RECTYPE": "D", "MH": "Giant Cells, Langhans", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Langhans Giant Cells|T025|EPO|EQV|NLM (1990)|890227|abcdef", "ENTRY": "Langhans Type Giant Cells", "MN": "A15.382.680.397.380", "MH_TH": "NLM (1990)", "ST": "T025", "AN": "do not confuse with LANGERHANS CELLS nor with ISLETS OF LANGERHANS ", "PI": "Macrophages (1966-1989)", "MS": "Multinucleated cells (fused macrophages) seen in granulomatous inflammations such as tuberculosis, syphilis, sarcoidosis, and deep fungal infections. They resemble foreign-body giant cells (GIANT CELLS, FOREIGN BODY) but Langhans giant cells contain less chromatin and their nuclei are arranged peripherally in a horseshoe-shaped pattern. Langhans giant cells occur frequently in delayed hypersensitivity.", "PM": "91; was see under GIANT CELLS 1990", "HN": "91(90); was see under GIANT CELLS 1990", "MR": "20180630", "DA": "19890407", "DC": "1", "DX": "19910101", "UI": "D015744"}, {"RECTYPE": "D", "MH": "Granuloma, Foreign-Body", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Foreign-Body Granuloma|T046|NON|EQV|NLM (1990)|890227|abcdef", "ENTRY": "Granulomas, Foreign-Body", "MN": "C26.392.560.325", "MH_TH": "NLM (1990)", "ST": "T046", "PI": "Granuloma (1966-1989)", "MS": "Histiocytic, inflammatory response to a foreign body. It consists of modified macrophages with multinucleated giant cells, in this case foreign-body giant cells (GIANT CELLS, FOREIGN-BODY), usually surrounded by lymphocytes.", "PM": "91; was see under FOREIGN BODY REACTION 1990", "HN": "91(90); was see under FOREIGN BODY REACTION 1990", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19890619", "DC": "1", "DX": "19910101", "UI": "D015745"}, {"RECTYPE": "D", "MH": "Abdominal Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pains, Colicky", "MN": "C23.888.821.030", "FX": "Colic", "MH_TH": "NLM (1990)", "ST": "T184", "AN": "ABDOMEN, ACUTE is also available", "PI": "Pain (1966-1989)", "MS": "Sensation of discomfort, distress, or agony in the abdominal region.", "PM": "1990; for COLICKY PAIN see COLIC 2004-2015", "HN": "1990; for COLICKY PAIN use COLIC 2004-2015", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015746"}, {"RECTYPE": "D", "MH": "Borrelia burgdorferi Group", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Borreliella garinii|T007|NON|NRW|NLM (2021)|190918|abcdef", "MN": "B03.851.595.193.150", "FX": "Lyme Disease", "MH_TH": "NLM (1990)", "ST": "T007", "RN": "txid64895", "RR": "txid29519", "AN": "infection: coord IM with LYME DISEASE or specifics (IM); BORRELIA BURGDORFERI is also available", "PI": "Lyme Disease (1984-1989)", "MS": "Gram-negative helical bacteria, in the genus BORRELIA, that are the etiologic agents of LYME DISEASE. The group comprises many specific species including Borrelia afzelii, Borellia garinii, and BORRELIA BURGDORFERI proper. These spirochetes are generally transmitted by several species of ixodid ticks.", "PM": "2002; see BORRELIA BURGDORFERI 1990-2001", "HN": "2002", "MR": "20200813", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015748"}, {"RECTYPE": "D", "MH": "Genes, gag", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "gag Genes|T028|EQV|NLM (1990)|890302|abdef", "ENTRY": "Gene, gag", "MN": "G05.360.340.358.840.500.258", "MH_TH": "NLM (1990)", "ST": "T028", "AN": "gag stands for \"Group-specific AntiGen\"; coord IM with specific virus /genet (IM)", "PI": "Genes, Viral (1977-1989)", "MS": "DNA sequences that form the coding region for proteins associated with the viral core in retroviruses. gag is short for group-specific antigen.", "OL": "use GENES, VIRAL to search GAG GENE 1987-89", "PM": "90; was GAG GENE see GENES, VIRAL 1987-89", "HN": "90; was GAG GENE see GENES, VIRAL 1987-89", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015750"}, {"RECTYPE": "D", "MH": "Genes, pol", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "pol Genes|T028|EQV|NLM (1990)|890302|abdef", "ENTRY": "Gene, pol", "MN": "G05.360.340.358.840.500.667", "MH_TH": "NLM (1990)", "ST": "T028", "AN": "pol stands for \"POLymerase\"; coord IM with specific virus /genet (IM)", "PI": "Genes, Viral (1977-1989)", "MS": "DNA sequences that form the coding region for retroviral enzymes including reverse transcriptase, protease, and endonuclease/integrase. \"pol\" is short for polymerase, the enzyme class of reverse transcriptase.", "OL": "use GENES, VIRAL to search POL GENE 1987-89", "PM": "90; was POL GENE see GENES, VIRAL 1987-89", "HN": "90; was POL GENE see GENES, VIRAL 1987-89", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890901", "DC": "1", "DX": "19900101", "UI": "D015751"}, {"RECTYPE": "D", "MH": "Genes, env", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "rev-Responsive Element|T028|NRW|NLM (1991)|900423|RRE|abdefv", "ENTRY": "rev-Responsive Elements, HIV", "MN": "G05.360.340.358.840.500.172", "MH_TH": "NLM (1990)", "ST": "T028", "AN": "env stands for \"envelope\"; coord IM with specific virus /genet (IM)", "PI": "Genes, Viral (1977-1989)", "MS": "DNA sequences that form the coding region for the viral envelope (env) proteins in retroviruses. The env genes contain a cis-acting RNA target sequence for the rev protein (= GENE PRODUCTS, REV), termed the rev-responsive element (RRE).", "OL": "use GENES, VIRAL to search ENV GENE 1987-89", "PM": "90; was ENV GENE see GENES, VIRAL 1987-89", "HN": "90; was ENV GENE see GENES, VIRAL 1987-89", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015752"}, {"RECTYPE": "D", "MH": "Genes, nef", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "nef Genes|T028|EQV|NLM (1990)|890302|abdef", "ENTRY": "nef Gene", "MN": "G05.360.340.358.840.500.600", "MH_TH": "NLM (1990)", "ST": "T028", "AN": "nef stands for \"NEgative Factor\"; coord IM with specific HIV /genet (IM)", "PI": "Genes, Viral (1987-1989)", "MS": "DNA sequences that form the coding region for a protein that down-regulates the expression of human immunodeficiency virus (HIV). nef is short for negative factor.", "PM": "91; was see under GENES, VIRAL 1990", "HN": "91(90); was see under GENES, VIRAL 1990", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19910101", "UI": "D015754"}, {"RECTYPE": "D", "MH": "Genes, tat", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "tat Genes|T028|EQV|NLM (1990)|890302|abdef", "ENTRY": "tat Gene", "MN": "G05.360.340.358.840.500.850", "MH_TH": "NLM (1990)", "ST": "T028", "AN": "tat stands for \"Trans-Activation of Transcription\"; coord IM with HIV /genet (IM)", "PI": "Genes, Viral (1988-1989)", "MS": "DNA sequences that form the coding region for the protein responsible for trans-activation of transcription (tat) in human immunodeficiency virus (HIV).", "PM": "91; was see under GENES, VIRAL 1990", "HN": "91(90); was see under GENES, VIRAL 1990", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19910101", "UI": "D015756"}, {"RECTYPE": "D", "MH": "Genes, rev", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "trs-art Genes|T028|EQV|NLM (1990)|890302|abdef", "ENTRY": "trs-art Gene", "MN": "G05.360.340.358.840.500.775", "MH_TH": "NLM (1990)", "ST": "T028", "AN": "rev stands for \"REgulator of Virion\"; coord IM with specific HIV /genet (IM)", "PI": "Genes, Viral (1986-1989)", "MS": "DNA sequences that form the coding region for a protein that regulates the expression of the viral structural and regulatory proteins in human immunodeficiency virus (HIV). rev is short for regulator of virion.", "PM": "91; was see under GENES, VIRAL 1990", "HN": "91(90); was see under GENES, VIRAL 1990", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19910101", "UI": "D015757"}, {"RECTYPE": "D", "MH": "Ionomycin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SQ23377", "MN": "D10.251.355.391", "PA": "Calcium Ionophores", "MH_TH": "NLM (1990)", "ST": "T121", "N1": "Ionomycin", "RN": "56092-81-0", "PI": "Ionophores (1976-1989)", "MS": "A divalent calcium ionophore that is widely used as a tool to investigate the role of intracellular calcium in cellular processes.", "PM": "90", "HN": "90", "MR": "20110624", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015759"}, {"RECTYPE": "D", "MH": "Alfentanil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alfentanyl|T109|T121|NON|EQV|NLM (1990)|890303|abbcdef", "ENTRY": "R39209", "MN": "D03.383.621.265.100", "PA": "Narcotics", "MH_TH": "NLM (1990)", "ST": "T121", "N1": "Propanamide, N-(1-(2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl)-4-(methoxymethyl)-4-piperidinyl)-N-phenyl-", "RN": "1N74HM2BS7", "RR": "71195-58-9 (Alfentanil)", "PI": "Fentanyl/analogs & derivatives (1966-1989)", "MS": "A short-acting opioid anesthetic and analgesic derivative of FENTANYL. It produces an early peak analgesic effect and fast recovery of consciousness. Alfentanil is effective as an anesthetic during surgery, for supplementation of analgesia during surgical procedures, and as an analgesic for critically ill patients.", "PM": "90", "HN": "90", "MR": "20160701", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015760"}, {"RECTYPE": "D", "MH": "4-Aminopyridine", "DS": "AMINOPYRIDINE 04", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "VMI103", "MN": "D03.383.725.050.060", "PA": "Potassium Channel Blockers", "MH_TH": "NLM (1990)", "ST": "T121", "N1": "4-Pyridinamine", "RN": "BH3B64OKL9", "RR": "504-24-5 (4-Aminopyridine)", "PI": "Pyridines (1966-1978)", "MS": "One of the POTASSIUM CHANNEL BLOCKERS with secondary effect on calcium currents which is used mainly as a research tool and to characterize channel subtypes.", "PM": "90", "HN": "90", "MR": "20170524", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015761"}, {"RECTYPE": "D", "MH": "2-Chloroadenosine", "DS": "CHLOROADENOSINE 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "2 Chloroadenosine", "MN": "D13.570.800.096.300", "MH_TH": "NLM (1990)", "ST": "T121", "N1": "Adenosine, 2-chloro-", "RN": "146-77-0", "AN": "an adenosine recept agonist", "PI": "Adenosine (1966-1989)", "MS": "2-Chloroadenosine. A metabolically stable analog of adenosine which acts as an adenosine receptor agonist. The compound has a potent effect on the peripheral and central nervous system.", "PM": "90", "HN": "90", "MR": "20160527", "DA": "19890516", "DC": "1", "DX": "19900101", "UI": "D015762"}, {"RECTYPE": "D", "MH": "2-Amino-5-phosphonovalerate", "DS": "AMINOPHOSPHONOVALERATE 0205", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2-Amino-5-phosphonovaleric Acid|T116|T121|NON|EQV|NLM (1990)|890303|AMINOPHOSPHONOVALERIC ACID 0205|abbcdefs", "ENTRY": "5 Phosphononorvaline", "MN": "D12.125.740.025", "PA": "Excitatory Amino Acid Antagonists", "MH_TH": "NLM (1990)", "ST": "T121", "N1": "Norvaline, 5-phosphono-", "RN": "76726-92-6", "PI": "Valine/analogs & derivatives (1975-1989)", "MS": "The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.", "PM": "90", "HN": "90", "MR": "20070709", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015763"}, {"RECTYPE": "D", "MH": "Bepridil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, alpha-Isomer Bepridil", "MN": "D03.383.773.107", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "1-Pyrrolidineethanamine, beta-((2-methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-", "RN": "755BO701MA", "RR": "89035-90-5 ((+-)-isomer)", "PI": "Pyrrolidines (1966-1989)", "MS": "A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.", "PM": "90", "HN": "90", "MR": "20170524", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015764"}, {"RECTYPE": "D", "MH": "Almitrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Almitrine Bismesylate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1990)|890304|abbcdeef", "ENTRY": "Monomesylate, Almitrine", "MN": "D03.383.931.095", "PA": "Respiratory System Agents", "MH_TH": "NLM (1990)", "ST": "T121", "N1": "1,3,5-Triazine-2,4-diamine, 6-(4-(bis(4-fluorophenyl)methyl)-1-piperazinyl)-N,N'-di-2-propenyl-", "RN": "9A1222NBG4", "RR": "6RY6V6XM8T", "PI": "Piperazines (1966-1989)", "MS": "A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep.", "PM": "90", "HN": "90", "MR": "20170524", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015765"}, {"RECTYPE": "D", "MH": "Albendazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SKF62979", "MN": "D03.633.100.103.070", "PA": "Tubulin Modulators", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Carbamic acid, (5-(propylthio)-1H-benzimidazol-2-yl)-, methyl ester", "RN": "F4216019LN", "RR": "74759-08-3 (mono-HCl)", "PI": "Benzimidazoles (1966-1989)", "MS": "A benzimidazole broad-spectrum anthelmintic structurally related to MEBENDAZOLE that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38)", "PM": "90", "HN": "90", "MR": "20170117", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015766"}, {"RECTYPE": "D", "MH": "Mefloquine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "WR177,602", "MN": "D03.633.100.810.410", "PA": "Antimalarials", "MH_TH": "USAN (1975)", "ST": "T121", "N1": "4-Quinolinemethanol, alpha-2-piperidinyl-2,8-bis(trifluoromethyl)-, (R*,S*)-(+-)-", "RN": "TML814419R", "RR": "5Y9L3636O3", "PI": "Quinolines (1966-1989)", "MS": "A phospholipid-interacting antimalarial drug (ANTIMALARIALS). It is very effective against PLASMODIUM FALCIPARUM with very few side effects.", "PM": "90", "HN": "90", "MR": "20170524", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015767"}, {"RECTYPE": "D", "MH": "Granuloma, Respiratory Tract", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Granuloma, Respiratory System|T046|NON|EQV|NLM (2023)|220712|abcdef", "ENTRY": "Respiratory Tract Granulomas", "MN": "C23.550.382.968", "MH_TH": "NLM (1990)", "ST": "T046", "PI": "Respiratory Tract Diseases (1969-1997)", "MS": "Granulomatous disorders affecting one or more sites in the respiratory tract.", "PM": "98", "HN": "98; use explode 1990-97", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19890407", "DC": "1", "DX": "19980101", "UI": "D015769"}, {"RECTYPE": "D", "MH": "4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine", "DS": "DIHYDROTRIFLUOROMETHYLPHENYLPYRAZOLAMINE 04 05 01 03 01H 03", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "BW 755C", "MN": "D03.383.129.539.180", "PA": "Lipoxygenase Inhibitors", "MH_TH": "NLM (1995)", "ST": "T121", "N1": "1H-Pyrazol-3-amine, 4,5-dihydro-1-(3-(trifluoromethyl)phenyl)-", "RN": "66000-40-6", "PI": "Pyrazoles (1966-1989)", "MS": "A dual inhibitor of both cyclooxygenase and lipoxygenase pathways. It exerts an anti-inflammatory effect by inhibiting the formation of prostaglandins and leukotrienes. The drug also enhances pulmonary hypoxic vasoconstriction and has a protective effect after myocardial ischemia.", "PM": "2005; see BW-775C 1996-2004; see BW 755C 1990; see BW-755C 1990-1995", "HN": "2005(1991)", "MR": "20180630", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015772"}, {"RECTYPE": "D", "MH": "Enalaprilat", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Enalaprilic Acid|T116|T121|NON|REL|NLM (1990)|890404|abbcdef", "ENTRY": "MK422", "MN": "D12.644.456.345.360.300", "PA": "Antihypertensive Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "L-Proline, N-((1S)-1-carboxy-3-phenylpropyl)-L-alanyl-", "RN": "GV0O7ES0R3", "RR": "Q508Q118JM", "PI": "Enalapril (1986-1989)", "MS": "The active metabolite of ENALAPRIL and one of the potent, intravenously administered, ANGIOTENSIN-CONVERTING ENZYME INHIBITORS. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion.", "HN": "1990", "MR": "20180521", "DA": "19890719", "DC": "1", "DX": "19900101", "UI": "D015773"}, {"RECTYPE": "D", "MH": "Ganciclovir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RS-21592|T114|T121|LAB|NRW|NLM (1990)|890509|abbcdef", "MN": "D03.633.100.759.758.399.454.250.300", "PA": "Antiviral Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-", "RN": "P9G3CKZ4P5", "RR": "82410-32-0 (Ganciclovir)", "AN": "do not confuse DHPG, a common abbrev for ganciclovir with DHPG for both 3,4-dihydroxyphenylglycol & 3,4-dihydroxyphenylethylene glycol", "PI": "Guanine/analogs & derivatives (1982-1983)", "MS": "An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.", "PM": "90", "HN": "90", "MR": "20160531", "DA": "19890901", "DC": "1", "DX": "19900101", "UI": "D015774"}, {"RECTYPE": "D", "MH": "Fractures, Stress", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stress Fractures|T037|NON|EQV|NLM (1990)|890308|abcdef", "ENTRY": "Stress Fracture", "MN": "C26.404.437", "MH_TH": "NLM (1990)", "ST": "T037", "AN": "coordinate with specific organ /inj or organ/fracture term; entry term FATIGUE FRACTURES refers to bone fractures: do not use for metal fatigue as in fatigue fractures of amalgams, nails, screw plates, etc. (index STRESS, MECHANICAL)", "PI": "Stress, Mechanical (1971-1989)", "MS": "Fractures due to the strain caused by repetitive exercise. They are thought to arise from a combination of MUSCLE FATIGUE and bone failure, and occur in situations where BONE REMODELING predominates over repair. The most common sites of stress fractures are the METATARSUS; FIBULA; TIBIA; and FEMORAL NECK.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015775"}, {"RECTYPE": "D", "MH": "Keratoderma, Palmoplantar, Diffuse", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Unna-Thost Syndrome|T047|EPO|EQV|NLM (1990)|890309|abcdef", "ENTRY": "Unna Thost Syndrome", "MN": "C17.800.827.475.440", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "do not confuse with KERATODERMA, PALMOPLANTAR", "PI": "Keratosis (1966-1973)", "MS": "An autosomal dominant disorder characterized by a widely distributed, well-demarcated hyperkeratosis of the palms and soles. There is more than one genotypically distinct form, each of which is clinically similar but histologically distinguishable. Diffuse palmoplantar keratoderma is distinct from palmoplantar keratoderma (KERATODERMA, PALMOPLANTAR), as the former exhibits autosomal dominant inheritance and hyperhidrosis is frequently present.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19891019", "DC": "1", "DX": "19900101", "UI": "D015776"}, {"RECTYPE": "D", "MH": "Eicosanoids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Icosanoids|T109|NON|EQV|NLM (2003)|011119|abcdef", "MN": "D23.469.050.175", "FX": "Receptors, Eicosanoid", "MH_TH": "NLM (1990)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Thromboxanes (1978-1989)", "MS": "A class of compounds named after and generally derived from C20 fatty acids (EICOSANOIC ACIDS) that includes PROSTAGLANDINS; LEUKOTRIENES; THROMBOXANES, and HYDROXYEICOSATETRAENOIC ACIDS. They have hormone-like effects mediated by specialized receptors (RECEPTORS, EICOSANOID).", "PM": "90", "HN": "90", "MR": "20200527", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015777"}, {"RECTYPE": "D", "MH": "Minor Histocompatibility Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Minor Histocompatibility Peptides|T129|NON|EQV|NLM (1992)|900904|abcdef", "ENTRY": "Peptide, Minor Histocompatibility", "MN": "D23.050.705.552.600", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "Histocompatibility Antigens (1972-1989)", "MS": "Allelic alloantigens often responsible for weak graft rejection in cases when (major) histocompatibility has been established by standard tests. In the mouse they are coded by more than 500 genes at up to 30 minor histocompatibility loci. The most well-known minor histocompatibility antigen in mammals is the H-Y antigen.", "PM": "90", "HN": "90", "MR": "20200527", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015778"}, {"RECTYPE": "D", "MH": "Carbapenems", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Carbapenem|T195|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Carbapenem Antibiotics", "MN": "D03.633.100.300.124", "MH_TH": "NLM (1990)", "ST": "T195", "RN": "0", "PI": "Antibiotics, Lactam (1983-1989)", "MS": "A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain.", "PM": "90", "HN": "90", "MR": "20200527", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015780"}, {"RECTYPE": "D", "MH": "Aniridia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Irideremia|T019|NON|EQV|GHR (2014)|130418|abcdef", "MN": "C16.320.290.078", "MH_TH": "ORD (2010)", "ST": "T019", "AN": "rudimentary iris; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Iris/abnormalities (1966-1989)", "MS": "A congenital abnormality in which there is only a rudimentary iris. This is due to the failure of the optic cup to grow. Aniridia also occurs in a hereditary form, usually autosomal dominant.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015783"}, {"RECTYPE": "D", "MH": "Betaxolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SL75212", "MN": "D02.092.063.624.698.077", "PA": "Sympatholytics", "MH_TH": "NLM (1990)", "ST": "T121", "N1": "2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-", "RN": "O0ZR1R6RZ2", "RR": "6X97D2XT0O", "PI": "Propanolamines (1974-1989)", "MS": "A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.", "PM": "90", "HN": "90", "MR": "20160701", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015784"}, {"RECTYPE": "D", "MH": "Eye Diseases, Hereditary", "DE": "EYE DIS HEREDITARY", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hereditary Eye Disease", "MN": "C16.320.290", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Eye Diseases/genetics (1966-1989)", "MS": "Transmission of gene defects or chromosomal aberrations/abnormalities which are expressed in extreme variation in the structure or function of the eye. These may be evident at birth, but may be manifested later with progression of the disorder.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015785"}, {"RECTYPE": "D", "MH": "Cytochromes b5", "DS": "CYTOCHROMES B 05", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cytochrome b 5", "MN": "D12.776.422.220.187.500", "MH_TH": "NLM (2004)", "ST": "T126", "N1": "Cytochrome b5", "RN": "9035-39-6", "AN": "spell in titles & translations with lowercase b: cytochrome b5", "PI": "Cytochromes (1966-1982)", "MS": "Cytochromes of the b group that are found bound to cytoplasmic side of ENDOPLASMIC RETICULUM. They serve as electron carrier proteins for a variety of membrane-bound OXYGENASES. They are reduced by the enzyme CYTOCHROME-B(5) REDUCTASE.", "PM": "2004; see CYTOCHROME B5 1990-2003; APOCYTOCHROME B5 was indexed under CYTOCROME B & APOPROTEINS 1983-2003, under CYTOCHROMES 1979-1982", "HN": "2004(1990); for APOCYTOCHROME B5 use CYTOCHROMES B (NM) 1980-2003", "MR": "20040719", "DA": "19890714", "DC": "1", "DX": "19900101", "UI": "D015786"}, {"RECTYPE": "D", "MH": "Erythema Chronicum Migrans", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Erythema Migrans of Lyme Disease|T033|T047|NON|EQV|NLM (2023)|210831|abbcdef", "MN": "C17.800.838.765.310", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "from a tick bite; \"stage-1 manifestation of LYME DISEASE\"", "PI": "Ticks (1983-1989)", "MS": "A deep type of gyrate erythema that follows a bite by an ixodid tick; it is a stage-1 manifestation of LYME DISEASE. The site of the bite is characterized by a red papule that expands peripherally as a nonscaling, palpable band that clears centrally. This condition is often associated with systemic symptoms such as chills, fever, headache, malaise, nausea, vomiting, fatigue, backache, and stiff neck.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015787"}, {"RECTYPE": "D", "MH": "HLA-A1 Antigen", "DS": "HLA A 001 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, A 1 alpha Chain", "MN": "D23.050.705.552.450.370.372", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "HLA-A Antigens (1989)", "MS": "A specific HLA-A surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-A*01 allele family.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015788"}, {"RECTYPE": "D", "MH": "HLA-A2 Antigen", "DS": "HLA A 002 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, A 2 alpha Chain", "MN": "D23.050.705.552.450.370.374", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "HLA-A Antigens (1989)", "MS": "A specific HLA-A surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-A*02 allele family.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015789"}, {"RECTYPE": "D", "MH": "Cefonicid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SKF750732", "MN": "D03.633.100.300.249.177", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1990)", "ST": "T195", "N1": "5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-(sulfomethyl)-1H-tetrazol-5-yl)thio)methyl)-, (6R-(6alpha,7beta(R*)))-", "RN": "6532B86WFG", "RR": "QD9G66C5UF", "PI": "Cephalosporins (1966-1977)", "MS": "A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections.", "PM": "90", "HN": "90", "MR": "20160528", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015790"}, {"RECTYPE": "D", "MH": "HLA-A3 Antigen", "DS": "HLA A 003 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA A3 Antigen", "MN": "D23.050.705.552.450.370.376", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "HLA-A Antigens (1989)", "MS": "A specific HLA-A surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-A*03 allele family.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015791"}, {"RECTYPE": "D", "MH": "Retinal Dysplasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Retinal Dysplasias", "MN": "C16.320.290.660", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Retinal Degeneration (1970-1989)", "MS": "Congenital, often bilateral, retinal abnormality characterized by the arrangement of outer nuclear retinal cells in a palisading or radiating pattern surrounding a central ocular space. This disorder is sometimes hereditary.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015792"}, {"RECTYPE": "D", "MH": "HLA-B7 Antigen", "DS": "HLA B 007 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, B 7 alpha Chain", "MN": "D23.050.705.552.450.380.070", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "HLA-B Antigens (1989)", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*07 allele family.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015793"}, {"RECTYPE": "D", "MH": "Choroideremia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tapetochoroidal Dystrophies, Progressive", "MN": "C16.320.322.092", "FX": "Night Blindness", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "of the eye, not of the choroid plexus: progressive degen in male, nonprogressive in female", "PI": "Uveal Diseases/genetics (1977-1989)", "MS": "An X chromosome-linked abnormality characterized by atrophy of the choroid and degeneration of the retinal pigment epithelium causing night blindness.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015794"}, {"RECTYPE": "D", "MH": "HLA-B8 Antigen", "DS": "HLA B 008 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, B 8 alpha Chain", "MN": "D23.050.705.552.450.380.080", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "HLA-B Antigens (1989)", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*08 allele family.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015795"}, {"RECTYPE": "D", "MH": "HLA-B27 Antigen", "DS": "HLA B 027 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, B 27 alpha Chain", "MN": "D23.050.705.552.450.380.270", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "HLA-B Antigens (1989)", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*27 allele family.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015796"}, {"RECTYPE": "D", "MH": "HLA-B35 Antigen", "DS": "HLA B 035 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, B 35 alpha Chain", "MN": "D23.050.705.552.450.380.350", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "HLA-B Antigens (1989)", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*35 allele family.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015797"}, {"RECTYPE": "D", "MH": "HLA-DR1 Antigen", "DS": "HLA DR 01 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA DR1 Antigen", "MN": "D23.050.705.552.450.400.440.389.500", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "Histocompatibility Antigens Class II (1981-1986)", "MS": "An HLA-DR antigen associated with HLA-DRB1 CHAINS that are encoded by DRB1*01 alleles.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015798"}, {"RECTYPE": "D", "MH": "Gyrate Atrophy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ornithine Delta Aminotransferase Deficiency", "MN": "C16.320.290.468", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a hered eye dis; /congen permitted: read MeSH definition", "PI": "Retinal Degeneration (1970-1989)", "MS": "Progressive, autosomal recessive, diffuse atrophy of the choroid, pigment epithelium, and sensory retina that begins in childhood.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015799"}, {"RECTYPE": "D", "MH": "Protozoan Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Protozoan", "MN": "D12.776.820", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "/drug eff /ultrastruct permitted; /physiol permitted for function within the protozoon; coord IM with specific protein (IM) + specific protozoon (IM)", "PI": "Proteins (1966-1989)", "MS": "Proteins found in any species of protozoan.", "PM": "90", "HN": "90", "MR": "20050630", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015800"}, {"RECTYPE": "D", "MH": "Helminth Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Helminth Protein|T116|T123|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Proteins, Helminth", "MN": "D12.776.419", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "/drug eff /ultrastruct permitted; /physiol permitted for function within the helminth; coord IM with specific protein (IM) + specific helminth (IM)", "PI": "specific helminth (1966-1989)", "MS": "Proteins found in any species of helminth.", "PM": "90", "HN": "90", "MR": "20200527", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015801"}, {"RECTYPE": "D", "MH": "HLA-DR2 Antigen", "DS": "HLA DR 02 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA DR2 Antigen", "MN": "D23.050.705.552.450.400.440.389.750", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "Histocompatibility Antigens Class II (1980-1986)", "MS": "A broad specificity HLA-DR antigen that is associated with HLA-DRB1 CHAINS encoded by DRB1*01:15 and DRB1*01:16 alleles.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015802"}, {"RECTYPE": "D", "MH": "HLA-DR3 Antigen", "DS": "HLA DR 03 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA DR3 Antigen", "MN": "D23.050.705.552.450.400.440.389.875", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "Histocompatibility Antigens Class II (1980-1986)", "MS": "An HLA-DR antigen which is associated with HLA-DRB1 CHAINS encoded by DRB1*03 alleles.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015803"}, {"RECTYPE": "D", "MH": "HLA-DR4 Antigen", "DS": "HLA DR 04 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA DR4 Antigen", "MN": "D23.050.705.552.450.400.440.389.937", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "Histocompatibility Antigens Class II (1981-1986)", "MS": "An HLA-DR antigen which is associated with HLA-DRB1 CHAINS encoded by DRB1*04 alleles.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015804"}, {"RECTYPE": "D", "MH": "HLA-DR5 Antigen", "DS": "HLA DR 05 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA DR5 Antigen", "MN": "D23.050.705.552.450.400.440.389.968", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "Histocompatibility Antigens Class II (1980-1986)", "MS": "A broad-specificity HLA-DR antigen that is associated with HLA-DRB1 CHAINS encoded by DRB1*11 and DRB1*12 alleles.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015805"}, {"RECTYPE": "D", "MH": "Azospirillum brasilense", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Spirillum lipoferum|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.050.755.750.100.020", "MH_TH": "NLM (1990)", "ST": "T007", "RN": "txid192", "PI": "Spirillum (1978-1989)", "MS": "A species of motile, free-living, gram-negative bacteria that occur in the soil. They are aerobic or microaerophilic and are sometimes capable of nitrogen fixation.", "PM": "90", "HN": "90", "MR": "20200128", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015806"}, {"RECTYPE": "D", "MH": "Eye Injuries, Penetrating", "DE": "EYE INJ PENETRATING", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Penetrating Eye Injury", "MN": "C26.986.450", "MH_TH": "NLM (1990)", "ST": "T037", "PI": "Wounds, Penetrating (1974-1989)", "MS": "Deeply perforating or puncturing type intraocular injuries.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015807"}, {"RECTYPE": "D", "MH": "HLA-DR6 Antigen", "DS": "HLA DR 06 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA DR6 Antigen", "MN": "D23.050.705.552.450.400.440.389.984", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "Histocompatibility Antigens Class II (1981-1986)", "MS": "A broad-specificity HLA-DR antigen that is associated with HLA-DRB1 CHAINS encoded by DRB1*13 and DRB1*14 alleles.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015808"}, {"RECTYPE": "D", "MH": "HLA-DR7 Antigen", "DS": "HLA DR 07 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA DR7 Antigen", "MN": "D23.050.705.552.450.400.440.389.992", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "Histocompatibility Antigens Class II (1981-1986)", "MS": "A HLA-DR antigen that is associated with HLA-DRB1 CHAINS encoded by DRB1*07 alleles.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015809"}, {"RECTYPE": "D", "MH": "Linkage Disequilibrium", "AQ": "ES GE IM PH", "ENTRY": "Linkage Disequilibriums", "MN": "G05.348.500", "MH_TH": "NLM (1990)", "ST": "T081", "PI": "Linkage (1966-1989)", "MS": "Nonrandom association of linked genes. This is the tendency of the alleles of two separate but already linked loci to be found together more frequently than would be expected by chance alone.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015810"}, {"RECTYPE": "D", "MH": "Iris Neoplasms", "DE": "IRIS NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasm, Iris", "MN": "C11.941.855.400", "MH_TH": "NLM (1990)", "ST": "T191", "AN": "coordinate with histological type of neoplasm", "PI": "Melanoma (1968-1989)", "MS": "Tumors of the iris characterized by increased pigmentation of melanocytes. Iris nevi are composed of proliferated melanocytes and are associated with neurofibromatosis and malignant melanoma of the choroid and ciliary body. Malignant melanoma of the iris often originates from preexisting nevi.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015811"}, {"RECTYPE": "D", "MH": "Glaucoma, Angle-Closure", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Glaucoma, Closed-Angle|T047|NON|EQV|NLM (1990)|890316|abcdef", "ENTRY": "Uncompensative Glaucomas", "MN": "C11.525.381.056", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "do not confuse with GLAUCOMA, OPEN-ANGLE: note X ref", "PI": "Glaucoma (1966-1989)", "MS": "A form of glaucoma in which the intraocular pressure increases because the angle of the anterior chamber is blocked and the aqueous humor cannot drain from the anterior chamber.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19900529", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015812"}, {"RECTYPE": "D", "MH": "Substance Abuse Detection", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Substance Abuse Testing|T059|NON|EQV|NLM (1990)|890316|abcdef", "ENTRY": "Testings, Substance Abuse", "MN": "N06.850.780.500.765", "FX": "Enzyme Multiplied Immunoassay Technique", "MH_TH": "NLM (1990)", "ST": "T059", "AN": "coord IM with precoord substance abuse term (IM) or substance abused (IM)", "PI": "Substance Abuse (1968-1989)", "MS": "Detection of drugs that have been abused, overused, or misused, including legal and illegal drugs. Urine screening is the usual method of detection.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890516", "DC": "1", "DX": "19900101", "UI": "D015813"}, {"RECTYPE": "D", "MH": "Ocular Hypotension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ocular Hypotony|T047|T184|NON|EQV|NLM (1990)|890316|abbcdef", "ENTRY": "Hypotony, Ocular", "MN": "C11.540", "MH_TH": "NLM (1990)", "ST": "T184", "AN": "\"abnormally low intraocular pressure\": do not confuse with OCULAR HYPERTENSION", "PI": "Intraocular Pressure (1966-1989)", "MS": "Abnormally low intraocular pressure often related to chronic inflammation (uveitis).", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19930809", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015814"}, {"RECTYPE": "D", "MH": "Cell Adhesion Molecules", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Saccharide-Mediated Cell Adhesion Molecules|T116|T123|NON|NRW|NLM (1990)|890316|SAC CAMS|abbcdefv", "ENTRY": "Molecules, Leukocyte Adhesion", "MN": "D23.050.301.350", "FX": "Integrins", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Membrane Glycoproteins (1988-1989)", "MS": "Surface ligands, usually glycoproteins, that mediate cell-to-cell adhesion. Their functions include the assembly and interconnection of various vertebrate systems, as well as maintenance of tissue integration, wound healing, morphogenic movements, cellular migrations, and metastasis.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015815"}, {"RECTYPE": "D", "MH": "Cell Adhesion Molecules, Neuronal", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neuronal Cell Adhesion Molecules|T116|T123|NON|EQV|NLM (1990)|890316|abbcdef", "ENTRY": "Molecules, Axon-Associated Adhesion", "MN": "D23.050.301.350.250", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "do not confuse with CELL ADHESION MOLECULES, NEURON-GLIA; do not confuse entry term NEURONAL CELL ADHESION MOLECULES with NCAM for entry term NEURAL CELL ADHESION MOLECULE", "PI": "Membrane Glycoproteins (1988-1989)", "MS": "Surface ligands that mediate cell-to-cell adhesion and function in the assembly and interconnection of the vertebrate nervous system. These molecules promote cell adhesion via a homophilic mechanism. These are not to be confused with NEURAL CELL ADHESION MOLECULES, now known to be expressed in a variety of tissues and cell types in addition to nervous tissue.", "PM": "90", "HN": "90", "MR": "20230316", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015816"}, {"RECTYPE": "D", "MH": "Eye Infections", "DE": "EYE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Ocular Infections|T047|NON|EQV|NLM (1990)|890417|OCULAR INFECT|abcdefv", "ENTRY": "Ocular Infection", "MN": "C11.294", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "coordinate with specific infection", "PI": "Eye Diseases (1966-1989)", "MS": "Infection, moderate to severe, caused by bacteria, fungi, or viruses, which occurs either on the external surface of the eye or intraocularly with probable inflammation, visual impairment, or blindness.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015817"}, {"RECTYPE": "D", "MH": "Eye Infections, Bacterial", "DE": "EYE INFECT BACT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Ocular Infections, Bacterial|T047|NON|EQV|NLM (1990)|890417|OCULAR INFECT BACT|abcdefv", "ENTRY": "Ocular Infection, Bacterial", "MN": "C11.294.354", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "coordinate with specific bacterial disease", "PI": "specific bacterial infection (1966-1989)", "MS": "Infections in the inner or external eye caused by microorganisms belonging to several families of bacteria. Some of the more common genera found are Haemophilus, Neisseria, Staphylococcus, Streptococcus, and Chlamydia.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015818"}, {"RECTYPE": "D", "MH": "Substance Abuse, Intravenous", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Intravenous Drug Abuse|T048|T055|NON|NRW|NLM (1992)|901010|IVDA|abbcdefv", "ENTRY": "Parenteral Drug Abuse", "MN": "F03.900.793", "FX": "Needle-Exchange Programs", "MH_TH": "NLM (1990)", "ST": "T055", "AN": "IM + specific drug or substance IM (without qualif); for \"abuse, overuse or misuse\"", "PI": "Substance Abuse (1966-1989)", "MS": "Abuse, overuse, or misuse of a substance by its injection into a vein.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19890620", "DC": "1", "DX": "19900101", "UI": "D015819"}, {"RECTYPE": "D", "MH": "Cadherins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Uvomorulin|T116|T123|NON|NRW|NLM (1990)|890316|abbcdef", "ENTRY": "P Cadherins", "MN": "D23.050.301.350.200", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Membrane Glycoproteins (1988-1989)", "MS": "Calcium-dependent cell adhesion proteins. They are important in the formation of ADHERENS JUNCTIONS between cells. Cadherins are classified by their distinct immunological and tissue specificities, either by letters (E- for epithelial, N- for neural, and P- for placental cadherins) or by numbers (cadherin-12 or N-cadherin 2 for brain-cadherin). Cadherins promote cell adhesion via a homophilic mechanism as in the construction of tissues and of the whole animal body.", "OL": "use CADHERINS (NM) to search N CADHERIN 1994-95; use CELL ADHESION MOLECULES to search LIVER CELL ADHESION MOLECULES 1990-95", "PM": "90; N CADHERIN was indexed under CADHERINS 1994-95; LIVER CELL ADHESION MOLECULES was see CELL ADHESION MOLECULES 1990-95", "HN": "90; N CADHERIN was NM 1994-95; LIVER CELL ADHESION MOLECULES was see CELL ADHESION MOLECULES 1990-95", "MR": "20230316", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015820"}, {"RECTYPE": "D", "MH": "Eye Infections, Fungal", "DE": "EYE INFECT FUNGAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Oculomycosis|T047|NON|EQV|NLM (1990)|890417|abcdef", "ENTRY": "Oculomycoses", "MN": "C11.294.450", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "coordinate with specific fungal disease ", "PI": "specific fungal infection (1966-1989)", "MS": "Infection by a variety of fungi, usually through four possible mechanisms: superficial infection producing conjunctivitis, keratitis, or lacrimal obstruction; extension of infection from neighboring structures - skin, paranasal sinuses, nasopharynx; direct introduction during surgery or accidental penetrating trauma; or via the blood or lymphatic routes in patients with underlying mycoses.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190618", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015821"}, {"RECTYPE": "D", "MH": "Eye Infections, Parasitic", "DE": "EYE INFECT PARASITIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Parasitic Eye Infections|T047|NON|EQV|NLM (1990)|890519|PARASITIC EYE INFECT|abcdefv", "ENTRY": "Parasitic Ocular Infections", "MN": "C11.294.725", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "coord IM with specific parasitic dis (IM)", "PI": "specific parasitic infection (1966-1989)", "MS": "Mild to severe infections of the eye and its adjacent structures (adnexa) by adult or larval protozoan or metazoan parasites.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190529", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015822"}, {"RECTYPE": "D", "MH": "Acanthamoeba Keratitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Keratitis, Acanthamoeba|T047|NON|EQV|NLM (1990)|890418|abcdef", "ENTRY": "Keratitides, Acanthamoeba", "MN": "C11.294.725.125", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "note category: a corneal dis: do not confuse with KERATOACANTHOMA, a skin dis", "PI": "Keratitis (1975-1989)", "MS": "Infection of the cornea by an ameboid protozoan which may cause corneal ulceration leading to blindness.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015823"}, {"RECTYPE": "D", "MH": "Blood-Air Barrier", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Alveolocapillary Membrane|T030|NON|EQV|NLM (1990)|890317|abcdef", "ENTRY": "Membranes, Alveolocapillary", "MN": "A07.020", "FX": "Pulmonary Gas Exchange", "MH_TH": "NLM (1990)", "ST": "T030", "AN": "coord IM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM)", "PI": "Pulmonary Alveoli (1969-1989)", "MS": "The barrier between capillary blood and alveolar air comprising the alveolar EPITHELIUM and capillary ENDOTHELIUM with their adherent BASEMENT MEMBRANE and EPITHELIAL CELL cytoplasm. PULMONARY GAS EXCHANGE occurs across this membrane.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015824"}, {"RECTYPE": "D", "MH": "Chromosomes, Fungal", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "ENTRY": "Fungal Chromosomes", "MN": "G05.360.162.360", "MH_TH": "NLM (1990)", "ST": "T026", "PI": "Genes, Fungal (1984-1989)", "MS": "Structures within the nucleus of fungal cells consisting of or containing DNA, which carry genetic information essential to the cell.", "PM": "90", "HN": "90", "MR": "20090706", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015825"}, {"RECTYPE": "D", "MH": "Langer-Giedion Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Trichorhinophalangeal Syndrome Type II|T047|NON|EQV|GHR (2014)|NLM (1990)|890320|abcdeef", "ENTRY": "Tricho Rhino Phalangeal Syndrome Type II", "MN": "C05.116.099.708.582", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "an osteochondrodysplasia", "PI": "Exostoses, Multiple (1972-1989)", "MS": "Autosomal dominant disorder characterized by cone-shaped epiphyses in the hands and multiple cartilaginous exostoses. INTELLECTUAL DISABILITY and abnormalities of chromosome 8 are often present. The exostoses in this syndrome appear identical to those of hereditary multiple exostoses (EXOSTOSES, HEREDITARY MULTIPLE).", "OL": "use EXOSTOSES, MULTIPLE to search GIEDION-LANGER SYNDROME 1968-89", "PM": "90; was GIEDION-LANGER SYNDROME see EXOSTOSES, MULTIPLE 1968-89", "HN": "90; was GIEDION-LANGER SYNDROME see EXOSTOSES, MULTIPLE 1968-89", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015826"}, {"RECTYPE": "D", "MH": "Onchocerciasis, Ocular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "River Blindness|T047|NON|EQV|NLM (1990)|890321|abcdef", "ENTRY": "Onchocerciases, Ocular", "MN": "C11.294.725.562", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "PI": "Onchocerciasis (1966-1989)", "MS": "Filarial infection of the eyes transmitted from person to person by bites of Onchocerca volvulus-infected black flies. The microfilariae of Onchocerca are thus deposited beneath the skin. They migrate through various tissues including the eye. Those persons infected have impaired vision and up to 20% are blind. The incidence of eye lesions has been reported to be as high as 30% in Central America and parts of Africa.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015827"}, {"RECTYPE": "D", "MH": "Eye Infections, Viral", "DE": "EYE INFECT VIRAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Viral Eye Infections|T047|NON|EQV|NLM (1990)|890519|VIRAL EYE INFECT|abcdefv", "ENTRY": "Viral Ocular Infections", "MN": "C11.294.800", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "coordinate with specific viral disease", "PI": "specific viral infection (1966-1989)", "MS": "Infections of the eye caused by minute intracellular agents. These infections may lead to severe inflammation in various parts of the eye - conjunctiva, iris, eyelids, etc. Several viruses have been identified as the causative agents. Among these are Herpesvirus, Adenovirus, Poxvirus, and Myxovirus.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015828"}, {"RECTYPE": "D", "MH": "Uveitis, Suppurative", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Uveitides, Suppurative", "MN": "C11.941.879.960", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "coordinate IM with specific bacterial or fungal infect (IM)", "PI": "Uveitis (1966-1989)", "MS": "Intraocular infection caused mainly by pus-producing bacteria and rarely by fungi. The infection may be caused by an injury or surgical wound (exogenous) or by endogenous septic emboli in such diseases as bacterial endocarditis or meningococcemia.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015829"}, {"RECTYPE": "D", "MH": "Osteochondroma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Exostosis, Osteocartilaginous|T191|NON|EQV|NLM (1990)|890321|abcdef", "ENTRY": "Osteochondromas", "MN": "C05.116.099.708.670", "MH_TH": "NLM (1990)", "ST": "T191", "AN": "solitary; note OSTEOCHONDROMAS, MULTIPLE see EXOSTOSES, MULTIPLE HEREDITARY is available; coordinate with BONE NEOPLASMS or specific precoordinated bone/neoplasm term or specific bone + BONE NEOPLASMS ", "PI": "Chondroma (1966-1989)", "MS": "A cartilage-capped benign tumor that often appears as a stalk on the surface of bone. It is probably a developmental malformation rather than a true neoplasm and is usually found in the metaphysis of the distal femur, proximal tibia, or proximal humerus. Osteochondroma is the most common of benign bone tumors.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015831"}, {"RECTYPE": "D", "MH": "Cochlear Diseases", "DE": "COCHLEAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Cochlear", "MN": "C09.218.568.120", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Labyrinth Diseases (1966-1989)", "MS": "Pathological processes of the snail-like structure (COCHLEA) of the inner ear (LABYRINTH) which can involve its nervous tissue, blood vessels, or fluid (ENDOLYMPH).", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015834"}, {"RECTYPE": "D", "MH": "Ocular Motility Disorders", "DE": "OCULAR MOTILITY DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Smooth Pursuit Deficiency|T184|NON|NRW|NLM (2000)|991104|SMOOTH PURSUIT DEFIC|abcdefv", "ENTRY": "Syndrome, Parinaud's", "MN": "C11.590", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "specific eye disease (1966-1989)", "MS": "Disorders that feature impairment of eye movements as a primary manifestation of disease. These conditions may be divided into infranuclear, nuclear, and supranuclear disorders. Diseases of the eye muscles or oculomotor cranial nerves (III, IV, and VI) are considered infranuclear. Nuclear disorders are caused by disease of the oculomotor, trochlear, or abducens nuclei in the BRAIN STEM. Supranuclear disorders are produced by dysfunction of higher order sensory and motor systems that control eye movements, including neural networks in the CEREBRAL CORTEX; BASAL GANGLIA; CEREBELLUM; and BRAIN STEM. Ocular torticollis refers to a head tilt that is caused by an ocular misalignment. Opsoclonus refers to rapid, conjugate oscillations of the eyes in multiple directions, which may occur as a parainfectious or paraneoplastic condition (e.g., OPSOCLONUS-MYOCLONUS SYNDROME). (Adams et al., Principles of Neurology, 6th ed, p240)", "PM": "1990", "HN": "1990", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015835"}, {"RECTYPE": "D", "MH": "Vestibular Diseases", "DE": "VESTIBULAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vestibular Disease", "MN": "C09.218.568.900", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Labyrinth Diseases (1966-1989)", "MS": "Pathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19890516", "DC": "1", "DX": "19900101", "UI": "D015837"}, {"RECTYPE": "D", "MH": "Chondromatosis, Synovial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Synovial Osteochondromatosis|T047|NON|REL|NLM (1990)|890502|abcdef", "ENTRY": "Synovial Osteochondromatoses", "MN": "C05.550.287", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "non-neoplastic progressive joint metaplasia", "PI": "Chondroma (1966-1989)", "MS": "Rare, benign, chronic, progressive metaplasia in which cartilage is formed in the synovial membranes of joints, tendon sheaths, or bursae. Some of the metaplastic foci can become detached producing loose bodies. When the loose bodies undergo secondary calcification, the condition is called synovial osteochondromatosis.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19930524", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015838"}, {"RECTYPE": "D", "MH": "Oculomotor Nerve Diseases", "DE": "OCULOMOTOR NERVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Third-Nerve Palsy|T047|NON|EQV|NLM (1990)|890322|abcdef", "ENTRY": "Total Third-Nerve Palsies", "MN": "C11.590.436", "FX": "Ophthalmoplegia", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "do not confuse entry term OCULOMOTOR NERVE PALSY with oculomotor palsies caused by weakened 4th or 6th cranial nerves which are indexed: 4th= TROCHLEAR NERVE DISEASES and 6th= ABDUCENS NERVE DISEASES, if not specified use CRANIAL NERVE DISEASES; neoplasms: coordinate with CRANIAL NERVE NEOPLASMS + histologic type of neoplasm; do not confuse with OCULOMOTOR PARALYSIS see OPHTHALMOPLEGIA", "PI": "Ophthalmoplegia (1966-1989)", "MS": "Diseases of the oculomotor nerve or nucleus that result in weakness or paralysis of the superior rectus, inferior rectus, medial rectus, inferior oblique, or levator palpebrae muscles, or impaired parasympathetic innervation to the pupil. With a complete oculomotor palsy, the eyelid will be paralyzed, the eye will be in an abducted and inferior position, and the pupil will be markedly dilated. Commonly associated conditions include neoplasms, CRANIOCEREBRAL TRAUMA, ischemia (especially in association with DIABETES MELLITUS), and aneurysmal compression. (From Adams et al., Principles of Neurology, 6th ed, p270)", "PM": "2000; see OCULOMOTOR NERVE PARALYSIS 1990-1999", "HN": "2000(1990)", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015840"}, {"RECTYPE": "D", "MH": "Enophthalmos", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C11.675.319", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "recession of eye into orbit: do not confuse with EXOPHTHALMOS, protrusion", "PI": "Orbit (1966-1989)", "MS": "Recession of the eyeball into the orbit.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19930527", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015841"}, {"RECTYPE": "D", "MH": "Serine Proteinase Inhibitors", "DE": "SERINE PROTEINASE INHIB", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Serine Proteinase Inhibitors, Exogenous|T121|T123|NON|NRW|NLM (1990)|890426|SERINE PROTEINASE INHIB EXOGENOUS|abbcdefv", "ENTRY": "Proteinase Inhibitor, Serine", "MN": "D27.505.519.389.745.800", "FX": "Serpins", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Protease Inhibitors (1979-1989)", "MS": "Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES.", "PM": "90", "HN": "90", "MR": "20200527", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015842"}, {"RECTYPE": "D", "MH": "Serpins", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serpin Superfamily|T116|T121|T123|NON|BRD|NLM (1990)|890322|abbbcdef", "ENTRY": "Superfamily, Serpin", "MN": "D27.505.519.389.745.800.675", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Protease Inhibitors (1979-1989)", "MS": "A family of serine proteinase inhibitors which are similar in amino acid sequence and mechanism of inhibition but differ in their specificity toward proteolytic enzymes. Some members of the serpin family may be substrates rather than inhibitors of SERINE ENDOPEPTIDASES.", "PM": "90", "HN": "90", "MR": "20210630", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015843"}, {"RECTYPE": "D", "MH": "Heparin Cofactor II", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Heparin Co Factor II", "MN": "D12.776.872.060.750", "PA": "Serine Proteinase Inhibitors", "MH_TH": "NLM (1990)", "ST": "T129", "N1": "Heparin cofactor II", "RN": "81604-65-1", "PI": "Glycoproteins (1966-1989)", "MS": "A sulfated plasma protein with a MW of approximately 66kDa that resembles ANTITHROMBIN III. The protein is an inhibitor of thrombin in plasma and is activated by dermatan sulfate or heparin. It is a member of the serpin superfamily.", "PM": "90", "HN": "90", "MR": "20150622", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015844"}, {"RECTYPE": "D", "MH": "Tonic Pupil", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pupil, Tonic|T033|NON|EQV|NLM (1990)|890519|abcdef", "ENTRY": "Tonic Pupils, Neuropathic", "MN": "C23.888.592.708.575", "MH_TH": "NLM (1990)", "ST": "T033", "PI": "Pupil (1967-1989)", "MS": "A pupillary abnormality characterized by a poor pupillary light reaction, reduced accommodation, iris sector palsies, an enhanced pupillary response to near effort that results in a prolonged, \"tonic\" constriction, and slow pupillary redilation. This condition is associated with injury to the postganglionic parasympathetic innervation to the pupil. (From Miller et al., Clinical Neuro-Ophthalmology, 4th ed, pp492-500)", "PM": "1990", "HN": "1990", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015845"}, {"RECTYPE": "D", "MH": "Monokines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D23.529.374.500", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "AN": "/biosyn /drug eff /physiol /ultrastruct permitted", "PI": "Proteins (1981-1987)", "MS": "Soluble mediators of the immune response that are neither antibodies nor complement. They are produced largely, but not exclusively, by monocytes and macrophages.", "PM": "90", "HN": "90", "MR": "20060705", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015846"}, {"RECTYPE": "D", "MH": "Interleukin-4", "DS": "INTERLEUKIN 004", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mast Cell Growth Factor-2|T116|T129|NON|EQV|NLM (1990)|890323|abbcdef", "ENTRY": "Mast Cell Growth Factor 2", "MN": "D23.529.374.465.186", "PA": "Antirheumatic Agents", "FX": "Histocompatibility Antigens Class II", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "207137-56-2", "PI": "Lymphokines (1974-1987)", "MS": "A soluble factor produced by activated T-LYMPHOCYTES that induces the expression of MHC CLASS II GENES and FC RECEPTORS on B-LYMPHOCYTES and causes their proliferation and differentiation. It also acts on T-lymphocytes, MAST CELLS, and several other hematopoietic lineage cells.", "OL": "use INTERLEUKIN-4 to search B-CELL GROWTH FACTOR 1990-96", "PM": "90; B-CELL GROWTH FACTOR was see INTERLEUKIN-4 1990-96", "HN": "90; B-CELL GROWTH FACTOR was see INTERLEUKIN-4 1990-96", "MR": "20150415", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015847"}, {"RECTYPE": "D", "MH": "Interleukin-5", "DS": "INTERLEUKIN 005", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "T-Cell Replacing Factor|T116|T129|EQV|NLM (1990)|890323|abbdef", "ENTRY": "T Cell Replacing Factor", "MN": "D23.529.374.465.202", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "Lymphokines (1977-1987)", "MS": "A cytokine that promotes differentiation and activation of EOSINOPHILS. It also triggers activated B-LYMPHOCYTES to differentiate into IMMUNOGLOBULIN-secreting cells.", "PM": "90", "HN": "90", "MR": "20150415", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015848"}, {"RECTYPE": "D", "MH": "Plasminogen Inactivators", "DE": "PLASMINOGEN INACT", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Plasminogen Activator Inhibitors|T116|T123|NON|EQV|NLM (1990)|890512|PLASMINOGEN ACTIVATOR INHIB|abbcdefv", "ENTRY": "Inhibitors, Plasminogen Activator", "MN": "D23.119.832", "PA": "Serine Proteinase Inhibitors", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Plasminogen Activators/antagonists & inhibitors (1976-1989)", "MS": "Important modulators of the activity of plasminogen activators. The inhibitors belong to the serpin family of proteins and inhibit both the tissue-type and urokinase-type plasminogen activators.", "PM": "90", "HN": "90", "MR": "20200527", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015849"}, {"RECTYPE": "D", "MH": "Interleukin-6", "DS": "INTERLEUKIN 006", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Plasmacytoma Growth Factor|T116|T129|NON|EQV|NLM (1990)|890323|abbcdef", "ENTRY": "beta-2, Interferon", "MN": "D23.529.374.465.224", "FX": "Plasmacytoma", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "Lymphokines (1987)", "MS": "A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS.", "PM": "90", "HN": "90", "MR": "20160418", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015850"}, {"RECTYPE": "D", "MH": "Interleukin-7", "DS": "INTERLEUKIN 007", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "IL-7|T116|T129|ABB|EQV|NLM (1990)|890525|IL 007|abbcdefs", "ENTRY": "Lymphopoietin 1", "MN": "D23.529.374.465.246", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "Interleukins (1988-1989)", "MS": "A cytokine produced by bone marrow stromal cells that promotes the growth of B-LYMPHOCYTE precursors and is co-mitogenic with INTERLEUKIN-2 for mature T-LYMPHOCYTE activation.", "PM": "90", "HN": "90", "MR": "20150415", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015851"}, {"RECTYPE": "D", "MH": "Eukaryotic Initiation Factor-2", "DS": "EUKARYOTIC INITIATION FACTOR 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Initiation Factor EIF-2|T116|T123|EQV|NLM (1990)|890510|PEPTIDE INITIATION FACTOR EIF 02|abbdefs", "ENTRY": "Peptide Initiation Factor EIF 2", "MN": "D12.776.835.725.868.249", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Peptide Initiation Factors (1978-1989)", "MS": "Eukaryotic initiation factor of protein synthesis. In higher eukaryotes the factor consists of three subunits: alpha, beta, and gamma. As initiation proceeds, eIF-2 forms a ternary complex with Met-tRNAi and GTP.", "PM": "2003; see EIF-2 1990-2002", "HN": "2003(1990)", "MR": "20020703", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015852"}, {"RECTYPE": "D", "MH": "Cysteine Proteinase Inhibitors", "DE": "CYSTEINE PROTEINASE INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "alpha-Cysteine Protease Inhibitor|T121|T123|NON|NRW|NLM (2021)|191119|abbcdef", "ENTRY": "alpha Cysteine Protease Inhibitors", "MN": "D27.505.519.389.745.325", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Protease Inhibitors (1979-1989)", "MS": "Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES.", "PM": "90", "HN": "90", "MR": "20200527", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015853"}, {"RECTYPE": "D", "MH": "Up-Regulation", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Upregulation|T043|T044|NON|EQV|NLM (1990)|890327|UPREG|abbcdefv", "ENTRY": "Up Regulation", "MN": "G07.690.773.998", "FX": "Feedback, Physiological", "MH_TH": "NLM (1990)", "ST": "T044", "MS": "A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins.", "PM": "2002; see Up-Regulation (Physiology) 1990-2001", "HN": "2002 (1990)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015854"}, {"RECTYPE": "D", "MH": "Anisometropia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C11.744.126", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Refractive Errors (1966-1989)", "MS": "A condition of an inequality of refractive power of the two eyes.", "OL": "use REFRACTIVE ERRORS to search ANISOMETROPIA 1984-89", "PM": "90; was see REFRACTIVE ERRORS 1984-89", "HN": "90; was see REFRACTIVE ERRORS 1984-89", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015858"}, {"RECTYPE": "D", "MH": "Retinal Neovascularization", "DE": "RETINAL NEOVASC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sea Fan Neovascularization|T033|T046|NON|NRW|NLM (2020)|190213|abbcdef", "ENTRY": "Sea Fan Neovascularizations", "MN": "C23.550.589.500.725", "MH_TH": "NLM (1990)", "ST": "T046", "PI": "Retinal Vessels (1969-1989)", "MS": "Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190408", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015861"}, {"RECTYPE": "D", "MH": "Choroid Diseases", "DE": "CHOROID DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diseases, Choroidal", "MN": "C11.941.160", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "of the eye, not of the choroid plexus", "MS": "Disorders of the choroid including hereditary choroidal diseases, neoplasms, and other abnormalities of the vascular layer of the uvea.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19930526", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015862"}, {"RECTYPE": "D", "MH": "Iridocyclitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Heterochromic Cyclitis|T047|NON|EQV|NLM (1990)|890329|abcdef", "ENTRY": "Iridocyclitides", "MN": "C11.941.879.780.880.400", "MH_TH": "NLM (1990)", "ST": "T047", "AN": "a type of anterior uveitis", "PI": "Uveitis, Anterior (1966-1989)", "MS": "Acute or chronic inflammation of the iris and ciliary body characterized by exudates into the anterior chamber, discoloration of the iris, and constricted, sluggish pupil. Symptoms include radiating pain, photophobia, lacrimation, and interference with vision.", "OL": "use UVEITIS, ANTERIOR to search IRIDOCYCLITIS 1966-89", "PM": "90; was see UVEITIS, ANTERIOR 1985-89; was heading 1963-85", "HN": "90; was see UVEITIS, ANTERIOR 1985-89; was heading 1963-85", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015863"}, {"RECTYPE": "D", "MH": "Panuveitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C11.941.879.780", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "inflamm of anterior & posterior uvea", "PI": "Uveitis (1977-1989)", "MS": "Inflammation in which both the anterior and posterior segments of the uvea are involved and a specific focus is not apparent. It is often severe and extensive and a serious threat to vision. Causes include systemic diseases such as tuberculosis, sarcoidosis, and syphilis, as well as malignancies. The intermediate segment of the eye is not involved.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015864"}, {"RECTYPE": "D", "MH": "Racquet Sports", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Racquetball|T056|NON|NRW|NLM (1990)|890329|abcdef", "ENTRY": "Sports, Racquet", "MN": "I03.450.642.845.600", "MH_TH": "NLM (1990)", "ST": "T056", "AN": "/inj: coord IM with specific injury (IM); Manual 30.15.1; do not confuse entry term SQUASH (SPORT) with SQUASH PLANT see CUCURBITA", "PI": "Tennis (1978-1989)", "MS": "Games in which players use a racquet to hit a ball or similar type object.", "PM": "90", "HN": "90", "MR": "20010725", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015865"}, {"RECTYPE": "D", "MH": "Uveitis, Posterior", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Posterior Uveitis", "MN": "C11.941.879.780.900", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Uveitis (1966-1989)", "MS": "Inflammation of the choroid as well as the retina and vitreous body. Some form of visual disturbance is usually present. The most important characteristics of posterior uveitis are vitreous opacities, choroiditis, and chorioretinitis.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19900529", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015866"}, {"RECTYPE": "D", "MH": "Uveitis, Intermediate", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cyclitis, Chronic|T047|NON|EQV|NLM (1990)|890329|abcdef", "ENTRY": "Intermediate Uveitis", "MN": "C11.941.879.900", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Uveitis (1971-1989)", "MS": "Inflammation of the pars plana, ciliary body, and adjacent structures.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19900529", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015867"}, {"RECTYPE": "D", "MH": "Pars Planitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Planitis, Pars", "MN": "C11.941.879.900.500", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a type of uveitis", "PI": "Uveitis (1971-1989)", "MS": "Form of granulomatous uveitis occurring in the region of the pars plana. This disorder is a common condition with no detectable focal pathology. It causes fibrovascular proliferation at the inferior ora serrata.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015868"}, {"RECTYPE": "D", "MH": "Gene Expression", "AQ": "DE ES GE IM PH RE", "ENTRY": "Gene Expressions", "MN": "G05.297", "FX": "Phenotype", "MH_TH": "NLM (1990)", "ST": "T045", "PI": "Phenotype (1969-1989)", "MS": "The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION.", "OL": "use GENE EXPRESSION to search MYELOID ANTIGEN EXPRESSION 1994", "PM": "90; MYELOID ANTIGEN EXPRESSION was heading 1994", "HN": "90; MYELOID ANTIGEN EXPRESSION was heading 1994", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19891016", "DC": "1", "DX": "19900101", "UI": "D015870"}, {"RECTYPE": "D", "MH": "Scientific Misconduct", "AQ": "CL ES HI LJ PX SN TD", "PRINT ENTRY": "Research Misconduct|T080|NON|NRW|NLM (1998)|961029|abcdef", "ENTRY": "Scientific Frauds", "MN": "N05.350.979.500", "FX": "United States Office of Research Integrity", "MH_TH": "NLM (1990)", "ST": "T080", "AN": "PROFESSIONAL MISCONDUCT is also available", "PI": "Fraud (1974-1989)", "MS": "Intentional falsification of scientific data by presentation of fraudulent or incomplete or uncorroborated findings as scientific fact.", "PM": "90", "HN": "90", "MR": "20190711", "DA": "19890516", "DC": "1", "DX": "19900101", "UI": "D015871"}, {"RECTYPE": "D", "MH": "Northwest Territories", "AQ": "EH EP", "ENTRY": "Northwest Territory|T083|NAM|EQV|NLM (1990)|890330|abcdef", "MN": "Z01.107.567.176.564", "MH_TH": "NLM (1990)", "ST": "T083", "AN": "a division of northwestern Canada; do not confuse with NORTHERN TERRITORY in Australia", "PI": "Canada (1966-1989)", "MS": "A federally administered division of Canada. Its capital is Yellowknife. The former northern and eastern-most parts of the Territory comprise the new territory of Nunavut, effective April 1, 1999.", "HN": "90", "MR": "19991108", "DA": "19891013", "DC": "4", "DX": "19900101", "UI": "D015873"}, {"RECTYPE": "D", "MH": "Yukon Territory", "AQ": "EH EP", "ENTRY": "Yukon|T083|NAM|EQV|NLM (1990)|890404|abcdef", "MN": "Z01.107.567.176.929", "MH_TH": "NLM (1990)", "ST": "T083", "AN": "a division of northwest Canada", "PI": "Canada (1966-1989)", "MS": "A territory of northwest Canada, bounded on the north by the Arctic Ocean, on the south by British Columbia, and on the west by Alaska. Its capital is Whitehorse. It takes its name from the Yukon River, the Indian yu-kun-ah, meaning big river. (From Webster's New Geographical Dictionary, 1988, p1367 & Room, Brewer's Dictionary of Names, 1992, p608)", "HN": "90", "MR": "19950221", "DA": "19891013", "DC": "4", "DX": "19900101", "UI": "D015874"}, {"RECTYPE": "D", "MH": "Anisocoria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anisocoria, Physiologic|T032|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Physiologic Anisocoria", "MN": "C23.888.592.708.150", "MH_TH": "NLM (1990)", "ST": "T033", "AN": "consider also PUPIL DISORDERS or MIOSIS", "PI": "Pupil (1966-1989)", "MS": "Unequal pupil size, which may represent a benign physiologic variant or a manifestation of disease. Pathologic anisocoria reflects an abnormality in the musculature of the iris (IRIS DISEASES) or in the parasympathetic or sympathetic pathways that innervate the pupil. Physiologic anisocoria refers to an asymmetry of pupil diameter, usually less than 2mm, that is not associated with disease.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20040719", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015875"}, {"RECTYPE": "D", "MH": "Northern Territory", "AQ": "EH EP", "MN": "Z01.678.100.373.875", "MH_TH": "NLM (1990)", "ST": "T083", "AN": "a territory of Australia; do not confuse with NORTHWEST TERRITORIES, a division of Canada", "PI": "Australia (1969-1989)", "MS": "Territory in north central Australia, between the states of Queensland and Western Australia. Its capital is Darwin.", "HN": "90", "MR": "20150623", "DA": "19891013", "DC": "4", "DX": "19900101", "UI": "D015876"}, {"RECTYPE": "D", "MH": "Miosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pupillary Miosis|T033|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Small Pupils", "MN": "C23.888.592.708.362", "FX": "Miotics", "MH_TH": "NLM (1990)", "ST": "T033", "AN": "do not confuse with MEIOSIS nor with MITOSIS, both cell division concepts", "PI": "Pupils (1966-1989)", "MS": "Pupillary constriction. This may result from congenital absence of the dilatator pupillary muscle, defective sympathetic innervation, or irritation of the CONJUNCTIVA or CORNEA.", "PM": "1990", "HN": "1990", "CATSH": "CAT LIST", "MR": "19991208", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015877"}, {"RECTYPE": "D", "MH": "Mydriasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C11.710.570", "FX": "Mydriatics", "MH_TH": "NLM (1990)", "ST": "T184", "PI": "Pupil (1967-1989)", "MS": "Dilation of pupils to greater than 6 mm combined with failure of the pupils to constrict when stimulated with light. This condition may occur due to injury of the pupillary fibers in the oculomotor nerve, in acute angle-closure glaucoma, and in ADIE SYNDROME.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19991109", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015878"}, {"RECTYPE": "D", "MH": "Myosin Subfragments", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myosin S-2|T116|NRW|NLM (1990)|890330|MYOSIN S 02|abdefs", "ENTRY": "Subfragments, Myosin", "MN": "D12.776.220.525.475.300", "MH_TH": "NLM (1990)", "ST": "T116", "RN": "0", "PI": "Peptide Fragments (1974-1989)", "MS": "Parts of the myosin molecule resulting from cleavage by proteolytic enzymes (PAPAIN; TRYPSIN; or CHYMOTRYPSIN) at well-localized regions. Study of these isolated fragments helps to delineate the functional roles of different parts of myosin. Two of the most common subfragments are myosin S-1 and myosin S-2. S-1 contains the heads of the heavy chains plus the light chains and S-2 contains part of the double-stranded, alpha-helical, heavy chain tail (myosin rod).", "OL": "use MYOSIN SUBFRAGMENTS to search MEROMYOSINS 1971-90 (as Prov 1971-73)", "PM": "90; MEROMYOSINS was heading 1974-90", "HN": "90; MEROMYOSINS was heading 1971-90 (Prov 1971-73)", "MR": "20050722", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015879"}, {"RECTYPE": "D", "MH": "Retinal Necrosis Syndrome, Acute", "DE": "ARN SYNDROME", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Acute Retinal Necrosis|T047|NON|EQV|NLM (1990)|890331|abcdef", "ENTRY": "Retinal Necrosis, Acute", "MN": "C11.768.773.674", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Retinitis (1975-1989)", "MS": "Mild to fulminant necrotizing vaso-occlusive retinitis associated with a high incidence of retinal detachment and poor vision outcome.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19930524", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015882"}, {"RECTYPE": "D", "MH": "Cystatins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stefin|T116|T123|NON|NRW|NLM (2021)|200117|abbcdef", "ENTRY": "Cystatins, Type III", "MN": "D12.776.215", "PA": "Cysteine Proteinase Inhibitors", "MH_TH": "NLM (1990)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Protease Inhibitors (1979-1989)", "MS": "A homologous group of endogenous CYSTEINE PROTEINASE INHIBITORS. The cystatins inhibit most CYSTEINE ENDOPEPTIDASES such as PAPAIN, and other peptidases which have a sulfhydryl group at the active site.", "PM": "90", "HN": "90", "MR": "20200527", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015891"}, {"RECTYPE": "D", "MH": "Genome, Human", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Human Genome|T028|NON|EQV|NLM (1990)|890501|abcdef", "ENTRY": "Human Genomes", "MN": "G05.360.340.350", "MH_TH": "NLM (1990)", "ST": "T028", "PI": "Genes (1972-1989)", "MS": "The complete genetic complement contained in the DNA of a set of CHROMOSOMES in a HUMAN. The length of the human genome is about 3 billion base pairs.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015894"}, {"RECTYPE": "D", "MH": "Relative Value Scales", "DE": "RELAT VALUE SCALES", "PRINT ENTRY": "Resource-Based Relative Value Scale|T081|NON|NRW|IOM (1990)|890410|RBRVS|abcdefv", "ENTRY": "Schedules, Relative-Value", "MN": "N04.452.313.500", "MH_TH": "NLM (1990)", "ST": "T170", "PI": "Reimbursement Mechanisms (1986-1989)", "MS": "Coded listings of physician or other professional services using units that indicate the relative value of the various services they perform. They take into account time, skill, and overhead cost required for each service, but generally do not consider the relative cost-effectiveness. Appropriate conversion factors can be used to translate the abstract units of the relative value scales into dollar fees for each service based on work expended, practice costs, and training costs.", "PM": "90", "HN": "90", "MR": "19910531", "DA": "19891003", "DC": "1", "DX": "19900101", "UI": "D015895"}, {"RECTYPE": "D", "MH": "Comorbidity", "AQ": "TD", "MN": "N06.850.490.687", "MH_TH": "NLM (1990)", "ST": "T078", "AN": "\"presence of co-existing or additional diseases\" in epidemiologic studies: do not confuse with /compl; IM general only; coordinate NIM with each disease /epidemiol (IM), not /compl; specify geographic term if pertinent", "PI": "specific disease/complications (1977-1989)", "MS": "The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.", "PM": "90", "HN": "90", "MR": "20180227", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015897"}, {"RECTYPE": "D", "MH": "Tomography Scanners, X-Ray Computed", "DE": "TOMOGR SCANNERS X RAY COMPUTED", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Tomography, X-Ray Computed, Scanners|T074|NON|EQV|IOM (1990)|890413|TOMOGR X RAY COMPUTED SCANNERS|abcdefv", "ENTRY": "X-Ray CT Scanners", "MN": "E07.913", "FX": "Radiographic Image Enhancement", "MH_TH": "IOM (1990)", "ST": "T074", "PI": "Tomography, X-Ray/instrumentation (1974-1976)", "MS": "X-ray image-detecting devices that make a focused image of body structures lying in a predetermined plane from which more complex images are computed.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890516", "DC": "1", "DX": "19900101", "UI": "D015898"}, {"RECTYPE": "D", "MH": "Tomography, Emission-Computed, Single-Photon", "DE": "CT SINGLE PHOTON EMISS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tomography, Single-Photon, Emission-Computed|T060|NON|EQV|IOM (1990)|890419|EMISS CT SINGLE PHOTON|abcdefv", "ENTRY": "Tomography, Single-Photon Emission-Computed", "MN": "E01.370.384.730.800.800", "MH_TH": "IOM (1990)", "ST": "T060", "PI": "Tomography, X-Ray Computed (1977-1979)", "MS": "A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image.", "OL": "use TOMOGRAPHY, EMISSION-COMPUTED to search SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY & SPECT 1989", "PM": "90; was SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY & SPECT see TOMOGRAPHY, EMISSION-COMPUTED 1989", "HN": "90; was SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY & SPECT see TOMOGRAPHY, EMISSION-COMPUTED 1989", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890516", "DC": "1", "DX": "19900101", "UI": "D015899"}, {"RECTYPE": "D", "MH": "Radiography, Dual-Energy Scanned Projection", "DE": "D SCAN RADIOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Dual-Energy Scanned Projection Radiography|T060|NON|EQV|IOM (1990)|890419|DUAL ENERGY SCANNED PROJECTION RADIOGR|abcdefv", "ENTRY": "Radiography, Dual Energy Scanned Projection|T060|NON|EQV|NLM (1990)|890413|RADIOGR DUAL ENERGY SCANNED PROJECTION|abcdefv", "MN": "L01.224.308.380.800", "MH_TH": "IOM (1990)", "ST": "T060", "PI": "Subtraction Technique (1981-1989)", "MS": "A method of producing a high-quality scan by digitizing and subtracting the images produced by high- and low-energy x-rays.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19890516", "DC": "1", "DX": "19900101", "UI": "D015900"}, {"RECTYPE": "D", "MH": "Angiography, Digital Subtraction", "DE": "DS ANGIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Subtraction Angiography, Digital|T060|NON|EQV|IOM (1990)|890413|SUBTRACTION ANGIOGR DIGITAL|abcdefv", "MN": "E01.370.370.050.060", "MH_TH": "IOM (1990)", "ST": "T060", "PI": "Subtraction Technique (1980-1989)", "MS": "A method of delineating blood vessels by subtracting a tissue background image from an image of tissue plus intravascular contrast material that attenuates the X-ray photons. The background image is determined from a digitized image taken a few moments before injection of the contrast material. The resulting angiogram is a high-contrast image of the vessel. This subtraction technique allows extraction of a high-intensity signal from the superimposed background information. The image is thus the result of the differential absorption of X-rays by different tissues.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015901"}, {"RECTYPE": "D", "MH": "Gamma Cameras", "AQ": "CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Scintillation Cameras|T074|NON|EQV|NLM (1990)|890512|abcdef", "ENTRY": "Scintillation Camera", "MN": "E07.420", "MH_TH": "IOM (1990)", "ST": "T074", "PI": "Scintillation Counting (1979-1989)", "MS": "Electronic instruments that produce photographs or cathode-ray tube images of the gamma-ray emissions from organs containing radionuclide tracers.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20170602", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015902"}, {"RECTYPE": "D", "MH": "Moire Topography", "DE": "MOIRE TOPOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Topography, Moire|T059|NON|EQV|IOM (1990)|890413|TOPOGR MOIRE|abcdefv", "ENTRY": "Photographs, Moire", "MN": "E05.490.815", "MH_TH": "IOM (1990)", "ST": "T059", "PI": "Photogrammetry (1974-1989)", "MS": "A method of three-dimensional morphometry in which contour maps are produced from the overlapping interference fringes created when an object is illuminated by beams of coherent light issuing from two different point sources.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20150112", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015903"}, {"RECTYPE": "D", "MH": "Biliopancreatic Diversion", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Biliopancreatic Bypass|T061|NON|EQV|IOM (1990)|890413|abcdef", "ENTRY": "Pancreatic Diversions, Bilio", "MN": "E04.210.169", "MH_TH": "IOM (1990)", "ST": "T061", "PI": "Obesity/therapy (1977-1989)", "MS": "A surgical procedure which diverts pancreatobiliary secretions via the duodenum and the jejunum into the colon, the remaining small intestine being anastomosed to the stomach after antrectomy. The procedure produces less diarrhea than does jejunoileal bypass.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015904"}, {"RECTYPE": "D", "MH": "Gastric Balloon", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Gastric Bubble|T074|NON|EQV|IOM (1990)|961120|abcdef", "ENTRY": "Gastric Bubbles", "MN": "E07.430", "MH_TH": "IOM (1990)", "ST": "T074", "AN": "note category: an inflatable device; do not confuse with digestive gases; used in ther of morbid obesity: note XR & do not coord with OBESITY, MORBID unless particularly discussed", "PI": "Obesity, Morbid (1987-1989)", "MS": "An inflatable device implanted in the stomach as an adjunct to therapy of morbid obesity. Specific types include the silicone Garren-Edwards Gastric Bubble (GEGB), approved by the FDA in 1985, and the Ballobes Balloon.", "PM": "98; was GASTRIC BUBBLE 1990-97; GASTRIC BALLOON was see GASTRIC BUBBLE 1990-97", "HN": "98; was GASTRIC BUBBLE 1990-97; GASTRIC BALLOON was see GASTRIC BUBBLE 1990-97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015905"}, {"RECTYPE": "D", "MH": "Angioplasty, Balloon, Coronary", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Percutaneous Transluminal Coronary Angioplasty|T061|NON|NRW|IOM (1990)|890419|abcdef", "ENTRY": "Coronary Balloon Angioplasty", "MN": "E05.157.016.060.100", "MH_TH": "NLM (1993)", "ST": "T061", "AN": "if laser, coordinate with ANGIOPLASTY, BALLOON, LASER-ASSISTED ", "PI": "Heart Catheterization (1976-1981)", "MS": "Dilation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply.", "PM": "2011; see ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY 1990-2010", "HN": "2011(1990)", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015906"}, {"RECTYPE": "D", "MH": "Hysteroscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Uterine Endoscopy|T060|T061|NON|EQV|NLM (1990)|890505|abbcdef", "ENTRY": "Uteroscopies", "MN": "E04.950.300.539", "FX": "Hysteroscopes", "MH_TH": "POPLINE (1978)", "ST": "T061", "AN": "/ instrum permitted but consider also HYSTEROSCOPES", "PI": "Endoscopy (1966-1989)", "MS": "Endoscopic examination, therapy or surgery of the interior of the uterus.", "OL": "use ENDOSCOPY to search HYSTEROSCOPY 1979-89", "PM": "90; was see ENDOSCOPY 1979-89", "HN": "90; was see ENDOSCOPY 1979-89", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19891004", "DC": "1", "DX": "19900101", "UI": "D015907"}, {"RECTYPE": "D", "MH": "Counterpulsation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Diastolic Counterpulsation|T061|NON|NRW|IOM (1990)|890413|abcdef", "ENTRY": "External Counterpulsation", "MN": "E04.050.215", "FX": "Heart-Assist Devices", "MH_TH": "IOM (1990)", "ST": "T061", "PI": "Intra-Aortic Balloon Pumping (1977-1989)", "MS": "A technique for assisting the circulation by decreasing the afterload of the left ventricle and augmenting the diastolic pressure. It may be achieved by intra-aortic balloon, or by implanting a special pumping device in the chest, or externally by applying a negative pressure to the lower extremities during cardiac systole.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19900216", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015908"}, {"RECTYPE": "D", "MH": "Sclerotherapy", "DE": "SCLEROTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Sclerotherapies", "MN": "E02.319.805", "FX": "Sclerosing Solutions", "MH_TH": "IOM (1990)", "ST": "T061", "AN": "coord IM with dis /ther (IM), not /drug ther", "PI": "Sclerosing Solutions (1966-1989)", "MS": "Treatment of varicose veins, hemorrhoids, gastric and esophageal varices, and peptic ulcer hemorrhage by injection or infusion of chemical agents which cause localized thrombosis and eventual fibrosis and obliteration of the vessels.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19910620", "DA": "19890516", "DC": "1", "DX": "19900101", "UI": "D015911"}, {"RECTYPE": "D", "MH": "Thrombolytic Therapy", "DE": "THROMBOLYTIC THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Thrombolysis, Therapeutic|T061|NON|EQV|IOM (1990)|890414|THROMBOLYSIS THER|abcdefv", "ENTRY": "Thrombolytic Therapies", "MN": "E02.319.913", "FX": "Thrombectomy", "MH_TH": "IOM (1990)", "ST": "T061", "AN": "coordinate IM with specific thrombolytic agents /ther use (IM) if specified + disease /drug ther (IM)", "PI": "Thrombosis/drug therapy (1966-1989)", "MS": "Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015912"}, {"RECTYPE": "D", "MH": "Chelation Therapy", "DE": "CHELATION THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapies, Chelation", "MN": "E02.319.155", "MH_TH": "IOM (1990)", "ST": "T061", "AN": "coord IM with specific chelating agent /ther use (IM) + metal being chelated with no qualif", "PI": "Chelating Agents/therapeutic use (1966-1989)", "MS": "Therapy of heavy metal poisoning using agents which sequester the metal from organs or tissues and bind it firmly within the ring structure of a new compound which can be eliminated from the body.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19900322", "DA": "19891003", "DC": "1", "DX": "19900101", "UI": "D015913"}, {"RECTYPE": "D", "MH": "Estrogen Replacement Therapy", "DE": "ESTROGEN REPLACE THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Replacement Therapy, Estrogen|T061|NON|EQV|NLM (1990)|890414|REPLACE THER ESTROGEN|abcdefv", "ENTRY": "Therapies, Estrogen Replacement", "MN": "E02.319.452.150", "MH_TH": "IOM (1990)", "ST": "T061", "AN": "coordinate with specific estrogen and also specific progestational agent if pertinent; check tag FEMALE", "PI": "Menopause (1966-1989)", "MS": "The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19890719", "DC": "1", "DX": "19900101", "UI": "D015914"}, {"RECTYPE": "D", "MH": "Motion Therapy, Continuous Passive", "DE": "MOTION THER CONTINUOUS PASSIVE", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Passive Motion Therapy, Continuous|T061|NON|EQV|IOM (1990)|890414|PASSIVE MOTION THER CONTINUOUS|abcdefv", "ENTRY": "Therapy, CPM", "MN": "E02.831.535.867.761", "MH_TH": "NLM (1990)", "ST": "T061", "PI": "Physical Therapy (1966-1989)", "MS": "Movement of a body part initiated and maintained by a mechanical or electrical device to restore normal range of motion to joints, muscles, or tendons after surgery, prosthesis implantation, contracture flexion, or long immobilization.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015915"}, {"RECTYPE": "D", "MH": "Drainage, Postural", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Respiratory Drainage, Postural|T061|NON|EQV|IOM (1990)|890414|abcdef", "ENTRY": "Pulmonary Postural Drainage", "MN": "E02.880.150", "MH_TH": "IOM (1990)", "ST": "T061", "PI": "Posture (1966-1989)", "MS": "A rehabilitation therapy for removal of copious mucus secretion from the lung of patients with diseases such as CHRONIC BRONCHITIS; BRONCHIECTASIS; PULMONARY ABSCESS; or CYSTIC FIBROSIS. The patient's head is placed in a downward incline (so the TRACHEA is inferior to the affected area) for 15- to 20-minute sessions.", "PM": "1990", "HN": "1990", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015916"}, {"RECTYPE": "D", "MH": "Penile Prosthesis", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Penis, Artificial|T074|NON|EQV|NLM (1990)|890414|abcdef", "ENTRY": "Prosthesis, Penis", "MN": "E07.695.610", "FX": "Penile Implantation", "MH_TH": "IOM (1990)", "ST": "T074", "PI": "Prosthesis (1966-1989)", "MS": "Rigid, semi-rigid, or inflatable cylindric hydraulic devices, with either combined or separate reservoir and pumping systems, implanted for the surgical treatment of organic ERECTILE DYSFUNCTION.", "OL": "use PENILE PROSTHESIS to search PROSTHESIS, PENILE 1990", "PM": "90; PROSTHESIS, PENILE was see PENILE PROSTHESIS 1990", "HN": "90; PROSTHESIS, PENILE was see PENILE PROSTHESIS 1990", "CATSH": "CAT LIST", "MR": "20070711", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015917"}, {"RECTYPE": "D", "MH": "Infusion Pumps, Implantable", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Programmable Implantable Medication Systems|T074|NON|NRW|NLM (1992)|910114|PIMS|abcdefv", "ENTRY": "Pumps, Implantable Peristaltic", "MN": "E07.858.082.505.254", "FX": "Drug Implants", "MH_TH": "IOM (1990)", "ST": "T074", "PI": "Infusions, Parenteral (1975-1986)", "MS": "Implanted fluid propulsion systems with self-contained power source for providing long-term controlled-rate delivery of drugs such as chemotherapeutic agents or analgesics. Delivery rate may be externally controlled or osmotically or peristatically controlled with the aid of transcutaneous monitoring.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20040730", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015918"}, {"RECTYPE": "D", "MH": "Ventilators, Negative-Pressure", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Ventilators, Pulmonary, Negative-Pressure|T074|NON|EQV|IOM (1990)|890419|VENTILATORS PULM NEGATIVE PRESSURE|abcdefv", "ENTRY": "Ventilators, Tank", "MN": "E07.950.500", "MH_TH": "IOM (1990)", "ST": "T074", "PI": "Ventilators, Mechanical (1966-1989)", "MS": "Body ventilators that assist ventilation by applying intermittent subatmospheric pressure around the thorax, abdomen, or airway and periodically expand the chest wall and inflate the lungs. They are relatively simple to operate and do not require tracheostomy. These devices include the tank ventilators (\"iron lung\"), Portalung, Pneumowrap, and chest cuirass (\"tortoise shell\").", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19920518", "DA": "19890516", "DC": "1", "DX": "19900101", "UI": "D015919"}, {"RECTYPE": "D", "MH": "Gas Scavengers", "AQ": "CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Anesthetic Gas Scavengers|T074|NON|NRW|IOM (1990)|890414|abcdef", "ENTRY": "Scavengers, Gas", "MN": "E07.427", "MH_TH": "IOM (1990)", "ST": "T074", "PI": "Operating Rooms (1977-1989)", "MS": "Apparatus for removing exhaled or leaked anesthetic gases or other volatile agents, thus reducing the exposure of operating room personnel to such agents, as well as preventing the buildup of potentially explosive mixtures in operating rooms or laboratories.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20170602", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015920"}, {"RECTYPE": "D", "MH": "Dental Implants", "DE": "DENT IMPLANTS", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Implants, Dental|T074|NON|EQV|IOM (1990)|890414|IMPLANTS DENT|abcdefv", "ENTRY": "Mini Dental Implants", "MN": "J01.637.051.339.312", "FX": "Tooth, Artificial", "MH_TH": "IOM (1990)", "ST": "T074", "RN": "0", "PI": "Dental Implantation (1966-1989)", "MS": "Biocompatible materials placed into (endosseous) or onto (subperiosteal) the jawbone to support a crown, bridge, or artificial tooth, or to stabilize a diseased tooth.", "OL": "use DENTAL IMPLANTATION to search DENTAL PROSTHESIS, SURGICAL 1975-89", "PM": "90; DENTAL PROSTHESIS, SURGICAL was see DENTAL IMPLANTATION 1975-89", "HN": "90; DENTAL PROSTHESIS, SURGICAL was see DENTAL IMPLANTATION 1975-89", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015921"}, {"RECTYPE": "D", "MH": "Complement C1q", "DS": "COMPLEMENT C 01 Q", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 1q, Complement", "MN": "D12.776.124.486.274.050.270", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "N1": "Complement C1q", "RN": "80295-33-6", "PI": "Complement Activating Enzymes (1979-1989)", "MS": "A subcomponent of complement C1, composed of six copies of three polypeptide chains (A, B, and C), each encoded by a separate gene (C1QA; C1QB; C1QC). This complex is arranged in nine subunits (six disulfide-linked dimers of A and B, and three disulfide-linked homodimers of C). C1q has binding sites for antibodies (the heavy chain of IMMUNOGLOBULIN G or IMMUNOGLOBULIN M). The interaction of C1q and immunoglobulin activates the two proenzymes COMPLEMENT C1R and COMPLEMENT C1S, thus initiating the cascade of COMPLEMENT ACTIVATION via the CLASSICAL COMPLEMENT PATHWAY.", "PM": "2006; see COMPLEMENT 1Q 1990-2005", "HN": "2006 (1990)", "MR": "20050630", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015922"}, {"RECTYPE": "D", "MH": "Complement C1r", "DS": "COMPLEMENT C 01 R", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 1r, Complement", "MN": "D12.776.124.486.274.050.280", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "EC 3.4.21.41", "PI": "Enzyme Precursors (1979-1982)", "MS": "A 80-kDa subcomponent of complement C1, existing as a SERINE PROTEASE proenzyme in the intact complement C1 complex. When COMPLEMENT C1Q is bound to antibodies, the changed tertiary structure causes autolytic activation of complement C1r which is cleaved into two chains, A (heavy) and B (light, the serine protease), connected by disulfide bonds. The activated C1r serine protease, in turn, activates COMPLEMENT C1S proenzyme by cleaving the Arg426-Ile427 bond. No fragment is released when either C1r or C1s is cleaved.", "PM": "2006; see COMPLEMENT 1R 1990-2005", "HN": "2006 (1990)", "MR": "20060705", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015923"}, {"RECTYPE": "D", "MH": "Blood Pressure Monitors", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Sphygmomanometers, Continuous|T074|NON|EQV|IOM (1990)|890414|abcdef", "ENTRY": "Sphygmomanometer, Continuous", "MN": "E07.230.740.100", "MH_TH": "IOM (1990)", "ST": "T074", "PI": "Monitoring, Physiologic/instrumentation (1970-1989)", "MS": "Devices for continuously measuring and displaying the arterial blood pressure.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015924"}, {"RECTYPE": "D", "MH": "Cryopreservation", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Cryofixation|T059|T062|NON|EQV|NLM (1992)|901029|abbcdef", "ENTRY": "Suspension, Cryonic", "MN": "E05.760.156", "FX": "Vitrification", "MH_TH": "IOM (1990)", "ST": "T062", "AN": "coordinate IM with specific organ, tissue or cell heading (IM with no qualifiers)", "PI": "Preservation, Biological (1975-1989)", "MS": "Preservation of cells, tissues, organs, or embryos by freezing. In histological preparations, cryopreservation or cryofixation is used to maintain the existing form, structure, and chemical composition of all the constituent elements of the specimens.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20210312", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015925"}, {"RECTYPE": "D", "MH": "Complement C3a", "DS": "COMPLEMENT C 03 A", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 3a, Complement", "MN": "D12.776.124.486.274.250.250", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "N1": "Complement C3a", "RN": "80295-42-7", "PI": "Complement 3 (1975-1989)", "MS": "The smaller fragment generated from the cleavage of complement C3 by C3 CONVERTASE. C3a, a 77-amino acid peptide, is a mediator of local inflammatory process. It induces smooth MUSCLE CONTRACTION, and HISTAMINE RELEASE from MAST CELLS and LEUKOCYTES. C3a is considered an anaphylatoxin along with COMPLEMENT C4A; COMPLEMENT C5A; and COMPLEMENT C5A, DES-ARGININE.", "PM": "2006; see COMPLEMENT 3A 1990-2005", "HN": "2006 (1990)", "MR": "20130709", "DA": "19890714", "DC": "1", "DX": "19900101", "UI": "D015926"}, {"RECTYPE": "D", "MH": "Skin Test End-Point Titration", "DE": "STEPT", "AQ": "AE CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Titration Skin Test, End-Point|T060|NON|EQV|IOM (1990)|890414|abcdef", "ENTRY": "Titrations, Skin End-Point", "MN": "E05.478.594.890.300.750", "MH_TH": "IOM (1990)", "ST": "T060", "PI": "Skin Tests (1975-1989)", "MS": "A quantitative form of intradermal testing for the relative allergenicity of a substance. It is used to determine the amount of an allergen that will be tolerated in ALLERGEN IMMUNOTHERAPY.", "PM": "91; was see under SKIN TESTS 1990", "HN": "91(90); was see under SKIN TESTS 1990", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19890516", "DC": "1", "DX": "19910101", "UI": "D015927"}, {"RECTYPE": "D", "MH": "Cognitive Behavioral Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Psychotherapy, Cognitive|T061|NON|EQV|IOM (1990)|890414|PSYCHOTHER COGNITIVE|abcdefv", "ENTRY": "Therapy, Cognitive Behaviour", "MN": "F04.754.137.350", "MH_TH": "NLM (2013)", "ST": "T061", "PI": "Cognition (1967-1989)", "MS": "A directive form of psychotherapy based on the interpretation of situations (cognitive structure of experiences) that determine how an individual feels and behaves. It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behavior. The therapy uses behavioral and verbal techniques to identify and correct negative thinking that is at the root of the aberrant behavior.", "PM": "2019; see Cognitive Therapy 1990-2018", "HN": "2019(1990); was Cognitive Therapy 1990-2018", "CATSH": "CAT LIST", "MR": "20210305", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015928"}, {"RECTYPE": "D", "MH": "Diet Records", "PRINT ENTRY": "Food Diaries|T073|NON|EQV|IOM (1990)|890417|abcdef", "ENTRY": "Records, Dietary", "MN": "N04.452.859.360", "MH_TH": "IOM (1990)", "ST": "T073", "PI": "Nutrition Surveys (1971-1989)", "MS": "Records of nutrient intake over a specific period of time, usually kept by the patient.", "PM": "90", "HN": "90", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015930"}, {"RECTYPE": "D", "MH": "Intensive Care, Neonatal", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "PRINT ENTRY": "Neonatal Intensive Care|T058|NON|EQV|NLM (1990)|890417|abcdef", "ENTRY": "Care, Neonatal Intensive", "MN": "N02.421.585.190.500", "MH_TH": "IOM (1990)", "ST": "T058", "AN": "check also tags HUMANS & INFANT, NEWBORN", "PI": "Intensive Care Units, Neonatal (1982-1989)", "MS": "Continuous care and monitoring of newborn infants with life-threatening conditions, in any setting.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19890515", "DC": "1", "DX": "19900101", "UI": "D015931"}, {"RECTYPE": "D", "MH": "Complement C3c", "DS": "COMPLEMENT C 03 C", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fragment, Complement C3c", "MN": "D12.776.124.486.274.250.260.500", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "N1": "Complement C3c", "RN": "80295-44-9", "PI": "Complement 3 (1974-1989)", "MS": "A 206-amino-acid fragment in the alpha chain (672-1663) of C3b. It is generated when C3b is inactivated (iC3b) and its alpha chain is cleaved by COMPLEMENT FACTOR I into C3c (749-954), and C3dg (955-1303) in the presence COMPLEMENT FACTOR H.", "PM": "2006; see COMPLEMENT 3C 1990-2005", "HN": "2006 (1990)", "MR": "20050630", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015932"}, {"RECTYPE": "D", "MH": "Complement C3d", "DS": "COMPLEMENT C 03 D", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fragment, Complement C3d", "MN": "D12.776.124.486.274.250.260.750", "PA": "Immunologic Factors", "FX": "Receptors, Complement 3d", "MH_TH": "NLM (2006)", "ST": "T129", "N1": "Complement C3d", "RN": "80295-45-0", "PI": "Complement 3 (1975-1989)", "MS": "A 302-amino-acid fragment in the alpha chain (672-1663) of C3b. It is generated when C3b is inactivated (iC3b) and its alpha chain is cleaved by COMPLEMENT FACTOR I into C3c, and C3dg (955-1303) in the presence COMPLEMENT FACTOR H. Serum proteases further degrade C3dg into C3d (1002-1303) and C3g (955-1001).", "PM": "2006; see COMPLEMENT 3D 1990-2005", "HN": "2006 (1990)", "MR": "20050630", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015933"}, {"RECTYPE": "D", "MH": "Complement C4a", "DS": "COMPLEMENT C 04 A", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 4a, Complement", "MN": "D12.776.124.486.274.350.250", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "N1": "Complement C4a", "RN": "80295-49-4", "PI": "Complement 4 (1978-1989)", "MS": "The smaller fragment formed when complement C4 is cleaved by COMPLEMENT C1S. It is an anaphylatoxin that causes symptoms of immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE) but its activity is weaker than that of COMPLEMENT C3A or COMPLEMENT C5A.", "PM": "2006; see COMPLEMENT 4A 1990-2005", "HN": "2006 (1990)", "MR": "20050630", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015934"}, {"RECTYPE": "D", "MH": "Complement C4b", "DS": "COMPLEMENT C 04 B", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 4b, Complement", "MN": "D12.776.124.486.274.350.260", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "N1": "Complement C4b", "RN": "80295-50-7", "PI": "Complement 4 (1975-1989)", "MS": "The large fragment formed when COMPLEMENT C4 is cleaved by COMPLEMENT C1S. The membrane-bound C4b binds COMPLEMENT C2A, a SERINE PROTEASE, to form C4b2a (CLASSICAL PATHWAY C3 CONVERTASE) and subsequent C4b2a3b (CLASSICAL PATHWAY C5 CONVERTASE).", "PM": "2006; see COMPLEMENT 4B 1990-2005", "HN": "2006 (1990)", "MR": "20050630", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015935"}, {"RECTYPE": "D", "MH": "Complement C5a", "DS": "COMPLEMENT C 05 A", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 5a, Complement", "MN": "D12.776.124.486.274.450.250", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "N1": "Complement C5a", "RN": "80295-54-1", "PI": "Complement 5 (1975-1989)", "MS": "The minor fragment formed when C5 convertase cleaves C5 into C5a and COMPLEMENT C5B. C5a is a 74-amino-acid glycopeptide with a carboxy-terminal ARGININE that is crucial for its spasmogenic activity. Of all the complement-derived anaphylatoxins, C5a is the most potent in mediating immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE), smooth MUSCLE CONTRACTION; HISTAMINE RELEASE; and migration of LEUKOCYTES to site of INFLAMMATION.", "PM": "2006; see COMPLEMENT 5A 1990-2005", "HN": "2006 (1990)", "MR": "20160628", "DA": "19890714", "DC": "1", "DX": "19900101", "UI": "D015936"}, {"RECTYPE": "D", "MH": "Complement C5a, des-Arginine", "DE": "C5A DES ARG", "DS": "COMPLEMENT C 05 A DES ARGININE", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "des-Arginine, C5a", "MN": "D12.776.124.486.274.450.250.255", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Complement 5 (1979-1989)", "MS": "A derivative of complement C5a, generated when the carboxy-terminal ARGININE is removed by CARBOXYPEPTIDASE B present in normal human serum. C5a des-Arg shows complete loss of spasmogenic activity though it retains some chemotactic ability (CHEMOATTRACTANTS).", "PM": "2006; see COMPLEMENT 5A, DES-ARGININE 1990-2005", "HN": "2006 (1990)", "MR": "20050630", "DA": "19890714", "DC": "1", "DX": "19900101", "UI": "D015937"}, {"RECTYPE": "D", "MH": "Complement Membrane Attack Complex", "DE": "COMPLEMENT MAC", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Membrane Attack Complex|T116|T129|NON|EQV|NLM (1990)|890418|abbcdef", "ENTRY": "Complex, Terminal Complement", "MN": "D12.776.124.486.274.930", "PA": "Immunologic Factors", "MH_TH": "NLM (1990)", "ST": "T129", "RN": "0", "PI": "Complement (1973-1989)", "MS": "A product of COMPLEMENT ACTIVATION cascade, regardless of the pathways, that forms transmembrane channels causing disruption of the target CELL MEMBRANE and cell lysis. It is formed by the sequential assembly of terminal complement components (COMPLEMENT C5B; COMPLEMENT C6; COMPLEMENT C7; COMPLEMENT C8; and COMPLEMENT C9) into the target membrane. The resultant C5b-8-poly-C9 is the \"membrane attack complex\" or MAC.", "PM": "90", "HN": "90", "MR": "20050630", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015938"}, {"RECTYPE": "D", "MH": "Kitasamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Leucomycin|T109|T195|NON|EQV|NLM (1990)|890418|abbcdef", "MN": "D02.540.576.500.999.450", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1967)", "ST": "T195", "N1": "Leucomycin", "RN": "1392-21-8", "AN": "do not use /biosyn unless by living matter; do not confuse entry term LEUCOMYCIN see KITASAMYCIN with LEUCOMYCINS", "PI": "Leucomycins (1981-1989)", "MS": "A macrolide antibiotic produced by Streptomyces kitasatoensis. The drug has antimicrobial activity against a wide spectrum of pathogens.", "OL": "use KITASAMYCINS to search KITASAMICIN 1976-80; use LEUCOMYCINS 1981-89", "PM": "90; was KITASAMYCINS see under ANTIBIOTICS 1976-80; was see LEUCOMYCINS 1981-89", "HN": "90; was KITASAMYCINS see under ANTIBIOTICS 1976-80; was see LEUCOMYCINS 1981-89", "MR": "20150622", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015939"}, {"RECTYPE": "D", "MH": "Complement Hemolytic Activity Assay", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Whole Complement Titer|T034|NON|NRW|NLM (1990)|890418|abcdef", "ENTRY": "Whole Complement Titers", "MN": "E05.478.594.760.155", "MH_TH": "NLM (1990)", "ST": "T059", "PI": "Complement/analysis (1969-1989)", "MS": "A screening assay for circulating COMPLEMENT PROTEINS. Diluted SERUM samples are added to antibody-coated ERYTHROCYTES and the percentage of cell lysis is measured. The values are expressed by the so called CH50, in HEMOLYTIC COMPLEMENT units per milliliter, which is the dilution of serum required to lyse 50 percent of the erythrocytes in the assay.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015941"}, {"RECTYPE": "D", "MH": "Factor VIIa", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Factor VII, Activated|T116|T126|NON|EQV|NLM (1990)|890517|abbcdef", "ENTRY": "Factor VIIa, Coagulation", "MN": "D23.119.325.300", "FX": "Coagulants", "EC": "deficiency:Factor VII Deficiency", "MH_TH": "NLM (1990)", "ST": "T126", "RN": "EC 3.4.21.21", "PI": "Factor VII (1975-1989)", "MS": "Activated form of factor VII. Factor VIIa activates factor X in the extrinsic pathway of blood coagulation.", "PM": "90", "HN": "90", "MR": "20170620", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015942"}, {"RECTYPE": "D", "MH": "Factor Va", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Factor V, Activated|T116|T123|NON|EQV|NLM (1990)|890517|abbcdef", "ENTRY": "Factor Va, Coagulation", "MN": "D23.119.300.300", "FX": "Coagulants", "MH_TH": "NLM (1990)", "ST": "T123", "N1": "Blood-coagulation factor Va", "RN": "65522-14-7", "PI": "Factor V (1974-1989)", "MS": "Activated form of factor V. It is an essential cofactor for the activation of prothrombin catalyzed by factor Xa.", "PM": "90", "HN": "90", "MR": "20170224", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015943"}, {"RECTYPE": "D", "MH": "Factor VIIIa", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Factor VIII, Thrombin-Activated|T116|T123|NON|EQV|NLM (1990)|890421|abbcdef", "ENTRY": "Thrombin-Activated Factor VIII", "MN": "D23.119.350.300", "FX": "Coagulants", "EC": "deficiency:Hemophilia A", "MH_TH": "NLM (1990)", "ST": "T123", "N1": "Blood-coagulation factor VIIIa, procoagulant", "RN": "72175-66-7", "PI": "Factor VIII (1981-1989)", "MS": "Activated form of factor VIII. The B-domain of factor VIII is proteolytically cleaved by thrombin to form factor VIIIa. Factor VIIIa exists as a non-covalent dimer in a metal-linked (probably calcium) complex and functions as a cofactor in the enzymatic activation of factor X by factor IXa. Factor VIIIa is similar in structure and generation to factor Va.", "PM": "90", "HN": "90", "MR": "20190530", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015944"}, {"RECTYPE": "D", "MH": "Factor XIa", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Factor XI, Activated|T116|T126|NON|EQV|NLM (1990)|890517|abbcdef", "ENTRY": "Factor XIa, Coagulation", "MN": "D23.119.425.320", "FX": "Coagulants", "MH_TH": "NLM (1990)", "ST": "T126", "RN": "EC 3.4.21.27", "PI": "Serine Proteinases (1988-1989)", "MS": "Activated form of factor XI. In the intrinsic pathway, Factor XI is activated to XIa by factor XIIa in the presence of cofactor HMWK; (HIGH MOLECULAR WEIGHT KININOGEN). Factor XIa then activates factor IX to factor IXa in the presence of calcium.", "PM": "90", "HN": "90", "MR": "20190530", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015945"}, {"RECTYPE": "D", "MH": "Ethylene Dibromide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "1,2-Dibromoethane|T109|T131|NON|EQV|FDA SRS (2014)|NLM (1990)|890419|DIBROMOETHANE 0102|abbcdeefs", "ENTRY": "sym Dibromoethane", "MN": "D02.455.526.368.225", "MH_TH": "NLM (1990)", "ST": "T131", "N1": "Ethane, 1,2-dibromo-", "RN": "1N41638RNO", "RR": "106-93-4 (Ethylene Dibromide)", "PI": "Hydrocarbons, Brominated (1974)", "MS": "An effective soil fumigant, insecticide, and nematocide. In humans, it causes severe burning of skin and irritation of the eyes and respiratory tract. Prolonged inhalation may cause liver necrosis. It is also used in gasoline. Members of this group have caused liver and lung cancers in rodents. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), 1,2-dibromoethane may reasonably be anticipated to be a carcinogen.", "OL": "use ETHYLENE DIBROMIDE to search ETHYLENE DIBROMIDES 1975-90", "PM": "90; was ETHYLENE DIBROMIDES see under HYDROCARBONS, BROMINATED 1977-89; was ETHYLENE DIBROMIDE see under HYDROCARBONS, BROMINATED 1975-76; ETHYLENE DIBROMIDES was see under HYDROCARBONS, BROMINATED 1977-90", "HN": "90; was ETHYLENE DIBROMIDES see under HYDROCARBONS, BROMINATED 1977-89; was ETHYLENE DIBROMIDE see under HYDROCARBONS, BROMINATED 1975-76; ETHYLENE DIBROMIDES was see under HYDROCARBONS, BROMINATED 1977-90", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015946"}, {"RECTYPE": "D", "MH": "Keratoplasty, Penetrating", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Penetrating Keratoplasty", "MN": "E04.936.580.225.350", "MH_TH": "NLM (1990)", "ST": "T061", "PI": "Cornea/transplantation (1966-1989)", "MS": "Partial or total replacement of all layers of a central portion of the cornea.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015948"}, {"RECTYPE": "D", "MH": "Factor IXa", "DS": "FACTOR VIIIIA", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Factor IX, Activated|T116|T126|NON|EQV|NLM (1990)|890517|FACTOR VIIII ACTIVATED|abbcdefs", "ENTRY": "Factor IXa, Coagulation", "MN": "D23.119.375.310", "FX": "Coagulants", "EC": "deficiency:Hemophilia B", "MH_TH": "NLM (1990)", "ST": "T126", "RN": "EC 3.4.21.22", "PI": "Serine Proteinases (1988-1989)", "MS": "Activated form of factor IX. This activation can take place via the intrinsic pathway of blood coagulation by the action of factor XIa and calcium, or via the extrinsic pathway by the action of factor VIIa, thromboplastin, and calcium. Factor IXa serves to activate factor X to Xa by cleaving the arginyl-leucine peptide bond in factor X.", "PM": "90", "HN": "90", "MR": "20170620", "DA": "19890714", "DC": "1", "DX": "19900101", "UI": "D015949"}, {"RECTYPE": "D", "MH": "Factor Xa", "AQ": "AA AD AE AG AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thrombokinase|T116|T126|NON|EQV|NLM (1990)|890424|abbcdef", "ENTRY": "Factor Xa, Coagulation", "MN": "D23.119.400.315", "FX": "Coagulants", "EC": "deficiency:Factor X Deficiency", "MH_TH": "NLM (1990)", "ST": "T126", "RN": "EC 3.4.21.6", "PI": "Serine Proteinases (1988-1989)", "MS": "Activated form of factor X that participates in both the intrinsic and extrinsic pathways of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction with other cofactors.", "PM": "90", "HN": "90", "MR": "20190530", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015951"}, {"RECTYPE": "D", "MH": "Factor XIIa", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Factor XII, Activated|T116|T126|NON|EQV|NLM (1990)|890517|abbcdef", "ENTRY": "Hageman Factor Fragments", "MN": "D23.119.450.324", "FX": "Coagulants", "MH_TH": "NLM (1990)", "ST": "T126", "RN": "EC 3.4.21.38", "PI": "Serine Proteinases (1988-1989)", "MS": "Activated form of factor XII. In the initial event in the intrinsic pathway of blood coagulation, kallikrein (with cofactor HIGH MOLECULAR WEIGHT KININOGEN) cleaves factor XII to XIIa. Factor XIIa is then further cleaved by kallikrein, plasmin, and trypsin to yield smaller factor XII fragments (Hageman-Factor fragments). These fragments increase the activity of prekallikrein to kallikrein but decrease the procoagulant activity of factor XII.", "PM": "90", "HN": "90", "MR": "20190530", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015956"}, {"RECTYPE": "D", "MH": "Gene Expression Regulation, Bacterial", "DE": "GENE EXPRESSION REG BACT", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Regulation of Gene Expression, Bacterial|T045|NON|EQV|NLM (1990)|890425|REG GENE EXPRESSION BACT|abcdefv", "ENTRY": "Regulation, Gene Expression, Bacterial|T045|NON|EQV|NLM (1992)|901015|abcdef", "MN": "G05.308.300", "MH_TH": "NLM (1990)", "ST": "T045", "AN": "coordinate with specific bacterium /genet ", "PI": "specific bacteria (1973-1989)", "MS": "Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015964"}, {"RECTYPE": "D", "MH": "Gene Expression Regulation, Fungal", "DE": "GENE EXPRESSION REG FUNGAL", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Regulation of Gene Expression, Fungal|T045|NON|EQV|NLM (1990)|890425|REG GENE EXPRESSION FUNGAL|abcdefv", "ENTRY": "Regulation, Gene Expression, Fungal|T045|NON|EQV|NLM (1992)|901015|abcdef", "MN": "G05.308.330", "MH_TH": "NLM (1990)", "ST": "T045", "AN": "coordinate with specific fungus /genet ", "PI": "specific fungi (1972-1989)", "MS": "Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in fungi.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015966"}, {"RECTYPE": "D", "MH": "Gene Expression Regulation, Viral", "DE": "GENE EXPRESSION REG VIRAL", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Viral Gene Expression Regulation|T045|NON|EQV|NLM (1990)|890517|VIRAL GENE EXPRESSION REG|abcdefv", "ENTRY": "Regulation, Gene Expression, Viral|T045|NON|EQV|NLM (1992)|901015|abcdef", "MN": "G05.308.385", "MH_TH": "NLM (1990)", "ST": "T045", "AN": "coordinate with specific virus /genet ", "PI": "specific viruses (1973-1989)", "MS": "Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015967"}, {"RECTYPE": "D", "MH": "National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division", "AQ": "HI OG", "PRINT ENTRY": "United States National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division|T093|NAM|EQV|NLM (2020)|181226|abcdef", "ENTRY": "United States National Academies of Science, Engineering, and Medicine, Health and Medicine Division|T093|NAM|EQV|NLM (2020)|181010|abcdef", "MN": "N03.540.052.500.500", "MH_TH": "NLM (2020)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, NON-U.S. GOV'T; CATALOGER: Use NAF entry", "PI": "Organizations (1986-1989)", "MS": "An organization that initiates and conducts studies of national policy and planning for health care and health-related education and research; it also responds to requests from the federal government and other agencies for studies and advice. Was founded as the Institute of Medicine in 1970 and changed in 2016 to a Division of the Academies.", "PM": "2020; was NATIONAL ACADEMIES OF SCIENCE, ENGINEERING, AND MEDICINE (U.S.) HEALTH AND MEDICINE DIVISION 2017-2019; see INSTITUTE OF MEDICINE 1990-2016", "HN": "2020 (1990); was NATIONAL ACADEMIES OF SCIENCE, ENGINEERING, AND MEDICINE (U.S.) HEALTH AND MEDICINE DIVISION 2017-2019; use INSTITUTE OF MEDICINE 1990-2016", "MR": "20190118", "DA": "19890703", "DC": "1", "DX": "19900101", "UI": "D015969"}, {"RECTYPE": "D", "MH": "Gene Expression Regulation, Enzymologic", "DE": "GENE EXPRESSION REG ENZYMOL", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Regulation of Gene Expression, Enzymologic|T045|NON|EQV|NLM (1990)|890427|REG GENE EXPRESSION ENZYMOL|abcdefv", "ENTRY": "Regulation, Gene Expression, Enzymologic|T045|NON|EQV|NLM (1992)|901015|abcdef", "MN": "G05.308.320", "MH_TH": "NLM (1990)", "ST": "T045", "AN": "coordinate with specific enzyme /genet ", "PI": "Genes, Regulator (1972-1980)", "MS": "Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015971"}, {"RECTYPE": "D", "MH": "Gene Expression Regulation, Neoplastic", "DE": "GENE EXPRESSION REG NEOPL", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Regulation of Gene Expression, Neoplastic|T045|NON|EQV|NLM (1990)|890427|REG GENE EXPRESSION NEOPL|abcdefv", "ENTRY": "Regulation, Gene Expression, Neoplastic|T045|NON|EQV|NLM (1992)|901015|abcdef", "MN": "G05.308.370", "MH_TH": "NLM (1990)", "ST": "T045", "AN": "coordinate with specific neoplasm term(s) /genet ", "PI": "specific neoplasm (1972-1989)", "MS": "Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015972"}, {"RECTYPE": "D", "MH": "Gene Expression Regulation, Leukemic", "DE": "GENE EXPRESSION REG LEUKEMIC", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Regulation of Gene Expression, Leukemic|T045|NON|EQV|NLM (1990)|890427|REG GENE EXPRESSION LEUKEMIC|abcdefv", "ENTRY": "Regulation, Gene Expression, Leukemic|T045|NON|EQV|NLM (1992)|901015|abcdef", "MN": "G05.308.370.500", "MH_TH": "NLM (1990)", "ST": "T045", "AN": "oordinate with specific type of LEUKEMIA /genet ", "PI": "specific leukemia (1973-1989)", "MS": "Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in leukemia.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015973"}, {"RECTYPE": "D", "MH": "Wrongful Life", "AQ": "ES HI", "PRINT ENTRY": "Wrongful Birth|T080|NON|NRW|BIOETHICS (1990)|890428|abcdef", "ENTRY": "Wrongful Births", "MN": "N03.706.535.803", "MH_TH": "BIOETHICS (1990)", "ST": "T080", "AN": "legal action alleging \"that a defendant has wrongfully caused a child to be born\"", "PI": "Malpractice (1973-1989)", "MS": "In civil law a cause of action which alleges that a defendant has wrongfully caused a child to be born.", "PM": "90", "HN": "90", "MR": "20021031", "DA": "19890705", "DC": "1", "DX": "19900101", "UI": "D015974"}, {"RECTYPE": "D", "MH": "Consensus Development Conferences, NIH as Topic", "PRINT ENTRY": "NIH Consensus Statement Conferences as Topic|T058|NON|EQV|NLM (2022)|210312|abcdef", "MN": "N03.540.199.205.500", "MH_TH": "NLM (2008)", "ST": "T058", "AN": "IM for general design of NIH consensus development conferences as a subject or means of scientific communication; add NIH; a different main heading CONSENSUS DEVELOPMENT CONFERENCES, NIH is used for original report of a specific NIH consensus development conference", "PI": "National Institutes of Health (U.S.) (1982-1987)", "MS": "Articles on conferences sponsored by NIH presenting summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus on a subject of interest. This heading is used for NIH consensus conferences as a means of scientific communication. In indexing it is viewed as a type of review article and as a tag for any article appearing in any publication of the NIH Office of Medical Applications of Research (OMAR).", "PM": "2008; see CONSENSUS DEVELOPMENT CONFERENCES, NIH 1990-2007; was see CONSENSUS DEVELOPMENT CONFERENCES 1988-1989; was NIH CONSENSUS DEVELOPMENT see NATIONAL INSTITUTES OF HEALTH (U.S) 1982-1987", "HN": "2008(1988)", "MR": "20220712", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015975"}, {"RECTYPE": "D", "MH": "Eukaryotic Initiation Factor-1", "DS": "EUKARYOTIC INITIATION FACTOR 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Initiation Factor EIF-1|T116|T123|ACX|EQV|NLM (1990)|890510|PEPTIDE INITIATION FACTOR EIF 01|abbcdefs", "ENTRY": "Peptide Initiation Factor EIF 1", "MN": "D12.776.835.725.868.124", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Peptide Initiation Factors (1978-1989)", "MS": "A eukaryotic initiation factor that binds to 40S ribosomal subunits. Although initially considered a \"non-essential\" factor for eukaryotic transcription initiation, eukaryotic initiation factor-1 is now thought to play an important role in localizing RIBOSOMES at the initiation codon of MRNA.", "PM": "2003; see EIF-1 1990-2002", "HN": "2003(1990)", "MR": "20130709", "DA": "19891018", "DC": "1", "DX": "19900101", "UI": "D015977"}, {"RECTYPE": "D", "MH": "Trichosanthin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-Trichosanthin|T116|T121|NON|EQV|NLM (1990)|890504|abbcdef", "ENTRY": "alpha Trichosanthin", "MN": "D12.776.765.710.500.500", "PA": "Antineoplastic Agents, Phytogenic", "MH_TH": "NLM (1990)", "ST": "T121", "N1": "Proteins, specific or class, trichosanthins", "RN": "60318-52-7", "AN": "/drug eff /ultrastruct permitted", "PI": "Plant Proteins (1976-1989)", "MS": "Plant-derived ribosome-inactivating protein (RIP) purified from the Chinese medicinal herb tian-hua-fen which is obtained from the root tubers of Trichosanthes kirilowii. It has been used as an abortifacient and in the treatment of trophoblastic tumors. GLQ223 (Compound Q), a highly purified form of trichosanthin, has been proposed as antiviral treatment for AIDS.", "PM": "90", "HN": "90", "MR": "20070709", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015978"}, {"RECTYPE": "D", "MH": "Killer Cells, Lymphokine-Activated", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Lymphokine-Activated Killer Cells|T025|NON|EQV|NLM (1990)|890504|abcdef", "ENTRY": "Lymphokine-Activated Killer Cell", "MN": "A15.382.490.555.567.537.500", "FX": "Interleukin-2", "MH_TH": "NLM (1990)", "ST": "T025", "AN": "if subpopulations are discussed, coordinate IM with LYMPHOCYTE SUBSETS (IM)", "PI": "Killer Cells, Natural (1982-1989)", "MS": "Cytolytic lymphocytes with the unique capacity of killing natural killer (NK)-resistant fresh tumor cells. They are INTERLEUKIN-2-activated NK cells that have no MAJOR HISTOCOMPATIBILITY COMPLEX restriction or need for antigen stimulation. LAK cells are used for ADOPTIVE IMMUNOTHERAPY in cancer patients.", "PM": "90", "HN": "90", "MR": "20080708", "DA": "19890626", "DC": "1", "DX": "19900101", "UI": "D015979"}, {"RECTYPE": "D", "MH": "Public Health Practice", "AQ": "CL EC ES HI LJ SN ST", "ENTRY": "Public Health Practices", "MN": "N06.850.780", "MH_TH": "NLM (1990)", "ST": "T058", "AN": "general or unspecified; prefer specifics", "PI": "Public Health Administration (1968-1997)", "MS": "The activities and endeavors of the public health services in a community on any level.", "PM": "98", "HN": "98; use explode 1990-97", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19980101", "UI": "D015980"}, {"RECTYPE": "D", "MH": "Epidemiologic Factors", "DE": "EPIDEMIOL FACTORS", "PRINT ENTRY": "Epidemiologic Determinants|T169|NON|EQV|NLM (1990)|890511|EPIDEMIOL DETERMINANTS|abcdefv", "ENTRY": "Factors, Epidemiologic|T169|NON|EQV|NLM (1994)|920831|FACTORS EPIDEMIOL|abcdefv", "MN": "N06.850.490", "MH_TH": "NLM (1990)", "ST": "T169", "AN": "IM general only; for epidemiologic factors of a disease, index only disease /epidemiol ", "PI": "Epidemiology (1966-1989)", "MS": "Events, characteristics, or other definable entities that have the potential to bring about a change in a health condition or other defined outcome.", "PM": "90", "HN": "90", "MR": "20080708", "DA": "19890526", "DC": "1", "DX": "19900101", "UI": "D015981"}, {"RECTYPE": "D", "MH": "Bias", "PRINT ENTRY": "Systematic Bias|T078|NON|NRW|NLM (1990)|890511|abcdef", "ENTRY": "Outcome Measurement Error", "MN": "N06.850.490.500", "MH_TH": "NLM (2018)", "ST": "T078", "AN": "IM general only; coordinate NIM with disease /epidemiol, not /etiol; add geographic term if pertinent; do not use for \"bias\" as prejudice or subjectivity (= PREJUDICE or specifics)", "PI": "Risk (1966-1989)", "MS": "Any deviation of results or inferences from the truth, or processes leading to such deviation. Bias can result from several sources: one-sided or systematic variations in measurement from the true value (systematic error); flaws in study design; deviation of inferences, interpretations, or analyses based on flawed data or data collection; etc. There is no sense of prejudice or subjectivity implied in the assessment of bias under these conditions.", "OL": "use RESEARCH to search BIAS (EPIDEMIOLOGY) 1987-89", "PM": "2018; was Research 1987-1989", "HN": "2018(1990); use Research 1987-1989", "MR": "20190701", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015982"}, {"RECTYPE": "D", "MH": "Selection Bias", "PRINT ENTRY": "Sampling Bias|T081|NON|NRW|NLM (1990)|890510|abcdef", "ENTRY": "Sampling Errors", "MN": "N06.850.490.500.500", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "usually NIM", "PI": "Research Design (1972-1989)", "MS": "The introduction of error due to systematic differences in the characteristics between those selected and those not selected for a given study. In sampling bias, error is the result of failure to ensure that all members of the reference population have a known chance of selection in the sample.", "PM": "91; was see under BIAS (EPIDEMIOLOGY) 1990", "HN": "91(90); was see under BIAS (EPIDEMIOLOGY) 1990", "MR": "20170712", "DA": "19890525", "DC": "1", "DX": "19910101", "UI": "D015983"}, {"RECTYPE": "D", "MH": "Causality", "PRINT ENTRY": "Reinforcing Factors|T078|NON|NRW|NLM (1990)|890508|abcdef", "ENTRY": "Reinforcing Factor", "MN": "N06.850.490.625", "FX": "Mediation Analysis", "MH_TH": "NLM (1990)", "ST": "T078", "PI": "specific disease/etiology (1966-1989)", "MS": "The relating of causes to the effects they produce. Causes are termed necessary when they must always precede an effect and sufficient when they initiate or produce an effect. Any of several factors may be associated with the potential disease causation or outcome, including predisposing factors, enabling factors, precipitating factors, reinforcing factors, and risk factors.", "PM": "90", "HN": "90", "MR": "20200609", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015984"}, {"RECTYPE": "D", "MH": "Precipitating Factors", "ENTRY": "Precipitating Factor", "MN": "N06.850.490.625.500", "MH_TH": "NLM (1990)", "ST": "T080", "AN": "IM general only; coordinate NIM with disease, accident, or behavioral response ", "PI": "specific disease/etiology (1966-1989)", "MS": "Factors associated with the definitive onset of a disease, illness, accident, behavioral response, or course of action. Usually one factor is more important or more obviously recognizable than others, if several are involved, and one may often be regarded as \"necessary\". Examples include exposure to specific disease; amount or level of an infectious organism, drug, or noxious agent, etc.", "PM": "90", "HN": "90", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015985"}, {"RECTYPE": "D", "MH": "Confounding Factors, Epidemiologic", "ENTRY": "Variables, Epidemiological Confounding", "MN": "N06.850.490.718", "MH_TH": "NLM (2020)", "ST": "T169", "AN": "IM general only; coordinate NIM with disease /epidemiol, not  /etiol; specify geographic location if pertinent ", "MS": "Factors that can cause or prevent the outcome of interest but are not intermediate variables of the factor(s) under investigation.", "PM": "1990", "HN": "2020 (1990); was CONFOUNDING FACTORS (EPIDEMIOLOGY) 1990-2019", "MR": "20200429", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015986"}, {"RECTYPE": "D", "MH": "Effect Modifier, Epidemiologic", "DE": "EFF MODIFIER EPIDEMIOL", "PRINT ENTRY": "Interviewer Effect|T169|NON|NRW|NLM (1990)|890508|INTERVIEWER EFF|abcdefv", "ENTRY": "Variables, Moderator", "MN": "N06.850.490.734", "MH_TH": "NLM (1994)", "ST": "T169", "AN": "IM general only; coordinate NIM with disease /epidemiol ", "MS": "Factors that modify the effect of the putative causal factor(s) under study.", "PM": "2012; see EFFECT MODIFIERS (EPIDEMIOLOGY) 1990-2011", "HN": "2012 (1990)", "MR": "20110624", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015987"}, {"RECTYPE": "D", "MH": "Cohort Effect", "DE": "COHORT EFF", "PRINT ENTRY": "Generation Effect|T080|T081|NON|EQV|NLM (1990)|890508|GENERATION EFF|abbcdefv", "ENTRY": "Generation Effects", "MN": "N06.850.490.734.500", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "IM general only; coordinate NIM with disease /epidemiol ", "MS": "Variation in health status arising from different causal factors to which each birth cohort in a population is exposed as environment and society change.", "PM": "90", "HN": "90", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015988"}, {"RECTYPE": "D", "MH": "Healthy Worker Effect", "DE": "HEALTHY WORKER EFF", "ENTRY": "Healthy Worker Effects", "MN": "N06.850.490.734.750", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "usually NIM; coordinate with disease /epidemiol ", "MS": "Phenomenon of workers' usually exhibiting overall death rates lower than those of the general population due to the fact that the severely ill and disabled are ordinarily excluded from employment.", "PM": "90", "HN": "90", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015989"}, {"RECTYPE": "D", "MH": "Placebo Effect", "DE": "PLACEBO EFF", "PRINT ENTRY": "Placebo Response|T078|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Response, Placebo", "MN": "N06.850.490.734.875", "MH_TH": "NLM (1990)", "ST": "T078", "AN": "not restricted to drugs; IM general only", "PI": "Placebos (1966-1989)", "MS": "An effect usually, but not necessarily, beneficial that is attributable to an expectation that the regimen will have an effect, i.e., the effect is due to the power of suggestion.", "PM": "90", "HN": "90", "MR": "20210512", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015990"}, {"RECTYPE": "D", "MH": "Epidemiologic Measurements", "DE": "EPIDEMIOL MEASUREMENTS", "ENTRY": "Measurement, Epidemiologic", "MN": "N06.850.505", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "general or unspecified; prefer specifics", "MS": "Statistical calculations on the occurrence of disease or other health-related conditions in defined populations.", "PM": "98", "HN": "98; use explode 1990-97", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19980101", "UI": "D015991"}, {"RECTYPE": "D", "MH": "Body Mass Index", "PRINT ENTRY": "Quetelet Index|T033|EPO|EQV|NLM (2006)|040923|abcdef", "ENTRY": "Quetelets Index", "MN": "N06.850.505.200.100.175", "MH_TH": "NLM (1990)", "ST": "T033", "PI": "Body Weight (1966-1989)", "MS": "An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015992"}, {"RECTYPE": "D", "MH": "Life Tables", "PRINT ENTRY": "Life Table Models|T081|T170|NON|NRW|NLM (1990)|890508|abbcdef", "ENTRY": "Tables, Life", "MN": "N06.850.520.308.985.450.750", "MH_TH": "POPLINE (1981)", "ST": "T170", "PI": "Life Expectancy (1966-1978)", "MS": "Summarizing techniques used to describe the pattern of mortality and survival in populations. These methods can be applied to the study not only of death, but also of any defined endpoint such as the onset of disease or the occurrence of disease complications.", "OL": "use ACTUARIAL ANALYSIS to search LIFE TABLE METHODS 1979-89", "PM": "90; LIFE TABLE METHODS was see ACTUARIAL ANALYSIS 1979-89", "HN": "90; LIFE TABLE METHODS was see ACTUARIAL ANALYSIS 1979-89", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015993"}, {"RECTYPE": "D", "MH": "Incidence", "PRINT ENTRY": "Secondary Attack Rate|T081|NON|NRW|NLM (2021)|210510|abcdef", "ENTRY": "Secondary Attack Rates", "MN": "N06.850.520.308.985.525.375", "FX": "Risk", "MH_TH": "POPLINE (1978)", "ST": "T081", "AN": "IM general only; coordinate NIM with disease /epidemiol; specify geographic term if pertinent", "PI": "Incidence Studies (1989)", "MS": "The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time.", "OL": "use INCIDENCE STUDIES to search INCIDENCE 1989", "PM": "90; was see INCIDENCE STUDIES 1989", "HN": "90; was see INCIDENCE STUDIES 1989", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015994"}, {"RECTYPE": "D", "MH": "Prevalence", "PRINT ENTRY": "Point Prevalence|T081|NON|NRW|NLM (2021)|200410|abcdef", "ENTRY": "Prevalences", "MN": "N06.850.520.308.985.525.750", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "IM general only; coordinate NIM with disease /epidemiol; specify geographic term if pertinent", "PI": "Prevalence Studies (1989)", "MS": "The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.", "OL": "use PREVALENCE STUDIES to search PREVALENCE 1989", "PM": "90; was see PREVALENCE STUDIES 1989", "HN": "90; was see PREVALENCE STUDIES 1989", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D015995"}, {"RECTYPE": "D", "MH": "Survival Rate", "AQ": "TD", "PRINT ENTRY": "Cumulative Survival Rate|T081|NON|NRW|NLM (1990)|890512|abcdef", "ENTRY": "Times, Mean Survival", "MN": "N06.850.520.308.985.550.900", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "IM GEN only; coord NIM with disease /mortal (IM); specify geog if pertinent", "PI": "specific disease/mortality (1966-1989)", "MS": "The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015996"}, {"RECTYPE": "D", "MH": "Neonatal Screening", "AQ": "AE CL EC ES HI IS LJ MO MT NU OG PX ST TD VE", "PRINT ENTRY": "Newborn Infant Screening|T058|NON|EQV|NLM (1990)|890508|abcdef", "ENTRY": "Screenings, Newborn Infant", "MN": "N06.850.780.500.580", "FX": "Prenatal Diagnosis", "MH_TH": "NLM (1990)", "ST": "T058", "AN": "check tag INFANT, NEWBORN", "PI": "Mass Screening (1966-1989)", "MS": "The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates (INFANT, NEWBORN) from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015997"}, {"RECTYPE": "D", "MH": "Abbreviated Injury Scale", "DE": "ABBREVIATED INJ SCALE", "ENTRY": "Scales, Abbreviated Injury", "MN": "N05.715.360.300.715.500.800.100", "MH_TH": "NLM (1990)", "ST": "T170", "PI": "Wounds and Injuries/classification (1966-1989)", "MS": "Classification system for assessing impact injury severity developed and published by the American Association for Automotive Medicine. It is the system of choice for coding single injuries and is the foundation for methods assessing multiple injuries or for assessing cumulative effects of more than one injury. These include Maximum AIS (MAIS), Injury Severity Score (ISS), and Probability of Death Score (PODS).", "PM": "91; was see under TRAUMA SEVERITY INDICES 1990", "HN": "91(90); was see under TRAUMA SEVERITY INDICES 1990", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19890525", "DC": "1", "DX": "19910101", "UI": "D015998"}, {"RECTYPE": "D", "MH": "Multivariate Analysis", "DE": "MULTIVARIATE ANAL", "ENTRY": "Multivariate Analyses", "MN": "N06.850.520.830.150.500", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "usually NIM", "PI": "Statistics (1966-1989)", "MS": "A set of techniques used when variation in several variables are studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D015999"}, {"RECTYPE": "D", "MH": "Cluster Analysis", "DE": "CLUSTER ANAL", "PRINT ENTRY": "Clustering|T081|NON|EQV|NLM (1990)|890509|abcdef", "ENTRY": "Clusterings", "MN": "N06.850.520.830.250", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "usually NIM", "PI": "Statistics (1966-1989)", "MS": "A set of statistical methods used to group variables or observations into strongly inter-related subgroups. In epidemiology, it may be used to analyze a closely grouped series of events or cases of disease or other health-related phenomenon with well-defined distribution patterns in relation to time or place or both.", "OL": "use SPACE-TIME CLUSTERING to search CLUSTERING 1978-89", "PM": "90; CLUSTERING was see SPACE-TIME CLUSTERING 1978-89", "HN": "90; CLUSTERING was see SPACE-TIME CLUSTERING 1978-89", "CATSH": "CAT LIST", "MR": "20200708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016000"}, {"RECTYPE": "D", "MH": "Confidence Intervals", "ENTRY": "Intervals, Confidence", "MN": "N06.850.520.830.275", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "usually NIM", "PI": "Statistics (1972-1989)", "MS": "A range of values for a variable of interest, e.g., a rate, constructed so that this range has a specified probability of including the true value of the variable.", "PM": "91; was see under STATISTICS 1990", "HN": "91(90); was see under STATISTICS 1990", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19910101", "UI": "D016001"}, {"RECTYPE": "D", "MH": "Discriminant Analysis", "DE": "DISCRIMINANT ANAL", "ENTRY": "Discriminant Analyses", "MN": "N06.850.520.830.350", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "usually NIM", "PI": "Statistics (1966-1989)", "MS": "A statistical analytic technique used with discrete dependent variables, concerned with separating sets of observed values and allocating new values. It is sometimes used instead of regression analysis.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016002"}, {"RECTYPE": "D", "MH": "Statistical Distributions", "DE": "STATIST DISTRIBUTIONS", "ENTRY": "Statistical Distribution", "MN": "N06.850.520.830.994", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "general or unspecified; prefer specifics; coordinate with subject of data /epidemiol or /statist ", "MS": "The complete summaries of the frequencies of the values or categories of a measurement made on a group of items, a population, or other collection of data. The distribution tells either how many or what proportion of the group was found to have each value (or each range of values) out of all the possible values that the quantitative measure can have.", "PM": "98", "HN": "98; use explode 1990-97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19890525", "DC": "1", "DX": "19980101", "UI": "D016008"}, {"RECTYPE": "D", "MH": "Chi-Square Distribution", "PRINT ENTRY": "Chi-Square Test|T081|NON|REL|NLM (1990)|890512|abcdef", "ENTRY": "Tests, Chi-Square", "MN": "N06.850.520.830.994.300", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "usually NIM", "MS": "A distribution in which a variable is distributed like the sum of the squares of any given independent random variable, each of which has a normal distribution with mean of zero and variance of one. The chi-square test is a statistical test based on comparison of a test statistic to a chi-square distribution. The oldest of these tests are used to detect whether two or more population distributions differ from one another.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016009"}, {"RECTYPE": "D", "MH": "Binomial Distribution", "PRINT ENTRY": "Negative Binomial Distribution|T081|NON|NRW|NLM (1990)|890509|abcdef", "ENTRY": "Negative Binomial Distributions", "MN": "N06.850.520.830.994.250", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "usually NIM", "MS": "The probability distribution associated with two mutually exclusive outcomes; used to model cumulative incidence rates and prevalence rates. The Bernoulli distribution is a special case of binomial distribution.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016010"}, {"RECTYPE": "D", "MH": "Normal Distribution", "PRINT ENTRY": "Gaussian Distribution|T081|EPO|EQV|NLM (1990)|890512|abcdef", "ENTRY": "Normal Distributions", "MN": "N06.850.520.830.994.500", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "usually NIM", "MS": "Continuous frequency distribution of infinite range. Its properties are as follows: 1, continuous, symmetrical distribution with both tails extending to infinity; 2, arithmetic mean, mode, and median identical; and 3, shape completely determined by the mean and standard deviation.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016011"}, {"RECTYPE": "D", "MH": "Poisson Distribution", "ENTRY": "Distribution, Poisson", "MN": "N06.850.520.830.994.750", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "usually NIM", "MS": "A distribution function used to describe the occurrence of rare events or to describe the sampling distribution of isolated counts in a continuum of time or space.", "OL": "use PROBABILITY to search POISSON DISTRIBUTION 1969-89", "PM": "90; was see PROBABILITY 1979-89; was see under PROBABILITY 1969-78", "HN": "90; was see PROBABILITY 1979-89; was see under PROBABILITY 1969-78", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016012"}, {"RECTYPE": "D", "MH": "Likelihood Functions", "PRINT ENTRY": "Maximum Likelihood Estimates|T081|T170|NON|NRW|NLM (1990)|890509|abbcdef", "ENTRY": "Test, Likelihood Ratio", "MN": "N06.850.520.830.600.400", "MH_TH": "NLM (1990)", "ST": "T170", "AN": "usually NIM", "PI": "Probability (1966-1989)", "MS": "Functions constructed from a statistical model and a set of observed data which give the probability of that data for various values of the unknown model parameters. Those parameter values that maximize the probability are the maximum likelihood estimates of the parameters.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016013"}, {"RECTYPE": "D", "MH": "Linear Models", "PRINT ENTRY": "Models, Linear|T081|NON|EQV|NLM (1990)|890510|abcdef", "ENTRY": "Regressions, Linear", "MN": "N06.850.520.830.750.425", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "usually NIM", "PI": "Regression Analysis (1966-1993)", "MS": "Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression.", "OL": "use REGRESSION ANALYSIS to search LINEAR REGRESSION 1990-93", "PM": "90; LINEAR REGRESSION was see REGRESSION ANALYSIS 1990-93", "HN": "90; LINEAR REGRESSION was see REGRESSION ANALYSIS 1990-93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016014"}, {"RECTYPE": "D", "MH": "Logistic Models", "PRINT ENTRY": "Models, Logistic|T081|T170|NON|EQV|NLM (1990)|890510|abbcdef", "ENTRY": "Regressions, Logistic", "MN": "N06.850.520.830.750.450", "MH_TH": "NLM (1990)", "ST": "T170", "AN": "usually NIM", "PI": "Statistics (1974-1979)", "MS": "Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016015"}, {"RECTYPE": "D", "MH": "Proportional Hazards Models", "PRINT ENTRY": "Proportional Hazards Model|T081|T170|NON|EQV|NLM (2021)|191230|abbcdef", "ENTRY": "Models, Proportional Hazard", "MN": "N06.850.520.830.998.912", "MH_TH": "NLM (1990)", "ST": "T170", "AN": "IM general only; coordinate NIM with specific subject /statist ", "PI": "Models, Theoretical (1977-1989)", "MS": "Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016016"}, {"RECTYPE": "D", "MH": "Odds Ratio", "PRINT ENTRY": "Risk Ratio|T081|NON|EQV|NLM (1990)|890525|abcdef", "ENTRY": "Risk Ratios", "MN": "N06.850.520.830.600.600", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "usually NIM", "PI": "Risk (1977-1989)", "MS": "The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases.", "PM": "91; was see under PROBABILITY 1990", "HN": "91(90); was see under PROBABILITY 1990", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19890525", "DC": "1", "DX": "19910101", "UI": "D016017"}, {"RECTYPE": "D", "MH": "Least-Squares Analysis", "DE": "LEAST SQUARES ANAL", "PRINT ENTRY": "Rietveld Refinement|T081|EPO|NRW|NLM (2003)|011019|abcdef", "ENTRY": "Refinement, Rietveld", "MN": "N06.850.520.830.750.400", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "IM GEN only; coord NIM with specific disease or other concept (IM);", "PI": "Regression Analysis (1973-1989)", "MS": "A principle of estimation in which the estimates of a set of parameters in a statistical model are those quantities minimizing the sum of squared differences between the observed values of a dependent variable and the values predicted by the model.", "PM": "91; was see under REGRESSION ANALYSIS 1990", "HN": "91(90); was see under REGRESSION ANALYSIS 1990", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19890525", "DC": "1", "DX": "19910101", "UI": "D016018"}, {"RECTYPE": "D", "MH": "Survival Analysis", "DE": "SURVIVAL ANAL", "ENTRY": "Survival Analyses", "MN": "N06.850.520.830.998", "FX": "Proportional Hazards Models", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "IM GEN only; coord NIM with specific disease (IM)", "MS": "A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016019"}, {"RECTYPE": "D", "MH": "Epidemiologic Study Characteristics", "DE": "EPIDEMIOL STUDY CHARACTERISTICS", "ENTRY": "Study Characteristics, Epidemiologic", "MN": "N06.850.520.450", "MH_TH": "NLM (1990)", "ST": "T170", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "PI": "Research (1966-1997)", "MS": "Works about types and formulations of studies used in epidemiological research.", "PM": "2018; EPIDEMIOLOGIC STUDY CHARACTERISTICS AS TOPIC 1998-2017", "HN": "2018 (1998)", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19890525", "DC": "1", "DX": "19980101", "UI": "D016020"}, {"RECTYPE": "D", "MH": "Epidemiologic Studies", "DE": "EPIDEMIOL STUDIES", "ENTRY": "Study, Epidemiological", "MN": "N06.850.520.450.500", "MH_TH": "NLM (1990)", "ST": "T062", "AN": "exam & anal of data leading to epidemiol conclusions: differentiate from EPIDEMIOLOGY, the specialty; GEN or unspecified; prefer specifics", "PI": "Epidemiology (1967-1997)", "MS": "Studies designed to examine associations, commonly, hypothesized causal relations. They are usually concerned with identifying or measuring the effects of risk factors or exposures. The common types of analytic study are CASE-CONTROL STUDIES; COHORT STUDIES; and CROSS-SECTIONAL STUDIES.", "PM": "98", "HN": "98; use explode 1990-97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19890901", "DC": "1", "DX": "19980101", "UI": "D016021"}, {"RECTYPE": "D", "MH": "Case-Control Studies", "PRINT ENTRY": "Nested Case-Control Studies|T062|NON|NRW|NLM (1990)|890510|abcdef", "ENTRY": "Study, Nested Case-Control", "MN": "N06.850.520.450.500.500", "MH_TH": "NLM (1990)", "ST": "T062", "AN": "usually NIM", "PI": "Epidemiologic Methods (1966-1989)", "MS": "Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016022"}, {"RECTYPE": "D", "MH": "Integrins", "AQ": "AD AG AI AN BI BL CF CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Integrin|T116|T129|T192|NON|EQV|NLM (2021)|191113|abbbcdef", "MN": "D12.776.543.750.705.408", "FX": "Cell Adhesion Molecules", "MH_TH": "NLM (1990)", "ST": "T192", "RN": "0", "AN": "prefer specifics", "PI": "Receptors, Immunologic (1980-1989)", "MS": "A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.", "PM": "90", "HN": "90", "MR": "20210630", "DA": "19890707", "DC": "1", "DX": "19900101", "UI": "D016023"}, {"RECTYPE": "D", "MH": "Receptors, Cytoadhesin", "DE": "RECEPT CYTOADHESIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Extracellular Matrix Glycoprotein|T116|T129|T192|NON|BRD|NLM (1990)|890510|RECEPT EXTRACELLULAR MATRIX GLYCOPROTEIN|abbbcdefv", "ENTRY": "Extracellular Matrix Glycoprotein Receptors|T116|T129|T192|NON|BRD|NLM (1990)|890510|EXTRACELLULAR MATRIX GLYCOPROTEIN RECEPT|abbbcdefv", "MN": "D12.776.543.750.705.408.460", "MH_TH": "NLM (1990)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (1973-1989)", "MS": "A group of INTEGRINS that includes the platelet outer membrane glycoprotein GPIIb-IIIa (PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX) and the vitronectin receptor (RECEPTORS, VITRONECTIN). They play a major role in cell adhesion and serve as receptors for fibronectin, von Willebrand factor, and vitronectin.", "PM": "90", "HN": "90", "MR": "20030709", "DA": "19890707", "DC": "1", "DX": "19900101", "UI": "D016024"}, {"RECTYPE": "D", "MH": "Bone Transplantation", "DE": "BONE TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Bone|T061|NON|EQV|NLM (1990)|890510|TRANSPL BONE|abcdefv", "ENTRY": "Bone Grafting", "MN": "E04.936.580.052", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "may refer to a whole bone or a segment of bone; do not coordinate with TRANSPLANTATION, AUTOLOGOUS or TRANSPLANTATION, HETEROTOPIC unless particularly discussed", "PI": "Bone and Bones/transplantation (1966-1989)", "MS": "The grafting of bone from a donor site to a recipient site.", "PM": "90; was BONE AND BONES/transplantation 1966-89; was heading 1963-65", "HN": "90; was BONE AND BONES/transplantation 1966-89; was heading 1963-65", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19890906", "DC": "1", "DX": "19900101", "UI": "D016025"}, {"RECTYPE": "D", "MH": "Bone Marrow Transplantation", "DE": "BONE MARROW TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Bone Marrow Cell|T061|NON|NRW|NLM (2004)|030613|TRANSPL BONE MARROW CELL|abcdefv", "ENTRY": "Bone Marrow Grafting", "MN": "E04.936.580.040", "FX": "Hematopoietic Stem Cell Transplantation", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; coordinate with disease /ther; conditioning before transplantation of bone marrow: coordinate with TRANSPLANTATION CONDITIONING ", "PI": "Bone Marrow/transplantation (1966-1989)", "MS": "The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION.", "PM": "90; was BONE MARROW/transplantation 1966-89; was heading 1964-65", "HN": "90; was BONE MARROW/transplantation 1966-89; was heading 1964-65", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016026"}, {"RECTYPE": "D", "MH": "Heart Transplantation", "DE": "HEART TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Heart|T061|NON|EQV|NLM (1990)|890510|TRANSPL HEART|abcdefv", "ENTRY": "Transplantations, Heart", "MN": "E04.936.450.475", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; HEART-LUNG TRANSPLANTATION is also available", "PI": "Heart/transplantation (1966-1989)", "MS": "The transference of a heart from one human or animal to another.", "PM": "90; was HEART/transplantation 1966-89", "HN": "90; was HEART/transplantation 1966-89", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016027"}, {"RECTYPE": "D", "MH": "Receptors, Leukocyte-Adhesion", "DE": "RECEPT LEUKOCYTE ADHESION", "AQ": "AD AG AI AN BI BL CH CL DE GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Leukocyte-Adhesion Receptors|T116|T129|T192|NON|EQV|NLM (1990)|890621|LEUKOCYTE ADHESION RECEPT|abbbcdefv", "ENTRY": "Receptors, Leukocyte Adhesion", "MN": "D12.776.543.750.705.408.600", "FX": "Leukocyte-Adhesion Deficiency Syndrome", "MH_TH": "NLM (1990)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1980-1989)", "MS": "Family of proteins associated with the capacity of LEUKOCYTES to adhere to each other and to certain substrata, e.g., the C3bi component of complement. Members of this family are the LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; (LFA-1), the MACROPHAGE-1 ANTIGEN; (Mac-1), and the INTEGRIN ALPHAXBETA2 or p150,95 leukocyte adhesion protein. They all share a common beta-subunit which is the CD18 antigen. All three of the above antigens are absent in inherited LEUKOCYTE-ADHESION DEFICIENCY SYNDROME, which is characterized by recurrent bacterial infections, impaired pus formation, and wound healing as well as abnormalities in a wide spectrum of adherence-dependent functions of granulocytes, monocytes, and lymphoid cells.", "PM": "90", "HN": "90", "MR": "20030709", "DA": "19890707", "DC": "1", "DX": "19900101", "UI": "D016028"}, {"RECTYPE": "D", "MH": "Receptors, Very Late Antigen", "DE": "RECEPT VLA", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "VLA Protein Complex|T116|T129|T192|EQV|NLM (1990)|890510|abbbdef", "ENTRY": "Protein Complex, VLA", "MN": "D12.776.543.750.705.408.850", "MH_TH": "NLM (1990)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1980-1989)", "MS": "Members of the integrin family appearing late after T-cell activation. They are a family of proteins initially identified at the surface of stimulated T-cells, but now identified on a variety of cell types. At least six VLA antigens have been identified as heterodimeric adhesion receptors consisting of a single common beta-subunit and different alpha-subunits.", "PM": "90", "HN": "90", "MR": "20030709", "DA": "19890707", "DC": "1", "DX": "19900101", "UI": "D016029"}, {"RECTYPE": "D", "MH": "Kidney Transplantation", "DE": "KIDNEY TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Renal|T061|NON|EQV|NLM (1990)|890510|TRANSPL RENAL|abcdefv", "ENTRY": "Transplantations, Renal", "MN": "E04.950.774.400", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed", "PI": "Kidney/transplantation (1966-1989)", "MS": "The transference of a kidney from one human or animal to another.", "PM": "90; was KIDNEY/transplantation 1966-89; was heading 1963-65", "HN": "90; was KIDNEY/transplantation 1966-89; was heading 1963-65", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016030"}, {"RECTYPE": "D", "MH": "Liver Transplantation", "DE": "LIVER TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Liver|T061|NON|EQV|NLM (1990)|890510|TRANSPL LIVER|abcdefv", "ENTRY": "Transplant, Liver", "MN": "E04.936.580.490", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed", "PI": "Liver/transplantation(1966-1989)", "MS": "The transference of a part of or an entire liver from one human or animal to another.", "PM": "90; was LIVER/transplantation 1966-89", "HN": "90; was LIVER/transplantation 1966-89", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016031"}, {"RECTYPE": "D", "MH": "Randomized Controlled Trials as Topic", "AQ": "CL EC ES HI IS LJ MT PX SN ST VE", "PRINT ENTRY": "Controlled Clinical Trials, Randomized|T062|T170|NON|NRW|NLM (1990)|890510|CONTROLLED CLIN TRIALS RANDOMIZED|abbcdefv", "ENTRY": "Trials, Randomized Clinical|T062|T170|NON|NRW|NLM (1994)|920817|TRIALS RANDOMIZED CLIN|abbcdefv", "MN": "N06.850.520.450.250.250.365.500", "FX": "Non-Randomized Controlled Trials as Topic", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "for general design, methodology, economics, etc. of randomized controlled trials; a different heading RANDOMIZED CONTROLLED TRIAL is used for reports of a specific randomized trial", "PI": "Clinical Trials (1966-1989)", "MS": "Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.", "PM": "2008; see RANDOMIZED CONTROLLED TRIALS 1990-2007", "HN": "2008(1990)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016032"}, {"RECTYPE": "D", "MH": "Pancreas Transplantation", "DE": "PANCREAS TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Pancreas|T061|NON|EQV|NLM (1990)|890510|TRANSPL PANCREAS|abcdefv", "ENTRY": "Transplantations, Pancreas", "MN": "E04.936.450.650", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; in therapy of diabetes mellitus, ISLETS OF LANGERHANS TRANSPLANTATION is probably the correct term", "PI": "Pancreas/transplantation (1966-1989)", "MS": "The transference of a pancreas from one human or animal to another.", "PM": "90; was PANCREAS/transplantation 1966-89", "HN": "90; was PANCREAS/transplantation 1966-89", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016035"}, {"RECTYPE": "D", "MH": "Seroepidemiologic Studies", "DE": "SEROEPIDEMIOL STUDIES", "PRINT ENTRY": "Seroprevalence|T062|NON|NRW|NLM (1999)|980519|abcdef", "ENTRY": "Study, Seroepidemiological", "MN": "N06.850.520.450.500.950", "MH_TH": "NLM (1990)", "ST": "T062", "AN": "IM GEN only; coord NIM with specific disease (IM); specify geog if pertinent", "PI": "Epidemiologic Methods (1977-1989)", "MS": "EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases.", "PM": "99; see SEROEPIDEMIOLOGIC METHODS 1990-98", "HN": "99(90)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19890706", "DC": "1", "DX": "19900101", "UI": "D016036"}, {"RECTYPE": "D", "MH": "Single-Blind Method", "PRINT ENTRY": "Single-Masked Study|T062|NON|REL|NLM (1995)|940124|abcdef", "ENTRY": "Study, Single-Masked", "MN": "N06.850.520.445.850", "MH_TH": "NLM (1990)", "ST": "T062", "AN": "IM general only; coordinate NIM with specific disease; when pertinent add CLINICAL TRIAL (PT) or RANDOMIZED CONTROLLED TRIAL (PT); do not index PLACEBOS unless particularly discussed", "MS": "A method in which either the observer(s) or the subject(s) is kept ignorant of the group to which the subjects are assigned.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19890621", "DC": "1", "DX": "19900101", "UI": "D016037"}, {"RECTYPE": "D", "MH": "Skin Transplantation", "DE": "SKIN TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Skin|T061|NON|EQV|NLM (1990)|890510|TRANSPL SKIN|abcdefv", "ENTRY": "Transplantations, Skin", "MN": "E04.936.580.700", "FX": "Surgical Flaps", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "do not coordinate with TRANSPLANTATION, AUTOLOGOUS or TRANSPLANTATION, HETEROTOPIC unless particularly discussed", "PI": "Skin/transplantation (1966-1989)", "MS": "The grafting of skin in humans or animals from one site to another to replace a lost portion of the body surface skin.", "PM": "90; was SKIN/transplantation 1966-89; was heading 1963-65", "HN": "90; was SKIN/transplantation 1966-89; was heading 1963-65", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016038"}, {"RECTYPE": "D", "MH": "Corneal Transplantation", "DE": "CORNEAL TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Corneal|T061|NON|EQV|NLM (1990)|890510|TRANSPL CORNEAL|abcdefv", "ENTRY": "Transplantations, Corneal", "MN": "E04.936.580.225", "FX": "Eye Banks", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed", "PI": "Cornea/transplantation (1966-1989)", "MS": "Partial or total replacement of the CORNEA from one human or animal to another.", "PM": "90; was CORNEA/transplantation 1966-89; was heading 1963-65", "HN": "90; was CORNEA/transplantation 1966-89; was heading 1963-65", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016039"}, {"RECTYPE": "D", "MH": "Lung Transplantation", "DE": "LUNG TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Lung|T061|NON|EQV|NLM (1990)|890510|TRANSPL LUNG|abcdefv", "ENTRY": "Transplantations, Lung", "MN": "E04.936.450.495", "FX": "Heart-Lung Transplantation", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; HEART-LUNG TRANSPLANTATION is also available", "PI": "Lung/transplantation (1966-1989)", "MS": "The transference of either one or both of the lungs from one human or animal to another.", "PM": "90; was LUNG/transplantation 1966-89", "HN": "90; was LUNG/transplantation 1966-89", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016040"}, {"RECTYPE": "D", "MH": "Heart-Lung Transplantation", "DE": "HEART LUNG TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Heart-Lung|T061|NON|EQV|NLM (1990)|890510|TRANSPL HEART LUNG|abcdefv", "ENTRY": "Transplantations, Heart-Lung", "MN": "E04.936.450.495.450", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed", "PI": "Lung/transplantation (1966-1989)", "MS": "The simultaneous, or near simultaneous, transference of heart and lungs from one human or animal to another.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016041"}, {"RECTYPE": "D", "MH": "Transplantation, Heterotopic", "DE": "TRANSPL HETEROTOPIC", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Transplantations, Heterotopic", "MN": "E04.936.800", "MH_TH": "NLM (1990)", "ST": "T061", "AN": "coordinate with organ/transpl or precoordinated organ/transpl term + implant site with no qualifiers; do not confuse with TRANSPLANTATION, HETEROLOGOUS; Manual 19.8.75", "PI": "Transplantation, Homologous (1966-1989)", "MS": "Transplantation of tissue typical of one area to a different recipient site. The tissue may be autologous, heterologous, or homologous.", "PM": "90", "HN": "90", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19890620", "DC": "1", "DX": "19900101", "UI": "D016042"}, {"RECTYPE": "D", "MH": "Fusion Proteins, bcr-abl", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "bcr-abl Fusion Proteins|T116|T126|ABX|EQV|NLM (1991)|900514|abbcdef", "ENTRY": "bcr abl Fusion Proteins", "MN": "D12.776.624.664.700.171.500", "FX": "Philadelphia Chromosome", "MH_TH": "NLM (1990)", "ST": "T126", "RN": "EC 2.7.10.2", "PI": "Neoplasm Proteins (1986-1989)", "MS": "Translation products of a fusion gene derived from CHROMOSOMAL TRANSLOCATION of C-ABL GENES to the genetic locus of the breakpoint cluster region gene on chromosome 22. Several different variants of the bcr-abl fusion proteins occur depending upon the precise location of the chromosomal breakpoint. These variants can be associated with distinct subtypes of leukemias such as PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; and NEUTROPHILIC LEUKEMIA, CHRONIC.", "OL": "use FUSION PROTEINS, BCR-ABL to search BCR-ABL FUSION PROTEINS 1990", "PM": "91; was BCR-ABL FUSION PROTEINS 1990", "HN": "91; was BCR-ABL FUSION PROTEINS 1990", "MR": "20210630", "DA": "19890525", "DC": "1", "DX": "19900101", "UI": "D016044"}, {"RECTYPE": "D", "MH": "Human Genome Project", "AQ": "EC ES HI LJ OG", "PRINT ENTRY": "Human Genome Diversity Project|T062|NON|REL|NLM (2002)|001114|abcdef", "ENTRY": "Projects, Human Genome", "MN": "L01.462.750.450", "FX": "Genomics", "MH_TH": "NLM (1990)", "ST": "T062", "AN": "CATALOGER: Coordinate with specific NAF entry if applicable", "PI": "Chromosomes, Human (1987-1989)", "MS": "A coordinated effort of researchers to map (CHROMOSOME MAPPING) and sequence (SEQUENCE ANALYSIS, DNA) the human GENOME.", "PM": "90", "HN": "90", "MR": "20220712", "DA": "19890606", "DC": "1", "DX": "19900101", "UI": "D016045"}, {"RECTYPE": "D", "MH": "Zalcitabine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ddC (Antiviral)|T114|T121|EQV|NLM (1990)|890619|DDC|abbdefs", "ENTRY": "NSC606170", "MN": "D13.570.685.245.500.950", "PA": "Reverse Transcriptase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Cytidine, 2',3'-dideoxy-", "RN": "6L3XT8CB3I", "RR": "7481-89-2 (Zalcitabine)", "PI": "Dideoxynucleosides (1989)", "MS": "A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy.", "OL": "use ZALCITABINE to search DIDEOXYCYTIDINE 1990-93", "PM": "94; was DIDEOXYCYTIDINE 1990-93", "HN": "94; was DIDEOXYCYTIDINE 1990-93", "MR": "20170524", "DA": "19890714", "DC": "1", "DX": "19900101", "UI": "D016047"}, {"RECTYPE": "D", "MH": "Dideoxyadenosine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ddA (Antiviral)|T114|T121|EQV|NLM (1990)|890620|abbdef", "ENTRY": "2',3' Dideoxyadenosine", "MN": "D13.570.583.138.325.105", "PA": "Antiviral Agents", "MH_TH": "NLM (1990)", "ST": "T121", "N1": "Adenosine, 2',3'-dideoxy-", "RN": "4Q86AH641A", "RR": "4097-22-7 (Dideoxyadenosine)", "AN": "an antiviral; inhibits HIV replication", "PI": "Dideoxynucleosides (1989)", "MS": "A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is an inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal side effect is nephrotoxicity. In vivo, dideoxyadenosine is rapidly metabolized to DIDANOSINE (ddI) by enzymatic deamination; ddI is then converted to dideoxyinosine monophosphate and ultimately to dideoxyadenosine triphosphate, the putative active metabolite.", "PM": "90", "HN": "90", "MR": "20160531", "DA": "19890714", "DC": "1", "DX": "19900101", "UI": "D016048"}, {"RECTYPE": "D", "MH": "Didanosine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ddI (Antiviral)|T114|T121|EQV|NLM (1990)|890620|DDI|abbdefv", "ENTRY": "NSC612049", "MN": "D13.570.800.573.130", "PA": "Reverse Transcriptase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Inosine, 2',3'-dideoxy-", "RN": "K3GDH6OH08", "RR": "69655-05-6 (Didanosine)", "PI": "Inosine/analogs & derivatives (1987-1989)", "MS": "A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite.", "OL": "use DIDANOSINE to search DIDEOXYINOSINE 1990-91", "PM": "92; was DIDEOXYINOSINE 1990-91", "HN": "92; was DIDEOXYINOSINE 1990-91", "MR": "20170524", "DA": "19890714", "DC": "1", "DX": "19900101", "UI": "D016049"}, {"RECTYPE": "D", "MH": "Protozoan Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Protozoan", "MN": "D20.215.894.582", "MH_TH": "NLM (1991)", "ST": "T129", "RN": "0", "AN": "coord IM with specific protozoon /immunol (IM)", "PI": "specific Protozoa (1977-1990)", "MS": "Suspensions of attenuated or killed protozoa administered for the prevention or treatment of infectious protozoan disease.", "PM": "91", "HN": "91", "MR": "20050630", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016052"}, {"RECTYPE": "D", "MH": "RNA, Protozoan", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protozoan RNA|T114|NON|EQV|NLM (1991)|900125|abcdef", "MN": "D13.444.735.650", "MH_TH": "NLM (1991)", "ST": "T114", "RN": "0", "AN": "IM; coord with specific protozoon (IM); /drug eff /ultrastruct permitted", "PI": "specific protozoa (1966-1990)", "MS": "Ribonucleic acid in protozoa having regulatory and catalytic roles as well as involvement in protein synthesis.", "PM": "91", "HN": "91", "MR": "19950608", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016053"}, {"RECTYPE": "D", "MH": "DNA, Protozoan", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protozoan DNA|T114|NON|EQV|NLM (1991)|900125|abcdef", "MN": "D13.444.308.442", "MH_TH": "NLM (1991)", "ST": "T114", "RN": "0", "AN": "IM; coord with specific protozoon (IM); /drug eff /ultrastruct permitted", "PI": "specific protozoa (1966-1990)", "MS": "Deoxyribonucleic acid that makes up the genetic material of protozoa.", "PM": "91", "HN": "91", "MR": "19950608", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016054"}, {"RECTYPE": "D", "MH": "Urinary Retention", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Retention, Urinary", "MN": "C12.950.934.880", "FX": "Urinary Catheterization", "MH_TH": "NLM (1991)", "ST": "T184", "AN": "do not confuse with ANURIA, total suppression of urine production by the kidneys", "PI": "Urination Disorders (1966-1990)", "MS": "Inability to empty the URINARY BLADDER with voiding (URINATION).", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016055"}, {"RECTYPE": "D", "MH": "Immunodominant Epitopes", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunodominant Site|T129|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Sites, Immunodominant", "MN": "D23.050.550.500", "MH_TH": "NLM (1991)", "ST": "T129", "RN": "0", "AN": "subunits of epitopes most easily recognized by the immune system", "PI": "Antigenic Determinants (1966-1990)", "MS": "Subunits of the antigenic determinant that are most easily recognized by the immune system and thus most influence the specificity of the induced antibody.", "PM": "91", "HN": "91", "MR": "20200527", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016056"}, {"RECTYPE": "D", "MH": "Evoked Potentials, Auditory, Brain Stem", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Evoked Responses, Auditory, Brain Stem|T042|T060|NON|EQV|NLM (1991)|890804|BAER|abbcdefv", "ENTRY": "Responses, Auditory Brainstem", "MN": "G11.561.200.500.370.300", "FX": "Audiometry, Evoked Response", "MH_TH": "NLM (1991)", "ST": "T060", "PI": "Evoked Potentials, Auditory (1979-1990)", "MS": "Electrical waves in the CEREBRAL CORTEX generated by BRAIN STEM structures in response to auditory click stimuli. These are found to be abnormal in many patients with CEREBELLOPONTINE ANGLE lesions, MULTIPLE SCLEROSIS, or other DEMYELINATING DISEASES.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016057"}, {"RECTYPE": "D", "MH": "Analgesia, Patient-Controlled", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Patient Controlled Analgesia", "MN": "E03.091.120", "MH_TH": "NLM (1991)", "ST": "T061", "PI": "Self Administration (1979-1990)", "MS": "Relief of PAIN, without loss of CONSCIOUSNESS, through ANALGESIC AGENTS administered by the patients. It has been used successfully to control POSTOPERATIVE PAIN, during OBSTETRIC LABOR, after BURNS, and in TERMINAL CARE. The choice of agent, dose, and lockout interval greatly influence effectiveness. The potential for overdose can be minimized by combining small bolus doses with a mandatory interval between successive doses (lockout interval).", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016058"}, {"RECTYPE": "D", "MH": "Range of Motion, Articular", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Passive Range of Motion|T042|NON|NRW|NLM (1991)|890804|abcdef", "ENTRY": "Flexibility, Joint", "MN": "G11.427.760", "FX": "Pliability", "MH_TH": "NLM (1991)", "ST": "T081", "PI": "specific joints (1966-1990)", "MS": "The distance and direction to which a bone joint can be extended. Range of motion is a function of the condition of the joints, muscles, and connective tissues involved. Joint flexibility can be improved through appropriate MUSCLE STRETCHING EXERCISES.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016059"}, {"RECTYPE": "D", "MH": "Sorption Detoxification", "DE": "SORPTION DETOX", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Sorption Detoxifications", "MN": "E02.912", "MH_TH": "NLM (1991)", "ST": "T061", "PI": "Hemoperfusion (1983-1990)", "MS": "Elimination of toxic or biologically active substances from body fluids by interaction with a sorbent medium. The types of media include absorbents, adsorbents, ion-exchange materials, and complexing agents. Detoxification can be extracorporeal (hemodialysis, hemofiltration, hemoperfusion, plasmapheresis), or occur inside the body (enterosorption, peritoneal dialysis).", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016060"}, {"RECTYPE": "D", "MH": "Enterosorption", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Enterosorptions", "MN": "E02.912.300", "MH_TH": "NLM (1991)", "ST": "T061", "PI": "Intestinal Absorption (1983-1990)", "MS": "Adsorption of substances from the gastrointestinal tract onto an orally administered sorbent medium like activated charcoal. This technique is used to eliminate toxic and some biologically active substances and serves to modify the lipid and amino acid spectrum of the intestinal contents.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016061"}, {"RECTYPE": "D", "MH": "Porosity", "AQ": "DE RE", "ENTRY": "Porosities", "MN": "G01.374.710", "MH_TH": "NLM (1991)", "ST": "T080", "AN": "almost never IM", "PI": "Surface Properties (1966-1990)", "MS": "Condition of having pores or open spaces. This often refers to bones, bone implants, or bone cements, but can refer to the porous state of any solid substance.", "PM": "91", "HN": "91", "MR": "20080708", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016062"}, {"RECTYPE": "D", "MH": "Blood Loss, Surgical", "DE": "BLOOD LOSS SURG", "AQ": "MO NU PC PP SN VE", "PRINT ENTRY": "Surgical Blood Loss|T033|T046|NON|EQV|NLM (1991)|890828|SURG BLOOD LOSS|abbcdefv", "ENTRY": "Surgical Hemorrhages", "MN": "C23.550.505.300", "FX": "Hemostasis, Surgical", "MH_TH": "NLM (1991)", "ST": "T046", "AN": "/prev: consider also HEMOSTASIS, SURGICAL; for vol of blood lost, coord IM with BLOOD VOLUME (NIM)", "PI": "Hemorrhage (1966-1990)", "MS": "Loss of blood during a surgical procedure.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016063"}, {"RECTYPE": "D", "MH": "Vaginal Birth after Cesarean", "DE": "VBAC", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Vaginal Births after Cesarean|T061|NON|EQV|NLM (1991)|890901|abcdef", "MN": "E04.520.252.992", "MH_TH": "NLM (1991)", "ST": "T061", "PI": "Labor (1980-1987)", "MS": "Delivery of an infant through the vagina in a female who has had a prior cesarean section.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016064"}, {"RECTYPE": "D", "MH": "Myoelectric Complex, Migrating", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Migrating Motor Complex|T042|NON|EQV|NLM (1991)|890905|abcdef", "ENTRY": "Myoelectric Complexes, Migrating", "MN": "G11.561.570.837", "MH_TH": "NLM (1991)", "ST": "T042", "PI": "Gastrointestinal Motility (1977-1990)", "MS": "A pattern of gastrointestinal muscle contraction and depolarizing myoelectric activity that moves from the stomach to the ILEOCECAL VALVE at regular frequency during the interdigestive period. The complex and its accompanying motor activity periodically cleanse the bowel of interdigestive secretion and debris in preparation for the next meal.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016065"}, {"RECTYPE": "D", "MH": "Pleural Effusion, Malignant", "AQ": "BL CF CH CI CL CN CO CY DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Malignant Pleural Effusion|T191|NON|EQV|NLM (2023)|210920|abcdef", "ENTRY": "Pleural Effusions, Malignant", "MN": "C08.785.640.700", "MH_TH": "NLM (1991)", "ST": "T191", "AN": "do not confuse with PRIMARY EFFUSION LYMPHOMA, often found in the pleural cavity", "PI": "specific neoplasm (1966-1990)", "MS": "Presence of fluid in the PLEURAL CAVITY as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016066"}, {"RECTYPE": "D", "MH": "Nerve Transfer", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Neurotization|T061|NON|EQV|NLM (1991)|900319|abcdef", "ENTRY": "Transfers, Nerve", "MN": "E04.525.550", "FX": "Nerve Regeneration", "MH_TH": "NLM (1991)", "ST": "T061", "PI": "specific nerve/transplantation (1972-1990)", "MS": "Surgical reinnervation of a denervated peripheral target using a healthy donor nerve and/or its proximal stump. The direct connection is usually made to a healthy postlesional distal portion of a non-functioning nerve or implanted directly into denervated muscle or insensitive skin. Nerve sprouts will grow from the transferred nerve into the denervated elements and establish contact between them and the neurons that formerly controlled another area.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016067"}, {"RECTYPE": "D", "MH": "Refusal to Treat", "AQ": "ES LJ SN", "PRINT ENTRY": "Physician Refusal to Treat|T058|NON|NRW|NLM (1991)|900118|abcdef", "ENTRY": "Abandonment, Patient", "MN": "N05.300.100.675", "MH_TH": "NLM (1991)", "ST": "T058", "AN": "refusal of a health professional to treat a patient: do not confuse with PATIENT REFUSAL OF TREATMENT see TREATMENT REFUSAL", "PI": "Physician-Patient Relations (1966-1990)", "MS": "Refusal of the health professional to initiate or continue treatment of a patient or group of patients. The refusal can be based on any reason. The concept is differentiated from PATIENT REFUSAL OF TREATMENT see TREATMENT REFUSAL which originates with the patient and not the health professional.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20021031", "DA": "19900607", "DC": "1", "DX": "19910101", "UI": "D016079"}, {"RECTYPE": "D", "MH": "Arachnoid Cysts", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Leptomeningeal Cysts|T020|NON|EQV|NLM (1991)|900309|abcdef", "ENTRY": "Leptomeningeal Cyst", "MN": "C16.131.666.142.100", "MH_TH": "NLM (1991)", "ST": "T020", "AN": "non-neoplastic", "PI": "Cysts (1966-1990)", "MS": "Intracranial or spinal cavities containing a cerebrospinal-like fluid, the wall of which is composed of arachnoidal cells. They are most often developmental or related to trauma. Intracranial arachnoid cysts usually occur adjacent to arachnoidal cistern and may present with HYDROCEPHALUS; HEADACHE; SEIZURES; and focal neurologic signs. (From Joynt, Clinical Neurology, 1994, Ch44, pp105-115)", "PM": "1991", "HN": "1991", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016080"}, {"RECTYPE": "D", "MH": "Moon", "PRINT ENTRY": "Lunar Phases|T079|NON|REL|NLM (1991)|891120|abcdef", "ENTRY": "Phases, Moon", "MN": "G01.060.075.730.700.200.500", "MH_TH": "NLM (1991)", "ST": "T083", "AN": "moon illusion: coordinate with OPTICAL ILLUSIONS ", "PI": "Space Flight (1966-1990)", "MS": "The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.", "PM": "91", "HN": "91", "MR": "20160617", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016081"}, {"RECTYPE": "D", "MH": "Solar System", "AQ": "CH", "PRINT ENTRY": "Sun|T083|NON|NRW|NLM (1995)|940205|abcdef", "ENTRY": "System, Solar", "MN": "G01.060.075.730", "MH_TH": "NLM (1991)", "ST": "T169", "PI": "Extraterrestrial Environment (1966-1990)", "MS": "The group of celestial bodies, including the EARTH, orbiting around and gravitationally bound by the sun. It includes eight planets, one minor planet, and 34 natural satellites, more than 1,000 observed comets, and thousands of lesser bodies known as MINOR PLANETS (asteroids) and METEOROIDS. (From Academic American Encyclopedia, 1983)", "PM": "91", "HN": "91", "MR": "20160617", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016082"}, {"RECTYPE": "D", "MH": "Planets", "ENTRY": "Planet", "MN": "G01.060.075.730.700", "FX": "Minor Planets", "MH_TH": "NLM (1991)", "ST": "T169", "AN": "MINOR PLANETS is also available", "PI": "Extraterrestrial Environment (1966-1990)", "MS": "Celestial bodies orbiting around the sun or other stars.", "PM": "91", "HN": "91", "MR": "20160617", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016083"}, {"RECTYPE": "D", "MH": "Bronchoconstriction", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Bronchial Constriction|T042|NON|EQV|NLM (1991)|891121|abcdef", "ENTRY": "Constrictions, Bronchial", "MN": "G09.772.705.700.080", "FX": "Bronchoconstrictor Agents", "MH_TH": "NLM (1991)", "ST": "T042", "PI": "Bronchi/physiology (1966-1990)", "MS": "Narrowing of the caliber of the BRONCHI, physiologically or as a result of pharmacological intervention.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016084"}, {"RECTYPE": "D", "MH": "Bronchoconstrictor Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bronchial-Constricting Agents|T121|NON|EQV|NLM (1991)|891121|abcdef", "ENTRY": "Effects, Bronchoconstrictor", "MN": "D27.505.954.796.170", "MH_TH": "NLM (1991)", "ST": "T121", "RN": "0", "AN": "note entry term BRONCHOCONSTRICTOR EFFECT: use only for the bronchoconstrictor effect of a chemical substance", "PI": "Bronchi/drug effects (1966-1990)", "MS": "Agents causing the narrowing of the lumen of a bronchus or bronchiole.", "PM": "91", "HN": "91", "MR": "20110624", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016085"}, {"RECTYPE": "D", "MH": "Lentivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Lentivirinae|T005|NON|BRD|NLM (1994)|921125|abcdef", "ENTRY": "Lentiviruses", "MN": "B04.820.650.589", "MH_TH": "NLM (1991)", "ST": "T005", "RN": "txid11646", "PI": "Visna Virus (1979-1990)", "MS": "A genus of the family RETROVIRIDAE consisting of non-oncogenic retroviruses that produce multi-organ diseases characterized by long incubation periods and persistent infection. Lentiviruses are unique in that they contain open reading frames (ORFs) between the pol and env genes and in the 3' env region. Five serogroups are recognized, reflecting the mammalian hosts with which they are associated. HIV-1 is the type species.", "OL": "use LENTIVIRUS to search LENTIVIRINAE 1991-93", "PM": "94; was LENTIVIRINAE 1991-93", "HN": "94; was LENTIVIRINAE 1991-93", "MR": "20200902", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016086"}, {"RECTYPE": "D", "MH": "Immunodeficiency Virus, Bovine", "DE": "IMMUNODEFIC VIRUS BOVINE", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Immunodeficiency-Like Viruses, Bovine", "MN": "B04.820.650.589.500.400", "MH_TH": "NLM (1991)", "ST": "T005", "RN": "txid11657", "AN": "infection: coord IM with LENTIVIRUS INFECTIONS (IM)", "PI": "Retroviridae (1987-1990)", "MS": "The type species of LENTIVIRUS, subgenus bovine lentiviruses (LENTIVIRUSES, BOVINE), found in cattle and causing lymphadenopathy, LYMPHOCYTOSIS, central nervous system lesions, progressive weakness, and emaciation. It has immunological cross-reactivity with other lentiviruses including HIV.", "OL": "use IMMUNODEFICIENCY VIRUS, BOVINE to search BOVINE IMMUNODEFICIENCY-LIKE VIRUS 1991-93", "PM": "94; was BOVINE IMMUNODEFICIENCY-LIKE VIRUS 1991-93", "HN": "94; was BOVINE IMMUNODEFICIENCY-LIKE VIRUS 1991-93", "MR": "20200813", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016087"}, {"RECTYPE": "D", "MH": "Arthritis-Encephalitis Virus, Caprine", "DE": "ARTHRITIS ENCEPH VIRUS CAPRINE", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Caprine arthritis-encephalitis virus|T005|NON|EQV|NLM (1994)|921204|CAPRINE ARTHRITIS ENCEPH VIRUS|abcdefv", "ENTRY": "Caprine arthritis encephalitis virus", "MN": "B04.820.650.589.600.070", "MH_TH": "NLM (1991)", "ST": "T005", "RN": "txid11660", "AN": "infection: coord IM with LENTIVIRUS INFECTIONS (IM)", "PI": "Visna Virus (1983-1990)", "MS": "A species of LENTIVIRUS, subgenus ovine-caprine lentiviruses (LENTIVIRUSES, OVINE-CAPRINE), closely related to VISNA-MAEDI VIRUS and causing acute encephalomyelitis; chronic arthritis; PNEUMONIA; MASTITIS; and GLOMERULONEPHRITIS in goats. It is transmitted mainly in the colostrum and milk.", "OL": "use ARTHRITIS-ENCEPHALITIS VIRUS, CAPRINE to search CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS 1991-93", "PM": "94; was CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS 1991-93", "HN": "94; was CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS 1991-93", "MR": "20200813", "DA": "19900607", "DC": "1", "DX": "19910101", "UI": "D016088"}, {"RECTYPE": "D", "MH": "Immunodeficiency Virus, Feline", "DE": "IMMUNODEFIC VIRUS FELINE", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Puma lentivirus|T005|NON|NRW|NLM (2002)|010511|abcdef", "ENTRY": "T-Lymphotropic Virus, Feline", "MN": "B04.820.650.589.530.400", "MH_TH": "NLM (1991)", "ST": "T005", "RN": "txid11673", "RR": "txid12804", "AN": "infection: coordinate with LENTIVIRUS INFECTIONS or FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME if specified by author", "PI": "Retroviridae (1987-1990)", "MS": "A species of LENTIVIRUS, subgenus feline lentiviruses (LENTIVIRUSES, FELINE) isolated from cats with a chronic wasting syndrome, presumed to be immune deficiency. There are 3 strains: Petaluma (FIP-P), Oma (FIP-O) and Puma lentivirus (PLV). There is no antigenic relationship between FIV and HIV, nor does FIV grow in human T-cells.", "OL": "use IMMUNODEFICIENCY VIRUS, FELINE to search FELINE IMMUNODEFICIENCY VIRUS 1991-93", "PM": "94; was FELINE IMMUNODEFICIENCY VIRUS 1991-93", "HN": "94; was FELINE IMMUNODEFICIENCY VIRUS 1991-93", "MR": "20200813", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016089"}, {"RECTYPE": "D", "MH": "Spumavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Spumavirinae|T005|NON|BRD|NLM (1994)|930223|abcdef", "ENTRY": "viruses, Feline foamy", "MN": "B04.820.650.850", "MH_TH": "NLM (1991)", "ST": "T005", "RN": "txid11640", "RR": "txid53182", "AN": "infection: coordinate IM with RETROVIRIDAE INFECTIONS (IM); note HUMAN SPUMAVIRUS and CHIMPANZEE FOAMY VIRUS are entry terms to SIMIAN FOAMY VIRUS", "PI": "Retroviridae (1977-1990)", "MS": "Genus of non-oncogenic retroviruses which establish persistent infections in many animal species but are considered non-pathogenic. Its species have been isolated from primates (including humans), cattle, cats, hamsters, horses, and sea lions. Spumaviruses have a foamy or lace-like appearance and are often accompanied by syncytium formation. SIMIAN FOAMY VIRUS is the type species.", "OL": "use SPUMAVIRUS to search SPUMAVIRINAE 1991-93", "PM": "94; was SPUMAVIRINAE 1991-93; FOAMY VIRUS was see under RETROVIRIDAE 1981-90, was see under LEUKOVIRUSES 1978-80, & was see under LEUKEMOGENIC VIRUSES 1975-77.", "HN": "94; was SPUMAVIRINAE 1991-93; FOAMY VIRUS was see under RETROVIRIDAE 1981-90, was see under LEUKOVIRUSES 1978-80, & was see under LEUKEMOGENIC VIRUSES 1975-77.", "MR": "20200902", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016092"}, {"RECTYPE": "D", "MH": "Mason-Pfizer monkey virus", "DE": "MPMV", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Simian retrovirus 2|T005|NON|NRW|NLM (2002)|010428|SIMIAN RETROVIRUS 002|abcdefs", "ENTRY": "Mason Pfizer monkey virus", "MN": "B04.820.650.805.550", "MH_TH": "NLM (1991)", "ST": "T005", "RN": "txid11855", "RR": "txid39068", "AN": "infection: coordinate with SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME or if not so specified RETROVIRIDAE INFECTIONS + TUMOR VIRUS INFECTIONS ", "PI": "Vertebrate Viruses, Unclassified (1966-1971)", "MS": "A species of BETARETROVIRUS isolated from mammary carcinoma in rhesus monkeys. It appears to have evolved from a recombination between a murine B oncovirus and a primate C oncovirus related to the baboon endogenous virus. Several serologically distinct strains exist. MPMV induces SIMIAN AIDS.", "OL": "use SIV to search MASON-PFIZER MONKEY VIRUS 1989-90", "PM": "91; was see SIV 1989-90", "HN": "91; was see SIV 1989-90", "MR": "20200813", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016093"}, {"RECTYPE": "D", "MH": "Simian Acquired Immunodeficiency Syndrome", "DE": "SIMIAN ACQUIRED IMMUNODEFIC SYNDROME", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Simian AIDS|T047|EQV|NLM (1991)|891207|abdef", "ENTRY": "Simian Acquired Immuno Deficiency Syndrome", "MN": "C22.735.500.850", "MH_TH": "NLM (1991)", "ST": "T047", "AN": "coord IM with RETROVIRUSES, SIMIAN or a specific (IM) or MASON-PFIZER MONKEY VIRUS (IM) or SIMIAN IMMUNODEFICIENCY VIRUS (IM) if pertinent", "PI": "Retrovirus Infections (1986-1990)", "MS": "Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20190529", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016097"}, {"RECTYPE": "D", "MH": "Gerstmann-Straussler-Scheinker Disease", "DE": "GERSTMANN STRAUSSLER SCHEINKER DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Gerstmann-Straussler Syndrome|T047|EPO|EQV|NLM (1991)|990101|abcdef", "ENTRY": "Inherited Spongiform Encephalopathy, Gerstmann Straussler", "MN": "C16.320.400.350", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a prion dis: do not confuse with GERSTMANN SYNDROME, a type of agnosia", "PI": "Slow Virus Diseases (1988-1990)", "MS": "An autosomal dominant familial prion disease with a wide spectrum of clinical presentations including ATAXIA, spastic paraparesis, extrapyramidal signs, and DEMENTIA. Clinical onset is in the third to sixth decade of life and the mean duration of illness prior to death is five years. Several kindreds with variable clinical and pathologic features have been described. Pathologic features include cerebral prion protein amyloidosis, and spongiform or neurofibrillary degeneration. (From Brain Pathol 1998 Jul;8(3):499-513; Brain Pathol 1995 Jan;5(1):61-75)", "PM": "2000; see GERSTMANN-STRAUSSLER SYNDROME 1991-1999; see SLOW VIRUS DISEASES 1988-1990; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE was GERSTMANN-STRAUSSLER-SCHEINDER DISEASE see GERSTMANN-STRAUSSLER SYNDROME 1991", "HN": "2000(1991); use SLOW VIRUS DISEASES 1988-1990; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE was GERSTMANN-STRAUSSLER-SCHEINDER DISEASE see GERSTMANN-STRAUSSLER SYNDROME 1991", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016098"}, {"RECTYPE": "D", "MH": "Endoscopy, Gastrointestinal", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Endoscopic Gastrointestinal|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES ENDOSCOPIC GASTROINTESTINAL|abbcdefv", "ENTRY": "Surgery, Endoscopic Gastrointestinal", "MN": "E04.502.250.250.250", "FX": "Endoscopes, Gastrointestinal", "MH_TH": "NLM (1991)", "ST": "T061", "AN": "general or unspecified; prefer specifics; / instrum permitted but consider ENDOSCOPES, GASTROINTESTINAL", "PI": "Gastroscopy (1966-1990)", "MS": "Endoscopic examination, therapy or surgery of the gastrointestinal tract.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016099"}, {"RECTYPE": "D", "MH": "Spinal Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spinal Fracture", "MN": "C26.404.812", "MH_TH": "NLM (1991)", "ST": "T037", "AN": "coordinate with specific vertebrae /inj", "PI": "Spinal Injuries (1966-1990)", "MS": "Broken bones in the vertebral column.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160609", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016103"}, {"RECTYPE": "D", "MH": "Oligohydramnios", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C12.050.703.560", "MH_TH": "NLM (1991)", "ST": "T047", "PI": "Polyhydramnios (1966-1990)", "MS": "A condition of abnormally low AMNIOTIC FLUID volume. Principal causes include malformations of fetal URINARY TRACT; FETAL GROWTH RETARDATION; GESTATIONAL HYPERTENSION; nicotine poisoning; and PROLONGED PREGNANCY.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016104"}, {"RECTYPE": "D", "MH": "Parathyroidectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Parathyroidectomies", "MN": "E04.270.694", "MH_TH": "NLM (1991)", "ST": "T061", "PI": "Parathyroid Glands/surgery (1966-1990)", "MS": "Excision of one or more of the parathyroid glands.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016105"}, {"RECTYPE": "D", "MH": "Methicillin Resistance", "AQ": "DE EH GE IM PH RE", "ENTRY": "Resistance, Methicillin", "MN": "G07.690.773.984.269.347.500.600.525", "FX": "Methicillin-Resistant Staphylococcus aureus", "MH_TH": "NLM (1991)", "ST": "T032", "PI": "Penicillin Resistance (1966-1990)", "MS": "Non-susceptibility of a microbe to the action of METHICILLIN, a semi-synthetic penicillin derivative.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016106"}, {"RECTYPE": "D", "MH": "Epidermolysis Bullosa Acquisita", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Epidermolysis Bullosa, Acquired|T047|NON|EQV|NLM (1991)|891221|abcdef", "ENTRY": "Acquired Epidermolysis Bullosa", "MN": "C17.800.865.410.080", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "note that this is acquired", "PI": "Epidermolysis Bullosa (1966-1990)", "MS": "Form of epidermolysis bullosa characterized by trauma-induced, subepidermal blistering with no family history of the disease. Direct immunofluorescence shows IMMUNOGLOBULIN G deposited at the dermo-epidermal junction.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016107"}, {"RECTYPE": "D", "MH": "Epidermolysis Bullosa Dystrophica", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hallopeau-Siemens Disease|T047|EPO|NRW|NLM (1991)|891221|HALLOPEAU SIEMENS DIS|abcdefv", "ENTRY": "Hallopeau Siemens Disease", "MN": "C17.800.865.410.160", "MH_TH": "NLM (1991)", "ST": "T047", "PI": "Epidermolysis Bullosa (1966-1990)", "MS": "Form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. It is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. All forms of dystrophic epidermolysis bullosa result from mutations in COLLAGEN TYPE VII, a major component fibrils of BASEMENT MEMBRANE and EPIDERMIS.", "PM": "1991", "HN": "1991", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016108"}, {"RECTYPE": "D", "MH": "Epidermolysis Bullosa, Junctional", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lethal Junctional Epidermolysis Bullosa|T047|NON|NRW|NLM (1991)|891221|abcdef", "ENTRY": "Letalis, Epidermolysis Bullosa", "MN": "C17.800.865.410.170", "MH_TH": "NLM (1991)", "ST": "T047", "PI": "Epidermolysis Bullosa (1966-1990)", "MS": "Form of epidermolysis bullosa having onset at birth or during the neonatal period and transmitted through autosomal recessive inheritance. It is characterized by generalized blister formation, extensive denudation, and separation and cleavage of the basal cell plasma membranes from the basement membrane.", "OL": "use EPIDERMOLYSIS BULLOSA, JUNCTIONAL to search HERLITZ'S DISEASE 1991-92", "PM": "91; HERLITZ DISEASE was HERLITZ'S DISEASE 1991-92", "HN": "91; HERLITZ DISEASE was HERLITZ'S DISEASE 1991-92", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016109"}, {"RECTYPE": "D", "MH": "Epidermolysis Bullosa Simplex", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Weber-Cockayne Syndrome|T047|EPO|NRW|NLM (1991)|ORD (2010)|891221|abcdeef", "ENTRY": "Weber Cockayne Type Epidermolysis Bullosa Simplex", "MN": "C17.800.865.410.180", "FX": "Keratin-5", "MH_TH": "NLM (1991)", "ST": "T047", "PI": "Epidermolysis Bullosa (1966-1990)", "MS": "A form of epidermolysis bullosa characterized by serous bullae that heal without scarring. Mutations in the genes that encode KERATIN-5 and KERATIN-14 have been associated with several subtypes of epidermolysis bullosa simplex.", "PM": "1991", "HN": "1991", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016110"}, {"RECTYPE": "D", "MH": "Sjogren-Larsson Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sjogren Larsson Syndrome", "MN": "C18.452.648.398.641.723", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with SJOGREN'S SYNDROME; in titles & translations use diacritic: Sj\u00f6gren-Larsson", "PI": "Ichthyosis (1966-1990)", "MS": "An autosomal recessive neurocutaneous disorder characterized by severe ichthyosis MENTAL RETARDATION; SPASTIC PARAPLEGIA; and congenital ICHTHYOSIS. It is caused by mutation of gene encoding microsomal fatty ALDEHYDE DEHYDROGENASE leading to defect in fatty alcohol metabolism.", "PM": "1991; see ICHTHYOSIS 1984-1990", "HN": "1991; use ICHTHYOSIS 1984-1990", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016111"}, {"RECTYPE": "D", "MH": "Ichthyosis Vulgaris", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ichthyosis Simplices", "MN": "C17.800.827.405", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Ichthyosis (1966-1990)", "MS": "Most common form of ICHTHYOSIS characterized by prominent scaling especially on the exterior surfaces of the extremities. It is inherited as an autosomal dominant trait.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016112"}, {"RECTYPE": "D", "MH": "Ichthyosiform Erythroderma, Congenital", "DE": "ICHTHYOSIFORM ERYTHRODERMA CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Congenital Ichthyosiform Erythroderma|T047|NON|EQV|NLM (1991)|891222|CONGEN ICHTHYOSIFORM ERYTHRODERMA|abcdefv", "ENTRY": "Ichthyosiform Erythrodermas, Congenital", "MN": "C17.800.827.400", "MH_TH": "NLM (1991)", "ST": "T047", "AN": "an ichthyosis rather than an erythroderma; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Ichthyosis (1966-1990)", "MS": "Designation for several severe forms of ichthyosis, present at birth, that are characterized by hyperkeratotic scaling. Infants may be born encased in a collodion membrane which begins shedding within 24 hours. This is followed in about two weeks by persistent generalized scaling. The forms include bullous (HYPERKERATOSIS, EPIDERMOLYTIC), non-bullous (ICHTHYOSIS, LAMELLAR), wet type, and dry type.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016113"}, {"RECTYPE": "D", "MH": "Ichthyosis, X-Linked", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Steroid Sulfatase Deficiency Disease|T047|NON|NRW|NLM (2010)|OMIM (2013)|ORD (2010)|090608|abcdeeef", "ENTRY": "Sulfatase Deficiency, Steroid", "MN": "C18.452.648.925.400", "FX": "Steryl-Sulfatase", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Ichthyosis (1966-1990)", "MS": "Chronic form of ichthyosis that is inherited as a sex-linked recessive trait carried on the X-chromosome and transmitted to the male offspring. It is characterized by severe scaling, especially on the extremities, and is associated with steroid sulfatase deficiency.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016114"}, {"RECTYPE": "D", "MH": "Albinism, Oculocutaneous", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Albinism, Yellow-Mutant|T019|NON|NRW|NLM (1991)|891222|abcdef", "ENTRY": "Yellow-Mutant Albinism", "MN": "C18.452.648.100.102.100", "MH_TH": "NLM (1991)", "ST": "T019", "PI": "Albinism (1966-1990)", "MS": "Heterogeneous group of autosomal recessive disorders comprising at least four recognized types, all having in common varying degrees of hypopigmentation of the skin, hair, and eyes. The two most common are the tyrosinase-positive and tyrosinase-negative types.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016115"}, {"RECTYPE": "D", "MH": "Piebaldism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Albinism, Partial|T047|NON|EQV|NLM (1991)|OMIM (2013)|891222|abcdeef", "ENTRY": "Partial Albinism", "MN": "C18.452.648.100.102.600", "FX": "Waardenburg Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Pigmentation Disorders (1966-1990)", "MS": "Autosomal dominant, congenital disorder characterized by localized hypomelanosis of the skin and hair. The most familiar feature is a white forelock presenting in 80 to 90 percent of the patients. The underlying defect is possibly related to the differentiation and migration of melanoblasts, as well as to defective development of the neural crest (neurocristopathy). Piebaldism may be closely related to WAARDENBURG SYNDROME.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016116"}, {"RECTYPE": "D", "MH": "Albinism, Ocular", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ocular Albinism|T019|NON|EQV|GHR (2014)|130418|abcdef", "MN": "C18.452.648.100.102.090", "MH_TH": "NLM (1991)", "ST": "T019", "AN": "hypopigmentation of eye; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Albinism (1966-1990)", "MS": "Albinism affecting the eye in which pigment of the hair and skin is normal or only slightly diluted. The classic type is X-linked (Nettleship-Falls), but an autosomal recessive form also exists. Ocular abnormalities may include reduced pigmentation of the iris, nystagmus, photophobia, strabismus, and decreased visual acuity.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016117"}, {"RECTYPE": "D", "MH": "Anterior Cruciate Ligament", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cruciate Ligament, Anterior|T023|NON|EQV|NLM (1991)|900119|abcdef", "ENTRY": "Ligaments, Cranial Cruciate", "MN": "A10.165.669.514.100", "FX": "Posterior Cruciate Ligament", "EC": "injuries:Anterior Cruciate Ligament Injuries", "MH_TH": "NLM (1991)", "ST": "T023", "AN": "/surg: consider also ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION", "PI": "Ligaments, Articular (1966-1990)", "MS": "A strong ligament of the knee that originates from the posteromedial portion of the lateral condyle of the femur, passes anteriorly and inferiorly between the condyles, and attaches to the depression in front of the intercondylar eminence of the tibia.", "PM": "91", "HN": "91", "MR": "20190705", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016118"}, {"RECTYPE": "D", "MH": "Posterior Cruciate Ligament", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cruciate Ligament, Posterior|T023|NON|EQV|NLM (1991)|900119|abcdef", "ENTRY": "Posterior Cruciate Ligaments", "MN": "A10.165.669.514.600", "FX": "Medial Collateral Ligament, Knee", "MH_TH": "NLM (1991)", "ST": "T023", "AN": "a ligament of the knee", "PI": "Ligaments, Articular (1973-1990)", "MS": "A strong ligament of the knee that originates from the anterolateral surface of the medial condyle of the femur, passes posteriorly and inferiorly between the condyles, and attaches to the posterior intercondylar area of the tibia.", "PM": "91", "HN": "91", "MR": "20170620", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016119"}, {"RECTYPE": "D", "MH": "Brachiocephalic Veins", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Innominate Veins|T023|NON|EQV|UNK (1989)|891227|abcdef", "ENTRY": "Veins, Innominate", "MN": "A07.015.908.130", "MH_TH": "NLM (1991)", "ST": "T023", "PI": "Innominate Vein (1966-1990)", "MS": "Large veins on either side of the root of the neck formed by the junction of the internal jugular and subclavian veins. They drain blood from the head, neck, and upper extremities, and unite to form the superior vena cava.", "OL": "use BRACHIOCEPHALIC VEINS to search INNOMINATE VEIN 1966-90", "PM": "91; INNOMINATE VEIN was heading 1963-90", "HN": "91; INNOMINATE VEIN was heading 1963-90", "MR": "20180630", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016121"}, {"RECTYPE": "D", "MH": "Brachiocephalic Trunk", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Innominate Artery|T023|NON|EQV|UNK (1989)|891227|abcdef", "ENTRY": "Trunks, Brachiocephalic", "MN": "A07.015.114.145", "MH_TH": "NLM (1991)", "ST": "T023", "AN": "note X ref", "PI": "Innominate Artery (1966-1990)", "MS": "The first and largest artery branching from the aortic arch. It distributes blood to the right side of the head and neck and to the right arm.", "OL": "use BRACHIOCEPHALIC TRUNK to search INNOMINATE ARTERY 1966-90", "PM": "91; BRACHIOCEPHALIC TRUNK was see INNOMINATE ARTERY 1963-90", "HN": "91; BRACHIOCEPHALIC TRUNK was see INNOMINATE ARTERY 1963-90", "MR": "20180630", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016122"}, {"RECTYPE": "D", "MH": "Campylobacter jejuni", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Vibrio jejuni|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.150.235.250.500.375", "MH_TH": "NLM (1991)", "ST": "T007", "RN": "txid197", "AN": "infection: coord IM with CAMPYLOBACTER INFECTIONS (IM)", "PI": "Campylobacter fetus (1974-1990)", "MS": "A species of bacteria that resemble small tightly coiled spirals. Its organisms are known to cause abortion in sheep and fever and enteritis in man and may be associated with enteric diseases of calves, lambs, and other animals.", "OL": "use CAMPYLOBACTER FETUS to search CAMPYLOBACTER JEJUNI 1984-90", "PM": "91; was see CAMPYLOBACTER FETUS 1984-90", "HN": "91; was see CAMPYLOBACTER FETUS 1984-90", "MR": "20200128", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016123"}, {"RECTYPE": "D", "MH": "Eikenella corrodens", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Ristella corrodens|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.075.525.170.100", "MH_TH": "NLM (1991)", "ST": "T007", "RN": "txid539", "AN": "normal bacterium in man & animal but if causing infect, coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Bacteroides corrodens (1976-1990)", "MS": "Gram-negative bacteria isolated from infections of the respiratory and intestinal tracts and from the buccal cavity, intestinal tract, and urogenital tract. They are probably part of the normal flora of man and animals.", "OL": "use EIKENELLA CORRODENS to search BACTEROIDES CORRODENS 1976-90", "PM": "91; BACTEROIDES CORRODENS (with EIKENELLA CORRODENS as see ref to it) was see under BACTEROIDES 1976-90", "HN": "91; BACTEROIDES CORRODENS (with EIKENELLA CORRODENS as see ref to it) was see under BACTEROIDES 1976-90", "MR": "20200128", "DA": "19900212", "DC": "1", "DX": "19910101", "UI": "D016124"}, {"RECTYPE": "D", "MH": "Heart Valve Prolapse", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Valve Prolapses, Heart", "MN": "C14.280.484.400", "MH_TH": "NLM (1991)", "ST": "T047", "AN": "general or unspecified: prefer specific valve prolapse", "PI": "Heart Valve Diseases (1967-1990)", "MS": "Downward displacement of any one of the HEART VALVES from its normal position. This usually results in failed valve closure.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016127"}, {"RECTYPE": "D", "MH": "Immunophenotyping", "AQ": "AE CL EC HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Lymphocyte Subtyping|T059|NON|NRW|NLM (1991)|900108|abcdef", "ENTRY": "Subtypings, Lymphocyte", "MN": "E05.478.594.450", "MH_TH": "NLM (1991)", "ST": "T059", "PI": "Phenotype (1979-1990)", "MS": "Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016130"}, {"RECTYPE": "D", "MH": "Lymphocyte Subsets", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Lymphocyte Subpopulations|T170|NON|EQV|NLM (1991)|900108|abcdef", "ENTRY": "Subsets, Lymphocyte", "MN": "A15.382.490.555.567.550", "FX": "Immunophenotyping", "MH_TH": "NLM (1991)", "ST": "T170", "AN": "general or unspecified; prefer specifics", "PI": "Lymphocytes/classification (1977-1990)", "MS": "A classification of lymphocytes based on structurally or functionally different populations of cells.", "PM": "91", "HN": "91", "MR": "20030709", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016131"}, {"RECTYPE": "D", "MH": "Polymerase Chain Reaction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "PCR|T063|ABB|EQV|NLM (1990)|900111|abcdef", "ENTRY": "Reactions, Polymerase Chain", "MN": "E05.393.620.500", "FX": "Sequence Tagged Sites", "MH_TH": "NLM (1990)", "ST": "T063", "PI": "Gene Amplification (1988-1989)", "MS": "In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.", "PM": "91; was see under GENE AMPLIFICATION 1990", "HN": "91(90); was see under GENE AMPLIFICATION 1990", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19900111", "DC": "1", "DX": "19910101", "UI": "D016133"}, {"RECTYPE": "D", "MH": "Organizational Policy", "DE": "ORGAN POLICY", "PRINT ENTRY": "Institutional Policy|T170|NON|NRW|BIOETHICS (1989)|900111|abcdef", "ENTRY": "Policy, Organizational|T170|NON|EQV|NLM (1991)|900111|POLICY ORGAN|abcdefv", "MN": "N03.623.500.550", "MH_TH": "NLM (1991)", "ST": "T170", "PI": "Public Policy (1978-1990)", "MS": "A course or method of action selected, usually by an organization, institution, university, society, etc., from among alternatives to guide and determine present and future decisions and positions on matters of public interest or social concern. It does not include internal policy relating to organization and administration within the corporate body, for which ORGANIZATION AND ADMINISTRATION is available.", "PM": "91", "HN": "91", "MR": "20100625", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016134"}, {"RECTYPE": "D", "MH": "Spinal Dysraphism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Status Dysraphicus|T019|NON|BRD|UNK (1991)|900112|abcdef", "ENTRY": "Spine, Open", "MN": "C16.131.666.680.800", "MH_TH": "NLM (1991)", "ST": "T019", "AN": "general or unspecified; prefer specifics", "MS": "Congenital defects of closure of one or more vertebral arches, which may be associated with malformations of the spinal cord, nerve roots, congenital fibrous bands, lipomas, and congenital cysts. These malformations range from mild (e.g., SPINA BIFIDA OCCULTA) to severe, including rachischisis where there is complete failure of neural tube and spinal cord fusion, resulting in exposure of the spinal cord at the surface. Spinal dysraphism includes all forms of spina bifida. The open form is called SPINA BIFIDA CYSTICA and the closed form is SPINA BIFIDA OCCULTA. (From Joynt, Clinical Neurology, 1992, Ch55, p34)", "PM": "1991; see STATUS DYSRAPHICUS 1964-90 ; for SPINA BIFIDA see SPINA BIFIDA OCCULTA 1978-1990, see SPINAL DYSRAPHISM 1966-1977", "HN": "1991(1964); for SPINA BIFIDA use SPINA BIFIDA OCCULTA 1978-1990, use SPINAL DYSRAPHISM 1966-1970", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19900727", "DC": "1", "DX": "19910101", "UI": "D016135"}, {"RECTYPE": "D", "MH": "Spina Bifida Occulta", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spinal Bifida, Closed|T019|NON|EQV|NLM (1991)|900308|abcdef", "ENTRY": "Spina Bifida, Occult", "MN": "C16.131.666.680.800.750", "MH_TH": "NLM (1991)", "ST": "T019", "PI": "Spinal Dysraphism (1966-1977)", "MS": "A common congenital midline defect of fusion of the vertebral arch without protrusion of the spinal cord or meninges. The lesion is also covered by skin. L5 and S1 are the most common vertebrae involved. The condition may be associated with an overlying area of hyperpigmented skin, a dermal sinus, or an abnormal patch of hair. The majority of individuals with this malformation are asymptomatic although there is an increased incidence of tethered cord syndrome and lumbar SPONDYLOSIS. (From Joynt, Clinical Neurology, 1992, Ch55, p34)", "PM": "1991; was SPINA BIFIDA 1978-1990; for DERMAL SINUS see NEURAL TUBE DEFECTS 1979-1990", "HN": "1991; was SPINA BIFIDA 1978-1990; for DERMAL SINUS use NEURAL TUBE DEFECTS 1979-1990", "CATSH": "CAT LIST", "MR": "19991208", "DA": "19900605", "DC": "1", "DX": "19910101", "UI": "D016136"}, {"RECTYPE": "D", "MH": "Spina Bifida Cystica", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spina Bifida, Open|T019|NON|REL|NLM (1991)|900308|abcdef", "ENTRY": "Open Spina Bifida", "MN": "C16.131.666.680.800.730", "MH_TH": "NLM (1991)", "ST": "T019", "PI": "Spinal Dysraphism (1966-1977)", "MS": "A form of spinal dysraphism associated with a protruding cyst made up of either meninges (i.e., a MENINGOCELE) or meninges in combination with spinal cord tissue (i.e., a MENINGOMYELOCELE). These lesions are frequently associated with spinal cord dysfunction, HYDROCEPHALUS, and SYRINGOMYELIA. (From Davis et al., Textbook of Neuropathology, 2nd ed, pp224-5)", "OL": "search MENINGOMYELOCELE 1978-90", "PM": "91; was see MENINGOMYELOCELE 1978-90", "HN": "91; was see MENINGOMYELOCELE 1978-90", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19900605", "DC": "1", "DX": "19910101", "UI": "D016137"}, {"RECTYPE": "D", "MH": "Walking", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Ambulation|T056|NON|NRW|NLM (2006)|050202|abcdef", "MN": "I03.450.642.845.940", "FX": "Gait", "MH_TH": "NLM (1991)", "ST": "T061", "AN": "human & animal; differentiate from GAIT, the way one walks", "PI": "Exertion (1966-1990)", "MS": "An activity in which the body advances at a slow to moderate pace by moving the feet in a coordinated fashion. This includes recreational walking, walking for fitness, and competitive race-walking.", "PM": "91", "HN": "91", "MR": "20160520", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016138"}, {"RECTYPE": "D", "MH": "Martial Arts", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "PRINT ENTRY": "Tae Kwon Do|T056|NON|NRW|NLM (1991)|900215|abcdef", "ENTRY": "Fu, Gong", "MN": "I03.450.642.845.560", "FX": "Wrestling", "MH_TH": "NLM (1991)", "ST": "T056", "AN": "/ inj: coordinate IM with specific injury (IM)", "PI": "Sports (1968-1990)", "MS": "Activities in which participants learn self-defense mainly through the use of hand-to-hand combat. Judo involves throwing an opponent to the ground while karate (which includes kung fu and tae kwon do) involves kicking and punching an opponent.", "PM": "91", "HN": "91", "MR": "20190705", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016139"}, {"RECTYPE": "D", "MH": "Holoprosencephaly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Semilobar Holoprosencephaly|T019|NON|NRW|NLM (2000)|991105|abcdef", "ENTRY": "Semilobar Holoprosencephalies", "MN": "C16.320.180.380", "MH_TH": "ORD (2010)", "ST": "T019", "PI": "Brain/abnormalities (1966-1990)", "MS": "Anterior midline brain, cranial, and facial malformations resulting from the failure of the embryonic prosencephalon to undergo segmentation and cleavage. Alobar prosencephaly is the most severe form and features anophthalmia; cyclopia; severe INTELLECTUAL DISABILITY; CLEFT LIP; CLEFT PALATE; SEIZURES; and microcephaly. Semilobar holoprosencepaly is characterized by hypotelorism, microphthalmia, coloboma, nasal malformations, and variable degrees of INTELLECTUAL DISABILITY. Lobar holoprosencephaly is associated with mild (or absent) facial malformations and intellectual abilities that range from mild INTELLECTUAL DISABILITY to normal. Holoprosencephaly is associated with CHROMOSOME ABNORMALITIES.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20140610", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016142"}, {"RECTYPE": "D", "MH": "Endoscopy, Digestive System", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Endoscopic, Digestive System|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES ENDOSCOPIC DIGESTIVE SYSTEM|abbcdefv", "ENTRY": "Esophagogastroduodenoscopies", "MN": "E04.502.250.250", "MH_TH": "NLM (1991)", "ST": "T061", "AN": "general or unspecified; prefer specifics but note entry term ESOPHAGOGASTRODUODENOSCOPY", "PI": "Endoscopy (1966-1990)", "MS": "Endoscopic examination, therapy or surgery of the digestive tract.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016145"}, {"RECTYPE": "D", "MH": "Genes, Tumor Suppressor", "AQ": "DE ES PH RE", "PRINT ENTRY": "Tumor Suppressor Genes|T028|NON|EQV|NLM (1991)|900129|abcdef", "ENTRY": "Tumor Suppressor Gene", "MN": "G05.360.340.024.340.415.400", "FX": "Tumor Suppressor Proteins", "MH_TH": "NLM (1991)", "ST": "T028", "AN": "Manual 24.4.4.3", "PI": "Suppression, Genetic (1986-1990)", "MS": "Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.", "PM": "2002; see GENES, SUPPRESSOR, TUMOR 1991-2001", "HN": "2002 (1991)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016147"}, {"RECTYPE": "D", "MH": "Genes, Suppressor", "AQ": "DE ES PH RE", "PRINT ENTRY": "Second-Site Suppressor Genes|T028|NON|EQV|NLM (2002)|001103|abcdef", "ENTRY": "Suppressor Genes, Second-Site", "MN": "G05.360.340.024.340.460", "FX": "Suppression, Genetic", "MH_TH": "NLM (1991)", "ST": "T028", "PI": "Suppression, Genetic (1980-1990)", "MS": "Genes that have a suppressor allele or suppressor mutation (SUPPRESSION, GENETIC) which cancels the effect of a previous mutation, enabling the wild-type phenotype to be maintained or partially restored. For example, amber suppressors cancel the effect of an AMBER NONSENSE MUTATION.", "OL": "use SUPPRESSION, GENETIC to search GENES, SUPPRESSOR 1968-90 (Prov 1968-69)", "PM": "91; was see SUPPRESSION, GENETIC 1980-90; was heading 1970-79", "HN": "91; was see SUPPRESSION, GENETIC 1980-90; was heading 1968-79 (Prov 1968-69)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016153"}, {"RECTYPE": "D", "MH": "Digestive System Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fistulas, Digestive System", "MN": "C23.300.575.185", "MH_TH": "NLM (1991)", "ST": "T190", "AN": "general or unspecified; prefer specifics", "PI": "specific fistula (1966-1997)", "MS": "An abnormal passage communicating between any components of the digestive system, or between any part of the digestive system and surrounding organ(s).", "PM": "98", "HN": "98; use explode 1991-97", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19900424", "DC": "1", "DX": "19980101", "UI": "D016154"}, {"RECTYPE": "D", "MH": "Oral Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Oral Fistulas", "MN": "C23.300.575.500", "MH_TH": "NLM (1991)", "ST": "T190", "AN": "general or unspecified; prefer specifics", "PI": "specific fistula (1966-1997)", "MS": "An abnormal passage within the mouth communicating between two or more anatomical structures.", "PM": "98", "HN": "98; use explode 1991-97", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19900424", "DC": "1", "DX": "19980101", "UI": "D016155"}, {"RECTYPE": "D", "MH": "Respiratory Tract Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Respiratory System Fistula|T046|T190|NON|EQV|NLM (2023)|220712|abbcdef", "ENTRY": "Respiratory Tract Fistulas", "MN": "C23.300.575.687", "MH_TH": "NLM (1991)", "ST": "T190", "AN": "general or unspecified; prefer specifics", "PI": "specific fistula (1966-1997)", "MS": "An abnormal passage communicating between any component of the respiratory tract or between any part of the respiratory system and surrounding organs.", "PM": "98", "HN": "98; use explode 1991-97", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19900424", "DC": "1", "DX": "19980101", "UI": "D016156"}, {"RECTYPE": "D", "MH": "Vascular Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vascular Fistulas", "MN": "C23.300.575.950", "MH_TH": "NLM (1991)", "ST": "T190", "AN": "general or unspecified; prefer ARTERIO-ARTERIAL FISTULA or ARTERIOVENOUS FISTULA; fistula policy: Manual 23.19+", "PI": "specific fistula (1966-1997)", "MS": "An abnormal passage between two or more BLOOD VESSELS, between ARTERIES; VEINS; or between an artery and a vein.", "PM": "98", "HN": "98; use explode 1991-97", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19900424", "DC": "1", "DX": "19980101", "UI": "D016157"}, {"RECTYPE": "D", "MH": "Genes, p53", "DS": "GENES P 053", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "p53 Genes|T028|NON|EQV|NLM (1991)|900503|P A 053 GENES|abcdefs", "ENTRY": "p53 Gene", "MN": "G05.360.340.024.340.415.400.385", "FX": "Tumor Suppressor Protein p53", "MH_TH": "NLM (1991)", "ST": "T028", "PI": "Genes, Structural (1986-1990)", "MS": "Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016158"}, {"RECTYPE": "D", "MH": "Tumor Suppressor Protein p53", "DS": "TUMOR SUPPRESSOR PROTEIN P 053", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p53 Tumor Suppressor Protein|T116|T123|NON|EQV|NLM (2006)|050203|P A 053 TUMOR SUPPRESSOR PROTEIN|abbcdefs", "ENTRY": "Phosphoprotein, pp53", "MN": "D12.776.744.845", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Phosphoproteins (1981-1990)", "MS": "Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER.", "PM": "2005; see TP53 PROTEIN 1991-2005; TP53 PROTEIN was indexed under NERVE TISSUE PROTEINS & NEOPLASM PROTEINS 1992-1993", "HN": "2005(1991);", "MR": "20170524", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016159"}, {"RECTYPE": "D", "MH": "Retinoblastoma Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p105-Rb Protein|T116|NRW|NLM (1991)|900201|P A 105 RB PROTEIN|abdefs", "ENTRY": "p105 Rb Protein", "MN": "D12.776.744.770", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "AN": "/biosyn /drug eff /physiol /ultrastruct permitted", "PI": "Phosphoproteins (1990)", "MS": "Product of the retinoblastoma tumor suppressor gene. It is a nuclear phosphoprotein hypothesized to normally act as an inhibitor of cell proliferation. Rb protein is absent in retinoblastoma cell lines. It also has been shown to form complexes with the adenovirus E1A protein, the SV40 T antigen, and the human papilloma virus E7 protein.", "PM": "91", "HN": "91", "MR": "20050630", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016160"}, {"RECTYPE": "D", "MH": "Genes, Retinoblastoma", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Retinoblastoma Genes|T028|NON|EQV|NLM (1991)|900416|abcdef", "ENTRY": "Retinoblastoma Gene", "MN": "G05.360.340.024.340.415.400.400", "FX": "Retinoblastoma", "MH_TH": "NLM (1991)", "ST": "T028", "PI": "Retinoblastoma/genetics (1972-1990)", "MS": "Tumor suppressor genes located on human chromosome 13 in the region 13q14 and coding for a family of phosphoproteins with molecular weights ranging from 104 kDa to 115 kDa. One copy of the wild-type Rb gene is necessary for normal retinal development. Loss or inactivation of both alleles at this locus results in retinoblastoma.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016161"}, {"RECTYPE": "D", "MH": "Genes, Wilms Tumor", "AQ": "DE ES PH RE", "PRINT ENTRY": "Wilms' Tumor Gene|T028|NON|EQV|NLM (2022)|201007|abcdef", "ENTRY": "Wilms' Genes", "MN": "G05.360.340.024.340.415.400.420", "FX": "Wilms Tumor", "MH_TH": "NLM (1991)", "ST": "T028", "MS": "Genes at loci that are involved in the development of WILMS TUMOR. Included are human WT1 at 11p13 and human WT2 (MTACR1) at 11p15.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016162"}, {"RECTYPE": "D", "MH": "Genes, DCC", "AQ": "DE ES GE IM PH RE", "ENTRY": "Gene, DCC", "MN": "G05.360.340.024.340.415.400.200", "FX": "Genes, MCC", "MH_TH": "NLM (1991)", "ST": "T028", "AN": "DCC stands for \"Deleted in Colorectal Cancer\"", "MS": "Tumor suppressor genes located in the 18q21-qter region of human chromosome 18. The absence of these genes is associated with the formation of colorectal cancer (DCC stands for deleted in colorectal cancer). The products of these genes show significant homology to neural cell adhesion molecules and other related cell surface glycoproteins.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016163"}, {"RECTYPE": "D", "MH": "Bison", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Buffalo, American|T015|NON|NRW|NLM (1991)|900319|abcdef", "ENTRY": "Bisons", "MN": "B01.050.150.900.649.313.500.380.120", "MH_TH": "NLM (1991)", "ST": "T015", "RN": "txid9900", "AN": "note entry term BUFFALOES, AMERICAN: BUFFALOES is also available", "PI": "Artiodactyla (1973-1990)", "MS": "A genus of the family Bovidae having two species: B. bison and B. bonasus. This concept is differentiated from BUFFALOES, which refers to Bubalus arnee and Syncerus caffer.", "PM": "91", "HN": "91", "MR": "20200902", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016164"}, {"RECTYPE": "D", "MH": "Free Radical Scavengers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Free Radical Scavenger|T120|NON|EQV|NLM (2021)|200204|abcdef", "ENTRY": "Scavengers, Free Radical", "MN": "D27.505.519.217.500", "FX": "Oxygen Radical Absorbance Capacity", "MH_TH": "NLM (1991)", "ST": "T120", "RN": "0", "PI": "Free Radicals (1967-1990)", "MS": "Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY.", "PM": "91", "HN": "91", "MR": "20200527", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016166"}, {"RECTYPE": "D", "MH": "Integrin alphaXbeta2", "DS": "INTEGRIN ALPHA X BETA 02", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "p150,95 Antigen|T116|T129|T192|NON|EQV|NLM (1991)|900319|P A 150 095 ANTIGEN|P15095 ANTIGEN|abbbcdefsv", "ENTRY": "alphaXbeta2, Integrin", "MN": "D23.050.301.350.275", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Receptors, Leukocyte-Adhesion (1989-1990)", "MS": "A major adhesion-associated heterodimer molecule expressed by MONOCYTES; GRANULOCYTES; NK CELLS; and some LYMPHOCYTES. The alpha subunit is the CD11C ANTIGEN, a surface antigen expressed on some myeloid cells. The beta subunit is the CD18 ANTIGEN.", "PM": "2003; see COMPLEMENT 4-BINDING PROTEIN 2002, see ANTIGEN P150,95 1991-2001; INTEGRIN APHAXBETA2 was indexed under MEMBRANE GLYCOPROTEINS 1988-2002 & GLYCOPROTEINS 1985-1987", "HN": "2003 (1991); use INTEGRIN ALPHAXBETA2 (NM) 1985-2002", "MR": "20230316", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016167"}, {"RECTYPE": "D", "MH": "Lymphocyte Function-Associated Antigen-1", "DE": "LFA1", "DS": "LYMPHOCYTE FUNCTION ASSOCIATED 01 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Leukocyte Function Associated Antigen-1|T116|T129|T192|NON|EQV|NLM (1991)|900212|LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN 01|abbbcdefs", "ENTRY": "alphaLbeta2, Integrin", "MN": "D23.050.301.350.625.550", "MH_TH": "NLM (1991)", "ST": "T192", "RN": "0", "PI": "Receptors, Leukocyte-Adhesion (1989-1990)", "MS": "An integrin heterodimer widely expressed on cells of hematopoietic origin. CD11A ANTIGEN comprises the alpha chain and the CD18 antigen (CD18 ANTIGENS) the beta chain. Lymphocyte function-associated antigen-1 is a major receptor of T-CELLS; B-CELLS; and GRANULOCYTES. It mediates the leukocyte adhesion reactions underlying cytolytic conjugate formation, helper T-cell interactions, and antibody-dependent killing by NATURAL KILLER CELLS and granulocytes. Intracellular adhesion molecule-1 has been defined as a ligand for lymphocyte function-associated antigen-1.", "PM": "1991", "HN": "1991", "MR": "20230316", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016169"}, {"RECTYPE": "D", "MH": "Accelerated Idioventricular Rhythm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "AIVR|T047|ABB|EQV|NLM (1991)|900212|abcdef", "ENTRY": "Ventricular Tachycardias, Slow", "MN": "C23.550.073.845.940.349", "MH_TH": "NLM (1991)", "ST": "T047", "PI": "Tachycardia (1975-1990)", "MS": "A type of automatic, not reentrant, ectopic ventricular rhythm with episodes lasting from a few seconds to a minute which usually occurs in patients with acute myocardial infarction or with DIGITALIS toxicity. The ventricular rate is faster than normal but slower than tachycardia, with an upper limit of 100 -120 beats per minute. Suppressive therapy is rarely necessary.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016170"}, {"RECTYPE": "D", "MH": "Torsades de Pointes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "de Pointes, Torsades", "MN": "C23.550.073.845.940.700", "MH_TH": "NLM (1991)", "ST": "T047", "AN": "in translation, \"torsade\" or \"torsades\" is acceptable: use word of author", "PI": "Tachycardia (1974-1990)", "MS": "A malignant form of polymorphic ventricular tachycardia that is characterized by HEART RATE between 200 and 250 beats per minute, and QRS complexes with changing amplitude and twisting of the points. The term also describes the syndrome of tachycardia with prolonged ventricular repolarization, long QT intervals exceeding 500 milliseconds or BRADYCARDIA. Torsades de pointes may be self-limited or may progress to VENTRICULAR FIBRILLATION.", "OL": "use TACHYCARDIA to search TORSADES DE POINTES 1983-90", "PM": "91; was see TACHYCARDIA 1983-90", "HN": "91; was see TACHYCARDIA 1983-90", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016171"}, {"RECTYPE": "D", "MH": "DNA Fingerprinting", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "PRINT ENTRY": "Genetic Fingerprinting|T063|NON|BRD|NLM (1999)|980522|abcdef", "ENTRY": "Typings, DNA", "MN": "N04.452.910.099.750", "FX": "Polymorphism, Restriction Fragment Length", "MH_TH": "NLM (1991)", "ST": "T063", "AN": "DNA FOOTPRINTING is available; do not confuse entry term DNA PROFILING with GENE EXPRESSION PROFILING", "PI": "Nucleotide Mapping (1986-1990)", "MS": "A technique for identifying individuals of a species that is based on the uniqueness of their DNA sequence. Uniqueness is determined by identifying which combination of allelic variations occur in the individual at a statistically relevant number of different loci. In forensic studies, RESTRICTION FRAGMENT LENGTH POLYMORPHISM of multiple, highly polymorphic VNTR LOCI or MICROSATELLITE REPEAT loci are analyzed. The number of loci used for the profile depends on the ALLELE FREQUENCY in the population.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20200623", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016172"}, {"RECTYPE": "D", "MH": "Macrophage Colony-Stimulating Factor", "DE": "MCSF", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "M-CSF|T116|T129|ABB|EQV|NLM (1991)|900213|abbcdef", "ENTRY": "Colony Stimulating Factor, Macrophage", "MN": "D23.529.374.410.240.500", "FX": "Receptor, Macrophage Colony-Stimulating Factor", "MH_TH": "NLM (1991)", "ST": "T129", "N1": "Colony-stimulating factor 1", "RN": "81627-83-0", "PI": "Colony-Stimulating Factors (1976-1990)", "MS": "A mononuclear phagocyte colony-stimulating factor (M-CSF) synthesized by mesenchymal cells. The compound stimulates the survival, proliferation, and differentiation of hematopoietic cells of the monocyte-macrophage series. M-CSF is a disulfide-bonded glycoprotein dimer with a MW of 70 kDa. It binds to a specific high affinity receptor (RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR).", "PM": "91", "HN": "91", "MR": "20230316", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016173"}, {"RECTYPE": "D", "MH": "Hepacivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hepatitis C virus|T005|NON|NRW|NLM (1994)|930202|abcdef", "ENTRY": "Hepatitis C-Like Virus", "MN": "B04.820.578.344.475", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11102", "RR": "txid11103", "PI": "Hepatitis Viruses (1988-1990)", "MS": "A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species.", "PM": "2002; see HEPATITIS C-LIKE VIRUSES 1997-2001, see HEPATITIS C VIRUSES 1994-1996, see HEPATITIS C VIRUS 1991-1993", "HN": "2002 (1991)", "MR": "20200813", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016174"}, {"RECTYPE": "D", "MH": "B-Lymphocyte Subsets", "DS": "LYMPHOCYTE SUBSETS B", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Tumor-Infiltrating B Lymphocytes|T025|NON|NRW|NLM (2023)|220411|abcdef", "ENTRY": "Tumor-Infiltrating B Lymphocyte", "MN": "A15.382.490.555.567.562.450", "MH_TH": "NLM (1991)", "ST": "T170", "PI": "B-Lymphocytes/classification (1980-1990)", "MS": "A classification of B-lymphocytes based on structurally or functionally different populations of cells.", "PM": "91", "HN": "91", "MR": "20220523", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016175"}, {"RECTYPE": "D", "MH": "T-Lymphocyte Subsets", "DS": "LYMPHOCYTE SUBSETS T", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "T-Lymphocyte Subset|T170|NON|EQV|NLM (2021)|200304|abcdef", "ENTRY": "T Lymphocyte Subsets", "MN": "A15.382.490.555.567.569.500", "FX": "CD4-CD8 Ratio", "MH_TH": "NLM (1991)", "ST": "T170", "AN": "general or unspecified; prefer specifics", "PI": "T-Lymphocytes/classification (1977-1990)", "MS": "A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells.", "PM": "91", "HN": "91", "MR": "20200527", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016176"}, {"RECTYPE": "D", "MH": "Macrophage-1 Antigen", "DS": "MACROPHAGE 001 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Receptor, Complement 3|T116|T129|T192|NON|EQV|NLM (1991)|900215|RECEPTOR COMPLEMENT 03|RECEPT COMPLEMENT 3|abbbcdefsv", "ENTRY": "alphaMbeta2, Integrin", "MN": "D12.776.543.750.705.833.500", "MH_TH": "NLM (1991)", "ST": "T192", "RN": "0", "PI": "Receptors, Leukocyte-Adhesion (1989-1990)", "MS": "An adhesion-promoting leukocyte surface membrane heterodimer. The alpha subunit consists of the CD11b ANTIGEN and the beta subunit the CD18 ANTIGEN. The antigen, which is an integrin, functions both as a receptor for complement 3 and in cell-cell and cell-substrate adhesive interactions.", "OL": "use MACROPHAGE-1 ANTIGEN (NM) to search INTEGRIN ALPHA(M)BETA(2) 1994-95", "PM": "91; INTEGRIN ALPHA(M)BETA(2) was indexed under INTEGRINS 1994-95", "HN": "91; INTEGRIN ALPHA(M)BETA(2) was NM 1994-95", "MR": "20030709", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016177"}, {"RECTYPE": "D", "MH": "Granulocyte-Macrophage Colony-Stimulating Factor", "DE": "GMCSF", "DS": "GRANULOCYTE MACROPHAGE COLONY A STIMULATING FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Histamine-Producing Cell-Stimulating Factor|T116|T129|NON|EQV|NLM (1992)|910503|abbcdef", "ENTRY": "Tumor Cell Human GM Colony Stimulating Factor", "MN": "D23.529.374.410.240.375", "FX": "Receptors, Granulocyte-Macrophage Colony-Stimulating Factor", "MH_TH": "NLM (1991)", "ST": "T129", "N1": "Colony-stimulating factor 2", "RN": "83869-56-1", "PI": "Interleukin-3 (1981-1987)", "MS": "An acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages.", "OL": "use INTERLEUKIN-3 to search HISTAMINE-PRODUCING CELL-STIMULATING FACTOR 1987-91", "PM": "91; HISTAMINE-PRODUCING CELL-STIMULATING FACTOR was HISTAMINE-PRODUCING CELL STIMULATING FACTOR see INTERLEUKIN-3 1987-91", "HN": "91; HISTAMINE-PRODUCING CELL-STIMULATING FACTOR was HISTAMINE-PRODUCING CELL STIMULATING FACTOR see INTERLEUKIN-3 1987-91", "MR": "20230316", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016178"}, {"RECTYPE": "D", "MH": "Granulocyte Colony-Stimulating Factor", "DE": "GCSF", "DS": "GRANULOCYTE COLONY A STIMULATING FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myeloid Growth Factor|T116|T129|NON|EQV|NLM (2024)|221019|abbcdef", "ENTRY": "Growth Factor, Myeloid", "MN": "D23.529.374.410.240.350", "FX": "Receptors, Granulocyte Colony-Stimulating Factor", "MH_TH": "NLM (1991)", "ST": "T129", "RN": "143011-72-7", "PI": "Colony-Stimulating Factors (1976-1990)", "MS": "A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines.", "PM": "91", "HN": "91", "MR": "20230601", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016179"}, {"RECTYPE": "D", "MH": "Lentivirus Infections", "DE": "LENTIVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Lentivirus Infection", "MN": "C01.925.782.815.616", "MH_TH": "NLM (1991)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Retrovirus Infections (1981-1990)", "MS": "Virus diseases caused by the Lentivirus genus. They are multi-organ diseases characterized by long incubation periods and persistent infection.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016180"}, {"RECTYPE": "D", "MH": "Feline Acquired Immunodeficiency Syndrome", "DE": "FELINE ACQUIRED IMMUNODEFIC SYNDROME", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Feline AIDS|T047|EQV|NLM (1991)|900215|abdef", "ENTRY": "Feline Acquired Immuno Deficiency Syndrome", "MN": "C22.180.350", "MH_TH": "NLM (1991)", "ST": "T047", "AN": "coordinate with FELINE IMMUNODEFICIENCY VIRUS or LEUKEMIA VIRUS, FELINE ", "PI": "Immunologic Deficiency Syndromes (1988-1990)", "MS": "Acquired defect of cellular immunity that occurs in cats infected with feline immunodeficiency virus (FIV) and in some cats infected with feline leukemia virus (FeLV).", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016181"}, {"RECTYPE": "D", "MH": "Visna", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Encephalomyelitis, Ovine|T047|NON|EQV|NLM (1991)|900215|ENCEPH OVINE|abcdefv", "ENTRY": "Visnas", "MN": "C22.836.900", "MH_TH": "NLM (1991)", "ST": "T047", "AN": "caused by a lentivirus; don't forget also SHEEP (NIM) & check tag ANIMALS", "MS": "Demyelinating leukoencephalomyelitis of sheep caused by the VISNA-MAEDI VIRUS. It is similar to but not the same as SCRAPIE.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016182"}, {"RECTYPE": "D", "MH": "Murine Acquired Immunodeficiency Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Murine AIDS|T050|EQV|NLM (1991)|900215|abdef", "ENTRY": "Murine Acquired Immuno Deficiency Syndrome", "MN": "C22.795.650", "MH_TH": "NLM (1991)", "ST": "T050", "AN": "don't forget check tag MICE ", "PI": "Retrovirus Infections (1987-1990)", "MS": "Acquired defect of cellular immunity that occurs in mice infected with mouse leukemia viruses (MuLV). The syndrome shows striking similarities with human AIDS and is characterized by lymphadenopathy, profound immunosuppression, enhanced susceptibility to opportunistic infections, and B-cell lymphomas.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19900323", "DC": "1", "DX": "19910101", "UI": "D016183"}, {"RECTYPE": "D", "MH": "Receptors, Colony-Stimulating Factor", "DE": "RECEPT CSF", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Hematopoietic Growth Factors|T116|T192|NON|EQV|NLM (1991)|900216|RECEPT HEMATOPOIETIC GROWTH FACTORS|abbcdefv", "ENTRY": "Receptors, Colony Stimulating Factor", "MN": "D12.776.543.750.750.400.200", "MH_TH": "NLM (1991)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1973-1990)", "MS": "Cell surface receptors for colony stimulating factors, local mediators, and hormones that regulate the survival, proliferation, and differentiation of hemopoietic cells.", "PM": "91", "HN": "91", "MR": "20030709", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016184"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-3", "DE": "RECEPT IL 3", "DS": "RECEPTORS INTERLEUKIN 003", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, IL-3|T116|T129|T192|EQV|NLM (1991)|900217|RECEPTORS IL 003|RECEPT IL3|abbbdefsv", "ENTRY": "Receptors, Interleukin 3", "MN": "D12.776.543.750.750.400.200.480", "MH_TH": "NLM (1991)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1980-1990)", "MS": "High affinity receptors for INTERLEUKIN-3. They are found on early HEMATOPOIETIC PROGENITOR CELLS; progenitors of MYELOID CELLS; EOSINOPHILS; and BASOPHILS. Interleukin-3 receptors are formed by the dimerization of the INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR COMMON BETA SUBUNIT.", "PM": "91", "HN": "91", "MR": "20060705", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016185"}, {"RECTYPE": "D", "MH": "Receptor, Macrophage Colony-Stimulating Factor", "DE": "RECEPT MCSF", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "fms Proto-Oncogene Protein|T116|T126|T192|EQV|NLM (1991)|900411|abbbdef", "ENTRY": "fms Proto Oncogene Protein", "MN": "D12.776.624.664.700.800", "FX": "Genes, fms", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptors, Endogenous Substances (1973-1990)", "MS": "A receptor for MACROPHAGE COLONY-STIMULATING FACTOR encoded by the c-fms proto-oncogene (GENES, FMS). It contains an intrinsic protein-tyrosine kinase activity. When activated the receptor undergoes autophosphorylation, phosphorylation of down-stream signaling molecules and rapid down-regulation.", "PM": "2000; was RECEPTORS, MACROPHAGE COLONY-STIMULATING FACTOR 1993-1999; was RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR 1991-1992", "HN": "2000(1991)", "MR": "20210521", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016186"}, {"RECTYPE": "D", "MH": "Receptors, Granulocyte-Macrophage Colony-Stimulating Factor", "DE": "RECEPT GMCSF", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "GM-CSF Receptors|T116|T129|T192|EQV|NLM (1991)|900217|GM CSF RECEPT|abbbdefv", "ENTRY": "Receptors, Granulocyte Macrophage Colony Stimulating Factor", "MN": "D12.776.543.750.750.400.200.420", "MH_TH": "NLM (1991)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1973-1990)", "MS": "Receptors that bind and internalize the granulocyte-macrophage stimulating factor. Their MW is believed to be 84 kD. The most mature myelomonocytic cells, specifically human neutrophils, macrophages, and eosinophils, express the highest number of affinity receptors for this growth factor.", "OL": "use RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR to search RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR & GM-CSF RECEPTOR 1991-92", "PM": "93; was RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTORS was GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR see RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92; GM-CSF RECEPTORS was GM-CSF RECEPTOR see RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92", "HN": "93; was RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTORS was GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR see RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92; GM-CSF RECEPTORS was GM-CSF RECEPTOR see RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92", "MR": "20040713", "DA": "19900705", "DC": "1", "DX": "19910101", "UI": "D016187"}, {"RECTYPE": "D", "MH": "Receptors, Granulocyte Colony-Stimulating Factor", "DE": "RECEPT GCSF", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "G-CSF Receptors|T116|T192|EQV|NLM (1991)|900217|GCSF RECEPT|abbdefv", "ENTRY": "Receptors, Granulocyte Colony Stimulating Factor", "MN": "D12.776.543.750.750.400.200.400", "MH_TH": "NLM (1991)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1973-1990)", "MS": "Receptors that bind and internalize GRANULOCYTE COLONY-STIMULATING FACTOR. Their MW is believed to be 150 kD. These receptors are found mainly on a subset of myelomonocytic cells.", "OL": "use RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR to search GRANULOCYTE-COLONY-STIMULATING FACTOR RECEPTORS 1993-96, RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR; G-CSF RECEPTOR & GRANULOCYTE-COLONY-STIMULATING RECEPTOR 1991-92", "PM": "93; was RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92; G-CSF RECEPTORS was G-CSF RECEPTOR see RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92; GRANULOCYTE-COLONY-STIMULATING FACTOR RECEPTORS was see RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR 1993-96, was GRANULOCYTE-COLONY-STIMULATING FACTOR RECEPTOR see RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92", "HN": "93; was RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92; G-CSF RECEPTORS was G-CSF RECEPTOR see RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92; GRANULOCYTE-COLONY-STIMULATING FACTOR RECEPTORS was see RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR 1993-96, was GRANULOCYTE-COLONY-STIMULATING FACTOR RECEPTOR see RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92", "MR": "20050630", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016188"}, {"RECTYPE": "D", "MH": "Dystrophin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.543.250", "FX": "Muscular Dystrophy, Duchenne", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "AN": "a muscle protein: see MeSH definition for relation to musc dystrophy; /biosyn /drug eff /physiol /ultrastruct permitted", "PI": "Muscle Proteins (1988-1990)", "MS": "A muscle protein localized in surface membranes which is the product of the Duchenne/Becker muscular dystrophy gene. Individuals with Duchenne muscular dystrophy usually lack dystrophin completely while those with Becker muscular dystrophy have dystrophin of an altered size. It shares features with other cytoskeletal proteins such as SPECTRIN and alpha-actinin but the precise function of dystrophin is not clear. One possible role might be to preserve the integrity and alignment of the plasma membrane to the myofibrils during muscle contraction and relaxation. MW 400 kDa.", "PM": "91", "HN": "91", "MR": "19991103", "DA": "19900617", "DC": "1", "DX": "19910101", "UI": "D016189"}, {"RECTYPE": "D", "MH": "Carboplatin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "cis-Diammine(cyclobutanedicarboxylato)platinum II|T109|T121|NON|EQV|NLM (1991)|900220|DIAMMINECYCLOBUTANEDICARBOXYLATOPLATINUM II|abbcdefs", "ENTRY": "NSC241240", "MN": "D02.257.125", "PA": "Cross-Linking Reagents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Platinum, diammine(1,1-cyclobutanedicarboxylato(2-))-, (SP-4-2)-", "RN": "BG3F62OND5", "RR": "41575-94-4 (Carboplatin)", "PI": "Organoplatinum Compounds (1978-1990)", "MS": "An organoplatinum compound that possesses antineoplastic activity.", "PM": "91", "HN": "91", "MR": "20190705", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016190"}, {"RECTYPE": "D", "MH": "Resting Phase, Cell Cycle", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "G0 Phase|T043|T079|NON|EQV|NLM (1991)|990101|G A 00 PHASE|abbcdefs", "ENTRY": "Phases, G0", "MN": "G04.144.500.300", "MH_TH": "NLM (2017)", "ST": "T079", "PI": "Interphase (1978-1990)", "MS": "A quiescent state of cells during G1 PHASE.", "PM": "1991; for RESTING PHASE see INTERPHASE (1997-2004)", "HN": "1991; for RESTING PHASE use INTERPHASE (1997-2004)", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016192"}, {"RECTYPE": "D", "MH": "G1 Phase", "DS": "G A 01 PHASE", "AQ": "DE ES GE IM PH RE", "ENTRY": "Phases, G1b", "MN": "G04.144.500.320", "MH_TH": "NLM (1991)", "ST": "T079", "PI": "Interphase (1978-1990)", "MS": "The period of the CELL CYCLE preceding DNA REPLICATION in S PHASE. Subphases of G1 include \"competence\" (to respond to growth factors), G1a (entry into G1), G1b (progression), and G1c (assembly). Progression through the G1 subphases is effected by limiting growth factors, nutrients, or inhibitors.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016193"}, {"RECTYPE": "D", "MH": "Receptors, N-Methyl-D-Aspartate", "DE": "RECEPT NMDA", "DS": "RECEPTORS METHYL ASPARTATE ND", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, NMDA|T116|T192|EQV|NLM (1994)|930222|abbdef", "ENTRY": "Receptors, N Methylaspartate", "MN": "D12.776.543.750.720.200.450.400.500", "MH_TH": "NLM (1991)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurotransmitter (1985-1990)", "MS": "A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity.", "OL": "use RECEPTORS, N-METHYL-D-ASPARTATE to search RECEPTOR, N-METHYL-D-ASPARTATE & N-METHYL-D-ASPARTATE RECEPTOR 1991-92", "PM": "93; was RECEPTOR, N-METHYL-D-ASPARTATE 1991-92; N-METHYL-D-ASPARTATE RECEPTORS was N-METHYL-D-ASPARTATE RECEPTOR see RECEPTOR, N-METHYL-D-ASPARTATE 1991-92", "HN": "93; was RECEPTOR, N-METHYL-D-ASPARTATE 1991-92; N-METHYL-D-ASPARTATE RECEPTORS was N-METHYL-D-ASPARTATE RECEPTOR see RECEPTOR, N-METHYL-D-ASPARTATE 1991-92", "MR": "20200527", "DA": "19900531", "DC": "1", "DX": "19910101", "UI": "D016194"}, {"RECTYPE": "D", "MH": "G2 Phase", "DS": "G A 02 PHASE", "AQ": "DE ES GE IM PH RE", "ENTRY": "Second Gap Phases", "MN": "G04.144.500.340", "MH_TH": "NLM (1991)", "ST": "T079", "PI": "Interphase (1978-1990)", "MS": "The period of the CELL CYCLE following DNA synthesis (S PHASE) and preceding M PHASE (cell division phase). The CHROMOSOMES are tetraploid in this point.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016195"}, {"RECTYPE": "D", "MH": "S Phase", "AQ": "DE GE IM PH RE", "ENTRY": "S Phases", "MN": "G05.226.880", "FX": "DNA Replication Timing", "MH_TH": "NLM (1991)", "ST": "T079", "PI": "Interphase (1978-1990)", "MS": "Phase of the CELL CYCLE following G1 and preceding G2 when the entire DNA content of the nucleus is replicated. It is achieved by bidirectional replication at multiple sites along each chromosome.", "OL": "use INTERPHASE to search S PERIOD 1981-90", "PM": "91; was S PERIOD see INTERPHASE 1981-90", "HN": "91; was S PERIOD see INTERPHASE 1981-90", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016196"}, {"RECTYPE": "D", "MH": "Herpesvirus 7, Human", "DE": "HHV 7", "DS": "HERPESVIRUS HUMAN 07", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Human Herpesvirus 7|T005|NON|EQV|NLM (2002)|150624|HUMAN HERPESVIRUS 07|abcdefs", "MN": "B04.280.382.150.750.420", "MH_TH": "NLM (1991)", "ST": "T005", "RN": "txid10372", "AN": "infection: coord IM with ROSEOLOVIRUS INFECTIONS (IM)", "PI": "Herpesviridae (1990)", "MS": "A species in the genus ROSEOLOVIRUS, of the family HERPESVIRIDAE. It was isolated from activated, CD4-positive T-lymphocytes taken from the blood of a healthy human.", "OL": "use HERPESVIRUS 7, HUMAN to search HERPESVIRUS-7, HUMAN & HUMAN HERPESVIRUS-7 1991-93", "PM": "94; was HERPESVIRUS-7, HUMAN 1991-93; HUMAN HERPESVIRUS-7 was see HERPESVIRUS-7, HUMAN 1991-93", "HN": "94; was HERPESVIRUS-7, HUMAN 1991-93; HUMAN HERPESVIRUS-7 was see HERPESVIRUS-7, HUMAN 1991-93", "MR": "20200813", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016199"}, {"RECTYPE": "D", "MH": "Maturation-Promoting Factor", "DE": "MPF", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mitosis-Promoting Factor|T116|T123|T126|NON|EQV|NLM (1991)|900221|abbbcdef", "ENTRY": "Mitosis Promoting Factor", "MN": "D12.776.476.563.646.500.984", "FX": "Cyclins", "MH_TH": "NLM (1991)", "ST": "T126", "RN": "EC 2.7.11.22", "PI": "Growth Substances (1979-1990)", "MS": "Protein kinase that drives both the mitotic and meiotic cycles in all eukaryotic organisms. In meiosis it induces immature oocytes to undergo meiotic maturation. In mitosis it has a role in the G2/M phase transition. Once activated by CYCLINS; MPF directly phosphorylates some of the proteins involved in nuclear envelope breakdown, chromosome condensation, spindle assembly, and the degradation of cyclins. The catalytic subunit of MPF is PROTEIN P34CDC2.", "PM": "91; HISTONE H1 KINASE, M-PHASE-SPECIFIC was HISTONE H1 KINASE, M PHASE-SPECIFIC 1991-93", "HN": "91; HISTONE H1 KINASE, M-PHASE-SPECIFIC was HISTONE H1 KINASE, M PHASE-SPECIFIC 1991-93", "MR": "20210521", "DA": "19900617", "DC": "1", "DX": "19910101", "UI": "D016200"}, {"RECTYPE": "D", "MH": "Receptors, Lymphocyte Homing", "DE": "RECEPT LYMPHOCYTE HOMING", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Lymphocyte Homing Receptors|T116|T129|T192|NON|EQV|NLM (1991)|900221|LYMPHOCYTE HOMING RECEPT|abbbcdefv", "ENTRY": "T-Cell Homing Receptors", "MN": "D23.050.301.350.625", "MH_TH": "NLM (1991)", "ST": "T192", "RN": "0", "PI": "Cell Adhesion Molecules (1990)", "MS": "Cell surface glycoproteins on lymphocytes and other leukocytes that mediate adhesion to specialized blood vessels called high endothelial venules. Several different classes of lymphocyte homing receptors have been identified, and they appear to target different surface molecules (addressins) on high endothelial venules in different tissues. The adhesion plays a crucial role in the trafficking of lymphocytes.", "PM": "1991; for ANTIGENS, CD44, CD44 ANTIGENS and PgP-1 ANTIGENS see RECEPTORS, LYMPHOCYTE HOMING 1991-93; ANTIGENS, CD44 was ANTIGEN, CD44 see RECEPTORS, LYMPHOCYTE HOMING 1991-92;  CD44 ANTIGENS was CD44 ANTIGEN see RECEPTORS, LYMPHOCYTE HOMING 1991-92", "HN": "1991; for ANTIGENS, CD44, CD44 ANTIGENS and PgP-1 ANTIGEN use RECEPTORS, LYMPHOCYTE HOMING 1991-93; ANTIGENS, CD44 was ANTIGEN, CD44 use RECEPTORS, LYMPHOCYTE HOMING 1991-92; CD44 ANTIGENS was CD44 ANTIGEN use RECEPTORS, LYMPHOCYTE HOMING 1991-92", "MR": "20230316", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016201"}, {"RECTYPE": "D", "MH": "N-Methylaspartate", "DS": "METHYLASPARTATE N", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "NMDA|T116|T121|ABB|EQV|NLM (1995)|940328|abbcdef", "ENTRY": "N Methylaspartate", "MN": "D12.125.119.170.400", "PA": "Excitatory Amino Acid Agonists", "FX": "Receptors, N-Methyl-D-Aspartate", "MH_TH": "NLM (1991)", "ST": "T121", "N1": "D-Aspartic acid, N-methyl-", "RN": "6384-92-5", "PI": "Convulsants (1975-1990)", "MS": "An amino acid that, as the D-isomer, is the defining agonist for the NMDA receptor subtype of glutamate receptors (RECEPTORS, NMDA).", "PM": "91", "HN": "91", "MR": "20080708", "DA": "19900629", "DC": "1", "DX": "19910101", "UI": "D016202"}, {"RECTYPE": "D", "MH": "CDC2 Protein Kinase", "DS": "CDC 002 PROTEIN KINASE", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p34cdc2 Protein|T116|T126|ACX|NRW|NLM (1991)|900221|P A 034 CDC 02 PROTEIN|P34CDC2|abbcdefsv", "ENTRY": "p34cdc2, Protein", "MN": "D12.776.744.360", "MH_TH": "NLM (1991)", "ST": "T126", "RN": "EC 2.7.11.22", "RR": "EC 2.7.11.22", "PI": "Phosphoproteins (1987-1990)", "MS": "Phosphoprotein with protein kinase activity that functions in the G2/M phase transition of the CELL CYCLE. It is the catalytic subunit of the MATURATION-PROMOTING FACTOR and complexes with both CYCLIN A and CYCLIN B in mammalian cells. The maximal activity of cyclin-dependent kinase 1 is achieved when it is fully dephosphorylated.", "PM": "2004; see PROTEIN P34CDC2 1991-2003", "HN": "2004(1991)", "MR": "20210521", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016203"}, {"RECTYPE": "D", "MH": "Sigmodontinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Sigmodon|T015|NON|NRW|NLM (1991)|900222|abcdef", "ENTRY": "Rice Rats", "MN": "B01.050.150.900.649.313.992.635.075.500", "MH_TH": "NLM (2006)", "ST": "T015", "RN": "txid40141", "RR": "txid42414", "AN": "for entry term RATS, RICE and other species commonly called \"rats\" but taxonomically SIGMODONTINAE, do not use the check tag RATS.", "PI": "Rodentia (1966-1981)", "MS": "A subfamily of the family MURIDAE comprised of 69 genera. New World mice and rats are included in this subfamily.", "PM": "2006; see HESPEROMYINAE 1991-2005; for NEOTOMA, SIGMODON, and RATS, COTTON see CRICETIDAE 1982-1990", "HN": "2006 (1991); for NEOTOMA, SIGMODON, and RATS, COTTON use ARVICOLINAE 1982-1990", "MR": "20200902", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016205"}, {"RECTYPE": "D", "MH": "Databases, Bibliographic", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Database, Bibliographic", "MN": "L01.470.750.500", "MH_TH": "NLM (1991)", "ST": "T170", "PI": "Information Systems (1966-1981)", "MS": "Extensive collections, reputedly complete, of references and citations to books, articles, publications, etc., generally on a single subject or specialized subject area. Databases can operate through automated files, libraries, or computer disks. The concept should be differentiated from DATABASES, FACTUAL which is used for collections of data and facts apart from bibliographic references to them.", "OL": "use INFORMATION SYSTEMS to search DATABASES 1982-90", "PM": "91; DATABASES was see INFORMATION SYSTEMS 1982-90", "HN": "91; DATABASES was see INFORMATION SYSTEMS 1982-90", "MR": "20150622", "DA": "19900814", "DC": "1", "DX": "19910101", "UI": "D016206"}, {"RECTYPE": "D", "MH": "Cytokines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytokine|T116|T129|NON|EQV|NLM (2021)|191113|abbcdef", "MN": "D23.529.374", "MH_TH": "NLM (1991)", "ST": "T129", "RN": "0", "PI": "Biological Products (1976-1988)", "MS": "Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.", "PM": "91", "HN": "91", "MR": "20200114", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016207"}, {"RECTYPE": "D", "MH": "Databases, Factual", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Databanks, Factual|T170|NON|EQV|NLM (1991)|900223|abcdef", "ENTRY": "Factual Databases", "MN": "L01.470.750.750", "MH_TH": "NLM (1991)", "ST": "T170", "PI": "Information Systems (1966-1990)", "MS": "Extensive collections, reputedly complete, of facts and data garnered from material of a specialized subject area and made available for analysis and application. The collection can be automated by various contemporary methods for retrieval. The concept should be differentiated from DATABASES, BIBLIOGRAPHIC which is restricted to collections of bibliographic references.", "PM": "1991", "HN": "1991", "MR": "20150622", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016208"}, {"RECTYPE": "D", "MH": "Interleukin-8", "DE": "IL 8", "DS": "INTERLEUKIN 008", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neutrophil-Activating Peptide, Monocyte-Derived|T116|T129|NON|EQV|NLM (1991)|900226|MONAP|abbcdefv", "ENTRY": "Peptide, Anionic Neutrophil-Activating", "MN": "D23.529.374.465.312", "FX": "Neutrophil Activation", "MH_TH": "NLM (1991)", "ST": "T129", "RN": "0", "PI": "Interleukins (1988-1990)", "MS": "A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells.", "PM": "1991; ALVEOLAR MACROPHAGE CHEMOTACTIC FACTOR-I was indexed under CHEMOTACTIC FACTORS 1991-2007", "HN": "1991", "MR": "20150415", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016209"}, {"RECTYPE": "D", "MH": "Methacholine Chloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methacholine|T109|T121|T130|NON|BRD|FDA SRS (2014)|NLM (1991)|900319|abbbcdeef", "ENTRY": "Chloride, Methacholine", "MN": "D02.675.276.534.500", "PA": "Parasympathomimetics", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "1-Propanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, chloride", "RN": "0W5ETF9M2K", "RR": "62-51-1 (Methacholine Chloride)", "PI": "Methacholine Compounds (1966-1990)", "MS": "A quaternary ammonium parasympathomimetic agent with the muscarinic actions of ACETYLCHOLINE. It is hydrolyzed by ACETYLCHOLINESTERASE at a considerably slower rate than ACETYLCHOLINE and is more resistant to hydrolysis by nonspecific CHOLINESTERASES so that its actions are more prolonged. It is used as a parasympathomimetic bronchoconstrictor agent and as a diagnostic aid for bronchial asthma. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1116)", "PM": "91", "HN": "91", "MR": "20160701", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016210"}, {"RECTYPE": "D", "MH": "Transforming Growth Factor alpha", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "TGF-alpha|T116|T123|ABB|EQV|NLM (1991)|900226|abbcdef", "ENTRY": "Epidermal Growth Factor Related Transforming Growth Factor", "MN": "D23.529.960.360", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "PI": "Transforming Growth Factors (1989-1990)", "MS": "An EPIDERMAL GROWTH FACTOR related protein that is found in a variety of tissues including EPITHELIUM, and maternal DECIDUA. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form which binds to the EGF RECEPTOR.", "OL": "use TRANSFORMING GROWTH FACTORS to search TRANSFORMING GROWTH FACTOR ALPHA & TGF-ALPHA 1989-90", "PM": "91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-ALPHA was see TRANSFORMING GROWTH FACTORS 1989-90", "HN": "91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-ALPHA was see TRANSFORMING GROWTH FACTORS 1989-90", "MR": "20150623", "DA": "19900629", "DC": "1", "DX": "19910101", "UI": "D016211"}, {"RECTYPE": "D", "MH": "Transforming Growth Factor beta", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "TGF-beta|T116|T123|ABB|EQV|NLM (1991)|900227|abbcdef", "ENTRY": "Growth Factor, Milk", "MN": "D23.529.942.775", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "PI": "Transforming Growth Factors (1989-1990)", "MS": "A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 (TGF-beta1.2) or of TGF-beta2 and 3 (TGF-beta2.3) have been isolated. The TGF-beta proteins are synthesized as precursor proteins.", "OL": "use TRANSFORMING GROWTH FACTORS to search TRANSFORMING GROWTH FACTOR BETA & TGF-BETA 1989-90", "PM": "91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-BETA was see TRANSFORMING GROWTH FACTORS 1989-90", "HN": "91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-BETA was see TRANSFORMING GROWTH FACTORS 1989-90", "MR": "20150602", "DA": "19900629", "DC": "1", "DX": "19910101", "UI": "D016212"}, {"RECTYPE": "D", "MH": "Cyclins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cyclin|T116|T123|NON|EQV|NLM (1993)|911231|abbcdef", "MN": "D12.776.476.262", "FX": "Maturation-Promoting Factor", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "AN": "note specifics", "PI": "Invertebrate Hormones (1987-1990)", "MS": "A large family of regulatory proteins that function as accessory subunits to a variety of CYCLIN-DEPENDENT KINASES. They generally function as ENZYME ACTIVATORS that drive the CELL CYCLE through transitions between phases. A subset of cyclins may also function as transcriptional regulators.", "OL": "use CYCLINS to search CYCLIN 1991-2", "PM": "93; was CYCLIN 1991-2", "HN": "93; was CYCLIN 1991-2", "MR": "20151123", "DA": "19900617", "DC": "1", "DX": "19910101", "UI": "D016213"}, {"RECTYPE": "D", "MH": "Macrophage-Activating Factors", "DE": "MAF", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Macrophage Activating Factors", "MN": "D23.529.374.480.615", "MH_TH": "NLM (1991)", "ST": "T129", "RN": "0", "PI": "Lymphokines (1976-1990)", "MS": "Factors secreted by stimulated lymphocytes that prime macrophages to become nonspecifically cytotoxic to tumors. They also modulate the expression of macrophage cell surface Ia antigens. One MAF is INTERFERON-GAMMA. Other factors antigenically distinct from IFN-gamma have also been identified.", "PM": "91", "HN": "91", "MR": "20080710", "DA": "19900424", "DC": "1", "DX": "19910101", "UI": "D016215"}, {"RECTYPE": "D", "MH": "Ultrasonography, Prenatal", "DE": "ULTRASONOGR PRENATAL", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Ultrasonography, Fetal|T060|NON|NRW|NLM (1993)|911113|ULTRASONOGR FETAL|abcdefv", "ENTRY": "Ultrasonic Prenatal Diagnoses", "MN": "E01.370.378.630.865", "MH_TH": "NLM (1991)", "ST": "T060", "AN": "coordinate with specific fetal anatomic, physiologic or other clinical feature; if on mother, coordinate with specific maternal aspect; check tags FEMALE & PREGNANCY", "PI": "Ultrasonography (1985-1990)", "MS": "The visualization of tissues during pregnancy through recording of the echoes of ultrasonic waves directed into the body. The procedure may be applied with reference to the mother or the fetus and with reference to organs or the detection of maternal or fetal disease.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016216"}, {"RECTYPE": "D", "MH": "Ultrasonography, Mammary", "DE": "ULTRASONOGR MAMMARY", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Mammography, Ultrasonic|T060|NON|EQV|NLM (1991)|900418|MAMMOGR ULTRASONIC|abcdefv", "ENTRY": "Ultrasound Mammographies", "MN": "E01.370.378.850", "MH_TH": "NLM (1991)", "ST": "T060", "AN": "check tag usually FEMALE", "PI": "Ultrasonography (1985-1990)", "MS": "Use of ultrasound for imaging the breast. The most frequent application is the diagnosis of neoplasms of the female breast.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160317", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016217"}, {"RECTYPE": "D", "MH": "Immunotherapy, Adoptive", "DE": "IMMUNOTHER ADOPTIVE", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Adoptive Cellular Immunotherapy|T061|NON|EQV|NLM (1991)|900321|ADOPTIVE CELLULAR IMMUNOTHER|abcdefv", "ENTRY": "Therapy, CAR T-Cell", "MN": "E05.478.550.520.050.400", "FX": "Receptors, Chimeric Antigen", "MH_TH": "NLM (1991)", "ST": "T061", "AN": "for CAR T-Cell Therapy, coordinate with RECEPTORS, CHIMERIC ANTIGEN", "PI": "Immunization, Passive (1983-1990)", "MS": "Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)", "HN": "1991", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016219"}, {"RECTYPE": "D", "MH": "Fibroblast Growth Factor 1", "DS": "FIBROBLAST GROWTH FACTOR A 001", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heparin-Binding Growth Factor, Class I|T116|T123|NON|EQV|NLM (1991)|900301|abbcdef", "ENTRY": "Heparin Binding Growth Factor, Class I", "MN": "D23.529.624.110", "MH_TH": "NLM (2002)", "ST": "T123", "N1": "Fibroblast growth factor (human brain acidic protein moiety reduced)", "RN": "104781-85-3", "PI": "Growth Substances (1974-1983)", "MS": "A 17-kDa single-chain polypeptide growth factor that plays a significant role in the process of WOUND HEALING and is a potent inducer of PHYSIOLOGIC ANGIOGENESIS. It binds to HEPARIN, which potentiates its biological activity and protects it from proteolysis. The growth factor is an extremely potent inducer of DNA synthesis in a variety of cell types from mesoderm and neuroectoderm lineages, and also has chemotactic and mitogenic activities. It was originally named acidic fibroblast growth factor based upon its chemical properties and to distinguish it from basic fibroblast growth factor (FIBROBLAST GROWTH FACTOR 2).", "PM": "2002; FIBROBLAST GROWTH FACTOR-1 was indexed under FIBROBLAST GROWTH FACTOR ACIDIC 2001, FIBROBLAST GROWTH FACTOR 2000-2001 & under FIBROBLAST GROWTH FACTOR, BASIC 1998-2000", "HN": "2002(1991); for FIBROBLAST GROWTH FACTOR-1 use FIBROBLAST GROWTH FACTOR 1(NM) 1998-2001", "MR": "20060705", "DA": "19900705", "DC": "1", "DX": "19910101", "UI": "D016220"}, {"RECTYPE": "D", "MH": "Festschrift", "ENTRY": "Festschriften|T170|EQV|NLM (1991)|900301|abdef", "MN": "V02.672.500", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: check appropriate century tags", "PI": "Historical Biography (1966-1990)", "MS": "Work consisting of a collection of essays or other writings contributed by students, teachers, colleagues, and associates to honor a person or institution, usually on the occasion of an anniversary celebration or other event of importance.", "HN": "2008(1991)", "MR": "20070709", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016221"}, {"RECTYPE": "D", "MH": "Fibroblast Growth Factor 2", "DS": "FIBROBLAST GROWTH FACTOR A 002", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HBGF-2|T116|T123|ABB|EQV|NLM (1991)|900301|HBGF 02|abbcdefs", "ENTRY": "FGF 2", "MN": "D23.529.624.120", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "103107-01-3", "PI": "Growth Substances (1974-1983)", "MS": "A single-chain polypeptide growth factor that plays a significant role in the process of WOUND HEALING and is a potent inducer of PHYSIOLOGIC ANGIOGENESIS. Several different forms of the human protein exist ranging from 18-24 kDa in size due to the use of alternative start sites within the fgf-2 gene. It has a 55 percent amino acid residue identity to FIBROBLAST GROWTH FACTOR 1 and has potent heparin-binding activity. The growth factor is an extremely potent inducer of DNA synthesis in a variety of cell types from mesoderm and neuroectoderm lineages. It was originally named basic fibroblast growth factor based upon its chemical properties and to distinguish it from acidic fibroblast growth factor (FIBROBLAST GROWTH FACTOR 1).", "PM": "2001; FIBROBLAST GROWTH FACTOR-2 was indexed under FIBROBLAST GROWTH FACTOR, BASIC 1996-2001 & under FIBROBLAST GROWTH FACTOR 1995; PROSTATROPIN was indexed under NERVE TISSUE PROTEINS 1986-2001; CARTILAGE-DERIVED GROWTH FACTOR was indexed under PROTEINS 2005-2006", "HN": "2001(1991); for FIBROBLAST GROWTH FACTOR-2 use FIBROBLAST GROWTH FACTOR 2 (NM) 1995; for PROSTATROPIN use FIBROBLAST GROWTH FACTOR 2 (NM) 1986-2001", "MR": "20130709", "DA": "19900628", "DC": "1", "DX": "19910101", "UI": "D016222"}, {"RECTYPE": "D", "MH": "Advance Directives", "AQ": "CL EC EH ES HI LJ PX SN TD", "PRINT ENTRY": "Medical Power of Attorney|T089|NON|NRW|NLM (1998)|961120|abcdef", "ENTRY": "Wills, Psychiatric", "MN": "N04.590.233.624.124.050", "FX": "Right to Die", "MH_TH": "BIOETHICS (1989)", "ST": "T170", "PI": "Wills (1966-1990)", "MS": "Declarations by patients, made in advance of a situation in which they may be incompetent to decide about their own care, stating their treatment preferences or authorizing a third party to make decisions for them. (Bioethics Thesaurus)", "PM": "1991", "HN": "1991", "MR": "20020702", "DA": "19900601", "DC": "1", "DX": "19910101", "UI": "D016223"}, {"RECTYPE": "D", "MH": "Living Wills", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Wills, Living", "MN": "N04.590.233.624.124.050.500", "FX": "Right to Die", "MH_TH": "BIOETHICS (1989)", "ST": "T089", "PI": "Wills (1977-1986)", "MS": "Written, witnessed declarations in which persons request that if they become disabled beyond reasonable expectation of recovery, they be allowed to die rather than be kept alive by extraordinary means. (Bioethics Thesaurus)", "OL": "use RIGHT TO DIE to search LIVING WILLS 1987-90; use WILLS to search LIVING WILLS 1977-86", "PM": "91; was see RIGHT TO DIE 1987-90; was see WILLS 1977-86", "HN": "91; was see RIGHT TO DIE 1987-90; was see WILLS 1977-86", "MR": "20030709", "DA": "19900803", "DC": "1", "DX": "19910101", "UI": "D016224"}, {"RECTYPE": "D", "MH": "Phosphorus, Dietary", "AQ": "AD AE AG AI AN BL CF CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dietary Phosphorus|T197|NON|EQV|NLM (1991)|900303|abcdef", "MN": "D01.695.635", "EC": "deficiency:Phosphorus:deficiency", "MH_TH": "NLM (1991)", "ST": "T197", "RN": "0", "AN": "/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther", "PI": "Phosphorus (1966-1990)", "MS": "Phosphorus used in foods or obtained from food. This element is a major intracellular component which plays an important role in many biochemical pathways relating to normal physiological functions. High concentrations of dietary phosphorus can cause nephrocalcinosis which is associated with impaired kidney function. Low concentrations of dietary phosphorus cause an increase in calcitriol in the blood and osteoporosis.", "PM": "91", "HN": "91", "MR": "19930602", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016226"}, {"RECTYPE": "D", "MH": "Benzoquinones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzodiones|T109|NON|EQV|NLM (1991)|900303|abcdef", "ENTRY": "p-Benzoquinones|T109|NON|NRW|NLM (1991)|900303|abcdef", "MN": "D02.806.250", "FX": "Cyclohexenes", "MH_TH": "NLM (1991)", "ST": "T109", "RN": "0", "PI": "Quinones (1966-1990)", "MS": "Benzene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.", "PM": "91", "HN": "91", "MR": "20060705", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016227"}, {"RECTYPE": "D", "MH": "Endothelial Growth Factors", "DE": "ECGF", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Endothelial Growth Factor|T123|NON|NRW|NLM (1991)|900305|abcdef", "ENTRY": "beta Endothelial Growth Factor", "MN": "D23.529.390", "PA": "Growth Substances", "FX": "Vascular Endothelial Growth Factor A", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "AN": "do not confuse with EGF; (EPIDERMAL GROWTH FACTOR)", "PI": "Growth Substances (1966-1983)", "MS": "These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesize DNA. The factors are related to both the basic and acidic FIBROBLAST GROWTH FACTORS but have different amino acid sequences.", "PM": "91", "HN": "91", "MR": "20060705", "DA": "19900530", "DC": "1", "DX": "19910101", "UI": "D016228"}, {"RECTYPE": "D", "MH": "Amyloid beta-Peptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Amyloid Protein|T116|NON|EQV|NLM (1991)|900306|abcdef", "ENTRY": "beta-Proteins, Amyloid", "MN": "D12.776.543.039.500", "FX": "Cerebral Amyloid Angiopathy", "MH_TH": "NLM (2011)", "ST": "T116", "RN": "0", "PI": "Amyloid (1966-1990)", "MS": "Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.", "PM": "91", "HN": "91", "MR": "20200116", "DA": "19900617", "DC": "1", "DX": "19910101", "UI": "D016229"}, {"RECTYPE": "D", "MH": "Fluorescence Polarization Immunoassay", "DE": "FPIA", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Polarization Fluoroimmunoassay|T059|NON|EQV|NLM (1992)|910109|abcdef", "ENTRY": "Polarization Immunoassays, Fluorescence", "MN": "E05.478.583.375.655.350", "MH_TH": "NLM (1991)", "ST": "T059", "AN": "usually NIM; application of fluorescence polarization to hapten-antibody reaction: do not confuse with FLUORESCENCE POLARIZATION, determmination of polarization of fluorescent light", "PI": "Fluoroimmunoassay (1989-1990)", "MS": "Fluoroimmunoassay where detection of the hapten-antibody reaction is based on measurement of the increased polarization of fluorescence-labeled hapten when it is combined with antibody. The assay is very useful for the measurement of small haptenic antigens such as drugs at low concentrations.", "OL": "use FLUOROIMMUNOASSAY to search POLARIZATION FLUOROIMMUNOASSAY 1989-91", "PM": "91; POLARIZATION FLUOROIMMUNOASSAY was see FLUOROIMMUNOASSAY 1989-91", "HN": "91; POLARIZATION FLUOROIMMUNOASSAY was see FLUOROIMMUNOASSAY 1989-91", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016231"}, {"RECTYPE": "D", "MH": "Endothelins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Endothelium-Derived Vasoconstrictor Factors|T116|T123|NON|EQV|NLM (1991)|900310|EDCF|abbcdefv", "ENTRY": "Vasoconstrictor Factors, Endothelium-Derived", "MN": "D23.529.400", "FX": "Receptors, Endothelin", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Peptides (1966-1990)", "MS": "21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides.", "PM": "91", "HN": "91", "MR": "20060705", "DA": "19900628", "DC": "1", "DX": "19910101", "UI": "D016232"}, {"RECTYPE": "D", "MH": "Immunotherapy, Active", "DE": "IMMUNOTHER ACTIVE", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Vaccine Therapy|T061|NON|NRW|NLM (1991)|900312|VACCINE THER|abcdefv", "ENTRY": "Vaccine Therapies", "MN": "E05.478.550.600", "MH_TH": "NLM (1991)", "ST": "T061", "PI": "Immunotherapy (1967-1990)", "MS": "Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system.", "OL": "use IMMUNIZATION, PASSIVE to search IMMUNE RNA MANIPULATION 1983-96; use IMMUNOTHERAPY to search VACCINE THERAPY 1990", "PM": "91; IMMUNE RNA MANIPULATION was see IMMUNIZATION, PASSIVE 1983-96; VACCINE THERAPY was see IMMUNOTHERAPY 1990, was heading 1963-82", "HN": "91; IMMUNE RNA MANIPULATION was see IMMUNIZATION, PASSIVE 1983-96; VACCINE THERAPY was see IMMUNOTHERAPY 1990, was heading 1963-82", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016233"}, {"RECTYPE": "D", "MH": "Kallikrein-Kinin System", "DE": "KK SYSTEM", "AQ": "DE GE IM PH RE", "ENTRY": "Systems, Kallikrein-Kinin", "MN": "G09.330.380.690", "FX": "Renin-Angiotensin System", "MH_TH": "NLM (1991)", "ST": "T022", "PI": "Kinins (1966-1990)", "MS": "A system of metabolic interactions by products produced in the distal nephron of the KIDNEY. These products include KALLIKREIN; KININS; KININASE I; KININASE II; and ENKEPHALINASE. This system participates in the control of renal functions. It interacts with the RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM to regulate BLOOD PRESSURE, generation of PROSTAGLANDINS, release of VASOPRESSINS, and WATER-ELECTROLYTE BALANCE.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016234"}, {"RECTYPE": "D", "MH": "American Speech-Language-Hearing Association", "DE": "ASHA", "AQ": "EC HI OG", "ENTRY": "Speech-Language-Hearing Association, American", "MN": "N03.540.828.105", "MH_TH": "NLM (1991)", "ST": "T094", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "PI": "Speech-Language Pathology (1980-1990)", "MS": "A professional society concerned with the diagnosis, prevention, treatment, and remediation of speech, language, and hearing disorders.", "PM": "91", "HN": "91", "MR": "20150605", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016235"}, {"RECTYPE": "D", "MH": "Genes, fms", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "v-fms Genes|T028|NRW|NLM (1991)|900330|abdef", "ENTRY": "v-fms Oncogene", "MN": "G05.360.340.024.340.375.500.791.325", "FX": "Receptor, Macrophage Colony-Stimulating Factor", "MH_TH": "NLM (1991)", "ST": "T028", "PI": "Proto-Oncogenes (1986-1990)", "MS": "Family of genes originally isolated from the Susan McDonough strain of feline sarcoma virus (SARCOMA VIRUSES, FELINE). The proto-oncogene fms (c-fms) codes for the MCSF receptor (RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR). The oncogene fms (v-fms) codes for ONCOGENE PROTEIN GP140(V-FMS) which is a mutated form of the MCSF. The human c-fms gene is located between 5q33.2 and 5q33.3.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900628", "DC": "1", "DX": "19910101", "UI": "D016236"}, {"RECTYPE": "D", "MH": "Cytapheresis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Cytaphereses", "MN": "E05.242.363.171", "FX": "Immunotherapy, Adoptive", "MH_TH": "NLM (1991)", "ST": "T061", "PI": "Cell Separation (1978-1990)", "MS": "Separation of one or more kinds of cells from whole blood with the return of other blood cell constituents to the patient or donor. This is accomplished with an instrument that uses centrifugation to separate the cells into different layers based on the differences in cell density (displacement) or drag coefficients in a current (elutriation). The procedure is commonly used in adoptive transfer to isolate NK cells, lymphocytes, or monocytes.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016238"}, {"RECTYPE": "D", "MH": "MEDLINE", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Index Medicus|T073|T170|NON|NRW|UNK (19XX)|780316|abbcdef", "MN": "L01.470.750.500.650.500", "FX": "PubMed", "MH_TH": "NLM (1991)", "ST": "T170", "AN": "CATALOGER: Use NAF entry", "PI": "National Library of Medicine (U.S.) (1966-1977)", "MS": "The premier bibliographic database of the NATIONAL LIBRARY OF MEDICINE. MEDLINE\u00ae (MEDLARS Online) is the primary subset of PUBMED and can be searched on NLM's Web site in PubMed or the NLM Gateway. MEDLINE references are indexed with MEDICAL SUBJECT HEADINGS (MeSH).", "PM": "1991; see MEDLARS-MEDLINE INFORMATION SYSTEM 1978-1990; for INDEX MEDICUS see MEDLINE 1979-2004", "HN": "1991; use MEDLARS 1978-1990; for INDEX MEDICUS use MEDLINE 1979-2004", "MR": "20180629", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016239"}, {"RECTYPE": "D", "MH": "Grateful Med", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "MN": "L01.313.500.750.280.400", "MH_TH": "NLM (1991)", "ST": "T170", "AN": "CATALOGER: Use NAF entry", "PI": "MEDLARS (1986-1990)", "MS": "A microcomputer-based software package providing a user-friendly interface to the MEDLARS system of the National Library of Medicine.", "PM": "91", "HN": "91", "MR": "20180629", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016240"}, {"RECTYPE": "D", "MH": "Child of Impaired Parents", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Offspring of Impaired Parents|T098|NON|EQV|NLM (1992)|910116|abcdef", "ENTRY": "Parents Offsprings, Impaired", "MN": "M01.106", "MH_TH": "NLM (1991)", "ST": "T098", "AN": "coord IM with parental dis (IM with no qualif); restrict to impaired parents: for child with impaired siblings; index CHILD (IM) + disease of sibling (IM) + SIBLINGS (IM); interpret \"child\" as \"offspring\" & check appropriate age check tags", "MS": "Child with one or more parents afflicted by a physical or mental disorder.", "PM": "91", "HN": "91", "MR": "20060705", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016241"}, {"RECTYPE": "D", "MH": "Library Automation", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Automation, Library", "MN": "L01.583.400", "MH_TH": "NLM (1991)", "ST": "T057", "PI": "Libraries (1966-1990)", "MS": "The use of automatic machines or processing devices in libraries. The automation may be applied to library administrative activities, office procedures, and delivery of library services to users.", "PM": "91", "HN": "91", "MR": "19920325", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016242"}, {"RECTYPE": "D", "MH": "Library Collection Development", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Collection Development (Libraries)|T057|NON|EQV|NLM (1991)|900322|COLLECTION DEVELOPMENT|abcdefv", "ENTRY": "Developments, Collection (Libraries)", "MN": "L01.583.410", "MH_TH": "NLM (1991)", "ST": "T057", "PI": "Book Selection (1966-1990)", "MS": "Development of a library collection, including the determination and coordination of selection policy, assessment of needs of users and potential users, collection use studies, collection evaluation, identification of collection needs, selection of materials, planning for resource sharing, collection maintenance and weeding, and budgeting.", "PM": "91", "HN": "91", "MR": "19920325", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016243"}, {"RECTYPE": "D", "MH": "Guanosine 5'-O-(3-Thiotriphosphate)", "DE": "GUANOSINE 5 O 3 THIOTRIPHOSPHATE", "DS": "GUANOSINETHIOTRIPHOSPHATE O0503", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "gamma-Thio-GTP|T114|T121|EQV|NLM (1991)|900322|abbdef", "ENTRY": "gamma Thio GTP", "MN": "D13.695.900.380", "MH_TH": "NLM (1991)", "ST": "T121", "N1": "Guanosine 5'-(trihydrogen diphosphate), P'-anhydride with phosphorothioic acid", "RN": "37589-80-3", "AN": "/biosyn /physiol permitted", "PI": "Thionucleotides (1977-1990)", "MS": "Guanosine 5'-(trihydrogen diphosphate), monoanhydride with phosphorothioic acid. A stable GTP analog which enjoys a variety of physiological actions such as stimulation of guanine nucleotide-binding proteins, phosphoinositide hydrolysis, cyclic AMP accumulation, and activation of specific proto-oncogenes.", "PM": "91", "HN": "91", "MR": "20050630", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016244"}, {"RECTYPE": "D", "MH": "Librarians", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Librarian", "MN": "M01.526.555", "MH_TH": "NLM (1991)", "ST": "T097", "AN": "coordinate with area of specialism of the librarian", "PI": "Libraries (1966-1990)", "MS": "Specialists in the management of a library or the services rendered by a library, bringing professional skills to administration, organization of material and personnel, interpretation of bibliothecal rules, the development and maintenance of the library's collection, and the provision of information services.", "PM": "91", "HN": "91", "MR": "20170308", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016245"}, {"RECTYPE": "D", "MH": "Lymphocytes, Tumor-Infiltrating", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Tumor-Infiltrating Lymphocytes|T025|NON|EQV|NLM (1991)|900322|TIL|abcdefv", "ENTRY": "Tumor Infiltrating Lymphocytes", "MN": "A15.382.490.555.567.650", "FX": "Immunotherapy, Adoptive", "MH_TH": "NLM (1991)", "ST": "T025", "AN": "subpopulations: coordinate with LYMPHOCYTE SUBSETS or specifics", "PI": "T-Lymphocytes, Cytotoxic (1984-1990)", "MS": "Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer.", "PM": "91", "HN": "91", "MR": "20200527", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016246"}, {"RECTYPE": "D", "MH": "Information Storage and Retrieval", "DE": "INFORMATION STORAGE RETRIEVAL", "AQ": "CL EC ES HI LJ MT SN ST TD", "PRINT ENTRY": "Information Retrieval|T057|T066|NON|NRW|NLM (1991)|900322|abbcdef", "ENTRY": "Storage, Data", "MN": "L01.470", "MH_TH": "NLM (1991)", "ST": "T066", "PI": "Information Systems (1966-1990)", "MS": "Organized activities related to the storage, location, search, and retrieval of information.", "OL": "use INFORMATION SYSTEMS to search INFORMATION STORAGE AND RETRIEVAL 1982-90", "PM": "1991; was see INFORMATION SYSTEMS 1982-1990;  for DATA FILES use AUTOMATIC DATA PROCESSING 1994-2015, for DATA SOURCES use DATA COLLECTION 1987-2015, for DATA FILES use AUTOMATIC DATA PROCESSING 1994-2015, for DATA SOURCES use DATA COLLECTION 1987-2015,for DATA LINKAGE see DATA COLLECTION 1989-2015", "HN": "1991; was see INFORMATION SYSTEMS 1982-1990; for DATA FILES use AUTOMATIC DATA PROCESSING 1994-2015, for DATA SOURCES use DATA COLLECTION 1987-2015, for DATA LINKAGE use DATA COLLECTION 1989-2015", "MR": "20220712", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016247"}, {"RECTYPE": "D", "MH": "Computer Storage Devices", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Mass Storage Devices|T073|NON|EQV|NLM (1991)|900323|abcdef", "ENTRY": "Systems, Computer Memory", "MN": "L01.224.230.260.115.475", "MH_TH": "NLM (1991)", "ST": "T073", "PI": "Computers (1966-1990)", "MS": "Devices capable of receiving data, retaining data for an indefinite or finite period of time, and supplying data upon demand.", "PM": "91", "HN": "91", "MR": "20170703", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016248"}, {"RECTYPE": "D", "MH": "Optical Storage Devices", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "WORM Disks|T073|NON|NRW|NLM (1991)|900502|abcdef", "ENTRY": "WORM Disk", "MN": "L01.462.500.820.090.668", "MH_TH": "NLM (1991)", "ST": "T073", "MS": "A computer disk read by a laser beam, containing data prerecorded by a vendor. The buyer cannot enter or modify data in any way but the advantages lie in the speed of accessibility, relative immunity to damage, and relatively low cost of purchase.", "PM": "91", "HN": "91", "MR": "20220712", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016249"}, {"RECTYPE": "D", "MH": "Compact Disks", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Disks, Compact", "MN": "L01.462.500.820.090.898.800.250", "MH_TH": "NLM (1991)", "ST": "T073", "MS": "Computer disks storing data with a maximum reduction of space and bandwidth. The compact size reduces cost of transmission and storage.", "PM": "91", "HN": "91", "MR": "20220712", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016250"}, {"RECTYPE": "D", "MH": "CD-ROM", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Compact Disk Read-Only Memory|T073|T170|NON|EQV|NLM (1991)|900323|abbcdef", "ENTRY": "Compact Disk Read Only Memory", "MN": "L01.462.500.820.090.898.800.250.200", "MH_TH": "NLM (1991)", "ST": "T170", "MS": "An optical disk storage system for computers on which data can be read or from which data can be retrieved but not entered or modified. A CD-ROM unit is almost identical to the compact disk playback device for home use.", "PM": "91", "HN": "91", "MR": "20220712", "DA": "19900611", "DC": "1", "DX": "19910101", "UI": "D016251"}, {"RECTYPE": "D", "MH": "Microscopy, Scanning Tunneling", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Scanning Tunneling Microscopy|T059|NON|EQV|NLM (1991)|900323|abcdef", "ENTRY": "Tunnelling Microscopy, Scanning", "MN": "E05.595.666.500", "FX": "Microscopy, Atomic Force", "MH_TH": "NLM (1991)", "ST": "T059", "PI": "Microscopy, Electron, Scanning (1987-1990)", "MS": "A type of scanning probe microscopy in which a very sharp conducting needle is swept just a few angstroms above the surface of a sample. The tiny tunneling current that flows between the sample and the needle tip is measured, and from this are produced three-dimensional topographs. Due to the poor electron conductivity of most biological samples, thin metal coatings are deposited on the sample.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016252"}, {"RECTYPE": "D", "MH": "Microscopy, Immunoelectron", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Immunoelectron Microscopy|T060|NON|EQV|NLM (1991)|900323|abcdef", "ENTRY": "Microscopy, Immuno Electron", "MN": "E05.595.402.625", "MH_TH": "NLM (1991)", "ST": "T060", "AN": "NIM", "PI": "Microscopy, Electron (1973-1990)", "MS": "Microscopy in which the samples are first stained immunocytochemically and then examined using an electron microscope. Immunoelectron microscopy is used extensively in diagnostic virology as part of very sensitive immunoassays.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016253"}, {"RECTYPE": "D", "MH": "Mutagenesis, Insertional", "AQ": "DE EC GE HI IM IS MT PH RE SN ST", "PRINT ENTRY": "Viral Insertional Mutagenesis|T045|T063|NON|NRW|NLM (1991)|900412|abbcdef", "ENTRY": "Sequence Insertions", "MN": "G05.558.550", "FX": "DNA Transposable Elements", "MH_TH": "NLM (1991)", "ST": "T063", "PI": "Mutation (1982-1990)", "MS": "Mutagenesis where the mutation is caused by the introduction of foreign DNA sequences into a gene or extragenic sequence. This may occur spontaneously in vivo or be experimentally induced in vivo or in vitro. Proviral DNA insertions into or adjacent to a cellular proto-oncogene can interrupt GENETIC TRANSLATION of the coding sequences or interfere with recognition of regulatory elements and cause unregulated expression of the proto-oncogene resulting in tumor formation.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016254"}, {"RECTYPE": "D", "MH": "Anistreplase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Anisoylated Plasminogen-Streptokinase Activator Complex|T116|T121|T126|NON|EQV|NLM (1991)|900326|ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX|abbbcdefv", "ENTRY": "BRL26921", "MN": "D12.776.124.125.662.537.075", "PA": "Fibrinolytic Agents", "MH_TH": "USAN (1989)", "ST": "T126", "N1": "Anistreplase", "RN": "81669-57-0", "PI": "Streptokinase (1966-1990)", "MS": "An acylated inactive complex of streptokinase and human lysine-plasminogen. After injection, the acyl group is slowly hydrolyzed, producing an activator that converts plasminogen to plasmin, thereby initiating fibrinolysis. Its half-life is about 90 minutes compared to 5 minutes for TPA; (TISSUE PLASMINOGEN ACTIVATOR); 16 minutes for UROKINASE-TYPE PLASMINOGEN ACTIVATOR and 23 minutes for STREPTOKINASE. If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. Bleeding complications are similar to other thrombolytic agents.", "PM": "91", "HN": "91", "MR": "20160701", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016255"}, {"RECTYPE": "D", "MH": "Lewis X Antigen", "AQ": "AA AD AE AN BI BL CF CH CL EC GE HI IM IP ME PD PH PO TO TU UL UR", "PRINT ENTRY": "Stage-Specific Embryonic Antigen-1|T088|T109|T129|NON|EQV|NLM (1995)|940415|STAGE SPECIFIC EMBRYONIC ANTIGEN 001|SSEA1|abbbcdefsv", "ENTRY": "X Hapten, Lewis", "MN": "D23.101.140.075.050", "MH_TH": "NLM (1991)", "ST": "T129", "RN": "0", "PI": "Tumor Markers, Biological (1988-1990)", "MS": "A trisaccharide antigen expressed on glycolipids and many cell-surface glycoproteins. In the blood the antigen is found on the surface of NEUTROPHILS; EOSINOPHILS; and MONOCYTES. In addition, Lewis X antigen is a stage-specific embryonic antigen.", "PM": "2018; see ANTIGENS, CD15 1995-2017 and STAGE-SPECIFIC EMBRYONIC ANTIGEN-1 1991-94; for LEU-M1 ANTIGENS see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; LEWIS X ANTIGEN was indexed under ANTIGENS, CD and ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1992-94; and under ANTIGENS, DIFFERENTIATION 1987-91; LEWIS X HAPTEN was indexed under GANGLIOSIDES 1987-94", "HN": "2018 (1990); for LEU-M1 ANTIGENS use ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; for CD15 ANTIGENS use CD15 ANTIGEN 1987-94; use LEWIS X HAPTEN  1987-94", "MR": "20190709", "DA": "19900608", "DC": "1", "DX": "19910101", "UI": "D016256"}, {"RECTYPE": "D", "MH": "Fura-2", "DS": "FURA 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Fura 2", "MN": "D03.633.100.127.250", "PA": "Fluorescent Dyes", "MH_TH": "NLM (1991)", "ST": "T130", "N1": "5-Oxazolecarboxylic acid, 2-(6-(bis(carboxymethyl)amino)-5-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)-2-benzofuranyl)-", "RN": "TSN3DL106G", "RR": "96314-98-6 (Fura-2)", "PI": "Oxazoles (1966-1990)", "MS": "A fluorescent calcium chelating agent which is used to study intracellular calcium in tissues.", "PM": "91", "HN": "91", "MR": "20160531", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016257"}, {"RECTYPE": "D", "MH": "Genes, mos", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "v-mos Genes|T028|NRW|NLM (1991)|900327|abdef", "ENTRY": "v-mos Oncogene", "MN": "G05.360.340.024.340.375.500.791.400", "FX": "Genes, Intracisternal A-Particle", "MH_TH": "NLM (1991)", "ST": "T028", "AN": "mos stands for \"MOloney Sarcoma\"", "PI": "Proto-Oncogenes (1986-1990)", "MS": "Retrovirus-associated DNA sequences (mos) originally isolated from the Moloney murine sarcoma virus (Mo-MSV). The proto-oncogene mos (c-mos) codes for a protein which is a member of the serine kinase family. There is no evidence as yet that human c-mos can become transformed or has a role in human cancer. However, in mice, activation can occur when the retrovirus-like intracisternal A-particle inserts itself near the c-mos sequence. The human c-mos gene is located at 8q22 on the long arm of chromosome 8.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016258"}, {"RECTYPE": "D", "MH": "Genes, myc", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "v-myc Genes|T028|NRW|NLM (1991)|900327|abdef", "ENTRY": "v-myc Oncogene", "MN": "G05.360.340.024.340.375.500.791.420", "FX": "Proto-Oncogene Proteins c-myc", "MH_TH": "NLM (1991)", "ST": "T028", "AN": "myc stands for \"MYeloCytomatosis\"", "PI": "Oncogenes (1983-1990)", "MS": "Family of retrovirus-associated DNA sequences (myc) originally isolated from an avian myelocytomatosis virus. The proto-oncogene myc (c-myc) codes for a nuclear protein which is involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Truncation of the first exon, which appears to regulate c-myc expression, is crucial for tumorigenicity. The human c-myc gene is located at 8q24 on the long arm of chromosome 8.", "OL": "use ONCOGENES to search MYC GENES 1985-90", "PM": "91; was MYC GENES see ONCOGENES 1985-90", "HN": "91; was MYC GENES see ONCOGENES 1985-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900628", "DC": "1", "DX": "19910101", "UI": "D016259"}, {"RECTYPE": "D", "MH": "Monocytes, Activated Killer", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Killer Monocytes, Activated|T025|NON|EQV|NLM (1991)|900330|abcdef", "ENTRY": "Monocyte, Activated Killer", "MN": "A15.382.680.547.500", "FX": "Immunotherapy, Adoptive", "MH_TH": "NLM (1991)", "ST": "T025", "PI": "Monocytes (1988-1990)", "MS": "Monocytes made cytotoxic by IN VITRO incubation with CYTOKINES, especially INTERFERON-GAMMA. The cells are used for ADOPTIVE IMMUNOTHERAPY in cancer patients.", "PM": "91", "HN": "91", "MR": "20180701", "DA": "19900606", "DC": "1", "DX": "19910101", "UI": "D016260"}, {"RECTYPE": "D", "MH": "Postpoliomyelitis Syndrome", "DE": "POSTPOLIO SYNDROME", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Postpoliomyelitis Muscular Atrophy|T047|NON|EQV|NLM (1991)|900329|PPMA|abcdefv", "ENTRY": "Postpoliomyelitis Muscular Atrophies", "MN": "C10.668.864.500", "FX": "Poliomyelitis", "MH_TH": "NLM (1991)", "ST": "T047", "PI": "Poliomyelitis/complications (1983-1990)", "MS": "A syndrome characterized by new neuromuscular symptoms that occur at least 15 years after clinical stability has been attained in patients with a prior history of symptomatic poliomyelitis. Clinical features include new muscular weakness and atrophy of the limbs, bulbar innervated musculature, and muscles of respiration, combined with excessive fatigue, joint pain, and reduced stamina. The process is marked by slow progression and periods of stabilization. (From Ann NY Acad Sci 1995 May 25;753:68-80)", "PM": "1991", "HN": "1991", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19991108", "DC": "1", "DX": "19910101", "UI": "D016262"}, {"RECTYPE": "D", "MH": "AIDS-Associated Nephropathy", "DE": "AIDS ASSOC NEPHROPATHY", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Human Immunodeficiency Virus-Associated Nephropathy|T047|NON|EQV|NLM (1991)|900328|HUMAN IMMUNODEFIC VIRUS ASSOC NEPHROPATHY|abcdefv", "ENTRY": "Nephropathy, HIV Related", "MN": "C20.673.480.050", "MH_TH": "NLM (1991)", "ST": "T047", "AN": "coord IM with specific kidney dis (IM); specify HIV-1 or HIV-2 (IM or NIM) if pertinent", "PI": "specific kidney diseases (1984-1990)", "MS": "Renal syndrome in human immunodeficiency virus-infected patients characterized by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016263"}, {"RECTYPE": "D", "MH": "Dextran Sulfate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sodium Dextran Sulfate|T109|T121|NON|NRW|NLM (1991)|900416|abbcdef", "ENTRY": "Sulfate, Sodium Dextran", "MN": "D09.698.365.272.300", "MH_TH": "NLM (1991)", "ST": "T121", "N1": "Dextran, hydrogen sulfate", "RN": "9042-14-2", "PI": "Dextrans (1966-1990)", "MS": "Long-chain polymer of glucose containing 17-20% sulfur. It has been used as an anticoagulant and also has been shown to inhibit the binding of HIV-1 to CD4-POSITIVE T-LYMPHOCYTES. It is commonly used as both an experimental and clinical laboratory reagent and has been investigated for use as an antiviral agent, in the treatment of hypolipidemia, and for the prevention of free radical damage, among other applications.", "PM": "91", "HN": "91", "MR": "20070709", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016264"}, {"RECTYPE": "D", "MH": "Conflict of Interest", "AQ": "EC LJ", "ENTRY": "Interest Conflicts", "MN": "N05.350.225", "FX": "Professional Misconduct", "MH_TH": "BIOETHICS (1989)", "ST": "T078", "PI": "Ethics (1966-1990)", "MS": "A situation in which an individual might benefit personally from official or professional actions. It includes a conflict between a person's private interests and official responsibilities in a position of trust. The term is not restricted to government officials. The concept refers both to actual conflict of interest and the appearance or perception of conflict.", "PM": "1991", "HN": "1991", "MR": "20150622", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016265"}, {"RECTYPE": "D", "MH": "Food Parasitology", "DE": "FOOD PARASITOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Parasitology, Food|T067|NON|EQV|NLM (1991)|900514|PARASITOL FOOD|abcdefv", "MN": "N06.850.601.500.249.650", "MH_TH": "NLM (1991)", "ST": "T067", "AN": "coordinate with specific food / parasitol and specific parasite", "PI": "specific parasite (1966-1990)", "MS": "The presence of parasites in food and food products. For the presence of bacteria, viruses, and fungi in food, FOOD MICROBIOLOGY is available.", "PM": "91", "HN": "91", "MR": "20120703", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016266"}, {"RECTYPE": "D", "MH": "External Fixators", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Fixation Devices, External|T074|NON|EQV|NLM (1991)|900426|abcdef", "ENTRY": "Fixators, External", "MN": "E07.858.690.725.430", "FX": "Osteogenesis, Distraction", "MH_TH": "NLM (1991)", "ST": "T074", "AN": "for fracture fixation", "PI": "Orthopedic Fixation Devices (1979-1990)", "MS": "External devices which hold wires or pins that are placed through one or both cortices of bone in order to hold the position of a fracture in proper alignment. These devices allow easy access to wounds, adjustment during the course of healing, and more functional use of the limbs involved.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016267"}, {"RECTYPE": "D", "MH": "Internal Fixators", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Fixation Devices, Internal|T074|NON|EQV|NLM (1991)|900427|abcdef", "ENTRY": "Internal Fixator", "MN": "E07.858.690.725.460", "MH_TH": "NLM (1991)", "ST": "T074", "AN": "for fracture fixation", "PI": "Orthopedic Fixation Devices (1986-1990)", "MS": "Internal devices used in osteosynthesis to hold the position of the fracture in proper alignment. By applying the principles of biomedical engineering, the surgeon uses metal plates, nails, rods, etc., for the correction of skeletal defects.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016268"}, {"RECTYPE": "D", "MH": "Milk Hypersensitivity", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypersensitivity, Milk|T047|NON|EQV|NLM (1993)|920203|abcdef", "ENTRY": "Milk Hypersensitivities", "MN": "C20.543.480.370.500", "FX": "Lactose Intolerance", "MH_TH": "NLM (1991)", "ST": "T047", "AN": "coordinate with specific milk product /adv eff if pertinent; do not confuse with LACTOSE INTOLERANCE, a lactase deficiency", "PI": "Milk/adverse effects (1966-1990)", "MS": "Allergic reaction to milk (usually cow's milk) or milk products. MILK HYPERSENSITIVITY should be differentiated from LACTOSE INTOLERANCE, an intolerance to milk as a result of congenital deficiency of lactase.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016269"}, {"RECTYPE": "D", "MH": "United States Agency for Healthcare Research and Quality", "DE": "AHRQ", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "United States Agency for Health Care Policy and Research|T093|NAM|EQV|NLM (1991)|990101|AHCPR|abcdefv", "ENTRY": "Agency for Healthcare Research and Quality (U.S.)|T093|NAM|EQV|NLM (2008)|070226|abcdef", "MN": "N03.540.348.500.500.600.650.592", "MH_TH": "NLM (2001)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; CATALOGER: Use NAF entry", "MS": "An agency of the PUBLIC HEALTH SERVICE established in 1990 to \"provide indexing, abstracting, translating, publishing, and other services leading to a more effective and timely dissemination of information on research, demonstration projects, and evaluations with respect to health care to public and private entities and individuals engaged in the improvement of health care delivery...\" It supersedes the National Center for Health Services Research. The United States Agency for Health Care Policy and Research was renamed Agency for Healthcare Research and Quality (AHRQ) under the Healthcare Research and Quality Act of 1999.", "PM": "91", "HN": "91", "MR": "20150629", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016270"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-myc", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p62(c-myc)|T116|T123|EQV|NLM (1991)|900402|P A 062 C MYC|P62C MYC|abbdefsv", "ENTRY": "p62 c myc", "MN": "D12.776.930.125.813", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "PI": "Proto-Oncogene Proteins (1986-1990)", "MS": "Basic helix-loop-helix transcription factors encoded by the c-myc genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated (constitutive) expression of c-myc proteins can cause tumorigenesis.", "PM": "91", "HN": "91", "MR": "20180701", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016271"}, {"RECTYPE": "D", "MH": "Occupational Health", "DE": "OCCUP HEALTH", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "PRINT ENTRY": "Occupational Safety|T078|NON|NRW|NLM (1991)|900514|OCCUP SAFETY|abcdefv", "ENTRY": "Health, Occupational", "MN": "N01.400.525", "MH_TH": "POPLINE (1993)", "ST": "T078", "PI": "Occupational Medicine (1966-1990)", "MS": "The promotion and maintenance of physical and mental health in the work environment.", "PM": "91", "HN": "91", "MR": "20180629", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016272"}, {"RECTYPE": "D", "MH": "Occupational Exposure", "DE": "OCCUP EXPOSURE", "AQ": "AE AN CL EC ES HI LJ PC SN ST", "ENTRY": "Occupational Exposures", "MN": "N06.850.460.350.600", "FX": "Multiple Chemical Sensitivity", "MH_TH": "NLM (1991)", "ST": "T037", "AN": "coord IM with specific occup dis (IM) or specific occupation (IM)", "PI": "Occupational Diseases (1966-1989)", "MS": "The exposure to potentially harmful chemical, physical, or biological agents that occurs as a result of one's occupation.", "OL": "use ENVIRONMENTAL EXPOSURE to search OCCUPATIONAL EXPOSURE 1989-90", "PM": "91; was see ENVIRONMENTAL EXPOSURE 1989-90", "HN": "91; was see ENVIRONMENTAL EXPOSURE 1989-90", "MR": "20190524", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016273"}, {"RECTYPE": "D", "MH": "Oncogene Protein p55(v-myc)", "DS": "ONCOGENE PROTEIN P 055 V MYC", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-myc Protein p55|T116|T123|EQV|NLM (1991)|900409|V MYC PROTEIN P A 055|abbdefs", "ENTRY": "v myc Protein p55", "MN": "D12.776.964.775.750.750", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "AN": "IM; coord with specific virus (IM); /drug eff /ultrastruct permitted", "PI": "Retroviridae Proteins, Oncogenic (1990)", "MS": "Transforming protein coded by myc oncogenes. The v-myc protein has been found in several replication-defective avian retrovirus isolates which induce a broad spectrum of malignancies.", "PM": "91", "HN": "91", "MR": "20190524", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016274"}, {"RECTYPE": "D", "MH": "Atrial Function", "AQ": "DE GE IM PH RE", "ENTRY": "Functions, Atrial", "MN": "G09.330.040", "MH_TH": "NLM (1991)", "ST": "T042", "PI": "Heart/physiology (1966-1990)", "MS": "The hemodynamic and electrophysiological action of the HEART ATRIA.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016275"}, {"RECTYPE": "D", "MH": "Ventricular Function", "AQ": "DE ES GE IM PH RE", "ENTRY": "Ventricular Functions", "MN": "G09.330.955", "FX": "Heart Function Tests", "MH_TH": "NLM (1991)", "ST": "T042", "PI": "Heart/physiology (1966-1990)", "MS": "The hemodynamic and electrophysiological action of the HEART VENTRICLES.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016276"}, {"RECTYPE": "D", "MH": "Ventricular Function, Left", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Left Ventricular Function|T042|NON|EQV|NLM (1991)|900503|abcdef", "ENTRY": "Ventricular Functions, Left", "MN": "G09.330.955.800", "MH_TH": "NLM (1991)", "ST": "T042", "PI": "Heart/physiology (1966-1990)", "MS": "The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016277"}, {"RECTYPE": "D", "MH": "Ventricular Function, Right", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Right Ventricular Function|T042|NON|EQV|NLM (1991)|900503|abcdef", "ENTRY": "Ventricular Functions, Right", "MN": "G09.330.955.900", "MH_TH": "NLM (1991)", "ST": "T042", "PI": "Heart/physiology (1966-1990)", "MS": "The hemodynamic and electrophysiological action of the right HEART VENTRICLE.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016278"}, {"RECTYPE": "D", "MH": "Atrial Function, Left", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Left Atrial Function|T042|NON|EQV|NLM (1991)|900503|abcdef", "ENTRY": "Left Atrial Functions", "MN": "G09.330.040.100", "MH_TH": "NLM (1991)", "ST": "T042", "PI": "Heart/physiology (1966-1990)", "MS": "The hemodynamic and electrophysiological action of the LEFT ATRIUM.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016279"}, {"RECTYPE": "D", "MH": "Atrial Function, Right", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Right Atrial Function|T042|NON|EQV|NLM (1991)|900503|abcdef", "ENTRY": "Right Atrial Functions", "MN": "G09.330.040.200", "MH_TH": "NLM (1991)", "ST": "T042", "PI": "Heart/physiology (1966-1990)", "MS": "The hemodynamic and electrophysiological action of the RIGHT ATRIUM.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016280"}, {"RECTYPE": "D", "MH": "Oncogene Protein gp140(v-fms)", "DS": "ONCOGENE PROTEIN GP 140 V FMS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-fms Protein|T116|T123|EQV|NLM (1991)|900410|abbdef", "ENTRY": "v-fms, gp140", "MN": "D12.776.964.775.750.650", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "AN": "IM; coord with specific virus (IM); /drug eff /ultrastruct permitted", "PI": "Retroviridae Proteins, Oncogenic (1990)", "MS": "Transforming glycoprotein coded by the fms oncogene from the Susan McDonough strain of feline sarcoma virus (SM-FeSV). The oncogene protein v-fms lacks sequences, which, in the highly homologous proto-oncogene protein c-fms (CSF-1 receptor), normally serve to regulate its tyrosine kinase activity. The missing sequences in v-fms mimic the effect of ligand and lead to constitutive cell growth. The protein gp120(v-fms) is post-translationally modified to generate gp140(v-fms).", "PM": "91", "HN": "91", "MR": "20190524", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016281"}, {"RECTYPE": "D", "MH": "Aspartic Acid Endopeptidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aspartic Endopeptidases|T116|T126|NON|EQV|NLM (2000)|991109|abbcdef", "ENTRY": "Endopeptidases, Aspartyl", "MN": "D08.811.277.656.300.048", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.4.23.-", "PI": "Peptide Peptidohydrolases (1966-1990)", "MS": "A sub-subclass of endopeptidases that depend on an ASPARTIC ACID residue for their activity.", "PM": "2010; see ASPARTIC PROTEINASES 1991-1999", "HN": "2010(1991)", "MR": "20090706", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016282"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins p21(ras)", "DS": "PROTO ONCOGENE PROTEINS P 021 RAS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ras Proto-Oncogene Protein p21|T116|T126|EQV|NLM (1991)|900404|RAS PROTO ONCOGENE PROTEIN P 021|abbdefs", "ENTRY": "ras, Proto-Oncogene Protein", "MN": "D12.776.624.664.700.200", "FX": "Costello Syndrome", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "Proto-Oncogene Proteins (1987-1990)", "MS": "Cellular proteins encoded by the H-ras, K-ras and N-ras genes. The proteins have GTPase activity and are involved in signal transduction as monomeric GTP-binding proteins. Elevated levels of p21 c-ras have been associated with neoplasia. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2006; for P21(RAS) see ONCOGENE PROTEIN P21(RAS) 1990", "HN": "2006(1991)", "MR": "20210521", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016283"}, {"RECTYPE": "D", "MH": "Technetium Tc 99m Pentetate", "DE": "TCDTPA", "DS": "TECHNETIUM TC PENTETATE 099M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Technetium-DTPA|T109|T130|EQV|NLM (1991)|900405|abbdef", "ENTRY": "Technetium DTPA", "MN": "D02.691.825.875", "PA": "Radiopharmaceuticals", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "Technetate(1-)-99Tc, (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, sodium", "RN": "VW78417PU1", "RR": "65454-61-7 (Technetium Tc 99m Pentetate)", "AN": "for routine use as label, use no qualifiers", "PI": "Technetium (1966-1990)", "MS": "A technetium imaging agent used in renal scintigraphy, computed tomography, lung ventilation imaging, gastrointestinal scintigraphy, and many other procedures which employ radionuclide imaging agents.", "OL": "use TECHNETIUM TC 99M PENTETATE to search 99MTC-DTPA 1991-92", "PM": "91; 99MTC-DTPA was see TECHNETIUM TC 99M PENTETATE 1991-92", "HN": "91; 99MTC-DTPA was see TECHNETIUM TC 99M PENTETATE 1991-92", "MR": "20170309", "DA": "19900608", "DC": "1", "DX": "19910101", "UI": "D016284"}, {"RECTYPE": "D", "MH": "Iloprost", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ciloprost|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1991)|900405|abbcdeef", "ENTRY": "ZK36374", "MN": "D23.469.700.275", "PA": "Vasodilator Agents", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Pentanoic acid, 5-(hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octen-6-ynyl)-2(1H)-pentalenylidene)-", "RN": "JED5K35YGL", "RR": "78919-13-8 (Iloprost)", "PI": "Vasodilator Agents (1966-1990)", "MS": "An eicosanoid, derived from the cyclooxygenase pathway of arachidonic acid metabolism. It is a stable and synthetic analog of EPOPROSTENOL, but with a longer half-life than the parent compound. Its actions are similar to prostacyclin. Iloprost produces vasodilation and inhibits platelet aggregation.", "PM": "91", "HN": "91", "MR": "20160701", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016285"}, {"RECTYPE": "D", "MH": "Computer Peripherals", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Peripheral Equipment, Computer|T073|NON|EQV|NLM (1991)|900407|abcdef", "ENTRY": "Peripherals, Computer", "MN": "L01.224.230.260.115", "MH_TH": "NLM (1991)", "ST": "T073", "PI": "Computers (1966-1990)", "MS": "Various units or machines that operate in combination or in conjunction with a computer but are not physically part of it. Peripheral devices typically display computer data, store data from the computer and return the data to the computer on demand, prepare data for human use, or acquire data from a source and convert it to a form usable by a computer. (Computer Dictionary, 4th ed.)", "PM": "91", "HN": "91", "MR": "20170703", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016287"}, {"RECTYPE": "D", "MH": "Computer Terminals", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Video Display Terminals|T073|NON|EQV|NLM (1991)|900407|abcdef", "ENTRY": "Video Display Terminal", "MN": "L01.224.230.260.115.500", "MH_TH": "NLM (1991)", "ST": "T073", "PI": "Computer Systems (1987-1990)", "MS": "Input/output devices designed to receive data in an environment associated with the job to be performed, and capable of transmitting entries to, and obtaining output from, the system of which it is a part. (Computer Dictionary, 4th ed.)", "OL": "use COMPUTER SYSTEMS to search COMPUTER TERMINALS 1987-90", "PM": "91; was see COMPUTER SYSTEMS 1987-90", "HN": "91; was see COMPUTER SYSTEMS 1987-90", "MR": "20170703", "DA": "19900507", "DC": "1", "DX": "19910101", "UI": "D016288"}, {"RECTYPE": "D", "MH": "Dizocilpine Maleate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dizocilpine|T109|T121|NON|NRW|FDA SRS (2014)|INN (19XX)|NLM (1991)|900410|abbcdeeef", "ENTRY": "MK801", "MN": "D04.615.181.384.380", "PA": "Neuroprotective Agents", "MH_TH": "USAN (1989)", "ST": "T121", "N1": "5H-Dibenzo(a,d)cyclohepten-5,10-imine, 10,11-dihydro-5-methyl-, (5S)-, (Z)-2-butenedioate (1:1)", "RN": "6LR8C1B66Q", "RR": "7PY8KH681I", "PI": "Dibenzocycloheptenes (1968-1990)", "MS": "A potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) used mainly as a research tool. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role. Its use has been primarily limited to animal and tissue experiments because of its psychotropic effects.", "PM": "91", "HN": "91", "MR": "20130708", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016291"}, {"RECTYPE": "D", "MH": "Conscious Sedation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Sedation, Moderate|T061|NON|EQV|NLM (2008)|070316|abcdef", "ENTRY": "Moderate Sedation|T061|NON|EQV|NLM (2008)|070316|abcdef", "MN": "E03.250", "MH_TH": "NLM (1991)", "ST": "T061", "AN": "coordinate IM with specific procedure (IM) or specific sedative, analgesic or anesthetic (IM with no qualifiers)", "PI": "Preanesthetic Medication (1980-1990)", "MS": "A drug-induced depression of consciousness during which patients respond purposefully to verbal commands, either alone or accompanied by light tactile stimulation. No interventions are required to maintain a patent airway. (From: American Society of Anesthesiologists Practice Guidelines)", "OL": "use CONSCIOUS SEDATION to search DENTAL SEDATION 1991-92", "PM": "91; DENTAL SEDATION was see CONSCIOUS SEDATION 1991-92", "HN": "91; DENTAL SEDATION was see CONSCIOUS SEDATION 1991-92", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016292"}, {"RECTYPE": "D", "MH": "Moricizine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Moracizin|T109|T121|NON|EQV|NLM (1991)|900411|abbcdef", "ENTRY": "Hydrochloride, Moricizine", "MN": "D03.633.300.783.533", "PA": "Voltage-Gated Sodium Channel Blockers", "MH_TH": "USAN (1981)", "ST": "T121", "N1": "Carbamic acid, (10-(3-(4-morpholinyl)-1-oxopropyl)-10H-phenothiazin-2-yl)-, ethyl ester", "RN": "2GT1D0TMX1", "RR": "71OK3Z1ESP", "PI": "Phenothiazines (1966-1990)", "MS": "An antiarrhythmia agent used primarily for ventricular rhythm disturbances.", "PM": "91", "HN": "91", "MR": "20180705", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016293"}, {"RECTYPE": "D", "MH": "Models, Nursing", "DE": "MODELS NURS", "PRINT ENTRY": "Nursing Models|T170|NON|EQV|NLM (1991)|900411|NURS MODELS|abcdefv", "ENTRY": "Self-Care Models, Orem", "MN": "E05.599.645", "MH_TH": "NLM (1991)", "ST": "T170", "PI": "Models, Theoretical (1977-1990)", "MS": "Theoretical models simulating behavior or activities in nursing, including nursing care, management and economics, theory, assessment, research, and education. Some examples of these models include Orem Self-Care Model, Roy Adaptation Model, and Rogers Life Process Model.", "PM": "91", "HN": "91", "MR": "20080708", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016294"}, {"RECTYPE": "D", "MH": "Mutagenesis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Mutageneses", "MN": "G05.558", "FX": "Teratogenesis", "MH_TH": "NLM (1991)", "ST": "T044", "PI": "Mutation (1966-1990)", "MS": "Process of generating a genetic MUTATION. It may occur spontaneously or be induced by MUTAGENS.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016296"}, {"RECTYPE": "D", "MH": "Mutagenesis, Site-Directed", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "PRINT ENTRY": "Site-Specific Mutagenesis|T045|NON|EQV|NLM (1991)|900412|abcdef", "ENTRY": "Site-Specific Mutageneses", "MN": "E05.393.420.601.575", "FX": "Gene Editing", "MH_TH": "NLM (1991)", "ST": "T045", "PI": "Mutation (1972-1990)", "MS": "Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016297"}, {"RECTYPE": "D", "MH": "Hematopoietic Cell Growth Factors", "DE": "HCGF", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hematopoietins|T116|T123|NON|EQV|NLM (1991)|900413|abbcdef", "ENTRY": "Hematopoietic CGF", "MN": "D23.529.374.410", "FX": "Receptors, Colony-Stimulating Factor", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "PI": "Growth Substances (1966-1990)", "MS": "These growth factors comprise a family of hematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. ERYTHROPOIETIN and the COLONY-STIMULATING FACTORS belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes.", "PM": "91", "HN": "91", "MR": "20060705", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016298"}, {"RECTYPE": "D", "MH": "Dental Implantation, Subperiosteal", "DE": "DENT IMPLANT SUBPERIOSTEAL", "AQ": "AE CL EC ED ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Subperiosteal Implantation|T061|NON|EQV|NLM (1991)|900413|SUBPERIOSTEAL IMPLANT|abcdefv", "ENTRY": "Therapy, Subperiosteal Implant", "MN": "E06.780.314.482", "MH_TH": "NLM (1991)", "ST": "T061", "PI": "Dental Implantation (1966-1990)", "MS": "The grafting or inserting of an appliance designed to fit over the surface of the mandible or the maxilla, beneath the specialized connective tissue that covers the bone (periosteum).", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016299"}, {"RECTYPE": "D", "MH": "Radiography, Bitewing", "DE": "RADIOGR BITEWING", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Bitewing Radiography|T060|NON|EQV|NLM (1991)|900413|BITEWING RADIOGR|abcdefv", "ENTRY": "Radiographies, Bitewing", "MN": "E06.342.764.600", "MH_TH": "NLM (1991)", "ST": "T060", "PI": "Radiography, Dental (1968-1990)", "MS": "Technique involving the passage of X-rays through oral structures to create a film record while a central tab or wing of dental X-ray film is being held between upper and lower teeth.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160311", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016300"}, {"RECTYPE": "D", "MH": "Alveolar Bone Loss", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Periodontal Resorption|T047|NON|EQV|NLM (1991)|900413|abcdef", "ENTRY": "Resorptions, Alveolar", "MN": "C07.465.714.354.500", "FX": "Bone Resorption", "MH_TH": "NLM (1991)", "ST": "T047", "AN": "coordinate IM with MANDIBULAR DISEASES or MAXILLARY DISEASES (IM or NIM)", "PI": "Bone Resorption (1966-1990)", "MS": "Resorption or wasting of the tooth-supporting bone (ALVEOLAR PROCESS) in the MAXILLA or MANDIBLE.", "OL": "use BONE RESORPTION to search ALVEOLAR BONE LOSS 1987-90", "PM": "91; was see BONE RESORPTION 1987-90", "HN": "91; was see BONE RESORPTION 1987-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016301"}, {"RECTYPE": "D", "MH": "Centric Relation", "DE": "CENTRIC RELAT", "PRINT ENTRY": "Dental Centric Relation|T082|NON|EQV|NLM (1991)|900511|DENT CENTRIC RELAT|abcdefv", "ENTRY": "Relation, Dental Centric|T082|NON|EQV|NLM (1991)|900511|RELAT DENT CENTRIC|abcdefv", "MN": "E06.520.200", "MH_TH": "NLM (1991)", "ST": "T082", "AN": "usually NIM", "PI": "Dental Occlusion, Centric (1966-1990)", "MS": "The location of the maxillary and the mandibular condyles when they are in their most posterior and superior positions in their fossae of the temporomandibular joint.", "OL": "use DENTAL OCCLUSION, CENTRIC to search CENTRIC RELATION 1975-90", "PM": "91; was see DENTAL OCCLUSION, CENTRIC 1975-90", "HN": "91; was see DENTAL OCCLUSION, CENTRIC 1975-90", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016302"}, {"RECTYPE": "D", "MH": "Clinical Pharmacy Information Systems", "DE": "CLIN PHARM INFORMATION SYSTEMS", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Information Systems, Clinical Pharmacy|T170|NON|EQV|NLM (1991)|900416|INFORMATION SYSTEMS CLIN PHARM|abcdefv", "MN": "N04.452.515.095", "FX": "Medication Systems, Hospital", "MH_TH": "NLM (1991)", "ST": "T170", "MS": "Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of clinical pharmacy services.", "PM": "91", "HN": "91", "MR": "20180629", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016303"}, {"RECTYPE": "D", "MH": "Hospitals, Private", "DE": "HOSP PRIVATE", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Private Hospitals|T073|T093|NON|EQV|NLM (1991)|900430|PRIVATE HOSP|abbcdefv", "ENTRY": "Private Hospital", "MN": "N02.278.421.481", "MH_TH": "NLM (1991)", "ST": "T093", "AN": "non-government profit or not-for-profit; coord NIM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE) or med specialty (IM or NIM) if pertinent; specify geog", "PI": "Hospitals, Proprietary (1975-1990)", "MS": "A class of hospitals that includes profit or not-for-profit hospitals that are controlled by a legal entity other than a government agency. (Hospital Administration Terminology, AHA, 2d ed)", "PM": "91", "HN": "91", "MR": "19991103", "DA": "19900626", "DC": "1", "DX": "19910101", "UI": "D016304"}, {"RECTYPE": "D", "MH": "Thymopentin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thymopoietin Pentapeptide|T121|T123|NON|EQV|FDA SRS (2014)|NLM (1991)|900416|abbcdeef", "ENTRY": "Pentapeptide, Thymopoietin", "MN": "D06.472.910.800.850", "PA": "Adjuvants, Immunologic", "MH_TH": "USAN (19XX)", "ST": "T123", "N1": "L-Tyrosine, N-(N-(N-(N2-L-arginyl-L-lysyl)-L-alpha-aspartyl)-L-valyl)-", "RN": "O3Y80ZF13F", "RR": "69558-55-0 (Thymopentin)", "PI": "Thymopoietins (1981-1990)", "MS": "Synthetic pentapeptide corresponding to the amino acids 32-36 of thymopoietin and exhibiting the full biological activity of the natural hormone. It is an immunomodulator which has been studied for possible use in the treatment of rheumatoid arthritis, AIDS, and other primary immunodeficiencies.", "PM": "91", "HN": "91", "MR": "20130708", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016305"}, {"RECTYPE": "D", "MH": "Vena Cava Filters", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Umbrella Filters|T074|NON|NRW|NLM (1991)|900522|abcdef", "ENTRY": "Vena Cava Filter", "MN": "E07.695.207.500", "MH_TH": "NLM (1991)", "ST": "T074", "PI": "Vena Cava, Inferior (1972-1990)", "MS": "Mechanical devices inserted in the inferior vena cava that prevent the migration of blood clots from deep venous thrombosis of the leg.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016306"}, {"RECTYPE": "D", "MH": "Enkephalin, Leucine-2-Alanine", "DS": "ENKEPHALIN LEUCINE ALANINE 02", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Leucine Enkephalin-2-Alanine|T116|T121|NON|EQV|NLM (1991)|900417|LEUCINE ENKEPHALIN ALANINE 02|abbcdefs", "ENTRY": "Leucine-2-Alanine Enkephalin", "MN": "D12.776.631.650.575.281.231.500", "MH_TH": "NLM (1991)", "ST": "T121", "N1": "D-Leucine, N-(N-(N-(N-L-tyrosyl-D-alanyl)glycyl)-L-phenylalanyl)-", "RN": "63631-40-3", "PI": "Enkephalins (1977-1982)", "MS": "A delta-selective opioid (ANALGESICS, OPIOID). It can cause transient depression of mean arterial blood pressure and heart rate.", "PM": "91", "HN": "91", "MR": "20151123", "DA": "19900628", "DC": "1", "DX": "19910101", "UI": "D016308"}, {"RECTYPE": "D", "MH": "Outliers, DRG", "AQ": "EC SN", "PRINT ENTRY": "Diagnosis-Related Group Outliers|T101|NON|EQV|NLM (1991)|900515|DIAG RELAT GROUP OUTLIERS|abcdefv", "ENTRY": "Outliers, Diagnostic-Related Group", "MN": "N03.219.521.710.305.200.080.550", "MH_TH": "NLM (1991)", "ST": "T101", "AN": "a concept in health care reimbursement; outliers as a statist concept, index under STATISTICS AS TOPIC or specific statist term", "PI": "Diagnosis-Related Groups (1986-1990)", "MS": "In health care reimbursement, especially in the prospective payment system, those patients who require an unusually long hospital stay or whose stay generates unusually high costs.", "PM": "91; DIAGNOSIS-RELATED GROUP OUTLIERS was DIAGNOSTIC RELATED GROUP OUTLIERS 1991", "HN": "91; DIAGNOSIS-RELATED GROUP OUTLIERS was DIAGNOSTIC RELATED GROUP OUTLIERS 1991", "MR": "20070711", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016311"}, {"RECTYPE": "D", "MH": "Treatment Refusal", "AQ": "EH ES HI LJ PX SN TD", "PRINT ENTRY": "Refusal of Treatment|T055|NON|EQV|NLM (1991)|900417|abcdef", "ENTRY": "Treatment Refusals", "MN": "N05.300.150.800.750", "FX": "Patient Dropouts", "MH_TH": "BIOETHICS (1989)", "ST": "T055", "AN": "for patient non-compliance index PATIENT NON-COMPLIANCE see PATIENT COMPLIANCE; do not confuse with PHYSICIAN REFUSAL TO TREAT see REFUSAL TO TREAT", "PI": "Patient Compliance (1975-1990)", "MS": "Patient or client refusal of or resistance to medical, psychological, or psychiatric treatment. (APA, Thesaurus of Psychological Index Terms, 8th ed.)", "PM": "1991", "HN": "1991", "CATSH": "CAT LIST", "MR": "20230412", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016312"}, {"RECTYPE": "D", "MH": "Genes, abl", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "v-abl Genes|T028|NRW|NLM (1991)|900417|abdef", "ENTRY": "v-abl Oncogene", "MN": "G05.360.340.024.340.375.500.791.100", "FX": "Proto-Oncogene Proteins c-abl", "MH_TH": "NLM (1991)", "ST": "T028", "AN": "abl stands for \"ABelson Leukemia\"", "PI": "Oncogenes (1982-1990)", "MS": "Retrovirus-associated DNA sequences (abl) originally isolated from the Abelson murine leukemia virus (Ab-MuLV). The proto-oncogene abl (c-abl) codes for a protein that is a member of the tyrosine kinase family. The human c-abl gene is located at 9q34.1 on the long arm of chromosome 9. It is activated by translocation to bcr on chromosome 22 in chronic myelogenous leukemia.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900628", "DC": "1", "DX": "19910101", "UI": "D016313"}, {"RECTYPE": "D", "MH": "Ethylketocyclazocine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ethylketazocine|T109|T121|NON|EQV|NLM (1991)|900417|abbcdef", "ENTRY": "Win351972", "MN": "D03.605.168.350", "PA": "Analgesics, Opioid", "MH_TH": "NLM (1991)", "ST": "T121", "N1": "2,6-Methano-3-benzazocin-1(2H)-one, 3-(cyclopropylmethyl)-6-ethyl-3,4,5,6-tetrahydro-8-hydroxy-11-methyl-, (2alpha,6alpha,11S*)-(+-)-", "RN": "58640-84-9", "PI": "Cyclazocine (1966-1990)", "MS": "A kappa opioid receptor agonist. The compound has analgesic action and shows positive inotropic effects on the electrically stimulated left atrium. It also affects various types of behavior in mammals such as locomotion, rearing, and grooming.", "PM": "91", "HN": "91", "MR": "20160531", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016314"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-abl", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-abl Proteins|T116|T126|NON|EQV|NLM (1991)|900417|abbcdef", "ENTRY": "c-abl, Proto-Oncogene Proteins", "MN": "D12.776.624.664.700.167", "FX": "Fusion Proteins, bcr-abl", "MH_TH": "NLM (1991)", "ST": "T126", "RN": "EC 2.7.10.2", "PI": "Proto-Oncogene Proteins (1986-1990)", "MS": "Non-receptor tyrosine kinases encoded by the C-ABL GENES. They are distributed in both the cytoplasm and the nucleus. c-Abl plays a role in normal HEMATOPOIESIS especially of the myeloid lineage. Oncogenic transformation of c-abl arises when specific N-terminal amino acids are deleted, releasing the kinase from negative regulation.", "PM": "91", "HN": "91", "MR": "20210521", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016315"}, {"RECTYPE": "D", "MH": "Guanfacine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Guanfacine", "MN": "D02.241.223.601.329", "PA": "Antihypertensive Agents", "MH_TH": "NLM (1991)", "ST": "T121", "N1": "Benzeneacetamide, N-(aminoiminomethyl)-2,6-dichloro-", "RN": "30OMY4G3MK", "RR": "PML56A160O", "PI": "Phenylacetates (1966-1990)", "MS": "A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.", "PM": "91", "HN": "91", "MR": "20130708", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016316"}, {"RECTYPE": "D", "MH": "Quisqualic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Quisqualate|T116|T121|NON|NRW|NLM (1991)|900417|abbcdef", "MN": "D12.125.755", "PA": "Excitatory Amino Acid Agonists", "MH_TH": "NLM (1991)", "ST": "T121", "N1": "1,2,4-Oxadiazolidine-2-propanoic acid, alpha-amino-3,5-dioxo-, (S)-", "RN": "8OC22C1B99", "RR": "52809-07-1 (Quisqualic Acid)", "PI": "Oxadiazoles (1966-1990)", "MS": "An agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis.", "PM": "91", "HN": "91", "MR": "20160531", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016318"}, {"RECTYPE": "D", "MH": "Corrosion Casting", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Corrosion Castings", "MN": "E05.200.750.600.620.150", "MH_TH": "NLM (1991)", "ST": "T059", "MS": "A tissue preparation technique that involves the injecting of plastic (acrylates) into blood vessels or other hollow viscera and treating the tissue with a caustic substance. This results in a negative copy or a solid replica of the enclosed space of the tissue that is ready for viewing under a scanning electron microscope.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016319"}, {"RECTYPE": "D", "MH": "Substance Abuse Treatment Centers", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Rehabilitation Centers, Drug|T093|NON|NRW|NLM (1991)|900417|REHABIL CENTERS DRUG|abcdefv", "ENTRY": "Treatment Center, Drug", "MN": "N02.278.808.930", "FX": "Needle-Exchange Programs", "MH_TH": "NLM (1991)", "ST": "T093", "MS": "Health facilities providing therapy and/or rehabilitation for substance-dependent individuals. Methadone distribution centers are included.", "OL": "use SUBSTANCE ABUSE TREATMENT CENTERS to search DRUG TREATMENT CENTERS 1991-93", "PM": "94; was DRUG TREATMENT CENTERS 1991-93; SUBSTANCE ABUSE TREATMENT CENTERS was see DRUG TREATMENT CENTERS 1991-93", "HN": "94; was DRUG TREATMENT CENTERS 1991-93; SUBSTANCE ABUSE TREATMENT CENTERS was see DRUG TREATMENT CENTERS 1991-93", "MR": "20080708", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016320"}, {"RECTYPE": "D", "MH": "Dental Care for Aged", "DE": "DENT CARE AGED", "AQ": "AE CL EC ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Dentistry for Aged|T058|NON|EQV|NLM (1991)|900430|DENT AGED|abcdefv", "ENTRY": "Aged, Dentistry for", "MN": "N02.421.240.190.210", "MH_TH": "NLM (1991)", "ST": "T058", "AN": "= professional care by a professional; do not confuse with GERIATRIC DENTISTRY, the specialty; check tag AGED", "PI": "Health Services for the Aged (1981-1990)", "MS": "The giving of attention to the special dental needs of the elderly for proper maintenance or treatment. The dental care may include the services provided by dental specialists.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016321"}, {"RECTYPE": "D", "MH": "HIV Enhancer", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "NF-kappa B-Binding Site, HIV|T114|NRW|NLM (1991)|900418|NFKB BINDING SITE HIV|abdefv", "ENTRY": "Sites, HIV NF-kB-Binding", "MN": "G05.360.340.024.340.137.750.249.400", "FX": "NF-kappa B", "MH_TH": "NLM (1991)", "ST": "T123", "PI": "Enhancer Elements (Genetics) (1986-1990)", "MS": "Cis-acting regulatory sequences in the HIV long terminal repeat (LTR) which play a major role in induction or augmentation of HIV gene expression in response to environmental stimuli such as mitogens, phorbol esters, or other viruses. The HIV enhancer is the binding site for many cellular transcription factors including the nuclear factor NF-kappa B.", "PM": "1991", "HN": "1991", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900628", "DC": "1", "DX": "19910101", "UI": "D016322"}, {"RECTYPE": "D", "MH": "Sequence Tagged Sites", "DE": "SEQ TAGGED SITES", "ENTRY": "Tagged Sites, Sequence", "MN": "G05.360.340.024.810", "FX": "Expressed Sequence Tags", "MH_TH": "NLM (1991)", "ST": "T123", "MS": "Short tracts of DNA sequence that are used as landmarks in GENOME mapping. In most instances, 200 to 500 base pairs of sequence define a Sequence Tagged Site (STS) that is operationally unique in the human genome (i.e., can be specifically detected by the polymerase chain reaction in the presence of all other genomic sequences). The overwhelming advantage of STSs over mapping landmarks defined in other ways is that the means of testing for the presence of a particular STS can be completely described as information in a database.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016324"}, {"RECTYPE": "D", "MH": "HIV Long Terminal Repeat", "DE": "HIV LTR", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Trans-Acting Responsive Region, HIV|T114|NRW|NLM (1991)|900418|TAR HIV|abdefv", "ENTRY": "Trans Activation Responsive Region, HIV", "MN": "G05.360.080.708.850.400", "FX": "Sp1 Transcription Factor", "MH_TH": "NLM (1991)", "ST": "T114", "PI": "Repetitive Sequences, Nucleic Acid (1986-1990)", "MS": "Regulatory sequences important for viral replication that are located on each end of the HIV genome. The LTR includes the HIV ENHANCER, promoter, and other sequences. Specific regions in the LTR include the negative regulatory element (NRE), NF-kappa B binding sites , Sp1 binding sites, TATA BOX, and trans-acting responsive element (TAR). The binding of both cellular and viral proteins to these regions regulates HIV transcription.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900628", "DC": "1", "DX": "19910101", "UI": "D016325"}, {"RECTYPE": "D", "MH": "Extracellular Matrix Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Extracellular Matrix Protein|T116|T123|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Proteins, Extracellular Matrix", "MN": "D12.776.860.300", "FX": "Receptors, Cytoadhesin", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "AN": "/drug eff /ultrastruct permitted", "PI": "Extracellular Matrix (1984-1990)", "MS": "Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ).", "PM": "91", "HN": "91", "MR": "20200527", "DA": "19900617", "DC": "1", "DX": "19910101", "UI": "D016326"}, {"RECTYPE": "D", "MH": "NF-kappa B", "DE": "NFKB", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "kappa B Enhancer Binding Protein|T116|T129|NON|EQV|NLM (1991)|900514|abbcdef", "ENTRY": "Transcription Factor NF kB", "MN": "D12.776.930.600", "FX": "I-kappa B Proteins", "MH_TH": "NLM (1991)", "ST": "T129", "RN": "0", "PI": "Transcription Factors (1987-1990)", "MS": "Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA.", "PM": "91", "HN": "91", "MR": "20200527", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016328"}, {"RECTYPE": "D", "MH": "Sp1 Transcription Factor", "DS": "SP A 01 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transcription Factor, Sp1|T116|T123|ABX|EQV|NLM (1991)|990101|TRANSCRIPTION FACTOR SP 001|abbcdefs", "ENTRY": "Specificity Protein 1 Transcription Factor|T116|T123|NON|EQV|NLM (2006)|050510|abbcdef", "MN": "D12.776.930.375.750.249", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "AN": "/drug eff /ultrastruct permitted; in titles & translations use SP1 (the figure one), not SPl (the letter l)", "PI": "Transcription Factors (1986-1990)", "MS": "Promoter-specific RNA polymerase II transcription factor that binds to the GC box, one of the upstream promoter elements, in mammalian cells. The binding of Sp1 is necessary for the initiation of transcription in the promoters of a variety of cellular and viral GENES.", "PM": "2006; see TRANSCRIPTION FACTOR, SP1 1991-2005", "HN": "2006(1991)", "MR": "20090714", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016329"}, {"RECTYPE": "D", "MH": "Frail Elderly", "AQ": "PX SN", "PRINT ENTRY": "Functionally-Impaired Elderly|T098|NON|NRW|NLM (1991)|900419|abcdef", "ENTRY": "Older Adults, Frail", "MN": "M01.060.116.100.540", "FX": "Homebound Persons", "MH_TH": "NLM (1991)", "ST": "T100", "AN": "check the tags AGED or AGED, 80 AND OVER", "PI": "Health Services for the Aged (1983-1990)", "MS": "Older adults or aged individuals who are lacking in general strength and are unusually susceptible to disease or to other infirmity.", "PM": "91", "HN": "91", "MR": "20051011", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016330"}, {"RECTYPE": "D", "MH": "Parenteral Nutrition, Home", "DE": "HPN", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Parenteral Feeding, Home|T061|NON|NRW|NLM (1991)|900430|abcdef", "ENTRY": "Feeding, Home Parenteral", "MN": "N02.421.143.524.650", "MH_TH": "NLM (1991)", "ST": "T061", "PI": "Parenteral Feeding (1974-1990)", "MS": "The at-home administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered via a route other than the alimentary canal (e.g., intravenously, subcutaneously).", "OL": "use PARENTERAL NUTRITION, HOME to search HOME PARENTERAL NUTRITION 1991", "PM": "92; was HOME PARENTERAL NUTRITION 1991", "HN": "92; was HOME PARENTERAL NUTRITION 1991", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016331"}, {"RECTYPE": "D", "MH": "Fetal Tissue Transplantation", "DE": "FETAL TISSUE TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Fetal Tissue|T061|NON|EQV|NLM (1991)|900426|TRANSPL FETAL TISSUE|abcdefv", "ENTRY": "Transplantations, Fetal Tissue", "MN": "E04.936.580.300", "FX": "Fetal Research", "MH_TH": "NLM (1991)", "ST": "T061", "AN": "fetal or embryonic; coordinate IM with specific embryonic tissue / transpl or specific organ / embryol + / transpl; do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; transplantation of fetal brain tissue: coordinate IM with BRAIN TISSUE TRANSPLANTATION (IM) + specific brain tissue / transpl + / embryol if pertinent", "PI": "Transplantation, Homologous (1968-1990)", "MS": "Transference of fetal tissue between individuals of the same species or between individuals of different species.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016332"}, {"RECTYPE": "D", "MH": "HIV Protease", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HTLV-III Protease|T116|T126|ABX|EQV|NLM (1991)|900501|HTLV WIII PROTEASE|abbcdefs", "ENTRY": "Protease, HTLV-III", "MN": "D12.776.964.900.500.625", "EC": "antagonists & inhibitors:HIV Protease Inhibitors", "MH_TH": "NLM (1991)", "ST": "T126", "RN": "EC 3.4.23.-", "PI": "Peptide Peptidohydrolases (1987-1990)", "MS": "Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene.", "PM": "91", "HN": "91", "MR": "20200622", "DA": "19900607", "DC": "1", "DX": "19910101", "UI": "D016333"}, {"RECTYPE": "D", "MH": "Genes, vpr", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "vpr Genes|T028|EQV|NLM (1993)|911011|abdef", "ENTRY": "rap Genes", "MN": "G05.360.340.358.840.500.897", "MH_TH": "NLM (1991)", "ST": "T028", "AN": "vpr stands for \"Viral Protein R\"; in entry term GENES, RAP, rap stands for \"R Activation Protein\"", "PI": "Genes, Viral (1989-1990)", "MS": "DNA sequences that form the coding region for a trans-activator protein that specifies rapid growth in human immunodeficiency virus (HIV). vpr is short for viral protein R, where R is undefined.", "OL": "use GENES, VPR to search GENES, RAP 1991-92", "PM": "93; was GENES, RAP 1991-92; GENES, VPR was see GENES, RAP 1991-92", "HN": "93; was GENES, RAP 1991-92; GENES, VPR was see GENES, RAP 1991-92", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016334"}, {"RECTYPE": "D", "MH": "Zinc Fingers", "AQ": "DE GE IM PH RE", "ENTRY": "Zinc Finger Motif", "MN": "G02.111.570.820.709.275.500.985", "MH_TH": "NLM (1991)", "ST": "T082", "PI": "Molecular Sequence Data (1988-1990)", "MS": "Motifs in DNA- and RNA-binding proteins whose amino acids are folded into a single structural unit around a zinc atom. In the classic zinc finger, one zinc atom is bound to two cysteines and two histidines. In between the cysteines and histidines are 12 residues which form a DNA binding fingertip. By variations in the composition of the sequences in the fingertip and the number and spacing of tandem repeats of the motif, zinc fingers can form a large number of different sequence specific binding sites.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016335"}, {"RECTYPE": "D", "MH": "Gene Products, vpr", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "vpr Protein|T116|T123|ABX|EQV|NLM (1993)|910926|abbcdef", "ENTRY": "vpr Gene Product", "MN": "D12.776.964.925.984.430", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "PI": "Retroviridae Proteins (1990)", "MS": "Trans-acting proteins which accelerate retroviral virus replication. The vpr proteins act in trans to increase the levels of specified proteins. vpr is short for viral protein R, where R is undefined.", "OL": "use GENE PRODUCTS, VPR to search GENE PRODUCTS, RAP & RAP PROTEIN & HIV RAP GENE PRODUCT 1991-92", "PM": "93; was GENE PRODUCT, RAP 1991-92; GENE PRODUCTS, VPR & RAP PROTEIN & HIV RAP GENE PRODUCT were see GENE PRODUCTS, RAP 1991-92", "HN": "93; was GENE PRODUCTS, RAP 1991-92; GENE PRODUCTS, VPR & RAP PROTEIN & HIV RAP GENE PRODUCT were see GENE PRODUCTS, RAP 1991-92", "MR": "20160628", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016336"}, {"RECTYPE": "D", "MH": "RNA, Catalytic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ribozymes|T114|T126|NON|EQV|NLM (1991)|900502|abbcdef", "MN": "D13.444.735.790.199", "MH_TH": "NLM (1991)", "ST": "T126", "RN": "0", "PI": "RNA, Ribosomal (1986-1990)", "MS": "RNA that has catalytic activity. The catalytic RNA sequence folds to form a complex surface that can function as an enzyme in reactions with itself and other molecules. It may function even in the absence of protein. There are numerous examples of RNA species that are acted upon by catalytic RNA, however the scope of this enzyme class is not limited to a particular type of substrate.", "PM": "91", "HN": "91", "MR": "20200527", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016337"}, {"RECTYPE": "D", "MH": "Genes, vpu", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "vpu Genes|T028|EQV|NLM (1991)|900420|abdef", "ENTRY": "vpu Gene", "MN": "G05.360.340.358.840.500.900", "MH_TH": "NLM (1991)", "ST": "T028", "AN": "vpu stands for \"Viral Protein U\"", "PI": "Genes, Viral (1988-1990)", "MS": "DNA sequences that form the coding region for the HIV-1 regulatory protein vpu (viral protein U) that greatly increases the export of virus particles from infected cells. The vpu genes are not present in HIV-2 or SIMIAN IMMUNODEFICIENCY VIRUS.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20150713", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016338"}, {"RECTYPE": "D", "MH": "Spectrometry, Mass, Fast Atom Bombardment", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Spectroscopy, Mass, Fast Atom Bombardment|T060|T062|NON|EQV|NLM (1991)|900420|abbcdef", "MN": "E05.196.566.750", "MH_TH": "NLM (1991)", "ST": "T062", "PI": "Spectrum Analysis, Mass (1982-1990)", "MS": "A mass spectrometric technique that is used for the analysis of a wide range of biomolecules, such as glycoalkaloids, glycoproteins, polysaccharides, and peptides. Positive and negative fast atom bombardment spectra are recorded on a mass spectrometer fitted with an atom gun with xenon as the customary beam. The mass spectra obtained contain molecular weight recognition as well as sequence information.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016339"}, {"RECTYPE": "D", "MH": "Genes, vif", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "vif Genes|T028|EQV|NLM (1991)|900420|abdef", "ENTRY": "vif Gene", "MN": "G05.360.340.358.840.500.890", "MH_TH": "NLM (1991)", "ST": "T028", "AN": "vif stands for \"Virion Infectivity Factor\"; in entry term GENES, SOR, sor stands for \"Short Open Reading frame\"", "PI": "Genes, Viral (1986-1990)", "MS": "DNA sequences that form the coding region for the vif (virion infectivity factor) protein that is important for the generation of infectious virions in human immunodeficiency virus (HIV). The former name of this gene was sor (short open reading frame).", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016341"}, {"RECTYPE": "D", "MH": "Angioplasty, Laser", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Laser Angioplasty|T061|NON|EQV|NLM (1991)|900420|abcdef", "ENTRY": "Laser Angioplasties", "MN": "E05.157.016.075", "FX": "Catheter Ablation", "MH_TH": "NLM (1991)", "ST": "T061", "AN": "ANGIOPLASTY, BALLOON, LASER-ASSISTED is also available", "PI": "Lasers (1982-1986)", "MS": "A technique utilizing a laser coupled to a catheter which is used in the dilatation of occluded blood vessels. This includes laser thermal angioplasty where the laser energy heats up a metal tip, and direct laser angioplasty where the laser energy directly ablates the occlusion. One form of the latter approach uses an EXCIMER LASER which creates microscopically precise cuts without thermal injury. When laser angioplasty is performed in combination with balloon angioplasty it is called laser-assisted balloon angioplasty (ANGIOPLASTY, BALLOON, LASER-ASSISTED).", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016342"}, {"RECTYPE": "D", "MH": "Monitoring, Intraoperative", "DE": "MONITORING INTRAOP", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Intraoperative Monitoring|T060|NON|EQV|NLM (1998)|970313|INTRAOP MONITORING|abcdefv", "MN": "E04.510", "MH_TH": "NLM (1991)", "ST": "T060", "PI": "Monitoring, Physiologic (1978-1990)", "MS": "The constant checking on the state or condition of a patient during the course of a surgical operation (e.g., checking of vital signs).", "PM": "98; see INTRAOPERATIVE MONITORING 1991-97, for MONITORING, INTRAOPERATIVE see INTRAOPERATIVE MONITORING 1991-97", "HN": "98(91)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016343"}, {"RECTYPE": "D", "MH": "Medicare Part A", "DE": "MEDICARE A", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Medicare Hospital Insurance Program|T089|NON|EQV|NLM (1991)|900427|MEDICARE HOSP INSURANCE PROGRAM|abcdefv", "ENTRY": "Part A, Medicare", "MN": "N03.706.615.698", "MH_TH": "NLM (1991)", "ST": "T089", "AN": "specify state if given", "PI": "Medicare (1966-1990)", "MS": "The compulsory portion of Medicare that is known as the Hospital Insurance Program. All persons 65 years and older who are entitled to benefits under the Old Age, Survivors, Disability and Health Insurance Program or railroad retirement, persons under the age of 65 who have been eligible for disability for more than two years, and insured workers (and their dependents) requiring renal dialysis or kidney transplantation are automatically enrolled in Medicare Part A.", "PM": "91", "HN": "91", "MR": "20090706", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016344"}, {"RECTYPE": "D", "MH": "Medicare Part B", "DE": "MEDICARE B", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Supplementary Medical Insurance Program, Medicare|T089|NON|EQV|NLM (1992)|910212|SUPPLEMENTARY MED INSURANCE PROGRAM MEDICARE|abcdefv", "ENTRY": "SMI Programs", "MN": "N03.706.615.699", "MH_TH": "NLM (1991)", "ST": "T089", "AN": "specify state if given", "PI": "Medicare (1979-1990)", "MS": "The voluntary portion of Medicare, known as the Supplementary Medical Insurance (SMI) Program, that includes physician's services, home health care, medical services, outpatient hospital services, and laboratory, pathology, and radiology services. All persons entitled to Medicare Part A may enroll in Medicare Part B on a monthly premium basis.", "PM": "91", "HN": "91", "MR": "20180630", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016345"}, {"RECTYPE": "D", "MH": "Gene Products, vif", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "vif Protein|T116|T123|ABX|EQV|NLM (1991)|900511|abbcdef", "ENTRY": "vif Gene Product", "MN": "D12.776.964.925.875", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "PI": "Viral Proteins (1987-1990)", "MS": "Retrovirally encoded accessary proteins that play an essential role VIRUS REPLICATION. They are found in the cytoplasm of host cells and associate with a variety of host cell proteins. Vif stands for \"virion infectivity factor\".", "PM": "91", "HN": "91", "MR": "20070709", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016346"}, {"RECTYPE": "D", "MH": "Medical Records Systems, Computerized", "DE": "MED RECORDS SYSTEMS COMPUTERIZED", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Computerized Medical Records Systems|T073|T170|NON|EQV|NLM (1991)|900423|COMPUTERIZED MED RECORDS SYSTEMS|abbcdefv", "ENTRY": "Medical Records Systems, Automated|T073|T170|NON|EQV|NLM (1991)|900423|MED RECORDS SYSTEMS AUTOMATED|abbcdefv", "MN": "N06.850.520.308.940.968.625", "MH_TH": "NLM (1991)", "ST": "T170", "MS": "Computer-based systems for input, storage, display, retrieval, and printing of information contained in a patient's medical record.", "PM": "91", "HN": "91", "MR": "20170703", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016347"}, {"RECTYPE": "D", "MH": "Osseointegration", "AQ": "DE GE IM PH RE", "ENTRY": "Peri-implant Endosseous Healings", "MN": "G16.762.150.150.570", "FX": "Hip Prosthesis", "MH_TH": "NLM (1991)", "ST": "T042", "AN": "must involve bone growth in relation to surgically implanted material; do not confuse with OSSIFICATION, HETEROTOPIC", "MS": "The growth action of bone tissue as it assimilates surgically implanted devices or prostheses to be used as either replacement parts (e.g., hip) or as anchors (e.g., endosseous dental implants).", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016348"}, {"RECTYPE": "D", "MH": "Leucine Zippers", "AQ": "DE GE IM PH RE", "ENTRY": "Zippers, Leucine", "MN": "G02.111.570.820.709.275.500.520", "MH_TH": "NLM (1991)", "ST": "T082", "PI": "Molecular Sequence Data (1989-1990)", "MS": "DNA-binding motifs formed from two alpha-helixes which intertwine for about eight turns into a coiled coil and then bifurcate to form Y shaped structures. Leucines occurring in heptad repeats end up on the same sides of the helixes and are adjacent to each other in the stem of the Y (the \"zipper\" region). The DNA-binding residues are located in the bifurcated region of the Y.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016350"}, {"RECTYPE": "D", "MH": "Group Homes", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Homes, Group", "MN": "N02.278.825.375", "MH_TH": "POPLINE (1987)", "ST": "T093", "AN": "in med & non-med contexts", "PI": "Residential Facilities (1970-1990)", "MS": "Housing for groups of patients, children, or others who need or desire emotional or physical support. They are usually established as planned, single housekeeping units in residential dwellings that provide care and supervision for small groups of residents, who, although unrelated, live together as a family.", "OL": "use RESIDENTIAL FACILITIES to search GROUP HOMES 1990", "PM": "91; was see RESIDENTIAL FACILITIES 1990", "HN": "91; was see RESIDENTIAL FACILITIES 1990", "MR": "20160608", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016352"}, {"RECTYPE": "D", "MH": "Self-Examination", "DE": "SELF EXAM", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Self-Examinations", "MN": "F01.145.488.700", "MH_TH": "NLM (1991)", "ST": "T060", "AN": "coord IM with organ with no qualif (IM) + disease term /diag (IM) if discussed; BREAST SELF-EXAMINATION is also available; DF: SELF EXAM", "PI": "Palpation (1969-1990)", "MS": "The inspection of one's own body, usually for signs of disease (e.g., BREAST SELF-EXAMINATION, testicular self-examination).", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016353"}, {"RECTYPE": "D", "MH": "Rhodobacter capsulatus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rhodopseudomonas capsulatus|T007|NON|EQV|NLM (1991)|900423|abcdef", "ENTRY": "Rhodopseudomonas capsulata|T007|NON|EQV|NLM (1991)|900423|abcdef", "MN": "B03.660.050.750.700.225", "MH_TH": "NLM (1991)", "ST": "T007", "RN": "txid1061", "AN": "in fresh & marine water", "PI": "Rhodopseudomonas (1968-1990)", "MS": "Non-pathogenic ovoid to rod-shaped bacteria that are widely distributed and found in fresh water as well as marine and hypersaline habitats.", "PM": "91", "HN": "91", "MR": "20200128", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016354"}, {"RECTYPE": "D", "MH": "Genes, pX", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "tax Genes|T028|NRW|NLM (1991)|900423|abdef", "ENTRY": "tax Genes, HTLV-II", "MN": "G05.360.340.358.840.500.735", "MH_TH": "NLM (1991)", "ST": "T028", "PI": "Genes, Viral (1984-1990)", "MS": "DNA sequences that form the coding region for at least three proteins which regulate the expression of HUMAN T-LYMPHOTROPIC VIRUS 1 and HUMAN T-LYMPHOTROPIC VIRUS 2. The proteins are p21(x), p27(rex), and p40(tax). The tax (trans-activator x) and rex (regulator x) genes are part of pX but are in overlapping reading frames. X was the original designation for the sequences or region (at that time of unknown function) in the long open reading frame (lor) which is now called pX.", "PM": "91; LOR PROTEINS & PX PROTEINS were see TRANS-ACTIVATORS 1990", "HN": "91; LOR PROTEINS & PX PROTEINS were see TRANS-ACTIVATORS 1990", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19900607", "DC": "1", "DX": "19910101", "UI": "D016355"}, {"RECTYPE": "D", "MH": "Gene Products, tax", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tax Protein|T116|T123|ABX|EQV|NLM (1991)|900511|abbcdef", "ENTRY": "tax Gene Product", "MN": "D12.776.964.925.984.410", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1986-1989)", "MS": "Transcriptional trans-acting proteins of the promoter elements found in the long terminal repeats (LTR) of HUMAN T-LYMPHOTROPIC VIRUS 1 and HUMAN T-LYMPHOTROPIC VIRUS 2. The tax (trans-activator x; x is undefined) proteins act by binding to enhancer elements in the LTR.", "OL": "use TRANS-ACTIVATORS to search HTLV-I TRANS-ACTIVATOR PROTEIN, TRANS-ACTIVATOR PROTEIN P40(X), & TAX PROTEIN 1990", "PM": "91; HTLV-I TRANS-ACTIVATOR PROTEIN, TRANS-ACTIVATOR PROTEIN P40(X), & TAX PROTEIN were see TRANS-ACTIVATORS 1990", "HN": "91; HTLV-I TRANS-ACTIVATOR PROTEIN, TRANS-ACTIVATOR PROTEIN P40(X), & TAX PROTEIN were see TRANS-ACTIVATORS 1990", "MR": "20070709", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016356"}, {"RECTYPE": "D", "MH": "Infection Control Practitioners", "DE": "INFECT CONTROL PRACTITIONERS", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Practitioners, Infection Control|T097|NON|EQV|NLM (1991)|900424|PRACTITIONERS INFECT CONTROL|abcdefv", "MN": "N02.360.490", "MH_TH": "NLM (1991)", "ST": "T097", "MS": "Physicians or other qualified individuals responsible for implementing and overseeing the policies and procedures followed by a health care facility to reduce the risk of infection to patients and staff.", "PM": "91", "HN": "91", "MR": "20180629", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016357"}, {"RECTYPE": "D", "MH": "Contact Tracing", "AQ": "EC ES HI IS LJ MT SN TD VE", "PRINT ENTRY": "Person Under Investigation Epidemiology|T058|NON|REL|NLM (2021)|200612|abcdef", "ENTRY": "Tracing, Contact", "MN": "N06.850.780.200.225", "MH_TH": "NLM (1991)", "ST": "T058", "AN": "coordinate with disease /\u200cepidemiol or /\u200ctransm", "PI": "specific infection/prevention & control (1986-1990)", "MS": "Identification of those persons (or animals) who have had such an association with an infected person, animal, or contaminated environment as to have had the opportunity to acquire the infection.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20200630", "DA": "19900802", "DC": "1", "DX": "19910101", "UI": "D016358"}, {"RECTYPE": "D", "MH": "Clostridioides difficile", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Clostridium difficile|T007|NON|EQV|NLM (1991)|990101|abcdef", "MN": "B03.353.625.657.500", "FX": "Enterocolitis, Pseudomembranous", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid1496", "AN": "infection: coordinate with probably ENTEROCOLITIS, PSEUDOMEMBRANOUS; otherwise coordinate with CLOSTRIDIOIDES DIFFICILE INFECTIONS see CLOSTRIDIUM INFECTIONS", "PI": "Clostridium (1976-1990)", "MS": "A common inhabitant of the colon flora in human infants and sometimes in adults. The type species Clostridioides difficile is formerly known as Clostridium difficile. It is a causative agent for CLOSTRIDIOIDES INFECTIONS and is associated with PSEUDOMEMBRANOUS ENTEROCOLITIS in patients receiving antibiotic therapy.", "PM": "2021; see Clostridium difficile 1991-2020", "HN": "2021(1991)", "MR": "20210510", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016360"}, {"RECTYPE": "D", "MH": "Bankruptcy", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Financial Insolvency|T078|NON|EQV|NLM (1991)|900424|abcdef", "ENTRY": "Insolvency, Financial", "MN": "N03.219.463.045", "MH_TH": "NLM (1991)", "ST": "T078", "MS": "The state of legal insolvency with assets taken over by judicial process so that they may be distributed among creditors.", "PM": "91", "HN": "91", "MR": "19930916", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016361"}, {"RECTYPE": "D", "MH": "Analgesia, Obstetrical", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Obstetrical Analgesia|T061|NON|EQV|NLM (1991)|900521|abcdef", "ENTRY": "Obstetric Analgesia", "MN": "E03.091.110", "MH_TH": "NLM (1991)", "ST": "T061", "AN": "do not confuse with ANESTHESIA, OBSTETRICAL; coordinate IM with specific type of analgesia (IM) or analgesic (IM)", "PI": "Anesthesia, Obstetrical (1976-1990)", "MS": "The elimination of PAIN, without the loss of CONSCIOUSNESS, during OBSTETRIC LABOR; OBSTETRIC DELIVERY; or the POSTPARTUM PERIOD, usually through the administration of ANALGESICS.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016362"}, {"RECTYPE": "D", "MH": "Antitrust Laws", "AQ": "CL EC ES HI OG SN ST TD", "PRINT ENTRY": "Sherman Antitrust Act|T089|EPO|NRW|NLM (1991)|900424|abcdef", "ENTRY": "Liability, Antitrust", "MN": "N03.706.615.100", "MH_TH": "NLM (1991)", "ST": "T089", "AN": "specify geog", "PI": "Economics/legislation & jurisprudence (1982-1990)", "MS": "Those federal and state laws, and their enforcement, that protect trade and commerce from unlawful restraints and monopolies or unfair business practices.", "PM": "91", "HN": "91", "MR": "19991103", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016363"}, {"RECTYPE": "D", "MH": "Reading Frames", "AQ": "DE ES GE IM PH RE", "ENTRY": "Reading Frame", "MN": "G05.360.335.760", "FX": "Codon", "MH_TH": "NLM (1991)", "ST": "T086", "PI": "Base Sequence (1980-1990)", "MS": "The three possible sequences of CODONS by which GENETIC TRANSLATION may occur from one nucleotide sequence. A segment of mRNA 5'AUCCGA3' could be translated as 5'AUC.. or 5'UCC.. or 5'CCG.., depending on the location of the START CODON.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016364"}, {"RECTYPE": "D", "MH": "Liability, Legal", "AQ": "EC HI", "PRINT ENTRY": "Professional Liability|T080|NON|NRW|NLM (1991)|900430|abcdef", "ENTRY": "Tort", "MN": "N03.706.535.547", "FX": "Malpractice", "MH_TH": "NLM (1991)", "ST": "T080", "AN": "statement of responsibility: do not confuse with MALPRACTICE, the commission of a harmful act; coord IM with specialty (IM) if relevant or area of responsibility (IM) if relevant", "PI": "Malpractice/legislation & jurisprudence (1981-1990)", "MS": "Accountability and responsibility to another, enforceable by civil or criminal sanctions.", "PM": "91", "HN": "91", "MR": "20020703", "DA": "19900802", "DC": "1", "DX": "19910101", "UI": "D016365"}, {"RECTYPE": "D", "MH": "Open Reading Frames", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "sORF|T028|ACR|NRW|NLM (2024)|230320|abcdef", "ENTRY": "Unidentified Reading Frames", "MN": "G05.360.340.024.340.137.650", "MH_TH": "NLM (1991)", "ST": "T028", "PI": "Base Sequence (1977-1990)", "MS": "A sequence of successive nucleotide triplets that are read as CODONS specifying AMINO ACIDS and begin with an INITIATOR CODON and end with a stop codon (CODON, TERMINATOR).", "PM": "1991; for UNIDENTIFIED READING FRAME and UNASSIGNED READING FRAMES see READING FRAMES 1991-2004", "HN": "1991; for UNIDENTIFIED READING FRAME and UNASSIGNED READING FRAMES use READING FRAMES 1991-2004", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016366"}, {"RECTYPE": "D", "MH": "Baculoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Baculoviruses", "MN": "B04.525.100", "MH_TH": "NLM (1991)", "ST": "T005", "RN": "txid10442", "AN": "coordinate with specific insect /virol", "PI": "Polyhedrosis Viruses (1973-1990)", "MS": "Family of INSECT VIRUSES which contain polyhedron-shaped or ovocylindrical occlusion bodies. The genera include ALPHABACULOVIRUS; GAMMABACULOVIRUS; and DELTABACULOVIRUS (commonly known as NUCLEOPOLYHEDROVIRUSES) and BETABACULOVIRUS (commonly known as GRANULOVIRUSES). Baculovirus vectors are used for expression of foreign genes in insects and as BIOPESTICIDES for controlling insect populations.", "PM": "91", "HN": "91", "MR": "20200813", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016367"}, {"RECTYPE": "D", "MH": "Frameshift Mutation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Mutation, Frameshift|T045|NON|EQV|NLM (1993)|920226|abcdef", "ENTRY": "Out-of-Frame Mutations", "MN": "G05.365.590.265", "MH_TH": "NLM (1991)", "ST": "T045", "AN": "do not confuse with FRAMESHIFTING, RIBOSOMAL, physiology process & form of genetic translation; do not confuse effects of drug & radiation on frameshift mutation with drug- & radiation-induced frameshift mutation", "PI": "Mutation (1968-1990)", "MS": "A type of mutation in which a number of NUCLEOTIDES deleted from or inserted into a protein coding sequence is not divisible by three, thereby causing an alteration in the READING FRAMES of the entire coding sequence downstream of the mutation. These mutations may be induced by certain types of MUTAGENS or may occur spontaneously.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016368"}, {"RECTYPE": "D", "MH": "Smear Layer", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Layer, Smear", "MN": "C07.793.208.688", "MH_TH": "NLM (1992)", "ST": "T020", "AN": "note category: in dental cavity preparation", "PI": "Dentin (1981-1991)", "MS": "Adherent debris produced when cutting the enamel or dentin in cavity preparation. It is about 1 micron thick and its composition reflects the underlying dentin, although different quantities and qualities of smear layer can be produced by the various instrumentation techniques. Its function is presumed to be protective, as it lowers dentin permeability. However, it masks the underlying dentin and interferes with attempts to bond dental material to the dentin.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016369"}, {"RECTYPE": "D", "MH": "Gene Products, rex", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rex Protein|T116|T123|ABX|EQV|NLM (1991)|900511|abbcdef", "ENTRY": "rex Gene Product", "MN": "D12.776.964.925.750", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "PI": "Viral Regulatory Proteins (1990)", "MS": "Post-transcriptional regulatory proteins required for the accumulation of mRNAs that encode the gag and env gene products in HUMAN T-LYMPHOTROPIC VIRUS 1 and HUMAN T-LYMPHOTROPIC VIRUS 2. The rex (regulator x; x is undefined) products act by binding to elements in the LONG TERMINAL REPEAT.", "PM": "91", "HN": "91", "MR": "20070709", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016370"}, {"RECTYPE": "D", "MH": "Cranial Irradiation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Irradiations, Cranial", "MN": "E02.815.190", "FX": "Pituitary Irradiation", "MH_TH": "NLM (1991)", "ST": "T061", "MS": "The exposure of the head to roentgen rays or other forms of radioactivity for therapeutic or preventive purposes.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016371"}, {"RECTYPE": "D", "MH": "RNA, Antisense", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antisense RNA|T114|T123|T130|EQV|NLM (1991)|900424|abbbdef", "ENTRY": "RNA, Anti-Sense", "MN": "D27.720.470.530.600.150.760", "MH_TH": "NLM (1991)", "ST": "T130", "RN": "0", "PI": "RNA (1985-1990)", "MS": "RNA molecules which hybridize to complementary sequences in either RNA or DNA altering the function of the latter. Endogenous antisense RNAs function as regulators of gene expression by a variety of mechanisms. Synthetic antisense RNAs are used to effect the functioning of specific genes for investigative or therapeutic purposes.", "PM": "91", "HN": "91", "MR": "20110624", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016372"}, {"RECTYPE": "D", "MH": "DNA, Antisense", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antisense DNA|T114|T123|T130|EQV|NLM (1991)|900424|abbbdef", "ENTRY": "DNA, Anti-Sense", "MN": "D27.720.470.530.600.150.200", "MH_TH": "NLM (1991)", "ST": "T130", "RN": "0", "PI": "DNA (1988-1990)", "MS": "DNA that is complementary to the sense strand. (The sense strand has the same sequence as the mRNA transcript. The antisense strand is the template for mRNA synthesis.) Synthetic antisense DNAs are used to hybridize to complementary sequences in target RNAs or DNAs to effect the functioning of specific genes for investigative or therapeutic purposes.", "PM": "91", "HN": "91", "MR": "20030709", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016373"}, {"RECTYPE": "D", "MH": "Oncogene Proteins v-abl", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-abl Proteins|T116|EQV|NLM (1991)|900424|abdef", "ENTRY": "v-abl, Oncogene Proteins", "MN": "D12.776.964.775.750.875", "MH_TH": "NLM (1991)", "ST": "T116", "RN": "0", "PI": "Viral Proteins (1984-1986)", "MS": "Transforming proteins encoded by the abl oncogenes. Oncogenic transformation of c-abl to v-abl occurs by insertional activation that results in deletions of specific N-terminal amino acids.", "PM": "91", "HN": "91", "MR": "20050630", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016374"}, {"RECTYPE": "D", "MH": "Antisense Elements (Genetics)", "DE": "ANTISENSE ELEMENTS", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antisense Probes|T114|T130|NON|NRW|NLM (1991)|900424|abbcdef", "ENTRY": "Probes, Antisense", "MN": "D27.720.470.530.600.150", "FX": "Transcription, Genetic", "MH_TH": "NLM (1991)", "ST": "T130", "RN": "0", "MS": "Nucleic acids which hybridize to complementary sequences in other target nucleic acids causing the function of the latter to be affected.", "PM": "91", "HN": "91", "MR": "20030709", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016375"}, {"RECTYPE": "D", "MH": "Oligonucleotides, Antisense", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antisense Oligonucleotides|T114|T123|T130|NON|EQV|NLM (1991)|900426|abbbcdef", "ENTRY": "Oligonucleotides, Anti-Sense", "MN": "D27.720.470.530.600.150.640", "FX": "Morpholinos", "MH_TH": "NLM (1991)", "ST": "T130", "RN": "0", "AN": "coord IM with THIONUCLEOTIDES (IM or NIM if pertinent)", "PI": "Oligonucleotides (1987-1990)", "MS": "Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize.", "PM": "91", "HN": "91", "MR": "20200527", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016376"}, {"RECTYPE": "D", "MH": "Organ Transplantation", "DE": "ORGAN TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Organ|T061|NON|EQV|NLM (1991)|900426|TRANSPL ORGAN|abcdefv", "ENTRY": "Transplantations, Organ", "MN": "E04.936.450", "FX": "Transplantation Immunology", "MH_TH": "NLM (1991)", "ST": "T061", "PI": "specific organ/transplantation (1966-1990)", "MS": "Transference of an organ between individuals of the same species or between individuals of different species.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016377"}, {"RECTYPE": "D", "MH": "Tissue Transplantation", "DE": "TISSUE TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Tissue|T061|NON|EQV|NLM (1991)|900426|TRANSPL TISSUE|abcdefv", "ENTRY": "Tissue Grafting", "MN": "E04.936.580", "FX": "Transplantation Immunology", "MH_TH": "NLM (1991)", "ST": "T061", "PI": "specific tissue/transplantation (1966-1990)", "MS": "Transference of tissue within an individual, between individuals of the same species, or between individuals of different species.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19900802", "DC": "1", "DX": "19910101", "UI": "D016378"}, {"RECTYPE": "D", "MH": "Denture, Partial, Fixed, Resin-Bonded", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Resin-Bonded Fixed Partial Denture|T074|NON|EQV|NLM (1992)|900426|abcdef", "ENTRY": "Resin-Bonded Bridges", "MN": "E07.695.190.200.220.220.220", "MH_TH": "NLM (1992)", "ST": "T074", "PI": "Denture, Partial, Fixed (1982-1991)", "MS": "A commonly used prosthesis that results in a strong, permanent restoration. It consists of an electrolytically etched cast-metal retainer that is cemented (bonded), using resins, to adjacent teeth whose enamel was previously acid-treated (acid-etched). This type of bridgework is sometimes referred to as a Maryland bridge.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016379"}, {"RECTYPE": "D", "MH": "Brain Tissue Transplantation", "DE": "BRAIN TISSUE TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Brain Tissue|T061|T062|NON|EQV|NLM (1991)|900426|TRANSPL BRAIN TISSUE|abbcdefv", "ENTRY": "Transplantations, Brain Tissue", "MN": "E04.936.580.090", "MH_TH": "NLM (1991)", "ST": "T062", "AN": "coordinate IM with specific tissue / transpl (IM or NIM); do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; transplantation of fetal or embryonic brain tissue: coordinate IM with FETAL TISSUE TRANSPLANTATION (IM) + specific tissue / transpl + / embryol if pertinent (IM or NIM)", "PI": "Brain/transplantation (1966-1990)", "MS": "Transference of brain tissue, either from a fetus or from a born individual, between individuals of the same species or between individuals of different species.", "PM": "91; was BRAIN/transplantation 1966-90", "HN": "91; was BRAIN/transplantation 1966-90", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016380"}, {"RECTYPE": "D", "MH": "Islets of Langerhans Transplantation", "DE": "ISLETS TRANSPL", "AQ": "AE CL DG EC ED EH ES HI IM IS LJ MO MT NU PA PH PX RH SN ST TD VE", "PRINT ENTRY": "Transplantation, Pancreatic Islets|T061|NON|EQV|NLM (1991)|900426|TRANSPL PANCREATIC ISLETS|abcdefv", "ENTRY": "Transplantations, Islet", "MN": "E04.936.225.375", "MH_TH": "NLM (1991)", "ST": "T061", "AN": "do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; in therapy of diabetes mellitus, coordinate IM with disease / surg (IM), not / ther", "PI": "Islets of Langerhans/transplantation (1966-1990)", "MS": "The transference of pancreatic islets within an individual, between individuals of the same species, or between individuals of different species.", "PM": "91; was ISLANDS OF LANGERHANS/transplantation 1966-90", "HN": "91; was ISLANDS OF LANGERHANS/transplantation 1966-90", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016381"}, {"RECTYPE": "D", "MH": "Orthodontic Appliance Design", "AQ": "AE CL EC ES HI IS MT NU PX SN ST TD VE", "ENTRY": "Orthodontic Appliance Designs", "MN": "E06.912.675", "MH_TH": "NLM (1992)", "ST": "T091", "AN": "coordinate with specific appliance", "PI": "Orthodontic Appliances (1972-1991)", "MS": "The planning, calculation, and creation of an apparatus for the purpose of correcting the placement or straightening of teeth.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016382"}, {"RECTYPE": "D", "MH": "Consensus Sequence", "DE": "CONSENSUS SEQ", "AQ": "DE ES GE IM PH RE", "ENTRY": "Sequences, Consensus", "MN": "G02.111.570.580.175", "FX": "Conserved Sequence", "MH_TH": "NLM (1991)", "ST": "T170", "PI": "Molecular Sequence Data (1988-1990)", "MS": "A theoretical representative nucleotide or amino acid sequence in which each nucleotide or amino acid is the one which occurs most frequently at that site in the different sequences which occur in nature. The phrase also refers to an actual sequence which approximates the theoretical consensus. A known CONSERVED SEQUENCE set is represented by a consensus sequence. Commonly observed supersecondary protein structures (AMINO ACID MOTIFS) are often formed by conserved sequences.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016384"}, {"RECTYPE": "D", "MH": "TATA Box", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Hogness Box|T114|T123|EPO|EQV|NLM (1991)|900427|abbcdef", "ENTRY": "Box, TATA", "MN": "G05.360.340.024.340.137.750.680.850", "MH_TH": "NLM (1991)", "ST": "T123", "PI": "Molecular Sequence Data (1988-1990)", "MS": "A conserved A-T rich sequence which is contained in promoters for RNA polymerase II. The segment is seven base pairs long and the nucleotides most commonly found are TATAAAA.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016385"}, {"RECTYPE": "D", "MH": "Chromosome Walking", "AQ": "IS MT", "ENTRY": "Walkings, Chromosome", "MN": "E05.393.183.250", "MH_TH": "NLM (1991)", "ST": "T063", "AN": "technique for exploring an unknown region of a CHROMOSOME", "PI": "Cloning, Molecular (1983-1990)", "MS": "A technique with which an unknown region of a chromosome can be explored. It is generally used to isolate a locus of interest for which no probe is available but that is known to be linked to a gene which has been identified and cloned. A fragment containing a known gene is selected and used as a probe to identify other overlapping fragments which contain the same gene. The nucleotide sequences of these fragments can then be characterized. This process continues for the length of the chromosome.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "19920507", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016386"}, {"RECTYPE": "D", "MH": "Women's Health", "AQ": "CL EC EH ES HI LJ SN ST TD", "ENTRY": "Health, Womens", "MN": "N01.400.900", "MH_TH": "BIOETHICS (1994)", "ST": "T078", "MS": "The concept covering the physical and mental conditions of women.", "PM": "91", "HN": "91", "MR": "20150305", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016387"}, {"RECTYPE": "D", "MH": "Tooth Loss", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Loss, Tooth", "MN": "C07.793.870", "MH_TH": "NLM (1991)", "ST": "T047", "AN": "from dis or inj; note category", "MS": "The failure to retain teeth as a result of disease or injury.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "19930603", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016388"}, {"RECTYPE": "D", "MH": "Maternal-Child Nursing", "DE": "MATERNAL CHILD NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Nursing, Maternal-Child|T091|NON|EQV|NLM (1991)|900430|NURS MATERNAL CHILD|abcdefv", "ENTRY": "Nursing, Maternal Child", "MN": "N02.421.533.460", "MH_TH": "NLM (1991)", "ST": "T091", "AN": "do not confuse with PEDIATRIC NURSING, nursing of only infants & children; NEONATAL NURSING & OBSTETRIC NURSING are available; check also tags PREGNANCY & INFANT, NEWBORN", "MS": "The nursing specialty that deals with the care of women throughout their pregnancy and childbirth and the care of their newborn children.", "PM": "91", "HN": "91", "MR": "20150629", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016389"}, {"RECTYPE": "D", "MH": "Allied Health Occupations", "DE": "ALLIED HEALTH OCCUP", "AQ": "CL EC ED ES HI LJ SN ST TD", "ENTRY": "Occupation, Allied Health", "MN": "H02.010", "MH_TH": "NLM (1991)", "ST": "T091", "PI": "Health Occupations (1974-1990)", "MS": "Occupations of medical personnel who are not physicians, and are qualified by special training and, frequently, by licensure to work in supporting roles in the health care field. These occupations include, but are not limited to, medical technology, physical therapy, physician assistant, etc.", "OL": "use HEALTH OCCUPATIONS to search ALLIED HEALTH OCCUPATIONS 1975-90", "PM": "91; was see HEALTH OCCUPATIONS 1975-90", "HN": "91; was see HEALTH OCCUPATIONS 1975-90", "MR": "20180629", "DA": "19900525", "DC": "1", "DX": "19910101", "UI": "D016390"}, {"RECTYPE": "D", "MH": "Genes, src", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "v-src Genes|T028|NRW|NLM (1991)|900503|abdef", "ENTRY": "v-src Oncogene", "MN": "G05.360.340.024.340.375.500.791.570", "FX": "src Homology Domains", "MH_TH": "NLM (1991)", "ST": "T028", "AN": "src stands for \"SaRComa\": see MeSH definition", "PI": "Oncogenes (1983-1990)", "MS": "Retrovirus-associated DNA sequences (src) originally isolated from the Rous sarcoma virus (RSV). The proto-oncogene src (c-src) codes for a protein that is a member of the tyrosine kinase family and was the first proto-oncogene identified in the human genome. The human c-src gene is located at 20q12-13 on the long arm of chromosome 20.", "OL": "use ONCOGENES to search SRC GENES 1985-90", "PM": "91; was SRC GENES see ONCOGENES 1985-90", "HN": "91; was SRC GENES see ONCOGENES 1985-90", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900529", "DC": "1", "DX": "19910101", "UI": "D016391"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins pp60(c-src)", "DS": "PROTO ONCOGENE PROTEINS PP 060 C SRC", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "src Proto-Oncogene Protein pp60|T116|T126|EQV|NLM (1991)|900503|SRC PROTO ONCOGENE PROTEIN PP 060|abbdefs", "ENTRY": "src Proto Oncogene Protein pp60", "MN": "D12.776.624.664.700.202", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.10.2", "PI": "Proto-Oncogene Proteins (1986-1990)", "MS": "Membrane-associated tyrosine-specific kinases encoded by the c-src genes. They have an important role in cellular growth control. Truncation of carboxy-terminal residues in pp60(c-src) leads to PP60(V-SRC) which has the ability to transform cells. This kinase pp60 c-src should not be confused with csk, also known as c-src kinase.", "PM": "2006; see PROTO-ONCOGENE PROTEIN PP60(C-SRC) 1991-2005", "HN": "2006(1991)", "MR": "20210521", "DA": "19900619", "DC": "1", "DX": "19910101", "UI": "D016392"}, {"RECTYPE": "D", "MH": "Lymphoma, B-Cell", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "B-Cell Lymphoma|T191|EQV|NLM (1991)|900513|abdef", "ENTRY": "Lymphomas, B-Cell", "MN": "C20.683.515.761.480.150", "MH_TH": "NLM (1991)", "ST": "T191", "AN": "a non-Hodgkin's lymphoma; LYMPHOMA, T-CELL is also available", "PI": "Lymphoma, Non-Hodgkin's (1987-1990)", "MS": "A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19900601", "DC": "1", "DX": "19910101", "UI": "D016393"}, {"RECTYPE": "D", "MH": "Lymphoma, T-Cell", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "T-Cell Lymphoma|T191|NON|EQV|NLM (1991)|900513|abcdef", "ENTRY": "T-Cell Lymphomas", "MN": "C20.683.515.761.480.750", "MH_TH": "NLM (1991)", "ST": "T191", "AN": "a non-Hodgkin's lymphoma; LYMPHOMA, T-CELL, CUTANEOUS & LYMPHOMA, T-CELL, PERIPHERAL are also available", "PI": "T-Lymphocytes (1980-1990)", "MS": "A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19900601", "DC": "1", "DX": "19910101", "UI": "D016399"}, {"RECTYPE": "D", "MH": "Lymphoma, Large-Cell, Immunoblastic", "DE": "LYMPHOMA LARGE IMMUNOBLASTIC", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Sarcoma, Immunoblastic|T191|NON|EQV|NLM (1991)|900513|abcdef", "ENTRY": "Sarcomas, Immunoblastic", "MN": "C20.683.515.761.480.487", "FX": "Lymphoma, T-Cell, Peripheral", "MH_TH": "NLM (1991)", "ST": "T191", "MS": "Malignant lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, one or more prominent nucleoli, and abundant cytoplasm. This class may be subdivided into plasmacytoid and clear-cell types based on cytoplasmic characteristics. A third category, pleomorphous, may be analogous to some of the peripheral T-cell lymphomas (LYMPHOMA, T-CELL, PERIPHERAL) recorded in both the United States and Japan.", "OL": "use LYMPHOMA to search IMMUNOBLASTOMA & SARCOMA, IMMUNOBLASTIC 1981-90", "PM": "91; IMMUNOBLASTOMA & SARCOMA, IMMUNOBLASTIC were see LYMPHOMA 1981-90", "HN": "91; IMMUNOBLASTOMA & SARCOMA, IMMUNOBLASTIC were see LYMPHOMA 1981-90", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19900601", "DC": "1", "DX": "19910101", "UI": "D016400"}, {"RECTYPE": "D", "MH": "Lymphoma, Large B-Cell, Diffuse", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Lymphoma, Histiocytic, Diffuse|T191|NON|EQV|NLM (1991)|900513|abcdef", "ENTRY": "Lymphoma, Diffuse Large Cell", "MN": "C20.683.515.761.480.150.585", "MH_TH": "NLM (2008)", "ST": "T191", "MS": "Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.", "PM": "2008; see LYMPHOMA, LARGE-CELL, DIFFUSE 1991-2007; for LYMPHOMA, LARGE-CELL see LYMPHOMA, LARGE-CELL 1991-2007, see LYMPHOMA, HISTIOCYTIC", "HN": "2008 (1991)", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19900601", "DC": "1", "DX": "19910101", "UI": "D016403"}, {"RECTYPE": "D", "MH": "Lymphoma, T-Cell, Cutaneous", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "T-Cell Lymphoma, Cutaneous|T191|EQV|NLM (1991)|900514|abdef", "ENTRY": "T-Cell Lymphomas, Cutaneous", "MN": "C20.683.515.761.480.750.800", "MH_TH": "NLM (1991)", "ST": "T191", "AN": "coordinate IM with SKIN NEOPLASMS (IM)", "MS": "A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. MYCOSIS FUNGOIDES; SEZARY SYNDROME; LYMPHOMATOID PAPULOSIS; and PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA are the best characterized of these disorders.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19900601", "DC": "1", "DX": "19910101", "UI": "D016410"}, {"RECTYPE": "D", "MH": "Lymphoma, T-Cell, Peripheral", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "T-Cell Lymphoma, Peripheral|T191|NON|EQV|NLM (1991)|900514|abcdef", "ENTRY": "T-Cell Lymphomas, Peripheral", "MN": "C20.683.515.761.480.750.825", "MH_TH": "NLM (1991)", "ST": "T191", "AN": "a non-Hodgkin's lymphoma", "PI": "T-Lymphocytes (1977-1990)", "MS": "A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. They include a broad spectrum of lymphocyte morphology, but in all instances express T-cell markers admixed with epithelioid histiocytes, plasma cells, and eosinophils. Although markedly similar to large-cell immunoblastic lymphoma (LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC), this group's unique features warrant separate treatment.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19900601", "DC": "1", "DX": "19910101", "UI": "D016411"}, {"RECTYPE": "D", "MH": "Resuscitation Orders", "AQ": "ES LJ PX", "PRINT ENTRY": "Resuscitation Decisions|T170|NON|BRD|NLM (1991)|900524|abcdef", "ENTRY": "Resuscitation Policy", "MN": "N03.706.535.704", "FX": "Withholding Treatment", "MH_TH": "NLM (1991)", "ST": "T170", "PI": "Resuscitation (1975-1990)", "MS": "Instructions issued by a physician pertaining to the institution, continuation, or withdrawal of life support measures. The concept includes policies, laws, statutes, decisions, guidelines, and discussions that may affect the issuance of such orders.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20210510", "DA": "19900601", "DC": "1", "DX": "19910101", "UI": "D016414"}, {"RECTYPE": "D", "MH": "Sequence Alignment", "DE": "SEQ ALIGNMENT", "AQ": "AE CL EC HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Sequence Homology Determination|T063|NON|BRD|NLM (1991)|900524|SEQ HOMOL DETERMINATION|abcdefv", "ENTRY": "Sequence Homology Determinations", "MN": "E05.393.751", "MH_TH": "NLM (1991)", "ST": "T063", "MS": "The arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19900601", "DC": "1", "DX": "19910101", "UI": "D016415"}, {"RECTYPE": "D", "MH": "Meeting Abstract", "PRINT ENTRY": "Meeting Abstracts|T170|NON|EQV|NLM (2008)|070621|abcdef", "MN": "V02.650", "FX": "Congress", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. used for abstracts of presentations at various types of meetings: not for designating abstracts accompanying journal articles; Abstracts as a subject are indexed under the main heading ABSTRACTING AND INDEXING. INDEXER: Do not use; CATALOGER: Do not use, use publication type CONGRESS ", "MS": "Individual abstracts of presentations at meetings, congresses, conferences, symposia, colloquia, seminars, workshops, round tables, and other professional gatherings.", "HN": "2008(1991)", "MR": "20190710", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016416"}, {"RECTYPE": "D", "MH": "Bibliography", "MN": "V02.165", "FX": "Resource Guide", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. Bibliographies as a subject are indexed under the main heading BIBLIOGRAPHIES AS TOPIC. CATALOGER: Use for lists of print or non-print materials. For annotated bibliographies use Publication Type ABSTRACTS", "MS": "A work consisting of a list of books, articles, documents, publications, and other items, usually on a single subject or related subjects.", "HN": "2008(1991)", "MR": "20190710", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016417"}, {"RECTYPE": "D", "MH": "Legal Case", "PRINT ENTRY": "Legal Cases|T170|NON|EQV|NLM (2008)|070625|abcdef", "ENTRY": "Legal Brief|T170|NON|NRW|NLM (2008)|070625|abcdef", "MN": "V02.610", "FX": "Legislation", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "this heading is used as a Publication Type", "MS": "Work consisting of collections of law reports or the published reports of decided cases and documents or filings related to those cases.", "HN": "2019(1991)", "MR": "20190705", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016418"}, {"RECTYPE": "D", "MH": "Classical Article", "MN": "V02.530.250", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "this heading is used as a Publication Type; CATALOGER: Do not use", "MS": "Works consisting of a current presentation of a previously printed seminal article marking a milestone in the history of medicine or science. It is usually accompanied by introductory remarks heralding its reprinting, often on the anniversary of its original publication or on an anniversary of the author's birth or death. It is usually reprinted in full, with complete bibliographical reference to the original appearance.", "HN": "2008(1991)", "MR": "20150629", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016419"}, {"RECTYPE": "D", "MH": "Comment", "ENTRY": "Viewpoint|T170|NON|EQV|NLM (1996)|950623|abcdef", "MN": "V02.267", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "This heading is used as a Publication Type. for critical or explanatory remarks on previously published articles; CATALOGER: Do not use", "MS": "Work consisting of a critical or explanatory note written to discuss, support, or dispute an article or other presentation previously published. It may take the form of an article, letter, editorial, etc. It appears in publications under a variety of names: comment, commentary, editorial comment, viewpoint, etc.", "HN": "1996(1991)", "MR": "20150605", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016420"}, {"RECTYPE": "D", "MH": "Editorial", "MN": "V02.335", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "This heading is used as a Publication Type. CATALOGER: Do not use", "MS": "Work consisting of a statement of the opinions, beliefs, and policy of the editor or publisher of a journal, usually on current matters of medical or scientific significance to the medical community or society at large. The editorials published by editors of journals representing the official organ of a society or organization are generally substantive.", "HN": "2008(1991)", "MR": "20150605", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016421"}, {"RECTYPE": "D", "MH": "Letter", "MN": "V02.625", "FX": "Collected Correspondence", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. Letters & correspondence as a subject are indexed under the main heading CORRESPONDENCE AS TOPIC. For collections of letters, use COLLECTED CORRESPONDENCE. ", "MS": "Work consisting of written or printed communication between individuals or between persons and representatives of corporate bodies. The correspondence may be personal or professional. In medical and other scientific publications the letter is usually from one or more authors to the editor of the journal or book publishing the item being commented upon or discussed. LETTER is often accompanied by COMMENT.", "HN": "2008(1991)", "MR": "20150629", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016422"}, {"RECTYPE": "D", "MH": "Congress", "PRINT ENTRY": "Meeting Report|T170|NON|EQV|NLM (2021)|200129|abcdef", "ENTRY": "Meeting Reports|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V02.270", "FX": "Meeting Abstract", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Congresses as a subject are indexed under the main heading CONGRESSES AS TOPIC. CATALOGER: Use for proceedings of a conference, works that are based on a conference or that consist of expanded (updated) papers from a conference, or abstracts of papers from a conference. Do not use Publication Type MEETING ABSTRACT. Do not use for works containing only one or two papers from a conference, or for personally authored summaries of a conference", "MS": "Published record of the papers delivered at or issued on the occasion of individual congresses, symposia, and meetings; abstracts of papers delivered at such congresses; reports of the officers and delegates of such congresses; combinations of the foregoing; or proceedings of the conference of a society if they are not limited to matters of internal organization.", "HN": "2019(2008)", "MR": "20200527", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016423"}, {"RECTYPE": "D", "MH": "Overall", "MN": "V02.672", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "This heading is used as a Publication Type. CATALOGER: do not use", "MS": "A single citation covering papers or abstracts presented at a meeting. The publication type may be used for a single citation with or without the additional indexing or cataloging of individual papers. The individual papers, however, are not labeled OVERALL.", "HN": "2008(1991)", "MR": "20150701", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016424"}, {"RECTYPE": "D", "MH": "Published Erratum", "ENTRY": "Errata|T170|NON|EQV|NLM (1996)|950623|abcdef", "MN": "V02.737", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "This heading is used as a Publication Type. See also the Publication Type CORRECTED AND REPUBLISHED ARTICLE. CATALOGER: Do not use", "MS": "Work consisting of an acknowledgment of an error, issued by a publisher, editor, or author. It customarily cites the source where the error occurred, giving complete bibliographic data for retrieval. In the case of books and monographs, author, title, imprint, paging, and other helpful references will be given; in the case of journal articles, the author, title, paging, and journal reference will be shown. An erratum notice is variously cited as Errata or Corrigenda.", "HN": "2008(1991)", "MR": "20150605", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016425"}, {"RECTYPE": "D", "MH": "Scientific Integrity Review", "MN": "V03.800", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "this heading is used as a Publication Type; for reports of questionable data identified by the UNITED STATES OFFICE OF RESEARCH INTEGRITY and carried in the NIH Guide to Grants and Contracts; not a review article; for scientific integrity as a subject, consider the main heading SCIENTIFIC MISCONDUCT", "MS": "Work consisting of reports by the United States Office of Research Integrity, identifying questionable research published in articles or books. Notification of the questionable data is carried in the NIH Guide for Grants and Contracts.", "HN": "2008(1991)", "MR": "20070709", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016426"}, {"RECTYPE": "D", "MH": "Technical Report", "MN": "V02.935", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "this heading is used as a Publication Type", "MS": "Work consisting of a formal report giving details of the investigation and results of a medical or other scientific problem. When issued by a government agency or comparable official body, its contents may be classified, unclassified, or declassified with regard to security clearance. This publication type may also cover a scientific paper or article that records the current state or current position of scientific research and development. If so labeled by the editor or publisher, this publication type may be properly used for journal articles.", "HN": "2008(1991)", "MR": "20120703", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016427"}, {"RECTYPE": "D", "MH": "Journal Article", "MN": "V02.600", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "This heading is used as a Publication Type. for original full text research, review or other reports published in a journal; CATALOGER: Do not use", "MS": "The predominant publication type for articles and other items indexed for NLM databases.", "HN": "2008(1991)", "MR": "20150605", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016428"}, {"RECTYPE": "D", "MH": "Clinical Conference", "ENTRY": "Clinico-Pathological Conference|T170|NON|EQV|NLM (1996)|950623|abcdef", "MN": "V03.150", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "This heading is used as a Publication Type. CATALOGER: Do not use", "MS": "Work that consists of a conference of physicians on their observations of a patient at the bedside, regarding the physical state, laboratory and other diagnostic findings, clinical manifestations, results of current therapy, etc. A clinical conference usually ends with a confirmation or correction of clinical findings by a pathological diagnosis performed by a pathologist. \"Clinical conference\" is often referred to as a \"clinico-pathological conference.\"", "HN": "2008(1991)", "MR": "20150605", "DA": "19950627", "DC": "2", "DX": "19960101", "UI": "D016429"}, {"RECTYPE": "D", "MH": "Clinical Trial", "ENTRY": "Intervention Study|T061|T062|T170|NON|EQV|NLM (2016)|150409|abbbcdef", "MN": "V03.175.250", "FX": "Validation Study", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific clinical trial; a different heading CLINICAL TRIALS AS TOPIC is used for general design, methodology, economics, etc. of clinical trials. Clinical trials on veterinary animals see CLINICAL TRIAL, VETERINARY starting in 2019.", "MS": "A work that reports on the results of a clinical study in which participants are assigned to receive one or more interventions so that researchers can evaluate the interventions on biomedical or health-related outcomes. The assignments are determined by the study protocol. Participants may receive diagnostic, therapeutic, or other types of interventions. For clinical trials on  veterinary animals see CLINICAL TRIAL, VETERINARY. Clinical Trials was used for both humans and non-humans prior to 2019.", "HN": "2008(1991)", "MR": "20190711", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016430"}, {"RECTYPE": "D", "MH": "Guideline", "MN": "V02.515", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original specific guidelines unrelated to healthcare; a different heading GUIDELINES AS TOPIC is used for general design, methodology, economics, etc of guidelines", "MS": "Work consisting of a set of statements, directions, or principles presenting current or future rules or policy. Guidelines may be developed by government agencies at any level, institutions, organizations such as professional societies or governing boards, or by the convening of expert panels. The text may be cursive or in outline form, but it is generally a comprehensive guide to problems and approaches in any discipline or activity. This concept relates to the general conduct and administration of health care activities rather than to specific decisions for a particular clinical condition. For that aspect, PRACTICE GUIDELINE is available.", "HN": "2008(1991)", "MR": "20070709", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016431"}, {"RECTYPE": "D", "MH": "News", "PRINT ENTRY": "Press Release|T170|NON|NRW|NLM (2021)|191120|abcdef", "ENTRY": "Press Releases|T170|NRW|NLM (1991)|900628|abdef", "MN": "V02.665", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "This heading is used as a Publication Type. For news items indexed from journals: do not confuse with the Publication Type NEWSPAPER ARTICLE for news indexed from newspapers. CATALOGER: do not use", "MS": "Works consisting of an announcement or statement of recent or current events of new data and matters of interest in the field of medicine or science. In some publications, such as \"Nature\" or \"Science,\" the news reports are substantively written and herald medical and scientific data of vital or controversial importance.", "HN": "2008(1991)", "MR": "20200527", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016433"}, {"RECTYPE": "D", "MH": "Directory", "PRINT ENTRY": "Register|T170|NON|REL|NLM (2021)|191129|abcdef", "ENTRY": "Registers|T170|NON|REL|NLM (2008)|070625|abcdef", "MN": "V02.312", "FX": "Resource Guide", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "this heading is used as a Publication Type; for directories & lists of members of societies & academies, etc.; index under specialty (IM) + SOCIETIES or other specific corporate heading (IM) + geographic term (NIM) + Publication Type DIRECTORY; directories as a subject are indexed under main heading DIRECTORIES AS TOPIC", "MS": "Work consisting of an alphabetical or classified list of names, organizations, subjects, etc., giving usually titles, addresses, affiliations, and other professional data.", "HN": "2008(1991)", "MR": "20200527", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016435"}, {"RECTYPE": "D", "MH": "Dictionary", "PRINT ENTRY": "Glossary|T073|T170|NON|REL|NLM (2011)|091026|abbcdef", "ENTRY": "Glossaries|T073|T170|NON|REL|NLM (2011)|091127|abbcdef", "MN": "V02.310", "FX": "Terminology", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "this heading is used as a Publication Type. Works on Dictionaries as a subject are indexed under the main heading DICTIONARIES AS TOPIC. INDEXER: Do not use                ", "MS": "A reference book containing a list of words - usually in alphabetical order - giving information about form, pronunciation, etymology, grammar, and meaning. A foreign-language dictionary is an alphabetical list of words of one language with their meaning and equivalents in another language.", "HN": "2008(1991)", "MR": "20180702", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016437"}, {"RECTYPE": "D", "MH": "Duplicate Publication", "MN": "V02.320", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. Use for an individual item identified as a duplicate publication. Duplicate publications as a subject are indexed under the main heading: DUPLICATE PUBLICATONS AS TOPIC. CATALOGER: Used by collaborating partners only ", "MS": "Work consisting of an article or book of identical or nearly identical material published simultaneously or successively to material previously published elsewhere, without acknowledgment of the prior publication.", "HN": "2008(1991)", "MR": "20070709", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016438"}, {"RECTYPE": "D", "MH": "Corrected and Republished Article", "ENTRY": "Republished Article|T170|NON|NRW|NLM (1996)|950623|abcdef", "MN": "V02.275", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "This heading is used as a Publication Type. See also the Publication Type PUBLISHED ERRATUM. CATALOGER: Do not use", "MS": "Work that is the republication of an article to correct, amplify, or restore text and data of the originally published article.", "HN": "2008(1991)", "MR": "20150605", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016439"}, {"RECTYPE": "D", "MH": "Retraction of Publication", "MN": "V02.825", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. Do not confuse with the Publication Type RETRACTED PUBLICATION which labels the article being retracted. Do not confuse with the Publication Type PUBLISHED ERRATUM. Publication retraction as a subject is indexed under the main heading RETRACTION OF PUBLICATION AS TOPIC. CATALOGER: Do not use", "MS": "Work consisting of a statement issued by one or more authors of an article or a book, withdrawing or disavowing acknowledgment of their participation in performing research or writing the results of their study. In indexing, the retraction is sent to the editor of the publication in which the article appeared and is published under the rubric \"retraction\" or in the form of a letter. This publication type designates the author's statement of retraction: it should be differentiated from RETRACTED PUBLICATION which labels the retracted publication.", "HN": "2008(1991)", "MR": "20150605", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016440"}, {"RECTYPE": "D", "MH": "Retracted Publication", "MN": "V02.800", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "this heading is used as a Publication Type; designates an article or book cited by the author or author's representative as having been retracted after formal notice by the publication type RETRACTION OF PUBLICATION", "MS": "Work consisting of the designation of an article or book as retracted in whole or in part by an author or authors or an authorized representative. It identifies a citation previously published and now retracted through a formal issuance from the author, publisher, or other authorized agent, and is distinguished from RETRACTION OF PUBLICATION, which identifies the citation retracting the original published item.", "HN": "2008(1989)", "MR": "20070709", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016441"}, {"RECTYPE": "D", "MH": "Consensus Development Conference", "PRINT ENTRY": "Consensus Statement Conference|T170|NON|EQV|NLM (2022)|210312|abcdef", "MN": "V03.300", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of a specific consensus development conference; a different heading CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC is used for general design of consensus development conferences as a subject or means of scientific communication; the Publication Type CONSENSUS DEVELOPMENT CONFERENCE, NIH is also available", "MS": "Official statements of the findings or recommendations expressing the outcome of a meeting convened to evaluate current thought and research on a subject of interest.", "HN": "2008(1991)", "MR": "20210312", "DA": "19950627", "DC": "2", "DX": "19960101", "UI": "D016446"}, {"RECTYPE": "D", "MH": "Consensus Development Conference, NIH", "PRINT ENTRY": "NIH Consensus Statement Conference|T170|NON|EQV|NLM (2022)|210312|abcdef", "MN": "V03.300.300", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "this heading is used as a Publication Type; used for any article in any publication of the NIH Office of Medical Applications of Research (OMAR); considered as a type of review; a different main heading CONSENSUS DEVELOPMENT CONFERENCES, NIH AS TOPIC is used for NIH consensus conferences as a subject or means of scientific communication; add United States; the Publication Type CONSENSUS DEVELOPMENT CONFERENCE is also available", "MS": "Official statements of the finding or recommendations expressing the outcome from a conference sponsored by NIH.", "HN": "2008(2005)", "MR": "20210312", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016447"}, {"RECTYPE": "D", "MH": "Multicenter Study", "ENTRY": "Multicenter Studies|T062|T170|NON|EQV|NLM (2008)|070702|abbcdef", "MN": "V03.650", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific multicenter study; a different heading MULTICENTER STUDIES AS TOPIC is used for general design, methodology, economics, etc. of multicenter studies; specify geographic term if pertinent; add the Publication Type CLINICAL TRIAL or specific if appropriate", "MS": "A work that reports on a study executed by several cooperating institutions.", "HN": "2008(1991)", "MR": "20150415", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016448"}, {"RECTYPE": "D", "MH": "Randomized Controlled Trial", "MN": "V03.175.250.500.500", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific randomized controlled trial; a different heading RANDOMIZED CONTROLLED TRIALS AS TOPIC is used for general design, methodology, economics, etc. of randomized controlled trials", "MS": "A work that reports on a clinical trial that involves at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.", "HN": "2008(1991)", "MR": "20150415", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016449"}, {"RECTYPE": "D", "MH": "Periodical Index", "MN": "V02.682", "FX": "Index", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "this heading is used as a Publication Type", "PI": "Bibliography (1968-1989)", "MS": "Work consisting of a subject approach to the contents of a periodical issuing an annual, biennial, quinquennial, decennial, etc., index. The heading is used for the overall body of articles published by a periodical in the same sense that BIBLIOGRAPHY is useful when published as a single article.", "HN": "2008(1990)", "MR": "20180716", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016453"}, {"RECTYPE": "D", "MH": "Review", "ENTRY": "Review, Multicase|T170|NON|NRW|NLM (1996)|950623|abcdef", "MN": "V02.912", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "This heading is used as a Publication Type. Review articles as a bibliographic form are indexed under the main heading REVIEW LITERATURE AS TOPIC", "MS": "An article or book published after examination of published material on a subject. It may be comprehensive to various degrees and the time range of material scrutinized may be broad or narrow, but the reviews most often desired are reviews of the current literature. The textual material examined may be equally broad and can encompass, in medicine specifically, clinical material as well as experimental research or case reports. State-of-the-art reviews tend to address more current matters. A review of the literature must be differentiated from HISTORICAL ARTICLE on the same subject, but a review of historical literature is also within the scope of this publication type.", "HN": "2008(1966)", "MR": "20180623", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016454"}, {"RECTYPE": "D", "MH": "Historical Article", "ENTRY": "Historical Survey|T170|NON|NRW|NLM (2008)|070625|abcdef", "MN": "V02.530", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "This heading is used as a Publication Type. Check appropriate century tags. CATALOGER: do not use", "MS": "An article or portion of an article giving an account of past events or circumstances significant in a field of study, a profession, a discovery, an invention, etc. The concept of history is very wide, ranging from the dawn of time to the present. This publication type is often checked in conjunction with BIOGRAPHY.", "HN": "2008(1966)", "MR": "20150605", "DA": "19950627", "DC": "2", "DX": "19960101", "UI": "D016456"}, {"RECTYPE": "D", "MH": "Prosthesis-Related Infections", "DE": "PROSTHESIS RELAT INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Prosthesis-Related Infection|T046|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Related Infections, Prosthesis", "MN": "C23.550.767.868", "FX": "Biofilms", "MH_TH": "NLM (1992)", "ST": "T046", "AN": "coord IM with specific infect (IM) and specific prosthesis /adv eff (IM), as EYE, ARTIFICIAL /adv eff; infect by biofilm: coord IM with BIOFILMS (IM) but see note there", "PI": "specific prosthesis/adverse effects (1966-1991)", "MS": "Infections resulting from the implantation of prosthetic devices. The infections may be acquired from intraoperative contamination (early) or hematogenously acquired from other sites (late).", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016459"}, {"RECTYPE": "D", "MH": "Granuloma Annulare", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.550.382.375", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "non-neoplastic; of the skin, so do not coord with SKIN DISEASES; coord IM with specific site or precoord site heading if pertinent (IM)", "PI": "Skin Diseases (1966-1991)", "MS": "Benign granulomatous disease of unknown etiology characterized by a ring of localized or disseminated papules or nodules on the skin and palisading histiocytes surrounding necrobiotic tissue resulting from altered collagen structures.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016460"}, {"RECTYPE": "D", "MH": "Chemoembolization, Therapeutic", "DE": "CHEMOEMBOLIZATION THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapeutic Chemoembolizations", "MN": "E02.926.500.150", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "coordinate with disease /ther, not /surg & with antineoplastic agent /admin ", "PI": "Embolization, Therapeutic (1979-1991)", "MS": "Administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016461"}, {"RECTYPE": "D", "MH": "Mammaplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Breast Reconstruction|T061|NON|EQV|NLM (1992)|900710|abcdef", "ENTRY": "Reconstructions, Breast", "MN": "E04.617.500", "FX": "Breast Implants", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "BREAST IMPLANTS is also available", "PI": "Surgery, Plastic (1966-1991)", "MS": "Surgical reconstruction of the breast including both augmentation and reduction.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016462"}, {"RECTYPE": "D", "MH": "Sweet Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sweet's Syndrome|T047|EPO|EQV|NLM (1992)|990101|abcdef", "ENTRY": "Syndrome, Sweet's", "MN": "C17.800.229.800", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Skin Diseases (1966-1991)", "MS": "Condition characterized by large, rapidly extending, erythematous, tender plaques on the upper body usually accompanied by fever and dermal infiltration of neutrophilic leukocytes. It occurs mostly in middle-aged women, is often preceded by an upper respiratory infection, and clinically resembles ERYTHEMA MULTIFORME. Sweet syndrome is associated with LEUKEMIA.", "PM": "2009; see SWEET'S SYNDROME 1992-2008", "HN": "2009 (1992)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016463"}, {"RECTYPE": "D", "MH": "Lysosomal Storage Diseases", "DE": "LYSOSOMAL STORAGE DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lysosomal Enzyme Disorders|T047|NON|EQV|NLM (1992)|900910|LYSOSOMAL ENZYME DIS|abcdefv", "ENTRY": "Lysosomal Storage Disease", "MN": "C18.452.648.595", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "an inborn error of metab; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Metabolism, Inborn Errors (1972-1991)", "MS": "Inborn errors of metabolism characterized by defects in specific lysosomal hydrolases and resulting in intracellular accumulation of unmetabolized substrates.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016464"}, {"RECTYPE": "D", "MH": "Bone Marrow Purging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Hematopoietic Stem Cell Purging|T061|NON|REL|NLM (2001)|991227|abcdef", "ENTRY": "Purging, Bone Marrow", "MN": "E02.120.142", "FX": "Immunomagnetic Separation", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "coord IM with purging agent or method (IM with no qualif)", "PI": "Bone Marrow Transplantation (1988-1991)", "MS": "Techniques for the removal of subpopulations of cells (usually residual tumor cells) from the bone marrow ex vivo before it is infused. The purging is achieved by a variety of agents including pharmacologic agents, biophysical agents (laser photoirradiation or radioisotopes) and immunologic agents. Bone marrow purging is used in both autologous and allogeneic BONE MARROW TRANSPLANTATION.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016465"}, {"RECTYPE": "D", "MH": "CHO Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cells, CHO", "MN": "A11.436.155", "MH_TH": "NLM (1992)", "ST": "T025", "AN": "CHO stands for \"Chinese Hamster Ovary\"; almost always NIM with no subheadings; check ANIMALS & add HAMSTERS, CHINESE (NIM); do not routinely add OVARY", "PI": "Cell Line (1972-1991)", "MS": "CELL LINE derived from the ovary of the Chinese hamster, Cricetulus griseus (CRICETULUS). The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells.", "PM": "92", "HN": "92", "MR": "20030730", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016466"}, {"RECTYPE": "D", "MH": "Monograph", "MN": "V02.660", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "INDEXER: Do not use; CATALOGER: Do not use", "MS": "Work that is any publication that is not a serial or integrating resource. In cataloging usage, It is usually on a single subject or related subjects and is complete in itself, whether constructed of chapters, sections, or parts. While any article encountered in indexing journals can be, strictly speaking, a monograph, as a publication type, a monograph will refer to a cataloging item.", "HN": "2008(1976)", "MR": "20150622", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D016467"}, {"RECTYPE": "D", "MH": "Forestry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "J01.576.430", "FX": "Trees", "MH_TH": "NLM (1992)", "ST": "T090", "PI": "Trees (1966-1991)", "MS": "The science of developing, caring for, or cultivating forests.", "PM": "92", "HN": "92", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016468"}, {"RECTYPE": "D", "MH": "Fungemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C23.550.470.790.500.360", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "coord with specific fungus/infect heading or specific fungus if specific fungus infect is not in MeSH (do not use /blood to indicate -emia)", "PI": "specific fungal infection (1966-1991)", "MS": "The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016469"}, {"RECTYPE": "D", "MH": "Bacteremia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Bacteremias", "MN": "C23.550.470.790.500.100", "FX": "Endotoxemia", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "coord with specific bact/infect heading or specific bacterium if specific bact infect is not in MeSH (do not use /blood to indicate -emia)", "PI": "specific bacterial infection (1966-1991)", "MS": "The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.", "OL": "use SEPTICEMIA to search BACTEREMIA 1975-91", "PM": "92; was see SEPTICEMIA 1975-91", "HN": "92; was see SEPTICEMIA 1975-91", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016470"}, {"RECTYPE": "D", "MH": "Ovarian Hyperstimulation Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ovarian Hyperstimulation Syndromes", "MN": "C19.391.630.642", "FX": "Ovulation Induction", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Ovulation Induction/adverse effects (1978-1991)", "MS": "A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016471"}, {"RECTYPE": "D", "MH": "Motor Neuron Disease", "DE": "MOTOR NEURON DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Motor Neuron Disease, Upper|T047|NON|NRW|NLM (2000)|991104|MOTOR NEURON DIS UPPER|abcdefv", "ENTRY": "Sclerosis, Primary Lateral", "MN": "C10.668.467", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Neuromuscular Diseases (1972-1991)", "MS": "Diseases characterized by a selective degeneration of the motor neurons of the spinal cord, brainstem, or motor cortex. Clinical subtypes are distinguished by the major site of degeneration. In AMYOTROPHIC LATERAL SCLEROSIS there is involvement of upper, lower, and brainstem motor neurons. In progressive muscular atrophy and related syndromes (see MUSCULAR ATROPHY, SPINAL) the motor neurons in the spinal cord are primarily affected. With progressive bulbar palsy (BULBAR PALSY, PROGRESSIVE), the initial degeneration occurs in the brainstem. In primary lateral sclerosis, the cortical neurons are affected in isolation. (Adams et al., Principles of Neurology, 6th ed, p1089)", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016472"}, {"RECTYPE": "D", "MH": "Gallbladder Emptying", "AQ": "DE ES GE IM PH RE", "ENTRY": "Emptying, Gallbladder", "MN": "G10.261.345", "MH_TH": "NLM (1992)", "ST": "T042", "PI": "Gallbladder (1975-1991)", "MS": "A process whereby bile is delivered from the gallbladder into the duodenum. The emptying is caused by both contraction of the gallbladder and relaxation of the sphincter mechanism at the choledochal terminus.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016473"}, {"RECTYPE": "D", "MH": "Weight-Bearing", "AQ": "PH", "PRINT ENTRY": "Load-Bearing|T042|NON|EQV|NLM (1992)|901119|abcdef", "ENTRY": "Weight Bearing", "MN": "G01.374.965", "MH_TH": "NLM (1992)", "ST": "T042", "AN": "by machines & humans or animals; for weight-bearing bones or joints, coordinate NIM with specific bone or joint with /physiol (IM)", "MS": "The physical state of supporting an applied load. This often refers to the weight-bearing bones or joints that support the body's weight, especially those in the spine, hip, knee, and foot.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016474"}, {"RECTYPE": "D", "MH": "3T3 Cells", "DS": "T AAA A CELLS 03 03", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cells, 3T3", "MN": "A11.329.228.100", "MH_TH": "NLM (1992)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMALS & MICE; do not routinely add FIBROBLASTS or EMBRYO, MAMMALIAN", "PI": "Cell Line (1966-1991)", "MS": "Cell lines whose original growing procedure consisted being transferred (T) every 3 days and plated at 300,000 cells per plate (J Cell Biol 17:299-313, 1963). Lines have been developed using several different strains of mice. Tissues are usually fibroblasts derived from mouse embryos but other types and sources have been developed as well. The 3T3 lines are valuable in vitro host systems for oncogenic virus transformation studies, since 3T3 cells possess a high sensitivity to CONTACT INHIBITION.", "PM": "1992", "HN": "1992", "MR": "20130708", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016475"}, {"RECTYPE": "D", "MH": "Urinary Reservoirs, Continent", "AQ": "AE BS CL EC ES HI IM IR MI PA PH PS SD SN ST TD VE VI", "PRINT ENTRY": "Continent Urinary Reservoirs|T017|NON|EQV|NLM (1992)|900802|abcdef", "ENTRY": "Urinary Reservoirs, Colonic", "MN": "E07.862.750", "MH_TH": "NLM (1992)", "ST": "T017", "PI": "Urinary Diversion (1972-1991)", "MS": "Structures which collect and store urine and are emptied by catheterization of a cutaneous stoma or internal diversion to the urethra. The reservoirs are surgically created during procedures for urinary diversion.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016476"}, {"RECTYPE": "D", "MH": "Artifacts", "ENTRY": "Artifact", "MN": "E05.047", "MH_TH": "NLM (1992)", "ST": "T068", "AN": "restrict to histology, microscopy, radiography, ECG; EEG & other procedures: not for products of human workmanship in arts & crafts; coordinate with specific procedure", "MS": "Any visible result of a procedure which is caused by the procedure itself and not by the entity being analyzed. Common examples include histological structures introduced by tissue processing, radiographic images of structures that are not naturally present in living tissue, and products of chemical reactions that occur during analysis.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016477"}, {"RECTYPE": "D", "MH": "Helicobacter pylori", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Helicobacter nemestrinae|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.150.235.500.250.550", "MH_TH": "NLM (1991)", "ST": "T007", "RN": "txid210", "AN": "infection: coordinate with HELICOBACTER INFECTIONS", "PI": "Campylobacter (1984-1990)", "MS": "A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405).", "PM": "91", "HN": "91", "MR": "20200128", "DA": "19900803", "DC": "1", "DX": "19910101", "UI": "D016480"}, {"RECTYPE": "D", "MH": "Helicobacter Infections", "DE": "HELICOBACTER INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Helicobacter", "MN": "C01.150.252.400.466", "MH_TH": "NLM (1991)", "ST": "T047", "MS": "Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.", "PM": "91", "HN": "91", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19900803", "DC": "1", "DX": "19910101", "UI": "D016481"}, {"RECTYPE": "D", "MH": "Urinalysis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Urinalyses", "MN": "E05.200.124.810", "MH_TH": "NLM (1992)", "ST": "T059", "AN": "general or unspecified; prefer specifics; for urinalysis of specific substances in the urine prefer /urine", "PI": "Urine/analysis (1966-1991)", "MS": "Examination of urine by chemical, physical, or microscopic means. Routine urinalysis usually includes performing chemical screening tests, determining specific gravity, observing any unusual color or odor, screening for bacteriuria, and examining the sediment microscopically.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016482"}, {"RECTYPE": "D", "MH": "Lymphoma, AIDS-Related", "DE": "LYMPHOMA AIDS RELAT", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Lymphoma, HIV-Related|T191|EQV|NLM (1995)|940121|LYMPHOMA HIV RELAT|abdefv", "ENTRY": "Lymphomas, HIV-Related", "MN": "C20.683.515.761.480.150.450", "MH_TH": "NLM (1992)", "ST": "T191", "AN": "a B-cell lymphoma but use for any AIDS-related lymphoma; coordinate IM with specific type of lymphoma (IM); coordinate with HIV-1 or HIV-2 if pertinent", "PI": "Lymphoma (1986-1991)", "MS": "B-cell lymphoid tumors that occur in association with AIDS. Patients often present with an advanced stage of disease and highly malignant subtypes including BURKITT LYMPHOMA; IMMUNOBLASTIC LARGE-CELL LYMPHOMA; PRIMARY EFFUSION LYMPHOMA; and DIFFUSE, LARGE B-CELL, LYMPHOMA. The tumors are often disseminated in unusual extranodal sites and chromosomal abnormalities are frequently present. It is likely that polyclonal B-cell lymphoproliferation in AIDS is a complex result of EBV infection, HIV antigenic stimulation, and T-cell-dependent HIV activation.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016483"}, {"RECTYPE": "D", "MH": "Needle Sharing", "AQ": "AE EC HI LJ PX SN TD", "PRINT ENTRY": "Syringe Sharing|T054|NON|EQV|NLM (1992)|900813|abcdef", "ENTRY": "Sharing, Syringe", "MN": "I01.880.735.580", "FX": "Needle-Exchange Programs", "MH_TH": "NLM (1992)", "ST": "T054", "AN": "by intravenous drug users", "PI": "Syringes (1985-1991)", "MS": "Usage of a single needle among two or more people for injecting drugs. Needle sharing is a high-risk behavior for contracting infectious disease.", "PM": "92", "HN": "92", "MR": "19940523", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016485"}, {"RECTYPE": "D", "MH": "Parenting", "AQ": "EH HI PX TD", "MN": "F01.829.263.370.310", "FX": "Child Rearing", "MH_TH": "NLM (1992)", "ST": "T054", "AN": "parenting education: coordinate IM with EDUCATION, NONPROFESSIONAL (IM)", "PI": "Parent-Child Relations (1970-1991)", "MS": "Performing the role of a parent by care-giving, nurturance, and protection of the child by a natural or substitute parent. The parent supports the child by exercising authority and through consistent, empathic, appropriate behavior in response to the child's needs. PARENTING differs from CHILD REARING in that in child rearing the emphasis is on the act of training or bringing up the children and the interaction between the parent and child, while parenting emphasizes the responsibility and qualities of exemplary behavior of the parent.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016487"}, {"RECTYPE": "D", "MH": "Medicine, African Traditional", "DE": "MED AFRICAN TRADITIONAL", "AQ": "AE EC HI IS MT PX SN ST TD", "PRINT ENTRY": "Traditional Medicine, African|T058|T091|NON|EQV|NLM (1992)|900815|TRADITIONAL MED AFRICAN|abbcdefv", "ENTRY": "Traditional African Medicine|T058|T091|NON|EQV|NLM (1992)|900815|TRADITIONAL AFRICAN MED|abbcdefv", "MN": "I01.076.201.450.654.505", "FX": "Traditional Medicine Practitioners", "MH_TH": "NLM (1992)", "ST": "T091", "PI": "Medicine, Traditional (1966-1991)", "MS": "A system of traditional medicine which is based on the beliefs and practices of the African peoples. It includes treatment by MEDICINAL PLANTS and other MATERIA MEDICA as well as by the ministrations of diviners, MEDICINE MEN, witch doctors, and sorcerers.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19910703", "DC": "1", "DX": "19920101", "UI": "D016488"}, {"RECTYPE": "D", "MH": "Head Injuries, Closed", "DE": "HEAD INJ CLOSED", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Head Trauma, Closed|T037|NON|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Nonpenetrating Head Injury", "MN": "C26.974.382", "MH_TH": "NLM (1992)", "ST": "T037", "AN": "coordinate with BRAIN INJURIES, TRAUMATIC only if both are discussed", "PI": "Head Injuries (1966-1991)", "MS": "Traumatic injuries to the cranium where the integrity of the skull is not compromised and no bone fragments or other objects penetrate the skull and DURA MATER. This frequently results in mechanical injury being transmitted to intracranial structures which may produce TRAUMATIC BRAIN INJURIES, hemorrhage, or CRANIAL NERVE INJURIES. (From Rowland, Merritt's Textbook of Neurology, 9th ed, p417)", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180726", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016489"}, {"RECTYPE": "D", "MH": "Integrated Advanced Information Management Systems", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Integrated Academic Information Management Systems|T170|NON|NRW|NLM (1994)|930222|abcdef", "MN": "L01.313.500.750.300.420", "MH_TH": "NLM (1992)", "ST": "T170", "PI": "National Library of Medicine (U.S.) (1986-1988)", "MS": "A concept, developed in 1983 under the aegis of and supported by the National Library of Medicine under the name of Integrated Academic Information Management Systems, to provide professionals in academic health sciences centers and health sciences institutions with convenient access to an integrated and comprehensive network of knowledge. It addresses a wide cross-section of users from administrators and faculty to students and clinicians and has applications to planning, clinical and managerial decision-making, teaching, and research. It provides access to various types of clinical, management, educational, etc., databases, as well as to research and bibliographic databases. In August 1992 the name was changed from Integrated Academic Information Management Systems to Integrated Advanced Information Management Systems to reflect use beyond the academic milieu.", "OL": "use INTEGRATED ADVANCED INFORMATION MANAGEMENT SYSTEMS to search INTEGRATED ACADEMIC INFORMATION MANAGEMENT SYSTEMS 1992-93", "PM": "94; was INTEGRATED ACADEMIC INFORMATION MANAGEMENT SYSTEMS 1992-93", "HN": "94; was INTEGRATED ACADEMIC INFORMATION MANAGEMENT SYSTEMS 1992-93", "MR": "20150622", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016490"}, {"RECTYPE": "D", "MH": "Peripheral Vascular Diseases", "DE": "PERIPHERAL VASCULAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vascular Diseases, Peripheral|T047|NON|EQV|NLM (1992)|900816|VASCULAR DIS PERIPHERAL|abcdefv", "ENTRY": "Vascular Disease, Peripheral", "MN": "C14.907.617", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Vascular Diseases (1966-1991)", "MS": "Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016491"}, {"RECTYPE": "D", "MH": "Computer Security", "AQ": "CL EC ES HI IS LJ SN ST TD", "PRINT ENTRY": "Data Security|T080|NON|NRW|NLM (1992)|900820|abcdef", "ENTRY": "Worms, Computer", "MN": "N04.452.910.200", "MH_TH": "NLM (1992)", "ST": "T057", "AN": "do not use for confidentiality of records (= CONFIDENTIALITY + RECORDS or specific records term)", "PI": "Information Systems (1982-1991)", "MS": "Protective measures against unauthorized access to or interference with computer operating systems, telecommunications, or accompanying data; especially the modification, deletion, destruction, or release of data in computers. It includes methods of forestalling interference by computer viruses or computer hackers aiming to compromise stored data.", "PM": "92", "HN": "92", "MR": "20180713", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016494"}, {"RECTYPE": "D", "MH": "Police", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Law Enforcement Officers|T097|NON|BRD|NLM (1992)|900820|abcdef", "ENTRY": "Police Officer", "MN": "M01.526.760", "FX": "Law Enforcement", "MH_TH": "NLM (1992)", "ST": "T097", "PI": "Social Control, Formal (1971-1991)", "MS": "Agents of the law charged with the responsibility of maintaining and enforcing law and order among the citizenry.", "PM": "92", "HN": "92", "MR": "20150630", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016495"}, {"RECTYPE": "D", "MH": "Incontinence Pads", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Pads, Incontinence", "MN": "E07.325.068.500", "MH_TH": "NLM (1992)", "ST": "T074", "AN": "restrict to ELDERLY or adults; for infants use DIAPERS, INFANT see INFANT CARE", "PI": "Disposable Equipment (1986-1991)", "MS": "Absorbent pads used for URINARY INCONTINENCE and usually worn as underpants or pants liners by the ELDERLY.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016496"}, {"RECTYPE": "D", "MH": "Adolescent Health Services", "DE": "ADOLESCENT HEALTH SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Health Services, Adolescent|T058|NON|EQV|NLM (1996)|940811|HEALTH SERV ADOLESCENT|abcdefv", "ENTRY": "Service, Adolescent Health", "MN": "N02.421.044", "FX": "Adolescent Medicine", "MH_TH": "NLM (1992)", "ST": "T058", "AN": "check also tags HUMANS & ADOLESCENCE", "PI": "Health Services (1972-1991)", "MS": "Organized services to provide health care to adolescents, ages ranging from 13 through 18 years.", "PM": "1992", "HN": "1992", "MR": "20150626", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016497"}, {"RECTYPE": "D", "MH": "Radioimmunotherapy", "DE": "RADIOIMMUNOTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Radioimmunotherapies", "MN": "E02.815.520", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "coordinate with disease /radiother ", "PI": "specific radioisotope/therapeutic use (1981-1991)", "MS": "Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY).", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016499"}, {"RECTYPE": "D", "MH": "Color Therapy", "DE": "COLOR THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Chromotherapy|T061|NON|EQV|NLM (1992)|900821|CHROMOTHER|abcdefv", "ENTRY": "Therapy, Color|T061|NON|EQV|NLM (1992)|901015|THER COLOR|abcdefv", "MN": "F04.754.215", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "treatment of dis with color; coord IM with disease /ther (IM)", "PI": "Phototherapy (1972-1991)", "MS": "A form of phototherapy using color to influence health and to treat various physical or mental disorders. The color rays may be in the visible or invisible spectrum and can be administered through colored lights or applied mentally through suggestion.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016500"}, {"RECTYPE": "D", "MH": "Neurites", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Neurite", "MN": "A11.671.543", "FX": "Nerve Growth Factors", "MH_TH": "NLM (1992)", "ST": "T026", "AN": "do not confuse with the French \"nevrite\" or other vernac \"nevrit-\" which means \"neuritis\"", "PI": "Neurons (1970-1991)", "MS": "In tissue culture, hairlike projections of neurons stimulated by growth factors and other molecules. These projections may go on to form a branched tree of dendrites or a single axon or they may be reabsorbed at a later stage of development. \"Neurite\" may refer to any filamentous or pointed outgrowth of an embryonal or tissue-culture neural cell.", "PM": "92", "HN": "92", "MR": "20000622", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016501"}, {"RECTYPE": "D", "MH": "Drug Delivery Systems", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Drug Targeting|T074|NON|EQV|NLM (2001)|000328|abcdef", "ENTRY": "Targetings, Drug", "MN": "E02.319.300", "FX": "Drug Carriers", "MH_TH": "NLM (1992)", "ST": "T074", "AN": "coordinate with drug / admin; do not confuse with MEDICATION SYSTEMS, an organizational concept in patient care for providing medication; note entry term DRUG TARGETING: do not confuse with MOLECULAR TARGETED THERAPY", "MS": "Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016503"}, {"RECTYPE": "D", "MH": "Breast Self-Examination", "DE": "BREAST SELF EXAM", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Self-Examination, Breast|T060|NON|EQV|NLM (1992)|910102|SELF EXAM BREAST|abcdefv", "ENTRY": "Self-Examinations, Breast", "MN": "F01.145.488.700.100", "MH_TH": "NLM (1992)", "ST": "T060", "AN": "coordinate with disease /diag if discussed", "PI": "Palpation (1966-1991)", "MS": "The inspection of one's breasts, usually for signs of disease, especially neoplastic disease.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19910208", "DC": "1", "DX": "19920101", "UI": "D016504"}, {"RECTYPE": "D", "MH": "Pemphigus, Benign Familial", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hailey-Hailey Disease|T047|EPO|EQV|NLM (1992)|OMIM (2013)|ORD (2010)|900823|HAILEY HAILEY DIS|abcdeeefv", "ENTRY": "Hailey Hailey Disease", "MN": "C17.800.865.858", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Pemphigus (1966-1991)", "MS": "An autosomal dominantly inherited skin disorder characterized by recurrent eruptions of vesicles and BULLAE mainly on the neck, axillae, and groin. Mutations in the ATP2C1 gene (encoding the secretory pathway Ca2++/Mn2++ ATPase 1 (SPCA1)) cause this disease. It is clinically and histologically similar to DARIER DISEASE - both have abnormal, unstable DESMOSOMES between KERATINOCYTES and defective CALCIUM-TRANSPORTING ATPASES. It is unrelated to PEMPHIGUS VULGARIS though it closely resembles that disease.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016506"}, {"RECTYPE": "D", "MH": "Cardiology Service, Hospital", "DE": "CARDIOL SERV HOSP", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Hospital Cardiology Service|T058|NON|EQV|NLM (1992)|910102|HOSP CARDIOL SERV|abcdefv", "ENTRY": "Services, Hospital Cardiology", "MN": "N04.452.442.452.422.215", "FX": "Coronary Care Units", "MH_TH": "NLM (1992)", "ST": "T058", "MS": "The hospital department responsible for the administration and provision of diagnostic and therapeutic services for the cardiac patient.", "PM": "92", "HN": "92", "MR": "20190709", "DA": "19910208", "DC": "1", "DX": "19920101", "UI": "D016507"}, {"RECTYPE": "D", "MH": "Fluorescent Treponemal Antibody-Absorption Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "FTA-ABS Test|T059|EQV|NLM (1992)|900824|abdef", "ENTRY": "Tests, FTA-ABS", "MN": "E05.478.594.760.850.200", "MH_TH": "NLM (1992)", "ST": "T059", "PI": "Syphilis Serodiagnosis (1966-1991)", "MS": "Serologic assay that detects antibodies to Treponema pallidum, the etiologic agent of syphilis. After diluting the patient's serum to remove non-specific antibodies, the serum is mixed on a glass slide with Nichol's strain of Treponema pallidum. An antigen-antibody reaction occurs if the test is positive and the bound antibodies are detected with fluoresceinated antihuman gamma-globulin antibody.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016508"}, {"RECTYPE": "D", "MH": "Corneal Neovascularization", "DE": "CORNEAL NEOVASC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Corneal Angiogenesis|T046|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Neovascularizations, Corneal", "MN": "C23.550.589.500.435", "MH_TH": "NLM (1992)", "ST": "T046", "PI": "Neovascularization (1980-1991)", "MS": "New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190429", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016510"}, {"RECTYPE": "D", "MH": "Severe Combined Immunodeficiency", "DE": "SEVERE COMBINED IMMUNODEFIC", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Omenn Syndrome|T047|EPO|NRW|NLM (2009)|OMIM (2013)|ORD (2010)|080410|abcdeeef", "ENTRY": "Syndromes, Bare Lymphocyte", "MN": "C20.673.795.750", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Immunologic Deficiency Syndromes (1974-1991)", "MS": "Group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an X-linked or autosomal recessive defect. Mutations occurring in many different genes cause human Severe Combined Immunodeficiency (SCID).", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016511"}, {"RECTYPE": "D", "MH": "Ankle Injuries", "DE": "ANKLE INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndesmotic Injury", "MN": "C26.558.100", "MH_TH": "NLM (1992)", "ST": "T037", "AN": "consider also TARSAL BONES /inj", "PI": "Ankle/injuries (1966-1991)", "MS": "Harm or hurt to the ankle or ankle joint usually inflicted by an external source.", "OL": "use ANKLE INJURIES to search ANKLE/injuries 1966-91", "PM": "92; was ANKLE/injuries 1966-91", "HN": "92; was ANKLE/injuries 1966-91", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19910531", "DC": "1", "DX": "19920101", "UI": "D016512"}, {"RECTYPE": "D", "MH": "Mice, SCID", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Severe Combined Immunodeficient Mice|T015|NON|EQV|NLM (1992)|900827|SEVERE COMBINED IMMUNODEFIC MICE|abcdefv", "ENTRY": "SCID-hu Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.550.780", "MH_TH": "NLM (1992)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mice, Mutant Strains (1983-1991)", "MS": "Mice homozygous for the mutant autosomal recessive gene \"scid\" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016513"}, {"RECTYPE": "D", "MH": "Genes, Neurofibromatosis 1", "DS": "GENES NEUROFIBROMATOSIS 01", "AQ": "DE ES PH RE", "PRINT ENTRY": "nf1 Genes|T028|EQV|NLM (1992)|901016|NF GENES 01|abdefs", "ENTRY": "nf1 Gene", "MN": "G05.360.340.024.340.415.400.340", "FX": "Neurofibromin 1", "MH_TH": "NLM (1992)", "ST": "T028", "PI": "Neurofibromatosis 1/genetics (1987-1991)", "MS": "Tumor suppressor genes located on the long arm of human chromosome 17 in the region 17q11.2. Mutation of these genes is thought to cause NEUROFIBROMATOSIS 1, Watson syndrome, and LEOPARD syndrome.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016514"}, {"RECTYPE": "D", "MH": "Genes, Neurofibromatosis 2", "DS": "GENES NEUROFIBROMATOSIS 02", "AQ": "DE ES PH RE", "PRINT ENTRY": "nf2 Genes|T028|EQV|NLM (1992)|901017|NF GENES 02|abdefs", "ENTRY": "nf2 Gene", "MN": "G05.360.340.024.340.415.400.345", "FX": "Neurofibromin 2", "MH_TH": "NLM (1992)", "ST": "T028", "PI": "Neuroma, Acoustic/genetics (1988-1991)", "MS": "Tumor suppressor genes located on the long arm of human chromosome 22. Mutation or loss of these genes causes NEUROFIBROMATOSIS 2.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016515"}, {"RECTYPE": "D", "MH": "CD4-CD8 Ratio", "DS": "CD 004 CD 008 RATIO", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "T4-T8 Ratio|T034|T081|EQV|NLM (1992)|900831|T AAB T RATIO 04 08|abbdefs", "ENTRY": "T4-T8 Ratios", "MN": "G12.248", "MH_TH": "NLM (1992)", "ST": "T081", "PI": "Leukocyte Count (1986-1991)", "MS": "Ratio of T-LYMPHOCYTES that express the CD4 ANTIGEN to those that express the CD8 ANTIGEN. This value is commonly assessed in the diagnosis and staging of diseases affecting the IMMUNE SYSTEM including HIV INFECTIONS.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016516"}, {"RECTYPE": "D", "MH": "Neurofibromatosis 2", "DS": "NEUROFIBROMATOSIS A 02", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Schwannoma, Acoustic, Bilateral|T191|NON|NRW|GHR (2014)|NLM (1992)|900905|abcdeef", "ENTRY": "Type II Neurofibromatosis", "MN": "C16.320.700.633.655", "FX": "Neurofibromin 2", "MH_TH": "NLM (1992)", "ST": "T191", "AN": "do not confuse with NEUROFIBROMATOSIS 1; coord IM with precoord/neopl term (IM) if relevant", "PI": "Neuroma, Acoustic (1978-1991)", "MS": "An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (NEURILEMMOMA) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the NF2 gene (GENES, NEUROFIBROMATOSIS 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.", "PM": "1992; NEUROFIBROMATOSIS, CENTRAL, NF2 see NEUROFIBROMATOSIS, CENTRAL, NF-2 see NEUROMA, ACOUSTIC 1989-1991; NEUROMA, ACOUSTIC, BILATERAL see NEUROMA, ACOUSTIC 1989-1991", "HN": "1992; NEUROFIBROMATOSIS, CENTRAL, NF2 use NEUROFIBROMATOSIS, CENTRAL, NF-2 use NEUROMA, ACOUSTIC 1989-1991; NEUROMA, ACOUSTIC, BILATERAL use NEUROMA, ACOUSTIC 1989-91", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016518"}, {"RECTYPE": "D", "MH": "Hospitals, Religious", "DE": "HOSP RELIGIOUS", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Religious Hospitals|T093|NON|EQV|NLM (1992)|910102|RELIGIOUS HOSP|abcdefv", "ENTRY": "Religious Hospital", "MN": "N02.278.421.481.600", "MH_TH": "NLM (1992)", "ST": "T093", "AN": "coord IM with specific religion or religious group (NIM) or with special hosp (e.g., HOSPITALS, CHRONIC DISEASE) or med specialty (IM); specify geog", "PI": "Hospitals, Voluntary (1985-1990)", "MS": "Private hospitals that are owned or sponsored by religious organizations.", "OL": "use HOSPITALS, PRIVATE to search HOSPITALS, RELIGIOUS 1991", "PM": "92; was see HOSPITALS, PRIVATE 1991", "HN": "92; was see HOSPITALS, PRIVATE 1991", "MR": "19991103", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016519"}, {"RECTYPE": "D", "MH": "Entrepreneurship", "AQ": "CL EC ES HI LJ OG SN ST TD", "MN": "N04.452.610.250", "MH_TH": "NLM (1992)", "ST": "T055", "PI": "Organizational Innovation (1985-1991)", "MS": "The organization, management, and assumption of risks of a business or enterprise, usually implying an element of change or challenge and a new opportunity.", "PM": "92", "HN": "92", "MR": "20000622", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016520"}, {"RECTYPE": "D", "MH": "Electrophoresis, Gel, Pulsed-Field", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Gel Electrophoresis, Pulsed-Field|T059|NON|EQV|NLM (1992)|900906|abcdef", "ENTRY": "Pulsed Field Gel Electrophoresis", "MN": "E05.301.300.220", "MH_TH": "NLM (1992)", "ST": "T059", "PI": "Electrophoresis (1986-1991)", "MS": "Gel electrophoresis in which the direction of the electric field is changed periodically. This technique is similar to other electrophoretic methods normally used to separate double-stranded DNA molecules ranging in size up to tens of thousands of base-pairs. However, by alternating the electric field direction one is able to separate DNA molecules up to several million base-pairs in length.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016521"}, {"RECTYPE": "D", "MH": "Oncology Service, Hospital", "DE": "ONCOL SERV HOSP", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Cancer Care Units|T093|NON|NRW|NLM (1992)|910208|abcdef", "ENTRY": "Units, Cancer Care", "MN": "N04.452.442.452.422.513", "MH_TH": "NLM (1992)", "ST": "T093", "MS": "The hospital department responsible for the administration and provision of diagnostic and therapeutic services for the cancer patient.", "OL": "use HOSPITAL UNITS to search CANCER CARE UNITS 1986-91", "PM": "92; CANCER CARE UNITS was see HOSPITAL UNITS 1986-91", "HN": "92; CANCER CARE UNITS was see HOSPITAL UNITS 1986-91", "MR": "20190709", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016522"}, {"RECTYPE": "D", "MH": "Foot Ulcer", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Plantar Ulcer|T047|NON|NRW|NLM (1992)|900907|abcdef", "ENTRY": "Ulcers, Plantar", "MN": "C17.800.893.592.450", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "DIABETIC FOOT is also available", "PI": "Skin Ulcer (1966-1991)", "MS": "Lesion on the surface of the skin of the foot, usually accompanied by inflammation. The lesion may become infected or necrotic and is frequently associated with diabetes or leprosy.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016523"}, {"RECTYPE": "D", "MH": "Parental Leave", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Paternity Leave|T064|NON|NRW|NLM (1992)|910103|abcdef", "ENTRY": "Leave, Paternity", "MN": "N04.452.677.800.162.500", "MH_TH": "NLM (1992)", "ST": "T064", "AN": "prenatal & postnatal leave, leave for illness of a child or leave for adoption procedures; do not confuse with FAMILY LEAVE: see MeSH definition", "PI": "Salaries and Fringe Benefits (1981-1990)", "MS": "The authorized absence from work of either parent prior to and after the birth of their child. It includes also absence because of the illness of a child or at the time of the adoption of a child. It does not include leave for care of siblings, parents, or other family members: for this FAMILY LEAVE is available.", "PM": "92", "HN": "92", "MR": "19940505", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016524"}, {"RECTYPE": "D", "MH": "Antigenic Modulation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Modulations, Antigenic", "MN": "G12.122.140", "MH_TH": "NLM (1992)", "ST": "T044", "PI": "Antigens, Surface/immunology (1979-1988)", "MS": "Loss of detectable antigen from the surface of a cell after incubation with antibodies. This is one method in which some tumors escape detection by the immune system. Antigenic modulation of target antigens also reduces the therapeutic effectiveness of treatment by monoclonal antibodies.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016525"}, {"RECTYPE": "D", "MH": "Workload", "AQ": "CL EC LJ PX SN ST", "PRINT ENTRY": "Staff Workload|T081|NON|NRW|NLM (1992)|900907|abcdef", "ENTRY": "Workloads, Staff", "MN": "N04.452.677.650.500", "MH_TH": "NLM (1992)", "ST": "T081", "PI": "Task Performance and Analysis (1971-1991)", "MS": "The total amount of work to be performed by an individual, a department, or other group of workers in a period of time.", "PM": "92", "HN": "92", "MR": "20170224", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016526"}, {"RECTYPE": "D", "MH": "Drug Costs", "AQ": "CL ES HI LJ SN ST TD", "ENTRY": "Drug Cost", "MN": "N05.300.375.300", "MH_TH": "NLM (1992)", "ST": "T081", "AN": "costs to a health care facility or organiz: do not confuse with FEES, PHARMACEUTICAL or PRESCRIPTION FEES which are costs to the patient", "PI": "Fees, Pharmaceutical (1968-1977)", "MS": "The amount that a health care institution or organization pays for its drugs. It is one component of the final price that is charged to the consumer (FEES, PHARMACEUTICAL or PRESCRIPTION FEES).", "PM": "92", "HN": "92", "MR": "20180629", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016527"}, {"RECTYPE": "D", "MH": "Postanesthesia Nursing", "DE": "POSTANESTHESIA NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Recovery Room Nursing|T058|T091|NON|EQV|NLM (1992)|910208|RECOVERY ROOM NURS|abbcdefv", "ENTRY": "Post Surgical Nursing", "MN": "N02.421.533.710.650", "MH_TH": "NLM (1992)", "ST": "T091", "PI": "Surgical Nursing (1975-1991)", "MS": "The specialty or practice of nursing in the care of patients in the recovery room following surgery and/or anesthesia.", "OL": "use POSTANESTHESIA NURSING to search POST-ANESTHESIA NURSING 1992", "PM": "93; was POST-ANESTHESIA NURSING 1992", "HN": "93; was POST-ANESTHESIA NURSING 1992", "MR": "20150629", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016528"}, {"RECTYPE": "D", "MH": "Emergency Nursing", "DE": "EMERGENCY NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Emergency Room|T058|T091|NON|EQV|NLM (1992)|910102|NURS EMERGENCY ROOM|abbcdefv", "MN": "N02.421.533.200", "MH_TH": "NLM (1992)", "ST": "T091", "PI": "Specialties, Nursing (1973-1991)", "MS": "The specialty or practice of nursing in the care of patients admitted to the emergency department.", "PM": "92", "HN": "92", "MR": "20150629", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016529"}, {"RECTYPE": "D", "MH": "Orthopedic Nursing", "DE": "ORTHOPEDIC NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Orthopedic|T058|T091|NON|EQV|NLM (1992)|900911|NURS ORTHOPEDIC|abbcdefv", "MN": "N02.421.533.635", "MH_TH": "NLM (1992)", "ST": "T091", "PI": "Specialties, Nursing (1972-1991)", "MS": "The specialty or practice of nursing in the care of the orthopedic patient.", "PM": "92", "HN": "92", "MR": "20150629", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016530"}, {"RECTYPE": "D", "MH": "Mucopolysaccharidosis II", "DE": "MPS II", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sulfoiduronate Sulfatase Deficiency|T047|NON|REL|NLM (2010)|ORD (2010)|090608|abcdeef", "ENTRY": "Syndrome, Hunter's", "MN": "C18.452.648.595.600.645", "FX": "Mucopolysaccharidosis I", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Mucopolysaccharidosis I (1966-1991)", "MS": "Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15.", "PM": "1992; for MUCOPOLYSACCHARIDOSIS 2 and HUNTER'S SYNDROME see LIPOCHONDRODYSTROPHY 1976-1991", "HN": "1992; for MUCOPOLYSACCHARIDOSIS 2 and HUNTER'S SYNDROME use LIPOCHONDRODYSTROPHY 1976-1991", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016532"}, {"RECTYPE": "D", "MH": "Mycological Typing Techniques", "DE": "MYCOL TYPING TECHNIQUES", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Typing, Fungal|T059|NON|BRD|NLM (1992)|901119|abcdef", "ENTRY": "Typing Techniques, Fungal", "MN": "E05.200.875.610", "MH_TH": "NLM (1992)", "ST": "T059", "AN": "usually NIM; coordinate with fungus /class ", "PI": "specific fungus/classification (1978-1991)", "MS": "Procedures for identifying types and strains of fungi.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016533"}, {"RECTYPE": "D", "MH": "Cardiac Output, High", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "High Cardiac Output|T033|NON|EQV|NLM (1992)|900911|abcdef", "ENTRY": "High Cardiac Outputs", "MN": "C23.888.176", "MH_TH": "NLM (1992)", "ST": "T033", "AN": "note category: do not confuse with CARDIAC OUTPUT, a physiological concept", "PI": "Cardiac Output (1967-1991)", "MS": "A state of elevated cardiac output due to conditions of either increased hemodynamic demand or reduced cardiac oxygen output. These conditions may include ANEMIA; ARTERIOVENOUS FISTULA; THYROTOXICOSIS; PREGNANCY; EXERCISE; FEVER; and HYPOXIA. In time, compensatory changes of the heart can lead to pathological form of high cardiac output and eventual HEART FAILURE.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20160712", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016534"}, {"RECTYPE": "D", "MH": "Bronchial Hyperreactivity", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperreactivity, Bronchial", "MN": "C08.127.210", "FX": "Asthma", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "note category; if present in asthma, coord IM with ASTHMA /physiopathol (IM)", "PI": "Respiratory Hypersensitivity (1970-1991)", "MS": "Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016535"}, {"RECTYPE": "D", "MH": "Competitive Medical Plans", "DE": "COMPETITIVE MED PLANS", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Plans, Competitive Medical", "MN": "N04.590.374.410.175", "FX": "Preferred Provider Organizations", "MH_TH": "NLM (1992)", "ST": "T058", "PI": "Health Maintenance Organizations (1984-1991)", "MS": "Alternative health care delivery mechanisms, such as PREFERRED PROVIDER ORGANIZATIONS or other health insurance services or prepaid plans (other than HEALTH MAINTENANCE ORGANIZATIONS), that meet Medicare qualifications for a risk-sharing contract. (From Facts on File Dictionary of Health Care Management, 1988)", "PM": "92", "HN": "92", "MR": "19991103", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016536"}, {"RECTYPE": "D", "MH": "Gangliosidosis, GM1", "DS": "GANGLIOSIDOSIS GM 01", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "G(M1) Gangliosidosis|T047|NON|EQV|NLM (1992)|901018|GM GANGLIOSIDOSIS 01|abcdefs", "ENTRY": "Type III GM1-Gangliosidosis", "MN": "C18.452.648.595.554.825.300.400", "FX": "beta-Galactosidase", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Metabolism, Inborn Errors (1966-1975)", "MS": "An autosomal recessive neurodegenerative disorder caused by the absence or deficiency of BETA-GALACTOSIDASE. It is characterized by intralysosomal accumulation of G(M1) GANGLIOSIDE and oligosaccharides, primarily in neurons of the central nervous system. The infantile form is characterized by MUSCLE HYPOTONIA, poor psychomotor development, HIRSUTISM, hepatosplenomegaly, and facial abnormalities. The juvenile form features HYPERACUSIS; SEIZURES; and psychomotor retardation. The adult form features progressive DEMENTIA; ATAXIA; and MUSCLE SPASTICITY. (From Menkes, Textbook of Child Neurology, 5th ed, pp96-7)", "PM": "2007; see GANGIOSIDOSIS GM1 2000-2006, see GANGLIOSIDOSIS G(M1) 1992-1999", "HN": "2007(1992)", "CATSH": "CAT LIST", "MR": "20210701", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016537"}, {"RECTYPE": "D", "MH": "Mucopolysaccharidosis VII", "DE": "MPS VII", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sly Syndrome|T047|EPO|EQV|GHR (2014)|NLM (1992)|OMIM (2013)|900913|abcdeeef", "ENTRY": "beta-Glucuronidase Deficiencies", "MN": "C18.452.648.595.600.675", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Mucopolysaccharidoses (1974-1991)", "MS": "Mucopolysaccharidosis characterized by excessive dermatan and heparan sulfates in the urine and Hurler-like features. It is caused by a deficiency of beta-glucuronidase.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016538"}, {"RECTYPE": "D", "MH": "Reed-Sternberg Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Sternberg Reed Cells", "MN": "A11.828", "FX": "Hodgkin Disease", "MH_TH": "NLM (1992)", "ST": "T025", "PI": "Hodgkin's Disease/pathology (1966-1991)", "MS": "Large cells, usually multinucleate, whose presence is a common histologic characteristic of classical HODGKIN DISEASE.", "PM": "92", "HN": "92", "MR": "20070709", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016539"}, {"RECTYPE": "D", "MH": "Smoking Cessation", "AQ": "EC EH HI LJ MT PX SN", "ENTRY": "Up Smoking, Giving", "MN": "F01.145.488.732", "MH_TH": "NLM (1992)", "ST": "T055", "AN": "TOBACCO USE CESSATION is also available", "PI": "Smoking/therapy (1972-1991)", "MS": "Discontinuing the habit of SMOKING.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20170522", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016540"}, {"RECTYPE": "D", "MH": "Chief Executive Officers, Hospital", "DE": "CHIEF EXECUTIVE OFFICERS HOSP", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Hospital Chief Executive Officers|T097|NON|EQV|NLM (1992)|910102|HOSP CHIEF EXECUTIVE OFFICERS|abcdefv", "ENTRY": "Hospital Chief Executive Officer|T097|NON|EQV|NLM (1992)|900920|HOSP CHIEF EXECUTIVE OFFICER|abcdefv", "MN": "N02.360.740.380.100", "MH_TH": "NLM (1992)", "ST": "T097", "PI": "Hospital Administrators (1975-1991)", "MS": "Individuals who have the formal authority to manage a hospital, including its programs and services, in accordance with the goals and objectives established by a governing body (GOVERNING BOARD).", "PM": "92", "HN": "92", "MR": "20180629", "DA": "19910613", "DC": "1", "DX": "19920101", "UI": "D016542"}, {"RECTYPE": "D", "MH": "Central Nervous System Neoplasms", "DE": "CNS NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Primary Central Nervous System Neoplasm|T191|NON|NRW|NLM (2021)|191120|abcdef", "ENTRY": "Neoplasms, CNS", "MN": "C10.551.240", "MH_TH": "NLM (1992)", "ST": "T191", "AN": "general or unspecified; prefer specifics; coordinate with histological type of neoplasm", "PI": "Spinal Cord Neoplasms (1966-1991)", "MS": "Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016543"}, {"RECTYPE": "D", "MH": "Patient Simulation", "ENTRY": "Simulations, Patient", "MN": "I02.903.847.500", "MH_TH": "NLM (1992)", "ST": "T065", "MS": "The use of persons coached to feign symptoms or conditions of real diseases in a life-like manner in order to teach or evaluate medical personnel.", "PM": "92", "HN": "92", "MR": "20141016", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016544"}, {"RECTYPE": "D", "MH": "Choroid Plexus Neoplasms", "DE": "CHOROID PLEXUS NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Choroid Plexus Tumors|T191|NON|EQV|NLM (2000)|991105|abcdef", "ENTRY": "Neoplasm, Choroid Plexus", "MN": "C10.551.240.250.200.200", "MH_TH": "NLM (1992)", "ST": "T191", "AN": "in the brain: do not confuse with CHOROID NEOPLASMS (in the eye); coord IM with histol type of neopl (IM)", "PI": "Choroid Plexus (1966-1991)", "MS": "Benign or malignant tumors which arise from the choroid plexus of the ventricles of the brain. Papillomas (see PAPILLOMA, CHOROID PLEXUS) and carcinomas are the most common histologic subtypes, and tend to seed throughout the ventricular and subarachnoid spaces. Clinical features include headaches, ataxia and alterations of consciousness, primarily resulting from associated HYDROCEPHALUS. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2072; J Neurosurg 1998 Mar;88(3):521-8)", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "19991208", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016545"}, {"RECTYPE": "D", "MH": "Kinesins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Kinesin Superfamily|T116|T126|NON|EQV|NLM (2022)|210603|abbcdef", "ENTRY": "Superfamily, Kinesin", "MN": "D12.776.631.560.450", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "EC 3.6.4.4", "AN": "a microtubule-associated protein", "PI": "Nerve Tissue Proteins (1966-1991)", "MS": "A family of microtubule-associated mechanical adenosine triphosphatases, that uses the energy of ATP hydrolysis to move organelles along microtubules including mitosis, meiosis, and axonal transport.", "OL": "use KINESIN (NM) to search KINESIN 1985-91", "PM": "92; KINESIN was indexed under ADENOSINE TRIPHOSPHATASE 1985-91 & under NERVE TISSUE PROTEINS 1985-89", "HN": "92; was KINESIN (NM) 1985-91", "MR": "20210629", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016547"}, {"RECTYPE": "D", "MH": "Prosencephalon", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Forebrain|T023|NON|EQV|NLM (1992)|900919|abcdef", "ENTRY": "Forebrains", "MN": "A08.186.211.200", "MH_TH": "NLM (1992)", "ST": "T023", "PI": "Telencephalon (1966-1991)", "MS": "The anterior of the three primitive cerebral vesicles of the embryonic brain arising from the NEURAL TUBE. It subdivides to form DIENCEPHALON and TELENCEPHALON. (Stedmans Medical Dictionary, 27th ed)", "PM": "92", "HN": "92", "MR": "20180701", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016548"}, {"RECTYPE": "D", "MH": "United States Indian Health Service", "DE": "IHS", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Indian Health Service (U.S.)|T093|NAM|EQV|NLM (1992)|910208|INDIAN HEALTH SERV|abcdefv", "ENTRY": "Indian Health Services", "MN": "N03.540.348.500.500.600.650.825", "MH_TH": "NLM (1992)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.; CATALOGER: Use NAF entry", "PI": "United States Public Health Service (1975-1991)", "MS": "A division of the UNITED STATES PUBLIC HEALTH SERVICE that is responsible for the public health and the provision of medical services to NATIVE AMERICANS in the United States, primarily those residing on reservation lands.", "PM": "92", "HN": "92", "MR": "20150629", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016549"}, {"RECTYPE": "D", "MH": "Birthing Centers", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Birthing Centers, Free-Standing|T073|T093|NON|NRW|NLM (1992)|910102|abbcdef", "ENTRY": "Free-Standing Birthing Centers", "MN": "N02.278.080", "MH_TH": "NLM (1992)", "ST": "T093", "AN": "note entry term BIRTHING CENTERS, FREE-STANDING: do not confuse with BIRTHING CENTERS, HOSPITAL see DELIVERY ROOMS; check also tags PREGNANCY, and INFANT, NEWBORN", "MS": "Free-standing facilities that provide prenatal, childbirth, and postnatal care and usually incorporate family-centered maternity care concepts and practices.", "PM": "92", "HN": "92", "MR": "19920325", "DA": "19910208", "DC": "1", "DX": "19920101", "UI": "D016550"}, {"RECTYPE": "D", "MH": "Ergometry", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Ergometries", "MN": "E05.333", "FX": "Physical Exertion", "MH_TH": "NLM (1992)", "ST": "T058", "PI": "Exertion (1966-1991)", "MS": "Any method of measuring the amount of work done by an organism, usually during PHYSICAL EXERTION. Ergometry also includes measures of power. Some instruments used in these determinations include the hand crank and the bicycle ergometer.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20080709", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016552"}, {"RECTYPE": "D", "MH": "Purpura, Thrombocytopenic, Idiopathic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Werlhof's Disease|T047|EPO|EQV|NLM (1992)|901016|WERLHOFS DIS|abcdefv", "ENTRY": "Werlhofs Disease", "MN": "C23.888.885.687.687.600", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Purpura, Thrombocytopenic (1966-1991)", "MS": "Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.", "PM": "1992; for WERLHOF'S DISEASE see PURPURA, THROMBOCYTOPENIC 1975-1991", "HN": "1992; for WERLHOF'S DISEASE use PURPURA, THROMBOCYTOPENIC 1975-1991", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016553"}, {"RECTYPE": "D", "MH": "Matched-Pair Analysis", "DE": "MATCHED PAIR ANAL", "ENTRY": "Paired Comparison", "MN": "N06.850.520.830.475", "MH_TH": "NLM (1992)", "ST": "T081", "AN": "usually NIM; coordinate with specific disease or other concept + matched parameter (e.g. age, sex, physiologic state)", "MS": "A type of analysis in which subjects in a study group and a comparison group are made comparable with respect to extraneous factors by individually pairing study subjects with the comparison group subjects (e.g., age-matched controls).", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D016555"}, {"RECTYPE": "D", "MH": "Crown Lengthening", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Lengthening, Crown", "MN": "E06.658.578.099", "FX": "Orthodontic Extrusion", "MH_TH": "NLM (1992)", "ST": "T061", "MS": "Technique combining controlled eruptive TOOTH MOVEMENT TECHNIQUES and incision of the supracrestal gingival attachment to allow for proper restoration of a destroyed or damaged crown of a tooth. Controlled eruption of the tooth is obtained using ORTHODONTIC APPLIANCES. During this eruptive phase, repeated incisions are made at the junctional epithelium of the sulcus and the supracrestal connective tissue to prevent coronal displacement of the gingiva and of the attachment apparatus.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20230705", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016556"}, {"RECTYPE": "D", "MH": "Guided Tissue Regeneration, Periodontal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Regeneration, Periodontal Guided Tissue|T061|NON|EQV|NLM (2005)|040210|abcdef", "MN": "E06.721.485", "MH_TH": "NLM (2005)", "ST": "T061", "PI": "Regeneration (1986-1991)", "MS": "Techniques for enhancing and directing cell growth to repopulate specific parts of the PERIODONTIUM that have been damaged by PERIODONTAL DISEASES; TOOTH DISEASES; or TRAUMA, or to correct TOOTH ABNORMALITIES. Repopulation and repair is achieved by guiding the progenitor cells to reproduce in the desired location by blocking contact with surrounding tissue by use of membranes composed of synthetic or natural material that may include growth inducing factors as well.", "PM": "2005; see GUIDED TISSUE REGENERATION 1992-2004", "HN": "2005(1992)", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016557"}, {"RECTYPE": "D", "MH": "Hemostasis, Endoscopic", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Endoscopic Hemostasis|T061|NON|EQV|NLM (1992)|900921|abcdef", "ENTRY": "Hemostases, Endoscopic", "MN": "E02.520.425", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "coordinate with disease /ther, not /surg", "PI": "Hemostatic Techniques (1976-1991)", "MS": "Control of bleeding performed through the channel of the endoscope. Techniques include use of lasers, heater probes, bipolar electrocoagulation, and local injection. Endoscopic hemostasis is commonly used to treat bleeding esophageal and gastrointestinal varices and ulcers.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016558"}, {"RECTYPE": "D", "MH": "Tacrolimus", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tacrolimus, Anhydrous", "MN": "D02.540.505.810", "PA": "Immunosuppressive Agents", "MH_TH": "USAN (1992)", "ST": "T121", "N1": "15,19-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-(2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl)-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-, monohydrate, (3S-(3R*(E(1S*,3S*,4S*)),4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*))-", "RN": "WM0HAQ4WNM", "RR": "Y5L2157C4J", "PI": "Immunosuppressive Agents (1987-1991)", "MS": "A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro.", "OL": "use TACROLIMUS (NM) to search FK-506 1987-91", "PM": "96; was FK-506 1992-95; FK-506 was indexed under ANTIBIOTICS, MACROLIDE 1989-91 & PYRIDINES 1987-89", "HN": "96; was FK-506 1992-95, was FK 506 (NM) 1987-91", "MR": "20160701", "DA": "19910424", "DC": "1", "DX": "19920101", "UI": "D016559"}, {"RECTYPE": "D", "MH": "Parenteral Nutrition, Home Total", "DE": "HOME TPN", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Total Parenteral Nutrition, Home|T061|NON|EQV|NLM (1992)|901016|abcdef", "ENTRY": "Home Parenteral Nutrition, Total|T061|NON|EQV|NLM (1992)|901128|abcdef", "MN": "N02.421.143.524.650.565", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "coordinate with disease /ther, not disease /diet ther ", "PI": "Parenteral Nutrition, Total (1975-1991)", "MS": "The at-home administering of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously or by some other non-alimentary route.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016562"}, {"RECTYPE": "D", "MH": "Filoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Filoviruses", "MN": "B04.820.480.937.300", "MH_TH": "NLM (1992)", "ST": "T005", "RN": "txid11266", "PI": "Rhabdoviridae (1987-1991)", "MS": "A family of RNA viruses, of the order MONONEGAVIRALES, containing filamentous virions. Although they resemble RHABDOVIRIDAE in possessing helical nucleocapsids, Filoviridae differ in the length and degree of branching in their virions. There are two genera: EBOLAVIRUS and MARBURGVIRUS.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016563"}, {"RECTYPE": "D", "MH": "Amyloid beta-Protein Precursor", "DE": "ABPP", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Amyloid Protein Precursor|T116|T123|NON|EQV|NLM (1992)|901207|abbcdef", "ENTRY": "beta-Protein Precursor, Amyloid", "MN": "D12.776.815.468.500", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "PI": "Protein Precursors (1988-1991)", "MS": "A single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES.", "OL": "use AMYLOID BETA-PROTEIN PRECURSOR (NM) to search AMYLOID BETA-PROTEIN PRECURSOR 1988-91 & AMYLOID A4 PROTEIN PRECURSOR 1987-94", "PM": "92; AMYLOID BETA-PROTEIN PRECURSOR was indexed under AMYLOID BETA-PROTEIN 1990-91 and AMYLOID & PROTEIN PRECURSORS 1988-91; AMYLOID A4 PROTEIN PRECURSOR was indexed under AMYLOID BETA-PROTEIN PRECURSOR 1993-94, AMYLOID BETA-PROTEIN 1991-92, PROTEIN PRECURSORS 1987-92, & AMYLOID 1987-90", "HN": "92; was AMYLOID BETA PROTEIN PRECURSOR (NM) 1988-91; AMYLOID A4 PROTEIN PRECURSOR was NM 1987-94", "MR": "20220712", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016564"}, {"RECTYPE": "D", "MH": "Cheirogaleidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Phaner|T015|NON|NRW|NLM (1992)|901001|abcdef", "ENTRY": "Mouse Lemurs", "MN": "B01.050.150.900.649.313.988.700.200", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid30615", "RR": "txid9459", "AN": "note entry terms LEMUR, DWARF and LEMUR, MOUSE: the genus LEMUR is also available", "PI": "Strepsirhini (1976-1991)", "MS": "A family of the order PRIMATES, suborder Strepsirhini (PROSIMII), containing five genera. All inhabitants of Madagascar, the genera are: Allocebus, Cheirogaleus (dwarf lemurs), Microcebus (mouse lemurs), Mirza, and Phaner.", "OL": "use LEMURIDAE to search CHEIROGALEUS; LEMUR, DWARF; LEMUR, MOUSE and MICROCEBUS 1981-91", "PM": "92; CHEIROGALEUS; LEMUR, DWARF; LEMUR, MOUSE and MICROCEBUS were see LEMURIDAE 1981-91", "HN": "92; CHEIROGALEUS; LEMUR, DWARF; LEMUR, MOUSE and MICROCEBUS were see LEMURIDAE 1981-91", "MR": "20200813", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016565"}, {"RECTYPE": "D", "MH": "Organoselenium Compounds", "DE": "ORGANOSELENIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Organoselenium", "MN": "D02.731", "MH_TH": "NLM (1992)", "ST": "T109", "RN": "0", "PI": "Selenium (1966-1991)", "MS": "Organic compounds which contain selenium as an integral part of the molecule.", "PM": "92", "HN": "92", "MR": "20190701", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016566"}, {"RECTYPE": "D", "MH": "Nizatidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "LY139037", "MN": "D03.383.129.708.500", "PA": "Histamine H2 Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1,1-Ethenediamine, N-(2-(((2-((dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-", "RN": "P41PML4GHR", "RR": "76963-41-2 (Nizatidine)", "PI": "Thiazoles (1966-1991)", "MS": "A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers.", "OL": "use NIZATIDINE (NM) to search NIZATIDINE 1985-91", "PM": "92; NIZATIDINE was indexed under THIAZOLES 1985-91", "HN": "92; was NIZATIDINE (NM) 1985-91", "MR": "20160531", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016567"}, {"RECTYPE": "D", "MH": "Drugs, Generic", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Generic Drugs|T121|NON|EQV|NLM (1998)|961106|abcdef", "ENTRY": "Nonproprietary Drugs", "MN": "D26.360", "MH_TH": "NLM (1992)", "ST": "T121", "RN": "0", "AN": "coordinate with specific drug if relevant", "PI": "Drugs (1966-1991)", "MS": "Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.", "PM": "92", "HN": "92", "MR": "20200527", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016568"}, {"RECTYPE": "D", "MH": "Blepharophimosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Blepharophimoses", "MN": "C16.131.384.190", "MH_TH": "NLM (1992)", "ST": "T019", "AN": "eyelid abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Eyelids/abnormalities (1966-1991)", "MS": "The abnormal narrowness of the palpebral fissure in the horizontal direction caused by the lateral displacement of the medial canthi of the eyelids. (Dorland, 27th ed)", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016569"}, {"RECTYPE": "D", "MH": "Bruch Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Lamina Basalis Choroideae|T024|NON|EQV|NLM (1992)|901003|abcdef", "ENTRY": "Complexus Basali", "MN": "A10.615.179.250", "MH_TH": "NLM (1992)", "ST": "T024", "PI": "Membranes (1972-1991)", "MS": "The inner layer of CHOROID, also called the lamina basalis choroideae, located adjacent to the RETINAL PIGMENT EPITHELIUM; (RPE) of the EYE. It is a membrane composed of the basement membranes of the choriocapillaris ENDOTHELIUM and that of the RPE. The membrane stops at the OPTIC NERVE, as does the RPE.", "PM": "92", "HN": "92", "MR": "20230426", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016570"}, {"RECTYPE": "D", "MH": "Neural Networks, Computer", "PRINT ENTRY": "Perceptrons|T066|T170|NON|EQV|NLM (1992)|901009|abbcdef", "ENTRY": "Perceptron", "MN": "L01.224.050.375.605", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "do not confuse with NEURAL NETWORKS (ANATOMIC) see NERVE NET", "PI": "Image Processing, Computer-Assisted (1990-1991)", "MS": "A computer architecture, implementable in either hardware or software, modeled after biological neural networks. Like the biological system in which the processing capability is a result of the interconnection strengths between arrays of nonlinear processing nodes, computerized neural networks, often called perceptrons or multilayer connectionist models, consist of neuron-like units. A homogeneous group of units makes up a layer. These networks are good at pattern recognition. They are adaptive, performing tasks by example, and thus are better for decision-making than are linear learning machines or cluster analysis. They do not require explicit programming.", "PM": "2020; was NEURAL NETWORKS (COMPUTER) 1992-2019", "HN": "2020 (1992); was NEURAL NETWORKS (COMPUTER) 1992-2019", "MR": "20190118", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016571"}, {"RECTYPE": "D", "MH": "Cyclosporine", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclosporin A|T116|T121|NON|EQV|FDA SRS (2014)|NLM (1992)|901004|abbcdeef", "ENTRY": "OL 27400", "MN": "D12.644.641.235.300", "PA": "Immunosuppressive Agents", "EC": "analogs & derivatives:Cyclosporins", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Cyclosporin A", "RN": "83HN0GTJ6D", "RR": "59865-13-3 (Cyclosporine)", "AN": "a specific drug: do not confuse with CYCLOSPORINS", "PI": "Peptides, Cyclic (1971-1981)", "MS": "A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).", "PM": "1992(1982); for CYCLOSPORIN A see CYCLOSPORINS 1982-1991", "HN": "1992(1982)", "MR": "20190701", "DA": "19910108", "DC": "1", "DX": "19920101", "UI": "D016572"}, {"RECTYPE": "D", "MH": "Agrochemicals", "DE": "AGROCHEM", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Agrochemical|T120|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Chemical, Agricultural", "MN": "D27.720.031", "FX": "Pesticides", "MH_TH": "NLM (1992)", "ST": "T120", "RN": "0", "MS": "Chemicals used in agriculture. These include pesticides, fumigants, fertilizers, plant hormones, steroids, antibiotics, mycotoxins, etc.", "PM": "92", "HN": "92", "MR": "20200527", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016573"}, {"RECTYPE": "D", "MH": "Seasonal Affective Disorder", "DE": "SAD", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Winter Depression|T048|NON|NRW|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Seasonal Mood Disorders", "MN": "F03.600.300.775", "MH_TH": "OMIM (2013)", "ST": "T048", "PI": "Seasons (1984-1991)", "MS": "A syndrome characterized by depressions that recur annually at the same time each year, usually during the winter months. Other symptoms include anxiety, irritability, decreased energy, increased appetite (carbohydrate cravings), increased duration of sleep, and weight gain. SAD (seasonal affective disorder) can be treated by daily exposure to bright artificial lights (PHOTOTHERAPY), during the season of recurrence.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016574"}, {"RECTYPE": "D", "MH": "Hidradenitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neutrophilic Eccrine Hidradenitis|T047|NON|REL|NLM (1993)|920407|abcdef", "ENTRY": "Neutrophilic Eccrine Hidradenitides", "MN": "C17.800.946.315", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "inflamm of a sweat gland", "PI": "Sweat Glands (1966-1991)", "MS": "The inflammation of a sweat gland (usually of the apocrine type). The condition can be idiopathic or occur as a result of or in association with another underlying condition. Neutrophilic eccrine hidradenitis is a relatively rare variant that has been reported in patients undergoing chemotherapy, usually for non-Hodgkin lymphomas or leukemic conditions.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016575"}, {"RECTYPE": "D", "MH": "Fleroxacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro 236240", "MN": "D03.633.100.810.835.322.186.400", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USAN (1987)", "ST": "T121", "N1": "3-Quinolinecarboxylic acid, 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-", "RN": "N804LDH51K", "RR": "79660-72-3 (Fleroxacin)", "PI": "Quinolines (1966-1986)", "MS": "A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.", "OL": "use FLEROXACIN (NM) to search FLEROXACIN 1986-91", "PM": "92; FLEROXACIN was indexed under QUINOLINES 1986 & under CIPROFLOXACIN/analogs & derivatives 1987-91", "HN": "92; was FLEROXACIN (NM) 1986-91", "MR": "20170524", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016576"}, {"RECTYPE": "D", "MH": "Pancreaticoduodenectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Pancreatoduodenectomy|T061|NON|EQV|NLM (1995)|940318|abcdef", "ENTRY": "Pancreatoduodenectomies", "MN": "E04.210.760", "MH_TH": "NLM (1992)", "ST": "T061", "PI": "Pancreatectomy (1966-1991)", "MS": "The excision of the head of the pancreas and the encircling loop of the duodenum to which it is connected.", "OL": "use PANCREATICODUODENECTOMY to search PANCREATODUODENECTOMY 1992-94", "PM": "95; was PANCREATODUODENECTOMY 1992-94", "HN": "95; was PANCREATODUODENECTOMY 1992-94", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19910103", "DC": "1", "DX": "19920101", "UI": "D016577"}, {"RECTYPE": "D", "MH": "Crack Cocaine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Cocaine, Crack", "MN": "D26.878.250", "MH_TH": "NLM (1992)", "ST": "T131", "RN": "0", "PI": "Cocaine (1986-1991)", "MS": "The purified, alkaloidal, extra-potent form of cocaine. It is smoked (free-based), injected intravenously, and orally ingested. Use of crack results in alterations in function of the cardiovascular system, the autonomic nervous system, the central nervous system, and the gastrointestinal system. The slang term \"crack\" was derived from the crackling sound made upon igniting of this form of cocaine for smoking.", "PM": "92", "HN": "92", "MR": "20210701", "DA": "19910102", "DC": "1", "DX": "19920101", "UI": "D016578"}, {"RECTYPE": "D", "MH": "Leukemia, Feline", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Feline Leukemia|T191|NON|EQV|NLM (1992)|901009|abcdef", "ENTRY": "Leukemias, Feline", "MN": "C22.180.500", "MH_TH": "NLM (1992)", "ST": "T191", "AN": "caused by a retrovirus; don't forget also CATS (NIM) & check tag ANIMALS", "PI": "Leukemia/veterinary (1966-1991)", "MS": "A neoplastic disease of cats frequently associated with feline leukemia virus infection.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016582"}, {"RECTYPE": "D", "MH": "Enzootic Bovine Leukosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Lymphosarcoma, Bovine|T191|NON|NRW|NLM (1992)|901221|abcdef", "ENTRY": "Lymphosarcomas, Bovine", "MN": "C22.196.260", "MH_TH": "NLM (1992)", "ST": "T191", "AN": "a specific dis caused by BOVINE LEUKEMIA VIRUS (see LEUKEMIA VIRUS, BOVINE): do not confuse with the general group BLV INFECTIONS see DELTARETROVIRUS INFECTIONS; don't forget also CATTLE (NIM) & check tag ANIMALS", "PI": "Leukemia/veterinary (1966-1991)", "MS": "A lymphoid neoplastic disease in cattle caused by the bovine leukemia virus. Enzootic bovine leukosis may take the form of lymphosarcoma, malignant lymphoma, or leukemia but the presence of malignant cells in the blood is not a consistent finding.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016583"}, {"RECTYPE": "D", "MH": "Panic Disorder", "DE": "PANIC DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Panic Attacks|T048|NON|NRW|NLM (1992)|901010|abcdef", "ENTRY": "Panic Disorders", "MN": "F03.080.700", "MH_TH": "OMIM (2013)", "ST": "T048", "AN": "note category: do not confuse with PANIC (Cat F1)", "PI": "Panic (1978-1991)", "MS": "A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016584"}, {"RECTYPE": "D", "MH": "Vaginosis, Bacterial", "DE": "VAGINOSIS BACT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Vaginitis, Nonspecific|T047|NON|EQV|NLM (1992)|901010|abcdef", "ENTRY": "Nonspecific Vaginitis", "MN": "C12.100.250.894.906.800", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "coord IM with specific bacterium/infections heading (IM) or specific bacterium (IM) if no precoord bact/infect term exists", "PI": "Vaginitis (1983-1991)", "MS": "Polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli. It remains unclear whether the initial pathogenic event is caused by the growth of anaerobes or a primary decrease in lactobacilli.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016585"}, {"RECTYPE": "D", "MH": "Granular Cell Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Myoblastoma, Granular Cell|T191|NON|EQV|NLM (1994)|930625|abcdef", "ENTRY": "Tumors, Granular Cell", "MN": "C04.557.450.590.350", "MH_TH": "NLM (1992)", "ST": "T191", "AN": "benign or malignant; coordinate with precoordinated organ/neoplasm term; do not confuse with GRANULOSA CELL TUMOR, an ovarian neoplasm", "PI": "Myoblastoma (1966-1991)", "MS": "Unusual tumor affecting any site of the body, but most often encountered in the head and neck. Considerable debate has surrounded the histogenesis of this neoplasm; however, it is considered to be a myoblastoma of, usually, a benign nature. It affects women more often than men. When it develops beneath the epidermis or mucous membrane, it can lead to proliferation of the squamous cells and mimic squamous cell carcinoma.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016586"}, {"RECTYPE": "D", "MH": "Antimutagenic Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Antimutagenic Agent|T120|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Effects, Antimutagenic", "MN": "D27.720.799.042", "FX": "Anticarcinogenic Agents", "MH_TH": "NLM (1992)", "ST": "T120", "RN": "0", "AN": "note entry term ANTIMUTAGENIC EFFECT: use only for the antimutagenic effect of a chemical substance", "PI": "Mutation (1966-1991)", "MS": "Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved.", "PM": "92", "HN": "92", "MR": "20200527", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016587"}, {"RECTYPE": "D", "MH": "Anticarcinogenic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Anticarcinogenic", "MN": "D27.720.799.018", "FX": "Antineoplastic Agents", "MH_TH": "NLM (1992)", "ST": "T121", "RN": "0", "AN": "do not confuse with ANTINEOPLASTIC AGENTS which treat or affect cancer already developed while ANTICARCINOGENIC AGENTS prevent or reduce the development of cancer; note entry term ANTI-CARCINOGENIC EFFECT: use only for the anti-carcinogenic effect of a chemical substance", "MS": "Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved.", "PM": "92", "HN": "92", "MR": "20140625", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016588"}, {"RECTYPE": "D", "MH": "Astemizole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ratiopharm, Astemizol", "MN": "D03.633.100.103.105", "PA": "Histamine H1 Antagonists, Non-Sedating", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Benzimidazol-2-amine, 1-((4-fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl)-4-piperidinyl)-", "RN": "7HU6337315", "RR": "68844-77-9 (Astemizole)", "PI": "Histamine H1 Receptor Blockaders (1966-1991)", "MS": "Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.", "OL": "use ASTEMIZOLE (NM) to search ASTEMIZOLE 1981-91", "PM": "92; ASTEMIZOLE was indexed under BENZIMIDAZOLES 1981-91", "HN": "92; was ASTEMIZOLE (NM) 1981-91", "MR": "20170524", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016589"}, {"RECTYPE": "D", "MH": "Aphidicolin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NSC351140", "MN": "D02.455.849.291.075", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1992)", "ST": "T121", "N1": "9,15-Cyclo-C,18-dinor-14,15-secoandrostane-4,17-dimethanol, 3,17-dihydroxy-4-methyl-, (3alpha,4alpha,5alpha,17alpha)-", "RN": "38966-21-1", "RR": "52645-92-8 ((3-S-(3alpha,4beta,4abeta,6aalpha,8alpha,9alpha,11aalpha,11balpha))-isomer)", "PI": "Diterpenes (1974-1991)", "MS": "An antiviral antibiotic produced by Cephalosporium aphidicola and other fungi. It inhibits the growth of eukaryotic cells and certain animal viruses by selectively inhibiting the cellular replication of DNA polymerase II or the viral-induced DNA polymerases. The drug may be useful for controlling excessive cell proliferation in patients with cancer, psoriasis or other dermatitis with little or no adverse effect upon non-multiplying cells.", "OL": "use APHIDICOLIN (NM) to search APHIDICOLIN 1980-91", "PM": "92; APHIDICOLIN was indexed under DITERPENES 1974-91", "HN": "92; was APHIDICOLIN (NM) 1974-91", "MR": "20000621", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016590"}, {"RECTYPE": "D", "MH": "Histocytological Preparation Techniques", "DE": "HISTOCYTOL PREP TECHNIQUES", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Cytohistological Preparation Techniques|T059|NON|EQV|NLM (1992)|901220|CYTOHISTOL PREP TECHNIQUES|abcdefv", "ENTRY": "Cytohistologic Preparation Technic", "MN": "E05.200.750.600", "FX": "Analytic Sample Preparation Methods", "MH_TH": "NLM (1992)", "ST": "T059", "MS": "Methods of preparing cells or tissues for examination and study of their origin, structure, function, or pathology. The methods include preservation, fixation, sectioning, staining, replica, or other technique to allow for viewing using a microscope.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016591"}, {"RECTYPE": "D", "MH": "Terfenadine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Terfenadin Ratiopharm", "MN": "D03.383.621.855", "PA": "Histamine H1 Antagonists, Non-Sedating", "MH_TH": "USP (19XX)", "ST": "T109", "N1": "1-Piperidinebutanol, alpha-(4-(1,1-dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-", "RN": "7BA5G9Y06Q", "RR": "50679-08-8 (Terfenadine)", "PI": "Piperidines (1966-1991)", "MS": "A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.", "OL": "use TERFENADINE (NM) to search TERFENADINE 1980-91", "PM": "92; TERFENADINE was indexed under BENZHYDRYL COMPOUNDS 1978-91", "HN": "92; was TERFENADINE (NM) 1978-91", "MR": "20170524", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016593"}, {"RECTYPE": "D", "MH": "Misoprostol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SC30249", "MN": "D23.469.700.660.500", "PA": "Oxytocics", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13E)-", "RN": "0E43V0BB57", "RR": "92999-98-9 ((11alpha,13E)-isomer)", "PI": "Anti-Ulcer Agents (1977-1991)", "MS": "A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties.", "OL": "use MISOPROSTOL (NM) to search MISOPROSTOL 1980-91", "PM": "92; MISOPROSTOL was indexed under ALPROSTADIL/analogs & derivatives 1986-91, under PROSTAGLANDINS E, SYNTHETIC 1979-85 & under PROSTAGLANDINS, SYNTHETIC 1977-78", "HN": "92; was MISOPROSTOL (NM) 1977-91", "MR": "20160701", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016595"}, {"RECTYPE": "D", "MH": "Vinculin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Vinculin|T116|T123|NON|REL|NLM (1992)|901224|abbcdef", "ENTRY": "beta Vinculin", "MN": "D12.776.220.990", "MH_TH": "NLM (1992)", "ST": "T123", "N1": "Vinculin (Caenorhabditis elegans clone pRB9.1 protein moiety reduced)", "RN": "125361-02-6", "AN": "a cytoskeletal protein in cell-cell & cell-matrix interactions; /drug eff /ultrastruct permitted", "PI": "Muscle Proteins (1980-1989)", "MS": "A cytoskeletal protein associated with cell-cell and cell-matrix interactions. The amino acid sequence of human vinculin has been determined. The protein consists of 1066 amino acid residues and its gene has been assigned to chromosome 10.", "OL": "use VINCULIN (NM) to search VINCULIN 1980-91", "PM": "92; VINCULIN was indexed under CYTOSKELETAL PROTEINS 1990-91 & under MUSCLE PROTEINS 1980-89", "HN": "92; was VINCULIN (NM) 1980-91", "MR": "20040713", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016596"}, {"RECTYPE": "D", "MH": "Trimetrexate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NSC328564", "MN": "D03.633.100.786.925", "PA": "Folic Acid Antagonists", "MH_TH": "USAN (1981)", "ST": "T121", "N1": "2,4-Quinazolinediamine, 5-methyl-6-(((3,4,5-trimethoxyphenyl)amino)methyl)-", "RN": "UPN4ITI8T4", "RR": "52128-35-5 (Trimetrexate)", "PI": "Quinazolines (1966-1991)", "MS": "A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect.", "OL": "use TRIMETREXATE (NM) to search TRIMETREXATE 1980-91", "PM": "92; TRIMETREXATE was indexed under QUINAZOLINES 1979-91", "HN": "92; was TRIMETREXATE (NM) 1979-91", "MR": "20170524", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016597"}, {"RECTYPE": "D", "MH": "RNA-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ds RNA-Binding Protein|T116|T123|NON|NRW|NLM (2021)|191120|abbcdef", "ENTRY": "ds RNA Binding Protein", "MN": "D12.776.664.962", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "RNA (1966-1991)", "MS": "Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA.", "OL": "use RNA-BINDING PROTEINS (NM) to search RNA-BINDING PROTEINS 1980-91", "PM": "92; RNA-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-91", "HN": "92; was RNA-BINDING PROTEINS (NM) 1980-91", "MR": "20200527", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016601"}, {"RECTYPE": "D", "MH": "Needlestick Injuries", "DE": "NEEDLESTICK INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sharps Injuries|T037|NON|BRD|NLM (2005)|040414|abcdef", "ENTRY": "Sticks, Needle", "MN": "C26.986.950.500", "MH_TH": "NLM (1992)", "ST": "T037", "AN": "IM; coord with organ/inj or precoord inj term (IM)", "PI": "Needles (1978-1991)", "MS": "Penetrating stab wounds caused by needles. They are of special concern to health care workers since such injuries put them at risk for developing infectious disease.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016602"}, {"RECTYPE": "D", "MH": "Eosinophilia-Myalgia Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, L-Tryptophan-Related Eosinophilia-Myalgia", "MN": "C15.378.553.231.335", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Tryptophan/adverse effects (1989-1990)", "MS": "A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93)", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016603"}, {"RECTYPE": "D", "MH": "Aflatoxin B1", "DE": "AFB1", "DS": "AFLATOXIN B01", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aflatoxin B(1)|T109|T131|NON|EQV|NLM (2021)|200128|abbcdef", "ENTRY": "NSC529592", "MN": "D23.946.587.142.075", "PA": "Poisons", "MH_TH": "NLM (1992)", "ST": "T131", "N1": "Cyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-1,11-dione, 2,3,6a,9a-tetrahydro-4-methoxy-, (6aR-cis)-", "RN": "9N2N2Y55MH", "RR": "84415-24-7 (di-HCl(6aR-cis)-isomer)", "AN": "/antag permitted but consider also ANTITOXINS", "PI": "Aflatoxins (1966-1991)", "MS": "A potent hepatotoxic and hepatocarcinogenic mycotoxin produced by the Aspergillus flavus group of fungi. It is also mutagenic, teratogenic, and causes immunosuppression in animals. It is found as a contaminant in peanuts, cottonseed meal, corn, and other grains. The mycotoxin requires epoxidation to aflatoxin B1 2,3-oxide for activation. Microsomal monooxygenases biotransform the toxin to the less toxic metabolites aflatoxin M1 and Q1.", "OL": "use AFLATOXIN B1 (NM) to search AFLATOXIN B1 1979-91", "PM": "92; AFLATOXIN B1 was indexed under AFLATOXINS 1980-91", "HN": "92; was AFLATOXIN B1 (NM) 1980-91", "MR": "20200527", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016604"}, {"RECTYPE": "D", "MH": "Thyroid Nodule", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Thyroid Nodules", "MN": "C19.874.788.800", "FX": "Goiter, Nodular", "MH_TH": "NLM (1992)", "ST": "T191", "PI": "Thyroid Neoplasms (1966-1991)", "MS": "A small circumscribed mass in the THYROID GLAND that can be of neoplastic growth or non-neoplastic abnormality. It lacks a well-defined capsule or glandular architecture. Thyroid nodules are often benign but can be malignant. The growth of nodules can lead to a multinodular goiter (GOITER, NODULAR).", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016606"}, {"RECTYPE": "D", "MH": "Aflatoxin M1", "DE": "AFM1", "DS": "AFLATOXIN M01", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aflatoxin M(1)|T109|T131|NON|EQV|NLM (2021)|200128|abbcdef", "ENTRY": "4 Hydroxyaflatoxin B1", "MN": "D23.946.587.142.100", "PA": "Poisons", "MH_TH": "NLM (1992)", "ST": "T131", "N1": "Cyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-1,11-dione, 2,3,6a,9a-tetrahydro-9a-hydroxy-4-methoxy-, (6aR-cis)-", "RN": "6795-23-9", "RR": "25325-49-9 (cis(+-)-isomer)", "AN": "/antag permitted but consider also ANTITOXINS", "PI": "Aflatoxins (1969-1991)", "MS": "A 4-hydroxylated metabolite of AFLATOXIN B1, one of the MYCOTOXINS from ASPERGILLUS tainted food. It is associated with LIVER damage and cancer resulting from its P450 activation to the epoxide which alkylates DNA. Toxicity depends on the balance of liver enzymes that activate it (CYTOCHROME P-450) and others that detoxify it (GLUTATHIONE S TRANSFERASE) (Pharmac Ther 50.443 1991). Primates & rat are sensitive while mouse and hamster are tolerant (Canc Res 29.236 1969).", "OL": "use AFLATOXIN M1 (NM) to search AFLATOXIN M1 1979-91", "PM": "92; AFLATOXIN M1 was indexed under AFLATOXINS 1980-91", "HN": "92; was AFLATOXIN (NM) 1980-91", "MR": "20200527", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016607"}, {"RECTYPE": "D", "MH": "Talin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, Band 2", "MN": "D12.776.220.985", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "AN": "a cytoplasmic protein; /drug eff /ultrastruct permitted", "PI": "Muscle Proteins (1984-1986)", "MS": "A 235-kDa cytoplasmic protein that is also found in platelets. It has been localized to regions of cell-substrate adhesion. It binds to INTEGRINS; VINCULIN; and ACTINS and appears to participate in generating a transmembrane connection between the extracellular matrix and the cytoskeleton.", "OL": "use TALIN (NM) to search TALIN 1977-91", "PM": "92; TALIN was indexed under CYTOSKELETAL PROTEINS 1987-91, under MUSCLE PROTEINS 1984-86 & under CONTRACTILE PROTEINS 1982-86", "HN": "92; was TALIN (NM) 1984-91", "MR": "20010725", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016608"}, {"RECTYPE": "D", "MH": "Neoplasms, Second Primary", "DE": "NEOPL SECOND PRIMARY", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Treatment-Related Cancer|T191|NON|NRW|NLM (2000)|991103|TREATMENT RELAT CANCER|abcdefv", "ENTRY": "Treatment-Related Neoplasm", "MN": "C04.692", "FX": "Neoplasms, Multiple Primary", "MH_TH": "NLM (1992)", "ST": "T191", "AN": "a 2d or more neopl of same or different histol type at same or different sites: do not confuse with NEOPLASMS, MULTIPLE PRIMARY (see note there); often follows ther (note X refs); IM; coord with each specific histol type (IM) & each precoord organ/neopl term (IM); do not use /compl with specific multiple neopl terms to show multiplicity; Manual 24.4.1.7; differentiate from NEOPLASM METASTASIS (Manual 24.4.1.3+) & NEOPLASM RECURRENCE, LOCAL: Manual 24.4.1.5", "PI": "Neoplasms, Multiple Primary (1966-1991)", "MS": "Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016609"}, {"RECTYPE": "D", "MH": "Tissue Embedding", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Embedding, Tissue", "MN": "E05.200.750.600.760.440", "MH_TH": "NLM (1992)", "ST": "T059", "AN": "embedding of cells or tissue in a supporting medium", "MS": "The technique of placing cells or tissue in a supporting medium so that thin sections can be cut using a microtome. The medium can be paraffin wax (PARAFFIN EMBEDDING) or plastics (PLASTIC EMBEDDING) such as epoxy resins.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180614", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016610"}, {"RECTYPE": "D", "MH": "Paraffin Embedding", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Embedding, Paraffin", "MN": "E05.200.750.600.760.440.610", "MH_TH": "NLM (1992)", "ST": "T059", "PI": "Paraffin (1966-1991)", "MS": "The infiltrating of tissue specimens with paraffin, as a supporting substance, to prepare for sectioning with a microtome.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180614", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016612"}, {"RECTYPE": "D", "MH": "Plastic Embedding", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Embedding, Plastic", "MN": "E05.200.750.600.760.440.640", "MH_TH": "NLM (1992)", "ST": "T059", "AN": "coord IM with embedding material (IM or NIM with no qualif)", "PI": "Plastics (1966-1991)", "MS": "The infiltrating of histological specimens with plastics, including acrylic resins, epoxy resins and polyethylene glycol, for support of the tissues in preparation for sectioning with a microtome.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180614", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016613"}, {"RECTYPE": "D", "MH": "Telomere", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Telomeres|T026|NON|EQV|NLM (2012)|101103|abcdef", "MN": "G05.360.160.845", "MH_TH": "NLM (1992)", "ST": "T026", "PI": "Chromosomes (1976-1991)", "MS": "A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs.", "PM": "92", "HN": "92", "MR": "20110624", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016615"}, {"RECTYPE": "D", "MH": "Cryoultramicrotomy", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Cryosectioning|T059|NON|EQV|NLM (1992)|901029|abcdef", "ENTRY": "Sectioning, Freeze", "MN": "E05.200.750.600.530.160", "MH_TH": "NLM (1992)", "ST": "T059", "PI": "Microtomy (1975-1991)", "MS": "The technique of using a cryostat or freezing microtome, in which the temperature is regulated to -20 degrees Celsius, to cut ultrathin frozen sections for microscopic (usually, electron microscopic) examination.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016616"}, {"RECTYPE": "D", "MH": "Enprostil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RS84135", "MN": "D23.469.700.660.250", "PA": "Anti-Ulcer Agents", "MH_TH": "USAN (1983)", "ST": "T121", "N1": "4,5-Heptadienoic acid, 7-(3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)-, methyl ester, (1alpha,2beta(1E,3R*),3alpha)-", "RN": "J4IP5Z9DAU", "RR": "99631-11-5", "PI": "Prostaglandins E, Synthetic (1978-1991)", "MS": "A synthetic PGE2 analog that has an inhibitory effect on gastric acid secretion, a mucoprotective effect, and a postprandial lowering effect on gastrin. It has been shown to be efficient and safe in the treatment of gastroduodenal ulcers.", "OL": "use ENPROSTIL (NM) to search ENPROSTIL 1985-91", "PM": "92; ENPROSTIL was indexed under PROSTAGLANDINS E, SYNTHETIC 1985-91", "HN": "92; was ENPROSTIL (NM) 1985-91", "MR": "20150608", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016620"}, {"RECTYPE": "D", "MH": "Silver Staining", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Silver Nitrate Staining|T059|NON|NRW|NLM (1992)|901030|abcdef", "ENTRY": "Staining, Silver Nitrate", "MN": "E05.200.750.600.670.780", "MH_TH": "NLM (1992)", "ST": "T059", "AN": "do not coordinate with SILVER NITRATE", "PI": "Staining (1966-1991)", "MS": "The use of silver, usually silver nitrate, as a reagent for producing contrast or coloration in tissue specimens.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016622"}, {"RECTYPE": "D", "MH": "Ion Pumps", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pumps, Ion", "MN": "D12.776.543.585.450", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "specific ion/metabolism (1967-1991)", "MS": "A general class of integral membrane proteins that transport ions across a membrane against an electrochemical gradient.", "PM": "1994; see ION PUMP 1992-1993; for ION PUMP see BIOLOGICAL TRANSPORT, ACTIVE 1991", "HN": "1994(1992);", "MR": "20050630", "DA": "19910613", "DC": "1", "DX": "19920101", "UI": "D016623"}, {"RECTYPE": "D", "MH": "Negative Staining", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Staining, Negative", "MN": "E05.200.750.600.670.520", "MH_TH": "NLM (1992)", "ST": "T059", "PI": "Staining (1966-1991)", "MS": "The technique of washing tissue specimens with a concentrated solution of a heavy metal salt and letting it dry. The specimen will be covered with a very thin layer of the metal salt, being excluded in areas where an adsorbed macromolecule is present. The macromolecules allow electrons from the beam of an electron microscope to pass much more readily than the heavy metal; thus, a reversed or negative image of the molecule is created.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016624"}, {"RECTYPE": "D", "MH": "Shadowing Technique, Histology", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Shadowing, Histology|T059|NON|EQV|NLM (2020)|190118|abcdef", "ENTRY": "Techniques, Shadowing (Histology)", "MN": "E05.200.750.600.670.770", "MH_TH": "NLM (2020)", "ST": "T059", "PI": "Staining (1966-1991)", "MS": "The technique of spraying a tissue specimen with a thin coat of a heavy metal such as platinum. The specimen is sprayed from an oblique angle, which results in the uneven deposition of the coating. The varying thicknesses create a shadow effect and give a three-dimensional appearance to the specimen.", "PM": "2020; was SHADOWING (HISTOLOGY) 1992-2019", "HN": "2020 (1992); was SHADOWING (HISTOLOGY) 1992-2019", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016626"}, {"RECTYPE": "D", "MH": "Oxidopamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "6-OHDA|T109|T121|ABB|EQV|NLM (1992)|901224|OHDA 06|abbcdefs", "ENTRY": "Hydrochloride, Oxidopamine", "MN": "D02.455.426.559.389.657.166.175.342.478.650", "PA": "Sympatholytics", "MH_TH": "USAN (1977)", "ST": "T121", "N1": "1,2,4-Benzenetriol, 5-(2-aminoethyl)-", "RN": "8HW4YBZ748", "RR": "636-00-0 (HBr)", "PI": "Hydroxydopamines (1973-1991)", "MS": "A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.", "OL": "use OXIDOPAMINE (NM) to search 6-HYDROXYDOPAMINE (NM) 1980-91", "PM": "92; 6-HYDROXYDOPAMINE was indexed under HYDROXYDOPAMINES 1982-91 & under HYDROXYDOPAMINE 1981", "HN": "92; was 6-HYDROXYDOPAMINE (NM) 1981-91", "MR": "20180702", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016627"}, {"RECTYPE": "D", "MH": "Replica Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Techniques, Replica", "MN": "E05.200.750.600.620", "MH_TH": "NLM (1992)", "ST": "T059", "PI": "Microscopy, Electron, Scanning (1967-1991)", "MS": "Methods of preparing tissue specimens for visualization using an electron microscope, usually a scanning electron microscope. The methods involve the creation of exact copies of the specimens by making a mold or cast (i.e., replica) of the specimen.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016628"}, {"RECTYPE": "D", "MH": "Esophagectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Esophagectomies", "MN": "E04.210.346", "MH_TH": "NLM (1992)", "ST": "T061", "PI": "Esophagus/surgery (1966-1991)", "MS": "Excision of part (partial) or all (total) of the esophagus. (Dorland, 28th ed)", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016629"}, {"RECTYPE": "D", "MH": "Rioprostil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TR4698", "MN": "D23.469.700.660.750", "PA": "Anti-Ulcer Agents", "MH_TH": "USAN (1983)", "ST": "T121", "N1": "Prost-13-en-9-one, 1,11,16-trihydroxy-16-methyl-, (11alpha,13E)-", "RN": "7JL402PVQR", "RR": "77287-05-9 (Rioprostil)", "PI": "Prostaglandins, Synthetic (1977-1991)", "MS": "A synthetic methylprostaglandin E1 analog that reduces gastric acid secretion and enhances the gastric mucus-bicarbonate barrier. It is effective in the therapy of gastric ulcers and gives significant protection against NSAID-induced gastric mucosal damage. The drug also prevents cyclosporin A-induced damage to endocrine and exocrine pancreatic secretions. It shows a low order of acute toxicity and there is no evidence of embryotoxicity, fetotoxicity, teratogenicity, or mutagenicity in animal studies.", "OL": "use RIOPROSTIL (NM) to search RIOPROSTIL 1985-91", "PM": "92; RIOPROSTIL was indexed under PROSTAGLANDINS E 1985-91", "HN": "92; was RIOPROSTIL (NM) 1985-91", "MR": "20150608", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016630"}, {"RECTYPE": "D", "MH": "Lewy Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Lewy Neurites|T026|EPO|REL|NLM (2020)|190411|abcdef", "ENTRY": "Neurite, Lewy", "MN": "A11.284.420.460", "FX": "Synucleinopathies", "MH_TH": "NLM (1992)", "ST": "T026", "AN": "LEWY BODY DISEASE is also available", "PI": "Cytoplasmic Granules (1966-1991)", "MS": "Intracytoplasmic, eosinophilic, round to elongated inclusions found in vacuoles of injured or fragmented neurons. The presence of Lewy bodies is the histological marker of the degenerative changes in LEWY BODY DISEASE and PARKINSON DISEASE but they may be seen in other neurological conditions. They are typically found in the substantia nigra and locus coeruleus but they are also seen in the basal forebrain, hypothalamic nuclei, and neocortex.", "PM": "92", "HN": "92", "MR": "20200527", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016631"}, {"RECTYPE": "D", "MH": "Apolipoprotein A-I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Apo A-I|T116|T123|ABB|EQV|NLM (1992)|901031|abbcdef", "ENTRY": "Pro Apolipoprotein A I", "MN": "D12.776.521.120.200.100", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins A (1985-1991)", "MS": "The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE.", "PM": "1992; APOLIPOPROTEIN A-I was indexed under APOLIPOPROTEINS A 1985-1991, under APOLIPOPROTEINS 1979-1984 & under APOPROTEINS 1974-1978; PRO-APOLIPOPROTEIN A-I was indexed under APOLIPOPROTEINS A & PROTEIN PRECURSORS 1983-2006; APOLIPOPROTEIN A-I ISOPROTEINS was indexed under APOLIPOPROTEINS A 1980-2006", "HN": "1992 (1974); for PRO-APOLIPOPROTEIN A-I (NM) use APOLIPOPROTEINS A & PROTEIN PRECURSORS 1983-2006; for APOLIPOPROTEIN A-I ISOPROTEINS (NM) use APOLIPOPROTEINS A 1980-2006", "MR": "20060705", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016632"}, {"RECTYPE": "D", "MH": "Apolipoprotein A-II", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Apo A-II|T116|T123|ABB|EQV|NLM (1992)|901101|abbcdef", "ENTRY": "Proapolipoprotein A II", "MN": "D12.776.521.120.200.150", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins A (1985-1991)", "MS": "The second most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. It has a high lipid affinity and is known to displace APOLIPOPROTEIN A-I from HDL particles and generates a stable HDL complex. ApoA-II can modulate the activation of LECITHIN CHOLESTEROL ACYLTRANSFERASE in the presence of APOLIPOPROTEIN A-I, thus affecting HDL metabolism.", "OL": "use APOLIPOPROTEIN A-II (NM) to search APOLIPOPROTEIN A-II 1980-91", "PM": "1992; APOLIPOPROTEIN A-II was indexed under APOLIPOPROTEINS A 1985-1991, under APOLIPOPROTEINS 1978-1984; PRO-APOLIPOPROTEIN A-II was indexed under APOLIPOPROTEINS A & PROTEIN PRECURSORS 1985-2006; APOLIPOPROTEIN A-II ISOPROTEINS was indexed under APOLIPOPROTEINS A 1983-2006", "HN": "1992 (1978); for PRO-APOLIPOPROTEIN A-II (NM) use APOLIPOPROTEINS A & PROTEIN PRECURSORS 1985-2006; for APOLIPOPROTEIN A-II ISOPROTEINS (NM) use APOLIPOPROTEINS A 1983-2006", "MR": "20060705", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016633"}, {"RECTYPE": "D", "MH": "Radiosurgery", "DE": "RADIOSURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Stereotactic Radiosurgery|T061|NON|NRW|NLM (1992)|901101|STEREOTACTIC RADIOSURG|abcdefv", "ENTRY": "Therapy, Stereotactic Radiation", "MN": "E05.873.500", "FX": "Radiotherapy, Conformal", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "do not confuse with COMBINED MODALITY THERAPY using surgery + radiotherapy; coordinate with disease /radiother; gamma knife, CyberKnife & linear accelerator: index RADIOSURGERY /instrum & do not coordinate with GAMMA RAYS or PARTICLE ACCELERATORS unless particularly discussed", "PI": "Stereotaxic Techniques (1971-1991)", "MS": "A radiological stereotactic technique developed for cutting or destroying tissue by high doses of radiation in place of surgical incisions. It was originally developed for neurosurgery on structures in the brain and its use gradually spread to radiation surgery on extracranial structures as well. The usual rigid needles or probes of stereotactic surgery are replaced with beams of ionizing radiation directed toward a target so as to achieve local tissue destruction.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180301", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016634"}, {"RECTYPE": "D", "MH": "Universal Precautions", "AQ": "CL EC HI IS LJ MT SN TD", "PRINT ENTRY": "Precautions, Universal|T061|NON|EQV|NLM (1992)|901101|abcdef", "ENTRY": "Universal Precaution", "MN": "N06.850.780.200.925", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "restrict to \"prudent prev measures\" in contacts with patients having communicable dis; IM; coord IM with specific dis /prev (IM)", "PI": "specific disease/prevention & control (1988-1991)", "MS": "Prudent standard preventive measures to be taken by professional and other health personnel in contact with persons afflicted with a communicable disease, to avoid contracting the disease by contagion or infection. Precautions are especially applicable in the diagnosis and care of AIDS patients.", "PM": "92", "HN": "92", "MR": "20080708", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D016635"}, {"RECTYPE": "D", "MH": "Telefacsimile", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Fax|T066|NON|EQV|NLM (1992)|901101|abcdef", "ENTRY": "Transmissions, Facsimile", "MN": "L01.462.500.847.606", "MH_TH": "NLM (1992)", "ST": "T066", "PI": "Telecommunications (1986-1991)", "MS": "A telecommunication system combining the transmission of a document scanned at a transmitter, its reconstruction at a receiving station, and its duplication there by a copier.", "PM": "92", "HN": "92", "MR": "20220712", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016636"}, {"RECTYPE": "D", "MH": "Critical Illness", "AQ": "CL EC EP MO NU PX RH TH", "ENTRY": "Illnesses, Critical", "MN": "C23.550.291.625", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "IM GEN only; do not index with specific dis of critically ill patient unless particularly discussed & then NIM with no qualif; /ther: consider also CRITICAL CARE", "PI": "Critical Care (1975-1991)", "MS": "A disease or state in which death is possible or imminent.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016638"}, {"RECTYPE": "D", "MH": "Scleroplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Scleroplasties", "MN": "E04.617.700", "MH_TH": "NLM (1992)", "ST": "T061", "PI": "Sclera/surgery (1972-1991)", "MS": "Plastic surgery of the SCLERA. This procedure is used frequently to prevent blindness and poor vision in patients, especially children, with MYOPIA.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20220406", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016639"}, {"RECTYPE": "D", "MH": "Diabetes, Gestational", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gestational Diabetes|T047|NON|EQV|NLM (1992)|901102|abcdef", "ENTRY": "Pregnancy-Induced Diabetes", "MN": "C19.246.200", "FX": "Pregnancy in Diabetics", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "refers to DIABETES MELLITUS, not DIABETES INSIPIDUS; do not confuse with PREGNANCY IN DIABETICS where a diabetic becomes pregnant", "PI": "Pregnancy in Diabetes (1966-1991)", "MS": "Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016640"}, {"RECTYPE": "D", "MH": "Bupropion", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Zyntabac|T109|T121|TRD|NRW|ES|040504|abbcdef", "MN": "D02.522.818.110", "PA": "Dopamine Uptake Inhibitors", "FX": "Smoking Cessation", "MH_TH": "NLM (1992)", "ST": "T121", "N1": "1-Propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-", "RN": "01ZG3TPX31", "RR": "ZG7E5POY8O", "PI": "Propiophenones (1966-1991)", "MS": "A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.", "PM": "1992; BUPROPION was indexed under PROPIOPHENONES 1978-1991", "HN": "1992 (1978)", "MR": "20180410", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016642"}, {"RECTYPE": "D", "MH": "Encephalopathy, Bovine Spongiform", "DE": "ENCEPH BOVINE SPONGIFORM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Spongiform Encephalopathy, Bovine|T047|NON|EQV|NLM (1993)|911011|SPONGIFORM ENCEPH BOVINE|abcdefv", "ENTRY": "Mad Cow Diseases", "MN": "C22.196.250", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "if transmitted to man, coord IM (with probably /transm) with specific brain or other neurol dis in text (IM); if transmitted to another species of animal, coord IM (with probably /transm) with animal/dis precoord (IM) and specific animal IM or NIM", "PI": "Cattle Diseases (1988-1991)", "MS": "A transmissible spongiform encephalopathy of cattle associated with abnormal prion proteins in the brain. Affected animals develop excitability and salivation followed by ATAXIA. This disorder has been associated with consumption of SCRAPIE infected ruminant derived protein. This condition may be transmitted to humans, where it is referred to as variant or new variant CREUTZFELDT-JAKOB SYNDROME. (Vet Rec 1998 Jul 25;143(41):101-5)", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016643"}, {"RECTYPE": "D", "MH": "Canthaxanthin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Roxanthin Red 10|T109|T121|T123|TRD|NRW|NLM (1992)|901102|abbbcdef", "MN": "D23.767.261.887.249", "PA": "Antioxidants", "MH_TH": "NLM (1992)", "ST": "T123", "N1": "beta,beta-Carotene-4,4'-dione", "RN": "4C3C6403MU", "RR": "514-78-3 (Canthaxanthin)", "PI": "Carotene/analogs & derivatives (1975-1991)", "MS": "A trans-carotenoid pigment widely distributed in nature. The compound is used as an oral suntanning agent and as a food and drug coloring agent. Oral ingestion of the compound causes canthaxanthin retinopathy.", "OL": "use CANTHAXANTHIN (NM) to search CANTHAXANTHIN 1980-91", "PM": "92; CANTHAXANTHIN was indexed under CAROTENE/analogs & derivatives 1978-91", "HN": "92; was CANTHAXANTHIN (NM) 1978-91", "MR": "20130708", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016644"}, {"RECTYPE": "D", "MH": "Aotidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Owl Monkey|T015|NON|EQV|NLM (1992)|901128|abcdef", "ENTRY": "Owl Monkeys", "MN": "B01.050.150.900.649.313.988.400.600.037", "MH_TH": "NLM (2007)", "ST": "T015", "RN": "txid376918", "RR": "txid9504", "AN": "index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)", "MS": "A family of the New World monkeys inhabiting the forests of South and Central America. There is a single genus (Aotus) and several species occurring in this family, including AOTUS TRIVIRGATUS (Northern night monkeys).", "PM": "2007; see AOTINAE 1992-2007; for DOUROUCOULI see AOTUS TRIVIRGATUS 1981-1991; for MONKEY, NIGHT see AOTUS TRIVIRGATUS 1981-1991, see MONKEYS 1975-1980; for MONKEY, OWL see AOTUS TRIVIRGATUS 1981-1991", "HN": "2007 (1992); for DOUROUCOULI use AOTUS TRIVIRGATUS 1981-1991; for MONKEY, NIGHT use AOTUS TRIVIRGATUS 1981-1991, use MONKEYS 1975-1980; for MONKEY, OWL use AOTUS TRIVIRGATUS 1981-1991", "MR": "20200813", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016645"}, {"RECTYPE": "D", "MH": "Cebinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "MN": "B01.050.150.900.649.313.988.400.600.150.170", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid38070", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "MS": "A subfamily of New World monkeys in the family CEBIDAE. They inhabit the forests of South and Central America and comprise members of the genus CEBUS.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016646"}, {"RECTYPE": "D", "MH": "Callimico", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Marmosets, Goeldi's|T015|EPO|EQV|NLM (1992)|901219|abcdef", "ENTRY": "Monkey, Goeldi's", "MN": "B01.050.150.900.649.313.988.400.600.150.150.105", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid9494", "RR": "txid9495", "AN": "index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)", "MS": "A genus in the subfamily CALLITRICHINAE, comprising a single species with the common name Goeldi's monkey.", "PM": "2006; see CALLIMICONINAE 1992-2005, see CALLITHRICIDAE 1981-1991, see MONKEYS 1975-1980", "HN": "2006 (1975); see CALLITHRICIDAE 1981-1991", "MR": "20200902", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016647"}, {"RECTYPE": "D", "MH": "Saimirinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.649.313.988.400.600.150.710", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid378850", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "MS": "A subfamily of CEBIDAE inhabiting the forests of Central and South America. This subfamily of New World monkeys consists of one genus, the SAIMIRI or squirrel monkeys.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016648"}, {"RECTYPE": "D", "MH": "Primary Ovarian Insufficiency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Resistant Ovary Syndrome|T047|NON|NRW|NLM (1992)|910308|abcdef", "ENTRY": "X Linked Hypergonadotropic Ovarian Failure", "MN": "C19.391.630.750", "FX": "Menopause, Premature", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Ovarian Diseases (1966-1991)", "MS": "Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections. The most commonly known genetic cause is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene.", "PM": "2011; see Ovarian Failure, Premature 1992-2010", "HN": "2011(1992)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016649"}, {"RECTYPE": "D", "MH": "Fluorescein-5-isothiocyanate", "DS": "FLUORESCEIN ISOTHIOCYANATE 05", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "FITC|T109|T130|ABB|EQV|NLM (1992)|901105|abbcdef", "ENTRY": "Hydrochloride, Fluorescein-5-isothiocyanate", "MN": "D04.711.347.400", "PA": "Fluorescent Dyes", "MH_TH": "NLM (1992)", "ST": "T130", "N1": "Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 3',6'-dihydroxy-5-isothiocyanato-", "RN": "I223NX31W9", "RR": "63469-13-6 (HCl)", "PI": "Thiocyanates (1966-1991)", "MS": "Fluorescent probe capable of being conjugated to tissue and proteins. It is used as a label in fluorescent antibody staining procedures as well as protein- and amino acid-binding techniques.", "OL": "use FLUORESCEIN-5-ISOTHIOCYANATE (NM) to search FLUORESCEIN-5-ISOTHIOCYANATE 1979-91", "PM": "92; FLUORESCEIN-5-ISOTHIOCYANATE was indexed under FLUORESCEINS & THIOCYANATES 1978-91", "HN": "92; was FLUORESCEIN-5-ISOTHIOCYANATE (NM) 1978-91", "MR": "20160531", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016650"}, {"RECTYPE": "D", "MH": "Lithium Carbonate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Quilinormretard", "MN": "D01.510.475", "PA": "Enzyme Inhibitors", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Carbonic acid, dilithium salt", "RN": "2BMD2GNA4V", "RR": "554-13-2 (Lithium Carbonate)", "PI": "Tranquilizing Agents (1966-1991)", "MS": "A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems.", "OL": "use LITHIUM CARBONATE (NM) to search LITHIUM CARBONATE 1977-91", "PM": "92; LITHIUM CARBONATE was indexed under LITHIUM 1969-91", "HN": "92; was LITHIUM CARBONATE (NM) 1969-91", "MR": "20150623", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016651"}, {"RECTYPE": "D", "MH": "Genes, RAG-1", "DS": "GENES RAG 01", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Recombination-Activating Genes-1|T028|NON|EQV|NLM (1992)|901105|RECOMBINATION ACTIVATING GENE 01|abcdefs", "ENTRY": "Recombination Activating Genes 1", "MN": "G05.360.340.024.340.400", "MH_TH": "NLM (1992)", "ST": "T028", "AN": "RAG stands for \"Recombination-Activating Gene\"", "MS": "Genes involved in activating the enzyme VDJ recombinase. RAG-1 is located on chromosome 11 in humans (chromosome 2 in mice) and is expressed exclusively in maturing lymphocytes.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016654"}, {"RECTYPE": "D", "MH": "HIV Core Protein p24", "DS": "HIV CORE PROTEIN P 024", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p24(HIV)|T116|T121|T129|ABX|EQV|NLM (1992)|901106|P A 024 HIV|P24HIV|abbbcdefsv", "ENTRY": "p24, HTLV-III", "MN": "D23.050.327.520.300", "MH_TH": "NLM (1992)", "ST": "T129", "RN": "0", "PI": "Viral Core Proteins (1985-1991)", "MS": "A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by ELISA and Western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines.", "OL": "use HIV CORE PROTEIN P24 (NM) to search HIV MAJOR CORE PROTEIN P24 (NM) 1987-91", "PM": "92; HIV MAJOR CORE PROTEIN P24 was indexed under GENE PRODUCTS, GAG & VIRAL CORE PROTEINS 1990-91 & under RETROVIRIDAE PROTEINS 1987-89", "HN": "92; was HIV MAJOR CORE PROTEIN P24 (NM) 1987-91", "MR": "20220413", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016655"}, {"RECTYPE": "D", "MH": "Family Planning Policy", "AQ": "EC HI LJ TD", "ENTRY": "Pronatalist Policies", "MN": "N03.623.500.608.214", "MH_TH": "POPLINE (1978)", "ST": "T170", "AN": "by government: for planning on family or personal level index under FAMILY PLANNING; specify state or country", "PI": "Public Policy (1978-1991)", "MS": "A course or method of action selected, usually by a government, to guide and determine present and future decisions on population control by limiting the number of children or controlling fertility, notably through family planning and contraception within the nuclear family.", "PM": "92", "HN": "92", "MR": "20100625", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016656"}, {"RECTYPE": "D", "MH": "Cerebral Amyloid Angiopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sporadic Cerebral Amyloid Angiopathy|T047|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Congophilic Angiopathies", "MN": "C18.452.845.500.100", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "/genet:consider also CEREBRAL AMYLOID ANGIOPATHY, FAMILIAL", "PI": "Cerebrovascular Disorders (1974-1991)", "MS": "A heterogeneous group of sporadic or familial disorders characterized by AMYLOID deposits in the walls of small and medium sized blood vessels of CEREBRAL CORTEX and MENINGES. Clinical features include multiple, small lobar CEREBRAL HEMORRHAGE; cerebral ischemia (BRAIN ISCHEMIA); and CEREBRAL INFARCTION. Cerebral amyloid angiopathy is unrelated to generalized AMYLOIDOSIS. Amyloidogenic peptides in this condition are nearly always the same ones found in ALZHEIMER DISEASE. (from Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7th ed., 2005)", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016657"}, {"RECTYPE": "D", "MH": "Psoas Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Psoas Muscle", "MN": "A02.633.567.825", "MH_TH": "NLM (1992)", "ST": "T023", "PI": "Muscles (1968-1991)", "MS": "A powerful flexor of the thigh at the hip joint (psoas major) and a weak flexor of the trunk and lumbar spinal column (psoas minor). Psoas is derived from the Greek \"psoa\", the plural meaning \"muscles of the loin\". It is a common site of infection manifesting as abscess (PSOAS ABSCESS). The psoas muscles and their fibers are also used frequently in experiments in muscle physiology.", "PM": "92", "HN": "92", "MR": "20080708", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016658"}, {"RECTYPE": "D", "MH": "Psoas Abscess", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Iliopsoas Abscess|T047|NON|EQV|NLM (2003)|011114|abcdef", "ENTRY": "Pyogenic Iliopsoas Abscesses", "MN": "C01.830.025.700", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "for coord read note on ABSCESS", "PI": "Muscular Diseases (1968-1991)", "MS": "Abscess of the PSOAS MUSCLES resulting usually from disease of the lumbar vertebrae, with the pus descending into the muscle sheath. The infection is most commonly tuberculous or staphylococcal.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016659"}, {"RECTYPE": "D", "MH": "NAD(P)H Dehydrogenase (Quinone)", "DE": "NADPH DEHYDROGENASE QUINONE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vitamin K Reductase|T116|T126|NON|NRW|NLM (1992)|901108|abbcdef", "ENTRY": "Reductase, Vitamin K", "MN": "D08.811.682.608.800.500", "MH_TH": "NLM (1992)", "ST": "T126", "N1": "NAD(P)H:(quinone-acceptor) oxidoreductase", "RN": "EC 1.6.5.2", "PI": "Oxidoreductases (1966-1974)", "MS": "A flavoprotein that reversibly catalyzes the oxidation of NADH or NADPH by various quinones and oxidation-reduction dyes. The enzyme is inhibited by dicoumarol, capsaicin, and caffeine.", "OL": "use NAD(P)H DEHYDROGENASE (QUINONE) (NM) to search NAD(P)H DEHYDROGENASE (QUINONE) 1980-91", "PM": "92; NAD(P)H DEHYDROGENASE (QUINONE) was indexed under OXIDOREDUCTASES 1973, under NADH, NADPH OXIDOREDUCTASES 1974-79 & under QUINONE REDUCTASES 1980-91", "HN": "92; was NAD(P)H DEHYDROGENASE (QUINONE) (NM) 1973-91", "MR": "20070709", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016660"}, {"RECTYPE": "D", "MH": "Alouattinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "MN": "B01.050.150.900.649.313.988.400.600.075.050", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid38066", "AN": "index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)", "MS": "A subfamily of ATELIDAE inhabiting the forests of Central and South America. The genus ALOUATTA, or howler monkeys, belongs to this subfamily.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016661"}, {"RECTYPE": "D", "MH": "Virus Integration", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Provirus Integration|T070|NON|NRW|NLM (1992)|901109|abcdef", "ENTRY": "integrations, Viral", "MN": "G06.920.877", "FX": "Proviruses", "MH_TH": "NLM (1992)", "ST": "T070", "PI": "Proviruses (1988-1991)", "MS": "Insertion of viral DNA into host-cell DNA. This includes integration of phage DNA into bacterial DNA; (LYSOGENY); to form a PROPHAGE or integration of retroviral DNA into cellular DNA to form a PROVIRUS.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016662"}, {"RECTYPE": "D", "MH": "Cercopithecinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "MN": "B01.050.150.900.649.313.988.400.112.199.120", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid9528", "AN": " a subfamily of Old World monkeys: do not confuse with CERCOPITHECIDAE, the family; NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "MS": "A subfamily of the Old World monkeys, CERCOPITHECIDAE. They inhabit the forests and savannas of Africa. This subfamily contains the following genera: CERCOCEBUS; CERCOPITHECUS; ERYTHROCEBUS; MACACA; PAPIO; and THEROPITHECUS.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016663"}, {"RECTYPE": "D", "MH": "Cercocebus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Mangabeys|T015|NON|EQV|NLM (1992)|901107|abcdef", "ENTRY": "Mangabey", "MN": "B01.050.150.900.649.313.988.400.112.199.120.120", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid9529", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "MS": "A genus of the subfamily CERCOPITHECINAE inhabiting the African forests. They are also known as mangabeys.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016664"}, {"RECTYPE": "D", "MH": "Cercocebus atys", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Sooty Mangabey|T015|NON|EQV|NLM (1992)|901107|abcdef", "ENTRY": "Sooty Mangabeys", "MN": "B01.050.150.900.649.313.988.400.112.199.120.120.110", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid9531", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "MS": "A species of Old World monkeys from the genera CERCOCEBUS that is important in AIDS research. They may be naturally or experimentally infected with the SIMIAN IMMUNODEFICIENCY VIRUS. They inhabit African forests from Sierra Leone to the Congo Republic.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016665"}, {"RECTYPE": "D", "MH": "Fluvoxamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ratio Fluvoxamine", "MN": "D02.092.570.665.250", "PA": "Selective Serotonin Reuptake Inhibitors", "MH_TH": "NLM (1992)", "ST": "T121", "N1": "1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-", "RN": "O4L1XPO44W", "RR": "89035-92-7 ((Z)-isomer)", "PI": "Serotonin Antagonists (1978-1991)", "MS": "A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS.", "OL": "use FLUVOXAMINE (NM) to search FLUVOXAMINE 1980-91", "PM": "92; FLUVOXAMINE was indexed under OXIMES 1978-91", "HN": "92; was FLUVOXAMINE (NM) 1978-91", "MR": "20220718", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016666"}, {"RECTYPE": "D", "MH": "Bacterial Capsules", "DE": "BACT CAPSULES", "AQ": "CH CL DE EN GE IM ME PA PH RE TR UL VI", "ENTRY": "Capsules, Bacterial|T026|NON|EQV|NLM (1992)|901107|CAPSULES BACT|abcdefv", "MN": "A20.186", "MH_TH": "NLM (1992)", "ST": "T026", "PI": "Polysaccharides, Bacterial (1966-1991)", "MS": "An envelope of loose gel surrounding a bacterial cell which is associated with the virulence of pathogenic bacteria. Some capsules have a well-defined border, whereas others form a slime layer that trails off into the medium. Most capsules consist of relatively simple polysaccharides but there are some bacteria whose capsules are made of polypeptides.", "PM": "92", "HN": "92", "MR": "20120703", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016667"}, {"RECTYPE": "D", "MH": "Erythrocebus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "MN": "B01.050.150.900.649.313.988.400.112.199.120.260", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid9537", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "MS": "a genus of Old World monkeys of the family CERCOPITHECINAE that inhabit the forests and savannas of Africa. It contains only one species, ERYTHROCEBUS PATAS, also known as the patas monkey or red monkey.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016669"}, {"RECTYPE": "D", "MH": "Gabexate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monomethanesulfonate, Gabexate", "MN": "D02.078.370.380", "PA": "Serine Proteinase Inhibitors", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzoic acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, ethyl ester", "RN": "4V7M9137X9", "RR": "E3Q07L0649", "PI": "Serine Proteinase Inhibitors (1990-1991)", "MS": "A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.", "OL": "use GABEXATE (NM) to search GABEXATE 1979-91", "PM": "92; GABEXATE was indexed under GUANIDINES 1976-91", "HN": "92; was GABEXATE (NM) 1976-91", "MR": "20130708", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016670"}, {"RECTYPE": "D", "MH": "Theropithecus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Theropithecus gelada|T015|NON|NRW|NLM (1997)|960416|abcdef", "ENTRY": "gelada, Theropithecus", "MN": "B01.050.150.900.649.313.988.400.112.199.120.730", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid9564", "RR": "txid9565", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "MS": "A genus of Old World monkeys of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, that inhabits the mountainous regions of Ethiopia. The genus consists of only one species, Theropithecus gelada.", "PM": "92; THEROPITHECUS GELADA was heading 1981-96 (see under CERCOPITHECIDAE 1981-90); was GELADA see under MONKEYS 1975-80", "HN": "92; THEROPITHECUS GELADA was heading 1981-96 (see under CERCOPITHECIDAE 1981-90); was GELADA see under MONKEYS 1975-80", "MR": "20200813", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016671"}, {"RECTYPE": "D", "MH": "Zenker Diverticulum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Zenker's Diverticulum|T047|EPO|EQV|NLM (1992)|990101|abcdef", "ENTRY": "Zenkers Diverticulum", "MN": "C23.300.415.625.900", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "inflamm divertic or diverticulitis: coord IM with DIVERTICULITIS (IM)", "PI": "Esophageal Diverticulum (1966-1991)", "MS": "A DIVERTICULUM at the upper end of the ESOPHAGUS through the cricopharyngeal muscle at the junction of the PHARYNX and the esophagus.", "PM": "2000; see ZENKER's DIVERTICULUM 1992-1999; see ZENKER's DIVERTICULUM 1992-1999", "HN": "2000(1992)", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016672"}, {"RECTYPE": "D", "MH": "Colobinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Red Colobus|T015|NON|NRW|NLM (2020)|190327|abcdef", "ENTRY": "Colobus, Red", "MN": "B01.050.150.900.649.313.988.400.112.199.150", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid9569", "RR": "txid591932", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES ", "MS": "A subfamily of the Old World monkeys, CERCOPITHECIDAE, that inhabits the forests of Africa and Asia. The genera COLOBUS, Piliocolobus and Procolobus under Tribe Colobini and Nasalis (proboscis monkey), Presbytis, Pygathrix, Rhinopithecus (snub-nosed monkey), Semnopithecus (Indian langurs), Simias (pig-tailed langur) and Trachypithecus under Tribe PRESBYTINI (Asian colobines) belong to this subfamily.", "PM": "1992; for PROCOLOBUS see COLOBUS 1992-2019", "HN": "1992; for PROCOLOBUS use COLOBUS 1992-2019", "MR": "20200902", "DA": "19910124", "DC": "1", "DX": "19920101", "UI": "D016673"}, {"RECTYPE": "D", "MH": "Hylobatidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Symphalangus syndactylus|T015|NON|NRW|NLM (2020)|190326|abcdef", "ENTRY": "Siamangs", "MN": "B01.050.150.900.649.313.988.400.112.420", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid9577", "RR": "txid9590", "AN": "gibbon, not monkey & not ape; diseases: coordinate with specific disease /vet ", "PI": "Pongidae (1967-1991)", "MS": "A family of the suborder HAPLORHINI comprising four genera, HYLOBATES (dwarf gibbons); Hoolock; Nomascus; and Symphalangus.", "PM": "1992; for SIAMANG and SYMPHALANGUS see HYLOBATES 1981-2019, for NOMASCUS see HYLOBATES 1992-2019", "HN": "1992; for SIAMANG and SYMPHALANGUS use HYLOBATES 1981-2019, for NOMASCUS use HYLOBATES 1992-2019", "MR": "20200813", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016674"}, {"RECTYPE": "D", "MH": "Scandentia", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Scandentias", "MN": "B01.050.150.900.649.313.996", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid9392", "MS": "An order of the class MAMMALS that consists of one family, TUPAIIDAE (tree shrews), 5 genera (one of which is TUPAIA), and 16 species. Their recent distribution is from India to the Philippines, southern China to Java, Borneo, Sumatra, Bali, and other islands in those regions.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016675"}, {"RECTYPE": "D", "MH": "Macrophages, Alveolar", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Pulmonary Macrophages|T025|NON|EQV|NLM (1992)|901108|PULM MACROPHAGES|abcdefv", "ENTRY": "Macrophage, Alveolar", "MN": "A15.382.680.397.600", "MH_TH": "NLM (1992)", "ST": "T025", "PI": "Pulmonary Alveoli (1966-1991)", "MS": "Round, granular, mononuclear phagocytes found in the alveoli of the lungs. They ingest small inhaled particles resulting in degradation and presentation of the antigen to immunocompetent cells.", "PM": "92", "HN": "92", "MR": "20180630", "DA": "19910214", "DC": "1", "DX": "19920101", "UI": "D016676"}, {"RECTYPE": "D", "MH": "Tocainide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "W36095", "MN": "D02.092.146.113.920", "PA": "Voltage-Gated Sodium Channel Blockers", "MH_TH": "USAN (1976)", "ST": "T121", "N1": "Propanamide, 2-amino-N-(2,6-dimethylphenyl)-", "RN": "27DXO59SAN", "RR": "86516-38-3", "PI": "Lidocaine/analogs & derivatives (1982-1991)", "MS": "An antiarrhythmic agent which exerts a potential- and frequency-dependent block of SODIUM CHANNELS.", "OL": "use TOCAINIDE (NM) to search TOCAINIDE 1979-91", "PM": "92; TOCAINIDE was indexed under LIDOCAINE 1974 & under LIDOCAINE/analogs and derivatives 1975-91", "HN": "92; was TOCAINIDE (NM) 1974-91", "MR": "20160701", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016677"}, {"RECTYPE": "D", "MH": "Genome", "AQ": "DE ES GE IM PH RE", "ENTRY": "Genomes", "MN": "G05.360.340", "FX": "Genomics", "MH_TH": "NLM (1992)", "ST": "T028", "AN": "general or unspecified; prefer specifics; coordinate IM with animal /genet (IM) or organism /genet (IM)", "PI": "Genomic Library (1990-1991)", "MS": "The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA.", "OL": "use GENOMIC LIBRARY to search GENOME 1990-91", "PM": "92; was see GENOMIC LIBRARY 1990-91", "HN": "92; was see GENOMIC LIBRARY 1990-91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016678"}, {"RECTYPE": "D", "MH": "Genome, Viral", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Viral Genome|T028|NON|EQV|NLM (1992)|901113|abcdef", "ENTRY": "Viral Genomes", "MN": "G05.360.340.358.840", "FX": "Genes, Viral", "MH_TH": "NLM (1992)", "ST": "T028", "AN": "coordinate IM with specific virus /genet (IM)", "PI": "RNA, Viral (1966-1977)", "MS": "The complete genetic complement contained in a DNA or RNA molecule in a virus.", "OL": "use GENES, VIRAL to search GENOME, VIRAL & VIRAL GENOME 1978-91", "PM": "92; was see GENES, VIRAL 1978-91; VIRAL GENOME was see GENES, VIRAL 1978-91", "HN": "92; was see GENES, VIRAL 1978-91; VIRAL GENOME was see GENES, VIRAL 1978-91", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016679"}, {"RECTYPE": "D", "MH": "Genome, Bacterial", "DE": "GENOME BACT", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Bacterial Genome|T028|NON|EQV|NLM (1992)|901113|BACT GENOME|abcdefv", "ENTRY": "Genomes, Bacterial|T028|NON|EQV|NLM (1994)|930212|GENOMES BACT|abcdefv", "MN": "G05.360.340.358.207", "FX": "Genes, Bacterial", "MH_TH": "NLM (1992)", "ST": "T028", "AN": "coordinate with specific bacterium /genet ", "PI": "DNA, Bacterial (1966-1991)", "MS": "The genetic complement of a BACTERIA as represented in its DNA.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016680"}, {"RECTYPE": "D", "MH": "Genome, Fungal", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Fungal Genome|T028|NON|EQV|NLM (1992)|901113|abcdef", "ENTRY": "Genomes, Fungal", "MN": "G05.360.340.358.365", "FX": "Genes, Fungal", "MH_TH": "NLM (1992)", "ST": "T028", "AN": "coordinate IM with specific fungus /genet (IM)", "PI": "Genes, Fungal (1984-1991)", "MS": "The complete gene complement contained in a set of chromosomes in a fungus.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016681"}, {"RECTYPE": "D", "MH": "Lupus Coagulation Inhibitor", "DE": "LUPUS COAG INHIB", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Lupus Anticoagulant Autoantibody|T116|T129|NON|EQV|NLM (2023)|210924|abbcdef", "ENTRY": "Autoantibody, Lupus Anticoagulant", "MN": "D23.113.475", "PA": "Immunologic Factors", "FX": "Antiphospholipid Syndrome", "MH_TH": "NLM (1992)", "ST": "T129", "RN": "0", "PI": "Blood Coagulation Factors (1966-1991)", "MS": "An antiphospholipid antibody found in association with a variety of diseases (e.g., SYSTEMIC LUPUS ERYTHEMATOSUS and ANTIPHOSPHOLIPID SYNDROME) as well as in healthy individuals. In vitro, the antibody interferes with the conversion of prothrombin to thrombin and prolongs the partial thromboplastin time. In vivo, it exerts a procoagulant effect resulting in thrombosis mainly in the larger veins and arteries. It further causes obstetrical complications, including fetal death and spontaneous abortion, as well as a variety of hematologic and neurologic complications.", "OL": "use LUPUS COAGULATION INHIBITOR (NM) to search LUPUS COAGULATION INHIBITOR 1980-91", "PM": "92; LUPUS COAGULATION INHIBITOR was indexed under BLOOD COAGULATION FACTORS/immunology 1986-91 & BLOOD COAGULATION FACTORS/antagonists & inhibitors 1978-88", "HN": "92; was LUPUS COAGULATION INHIBITOR (NM) 1978-91", "MR": "20220413", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016682"}, {"RECTYPE": "D", "MH": "Supine Position", "AQ": "PH", "PRINT ENTRY": "Dorsal Position|T032|NON|EQV|NLM (1992)|901113|abcdef", "ENTRY": "Supine Positions", "MN": "G11.427.695.625", "MH_TH": "NLM (1992)", "ST": "T032", "AN": "almost never IM; do not confuse with SUPINATION, a movement of the foot or forearm", "PI": "Supination (1988-1991)", "MS": "The posture of an individual lying face up.", "OL": "use SUPINATION to search SUPINE POSITION 1988-91", "PM": "92; was see SUPINATION 1988-91", "HN": "92; was see SUPINATION 1988-91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016683"}, {"RECTYPE": "D", "MH": "Prone Position", "AQ": "PH", "ENTRY": "Prone Positions", "MN": "G11.427.695.525", "MH_TH": "NLM (1992)", "ST": "T082", "AN": "almost never IM; do not confuse with PRONATION, a movement of the foot or forearm", "PI": "Pronation (1988-1991)", "MS": "The posture of an individual lying face down.", "OL": "use PRONATION to search PRONE POSITION 1988-91", "PM": "92; was see PRONATION 1988-91", "HN": "92; was see PRONATION 1988-91", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016684"}, {"RECTYPE": "D", "MH": "Mitomycin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mitomycin C|T109|T195|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|JAN (19XX)|NLM (1992)|USP (19XX)|990101|abbcdeeeeeef", "ENTRY": "NSC26980", "MN": "D03.633.100.473.412.249.350", "PA": "Nucleic Acid Synthesis Inhibitors", "EC": "analogs & derivatives:Mitomycins", "MH_TH": "USAN (1972)", "ST": "T195", "N1": "Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS-(1aalpha,8beta,8aalpha,8balpha))-", "RN": "50SG953SK6", "RR": "69515-74-8 ((1aalpha,8beta,8aalpha,8balpha)-isomer)", "AN": "MITOMYCINS is also available", "PI": "Mitomycins (1966-1991)", "MS": "An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.", "PM": "2000; see MITOMYCIN C 1992-1999; MITOMYCIN C was indexed under MITOMYCINS 1981-1990", "HN": "2000(1992); for MITOMYCIN use MITOMYCIN (NM) 1981-1991", "MR": "20190701", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016685"}, {"RECTYPE": "D", "MH": "Monocrotaline", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monocrotaline, (all-xi)-Isomer|T109|T131|NRW|NLM (1999)|990913|abbdef", "MN": "D03.633.100.772.500", "MH_TH": "NLM (1992)", "ST": "T131", "N1": "20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13alpha,14alpha)-", "RN": "73077K8HYV", "RR": "901-82-6 (HCl(13alpha,14alpha)-isomer)", "PI": "Pyrrolizidine Alkaloids (1971-1973)", "MS": "A pyrrolizidine alkaloid and a toxic plant constituent that poisons livestock and humans through the ingestion of contaminated grains and other foods. The alkaloid causes pulmonary artery hypertension, right ventricular hypertrophy, and pathological changes in the pulmonary vasculature. Significant attenuation of the cardiopulmonary changes are noted after oral magnesium treatment.", "OL": "use MONOCROTALINE (NM) to search MONOCROTALINE 1980-91", "PM": "92; MONOCROTALINE was indexed under PYRROLIZIDINE ALKALOIDS 1973-91", "HN": "92; was MONOCROTALINE (NM) 1973-91", "MR": "20160531", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016686"}, {"RECTYPE": "D", "MH": "Polydioxanone", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Polydioxanones", "MN": "J01.637.051.720.728.700", "MH_TH": "NLM (1992)", "ST": "T122", "N1": "Poly(oxy(1-oxo-1,2-ethanediyl)oxy-1,2-ethanediyl)", "RN": "31621-87-1", "PI": "Sutures (1966-1991)", "MS": "An absorbable suture material used also as ligating clips, as pins for internal fixation of broken bones, and as ligament reinforcement for surgically managed ligament injuries. Its promising characteristics are elasticity, complete biodegradability, and lack of side effects such as infections.", "OL": "use POLYDIOXANONE (NM) to search POLYDIOXANONE 1981-91", "PM": "92; POLYDIOXANONE was indexed under POLYESTERS 1979-91", "HN": "92; was POLYDIOXANONE (NM) 1979-91", "MR": "20060705", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016687"}, {"RECTYPE": "D", "MH": "Mice, Inbred NOD", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Non-Obese Diabetic Mice|T015|NON|EQV|NLM (1992)|901114|NONOBESE DIABETIC MICE|abcdefs", "ENTRY": "Non Obese Diabetic Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.400.565", "MH_TH": "NLM (1992)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal; a model for DIABETES MELLITUS, INSULIN-DEPENDENT not DIABETES MELLITUS, EXPERIMENTAL ", "PI": "Mice (1980-1991)", "MS": "A strain of non-obese diabetic mice developed in Japan that has been widely studied as a model for T-cell-dependent autoimmune insulin-dependent diabetes mellitus in which insulitis is a major histopathologic feature, and in which genetic susceptibility is strongly MHC-linked.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016688"}, {"RECTYPE": "D", "MH": "Trypanosoma vivax", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "vivax, Trypanosoma", "MN": "B01.268.475.868.887.850", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5699", "AN": "causes nagana in African cattle & other animals: see note at TRYPANOSOMIASIS, AFRICAN; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN", "PI": "Trypanosoma (1966-1991)", "MS": "An active blood parasite that is present in practically all domestic animals in Africa, the West Indies, and parts of Central and South America. In Africa, the insect vector is the tsetse fly. In other countries, infection is by mechanical means indicating that the parasites have been introduced to these countries and have been able to maintain themselves in spite of the lack of a suitable intermediate host. It is a cause of nagana, the severity of which depends on the species affected.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016689"}, {"RECTYPE": "D", "MH": "Receptors, Antigen, T-Cell, gamma-delta", "DE": "RECEPT ANTIGEN T CELL GAMMA DELTA", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "TcR gamma-delta|T116|T129|T192|EQV|NLM (1992)|901115|TCR G D|abbbdefv", "ENTRY": "gamma-delta, TcR", "MN": "D12.776.543.750.705.816.824.830", "FX": "Genes, T-Cell Receptor gamma", "MH_TH": "NLM (1992)", "ST": "T192", "RN": "0", "PI": "Receptors, Antigen, T-Cell (1986-1991)", "MS": "T-cell receptors composed of CD3-associated gamma and delta polypeptide chains and expressed primarily in CD4-/CD8- T-cells. The receptors appear to be preferentially located in epithelial sites and probably play a role in the recognition of bacterial antigens. The T-cell receptor gamma/delta chains are separate and not related to the gamma and delta chains which are subunits of CD3 (see ANTIGENS, CD3).", "OL": "use RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA (NM) to search T-CELL RECEPTORS DELTA CHAIN (NM) 1988-91 & T-CELL RECEPTORS GAMMA CHAIN 1986-91", "PM": "92; T-CELL RECEPTORS DELTA CHAIN was indexed under RECEPTORS, ANTIGEN, T-CELL 1988-91; T-CELL RECEPTORS GAMMA CHAIN was indexed under RECEPTORS, ANTIGEN, T-CELL 1987-91 & under PEPTIDE FRAGMENTS 1986-87", "HN": "92; T-CELL RECEPTORS DELTA CHAIN was ANTIGEN T CELL RECEPTOR, DELTA CHAIN (NM) 1988-91; T-CELL RECEPTORS GAMMA CHAIN was ANTIGEN T CELL RECEPTOR, GAMMA CHAIN (NM) 1986-91", "MR": "20030709", "DA": "19910813", "DC": "1", "DX": "19920101", "UI": "D016692"}, {"RECTYPE": "D", "MH": "Receptors, Antigen, T-Cell, alpha-beta", "DE": "RECEPT ANTIGEN T CELL ALPHA BETA", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "TcR alpha-beta|T116|T129|T192|EQV|NLM (1992)|901115|TCR A B|abbbdefv", "ENTRY": "beta-Chain, T-Cell Receptors", "MN": "D12.776.543.750.705.816.824.825", "FX": "Genes, T-Cell Receptor beta", "MH_TH": "NLM (1992)", "ST": "T192", "RN": "0", "PI": "Receptors, Antigen, T-Cell (1980-1991)", "MS": "T-cell receptors composed of CD3-associated alpha and beta polypeptide chains and expressed primarily in CD4+ or CD8+ T-cells. Unlike immunoglobulins, the alpha-beta T-cell receptors recognize antigens only when presented in association with major histocompatibility (MHC) molecules.", "OL": "use RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA (NM) to search T-CELL RECEPTORS ALPHA-CHAIN (NM) 1986-91 & T-CELL RECEPTORS BETA-CHAIN (NM) 1986-91", "PM": "92; T-CELL RECEPTORS ALPHA-CHAIN & T-CELL RECEPTORS BETA-CHAIN were indexed under RECEPTORS, ANTIGEN, T-CELL 1986-91", "HN": "92; T-CELL RECEPTORS ALPHA-CHAIN was ANTIGEN T CELL RECEPTOR, ALPHA CHAIN (NM) 1986-91; T-CELL RECEPTORS BETA-CHAIN was ANTIGEN T CELL RECEPTOR, BETA CHAIN (NM) 1986-91", "MR": "20180701", "DA": "19910813", "DC": "1", "DX": "19920101", "UI": "D016693"}, {"RECTYPE": "D", "MH": "Gene Rearrangement, delta-Chain T-Cell Antigen Receptor", "DE": "GENE REARR DELTA CHAIN", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "T-Lymphocyte Antigen Receptor delta-Chain Gene Rearrangement|T045|EQV|NLM (1992)|901115|LYMPHOCYTE ANTIGEN RECEPTOR DELTA CHAIN GENE REARRANGEMENT T|T LYMPHOCYTE ANTIGEN RECEPT D CHAIN GENE REARR|abdefsv", "ENTRY": "T Lymphocyte delta Chain Gene Rearrangement", "MN": "G12.500.287.261", "MH_TH": "NLM (1992)", "ST": "T045", "PI": "Receptors, Antigen, T-Cell/genetics (1987-1988)", "MS": "Ordered rearrangement of T-cell variable gene regions coding for the delta-chain of antigen receptors.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016694"}, {"RECTYPE": "D", "MH": "Glycosyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glycosyltransferase|T116|T126|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Transferases, Glycoside", "MN": "D08.811.913.400", "MH_TH": "NLM (1992)", "ST": "T126", "RN": "EC 2.4.-", "RR": "9033-07-2 (CAS RN)", "PI": "Transferases (1966-1991)", "MS": "Enzymes that catalyze the transfer of glycosyl groups to an acceptor. Most often another carbohydrate molecule acts as an acceptor, but inorganic phosphate can also act as an acceptor, such as in the case of PHOSPHORYLASES. Some of the enzymes in this group also catalyze hydrolysis, which can be regarded as transfer of a glycosyl group from the donor to water. Subclasses include the HEXOSYLTRANSFERASES; PENTOSYLTRANSFERASES; SIALYLTRANSFERASES; and those transferring other glycosyl groups. EC 2.4.", "PM": "92", "HN": "92", "MR": "20200527", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016695"}, {"RECTYPE": "D", "MH": "Herpes Zoster Oticus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Ramsay Hunt Syndrome|T047|EPO|EQV|NLM (2012)|OMIM (2013)|ORD (2010)|100910|abcdeeef", "ENTRY": "Syndrome, Ramsay Hunt", "MN": "C10.292.319.750", "FX": "Facial Paralysis", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse entry term RAMSAY HUNT SYNDROME with RAMSAY HUNT PARALYSIS SYNDROME see PARKINSONIAN DISORDERS or RAMSAY HUNT CEREBELLAR SYNDROME see MYOCLONIC CEREBELLAR DYSSYNERGlA", "PI": "Herpes Zoster (1966-1991)", "MS": "A syndrome characterized by facial palsy in association with a herpetic eruption of the external auditory meatus. This may occasionally be associated with tinnitus, vertigo, deafness, severe otalgia, and inflammation of the pinna. The condition is caused by reactivation of a latent HERPESVIRUS 3, HUMAN infection which causes inflammation of the facial and vestibular nerves, and may occasionally involve additional cranial nerves. (From Adams et al., Principles of Neurology, 6th ed, p757)", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910703", "DC": "1", "DX": "19920101", "UI": "D016697"}, {"RECTYPE": "D", "MH": "Technetium Tc 99m Pyrophosphate", "DE": "TC PYRO", "DS": "TECHNETIUM TC PYROPHOSPHATE 099M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tc 99m-Pyrophosphate|T104|T130|NON|EQV|NLM (1993)|920227|TC PYROPHOSPHATE 099M|abbcdefs", "ENTRY": "Tc PYP", "MN": "D01.925.925", "PA": "Radiopharmaceuticals", "MH_TH": "USP (19XX)", "ST": "T130", "RN": "5L76I61H2B", "RR": "69271-94-9 (Tc(4+) salt (1:1))", "AN": "for routine use as label, use no qualifiers", "PI": "Technetium (1966-1991)", "MS": "A radionuclide imaging agent used primarily in scintigraphy or tomography of the heart to evaluate the extent of the necrotic myocardial process. It has also been used in noninvasive tests for the distribution of organ involvement in different types of amyloidosis and for the evaluation of muscle necrosis in the extremities.", "OL": "use TECHNETIUM TC 99M PYROPHOSPHATE (NM) to search TECHNETIUM TC 99M PYROPHOSPHATE 1978-91", "PM": "92; TECHNETIUM TC 99M PYROPHOSPHATE was indexed under TECHNETIUM 1978-91", "HN": "92; was TECHNETIUM TC 99M PYROPHOSPHATE (NM) 1978-91", "MR": "20150605", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016698"}, {"RECTYPE": "D", "MH": "Tarsiidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Tarsius|T015|NON|NRW|NLM (1992)|901210|abcdef", "ENTRY": "Tarsier", "MN": "B01.050.150.900.649.313.988.400.800.500", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid9475", "RR": "txid9476", "AN": "diseases: coordinate IM with PRIMATE DISEASES (IM)", "MS": "The single family of PRIMATES in the infraorder TARSII, suborder HAPLORHINI. It is comprised of one genus, Tarsius, that inhabits southern Sumatra, Borneo, Sulawesi, and the Philippines.", "OL": "use PROSIMII to search TARSIIDAE & TARSIUS 1981-91", "PM": "92; TARSIIDAE & TARSIUS were see PROSIMII 1981-91", "HN": "92; TARSIIDAE & TARSIUS were see PROSIMII 1981-91", "MR": "20200813", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016699"}, {"RECTYPE": "D", "MH": "Encainide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MJ9067", "MN": "D02.092.146.113.385", "PA": "Voltage-Gated Sodium Channel Blockers", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Benzamide, 4-methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)-, (+-)-", "RN": "SY3J0147NB", "RR": "66794-74-9 (Encainide Hydrochloride)", "PI": "Anti-Arrhythmia Agents (1966-1991)", "MS": "One of the ANTI-ARRHYTHMIA AGENTS, it blocks VOLTAGE-GATED SODIUM CHANNELS and slows conduction within the His-Purkinje system and MYOCARDIUM.", "OL": "use ENCAINIDE (NM) to search ENCAINIDE 1980-91", "PM": "92; ENCAINIDE was indexed under ANILIDES 1979-91", "HN": "92; was ENCAINIDE (NM) 1979-91", "MR": "20160701", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016700"}, {"RECTYPE": "D", "MH": "Guinea", "AQ": "EH EP", "PRINT ENTRY": "Guinea, French|T083|NAM|EQV|NLM (1992)|901231|abcdef", "ENTRY": "Republic of Guinea|T083|NAM|EQV|NLM (2009)|080327|abcdef", "MN": "Z01.058.290.190.375", "MH_TH": "NLM (2009)", "ST": "T083", "AN": "entry term FRENCH GUINEA was its former name; do not confuse with GUINEA-BISSAU (formerly Portuguese Guinea) or EQUATORIAL GUINEA (formerly Spanish Guinea); do not confuse with GUYANA in South America", "PI": "Africa, Western (1966-1991)", "MS": "A republic in western Africa, south of SENEGAL and MALI, east of GUINEA-BISSAU. Its capital is Conakry.", "HN": "92; was REPUBLIC OF GUINEA see AFRICA, WESTERN 1988-91; was see GUINEA-BISSAU 1980-82; was heading 1966-79", "MR": "20080708", "DA": "19910211", "DC": "4", "DX": "19920101", "UI": "D016701"}, {"RECTYPE": "D", "MH": "Equatorial Guinea", "AQ": "EH EP", "PRINT ENTRY": "Rio Muni|T083|NAM|NRW|NLM (1992)|901207|abcdef", "ENTRY": "Spanish Guinea|T083|NAM|EQV|NLM (1992)|901207|abcdef", "MN": "Z01.058.290.100.300", "MH_TH": "NLM (2009)", "ST": "T083", "AN": "formerly Spanish Guinea; do not confuse with GUINEA (formerly French Guinea) or GUINEA-BISSAU (formerly Portuguese Guinea); in titles & translations spell R\u00edo Muni with accent", "PI": "Africa, Central (1966-1991)", "MS": "A republic in central Africa, bordering the Bay of Biafra, CAMEROON is to the north and GABON to the south. Its capital is Malabo.", "HN": "92; was see AFRICA, CENTRAL 1987-91", "MR": "20130709", "DA": "19910211", "DC": "4", "DX": "19920101", "UI": "D016703"}, {"RECTYPE": "D", "MH": "Synapsins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Synapsin III|T116|T123|NON|NRW|NLM (2005)|031021|abbcdef", "MN": "D12.776.744.840", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "PI": "Phosphoproteins (1970-1991)", "MS": "A family of synaptic vesicle-associated proteins involved in the short-term regulation of NEUROTRANSMITTER release. Synapsin I, the predominant member of this family, links SYNAPTIC VESICLES to ACTIN FILAMENTS in the presynaptic nerve terminal. These interactions are modulated by the reversible PHOSPHORYLATION of synapsin I through various signal transduction pathways. The protein is also a substrate for cAMP- and CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES. It is believed that these functional properties are also shared by synapsin II.", "PM": "1992", "HN": "1992; use SYNAPSINS (NM) 1981-1991", "MR": "20200527", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016704"}, {"RECTYPE": "D", "MH": "Still's Disease, Adult-Onset", "DE": "STILLS DIS ADULT ONSET", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stills Disease, Adult-Onset", "MN": "C20.111.199.870", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "a type of rheum arthritis; do not confuse with STILL'S DISEASE, JUVENILE-ONSET", "PI": "Arthritis, Juvenile Rheumatoid (1966-1991)", "MS": "Systemic-onset rheumatoid arthritis in adults. It differs from classical rheumatoid arthritis in that it is more often marked by acute febrile onset, and generalized lymphadenopathy and hepatosplenomegaly are more prominent.", "OL": "use ARTHRITIS, JUVENILE RHEMUMATOID to search STILL'S DISEASE 1975-91", "PM": "92; STILL'S DISEASE was see ARTHRITIS, JUVENILE RHEUMATOID 1975-91", "HN": "92; STILL'S DISEASE was see ARTHRITIS, JUVENILE RHEUMATOID 1975-91", "CATSH": "CAT LIST", "MR": "20130710", "DA": "19910125", "DC": "1", "DX": "19920101", "UI": "D016706"}, {"RECTYPE": "D", "MH": "Tissue Fixation", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Fixation, Tissue|T059|NON|EQV|NLM (1992)|901207|abcdef", "MN": "E05.200.750.600.760.720", "FX": "Fixatives", "MH_TH": "NLM (1992)", "ST": "T059", "MS": "The technique of using FIXATIVES in the preparation of cytologic, histologic, or pathologic specimens for the purpose of maintaining the existing form and structure of all the constituent elements.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016707"}, {"RECTYPE": "D", "MH": "Synaptophysin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p38 Membrane Protein, Synaptic Vesicle|T116|T123|NON|EQV|NLM (2013)|120502|abbcdef", "MN": "D23.101.140.800", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1966-1991)", "MS": "A MARVEL domain-containing protein found in the presynaptic vesicles of NEURONS and NEUROENDOCRINE CELLS. It is commonly used as an immunocytochemical marker for neuroendocrine differentiation.", "OL": "use SYNAPTOPHYSIN (NM) to search SYNAPTOPHYSIN 1985-91", "PM": "92; SYNAPTOPHYSIN was indexed under MEMBRANE PROTEINS 1985-91", "HN": "92; was SYNAPTOPHYSIN (NM) 1985-91", "MR": "20151124", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016708"}, {"RECTYPE": "D", "MH": "Yin-Yang", "AQ": "HI", "ENTRY": "Yin Yang", "MN": "K01.752.967", "FX": "Yin Deficiency", "MH_TH": "NLM (1992)", "ST": "T078", "AN": "yang exuberance syndrome can go here, defic syndromes: index YIN DEFICIENCY or YANG DEFICIENCY: see notes there", "PI": "Medicine, Chinese Traditional (1968-1991)", "MS": "In Chinese philosophy and religion, two principles, one negative, dark, and feminine (yin) and one positive, bright, and masculine (yang), from whose interaction all things are produced and all things are dissolved. As a concept the two polar elements referred originally to the shady and sunny sides of a valley or a hill but it developed into the relationship of any contrasting pair: those specified above (female-male, etc.) as well as cold-hot, wet-dry, weak-strong, etc. It is not a distinct system of thought by itself but permeates Chinese life and thought. A balance of yin and yang is essential to health. A deficiency of either principle can manifest as disease. (Encyclopedia Americana)", "PM": "92", "HN": "92", "MR": "20090706", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016709"}, {"RECTYPE": "D", "MH": "Yin Deficiency", "DE": "YIN DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Yinxu|T033|T046|NON|EQV|NLM (1992)|901228|abbcdef", "ENTRY": "Yin Deficiencies", "MN": "C23.550.972", "FX": "Yin-Yang", "MH_TH": "NLM (1992)", "ST": "T046", "AN": "coord IM with clin manifest (IM) or precoord organ/dis term (IM)", "PI": "Medicine, Chinese Traditional (1983-1991)", "MS": "In the YIN-YANG system of philosophy and medicine, an insufficiency of body fluid (called yinxu), manifesting often as irritability, thirst, constipation, etc. (The Pinyin Chinese-English Dictionary, 1979).", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016710"}, {"RECTYPE": "D", "MH": "Yang Deficiency", "DE": "YANG DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Yangxu|T033|T046|NON|EQV|NLM (1992)|901228|abbcdef", "ENTRY": "Xu, Yang", "MN": "C23.550.945", "FX": "Yin-Yang", "MH_TH": "NLM (1992)", "ST": "T046", "AN": "coord IM with clin manifest (IM) or precoord organ/dis term (IM)", "PI": "Medicine, Chinese Traditional (1983-1991)", "MS": "In the YIN-YANG system of philosophy and medicine, a lack of vital energy (called yangxu in Chinese). It manifests itself in various systemic and organic diseases. (The Pinyin Chinese-English Dictionary, 1979)", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016711"}, {"RECTYPE": "D", "MH": "Mupirocin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pseudomonic Acid|T109|NON|BRD|FDA SRS (2014)|NLM (1992)|901210|abcdeef", "ENTRY": "Mupirocin, 14C Labeled", "MN": "D10.251.536", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Nonanoic acid, 9-((3-methyl-1-oxo-4-(tetrahydro-3,4-dihydroxy-5-((3-(2-hydroxy-1-methylpropyl)oxiranyl)methyl)-2H-pyran-2-yl)-2-butenyl)oxy)-, (2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))-", "RN": "D0GX863OA5", "RR": "RG38I2P540", "PI": "Fatty Acids (1966-1991)", "MS": "A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.", "OL": "use MUPIROCIN (NM) to search PSEUDOMONIC ACID (NM) 1980-91", "PM": "1992; PSEUDOMONIC ACID was indexed under ANTIBIOTICS 1977-91", "HN": "1992; was PSEUDOMONIC ACID (NM) 1977-91", "MR": "20180521", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016712"}, {"RECTYPE": "D", "MH": "Ritanserin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R55667", "MN": "D03.383.742.698.700", "PA": "Serotonin Antagonists", "MH_TH": "USAN (1985)", "ST": "T121", "N1": "5H-Thiazolo(3,2-a)pyrimidin-5-one, 6-(2-(4-(bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-", "RN": "145TFV465S", "RR": "98185-19-4 (HCl)", "PI": "Piperidines (1966-1991)", "MS": "A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.", "OL": "use RITANSERIN (NM) to search RITANSERIN 1985-91", "PM": "92; RITANSERIN was indexed under PIPERIDINES 1985-91", "HN": "92; was RITANSERIN (NM) 1985-91", "MR": "20160531", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016713"}, {"RECTYPE": "D", "MH": "Proteus Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Elephant Man Disease|T191|NON|EQV|NLM (1992)|910103|ELEPHANT MAN DIS|abcdefv", "ENTRY": "Syndrome, Proteus-Like", "MN": "C16.131.621.585.620", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "hamartomas & multiple abnorm; \"Proteus\" refers to the sea god in Greek mythol who could assume many forms; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Neurofibromatosis 1 (1979-1990)", "MS": "Hamartoneoplastic malformation syndrome of uncertain etiology characterized by partial GIGANTISM of the hands and/or feet, asymmetry of the limbs, plantar hyperplasia, hemangiomas (HEMANGIOMA), lipomas (LIPOMA), lymphangiomas (LYMPHANGIOMA), epidermal NEVI; MACROCEPHALY; cranial HYPEROSTOSIS, and long-bone overgrowth. Joseph Merrick, the so-called \"elephant man\", apparently suffered from Proteus syndrome and not NEUROFIBROMATOSIS, a disorder with similar characteristics.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016715"}, {"RECTYPE": "D", "MH": "PC12 Cells", "DS": "PC A 012 CELLS", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Pheochromocytoma Cell Line|T025|NON|EQV|NLM (1992)|901213|abcdef", "ENTRY": "Pheochromocytoma Cell Lines", "MN": "A11.299.500", "MH_TH": "NLM (1992)", "ST": "T025", "AN": "PC stands for PheochromoCytoma; almost always NIM with no subheadings; check ANIMAL; & RATS; do not routinely add PHEOCHROMOCYTOMA or ADRENAL GLAND NEOPLASMS", "PI": "Tumor Cells, Cultured (1987-1991)", "MS": "A CELL LINE derived from a PHEOCHROMOCYTOMA of the rat ADRENAL MEDULLA. PC12 cells stop dividing and undergo terminal differentiation when treated with NERVE GROWTH FACTOR, making the line a useful model system for NERVE CELL differentiation.", "PM": "92", "HN": "92", "MR": "20030709", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016716"}, {"RECTYPE": "D", "MH": "Sphincterotomy, Endoscopic", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Endoscopic Sphincterotomy|T060|T061|NON|EQV|NLM (1992)|901218|abbcdef", "ENTRY": "Sphincterotomy, Endoscopic Biliary", "MN": "E04.515.750.500", "FX": "Cholangiopancreatography, Endoscopic Retrograde", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "refers to SPHINCTER OF ODDI or VATER'S AMPULLA only; coordinate with disease /surg, not  /diag;  /instrum is probably DUODENOSCOPES", "PI": "Vater's Ampulla/surgery (1974-1991)", "MS": "Incision of SPHINCTER OF ODDI or VATER'S AMPULLA performed by inserting a sphincterotome through DUODENOSCOPE often following or performed during ERCP (ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY).", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016717"}, {"RECTYPE": "D", "MH": "Arachidonic Acid", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Arachidonate, Sodium", "MN": "D10.251.355.310.166.100", "EC": "analogs & derivatives:Arachidonic Acids", "MH_TH": "NLM (1992)", "ST": "T109", "N1": "5,8,11,14-Eicosatetraenoic acid, (all-Z)-", "RN": "27YG812J1I", "RR": "97011-20-6 (Li salt (all-Z)-isomer)", "AN": "do not confuse with ARACHIDONIC ACIDS", "PI": "Arachidonic Acids (1975-1991)", "MS": "An unsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins, thromboxanes, and leukotrienes.", "OL": "use ARACHIDONIC ACID (NM) to search ARACHIDONIC ACID 1977-91", "PM": "92; ARACHIDONIC ACID was indexed under ARACHIDONIC ACIDS 1981-91", "HN": "92; was ARACHIDONIC ACID (NM) 1981-91", "MR": "20150623", "DA": "19910208", "DC": "1", "DX": "19920101", "UI": "D016718"}, {"RECTYPE": "D", "MH": "Radioimmunodetection", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Radioimmunoscintigraphy|T060|NON|EQV|NLM (1992)|901220|RADIOIMMUNOSCINTIGR|abcdefv", "ENTRY": "Radiolabelled Immunoscintigraphies", "MN": "E05.478.805", "MH_TH": "NLM (1992)", "ST": "T060", "AN": "coordinate with disease /diag image + specific radioisotope", "PI": "Radionuclide Imaging (1980-1991)", "MS": "Use of radiolabeled antibodies for diagnostic imaging of neoplasms. Antitumor antibodies are labeled with diverse radionuclides including iodine-131, iodine-123, indium-111, or technetium-99m and injected into the patient. Images are obtained by a scintillation camera.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016719"}, {"RECTYPE": "D", "MH": "Pneumocystis Infections", "DE": "PNEUMOCYSTIS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pneumocystis jirovecii Infection|T047|NON|NRW|NLM (2021)|200207|abcdef", "ENTRY": "Pneumocystis jirovecii Infections", "MN": "C01.150.703.770", "MH_TH": "NLM (2004)", "ST": "T047", "AN": "coordinate with precoordinated organ/disease term  but consider more commonly PNEUMONIA, PNEUMOCYSTIS", "PI": "Protozoan Infections (1985-1988)", "MS": "Infections with species in the genus PNEUMOCYSTIS, a fungus causing interstitial plasma cell pneumonia (PNEUMONIA, PNEUMOCYSTIS) and other infections in humans and other MAMMALS. Immunocompromised patients, especially those with AIDS, are particularly susceptible to these infections. Extrapulmonary sites are rare but seen occasionally.", "PM": "2004; see PNEUMOCYSTIS CARINII INFECTIONS 1992-2003", "HN": "2004 (1992)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016720"}, {"RECTYPE": "D", "MH": "Radiation Leukemia Virus", "DE": "RAD LEUKEMIA VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "RadLV|T005|EQV|NLM (1992)|910128|abdef", "ENTRY": "Radiation Leukemia Viruses", "MN": "B04.820.650.375.525.750", "MH_TH": "NLM (1992)", "ST": "T005", "RN": "txid11787", "AN": "infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + LEUKEMIA, EXPERIMENTAL (IM) or LEUKEMIA (IM) (for spontaneous leukemia)", "PI": "Retroviridae (1966-1987)", "MS": "A strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) isolated from radiation-induced lymphomas in C57BL mice. It is leukemogenic, thymotrophic, can be transmitted vertically, and replicates only in vivo.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016721"}, {"RECTYPE": "D", "MH": "Cermet Cements", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Cermet|T122|ABB|EQV|NLM (1997)|960229|abcdef", "ENTRY": "KetacSilver", "MN": "J01.637.051.339.291.402.120", "MH_TH": "NLM (1992)", "ST": "T122", "RN": "0", "PI": "Silver (1988-1991)", "MS": "Fluoride-releasing restorative materials made by the sintering of metal (usually silver) particles to glass ionomer powder. Glass ionomers are fluoride-releasing cements that are not very durable. Sintering of the metal particles is a means of improving those physical properties that will make the glass ionomer cement more durable.", "PM": "92", "HN": "92", "MR": "20060705", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016722"}, {"RECTYPE": "D", "MH": "Bone Remodeling", "AQ": "DE GE IM PH RE", "ENTRY": "Turnovers, Bone", "MN": "G16.762.150", "MH_TH": "NLM (1992)", "ST": "T042", "AN": "note category: an aspect of bone physiol", "PI": "Bone Resorption (1967-1991)", "MS": "The continuous turnover of BONE MATRIX and mineral that involves first an increase in BONE RESORPTION (osteoclastic activity) and later, reactive BONE FORMATION (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium HOMEOSTASIS. An imbalance in the regulation of bone remodeling's two contrasting events, bone resorption and bone formation, results in many of the metabolic bone diseases, such as OSTEOPOROSIS.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016723"}, {"RECTYPE": "D", "MH": "Empyema, Pleural", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pyothorax|T047|NON|EQV|NLM (1992)|901228|abcdef", "ENTRY": "Thoracic Empyemas", "MN": "C23.550.470.756.305.250", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Empyema (1966-1991)", "MS": "Suppurative inflammation of the pleural space.", "OL": "use EMPYEMA to search EMPYEMA, PLEURAL & PYOTHORAX 1984-91", "PM": "92; was see EMPYEMA 1984-91; PYOTHORAX was see EMPYEMA 1984-91", "HN": "92; was see EMPYEMA 1984-91; PYOTHORAX was see EMPYEMA 1984-91", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016724"}, {"RECTYPE": "D", "MH": "Plasma Cell Granuloma, Pulmonary", "DE": "PLASMA CELL GRANULOMA PULM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Inflammatory Pseudotumor of Lung|T047|NON|EQV|NLM (1992)|901231|INFLAMM PSEUDOTUMOR LUNG|abcdefv", "ENTRY": "Pulmonary Pseudotumors, Inflammatory", "MN": "C08.381.600", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "non-neoplastic", "PI": "Lung Diseases (1966-1991)", "MS": "A tumor-like inflammatory lesion of the lung that is composed of PLASMA CELLS and fibrous tissue. It is also known as an inflammatory pseudotumor, often with calcification and measuring between 2 and 5 cm in diameter.", "PM": "2009; see GRANULOMA, PLASMA CELL, PULMONARY 1992-2008", "HN": "2009 (1992)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016726"}, {"RECTYPE": "D", "MH": "Orbital Pseudotumor", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Inflammatory Pseudotumor, Orbital|T047|NON|EQV|NLM (1992)|901231|INFLAMM PSEUDOTUMOR ORBITAL|abcdefv", "ENTRY": "Pseudotumors, Orbital", "MN": "C11.675.679", "MH_TH": "NLM (2009)", "ST": "T047", "AN": "non-neoplastic", "PI": "Orbital Diseases (1981-1991)", "MS": "A nonspecific tumor-like inflammatory lesion in the ORBIT of the eye. It is usually composed of mature LYMPHOCYTES; PLASMA CELLS; MACROPHAGES; LEUKOCYTES with varying degrees of FIBROSIS. Orbital pseudotumors are often associated with inflammation of the extraocular muscles (ORBITAL MYOSITIS) or inflammation of the lacrimal glands (DACRYOADENITIS).", "PM": "2009; see GRANULOMA, PLASMA CELL, ORBITAL 1992-2008", "HN": "2009 (1992)", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19910211", "DC": "1", "DX": "19920101", "UI": "D016727"}, {"RECTYPE": "D", "MH": "Self-Injurious Behavior", "DE": "SELF INJ BEHAVIOR", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Self-Destructive Behavior|T055|T184|NON|EQV|NLM (1992)|910228|abbcdef", "ENTRY": "Self-Injurious Behaviors", "MN": "F01.145.126.980", "MH_TH": "NLM (1992)", "ST": "T184", "AN": "SELF MUTILATION is also available", "PI": "Self Mutilation (1968-1991)", "MS": "Behavior in which persons hurt or harm themselves without the motive of suicide or of sexual deviation.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016728"}, {"RECTYPE": "D", "MH": "Leuprolide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Leuprorelin|T116|T121|T123|T125|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|NLM (1992)|910103|abbbbcdeeeef", "ENTRY": "TAP144", "MN": "D12.776.631.650.405.740.320.400", "PA": "Fertility Agents, Female", "MH_TH": "NLM (1992)", "ST": "T125", "N1": "Luteinizing hormone-releasing factor (pig), 6-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-", "RN": "EFY6W0M8TG", "RR": "88793-81-1 (acetate)", "PI": "Gonadorelin/analogs & derivatives (1980-1991)", "MS": "A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE that regulates the synthesis and release of pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE.", "OL": "use LEUPROLIDE (NM) to search LEUPROLIDE 1980-91", "PM": "92; LEUPROLIDE was indexed under PEPTIDES 1975-76 & GONADORELIN/analogs & derivatives 1977-91", "HN": "92; was LEUPROLIDE (NM) 1975-91", "MR": "20151124", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016729"}, {"RECTYPE": "D", "MH": "Program Development", "AQ": "EC MT SN ST", "ENTRY": "Program Description", "MN": "N04.452.760", "MH_TH": "NLM (1992)", "ST": "T057", "AN": "coord IM with specific subject (IM); not for computer programs", "MS": "The process of formulating, improving, and expanding educational, managerial, or service-oriented work plans (excluding computer program development).", "PM": "92", "HN": "92", "MR": "20100625", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016730"}, {"RECTYPE": "D", "MH": "Erythema Infectiosum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Fifth Disease|T047|NON|EQV|NLM (1992)|ORD (2010)|910104|FIFTH DIS|abcdeefv", "ENTRY": "Parvovirus B19 Infections", "MN": "C17.800.838.790.260", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Virus Diseases (1966-1982)", "MS": "Contagious infection with human B19 Parvovirus most commonly seen in school age children and characterized by fever, headache, and rashes of the face, trunk, and extremities. It is often confused with RUBELLA.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016731"}, {"RECTYPE": "D", "MH": "Parvovirus B19, Human", "DS": "PARVOVIRUS B HUMAN 19", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Parvovirus B19|T005|NON|EQV|NLM (2021)|200131|abcdef", "ENTRY": "Parvovirus B19s", "MN": "B04.280.580.650.200.650", "FX": "Erythema Infectiosum", "MH_TH": "NLM (1992)", "ST": "T005", "RN": "txid10798", "PI": "Parvoviridae (1981-1991)", "MS": "The type species of ERYTHROVIRUS and the etiological agent of ERYTHEMA INFECTIOSUM, a disease most commonly seen in school-age children.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016732"}, {"RECTYPE": "D", "MH": "Rubber Dams", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Rubberdams", "MN": "E07.222.670", "MH_TH": "NLM (1992)", "ST": "T074", "PI": "Dentistry, Operative/instrumentation (1977-1991)", "MS": "Sheets of latex rubber punched and placed over the teeth during dental procedures to isolate the field of operation from the rest of the oral cavity (Jablonski; Illustrated Dictionary of Dentistry, 1982). Rubber dams are useful in preventing the swallowing of instruments or restorations during dental work.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "19920421", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016733"}, {"RECTYPE": "D", "MH": "Dental Clasps", "DE": "DENT CLASPS", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Denture Clasps|T074|NON|EQV|NLM (1992)|910228|abcdef", "ENTRY": "Denture Clasp", "MN": "E07.695.190.180", "MH_TH": "NLM (1992)", "ST": "T074", "AN": "for any prosthesis; do not confuse entry term DENTURE CLASPS with DENTURE PRECISION ATTACHMENT, a special type of precision device for use with partial dentures; do not use for orthodontic clasps", "PI": "Denture, Partial, Removable (1966-1991)", "MS": "Metal devices for fastening together two or more parts of dental prostheses for stabilizing or retaining them by attachment to abutment teeth. For a precision attachment for a partial denture DENTURE PRECISION ATTACHMENT is available.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016734"}, {"RECTYPE": "D", "MH": "Munchausen Syndrome by Proxy", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM LJ ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "MN": "F03.875.375.800", "FX": "Child Abuse", "MH_TH": "NLM (1992)", "ST": "T048", "PI": "Munchausen Syndrome (1977-1991)", "MS": "A phenomenon in which symptoms of a disease are fabricated by an individual other than the patient causing unnecessary, and often painful, physical examinations and treatments. This syndrome is considered a form of CHILD ABUSE, since another individual, usually a parent, is the source of the fabrication of symptoms and presents the child for medical care.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016735"}, {"RECTYPE": "D", "MH": "Antiphospholipid Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Hughes", "MN": "C20.111.197", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Phospholipids/immunology (1977-1991)", "MS": "The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).", "OL": "use ANTIPHOSPHOLIPID SYNDROME to search PHOSPHOLIPID ANTIBODY SYNDROME 1992", "PM": "92; PHOSPHOLIPID ANTIBODY SYNDROME was see ANTIPHOSPHOLIPID SYNDROME 1992", "HN": "92; PHOSPHOLIPID ANTIBODY SYNDROME was see ANTIPHOSPHOLIPID SYNDROME 1992", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016736"}, {"RECTYPE": "D", "MH": "Proctocolectomy, Restorative", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Coloproctectomy, Restorative|T061|NON|EQV|NLM (1992)|910311|abcdef", "ENTRY": "Total Proctocolectomies", "MN": "E04.210.895.500", "FX": "Pouchitis", "MH_TH": "NLM (1992)", "ST": "T061", "PI": "Colectomy (1981-1991)", "MS": "A surgical procedure involving the excision of the COLON and RECTUM and the formation of an ILEOANAL RESERVOIR (pouch). In patients with intestinal diseases, such as ulcerative colitis, this procedure avoids the need for an OSTOMY by allowing for transanal defecation.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016737"}, {"RECTYPE": "D", "MH": "Alagille Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dysplasia, Arteriohepatic|T019|T047|NON|EQV|NLM (1992)|910109|abbcdef", "ENTRY": "syndrome, Watson-Miller", "MN": "C16.320.051", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Pulmonary Artery/abnormalities (1988-1991)", "MS": "A multisystem disorder that is characterized by aplasia of intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC), and malformations in the cardiovascular system, the eyes, the vertebral column, and the facies. Major clinical features include JAUNDICE, and congenital heart disease with peripheral PULMONARY STENOSIS. Alagille syndrome may result from heterogeneous gene mutations, including mutations in JAG1 on CHROMOSOME 20 (Type 1) and NOTCH2 on CHROMOSOME 1 (Type 2).", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016738"}, {"RECTYPE": "D", "MH": "Behavior, Addictive", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Addictive Behavior|T048|T055|NON|EQV|NLM (1992)|910109|abbcdef", "ENTRY": "Behaviors, Addictive", "MN": "F01.145.527.100.120", "FX": "Substance-Related Disorders", "MH_TH": "NLM (1992)", "ST": "T055", "PI": "Substance Dependence (1974-1991)", "MS": "The observable, measurable, and often pathological activity of an organism that portrays its inability to overcome a habit resulting in an insatiable craving for a substance or for performing certain acts. The addictive behavior includes the emotional and physical overdependence on the object of habit in increasing amount or frequency.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016739"}, {"RECTYPE": "D", "MH": "Meridians", "AQ": "CL", "PRINT ENTRY": "Jingluo|T029|NON|EQV|NLM (1992)|910109|abcdef", "ENTRY": "Luo, Jing", "MN": "I01.076.201.450.654.558.520.300.500", "MH_TH": "NLM (1992)", "ST": "T029", "AN": "not for meridians in ophthalmology: index under OPTICS AND PHOTONICS (IM) + EYE; CORNEA; VISUAL FIELD or other applicable ophthalmologic term (IM)", "PI": "Acupuncture (1968-1991)", "MS": "Classical loci in ACUPUNCTURE. They are main and collateral channels, regarded as a network of passages, through which vital energy (Qi) circulates and along which acupoints (ACUPUNCTURE POINTS) are distributed. The meridians are a series of 14 lines upon which more than 400 acupoints are located on the body. (The Pinyin Chinese-English Dictionary, p. 359; Dr. Wu Lancheng, Academy of Traditional Chinese Medicine, Beijing)", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20090714", "DA": "19910531", "DC": "1", "DX": "19920101", "UI": "D016740"}, {"RECTYPE": "D", "MH": "Urinary Sphincter, Artificial", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Genitourinary Sphincter, Artificial|T074|NON|EQV|NLM (1992)|910109|abcdef", "ENTRY": "Urinary Sphincters, Artificial", "MN": "E07.858.082.900", "MH_TH": "NLM (1992)", "ST": "T074", "AN": "/psychol permitted", "PI": "Urinary Incontinence/surgery (1969-1991)", "MS": "An artifical implanted device, usually in the form of an inflatable silicone cuff, inserted in or around the bladder neck in the surgical treatment of urinary incontinence caused by sphincter weakness. Often it is placed around the bulbous urethra in adult males. The artificial urinary sphincter is considered an alternative to urinary diversion.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016741"}, {"RECTYPE": "D", "MH": "Preconception Care", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Care, Preconception", "MN": "N02.421.920.660", "FX": "Prenatal Care", "MH_TH": "NLM (1992)", "ST": "T058", "AN": "may refer to prospective mother or father", "PI": "Pregnancy (1981-1991)", "MS": "An organized and comprehensive program of health care that identifies and reduces a woman's reproductive risks before conception through risk assessment, health promotion, and interventions. Preconception care programs may be designed to include the male partner in providing counseling and educational information in preparation for fatherhood, such as genetic counseling and testing, financial and family planning, etc. This concept is different from PRENATAL CARE, which occurs during pregnancy.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19910507", "DC": "1", "DX": "19920101", "UI": "D016742"}, {"RECTYPE": "D", "MH": "Mental Competency", "AQ": "CL LJ PX ST", "PRINT ENTRY": "Incompetency, Mental|T080|NON|REL|NLM (1992)|910109|abcdef", "ENTRY": "Mental Incompetency", "MN": "N03.706.535.625", "FX": "Treatment Refusal", "MH_TH": "NLM (1992)", "ST": "T080", "AN": "in mental retard or organic or psychiat mental disord; coord IM with concomitant disord /psychol (IM); competency to consent: coord IM with INFORMED CONSENT (IM)", "PI": "Mental Retardation (1966-1991)", "MS": "The ability to understand the nature and effect of the act in which the individual is engaged. (From Black's Law Dictionary, 6th ed).", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19910726", "DC": "1", "DX": "19920101", "UI": "D016743"}, {"RECTYPE": "D", "MH": "Minor Lymphocyte Stimulatory Loci", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Mls Loci|T028|EQV|NLM (1992)|910110|abdef", "ENTRY": "Mls Locus", "MN": "G12.500.560", "FX": "Minor Lymphocyte Stimulatory Antigens", "MH_TH": "NLM (1992)", "ST": "T028", "MS": "Genetic loci responsible for the encoding of minor lymphocyte stimulatory antigens. There are at least two unlinked loci (in the mouse) and they appear to be separate from the MAJOR HISTOCOMPATIBILITY COMPLEX and MINOR HISTOCOMPATIBILITY LOCI. The mouse mammary tumor virus (see MAMMARY TUMOR VIRUS, MOUSE) has the ability to integrate into these loci. The antigens induce strong T-cell proliferative responses in mixed lymphocyte reactions.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016744"}, {"RECTYPE": "D", "MH": "Root Planing", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Root Planings", "MN": "E06.761.227.350.650", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "do not confuse with ROOT SCALING see DENTAL SCALING", "PI": "Tooth Root (1966-1991)", "MS": "A procedure for smoothing of the roughened root surface or cementum of a tooth after subgingival curettage or scaling, as part of periodontal therapy.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016745"}, {"RECTYPE": "D", "MH": "Transcultural Nursing", "DE": "TRANSCULTURAL NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Nursing, Transcultural|T058|T091|NON|EQV|NLM (1992)|910111|NURS TRANSCULTURAL|abbcdefv", "MN": "H02.478.676.920", "FX": "Ethnopsychology", "MH_TH": "NLM (1992)", "ST": "T091", "AN": "specialty; on an international or cultural level only; coordinate IM with nursing specialty (IM) if pertinent + culture or ethnic group (IM) if pertinent; specify geography; consider also CULTURAL COMPETENCY", "PI": "Primary Nursing Care (1977-1991)", "MS": "A nursing specialty created to answer the need for developing a global perspective in the practice of nursing in a world of interdependent nations and people. The focus of this nursing discipline is on the integration of international and transcultural content into the training. Courses include study in the area of cultural differences, nursing in other countries, and international health issues and organizations, as an example.", "PM": "92", "HN": "92", "MR": "20190524", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016746"}, {"RECTYPE": "D", "MH": "Minor Lymphocyte Stimulatory Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Mls Determinants|T116|T129|EQV|NLM (1992)|910114|abbdef", "ENTRY": "Minor Lymphocyte Stimulating Determinants", "MN": "D23.050.820.625", "MH_TH": "NLM (1992)", "ST": "T129", "RN": "0", "MS": "Endogenous superantigens responsible for inducing strong proliferative responses in T-cells in mixed lymphocyte reactions (see LYMPHOCYTE CULTURE TEST, MIXED). They are encoded by mouse mammary tumor viruses that have integrated into the germ line as DNA proviruses (MINOR LYMPHOCYTE STIMULATORY LOCI).", "OL": "use MINOR LYMPHOCYTE STIMULATORY ANTIGENS (NM) to search MLS ANTIGENS 1987-91", "PM": "92; MLS ANTIGENS was indexed under ANTIGENS, SURFACE 1987-91", "HN": "92; was MLS ANTIGENS (NM) 1987-91", "MR": "20050630", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016747"}, {"RECTYPE": "D", "MH": "Venous Cutdown", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Venostomy|T061|NON|EQV|NLM (1992)|910114|abcdef", "ENTRY": "Venous Cutdowns", "MN": "E04.100.814.895", "MH_TH": "NLM (1992)", "ST": "T061", "MS": "Creation of a small incised opening in a vein to permit the passage of a needle or cannula for withdrawal of blood, administration of medication, or in diagnostic or therapeutic catheterization. (Dorland, 28th ed.; Stedman, 26th ed.)", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016748"}, {"RECTYPE": "D", "MH": "National Practitioner Data Bank", "AQ": "EC HI LJ SN", "ENTRY": "Practitioner Databanks, National", "MN": "L01.470.750.750.600", "MH_TH": "NLM (1992)", "ST": "T170", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "PI": "Malpractice (1989-1991)", "MS": "A databank established by the Health Care Quality Improvement Act of 1986 authorizing the Department of Health and Human Services to collect and release information on the professional competence and conduct of physicians, dentists, nurses, and other health care practitioners. The data include adverse actions on physicians' malpractice, licensure, hospital privileges, concealing of pertinent information, and the like.", "PM": "92", "HN": "92", "MR": "20180629", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016749"}, {"RECTYPE": "D", "MH": "Stiff-Person Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stiff-Man Syndrome|T047|NON|EQV|NLM (1992)|OMIM (2013)|ORD (2010)|990101|abcdeeef", "ENTRY": "Syndromes, Stiff-Trunk", "MN": "C20.111.258.850", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Neuromuscular Diseases (1972-1991)", "MS": "A condition characterized by persistent spasms (SPASM) involving multiple muscles, primarily in the lower limbs and trunk. The illness tends to occur in the fourth to sixth decade of life, presenting with intermittent spasms that become continuous. Minor sensory stimuli, such as noise and light touch, precipitate severe spasms. Spasms do not occur during sleep and only rarely involve cranial muscles. Respiration may become impaired in advanced cases. (Adams et al., Principles of Neurology, 6th ed, p1492; Neurology 1998 Jul;51(1):85-93)", "PM": "2000; see STIFF-MAN SYNDROME 1992-1999", "HN": "2000(1992)", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016750"}, {"RECTYPE": "D", "MH": "Hepatitis E", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Hepatitis, Water-Borne|T047|NON|EQV|NLM (1992)|910116|abcdef", "ENTRY": "Water-Borne Hepatitis", "MN": "C06.552.380.705.470", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Hepatitis, Viral, Human (1990-1991)", "MS": "Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016751"}, {"RECTYPE": "D", "MH": "Hepatitis E virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Paslahepevirus balayani|T005|NON|REL|NLM (2024)|230410|abcdef", "ENTRY": "Paslahepeviruses", "MN": "B04.820.578.407.400", "MH_TH": "NLM (1992)", "ST": "T005", "RN": "txid12461", "RR": "txid31767", "PI": "Hepatitis Viruses (1990-1991)", "MS": "A positive-stranded RNA virus species, causing enterically-transmitted non-A, non-B hepatitis (HEPATITIS E).", "PM": "92", "HN": "92", "MR": "20230531", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016752"}, {"RECTYPE": "D", "MH": "Interleukin-10", "DS": "INTERLEUKIN 010", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "IL-10|T116|T129|ABB|EQV|NLM (1992)|910321|IL 010|abbcdefs", "ENTRY": "Interleukin 10", "MN": "D23.529.374.465.510", "MH_TH": "NLM (1992)", "ST": "T129", "N1": "Cytokine formation-inhibiting factor (mouse clone F115 protein moiety reduced)", "RN": "130068-27-8", "PI": "Interleukins (1990-1991)", "MS": "A cytokine produced by a variety of cell types, including T-LYMPHOCYTES; MONOCYTES; DENDRITIC CELLS; and EPITHELIAL CELLS that exerts a variety of effects on immunoregulation and INFLAMMATION. Interleukin-10 combines with itself to form a homodimeric molecule that is the biologically active form of the protein.", "OL": "use INTERLEUKIN-10 (NM) to search INTERLEUKIN-10 1990-91", "PM": "92; INTERLEUKIN-10 (NM) was indexed under INTERLEUKINS 1990-91", "HN": "92; was INTERLEUKIN-10 (NM) 1990-91", "MR": "20060705", "DA": "19910627", "DC": "1", "DX": "19920101", "UI": "D016753"}, {"RECTYPE": "D", "MH": "Boron Neutron Capture Therapy", "DE": "BNCT", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Boron-Neutron Capture", "MN": "E02.815.722.500.100", "MH_TH": "NLM (1993)", "ST": "T061", "AN": "coordinate with disease /radiother ", "PI": "Radiotherapy, High-Energy (1966-1992)", "MS": "A technique for the treatment of neoplasms, especially gliomas and melanomas in which boron-10, an isotope, is introduced into the target cells followed by irradiation with thermal neutrons.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D016754"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-jun", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p39(c-jun)|T116|T123|EQV|NLM (1992)|910118|P A 039 C JUN|P39C JUN|abbdefsv", "ENTRY": "p39 c jun", "MN": "D12.776.930.127.820", "FX": "Transcription Factor AP-1", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1987-1991)", "MS": "Cellular DNA-binding proteins encoded by the c-jun genes (GENES, JUN). They are involved in growth-related transcriptional control. There appear to be three distinct functions: dimerization (with c-fos), DNA-binding, and transcriptional activation. Oncogenic transformation can take place by constitutive expression of c-jun.", "OL": "use PROTO-ONCOGENE PROTEINS C-JUN (NM) to search PROTO-ONCOGENE PROTEIN JUN (NM) 1988-91", "PM": "92; PROTO-ONCOGENE PROTEIN JUN (NM) was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1988-91", "HN": "92; was PROTO-ONCOGENE PROTEIN JUN (NM) 1988-91", "MR": "20050630", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016755"}, {"RECTYPE": "D", "MH": "Immunoglobulins, Intravenous", "DE": "IG IV", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE ST TO TU UL UR", "PRINT ENTRY": "Intravenous Immunoglobulins|T116|T121|T129|NON|EQV|NLM (1992)|910122|IV IG|abbbcdefv", "ENTRY": "Venoglobulin I", "MN": "D12.776.377.715.548.114.632", "PA": "Immunologic Factors", "MH_TH": "NLM (1992)", "ST": "T129", "RN": "0", "PI": "Immunoglobulins (1970-1991)", "MS": "Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.", "PM": "1992; GLOBULIN-N was indexed under IGG, IGA, & DRUG COMBINATIONS 1986-1991; VENOGLOBULIN was indexed under GAMMA GLOBULINS, FIBRINOLYSIN, & DRUG COMBINATIONS 1983-1991; INTRAGLOBIN was indexed under IGG/analogs 1982-1991; GAMMONATIV was indexed under IGG 1982-1990; MODIFIED IMMUNE GLOBULIN (ANTI-ECHOVIRUS ANTIBODY) was indexed under IMMUNOGLOBULINS & ANTIBODIES, VIRAL 1981-1990; SANDOGLOBULIN was indexed under IGG 1981-1991; GAMUNEX was indexed under CAPRYLATES and IMMUNOGLOBULINS, INTRAVENOUS 2004-2012, FLEBOGAMMA DIF was indexed under IMMUNOGLOBULINS, INTRAVENOUS 2011-2012, PRIVEGEN was indexed under IMMUNOGLOBULINS, INTRAVENOUS 2009-2012", "HN": "1992", "MR": "20200527", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016756"}, {"RECTYPE": "D", "MH": "Death, Sudden, Cardiac", "AQ": "EH EP ET PA PC VE", "PRINT ENTRY": "Sudden Cardiac Death|T033|T046|NON|EQV|NLM (1992)|OMIM (2013)|910123|abbcdeef", "ENTRY": "Sudden Death, Cardiac", "MN": "C23.550.260.322.250", "FX": "Commotio Cordis", "MH_TH": "NLM (1992)", "ST": "T046", "AN": "do not confuse with DEATH, SUDDEN or with HEART ARREST", "PI": "Death, Sudden (1966-1991)", "MS": "Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19910429", "DC": "1", "DX": "19920101", "UI": "D016757"}, {"RECTYPE": "D", "MH": "Genes, jun", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "v-jun Genes|T028|NON|NRW|NLM (1992)|910123|abcdef", "ENTRY": "v-jun Oncogene", "MN": "G05.360.340.024.340.375.500.791.365", "FX": "Proto-Oncogene Proteins c-jun", "MH_TH": "NLM (1992)", "ST": "T028", "AN": "jun stands for \"JU-Nana\", Japanese for 17 (avian sarcoma virus 17)", "PI": "Proto-Oncogenes (1987-1991)", "MS": "Retrovirus-associated DNA sequences (jun) originally isolated from the avian sarcoma virus 17 (ASV 17). The proto-oncogene jun (c-jun) codes for a nuclear protein which is involved in growth-related transcriptional control. Insertion of c-jun into ASV-17 or the constitutive expression of the c-jun protein produces tumorgenicity. The human c-jun gene is located at 1p31-32 on the short arm of chromosome 1.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016758"}, {"RECTYPE": "D", "MH": "Oncogene Protein p65(gag-jun)", "DE": "ONCOGENE PROTEIN P65GAG JUN", "DS": "ONCOGENE PROTEIN P 065 GAG JUN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-jun Protein|T116|EQV|NLM (1992)|910123|abdef", "ENTRY": "v-jun, Oncogene Protein", "MN": "D12.776.964.775.750.320.700", "MH_TH": "NLM (1992)", "ST": "T116", "RN": "0", "PI": "Retroviridae Proteins, Oncogenic (1990-1991)", "MS": "Transforming protein coded by jun oncogenes (GENES, JUN). This is a gag-onc fusion protein of about 65 kDa derived from avian sarcoma virus. v-jun lacks a negative regulatory domain that regulates transcription in c-jun.", "OL": "use ONCOGENE PROTEIN P65(GAG-JUN) (NM) to search ONCOGENE PROTEIN JUN (NM) 1987-91", "PM": "92; ONCOGENE PROTEIN JUN (NM) was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-91 & under RETROVIRIDAE PROTEINS 1987-89", "HN": "92; was ONCOGENE PROTEIN JUN (NM) 1987-91", "MR": "20050630", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016759"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-fos", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p55(c-fos)|T116|T123|EQV|NLM (1992)|910125|P A 055 C FOS|P55C FOS|abbdefsv", "ENTRY": "p55 c fos", "MN": "D12.776.930.127.765", "FX": "Transcription Factor AP-1", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "PI": "Proto-Oncogene Proteins (1985-1991)", "MS": "Cellular DNA-binding proteins encoded by the c-fos genes (GENES, FOS). They are involved in growth-related transcriptional control. c-fos combines with c-jun (PROTO-ONCOGENE PROTEINS C-JUN) to form a c-fos/c-jun heterodimer (TRANSCRIPTION FACTOR AP-1) that binds to the TRE (TPA-responsive element) in promoters of certain genes.", "OL": "use PROTO-ONCOGENE PROTEINS C-FOS (NM) to search PROTO-ONCOGENE PROTEIN FOS (NM) 1985-91 & FOS B PROTEIN (NM) 1990-91", "PM": "92; PROTO-ONCOGENE PROTEIN FOS (NM) was indexed under PROTO-ONCOGENE PROTEINS 1985-91; FOS B PROTEIN (NM) was indexed under NUCLEAR PROTEINS 1990-91", "HN": "92; was PROTO-ONCOGENE PROTEIN FOS (NM) 1985-91; FOS B PROTEIN was FOS B PROTEIN (NM) 1990-91", "MR": "20200527", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016760"}, {"RECTYPE": "D", "MH": "Oncogene Proteins v-fos", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-fos Proteins|T116|T123|EQV|NLM (1992)|910124|abbdef", "ENTRY": "v fos Proteins", "MN": "D12.776.964.775.750.887", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "AN": "coordinate with specific virus", "PI": "Retroviridae Proteins (1987-1988)", "MS": "Transforming proteins coded by fos oncogenes. These proteins have been found in the Finkel-Biskis-Jinkins (FBJ-MSV) and Finkel-Biskis-Reilly (FBR-MSV) murine sarcoma viruses which induce osteogenic sarcomas in mice. The FBJ-MSV v-fos gene encodes a p55-kDa protein and the FBR-MSV v-fos gene encodes a p75-kDa fusion protein.", "OL": "use ONCOGENE PROTEINS V-FOS (NM) to search ONCOGENE PROTEIN FOS (NM) 1990-91", "PM": "92; ONCOGENE PROTEIN FOS (NM) was indexed under ONCOGENE PROTEINS, VIRAL 1990-91", "HN": "92; was ONCOGENE PROTEIN FOS (NM) 1990-91", "MR": "20180701", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016761"}, {"RECTYPE": "D", "MH": "Genes, fos", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "v-fos Genes|T028|NON|NRW|NLM (1992)|910125|abcdef", "ENTRY": "v-fos Oncogene", "MN": "G05.360.340.024.340.375.500.791.330", "FX": "Proto-Oncogene Proteins c-fos", "MH_TH": "NLM (1992)", "ST": "T028", "AN": "fos stands for \"Finkel\" & \"Osteogenic Sarcoma\"", "PI": "Proto-Oncogenes (1985-1991)", "MS": "Retrovirus-associated DNA sequences (fos) originally isolated from the Finkel-Biskis-Jinkins (FBJ-MSV) and Finkel-Biskis-Reilly (FBR-MSV) murine sarcoma viruses. The proto-oncogene protein c-fos codes for a nuclear protein which is involved in growth-related transcriptional control. The insertion of c-fos into FBJ-MSV or FBR-MSV induces osteogenic sarcomas in mice. The human c-fos gene is located at 14q21-31 on the long arm of chromosome 14.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016762"}, {"RECTYPE": "D", "MH": "Cell Polarity", "AQ": "DE ES GE IM PH RE", "ENTRY": "Polarity, Cell", "MN": "G04.250", "MH_TH": "NLM (1992)", "ST": "T082", "AN": "orientation of intracell struct to plasma membrane", "MS": "Orientation of intracellular structures especially with respect to the apical and basolateral domains of the plasma membrane. Polarized cells must direct proteins from the Golgi apparatus to the appropriate domain since tight junctions prevent proteins from diffusing between the two domains.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016764"}, {"RECTYPE": "D", "MH": "Coronavirus, Feline", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Infectious Peritonitis Virus, Feline|T005|NON|REL|NLM (1992)|990101|INFECT PERITONITIS VIRUS FELINE|abcdefv", "ENTRY": "Feline Enteric Coronaviruses", "MN": "B04.820.578.500.540.150.075.500.375", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid12663", "RR": "txid11135", "PI": "Coronaviridae (1977-1991)", "MS": "A species of CORONAVIRUS infecting cats of all ages and commonly found in catteries and zoos. Cats are often found carrying the virus but only a small proportion develop disease. Feline coronavirus and Feline infectious peritonitis virus (FIPV) are virtually the same virus in genetic and antigenetic terms, and are morphologically indistinguishable. Since they only differ in their disease potential (with FIPV causing a more serious illness), they are considered biotypes of each other.", "PM": "2002; see INFECTIOUS PERITONITIS VIRUS, FELINE 1994-2001, see FELINE INFECTIOUS PERITONITIS VIRUS 1992-1993; for INFECTIOUS PERITONITIS VIRUS, FELINE see FELINE INFECTIOUS PERITONITIS VIRUS 1992-93", "HN": "2002 (1992)", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016765"}, {"RECTYPE": "D", "MH": "Feline Infectious Peritonitis", "DE": "FELINE INFECT PERITONITIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Peritonitis, Feline Infectious", "MN": "C22.180.440", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Coronavirus Infections (1978-1991)", "MS": "Common coronavirus infection of cats caused by the feline infectious peritonitis virus (CORONAVIRUS, FELINE). The disease is characterized by a long incubation period, fever, depression, loss of appetite, wasting, and progressive abdominal enlargement. Infection of cells of the monocyte-macrophage lineage appears to be essential in FIP pathogenesis.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016766"}, {"RECTYPE": "D", "MH": "Caroli Disease", "DE": "CAROLI DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Caroli's Disease|T019|T047|NON|EQV|NLM (1993)|990101|CAROLIS DIS|abbcdefv", "ENTRY": "Syndrome, Caroli's", "MN": "C16.320.184.250", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Biliary Dyskinesia (1966-1984)", "MS": "Congenital cystic dilatation of the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC). It consists of 2 types: simple Caroli disease is characterized by bile duct dilatation (ectasia) alone; and complex Caroli disease is characterized by bile duct dilatation with extensive hepatic fibrosis and portal hypertension (HYPERTENSION, PORTAL). Benign renal tubular ectasia is associated with both types of Caroli disease.", "PM": "2004; see CAROLI'S DISEASE 1993-2003", "HN": "2004 (1993)", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D016767"}, {"RECTYPE": "D", "MH": "Embolism and Thrombosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thrombosis and Embolism", "MN": "C14.907.355", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "A collective term for pathological conditions which are caused by the formation of a blood clot (THROMBUS) in a blood vessel, or by blocking of a blood vessel with an EMBOLUS, undissolved materials in the blood stream.", "PM": "98", "HN": "98; use explode 1992-97", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19910823", "DC": "1", "DX": "19980101", "UI": "D016769"}, {"RECTYPE": "D", "MH": "Ciliophora Infections", "DE": "CILIOPHORA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Ciliophora", "MN": "C01.610.752.200", "MH_TH": "NLM (1992)", "ST": "T047", "MS": "Infections with protozoa of the phylum CILIOPHORA.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016770"}, {"RECTYPE": "D", "MH": "Leishmaniasis, Cutaneous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Oriental Sore|T047|EPO|NRW|NLM (1992)|910204|abcdef", "ENTRY": "Sore, Oriental", "MN": "C17.800.838.775.560.400", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent; LEISHMANIASIS, DIFFUSE CUTANEOUS & LEISHMANIASIS, MUCOCUTANEOUS are also available; tegumentary leishmaniasis goes here", "PI": "Leishmaniasis (1966-1991)", "MS": "An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.", "PM": "1992; see LEISHMANIASIS 1979-1991; for ORIENTAL SORE see LEISHMANIASIS 1979-1991", "HN": "1992; use LEISHMANIASIS 1979-1991; for ORIENTAL SORE use LEISHMANIASIS 1979-1991, use LEISHMANIASIS 1963-78", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016773"}, {"RECTYPE": "D", "MH": "Leishmaniasis, Diffuse Cutaneous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Leishmaniases, Diffuse Cutaneous", "MN": "C17.800.838.775.560.400.350", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "PI": "Leishmaniasis (1966-1991)", "MS": "A form of LEISHMANIASIS, CUTANEOUS caused by Leishmania aethiopica in Ethiopia and Kenya, L. pifanoi in Venezuela, L. braziliensis in South America, and L. mexicana in Central America. This disease is characterized by massive dissemination of skin lesions without visceral involvement.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016774"}, {"RECTYPE": "D", "MH": "Blastocystis Infections", "DE": "BLASTOCYSTIS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Blastocystis hominis", "MN": "C06.405.469.452.250", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Protozoan Infections (1983-1991)", "MS": "Infections with organisms of the genus BLASTOCYSTIS. The species B. hominis is responsible for most infections. Parasitologic surveys have generally found small numbers of this species in human stools, but higher positivity rates and organism numbers in AIDS patients and other immunosuppressed patients (IMMUNOCOMPROMISED HOST). Symptoms include ABDOMINAL PAIN; DIARRHEA; CONSTIPATION; VOMITING; and FATIGUE.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016776"}, {"RECTYPE": "D", "MH": "Malaria, Falciparum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Plasmodium falciparum Malaria|T047|NON|EQV|NLM (1992)|910430|abcdef", "ENTRY": "Malaria, Plasmodium falciparum", "MN": "C01.920.852.750.650", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Malaria (1966-1991)", "MS": "Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016778"}, {"RECTYPE": "D", "MH": "Malaria, Cerebral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Malaria Meningitis|T047|NON|REL|NLM (2000)|991103|abcdef", "ENTRY": "Meningitis, Malaria", "MN": "C10.228.228.205.300.500", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "coordinate IM with probably  MALARIA, FALCIPARUM (IM); otherwise coordinate IM with other  Plasmodium species (IM)", "PI": "Malaria (1966-1991)", "MS": "A condition characterized by somnolence or coma in the presence of an acute infection with PLASMODIUM FALCIPARUM (and rarely other Plasmodium species). Initial clinical manifestations include HEADACHES; SEIZURES; and alterations of mentation followed by a rapid progression to COMA. Pathologic features include cerebral capillaries filled with parasitized erythrocytes and multiple small foci of cortical and subcortical necrosis. (From Adams et al., Principles of Neurology, 6th ed, p136)", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19991103", "DC": "1", "DX": "19920101", "UI": "D016779"}, {"RECTYPE": "D", "MH": "Malaria, Vivax", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Plasmodium vivax Malaria|T047|NON|EQV|NLM (1992)|910430|abcdef", "ENTRY": "Vivax Malaria", "MN": "C01.920.852.750.700", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Malaria (1966-1991)", "MS": "Malaria caused by PLASMODIUM VIVAX. This form of malaria is less severe than MALARIA, FALCIPARUM, but there is a higher probability for relapses to occur. Febrile paroxysms often occur every other day.", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016780"}, {"RECTYPE": "D", "MH": "Toxoplasmosis, Cerebral", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Toxoplasmosis, Central Nervous System|T047|NON|BRD|NLM (2000)|991103|TOXOPLASMOSIS CNS|abcdefv", "ENTRY": "Toxoplasmosis, Intracranial", "MN": "C10.228.228.205.300.800", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "coord IM with specific brain disease (IM) or specific site (IM) if pertinent; congenital: coord IM with TOXOPLASMOSIS, CONGENITAL (IM)", "PI": "Toxoplasmosis (1966-1991)", "MS": "Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES (see also AIDS-RELATED OPPORTUNISTIC INFECTIONS). The infection may involve the brain diffusely or form discrete abscesses. Clinical manifestations include SEIZURES, altered mentation, headache, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. (From Joynt, Clinical Neurology, 1998, Ch27, pp41-3)", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016781"}, {"RECTYPE": "D", "MH": "Apicomplexa", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Sporozoeas", "MN": "B01.043.075", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5794", "AN": "general; prefer specifics; infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent", "MS": "A phylum of unicellular parasitic EUKARYOTES characterized by the presence of complex apical organelles generally consisting of a conoid that aids in penetrating host cells, rhoptries that possibly secrete a proteolytic enzyme, and subpellicular microtubules that may be related to motility.", "PM": "1992", "HN": "1992", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016782"}, {"RECTYPE": "D", "MH": "Eucoccidiida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Eucoccidiidas", "MN": "B01.043.075.189.275", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid75739", "AN": "infection: coordinate IM with COCCIDIOSIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "An order of parasitic protozoa found in blood cells and epithelial cells of vertebrates and invertebrates. Life cycles involve both sexual and asexual phases.", "PM": "1992", "HN": "1992", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016783"}, {"RECTYPE": "D", "MH": "Cryptosporidium parvum", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "parvum, Cryptosporidium", "MN": "B01.043.075.189.250.150.160.170", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5807", "AN": "infection: coordinate IM with CRYPTOSPORIDIOSIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Cryptosporidium (1985-1991)", "MS": "A species of parasitic protozoa that infects humans and most domestic mammals. Its oocysts measure five microns in diameter. These organisms exhibit alternating cycles of sexual and asexual reproduction.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016785"}, {"RECTYPE": "D", "MH": "Eimeria tenella", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "tenella, Eimeria", "MN": "B01.043.075.189.250.250.250.250", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5802", "AN": "infection: coordinate IM with COCCIDIOSIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Eimeria (1966-1991)", "MS": "A species of coccidian protozoa that mainly infects domestic poultry.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016786"}, {"RECTYPE": "D", "MH": "Haemosporida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Haemosporinas", "MN": "B01.043.075.380", "MH_TH": "NLM (2001)", "ST": "T204", "RN": "txid5819", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "An order of heteroxenous protozoa in which the macrogamete and microgamont develop independently. A conoid is usually absent.", "PM": "2001; see HAEMOSPORINA 1992-2000", "HN": "2001(1992)", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016787"}, {"RECTYPE": "D", "MH": "Plasmodium chabaudi", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "chabaudus, Plasmodium", "MN": "B01.043.075.380.611.490", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5825", "AN": "infection: coordinate IM with MALARIA (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Plasmodium (1966-1991)", "MS": "A protozoan parasite of rodents transmitted by the mosquito Anopheles stephensi.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016788"}, {"RECTYPE": "D", "MH": "Plasmodium cynomolgi", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "cynomolgus, Plasmodium", "MN": "B01.043.075.380.611.505", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5827", "AN": "infection: coord IM with MALARIA (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Plasmodium (1966-1991)", "MS": "A protozoan parasite that occurs naturally in the macaque. It is similar to PLASMODIUM VIVAX and produces a type of malaria similar to vivax malaria (MALARIA, VIVAX). This species has been found to give rise to both natural and experimental human infections.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016789"}, {"RECTYPE": "D", "MH": "Plasmodium knowlesi", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "knowlesi, Plasmodium", "MN": "B01.043.075.380.611.610", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5850", "AN": "infection: coordinate IM with MALARIA (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Plasmodium (1966-1991)", "MS": "A protozoan parasite from Southeast Asia that causes monkey malaria. It is naturally acquired by man in Malaysia and can also be transmitted experimentally to humans.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016790"}, {"RECTYPE": "D", "MH": "Piroplasmia", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Piroplasmias", "MN": "B01.043.075.600", "MH_TH": "NLM (1992)", "ST": "T204", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent; do not confuse with order PIROPLASMIDA", "MS": "A subclass of heteroxenous parasitic protozoa usually transmitted by ticks. Its organisms are rod-shaped or amoeboid with conoid, oocysts, spores, and pseudocysts absent. Locomotion is by body flexion, gliding, or, in sexual stages, by large axopodium-like organelles.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016791"}, {"RECTYPE": "D", "MH": "Piroplasmida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Piroplasmidas", "MN": "B01.043.075.600.580", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5863", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent; do not confuse with subclass PIROPLASMIA", "MS": "An order of protozoa comprising heteroxenous tick-borne blood parasites. Representative genera include BABESIA, Dactylosoma, and THEILERIA.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016792"}, {"RECTYPE": "D", "MH": "Babesia bovis", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "bovis, Babesia", "MN": "B01.043.075.600.580.070.100", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5865", "AN": "infection: coordinate IM with BABESIOSIS (IM) + probably CATTLE DISEASES (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Babesia (1975-1991)", "MS": "A species of protozoa that is a cause of bovine babesiosis. Ticks of the genera Boophilus, Rhipicephalus, and IXODES are the chief vectors.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016793"}, {"RECTYPE": "D", "MH": "Theileria", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Theilerias", "MN": "B01.043.075.600.580.700", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5873", "PI": "Sporozoea (1966-1991)", "MS": "A genus of tick-borne protozoa parasitic in the lymphocytes, erythrocytes, and endothelial cells of mammals. Its organisms multiply asexually and then invade erythrocytes, where they undergo no further reproduction until ingested by a transmitting tick.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016794"}, {"RECTYPE": "D", "MH": "Theileria annulata", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "annulatas, Theileria", "MN": "B01.043.075.600.580.700.100", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5874", "AN": "infection: coordinate IM with THEILERIASIS (IM) + check tags ANIMALS & CATTLE but not also CATTLE DISEASES; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Sporozoea (1966-1991)", "MS": "A protozoan parasite causing tropical theileriasis in cattle. It is transmitted by ticks of the Hyalomma genus.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016796"}, {"RECTYPE": "D", "MH": "Theileria parva", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "parvas, Theileria", "MN": "B01.043.075.600.580.700.500", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5875", "AN": "infection: coordinate IM with THEILERIASIS (IM) + check tags ANIMALS & CATTLE but not also CATTLE DISEASES; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Sporozoea (1966-1991)", "MS": "A protozoan parasite that is the etiologic agent of East Coast fever (THEILERIASIS). Transmission is by ticks of the Physicephalus and Hyalomma genera.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016797"}, {"RECTYPE": "D", "MH": "Ciliophora", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Ciliata|T204|NON|REL|UNK (1991)|910219|abcdef", "ENTRY": "Ciliophoras", "MN": "B01.043.185", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5878", "PI": "Protozoa (1975-1991)", "MS": "A phylum of EUKARYOTES characterized by the presence of cilia at some time during the life cycle. It comprises three classes: KINETOFRAGMINOPHOREA; OLIGOHYMENOPHOREA; and POLYMENOPHOREA.", "OL": "use CILIOPHORA to search CILIATA 1966-91", "PM": "92; CILIATA was heading 1963-91", "HN": "92; CILIATA was heading 1963-91", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016798"}, {"RECTYPE": "D", "MH": "Kinetofragminophorea", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Suctoria|T204|NON|NRW|NLM (1992)|910211|abcdef", "ENTRY": "Suctorias", "MN": "B01.043.185.375", "MH_TH": "NLM (1992)", "ST": "T204", "RR": "txid39462", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A class of ciliate protozoa. Prominent cytopharyngeal apparatus is characteristic of this class as is only a slight distinction between oral and somatic cilia.", "OL": "use CILIOPHORA to search SUCTORIA 1966-91", "PM": "92; SUCTORIA was see CILIATA 1985-91, was heading 1963-84", "HN": "92; SUCTORIA was see CILIATA 1985-91, was heading 1963-84", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016799"}, {"RECTYPE": "D", "MH": "Trichostomatida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Trichostomatidas", "MN": "B01.043.185.375.650", "MH_TH": "NLM (1992)", "ST": "T204", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "An order of ciliate protozoa in which the cytostome is usually situated at the base of an oral groove, the wall of which bears dense cilia.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016800"}, {"RECTYPE": "D", "MH": "Trichostomatina", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Trichostomatinas", "MN": "B01.043.185.375.650.650", "MH_TH": "NLM (1992)", "ST": "T204", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A suborder of ciliate protozoa characterized by non-reduction of the somatic ciliature.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016801"}, {"RECTYPE": "D", "MH": "Oligohymenophorea", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Oligohymenophoreas", "MN": "B01.043.185.650", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid6020", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A class of ciliate protozoa. Characteristics include the presence of a well developed oral apparatus and oral cilia being clearly distinct from somatic cilia.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016802"}, {"RECTYPE": "D", "MH": "Hymenostomatida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Hymenostomatidas", "MN": "B01.043.185.650.375", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid31277", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "An order of ciliate protozoa. Characteristics include a ventral oral area and a well-defined buccal cavity. It comprises three suborders: TETRAHYMENINA, Ophryoglenina, and PENICULINA.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016803"}, {"RECTYPE": "D", "MH": "Peniculina", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Peniculinas", "MN": "B01.043.185.650.375.550", "MH_TH": "NLM (1992)", "ST": "T204", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A suborder of protozoa characterized by peniculi, which are often situated deep in the buccal cavity, and by fusiform trichocysts.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016804"}, {"RECTYPE": "D", "MH": "Paramecium tetraurelia", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "tetraurelias, Paramecium", "MN": "B01.043.185.650.375.550.637.700", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5888", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Paramecium (1976-1991)", "MS": "A species of ciliate protozoa. It is used in biomedical research.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016805"}, {"RECTYPE": "D", "MH": "Tetrahymenina", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Tetrahymeninas", "MN": "B01.043.185.650.375.750", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid37093", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent; do not confuse with genus TETRAHYMENA", "MS": "A suborder of ciliate protozoa. Most organisms are free-living in fresh water and many species are used extensively for experimental studies.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016806"}, {"RECTYPE": "D", "MH": "Tetrahymena thermophila", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "thermophilas, Tetrahymena", "MN": "B01.043.185.650.375.750.850.875", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5911", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Tetrahymena (1978-1991)", "MS": "A species of ciliate protozoa used in genetic and cytological research.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016808"}, {"RECTYPE": "D", "MH": "Polymenophorea", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Polymenophoreas", "MN": "B01.043.185.700", "MH_TH": "NLM (1992)", "ST": "T204", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A class of ciliate protozoa characterized by a well-developed, conspicuous adoral zone of numerous buccal or peristomial organelles, often extending out onto the body surface.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016809"}, {"RECTYPE": "D", "MH": "Hypotrichida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Hypotrichidas", "MN": "B01.043.185.700.400", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5934", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Ciliophora (1966-1991)", "MS": "An order of ciliate protozoa. Characteristics include a dorsoventrally flattened, highly mobile body with a unique cursorial type of locomotion.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016810"}, {"RECTYPE": "D", "MH": "Sporadotrichina", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Sporadotrichinas", "MN": "B01.043.185.700.400.750", "MH_TH": "NLM (1992)", "ST": "T204", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A suborder of ciliate protozoa having a body that is commonly oval to elliptical in shape. Most species are free-living in widely diverse habitats.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016811"}, {"RECTYPE": "D", "MH": "Euplotes", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Euplote", "MN": "B01.043.185.700.400.750.375", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5935", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Ciliophora (1966-1991)", "MS": "A genus of ciliate protozoa having a dorsoventrally flattened body with widely spaced rows of short bristle-like cilia on the dorsal surface.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016812"}, {"RECTYPE": "D", "MH": "Oxytricha", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Oxytrichas", "MN": "B01.043.185.700.400.750.600", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5943", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Ciliophora (1973-1991)", "MS": "A genus of ciliate protozoa having a unique cursorial type of locomotion.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016813"}, {"RECTYPE": "D", "MH": "Microsporidia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Microsporidians|T004|NON|EQV|NLM (2021)|210209|abcdef", "ENTRY": "Microsporidias", "MN": "B01.300.360", "MH_TH": "NLM (1992)", "ST": "T004", "RN": "txid6029", "MS": "A phylum of fungi comprising minute intracellular PARASITES with FUNGAL SPORES of unicellular origin. It has two classes: Rudimicrosporea and MICROSPOREA.", "PM": "2006; see MICROSPORA 1992-2005, see MICROSPORIDA 1991-2000", "HN": "2006 (1992); use MICROSPORIDA 1991-2000", "MR": "20210209", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016814"}, {"RECTYPE": "D", "MH": "Microsporea", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Microsporeas", "MN": "B01.300.360.500", "MH_TH": "NLM (1992)", "ST": "T004", "AN": "do not confuse with fungal phylum MICROSPORA see MICROSPORIDIA; infection: coordinate with MICROSPORIDIOSIS; coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc.) if pertinent", "MS": "A class of parasitic FUNGI. Characteristics include spores that are spherical, oval, or tubular in shape and sporoplasm which is uninuclear or binuclear. Microsporea is a heterotypic synonym for Microsporidia.", "PM": "1992", "HN": "1992", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016815"}, {"RECTYPE": "D", "MH": "Microsporida", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Microsporidas", "MN": "B01.300.360.500.500", "MH_TH": "NLM (1992)", "ST": "T004", "AN": "do not confuse with the fungal phylum MICROSPORIDIA; infection: coordinate IM with MICROSPORIDIOSIS (IM); coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc) if pertinent", "PI": "Sporozoea (1969-1991)", "MS": "An order of parasitic FUNGI found mostly in ARTHROPODS; FISHES; and in some VERTEBRATES including humans. It comprises two suborders: Pansporoblastina and APANSPOROBLASTINA.", "PM": "1992", "HN": "1992", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016816"}, {"RECTYPE": "D", "MH": "Apansporoblastina", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Apansporoblastinas", "MN": "B01.300.360.500.500.100", "MH_TH": "NLM (1992)", "ST": "T004", "RN": "txid6032", "AN": "infection: coordinate IM with MICROSPORIDIOSIS (IM)", "MS": "A suborder of FUNGI in the phylum MICROSPORIDIA, commonly lacking a pansporoblastic membrane. The sporoblast is usually dinucleate.", "PM": "1992", "HN": "1992", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016817"}, {"RECTYPE": "D", "MH": "Nosema", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Nosemas", "MN": "B01.300.360.500.500.100.400", "MH_TH": "NLM (1992)", "ST": "T004", "RN": "txid27977", "AN": "note NOSEMA CUNICULI see ENCEPHALITOZOON CUNICULI and NOSEMA CORNEUM see VITTAFORMA; infection: coordinate IM with MICROSPORIDIOSIS (IM); coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc) if pertinent", "PI": "Sporozoea (1966-1991)", "MS": "A genus of parasitic FUNGI in the family Nosematidae. Some species are pathogenic for invertebrates of economic importance while others are being researched for possible roles in controlling pest INSECTS. They are also pathogenic in humans.", "PM": "1992", "HN": "1992", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016818"}, {"RECTYPE": "D", "MH": "Encephalitozoon", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Encephalitozoons", "MN": "B01.300.360.500.500.100.175", "MH_TH": "NLM (1992)", "ST": "T004", "RN": "txid6033", "PI": "Sporozoea (1973-1991)", "MS": "A genus of FUNGI originally considered a member of the class SPOROZOEA but now recognized as part of the class MICROSPOREA.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016819"}, {"RECTYPE": "D", "MH": "Euglenida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Euglenophyta|T204|NON|EQV|NLM (2004)|030128|abcdef", "ENTRY": "Euglenophytas", "MN": "B01.268.250", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid3035", "AN": "infection; coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A phylum of unicellular flagellates of ancient eukaryotic lineage with unclear taxonomy. They lack a CELL WALL but are covered by a proteinaceous flexible coat, the pellicle, that allows the cell to change shape. Historically some authorities considered them to be an order of protozoa and others classed them as ALGAE (some members have CHLOROPLASTS and some don't).", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016822"}, {"RECTYPE": "D", "MH": "Volvocida", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Volvocidas", "MN": "B01.875.150.925", "MH_TH": "NLM (1992)", "ST": "T204", "MS": "Order of CHLOROPHYTA commonly found in freshwater habitats. Characteristics include the presence of a cellulose wall and two to four equal, smooth, apical flagella.", "PM": "92", "HN": "92", "MR": "20210630", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016823"}, {"RECTYPE": "D", "MH": "Antigens, Human Platelet", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Platelet-Specific Antigens|T129|NON|EQV|NLM (1992)|910212|abcdef", "ENTRY": "Platelet Specific Antigens", "MN": "D23.050.705.115", "MH_TH": "NLM (1992)", "ST": "T129", "RN": "0", "AN": "restrict to antigens expressed on only platelets: do not confuse with HLA & other antigens expressed on platelets or other blood cells", "PI": "Isoantigens (1976-1991)", "MS": "Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy.", "PM": "92", "HN": "92", "MR": "20210630", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016824"}, {"RECTYPE": "D", "MH": "Chlamydomonas reinhardtii", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "reinhardtii, Chlamydomonas", "MN": "B01.875.150.385.650", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid3055", "PI": "Chlamydomonas (1972-1991)", "MS": "A species of GREEN ALGAE. Delicate, hairlike appendages arise from the flagellar surface in these organisms.", "PM": "92", "HN": "92", "MR": "20210630", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016825"}, {"RECTYPE": "D", "MH": "CD8 Antigens", "DS": "CD 008 ANTIGENS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "T8 Antigens, T-Cell|T116|T129|EQV|NLM (1992)|910212|T AAD ANTIGENS 08 T CELL|abbdefs", "ENTRY": "T8 Antigens, T Cell", "MN": "D23.101.100.894.108", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (1992)", "ST": "T129", "RN": "0", "PI": "Antigens, Surface (1985-1991)", "MS": "Differentiation antigens found on thymocytes and on cytotoxic and suppressor T-lymphocytes. T8 antigens are members of the immunoglobulin supergene family and are associative recognition elements in MHC (Major Histocompatibility Complex) Class I-restricted interactions.", "PM": "2018; see ANTIGENS, CD8 1992-2017 and CD8 ANTIGEN 1988-1991; CD8 ANTIGENS was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-91", "HN": "2018 (1988)", "MR": "20170602", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016827"}, {"RECTYPE": "D", "MH": "Diplomonadida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Diplomonadidas", "MN": "B01.237", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5738", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent", "MS": "A group of flagellated, mostly symbiotic EUKARYOTES characterized by twofold symmetry associated with the presence of a pair of karyomastigont organellar systems. Two nuclei are attached by fibers to the flagella and there are no MITOCHONDRIA. Diplomonadida were formerly members of the class Zoomastigophora in the old five kingdom paradigm.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016828"}, {"RECTYPE": "D", "MH": "Giardia lamblia", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Lamblia intestinalis|T204|NON|EQV|NLM (1992)|910213|abcdef", "ENTRY": "Giardia lamblias", "MN": "B01.237.385.400", "FX": "Giardiavirus", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5741", "AN": "infection: coordinate IM with GIARDIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent; a virus infecting Giardia lamblia is named GIARDIAVIRUS", "PI": "Giardia (1967-1991)", "MS": "A species of parasitic EUKARYOTES that attaches itself to the intestinal mucosa and feeds on mucous secretions. The organism is roughly pear-shaped and motility is somewhat erratic, with a slow oscillation about the long axis.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016829"}, {"RECTYPE": "D", "MH": "Kinetoplastida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Kinetoplastidas", "MN": "B01.268.475", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5653", "AN": "infection: coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "An order of flagellate protozoa. Characteristics include the presence of one or two flagella arising from a depression in the cell body and a single mitochondrion that extends the length of the body.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016830"}, {"RECTYPE": "D", "MH": "Crithidia fasciculata", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "fasciculata, Crithidia", "MN": "B01.268.475.868.110.350", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5656", "AN": "infection: coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Mastigophora (1966-1978)", "MS": "A species of monogenetic, parasitic protozoa usually found in insects.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016831"}, {"RECTYPE": "D", "MH": "Employment, Supported", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "PRINT ENTRY": "Supported Employment|T057|NON|EQV|NLM (1992)|910213|abcdef", "MN": "N02.421.784.644.350", "MH_TH": "NLM (1992)", "ST": "T057", "AN": "full or part-time employment program for the disabled", "PI": "Rehabilitation, Vocational (1988-1991)", "MS": "Paid work for mentally or physically disabled persons, taking place in regular or normal work settings. It may be competitive employment (work that pays minimum wage) or employment with subminimal wages in individualized or group placement situations. It is intended for persons with severe disabilities who require a range of support services to maintain employment. Supported employment differs from SHELTERED WORKSHOPS in that work in the latter takes place in a controlled working environment. Federal regulations are authorized and administered by the U.S. Department of Education, Office of Special Education and Rehabilitative Services.", "PM": "92", "HN": "92", "MR": "20180629", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016832"}, {"RECTYPE": "D", "MH": "Trypanosoma brucei rhodesiense", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Trypanosoma rhodesiense|T204|NON|EQV|NLM (1992)|910214|abcdef", "ENTRY": "rhodesienses, Trypanosoma brucei", "MN": "B01.268.475.868.887.115", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid31286", "AN": "causes Rhodesian sleeping sickness; infection: coord IM with TRYPANOSOMIASIS, AFRICAN (IM); for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN", "PI": "Trypanosoma brucei brucei (1972-1991)", "MS": "A hemoflagellate subspecies of parasitic protozoa that causes Rhodesian sleeping sickness in humans. It is carried by Glossina pallidipes, G. morsitans and occasionally other species of game-attacking tsetse flies.", "OL": "use TRYPANOSOMA BRUCEI BRUCEI to search TRYPANOSOMA BRUCEI RHODESIENSE & TRYPANOSOMA RHODESIENSE 1987-91", "PM": "92; was see TRYPANOSOMA BRUCEI BRUCEI 1987-91; TRYPANOSOMA RHODESIENSE was see TRYPANOSOMA BRUCEI BRUCEI 1987-91", "HN": "92; was see TRYPANOSOMA BRUCEI BRUCEI 1987-91; TRYPANOSOMA RHODESIENSE was see TRYPANOSOMA BRUCEI BRUCEI 1987-91", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016833"}, {"RECTYPE": "D", "MH": "Trichomonadida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Trichomonadidas", "MN": "B01.630.800", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid37104", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent", "MS": "An order of parasitic EUKARYOTES typically having four to six flagella. True cysts are known in very few species. Trichomonadida were formerly members of the class Zoomastigophora in the old five kingdom paradigm.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016834"}, {"RECTYPE": "D", "MH": "Tritrichomonas foetus", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.630.800.849.325", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid1144522", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM) and ABORTION, VETERINARY (IM) if pertinent; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Tritrichomonas (1972-1991)", "MS": "A species of flagellate parasitic EUKARYOTE. It possesses a long undulating membrane that is bordered on its outer margin by a flagellum that becomes free posteriorly. This organism causes infections in cows that could lead to temporary infertility or abortion.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016835"}, {"RECTYPE": "D", "MH": "Dictyosteliida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Slime Molds, Cellular|T204|NON|EQV|NLM (1999)|971215|abcdef", "ENTRY": "Slime Mold, Cellular", "MN": "B01.046.550.200", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid33083", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "An order of protozoa characterized by their ability to aggregate to form a multicellular pseudoplasmodium, which gives rise to a multispored fruiting body. A stalk tube is present.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016837"}, {"RECTYPE": "D", "MH": "Physarida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Physaridas", "MN": "B01.046.550.550.600", "MH_TH": "NLM (1992)", "ST": "T204", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "An order of protozoa characterized by a peridium and capillitium that are calcareous and a spore mass that is usually dark-colored.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016838"}, {"RECTYPE": "D", "MH": "Physarum polycephalum", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "polycephalum, Physarum", "MN": "B01.046.550.550.600.700.550", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5791", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Physarum (1966-1991)", "MS": "A protozoan, previously also considered a fungus. Characteristics include sporangia that are stalked and multilobed. It is widely used in biomedical research.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016839"}, {"RECTYPE": "D", "MH": "Lobosea", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Tubulinea|T204|NON|EQV|NLM (2010)|090226|abcdef", "MN": "B01.046.500", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid555369", "AN": "general; prefer specifics; infection: coordinate IM with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent", "MS": "A class of amoeboid EUKARYOTES that forms either filiform subpseudopodia or lobopodia. Characteristics include the absence of sorocarps, sporangia, or similar fruiting bodies. Lobosea were formerly members of the phylum Sarcomastigophora, subphylum Sarcodina, under the old five kingdom paradigm.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016840"}, {"RECTYPE": "D", "MH": "Amoebida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Amoebidas", "MN": "B01.046.500.100", "MH_TH": "NLM (1992)", "ST": "T204", "AN": "infection: coordinate IM with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "An order of ameboid protozoa that is commonly uninucleate and possess mitochondria. Most organisms are nonpathogenic.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016841"}, {"RECTYPE": "D", "MH": "Acanthopodina", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Acanthopodinas", "MN": "B01.046.500.100.075", "MH_TH": "NLM (1992)", "ST": "T204", "AN": "infection: coordinate IM with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A suborder of ameboid protozoa. Characteristics include subpseudopodia that are more or less finely tipped, occasionally filiform, commonly furcate hyaline, and produced from a broad hyaline lobe. Cysts are usually formed and nuclear division is mesomitotic or metamitotic.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016842"}, {"RECTYPE": "D", "MH": "Blastocystina", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Blastocystinas", "MN": "B01.046.500.100.200", "MH_TH": "NLM (1992)", "ST": "T204", "AN": "infection: coordinate IM with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A suborder of protozoa of the class LOBOSEA.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016843"}, {"RECTYPE": "D", "MH": "Blastocystis", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Blastocysti", "MN": "B01.046.500.100.200.200", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid12967", "PI": "Zygomycotina (1980-1985)", "MS": "A genus of protozoa of the suborder BLASTOCYSTINA. It was first classified as a yeast but further studies have shown it to be a protozoan.", "OL": "use PROTOZOA to search BLASTOCYSTIS 1989-91", "PM": "92; was see PROTOZOA 1989-91", "HN": "92; was see PROTOZOA 1989-91", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016844"}, {"RECTYPE": "D", "MH": "Blastocystis hominis", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "hominis, Blastocystis", "MN": "B01.046.500.100.200.200.375", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid12968", "AN": "infection: coordinate IM with BLASTOCYSTIS INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Zygomycotina (1980-1985)", "MS": "A species of parasitic protozoa found in the intestines of humans and other primates. It was classified as a yeast in 1912. Over the years, questions arose about this designation. In 1967, many physiological and morphological B. hominis characteristics were reported that fit a protozoan classification. Since that time, other papers have corroborated this work and the organism is now recognized as a protozoan parasite of humans causing intestinal disease with potentially disabling symptoms.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016845"}, {"RECTYPE": "D", "MH": "Tubulina", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Tubulinas", "MN": "B01.046.500.100.700", "MH_TH": "NLM (1992)", "ST": "T204", "AN": "infection: coordinate IM with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A suborder of ameboid protozoa characterized by a branched or unbranched cylindrical body and the absence of bidirectional cytoplasmic flow. Nuclear division is mesomitotic.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016846"}, {"RECTYPE": "D", "MH": "Schizopyrenida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Schizopyrenidas", "MN": "B01.046.500.700", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid41165", "AN": "infection: coordinate IM with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "An order of ameboid protozoa commonly having a monopodial cylindrically shaped body. Nuclear division is promitotic and most species have a temporary flagellate stage.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016847"}, {"RECTYPE": "D", "MH": "Naegleria fowleri", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "fowlerus, Naegleria", "MN": "B01.046.500.700.710.375", "MH_TH": "NLM (1992)", "ST": "T204", "RN": "txid5763", "PI": "Naegleria (1988-1991)", "MS": "A species of parasitic protozoa having both an ameboid and flagellate stage in its life cycle. Infection with this pathogen produces PRIMARY AMEBIC MENINGOENCEPHALITIS.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016848"}, {"RECTYPE": "D", "MH": "Keratitis, Herpetic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Herpes Simplex, Ocular|T047|NON|EQV|NLM (1992)|910219|abcdef", "ENTRY": "Keratitis, Herpes Simplex", "MN": "C11.294.800.475", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "herpes simplex of the cornea", "PI": "Keratitis, Dendritic (1966-1991)", "MS": "A superficial, epithelial Herpesvirus hominis infection of the cornea, characterized by the presence of small vesicles which may break down and coalesce to form dendritic ulcers (KERATITIS, DENDRITIC). (Dictionary of Visual Science, 3d ed)", "OL": "use KERATITIS, DENDRITIC to search HERPES SIMPLEX, OCULAR 1966-91 & OCULAR HERPES SIMPLEX 1990-91", "PM": "92; HERPES SIMPLEX, OCULAR was see KERATITIS, DENDRITIC 1963-91; OCULAR HERPES SIMPLEX was see KERATITIS, DENDRITIC 1990-91", "HN": "92; HERPES SIMPLEX, OCULAR was see KERATITIS, DENDRITIC 1963-91; OCULAR HERPES SIMPLEX was see KERATITIS, DENDRITIC 1990-91", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016849"}, {"RECTYPE": "D", "MH": "Limbus Corneae", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Sclerocorneal Limbus|T023|NON|EQV|NLM (1992)|910220|abcdef", "ENTRY": "Limbus, Sclerocorneal", "MN": "A09.371.060.217.659", "MH_TH": "NLM (1992)", "ST": "T023", "AN": "a slight furrow between cornea & sclera: do not index under SCLERA unless sclera is particularly discussed; /transpl is unlikely: article will likely be on CORNEAL TRANSPLANTATION with anat or physiol ref to LIMBUS CORNEAE with pertinent qualif", "PI": "Cornea (1966-1991)", "MS": "An annular transitional zone, approximately 1 mm wide, between the cornea and the bulbar conjunctiva and sclera. It is highly vascular and is involved in the metabolism of the cornea. It is ophthalmologically significant in that it appears on the outer surface of the eyeball as a slight furrow, marking the line between the clear cornea and the sclera. (Dictionary of Visual Science, 3d ed)", "PM": "92", "HN": "92", "MR": "19911125", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016850"}, {"RECTYPE": "D", "MH": "Orthobunyavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Guama virus|T005|EPO|NRW|NLM (1992)|910401|abcdef", "ENTRY": "Orthobunyaviruses", "MN": "B04.820.480.750.640", "MH_TH": "NLM (2005)", "ST": "T005", "RN": "txid11572", "RR": "txid334520", "AN": "infection: coord IM with BUNYAVIRIDAE INFECTIONS (IM)", "PI": "Bunyaviridae (1979-1991)", "MS": "A genus of the family BUNYAVIRIDAE containing over 150 viruses, most of which are transmitted by mosquitoes or flies. They are arranged in groups defined by serological criteria, each now named for the original reference species (previously called serogroups). Many species have multiple serotypes or strains.", "PM": "2005; see BUNYAVIRUS 1992-2004; for APEU VIRUS see APEU VIRUS 1991, see BUNYAVIRIDAE 1981-1990, see ARBOVIRUSES 1975-1980; for CATU VIRUS & GUAMA VIRUS see GUAMA GROUP VIRUSES 1975-1991", "HN": "2005 (1992); for APEU VIRUS use APEU VIRUS 1991, use BUNYAVIRIDAE 1981-1990, use ARBOVIRUSES 1975-1980; for CATU VIRUS & GUAMA VIRUS use GUAMA GROUP VIRUSES 1975-1991", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016851"}, {"RECTYPE": "D", "MH": "Housing for the Elderly", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Life Care Centers, Retirement|T073|NON|NRW|NLM (1992)|910425|abcdef", "MN": "N06.230.150.360.260", "FX": "Homes for the Aged", "MH_TH": "NLM (1992)", "ST": "T073", "AN": "for the able-bodied: do not confuse with HOMES FOR THE AGED, med & nurs care for the aged sick", "PI": "Housing (1967-1991)", "MS": "Housing arrangements for the elderly or aged, intended to foster independent living. The housing may take the form of group homes or small apartments. It is available to the economically self-supporting but the concept includes housing for the elderly with some physical limitations. The concept should be differentiated from HOMES FOR THE AGED which is restricted to long-term geriatric facilities providing supervised medical and nursing services.", "PM": "92", "HN": "92", "MR": "20160623", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016852"}, {"RECTYPE": "D", "MH": "Muromonab-CD3", "AQ": "AD AE AN BI BL CF CH CL DE DT EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "PRINT ENTRY": "Monoclonal Antibody OKT3|T116|T121|T129|EQV|NLM (1992)|910220|abbbdef", "ENTRY": "Muromonab CD3", "MN": "D12.776.377.715.548.114.619.393.570", "PA": "Immunosuppressive Agents", "MH_TH": "USAN (1989)", "ST": "T129", "RN": "0", "AN": "do not coordinate with ANTIBODY FORMATION for biosyn", "PI": "Antibodies, Monoclonal (1981-1991)", "MS": "Anti-CD3 monoclonal antibody that exerts immunosuppressive effects by inducing peripheral T-cell depletion and modulation of the T-cell receptor complex (CD3/Ti).", "OL": "use MUROMONAB-CD3 (NM) to search MONOCLONAL ANTIBODY OKT3 (NM) 1987-91", "PM": "92; MONOCLONAL ANTIBODY OKT3 was indexed under ANTIBODIES, MONOCLONAL 1987-91", "HN": "92; MONOCLONAL ANTIBODY OKT3 was MONOCLONAL ANTIBODY OKT3, ORTHOCLONE (NM) 1987-91", "MR": "20160701", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016853"}, {"RECTYPE": "D", "MH": "Dental Anxiety", "DE": "DENT ANXIETY", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Fear, Dental|T041|NON|REL|NLM (1992)|910220|FEAR DENT|abcdefv", "ENTRY": "Odontophobias", "MN": "F01.470.132.300", "MH_TH": "NLM (1992)", "ST": "T041", "PI": "Fear (1966-1991)", "MS": "Abnormal fear or dread of visiting the dentist for preventive care or therapy and unwarranted anxiety over dental procedures.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016854"}, {"RECTYPE": "D", "MH": "Nairovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Nairoviruses", "MN": "B04.820.480.750.565", "MH_TH": "NLM (1992)", "ST": "T005", "RN": "txid1980517", "PI": "Bunyaviridae (1980-1991)", "MS": "A genus of the family BUNYAVIRIDAE named after NAIROBI SHEEP DISEASE, an acute, hemorrhagic, tick-borne, gastroenteritis affecting sheep and goats. The type species is Dugbe virus. Some viruses in this genus are capable of causing severe and fatal disease in humans.", "PM": "1992; for DUGBE VIRUS see NAIROBI SHEEP DISEASE VIRUSES 1994-2001", "HN": "1992", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016855"}, {"RECTYPE": "D", "MH": "Phlebovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Sandfly Fever Sicilian Virus|T005|EPO|NRW|NLM (1994)|930108|abcdef", "ENTRY": "Phleboviruses", "MN": "B04.820.480.750.710", "MH_TH": "NLM (1992)", "ST": "T005", "RN": "txid11584", "RR": "txid28292", "AN": "do not confuse entry term SANDFLY FEVER SICILIAN VIRUS with SANDFLY FEVER NAPLES VIRUS; infection: coord IM with PHLEBOTOMUS FEVER (IM) or if not so specified coord IM with BUNYAVIRIDAE INFECTIONS (IM)", "PI": "Bunyaviridae (1983-1991)", "MS": "A genus of the family BUNYAVIRIDAE comprising many viruses, most of which are transmitted by Phlebotomus flies and cause PHLEBOTOMUS FEVER. The type species is RIFT VALLEY FEVER VIRUS.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016856"}, {"RECTYPE": "D", "MH": "Hypocapnia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypocapnias", "MN": "C23.888.852.614", "FX": "Alkalosis, Respiratory", "MH_TH": "NLM (1992)", "ST": "T184", "AN": "CARBON DIOXIDE/blood is also available", "PI": "Carbon Dioxide/blood (1966-1991)", "MS": "Clinical manifestation consisting of a deficiency of carbon dioxide in arterial blood.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016857"}, {"RECTYPE": "D", "MH": "Mycoplasma fermentans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mycoplasma incognitus|T007|NON|NRW|NLM (1992)|910225|abcdef", "MN": "B03.440.860.580.553.553.315", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid2115", "RR": "txid2101", "AN": "infection: coordinate with MYCOPLASMA INFECTIONS", "PI": "Mycoplasma (1970-1991)", "MS": "A species of the genus MYCOPLASMA, originally isolated infrequently from the lower genital tract of humans, and possessing uncertain pathogenicity. The incognitus strain of M. fermentans has been identified in necrotizing lesions of multiple organs from AIDS and non-AIDS patients dying of an acute influenza-like disease.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016858"}, {"RECTYPE": "D", "MH": "Lipoxygenase Inhibitors", "DE": "LIPOXYGENASE INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lipoxygenase Inhibitor|T121|NON|EQV|NLM (2022)|201007|abcdef", "ENTRY": "Inhibitors, Arachidonate 5-Lipoxygenase", "MN": "D27.505.519.389.480", "MH_TH": "NLM (1992)", "ST": "T121", "RN": "0", "PI": "Lipoxygenase/antagonists & inhibitors (1978-1991)", "MS": "Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES.", "OL": "use LIPOXYGENASE INHIBITORS to search 5-LIPOXYGENASE INHIBITORS 1992-94; use ARACHIDONATE 5-LIPOXYGENASE/ai 1995 forward", "PM": "92; 5-LIPOXYGENASE INHIBITORS was see LIPOXYGENASE INHIBITORS 1992-94", "HN": "92; 5-LIPOXYGENASE INHIBITORS was see LIPOXYGENASE INHIBITORS 1992-94", "MR": "20210630", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016859"}, {"RECTYPE": "D", "MH": "CD4 Immunoadhesins", "DS": "CD 004 IMMUNOADHESINS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immunoadhesins, CD4|T116|T121|T129|NON|EQV|NLM (1992)|910226|IMMUNOADHESINS CD 004|abbbcdefs", "ENTRY": "CD4 IgG", "MN": "D23.050.301.350.230", "PA": "Immunologic Factors", "MH_TH": "NLM (1992)", "ST": "T129", "RN": "0", "PI": "IgG (1989-1991)", "MS": "Chimeric molecules resulting from the fusion of recombinant soluble CD4 to the Fc portion of immunoglobulins. These have potential use in the therapy of AIDS since they possess both the gp120-binding and HIV-blocking properties of rCD4 as well as the long plasma half-life and Fc receptor-binding functions of immunoglobulin.", "OL": "use CD4 IMMUNOADHESINS (NM) to search CD4 IMMUNOADHESIN (NM) 1989-91", "PM": "92; CD4 IMMUNOADHESIN (NM) was indexed under IGG & ANTIGENS, CD & ANTIBODIES, ANTI-IDIOTYPIC 1990-91 and under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989.", "HN": "92; was CD4 IMMUNOADHESIN (NM) 1989-91", "MR": "20230316", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016860"}, {"RECTYPE": "D", "MH": "Cyclooxygenase Inhibitors", "DE": "CYCLOOXYGENASE INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prostaglandin Synthesis Antagonists|T121|NON|EQV|NLM (1995)|931206|PG SYN ANTAG|abcdefv", "ENTRY": "Synthesis Antagonist, Prostaglandin", "MN": "D27.505.954.329.030.500", "MH_TH": "NLM (1992)", "ST": "T121", "RN": "0", "PI": "Prostaglandin-Endoperoxide Synthase/antagonists & inhibitors (1981-1991)", "MS": "Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.", "OL": "use ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL to search PROSTAGLANDIN SYNTHESIS ANTAGONISTS 1987-94", "PM": "92; PROSTAGLANDIN SYNTHESIS ANTAGONISTS was see ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1987-94", "HN": "92; PROSTAGLANDIN SYNTHESIS ANTAGONISTS was see ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1987-94", "MR": "20200527", "DA": "19910718", "DC": "1", "DX": "19920101", "UI": "D016861"}, {"RECTYPE": "D", "MH": "Tuberculoma, Intracranial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Intracranial Tuberculoma|T047|NON|EQV|NLM (1992)|910226|abcdef", "MN": "C10.228.228.180.850.400", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "not a neoplasm; coord IM with specif part of brain or precoord brain/dis (IM)", "PI": "Tuberculoma (1968-1991)", "MS": "A well-circumscribed mass composed of tuberculous granulation tissue that may occur in the cerebral hemispheres, cerebellum, brain stem, or perimeningeal spaces. Multiple lesions are quite common. Management of intracranial manifestations vary with lesion site. Intracranial tuberculomas may be associated with SEIZURES, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. Spinal cord tuberculomas may be associated with localized or radicular pain, weakness, sensory loss, and incontinence. Tuberculomas may arise as OPPORTUNISTIC INFECTIONS, but also occur in immunocompetent individuals.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016862"}, {"RECTYPE": "D", "MH": "Bacillaceae Infections", "DE": "BACILLACEAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Bacillaceae", "MN": "C01.150.252.410.090", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Infections with bacteria of the family BACILLACEAE.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016863"}, {"RECTYPE": "D", "MH": "Li-Fraumeni Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Li Fraumeni Syndrome", "MN": "C18.452.284.520", "FX": "Genes, p53", "MH_TH": "ORD (2010)", "ST": "T191", "PI": "Syndrome (1982-1986)", "MS": "Rare autosomal dominant syndrome characterized by mesenchymal and epithelial neoplasms at multiple sites. MUTATION of the p53 tumor suppressor gene, a component of the DNA DAMAGE response pathway, apparently predisposes family members who inherit it to develop certain cancers. The spectrum of cancers in the syndrome was shown to include, in addition to BREAST CANCER and soft tissue sarcomas (SARCOMA); BRAIN TUMORS; OSTEOSARCOMA; LEUKEMIA; and ADRENOCORTICAL CARCINOMA.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016864"}, {"RECTYPE": "D", "MH": "Reassortant Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, Reassortant", "MN": "B04.800", "MH_TH": "NLM (1992)", "ST": "T005", "AN": "\"viruses containing 2 or more pieces of nucleic acid from different parents\": see MeSH definition; coord IM with specific parent viruses (IM)", "PI": "specific virus/genetics (1981-1991)", "MS": "Viruses containing two or more pieces of nucleic acid (segmented genome) from different parents. Such viruses are produced in cells coinfected with different strains of a given virus.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016865"}, {"RECTYPE": "D", "MH": "Bacteroidaceae Infections", "DE": "BACTEROIDACEAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Bacteroidaceae", "MN": "C01.150.252.400.110", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "note BACTEROIDES INFECTIONS is also available", "MS": "Infections with bacteria of the family BACTEROIDACEAE.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016866"}, {"RECTYPE": "D", "MH": "Immunocompromised Host", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Immunosuppressed Host|T204|NON|EQV|NLM (1992)|910425|abcdef", "ENTRY": "Patients, Immunocompromised", "MN": "G12.470", "MH_TH": "NLM (1992)", "ST": "T204", "AN": "note category: a physiol state in man or animal; coord IM with disease or physiol state complicating the immunocompromised state (IM with /immunol) or with the immunosuppressive agent (IM with pertinent subh)", "PI": "Immunosuppression (1976-1991)", "MS": "A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016867"}, {"RECTYPE": "D", "MH": "Serratia Infections", "DE": "SERRATIA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Serratia Infection", "MN": "C01.150.252.400.310.850", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "gram-neg bact infect", "PI": "Serratia marcescens (1972-1991)", "MS": "Infections with bacteria of the genus SERRATIA.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016868"}, {"RECTYPE": "D", "MH": "Ureaplasma Infections", "DE": "UREAPLASMA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Ureaplasma Infection", "MN": "C01.150.252.400.610.850", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Ureaplasma (1977-1991)", "MS": "Infections with bacteria of the genus UREAPLASMA.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016869"}, {"RECTYPE": "D", "MH": "Neisseriaceae Infections", "DE": "NEISSERIACEAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Neisseriaceae Infection", "MN": "C01.150.252.400.625", "MH_TH": "NLM (1992)", "ST": "T047", "MS": "Infections with bacteria of the family NEISSERIACEAE.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016870"}, {"RECTYPE": "D", "MH": "Pasteurellaceae Infections", "DE": "PASTEURELLACEAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Pasteurellaceae Infection", "MN": "C01.150.252.400.700", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Infections with bacteria of the family PASTEURELLACEAE.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016871"}, {"RECTYPE": "D", "MH": "Ehrlichiosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, E chaffeensis", "MN": "C01.920.930.300", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Rickettsiaceae Infections (1975-1991)", "MS": "A tick-borne disease characterized by FEVER; HEADACHE; myalgias; ANOREXIA; and occasionally RASH. It is caused by several bacterial species and can produce disease in DOGS; CATTLE; SHEEP; GOATS; HORSES; and humans. The primary species causing human disease are EHRLICHIA CHAFFEENSIS; ANAPLASMA PHAGOCYTOPHILUM; and Ehrlichia ewingii.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016873"}, {"RECTYPE": "D", "MH": "Neurofibrillary Tangles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Tangles, Neurofibrillary", "MN": "A11.671.573.520", "FX": "Tauopathies", "MH_TH": "NLM (1992)", "ST": "T020", "PI": "Neurofibrils (1968-1991)", "MS": "Abnormal structures located in various parts of the brain and composed of dense arrays of paired helical filaments (neurofilaments and microtubules). These double helical stacks of transverse subunits are twisted into left-handed ribbon-like filaments that likely incorporate the following proteins: (1) the intermediate filaments: medium- and high-molecular-weight neurofilaments; (2) the microtubule-associated proteins map-2 and tau; (3) actin; and (4) UBIQUITINS. As one of the hallmarks of ALZHEIMER DISEASE, the neurofibrillary tangles eventually occupy the whole of the cytoplasm in certain classes of cell in the neocortex, hippocampus, brain stem, and diencephalon. The number of these tangles, as seen in post mortem histology, correlates with the degree of dementia during life. Some studies suggest that tangle antigens leak into the systemic circulation both in the course of normal aging and in cases of Alzheimer disease.", "PM": "92", "HN": "92", "MR": "20140613", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016874"}, {"RECTYPE": "D", "MH": "tau Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, tau", "MN": "D12.776.631.560.510", "FX": "Tauopathies", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "PI": "Microtubules (1976-1985)", "MS": "Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES).", "OL": "use TAU PROTEINS (NM) to search TAU (NM) 1980-90", "PM": "1992; TAU (NM) was indexed under MICROTUBULE-ASSOCIATED PROTEINS 1985-91 & under PROTEINS 1977-84", "HN": "1992; use TAU (NM) 1977-91", "MR": "20160705", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016875"}, {"RECTYPE": "D", "MH": "Metal Ceramic Alloys", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Porcelain-Metal Alloys|T122|NON|EQV|NLM (1992)|910424|abcdef", "ENTRY": "Restorations, Metal Ceramic", "MN": "J01.637.051.339.208.720", "MH_TH": "NLM (1992)", "ST": "T122", "RN": "0", "AN": "specify metals if particularly discussed", "PI": "Dental Alloys (1971-1991)", "MS": "The fusion of ceramics (porcelain) to an alloy of two or more metals for use in restorative and prosthodontic dentistry. Examples of metal alloys employed include cobalt-chromium, gold-palladium, gold-platinum-palladium, and nickel-based alloys.", "PM": "92", "HN": "92", "MR": "20060705", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016876"}, {"RECTYPE": "D", "MH": "Oxidants", "AQ": "AA AD AE AG AI BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxidizing Agents|T120|NON|EQV|NLM (1992)|910308|abcdef", "ENTRY": "Agents, Oxidizing", "MN": "D27.888.569.540", "FX": "Antioxidants", "MH_TH": "NLM (1992)", "ST": "T120", "RN": "0", "PI": "Oxidation-Reduction (1966-1991)", "MS": "Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION).", "PM": "92", "HN": "92", "MR": "20200527", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016877"}, {"RECTYPE": "D", "MH": "POEMS Syndrome", "DE": "POEMS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Takatsuki's Syndrome|T047|EPO|EQV|NLM (1992)|910301|abcdef", "ENTRY": "Takatsuki Syndrome", "MN": "C20.683.780.750", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A multisystemic disorder characterized by a sensorimotor polyneuropathy (POLYNEUROPATHIES), organomegaly, endocrinopathy, monoclonal gammopathy, and pigmentary skin changes. Other clinical features which may be present include EDEMA; CACHEXIA; microangiopathic glomerulopathy; pulmonary hypertension (HYPERTENSION, PULMONARY); cutaneous necrosis; THROMBOCYTOSIS; and POLYCYTHEMIA. This disorder is frequently associated with osteosclerotic myeloma. (From Adams et al., Principles of Neurology, 6th ed, p1335; Rev Med Interne 1997;18(7):553-62)", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016878"}, {"RECTYPE": "D", "MH": "Salvage Therapy", "DE": "SALVAGE THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Treatments, Salvage", "MN": "E02.895", "MH_TH": "NLM (1992)", "ST": "T061", "MS": "A therapeutic approach, involving chemotherapy, radiation therapy, or surgery, after initial regimens have failed to lead to improvement in a patient's condition. Salvage therapy is most often used for neoplastic diseases.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016879"}, {"RECTYPE": "D", "MH": "Anisotropy", "ENTRY": "Anisotropies", "MN": "G02.050", "MH_TH": "NLM (1992)", "ST": "T070", "AN": "usually NIM", "MS": "A physical property showing different values in relation to the direction in or along which the measurement is made. The physical property may be with regard to thermal or electric conductivity or light refraction. In crystallography, it describes crystals whose index of refraction varies with the direction of the incident light. It is also called acolotropy and colotropy. The opposite of anisotropy is isotropy wherein the same values characterize the object when measured along axes in all directions.", "PM": "92", "HN": "92", "MR": "20160115", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016880"}, {"RECTYPE": "D", "MH": "Microsporidiosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Microspora Infections|T047|NON|EQV|NLM (1992)|990101|MICROSPORA INFECT|abcdefv", "ENTRY": "Microsporidioses", "MN": "C01.150.703.617", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with Microsporum infections, one of the DERMATOMYCOSES (see note at MICROSPORUM)", "MS": "Infections with FUNGI of the phylum MICROSPORIDIA.", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016881"}, {"RECTYPE": "D", "MH": "ISCOMs", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PO RE TO TU UL UR", "PRINT ENTRY": "Immunostimulating Complexes|T121|T129|NON|EQV|NLM (1992)|910306|abbcdef", "ENTRY": "Immuno Stimulating Complexes", "MN": "D20.215.894.860.449", "PA": "Adjuvants, Immunologic", "FX": "Saponins", "MH_TH": "NLM (1992)", "ST": "T129", "RN": "0", "AN": "coord IM with specific type of vaccine (IM or NIM)", "PI": "Viral Vaccines (1985-1991)", "MS": "A formulation for presenting an antigen to induce specific immunologic responses. It consists of an assembly of antigens in multimeric form. The assembly is attached to a matrix with a built-in adjuvant, saponin. ISCOMs induce strong serum antibody responses, and are used as highly immunogenic forms of subunit vaccines.", "PM": "92", "HN": "92", "MR": "20050630", "DA": "19910817", "DC": "1", "DX": "19920101", "UI": "D016882"}, {"RECTYPE": "D", "MH": "Diabetic Ketoacidosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ketosis, Diabetic|T047|NON|EQV|NLM (1992)|910307|abcdef", "ENTRY": "Ketoses, Diabetic", "MN": "C19.246.099.812", "MH_TH": "NLM (1992)", "ST": "T047", "MS": "A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.", "OL": "use DIABETIC KETOACIDOSIS to search KETOSIS, DIABETIC 1975-91 & ACIDOSIS, DIABETIC 1966-91", "PM": "92; KETOSIS, DIABETIC was heading 1975-91 (see under ACIDOSIS, DIABETIC 1975-90); ACIDOSIS, DIABETIC was heading 1966-91", "HN": "92; KETOSIS, DIABETIC was heading 1975-91 (see under ACIDOSIS, DIABETIC 1975-90); ACIDOSIS, DIABETIC was heading 1966-91", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016883"}, {"RECTYPE": "D", "MH": "Polyendocrinopathies, Autoimmune", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Schmidt's Syndrome|T047|EPO|NRW|NLM (1992)|ORD (2010)|910307|abcdeef", "ENTRY": "Syndrome, Schmidt's", "MN": "C20.111.750", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "do not coordinate with specific endocrine disease term or CANDIDIASIS unless particularly discussed", "PI": "Endocrine Diseases (1978-1991)", "MS": "Autoimmune diseases affecting multiple endocrine organs. Type I is characterized by childhood onset and chronic mucocutaneous candidiasis (CANDIDIASIS, CHRONIC MUCOCUTANEOUS), while type II exhibits any combination of adrenal insufficiency (ADDISON'S DISEASE), lymphocytic thyroiditis (THYROIDITIS, AUTOIMMUNE;), HYPOPARATHYROIDISM; and gonadal failure. In both types organ-specific ANTIBODIES against a variety of ENDOCRINE GLANDS have been detected. The type II syndrome differs from type I in that it is associated with HLA-A1 and B8 haplotypes, onset is usually in adulthood, and candidiasis is not present.", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016884"}, {"RECTYPE": "D", "MH": "United States Department of Agriculture", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "USDA|T092|ACR|EQV|NLM (2008)|070223|abcdef", "ENTRY": "United States. Dept. of Agriculture|T092|NAM|EQV|NLM (2008)|070223|abcdef", "MN": "N03.540.348.500.500.400", "MH_TH": "NLM (1992)", "ST": "T092", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.; CATALOGER: Use NAF entry", "PI": "Government Agencies (1966-1991)", "MS": "A cabinet department in the Executive Branch of the United States Government concerned with improving and maintaining farm income and developing and expanding markets for agricultural products. Through inspection and grading services it safeguards and insures standards of quality in food supply and production.", "PM": "1992", "HN": "1992", "MR": "20150629", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016885"}, {"RECTYPE": "D", "MH": "Cardiopulmonary Resuscitation", "DE": "CARDIOPULM RESUSCITATION", "AQ": "AE CL EC ED ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Mouth-to-Mouth Resuscitation|T061|NON|NRW|IOM (1990)|910312|abcdef", "ENTRY": "Resuscitations, Mouth-to-Mouth", "MN": "E02.365.647.110", "FX": "Heart Arrest", "MH_TH": "NLM (1992)", "ST": "T061", "PI": "Resuscitation (1971-1991)", "MS": "The artificial substitution of heart and lung action as indicated for HEART ARREST resulting from electric shock, DROWNING, respiratory arrest, or other causes. The two major components of cardiopulmonary resuscitation are artificial ventilation (RESPIRATION, ARTIFICIAL) and closed-chest CARDIAC MASSAGE.", "OL": "use RESUSCITATION to search CARDIOPULMONARY RESUSCITATION 1978-91 & MOUTH-TO-MOUTH RESUSCITATION 1990-91", "PM": "92; was see RESUSCITATION 1978-91; MOUTH-TO-MOUTH RESUSCITATION was see RESUSCITATION 1990-91", "HN": "92; was see RESUSCITATION 1978-91; MOUTH-TO-MOUTH RESUSCITATION was see RESUSCITATION 1990-91", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016887"}, {"RECTYPE": "D", "MH": "Angiodysplasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Angiodysplasias", "MN": "C14.907.075", "EC": "congenital:Arteriovenous Malformations", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Gastrointestinal Hemorrhage (1976-1991)", "MS": "Acquired degenerative dilation or expansion (ectasia) of normal BLOOD VESSELS, often associated with aging. They are isolated, tortuous, thin-walled vessels and sources of bleeding. They occur most often in mucosal capillaries of the GASTROINTESTINAL TRACT leading to GASTROINTESTINAL HEMORRHAGE and ANEMIA.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016888"}, {"RECTYPE": "D", "MH": "Endometrial Neoplasms", "DE": "ENDOMETRIAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Endometrial Carcinoma|T191|NON|NRW|NLM (2003)|011211|abcdef", "ENTRY": "Neoplasm, Endometrial", "MN": "C12.900.418.875.200", "MH_TH": "NLM (1992)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "PI": "Uterine Neoplasms (1966-1991)", "MS": "Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016889"}, {"RECTYPE": "D", "MH": "Encephalitozoonosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Encephalitozoonoses", "MN": "C01.150.703.617.300", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Sporozoea (1972-1981)", "MS": "Infection with FUNGI of the genus ENCEPHALITOZOON. Lesions commonly occur in the BRAIN and KIDNEY tubules. Other sites of infection in MAMMALS are the LIVER; ADRENAL GLANDS; OPTIC NERVES; RETINA; and MYOCARDIUM.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910502", "DC": "1", "DX": "19920101", "UI": "D016890"}, {"RECTYPE": "D", "MH": "Polycystic Kidney, Autosomal Dominant", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Kidney, Polycystic, Autosomal Dominant|T047|NON|EQV|NLM (1992)|990101|KPAD|abcdefv", "ENTRY": "Polycystic Kidney, Type 2 Autosomal Dominant Disease|T047|NON|NRW|NLM (2001)|000112|POLYCYSTIC KIDNEY TYPE 2 AUTOSOMAL DOMINANT DIS|abcdefv", "MN": "C16.320.184.625.500", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Kidney, Polycystic (1974-1991)", "MS": "Kidney disorders with autosomal dominant inheritance and characterized by multiple CYSTS in both KIDNEYS with progressive deterioration of renal function.", "PM": "1992; see KIDNEY, POLYCYSTIC, AUTOSOMAL DOMINANT 1992-2000", "HN": "1992", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016891"}, {"RECTYPE": "D", "MH": "Carotid Stenosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Carotid Ulcer|T020|NON|REL|NLM (2000)|991103|abcdef", "ENTRY": "Ulcers, Carotid", "MN": "C14.907.253.123.360", "FX": "Endarterectomy, Carotid", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "coordinate IM with specific carotid artery (IM)", "PI": "Carotid Artery Diseases (1966-1991)", "MS": "Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3)", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20150709", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016893"}, {"RECTYPE": "D", "MH": "Endarterectomy, Carotid", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Carotid Endarterectomy|T061|NON|EQV|NLM (1992)|910315|abcdef", "ENTRY": "Endarterectomies, Carotid", "MN": "E04.100.814.456.250", "FX": "Carotid Stenosis", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "specify CAROTID ARTERY, EXTERNAL or CAROTID ARTERY, INTERNAL (IM or NIM) if pertinent", "PI": "Endarterectomy (1966-1991)", "MS": "The excision of the thickened, atheromatous tunica intima of a carotid artery.", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016894"}, {"RECTYPE": "D", "MH": "Culture Media, Serum-Free", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO", "PRINT ENTRY": "Serum-Free Media|T130|NON|EQV|NLM (1992)|910418|abcdef", "ENTRY": "Serum-Free Culture Media", "MN": "E07.206.255", "MH_TH": "NLM (1992)", "ST": "T130", "RN": "0", "AN": "usually NIM", "PI": "Culture Media (1966-1991)", "MS": "CULTURE MEDIA free of serum proteins but including the minimal essential substances required for cell growth. This type of medium avoids the presence of extraneous substances that may affect cell proliferation or unwanted activation of cells.", "PM": "92", "HN": "92", "MR": "20030709", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016895"}, {"RECTYPE": "D", "MH": "Treatment Outcome", "PRINT ENTRY": "Treatment Effectiveness|T080|NON|REL|NLM (1992)|910516|abcdef", "ENTRY": "Patient-Relevant Outcomes", "MN": "N05.715.360.575.575.800", "MH_TH": "NLM (1992)", "ST": "T080", "AN": "IM general only; coordinate NIM with disease /ther ", "MS": "Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D016896"}, {"RECTYPE": "D", "MH": "Respiratory Burst", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Oxidative Burst|T043|NON|EQV|NLM (1992)|910318|abcdef", "ENTRY": "Respiratory Bursts", "MN": "G04.270.620", "FX": "Granulomatous Disease, Chronic", "MH_TH": "NLM (1992)", "ST": "T043", "PI": "Oxygen Consumption (1976-1991)", "MS": "A large increase in oxygen uptake by neutrophils and most types of tissue macrophages through activation of an NADPH-cytochrome b-dependent oxidase that reduces oxygen to a superoxide. Individuals with an inherited defect in which the oxidase that reduces oxygen to superoxide is decreased or absent (GRANULOMATOUS DISEASE, CHRONIC) often die as a result of recurrent bacterial infections.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016897"}, {"RECTYPE": "D", "MH": "Interferon-alpha", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-Interferon|T116|T121|T129|NON|EQV|NLM (1992)|910318|abbbcdef", "ENTRY": "alpha Interferon", "MN": "D23.529.374.440.890.250", "PA": "Immunologic Factors", "MH_TH": "NLM (1992)", "ST": "T129", "RN": "0", "PI": "Interferon Type I (1983-1991)", "MS": "One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways.", "PM": "1992; see INTERFERON TYPE I 1983-1991, INTERFERON ALPHA-1 was indexed under INTERFERON-ALPHA 2001-2011, INTERFERON-ALPHA 2 was indexed under INTERFERON-ALPHA 1997-2011, INTERFERON ALPHA4 was indexed under INTERFERON-ALPHA 1993-2001, INTERFERON ALPHA5 was indexed under INTERFERON-ALPHA 1996-2001", "HN": "1992; for INTERFERON, LYMPHOBLAST and INTERFERON, LEUKOCYTE use INTERFERON TYPE I 1989-1991", "MR": "20180111", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016898"}, {"RECTYPE": "D", "MH": "Interferon-beta", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Interferon|T116|T121|T129|NON|EQV|NLM (1992)|910319|abbbcdef", "ENTRY": "beta Interferon", "MN": "D23.529.374.440.890.275", "PA": "Immunologic Factors", "MH_TH": "NLM (1992)", "ST": "T129", "RN": "77238-31-4", "PI": "Interferon Type I (1984-1991)", "MS": "One of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA. It is a cytokine with antiviral, antiproliferative, and immunomodulating activity.", "OL": "use INTERFERON TYPE I to search INTERFERON, BETA & INTERFERON, FIBROBLAST 1983-91", "PM": "92; was INTERFERON, BETA see INTERFERON TYPE I 1983-91; INTERFERON, FIBROBLAST was see INTERFERON TYPE I 1983-91", "HN": "92; was INTERFERON, BETA see INTERFERON TYPE I 1983-91; INTERFERON, FIBROBLAST was see INTERFERON TYPE I 1983-91", "MR": "20160701", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016899"}, {"RECTYPE": "D", "MH": "Neurofilament Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neurofilament Protein|T116|T123|NON|EQV|NLM (2021)|200603|abbcdef", "ENTRY": "Triplet Proteins, Neurofilament", "MN": "D12.776.631.630", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Nerve Tissue Proteins (1970-1982)", "MS": "Type III intermediate filament proteins that assemble into neurofilaments, the major cytoskeletal element in nerve axons and dendrites. They consist of three distinct polypeptides, the neurofilament triplet. Types I, II, and IV intermediate filament proteins form other cytoskeletal elements such as keratins and lamins. It appears that the metabolism of neurofilaments is disturbed in Alzheimer's disease, as indicated by the presence of neurofilament epitopes in the neurofibrillary tangles, as well as by the severe reduction of the expression of the gene for the light neurofilament subunit of the neurofilament triplet in brains of Alzheimer's patients. (Can J Neurol Sci 1990 Aug;17(3):302)", "OL": "use NEUROFILAMENT PROTEINS (NM) to search NEUROFILAMENT PROTEINS 1977-91", "PM": "92; NEUROFILAMENT PROTEINS was indexed under INTERMEDIATE FILAMENT PROTEINS 1982-91 & NERVE TISSUE PROTEINS 1977-82", "HN": "92; was NEUROFILAMENT PROTEINS (NM) 1977-91", "MR": "20200617", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016900"}, {"RECTYPE": "D", "MH": "Intergenerational Relations", "DE": "INTERGENERAT RELAT", "AQ": "EH", "PRINT ENTRY": "Generation Gap|T080|NON|NRW|NLM (1998)|960717|abcdef", "ENTRY": "Relation, Intergenerational", "MN": "F01.829.401.190", "MH_TH": "NLM (1992)", "ST": "T054", "MS": "The interactions between individuals of different generations. These interactions include communication, caring, accountability, loyalty, and even conflict between related or non-related individuals.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016901"}, {"RECTYPE": "D", "MH": "Air Pollution, Indoor", "AQ": "AE AN EC HI LJ PC SN", "PRINT ENTRY": "Indoor Air Quality|T069|NON|BRD|NLM (1992)|910319|abcdef", "ENTRY": "Pollution, Indoor Air", "MN": "N06.850.460.100.080", "FX": "Tobacco Smoke Pollution", "MH_TH": "NLM (1992)", "ST": "T069", "PI": "Air Pollution (1968-1991)", "MS": "The contamination of indoor air.", "PM": "92", "HN": "92", "MR": "20170501", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016902"}, {"RECTYPE": "D", "MH": "Drug Monitoring", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Therapeutic Drug Monitoring|T061|NON|NRW|NLM (2007)|060302|abcdef", "ENTRY": "Monitoring, Therapeutic Drug", "MN": "E01.370.520.200", "FX": "Pharmacovigilance", "MH_TH": "NLM (1992)", "ST": "T061", "MS": "The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016903"}, {"RECTYPE": "D", "MH": "Gram-Negative Bacterial Infections", "DE": "GRAM NEG BACT INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Bacterial Infections, Gram-Negative|T047|NON|EQV|NLM (1992)|910418|BACT INFECT GRAM NEG|abcdefv", "ENTRY": "Infection, Gram-Negative Bacterial", "MN": "C01.150.252.400", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "general; prefer specifics", "PI": "specific bacterial infection (1966-1971)", "MS": "Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016905"}, {"RECTYPE": "D", "MH": "Interleukin-9", "DS": "INTERLEUKIN 009", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "T-Cell Growth Factor P40|T116|T129|NON|EQV|NLM (1992)|910321|T CELL GROWTH FACTOR P 040|abbcdefs", "ENTRY": "T Cell Growth Factor P40", "MN": "D23.529.374.465.377", "MH_TH": "NLM (1992)", "ST": "T129", "RN": "0", "PI": "Interleukins (1990-1991)", "MS": "A multifunctional cytokine secreted by primarily by activated TH2 CELLS that may play a role as a regulator of allergic INFLAMMATION. It has been shown to enhance the growth and CELL DIFFERENTIATION of MAST CELLS, and can act on a variety of other immune cells.", "OL": "use INTERLEUKIN-9 (NM) to search INTERLEUKIN-9 1989-91", "PM": "92; INTERLEUKIN 9 (NM) was indexed under INTERLEUKINS 1990-91 & under GROWTH SUBSTANCES 1989-90", "HN": "92; was INTERLEUKIN 9 (NM) 1989-91", "MR": "20150415", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016906"}, {"RECTYPE": "D", "MH": "Adverse Drug Reaction Reporting Systems", "DE": "ADR REPORT SYSTEMS", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Drug Reaction Reporting Systems, Adverse|T170|NON|EQV|NLM (1992)|910321|abcdef", "MN": "N02.421.668.320.120", "MH_TH": "NLM (1992)", "ST": "T170", "PI": "specific drug/adverse effects (1966-1991)", "MS": "Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016907"}, {"RECTYPE": "D", "MH": "Gram-Positive Bacterial Infections", "DE": "GRAM POS BACT INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Bacterial Infections, Gram-Positive|T047|NON|EQV|NLM (1992)|910418|BACT INFECT GRAM POS|abcdefv", "ENTRY": "Infections, Gram Positive Bacterial", "MN": "C01.150.252.410", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "specific bacterial infection (1966-1971)", "MS": "Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016908"}, {"RECTYPE": "D", "MH": "Tibial Arteries", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tibial Artery, Posterior", "MN": "A07.015.114.895", "MH_TH": "NLM (1992)", "ST": "T023", "PI": "Tibia (1972-1991)", "MS": "The anterior and posterior arteries created at the bifurcation of the popliteal artery. The anterior tibial artery begins at the lower border of the popliteus muscle and lies along the tibia at the distal part of the leg to surface superficially anterior to the ankle joint. Its branches are distributed throughout the leg, ankle, and foot. The posterior tibial artery begins at the lower border of the popliteus muscle, lies behind the tibia in the lower part of its course, and is found situated between the medial malleolus and the medial process of the calcaneal tuberosity. Its branches are distributed throughout the leg and foot.", "PM": "92", "HN": "92", "MR": "20180630", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016909"}, {"RECTYPE": "D", "MH": "Orthodontic Brackets", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Orthodontic Bracket", "MN": "E06.658.453.255.500", "MH_TH": "NLM (1992)", "ST": "T074", "PI": "Orthodontic Appliances (1967-1991)", "MS": "Small metal or ceramic attachments used to fasten an arch wire. These attachments are soldered or welded to an orthodontic band or cemented directly onto the teeth. Bowles brackets, edgewise brackets, multiphase brackets, ribbon arch brackets, twin-wire brackets, and universal brackets are all types of orthodontic brackets.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016910"}, {"RECTYPE": "D", "MH": "Koro", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Koro Syndrome|T048|NON|EQV|NLM (2022)|210630|abcdef", "ENTRY": "Syndrome, Koro", "MN": "F01.470.132.150.500", "MH_TH": "NLM (1992)", "ST": "T048", "AN": "a depersonalization disorder; do not confuse with KURU, a neurological disorder; specify ethnic group if pertinent; check tag MALE", "PI": "Depersonalization Disorder (1969-1991)", "MS": "A culture-specific acute delusional syndrome occurring mostly in the Malay people and Southern Chinese. The syndrome is characterized by the individual's sudden experience of depersonalization depicted by the belief that his penis is shrinking into his abdomen and that he will die when this occurs. Although generally classified as a culture-specific syndrome, koro may be no more than a variant of castration anxiety (ANXIETY, CASTRATION) as it has been described in non-Asian patients.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016911"}, {"RECTYPE": "D", "MH": "Levonorgestrel", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "l-Norgestrel|T109|T121|NON|EQV|NLM (1992)|910322|NORGESTREL L|abbcdefs", "ENTRY": "l Norgestrel", "MN": "D04.210.500.668.651.693.762.450", "PA": "Contraceptives, Oral, Synthetic", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "5W7SIA7YZW", "RR": "797-63-7 (Levonorgestrel)", "PI": "Norgestrel (1980-1991)", "MS": "A synthetic progestational hormone with actions similar to those of PROGESTERONE and about twice as potent as its racemic or (+-)-isomer (NORGESTREL). It is used for contraception, control of menstrual disorders, and treatment of endometriosis.", "PM": "1992; LEVONORGESTREL was indexed under NORGESTREL 1980-1991; for D-NORGESTREL use NORGESTREL 1978-2001", "HN": "1992; use LEVONORGESTREL (NM) 1980-1991; for D-NORGESTREL use NORGESTREL 1978-2001", "MR": "20190116", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016912"}, {"RECTYPE": "D", "MH": "Blood Component Transfusion", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Transfusions, Blood Component", "MN": "E02.095.135.140", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "general or unspecified; prefer specifics; for transfusion back to donor, coordinate with BLOOD TRANSFUSION, AUTOLOGOUS; do not confuse with BLOOD COMPONENT REMOVAL & its specifics where component is removed but remainder goes back to donor; /adv eff: coordinate with TRANSFUSION REACTION if pertinent", "PI": "Blood Transfusion (1974-1991)", "MS": "The transfer of blood components such as erythrocytes, leukocytes, platelets, and plasma from a donor to a recipient or back to the donor. This process differs from the procedures undertaken in PLASMAPHERESIS and types of CYTAPHERESIS; (PLATELETPHERESIS and LEUKAPHERESIS) where, following the removal of plasma or the specific cell components, the remainder is transfused back to the donor.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D016913"}, {"RECTYPE": "D", "MH": "Ribonuclease H", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ribonuclease H, Calf Thymus|T116|T126|NON|NRW|NLM (1992)|990101|abbcdef", "ENTRY": "RNAase H|T116|T126|ABX|EQV|NLM (1992)|910322|abbcdef", "MN": "D08.811.277.352.700.350.700", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 3.1.26.4", "RR": "EC 3.1.26.4", "PI": "Ribonucleases (1973-1982)", "MS": "A ribonuclease that specifically cleaves the RNA moiety of RNA:DNA hybrids. It has been isolated from a wide variety of prokaryotic and eukaryotic organisms as well as RETROVIRUSES.", "PM": "2008, 1992-1993; see RIBONUCLEASE H, CALF THYMUS 1994-2007; ENDORIBONUCLEASE H was indexed under ENDORIBONUCLEASES 1983-1991 and under ENDONUCLEASES & RIBONUCLEASES 1973-1982", "HN": "2008, 1992-1993 (1973)", "MR": "20070709", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D016914"}, {"RECTYPE": "D", "MH": "AIDS Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "HIV Vaccines|T121|T129|REL|NLM (1992)|910322|abbdef", "ENTRY": "Vaccine, HIV", "MN": "D20.215.894.899.050", "MH_TH": "NLM (1992)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1987-1991)", "MS": "Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent or treat AIDS. Some vaccines containing antigens are recombinantly produced.", "PM": "92", "HN": "92", "MR": "20200527", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016915"}, {"RECTYPE": "D", "MH": "Joint Deformities, Acquired", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Joint Deformity, Acquired", "MN": "C05.550.515", "MH_TH": "NLM (1992)", "ST": "T020", "AN": "coord IM with specific joint (IM); HAND DEFORMITIES, ACQUIRED & FOOT DEFORMITIES, ACQUIRED are also available", "MS": "Deformities acquired after birth as the result of injury or disease. The joint deformity is often associated with rheumatoid arthritis and leprosy.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "19920520", "DA": "19910627", "DC": "1", "DX": "19920101", "UI": "D016916"}, {"RECTYPE": "D", "MH": "Angiomatosis, Bacillary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Bacillary Angiomatosis|T047|NON|EQV|NLM (2008)|061006|abcdef", "ENTRY": "Peliosis, Bacillary", "MN": "C17.800.862.060", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Angiomatosis (1989-1991)", "MS": "A reactive vascular proliferation that is characterized by the multiple tumor-like lesions in skin, bone, brain, and other organs. Bacillary angiomatosis is caused by infection with gram-negative Bartonella bacilli (such as BARTONELLA HENSELAE), and is often seen in AIDS patients and other IMMUNOCOMPROMISED HOSTS.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016917"}, {"RECTYPE": "D", "MH": "Arthritis, Reactive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Arthritis, Postinfectious|T047|NON|EQV|NLM (1992)|910325|ARTHRITIS POSTINFECT|abcdefv", "ENTRY": "Reiters Syndrome", "MN": "C23.550.291.500.829.125", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "coordinate with specific infection or organism/infection precoordinate", "PI": "Arthritis, Infectious (1966-1991)", "MS": "An aseptic, inflammatory arthritis developing secondary to a primary extra-articular infection, most typically of the GASTROINTESTINAL TRACT or UROGENITAL SYSTEM. The initiating trigger pathogens are usually SHIGELLA; SALMONELLA; YERSINIA; CAMPYLOBACTER; or CHLAMYDIA TRACHOMATIS. Reactive arthritis is strongly associated with HLA-B27 ANTIGEN.", "PM": "1992; for REITER SYNDROME see REITER SYNDROME 2007, see REITER DISEASE 2002-2006, see REITER'S DISEASE 1963-2001", "HN": "1992", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19910624", "DC": "1", "DX": "19920101", "UI": "D016918"}, {"RECTYPE": "D", "MH": "Meningitis, Cryptococcal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Toruloma|T047|NON|REL|NLM (2000)|991103|abcdef", "ENTRY": "Torulomas", "MN": "C10.586.625.300.500", "FX": "Cranial Nerve Diseases", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Meningitis (1967-1991)", "MS": "Meningeal inflammation produced by CRYPTOCOCCUS NEOFORMANS, an encapsulated yeast that tends to infect individuals with ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunocompromised states. The organism enters the body through the respiratory tract, but symptomatic infections are usually limited to the lungs and nervous system. The organism may also produce parenchymal brain lesions (torulomas). Clinically, the course is subacute and may feature HEADACHE; NAUSEA; PHOTOPHOBIA; focal neurologic deficits; SEIZURES; cranial neuropathies; and HYDROCEPHALUS. (From Adams et al., Principles of Neurology, 6th ed, pp721-2)", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016919"}, {"RECTYPE": "D", "MH": "Meningitis, Bacterial", "DE": "MENINGITIS BACT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Bacterial Meningitis|T047|NON|EQV|NLM (1992)|910325|BACT MENINGITIS|abcdefv", "ENTRY": "Meningitides, Bacterial|T047|NON|EQV|NLM (1994)|930212|MENINGITIDES BACT|abcdefv", "MN": "C10.586.625.280", "FX": "Cerebral Ventriculitis", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "general or unspecified; prefer specifics, otherwise coordinate IM with specific bacterial infection (IM)", "PI": "specific bacterium (1966-1991)", "MS": "Bacterial infections of the leptomeninges and subarachnoid space, frequently involving the cerebral cortex, cranial nerves, cerebral blood vessels, spinal cord, and nerve roots.", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016920"}, {"RECTYPE": "D", "MH": "Meningitis, Fungal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Fungal Meningitis|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Pachymeningitides, Fungal", "MN": "C10.586.625.300", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "coord IM with specific fungus (IM) or specific fungal disease (IM)", "PI": "specific mycosis (1966-1991)", "MS": "Meningitis caused by fungal agents which may occur as OPPORTUNISTIC INFECTIONS or arise in immunocompetent hosts.", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016921"}, {"RECTYPE": "D", "MH": "Cellular Senescence", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Senescence, Replicative|T043|NON|NRW|NLM (1999)|970911|abcdef", "ENTRY": "Senescence, Cell", "MN": "G07.345.124.130", "FX": "Plant Senescence", "MH_TH": "NLM (2018)", "ST": "T043", "AN": "not for micro-organisms", "PI": "Erythrocyte Aging (1967-1991)", "MS": "Process by which cells irreversibly stop dividing and enter a state of permanent growth arrest without undergoing CELL DEATH. Senescence can be induced by DNA DAMAGE or other cellular stresses, such as OXIDATIVE STRESS.", "PM": "2018; see CELL AGING 1992-2017; see CELL SURVIVAL 1977-1991; for CELL SENESCENCE and SENESCENCE, CELLULAR see CELL SURVIVAL 1991", "HN": "2018 (1992); use CELL SURVIVAL 1977-1991", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016922"}, {"RECTYPE": "D", "MH": "Cell Death", "AQ": "DE ES GE IM PH RE", "ENTRY": "Death, Cell", "MN": "G04.146", "FX": "Necrosis", "MH_TH": "NLM (1992)", "ST": "T043", "AN": "not for micro-organisms", "PI": "Cell Survival (1971-1991)", "MS": "The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability.", "OL": "use CELL SURVIVAL to search CELL DEATH 1978-91", "PM": "92; was see CELL SURVIVAL 1978-91", "HN": "92; was see CELL SURVIVAL 1978-91", "CATSH": "CAT LIST", "MR": "20160125", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016923"}, {"RECTYPE": "D", "MH": "Actinomyces viscosus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.049.049.178.800", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid1656", "AN": "infection: coord IM with ACTINOMYCOSIS", "PI": "Actinomyces (1969-1991)", "MS": "A species of ACTINOMYCES found in the oral cavity of man and hamsters. It has been isolated from actinomycotic lesions in swine, cats, and dogs and has been identified as a causative agent of animal diseases.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016924"}, {"RECTYPE": "D", "MH": "Corynebacterium pseudotuberculosis", "DE": "CORYNEBACT PSEUDOTUBERC", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.200.600", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid1719", "AN": "infection: coordinate with CORYNEBACTERIUM INFECTIONS", "PI": "Corynebacterium (1967-1991)", "MS": "A species of gram-positive, asporogenous bacteria that was originally isolated from necrotic areas in the kidney of a sheep. It may cause ulcerative lymphangitis, abscesses, and other chronic purulent infections in sheep, horses, and other warm-blooded animals. Human disease may form from contact with infected animals.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910621", "DC": "1", "DX": "19920101", "UI": "D016925"}, {"RECTYPE": "D", "MH": "Mycobacterium chelonae", "DE": "MYCOBACT CHELONAE", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mycobacterium chelonei|T007|NON|EQV|NLM (1992)|910405|MYCOBACT CHELONEI|abcdefv", "ENTRY": "Mycobacterium chelonei subsp. chelonei|T007|EQV|NLM (2020)|191001|abdef", "MN": "B03.510.460.400.410.552.552.720.225", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid1774", "RR": "txid2099321", "AN": "infection: coordinate with MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS", "PI": "Mycobacterium, Atypical (1986-1991)", "MS": "A species of gram-positive, aerobic bacteria commonly found in soil and occasionally isolated from sputum. It causes postoperative wound infections as well as gluteal abscesses.", "PM": "92", "HN": "92", "MR": "20200527", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016926"}, {"RECTYPE": "D", "MH": "Mycobacterium avium subsp. paratuberculosis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mycobacterium paratuberculosis|T007|NON|EQV|NLM (1992)|990101|MYCOBACT PARATUBERC|abcdefv", "ENTRY": "Mycobacterium avium subspecies paratuberculosis|T007|NON|EQV|NLM (2008)|070330|abcdef", "MN": "B03.510.460.400.410.552.552.300.600", "MH_TH": "NLM (2008)", "ST": "T007", "RN": "txid1770", "PI": "Mycobacterium (1966-1991)", "MS": "A subspecies of gram-positive, aerobic bacteria. It is the etiologic agent of Johne's disease (PARATUBERCULOSIS), a chronic GASTROENTERITIS in RUMINANTS.", "PM": "2008; see MYCOBACTERIUM PARATUBERCULOSIS 1992-2007", "HN": "2008 (1992)", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016927"}, {"RECTYPE": "D", "MH": "Rhodococcus equi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Corynebacterium equi|T007|NON|EQV|NLM (1992)|910402|CORYNEBACT EQUI|abcdefv", "MN": "B03.510.024.981.775.700", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid43767", "AN": "in soil, dung, cows, sheep, pigs as well as horses (equ-); infection: coord IM with ACTINOMYCETALES INFECTIONS (IM)", "PI": "Rhodococcus (1987-1991)", "MS": "A species of RHODOCOCCUS found in soil, herbivore dung, and in the intestinal tract of cows, horses, sheep, and pigs. It causes bronchopneumonia in foals and can be responsible for infection in humans compromised by immunosuppressive drug therapy, lymphoma, or AIDS.", "OL": "use RHODOCOCCUS to search CORYNEBACTERIUM EQUI 1987-91", "PM": "92; CORYNEBACTERIUM EQUI was see RHODOCOCCUS 1987-91", "HN": "92; CORYNEBACTERIUM EQUI was see RHODOCOCCUS 1987-91", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016929"}, {"RECTYPE": "D", "MH": "Saccharopolyspora", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Streptomyces erythraea|T007|NON|NRW|NLM (1992)|910330|abcdef", "MN": "B03.510.460.410.790", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid1835", "RR": "txid1836", "AN": "a gram-pos bacterium", "PI": "Streptomyces (1988-1991)", "MS": "A genus of gram-positive bacteria whose spores are round to oval and covered by a sheath.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016930"}, {"RECTYPE": "D", "MH": "Halobacteriales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Halophiles, Extreme|T194|NON|REL|NLM (1998)|961004|abcdef", "MN": "B02.200.400", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2235", "AN": "an order of the kingdom of Euryarchaeota, of the domain Archaea", "MS": "An order of extremely halophilic archaea, in the kingdom EURYARCHAEOTA. They occur ubiquitously in nature where the salt concentration is high, and are chemoorganotrophic, using amino acids or carbohydrates as a carbon source.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016931"}, {"RECTYPE": "D", "MH": "Caulobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.090.100", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid75", "PI": "Bacteria (1966-1991)", "MS": "A genus of gram-negative, aerobic, rod- or vibroid-shaped or fusiform bacteria that commonly produce a stalk. They are found in fresh water and soil and divide by binary transverse fission.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016934"}, {"RECTYPE": "D", "MH": "Caulobacter crescentus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Caulobacter vibrioides|T007|EQV|NLM (2020)|191001|abdef", "MN": "B03.660.050.090.100.100", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid155892", "PI": "Bacteria (1966-1991)", "MS": "A species of gram-negative, aerobic bacteria that consist of slender vibroid cells.", "PM": "92", "HN": "92", "MR": "20211018", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016935"}, {"RECTYPE": "D", "MH": "Gram-Positive Endospore-Forming Bacteria", "DE": "GRAM POS ENDOSPORE FORMING BACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Positive Endospore Forming Bacteria|T007|EPO|EQV|NLM (1992)|910330|abcdef", "MN": "B03.510.415", "MH_TH": "NLM (1992)", "ST": "T007", "AN": "do not confuse with GRAM-POSITIVE ENDOSPORE-FORMING RODS; avoid: too general; prefer specific families & genera; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM); DF: GRAM POS ENDOSPORE FORMING BACT", "MS": "Bacteria that form endospores and are gram-positive. Representative genera include BACILLUS; CLOSTRIDIUM; MICROMONOSPORA; SACCHAROPOLYSPORA; and STREPTOMYCES.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016936"}, {"RECTYPE": "D", "MH": "Gram-Positive Endospore-Forming Rods", "DE": "GRAM POS ENDOSPORE FORMING RODS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Positive Endospore Forming Rods|T007|EPO|EQV|NLM (1992)|910329|abcdef", "MN": "B03.510.460.410", "MH_TH": "NLM (1992)", "ST": "T007", "AN": "do not confuse with GRAM-POSITIVE ENDOSPORE-FORMING BACTERIA; avoid: too general; prefer specific families & genera; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM)", "MS": "Rod-shaped bacteria that form endospores and are gram-positive. Representative genera include BACILLUS and CLOSTRIDIUM.", "PM": "98", "HN": "98; use explode 1992-97", "MR": "20200902", "DA": "19910823", "DC": "1", "DX": "19980101", "UI": "D016937"}, {"RECTYPE": "D", "MH": "Myxococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.125.500.605", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid32", "PI": "Myxococcales (1974-1991)", "MS": "A genus of gliding bacteria that are common inhabitants on tree bark and decomposing vegetation. The cells are slender rods with tapering ends.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016940"}, {"RECTYPE": "D", "MH": "Myxococcus xanthus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.125.500.605.900", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid34", "PI": "Myxococcales (1974-1991)", "MS": "A species of gliding bacteria found on soil as well as in surface fresh water and coastal seawater.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016941"}, {"RECTYPE": "D", "MH": "Sulfolobales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.075.725", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2281", "AN": "an order of Crenarchaeota, of the domain Archaea", "MS": "An order of CRENARCHAEOTA consisting of aerobic or facultatively aerobic, chemolithotrophic cocci which are extreme thermoacidophiles. They lack peptidoglycan in their cell walls.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016942"}, {"RECTYPE": "D", "MH": "Sulfolobaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Sulfurococcus|T194|NON|NRW|NLM (2004)|020911|abcdef", "MN": "B02.075.725.725", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid118883", "RR": "txid69655", "MS": "A family of SULFOLOBALES consisting of aerobic or facultatively anaerobic chemolithotrophic cocci, usually occurring singly. They grow best at a pH of about 2.", "PM": "1992", "HN": "1992", "MR": "20200902", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016943"}, {"RECTYPE": "D", "MH": "Sulfolobus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Sulfolobus tokodaii|T194|NON|NRW|NLM (2014)|120917|abcdef", "MN": "B02.075.725.725.725", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2284", "RR": "txid47303", "PI": "Bacteria (1972-1991)", "MS": "A genus of aerobic, chemolithotrophic, coccoid ARCHAEA whose organisms are thermoacidophilic. Its cells are highly irregular in shape, often lobed, but occasionally spherical. It has worldwide distribution with organisms isolated from hot acidic soils and water. Sulfur is used as an energy source.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016944"}, {"RECTYPE": "D", "MH": "Sulfolobus acidocaldarius", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.075.725.725.725.070", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2285", "AN": "a species of archaea", "PI": "Bacteria (1973-1991)", "MS": "A species of aerobic, chemolithotrophic ARCHAEA consisting of coccoid cells that utilize sulfur as an energy source. The optimum temperature for growth is 70-75 degrees C. They are isolated from acidic fields.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016945"}, {"RECTYPE": "D", "MH": "Gram-Negative Aerobic Rods and Cocci", "DE": "GRAM NEG AEROBIC RODS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Negative Aerobic Rods and Cocci|T007|EPO|EQV|NLM (1992)|910401|GRAM NEGATIVE AEROBIC RODS COCCI|abcdefv", "MN": "B03.440.400.425", "MH_TH": "NLM (1992)", "ST": "T007", "AN": "avoid: too general; prefer specific families & genera; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM); DF: GRAM NEG AEROBIC RODS", "PI": "Gram-Negative Aerobic Bacteria (1992-1997)", "MS": "A group of gram-negative bacteria consisting of rod- and coccus-shaped cells. They are both aerobic (able to grow under an air atmosphere) and microaerophilic (grow better in low concentrations of oxygen) under nitrogen-fixing conditions but, when supplied with a source of fixed nitrogen, they grow as aerobes.", "PM": "98", "HN": "98; use explode 1992-97", "MR": "20200902", "DA": "19910823", "DC": "1", "DX": "19980101", "UI": "D016946"}, {"RECTYPE": "D", "MH": "Acetobacteraceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.755.050", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid433", "MS": "A family of gram-negative aerobic bacteria consisting of ellipsoidal to rod-shaped cells that occur singly, in pairs, or in chains.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016947"}, {"RECTYPE": "D", "MH": "Azotobacter vinelandii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Azotobacter miscellum|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.580.022.820", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid354", "PI": "Azotobacter (1966-1991)", "MS": "A species of gram-negative, aerobic bacteria first isolated from soil in Vineland, New Jersey. Ammonium and nitrate are used as nitrogen sources by this bacterium. It is distinguished from other members of its genus by the ability to use rhamnose as a carbon source. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "92", "HN": "92", "MR": "20200128", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016948"}, {"RECTYPE": "D", "MH": "Azospirillum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.755.750.100", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid191", "MS": "A genus of gram-negative aerobic bacteria that occurs free-living in the soil or associated with the roots of cereal crops or grasses (POACEAE).", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016949"}, {"RECTYPE": "D", "MH": "Bordetella bronchiseptica", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Haemophilus bronchisepticus|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.075.090.344.425.050", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid518", "AN": "infection: coord IM with BORDETELLA INFECTIONS (IM)", "PI": "Bordetella (1966-1991)", "MS": "A species of BORDETELLA that is parasitic and pathogenic. It is found in the respiratory tract of domestic and wild mammalian animals and can be transmitted from animals to man. It is a common cause of bronchopneumonia in lower animals.", "PM": "92", "HN": "92", "MR": "20200206", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016950"}, {"RECTYPE": "D", "MH": "Legionellaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.460", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid444", "MS": "A family of gram-negative, aerobic bacteria that do not form endospores or microcysts.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016951"}, {"RECTYPE": "D", "MH": "Legionella pneumophila", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.460.460.580", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid446", "PI": "Legionella (1981-1991)", "MS": "A species of gram-negative, aerobic bacteria that is the causative agent of LEGIONNAIRES' DISEASE. It has been isolated from numerous environmental sites as well as from human lung tissue, respiratory secretions, and blood.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016952"}, {"RECTYPE": "D", "MH": "Leptospiraceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.851.475", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid170", "AN": "a family of gram-neg aerobic bacteria", "MS": "A family of bacteria consisting of flexible helical cells exhibiting a right-handed conformation. It consists of a single genus, LEPTOSPIRA.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016953"}, {"RECTYPE": "D", "MH": "Acinetobacter calcoaceticus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Neisseria winogradskyi|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.530.050.200", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid471", "AN": "in soil & water; nosocomial; infection: coord IM with ACINETOBACTER INFECTIONS (IM)", "PI": "Alcaligenes (1971-1974)", "MS": "A species of gram-negative, aerobic bacteria found in soil and water. Although considered to be normally nonpathogenic, this bacterium is a causative agent of nosocomial infections, particularly in debilitated individuals.", "PM": "92", "HN": "92", "MR": "20200128", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016954"}, {"RECTYPE": "D", "MH": "Moraxella bovis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Moraxella (Moraxella) bovis|T007|NON|EQV|NLM (1992)|990101|abcdef", "MN": "B03.660.250.530.525.500", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid476", "AN": "infection: coord IM with MORAXELLACEAE INFECTIONS (IM)", "PI": "Moraxella (1966-1991)", "MS": "A species of gram-negative, aerobic bacteria that is most frequently isolated from bovine eyes in cases of infectious keratoconjunctivitis (KERATOCONJUNCTIVITIS, INFECTIOUS), but also occurs in unaffected eyes and the nasal cavity of cattle.", "PM": "2020; was MORAXELLA (MORAXELLA) BOVIS 1992-2019", "HN": "2020 (1992); was MORAXELLA (MORAXELLA) BOVIS 1992-2019", "MR": "20200128", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016955"}, {"RECTYPE": "D", "MH": "Burkholderia cepacia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pseudomonas multivorans|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.075.090.688.100.110.500", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid292", "AN": "nosocomial & opportunistic; infection: coord IM with BURKHOLDERIA INFECTIONS (IM)", "PI": "Pseudomonas (1971-1991)", "MS": "A species of BURKHOLDERIA considered to be an opportunistic human pathogen. It has been associated with various types of infections of nosocomial origin.", "PM": "96; was PSEUDOMONAS CEPACIA 1992-95", "HN": "96; was PSEUDOMONAS CEPACIA 1992-95", "MR": "20200128", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016956"}, {"RECTYPE": "D", "MH": "Burkholderia pseudomallei", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pseudomonas pseudomallei|T007|NON|EQV|NLM (1996)|950331|abcdef", "MN": "B03.660.075.090.688.100.600", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid28450", "PI": "Pseudomonas (1967-1991)", "MS": "A species of gram-negative, aerobic bacteria that causes MELIOIDOSIS. It has been isolated from soil and water in tropical regions, particularly Southeast Asia.", "PM": "96; was PSEUDOMONAS PSEUDOMALLEI 1992-95", "HN": "96; was PSEUDOMONAS PSEUDOMALLEI 1992-95", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016957"}, {"RECTYPE": "D", "MH": "Pseudomonas putida", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.580.590.580", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid303", "AN": "infection: coord IM with PSEUDOMONAS INFECTIONS (IM)", "PI": "Pseudomonas (1966-1991)", "MS": "A species of gram-negative, aerobic bacteria isolated from soil and water as well as clinical specimens. Occasionally it is an opportunistic pathogen.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016958"}, {"RECTYPE": "D", "MH": "Xanthomonas campestris", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pseudomonas campestris|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.915.930.100", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid339", "PI": "Xanthomonas (1966-1991)", "MS": "A species of gram-negative, aerobic bacteria that is pathogenic for plants.", "PM": "92", "HN": "92", "MR": "20200206", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016959"}, {"RECTYPE": "D", "MH": "Agrobacterium tumefaciens", "DE": "AGROBACT TUMEFACIENS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rhizobium radiobacter|T007|NON|EQV|NLM (2004)|021022|RHIZOBIUM RADIOBACT|abcdefv", "ENTRY": "Agrobacterium radiobacter|T007|NON|EQV|NLM (2012)|101221|abcdef", "MN": "B03.660.050.662.024.500", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid358", "PI": "Agrobacterium (1966-1991)", "MS": "A species of gram-negative, aerobic bacteria isolated from soil and the stems, leafs, and roots of plants. Some biotypes are pathogenic and cause the formation of PLANT TUMORS in a wide variety of higher plants. The species is a major research tool in biotechnology.", "PM": "2012; see RHIZOBIUM RADIOBACTER 2004-2011, see AGROBACTERIUM TUMEFACIENS 1992-2003", "HN": "2012, 1992-2003", "MR": "20200128", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016960"}, {"RECTYPE": "D", "MH": "Rhizobium leguminosarum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.662.670.450", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid384", "PI": "Rhizobium (1966-1991)", "MS": "A species of gram-negative, aerobic bacteria that is found in soil and which causes formation of root nodules on some, but not all, types of field pea, lentil, kidney bean, and clover.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016961"}, {"RECTYPE": "D", "MH": "Sinorhizobium meliloti", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rhizobium meliloti|T007|NON|EQV|NLM (1992)|990101|abcdef", "MN": "B03.660.050.662.835.800", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid382", "PI": "Rhizobium (1966-1991)", "MS": "A species of gram-negative, aerobic bacteria that causes formation of root nodules on some, but not all, types of sweet clover, MEDICAGO SATIVA, and fenugreek.", "PM": "2000; see RHIZOBIUM MELILOTI 1992-1999", "HN": "2000(1992)", "MR": "20200206", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016962"}, {"RECTYPE": "D", "MH": "Thermus thermophilus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.400.425.875.875", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid274", "AN": "found in hot springs & hot-water tanks", "PI": "Thermus (1978-1991)", "MS": "A species of gram-negative, aerobic, rod-shaped bacteria found in hot springs of neutral to alkaline pH, as well as in hot-water heaters.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016963"}, {"RECTYPE": "D", "MH": "Gram-Negative Anaerobic Cocci", "DE": "GRAM NEG ANAEROBIC COCCI", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Negative Anaerobic Cocci|T007|NON|EQV|NLM (1992)|910403|abcdef", "MN": "B03.440.425.400", "MH_TH": "NLM (1992)", "ST": "T007", "AN": "general or unspecified; prefer specifics; infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS ", "PI": "Gram-Negative Anaerobic Bacteria (1976-1991)", "MS": "A group of anaerobic coccoid bacteria that show up as pink (negative) when treated by the gram-staining method.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016964"}, {"RECTYPE": "D", "MH": "Gram-Negative Anaerobic Straight, Curved, and Helical Rods", "DE": "GRAM NEG ANAEROBIC RODS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Negative Anaerobic Straight, Curved, and Helical Rods|T007|EPO|EQV|NLM (1992)|910403|abcdef", "MN": "B03.440.425.410", "MH_TH": "NLM (1992)", "ST": "T007", "AN": "avoid: too general; prefer specific families & genera; coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Gram-Negative Anaerobic Bacteria (1992-1997)", "MS": "A group of anaerobic, rod-shaped bacteria that show up as pink (negative) when treated by the Gram-staining method.", "PM": "98", "HN": "98; use explode 1992-97", "MR": "20200902", "DA": "19910823", "DC": "1", "DX": "19980101", "UI": "D016965"}, {"RECTYPE": "D", "MH": "Porphyromonas gingivalis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Bacteroides gingivalis|T007|NON|EQV|NLM (1994)|921022|abcdef", "MN": "B03.440.425.410.194.625.515", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid837", "AN": "infection: coordinate with BACTEROIDACEAE INFECTIONS", "PI": "Bacteroides (1981-1991)", "MS": "A species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium produces a cell-bound, oxygen-sensitive collagenase and is isolated from the human mouth.", "OL": "use PORPHYROMONAS GINGIVALIS to search BACTEROIDES GINGIVALIS 1992-93", "PM": "94; was BACTEROIDES GINGIVALIS 1992-93", "HN": "94; was BACTEROIDES GINGIVALIS 1992-93", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016966"}, {"RECTYPE": "D", "MH": "Fusobacterium nucleatum", "DE": "FUSOBACT NUCLEATUM", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.420.500", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid851", "AN": "infection: coordinate with FUSOBACTERIUM INFECTIONS ", "PI": "Fusobacterium (1977-1991)", "MS": "A species of gram-negative, anaerobic, rod-shaped bacteria isolated from the gingival margin and sulcus and from infections of the upper respiratory tract and pleural cavity.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016967"}, {"RECTYPE": "D", "MH": "Wolinella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Wolinella succinogenes|T007|NON|NRW|NLM (1992)|910326|abcdef", "MN": "B03.660.150.235.500.500", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid843", "RR": "txid844", "AN": "infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM) ", "PI": "Bacteroidaceae (1986-1991)", "MS": "A genus of gram-negative, anaerobic, rod-shaped bacteria isolated from the bovine RUMEN, the human gingival sulcus, and dental PULPITIS infections.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016968"}, {"RECTYPE": "D", "MH": "Desulfovibrio vulgaris", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.900.350.875", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid881", "AN": "infection: coordinate with DESULFOVIBRIONACEAE INFECTIONS", "PI": "Desulfovibrio (1968-1991)", "MS": "A species of gram-negative, anaerobic, rod-shaped bacteria isolated from soil, animal intestines and feces, and fresh and salt water.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016969"}, {"RECTYPE": "D", "MH": "Eikenella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.525.170", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid538", "AN": "in mouth & intestine; opportunistic; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Eikenella corrodens (1976-1991)", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the human mouth and intestine. Organisms of this genus can be opportunistic pathogens.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016970"}, {"RECTYPE": "D", "MH": "Citrobacter freundii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Salmonella hormaechei|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.150.100.210", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid546", "AN": "infection: coordinate with ENTEROBACTERIACEAE INFECTIONS", "PI": "Escherichia (1966-1974)", "MS": "A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in humans and other animals including MAMMALS; BIRDS; REPTILES; and AMPHIBIANS. It has also been isolated from SOIL and WATER as well as from clinical specimens such as URINE; THROAT; SPUTUM; BLOOD; and wound swabs as an opportunistic pathogen.", "PM": "92", "HN": "92", "MR": "20200128", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016971"}, {"RECTYPE": "D", "MH": "Enterobacter cloacae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.170.100", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid550", "AN": "infection: coordinate with ENTEROBACTERIACEAE INFECTIONS ", "PI": "Enterobacter (1966-1991)", "MS": "A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in water, sewage, soil, meat, hospital environments, and on the skin and in the intestinal tract of man and animals as a commensal.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016972"}, {"RECTYPE": "D", "MH": "Pectobacterium carotovorum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Erwinia carotovora|T007|NON|EQV|NLM (1992)|990101|abcdef", "MN": "B03.660.250.150.542.120", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid554", "PI": "Erwinia (1967-1991)", "MS": "A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that causes rotting, particularly of storage tissues, of a wide variety of plants and causes a vascular disease in CARROTS; and POTATO plants.", "PM": "2004; see ERWINIA CAROTOVORA 1992-2003", "HN": "2004 (1992)", "MR": "20200128", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016973"}, {"RECTYPE": "D", "MH": "Dickeya chrysanthemi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pectobacterium chrysanthemi|T007|NON|EQV|NLM (2004)|021219|abcdef", "MN": "B03.660.250.139.500", "MH_TH": "NLM (2021)", "ST": "T007", "RN": "txid556", "PI": "Erwinia (1980-1991)", "MS": "A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that causes vascular wilts on a wide range of plant species. It was formerly named Erwinia chrysanthemi and Pectobacterium chrysanthemi.", "PM": "2021; see PECTOBACTERIUM CHRYSANTHEMI 2004-2020; ERWINIA CHRYSANTHEMI 1992-2003", "HN": "2021(1992)", "MR": "20210510", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016974"}, {"RECTYPE": "D", "MH": "Gardnerella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.024.400", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid2701", "AN": "infection: coordinate with GRAM-POSITIVE BACTERIAL INFECTIONS and also with VAGINOSIS, BACTERIAL if pertinent ", "PI": "Gardnerella vaginalis (1975-1991)", "MS": "A genus of bacteria found in the human genital and urinary tract. It is considered to be a major cause of bacterial vaginosis (VAGINOSIS, BACTERIAL).", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016975"}, {"RECTYPE": "D", "MH": "Aggregatibacter actinomycetemcomitans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Haemophilus actinomyceticomitans|T007|NON|EQV|NLM (2021)|190919|abcdef", "ENTRY": "Haemophilus actinomycetemcomitans|T007|NON|EQV|NLM (2014)|130110|abcdef", "MN": "B03.660.250.550.170.500", "MH_TH": "NLM (2014)", "ST": "T007", "RN": "txid714", "AN": "infection: coordinate with PASTEURELLACEAE INFECTIONS", "PI": "Actinobacillus (1966-1991)", "MS": "A species of Gram-negative, facultatively anaerobic spherical or rod-shaped bacteria indigenous to dental surfaces. It is associated with PERIODONTITIS; BACTERIAL ENDOCARDITIS; and ACTINOMYCOSIS.", "PM": "2014(1992)", "HN": "2014(1992)", "MR": "20200317", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016976"}, {"RECTYPE": "D", "MH": "Actinobacillus pleuropneumoniae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Haemophilus pleuropneumoniae|T007|NON|EQV|NLM (1992)|910403|abcdef", "ENTRY": "Hemophilus pleuropneumoniae|T007|NON|EQV|NLM (1992)|910403|abcdef", "MN": "B03.660.250.550.050.580", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid715", "AN": "infection: coord IM with ACTINOBACILLUS INFECTIONS (IM)", "PI": "Haemophilus (1980-1985)", "MS": "A species of gram-negative, facultatively anaerobic coccobacillus-shaped bacteria that has been isolated from pneumonic lesions and blood. It produces pneumonia with accompanying fibrinous pleuritis in swine.", "PM": "92", "HN": "92", "MR": "20200128", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016977"}, {"RECTYPE": "D", "MH": "Mannheimia haemolytica", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pasteurella haemolytica|T007|NON|EQV|NLM (1992)|990101|abcdef", "ENTRY": "Pasteurella hemolytica|T007|NON|EQV|NLM (1992)|910415|abcdef", "MN": "B03.660.250.550.500.500", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid75985", "AN": "infection: coordinate IM with PASTEURELLACEAE INFECTIONS (IM) or PASTEURELLOSIS, PNEUMONIC (IM) or PNEUMONIA OF CALVES, ENZOOTIC (IM) if pertinent", "PI": "Pasteurella (1966-1991)", "MS": "A species of gram-negative, facultatively anaerobic, rod-shaped bacteria normally commensal in the flora of CATTLE and SHEEP. But under conditions of physical or PHYSIOLOGICAL STRESS, it can cause MASTITIS in sheep and SHIPPING FEVER or ENZOOTIC CALF PNEUMONIA in cattle. Its former name was Pasteurella haemolytica.", "PM": "2003; see PASTEURELLA HAEMOLYTICA 1992-2002", "HN": "2003 (1992)", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016978"}, {"RECTYPE": "D", "MH": "Pasteurella multocida", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.550.590.500", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid747", "AN": "infection: coord IM with PASTEURELLA INFECTIONS (IM) or specific indentions (IM) if pertinent", "PI": "Pasteurella (1966-1991)", "MS": "A species of gram-negative, facultatively anaerobic, rod-shaped bacteria normally found in the flora of the mouth and respiratory tract of animals and birds. It causes shipping fever (see PASTEURELLOSIS, PNEUMONIC); HEMORRHAGIC BACTEREMIA; and intestinal disease in animals. In humans, disease usually arises from a wound infection following a bite or scratch from domesticated animals.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016979"}, {"RECTYPE": "D", "MH": "Aeromonas hydrophila", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.450.019.025.380", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid644", "AN": "infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS", "PI": "Aeromonas (1967-1991)", "MS": "A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that may be pathogenic for frogs, fish, and mammals, including man. In humans, cellulitis and diarrhea can result from infection with this organism.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016980"}, {"RECTYPE": "D", "MH": "Plesiomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Plesiomonas shigelloides|T007|NON|NRW|NLM (1992)|910326|abcdef", "MN": "B03.660.250.150.550", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid702", "RR": "txid703", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Vibrionaceae (1978-1991)", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in fish and other aquatic animals and in a variety of mammals, including man. Its organisms probably do not belong to the normal intestinal flora of man and can cause diarrhea.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016981"}, {"RECTYPE": "D", "MH": "Micrococcus luteus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.500.500.400", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid1270", "AN": "found on mammalian skin", "PI": "Micrococcus (1968-1991)", "MS": "A species of gram-positive, spherical bacteria whose organisms occur in tetrads and in irregular clusters of tetrads. The primary habitat is mammalian skin.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016982"}, {"RECTYPE": "D", "MH": "Enterococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.250.250", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid1350", "AN": "\"normal flora of the intestinal tract\"; usually non-pathogenic", "PI": "Streptococcus (1966-1991)", "MS": "A genus of gram-positive, coccoid bacteria consisting of organisms causing variable hemolysis that are normal flora of the intestinal tract. Previously thought to be a member of the genus STREPTOCOCCUS, it is now recognized as a separate genus.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016983"}, {"RECTYPE": "D", "MH": "Enterococcus faecium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Streptococcus faecium|T007|NON|EQV|NLM (1992)|910329|STREP FAECIUM|abcdefv", "MN": "B03.510.550.250.250.300", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid1352", "AN": "normal intestinal flora; do not confuse with ENTEROCOCCUS FAECALIS; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM)", "PI": "Streptococcus (1966-1991)", "MS": "A species of gram-positive, coccoid bacteria whose organisms are normal flora of the intestinal tract. Unlike ENTEROCOCCUS FAECALIS, this species may produce an alpha-hemolytic reaction on blood agar and is unable to utilize pyruvic acid as an energy source.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016984"}, {"RECTYPE": "D", "MH": "Streptococcus bovis", "DE": "STREP BOVIS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Streptococcus equinus|T007|EQV|NLM (2020)|191001|abdef", "MN": "B03.510.550.737.872.150", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid1335", "AN": "infection: coordinate with STREPTOCOCCAL INFECTIONS", "PI": "Streptococcus (1966-1991)", "MS": "A species of gram-positive, coccoid bacteria commonly found in the alimentary tract of cows, sheep, and other ruminants. It occasionally is encountered in cases of human endocarditis. This species is nonhemolytic.", "PM": "1992; for STREPTOCOCCUS EQUINUS see under STREPTOCOCCUS BOVIS 2020-2022", "HN": "1992; for STREPTOCOCCUS EQUINUS use under STREPTOCOCCUS BOVIS 2020-2022", "MR": "20220711", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016985"}, {"RECTYPE": "D", "MH": "Streptococcus sobrinus", "DE": "STREP SOBRINUS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872.875.750", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid1310", "AN": "infection: coordinate IM with STREPTOCOCCAL INFECTIONS (IM)", "PI": "Streptococcus (1986-1991)", "MS": "A species of gram-positive, coccoid bacteria isolated from the human tooth surface. Strains have been shown to be cariogenic in experimental animals and may be associated with human dental caries.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016986"}, {"RECTYPE": "D", "MH": "Gram-Positive Rods", "DE": "GRAM POS RODS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Positive Rods|T007|NON|EQV|NLM (1992)|910329|abcdef", "MN": "B03.510.460", "MH_TH": "NLM (1992)", "ST": "T007", "AN": "general or unspecified; prefer specifics; infection: coordinate with GRAM-POSITIVE BACTERIAL INFECTIONS", "MS": "A large group of rod-shaped bacteria that retains the crystal violet stain when treated by Gram's method.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016987"}, {"RECTYPE": "D", "MH": "Gram-Positive Asporogenous Rods, Irregular", "DE": "GRAM POS ASPOROGENOUS RODS IRREGULAR", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Positive Asporogenous Rods, Irregular|T007|EPO|EQV|NLM (1992)|910329|abcdef", "MN": "B03.510.460.400.400", "MH_TH": "NLM (1992)", "ST": "T007", "AN": "do not confuse with GRAM-POSITIVE ASPOROGENOUS RODS, REGULAR; avoid: too general; prefer specific families & genera; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM)", "PI": "Gram-Positive Asporogenous Rods (1992-1997)", "MS": "A group of irregular rod-shaped bacteria that stain gram-positive and do not produce endospores.", "PM": "98", "HN": "98; use explode 1992-97", "MR": "20200902", "DA": "19910823", "DC": "1", "DX": "19980101", "UI": "D016988"}, {"RECTYPE": "D", "MH": "Gram-Positive Asporogenous Rods, Regular", "DE": "GRAM POS ASPOROGENOUS RODS REGULAR", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Positive Asporogenous Rods, Regular|T007|EPO|EQV|NLM (1992)|910404|abcdef", "MN": "B03.510.460.400.410", "MH_TH": "NLM (1992)", "ST": "T007", "AN": "do not confuse with GRAM-POSITIVE ASPOROGENOUS RODS, IRREGULAR; avoid: too general; prefer specific families & genera; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM)", "PI": "Gram-Positive Asporogenous Rods (1992-1997)", "MS": "A group of regular rod-shaped bacteria that stain gram-positive and do not produce endospores.", "PM": "98", "HN": "98; use explode 1992-97", "MR": "20200902", "DA": "19910823", "DC": "1", "DX": "19980101", "UI": "D016989"}, {"RECTYPE": "D", "MH": "Ureaplasma urealyticum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Ureaplasma urealyticum biovar 2|T007|NON|EQV|NLM (2003)|020305|abcdef", "MN": "B03.440.860.580.553.900.800", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid2130", "AN": "infection: coord IM with UREAPLASMA INFECTIONS (IM)", "PI": "Ureaplasma (1976-1991)", "MS": "A species of gram-negative bacteria found in the human genitourinary tract (UROGENITAL SYSTEM), oropharynx, and anal canal. Serovars 1, 3, 6, and 14 have been reclassed into a separate species UREAPLASMA parvum.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016990"}, {"RECTYPE": "D", "MH": "Spiroplasmataceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.300.750", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid2131", "MS": "A family of gram-negative, helical bacteria in the order Entomoplasmatales, that require STEROLS for growth.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016991"}, {"RECTYPE": "D", "MH": "Rhodobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.750.700", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid1060", "AN": "in fresh & sea water", "PI": "Rhodopseudomonas (1966-1991)", "MS": "A genus of gram-negative bacteria widely distributed in fresh water as well as marine and hypersaline habitats.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016992"}, {"RECTYPE": "D", "MH": "Chlamydophila pneumoniae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Chlamydia pneumoniae|T007|NON|EQV|NLM (1992)|990101|abcdef", "MN": "B03.440.190.190.230.249", "MH_TH": "NLM (2001)", "ST": "T007", "RN": "txid83558", "AN": "infection: coord IM with CHLAMYDOPHILA INFECTIONS (IM); index also PNEUMONIA, BACTERIAL if pertinent", "PI": "Chlamydia (1989-1991)", "MS": "A species of CHLAMYDOPHILA that causes acute respiratory infection, especially atypical pneumonia, in humans, horses, and koalas.", "PM": "2001; use CHLAMYDIA PNEUMONIAE 1992-2000", "HN": "2001 (1992)", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016993"}, {"RECTYPE": "D", "MH": "Ehrlichia ruminantium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Cowdria ruminantium|T007|NON|EQV|NLM (1992)|910326|abcdef", "MN": "B03.660.050.783.500.287.700", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid779", "PI": "Rickettsiaceae (1981-1991)", "MS": "A species of gram-negative bacteria in the family ANAPLASMATACEAE, that causes HEARTWATER DISEASE in ruminants.", "PM": "2003; see COWDRIA 1992-2002", "HN": "2003 (1992)", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016995"}, {"RECTYPE": "D", "MH": "Rickettsieae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.875.650", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid33988", "AN": "a tribe: do not confuse with RICKETTSIACEAE, a family; infection: coord IM with RICKETTSIACEAE INFECTIONS (IM)", "MS": "A tribe of gram-negative bacteria of the family RICKETTSIACEAE whose organisms are found in arthropods and are pathogenic for man and certain other vertebrate hosts.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016996"}, {"RECTYPE": "D", "MH": "Coxiella burnetii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.132.150.100", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid777", "PI": "Coxiella (1967-1991)", "MS": "A species of gram-negative bacteria that grows preferentially in the vacuoles of the host cell. It is the etiological agent of Q FEVER.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016997"}, {"RECTYPE": "D", "MH": "Helicobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gastrospirillum|T007|NON|REL|NLM (1994)|990101|abcdef", "MN": "B03.660.150.235.500.250", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid209", "PI": "Campylobacter (1984-1990)", "MS": "A genus of gram-negative, spiral-shaped bacteria that has been isolated from the intestinal tract of mammals, including humans. It has been associated with PEPTIC ULCER.", "PM": "1992; for GASTROSPIRILLUM, see GASTROSPIRILLUM 1994-2006", "HN": "1992", "MR": "20200902", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016998"}, {"RECTYPE": "D", "MH": "Sulfur-Reducing Bacteria", "DE": "SULFUR REDUCING BACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Sulfur Reducing Bacteria|T007|NON|EQV|NLM (1992)|910404|abcdef", "MN": "B03.900", "MH_TH": "NLM (1992)", "ST": "T007", "AN": "gram-neg anaerobic bacteria", "MS": "A group of gram-negative, anaerobic bacteria that is able to oxidize acetate completely to carbon dioxide using elemental sulfur as the electron acceptor.", "PM": "92", "HN": "92", "MR": "20200902", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D016999"}, {"RECTYPE": "D", "MH": "Campylobacter coli", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Vibrio coli|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.150.235.250.500.100", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid195", "AN": "in intestines of man, swine & poultry; infection: coord IM with CAMPYLOBACTER INFECTIONS (IM)", "PI": "Campylobacter (1983-1991)", "MS": "A species of gram-negative, rod-shaped bacteria isolated from the intestinal tract of swine, poultry, and man. It may be pathogenic.", "PM": "92", "HN": "92", "MR": "20200128", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017000"}, {"RECTYPE": "D", "MH": "Tooth Demineralization", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Demineralization, Tooth|T047|NON|EQV|NLM (1992)|910326|abcdef", "MN": "C07.793.720", "FX": "Dental Caries", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "a tooth disease; white spots or white lesions do not go here: note WHITE SPOTS see DENTAL CARIES", "MS": "A tooth's loss of minerals, such as calcium in hydroxyapatite from the tooth matrix, caused by acidic exposure. An example of the occurrence of demineralization is in the formation of dental caries.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017001"}, {"RECTYPE": "D", "MH": "Torovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Toroviridae|T005|NON|EQV|NLM (1994)|921117|abcdef", "ENTRY": "Toroviruses", "MN": "B04.820.578.500.540.800", "MH_TH": "NLM (1992)", "ST": "T005", "RN": "txid11155", "RR": "txid74501", "PI": "RNA Viruses (1984-1991)", "MS": "A genus of the family CORONAVIRIDAE characterized by enveloped, peplomer-bearing particles containing an elongated tubular nucleocapsid with helical symmetry. Toroviruses have been found in association with enteric infections in horses (Berne virus), cattle (Breda virus), swine, and humans. Transmission probably takes place via the fecal-oral route.", "OL": "use TOROVIRUS to search TOROVIRIDAE & TOROVIRUSES 1992-93", "PM": "94; was TOROVIRIDAE 1992-93; TOROVIRUSES was see TOROVIRIDAE 1992-93", "HN": "94; was TOROVIRIDAE 1992-93; TOROVIRUSES was see TOROVIRIDAE 1992-93", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017003"}, {"RECTYPE": "D", "MH": "Codependency, Psychological", "AQ": "CL DE ES PH RE", "ENTRY": "Psychology Codependency", "MN": "F01.145.194", "FX": "Substance-Related Disorders", "MH_TH": "NLM (2020)", "ST": "T055", "PI": "Dependency (Psychology) (1987-1991)", "MS": "A relational pattern in which a person attempts to derive a sense of purpose through relationships with others.", "PM": "1998; see CO-DEPENDENCY (PSYCHOLOGY) 1992-1997", "HN": "2020 (1992); was CODEPENDENCY (PSYCHOLOGY) 1998-2019; was CO-DEPENDENCY (PSYCHOLOGY) 1992-1997", "CATSH": "CAT LIST", "MR": "20181010", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017004"}, {"RECTYPE": "D", "MH": "Dental Debonding", "DE": "DENT DEBONDING", "AQ": "AE CL EC ES HI IS MT NU PX SN ST TD VE", "ENTRY": "Debonding, Dental|T061|NON|EQV|NLM (1992)|910408|DEBONDING DENT|abcdefv", "MN": "E06.178", "MH_TH": "NLM (1992)", "ST": "T061", "PI": "Dental Bonding (1977-1991)", "MS": "Techniques used for removal of bonded orthodontic appliances, restorations, or fixed dentures from teeth.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017005"}, {"RECTYPE": "D", "MH": "Rotator Cuff", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cuff, Rotator|T023|NON|EQV|NLM (1992)|910327|abcdef", "ENTRY": "Rotator Cuffs", "MN": "A02.880.700", "FX": "Shoulder Impingement Syndrome", "EC": "injuries:Rotator Cuff Injuries", "MH_TH": "NLM (1992)", "ST": "T023", "PI": "Tendons, Para-Articular (1972-1991)", "MS": "The musculotendinous sheath formed by the supraspinatus, infraspinatus, subscapularis, and teres minor muscles. These help stabilize the HUMERAL HEAD in the GLENOID CAVITY of the SCAPULA and allow for rotation of the SHOULDER JOINT about its longitudinal axis.", "PM": "92", "HN": "92", "MR": "20160120", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017006"}, {"RECTYPE": "D", "MH": "Duty to Warn", "AQ": "ES LJ PX", "ENTRY": "to Warn, Duty", "MN": "N03.706.535.230.270", "FX": "Mandatory Reporting", "MH_TH": "NLM (1992)", "ST": "T078", "PI": "Confidentiality (1976-1991)", "MS": "A health professional's obligation to breach patient CONFIDENTIALITY to warn third parties of the danger of their being assaulted or of contracting a serious infection.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19910726", "DC": "1", "DX": "19920101", "UI": "D017007"}, {"RECTYPE": "D", "MH": "Negotiating", "AQ": "MT PX", "PRINT ENTRY": "Mediating|T054|NON|NRW|NLM (1992)|910328|abcdef", "ENTRY": "Resolution, Conflict", "MN": "N04.452.677.430", "FX": "Collective Bargaining", "MH_TH": "NLM (1992)", "ST": "T054", "AN": "not restricted to labor unions: used also for interpersonal communications, personnel management, business transactions, etc.", "MS": "The process of bargaining in order to arrive at an agreement or compromise on a matter of importance to the parties involved. It also applies to the hearing and determination of a case by a third party chosen by the parties in controversy, as well as the interposing of a third party to reconcile the parties in controversy.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20150616", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017008"}, {"RECTYPE": "D", "MH": "Professional Autonomy", "ENTRY": "Regulation, Professional Self", "MN": "N04.452.758.752", "FX": "Personal Autonomy", "MH_TH": "NLM (1992)", "ST": "T078", "MS": "The quality or state of being independent and self-directing, especially in making decisions, enabling professionals to exercise judgment as they see fit during the performance of their jobs.", "PM": "92", "HN": "92", "MR": "20010725", "DA": "19910726", "DC": "1", "DX": "19920101", "UI": "D017009"}, {"RECTYPE": "D", "MH": "Reminder Systems", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "ENTRY": "Systems, Reminder", "MN": "L01.313.500.750.300.790", "MH_TH": "NLM (1992)", "ST": "T170", "MS": "Systems used to prompt or aid the memory. The systems can be computerized reminders, color coding, telephone calls, or devices such as letters and postcards.", "PM": "92", "HN": "92", "MR": "20150623", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017010"}, {"RECTYPE": "D", "MH": "Streptococcus suis", "DE": "STREP SUIS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872.750", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid1307", "AN": "pathogenic for swine; infection: coord IM with STREPTOCOCCAL INFECTIONS (IM)", "PI": "Streptococcus (1966-1991)", "MS": "A species of STREPTOCOCCUS isolated from pigs. It is a pathogen of swine but rarely occurs in humans.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017011"}, {"RECTYPE": "D", "MH": "Methanobacteriales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.492", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2158", "AN": "an order of methanogens found throughout nature", "MS": "An order of anaerobic, coccoid to rod-shaped methanogens, in the kingdom EURYARCHAEOTA. They are nonmotile, do not catabolize carbohydrates, proteinaceous material, or organic compounds other than formate or carbon monoxide, and are widely distributed in nature.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017012"}, {"RECTYPE": "D", "MH": "Methanobacteriaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Methanothermobacter|T194|NON|NRW|NLM (2004)|020930|abcdef", "MN": "B02.200.492.500", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2159", "RR": "txid2316", "MS": "A family of anaerobic, coccoid to rod-shaped METHANOBACTERIALES. Cell membranes are composed mainly of polyisoprenoid hydrocarbons ether-linked to glycerol. Its organisms are found in anaerobic habitats throughout nature.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017013"}, {"RECTYPE": "D", "MH": "Methanobacterium", "DE": "METHANOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.492.500.500", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2160", "AN": "a genus of methanogens found throughout nature and in gastrointestinal tract of animals: do not confuse with plural see ref METHANOBACTERIA see EURYARCHAEOTA", "PI": "Methanogens (1979-1991)", "MS": "A genus of anaerobic, rod-shaped METHANOBACTERIACEAE. Its organisms are nonmotile and use ammonia as the sole source of nitrogen. These methanogens are found in aquatic sediments, soil, sewage, and the gastrointestinal tract of animals.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017014"}, {"RECTYPE": "D", "MH": "Methanococcales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.538", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2182", "AN": "an order of methanogens", "MS": "An order of anaerobic methanogens in the kingdom EURYARCHAEOTA. They are pseudosarcina, coccoid or sheathed rod-shaped and catabolize methyl groups. The cell wall is composed of protein. The order includes one family, METHANOCOCCACEAE. (From Bergey's Manual of Systemic Bacteriology, 1989)", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017015"}, {"RECTYPE": "D", "MH": "Methanococcaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Methanothermococcus|T194|NON|NRW|NLM (2004)|020930|abcdef", "MN": "B02.200.538.525", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2183", "RR": "txid155862", "MS": "A family of anaerobic METHANOCOCCALES whose organisms are motile by means of flagella. These methanogens use carbon dioxide as an electron acceptor.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017016"}, {"RECTYPE": "D", "MH": "Methanococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.538.525.500", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2184", "AN": "a genus of methanogens found in aquatic environments & in animal intestine", "PI": "Methanogens (1979-1991)", "MS": "A genus of anaerobic coccoid METHANOCOCCACEAE whose organisms are motile by means of polar tufts of flagella. These methanogens are found in salt marshes, marine and estuarine sediments, and the intestinal tract of animals.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017017"}, {"RECTYPE": "D", "MH": "Methanomicrobiales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Methanocorpusculaceae|T194|NON|NRW|NLM (2004)|020930|abcdef", "MN": "B02.200.705", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2191", "RR": "txid88404", "MS": "An order of anaerobic, highly specialized methanogens, in the kingdom EURYARCHAEOTA. Its organisms are nonmotile or motile, with cells occurring as coccoid bodies, pseudosarcina, or rods. Families include METHANOMICROBIACEAE, Methanocorpusculaceae, and Methanospirillaceae.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017018"}, {"RECTYPE": "D", "MH": "Methanosarcinaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Methanothrix|T194|NON|NRW|NLM (1998)|961009|abcdef", "MN": "B02.200.765.550", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2206", "RR": "txid2225", "AN": "a family of methanogens \"found in any anaerobic environment\"", "MS": "A family of anaerobic METHANOSARCINALES whose cells are mesophilic or thermophilic and appear as irregular spheroid bodies or sheathed rods. These methanogens are found in any anaerobic environment including aquatic sediments, anaerobic sewage digesters and gastrointestinal tracts. There are four genera: METHANOSARCINA, Methanolobus, Methanothrix, and Methanococcoides.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017019"}, {"RECTYPE": "D", "MH": "Methanosarcina", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.765.550.550", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2207", "AN": "a genus of methanogens found in aquatic environments", "PI": "Sarcina (1966-1974)", "MS": "A genus of anaerobic, irregular spheroid-shaped METHANOSARCINALES whose organisms are nonmotile. Endospores are not formed. These archaea derive energy via formation of methane from acetate, methanol, mono-, di-, and trimethylamine, and possibly, carbon monoxide. Organisms are isolated from freshwater and marine environments.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017020"}, {"RECTYPE": "D", "MH": "Methanosarcina barkeri", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.765.550.550.200", "MH_TH": "NLM (1992)", "ST": "T194", "RN": "txid2208", "AN": "a gram-pos methanogen found in mud & ungulate rumens", "PI": "Sarcina (1966-1968)", "MS": "A species of halophilic archaea whose organisms are nonmotile. Habitats include freshwater and marine mud, animal-waste lagoons, and the rumens of ungulates.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017021"}, {"RECTYPE": "D", "MH": "Flow Injection Analysis", "DE": "FLOW INJECT ANAL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Injection Analysis, Flow", "MN": "E05.196.460", "MH_TH": "NLM (1992)", "ST": "T062", "MS": "The analysis of a chemical substance by inserting a sample into a carrier stream of reagent using a sample injection valve that propels the sample downstream where mixing occurs in a coiled tube, then passes into a flow-through detector and a recorder or other data handling device.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "19940512", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017022"}, {"RECTYPE": "D", "MH": "Coronary Angiography", "DE": "CORONARY ANGIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Angiography, Coronary|T060|NON|EQV|NLM (1992)|910401|ANGIOGR CORONARY|abcdefv", "ENTRY": "Coronary Angiographies", "MN": "E01.370.370.380.200", "MH_TH": "NLM (1992)", "ST": "T060", "AN": "for radiography of coronary vessels using non-contrast methods, index CORONARY VESSELS /diag image + specific radiographic technique", "PI": "Coronary Vessels/radiography (1966-1991)", "MS": "Radiography of the vascular system of the heart muscle after injection of a contrast medium.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017023"}, {"RECTYPE": "D", "MH": "Chemotherapy, Adjuvant", "DE": "CHEMOTHER ADJUVANT", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Drug Therapy, Adjuvant|T061|NON|EQV|NLM (1992)|910417|DRUG THER ADJUVANT|abcdefv", "ENTRY": "Adjuvant Drug Therapy|T061|NON|EQV|NLM (1992)|911120|ADJUVANT DRUG THER|abcdefv", "MN": "E02.319.170", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "coordinate with disease /\u200cdrug ther and specific drug or drugs /\u200cther use and other form of therapy to which this is adjuvant", "PI": "specific drug/therapeutic use (1966-1991)", "MS": "Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017024"}, {"RECTYPE": "D", "MH": "Swainsonine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Swainsonine, (8a alpha)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef", "MN": "D03.132.830", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1992)", "ST": "T121", "N1": "1,2,8-Indolizinetriol, octahydro-, (1S-(1alpha,2alpha,8beta,8abeta))-", "RN": "RSY4RK37KQ", "RR": "96648-51-0 ((8 alpha)-isomer)", "PI": "Alkaloids (1980-1991)", "MS": "An indolizidine alkaloid from the plant Swainsona canescens that is a potent alpha-mannosidase inhibitor. Swainsonine also exhibits antimetastatic, antiproliferative, and immunomodulatory activity.", "OL": "use SWAINSONINE (NM) to search SWAINSONINE 1981-91", "PM": "92; SWAINSONINE was indexed under ALKALOIDS 1981-91", "HN": "92; was SWAINSONINE (NM) 1981-91", "MR": "20130708", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D017026"}, {"RECTYPE": "D", "MH": "Protein Tyrosine Phosphatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tyrosyl Phosphoprotein Phosphatase|T116|T126|NON|EQV|NLM (1992)|910403|abbcdef", "ENTRY": "Tyrosine Phosphatases, Protein", "MN": "D12.776.476.564", "MH_TH": "NLM (2008)", "ST": "T126", "N1": "Protein-tyrosine-phosphate phosphohydrolase", "RN": "EC 3.1.3.48", "RR": "79747-53-8 (CAS RN)", "AN": "general; prefer specifics", "PI": "Phosphoprotein Phosphatases (1985-1991)", "MS": "An enzyme group that specifically dephosphorylates phosphotyrosyl residues in selected proteins. Together with PROTEIN-TYROSINE KINASE, it regulates tyrosine phosphorylation and dephosphorylation in cellular signal transduction and may play a role in cell growth control and carcinogenesis.", "PM": "2008; see PROTEIN-TYROSINE-PHOSPHATASE 1992-2007; PROTEIN-TYROSINE PHOSPHATASE was indexed under PHOSPHOPROTEIN PHOSPHATASES 1985-1991", "HN": "2008(1985)", "MR": "20210521", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017027"}, {"RECTYPE": "D", "MH": "Caregivers", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Spouse Caregivers|T099|NON|NRW|NLM (1992)|910404|abcdef", "ENTRY": "Spouse Caregiver", "MN": "N02.360.200", "MH_TH": "NLM (1992)", "ST": "T098", "MS": "Persons who provide care to those who need supervision or assistance in illness or disability. They may provide the care in the home, in a hospital, or in an institution. Although caregivers include trained medical, nursing, and other health personnel, the concept also refers to parents, spouses, or other family members, friends, members of the clergy, teachers, social workers, fellow patients.", "PM": "92", "HN": "92", "MR": "20210115", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017028"}, {"RECTYPE": "D", "MH": "Epilepsy, Complex Partial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Complex Partial Seizure Disorder|T047|NON|EQV|NLM (2000)|991103|COMPLEX PARTIAL SEIZURE DIS|abcdefv", "ENTRY": "Psychomotor Epilepsy", "MN": "C10.228.140.490.360.260", "MH_TH": "NLM (1992)", "ST": "T047", "AN": "do not confuse with EPILEPSY, SIMPLE PARTIAL see EPILEPSIES, PARTIAL", "PI": "Epilepsy, Temporal Lobe (1979-1991)", "MS": "A disorder characterized by recurrent partial seizures marked by impairment of cognition. During the seizure the individual may experience a wide variety of psychic phenomenon including formed hallucinations, illusions, deja vu, intense emotional feelings, confusion, and spatial disorientation. Focal motor activity, sensory alterations and AUTOMATISM may also occur. Complex partial seizures often originate from foci in one or both temporal lobes. The etiology may be idiopathic (cryptogenic partial complex epilepsy) or occur as a secondary manifestation of a focal cortical lesion (symptomatic partial complex epilepsy). (From Adams et al., Principles of Neurology, 6th ed, pp317-8)", "PM": "1992; see EPILEPSY, TEMPORAL LOBE 1977-1991; for EPILEPSY, PSYCHIC EQUIVALENT see EPILEPSY, TEMPORAL LOBE 1975-1991; for EPILEPSY, PSYCHOMOTOR see EPILEPSY, TEMPORAL LOBE 1964-1991", "HN": "1992; use EPILEPSY, TEMPORAL LOBE 1977-1991; for EPILEPSY, PSYCHIC EQUIVALENT use EPILEPSY, TEMPORAL LOBE 1975-1991; for EPILEPSY, PSYCHOMOTOR use EPILEPSY, TEMPORAL LOBE 1964-1991", "CATSH": "CAT LIST", "MR": "19991209", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017029"}, {"RECTYPE": "D", "MH": "Anabaena", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.585.051", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid1163", "AN": "general or unspecified; prefer specifics", "PI": "Cyanobacteria (1970-1991)", "MS": "A genus of CYANOBACTERIA consisting of trichomes that are untapered with conspicuous constrictions at cross-walls. A firm individual sheath is absent, but a soft covering is often present. Many species are known worldwide as major components of freshwater PLANKTON and also of many saline lakes. The species DOLICHOSPERMUM FLOS-AQUAE is responsible for acute poisonings of various animals.", "PM": "92", "HN": "92", "MR": "20210712", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017033"}, {"RECTYPE": "D", "MH": "Epilepsy, Frontal Lobe", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Frontal Lobe Epilepsy|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Supplementary Motor Epilepsy", "MN": "C10.228.140.490.493.188", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Epilepsy, Temporal Lobe (1966-1991)", "MS": "A localization-related (focal) form of epilepsy characterized by seizures which arise in the FRONTAL LOBE.", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017034"}, {"RECTYPE": "D", "MH": "Pravastatin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Eptastatin|T109|T121|NON|EQV|NLM (1992)|910405|abbcdef", "ENTRY": "Sodium Salt, Pravastatin", "MN": "D04.615.638.930", "PA": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", "MH_TH": "NLM (1992)", "ST": "T121", "N1": "1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-", "RN": "KXO2KT9N0G", "RR": "81176-41-2 ((6 beta)-isomer, mono-Na salt)", "MS": "An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES).", "OL": "use PRAVASTATIN (NM) to search PRAVASTATIN 1986-91", "PM": "92; PRAVASTATIN was indexed under NAPHTHALENES & HEPTANOIC ACIDS 1986-91", "HN": "92; was PRAVASTATIN (NM) 1986-91", "MR": "20160701", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D017035"}, {"RECTYPE": "D", "MH": "Epilepsia Partialis Continua", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Kozhevnikov Syndrome|T047|EPO|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Kojewnikov Epilepsy", "MN": "C23.888.592.742.785.260", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Epilepsy, Temporal Lobe (1966-1991)", "MS": "A variant of EPILEPSY characterized by continuous focal jerking of a body part over a period of hours, days, or even years without spreading to other body regions. Contractions may be aggravated by movement and are reduced, but not abolished during sleep. ELECTROENCEPHALOGRAPHY demonstrates epileptiform (spike and wave) discharges over the hemisphere opposite to the affected limb in most instances. The repetitive movements may originate from the CEREBRAL CORTEX or from subcortical structures (e.g., BRAIN STEM; BASAL GANGLIA). This condition is associated with Russian Spring and Summer encephalitis (see ENCEPHALITIS, TICK BORNE); Rasmussen syndrome (see ENCEPHALITIS); MULTIPLE SCLEROSIS; DIABETES MELLITUS; BRAIN NEOPLASMS; and CEREBROVASCULAR DISORDERS. (From Brain, 1996 April;119(pt2):393-407; Epilepsia 1993;34;Suppl 1:S29-S36; and Adams et al., Principles of Neurology, 6th ed, p319)", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017036"}, {"RECTYPE": "D", "MH": "Dinitrogenase Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Azoferredoxin|T116|T126|NON|EQV|NLM (1992)|910405|abbcdef", "ENTRY": "Reductase, Dinitrogenase", "MN": "D08.811.682.647.200", "MH_TH": "NLM (1992)", "ST": "T126", "RN": "0", "AN": "from bacteria", "PI": "Ferredoxins (1977-1991)", "MS": "A non-heme iron-sulfur protein isolated from Clostridium pasteurianum and other bacteria. It is a component of NITROGENASE along with molybdoferredoxin and is active in nitrogen fixation.", "OL": "use DINITROGENASE REDUCTASE (NM) to search AZOFERREDOXIN (NM) 1985-91", "PM": "92; AZOFERREDOXIN (NM) was indexed under FERREDOXINS 1985-91; AZOFERREDOXIN was see under FERREDOXINS 1977-85", "HN": "92; was AZOFERREDOXIN (NM) 1985-91; AZOFERREDOXIN was see under FERREDOXINS 1977-85", "MR": "20030709", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D017037"}, {"RECTYPE": "D", "MH": "Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endoglycosidase F|T116|T126|NON|NRW|NLM (1992)|910409|abbcdef", "ENTRY": "beta-N-Acetylglucosaminidase, Di-N-Acetylchitobiosyl", "MN": "D08.811.277.450.483.765", "MH_TH": "NLM (1992)", "ST": "T126", "N1": "Glycopeptide-D-mannosyl-N(4)-(N-acetyl-D-glucosaminyl)2-asparagine 1,4-N-acetyl-beta-glucosaminohydrolase", "RN": "EC 3.2.1.96", "RR": "EC 3.2.1.96", "PI": "Glycoside Hydrolases (1979-1985)", "MS": "A group of related enzymes responsible for the endohydrolysis of the di-N-acetylchitobiosyl unit in high-mannose-content glycopeptides and GLYCOPROTEINS.", "PM": "1992; for ENDOGLUCOSAMINIDASE F use GLUCOSAMINIDASE 1987-2004, for ENDOGLUCOSAMINIDASE H use GLUCOSAMINIDASE 1983-2004; for ENDOGLYCOSIDASE D use GLUCOSAMINIDASE 1980-2004; ENDO-BETA-ACETYLGLUCOSAMINIDASE was indexed under ACETYLGLUCOSAMINIDASE 1986-1991 & under GLYCOSIDE HYDROLASES 1979-1985; ENDOGLYCOSIDASE F was indexed under GLYCOSIDE HYDROLASES 1983-1991; ENDOHEXOSAMINIDASE H was indexed under HEXOSAMINIDASES 1982-1992", "HN": "1992 (1979); for ENDOGLUCOSAMINIDASE F use GLUCOSAMINIDASE 1987-2004; for ENDOGLUCOSAMINIDASE H use GLUCOSAMINIDASE 1983-2004; for ENDOGLYCOSIDASE D use GLUCOSAMINIDASE 1980-2004", "MR": "20130709", "DA": "19910712", "DC": "1", "DX": "19920101", "UI": "D017038"}, {"RECTYPE": "D", "MH": "Ethics Committees", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Institutional Ethics Committees|T097|NON|NRW|NLM (1992)|910415|abcdef", "ENTRY": "Regional Ethics Committee", "MN": "N05.700.685.300", "FX": "Ethical Review", "MH_TH": "NLM (1992)", "ST": "T097", "PI": "Professional Staff Committees (1975-1991)", "MS": "Committees established by professional societies, health facilities, or other institutions to consider decisions that have bioethical implications. The role of these committees may include consultation, education, mediation, and/or review of policies and practices. Committees that consider the ethical dimensions of patient care are ETHICS COMMITTEES, CLINICAL; committees established to protect the welfare of research subjects are ETHICS COMMITTEES, RESEARCH.", "PM": "92", "HN": "92", "MR": "20150622", "DA": "19910726", "DC": "1", "DX": "19920101", "UI": "D017041"}, {"RECTYPE": "D", "MH": "Phenylketonuria, Maternal", "DE": "PKU MATERNAL", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pregnancy in Phenylketonuria|T047|NON|EQV|NLM (2000)|991104|PREGN PHENYLKETONURIA|abcdefv", "ENTRY": "Phenylketonuria, Pregnancy in", "MN": "C18.452.648.189.687.500", "FX": "Phenylalanine Hydroxylase", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "check the tags PREGNANCY & FEMALE; consider also PHENYLALANINE HYDROXYLASE /defic", "PI": "Phenylketonuria (1966-1991)", "MS": "A condition occurring in untreated or partially treated females with PHENYLKETONURIA when they become pregnant. This may result in damages to the FETUS, including MICROCEPHALY; MENTAL RETARDATION; congenital heart disease; FETAL GROWTH RETARDATION; and CRANIOFACIAL ABNORMALITIES. (From Am J Med Genet 1997 Mar 3;69(1):89-95)", "PM": "1992", "HN": "1992", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017042"}, {"RECTYPE": "D", "MH": "Chalazion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Meibomian Cyst|T047|EPO|EQV|NLM (1992)|910417|abcdef", "ENTRY": "Cyst, Meibomian", "MN": "C11.338.300", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Meibomian Glands (1975-1990)", "MS": "A non-neoplastic cyst of the MEIBOMIAN GLANDS of the eyelid.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017043"}, {"RECTYPE": "D", "MH": "Polycystic Kidney, Autosomal Recessive", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polycystic Kidney Disease, Infantile, Type I|T019|T047|NON|EQV|NLM (2006)|OMIM (2013)|050407|abbcdeef", "ENTRY": "Polycystic Kidney and Hepatic Disease 1 (Autosomal Recessive)|T019|T047|NON|EQV|NLM (2006)|050510|abbcdef", "MN": "C16.320.184.625.510", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Kidney, Polycystic (1966-1991)", "MS": "A genetic disorder with autosomal recessive inheritance, characterized by multiple CYSTS in both KIDNEYS and associated LIVER lesions. Serious manifestations are usually present at BIRTH with high PERINATAL MORTALITY.", "PM": "1992; see KIDNEY, POLYCYCSTIC, AUTOSOMAL RECESSIVE 1992-2000", "HN": "1992", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017044"}, {"RECTYPE": "D", "MH": "Lactococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.500", "MH_TH": "NLM (1992)", "ST": "T007", "RN": "txid1357", "AN": "usually non-pathogenic; in milk & milk products", "PI": "Streptococcus (1988-1991)", "MS": "A genus of gram-positive, coccoid bacteria mainly isolated from milk and milk products. These bacteria are also found in plants and nonsterile frozen and dry foods. Previously thought to be a member of the genus STREPTOCOCCUS (group N), it is now recognized as a separate genus.", "PM": "92", "HN": "92", "MR": "20200813", "DA": "19910530", "DC": "1", "DX": "19920101", "UI": "D017045"}, {"RECTYPE": "D", "MH": "Cost Savings", "AQ": "CL EC ES HI LJ MT SN ST TD", "ENTRY": "Savings, Cost", "MN": "N03.219.151.160.200", "MH_TH": "NLM (1992)", "ST": "T081", "AN": "a saving for the provider of goods or services or for the recipient or consumer", "PI": "Cost Control (1979-1991)", "MS": "Reductions in all or any portion of the costs of providing goods or services. Savings may be incurred by the provider or the consumer.", "PM": "92", "HN": "92", "MR": "19930916", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017046"}, {"RECTYPE": "D", "MH": "Cost Sharing", "AQ": "CL EC ES HI LJ MT SN ST TD", "ENTRY": "Sharing, Cost", "MN": "N03.219.521.576.090", "FX": "Managed Care Programs", "MH_TH": "NLM (1992)", "ST": "T081", "AN": "restrict to insurance: sharing of costs by both insured & insurer", "PI": "Deductibles and Coinsurance (1968-1991)", "MS": "Provisions of an insurance policy that require the insured to pay some portion of covered expenses. Several forms of sharing are in use, e.g., deductibles, coinsurance, and copayments. Cost sharing does not refer to or include amounts paid in premiums for the coverage. (From Dictionary of Health Services Management, 2d ed)", "OL": "use DEDUCTIBLES AND COINSURANCE to search COST SHARING INSURANCE 1978-91", "PM": "92; COST SHARING INSURANCE was see DEDUCTIBLES AND COINSURANCE 1978-91", "HN": "92; COST SHARING INSURANCE was see DEDUCTIBLES AND COINSURANCE 1978-91", "MR": "19930916", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017047"}, {"RECTYPE": "D", "MH": "Health Care Costs", "AQ": "CL ES HI LJ SN ST TD", "PRINT ENTRY": "Treatment Costs|T081|NON|NRW|NLM (1992)|910429|abcdef", "ENTRY": "Treatment Cost", "MN": "N05.300.375", "FX": "Health Expenditures", "MH_TH": "NLM (1992)", "ST": "T081", "AN": "actual cost of providing care: do not confuse with HEALTH EXPENDITURES (the amount paid for the service) or with FEES AND CHARGES (the amount charged regardless of cost); do not confuse with COST OF ILLNESS which is a personal cost (psychol, social, etc.) as well as a monetary cost for services", "PI": "Health Expenditures (1968-1991)", "MS": "The actual costs of providing services related to the delivery of health care, including the costs of procedures, therapies, and medications. It is differentiated from HEALTH EXPENDITURES, which refers to the amount of money paid for the services, and from fees, which refers to the amount charged, regardless of cost.", "PM": "92", "HN": "92", "MR": "20180629", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017048"}, {"RECTYPE": "D", "MH": "Employer Health Costs", "AQ": "CL ES HI LJ SN ST TD", "PRINT ENTRY": "Health Costs, Employer|T081|NON|EQV|NLM (1992)|910429|abcdef", "ENTRY": "Health Cost, Employer", "MN": "N05.300.375.350", "MH_TH": "NLM (1992)", "ST": "T081", "AN": "health care cost paid by employer", "PI": "Health Expenditures (1968-1991)", "MS": "That portion of total HEALTH CARE COSTS borne by an individual's or group's employing organization.", "PM": "92", "HN": "92", "MR": "20180629", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017049"}, {"RECTYPE": "D", "MH": "Episode of Care", "PRINT ENTRY": "Patient Care Episodes|T058|T079|NON|EQV|NLM (1992)|910508|abbcdef", "ENTRY": "Patient Care Episode", "MN": "N02.421.585.300", "MH_TH": "NLM (1992)", "ST": "T079", "MS": "An interval of care by a health care facility or provider for a specific medical problem or condition. It may be continuous or it may consist of a series of intervals marked by one or more brief separations from care, and can also identify the sequence of care (e.g., emergency, inpatient, outpatient), thus serving as one measure of health care provided.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017050"}, {"RECTYPE": "D", "MH": "Hospice Care", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "PRINT ENTRY": "Hospice Programs|T058|NON|BRD|NLM (1992)|910501|abcdef", "ENTRY": "Programs, Hospice", "MN": "N02.421.585.905.400", "FX": "Respite Care", "MH_TH": "NLM (1992)", "ST": "T058", "AN": "for the dying; /psychol permitted", "PI": "Hospices (1977-1991)", "MS": "Specialized health care, supportive in nature, provided to a dying person. A holistic approach is often taken, providing patients and their families with legal, financial, emotional, or spiritual counseling in addition to meeting patients' immediate physical needs. Care may be provided in the home, in the hospital, in specialized facilities (HOSPICES), or in specially designated areas of long-term care facilities. The concept also includes bereavement care for the family. (From Dictionary of Health Services Management, 2d ed)", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017051"}, {"RECTYPE": "D", "MH": "Hospital Mortality", "DE": "HOSP MORTAL", "AQ": "EH HI TD", "PRINT ENTRY": "Mortality, Hospital|T080|NON|EQV|NLM (1992)|910501|MORTAL HOSP|abcdefv", "ENTRY": "Mortality, In-house", "MN": "N06.850.520.308.985.550.400", "MH_TH": "NLM (1992)", "ST": "T080", "PI": "Mortality (1966-1991)", "MS": "A vital statistic measuring or recording the rate of death from any cause in hospitalized populations.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017052"}, {"RECTYPE": "D", "MH": "Infection Control", "DE": "INFECT CONTROL", "AQ": "EC HI IS LJ MT OG SN ST TD", "ENTRY": "Control, Infection|T058|NON|EQV|NLM (1992)|910501|CONTROL INFECT|abcdefv", "MN": "N06.850.780.200.450", "MH_TH": "NLM (1992)", "ST": "T058", "AN": "differentiate from COMMUNICABLE DISEASE CONTROL which tends to be on a large geographic, demographic or social level (e.g., city, underprivileged, elementary school, prisons) while INFECTION CONTROL tends to be restricted within health care facilities", "PI": "Infection/prevention & control (1966-1991)", "MS": "Programs of disease surveillance, generally within health care facilities, designed to investigate, prevent, and control the spread of infections and their causative microorganisms.", "OL": "use INFECTION CONTROL to search INFECTION/prevention & control 1966-91", "PM": "92; was INFECTION/prevention & control 1966-91", "HN": "92; was INFECTION/prevention & control 1966-91", "MR": "20080708", "DA": "19910719", "DC": "1", "DX": "19920101", "UI": "D017053"}, {"RECTYPE": "D", "MH": "Insurance, Medigap", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Medigap Insurance|T058|NON|EQV|NLM (1992)|910503|abcdef", "ENTRY": "Supplemental Insurance, Medicare", "MN": "N03.219.521.576.343.539", "MH_TH": "NLM (1992)", "ST": "T058", "AN": "insures the gap between payments by private insurers & Medicare; specify geog", "PI": "Medicare (1977-1991)", "MS": "A supplemental health insurance policy sold by private insurance companies and designed to pay for health care costs and services that are not paid for either by Medicare alone or by a combination of Medicare and existing private health insurance benefits. (From Facts on File Dictionary of Health Care Management, 1988)", "PM": "92", "HN": "92", "MR": "20190530", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017054"}, {"RECTYPE": "D", "MH": "Medical Laboratory Personnel", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Technologists, Medical", "MN": "N02.360.510", "FX": "Medical Laboratory Science", "MH_TH": "NLM (2012)", "ST": "T097", "MS": "Health care professionals, technicians, and assistants staffing LABORATORIES in research or health care facilities.", "PM": "2012; see Laboratory Personnel (1992-2011)", "HN": "2012 (1992)", "MR": "20180629", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017056"}, {"RECTYPE": "D", "MH": "Medically Uninsured", "DE": "MED UNINSURED", "AQ": "CL EH HI LJ PX SN", "PRINT ENTRY": "Medically Underinsured|T098|NON|BRD|NLM (1992)|910503|MED UNDERINSURED|abcdefv", "ENTRY": "Uninsured|T098|NON|BRD|NLM (1992)|910503|abcdef", "MN": "M01.385", "FX": "Uncompensated Care", "MH_TH": "NLM (1992)", "ST": "T098", "MS": "Individuals or groups with no or inadequate health insurance coverage. Those falling into this category usually comprise three primary groups: the medically indigent (MEDICAL INDIGENCY); those whose clinical condition makes them medically uninsurable; and the working uninsured.", "PM": "92", "HN": "92", "MR": "19940616", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017057"}, {"RECTYPE": "D", "MH": "Mexican Americans", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Chicanos|T098|NON|EQV|NLM (1992)|910503|abcdef", "ENTRY": "Mexican American", "MN": "M01.686.477.625.188.441.250", "MH_TH": "NLM (1992)", "ST": "T098", "AN": "specify geog if relevant", "PI": "Mexico/ethnology (1978-1991)", "MS": "Persons living in the United States of Mexican descent.", "OL": "use HISPANIC AMERICANS to search MEXICAN AMERICANS 1978-91 & CHICANOS 1990-91", "PM": "92; was see HISPANIC AMERICANS 1978-91; CHICANOS was see HISPANIC AMERICANS 1990-91", "HN": "92; was see HISPANIC AMERICANS 1978-91; CHICANOS was see HISPANIC AMERICANS 1990-91", "MR": "20220713", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017058"}, {"RECTYPE": "D", "MH": "Models, Econometric", "PRINT ENTRY": "Econometric Models|T081|T170|NON|EQV|NLM (1992)|910503|abbcdef", "ENTRY": "Model, Econometric", "MN": "N06.850.520.830.500.600.500", "MH_TH": "NLM (1992)", "ST": "T170", "MS": "The application of mathematical formulas and statistical techniques to the testing and quantifying of economic theories and the solution of economic problems.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017059"}, {"RECTYPE": "D", "MH": "Patient Satisfaction", "AQ": "EC EH LJ SN", "ENTRY": "Satisfaction, Patient", "MN": "N05.715.360.600", "FX": "Patient Acceptance of Health Care", "MH_TH": "NLM (1992)", "ST": "T080", "AN": "PATIENT PREFERENCE is also available", "PI": "Consumer Satisfaction (1966-1991)", "MS": "The degree to which the individual regards the health care service or product or the manner in which it is delivered by the provider as useful, effective, or beneficial.", "OL": "use CONSUMER SATISFACTION to search PATIENT SATISFACTION 1982-91", "PM": "92; was see CONSUMER SATISFACTION 1982-91", "HN": "92; was see CONSUMER SATISFACTION 1982-91", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017060"}, {"RECTYPE": "D", "MH": "Prepaid Health Plans", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Health Plans, Prepaid|T058|NON|EQV|NLM (1992)|910506|abcdef", "ENTRY": "Prepaid Health Plan", "MN": "N03.219.521.576.343.925", "FX": "Group Practice, Prepaid", "MH_TH": "NLM (1992)", "ST": "T058", "PI": "Insurance, Health (1966-1991)", "MS": "Contracts between an insurer and a subscriber or a group of subscribers whereby a specified set of health benefits is provided in return for a periodic premium.", "PM": "92", "HN": "92", "MR": "19930916", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017061"}, {"RECTYPE": "D", "MH": "Small-Area Analysis", "DE": "SMALL AREA ANAL", "ENTRY": "Variations, Small-Area", "MN": "N06.850.520.830.250.675", "MH_TH": "NLM (1992)", "ST": "T062", "MS": "A method of analyzing the variation in utilization of health care in small geographic or demographic areas. It often studies, for example, the usage rates for a given service or procedure in several small areas, documenting the variation among the areas. By comparing high- and low-use areas, the analysis attempts to determine whether there is a pattern to such use and to identify variables that are associated with and contribute to the variation.", "PM": "92", "HN": "92", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017062"}, {"RECTYPE": "D", "MH": "Outcome Assessment, Health Care", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Outcomes Research|T058|T062|NON|REL|NLM (1992)|910516|abbcdef", "ENTRY": "Study, Outcome", "MN": "N05.715.360.575.575", "MH_TH": "NLM (2020)", "ST": "T057", "AN": "note category: for admin aspects of patient assessment; outcome only: for outcome assessment with process assessment, OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE) and TREATMENT OUTCOME are available", "PI": "Outcome and Process Assessment (Health Care) (1979-1991)", "MS": "Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure).", "PM": "2020; was OUTCOME ASSESSMENT (HEALTH CARE) 1992-2019; for PATIENT OUTCOME ASSESSMENT see OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE) 1979-1991", "HN": "2020 (1992); was OUTCOME ASSESSMENT (HEALTH CARE) 1992-2019; for PATIENT OUTCOME ASSESSMENT use OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE) 1979-1991", "MR": "20210630", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017063"}, {"RECTYPE": "D", "MH": "Process Assessment, Health Care", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Process Assessment (Health Care)|T058|NON|EQV|NLM (1992)|990101|PROCESS ASSESS|abcdefv", "ENTRY": "Process Measure", "MN": "N05.715.360.575.625", "MH_TH": "NLM (2020)", "ST": "T058", "AN": "note category; process only: for outcome assessment with process assessment, OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE) is available", "PI": "Outcome and Process Assessment (Health Care) (1979-1991)", "MS": "An evaluation procedure that focuses on how care is delivered, based on the premise that there are standards of performance for activities undertaken in delivering patient care, in which the specific actions taken, events occurring, and human interactions are compared with accepted standards.", "PM": "2020; was PROCESS ASSESSMENT (HEALTH CARE) 1992-2019; see OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE) 1979-1991", "HN": "2020 (1992); was PROCESS ASSESSMENT (HEALTH CARE) 1992-2019; use OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE) 1979-1991", "MR": "20190118", "DA": "19910620", "DC": "1", "DX": "19920101", "UI": "D017064"}, {"RECTYPE": "D", "MH": "Practice Guideline", "PRINT ENTRY": "Clinical Guidelines|T170|NON|NRW|NLM (2021)|200513|abcdef", "ENTRY": "Clinical Practice Guideline|T170|NON|NRW|NLM (1996)|950623|abcdef", "MN": "V02.515.500", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original specific guidelines related to healthcare; a different heading PRACTICE GUIDELINES AS TOPIC is used for general design, methodology, economics, etc of practice guidelines", "MS": "Work consisting of a set of directions or principles to assist the health care practitioner with patient care decisions about appropriate diagnostic, therapeutic, or other clinical procedures for specific clinical circumstances. Practice guidelines may be developed by government agencies at any level, institutions, organizations such as professional societies or governing boards, or by the convening of expert panels. They can provide a foundation for assessing and evaluating the quality and effectiveness of health care in terms of measuring improved health, reduction of variation in services or procedures performed, and reduction of variation in outcomes of health care delivered.", "HN": "2008(1992)", "MR": "20200527", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D017065"}, {"RECTYPE": "D", "MH": "Neostriatum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "MN": "A08.186.211.200.885.287.249.487.550", "MH_TH": "NLM (1993)", "ST": "T023", "AN": "the newer part of the corpus striatum, hence neo-; also called \"striatum\"", "PI": "Corpus Striatum (1974-1992)", "MS": "The phylogenetically newer part of the CORPUS STRIATUM consisting of the CAUDATE NUCLEUS and PUTAMEN. It is often called simply the striatum.", "PM": "93", "HN": "93", "MR": "20180701", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017072"}, {"RECTYPE": "D", "MH": "Atherectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Percutaneous Atherectomy|T061|NON|EQV|NLM (1993)|910917|abcdef", "ENTRY": "Transluminal Atherectomy, Percutaneous", "MN": "E05.157.016.120", "FX": "Endarterectomy", "MH_TH": "NLM (1993)", "ST": "T061", "PI": "Atherosclerosis (1987-1992)", "MS": "Endovascular procedure in which atheromatous plaque is excised by a cutting or rotating catheter. It differs from balloon and laser angioplasty procedures which enlarge vessels by dilation but frequently do not remove much plaque. If the plaque is removed by surgical excision under general anesthesia rather than by an endovascular procedure through a catheter, it is called ENDARTERECTOMY.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017073"}, {"RECTYPE": "D", "MH": "Common Variable Immunodeficiency", "DE": "COMMON VARIABLE IMMUNODEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Immunodeficiency, Common Variable|T047|NON|EQV|GHR (2014)|NLM (1993)|911009|IMMUNODEFIC COMMON VARIABLE|abcdeefv", "ENTRY": "Variable Hypogammaglobulinemias, Common", "MN": "C20.673.330", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "an immunodefic syndrome with hypogammaglobulinemia", "PI": "Immunologic Deficiency Syndromes (1975-1992)", "MS": "Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017074"}, {"RECTYPE": "D", "MH": "Laser Coagulation", "DE": "LASER COAG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Thermocoagulation, Laser|T061|NON|EQV|NLM (1998)|960723|THERMOCOAG LASER|abcdefv", "ENTRY": "Thermocoagulations, Laser", "MN": "E04.540.630.410", "FX": "Argon Plasma Coagulation", "MH_TH": "NLM (1993)", "ST": "T061", "AN": "do not confuse with LIGHT COAGULATION or with LASER SURGERY; coordinate IM with disease /surg (IM)", "PI": "Light Coagulation (1966-1992)", "MS": "The use of green light-producing LASERS to stop bleeding. The green light is selectively absorbed by HEMOGLOBIN, thus triggering BLOOD COAGULATION.", "OL": "use LIGHT COAGULATION to search LASER COAGULATION 1992 & use LASERS/TU 1968-85", "PM": "93; was see LIGHT COAGULATION 1992; was heading 1968-85", "HN": "93; was see LIGHT COAGULATION 1992; was heading 1968-85", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017075"}, {"RECTYPE": "D", "MH": "Computer-Aided Design", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "PRINT ENTRY": "Computer-Assisted Manufacturing|T066|NON|REL|NLM (1993)|911016|abcdef", "ENTRY": "Manufacturing, Computer-Assisted", "MN": "L01.296.110.150", "MH_TH": "NLM (1993)", "ST": "T066", "AN": "in design of equipment or drugs", "PI": "Computers (1968-1992)", "MS": "The use of computers for designing and/or manufacturing of anything, including drugs, surgical procedures, orthotics, and prosthetics.", "PM": "93", "HN": "93", "MR": "20170703", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017076"}, {"RECTYPE": "D", "MH": "Culture Media, Conditioned", "AQ": "AE AN CH CL EC HI IP ME PD PK PO RE SD ST TO", "PRINT ENTRY": "Conditioned Culture Media|T130|NON|EQV|NLM (1993)|910924|abcdef", "ENTRY": "Medium, Conditioned", "MN": "E07.206.250", "MH_TH": "NLM (1993)", "ST": "T130", "RN": "0", "AN": "usually NIM", "PI": "Culture Media (1967-1992)", "MS": "Culture media containing biologically active components obtained from previously cultured cells or tissues that have released into the media substances affecting certain cell functions (e.g., growth, lysis).", "PM": "93", "HN": "93", "MR": "20030709", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017077"}, {"RECTYPE": "D", "MH": "Laser-Doppler Flowmetry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Velocimetry, Laser-Doppler|T060|EPO|NRW|NLM (1993)|920511|abcdef", "ENTRY": "Velocimetry, Laser Doppler", "MN": "E05.830.500", "MH_TH": "NLM (1993)", "ST": "T060", "AN": "index laser velocimeters & Doppler velocimeters here with / instrum & do not coordinate with LASERS or DOPPLER EFFECT", "PI": "Lasers (1966-1992)", "MS": "A method of non-invasive, continuous measurement of MICROCIRCULATION. The technique is based on the values of the DOPPLER EFFECT of low-power laser light scattered randomly by static structures and moving tissue particulates.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017078"}, {"RECTYPE": "D", "MH": "Exercise Tolerance", "AQ": "DE ES GE IM PH RE", "ENTRY": "Tolerance, Exercise", "MN": "G11.427.680.270", "MH_TH": "NLM (1993)", "ST": "T081", "PI": "Exercise Test (1966-1992)", "MS": "The exercise capacity of an individual as measured by endurance (maximal exercise duration and/or maximal attained work load) during an EXERCISE TEST.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19920526", "DC": "1", "DX": "19930101", "UI": "D017079"}, {"RECTYPE": "D", "MH": "Cholecystectomy, Laparoscopic", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Laparoscopic Cholecystectomy|T061|NON|EQV|NLM (1993)|910925|abcdef", "ENTRY": "Laparoscopic Cholecystectomies", "MN": "E04.502.250.520.160", "MH_TH": "NLM (1993)", "ST": "T061", "PI": "Laparoscopy (1989-1992)", "MS": "Excision of the gallbladder through an abdominal incision using a laparoscope.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19920526", "DC": "1", "DX": "19930101", "UI": "D017081"}, {"RECTYPE": "D", "MH": "Portal Pressure", "AQ": "DE GE IM PH RE", "ENTRY": "Venous Pressure, Portal", "MN": "G09.330.380.076.732.650", "MH_TH": "NLM (1993)", "ST": "T040", "PI": "Blood Pressure (1966-1992)", "MS": "The venous pressure measured in the PORTAL VEIN.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017082"}, {"RECTYPE": "D", "MH": "Otoacoustic Emissions, Spontaneous", "AQ": "DE GE IM PH RE", "ENTRY": "Spontaneous Otoacoustic Emission", "MN": "G11.561.790.263.570", "MH_TH": "NLM (1993)", "ST": "T042", "PI": "Cochlea (1983-1992)", "MS": "Self-generated faint acoustic signals from the inner ear (COCHLEA) without external stimulation. These faint signals can be recorded in the EAR CANAL and are indications of active OUTER AUDITORY HAIR CELLS. Spontaneous otoacoustic emissions are found in all classes of land vertebrates.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20200609", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017084"}, {"RECTYPE": "D", "MH": "alpha-Thalassemia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thalassemia-alpha|T047|NON|EQV|NLM (1994)|930524|abcdef", "ENTRY": "alpha-Thalassemias", "MN": "C16.320.365.826.100", "FX": "Hemoglobin H", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Thalassemia (1966-1992)", "MS": "A disorder characterized by reduced synthesis of the alpha chains of hemoglobin. The severity of this condition can vary from mild anemia to death, depending on the number of genes deleted.", "OL": "use THALASSEMIA to search ALPHA-THALASSEMIA 1988-92 & HEMOGLOBIN H DISEASE 1982-92", "PM": "93; was see THALASSEMIA 1988-92; HEMOGLOBIN H DISEASE was see THALASSEMIA 1982-92", "HN": "93; was see THALASSEMIA 1988-92; HEMOGLOBIN H DISEASE was see THALASSEMIA 1982-92", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017085"}, {"RECTYPE": "D", "MH": "beta-Thalassemia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thalassemia Minor|T047|NON|NRW|NLM (1993)|ORD (2010)|910926|abcdeef", "ENTRY": "beta Type Thalassemias", "MN": "C16.320.365.826.150", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Thalassemia (1966-1992)", "MS": "A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form (thalassemia minor), which is asymptomatic, while in the homozygous form (thalassemia major, Cooley's anemia, Mediterranean anemia, erythroblastic anemia), which can result in severe complications and even death, hemoglobin A synthesis is absent.", "OL": "use THALASSEMIA to search ANEMIA, ERYTHROBLASTIC & ANEMIA, COOLEY'S & ANEMIA, MEDITERRANEAN 1966-92 and HEMOGLOBIN F DISEASE & THALASSEMIA MAJOR 1988-92", "PM": "93; was see THALASSEMIA 1988-92; ANEMIA, ERYTHROBLASTIC was see THALASSEMIA 1965-92, was heading 1963-64; ANEMIA, COOLEY'S was see THALASSEMIA 1963-92; ANEMIA, MEDITERRANEAN was see THALASSEMIA 1965-92; HEMOGLOBIN F DISEASE & THALASSEMIA MAJOR were see THALASSEMIA 1988-92", "HN": "93; was see THALASSEMIA 1988-92; ANEMIA, ERYTHROBLASTIC was see THALASSEMIA 1965-92, was heading 1963-64; ANEMIA, COOLEY'S was see THALASSEMIA 1963-92; ANEMIA, MEDITERRANEAN was see THALASSEMIA 1965-92; HEMOGLOBIN F DISEASE & THALASSEMIA MAJOR were see THALASSEMIA 1988-92", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017086"}, {"RECTYPE": "D", "MH": "Animal Rights", "AQ": "EC HI LJ SN ST TD", "PRINT ENTRY": "Speciesism|T078|NON|REL|BIOETHICS (1986)|NLM (1993)|910926|abcdeef", "ENTRY": "Rights, Animal", "MN": "I01.880.604.100.100", "MH_TH": "NLM (1993)", "ST": "T078", "AN": "refers to domestic, laboratory or wild animals; ANIMAL WELFARE is also available", "PI": "Animal Welfare (1986-1992)", "MS": "The moral and ethical bases of the protection of animals from cruelty and abuse. The rights are extended to domestic animals, laboratory animals, and wild animals.", "OL": "use ANIMAL WELFARE to search ANIMAL RIGHTS 1986-92 and SPECIESISM 1987-92", "PM": "93; was see ANIMAL WELFARE 1986-92; SPECIESISM was see ANIMAL WELFARE 1987-92", "HN": "93; was see ANIMAL WELFARE 1986-92; SPECIESISM was see ANIMAL WELFARE 1987-92", "MR": "20030709", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017087"}, {"RECTYPE": "D", "MH": "AIDS-Related Opportunistic Infections", "DE": "AIDS RELAT OPPORTUNISTIC INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Opportunistic Infections, HIV-Related|T047|EQV|NLM (1995)|940121|OPPORTUNISTIC INFECT HIV RELAT|abdefv", "ENTRY": "Opportunistic Infections, HIV Related", "MN": "C20.673.480.100", "FX": "Toxoplasmosis, Cerebral", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "coord IM with HIV-1 or HIV-2 (IM or NIM if pertinent); coord IM with specific opportunistic infect (IM)", "PI": "specific opportunistic infection (1983-1992)", "MS": "Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017088"}, {"RECTYPE": "D", "MH": "Ankyrin Repeat", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "ANK Repeat|T044|T082|NON|EQV|NLM (2000)|991105|abbcdef", "ENTRY": "Repeats, Ankyrin-Like", "MN": "G02.111.570.820.709.275.875.030", "MH_TH": "NLM (1993)", "ST": "T082", "PI": "Membrane Proteins (1990-1992)", "MS": "Protein motif that contains a 33-amino acid long sequence that often occurs in tandem arrays. This repeating sequence of 33-amino acids was discovered in ANKYRIN where it is involved in interaction with the anion exchanger (ANION EXCHANGE PROTEIN 1, ERYTHROCYTE). Ankyrin repeats cooperatively fold into domains that mediate molecular recognition via protein-protein interactions.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20160527", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017089"}, {"RECTYPE": "D", "MH": "Occlusal Splints", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Splints, Occlusal|T074|NON|EQV|NLM (1993)|911016|abcdef", "ENTRY": "Splints, Mandibular Advancement", "MN": "E07.858.442.743.829", "MH_TH": "NLM (1993)", "ST": "T074", "AN": "rigid or flexible splint used in orthodontics & treatment of clenching & bruxism", "PI": "Orthodontic Appliances (1969-1992)", "MS": "Rigid or flexible appliances that overlay the occlusal surfaces of the teeth. They are used to treat OBSTRUCTIVE SLEEP APNEA, clenching, BRUXISM, and their sequelae, and to provide temporary relief from muscle or temporomandibular joint pain.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017090"}, {"RECTYPE": "D", "MH": "Colitis, Ischemic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ischemic Colitis|T047|NON|EQV|NLM (1993)|911008|abcdef", "MN": "C14.907.286", "FX": "Mesenteric Ischemia", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Ischemia (1967-1992)", "MS": "Inflammation of the COLON due to colonic ISCHEMIA resulting from alterations in systemic circulation or local vasculature.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017091"}, {"RECTYPE": "D", "MH": "Porphyria, Erythropoietic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Uroporphyrinogen III Synthase, Deficiency of|T047|NON|REL|NLM (2010)|OMIM (2013)|ORD (2010)|090608|abcdeeef", "ENTRY": "Porphyrias, Erythropoietic", "MN": "C18.452.811.250", "FX": "Uroporphyrinogen III Synthetase", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "do not confuse with PROTOPORPHYRIA, ERYTHROPOIETIC or PORPHYRIA, HEPATOERYTHROPOIETIC", "PI": "Porphyria (1966-1992)", "MS": "An autosomal recessive porphyria that is due to a deficiency of UROPORPHYRINOGEN III SYNTHASE in the BONE MARROW; also known as congenital erythropoietic porphyria. This disease is characterized by SPLENOMEGALY; ANEMIA; photosensitivity; cutaneous lesions; accumulation of hydroxymethylbilane; and increased excretion of UROPORPHYRINS and COPROPORPHYRINS.", "PM": "1993", "HN": "1993", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017092"}, {"RECTYPE": "D", "MH": "Liver Failure", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hepatic Failure|T046|NON|EQV|NLM (1993)|911009|abcdef", "MN": "C06.552.308.500", "MH_TH": "NLM (1993)", "ST": "T046", "AN": "if coma is present, index under HEPATIC ENCEPHALOPATHY; LIVER FAILURE, ACUTE is also available", "PI": "Liver Diseases (1966-1992)", "MS": "Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)", "PM": "1993; for FULMINATING HEPATIC FAILURE; HEPATIC FAILURE, FULMINANT; and LIVER FAILURE, FULMINANT see HEPATIC ENCEPHALOPATHY 1993-1999", "HN": "1993; for FULMINATING HEPATIC FAILURE; HEPATIC FAILURE, FULMINANT; and LIVER FAILURE, FULMINANT use HEPATIC ENCEPHALOPATHY 1993-1999", "CATSH": "CAT LIST", "MR": "20090714", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017093"}, {"RECTYPE": "D", "MH": "Porphyrias, Hepatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hepatic Porphyria|T047|NON|EQV|NLM (1993)|911023|abcdef", "ENTRY": "Hepatic Porphyrias", "MN": "C18.452.811.400", "MH_TH": "NLM (2005)", "ST": "T047", "AN": "do not confuse with PORPHYRIA, ERYTHROHEPATIC", "PI": "Porphyria (1966-1992)", "MS": "A group of metabolic diseases due to deficiency of one of a number of LIVER enzymes in the biosynthetic pathway of HEME. They are characterized by the accumulation and increased excretion of PORPHYRINS or its precursors. Clinical features include neurological symptoms (PORPHYRIA, ACUTE INTERMITTENT), cutaneous lesions due to photosensitivity (PORPHYRIA CUTANEA TARDA), or both (HEREDITARY COPROPORPHYRIA). Hepatic porphyrias can be hereditary or acquired as a result of toxicity to the hepatic tissues.", "PM": "2005; see PORPHYRIA, HEPATIC 1993-2004", "HN": "2005 (1993)", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017094"}, {"RECTYPE": "D", "MH": "Prion Diseases", "DE": "PRION DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Transmissible Dementias|T047|NON|EQV|GHR (2014)|NLM (1993)|911001|TRANSM DEMENTIAS|abcdeefv", "ENTRY": "Transmissible Spongiform Encephalopathy", "MN": "C10.574.843", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Slow Virus Diseases (1966-1992)", "MS": "A group of genetic, infectious, or sporadic degenerative human and animal nervous system disorders associated with abnormal PRIONS. These diseases are characterized by conversion of the normal prion protein to an abnormal configuration via a post-translational process. In humans, these conditions generally feature DEMENTIA; ATAXIA; and a fatal outcome. Pathologic features include a spongiform encephalopathy without evidence of inflammation. The older literature occasionally refers to these as unconventional SLOW VIRUS DISEASES. (From Proc Natl Acad Sci USA 1998 Nov 10;95(23):13363-83)", "PM": "1993", "HN": "1993", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017096"}, {"RECTYPE": "D", "MH": "Electric Impedance", "AQ": "AE CL HI TU", "PRINT ENTRY": "Ohmic Resistance|T070|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Resistances, Ohmic", "MN": "G01.358.500.249.277.350", "MH_TH": "NLM (1993)", "ST": "T039", "AN": "bioelectric impedance analysis of body composition: coordinate with BODY COMPOSITION", "PI": "Electrophysiology (1966-1967)", "MS": "The resistance to the flow of either alternating or direct electrical current.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20160125", "DA": "19920508", "DC": "1", "DX": "19930101", "UI": "D017097"}, {"RECTYPE": "D", "MH": "IgA Deficiency", "DE": "IGA DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "IgA Deficiencies", "MN": "C20.673.430.500", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "IgA/deficiency (1971-1992)", "MS": "A dysgammaglobulinemia characterized by a deficiency of IMMUNOGLOBULIN A.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20010803", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017098"}, {"RECTYPE": "D", "MH": "IgG Deficiency", "DE": "IGG DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "IgG Deficiencies", "MN": "C20.673.430.750", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "IgG/deficiency (1973-1992)", "MS": "A dysgammaglobulinemia characterized by a deficiency of IMMUNOGLOBULIN G.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20010807", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017099"}, {"RECTYPE": "D", "MH": "Bacteriophage P22", "DS": "BACTERIOPHAGE P 022", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Phage P22|T005|NON|EQV|NLM (1993)|911009|PHAGE P 022|abcdefs", "ENTRY": "Phages, P22", "MN": "B04.280.090.700.070", "MH_TH": "NLM (1993)", "ST": "T005", "RN": "txid10754", "AN": "coord IM with specific Salmonella /virol", "PI": "Salmonella Phages (1966-1992)", "MS": "A species of temperate bacteriophage in the genus P22-like viruses, family PODOVIRIDAE, that infects SALMONELLA species. The genome consists of double-stranded DNA, terminally redundant, and circularly permuted.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017100"}, {"RECTYPE": "D", "MH": "Bacteriophage P1", "DS": "BACTERIOPHAGE P 001", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Phage P1|T005|NON|EQV|NLM (1993)|911003|PHAGE P 001|abcdefs", "ENTRY": "Phages, P1", "MN": "B04.280.090.500.300", "MH_TH": "NLM (1993)", "ST": "T005", "RN": "txid10678", "PI": "Coliphages (1966-1992)", "MS": "A species of temperate bacteriophage in the genus P1-like viruses, family MYOVIRIDAE, which infects E. coli. It is the largest of the COLIPHAGES and consists of double-stranded DNA, terminally redundant, and circularly permuted.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017101"}, {"RECTYPE": "D", "MH": "Fracture Healing", "AQ": "DE ES GE IM PH RE", "ENTRY": "Healings, Fracture", "MN": "G16.762.891.500", "FX": "Bony Callus", "MH_TH": "NLM (1993)", "ST": "T042", "AN": "coord IM with type of fracture (IM) + bone injured (IM)", "PI": "Wound Healing (1966-1992)", "MS": "The physiological restoration of bone tissue and function after a fracture. It includes BONY CALLUS formation and normal replacement of bone tissue.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017102"}, {"RECTYPE": "D", "MH": "Bacillus Phages", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Phage phi 29|T005|NON|NRW|NLM (1993)|911009|PHAGE PHI 029|abcdefs", "ENTRY": "Bacteriophages, Bacillus", "MN": "B04.123.100", "MH_TH": "NLM (1993)", "ST": "T005", "AN": "coord IM with specific Bacillus (NIM)", "PI": "Bacteriophages (1966-1992)", "MS": "Viruses whose host is Bacillus. Frequently encountered Bacillus phages include bacteriophage phi 29 and bacteriophage phi 105.", "PM": "93", "HN": "93", "MR": "20200902", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017103"}, {"RECTYPE": "D", "MH": "Bacteriophage M13", "DS": "BACTERIOPHAGE M 013", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "fd Phage|T005|NON|REL|NLM (1994)|930113|abcdef", "ENTRY": "fd Phages", "MN": "B04.280.400.400.250", "MH_TH": "NLM (1993)", "ST": "T005", "RN": "txid1977402", "RR": "txid10864", "PI": "Coliphages (1966-1992)", "MS": "Temperate bacteriophage of the genus INOVIRUS which infects enterobacteria, especially E. coli. It is a filamentous phage consisting of single-stranded DNA and is circularly permuted.", "PM": "1993; for PHAGE FD, FD PHAGE, BACTERIOPHAGE FD, & COLIPHAGE FD see INOVIRUS 1994-2001", "HN": "1993; for PHAGE FD, FD PHAGE, BACTERIOPHAGE FD, & COLIPHAGE FD use INOVIRUS 1994-2001", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017104"}, {"RECTYPE": "D", "MH": "Pseudomonas Phages", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Pseudomonas Phage", "MN": "B04.123.660", "MH_TH": "NLM (1993)", "ST": "T005", "AN": "coord IM with specific Pseudomonas (NIM)", "PI": "Bacteriophages (1966-1992)", "MS": "Viruses whose host is Pseudomonas. A frequently encountered Pseudomonas phage is BACTERIOPHAGE PHI 6.", "PM": "93", "HN": "93", "MR": "20200902", "DA": "19920526", "DC": "1", "DX": "19930101", "UI": "D017105"}, {"RECTYPE": "D", "MH": "Streptococcus Phages", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Streptococcal Phages|T005|NON|EQV|NLM (1993)|911118|abcdef", "ENTRY": "Streptococcus Phage", "MN": "B04.123.850", "MH_TH": "NLM (1993)", "ST": "T005", "AN": "coord IM with specific Streptococcus (NIM)", "PI": "Bacteriophages (1966-1992)", "MS": "Viruses whose host is Streptococcus.", "PM": "93", "HN": "93", "MR": "20200902", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017108"}, {"RECTYPE": "D", "MH": "Akathisia, Drug-Induced", "DE": "AKATHISIA DRUG IND", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pseudoakathisia|T047|NON|REL|NLM (2000)|991108|abcdef", "ENTRY": "Tardive Akathisia", "MN": "C25.723.705.100", "FX": "Dyskinesia, Drug-Induced", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "do not confuse with DYSKINESIA, DRUG-INDUCED", "PI": "Psychomotor Agitation (1978-1992)", "MS": "A condition associated with the use of certain medications and characterized by an internal sense of motor restlessness often described as an inability to resist the urge to move.", "PM": "1993", "HN": "1993", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017109"}, {"RECTYPE": "D", "MH": "Freeze Substitution", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Substitution, Freeze", "MN": "E05.760.156.260.270", "MH_TH": "NLM (1993)", "ST": "T062", "AN": "in freeze drying, replacement of ice by alcohol or other solvent", "PI": "Freezing (1966-1992)", "MS": "A modification of the freeze-drying method in which the ice within the frozen tissue is replaced by alcohol or other solvent at a very low temperature.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017110"}, {"RECTYPE": "D", "MH": "Phodopus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Siberian Hamster|T015|EPO|NRW|NLM (1993)|911004|abcdef", "ENTRY": "sungorus campbelli, Phodopus", "MN": "B01.050.150.900.649.313.992.635.075.250.630", "MH_TH": "NLM (1993)", "ST": "T015", "RN": "txid10043", "RR": "txid47665", "AN": "NIM with no qualifiers when experimental animal", "PI": "Hamsters (1970-1992)", "MS": "A genus of hamsters characterized by small size, very short tail, and short, broad feet with hairy soles.", "OL": "use HAMSTERS to search PHODOPUS and DJUNGARIAN 1982-92 and DJUNGARIAN HAMSTER 1984-92", "PM": "93; was see HAMSTERS 1982-92; DJUNGARIAN was see HAMSTERS 1982-92; DJUNGARIAN HAMSTERS was DJUNGARIAN HAMSTER see HAMSTERS 1984-92", "HN": "93; was see HAMSTERS 1982-92; DJUNGARIAN was see HAMSTERS 1982-92; DJUNGARIAN HAMSTERS was DJUNGARIAN HAMSTER see HAMSTERS 1984-92", "MR": "20200902", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017111"}, {"RECTYPE": "D", "MH": "Liver Failure, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Liver Failure, Fulminant|T047|NON|NRW|NLM (1993)|911001|abcdef", "ENTRY": "Liver Failure, Fulminating", "MN": "C06.552.308.500.750", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Liver Diseases (1966-1992)", "MS": "A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017114"}, {"RECTYPE": "D", "MH": "Catheter Ablation", "DE": "CATH ABLATION", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Catheter Ablation, Transvenous|T061|NON|NRW|NLM (1993)|911016|CATH ABLATION TRANSVENOUS|abcdefv", "ENTRY": "Transvenous Electrical Ablation", "MN": "E04.014.760.500", "FX": "Angioplasty, Laser", "MH_TH": "NLM (1993)", "ST": "T061", "AN": "coordinate organ or disease with /surg", "PI": "Heart Catheterization (1981-1992)", "MS": "Removal of tissue with electrical current delivered via electrodes positioned at the distal end of a catheter. Energy sources are commonly direct current (DC-shock) or alternating current at radiofrequencies (usually 750 kHz). The technique is used most often to ablate the AV junction and/or accessory pathways in order to interrupt AV conduction and produce AV block in the treatment of various tachyarrhythmias.", "OL": "use ELECTROCOAGULATION to search ABLATION, TRANSVENOUS ELECTRIC and CATHETER ABLATION, ELECTRIC 1989-92", "PM": "93; ABLATION, TRANSVENOUS ELECTRIC and CATHETER ABLATION, ELECTRIC were see ELECTROCOAGULATION 1989-92", "HN": "93; ABLATION, TRANSVENOUS ELECTRIC and CATHETER ABLATION, ELECTRIC were see ELECTROCOAGULATION 1989-92", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017115"}, {"RECTYPE": "D", "MH": "Low Back Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lumbago|T184|NON|EQV|NLM (1993)|911009|abcdef", "ENTRY": "Pains, Lower Back", "MN": "C23.888.592.612.107.400", "FX": "Sciatica", "MH_TH": "NLM (1993)", "ST": "T184", "AN": "\"lombo-sciatique\" in French texts is indexed here (IM) + SCIATICA (IM)", "PI": "Back Pain (1966-1992)", "MS": "Acute or chronic pain in the lumbar or sacral regions, which may be associated with musculo-ligamentous SPRAINS AND STRAINS; INTERVERTEBRAL DISK DISPLACEMENT; and other conditions.", "PM": "1993; see BACKACHE 1987-1992; for LUMBAGO see BACKACHE 1963-1992", "HN": "1993; use BACKACHE 1987-1992; for LUMBAGO use BACKACHE 1963-1992", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017116"}, {"RECTYPE": "D", "MH": "Porphyria, Acute Intermittent", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Uroporphyrinogen Synthase Deficiency|T047|NON|REL|NLM (2010)|OMIM (2013)|ORD (2010)|090608|abcdeeef", "ENTRY": "Uroporphyrinogen Synthase Deficiencies", "MN": "C18.452.811.400.150", "FX": "Hydroxymethylbilane Synthase", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Porphyria (1966-1992)", "MS": "An autosomal dominant porphyria that is due to a deficiency of HYDROXYMETHYLBILANE SYNTHASE in the LIVER, the third enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features are recurrent and life-threatening neurologic disturbances, ABDOMINAL PAIN, and elevated level of AMINOLEVULINIC ACID and PORPHOBILINOGEN in the urine.", "PM": "1993", "HN": "1993", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017118"}, {"RECTYPE": "D", "MH": "Porphyria Cutanea Tarda", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C18.452.811.400.250", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Porphyria (1966-1992)", "MS": "An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.", "OL": "use PORPHYRIA CUTANEA TARDA to search PORPHYRIA, CUTANEA TARDA 1993-94", "PM": "95; was PORPHYRIA, CUTANEA TARDA 1993-94", "HN": "95; was PORPHYRIA, CUTANEA TARDA 1993-94", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017119"}, {"RECTYPE": "D", "MH": "Nystagmus, Optokinetic", "AQ": "DE ES GE IM PH RE", "ENTRY": "Optokinetic Nystagmus", "MN": "G14.350.378.500", "MH_TH": "NLM (1993)", "ST": "T039", "PI": "Nystagmus, Physiologic (1983-1992)", "MS": "Normal nystagmus produced by looking at objects moving across the field of vision.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017120"}, {"RECTYPE": "D", "MH": "Porphyria, Hepatoerythropoietic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Porphyria, Erythrohepatic|T047|NON|EQV|NLM (1993)|990101|abcdef", "ENTRY": "Porphyrias, Hepatoerythropoietic", "MN": "C18.452.811.400.437", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "do not confuse with PORPHYRIAS, HEPATIC or PORPHYRIA, ERYTHROPOIETIC", "PI": "Porphyria (1966-1992)", "MS": "An autosomal recessive cutaneous porphyria that is due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in both the LIVER and the BONE MARROW. Similar to PORPHYRIA CUTANEA TARDA, this disorder is caused by defects in the fifth enzyme in the 8-enzyme biosynthetic pathway of HEME, but is a homozygous enzyme deficiency with less than 10% of the normal enzyme activity. Cutaneous lesions are severe and mutilating.", "PM": "2005; see PORPHYRIA, ERYTHROHEPATIC 1993-2004", "HN": "2005 (1993)", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017121"}, {"RECTYPE": "D", "MH": "Bacteriophage T4", "DS": "BACTERIOPHAGE T 004", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "T4 Phage|T005|NON|EQV|NLM (1994)|930113|T AAB PHAGE 04|abcdefs", "ENTRY": "T4 Phages", "MN": "B04.280.090.500.350", "MH_TH": "NLM (1993)", "ST": "T005", "RN": "txid10665", "RR": "txid10664", "PI": "T-Phages (1980-1992)", "MS": "Virulent bacteriophage and type species of the genus T4-like phages, in the family MYOVIRIDAE. It infects E. coli and is the best known of the T-even phages. Its virion contains linear double-stranded DNA, terminally redundant and circularly permuted.", "PM": "1993; for BACTERIOPHAGE T2 see MYOVIRIDAE 1994-2001", "HN": "1993; for BACTERIOPHAGE T2 use MYOVIRIDAE 1994-2001", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017122"}, {"RECTYPE": "D", "MH": "Bacteriophage T7", "DS": "BACTERIOPHAGE T 007", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "T7 Phage|T005|NON|EQV|NLM (1994)|930113|T AACZ PHAGE 07|abcdefs", "ENTRY": "T7 Phages", "MN": "B04.280.090.700.230", "MH_TH": "NLM (1993)", "ST": "T005", "RN": "txid10760", "AN": "T7-LIKE PHAGES see PODOVIRIDAE is also available", "PI": "T-Phages (1980-1992)", "MS": "Virulent bacteriophage and type species of the genus T7-like phages, in the family PODOVIRIDAE, that infects E. coli. It consists of linear double-stranded DNA, terminally redundant, and non-permuted.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017123"}, {"RECTYPE": "D", "MH": "Conserved Sequence", "DE": "CONSERVED SEQ", "AQ": "DE ES GE IM PH RE", "ENTRY": "Sequences, Conserved", "MN": "G02.111.570.580", "FX": "Consensus Sequence", "MH_TH": "NLM (1993)", "ST": "T086", "AN": "coord with AMINO ACID SEQUENCE (NIM) or BASE SEQUENCE (NIM)", "PI": "Base Sequence (1973-1992)", "MS": "A sequence of amino acids in a polypeptide or of nucleotides in DNA or RNA that is similar across multiple species. A known set of conserved sequences is represented by a CONSENSUS SEQUENCE. AMINO ACID MOTIFS are often composed of conserved sequences.", "OL": "use BASE SEQUENCE to search CONSERVED SEQUENCE 1988-92", "PM": "93; was see BASE SEQUENCE 1988-92", "HN": "93; was see BASE SEQUENCE 1988-92", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017124"}, {"RECTYPE": "D", "MH": "Genes, Protozoan", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Protozoan Genes|T028|NON|EQV|NLM (1993)|911017|abcdef", "ENTRY": "Protozoan Gene", "MN": "G05.360.340.397.500", "FX": "Genome, Protozoan", "MH_TH": "NLM (1993)", "ST": "T028", "AN": "coordinate IM with specific protozoon /genet (IM)", "PI": "specific protozoa (1966-1992)", "MS": "The functional hereditary units of protozoa.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017125"}, {"RECTYPE": "D", "MH": "Bacteriophage phi 6", "DS": "BACTERIOPHAGE PHI 006", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "phi 6 Phage|T005|NON|EQV|NLM (1994)|930113|PHI 006 PHAGE|abcdefs", "ENTRY": "phi 6 Phages", "MN": "B04.820.223.625.070", "MH_TH": "NLM (1993)", "ST": "T005", "RN": "txid10879", "AN": "coord IM with specific Pseudomonas /virol", "PI": "Bacteriophages (1966-1992)", "MS": "Virulent bacteriophage and sole member of the genus Cystovirus that infects Pseudomonas species. The virion has a segmented genome consisting of three pieces of doubled-stranded DNA and also a unique lipid-containing envelope.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017126"}, {"RECTYPE": "D", "MH": "Glycation End Products, Advanced", "AQ": "AD AE AG AI AN BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Maillard Reaction Product|T123|NON|NRW|NLM (2021)|191120|abcdef", "ENTRY": "Reaction Products, Maillard", "MN": "D23.946.381", "FX": "Receptor for Advanced Glycation End Products", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "PI": "Glycosylation (1988-1992)", "MS": "A heterogeneous group of compounds derived from rearrangements, oxidation, and cross-linking reactions that follow from non-enzymatic glycation of amino groups in PROTEINS; LIPIDS; or NUCLEIC ACIDS. Their accumulation in vivo accelerates under hyperglycemic, oxidative, or inflammatory conditions. Heat also accelerates the formation of advanced glycation end products (AGEs) such seen with the browning of food during cooking.", "PM": "2018; was GLYCOSYLATION END PRODUCTS, ADVANCED 1993-2017", "HN": "2018 (1993)", "MR": "20230226", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017127"}, {"RECTYPE": "D", "MH": "Embolectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Embolectomies", "MN": "E04.100.814.445", "FX": "Thrombectomy", "MH_TH": "NLM (1993)", "ST": "T061", "PI": "specific embolism/surgery (1966-1992)", "MS": "Surgical removal of an obstructing clot or foreign material which has been transported from a distant vessel by the bloodstream. Removal of a clot at its original site is called THROMBECTOMY.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19920508", "DC": "1", "DX": "19930101", "UI": "D017128"}, {"RECTYPE": "D", "MH": "Anisakiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Anisakis", "MN": "C06.405.469.452.060", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Nematode Infections (1967-1992)", "MS": "Infection with roundworms of the genus ANISAKIS. Human infection results from the consumption of fish harboring roundworm larvae. The worms may cause acute NAUSEA; VOMITING; or penetrate into the wall of the DIGESTIVE TRACT where they give rise to EOSINOPHILIC GRANULOMA in the STOMACH; INTESTINES; or the OMENTUM.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017129"}, {"RECTYPE": "D", "MH": "Angioplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Percutaneous Transluminal Angioplasty|T061|NON|NRW|UNK (19XX)|810223|abcdef", "ENTRY": "Transluminal Angioplasty, Percutaneous", "MN": "E05.157.016", "FX": "Endarterectomy", "MH_TH": "NLM (1993)", "ST": "T061", "PI": "Catheterization (1966-1981)", "MS": "Reconstruction or repair of a blood vessel, which includes the widening of a pathological narrowing of an artery or vein by the removal of atheromatous plaque material and/or the endothelial lining as well, or by dilatation (BALLOON ANGIOPLASTY) to compress an ATHEROMA. Except for ENDARTERECTOMY, usually these procedures are performed via catheterization as minimally invasive ENDOVASCULAR PROCEDURES.", "PM": "1993; for ANGIOPLASTY, TRANSLUMINAL see ANGIOPLASTY, TRANSLUMINAL1982 -1992 and ANGIOPLASTY, BALLOON 1993-2010; for PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY see ANGIOPLASTY, TRANSLUMINAL1982 -1992 and ANGIOPLASTY, BALLOON 1993-2010", "HN": "1993; for ANGIOPLASTY, TRANSLUMINAL use ANGIOPLASTY, BALLOON 1982-2010; for PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY use ANGIOPLASTY, BALLOON 1982-2010", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017130"}, {"RECTYPE": "D", "MH": "Thrombectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Thrombectomy, Percutaneous Aspiration", "MN": "E04.100.814.842", "FX": "Thrombolytic Therapy", "MH_TH": "NLM (1993)", "ST": "T061", "PI": "Thrombosis/surgery (1966-1992)", "MS": "Surgical removal of an obstructing clot or foreign material from a blood vessel at the point of its formation. Removal of a clot arising from a distant site is called EMBOLECTOMY.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017131"}, {"RECTYPE": "D", "MH": "Workplace", "AQ": "CL EC HI LJ OG PX SN ST", "ENTRY": "Worksites", "MN": "N04.452.677.975", "MH_TH": "NLM (1993)", "ST": "T082", "AN": "coordinate with specific industry or occupation  or specific facility (clinic, laboratory, hospital, school, etc.)", "MS": "Place or physical location of work or employment.", "PM": "93", "HN": "93", "MR": "20220413", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017132"}, {"RECTYPE": "D", "MH": "Desogestrel", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17alpha)-|T109|T121|T125|NON|EQV|NLM (2020)|190705|abbbcdef", "ENTRY": "alpha-pregn-4-en-20-yn-17-ol, 13-Ethyl-11-methylene-18,19-dinor-17", "MN": "D04.210.500.668.651.693.175", "PA": "Progestins", "MH_TH": "USAN (1990)", "ST": "T125", "RN": "81K9V7M3A3", "RR": "54024-22-5 (Desogestrel)", "PI": "Progestational Hormones, Synthetic (1979-1992)", "MS": "A synthetic progestational hormone used often as the progestogenic component of combined oral contraceptive agents (ORAL CONTRACEPTIVES, COMBINED).", "OL": "use DESOGESTREL (NM) to search DESOGESTREL 1979-92", "PM": "93; was indexed under NORPREGNENES 1979-92", "HN": "93; was DESOGESTREL (NM) 1977-92", "MR": "20190705", "DA": "19920508", "DC": "1", "DX": "19930101", "UI": "D017135"}, {"RECTYPE": "D", "MH": "Ion Transport", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Uniport|T043|NON|NRW|NLM (1993)|911101|abcdef", "ENTRY": "Transport, Ion", "MN": "G03.143.500", "FX": "Symporters", "MH_TH": "NLM (1993)", "ST": "T043", "AN": "in biol systems: do not confuse with ION EXCHANGE, a physicochem process; coord NIM with endogenous substance /metab (IM) or with exogenous substance /pharmacokin (IM); if active transport, coord with BIOLOGICAL TRANSPORT, ACTIVE", "PI": "Ion Exchange (1966-1992)", "MS": "The movement of ions across energy-transducing cell membranes. Transport can be active, passive or facilitated. Ions may travel by themselves (uniport), or as a group of two or more ions in the same (symport) or opposite (antiport) directions.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017136"}, {"RECTYPE": "D", "MH": "Nonoxynol", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Nonylphenoxypolyethoxyethanols|T109|T121|NON|EQV|NLM (1993)|911101|abbcdef", "ENTRY": "Oval, Patentex", "MN": "J01.637.051.720.741.575", "PA": "Surface-Active Agents", "MH_TH": "NLM (1994)", "ST": "T121", "N1": "Poly(oxy-1,2-ethanediyl), alpha-(4-nonylphenyl)-omega-hydroxy-", "RN": "26027-38-3", "RR": "9014-90-8", "PI": "Polyethylene Glycols (1975-1992)", "MS": "Nonionic surfactant mixtures varying in the number of repeating ethoxy (oxy-1,2-ethanediyl) groups. They are used as detergents, emulsifiers, wetting agents, defoaming agents, etc. Nonoxynol-9, the compound with 9 repeating ethoxy groups, is a spermatocide, formulated primarily as a component of vaginal foams and creams.", "PM": "1994, see NONOXYNOLS 1993; NONOXYNOLS was indexed under POLYETHYLENE GLYCOLS 1974-1992; ADVANTAGE-S was indexed under NONOXYNOL 2002-2006", "HN": "1994 (1974)", "MR": "20160701", "DA": "19920519", "DC": "1", "DX": "19930101", "UI": "D017137"}, {"RECTYPE": "D", "MH": "Fuzzy Logic", "PRINT ENTRY": "Logic, Fuzzy|T170|NON|EQV|NLM (1993)|911104|abcdef", "MN": "L01.224.050.375.250", "MH_TH": "NLM (1993)", "ST": "T170", "PI": "Models, Theoretical (1974-1992)", "MS": "Approximate, quantitative reasoning that is concerned with the linguistic ambiguity which exists in natural or synthetic language. At its core are variables such as good, bad, and young as well as modifiers such as more, less, and very. These ordinary terms represent fuzzy sets in a particular problem. Fuzzy logic plays a key role in many medical expert systems.", "PM": "93", "HN": "93", "MR": "20170703", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017143"}, {"RECTYPE": "D", "MH": "Focus Groups", "AQ": "MT SN ST", "ENTRY": "Groups, Focus", "MN": "N06.850.520.308.112", "FX": "Qualitative Research", "MH_TH": "POPLINE (1986)", "ST": "T096", "PI": "Marketing of Health Services (1987-1992)", "MS": "A method of data collection and a QUALITATIVE RESEARCH tool in which a small group of individuals are brought together and allowed to interact in a discussion of their opinions about topics, issues, or questions.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017144"}, {"RECTYPE": "D", "MH": "Models, Educational", "DE": "MODELS EDUC", "PRINT ENTRY": "Instructional Models|T062|T170|NON|EQV|NLM (1993)|911104|abbcdef", "ENTRY": "Models, Instructional", "MN": "I02.903.302", "MH_TH": "NLM (1993)", "ST": "T170", "PI": "Teaching (1966-1992)", "MS": "Theoretical models which propose methods of learning or teaching as a basis or adjunct to changes in attitude or behavior. These educational interventions are usually applied in the fields of health and patient education but are not restricted to patient care.", "PM": "93", "HN": "93", "MR": "20080708", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017145"}, {"RECTYPE": "D", "MH": "Models, Organizational", "DE": "MODELS ORGAN", "PRINT ENTRY": "Organizational Models|T062|T170|NON|EQV|NLM (1993)|911120|ORGAN MODELS|abbcdefv", "ENTRY": "Organizational Model", "MN": "N04.452.534", "MH_TH": "NLM (1993)", "ST": "T170", "PI": "Models, Theoretical (1968-1992)", "MS": "Theoretical representations and constructs that describe or explain the structure and hierarchy of relationships and interactions within or between formal organizational entities or informal social groups.", "PM": "93", "HN": "93", "MR": "20080708", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017146"}, {"RECTYPE": "D", "MH": "Defibrillators, Implantable", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Implantable Defibrillators|T074|NON|EQV|NLM (1993)|911105|abcdef", "ENTRY": "Implantable Defibrillator", "MN": "E07.695.202.175", "MH_TH": "NLM (1993)", "ST": "T074", "AN": "coordinate disease with / ther, not / surg for treatment with this instrument", "PI": "Implants, Artificial (1982-1992)", "MS": "Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017147"}, {"RECTYPE": "D", "MH": "Infusions, Intraosseous", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Infusions, Intra-Osseous|T061|NON|EQV|NLM (1993)|911125|abcdef", "ENTRY": "Intraosseous Infusions", "MN": "E02.319.267.510.560", "MH_TH": "NLM (1993)", "ST": "T061", "PI": "Infusions, Parenteral (1976-1992)", "MS": "The administration of medication or fluid through a needle directly into the bone marrow. The technique is especially useful in the management of pediatric emergencies when intravenous access to the systemic circulation is difficult.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017148"}, {"RECTYPE": "D", "MH": "Private Sector", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Private Enterprise|T057|NON|REL|NLM (1993)|911105|abcdef", "ENTRY": "Sector, Private", "MN": "N04.452.633.390", "MH_TH": "POPLINE (1978)", "ST": "T098", "AN": "IM; specify nature of private endeavor (IM); specify geog if pertinent", "PI": "Health Facilities, Proprietary (1979-1992)", "MS": "That distinct portion of the institutional, industrial, or economic structure of a country that is controlled or owned by non-governmental, private interests.", "PM": "93", "HN": "93", "MR": "20180629", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017149"}, {"RECTYPE": "D", "MH": "Public Sector", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Public Enterprise|T064|NON|REL|NLM (1993)|911120|abcdef", "ENTRY": "Sectors, Public", "MN": "N04.452.633.890", "MH_TH": "POPLINE (1978)", "ST": "T098", "AN": "IM; specify nature of public endeavor (IM); specify geog if pertinent", "PI": "Government Agencies (1979-1992)", "MS": "The area of a nation's economy that is tax-supported and under government control.", "PM": "93", "HN": "93", "MR": "20180629", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017150"}, {"RECTYPE": "D", "MH": "Antibodies, Catalytic", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Catalytic Antibodies|T116|T123|NON|EQV|NLM (1993)|911105|abbcdef", "ENTRY": "Catalytic Antibody", "MN": "D12.776.377.715.548.114.167", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "AN": "do not coord with ANTIBODY FORMATION for /biosyn", "PI": "Catalysis (1986-1992)", "MS": "Antibodies that can catalyze a wide variety of chemical reactions. They are characterized by high substrate specificity and share many mechanistic features with enzymes.", "PM": "93", "HN": "93", "MR": "20050630", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017151"}, {"RECTYPE": "D", "MH": "Antibodies, Antiphospholipid", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Phospholipid Autoantibody|T116|T129|NON|EQV|NLM (2023)|210924|abbcdef", "ENTRY": "Autoantibody, Phospholipid", "MN": "D12.776.377.715.548.114.323.210", "PA": "Immunologic Factors", "FX": "Antiphospholipid Syndrome", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "AN": "do not coordinate with ANTIBODY FORMATION for /biosyn", "PI": "Autoantibodies (1983-1992)", "MS": "Autoantibodies directed against phospholipids. These antibodies are characteristically found in patients with certain autoimmune diseases (e.g., SYSTEMIC LUPUS ERYTHEMATOSUS and ANTIPHOSPHOLIPID SYNDROME), some non-autoimmune diseases, and also in healthy individuals.", "PM": "93", "HN": "93", "MR": "20220413", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017152"}, {"RECTYPE": "D", "MH": "Antibodies, Anticardiolipin", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Cardiolipin Autoantibody|T116|T129|NON|EQV|NLM (2023)|210924|abbcdef", "ENTRY": "Autoantibody, Cardiolipin", "MN": "D12.776.377.715.548.114.323.210.100", "PA": "Immunologic Factors", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "AN": "do not coordinate with ANTIBODY FORMATION for /biosyn", "PI": "Autoantibodies (1984-1992)", "MS": "Antiphospholipid antibodies found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. The antibodies are detected by solid-phase IMMUNOASSAY employing the purified phospholipid antigen CARDIOLIPIN.", "PM": "93", "HN": "93", "MR": "20220413", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017153"}, {"RECTYPE": "D", "MH": "Stromal Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Stromal Cell", "MN": "A11.329.830", "MH_TH": "NLM (1993)", "ST": "T025", "AN": "connective tissue cells; NIM; coord with organ /cytol (IM)", "MS": "Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere.", "PM": "93", "HN": "93", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017154"}, {"RECTYPE": "D", "MH": "Wettability", "AQ": "DE RE", "PRINT ENTRY": "Hygroscopicity|T080|NON|EQV|NLM (1993)|911106|abcdef", "ENTRY": "Wettabilities", "MN": "G02.860.908", "FX": "Electrowetting", "MH_TH": "NLM (1993)", "ST": "T080", "PI": "Surface Properties (1968-1992)", "MS": "The quality or state of being wettable or the degree to which something can be wet. This is also the ability of any solid surface to be wetted when in contact with a liquid whose surface tension is reduced so that the liquid spreads over the surface of the solid.", "PM": "93", "HN": "93", "MR": "20160617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017155"}, {"RECTYPE": "D", "MH": "Photoplethysmography", "DE": "PHOTOPLETHYSMOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Rheographies, Light Reflection", "MN": "E01.370.370.610.600", "MH_TH": "NLM (1993)", "ST": "T060", "PI": "Plethysmography (1966-1992)", "MS": "Plethysmographic determination in which the intensity of light reflected from the skin surface and the red cells below is measured to determine the blood volume of the respective area. There are two types, transmission and reflectance.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017156"}, {"RECTYPE": "D", "MH": "Adenophorea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Aphasmidia|T204|NON|EQV|NLM (1993)|911106|abcdef", "ENTRY": "Aphasmidias", "MN": "B01.050.500.500.294.100", "MH_TH": "NLM (1993)", "ST": "T204", "MS": "A subclass of nematodes characterized by reduced or absent caudal papillae and an excretory system lacking lateral canals. Its organisms are usually infective to their final host.", "PM": "93", "HN": "93", "MR": "20200902", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017157"}, {"RECTYPE": "D", "MH": "Enoplida", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Enoplidas", "MN": "B01.050.500.500.294.100.275", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid57287", "MS": "An order of nematodes of the subclass ADENOPHOREA. Its organisms commonly have a cylindrical esophagus. The superfamilies of this order are DIOCTOPHYMATOIDEA; MERMITHOIDEA; and TRICHUROIDEA.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920508", "DC": "1", "DX": "19930101", "UI": "D017158"}, {"RECTYPE": "D", "MH": "Dioctophymatoidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Dioctophyme|T204|NON|NRW|NLM (2022)|210317|abcdef", "MN": "B01.050.500.500.294.100.275.200", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid241475", "RR": "txid513042", "AN": "infection: coordinate with ENOPLIDA INFECTIONS ", "PI": "Nematoda (1966-1992)", "MS": "A superfamily of nematodes of the order ENOPLIDA. Characteristics include a well developed cylindrical esophagus.", "OL": "use NEMATODA to search DIOCTOPHYMA 1966-92", "PM": "93; DIOCTOPHYMA was see NEMATODA 1986-92; was heading 1963-85", "HN": "93; DIOCTOPHYMA was see NEMATODA 1986-92; was heading 1963-85", "MR": "20220413", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017159"}, {"RECTYPE": "D", "MH": "Trichinella spiralis", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Trichina spiralis|T204|NON|EQV|NLM (1993)|911106|abcdef", "ENTRY": "spiralis, Trichinella", "MN": "B01.050.500.500.294.100.275.780.608.700", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6334", "AN": "a species of nematode common in rats & swine; infection: coord IM with TRICHINELLOSIS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Trichinella (1966-1992)", "MS": "A parasite of carnivorous mammals that causes TRICHINELLOSIS. It is especially common in rats and in swine fed uncooked garbage. Human infection is initiated by the consumption of raw or insufficiently cooked pork or other meat containing the encysted larvae.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017160"}, {"RECTYPE": "D", "MH": "Ascaridida", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Ascarididas", "MN": "B01.050.500.500.294.400.500", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6249", "MS": "An order of nematodes of the subclass SECERNENTEA. Its organisms possess two or three pairs of dorsolateral caudal papillae.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017162"}, {"RECTYPE": "D", "MH": "Anisakis", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Anisaki", "MN": "B01.050.500.500.294.400.500.100.075", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6268", "PI": "Nematoda (1966-1992)", "MS": "A genus of nematodes of the superfamily ASCARIDOIDEA. Its organisms are found in the stomachs of marine animals and birds. Human infection occurs by ingestion of raw fish that contain larvae.", "OL": "use NEMATODA to search ANISAKIS 1989-92", "PM": "93; was see NEMATODA 1989-92", "HN": "93; was see NEMATODA 1989-92", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017163"}, {"RECTYPE": "D", "MH": "Ascaris lumbricoides", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "lumbricoides, Ascaris", "MN": "B01.050.500.500.294.400.500.100.108.425", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6252", "AN": "a species of nematode, the largest found in the human intestine; infection: coord IM with ASCARIASIS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Ascaris (1966-1992)", "MS": "A species of parasitic nematode that is the largest found in the human intestine. Its distribution is worldwide, but it is more prevalent in areas of poor sanitation. Human infection with A. lumbricoides is acquired by swallowing fully embryonated eggs from contaminated soil.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017164"}, {"RECTYPE": "D", "MH": "Ascaris suum", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "suum, Ascaris", "MN": "B01.050.500.500.294.400.500.100.108.700", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6253", "AN": "a species of nematode usually found in pigs, transmissible to humans; infection: coord IM with ASCARIASIS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Ascaris (1966-1992)", "MS": "A species of parasitic nematode usually found in domestic pigs and a few other animals. Human infection can also occur, presumably as result of handling pig manure, and can lead to intestinal obstruction.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017165"}, {"RECTYPE": "D", "MH": "Toxocara canis", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "canis, Toxocara", "MN": "B01.050.500.500.294.400.500.100.780.225", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6265", "AN": "a species of nematode found in the dog intestine; infection: coord IM with TOXOCARIASIS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Toxocara (1966-1992)", "MS": "A species of parasitic nematode found in the intestine of dogs. Lesions in the brain, liver, eye, kidney, and lung are caused by migrating larvae. In humans, these larvae do not follow normal patterns and may produce visceral larva migrans (LARVA MIGRANS, VISCERAL).", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017166"}, {"RECTYPE": "D", "MH": "Oxyurida", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Oxyuridas", "MN": "B01.050.500.500.294.400.750", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid70426", "MS": "An order of nematodes of the subclass SECERNENTEA. Its organisms are characterized by a single, ventral excretory gland and a relatively stout, short body.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017167"}, {"RECTYPE": "D", "MH": "Rhabditida", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Rhabditidas", "MN": "B01.050.500.500.294.400.875", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6236", "MS": "An order of nematodes of the subclass SECERNENTEA. Its organisms are characterized by an annulated or smooth cuticle and the absence of caudal glands.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017168"}, {"RECTYPE": "D", "MH": "Neoplasms, Post-Traumatic", "DE": "NEOPL POST TRAUMATIC", "DS": "NEOPLASMS POSTTRAUMATIC", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Post-Traumatic Neoplasms|T191|NON|EQV|NLM (1993)|911120|POSTTRAUMATIC NEOPLASMS|POST TRAUMATIC NEOPL|abcdefsv", "ENTRY": "Post-Traumatic Neoplasm", "MN": "C04.666", "MH_TH": "NLM (1993)", "ST": "T191", "AN": "IM; coord with specific histol type (IM) + organ/neopl term (IM)", "MS": "Tumors, cancer or other neoplasms caused by or resulting from trauma or other non-radiation injuries.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017169"}, {"RECTYPE": "D", "MH": "Strongyloides ratti", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "ratti, Strongyloides", "MN": "B01.050.500.500.294.400.875.640.680.600", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid34506", "AN": "a species of nematode; infection: coord IM with STRONGYLOIDIASIS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Strongyloides (1968-1992)", "MS": "A species of parasitic nematode found in rats.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017170"}, {"RECTYPE": "D", "MH": "Strongyloides stercoralis", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "stercoralis, Strongyloides", "MN": "B01.050.500.500.294.400.875.640.680.700", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6248", "AN": "infection: coordinate with STRONGYLOIDIASIS; coordinate with specific helminth terms (ANTIGENS, HELMINTH, etc.) if pertinent ", "PI": "Strongyloides (1966-1992)", "MS": "A species of parasitic nematode widely distributed in tropical and subtropical countries. The females and their larvae inhabit the mucosa of the intestinal tract, where they cause ulceration and diarrhea.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017171"}, {"RECTYPE": "D", "MH": "Rhabditoidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Turbatrix|T204|NON|NRW|NLM (1993)|911107|abcdef", "ENTRY": "Turbatrices", "MN": "B01.050.500.500.294.400.875.660", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid55879", "RR": "txid6244", "AN": "a superfamily of nematodes; do not confuse with the order RHABDITIDA; infection: coord IM with RHABDITIDA INFECTIONS (IM)", "PI": "Nematoda (1966-1992)", "MS": "A superfamily of nematodes of the order RHABDITIDA. Characteristics include an open tube stoma and an excretory system with lateral canals.", "OL": "use NEMATODA to search RHABDITOIDEA 1966-92 & RHABDITIS & TURBATRIX 1986-92", "PM": "93,63-85; was see NEMATODA 1986-92; RHABDITIS & TURBATRIX were see NEMATODA 1986-92", "HN": "93,63-85; was see NEMATODA 1986-92; RHABDITIS & TURBATRIX were see NEMATODA 1986-92", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017172"}, {"RECTYPE": "D", "MH": "Caenorhabditis elegans", "DE": "C ELEGANS", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "elegan, Caenorhabditis", "MN": "B01.050.500.500.294.400.875.660.250.250", "FX": "Caenorhabditis elegans Proteins", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6239", "PI": "Nematoda (1968-1978)", "MS": "A species of nematode that is widely used in biological, biochemical, and genetic studies.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017173"}, {"RECTYPE": "D", "MH": "Spirurida", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Spiruridas", "MN": "B01.050.500.500.294.400.937", "MH_TH": "NLM (1993)", "ST": "T204", "MS": "An order of nematodes of the subclass SECERNENTEA. Characteristics include ventral or caudoventral papillae and an esophagus divided into anterior muscular and posterior glandular parts.", "PM": "93", "HN": "93", "MR": "20200902", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017174"}, {"RECTYPE": "D", "MH": "Camallanina", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Camallaninas", "MN": "B01.050.500.500.294.400.937.225", "MH_TH": "NLM (1993)", "ST": "T204", "AN": "a suborder of nematodes; infection: coord IM with SPIRURIDA INFECTIONS (IM)", "MS": "A suborder of nematodes characterized by larvae lacking cephalic hooks and a tail that is generally long and pointed.", "PM": "93", "HN": "93", "MR": "20200902", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017175"}, {"RECTYPE": "D", "MH": "Dracunculoidea", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Dracunculoideas", "MN": "B01.050.500.500.294.400.937.225.250", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid55872", "AN": "a superfamily of nematodes; infection: coord IM with SPIRURIDA INFECTIONS (IM)", "MS": "A superfamily of nematodes of the suborder CAMALLANINA. Its organisms possess a poorly developed buccal cavity and a rudimentary esophagus and intestine.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017176"}, {"RECTYPE": "D", "MH": "Spirurina", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Spirurinas", "MN": "B01.050.500.500.294.400.937.700", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6274", "AN": "a suborder of nematodes; do not confuse with the order SPIRURIDA or the superfamily SPIRUROIDEA; infection: coord IM with SPIRURIDA INFECTIONS (IM)", "MS": "A suborder of nematodes characterized by larvae possessing cephalic hooks and multinucleated esophageal glands.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017177"}, {"RECTYPE": "D", "MH": "Brugia malayi", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "malayi, Brugia", "MN": "B01.050.500.500.294.400.937.463.088.500", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6279", "AN": "infection: coord IM with FILARIASIS (IM) or if with possible lymphatic involvement, ELEPHANTIASIS, FILARIAL (IM); coord with specific helminth term (ANTIGENS, HELMINTH, etc) if pertinent; /drug eff: consider FILARICIDES", "PI": "Filarioidea (1966-1974)", "MS": "A species of parasitic nematode causing Malayan filariasis and having a distribution centering roughly on the Malay peninsula. The life cycle of B. malayi is similar to that of WUCHERERIA BANCROFTI, except that in most areas the principal mosquito vectors belong to the genus Mansonia.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017178"}, {"RECTYPE": "D", "MH": "Brugia pahangi", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "pahangus, Brugia", "MN": "B01.050.500.500.294.400.937.463.088.550", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6280", "AN": "infection: coord IM with FILARIASIS (IM); coord with specific helminth term (ANTIGENS, HELMINTH, etc) if pertinent; /drug eff: consider FILARICIDES", "PI": "Filarioidea (1966-1974)", "MS": "A species of parasitic nematode found in man and other mammals. It has been reported from Malaya and East Pakistan and may produce symptoms of tropical eosinophilia.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017179"}, {"RECTYPE": "D", "MH": "Tachycardia, Ventricular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ventricular Tachycardia|T046|NON|EQV|NLM (2008)|060925|abcdef", "ENTRY": "Ventricular Tachycardias", "MN": "C23.550.073.845.940", "MH_TH": "NLM (1993)", "ST": "T046", "AN": "do not confuse with TACHYCARDIA, SUPRAVENTRICULAR which originates above the bundle of His", "PI": "Tachycardia (1966-1992)", "MS": "An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017180"}, {"RECTYPE": "D", "MH": "Onchocerca volvulus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.294.400.937.463.510.850", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6282", "AN": "infection: coord IM with ONCHOCERCIASIS (IM); coord with specific helminth term (ANTIGENS, HELMINTH, etc) if pertinent; /drug eff: consider FILARICIDES", "PI": "Onchocerca (1966-1992)", "MS": "A species of parasitic nematodes widely distributed throughout central Africa and also found in northern South America, southern Mexico, and Guatemala. Its intermediate host and vector is the blackfly or buffalo gnat.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017181"}, {"RECTYPE": "D", "MH": "Setaria Nematode", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Setaria Nematodes", "MN": "B01.050.500.500.294.400.937.463.700", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid48796", "PI": "Filarioidea (1966-1992)", "MS": "A genus of parasitic nematodes found in the peritoneal cavity of wild or domestic cattle or equines.", "PM": "2003; see SETARIA 1993-2003", "HN": "2003(1993)", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017182"}, {"RECTYPE": "D", "MH": "Strongylida", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Strongylidas", "MN": "B01.050.500.500.294.400.968", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6308", "MS": "An order of nematodes of the subclass SECERNENTEA. Characteristics include an H-shaped excretory system with two subventral glands.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017183"}, {"RECTYPE": "D", "MH": "Nematospiroides", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Nematospiroide", "MN": "B01.050.500.500.294.400.968.400.550", "MH_TH": "NLM (1993)", "ST": "T204", "AN": "a genus of nematode found in mice; infection: coord IM with STRONGYLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Nematoda (1966-1985)", "MS": "A genus of nematodes found mainly in mice. Its organisms are used in biomedical research.", "PM": "93", "HN": "93", "MR": "20200902", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017184"}, {"RECTYPE": "D", "MH": "Angiostrongylus cantonensis", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.294.400.968.588.080.225", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid6313", "AN": "a species of nematode in rat & man; ANGIOSTRONGYLUS CANTONENSIS INFECTION is available; for antigens, coordinate with ANTIGENS, HELMINTH, for antibodies, coordinate with ANTIBODIES, HELMINTH", "PI": "Metastrongyloidea (1966-1990)", "MS": "A species of parasitic nematodes distributed throughout the Pacific islands that infests the lungs of domestic rats. Human infection, caused by consumption of raw slugs and land snails, results in eosinophilic meningitis.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017185"}, {"RECTYPE": "D", "MH": "Titrimetry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "MN": "E05.196.922", "MH_TH": "NLM (1993)", "ST": "T059", "AN": "general or unspecified; prefer specifics", "PI": "specific technique (1966-1992)", "MS": "The determination of the concentration of a given component in solution (the analyte) by addition of a liquid reagent of known strength (the titrant) until an equivalence point is reached (when the reactants are present in stoichiometric proportions). Often an indicator is added to make the equivalence point visible (e.g., a change in color).", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017186"}, {"RECTYPE": "D", "MH": "Tylenchida", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Tylenchidas", "MN": "B01.050.500.500.294.400.984", "MH_TH": "NLM (1993)", "ST": "T204", "AN": "an order of nematodes in plants; transmit plant viruses", "MS": "An order of nematodes consisting of many species which are plant parasites. Female worms lay eggs that hatch either in soil or in the host plant.", "OL": "use TYLENCHOIDEA to search TYLENCHIDA 1986-92", "PM": "93; was see TYLENCHOIDEA 1986-92", "HN": "93; was see TYLENCHOIDEA 1986-92", "MR": "20200902", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017187"}, {"RECTYPE": "D", "MH": "Adenophorea Infections", "DE": "ADENOPHOREA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Aphasmidia Infections|T047|NON|EQV|NLM (1993)|911112|APHASMIDIA INFECT|abcdefv", "ENTRY": "Infection, Aphasmidia", "MN": "C01.610.335.508.100", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "nematode infect", "MS": "Infections with nematodes of the subclass ADENOPHOREA.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017188"}, {"RECTYPE": "D", "MH": "Enoplida Infections", "DE": "ENOPLIDA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Giant Kidney Worm Infection|T047|NON|REL|NLM (2023)|211012|abcdef", "ENTRY": "Intestinal Capillariases", "MN": "C01.610.335.508.100.275", "MH_TH": "NLM (1993)", "ST": "T047", "MS": "Infections with nematodes of the order ENOPLIDA.", "OL": "use ENOPLIDA INFECTIONS to search DIOCTOPHYMA RENALE INFECTIONS 1968-92", "PM": "93; DIOCTOPHYMA RENALE INFECTIONS was heading 1968-92", "HN": "93; DIOCTOPHYMA RENALE INFECTIONS was heading 1968-92", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19920508", "DC": "1", "DX": "19930101", "UI": "D017189"}, {"RECTYPE": "D", "MH": "Secernentea Infections", "DE": "SECERNENTEA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Phasmidia Infections|T047|NON|EQV|NLM (1993)|911112|PHASMIDIA INFECT|abcdefv", "ENTRY": "Secernentea Infection", "MN": "C01.610.335.508.700", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "nematode infect", "MS": "Infections with nematodes of the subclass SECERNENTEA.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017190"}, {"RECTYPE": "D", "MH": "Ascaridida Infections", "DE": "ASCARIDIDA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Roundworm Infections, Raccoon", "MN": "C01.610.335.508.700.100", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "nematoda infect caused by ASCARIDIDA; do not confuse with ASCARIDIASIS (caused by ASCARIDIA)", "MS": "Infections with nematodes of the order ASCARIDIDA.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017191"}, {"RECTYPE": "D", "MH": "Skin Diseases, Bacterial", "DE": "SKIN DIS BACT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Skin Disease, Bacterial", "MN": "C17.800.838.765", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "general or unspecified; coordinate  with precoordinated bacterial infection ", "MS": "Skin diseases caused by bacteria.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017192"}, {"RECTYPE": "D", "MH": "Skin Diseases, Viral", "DE": "SKIN DIS VIRAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Viral Skin Disease", "MN": "C17.800.838.790", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "general or unspecified; coordinate with precoordinated viral infection", "MS": "Skin diseases caused by viruses.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017193"}, {"RECTYPE": "D", "MH": "Oxyurida Infections", "DE": "OXYURIDA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Oxyurida Infection", "MN": "C01.610.335.508.700.550", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "nematode infect", "MS": "Infections with nematodes of the order OXYURIDA.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017194"}, {"RECTYPE": "D", "MH": "Adolescent Nutritional Physiological Phenomena", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Adolescent Nutrition Physiology|T040|NON|EQV|NLM (2007)|051123|abcdef", "ENTRY": "Physiology, Adolescent Nutritional", "MN": "G07.203.650.220.060", "MH_TH": "NLM (2009)", "ST": "T040", "AN": "check the tag ADOLESCENCE", "PI": "Nutrition (1970-1992)", "MS": "Nutritional physiology of children aged 13-18 years.", "PM": "2009; see ADOLESCENT NUTRITION PHYSIOLOGY 2007-2008, see ADOLESCENT NUTRITION 1993-2006", "HN": "2009 (1993)", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19920511", "DC": "1", "DX": "19930101", "UI": "D017195"}, {"RECTYPE": "D", "MH": "Rhabditida Infections", "DE": "RHABDITIDA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Rhabditida Infection", "MN": "C01.610.335.508.700.700", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "nematode infect", "MS": "Infections with nematodes of the order RHABDITIDA.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017196"}, {"RECTYPE": "D", "MH": "Virus Shedding", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Viral Shedding|T039|NON|EQV|NLM (1993)|911113|abcdef", "ENTRY": "Shedding, Virus", "MN": "G07.925", "MH_TH": "NLM (1993)", "ST": "T039", "AN": "do not confuse with VIRUS RELEASE", "MS": "The expelling of virus particles from the body. Important routes include the respiratory tract, genital tract (important in INFECTIOUS DISEASE TRANSMISSION, VERTICAL), and intestinal tract.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017201"}, {"RECTYPE": "D", "MH": "Myocardial Ischemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ischemic Heart Disease|T047|NON|EQV|NLM (1993)|920416|ISCHEMIC HEART DIS|abcdefv", "ENTRY": "Myocardial Ischemias", "MN": "C14.907.585", "FX": "Myocardial Stunning", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Coronary Disease (1966-1992)", "MS": "A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).", "OL": "use CORONARY DISEASE to search HEART DISEASE, ISCHEMIC & ISCHEMIC HEART DISEASE 1969-92", "PM": "93; HEART DISEASE, ISCHEMIC & ISCHEMIC HEART DISEASE were see CORONARY DISEASE 1969-92", "HN": "93; HEART DISEASE, ISCHEMIC & ISCHEMIC HEART DISEASE were see CORONARY DISEASE 1969-92", "CATSH": "CAT LIST", "MR": "20070710", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017202"}, {"RECTYPE": "D", "MH": "Interview", "ENTRY": "Oral History|T170|NON|REL|NLM (2013)|120621|abcdef", "MN": "V02.530.150.500", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "this heading is used as a Publication Type; interviews as a subject are indexed under the main heading INTERVIEWS AS TOPIC", "MS": "Work consisting of a conversation with an individual regarding his or her background and other personal and professional details, opinions on specific subjects posed by the interviewer, etc.", "HN": "2008(1993)", "MR": "20150626", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D017203"}, {"RECTYPE": "D", "MH": "Angelman Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Puppet Children|T047|NON|EQV|NLM (1993)|911114|abcdef", "ENTRY": "Syndrome, Happy Puppet", "MN": "C16.320.447.250", "FX": "Intellectual Disability", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Movement Disorders (1967-1992)", "MS": "A syndrome characterized by multiple abnormalities, MENTAL RETARDATION, and movement disorders. Present usually are skull and other abnormalities, frequent infantile spasms (SPASMS, INFANTILE); easily provoked and prolonged paroxysms of laughter (hence \"happy\"); jerky puppetlike movements (hence \"puppet\"); continuous tongue protrusion; motor retardation; ATAXIA; MUSCLE HYPOTONIA; and a peculiar facies. It is associated with maternal deletions of chromosome 15q11-13 and other genetic abnormalities. (From Am J Med Genet 1998 Dec 4;80(4):385-90; Hum Mol Genet 1999 Jan;8(1):129-35)", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20230414", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017204"}, {"RECTYPE": "D", "MH": "Spirurida Infections", "DE": "SPIRURIDA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Habronemiasis|T047|NON|NRW|NLM (1993)|911115|abcdef", "ENTRY": "Spirurida Infection", "MN": "C01.610.335.508.700.750", "MH_TH": "NLM (1993)", "ST": "T047", "MS": "Infections with nematodes of the order SPIRURIDA.", "OL": "use SPIRURIDA INFECTIONS to search HABRONEMIASIS 1968-92", "PM": "93; HABRONEMIASIS was heading 1968-92", "HN": "93; HABRONEMIASIS was heading 1968-92", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017205"}, {"RECTYPE": "D", "MH": "Strongylida Infections", "DE": "STRONGYLIDA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Syngamiasis|T047|NON|NRW|NLM (1993)|911118|abcdef", "ENTRY": "Syngamiases", "MN": "C01.610.335.508.700.775", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "nematode infect", "MS": "Infections with nematodes of the order STRONGYLIDA.", "OL": "use STRONGYLIDA INFECTIONS to search STEPHANURUS DENTATUS INFECTION 1975-92, SYNGAMIASIS 1968-92 & SYNGAMOSIS 1967", "PM": "93; STEPHANURUS DENTATUS INFECTION was heading 1975-92 (see under NEMATODE INFECTIONS 1975-90); SYNGAMIASIS was heading 1968-92, was SYNGAMOSIS 1967", "HN": "93; STEPHANURUS DENTATUS INFECTION was heading 1975-92 (see under NEMATODE INFECTIONS 1975-90); SYNGAMIASIS was heading 1968-92, was SYNGAMOSIS 1967", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017206"}, {"RECTYPE": "D", "MH": "Rats, Sprague-Dawley", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Sprague-Dawley Rat|T015|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Sprague-Dawley Rats", "MN": "B01.050.150.900.649.313.992.635.505.700.750", "MH_TH": "NLM (1993)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Rats, Inbred Strains (1982-1992)", "MS": "A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.", "OL": "use RATS, INBRED STRAINS to search RATS, SPRAGUE-DAWLEY 1982-92", "PM": "93; was see RATS, INBRED STRAINS 1982-92", "HN": "93; was see RATS, INBRED STRAINS 1982-92", "MR": "20200902", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017207"}, {"RECTYPE": "D", "MH": "Rats, Wistar", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Wistar Rat|T015|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Wistar Rats", "MN": "B01.050.150.900.649.313.992.635.505.700.900", "MH_TH": "NLM (1993)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Rats, Inbred Strains (1980-1992)", "MS": "A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.", "OL": "use RATS, INBRED STRAINS to search RATS, WISTAR 1982-92", "PM": "93; was see RATS, INBRED STRAINS 1982-92", "HN": "93; was see RATS, INBRED STRAINS 1982-92", "MR": "20200902", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017208"}, {"RECTYPE": "D", "MH": "Apoptosis", "AQ": "DE GE IM PH RE", "ENTRY": "Intrinsic Pathway Apoptosis", "MN": "G04.146.954.035", "FX": "Necrosis", "MH_TH": "NLM (1993)", "ST": "T043", "AN": "general or unspecified, note specifics", "PI": "Cell Survival (1972-1992)", "MS": "A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION.  It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017209"}, {"RECTYPE": "D", "MH": "Tilapia", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Tilapia mossambica|T013|NON|NRW|NLM (1993)|911120|abcdef", "ENTRY": "Tilapias, Mozambique", "MN": "B01.050.150.900.493.602.200.800", "MH_TH": "NLM (1993)", "ST": "T013", "RN": "txid8126", "RR": "txid8127", "AN": "TILAPIA NILOTICA and NILE TILAPIA see CICHLIDS are also available", "PI": "Fishes (1966-1992)", "MS": "A freshwater fish used as an experimental organism and for food. This genus of the family Cichlidae (CICHLIDS) inhabits Central and South America (one species extends north into Texas), West Indies, Africa, Madagascar, Syria, and coastal India.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017210"}, {"RECTYPE": "D", "MH": "Treatment Failure", "ENTRY": "Treatment Failures", "MN": "N05.715.360.575.575.800.760", "MH_TH": "NLM (1993)", "ST": "T080", "AN": "coordinate with disease /ther, as \"analysis of treatment failure in AIDS\" or with specific therapy or intervention ", "MS": "A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19980611", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017211"}, {"RECTYPE": "D", "MH": "Root Caries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cervical Caries|T047|NON|NRW|NLM (1997)|960530|abcdef", "ENTRY": "Cervical Cary", "MN": "C07.793.720.210.650", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "caries of root, cementum or cervical portion of tooth", "PI": "Tooth Root (1966-1992)", "MS": "Dental caries involving the tooth root, cementum, or cervical area of the tooth.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017213"}, {"RECTYPE": "D", "MH": "Laryngeal Masks", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Laryngeal Mask Airway|T074|NON|EQV|NLM (1993)|911120|abcdef", "ENTRY": "Masks, Laryngeal", "MN": "J01.637.708.560.782.450", "MH_TH": "NLM (1993)", "ST": "T074", "AN": "\"an alternative to endotracheal intubation\"", "PI": "Masks (1989-1992)", "MS": "A type of oropharyngeal airway that provides an alternative to endotracheal intubation and standard mask anesthesia in certain patients. It is introduced into the hypopharynx to form a seal around the larynx thus permitting spontaneous or positive pressure ventilation without penetration of the larynx or esophagus. It is used in place of a facemask in routine anesthesia. The advantages over standard mask anesthesia are better airway control, minimal anesthetic gas leakage, a secure airway during patient transport to the recovery area, and minimal postoperative problems.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017214"}, {"RECTYPE": "D", "MH": "Satellite Communications", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Telecommunications, Satellite|T068|NON|EQV|NLM (1993)|911217|abcdef", "ENTRY": "Telecommunication, Satellite", "MN": "L01.462.500.847.550", "MH_TH": "POPLINE (1990)", "ST": "T068", "PI": "Telecommunications (1976-1992)", "MS": "Communications using an active or passive satellite to extend the range of radio, television, or other electronic transmission by returning signals to earth from an orbiting satellite.", "OL": "use TELECOMMUNICATIONS to search SATELLITE COMMUNICATIONS 1985-92", "PM": "93; was see TELECOMMUNICATIONS 1985-92", "HN": "93; was see TELECOMMUNICATIONS 1985-92", "MR": "20220712", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017215"}, {"RECTYPE": "D", "MH": "Telemedicine", "DE": "TELEMED", "AQ": "CL EC ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Virtual Medicine|T058|NON|EQV|NLM (2023)|210820|abcdef", "ENTRY": "Tele-Referrals", "MN": "N04.590.374.800", "FX": "Telemetry", "MH_TH": "NLM (1993)", "ST": "T058", "AN": "note specifics", "PI": "Telecommunications (1976-1992)", "MS": "Delivery of health services via remote telecommunications. This includes interactive consultative and diagnostic services.", "PM": "93", "HN": "93", "MR": "20230426", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017216"}, {"RECTYPE": "D", "MH": "Blood Patch, Epidural", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Epidural Blood Patch|T061|NON|EQV|NLM (1993)|911121|abcdef", "ENTRY": "Patchs, Epidural Blood", "MN": "E02.319.267.530.580.300.145", "MH_TH": "NLM (1993)", "ST": "T061", "AN": "IM; for repair of epidural puncture", "PI": "Injections, Epidural (1989-1992)", "MS": "The injection of autologous blood into the epidural space either as a prophylactic treatment immediately following an epidural puncture or for treatment of headache as a result of an epidural puncture.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017217"}, {"RECTYPE": "D", "MH": "Cordocentesis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Samplings, Cord Blood", "MN": "E05.200.998.329.543", "MH_TH": "NLM (1993)", "ST": "T060", "PI": "Blood Specimen Collection (1987-1992)", "MS": "The collecting of fetal blood samples typically via ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION from the umbilical vein.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017218"}, {"RECTYPE": "D", "MH": "Gastric Outlet Obstruction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Outlet Obstructions, Gastric", "MN": "C06.405.748.340", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "coord IM with cause of obstruct (IM)", "PI": "Stomach Diseases (1978-1992)", "MS": "The hindering of output from the STOMACH into the SMALL INTESTINE. This obstruction may be of mechanical or functional origin such as EDEMA from PEPTIC ULCER; NEOPLASMS; FOREIGN BODIES; or AGING.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017219"}, {"RECTYPE": "D", "MH": "Dentin-Bonding Agents", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Dentin-Bonding Agent|T122|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Dentin Bonding Agents", "MN": "J01.637.051.339.291.300", "MH_TH": "NLM (1993)", "ST": "T122", "RN": "0", "PI": "Dental Bonding (1976-1992)", "MS": "Cements that act through infiltration and polymerization within the dentinal matrix and are used for dental restoration. They can be adhesive resins themselves, adhesion-promoting monomers, or polymerization initiators that act in concert with other agents to form a dentin-bonding system.", "PM": "93", "HN": "93", "MR": "20210630", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017220"}, {"RECTYPE": "D", "MH": "Necator americanus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Hookworm, New World|T204|NON|EQV|NLM (1994)|930211|abcdef", "ENTRY": "New World Hookworms", "MN": "B01.050.500.500.294.400.968.100.550.100", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid51031", "AN": "a species of intestinal hookworm; coord IM with NECATORIASIS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH", "PI": "Necator (1966-1992)", "MS": "A common parasite of humans in the moist tropics and subtropics. These organisms attach to villi in the small intestine and suck blood causing diarrhea, anorexia, and anemia.", "OL": "use NECATOR to search NECATOR AMERICANUS 1979-92 & HOOKWORM, NEW WORLD 1979-93", "PM": "93; was see NECATOR 1979-92; HOOKWORM, NEW WORLD was see NECATOR 1979-93", "HN": "93; was see NECATOR 1979-92; HOOKWORM, NEW WORLD was see NECATOR 1979-93", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017221"}, {"RECTYPE": "D", "MH": "Angioplasty, Balloon, Laser-Assisted", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Percutaneous Transluminal Laser Angioplasty|T061|NON|EQV|NLM (1993)|911127|PTLA|abcdefv", "ENTRY": "Laser-Assisted Balloon Angioplasties", "MN": "E05.157.016.075.080", "MH_TH": "NLM (1993)", "ST": "T061", "PI": "Lasers (1985-1992)", "MS": "Techniques using laser energy in combination with a balloon catheter to perform angioplasty. These procedures can take several forms including: 1, laser fiber delivering the energy while the inflated balloon centers the fiber and occludes the blood flow; 2, balloon angioplasty immediately following laser angioplasty; or 3, laser energy transmitted through angioplasty balloons that contain an internal fiber.", "OL": "use ANGIOPLASTY, LASER to search PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY 1991-92", "PM": "93; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY was see ANGIOPLASTY, LASER 1991-92", "HN": "93; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY was see ANGIOPLASTY, LASER 1991-92", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017222"}, {"RECTYPE": "D", "MH": "Atherectomy, Coronary", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Rotational Atherectomy|T061|NON|NRW|NLM (1993)|911224|abcdef", "ENTRY": "Rotational Atherectomies", "MN": "E05.157.016.120.125", "MH_TH": "NLM (1993)", "ST": "T061", "PI": "Coronary Arteriosclerosis (1989-1992)", "MS": "Percutaneous transluminal procedure for removing atheromatous plaque from the coronary arteries. Both directional (for removing focal atheromas) and rotational (for removing concentric atheromatous plaque) atherectomy devices have been used.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017225"}, {"RECTYPE": "D", "MH": "Toxascariasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Toxascariases", "MN": "C01.610.335.508.700.100.850", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "an Ascaridida infect but differentiate from TOXOCARIASIS, also an Ascaridida infect", "MS": "Infections with nematodes of the genus TOXASCARIS.", "OL": "use NEMATODE INFECTIONS to search TOXASCARIASIS 1968-92", "PM": "93; was see NEMATODE INFECTIONS 1989-92; was see under ASCARIASIS 1968-88", "HN": "93; was see NEMATODE INFECTIONS 1989-92; was see under ASCARIASIS 1968-88", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017227"}, {"RECTYPE": "D", "MH": "Hepatocyte Growth Factor", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Scatter Factor|T116|T123|NON|EQV|NLM (1993)|911206|abbcdef", "ENTRY": "Growth Factor, Hepatocyte", "MN": "D23.529.374.420", "MH_TH": "NLM (1993)", "ST": "T123", "N1": "Lymphokines and Cytokines, scatter factor", "RN": "67256-21-7", "RR": "72980-71-3 (hepatopoietin)", "PI": "Growth Substances (1992)", "MS": "Multifunctional growth factor which regulates both cell growth and cell motility. It exerts a strong mitogenic effect on hepatocytes and primary epithelial cells. Its receptor is PROTO-ONCOGENE PROTEINS C-MET.", "OL": "use HEPATOCYTE GROWTH FACTOR (NM) to search HEPATOCYTE GROWTH FACTOR 1984-92 and SCATTER FACTOR 1987-92", "PM": "93; HEPATOCYTE GROWTH FACTOR was indexed under GROWTH SUBSTANCES 1992 and under BLOOD PROTEINS 1984-91; SCATTER FACTOR was indexed under CYTOKINES 1992 and under PROTEINS 1987-91", "HN": "93; was HEPATOCYTE GROWTH FACTOR (NM) 1984-92 and SCATTER FACTOR (NM) 1987-92", "MR": "20060705", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017228"}, {"RECTYPE": "D", "MH": "Enterobiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Oxyuris vermicularis Infection|T047|NON|EQV|NLM (1998)|960729|OXYURIS VERMICULARIS INFECT|abcdefv", "ENTRY": "Pinworm Infections", "MN": "C01.610.335.508.700.550.550.375", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "nematode infect caused by Enterobius", "PI": "Oxyuriasis (1966-1992)", "MS": "Infection with nematodes of the genus ENTEROBIUS; E. vermicularis, the pinworm of man, causes a crawling sensation and pruritus. This condition results in scratching the area, occasionally causing scarification.", "OL": "use OXYURIASIS to search ENTEROBIASIS 1966-92", "PM": "93; was see OXYURIASIS 1975-92; was see under OXYURIASIS 1967-74", "HN": "93; was see OXYURIASIS 1975-92; was see under OXYURIASIS 1967-74", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920508", "DC": "1", "DX": "19930101", "UI": "D017229"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-mos", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "pp39(c-mos)|T116|T126|NON|EQV|NLM (1993)|911206|PP 039 C MOS|PP39C MOS|abbcdefsv", "ENTRY": "pp39 c mos", "MN": "D12.776.624.664.700.187", "MH_TH": "NLM (1993)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Proto-Oncogene Proteins (1987-1992)", "MS": "Cellular proteins encoded by the c-mos genes (GENES, MOS). They function in the cell cycle to maintain MATURATION PROMOTING FACTOR in the active state and have protein-serine/threonine kinase activity. Oncogenic transformation can take place when c-mos proteins are expressed at the wrong time.", "OL": "use PROTO-ONCOGENE PROTEINS C-MOS (NM) to search PROTO-ONCOGENE PROTEIN C-MOS 1987-92", "PM": "93; PROTO-ONCOGENE PROTEIN C-MOS (NM) was indexed under PROTO-ONCOGENE PROTEINS 1987-92", "HN": "93; was PROTO-ONCOGENE PROTEIN C-MOS (NM) 1987-92", "MR": "20210521", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017231"}, {"RECTYPE": "D", "MH": "Oncogene Proteins v-mos", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-mos Proteins|T116|EQV|NLM (1993)|911206|abdef", "ENTRY": "v-mos, p37", "MN": "D12.776.964.775.750.900", "MH_TH": "NLM (1993)", "ST": "T116", "RN": "0", "AN": "IM; coord with specific virus (IM); /drug eff /ultrastruct permitted", "PI": "Retroviridae Proteins, Oncogenic (1990-1992)", "MS": "Transforming proteins coded by mos oncogenes. The v-mos proteins were originally isolated from the Moloney murine sarcoma virus (Mo-MSV).", "OL": "use ONCOGENE PROTEINS V-MOS (NM) to search ONCOGENE PROTEIN P37(MOS) 1989-92 & ONCOGENE PROTEIN MOS 1987-92", "PM": "93; ONCOGENE PROTEIN P37(MOS) was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1989-92; ONCOGENE PROTEIN MOS was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1989-92 & under RETROVIRIDAE PROTEINS 1987-89", "HN": "93; was ONCOGENE PROTEIN P37(MOS) (NM) 1989-92 and ONCOGENE PROTEIN MOS (NM) 1987-92", "MR": "20190524", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017232"}, {"RECTYPE": "D", "MH": "Orbit Evisceration", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Orbital Eviscerations", "MN": "E04.540.760", "FX": "Eye Evisceration", "MH_TH": "NLM (1993)", "ST": "T061", "AN": "do not confuse with EYE EVISCERATION, \"removal of the inner contents of the eye, leaving the sclera intact\"", "PI": "Orbit/surgery (1966-1992)", "MS": "The surgical removal of the contents of the orbit. This includes the eyeball, blood vessels, muscles, fat, nerve supply, and periosteum. It should be differentiated from EYE EVISCERATION which removes the inner contents of the eye, leaving the sclera intact.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017233"}, {"RECTYPE": "D", "MH": "Eye Evisceration", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Eye Eviscerations", "MN": "E04.540.431", "FX": "Orbit Evisceration", "MH_TH": "NLM (1993)", "ST": "T061", "AN": "do not confuse with EYE ENUCLEATION (\"removal of eyeball leaving eye muscle & remaining orbital contents intact\") or ORBIT EVISCERATION (\"removal of contents of orbit, including eyeball, blood vessels, muscles, fat, nerve supply & periosteum\")", "PI": "Eye/surgery (1966-1988)", "MS": "The surgical removal of the inner contents of the eye, leaving the sclera intact. It should be differentiated from ORBIT EVISCERATION which removes the entire contents of the orbit, including eyeball, blood vessels, muscles, fat, nerve supply, and periosteum.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19920508", "DC": "1", "DX": "19930101", "UI": "D017234"}, {"RECTYPE": "D", "MH": "Suicide, Assisted", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Physician-Assisted Suicide|T054|NON|NRW|NLM (1993)|911211|abcdef", "ENTRY": "Suicides, Physician-Assisted", "MN": "N02.421.585.905.850", "FX": "Euthanasia, Active, Voluntary", "MH_TH": "NLM (1993)", "ST": "T054", "PI": "Suicide (1976-1992)", "MS": "Provision (by a physician or other health professional, or by a family member or friend) of support and/or means that gives a patient the power to terminate his or her own life. (from APA, Thesaurus of Psychological Index Terms, 8th ed).", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017236"}, {"RECTYPE": "D", "MH": "Mitochondrial Encephalomyopathies", "DE": "MITOCHONDRIAL ENCEPH", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Encephalomyopathies, Mitochondrial|T047|NON|EQV|NLM (2000)|991103|ENCEPH MITOCHONDRIAL|abcdefv", "ENTRY": "Mitochondrial Encephalomyopathy", "MN": "C18.452.660.560.620", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with specific dysfunction if pertinent", "PI": "Neuromuscular Diseases (1977-1992)", "MS": "A heterogenous group of disorders characterized by alterations of mitochondrial metabolism that result in muscle and nervous system dysfunction. These are often multisystemic and vary considerably in age at onset (usually in the first or second decade of life), distribution of affected muscles, severity, and course. (From Adams et al., Principles of Neurology, 6th ed, pp984-5)", "PM": "1993", "HN": "1993", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017237"}, {"RECTYPE": "D", "MH": "Genes, Helminth", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Helminth Genes|T028|NON|EQV|NLM (1993)|911211|abcdef", "ENTRY": "Helminth Gene", "MN": "G05.360.340.337.500", "FX": "Genome, Helminth", "MH_TH": "NLM (1993)", "ST": "T028", "AN": "coordinate IM with specific helminth /genet (IM)", "PI": "specific helminths (1974-1992)", "MS": "The functional hereditary units of HELMINTHS.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017238"}, {"RECTYPE": "D", "MH": "Paclitaxel", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Taxol, Bris", "MN": "D02.455.849.291.850.777", "PA": "Tubulin Modulators", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alphaR*,betaS*),11alpha,1-2alpha,12aalpha,12balpha))-", "RN": "P88XT4IS4D", "RR": "33069-62-4", "PI": "Terpenes (1977-1981)", "MS": "A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS BREVIFOLIA. It stabilizes MICROTUBULES in their polymerized form leading to cell death.", "OL": "use PACLITAXEL to search TAXOL 1993-94; use PACLITAXEL (NM) to search TAXOL A 1977-92", "PM": "95; was TAXOL 1993-94; TAXOL A was indexed under ALKALOIDS 1982-92 & TERPENES 1977-81", "HN": "95; was TAXOL 1993-94; was TAXOL A (NM) 1977-92", "MR": "20141014", "DA": "19991104", "DC": "1", "DX": "19930101", "UI": "D017239"}, {"RECTYPE": "D", "MH": "Mitochondrial Myopathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myopathies, Mitochondrial|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Pleoconial Myopathy", "MN": "C18.452.660.560", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Muscular Diseases (1968-1992)", "MS": "A group of muscle diseases associated with abnormal mitochondria function.", "PM": "1993", "HN": "1993", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017240"}, {"RECTYPE": "D", "MH": "MELAS Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mitochondrial Myopathy, Lactic Acidosis, Stroke-Like Episode|T047|NON|EQV|GHR (2014)|NLM (2000)|991103|abcdeef", "ENTRY": "Syndrome, MELAS", "MN": "C18.452.660.560.620.520", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Neuromuscular Diseases (1987-1992)", "MS": "A mitochondrial disorder characterized by focal or generalized seizures, episodes of transient or persistent neurologic dysfunction resembling strokes, and ragged-red fibers on muscle biopsy. Affected individuals tend to be normal at birth through early childhood, then experience growth failure, episodic vomiting, and recurrent cerebral insults resulting in visual loss and hemiparesis. The cortical lesions tend to occur in the parietal and occipital lobes and are not associated with vascular occlusion. VASCULAR HEADACHE is frequently associated and the disorder tends to be familial. (From Joynt, Clinical Neurology, 1992, Ch56, p117)", "PM": "1993", "HN": "1993", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017241"}, {"RECTYPE": "D", "MH": "Complement Factor H", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Factor H|T116|T129|NON|EQV|NLM (1993)|911216|abbcdef", "ENTRY": "Factor H, Complement", "MN": "D12.776.377.715.182.200", "PA": "Complement Inactivating Agents", "MH_TH": "NLM (1993)", "ST": "T129", "N1": "Complement factor H", "RN": "80295-65-4", "RR": "103371-28-4 (mouse protein moiety reduced)", "PI": "Glycoproteins (1978-1979)", "MS": "An important soluble regulator of the alternative pathway of complement activation (COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE). It is a 139-kDa glycoprotein expressed by the liver and secreted into the blood. It binds to COMPLEMENT C3B and makes iC3b (inactivated complement 3b) susceptible to cleavage by COMPLEMENT FACTOR I. Complement factor H also inhibits the association of C3b with COMPLEMENT FACTOR B to form the C3bB proenzyme, and promotes the dissociation of Bb from the C3bBb complex (COMPLEMENT C3 CONVERTASE, ALTERNATIVE PATHWAY).", "OL": "use COMPLEMENT FACTOR H (NM) to search COMPLEMENT FACTOR H 1978-92", "PM": "93; COMPLEMENT FACTOR H was indexed under COMPLEMENT 3B INACTIVATORS 1980-92 & under BETA GLOBULINS and GLYCOPROTEINS 1978-79", "HN": "93; was COMPLEMENT FACTOR H (NM) 1978-92", "MR": "20050707", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017242"}, {"RECTYPE": "D", "MH": "MERRF Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myoclonic Epilepsy with Ragged Red Fibers|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Syndrome, MERRF", "MN": "C18.452.660.560.620.530", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Mitochondria, Muscle (1980-1992)", "MS": "A mitochondrial encephalomyopathy characterized clinically by a mixed seizure disorder, myoclonus, progressive ataxia, spasticity, and a mild myopathy. Dysarthria, optic atrophy, growth retardation, deafness, and dementia may also occur. This condition tends to present in childhood and to be transmitted via maternal lineage. Muscle biopsies reveal ragged-red fibers and respiratory chain enzymatic defects. (From Adams et al., Principles of Neurology, 6th ed, p986)", "PM": "1993", "HN": "1993", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017243"}, {"RECTYPE": "D", "MH": "Complement Factor I", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Inactivator, Complement C4b-C3b", "MN": "D12.776.124.486.274.920.325.210", "PA": "Complement Inactivating Agents", "MH_TH": "NLM (1993)", "ST": "T126", "RN": "EC 3.4.21.45", "AN": "do not confuse with FACTOR I see FIBRINOGEN", "PI": "Serine Proteinases (1988-1992)", "MS": "A plasma serine proteinase that cleaves the alpha-chains of C3b and C4b in the presence of the cofactors COMPLEMENT FACTOR H and C4-binding protein, respectively. It is a 66-kDa glycoprotein that converts C3b to inactivated C3b (iC3b) followed by the release of two fragments, C3c (150-kDa) and C3dg (41-kDa). It was formerly called KAF, C3bINF, or enzyme 3b inactivator.", "OL": "use COMPLEMENT FACTOR I (NM) to search FACTOR I, C 3B INACTIVATOR 1983-92", "PM": "93; COMPLEMENT FACTOR I was indexed under SERINE PROTEINASES 1988-92 & under PEPTIDE PEPTIDOHYDROLASES 1983-87", "HN": "93; was FACTOR I, C 3B INACTIVATOR (NM) 1983-92", "MR": "20090706", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017244"}, {"RECTYPE": "D", "MH": "Foscarnet", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphonoformic Acid|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1993)|911216|abbcdeef", "ENTRY": "Trisodium Phosphonoformate|T109|T121|NON|NRW|NLM (1993)|911216|abbcdef", "MN": "D02.705.429.875.500", "PA": "Reverse Transcriptase Inhibitors", "MH_TH": "NLM (1993)", "ST": "T121", "N1": "Phosphinecarboxylic acid, dihydroxy-, oxide", "RN": "364P9RVW4X", "RR": "964YS0OOG1", "PI": "Phosphonoacetic Acid (1981-1992)", "MS": "An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.", "PM": "1993; FOSCARNET was indexed under PHOSPHONOACETIC ACID 1981-1992 and under ORGANOPHOSPHORUS COMPOUNDS and FORMATES 1978-1980", "HN": "1993 (1980); FOSCARNET was SY to PHOSPHONOFORMIC ACID (NM) 1983-1992", "MR": "20180613", "DA": "19920519", "DC": "1", "DX": "19930101", "UI": "D017245"}, {"RECTYPE": "D", "MH": "Ophthalmoplegia, Chronic Progressive External", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ocular Muscular Dystrophy|T047|NON|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Ocular Myopathy, Mitochondrial", "MN": "C23.888.592.636.447.511", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Ophthalmoplegia (1966-1992)", "MS": "A mitochondrial myopathy characterized by slowly progressive paralysis of the levator palpebrae, orbicularis oculi, and extraocular muscles. Ragged-red fibers and atrophy are found on muscle biopsy. Familial and sporadic forms may occur. Disease onset is usually in the first or second decade of life, and the illness slowly progresses until usually all ocular motility is lost. (From Adams et al., Principles of Neurology, 6th ed, p1422)", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20210312", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017246"}, {"RECTYPE": "D", "MH": "Neutron Capture Therapy", "DE": "NEUTRON CAPTURE THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Neutron Capturing", "MN": "E02.815.722.500", "MH_TH": "NLM (1993)", "ST": "T061", "AN": "coordinate with disease /radiother ", "PI": "Radiotherapy, High-Energy (1966-1992)", "MS": "A technique for the treatment of neoplasms in which an isotope is introduced into target cells followed by irradiation with thermal neutrons.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017247"}, {"RECTYPE": "D", "MH": "Enzyme Multiplied Immunoassay Technique", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "EMIT Assays", "MN": "E05.601.470.350.180", "FX": "Substance Abuse Detection", "MH_TH": "NLM (1993)", "ST": "T059", "PI": "Immunoenzyme Techniques (1976-1992)", "MS": "An immunoenzyme test for the presence of drugs and other substances in urine and blood. The test uses enzyme linked antibodies that react only with the particular drug for which the sample is being tested.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19920508", "DC": "1", "DX": "19930101", "UI": "D017248"}, {"RECTYPE": "D", "MH": "Caliciviridae Infections", "DE": "CALICIVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Calicivirus Infections|T047|NON|NRW|NLM (1994)|930511|CALICIVIRUS INFECT|abcdefv", "ENTRY": "Norovirus Infection", "MN": "C01.925.782.160", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Virus Diseases (1975-1979)", "MS": "Virus diseases caused by CALICIVIRIDAE. They include HEPATITIS E; VESICULAR EXANTHEMA OF SWINE; acute respiratory infections in felines, rabbit hemorrhagic disease, and some cases of gastroenteritis in humans.", "OL": "use CALICIVIRIDAE INFECTIONS to search CALICIVIRUS INFECTIONS 1993", "PM": "94; was CALICIVIRUS INFECTIONS 1993", "HN": "94; was CALICIVIRUS INFECTIONS 1993", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017250"}, {"RECTYPE": "D", "MH": "CD3 Complex", "DS": "CD 003 COMPLEX", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "T3 Antigens|T116|T129|EQV|NLM (1993)|911230|T AAA ANTIGENS 03|abbdefs", "ENTRY": "Antigens, T3", "MN": "D23.101.100.894.095", "FX": "Receptors, Antigen, T-Cell", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "PI": "Receptors, Antigen, T-Cell (1990-1992)", "MS": "Complex of at least five membrane-bound polypeptides in mature T-lymphocytes that are non-covalently associated with one another and with the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL). The CD3 complex includes the gamma, delta, epsilon, zeta, and eta chains (subunits). When antigen binds to the T-cell receptor, the CD3 complex transduces the activating signals to the cytoplasm of the T-cell. The CD3 gamma and delta chains (subunits) are separate from and not related to the gamma/delta chains of the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA).", "PM": "2018; see ANTIGENS, CD3 1993-2017; CD3 COMPLEX was indexed under RECEPTORS, ANTIGEN, T-CELL 1990-92;  under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92; under ANTIGENS, SURFACE 1983-87; and under ANTIGENS 1983-84; for T3 ANTIGENS see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92", "HN": "2018 (1993); use T3 ANTIGEN COMPLEX 1983-92; use ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92", "MR": "20170602", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017252"}, {"RECTYPE": "D", "MH": "Neurofibromatoses", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neurofibromatosis Type 3|T191|NON|NRW|NLM (2010)|ORD (2010)|090505|abcdeef", "ENTRY": "Type 3, Neurofibromatosis", "MN": "C16.320.700.633", "MH_TH": "NLM (1993)", "ST": "T191", "AN": "multiple neurofibromas; specifics are available", "MS": "A group of disorders characterized by an autosomal dominant pattern of inheritance with high rates of spontaneous mutation and multiple neurofibromas or neurilemmomas. NEUROFIBROMATOSIS 1 (generalized neurofibromatosis) accounts for approximately 95% of cases, although multiple additional subtypes (e.g., NEUROFIBROMATOSIS 2, neurofibromatosis 3, etc.) have been described. (From Neurochirurgie 1998 Nov;44(4):267-72)", "PM": "2000; see NEUROFIBROMATOSIS 1993-1999", "HN": "2000(1993)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017253"}, {"RECTYPE": "D", "MH": "Leukemic Infiltration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Leukemic Infiltrations", "MN": "C23.550.727.645.500", "MH_TH": "NLM (1993)", "ST": "T191", "PI": "specific neoplasm (1966-1992)", "MS": "A pathologic change in leukemia in which leukemic cells permeate various organs at any stage of the disease. All types of leukemia show various degrees of infiltration, depending upon the type of leukemia. The degree of infiltration may vary from site to site. The liver and spleen are common sites of infiltration, the greatest appearing in myelocytic leukemia, but infiltration is seen also in the granulocytic and lymphocytic types. The kidney is also a common site and of the gastrointestinal system, the stomach and ileum are commonly involved. In lymphocytic leukemia the skin is often infiltrated. The central nervous system too is a common site.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20070711", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017254"}, {"RECTYPE": "D", "MH": "Acitretin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isoetretin|T109|T121|NON|REL|NLM (1993)|920103|abbcdef", "ENTRY": "Ro137652", "MN": "D23.767.261.700.050", "PA": "Keratolytic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-E)-", "RN": "LCH760E9T7", "RR": "69427-46-9 ((Z,E,E,E)-isomer)", "PI": "Tretinoin/analogs & derivatives (1977-1992)", "MS": "An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.", "OL": "use ACITRETIN (NM) to search ACITRETIN 1980-92", "PM": "93; ACITRETIN was indexed under TRETINOIN/analogs & derivatives 1977-92", "HN": "93; was ACITRETIN (NM) 1977-91", "MR": "20170224", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017255"}, {"RECTYPE": "D", "MH": "Technetium Tc 99m Sestamibi", "DS": "TECHNETIUM TC SESTAMIBI 099M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tc MIBI|T109|T130|EQV|NLM (1999)|980409|abbdef", "ENTRY": "Technetium Tc 99m 2 Methoxy 2 methylpropylisonitrile", "MN": "D02.691.825.937", "PA": "Radiopharmaceuticals", "MH_TH": "USAN (1990)", "ST": "T130", "N1": "Technetium(1+)-99Tc, hexakis(1-isocyano-2-methoxy-2-methylpropane)-, (OC-6-11)-", "RN": "971Z4W1S09", "RR": "113720-90-4 (unlabeled cpd)", "AN": "for routine use as label, use no qualifiers", "PI": "Technetium (1987-1989)", "MS": "A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack.", "OL": "use TECHNETIUM TC 99M SESTAMIBI (NM) to search TECHNETIUM TC 99M HEXAKIS(2-METHOXY-2-METHYLPROPYLISONITRILE) 1987-92", "PM": "93; TECHNETIUM TC 99M HEXAKIS(2-METHOXY-2-METHYLPROPYLISONITRILE) was indexed under ORGANOTECHNETIUM COMPOUNDS 1989-92 and ORGANOMETALLIC COMPOUNDS & TECHNETIUM 1987-92; TECHNETIUM TC 99M 2-METHOXY-2-METHYLPROPYLISONITRILE was indexed under NITRILES (1987-93), ORGANOMETALLIC COMPOUNDS (1987-89), ORGANOTECHNETIUM COMPOUNDS (1990-93), & TECHNETIUM TC 99M SESTAMIMBI (1994-98)", "HN": "93; was TECHNETIUM TC 99M HEXAKIS(2-METHOXY-2-METHYLPROPYLISONITRILE) 1987-92; for TECHNETIUM TC 99M 2-METHOXY-2-METHYLPROPYLISONITRILE use TECHNETIUM TC 99M SESTAMIBI (NM) 1987-98", "MR": "20160701", "DA": "19920629", "DC": "1", "DX": "19930101", "UI": "D017256"}, {"RECTYPE": "D", "MH": "Ramipril", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "HOE498", "MN": "D03.633.100.893", "PA": "Antihypertensive Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Cyclopenta(b)pyrrole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, (2S-(1(R*(R*)),2alpha,3abeta,6abeta))-", "RN": "L35JN3I7SJ", "RR": "87333-19-5 (Ramipril)", "PI": "Bicyclo Compounds (1984-1992)", "MS": "A long-acting angiotensin-converting enzyme inhibitor. It is a prodrug that is transformed in the liver to its active metabolite ramiprilat.", "OL": "use RAMIPRIL (NM) to search RAMIPRIL 1984-92", "PM": "93; RAMIPRIL was indexed under BICYCLO COMPOUNDS 1984-92", "HN": "93; was RAMIPRIL (NM) 1984-92", "MR": "20160531", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017257"}, {"RECTYPE": "D", "MH": "Medroxyprogesterone Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)-|T109|T121|T125|NON|EQV|NLM (2020)|190708|abbbcdef", "ENTRY": "Medroxyprogesterone 17 Acetate", "MN": "D04.210.500.745.745.654.829.395.700.500", "PA": "Contraceptive Agents, Male", "MH_TH": "USP (19XX)", "ST": "T125", "RN": "C2QI4IOI2G", "RR": "71-58-9 (Medroxyprogesterone Acetate)", "PI": "Medroxyprogesterone/analogs & derivatives (1978-1992)", "MS": "A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.", "PM": "2010; see MEDROXYPROGESTERONE 17-ACETATE 1993-2009; MEDROXYPROGESTERONE 17-ACETATE was indexed under MEDROXYPROGESTERONE/analogs & derivatives 1978-1992, HYDROXYPROGESTERONES 1976-78, & MEDROXYPROGESTERONE 1973-75", "HN": "2010 (1973)", "MR": "20190708", "DA": "19920518", "DC": "1", "DX": "19930101", "UI": "D017258"}, {"RECTYPE": "D", "MH": "Dimaprit", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dihydrochloride, Dimaprit", "MN": "D02.886.904.282", "PA": "Histamine Agonists", "MH_TH": "NLM (1993)", "ST": "T121", "N1": "Carbamimidothioic acid, 3-(dimethylamino)propyl ester", "RN": "ZZQ699148P", "RR": "72705-00-1 (maleate (1:1))", "AN": "dimaprit stands for DI-Methyl-Amino-Propyl-Iso-Thiourea", "PI": "Thiourea/analogs & derivatives (1977-1979)", "MS": "A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.", "OL": "use DIMAPRIT (NM) to search DIMAPRIT 1980-92", "PM": "93; DIMAPRIT was indexed under APT 1980-92, APT/analogs & derivatives 1979-80 & THIOUREA/analogs & derivatives 1977-79", "HN": "93; was DIMAPRIT (NM) 1977-92", "MR": "20200527", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017259"}, {"RECTYPE": "D", "MH": "Receptor-CD3 Complex, Antigen, T-Cell", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "TCR-CD3 Complex|T116|T129|T192|EQV|NLM (1993)|920110|abbbdef", "ENTRY": "TCR CD3 Complex", "MN": "D23.101.100.894.095.800", "FX": "Signal Transduction", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Antigen, T-Cell, gamma-delta (1992)", "MS": "Molecule composed of the non-covalent association of the T-cell antigen receptor (RECEPTORS, ANTIGEN, T-CELL) with the CD3 complex (CD3 COMPLEX). This association is required for the surface expression and function of both components. The molecule consists of up to seven chains: either the alpha/beta or gamma/delta chains of the T-cell receptor, and four or five chains in the CD3 complex.", "PM": "1993", "HN": "1993", "MR": "20170713", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017260"}, {"RECTYPE": "D", "MH": "Glycosylphosphatidylinositols", "DE": "GPTI", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphatidylinositol Glycan|T109|T123|NON|NRW|NLM (1998)|961105|abbcdef", "ENTRY": "Phosphatidylinositols, Glycosylated", "MN": "D10.570.755.375.760.400.942.250", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "PI": "Phosphatidylinositols (1988-1992)", "MS": "Compounds containing carbohydrate or glycosyl groups linked to phosphatidylinositols. They anchor GPI-LINKED PROTEINS or polysaccharides to cell membranes.", "OL": "use GLYCOSYLPHOSPHATIDYLINOSITOLS (NM) to search GLYCOSYL-PHOSPHATIDYLINOSITOL (NM) 1988-92", "PM": "93; GLYCOSYL-PHOSPHATIDYLINOSITOL was indexed under GLYCOLIPIDS & PHOSPHATIDYLINOSITOLS 1988-92", "HN": "93; was GLYCOSYL-PHOSPHATIDYLINOSITOL (NM) 1988-92", "MR": "20200527", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017261"}, {"RECTYPE": "D", "MH": "Siderophores", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Siderophore|T109|T123|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Siderochromes|T109|T123|NON|EQV|NLM (1993)|920113|abbcdef", "MN": "D27.720.832.500.410.750", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "PI": "Peptides (1972-1978)", "MS": "Low-molecular-weight compounds produced by microorganisms that aid in the transport and sequestration of ferric iron. (The Encyclopedia of Molecular Biology, 1994)", "OL": "use SIDEROPHORES (NM) to search SIDEROCHROMES 1980-92", "PM": "93; SIDEROCHROMES was indexed under IRON CHELATES 1981-92, HYDROXAMIC ACIDS 1972-81, PEPTIDES 1972-78 & CATECHOLS 1972-75", "HN": "93; was SIDEROCHROMES (NM) 1972-92", "MR": "20200527", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017262"}, {"RECTYPE": "D", "MH": "Technetium Tc 99m Mertiatide", "DE": "TC MERTIATIDE", "DS": "TECHNETIUM TC MERTIATIDE 099M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Technetium-99m-MAG3|T116|T130|EQV|NLM (1993)|920115|TECHNETIUM A 099M MAG 03|abbdefs", "ENTRY": "Technetium 99m Mercaptoacetyltriglycine", "MN": "D12.644.456.805", "PA": "Radiopharmaceuticals", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "Technetate(2-)-99Tc, (N-(N-(N-(mercaptoacetyl)glycyl)glycyl)glycinato(5-)-N,N',N'',S)oxo-, disodium, (SP-5-25)-", "RN": "36ITO9SKQJ", "RR": "125224-05-7 (Technetium Tc 99m Mertiatide)", "AN": "for routine use as label, use no qualifiers", "PI": "Technetium (1986-1989)", "MS": "A technetium diagnostic aid used in renal function determination.", "OL": "use TECHNETIUM TC 99M MERTIATIDE (NM) to search TECHNETIUM TC 99M MERCAPTOACETYLGLYCYL-GLYCYL-GLYCINE (NM) 1986-92", "PM": "93; TECHNETIUM TC 99M MERTIATIDE was indexed under ORGANOTECHNETIUM COMPOUNDS 1990-92, OLIGOPEPTIDES & TECHNETIUM 1986-92, & ORGANOMETALLIC COMPOUNDS 1986-89", "HN": "93; was TECHNETIUM TC 99M MERCAPTOACETYLGLYCYL-GLYCYL-GLYCINE (NM) 1986-92", "MR": "20150605", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017263"}, {"RECTYPE": "D", "MH": "Procaterol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ProAir", "MN": "D03.633.100.810.350.700", "PA": "Sympathomimetics", "MH_TH": "NLM (1993)", "ST": "T121", "N1": "2(1H)-Quinolinone, 8-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-, (R*,S*)-(+-)-", "RN": "X7I3EMM5K0", "RR": "94198-40-0", "PI": "Hydroxyquinolines (1978-1980)", "MS": "A long-acting beta-2-adrenergic receptor agonist.", "OL": "use PROCATEROL (NM) to search PROCATEROL 1979-92", "PM": "93; PROCATEROL was indexed under ETHANOLAMINES 1981-92 & AMINO ALCOHOLS & HYDROXYQUINOLINES 1978-80", "HN": "93; was PROCATEROL (NM) 1978-92", "MR": "20160531", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017265"}, {"RECTYPE": "D", "MH": "Dental Prosthesis", "DE": "DENT PROSTHESIS", "AQ": "AE CL EC ES HI IS MI MO MT NU PS PX SN ST TD VE VI", "PRINT ENTRY": "Prosthesis, Dental|T074|NON|EQV|NLM (1993)|920121|PROSTHESIS DENT|abcdefv", "ENTRY": "Prostheses, Dental|T074|NON|EQV|NLM (1998)|961121|PROSTHESES DENT|abcdefv", "MN": "E07.695.190", "FX": "Dentures", "MH_TH": "NLM (1993)", "ST": "T074", "AN": "general or unspecified; prefer specifics; specialty is PROSTHODONTICS", "PI": "Dentures (1991-1992)", "MS": "An artificial replacement for one or more natural teeth or part of a tooth, or associated structures, ranging from a portion of a tooth to a complete denture. The dental prosthesis is used for cosmetic or functional reasons, or both. DENTURES and specific types of dentures are also available. (From Boucher's Clinical Dental Terminology, 4th ed, p244 & Jablonski, Dictionary of Dentistry, 1992, p643)", "OL": "use DENTURES to search DENTAL PROSTHESIS 1966-92", "PM": "93; was heading 1963-90; was see DENTURES 1991-92", "HN": "93; was heading 1963-90; was see DENTURES 1991-92", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017266"}, {"RECTYPE": "D", "MH": "Dental Prosthesis Design", "DE": "DENT PROSTHESIS DESIGN", "AQ": "AE CL EC ES HI IS MT NU PX SN ST TD VE", "ENTRY": "Prosthesis Designs, Dental|T170|NON|EQV|NLM (1993)|920121|PROSTHESIS DESIGNS DENT|abcdefv", "MN": "E06.912.145", "MH_TH": "NLM (1993)", "ST": "T170", "AN": "coordinate with specific dental prosthesis; specify material of framework if pertinent; DENTURE DESIGN is also available", "PI": "Denture Design (1970-1992)", "MS": "The plan and delineation of dental prostheses in general or a specific dental prosthesis. It does not include DENTURE DESIGN. The framework usually consists of metal.", "OL": "use DENTURE DESIGN to search DENTAL PROSTHESIS DESIGN 1970-92 & PROSTHESIS DESIGN, DENTAL 1992", "PM": "93; was heading 1970-90, was see DENTURE DESIGN 1991-92; PROSTHESIS DESIGN, DENTAL was see DENTURE DESIGN 1992", "HN": "93; was heading 1970-90, was see DENTURE DESIGN 1991-92; PROSTHESIS DESIGN, DENTAL was see DENTURE DESIGN 1992", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017267"}, {"RECTYPE": "D", "MH": "Dental Prosthesis Retention", "DE": "DENT PROSTHESIS RETENTION", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Retention, Dental Prosthesis|T169|NON|EQV|NLM (1993)|920121|RETENTION DENT PROSTHESIS|abcdefv", "MN": "E06.780.346.687", "FX": "Prosthesis Retention", "MH_TH": "NLM (1993)", "ST": "T169", "AN": "coordinate with specific prosthesis with no qualifiers; PROSTHESIS RETENTION is also available", "PI": "Denture Retention (1990-1992)", "MS": "Holding a DENTAL PROSTHESIS in place by its design, or by the use of additional devices or adhesives.", "OL": "use DENTURE RETENTION to search DENTAL PROSTHESIS RETENTION 1966-92", "PM": "93; was heading 1966-90; was see DENTURE RETENTION 1991-92", "HN": "93; was heading 1966-90; was see DENTURE RETENTION 1991-92", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017268"}, {"RECTYPE": "D", "MH": "Dental Prosthesis Repair", "DE": "DENT PROSTHESIS REPAIR", "AQ": "AE CL EC ES HI IS MT NU PX SN ST TD VE", "ENTRY": "Repairs, Dental Prosthesis|T058|NON|EQV|NLM (1993)|920121|REPAIRS DENT PROSTHESIS|abcdefv", "MN": "E06.912.160", "MH_TH": "NLM (1993)", "ST": "T058", "AN": "coordinate with specific prosthesis ", "PI": "Denture Repair (1972-1992)", "MS": "The process of reuniting or replacing a broken or worn dental prosthesis or its part.", "OL": "use DENTURE REPAIR to search DENTAL PROSTHESIS REPAIR 1972-92 (as Prov 1972-73)", "PM": "93; was heading 1974-90; was see DENTURE REPAIR 1991-92", "HN": "93; was heading 1972-90 (Prov 1972-73); was see DENTURE REPAIR 1991-92", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017269"}, {"RECTYPE": "D", "MH": "Lipoprotein(a)", "DS": "LIPOPROTEIN A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lipoprotein a|T116|T123|NON|EQV|NLM (1993)|920203|abbcdef", "MN": "D12.776.521.400", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "PI": "Lipoproteins (1977-1992)", "MS": "A lipoprotein that resembles the LOW-DENSITY LIPOPROTEINS but with an extra protein moiety, APOPROTEIN (A) also known as APOLIPOPROTEIN (A), linked to APOLIPOPROTEIN B-100 on the LDL by one or two disulfide bonds. High plasma level of lipoprotein (a) is associated with increased risk of atherosclerotic cardiovascular disease.", "OL": "use LIPOPROTEIN(A) (NM) to search LIPOPROTEIN LP(A) 1980-92", "PM": "93; LIPOPROTEIN LP(A) was indexed under LIPOPROTEINS 1977-92", "HN": "93; was LIPOPROTEIN LP(A) (NM) 1977-92", "MR": "20060705", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017270"}, {"RECTYPE": "D", "MH": "Craniomandibular Disorders", "DE": "CMD", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Disorders, Craniomandibular", "MN": "C07.320.610.291", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Temporomandibular Joint Syndrome (1979-1992)", "MS": "Diseases or disorders of the muscles of the head and neck, with special reference to the masticatory muscles. The most notable examples are TEMPOROMANDIBULAR JOINT DISORDERS and TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME.", "OL": "use TEMPOROMANDIBULAR JOINT SYNDROME to search CRANIOMANDIBULAR DISORDERS 1991-92", "PM": "93; was see TEMPOROMANDIBULAR JOINT SYNDROME 1991-92", "HN": "93; was see TEMPOROMANDIBULAR JOINT SYNDROME 1991-92", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017271"}, {"RECTYPE": "D", "MH": "Celiprolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ST1396", "MN": "D02.455.426.559.389.703.241", "PA": "Vasodilator Agents", "MH_TH": "NLM (1993)", "ST": "T121", "N1": "Urea, N'-(3-acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethyl-", "RN": "DRB57K47QC", "RR": "G1M3398594", "PI": "Urea/analogs & derivatives (1978-1982)", "MS": "A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.", "OL": "use CELIPROLOL (NM) to search CELIPROLOL 1982-92", "PM": "93; CELIPROLOL was indexed under PROPANOLAMINES 1982-92 & under UREA/analogs & derivatives 1978-82", "HN": "93; was CELIPROLOL (NM) 1978-92", "MR": "20200527", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017272"}, {"RECTYPE": "D", "MH": "Goserelin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ICI118630", "MN": "D12.776.631.650.405.740.320.340", "PA": "Antineoplastic Agents, Hormonal", "MH_TH": "USAN (1987)", "ST": "T121", "N1": "Luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-10-deglycinamide-, 2-(aminocarbonyl)hydrazide", "RN": "0F65R8P09N", "RR": "65807-02-5 (Goserelin)", "PI": "Gonadorelin/analogs & derivatives (1979-1984)", "MS": "A synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE. Goserelin is used in treatments of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic breast cancer.", "OL": "use GOSERELIN (NM) to search ICI 118630 1980-92", "PM": "93; ICI 118630 was indexed under BUSERELIN/analogs & derivatives 1984-92 & GONADORELIN/analogs & derivatives 1979-84", "HN": "93; was ICI 118630 (NM) 1979-92", "MR": "20151123", "DA": "19920519", "DC": "1", "DX": "19930101", "UI": "D017273"}, {"RECTYPE": "D", "MH": "Nafarelin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RS94991298", "MN": "D12.776.631.650.405.740.320.580", "PA": "Fertility Agents, Female", "MH_TH": "NLM (1993)", "ST": "T121", "N1": "Luteinizing hormone-releasing factor (pig), 6-(3-(2-naphthalenyl)-D-alanine)-", "RN": "1X0094V6JV", "RR": "86220-42-0 (acetate (salt), hydrate)", "PI": "Gonadorelin/analogs & derivatives (1981-1992)", "MS": "A potent synthetic agonist of GONADOTROPIN-RELEASING HORMONE with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central PRECOCIOUS PUBERTY and ENDOMETRIOSIS.", "OL": "use NAFARELIN (NM) to search NAFARELIN 1981-92", "PM": "93; NAFARELIN was indexed under GONADORELIN/analogs & derivatives 1981-92", "HN": "93; was NAFARELIN (NM) 1981-92", "MR": "20151124", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017274"}, {"RECTYPE": "D", "MH": "Isradipine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "PN205034", "MN": "D03.383.725.203.310", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester", "RN": "YO1UK1S598", "RR": "88977-22-4 ((+-)-isomer)", "PI": "Pyridines (1987-1991)", "MS": "A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.", "OL": "use ISRADIPINE (NM) to search ISRADIPINE 1983-92", "PM": "93; ISRADIPINE was indexed under DIHYDROPYRIDINES 1991-92, PYRIDINES 1987-91, & OXADIAZOLES 1983-91", "HN": "93; was ISRADIPINE (NM) 1983-92", "MR": "20160531", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017275"}, {"RECTYPE": "D", "MH": "Friction", "AQ": "DE PH RE", "MN": "G01.374.618", "MH_TH": "NLM (1993)", "ST": "T070", "AN": "biological and non-biological application", "MS": "Surface resistance to the relative motion of one body against the rubbing, sliding, rolling, or flowing of another with which it is in contact.", "PM": "93", "HN": "93", "MR": "20080708", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017276"}, {"RECTYPE": "D", "MH": "Drug Approval", "AQ": "EC HI LJ MT OG SN", "PRINT ENTRY": "New Drug Approval|T064|NON|NRW|NLM (1993)|920122|abcdef", "ENTRY": "Processes, Drug Approval", "MN": "I01.880.604.605.250.250", "FX": "Drugs, Investigational", "MH_TH": "NLM (1993)", "ST": "T064", "AN": "by govt regulatory agency, U.S. (not restricted to FDA) or foreign", "MS": "Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017277"}, {"RECTYPE": "D", "MH": "Air Bags", "AQ": "AE CL EC ES HI LJ MI PS SD SN ST TD VE VI", "ENTRY": "Bags, Air", "MN": "J01.637.708.100", "FX": "Seat Belts", "MH_TH": "NLM (1993)", "ST": "T073", "PI": "Protective Devices (1980-1992)", "MS": "Automotive safety devices consisting of a bag designed to inflate upon collision and prevent passengers from pitching forward. (American Heritage Dictionary, 1982)", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017278"}, {"RECTYPE": "D", "MH": "Selenocysteine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "L-Alanine, 3-selenyl-|T116|T123|NON|EQV|NLM (2020)|190626|abbcdef", "ENTRY": "Selenocysteine, DL Isomer", "MN": "D12.125.166.230.700", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0CH9049VIS", "RR": "3614-08-2 (cpd w/o isomeric designation)", "PI": "Selenium (1977-1991)", "MS": "A naturally occurring amino acid in both eukaryotic and prokaryotic organisms. It is found in tRNAs and in the catalytic site of some enzymes. The genes for glutathione peroxidase and formate dehydrogenase contain the TGA codon, which codes for this amino acid.", "OL": "use SELENOCYSTEINE (NM) to search SELENOCYSTEINE 1980-92", "PM": "93; SELENOCYSTEINE was indexed under CYSTEINE/analogs & derivatives 1977-92, ORGANOSELENIUM COMPOUNDS 1991-92, & SELENIUM 1977-91", "HN": "93; was SELENOCYSTEINE (NM) 1977-92", "MR": "20190701", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017279"}, {"RECTYPE": "D", "MH": "Condoms", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Manufacture, Condom", "MN": "E07.190.270.150", "MH_TH": "NLM (1993)", "ST": "T074", "AN": "CONDOMS, FEMALE is also available", "PI": "Contraceptive Devices, Male (1975-1992)", "MS": "A sheath that is worn over the penis during sexual behavior in order to prevent pregnancy or spread of sexually transmitted disease.", "OL": "use CONTRACEPTIVE DEVICES, MALE to search CONDOMS 1988-92", "PM": "93; was see CONTRACEPTIVE DEVICES, MALE 1988-92", "HN": "93; was see CONTRACEPTIVE DEVICES, MALE 1988-92", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017280"}, {"RECTYPE": "D", "MH": "Cost of Illness", "PRINT ENTRY": "Disease Costs|T081|NON|EQV|NLM (1993)|920504|DIS COSTS|abcdefv", "ENTRY": "Sickness Costs", "MN": "N06.850.520.308.980.438.475.046", "FX": "Quality of Life", "MH_TH": "NLM (1993)", "ST": "T081", "AN": "coordinate with specific disease; if monetary cost in disease, coordinate with specific disease /econ", "PI": "specific disease (1966-1992)", "MS": "The personal cost of disease which may be economic, social, or psychological. The cost of illness may be reflected in absenteeism, productivity, response to treatment, peace of mind, or QUALITY OF LIFE. It differs from HEALTH CARE COSTS, the societal cost of providing services related to the delivery of health care.", "PM": "93", "HN": "93", "MR": "20200116", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017281"}, {"RECTYPE": "D", "MH": "Tick-Borne Diseases", "DE": "TICK BORNE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Tick-Borne Infection|T047|NON|NRW|NLM (2021)|200317|abcdef", "ENTRY": "Tick-Borne Disease", "MN": "C01.920.930", "MH_TH": "NLM (1993)", "ST": "T047", "MS": "Bacterial, viral, or parasitic diseases transmitted to humans and animals by the bite of infected ticks. The families Ixodidae and Argasidae contain many bloodsucking species that are important pests of man and domestic birds and mammals and probably exceed all other arthropods in the number and variety of disease agents they transmit. Many of the tick-borne diseases are zoonotic.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017282"}, {"RECTYPE": "D", "MH": "Neonatal Nursing", "DE": "NEONATAL NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Perinatal Nursing|T091|NON|BRD|NLM (1993)|201110|abcdef", "ENTRY": "Nursing, Neonatal|T091|NON|EQV|NLM (1993)|920124|NURS NEONATAL|abcdefv", "MN": "N02.421.533.691.600", "MH_TH": "NLM (1993)", "ST": "T091", "AN": "check also tag INFANT, NEWBORN", "PI": "Maternal-Child Nursing (1991-1992)", "MS": "The nursing specialty that deals with the care of newborn infants during the first four weeks after birth.", "OL": "use MATERNAL-CHILD NURSING to search NEONATAL NURSING & PERINATAL NURSING 1991-92", "PM": "93; NEONATAL NURSING & PERINATAL NURSING were see MATERNAL-CHILD NURSING 1991-92", "HN": "93; NEONATAL NURSING & PERINATAL NURSING were see MATERNAL-CHILD NURSING 1991-92", "MR": "20201110", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017283"}, {"RECTYPE": "D", "MH": "Polymyositis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myositis, Multiple|T047|NON|EQV|NLM (1993)|920227|abcdef", "ENTRY": "Polymyositides, Idiopathic", "MN": "C10.668.491.562.575", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Myositis (1966-1992)", "MS": "Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017285"}, {"RECTYPE": "D", "MH": "Polysomnography", "DE": "POLYSOMNOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Somnography|T060|NON|EQV|NLM (1993)|920210|SOMNOGR|abcdefv", "ENTRY": "Somnographies", "MN": "E01.370.520.625", "FX": "Actigraphy", "MH_TH": "NLM (1993)", "ST": "T060", "PI": "Sleep (1972-1992)", "MS": "Simultaneous and continuous monitoring of several parameters during sleep to study normal and abnormal sleep. The study includes monitoring of brain waves, to assess sleep stages, and other physiological variables such as breathing, eye movements, and blood oxygen levels which exhibit a disrupted pattern with sleep disturbances.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017286"}, {"RECTYPE": "D", "MH": "Ventriculoperitoneal Shunt", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Ventriculoperitoneal Shunts", "MN": "E04.525.170.850", "MH_TH": "NLM (1993)", "ST": "T061", "AN": "ventriculo- refers to cerebral ventricles; a type of csf shunt", "PI": "Cerebrospinal Fluid Shunts (1969-1992)", "MS": "Surgical creation of a communication between a cerebral ventricle and the peritoneum by means of a plastic tube to permit drainage of cerebrospinal fluid for relief of hydrocephalus. (From Dorland, 28th ed)", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017287"}, {"RECTYPE": "D", "MH": "Pain Threshold", "AQ": "CL DE EH ES PH PX RE", "ENTRY": "Thresholds, Pain", "MN": "G11.561.790.444.700", "MH_TH": "NLM (1993)", "ST": "T081", "PI": "Sensory Thresholds (1979-1992)", "MS": "Amount of stimulation required before the sensation of pain is experienced.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017288"}, {"RECTYPE": "D", "MH": "Orthodontic Appliances, Functional", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Regulator, Frankel Function", "MN": "E06.658.453.560", "MH_TH": "NLM (1993)", "ST": "T074", "PI": "Activator Appliances (1975-1992)", "MS": "Loose, usually removable intra-oral devices which alter the muscle forces against the teeth and craniofacial skeleton. These are dynamic appliances which depend on altered neuromuscular action to effect bony growth and occlusal development. They are usually used in mixed dentition to treat pediatric malocclusions. (ADA, 1992)", "OL": "use ACTIVATOR APPLIANCES to search FUNCTIONAL ORTHODONTIC APPLIANCES 1975-92", "PM": "93; was FUNCTIONAL ORTHODONIC APPLIANCES see ACTIVATOR APPLIANCES 1975-92", "HN": "93; was FUNCTIONAL ORTHODONTIC APPLIANCES see ACTIVATOR APPLIANCES 1975-92", "CATSH": "CAT LIST", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017289"}, {"RECTYPE": "D", "MH": "Menogaril", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TUT7", "MN": "D09.408.051.059.200.650.500", "PA": "Antibiotics, Antineoplastic", "MH_TH": "USAN (1986)", "ST": "T121", "N1": "2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-9,16-dione, 4-(dimethylamino)-3,4,5,6,11,12,13,14-octahydro-3,5,8,10,13-pentahydroxy-11-methoxy-6,13-dimethyl-, (2R-(2alpha,3beta,4alpha,5beta,6alpha,11alpha,13alpha))-", "RN": "8JSV4O30HQ", "RR": "71628-96-1 (Menogaril)", "PI": "Nogalamycin/analogs & derivatives (1979-1992)", "MS": "A semisynthetic anthracycline with the amino sugar on the D ring. It displays broad-spectrum antineoplastic activity against a variety of tumors.", "OL": "use MENOGARIL (NM) to search 7-O-METHYLNOGAROL 1980-93", "PM": "93; 7-O-METHYLNOGAROL was indexed under NOGALAMYCIN/analogs & derivatives 1979-92", "HN": "93; was 7-O-METHYLNOGAROL (NM) 1979-92", "MR": "20130708", "DA": "19920518", "DC": "1", "DX": "19930101", "UI": "D017290"}, {"RECTYPE": "D", "MH": "Clarithromycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TE031", "MN": "D02.540.576.500.992.100", "PA": "Protein Synthesis Inhibitors", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Erythromycin, 6-O-methyl-", "RN": "H1250JIK0A", "RR": "81103-11-9 (Clarithromycin)", "PI": "Erythromycin/analogs & derivatives (1987-1992)", "MS": "A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit PROTEIN SYNTHESIS in BACTERIA by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.", "OL": "use CLARITHROMYCIN (NM) to search CLARITHROMYCIN 1987-92", "PM": "93; CLARITHROMYCIN was indexed under ERYTHROMYCIN/analogs & derivatives 1987-92", "HN": "93; was CLARITHROMYCIN (NM) 1987-92", "MR": "20150622", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017291"}, {"RECTYPE": "D", "MH": "Doxazosin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Doxazosin Mesylate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1993)|USAN (1981)|USP (19XX)|920129|abbcdeeeef", "ENTRY": "ratio Doxazosin", "MN": "D03.633.100.786.750.200", "PA": "Antihypertensive Agents", "MH_TH": "NLM (1993)", "ST": "T121", "N1": "Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)-", "RN": "NW1291F1W8", "RR": "86P6PQK0MU", "PI": "Prazosin/analogs & derivatives (1980-1992)", "MS": "A prazosin-related compound that is a selective alpha-1-adrenergic blocker.", "OL": "use DOXAZOSIN (NM) to search UK 33274 1980-92", "PM": "93; UK 33274 was indexed under PRAZOSIN/analogs & derivatives 1980-92", "HN": "93; was UK 33274 (NM) 1980-92", "MR": "20170524", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017292"}, {"RECTYPE": "D", "MH": "Protein S", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vitamin K-Dependent Protein S|T116|T123|NON|EQV|NLM (1993)|920130|abbcdef", "ENTRY": "Vitamin K Dependent Protein S", "MN": "D23.113.725", "PA": "Anticoagulants", "EC": "deficiency:Protein S Deficiency", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "AN": "a blood protein; an anticoagulant", "PI": "Vitamin K (1979-1980)", "MS": "The vitamin K-dependent cofactor of activated PROTEIN C. Together with protein C, it inhibits the action of factors VIIIa and Va. A deficiency in protein S; (PROTEIN S DEFICIENCY); can lead to recurrent venous and arterial thrombosis.", "OL": "use PROTEIN S (NM) to search PROTEIN S, VITAMIN K-DEPENDENT 1980-92", "PM": "93; PROTEIN S, VITAMIN K-DEPENDENT was indexed under GLYCOPROTEINS 1980-92, & VITAMIN K 1979-80", "HN": "93; was PROTEIN S, VITAMIN K-DEPENDENT (NM) 1979-92", "MR": "20230316", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017293"}, {"RECTYPE": "D", "MH": "Ondansetron", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Zofran ODT|T109|TRD|NRW|NLM (2023)|220105|abcdef", "ENTRY": "SN307", "MN": "D03.633.300.148.500", "PA": "Antipruritics", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "4AF302ESOS", "RR": "NMH84OZK2B", "PI": "Imidazoles (1987-1992)", "MS": "A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.", "OL": "use ONDANSETRON (NM) to search ONDANSETRON 1987-92", "PM": "93; ONDANSETRON was indexed under IMIDAZOLES 1987-92", "HN": "93; was ONDANSETRON (NM) 1987-92", "MR": "20220714", "DA": "19920519", "DC": "1", "DX": "19930101", "UI": "D017294"}, {"RECTYPE": "D", "MH": "Bisoprolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Bisoprolol", "MN": "D02.092.063.624.698.085", "PA": "Sympatholytics", "MH_TH": "USAN (1987)", "ST": "T121", "N1": "2-Propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-", "RN": "Y41JS2NL6U", "RR": "UR59KN573L", "PI": "Propanolamines (1984-1992)", "MS": "A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.", "OL": "use BISOPROLOL (NM) to search BISOPROLOL 1984-92", "PM": "93; BISOPROLOL was indexed under PROPANOLAMINES 1984-92", "HN": "93; was BISOPROLOL (NM) 1984-92", "MR": "20160701", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017298"}, {"RECTYPE": "D", "MH": "Rod Opsins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Rod-Opsin|T116|T123|NON|EQV|NLM (1998)|961213|abbcdef", "ENTRY": "Rod Opsin", "MN": "D23.767.930.750.500", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "AN": "do not confuse entry term ROD-OPSIN with RHODOPSIN", "PI": "Eye Proteins (1973-1992)", "MS": "Photosensitive proteins expressed in the ROD PHOTORECEPTOR CELLS. They are the protein components of rod photoreceptor pigments such as RHODOPSIN.", "PM": "2009; see OPSIN 1993-2008; OPSIN was indexed under EYE PROTEINS 1973-1992", "HN": "2009 (1973)", "MR": "20080708", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017299"}, {"RECTYPE": "D", "MH": "Pipecuronium", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pipecurium|T109|T121|NON|EQV|NLM (1993)|920313|abbcdef", "ENTRY": "RGH1106", "MN": "D03.383.606.760", "PA": "Nicotinic Antagonists", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Piperazinium, 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl)", "RN": "1N3O74HM92", "RR": "R6ZTY81RE1", "PI": "Steroids (1979-1980)", "MS": "A piperazinyl androstane derivative which is a non-depolarizing neuromuscular blocking agent (NEUROMUSCULAR NONDEPOLARIZING AGENTS). It is used as a muscle relaxant during ANESTHESIA and surgical procedures.", "OL": "use PIPECURONIUM (NM) to search PIPECURIUM 1979-92", "PM": "93; PIPECURIUM was indexed under PIPERAZINES & ANDROSTANES 1980-92 & STEROIDS 1979-80", "HN": "93; was PIPECURIUM (NM) 1979-92", "MR": "20160531", "DA": "19920519", "DC": "1", "DX": "19930101", "UI": "D017300"}, {"RECTYPE": "D", "MH": "Ca(2+) Mg(2+)-ATPase", "DS": "CA 02 MG 02 ATPASE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Magnesium Adenosinetriphosphatase|T116|T126|NON|EQV|NLM (1993)|920211|abbcdef", "ENTRY": "Mg2+ Dependent ATPase", "MN": "D08.811.277.040.025.095", "FX": "Calcium-Transporting ATPases", "MH_TH": "NLM (1993)", "ST": "T126", "RN": "EC 3.6.1.-", "PI": "Magnesium (1979-1980)", "MS": "An enzyme that catalyzes the hydrolysis of ATP and is activated by millimolar concentrations of either Ca(2+) or Mg(2+). Unlike CA(2+)-TRANSPORTING ATPASE it does not require the second divalent cation for its activity, and is not sensitive to orthovanadate. (Prog Biophys Mol Biol 1988;52(1):1). A subgroup of EC 3.6.1.3.", "OL": "use CA(2+) MG(2+)-ATPASE (NM) to search CALCIUM MAGNESIUM ATPASE 1979-92, ADENOSINE TRIPHOSPHATASE, MAGNESIUM, MAGNESIUM ATPASE & ATPASE, MAGNESIUM 1986-92, & MAGNESIUM ADENOSINE TRIPHOSPHATASE 1989-92", "PM": "93; ADENOSINE TRIPHOSPHATASE, MAGNESIUM was heading 1986-92; CALCIUM MAGNESIUM ATPASE was indexed under ADENOSINE TRIPHOSPHATASE, CALCIUM & ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1986-92, ADENOSINE TRIPHOSPHATASE 1981-92, & MAGNESIUM 1979-80; MAGNESIUM ADENOSINE TRIPHOSPHATASE was see ADENOSINE TRIPHOSPHATASE 1989-92; MAGNESIUM ATPASE & ATPASE, MAGNESIUM were see ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1986-92", "HN": "93; ADENOSINE TRIPHOSPHATASE, MAGNESIUM was heading 1986-92; CALCIUM MAGNESIUM ATPASE was NM 1979-92; MAGNESIUM ADENOSINE TRIPHOSPHATASE was see ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1989-92; MAGNESIUM ATPASE & ATPASE, MAGNESIUM were see ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1986-92", "MR": "20130709", "DA": "19920629", "DC": "1", "DX": "19930101", "UI": "D017301"}, {"RECTYPE": "D", "MH": "Annexins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lipocortins|T116|T123|NON|EQV|NLM (1993)|920312|abbcdef", "ENTRY": "Lipocortin|T116|T123|NON|EQV|NLM (1993)|920313|abbcdef", "MN": "D12.776.157.125.050", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "PI": "Calcium-Binding Proteins (1984-1992)", "MS": "Family of calcium- and phospholipid-binding proteins which are structurally related and exhibit immunological cross-reactivity. Each member contains four homologous 70-kDa repeats. The annexins are differentially distributed in vertebrate tissues (and lower eukaryotes) and appear to be involved in MEMBRANE FUSION and SIGNAL TRANSDUCTION.", "PM": "1993; ANNEXIN XI was indexed under CALCIUM-BINDING PROTEINS 1992; ANNEXIN IX & ANNEXIN X were indexed under CALCIUM-BINDING PROTEINS 1990-1992; VASCULAR ANTICOAGULANT (ENDOGENOUS) was indexed under PEPTIDES 1988-1992; PLACENTAL ANTICOAGULANT PROTEINS was indexed under PREGNANCY PROTEINS 1987-1992; LIPOCORTINS was indexed under CALCIUM-BINDING PROTEINS 1985-1992; CALPACTIN & CALCIMEDINS were indexed under CALCIUM-BINDING PROTEINS 1984-1992; CALELECTRIN was indexed under CALCIUM-BINDING PROTEINS 1982-1992; CHROMOBINDINS was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 1986-2004", "HN": "1993", "MR": "20200527", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017302"}, {"RECTYPE": "D", "MH": "Annexin A5", "DS": "ANNEXIN A 05", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Placental Anticoagulant Protein I|T116|T123|NON|EQV|NLM (1993)|920212|abbcdef", "ENTRY": "Lipocortin-V|T116|T123|NON|EQV|NLM (1993)|920213|abbcdef", "MN": "D12.776.157.125.050.100", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Pregnancy Proteins (1984-1992)", "MS": "A protein of the annexin family isolated from human PLACENTA and other tissues. It inhibits cytosolic PHOSPHOLIPASE A2, and displays anticoagulant activity.", "PM": "2005; ANNEXIN V was indexed under CALCIUM-BINDING PROTEINS and PREGNANCY PROTEINS 1984-1992; ANNEXIN A5 was indexed under ANNEXINS 2003-2004 & under ANNEXIN V 2004", "HN": "2005(1984)", "MR": "20040713", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017304"}, {"RECTYPE": "D", "MH": "Annexin A1", "DS": "ANNEXIN A 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lipocortin I|T116|T123|NON|EQV|NLM (1993)|920212|abbcdef", "ENTRY": "Renocortin|T116|T123|NON|EQV|NLM (2005)|abbcde", "MN": "D12.776.157.125.050.050", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Calcium-Binding Proteins (1984-1992)", "MS": "Protein of the annexin family exhibiting lipid interaction and steroid-inducibility.", "PM": "2005; see ANNEXIN I 1993-2004; LIPOCORTIN 1 was indexed under CALCIUM-BINDING PROTEINS 1985-1992, ANNEXIN I & CALPACTIN II were indexed under CALCIUM-BINDING PROTEINS 1984-1992, ANNEXIN A1 was indexed under ANNEXIN I 2004; RENOCORTIN was indexed under GLYCOPROTEINS 1986-2004 & under PROTEINS 1983-1985; CHROMOBINDIN 9 was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 1986-2004", "HN": "2005(1993); for LIPOCORTIN I use ANNEXINS (NM) 1985-1992, for ANNEXIN I & CALPACTIN II use ANNEXINS (NM) 1984-1992", "MR": "20040707", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017305"}, {"RECTYPE": "D", "MH": "Annexin A2", "DS": "ANNEXIN A 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lipocortin II|T116|T123|NON|EQV|NLM (1993)|920212|abbcdef", "ENTRY": "P36 Annexin II", "MN": "D12.776.157.125.050.060", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Calcium-Binding Proteins (1984-1992)", "MS": "A member of the annexin family that is a substrate for a tyrosine kinase, ONCOGENE PROTEIN PP60(V-SRC). Annexin A2 occurs as a 36-KDa monomer and in a 90-KDa complex containing two subunits of annexin A2 and two subunits of S100 FAMILY PROTEIN P11. The monomeric form of annexin A2 was formerly referred to as calpactin I heavy chain.", "PM": "2005; use ANNEXIN II 1993-2004; ANNEXIN II & CALPACTIN I were indexed under CALCIUM-BINDING PROTEINS 1984-1992, ANNEXIN A2 was indexed under ANNEXIN II 2004", "HN": "2005(1993) for ANNEXIN II & CALPACTIN I use ANNEXINS 1984-1992", "MR": "20050722", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017306"}, {"RECTYPE": "D", "MH": "Xamoterol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Xamoterol", "MN": "D03.383.533.640.950", "PA": "Adrenergic beta-1 Receptor Agonists", "MH_TH": "USAN (1984)", "ST": "T121", "N1": "4-Morpholinecarboxamide, N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-, (+-)-", "RN": "7HE0JQL703", "RR": "N87007N668", "PI": "Propanolamines (1984-1992)", "MS": "A phenoxypropanolamine derivative that is a selective beta-1-adrenergic agonist.", "OL": "use XAMOTEROL (NM) to search XAMOTEROL 1984-92", "PM": "93; XAMOTEROL was indexed under PROPANOLAMINES 1984-92", "HN": "93; was XAMOTEROL (NM) 1984-92", "MR": "20160601", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017307"}, {"RECTYPE": "D", "MH": "Etodolac", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "AY 24236", "MN": "D03.633.100.473.404.200", "PA": "Cyclooxygenase 2 Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-", "RN": "2M36281008", "RR": "87249-11-4", "PI": "Indoleacetic Acids (1976-1992)", "MS": "A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).", "PM": "1993; ETODOLAC was indexed under INDOLEACETIC ACIDS 1989-1992 and 1976-79, and under ACETIC ACIDS 1976-1988", "HN": "1993 (1976)", "MR": "20180410", "DA": "19920508", "DC": "1", "DX": "19930101", "UI": "D017308"}, {"RECTYPE": "D", "MH": "Annexin A7", "DS": "ANNEXIN A 07", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Annexin VII|T116|T123|NON|EQV|NLM (1993)|990101|abbcdef", "ENTRY": "Synexin|T116|T123|NON|EQV|NLM (1993)|920213|abbcdef", "MN": "D12.776.157.125.050.120", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Proteins (1978-1992)", "MS": "An annexin family member that plays a role in MEMBRANE FUSION and signaling via VOLTAGE-DEPENDENT CALCIUM CHANNELS.", "PM": "2005; see ANNEXIN VII 1993-2004; SYNEXIN was indexed under PROTEINS 1978-1992; ANNEXIN A7 was indexed under ANNEXIN VIII 2004", "HN": "2005(1978)", "MR": "20040707", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017310"}, {"RECTYPE": "D", "MH": "Amlodipine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Norvasc|T109|T121|TRD|NRW|AU|CA|DE|FR|NL|US|920213|abbcdeeeeeef", "MN": "D03.383.725.203.065", "PA": "Vasodilator Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester", "RN": "1J444QC288", "RR": "CQ27G2BZJM", "PI": "Nifedipine/analogs & derivatives (1986-1992)", "MS": "A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.", "OL": "use AMLODIPINE (NM) to search AMLODIPINE 1986-92", "PM": "93; AMLODIPINE was indexed under NIFEDIPINE/analogs & derivatives 1986-92", "HN": "93; was AMLODIPINE (NM) 1986-92", "MR": "20170524", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017311"}, {"RECTYPE": "D", "MH": "Toremifene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "FC1157a", "MN": "D02.455.426.559.389.150.700.900.900", "PA": "Selective Estrogen Receptor Modulators", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "Ethanamine, 2-(4-(4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-", "RN": "7NFE54O27T", "RR": "89778-29-0 ((E)-isomer)", "PI": "Tamoxifen/analogs & derivatives (1985-1992)", "MS": "A first generation selective estrogen receptor modulator (SERM). Like TAMOXIFEN, it is an estrogen agonist for bone tissue and cholesterol metabolism but is antagonistic on mammary and uterine tissue.", "OL": "use TOREMIFENE (NM) to search TOREMIFENE 1985-92", "PM": "93; TOREMIFENE was indexed under TAMOXIFEN/analogs & derivatives 1985-92", "HN": "93; was TOREMIFENE (NM) 1985-92", "MR": "20130708", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017312"}, {"RECTYPE": "D", "MH": "Fenretinide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "4-HPR|T109|T121|ABB|EQV|NLM (1993)|920214|HPR 04|abbcdefs", "ENTRY": "MCNR1967", "MN": "D23.767.261.700.270", "PA": "Antineoplastic Agents", "MH_TH": "USAN (1984)", "ST": "T121", "N1": "Retinamide, N-(4-hydroxyphenyl)-", "RN": "187EJ7QEXL", "RR": "75686-07-6 (13-cis-isomer)", "PI": "Tretinoin/analogs & derivatives (1979-1992)", "MS": "A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.", "OL": "use FENRETINIDE (NM) to search FENRETINIDE 1979-92", "PM": "93; FENRETINIDE was indexed under TRETINOIN/analogs & derivatives 1979-92", "HN": "93; was FENRETINIDE (NM) 1979-92", "MR": "20130708", "DA": "19920519", "DC": "1", "DX": "19930101", "UI": "D017313"}, {"RECTYPE": "D", "MH": "Annexin A4", "DS": "ANNEXIN A 04", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Placental Anticoagulant Protein II|T116|T123|NON|EQV|NLM (1993)|920214|abbcdef", "ENTRY": "Calelectrin 32 kDa", "MN": "D12.776.157.125.050.080", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Calcium-Binding Proteins (1982-1992)", "MS": "Protein of the annexin family originally isolated from the electric organ of the electric ray Torpedo marmorata. It has been found in a wide range of mammalian tissue where it is localized to the apical membrane of polarized EPITHELIAL CELLS.", "PM": "1993; ANNEXIN IV were indexed under PREGNANCY PROTEINS 1987-1992; LIPOCORTIN IV was indexed under CALCIUM-BINDING PROTEINS 1982-1992; ANNEXIN A4 was indexed under ANNEXIN IV 2004", "HN": "2005(1993); for ANNEXIN IV use ANNEXINS 1987-1992", "MR": "20040707", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017314"}, {"RECTYPE": "D", "MH": "Cilazapril", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro312848", "MN": "D03.383.710.100", "PA": "Antihypertensive Agents", "MH_TH": "USAN (1986)", "ST": "T121", "N1": "6H-Pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, 9-(((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)octahydro-10-oxo-, (1S,9S)-", "RN": "19KW7PI29F", "RR": "92077-78-6 (Cilazapril)", "PI": "Pyridazines (1984-1992)", "MS": "One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors) used for hypertension. It is a prodrug that is hydrolyzed after absorption to its main metabolite cilazaprilat.", "PM": "1993; CILAZAPRIL was indexed under PYRIDAZINES 1984-1992", "HN": "1993 (1984)", "MR": "20180228", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017315"}, {"RECTYPE": "D", "MH": "Fadrozole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Fadrozole", "MN": "D03.383.129.308.270", "PA": "Estrogen Antagonists", "MH_TH": "NLM (1993)", "ST": "T121", "N1": "Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-", "RN": "H3988M64PU", "RR": "H0Q44H4ECQ", "PI": "Nitriles (1988-1992)", "MS": "A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.", "PM": "1993; CGS 16949A was indexed under IMIDAZOLES & NITRILES 1988-1992; CGS 020286A was indexed under FADROZOLE 2012, and under IMIDAZOLES & IMIDAZOLES 2010-2011", "HN": "1993", "MR": "20160701", "DA": "19920519", "DC": "1", "DX": "19930101", "UI": "D017316"}, {"RECTYPE": "D", "MH": "Annexin A6", "DS": "ANNEXIN A 06", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lipocortin VI|T116|T123|NON|EQV|NLM (1993)|920214|abbcdef", "ENTRY": "Calelectrin 67 kDa", "MN": "D12.776.157.125.050.110", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Calcium-Binding Proteins (1984-1992)", "MS": "Protein of the annexin family with a probable role in exocytotic and endocytotic membrane events.", "PM": "2005; ANNEXIN VI was indexed under CALCIUM-BINDING PROTEINS 1990-1992; CALPHOBINDIN II was indexed under PREGNANCY PROTEINS 1987-1992; CALCIUM AND PHOSPHOLIPID-BINDING PROTEIN P68 was indexed under BINDING PROTEINS & CALCIUM 1979-1980; CALCIUM-BINDING PROTEINS 1981-2004 & ANNEXIN VI 2004", "HN": "2005(1987)", "MR": "20040707", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017317"}, {"RECTYPE": "D", "MH": "Annexin A3", "DS": "ANNEXIN A 03", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Placental Anticoagulant Protein III|T116|T126|NON|EQV|NLM (1993)|920218|abbcdef", "MN": "D12.776.157.125.050.070", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 3.1.4.43", "PI": "Calcium-Binding Proteins (1991-1992)", "MS": "A protein of the annexin family that catalyzes the conversion of 1-D-inositol 1,2-cyclic phosphate and water to 1-D-myo-inositol 1-phosphate.", "PM": "2005; ANNEXIN III was indexed under CALCIUM-BINDING PROTEINS 1991-1992; ANNEXIN A3 was indexed under ANNEXIN III 2004", "HN": "2005(1991)", "MR": "20130709", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017318"}, {"RECTYPE": "D", "MH": "Photosensitizing Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Photosensitizing Agent|T121|NON|EQV|NLM (2022)|201022|abcdef", "ENTRY": "Effects, Photosensitizing", "MN": "D27.505.954.600.710", "FX": "Photochemotherapy", "MH_TH": "NLM (1993)", "ST": "T121", "RN": "0", "AN": "note entry term PHOTOSENSITIZING EFFECT: use only for the photosensitizing effect of a chemical substance", "MS": "Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.", "PM": "93", "HN": "93", "MR": "20210630", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017319"}, {"RECTYPE": "D", "MH": "HIV Protease Inhibitors", "DE": "HIV PROTEASE INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "HIV Protease Inhibitor|T121|NON|EQV|NLM (2021)|200325|abcdef", "ENTRY": "Protease Inhibitors, HIV", "MN": "D27.505.954.122.388.769.500", "MH_TH": "NLM (1993)", "ST": "T121", "RN": "0", "PI": "HIV Protease/antagonists & inhibitors (1990-1992)", "MS": "Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly.", "PM": "93", "HN": "93", "MR": "20220413", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017320"}, {"RECTYPE": "D", "MH": "Clinical Trials, Phase I as Topic", "AQ": "CL EC ES HI IS LJ MT PX SN ST VE", "PRINT ENTRY": "Phase I Clinical Trials|T062|NON|EQV|NLM (1993)|920219|PHASE I CLIN TRIALS|abcdefv", "ENTRY": "Trials, Human Microdosing", "MN": "N06.850.520.450.250.250.200", "FX": "Nontherapeutic Human Experimentation", "MH_TH": "NLM (2008)", "ST": "T062", "AN": "for general design, methodology, economics, etc. of phase I clinical trials; a different heading CLINICAL TRIAL, PHASE I is used for reports of a specific phase I clinical trial", "PI": "Drug Evaluation (1980-1992)", "MS": "Works about studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries.", "PM": "2008; see CLINICAL TRIALS, PHASE I 1993-2007; for DRUG EVALUATION, FDA PHASE I see DRUG EVALUATION 1980-1992; for EVALUATION STUDIES, FDA PHASE I see DRUG EVALUATION 1982-1992", "HN": "2008(1993)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017321"}, {"RECTYPE": "D", "MH": "Clinical Trials, Phase II as Topic", "AQ": "CL EC ES HI IS LJ MT PX SN ST VE", "ENTRY": "Evaluation Studies, FDA Phase II as Topic|T062|T064|NON|NRW|NLM (2008)|070625|abbcdef", "MN": "N06.850.520.450.250.250.210", "MH_TH": "NLM (2008)", "ST": "T064", "AN": "for general design, methodology, economics, etc. of phase II clinical trials; a different heading CLINICAL TRIAL, PHASE II is used for reports of a specific phase II clinical trial", "PI": "Drug Evaluation (1980-1992)", "MS": "Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.", "PM": "2008; see CLINICAL TRIALS, PHASE II 1993-2007; for DRUG EVALUATION, FDA PHASE II see DRUG EVALUATION 1980-1992; for EVALUATION STUDIES, FDA PHASE II see DRUG EVALUATION 1982-1992", "HN": "2008(1993)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017322"}, {"RECTYPE": "D", "MH": "Dihematoporphyrin Ether", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Porfimer|T109|T121|NON|EQV|NLM (1997)|960131|abbcdef", "ENTRY": "Ether, Dihematoporphyrin", "MN": "D23.767.727.462.400.200", "PA": "Photosensitizing Agents", "FX": "Hematoporphyrin Photoradiation", "MH_TH": "NLM (1993)", "ST": "T121", "N1": "21H,23H-Porphine-2,18-dipropanoic acid, 7-(1-(1-(8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21H,23H-porphin-2-yl)ethoxy)ethyl)-12-(1-hydroxyethyl)-3,8,13,17-tetramethyl-", "RN": "97067-70-4", "RR": "87806-31-3 (porfimer sodium)", "PI": "Hematoporphyrins (1985-1992)", "MS": "The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States.", "OL": "use DIHEMATOPORPHYRIN ETHER (NM) to search DIHEMATOPORPHYRIN ETHER 1985-92", "PM": "93; DIHEMATOPORPHYRIN ETHER was indexed under HEMATOPORPHYRINS 1985-92", "HN": "93; was DIHEMATOPORPHYRIN ETHER (NM) 1985-92", "MR": "20160531", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017323"}, {"RECTYPE": "D", "MH": "Hematoporphyrin Derivative", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hematoporphyrin D|T109|T121|EQV|NLM (1993)|920313|abbdef", "ENTRY": "YHPD, Hematoporphyrin", "MN": "D23.767.727.462.400", "PA": "Photosensitizing Agents", "FX": "Hematoporphyrin Photoradiation", "MH_TH": "NLM (1993)", "ST": "T121", "N1": "Hematoporphyrin D", "RN": "68335-15-9", "PI": "Hematoporphyrins (1980-1992)", "MS": "A complex mixture of monomeric and aggregated porphyrins used in the photodynamic therapy of tumors (HEMATOPORPHYRIN PHOTORADIATION). A purified component of this mixture is known as DIHEMATOPORPHYRIN ETHER.", "OL": "use HEMATOPORPHYRIN DERIVATIVE (NM) to search HEMATOPORPHYRIN D 1981-92", "PM": "93; HEMATOPORPHYRIN D was indexed under HEMATOPORPHYRINS 1981-92", "HN": "93; was HEMATOPORPHYRIN D (NM) 1981-92", "MR": "20160531", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017324"}, {"RECTYPE": "D", "MH": "Hepatitis B Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Hepatitis B", "MN": "D20.215.894.899.955.400", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1982-1984)", "MS": "Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced.", "OL": "use HEPATITIS B VACCINES (NM) to search HEPATITIS B VACCINE 1982-92", "PM": "93; HEPATITIS B VACCINE was indexed under VIRAL HEPATITIS VACCINES 1985-92 & VIRAL VACCINES 1982-84", "HN": "93; was HEPATITIS B VACCINE (NM) 1982-92", "MR": "20050630", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017325"}, {"RECTYPE": "D", "MH": "Clinical Trials, Phase III as Topic", "AQ": "CL EC ES HI IS LJ MT PX SN ST VE", "ENTRY": "Evaluation Studies, FDA Phase III as Topic|T062|T064|NON|NRW|NLM (2008)|070625|abbcdef", "MN": "N06.850.520.450.250.250.220", "MH_TH": "NLM (2008)", "ST": "T062", "AN": "for general design, methodology, economics, etc. of phase III clinical trials; a different heading CLINICAL TRIAL, PHASE III is used for reports of a specific phase III clinical trial", "PI": "Clinical Trials (1980-1992)", "MS": "Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.", "PM": "2008; see CLINICAL TRIALS, PHASE III 1993-2007; for DRUG EVALUATION, FDA PHASE III see CLINICAL TRIALS 1980-1992; for EVALUATION STUDIES, FDA PHASE III see CLINICAL TRIALS 1982-1992", "HN": "2008(1993)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017326"}, {"RECTYPE": "D", "MH": "Clinical Trials, Phase IV as Topic", "AQ": "CL EC ES HI IS LJ MT PX SN ST VE", "ENTRY": "Evaluation Studies, FDA Phase IV as Topic|T062|T064|NON|REL|NLM (2008)|070625|abbcdef", "MN": "N06.850.520.450.250.250.230", "FX": "Drug-Related Side Effects and Adverse Reactions", "MH_TH": "NLM (2008)", "ST": "T062", "AN": "for general design, methodology, economics, etc. of phase IV clinical trials; a different heading CLINICAL TRIAL, PHASE IV is used for reports of a specific phase IV clinical trial", "PI": "Clinical Trials (1980-1992)", "MS": "Works about planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries.", "PM": "2008; see CLINICAL TRIALS, PHASE IV 1993-2007; for DRUG EVALUATION, FDA PHASE IV see CLINICAL TRIALS 1981-1992; for EVALUATION STUDIES, FDA PHASE IV see CLINICAL TRIALS 1982-1992", "HN": "2008(1993)", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017327"}, {"RECTYPE": "D", "MH": "Fosinopril", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fosenopril|T109|T116|T121|NON|EQV|NLM (1993)|920220|abbbcdef", "ENTRY": "Sodium, Fosinopril", "MN": "D12.125.072.401.623.374", "PA": "Antihypertensive Agents", "MH_TH": "INN (19XX)", "ST": "T121", "N1": "L-Proline, 4-cyclohexyl-1-(((2-methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl)acetyl)-, (1(S*(R*)),2alpha,4beta)-", "RN": "R43D2573WO", "RR": "NW2RTH6T2N", "PI": "Proline/analogs & derivatives (1985-1992)", "MS": "A phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat.", "OL": "use FOSINOPRIL (NM) to search FOSENOPRIL 1985-92", "PM": "93; FOSENOPRIL was indexed under PROLINE/analogs & derivatives 1985-92", "HN": "93; was FOSENOPRIL (NM) 1985-92", "MR": "20160701", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017328"}, {"RECTYPE": "D", "MH": "Triptorelin Pamoate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Triptorelin|T116|T121|T125|NON|NRW|INN (19XX)|NLM (1993)|USAN (1987)|990101|abbbcdeeef", "ENTRY": "Wy42462", "MN": "D12.776.631.650.405.740.320.790", "PA": "Luteolytic Agents", "MH_TH": "USAN (19XX)", "ST": "T125", "N1": "5-oxo-Pro-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2", "RN": "08AN7WA2G0", "RR": "57773-63-4", "PI": "Gonadorelin/analogs & derivatives (1978-1992)", "MS": "A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE with D-tryptophan substitution at residue 6.", "PM": "1993; TRIPTORELIN was indexed under GONADORELIN/analogs & derivatives 1978-1992", "HN": "1993; use TRIPTORELIN (NM) 1980-1992; for LHRH, TRP(6)- use TRIPTORELIN (NM) 1995-1999", "MR": "20180612", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017329"}, {"RECTYPE": "D", "MH": "Remoxipride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, Remoxipride", "MN": "D02.455.426.559.389.127.150.500", "PA": "Dopamine Antagonists", "MH_TH": "USAN (1985)", "ST": "T121", "N1": "Benzamide, 3-bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxy-, (S)-", "RN": "0223RD59PE", "RR": "QS4S72U30K", "PI": "Benzamides (1984-1992)", "MS": "An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia.", "OL": "use REMOXIPRIDE (NM) to search REMOXIPRIDE 1984-92", "PM": "93; REMOXIPRIDE was indexed under BENZAMIDES 1984-92", "HN": "93; was REMOXIPRIDE (NM) 1984-92", "MR": "20130708", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017330"}, {"RECTYPE": "D", "MH": "Cetirizine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aller-Tec|T109|T121|TRD|NRW|NLM (2023)|220411|abbcdef", "ENTRY": "P071", "MN": "D03.383.606.515.200", "PA": "Histamine H1 Antagonists, Non-Sedating", "MH_TH": "NLM (1993)", "ST": "T121", "N1": "Acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-", "RN": "YO7261ME24", "RR": "83881-52-1 (di-HCl)", "PI": "Hydroxyzine/analogs & derivatives (1987-1992)", "MS": "A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.", "OL": "use CETIRIZINE (NM) to search CETIRIZINE 1987-92", "PM": "93; CETIRIZINE was indexed under HYDROXYZINE/analogs & derivatives 1987-92", "HN": "93; was CETIRIZINE (NM) 1987-92", "MR": "20220523", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017332"}, {"RECTYPE": "D", "MH": "Teicoplanin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Teichomycin|T116|T195|NON|EQV|NLM (1993)|920221|abbcdef", "ENTRY": "Teichomycin A2|T116|T195|NRW|NLM (1999)|990913|abbdef", "MN": "D12.644.233.352.500", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (1986)", "ST": "T195", "N1": "Teicoplanin", "RN": "61036-62-2", "RR": "61036-64-4 (teichomycin A2)", "PI": "Glycopeptides (1978-1992)", "MS": "Lipoglycopeptide antibiotic from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety.", "OL": "use TEICOPLANIN (NM) to search TEICHOMYCINS 1980-92", "PM": "93; TEICOMYCINS was indexed under GLYCOPEPTIDES 1978-92", "HN": "93; was TEICHOMYCINS (NM) 1978-92", "MR": "20180308", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017334"}, {"RECTYPE": "D", "MH": "Enoximone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MDL19,438", "MN": "D03.383.129.308.253", "PA": "Vasodilator Agents", "MH_TH": "USAN (1986)", "ST": "T121", "N1": "2H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-(4-(methylthio)benzoyl)-", "RN": "C7Z4ITI7L7", "RR": "77671-31-9 (Enoximone)", "PI": "Imidazoles (1982-1992)", "MS": "A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with CONGESTIVE HEART FAILURE.", "OL": "use ENOXIMONE (NM) to search MDL 17043 1982-92", "PM": "93; MDL 17043 was indexed under IMIDAZOLES 1982-92", "HN": "93; was MDL 17043 (NM) 1982-92", "MR": "20170524", "DA": "19920508", "DC": "1", "DX": "19930101", "UI": "D017335"}, {"RECTYPE": "D", "MH": "Loratadine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sch29851", "MN": "D04.615.181.384.340.500", "PA": "Histamine H1 Antagonists, Non-Sedating", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-, ethyl ester", "RN": "7AJO3BO7QN", "RR": "79794-75-5 (Loratadine)", "PI": "Piperidines (1984-1986)", "MS": "A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.", "OL": "use LORATADINE (NM) to search LORATADINE 1984-92", "PM": "93; LORATADINE was indexed under CYPROHEPTADINE/analogs & derivatives 1976-92 & PIPERIDINES 1984-86", "HN": "93; was LORATADINE (NM) 1984-92", "MR": "20170524", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017336"}, {"RECTYPE": "D", "MH": "Sermorelin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Somatotropin-Releasing-Hormone(1-29)Amide|T116|T121|T125|NON|EQV|NLM (1993)|920224|SOMATOTROPIN RELEASING HORMONE AMIDE 001 029|abbbcdefs", "ENTRY": "hGHRH(1-29)NH2|T116|T121|T125|EQV|NLM (1993)|920224|abbbdef", "MN": "D12.776.631.650.405.740.860.780", "MH_TH": "NLM (1993)", "ST": "T125", "N1": "Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2", "RN": "86168-78-7", "RR": "114466-38-5 (acetate)", "PI": "Somatotropin-Releasing Hormone/analogs & derivatives (1984-1992)", "MS": "The biologically active fragment of human growth hormone-releasing factor, consisting of GHRH(1-29)-amide. This N-terminal sequence is identical in several mammalian species, such as human, pig, and cattle. It is used to diagnose or treat patients with GROWTH HORMONE deficiency.", "OL": "use SERMORELIN (NM) to search SOMATOTROPIN RELEASING HORMONE(1-29)AMIDE 1984-92", "PM": "93; SOMATOTROPIN RELEASING HORMONE(1-29)AMIDE was indexed under SOMATOTROPIN-RELEASING HORMONE/analogs & derivatives & PEPTIDE FRAGMENTS 1984-92", "HN": "93; was SOMATOTROPIN RELEASING HORMONE(1-29)AMIDE (NM) 1984-92", "MR": "20160701", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017337"}, {"RECTYPE": "D", "MH": "Cladribine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2-Chlorodeoxyadenosine|T114|T121|NON|EQV|FDA SRS (2014)|NLM (1995)|931117|CHLORODEOXYADENOSINE 02|abbcdeefs", "ENTRY": "Leustatin|T114|T121|TRD|NRW|NLM (1998)|961206|abbcdef", "MN": "D13.570.800.096.300.200", "PA": "Immunosuppressive Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Adenosine, 2-chloro-2'-deoxy-", "RN": "47M74X9YT5", "RR": "4291-63-8 (Cladribine)", "PI": "Deoxyadenosines (1986-1992)", "MS": "An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia.", "OL": "use CLADRIBINE to search 2-CHLORODEOXYADENOSINE 1993-94; use CLADRIBINE (NM) to search 2-CHLORO-2'-DEOXYADENOSINE 1986-92", "PM": "95; was 2-CHLORODEOXYADENOSINE 1993-94; 2-CHLORO-2'-DEOXYADENOSINE was indexed under 2-CHLOROADENOSINE/analogs & derivatives & DEOXYADENOSINES 1986-92", "HN": "95; was 2-CHLORODEOXYADENOSINE 1993-94; was 2-CHLORO-2'-DEOXYADENOSINE (NM) 1986-92", "MR": "20160528", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017338"}, {"RECTYPE": "D", "MH": "Etanidazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SR2508", "MN": "D03.383.129.308.658.250", "PA": "Radiation-Sensitizing Agents", "MH_TH": "USAN (1987)", "ST": "T121", "N1": "1H-Imidazole-1-acetamide, N-(2-hydroxyethyl)-2-nitro-", "RN": "30DKA3Q1HL", "RR": "22668-01-5 (Etanidazole)", "PI": "Nitroimidazoles (1981-1992)", "MS": "A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.", "OL": "use ETANIDAZOLE (NM) to search ETANIDAZOLE 1981-92", "PM": "93; ETANIDAZOLE was indexed under NITROIMIDAZOLES 1981-92", "HN": "93; was ETANIDAZOLE (NM) 1981-92", "MR": "20160531", "DA": "19920508", "DC": "1", "DX": "19930101", "UI": "D017341"}, {"RECTYPE": "D", "MH": "Genes, Plant", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Plant Genes|T028|NON|EQV|NLM (1993)|920225|abcdef", "ENTRY": "Plant Gene", "MN": "G05.360.340.365.500", "FX": "Genome, Plant", "MH_TH": "NLM (1993)", "ST": "T028", "AN": "coordinate IM with specific plant term /genet (IM)", "PI": "specific plant (1966-1992)", "MS": "The functional hereditary units of PLANTS.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017343"}, {"RECTYPE": "D", "MH": "Genes, Insect", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Insect Genes|T028|NON|EQV|NLM (1993)|920225|abcdef", "ENTRY": "Insect Gene", "MN": "G05.360.340.357.500", "FX": "Genome, Insect", "MH_TH": "NLM (1993)", "ST": "T028", "AN": "coordinate IM with specific insect /genet (IM)", "PI": "specific insect (1966-1992)", "MS": "The functional hereditary units of INSECTS.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017344"}, {"RECTYPE": "D", "MH": "Protein Serine-Threonine Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serine-Threonine Protein Kinases|T116|T126|NON|EQV|NLM (1993)|920325|abbcdef", "ENTRY": "Serine Threonine Protein Kinases", "MN": "D12.776.476.563", "MH_TH": "NLM (2022)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Protein Kinases (1983-1992)", "MS": "A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors.", "PM": "2022; see PROTEIN-SERINE-THREONINE KINASES 1993-2021; SERINE KINASE was indexed under PROTEIN KINASES 1985-1992; PROTEIN-THREONINE KINASE was indexed under PROTEIN KINASES 1983-1992", "HN": "2022(1993)", "MR": "20210627", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017346"}, {"RECTYPE": "D", "MH": "Brucella melitensis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.070.100.500", "MH_TH": "NLM (1993)", "ST": "T007", "RN": "txid29459", "AN": "note specific biovars are X refs to other species; infection: coord IM with BRUCELLOSIS (IM)", "PI": "Brucella (1966-1992)", "MS": "A species of the genus BRUCELLA whose natural hosts are sheep and goats. Other mammals, including humans, may be infected. In general, these organisms tend to be more virulent for laboratory animals than BRUCELLA ABORTUS and may cause fatal infections.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017347"}, {"RECTYPE": "D", "MH": "Microscopy, Electron, Scanning Transmission", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Scanning Transmission Electron Microscopy|T059|NON|EQV|NLM (1993)|920225|abcdef", "MN": "E05.595.402.580.480", "MH_TH": "NLM (1993)", "ST": "T059", "AN": "do not confuse with MICROSCOPY, ELECTRON, SCANNING nor with MICROSCOPY, ELECTRON, TRANSMISSION; since the techniques have different applications, do not interpret: if in doubt, use words of author", "PI": "Microscopy, Electron, Scanning (1969-1992)", "MS": "A type of TRANSMISSION ELECTRON MICROSCOPY in which the object is examined directly by an extremely narrow electron beam scanning the specimen point-by-point and using the reactions of the electrons that are transmitted through the specimen to create the image. It should not be confused with SCANNING ELECTRON MICROSCOPY.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19920518", "DC": "1", "DX": "19930101", "UI": "D017348"}, {"RECTYPE": "D", "MH": "N-Acetylhexosaminyltransferases", "DE": "HEXNAC TRANSFERASES", "DS": "ACETYLHEXOSAMINYLTRANSFERASES N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transferases, N-Acetylhexosamine", "MN": "D08.811.913.400.100", "MH_TH": "NLM (1993)", "ST": "T126", "RN": "EC 2.4.1.-", "PI": "Hexosyltransferases (1972-1992)", "MS": "Enzymes that catalyze the transfer of N-acetylhexosaminyl groups to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.", "PM": "93", "HN": "93", "MR": "20060705", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017349"}, {"RECTYPE": "D", "MH": "N-Acetylgalactosaminyltransferases", "DE": "GALNAC TRANSFERASES", "DS": "ACETYLGALACTOSAMINYLTRANSFERASES N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transferases, N-Acetylgalactosamine", "MN": "D08.811.913.400.100.200", "MH_TH": "NLM (1993)", "ST": "T126", "RN": "EC 2.4.1.-", "PI": "Galactosyltransferases (1976-1992)", "MS": "Enzymes that catalyze the transfer of N-acetylgalactosamine from a nucleoside diphosphate N-acetylgalactosamine to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.", "PM": "93", "HN": "93", "MR": "20030709", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017350"}, {"RECTYPE": "D", "MH": "N-Acetylglucosaminyltransferases", "DE": "GLCNAC TRANSFERASES", "DS": "ACETYLGLUCOSAMINYLTRANSFERASES N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transferases, N-Acetylglucosamine", "MN": "D08.811.913.400.100.250", "MH_TH": "NLM (1993)", "ST": "T126", "RN": "EC 2.4.1.-", "PI": "Glucosyltransferases (1966-1992)", "MS": "Enzymes that catalyze the transfer of N-acetylglucosamine from a nucleoside diphosphate N-acetylglucosamine to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.", "PM": "93", "HN": "93", "MR": "20030709", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017351"}, {"RECTYPE": "D", "MH": "Echo-Planar Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Magnetic Resonance Imaging, Echo-Planar|T060|NON|EQV|NLM (1996)|941109|MRI ECHO PLANAR|abcdefv", "ENTRY": "Tomography, Echoplanar MR", "MN": "E01.370.350.825.500.200", "MH_TH": "NLM (1993)", "ST": "T060", "AN": "a type of magnetic resonance imaging; for coord see note on MAGNETIC RESONANCE IMAGING", "PI": "Nuclear Magnetic Resonance (1984-1987)", "MS": "A type of MAGNETIC RESONANCE IMAGING that uses only one nuclear spin excitation per image and therefore can obtain images in a fraction of a second rather than the minutes required in traditional MRI techniques. It is used in a variety of medical and scientific applications.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19920508", "DC": "1", "DX": "19930101", "UI": "D017352"}, {"RECTYPE": "D", "MH": "Gene Deletion", "ENTRY": "Gene Deletions", "MN": "G05.558.800.320", "FX": "Chromosome Deletion", "MH_TH": "NLM (1993)", "ST": "T045", "PI": "Mutation (1972-1975)", "MS": "A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus.", "OL": "use CHROMOSOME DELETION to search GENE DELETION 1984-92", "PM": "93; was see CHROMOSOME DELETION 1984-92", "HN": "93; was see CHROMOSOME DELETION 1984-92", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017353"}, {"RECTYPE": "D", "MH": "Point Mutation", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Mutation, Point|T045|NON|EQV|NLM (1993)|920226|abcdef", "ENTRY": "Point Mutations", "MN": "G05.365.590.675", "FX": "Mutation, Missense", "MH_TH": "NLM (1993)", "ST": "T045", "AN": "see MUTATION for correct use of /drug eff & /rad eff", "PI": "Mutation (1966-1992)", "MS": "A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017354"}, {"RECTYPE": "D", "MH": "Zymomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Zymomonas mobilis|T007|NON|NRW|NLM (1993)|920226|abcdef", "MN": "B03.660.050.800.990", "MH_TH": "NLM (1993)", "ST": "T007", "RN": "txid541", "RR": "txid542", "AN": "non-pathogenic but spoils fermented beverages", "PI": "Gram-Negative Bacteria (1984-1992)", "MS": "A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that is not known to be pathogenic for man, animals, or plants. Its organisms are spoilers for beers and ciders and in sweet English ciders they are the causative agents of a secondary fermentation known as \"cider sickness.\" The species Z. mobilis is used for experiments in molecular genetic studies.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017355"}, {"RECTYPE": "D", "MH": "Synchrotrons", "AQ": "CL EC HI IS LJ SD SN ST", "ENTRY": "Synchrotron", "MN": "E07.710.680.700", "MH_TH": "NLM (1993)", "ST": "T073", "AN": "particle accelerators; do not confuse with SYNCHROCYCLOTRONS see CYCLOTRONS", "PI": "Particle Accelerators (1978-1992)", "MS": "Devices for accelerating protons or electrons in closed orbits where the accelerating voltage and magnetic field strength varies (the accelerating voltage is held constant for electrons) in order to keep the orbit radius constant.", "OL": "use PARTICLE ACCELERATORS to search SYNCHROTRONS 1978-92", "PM": "93; was see PARTICLE ACCELERATORS 1978-92", "HN": "93; was see PARTICLE ACCELERATORS 1978-92", "MR": "20180629", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017356"}, {"RECTYPE": "D", "MH": "Cyclotrons", "AQ": "CL EC HI IS LJ SD SN ST", "PRINT ENTRY": "Synchrocyclotrons|T073|NON|NRW|NLM (1993)|920226|abcdef", "ENTRY": "Synchrocyclotron", "MN": "E07.710.680.250", "MH_TH": "NLM (1993)", "ST": "T073", "AN": "particle accelerators; do not confuse entry term SYNCHROCYCLOTRONS with SYNCHROTRONS", "PI": "Particle Accelerators (1978-1992)", "MS": "Devices for accelerating charged particles in a spiral path by a constant-frequency alternating electric field. This electric field is synchronized with the movement of the particles in a constant magnetic field.", "OL": "use PARTICLE ACCELERATORS to search CYCLOTRONS & SYNCHROCYCLOTRONS 1978-92", "PM": "93; was see PARTICLE ACCELERATORS 1978-92; SYNCHROCYCLOTRONS was see PARTICLE ACCELERATORS 1978-92", "HN": "93; was see PARTICLE ACCELERATORS 1978-92; SYNCHROCYCLOTRONS was see PARTICLE ACCELERATORS 1978-92", "MR": "20180629", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017357"}, {"RECTYPE": "D", "MH": "Cell Wall Skeleton", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.395.560.186", "PA": "Adjuvants, Immunologic", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "AN": "restrict to bacteria; a mucoprotein of the bact cell wall: do not confuse with CYTOSKELETON, a network within the cytoplasm; coord IM with specific bacterium /ultrastruct, /chem or other pertinent qualif", "PI": "Polysaccharides (1974-1975)", "MS": "A mucoprotein found in the cell wall of various types of bacteria. It has adjuvant and antitumor activities and has been used to augment the production of lymphokine-activated killer (LAK) cells.", "OL": "use CELL WALL SKELETON (NM) to search CELL WALL SKELETON 1982-92", "PM": "93; CELL WALL SKELETON was indexed under MYCOLIC ACIDS & MUCOPROTEINS 1976-92 & POLYSACCHARIDES & PEPTIDES 1974-75", "HN": "93; was CELL WALL SKELETON (NM) 1974-92", "MR": "20230316", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017358"}, {"RECTYPE": "D", "MH": "HELLP Syndrome", "DE": "HELLP", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, HELLP", "MN": "C12.050.703.395.186", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Thrombocytopenia (1982-1992)", "MS": "A syndrome of HEMOLYSIS, elevated liver ENZYMES, and low blood platelets count (THROMBOCYTOPENIA). HELLP syndrome is observed in pregnant women with PRE-ECLAMPSIA or ECLAMPSIA who also exhibit LIVER damage and abnormalities in BLOOD COAGULATION.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19920518", "DC": "1", "DX": "19930101", "UI": "D017359"}, {"RECTYPE": "D", "MH": "Arabidopsis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cress, Mouse-ear|T002|NON|NRW|NLM (2003)|010828|abcdef", "ENTRY": "thalianas, A.", "MN": "B01.875.800.575.912.250.157.100", "MH_TH": "NLM (1993)", "ST": "T002", "RN": "txid3701", "RR": "txid3702", "PI": "Plants (1966-1992)", "MS": "A plant genus of the family BRASSICACEAE that contains ARABIDOPSIS PROTEINS and MADS DOMAIN PROTEINS. The species A. thaliana is used for experiments in classical plant genetics as well as molecular genetic studies in plant physiology, biochemistry, and development.", "PM": "93", "HN": "93", "MR": "20210630", "DA": "19920507", "DC": "1", "DX": "19930101", "UI": "D017360"}, {"RECTYPE": "D", "MH": "Viral Nonstructural Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nonstructural Proteins, Viral|T116|T123|NON|EQV|NLM (1993)|920227|abbcdef", "ENTRY": "Viral Non Structural Proteins", "MN": "D12.776.964.900", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "AN": "coordinate IM with specific protein (IM) + specific virus (IM)", "PI": "Viral Proteins (1980-1988)", "MS": "Proteins encoded by a VIRAL GENOME that are not structural components of VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY.", "PM": "1993; NS PROTEINS was indexed under VIRAL CORE PROTEINS & CAPSID 1988-1992, & VIRAL PROTEINS 1980-1988", "HN": "1993", "MR": "20200622", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017361"}, {"RECTYPE": "D", "MH": "Cyclic AMP Response Element-Binding Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA-Binding Protein, Cyclic AMP-Responsive|T116|T123|ACX|EQV|NLM (1993)|990101|abbcdef", "ENTRY": "cAMP Response Element Binding Protein", "MN": "D12.776.930.127.184", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "PI": "DNA-Binding Proteins (1989-1992)", "MS": "A protein that has been shown to function as a calcium-regulated transcription factor as well as a substrate for depolarization-activated CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES. This protein functions to integrate both calcium and cAMP signals.", "OL": "use DNA-BINDING PROTEIN, CYCLIC AMP-RESPONSIVE (NM) to search CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN 1989-92", "PM": "93; CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN was indexed under DNA-BINDING PROTEINS 1989-92", "HN": "93; was CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN (NM) 1989-92", "MR": "20090714", "DA": "19920514", "DC": "1", "DX": "19930101", "UI": "D017362"}, {"RECTYPE": "D", "MH": "Collagenases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peptidase, Collagen", "MN": "D08.811.277.656.675.374.205", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (1993)", "ST": "T126", "RN": "EC 3.4.24.-", "AN": "general or unspecified; prefer specifics", "PI": "Clostridium histolyticum Collagenase (1975-1992)", "MS": "Enzymes that catalyze the degradation of collagen by acting on the peptide bonds.", "OL": "use CLOSTRIDIUM HISTOLYTICUM COLLAGENASE to search COLLAGENASE 1966-92", "PM": "93; COLLAGENASE was see CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1966-92", "HN": "93; COLLAGENASE was see CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1966-92", "MR": "20120703", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017364"}, {"RECTYPE": "D", "MH": "Spices", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Spice", "MN": "J02.500.250.725", "MH_TH": "NLM (1993)", "ST": "T168", "AN": "coord with specific plant + specific plant component (if pertinent); for use in therapy coord with PHYTOTHERAPY (IM) + disease /*drug ther (IM)", "PI": "Condiments (1966-1992)", "MS": "The dried seeds, bark, root, stems, buds, leaves, or fruit of aromatic plants used to season food.", "PM": "93; was see CONDIMENTS 1984-92; was see under CONDIMENTS 1963-82", "HN": "93; was see CONDIMENTS 1984-92; was see under CONDIMENTS 1963-82", "MR": "20141014", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017365"}, {"RECTYPE": "D", "MH": "Serotonin Receptor Agonists", "DE": "SEROTONIN RECEPT AG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Serotonin Agonists|T121|NON|EQV|NLM (1993)|990101|SEROTONIN AG|abcdefv", "ENTRY": "Receptor Agonist, Serotonin", "MN": "D27.505.696.577.850.800", "MH_TH": "NLM (1993)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; note entry term SEROTONIN AGONISTS: do not confuse with SEROTONIN ANTAGONISTS", "PI": "Serotonin/physiology (1966-1992)", "MS": "Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS.", "PM": "2011; see SEROTONIN AGONISTS 1993-2010", "HN": "2011(1993)", "MR": "20100625", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017366"}, {"RECTYPE": "D", "MH": "Selective Serotonin Reuptake Inhibitors", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Serotonin Uptake Inhibitors|T121|NON|BRD|NLM (1993)|990101|SEROTONIN UPTAKE INHIB|abcdefv", "ENTRY": "Uptake Inhibitor, Serotonin", "MN": "D27.505.696.577.850.900", "FX": "Antidepressive Agents, Second-Generation", "MH_TH": "NLM (2012)", "ST": "T121", "RN": "0", "AN": "do not confuse with SEROTONIN ANTAGONISTS", "PI": "Serotonin Antagonists (1978-1992)", "MS": "Compounds that specifically inhibit the reuptake of serotonin in the brain.", "PM": "2023; SEE SEROTONIN ANTAGONISTS 1993 - 2022", "HN": "2023(1993)", "MR": "20230426", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017367"}, {"RECTYPE": "D", "MH": "Protein Prenylation", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Protein Isoprenylation|T045|NON|NRW|NLM (1993)|990101|abcdef", "ENTRY": "Prenylation, Protein", "MN": "G05.308.670.600.400", "MH_TH": "NLM (1993)", "ST": "T045", "PI": "Protein Processing, Post-Translational (1987-1992)", "MS": "A post-translational modification of proteins by the attachment of an isoprenoid to the C-terminal cysteine residue. The isoprenoids used, farnesyl diphosphate or geranylgeranyl diphosphate, are derived from the same biochemical pathway that produces cholesterol.", "PM": "2008; see PROTEIN ISOPRENYLATION 1993-2007", "HN": "2008(1993)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19920603", "DC": "1", "DX": "19930101", "UI": "D017368"}, {"RECTYPE": "D", "MH": "Interleukin-11", "DS": "INTERLEUKIN 011", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "IL-11|T116|T129|ABB|EQV|NLM (1993)|920306|IL 011|abbcdefs", "ENTRY": "Interleukin 11", "MN": "D23.529.374.465.511", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "PI": "Interleukins (1990-1992)", "MS": "A lymphohematopoietic cytokine that plays a role in regulating the proliferation of ERYTHROID PRECURSOR CELLS. It induces maturation of MEGAKARYOCYTES which results in increased production of BLOOD PLATELETS. Interleukin-11 was also initially described as an inhibitor of ADIPOGENESIS of cultured preadipocytes.", "OL": "use INTERLEUKIN-11 (NM) to search INTERLEUKIN 11 1990-92", "PM": "93; INTERLEUKIN-11 was indexed under INTERLEUKINS 1990-92", "HN": "93; was INTERLEUKIN 11 (NM) 1990-92", "MR": "20080709", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017370"}, {"RECTYPE": "D", "MH": "8-Hydroxy-2-(di-n-propylamino)tetralin", "DS": "HYDROXYDIPROPYLAMINOTETRALIN N 08 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "8-OH-DPAT|T109|T121|ABB|EQV|NLM (1993)|920306|OH DPAT 08|abbcdefs", "ENTRY": "8-Hydroxy-2-(di-n-propylamino)tetralin, (S)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef", "MN": "D04.615.638.960.400", "PA": "Serotonin Receptor Agonists", "MH_TH": "NLM (1993)", "ST": "T121", "N1": "1-Naphthalenol, 7-(dipropylamino)-5,6,7,8-tetrahydro-", "RN": "78950-78-4", "RR": "87394-87-4 ((+-)-isomer, HBr)", "PI": "Tetrahydronaphthalenes (1982-1992)", "MS": "A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.", "OL": "use 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN (NM) to search 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN 1982-92", "PM": "93; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN was indexed under TETRAHYDRONAPHTHALENES 1982-92", "HN": "93; was 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN (NM) 1982-92", "MR": "20100628", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017371"}, {"RECTYPE": "D", "MH": "Cyproterone Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Cyproterone Acetate, (17 alpha)-Isomer|T109|T121|NRW|NLM (1999)|990913|abbdef", "MN": "D04.210.500.883.419.150", "PA": "Contraceptive Agents, Male", "MH_TH": "USAN (1965)", "ST": "T121", "N1": "3'H-Cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 17-(acetyloxy)-6-chloro-1,2-dihydro-, (1beta,2beta)-", "RN": "4KM2BN5JHF", "RR": "86782-20-9 ((17 alpha)-isomer)", "PI": "Cyproterone/analogs & derivatives (1980-1992)", "MS": "An agent with anti-androgen and progestational properties. It shows competitive binding with dihydrotestosterone at androgen receptor sites.", "OL": "use CYPROTERONE ACETATE (NM) to search CYPROTERONE ACETATE 1980-92", "PM": "93; CYPROTERONE ACETATE was indexed under CYPROTERONE/analogs & derivatives 1980-92", "HN": "93; was CYPROTERONE ACETATE (NM) 1980-92", "MR": "20160528", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017373"}, {"RECTYPE": "D", "MH": "Paroxetine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "FG7051", "MN": "D03.383.621.600", "PA": "Selective Serotonin Reuptake Inhibitors", "MH_TH": "USAN (1989)", "ST": "T121", "N1": "Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S-trans)-", "RN": "41VRH5220H", "RR": "YPO0NTK49O", "PI": "Piperidines (1982-1992)", "MS": "A serotonin uptake inhibitor that is effective in the treatment of depression.", "PM": "1993; PAROXETINE was indexed under PIPERIDINES 1982-1992 and under DIOXOLANES 1978-1982", "HN": "1993 (1978)", "MR": "20220718", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017374"}, {"RECTYPE": "D", "MH": "Viral Tail Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tail Proteins, Virus", "MN": "D12.776.964.970.910", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "AN": "found in tails of viruses; coord IM with specific virus (IM)", "PI": "Viral Proteins (1980-1992)", "MS": "Proteins found in the tail sections of DNA and RNA viruses. It is believed that these proteins play a role in directing chain folding and assembly of polypeptide chains.", "OL": "use VIRAL TAIL PROTEINS (NM) to search VIRAL TAIL PROTEINS 1981-92", "PM": "93; VIRAL TAIL PROTEINS was indexed under VIRAL PROTEINS 1981-92", "HN": "93; was VIRAL TAIL PROTEINS (NM) 1981-92", "MR": "20050630", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017376"}, {"RECTYPE": "D", "MH": "Diatoms", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Bacillariophyta|T204|NON|EQV|NLM (2003)|020628|abcdef", "ENTRY": "Diatom", "MN": "B01.750.200", "FX": "Phytoplankton", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid2836", "PI": "Algae (1966-1992)", "MS": "The common name for the phylum of microscopic unicellular STRAMENOPILES. Most are aquatic, being found in fresh, brackish, and salt water. Diatoms are noted for the symmetry and sculpturing of their siliceous cell walls. They account for 40% of PHYTOPLANKTON, but not all diatoms are planktonic.", "PM": "93", "HN": "93", "MR": "20200813", "DA": "19920514", "DC": "1", "DX": "19930101", "UI": "D017377"}, {"RECTYPE": "D", "MH": "Quinolinic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Quinolinate|T109|T123|NON|NRW|NLM (1993)|920310|abbcdef", "ENTRY": "Quinolinic Acid, Strontium Salt|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef", "MN": "D03.383.725.822.700", "EC": "analogs & derivatives:Quinolinic Acids", "MH_TH": "NLM (1993)", "ST": "T123", "N1": "2,3-Pyridinedicarboxylic acid", "RN": "F6F0HK1URN", "RR": "89-00-9 (Quinolinic Acid)", "PI": "Quinolinic Acids (1981-1992)", "MS": "A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.", "OL": "use QUINOLINIC ACID (NM) to search QUINOLINIC ACID 1981-92", "PM": "93; QUINOLINIC ACID was indexed under QUINOLINIC ACIDS 1981-92", "HN": "93; was QUINOLINIC ACID (NM) 1981-92", "MR": "20160531", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017378"}, {"RECTYPE": "D", "MH": "Hypertrophy, Left Ventricular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ventricular Hypertrophy, Left|T046|T184|NON|EQV|NLM (1993)|920310|abbcdef", "ENTRY": "Ventricular Hypertrophies, Left", "MN": "C23.300.775.250.400", "MH_TH": "NLM (1993)", "ST": "T184", "PI": "Heart Hypertrophy (1966-1992)", "MS": "Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017379"}, {"RECTYPE": "D", "MH": "Hypertrophy, Right Ventricular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ventricular Hypertrophy, Right|T046|T184|NON|EQV|NLM (1993)|920310|abbcdef", "ENTRY": "Ventricular Hypertrophies, Right", "MN": "C23.300.775.250.401", "MH_TH": "NLM (1993)", "ST": "T184", "PI": "Heart Hypertrophy (1966-1992)", "MS": "Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017380"}, {"RECTYPE": "D", "MH": "Spliceosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Spliceosome", "MN": "A11.284.430.106.279.345.850", "FX": "RNA Splicing Factors", "MH_TH": "NLM (1993)", "ST": "T026", "PI": "Ribonucleoproteins (1986-1992)", "MS": "Organelles in which the splicing and excision reactions that remove introns from precursor messenger RNA molecules occur. One component of a spliceosome is five small nuclear RNA molecules (U1, U2, U4, U5, U6) that, working in conjunction with proteins, help to fold pieces of RNA into the right shapes and later splice them into the message.", "PM": "93", "HN": "93", "MR": "20160617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017381"}, {"RECTYPE": "D", "MH": "Reactive Oxygen Species", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Reactive Oxygen Intermediates|T123|T196|NON|EQV|NLM (2023)|220311|abbcdef", "ENTRY": "Radical, Oxygen", "MN": "D02.389.593", "FX": "Oxygen Radical Absorbance Capacity", "MH_TH": "NLM (1993)", "ST": "T196", "RN": "0", "MS": "Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS.", "PM": "1993", "HN": "1993", "MR": "20230226", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017382"}, {"RECTYPE": "D", "MH": "Sequence Deletion", "DE": "SEQ DELETION", "AQ": "DE GE IM PH RE", "ENTRY": "Sequence Deletions", "MN": "G05.558.800", "MH_TH": "NLM (1993)", "ST": "T049", "AN": "coordinate IM with BASE SEQUENCE or AMINO ACID SEQUENCE (IM)", "PI": "Mutation (1976-1992)", "MS": "Deletion of sequences of nucleic acids from the genetic material of an individual.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017384"}, {"RECTYPE": "D", "MH": "Sequence Homology", "DE": "SEQ HOMOL", "PRINT ENTRY": "Homologous Sequences|T085|NON|REL|NLM (1993)|920313|HOMOL SEQ|abcdefv", "ENTRY": "Sequences, Homologous", "MN": "G05.810", "MH_TH": "NLM (1993)", "ST": "T081", "AN": "general or unspecified; prefer specifics", "PI": "Nucleic Acid Hybridization (1971-1985)", "MS": "The degree of similarity between sequences. Studies of AMINO ACID SEQUENCE HOMOLOGY and NUCLEIC ACID SEQUENCE HOMOLOGY provide useful information about the genetic relatedness of genes, gene products, and species.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017385"}, {"RECTYPE": "D", "MH": "Sequence Homology, Amino Acid", "DE": "SEQ HOMOL AA", "PRINT ENTRY": "Homologous Sequences, Amino Acid|T087|NON|REL|NLM (1993)|920313|HOMOL SEQ AA|abcdefv", "ENTRY": "Sequence Homologs, Protein", "MN": "G05.810.200", "FX": "Structural Homology, Protein", "MH_TH": "NLM (1993)", "ST": "T081", "PI": "Molecular Sequence Data (1988-1992)", "MS": "The degree of similarity between sequences of amino acids. This information is useful for the analyzing genetic relatedness of proteins and species.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017386"}, {"RECTYPE": "D", "MH": "Investigational New Drug Application", "DE": "IND APPLICATION", "AQ": "EC HI LJ MT OG SN", "ENTRY": "Investigational New Drug Applications|T170|NON|EQV|NLM (1993)|920319|IND APPLICATIONS|abcdefv", "MN": "E05.337.300.400", "MH_TH": "NLM (1993)", "ST": "T170", "AN": "U.S. or foreign, but if U.S., new drug \"must be submitted to the FDA\" before study in humans", "PI": "Drugs, Investigational (1990-1992)", "MS": "An application that must be submitted to a regulatory agency (the FDA in the United States) before a drug can be studied in humans. This application includes results of previous experiments; how, where, and by whom the new studies will be conducted; the chemical structure of the compound; how it is thought to work in the body; any toxic effects found in animal studies; and how the compound is manufactured. (From the \"New Medicines in Development\" Series produced by the Pharmaceutical Manufacturers Association and published irregularly.)", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017387"}, {"RECTYPE": "D", "MH": "Zygote Intrafallopian Transfer", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "ZIFT|T061|ABB|EQV|NLM (1993)|920319|abcdef", "ENTRY": "Zygote Intrafallopian Transfers", "MN": "E05.820.800.992", "MH_TH": "NLM (1993)", "ST": "T061", "PI": "Zygote (1988-1992)", "MS": "A technique in assisted reproduction (REPRODUCTIVE TECHNIQUES, ASSISTED) consisting of hormonal stimulation of the ovaries, follicular aspiration of preovulatory oocytes, in-vitro fertilization, and intrafallopian transfer of zygotes at the pronuclear stage (before cleavage).", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017388"}, {"RECTYPE": "D", "MH": "Epikeratophakia", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Epikeratoplasties", "MN": "E04.936.580.225.225", "MH_TH": "NLM (1993)", "ST": "T061", "AN": "do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed", "PI": "Corneal Transplantation (1981-1992)", "MS": "A procedure that modifies REFRACTIVE ERRORS by the transplantation of a donor CORNEA to the anterior surface of the patient's cornea.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017391"}, {"RECTYPE": "D", "MH": "Thiobarbituric Acid Reactive Substances", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "TBARs|T109|T130|ABB|EQV|NLM (1993)|920401|abbcdef", "MN": "D27.720.470.410.750", "MH_TH": "NLM (1993)", "ST": "T130", "RN": "0", "MS": "Low-molecular-weight end products, probably malondialdehyde, that are formed during the decomposition of lipid peroxidation products. These compounds react with thiobarbituric acid to form a fluorescent red adduct.", "PM": "93", "HN": "93", "MR": "20030709", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017392"}, {"RECTYPE": "D", "MH": "RNA Editing", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "RNA, Messenger, Editing|T045|EQV|NLM (1993)|920320|abdef", "ENTRY": "RNA Editings", "MN": "G05.308.700.250", "MH_TH": "NLM (1993)", "ST": "T045", "AN": "a type of post-transcriptional RNA processing", "PI": "RNA Processing, Post-Transcriptional (1988-1992)", "MS": "A process that changes the nucleotide sequence of mRNA from that of the DNA template encoding it. Some major classes of RNA editing are as follows: 1, the conversion of cytosine to uracil in mRNA; 2, the addition of variable number of guanines at pre-determined sites; and 3, the addition and deletion of uracils, templated by guide-RNAs (RNA, GUIDE, KINETOPLASTIDA).", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20220715", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017393"}, {"RECTYPE": "D", "MH": "RNA, Guide, Kinetoplastida", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gRNA, Trypanosoma|T114|NON|NRW|NLM (2023)|220415|abcdef", "ENTRY": "Trypanosoma RNA, Guide", "MN": "D13.444.735.790.552.625", "FX": "RNA Editing", "MH_TH": "NLM (2023)", "ST": "T130", "RN": "0", "AN": "Do not confuse with RNA, GUIDE, CRISPR-Cas SYSTEMS", "PI": "RNA (1990-1992)", "MS": "Small kinetoplastid mitochondrial RNA that plays a major role in RNA EDITING. These molecules form perfect hybrids with edited mRNA sequences and possess nucleotide sequences at their 5'-ends that are complementary to the sequences of the mRNA's immediately downstream of the pre-edited regions.", "OL": "use RNA, GUIDE (NM) to search GUIDE RNA 1990-92", "PM": "see RNA, GUIDE (1990-2022); was GUIDE RNA (NM) 1990-1992", "HN": "use RNA, GUIDE 1990-2022", "MR": "20220708", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017394"}, {"RECTYPE": "D", "MH": "Plasminogen Activator Inhibitor 1", "DE": "PLASMINOGEN ACTIVATOR INHIB 1", "DS": "PLASMINOGEN ACTIVATOR INHIBITOR 01", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PAI-1|T116|T123|ABB|EQV|NLM (1993)|920320|PAI 01|abbcdefs", "ENTRY": "Protein, SERPINE1", "MN": "D23.119.832.500", "PA": "Serine Proteinase Inhibitors", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "PI": "Plasminogen Inactivators (1990-1992)", "MS": "A member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators.", "OL": "use PLASMINOGEN INACTIVATORS to search PAI-1 1990-92", "PM": "93; PAI-1 was see PLASMINOGEN INACTIVATORS 1990-92", "HN": "93; PAI-1 was see PLASMINOGEN INACTIVATORS 1990-92", "MR": "20151123", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017395"}, {"RECTYPE": "D", "MH": "Plasminogen Activator Inhibitor 2", "DE": "PLASMINOGEN ACTIVATOR INHIB 2", "DS": "PLASMINOGEN ACTIVATOR INHIBITOR 02", "AQ": "AA AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PAI-2|T116|T123|ABB|EQV|NLM (1993)|920320|PAI 02|abbcdefs", "ENTRY": "Type 2 Plasminogen Activator Inhibitor|T116|T123|NON|EQV|NLM (1993)|920320|TYPE 2 PLASMINOGEN ACTIVATOR INHIB|abbcdefv", "MN": "D23.119.832.750", "PA": "Serine Proteinase Inhibitors", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "PI": "Plasminogen Inactivators (1990-1992)", "MS": "Member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators.", "OL": "use PLASMINOGEN INACTIVATORS to search PAI-2 1990-92", "PM": "93; PAI-2 was see PLASMINOGEN INACTIVATORS 1990-92", "HN": "93; PAI-2 was see PLASMINOGEN INACTIVATORS 1990-92", "MR": "20150623", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017396"}, {"RECTYPE": "D", "MH": "Prefrontal Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Pars Orbitalis|T023|NON|NRW|NLM (2022)|201009|abcdef", "ENTRY": "Ventromedial Prefrontal Cortices", "MN": "A08.186.211.200.885.287.500.270.700", "MH_TH": "NLM (1993)", "ST": "T023", "PI": "Frontal Lobe (1966-1992)", "MS": "The rostral part of the frontal lobe, bounded by the inferior precentral fissure in humans, which receives projection fibers from the MEDIODORSAL NUCLEUS OF THE THALAMUS. The prefrontal cortex receives afferent fibers from numerous structures of the DIENCEPHALON; MESENCEPHALON; and LIMBIC SYSTEM as well as cortical afferents of visual, auditory, and somatic origin.", "PM": "93", "HN": "93", "MR": "20210305", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017397"}, {"RECTYPE": "D", "MH": "Alternative Splicing", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Splicing, Alternative|T045|NON|EQV|NLM (1993)|920330|abcdef", "ENTRY": "Transcripts, Nested", "MN": "G05.308.700.700.100", "FX": "RNA Splice Sites", "MH_TH": "NLM (1993)", "ST": "T045", "AN": "for NESTED TRANSCRIPTS also index the RNA; do not confuse with NESTED GENES; for nested primers use NESTED PCR; (POLYMERASE CHAIN REACTION)", "PI": "RNA Splicing (1982-1992)", "MS": "A process whereby multiple RNA transcripts are generated from a single gene. Alternative splicing involves the splicing together of other possible sets of EXONS during the processing of some, but not all, transcripts of the gene. Thus a particular exon may be connected to any one of several alternative exons to form a mature RNA. The alternative forms of mature MESSENGER RNA produce PROTEIN ISOFORMS in which one part of the isoforms is common while the other parts are different.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017398"}, {"RECTYPE": "D", "MH": "Brachyspira", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Serpulina innocens|T007|NON|NRW|NLM (1993)|920323|abcdef", "ENTRY": "Treponema innocens|T007|NON|NRW|NLM (1993)|920323|abcdef", "MN": "B03.440.425.410.220", "MH_TH": "NLM (2008)", "ST": "T007", "RN": "txid29521", "RR": "txid13264", "AN": "infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Treponema (1980-1992)", "MS": "A genus of spiral bacteria of the family Brachyspiraceae.", "PM": "2008; see SERPULINA 1993-2007", "HN": "2008 (1993)", "MR": "20200813", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017400"}, {"RECTYPE": "D", "MH": "Brachyspira hyodysenteriae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Serpulina hyodysenteriae|T007|NON|EQV|NLM (1993)|990101|abcdef", "ENTRY": "Treponema hyodysenteriae|T007|NON|EQV|NLM (1993)|920323|abcdef", "MN": "B03.440.425.410.220.100", "MH_TH": "NLM (2008)", "ST": "T007", "RN": "txid159", "AN": "infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Treponema (1974-1992)", "MS": "A species of anaerobic, spiral bacteria that was formerly classified as Serpulina hyodysenteriae and Treponema hyodysenteriae (and for a short while, Serpula hyodysenteriae). This organism is the agent of swine dysentery.", "PM": "2008; see SERPULINA HYODYSENTERIAE 1993-2007", "HN": "2008", "MR": "20200128", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017401"}, {"RECTYPE": "D", "MH": "Chlorofluorocarbons", "DE": "CFCS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Freons|T109|NON|NRW|NLM (1973)|990101|abcdef", "ENTRY": "Derivatives, Chlorofluorocarbon", "MN": "D02.455.526.510.140", "MH_TH": "NLM (1993)", "ST": "T109", "RN": "0", "AN": "do not confuse with FLUOROCARBONS or HYDROCARBONS, CHLORINATED or HYDROCARBONS, FLUORINATED", "MS": "A series of hydrocarbons containing both chlorine and fluorine. These have been used as refrigerants, blowing agents, cleaning fluids, solvents, and as fire extinguishing agents. They have been shown to cause stratospheric ozone depletion and have been banned for many uses.", "PM": "1993; for FREONS and FREON see CHLOROFLUORCARBONS, METHANE 1973 - 2001", "HN": "1993; for FREONS and FREON use CHLOROFLUORCARBONS, METHANE 1973 - 2001", "MR": "20210304", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017402"}, {"RECTYPE": "D", "MH": "In Situ Hybridization", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Hybridization in Situ|T059|T063|NON|EQV|NLM (1993)|920323|abbcdef", "ENTRY": "In Situ Hybridizations", "MN": "E05.393.661.475", "MH_TH": "NLM (1993)", "ST": "T063", "AN": "to locate specific nucleic acid seq", "PI": "Nucleic Acid Hybridization (1971-1992)", "MS": "A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017403"}, {"RECTYPE": "D", "MH": "In Situ Hybridization, Fluorescence", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Hybridization in Situ, Fluorescence|T059|T063|NON|EQV|NLM (1993)|920323|abbcdef", "ENTRY": "Techniques, FISH", "MN": "E05.393.661.475.350", "MH_TH": "NLM (1993)", "ST": "T063", "PI": "Nucleic Acid Hybridization (1977-1992)", "MS": "A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017404"}, {"RECTYPE": "D", "MH": "Herpes Simplex Virus Protein Vmw65", "DE": "HSV VMW65", "DS": "HERPES SIMPLEX VIRUS PROTEIN VMW 065", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-Trans-Inducing Factor, Herpes Simplex Virus 1|T116|T123|T129|NON|EQV|NLM (1997)|960305|abbbcdef", "ENTRY": "alpha Trans Inducing Factor, Herpes Simplex Virus 1", "MN": "D12.776.964.925.984.445", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "PI": "Viral Proteins (1984-1990)", "MS": "Trans-acting protein that combines with host factors to induce immediate early gene transcription in herpes simplex virus.", "OL": "use TRANS-ACTIVATORS to search HERPES SIMPLEX VIRUS TRANSCRIPTIONAL ACTIVATOR VMW65 1991-92; use HERPES SIMPLEX VIRUS PROTEIN VMW65 (NM) to search ALPHA-TRANS INDUCING FACTOR, HERPES SIMPLEX VIRUS 1 1987-96 & HERPES SIMPLEX VIRUS TYPE 2 PROTEIN VP16 1991-92", "PM": "93; was HERPES SIMPLEX VIRUS TRANSCRIPTIONAL ACTIVATOR VMW65 see TRANS-ACTIVATORS 1991-92; ALPHA-TRANS INDUCING FACTOR, HERPES SIMPLEX VIRUS 1 was indexed under HERPES SIMPLEX VIRUS PROTEIN VMW65 1993-96 & VIRAL PROTEINS 1987-92; HERPES SIMPLEX VIRUS TYPE 2 PROTEIN VP16 was indexed under VIRAL PROTEINS 1991-92", "HN": "93; was HERPES SIMPLEX VIRUS TRANSCRIPTIONAL ACTIVATOR VMW65 see TRANS-ACTIVATORS 1991-92; was also ALPHA-TRANS INDUCING FACTOR, HERPES SIMPLEX VIRUS 1 (NM) 1987-96; HERPES SIMPLEX VIRUS PROTEIN VP16 was HERPES SIMPLEX VIRUS TYPE 2 PROTEIN VP16 (NM) 1991-92", "MR": "20070709", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017405"}, {"RECTYPE": "D", "MH": "Sexual Harassment", "AQ": "CL EC EH ES HI LJ PC PX SN", "PRINT ENTRY": "Harassment, Sexual|T048|T054|NON|EQV|NLM (1993)|920324|abbcdef", "ENTRY": "Sexual Harrassments", "MN": "F01.145.813.606", "MH_TH": "NLM (1993)", "ST": "T054", "AN": "HARASSMENT, NONSEXUAL is also available", "PI": "Sex Behavior (1979-1992)", "MS": "A form of discrimination in the workplace which violates the Civil Rights Act of 1964. Offensive sexual conduct may include unwelcome advances, comments, touching, questions about marital status and sex practices, etc. Both men and women may be aggressors or victims. (Slee and Slee, Health Care Terms, 2d ed, p.404). While civil rights legislation deals with sexual harassment in the workplace, the behavior is not restricted to this; it may take place outside the work environment: in schools, athletics, and other social milieus and activities.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20220511", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017406"}, {"RECTYPE": "D", "MH": "Family Leave", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Leave, Family", "MN": "N04.452.677.800.162", "MH_TH": "NLM (1993)", "ST": "T064", "AN": "to care for sibs, parents or other family members: do not confuse with PARENTAL LEAVE", "PI": "Parental Leave (1988-1992)", "MS": "The authorized absence from work of a family member to attend the illness or participate in the care of a parent, a sibling, or other family member. For the care of a parent for a child or for pre- or postnatal leave of a parent, PARENTAL LEAVE is available.", "OL": "use PARENTAL LEAVE to search FAMILY LEAVE 1992", "PM": "93; was see PARENTAL LEAVE 1992", "HN": "93; was see PARENTAL LEAVE 1992", "MR": "19940505", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017407"}, {"RECTYPE": "D", "MH": "Guidelines as Topic", "AQ": "ST", "ENTRY": "Guidelines as Topics", "MN": "N05.700.350", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "for general design, methodology, economics, etc. of guidelines unrelated to healthcare; do not confuse with the Publication Type GUIDELINE", "MS": "Works about a systematic statement of policy rules or principles. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by convening expert panels. For guidelines in the field of health care and clinical medicine, PRACTICE GUIDELINES AS TOPIC is available.", "PM": "2008; see GUIDELINES 1993-2007", "HN": "2008(1993)", "MR": "20170208", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017408"}, {"RECTYPE": "D", "MH": "Sufentanil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SufentanilRatiopharm", "MN": "D03.383.621.265.900", "PA": "Narcotics", "MH_TH": "USAN (1972)", "ST": "T121", "N1": "Propanamide, N-(4-(methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenyl-", "RN": "AFE2YW0IIZ", "RR": "S9ZFX8403R", "PI": "Piperidines (1977-1978)", "MS": "An opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent.", "OL": "use SUFENTANIL (NM) to search SULFENTANIL 1979-92", "PM": "93; SULFENTANIL was indexed under FENTANYL/analogs & derivatives 1979-92 & ANILIDES & PIPERIDINES 1977-78", "HN": "93; was SULFENTANIL (NM) 1977-92", "MR": "20170524", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017409"}, {"RECTYPE": "D", "MH": "Practice Guidelines as Topic", "AQ": "ST", "PRINT ENTRY": "Clinical Guidelines as Topic|T170|NON|EQV|NLM (2021)|200513|abcdef", "ENTRY": "Best Practice", "MN": "N05.700.350.650", "FX": "Consensus", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "for general design, methodology, economics, etc. of guidelines related to healthcare;  do not confuse with the Publication Type PRACTICE GUIDELINE", "MS": "Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery.", "PM": "2008; see PRACTICE GUIDELINES 1993-2007", "HN": "2008(1993)", "MR": "20200527", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017410"}, {"RECTYPE": "D", "MH": "Ribonucleoproteins, Small Nuclear", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "snRNP|T116|T123|ABB|EQV|NLM (1993)|920324|abbcdef", "ENTRY": "Ribonucleoprotein, Small Nuclear", "MN": "D12.776.664.962.500.875", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1981-1992)", "MS": "Highly conserved nuclear RNA-protein complexes that function in RNA processing in the nucleus, including pre-mRNA splicing and pre-mRNA 3'-end processing in the nucleoplasm, and pre-rRNA processing in the nucleolus (see RIBONUCLEOPROTEINS, SMALL NUCLEOLAR).", "OL": "use RIBONUCLEOPROTEINS, SMALL NUCLEAR (NM) to search SMALL RIBONUCLEOPROTEINS 1981-92", "PM": "93; SMALL RIBONUCLEOPROTEINS was indexed under RIBONUCLEOPROTEINS 1982-92", "HN": "93; was SMALL RIBONUCLEOPROTEINS (NM) 1982-92", "MR": "20050630", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017411"}, {"RECTYPE": "D", "MH": "Ribonucleoprotein, U1 Small Nuclear", "DS": "RIBONUCLEOPROTEINS U 001 SMALL NUCLEAR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "U1 snRNP|T116|T123|ABB|EQV|NLM (1993)|920325|SNRNP U 001|abbcdefs", "ENTRY": "Ribonucleoproteins, Small, U1|T116|T123|NON|EQV|NLM (1993)|990101|abbcdef", "MN": "D12.776.664.962.829.313", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1975-1992)", "MS": "A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U1 snRNP along with other small nuclear ribonucleoproteins (U2, U4-U6, and U5) assemble into SPLICEOSOMES that remove introns from pre-mRNA by splicing. The U1 snRNA forms base pairs with conserved sequence motifs at the 5'-splice site and recognizes both the 5'- and 3'-splice sites and may have a fundamental role in aligning the two sites for the splicing reaction.", "PM": "2000; RIBONUCLEOPROTEINS, SMALL, U1 was heading 1993-1999; U1-RNP was indexed under RIBONUCLEOPROTEINS 1982-92", "HN": "2000; U1 SNRNP was U1-RNP (SY) to SMALL RIBONUCLEOPROTEINS (NM) 1982-92", "MR": "20160705", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017412"}, {"RECTYPE": "D", "MH": "Ribonucleoprotein, U2 Small Nuclear", "DS": "RIBONUCLEOPROTEINS U 002 SMALL NUCLEAR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "U2 snRNP|T116|T123|ABB|EQV|NLM (1993)|920325|SNRNP U 002|abbcdefs", "ENTRY": "Ribonucleoproteins, Small, U2|T116|T123|NON|EQV|NLM (1993)|990101|abbcdef", "MN": "D12.776.664.962.829.344", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1975-1992)", "MS": "A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U2 snRNP along with other small nuclear ribonucleoproteins (U1, U4-U6, and U5) assemble into SPLICEOSOMES that remove introns from pre-mRNA by splicing. The U2 snRNA forms base pairs with conserved sequence motifs at the branch point, which associates with a heat- and RNAase-sensitive factor in an early step of splicing.", "PM": "2000; RIBONUCLEOPROTEINS, SMALL, U2 was heading 1993-1999; SNRNP-U2 was indexed under RIBONUCLEOPROTEINS 1982-92", "HN": "2000; U2 SNRNP was SNRNP-U2 (SY) to SMALL RIBONUCLEOPROTEINS (NM) 1982-92", "MR": "20160705", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017413"}, {"RECTYPE": "D", "MH": "Ribonucleoprotein, U4-U6 Small Nuclear", "DS": "RIBONUCLEOPROTEINS U 004 U 006 SMALL NUCLEAR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "U6 snRNP|T116|T123|ABB|NRW|NLM (1993)|920325|SNRNP U 006|abbcdefs", "ENTRY": "U4 U6 Small Nuclear Ribonucleoproteins", "MN": "D12.776.664.962.500.875.615", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1982-1992)", "MS": "A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U4-U6 snRNP along with the U5 snRNP preassemble into a single 25S particle that binds to the U1 and U2 snRNPs and the substrate to form mature SPLICEOSOMES. There is also evidence for the existence of individual U4 or U6 snRNPs in addition to their organization as a U4-U6 snRNP.", "PM": "2000; RIBONUCLEOPROTEINS, SMALL, U4-U6 was heading 1993-1999; U4 RNP & U6 RNP were indexed under RIBONUCLEPROTEINS 1982-92", "HN": "2000; U4 SNRNP was U4 RNP (SY) to SMALL NUCLEAR RIBONUCLEOPROTEINS (NM) 1982-92; U6 SNRNP was U6 RNP (SY) to SMALL NUCLEAR RIBONUCLEOPROTEINS (NM) 1982-92", "MR": "20130709", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017414"}, {"RECTYPE": "D", "MH": "Ribonucleoprotein, U5 Small Nuclear", "DS": "RIBONUCLEOPROTEINS U 005 SMALL NUCLEAR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "U5 snRNP|T116|T123|ABB|EQV|NLM (1993)|920325|SNRNP U 005|abbcdefs", "ENTRY": "Ribonucleoproteins, Small, U5|T116|T123|NON|EQV|NLM (1993)|990101|abbcdef", "MN": "D12.776.664.962.829.375", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1982-1992)", "MS": "A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U5 snRNP along with U4-U6 snRNP preassemble into a single 25S particle that binds to the U1 and U2 snRNPs and the substrate to form SPLICEOSOMES.", "OL": "use RIBONUCLEOPROTEINS, SMALL NUCLEAR (NM) to search U5 SNRNP 1982-92", "PM": "2000; RIBONUCLEOPROTEINS, SMALL, U5 was heading 1993-1999; U5 SNRNP was indexed under RIBONUCLEOPROTEINS 1982-92", "HN": "2000; U5 SNRNP was SY to SMALL RIBONUCLEOPROTEINS (NM) 1982-92", "MR": "20160705", "DA": "19920603", "DC": "1", "DX": "19930101", "UI": "D017415"}, {"RECTYPE": "D", "MH": "Meta-Analysis", "MN": "V03.600", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific meta-analysis study; a different heading META-ANALYSIS AS TOPIC is used for general design, methodology, economics, etc of meta-analyses", "MS": "Works consisting of studies using a quantitative method of combining the results of independent studies (usually drawn from the published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc. It is often an overview of clinical trials. It is usually called a meta-analysis by the author or sponsoring body and should be differentiated from reviews of literature.", "HN": "2008(1993)", "MR": "20130709", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D017418"}, {"RECTYPE": "D", "MH": "Potassium, Dietary", "AQ": "AD AE AG AI AN BL CF CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dietary Potassium|T168|T197|NON|EQV|NLM (1993)|920325|abbcdef", "MN": "D01.745.775", "EC": "chemistry:Potassium:chemistry", "MH_TH": "NLM (1993)", "ST": "T197", "RN": "0", "AN": "/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther", "PI": "Potassium (1966-1992)", "MS": "Potassium or potassium compounds used in foods or as foods.", "PM": "93", "HN": "93", "MR": "20180702", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017419"}, {"RECTYPE": "D", "MH": "Sequence Analysis", "DE": "SEQ ANAL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Sequence Determination|T059|T063|NON|NRW|NLM (1993)|920326|SEQ DETERMINATION|abbcdefv", "ENTRY": "Sequence Analyses", "MN": "E05.393.760", "MH_TH": "NLM (1993)", "ST": "T063", "AN": "general or unspecified; prefer specifics", "PI": "Base Sequence (1971-1992)", "MS": "A multistage process that includes the determination of a sequence (protein, carbohydrate, etc.), its fragmentation and analysis, and the interpretation of the resulting sequence information.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017421"}, {"RECTYPE": "D", "MH": "Sequence Analysis, DNA", "DE": "SEQ ANAL DNA", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Sequence Determination, DNA|T059|T063|NRW|NLM (1993)|920326|SEQ DETERMINATION DNA|abbdefv", "ENTRY": "Sequencing, DNA", "MN": "E05.393.760.700", "FX": "Molecular Sequence Annotation", "MH_TH": "NLM (1993)", "ST": "T063", "PI": "DNA (1966-1992)", "MS": "A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017422"}, {"RECTYPE": "D", "MH": "Sequence Analysis, RNA", "DE": "SEQ ANAL RNA", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Sequence Determination, RNA|T059|T063|NRW|NLM (1993)|920326|SEQ DETERMINATION RNA|abbdefv", "ENTRY": "Sequencing, RNA", "MN": "E05.393.760.710", "FX": "Molecular Sequence Annotation", "MH_TH": "NLM (1993)", "ST": "T063", "PI": "RNA (1966-1992)", "MS": "A multistage process that includes cloning, physical mapping, subcloning, sequencing, and information analysis of an RNA SEQUENCE.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017423"}, {"RECTYPE": "D", "MH": "Clinical Trial, Phase I", "ENTRY": "Clinical Trial, Phase 1|T062|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V03.175.250.100", "MH_TH": "NLM (1996)", "ST": "T062", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific phase I clinical trial; a different heading CLINICAL TRIALS, PHASE I AS TOPIC is used for general design, methodology, economics, etc. of phase I clinical trials.", "MS": "Work that is the report of a pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques based on a small number of healthy persons and conducted over the period of about a year in either the United States or a foreign country.", "HN": "2008(1993)", "MR": "20150415", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D017426"}, {"RECTYPE": "D", "MH": "Clinical Trial, Phase II", "ENTRY": "Clinical Trial, Phase 2|T061|T062|T064|NON|EQV|NLM (2008)|070625|abbbcdef", "MN": "V03.175.250.200", "MH_TH": "NLM (1996)", "ST": "T064", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific phase II clinical trial; a different heading CLINICAL TRIALS, PHASE II AS TOPIC is used for general design, methodology, economics, etc. of phase II clinical trials.", "MS": "Work that is a report of a pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques based on several hundred volunteers, including a limited number of patients, and conducted over a period of about two years in either the United States or a foreign country.", "HN": "2008(1993)", "MR": "20150415", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D017427"}, {"RECTYPE": "D", "MH": "Clinical Trial, Phase III", "ENTRY": "Clinical Trial, Phase 3|T062|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V03.175.250.300", "MH_TH": "NLM (1996)", "ST": "T062", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific phase III clinical trial; a different heading CLINICAL TRIALS, PHASE III AS TOPIC is used for general design, methodology, economics, etc. of Phase III clinical trials.", "MS": "Work that is a report of a pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques after phase II trials. A large enough group of patients is studied and closely monitored by physicians for adverse response to long-term exposure, over a period of about three years in either the United States or a foreign country.", "HN": "2008(1993)", "MR": "20150415", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D017428"}, {"RECTYPE": "D", "MH": "Clinical Trial, Phase IV", "ENTRY": "Clinical Trial, Phase 4|T061|T062|NON|EQV|NLM (2008)|070625|abbcdef", "MN": "V03.175.250.400", "MH_TH": "NLM (1996)", "ST": "T062", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific phase IV clinical trial; a different heading CLINICAL TRIALS, PHASE IV AS TOPIC is used for general design, methodology, economics, etc. of phase IV clinical trials.", "MS": "Work that is a report of a planned post-marketing study of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale after clinical trials, phases I, II, and III. These studies, conducted in the United States or a foreign country, often garner additional data about the safety and efficacy of a product.", "HN": "2008(1993)", "MR": "20150415", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D017429"}, {"RECTYPE": "D", "MH": "Prostate-Specific Antigen", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "hK3 Kallikrein|T116|T126|EQV|NLM (1999)|980213|HK 003 KALLIKREIN|abbdefs", "ENTRY": "gamma Seminoprotein", "MN": "D23.101.140.625", "FX": "Prostatic Neoplasms", "MH_TH": "NLM (1993)", "ST": "T126", "RN": "EC 3.4.21.77", "PI": "Antigens, Neoplasm (1982-1992)", "MS": "A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.", "OL": "use PROSTATE-SPECIFIC ANTIGEN (NM) to search PROSTATE CANCER SPECIFIC ANTIGENS 1982-92 & SEMENOGELASE 1980-95", "PM": "93; PROSTATE CANCER SPECIFIC ANTIGENS was indexed under ANTIGENS, NEOPLASM 1982-92; SEMENOGELASE was indexed under PROSTATE-SPECIFIC ANTIGEN 1988-95 & PEPTIDE PEPTIDOHYDROLASE 1976-87", "HN": "93; was PROSTATE CANCER SPECIFIC ANTIGENS (NM) 1982-92; SEMENOGELASE was NM 1976-95", "MR": "20220708", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017430"}, {"RECTYPE": "D", "MH": "Genes, MCC", "AQ": "DE ES GE IM PH RE", "ENTRY": "MCC Genes", "MN": "G05.360.340.024.340.415.400.320", "FX": "Genes, DCC", "MH_TH": "NLM (1993)", "ST": "T028", "AN": "MCC stands for \"Mutated in Colorectal Cancer\"", "PI": "Genes, Suppressor, Tumor (1991-1992)", "MS": "Tumor suppressor genes located in the 5q21 region on the long arm of human chromosome 5. The mutation of these genes is associated with the formation of colorectal cancer (MCC stands for mutated in colorectal cancer).", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017431"}, {"RECTYPE": "D", "MH": "Unified Medical Language System", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "UMLS|T062|T170|ABB|EQV|NLM (1992)|920327|abbcdef", "MN": "L01.462.750.245.945.800", "FX": "Terminology as Topic", "MH_TH": "NLM (1992)", "ST": "T170", "AN": "CATALOGER: Use NAF entry", "MS": "A research and development program initiated by the NATIONAL LIBRARY OF MEDICINE to build knowledge sources for the purpose of aiding the development of systems that help health professionals retrieve and integrate biomedical information. The knowledge sources can be used to link disparate information systems to overcome retrieval problems caused by differences in terminology and the scattering of relevant information across many databases. The three knowledge sources are the Metathesaurus, the Semantic Network, and the Specialist Lexicon.", "PM": "92", "HN": "92", "MR": "20220712", "DA": "19920327", "DC": "1", "DX": "19930101", "UI": "D017432"}, {"RECTYPE": "D", "MH": "Protein Structure, Secondary", "DE": "PROTEIN STRUCT SECOND", "AQ": "DE GE PH RE", "ENTRY": "Structures, Secondary Protein", "MN": "G02.111.570.820.709.600", "MH_TH": "NLM (1993)", "ST": "T082", "AN": "IM general only; coordinate NIM with specific protein", "PI": "Proteins (1966-1971)", "MS": "The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to ALPHA-HELICES; BETA-STRANDS (which align to form BETA-SHEETS), or other types of coils. This is the first folding level of protein conformation.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20160705", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017433"}, {"RECTYPE": "D", "MH": "Protein Structure, Tertiary", "AQ": "DE GE PH RE", "ENTRY": "Tertiary Protein Structures", "MN": "G02.111.570.820.709.610", "MH_TH": "NLM (1993)", "ST": "T082", "AN": "IM general only; coordinate NIM with specific protein", "PI": "Proteins (1966-1971)", "MS": "The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20160705", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017434"}, {"RECTYPE": "D", "MH": "Kallmann Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Kallmann's", "MN": "C19.391.482.600", "FX": "Receptor, Fibroblast Growth Factor, Type 1", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Hypogonadism (1966-1992)", "MS": "A genetically heterogeneous disorder caused by hypothalamic GNRH deficiency and OLFACTORY NERVE defects. It is characterized by congenital HYPOGONADOTROPIC HYPOGONADISM and ANOSMIA, possibly with additional midline defects. It can be transmitted as an X-linked (GENETIC DISEASES, X-LINKED), an autosomal dominant, or an autosomal recessive trait.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017436"}, {"RECTYPE": "D", "MH": "Skin and Connective Tissue Diseases", "DE": "SKIN CONNECTIVE TISSUE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17", "RH": "C17 - DISEASES - DERMATOLOGIC AND CONNECTIVE TISSUE", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "A collective term for diseases of the skin and its appendages and of connective tissue.", "PM": "98", "HN": "98; use explode 1993-97", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19920522", "DC": "1", "DX": "19980101", "UI": "D017437"}, {"RECTYPE": "D", "MH": "Bisphenol A-Glycidyl Methacrylate", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Bis-GMA Polymer|T109|T122|ABX|NRW|NLM (1993)|920410|BISGMA POLYMER|abbcdefs", "ENTRY": "Resins, Concise Composite", "MN": "J01.637.051.720.716.822.308.200", "MH_TH": "NLM (1993)", "ST": "T122", "N1": "2-Propenoic acid, 2-methyl-, (1-methylethylidene)bis(4,1-phenyleneoxy(2-hydroxy-3,1-propanediyl)) ester", "RN": "454I75YXY0", "RR": "83382-93-8 (Silux)", "PI": "Resins, Synthetic (1979-1980)", "MS": "The reaction product of bisphenol A and glycidyl methacrylate that undergoes polymerization when exposed to ultraviolet light or mixed with a catalyst. It is used as a bond implant material and as the resin component of dental sealants and composite restorative materials.", "PM": "1993; BIS(PHENOL A-GLYCYDYL METHACRYLATE) was indexed under METHACRYLATES 1987-1992; PANVIA OPAQUE was indexed under DENTIN-BONDING AGENTS 1992-2000 & under ADHESIVES 1992; RETROPLAST was indexed under POLYMETHACRYLIC ACIDS 1992; SILUX was indexed under COMPOSITE RESINS 1984-1992; ADAPTIC was indexed under POLYMETHACRYLIC ACIDS 1981-1992; CONCISE WHITE SEALANT was indexed under COMPOSITE RESINS 1981-1992; BIS(PHENOL A-GLYCYDYL METHACRYLATE) HOMOPOLYMER was indexed under POLYMETHACRYLIC ACIDS 1984-1992, METHACRYLATES 1975-1983, EPOXY RESINS 1979-1982 & RESINS, SYNTHETIC 1979-1980", "HN": "1993; use BIS(PHENOL A-GLYCYDYL METHACRYLATE) (NM) 1975-1992; for PANVIA OPAQUE use BIS(PHENOL A-GLYCYDYL METHACRYLATE) (NM) 1992-2000; for RETROPLAST use BIS(PHENOL A-GLYCYDYL METHACRYLATE) (NM) 1992; for SILUX use BIS(PHENOL A-GLYCYDYL METHACRYLATE) (NM) 1984-1992; for ADAPTIC, CONCISE & CONCISE WHITE SEALANT use BIS(PHENOL A-GLYCYDYL METHACRYLATE) (NM) 1981-1992; BIS(PHENOL A-GLYCIDYL METHACRYLATE), HOMOPOLYMER use BIS(PHENOL A-GLYCYDYL METHACRYLATE) (NM) 1975-1992", "MR": "20130708", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017438"}, {"RECTYPE": "D", "MH": "Cicatrix, Hypertrophic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Scars, Hypertrophic|T020|NON|EQV|NLM (1993)|920330|abcdef", "ENTRY": "Scar, Hypertrophic", "MN": "C23.550.355.274.505", "FX": "Keloid", "MH_TH": "NLM (1993)", "ST": "T020", "AN": "does not spread to surrounding tissue: do not confuse with KELOID which does; follow text of author", "PI": "Cicatrix (1966-1992)", "MS": "An elevated scar, resembling a KELOID, but which does not spread into surrounding tissues. It is formed by enlargement and overgrowth of cicatricial tissue and regresses spontaneously.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017439"}, {"RECTYPE": "D", "MH": "Photoperiod", "ENTRY": "Photoperiods", "MN": "G01.910.675", "FX": "Circadian Rhythm", "MH_TH": "NLM (1993)", "ST": "T079", "PI": "Periodicity (1966-1992)", "MS": "The time period of daily exposure that an organism receives from daylight or artificial light. It is believed that photoperiodic responses may affect the control of energy balance and thermoregulation.", "PM": "93", "HN": "93", "MR": "20100625", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017440"}, {"RECTYPE": "D", "MH": "Necrobiotic Disorders", "DE": "NECROBIOTIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Necrobiotic Disorder", "MN": "C17.800.550", "MH_TH": "NLM (1993)", "ST": "T046", "AN": "a group of collagen dis affecting the \"collagen bundles in the dermis\"; NECROBIOSIS LIPOIDICA with or without diabetes mellitus is also available", "MS": "A group of disorders characterized by swelling, basophilia, and distortion of collagen bundles in the dermis.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017441"}, {"RECTYPE": "D", "MH": "Histamine Agonists", "DE": "HISTAMINE AG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Histamine H3 Agonists|T121|NON|NRW|NLM (1995)|940505|HISTAMINE AGONISTS H 003|HISTAMINE H3 AGON|abcdefsv", "ENTRY": "H3 Agonists, Histamine", "MN": "D27.505.696.577.375.400", "MH_TH": "NLM (1993)", "ST": "T121", "RN": "0", "AN": "do not confuse with HISTAMINE ANTAGONISTS", "PI": "Receptors, Histamine/drug effects (1975-1992)", "MS": "Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically.", "OL": "use HISTAMINE AGONISTS to search HISTAMINE H1 RECEPTOR AGONISTS & HISTAMINE H2 RECEPTOR AGONISTS 1993-94", "PM": "93; HISTAMINE H1 RECEPTOR AGONISTS & HISTAMINE H2 RECEPTOR AGONISTS were see HISTAMINE AGONISTS 1993-94", "HN": "93; HISTAMINE H1 RECEPTOR AGONISTS & HISTAMINE H2 RECEPTOR AGONISTS were see HISTAMINE AGONISTS 1993-94", "MR": "20050630", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017442"}, {"RECTYPE": "D", "MH": "Skin Diseases, Eczematous", "DE": "SKIN DIS ECZEMATOUS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Eczematous Skin Diseases|T047|NON|EQV|NLM (1993)|920331|ECZEMATOUS SKIN DIS|abcdefv", "ENTRY": "Skin Disease, Eczematous", "MN": "C17.800.815", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "general or unspecified; prefer ECZEMA or specific eczematous skin disease", "PI": "Skin Diseases (1966-1992)", "MS": "Any of a variety of eruptive skin disorders characterized by erythema, oozing, vesiculation, and scaling. Etiology is varied.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017443"}, {"RECTYPE": "D", "MH": "Skin Diseases, Papulosquamous", "DE": "SKIN DIS PAPULOSQUAMOUS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Papulosquamous Disorders|T047|NON|EQV|NLM (1993)|920422|PAPULOSQUAMOUS DIS|abcdefv", "ENTRY": "Skin Disease, Papulosquamous", "MN": "C17.800.859", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Skin Diseases (1966-1992)", "MS": "A group of dermatoses with distinct morphologic features. The primary lesion is most commonly a papule, usually erythematous, with a variable degree of scaling on the surface. Plaques form through the coalescing of primary lesions.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017444"}, {"RECTYPE": "D", "MH": "Skin Diseases, Vascular", "DE": "SKIN DIS VASCULAR", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cutaneous Vasculitis|T047|NON|NRW|NLM (2023)|210910|abcdef", "ENTRY": "Vasculitis, Cutaneous", "MN": "C17.800.862", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Skin Diseases (1966-1992)", "MS": "Skin diseases affecting or involving the cutaneous blood vessels and generally manifested as inflammation, swelling, erythema, or necrosis in the affected area.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017445"}, {"RECTYPE": "D", "MH": "Impromidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trihydrochloride, Impromidine", "MN": "D03.383.129.308.445", "PA": "Histamine Agonists", "MH_TH": "NLM (1993)", "ST": "T121", "N1": "Guanidine, N-(3-(1H-imidazol-4-yl)propyl)-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)-", "RN": "931L4X5WMM", "RR": "E57WP5Y41J", "PI": "Imidazoles (1979-1992)", "MS": "A highly potent and specific histamine H2 receptor agonist. It has been used diagnostically as a gastric secretion indicator.", "OL": "use IMPROMIDINE (NM) to search IMPROMIDINE 1980-92", "PM": "93; IMPROMIDINE was indexed under GUANIDINES 1979-82 & 1989-92, & IMIDAZOLES 1979-92", "HN": "93; was IMPROMIDINE (NM) 1979-92", "MR": "20160531", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017446"}, {"RECTYPE": "D", "MH": "Receptors, Dopamine D1", "DE": "RECEPT DOPAMINE D1", "DS": "RECEPTORS DOPAMINE D 001", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Dopamine D1 Receptors|T116|T192|NON|EQV|NLM (1993)|920331|DOPAMINE RECEPTORS D 01|DOPAMINE D1 RECEPT|abbcdefsv", "ENTRY": "Receptor, Dopamine-D1", "MN": "D12.776.543.750.720.330.400.400", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Dopamine (1982-1992)", "MS": "A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D1-class receptor genes lack INTRONS, and the receptors stimulate ADENYLYL CYCLASES.", "OL": "use RECEPTORS, DOPAMINE D1 (NM) to search DOPAMINE-D1 RECEPTOR 1982-92", "PM": "93; DOPAMINE-D1 RECEPTOR was indexed under RECEPTORS, DOPAMINE 1982-92", "HN": "93; was DOPAMINE-D1 RECEPTOR (NM) 1982-92", "MR": "20160617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017447"}, {"RECTYPE": "D", "MH": "Receptors, Dopamine D2", "DE": "RECEPT DOPAMINE D2", "DS": "RECEPTORS DOPAMINE D 002", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Dopamine D2 Receptors|T116|T192|NON|EQV|NLM (1993)|920331|DOPAMINE RECEPTORS D 02|DOPAMINE D2 RECEPT|abbcdefsv", "ENTRY": "Receptor, Dopamine-D2", "MN": "D12.776.543.750.720.330.400.500", "EC": "antagonists & inhibitors:Dopamine D2 Receptor Antagonists", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Dopamine (1982-1992)", "MS": "A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES.", "OL": "use RECEPTORS, DOPAMINE D2 (NM) to search DOPAMINE-D2 RECEPTOR 1982-92", "PM": "93; DOPAMINE-D2 RECEPTOR was indexed under RECEPTORS, DOPAMINE 1982-92", "HN": "93; was DOPAMINE-D2 RECEPTOR (NM) 1982-92", "MR": "20160617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017448"}, {"RECTYPE": "D", "MH": "Dermatitis, Allergic Contact", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dermatitis, Contact, Allergic|T047|NON|EQV|NLM (1993)|920331|abcdef", "ENTRY": "Eczematous Dermatitis, Allergic", "MN": "C20.543.418.150", "FX": "Latex Hypersensitivity", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Dermatitis, Contact (1966-1992)", "MS": "A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20010814", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017449"}, {"RECTYPE": "D", "MH": "Receptors, Opioid, mu", "DE": "RECEPT OPIOID MU", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "mu Receptors|T116|T192|NON|EQV|NLM (1993)|920331|MU RECEPT|abbcdefv", "ENTRY": "mu Opioid Receptors", "MN": "D12.776.543.750.750.555.610.550", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Endorphin (1981-1992)", "MS": "A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine.", "OL": "use RECEPTORS, OPIOID, MU to search RECEPTORS, MU 1993; use RECEPTORS, OPIOID, MU (NM) to search MU RECEPTOR 1981-92; use RECEPTORS, OPIOID to search MORPHINE RECEPTORS & RECEPTORS, MORPHINE 1977-94", "PM": "94; was RECEPTORS, MU 1993; MU RECEPTOR was indexed under RECEPTORS, ENDORPHIN 1981-92; MORPHINE RECEPTORS & RECEPTORS, MORPHINE were see RECEPTORS, OPIOID 1977-94", "HN": "94; was RECEPTORS, MU 1993; was MU RECEPTOR (NM) 1981-92; MORPHINE RECEPTORS & RECEPTORS, MORPHINE were see RECEPTORS, OPIOID 1977-94", "MR": "20160617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017450"}, {"RECTYPE": "D", "MH": "Receptors, Somatomedin", "DE": "RECEPT SOMATOMEDIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Somatomedin Receptors|T116|T192|NON|EQV|NLM (1993)|920416|SOMATOMEDIN RECEPT|abbcdefv", "ENTRY": "Receptors, Insulin Like Growth Factors", "MN": "D12.776.543.750.750.400.780", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "AN": "specifics are also available", "PI": "Receptors, Insulin (1980-1989)", "MS": "Cell surface receptors that bind somatomedins and trigger intracellular changes which influence the behavior of cells. Studies have disclosed two types of receptors for this family of peptide hormones. The type I receptor is homologous to the insulin receptor and has tyrosine kinase activity. The type II receptor is identical to the mannose-6-phosphate receptor which is important in trafficking of lysosomal enzymes.", "OL": "use RECEPTORS, SOMATOMEDIN (NM) to search INSULIN-LIKE GROWTH FACTOR RECEPTOR 1980-92; use RECEPTORS, SOMATOMEDIN to search INSULIN-LIKE GROWTH FACTORS RECEPTOR 1993", "PM": "93; INSULIN-LIKE GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1980-92 & RECEPTORS, INSULIN 1980-89; INSULIN-LIKE GROWTH FACTORS RECEPTORS was see RECEPTORS, SOMATOMEDIN 1993", "HN": "93; was INSULIN-LIKE GROWTH FACTOR RECEPTOR (NM) 1980-92; INSULIN-LIKE GROWTH FACTORS RECEPTORS was see RECEPTORS, SOMATOMEDIN 1993", "MR": "19970620", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017451"}, {"RECTYPE": "D", "MH": "Receptors, IgG", "DE": "RECEPT IGG", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "gamma Fc Receptors|T116|T129|T192|EQV|NLM (1993)|920331|GAMMA FC RECEPT|abbbdefv", "ENTRY": "gamma Receptors, Fc", "MN": "D12.776.543.750.705.871.300", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1981-1987)", "MS": "Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IMMUNOGLOBULIN Gs. Three subclasses exist: Fc gamma RI (the CD64 antigen, a low affinity receptor), Fc gamma RII (the CD32 antigen, a high affinity receptor), and Fc gamma RIII (the CD16 antigen, a low affinity receptor).", "PM": "1993; see CD32 ANTIGEN 1988-1992; IMMUNOGLOBULIN G RECEPTOR was indexed under ANTIGENS, DIFFERENTIATION 1988-92, RECEPTORS, FC 1981-92 & RECEPTORS, IMMUNOLOGIC 1981-87; CD32 ANTIGEN was indexed under ANTIGENS, CD 1990-92 & ANTIGENS, DIFFERENTIATION 1988-91", "HN": "1993; use CD32 ANTIGEN 1988-1992", "MR": "20200527", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017452"}, {"RECTYPE": "D", "MH": "Dermatitis, Irritant", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Irritant Dermatitis|T047|NON|EQV|NLM (1993)|920331|abcdef", "ENTRY": "Primary Irritant Dermatitis", "MN": "C17.800.815.255.400", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "\"a non-allergic contact dermatitis caused by prolonged exposure to irritants\"", "PI": "Dermatitis, Contact (1966-1992)", "MS": "A non-allergic contact dermatitis caused by prolonged exposure to irritants and not explained by delayed hypersensitivity mechanisms.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017453"}, {"RECTYPE": "D", "MH": "Dermatitis, Photoallergic", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Photoallergy|T047|NON|BRD|NLM (1993)|920331|abcdef", "ENTRY": "Photosensitive Contact Dermatitides", "MN": "C20.543.418.150.600", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "a delayed hypersensitivity", "PI": "Photosensitivity Disorders (1966-1992)", "MS": "A delayed hypersensitivity involving the reaction between sunlight or other radiant energy source and a chemical substance to which the individual has been previously exposed and sensitized. It manifests as a papulovesicular, eczematous, or exudative dermatitis occurring chiefly on the light-exposed areas of the skin.", "OL": "use PHOTOSENSITIVITY DISORDERS to search DERMATITIS, CONTACT, PHOTOSENSITIVE; DERMATITIS, PHOTOCONTACT; & PHOTOALLERGY 1979-92", "PM": "93; DERMATITIS, CONTACT, PHOTOSENSITIVE; DERMATITIS, PHOTOCONTACT; & PHOTOALLERGY were see PHOTOSENSITIVITY DISORDERS 1979-92", "HN": "93; DERMATITIS, CONTACT, PHOTOSENSITIVE; DERMATITIS, PHOTOCONTACT; & PHOTOALLERGY were see PHOTOSENSITIVITY DISORDERS 1979-92", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017454"}, {"RECTYPE": "D", "MH": "Receptors, IgE", "DE": "RECEPT IGE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "epsilon Fc Receptors|T116|T129|T192|EQV|NLM (1993)|920331|EPSILON FC RECEPT|abbbdefv", "ENTRY": "epsilon Receptors, Fc", "MN": "D12.776.543.750.705.871.280", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1981-1987)", "MS": "Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI).", "PM": "1993; see IMMUNOGLOBULIN E RECEPTOR 1991-1992; RECEPTORS, IGE was indexed under RECEPTORS, FC 1981-92, ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-92, and under RECEPTORS, IMMUNOLOGIC 1981-87", "HN": "1993", "MR": "20200527", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017455"}, {"RECTYPE": "D", "MH": "Adenovirus Early Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenovirus Early Region Transforming Proteins|T116|T129|NON|EQV|NLM (1993)|920408|abbcdef", "ENTRY": "Proteins, Adenovirus E29", "MN": "D23.050.327.045", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Oncogene Proteins, Viral (1985-1992)", "MS": "Proteins encoded by adenoviruses that are synthesized prior to, and in the absence of, viral DNA replication. The proteins are involved in both positive and negative regulation of expression in viral and cellular genes, and also affect the stability of viral mRNA. Some are also involved in oncogenic transformation.", "OL": "use ADENOVIRUS EARLY PROTEINS (NM) to search ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS 1985-92", "PM": "93; ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS was indexed under ONCOGENE PROTEINS, VIRAL 1985-92 & ANTIGENS, VIRAL, TUMOR 1985", "HN": "93; was ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS (NM) 1985-92", "MR": "20220413", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017456"}, {"RECTYPE": "D", "MH": "Receptors, Albumin", "DE": "RECEPT ALBUMIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Albumin Receptors|T116|T192|NON|EQV|NLM (1993)|920331|ALBUMIN RECEPT|abbcdefv", "ENTRY": "Receptor, Albumin", "MN": "D12.776.543.750.750.100", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "AN": "coord IM with specific albumin (IM)", "PI": "Receptors, Endogenous Substances (1981-1992)", "MS": "Cell surface proteins that bind albumin with high affinity and trigger intracellular changes influencing the behavior of cells.", "OL": "use RECEPTORS, ALBUMIN (NM) to search ALBUMIN RECEPTOR 1981-92", "PM": "93; ALBUMIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-92 & RECEPTORS, HORMONE 1981-82", "HN": "93; was ALBUMIN RECEPTOR (NM) 1981-92", "MR": "19970620", "DA": "19920526", "DC": "1", "DX": "19930101", "UI": "D017457"}, {"RECTYPE": "D", "MH": "Receptors, Amino Acid", "DE": "RECEPT AA", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Amino Acid Receptors|T116|T192|NON|EQV|NLM (1993)|920331|AA RECEPT|abbcdefv", "ENTRY": "Amino Acids Receptors", "MN": "D12.776.543.750.720.200", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "AN": "coord IM with specific amino acid (IM)", "PI": "Receptors, Endogenous Substances (1981-1992)", "MS": "Cell surface proteins that bind amino acids and trigger changes which influence the behavior of cells. Glutamate receptors are the most common receptors for fast excitatory synaptic transmission in the vertebrate central nervous system, and GAMMA-AMINOBUTYRIC ACID and glycine receptors are the most common receptors for fast inhibition.", "OL": "use RECEPTORS, AMINO ACID (NM) to search AMINO ACID RECEPTOR 1981-92", "PM": "93; AMINO ACID RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-92", "HN": "93; was AMINO ACID RECEPTOR (NM) 1981-92", "MR": "20190524", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017459"}, {"RECTYPE": "D", "MH": "Receptors, Atrial Natriuretic Factor", "DE": "RECEPT ATRIAL NATRIURETIC FACTOR", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Atriopeptin|T116|T126|T192|NON|EQV|NLM (1993)|920416|RECEPT ATRIOPEPTIN|abbbcdefv", "ENTRY": "Receptor, ANP", "MN": "D12.776.543.750.750.160", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "EC 4.6.1.2", "PI": "Receptors, Endogenous Substances (1984-1992)", "MS": "Cell surface proteins that bind ATRIAL NATRIURETIC FACTOR with high affinity and trigger intracellular changes influencing the behavior of cells. They contain intrinsic guanylyl cyclase activity.", "OL": "use RECEPTORS, ATRIAL NATRIURETIC FACTOR (NM) to search ATRIAL NATRIURETIC FACTOR RECEPTOR 1984-92", "PM": "93; ATRIAL NATRIURETIC FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1984-92 & MUSCLE PROTEINS 1984-85", "HN": "93; was ATRIAL NATRIURETIC FACTOR RECEPTOR (NM) 1984-92", "MR": "20210630", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017461"}, {"RECTYPE": "D", "MH": "Receptors, Complement 3b", "DE": "RECEPT C 3B", "DS": "RECEPTORS COMPLEMENT 03 B", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, CR1|T116|T129|T192|EQV|NLM (1993)|920331|RECEPTORS CR 01|RECEPT CR1|abbbdefsv", "ENTRY": "Receptor, Complement 3b", "MN": "D12.776.543.750.705.833.600", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Complement (1982-1992)", "MS": "Molecular sites on or in some B-lymphocytes and macrophages that recognize and combine with COMPLEMENT C3B. The primary structure of these receptors reveal that they contain transmembrane and cytoplasmic domains, with their extracellular portion composed entirely of thirty short consensus repeats each having 60 to 70 amino acids.", "PM": "1993; see COMPLEMENT 3B RECEPTOR 1982-92; RECEPTORS, COMPLEMENT 3B was indexed under RECEPTORS, COMPLEMENT 1982-92", "HN": "1993", "MR": "20170524", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017463"}, {"RECTYPE": "D", "MH": "Receptors, Complement 3d", "DE": "RECEPT C 3D", "DS": "RECEPTORS COMPLEMENT 03 D", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, CR2|T116|T129|T192|EQV|NLM (1993)|920331|RECEPTORS CR 02|RECEPT CR2|abbbdefsv", "ENTRY": "Virus Receptors, Epstein-Barr", "MN": "D12.776.543.750.830.250", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Complement (1981-1992)", "MS": "Molecular sites on or in B-lymphocytes, follicular dendritic cells, lymphoid cells, and epithelial cells that recognize and combine with COMPLEMENT C3D. Human complement receptor 2 (CR2) serves as a receptor for both C3dg and the gp350/220 glycoprotein of HERPESVIRUS 4, HUMAN, and binds the monoclonal antibody OKB7, which blocks binding of both ligands to the receptor.", "PM": "1993; EPSTEIN-BARR VIRUS RECEPTOR was indexed under RECEPTORS, VIRUS 1981-98; RECEPTORS, COMPLEMENT 3D was indexed under RECEPTORS, COMPLEMENT and ANTIGENS 1981-92, and under DIFFERENTIATION, B-LYMPHOCYTE 1988-92", "HN": "1993", "MR": "20170524", "DA": "19920603", "DC": "1", "DX": "19930101", "UI": "D017464"}, {"RECTYPE": "D", "MH": "Receptors, Opioid, delta", "DE": "RECEPT OPIOID DELTA", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "delta Receptors|T116|T192|NON|EQV|NLM (1993)|920331|DELTA RECEPT|abbcdefv", "ENTRY": "delta Opioid Receptors", "MN": "D12.776.543.750.750.555.610.200", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Endorphin (1982-1992)", "MS": "A class of opioid receptors recognized by its pharmacological profile. Delta opioid receptors bind endorphins and enkephalins with approximately equal affinity and have less affinity for dynorphins.", "OL": "use RECEPTORS, OPIOID, DELTA to search RECEPTORS, DELTA 1993; use RECEPTORS, OPIOID, DELTA (NM) to search DELTA RECEPTOR 1982-92", "PM": "94; was RECEPTORS, DELTA 1993; DELTA RECEPTOR was indexed under RECEPTORS, ENDORPHIN 1982-92", "HN": "94; was RECEPTORS, DELTA 1993; was DELTA RECEPTOR (NM) 1982-92", "MR": "20160617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017465"}, {"RECTYPE": "D", "MH": "Receptors, Endothelin", "DE": "RECEPT ENDOTHELIN", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Endothelium-Derived Vasoconstrictor Factor|T116|T192|NON|EQV|NLM (1994)|930506|RECEPT ENDOTHELIUM DERIVED VASOCONSTRICTOR FACTOR|abbcdefv", "ENTRY": "Receptors, Endothelium Derived Vasoconstrictor Factor", "MN": "D12.776.543.750.750.320", "EC": "antagonists & inhibitors:Endothelin Receptor Antagonists", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1988-1992)", "MS": "Cell surface proteins that bind ENDOTHELINS with high affinity and trigger intracellular changes which influence the behavior of cells.", "OL": "use RECEPTORS, ENDOTHELIN to search ENDOTHELIN DERIVED VASOCONSTRICTOR FACTORS RECEPTORS & RECEPTORS, ENDOTHELIUM DERIVED VASOCONSTRICTOR FACTORS 1993; use RECEPTORS, ENDOTHELIN (NM) to search ENDOTHELIN RECEPTOR 1988-92", "PM": "93; ENDOTHELIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1988-92; ENDOTHELIN DERIVED VASOCONSTRICTOR FACTORS RECEPTORS & RECEPTORS, ENDOTHELIUM DERIVED VASOCONSTRICTOR FACTORS were see RECEPTORS, ENDOTHELIN 1993", "HN": "93; was ENDOTHELIN RECEPTOR (NM) 1988-92; ENDOTHELIN DERIVED VASOCONSTRICTOR FACTORS RECEPTORS & RECEPTORS, ENDOTHELIUM-DERIVED VASOCONSTRICTOR FACTORS were see RECEPTORS, ENDOTHELIN 1993", "MR": "20160617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017466"}, {"RECTYPE": "D", "MH": "Receptors, Erythropoietin", "DE": "RECEPT ERYTHROPOIETIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Erythropoietin Receptors|T116|T192|NON|EQV|NLM (1993)|920331|ERYTHROPOIETIN RECEPT|abbcdefv", "ENTRY": "Receptor, Erythropoietin", "MN": "D12.776.543.750.750.400.200.340", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1985-1992)", "MS": "Cell surface proteins that bind erythropoietin with high affinity and trigger intracellular changes influencing the behavior of cells.", "OL": "use RECEPTORS, ERYTHROPOIETIN (NM) to search ERYTHROPOIETIN RECEPTOR 1985-92", "PM": "93; ERYTHROPOIETIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1985-92", "HN": "93; was ERYTHROPOIETIN RECEPTOR (NM) 1985-92", "MR": "20030709", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017467"}, {"RECTYPE": "D", "MH": "Receptors, Fibroblast Growth Factor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, FGF|T116|T192|ACX|EQV|NLM (1993)|920331|RECEPT FGF|abbcdefv", "ENTRY": "Receptor, FGF", "MN": "D12.776.543.750.750.400.370", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "AN": "coordinate with specific FIBROBLAST GROWTH FACTORS ", "PI": "Receptors, Mitogen (1985-2004)", "MS": "Specific molecular sites or structures on cell membranes that react with FIBROBLAST GROWTH FACTORS (both the basic and acidic forms), their analogs, or their antagonists to elicit or to inhibit the specific response of the cell to these factors. These receptors frequently possess tyrosine kinase activity.", "PM": "2004; FIBROBLAST GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1985-1992; HEPARIN-BINDING GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, MITOGEN & RECEPTORS, GROWTH FACTOR 1985-2003", "HN": "2004; use FIBROBLAST GROWTH FACTOR RECEPTOR (NM) 1985-1992", "MR": "20210628", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017468"}, {"RECTYPE": "D", "MH": "Receptors, Fibronectin", "DE": "RECEPT FIBRONECTIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Fibronectin Receptors|T116|T129|T192|NON|EQV|NLM (1993)|920331|FIBRONECTIN RECEPT|abbbcdefv", "MN": "D12.776.543.750.705.408.530", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "AN": "do not confuse with FIBRONECTIN RECEPTOR see INTEGRIN ALPHA5BETA1", "PI": "Receptors, Immunologic (1984-1992)", "MS": "Specific cell surface receptors which bind to FIBRONECTINS. Studies have shown that these receptors function in certain types of adhesive contact as well as playing a major role in matrix assembly. These receptors include the traditional fibronectin receptor, also called INTEGRIN ALPHA5BETA1 and several other integrins.", "PM": "1993; FIBRONECTIN RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1984-1992 & RECEPTORS, ENDOGENOUS SUBSTANCES 1981-84", "HN": "1993; use FIBRONECTIN RECEPTOR (NM) 1981-1992", "MR": "20030709", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017469"}, {"RECTYPE": "D", "MH": "Receptors, Glutamate", "DE": "RECEPT GLUTAMATE", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Excitatory Amino Acid|T116|T192|NON|REL|NLM (1994)|930202|RECEPT EXCITATORY AA|abbcdefv", "ENTRY": "Receptor, Glutamate", "MN": "D12.776.543.750.720.200.450", "EC": "antagonists & inhibitors:Excitatory Amino Acid Antagonists", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "AN": " general or unspecified; prefer specifics ", "PI": "Receptors, Synaptic (1980-1992)", "MS": "Cell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells. Glutamate receptors include ionotropic receptors (AMPA, kainate, and N-methyl-D-aspartate receptors), which directly control ion channels, and metabotropic receptors which act through second messenger systems. Glutamate receptors are the most common mediators of fast excitatory synaptic transmission in the central nervous system. They have also been implicated in the mechanisms of memory and of many diseases.", "OL": "use RECEPTORS, GLUTAMATE (NM) to search GLUTAMATE RECEPTOR 1980-92; use RECEPTORS, AMINO ACID to search EXCITATORY AMINO ACID RECEPTORS & RECEPTORS, EXCITATORY AMINO ACID 1993", "PM": "93; GLUTAMATE RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1980-92, RECEPTORS, ENDOGENOUS SUBSTANCES 1980-84 & RECEPTORS, DRUG 1980-81; EXCITATORY AMINO ACID RECEPTORS & RECEPTORS, EXCITATORY AMINO ACID were see RECEPTORS, AMINO ACID 1993", "HN": "93; was GLUTAMATE RECEPTOR (NM) 1980-92; EXCITATORY AMINO ACID RECEPTORS & RECEPTORS, EXCITATORY AMINO ACID were see RECEPTORS, AMINO ACID 1993", "MR": "20180701", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017470"}, {"RECTYPE": "D", "MH": "Receptors, Interferon", "DE": "RECEPT INTERFERON", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interferon Receptors|T116|T129|T192|NON|EQV|NLM (1993)|920331|INTERFERON RECEPT|abbbcdefv", "ENTRY": "Receptor, Interferon", "MN": "D12.776.543.750.705.852.400", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1984-1992)", "MS": "Specific molecular sites or structures on or in cells with which interferons react or to which they bind in order to modify the function of the cells. Interferons exert their pleiotropic effects through two different receptors. alpha- and beta-interferon crossreact with common receptors, while gamma-interferon initiates its biological effects through its own specific receptor system.", "OL": "use RECEPTORS, INTERFERON (NM) to search INTERFERON RECEPTOR 1980-92", "PM": "93; INTERFERON RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1984-92, RECEPTORS, ENDOGENOUS SUBSTANCES 1980-84 & RECEPTORS, DRUG 1980-81", "HN": "93; was INTERFERON RECEPTOR (NM) 1980-92", "MR": "20030709", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017471"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-1", "DE": "RECEPT IL 1", "DS": "RECEPTORS INTERLEUKIN 001", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, IL-1|T116|T192|EQV|NLM (1993)|920417|RECEPTORS IL 001|RECEPT IL1|abbdefsv", "ENTRY": "Receptors, Interleukin 1", "MN": "D12.776.543.750.705.852.420.300", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1985-1992)", "MS": "Cell surface receptors that are specific for INTERLEUKIN-1. Included under this heading are signaling receptors, non-signaling receptors and accessory proteins required for receptor signaling. Signaling from interleukin-1 receptors occurs via interaction with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88.", "PM": "1993; INTERLEUKIN 1 RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1985-1992", "HN": "1993(1985)", "MR": "20200527", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017472"}, {"RECTYPE": "D", "MH": "Receptors, Opioid, kappa", "DE": "RECEPT OPIOID KAPPA", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "kappa Receptors|T116|T192|NON|EQV|NLM (1993)|920331|KAPPA RECEPT|abbcdefv", "ENTRY": "kappa Opioid Receptors", "MN": "D12.776.543.750.750.555.610.400", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Endorphin (1980-1992)", "MS": "A class of opioid receptors recognized by its pharmacological profile. Kappa opioid receptors bind dynorphins with a higher affinity than endorphins which are themselves preferred to enkephalins.", "OL": "use RECEPTORS, OPIOID, KAPPA to search RECEPTORS, KAPPA 1993; use RECEPTORS, OPIOID, KAPPA (NM) to search KAPPA RECEPTOR 1980-92", "PM": "94; was RECEPTORS, KAPPA 1993; KAPPA RECEPTOR was indexed under RECEPTORS, ENDORPHIN 1980-92", "HN": "94; was RECEPTORS, KAPPA 1993; was KAPPA RECEPTOR (NM) 1980-92", "MR": "20160617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017473"}, {"RECTYPE": "D", "MH": "Receptors, Laminin", "DE": "RECEPT LAMININ", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Laminin Receptors|T116|T129|T192|NON|EQV|NLM (1993)|920331|LAMININ RECEPT|abbbcdefv", "ENTRY": "Receptor, Laminin", "MN": "D12.776.543.750.705.876", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1984-1992)", "MS": "Glycoprotein molecules on the surface of cells that react with or bind to laminin whose function allows the binding of epithelial cells to the basement membrane. The molecular weight of this high-affinity receptor is 67 kD.", "OL": "use RECEPTORS, LAMININ (NM) to search LAMININ RECEPTOR 1983-92", "PM": "93; LAMININ RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1984-92 & RECEPTORS, ENDOGENOUS SUBSTANCES 1983-84", "HN": "93; was LAMININ RECEPTOR (NM) 1983-92", "MR": "20030709", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017474"}, {"RECTYPE": "D", "MH": "Receptors, Nerve Growth Factor", "DE": "RECEPT NERVE GROWTH FACTOR", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Neurotrophin|T116|T192|NON|EQV|NLM (2000)|991103|RECEPT NEUROTROPHIN|abbcdefv", "ENTRY": "Receptor, Neurotrophin", "MN": "D12.776.543.750.750.400.550", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "AN": "coord IM with specific nerve growth factor (IM) but note RECEPTOR, NERVE GROWTH FACTOR and other specifics are available", "PI": "Receptors, Endogenous Substances (1980-1992)", "MS": "Cell surface receptors that bind NERVE GROWTH FACTOR; (NGF) and a NGF-related family of neurotrophic factors that includes neurotrophins, BRAIN-DERIVED NEUROTROPHIC FACTOR and CILIARY NEUROTROPHIC FACTOR.", "OL": "use RECEPTORS, NERVE GROWTH FACTOR (NM) to search NERVE GROWTH FACTORS RECEPTOR 1980-92", "PM": "93; NERVE GROWTH FACTORS RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1980-92", "HN": "93; was NERVE GROWTH FACTORS RECEPTOR (NM) 1980-92", "MR": "20210630", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017475"}, {"RECTYPE": "D", "MH": "Receptors, Neuropeptide Y", "DE": "RECEPT NEUROPEPTIDE Y", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Neuropeptide Y Receptors|T116|T192|NON|EQV|NLM (1993)|920401|NEUROPEPTIDE Y RECEPT|abbcdefv", "ENTRY": "Receptor, Neuropeptide Y", "MN": "D12.776.543.750.750.555.540", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurohumor (1986-1992)", "MS": "Cell surface proteins that bind neuropeptide Y with high affinity and trigger intracellular changes which influence the behavior of cells.", "OL": "use RECEPTORS, NEUROPEPTIDE Y (NM) to search NEUROPEPTIDE Y RECEPTOR 1985-92", "PM": "93; NEUROPEPTIDE Y RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1986-92 & RECEPTORS, ENDOGENOUS SUBSTANCES 1985-86", "HN": "93; was NEUROPEPTIDE Y RECEPTOR (NM) 1985-92", "MR": "20160617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017476"}, {"RECTYPE": "D", "MH": "Receptors, Phencyclidine", "DE": "RECEPT PHENCYCLIDINE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, PCP|T116|T192|EQV|NLM (1993)|920401|RECEPT PCP|abbdefv", "ENTRY": "Receptor, Phencylidine", "MN": "D12.776.827.550", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Synaptic (1983-1992)", "MS": "Specific sites or molecular structures on cell membranes or in cells with which phencyclidine reacts or to which it binds to elicit the specific response of the cell to phencyclidine. Studies have demonstrated the presence of multiple receptor sites for PCP. These are the PCP/sigma site, which binds both PCP and psychotomimetic opiates but not certain antipsychotics, and the PCP site, which selectively binds PCP analogs.", "OL": "use RECEPTORS, PHENCYCLIDINE (NM) to search PHENCYCLIDINE RECEPTOR 1981-92", "PM": "93; PHENCYCLIDINE RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1983-92 & RECEPTORS, DRUG 1981-83", "HN": "93; was PHENCYCLIDINE RECEPTOR (NM) 1981-92", "MR": "19970620", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017478"}, {"RECTYPE": "D", "MH": "Receptors, Platelet-Derived Growth Factor", "DE": "RECEPT PLATELET DERIVED GROWTH FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Receptors, PDGF|T116|T126|T192|EQV|NLM (1993)|920401|RECEPT PDGF|abbbdefv", "ENTRY": "Receptors, Platelet Derived Growth Factor", "MN": "D12.776.543.750.750.400.630", "FX": "Platelet-Derived Growth Factor", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptors, Endogenous Substances (1982-1992)", "MS": "Specific receptors on cell membranes that react with PLATELET-DERIVED GROWTH FACTOR, its analogs, or antagonists. The alpha PDGF receptor (RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA) and the beta PDGF receptor (RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA) are the two principle types of PDGF receptors. Activation of the protein-tyrosine kinase activity of the receptors occurs by ligand-induced dimerization or heterodimerization of PDGF receptor types.", "PM": "93; PLATELET-DERIVED GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1982-92; PLATELET DERIVED GROWTH FACTOR RECEPTOR-KINASE was indexed under PROTEIN KINASES 1989-92", "HN": "93; was PLATELET-DERIVED GROWTH FACTOR RECEPTOR (NM) 1982-92; PLATELET DERIVED GROWTH FACTOR RECEPTOR-KINASE was NM 1989-92", "MR": "20210521", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017479"}, {"RECTYPE": "D", "MH": "Receptors, sigma", "DE": "RECEPT SIGMA", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "sigma Receptors|T116|T192|NON|EQV|NLM (1993)|920401|SIGMA RECEPT|abbcdefv", "ENTRY": "sigma Opioid Receptors", "MN": "D12.776.543.750.750.555.610.775", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Endorphin (1981-1992)", "MS": "A class of cell surface receptors recognized by its pharmacological profile. Sigma receptors were originally considered to be opioid receptors because they bind certain synthetic opioids. However they also interact with a variety of other psychoactive drugs, and their endogenous ligand is not known (although they can react to certain endogenous steroids). Sigma receptors are found in the immune, endocrine, and nervous systems, and in some peripheral tissues.", "OL": "use RECEPTORS, SIGMA (NM) to search SIGMA RECEPTOR 1981-92", "PM": "93; SIGMA RECEPTOR was indexed under RECEPTORS, ENDORPHIN 1981-92", "HN": "93; was SIGMA RECEPTOR (NM) 1981-92", "MR": "20160617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017480"}, {"RECTYPE": "D", "MH": "Receptors, Somatostatin", "DE": "RECEPT SOMATOSTATIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Somatostatin Receptors|T116|T192|NON|EQV|NLM (1993)|920401|SOMATOSTATIN RECEPT|abbcdefv", "ENTRY": "Receptor, Somatostatin", "MN": "D12.776.543.750.750.700.800", "FX": "Somatostatin", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurohumor (1986-1992)", "MS": "Cell surface proteins that bind somatostatin and trigger intracellular changes which influence the behavior of cells. Somatostatin is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Activated somatostatin receptors on pituitary cells inhibit the release of growth hormone; those on endocrine and gastrointestinal cells regulate the absorption and utilization of nutrients; and those on neurons mediate somatostatin's role as a neurotransmitter.", "OL": "use RECEPTORS, SOMATOSTATIN (NM) to search SOMATOSTATIN RECEPTOR 1981-92", "PM": "93; SOMATOSTATIN RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1986-92 & RECEPTORS, ENDOGENOUS SUBSTANCES 1981-86", "HN": "93; was SOMATOSTATIN RECEPTOR (NM) 1981-92", "MR": "20160617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017481"}, {"RECTYPE": "D", "MH": "Receptors, Thromboxane", "DE": "RECEPT THROMBOXANE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Thromboxane Receptors|T116|T192|NON|EQV|NLM (1993)|920401|THROMBOXANE RECEPT|abbcdefv", "ENTRY": "Thromboxanes Receptors", "MN": "D12.776.543.750.695.200.800", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "AN": "RECEPTORS, THROMBOXANE A2 is also available", "PI": "Receptors, Prostaglandin (1981-1992)", "MS": "Cell surface proteins that bind THROMBOXANES with high affinity and trigger intracellular changes influencing the behavior of cells. Some thromboxane receptors act via the inositol phosphate and diacylglycerol second messenger systems.", "OL": "use RECEPTORS, THROMBOXANE (NM) to search THROMBOXANE RECEPTOR 1981-92", "PM": "93; THROMBOXANE RECEPTOR was indexed under RECEPTORS, PROSTAGLANDIN 1981-92", "HN": "93; was THROMBOXANE RECEPTOR (NM) 1981-92", "MR": "20160617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017482"}, {"RECTYPE": "D", "MH": "Receptors, Vasopressin", "DE": "RECEPT VASOPRESSIN", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Vasopressin Receptors|T116|T192|NON|EQV|NLM (1993)|920401|VASOPRESSIN RECEPT|abbcdefv", "ENTRY": "Vasopressin Receptor, V1b", "MN": "D12.776.543.750.750.660.900", "FX": "Diabetes Insipidus, Nephrogenic", "EC": "antagonists & inhibitors:Antidiuretic Hormone Receptor Antagonists", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "0", "AN": "coordinate IM with specific vasopressin (IM)", "PI": "Receptors, Cell Surface (1981-1984)", "MS": "Specific molecular sites or proteins on or in cells to which VASOPRESSINS bind or interact in order to modify the function of the cells. Two types of vasopressin receptor exist, the V1 receptor in the vascular smooth muscle and the V2 receptor in the kidneys. The V1 receptor can be subdivided into V1a and V1b (formerly V3) receptors.", "PM": "1993; VASOPRESSIN RECEPTOR was indexed under RECEPTORS, ANGIOTENSIN 1984-1992 & RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1984; ARGIPRESSIN RECEPTOR was indexed under RECEPTORS, VASOPRESSIN 1984-2006", "HN": "1993 (1981)", "MR": "20160617", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017483"}, {"RECTYPE": "D", "MH": "Dermatitis, Phototoxic", "DE": "DERMATITIS PHOTOTOX", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Phototoxicity|T047|NON|BRD|NLM (1993)|920402|PHOTOTOX|abcdefv", "ENTRY": "Phototoxic Dermatitides", "MN": "C17.800.815.255.400.225", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Photosensitivity Disorders (1966-1992)", "MS": "A nonimmunologic, chemically induced type of photosensitivity producing a sometimes vesiculating dermatitis. It results in hyperpigmentation and desquamation of the light-exposed areas of the skin.", "OL": "use PHOTOSENSITIVITY DISORDERS to search PHOTOTOXICITY 1979-92", "PM": "93; PHOTOTOXICITY was see PHOTOSENSITIVITY DISORDERS 1979-92", "HN": "93; PHOTOTOXICITY was see PHOTOSENSITIVITY DISORDERS 1979-92", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017484"}, {"RECTYPE": "D", "MH": "1-Deoxynojirimycin", "DE": "DEOXYNOJIRIMYCIN", "DS": "DEOXYNOJIRIMYCIN 01", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "1-Deoxymannojirimycin|T109|T121|NON|REL|NLM (1993)|920402|DEOXYMANNOJIRIMYCIN 01|abbcdefs", "ENTRY": "1 Deoxynojirimycin Hydrochloride", "MN": "D09.553.500.033", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1993)", "ST": "T121", "N1": "3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-", "RN": "19130-96-2", "RR": "84444-90-6 (1,5-dideoxy-1,5-imino-D-mannitol)", "PI": "Glucosamine/analogs & derivatives (1981-1992)", "MS": "An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity.", "OL": "use 1-DEOXYNOJIRIMYCIN (NM) to search 1,5-DIDEOXY-1,5-IMINO-D-MANNITOL 1984-92 & DEOXYNOJIRIMYCIN 1981-92", "PM": "93; DEOXYNOJIRIMYCIN was indexed under GLUCOSAMINE/analogs & derivatives 1981-92; 1,5-DEOXY-1,5-IMINO-D-MANNITOL was indexed under MANNITOL/analogs & derivatives 1984-92", "HN": "93; was DEOXYNOJIRIMYCIN (NM) 1981-92; 1,5-DIDEOXY-1,5-IMINO-D-MANNITOL was NM 1984-92", "MR": "20170410", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017485"}, {"RECTYPE": "D", "MH": "Acneiform Eruptions", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Eruptions, Acneiform", "MN": "C17.800.030", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Acne Vulgaris (1966-1997)", "MS": "Visible efflorescent lesions of the skin caused by acne or resembling acne. (Dorland, 28th ed, p18, 575)", "PM": "98", "HN": "98; use explode 1993-97", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19920520", "DC": "1", "DX": "19980101", "UI": "D017486"}, {"RECTYPE": "D", "MH": "Ankyrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ankyrin|T116|T123|NON|EQV|NLM (1993)|920408|abbcdef", "MN": "D12.776.543.080", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "AN": "membrane proteins; from the Greek word for anchor with ref to their role in attachment of the cytoskeleton; /drug eff /ultrastruct permitted", "PI": "Membrane Proteins (1979-1992)", "MS": "A family of membrane-associated proteins responsible for the attachment of the cytoskeleton. Erythrocyte-related isoforms of ankyrin attach the SPECTRIN cytoskeleton to a transmembrane protein (ANION EXCHANGE PROTEIN 1, ERYTHROCYTE) in the erythrocyte plasma membrane. Brain-related isoforms of ankyrin also exist.", "OL": "use ANKYRINS (NM) to search ANKYRINS 1979-92", "PM": "93; ANKYRIN was indexed under BLOOD PROTEINS & MEMBRANE PROTEINS 1979-92", "HN": "93; was ANKYRIN (NM) 1979-92", "MR": "20170630", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017487"}, {"RECTYPE": "D", "MH": "Hyperkeratosis, Epidermolytic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ichthyosiform Erythroderma, Bullous Congenital|T047|NON|EQV|NLM (1993)|920403|ICHTHYOSIFORM ERYTHRODERMA BULLOUS CONGEN|abcdefv", "ENTRY": "Ichthyosiformes, Bullous Erythroderma", "MN": "C17.800.827.400.375", "FX": "Keratin-10", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Skin Diseases, Vesiculobullous (1972-1992)", "MS": "A form of congenital ichthyosis inherited as an autosomal dominant trait and characterized by ERYTHRODERMA and severe hyperkeratosis. It is manifested at birth by blisters followed by the appearance of thickened, horny, verruciform scales over the entire body, but accentuated in flexural areas. Mutations in the genes that encode KERATIN-1 and KERATIN-10 have been associated with this disorder.", "PM": "1993; see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-1992; for ERYTHRODERMA ICHTHYOSIFORME, BULLOUS see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-1992, see SKIN DISEASES, BULLOUS 1979-1990", "HN": "1993(1979); use ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-1992; for ERYTHRODERMA ICHTHYOSIFORME, BULLOUS use ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-1992, use SKIN DISEASES, BULLOUS 1979-1990", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017488"}, {"RECTYPE": "D", "MH": "CDC28 Protein Kinase, S cerevisiae", "DS": "CDC 028 PROTEIN KINASE S CEREVISIAE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p34cdc28 Kinase, S cerevisiae|T116|T126|NON|NRW|NLM (2005)|040324|abbcdef", "MN": "D12.776.476.563.646.500.500.375", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.7.11.22", "RR": "EC 2.7.11.22", "PI": "Protein Kinases (1988-1993)", "MS": "A protein kinase encoded by the Saccharomyces cerevisiae CDC28 gene and required for progression from the G1 PHASE to the S PHASE in the CELL CYCLE.", "PM": "1993; CDC28 PROTEIN KINASE (now CDC28 PROTEIN KINASE, S CEREVISIAE) was indexed under PROTEIN KINASES 1991-1993", "HN": "2004(1993)", "MR": "20210521", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017489"}, {"RECTYPE": "D", "MH": "Ichthyosis, Lamellar", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ichthyosiform Erythroderma, Nonbullous Congenital|T019|T047|NON|EQV|NLM (1993)|ORD (2010)|920403|ICHTHYOSIFORM ERYTHRODERMA NONBULLOUS CONGEN|abbcdeefv", "ENTRY": "Syndromes, Harlequin Baby", "MN": "C17.800.827.400.410", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not coord with INFANT, NEWBORN, DISEASES", "PI": "Ichthyosis (1966-1992)", "MS": "A chronic, congenital ichthyosis inherited as an autosomal recessive trait. Infants are usually born encased in a collodion membrane which sheds within a few weeks. Scaling is generalized and marked with grayish-brown quadrilateral scales, adherent at their centers and free at the edges. In some cases, scales are so thick that they resemble armored plate.", "PM": "1993; see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-1992; ERYTHRODERMA ICHTHYOSIFORME, NONBULLOUS see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-1992, see ICHTHYOSIS 1979-1990", "HN": "1993; use ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-1992; ERYTHRODERMA ICHTHYOSIFORME, NONBULLOUS use ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-1992, use ICHTHYOSIS 1979-1990", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017490"}, {"RECTYPE": "D", "MH": "Genes, APC", "AQ": "DE ES PH RE", "PRINT ENTRY": "Genes, Adenomatous Polyposis Coli|T028|NON|EQV|NLM (2002)|010212|abcdef", "ENTRY": "Gene, APC", "MN": "G05.360.340.024.340.415.400.050", "FX": "Gardner Syndrome", "MH_TH": "NLM (1993)", "ST": "T028", "PI": "Polyposis Syndrome, Familial/genetics (1989-1992)", "MS": "Tumor suppressor genes located in the 5q21 region on the long arm of human chromosome 5. The mutation of these genes is associated with familial adenomatous polyposis (ADENOMATOUS POLYPOSIS COLI) and GARDNER SYNDROME, as well as some sporadic colorectal cancers.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017491"}, {"RECTYPE": "D", "MH": "Keratosis, Seborrheic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Seborrheic Keratosis|T191|NON|EQV|NLM (1993)|ORD (2010)|920403|abcdeef", "ENTRY": "Seborrheic Keratoses", "MN": "C17.800.428.580", "MH_TH": "ORD (2010)", "ST": "T191", "PI": "Keratosis (1966-1992)", "MS": "Benign eccrine poromas that present as multiple oval, brown-to-black plaques, located mostly on the chest and back. The age of onset is usually in the fourth or fifth decade.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017492"}, {"RECTYPE": "D", "MH": "Leukocyte Common Antigens", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Tyrosine Phosphatase, Receptor Type, C|T116|T126|T129|T192|NON|EQV|NLM (2008)|070202|abbbbcdef", "ENTRY": "L CA Antigens", "MN": "D12.776.543.733.937.500", "MH_TH": "NLM (1993)", "ST": "T192", "RN": "EC 3.1.3.48", "PI": "Histocompatibility Antigens (1984-1992)", "MS": "High-molecular weight glycoproteins uniquely expressed on the surface of LEUKOCYTES and their hemopoietic progenitors. They contain two FIBRONECTIN TYPE III DOMAINS and possess cytoplasmic protein tyrosine phosphatase activity, which plays a role in intracellular signaling from the CELL SURFACE RECEPTORS. Leukocyte common antigens occur as multiple isoforms that result from alternative mRNA splicing and differential usage of three exons.", "PM": "2018; see ANTIGENS, CD45 1993-2017 and CD45 ANTIGEN 1984-1992; CD45 ANTIGEN was indexed under ANTIGENS, CD 1989-92 and HISTOCOMPATIBILITY ANTIGENS & ANTIGENS, DIFFERENTIATION 1984-92; RT7 ANTIGEN was indexed under HISTOCOMPATIBILITY ANTIGENS 1983-92; B220 ANTIGEN was indexed under ANTIGENS, SURFACE 1990-95", "HN": "2018 (1993); for RT7 use HISTOCOMPATIBILITY ANTIGENS RT 1983-92; for B220 ANTIGEN use ANTIGENS, CD45 1990-95", "MR": "20210521", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017493"}, {"RECTYPE": "D", "MH": "Proton Pumps", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "H(+) Pump|T116|T126|NON|EQV|NLM (1993)|920406|H AA PUMP|abbcdefs", "ENTRY": "Pumps, Proton", "MN": "D12.776.543.585.450.250.875", "EC": "antagonists & inhibitors:Proton Pump Inhibitors", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "0", "AN": "/antag - consider also POTASSIUM HYDROGEN ATPASE /antag", "PI": "Proton-Translocating ATPases (1984-1992)", "MS": "Integral membrane proteins that transport protons across a membrane. This transport can be linked to the hydrolysis of ADENOSINE TRIPHOSPHATE. What is referred to as proton pump inhibitors frequently is about POTASSIUM HYDROGEN ATPASE.", "PM": "2002; see PROTON PUMP 1993-2001", "HN": "2002(1993)", "MR": "20130708", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017494"}, {"RECTYPE": "D", "MH": "Hyperpigmentation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypermelanoses", "MN": "C17.800.621.430", "MH_TH": "NLM (1993)", "ST": "T046", "AN": "do not confuse with HYPOPIGMENTATION", "PI": "Pigmentation Disorders (1966-1992)", "MS": "Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017495"}, {"RECTYPE": "D", "MH": "Hypopigmentation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypomelanoses", "MN": "C17.800.621.440", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "do not confuse with HYPERPIGMENTATION", "PI": "Pigmentation Disorders (1966-1992)", "MS": "A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017496"}, {"RECTYPE": "D", "MH": "Hidradenitis Suppurativa", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Acne Inversa|T047|NON|EQV|GHR (2014)|NLM (2010)|081009|abcdeef", "ENTRY": "Inversas, Acne", "MN": "C17.800.946.315.320", "FX": "Acne Vulgaris", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Sweat Glands (1966-1975)", "MS": "A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017497"}, {"RECTYPE": "D", "MH": "Adenovirus E1 Proteins", "DS": "ADENOVIRUS E01 PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Adenovirus E1", "MN": "D23.050.327.045.050", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "AN": "adenovirus early proteins; /drug eff /ultrastruct permitted", "PI": "Oncogene Proteins, Viral (1986-1992)", "MS": "The very first viral gene products synthesized after cells are infected with adenovirus. The E1 region of the genome has been divided into two major transcriptional units, E1A and E1B, each expressing proteins of the same name (ADENOVIRUS E1A PROTEINS and ADENOVIRUS E1B PROTEINS).", "PM": "93", "HN": "93", "MR": "20220413", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017498"}, {"RECTYPE": "D", "MH": "Porokeratosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Porokeratosis, Punctate|T047|NON|NRW|NLM (2002)|010119|abcdef", "ENTRY": "Punctate Porokeratosis", "MN": "C17.800.827.730", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "do not confuse with PARAKERATOSIS", "PI": "Keratosis (1966-1992)", "MS": "A heritable disorder of faulty keratinization characterized by the proliferation of abnormal clones of KERATINOCYTES and lesions showing varying atrophic patches surrounded by an elevated, keratotic border. These keratotic lesions can progress to overt cutaneous neoplasm. Several clinical variants are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017499"}, {"RECTYPE": "D", "MH": "Adenovirus E1A Proteins", "DS": "ADENOVIRUS E01A PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenovirus E1A Protein Domain 3|T116|T129|NON|NRW|NLM (1993)|920408|ADENOVIRUS E01A PROTEIN DOMAIN 03|abbcdefs", "ENTRY": "E1A Proteins, Adenovirus", "MN": "D23.050.327.062.045", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "PI": "Transcription Factors (1985-1992)", "MS": "Proteins transcribed from the E1A genome region of ADENOVIRUSES which are involved in positive regulation of transcription of the early genes of host infection.", "OL": "use ADENOVIRUS EARLY PROTEINS (NM) to search ADENOVIRUS E1A PROTEINS 1985-92; use ADENOVIRUS E1A PROTEINS (NM) to search ADENOVIRUS E1A PROTEIN DOMAIN 3 1988-92", "PM": "93; ADENOVIRUS E1A PROTEIN was indexed under ONCOGENE PROTEINS, VIRAL 1985-92 & ANTIGENS, VIRAL, TUMOR 1985; ADENOVIRUS E1A PROTEIN DOMAIN 3 was indexed under ONCOGENE PROTEINS, VIRAL & TRANSCRIPTION FACTORS 1988-92", "HN": "93; ADENOVIRUS E1A PROTEIN was SY to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS (NM) 1985-92; ADENOVIRUS E1A PROTEIN DOMAIN 3 was NM 1988-92", "MR": "20220413", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017500"}, {"RECTYPE": "D", "MH": "Adenovirus E1B Proteins", "DS": "ADENOVIRUS E01B PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenovirus E1B 19K Protein|T116|T129|NON|NRW|NLM (1993)|920408|ADENOVIRUS E01B PROTEIN 019K|abbcdefs", "ENTRY": "E1B Proteins, Adenovirus", "MN": "D23.050.327.062.050", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "PI": "Oncogene Proteins, Viral (1986-1992)", "MS": "Proteins transcribed from the E1B region of ADENOVIRUSES which are involved in regulation of the levels of early and late viral gene expression.", "OL": "use ADENOVIRUS EARLY PROTEINS (NM) to search ADENOVIRUS E1B PROTEINS 1985-92", "PM": "93; ADENOVIRUS E1B PROTEIN was indexed under ONCOGENE PROTEINS, VIRAL 1985-92 & ANTIGENS, VIRAL, TUMOR 1985", "HN": "93; ADENOVIRUS E1B PROTEIN was SY to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS (NM) 1985-92", "MR": "20220413", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017501"}, {"RECTYPE": "D", "MH": "Adenovirus E2 Proteins", "DS": "ADENOVIRUS E02 PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenovirus E2F Proteins|T116|T129|NON|NRW|NLM (1993)|920408|ADENOVIRUS E02F PROTEINS|abbcdefs", "ENTRY": "E2F Proteins, Adenovirus", "MN": "D23.050.327.045.060", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "PI": "Oncogene Proteins (1985-1992)", "MS": "Proteins transcribed from the E2 region of ADENOVIRUSES. Several of these are required for viral DNA replication.", "OL": "use ADENOVIRUS EARLY PROTEINS (NM) to search ADENOVIRUS E2A PROTEIN & ADENOVIRUS E2F PROTEIN 1985-92", "PM": "93; ADENOVIRUS E2A PROTEIN & ADENOVIRUS E2F PROTEIN were indexed under ONCOGENE PROTEINS, VIRAL 1985-92; ADENOVIRUS 72K PROTEIN & ADENOVIRUS DNA-BINDING PROTEIN were indexed under VIRAL PROTEINS & DNA-BINDING PROTEINS 1984-92", "HN": "93; ADENOVIRUS E2A PROTEIN & ADENOVIRUS E2F PR0TEIN were SY to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS (NM) 1985-92; ADENOVIRUS E2A 72K PROTEIN was ADENOVIRUS 72K PROTEIN (NM) 1984-92; ADENOVIRUS E2A DNA-BINDING PROTEIN was ADENOVIRUS DNA-BINDING PROTEIN (SY) to ADENOVIRUS 72K PROTEIN (NM) 1984-92", "MR": "20220413", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017502"}, {"RECTYPE": "D", "MH": "Adenovirus E3 Proteins", "DS": "ADENOVIRUS E03 PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenovirus E3 19K Protein|T116|T129|NON|NRW|NLM (1993)|920408|ADENOVIRUS E03 PROTEIN 019K|abbcdefs", "ENTRY": "E3 Proteins, Adenovirus", "MN": "D23.050.327.045.070", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "PI": "Oncogene Proteins, Viral (1985-1992)", "MS": "Proteins transcribed from the E3 region of ADENOVIRUSES but not essential for viral replication. The E3 19K protein mediates adenovirus persistence by reducing the expression of class I major histocompatibility complex antigens on the surface of infected cells.", "OL": "use ADENOVIRUS EARLY PROTEINS (NM) to search ADENOVIRUS E3 PROTEINS 1985-92 & ADENOVIRUS TYPE 2 E3-19K PROTEIN 1987-92", "PM": "93; ADENOVIRUS E3 PROTEINS was indexed under ONCOGENE PROTEINS, VIRAL 1985-92; ADENOVIRUS E3 19K PROTEIN was indexed under VIRAL PROTEINS 1987-92", "HN": "93; was ADENOVIRUS E3 PROTEINS (SY) to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS (NM) 1985-92; ADENOVIRUS E3 19K PROTEIN was ADENOVIRUS TYPE 2 E3-19K PROTEIN (NM) 1987-92", "MR": "20220413", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017503"}, {"RECTYPE": "D", "MH": "Adenovirus E4 Proteins", "DS": "ADENOVIRUS E04 PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenovirus E4F Protein|T116|T129|NON|NRW|NLM (1993)|920408|ADENOVIRUS E04F PROTEIN|abbcdefs", "ENTRY": "E4 Proteins, Adenovirus", "MN": "D23.050.327.045.080", "MH_TH": "NLM (1993)", "ST": "T129", "RN": "0", "PI": "Oncogene Proteins, Viral (1985-1992)", "MS": "Proteins transcribed from the E4 region of ADENOVIRUSES. The E4 19K protein transactivates transcription of the adenovirus E2F protein and complexes with it.", "OL": "use ADENOVIRUS EARLY PROTEINS (NM) to search ADENOVIRUS E4 PROTEINS & ADENOVIRUS E4F 1985-92", "PM": "93; ADENOVIRUS E4 PROTEIN & ADENOVIRUS E4F were indexed under ONCOGENIC PROTEINS, VIRAL 1985-92", "HN": "93; ADENOVIRUS E4 PROTEIN was SY to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS (NM) 1985-92; ADENOVIRUS E4F PROTEIN was ADENOVIRUS E4F (SY) to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS (NM) 1985-92", "MR": "20220413", "DA": "19920513", "DC": "1", "DX": "19930101", "UI": "D017504"}, {"RECTYPE": "D", "MH": "H(+)-K(+)-Exchanging ATPase", "DE": "H K ATPASE", "DS": "H AA K EXCHANGING ATPASE", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hydrogen, Potassium, Adenosinetriphosphatase|T116|T126|NON|EQV|NLM (1993)|920414|abbcdef", "ENTRY": "Hydrogen Potassium Exchanging ATPase", "MN": "D12.776.543.585.813.625", "EC": "antagonists & inhibitors:Proton Pump Inhibitors", "MH_TH": "NLM (1993)", "ST": "T126", "N1": "ATP phosphohydrolase (H+/K+-transporting)", "RN": "EC 3.6.3.10", "AN": "do not confuse entry term H(+)-K(+)-TRANSPORTING ATPASE with PROTON-TRANSLOCATING ATPASES", "PI": "Adenosinetriphosphatase (1980-1992)", "MS": "An enzyme isolated from the GASTRIC MUCOSA that catalyzes the hydrolysis of ATP coupled with the exchange of hydrogen and potassium ions across the cell wall. This enzyme was formerly listed as EC 3.6.1.36.", "OL": "use H(+)-K(+)-EXCHANGING ATPASE to search H(+)-K(+)-TRANSPORTING ATPASE 1993; use H(+)-K(+)-EXCHANGING ATPASE (NM) to search POTASSIUM HYDROGEN ATPASE 1980-92", "PM": "94; was H(+)-K(+)-TRANSPORTING ATPASE 1993; POTASSIUM HYDROGEN ATPASE was indexed under ADENOSINE TRIPHOSPHATASE 1980-92", "HN": "94; was H(+)-K(+)-TRANSPORTING ATPASE 1993; was POTASSIUM HYDROGEN ATPASE (NM) 1980-92", "MR": "20170117", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017506"}, {"RECTYPE": "D", "MH": "Comoros", "AQ": "EH EP", "PRINT ENTRY": "Mayotte|T083|NAM|NRW|NLM (1993)|POPLINE (1983)|920417|abcdeef", "MN": "Z01.639.520.200", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "a group of Indian Ocean Islands between Mozambique & Madagascar", "PI": "Africa, Eastern (1983-1992)", "MS": "A group of Indian Ocean Islands, the islands of Great Comoro, Anjouan, Mayotte, and Moheli, lying between northeast Mozambique and northwest Madagascar. The capital is Moroni. In 1914 they became a colony attached to Madagascar administratively and were made a French overseas territory in 1947. Except for Mayotte which remained French, Comoros became an independent republic in 1975. Comoros represents the Arabic qamar, moon, said by some scholars to be linked with the mystical Mountains of the Moon said to be somewhere in equatorial Africa. (From Webster's New Geographical Dictionary, 1988, p283 & Room, Brewer's Dictionary of Names, 1992, p122)", "OL": "93; use AFRICA, EASTERN to search COMOROS 1987-92", "HN": "93; was see AFRICA, EASTERN 1987-92", "MR": "20220708", "DA": "19920520", "DC": "4", "DX": "19930101", "UI": "D017507"}, {"RECTYPE": "D", "MH": "Reunion", "AQ": "EH EP", "MN": "Z01.639.520.700", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "one of the Indian Ocean Islands east of Madagascar; in translations use accent: R\u00e9union", "PI": "Indian Ocean Islands (1983-1992)", "MS": "One of the Indian Ocean Islands, east of Madagascar. Its capital is Saint-Denis. It was discovered in 1507 by the Portuguese and claimed by France in 1638. It was first colonized in 1662 as Isle de Bourbon but renamed Reunion in 1793. In 1946 it was made an overseas department of France. The name commemorates the reunion of the revolutionaries from Marseilles with the National Guard in Paris in 1792. (From Webster's New Geographical Dictionary, 1988, p1011; Room, Brewer's Dictionary of Names, 1992, p454; French Embassy)", "OL": "use INDIAN OCEAN ISLANDS to search REUNION 1987-92", "HN": "93; was see INDIAN OCEAN ISLANDS 1987-92", "MR": "20150112", "DA": "19920522", "DC": "4", "DX": "19930101", "UI": "D017508"}, {"RECTYPE": "D", "MH": "Protein Folding", "AQ": "DE RE", "PRINT ENTRY": "Protein Folding, Globular|T044|NON|NRW|NLM (1993)|920421|abcdef", "ENTRY": "Protein Foldings, Globular", "MN": "G02.111.688", "FX": "Proteostasis", "MH_TH": "NLM (1993)", "ST": "T044", "PI": "Protein Conformation (1971-1992)", "MS": "Processes involved in the formation of TERTIARY PROTEIN STRUCTURE.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20170405", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017510"}, {"RECTYPE": "D", "MH": "Pyoderma Gangrenosum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.893.675", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "severe type of skin ulcer appearing mostly on the legs", "PI": "Pyoderma (1966-1992)", "MS": "An idiopathic, rapidly evolving, and severely debilitating disease occurring most commonly in association with chronic ulcerative colitis. It is characterized by the presence of boggy, purplish ulcers with undermined borders, appearing mostly on the legs. The majority of cases are in people between 40 and 60 years old. Its etiology is unknown.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017511"}, {"RECTYPE": "D", "MH": "Lichenoid Eruptions", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Licheniform Eruptions|T047|NON|EQV|NLM (1993)|920422|abcdef", "ENTRY": "Lichenoid Eruption", "MN": "C17.800.859.475", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Conditions in which there is histological damage to the lower epidermis along with a grouped chronic inflammatory infiltrate in the papillary dermis disturbing the interface between the epidermis and dermis. LICHEN PLANUS is the prototype of all lichenoid eruptions. (From Rook et al., Textbook of Dermatology, 4th ed, p398)", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017512"}, {"RECTYPE": "D", "MH": "Lichen Nitidus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.859.475.545", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "a skin dis, not a plant", "MS": "A chronic inflammatory disease characterized by shiny, flat-topped, usually flesh-colored micropapules no larger than the head of a pin. Lesions are localized in the early stages, found chiefly on the lower abdomen, penis, and inner surface of the thighs. Distribution may become generalized as the disease progresses.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017513"}, {"RECTYPE": "D", "MH": "Pityriasis Lichenoides", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pityriasis Lichenoides et Varioliformis Acuta|T047|NON|NRW|NLM (1993)|ORD (2010)|920422|PLEVA|abcdeefv", "ENTRY": "Mucha Habermann Disease", "MN": "C17.800.859.600.650", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Pityriasis (1977-1992)", "MS": "A subgroup of PARAPSORIASIS itself divided into acute and chronic forms. The acute form is characterized by the abrupt onset of a generalized, reddish-brown, maculopapular eruption. Lesions may be vesicular, hemorrhagic, crusted, or necrotic. Histologically the disease is characterized by epidermal necrolysis. The chronic form shows milder skin changes with necrosis.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017514"}, {"RECTYPE": "D", "MH": "Pityriasis Rosea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C17.800.859.600.675", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Pityriasis (1966-1992)", "MS": "A mild exanthematous inflammation of unknown etiology. It is characterized by the presence of salmon-colored maculopapular lesions. The most striking feature is the arrangement of the lesions such that the long axis is parallel to the lines of cleavage. The eruptions are usually generalized, affecting chiefly the trunk, and the course is often self-limiting.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017515"}, {"RECTYPE": "D", "MH": "Historical Geographic Locations", "AQ": "EH EP", "MN": "Z01.586", "MH_TH": "NLM (1993)", "ST": "T083", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "PI": "specific geographic location (1966-1997)", "MS": "Countries known in remote history (as BYZANTIUM) or former names of countries reflecting political changes in the 19th or 20th century (as GERMANY, EAST).", "HN": "98; use explode 1993-97", "MR": "20150605", "DA": "19920520", "DC": "4", "DX": "19980101", "UI": "D017516"}, {"RECTYPE": "D", "MH": "Commonwealth of Independent States", "AQ": "EH EP", "PRINT ENTRY": "CIS Nations|T092|EQV|NLM (1993)|920513|abdef", "MN": "Z01.586.200", "MH_TH": "NLM (1993)", "ST": "T092", "AN": "each independent state is available; consider also RUSSIA (PRE-1917) & USSR for historical material; CATALOGER: Use NAF entry", "PI": "specific Soviet republic (1975-1992)", "MS": "An economic union of Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine.", "HN": "93", "MR": "20170717", "DA": "19920514", "DC": "1", "DX": "19930101", "UI": "D017517"}, {"RECTYPE": "D", "MH": "Mucinoses", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mucinosis|T047|NON|EQV|NLM (1993)|920424|abcdef", "MN": "C17.300.550", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "elevated deposition of mucin in skin", "PI": "Skin Diseases (1966-1992)", "MS": "Mucoid states characterized by the elevated deposition and accumulation of mucin (mucopolysaccharides) in dermal tissue. The fibroblasts are responsible for the production of acid mucopolysaccharides (GLYCOSAMINOGLYCANS) in the ground substance of the connective tissue system. When fibroblasts produce abnormally large quantities of mucopolysaccharides as hyaluronic acid, chondroitin sulfate, or heparin, they accumulate in large amounts in the dermis.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "19930602", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017520"}, {"RECTYPE": "D", "MH": "Bosnia and Herzegovina", "AQ": "EH EP", "PRINT ENTRY": "Bosnia-Herzegovina|T083|NAM|EQV|NLM (1993)|990101|abcdef", "ENTRY": "Bosnia|T083|NAM|EQV|NLM (1993)|920430|abcdef", "MN": "Z01.542.248.160", "MH_TH": "POPLINE (1993)", "ST": "T083", "AN": "formerly provinces of Yugoslavia; use this spelling in translations: z, not c", "PI": "Yugoslavia (1966-1992)", "MS": "A country of eastern Europe, formerly the province of Bosnia in Yugoslavia, uniting with the province of Herzegovina to form the Republic of Bosnia and Herzegovina in 1946. It was created 7 April 1992 as a result of the division of Yugoslavia and recognized by the United States as an independent state. Bosnia takes is name from the river Bosna, in turn from the Indoeuropean root bhog, \"current\"; Herzegovina is from the Serbian herceg (duke) + -ov (the possessive) + -ina (country or territory).", "OL": "use YUGOSLAVIA to search BOSNIA-HERZEGOVINA 1966-92", "HN": "93", "MR": "20160708", "DA": "19920520", "DC": "4", "DX": "19930101", "UI": "D017522"}, {"RECTYPE": "D", "MH": "Croatia", "AQ": "EH EP", "MN": "Z01.542.248.295", "MH_TH": "POPLINE (1993)", "ST": "T083", "PI": "Yugoslavia (1966-1992)", "MS": "Created 7 April 1992 as a result of the division of Yugoslavia.", "OL": "use YUGOSLAVIA to search CROATIA 1966-92", "HN": "93", "MR": "20150629", "DA": "19920520", "DC": "4", "DX": "19930101", "UI": "D017523"}, {"RECTYPE": "D", "MH": "Slovenia", "AQ": "EH EP", "MN": "Z01.542.248.820", "MH_TH": "POPLINE (1993)", "ST": "T083", "PI": "Yugoslavia (1966-1992)", "MS": "Created 7 April 1992 as a result of the division of Yugoslavia.", "OL": "use YUGOSLAVIA to search SLOVENIA 1966-92", "HN": "93", "MR": "20150629", "DA": "19920522", "DC": "4", "DX": "19930101", "UI": "D017524"}, {"RECTYPE": "D", "MH": "Receptor, IGF Type 1", "DE": "RECEPT IGF TYPE 1", "DS": "RECEPTOR IGF TYPE 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Receptor, Insulin-Like Growth Factor Type 1|T116|T126|T192|NON|EQV|NLM (2000)|991103|RECEPTOR INSULIN LIKE GROWTH T 001|RECEPT INSULIN LIKE GROWTH FACTOR TYPE 1|abbbcdefsv", "ENTRY": "Receptors, IGF 1", "MN": "D12.776.543.750.750.400.780.400", "FX": "Insulin-Like Growth Factor II", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptors, Endogenous Substances (1986-1992)", "MS": "A protein-tyrosine kinase receptor that is closely related in structure to the INSULIN RECEPTOR. Although commonly referred to as the IGF-I receptor, it binds both IGF-I and IGF-II with high affinity. It is comprised of a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The beta subunit contains an intrinsic tyrosine kinase domain.", "PM": "2000; see RECEPTOR, INSULIN-LIKE-GROWTH FACTOR I 1993-1999", "HN": "2000(1993);", "MR": "20210521", "DA": "19920529", "DC": "1", "DX": "19930101", "UI": "D017526"}, {"RECTYPE": "D", "MH": "Receptor, IGF Type 2", "DE": "RECEPT IGF TYPE 2", "DS": "RECEPTOR IGF TYPE 002", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptor, Mannose-6-Phosphate|T116|T192|NON|EQV|NLM (2000)|991103|RECEPTOR MANNOSEPHOSPHATE 06|RECEPT MANNOSE 6 PHOSPHATE|abbcdefsv", "ENTRY": "Receptors, Insulin Like Growth Factor II", "MN": "D12.776.543.750.750.400.780.410", "FX": "Insulin-Like Growth Factor II", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1981-1992)", "MS": "A receptor that is specific for IGF-II and mannose-6-phosphate. The receptor is a 250-kDa single chain polypeptide which is unrelated in structure to the type 1 IGF receptor (RECEPTOR, IGF TYPE 1) and does not have a tyrosine kinase domain.", "PM": "2000; MANNOSE-6-PHOSPHATE RECEPTOR (now RECEPTOR, IGF TYPE 2) was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1992", "HN": "2000(1993); use RECEPTOR, IGF TYPE 2 (NM) 1981-1992", "MR": "20040707", "DA": "19920529", "DC": "1", "DX": "19930101", "UI": "D017527"}, {"RECTYPE": "D", "MH": "Health Care Quality, Access, and Evaluation", "ENTRY": "Healthcare Quality, Access, and Evaluation|T078|NON|EQV|NLM (1998)|970110|abcdef", "MN": "N05", "RH": "N5 - HEALTH CARE QUALITY, ACCESS, AND EVALUATION", "MH_TH": "NLM (1993)", "ST": "T078", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "The concept concerned with all aspects of the quality, accessibility, and appraisal of health care and health care delivery.", "PM": "98", "HN": "98; use explode", "MR": "20150605", "DA": "19920625", "DC": "1", "DX": "19980101", "UI": "D017530"}, {"RECTYPE": "D", "MH": "Health Care Evaluation Mechanisms", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Mechanisms, Healthcare Evaluation", "MN": "N05.715.360", "MH_TH": "NLM (1993)", "ST": "T057", "AN": "INDEXER: Do not use", "PI": "Quality of Health Care (1966-1997)", "MS": "Methods and techniques used in evaluating the quality of health care, its planning, and delivery.", "PM": "98", "HN": "98; use explode", "MR": "20150605", "DA": "19920520", "DC": "1", "DX": "19980101", "UI": "D017531"}, {"RECTYPE": "D", "MH": "Marital Status", "AQ": "EH SN", "ENTRY": "Status, Marital", "MN": "N01.824.308.500", "MH_TH": "POPLINE (1978)", "ST": "T102", "AN": "a demographic & statist concept: differentiate from MARRIAGE, a sociol & anthropol concept; includes marital state, divorce, widowhood, singleness", "PI": "Marriage (1966-1992)", "MS": "A demographic parameter indicating a person's status with respect to marriage, divorce, widowhood, singleness, etc.", "OL": "use MARRIAGE to search MARITAL STATUS 1990-92", "PM": "93; was see MARRIAGE 1990-92", "HN": "93; was see MARRIAGE 1990-92", "CATSH": "CAT LIST", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017533"}, {"RECTYPE": "D", "MH": "Radial Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Radial Arteries", "MN": "A07.015.114.740", "MH_TH": "NLM (1993)", "ST": "T023", "AN": "diseases: coord IM with PERIPHERAL VASCULAR DISEASES (IM)", "PI": "Hand/blood supply (1966-1992)", "MS": "The direct continuation of the brachial trunk, originating at the bifurcation of the brachial artery opposite the neck of the radius. Its branches may be divided into three groups corresponding to the three regions in which the vessel is situated, the forearm, wrist, and hand.", "PM": "93", "HN": "93", "MR": "20180701", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017534"}, {"RECTYPE": "D", "MH": "Ulnar Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ulnar Arteries", "MN": "A07.015.114.920", "MH_TH": "NLM (1993)", "ST": "T023", "AN": "diseases: coord IM with PERIPHERAL VASCULAR DISEASES (IM)", "PI": "Hand/blood supply (1966-1992)", "MS": "The larger of the two terminal branches of the brachial artery, beginning about one centimeter distal to the bend of the elbow. Like the RADIAL ARTERY, its branches may be divided into three groups corresponding to their locations in the forearm, wrist, and hand.", "PM": "93", "HN": "93", "MR": "20180630", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017535"}, {"RECTYPE": "D", "MH": "Carotid Artery, Common", "AQ": "AB AH CH CY DE DG EM EN GD IM IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Common Carotid Artery|T023|NON|EQV|NLM (2020)|190424|abcdef", "ENTRY": "Common Carotid Arteries", "MN": "A07.015.114.186.200", "EC": "injuries:Carotid Artery Injuries", "MH_TH": "NLM (1993)", "ST": "T023", "AN": "disease: coordinate IM with CAROTID ARTERY DISEASES (IM) injuries: coordinate IM with CAROTID ARTERY INJURIES (IM) or specifics (IM)", "PI": "Carotid Arteries (1966-1992)", "MS": "The two principal arteries supplying the structures of the head and neck. They ascend in the neck, one on each side, and at the level of the upper border of the thyroid cartilage, each divides into two branches, the external (CAROTID ARTERY, EXTERNAL) and internal (CAROTID ARTERY, INTERNAL) carotid arteries.", "PM": "93", "HN": "93", "MR": "20190530", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017536"}, {"RECTYPE": "D", "MH": "Mesenteric Artery, Inferior", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Mesenteric Arteries, Inferior", "MN": "A07.015.114.565.510", "MH_TH": "NLM (1993)", "ST": "T023", "AN": "disease is usually MESENTERIC VASCULAR OCCLUSION but coord IM with MESENTERIC ARTERY, INFERIOR (NIM); embolism or thrombosis: coord NIM with MESENTERIC VASCULAR OCCLUSION (IM) + EMBOLISM or THROMBOSIS (IM)", "PI": "Mesenteric Arteries (1966-1992)", "MS": "The artery supplying nearly all the left half of the transverse colon, the whole of the descending colon, the sigmoid colon, and the greater part of the rectum. It is smaller than the superior mesenteric artery (MESENTERIC ARTERY, SUPERIOR) and arises from the aorta above its bifurcation into the common iliac arteries.", "PM": "93", "HN": "93", "MR": "20180701", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017537"}, {"RECTYPE": "D", "MH": "Mesenteric Artery, Superior", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Superior Mesenteric Artery", "MN": "A07.015.114.565.755", "FX": "Superior Mesenteric Artery Syndrome", "MH_TH": "NLM (1993)", "ST": "T023", "PI": "Mesenteric Arteries (1966-1992)", "MS": "A large vessel supplying the whole length of the small intestine except the superior part of the duodenum. It also supplies the cecum and the ascending part of the colon and about half the transverse part of the colon. It arises from the anterior surface of the aorta below the celiac artery at the level of the first lumbar vertebra.", "PM": "93", "HN": "93", "MR": "20180701", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017538"}, {"RECTYPE": "D", "MH": "Tunica Intima", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Vascular Intima|T024|NON|EQV|NLM (1993)|920512|abcdef", "ENTRY": "Venous Intimas", "MN": "A07.015.700", "FX": "Neointima", "MH_TH": "NLM (1993)", "ST": "T024", "AN": "/pathol is more likely than \"diseases of the tunica intima\"; coordinate with specific blood vessel", "PI": "specific blood vessel (1966-1987)", "MS": "The innermost layer of an artery or vein, made up of one layer of endothelial cells and supported by an internal elastic lamina.", "PM": "93", "HN": "93", "MR": "20220523", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017539"}, {"RECTYPE": "D", "MH": "Tunica Media", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Vascular Media|T024|NON|EQV|NLM (1993)|920512|abcdef", "ENTRY": "Venous Medias", "MN": "A07.015.733", "MH_TH": "NLM (1993)", "ST": "T024", "AN": "/pathol is more likely than \"diseases of the tunica media\"; coordinate IM with specific blood vessel (IM)", "PI": "specific blood vessel (1966-1992)", "MS": "The middle layer of blood vessel walls, composed principally of thin, cylindrical, smooth muscle cells and elastic tissue. It accounts for the bulk of the wall of most arteries. The smooth muscle cells are arranged in circular layers around the vessel, and the thickness of the coat varies with the size of the vessel.", "PM": "93", "HN": "93", "MR": "20180630", "DA": "19920522", "DC": "1", "DX": "19930101", "UI": "D017540"}, {"RECTYPE": "D", "MH": "Aneurysm, False", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pseudoaneurysm|T047|NON|EQV|NLM (1997)|960419|abcdef", "ENTRY": "Pseudoaneurysms", "MN": "C14.907.065", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "coordinate IM with specific vessel or precoordinated vascular disease if available ", "PI": "Aneurysm (1966-1992)", "MS": "Not an aneurysm but a well-defined collection of blood and CONNECTIVE TISSUE outside the wall of a blood vessel or the heart. It is the containment of a ruptured blood vessel or heart, such as sealing a rupture of the left ventricle. False aneurysm is formed by organized THROMBUS and HEMATOMA in surrounding tissue.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017541"}, {"RECTYPE": "D", "MH": "Aneurysm, Ruptured", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ruptured Aneurysms", "MN": "C14.907.055.185", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "coordinate IM with specific vessel (IM) or precoordinated vascular disease if available (IM); if spontaneous, coordinate with RUPTURE, SPONTANEOUS (NIM)", "PI": "Rupture, Spontaneous (1968-1992)", "MS": "The tearing or bursting of the weakened wall of the aneurysmal sac, usually heralded by sudden worsening pain. The great danger of a ruptured aneurysm is the large amount of blood spilling into the surrounding tissues and cavities, causing HEMORRHAGIC SHOCK.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017542"}, {"RECTYPE": "D", "MH": "Iliac Aneurysm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aneurysm, Iliac|T047|NON|EQV|NLM (2008)|061005|abcdef", "ENTRY": "Iliac Aneurysms", "MN": "C14.907.055.625", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "dissecting aneurysm: coordinate with DISSECTION BLOOD VESSEL; rupture: coordinate with ANEURYSM, RUPTURED or if spontaneous, with RUPTURE, SPONTANEOUS ", "PI": "Iliac Artery (1966-1992)", "MS": "Abnormal balloon- or sac-like dilatation in the wall of any one of the iliac arteries including the common, the internal, or the external ILIAC ARTERY.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017543"}, {"RECTYPE": "D", "MH": "Aortic Aneurysm, Abdominal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aneurysm, Abdominal Aorta|T190|NON|EQV|NLM (2023)|220408|abcdef", "ENTRY": "Aorta Aneurysm, Abdominal", "MN": "C14.907.109.139.075", "MH_TH": "ORD (2010)", "ST": "T190", "AN": "dissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE", "PI": "Aortic Aneurysm (1966-1992)", "MS": "An abnormal balloon- or sac-like dilatation in the wall of the ABDOMINAL AORTA which gives rise to the visceral, the parietal, and the terminal (iliac) branches below the aortic hiatus at the diaphragm.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017544"}, {"RECTYPE": "D", "MH": "Aortic Aneurysm, Thoracic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thoracic Aortic Aneurysm|T047|NON|EQV|NLM (2023)|220408|abcdef", "ENTRY": "Thoracic Aortic Aneurysms", "MN": "C14.907.109.139.125", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "dissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE", "PI": "Aortic Aneurysm (1966-1992)", "MS": "An abnormal balloon- or sac-like dilatation in the wall of the THORACIC AORTA. This proximal descending portion of aorta gives rise to the visceral and the parietal branches above the aortic hiatus at the diaphragm.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017545"}, {"RECTYPE": "D", "MH": "Angioscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Angioscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES ANGIOSCOPIC|abbcdefv", "ENTRY": "Surgical Procedure, Angioscopic", "MN": "E04.502.382.500", "FX": "Angioscopes", "MH_TH": "NLM (1993)", "ST": "T061", "AN": "coordinate with specific vessel (IM); do not confuse with MICROSCOPIC ANGIOSCOPY; /instrum permitted but consider also ANGIOSCOPES", "PI": "Endoscopy (1977-1992)", "MS": "Endoscopic examination, therapy or surgery performed on the interior of blood vessels.", "PM": "93", "HN": "93", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19920520", "DC": "1", "DX": "19930101", "UI": "D017546"}, {"RECTYPE": "D", "MH": "Echocardiography, Transesophageal", "DE": "ECHOCARDIOGR TRANSESOPHAGEAL", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Transesophageal Echocardiography|T060|NON|EQV|NLM (1994)|920529|TEE|abcdefv", "MN": "E01.370.370.380.220.235", "MH_TH": "NLM (1994)", "ST": "T060", "AN": "coordinate with specific heart disease /diag image and with specific type of echocardiography if pertinent", "PI": "Echocardiography (1977-1993)", "MS": "Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues using a transducer placed in the esophagus.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017548"}, {"RECTYPE": "D", "MH": "Spectroscopy, Fourier Transform Infrared", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Spectroscopy, Infrared, Fourier Transform|T062|NON|EQV|NLM (1994)|920529|abcdef", "MN": "E05.196.867.826.676.700", "MH_TH": "NLM (1994)", "ST": "T062", "AN": "usually NIM", "PI": "Spectrophotometry, Infrared (1972-1993)", "MS": "A spectroscopic technique in which a range of wavelengths is presented simultaneously with an interferometer and the spectrum is mathematically derived from the pattern thus obtained.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017550"}, {"RECTYPE": "D", "MH": "Microdialysis", "AQ": "AE CL EC ES HI IS MT SN ST TD VE", "MN": "E05.196.353.500", "MH_TH": "NLM (1994)", "ST": "T062", "PI": "Dialysis (1966-1993)", "MS": "A technique for measuring extracellular concentrations of substances in tissues, usually in vivo, by means of a small probe equipped with a semipermeable membrane. Substances may also be introduced into the extracellular space through the membrane.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017551"}, {"RECTYPE": "D", "MH": "Solitary Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Nucleus Solitarius|T023|NON|EQV|NLM (1994)|920602|abcdef", "ENTRY": "Tractus Solitarius, Nuclei", "MN": "A08.186.211.132.810.591.500.750", "MH_TH": "NLM (1994)", "ST": "T023", "PI": "Medulla Oblongata (1966-1993)", "MS": "GRAY MATTER located in the dorsomedial part of the MEDULLA OBLONGATA associated with the solitary tract. The solitary nucleus receives inputs from most organ systems including the terminations of the facial, glossopharyngeal, and vagus nerves. It is a major coordinator of AUTONOMIC NERVOUS SYSTEM regulation of cardiovascular, respiratory, gustatory, gastrointestinal, and chemoreceptive aspects of HOMEOSTASIS. The solitary nucleus is also notable for the large number of NEUROTRANSMITTERS which are found therein.", "PM": "94", "HN": "94", "MR": "20150623", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017552"}, {"RECTYPE": "D", "MH": "Phosphorus Compounds", "DE": "PHOSPHORUS CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Phosphorus", "MN": "D01.695", "FX": "Organophosphorus Compounds", "MH_TH": "NLM (1993)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Phosphorus (1966-1993)", "MS": "Inorganic compounds that contain phosphorus as an integral part of the molecule.", "PM": "98", "HN": "98; use explode 1994-97", "MR": "19970620", "DA": "19930629", "DC": "1", "DX": "19980101", "UI": "D017553"}, {"RECTYPE": "D", "MH": "Carbon Compounds, Inorganic", "DE": "CARBON CPDS INORGANIC", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Inorganic Carbon Compounds|T197|NON|EQV|NLM (1998)|961217|INORGANIC CARBON CPDS|abcdefv", "ENTRY": "Compounds, Inorganic Carbon", "MN": "D01.200", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Carbon (1966-1993)", "MS": "Inorganic compounds that contain carbon as an integral part of the molecule but are not derived from hydrocarbons.", "PM": "98", "HN": "98; use explode 1994-97", "MR": "19970620", "DA": "19930629", "DC": "1", "DX": "19980101", "UI": "D017554"}, {"RECTYPE": "D", "MH": "Technetium Compounds", "DE": "TECHNETIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Technetium", "MN": "D01.925", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Technetium (1966-1993)", "MS": "Inorganic compounds that contain TECHNETIUM as an integral part of the molecule. Technetium 99m (m=metastable) is an isotope of technetium that has a half-life of about 6 hours. Technetium 99, which has a half-life of 210,000 years, is a decay product of technetium 99m.", "PM": "94", "HN": "94", "MR": "20020703", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017556"}, {"RECTYPE": "D", "MH": "Ventral Tegmental Area", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tegmentalis Ventralis, Area", "MN": "A08.186.211.132.659.413.875.820", "MH_TH": "NLM (1994)", "ST": "T023", "PI": "Tegmentum Mesencephali (1971-1993)", "MS": "A region in the MESENCEPHALON which is dorsomedial to the SUBSTANTIA NIGRA and ventral to the RED NUCLEUS. The mesocortical and mesolimbic dopaminergic systems originate here, including an important projection to the NUCLEUS ACCUMBENS. Overactivity of the cells in this area has been suspected to contribute to the positive symptoms of SCHIZOPHRENIA.", "PM": "94", "HN": "94", "MR": "20150623", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017557"}, {"RECTYPE": "D", "MH": "Elective Surgical Procedures", "DE": "ELECTIVE SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Elective|T061|NON|EQV|NLM (1994)|990101|SURG PROCEDURES ELECTIVE|abcdefv", "ENTRY": "Surgical Procedure, Elective|T061|NON|EQV|NLM (1998)|970530|SURG PROCEDURE ELECTIVE|abcdefv", "MN": "E04.249", "FX": "Prophylactic Surgical Procedures", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Surgical Procedures, Operative (1966-1993)", "MS": "Surgery which could be postponed or not done at all without danger to the patient. Elective surgery includes procedures to correct non-life-threatening medical problems as well as to alleviate conditions causing psychological stress or other potential risk to patients, e.g., cosmetic or contraceptive surgery.", "PM": "2015; see SURGICAL PROCEDURES, ELECTIVE 1998-2014; see SURGERY, ELECTIVE 1994-1997", "HN": "2015(1994)", "CATSH": "CAT LIST", "MR": "20140623", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017558"}, {"RECTYPE": "D", "MH": "Postcholecystectomy Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sump Syndrome|T047|NON|NRW|NLM (1998)|961217|abcdef", "ENTRY": "Syndromes, Sump", "MN": "C23.550.767.775", "FX": "Choledochostomy", "MH_TH": "NLM (1994)", "ST": "T047", "PI": "Postoperative Complications (1966-1993)", "MS": "Abdominal symptoms after removal of the GALLBLADDER. The common postoperative symptoms are often the same as those present before the operation, such as COLIC, bloating, NAUSEA, and VOMITING. There is pain on palpation of the right upper quadrant and sometimes JAUNDICE. The term is often used, inaccurately, to describe such postoperative symptoms not due to gallbladder removal.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20050714", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017562"}, {"RECTYPE": "D", "MH": "Lung Diseases, Interstitial", "DE": "LUNG DIS INTERSTITIAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pneumonitis, Interstitial|T047|NON|NRW|NLM (1994)|920701|abcdef", "ENTRY": "Pneumonitides, Interstitial", "MN": "C08.381.483", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Pulmonary Fibrosis (1966-1993)", "MS": "A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.", "OL": "use PULMONARY FIBROSIS to search LUNG DISEASE, INTERSTITIAL & PNEUMONITIS, INTERSTITIAL 1985-93 & PNEUMONIA, INTERSTITIAL 1966-93", "PM": "94; was LUNG DISEASE, INTERSTITIAL see PULMONARY FIBROSIS 1985-93; PNEUMONITIS, INTERSTITIAL was see PULMONARY FIBROSIS 1985-93; PNEUMONIA, INTERSTITIAL was see under PULMONARY FIBROSIS 1963-74, was see PULMONARY FIBROSIS 1975-93", "HN": "94; was LUNG DISEASE, INTERSTITIAL see PULMONARY FIBROSIS 1985-93; PNEUMONITIS, INTERSTITIAL was see PULMONARY FIBROSIS 1985-93; PNEUMONIA, INTERSTITIAL was see under PULMONARY FIBROSIS 1963-74, was see PULMONARY FIBROSIS 1975-93", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D017563"}, {"RECTYPE": "D", "MH": "Radiation Pneumonitis", "DE": "RAD PNEUMONITIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pneumonitis, Radiation|T037|T047|NON|EQV|NLM (1994)|920605|PNEUMONITIS RAD|abbcdefv", "ENTRY": "Radiation Pneumonia|T037|T047|NON|EQV|NLM (1994)|920701|RAD PNEUMONIA|abbcdefv", "MN": "G01.750.748.500.762", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "assume to be caused by radiotherapy so do not coordinate routinely with RADIOTHERAPY /\u200cadv eff; coordinate with other type or source of radiation with /\u200cadv eff  if pertinent", "PI": "Radiotherapy/adverse effects (1967-1993)", "MS": "Inflammation of the lung due to harmful effects of ionizing or non-ionizing radiation.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20210305", "DA": "19930602", "DC": "1", "DX": "19940101", "UI": "D017564"}, {"RECTYPE": "D", "MH": "Sarcoidosis, Pulmonary", "DE": "SARCOIDOSIS PULM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulmonary Sarcoidosis|T047|NON|EQV|NLM (1993)|ORD (2010)|920605|PULM SARCOIDOSIS|abcdeefv", "ENTRY": "Sarcoidoses, Pulmonary", "MN": "C20.543.418.575.725", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Sarcoidosis (1966-1993)", "MS": "Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19930303", "DC": "1", "DX": "19940101", "UI": "D017565"}, {"RECTYPE": "D", "MH": "Microvascular Angina", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Syndrome X, Cardiac|T047|NON|EQV|NLM (2004)|030317|abcdef", "ENTRY": "Syndrome, Angina X", "MN": "C14.907.585.187.575", "FX": "Metabolic Syndrome", "MH_TH": "NLM (2004)", "ST": "T047", "AN": "do not confuse with METABOLIC SYNDROME", "PI": "Angina Pectoris (1977-1993)", "MS": "ANGINA PECTORIS or angina-like chest pain with a normal coronary arteriogram and positive EXERCISE TEST. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. (Braunwald, Heart Disease, 4th ed, p1346; Jablonski Dictionary of Syndromes & Eponymic Diseases, 2d ed). It is different from METABOLIC SYNDROME X, a syndrome characterized by INSULIN RESISTANCE and HYPERINSULINEMIA, that has increased risk for cardiovascular disease.", "PM": "2005; see SYNDROME X 1994-2004", "HN": "2005(1994)", "CATSH": "CAT LIST", "MR": "20190701", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017566"}, {"RECTYPE": "D", "MH": "Karnofsky Performance Status", "AQ": "HI SN ST", "PRINT ENTRY": "Karnofsky Scale|T034|T060|EPO|EQV|NLM (1994)|921217|abbcdef", "ENTRY": "Status, Karnofsky Performance", "MN": "N06.850.520.308.980.438.475.364.500.500", "FX": "Quality of Life", "MH_TH": "NLM (1994)", "ST": "T060", "MS": "A performance measure for rating the ability of a person to perform usual activities, evaluating a patient's progress after a therapeutic procedure, and determining a patient's suitability for therapy. It is used most commonly in the prognosis of cancer therapy, usually after chemotherapy and customarily administered before and after therapy. It was named for Dr. David A. Karnofsky, an American specialist in cancer chemotherapy.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017567"}, {"RECTYPE": "D", "MH": "Rectus Abdominis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Rectus Abdominus|T024|NON|EQV|NLM (2022)|210316|abcdef", "ENTRY": "Abdominus, Rectus", "MN": "A02.633.567.050.800", "MH_TH": "NLM (1994)", "ST": "T024", "AN": "/growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent", "PI": "Abdominal Muscles (1966-1993)", "MS": "A long flat muscle that extends along the whole length of both sides of the abdomen. It flexes the vertebral column, particularly the lumbar portion; it also tenses the anterior abdominal wall and assists in compressing the abdominal contents. It is frequently the site of hematomas. In PLASTIC SURGERY PROCEDURES it is often used for the creation of MYOCUTANEOUS FLAP. (From Gray's Anatomy, 30th American ed, p491)", "PM": "94", "HN": "94", "MR": "20220715", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017568"}, {"RECTYPE": "D", "MH": "MyoD Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, MyoD", "MN": "D12.776.930.125.750.590", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "AN": "a myogenic regulatory factor controlling myogenesis", "PI": "Muscle Proteins (1989-1993)", "MS": "A myogenic regulatory factor that controls myogenesis. Though it is not clear how its function differs from the other myogenic regulatory factors, MyoD appears to be related to fusion and terminal differentiation of the muscle cell.", "OL": "use MYOD PROTEIN (NM) to search MYOD FACTOR 1989-93", "PM": "94; MYOD FACTOR was indexed under MUSCLE PROTEINS 1989-93", "HN": "94; was MYOD FACTOR (NM) 1989-93", "MR": "20050630", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017570"}, {"RECTYPE": "D", "MH": "Leukotriene A4", "DS": "LEUKOTRIENE A 04", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "LTA4|T109|ABB|EQV|NLM (1993)|920609|LTA 04|abcdefs", "ENTRY": "Leukotriene A 4", "MN": "D23.469.050.175.450.400", "MH_TH": "NLM (1994)", "ST": "T109", "RN": "0", "AN": "/biosyn /physiol permitted", "PI": "Leukotrienes (1989-1993)", "MS": "(2S-(2 alpha,3 beta(1E,3E,5Z,8Z)))-3-(1,3,5,8-Tetradecatetraenyl)oxiranebutanoic acid. An unstable allylic epoxide, formed from the immediate precursor 5-HPETE via the stereospecific removal of a proton at C-10 and dehydration. Its biological actions are determined primarily by its metabolites, i.e., LEUKOTRIENE B4 and cysteinyl-leukotrienes. Alternatively, leukotriene A4 is converted into LEUKOTRIENE C4 by glutathione-S-transferase or into 5,6-di-HETE by the epoxide-hydrolase. (From Dictionary of Prostaglandins and Related Compounds, 1990)", "OL": "use LEUKOTRIENE A4 (NM) to search LEUKOTRIENE A 1980-93", "PM": "94; LEUKOTRIENE A was indexed under LEUKOTRIENES 1989-93 & ARACHIDONIC ACIDS 1980-88", "HN": "94; was LEUKOTRIENE A (NM) 1980-93", "MR": "20150608", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017572"}, {"RECTYPE": "D", "MH": "Focal Epithelial Hyperplasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperplasia, Focal Epithelial|T047|NON|EQV|NLM (1994)|920611|abcdef", "ENTRY": "Hyperplasias, Focal Epithelial", "MN": "C07.465.342", "MH_TH": "NLM (1994)", "ST": "T047", "PI": "Mouth Diseases (1966-1993)", "MS": "Hyperplasia of the mucous membrane of the lips, tongue, and less commonly, the buccal mucosa, floor of the mouth, and palate, presenting soft, painless, round to oval sessile papules about 1 to 4 mm in diameter. The condition usually occurs in children and young adults and has familial predilection, lasting for several months, sometimes years, before running its course. A viral etiology is suspected, the isolated organism being usually the human papillomavirus. (Jablonski, Illustrated Dictionary of Dentistry; Belshe, Textbook of Human Virology, 2d ed, p954)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017573"}, {"RECTYPE": "D", "MH": "Parasystole", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Parasystoles", "MN": "C23.550.073.670", "MH_TH": "NLM (1994)", "ST": "T046", "AN": "coordinate IM with HEART ATRIUM; HEART VENTRICLES or other site in heart (NIM) if pertinent; sinus parasystole: coordinate IM with ARRHYTHMIA, SINUS (IM)", "PI": "Arrhythmia (1966-1993)", "MS": "A cardiac arrhythmia that is caused by interaction of two independently initiated cardiac impulses of different rates from two separate foci. Generally one focus is the SINOATRIAL NODE, the normal pacemaker. The ectopic focus is usually in the HEART VENTRICLE but can be in the HEART ATRIUM or the ATRIOVENTRICULAR NODE. Modulation of the parasystolic rhythm by the sinus rhythm depends on the completeness of entrance block surrounding the parasystolic focus.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017574"}, {"RECTYPE": "D", "MH": "Gloves, Protective", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Protective Gloves|T073|NON|EQV|NLM (1994)|920909|abcdef", "MN": "J01.637.708.560.875.400", "MH_TH": "NLM (1994)", "ST": "T073", "AN": "GLOVES, SURGICAL is also available", "PI": "Protective Clothing (1970-1993)", "MS": "Covering for the hands usually with separation for the fingers, made of various materials for protection against infections, toxic substances, extremes of hot and cold, radiation, water immersion, etc. Protective gloves may be worn by patients, care givers, laboratory personnel, industrial workers, and police, among others.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20220714", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017575"}, {"RECTYPE": "D", "MH": "Daptomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "LY146032", "MN": "D12.644.641.270", "PA": "Anti-Bacterial Agents", "MH_TH": "USAN (19XX)", "ST": "T195", "N1": "N-decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine-epsilon1-lactone", "RN": "NWQ5N31VKK", "RR": "123180-72-3", "PI": "Peptides (1987-1993)", "MS": "A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.", "OL": "use DAPTOMYCIN (NM) to search DAPTOMYCIN 1987-93", "PM": "94; DAPTOMYCIN was indexed under PEPTIDES & ANTIBIOTICS 1987-93", "HN": "94; was DAPTOMYCIN (NM) 1987-93", "MR": "20150526", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017576"}, {"RECTYPE": "D", "MH": "Cutaneous Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Skin Fistula|T046|T190|NON|EQV|NLM (1994)|920612|abbcdef", "ENTRY": "Skin Fistulas", "MN": "C23.300.575.150", "MH_TH": "NLM (1994)", "ST": "T190", "AN": "fistula policy: Manual 23.19+; anal fistula (one opening on the cutaneous surface near the anus) is indexed as ANAL FISTULA see RECTAL FISTULA", "PI": "Skin Diseases (1966-1993)", "MS": "An abnormal passage or communication leading from an internal organ to the surface of the body.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017577"}, {"RECTYPE": "D", "MH": "Immunoglobulin Class Switching", "DE": "IG CLASS SWITCHING", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Isotype Switching|T045|NON|EQV|NLM (1994)|920612|abcdef", "ENTRY": "Switchings, Isotype", "MN": "G12.500.274.501.450", "MH_TH": "NLM (1994)", "ST": "T045", "PI": "Immunoglobulins, Heavy-Chain/genetics (1980-1993)", "MS": "Gene rearrangement of the B-lymphocyte which results in a substitution in the type of heavy-chain constant region that is expressed. This allows the effector response to change while the antigen binding specificity (variable region) remains the same. The majority of class switching occurs by a DNA recombination event but it also can take place at the level of RNA processing.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19930617", "DC": "1", "DX": "19940101", "UI": "D017578"}, {"RECTYPE": "D", "MH": "Domestic Violence", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Family Violence|T054|T055|NON|REL|NLM (1994)|920612|abbcdef", "ENTRY": "Violence, Family", "MN": "I01.880.735.900.350", "FX": "Sex Offenses", "MH_TH": "POPLINE (1993)", "ST": "T054", "AN": "general or unspecified; prefer specifics", "PI": "specific type of abuse (1966-1993)", "MS": "Deliberate, often repetitive physical, verbal, and/or other types of abuse by one or more members against others of a household.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20230531", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017579"}, {"RECTYPE": "D", "MH": "Renal Replacement Therapy", "DE": "RENAL REPLACE THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Kidney Replacement Therapy|T061|NON|EQV|NLM (1994)|920916|KIDNEY REPLACE THER|abcdefv", "ENTRY": "Therapies, Renal Replacement", "MN": "E02.870", "FX": "Kidney Diseases", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "MS": "Procedures which temporarily or permanently remedy insufficient cleansing of body fluids by the kidneys.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017582"}, {"RECTYPE": "D", "MH": "Hemodiafiltration", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Biofiltration, Acetate-Free|T061|NON|NRW|NLM (1996)|941121|abcdef", "ENTRY": "Biofiltrations, Acetate-Free", "MN": "E04.292.471.350", "MH_TH": "NLM (1994)", "ST": "T061", "PI": "Ultrafiltration (1975-1993)", "MS": "The combination of hemodialysis and hemofiltration either simultaneously or sequentially. Convective transport (hemofiltration) may be better for removal of larger molecular weight substances and diffusive transport (hemodialysis) for smaller molecular weight solutes.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19930702", "DC": "1", "DX": "19940101", "UI": "D017583"}, {"RECTYPE": "D", "MH": "Reproductive History", "DE": "REPRODUCTIVE HIST", "ENTRY": "Reproductive Histories", "MN": "N06.850.490.812", "FX": "Time-to-Pregnancy", "MH_TH": "NLM (1994)", "ST": "T081", "AN": "general or unspecified; prefer specific concepts in MeSH definition ", "MS": "An important aggregate factor in epidemiological studies of women's health. The concept usually includes the number and timing of pregnancies and their outcomes, the incidence of breast feeding, and may include age of menarche and menopause, regularity of menstruation, fertility, gynecological or obstetric problems, or contraceptive usage.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017584"}, {"RECTYPE": "D", "MH": "Ultrasonography, Doppler, Transcranial", "DE": "ULTRASONOGR DOPPLER TRANSCRANIAL", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Ultrasonography, Transcranial Doppler|T060|EPO|EQV|NLM (1995)|940111|ULTRASONOGR TRANSCRANIAL DOPPLER|abcdefv", "ENTRY": "Neurosonologies", "MN": "E05.629.937.260.850", "MH_TH": "NLM (1994)", "ST": "T060", "PI": "Ultrasonography (1985-1993)", "MS": "A non-invasive technique using ultrasound for the measurement of cerebrovascular hemodynamics, particularly cerebral blood flow velocity and cerebral collateral flow. With a high-intensity, low-frequency pulse probe, the intracranial arteries may be studied transtemporally, transorbitally, or from below the foramen magnum.", "OL": "use ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL to search ULTRASONOGRAPHY, TRANSCRANIAL DOPPLER 1994", "PM": "95; was ULTRASONOGRAPHY, TRANSCRANIAL DOPPLER 1994", "HN": "95; was ULTRASONOGRAPHY, TRANSCRANIAL DOPPLER 1994", "CATSH": "CAT LIST", "MR": "20160317", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017585"}, {"RECTYPE": "D", "MH": "Diskectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Discectomy|T061|NON|EQV|NLM (1994)|920617|abcdef", "ENTRY": "Diskectomies", "MN": "E04.555.200", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "DISKECTOMY, PERCUTANEOUS is also available", "PI": "Intervertebral Disk/surgery (1966-1993)", "MS": "Excision, in part or whole, of an INTERVERTEBRAL DISC. The most common indication is disk displacement or herniation. In addition to standard surgical removal, it can be performed by percutaneous diskectomy (DISKECTOMY, PERCUTANEOUS) or by laparoscopic diskectomy, the former being the more common.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017586"}, {"RECTYPE": "D", "MH": "Diskectomy, Percutaneous", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Nucleotomy, Percutaneous|T061|NON|NRW|NLM (1994)|920618|abcdef", "ENTRY": "Percutaneous Nucleotomy", "MN": "E04.555.200.200", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "entry term NUCLEOTOMY, PERCUTANEOUS refers only to the NUCLEUS PULPOSUS", "PI": "Intervertebral Disk/surgery (1983-1993)", "MS": "Percutaneous excision of a herniated or displaced INTERVERTEBRAL DISC by posterolateral approach, always remaining outside the spinal canal. Percutaneous nucleotomy was first described by Hijikata in Japan in 1975. In 1985 Onik introduced automated percutaneous nucleotomy which consists in percutaneous aspiration of the nucleus pulposus. It is carried out under local anesthesia, thus reducing the surgical insult and requiring brief hospitalization, often performed on an outpatient basis. It appears to be a well-tolerated alternative to surgical diskectomy and chymopapain nucleolysis.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017587"}, {"RECTYPE": "D", "MH": "Hyperandrogenism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C19.391.119.090.750", "FX": "Virilism", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "general or unspecified; prefer specific manifestation such as HIRSUTISM; VIRILISM; etc.", "PI": "Androgens (1966-1993)", "MS": "A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017588"}, {"RECTYPE": "D", "MH": "Immunization Programs", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Vaccination Promotions", "MN": "N02.421.726.608", "MH_TH": "NLM (1994)", "ST": "T058", "AN": "IM; coord with specific dis /prev (IM) or specific vaccine or other type of immunization (IM); specify geog if pertinent", "PI": "Vaccination (1966-1993)", "MS": "Organized services to administer immunization procedures in the prevention of various diseases. The programs are made available over a wide range of sites: schools, hospitals, public health agencies, voluntary health agencies, etc. They are administered to an equally wide range of population groups or on various administrative levels: community, municipal, state, national, international.", "PM": "94", "HN": "94", "MR": "20151124", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017589"}, {"RECTYPE": "D", "MH": "Myelinolysis, Central Pontine", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Extrapontine Myelinolysis|T047|NON|REL|NLM (2000)|991103|abcdef", "ENTRY": "Myelinolysis, Extrapontine", "MN": "C18.452.132.560", "MH_TH": "NLM (1994)", "ST": "T047", "PI": "Pons (1966-1993)", "MS": "A demyelinating condition affecting the PONS and characterized clinically by an acute progressive QUADRIPLEGIA; DYSARTHRIA; DYSPHAGIA; and alterations of consciousness. Pathologic features include prominent demyelination in the central PONS with sparing of axons and neurons. This condition is usually associated with systemic disorders such as HYPONATREMIA; chronic ALCOHOLISM; LIVER FAILURE; severe BURNS; malignant NEOPLASMS; hemorrhagic PANCREATITIS; HEMODIALYSIS; and SEPSIS. The rapid medical correction of hyponatremia has been cited as a cause of this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1125-6)", "PM": "1994", "HN": "1994", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017590"}, {"RECTYPE": "D", "MH": "Petrosal Sinus Sampling", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Inferior Petrosal Sinus Sampling|T060|NON|EQV|NLM (1994)|920618|abcdef", "ENTRY": "Samplings, Petrosal Sinus", "MN": "E05.200.998.110.600", "MH_TH": "NLM (1994)", "ST": "T060", "PI": "Corticotropin/blood (1985-1993)", "MS": "Sampling of blood levels of the adrenocorticotropic hormone (ACTH) by withdrawal of blood from the inferior petrosal sinus. The inferior petrosal sinus arises from the cavernous sinus and runs to the internal jugular vein. Sampling of blood at this level is a valuable tool in the differential diagnosis of Cushing disease, Cushing syndrome, and other adrenocortical diseases.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D017591"}, {"RECTYPE": "D", "MH": "Skin Care", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Care, Skin", "MN": "E02.547.800", "MH_TH": "NLM (1994)", "ST": "T055", "AN": "IM; coord with specific agent used in the care, as SOAPS; OINTMENTS; DETERGENTS; etc. (IM or NIM) or specific type of care, as BATHS (IM or NIM) or specific ther agent (IM or NIM)", "MS": "Maintenance of the hygienic state of the skin under optimal conditions of cleanliness and comfort. Effective in skin care are proper washing, bathing, cleansing, and the use of soaps, detergents, oils, etc. In various disease states, therapeutic and protective solutions and ointments are useful. The care of the skin is particularly important in various occupations, in exposure to sunlight, in neonates, and in PRESSURE ULCER.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20050701", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017592"}, {"RECTYPE": "D", "MH": "Kleine-Levin Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypersomnia, Periodic|T047|NON|EQV|NLM (1994)|920618|abcdef", "ENTRY": "Syndrome, Kleine-Levin-Critchley", "MN": "F03.870.400.800.200.500", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Sleep Disorders (1966-1979)", "MS": "A rare condition characterized by recurrent hypersomnias associated with hyperphagia, occurring primarily in males in the second to third decade of life. Clinical features include mental confusion, excessive sleep requirements (approximately 18 hours per day), restlessness, and in some cases hallucinations. Episodes have a duration of days to weeks, and may recur several times per year. This condition may resolve spontaneously over several years. (From Adams, et al., Principles of Neurology, 6th ed, p569)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017593"}, {"RECTYPE": "D", "MH": "Publication Bias", "AQ": "HI LJ SN TD", "ENTRY": "Bias, Publication", "MN": "L01.737.813", "MH_TH": "NLM (1994)", "ST": "T080", "AN": "IM; coord with basis for bias (e.g., FALSE POSITIVE REACTIONS) or milieu (e.g., CLINICAL TRIALS AS TOPIC) if pertinent (IM or NIM)", "PI": "Publishing (1986-1993)", "MS": "The influence of study results on the chances of publication and the tendency of investigators, reviewers, and editors to submit or accept manuscripts for publication based on the direction or strength of the study findings. Publication bias has an impact on the interpretation of clinical trials and meta-analyses. Bias can be minimized by insistence by editors on high-quality research, thorough literature reviews, acknowledgement of conflicts of interest, modification of peer review practices, etc.", "PM": "94", "HN": "94", "MR": "20090714", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017594"}, {"RECTYPE": "D", "MH": "Renal Plasma Flow", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Plasma Flow, Renal|T034|NON|EQV|NLM (1994)|920706|abcdef", "ENTRY": "Flow, Renal Plasma", "MN": "G09.330.100.812.740", "MH_TH": "NLM (1994)", "ST": "T034", "AN": "do not confuse with RENAL BLOOD FLOW see RENAL CIRCULATION or RENAL PLASMA FLOW, EFFECTIVE", "PI": "Renal Circulation (1982-1993)", "MS": "The amount of PLASMA that perfuses the KIDNEYS per unit time, approximately 10% greater than effective renal plasma flow (RENAL PLASMA FLOW, EFFECTIVE). It should be differentiated from the RENAL BLOOD FLOW; (RBF), which refers to the total volume of BLOOD flowing through the renal vasculature, while the renal plasma flow refers to the rate of plasma flow (RPF).", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017595"}, {"RECTYPE": "D", "MH": "Renal Plasma Flow, Effective", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Plasma Flow, Renal, Effective|T042|NON|EQV|NLM (1994)|920706|abcdef", "ENTRY": "Effective Renal Plasma Flow|T042|NON|EQV|NLM (1994)|920706|abcdef", "MN": "G09.330.100.812.750", "MH_TH": "NLM (1994)", "ST": "T042", "AN": "do not confuse with RENAL PLASMA FLOW or RENAL BLOOD FLOW, EFFECTIVE", "PI": "Renal Circulation (1982-1993)", "MS": "The amount of PLASMA flowing to the parts of the KIDNEY that function in the production of urine. It is the amount of plasma perfusing the KIDNEY TUBULES per unit time, generally measured by P-AMINOHIPPURATE clearance. It should be differentiated from RENAL PLASMA FLOW which is approximately 10% greater than the effective renal plasma flow.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017596"}, {"RECTYPE": "D", "MH": "Renal Blood Flow, Effective", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "ERBF|T042|ABB|EQV|NLM (1994)|920623|abcdef", "ENTRY": "Effective Renal Blood Flow|T042|NON|EQV|NLM (1994)|920706|abcdef", "MN": "G09.330.100.812.700", "MH_TH": "NLM (1991)", "ST": "T042", "AN": "do not confuse with RENAL PLASMA FLOW, EFFECTIVE or RENAL BLOOD FLOW see RENAL CIRCULATION", "PI": "Renal Circulation (1982-1993)", "MS": "The amount of the RENAL BLOOD FLOW that is going to the functional renal tissue, i.e., parts of the KIDNEY that are involved in production of URINE.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017597"}, {"RECTYPE": "D", "MH": "Efficiency, Organizational", "DE": "EFFICIENCY ORGAN", "AQ": "CL EC ES HI LJ SN ST TD", "PRINT ENTRY": "Program Efficiency|T078|NON|NRW|POPLINE (1978)|920909|abcdef", "ENTRY": "Program Efficiencies", "MN": "N04.452.209.500", "MH_TH": "NLM (1994)", "ST": "T078", "PI": "Efficiency (1972-1993)", "MS": "The capacity of an organization, institution, or business to produce desired results with a minimum expenditure of energy, time, money, personnel, material, etc.", "PM": "94", "HN": "94", "MR": "20180629", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017598"}, {"RECTYPE": "D", "MH": "Neuroectodermal Tumors", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Neuroectodermal", "MN": "C04.557.580.625", "MH_TH": "NLM (1993)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "Malignant neoplasms arising in the neuroectoderm, the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems, including some glial cells.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D017599"}, {"RECTYPE": "D", "MH": "Neuroectodermal Tumor, Melanotic", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Retinal Anlage Tumor|T191|NON|EQV|NLM (1994)|930420|abcdef", "ENTRY": "Tumors, Retinal Anlage", "MN": "C04.557.580.625.630", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Neoplasms, Germ Cell and Embryonal (1966-1993)", "MS": "A benign, rapidly growing, deeply pigmented tumor of the jaw and occasionally of other sites, consisting of an infiltrating mass of cells arranged in an alveolar pattern, and occurring almost exclusively in infants. Its source of origin is in dispute, the various theories giving rise to its several names. (Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D017600"}, {"RECTYPE": "D", "MH": "Oxygen Compounds", "DE": "OXYGEN CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Oxygen", "MN": "D01.650", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Oxygen (1966-1993)", "MS": "Inorganic compounds that contain oxygen as an integral part of the molecule.", "PM": "98", "HN": "98; use explode 1994-97", "MR": "19970620", "DA": "19930629", "DC": "1", "DX": "19980101", "UI": "D017601"}, {"RECTYPE": "D", "MH": "Lithotripsy, Laser", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Laser-Induced Shockwave Lithotripsy|T061|NON|NRW|NLM (1994)|920626|LISL|abcdefv", "ENTRY": "Shockwave Lithotripsy, Laser Induced", "MN": "E04.943.500.500", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "coordinate IM with disease /ther, not /surg (IM)", "PI": "Lithotripsy (1986-1993)", "MS": "Fragmentation of CALCULI, notably urinary or biliary, by LASER.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017602"}, {"RECTYPE": "D", "MH": "Signal Detection, Psychological", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Signal Detection (Psychology)|T078|NON|EQV|NLM (1994)|990101|SIGNAL DETECTION|abcdefv", "ENTRY": "Theory, Signal Detection", "MN": "F04.669.908", "FX": "Sensory Thresholds", "MH_TH": "NLM (2009)", "ST": "T078", "PI": "Discrimination (Psychology) (1968-1993)", "MS": "Psychophysical technique that permits the estimation of the bias of the observer as well as detectability of the signal (i.e., stimulus) in any sensory modality. (From APA, Thesaurus of Psychological Index Terms, 8th ed.)", "PM": "2009; see SIGNAL DETECTION (PSYCHOLOGY) 1994-2008", "HN": "2009 (1994)", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017603"}, {"RECTYPE": "D", "MH": "Cesarean Section, Repeat", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Repeat Cesarean Section|T061|NON|EQV|NLM (1994)|921230|abcdef", "ENTRY": "Sections, Repeat Cesarean", "MN": "E04.520.252.500.150", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "check the tags FEMALE & PREGNANCY", "PI": "Cesarean Section (1971-1993)", "MS": "Extraction of the fetus by abdominal hysterotomy anytime following a previous cesarean.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017604"}, {"RECTYPE": "D", "MH": "Bromine Compounds", "DE": "BROMINE CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Bromine", "MN": "D01.139", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Bromine (1966-1993)", "MS": "Inorganic compounds that contain bromine as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017605"}, {"RECTYPE": "D", "MH": "Chlorine Compounds", "DE": "CHLORINE CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inorganic Chlorine Compounds", "MN": "D01.210", "FX": "Hydrocarbons, Chlorinated", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics; used for mapping supplementary chemicals", "MS": "Inorganic compounds that contain chlorine as an integral part of the molecule.", "PM": "98", "HN": "98; use explode 1994-97", "MR": "20060705", "DA": "19930629", "DC": "1", "DX": "19980101", "UI": "D017606"}, {"RECTYPE": "D", "MH": "Aluminum Compounds", "DE": "ALUMINUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Aluminum", "MN": "D01.056", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Aluminum (1966-1993)", "MS": "Inorganic compounds that contain aluminum as an integral part of the molecule.", "PM": "94", "HN": "94", "MR": "20170410", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017607"}, {"RECTYPE": "D", "MH": "Chromium Compounds", "DE": "CHROMIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Chromium", "MN": "D01.220", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Chromium (1966-1993)", "MS": "Inorganic compounds that contain chromium as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017608"}, {"RECTYPE": "D", "MH": "Barium Compounds", "DE": "BARIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Barium", "MN": "D01.103", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Barium (1966-1993)", "MS": "Inorganic compounds that contain barium as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017609"}, {"RECTYPE": "D", "MH": "Calcium Compounds", "DE": "CALCIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Calcium", "MN": "D01.146", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Calcium (1966-1993)", "MS": "Inorganic compounds that contain calcium as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017610"}, {"RECTYPE": "D", "MH": "Fluorine Compounds", "DE": "FLUORINE CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Fluorine", "MN": "D01.303", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Fluorine (1966-1993)", "MS": "Inorganic compounds that contain fluorine as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017611"}, {"RECTYPE": "D", "MH": "Gold Compounds", "DE": "GOLD CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Gold", "MN": "D01.379", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Gold (1966-1993)", "MS": "Inorganic compounds that contain gold as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017612"}, {"RECTYPE": "D", "MH": "Iodine Compounds", "DE": "IODINE CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Iodine", "MN": "D01.475", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Iodine (1966-1993)", "MS": "Inorganic compounds that contain iodine as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017613"}, {"RECTYPE": "D", "MH": "Enteric Nervous System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Systems, Enteric Nervous", "MN": "A08.800.050.150", "MH_TH": "NLM (1993)", "ST": "T022", "AN": "a major division of the autonomic nerv syst", "MS": "Two ganglionated neural plexuses in the gut wall which form one of the three major divisions of the autonomic nervous system. The enteric nervous system innervates the gastrointestinal tract, the pancreas, and the gallbladder. It contains sensory neurons, interneurons, and motor neurons. Thus the circuitry can autonomously sense the tension and the chemical environment in the gut and regulate blood vessel tone, motility, secretions, and fluid transport. The system is itself governed by the central nervous system and receives both parasympathetic and sympathetic innervation. (From Kandel, Schwartz, and Jessel, Principles of Neural Science, 3d ed, p766)", "PM": "94", "HN": "94", "MR": "19950608", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017615"}, {"RECTYPE": "D", "MH": "Magnesium Compounds", "DE": "MAGNESIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Magnesium", "MN": "D01.524", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Magnesium (1966-1993)", "MS": "Inorganic compounds that contain magnesium as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017616"}, {"RECTYPE": "D", "MH": "Hemibody Irradiation", "DE": "HEMIBODY IRRAD", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Systemic Hemibody Irradiation|T061|NON|EQV|NLM (1994)|920702|SYSTEMIC HEMIBODY IRRAD|abcdefv", "ENTRY": "Systemic Hemibody Irradiations", "MN": "E02.815.270", "FX": "Whole-Body Irradiation", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "in radiotherapy, coordinate with disease /radiother; for hemibody irradiation experiments, coordinate with organ or process /\u200crad eff ", "PI": "Whole-Body Irradiation (1981-1993)", "MS": "Irradiation of one half or both halves of the body in the treatment of disseminated cancer or widespread metastases. It is used to treat diffuse metastases in one session as opposed to multiple fields over an extended period. The more frequent treatment modalities are upper hemibody irradiation (UHBI) or lower hemibody irradiation (LHBI). Less common is mid-body irradiation (MBI). In the treatment of both halves of the body sequentially, hemibody irradiation permits radiotherapy of the whole body with larger doses of radiation than could be accomplished with WHOLE-BODY IRRADIATION. It is sometimes called \"systemic\" hemibody irradiation with reference to its use in widespread cancer or metastases. (P. Rubin et al. Cancer, Vol 55, p2210, 1985)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017619"}, {"RECTYPE": "D", "MH": "Periodontal Attachment Loss", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Attachment Loss, Periodontal|T047|NON|EQV|NLM (1994)|920911|abcdef", "ENTRY": "Loss, Periodontal Attachment", "MN": "C07.465.714.354.750", "MH_TH": "NLM (1994)", "ST": "T047", "PI": "Periodontitis (1976-1993)", "MS": "Loss or destruction of periodontal tissue caused by periodontitis or other destructive periodontal diseases or by injury during instrumentation. Attachment refers to the periodontal ligament which attaches to the alveolar bone. It has been hypothesized that treatment of the underlying periodontal disease and the seeding of periodontal ligament cells enable the creating of new attachment.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017622"}, {"RECTYPE": "D", "MH": "WAGR Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wilms Tumor-Aniridia-Gonadoblastoma-Mental Retardation Syndrome|T019|T191|EPO|EQV|NLM (2010)|ORD (2010)|090515|abbcdeef", "ENTRY": "WAGR Syndromes", "MN": "C19.391.119.096.875", "FX": "Genes, Wilms Tumor", "MH_TH": "ORD (2010)", "ST": "T191", "PI": "Urogenital System/abnormalities (1984-1993)", "MS": "A contiguous gene syndrome associated with hemizygous deletions of chromosome region 11p13. The condition is marked by the combination of WILMS TUMOR; ANIRIDIA; GENITOURINARY ABNORMALITIES; and INTELLECTUAL DISABILITY.", "PM": "1994", "HN": "1994", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D017624"}, {"RECTYPE": "D", "MH": "Cochlear Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nucleus, Cochlear", "MN": "A08.186.211.132.810.428.600.135", "MH_TH": "NLM (1994)", "ST": "T023", "PI": "Brain Stem (1966-1993)", "MS": "The brain stem nucleus that receives the central input from the cochlear nerve. The cochlear nucleus is located lateral and dorsolateral to the inferior cerebellar peduncles and is functionally divided into dorsal and ventral parts. It is tonotopically organized, performs the first stage of central auditory processing, and projects (directly or indirectly) to higher auditory areas including the superior olivary nuclei, the medial geniculi, the inferior colliculi, and the auditory cortex.", "PM": "94", "HN": "94", "MR": "20150622", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017626"}, {"RECTYPE": "D", "MH": "Microglia", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Microglial Cell|T025|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Microglias", "MN": "A11.650.400", "MH_TH": "NLM (1994)", "ST": "T025", "PI": "Neuroglia (1966-1993)", "MS": "The third type of glial cell, along with astrocytes and oligodendrocytes (which together form the macroglia). Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion (e.g., of cytokines and neural growth factors), in immunological processing (e.g., antigen presentation), and in central nervous system development and remodeling.", "PM": "94", "HN": "94", "MR": "20200116", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017628"}, {"RECTYPE": "D", "MH": "Gap Junctions", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "ENTRY": "Junctions, Gap", "MN": "A11.284.149.165.420.471", "FX": "Connexins", "MH_TH": "NLM (1994)", "ST": "T030", "PI": "Intercellular Junctions (1971-1993)", "MS": "Connections between cells which allow passage of small molecules and electric current. Gap junctions were first described anatomically as regions of close apposition between cells with a narrow (1-2 nm) gap between cell membranes. The variety in the properties of gap junctions is reflected in the number of CONNEXINS, the family of proteins which form the junctions.", "PM": "94", "HN": "94", "MR": "20000622", "DA": "19930806", "DC": "1", "DX": "19940101", "UI": "D017629"}, {"RECTYPE": "D", "MH": "Connexins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gap Junction Proteins|T116|T123|NON|EQV|NLM (1993)|920709|abbcdef", "ENTRY": "Junction Proteins, Gap", "MN": "D12.776.543.585.250", "FX": "Erythrokeratodermia Variabilis", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1981-1993)", "MS": "A group of homologous proteins which form the intermembrane channels of GAP JUNCTIONS. The connexins are the products of an identified gene family which has both highly conserved and highly divergent regions. The variety contributes to the wide range of functional properties of gap junctions.", "OL": "use CONNEXINS (NM) to search GAP JUNCTION PROTEIN 1982-93", "PM": "94; GAP JUNCTION PROTEIN was indexed under MEMBRANE PROTEINS 1982-93", "HN": "94; GAP JUNCTION PROTEIN was (NM) 1982-93", "MR": "20230531", "DA": "19930806", "DC": "1", "DX": "19940101", "UI": "D017630"}, {"RECTYPE": "D", "MH": "Asbestos, Serpentine", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Serpentine Asbestos|T131|T197|NON|EQV|NLM (1994)|921216|abbcdef", "ENTRY": "Asbestos, Serpentine, Chrysotile (Mg3(OH)4(Si2O5))|T131|T197|NON|NRW|NLM (1999)|990913|abbcdef", "MN": "D01.837.725.700.760.535.400", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "RR": "12135-86-3", "AN": "serpentine refers to the mottled or spotted surface resembling a serpent's skin", "PI": "Asbestos (1969-1993)", "MS": "A type of asbestos that occurs in nature as the dihydrate of magnesium silicate. It exists in two forms: antigorite, a plated variety, and chrysotile, a fibrous variety. The latter makes up 95% of all asbestos products. (From Merck Index, 11th ed, p.893)", "OL": "use ASBESTOS, SERPENTINE (NM) to search CHRYSOTILE 1980-93", "PM": "94; CHRYSOTILE was indexed under ASBESTOS 1974-93", "HN": "94; CHRYSOTILE was (NM) 1974-93", "MR": "20010725", "DA": "19930616", "DC": "1", "DX": "19940101", "UI": "D017632"}, {"RECTYPE": "D", "MH": "Magnesium Silicates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Silicates, Magnesium", "MN": "D01.837.725.700.760.535", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "inorganic cpds; TALC & ASBESTOS are examples of magnesium silicates", "PI": "Silicic Acid (1966-1993)", "MS": "A generic term for a variety of compounds that contain silicon, oxygen, and magnesium, and may contain hydrogen. Examples include TALC and some kinds of ASBESTOS.", "PM": "94", "HN": "94", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017633"}, {"RECTYPE": "D", "MH": "Self Tolerance", "AQ": "DE ES GE IM PH RE", "ENTRY": "Tolerances, Self", "MN": "G12.535.425.800", "FX": "Clonal Deletion", "MH_TH": "NLM (1994)", "ST": "T042", "AN": "a form of immune tolerance", "PI": "Immune Tolerance (1973-1993)", "MS": "The normal lack of the ability to produce an immunological response to autologous (self) antigens. A breakdown of self tolerance leads to autoimmune diseases. The ability to recognize the difference between self and non-self is the prime function of the immune system.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017634"}, {"RECTYPE": "D", "MH": "Clonal Anergy", "AQ": "DE ES GE IM PH RE", "ENTRY": "Clonal Anergies", "MN": "G12.535.425.100", "MH_TH": "NLM (1994)", "ST": "T042", "AN": "a form of immune tolerance", "PI": "specific cells/immunology (1980-1993)", "MS": "Functional inactivation of T- or B-lymphocytes rendering them incapable of eliciting an immune response to antigen. This occurs through different mechanisms in the two kinds of lymphocytes and can contribute to SELF TOLERANCE.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160616", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017635"}, {"RECTYPE": "D", "MH": "Asbestos, Amphibole", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Amphibole Asbestos|T131|T197|NON|EQV|NLM (1994)|921216|abbcdef", "ENTRY": "Asbestos, Amphibole group Minerals", "MN": "D01.837.725.700.760.070.050", "MH_TH": "NLM (1993)", "ST": "T197", "RN": "0", "RR": "1318-09-8 (amphibole-group minerals)", "PI": "Silicon Dioxide (1979-1993)", "MS": "A class of asbestos that includes silicates of magnesium, iron, calcium, and sodium. The fibers are generally brittle and cannot be spun, but are more resistant to chemicals and heat than ASBESTOS, SERPENTINE. (From Hawley's Condensed Chemical Dictionary, 11th ed)", "OL": "use ASBESTOS, AMPHIBOLE (NM) to search AMPHIBOLES 1980-93", "PM": "94; AMPHIBOLES was indexed under SILICA 1979-93", "HN": "94; was AMPHIBOLES (NM) 1979-93", "MR": "20200527", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017636"}, {"RECTYPE": "D", "MH": "Clonal Deletion", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Clonal Abortion|T042|NON|REL|NLM (1994)|921203|abcdef", "ENTRY": "Deletions, Clonal", "MN": "G12.535.425.120", "FX": "Apoptosis", "MH_TH": "NLM (1994)", "ST": "T042", "AN": "a form of immune tolerance", "PI": "specific cell/immunology (1978-1993)", "MS": "Removal, via CELL DEATH, of immature lymphocytes that interact with antigens during maturation. For T-lymphocytes this occurs in the thymus and ensures that mature T-lymphocytes are self tolerant. B-lymphocytes may also undergo clonal deletion.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160616", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017637"}, {"RECTYPE": "D", "MH": "Asbestos, Crocidolite", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Crocidolite Asbestos|T131|T197|NON|EQV|NLM (1994)|921223|abbcdef", "ENTRY": "Asbestos, Blue", "MN": "D01.837.725.700.760.070.050.090", "MH_TH": "NLM (1994)", "ST": "T197", "N1": "Crocidolite", "RN": "12001-28-4", "RR": "61105-31-5 (Fe2Mg3Na2(SiO3)8)", "PI": "Asbestos (1975-1993)", "MS": "A lavender, acid-resistant asbestos.", "OL": "use ASBESTOS, CROCIDOLITE (NM) to search CROCIDOLITE 1980-93", "PM": "94; CROCIDOLITE was indexed under ASBESTOS 1975-93", "HN": "94; was CROCIDOLITE (NM) 1975-93", "MR": "20010725", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017638"}, {"RECTYPE": "D", "MH": "Asbestos, Amosite", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Amosite Asbestos|T131|T197|NON|EQV|NLM (1994)|921216|abbcdef", "ENTRY": "Cummingtonite Grunerite", "MN": "D01.837.725.700.760.535.040", "MH_TH": "NLM (1994)", "ST": "T197", "N1": "Asbestos, grunerite", "RN": "12172-73-5", "PI": "Asbestos (1974-1993)", "MS": "Asbestos, grunerite. A monoclinic amphibole form of asbestos having long fibers and a high iron content. It is used in insulation. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "OL": "use ASBESTOS, AMOSITE (NM) to search AMOSITE 1980-93", "PM": "94; AMOSITE was indexed under ASBESTOS 1974-93", "HN": "94; was AMOSITE (NM) 1974-93", "MR": "19991103", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017639"}, {"RECTYPE": "D", "MH": "Silicates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Silicate|T197|NON|EQV|NLM (1993)|920709|abcdef", "MN": "D01.837.725.700.760", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Silicic Acid (1981-1993)", "MS": "The generic term for salts derived from silica or the silicic acids. They contain silicon, oxygen, and one or more metals, and may contain hydrogen. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th Ed)", "PM": "94", "HN": "94", "MR": "20100625", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017640"}, {"RECTYPE": "D", "MH": "Zeolites", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Zeolite|T197|NON|EQV|NLM (1994)|921027|abcdef", "MN": "D01.837.725.700.760.050.950", "MH_TH": "NLM (1994)", "ST": "T197", "N1": "Zeolites", "RN": "1318-02-1", "AN": "aluminum silicates; cation exchangers, molecular sieves, water softeners & adsorbents", "PI": "Sodium Hydroxide (1972-1980)", "MS": "Zeolites. A group of crystalline, hydrated alkali-aluminum silicates. They occur naturally in sedimentary and volcanic rocks, altered basalts, ores, and clay deposits. Some 40 known zeolite minerals and a great number of synthetic zeolites are available commercially. (From Merck Index, 11th ed)", "OL": "use ZEOLITES (NM) to search ZEOLITE 1980-93", "PM": "94; ZEOLITES was indexed under ALUMINUM SILICATES 1981-93 & SODIUM HYDROXIDE 1972-80", "HN": "94; was ZEOLITE (NM) 1972-93", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017641"}, {"RECTYPE": "D", "MH": "Organosilicon Compounds", "DE": "ORGANOSILICON CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Organosilanes|T109|NON|NRW|NLM (2020)|190628|abcdef", "MN": "D02.756", "MH_TH": "NLM (1994)", "ST": "T109", "RN": "0", "PI": "Silicon (1966-1993)", "MS": "Organic compounds that contain silicon as an integral part of the molecule.", "PM": "94", "HN": "94", "MR": "20190701", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017646"}, {"RECTYPE": "D", "MH": "Silicon Compounds", "DE": "SILICON CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Silicon", "MN": "D01.837", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Silicon (1966-1993)", "MS": "Inorganic compounds that contain silicon as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017655"}, {"RECTYPE": "D", "MH": "Autoreceptors", "DE": "AUTORECEPT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Autoreceptor|T116|T192|NON|EQV|NLM (1994)|930222|abbcdef", "MN": "D12.776.543.750.720.670.100", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "MS": "Transmitter receptors on or near presynaptic terminals (or varicosities) which are sensitive to the transmitter(s) released by the terminal itself. Receptors for the hormones released by hormone-releasing cells are also included.", "PM": "94", "HN": "94", "MR": "20160527", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D017660"}, {"RECTYPE": "D", "MH": "Receptors, Presynaptic", "DE": "RECEPT PRESYNAPTIC", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Presynaptic Receptors|T116|T192|NON|EQV|NLM (1994)|930413|PRESYNAPTIC RECEPT|abbcdefv", "ENTRY": "Receptor, Presynaptic", "MN": "D12.776.543.750.720.670", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "cell surface receptors: do not confuse with NEURORECEPTORS see SENSORY RECEPTOR CELLS or with RECEPTORS, NEUROTRANSMITTER", "MS": "Neurotransmitter receptors located on or near presynaptic terminals or varicosities. Presynaptic receptors which bind transmitter molecules released by the terminal itself are termed AUTORECEPTORS.", "PM": "94", "HN": "94", "MR": "20080710", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017661"}, {"RECTYPE": "D", "MH": "Peplomycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pepleomycin|T116|T195|NON|EQV|FDA SRS (2014)|NLM (1994)|920723|abbcdeef", "ENTRY": "Sulfate, Peplomycin", "MN": "D12.644.233.110.690", "PA": "Antibiotics, Antineoplastic", "MH_TH": "NLM (1994)", "ST": "T195", "N1": "Bleomycinamide, N1-(3-((1-phenylethyl)amino)propyl)-, (S)-", "RN": "56H9L80NIZ", "RR": "73228-94-1 (unspecified sulfate)", "PI": "Bleomycins (1979-1993)", "MS": "An antineoplastic agent derived from BLEOMYCIN.", "OL": "use PEPLOMYCIN (NM) to search PEPLEOMYCIN 1980-93", "PM": "94; PEPLEOMYCIN was indexed under BLEOMYCINS 1979-93", "HN": "94; was PEPLEOMYCIN (NM) 1979-93", "MR": "20130708", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017663"}, {"RECTYPE": "D", "MH": "Uncompensated Care", "AQ": "CL EC ES HI LJ SN TD", "PRINT ENTRY": "Indigent Care|T058|NON|NRW|UNK (19XX)|750101|abcdef", "ENTRY": "Care, Uncompensated", "MN": "N05.300.830", "FX": "Medically Uninsured", "MH_TH": "NLM (1994)", "ST": "T058", "AN": "absence of payment to physician, dentist, other health professional, hosp; includes lack of compensation in pro bono work & charity care & as a result of bad debts", "MS": "Medical services for which no payment is received. Uncompensated care includes charity care and bad debts.", "PM": "1994; for INDIGENT CARE see MEDICAL INDIGENCY 1968-1999, see INDIGENT CARE 1963-1967", "HN": "1994; for INDIGENT CARE use MEDICAL INDIGENCY 1968-1999, use INDIGENT CARE 1963-1967", "MR": "20180629", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017664"}, {"RECTYPE": "D", "MH": "Hydroxyl Radical", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D01.339.431.249", "PA": "Oxidants", "MH_TH": "NLM (1994)", "ST": "T197", "N1": "Hydroxyl", "RN": "3352-57-6", "PI": "Hydroxides (1978-1993)", "MS": "The univalent radical OH. Hydroxyl radical is a potent oxidizing agent.", "OL": "use HYDROXYL RADICAL (NM) to search HYDROXYL RADICAL 1980-93", "PM": "94; HYDROXYL RADICAL was indexed under HYDROXIDES 1978-93", "HN": "94; was HYDROXYL RADICAL (NM) 1978-93", "MR": "20230226", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D017665"}, {"RECTYPE": "D", "MH": "Deuterium Oxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Heavy Water|T197|NON|EQV|NLM (1994)|920730|abcdef", "ENTRY": "Water, Heavy", "MN": "D01.362.340.500.250", "PA": "Radiation-Protective Agents", "MH_TH": "USAN (1963)", "ST": "T197", "N1": "Water-d2", "RN": "J65BV539M3", "RR": "7789-20-0 (Deuterium Oxide)", "PI": "Water (1980-1993)", "MS": "The isotopic compound of hydrogen of mass 2 (deuterium) with oxygen. (From Grant & Hackh's Chemical Dictionary, 5th ed) It is used to study mechanisms and rates of chemical or nuclear reactions, as well as biological processes.", "OL": "use DEUTERIUM OXIDE (NM) to search DEUTERIUM OXIDE 1980-93", "PM": "94; DEUTERIUM OXIDE was indexed under DEUTERIUM & WATER 1980-93", "HN": "94; was DEUTERIUM OXIDE (NM) 1980-93", "MR": "20150622", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017666"}, {"RECTYPE": "D", "MH": "Adipocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Fat Cells|T025|NON|EQV|NLM (1994)|920731|abcdef", "ENTRY": "Lipocyte", "MN": "A11.329.114", "MH_TH": "NLM (1994)", "ST": "T025", "PI": "Adipose Tissue (1967-1993)", "MS": "Cells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous tissue. BROWN ADIPOCYTES are thermogenic cells that can be found in newborns of some species and hibernating mammals.", "PM": "94", "HN": "94", "MR": "20130709", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017667"}, {"RECTYPE": "D", "MH": "Age of Onset", "ENTRY": "Onset Age", "MN": "N06.850.490.250.100", "MH_TH": "NLM (1994)", "ST": "T081", "AN": "IM general only; coordinate NIM with specific disease (IM);  not for routine age of onset of disease in individual case reports", "PI": "Age Factors (1966-1993)", "MS": "The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual.", "PM": "94", "HN": "94", "MR": "20150707", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017668"}, {"RECTYPE": "D", "MH": "Mercury Compounds", "DE": "MERCURY CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Mercury", "MN": "D01.538", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Mercury (1966-1993)", "MS": "Inorganic compounds that contain mercury as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017669"}, {"RECTYPE": "D", "MH": "Sodium Compounds", "DE": "SODIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Sodium", "MN": "D01.857", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Sodium (1966-1993)", "MS": "Inorganic compounds that contain sodium as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017670"}, {"RECTYPE": "D", "MH": "Platinum Compounds", "DE": "PLATINUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Platinum-Containing Compounds|T197|NON|EQV|NLM (2018)|210209|abcdef", "ENTRY": "Platinum Containing Compounds", "MN": "D01.710", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Platinum (1966-1993)", "MS": "Inorganic compounds which contain platinum as the central atom.", "PM": "94", "HN": "94", "MR": "20210209", "DA": "19930602", "DC": "1", "DX": "19940101", "UI": "D017671"}, {"RECTYPE": "D", "MH": "Nitrogen Compounds", "DE": "NITROGEN CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Nitrogen", "MN": "D01.625", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Nitrogen (1966-1993)", "MS": "Inorganic compounds that contain nitrogen as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017672"}, {"RECTYPE": "D", "MH": "Sodium Chloride, Dietary", "AQ": "AD AE AG AI AN BL CF CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Table Salt|T168|T197|NON|EQV|NLM (1994)|921207|abbcdef", "ENTRY": "Salt, Table", "MN": "D01.857.875.705", "EC": "chemistry:Sodium Chloride:chemistry", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "note entry term TABLE SALT; /adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther", "PI": "Sodium, Dietary (1988-1993)", "MS": "Sodium chloride used in foods.", "PM": "94", "HN": "94", "MR": "20180702", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017673"}, {"RECTYPE": "D", "MH": "Hypophosphatemia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypophosphatemias", "MN": "C18.452.750.400", "EC": "congenital:Hypophosphatemia, Familial", "MH_TH": "NLM (1994)", "ST": "T047", "PI": "Phosphates/blood (1966-1993)", "MS": "A condition of an abnormally low level of PHOSPHATES in the blood.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D017674"}, {"RECTYPE": "D", "MH": "CREST Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "CRST Syndrome|T047|NRW|NLM (1994)|920803|abdef", "ENTRY": "Syndrome, CRST", "MN": "C18.452.174.130.204", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "CREST syndrome: an acronym for Calcinosis, Raynaud phenomenon, Esophageal dysfunction, Sclerodactyly, Telangiectasis", "PI": "Scleroderma, Systemic (1975-1993)", "MS": "A mild form of LIMITED SCLERODERMA, a multi-system disorder. Its features include symptoms of CALCINOSIS; RAYNAUD DISEASE; ESOPHAGEAL MOTILITY DISORDERS; sclerodactyly, and TELANGIECTASIS. When the defect in esophageal function is not prominent, it is known as CRST syndrome.", "PM": "1994", "HN": "1994", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017675"}, {"RECTYPE": "D", "MH": "Lichen Planus, Oral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Oral Lichen Planus", "MN": "C17.800.859.475.560.397", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "alone or with cutaneous lichen planus", "PI": "Mouth Diseases (1966-1993)", "MS": "Oral lesions accompanying cutaneous lichen planus or often occurring alone. The buccal mucosa, lips, gingivae, floor of the mouth, and palate are usually affected (in a descending order of frequency). Typically, oral lesions consist of radiating white or gray, velvety, threadlike lines, arranged in a reticular pattern, at the intersection of which there may be minute, white, elevated dots or streaks (Wickham's striae). (Jablonski, Illustrated Dictionary of Dentistry)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017676"}, {"RECTYPE": "D", "MH": "Age Distribution", "ENTRY": "Distributions, Age", "MN": "N06.850.505.400.050", "MH_TH": "POPLINE (1978)", "ST": "T081", "AN": "usually NIM; human & animal; do not confuse with AGE FACTORS", "PI": "Aging (1966-1967)", "MS": "The frequency of different ages or age groups in a given population. The distribution may refer to either how many or what proportion of the group. The population is usually patients with a specific disease but the concept is not restricted to humans and is not restricted to medicine.", "PM": "94", "HN": "94", "MR": "20160208", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017677"}, {"RECTYPE": "D", "MH": "Sex Distribution", "ENTRY": "Sex Distributions", "MN": "N06.850.505.400.850", "MH_TH": "NLM (1994)", "ST": "T081", "AN": "usually NIM; human & animal; do not confuse with SEX FACTORS", "PI": "Sex Factors (1968-1993)", "MS": "The number of males and females in a given population. The distribution may refer to how many men or women or what proportion of either in the group. The population is usually patients with a specific disease but the concept is not restricted to humans and is not restricted to medicine.", "PM": "94", "HN": "94", "MR": "20160119", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017678"}, {"RECTYPE": "D", "MH": "Cryotherapy", "DE": "CRYOTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Cold Therapy|T061|NON|REL|NLM (1994)|920804|COLD THER|abcdefv", "ENTRY": "Therapies, Cold", "MN": "E02.258", "FX": "Hypothermia, Induced", "MH_TH": "NLM (1994)", "ST": "T061", "PI": "Cryosurgery (1966-1993)", "MS": "A form of therapy consisting in the local or general use of cold. The selective destruction of tissue by extreme cold or freezing is CRYOSURGERY. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "OL": "use CRYOSURGERY to search CRYOTHERAPY 1984-93", "PM": "94; was see CRYOSURGERY 1984-93", "HN": "94; was see CRYOSURGERY 1984-93", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017679"}, {"RECTYPE": "D", "MH": "Potassium Compounds", "DE": "POTASSIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Potassium", "MN": "D01.745", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Potassium (1966-1993)", "MS": "Inorganic compounds that contain potassium as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017680"}, {"RECTYPE": "D", "MH": "Hypereosinophilic Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Loeffler's Endocarditis|T047|EPO|NRW|NLM (1994)|920804|abcdef", "ENTRY": "Syndromes, Idiopathic Hypereosinophilic", "MN": "C15.378.553.231.549", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "do not confuse entry term LOEFFLER'S ENDOCARDITIS with LOEFFLER SYNDROME see PULMONARY EOSINOPHILIA", "PI": "Eosinophilia (1966-1993)", "MS": "A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017681"}, {"RECTYPE": "D", "MH": "Myocardial Stunning", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stunned Myocardium|T047|NON|REL|NLM (1994)|920804|abcdef", "ENTRY": "Stunning, Myocardial", "MN": "C23.888.582", "MH_TH": "NLM (1994)", "ST": "T047", "PI": "Myocardial Reperfusion Injury (1989-1993)", "MS": "Prolonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20150608", "DA": "19930602", "DC": "1", "DX": "19940101", "UI": "D017682"}, {"RECTYPE": "D", "MH": "Oncorhynchus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.493.817.750.825.580", "MH_TH": "NLM (1994)", "ST": "T013", "RN": "txid8016", "PI": "Salmonidae (1968-1972)", "MS": "A genus of the family SALMONIDAE (salmons and trouts). They are named for their hooked (onco) nose (rhynchus). They are usually anadromous and occasionally inhabit freshwater. They can be found in North Pacific coastal areas from Japan to California and adjacent parts of the Arctic Ocean. Salmon and trout are popular game and food fish. Various species figure heavily in genetic, metabolism, and hormone research.", "OL": "use SALMON to search ONCORHYNCHUS 1987-93", "PM": "94; was see SALMON 1987-93", "HN": "94; was see SALMON 1987-93", "MR": "20200813", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017683"}, {"RECTYPE": "D", "MH": "Oncorhynchus kisutch", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Salmon, Silver|T013|NON|EQV|NLM (1994)|920805|abcdef", "ENTRY": "Silver Salmon", "MN": "B01.050.150.900.493.817.750.705.580.410", "MH_TH": "NLM (1994)", "ST": "T013", "RN": "txid8019", "PI": "Salmonidae (1968-1971)", "MS": "An anadromous species of SALMON ranging from the Arctic and Pacific Oceans to Monterey Bay, California and inhabiting ocean and coastal streams. It is familiarly known as the coho or silver salmon. It is relatively small but its light-colored flesh is of good flavor.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017684"}, {"RECTYPE": "D", "MH": "Oncorhynchus keta", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Salmon, Dog|T013|NON|EQV|NLM (1994)|920805|abcdef", "ENTRY": "Dog Salmon", "MN": "B01.050.150.900.493.817.750.705.580.400", "MH_TH": "NLM (1994)", "ST": "T013", "RN": "txid8018", "PI": "Salmonidae (1968-1971)", "MS": "An anadromous species of SALMON found in the streams of the Pacific coast from Sacramento north, and also common in Japan. It is used frequently in genetic and other medical research.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017685"}, {"RECTYPE": "D", "MH": "Oncorhynchus mykiss", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Trout, Redband|T013|NON|NRW|NLM (1994)|920805|abcdef", "ENTRY": "Steelheads", "MN": "B01.050.150.900.493.817.750.825.580.600", "MH_TH": "NLM (1994)", "ST": "T013", "RN": "txid8022", "AN": "do not confuse entry term SALMO GAIRDNERI with SALMON", "PI": "Trout (1975-1993)", "MS": "A large stout-bodied, sometimes anadromous, TROUT found in still and flowing waters of the Pacific coast from southern California to Alaska. It has a greenish back, a whitish belly, and pink, red, or lavender stripes on the sides, with usually a sprinkling of black dots. It is highly regarded as a sport and food fish. Its former name was Salmo gairdneri. The sea-run rainbow trouts are often called steelheads. Redband trouts refer to interior populations of rainbows.", "OL": "use TROUT to search SALMO GAIRDNERI 1987-93", "PM": "94; SALMO GAIRDNERI was see TROUT 1987-93", "HN": "94; SALMO GAIRDNERI was see TROUT 1987-93", "MR": "20200902", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017686"}, {"RECTYPE": "D", "MH": "Radon Daughters", "AQ": "AD AE AN BL CF CH CL EC HI IP ME PD PK PO SD ST TO TU UR", "ENTRY": "Decay Products, Thoron", "MN": "D01.496.749.305.800.500", "PA": "Carcinogens, Environmental", "MH_TH": "NLM (1994)", "ST": "T196", "RN": "0", "PI": "Radon (1993)", "MS": "Short-lived radioactive decay products of radon that include 216-Po, 214-Pb, 214-Bi, and 214-Po. They have an effective half-life of about 30 minutes and are solids that can deposit on the bronchial airways during inhalation and exhalation. This results in exposure of the respiratory airways to alpha radiation and can lead to diseases of the respiratory system, including lung cancer. (From Casarett and Doull's Toxicology, 4th ed, p740)", "OL": "use RADON DAUGHTERS (NM) to search RADON DAUGHTERS 1981-93", "PM": "94; RADON DAUGHTERS was indexed under RADON 1993 & BISMUTH, LEAD & POLONIUM 1981-92", "HN": "94; was RADON DAUGHTERS (NM) 1981-93", "MR": "20170711", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017687"}, {"RECTYPE": "D", "MH": "Cholera Morbus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cholera, Summer|T047|NON|EQV|NLM (1994)|920806|abcdef", "ENTRY": "Summer Choleras", "MN": "C06.405.205.200", "FX": "Cholera", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "an old name for a type of gastroenteritis: do not confuse with classical CHOLERA", "MS": "An old term that is no longer used in the scientific literature. Cholera morbus refers to acute GASTROENTERITIS occurring in summer or autumn; characterized by severe cramps, diarrhea, and vomiting.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017688"}, {"RECTYPE": "D", "MH": "Polydactyly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Polydactylisms", "MN": "C16.131.621.585.600", "FX": "Syndactyly", "MH_TH": "OMIM (2013)", "ST": "T019", "AN": "do not confuse with SYNDACTYLY; coord IM with FINGERS /abnorm (IM) or TOES /abnorm (IM); SHORT RIB-POLYDACTYLY SYNDROME is also available", "PI": "Toes/abnormalities (1966-1993)", "MS": "A congenital anomaly of the hand or foot, marked by the presence of supernumerary digits.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017689"}, {"RECTYPE": "D", "MH": "Cell Transplantation", "DE": "CELL TRANSPL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Transplantation, Cell|T061|NON|EQV|NLM (1994)|920909|TRANSPL CELL|abcdefv", "MN": "E04.936.225", "FX": "Transplantation Immunology", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "general or unspecified only: prefer precoordinated cell/transplantation terms or /transpl with specific cells but note BLOOD COMPONENT TRANSFUSION and specifics are available; for transplantation of cells of organs (lung cells for example), coordinate CELL TRANSPLANTATION  with organ /cytol (LUNG /cytol)", "PI": "specific cell/transplantation (1966-1993)", "MS": "Transference of cells within an individual, between individuals of the same species, or between individuals of different species.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017690"}, {"RECTYPE": "D", "MH": "Caribbean Region", "AQ": "EH EP", "PRINT ENTRY": "West Indies Region|T083|NAM|EQV|NLM (1994)|920806|abcdef", "ENTRY": "Caribbean Sea Region|T083|NAM|EQV|LCSH (1989)|920806|abcdef", "MN": "Z01.107.084", "MH_TH": "NLM (1994)", "ST": "T083", "AN": "general or unspecified for Caribbean Sea, region, islands or population; do not confuse entry term WEST INDIES REGION with WEST INDIES or any of its specific islands", "PI": "West Indies (1966-1993)", "MS": "The area that lies between continental North and South America and comprises the Caribbean Sea, the West Indies, and the adjacent mainland regions of southern Mexico, Central America, Colombia, and Venezuela.", "HN": "94", "MR": "19950608", "DA": "19930526", "DC": "4", "DX": "19940101", "UI": "D017691"}, {"RECTYPE": "D", "MH": "Sodium Bicarbonate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Baking Soda|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1994)|920807|abbcdeef", "ENTRY": "Soda, Baking", "MN": "D01.857.625", "FX": "Buffers", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Carbonic acid monosodium salt", "RN": "8MDF5V39QO", "RR": "144-55-8 (Sodium Bicarbonate)", "PI": "Sodium (1980-1993)", "MS": "A white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.", "OL": "use SODIUM BICARBONATE (NM) to search SODIUM BICARBONATE 1980-93", "PM": "94; SODIUM BICARBONATE was indexed under BICARBONATES & SODIUM 1980-93", "HN": "94; was SODIUM BICARBONATE (NM) 1980-93", "MR": "20130708", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017693"}, {"RECTYPE": "D", "MH": "Rewarming", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Rewarmings", "MN": "E02.891", "FX": "Hypothermia", "MH_TH": "NLM (1994)", "ST": "T061", "PI": "Heat/therapeutic use (1966-1993)", "MS": "Application of heat to correct hypothermia, accidental or induced.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017694"}, {"RECTYPE": "D", "MH": "Soft Tissue Injuries", "DE": "SOFT TISSUE INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Soft Tissue Injury", "MN": "C26.808", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "IM GEN or unspecified; coord NIM with specific organ or region /inj (IM)", "PI": "specific tissue/injuries (1966-1993)", "MS": "Injuries of tissue other than bone. The concept is usually general and does not customarily refer to internal organs or viscera. It is meaningful with reference to regions or organs where soft tissue (muscle, fat, skin) should be differentiated from bones or bone tissue, as \"soft tissue injuries of the hand\".", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017695"}, {"RECTYPE": "D", "MH": "Myopathies, Nemaline", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nemaline Myopathies|T047|NON|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Rod-Body Myopathies", "MN": "C10.668.491.550.290", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Neuromuscular Diseases (1971-1993)", "MS": "A group of inherited congenital myopathic conditions characterized clinically by weakness, hypotonia, and prominent hypoplasia of proximal muscles including the face. Muscle biopsy reveals large numbers of rod-shaped structures beneath the muscle fiber plasma membrane. This disorder is genetically heterogeneous and may occasionally present in adults. (Adams et al., Principles of Neurology, 6th ed, p1453)", "PM": "2000; see NEMALINE MYOPATHY 1994-1999", "HN": "2000(1994)", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19991108", "DC": "1", "DX": "19940101", "UI": "D017696"}, {"RECTYPE": "D", "MH": "Premenopause", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Pre-Menopause|T039|NON|EQV|NLM (1994)|920910|abcdef", "ENTRY": "Period, Pre-menopausal", "MN": "G08.686.841.249.500.812", "MH_TH": "NLM (1994)", "ST": "T039", "PI": "Menstruation (1966-1993)", "MS": "The period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017697"}, {"RECTYPE": "D", "MH": "Postmenopause", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "ENTRY": "Post-Menopauses", "MN": "G08.686.841.249.500.625", "MH_TH": "NLM (1994)", "ST": "T040", "PI": "Menstruation (1966-1993)", "MS": "The physiological period following the MENOPAUSE, the permanent cessation of the menstrual life.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017698"}, {"RECTYPE": "D", "MH": "Pelvic Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pelvic Pains", "MN": "C23.888.592.612.944", "MH_TH": "NLM (1994)", "ST": "T184", "AN": "refers to region, not pelvic bones", "PI": "Pelvis (1966-1993)", "MS": "Pain in the pelvic region of genital and non-genital origin.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20170707", "DA": "19930809", "DC": "1", "DX": "19940101", "UI": "D017699"}, {"RECTYPE": "D", "MH": "Embolism, Cholesterol", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cholesterol Embolism|T047|NON|EQV|NLM (1994)|920916|abcdef", "ENTRY": "Embolisms, Cholesterol", "MN": "C14.907.355.350.454.500", "FX": "Blue Toe Syndrome", "MH_TH": "NLM (1994)", "ST": "T047", "PI": "Embolism (1966-1993)", "MS": "Blocking of a blood vessel by CHOLESTEROL-rich atheromatous deposits, generally occurring in the flow from a large artery to small arterial branches. It is also called arterial-arterial embolization or atheroembolism which may be spontaneous or iatrogenic. Patients with spontaneous atheroembolism often have painful, cyanotic digits of acute onset.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017700"}, {"RECTYPE": "D", "MH": "Reticulocyte Count", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Reticulocyte Numbers", "MN": "G09.188.105.330.725", "FX": "Reticulocytosis", "MH_TH": "NLM (1994)", "ST": "T081", "AN": "usually NIM; coord with disease /blood, not /physiopathol", "PI": "Reticulocytes (1966-1993)", "MS": "The number of RETICULOCYTES per unit volume of BLOOD. The values are expressed as a percentage of the ERYTHROCYTE COUNT or in the form of an index (\"corrected reticulocyte index\"), which attempts to account for the number of circulating erythrocytes.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017701"}, {"RECTYPE": "D", "MH": "Retropharyngeal Abscess", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Abscess, Retropharyngeal|T047|NON|EQV|NLM (1994)|920812|abcdef", "ENTRY": "Retropharyngeal Abscesses", "MN": "C09.775.649.625", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "coordinate IM with infection term (IM) but not BACTERIAL INFECTIONS (since most abscesses are bacterial)", "PI": "Pharynx (1984-1992)", "MS": "An accumulation of purulent material in the space between the PHARYNX and the CERVICAL VERTEBRAE. This usually results from SUPPURATION of retropharyngeal LYMPH NODES in patients with UPPER RESPIRATORY TRACT INFECTIONS, perforation of the pharynx, or head and neck injuries.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017703"}, {"RECTYPE": "D", "MH": "Baroreflex", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Reflex, Baroreceptor|T042|NON|EQV|NLM (1994)|921008|abcdef", "ENTRY": "Reflexes, Baroreceptor", "MN": "G11.561.731.063", "MH_TH": "NLM (1994)", "ST": "T042", "PI": "Pressoreceptors (1966-1993)", "MS": "A response by the BARORECEPTORS to increased BLOOD PRESSURE. Increased pressure stretches BLOOD VESSELS which activates the baroreceptors in the vessel walls. The net response of the CENTRAL NERVOUS SYSTEM is a reduction of central sympathetic outflow. This reduces blood pressure both by decreasing peripheral VASCULAR RESISTANCE and by lowering CARDIAC OUTPUT. Because the baroreceptors are tonically active, the baroreflex can compensate rapidly for both increases and decreases in blood pressure.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017704"}, {"RECTYPE": "D", "MH": "Lignans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neolignans|T109|NON|REL|NLM (1994)|920812|abcdef", "MN": "D02.455.426.559.389.140.450", "MH_TH": "NLM (1994)", "ST": "T109", "RN": "0", "AN": "do not confuse with LIGNIN, also found in plants", "PI": "Plant Extracts (1981-1989)", "MS": "A class of dibenzylbutane derivatives which occurs in higher plants and in fluids (bile, serum, urine, etc.) in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro by human fecal flora. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)", "OL": "use LIGNANS (NM) to search LIGNANS 1980-93", "PM": "94; LIGNANS was indexed under LIGNIN 1990-93 & PLANT EXTRACTS 1979-89", "HN": "94; was LIGNANS (NM) 1979-93", "MR": "20200527", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017705"}, {"RECTYPE": "D", "MH": "Lisinopril", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Zestril|T116|T121|TRD|NRW|NLM (1994)|920812|abbcdef", "MN": "D12.644.456.345.600", "PA": "Cardiotonic Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-", "RN": "E7199S1YWR", "RR": "94133-19-4 (maleate (1:1))", "PI": "Enalapril/analogs & derivatives (1986-1992)", "MS": "One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure.", "OL": "use LISINOPRIL (NM) to search LISINOPRIL 1981-93", "PM": "94; LISINOPRIL was indexed under ENALAPRIL/analogs & derivatives 1986-92 & DIPEPTIDES 1981-85, 93", "HN": "94; was LISINOPRIL (NM) 1981-93", "MR": "20130708", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017706"}, {"RECTYPE": "D", "MH": "Erythrocyte Transfusion", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Red Blood Cell Transfusion|T061|NON|EQV|NLM (1994)|920813|abcdef", "ENTRY": "Transfusions, Erythrocyte", "MN": "E02.095.135.140.275", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "for transfusion back to donor, coordinate with BLOOD TRANSFUSION, AUTOLOGOUS; /adv eff: coordinate with TRANSFUSION REACTION if pertinent  ", "PI": "Erythrocytes/transplantation (1968-1992)", "MS": "The transfer of erythrocytes from a donor to a recipient or reinfusion to the donor.", "OL": "use BLOOD COMPONENT TRANSFUSION to search ERYTHROCYTE TRANSFUSION 1992-93", "PM": "94; was see BLOOD COMPONENT TRANSFUSION 1992-93", "HN": "94; was see BLOOD COMPONENT TRANSFUSION 1992-93", "CATSH": "CAT LIST", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017707"}, {"RECTYPE": "D", "MH": "Leukocyte Transfusion", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "White Blood Cell Transfusion|T061|NON|EQV|NLM (1994)|920909|abcdef", "ENTRY": "Transfusions, Leukocyte", "MN": "E02.095.135.140.425", "FX": "Lymphocyte Transfusion", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "coordinate with specific leukocyte but note LYMPHOCYTE TRANSFUSION is available; for transfusion back to donor, coordinate with BLOOD TRANSFUSION, AUTOLOGOUS; /adv eff: coordinate with TRANSFUSION REACTION if pertinent  ", "PI": "Leukocytes/transplantation (1973-1992)", "MS": "The transfer of leukocytes from a donor to a recipient or reinfusion to the donor.", "OL": "use BLOOD COMPONENT TRANSFUSION to search LEUKOCYTE TRANSFUSION 1992-93", "PM": "94; was see BLOOD COMPONENT TRANSFUSION 1992-93", "HN": "94; was see BLOOD COMPONENT TRANSFUSION 1992-93", "CATSH": "CAT LIST", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017708"}, {"RECTYPE": "D", "MH": "Fractals", "AQ": "HI", "ENTRY": "Fractal", "MN": "G17.290", "FX": "Nonlinear Dynamics", "MH_TH": "NLM (1994)", "ST": "T077", "AN": "patterns which look similar at different magnifications; used in math & theoret models", "MS": "Patterns (real or mathematical) which look similar at different scales, for example the network of airways in the lung which shows similar branching patterns at progressively higher magnifications. Natural fractals are self-similar across a finite range of scales while mathematical fractals are the same across an infinite range. Many natural, including biological, structures are fractal (or fractal-like). Fractals are related to \"chaos\" (see NONLINEAR DYNAMICS) in that chaotic processes can produce fractal structures in nature, and appropriate representations of chaotic processes usually reveal self-similarity over time.", "PM": "94", "HN": "94", "MR": "20080708", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017709"}, {"RECTYPE": "D", "MH": "Lymphocyte Transfusion", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Transfusions, Lymphocyte", "MN": "E02.095.135.140.425.445", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "coordinate with specific lymphocyte; for transfusion back to donor, coordinate with BLOOD TRANSFUSION, AUTOLOGOUS; /adv eff: coordinate with TRANSFUSION REACTION if pertinent  ", "PI": "Lymphocytes/transplantation (1969-1993)", "MS": "The transfer of lymphocytes from a donor to a recipient or reinfusion to the donor.", "OL": "use BLOOD COMPONENT TRANSFUSION to search LYMPHOCYTE TRANSFUSION 1992-93", "PM": "94; was see BLOOD COMPONENT TRANSFUSION 1992-93", "HN": "94; was see BLOOD COMPONENT TRANSFUSION 1992-93", "CATSH": "CAT LIST", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017710"}, {"RECTYPE": "D", "MH": "Nonlinear Dynamics", "AQ": "HI", "PRINT ENTRY": "Models, Nonlinear|T077|NON|NRW|NLM (1994)|920814|abcdef", "ENTRY": "Theory, Chaos", "MN": "H01.548.675", "FX": "Fractals", "MH_TH": "NLM (1994)", "ST": "T170", "AN": "a math principle applied to theoret models", "PI": "Models, Biological (1970-1993)", "MS": "The study of systems which respond disproportionately (nonlinearly) to initial conditions or perturbing stimuli. Nonlinear systems may exhibit \"chaos\" which is classically characterized as sensitive dependence on initial conditions. Chaotic systems, while distinguished from more ordered periodic systems, are not random. When their behavior over time is appropriately displayed (in \"phase space\"), constraints are evident which are described by \"strange attractors\". Phase space representations of chaotic systems, or strange attractors, usually reveal fractal (FRACTALS) self-similarity across time scales. Natural, including biological, systems often display nonlinear dynamics and chaos.", "PM": "94", "HN": "94", "MR": "20080708", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017711"}, {"RECTYPE": "D", "MH": "Peer Review, Research", "DE": "PEER REV RESEARCH", "AQ": "ES LJ MT ST TD", "PRINT ENTRY": "Peer Review, Publishing|T057|NON|NRW|NLM (1994)|920910|PEER REV PUBLISHING|abcdefv", "ENTRY": "Reviews, Research Peer", "MN": "N03.706.700.700", "MH_TH": "NLM (1994)", "ST": "T057", "PI": "Peer Review (1971-1993)", "MS": "The evaluation by experts of the quality and pertinence of research or research proposals of other experts in the same field. Peer review is used by editors in deciding which submissions warrant publication, by granting agencies to determine which proposals should be funded, and by academic institutions in tenure decisions.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20170307", "DA": "19930708", "DC": "1", "DX": "19940101", "UI": "D017712"}, {"RECTYPE": "D", "MH": "Platelet Transfusion", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Blood Platelet Transfusion|T061|NON|EQV|NLM (1994)|920817|abcdef", "ENTRY": "Transfusions, Platelet", "MN": "E02.095.135.140.650", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "for transfusion back to donor, coordinate with BLOOD TRANSFUSION, AUTOLOGOUS; /adv eff: coordinate with TRANSFUSION REACTION if pertinent  ", "PI": "Blood Transfusion (1966-1991)", "MS": "The transfer of blood platelets from a donor to a recipient or reinfusion to the donor.", "OL": "use BLOOD COMPONENT TRANSFUSION to search PLATELET TRANSFUSION 1992-93", "PM": "94; was see BLOOD COMPONENT TRANSFUSION 1992-93", "HN": "94; was see BLOOD COMPONENT TRANSFUSION 1992-93", "CATSH": "CAT LIST", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017713"}, {"RECTYPE": "D", "MH": "Community-Acquired Infections", "DE": "COMMUNITY ACQUIRED INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Community-Acquired Infection|T047|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Infections, Community Acquired", "MN": "C01.234", "FX": "Cross Infection", "MH_TH": "NLM (1994)", "ST": "T047", "MS": "Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017714"}, {"RECTYPE": "D", "MH": "Diabetic Foot", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Foot Ulcer, Diabetic|T047|NON|NRW|NLM (1994)|921008|abcdef", "ENTRY": "Foot, Diabetic", "MN": "C19.246.099.937.250", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "coordinate IM with specific type of diabetes mellitus (IM) if pertinent", "PI": "Foot Ulcer (1992-1993)", "MS": "Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION, SURGICAL.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20220715", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017719"}, {"RECTYPE": "D", "MH": "Molecular Epidemiology", "DE": "MOL EPIDEMIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Epidemiology, Molecular|T057|T091|NON|EQV|NLM (1994)|990101|EPIDEMIOL MOL|abbcdefv", "ENTRY": "Molecular Epidemiologies", "MN": "N06.850.520.470", "MH_TH": "NLM (1994)", "ST": "T091", "MS": "The application of molecular biology to the answering of epidemiological questions. The examination of patterns of changes in DNA to implicate particular carcinogens and the use of molecular markers to predict which individuals are at highest risk for a disease are common examples.", "PM": "2010; see EPIDEMIOLOGY, MOLECULAR 1994-2009", "HN": "2010 (1994)", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017720"}, {"RECTYPE": "D", "MH": "Hospital Costs", "DE": "HOSP COSTS", "AQ": "CL ES HI LJ OG SN ST TD", "ENTRY": "Hospital Cost", "MN": "N05.300.375.500", "MH_TH": "NLM (1994)", "ST": "T081", "AN": "expenses incurred by hosp in providing services: do not confuse with HOSPITAL CHARGES, prices for services", "PI": "Economics, Hospital (1966-1993)", "MS": "The expenses incurred by a hospital in providing care. The hospital costs attributed to a particular patient care episode include the direct costs plus an appropriate proportion of the overhead for administration, personnel, building maintenance, equipment, etc. Hospital costs are one of the factors which determine HOSPITAL CHARGES (the price the hospital sets for its services).", "PM": "94", "HN": "94", "MR": "20190524", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017721"}, {"RECTYPE": "D", "MH": "Hospital Charges", "DE": "HOSP CHARGES", "AQ": "CL ES HI LJ OG SN ST TD", "ENTRY": "Hospital Charge|T081|NON|EQV|NLM (1997)|951003|HOSP CHARGE|abcdefv", "MN": "N03.219.442.613", "MH_TH": "NLM (1994)", "ST": "T081", "AN": "prices for services: do not confuse with HOSPITAL COSTS, expenses incurred by hosp in providing services", "PI": "Fees and Charges (1967-1993)", "MS": "The prices a hospital sets for its services. HOSPITAL COSTS (the direct and indirect expenses incurred by the hospital in providing the services) are one factor in the determination of hospital charges. Other factors may include, for example, profits, competition, and the necessity of recouping the costs of uncompensated care.", "PM": "94", "HN": "94", "MR": "20190524", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017722"}, {"RECTYPE": "D", "MH": "Drug Utilization Review", "DE": "DRUG UTIL REV", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Utilization Review, Drug|T058|NON|EQV|NLM (1994)|921116|UTIL REV DRUG|abcdefv", "ENTRY": "Utilization Reviews, Drug", "MN": "N05.700.900.300", "MH_TH": "NLM (1994)", "ST": "T058", "AN": "coordinate with specific drug with no qualifers  ", "PI": "Utilization Review (1972-1993)", "MS": "Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.", "PM": "94", "HN": "94", "MR": "19940505", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017723"}, {"RECTYPE": "D", "MH": "Ventricular Pressure", "AQ": "DE ES GE IM PH RE", "ENTRY": "Ventricular Pressures", "MN": "G09.330.955.950", "MH_TH": "NLM (1994)", "ST": "T042", "AN": "within heart, not cerebral ventricles", "MS": "The pressure within a CARDIAC VENTRICLE. Ventricular pressure waveforms can be measured in the beating heart by catheterization or estimated using imaging techniques (e.g., DOPPLER ECHOCARDIOGRAPHY). The information is useful in evaluating the function of the MYOCARDIUM; CARDIAC VALVES; and PERICARDIUM, particularly with simultaneous measurement of other (e.g., aortic or atrial) pressures.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017725"}, {"RECTYPE": "D", "MH": "Cytomegalovirus Retinitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Retinitis, Cytomegalovirus|T047|NON|EQV|NLM (1994)|920825|abcdef", "ENTRY": "Retinitis, Cytomegaloviral", "MN": "C11.768.773.360", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "often an opportunistic infect in AIDS", "PI": "Retinitis (1972-1993)", "MS": "Infection of the retina by cytomegalovirus characterized by retinal necrosis, hemorrhage, vessel sheathing, and retinal edema. Cytomegalovirus retinitis is a major opportunistic infection in AIDS patients and can cause blindness.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017726"}, {"RECTYPE": "D", "MH": "Chicken anemia virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Chicken Infectious Anemia Virus|T005|NON|EQV|NLM (1994)|920827|CHICKEN INFECT ANEMIA VIRUS|abcdefv", "ENTRY": "Chicken anemia viruses", "MN": "B04.280.120.400.150", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12618", "AN": "infection: coord IM with CIRCOVIRIDAE INFECTIONS (IM)", "PI": "Viruses (1983-1993)", "MS": "The type species of GYROVIRUS, a small, non-enveloped DNA virus originally isolated from contaminated vaccines in Japan. It causes chicken infectious anemia and may possibly play a key role in hemorrhagic anemia syndrome, anemia dermatitis, and blue wing disease.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017727"}, {"RECTYPE": "D", "MH": "Lymphoma, Large-Cell, Anaplastic", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Lymphoma, Large-Cell, Ki-1|T191|NON|EQV|NLM (1994)|990101|LYMPHOMA LARGE CELL KI 01|abcdefs", "ENTRY": "Systemic Anaplastic Large Cell Lymphoma", "MN": "C20.683.515.761.480.750.399", "FX": "Ki-1 Antigen", "MH_TH": "NLM (2008)", "ST": "T191", "PI": "Lymphoma, Non-Hodgkin's (1987-1993)", "MS": "A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called \"hallmark\" cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.", "PM": "2008; see LYMPHOMA, LARGE-CELL, KI-1 1994-2007", "HN": "2008 (1994)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D017728"}, {"RECTYPE": "D", "MH": "Presynaptic Terminals", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Synaptic Terminals|T026|NON|EQV|NLM (1994)|921127|abcdef", "ENTRY": "Terminals, Synaptic", "MN": "A11.671.501.145.750", "MH_TH": "NLM (1994)", "ST": "T026", "PI": "Synapses (1966-1993)", "MS": "The distal terminations of axons which are specialized for the release of neurotransmitters. Also included are varicosities along the course of axons which have similar specializations and also release transmitters. Presynaptic terminals in both the central and peripheral nervous systems are included.", "PM": "94", "HN": "94", "MR": "20220708", "DA": "19930629", "DC": "1", "DX": "19940101", "UI": "D017729"}, {"RECTYPE": "D", "MH": "Ki-1 Antigen", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 8|T116|T129|T192|NON|EQV|NLM (2005)|040210|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 08|TUMOR NECROSIS FACTOR RECEPT SUPERFAMILY MEMBER 8|abbbcdefsv", "ENTRY": "Receptor, TNFRSF8", "MN": "D23.101.140.055", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Antigens, Neoplasm (1985-1993)", "MS": "A member of the tumor necrosis factor receptor superfamily that may play a role in the regulation of NF-KAPPA B and APOPTOSIS. It is found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; NEUTROPHILS; EOSINOPHILS; MAST CELLS and NK CELLS. Overexpression of the Ki-1 antigen in hematopoietic malignancies make it clinically useful as a biological tumor marker. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.", "PM": "2018; see ANTIGENS, CD30 1994-2017 and CD30 ANTIGEN 1983-93", "HN": "2018 (1983)", "MR": "20170524", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017730"}, {"RECTYPE": "D", "MH": "Lymphomatoid Papulosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Papulosis, Lymphomatoid", "MN": "C20.683.515.761.480.750.800.528", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with SKIN NEOPLASMS (IM)", "PI": "Skin Neoplasms (1968-1993)", "MS": "Clinically benign, histologically malignant, recurrent cutaneous T-cell lymphoproliferative disorder characterized by an infiltration of large atypical cells surrounded by inflammatory cells. The atypical cells resemble REED-STERNBERG CELLS of HODGKIN DISEASE or the malignant cells of CUTANEOUS T-CELL LYMPHOMA. In some cases, lymphomatoid papulosis progresses to lymphomatous conditions including MYCOSIS FUNGOIDES; HODGKIN DISEASE; CUTANEOUS T-CELL LYMPHOMA; or ANAPLASTIC LARGE-CELL LYMPHOMA.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017731"}, {"RECTYPE": "D", "MH": "Air Ambulances", "AQ": "CL EC ES HI LJ OG SD SN ST", "PRINT ENTRY": "Helicopter Ambulances|T073|NON|REL|NLM (1994)|920831|abcdef", "ENTRY": "Helicopters, Emergency", "MN": "N02.421.297.879.100.100", "MH_TH": "NLM (1994)", "ST": "T073", "AN": "airplanes & helicopters", "PI": "Ambulances (1966-1993)", "MS": "Fixed-wing aircraft or helicopters equipped for air transport of patients.", "PM": "94", "HN": "94", "MR": "20180629", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017732"}, {"RECTYPE": "D", "MH": "Leukoplakia, Hairy", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Oral Hairy Leukoplakia|T191|NON|EQV|NLM (1994)|920831|abcdef", "ENTRY": "Oral Hairy Leukoplakias", "MN": "C23.300.816.513.500", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "a form of oral leukoplakia seen in HIV infect; do not confuse with TONGUE, HAIRY", "PI": "Leukoplakia, Oral (1985-1993)", "MS": "Epithelial hyperplasia of the oral mucosa associated with Epstein-Barr virus (HERPESVIRUS 4, HUMAN) and found almost exclusively in persons with HIV infection. The lesion consists of a white patch that is often corrugated or hairy.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017733"}, {"RECTYPE": "D", "MH": "Bile Ducts, Extrahepatic", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Extrahepatic Biliary System|T023|NON|EQV|NLM (1994)|920831|abcdef", "ENTRY": "Systems, Extrahepatic Biliary", "MN": "A03.159.183.079", "MH_TH": "NLM (1994)", "ST": "T023", "AN": "do not confuse with BILE DUCTS, INTRAHEPATIC; do not confuse with HEPATIC DUCT, COMMON, the external junction of right & left hepatic ducts; diseases: coord IM with BILE DUCT DISEASES (IM) but note BILE DUCT OBSTRUCTION, EXTRAHEPATIC; neopl: coord IM with BILE DUCT NEOPLASMS (IM); inflammation: coord IM with CHOLANGITIS (IM)", "PI": "Hepatic Duct, Common (1966-1993)", "MS": "Passages external to the liver for the conveyance of bile. These include the COMMON BILE DUCT and the common hepatic duct (HEPATIC DUCT, COMMON).", "PM": "94", "HN": "94", "MR": "19980610", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D017734"}, {"RECTYPE": "D", "MH": "Virus Latency", "AQ": "DE ES GE IM PH RE", "ENTRY": "Virus Latencies", "MN": "G06.920.900", "FX": "Virus Activation", "MH_TH": "NLM (1994)", "ST": "T040", "AN": "coord with specific virus /physiol (IM or NIM)", "PI": "Virus Replication (1968-1993)", "MS": "The ability of a pathogenic virus to lie dormant within a cell (LATENT INFECTION). In eukaryotes, subsequent activation and viral replication is thought to be caused by extracellular stimulation of cellular transcription factors. Latency in bacteriophage is maintained by the expression of virally encoded repressors.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017735"}, {"RECTYPE": "D", "MH": "Ion-Selective Electrodes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Ion-Sensitive Electrode|T074|T075|NON|EQV|NLM (2022)|201019|abbcdef", "ENTRY": "Selective Electrodes, Ion", "MN": "E07.305.250.471", "MH_TH": "NLM (1994)", "ST": "T075", "AN": "designed to measure specific ion concentrations in cells, tissue or solutions", "PI": "Electrodes (1966-1993)", "MS": "Electrodes which can be used to measure the concentration of particular ions in cells, tissues, or solutions.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017736"}, {"RECTYPE": "D", "MH": "Macrophages, Peritoneal", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Peritoneal Macrophages|T025|NON|EQV|NLM (1994)|920901|abcdef", "ENTRY": "Peritoneal Macrophage", "MN": "A15.382.680.397.630", "MH_TH": "NLM (1994)", "ST": "T025", "PI": "Peritoneum (1966-1971)", "MS": "Mononuclear phagocytes derived from bone marrow precursors but resident in the peritoneum.", "PM": "94", "HN": "94", "MR": "20180630", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D017737"}, {"RECTYPE": "D", "MH": "Alkanesulfonic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Alkanesulfonic", "MN": "D02.886.645.600.055", "MH_TH": "NLM (1994)", "ST": "T109", "RN": "0", "PI": "Sulfonic Acids (1966-1993)", "MS": "Sulfonic acid derivatives that are substituted with an aliphatic hydrocarbon group.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017738"}, {"RECTYPE": "D", "MH": "Arylsulfonic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Arylsulfonic", "MN": "D02.886.645.600.080", "MH_TH": "NLM (1994)", "ST": "T109", "RN": "0", "PI": "Sulfonic Acids (1966-1993)", "MS": "Organic sulfonic acid derivatives which contain an aromatic hydrocarbon radical.", "PM": "94", "HN": "94", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017739"}, {"RECTYPE": "D", "MH": "Survivors", "AQ": "CL HI LJ PX SN", "PRINT ENTRY": "Long-Term Survivors|T101|NON|NRW|NLM (1994)|920908|abcdef", "ENTRY": "Survivors, Long-Term", "MN": "M01.860", "FX": "Survivorship", "MH_TH": "NLM (1994)", "ST": "T101", "MS": "Persons who have experienced a prolonged survival after serious disease or who continue to live with a usually life-threatening condition as well as family members, significant others, or individuals surviving traumatic life events.", "PM": "94", "HN": "94", "MR": "20170114", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017741"}, {"RECTYPE": "D", "MH": "Dental Care for Chronically Ill", "DE": "DENT CARE CHRONIC ILL", "AQ": "AE CL EC ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Dentistry for Chronically Ill|T058|NON|BRD|NLM (1994)|920909|DENT CHRONIC ILL|abcdefv", "ENTRY": "Dentistry Chronically Ill", "MN": "N02.421.240.190.220", "MH_TH": "NLM (1994)", "ST": "T058", "AN": "= professional care by a professional", "PI": "Dental Care for Disabled (1980-1993)", "MS": "Dental care for patients with chronic diseases. These diseases include chronic cardiovascular, endocrinologic, hematologic, immunologic, neoplastic, and renal diseases. The concept does not include dental care for the mentally or physically disabled which is DENTAL CARE FOR DISABLED.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017742"}, {"RECTYPE": "D", "MH": "Equipment Reuse", "AQ": "EC LJ SN ST VE", "PRINT ENTRY": "Recycling, Equipment|T052|NON|EQV|NLM (1994)|920909|abcdef", "ENTRY": "Reuse, Equipment", "MN": "N06.850.585", "MH_TH": "NLM (1994)", "ST": "T052", "AN": "coordinate with specific equipment or specific technique /instrum", "MS": "Further or repeated use of equipment, instruments, devices, or materials. It includes additional use regardless of the original intent of the producer as to disposability or durability. It does not include the repeated use of fluids or solutions.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017743"}, {"RECTYPE": "D", "MH": "Medical Waste Disposal", "DE": "MED WASTE DISPOSAL", "AQ": "EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Waste Disposal, Medical|T058|NON|EQV|NLM (1994)|920910|WASTE DISPOSAL MED|abcdefv", "ENTRY": "Waste Disposal, Biologic", "MN": "N06.850.860.510.900.600.600", "MH_TH": "NLM (1994)", "ST": "T058", "RN": "0", "AN": "disposal of dental waste: coord IM with DENTAL WASTE (IM)", "PI": "Waste Products (1978-1990)", "MS": "Management, removal, and elimination of biologic, infectious, pathologic, and dental waste. The concept includes blood, mucus, tissue removed at surgery or autopsy, soiled surgical dressings, and other materials requiring special control and handling. Disposal may take place where the waste is generated or elsewhere.", "PM": "94", "HN": "94", "MR": "20080708", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017744"}, {"RECTYPE": "D", "MH": "Incineration", "AQ": "EC ES HI IS LJ MT SN ST", "ENTRY": "Thermal Destructions", "MN": "N06.850.860.510.900.600.500", "MH_TH": "NLM (1994)", "ST": "T068", "AN": "restrict to waste disposal", "PI": "Refuse Disposal (1966-1993)", "MS": "High temperature destruction of waste by burning with subsequent reduction to ashes or conversion to an inert mass.", "PM": "94", "HN": "94", "MR": "20080708", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017745"}, {"RECTYPE": "D", "MH": "Joint Capsule", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Synovial Plicae|T023|NON|NRW|NLM (2020)|190121|abcdef", "ENTRY": "Synovial Fold", "MN": "A02.835.583.443", "MH_TH": "NLM (1994)", "ST": "T023", "AN": "coordinate with specific joint or bone if no joint term is available ", "PI": "Joints (1966-1993)", "MS": "The sac enclosing a joint. It is composed of an outer fibrous articular capsule and an inner SYNOVIAL MEMBRANE.", "PM": "94", "HN": "94", "MR": "20190411", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017746"}, {"RECTYPE": "D", "MH": "Seafood", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Seafoods", "MN": "J02.500.600.875", "MH_TH": "NLM (1994)", "ST": "T168", "AN": "\"marine fish & shellfish used as food\"; coord IM with specific fish or shellfish (IM)", "MS": "Marine fish and shellfish used as food or suitable for food. (Webster, 3d ed) SHELLFISH and FISH PRODUCTS are more specific types of SEAFOOD.", "PM": "94", "HN": "94", "MR": "20141014", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017747"}, {"RECTYPE": "D", "MH": "Time Management", "AQ": "EC MT OG PX", "ENTRY": "Time Managements", "MN": "N04.452.932", "MH_TH": "NLM (1994)", "ST": "T057", "MS": "Planning and control of time to improve efficiency and effectiveness.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017748"}, {"RECTYPE": "D", "MH": "Total Quality Management", "DE": "TQM", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Continuous Quality Management|T057|NON|EQV|NLM (1994)|920911|CQM|abcdefv", "ENTRY": "Six Sigmas, Lean", "MN": "N05.700.792", "FX": "Quality Control", "MH_TH": "NLM (1994)", "ST": "T057", "AN": "not restricted to health care", "PI": "Quality Assurance, Health Care (1989-1993)", "MS": "The application of industrial management practice to systematically maintain and improve organization-wide performance. Effectiveness and success are determined and assessed by quantitative quality measures.", "PM": "94", "HN": "94", "MR": "20180629", "DA": "19930505", "DC": "1", "DX": "19940101", "UI": "D017749"}, {"RECTYPE": "D", "MH": "Animal Technicians", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Veterinary Nurses|T097|NON|EQV|NLM (1998)|960715|VET NURSES|abcdefv", "ENTRY": "Veterinary Technician", "MN": "N02.360.067.040", "MH_TH": "NLM (1994)", "ST": "T097", "AN": "entry term VETERINARY NURSES is British", "PI": "Veterinary Medicine (1966-1993)", "MS": "Assistants to a veterinarian, biological or biomedical researcher, or other scientist who are engaged in the care and management of animals, and who are trained in basic principles of animal life processes and routine laboratory and animal health care procedures. (Facts on File Dictionary of Health Care Management, 1988)", "PM": "94", "HN": "94", "MR": "20180629", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017750"}, {"RECTYPE": "D", "MH": "Safety Management", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Hazard Management|T057|NON|NRW|NLM (1994)|920911|abcdef", "ENTRY": "Surveillance Programs, Hazard", "MN": "N06.850.135.060.075.800", "FX": "Organizational Culture", "MH_TH": "NLM (1994)", "ST": "T057", "PI": "Safety (1966-1993)", "MS": "The development of systems to prevent accidents, injuries, and other adverse occurrences in an institutional setting. The concept includes prevention or reduction of adverse events or incidents involving employees, patients, or facilities. Examples include plans to reduce injuries from falls or plans for fire safety to promote a safe institutional environment.", "PM": "94", "HN": "94", "MR": "20150113", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017751"}, {"RECTYPE": "D", "MH": "Greenhouse Effect", "DE": "GREENHOUSE EFF", "AQ": "EC HI LJ MO PC SN", "ENTRY": "Effect, Greenhouse", "MN": "N06.230.265", "FX": "Greenhouse Gases", "MH_TH": "NLM (1994)", "ST": "T069", "AN": "specify geographic term if pertinent", "PI": "Climate (1966-1993)", "MS": "The effect of GREENHOUSE GASES and the resulting increase in world temperatures. The predicted health effects of such long-term climatic change include increased incidence of respiratory, water-borne, and vector-borne diseases.", "PM": "94", "HN": "94", "MR": "20170410", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017752"}, {"RECTYPE": "D", "MH": "Ecosystem", "PRINT ENTRY": "Ecosystems|T070|NON|EQV|NLM (2023)|220502|abcdef", "ENTRY": "Systems, Ecologic", "MN": "N06.230.124", "FX": "Ecology", "MH_TH": "NLM (1994)", "ST": "T070", "AN": "the specialty ECOLOGY is also available; specify geographic term if pertinent", "MS": "A functional system which includes the organisms of a natural community together with their environment. (McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed)", "OL": "use ECOLOGY to search ECOSYSTEM 1993", "PM": "94; was see ECOLOGY 1993", "HN": "94; was see ECOLOGY 1993", "MR": "20220708", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017753"}, {"RECTYPE": "D", "MH": "Group Purchasing", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Shared Purchasing|T058|NON|EQV|NLM (1994)|920914|abcdef", "ENTRY": "Purchasing, Shared", "MN": "N04.452.442.452.422.679.375", "FX": "Purchasing, Hospital", "MH_TH": "NLM (1994)", "ST": "T058", "AN": "not restricted to hosp purchasing", "PI": "Purchasing, Hospital (1978-1993)", "MS": "A shared service which combines the purchasing power of individual organizations or facilities in order to obtain lower prices for equipment and supplies. (From Health Care Terms, 2nd ed)", "PM": "94", "HN": "94", "MR": "20190709", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017754"}, {"RECTYPE": "D", "MH": "Prosthesis Fitting", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Prosthesis Fittings", "MN": "E02.794", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "coordinate with specific prosthesis with no qualifiers", "MS": "The fitting and adjusting of artificial parts of the body. (From Stedman's, 26th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017755"}, {"RECTYPE": "D", "MH": "Aquaculture", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Biofloc", "MN": "J01.040.168", "FX": "Hydrobiology", "MH_TH": "NLM (1994)", "ST": "T090", "AN": "restrict to fauna in waters", "PI": "Fisheries (1966-1993)", "MS": "The farming, breeding, rearing, and harvesting of plants and animals in all types of water environments including ponds, rivers, lakes, and the ocean.", "PM": "1994", "HN": "1994", "MR": "20230531", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017756"}, {"RECTYPE": "D", "MH": "Infectious Disease Transmission, Professional-to-Patient", "AQ": "CL EC ES HI LJ PC SN", "PRINT ENTRY": "Transmission, Professional-to-Patient|T046|NON|EQV|NLM (1994)|930122|abcdef", "ENTRY": "Worker-Patient Transmission, Healthcare", "MN": "N06.850.335.750", "FX": "Blood-Borne Pathogens", "MH_TH": "NLM (2009)", "ST": "T046", "AN": "coordinate IM with disease /transm (IM) + professional or profession (including DENTISTS or DENTISTRY) with no qualifiers (IM); do not confuse with INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL", "PI": "specific health professional (1974-1993)", "MS": "The transmission of infectious disease or pathogens from health professional or health care worker to patients. It includes transmission via direct or indirect exposure to bacterial, fungal, parasitic, or viral agents.", "PM": "2009; see DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT (1994-2008)", "HN": "2009 (1994)", "MR": "20200612", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D017757"}, {"RECTYPE": "D", "MH": "Infectious Disease Transmission, Patient-to-Professional", "AQ": "CL EC ES HI LJ PC SN", "PRINT ENTRY": "Transmission, Patient-to-Professional|T046|NON|EQV|NLM (1994)|920928|TRANSM PATIENT PROF|abcdefv", "ENTRY": "Transmission, Patient-Professional Pathogen", "MN": "N06.850.335.500", "FX": "Blood-Borne Pathogens", "MH_TH": "NLM (2009)", "ST": "T046", "AN": "coordinate IM with disease /transm (IM) + professional or profession with no qualifiers (IM); do not confuse with INFECTIOUS DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; DF: DIS TRANSM PATIENT PROF or PATIENT PROF TRANSM", "PI": "specific health professional (1974-1993)", "MS": "The transmission of infectious disease or pathogens from patients to health professionals or health care workers. It includes transmission via direct or indirect exposure to bacterial, fungal, parasitic, or viral agents.", "PM": "2009; see DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL (1994-2008)", "HN": "2009 (1994)", "MR": "20200612", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D017758"}, {"RECTYPE": "D", "MH": "Fractures, Malunited", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Malunited Fractures", "MN": "C26.404.249", "MH_TH": "NLM (1994)", "ST": "T037", "AN": "do not confuse with FRACTURES, UNUNITED; coordinate with specific bone /inj or precoordinated bone/fracture term", "MS": "Union of the fragments of a fractured bone in a faulty or abnormal position. If two bones parallel to one another unite by osseous tissue, the result is a crossunion. (From Manual of Orthopaedic Terminology, 4th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160613", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017759"}, {"RECTYPE": "D", "MH": "Bone Malalignment", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Misalignment, Bone", "MN": "C05.116.214", "MH_TH": "NLM (1994)", "ST": "T046", "AN": "congen or traum", "MS": "Displacement of bones out of line in relation to joints. It may be congenital or traumatic in origin.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017760"}, {"RECTYPE": "D", "MH": "Nadroparin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "LMF CY216", "MN": "D09.698.373.400.300.600", "PA": "Fibrinolytic Agents", "MH_TH": "NLM (1994)", "ST": "T121", "RN": "0", "AN": "a low-molec weight heparin fraction", "PI": "Heparin/analogs & derivatives (1987)", "MS": "A heparin fraction with a mean molecular weight of 4500 daltons. It is isolated from porcine mucosal heparin and used as an antithrombotic agent. (From Merck Index, 11th ed)", "PM": "94", "HN": "94", "MR": "20040707", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017762"}, {"RECTYPE": "D", "MH": "Autonomic Denervation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Denervation, Autonomic|T061|T062|NON|EQV|NLM (1994)|920923|abbcdef", "ENTRY": "Denervations, Autonomic", "MN": "E04.525.210.105", "MH_TH": "NLM (1994)", "ST": "T062", "AN": "coordinate with specific nerve /surg or plexus /surg ", "PI": "Sympathectomy (1989-1993)", "MS": "The removal or interruption of some part of the autonomic nervous system for therapeutic or research purposes.", "OL": "use SYMPATHECTOMY to search DENERVATION, AUTONOMIC 1989-93", "PM": "94; DENERVATION, AUTONOMIC was see SYMPATHECTOMY 1989-93", "HN": "94; DENERVATION, AUTONOMIC was see SYMPATHECTOMY 1989-93", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017763"}, {"RECTYPE": "D", "MH": "Parasympathectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Parasympathetic Denervation|T061|T062|NON|EQV|NLM (1994)|920923|abbcdef", "ENTRY": "Parasympathetic Denervations", "MN": "E04.525.210.105.600", "MH_TH": "NLM (1994)", "ST": "T062", "AN": "coordinate with specific nerve /surg or plexus /surg ", "MS": "The removal or interruption of some part of the parasympathetic nervous system for therapeutic or research purposes.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017764"}, {"RECTYPE": "D", "MH": "Acid Anhydride Hydrolases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hydrolases, Acid Anhydride", "MN": "D08.811.277.040", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 3.6.-", "PI": "Hydrolases (1966-1993)", "MS": "A group of enzymes that catalyze the hydrolysis of diphosphate bonds in compounds such as nucleoside di- and tri-phosphates, and sulfonyl-containing anhydrides such as adenylylsulfate. (Enzyme Nomenclature, 1992) EC 3.6.", "PM": "94", "HN": "94", "MR": "20060705", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017766"}, {"RECTYPE": "D", "MH": "Holocaust", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Holocausts", "MN": "I01.880.735.950.500.903.149.500", "FX": "National Socialism", "MH_TH": "NLM (1994)", "ST": "T052", "AN": "when used in reference to the extermination of Jews by Nazis, spell with uppercase H: Holocaust in titles and translations", "MS": "A massive slaughter, especially the systematic mass extermination of European Jews in Nazi concentration camps prior to and during World War II.", "PM": "94", "HN": "94", "MR": "20150629", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017767"}, {"RECTYPE": "D", "MH": "Skin, Artificial", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Skin Substitutes|T122|NON|REL|NLM (1994)|920925|abcdef", "ENTRY": "Substitutes, Skin", "MN": "E07.858.082.800", "MH_TH": "NLM (1994)", "ST": "T122", "AN": "to stimulate new skin growth before replacement by graft", "PI": "Skin (1966-1993)", "MS": "Synthetic material used for the treatment of burns and other conditions involving large-scale loss of skin. It often consists of an outer (epidermal) layer of silicone and an inner (dermal) layer of collagen and chondroitin 6-sulfate. The dermal layer elicits new growth and vascular invasion and the outer layer is later removed and replaced by a graft.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017768"}, {"RECTYPE": "D", "MH": "Ulnar Nerve Compression Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Guyon Syndrome|T047|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Ulnar Nerve Entrapments", "MN": "C26.844.150.957", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Ulnar Nerve (1966-1993)", "MS": "Ulnar neuropathies caused by mechanical compression of the nerve at any location from its origin at the BRACHIAL PLEXUS to its terminations in the hand. Common sites of compression include the retroepicondylar groove, cubital tunnel at the elbow (CUBITAL TUNNEL SYNDROME), and Guyon's canal at the wrist. Clinical features depend on the site of injury, but may include weakness or paralysis of wrist flexion, finger flexion, and ulnar innervated intrinsic hand muscles, and impaired sensation over the ulnar aspect of the hand, fifth finger, and ulnar half of the ring finger. (Joynt, Clinical Neurology, 1995, Ch51, p43)", "PM": "2000; see ULNAR NERVE COMPRESSION SYNDROME 1994-1999", "HN": "2000(1994)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017769"}, {"RECTYPE": "D", "MH": "Lifting", "AQ": "AE", "ENTRY": "Carrying|T052|NON|REL|NLM (1994)|920928|abcdef", "MN": "G01.374.669", "MH_TH": "NLM (1994)", "ST": "T052", "AN": "by machines or humans; PATIENT LIFTING see PATIENT MOVING AND LIFTING is available", "MS": "Moving or bringing something from a lower level to a higher one. The concept encompasses biomechanic stresses resulting from work done in transferring objects from one plane to another as well as the effects of varying techniques of patient handling and transfer.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017770"}, {"RECTYPE": "D", "MH": "Amyloid Neuropathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuropathies, Amyloid|T047|NON|EQV|NLM (1994)|ORD (2010)|921014|abcdeef", "ENTRY": "Secondary Amyloid Neuropathy", "MN": "C18.452.845.500.050", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coord IM with specific neurol dis (IM) or specific nerve (IM); /genet: consider also AMYLOID NEUROPATHIES, FAMILIAL", "PI": "Peripheral Nervous System Diseases (1967-1993)", "MS": "Disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. Familial, primary (nonfamilial), and secondary forms have been described. Some familial subtypes demonstrate an autosomal dominant pattern of inheritance. Clinical manifestations include sensory loss, mild weakness, autonomic dysfunction, and CARPAL TUNNEL SYNDROME. (Adams et al., Principles of Neurology, 6th ed, p1349)", "PM": "1994", "HN": "1994", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D017772"}, {"RECTYPE": "D", "MH": "Pelvic Floor", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Pelvic Diaphragms", "MN": "A02.633.567.050.750", "MH_TH": "NLM (1994)", "ST": "T023", "AN": "NIM when merely locational", "PI": "Pelvis (1966-1993)", "MS": "Soft tissue formed mainly by the pelvic diaphragm, which is composed of the two levator ani and two coccygeus muscles. The pelvic diaphragm lies just below the pelvic aperture (outlet) and separates the pelvic cavity from the PERINEUM. It extends between the PUBIC BONE anteriorly and the COCCYX posteriorly.", "PM": "94", "HN": "94", "MR": "20210706", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017773"}, {"RECTYPE": "D", "MH": "Long-Term Potentiation", "DE": "LTP", "AQ": "DE ES GE IM PH RE", "ENTRY": "Potentiations, Long-Term", "MN": "G11.561.638.350", "MH_TH": "NLM (1994)", "ST": "T042", "PI": "Synapses/physiology (1977-1993)", "MS": "A persistent increase in synaptic efficacy, usually induced by appropriate activation of the same synapses. The phenomenological properties of long-term potentiation suggest that it may be a cellular mechanism of learning and memory.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017774"}, {"RECTYPE": "D", "MH": "Autonomic Pathways", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Autonomic Nerves|T023|NON|NRW|NLM (1994)|921120|abcdef", "ENTRY": "Pathways, Autonomic", "MN": "A08.800.800.060", "MH_TH": "NLM (1994)", "ST": "T023", "PI": "Autonomic Nervous System (1966-1993)", "MS": "Nerves and plexuses of the autonomic nervous system. The central nervous system structures which regulate the autonomic nervous system are not included.", "PM": "94", "HN": "94", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017776"}, {"RECTYPE": "D", "MH": "Parasympathetic Fibers, Postganglionic", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Postganglionic Parasympathetic Fibers", "MN": "A11.671.501.234.700", "MH_TH": "NLM (1994)", "ST": "T023", "AN": "do not confuse with SYMPATHETIC FIBERS, POSTGANGLIONIC", "PI": "Ganglia, Autonomic (1966-1970)", "MS": "Nerve fibers which project from parasympathetic ganglia to synapses on target organs. Parasympathetic postganglionic fibers use acetylcholine as transmitter. They may also release peptide cotransmitters.", "PM": "94", "HN": "94", "MR": "20160418", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017777"}, {"RECTYPE": "D", "MH": "Vaccines, Combined", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaccines, Polyvalent|T121|T129|NON|REL|NLM (2021)|200306|abbcdef", "ENTRY": "Vaccines, Tetravalent", "MN": "D20.215.894.815", "MH_TH": "NLM (1994)", "ST": "T129", "RN": "0", "AN": "coordinate with specific vaccine", "MS": "Two or more vaccines in a single dosage form.", "PM": "94", "HN": "94", "MR": "20200617", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017778"}, {"RECTYPE": "D", "MH": "Sympathetic Fibers, Postganglionic", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sympathetic Fiber, Postganglionic", "MN": "A11.671.501.100.800", "MH_TH": "NLM (1994)", "ST": "T023", "AN": "do not confuse with PARASYMPATHETIC FIBERS, POSTGANGLIONIC", "PI": "Ganglia, Autonomic (1966-1970)", "MS": "Nerve fibers which project from sympathetic ganglia to synapses on target organs. Sympathetic postganglionic fibers use norepinephrine as transmitter, except for those innervating eccrine sweat glands (and possibly some blood vessels) which use acetylcholine. They may also release peptide cotransmitters.", "PM": "94", "HN": "94", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017779"}, {"RECTYPE": "D", "MH": "Malaria Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Malarial Vaccine|T121|T129|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Vaccines, Malarial", "MN": "D20.215.894.582.500", "MH_TH": "NLM (1994)", "ST": "T129", "RN": "0", "AN": "coord IM with specific Plasmodium /immunol (IM)", "PI": "Vaccines (1972-1993)", "MS": "Vaccines made from antigens arising from any of the four strains of Plasmodium which cause malaria in humans, or from P. berghei which causes malaria in rodents.", "PM": "94", "HN": "94", "MR": "20200527", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017780"}, {"RECTYPE": "D", "MH": "Genes, Immediate-Early", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Immediate-Early Genes|T028|NON|EQV|NLM (1994)|921021|abcdef", "ENTRY": "Immediate Early Genes", "MN": "G05.360.340.358.840.500.345", "FX": "Immediate-Early Proteins", "MH_TH": "NLM (1994)", "ST": "T028", "AN": "genes showing rapid & transient expression in absence of protein synthesis: read MeSH definition for history of \"immediate-early\"", "PI": "specific genes (1972-1993)", "MS": "Genes that show rapid and transient expression in the absence of de novo protein synthesis. The term was originally used exclusively for viral genes where immediate-early referred to transcription immediately following virus integration into the host cell. It is also used to describe cellular genes which are expressed immediately after resting cells are stimulated by extracellular signals such as growth factors and neurotransmitters.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017781"}, {"RECTYPE": "D", "MH": "Superior Cervical Ganglion", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ganglion, Superior Cervical", "MN": "A08.800.050.800.300.850", "MH_TH": "NLM (1994)", "ST": "T023", "AN": "the largest sympath ganglion", "PI": "Ganglia, Sympathetic (1980-1993)", "MS": "The largest and uppermost of the paravertebral sympathetic ganglia.", "PM": "94", "HN": "94", "MR": "19940411", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017783"}, {"RECTYPE": "D", "MH": "Milk Banks", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Milk Bank", "MN": "N02.278.065.600", "MH_TH": "NLM (1994)", "ST": "T093", "MS": "Centers for acquiring, storing, and distributing human milk.", "PM": "94", "HN": "94", "MR": "20040713", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017784"}, {"RECTYPE": "D", "MH": "Photons", "AQ": "AE CL HI TU", "MN": "G01.750.770.578.782", "MH_TH": "NLM (1994)", "ST": "T167", "AN": "elementary particles; IM", "MS": "Discrete concentrations of energy, apparently massless elementary particles, that move at the speed of light. They are the unit or quantum of electromagnetic radiation. Photons are emitted when electrons move from one energy state to another. (From Hawley's Condensed Chemical Dictionary, 11th ed)", "OL": "use RADIATION to search PHOTONS 1985-93", "PM": "94; was see RADIATION 1985-1993", "HN": "94; was see RADIATION 1985-1993", "MR": "20110624", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017785"}, {"RECTYPE": "D", "MH": "Carlavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Carnation latent virus|T005|NON|NRW|NLM (2002)|010419|abcdef", "ENTRY": "Carlaviruses", "MN": "B04.820.578.375.150", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12163", "RR": "txid12164", "PI": "Plant Viruses (1976-1993)", "MS": "A genus of RNA plant viruses in the family FLEXIVIRIDAE, containing slightly flexuous filaments, often transmitted by aphids in a non-persistent manner. Carnation latent virus is the type species.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017788"}, {"RECTYPE": "D", "MH": "Granuloma, Pyogenic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemangioma, Lobular Capillary|T047|NON|EQV|NLM (1994)|921006|abcdef", "ENTRY": "Pyogenic Granuloma", "MN": "C23.550.382.937", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "non-neoplastic; coordinate with organ/disease term; do not confuse entry term HEMANGIOMA, LOBULAR CAPILLARY with neoplasm HEMANGIOMA, CAPILLARY", "PI": "Hemangioma (1969-1993)", "MS": "A disorder of the skin, the oral mucosa, and the gingiva, that usually presents as a solitary polypoid capillary hemangioma often resulting from trauma. It is manifested as an inflammatory response with similar characteristics to those of a granuloma.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D017789"}, {"RECTYPE": "D", "MH": "Closterovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Beet yellows virus|T005|NON|NRW|NLM (2000)|991103|abcdef", "MN": "B04.820.578.313.150", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12160", "RR": "txid35290", "AN": "coord IM with specific plant /virol", "PI": "Plant Viruses (1979-1993)", "MS": "A genus of plant viruses in the family CLOSTEROVIRIDAE containing highly flexuous filaments. Some members are important pathogens of crop plants. Natural vectors include APHIDS, whiteflies, and mealybugs. The type species is Beet yellows virus.", "PM": "1994", "HN": "1994", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017790"}, {"RECTYPE": "D", "MH": "Geminiviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Mastrevirus|T005|NON|NRW|NLM (2002)|010104|abcdef", "ENTRY": "Topocuviruses", "MN": "B04.715.270", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10811", "RR": "txid220339", "PI": "Plant Viruses (1985-1993)", "MS": "A family of plant viruses where the VIRION possesses an unusual morphology consisting of a pair of isometric particles. Transmission occurs via leafhoppers or whitefly. Some viruses cause economically important diseases in cultivated plants. There are four genera: Mastrevirus, Curtovirus, Topocuvirus, and BEGOMOVIRUS.", "PM": "1997; see GEMINIVIRUS 1994-96", "HN": "1997(1994)", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017791"}, {"RECTYPE": "D", "MH": "Surgical Stapling", "DE": "SURG STAPLING", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Staplings", "MN": "E04.987.775.800", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "/instrum: consider also SURGICAL STAPLERS; coordinate with staple material if pertinent", "PI": "Surgical Staplers (1966-1993)", "MS": "A technique of closing incisions and wounds, or of joining and connecting tissues, in which staples are used as sutures.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017792"}, {"RECTYPE": "D", "MH": "Luteovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Beet Western Yellows Virus|T005|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Luteoviruses", "MN": "B04.820.578.469.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12036", "RR": "txid12042", "AN": "coord IM with specific plant /virol (IM or NIM)", "PI": "Plant Viruses (1986-1993)", "MS": "A genus of plant viruses that infects both monocotyledonous and dicotyledonous plants. Its organisms are persistently transmitted by aphids, and weeds may provide reservoirs of infection.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017793"}, {"RECTYPE": "D", "MH": "Alfalfa mosaic virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Alfalfa mosaic viruses", "MN": "B04.820.578.282.050.050", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12321", "AN": "coord IM with specific plant /virol", "PI": "Plant Viruses (1966-1993)", "MS": "The type species of the genus ALFAMOVIRUS that is non-persistently transmitted by aphids.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017794"}, {"RECTYPE": "D", "MH": "Bromovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Cowpea chlorotic mottle virus|T005|NON|NRW|NLM (1994)|921006|abcdef", "ENTRY": "Brome mosaic viruses", "MN": "B04.820.578.282.080", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12300", "RR": "txid12303", "AN": "coord IM with specific plant /virol", "PI": "Plant Viruses (1966-1993)", "MS": "A genus of tripartite plant viruses in the family BROMOVIRIDAE. Transmission is by beetles. Brome mosaic virus is the type species.", "OL": "use BROMOVIRUS to search BROME MOSAIC VIRUSES 1994-96", "PM": "94; BROME MOSAIC VIRUSES was see BROMOVIRUS 1994-96", "HN": "94; BROME MOSAIC VIRUSES was see BROMOVIRUS 1994-96", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017795"}, {"RECTYPE": "D", "MH": "Caulimovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Cauliflower Mosaic Virus|T005|NON|NRW|NLM (1994)|921006|abcdef", "ENTRY": "Viruses, Cauliflower Mosaic", "MN": "B04.715.464.100", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10639", "RR": "txid10641", "AN": "coord IM with specific plant /virol (IM or NIM)", "PI": "Plant Viruses (1969-1993)", "MS": "A genus of PLANT VIRUSES, in the family CAULIMOVIRIDAE, that are transmitted by APHIDS in a semipersistent manner. Aphid-borne transmission of some caulimoviruses requires certain virus-coded proteins termed transmission factors.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017796"}, {"RECTYPE": "D", "MH": "Prosthesis Coloring", "AQ": "AE CL EC ES HI IS MO MT PX SN ST TD VE", "PRINT ENTRY": "Dental Prosthesis Coloring|T061|NON|NRW|NLM (1994)|921008|DENT PROSTHESIS COLORING|abcdefv", "ENTRY": "Coloring, Prosthesis", "MN": "E07.695.680.550", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "coordinate with specific prosthesis; for dental prosthesis coordinate also with DENTAL PROSTHESIS DESIGN", "PI": "specific prosthesis (1966-1993)", "MS": "Coloring, shading, or tinting of prosthetic components, devices, and materials.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017797"}, {"RECTYPE": "D", "MH": "Comovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Cowpea Mosaic Virus|T005|NON|NRW|NLM (1997)|960325|abcdef", "ENTRY": "Mosaic Viruses, Cowpea", "MN": "B04.820.578.813.150", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12258", "RR": "txid12264", "AN": "coord IM with specific plant /virol", "PI": "Plant Viruses (1966-1993)", "MS": "A genus of plant viruses of the family COMOVIRIDAE in which the bipartite genome is encapsidated in separate icosahedral particles. Mosaic and mottle symptoms are characteristic, and transmission is exclusively by leaf-feeding beetles. Cowpea mosaic virus is the type species.", "OL": "use COMOVIRUS to search COWPEA MOSAIC VIRUSES 1994-96", "PM": "94; COWPEA MOSAIC VIRUSES was see COMOVIRUS 1994-96", "HN": "94; COWPEA MOSAIC VIRUSES was see COMOVIRUS 1994-96", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017798"}, {"RECTYPE": "D", "MH": "Cucumovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Cucumber mosaic virus|T005|NON|NRW|NLM (1997)|960325|abcdef", "ENTRY": "Cucumoviruses", "MN": "B04.820.578.282.180", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12304", "RR": "txid12305", "AN": "coord IM with specific plant /virol", "PI": "Plant Viruses (1966-1993)", "MS": "A genus of plant viruses of the family BROMOVIRIDAE, which infect cucurbits and solanaceous plants. Transmission occurs via aphids in a non-persistent manner, and also via seeds. The type species Cucumber mosaic virus, a CUCUMOVIRUS, should not be confused with Cucumber green mottle mosaic virus, a TOBAMOVIRUS.", "OL": "use CUCUMOVIRUS to search CUCUMBER MOSAIC VIRUSES 1994-96", "PM": "94; CUCUMBER MOSAIC VIRUSES was see CUCUMOVIRUS 1994-96", "HN": "94; CUCUMBER MOSAIC VIRUSES was see CUCUMOVIRUS 1994-96", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017799"}, {"RECTYPE": "D", "MH": "Potyvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Potato Virus Y|T005|NON|NRW|NLM (1994)|921006|abcdef", "ENTRY": "Ys, Potato Virus", "MN": "B04.820.578.782.600", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12195", "RR": "txid12216", "AN": "a genus of mosaic viruses; from POTato virus Y (Y is one of a series, e.g., A, M, S, V, etc.); coord IM with specific plant /virol (IM or NIM)", "PI": "Plant Viruses (1967-1993)", "MS": "A large genus of plant viruses of the family POTYVIRIDAE which infect mainly plants of the Solanaceae. Transmission is primarily by aphids in a non-persistent manner. The type species is potato virus Y.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017800"}, {"RECTYPE": "D", "MH": "Plum Pox Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, Plum Pox", "MN": "B04.820.578.782.600.600", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12211", "AN": "a species of Potyvirus, a mosaic virus", "PI": "Plant Viruses (1969-1993)", "MS": "A species of the genus POTYVIRUS that affects many species of Prunus. It is transmitted by aphids and by infected rootstocks.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017801"}, {"RECTYPE": "D", "MH": "Widowhood", "AQ": "EC EH HI LJ PX SN", "PRINT ENTRY": "Widows|T099|NON|REL|NLM (1994)|921006|abcdef", "ENTRY": "Widower", "MN": "N01.824.308.500.862", "MH_TH": "NLM (1994)", "ST": "T099", "AN": "woman or man: note X refs; spousal bereavement: coord IM with BEREAVEMENT (IM); coping behavior, coping strategy, coping style: coord IM with ADAPTATION, PSYCHOLOGICAL", "PI": "Single Person (1968-1993)", "MS": "The state of having lost a marital partner by death.", "OL": "use SINGLE PERSON to search WIDOWER & WIDOW 1983-93", "PM": "94; WIDOWERS & WIDOWS were WIDOWER & WIDOW see SINGLE PERSON 1983-93", "HN": "94; WIDOWERS & WIDOWS were WIDOWER & WIDOW see SINGLE PERSON 1983-93", "CATSH": "CAT LIST", "MR": "19931126", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017805"}, {"RECTYPE": "D", "MH": "Tymovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Turnip yellow mosaic virus|T005|NON|NRW|NLM (2005)|040212|abcdef", "ENTRY": "Tymoviruses", "MN": "B04.820.578.984.850", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12148", "RR": "txid12154", "PI": "Plant Viruses (1966-1993)", "MS": "A genus of plant viruses, in the family TYMOVIRIDAE, possessing a narrow host range that includes CRUCIFERAE. Transmission occurs by BEETLES and mechanical inoculation.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017806"}, {"RECTYPE": "D", "MH": "Fatal Outcome", "ENTRY": "Outcomes, Fatal", "MN": "N06.850.520.308.985.550.325", "FX": "Death", "MH_TH": "NLM (1994)", "ST": "T046", "PI": "specific procedure (1966-1993)", "MS": "Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20170630", "DA": "19930528", "DC": "1", "DX": "19940101", "UI": "D017809"}, {"RECTYPE": "D", "MH": "Colubridae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Water Snake|T014|NON|NRW|NLM (1994)|921007|abcdef", "ENTRY": "Water Snakes", "MN": "B01.050.150.900.833.672.125.750", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8578", "RR": "txid94873", "AN": "its venom: coordinate with SNAKE VENOMS", "PI": "Snakes (1968-1993)", "MS": "The largest family of snakes comprising five subfamilies: Colubrinae, Natricinae, Homalopsinae, Lycodontinae, and Xenodontinae. They show a great diversity of eating habits, from eating almost anything to having a specialized diet. They can be oviparous, ovoviviparous, or viviparous. The majority of North American snakes are colubrines. Among the colubrids are king snakes, water snakes, and garter snakes. Some genera are poisonous. (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp321-29)", "PM": "94", "HN": "94", "MR": "20230405", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017812"}, {"RECTYPE": "D", "MH": "Elapidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Pseudonaja|T014|NON|NRW|NLM (2024)|230303|abcdef", "ENTRY": "Snake, Elapid", "MN": "B01.050.150.900.833.672.562.750", "FX": "Elapid Venoms", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8602", "RR": "txid8672", "PI": "Snakes (1966-1993)", "MS": "A family of extremely venomous snakes which include coral snakes, cobras and sea snakes. They are widely distributed, occurring in the Southern United States, South America, Africa, Southern Asia, Australia, and the Pacific Islands. Like viperids (VIPERIDAE), they have fangs in the front part of the upper jaw which discharge venom that is neurotoxic.", "PM": "94", "HN": "94", "MR": "20230531", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017815"}, {"RECTYPE": "D", "MH": "Nasal Lavage Fluid", "AQ": "CH CY IM MI PS VI", "PRINT ENTRY": "Nasal Washings|T031|NON|EQV|NLM (1994)|930107|abcdef", "ENTRY": "Washing, Nasal", "MN": "E05.927.573.500", "MH_TH": "NLM (1994)", "ST": "T031", "AN": "do not confuse with NASAL LAVAGE, the irrigation technique", "PI": "Irrigation (1971-1993)", "MS": "Fluid obtained by THERAPEUTIC IRRIGATION or washout of the nasal cavity and NASAL MUCOSA. The resulting fluid is used in cytologic and immunologic assays of the nasal mucosa such as with the NASAL PROVOCATION TEST in the diagnosis of nasal hypersensitivity.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017817"}, {"RECTYPE": "D", "MH": "Viperidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "European Viper|T014|NON|NRW|NLM (1994)|921007|abcdef", "ENTRY": "Viper, European", "MN": "B01.050.150.900.833.672.562.875", "FX": "Viper Venoms", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8689", "RR": "txid35022", "PI": "Snakes (1968-1993)", "MS": "A family of snakes comprising four subfamilies: Azemiopinae (the mountain viper, the sole member of this subfamily), Viperinae (true vipers), Crotalinae (pit vipers) and Causinae. They are widespread throughout the world, being found in the United States, Central and South America, Europe, Asia and Africa. Their venoms act on the blood (hemotoxic) as compared to the venom of elapids which act on the nervous system (neurotoxic). (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp333-36)", "PM": "94", "HN": "94", "MR": "20230531", "DA": "19930507", "DC": "1", "DX": "19940101", "UI": "D017819"}, {"RECTYPE": "D", "MH": "Boidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Python|T014|NON|REL|NLM (1994)|921007|abcdef", "ENTRY": "Pythons", "MN": "B01.050.150.900.833.672.125.500", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8572", "RR": "txid8573", "PI": "Snakes (1966-1993)", "MS": "A family of snakes comprising the boas, anacondas, and pythons. They occupy a variety of habitats through the tropics and subtropics and are arboreal, aquatic or fossorial (burrowing). Some are oviparous, others ovoviviparous. Contrary to popular opinion, they do not crush the bones of their victims: their coils exert enough pressure to stop a prey's breathing, thus suffocating it. There are five subfamilies: Boinae, Bolyerinae, Erycinae, Pythoninae, and Tropidophiinae. (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p315-320)", "PM": "94", "HN": "94", "MR": "20230830", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017821"}, {"RECTYPE": "D", "MH": "Furcation Defects", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Furcation Defect", "MN": "C07.465.714.204", "MH_TH": "NLM (1994)", "ST": "T046", "AN": "a periodontal dis", "PI": "Tooth Root (1966-1993)", "MS": "Conditions in which a bifurcation or trifurcation of the molar tooth root becomes denuded as a result of periodontal disease. It may be followed by tooth mobility, temperature sensitivity, pain, and alveolar bone resorption.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017823"}, {"RECTYPE": "D", "MH": "Bone Cysts, Aneurysmal", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Cysts, Aneurysmal Bone", "MN": "C05.116.070.265", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "non-neoplastic; nothing to do with \"aneurysm\": see MeSH definition; /coordinate with precoordinated organ/diseases term (but not BONE DISEASES)", "MS": "Fibrous blood-filled cyst in the bone. Although benign it can be destructive causing deformity and fractures.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D017824"}, {"RECTYPE": "D", "MH": "Canavan Disease", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Von Bogaert Bertrand Disease", "MN": "C18.452.648.189.362.375", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse entry term CANAVAN-VAN BOGAERT-BERTRAND DISEASE with VAN BOGAERT'S LEUKOENCEPHALITIS see SUBACUTE SCLEROSING PANENCEPHALITIS", "PI": "Demyelinating Diseases (1967-1993)", "MS": "A rare neurodegenerative condition of infancy or childhood characterized by white matter vacuolization and demeylination that gives rise to a spongy appearance. Aspartoacylase deficiency leads to an accumulation of N-acetylaspartate in astrocytes. Inheritance may be autosomal recessive or the illness may occur sporadically. This illness occurs more frequently in individuals of Ashkenazic Jewish descent. The neonatal form features the onset of hypotonia and lethargy at birth, rapidly progressing to coma and death. The infantile form features developmental delay, DYSKINESIAS, hypotonia, spasticity, blindness, and megalencephaly. The juvenile form is characterized by ATAXIA; OPTIC ATROPHY; and DEMENTIA. (From Adams et al., Principles of Neurology, 6th ed, p944; Am J Med Genet 1988 Feb;29(2):463-71)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017825"}, {"RECTYPE": "D", "MH": "Machado-Joseph Disease", "DE": "MACHADO JOSEPH DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Striatonigral Degeneration, Autosomal Dominant|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Type IV Machado Joseph Disease", "MN": "C16.320.400.780.875.500", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Spinocerebellar Degeneration (1986-1993)", "MS": "A dominantly-inherited ATAXIA first described in people of Azorean and Portuguese descent, and subsequently identified in Brazil, Japan, China, and Australia. This disorder is classified as one of the SPINOCEREBELLAR ATAXIAS (Type 3) and has been associated with a mutation of the MJD1 gene on chromosome 14. Clinical features include progressive ataxia, DYSARTHRIA, postural instability, nystagmus, eyelid retraction, and facial FASCICULATIONS. DYSTONIA is prominent in younger patients (referred to as Type I Machado-Joseph Disease). Type II features ataxia and ocular signs; Type III features MUSCULAR ATROPHY and a sensorimotor neuropathy; and Type IV features extrapyramidal signs combined with a sensorimotor neuropathy. (From Clin Neurosci 1995;3(1):17-22; Ann Neurol 1998 Mar;43(3):288-96)", "OL": "use SPINOCEREBELLAR DEGENERATION to search MACHADO-JOSEPH DISEASE 1987-93", "PM": "94; was see SPINOCEREBELLAR DEGENERATION 1987-93", "HN": "94; was see SPINOCEREBELLAR DEGENERATION 1987-93", "CATSH": "CAT LIST", "MR": "20160628", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017827"}, {"RECTYPE": "D", "MH": "Rifabutin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "LM427", "MN": "D04.345.295.750.650", "PA": "Antibiotics, Antitubercular", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "Rifamycin XIV, 1',4-didehydro-1-deoxy-1,4-dihydro-5'-(2-methylpropyl)-1-oxo-", "RN": "1W306TDA6S", "RR": "72559-06-9 (Rifabutin)", "PI": "Rifamycins (1981-1993)", "MS": "A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.", "OL": "use RIFABUTIN (NM) to search RIFABUTINE 1981-93", "PM": "94; RIFABUTINE was indexed under RIFAMYCINS 1981-93", "HN": "94; was RIFABUTINE (NM) 1981-93", "MR": "20170524", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017828"}, {"RECTYPE": "D", "MH": "Granisetron", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-, endo-|T109|T121|NON|EQV|NLM (2023)|220607|abbcdef", "ENTRY": "Monohydrochloride, Granisetron", "MN": "D03.633.100.449.350", "PA": "Antiemetics", "MH_TH": "USAN (1991)", "ST": "T121", "RN": "0", "PI": "Indazoles (1988-1993)", "MS": "A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy patients.", "OL": "use GRANISETRON (NM) to search GRANISETRON 1988-93", "PM": "94; GRANISETRON was indexed under INDAZOLES 1988-93", "HN": "94; was GRANISETRON (NM) 1988-93", "MR": "20220714", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017829"}, {"RECTYPE": "D", "MH": "Octoxynol", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Octylphenoxypolyethoxyethanols|T109|T121|T122|NON|EQV|NLM (1994)|921009|abbbcdef", "ENTRY": "Triton X45", "MN": "J01.637.051.720.741.610", "PA": "Surface-Active Agents", "MH_TH": "NLM (1994)", "ST": "T122", "N1": "Poly(oxy-1,2-ethanediyl), alpha-(4-(1,1,3,3-tetramethylbutyl)phenyl)-omega-hydroxy-", "RN": "9002-93-1", "PI": "Polyethylene Glycols (1974-1993)", "MS": "Nonionic surfactant mixtures varying in the number of repeating ethoxy (oxy-1,2-ethanediyl) groups. They are used as detergents, emulsifiers, wetting agents, defoaming agents, etc. Octoxynol-9, the compound with 9 repeating ethoxy groups, is a spermatocide.", "OL": "use OCTOXYNOL (NM) to search OCTOXYNOL 1980-93", "PM": "94; OCTOXYNOL was indexed under POLYETHYLENE GLYCOLS 1983-94 & 1974-79, TRITONS 1979-82 & PHENYL ETHERS 1975-76", "HN": "94; was OCTOXYNOL (NM) 1974-93", "MR": "20060705", "DA": "19930712", "DC": "1", "DX": "19940101", "UI": "D017830"}, {"RECTYPE": "D", "MH": "Diagnosis, Dual (Psychiatry)", "DE": "DUAL DIAG", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Dual Diagnosis, Psychiatric|T060|NON|EQV|NLM (1994)|921009|DUAL DIAG PSYCHIATRIC|abcdefv", "ENTRY": "Psychiatric Dual Diagnoses", "MN": "E01.190", "MH_TH": "NLM (1994)", "ST": "T060", "AN": "restrict to substance abuse with ment disord; IM GEN only; coord NIM with specific addiction (IM) + specific ment disord (IM); DF: DUAL DIAG", "PI": "specific substance abuse disorder/diagnosis (1989-1993)", "MS": "The co-existence of a substance abuse disorder with a psychiatric disorder. The diagnostic principle is based on the fact that it has been found often that chemically dependent patients also have psychiatric problems of various degrees of severity.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017831"}, {"RECTYPE": "D", "MH": "Visceral Afferents", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Visceral Afferent", "MN": "A08.612.220.830", "MH_TH": "NLM (1994)", "ST": "T023", "PI": "Viscera/innervation (1986-1993)", "MS": "The sensory fibers innervating the viscera.", "PM": "94", "HN": "94", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017833"}, {"RECTYPE": "D", "MH": "Nedocromil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Nedocromil", "MN": "D03.633.100.810.835.830.550", "PA": "Anti-Inflammatory Agents", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "4H-Pyrano(3,2-g)quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-", "RN": "0B535E0BN0", "RR": "ET8IF4KS1T", "PI": "Quinolones (1989-1993)", "MS": "A pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with ASTHMA, including EOSINOPHILS; NEUTROPHILS; MACROPHAGES; MAST CELLS; MONOCYTES; AND PLATELETS.", "OL": "use NEDOCROMIL (NM) to search NEDOCROMIL 1984-93", "PM": "94; NEDOCROMIL was indexed under QUINOLINONES 1989-93 & QUINOLINES 1984-88", "HN": "94; was NEDOCROMIL (NM) 1984-93", "MR": "20200609", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017835"}, {"RECTYPE": "D", "MH": "Agkistrodon", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Western Cottonmouth|T014|NON|NRW|NLM (2024)|230311|abcdef", "ENTRY": "Western Cottonmouths", "MN": "B01.050.150.900.833.672.562.875.240.250", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8711", "RR": "txid8720", "PI": "Snakes (1966-1993)", "MS": "A genus of venomous snakes of the subfamily Crotalinae. Twelve species of this genus are found in North and Central America and Asia. Agkistrodon contortrix is the copperhead, A. piscivorus, the cottonmouth. The former is named for its russet or orange-brown color, the latter for the white interior of its mouth. (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p336; Moore, Poisonous Snakes of the World, 1980, p75)", "PM": "1994; for WATER MOCCASIN see COLUBRIDAE 1994-2022", "HN": "1994; for WATER MOCCASIN use COLUBRIDAE 1994-2022", "MR": "20230531", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017836"}, {"RECTYPE": "D", "MH": "Bothrops", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.833.672.562.875.240.375", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8721", "AN": "venom: coordinate with CROTALID VENOMS", "PI": "Snakes (1966-1993)", "MS": "A genus of poisonous snakes of the VIPERIDAE family. About 50 species are known and all are found in tropical America and southern South America. Bothrops atrox is the fer-de-lance and B. jararaca is the jararaca. (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p336)", "PM": "94", "HN": "94", "MR": "20230531", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017837"}, {"RECTYPE": "D", "MH": "Bungarus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Krait|T014|NON|EQV|NLM (1994)|921009|abcdef", "ENTRY": "Kraits", "MN": "B01.050.150.900.833.672.562.750.225", "FX": "Bungarotoxins", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8612", "AN": "a genus of poisonous snakes", "PI": "Snakes (1966-1993)", "MS": "A genus of poisonous snakes of the subfamily Elapinae of the family ELAPIDAE. They comprise the kraits. Twelve species are recognized and all inhabit southeast Asia. They are considered extremely dangerous. (Moore: Poisonous Snakes of the World, 1980, p120)", "PM": "94", "HN": "94", "MR": "20230531", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017838"}, {"RECTYPE": "D", "MH": "Crotalus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Rattlesnake|T014|NON|EQV|NLM (1994)|921013|abcdef", "ENTRY": "Rattlesnakes", "MN": "B01.050.150.900.833.672.562.875.240.500", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8728", "PI": "Snakes (1966-1993)", "MS": "A genus of snakes of the subfamily Crotalinae, having a hollowed out pit in the maxillary bone between the eye and nostril. Most well recognized species are found in the Southwestern United States and northern Mexico. Several species are found as far north as Canada and as far south as Brazil. They are named for the jointed rattle (Greek krotalon) at the tip of their tail.", "PM": "94", "HN": "94", "MR": "20230531", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017839"}, {"RECTYPE": "D", "MH": "Daboia", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Vipera russellii|T014|NON|NRW|NLM (2024)|230302|abcdef", "ENTRY": "Viper, Russell's", "MN": "B01.050.150.900.833.672.562.875.875.500", "MH_TH": "NLM (2024)", "ST": "T014", "RN": "txid8707", "RR": "txid97228", "AN": "a genus of vipers; its venom: coord IM with VIPER VENOMS (IM)", "PI": "Snakes (1966-1993)", "MS": "A genus of snakes of the family VIPERIDAE. It is distributed in West Pakistan, most of India, Burma, Ceylon, Thailand, southeast China, Taiwan, and a few islands of Indonesia. It hisses loudly when disturbed and strikes with great force and speed. Very prolific, it gives birth to 20-60 young. DABOIA is the leading cause of snakebite in India and Burma. (Moore: Poisonous Snakes of the World, 1980, p127)", "PM": "2024; see RUSSELL'S VIPER 1994-2023", "HN": "2024(1994)", "MR": "20230727", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017840"}, {"RECTYPE": "D", "MH": "Trimeresurus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Habu|T014|NON|EQV|NLM (1994)|921013|abcdef", "ENTRY": "Habus", "MN": "B01.050.150.900.833.672.562.875.240.750", "MH_TH": "NLM (1994)", "ST": "T014", "RN": "txid8764", "AN": "venom: coordinate with CROTALID VENOMS", "PI": "Snakes (1966-1993)", "MS": "A genus of snakes of the family VIPERIDAE. About 30 species are currently recognized, found in southeast Asia and adjacent island chains. The Okinawa habu frequently enters dwellings in search of rats and mice; the Chinese habu is often found in suburban and agricultural areas. They are quite irritable. (Moore: Poisonous Snakes of the World, 1980, p136)", "PM": "94", "HN": "94", "MR": "20230531", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017841"}, {"RECTYPE": "D", "MH": "Ligamentum Flavum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Ligamenta Flava|T023|NON|EQV|NLM (1994)|921013|abcdef", "ENTRY": "Ligaments, Flaval", "MN": "A10.165.669.514.287", "MH_TH": "NLM (1994)", "ST": "T023", "PI": "Ligaments (1966-1993)", "MS": "The paired bands of yellow elastic tissue that connect adjoining laminae of the vertebrae. With the laminae, it forms the posterior wall of the spinal canal and helps hold the body erect.", "PM": "94", "HN": "94", "MR": "20170620", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017843"}, {"RECTYPE": "D", "MH": "Lateral Ligament, Ankle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Ligamentum Laterale Articulationis Talocruralis|T023|NON|EQV|NLM (1994)|921013|abcdef", "ENTRY": "Talofibular Ligaments, Posterior", "MN": "A10.165.669.514.162.500", "MH_TH": "NLM (1994)", "ST": "T023", "PI": "Ligaments, Articular (1966-1993)", "MS": "LATERAL LIGAMENTS of the ANKLE JOINT. It includes inferior tibiofibular ligaments.", "PM": "94", "HN": "94", "MR": "20170620", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017844"}, {"RECTYPE": "D", "MH": "Longitudinal Ligaments", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Posterior Longitudinal Ligament|T023|NON|NRW|NLM (1994)|921026|abcdef", "ENTRY": "Posterior Longitudinal Ligaments", "MN": "A10.165.669.514.350", "FX": "Ossification of Posterior Longitudinal Ligament", "MH_TH": "NLM (1994)", "ST": "T023", "AN": "spinal ligaments; LIGAMENTUM FLAVUM, a vertebral ligament, is also available", "PI": "Ligaments, Articular (1968-1993)", "MS": "Two extensive fibrous bands running the length of the vertebral column. The anterior longitudinal ligament (ligamentum longitudinale anterius; lacertus medius) interconnects the anterior surfaces of the vertebral bodies; the posterior longitudinal ligament (ligamentum longitudinale posterius) interconnects the posterior surfaces. The commonest clinical consideration is OSSIFICATION OF POSTERIOR LONGITUDINAL LIGAMENT. (From Stedman, 25th ed)", "PM": "94", "HN": "94", "MR": "20170620", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017846"}, {"RECTYPE": "D", "MH": "Patellar Ligament", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Patellar Tendon|T023|NON|EQV|NLM (2007)|051229|abcdef", "ENTRY": "Tendons, Patellar", "MN": "A10.165.669.514.475", "FX": "Posterior Cruciate Ligament", "MH_TH": "NLM (1994)", "ST": "T023", "AN": "do not confuse with MEDIAL COLLATERAL LIGAMENT, KNEE", "PI": "Ligaments, Articular (1968-1993)", "MS": "A band of fibrous tissue that attaches the apex of the PATELLA to the lower part of the tubercle of the TIBIA. The ligament is actually the caudal continuation of the common tendon of the QUADRICEPS FEMORIS. The patella is embedded in that tendon. As such, the patellar ligament can be thought of as connecting the quadriceps femoris tendon to the tibia, and therefore it is sometimes called the patellar tendon.", "PM": "94", "HN": "94", "MR": "20170620", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017847"}, {"RECTYPE": "D", "MH": "Blood-Borne Pathogens", "AQ": "CL DE IP RE", "PRINT ENTRY": "Pathogens, Blood-Borne|T001|NON|EQV|NLM (1994)|921014|abcdef", "ENTRY": "Bloodborne Pathogens|T001|NON|EQV|NLM (1994)|921014|abcdef", "MN": "B05.155", "FX": "Universal Precautions", "MH_TH": "NLM (1994)", "ST": "T001", "AN": "coordinate with specific pathogen if pertinent; do not routinely add as a coordinate for infections in the blood (VIREMIA; BACTEREMIA; FUNGEMIA; PARASITEMIA)", "PI": "specific organism (1987-1993)", "MS": "Infectious organisms, including pathogenic bacteria, viruses, and fungi, that are present in the BLOOD.", "PM": "94", "HN": "94", "MR": "20210630", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017848"}, {"RECTYPE": "D", "MH": "Animals, Inbred Strains", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Strains, Inbred Animal", "MN": "B01.050.050.199.520", "MH_TH": "NLM (1994)", "ST": "T010", "AN": "IM general or unspecified; coordinate NIM with specific experimental animal (NIM)", "PI": "Inbreeding (1970-1993)", "MS": "Animals produced by the mating of progeny over multiple generations. The resultant strain of animals is virtually identical genotypically. Highly inbred animal lines allow the study of certain traits in a relatively pure form. (Segen, Dictionary of Modern Medicine, 1992)", "PM": "94", "HN": "94", "MR": "20200902", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017849"}, {"RECTYPE": "D", "MH": "Economics, Pharmaceutical", "DE": "ECON PHARM", "AQ": "CL ES HI LJ OG SN ST TD", "PRINT ENTRY": "Pharmacoeconomics|T081|NON|EQV|NLM (1994)|921014|PHARMACOECON|abcdefv", "ENTRY": "Pharmacy Economic", "MN": "N03.219.390", "FX": "Prescription Fees", "MH_TH": "NLM (1994)", "ST": "T081", "AN": "general or unspecified; prefer /econ with specific drugs or specific pharmaceutical subject", "PI": "Pharmacy/economics (1980-1993)", "MS": "Economic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. (From J Res Pharm Econ 1989;1(1); PharmacoEcon 1992;1(1))", "PM": "94", "HN": "94", "MR": "20180629", "DA": "19930527", "DC": "1", "DX": "19940101", "UI": "D017850"}, {"RECTYPE": "D", "MH": "Phosphotransferases (Carboxyl Group Acceptor)", "DE": "PHOSPHOTRANSFERASES CARBOXYL", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.913.696.630", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 2.7.2.-", "PI": "Phosphotransferases (1966-1993)", "MS": "A class of enzymes that transfers phosphate groups and has a carboxyl group as an acceptor. EC 2.7.2.", "PM": "94", "HN": "94", "MR": "20060705", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017851"}, {"RECTYPE": "D", "MH": "Phosphotransferases (Nitrogenous Group Acceptor)", "DE": "PHOSPHOTRANSFERASES NITROGENOUS", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.913.696.640", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 2.7.3.-", "PI": "Phosphotransferases (1966-1993)", "MS": "A group of enzymes that catalyzes the transfer of a phosphate group onto a nitrogenous group acceptor. EC 2.7.3.", "PM": "94", "HN": "94", "MR": "20060705", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017852"}, {"RECTYPE": "D", "MH": "Phosphotransferases (Alcohol Group Acceptor)", "DE": "PHOSPHOTRANSFERASES ALCOHOL", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.913.696.620", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 2.7.1.-", "PI": "Phosphotransferases (1966-1993)", "MS": "A group of enzymes that transfers a phosphate group onto an alcohol group acceptor. EC 2.7.1.", "PM": "94", "HN": "94", "MR": "20060705", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017853"}, {"RECTYPE": "D", "MH": "Diphosphotransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pyrophosphotransferases|T116|T126|NON|EQV|NLM (1994)|921015|abbcdef", "MN": "D08.811.913.696.175", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 2.7.6.-", "PI": "Phosphotransferases (1966-1993)", "MS": "A class of phosphotransferases that catalyzes the transfer of diphosphate-containing groups. EC 2.7.6.", "PM": "94", "HN": "94", "MR": "20060705", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017854"}, {"RECTYPE": "D", "MH": "Transferases (Other Substituted Phosphate Groups)", "DE": "TRANSFERASES OSPG", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphotransferases (Other Substituted Phosphate Groups)|T116|T126|NON|EQV|NLM (1994)|921015|PHOSPHOTRANSFERASES OSPG|abbcdefv", "MN": "D08.811.913.696.900", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 2.7.8.-", "PI": "Phosphotransferases (1966-1993)", "MS": "A class of enzymes that transfers substituted phosphate groups. EC 2.7.8.", "PM": "94", "HN": "94", "MR": "20060705", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017855"}, {"RECTYPE": "D", "MH": "Phosphotransferases (Phosphate Group Acceptor)", "DE": "PHOSPHOTRANSFERASES PHOSPHATE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.913.696.650", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 2.7.4.-", "PI": "Phosphotransferases (1966-1993)", "MS": "A group of enzymes that catalyzes the transfer of a phosphate group onto a phosphate group acceptor. EC 2.7.4.", "PM": "94", "HN": "94", "MR": "20180701", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017856"}, {"RECTYPE": "D", "MH": "Salmoniformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Salmoniforme", "MN": "B01.050.150.900.493.817", "MH_TH": "NLM (1994)", "ST": "T013", "RN": "txid8006", "AN": "general or unspecified; prefer specific families or specific genera", "MS": "An order of fish comprising salmons, trouts, whitefish, graylings, and other families. They are both marine and freshwater fish, found in all oceans and are quite numerous in the Northern Hemisphere. (From Nelson: Fishes of the World)", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017858"}, {"RECTYPE": "D", "MH": "Esocidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Pike|T013|NON|EQV|NLM (1994)|921016|abcdef", "ENTRY": "Pike, Northern", "MN": "B01.050.150.900.493.385.300", "MH_TH": "NLM (1994)", "ST": "T013", "RN": "txid8008", "RR": "txid8010", "MS": "A family of freshwater fish of the order ESOCIFORMES, comprising the pikes, inhabiting the waters of the Northern Hemisphere. There is one genus, Esox, with five species: northern pike, grass pickerel, chain pickerel, muskellunge, and Amur pike.", "OL": "use SALMONIDAE to search ESOX 1987-93", "PM": "94; ESOX was see SALMONIDAE 1987-93", "HN": "94; ESOX was see SALMONIDAE 1987-93", "MR": "20200813", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017859"}, {"RECTYPE": "D", "MH": "Nepovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Tobacco ringspot virus|T005|NON|NRW|NLM (1997)|960325|abcdef", "ENTRY": "Tobacco ringspot viruses", "MN": "B04.820.578.813.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12270", "RR": "txid12282", "AN": "coord IM with specific plant /virol", "PI": "Plant Viruses (1985-1993)", "MS": "A genus of polyhedral plant viruses of the family COMOVIRIDAE causing ringspots and spotting on leaves or sometimes symptomless infection. Transmission occurs by seeds, soil nematodes, or experimentally by mechanical inoculation. Tobacco ringspot virus is the type species.", "OL": "use NEPOVIRUS to search TOBACCO RINGSPOT VIRUSES 1994-96", "PM": "94; TOBACCO RINGSPOT VIRUSES was see NEPOVIRUS 1994-96", "HN": "94; TOBACCO RINGSPOT VIRUSES was see NEPOVIRUS 1994-96", "MR": "20200813", "DA": "19930629", "DC": "1", "DX": "19940101", "UI": "D017860"}, {"RECTYPE": "D", "MH": "Porphyromonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.194.625", "MH_TH": "NLM (1994)", "ST": "T007", "RN": "txid836", "AN": "infection: coord IM with BACTEROIDACEAE INFECTIONS (IM)", "PI": "Bacteroides (1988-1993)", "MS": "A genus of gram-negative, anaerobic, nonsporeforming, nonmotile rods or coccobacilli. Organisms in this genus had originally been classified as members of the BACTEROIDES genus but overwhelming biochemical and chemical findings indicated the need to separate them from other Bacteroides species, and hence, this new genus was created.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017861"}, {"RECTYPE": "D", "MH": "Phycodnaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Algal Viruses|T005|NON|EQV|NLM (1994)|921016|abcdef", "ENTRY": "Viruses, Algal", "MN": "B04.715.600", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10501", "AN": "a family of plant viruses infecting algae; from PHYCOs (Greek for alga) DNA viruses", "MS": "A family of DNA plant viruses that infect eukaryotic algae.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017862"}, {"RECTYPE": "D", "MH": "Potexvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Potato virus X|T005|NON|NRW|NLM (1994)|921016|abcdef", "ENTRY": "Potexviruses", "MN": "B04.820.578.375.575", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12176", "RR": "txid12183", "PI": "Plant Viruses (1988-1993)", "MS": "A genus of plant viruses in the family FLEXIVIRIDAE, that cause mosaic and ringspot symptoms. Transmission occurs mechanically. Potato virus X is the type species.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D017863"}, {"RECTYPE": "D", "MH": "Tombusvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Tomato bushy stunt virus|T005|NON|NRW|NLM (1997)|960325|abcdef", "ENTRY": "Cymbidium ringspot viruses", "MN": "B04.820.578.968.870", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12141", "RR": "txid12145", "PI": "Plant Viruses (1975-1993)", "MS": "A genus of plant viruses that infects ANGIOSPERMS. Transmission occurs mechanically and through soil, with one species transmitted via a fungal vector. The type species is Tomato bushy stunt virus.", "OL": "use TOMBUSVIRUS to search TOMATO BUSHY STUNT VIRUSES 1994-96", "PM": "94; TOMATO BUSHY STUNT VIRUSES was see TOMBUSVIRUS 1994-96", "HN": "94; TOMATO BUSHY STUNT VIRUSES was see TOMBUSVIRUS 1994-96", "MR": "20200813", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D017864"}, {"RECTYPE": "D", "MH": "Tospovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Tomato spotted wilt virus|T005|NON|NRW|NLM (1994)|921016|abcdef", "ENTRY": "Tospoviruses", "MN": "B04.820.480.750.855", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid2560196", "RR": "txid1933298", "AN": "coord IM with specific plant /virol", "PI": "Plant Viruses (1966-1993)", "MS": "A genus of plant viruses in the family BUNYAVIRIDAE. Tomato spotted wilt virus is the type species. Transmission occurs by at least nine species of thrips.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017865"}, {"RECTYPE": "D", "MH": "Phosphotransferases (Paired Acceptors)", "DE": "PHOSPHOTRANSFERASES PAIRED", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.913.696.645", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 2.7.9.-", "PI": "Phosphotransferases (1966-1993)", "MS": "A group of enzymes that transfers two phosphate groups from a donor such as ATP to two different acceptors. (From Enzyme Nomenclature, 1992) EC 2.7.9.", "PM": "94", "HN": "94", "MR": "20060705", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017866"}, {"RECTYPE": "D", "MH": "Cyclic Nucleotide-Regulated Protein Kinases", "DE": "CYCL NUC REG KINASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cyclic Nucleotide Regulated Protein Kinases", "MN": "D12.776.476.563.150", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 2.7.11.-", "AN": "general or unspecified; prefer specifics; used for mapping supplementary chemicals", "PI": "Protein Kinases (1973-1993)", "MS": "A group of enzymes that catalyzes the phosphorylation of serine or threonine residues of proteins and is dependent on cyclic nucleotides.", "PM": "98", "HN": "98; use explode 1994-97", "MR": "20210521", "DA": "19930826", "DC": "1", "DX": "19980101", "UI": "D017867"}, {"RECTYPE": "D", "MH": "Cyclic AMP-Dependent Protein Kinases", "DE": "CAMP PROTEIN KINASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "cAMP-Dependent Protein Kinases|T116|T126|ABX|EQV|NLM (1994)|921019|abbcdef", "ENTRY": "cAMP Dependent Protein Kinases", "MN": "D12.776.476.563.150.125", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 2.7.11.11", "PI": "Protein Kinases (1973-1993)", "MS": "A group of enzymes that are dependent on CYCLIC AMP and catalyze the phosphorylation of SERINE or THREONINE residues on proteins. Included under this category are two cyclic-AMP-dependent protein kinase subtypes, each of which is defined by its subunit composition.", "PM": "94; was CYCLIC AMP-DEPENDENT PROTEIN KINASE see PROTEIN KINASES 1984-93", "HN": "94; was CYCLIC AMP-DEPENDENT PROTEIN KINASE see PROTEIN KINASES 1984-93", "MR": "20210521", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017868"}, {"RECTYPE": "D", "MH": "Cyclic GMP-Dependent Protein Kinases", "DE": "CGMP PROTEIN KINASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "cGMP-Dependent Protein Kinases|T116|T126|EQV|NLM (1994)|921019|abbdef", "ENTRY": "cGMP Dependent Protein Kinases", "MN": "D12.776.476.563.150.150", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 2.7.11.12", "PI": "Protein Kinases (1982-1993)", "MS": "A group of cyclic GMP-dependent enzymes that catalyze the phosphorylation of SERINE or THREONINE residues of proteins.", "PM": "1994; PROTEIN KINASE G was indexed under PROTEIN KINASES 1999-2000", "HN": "1994; for PROTEIN KINASE G use CYCLIC GMP-DEPENDENT PROTEIN KINASES (NM) 1999-2000", "MR": "20210521", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017869"}, {"RECTYPE": "D", "MH": "Calcium-Calmodulin-Dependent Protein Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Restricted Calcium-Calmodulin-Dependent Protein Kinase|T116|T126|NON|NRW|NLM (2021)|191120|abbcdef", "ENTRY": "Restricted Calcium Calmodulin Dependent Protein Kinases", "MN": "D12.776.476.563.125", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 2.7.11.17", "RR": "EC 2.7.11.17", "AN": "general or unspecified; prefer specifics", "PI": "Protein Kinases (1990-1993)", "MS": "A CALMODULIN-dependent enzyme that catalyzes the phosphorylation of proteins. This enzyme is also sometimes dependent on CALCIUM. A wide range of proteins can act as acceptor, including VIMENTIN; SYNAPSINS; GLYCOGEN SYNTHASE; MYOSIN LIGHT CHAINS; and the MICROTUBULE-ASSOCIATED PROTEINS. (From Enzyme Nomenclature, 1992, p277)", "PM": "2008; see CA(2+)-CALMODULIN-DEPENDENT PROTEIN KINASE 1998-2007; see CALMODULIN-DEPENDENT PROTEIN KINASES 1994-1997 & PROTEIN KINASES 1990-1993; CALMODULIN-DEPENDENT MULTIPROTEIN KINASE was indexed under PROTEIN KINASES 1989-2007", "HN": "2008(1994)", "MR": "20210520", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D017871"}, {"RECTYPE": "D", "MH": "Immediate-Early Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proteins, Immediate-Early|T116|T123|NON|EQV|NLM (1994)|921019|abbcdef", "ENTRY": "Proteins, Immediate Early", "MN": "D12.776.964.925.968", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "AN": "proteins coded by immed-early genes: read MeSH definition for history of \"immediate-early\"", "PI": "Viral Proteins (1974-1993)", "MS": "Proteins that are coded by immediate-early genes, in the absence of de novo protein synthesis. The term was originally used exclusively for viral regulatory proteins that were synthesized just after viral integration into the host cell. It is also used to describe cellular proteins which are synthesized immediately after the resting cell is stimulated by extracellular signals.", "PM": "94", "HN": "94", "MR": "20070709", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017874"}, {"RECTYPE": "D", "MH": "Phosphotransferases (Phosphomutases)", "DE": "PHOSPHOTRANSFERASES PHOSPHOMUTASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphomutases|T116|T126|NON|EQV|NLM (1998)|970307|abbcdef", "MN": "D08.811.399.520.750", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 5.4.2.-", "PI": "Phosphotransferases (1966-1993)", "MS": "A group of enzymes that catalyze an intramolecular transfer of a phosphate group. It has been shown in some cases that the enzyme has a functional phosphate group, which can act as the donor. These were previously listed under PHOSPHOTRANSFERASES (EC 2.7.-). (From Enzyme Nomenclature, 1992) EC 5.4.2.", "PM": "94", "HN": "94", "MR": "20060705", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017875"}, {"RECTYPE": "D", "MH": "Umbridae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Umbra|T013|NON|NRW|NLM (1994)|921020|abcdef", "ENTRY": "Mudminnow", "MN": "B01.050.150.900.493.385.850", "MH_TH": "NLM (1994)", "ST": "T013", "RN": "txid30950", "RR": "txid75932", "AN": "note entry term; MINNOWS see CYPRINIDAE is also available", "MS": "A family of ESOCIFORMES comprising the mudminnows. There are three genera: Dallia, Novumbra, and Umbra, with much disagreement about their taxonomic interrelations. The Umbridae are freshwater fish inhabiting parts of the Northern Hemisphere.", "PM": "1994", "HN": "1994", "MR": "20200813", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D017877"}, {"RECTYPE": "D", "MH": "4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid", "DS": "DIISOTHIOCYANOSTILBENEDISULFONIC ACID 04 04 02 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "DIDS|T109|T121|ACR|EQV|FDA SRS (2014)|NLM (1994)|990101|abbcdeef", "MN": "D02.886.250.125", "MH_TH": "NLM (1994)", "ST": "T121", "N1": "Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis(5-isothiocyanato)-", "RN": "Q1O6DSW23R", "RR": "53005-05-3 (4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid)", "PI": "Stilbenes (1977-1980)", "MS": "An inhibitor of anion conductance including band 3-mediated anion transport.", "PM": "2001; see DIDS 1981-2000; 4,4'-DISOTHIOCYANOSTILBEN-2,2'-DISULFONIC ACID was indexed under SITS/analogs & derivatives 1981-1993 & STILBENES 1977-1980", "HN": "2001(1994); use DIDS (NM) 1977-93", "MR": "20130708", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017878"}, {"RECTYPE": "D", "MH": "Isothiocyanates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.886.250", "FX": "Thiocyanates", "MH_TH": "NLM (1994)", "ST": "T109", "RN": "0", "PI": "Thiocyanates (1966-1993)", "MS": "Organic compounds with the general formula R-NCS.", "PM": "94", "HN": "94", "MR": "20060705", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017879"}, {"RECTYPE": "D", "MH": "Limb Deformities, Congenital", "DE": "LIMB DEFORMITIES CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Limb Deformity, Congenital", "MN": "C16.131.621.585", "MH_TH": "NLM (1994)", "ST": "T019", "AN": "general or unspecified; LOWER EXTREMITY DEFORMITIES, CONGENITAL and UPPER EXTREMITY DEFORMITIES, CONGENITAL are available as well as /abnorm with specifics treed under UPPER EXTREMITIES and LOWER EXTREMITIES; DF: LIMB DEFORMITIES CONGEN", "PI": "Extremities/abnormalities (1968-1997)", "MS": "Congenital structural deformities of the upper and lower extremities collectively or unspecified.", "PM": "98", "HN": "98; use explode 1994-97", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19930826", "DC": "1", "DX": "19980101", "UI": "D017880"}, {"RECTYPE": "D", "MH": "Kingella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.525.410", "MH_TH": "NLM (1994)", "ST": "T007", "RN": "txid32257", "AN": "bacterium of upper resp mucous membranes; infection: coord IM with NEISSERIACEAE INFECTIONS (IM)", "PI": "Neisseriaceae (1983-1993)", "MS": "A genus of gram-negative, aerobic, rod-shaped bacteria whose organisms are part of the normal flora of the mucous membranes of the upper respiratory tract. Some species are pathogenic for man.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D017881"}, {"RECTYPE": "D", "MH": "Kingella kingae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Moraxella kingae|T007|NON|EQV|NLM (1994)|921022|abcdef", "ENTRY": "Moraxella kingii|T007|NON|EQV|NLM (1994)|921022|abcdef", "MN": "B03.660.075.525.410.410", "MH_TH": "NLM (1994)", "ST": "T007", "RN": "txid504", "AN": "formerly called Moraxella kingae; infection: coord IM with NEISSERIACEAE INFECTIONS (IM)", "PI": "Neisseriaceae (1983-1993)", "MS": "A species of gram-negative, aerobic, rod-shaped bacteria which is distinguished from other members of the genus KINGELLA by its beta hemolysis. It occurs normally in human mucous membranes of the upper respiratory tract, but can cause septic arthritis and endocarditis. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "94", "HN": "94", "MR": "20200128", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D017882"}, {"RECTYPE": "D", "MH": "Collateral Ligaments", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Ligaments, Lateral|T023|NON|REL|NLM (1994)|921026|abcdef", "ENTRY": "Ligament, Lateral", "MN": "A10.165.669.514.162", "MH_TH": "NLM (1994)", "ST": "T023", "AN": "artic ligaments of extremities; coord IM with specific joint or bone (IM)", "PI": "Ligaments, Articular (1968-1993)", "MS": "A number of ligaments on either side of, and serving as a radius of movement of, a joint having a hingelike movement. They occur at the elbow, knee, wrist, metacarpo- and metatarsophalangeal, proximal interphalangeal, and distal interphalangeal joints of the hands and feet. (Stedman, 25th ed)", "PM": "94", "HN": "94", "MR": "20170620", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017885"}, {"RECTYPE": "D", "MH": "Durapatite", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hydroxylapatite|T121|T122|T197|NON|EQV|FDA SRS (2014)|NLM (1994)|921026|abbbcdeef", "ENTRY": "Ossein Hydroxyapatite Compound", "MN": "D01.695.625.675.650.075.025.300.150", "PA": "Biocompatible Materials", "MH_TH": "USAN (1976)", "ST": "T197", "N1": "Hydroxylapatite (Ca5(OH)(PO4)3)", "RN": "91D9GV0Z28", "RR": "1306-06-5 (Durapatite)", "AN": "mineral component of bones & teeth; used as a biocompatible material", "PI": "Hydroxyapatites (1981-1993)", "MS": "The mineral component of bones and teeth; it has been used therapeutically as a prosthetic aid and in the prevention and treatment of osteoporosis.", "OL": "use DURAPATITE (NM) to search HYDROXYAPATITE 1981-93", "PM": "94; HYDROXYAPATITE was indexed under HYDROXYAPATITES 1981-93", "HN": "94; was HYDROXYAPATITE (NM) 1981-93", "MR": "20130708", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017886"}, {"RECTYPE": "D", "MH": "Ossification of Posterior Longitudinal Ligament", "DE": "OPLL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Calcification of Posterior Longitudinal Ligament|T046|NON|EQV|NLM (1994)|921026|abcdef", "ENTRY": "Posterior Longitudinal Ligament Ossification|T046|NON|EQV|NLM (1994)|921123|abcdef", "MN": "C23.550.751.500", "MH_TH": "ORD (2010)", "ST": "T046", "PI": "Ossification, Heterotopic (1967-1993)", "MS": "A calcification of the posterior longitudinal ligament of the spinal column, usually at the level of the cervical spine. It is often associated with anterior ankylosing hyperostosis.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017887"}, {"RECTYPE": "D", "MH": "Medial Collateral Ligament, Knee", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Tibial Collateral Ligament|T023|NON|EQV|NLM (1994)|921026|abcdef", "ENTRY": "Tibiales, Ligamentum Collaterale", "MN": "A10.165.669.514.162.600", "MH_TH": "NLM (1994)", "ST": "T023", "AN": "an artic ligament between tibia & femur: do not confuse with PATELLAR LIGAMENT, between patella & tibia", "PI": "Ligaments, Articular (1968-1993)", "MS": "The ligament that travels from the medial epicondyle of the FEMUR to the medial margin and medial surface of the TIBIA. The medial meniscus is attached to its deep surface.", "PM": "94", "HN": "94", "MR": "20170620", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017888"}, {"RECTYPE": "D", "MH": "Exfoliation Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pseudoexfoliation Syndrome|T047|NON|EQV|NLM (1994)|OMIM (2013)|921026|abcdeef", "ENTRY": "Syndromes, Pseudoexfoliation", "MN": "C11.941.375.285", "FX": "Glaucoma, Open-Angle", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "shedding of pigment from the iris", "PI": "Lens, Crystalline (1966-1976)", "MS": "The deposition of flaky, translucent fibrillar material most conspicuous on the anterior lens capsule and pupillary margin but also in both surfaces of the iris, the zonules, trabecular meshwork, ciliary body, corneal endothelium, and orbital blood vessels. It sometimes forms a membrane on the anterior iris surface. Exfoliation refers to the shedding of pigment by the iris. (Newell, Ophthalmology, 7th ed, p380)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D017889"}, {"RECTYPE": "D", "MH": "Splenosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Splenoses", "MN": "C26.761.555.500", "MH_TH": "NLM (1994)", "ST": "T047", "PI": "Splenic Rupture (1966-1993)", "MS": "The spontaneous transplantation of splenic tissue to unusual sites after open splenic trauma, e.g., after automobile accidents, gunshot or stab wounds. The splenic pulp implants appear as red-blue nodules on the peritoneum, omentum, and mesentery, morphologically similar to multifocal pelvic endometriosis. (Segen, Dictionary of Modern Medicine, 1992)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160119", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017890"}, {"RECTYPE": "D", "MH": "Pharmacoepidemiology", "DE": "PHARMACOEPIDEMIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Epidemiology, Pharmaceutical|T062|T091|NON|EQV|NLM (1994)|921123|EPIDEMIOL PHARM|abbcdefv", "ENTRY": "Pharmaceutical Epidemiologies", "MN": "H02.628.413", "MH_TH": "NLM (1994)", "ST": "T091", "PI": "Pharmacology (1984-1993)", "MS": "The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. (Pharmacoepidemiol Drug Saf 1992;1(1); J Pharmacoepidemiol 1990;1(1))", "PM": "94", "HN": "94", "MR": "20090706", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017891"}, {"RECTYPE": "D", "MH": "Osmium Compounds", "DE": "OSMIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Osmium", "MN": "D01.640", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Osmium (1966-1993)", "MS": "Inorganic compounds that contain osmium as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017892"}, {"RECTYPE": "D", "MH": "Photopheresis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Photochemotherapy, Extracorporeal|T061|NON|EQV|NLM (1994)|921028|PHOTOCHEMOTHER EXTRACORPOREAL|abcdefv", "ENTRY": "Photopheresis, Extracorporeal", "MN": "E04.292.762", "MH_TH": "NLM (1994)", "ST": "T061", "AN": "a form of PUVA THERAPY", "PI": "Photochemotherapy (1984-1993)", "MS": "A process in which peripheral blood is exposed in an extracorporeal flow system to photoactivated 8-methoxypsoralen (METHOXSALEN) and ultraviolet light - a procedure known as PUVA THERAPY. Photopheresis is at present a standard therapy for advanced cutaneous T-cell lymphoma; it shows promise in the treatment of autoimmune diseases.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20150618", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017893"}, {"RECTYPE": "D", "MH": "Manganese Compounds", "DE": "MANGANESE CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TU UR", "ENTRY": "Compounds, Manganese", "MN": "D01.530", "EC": "toxicity:Manganese Poisoning", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Manganese (1966-1993)", "MS": "Inorganic chemicals that contain manganese as an integral part of the molecule.", "PM": "94", "HN": "94", "MR": "19991103", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017895"}, {"RECTYPE": "D", "MH": "Tobamovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Odontoglossum ringspot virus|T005|NON|NRW|NLM (2007)|060407|abcdef", "ENTRY": "Tobamoviruses", "MN": "B04.820.578.844", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12234", "RR": "txid12238", "PI": "RNA Viruses (1990-1993)", "MS": "A genus of plant viruses in which the virion is a rigid filament. Transmission is by mechanical inoculation or seed. The type species is TOBACCO MOSAIC VIRUS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017898"}, {"RECTYPE": "D", "MH": "Caudovirales", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.280.090", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid28883", "AN": "an order of tailed (caudo-) bacteriophages", "MS": "An order comprising three families of tailed bacteriophages: MYOVIRIDAE; PODOVIRIDAE; and SIPHOVIRIDAE.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017899"}, {"RECTYPE": "D", "MH": "Myoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.280.090.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10662", "AN": "coord with specific bacterium /virol or specific Archaea /virol", "PI": "Bacteriophages (1983-1993)", "MS": "A family of BACTERIOPHAGES and ARCHAEAL VIRUSES which are characterized by complex contractile tails.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930706", "DC": "1", "DX": "19940101", "UI": "D017900"}, {"RECTYPE": "D", "MH": "Bacteriophage P2", "DS": "BACTERIOPHAGE P 002", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Phage P2|T005|NON|EQV|NLM (1994)|921029|PHAGE P 002|abcdefs", "ENTRY": "Phages, P2", "MN": "B04.280.090.500.305", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10679", "PI": "Coliphages (1966-1993)", "MS": "A species of temperate bacteriophage in the genus P2-like viruses, family MYOVIRIDAE, which infects E. coli. It consists of linear double-stranded DNA with 19-base sticky ends.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017901"}, {"RECTYPE": "D", "MH": "Podoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "T7-like viruses|T005|NON|NRW|NLM (2002)|001213|T AACZ LIKE VIRUSES 07|abcdefs", "ENTRY": "T7 like viruses", "MN": "B04.280.090.700", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10744", "RR": "txid477967", "AN": "coord with specific bacterium /virol; note X refs; BACTERIOPHAGE T7 is also available", "PI": "Bacteriophages (1983-1993)", "MS": "A family of bacteriophages which are characterized by short, non-contractile tails.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017902"}, {"RECTYPE": "D", "MH": "Bacteriophage T3", "DS": "BACTERIOPHAGE T 003", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "T3 Phage|T005|NON|EQV|NLM (1994)|930113|T AAA PHAGE 03|abcdefs", "ENTRY": "T3 Phages", "MN": "B04.280.090.700.100", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10759", "PI": "Coliphages (1966-1993)", "MS": "Bacteriophage in the genus T7-like phages, of the family PODOVIRIDAE, which is very closely related to BACTERIOPHAGE T7.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D017903"}, {"RECTYPE": "D", "MH": "Mobiluncus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mobiluncus mulieris|T007|NON|NRW|NLM (1994)|921029|abcdef", "MN": "B03.510.460.400.400.049.049.589", "MH_TH": "NLM (1994)", "ST": "T007", "RN": "txid2050", "RR": "txid2052", "AN": "infection: coordinate IM with ACTINOMYCETALES INFECTIONS (IM)", "PI": "Bacteria, Anaerobic (1984-1993)", "MS": "A genus of gram-negative, anaerobic, rod-shaped bacteria. Its organisms are found in the human vagina, particularly in association with Gardnerella vaginalis in cases of bacterial vaginosis.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017904"}, {"RECTYPE": "D", "MH": "Phosphites", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphite|T104|NON|EQV|NLM (2021)|200207|abcdef", "MN": "D01.695.625.700.675", "MH_TH": "NLM (1994)", "ST": "T104", "RN": "0", "PI": "Phosphorous Acids (1968-1993)", "MS": "Inorganic salts or organic esters of phosphorous acid that contain the (3-)PO3 radical. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "94", "HN": "94", "MR": "20200527", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017905"}, {"RECTYPE": "D", "MH": "Siphoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "lambda-like viruses|T005|NON|NRW|NLM (2002)|001214|abcdef", "ENTRY": "lambda like viruses", "MN": "B04.280.090.800", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10699", "RR": "txid187218", "AN": "coord with specific bacterium /virol or specific Archaea /virol; note X refs; BACTERIOPHAGE LAMBDA is also available", "PI": "Bacteriophages (1984-1993)", "MS": "A family of BACTERIOPHAGES and ARCHAEAL VIRUSES which are characterized by long, non-contractile tails.", "PM": "1994", "HN": "1994", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017906"}, {"RECTYPE": "D", "MH": "Leviviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Pseudomonas phage 7s|T005|NON|NRW|NLM (2002)|010312|PSEUDOMONAS PHAGE 007 S|abcdefs", "ENTRY": "Mu 2, Phage", "MN": "B04.820.578.438", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11989", "RR": "txid767473", "AN": "coordinate with specific bacterium /virol", "MS": "A family of bacteriophages that infects enterobacteria, CAULOBACTER, and PSEUDOMONAS. The genome consists of linear, positive-sense single-stranded RNA.", "PM": "1994; for PHAGE MU 2 see RNA PHAGES 1980-2001", "HN": "1994; for PHAGE MU 2 use RNA PHAGES 1980-2001", "MR": "20200902", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017907"}, {"RECTYPE": "D", "MH": "Allolevivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Q beta Phage|T005|NON|NRW|NLM (1994)|930113|abcdef", "ENTRY": "Q beta, Phage", "MN": "B04.820.578.438.050", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12008", "RR": "txid39803", "AN": "coord with specific bacterium /virol", "MS": "A bacteriophage genus of the family LEVIVIRIDAE, whose viruses contain the longer version of the genome and have no separate cell lysis gene.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017908"}, {"RECTYPE": "D", "MH": "Levivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Pseudomonas phage PP7|T005|NON|NRW|NLM (2002)|010312|PSEUDOMONAS PHAGE PP 007|abcdefs", "ENTRY": "Phages, MS2", "MN": "B04.820.578.438.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11990", "RR": "txid12026", "AN": "coord with specific bacterium /virol", "MS": "A bacteriophage genus of the family LEVIVIRIDAE, whose viruses contain the short version of the genome and have a separate gene for cell lysis.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017909"}, {"RECTYPE": "D", "MH": "Cystoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Cystovirus|T005|NON|NRW|NLM (1994)|921030|abcdef", "MN": "B04.820.223.625", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10877", "RR": "txid10878", "AN": "coordinate with specific bacterium /virol", "MS": "A family of bacteriophages containing one genus (Cystovirus) with one member (BACTERIOPHAGE PHI 6).", "PM": "1994; for CYSTOVIRUS see BACTERIOPHAGE PHI 6 1994-2001", "HN": "1994; for CYSTOVIRUS use BACTERIOPHAGE PHI 6 1994-2001", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017910"}, {"RECTYPE": "D", "MH": "Inoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.280.400", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10860", "AN": "a family of bacteriophages", "PI": "Bacteriophages (1984-1993)", "MS": "A family of rod-shaped or filamentous bacteriophages consisting of single-stranded DNA. There are two genera: INOVIRUS and PLECTROVIRUS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017911"}, {"RECTYPE": "D", "MH": "Inovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Filamentous Bacteriophages|T005|NON|EQV|NLM (2002)|010312|abcdef", "ENTRY": "Inoviruses", "MN": "B04.280.400.400", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10861", "AN": "coord with specific bacterium /virol", "PI": "Bacteriophages (1984-1993)", "MS": "A genus of filamentous bacteriophages of the family INOVIRIDAE. Organisms of this genus infect enterobacteria, PSEUDOMONAS; VIBRIO; and XANTHOMONAS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017912"}, {"RECTYPE": "D", "MH": "Plectrovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Plectroviruses", "MN": "B04.280.400.600", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10875", "AN": "a bacteriophage genus of the family Inoviridae", "MS": "A genus of bacteriophages of the family INOVIRIDAE. Organisms of this genus infect Acholeplasma and Spiroplasma.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017913"}, {"RECTYPE": "D", "MH": "Microviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.280.470", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10841", "AN": "coord with specific bacterium /virol", "PI": "Bacteriophages (1983-1993)", "MS": "A large family of lytic bacteriophages infecting enterobacteria; SPIROPLASMA; BDELLOVIBRIO; and CHLAMYDIA. It contains four genera: MICROVIRUS; Spiromicrovirus; Bdellomicrovirus; and Chlamydiamicrovirus.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017914"}, {"RECTYPE": "D", "MH": "Microvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Phage G4|T005|NON|NRW|NLM (1994)|930113|PHAGE G 004|abcdefs", "ENTRY": "Phages, G4", "MN": "B04.280.470.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10842", "RR": "txid10843", "AN": "a genus of bacteriophages of the family Microviridae", "MS": "A genus of bacteriophages of the family MICROVIRIDAE. The genome consists of isometric single-stranded DNA.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017915"}, {"RECTYPE": "D", "MH": "Tectiviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Tectivirus|T005|NON|NRW|NLM (1994)|921030|abcdef", "ENTRY": "Tectiviruses", "MN": "B04.280.900", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10656", "AN": "a family of lipid-containing bacteriophages", "MS": "A family of lipid-containing bacteriophages with double capsids which infect both gram-negative and gram-positive bacteria. It has one genus, Tectivirus.", "PM": "94", "HN": "94", "MR": "20200902", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017916"}, {"RECTYPE": "D", "MH": "Avihepadnavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Avihepadnaviruses", "MN": "B04.450.390.100", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10437", "AN": "from AVIan HEPAtotropic DNA virus; a genus of the family Hepadnaviridae infecting birds; infection: coord IM with HEPADNAVIRIDAE INFECTIONS (IM)", "MS": "A genus of HEPADNAVIRIDAE infecting birds but rarely causing clinical problems. Transmission is predominantly vertical. HEPATITIS B VIRUS, DUCK is the type species.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017917"}, {"RECTYPE": "D", "MH": "Orthohepadnavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hepatitis B Virus, Ground Squirrel|T005|NON|NRW|NLM (1994)|921103|abcdef", "ENTRY": "Orthohepadnaviruses", "MN": "B04.450.390.650", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10405", "RR": "txid10406", "AN": "infection: coord IM with HEPATITIS, VIRAL, HUMAN (IM) or HEPATITIS, VIRAL, ANIMAL (IM) + HEPADNAVIRIDAE INFECTIONS (IM)", "MS": "A genus of HEPADNAVIRIDAE causing HEPATITIS in humans, woodchucks (HEPATITIS B VIRUS, WOODCHUCK) and ground squirrels. Hepatitis B virus is the type species.", "PM": "1994", "HN": "1994", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017918"}, {"RECTYPE": "D", "MH": "Hepatitis B Virus, Woodchuck", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Woodchuck Hepatitis Virus|T005|NON|EQV|NLM (1994)|921104|abcdef", "ENTRY": "Woodchuck Hepatitis Viruses", "MN": "B04.450.390.650.460", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid35269", "AN": "a member of the genus Orthohepadnavirus; infection: coord IM with HEPATITIS B (IM)", "PI": "Hepatitis Viruses (1979-1993)", "MS": "An ORTHOHEPADNAVIRUS causing chronic liver disease and hepatocellular carcinoma in woodchucks. It closely resembles the human hepatitis B virus.", "PM": "97; was HEPATITIS VIRUS, WOODCHUCK 1994-96; HEPATITIS B VIRUS, WOODCHUCK was see HEPATITIS VIRUS, WOODCHUCK 1994-96", "HN": "97; was HEPATITIS VIRUS, WOODCHUCK 1994-96; HEPATITIS B VIRUS, WOODCHUCK was see HEPATITIS VIRUS, WOODCHUCK 1994-96", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017919"}, {"RECTYPE": "D", "MH": "Antiporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cation Exchange Proteins|T116|T123|NON|NRW|NLM (2002)|010319|abbcdef", "ENTRY": "Exchange Proteins, Cation", "MN": "D12.776.543.585.450.162", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1979-1993)", "MS": "Membrane transporters that co-transport two or more dissimilar molecules in the opposite direction across a membrane. Usually the transport of one ion or molecule is against its electrochemical gradient and is \"powered\" by the movement of another ion or molecule with its electrochemical gradient.", "PM": "1994; ANTIPORTERS was indexed under CARRIER PROTEINS 1980-1993", "HN": "1994; use ANTIPORTERS (NM) 1980-1993", "MR": "20200527", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017920"}, {"RECTYPE": "D", "MH": "Mastadenovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Mastadenoviruses", "MN": "B04.280.030.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10509", "AN": "infection: coord IM with ADENOVIRIDAE INFECTIONS (IM)", "PI": "Adenoviruses, Human (1983-1993)", "MS": "A genus of ADENOVIRIDAE that infects MAMMALS including humans and causes a wide range of diseases. The type species is Human adenovirus C (see ADENOVIRUSES, HUMAN).", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017921"}, {"RECTYPE": "D", "MH": "Sodium-Hydrogen Exchangers", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sodium-Hydrogen Antiporter|T116|T123|NON|EQV|NLM (1994)|990101|abbcdef", "ENTRY": "Sodium Proton Antiporters", "MN": "D12.776.543.585.937.828", "MH_TH": "NLM (2018)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1980-1993)", "MS": "A family of plasma membrane exchange glycoprotein antiporters that transport sodium ions and protons across lipid bilayers. They have critical functions in intracellular pH regulation, cell volume regulation, and cellular response to many different hormones and mitogens.", "OL": "use SODIUM-HYDROGEN ANTIPORTER (NM) to search SODIUM-HYDROGEN EXCHANGERS 1980-2017", "PM": "2018; SODIUM-HYDROGEN EXCHANGERS was indexed under CARRIER PROTEINS 1980-93", "HN": "2018 (1994); was SODIUM-HYDROGEN ANTIPORTER (NM) 1980-2017", "MR": "20170307", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017923"}, {"RECTYPE": "D", "MH": "Nucleopolyhedroviruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Nucleopolyhedrovirus|T005|NON|EQV|NLM (1994)|990101|abcdef", "ENTRY": "Viruses, Nuclear Polyhedrosis", "MN": "B04.525.100.500", "MH_TH": "NLM (2020)", "ST": "T005", "RR": "txid558019", "AN": "coordinate with specific insect /virol", "PI": "Baculoviridae (1973-1993)", "MS": "Genera of the family BACULOVIRIDAE, characterized by the formation of crystalline, polyhedral occlusion bodies in the host cell nucleus. Nucleopolyhedrovirus is the common name for viruses from the Alphabaculovirus, Deltabaculovirus, or Gammabaculovirus genera.", "PM": "2020; see NUCLEOPOLYHEDROVIRUS 1997-2019; see NUCLEAR POLYHEDROSIS VIRUS 1994-1996, see BACULOVIRIDAE 1991-1993, see POLYHEDROSIS VIRUSES 1975-1990; see POLYHEDROSIS VIRUSES 1978-1990; see INSECT VIRUSES 1973-1977", "HN": "2020 (1994); for NUCLEAR POLYHEDROSIS VIRUSES use BACULOVIRIDAE 1991-1993; use POLYHEDROSIS VIRUSES 1975-1990; use INSECT VIRUSES 1973-1977", "MR": "20200902", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D017924"}, {"RECTYPE": "D", "MH": "Circovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Circovirus, Porcine|T005|NON|NRW|NLM (1994)|930224|abcdef", "ENTRY": "Porcine Circoviruses", "MN": "B04.280.120.150", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid39725", "RR": "txid77856", "AN": "infection: coordinate IM with CIRCOVIRIDAE INFECTIONS (IM)", "PI": "DNA Viruses (1986-1993)", "MS": "A genus of the family CIRCOVIRIDAE that infects SWINE; PSITTACINES; and non-psittacine BIRDS. Species include Beak and feather disease virus causing a fatal disease in psittacine birds, and Porcine circovirus causing postweaning multisystemic wasting syndrome in pigs (PORCINE POSTWEANING MULTISYSTEMIC WASTING SYNDROME).", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017925"}, {"RECTYPE": "D", "MH": "Calicivirus, Feline", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Feline Calicivirus|T005|NON|EQV|NLM (1994)|150623|abcdef", "MN": "B04.820.578.298.887.150", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11978", "AN": "infection: coord IM with CALICIVIRIDAE INFECTIONS (IM)", "PI": "Picornaviridae (1972-1975)", "MS": "A species of the genus VESIVIRUS infecting cats. Transmission occurs via air and mechanical contact.", "OL": "use CALICIVIRIDAE to search FELINE CALICIVIRUSES 1978-92 & FELINE CALICIVIRUS 1975-78", "PM": "94; FELINE CALICIVIRUSES was see CALICIVIRIDAE 1978-92; FELINE CALICIVIRUS was see under CALICIVIRUSES 1975-78", "HN": "94; FELINE CALICIVIRUSES was see CALICIVIRIDAE 1978-92; FELINE CALICIVIRUS was see under CALICIVIRUSES 1975-78", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017927"}, {"RECTYPE": "D", "MH": "Vesicular exanthema of swine virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "VESV|T005|ABB|EQV|NLM (1994)|921112|abcdef", "MN": "B04.820.578.298.887.900", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid35612", "RR": "txid11982", "PI": "Picornaviridae (1966-1978)", "MS": "The type species of the genus VESIVIRUS infecting pigs. The resulting infection is an acute febrile disease which is clinically indistinguishable from FOOT AND MOUTH DISEASE. Transmission is by contaminated food.", "PM": "1994; see CALICIVIRIDAE 1993; for SAN MIGUEL SEA LION VIRUSES use CALICIVIRUS 1994-2001", "HN": "1994; use CALICIVIRIDAE 1993; for SAN MIGUEL SEA LION VIRUSES use CALICIVIRIDAE 1994-2001", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017928"}, {"RECTYPE": "D", "MH": "Hemorrhagic Disease Virus, Rabbit", "DE": "HEMORRHAGIC DIS VIRUS RABBIT", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Rabbit hemorrhagic disease virus|T005|NON|EQV|NLM (1994)|921113|RABBIT HEMORRHAGIC DIS VIRUS|abcdefv", "ENTRY": "Rabbit Haemorrhagic Disease Virus|T005|NON|EQV|NLM (1994)|921113|RABBIT HAEMORRHAGIC DIS VIRUS|abcdefv", "MN": "B04.820.578.298.500.380", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11976", "AN": "infection: coord IM with CALICIVIRIDAE INFECTIONS (IM)", "PI": "Caliciviridae (1991-1993)", "MS": "A species in the genus LAGOVIRUS which causes hemorrhagic disease, including hemorrhagic septicemia, in rabbits.", "OL": "use CALICIVIRIDAE to search RABBIT HEMORRHAGIC DISEASE VIRUS 1993", "PM": "94; RABBIT HEMORRHAGIC DISEASE VIRUS was see CALICIVIRIDAE 1993", "HN": "94; RABBIT HEMORRHAGIC DISEASE VIRUS was see CALICIVIRIDAE 1993", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017929"}, {"RECTYPE": "D", "MH": "Genes, Reporter", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Reporter Genes|T028|NON|EQV|NLM (1994)|921113|abcdef", "ENTRY": "Reporter Gene", "MN": "G05.360.340.024.340.435", "MH_TH": "NLM (1994)", "ST": "T028", "PI": "Promoter Regions (Genetics) (1987-1993)", "MS": "Genes whose expression is easily detectable and therefore used to study promoter activity at many positions in a target genome. In recombinant DNA technology, these genes may be attached to a promoter region of interest.", "PM": "1994", "HN": "1994", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017930"}, {"RECTYPE": "D", "MH": "DNA Primers", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oligonucleotide Primers|T114|NON|BRD|NLM (1994)|930106|abcdef", "ENTRY": "Primers, Oligonucleotide", "MN": "D27.720.470.530.600.223.600", "MH_TH": "NLM (1994)", "ST": "T114", "RN": "0", "AN": "short DNA seq important in transcription", "PI": "Oligodeoxyribonucleotides (1976-1993)", "MS": "Short sequences (generally about 10 base pairs) of DNA that are complementary to sequences of messenger RNA and allow reverse transcriptases to start copying the adjacent sequences of mRNA. Primers are used extensively in genetic and molecular biology techniques.", "PM": "94", "HN": "94", "MR": "20200527", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017931"}, {"RECTYPE": "D", "MH": "Peripheral Nervous System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Systems, Peripheral Nervous", "MN": "A08.800", "FX": "Neural Pathways", "MH_TH": "NLM (1994)", "ST": "T022", "PI": "Peripheral Nerves (1966-1993)", "MS": "The nervous system outside of the brain and spinal cord. The peripheral nervous system has autonomic and somatic divisions. The autonomic nervous system includes the enteric, parasympathetic, and sympathetic subdivisions. The somatic nervous system includes the cranial and spinal nerves and their ganglia and the peripheral sensory receptors.", "PM": "94", "HN": "94", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D017933"}, {"RECTYPE": "D", "MH": "Coronavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Coronaviruses|T005|NON|EQV|NLM (2021)|200407|abcdef", "ENTRY": "Rabbit Coronaviruses", "MN": "B04.820.578.500.540.150", "MH_TH": "NLM (1994)", "ST": "T005", "RR": "txid1898672", "MS": "A member of CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of vertebrates.", "PM": "1994", "HN": "1994", "MR": "20200902", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017934"}, {"RECTYPE": "D", "MH": "Cytochrome a Group", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochromes Type a|T116|T123|NON|EQV|NLM (2004)|030331|abbcdef", "ENTRY": "Heme a Cytochromes", "MN": "D12.776.422.220.175", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "AN": "spell in titles & translations with lowercase a: cytochrome a; do not confuse with CYTOCHROMES A", "PI": "Cytochromes (1979-1993)", "MS": "Cytochromes (electron-transporting proteins) in which the heme prosthetic group is heme a, i.e., the iron chelate of cytoporphyrin IX. (From Enzyme Nomenclature, 1992, p539)", "PM": "2004; see CYTOCHROME A 1994-2003, see CYTOCHROMES 1979-2003", "HN": "2004(1994); use CYTOCHROME A (NM) 1979-1993", "MR": "20030709", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017936"}, {"RECTYPE": "D", "MH": "Cytochrome d Group", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochromes d|T116|T126|NON|EQV|NLM (2004)|030403|abbcdef", "MN": "D12.776.422.220.300", "MH_TH": "NLM (2004)", "ST": "T126", "N1": "Cytochrome-d", "RN": "9035-36-3", "AN": "spell in titles & translations with lowercase d: cytochrome d", "PI": "Cytochromes (1979-1993)", "MS": "Cytochromes (electron-transporting proteins) with a tetrapyrrolic chelate of iron as a prosthetic group in which the degree of conjugation of double bonds is less than in porphyrin. (From Enzyme Nomenclature, 1992, p539)", "PM": "2004; see CYTOCHROME D 1994-2003, see CYTOCHROMES 1979-1993", "HN": "2004(1994)", "MR": "20030709", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017937"}, {"RECTYPE": "D", "MH": "Coronavirus, Bovine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Coronaviruses, Bovine", "MN": "B04.820.578.500.540.150.113.500.750", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11128", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS", "PI": "Coronaviridae (1977-1993)", "MS": "A species of CORONAVIRUS infecting neonatal calves, presenting as acute diarrhea, and frequently leading to death.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017938"}, {"RECTYPE": "D", "MH": "Coronavirus, Canine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Coronaviruses, Canine", "MN": "B04.820.578.500.540.150.075.500.250", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11153", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS ", "PI": "Coronaviridae (1976-1993)", "MS": "A species of CORONAVIRUS infecting dogs. Onset of symptoms is usually sudden and includes vomiting, diarrhea, and dehydration.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017939"}, {"RECTYPE": "D", "MH": "Coronavirus, Rat", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Rat Coronavirus|T005|NON|EQV|NLM (1994)|150623|abcdef", "MN": "B04.820.578.500.540.150.113.625", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid31632", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS", "PI": "Coronaviridae (1977-1993)", "MS": "A species of CORONAVIRUS causing pneumonia in newborn rats but a clinically inapparent infection in adults. It is separate but antigenically related to MURINE HEPATITIS VIRUS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017941"}, {"RECTYPE": "D", "MH": "Nitric Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Nitric", "MN": "D01.625.525", "PA": "Explosive Agents", "MH_TH": "NLM (1994)", "ST": "T197", "N1": "Nitric acid", "RN": "411VRN1TV4", "RR": "7697-37-2 (Nitric Acid)", "AN": "do not confuse with NITROUS ACID", "PI": "Nitrates (1980-1993)", "MS": "Nitric acid (HNO3). A colorless liquid that is used in the manufacture of inorganic and organic nitrates and nitro compounds for fertilizers, dye intermediates, explosives, and many different organic chemicals. Continued exposure to vapor may cause chronic bronchitis; chemical pneumonitis may occur. (From Merck Index, 11th ed)", "OL": "use NITRIC ACID (NM) to search NITRIC ACID 1980-93", "PM": "94; NITRIC ACID was indexed under NITRATES 1980-93", "HN": "94; was NITRIC ACID (NM) 1974-93", "MR": "20130708", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017942"}, {"RECTYPE": "D", "MH": "Cardiovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Cardioviruses", "MN": "B04.820.578.750.170", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12103", "PI": "Picornaviridae (1978-1993)", "MS": "A genus of the family PICORNAVIRIDAE causing encephalitis and myocarditis in rodents. ENCEPHALOMYOCARDITIS VIRUS is the type species.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017943"}, {"RECTYPE": "D", "MH": "Columbia SK virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "SK virus, Columbia", "MN": "B04.820.578.750.170.200.150", "MH_TH": "NLM (1994)", "ST": "T005", "AN": "infection: coord IM with CARDIOVIRUS INFECTIONS (IM)", "PI": "Encephalomyocarditis Virus (1979-1993)", "MS": "A strain of ENCEPHALOMYOCARDITIS VIRUS, a species of CARDIOVIRUS, that infects rodents.", "OL": "use ENCEPHALOMYOCARDITIS VIRUS to search COLUMBIA-SK VIRUSES 1966-93", "PM": "94; was COLUMBIA-SK VIRUSES see ENCEPHALOMYOCARDITIS VIRUSES 1979-93; was see under ENCEPHALOMYOCARDITIS VIRUSES 1965-78", "HN": "94; was COLUMBIA-SK VIRUSES see ENCEPHALOMYOCARDITIS VIRUSES 1979-93; was see under ENCEPHALOMYOCARDITIS VIRUSES 1965-78", "MR": "20200902", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D017944"}, {"RECTYPE": "D", "MH": "Theilovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Vilyuisk human encephalomyelitis virus|T005|EPO|NRW|NLM (2002)|010424|VILYUISK HUMAN ENCEPH VIRUS|abcdefv", "ENTRY": "Theiloviruses", "MN": "B04.820.578.750.170.800", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid204711", "RR": "txid12571", "AN": "do not confuse x-Ref ENCEPHALOMYELITIS VIRUS, MURINE, THEILER with ENCEPHALOMYELITIS VIRUS, MURINE, also a Cardiovirus; infection: coord IM with CARDIOVIRUS INFECTIONS (IM) or POLIOMYELITIS (IM); infection may also be a model for multiple sclerosis", "PI": "Enterovirus (1975-1993)", "MS": "A species of CARDIOVIRUS which contains three strains: Theiler's murine encephalomyelitis virus, Vilyuisk human encephalomyelitis virus, and Rat encephalomyelitis virus.", "PM": "2002; see THEILER MURINE ENCEPHALOMYELITIS VIRUS 1999-2001, see THEILER'S MURINE ENCEPHALOMYELITIS VIRUS 1997-1998, see POLIOVIRUSES, MURINE 1994-1996; for THEILER'S VIRUS see ENCEPHALOMYELITIS VIRUS, MURINE 1992-1993", "HN": "2002(1994); for THEILER'S VIRUS use ENCEPHALOMYELITIS, MURINE 1992-1993", "MR": "20200902", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D017945"}, {"RECTYPE": "D", "MH": "Retinal Rod Photoreceptor Cells", "DE": "RETINAL ROD PHOTORECEPT CELLS", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Rods (Retina)|T025|NON|EQV|NLM (1994)|990101|RODS|RODS|abcdefsv", "ENTRY": "Rods, Retinal", "MN": "A11.671.650.915.937.670.650", "MH_TH": "NLM (2009)", "ST": "T025", "PI": "Rods and Cones (1966-1993)", "MS": "Photosensitive afferent neurons located in the peripheral retina, with their density increases radially away from the FOVEA CENTRALIS. Being much more sensitive to light than the RETINAL CONE CELLS, the rod cells are responsible for twilight vision (at scotopic intensities) as well as peripheral vision, but provide no color discrimination.", "PM": "2009; see RODS (RETINA) 1994-2008", "HN": "2009 (1994)", "MR": "20150709", "DA": "19930616", "DC": "1", "DX": "19940101", "UI": "D017948"}, {"RECTYPE": "D", "MH": "Retinal Cone Photoreceptor Cells", "DE": "RETINAL CONE PHOTORECEPT CELLS", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Cones (Retina)|T025|NON|EQV|NLM (1994)|990101|CONES|abcdefv", "ENTRY": "Retinal Cones", "MN": "A11.671.650.915.937.670.100", "MH_TH": "NLM (2009)", "ST": "T025", "PI": "Rods and Cones (1966-1993)", "MS": "Photosensitive afferent neurons located primarily within the FOVEA CENTRALIS of the MACULA LUTEA. There are three major types of cone cells (red, blue, and green) whose photopigments have different spectral sensitivity curves. Retinal cone cells operate in daylight vision (at photopic intensities) providing color recognition and central visual acuity.", "PM": "2009; see CONES (RETINA) 1994-2008", "HN": "2009 (1994)", "MR": "20150709", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017949"}, {"RECTYPE": "D", "MH": "Ganglia, Sensory", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Sensory Ganglia|T023|NON|EQV|NLM (1994)|921120|abcdef", "ENTRY": "Sensory Ganglion", "MN": "A08.800.350", "MH_TH": "NLM (1994)", "ST": "T023", "AN": "ganglia of the peripheral nerv syst", "MS": "Clusters of neurons in the somatic peripheral nervous system which contain the cell bodies of sensory nerve axons. Sensory ganglia may also have intrinsic interneurons and non-neuronal supporting cells.", "PM": "94", "HN": "94", "MR": "19940411", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017950"}, {"RECTYPE": "D", "MH": "Antigen Presentation", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Antigen Processing|T043|NON|NRW|NLM (1994)|921120|abcdef", "ENTRY": "Antigen Processings", "MN": "G12.450.050.400.070", "FX": "Immunological Synapses", "MH_TH": "NLM (1994)", "ST": "T043", "AN": "process whereby an antigen is made recognizable to a lymphocyte", "PI": "Macrophages/immunology (1981-1993)", "MS": "The process by which antigen is presented to lymphocytes in a form they can recognize. This is performed by antigen presenting cells (APCs). Some antigens require processing before they can be recognized. Antigen processing consists of ingestion and partial digestion of the antigen by the APC, followed by presentation of fragments on the cell surface. (From Rosen et al., Dictionary of Immunology, 1989)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017951"}, {"RECTYPE": "D", "MH": "Ganglia, Invertebrate", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Invertebrate Ganglia|T023|NON|EQV|NLM (1994)|921120|abcdef", "ENTRY": "Invertebrate Ganglions", "MN": "A13.408", "MH_TH": "NLM (1994)", "ST": "T023", "PI": "Ganglia (1966-1993)", "MS": "Clusters of neuronal cell bodies in invertebrates. Invertebrate ganglia may also contain neuronal processes and non-neuronal supporting cells. Many invertebrate ganglia are favorable subjects for research because they have small numbers of functional neuronal types which can be identified from one animal to another.", "PM": "94", "HN": "94", "MR": "20040707", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017952"}, {"RECTYPE": "D", "MH": "Isocyanates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isocyanate|T109|NON|EQV|NLM (2021)|200225|abcdef", "MN": "D02.500", "MH_TH": "NLM (1994)", "ST": "T109", "RN": "0", "PI": "Cyanates (1966-1993)", "MS": "Organic compounds that contain the -NCO radical.", "OL": "use CYANATES to search ISOCYANATES 1993", "PM": "94; ISOCYANATES was see CYANATES 1993", "HN": "94; ISOCYANATES was see CYANATES 1993", "MR": "20200527", "DA": "19930216", "DC": "1", "DX": "19940101", "UI": "D017953"}, {"RECTYPE": "D", "MH": "Africa South of the Sahara", "AQ": "EH EP", "PRINT ENTRY": "Sub-Saharan Africa|T083|NAM|EQV|NLM (1994)|921123|abcdef", "ENTRY": "Subsaharan Africa|T083|NAM|EQV|NLM (1994)|921123|abcdef", "MN": "Z01.058.290", "MH_TH": "NLM (1994)", "ST": "T083", "AN": "all of Africa except Algeria, Egypt, Libya, Morocco, Tunisia", "MS": "All of Africa except Northern Africa (AFRICA, NORTHERN) including ANGOLA; BENIN; BOTSWANA; BURKINA FASO; CABO VERDE; CAMEROON; CENTRAL AFRICAN REPUBLIC; CHAD; CONGO; COTE D'IVOIRE; DEMOCRATIC REPUBLIC OF THE CONGO; DJIBOUTI; EQUATORIAL GUINEA; ERITREA; ESWATINI; ETHIOPIA; GABON; GAMBIA; GHANA; GUINEA; GUINEA-BISSAU; KENYA; LESOTHO; LIBERIA; MALAWI; MALI; MAURITANIA; MOZAMBIQUE; NAMIBIA; NIGER; NIGERIA; RWANDA; SAO TOME AND PRINCIPE; SENEGAL; SIERRA LEONE; SOMALIA; SOUTH AFRICA; SOUTH SUDAN; SUDAN; TANZANIA; TOGO; UGANDA; ZAMBIA; and ZIMBABWE.", "HN": "1994", "MR": "20220708", "DA": "19930603", "DC": "4", "DX": "19940101", "UI": "D017954"}, {"RECTYPE": "D", "MH": "Poliovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Leon Virus|T005|EPO|NRW|NLM (1994)|921124|abcdef", "ENTRY": "Polioviruses|T005|NON|EQV|NLM (1966)|990101|abcdef", "MN": "B04.820.578.750.284.184.500", "MH_TH": "NLM (2002)", "ST": "T005", "RR": "txid12086", "PI": "Polioviruses (1966-1993)", "MS": "A species of ENTEROVIRUS which is the causal agent of POLIOMYELITIS in humans. Three serotypes (strains) exist. Transmission is by the fecal-oral route, pharyngeal secretions, or mechanical vector (flies). Vaccines with both inactivated and live attenuated virus have proven effective in immunizing against the infection.", "PM": "2002; see POLIOVIRUSES, HUMAN 1-3 1994-2001; for BRUNHILDE VIRUS see POLIOVIRUS 1976-1993; POLIOVIRUSES was also a heading 1994-2006", "HN": "2002 (1994); POLIOVIRUSES was also a heading 1994-2006", "MR": "20200902", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D017955"}, {"RECTYPE": "D", "MH": "Photoreceptor Cells, Invertebrate", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Photoreceptors, Invertebrate|T025|NON|EQV|NLM (1994)|990101|PHOTORECEPT INVERTEBRATE|abcdefv", "ENTRY": "Photoreceptor, Invertebrate", "MN": "A13.750", "MH_TH": "NLM (2009)", "ST": "T025", "PI": "Photoreceptors (1966-1993)", "MS": "Specialized cells in the invertebrates that detect and transduce light. They are predominantly rhabdomeric with an array of photosensitive microvilli. Illumination depolarizes invertebrate photoreceptors by stimulating Na+ influx across the plasma membrane.", "PM": "2009; see PHOTORECEPTORS, INVERTEBRATE 1994-2008", "HN": "2009 (1994)", "MR": "20080708", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017956"}, {"RECTYPE": "D", "MH": "Hepatitis A Virus, Human", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human hepatitis A virus|T005|NON|EQV|NLM (1994)|930112|abcdef", "MN": "B04.820.578.750.400.410.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid208726", "PI": "Hepatovirus (1966-1993)", "MS": "A strain of HEPATITIS A VIRUS which causes hepatitis in humans. The virus replicates in hepatocytes and is presumed to reach the intestine via the bile duct. Transmission occurs by the fecal-oral route.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017957"}, {"RECTYPE": "D", "MH": "Lentiviruses, Primate", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Primate Immunodeficiency Viruses|T005|NON|EQV|NLM (1994)|921125|PRIMATE IMMUNODEFIC VIRUSES|abcdefv", "ENTRY": "Viruses, Primate Immunodeficiency", "MN": "B04.820.650.589.650", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11652", "AN": "infection: coordinate with LENTIVIRUS INFECTIONS ", "MS": "A subgenus of LENTIVIRUS comprising viruses that produce immunodeficiencies in primates, including humans.", "PM": "97; was IMMUNODEFICIENCY VIRUSES, PRIMATE 1994-96", "HN": "97; was IMMUNODEFICIENCY VIRUSES, PRIMATE 1994-96", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017958"}, {"RECTYPE": "D", "MH": "Lentiviruses, Bovine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Bovine Lentiviruses|T005|NON|EQV|NLM (1994)|921125|abcdef", "ENTRY": "Lentivirus, Bovine", "MN": "B04.820.650.589.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11656", "AN": "a subgenus of the genus Lentivirus; infection: coord IM with LENTIVIRUS INFECTIONS (IM)", "MS": "A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in cattle.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D017960"}, {"RECTYPE": "D", "MH": "Lentiviruses, Equine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Equine Lentiviruses|T005|NON|EQV|NLM (1994)|921125|abcdef", "ENTRY": "Lentivirus, Equine", "MN": "B04.820.650.589.520", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11654", "AN": "a subgenus of the genus Lentivirus; infection: coord IM with LENTIVIRUS INFECTIONS (IM)", "MS": "A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in horses.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017961"}, {"RECTYPE": "D", "MH": "alpha-Linolenic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Linolenic Acid|T109|T123|NON|BRD|FDA SRS (2014)|NLM (1994)|921127|abbcdeef", "ENTRY": "alpha Linolenic Acid, Zinc Salt", "MN": "D10.251.355.337.100", "MH_TH": "NLM (1994)", "ST": "T123", "N1": "9,12,15-Octadecatrienoic acid, (Z,Z,Z)-", "RN": "0RBV727H71", "RR": "94138-91-7 (Li salt)", "PI": "Linolenic Acids (1980-1993)", "MS": "A fatty acid that is found in plants and involved in the formation of prostaglandins.", "PM": "1994; ALPHA-LINOLENIC ACID was indexed under LINOLENIC ACIDS 1980-1993", "HN": "1994 (1980)", "MR": "20180228", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017962"}, {"RECTYPE": "D", "MH": "Azithromycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrate, Azithromycin", "MN": "D02.540.576.500.992.050", "PA": "Anti-Bacterial Agents", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-, (2R-(2R*,3S*,4R*,5R*,8R*,10R*,11R*,12S*,13S*,14R*))-", "RN": "83905-01-5", "RR": "JTE4MNN1MD", "PI": "Erythromycin/analogs & derivatives (1987-1993)", "MS": "A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.", "OL": "use AZITHROMYCIN (NM) to search AZITHROMYCIN 1987-93", "PM": "94; AZITHROMYCIN was indexed under ERYTHROMYCIN/*analogs & derivatives 1987-93", "HN": "94; was AZITHROMYCIN (NM) 1987-93", "MR": "20160701", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017963"}, {"RECTYPE": "D", "MH": "Itraconazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R51211", "MN": "D03.383.606.530", "PA": "Cytochrome P-450 CYP3A Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3H-1,2,4-Triazol-3-one, 4-(4-(4-(4-((2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-2,4-dihydro-2-(1-methylpropyl)-", "RN": "304NUG5GF4", "RR": "84625-61-6 (Itraconazole)", "PI": "Ketoconazole/analogs & derivatives (1984-1993)", "MS": "A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.", "OL": "use ITRACONAZOLE (NM) to search ITRACONAZOLE 1984-93", "PM": "94; ITRACONAZOLE was indexed under KETOCONAZOLE/*analogs & derivatives 1984-93", "HN": "94; was ITRACONAZOLE (NM) 1984-93", "MR": "20170524", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017964"}, {"RECTYPE": "D", "MH": "gamma-Linolenic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "gamma Linolenic Acid, Zinc Salt", "MN": "D10.251.355.343.249", "MH_TH": "NLM (1994)", "ST": "T123", "N1": "6,9,12-Octadecatrienoic acid, (Z,Z,Z)-", "RN": "78YC2MAX4O", "RR": "86761-55-9", "AN": "ALPHA-LINOLENIC ACID is an omega-3 fatty acid", "PI": "Linolenic Acids (1980-1993)", "MS": "An omega-6 fatty acid produced in the body as the delta 6-desaturase metabolite of linoleic acid. It is converted to dihomo-gamma-linolenic acid, a biosynthetic precursor of monoenoic prostaglandins such as PGE1. (From Merck Index, 11th ed)", "OL": "use GAMMA-LINOLENIC ACID (NM) to search GAMMA-LINOLENIC ACID 1980-93", "PM": "94; GAMMA-LINOLENIC ACID was indexed under LINOLENIC ACIDS 1980-93", "HN": "94; was GAMMA-LINOLENIC ACID (NM) 1980-93", "MR": "20150623", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017965"}, {"RECTYPE": "D", "MH": "Pyramidal Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Pyramidal Neuron", "MN": "A11.671.790", "FX": "CA3 Region, Hippocampal", "MH_TH": "NLM (1994)", "ST": "T025", "MS": "Projection neurons in the CEREBRAL CORTEX and the HIPPOCAMPUS. Pyramidal cells have a pyramid-shaped soma with the apex and an apical dendrite pointed toward the pial surface and other dendrites and an axon emerging from the base. The axons may have local collaterals but also project outside their cortical region.", "PM": "94", "HN": "94", "MR": "20141121", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D017966"}, {"RECTYPE": "D", "MH": "Zinc Compounds", "DE": "ZINC CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Zinc", "MN": "D01.975", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Zinc (1966-1993)", "MS": "Inorganic compounds that contain zinc as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017967"}, {"RECTYPE": "D", "MH": "Vanadium Compounds", "DE": "VANADIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Vanadium", "MN": "D01.960", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Vanadium (1966-1993)", "MS": "Inorganic compounds that contain vanadium as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017968"}, {"RECTYPE": "D", "MH": "Lentiviruses, Feline", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Feline Lentiviruses|T005|NON|EQV|NLM (1994)|921204|abcdef", "ENTRY": "Lentivirus, Feline", "MN": "B04.820.650.589.530", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11655", "AN": "a subgenus of the genus Lentivirus; infection: coord IM with LENTIVIRUS INFECTIONS (IM)", "MS": "A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in cats.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017969"}, {"RECTYPE": "D", "MH": "Thorium Compounds", "DE": "THORIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Thorium", "MN": "D01.930", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Thorium (1966-1993)", "MS": "Inorganic compounds that contain thorium as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017970"}, {"RECTYPE": "D", "MH": "Tin Compounds", "DE": "TIN CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Tin", "MN": "D01.935", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Tin (1966-1993)", "MS": "Inorganic compounds that contain tin as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017971"}, {"RECTYPE": "D", "MH": "Lentiviruses, Ovine-Caprine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Ovine-Caprine Lentiviruses|T005|NON|EQV|NLM (1994)|921204|abcdef", "ENTRY": "Ovine-Caprine Lentivirus", "MN": "B04.820.650.589.600", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11653", "AN": "a subgenus of the genus Lentivirus; infection: coord IM with LENTIVIRUS INFECTIONS (IM)", "MS": "A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in sheep and goats.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017972"}, {"RECTYPE": "D", "MH": "Tungsten Compounds", "DE": "TUNGSTEN CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Tungsten", "MN": "D01.940", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Tungsten (1966-1993)", "MS": "Inorganic compounds that contain tungsten as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017973"}, {"RECTYPE": "D", "MH": "Uranium Compounds", "DE": "URANIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Uranium", "MN": "D01.950", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Uranium (1966-1993)", "MS": "Inorganic compounds that contain uranium as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017974"}, {"RECTYPE": "D", "MH": "Ruthenium Compounds", "DE": "RUTHENIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Ruthenium", "MN": "D01.765", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Ruthenium (1966-1993)", "MS": "Inorganic compounds that contain ruthenium as an integral part of the molecule.", "PM": "94", "HN": "94", "MR": "20190524", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017975"}, {"RECTYPE": "D", "MH": "Phosphorus Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphonous Acids|T104|NON|NRW|NLM (1994)|921217|abcdef", "ENTRY": "Acids, Phosphorus", "MN": "D01.695.625", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "do not confuse with PHOSPHORIC ACIDS", "PI": "Phosphorus (1966-1993)", "MS": "Inorganic acids that contain phosphorus as an integral part of the molecule.", "OL": "use PHOSPHORUS ACIDS to search PHOSPHINOUS ACIDS & PHOSPHONOUS ACIDS 1968-93", "PM": "94; PHOSPHINOUS ACIDS & PHOSPHONOUS ACIDS were headings 1968-93", "HN": "94; PHOSPHINOUS ACIDS & PHOSPHONOUS ACIDS were headings 1968-93", "DA": "19930628", "DC": "1", "DX": "19940101", "UI": "D017976"}, {"RECTYPE": "D", "MH": "Deltaretrovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "T-Cell Leukemia Viruses, Human|T005|NRW|NLM (1994)|921207|abdef", "ENTRY": "HTLV BLV Viruses", "MN": "B04.820.650.200", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid153136", "MS": "A genus in the family RETROVIRIDAE consisting of exogenous horizontally-transmitted viruses found in a few groups of mammals. Infections caused by these viruses include human B- or adult T-cell leukemia/lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), and bovine leukemia (ENZOOTIC BOVINE LEUKOSIS). The type species is LEUKEMIA VIRUS, BOVINE.", "PM": "2002; see HTLV-BLV VIRUSES 1994-2001; for HTLV VIRUSES see HTLV VIRUSES 1989-1993, see HUMAN T-CELL LEUKEMIA VIRUS 1984-1988; for HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUSES & LEUKEMIA VIRUSES, HUMAN T-CELL see HUMAN T-CELL LEUKEMIA VIRUS 1985-1988, see HTLV VIRUSES 1989-1993; for HUMAN T-CELL LEUKEMIA VIRUSES & T-CELL LEUKEMIA VIRUSES, HUMAN see HTLV VIRUSES 1989-1993", "HN": "2002 (1994); for HTLV VIRUSES use HTLV VIRUSES 1989-1993, use HUMAN T-CELL LEUKEMIA VIRUS 1984-1988; for HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUSES & LEUKEMIA VIRUSES, HUMAN T-CELL use HUMAN T-CELL LEUKEMIA VIRUS 1985-1988, use HTLV VIRUSES 1989-1993; for HUMAN T-CELL LEUKEMIA VIRUSES & T-CELL LEUKEMIA VIRUSES, HUMAN use HTLV VIRUSES 1989-1993", "MR": "20200902", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017977"}, {"RECTYPE": "D", "MH": "Receptors, Growth Factor", "DE": "RECEPT GROWTH FACTOR", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Trophic Factor Receptors|T116|T192|NON|REL|NLM (1994)|921207|TROPHIC FACTOR RECEPT|abbcdefv", "ENTRY": "Receptor, Trophic Factor", "MN": "D12.776.543.750.750.400", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Cell Surface (1980-1993)", "MS": "Cell surface receptors that bind growth or trophic factors with high affinity, triggering intracellular responses which influence the growth, differentiation, or survival of cells.", "PM": "94", "HN": "94", "MR": "20200527", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017978"}, {"RECTYPE": "D", "MH": "Gold Colloid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Colloidal Gold|T121|T197|NON|EQV|NLM (1994)|921208|abbcdef", "ENTRY": "Gold, Colloidal", "MN": "D01.379.400", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Gold (1986-1993)", "MS": "A suspension of metallic gold particles.", "PM": "94", "HN": "94", "MR": "20000622", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017979"}, {"RECTYPE": "D", "MH": "Receptors, Neurotransmitter", "DE": "RECEPT NEUROTRANSM", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Synaptic Receptors|T116|T192|NON|NRW|NLM (1994)|930129|SYNAPTIC RECEPT|abbcdefv", "ENTRY": "Receptors, Neuroregulator", "MN": "D12.776.543.750.720", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behavior of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses.", "OL": "use RECEPTORS, NEUROTRANSMITTER to search NEUROTRANSMITTER RECEPTORS & SYNAPTIC RECEPTORS 1991-93; NEUROHUMOR RECEPTORS, NEUROMEDIATOR RECEPTORS, NEUROMODULATOR RECEPTORS, NEUROREGULATOR RECEPTORS & RECEPTORS, NEUROHUMOR 1987-93, & RECEPTORS, SYNAPTIC 1970-93 (as Prov 1970-72)", "PM": "94; was see RECEPTORS, SYNAPTIC 1984-93; RECEPTORS, NEUROHUMOR was heading 1987-93; RECEPTORS, SYNAPTIC was heading 1973-93 (was SYNAPTIC RECEPTORS 1973-90); NEUROTRANSMITTER RECEPTORS & SYNAPTIC RECEPTORS were see RECEPTORS, SYNAPTIC 1991-93; NEUROHUMOR RECEPTORS, NEUROMEDIATOR RECEPTORS, NEUROMODULATOR RECEPTORS, & NEUROREGULATOR RECEPTORS were see RECEPTORS, NEUROHUMOR 1987-93", "HN": "94; was see RECEPTORS, SYNAPTIC 1984-93; RECEPTORS, NEUROHUMOR was heading 1987-93; RECEPTORS, SYNAPTIC was heading 1970-93; was SYNAPTIC RECEPTORS 1970-90 (Prov 1970-72); NEUROTRANSMITTER RECEPTORS & SYNAPTIC RECEPTORS were see RECEPTORS, SYNAPTIC 1991-93; NEUROHUMOR RECEPTORS, NEUROMEDIATOR RECEPTORS, NEUROMODULATOR RECEPTORS, & NEUROREGULATOR RECEPTORS were see RECEPTORS, NEUROHUMOR 1987-93", "MR": "20210630", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D017981"}, {"RECTYPE": "D", "MH": "Receptors, Biogenic Amine", "DE": "RECEPT BIOGENIC AMINE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Biogenic Amine Receptors|T116|T192|NON|EQV|NLM (1994)|921209|BIOGENIC AMINE RECEPT|abbcdefv", "ENTRY": "Receptor, Biogenic Amine", "MN": "D12.776.543.750.670", "FX": "Trace Amine-Associated Receptors", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general; prefer specifics", "MS": "Cell surface proteins that bind biogenic amines with high affinity and regulate intracellular signals which influence the behavior of cells. Biogenic amine is a chemically imprecise term which, by convention, includes the catecholamines epinephrine, norepinephrine, and dopamine, the indoleamine serotonin, the imidazolamine histamine, and compounds closely related to each of these.", "PM": "94", "HN": "94", "MR": "20230226", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D017982"}, {"RECTYPE": "D", "MH": "Receptors, Catecholamine", "DE": "RECEPT CATECHOLAMINE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Catecholamine Receptors|T116|T192|NON|EQV|NLM (1994)|921208|CATECHOLAMINE RECEPT|abbcdefv", "ENTRY": "Receptor, Catecholamine", "MN": "D12.776.543.750.720.330", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Adrenergic (1982-1993)", "MS": "Cell surface proteins that bind catecholamines with high affinity and trigger intracellular changes which influence the behavior of cells. The catecholamine messengers epinephrine, norepinephrine, and dopamine are synthesized from tyrosine by a common biosynthetic pathway.", "OL": "use RECEPTORS, CATECHOLAMINE (NM) to search CATECHOLAMINE RECEPTOR 1982-93", "PM": "94; CATECHOLAMINE RECEPTOR was indexed under RECEPTORS, ADRENERGIC 1982-93", "HN": "94; was CATECHOLAMINE RECEPTOR (NM) 1982-93", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017983"}, {"RECTYPE": "D", "MH": "Enoxaparin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "PK10169", "MN": "D09.698.373.400.300.200", "PA": "Fibrinolytic Agents", "MH_TH": "BAN (19XX)", "ST": "T121", "RN": "0", "MS": "Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed)", "OL": "use HEPARIN, LOW-MOLECULAR-WEIGHT to search ENOXAPARIN 1990-93", "PM": "92; was heading 1992-93; was see HEPARIN, LOW MOLECULAR WEIGHT 1990-91", "HN": "94; was heading 1992-93; was see HEPARIN, LOW-MOLECULAR-WEIGHT 1990-91", "MR": "20050630", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017984"}, {"RECTYPE": "D", "MH": "Dalteparin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tedelparin|T109|T121|NON|EQV|NLM (1994)|990101|abbcdef", "ENTRY": "Sodium, Dalteparin", "MN": "D09.698.373.400.300.150", "PA": "Fibrinolytic Agents", "MH_TH": "NLM (1996)", "ST": "T121", "RN": "S79O08V79F", "RR": "12M44VTJ7B", "PI": "Heparin, Low-Molecular-Weight (1988-1993)", "MS": "A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)", "PM": "2006(1994); see TEDELPARIN 1994-2005, see HEPARIN, LOW-MOLECULAR-WEIGHT 1992-1993", "HN": "2006(1994); use HEPARIN, LOW-MOLECULAR-WEIGHT 1992-1993", "MR": "20160701", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D017985"}, {"RECTYPE": "D", "MH": "Reticuloendotheliosis Viruses, Avian", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Chick syncytial virus|T005|NON|NRW|NLM (2002)|010502|abcdef", "ENTRY": "viruses, Chick syncytial", "MN": "B04.820.650.375.700", "MH_TH": "NLM (2002)", "ST": "T005", "RR": "txid353768", "AN": "infection: coordinate IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "MS": "A group of viruses in the genus GAMMARETROVIRUS comprising a few isolates from birds, with no known corresponding endogenous relatives.", "PM": "2002; see RETICULOENDOTHELIOSIS VIRUSES 1994-2001", "HN": "2002 (1994)", "MR": "20200902", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017986"}, {"RECTYPE": "D", "MH": "Gammaretrovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Viper retrovirus|T005|NON|NRW|NLM (2002)|010502|abcdef", "ENTRY": "Viper retroviruses", "MN": "B04.820.650.375", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid153135", "AN": "infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "MS": "A genus of RETROVIRIDAE comprising endogenous sequences in mammals, related RETICULOENDOTHELIOSIS VIRUSES, AVIAN, and a reptilian virus. Many species contain oncogenes and cause leukemias and sarcomas.", "PM": "2002; see RETROVIRUSES TYPE C, MAMMALIAN 1994-2001; for TUMOR VIRUSES, MURINE see TUMOR VIRUSES, MURINE 1996-2002", "HN": "2002 (1994)", "MR": "20200902", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017988"}, {"RECTYPE": "D", "MH": "Leukemia Virus, Gibbon Ape", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Gibbon ape leukemia virus|T005|NON|EQV|NLM (1994)|921209|abcdef", "ENTRY": "GALV|T005|ACR|EQV|NLM (2002)|010604|abcdef", "MN": "B04.820.650.805.510", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11840", "AN": "infection: coordinate with RETROVIRIDAE INFECTIONS + TUMOR VIRUS INFECTIONS + LEUKEMIA if pertinent ", "MS": "A species of GAMMARETROVIRUS causing leukemia in the gibbon ape. Natural transmission is by contact.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017989"}, {"RECTYPE": "D", "MH": "Densovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Parvoviruses, Insect|T005|NON|EQV|NLM (1994)|930212|abcdef", "ENTRY": "Parvovirus, Insect", "MN": "B04.525.150.150", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10806", "RR": "txid12524", "AN": "coord IM with specific insect /virol (IM)", "PI": "Parvoviridae (1987-1993)", "MS": "A genus of PARVOVIRIDAE, subfamily DENSOVIRINAE, comprising helper-independent viruses containing only two species. Junonia coenia densovirus is the type species.", "OL": "use PARVOVIRIDAE to search DENSOVIRUS 1992-93", "PM": "94; was see PARVOVIRIDAE 1992-93", "HN": "94; was see PARVOVIRIDAE 1992-93", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017990"}, {"RECTYPE": "D", "MH": "Parvovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Parvovirus, Raccoon|T005|NON|NRW|NLM (1994)|921210|abcdef", "ENTRY": "Rat Virus, Kilham", "MN": "B04.280.580.650.600", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid1506574", "RR": "txid12441", "AN": "general or unspecified; prefer specifics; note PARVOVIRUS B19, HUMAN is available; infection: coordinate IM with PARVOVIRIDAE INFECTIONS (IM)", "PI": "Parvoviridae (1974-1993)", "MS": "A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, infecting a variety of vertebrates including humans. Parvoviruses are responsible for a number of important diseases but also can be non-pathogenic in certain hosts. The type species is MINUTE VIRUS OF MICE.", "PM": "1994; see PARVOVIRIDAE 1992-1993; for LATENT RAT VIRUS see LATENT RAT VIRUS 1991-2001, see PARVOVIRIDAE 1981-1990, see PARVOVIRUSES 1975-1980; for PARVOVIRUS, RACCOON see PARVIRUSES, FELINE 1994-2001", "HN": "1994; use PARVOVIRIDAE 1992-1993; for LATENT RAT VIRUS use LATENT RAT VIRUS 1975-1993; for PARVOVIRUS, RACCOON use PARVIRUSES, FELINE 1994-2001", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017992"}, {"RECTYPE": "D", "MH": "Parvovirus, Canine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Parvoviruses, Canine", "MN": "B04.280.580.650.600.325.660", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10788", "AN": "infection: coordinate IM with PARVOVIRIDAE INFECTIONS (IM); do not confuse with CANINE MINUTE VIRUS; infection in cats: coordinate IM with FELINE PANLEUKOPENIA (IM); infection in mink: coordinate IM with MINK VIRAL ENTERITIS (IM)", "PI": "Parvoviridae (1979-1993)", "MS": "A species of the genus PARVOVIRUS and a host range variant of FELINE PANLEUKOPENIA VIRUS. It causes a highly infectious fulminating ENTERITIS in dogs producing high mortality. It is distinct from CANINE MINUTE VIRUS, a species in the genus BOCAVIRUS. This virus can also infect cats and mink.", "PM": "1994", "HN": "1994", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017993"}, {"RECTYPE": "D", "MH": "Iridovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Iridoviruses", "MN": "B04.525.400", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10487", "AN": "coordinate IM with specific insect /virol [IM]", "PI": "Iridoviridae (1979-1993)", "MS": "A genus of IRIDOVIRIDAE comprising small iridescent insect viruses. The infected larvae and purified virus pellets exhibit a blue to purple iridescence.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017994"}, {"RECTYPE": "D", "MH": "Ranavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Frog Viruses|T005|NON|EQV|NLM (1994)|921211|abcdef", "ENTRY": "Ranaviruses", "MN": "B04.280.410.700", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10492", "RR": "txid10493", "AN": "infection: coordinate IM with DNA VIRUS INFECTIONS [IM]", "PI": "Iridoviridae (1977-1993)", "MS": "A genus of IRIDOVIRIDAE which infects fish, amphibians and reptiles. It is non-pathogenic for its natural host, Rana pipiens, but is lethal for other frogs, toads, turtles and salamanders. Frog virus 3 is the type species.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D017995"}, {"RECTYPE": "D", "MH": "Entomopoxvirinae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Entomopoxviruses|T005|NON|EQV|NLM (1994)|921211|abcdef", "ENTRY": "Entomopoxvirus", "MN": "B04.525.250", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10284", "AN": "coord IM with specific insect /virol (IM)", "PI": "Poxviridae (1966-1993)", "MS": "A subfamily of POXVIRIDAE comprising poxviruses infecting insects including members of COLEOPTERA; DIPTERA; LEPIDOPTERA; and ORTHOPTERA.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017996"}, {"RECTYPE": "D", "MH": "Leukotriene C4", "DS": "LEUKOTRIENE C 04", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "LTC4|T109|ABB|EQV|FDA SRS (2014)|NLM (1994)|921214|LTC 04|abcdeefs", "ENTRY": "Leukotriene C 4", "MN": "D23.469.050.175.450.725.400", "MH_TH": "NLM (1994)", "ST": "T109", "N1": "Glycine, N-(S-(1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-N-L-gamma-glutamyl-L-cysteinyl)-, (R-(R*,S*-(E,E,Z,Z)))-", "RN": "2CU6TT9V48", "RR": "72025-60-6 (Leukotriene C4)", "PI": "SRS-A (1981-1993)", "MS": "The conjugation product of LEUKOTRIENE A4 and glutathione. It is the major arachidonic acid metabolite in macrophages and human mast cells as well as in antigen-sensitized lung tissue. It stimulates mucus secretion in the lung, and produces contractions of nonvascular and some VASCULAR SMOOTH MUSCLE. (From Dictionary of Prostaglandins and Related Compounds, 1990)", "OL": "use SRS-A to search LEUKOTRIENE C1, LEUKOTRIENE C4 & LEUKOTRIENES C 1983-93", "PM": "94; was see SRS-A 1983-93; LEUKOTRIENE C1 & LEUKOTRIENES C were see SRS-A 1983-93", "HN": "94; was see SRS-A 1983-93; LEUKOTRIENE C1 & LEUKOTRIENES C were see SRS-A 1983-93", "MR": "20150608", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017997"}, {"RECTYPE": "D", "MH": "Leukotriene D4", "DS": "LEUKOTRIENE D 04", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "LTD4|T109|ABB|EQV|NLM (1994)|930322|LTD 04|abcdefs", "ENTRY": "Leukotriene D 4", "MN": "D23.469.050.175.450.725.415", "MH_TH": "NLM (1994)", "ST": "T109", "N1": "Glycine, N-(S-(1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)-, (R-(R*,S*-(E,E,Z,Z)))-", "RN": "73836-78-9", "PI": "SRS-A (1982-1993)", "MS": "One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. (From Dictionary of Prostaglandins and Related Compounds, 1990)", "OL": "use SRS-A to search LEUKOTRIENE D4 & LEUKOTRIENES D 1983-93", "PM": "94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93", "HN": "94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93", "MR": "20150608", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D017998"}, {"RECTYPE": "D", "MH": "Leukotriene E4", "DS": "LEUKOTRIENE E 04", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "LTE4|T109|ABB|EQV|NLM (1994)|921214|abcdef", "ENTRY": "Leukotriene E 4", "MN": "D23.469.050.175.450.725.425", "MH_TH": "NLM (1994)", "ST": "T109", "N1": "7,9,11,14-Eicosatetraenoic acid, 6-((2-amino-2-carboxyethyl)thio)-5-hydroxy-, (5S-(5R*,6S*(S*),7E,9E,11Z,14Z))-", "RN": "75715-89-8", "PI": "SRS-A/analogs & derivatives (1983-1993)", "MS": "A biologically active principle of SRS-A that is formed from LEUKOTRIENE D4 via a peptidase reaction that removes the glycine residue. The biological actions of LTE4 are similar to LTC4 and LTD4. (From Dictionary of Prostaglandins and Related Compounds, 1990)", "OL": "use LEUKOTRIENE E4 (NM) to search LEUKOTRIENE E 1980-93", "PM": "94; LEUKOTRIENE E was indexed under SRS-A/*ANALOGS & DERIVATIVES 1983-93 & ARACHIDONIC ACIDS 1980-82", "HN": "94; was LEUKOTRIENE E (NM) 1980-93", "MR": "20150608", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D017999"}, {"RECTYPE": "D", "MH": "Receptors, Peptide", "DE": "RECEPT PEPTIDE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Peptide Receptors|T116|T192|NON|EQV|NLM (1994)|921214|PEPTIDE RECEPT|abbcdefv", "ENTRY": "Receptors, Peptide Hormone", "MN": "D12.776.543.750.750", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics; coordinate with specific peptide ", "PI": "Receptors, Cell Surface (1973-1993)", "MS": "Cell surface receptors that bind peptide messengers with high affinity and regulate intracellular signals which influence the behavior of cells.", "PM": "94", "HN": "94", "MR": "19970620", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018000"}, {"RECTYPE": "D", "MH": "Receptors, Bradykinin", "DE": "RECEPT BRADYKININ", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Bradykinin Receptors|T116|T192|NON|EQV|NLM (1994)|921215|BRADYKININ RECEPT|abbcdefv", "ENTRY": "Receptor, Bradykinin", "MN": "D12.776.543.750.750.555.220", "EC": "antagonists & inhibitors:Bradykinin Receptor Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "note specific subtypes", "PI": "Receptors, Neurotransmitter (1985-1993)", "MS": "Cell surface receptors that bind BRADYKININ and related KININS with high affinity and trigger intracellular changes which influence the behavior of cells. The identified receptor types (B-1 and B-2, or BK-1 and BK-2) recognize endogenous KALLIDIN; t-kinins; and certain bradykinin fragments as well as bradykinin itself.", "OL": "use RECEPTORS, BRADYKININ (NM) to search RECEPTORS, KININ 1980-93", "PM": "94; KININ RECEPTORS was indexed under RECEPTORS, SYNAPTIC 1985-93 & RECEPTORS, ENDOGENOUS SUBSTANCES 1980-84", "HN": "94; was KININ RECEPTOR (NM) 1980-93", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018002"}, {"RECTYPE": "D", "MH": "Receptors, Calcitonin", "DE": "RECEPT CALCITONIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Calcitonin Receptors|T116|T192|NON|EQV|NLM (1994)|921215|CALCITONIN RECEPT|abbcdefv", "ENTRY": "Receptor, Calcitonin", "MN": "D12.776.543.750.750.200", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (1974-1993)", "MS": "Cell surface proteins that bind calcitonin and trigger intracellular changes which influence the behavior of cells. Calcitonin receptors outside the nervous system mediate the role of calcitonin in calcium homeostasis. The role of calcitonin receptors in the brain is not well understood.", "OL": "use RECEPTORS, CALCITONIN (NM) to search CALCITONIN RECEPTOR 1981-93", "PM": "94; CALCITONIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-93", "HN": "94; was CALCITONIN RECEPTOR (NM) 1981-93", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018003"}, {"RECTYPE": "D", "MH": "Receptors, Bombesin", "DE": "RECEPT BOMBESIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Neuromedin B|T116|T192|NON|EQV|NLM (1994)|921215|RECEPT NEUROMEDIN B|abbcdefv", "ENTRY": "Receptors, Gastrin Releasing Peptide", "MN": "D12.776.543.750.750.555.200", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurotransmitter (1987-1993)", "MS": "Cell surface proteins that bind bombesin or closely related peptides with high affinity and trigger intracellular changes influencing the behavior of cells. Gastrin- releasing peptide (GRP); GRP 18-27 (neuromedin C), and neuromedin B are endogenous ligands of bombesin receptors in mammals.", "OL": "use RECEPTORS, BOMBESIN (NM) to search BOMBESIN RECEPTOR 1982-93 & NEUROMEDIN B RECEPTOR 1992-93", "PM": "94; BOMBESIN RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1987-93 & RECEPTORS, ENDOGENOUS SUBSTANCE 1982-86; NEUROMEDIN B RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1992-93", "HN": "94; was BOMBESIN RECEPTOR (NM) 1982-93; NEUROMEDIN B RECEPTOR was (NM) 1992-93", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018004"}, {"RECTYPE": "D", "MH": "Receptors, Vasoactive Intestinal Peptide", "DE": "RECEPT VASOACTIVE INTESTINAL PEPTIDE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Vasoactive Intestinal Peptide Receptors|T116|T192|NON|EQV|NLM (1994)|921216|VASOACTIVE INTESTINAL PEPTIDE RECEPT|abbcdefv", "ENTRY": "Receptor, VIP", "MN": "D12.776.543.750.750.555.915", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Gastrointestinal Hormone (1987-1993)", "MS": "Cell surface proteins that bind VASOACTIVE INTESTINAL PEPTIDE and PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE with high affinity and trigger intracellular changes which influence the behavior of cells.", "OL": "use RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE (NM) to search VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 1980-93", "PM": "94; VASOACTIVE INTESTINAL PEPTIDE RECEPTOR was indexed under RECEPTORS, GASTROINTESTINAL HORMONE 1987-93 & RECEPTORS, ENDOGENOUS SUBSTANCES 1980-86", "HN": "94; was VASOACTIVE INTESTINAL PEPTIDE RECEPTOR (NM) 1980-93", "MR": "20200617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018005"}, {"RECTYPE": "D", "MH": "Myogenic Regulatory Factors", "DE": "MYOGENIC REG FACTORS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myogenic Regulatory Factor|T116|T123|NON|EQV|NLM (2021)|200312|abbcdef", "ENTRY": "Regulatory Factors, Myogenic", "MN": "D12.776.930.125.750", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "PI": "Muscle Proteins (1989-1993)", "MS": "A family of muscle-specific transcription factors which bind to DNA in control regions and thus regulate myogenesis. All members of this family contain a conserved helix-loop-helix motif which is homologous to the myc family proteins. These factors are only found in skeletal muscle. Members include the myoD protein (MYOD PROTEIN); MYOGENIN; myf-5, and myf-6 (also called MRF4 or herculin).", "PM": "94", "HN": "94", "MR": "20200527", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018006"}, {"RECTYPE": "D", "MH": "Myogenin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.930.125.750.600", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "AN": "a myogenic regulatory factor controlling myogenesis", "PI": "Muscle Proteins (1989-1993)", "MS": "A myogenic regulatory factor that controls myogenesis. Myogenin is induced during differentiation of every skeletal muscle cell line that has been investigated, in contrast to the other myogenic regulatory factors that only appear in certain cell types.", "OL": "use MYOGENIN (NM) to search MYOGENIN 1989-93", "PM": "94; MYOGENIN was indexed under MUSCLE PROTEINS 1989-93", "HN": "94; was MYOGENIN (NM) 1989-93", "MR": "20050630", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018008"}, {"RECTYPE": "D", "MH": "Receptors, Glycine", "DE": "RECEPT GLYCINE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Strychnine-Sensitive Glycine Receptor|T116|T192|NON|NRW|NLM (2021)|200211|abbcdef", "ENTRY": "Strychnine Sensitive Glycine Receptor", "MN": "D12.776.543.750.720.200.470", "FX": "Glycine Plasma Membrane Transport Proteins", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurotransmitter (1985-1993)", "MS": "Cell surface receptors that bind GLYCINE with high affinity and trigger intracellular changes which influence the behavior of cells. Glycine receptors in the CENTRAL NERVOUS SYSTEM have an intrinsic chloride channel. GlyA receptor is sensitive to STRYCHNINE and localized in the post-synaptic membrane of inhibitory glycinergic neurons. GlyB receptor is insensitive to strychnine and associated with the excitatory NMDA receptor.", "PM": "1994; was GLYCINE RECEPTOR (NM) 1981-1993; for GLYCINE RECEPTOR ALPHA1 see under RECEPTORS, GLYCINE 1995-2020; for GLYCINE RECEPTOR ALPHA1 see under RECEPTORS, GLYCINE 1997-2020", "HN": "1994; was GLYCINE RECEPTOR (NM) 1981-1993; for GLYCINE RECEPTOR ALPHA1 was under RECEPTORS, GLYCINE 1995-2020; for GLYCINE RECEPTOR ALPHA1 was under RECEPTORS, GLYCINE 1997-2020", "MR": "20210209", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018009"}, {"RECTYPE": "D", "MH": "Receptors, Invertebrate Peptide", "DE": "RECEPT INVERTEBRATE PEPTIDE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Peptide, Invertebrate|T116|T192|NON|EQV|NLM (1994)|930416|RECEPT PEPTIDE INVERTEBRATE|abbcdefv", "ENTRY": "Receptor, Invertebrate Peptide", "MN": "D12.776.543.750.750.460", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (1973-1993)", "MS": "Cell surface receptors for invertebrate peptide hormones or neuropeptides.", "PM": "94", "HN": "94", "MR": "19970620", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018010"}, {"RECTYPE": "D", "MH": "Chalcogens", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Elements, Group 16", "MN": "D01.268.185", "MH_TH": "NLM (1994)", "ST": "T196", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "The elements OXYGEN; POLONIUM; SELENIUM; SULFUR; and TELLURIUM; that form group 16 (formerly group VI) of the periodic table.", "PM": "1998", "HN": "1998", "MR": "20050722", "DA": "19930826", "DC": "1", "DX": "19980101", "UI": "D018011"}, {"RECTYPE": "D", "MH": "Receptors, Neuropeptide", "DE": "RECEPT NEUROPEPTIDE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Neuropeptide Receptors|T116|T192|NON|EQV|NLM (1994)|921216|NEUROPEPTIDE RECEPT|abbcdefv", "ENTRY": "Receptor, Neuropeptide", "MN": "D12.776.543.750.750.555", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Neurotransmitter (1970-1993)", "MS": "Cell surface receptors that bind specific neuropeptides with high affinity and trigger intracellular changes influencing the behavior of cells. Many neuropeptides are also hormones outside of the nervous system.", "PM": "94", "HN": "94", "MR": "20190524", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018013"}, {"RECTYPE": "D", "MH": "Gene Transfer Techniques", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Transfer Techniques, Gene", "MN": "E05.393.350", "FX": "Genetic Therapy", "MH_TH": "NLM (1994)", "ST": "T062", "AN": "note category: do not confuse with GENE TRANSFER, HORIZONTAL", "PI": "Transfection (1988-1993)", "MS": "The introduction of functional (usually cloned) GENES into cells. A variety of techniques and naturally occurring processes are used for the gene transfer such as cell hybridization, LIPOSOMES or microcell-mediated gene transfer, ELECTROPORATION, chromosome-mediated gene transfer, TRANSFECTION, and GENETIC TRANSDUCTION. Gene transfer may result in genetically transformed cells and individual organisms.", "PM": "2001; see GENE TRANSFER 1994-2000; see TRANSFECTION 1988-93", "HN": "2001(1994); use TRANSFECTION 1988-93", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018014"}, {"RECTYPE": "D", "MH": "Receptors, Calcitonin Gene-Related Peptide", "DE": "RECEPT CALCITONIN GENE RELAT PEPTIDE", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, CGRP|T116|T192|ABX|EQV|NLM (1994)|921217|RECEPT CGRP|abbcdefv", "ENTRY": "Receptors, Calcitonin Gene Related Peptide", "MN": "D12.776.543.750.750.555.260", "EC": "antagonists & inhibitors:Calcitonin Gene-Related Peptide Receptor Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (1986-1993)", "MS": "Cell surface proteins that bind CALCITONIN GENE-RELATED PEPTIDE with high affinity and trigger intracellular changes which influence the behavior of cells. CGRP receptors are present in both the CENTRAL NERVOUS SYSTEM and the periphery. They are formed via the heterodimerization of the CALCITONIN RECEPTOR-LIKE PROTEIN and RECEPTOR ACTIVITY-MODIFYING PROTEIN 1.", "PM": "1994; see RECEPTORS, CALCITONIN 1986-1993", "HN": "1994; use RECEPTORS, CALCITONIN 1986-1993", "MR": "20180110", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018015"}, {"RECTYPE": "D", "MH": "Receptors, Parathyroid Hormone", "DE": "RECEPT PARATHYROID HORMONE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Parathyroid Hormone Receptors|T116|T192|NON|EQV|NLM (1994)|921217|PARATHYROID HORMONE RECEPT|abbcdefv", "MN": "D12.776.543.750.750.600", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Cell Surface (1980-1993)", "MS": "Cell surface proteins that bind PARATHYROID HORMONE with high affinity and trigger intracellular changes which influence the behavior of cells. Parathyroid hormone receptors on BONE; KIDNEY; and gastrointestinal cells mediate the hormone's role in calcium and phosphate homeostasis.", "OL": "use RECEPTORS, PARATHYROID HORMONE (NM) to search PARATHYROID HORMONE RECEPTOR 1980-93", "PM": "94; PARATHYROID HORMONE RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1980-93", "HN": "94; was PARATHYROID HORMONE RECEPTOR (NM) 1980-93", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018016"}, {"RECTYPE": "D", "MH": "Receptors, Pituitary Hormone-Regulating Hormone", "DE": "RECEPT PHRH", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Pituitary Hormone-Releasing Hormone|T116|T192|NON|NRW|NLM (1994)|921217|RECEPT PITUITARY HORMONE RELEASING HORMONE|abbcdefv", "ENTRY": "Receptors, Pituitary Hormone Releasing Hormone", "MN": "D12.776.543.750.750.700", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "MS": "Cell surface receptors that bind the hypothalamic hormones regulating pituitary cell differentiation, proliferation, and hormone synthesis and release, including the pituitary-releasing and release-inhibiting hormones. The pituitary hormone-regulating hormones are also released by cells other than hypothalamic neurons, and their receptors also occur on non-pituitary cells, especially brain neurons, where their role is less well understood. Receptors for dopamine, which is a prolactin release-inhibiting hormone as well as a common neurotransmitter, are not included here.", "PM": "94", "HN": "94", "MR": "19970620", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018017"}, {"RECTYPE": "D", "MH": "Arterivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Simian hemorrhagic fever virus|T005|NON|NRW|NLM (1997)|950912|abcdef", "ENTRY": "Arteriviruses", "MN": "B04.820.578.500.080.500", "MH_TH": "NLM (1994)", "ST": "T005", "RR": "txid38143", "MS": "A genus of the family ARTERIVIRIDAE, in the order NIDOVIRALES. The type species is EQUARTEVIRUS.", "PM": "94", "HN": "94", "MR": "20200902", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018018"}, {"RECTYPE": "D", "MH": "Receptors, Corticotropin-Releasing Hormone", "DE": "RECEPT CORTICOTROPIN RELEASING HORMONE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, CRH|T116|T192|EQV|NLM (1994)|921217|RECEPT CRH|abbdefv", "ENTRY": "Releasing-Hormone Receptors, Corticotropin", "MN": "D12.776.543.750.750.700.150", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurohumor (1986-1993)", "MS": "Cell surface proteins that bind corticotropin-releasing hormone with high affinity and trigger intracellular changes which influence the behavior of cells. The corticotropin releasing-hormone receptors on anterior pituitary cells mediate the stimulation of corticotropin release by hypothalamic corticotropin releasing factor. The physiological consequence of activating corticotropin-releasing hormone receptors on central neurons is not well understood.", "OL": "use RECEPTORS, CORTICOTROPIN-RELEASING HORMONE (NM) to search CORTICOTROPIN RELEASING HORMONE RECEPTOR 1983-93", "PM": "94; CORTICOTROPIN RELEASING HORMONE RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1986-93 & RECEPTORS, ENDOGENOUS SUBSTANCES 1983-86", "HN": "94; was CORTICOTROPIN RELEASING HORMONE RECEPTOR (NM) 1983-93", "MR": "20200527", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018019"}, {"RECTYPE": "D", "MH": "Lithium Compounds", "DE": "LITHIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Lithium", "MN": "D01.510", "PA": "Antimanic Agents", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Lithium (1966-1993)", "MS": "Inorganic compounds that contain lithium as an integral part of the molecule.", "PM": "94", "HN": "94", "MR": "20070709", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018020"}, {"RECTYPE": "D", "MH": "Lithium Chloride", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Chloride, Lithium", "MN": "D01.510.500", "PA": "Antimanic Agents", "MH_TH": "NLM (1994)", "ST": "T197", "N1": "Lithium chloride (LiCl)", "RN": "G4962QA067", "RR": "7447-41-8 (Lithium Chloride)", "AN": "in exper med as immunomodulator", "PI": "Lithium (1977-1993)", "MS": "A salt of lithium that has been used experimentally as an immunomodulator.", "OL": "use LITHIUM CHLORIDE (NM) to search LITHIUM CHLORIDE 1980-93", "PM": "94; LITHIUM CHLORIDE was indexed under LITHIUM & CHLORIDES 1977-93", "HN": "94; was LITHIUM CHLORIDE (NM) 1977-93", "MR": "20130708", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018021"}, {"RECTYPE": "D", "MH": "HIV Seronegativity", "DE": "HIV SERONEG", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "HTLV-III Seronegativity|T034|EQV|NLM (1994)|921218|HTLV WIII SERONEGATIVITY|HTLV III SERONEG|abdefsv", "ENTRY": "Seronegativity, HTLV-III", "MN": "G12.400", "FX": "HIV Seropositivity", "MH_TH": "NLM (1994)", "ST": "T034", "AN": "note category; HIV SEROPOSITIVITY is available", "PI": "HIV Seropositivity (1988-1993)", "MS": "Immune status consisting of non-production of HIV antibodies, as determined by various serological tests.", "OL": "use HIV SEROPOSITIVITY to search HIV SERONEGATIVITY & HTLV-III SERONEGATIVITY 1988-93", "PM": "94; was see HIV SEROPOSITIVITY 1988-93; HTLV-III SERONEGATIVITY was see HIV SEROPOSITIVITY 1988-93", "HN": "94; was see HIV SEROPOSITIVITY 1988-93; HTLV-III SERONEGATIVITY was see HIV SEROPOSITIVITY 1988-93", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018023"}, {"RECTYPE": "D", "MH": "Peer Review, Health Care", "DE": "PEER REV HEALTH CARE", "AQ": "ES LJ MT ST TD", "MN": "N05.715.680", "MH_TH": "NLM (1994)", "ST": "T058", "PI": "Peer Review (1971-1993)", "MS": "The concurrent or retrospective review by practicing physicians or other health professionals of the quality and efficiency of patient care practices or services ordered or performed by other physicians or other health professionals (From The Facts On File Dictionary of Health Care Management, 1988).", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20021106", "DA": "19921228", "DC": "1", "DX": "19940101", "UI": "D018024"}, {"RECTYPE": "D", "MH": "Receptors, Thyrotropin-Releasing Hormone", "DE": "RECEPT THYROTROPIN RELEASING HORMONE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Thyrotropin Releasing Hormone Receptors|T116|T192|NON|EQV|NLM (1994)|921221|THYROTROPIN RELEASING HORMONE RECEPT|abbcdefv", "ENTRY": "Thyrotropin-Releasing Hormone Receptors", "MN": "D12.776.543.750.750.700.840", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurotransmitter (1987-1993)", "MS": "Cell surface receptors that bind thyrotropin releasing hormone (TRH) with high affinity and trigger intracellular changes which influence the behavior of cells. Activated TRH receptors in the anterior pituitary stimulate the release of thyrotropin (thyroid stimulating hormone, TSH); TRH receptors on neurons mediate neurotransmission by TRH.", "OL": "use RECEPTORS, THYROTROPIN-RELEASING HORMONE (NM) to search THYROTROPIN RELEASING HORMONE RECEPTOR 1981-93", "PM": "94; THYROTROPIN RELEASING HORMONE RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1987-93 & RECEPTORS, ENDOGENOUS SUSBSTANCES 1981-86", "HN": "94; was THYROTROPIN RELEASING HORMONE RECEPTOR (NM) 1981-93", "MR": "20020712", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018025"}, {"RECTYPE": "D", "MH": "Receptors, Pancreatic Hormone", "DE": "RECEPT PANCREATIC HORMONE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Pancreatic Hormone Receptors|T116|T192|NON|EQV|NLM (1994)|921221|PANCREATIC HORMONE RECEPT|abbcdefv", "ENTRY": "Receptor, Pancreatic Hormone", "MN": "D12.776.543.750.750.580", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Cell surface proteins that bind pancreatic hormones with high affinity and trigger intracellular changes which influence the behavior of cells. These include receptors for glucagon (secreted by alpha cells), insulin (secreted by beta cells), somatostatin (secreted by delta cells), and pancreatic peptide (secreted by PP cells). Some of these hormones and receptors also support neurotransmission.", "PM": "94", "HN": "94", "MR": "19970620", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018026"}, {"RECTYPE": "D", "MH": "Receptors, Glucagon", "DE": "RECEPT GLUCAGON", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Glucagon Receptors|T116|T192|NON|EQV|NLM (1994)|921221|GLUCAGON RECEPT|abbcdefv", "ENTRY": "Receptor, Glucagon", "MN": "D12.776.543.750.750.580.350", "FX": "Glucagon", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Gastrointestinal Hormone (1986-1993)", "MS": "Cell surface receptors that bind glucagon with high affinity and trigger intracellular changes which influence the behavior of cells. Activation of glucagon receptors causes a variety of effects; the best understood is the initiation of a complex enzymatic cascade in the liver which ultimately increases the availability of glucose to body organs.", "OL": "use RECEPTORS, GLUCAGON (NM) to search GLUCAGON RECEPTOR 1980-93", "PM": "94; GLUCAGON RECEPTOR was indexed under RECEPTORS, GASTROINTESTINAL HORMONE 1986-93, RECEPTORS, ENDOGENOUS SUBSTANCES 1981-86, & GLUCAGON 1980-81", "HN": "94; was GLUCAGON RECEPTOR (NM) 1980-93", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018027"}, {"RECTYPE": "D", "MH": "Receptors, Neurotensin", "DE": "RECEPT NEUROTENSIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Neurotensin Receptors|T116|T192|NON|EQV|NLM (1994)|921221|NEUROTENSIN RECEPT|abbcdefv", "ENTRY": "Receptor, Neurotensin", "MN": "D12.776.543.750.750.555.560", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurotransmitter (1985-1993)", "MS": "Cell surface proteins that bind neurotensin with high affinity and trigger intracellular changes which influence the behavior of cells. Neurotensin and neurotensin receptors are found in the central nervous system and in the periphery.", "OL": "use RECEPTORS, NEUROTENSIN (NM) to search NEUROTENSIN RECEPTOR 1980-93", "PM": "94; NEUROTENSIN RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1985-93 & RECEPTORS, ENDOGENOUS SUSBSTANCES 1980-84", "HN": "94; was NEUROTENSIN RECEPTOR (NM) 1980-93", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018028"}, {"RECTYPE": "D", "MH": "Rho(D) Immune Globulin", "DS": "RHO D IMMUNE GLOBULIN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Rh Immune Globulin|T116|T121|T129|BRD|NLM (1994)|921222|RHIG|abbbdefv", "ENTRY": "Globulin, Rh Immune", "MN": "D12.776.377.715.548.114.619.393.700", "PA": "Immunologic Factors", "MH_TH": "NLM (1994)", "ST": "T129", "RN": "0", "PI": "Immunoglobulins (1973-1993)", "MS": "Immunizing agent containing IMMUNOGLOBULIN G anti-Rho(D) used for preventing Rh immunization in Rh-negative individuals exposed to Rh-positive red blood cells.", "PM": "1994; RHO(D) IMMUNE GLOBULIN was indexed under IMMUNOGLOBULINS 1973-1993, ANTI-ANTIBODIES 1980-1983, and under GAMMA GLOBULINS 1978-1983", "HN": "1994 (1973)", "MR": "20180301", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D018029"}, {"RECTYPE": "D", "MH": "Silver Compounds", "DE": "SILVER CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Silver", "MN": "D01.847", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "AN": "inorganic; general or unspecified; prefer specifics", "PI": "Silver (1966-1993)", "MS": "Inorganic compounds that contain silver as an integral part of the molecule.", "PM": "94", "HN": "94", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018030"}, {"RECTYPE": "D", "MH": "Connexin 43", "DS": "CONNEXIN 043", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cx43|T116|T123|EQV|NLM (1994)|921223|CX 043|abbdefs", "ENTRY": "Connexin43|T116|T123|NON|EQV|NLM (1999)|971002|abbcdef", "MN": "D12.776.543.585.250.200", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1987-1993)", "MS": "A 43-kDa peptide which is a member of the connexin family of gap junction proteins. Connexin 43 is a product of a gene in the alpha class of connexin genes (the alpha-1 gene). It was first isolated from mammalian heart, but is widespread in the body including the brain.", "OL": "use CONNEXINS (NM) to search CONNEXIN 43 1991-93", "PM": "94; CONNEXIN 43 was indexed under MEMBRANE PROTEINS 1987-93", "HN": "94; CONNEXIN 43 was (SY) to GAP JUNCTION PROTEIN 1991-93", "MR": "20160628", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D018031"}, {"RECTYPE": "D", "MH": "Antibodies, Bispecific", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "PRINT ENTRY": "Bispecific Antibodies|T116|T121|T129|NON|EQV|NLM (1994)|921223|BSABS|abbbcdefv", "ENTRY": "Monoclonal Antibodies, Bispecific", "MN": "D12.776.377.715.548.114.134", "PA": "Immunologic Factors", "FX": "Radioimmunotherapy", "MH_TH": "NLM (1994)", "ST": "T129", "RN": "0", "AN": "do not coordinate with ANTIBODY FORMATION for /biosynthesis", "PI": "specific Antibodies (1985-1993)", "MS": "Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors.", "PM": "94", "HN": "94", "MR": "20100625", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018033"}, {"RECTYPE": "D", "MH": "Olfactory Receptor Neurons", "DE": "OLFACTORY RECEPT NEURONS", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Neurons, Olfactory Receptor|T025|NON|EQV|NLM (1994)|930111|NEURONS OLFACTORY RECEPT|abcdefv", "ENTRY": "Sensory Neurons, Olfactory", "MN": "A11.671.650.915.500.540", "FX": "Receptors, Odorant", "MH_TH": "NLM (1994)", "ST": "T025", "PI": "Receptors, Sensory (1966-1993)", "MS": "Neurons in the OLFACTORY EPITHELIUM with proteins (RECEPTORS, ODORANT) that bind, and thus detect, odorants. These neurons send their DENDRITES to the surface of the epithelium with the odorant receptors residing in the apical non-motile cilia. Their unmyelinated AXONS synapse in the OLFACTORY BULB of the BRAIN.", "PM": "94", "HN": "94", "MR": "20150109", "DA": "19930628", "DC": "1", "DX": "19940101", "UI": "D018034"}, {"RECTYPE": "D", "MH": "Receptors, Odorant", "DE": "RECEPT ODORANT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Olfactory Receptor Proteins|T116|T192|NON|EQV|NLM (1994)|921224|OLFACTORY RECEPT PROTEINS|abbcdefv", "ENTRY": "Receptors, Olfactory", "MN": "D12.776.543.750.695.600", "FX": "Olfactory Pathways", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Membrane Proteins (1990-1993)", "MS": "Proteins, usually projecting from the cilia of olfactory receptor neurons, that specifically bind odorant molecules and trigger responses in the neurons. The large number of different odorant receptors appears to arise from several gene families or subfamilies rather than from DNA rearrangement.", "OL": "use ODORANT-BINDING PROTEIN (NM) to search ODORANT RECEPTOR 1993", "PM": "94; ODORANT RECEPTOR was indexed under CARRIER PROTEINS 1993", "HN": "94; ODORANT RECEPTORS was ODORANT RECEPTOR (SY) to ODORANT-BINDING PROTEIN (NM) 1993", "MR": "20160622", "DA": "19930628", "DC": "1", "DX": "19940101", "UI": "D018035"}, {"RECTYPE": "D", "MH": "Selenium Compounds", "DE": "SELENIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Selenium", "MN": "D01.810", "MH_TH": "NLM (1994)", "ST": "T197", "RN": "0", "PI": "Selenium (1966-1993)", "MS": "Inorganic compounds that contain selenium as an integral part of the molecule.", "PM": "94", "HN": "94", "MR": "20180701", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018036"}, {"RECTYPE": "D", "MH": "Sodium Selenite", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Selenite, Sodium", "MN": "D01.857.850", "PA": "Trace Elements", "MH_TH": "NLM (1994)", "ST": "T197", "N1": "Selenious acid, disodium salt", "RN": "HIW548RQ3W", "RR": "HIM8PP9M79", "PI": "Selenium (1966-1993)", "MS": "The disodium salt of selenious acid. It is used therapeutically to supply the trace element selenium and is prepared by the reaction of SELENIUM DIOXIDE with SODIUM HYDROXIDE.", "OL": "use SODIUM SELENITE (NM) to search SODIUM SELENITE 1980-93", "PM": "94; SODIUM SELENITE was indexed under SELENIUM 1992-93", "HN": "94; was SODIUM SELENITE (NM) 1992-93; was SY to SELENIOUS ACID (NM) 1980-91", "MR": "20130708", "DA": "19930617", "DC": "1", "DX": "19940101", "UI": "D018038"}, {"RECTYPE": "D", "MH": "Receptors, Tachykinin", "DE": "RECEPT TACHYKININ", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Tachykinin Receptors|T116|T192|NON|EQV|NLM (1994)|921228|TACHYKININ RECEPT|abbcdefv", "ENTRY": "Tachykinins Receptors", "MN": "D12.776.543.750.750.555.830", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurotransmitter (1985-1993)", "MS": "Cell surface proteins that bind TACHYKININS with high affinity and trigger intracellular changes influencing the behavior of cells. Three classes of tachykinin receptors have been characterized, the NK-1; NK-2; and NK-3; which prefer, respectively, SUBSTANCE P; NEUROKININ A; and NEUROKININ B.", "OL": "use RECEPTORS, TACHYKININ (NM) to search TACHYKININ RECEPTOR 1984-93", "PM": "94; TACHYKININ RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1985-93 & RECEPTORS, ENDOGENOUS SUBSTANCES 1984", "HN": "94; was TACHYKININ RECEPTOR (NM) 1984-93", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018039"}, {"RECTYPE": "D", "MH": "Receptors, Neurokinin-1", "DE": "RECEPT NEUROKININ 1", "DS": "RECEPTORS NEUROKININ 01", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Substance P Receptors|T116|T192|NON|EQV|NLM (1994)|921229|SUBSTANCE P RECEPT|abbcdefv", "ENTRY": "SP P Receptors", "MN": "D12.776.543.750.750.555.830.500", "EC": "antagonists & inhibitors:Neurokinin-1 Receptor Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurotransmitter (1985-1993)", "MS": "A class of cell surface receptors for TACHYKININS with a preference for SUBSTANCE P. Neurokinin-1 (NK-1) receptors have been cloned and are members of the G protein coupled receptor superfamily. They are found on many cell types including central and peripheral neurons, smooth muscle cells, acinar cells, endothelial cells, fibroblasts, and immune cells.", "OL": "use RECEPTORS, NEUROKININ-1 (NM) to search SUBSTANCE P RECEPTOR 1981-93", "PM": "94; SUBSTANCE P RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1985-93 & RECEPTORS, ENDOGENOUS SUBSTANCES 1981-84", "HN": "94; was SUBSTANCE P RECEPTOR (NM) 1981-93; NK-1 RECEPTOR & NEUROKININ-1 RECEPTOR were SY to SUBSTANCE K RECEPTOR 1986-93; NK-1 RECEPTOR SITE was SY to TACHYKININ RECEPTOR 1989-93", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018040"}, {"RECTYPE": "D", "MH": "Receptors, Neurokinin-2", "DE": "RECEPT NEUROKININ 2", "DS": "RECEPTORS NEUROKININ 02", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Substance K Receptors|T116|T192|NON|EQV|NLM (1994)|921229|SUBSTANCE K RECEPT|abbcdefv", "ENTRY": "SP K Receptors", "MN": "D12.776.543.750.750.555.830.540", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurotransmitter (1985-1993)", "MS": "A class of cell surface receptors for tachykinins that prefers neurokinin A; (NKA, substance K, neurokinin alpha, neuromedin L), neuropeptide K; (NPK); or neuropeptide gamma over other tachykinins. Neurokinin-2 (NK-2) receptors have been cloned and are similar to other G-protein coupled receptors.", "OL": "use RECEPTORS, NEUROKININ-2 (NM) to search SUBSTANCE K RECEPTOR 1984-93", "PM": "94; SUBSTANCE K RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1984-93", "HN": "94; was SUBSTANCE K RECEPTOR (NM) 1984-93; NK-2 RECEPTOR SITE was SY to TACHYKININ RECEPTOR 1989-93", "MR": "20160701", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018041"}, {"RECTYPE": "D", "MH": "Receptors, Neurokinin-3", "DE": "RECEPT NEUROKININ 3", "DS": "RECEPTORS NEUROKININ 03", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, NK-3|T116|T192|EQV|NLM (1994)|921229|RECEPTORS NK 03|RECEPT NK 3|abbdefsv", "ENTRY": "Receptors, Neurokinin B", "MN": "D12.776.543.750.750.555.830.580", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurotransmitter (1987-1993)", "MS": "A class of cell surface receptors for tachykinins that prefers neurokinin B (neurokinin beta, neuromedin K) over other tachykinins. Neurokinin-3 (NK-3) receptors have been cloned and are members of the G-protein coupled receptor superfamily. They have been found in the central nervous system and in peripheral tissues.", "OL": "use RECEPTORS, NEUROKININ-3 to search NEUROMEDIN K RECEPTOR 1987-93", "PM": "94; NEUROMEDIN K RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1987-93", "HN": "94; was NEUROMEDIN K RECEPTOR (NM) 1987-93; NK-3 RECEPTOR SITE was SY to TACHYKININ RECEPTOR 1989-93", "MR": "20160617", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D018042"}, {"RECTYPE": "D", "MH": "Receptors, Corticotropin", "DE": "RECEPT CORTICOTROPIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Adrenocorticotropic Hormone|T116|T192|NON|EQV|NLM (1994)|921229|RECEPT ADRENOCORTICOTROPIC HORMONE|abbcdefv", "ENTRY": "Receptor, Corticotropin", "MN": "D12.776.543.750.750.660.285", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Pituitary Hormone (1987-1993)", "MS": "Cell surface receptors that bind CORTICOTROPIN; (ACTH, adrenocorticotropic hormone) with high affinity and trigger intracellular changes. Pharmacology suggests there may be multiple ACTH receptors. An ACTH receptor has been cloned and belongs to a subfamily of G-protein-coupled receptors. In addition to the adrenal cortex, ACTH receptors are found in the brain and immune systems.", "OL": "use RECEPTORS, CORTICOTROPIN (NM) to search CORTICOTROPIN RECEPTOR 1981-93", "PM": "94; CORTICOTROPIN RECEPTOR was indexed under RECEPTORS, PITUITARY HORMONE 1987-93 & RECEPTORS, ENDOGENOUS SUBSTANCES 1981-86", "HN": "94; was CORTICOTROPIN RECEPTOR (NM) 1981-93; CORTICOTROPIN RECEPTORS & ACTH RECEPTORS were SYs 1983-93", "MR": "20010725", "DA": "19930614", "DC": "1", "DX": "19940101", "UI": "D018043"}, {"RECTYPE": "D", "MH": "Receptors, Oxytocin", "DE": "RECEPT OXYTOCIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Oxytocin Receptors|T116|T192|NON|EQV|NLM (1994)|921230|OXYTOCIN RECEPT|abbcdefv", "ENTRY": "Receptor, Oxytocin", "MN": "D12.776.543.750.750.660.600", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (1981-1984)", "MS": "Cell surface proteins that bind oxytocin with high affinity and trigger intracellular changes which influence the behavior of cells. Oxytocin receptors in the uterus and the mammary glands mediate the hormone's stimulation of contraction and milk ejection. The presence of oxytocin and oxytocin receptors in neurons of the brain probably reflects an additional role as a neurotransmitter.", "OL": "use RECEPTORS, OXYTOCIN (NM) to search OXYTOCIN RECEPTOR 1981-93", "PM": "94; OXYTOCIN RECEPTOR was indexed under RECEPTORS, ANGIOTENSIN 1985-93 & RECEPTORS, ENDOGENOUS SUBSTANCES (1981-84)", "HN": "94; was OXYTOCIN RECEPTOR (NM) 1981-93", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018045"}, {"RECTYPE": "D", "MH": "Protein C Inhibitor", "DE": "PROTEIN C INHIB", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Plasminogen Activator Inhibitor 3|T116|T123|NON|EQV|NLM (1994)|921231|PLASMINOGEN ACTIVATOR INHIBITOR 03|PLASMINOGEN ACTIVATOR INHIB 3|abbcdefsv", "ENTRY": "Type 3 Plasminogen Activator Inhibitor|T116|T123|NON|EQV|NLM (1994)|921231|TYPE 3 PLASMINOGEN ACTIVATOR INHIB|abbcdefv", "MN": "D12.776.872.695.700", "PA": "Serine Proteinase Inhibitors", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "PI": "Plasminogen Inactivators (1990-1993)", "MS": "A member of the serpin family of proteins that is found in plasma and urine. It is dependent on heparin and is able to inhibit activated PROTEIN C; THROMBIN; KALLIKREIN; and other SERINE ENDOPEPTIDASES.", "OL": "use PROTEIN C INHIBITOR (NM) to search PROTEIN C INHIBITOR 1981-93; use PLASMINOGEN INACTIVATORS to search PAI-3 1990-93", "PM": "94; PROTEIN C INHIBITOR was indexed under PLASMINOGEN INACTIVATORS 1992-93 & BLOOD PROTEINS 1981-92; PAI-3 was see PLASMINOGEN INACTIVATORS 1990-93", "HN": "94; was PROTEIN C INHIBITOR (NM) 1981-93; PAI-3 was see PLASMINOGEN INACTIVATORS 1990-93", "MR": "20150623", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018046"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic P1", "DE": "RECEPT PURINERGIC P1", "DS": "RECEPTORS PURINERGIC P 01", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Adenosine|T116|T192|NON|EQV|NLM (1994)|930104|RECEPT ADENOSINE|abbcdefv", "ENTRY": "Receptor, Adenosine", "MN": "D12.776.543.750.720.700.700", "EC": "antagonists & inhibitors:Purinergic P1 Receptor Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Purinergic (1987-1993)", "MS": "A class of cell surface receptors that prefer ADENOSINE to other endogenous PURINES. Purinergic P1 receptors are widespread in the body including the cardiovascular, respiratory, immune, and nervous systems. There are at least two pharmacologically distinguishable types (A1 and A2, or Ri and Ra).", "OL": "use RECEPTORS, PURINERGIC to search ADENOSINE RECEPTORS 1987-93 & RECEPTORS, ADENOSINE 1993", "PM": "94; ADENOSINE RECEPTORS, was see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, ADENOSINE was see RECEPTORS, PURINERGIC 1993", "HN": "94; ADENOSINE RECEPTORS was see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, ADENOSINE was see RECEPTORS, PURINERGIC 1993", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018047"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic P2", "DE": "RECEPT PURINERGIC P2", "DS": "RECEPTORS PURINERGIC P 02", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, ATP|T116|T192|NRW|NLM (1994)|930104|RECEPT ATP|abbdefv", "ENTRY": "Receptor, ATP", "MN": "D12.776.543.750.720.700.720", "EC": "antagonists & inhibitors:Purinergic P2 Receptor Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Purinergic (1987-1993)", "MS": "A class of cell surface receptors for PURINES that prefer ATP or ADP over ADENOSINE. P2 purinergic receptors are widespread in the periphery and in the central and peripheral nervous system.", "OL": "use RECEPTORS, PURINERGIC to search ADP RECEPTORS & ATP RECEPTORS 1987-93 & RECEPTORS, ADP & RECEPTORS ATP 1993", "PM": "94; ADP RECEPTORS & ATP RECEPTORS were see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, ADP & RECEPTORS, ATP were see RECEPTORS, PURINERGIC 1993", "HN": "94; ADP RECEPTORS & ATP RECEPTORS were see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, ADP & RECEPTORS, ATP were see RECEPTORS, PURINERGIC 1993", "MR": "20160617", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D018048"}, {"RECTYPE": "D", "MH": "Arenaviruses, Old World", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Old World Arenaviruses|T005|NON|EQV|NLM (2002)|010409|abcdef", "ENTRY": "Lymphocytic Choriomeningitis Lassa Complex Viruses", "MN": "B04.820.480.500.070.100", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid208896", "AN": "infection: coord IM with ARENAVIRIDAE INFECTIONS (IM)", "MS": "One of two groups of viruses in the ARENAVIRUS genus and considered part of the Old World complex. It includes LASSA VIRUS and LYMPHOCYTIC CHORIOMENINGITIS VIRUS, although the latter has worldwide distribution now.", "PM": "2002; see LCM-LASSA COMPLEX VIRUSES 1994-2001", "HN": "2002 (1994)", "MR": "20200813", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D018049"}, {"RECTYPE": "D", "MH": "Arenavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Arenaviruses", "MN": "B04.820.480.500.070", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11618", "MS": "The only genus in the family ARENAVIRIDAE. It contains two groups ARENAVIRUSES, OLD WORLD and ARENAVIRUSES, NEW WORLD, which are distinguished by antigenic relationships and geographic distribution.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018050"}, {"RECTYPE": "D", "MH": "Junin virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hemorrhagic Fever Virus, Argentinian|T005|EPO|EQV|NLM (1994)|930105|abcdef", "MN": "B04.820.480.500.070.095.450", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid2169991", "AN": "infection: coordinate IM with HEMORRHAGIC FEVER, ARGENTINIAN see HEMORRHAGIC FEVER, AMERICAN (IM)", "PI": "Tacaribe Complex Viruses (1976-1993)", "MS": "A species of ARENAVIRUS, part of the New World Arenaviruses (ARENAVIRUSES, NEW WORLD), causing Argentinian hemorrhagic fever. The disease is characterized by congestion, edema, generalized lymphadenopathy and hemorrhagic necrosis and is sometimes fatal.", "OL": "use TACARIBE COMPLEX VIRUSES to search JUNIN VIRUS 1975-93 & HEMORRHAGIC FEVER VIRUS, ARGENTINIAN 1977-93", "PM": "94; was see HEMORRHAGIC FEVER VIRUSES, AMERICAN 1975-93; HEMORRHAGIC FEVER VIRUS, ARGENTINIAN was see HEMORRHAGIC FEVER VIRUSES, AMERICAN 1977-93", "HN": "94; was see HEMORRHAGIC FEVER VIRUSES, AMERICAN 1975-93; HEMORRHAGIC FEVER VIRUS, ARGENTINIAN was see HEMORRHAGIC FEVER VIRUSES, AMERICAN 1977-93", "MR": "20200813", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018051"}, {"RECTYPE": "D", "MH": "Pichinde virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.480.500.070.095.650", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid2169993", "AN": "infection: coordinate with ARENAVIRIDAE INFECTIONS", "PI": "Tacaribe Complex Viruses (1979-1993)", "MS": "A species of ARENAVIRUS, one of the New World Arenaviruses (ARENAVIRUSES, NEW WORLD), causing a fatal infection in the cricetine rodent Oryzomys albigularis. Asymptomatic laboratory infection in humans has been reported.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018052"}, {"RECTYPE": "D", "MH": "Arsenites", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D01.248.497.158.055", "MH_TH": "NLM (1994)", "ST": "T104", "RN": "0", "AN": "do not confuse with ARSENATES", "PI": "Arsenic (1966-1993)", "MS": "Inorganic salts or organic esters of arsenious acid.", "PM": "94", "HN": "94", "MR": "20190627", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018053"}, {"RECTYPE": "D", "MH": "Hydrobromic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Bromide, Hydrogen", "MN": "D01.139.300", "MH_TH": "NLM (1994)", "ST": "T197", "N1": "Hydrobromic acid", "RN": "3IY7CNP8XJ", "RR": "11071-85-5 (hydrogen bromide (HBr2))", "PI": "Bromides (1974-1982)", "MS": "Hydrobromic acid (HBr). A solution of hydrogen bromide gas in water.", "OL": "use HYDROBROMIC ACID (NM) to search HYDROBROMIC ACID 1980-93", "PM": "94; HYDROBROMIC ACID was indexed under ACIDS 1983-93 & BROMIDES 1974-82", "HN": "94; was HYDROBROMIC ACID (NM) 1974-93", "MR": "20130708", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018054"}, {"RECTYPE": "D", "MH": "Receptors, Eicosanoid", "DE": "RECEPT EICOSANOID", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Eicosanoid Receptors|T116|T192|NON|EQV|NLM (1994)|930106|EICOSANOID RECEPT|abbcdefv", "ENTRY": "Receptor, Eicosanoid", "MN": "D12.776.543.750.695.200", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general; prefer specifics", "PI": "Receptors, Thromboxane (1993)", "MS": "Cell surface proteins that bind eicosanoids with high affinity and trigger intracellular changes influencing the behavior of cells. Among the eicosanoid receptors are receptors for the prostaglandins, thromboxanes, and leukotrienes.", "PM": "94", "HN": "94", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018055"}, {"RECTYPE": "D", "MH": "Hemorheology", "DE": "HEMORHEOL", "AQ": "DE GE IM PH RE", "ENTRY": "Hemorrheology|T039|NON|EQV|NLM (1994)|930106|abcdef", "MN": "G09.330.380.630", "FX": "Erythrocyte Deformability", "MH_TH": "NLM (1994)", "ST": "T039", "PI": "Rheology (1966-1993)", "MS": "The deformation and flow behavior of BLOOD and its elements i.e., PLASMA; ERYTHROCYTES; WHITE BLOOD CELLS; and BLOOD PLATELETS.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19930602", "DC": "1", "DX": "19940101", "UI": "D018056"}, {"RECTYPE": "D", "MH": "Dental Waste", "DE": "DENT WASTE", "AQ": "AE AN CL EC ES HI LJ PC SN", "ENTRY": "Wastes, Dental", "MN": "N06.850.460.710.460.150", "MH_TH": "NLM (1994)", "ST": "T031", "RN": "0", "AN": "includes saliva, rinse, amalgams, etc.; disposal of dent waste: coord IM with MEDICAL WASTE DISPOSAL (IM)", "PI": "Waste Products (1976-1993)", "MS": "Any waste product generated by a dental office, surgery, clinic, or laboratory including amalgams, saliva, and rinse water.", "PM": "94", "HN": "94", "MR": "20080708", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018057"}, {"RECTYPE": "D", "MH": "Tympanic Membrane Perforation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tympanic Membrane Rupture|T037|T047|NON|EQV|NLM (1994)|930107|abbcdef", "ENTRY": "Rupture, Tympanic Membrane", "MN": "C26.930", "MH_TH": "NLM (1994)", "ST": "T047", "PI": "Tympanic Membrane/injuries (1966-1993)", "MS": "A temporary or persistent opening in the eardrum (TYMPANIC MEMBRANE). Clinical signs depend on the size, location, and associated pathological condition.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018058"}, {"RECTYPE": "D", "MH": "Birnaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.223.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10993", "PI": "Reoviridae (1990-1993)", "MS": "A family of bisegmented, double-stranded RNA viruses causing infection in fish, mollusks, fowl, and Drosophila. There are three genera: AQUABIRNAVIRUS; AVIBIRNAVIRUS; and ENTOMOBIRNAVIRUS. Horizontal and vertical transmission occurs for all viruses.", "OL": "use BIRNAVIRIDAE to search BIRNAVIRUS 1994-96", "PM": "94; BIRNAVIRUS was heading 1994-96", "HN": "94; BIRNAVIRUS was heading 1994-96", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018059"}, {"RECTYPE": "D", "MH": "Infectious pancreatic necrosis virus", "DE": "INFECT PANCREATIC NECROSIS VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Pancreatic Necrosis Virus, Infectious|T005|NON|EQV|NLM (1997)|960326|PANCREATIC NECROSIS VIRUS INFECT|abcdefv", "MN": "B04.820.223.500.050.430", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11002", "AN": "infection: coordinate with BIRNAVIRIDAE INFECTIONS ", "PI": "Reoviridae (1969-1993)", "MS": "The type species of AQUABIRNAVIRUS, causing infectious pancreatic necrosis in salmonid fish and other freshwater and marine animals including mollusks.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018061"}, {"RECTYPE": "D", "MH": "La Crosse virus", "DE": "LAC VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "LaCrosse Virus|T005|EPO|EQV|NLM (1994)|930420|abcdef", "MN": "B04.820.480.750.640.300.500", "FX": "Encephalitis, California", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11577", "AN": "infection: coord IM with ENCEPHALITIS, CALIFORNIA (IM)", "PI": "Encephalitis Viruses (1972-1974)", "MS": "A serotype of the species California encephalitis virus (ENCEPHALITIS VIRUS, CALIFORNIA), in the genus ORTHOBUNYAVIRUS, causing human MENINGOENCEPHALITIS. This is the agent most responsible for California encephalitis (ENCEPHALITIS, CALIFORNIA), the most prevalent mosquito-borne disease recognized in the United States.", "OL": "use CALIFORNIA GROUP VIRUSES to search LA CROSSE VIRUS 1976-93", "PM": "94; was see CALIFORNIA GROUP VIRUSES 1976-93", "HN": "94; was see CALIFORNIA GROUP VIRUSES 1976-93", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018062"}, {"RECTYPE": "D", "MH": "Hantaan virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hemorrhagic Nephroso-Nephritis Virus|T005|NON|EQV|NLM (1995)|940308|abcdef", "ENTRY": "Nephroso-Nephritis Viruses, Hemorrhagic", "MN": "B04.820.480.750.440.400", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid1980471", "AN": "infection: coord IM with HEMORRHAGIC FEVER WITH RENAL SYNDROME (IM)", "MS": "The type species of the genus ORTHOHANTAVIRUS infecting the rodent Apodemus agrarius and humans who come in contact with it. It causes syndromes of hemorrhagic fever associated with vascular and especially renal pathology.", "OL": "use HANTAVIRUS to search HEMORRHAGIC FEVER WITH RENAL SYNDROME VIRUS & HFRS VIRUS 1987-94, HANTAAN VIRUS 1987-93, HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1977-91, & EPIDEMIC HEMORRHAGIC FEVER VIRUS 1975-76; use ARBOVIRUSES 1966-74", "PM": "94; was see HANTAVIRUS 1992-93, was see HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1987-91; HEMORRHAGIC FEVER RENAL SYNDROME VIRUS was HEMORRHAGIC FEVER WITH RENAL SYNDROME VIRUS see HANTAVIRUS 1987-94; HFRS VIRUS was see HANTAVIRUS 1987-94; HEMORRHAGIC FEVER VIRUS, EPIDEMIC was see HANTAVIRUS 1992-94, was heading 1977-91 (see under RNA VIRUSES 1978-86, see under ARBOVIRUSES 1977), was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, see under ARBOVIRUS 1965-74, & see under ARBOVIRUSES 1963-64; HEMORRHAGIC FEVER VIRUS, KOREAN was see HANTAVIRUS 1977-94; HEMORRHAGIC NEPHROSO-NEPHRITIS VIRUS was see HANTAVIRUS 1976-94", "HN": "94; was see HANTAVIRUS 1992-93, was see HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1987-91; HEMORRHAGIC FEVER RENAL SYNDROME VIRUS was HEMORRHAGIC FEVER WITH RENAL SYNDROME VIRUS see HANTAVIRUS 1987-94; HFRS VIRUS was see HANTAVIRUS 1987-94; HEMORRHAGIC FEVER VIRUS, EPIDEMIC was see HANTAVIRUS 1992-94, was heading 1977-91 (see under RNA VIRUSES 1978-86, see under ARBOVIRUSES 1977), was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, see under ARBOVIRUS 1965-74, & see under ARBOVIRUSES 1963-64; HEMORRHAGIC FEVER VIRUS, KOREAN was see HANTAVIRUS 1977-94; HEMORRHAGIC NEPHROSO-NEPHRITIS VIRUS was see HANTAVIRUS 1976-94", "MR": "20220715", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018063"}, {"RECTYPE": "D", "MH": "Uukuniemi virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Uukuniemi Group Viruses|T005|EPO|EQV|NLM (1994)|990101|abcdef", "MN": "B04.820.480.750.710.900", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11591", "AN": "infection: coordinate with BUNYAVIRIDAE INFECTIONS", "PI": "Phlebovirus (1992)", "MS": "A species in the genus PHLEBOVIRUS of the family BUNYAVIRIDAE, infecting vertebrates and vectored by ticks. It has not been associated with human disease though antibodies have been isolated from human sera.", "PM": "2002; see UUKUNIEMI GROUP VIRUSES 1994-2001", "HN": "2002 (1994)", "MR": "20200813", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D018066"}, {"RECTYPE": "D", "MH": "Flaviviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.578.344", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11050", "PI": "Flavivirus (1985-1993)", "MS": "A family of RNA viruses, many of which cause disease in humans and domestic animals. There are three genera FLAVIVIRUS; PESTIVIRUS; and HEPACIVIRUS, as well as several unassigned species.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018067"}, {"RECTYPE": "D", "MH": "Encephalitis Virus, Murray Valley", "DE": "ENCEPH VIRUS MURRAY VALLEY", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Murray Valley encephalitis virus|T005|EPO|EQV|NLM (1994)|930111|MURRAY VALLEY ENCEPH VIRUS|abcdefv", "MN": "B04.820.578.344.350.300.300", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11079", "AN": "infection: coord IM with ENCEPHALITIS, ARBOVIRUS (IM)", "MS": "A species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE), found in Australia and New Guinea. It causes a fulminating viremia resembling Japanese encephalitis (ENCEPHALITIS, JAPANESE).", "OL": "use FLAVIVIRUS to search MURRAY VALLEY ENCEPHALITIS VIRUS 1981-93; use ENCEPHALITIS VIRUSES 1977-80; use ARBOVIRUSES 1975-76", "PM": "94; was MURRAY VALLEY ENCEPHALITIS VIRUS see FLAVIVIRUSES 1981-93, see ENCEPHALITIS VIRUSES 1977-80, see ARBOVIRUSES 1975-76", "HN": "94; was MURRAY VALLEY ENCEPHALITIS VIRUS see FLAVIVIRUSES 1981-93, see ENCEPHALITIS VIRUSES 1977-80, see ARBOVIRUSES 1975-76", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018068"}, {"RECTYPE": "D", "MH": "Hair Cells, Vestibular", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Vestibular Hair Cells|T025|NON|EQV|NLM (1994)|930112|abcdef", "ENTRY": "Vestibular Hair Cell", "MN": "A11.671.650.915.750.600.675", "FX": "Stereocilia", "MH_TH": "NLM (1994)", "ST": "T025", "PI": "Mechanoreceptors (1977-1979)", "MS": "Sensory cells in the acoustic maculae with their apical STEREOCILIA embedded in a gelatinous OTOLITHIC MEMBRANE. These hair cells are stimulated by the movement of otolithic membrane, and impulses are transmitted via the VESTIBULAR NERVE to the BRAIN STEM. Hair cells in the saccule and those in the utricle sense linear acceleration in vertical and horizontal directions, respectively.", "PM": "94", "HN": "94", "MR": "20210630", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D018069"}, {"RECTYPE": "D", "MH": "Biological Specimen Banks", "DE": "BIOL SPECIMEN BANKS", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Biorepository|T093|NON|NRW|NLM (2024)|220929|abcdef", "ENTRY": "Biorepositories", "MN": "N02.278.065", "MH_TH": "NLM (1994)", "ST": "T093", "AN": "human or animal material; general or unspecified; prefer specifics; American Type Culture Collection (ATCC) goes here", "MS": "Facilities that collect, store, and distribute tissues, e.g., cell lines, microorganisms, blood, sperm, milk, breast tissue, for use by others. Other uses may include transplantation and comparison of diseased tissues in the identification of cancer.", "PM": "94", "HN": "94", "MR": "20230426", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018070"}, {"RECTYPE": "D", "MH": "Polydnaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Braconid Viruses|T005|NON|NRW|NLM (1994)|930121|abcdef", "ENTRY": "Viruses, Braconid", "MN": "B04.525.630", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10482", "RR": "txid10485", "AN": "a family of insect viruses infecting hymenopterans; from POLY (several or many) DNA viruses; coord IM with specific insect /virol (IM)", "PI": "Insect Viruses (1984-1993)", "MS": "A family of insect viruses isolated from endoparasitic hymenopteran insects belonging to the families Ichneumonidae and Braconidae. The two genera are Ichnovirus and Bracovirus.", "OL": "use BACULOVIRIDAE to search BRACONID VIRUSES 1991-93", "PM": "94; BRACONID VIRUSES was see BACULOVIRIDAE 1991-93", "HN": "94; BRACONID VIRUSES was see BACULOVIRIDAE 1991-93", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018071"}, {"RECTYPE": "D", "MH": "Hair Cells, Auditory, Outer", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Hair Cells, Outer", "MN": "A11.671.650.915.750.600.350.365", "FX": "Stereocilia", "MH_TH": "NLM (2008)", "ST": "T025", "PI": "Organ of Corti (1966-1976)", "MS": "Sensory cells of organ of Corti. In mammals, they are usually arranged in three or four rows, and away from the core of spongy bone (the modiolus), lateral to the INNER AUDITORY HAIR CELLS and other supporting structures. Their cell bodies and STEREOCILIA increase in length from the cochlear base toward the apex and laterally across the rows, allowing differential responses to various frequencies of sound.", "PM": "2008; see HAIR CELLS 1994-2007", "HN": "2008 (1994)", "MR": "20180702", "DA": "19930629", "DC": "1", "DX": "19940101", "UI": "D018072"}, {"RECTYPE": "D", "MH": "Haemophilus Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Haemophilus influenzae Vaccines|T121|T129|NON|EQV|NLM (1998)|960729|abbcdef", "ENTRY": "Vaccines, Hemophilus", "MN": "D20.215.894.135.450", "MH_TH": "NLM (1994)", "ST": "T129", "RN": "0", "AN": "restricted to vaccines against Haemophilus influenzae; records for several specific Haemophilus influenzae vaccines are also available in the SCR", "PI": "Bacterial Vaccines (1975-1993)", "MS": "Vaccines or candidate vaccines containing antigenic polysaccharides from Haemophilus influenzae and designed to prevent infection. The vaccine can contain the polysaccharides alone or more frequently polysaccharides conjugated to carrier molecules. It is also seen as a combined vaccine with diphtheria-tetanus-pertussis vaccine.", "PM": "94", "HN": "94", "MR": "20070709", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018073"}, {"RECTYPE": "D", "MH": "Vaccines, Conjugate", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME MI PD PO RE ST TO TU UL UR VI", "PRINT ENTRY": "Conjugate Vaccine|T121|T129|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Vaccine, Conjugate", "MN": "D23.050.865.900", "MH_TH": "NLM (1994)", "ST": "T129", "RN": "0", "AN": "\"induce antibody formation in people not responsive to polysaccharide alone\"; semisynthetic vaccines; coord NIM with specific vaccine (IM)", "PI": "vaccine components/immunology (1984-1993)", "MS": "Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognized by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection.", "PM": "94", "HN": "94", "MR": "20200527", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018074"}, {"RECTYPE": "D", "MH": "RNA, Complementary", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "cRNA Probes|T114|T130|NRW|NLM (1994)|930224|abbdef", "ENTRY": "Probes, cRNA", "MN": "D27.720.470.530.600.825.840", "MH_TH": "NLM (1994)", "ST": "T130", "RN": "0", "PI": "specific RNA (1974-1993)", "MS": "Synthetic transcripts of a specific DNA molecule or fragment, made by an in vitro transcription system. This cRNA can be labeled with radioactive uracil and then used as a probe. (King & Stansfield, A Dictionary of Genetics, 4th ed)", "OL": "use RNA, COMPLEMENTARY (NM) to search COMPLEMENTARY RNA 1984-93", "PM": "94; COMPLEMENTARY RNA was indexed under RNA 1984-93", "HN": "94; was COMPLEMENTARY RNA (NM) 1984-93", "MR": "20030709", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018075"}, {"RECTYPE": "D", "MH": "DNA, Complementary", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "cDNA Probes|T114|T130|NRW|NLM (1994)|930224|abbdef", "ENTRY": "Probes, cDNA", "MN": "D27.720.470.530.600.223.260", "MH_TH": "NLM (1994)", "ST": "T130", "RN": "0", "AN": "a single-stranded DNA", "PI": "DNA (1966-1993)", "MS": "Single-stranded complementary DNA synthesized from an RNA template by the action of RNA-dependent DNA polymerase. cDNA (i.e., complementary DNA, not circular DNA, not C-DNA) is used in a variety of molecular cloning experiments as well as serving as a specific hybridization probe.", "OL": "use DNA to search COMPLEMENTARY DNA 1987-93", "PM": "94; COMPLEMENTARY DNA was see DNA 1987-93", "HN": "94; COMPLEMENTARY DNA was see DNA 1987-93", "MR": "20030709", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018076"}, {"RECTYPE": "D", "MH": "Receptors, Leukotriene", "DE": "RECEPT LEUKOTRIENE", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "SRS-A Receptors|T116|T192|NRW|NLM (1994)|930204|SRS A RECEPT|abbdefv", "ENTRY": "SRS A Receptors", "MN": "D12.776.543.750.695.200.450", "EC": "antagonists & inhibitors:Leukotriene Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "RECEPTORS, LEUKOTRIENE B4 is also available", "PI": "Receptors, Prostaglandin (1984-1989)", "MS": "Cell-surface receptors that bind LEUKOTRIENES with high affinity and trigger intracellular changes influencing the behavior of cells. The leukotriene receptor subtypes have been tentatively named according to their affinities for the endogenous leukotrienes LTB4; LTC4; LTD4; and LTE4.", "OL": "use RECEPTORS, LEUKOTRIENE (NM) to search SRS-A RECEPTOR 1983-94", "PM": "94; SRS-A RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1990-93, RECEPTORS, PROSTAGLANDIN 1984-89, & RECEPTORS, ENDOGENOUS SUBSTANCES 1983-84", "HN": "94; was SRS-A RECEPTOR (NM) 1983-93", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018077"}, {"RECTYPE": "D", "MH": "Receptors, Prostaglandin E", "DE": "RECEPT PGE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Prostaglandin E Receptors|T116|T192|NON|EQV|NLM (1994)|930129|PROSTAGLANDIN E RECEPT|abbcdefv", "ENTRY": "Receptor, Prostaglandin E", "MN": "D12.776.543.750.695.200.700.600", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "note specific subtypes are available", "PI": "Receptors, Prostaglandin (1981-1993)", "MS": "Cell surface receptors which bind prostaglandins with a high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin E receptors prefer prostaglandin E2 to other endogenous prostaglandins. They are subdivided into EP1, EP2, and EP3 types based on their effects and their pharmacology.", "OL": "use RECEPTORS, PROSTAGLANDIN E (NM) to search PROSTAGLANDINS E RECEPTOR 1981-93", "PM": "94; PROSTAGLANDINS E RECEPTOR was indexed under RECEPTORS, PROSTAGLANDIN 1981-93", "HN": "94; PROSTAGLANDINS E RECEPTOR was (NM) 1981-93", "MR": "20160617", "DA": "19930616", "DC": "1", "DX": "19940101", "UI": "D018078"}, {"RECTYPE": "D", "MH": "Receptors, GABA", "DE": "RECEPT GABA", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "gamma-Aminobutyric Acid Receptors|T116|T192|NON|EQV|NLM (1994)|930222|abbcdef", "ENTRY": "gamma Aminobutyric Acid Receptors", "MN": "D12.776.543.750.720.200.300", "FX": "GABA Plasma Membrane Transport Proteins", "EC": "antagonists & inhibitors:GABA Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, GABA-A (1985-1993)", "MS": "Cell-surface proteins that bind GAMMA-AMINOBUTYRIC ACID with high affinity and trigger changes that influence the behavior of cells. GABA-A receptors control chloride channels formed by the receptor complex itself. They are blocked by bicuculline and usually have modulatory sites sensitive to benzodiazepines and barbiturates. GABA-B receptors act through G-proteins on several effector systems, are insensitive to bicuculline, and have a high affinity for L-baclofen.", "OL": "use RECEPTORS, GABA-A to search GABA RECEPTORS & RECEPTORS, GAMMA-AMINOBUTYRIC ACID 1985-93", "PM": "94; GABA RECEPTORS & RECEPTORS, GAMMA-AMINOBUTYRIC ACID were see RECEPTORS, GABA-BENZODIAZEPINE 1985-93", "HN": "94; GABA RECEPTORS & RECEPTORS, GAMMA-AMINOBUTYRIC ACID were see RECEPTORS, GABA-BENZODIAZEPINE 1985-93", "MR": "20050630", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018079"}, {"RECTYPE": "D", "MH": "Receptors, GABA-B", "DE": "RECEPT GABA B", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "GABA-B Receptors|T116|T192|NON|EQV|NLM (1994)|930201|GABA B RECEPT|abbcdefv", "ENTRY": "rho1 subunit, GABA receptor|T116|T192|NRW|NLM (1997)|abbde", "MN": "D12.776.543.750.720.200.300.320", "EC": "antagonists & inhibitors:GABA-B Receptor Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, GABA-A (1985-1993)", "MS": "A subset of GABA RECEPTORS that signal through their interaction with HETEROTRIMERIC G-PROTEINS.", "OL": "use RECEPTORS, GABA-B (NM) to search BACLOFEN RECEPTORS 1985-93", "PM": "94; BACLOFEN RECEPTOR was indexed under RECEPTORS, GABA-BENZODIAZEPINE 1985-93", "HN": "94; BACLOFEN RECEPTORS was BACLOFEN RECEPTOR (NM) 1985-93", "MR": "20230612", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018080"}, {"RECTYPE": "D", "MH": "Kringles", "AQ": "DE GE IM PH RE", "ENTRY": "Kringle Domain", "MN": "G02.111.570.820.709.275.750.375", "MH_TH": "NLM (1994)", "ST": "T082", "PI": "Peptide Fragments (1980-1993)", "MS": "Triple-looped protein domains linked by disulfide bonds. These common structural domains, so-named for their resemblance to Danish pastries known as kringlers, play a role in binding membranes, proteins, and phospholipids as well as in regulating proteolysis. Kringles are also present in coagulation-related and fibrinolytic proteins and other plasma proteinases.", "OL": "use PEPTIDE FRAGMENTS (NM) to search KRINGLES 1980-93", "PM": "94; KRINGLES was indexed under PEPTIDE FRAGMENTS 1980-93", "HN": "94; was KRINGLES (NM) 1980-93", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018082"}, {"RECTYPE": "D", "MH": "Border disease virus", "DE": "BORDER DIS VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.578.344.700.100", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid358764", "PI": "Togaviridae (1980-1990)", "MS": "A species of PESTIVIRUS causing a congenital sheep disease characterized by an abnormally hairy birth-coat, tremors, and poor growth.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018083"}, {"RECTYPE": "D", "MH": "Ultrasonography, Interventional", "DE": "ULTRASONOGR INTERVENTIONAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ultrasound, Interventional|T060|NON|EQV|NLM (1994)|930203|abcdef", "ENTRY": "Interventional Ultrasound", "MN": "E04.502.890", "MH_TH": "NLM (1994)", "ST": "T060", "AN": "coordinate with specific minimally invasive procedure if pertinent", "PI": "Ultrasonography (1985-1993)", "MS": "The use of ultrasound to guide minimally invasive surgical procedures such as needle ASPIRATION BIOPSY; DRAINAGE; etc. Its widest application is intravascular ultrasound imaging but it is useful also in urology and intra-abdominal conditions.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018084"}, {"RECTYPE": "D", "MH": "Regulon", "AQ": "DE ES GE IM PH RE", "ENTRY": "Regulons", "MN": "G05.360.340.024.742", "MH_TH": "NLM (1994)", "ST": "T028", "AN": "in bacteria, coord IM with specific bacterium /genet (IM)", "PI": "Genes, Regulator (1969-1993)", "MS": "In eukaryotes, a genetic unit consisting of a noncontiguous group of genes under the control of a single regulator gene. In bacteria, regulons are global regulatory systems involved in the interplay of pleiotropic regulatory domains and consist of several OPERONS.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018085"}, {"RECTYPE": "D", "MH": "Glutamate Dehydrogenase (NADP+)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NADP+-Dependent Glutamate Dehydrogenase|T116|T126|EQV|NLM (1994)|930203|abbdef", "ENTRY": "NADPH Dependent Glutamate Dehydrogenase", "MN": "D08.811.682.664.500.410", "MH_TH": "NLM (1994)", "ST": "T126", "N1": "L-Glutamate:NADP+ oxidoreductase (deaminating)", "RN": "EC 1.4.1.4", "RR": "9029-11-2 (CAS RN)", "PI": "Glutamate Dehydrogenase (1982-1993)", "MS": "An enzyme that catalyzes the conversion of L-glutamate, H2O, and NADP+ to 2-oxoglutarate, NH3, and NADPH. (From Enzyme Nomenclature, 1992) EC 1.4.1.4.", "OL": "use GLUTAMATE DEHYDROGENASE (NADP+) (NM) to search GLUTAMATE DEHYDROGENASE (NADP+) 1982-93", "PM": "94; GLUTAMATE DEHYDROGENASE (NADP+) was indexed under GLUTAMATE DEHYDROGENASE 1982-93", "HN": "94; was GLUTAMATE DEHYDROGENASE (NADP+) (NM) 1982-93", "MR": "20050630", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018086"}, {"RECTYPE": "D", "MH": "Plastids", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Chromoplasts|T026|NON|NRW|NLM (1994)|930203|abcdef", "ENTRY": "Plastid", "MN": "A11.284.430.214.190.875.700", "MH_TH": "NLM (1994)", "ST": "T026", "PI": "Chloroplasts (1966-1993)", "MS": "Self-replicating cytoplasmic organelles of plant and algal cells that contain pigments and may synthesize and accumulate various substances. PLASTID GENOMES are used in phylogenetic studies.", "PM": "94", "HN": "94", "MR": "20100625", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018087"}, {"RECTYPE": "D", "MH": "Tuberculosis, Multidrug-Resistant", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Tuberculosis, Drug-Resistant|T047|NON|BRD|NLM (1994)|930203|abcdef", "ENTRY": "Tuberculosis, Multidrug Resistant", "MN": "C01.150.252.410.040.552.846.775", "FX": "Drug Resistance, Multiple, Bacterial", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "coordinate with specific type of tuberculosis + specific antitubercular agents if pertinent; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS is also available", "PI": "Tuberculosis, Pulmonary (1990-1993)", "MS": "Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018088"}, {"RECTYPE": "D", "MH": "Superantigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Superantigen|T116|T129|NON|EQV|NLM (2021)|200106|abbcdef", "MN": "D23.050.820", "FX": "Receptors, Antigen, T-Cell, alpha-beta", "MH_TH": "NLM (1994)", "ST": "T129", "RN": "0", "AN": "coordinate IM with specific microbe /immunol (IM); for interaction of superantigens with endotoxins, coordinate with ENDOTOXINS or specifics", "PI": "specific antigens (1989-1993)", "MS": "Microbial antigens that have in common an extremely potent activating effect on T-cells that bear a specific variable region. Superantigens cross-link the variable region with class II MHC proteins regardless of the peptide binding in the T-cell receptor's pocket. The result is a transient expansion and subsequent death and anergy of the T-cells with the appropriate variable regions.", "PM": "94", "HN": "94", "MR": "20200527", "DA": "19930701", "DC": "1", "DX": "19940101", "UI": "D018089"}, {"RECTYPE": "D", "MH": "Receptors, AMPA", "DE": "RECEPT AMPA", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Quisqualate Receptors|T116|T192|NON|EQV|NLM (1994)|930505|abbcdef", "ENTRY": "Receptors, Quisqualate", "MN": "D12.776.543.750.720.200.450.400.100", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurotransmitter (1990-1992)", "MS": "A class of ionotropic glutamate receptors characterized by their affinity for the agonist AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid).", "OL": "use RECEPTORS, AMPA (NM) to search AMPA RECEPTOR 1981-93", "PM": "94; AMPA RECEPTOR was indexed under RECEPTORS, GLUTAMATE 1993, RECEPTORS, SYNAPTIC 1990-92, & RECEPTORS, DRUG 1981-89", "HN": "94; was AMPA RECEPTOR (NM) 1981-93", "MR": "20160701", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018091"}, {"RECTYPE": "D", "MH": "Receptors, Kainic Acid", "DE": "RECEPT KAINIC ACID", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Kainate|T116|T192|NON|EQV|NLM (1994)|930413|RECEPT KAINATE|abbcdefv", "ENTRY": "Receptor, Kainic Acid", "MN": "D12.776.543.750.720.200.450.400.200", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurotransmitter (1985-1992)", "MS": "A class of ionotropic glutamate receptors characterized by their affinity for KAINIC ACID.", "OL": "use RECEPTORS, KAINIC ACID (NM) to search KAINIC ACID RECEPTOR 1981-93", "PM": "94; KAINIC ACID RECEPTOR was indexed under RECEPTORS, GLUTAMATE 1993, RECEPTORS, SYNAPTIC 1985-92, & RECEPTORS, ENDOGENOUS SUBSTANCES 1981-84", "HN": "94; was KAINIC ACID RECEPTOR (NM) 1981-93", "MR": "20160701", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018092"}, {"RECTYPE": "D", "MH": "Gelatinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Gelatinase|T116|T126|NON|EQV|NLM (1994)|930203|abbcdef", "MN": "D08.811.277.656.675.374.252", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 3.4.24.-", "AN": "MATRIX METALLOPROTEINASE 2 and MATRIX METALLOPROTEINASE 9 are available", "PI": "Peptide Peptidohydrolases (1993)", "MS": "A class of enzymes that catalyzes the degradation of gelatin by acting on the peptide bonds. EC 3.4.24.-.", "OL": "use GELATINASES (NM) to search GELATINASE 1973-93", "PM": "94; GELATINASE was indexed under PEPTIDE PEPTIDOHYDROLASES 1993, PEPSIN A 1975-92, GELATIN 1973-81 & PEPTIDE HYDROLASES 1973-74", "HN": "94; was GELATINASE (NM) 1973-93", "MR": "20060707", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018093"}, {"RECTYPE": "D", "MH": "Receptors, Metabotropic Glutamate", "DE": "RECEPT METAB GLUTAMATE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Glutamate, Metabotropic|T116|T192|NON|EQV|NLM (1994)|930203|RECEPT GLUTAMATE METAB|abbcdefv", "ENTRY": "Receptor, Metabotropic Glutamate", "MN": "D12.776.543.750.720.200.450.500", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Neurotransmitter (1988-1992)", "MS": "Cell surface proteins that bind glutamate and act through G-proteins to influence second messenger systems. Several types of metabotropic glutamate receptors have been cloned. They differ in pharmacology, distribution, and mechanisms of action.", "PM": "94", "HN": "94", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018094"}, {"RECTYPE": "D", "MH": "Germ-Line Mutation", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Mutation, Germ-Line|T045|NON|EQV|NLM (1994)|930203|abcdef", "ENTRY": "Mutations, Germline", "MN": "G05.365.590.350", "MH_TH": "NLM (1994)", "ST": "T045", "AN": "germ-line refers to germ cells (ovum or spermatozoon), not micro-organisms", "PI": "Mutation (1980-1993)", "MS": "Any detectable and heritable alteration in the lineage of germ cells. Mutations in these cells (i.e., \"generative\" cells ancestral to the gametes) are transmitted to progeny while those in somatic cells are not.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018095"}, {"RECTYPE": "D", "MH": "Mononegavirales", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.480.937", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11157", "MS": "An order comprising four families of eukaryotic viruses possessing linear, non-segmented, negative-strand RNA genomes. The families are BORNAVIRIDAE; FILOVIRIDAE; PARAMYXOVIRIDAE; and RHABDOVIRIDAE.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018096"}, {"RECTYPE": "D", "MH": "Paramyxovirinae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.480.937.600.650", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11159", "AN": "infection: coord IM with PARAMYXOVIRIDAE INFECTIONS (IM)", "MS": "A subfamily of PARAMYXOVIRIDAE. Genera include RUBULAVIRUS; RESPIROVIRUS; MORBILLIVIRUS; HENIPAVIRUS; and AVULAVIRUS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018098"}, {"RECTYPE": "D", "MH": "Pneumovirinae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.480.937.600.670", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11244", "AN": "infecton: coordinate with PARAMYXOVIRIDAE INFECTIONS", "MS": "A subfamily of PARAMYXOVIRIDAE containing two genera: PNEUMOVIRUS; and METAPNEUMOVIRUS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018099"}, {"RECTYPE": "D", "MH": "Receptors, Histamine H3", "DE": "RECEPT HISTAMINE H3", "DS": "RECEPTORS HISTAMINE H 03", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Histamine H3 Receptors|T116|T192|NON|EQV|NLM (1994)|930204|HISTAMINE RECEPTORS H 003|HISTAMINE H3 RECEPT|abbcdefsv", "ENTRY": "Receptors, H3", "MN": "D12.776.543.750.720.480.500", "EC": "antagonists & inhibitors:Histamine Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Histamine (1983-1993)", "MS": "A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H3 receptors were first recognized as inhibitory autoreceptors on histamine-containing nerve terminals and have since been shown to regulate the release of several neurotransmitters in the central and peripheral nervous systems. (From Biochem Soc Trans 1992 Feb;20(1):122-5)", "OL": "use RECEPTORS, HISTAMINE H3 (NM) to search HISTAMINE H3 RECEPTOR 1983-93", "PM": "94; HISTAMINE H3 RECEPTOR was indexed under RECEPTORS, HISTAMINE 1983-93", "HN": "94; was HISTAMINE H3 RECEPTOR (NM) 1983-93", "MR": "20200527", "DA": "19930616", "DC": "1", "DX": "19940101", "UI": "D018100"}, {"RECTYPE": "D", "MH": "Mice, Inbred mdx", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "mdx Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.550.265", "FX": "Muscular Dystrophies", "MH_TH": "NLM (1994)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal ", "PI": "Mice, Mutant Strains (1984-1993)", "MS": "A strain of mice arising from a spontaneous MUTATION (mdx) in inbred C57BL mice. This mutation is X chromosome-linked and produces viable homozygous animals that lack the muscle protein DYSTROPHIN, have high serum levels of muscle ENZYMES, and possess histological lesions similar to human MUSCULAR DYSTROPHY. The histological features, linkage, and map position of mdx make these mice a worthy animal model of DUCHENNE MUSCULAR DYSTROPHY.", "PM": "94", "HN": "94", "MR": "20200902", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018101"}, {"RECTYPE": "D", "MH": "Receptors, Leukotriene B4", "DE": "RECEPT LEUKOTRIENE B4", "DS": "RECEPTORS LEUKOTRIENE B004", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Leukotriene B4 Receptors|T116|T192|NON|EQV|NLM (1994)|930205|LEUKOTRIENE B004 RECEPTOR2|LEUKOTRIENE B4 RECEPT|abbcdefsv", "ENTRY": "Receptors, LTB4", "MN": "D12.776.543.750.695.200.450.300", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1985-1993)", "MS": "A class of cell surface leukotriene receptors with a preference for leukotriene B4. Leukotriene B4 receptor activation influences chemotaxis, chemokinesis, adherence, enzyme release, oxidative bursts, and degranulation in polymorphonuclear leukocytes. There are at least two subtypes of these receptors. Some actions are mediated through the inositol phosphate and diacylglycerol second messenger systems.", "OL": "use RECEPTORS, LEUKOTRIENE B4 (NM) to search LEUKOTRIENE B4 RECEPTOR 1982-93", "PM": "94; LEUKOTRIENE B4 RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1985-93, RECEPTORS, ENDOGENOUS SUBSTANCES 1982-84 & RECEPTORS, HORMONE 1982", "HN": "94; was LEUKOTRIENE B4 RECEPTOR (NM) 1982-93", "MR": "20160617", "DA": "19930616", "DC": "1", "DX": "19940101", "UI": "D018102"}, {"RECTYPE": "D", "MH": "Morbillivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Morbilliviruses", "MN": "B04.820.480.937.600.650.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11229", "PI": "specific Morbillivirus (1979-1993)", "MS": "A genus of the family PARAMYXOVIRIDAE (subfamily PARAMYXOVIRINAE) where the virions of most members have hemagglutinin but not neuraminidase activity. All members produce both cytoplasmic and intranuclear inclusion bodies. MEASLES VIRUS is the type species.", "OL": "use MEASLES VIRUS to search MORBILLI VIRUS 1975-93", "PM": "94; MORBILLI VIRUS was see MEASLES VIRUS 1975-93", "HN": "94; MORBILLI VIRUS was see MEASLES VIRUS 1975-93", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018103"}, {"RECTYPE": "D", "MH": "Distemper Virus, Phocine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Seal Distemper Virus|T005|NON|EQV|NLM (1994)|930510|abcdef", "ENTRY": "Seal Distemper Viruses", "MN": "B04.820.480.937.600.650.500.320", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11240", "AN": "infection: coord IM with DISTEMPER (IM); DISTEMPER VIRUS, CANINE is also available", "PI": "Paramyxoviridae (1989-1993)", "MS": "A species of MORBILLIVIRUS causing distemper in seals.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018104"}, {"RECTYPE": "D", "MH": "DNA, Kinetoplast", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Kinetoplast DNA Minicircles|T114|T123|NRW|NLM (1994)|930208|abbdef", "ENTRY": "Minicircles, kDNA", "MN": "D13.444.308.442.200", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "AN": "protozoan DNA; from Kinetoplastida, an order of flagellate protozoa; coord IM with specific protozoon (IM); /drug eff /ultrastruct permitted", "PI": "DNA, Protozoan (1991-1993)", "MS": "DNA of kinetoplasts which are specialized MITOCHONDRIA of trypanosomes and related parasitic protozoa within the order KINETOPLASTIDA. Kinetoplast DNA consists of a complex network of numerous catenated rings of two classes; the first being a large number of small DNA duplex rings, called minicircles, approximately 2000 base pairs in length, and the second being several dozen much larger rings, called maxicircles, approximately 37 kb in length.", "OL": "use DNA, KINETOPLAST (NM) to search KINETOPLAST DNA & KINETOPLAST DNA MAXICIRCLES 1987-93 & KINETOPLAST DNA MINICIRCLES 1980-93", "PM": "94; KINETOPLAST DNA was indexed under DNA, CIRCULAR 1987-93; KINETOPLAST DNA MAXICIRCLES was indexed under DNA, CIRCULAR 1987-93; KINETOPLAST DNA MINICIRCLES was indexed under DNA, CIRCULAR 1980-93", "HN": "94; was KINETOPLAST DNA (NM) 1987-93; KINETOPLAST DNA MAXICIRCLES was NM 1987-93; KINETOPLAST DNA MINICIRCLES was NM 1980-93", "MR": "20000622", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018105"}, {"RECTYPE": "D", "MH": "CD28 Antigens", "DS": "CD 028 ANTIGENS", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Antigens, CD28|T116|T129|T192|ACX|EQV|NLM (1994)|990101|ANTIGENS CD 028|abbbcdefs", "ENTRY": "T Cell Specific Surface Glycoprotein CD28", "MN": "D23.101.100.894.128", "FX": "B7-1 Antigen", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Antigens, Differentiation, T-Lymphocyte (1986-1993)", "MS": "Costimulatory T-LYMPHOCYTE receptors that have specificity for CD80 ANTIGEN and CD86 ANTIGEN. Activation of this receptor results in increased T-cell proliferation, cytokine production and promotion of T-cell survival.", "PM": "2018; see ANTIGENS, CD28 1994-2017 and CD28 ANTIGEN 1986-93; CD28 ANTIGENS was indexed under ANTIGENS, CD 1990-93 and ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1986-93", "HN": "2018 (1986)", "MR": "20170524", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018106"}, {"RECTYPE": "D", "MH": "Peste-des-petits-ruminants virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Peste des petits ruminants virus", "MN": "B04.820.480.937.600.650.500.650", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid2593991", "PI": "Rinderpest Virus (1971-1993)", "MS": "A species of MORBILLIVIRUS causing a severe, often fatal enteritis and pneumonia (PESTE-DES-PETITS-RUMINANTS) in sheep and goats.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D018107"}, {"RECTYPE": "D", "MH": "Respirovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Respiroviruses", "MN": "B04.820.480.937.600.650.700", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid186938", "PI": "Paramyxoviridae (1967-1993)", "MS": "A genus of the family PARAMYXOVIRIDAE (subfamily PARAMYXOVIRINAE) where all the virions have both HEMAGGLUTININ and NEURAMINIDASE activities and encode a non-structural C protein. SENDAI VIRUS is the type species.", "PM": "2002; see PARAMYXOVIRUS 1994-2001", "HN": "2002 (1994)", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018108"}, {"RECTYPE": "D", "MH": "Avulavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Paramyxoviruses, Avian|T005|NON|EQV|NLM (1994)|990101|abcdef", "ENTRY": "Paramyxovirus, Avian", "MN": "B04.820.480.937.600.650.070", "MH_TH": "NLM (2004)", "ST": "T005", "RN": "txid260963", "AN": "infection: coord IM with AVULAVIRUS INFECTIONS (IM)", "PI": "Paramyxoviridae (1975-1993)", "MS": "A genus in the subfamily PARAMYXOVIRINAE, family PARAMYXOVIRIDAE, causing disease in domestic fowl. There are many species, the most well-known being avian paramyxovirus 1 (NEWCASTLE DISEASE VIRUS).", "PM": "2004; see PARAMYXOVIRUSES, AVIAN 1994-2003", "HN": "2004 (1994)", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018109"}, {"RECTYPE": "D", "MH": "Receptors, Lipoprotein", "DE": "RECEPT LIPOPROTEIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Lipoprotein Receptors|T116|T192|NON|EQV|NLM (1994)|930209|LIPOPROTEIN RECEPT|abbcdefv", "ENTRY": "Receptor, Lipoprotein", "MN": "D12.776.543.750.710", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "RECEPTORS, LDL and specifics are available", "PI": "Receptors, Cell Surface (1981-1993)", "MS": "Cell surface proteins that bind lipoproteins with high affinity. Lipoprotein receptors in the liver and peripheral tissues mediate the regulation of plasma and cellular cholesterol metabolism and concentration. The receptors generally recognize the apolipoproteins of the lipoprotein complex, and binding is often a trigger for endocytosis.", "OL": "use RECEPTORS, LIPOPROTEIN (NM) to search LIPOPROTEIN RECEPTOR 1981-93", "PM": "94; LIPOPROTEIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-93", "HN": "94; was LIPOPROTEIN RECEPTOR (NM) 1981-93", "MR": "19950608", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018110"}, {"RECTYPE": "D", "MH": "Pneumovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.480.937.600.670.600", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11245", "PI": "Paramyxoviridae (1985-1993)", "MS": "A genus of the family PARAMYXOVIRIDAE (subfamily PNEUMOVIRINAE) where the human and bovine virions have neither hemagglutinin nor neuraminidase activity. RESPIRATORY SYNCYTIAL VIRUS, HUMAN is the type species.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018111"}, {"RECTYPE": "D", "MH": "Respiratory Syncytial Virus, Bovine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Bovine respiratory syncytial virus|T005|NON|EQV|NLM (1994)|930209|abcdef", "MN": "B04.820.480.937.600.670.600.750.700", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11246", "AN": "infection: coord IM with RESPIRATORY SYNCYTIAL VIRUS INFECTIONS (IM)", "PI": "Respiratory Syncytial Viruses (1968-1993)", "MS": "A species of PNEUMOVIRUS causing an important respiratory infection in cattle. Symptoms include fever, conjunctivitis, and respiratory distress.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018112"}, {"RECTYPE": "D", "MH": "Respiratory Syncytial Virus, Human", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "human RSV|T005|ABX|EQV|NLM (2024)|221104|abcdef", "ENTRY": "human RSVs", "MN": "B04.820.480.937.600.670.600.750.730", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11250", "AN": "infection: coord IM with RESPIRATORY SYNCYTIAL VIRUS INFECTIONS (IM)", "PI": "Respiratory Syncytial Viruses (1966-1993)", "MS": "The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.", "PM": "94", "HN": "94", "MR": "20230226", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018113"}, {"RECTYPE": "D", "MH": "Lyssavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Australian bat lyssavirus|T005|NON|NRW|NLM (2002)|010413|abcdef", "ENTRY": "lyssavirus, Australian bat", "MN": "B04.820.480.937.750.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11286", "RR": "txid90961", "AN": "infection: coordinate with RHABDOVIRIDAE INFECTIONS", "PI": "Rhabdoviridae (1978-1993)", "MS": "A genus of the family RHABDOVIRIDAE that includes RABIES VIRUS and other rabies-like viruses.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018114"}, {"RECTYPE": "D", "MH": "Ephemeral Fever Virus, Bovine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Bovine ephemeral fever virus|T005|NON|EQV|NLM (1994)|930209|abcdef", "MN": "B04.820.480.937.750.250.200", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11303", "PI": "Rhabdoviridae (1977-1993)", "MS": "The type species of EPHEMEROVIRUS causing disease in cattle. Transmission is by hematophagous arthropods and the virus has been isolated from both culicoides and mosquitoes.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018115"}, {"RECTYPE": "D", "MH": "Vesiculovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Vesicular stomatitis Alagoas virus|T005|NON|NRW|NLM (2008)|061026|abcdef", "ENTRY": "Vesiculoviruses", "MN": "B04.820.480.937.750.900", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11271", "RR": "txid198833", "AN": "infection: coordinate IM with RHABDOVIRIDAE INFECTIONS (IM) or VESICULAR STOMATITIS (IM) if pertinent", "PI": "Rhabdoviridae (1979-1993)", "MS": "A genus of the family RHABDOVIRIDAE that infects a wide range of vertebrates and invertebrates. The type species is VESICULAR STOMATITIS INDIANA VIRUS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018116"}, {"RECTYPE": "D", "MH": "Thogotovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Thogoto virus|T005|EPO|NRW|NLM (1994)|930211|abcdef", "ENTRY": "Thogotoviruses", "MN": "B04.820.480.968.850", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid35323", "RR": "txid11569", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans or ORTHOMYXOVIRIDAE INFECTIONS (IM) in animals", "PI": "Orthomyxoviridae (1987-1993)", "MS": "A genus of the family ORTHOMYXOVIRIDAE comprising tick-borne viruses occasionally infecting humans. Dhori and Thogoto viruses were formerly thought to be members of BUNYAVIRIDAE. Thogoto virus is the type species.", "PM": "2002; see THOGOTO-LIKE VIRUSES 1997-2001, see ORTHOMYXOVIRUSES TYPE D 1994-1996; for INFLUENZA D VIRUS see SENDAI VIRUS 2002-2006, see PARAMYXOVIRUS 1997-2001, use PARAINFLUENZA VIRUS I, HUMAN 1976-1996", "HN": "2002 (1994)", "MR": "20230405", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018117"}, {"RECTYPE": "D", "MH": "Chloride Channels", "DE": "CL CHANNELS", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ion Channels, Chloride|T116|T123|NON|EQV|NLM (1994)|930211|ION CHANNELS CL|abbcdefv", "ENTRY": "Chloride Channels, Calcium-Activated", "MN": "D12.776.543.585.400.175", "EC": "agonists:Chloride Channel Agonists", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1988-1993)", "MS": "Cell membrane glycoproteins that form channels to selectively pass chloride ions. Nonselective blockers include FENAMATES; ETHACRYNIC ACID; and TAMOXIFEN.", "OL": "use CHLORIDE CHANNELS (NM) to search CHLORIDE CHANNELS 1988-93", "PM": "94; CHLORIDE CHANNELS was indexed under MEMBRANE PROTEINS 1988-93", "HN": "94; was CHLORIDE CHANNELS (NM) 1988-93", "MR": "20200527", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018118"}, {"RECTYPE": "D", "MH": "Stavudine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "D4T|T114|T121|ABB|EQV|NLM (1994)|930211|D A 004 T|abbcdefs", "ENTRY": "BMY27857", "MN": "D13.570.685.705.875", "PA": "Reverse Transcriptase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Thymidine, 2',3'-didehydro-3'-deoxy-", "RN": "BO9LE4QFZF", "RR": "3056-17-5 (Stavudine)", "PI": "Thymidine/analogs & derivatives (1987-1988)", "MS": "A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.", "PM": "1994; STAVUDINE was indexed under DIDEOXYNUCLEOSIDES 1988-93 and under THYMIDINE/*ANALOGS & DERIVATIVES 1987-88", "HN": "1994; use STAVUDINE 1987-93", "MR": "20170524", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018119"}, {"RECTYPE": "D", "MH": "Finasteride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MK906", "MN": "D04.210.500.925.100.250", "PA": "Urological Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha,17beta)-", "RN": "57GNO57U7G", "RR": "98319-26-7 (Finasteride)", "PI": "Azasteroids (1988-1993)", "MS": "An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA.", "OL": "use FINASTERIDE (NM) to search FINASTERIDE 1988-93", "PM": "94; FINASTERIDE was indexed under ANDROSTENES & AZASTEROIDS 1988-93", "HN": "94; was FINASTERIDE (NM) 1988-93", "MR": "20170524", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D018120"}, {"RECTYPE": "D", "MH": "Receptors, Cytokine", "DE": "RECEPT CYTOKINE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Cytokine Receptors|T116|T129|T192|NON|EQV|NLM (1994)|930212|CYTOKINE RECEPT|abbbcdefv", "ENTRY": "Receptor, Cytokine", "MN": "D12.776.543.750.705.852", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1980-1993)", "MS": "Cell surface proteins that bind cytokines and trigger intracellular changes influencing the behavior of cells.", "PM": "94", "HN": "94", "MR": "20030709", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018121"}, {"RECTYPE": "D", "MH": "B7-1 Antigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD80 Antigens|T116|T129|ABX|EQV|NLM (1996)|950126|CD 080 ANTIGENS|abbcdefs", "ENTRY": "Ligand, B7-1", "MN": "D23.529.168.100", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Antigens, Surface (1991-1993)", "MS": "A costimulatory ligand membrane glycoprotein that contains a V2 type and C2 IMMUNOGLOBULIN DOMAIN and is expressed by ANTIGEN-PRESENTING CELLS. It binds to CTLA-4 ANTIGEN with high specificity and to CD28 ANTIGEN with low specificity. The interaction of CD80 with CD28 ANTIGEN provides a costimulatory signal to T-LYMPHOCYTES, while its interaction with CTLA-4 ANTIGEN may play a role in inducing PERIPHERAL TOLERANCE.", "PM": "2018; see ANTIGENS, CD80 1996-2017; see B-CELL ACTIVATION ANTIGEN 1994-95; B7-1 ANTIGEN was indexed under B-CELL ACTIVATION ANTIGEN 1994-95; B CELL ACTIVATION ANTIGEN B7 was indexed under ANTIGENS, SURFACE 1991-93", "HN": "2018 (1991)", "MR": "20170524", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018122"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin", "DE": "RECEPT INTERLEUKIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin Receptors|T116|T129|T192|NON|EQV|NLM (1994)|930216|INTERLEUKIN RECEPT|abbbcdefv", "ENTRY": "Receptor, Interleukin", "MN": "D12.776.543.750.705.852.420", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Immunologic (1980-1993)", "MS": "Cell surface proteins that bind interleukins and trigger intracellular changes influencing the behavior of cells.", "PM": "94", "HN": "94", "MR": "20030709", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018123"}, {"RECTYPE": "D", "MH": "Receptors, Tumor Necrosis Factor", "DE": "RECEPT TUMOR NECROSIS FACTOR", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Tumor Necrosis Factor Receptors|T116|T192|NON|EQV|NLM (1994)|930217|TUMOR NECROSIS FACTOR RECEPT|abbcdefv", "ENTRY": "Receptor, TNF", "MN": "D12.776.543.750.705.852.760", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general; prefer specifics", "PI": "Receptors, Cell Surface (1985-1993)", "MS": "Cell surface receptors that bind TUMOR NECROSIS FACTORS and trigger changes which influence the behavior of cells.", "OL": "use RECEPTORS, TUMOR NECROSIS FACTOR (NM) to search TUMOR NECROSIS FACTOR RECEPTOR 1985-93", "PM": "94; TUMOR NECROSIS FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1985-93", "HN": "94; was TUMOR NECROSIS FACTOR RECEPTOR (NM) 1985-93", "MR": "20040707", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018124"}, {"RECTYPE": "D", "MH": "Receptors, Transforming Growth Factor beta", "DE": "RECEPT TRANSFORMING GROWTH FACTOR BETA", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Transforming Growth Factor beta Receptors|T116|T129|T192|NON|EQV|NLM (1994)|930218|TRANSFORMING GROWTH FACTOR BETA RECEPT|abbbcdefv", "ENTRY": "TGF beta Receptors", "MN": "D12.776.543.750.750.400.820", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (1986-1993)", "MS": "Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behavior of cells. Two types of transforming growth factor receptors have been recognized. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action.", "OL": "use RECEPTORS, TRANSFORMING GROWTH FACTOR BETA (NM) to search TRANSFORMING GROWTH FACTOR RECEPTOR, BETA 1986-93", "PM": "94; TRANSFORMING GROWTH FACTOR RECEPTOR, BETA 1986-93 was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1986-93", "HN": "94; was TRANSFORMING GROWTH FACTOR RECEPTOR, BETA (NM) 1986-93", "MR": "20030709", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018125"}, {"RECTYPE": "D", "MH": "Odontodysplasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Odontogenic Dysplasia|T019|NON|EQV|NLM (1994)|930222|abcdef", "ENTRY": "Tooth, Ghost", "MN": "C16.131.850.800.600", "MH_TH": "NLM (1994)", "ST": "T019", "AN": "an abnorm of tooth develop; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "MS": "A localized arrested tooth development which appears to involve most commonly the anterior teeth, usually on one side of the midline, most often the maxillary central and lateral incisors. Roentgenographically, the teeth have a ghostlike appearance. Calcification and bits of prismatic enamel may be found in the pulp and the enamel is thin and absent in part. (Jablonski, Illustrated Dictionary of Dentistry, 1982)", "OL": "use ODONTODYSPLASIA to search ODONTOGENESIS IMPERFECTA 1966-93", "PM": "94; ODONTOGENESIS IMPERFECTA was heading 1965-93", "HN": "94; ODONTOGENESIS IMPERFECTA was heading 1965-93", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018126"}, {"RECTYPE": "D", "MH": "Tumor Necrosis Factor Receptor Superfamily, Member 7", "DE": "TUMOR NECROSIS FACTOR RECEPT SUPERFAMILY MEMBER 7", "DS": "TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 07", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "T-Cell Activation Antigen|T116|T129|T192|EQV|NLM (1994)|930222|abbbdef", "ENTRY": "T Cell Activation Antigen", "MN": "D23.101.100.894.127", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "PI": "Antigens, Differentiation, T-Lymphocyte (1989-1993)", "MS": "A member of the tumor necrosis factor receptor superfamily found on most T-LYMPHOCYTES. Activation of the receptor by CD70 ANTIGEN results in the increased proliferation of CD4-POSITIVE T-LYMPHOCYTES and CD8-POSITIVE T-LYMPHOCYTES. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.", "PM": "2018; see ANTIGENS, CD27 1994-2017 and CD27 ANTIGEN 1989-1993; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 7 was indexed under ANTIGENS, CD and ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989-93; T-CELL ACTIVATION ANTIGEN was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1983-93", "HN": "2018 (1989); use CD27 ANTIGEN 1989-1993", "MR": "20170524", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018127"}, {"RECTYPE": "D", "MH": "Phosphatidylinositol Phosphates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyphosphoinositides|T109|T123|NON|EQV|NLM (1994)|930222|abbcdef", "ENTRY": "Phosphates, Phosphatidylinositol", "MN": "D10.570.755.375.760.400.942.625", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "PI": "Polymers (1978-1982)", "MS": "Phosphatidylinositols in which one or more alcohol group of the inositol has been substituted with a phosphate group.", "OL": "use PHOSPHATIDYLINOSITOL PHOSPHATES (NM) to search POLYPHOSPHOINOSITIDES 1980-93; use PHOSPHATIDYLINOSITOLS to search PHOSPHATIDYLINOSITOL PHOSPHATES 1977-93", "PM": "94; POLYPHOSPHOINOSITIDES was indexed under PHOSPHOINOSITIDES 1983-93 & POLYMERS 1978-82; PHOSPHATIDYLINOSITOL PHOSPHATES was see PHOSPHOINOSITIDES 1977-93", "HN": "94; was POLYPHOSPHOINOSITIDES (NM) 1978-93; PHOSPHATIDYLINOSITOL PHOSPHATES was see PHOSPHOINOSITIDES 1977-93", "MR": "20040707", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018129"}, {"RECTYPE": "D", "MH": "Diamond", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Diamonds|T196|NON|EQV|NLM (1994)|930223|abcdef", "MN": "D01.268.150.200", "MH_TH": "NLM (1994)", "ST": "T196", "N1": "Diamond", "RN": "7782-40-3", "AN": "a form of carbon", "PI": "Carbon (1980-1993)", "MS": "Diamond. A crystalline form of carbon that occurs as hard, colorless or tinted isomeric crystals. It is used as a precious stone, for cutting glass, and as bearings for delicate mechanisms. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "OL": "use DIAMOND (NM) to search DIAMOND 1980-93", "PM": "94; DIAMOND was indexed under CARBON 1980-93", "HN": "94; was DIAMOND (NM) 1980-93", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018130"}, {"RECTYPE": "D", "MH": "Rubivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Rubiviruses", "MN": "B04.820.578.875.700", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11040", "MS": "A genus of the family TOGAVIRIDAE containing only one recognized species, RUBELLA VIRUS. Transmission is primarily by aerosolization.", "OL": "use RUBELLA VIRUS to search RUBIVIRUS 1981-93", "PM": "94; was see RUBELLA VIRUS 1981-93", "HN": "94; was see RUBELLA VIRUS 1981-93", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018132"}, {"RECTYPE": "D", "MH": "Circoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Cycloviruses", "MN": "B04.280.120", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid39724", "RR": "txid742914", "MS": "A family of very small viruses containing circular, single-stranded DNA and possessing no envelope. The modes of transmission are not known.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018136"}, {"RECTYPE": "D", "MH": "Alphaherpesvirinae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.280.382.100", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10293", "AN": "infection: coord IM with HERPESVIRIDAE INFECTIONS (IM)", "PI": "Herpesviridae (1988-1993)", "MS": "A subfamily of HERPESVIRIDAE characterized by a short replication cycle. The genera include: SIMPLEXVIRUS; VARICELLOVIRUS; MAREK'S DISEASE-LIKE VIRUSES; and ILTOVIRUS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018138"}, {"RECTYPE": "D", "MH": "Simplexvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Marmoset Virus|T005|NON|NRW|NLM (1994)|930329|abcdef", "ENTRY": "Viruses, Herpes Labialis", "MN": "B04.280.382.100.750", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10294", "MS": "A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. The type species is HERPESVIRUS 1, HUMAN.", "OL": "use SIMPLEXVIRUS to search FEVER BLISTER VIRUS 1976-93, MARMOSET VIRUS, HERPES-T VIRUS, & HERPESVIRUS PLATYRHINAE 1975-93, and HERPES SIMPLEX VIRUS & HERPESVIRUS HOMINIS 1966-93", "PM": "94; MARMOSET VIRUS was heading 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80); HERPESVIRUS HOMINIS was heading 1963-93; HERPES-T VIRUS & HERPESVIRUS PLATYRHINAE were see MARMOSET VIRUS 1975-93; FEVER BLISTER VIRUS was see HERPESVIRUS HOMINIS 1976-93; HERPES SIMPLEX VIRUS was see HERPESVIRUS HOMINIS 1963-93;", "HN": "94; MARMOSET VIRUS was heading 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80); HERPESVIRUS HOMINIS was heading 1963-93; HERPES-T VIRUS & HERPESVIRUS PLATYRHINAE were see MARMOSET VIRUS 1975-93; FEVER BLISTER VIRUS was see HERPESVIRUS HOMINIS 1976-93; HERPES SIMPLEX VIRUS was see HERPESVIRUS HOMINIS 1963-93", "MR": "20200902", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018139"}, {"RECTYPE": "D", "MH": "Varicellovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Herpesvirus 1, Caprine|T005|NON|NRW|NLM (2002)|010112|HERPESVIRUS CAPRINE 001|abcdefs", "ENTRY": "Varicelloviruses", "MN": "B04.280.382.100.900", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10319", "AN": "infection: coord IM with HERPESVIRIDAE INFECTIONS (IM)", "MS": "A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE. Its species include those causing CHICKENPOX and HERPES ZOSTER in humans (HERPESVIRUS 3, HUMAN), as well as several animal viruses.", "PM": "1994", "HN": "1994", "MR": "20200902", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018140"}, {"RECTYPE": "D", "MH": "Betaherpesvirinae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Probosciviruses", "MN": "B04.280.382.150", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10357", "RR": "txid548689", "AN": "infection: coord IM with HERPESVIRIDAE INFECTIONS (IM)", "MS": "A subfamily of HERPESVIRIDAE characterized by a relatively long replication cycle. Genera include: CYTOMEGALOVIRUS; MUROMEGALOVIRUS; and ROSEOLOVIRUS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018141"}, {"RECTYPE": "D", "MH": "Gammaherpesvirinae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Lymphoproliferative Viruses|T005|NON|EQV|NLM (1994)|930303|abcdef", "ENTRY": "Viruses, Lymphoproliferative", "MN": "B04.613.204.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10374", "RR": "txid548687", "AN": "infection: coord IM with HERPESVIRIDAE INFECTIONS (IM); if discussed as tumor viruses, add TUMOR VIRUS INFECTIONS (IM)", "MS": "A subfamily of HERPESVIRIDAE characterized by variable reproductive cycles. The genera include: LYMPHOCRYPTOVIRUS and RHADINOVIRUS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D018142"}, {"RECTYPE": "D", "MH": "Lymphocryptovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Lymphocryptoviruses", "MN": "B04.613.204.500.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10375", "AN": "infection: coord IM with HERPESVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "MS": "A genus of the family HERPESVIRIDAE, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans and new world primates. The type species human herpesvirus 4 (HERPESVIRUS 4, HUMAN) is better known as the Epstein-Barr virus.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018143"}, {"RECTYPE": "D", "MH": "Rhadinovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Murine herpesvirus 68|T005|NON|NRW|NLM (2002)|010122|MURINE HERPESVIRUS 068|abcdefs", "ENTRY": "Rhadinoviruses", "MN": "B04.613.204.500.700", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10379", "AN": "infection: coord IM with HERPESVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "MS": "A genus of the family HERPESVIRIDAE, subfamily GAMMAHERPESVIRINAE, infecting New World primates and other species. HERPESVIRUS 2, SAIMIRIINE is the type species.", "PM": "94", "HN": "94", "MR": "20200902", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018144"}, {"RECTYPE": "D", "MH": "Muromegalovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Rat Cytomegalovirus|T005|NON|NRW|NLM (2002)|010119|abcdef", "ENTRY": "Rat Cytomegaloviruses", "MN": "B04.280.382.150.500", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10365", "AN": "infection: coord IM with HERPESVIRIDAE INFECTIONS (IM)", "PI": "Cytomegalovirus (1966-1993)", "MS": "A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, causing infection involving several organs in mice and rats. Murid herpesvirus is the type species.", "OL": "search CYTOMEGALOVIRUS 1966-93", "PM": "94", "HN": "94", "MR": "20200902", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018146"}, {"RECTYPE": "D", "MH": "Chordopoxvirinae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.280.650.160", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10241", "AN": "infection: coordinate with POXVIRIDAE INFECTIONS", "MS": "A subfamily of the family POXVIRIDAE, containing eight genera comprising all the vertebrate poxviruses.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018147"}, {"RECTYPE": "D", "MH": "Suipoxvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Swinepox virus|T005|NON|NRW|NLM (1994)|930308|abcdef", "ENTRY": "Swinepox viruses", "MN": "B04.280.650.160.800", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10275", "RR": "txid10276", "AN": "infection: coordinate with POXVIRIDAE INFECTIONS", "MS": "A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, containing one species, swinepox virus.", "OL": "use POXVIRIDAE to search SWINEPOX VIRUS 1975-93", "PM": "94; SWINEPOX VIRUS was see POXVIRIDAE 1986-93; see under POXVIRIDAE 1981-85; see under POXVIRUSES 1975-80", "HN": "94; SWINEPOX VIRUS was see POXVIRIDAE 1986-93; see under POXVIRIDAE 1981-85; see under POXVIRUSES 1975-80", "MR": "20200813", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D018148"}, {"RECTYPE": "D", "MH": "Glucose Intolerance", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tolerances, Impaired Glucose", "MN": "C18.452.394.952.500", "FX": "Glucose Tolerance Test", "MH_TH": "NLM (1994)", "ST": "T047", "PI": "Blood Glucose (1966-1993)", "MS": "A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160630", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018149"}, {"RECTYPE": "D", "MH": "Avipoxvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Turkeypox virus|T005|NON|NRW|NLM (2007)|060105|abcdef", "ENTRY": "viruses, Turkeypox", "MN": "B04.280.650.160.100", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10260", "RR": "txid336486", "AN": "infection: coordinate IM with POXVIRIDAE INFECTIONS (IM)", "MS": "A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising bird poxviruses. The type species is FOWLPOX VIRUS. Transmission is mechanical by ARTHROPODS.", "OL": "use FOWLPOX VIRUS to search BIRD POX VIRUS & POXVIRUS AVIUM 1975-93", "PM": "94; BIRD POX VIRUS & POXVIRUS AVIUM were see FOWL POX VIRUS 1975-93", "HN": "94; BIRD POX VIRUS & POXVIRUS AVIUM were see FOWL POX VIRUS 1975-93", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018150"}, {"RECTYPE": "D", "MH": "Capripoxvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Sheeppox virus|T005|NON|NRW|NLM (1994)|930308|abcdef", "ENTRY": "Sheeppox viruses", "MN": "B04.280.650.160.150", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10265", "RR": "txid186805", "AN": "infection: coord IM with POXVIRIDAE INFECTIONS (IM)", "PI": "Poxviridae (1985-1993)", "MS": "A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising poxviruses infecting sheep, goats, and cattle. Transmission is usually mechanical by arthropods, but also includes contact, airborne routes, and non-living reservoirs (fomites).", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018151"}, {"RECTYPE": "D", "MH": "Leporipoxvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Leporipoxviruses", "MN": "B04.613.204.600", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10270", "AN": "infection: coordinate with POXVIRIDAE INFECTIONS + TUMOR VIRUS INFECTIONS ", "PI": "Poxviridae (1989-1993)", "MS": "A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, consisting of ether-sensitive viruses of leporids and squirrels. They commonly cause tumors and are usually transmitted mechanically by arthropods. MYXOMA VIRUS is the type species.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018152"}, {"RECTYPE": "D", "MH": "Czech Republic", "AQ": "EH EP", "MN": "Z01.542.248.395", "MH_TH": "POPLINE (1993)", "ST": "T083", "PI": "Czechoslovakia (1966-1993)", "MS": "Created 1 January 1993 as a result of the division of Czechoslovakia into the Czech Republic and Slovakia.", "OL": "use CZECHOSLOVAKIA to search CZECH REPUBLIC 1966-93", "HN": "94", "MR": "20150629", "DA": "19930526", "DC": "4", "DX": "19940101", "UI": "D018153"}, {"RECTYPE": "D", "MH": "Slovakia", "AQ": "EH EP", "PRINT ENTRY": "Slovak Republic|T083|NAM|EQV|NLM (1997)|951005|abcdef", "MN": "Z01.542.248.797", "MH_TH": "POPLINE (1993)", "ST": "T083", "PI": "Czechoslovakia (1966-1993)", "MS": "Created 1 January 1993 as a result of the division of Czechoslovakia into the Czech Republic and Slovakia.", "OL": "use CZECHOSLOVAKIA to search SLOVAKIA 1966-93", "HN": "94", "MR": "20150629", "DA": "19930603", "DC": "4", "DX": "19940101", "UI": "D018154"}, {"RECTYPE": "D", "MH": "Orthopoxvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "virus, Volepox", "MN": "B04.280.650.160.650", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10242", "RR": "txid397342", "AN": "infection: coordinate IM with POXVIRIDAE INFECTIONS (IM)", "PI": "Poxviridae (1977-1993)", "MS": "A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising many species infecting mammals. Viruses of this genus cause generalized infections and a rash in some hosts. The type species is VACCINIA VIRUS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018155"}, {"RECTYPE": "D", "MH": "Journalism, Medical", "DE": "JOURNALISM MED", "AQ": "HI ST", "PRINT ENTRY": "Medical Journalism|T091|NON|EQV|NLM (1994)|930309|MED JOURNALISM|abcdefv", "MN": "L01.737.498.550", "MH_TH": "NLM (1994)", "ST": "T091", "AN": "IM; JOURNALISM, DENTAL is also available", "PI": "Publishing (1966-1993)", "MS": "The collection, writing, and editing of current interest material on topics related to biomedicine for presentation through the mass media, including newspapers, magazines, radio, or television, usually for a public audience such as health care consumers.", "PM": "98; see JOURNALISM 1994-97", "HN": "98", "MR": "19980610", "DA": "19930602", "DC": "1", "DX": "19940101", "UI": "D018156"}, {"RECTYPE": "D", "MH": "Parapoxvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Parapoxviruses", "MN": "B04.280.650.160.670", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10257", "AN": "a genus of the family Poxviridae; infection: coord IM with POXVIRIDAE INFECTIONS (IM)", "PI": "Poxviridae (1978-1993)", "MS": "A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, which infect ungulates and may infect humans. ORF VIRUS is the type species.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D018157"}, {"RECTYPE": "D", "MH": "Yatapoxvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Tanapox virus|T005|NON|NRW|NLM (1994)|930309|abcdef", "ENTRY": "Yatapoxviruses", "MN": "B04.613.204.950", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10282", "RR": "txid99000", "AN": "infection: coord IM with POXVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "MS": "A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, causing tumors in primates. The type species is YABA MONKEY TUMOR VIRUS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018158"}, {"RECTYPE": "D", "MH": "Endolymphatic Hydrops", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hydrops, Endolymphatic", "MN": "C09.218.568.217", "FX": "Transtympanic Micropressure Treatment", "MH_TH": "NLM (1994)", "ST": "T047", "PI": "Meniere's Disease (1966-1993)", "MS": "An accumulation of ENDOLYMPH in the inner ear (LABYRINTH) leading to buildup of pressure and distortion of intralabyrinthine structures, such as COCHLEA and SEMICIRCULAR CANALS. It is characterized by SENSORINEURAL HEARING LOSS; TINNITUS; and sometimes VERTIGO.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930527", "DC": "1", "DX": "19940101", "UI": "D018159"}, {"RECTYPE": "D", "MH": "Receptors, Cytoplasmic and Nuclear", "DE": "RECEPT CYTOPLASMIC NUCLEAR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nuclear and Cytoplasmic Receptors|T116|T192|NON|EQV|NLM (1994)|930415|NUCLEAR CYTOPLASMIC RECEPT|abbcdefv", "ENTRY": "Receptors, Nuclear Hormone", "MN": "D12.776.826", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics; for hormone receptors, see note at RECEPTORS, CELL SURFACE", "PI": "Receptors, Cell Surface (1983-1993)", "MS": "Intracellular receptors that can be found in the cytoplasm or in the nucleus. They bind to extracellular signaling molecules that migrate through or are transported across the CELL MEMBRANE. Many members of this class of receptors occur in the cytoplasm and are transported to the CELL NUCLEUS upon ligand-binding where they signal via DNA-binding and transcription regulation. Also included in this category are receptors found on INTRACELLULAR MEMBRANES that act via mechanisms similar to CELL SURFACE RECEPTORS.", "PM": "94", "HN": "94", "MR": "20200527", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D018160"}, {"RECTYPE": "D", "MH": "Receptors, Mineralocorticoid", "DE": "RECEPT MINERALOCORTICOID", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Mineralocorticoid Receptors|T116|T192|NON|EQV|NLM (1994)|930310|MINERALOCORTICOID RECEPT|abbcdefv", "ENTRY": "Receptor, Mineralocorticoid", "MN": "D12.776.826.750.530", "EC": "antagonists & inhibitors:Mineralocorticoid Receptor Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Steroid (1980-1993)", "MS": "Cytoplasmic proteins that specifically bind MINERALOCORTICOIDS and mediate their cellular effects. The receptor with its bound ligand acts in the nucleus to induce transcription of specific segments of DNA.", "PM": "1994; MINERALOCORTICOID RECEPTOR was indexed under RECEPTORS, STEROID 1980-1993; for RECEPTORS, ALDOSTERONE use RECEPTORS, ALDOSTERONE 1993-2012", "HN": "1994", "MR": "20150623", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018161"}, {"RECTYPE": "D", "MH": "Coltivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Kadipiro virus|T005|EPO|NRW|NLM (2002)|010427|abcdef", "ENTRY": "Coltiviruses", "MN": "B04.820.223.719.160", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10911", "RR": "txid77763", "AN": "infection: coord IM with REOVIRIDAE INFECTIONS (IM)", "MS": "A genus of REOVIRIDAE infecting Ixodidae ticks and transmitted by them to humans, deer, and small animals. The type species is COLORADO TICK FEVER VIRUS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018162"}, {"RECTYPE": "D", "MH": "Orbivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Changuinola Virus|T005|EPO|NRW|NLM (1994)|930310|abcdef", "ENTRY": "Orbiviruses", "MN": "B04.820.223.719.550", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10892", "RR": "txid40065", "AN": "infection: coordinate with REOVIRIDAE INFECTIONS", "PI": "Reoviridae (1976-1993)", "MS": "A genus of REOVIRIDAE infecting a wide range of arthropods and vertebrates including humans. It comprises at least 21 serological subgroups. Transmission is by vectors such as midges, mosquitoes, sandflies, and ticks.", "PM": "1994; for CHANGUINOLA VIRUS see REOVIRIDAE 1976-1993; for CHENUDA VIRUS see KEMEROVO VIRUS 1994-2001, see REOVIRIDAE 1976-1993; for KEMEROVO VIRUS see KEMEROVO VIRUS 1994-2001, see KEMEROVO GROUP VIRUSES 1979-1993, REOVIRIDAE 1981-1990, see REOVIRUSES 1975-1980", "HN": "1994; for CHANGUINOLA VIRUS use REOVIRIDAE 1976-1993; for CHENUDA VIRUS see REOVIRIDAE 1976-1993; for KEMEROVO VIRUS, REOVIRIDAE 1981-1990", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018163"}, {"RECTYPE": "D", "MH": "Hemorrhagic Disease Virus, Epizootic", "DE": "HEMORRHAGIC DIS VIRUS EPIZOOTIC", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Epizootic hemorrhagic disease virus|T005|NON|EQV|NLM (1994)|930310|EPIZOOTIC HEMORRHAGIC DIS VIRUS|abcdefv", "MN": "B04.820.223.719.550.400", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid40054", "AN": "infection: coordinate with REOVIRIDAE INFECTIONS", "PI": "Reoviridae (1970-1993)", "MS": "A species of ORBIVIRUS causing a fatal disease in deer. It is transmitted by flies of the genus Culicoides.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018164"}, {"RECTYPE": "D", "MH": "Orthoreovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Orthoreovirus, Nelson Bay|T005|EPO|NRW|NLM (2002)|010428|abcdef", "ENTRY": "Orthoreoviruses", "MN": "B04.820.223.719.590", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10882", "RR": "txid75888", "AN": "infection: coord IM with REOVIRIDAE INFECTIONS (IM)", "MS": "A genus of the family REOVIRIDAE infecting vertebrates only. Transmission is horizontal and infected species include humans, birds, cattle, monkeys, sheep, swine, baboons, and bats. MAMMALIAN ORTHOREOVIRUS is the type species.", "PM": "1994", "HN": "1994", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018165"}, {"RECTYPE": "D", "MH": "Health Care Reform", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Reforms, Healthcare", "MN": "N05.300.380", "FX": "Single-Payer System", "MH_TH": "NLM (1994)", "ST": "T064", "AN": "not restricted to US; specify state or country", "PI": "Health Services (1977-1993)", "MS": "Innovation and improvement of the health care system by reappraisal, amendment of services, and removal of faults and abuses in providing and distributing health services to patients. It includes a re-alignment of health services and health insurance to maximum demographic elements (the unemployed, indigent, uninsured, elderly, inner cities, rural areas) with reference to coverage, hospitalization, pricing and cost containment, insurers' and employers' costs, pre-existing medical conditions, prescribed drugs, equipment, and services.", "PM": "94", "HN": "94", "MR": "20100625", "DA": "19930528", "DC": "1", "DX": "19940101", "UI": "D018166"}, {"RECTYPE": "D", "MH": "Receptors, Calcitriol", "DE": "RECEPT CALCITRIOL", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Vitamin D Receptors|T116|T192|NON|EQV|NLM (1994)|930311|VITAMIN D RECEPT|abbcdefv", "ENTRY": "Receptors, 1,25-Dihydroxyvitamin D3", "MN": "D12.776.826.535", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Steroid (1980-1993)", "MS": "Proteins, usually found in the cytoplasm, that specifically bind calcitriol, migrate to the nucleus, and regulate transcription of specific segments of DNA with the participation of D receptor interacting proteins (called DRIP). Vitamin D is converted in the liver and kidney to calcitriol and ultimately acts through these receptors.", "OL": "use RECEPTORS, CALCITRIOL (NM) to search 1,25-DIHYDROXYCHOLECALCIFEROL RECEPTOR 1980-93 & VITAMIN D3 RECEPTOR 1988-93", "PM": "94; 1,25-DIHYDROXYCHOLECALCIFEROL RECEPTOR was indexed under RECEPTORS, STEROID 1980-93; VITAMIN D3 RECEPTOR was indexed under RECEPTORS, STEROID 1988-93", "HN": "94; was 1,25-DIHYDROXYCHOLECALCIFEROL RECEPTOR (NM) 1980-93; VITAMIN D3 RECEPTOR was (NM) 1988-93", "MR": "20150623", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018167"}, {"RECTYPE": "D", "MH": "Receptors, Retinoic Acid", "DE": "RECEPT RETINOIC ACID", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Retinoic Acid-Binding Proteins|T116|T192|NON|BRD|NLM (1994)|930312|abbcdef", "ENTRY": "Retinoic Acid Binding Proteins", "MN": "D12.776.930.775", "FX": "Retinol-Binding Proteins", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Proteins (1976-1978)", "MS": "Proteins in the nucleus or cytoplasm that specifically bind RETINOIC ACID or RETINOL and trigger changes in the behavior of cells. Retinoic acid receptors, like steroid receptors, are ligand-activated transcription regulators. Several types have been recognized.", "OL": "use RECEPTORS, RETINOIC ACID (NM) to search RETINOIC ACID-BINDING PROTEINS 1980-93", "PM": "94; RETINOIC ACID-BINDING PROTEINS was indexed under CARRIER PROTEINS 1979-93 and under PROTEINS & PROTEIN BINDING 1976-78", "HN": "94; was RETINOIC ACID-BINDING PROTEINS (NM) 1976-93", "MR": "20150623", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018168"}, {"RECTYPE": "D", "MH": "Molluscipoxvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Molluscipoxviruses", "MN": "B04.280.650.160.550", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10278", "AN": "a genus of the subfamily Chordopoxvirinae; mollusci- refers to agent of the disease molluscum contagiosum, not to mollusks; infection: coord IM with POXVIRIDAE INFECTIONS (IM)", "MS": "A genus of POXVIRIDAE, subfamily CHORDOPOXVIRINAE, infecting humans. Transmission is by direct contact among children, by sexual contact among young adults, or by fomites. MOLLUSCUM CONTAGIOSUM VIRUS is the type species.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018169"}, {"RECTYPE": "D", "MH": "Sumatriptan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Succinate, Sumatriptan", "MN": "D03.633.100.473.914.907", "PA": "Vasoconstrictor Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Indole-5-methanesulfonamide, 3-(2-(dimethylamino)ethyl)-N-methyl-", "RN": "8R78F6L9VO", "RR": "J8BDZ68989", "PI": "Sulfonamides (1988-1993)", "MS": "A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.", "OL": "use SUMATRIPTAN (NM) to search SUMATRIPTAN 1988-93", "PM": "94; SUMATRIPTAN was indexed under INDOLES & SULFONAMIDES 1988-93", "HN": "94; was SUMATRIPTAN (NM) 1988-93", "MR": "20170524", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018170"}, {"RECTYPE": "D", "MH": "Agrin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.631.050", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "AN": "a nerve tissue protein", "PI": "Nerve Tissue Proteins (1988-1993)", "MS": "A protein component of the synaptic basal lamina. It has been shown to induce clustering of acetylcholine receptors on the surface of muscle fibers and other synaptic molecules in both synapse regeneration and development.", "OL": "use AGRIN (NM) to search AGRIN 1988-93", "PM": "94; AGRIN was indexed under NERVE TISSUE PROTEINS 1988-93", "HN": "94; was AGRIN (NM) 1988-93", "MR": "20151123", "DA": "19930616", "DC": "1", "DX": "19940101", "UI": "D018171"}, {"RECTYPE": "D", "MH": "United States Office of Research Integrity", "DE": "ORI", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "United States Office of the Assistant Secretary for Health Office of Research Integrity|T093|NON|EQV|NLM (2002)|001214|abcdef", "ENTRY": "U.S. Office of the Assistant Secretary for Health Office of Research Integrity|T093|NON|EQV|NLM (2002)|001214|abcdef", "MN": "N03.540.348.500.500.600.650.912", "MH_TH": "NLM (1994)", "ST": "T093", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "MS": "An office of the UNITED STATES PUBLIC HEALTH SERVICE organized in June 1992 to promote research integrity and investigate misconduct in research supported by the Public Health Service. It consolidates the Office of Scientific Integrity of the National Institutes of Health and the Office of Scientific Integrity Review in the Office of the Assistant Secretary for Health.", "OL": "use UNITED STATES OFFICE OF RESEARCH INTEGRITY to search NIH OFFICE OF SCIENTIFIC INTEGRITY, NATIONAL INSTITUTES OF HEALTH OFFICE OF SCIENTIFIC INTEGRITY & OFFICE OF SCIENTIFIC INTEGRITY (U.S.) 1991-93", "PM": "94; NIH OFFICE OF SCIENTIFIC INTEGRITY was heading 1991-93; NATIONAL INSTITUTES OF HEALTH OFFICE OF SCIENTIFIC INTEGRITY & OFFICE OF SCIENTIFIC INTEGRITY (U.S.) were see NIH OFFICE OF SCIENTIFIC INTEGRITY 1991-93", "HN": "1994; NIH OFFICE OF SCIENTIFIC INTEGRITY was heading 1991-1993; NATIONAL INSTITUTES OF HEALTH OFFICE OF SCIENTIFIC INTEGRITY & OFFICE OF SCIENTIFIC INTEGRITY (U.S.) were see NIH OFFICE OF SCIENTIFIC INTEGRITY 1991-1993", "MR": "20150629", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018172"}, {"RECTYPE": "D", "MH": "Circoviridae Infections", "DE": "CIRCOVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Circovirus Infections|T047|NON|NRW|NLM (1994)|930524|CIRCOVIRUS INFECT|abcdefv", "ENTRY": "Infection, Circovirus", "MN": "C01.925.256.200", "MH_TH": "NLM (1994)", "ST": "T047", "MS": "Virus diseases caused by the CIRCOVIRIDAE.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018173"}, {"RECTYPE": "D", "MH": "Arterivirus Infections", "DE": "ARTERIVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Arterivirus", "MN": "C01.925.782.600.100", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "caused by an RNA virus", "MS": "Infections caused by viruses of the genus ARTERIVIRUS.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018174"}, {"RECTYPE": "D", "MH": "Birnaviridae Infections", "DE": "BIRNAVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Birnaviridae", "MN": "C01.925.782.123", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Virus diseases caused by the BIRNAVIRIDAE.", "OL": "use BIRNAVIRIDAE INFECTIONS to search BIRNAVIRUS INFECTIONS 1994-96", "PM": "94; BIRNAVIRUS INFECTIONS was see BIRNAVIRIDAE INFECTIONS 1994-96", "HN": "94; BIRNAVIRUS INFECTIONS was see BIRNAVIRIDAE INFECTIONS 1994-96", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018175"}, {"RECTYPE": "D", "MH": "Torovirus Infections", "DE": "TOROVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Torovirus Infection", "MN": "C01.925.782.600.550.800", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "caused by a member of the family Coronaviridae", "MS": "Infections with viruses of the genus TOROVIRUS, family CORONAVIRIDAE.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018176"}, {"RECTYPE": "D", "MH": "Flavivirus Infections", "DE": "FLAVIVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Flavivirus", "MN": "C01.925.782.350.250", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "caused by members of the Flavivirus genus: do not confuse with FLAVIVIRIDAE INFECTIONS caused by members of the Flaviviridae family; GEN or unspecified; prefer specifics", "MS": "Infections with viruses of the genus FLAVIVIRUS, family FLAVIVIRIDAE.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018177"}, {"RECTYPE": "D", "MH": "Flaviviridae Infections", "DE": "FLAVIVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Flaviviridae", "MN": "C01.925.782.350", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "caused by members of the Flaviviridae family: do not confuse with FLAVIVIRUS INFECTIONS caused by members of the Flavivirus genus; GEN or unspecified; prefer specifics", "MS": "Infections with viruses of the family FLAVIVIRIDAE.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018178"}, {"RECTYPE": "D", "MH": "Receptors, Thrombin", "DE": "RECEPT THROMBIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Thrombin Receptors|T116|T192|NON|EQV|NLM (1994)|930319|THROMBIN RECEPT|abbcdefv", "ENTRY": "Receptor, Thrombin", "MN": "D12.776.543.750.792.500", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (1981-1993)", "MS": "A family of proteinase-activated receptors that are specific for THROMBIN. They are found primarily on PLATELETS and on ENDOTHELIAL CELLS. Activation of thrombin receptors occurs through the proteolytic action of THROMBIN, which cleaves the N-terminal peptide from the receptor to reveal a new N-terminal peptide that is a cryptic ligand for the receptor. The receptors signal through HETEROTRIMERIC GTP-BINDING PROTEINS. Small synthetic peptides that contain the unmasked N-terminal peptide sequence can also activate the receptor in the absence of proteolytic activity.", "PM": "1994; THROMBIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1993; TRAP PEPTIDE was indexed under PROTEINS 2000-2003", "HN": "1994; use THROMBIN RECEPTOR (NM) 1981-1993; for TRAP PEPTIDE use RECEPTORS, THROMBIN (NM) 2000-2003", "MR": "20230316", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D018179"}, {"RECTYPE": "D", "MH": "Thrombomodulin", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "MN": "D12.776.543.750.750.850.800", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "AN": "a thrombin receptor", "PI": "Receptors, Cell Surface (1981-1993)", "MS": "A cell surface glycoprotein of endothelial cells that binds thrombin and serves as a cofactor in the activation of protein C and its regulation of blood coagulation.", "OL": "use RECEPTORS, THROMBIN (NM) to search THROMBOMODULIN 1981-93", "PM": "94; RECEPTORS, THROMBIN was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-93", "HN": "94; THROMBOMODULIN was SY to THROMBIN RECEPTOR (NM) 1981-93", "MR": "20230316", "DA": "19930630", "DC": "1", "DX": "19940101", "UI": "D018180"}, {"RECTYPE": "D", "MH": "Mice, Inbred CFTR", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Inbred CFTR Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.400.445", "MH_TH": "NLM (1994)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal ", "PI": "Mice (1992-1993)", "MS": "A strain of mice widely studied as a model for cystic fibrosis. These mice are generated from embryonic stem cells in which the CFTR (cystic fibrosis transmembrane conductance regulator) gene is inactivated by gene targeting. As a result, all mice have one copy of this altered gene in all their tissues. Mice homozygous for the disrupted gene exhibit many features common to young cystic fibrosis patients, including failure to thrive, meconium ileus, and alteration of mucous and serous glands.", "PM": "94", "HN": "94", "MR": "20200902", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018181"}, {"RECTYPE": "D", "MH": "Pestivirus Infections", "DE": "PESTIVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Pestivirus Infection", "MN": "C01.925.782.350.675", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Infections with viruses of the genus PESTIVIRUS, family FLAVIVIRIDAE.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018182"}, {"RECTYPE": "D", "MH": "Transplantation Chimera", "DE": "TRANSPL CHIMERA", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Chimera, Transplantation|T001|NON|EQV|NLM (1994)|930322|CHIMERA TRANSPL|abcdefv", "ENTRY": "Transplantation Chimeras|T001|NON|EQV|NLM (1994)|930324|TRANSPL CHIMERAS|abcdefv", "MN": "B05.200.750", "MH_TH": "NLM (1994)", "ST": "T001", "PI": "Chimera (1978-1993)", "MS": "An organism that, as a result of transplantation of donor tissue or cells, consists of two or more cell lines descended from at least two zygotes. This state may result in the induction of donor-specific TRANSPLANTATION TOLERANCE.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20150612", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018183"}, {"RECTYPE": "D", "MH": "Paramyxoviridae Infections", "DE": "PARAMYXOVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Parainfluenza Virus Infections|T047|NON|NRW|NLM (1997)|960124|abcdef", "ENTRY": "Virus Infections, Parainfluenza", "MN": "C01.925.782.580.600", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Paramyxovirus Infections (1977-1993)", "MS": "Infections with viruses of the family PARAMYXOVIRIDAE. This includes MORBILLIVIRUS INFECTIONS; RESPIROVIRUS INFECTIONS; PNEUMOVIRUS INFECTIONS; HENIPAVIRUS INFECTIONS; AVULAVIRUS INFECTIONS; and RUBULAVIRUS INFECTIONS.", "OL": "use PARAMYXOVIRIDAE INFECTIONS to search PARAINFLUENZA 1994-96 & PARA-INFLUENZA 1966-93", "PM": "94; PARAINFLUENZA was heading 1994-96; was PARA-INFLUENZA 1963-93 (see under MYXOVIRUS INFECTIONS (now ORTHOMYXOVIRUS INFECTIONS) 1963-69)", "HN": "94; PARAINFLUENZA was heading 1994-96; was PARA-INFLUENZA 1963-93 (see under MYXOVIRUS INFECTIONS (now ORTHOMYXOVIRUS INFECTIONS) 1963-69)", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018184"}, {"RECTYPE": "D", "MH": "Morbillivirus Infections", "DE": "MORBILLIVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Morbillivirus Infection", "MN": "C01.925.782.580.600.500", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Infections with viruses of the genus MORBILLIVIRUS, family PARAMYXOVIRIDAE. Infections mainly cause acute disease in their hosts, although in some cases infection is persistent and leads to degenerative conditions.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018185"}, {"RECTYPE": "D", "MH": "Pneumovirus Infections", "DE": "PNEUMOVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Pneumovirus Infection", "MN": "C01.925.782.580.600.550", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "caused by a RESPIROVIRUS; GEN or unspecified", "MS": "Infections with viruses of the genus PNEUMOVIRUS, family PARAMYXOVIRIDAE. This includes RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, an important cause of respiratory disease in humans.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018186"}, {"RECTYPE": "D", "MH": "Personal Construct Theory", "ENTRY": "Theory, Personal Construct", "MN": "F02.739.660", "MH_TH": "NLM (1994)", "ST": "T170", "AN": "includes personal construct, personal construct method, personal construct organization, etc.; for personal construct therapy, coordinate with PSYCHOTHERAPY ", "MS": "A psychological theory based on dimensions or categories used by a given person in describing or explaining the personality and behavior of others or of himself. The basic idea is that different people will use consistently different categories. The theory was formulated in the fifties by George Kelly. Two tests devised by him are the role construct repertory test and the repertory grid test. (From Stuart Sutherland, The International Dictionary of Psychology, 1989)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "DA": "19930602", "DC": "1", "DX": "19940101", "UI": "D018187"}, {"RECTYPE": "D", "MH": "Cardiovirus Infections", "DE": "CARDIOVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Cardiovirus", "MN": "C01.925.782.687.150", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "caused by a picornavirus", "MS": "Infections caused by viruses of the genus CARDIOVIRUS, family PICORNAVIRIDAE.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018188"}, {"RECTYPE": "D", "MH": "Immunomagnetic Separation", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Immunomagnetic Purging|T059|T062|NON|EQV|NLM (1994)|930324|abbcdef", "ENTRY": "Separations, Immunomagnetic Cell", "MN": "E05.242.363.441", "FX": "Bone Marrow Purging", "MH_TH": "NLM (1994)", "ST": "T062", "PI": "Cell Separation (1983-1993)", "MS": "A cell-separation technique where magnetizable microspheres or beads are first coated with monoclonal antibody, allowed to search and bind to target cells, and are then selectively removed when passed through a magnetic field. Among other applications, the technique is commonly used to remove tumor cells from the marrow (BONE MARROW PURGING) of patients who are to undergo autologous bone marrow transplantation.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018189"}, {"RECTYPE": "D", "MH": "Lymphatic Vessel Tumors", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Lymphatic Vessel", "MN": "C04.557.375", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "neoplasms composed of lymphatic tissue, not located in lymphatic tissue; coordinate with precoordinated organ/neoplasm term", "PI": "Lymphoma (1970-1993)", "MS": "Neoplasms composed of lymphoid tissue, a lattice work of reticular tissue the interspaces of which contain lymphocytes. The concept does not refer to neoplasms located in lymphatic vessels.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930624", "DC": "1", "DX": "19940101", "UI": "D018190"}, {"RECTYPE": "D", "MH": "Lymphangioma, Cystic", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Hygroma, Cystic|T191|NON|EQV|NLM (1994)|930329|abcdef", "ENTRY": "Lymphangiomas, Cystic", "MN": "C04.557.375.450.450", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with precoordinated organ /neoplasm term (IM)", "PI": "Lymphangioma (1966-1993)", "MS": "A cystic growth originating from lymphatic tissue. It is usually found in the neck, axilla, or groin.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19930624", "DC": "1", "DX": "19940101", "UI": "D018191"}, {"RECTYPE": "D", "MH": "Lymphangioleiomyomatosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lymphangiomyomatoses", "MN": "C20.683.515.710.465", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "differentiate from LYMPHANGIOMYOMA; coordinate IM with precoordinated organ/neoplasm terms (IM) if relevant", "PI": "Lymphangioma (1968-1993)", "MS": "A disease characterized by the progressive invasion of SMOOTH MUSCLE CELLS into the LYMPHATIC VESSELS, and the BLOOD VESSELS. The majority of the cases occur in the LUNGS of women of child-bearing age, eventually blocking the flow of air, blood, and lymph. The common symptom is shortness of breath (DYSPNEA).", "PM": "2006; see LYMPHANGIOMYOMATOSIS 1994-2005", "HN": "2006 (1994)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19930624", "DC": "1", "DX": "19940101", "UI": "D018192"}, {"RECTYPE": "D", "MH": "Neoplasms, Complex and Mixed", "DE": "NEOPL COMPLEX MIXED", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Complex and Mixed Neoplasms|T191|NON|EQV|NLM (1998)|960905|COMPLEX MIXED NEOPL|abcdefv", "MN": "C04.557.435", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "indexing policy: Manual section 24; coordinate IM with precoordinated organ/neoplasm term (IM)", "PI": "specific neoplasm (1966-1997)", "MS": "Neoplasms composed of more than one type of neoplastic tissue.", "PM": "98", "HN": "98; use explode 1994-97", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19930826", "DC": "1", "DX": "19980101", "UI": "D018193"}, {"RECTYPE": "D", "MH": "Adenomyoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Adenomyomas", "MN": "C04.557.435.110", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Endometriosis (1975-1993)", "MS": "A benign neoplasm of muscle (usually smooth muscle) with glandular elements. It occurs most frequently in the uterus and uterine ligaments. (Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930624", "DC": "1", "DX": "19940101", "UI": "D018194"}, {"RECTYPE": "D", "MH": "Adenosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Adenosarcomas", "MN": "C04.557.450.795.135", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Nephroblastoma (1966-1993)", "MS": "A malignant neoplasm arising simultaneously or consecutively in mesodermal tissue and glandular epithelium of the same part. (Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018195"}, {"RECTYPE": "D", "MH": "Carcinoma, Adenosquamous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Carcinomas, Adenosquamous", "MN": "C04.557.470.200.150", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Carcinoma, Squamous Cell (1968-1993)", "MS": "A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018196"}, {"RECTYPE": "D", "MH": "Hepatoblastoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Hepatoblastomas", "MN": "C04.557.435.380", "MH_TH": "OMIM (2013)", "ST": "T191", "AN": "coordinate with LIVER NEOPLASMS", "PI": "Carcinoma, Hepatocellular (1966-1993)", "MS": "A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018197"}, {"RECTYPE": "D", "MH": "Mixed Tumor, Malignant", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Malignant Mixed", "MN": "C04.557.435.525", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Neoplasms, Germ Cell and Embryonal (1966-1993)", "MS": "A malignant tumor composed of more than one type of neoplastic tissue. (Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018198"}, {"RECTYPE": "D", "MH": "Mixed Tumor, Mesodermal", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Mesodermal Mixed", "MN": "C04.557.450.795.530", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with probably UTERINE NEOPLASMS", "PI": "Neoplasms, Germ Cell and Embryonal (1968-1993)", "MS": "A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. It is associated with previous pelvic radiation exposure in 20% of patients. (Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1702)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018199"}, {"RECTYPE": "D", "MH": "Mixed Tumor, Mullerian", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumor, Mullerian Mixed", "MN": "C04.557.435.540", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "in titles & translations use diacrit: M\u00fcllerian; coordinate with probably UTERINE NEOPLASMS", "PI": "Neoplasms, Germ Cell and Embryonal (1968-1993)", "MS": "A tumor, basically a carcinoma with a single sarcoma such as leiomyosarcoma or angiosarcoma or multiple sarcomas of uterine origin. The role of estrogen has been postulated as a possible etiological factor in this tumor. (Holland et al., Cancer Medicine, 3d ed, p1703)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20010813", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018200"}, {"RECTYPE": "D", "MH": "Nephroma, Mesoblastic", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Nephromas, Mesoblastic", "MN": "C12.950.983.535.790", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with KIDNEY NEOPLASMS (IM)", "PI": "Nephroblastoma (1973-1993)", "MS": "A solid, unencapsulated tumor of the KIDNEY composed of spindle mesenchymal cells that resemble FIBROBLASTS or muscle cells. The homogeneous mass typically extends into the renal parenchyma and replaces most of the kidney. In most cases, mesoblastic nephroma is benign and occurs in the fetus or newborn, and rarely in the older child or the adult.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19930628", "DC": "1", "DX": "19940101", "UI": "D018201"}, {"RECTYPE": "D", "MH": "Pulmonary Blastoma", "DE": "PULM BLASTOMA", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Blastoma, Pulmonary|T191|NON|EQV|NLM (1994)|930625|BLASTOMA PULM|abcdefv", "ENTRY": "Pulmonary Blastomas|T191|NON|EQV|NLM (1994)|930414|PULM BLASTOMAS|abcdefv", "MN": "C04.588.894.797.520.867", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coord IM with LUNG NEOPLASMS (IM)", "PI": "Lung Neoplasms (1966-1993)", "MS": "A malignant neoplasm of the lung composed chiefly or entirely of immature undifferentiated cells (i.e., blast forms) with little or virtually no stroma. (From Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018202"}, {"RECTYPE": "D", "MH": "Sarcoma, Endometrial Stromal", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Endometrial Stromal Sarcoma|T191|NON|EQV|NLM (1994)|ORD (2010)|930329|abcdeef", "ENTRY": "Stromal Sarcomas, Endometrial", "MN": "C12.900.418.875.200.374.500", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with ENDOMETRIAL NEOPLASMS (IM); SARCOMA, ENDOMETRIAL STROMAL, LOW-GRADE see ENDOMETRIAL STROMAL TUMORS is also available", "PI": "Sarcoma (1967-1993)", "MS": "A highly malignant subset of neoplasms arising from the endometrial stroma. Tumors in this group infiltrate the stroma with a wide range of atypia cells and numerous mitoses. They are capable of widespread metastases (NEOPLASM METASTASIS).", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018203"}, {"RECTYPE": "D", "MH": "Neoplasms, Connective and Soft Tissue", "DE": "NEOPL CONNECTIVE SOFT TISSUE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Connective and Soft Tissue Neoplasms|T191|NON|EQV|NLM (1998)|960905|CONNECTIVE SOFT TISSUE NEOPL|abcdefv", "MN": "C04.557.450", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "neoplasms composed of connective or soft tissue, NOT neoplasms located in these sites; coordinate with precoordinated organ/neoplasm term; NEOPLASMS, CONNECTIVE TISSUE is available for neoplasms composed of connective tissue but SOFT TISSUE NEOPLASMS is available for neoplasms located in soft tissue ", "MS": "Neoplasms developing from some structure of the connective and subcutaneous tissue. The concept does not refer to neoplasms located in connective or soft tissue.", "PM": "98", "HN": "98; use explode 1994-97", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19930826", "DC": "1", "DX": "19980101", "UI": "D018204"}, {"RECTYPE": "D", "MH": "Neoplasms, Adipose Tissue", "DE": "NEOPL ADIPOSE TISSUE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasm, Adipose Tissue", "MN": "C04.557.450.550", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "neoplasms composed of adipose or soft tissue, NOT neoplasms located in adipose or soft tissue; coordinate with precoordinated organ/neoplasm term", "PI": "Soft Tissue Neoplasms (1978-1993)", "MS": "Neoplasms composed of fatty tissue or connective tissue made up of fat cells in a meshwork of areolar tissue. The concept does not refer to neoplasms located in adipose tissue.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018205"}, {"RECTYPE": "D", "MH": "Angiolipoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Angiolipomas", "MN": "C04.557.450.550.100", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Lipoma (1966-1993)", "MS": "A benign neoplasm composed of a mixture of adipose tissue and blood vessels. (Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018206"}, {"RECTYPE": "D", "MH": "Angiomyolipoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Angiomyolipomas", "MN": "C04.557.450.692.249", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Lipoma (1966-1993)", "MS": "A benign tumor containing vascular, adipose, and muscle elements. It occurs most often in the kidney with smooth muscle elements (angiolipoleiomyoma) in association with tuberous sclerosis. (Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018207"}, {"RECTYPE": "D", "MH": "Liposarcoma, Myxoid", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Round Cell Liposarcomas", "MN": "C04.557.450.795.465.425", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Liposarcoma (1968-1993)", "MS": "A liposarcoma containing round mesenchymal cells and a myxoid extracellular matrix in stroma.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20180308", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018208"}, {"RECTYPE": "D", "MH": "Myelolipoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Myelolipomas", "MN": "C04.557.450.550.710", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with ADRENAL GLAND NEOPLASMS ", "PI": "Myeloid Metaplasia (1971-1979)", "MS": "A rare benign tumor of the adrenal gland, several centimeters in diameter, composed in varying proportions of adipose tissue, lymphocytes, and primitive myeloid cells, probably a developmental abnormality. (Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018209"}, {"RECTYPE": "D", "MH": "Chondromatosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Chondromatoses", "MN": "C04.557.450.565.265.270", "MH_TH": "NLM (1994)", "ST": "T191", "PI": "Synovitis (1966-1981)", "MS": "Multiple formation of chondromas. (Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018210"}, {"RECTYPE": "D", "MH": "Chondrosarcoma, Mesenchymal", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Mesenchymal Chondrosarcomas", "MN": "C04.557.450.795.300.280", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with BONE NEOPLASMS or specific precoordinated bone/neoplasm term or specific bone + BONE NEOPLASMS", "PI": "Mesenchymoma (1966-1991)", "MS": "A rare aggressive variant of chondrosarcoma, characterized by a biphasic histologic pattern of small compact cells intermixed with islands of cartilaginous matrix. Mesenchymal chondrosarcomas have a predilection for flat bones; long tubular bones are rarely affected. They tend to occur in the younger age group and are highly metastatic. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1456)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018211"}, {"RECTYPE": "D", "MH": "Giant Cell Tumor of Bone", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "MN": "C04.557.450.565.575.420", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with BONE NEOPLASMS or specific precoordinated bone/neoplasm term or specific bone + BONE NEOPLASMS; osteoblastoclastoma: coordinate with OSTEOBLASTOMA + organ/neoplasm coordinated term", "PI": "Giant Cell Tumors (1966-1993)", "MS": "A bone tumor composed of cellular spindle-cell stroma containing scattered multinucleated giant cells resembling osteoclasts. The tumors range from benign to frankly malignant lesions. The tumor occurs most frequently in an end of a long tubular bone in young adults. (From Dorland, 27th ed; Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930702", "DC": "1", "DX": "19940101", "UI": "D018212"}, {"RECTYPE": "D", "MH": "Neoplasms, Bone Tissue", "DE": "NEOPL BONE TISSUE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tissue Neoplasms, Bony", "MN": "C04.557.450.565.575", "MH_TH": "NLM (1994)", "ST": "T191", "PI": "Bone Neoplasms (1966-1993)", "MS": "Neoplasms composed of bony tissue, whether normal or of a soft tissue which has become ossified. The concept does not refer to neoplasms located in bones.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19960610", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018213"}, {"RECTYPE": "D", "MH": "Fibroma, Ossifying", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Ossifying Fibromas", "MN": "C04.557.450.565.590.340.360", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with BONE NEOPLASMS (IM) and specific bone (IM) if pertinent or specific precoordinated bone/neoplasm term (IM)", "PI": "Ossification, Heterotopic (1968-1993)", "MS": "A benign central bone tumor, usually of the jaws (especially the mandible), composed of fibrous connective tissue within which bone is formed.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018214"}, {"RECTYPE": "D", "MH": "Osteoblastoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Osteoma, Giant Osteoid|T191|NON|EQV|NLM (1994)|930329|abcdef", "ENTRY": "Osteomas, Giant Osteoid", "MN": "C04.557.450.565.575.600", "MH_TH": "NLM (1994)", "ST": "T191", "PI": "Osteoma, Osteoid (1966-1993)", "MS": "A benign, painful, tumor of bone characterized by the formation of osteoid tissue, primitive bone and calcified tissue. It occurs frequently in the spine of young persons. (From Dorland, 27th ed; Stedman, 25th ed)", "OL": "use OSTEOMA, OSTEOID to search OSTEOBLASTOMA & GIANT OSTEOID OSTEOMA 1985-93", "PM": "94; was see OSTEOMA, OSTEOID 1985-93; GIANT OSTEOID OSTEOMA was see OSTEOMA, OSTEOID 1985-93", "HN": "94; was see OSTEOMA, OSTEOID 1985-93; GIANT OSTEOID OSTEOMA was see OSTEOMA, OSTEOID 1985-93", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19930702", "DC": "1", "DX": "19940101", "UI": "D018215"}, {"RECTYPE": "D", "MH": "Osteochondromatosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Osteochondromatoses", "MN": "C05.116.099.708.670.615", "MH_TH": "ORD (2010)", "ST": "T191", "PI": "Synovial Membrane (1966-1971)", "MS": "A condition marked by the presence of multiple osteochondromas. (Dorland, 27th ed)", "OL": "use EXOSTOSES, MULTIPLE HEREDITARY to search OSTEOCHONDROMATOSIS 1990-93", "PM": "94; was see EXOSTOSES, MULTIPLE HEREDITARY 1990-93", "HN": "94; was see EXOSTOSES, MULTIPLE HEREDITARY 1990-93", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018216"}, {"RECTYPE": "D", "MH": "Osteosarcoma, Juxtacortical", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Osteosarcomas, Juxtacortical", "MN": "C04.557.450.795.620.655", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with BONE NEOPLASMS or specific precoordinated bone/neoplasm term or specific bone + BONE NEOPLASMS ", "PI": "Osteosarcoma (1966-1993)", "MS": "A form of osteogenic sarcoma of relatively low malignancy, probably arising from the periosteum and initially involving cortical bone and adjacent connective tissue. It occurs in middle-aged as well as young adults and most commonly affects the lower part of the femoral shaft. (Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190702", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018217"}, {"RECTYPE": "D", "MH": "Neoplasms, Fibrous Tissue", "DE": "NEOPL FIBROUS TISSUE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasm, Fibrous Tissue", "MN": "C04.557.450.565.590", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "neoplasms composed of fibrous tissue, NOT neoplasms located in fibrous tissue; coordinate with precoordinated organ/neoplasm term", "MS": "Neoplasms composed of fibrous tissue, the ordinary connective tissue of the body, made up largely of yellow or white fibers. The concept does not refer to neoplasms located in fibrous tissue.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018218"}, {"RECTYPE": "D", "MH": "Histiocytoma, Benign Fibrous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Histiocytoma, Fibrous|T191|NON|EQV|NLM (1994)|990101|abcdef", "ENTRY": "Sclerosing Hemangiomas", "MN": "C04.557.450.565.590.425.350", "FX": "Pulmonary Sclerosing Hemangioma", "MH_TH": "NLM (2006)", "ST": "T191", "PI": "Dermatofibroma (1968-1993)", "MS": "A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)", "PM": "2006; see HISTIOCYTOMA, FIBROUS 1994-2005; for DERMATOFIBROMA see DERMATOFIBROMA 1994-2005, see ANGIOMA SCLEROSING 1963-1993", "HN": "2006 (1994)", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018219"}, {"RECTYPE": "D", "MH": "Fibroma, Desmoplastic", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Fibroma, Collagenous", "MN": "C04.557.450.565.590.340.345", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with BONE NEOPLASMS or specific precoordinated bone/neoplasm term or specific bone + BONE NEOPLASMS ", "PI": "Fibroma (1966-1993)", "MS": "An extremely rare bone tumor characterized by abundant collagen formation and a fibrous stroma, without evidence of mitosis or pleomorphism. It appears on x-rays as an osteolytic lesion with well-defined margins and must be differentiated from primary fibrosarcoma of bone. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1441)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20180308", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018220"}, {"RECTYPE": "D", "MH": "Fibromatosis, Abdominal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fibromatoses, Abdominal", "MN": "C04.557.450.565.590.340.400", "MH_TH": "NLM (1994)", "ST": "T191", "PI": "Fibroma (1967-1993)", "MS": "A relatively large mass of unusually firm scarlike connective tissue resulting from active participation of fibroblasts, occurring most frequently in the abdominal muscles of women who have borne children. The fibroblasts infiltrate surrounding muscle and fascia. (Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018221"}, {"RECTYPE": "D", "MH": "Fibromatosis, Aggressive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Desmoid|T191|NON|EQV|NLM (1994)|930326|abcdef", "ENTRY": "Fibromatoses, Aggressive", "MN": "C04.557.450.565.590.340.410", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term if specified ", "PI": "Fibroma (1969-1993)", "MS": "A childhood counterpart of abdominal or extra-abdominal desmoid tumors, characterized by firm subcutaneous nodules that grow rapidly in any part of the body but do not metastasize. The adult form of abdominal fibromatosis is FIBROMATOSIS, ABDOMINAL. (Stedman, 25th ed)", "OL": "use FIBROMA to search DESMOID 1991-93", "PM": "94; DESMOID was see FIBROMA 1991-93", "HN": "94; DESMOID was see FIBROMA 1991-93", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018222"}, {"RECTYPE": "D", "MH": "Dermatofibrosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumor, Darier-Hoffmann", "MN": "C04.557.450.795.350.320", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with with SKIN NEOPLASMS", "PI": "Skin Neoplasms (1966-1993)", "MS": "A sarcoma of the deep layers of the skin. The tumors are locally aggressive tends to recur but rarely metastatic. It can be classified into variants depending on the cell type tumors are derived from or by its characteristics: Pigmented variant from MELANIN-containing DERMAL DENDRITIC CELLS; Myxoid variant, myxoid STROMAL CELLS; Giant cell variant characterized by GIANT CELLS in the tumors; and Fibrosarcomatous variant chracterized by tumor areas histologically indistinguishable from FIBROSARCOMA.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018223"}, {"RECTYPE": "D", "MH": "Myofibromatosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Myofibromatoses", "MN": "C04.557.450.565.590.550", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Leiomyoma (1984-1993)", "MS": "A condition characterized by multiple formations of myofibromas (LEIOMYOMA).", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018224"}, {"RECTYPE": "D", "MH": "Neoplasms, Fibroepithelial", "DE": "NEOPL FIBROEPITHELIAL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasm, Fibroepithelial", "MN": "C04.557.470.625", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "neoplasms composed of fibrous & epithelial elements, NOT neoplasms located in fibrous or epithelial tissue; coordinate with precoordinated organ/neoplasm term", "MS": "Neoplasms composed of fibrous and epithelial tissue. The concept does not refer to neoplasms located in fibrous tissue or epithelium.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018225"}, {"RECTYPE": "D", "MH": "Fibroadenoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Fibroadenomas", "MN": "C04.557.470.625.350", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "do not confuse with ADENOFIBROMA; coordinate with precoordinated organ/neoplasm term", "PI": "Breast Neoplasms (1966-1993)", "MS": "An adenoma containing fibrous tissue. It should be differentiated from ADENOFIBROMA which is a tumor composed of connective tissue (fibroma) containing glandular (adeno-) structures. (From Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018226"}, {"RECTYPE": "D", "MH": "Sarcoma, Clear Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Melanoma, Malignant, of Soft Parts|T191|NON|EQV|NLM (1994)|930416|abcdef", "ENTRY": "Sarcomas, Clear Cell", "MN": "C04.557.450.795.800", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term ", "PI": "Sarcoma (1966-1993)", "MS": "A sarcoma of young adults occurring in the lower extremities and acral regions. It is found intimately bound to tendons as a circumscribed but unencapsulated melanin-bearing tumor of neuroectodermal origin. Clear cell sarcoma is associated with a specific t(12;22)(q13;q12) translocation.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20181102", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018227"}, {"RECTYPE": "D", "MH": "Sarcoma, Small Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Small Cell Sarcomas", "MN": "C04.557.450.795.870", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Sarcoma, Ewing's (1986-1993)", "MS": "A sarcoma characterized by the presence of small cells, cells measuring 9-14 micrometers with a faint or indistinct rim of cytoplasm and an oval-to-elongated nucleus with relatively dense chromatin. (From Segen, Dictionary of Modern Medicine, 1992)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930628", "DC": "1", "DX": "19940101", "UI": "D018228"}, {"RECTYPE": "D", "MH": "Angiomyoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Leiomyoma, Vascular|T191|NON|EQV|NLM (1994)|930419|abcdef", "ENTRY": "Vascular Leiomyomas", "MN": "C04.557.450.590.450.125", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with organ/neopl term (IM)", "PI": "Leiomyoma (1975-1993)", "MS": "A benign tumor consisting of vascular and smooth muscle elements.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018229"}, {"RECTYPE": "D", "MH": "Leiomyoma, Epithelioid", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Leiomyoblastoma|T191|NON|EQV|NLM (1994)|930513|abcdef", "ENTRY": "Leiomyomas, Epithelioid", "MN": "C04.557.450.590.450.455", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Leiomyoma (1966-1993)", "MS": "A relatively rare smooth muscle tumor found most frequently in the wall of the gastrointestinal tract, especially in the stomach. It is similar to other smooth muscle tumors but may become very large and hemorrhage and exhibit small cystic areas. Simple excision is almost always curative. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1354)", "OL": "use LEIOMYOMA to search LEIOMYOBLASTOMA 1992-93", "PM": "94; LEIOMYOBLASTOMA was see LEIOMYOMA 1992-93", "HN": "94; LEIOMYOBLASTOMA was see LEIOMYOMA 1992-93", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018230"}, {"RECTYPE": "D", "MH": "Leiomyomatosis", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Leiomyomatoses", "MN": "C04.557.450.590.450.465", "MH_TH": "NLM (1994)", "ST": "T191", "PI": "Leiomyoma (1966-1993)", "MS": "The state of having multiple leiomyomas throughout the body. (Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19980610", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018231"}, {"RECTYPE": "D", "MH": "Rhabdomyosarcoma, Alveolar", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Rhabdomyosarcomas, Alveolar", "MN": "C04.557.450.795.550.660.665", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "\"alveolar\" does not refer to pulmonary alveoli: it refers to the pathological appearance; coordinate IM with precoordinated organ/neoplasm term (IM)", "PI": "Rhabdomyosarcoma (1968-1993)", "MS": "A form of RHABDOMYOSARCOMA occurring mainly in adolescents and young adults, affecting muscles of the extremities, trunk, orbital region, etc. It is extremely malignant, metastasizing widely at an early stage. Few cures have been achieved and the prognosis is poor. \"Alveolar\" refers to its microscopic appearance simulating the cells of the respiratory alveolus. (Holland et al., Cancer Medicine, 3d ed, p2188)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018232"}, {"RECTYPE": "D", "MH": "Rhabdomyosarcoma, Embryonal", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Rhabdomyosarcomas, Embryonal", "MN": "C04.557.450.795.550.660.675", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Rhabdomyosarcoma (1966-1993)", "MS": "A form of RHABDOMYOSARCOMA arising primarily in the head and neck, especially the orbit, of children below the age of 10. The cells are smaller than those of other rhabdomyosarcomas and are of two basic cell types: spindle cells and round cells. This cancer is highly sensitive to chemotherapy and has a high cure rate with multi-modality therapy. (From Holland et al., Cancer Medicine, 3d ed, p2188)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018233"}, {"RECTYPE": "D", "MH": "Sarcoma, Alveolar Soft Part", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Alveolar Soft Part Sarcoma|T191|NON|EQV|NLM (2010)|ORD (2010)|090608|abcdeef", "ENTRY": "Alveolar Soft-Part Sarcoma|T191|NON|EQV|OMIM (2013)|111115|abcdef", "MN": "C04.557.450.795.775", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "\"alveolar\" has nothing to do with pulmonary alveoli: it refers to sac-like pathology of soft part; coordinate with precoordinated organ/neoplasm term ", "PI": "Soft Tissue Neoplasms (1976-1993)", "MS": "A variety of rare sarcoma having a reticulated fibrous stroma enclosing groups of sarcoma cells, which resemble epithelial cells and are enclosed in alveoli walled with connective tissue. It is a rare tumor, usually occurring between 15 and 35 years of age. It appears in the muscles of the extremities in adults and most commonly in the head and neck regions of children. Though slow-growing, it commonly metastasizes to the lungs, brain, bones, and lymph nodes. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1365)", "PM": "1994", "HN": "1994", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018234"}, {"RECTYPE": "D", "MH": "Smooth Muscle Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Smooth Muscle", "MN": "C04.557.450.590.800", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "a specific histological type: do not confuse with NEOPLASMS, MUSCLE TISSUE, a group histological term; coordinate with precoordinated organ/neoplasm term", "PI": "Neoplasms, Muscle Tissue (1981-1993)", "MS": "A tumor composed of smooth muscle tissue, as opposed to leiomyoma, a tumor derived from smooth muscle.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018235"}, {"RECTYPE": "D", "MH": "Carcinoma, Embryonal", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Embryonal Carcinomas", "MN": "C04.557.465.200", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with OVARIAN NEOPLASMS or TESTICULAR NEOPLASMS & appropriate check tags", "PI": "Tumor Stem Cells (1985-1993)", "MS": "A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018236"}, {"RECTYPE": "D", "MH": "Germinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Germinomas", "MN": "C04.557.465.330", "FX": "Testicular Neoplasms", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "PI": "Teratoma (1966-1993)", "MS": "A malignant neoplasm of the germinal tissue of the GONADS; MEDIASTINUM; or pineal region. Germinomas are uniform in appearance, consisting of large, round cells with vesicular nuclei and clear or finely granular eosinophilic-staining cytoplasm. (Stedman, 265th ed; from DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1642-3)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018237"}, {"RECTYPE": "D", "MH": "Gonadoblastoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Gonadoblastomas", "MN": "C19.391.119.309.388.500", "MH_TH": "OMIM (2013)", "ST": "T191", "AN": "coordinate IM with OVARIAN NEOPLASMS (IM) or TESTICULAR NEOPLASMS (IM) & appropriate check tags", "PI": "Dysgerminoma (1966-1993)", "MS": "A complex neoplasm composed of a mixture of gonadal elements, such as large primordial GERM CELLS, immature SERTOLI CELLS or GRANULOSA CELLS of the sex cord, and gonadal stromal cells. Gonadoblastomas are most often associated with gonadal dysgenesis, 46, XY.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018238"}, {"RECTYPE": "D", "MH": "Seminoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Seminomas", "MN": "C04.557.465.330.800", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate with TESTICULAR NEOPLASMS", "PI": "Dysgerminoma (1966-1993)", "MS": "A radiosensitive, malignant neoplasm of the testis, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. There are three variants: classical (typical), the most common type; anaplastic; and spermatocytic. The classical seminoma is composed of fairly well differentiated sheets or cords of uniform polygonal or round cells (seminoma cells), each cell having abundant clear cytoplasm, distinct cell membranes, a centrally placed round nucleus, and one or more nucleoli. In the female, a grossly and histologically identical neoplasm, known as dysgerminoma, occurs. (Dorland, 27th ed)", "OL": "use DYSGERMINOMA to search SEMINOMA 1979-93", "PM": "94; was see DYSGERMINOMA 1979-93", "HN": "94; was see DYSGERMINOMA 1979-93", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018239"}, {"RECTYPE": "D", "MH": "Endodermal Sinus Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Yolk Sac Tumor|T191|NON|EQV|NLM (1994)|ORD (2010)|930329|abcdeef", "ENTRY": "Yolk Sac Tumors", "MN": "C04.557.465.510.350", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Mesonephroma (1968-1993)", "MS": "An unusual and aggressive tumor of germ-cell origin that reproduces the extraembryonic structures of the early embryo. It is the most common malignant germ cell tumor found in children. It is characterized by a labyrinthine glandular pattern of flat epithelial cells and rounded papillary processes with a central capillary (Schiller-Duval body). The tumor is rarely bilateral. Before the use of combination chemotherapy, the tumor was almost invariably fatal. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1189)", "OL": "use MESONEPHROMA to search ENDODERMAL SINUS TUMOR & YOLK SAC TUMOR 1979-93", "PM": "94; was see MESONEPHROMA 1979-93; YOLK SAC TUMOR was see MESONEPHROMA 1979-93", "HN": "94; was see MESONEPHROMA 1979-93; YOLK SAC TUMOR was see MESONEPHROMA 1979-93", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018240"}, {"RECTYPE": "D", "MH": "Neuroectodermal Tumors, Primitive, Peripheral", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Peripheral Primitive Neuroectodermal Tumors|T191|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Tumors, Peripheral Neuroectodermal", "MN": "C04.557.580.625.600.590.650", "MH_TH": "NLM (2000)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "PI": "Neuroepithelioma (1975-1989)", "MS": "A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with EWING SARCOMA.", "PM": "2000; see NEUROECTODERMAL TUMOR, PERIPHERAL 1994-1999; NEUROEPITHELIOMA was heading 1966-1999", "HN": "2000(1994)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018241"}, {"RECTYPE": "D", "MH": "Neuroectodermal Tumors, Primitive", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Spongioblastoma|T191|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Tumors, Primitive Neuroepithelial", "MN": "C04.557.580.625.600.590", "MH_TH": "NLM (2000)", "ST": "T191", "AN": "coord IM with BRAIN NEOPLASMS (IM) or specific precoord organ/neopl term (IM); do not confuse with MEDULLOBLASTOMA", "PI": "Neoplasms, Germ Cell and Embryonal (1979-1993)", "MS": "A group of malignant tumors of the nervous system that feature primitive cells with elements of neuronal and/or glial differentiation. Use of this term is limited by some authors to central nervous system tumors and others include neoplasms of similar origin which arise extracranially (i.e., NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL). This term is also occasionally used as a synonym for MEDULLOBLASTOMA. In general, these tumors arise in the first decade of life and tend to be highly malignant. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2059)", "PM": "2000; see NEUROECTODERMAL TUMOR, PRIMITIVE 1994-1999", "HN": "2000(1994)", "CATSH": "CAT LIST", "MR": "20050721", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018242"}, {"RECTYPE": "D", "MH": "Teratocarcinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Teratocarcinomas", "MN": "C04.557.465.900", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with probably TESTICULAR NEOPLASMS", "PI": "Teratoma (1967-1993)", "MS": "A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. (Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018243"}, {"RECTYPE": "D", "MH": "Chromosomes, Artificial, Yeast", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Yeast Artificial Chromosomes|T075|NON|EQV|NLM (1994)|930415|abcdef", "ENTRY": "Yeast Artificial Chromosome", "MN": "G05.360.337.249.200", "MH_TH": "NLM (2002)", "ST": "T075", "AN": "coordinate with specific yeast /genet only if particularly discussed", "PI": "Chromosomes, Fungal (1988-1993)", "MS": "Chromosomes in which fragments of exogenous DNA ranging in length up to several hundred kilobase pairs have been cloned into yeast through ligation to vector sequences. These artificial chromosomes are used extensively in molecular biology for the construction of comprehensive genomic libraries of higher organisms.", "PM": "2002; see CHROMOSOMES, YEAST ARTIFICIAL 1994-2001", "HN": "2002 (1994)", "MR": "20180630", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018244"}, {"RECTYPE": "D", "MH": "Trophoblastic Tumor, Placental Site", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Placental-Site Trophoblastic Tumor|T191|NON|EQV|NLM (1994)|930329|abcdef", "ENTRY": "Tumors, Placental-Site Trophoblastic", "MN": "C12.050.703.720.949.208.875", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with UTERINE NEOPLASMS (IM); check the tags FEMALE & PREGNANCY", "PI": "Trophoblastic Neoplasms (1980-1993)", "MS": "An uncommon variant of CHORIOCARCINOMA. It is composed almost entirely of mononuclear cytotrophoblasts (TROPHOBLASTS). Because its secretion of hCG (CHORIONIC GONADOTROPIN) is low, a large tumor may develop before the hCG can be detected.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018245"}, {"RECTYPE": "D", "MH": "Adrenocortical Adenoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Conn's Disease|T191|EPO|NRW|UNK (19XX)|740330|CONNS DIS|abcdefv", "ENTRY": "Disease, Conn's", "MN": "C19.344.078.265.500", "MH_TH": "NLM (2005)", "ST": "T191", "AN": "coordinate IM with ADRENAL CORTEX NEOPLASMS; do not confuse entry term CONN DISEASE with CONN SYNDROME see HYPERALDOSTERONISM", "PI": "Adenoma (1966-1993)", "MS": "A benign neoplasm of the ADRENAL CORTEX. It is characterized by a well-defined nodular lesion, usually less than 2.5 cm. Most adrenocortical adenomas are nonfunctional. The functional ones are yellow and contain LIPIDS. Depending on the cell type or cortical zone involved, they may produce ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE.", "PM": "2005; see ADENOMA, ADRENAL CORTICAL 1994-2004; for CONN'S DISEASE use HYPERALDOSTERONISM 1985-2004", "HN": "2005 (1994); for CONN'S DISEASE use HYPERALDOSTERONISM 1985-2004", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018246"}, {"RECTYPE": "D", "MH": "Helicobacter heilmannii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Helicobacter suis|T007|NON|REL|NLM (2001)|000207|abcdef", "ENTRY": "Candidatus Helicobacter suis|T007|NON|REL|NLM (2001)|000207|abcdef", "MN": "B03.660.150.235.500.250.400", "MH_TH": "NLM (2001)", "ST": "T007", "RN": "txid35817", "RR": "txid104628", "AN": "infection: coordinate with HELICOBACTER INFECTIONS", "PI": "Gram-Negative Bacteria (1989-1993)", "MS": "A species of gram-negative, spiral-shaped bacteria found in the gastric mucosa that is associated with chronic antral gastritis. This bacterium was first discovered in samples removed at endoscopy from patients investigated for HELICOBACTER PYLORI colonization.", "PM": "2001; see GASTROSPIRILLUM HOMINUS 1993-2000", "HN": "2001(1994); for GASTROSPIRILLUM SUIS use GASTROSPIRILLUM 1993-2000", "MR": "20200806", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018247"}, {"RECTYPE": "D", "MH": "Adenoma, Liver Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Hepatoma, Benign|T191|NON|EQV|NLM (1994)|930625|abcdef", "ENTRY": "Liver Cell Adenomas", "MN": "C06.552.697.040", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with LIVER NEOPLASMS (IM)", "PI": "Liver Neoplasms (1966-1993)", "MS": "A benign epithelial tumor of the LIVER.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018248"}, {"RECTYPE": "D", "MH": "Adenoma, Oxyphilic", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Oncocytoma|T191|NON|EQV|NLM (1997)|OMIM (2013)|950825|abcdeef", "ENTRY": "Oxyphilic Adenoma", "MN": "C04.557.470.035.140", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with precoord organ/neopl term (IM); for entry term HURTHLE CELL TUMOR, coord IM with THYROID NEOPLASMS", "PI": "Adenoma (1967-1993)", "MS": "A usually benign glandular tumor composed of oxyphil cells, large cells with small irregular nuclei and dense acidophilic granules due to the presence of abundant MITOCHONDRIA. Oxyphil cells, also known as oncocytes, are found in oncocytomas of the kidney, salivary glands, and endocrine glands. In the thyroid gland, oxyphil cells are known as Hurthle cells and Askanazy cells.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018249"}, {"RECTYPE": "D", "MH": "Acrospiroma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Spiradenoma|T191|NON|EQV|NLM (2020)|181115|abcdef", "ENTRY": "Spiradenomas, Eccrine", "MN": "C04.557.470.550.175.125", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with SWEAT GLAND NEOPLASMS (IM)", "PI": "Sweat Gland Neoplasms (1969-1984)", "MS": "A rare cutaneous tumor of apocrine or eccrine SWEAT GLAND origin. It is most commonly found on the extremities and is usually benign. It appears as a solitary nodule or cyst and may be solid or produce a watery discharge. It is related to POROMA except in acrospiroma it does not involve the epidermis. There is no indication that heredity or external agents cause these tumors.", "PM": "2010; see ACROSPIROMA, ECCRINE 1994-2009; for HIDRADENOMA see ADENOMA, SWEAT GLAND 1994-2009, see HIDRADENOMA 1963-1993", "HN": "2010 (1994); for HIDRADENOMA use ADENOMA, SWEAT GLAND 1963-2009", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018250"}, {"RECTYPE": "D", "MH": "Hidrocystoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Hidrocystomas", "MN": "C04.557.470.550.175.375", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with SWEAT GLAND NEOPLASMS", "PI": "Sweat Gland Neoplasms (1971-1993)", "MS": "A cystic form of sweat gland adenoma (ADENOMA, SWEAT GLAND). It is produced by the cystic proliferation of apocrine secretory glands. It is not uncommon, occurring in adult life in no particular age group, with males and females equally affected. The commonest site is around the eye, particularly lateral to the outer canthus. It is cured by surgical removal. (Stedman, 25th ed; Rook et al., Textbook of Dermatology, 4th ed, p2410)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018251"}, {"RECTYPE": "D", "MH": "Syringoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Syringomas", "MN": "C04.557.470.550.175.800", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with SWEAT GLAND NEOPLASMS", "PI": "Sweat Gland Neoplasms (1968-1993)", "MS": "A benign tumor of the sweat glands which is usually multiple and results from malformation of sweat ducts. It is uncommon and more common in females than in males. It is most likely to appear at adolescence, and further lesions may develop during adult life. It does not appear to be hereditary. (Rook et al., Textbook of Dermatology, 4th ed, pp2407-8)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018252"}, {"RECTYPE": "D", "MH": "Adenoma, Villous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Villous Adenomas", "MN": "C04.557.470.035.185", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with probably COLONIC NEOPLASMS", "PI": "Adenoma (1967-1993)", "MS": "An adenoma of the large intestine. It is usually a solitary, sessile, often large, tumor of colonic mucosa composed of mucinous epithelium covering delicate vascular projections. Hypersecretion and malignant changes occur frequently. (Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018253"}, {"RECTYPE": "D", "MH": "Adenomatoid Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Tumors, Adenomatoid", "MN": "C04.557.470.660.200", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated genital/neoplasm term", "MS": "A small, circumscribed, benign tumor of the genital tract, composed of small glandlike spaces lined by flattened or cuboidal mesothelium-like cells. (From Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018254"}, {"RECTYPE": "D", "MH": "Adenomatosis, Pulmonary", "DE": "ADENOMATOSIS PULM", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pulmonary Adenomatosis|T191|NON|EQV|NLM (1994)|930329|PULM ADENOMATOSIS|abcdefv", "ENTRY": "Pulmonary Adenomatoses", "MN": "C04.557.470.035.210", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with LUNG NEOPLASMS", "MS": "A neoplastic disease in which the alveoli and distal bronchi are filled with mucus and mucus-secreting columnar epithelial cells. It is characterized by abundant, extremely tenacious sputum, chills, fever, cough, dyspnea, and pleuritic pain. (Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018255"}, {"RECTYPE": "D", "MH": "Adenomatous Polyps", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Polyps, Adenomatous", "MN": "C04.557.470.035.215", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "neoplastic; coordinate with precoordinated organ/neoplasm term", "PI": "Polyps (1966-1993)", "MS": "Benign neoplasms derived from glandular epithelium. (From Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018256"}, {"RECTYPE": "D", "MH": "Helix-Loop-Helix Motifs", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "HLH Motifs|T082|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Motifs, Helix Loop Helix", "MN": "G02.111.570.820.709.275.500.360", "MH_TH": "NLM (1994)", "ST": "T082", "AN": "do not confuse with HELIX-TURN-HELIX MOTIFS", "PI": "Amino Acid Sequence (1989-1993)", "MS": "Recurring supersecondary structures characterized by 20 amino acids folding into two alpha helices connected by a non-helical \"loop\" segment. They are found in many sequence-specific DNA-BINDING PROTEINS and in CALCIUM-BINDING PROTEINS.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160527", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018257"}, {"RECTYPE": "D", "MH": "Herpesvirus 2, Human", "DE": "HHV 2", "DS": "HERPESVIRUS HUMAN 02", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human Herpesvirus 2|T005|NON|EQV|NLM (2002)|010108|HUMAN HERPESVIRUS 02|abcdefs", "ENTRY": "Herpesvirus 2 (alpha), Human|T005|NON|EQV|NLM (1994)|930329|HERPESVIRUS 2 ALPHA HUMAN|abcdefv", "MN": "B04.280.382.100.750.440", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10310", "PI": "Simplexvirus (1966-1993)", "MS": "A species of SIMPLEXVIRUS associated with genital infections (HERPES GENITALIS). It is transmitted by sexual intercourse and close personal contact.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018258"}, {"RECTYPE": "D", "MH": "Herpesvirus 1, Human", "DE": "HHV 1", "DS": "HERPESVIRUS HUMAN 01", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Herpes Simplex Virus 1|T005|NON|EQV|NLM (1994)|930413|HERPES SIMPLEX VIRUS 01|abcdefs", "ENTRY": "Human Herpesvirus 1|T005|NON|EQV|NLM (2002)|150623|HUMAN HERPESVIRUS 01|abcdefs", "MN": "B04.280.382.100.750.390", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10298", "AN": "infection: coordinate with HERPES SIMPLEX or its indentions ", "PI": "Simplexvirus (1966-1993)", "MS": "The type species of SIMPLEXVIRUS causing most forms of non-genital herpes simplex in humans. Primary infection occurs mainly in infants and young children and then the virus becomes latent in the dorsal root ganglion. It then is periodically reactivated throughout life causing mostly benign conditions.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018259"}, {"RECTYPE": "D", "MH": "Gelsolin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Serum Actin Inhibitory Protein|T116|T123|NON|EQV|NLM (2006)|abbcde", "MN": "D12.776.476.387.437", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "MS": "A 90-kDa protein produced by macrophages that severs ACTIN filaments and forms a cap on the newly exposed filament end. Gelsolin is activated by CALCIUM ions and participates in the assembly and disassembly of actin, thereby increasing the motility of some CELLS.", "PM": "1994; GELSOLIN was indexed under CALCIUM-BINDING PROTEINS and MICROFILAMENT PROTEINS 1980-1993; SERUM ACTIN IHIBITORY PROTEIN was indexed under MICROFILAMENT PROTEINS 1988-2005, & under MUSCLE PROTEINS & PROTEINS 1986-1987", "HN": "1994(1980)", "MR": "20170630", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018260"}, {"RECTYPE": "D", "MH": "Mesothelioma, Cystic", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Mesotheliomas, Cystic", "MN": "C04.557.470.660.510.515", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with PERITONEAL NEOPLASMS", "PI": "Mesothelioma (1979-1993)", "MS": "A peritoneal mesothelioma affecting mainly young females and producing cysts of variable size and number lined by a single layer of benign mesothelial cells. The disease follows a benign course and is compatible with a normal life expectancy, requiring occasionally partial excision or decompression for relief of pain or other symptoms. Malignant potential is exceptional. (From Holland et al., Cancer Medicine, 3d ed, p1345)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018261"}, {"RECTYPE": "D", "MH": "Adenocarcinoma, Clear Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Clear Cell Adenocarcinomas", "MN": "C04.557.470.200.025.045", "FX": "Cystadenofibroma", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "PI": "Adenocarcinoma (1966-1993)", "MS": "An adenocarcinoma characterized by the presence of varying combinations of clear and hobnail-shaped tumor cells. There are three predominant patterns described as tubulocystic, solid, and papillary. These tumors, usually located in the female reproductive organs, have been seen more frequently in young women since 1970 as a result of the association with intrauterine exposure to diethylstilbestrol. (From Holland et al., Cancer Medicine, 3d ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018262"}, {"RECTYPE": "D", "MH": "Adenocarcinoma, Follicular", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Thyroid Carcinomas, Follicular", "MN": "C04.557.470.200.025.060", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with THYROID NEOPLASMS (IM)", "PI": "Thyroid Neoplasms (1969-1993)", "MS": "An adenocarcinoma of the thyroid gland, in which the cells are arranged in the form of follicles. (From Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018263"}, {"RECTYPE": "D", "MH": "Carcinoma, Papillary, Follicular", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "MN": "C04.557.470.200.025.085.225", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with THYROID NEOPLASMS", "PI": "Carcinoma, Papillary (1970-1993)", "MS": "A thyroid neoplasm of mixed papillary and follicular arrangement. Its biological behavior and prognosis is the same as that of a papillary adenocarcinoma of the thyroid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1271)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018265"}, {"RECTYPE": "D", "MH": "Adenocarcinoma, Sebaceous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Sebaceous Adenocarcinomas", "MN": "C04.557.470.550.105", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with SEBACEOUS GLAND NEOPLASMS ", "PI": "Sebaceous Gland Neoplasms (1969-1993)", "MS": "A malignant tumor composed of cells showing differentiation toward sebaceous epithelium. The tumor is solitary, firm, somewhat raised, more or less translucent, and covered with normal or slightly verrucose epidermis. It may be yellow or orange. The face and scalp are the commonest sites. The growth can be slow or rapid but metastasis is uncommon. Surgery cures most of the cases. (From Rook et al., Textbook of Dermatology, 4th ed, pp2403-4)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018266"}, {"RECTYPE": "D", "MH": "Carcinoma, Acinar Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Acinic Cell", "MN": "C04.557.470.200.025.215", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Carcinoma (1966-1993)", "MS": "A malignant tumor arising from secreting cells of a racemose gland, particularly the salivary glands. Racemose (Latin racemosus, full of clusters) refers, as does acinar (Latin acinus, grape), to small saclike dilatations in various glands. Acinar cell carcinomas are usually well differentiated and account for about 13% of the cancers arising in the parotid gland. Lymph node metastasis occurs in about 16% of cases. Local recurrences and distant metastases many years after treatment are common. This tumor appears in all age groups and is most common in women. (Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1240; from DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018267"}, {"RECTYPE": "D", "MH": "Adrenocortical Carcinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Carcinoma, Adrenal Cortical|T191|NON|EQV|NLM (1994)|990101|abcdef", "ENTRY": "Carcinomas, Adrenocortical", "MN": "C19.344.078.265.750", "MH_TH": "NLM (2005)", "ST": "T191", "AN": "coordinate IM with ADRENAL CORTEX NEOPLASMS (IM)", "PI": "Carcinoma (1966-1993)", "MS": "A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.", "PM": "2005; see CARCINOMA, ADRENAL CORTICAL 1994-2004", "HN": "2005 (1994)", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018268"}, {"RECTYPE": "D", "MH": "Carcinoma, Endometrioid", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Endometrioid Carcinomas", "MN": "C19.391.630.705.331", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with OVARIAN NEOPLASMS (IM) or ENDOMETRIAL NEOPLASMS (IM)", "PI": "Ovarian Neoplasms (1966-1993)", "MS": "An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018269"}, {"RECTYPE": "D", "MH": "Carcinoma, Ductal, Breast", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Carcinoma, Infiltrating Duct|T191|NON|EQV|NLM (1994)|990101|abcdef", "ENTRY": "Mammary Ductal Carcinomas", "MN": "C17.800.090.500.390", "MH_TH": "NLM (2004)", "ST": "T191", "AN": "coord IM with BREAST NEOPLASMS (IM)", "MS": "An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.", "PM": "2004; see CARCINOMA, INFILTRATING DUCT 1994-2003", "HN": "2004 (1994)", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19930628", "DC": "1", "DX": "19940101", "UI": "D018270"}, {"RECTYPE": "D", "MH": "Signal Recognition Particle", "DE": "SIG REC PART", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SRP (Signal Recognition Particle)|T116|T123|ABB|EQV|NLM (1994)|930330|abbcdef", "ENTRY": "Recognition Particle, Signal", "MN": "D12.776.664.962.500.750.800", "FX": "Protein Sorting Signals", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1985-1993)", "MS": "A cytosolic ribonucleoprotein complex that acts to induce elongation arrest of nascent presecretory and membrane proteins until the ribosome becomes associated with the rough endoplasmic reticulum. It consists of a 7S RNA and at least six polypeptide subunits (relative molecular masses 9, 14, 19, 54, 68, and 72K).", "OL": "use SIGNAL RECOGNITION PARTICLE (NM) to search SIGNAL RECOGNITION PARTICLE 1985-93", "PM": "94; SIGNAL RECOGNITION PARTICLE was indexed under RIBONUCLEOPROTEINS 1985-93", "HN": "94; was SIGNAL RECOGNITION PARTICLE (NM) 1985-93", "MR": "20050630", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018271"}, {"RECTYPE": "D", "MH": "Porins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Porin|T116|T123|NON|EQV|NLM (2021)|200113|abbcdef", "ENTRY": "Proteins, Pore", "MN": "D12.776.543.585.400.730", "MH_TH": "NLM (1994)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1977-1984)", "MS": "Porins are protein molecules that were originally found in the outer membrane of GRAM-NEGATIVE BACTERIA and that form multi-meric channels for the passive DIFFUSION of WATER; IONS; or other small molecules. Porins are present in bacterial CELL WALLS, as well as in plant, fungal, mammalian and other vertebrate CELL MEMBRANES and MITOCHONDRIAL MEMBRANES.", "OL": "use PORINS (NM) to search PORINS & PHOE PROTEIN 1977-93", "PM": "94; PORINS & PHOE PROTEIN were indexed under BACTERIAL OUTER MEMBRANE PROTEINS 1985-93 & MEMBRANE PROTEINS 1977-93", "HN": "94; was PORINS (NM) 1977-93; PHOE PROTEIN was SY to PORINS (NM) 1977-93", "MR": "20200527", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018272"}, {"RECTYPE": "D", "MH": "Carcinoma, Islet Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Islet Cell Tumor, Malignant|T191|NON|EQV|NLM (1994)|930330|abcdef", "ENTRY": "Islet Cell Carcinomas", "MN": "C19.344.421.500", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coord IM with PANCREATIC NEOPLASMS (IM)", "PI": "Adenoma, Islet Cell (1966-1993)", "MS": "A primary malignant neoplasm of the pancreatic ISLET CELLS. Usually it involves the non-INSULIN-producing cell types, the PANCREATIC ALPHA CELLS and the pancreatic delta cells (SOMATOSTATIN-SECRETING CELLS) in GLUCAGONOMA and SOMATOSTATINOMA, respectively.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018273"}, {"RECTYPE": "D", "MH": "Electroporation", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Reversible Electroporation|T059|NON|NRW|NLM (2023)|211015|abcdef", "ENTRY": "Electroporation, Reversible", "MN": "E05.301.500", "MH_TH": "NLM (1994)", "ST": "T062", "MS": "A technique in which electric pulses, in kilovolts per centimeter and of microsecond-to-millisecond duration, cause a loss of the semipermeability of CELL MEMBRANES, thus leading to ion leakage, escape of metabolites, and increased uptake by cells of drugs, molecular probes, and DNA. Depending on the dosage, the formation of openings in the cell membranes caused by the electric pulses may or may not be reversible.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20220408", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018274"}, {"RECTYPE": "D", "MH": "Carcinoma, Lobular", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Lobular Carcinomas", "MN": "C17.800.090.500.437", "FX": "Breast Carcinoma In Situ", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with BREAST NEOPLASMS (IM)", "PI": "Carcinoma (1966-1993)", "MS": "A type of BREAST CANCER where the abnormal malignant cells form in the lobules, or milk-producing glands, of the breast.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20160613", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018275"}, {"RECTYPE": "D", "MH": "Carcinoma, Medullary", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Medullary Carcinomas", "MN": "C04.557.580.625.650.240.315", "FX": "Multiple Endocrine Neoplasia Type 2b", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Carcinoma (1966-1993)", "MS": "A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018276"}, {"RECTYPE": "D", "MH": "Carcinoma, Mucoepidermoid", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Mucoepidermoid Carcinomas", "MN": "C04.557.470.590.340", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018277"}, {"RECTYPE": "D", "MH": "Carcinoma, Neuroendocrine", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neuroendocrine Carcinomas", "MN": "C04.557.580.625.650.240", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round \"blue cells\", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small (\"oat\") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018278"}, {"RECTYPE": "D", "MH": "Carcinoma, Signet Ring Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Signet Ring Cell Carcinoma|T191|NON|EQV|NLM (1994)|930330|abcdef", "MN": "C04.557.470.590.415", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with precoord organ/neopl term (IM)", "PI": "Adenocarcinoma, Mucinous (1966-1993)", "MS": "A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19930628", "DC": "1", "DX": "19940101", "UI": "D018279"}, {"RECTYPE": "D", "MH": "Carcinoma, Skin Appendage", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Skin Appendage Carcinomas", "MN": "C04.557.470.550.420", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with SKIN NEOPLASMS (IM) or specific pre-coordinated skin appendage/ neoplasm term (IM)", "MS": "A malignant tumor of the skin appendages, which include the hair, nails, sebaceous glands, sweat glands, and the mammary glands. (From Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20050802", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018280"}, {"RECTYPE": "D", "MH": "Cholangiocarcinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cholangiocellular Carcinoma|T191|NON|EQV|NLM (2009)|071220|abcdef", "ENTRY": "Intrahepatic Cholangiocarcinomas", "MN": "C04.557.470.200.025.450", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with BILE DUCT NEOPLASMS (IM)", "PI": "Liver Neoplasms (1966-1993)", "MS": "A malignant tumor arising from the epithelium of the BILE DUCTS.", "PM": "94; for INTRAHEPATIC CHOLANGIOCARCINOMA see BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; and CHOLANGIOCARCINOMA 2010-2015", "HN": "94", "CATSH": "CAT LIST", "MR": "20150701", "DA": "19930628", "DC": "1", "DX": "19940101", "UI": "D018281"}, {"RECTYPE": "D", "MH": "Cystadenocarcinoma, Mucinous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Mucinous Cystadenocarcinomas", "MN": "C04.557.470.590.480.225", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Cystadenoma (1969-1979)", "MS": "A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. (Hughes, Obstetric-Gynecologic Terminology, 1972, p184)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190307", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018282"}, {"RECTYPE": "D", "MH": "Cystadenocarcinoma, Papillary", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Papillary Cystadenocarcinomas", "MN": "C04.557.470.590.480.230", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Cystadenoma (1966-1979)", "MS": "An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018283"}, {"RECTYPE": "D", "MH": "Cystadenocarcinoma, Serous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Serous Cystadenocarcinomas", "MN": "C04.557.470.590.480.240", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Cystadenoma (1966-1979)", "MS": "A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018284"}, {"RECTYPE": "D", "MH": "Klatskin Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Klatskin's Tumor|T191|EPO|EQV|NLM (1994)|ORD (2010)|990101|abcdeef", "ENTRY": "Tumor, Klatskin's", "MN": "C04.557.470.200.025.450.500", "MH_TH": "NLM (2016)", "ST": "T191", "AN": "coordinate IM with BILE DUCT NEOPLASMS (IM)", "PI": "Bile Duct Neoplasms (1981-1993)", "MS": "Cholangiocarcinoma arising near or at the confluence of the right and left hepatic ducts (COMMON HEPATIC DUCT). These tumors are generally small, sharply localized, and seldom metastasizing.", "PM": "2016; see Klatskin's Tumor (1994-2015)", "HN": "2016(1994)", "CATSH": "CAT LIST", "MR": "20150701", "DA": "19930628", "DC": "1", "DX": "19940101", "UI": "D018285"}, {"RECTYPE": "D", "MH": "Carcinoma, Giant Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Giant Cell Carcinomas", "MN": "C04.557.470.200.220", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Giant Cell Tumors (1966-1989)", "MS": "An epithelial neoplasm characterized by unusually large anaplastic cells. It is highly malignant with fulminant clinical course, bizarre histologic appearance and poor prognosis. It is most common in the lung and thyroid. (From Stedman, 25th ed & Segen, Dictionary of Modern Medicine, 1992)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018286"}, {"RECTYPE": "D", "MH": "Carcinoma, Large Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Large Cell Carcinomas", "MN": "C04.557.470.200.260", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term but probably LUNG NEOPLASMS", "PI": "Carcinoma, Oat Cell (1980-1993)", "MS": "A tumor of undifferentiated (anaplastic) cells of large size. It is usually bronchogenic. (From Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018287"}, {"RECTYPE": "D", "MH": "Carcinoma, Small Cell", "DE": "SCLC", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Carcinoma, Oat Cell|T191|NON|EQV|NLM (1994)|930401|abcdef", "ENTRY": "Small Cell Carcinomas", "MN": "C04.557.470.200.380", "FX": "Carcinoma, Non-Small-Cell Lung", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate (IM) with probably LUNG NEOPLASMS (IM), otherwise coordinate IM with other precoordinated organ/neoplasm term (IM) if appropriate; SMALL CELL LUNG CARCINOMA is also available DF: SCLC", "MS": "An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)", "OL": "use CARCINOMA, SMALL CELL to search CARCINOMA, OAT CELL 1972-93 (as Prov 1972-73), SMALL CELL LUNG CANCER 1991-93, CARCINOMA, RESERVE CELL 1976-93, & RESERVE CELL CARCINOMA 1974-93", "PM": "94; was see CARCINOMA, OAT CELL 1982-93; CARCINOMA, OAT CELL was heading 1974-93; SMALL CELL LUNG CANCER was see CARCINOMA, OAT CELL 1991-93; CARCINOMA, RESERVE CELL was see CARCINOMA, OAT CELL 1976-93; RESERVE CELL CARCINOMA was see CARCINOMA, OAT CELL 1974-93", "HN": "94; was see CARCINOMA, OAT CELL 1982-93; CARCINOMA, OAT CELL was heading 1972-93 (Prov 1972-73); SMALL CELL LUNG CANCER was see CARCINOMA, OAT CELL 1991-93; CARCINOMA, RESERVE CELL was see CARCINOMA, OAT CELL 1976-93; RESERVE CELL CARCINOMA was see CARCINOMA, OAT CELL 1974-93", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19930702", "DC": "1", "DX": "19940101", "UI": "D018288"}, {"RECTYPE": "D", "MH": "Carcinoma, Verrucous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Verrucous Carcinomas", "MN": "C04.557.470.700.450", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Carcinoma, Papillary (1969-1993)", "MS": "A variant of well-differentiated epidermoid carcinoma that is most common in the oral cavity, but also occurs in the larynx, nasal cavity, esophagus, penis, anorectal region, vulva, vagina, uterine cervix, and skin, especially on the sole of the foot. Most intraoral cases occur in elderly male abusers of smokeless tobacco. The treatment is surgical resection. Radiotherapy is not indicated, as up to 30% treated with radiation become highly aggressive within six months. (Segen, Dictionary of Modern Medicine, 1992)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018289"}, {"RECTYPE": "D", "MH": "Cystadenoma, Mucinous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Mucinous Cystadenomas", "MN": "C04.557.470.590.485.225", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with OVARIAN NEOPLASMS (IM) or other organ/neoplasm term (IM) if applicable", "PI": "Cystadenoma (1966-1993)", "MS": "A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential.", "PM": "1994, see CYSTADENOMA  1962-1993", "HN": "1994; use CYSTADENOMA  1962-1993", "CATSH": "CAT LIST", "MR": "20210304", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018291"}, {"RECTYPE": "D", "MH": "Cystadenoma, Papillary", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Papillary Cystadenomas", "MN": "C04.557.470.590.485.230", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with probably OVARIAN NEOPLASMS (IM)", "PI": "Cystadenoma (1966-1993)", "MS": "A benign neoplasm of the ovary.", "OL": "use CYSTADENOMA to search CYSTADENOMA, PAPILLARY 1966-93", "PM": "1994; see CYSTADENOMA, PAPILLARY 1966-1993", "HN": "1994; use CYSTADENOMA, PAPILLARY 1966-1993", "CATSH": "CAT LIST", "MR": "20210304", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018292"}, {"RECTYPE": "D", "MH": "Cystadenoma, Serous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Serous Cystadenomas", "MN": "C04.557.470.590.485.240", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with probably OVARIAN NEOPLASMS (IM)", "PI": "Cystadenoma (1966-1993)", "MS": "A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma (CYSTADENOMA, MUCINOUS). It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. (Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018293"}, {"RECTYPE": "D", "MH": "Neoplasms, Adnexal and Skin Appendage", "DE": "NEOPL ADNEXAL SKIN APPENDAGE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Adnexal and Skin Appendage Neoplasms|T191|NON|EQV|NLM (1998)|960904|ADNEXAL SKIN APPENDAGE NEOPL|abcdefv", "MN": "C04.557.470.550", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "neoplasms composed of sebaceous or sweat gland tissue or tissue of skin appendages, NOT neoplasms located in these sites; coordinate with precoordinated organ/neoplasm term ", "PI": "specific neoplasm (1966-1997)", "MS": "Neoplasms composed of sebaceous or sweat gland tissue or tissue of other skin appendages. The concept does not refer to neoplasms located in the sebaceous or sweat glands or in the other skin appendages.", "PM": "98", "HN": "98; use explode 1994-97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19930826", "DC": "1", "DX": "19980101", "UI": "D018294"}, {"RECTYPE": "D", "MH": "Neoplasms, Basal Cell", "DE": "NEOPL BASAL CELL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Basal Cell Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Basal Cell", "MN": "C04.557.470.565", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "MS": "Neoplasms composed of cells from the deepest layer of the epidermis. The concept does not refer to neoplasms located in the stratum basale.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018295"}, {"RECTYPE": "D", "MH": "Pilomatrixoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Pilomatrixoma, Benign", "MN": "C04.557.470.565.625", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "benign or malignant; coordinate with SKIN NEOPLASMS + HAIR DISEASES", "PI": "Skin Neoplasms (1966-1993)", "MS": "A tumor composed of cells resembling those of the hair matrix, which undergo 'mummification' and may calcify. It is a relatively uncommon tumor, which may occur at any age from infancy. The majority of patients are under 20, and females are affected more than males. The lesion is usually a solitary deep dermal or subcutaneous tumor 3-30 mm in diameter, situated in the head, neck, or upper extremity. (From Rook et al., Textbook of Dermatology, 4th ed, p2401)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018296"}, {"RECTYPE": "D", "MH": "Neoplasms, Cystic, Mucinous, and Serous", "DE": "NEOPL CYSTIC MUCINOUS SEROUS", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Serous Neoplasms|T191|NON|NRW|NLM (2023)|210901|abcdef", "ENTRY": "Serous Neoplasm", "MN": "C04.557.470.590", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "general or unspecified; prefer specifics; coordinate with precoordinated organ/neoplasm term ", "MS": "Neoplasms containing cyst-like formations or producing mucin or serum.", "PM": "98", "HN": "98; use explode 1994-97", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19930826", "DC": "1", "DX": "19980101", "UI": "D018297"}, {"RECTYPE": "D", "MH": "Mucoepidermoid Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Mucoepidermoid", "MN": "C04.557.470.590.580", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Myoepithelioma (1966-1974)", "MS": "A malignant epithelial tumor of glandular tissue, especially the salivary glands, characterized by acini with mucus-producing cells and by the presence of malignant squamous elements. Most mucoepidermoid tumors are low-grade lesions readily cured by adequate excision. They may appear in any age group. They grow slowly. If high-grade, they behave aggressively, widely infiltrating the salivary gland and producing lymph node and distant metastases. (Dorland, 27th ed; from DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930628", "DC": "1", "DX": "19940101", "UI": "D018298"}, {"RECTYPE": "D", "MH": "Neoplasms, Ductal, Lobular, and Medullary", "DE": "NEOPL DUCTAL LOBULAR MEDULLARY", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Ductal, Lobular, and Medullary Neoplasms|T191|NON|EQV|NLM (1998)|960905|DUCTAL LOBULAR MEDULLARY NEOPL|abcdefv", "MN": "C04.557.470.615", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "general or unspecified; prefer specifics; coordinate with precoordinated organ/neoplasm term ", "MS": "Neoplasms, usually carcinoma, located within the center of an organ or within small lobes, and in the case of the breast, intraductally. The emphasis of the name is on the location of the neoplastic tissue rather than on its histological type. Most cancers of this type are located in the breast.", "PM": "98", "HN": "98; use explode 1994-97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19930826", "DC": "1", "DX": "19980101", "UI": "D018299"}, {"RECTYPE": "D", "MH": "Papilloma, Intraductal", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Papillomas, Intraductal", "MN": "C04.557.470.615.670", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "intraductal refers to mammary ducts only; coordinate with BREAST NEOPLASMS", "PI": "Papilloma (1966-1993)", "MS": "A small, often impalpable benign papilloma arising in a lactiferous duct and frequently causing bleeding from the nipple. (Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930628", "DC": "1", "DX": "19940101", "UI": "D018300"}, {"RECTYPE": "D", "MH": "Neoplasms, Mesothelial", "DE": "NEOPL MESOTHELIAL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasm, Mesothelial", "MN": "C04.557.470.660", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "neoplasms composed of mesothelium, NOT neoplasms located in the mesothelium; coordinate with precoordinated organ/neoplasm term", "MS": "Neoplasms composed of tissue of the mesothelium, the layer of flat cells, derived from the mesoderm, which lines the body cavity of the embryo. In the adult it forms the simple squamous epithelium which covers all true serous membranes (peritoneum, pericardium, pleura). The concept does not refer to neoplasms located in these organs. (From Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018301"}, {"RECTYPE": "D", "MH": "Neoplasms, Neuroepithelial", "DE": "NEOPL NEUROEPITHELIAL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Spongioblastoma, Polar|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Tumors, Neuroepithelial", "MN": "C04.557.580.625.600", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "neoplasms composed of neural epithelium, NOT neoplasms located in the neural epithelium or neuroepithelium; coord IM with precoord organ/neopl term (IM)", "MS": "Neoplasms composed of neuroepithelial cells, which have the capacity to differentiate into NEURONS, oligodendrocytes, and ASTROCYTES. The majority of craniospinal tumors are of neuroepithelial origin. (From Dev Biol 1998 Aug 1;200(1):1-5)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018302"}, {"RECTYPE": "D", "MH": "Ganglioglioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Malignant Gangliogliomas", "MN": "C04.557.580.625.600.380.350", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coord IM with probably BRAIN NEOPLASMS (IM) + site (IM)", "PI": "Neuroblastoma (1966-1993)", "MS": "Rare indolent tumors comprised of neoplastic glial and neuronal cells which occur primarily in children and young adults. Benign lesions tend to be associated with long survival unless the tumor degenerates into a histologically malignant form. They tend to occur in the optic nerve and white matter of the brain and spinal cord.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018303"}, {"RECTYPE": "D", "MH": "Esthesioneuroblastoma, Olfactory", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Paranasal Sinus-Nasal Cavity Esthesioneuroblastoma|T191|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Paranasal Sinus Nasal Cavity Esthesioneuroblastoma", "MN": "C10.292.650.200", "MH_TH": "NLM (2000)", "ST": "T191", "AN": "coord IM with NASAL CAVITY (IM) + NOSE NEOPLASMS (IM)", "PI": "Neuroepithelioma (1966-1993)", "MS": "A malignant olfactory neuroblastoma arising from the olfactory epithelium of the superior nasal cavity and cribriform plate. It is uncommon (3% of nasal tumors) and rarely is associated with the production of excess hormones (e.g., SIADH, Cushing Syndrome). It has a high propensity for multiple local recurrences and bony metastases. (From Holland et al., Cancer Medicine, 3rd ed, p1245; J Laryngol Otol 1998 Jul;112(7):628-33)", "PM": "2000; see ESTHESIONEUROBLASTOMA 1994-1999", "HN": "2000(1994)", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018304"}, {"RECTYPE": "D", "MH": "Ganglioneuroblastoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Ganglioneuroblastomas", "MN": "C04.557.580.625.600.590.650.550.300", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Neuroblastoma (1966-1993)", "MS": "A moderately malignant neoplasm composed of primitive neuroectodermal cells dispersed in myxomatous or fibrous stroma intermixed with mature ganglion cells. It may undergo transformation into a neuroblastoma. It arises from the sympathetic trunk or less frequently from the adrenal medulla, cerebral cortex, and other locations. Cervical ganglioneuroblastomas may be associated with HORNER SYNDROME and the tumor may occasionally secrete vasoactive intestinal peptide, resulting in chronic diarrhea.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018305"}, {"RECTYPE": "D", "MH": "Neurocytoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Neurocytoma, Central|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neurocytomas, Central", "MN": "C10.551.240.250.550", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with specific precoord brain/neopl term (IM)", "PI": "Neuroblastoma (1973-1993)", "MS": "A benign brain tumor composed of neural elements which most often arise from the SEPTUM PELLUCIDUM and the walls of the lateral ventricles. Immunohistochemistry and electron microscopy evaluations may reveal expression of neuron specific enolase and synaptophysin and cells containing microtubuli, neurosecretory granules, and presynaptic vesicles. (From Acta Med Port 1994 Feb;7(2):113-9)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018306"}, {"RECTYPE": "D", "MH": "Neoplasms, Squamous Cell", "DE": "NEOPL SQUAMOUS CELL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Squamous Cell Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Squamous Cell Neoplasm", "MN": "C04.557.470.700", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "PI": "Carcinoma, Squamous Cell (1973-1993)", "MS": "Neoplasms of the SQUAMOUS EPITHELIAL CELLS. The concept does not refer to neoplasms located in tissue composed of squamous elements.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20140613", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018307"}, {"RECTYPE": "D", "MH": "Papilloma, Inverted", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Papillomas, Inverted", "MN": "C04.557.470.700.600.610", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Papilloma (1966-1993)", "MS": "A mucosal tumor of the urinary bladder or nasal cavity in which proliferating epithelium is invaginated beneath the surface and is more smoothly rounded than in other papillomas. (Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018308"}, {"RECTYPE": "D", "MH": "Neoplasms, Gonadal Tissue", "DE": "NEOPL GONADAL TISSUE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tissue Neoplasms, Gonadal", "MN": "C04.557.475", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "neoplasms composed of gonadal tissue, not neoplasms located in the ovaries or testes: Manual 24.2.2.5; coordinate IM with pre-coordinated organ/neoplasm term (IM)", "MS": "Neoplasms composed of tissues of the OVARY or the TESTIS, not neoplasms located in the ovaries or testes. Gonadal tissues include GERM CELLS, cells from the sex cord, and gonadal stromal cells.", "PM": "94; GYNANDROBLASTOMA was heading 1963-96", "HN": "94; GYNANDROBLASTOMA was heading 1963-96", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018309"}, {"RECTYPE": "D", "MH": "Sertoli-Leydig Cell Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Arrhenoblastoma|T191|NON|EQV|NLM (1994)|ORD (2010)|930331|abcdeef", "ENTRY": "Tumors, Sertoli-Leydig Cell", "MN": "C19.391.829.782.500", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with OVARIAN NEOPLASMS or TESTICULAR NEOPLASMS", "PI": "Sertoli Cell Tumor (1968-1993)", "MS": "A sex cord-gonadal stromal tumor consists of LEYDIG CELLS; SERTOLI CELLS; and FIBROBLASTS in varying proportions and degree of differentiation. Most such tumors produce ANDROGENS in the Leydig cells, formerly known as androblastoma or arrhenoblastoma. Androblastomas occur in the TESTIS or the OVARY causing precocious masculinization in the males, and defeminization, or virilization (VIRILISM) in the females. In some cases, the Sertoli cells produce ESTROGENS.", "PM": "1994; for ARRHENOBLASTOMA see ARRHENOBLASTOMA 1966-1994, see ANDROBLASTOMA 1994-2004; for ANDROBLASTOMA see ANDROBLASTOMA 1994-2004", "HN": "1994; for ARRHENOBLASTOMA use ARRHENOBLASTOMA 1966-1994, use ANDROBLASTOMA 1994-2004; for ANDROBLASTOMA use ANDROBLASTOMA 1994-2004", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018310"}, {"RECTYPE": "D", "MH": "Luteoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Pregnancy Luteoma|T046|NON|NRW|NLM (2005)|040203|abcdef", "ENTRY": "Pregnancy Luteomas", "MN": "C19.391.630.705.464", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with OVARIAN NEOPLASMS (IM)", "PI": "Thecoma (1966-1993)", "MS": "An ovarian neoplasm composed of LUTEAL CELLS derived from luteinized GRANULOSA CELLS and THECA CELLS. Luteomas respond to GONADOTROPINS, and vary in their hormone production (PROGESTERONE; ESTROGENS; or ANDROGENS). During PREGNANCY, a transient type of luteoma may develop due to an exaggerated LUTEINIZATION of the OVARY.", "PM": "1994; see THECA CELL TUMOR 1981-93; for LUTEINOMA see THECA CELL TUMOR 1981-1993", "HN": "1994; use THECOMA 1981-93; for LUTEINOMA use THECOMA 1981-1993", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018311"}, {"RECTYPE": "D", "MH": "Sex Cord-Gonadal Stromal Tumors", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Gynandroblastoma|T191|NON|NRW|NLM (1997)|ORD (2010)|960515|abcdeef", "ENTRY": "Tumors, Sex Cord-Stromal", "MN": "C04.557.475.750", "MH_TH": "NLM (2005)", "ST": "T191", "AN": "coordinate IM with TESTICULAR NEOPLASMS (IM) in male or OVARIAN NEOPLASMS (IM) if in female", "PI": "Testicular Neoplasms (1981-1993)", "MS": "Neoplasms derived from the primitive sex cord or gonadal stromal cells of the embryonic GONADS. They are classified by their presumed histogenesis and differentiation. From the sex cord, there are SERTOLI CELL TUMOR and GRANULOSA CELL TUMOR; from the gonadal stroma, LEYDIG CELL TUMOR and THECOMA. These tumors may be identified in either the OVARY or the TESTIS.", "PM": "2005; see SEX CORD-STROMAL TUMOR 1994-2004; for GYNANDROBLASTOMA see NEOPLASMS, GONADAL TISSUE 1997-2004", "HN": "2005 (1994); for GYNANDROBLASTOMA use NEOPLASMS, GONADAL TISSUE 1997-2004", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018312"}, {"RECTYPE": "D", "MH": "Leishmania enriettii", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Leishmania (Leishmania) enriettii|T204|NON|EQV|NLM (1994)|930331|abcdef", "ENTRY": "leishmania enriettus, Leishmania", "MN": "B01.268.475.868.488.240", "MH_TH": "NLM (1994)", "ST": "T204", "RN": "txid5663", "AN": "infection: coordinate with LEISHMANIASIS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent ", "PI": "Leishmania mexicana (1986-1993)", "MS": "A parasitic hemoflagellate of the subgenus Leishmania leishmania that has been found as a natural infection of the Brazilian guinea pig. Its host-tissue relationship is, in general, comparable to that of L. braziliensis.", "OL": "use LEISHMANIA MEXICANA to search LEISHMANIA ENRIETTI 1986-93", "PM": "94; was LEISHMANIA ENRIETTI see LEISHMANIA MEXICANA 1986-93", "HN": "94; was LEISHMANIA ENRIETTI see LEISHMANIA MEXICANA 1986-93", "MR": "20200813", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018313"}, {"RECTYPE": "D", "MH": "Leishmania infantum", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Leishmania donovani infantum|T204|NON|EQV|NLM (1994)|930408|abcdef", "ENTRY": "leishmania infantum, Leishmania", "MN": "B01.268.475.868.488.325", "MH_TH": "NLM (1994)", "ST": "T204", "RN": "txid5671", "RR": "txid44271", "AN": "infection: coordinate with LEISHMANIASIS, VISCERAL; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent", "PI": "Leishmania donovani (1986-1993)", "MS": "A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). Human infections are confined almost entirely to children. This parasite is commonly seen in dogs, other Canidae, and porcupines with humans considered only an accidental host. Transmission is by Phlebotomus sandflies.", "OL": "use LEISHMANIA DONOVANI to search LEISHMANIA DONOVANI INFANTUM & LEISHMANIA DONOVANI CHAGASI 1992-93 & LEISHMANIA INFANTUM & LEISHMANIA CHAGASI 1986-91", "PM": "94; was LEISHMANIA DONOVANI INFANTUM see LEISHMANIA DONOVANI 1992-93, was LEISHMANIA INFANTUM see LEISHMANIA DONOVANI 1986-91; LEISHMANIA DONOVANI CHAGASI was see LEISHMANIA DONOVANI 1992-93, was LEISHMANIA CHAGASI see LEISHMANIA DONOVANI 1986-91", "HN": "94; was LEISHMANIA DONOVANI INFANTUM see LEISHMANIA DONOVANI 1992-93, was LEISHMANIA INFANTUM see LEISHMANIA DONOVANI 1986-91; LEISHMANIA DONOVANI CHAGASI was see LEISHMANIA DONOVANI 1992-93, was LEISHMANIA CHAGASI see LEISHMANIA DONOVANI 1986-91", "MR": "20200813", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018314"}, {"RECTYPE": "D", "MH": "Glioma, Subependymal", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Subependymoma|T191|NON|EQV|NLM (2000)|OMIM (2013)|ORD (2010)|991103|abcdeeef", "ENTRY": "Subependymomas", "MN": "C04.557.580.625.600.380.290.390", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with precoord brain/neopl term (IM) + site (IM); do not confuse with ASTROCYTOMA, SUBEPENDYMAL GIANT CELL see ASTROCYTOMA", "MS": "Rare, slow-growing, benign intraventricular tumors, often asymptomatic and discovered incidentally. The tumors are classified histologically as ependymomas and demonstrate a proliferation of subependymal fibrillary astrocytes among the ependymal tumor cells. (From Clin Neurol Neurosurg 1997 Feb;99(1):17-22)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018315"}, {"RECTYPE": "D", "MH": "Gliosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Glioblastoma with Sarcomatous Component|T191|NON|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Sarcomatous Gliomas", "MN": "C04.557.580.625.600.380.400", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with precoord brain/neopl term (IM) + site (IM)", "PI": "Glioma (1967-1993)", "MS": "Rare mixed tumors of the brain and rarely the spinal cord which contain malignant neuroectodermal (glial) and mesenchymal components, including spindle-shaped fibrosarcoma cells. These tumors are highly aggressive and present primarily in adults as rapidly expanding mass lesions. They may arise in tissue that has been previously irradiated. (From Br J Neurosurg 1995 Apr;9(2):171-8)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19991108", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018316"}, {"RECTYPE": "D", "MH": "Nerve Sheath Neoplasms", "DE": "NERVE SHEATH NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Peripheral Nerve Sheath Tumors|T191|NON|NRW|NLM (2000)|991108|abcdef", "ENTRY": "Tumors, Nerve Sheath", "MN": "C10.668.829.725.500", "MH_TH": "NLM (2000)", "ST": "T191", "AN": "neoplasms composed of myelin sheaths, NOT neoplasms located in myelin sheaths: coordinate IM with precoordinated organ/neoplasm term (IM)", "MS": "Neoplasms which arise from nerve sheaths formed by SCHWANN CELLS in the PERIPHERAL NERVOUS SYSTEM or by OLIGODENDROCYTES in the CENTRAL NERVOUS SYSTEM. Malignant peripheral nerve sheath tumors, NEUROFIBROMA, and NEURILEMMOMA are relatively common tumors in this category.", "PM": "2006; see NERVE SHEATH TUMORS 1994-2005", "HN": "2006 (1994)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018317"}, {"RECTYPE": "D", "MH": "Neurofibroma, Plexiform", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Pachydermatocele|T191|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Plexiform Neuromas", "MN": "C10.668.829.725.500.600.500", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with precoord organ/neopl term (IM)", "PI": "Neurofibromatosis 1 (1966-1993)", "MS": "A type of neurofibroma manifesting as a diffuse overgrowth of subcutaneous tissue, usually involving the face, scalp, neck, and chest but occasionally occurring in the abdomen or pelvis. The tumors tend to progress, and may extend along nerve roots to eventually involve the spinal roots and spinal cord. This process is almost always a manifestation of NEUROFIBROMATOSIS 1. (From Adams et al., Principles of Neurology, 6th ed, p1016; J Pediatr 1997 Nov;131(5):678-82)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20040729", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018318"}, {"RECTYPE": "D", "MH": "Neurofibrosarcoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Sarcoma, Neurogenic|T191|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Sarcomas, Neurogenic", "MN": "C10.668.829.725.500.600.600", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate  IM with precoordinated organ/neoplasm term (IM)", "PI": "Neurofibroma (1969-1993)", "MS": "A malignant tumor that arises from small cutaneous nerves, is locally aggressive, and has a potential for metastasis. Characteristic histopathologic features include proliferating atypical spindle cells with slender wavy and pointed nuclei, hypocellular areas, and areas featuring organized whorls of fibroblastic proliferation. The most common primary sites are the extremities, retroperitoneum, and trunk. These tumors tend to present in childhood, often in association with NEUROFIBROMATOSIS 1. (From DeVita et al., Cancer: Principles & Practice of Oncology, 5th ed, p1662; Mayo Clin Proc 1990 Feb;65(2):164-72)", "PM": "1994; for Malignant Peripheral Nerve Sheath Tumors, see Neurilemoma 2000-2018", "HN": "1994; for Malignant Peripheral Nerve Sheath Tumors, use Neurilemoma 2000-2018", "CATSH": "CAT LIST", "MR": "20180308", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018319"}, {"RECTYPE": "D", "MH": "Leishmania major", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Leishmania tropica major|T204|NON|EQV|NLM (1994)|930408|abcdef", "ENTRY": "tropica majors, Leishmania", "MN": "B01.268.475.868.488.405", "MH_TH": "NLM (1994)", "ST": "T204", "RN": "txid5664", "AN": "infection: coordinate with LEISHMANIASIS, CUTANEOUS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent", "PI": "Leishmania tropica (1986-1993)", "MS": "A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) of the Old World. Transmission is by Phlebotomus sandflies.", "OL": "use LEISHMANIA TROPICA to search LEISHMANIA TROPICA MAJOR 1992-93 & LEISHMANIA MAJOR 1986-91", "PM": "94; was LEISHMANIA TROPICA MAJOR see LEISHMANIA TROPICA 1992-93; was LEISHMANIA MAJOR see LEISHMANIA TROPICA 1986-91", "HN": "94; was LEISHMANIA TROPICA MAJOR see LEISHMANIA TROPICA 1992-93; was LEISHMANIA MAJOR see LEISHMANIA TROPICA 1986-91", "MR": "20200813", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018320"}, {"RECTYPE": "D", "MH": "Neurothekeoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Myxoma, Nerve Sheath|T191|NON|EQV|NLM (1994)|930331|abcdef", "ENTRY": "Neurothekeomas", "MN": "C04.557.580.600.625", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "a nerve sheath tumor: Greek neuro-, nerve + theke, sheath; coordinate with precoordinated organ/neoplasm term", "PI": "Skin Neoplasms (1980-1993)", "MS": "A benign myxoma of cutaneous nerve sheath origin. Theke is from the Greek theke, sheath. (From Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018321"}, {"RECTYPE": "D", "MH": "Angiofibroma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Angiofibromas", "MN": "C04.557.645.100", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Dermatofibroma (1966-1993)", "MS": "A benign neoplasm of fibrous tissue in which there are numerous small and large, frequently dilated, vascular channels. (Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018322"}, {"RECTYPE": "D", "MH": "Hemangioendothelioma, Epithelioid", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Hemangioendotheliomas, Epithelioid", "MN": "C04.557.645.375.370.380", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term", "PI": "Hemangioendothelioma (1982-1993)", "MS": "A tumor of medium-to-large veins, composed of plump-to-spindled endothelial cells that bulge into vascular spaces in a tombstone-like fashion. These tumors are thought to have \"borderline\" aggression, where one-third develop local recurrences, but only rarely metastasize. It is unclear whether the epithelioid hemangioendothelioma is truly neoplastic or an exuberant tissue reaction, nor is it clear if this is equivalent to Kimura's disease (see ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA). (Segen, Dictionary of Modern Medicine, 1992)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018323"}, {"RECTYPE": "D", "MH": "Hemangioma, Capillary", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Hemangiomas, Capillary", "MN": "C04.557.645.375.380", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with precoord organ/neopl term (IM); do not confuse with HEMANGIOMA, LOBULAR CAPILLARY see GRANULOMA, PYOGENIC; distinguish from PORT-WINE STAIN", "PI": "Hemangioma (1966-1993)", "MS": "A dull red, firm, dome-shaped hemangioma, sharply demarcated from surrounding skin, usually located on the head and neck, which grows rapidly and generally undergoes regression and involution without scarring. It is caused by proliferation of immature capillary vessels in active stroma, and is usually present at birth or occurs within the first two or three months of life. (Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018324"}, {"RECTYPE": "D", "MH": "Hemangioblastoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Multiple Hemangioblastoma", "MN": "C04.557.645.375.380.370", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate with CEREBELLAR NEOPLASMS or other precoordinated brain/neoplasm term", "PI": "Hemangiosarcoma (1966-1993)", "MS": "A benign tumor of the nervous system that may occur sporadically or in association with VON HIPPEL-LINDAU DISEASE. It accounts for approximately 2% of intracranial tumors, arising most frequently in the cerebellar hemispheres and vermis. Histologically, the tumors are composed of multiple capillary and sinusoidal channels lined with endothelial cells and clusters of lipid-laden pseudoxanthoma cells. Usually solitary, these tumors can be multiple and may also occur in the brain stem, spinal cord, retina, and supratentorial compartment. Cerebellar hemangioblastomas usually present in the third decade with INTRACRANIAL HYPERTENSION, and ataxia. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2071-2)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018325"}, {"RECTYPE": "D", "MH": "Nevi and Melanomas", "DE": "NEVI MELANOMAS", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Melanomas and Nevi|T191|NON|EQV|NLM (1998)|960905|MELANOMAS NEVI|abcdefv", "MN": "C04.557.665", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "A collective term for the various types of nevi and melanomas.", "PM": "98", "HN": "98; use explode 1994-97", "CATSH": "CAT LIST", "MR": "20150605", "DA": "19930625", "DC": "1", "DX": "19980101", "UI": "D018326"}, {"RECTYPE": "D", "MH": "Hutchinson's Melanotic Freckle", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Melanotic Freckle|T191|NON|EQV|NLM (1998)|960801|abcdef", "ENTRY": "Melanotic Freckles", "MN": "C04.557.665.510.385", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with SKIN NEOPLASMS (IM) + site (IM or NIM) if relevant", "MS": "A cellular subtype of malignant melanoma. It is a pigmented lesion composed of melanocytes occurring on sun-exposed skin, usually the face and neck. The melanocytes are commonly multinucleated with a \"starburst\" appearance. It is considered by many to be the in situ phase of lentigo maligna melanoma.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018327"}, {"RECTYPE": "D", "MH": "Melanoma, Amelanotic", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Melanomas, Amelanotic", "MN": "C04.557.665.510.515", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM) (most likely SKIN NEOPLASMS)", "PI": "Melanoma (1966-1993)", "MS": "An unpigmented malignant melanoma. It is an anaplastic melanoma consisting of cells derived from melanoblasts but not forming melanin. (Dorland, 27th ed; Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018328"}, {"RECTYPE": "D", "MH": "Nevus, Blue", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Cellular Blue Nevus|T191|NON|NRW|NLM (2005)|040409|abcdef", "ENTRY": "Nevus, Cellular Blue", "MN": "C04.557.665.560.615.550", "FX": "Mongolian Spot", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with SKIN NEOPLASMS (IM) + site (IM or NIM) if relevant", "PI": "Nevus, Pigmented (1967-1993)", "MS": "Usually a benign tumor, that commonly presents as a solitary blue nodule with spindled MELANOCYTES covered by smooth SKIN. Several variants have been identified, one variant being malignant. The blue color is caused by large, densely packed melanocytes deep in the DERMIS of the nevus. In CHILDREN, they usually occur on the BUTTOCKS and LUMBOSACRAL REGION and are referred to as cellular blue nevi. Malignant blue nevi are more commonly found on the SCALP.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018329"}, {"RECTYPE": "D", "MH": "Nevus, Intradermal", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Intradermal Nevus", "MN": "C04.557.665.560.590", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with SKIN NEOPLASMS + site if relevant", "PI": "Nevus, Pigmented (1967-1993)", "MS": "A nevus in which nests of melanocytes are found in the dermis, but not at the epidermal-dermal junction. Benign pigmented nevi in adults are most commonly intradermal. (Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018330"}, {"RECTYPE": "D", "MH": "Nevus, Spindle Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Spindle Cell Nevus", "MN": "C04.557.665.560.615.625", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with SKIN NEOPLASMS + site if relevant", "PI": "Nevus, Pigmented (1973-1993)", "MS": "A form of pigmented nevus showing intense melanocytic activity around the dermo-epidermal junction. Large numbers of spindle-shaped melanocytes proliferate downward toward the dermis and usually a large amount of pigment is present. It was first described in 1976 and the bulk of patients reported have been young females with the lesions presenting on the thighs. (From Rook et al., Textbook of Dermatology, 4th ed, 1992, p185)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018331"}, {"RECTYPE": "D", "MH": "Nevus, Epithelioid and Spindle Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Spitz Nevus|T191|EPO|EQV|NLM (1994)|930401|abcdef", "ENTRY": "Nevus, Spitz", "MN": "C04.557.665.560.615.625.585", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate with SKIN NEOPLASMS + site if relevant", "PI": "Nevus, Pigmented (1977-1993)", "MS": "A benign compound nevus occurring most often in children before puberty, composed of spindle and epithelioid cells located mainly in the dermis, sometimes in association with large atypical cells and multinucleate cells, and having a close histopathological resemblance to malignant melanoma. The tumor presents as a smooth to slightly scaly, round to oval, raised, firm papule or nodule, ranging in color from pink-tan to purplish red, often with surface telangiectasia. (Dorland, 27th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018332"}, {"RECTYPE": "D", "MH": "Odontogenic Cyst, Calcifying", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Odontogenic Cysts, Calcifying", "MN": "C07.320.450.670.495", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "neoplastic; coordinate with probably JAW NEOPLASMS or precoordinated jaw/neoplasm term", "PI": "Odontogenic Tumors (1966-1993)", "MS": "A mixed radiolucent-radiopaque lesion of the jaws with features of both a cyst and a solid neoplasm. It is characterized microscopically by an epithelial lining showing a palisaded layer of columnar basal cells, presence of ghost cell keratinization, dentinoid, and calcification. (Stedman, 25th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "19950608", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018333"}, {"RECTYPE": "D", "MH": "Leishmania guyanensis", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Leishmania guyanensis guyanensis|T204|NON|NRW|NLM (1994)|930402|abcdef", "ENTRY": "viannia panamensis, Leishmania", "MN": "B01.268.475.868.488.285", "MH_TH": "NLM (1994)", "ST": "T204", "RN": "txid5670", "RR": "txid5679", "AN": "infection: coord IM with LEISHMANIASIS, MUCOCUTANEOUS (IM); for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN", "PI": "Leishmania braziliensis (1986-1993)", "MS": "A parasitic hemoflagellate of the subgenus Leishmania viannia that infects man and animals and causes mucocutaneous leishmaniasis (LEISHMANIASIS, MUCOCUTANEOUS). Transmission is by Lutzomyia sandflies.", "OL": "use LEISHMANIA BRAZILIENSIS to search LEISHMANIA BRAZILIENSIS GUYANENSIS 1992-93", "PM": "94; was LEISHMANIA BRAZILIENSIS GUYANENSIS see LEISHMANIA BRAZILIENSIS 1992-93", "HN": "94; was LEISHMANIA BRAZILIENSIS GUYANENSIS see LEISHMANIA BRAZILIENSIS 1992-93", "MR": "20200902", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018334"}, {"RECTYPE": "D", "MH": "Rhabdoid Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Rhabdoid", "MN": "C04.557.435.710", "MH_TH": "OMIM (2013)", "ST": "T191", "MS": "A rare but highly lethal childhood tumor found almost exclusively in infants. Histopathologically, it resembles RHABDOMYOSARCOMA but the tumor cells are not of myogenic origin. Although it arises primarily in the kidney, it may be found in other parts of the body. The rhabdoid cytomorphology is believed to be the expression of a very primitive malignant cell. (From Holland et al., Cancer Medicine, 3d ed, p2210)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018335"}, {"RECTYPE": "D", "MH": "Receptors, Aryl Hydrocarbon", "DE": "RECEPT ARYL HYDROCARBON", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "TCDD Receptors|T116|T192|EQV|NLM (1994)|930506|TCDD RECEPT|abbdefv", "ENTRY": "Receptor, TCDD", "MN": "D12.776.930.760", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Drug (1979-1993)", "MS": "Cytoplasmic proteins that bind certain aryl hydrocarbons, translocate to the nucleus, and activate transcription of particular DNA segments. AH receptors are identified by their high-affinity binding to several carcinogenic or teratogenic environmental chemicals including polycyclic aromatic hydrocarbons found in cigarette smoke and smog, heterocyclic amines found in cooked foods, and halogenated hydrocarbons including dioxins and polychlorinated biphenyls. No endogenous ligand has been identified, but an unknown natural messenger with a role in cell differentiation and development is suspected.", "OL": "use RECEPTORS, ARYL HYDROCARBON (NM) to search 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN RECEPTOR 1980-93 & ARYL HYDROCARBON RECEPTOR 1981-93", "PM": "94; ARYL HYDROCARBON RECEPTOR was indexed under RECEPTORS, DRUG 1981-93; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN RECEPTOR was indexed under RECEPTORS, DRUG 1979-93", "HN": "94; was ARYL HYDROCARBON RECEPTOR (NM) 1981-93; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN RECEPTOR was (NM) 1979-93", "MR": "20150623", "DA": "19930709", "DC": "1", "DX": "19940101", "UI": "D018336"}, {"RECTYPE": "D", "MH": "Receptors, Adrenergic, alpha-1", "DE": "RECEPT ADREN ALPHA 1", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "alpha-1 Adrenergic Receptors|T116|T192|NON|EQV|NLM (1994)|930416|ALPHA ADRENERGIC RECEPTORS 01|ALPHA 1 ADREN RECEPT|abbcdefsv", "ENTRY": "alpha-1D Receptors, Adrenergic", "MN": "D12.776.543.750.720.330.300.300.100", "EC": "antagonists & inhibitors:Adrenergic alpha-1 Receptor Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Adrenergic, alpha (1977-1993)", "MS": "A subclass of alpha-adrenergic receptors that mediate contraction of SMOOTH MUSCLE in a variety of tissues such as ARTERIOLES; VEINS; and the UTERUS. They are usually found on postsynaptic membranes and signal through GQ-G11 G-PROTEINS.", "PM": "1994; RECEPTOR, ADRENERGIC, ALPHA-1A was indexed under RECEPTORS, ADRENERGIC, ALPHA-1 1996-2010; RECEPTOR, ADRENERGIC, ALPHA-1B was indexed under RECEPTORS, ADRENERGIC, ALPHA-1 1994-2010; RECEPTOR, ADRENERGIC, ALPHA-1D was indexed under RECEPTORS, ADRENERGIC, ALPHA-1 1996-2010", "HN": "1994", "MR": "20160617", "DA": "19930616", "DC": "1", "DX": "19940101", "UI": "D018340"}, {"RECTYPE": "D", "MH": "Receptors, Adrenergic, alpha-2", "DE": "RECEPT ADREN ALPHA 2", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "alpha-2 Adrenergic Receptors|T116|T192|NON|EQV|NLM (1994)|930416|ALPHA ADRENERGIC RECEPTORS 02|ALPHA 2 ADREN RECEPT|abbcdefsv", "ENTRY": "alpha-2b, Adrenergic Receptor", "MN": "D12.776.543.750.720.330.300.300.200", "EC": "antagonists & inhibitors:Adrenergic alpha-2 Receptor Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Adrenergic, alpha (1977-1993)", "MS": "A subclass of alpha-adrenergic receptors found on both presynaptic and postsynaptic membranes where they signal through Gi-Go G-PROTEINS. While postsynaptic alpha-2 receptors play a traditional role in mediating the effects of ADRENERGIC AGONISTS, the subset of alpha-2 receptors found on presynaptic membranes signal the feedback inhibition of NEUROTRANSMITTER release.", "PM": "1994; RECEPTORS, ADRENERGIC, ALPHA-2A was indexed under RECEPTORS, ADRENERGIC, ALPHA-2 1996-2010; ADRENERGIC RECEPTOR ALPHA-2B was indexed under RECEPTORS, ADRENERGIC, ALPHA-2 1997-2010; ADRENERGIC RECEPTOR ALPHA(2C) was indexed under RECEPTORS, ADRENERGIC, ALPHA-2 1995-2010; ADRENERGIC RECEPTOR ALPHA(2D) was indexed under RECEPTORS, ADRENERGIC, ALPHA-2 1997-2010", "HN": "1994", "MR": "20160617", "DA": "19930621", "DC": "1", "DX": "19940101", "UI": "D018341"}, {"RECTYPE": "D", "MH": "Receptors, Adrenergic, beta-1", "DE": "RECEPT ADREN BETA 1", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "beta-1 Adrenergic Receptors|T116|T192|NON|EQV|NLM (1994)|930414|BETA ADRENERGIC RECEPTORS 01|BETA 1 ADREN RECEPT|abbcdefsv", "ENTRY": "beta-1 Receptors, Adrenergic", "MN": "D12.776.543.750.720.330.300.340.100", "EC": "antagonists & inhibitors:Adrenergic beta-1 Receptor Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Adrenergic, beta (1977-1993)", "MS": "A subclass of beta-adrenergic receptors (RECEPTORS, ADRENERGIC, BETA). The adrenergic beta-1 receptors are equally sensitive to EPINEPHRINE and NOREPINEPHRINE and bind the agonist DOBUTAMINE and the antagonist METOPROLOL with high affinity. They are found in the HEART, juxtaglomerular cells, and in the central and peripheral nervous systems.", "PM": "94", "HN": "94", "MR": "20210630", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018342"}, {"RECTYPE": "D", "MH": "Receptors, Adrenergic, beta-2", "DE": "RECEPT ADREN BETA 2", "DS": "RECEPTORS ADRENERGIC BETA 2", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "beta-2 Adrenergic Receptors|T116|T192|NON|EQV|NLM (1994)|930414|BETA ADRENERGIC RECEPTORS 02|BETA 2 ADREN RECEPT|abbcdefsv", "ENTRY": "beta-2 Receptors, Adrenergic", "MN": "D12.776.543.750.720.330.300.340.200", "EC": "antagonists & inhibitors:Adrenergic beta-2 Receptor Antagonists", "MH_TH": "NLM (1994)", "ST": "T192", "RN": "0", "PI": "Receptors, Adrenergic, beta (1977-1993)", "MS": "A subclass of beta-adrenergic receptors (RECEPTORS, ADRENERGIC, BETA). The adrenergic beta-2 receptors are more sensitive to EPINEPHRINE than to NOREPINEPHRINE and have a high affinity for the agonist TERBUTALINE. They are widespread, with clinically important roles in SKELETAL MUSCLE; LIVER; and vascular, bronchial, gastrointestinal, and genitourinary SMOOTH MUSCLE.", "PM": "94", "HN": "94", "MR": "20160617", "DA": "19930616", "DC": "1", "DX": "19940101", "UI": "D018343"}, {"RECTYPE": "D", "MH": "T-Lymphocytopenia, Idiopathic CD4-Positive", "DE": "CD4 LYMPHOCYTOPENIA", "DS": "LYMPHOCYTOPENIA IDIOPATHIC CD POSITIVE T 004", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Idiopathic CD4-Positive T-Lymphocytopenia|T047|EQV|NLM (1994)|ORD (2010)|930426|IDIOPATHIC CD POSITIVE LYMPHOCYTOPENIA 004 T|abdeefs", "ENTRY": "T-Lymphocytopenias, CD4+", "MN": "C20.673.627.800", "MH_TH": "NLM (1994)", "ST": "T047", "PI": "Lymphopenia (1990-1993)", "MS": "Reproducible depletion of CD4+ lymphocytes below 300 per cubic millimeter in the absence of HIV infection or other known causes of immunodeficiency. This is a rare, heterogeneous syndrome and does not appear to be caused by a transmissible agent.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19930615", "DC": "1", "DX": "19940101", "UI": "D018344"}, {"RECTYPE": "D", "MH": "Mice, Knockout", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Knockout Mice|T015|NON|EQV|NLM (1994)|930429|abcdef", "ENTRY": "Mice, Knock out", "MN": "B01.050.150.900.649.313.992.635.505.500.800.500", "FX": "Gene Knockout Techniques", "MH_TH": "NLM (1994)", "ST": "T015", "AN": "NIM no qualif when exper animal; do not forget also to check MICE", "PI": "Mice (1992-1993)", "MS": "Strains of mice in which certain GENES of their GENOMES have been disrupted, or \"knocked-out\". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.", "PM": "94", "HN": "94", "MR": "20200902", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018345"}, {"RECTYPE": "D", "MH": "Hepadnaviridae Infections", "DE": "HEPADNAVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Hepadnaviridae", "MN": "C01.925.256.430", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Virus diseases caused by the HEPADNAVIRIDAE.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018347"}, {"RECTYPE": "D", "MH": "Encephalitis Viruses, Japanese", "DE": "ENCEPH VIRUSES JAPANESE", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Japanese encephalitis virus group|T005|EPO|EQV|NLM (2002)|010420|abcdef", "ENTRY": "Viruses, Japanese Encephalitis|T005|EPO|EQV|NLM (1994)|930506|VIRUSES JAPANESE ENCEPH|abcdefv", "MN": "B04.820.578.344.350.300", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid11071", "AN": "do not confuse with ENCEPHALITIS VIRUS, JAPANESE, a species of Flavivirus; infection: coord IM with ENCEPHALITIS, ARBOVIRUS, (IM) + FLAVIVIRUS INFECTIONS (IM)", "MS": "A subgroup of the genus FLAVIVIRUS which comprises a number of viral species that are the etiologic agents of human encephalitis in many different geographical regions. These include Japanese encephalitis virus (ENCEPHALITIS VIRUS, JAPANESE), St. Louis encephalitis virus (ENCEPHALITIS VIRUS, ST. LOUIS), Murray Valley encephalitis virus (ENCEPHALITIS VIRUS, MURRAY VALLEY), and WEST NILE VIRUS.", "PM": "94", "HN": "94", "MR": "20200813", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018349"}, {"RECTYPE": "D", "MH": "alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid", "DS": "ALPHA AMINOHYDROXYMETHYLISOXAZOLEPROPIONIC ACID ALPHA 03 05 04", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "AMPA|T109|T121|T130|ABB|EQV|NLM (1994)|930506|abbbcdef", "ENTRY": "alpha Amino 3 hydroxy 5 methyl 4 isoxazolepropionic Acid", "MN": "D03.383.129.385.025", "PA": "Excitatory Amino Acid Agonists", "FX": "Receptors, AMPA", "MH_TH": "NLM (1994)", "ST": "T130", "N1": "4-Isoxazolepropanoic acid, alpha-amino-2,3-dihydro-5-methyl-3-oxo-", "RN": "77521-29-0", "RR": "84799-52-0 ((S)-isomer, mono-HBr)", "PI": "Ibotenic Acid/analogs & derivatives (1980-1993)", "MS": "An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.", "OL": "use ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID (NM) to search ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID 1980-93", "PM": "94; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID was indexed under IBOTENIC ACID/analogs & derivatives 1980-93", "HN": "94; was ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID (NM) 1980-93", "MR": "20160527", "DA": "19930618", "DC": "1", "DX": "19940101", "UI": "D018350"}, {"RECTYPE": "D", "MH": "Coronavirus Infections", "DE": "CORONAVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Coronavirus", "MN": "C01.925.782.600.550.200", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "do not confuse with CORONAVIRIDAE INFECTIONS; coordinate IM with specific coronavirus (IM) but note some specific coronavirus infection terms are available", "MS": "Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).", "OL": "use CORONAVIRIDAE INFECTIONS to search CORONAVIRUS INFECTIONS 1977-93", "PM": "94; was heading 1977-93", "HN": "94; was heading 1977-93", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018352"}, {"RECTYPE": "D", "MH": "Rhabdoviridae Infections", "DE": "RHABDOVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Rhabdoviridae Infection", "MN": "C01.925.782.580.830", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Virus diseases caused by RHABDOVIRIDAE. Important infections include RABIES; EPHEMERAL FEVER; and vesicular stomatitis.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018353"}, {"RECTYPE": "D", "MH": "Alphavirus Infections", "DE": "ALPHAVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Sindbis Virus Infection|T047|NON|NRW|NLM (2024)|230601|abcdef", "ENTRY": "Virus Infection, Sindbis", "MN": "C01.925.782.930.100", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Virus diseases caused by members of the ALPHAVIRUS genus of the family TOGAVIRIDAE.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20230601", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018354"}, {"RECTYPE": "D", "MH": "Rubivirus Infections", "DE": "RUBIVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Rubivirus Infection", "MN": "C01.925.782.930.700", "MH_TH": "NLM (1994)", "ST": "T047", "MS": "Virus diseases caused by the RUBIVIRUS genus, of the family TOGAVIRIDAE.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20190529", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018355"}, {"RECTYPE": "D", "MH": "Respiratory Syncytial Virus Infections", "DE": "RESPIRATORY SYNCYTIAL VIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "RSV Infection|T047|ABX|EQV|NLM (2024)|221024|abcdef", "ENTRY": "RSV Infections", "MN": "C01.925.782.580.600.550.750", "MH_TH": "NLM (1994)", "ST": "T047", "AN": "caused by a pneumovirus", "PI": "Respiratory Tract Infections (1966-1993)", "MS": "Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19930604", "DC": "1", "DX": "19940101", "UI": "D018357"}, {"RECTYPE": "D", "MH": "Neuroendocrine Tumors", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Neuroendocrine", "MN": "C04.557.580.625.650", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate with precoordinated organ/neoplasm term ", "MS": "Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19930625", "DC": "1", "DX": "19940101", "UI": "D018358"}, {"RECTYPE": "D", "MH": "Crystallography, X-Ray", "DE": "CRYSTALLOGR XRAY", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "X-Ray Crystallography|T059|NON|EQV|NLM (1994)|930601|X RAY CRYSTALLOGR|abcdefv", "ENTRY": "X Ray Crystallographies", "MN": "E05.196.309.742.225", "MH_TH": "NLM (1994)", "ST": "T059", "AN": "usually NIM", "MS": "The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "94", "HN": "94", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19930603", "DC": "1", "DX": "19940101", "UI": "D018360"}, {"RECTYPE": "D", "MH": "Neoplasm, Residual", "DE": "NEOPL RESIDUAL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Residual Tumor|T191|NON|REL|NLM (1995)|940103|abcdef", "ENTRY": "Tumour, Residual", "MN": "C23.550.727.700", "MH_TH": "NLM (1995)", "ST": "T191", "AN": "IM for general or unspecified; as NIM coordinate, use no qualifiers", "PI": "Neoplasm Recurrence, Local (1968-1994)", "MS": "Remnant of a tumor or cancer after primary, potentially curative therapy.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20170502", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018365"}, {"RECTYPE": "D", "MH": "Vasculitis, Leukocytoclastic, Cutaneous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vasculitis, Hypersensitivity|T047|NON|EQV|NLM (1995)|990101|abcdef", "ENTRY": "Vasculitis, Cutaneous Leukocytoclastic", "MN": "C20.543.520.910", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Vasculitis, Allergic Cutaneous (1978-1994)", "MS": "Disorder characterized by a vasculitic syndrome associated with exposure to an antigen such as a drug, infectious agent, or other foreign or endogenous substance. Its pathophysiology includes immune complex deposition and a wide range of skin lesions. Hypersensitivity or allergy is present in some but not all cases.", "PM": "2010; see VASCULITIS, HYPERSENSITIVITY 1995-2009; for VASCULITIS, ALLERGIC CUTANEOUS see VASCULITIS, ALLERGIC CUTANEOUS 1978-2009", "HN": "2010 (1995)", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018366"}, {"RECTYPE": "D", "MH": "Leukocyte-Adhesion Deficiency Syndrome", "DE": "LEUKOCYTE ADHESION DEFIC SYNDROME", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Leukocyte-Adhesion Deficiency Syndromes", "MN": "C20.673.795.719", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Receptors, Leukocyte-Adhesion/deficiency (1988-1990)", "MS": "Rare, autosomal recessive disorder caused by deficiency of the beta 2 integrin receptors (RECEPTORS, LEUKOCYTE-ADHESION) comprising the CD11/CD18 family of glycoproteins. The syndrome is characterized by abnormal adhesion-dependent functions, especially defective tissue emigration of neutrophils, leading to recurrent infection.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018370"}, {"RECTYPE": "D", "MH": "Peripheral Nervous System Agents", "DE": "PNS AGENTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Peripheral Nervous System Effects|T039|NON|REL|NLM (2012)|110330|abcdef", "MN": "D27.505.696.663", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; note entry term PERIPHERAL NERVOUS SYSTEM EFFECT: use only for the peripheral nervous system effect of a chemical substance", "MS": "Drugs that act principally at one or more sites within the peripheral neuroeffector systems, the autonomic system, and motor nerve-skeletal system. (From Smith and Reynard, Textbook of Pharmacology, 1991, p75)", "PM": "98", "HN": "98; use explode 1995-97", "MR": "20110624", "DA": "19940609", "DC": "1", "DX": "19980101", "UI": "D018373"}, {"RECTYPE": "D", "MH": "LLC-PK1 Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "LLC-PK1 Cell", "MN": "A11.436.520", "MH_TH": "NLM (1995)", "ST": "T025", "AN": "LLC stands for Lilly Laboratories Cell & PK for Porcine Kidney; almost always NIM with no subheadings; check ANIMALS & add SWINE (NIM); do not routinely add KIDNEY", "PI": "Cells, Cultured (1980-1993)", "MS": "Epithelial cell line originally derived from porcine kidneys. It is used for pharmacologic and metabolic studies.", "PM": "95", "HN": "95", "MR": "20030730", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018374"}, {"RECTYPE": "D", "MH": "Neutrophil Activation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Neutrophil Activations", "MN": "G12.604", "MH_TH": "NLM (1995)", "ST": "T039", "PI": "Neutrophils (1978-1994)", "MS": "The process in which the neutrophil is stimulated by diverse substances, resulting in degranulation and/or generation of reactive oxygen products, and culminating in the destruction of invading pathogens. The stimulatory substances, including opsonized particles, immune complexes, and chemotactic factors, bind to specific cell-surface receptors on the neutrophil.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018375"}, {"RECTYPE": "D", "MH": "Cardiovascular Abnormalities", "DE": "CARDIOVASC ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cardiovascular Abnormality", "MN": "C16.131.240", "FX": "Heart Defects, Congenital", "MH_TH": "NLM (1995)", "ST": "T019", "AN": "general or unspecified; prefer specifics, particularly HEART DEFECTS, CONGENITAL, or specific cardiovascular term /abnorm", "PI": "Heart Defects, Congenital (1966-1997)", "MS": "Congenital, inherited, or acquired anomalies of the CARDIOVASCULAR SYSTEM, including the HEART and BLOOD VESSELS.", "PM": "98", "HN": "98; use explode 1995-97", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19940603", "DC": "1", "DX": "19980101", "UI": "D018376"}, {"RECTYPE": "D", "MH": "Neurotransmitter Agents", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neurotransmitter Agent|T121|NON|EQV|NLM (2020)|181115|abcdef", "ENTRY": "Transmitter Substance, Nerve", "MN": "D27.505.696.577", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "general; prefer specifics", "MS": "Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.", "PM": "1998; for NEUROTRANSMITTERS see NEUROTRANSMITTERS 1968-2005; NEUROTRANSMITTERS was NEUROREGULATORS 1980-94, was NEUROHUMORS 1968-79, NEUROREGULATORS 1977-94", "HN": "1998; use explode 1995-1997", "MR": "20200527", "DA": "19940601", "DC": "1", "DX": "19980101", "UI": "D018377"}, {"RECTYPE": "D", "MH": "Hematopoietic Stem Cell Transplantation", "DE": "HEMATOPOIETIC STEM CELL TRANSPL", "AQ": "AE CL EC EH ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Stem Cell Transplantation, Hematopoietic|T061|NON|EQV|NLM (1995)|931206|STEM CELL TRANSPL HEMATOPOIETIC|abcdefv", "ENTRY": "Transplantation, Hematopoietic Stem Cell|T061|NON|EQV|NLM (1995)|931210|abcdef", "MN": "E04.936.225.687.500", "FX": "Hematopoietic Stem Cell Mobilization", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "conditioning before transpl of hematopoietic stem cells: coord IM with TRANSPLANTATION CONDITIONING (IM)", "PI": "Hematopoietic Stem Cells/transplantation (1971-1994)", "MS": "Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.", "PM": "95; was HEMATOPOIETIC STEM CELLS/transplantation 1972-94", "HN": "95; was HEMATOPOIETIC STEM CELLS/transplantation 1971-94", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018380"}, {"RECTYPE": "D", "MH": "Thyroid Hormone Resistance Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Refetoff Syndrome|T047|EPO|EQV|NLM (1995)|OMIM (2013)|ORD (2010)|930908|abcdeeef", "ENTRY": "Syndrome, Refetoff-DeWind-DeGroot", "MN": "C19.874.410.500", "FX": "Euthyroid Sick Syndromes", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "differentiate from EUTHYROID SICK SYNDROME where a non-thyroid disease is also present", "MS": "An inherited autosomal recessive trait, characterized by peripheral resistance to THYROID HORMONES and the resulting elevation in serum levels of THYROXINE and TRIIODOTHYRONINE. This syndrome is caused by mutations of gene THRB encoding the THYROID HORMONE RECEPTORS BETA in target cells. HYPOTHYROIDISM in these patients is partly overcome by the increased thyroid hormone levels.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018382"}, {"RECTYPE": "D", "MH": "Bay-Region, Polycyclic Aromatic Hydrocarbon", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Bay-Region Chemical Conformation|T082|T169|NON|EQV|NLM (2009)|080129|abbcdef", "ENTRY": "Polycyclic Aromatic Hydrocarbon Bay Region", "MN": "G02.111.570.820.117", "MH_TH": "NLM (2009)", "ST": "T169", "AN": "note category: a binding site; bay refers to an open graphic representation of a chemical structure resembling a bay", "MS": "A concave exterior region on some POLYCYCLIC AROMATIC HYDROCARBONS that have three phenyl rings in a non-linear arrangement.", "PM": "2009; see BAY REGION (CHEMISTRY) 1995-2008", "HN": "2009 (1995)", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19940527", "DC": "1", "DX": "19950101", "UI": "D018383"}, {"RECTYPE": "D", "MH": "Oxidative Stress", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Stress, Oxidative|T049|NON|EQV|NLM (1995)|930908|abcdef", "ENTRY": "Stresses, Nitro-Oxidative", "MN": "G07.775.750", "MH_TH": "NLM (1995)", "ST": "T049", "MS": "A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi).", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20200116", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018384"}, {"RECTYPE": "D", "MH": "Centrosome", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Pericentriolar Region|T026|NON|NRW|NLM (2001)|000503|abcdef", "ENTRY": "Region, Pericentriolar", "MN": "A11.284.430.214.190.750.820.500.500", "MH_TH": "NLM (1995)", "ST": "T026", "PI": "Centrioles (1982-1994)", "MS": "An organelle near the nucleus of the cell consisting (in animals and organisms that have CILIA) of two CENTRIOLES, and the surrounding pericentriolar material. It functions as the primary MICROTUBULE-ORGANIZING CENTER during the eukaryotic CELL CYCLE (https://doi.org/10.1038/nrm2180).", "PM": "95", "HN": "95", "MR": "20230705", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018385"}, {"RECTYPE": "D", "MH": "Kinetochores", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Kinetochore", "MN": "G05.360.160.165.500", "MH_TH": "NLM (1995)", "ST": "T026", "PI": "Chromosomes (1966-1994)", "MS": "Large multiprotein complexes that bind the centromeres of the chromosomes to the microtubules of the mitotic spindle during metaphase in the cell cycle.", "PM": "95", "HN": "95", "MR": "20080708", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018386"}, {"RECTYPE": "D", "MH": "Codon, Initiator", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Initiator Codon|T114|T123|NON|EQV|NLM (1995)|940106|abbcdef", "ENTRY": "Start Codons", "MN": "G05.360.340.024.340.137.190.225", "FX": "Protein Biosynthesis", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "PI": "Codon (1975-1994)", "MS": "A codon that directs initiation of protein translation (TRANSLATION, GENETIC) by stimulating the binding of initiator tRNA (RNA, TRANSFER, MET). In prokaryotes, the codons AUG or GUG can act as initiators while in eukaryotes, AUG is the only initiator codon.", "PM": "95", "HN": "95", "MR": "20080708", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018387"}, {"RECTYPE": "D", "MH": "Codon, Terminator", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Terminator Codon|T114|T123|NON|EQV|NLM (1995)|940106|abbcdef", "ENTRY": "UGA, Stop Codon", "MN": "G05.360.340.024.340.137.190.250", "FX": "Protein Biosynthesis", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "PI": "Genetic Code (1967-1974)", "MS": "Any codon that signals the termination of genetic translation (TRANSLATION, GENETIC). PEPTIDE TERMINATION FACTORS bind to the stop codon and trigger the hydrolysis of the aminoacyl bond connecting the completed polypeptide to the tRNA. Terminator codons do not specify amino acids.", "PM": "95", "HN": "95", "MR": "20080708", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018388"}, {"RECTYPE": "D", "MH": "Codon, Nonsense", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Unassigned Codon|T114|T123|NON|REL|NLM (2001)|000418|abbcdef", "ENTRY": "Unassigned Codons", "MN": "G05.365.590.195", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "AN": "for amber or ochre suppressor mutations use SUPPRESSION, GENETIC", "PI": "Genetic Code (1966-1974)", "MS": "An amino acid-specifying codon that has been converted to a stop codon (CODON, TERMINATOR) by mutation. Its occurance is abnormal causing premature termination of protein translation and results in production of truncated and non-functional proteins. A nonsense mutation is one that converts an amino acid-specific codon to a stop codon.", "PM": "95", "HN": "95", "MR": "20130709", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018389"}, {"RECTYPE": "D", "MH": "Gene Targeting", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Targetings, Gene", "MN": "E05.393.335", "MH_TH": "NLM (1995)", "ST": "T063", "MS": "The integration of exogenous DNA into the genome of an organism at sites where its expression can be suitably controlled. This integration occurs as a result of homologous recombination.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018390"}, {"RECTYPE": "D", "MH": "Genomic Imprinting", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Parental Imprinting|T045|NON|EQV|NLM (1995)|930915|abcdef", "ENTRY": "Imprinting, Parental", "MN": "G05.308.203.500", "FX": "DNA Methylation", "MH_TH": "NLM (1995)", "ST": "T045", "MS": "The variable phenotypic expression of a GENE depending on whether it is of paternal or maternal origin, which is a function of the DNA METHYLATION pattern. Imprinted regions are observed to be more methylated and less transcriptionally active. (Segen, Dictionary of Modern Medicine, 1992)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018392"}, {"RECTYPE": "D", "MH": "Mycobacterium haemophilum", "DE": "MYCOBACT HAEMOPHILUM", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Mycobacterium hemophilum|T007|NON|EQV|NLM (1995)|931208|MYCOBACT HEMOPHILUM|abcdefv", "MN": "B03.510.460.400.410.552.552.480", "MH_TH": "NLM (1995)", "ST": "T007", "RN": "txid29311", "AN": "infection: coord IM with MYCOBACTERIUM INFECTIONS (IM)", "PI": "Mycobacterium (1979-1994)", "MS": "A species of gram-positive, aerobic bacteria that causes granulomatous or ulcerating skin lesions in immunosuppressed persons. This organism owes its name to its requirement for growth of high levels of iron, conveniently supplied as blood, heme, or ferric ammonium citrate.", "PM": "95", "HN": "95", "MR": "20200813", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018393"}, {"RECTYPE": "D", "MH": "CA-125 Antigen", "DS": "CA ANTIGEN 125", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Antigen CA-125|T109|T129|EQV|NLM (1995)|940126|ANTIGEN CA 125|abbdefs", "ENTRY": "Mucin 16", "MN": "D23.101.140.075.225", "MH_TH": "NLM (1995)", "ST": "T129", "RN": "0", "PI": "Antigens, Tumor-Associated, Carbohydrate (1988-1994)", "MS": "A carbohydrate antigen that occurs in tumors of the ovary as well as in breast, kidney, and gastrointestinal tract tumors and normal tissue. While it is tumor-associated, it is not tumor-specific and may have a protective function against particles and infectious agents at mucosal surfaces.", "OL": "use ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE to search CA-125 ANTIGEN 1989-94", "PM": "95; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1989-94", "HN": "95; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1989-94", "MR": "20230316", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018394"}, {"RECTYPE": "D", "MH": "CA-19-9 Antigen", "DS": "CA ANTIGEN 019 009", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Sialyl Lewis(a) Tetrasaccharide|T109|T129|NON|EQV|NLM (1994)|190321|abbcdef", "ENTRY": "Lewis A, Sialyl", "MN": "D23.101.140.075.119", "MH_TH": "NLM (1995)", "ST": "T129", "RN": "0", "PI": "Antigens, Tumor-Associated, Carbohydrate (1989-1994)", "MS": "Sialylated Lewis(a) blood group carbohydrate antigen found in many adenocarcinomas of the digestive tract, especially pancreatic tumors.", "PM": "1995; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1989-1994; for Sialyl Lewis A see OLIGOSACCHARIDES 1994-2019", "HN": "1995; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1989-1994; for Sialyl Lewis A use OLIGOSACCHARIDES 1994-2019", "MR": "20190530", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018395"}, {"RECTYPE": "D", "MH": "Mucin-1", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Polymorphic Epithelial Mucin|T109|T129|NON|EQV|NLM (1997)|951108|abbcdef", "ENTRY": "Mucin, Polymorphic Epithelial", "MN": "D23.101.140.075.300", "MH_TH": "NLM (2009)", "ST": "T129", "RN": "0", "PI": "Antigens, Tumor-Associated, Carbohydrate (1989-1994)", "MS": "Carbohydrate antigen elevated in patients with tumors of the breast, ovary, lung, and prostate as well as other disorders. The mucin is expressed normally by most glandular epithelia but shows particularly increased expression in the breast at lactation and in malignancy. It is thus an established serum marker for breast cancer.", "PM": "2009; see CA-15-3 ANTIGEN 1995-2008, see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1990-1994; EPISIALIN was indexed under MEMBRANE GLYCOPROTEINS 1988-1996, MUCINS 1981-1996, MEMBRANE PROTEINS 1982-1987, & GLYCOPROTEINS 1981-1982", "HN": "2009(1995)", "MR": "20230316", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018396"}, {"RECTYPE": "D", "MH": "Equidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Zebras|T015|NON|NRW|NLM (1998)|960730|abcdef", "ENTRY": "Zebra", "MN": "B01.050.150.900.649.313.984.235", "MH_TH": "NLM (1995)", "ST": "T015", "RN": "txid9788", "PI": "Perissodactyla (1966-1994)", "MS": "A family of hoofed MAMMALS consisting of HORSES, donkeys, and zebras. Members of this family are strict herbivores and can be classified as either browsers or grazers depending on how they feed.  .", "PM": "95", "HN": "95", "MR": "20220711", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018397"}, {"RECTYPE": "D", "MH": "Homeodomain Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Homeotic Protein|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Proteins, Homeotic", "MN": "D12.776.260.400", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "AN": "DNA-binding proteins", "PI": "DNA-Binding Proteins (1988-1994)", "MS": "Proteins encoded by homeobox genes (GENES, HOMEOBOX) that exhibit structural similarity to certain prokaryotic and eukaryotic DNA-binding proteins. Homeodomain proteins are involved in the control of gene expression during morphogenesis and development (GENE EXPRESSION REGULATION, DEVELOPMENTAL).", "PM": "95", "HN": "95", "MR": "20200527", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018398"}, {"RECTYPE": "D", "MH": "Sample Size", "ENTRY": "Sizes, Sample", "MN": "N06.850.520.445.762", "MH_TH": "NLM (1995)", "ST": "T081", "AN": "usually NIM with specific population or circumstances sampled (IM); not restricted to epidemiology", "MS": "The number of units (persons, animals, patients, specified circumstances, etc.) in a population to be studied. The sample size should be big enough to have a high likelihood of detecting a true difference between two groups. (From Wassertheil-Smoller, Biostatistics and Epidemiology, 1990, p95)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018401"}, {"RECTYPE": "D", "MH": "Manduca", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Tobacco Hornworm|T204|NON|REL|NLM (1995)|931122|abcdef", "ENTRY": "sextas, Manduca", "MN": "B01.050.500.131.617.720.500.500.937.650.525", "MH_TH": "NLM (1995)", "ST": "T204", "RN": "txid7129", "RR": "txid7130", "AN": "a genus of moth; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111", "PI": "Moths (1975-1994)", "MS": "A genus of sphinx or hawk moths of the family Sphingidae. These insects are used in molecular biology studies during all stages of their life cycle.", "PM": "95", "HN": "95", "MR": "20200813", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018402"}, {"RECTYPE": "D", "MH": "Isochromosomes", "AQ": "DE ES GE IM PH RE", "ENTRY": "Isochromosome", "MN": "G05.365.590.175.430", "MH_TH": "NLM (1995)", "ST": "T020", "AN": "note category", "PI": "specific chromosome (1966-1994)", "MS": "Metacentric chromosomes produced during MEIOSIS or MITOSIS when the CENTROMERE splits transversely instead of longitudinally. The chromosomes produced by this abnormal division are one chromosome having the two long arms of the original chromosome, but no short arms, and the other chromosome consisting of the two short arms and no long arms. Each of these isochromosomes constitutes a simultaneous duplication and deletion.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018404"}, {"RECTYPE": "D", "MH": "Virus Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Virus Physiological Processes|T070|NON|NRW|NLM (2009)|080317|abcdef", "ENTRY": "Virus Physiological Concept", "MN": "G06.920", "FX": "Genetics, Microbial", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "PI": "Viruses/physiology (1966-1997)", "MS": "Biological properties, processes, and activities of VIRUSES, including the interactions with the cells they infect.", "PM": "2009; see VIRAL PHYSIOLOGY 1998-2008; for VIRUS PHYSIOLOGICAL PROCESSES see VIRUS PHYSIOLOGICAL PROCESSES 2009-2016", "HN": "20090 (1998)", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19940125", "DC": "1", "DX": "19980101", "UI": "D018406"}, {"RECTYPE": "D", "MH": "Bacterial Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Bacterial Processes|T070|NON|NRW|NLM (2009)|080317|abcdef", "ENTRY": "Processes, Bacterial", "MN": "G06.099", "FX": "Genetics, Microbial", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "PI": "Bacteria/physiology (1966-1997)", "MS": "Physiological processes and properties of BACTERIA.", "PM": "2009; see BACTERIAL PHYSIOLOGY 1998-2008; for BACTERIAL PROCESSES see  BACTERIAL PROCESSES 2009-2016", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19940125", "DC": "1", "DX": "19980101", "UI": "D018407"}, {"RECTYPE": "D", "MH": "Patch-Clamp Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Whole-Cell Recording|T062|NON|NRW|NLM (1995)|931210|abcdef", "ENTRY": "Whole-Cell Recordings", "MN": "E05.242.800", "MH_TH": "NLM (1995)", "ST": "T062", "AN": "a cytol technique for removing a tiny patch of plasma membrane; NIM", "PI": "Membrane Potentials (1975-1994)", "MS": "An electrophysiologic technique for studying cells, cell membranes, and occasionally isolated organelles. All patch-clamp methods rely on a very high-resistance seal between a micropipette and a membrane; the seal is usually attained by gentle suction. The four most common variants include on-cell patch, inside-out patch, outside-out patch, and whole-cell clamp. Patch-clamp methods are commonly used to voltage clamp, that is control the voltage across the membrane and measure current flow, but current-clamp methods, in which the current is controlled and the voltage is measured, are also used.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018408"}, {"RECTYPE": "D", "MH": "Foot Injuries", "DE": "FOOT INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Turf Toes", "MN": "C26.558.300", "MH_TH": "NLM (1995)", "ST": "T037", "AN": "general or unspecified; prefer specifics; consider also /inj with specific sites of foot", "PI": "Foot/injuries (1966-1994)", "MS": "General or unspecified injuries involving the foot.", "OL": "use FOOT INJURIES to search FOOT/injuries 1966-94", "PM": "95; was FOOT/injuries 1966-94", "HN": "95; was FOOT/injuries 1966-94", "CATSH": "CAT LIST", "MR": "20160226", "DA": "19940628", "DC": "1", "DX": "19950101", "UI": "D018409"}, {"RECTYPE": "D", "MH": "Pneumonia, Bacterial", "DE": "PNEUMONIA BACT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Pneumonias, Bacterial", "MN": "C08.730.610.540", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate IM with specific bacteria infection (IM)", "MS": "Inflammation of the lung parenchyma that is caused by bacterial infections.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190610", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018410"}, {"RECTYPE": "D", "MH": "Spodoptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Spodoptera frugiperda|T204|NON|NRW|NLM (1995)|930927|abcdef", "ENTRY": "frugiperdas, Spodoptera", "MN": "B01.050.500.131.617.720.500.500.937.650.700", "MH_TH": "NLM (1995)", "ST": "T204", "RN": "txid7106", "RR": "txid7108", "AN": "a genus of moths; /microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111", "PI": "Moths (1975-1994)", "MS": "A genus of owlet moths of the family Noctuidae. These insects are used in molecular biology studies during all stages of their life cycle.", "PM": "95", "HN": "95", "MR": "20200813", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018411"}, {"RECTYPE": "D", "MH": "Bartonella quintana", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rochalimaea quintana|T007|NON|EQV|NLM (1996)|950315|abcdef", "MN": "B03.660.050.030.040.650", "MH_TH": "NLM (1995)", "ST": "T007", "RN": "txid803", "PI": "Rickettsiaceae (1990-1994)", "MS": "A species of gram-negative bacteria in which man is the primary host and the human body louse, Pediculus humanus, the principal vector. It is the etiological agent of TRENCH FEVER.", "PM": "96; was ROCHALIMAEA QUINTANA 1995", "HN": "96; was ROCHALIMAEA QUINTANA 1995", "MR": "20200813", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018413"}, {"RECTYPE": "D", "MH": "CD8-Positive T-Lymphocytes", "DS": "CD 008 POSITIVE T LYMPHOCYTES", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "T8 Lymphocytes|T025|EQV|NLM (1995)|940412|LYMPHOCYTES J 08|abdefs", "ENTRY": "T8 Lymphocyte", "MN": "A15.382.490.555.567.569.220", "FX": "CD8 Antigens", "MH_TH": "NLM (1995)", "ST": "T025", "PI": "T-Lymphocytes (1982-1994)", "MS": "A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes.", "PM": "95", "HN": "95", "MR": "20170717", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018414"}, {"RECTYPE": "D", "MH": "Bartonella henselae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rochalimaea henselae|T007|NON|EQV|NLM (1996)|950315|abcdef", "MN": "B03.660.050.030.040.350", "MH_TH": "NLM (1995)", "ST": "T007", "RN": "txid38323", "PI": "Rickettsieae (1992-1994)", "MS": "A species of gram-negative bacteria that is the etiologic agent of bacillary angiomatosis (ANGIOMATOSIS, BACILLARY). This organism can also be a cause of CAT-SCRATCH DISEASE in immunocompetent patients.", "PM": "96; was ROCHALIMAEA HENSELAE 1995", "HN": "96; was ROCHALIMAEA HENSELAE 1995", "MR": "20200813", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018416"}, {"RECTYPE": "D", "MH": "Th1 Cells", "DS": "TH CELLS 001", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Th1 Cell", "MN": "A15.382.490.555.567.569.500.400.900", "MH_TH": "NLM (1995)", "ST": "T025", "PI": "T-Lymphocytes, Helper-Inducer (1985-1994)", "MS": "A subset of helper-inducer T-lymphocytes which synthesize and secrete INTERLEUKIN-2; INTERFERON-GAMMA; and INTERLEUKIN-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions.", "PM": "95", "HN": "95", "MR": "20160705", "DA": "19940512", "DC": "1", "DX": "19950101", "UI": "D018417"}, {"RECTYPE": "D", "MH": "Th2 Cells", "DS": "TH CELLS 002", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Type-2 Helper T Cell|T025|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Type 2 Helper T Cells", "MN": "A15.382.490.555.567.569.500.400.905", "MH_TH": "NLM (1995)", "ST": "T025", "PI": "T-Lymphocytes, Helper-Inducer (1985-1994)", "MS": "A subset of helper-inducer T-lymphocytes which synthesize and secrete the INTERLEUKINS IL-4; IL-5; IL-6; and IL-10. These cytokines influence B-cell development and antibody production as well as augmenting humoral responses.", "PM": "95", "HN": "95", "MR": "20200527", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018418"}, {"RECTYPE": "D", "MH": "Primate Diseases", "DE": "PRIMATE DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Primate Disease", "MN": "C22.735", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "animal only, not man; general or unspecified; prefer specifics; coordinate  with specific disease  /vet; for abnormalities or injuries, index under specific primate heading  /abnorm or  /inj; index also PRIMATES (NIM) if no specific primate is indexed", "MS": "Diseases of animals within the order PRIMATES. This term includes diseases of Haplorhini and Strepsirhini.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018419"}, {"RECTYPE": "D", "MH": "Ape Diseases", "DE": "APE DIS", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Pongidae Disease", "MN": "C22.735.050", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "coordinate with specific ape or with HOMINIDAE (NIM) if ape is not specified + specific disease /vet", "MS": "Diseases of chimpanzees, gorillas, and orangutans.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20040803", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018420"}, {"RECTYPE": "D", "MH": "Cardiomyoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Dynamic Cardiomyoplasty|T061|NON|EQV|NLM (1995)|931208|abcdef", "ENTRY": "Dynamic Cardiomyoplasties", "MN": "E04.928.220.220", "FX": "Skeletal Muscle Ventricle", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "a technique in heart surg using autol skeletal muscle", "PI": "Heart Surgery (1987-1994)", "MS": "An operation that uses stimulated latissimus dorsi muscle (SKELETAL MUSCLE VENTRICLE) to assist cardiac function. The latissimus dorsi muscle is mobilized from the chest wall and moved into the thorax through the bed of the resected 2nd or 3rd rib. The muscle is then wrapped around the left and right ventricles and stimulated to contract during cardiac systole by means of an implanted burst-stimulator. (Stedman, 26th ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018421"}, {"RECTYPE": "D", "MH": "Cholesteatoma, Middle Ear", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Middle Ear Cholesteatoma|T047|NON|EQV|NLM (1995)|930930|abcdef", "ENTRY": "Middle Ear Cholesteatomas", "MN": "C17.800.428.260.300", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Ear, Middle (1966-1994)", "MS": "A mass of KERATIN-producing squamous EPITHELIUM that resembles an inverted (suck-in) bag of skin in the MIDDLE EAR. It arises from the eardrum (TYMPANIC MEMBRANE) and grows into the MIDDLE EAR causing erosion of EAR OSSICLES and MASTOID that contains the INNER EAR.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018424"}, {"RECTYPE": "D", "MH": "SEER Program", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Surveillance, Epidemiology, and End Results Program|T064|T093|NON|EQV|NLM (1995)|930930|abbcdef", "ENTRY": "Program, SEER", "MN": "N06.850.520.308.970.725", "MH_TH": "NLM (1995)", "ST": "T093", "AN": "CATALOGER: Use NAF entry", "MS": "A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018426"}, {"RECTYPE": "D", "MH": "Breast Implants", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Implants, Breast|T074|NON|EQV|NLM (1995)|930930|abcdef", "ENTRY": "Prosthesis, Internal Breast", "MN": "E07.695.140", "FX": "Silicone Gels", "MH_TH": "NLM (1995)", "ST": "T074", "AN": "IM; coord with implant material (IM or NIM)", "PI": "Silicones (1967-1994)", "MS": "Implants used to reconstruct and/or cosmetically enhance the female breast. They have an outer shell or envelope of silicone elastomer and are filled with either saline or silicone gel. The outer shell may be either smooth or textured.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "19980610", "DA": "19940421", "DC": "1", "DX": "19950101", "UI": "D018427"}, {"RECTYPE": "D", "MH": "Drosophilidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.720.500.500.750.310", "MH_TH": "NLM (1995)", "ST": "T204", "RN": "txid7214", "AN": "a family of Diptera; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111", "MS": "A family of the order DIPTERA. These flies are generally found around decaying vegetation and fruit. Several species, because of their short life span, giant salivary gland chromosomes, and ease of culturing, have been used extensively in studies of heredity.", "PM": "95", "HN": "95", "MR": "20200813", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018428"}, {"RECTYPE": "D", "MH": "Glossinidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.720.500.500.750.400", "MH_TH": "NLM (1995)", "ST": "T204", "RN": "txid7392", "AN": "a family of Diptera occurring only in Africa; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111", "MS": "A family of the order DIPTERA that includes the TSETSE FLIES. These flies occur only in Africa.", "PM": "95", "HN": "95", "MR": "20200813", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018429"}, {"RECTYPE": "D", "MH": "Newspaper Article", "MN": "V02.667", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "This heading is used as a Publication Type. For items indexed from newspapers or newsletters: do not confuse with the Publication Type NEWS used for news items indexed from journals. CATALOGER: Do not use for current materials or for reprints of newspaper articles.", "MS": "Work consisting of a news item appearing in a general-interest newspaper or other general news periodical, containing information of current and timely interest in the field of medicine or science. This publication type should not be confused with NEWS Publication Type, reserved for news reports published in various medical or other scientific journals, such as \"Nature\".", "HN": "2008(1995)", "MR": "20150629", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D018431"}, {"RECTYPE": "D", "MH": "Drug Resistance, Multiple", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Multidrug Resistance|T032|NON|EQV|NLM (1995)|931004|abcdef", "ENTRY": "Resistance, Multiple Drug", "MN": "G07.690.773.984.300", "FX": "Multidrug Resistance-Associated Proteins", "MH_TH": "NLM (1995)", "ST": "T032", "AN": "DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, VIRAL; and DRUG RESISTANCE, MULTIPLE, FUNGAL are also available", "PI": "Drug Resistance, Microbial (1966-1994)", "MS": "Simultaneous resistance to several structurally and functionally distinct drugs.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20230405", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018432"}, {"RECTYPE": "D", "MH": "Twin Studies as Topic", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "MN": "N06.850.520.450.900", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "for general design, methodology, economics, etc of twin studies; main headings DISEASES IN TWINS; TWINS; and specifics are also available; do not confuse with the Publication Type TWIN STUDY", "PI": "Twins (1966-1994)", "MS": "Works about methods of detecting genetic etiology in human traits. The basic premise of twin studies is that monozygotic twins carry identical genes, while zygotic twins are genetically no more similar than two siblings born after separate pregnancies. (Last, J.M., A Dictionary of Epidemiology, 2d ed)", "PM": "2008; see TWIN STUDIES 1995-2007", "HN": "2008(1995)", "CATSH": "CAT LIST", "MR": "20180630", "DA": "19940527", "DC": "1", "DX": "19950101", "UI": "D018433"}, {"RECTYPE": "D", "MH": "Sickness Impact Profile", "ENTRY": "Sickness Impact Profiles", "MN": "N06.850.520.308.980.438.475.730", "MH_TH": "NLM (1995)", "ST": "T060", "AN": "a health status indicator", "PI": "Quality of Life (1976-1994)", "MS": "A quality-of-life scale developed in the United States in 1972 as a measure of health status or dysfunction generated by a disease. It is a behaviorally based questionnaire for patients and addresses activities such as sleep and rest, mobility, recreation, home management, emotional behavior, social interaction, and the like. It measures the patient's perceived health status and is sensitive enough to detect changes or differences in health status occurring over time or between groups. (From Medical Care, vol.xix, no.8, August 1981, p.787-805)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018434"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "P-Glycoproteins|T116|T123|ABX|EQV|NLM (1995)|990101|P GLYCOPROTEIN Z|abbcdefs", "ENTRY": "P Glycoproteins", "MN": "D12.776.543.585.450.074.500.500.250", "FX": "Rhodamine 123", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "AN": "note entry term: ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 is also available", "PI": "Membrane Proteins (1980-1988)", "MS": "A subfamily of transmembrane proteins from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS that are closely related in sequence to ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1. When overexpressed, they function as ATP-dependent efflux pumps able to extrude lipophilic drugs (especially ANTINEOPLASTIC AGENTS) from cells, causing multidrug resistance (DRUG RESISTANCE, MULTIPLE). Although ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B share functional similarities to MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS they are two distinct subclasses of ATP-BINDING CASSETTE TRANSPORTERS, and have little sequence homology.", "PM": "2019; see ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY B 2018; see P-GLYCOPROTEIN 1995-1998; P-GLYCOPROTEIN was indexed under CARRIER PROTEINS & MEMBRANE GLYCOPROTEINS 1980-1994, GLYCOPROTEINS 1980-1987, and MEMBRANE PROTEINS 1980-1982", "HN": "2019 (1999); use P-GLYCOPROTEIN 1995-1998", "MR": "20230316", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018435"}, {"RECTYPE": "D", "MH": "Ancient Lands", "AQ": "EH EP", "MN": "Z01.586.035", "MH_TH": "NLM (1995)", "ST": "T083", "AN": "\"ancient\" refers to a far-past date or period; general or unspecified; prefer specific ancient countries or empires; use historical tags", "PI": "specific geographic location (1966-1997)", "MS": "Geographical sites known to be extant in a remote period in the history of civilization, familiar as the names of ancient countries and empires.", "HN": "98; use explode 1995-97", "MR": "19970620", "DA": "19940419", "DC": "4", "DX": "19980101", "UI": "D018436"}, {"RECTYPE": "D", "MH": "Brown-Sequard Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spastic Spinal Monoplegia Syndrome|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Syndromes, Hemispinal Cord", "MN": "C23.888.592.636.637.300", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with flaccid paralysis of the bladder, also called Brown S\u00e9quard paralysis; in titles & translations use diacrit: Brown-Sequard", "PI": "Spinal Cord Injuries (1970-1994)", "MS": "A syndrome associated with injury to the lateral half of the spinal cord. The condition is characterized by the following clinical features (which are found below the level of the lesion): contralateral hemisensory anesthesia to pain and temperature, ipsilateral loss of propioception, and ipsilateral motor paralysis. Tactile sensation is generally spared. (From Adams et al., Principles of Neurology, 6th ed, p162).", "PM": "1995", "HN": "1995", "CATSH": "CAT LIST", "MR": "20150112", "DA": "19940706", "DC": "1", "DX": "19950101", "UI": "D018437"}, {"RECTYPE": "D", "MH": "Blue Toe Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Blue Toe", "MN": "C14.907.617.249", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Toes/blood supply (1976-1994)", "MS": "A condition that is caused by recurring atheroembolism in the lower extremities. It is characterized by cyanotic discoloration of the toes, usually the first, fourth, and fifth toes. Discoloration may extend to the lateral aspect of the foot. Despite the gangrene-like appearance, blue toes may respond to conservative therapy without AMPUTATION, SURGICAL.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20220715", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018438"}, {"RECTYPE": "D", "MH": "beta-Lactam Resistance", "AQ": "DE EH GE IM PH RE", "ENTRY": "beta Lactamase Resistant", "MN": "G07.690.773.984.269.347.500", "FX": "Carbapenem-Resistant Enterobacteriaceae", "MH_TH": "NLM (1995)", "ST": "T032", "AN": "general or unspecified; prefer specifics", "PI": "Lactams/pharmacology (1974-1994)", "MS": "Nonsusceptibility of bacteria to the action of the beta-lactam antibiotics. Mechanisms responsible for beta-lactam resistance may be degradation of antibiotics by BETA-LACTAMASES, failure of antibiotics to penetrate, or low-affinity binding of antibiotics to targets.", "PM": "1995", "HN": "1995", "CATSH": "CAT LIST", "MR": "20170207", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018440"}, {"RECTYPE": "D", "MH": "Biofilms", "AQ": "CL DE GD RE", "ENTRY": "Biofilm|T001|T167|NON|EQV|NLM (1995)|931229|abbcdef", "MN": "G06.120", "FX": "Prosthesis-Related Infections", "MH_TH": "NLM (1995)", "ST": "T167", "AN": "coordinate with specific organism /physiol; occurrence of biofilms on prostheses or other devices: coordinate with specific device; infection of prostheses by biofilms: coordinate BIOFILMS with specific prosthesis + PROSTHESIS-RELATED INFECTIONS + specific infection ", "PI": "Bacteria (1981-1994)", "MS": "Encrustations formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedded in an EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX that is secreted by the microbes. They occur on body surfaces such as teeth (DENTAL DEPOSITS); inanimate objects, and bodies of water. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and anti-fouling agents.", "PM": "95", "HN": "95", "MR": "20180228", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018441"}, {"RECTYPE": "D", "MH": "Lymphoma, B-Cell, Marginal Zone", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Marginal Zone B-Cell Lymphoma|T191|NON|EQV|NLM (2008)|061221|abcdef", "ENTRY": "Mucosa Associated Lymphoid Tissue Lymphoma", "MN": "C20.683.515.761.480.150.570", "MH_TH": "NLM (2008)", "ST": "T191", "PI": "Lymphoma, Non-Hodgkin's (1991-1994)", "MS": "Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder.", "PM": "2008; see LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE 1995-2007", "HN": "2008 (1995)", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018442"}, {"RECTYPE": "D", "MH": "Infectious Disease Transmission, Vertical", "AQ": "CL EC ES HI LJ PC SN VE", "ENTRY": "Vertical Pathogen Transmission", "MN": "N06.850.335.875", "MH_TH": "NLM (2009)", "ST": "T046", "AN": "coordinate IM with specific disease /transm (IM); INFECTIOUS DISEASE TRANSMISSION, HORIZONTAL see DISEASE TRANSMISSION, INFECTIOUS is also available", "PI": "specific diseases/transmission (1975-1994)", "MS": "The transmission of infectious disease or pathogens from one generation to another. It includes transmission in utero or intrapartum by exposure to blood and secretions, and postpartum exposure via breastfeeding.", "PM": "2009; see DISEASE TRANSMISSION, VERTICAL (1995-2008)", "HN": "2009 (1995)", "MR": "20200612", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018445"}, {"RECTYPE": "D", "MH": "Medical Futility", "DE": "MED FUTILITY", "AQ": "ES LJ PX", "PRINT ENTRY": "Treatment Futility|T078|NON|NRW|NLM (1995)|940408|abcdef", "ENTRY": "Treatments, Futile", "MN": "E01.789.600", "FX": "Resuscitation Orders", "MH_TH": "NLM (1995)", "ST": "T078", "PI": "Resuscitation (1989)", "MS": "The absence of a useful purpose or useful result in a diagnostic procedure or therapeutic intervention. The situation of a patient whose condition will not be improved by treatment or instances in which treatment preserves permanent unconsciousness or cannot end dependence on intensive medical care. (From Ann Intern Med 1990 Jun 15;112(12):949)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018447"}, {"RECTYPE": "D", "MH": "Models, Immunological", "DE": "MODELS IMMUNOL", "PRINT ENTRY": "Immunological Models|T170|NON|EQV|NLM (1995)|931028|IMMUNOL MODELS|abcdefv", "ENTRY": "Models, Immunologic", "MN": "E05.599.395.500", "MH_TH": "NLM (1995)", "ST": "T170", "PI": "Models, Biological (1967-1994)", "MS": "Theoretical representations that simulate the behavior or activity of immune system, processes, or phenomena. They include the use of mathematical equations, computers, and other electrical equipment.", "PM": "95", "HN": "95", "MR": "20080708", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018448"}, {"RECTYPE": "D", "MH": "SAIDS Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Simian AIDS Vaccines|T121|T129|EQV|NLM (1995)|940331|abbdef", "ENTRY": "Vaccines, Simian AIDS", "MN": "D20.215.894.899.790", "MH_TH": "NLM (1995)", "ST": "T129", "RN": "0", "AN": "coord IM with specific SAIDS virus (IM or NIM) if pertinent", "PI": "Viral Vaccines/immunology (1991-1994)", "MS": "Vaccines or candidate vaccines designed to prevent SAIDS; (SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME); and containing inactivated SIMIAN IMMUNODEFICIENCY VIRUS or type D retroviruses or some of their component antigens.", "PM": "95", "HN": "95", "MR": "20150713", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018449"}, {"RECTYPE": "D", "MH": "Disease Progression", "DE": "DIS PROGRESSION", "PRINT ENTRY": "Clinical Progression|T046|NON|REL|NLM (2023)|211022|abcdef", "ENTRY": "Progression, Disease", "MN": "C23.550.291.656", "MH_TH": "NLM (1995)", "ST": "T046", "MS": "The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018450"}, {"RECTYPE": "D", "MH": "Homosexuality, Male", "AQ": "EH GE HI PX SN", "ENTRY": "Male Homosexuality", "MN": "G08.686.867.500.600", "FX": "Sexual and Gender Minorities", "MH_TH": "NLM (1995)", "ST": "T053", "AN": "check tag MALE", "PI": "Homosexuality (1966-1994)", "MS": "Sexual attraction or relationship between males.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20170118", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018451"}, {"RECTYPE": "D", "MH": "Homosexuality, Female", "AQ": "EH GE HI PX SN", "PRINT ENTRY": "Lesbianism|T055|NON|EQV|NLM (1995)|931116|abcdef", "ENTRY": "Female Homosexuality", "MN": "G08.686.867.500.400", "FX": "Sexual and Gender Minorities", "MH_TH": "NLM (1995)", "ST": "T055", "PI": "Homosexuality (1966-1994)", "MS": "Sexual attraction or relationship between females.", "OL": "use HOMOSEXUALITY to search HOMOSEXUALITY, FEMALE 1976-80 & LESBIANISM 1968-94", "PM": "95; was see under HOMOSEXUALITY 1976-80; LESBIANISM was see HOMOSEXUALITY 1981-94, was see HOMOSEXUALITY, FEMALE 1976-80, & was see under HOMOSEXUALITY 1968-75", "HN": "95; was see under HOMOSEXUALITY 1976-80; LESBIANISM was see HOMOSEXUALITY 1981-94, was see HOMOSEXUALITY, FEMALE 1976-80, & was see under HOMOSEXUALITY 1968-75", "CATSH": "CAT LIST", "MR": "20170118", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018452"}, {"RECTYPE": "D", "MH": "Homeless Youth", "AQ": "CL ED EH HI LJ PX SN", "PRINT ENTRY": "Street Youth|T098|NON|NRW|NLM (1995)|940408|abcdef", "ENTRY": "Youths, Street", "MN": "M01.325.400", "MH_TH": "NLM (1995)", "ST": "T098", "AN": "check the tag CHILD or specific age group; specify geog if pertinent", "PI": "Homeless Persons (1987-1994)", "MS": "Runaway and homeless children and adolescents living on the streets of cities and having no fixed place of residence.", "PM": "95", "HN": "95", "MR": "20020703", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018453"}, {"RECTYPE": "D", "MH": "Spouses", "AQ": "CL ED EH HI LJ PX SN", "PRINT ENTRY": "Wives|T099|NON|REL|NLM (1995)|931116|abcdef", "ENTRY": "Persons, Married", "MN": "M01.816", "MH_TH": "NLM (1995)", "ST": "T099", "AN": "husbands, wives, or partners as persons: differentiate from MARRIAGE, the sociol or anthropol concept", "PI": "Marriage (1966-1994)", "MS": "Married persons, i.e., husbands and wives, or partners. Domestic partners, or spousal equivalents, are two adults who have chosen to share their lives in an intimate and committed relationship, reside together, and share a mutual obligation of support for the basic necessities of life.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20220413", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018454"}, {"RECTYPE": "D", "MH": "Protein S Deficiency", "DE": "PROTEIN S DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Protein S Deficiencies", "MN": "C15.378.925.800", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Protein S/deficiency (1993-1994)", "MS": "An autosomal dominant disorder showing decreased levels of plasma protein S antigen or activity, associated with venous thrombosis and pulmonary embolism. PROTEIN S is a vitamin K-dependent plasma protein that inhibits blood clotting by serving as a cofactor for activated PROTEIN C (also a vitamin K-dependent protein), and the clinical manifestations of its deficiency are virtually identical to those of protein C deficiency. Treatment with heparin for acute thrombotic processes is usually followed by maintenance administration of coumarin drugs for the prevention of recurrent thrombosis. (From Harrison's Principles of Internal Medicine, 12th ed, p1511; Wintrobe's Clinical Hematology, 9th ed, p1523)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018455"}, {"RECTYPE": "D", "MH": "Reproductive Medicine", "DE": "REPRODUCTIVE MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Reproductive|T091|NON|EQV|NLM (1995)|931117|MED REPRODUCTIVE|abcdefv", "MN": "H02.403.763", "FX": "Reproductive Techniques", "MH_TH": "NLM (1995)", "ST": "T091", "AN": "use for the specialty only; use REPRODUCTIVE HEALTH for the state of the reproductive system", "MS": "A medical-surgical specialty concerned with the morphology, physiology, biochemistry, and pathology of reproduction in man and other animals, and on the biological, medical, and veterinary problems of fertility and lactation. It includes ovulation induction, diagnosis of infertility and recurrent pregnancy loss, and assisted reproductive technologies such as embryo transfer, in vitro fertilization, and intrafallopian transfer of zygotes. (From Infertility and Reproductive Medicine Clinics of North America, Foreword 1990; Journal of Reproduction and Fertility, Notice to Contributors, Jan 1979)", "PM": "95", "HN": "95", "MR": "20110624", "DA": "19940317", "DC": "1", "DX": "19950101", "UI": "D018456"}, {"RECTYPE": "D", "MH": "Placenta, Retained", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Retained Placentas", "MN": "C12.050.703.590.767", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY", "PI": "Placenta Diseases (1970-1994)", "MS": "A placenta that fails to be expelled after BIRTH of the FETUS. A PLACENTA is retained when the UTERUS fails to contract after the delivery of its content, or when the placenta is abnormally attached to the MYOMETRIUM.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018457"}, {"RECTYPE": "D", "MH": "Persistent Vegetative State", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vegetative State, Persistent|T047|NON|EQV|BIOETHICS (19XX)|NLM (1995)|931117|abcdeef", "ENTRY": "Vegetative States, Transient", "MN": "C23.888.592.604.359.800.400", "FX": "Coma", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "see also AKINETIC MUTISM", "PI": "Coma (1972-1994)", "MS": "Vegetative state refers to the neurocognitive status of individuals with severe brain damage, in whom physiologic functions (sleep-wake cycles, autonomic control, and breathing) persist, but awareness (including all cognitive function and emotion) is abolished.", "PM": "1995; VEGETATIVE STATE was see COMA 1980-1994", "HN": "1995; VEGETATIVE STATE was see COMA 1980-1994", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018458"}, {"RECTYPE": "D", "MH": "Lichen Sclerosus et Atrophicus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lichen Sclerosus|T047|NON|EQV|NLM (1995)|ORD (2010)|940121|abcdeef", "ENTRY": "Sclerosus, Lichen", "MN": "C17.800.859.475.605", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with lichen planus atrophicus (index LICHEN PLANUS)", "PI": "Skin Diseases (1966-1992)", "MS": "A chronic inflammatory mucocutaneous disease usually affecting the female genitalia (VULVAR LICHEN SCLEROSUS) and BALANITIS XEROTICA OBLITERANS in males. It is also called white spot disease and Csillag's disease.", "PM": "1995", "HN": "1995", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018459"}, {"RECTYPE": "D", "MH": "Fractures, Comminuted", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fracture, Comminuted", "MN": "C26.404.186", "MH_TH": "NLM (1995)", "ST": "T037", "AN": "coordinate with specific bone /inj or precoordinated Bone/Fracture term", "PI": "specific fracture (1966-1994)", "MS": "A fracture in which the bone is splintered or crushed into a number of pieces.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160707", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018460"}, {"RECTYPE": "D", "MH": "Soft Tissue Infections", "DE": "SOFT TISSUE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Soft Tissue Infection", "MN": "C01.820", "FX": "Skin Diseases, Infectious", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "general or unspecified; prefer specific soft tissue; coordinate with organism/infection term", "MS": "Infections of non-skeletal tissue, i.e., exclusive of bone, ligaments, cartilage, and fibrous tissue. The concept is usually referred to as skin and soft tissue infections and usually subcutaneous and muscle tissue are involved. The predisposing factors in anaerobic infections are trauma, ischemia, and surgery. The organisms often derive from the fecal or oral flora, particularly in wounds associated with intestinal surgery, decubitus ulcer, and human bites. (From Cecil Textbook of Medicine, 19th ed, p1688)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018461"}, {"RECTYPE": "D", "MH": "Photobiology", "DE": "PHOTOBIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.158.273.738", "FX": "Photosynthesis", "MH_TH": "NLM (1995)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use PHOTOTROPHIC PROCESSES or specifics treed under it for processes and properties using sunlight by phototrophic organisms", "PI": "Light (1966-1994)", "MS": "The branch of biology dealing with the effect of light on organisms.", "PM": "95", "HN": "95", "MR": "20081208", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018462"}, {"RECTYPE": "D", "MH": "Filtering Surgery", "DE": "FILTERING SURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgery, Filtration|T061|NON|EQV|NLM (1995)|940214|SURG FILTRATION|abcdefv", "ENTRY": "Surgery, Filtering|T061|NON|EQV|NLM (1995)|940121|SURG FILTERING|abcdefv", "MN": "E04.540.450", "FX": "Molteno Implants", "MH_TH": "NLM (1995)", "ST": "T061", "PI": "Glaucoma/surgery (1966-1994)", "MS": "A surgical procedure used in treatment of glaucoma in which an opening is created through which aqueous fluid may pass from the anterior chamber into a sac created beneath the conjunctiva, thus lowering the pressure within the eye. (Hoffman, Pocket Glossary of Ophthalmologic Terminology, 1989)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018463"}, {"RECTYPE": "D", "MH": "Molteno Implants", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Implants, Molteno|T074|EPO|EQV|NLM (1995)|940214|abcdef", "ENTRY": "Shunts, Molteno", "MN": "E07.695.250.500", "MH_TH": "NLM (1995)", "ST": "T074", "PI": "Implants, Artificial (1980-1994)", "MS": "Devices implanted to control intraocular pressure by allowing aqueous fluid to drain from the anterior chamber. (Hoffman, Pocket Glossary of Ophthalmologic Terminology, 1989)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "19980610", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018465"}, {"RECTYPE": "D", "MH": "Gravity Sensing", "AQ": "DE GE IM PH RE", "ENTRY": "Sensing, Gravity", "MN": "G15.375", "MH_TH": "NLM (1995)", "ST": "T039", "PI": "Gravitation (1966-1994)", "MS": "Process whereby a cell, bodily structure, or organism (animal or plant) receives or detects a gravity stimulus. Gravity sensing plays an important role in the directional growth and development of an organism (GRAVITROPISM).", "PM": "2009; see GRAVITY PERCEPTION 1995-2008", "HN": "2009 (1995)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018466"}, {"RECTYPE": "D", "MH": "Positive-Pressure Respiration, Intrinsic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Positive-Pressure Respiration, Occult|T047|NON|EQV|NLM (1995)|931119|abcdef", "ENTRY": "Respiration, Occult Positive-Pressure", "MN": "C08.618.846.688", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "note category: a type of resp insuff; do not confuse with POSITIVE END-EXPIRATORY PRESSURE or PEEP see POSITIVE-PRESSURE RESPIRATION, a form of artif resp (Cat E)", "PI": "Positive-Pressure Respiration (1982-1994)", "MS": "Non-therapeutic positive end-expiratory pressure occurring frequently in patients with severe airway obstruction. It can appear with or without the administration of external positive end-expiratory pressure (POSITIVE-PRESSURE RESPIRATION). It presents an important load on the inspiratory muscles which are operating at a mechanical disadvantage due to hyperinflation. Auto-PEEP may cause profound hypotension that should be treated by intravascular volume expansion, increasing the time for expiration, and/or changing from assist mode to intermittent mandatory ventilation mode. (From Harrison's Principles of Internal Medicine, 12th ed, p1127)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018467"}, {"RECTYPE": "D", "MH": "Ehrlichia chaffeensis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.500.287.100", "MH_TH": "NLM (1995)", "ST": "T007", "RN": "txid945", "AN": "infection: coordinate with EHRLICHIOSIS", "PI": "Ehrlichia (1991-1994)", "MS": "A species of gram-negative bacteria that is the causative agent of human EHRLICHIOSIS. This organism was first discovered at Fort Chaffee, Arkansas, when blood samples from suspected human ehrlichiosis patients were studied.", "PM": "95", "HN": "95", "MR": "20200813", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018469"}, {"RECTYPE": "D", "MH": "Gravity, Altered", "AQ": "AE", "PRINT ENTRY": "Gravity, Artificial|T068|NON|REL|NLM (1995)|940111|abcdef", "ENTRY": "Artificial Gravity", "MN": "G01.060.350.369", "MH_TH": "NLM (1995)", "ST": "T067", "AN": "natural or artificial; /adv eff permitted", "PI": "Gravitation (1966-1994)", "MS": "A change in, or manipulation of, gravitational force. This may be a natural or artificial effect.", "PM": "95", "HN": "95", "MR": "20160617", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018470"}, {"RECTYPE": "D", "MH": "Hypergravity", "AQ": "AE", "PRINT ENTRY": "Increased Gravity|T070|NON|EQV|NLM (1995)|940114|abcdef", "ENTRY": "Gravity, Increased", "MN": "G01.060.350.369.300", "MH_TH": "NLM (1995)", "ST": "T070", "AN": "natural or artificial; do not confuse with HYPOGRAVITY; /adv eff permitted", "PI": "Gravitation (1966-1994)", "MS": "Condition wherein the force of gravity is greater than or is increased above that on the surface of the earth. This is expressed as being greater than 1 g.", "PM": "95", "HN": "95", "MR": "20160617", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018471"}, {"RECTYPE": "D", "MH": "Hypogravity", "AQ": "AE", "PRINT ENTRY": "Reduced Gravity|T070|NON|EQV|NLM (1995)|931119|abcdef", "ENTRY": "Gravity, Reduced", "MN": "G01.060.350.369.400", "FX": "Weightlessness", "MH_TH": "NLM (1995)", "ST": "T070", "AN": "natural or artificial; do not confuse with HYPERGRAVITY; /adv eff permitted", "PI": "Gravitation (1966-1994)", "MS": "Condition wherein the force of gravity is less than or is decreased below that on the surface of the earth. This is expressed as being between 0 and 1 g.", "PM": "95", "HN": "95", "MR": "20160617", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018472"}, {"RECTYPE": "D", "MH": "Weightlessness Simulation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Models, Weightlessness|T075|NON|REL|NLM (1996)|950213|abcdef", "ENTRY": "Weightlessness Models", "MN": "N06.230.150.440.950", "MH_TH": "NLM (1995)", "ST": "T068", "PI": "Weightlessness (1966-1994)", "MS": "Condition under normal Earth gravity where the force of gravity itself is not actually altered but its influence or effect may be modified and studied. (From ASGSB Bull 1992;5(2):27)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018474"}, {"RECTYPE": "D", "MH": "Head-Down Tilt", "AQ": "AE PH", "PRINT ENTRY": "Trendelenburg Position|T082|EPO|NRW|NLM (1997)|950926|abcdef", "ENTRY": "Tilt, Head-Down", "MN": "G11.427.695.300", "FX": "Tilt-Table Test", "MH_TH": "NLM (1995)", "ST": "T082", "AN": "not restricted to space flight; /adv eff /physiol permitted", "PI": "Posture (1966-1994)", "MS": "Posture while lying with the head lower than the rest of the body. Extended time in this position is associated with temporary physiologic disturbances.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018475"}, {"RECTYPE": "D", "MH": "Hypokinesia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypodynamia|T040|NON|REL|NLM (1995)|931122|abcdef", "ENTRY": "Hypokinesias, Antiorthostatic", "MN": "C23.888.592.350.400", "FX": "Immobilization", "MH_TH": "NLM (1995)", "ST": "T184", "PI": "Immobilization (1967-1994)", "MS": "Slow or diminished movement of body musculature. It may be associated with BASAL GANGLIA DISEASES; MENTAL DISORDERS; prolonged inactivity due to illness; and other conditions.", "PM": "1995; for HYPOKINESIA use IMMOBILIZATION 1992-1994", "HN": "1995; for KINESIA use IMMOBILIZATION 1992-1994", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018476"}, {"RECTYPE": "D", "MH": "Extravehicular Activity", "AQ": "AE PH", "PRINT ENTRY": "Space-Walk|T052|NON|NRW|NLM (1995)|940205|abcdef", "ENTRY": "Space-Walks", "MN": "J01.937.285.850.400", "MH_TH": "NLM (1995)", "ST": "T052", "PI": "Space Flight (1966-1994)", "MS": "Activities by crew members conducted outside the pressurized hull of a spacecraft.", "PM": "95", "HN": "95", "MR": "19970620", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018478"}, {"RECTYPE": "D", "MH": "Early Intervention, Educational", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Head Start Program|T064|T065|NON|REL|NLM (1999)|980324|abbcdef", "ENTRY": "Program, Head Start", "MN": "N02.421.726.320", "MH_TH": "NLM (2020)", "ST": "T064", "AN": "EARLY MEDICAL INTERVENTION is also available", "MS": "Procedures and programs that facilitate the development or skill acquisition in infants and young children who have disabilities, who are at risk for developing disabilities, or who are gifted. It includes programs that are designed to prevent handicapping conditions in infants and young children and family-centered programs designed to affect the functioning of infants and children with special needs. (From Journal of Early Intervention, Editorial, 1989, vol. 13, no. 1, p. 3; A Discursive Dictionary of Health Care, prepared for the U.S. House of Representatives Committee on Interstate and Foreign Commerce, 1976)", "PM": "2020; was EARLY INTERVENTION (EDUCATION) 1995-2019", "HN": "2020 (1995); was EARLY INTERVENTION (EDUCATION) 1995-2019", "MR": "20190117", "DA": "19940602", "DC": "1", "DX": "19950101", "UI": "D018479"}, {"RECTYPE": "D", "MH": "Astronauts", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Cosmonauts|T097|NON|EQV|NLM (1995)|931122|abcdef", "ENTRY": "Cosmonaut", "MN": "M01.526.173", "MH_TH": "NLM (1995)", "ST": "T097", "PI": "Space Flight (1966-1994)", "MS": "Members of spacecraft crew including those who travel in space, and those in training for space flight.", "PM": "95", "HN": "95", "MR": "20160208", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018480"}, {"RECTYPE": "D", "MH": "Convection", "MN": "G01.906.230", "MH_TH": "NLM (1995)", "ST": "T070", "PI": "Heat (1966-1994)", "MS": "Transmission of energy or mass by a medium involving movement of the medium itself. The circulatory movement that occurs in a fluid at a nonuniform temperature owing to the variation of its density and the action of gravity. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed; Webster, 10th ed)", "PM": "95", "HN": "95", "MR": "20080708", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018481"}, {"RECTYPE": "D", "MH": "Muscle, Skeletal", "DE": "MUSCLE SKELETAL", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Soleus Muscle|T023|NON|NRW|NLM (1995)|931122|abcdef", "ENTRY": "Voluntary Muscles", "MN": "A10.690.552.500", "FX": "Skeletal Muscle Enlargement", "MH_TH": "NLM (1995)", "ST": "T023", "AN": "/growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent", "PI": "Muscles (1966-1994)", "MS": "A subtype of striated muscle, attached by TENDONS to the SKELETON. Skeletal muscles are innervated and their movement can be consciously controlled. They are also called voluntary muscles.", "PM": "95", "HN": "95", "MR": "20200527", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018482"}, {"RECTYPE": "D", "MH": "Diaphyses", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Diaphysis|T023|NON|EQV|NLM (1995)|931122|abcdef", "MN": "A02.835.232.169", "MH_TH": "NLM (1995)", "ST": "T023", "AN": "IM GEN or unspecified; NIM with specific long bone IM; EPIPHYSES (end of long bones) is also available", "PI": "Bone and Bones (1966-1994)", "MS": "The shaft of long bones.", "PM": "95", "HN": "95", "MR": "20180629", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018483"}, {"RECTYPE": "D", "MH": "Muscle Fibers, Skeletal", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Skeletal Myocytes|T025|NON|EQV|NLM (2003)|010921|abcdef", "ENTRY": "Skeletal Myocyte", "MN": "A11.620.249", "FX": "Myoblasts, Skeletal", "MH_TH": "NLM (2009)", "ST": "T025", "AN": "MUSCLE FIBERS, FAST-TWITCH & MUSCLE FIBERS, SLOW-TWITCH are also available", "PI": "Muscles (1966-1994)", "MS": "Large, multinucleate single cells, either cylindrical or prismatic in shape, that form the basic unit of SKELETAL MUSCLE. They consist of MYOFIBRILS enclosed within and attached to the SARCOLEMMA. They are derived from the fusion of skeletal myoblasts (MYOBLASTS, SKELETAL) into a syncytium, followed by differentiation.", "PM": "2009; see MUSCLE FIBERS (1995-2008)", "HN": "2009 (1995)", "MR": "20080708", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018485"}, {"RECTYPE": "D", "MH": "Twin Study", "ENTRY": "Twin Studies|T170|NON|EQV|NLM (2008)|070626|abcdef", "MN": "V03.900", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "this heading is used as a Publication Type; main headings DISEASES IN TWINS; TWINS and specifics are also available; twin studies as a subject are indexed under the main heading TWIN STUDIES AS TOPIC", "MS": "Work consisting of reporting using a method of detecting genetic causes in human traits and genetic factors in behavior using sets of twins.", "HN": "2008(1995)", "MR": "20180701", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D018486"}, {"RECTYPE": "D", "MH": "Ventricular Dysfunction, Left", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Left Ventricular Systolic Dysfunction|T046|NON|NRW|NLM (2023)|210901|abcdef", "ENTRY": "Systolic Dysfunction, LV", "MN": "C14.280.945.900", "MH_TH": "NLM (1995)", "ST": "T046", "MS": "A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018487"}, {"RECTYPE": "D", "MH": "Bone Demineralization, Pathologic", "DE": "BONE DEMINERALIZATION PATHOL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pathologic Bone Demineralization|T047|NON|EQV|NLM (1995)|940302|PATHOL BONE DEMINERALIZATION|abcdefv", "MN": "C18.452.104.247", "FX": "Osteoporosis", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "do not confuse with BONE DEMINERALIZATION TECHNIQUE", "PI": "Bone and Bones (1966-1994)", "MS": "Decrease, loss, or removal of the mineral constituents of bones. Temporary loss of bone mineral content is especially associated with space flight, weightlessness, and extended immobilization. OSTEOPOROSIS is permanent, includes reduction of total bone mass, and is associated with increased rate of fractures. CALCIFICATION, PHYSIOLOGIC is the process of bone remineralizing. (From Dorland, 27th ed; Stedman, 25th ed; Nicogossian, Space Physiology and Medicine, 2d ed, pp327-33)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20151123", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018488"}, {"RECTYPE": "D", "MH": "Space Motion Sickness", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Space Adaptation Syndrome|T184|NON|EQV|NLM (1995)|931123|abcdef", "ENTRY": "Syndrome, Space Adaptation", "MN": "C23.888.571.800", "MH_TH": "NLM (1995)", "ST": "T184", "PI": "Space Flight (1979-1994)", "MS": "Disorder characterized by nausea, vomiting, and dizziness, possibly in response to vestibular disorientation or fluid shifts associated with space flight. (From Webster's New World Dictionary)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20170712", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018489"}, {"RECTYPE": "D", "MH": "Serotonin Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Serotoninergic", "MN": "D27.505.696.577.850", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics; note entry term SEROTONIN EFFECT: use only for the serotonin effect of a chemical substance", "PI": "Serotonin/pharmacology (1966-1994)", "MS": "Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons.", "PM": "95", "HN": "95; SEROTONIN NEURON AGENTS (NON MESH) was heading 1995", "MR": "20110624", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018490"}, {"RECTYPE": "D", "MH": "Dopamine Agonists", "DE": "DOPAMINE AG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dopaminergic Agonists|T121|NON|EQV|NLM (1995)|931123|DOPAMINERGIC AGON|abcdefv", "ENTRY": "Receptor Agonist, Dopamine", "MN": "D27.505.696.577.150.151", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "PI": "Dopamine Agents (1989-1994)", "MS": "Drugs that bind to and activate dopamine receptors.", "OL": "use DOPAMINERGIC AGENTS to search DOPAMINE AGONISTS & DOPAMINE RECEPTOR AGONISTS 1989-94", "PM": "95; DOPAMINE AGONISTS & DOPAMINE RECEPTOR AGONISTS were see DOPAMINERGIC AGENTS 1989-94", "HN": "95; DOPAMINE AGONISTS & DOPAMINE RECEPTOR AGONISTS were see DOPAMINERGIC AGENTS 1989-94", "MR": "20050630", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018491"}, {"RECTYPE": "D", "MH": "Dopamine Antagonists", "DE": "DOPAMINE ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dopaminergic Antagonists|T121|T123|NON|EQV|NLM (1995)|931123|DOPAMINERGIC ANTAG|abbcdefv", "ENTRY": "Receptor Antagonists, Dopamine", "MN": "D27.505.696.577.150.175", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "PI": "Dopamine/antagonists & inhibitors (1966-1994)", "MS": "Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME.", "PM": "95", "HN": "95", "MR": "20200527", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018492"}, {"RECTYPE": "D", "MH": "Cardiovascular Deconditioning", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Deconditioning, Cardiovascular|T039|NON|EQV|NLM (1995)|940108|abcdef", "MN": "G09.330.175", "MH_TH": "NLM (1995)", "ST": "T039", "PI": "Cardiovascular System (1966-1994)", "MS": "A change in cardiovascular function resulting in a reduction in BLOOD VOLUME, and reflex DIURESIS. It occurs frequently after actual or simulated WEIGHTLESSNESS.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018493"}, {"RECTYPE": "D", "MH": "Histamine Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Histaminergic", "MN": "D27.505.696.577.375", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; note entry term HISTAMINE EFFECT: use only for the histamine effect of a chemical substance", "PI": "Histamine/pharmacology (1966-1994)", "MS": "Drugs used for their actions on histaminergic systems. Included are drugs that act at histamine receptors, affect the life cycle of histamine, or affect the state of histaminergic cells.", "PM": "95", "HN": "95", "MR": "20110624", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018494"}, {"RECTYPE": "D", "MH": "Fluid Shifts", "AQ": "DE ES GE IM PH RE", "ENTRY": "Shifts, Fluid", "MN": "G07.313", "FX": "Lower Body Negative Pressure", "MH_TH": "NLM (1995)", "ST": "T039", "PI": "Body Fluids/physiology (1966-1994)", "MS": "Translocation of body fluids from one compartment to another, such as from the vascular to the interstitial compartments. Fluid shifts are associated with profound changes in vascular permeability and WATER-ELECTROLYTE IMBALANCE. The shift can also be from the lower body to the upper body as in conditions of weightlessness.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018495"}, {"RECTYPE": "D", "MH": "Hyperoxia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperoxias", "MN": "C23.888.852.567", "MH_TH": "NLM (1995)", "ST": "T184", "PI": "Oxygen/toxicity (1966-1994)", "MS": "An abnormal increase in the amount of oxygen in the tissues and organs.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160712", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018496"}, {"RECTYPE": "D", "MH": "Ventricular Dysfunction, Right", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Right Ventricular Dysfunction|T046|NON|EQV|NLM (1995)|931123|abcdef", "ENTRY": "Ventricular Dysfunctions, Right", "MN": "C14.280.945.910", "MH_TH": "NLM (1995)", "ST": "T046", "MS": "A condition in which the RIGHT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE or MYOCARDIAL INFARCTION, and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the right ventricular wall.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018497"}, {"RECTYPE": "D", "MH": "Linear Energy Transfer", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "LET|T067|ABB|EQV|NLM (1995)|931124|abcdef", "ENTRY": "Transfer, Linear Energy", "MN": "G02.216.400", "MH_TH": "NLM (1995)", "ST": "T067", "PI": "Energy Transfer (1968-1994)", "MS": "Rate of energy dissipation along the path of charged particles. In radiobiology and health physics, exposure is measured in kiloelectron volts per micrometer of tissue (keV/micrometer T).", "OL": "use ENERGY TRANSFER to search LINEAR ENERGY TRANSFER 1992-94 & LET 1968-94", "PM": "95; was see ENERGY TRANSFER 1992-94; LET was see ENERGY TRANSFER 1968-94", "HN": "95; was see ENERGY TRANSFER 1992-94; LET was see ENERGY TRANSFER 1968-94", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018499"}, {"RECTYPE": "D", "MH": "Diabetes Insipidus, Nephrogenic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vasopressin-Resistant Diabetes Insipidus|T047|NON|NRW|GHR (2014)|130418|abcdef", "MN": "C12.950.419.135.500", "FX": "Receptors, Vasopressin", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "do not confuse with DIABETIC NEPHROPATHIES which refers to diabetes mellitus or with DIABETES INSIPIDUS, NEUROGENIC", "PI": "Diabetes Insipidus (1966-1994)", "MS": "A genetic or acquired polyuric disorder characterized by persistent hypotonic urine and HYPOKALEMIA. This condition is due to renal tubular insensitivity to VASOPRESSIN and failure to reduce urine volume. It may be the result of mutations of genes encoding VASOPRESSIN RECEPTORS or AQUAPORIN-2; KIDNEY DISEASES; adverse drug effects; or complications from PREGNANCY.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018500"}, {"RECTYPE": "D", "MH": "Antirheumatic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Disease-Modifying Antirheumatic Drugs|T121|NON|NRW|NLM (1995)|940207|DIS MODIFYING ANTIRHEUMATIC DRUGS|abcdefv", "ENTRY": "Non-Steroidal Anti-Rheumatic Agents", "MN": "D27.505.954.329", "FX": "Immunosuppressive Agents", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "MS": "Drugs that are used to treat RHEUMATOID ARTHRITIS.", "OL": "use ANTI-INFLAMMATORY AGENTS to search ANTI-RHEUMATIC AGENTS 1987-94", "PM": "95; was ANTI-RHEUMATIC AGENTS see ANTI-INFLAMMATORY AGENTS 1987-94", "HN": "95; was ANTI-RHEUMATIC AGENTS see ANTI-INFLAMMATORY AGENTS 1987-94", "MR": "20200527", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018501"}, {"RECTYPE": "D", "MH": "Streptococcus equi", "DE": "STREP EQUI", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Streptococcus zooepidemicus|T007|NON|NRW|NLM (1995)|931126|STREP ZOOEPIDEMICUS|abcdefv", "MN": "B03.510.550.737.872.225", "MH_TH": "NLM (1995)", "ST": "T007", "RN": "txid1336", "RR": "txid40041", "AN": "infection: coordinate with STREPTOCOCCAL INFECTIONS", "PI": "Streptococcus (1967-1994)", "MS": "A species of gram-positive, coccoid bacteria isolated from abscesses in submaxillary glands and mucopurulent discharges of the upper respiratory tract of horses. This organism belongs to Group C streptococci with regards to antigen response and is known to cause strangles. The subspecies S. zooepidemicus is also considered a pathogen of horses.", "PM": "95", "HN": "95", "MR": "20200813", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018502"}, {"RECTYPE": "D", "MH": "Genome, Protozoan", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Protozoan Genome|T028|NON|EQV|NLM (1995)|931126|abcdef", "ENTRY": "Protozoan Genomes", "MN": "G05.360.340.397", "FX": "Genes, Protozoan", "MH_TH": "NLM (1995)", "ST": "T028", "AN": "coordinate IM with specific protozoan /genet (IM)", "PI": "specific protozoa (1966-1990)", "MS": "The complete genetic complement contained in a set of CHROMOSOMES in a protozoan.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018503"}, {"RECTYPE": "D", "MH": "Ecological Systems, Closed", "DE": "ECOL SYSTEMS CLOSED", "PRINT ENTRY": "Sealed Cabin Ecology|T169|NON|NRW|NLM (1995)|940111|SEALED CABIN ECOL|abcdefv", "ENTRY": "Systems, Closed Ecological", "MN": "N06.230.150.225", "FX": "Waste Management", "MH_TH": "NLM (1995)", "ST": "T068", "AN": "IM; coord with SPACE FLIGHT (IM) or SUBMARINE MEDICINE (IM), if pertinent", "PI": "Environment, Controlled (1973-1994)", "MS": "Systems that provide for the maintenance of life in an isolated living chamber through reutilization of the material available, in particular, by means of a cycle wherein exhaled carbon dioxide, urine, and other waste matter are converted chemically or by photosynthesis into oxygen, water, and food. (NASA Thesaurus, 1988)", "OL": "use ECOLOGICAL SYSTEMS, CLOSED to search SEALED CABIN ECOLOGY 1966-94", "PM": "95; SEALED CABIN ECOLOGY was heading 1963-94", "HN": "95; SEALED CABIN ECOLOGY was heading 1963-94", "MR": "20100625", "DA": "19940624", "DC": "1", "DX": "19950101", "UI": "D018504"}, {"RECTYPE": "D", "MH": "Waste Management", "AQ": "EC ES HI IS LJ MT SN ST", "ENTRY": "Waste Managements", "MN": "N06.850.860.510.900", "MH_TH": "POPLINE (1994)", "ST": "T068", "PI": "Refuse Disposal (1966-1994)", "MS": "Disposal, processing, controlling, recycling, and reusing the solid, liquid, and gaseous wastes of plants, animals, humans, and other organisms. It includes control within a closed ecological system to maintain a habitable environment.", "PM": "95", "HN": "95", "MR": "20080708", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018505"}, {"RECTYPE": "D", "MH": "Gene Expression Regulation, Plant", "DE": "GENE EXPRESSION REG PLANT", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Regulation of Gene Expression, Plant|T045|NON|EQV|NLM (1995)|931126|REG GENE EXPRESSION PLANT|abcdefv", "ENTRY": "Regulation, Gene Expression, Plant|T045|NON|EQV|NLM (1995)|931126|abcdef", "MN": "G05.308.375", "MH_TH": "NLM (1995)", "ST": "T045", "PI": "specific plant (1973-1994)", "MS": "Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in plants.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018506"}, {"RECTYPE": "D", "MH": "Gene Expression Regulation, Developmental", "DE": "GENE EXPRESSION REG DEVELOPMENTAL", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Regulation of Gene Expression, Embryologic|T045|NON|EQV|NLM (1995)|931126|REG GENE EXPRESSION EMBRYOL|abcdefv", "ENTRY": "Regulation, Gene Expression, Embryologic|T045|NON|EQV|NLM (1995)|931126|abcdef", "MN": "G05.308.310", "FX": "Genes, Developmental", "MH_TH": "NLM (1995)", "ST": "T045", "PI": "Genes, Regulator (1973-1980)", "MS": "Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action during the developmental stages of an organism.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018507"}, {"RECTYPE": "D", "MH": "Water Purification", "AQ": "EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Wastewater Treatment|T052|NON|NRW|NLM (2021)|191119|abcdef", "ENTRY": "Water Purification, Waste", "MN": "N06.850.860.510.900.900", "MH_TH": "NLM (1995)", "ST": "T052", "PI": "Water Pollution (1966-1994)", "MS": "Any of several processes in which undesirable impurities in water are removed or neutralized; for example, chlorination, filtration, primary treatment, ion exchange, and distillation. It includes treatment of WASTEWATER to provide potable and hygienic water in a controlled or closed environment as well as provision of public drinking water supplies.", "PM": "95", "HN": "95", "MR": "20220715", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018508"}, {"RECTYPE": "D", "MH": "DNA, Helminth", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Helminth DNA|T114|EQV|NLM (1995)|931126|abdef", "MN": "D13.444.308.315", "MH_TH": "NLM (1995)", "ST": "T114", "RN": "0", "AN": "IM; coord with specific helminth (IM); /drug eff /ultrastruct permitted", "PI": "DNA (1966-1994)", "MS": "Deoxyribonucleic acid that makes up the genetic material of helminths.", "PM": "95", "HN": "95", "MR": "19950608", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018509"}, {"RECTYPE": "D", "MH": "RNA, Helminth", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Helminth RNA|T114|EQV|NLM (1995)|931126|abdef", "MN": "D13.444.735.520", "MH_TH": "NLM (1995)", "ST": "T114", "RN": "0", "AN": "IM; coord with specific helminth; /drug eff /ultrastruct permitted", "PI": "RNA (1966-1994)", "MS": "Ribonucleic acid in helminths having regulatory and catalytic roles as well as involvement in protein synthesis.", "PM": "95", "HN": "95", "MR": "19950608", "DA": "19940421", "DC": "1", "DX": "19950101", "UI": "D018510"}, {"RECTYPE": "D", "MH": "Systems Integration", "ENTRY": "Systems Integrations", "MN": "L01.906.787", "MH_TH": "NLM (1995)", "ST": "T057", "MS": "The procedures involved in combining separately developed modules, components, or subsystems so that they work together as a complete system. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "95", "HN": "95", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018511"}, {"RECTYPE": "D", "MH": "Parasitemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Parasitemias", "MN": "C23.550.470.790.500.580", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "coord with specific parasitic disease or specific parasite if specific parasite dis is not in MeSH (do not use /blood to indicate -emia)", "PI": "specific parasitic disease/blood (1966-1994)", "MS": "The presence of parasites (especially malarial parasites) in the blood. (Dorland, 27th ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19940512", "DC": "1", "DX": "19950101", "UI": "D018512"}, {"RECTYPE": "D", "MH": "Plant Structures", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Plant Components|T002|NON|NRW|NLM (1995)|990101|abcdef", "ENTRY": "Structures, Plant", "MN": "A18", "RH": "A18 - ANATOMY - PLANT STRUCTURES", "MH_TH": "NLM (1998)", "ST": "T002", "AN": "general or unspecified; prefer specifics", "PI": "specific plant/anatomy & histology (1966-1997)", "MS": "The parts of plants, including SEEDS.", "PM": "2010; see PLANT COMPONENTS 1998-2009", "HN": "2010 (1998)", "MR": "20090706", "DA": "19940524", "DC": "1", "DX": "19980101", "UI": "D018514"}, {"RECTYPE": "D", "MH": "Plant Leaves", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plant Leave", "MN": "A18.024.812", "MH_TH": "NLM (1995)", "ST": "T002", "AN": "part of a plant shoot; IM GEN or unspecified; coord probably IM in genetics & space physiol, NIM in pharmacognosy, with specific plant (IM or NIM)", "PI": "Plants (1966-1994)", "MS": "Expanded structures, usually green, of vascular plants, characteristically consisting of a bladelike expansion attached to a stem, and functioning as the principal organ of photosynthesis and transpiration. (American Heritage Dictionary, 2d ed)", "PM": "95", "HN": "95", "MR": "20100625", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018515"}, {"RECTYPE": "D", "MH": "Pulvinus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "A18.024.812.700", "MH_TH": "NLM (1995)", "ST": "T002", "AN": "at base of a leaf: from the Latin for cushion; IM GEN or unspecified; coord probably IM in genetics & space physiol, NIM in pharmacognosy, with specific plant (IM or NIM)", "PI": "Plants (1966-1994)", "MS": "A group of cells at the base of a leaf in certain plants that, by rapidly losing water, brings about changes in the position of the leaves. (Concise Dictionary of Biology, 1990)", "PM": "95", "HN": "95", "MR": "20090706", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018516"}, {"RECTYPE": "D", "MH": "Plant Roots", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Roots, Plant", "MN": "A18.400", "MH_TH": "NLM (1995)", "ST": "T002", "AN": "coordinate with specific plant if pertinent", "PI": "Plants (1966-1994)", "MS": "The usually underground portions of a plant that serve as support, store food, and through which water and mineral nutrients enter the plant. (From American Heritage Dictionary, 1982; Concise Dictionary of Biology, 1990)", "PM": "95", "HN": "95", "MR": "20090706", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018517"}, {"RECTYPE": "D", "MH": "Plant Root Cap", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Root Caps, Plant", "MN": "A18.400.500.600", "MH_TH": "NLM (1995)", "ST": "T002", "AN": "composed of meristem cells; IM GEN or unspecified; coord probably IM in genetics & space physiol, NIM in pharmacognosy, with specific plant (IM or NIM)", "PI": "Plants (1966-1994)", "MS": "A cone-shaped structure in plants made up of a mass of meristematic cells that covers and protects the tip of a growing root. It is the putative site of gravity sensing in plant roots.", "PM": "95", "HN": "95", "MR": "20090706", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018518"}, {"RECTYPE": "D", "MH": "Meristem", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Root Tip|T002|NON|NRW|NLM (2003)|011211|abcdef", "ENTRY": "Tips, Root", "MN": "A18.400.500", "MH_TH": "NLM (1995)", "ST": "T002", "AN": "coord with specific plant", "PI": "Plants (1966-1994)", "MS": "A group of plant cells that are capable of dividing infinitely and whose main function is the production of new growth at the growing tip of a root or stem. (From Concise Dictionary of Biology, 1990)", "PM": "95", "HN": "95", "MR": "20090706", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018519"}, {"RECTYPE": "D", "MH": "Plant Shoots", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Shoots, Plant", "MN": "A18.024.875", "FX": "Seedlings", "MH_TH": "NLM (1995)", "ST": "T002", "AN": "for new root growth use MERISTEM; coordinate with specific plant", "PI": "Plants (1966-1994)", "MS": "New immature growth of a plant including stem, leaves, tips of branches, and SEEDLINGS.", "PM": "95", "HN": "95", "MR": "20150714", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018520"}, {"RECTYPE": "D", "MH": "Plant Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Plant Physiology|T039|NON|EQV|NLM (1995)|990101|PLANT PHYSIOL|abcdefv", "ENTRY": "Processes, Plant Physiological", "MN": "G15", "RH": "G15 - PLANT PHYSIOLOGICAL PHENOMENA", "MH_TH": "NLM (2009)", "ST": "T039", "AN": "general or unspecified; prefer specifics", "PI": "Plants/physiology (1966-1997)", "MS": "The physiological processes, properties, and states characteristic of plants.", "PM": "2009; see PLANT PHYSIOLOGY 1998-2008; for PLANT PHYSIOLOGICAL PROCESSES see PLANT PHYSIOLOGICAL PROCESSES 2009-2016", "HN": "2009 (1998)", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19940524", "DC": "1", "DX": "19980101", "UI": "D018521"}, {"RECTYPE": "D", "MH": "Gravitropism", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Geotropism|T039|NON|NRW|NLM (1995)|931129|abcdef", "ENTRY": "Gravitropisms", "MN": "G15.920.400", "MH_TH": "NLM (1995)", "ST": "T039", "AN": "directional growth of a plant in response to gravity", "MS": "The directional growth of organisms in response to gravity. In plants, the main root is positively gravitropic (growing downwards) and a main stem is negatively gravitropic (growing upwards), irrespective of the positions in which they are placed. Plant gravitropism is thought to be controlled by auxin (AUXINS), a plant growth substance. (From Concise Dictionary of Biology, 1990)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018522"}, {"RECTYPE": "D", "MH": "Tropism", "AQ": "DE ES GE IM PH RE", "ENTRY": "Tropisms", "MN": "G15.920", "FX": "Viral Tropism", "MH_TH": "NLM (1995)", "ST": "T039", "AN": "distinguish -tropic from -trophic (nutritional)", "MS": "The directional growth of an organism in response to an external stimulus such as light, touch, or gravity. Growth towards the stimulus is a positive tropism; growth away from the stimulus is a negative tropism. (From Concise Dictionary of Biology, 1990)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018523"}, {"RECTYPE": "D", "MH": "Phototropism", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Heliotropism|T039|NON|NRW|NLM (1995)|931129|abcdef", "ENTRY": "Phototropisms", "MN": "G15.920.700", "FX": "Phototaxis", "MH_TH": "NLM (1995)", "ST": "T039", "AN": "distinguish from PHOTOTROPHIC PROCESSES", "PI": "Plants (1966-1994)", "MS": "The directional growth of organisms in response to light. In plants, aerial shoots usually grow towards light. The phototropic response is thought to be controlled by auxin (= AUXINS), a plant growth substance. (From Concise Dictionary of Biology, 1990)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018524"}, {"RECTYPE": "D", "MH": "Germination", "AQ": "DE GE IM PH RE", "ENTRY": "Germinations", "MN": "G15.589.250", "FX": "Seedlings", "MH_TH": "NLM (1995)", "ST": "T038", "PI": "Plants (1966-1994)", "MS": "The initial stages of the growth of SEEDS into a SEEDLINGS. The embryonic shoot (plumule) and embryonic PLANT ROOTS (radicle) emerge and grow upwards and downwards respectively. Food reserves for germination come from endosperm tissue within the seed and/or from the seed leaves (COTYLEDON). (Concise Dictionary of Biology, 1990)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20210707", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018525"}, {"RECTYPE": "D", "MH": "Plant Transpiration", "AQ": "DE ES GE IM PH RE", "ENTRY": "Transpirations, Plant", "MN": "G15.713", "MH_TH": "NLM (1995)", "ST": "T039", "AN": "loss of water vapor in plants", "MS": "The loss of water vapor by plants to the atmosphere. It occurs mainly from the leaves through pores (stomata) whose primary function is gas exchange. The water is replaced by a continuous column of water moving upwards from the roots within the xylem vessels. (Concise Dictionary of Biology, 1990)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018526"}, {"RECTYPE": "D", "MH": "Hydroponics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Hydroponic", "MN": "J01.040.581", "MH_TH": "NLM (1995)", "ST": "T090", "PI": "Plants (1966-1994)", "MS": "A technique for growing plants in culture solutions rather than in soil. The roots are immersed in an aerated solution containing the correct proportions of essential mineral salts. (From Concise Dictionary of Biology, 1990)", "PM": "95", "HN": "95", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018527"}, {"RECTYPE": "D", "MH": "ATP-Binding Cassette Transporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ATP-Binding Cassette Transporter|T116|T123|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Transporters, ATP-Binding Cassette", "MN": "D12.776.543.585.100", "FX": "Nesidioblastosis", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1990-1994)", "MS": "A family of MEMBRANE TRANSPORT PROTEINS that require ATP hydrolysis for the transport of substrates across membranes. The protein family derives its name from the ATP-binding domain found on the protein.", "PM": "2002; see ABC TRANSPORTERS 1995-2001", "HN": "2002(1995)", "MR": "20230316", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018528"}, {"RECTYPE": "D", "MH": "Nutritional Support", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Support, Nutritional", "MN": "E02.642.500", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "PI": "Parenteral Nutrition (1966-1994)", "MS": "The administration of nutrients for assimilation and utilization by a patient by means other than normal eating. It does not include FLUID THERAPY which normalizes body fluids to restore WATER-ELECTROLYTE BALANCE.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018529"}, {"RECTYPE": "D", "MH": "Gastric Stump", "AQ": "BS DG IR PA PP SU", "ENTRY": "Stumps, Gastric", "MN": "A03.556.875.875.578", "MH_TH": "NLM (1995)", "ST": "T023", "AN": "stomach remnant after gastrectomy; a common site of neopl: coord IM with STOMACH NEOPLASMS (IM) + histol type of neopl (IM)", "PI": "Stomach Neoplasms (1966-1994)", "MS": "That portion of the stomach remaining after gastric surgery, usually gastrectomy or gastroenterostomy for cancer of the stomach or peptic ulcer. It is a common site of cancer referred to as stump cancer or carcinoma of the gastric stump.", "PM": "95", "HN": "95", "MR": "20160601", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018530"}, {"RECTYPE": "D", "MH": "Spacecraft", "AQ": "CL EC HI IS LJ SN ST", "PRINT ENTRY": "Spaceship|T073|NON|EQV|NLM (2020)|190518|abcdef", "ENTRY": "Vehicles, Launch", "MN": "J01.937.285.850.900", "MH_TH": "NLM (1995)", "ST": "T073", "PI": "Space Flight (1966-1994)", "MS": "Devices, manned and unmanned, which are designed to be placed into an orbit about the Earth or into a trajectory to another celestial body. (NASA Thesaurus, 1988)", "PM": "95", "HN": "95", "MR": "20190521", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018531"}, {"RECTYPE": "D", "MH": "Pisum sativum", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Peas|T168|NON|REL|NLM (1995)|990101|abcdef", "ENTRY": "Pea", "MN": "B01.875.800.575.912.250.401.630", "MH_TH": "NLM (1995)", "ST": "T002", "RN": "txid3888", "RR": "txid3887", "PI": "Legumes (1978-1994)", "MS": "A variable annual leguminous vine that is cultivated for its rounded smooth or wrinkled edible protein-rich seeds, the seed of the pea, and the immature pods with their included seeds. (From Webster's New Collegiate Dictionary, 1973)", "OL": "use LEGUMES to search PEAS 1978-94", "PM": "1995; was see LEGUMES 1978-1994; use PEAS 1995-2023", "HN": "1995; was see LEGUMES 1978-1994; use PEAS 1995-2023", "MR": "20230526", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018532"}, {"RECTYPE": "D", "MH": "Biomass", "ENTRY": "Biomasses", "MN": "N06.230.124.100", "MH_TH": "NLM (1995)", "ST": "T081", "PI": "Ecology (1982-1994)", "MS": "Total mass of all the organisms of a given type and/or in a given area. (From Concise Dictionary of Biology, 1990) It includes the yield of vegetative mass produced from any given crop.", "OL": "use ECOLOGY to search BIOMASS 1982-94", "PM": "95; was see ECOLOGY 1982-94", "HN": "95; was see ECOLOGY 1982-94", "MR": "20100625", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018533"}, {"RECTYPE": "D", "MH": "Earth, Planet", "PRINT ENTRY": "Planet Earth|T083|NON|EQV|NLM (2020)|190117|abcdef", "MN": "G01.060.075.730.700.200", "MH_TH": "NLM (2020)", "ST": "T083", "PI": "Planets (1991-1994)", "MS": "Planet that is the third in order from the sun. It is one of the four inner or terrestrial planets of the SOLAR SYSTEM.", "PM": "2020; was EARTH (PLANET) 1995-2019", "HN": "2020 (1995); was EARTH (PLANET) 1995-2019", "MR": "20190117", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018534"}, {"RECTYPE": "D", "MH": "Mars", "PRINT ENTRY": "Phobos|T083|NAM|REL|NLM (1995)|931202|abcdef", "MN": "G01.060.075.730.700.625", "MH_TH": "NLM (1995)", "ST": "T083", "PI": "Planets (1991-1994)", "MS": "The fourth planet in order from the sun. Its two natural satellites are Deimos and Phobos. It is one of the four inner or terrestrial planets of the solar system.", "PM": "95", "HN": "95", "MR": "20160617", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018535"}, {"RECTYPE": "D", "MH": "Venus", "MN": "G01.060.075.730.700.900", "MH_TH": "NLM (1995)", "ST": "T083", "PI": "Planets (1991-1994)", "MS": "The second planet in order from the sun. It has no known natural satellites. It is one of the four inner or terrestrial planets of the solar system.", "PM": "95", "HN": "95", "MR": "20160617", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018536"}, {"RECTYPE": "D", "MH": "Mercury, Planet", "PRINT ENTRY": "Planet Mercury|T082|NAM|EQV|NLM (2020)|190118|abcdef", "MN": "G01.060.075.730.700.762", "MH_TH": "NLM (2020)", "ST": "T082", "PI": "Planets (1991-1994)", "MS": "The first planet in order from the sun. It has no known natural satellites. It is one of the four inner or terrestrial planets of the solar system.", "PM": "2020; was MERCURY (PLANET) 1995-2019", "HN": "2020 (1995); was MERCURY (PLANET) 1995-2019", "MR": "20190118", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018537"}, {"RECTYPE": "D", "MH": "Jupiter", "PRINT ENTRY": "Io|T083|NAM|REL|NLM (1995)|931202|abcdef", "MN": "G01.060.075.730.700.412", "MH_TH": "NLM (1995)", "ST": "T083", "PI": "Planets (1991-1994)", "MS": "The fifth planet in order from the sun. It is one of the five outer planets of the solar system. Its sixteen natural satellites include Callisto, Europa, Ganymede, and Io.", "PM": "95", "HN": "95", "MR": "20160617", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018538"}, {"RECTYPE": "D", "MH": "Saturn", "PRINT ENTRY": "Titan|T083|NAM|REL|NLM (1995)|931202|abcdef", "MN": "G01.060.075.730.700.831", "MH_TH": "NLM (1995)", "ST": "T083", "PI": "Planets (1991-1994)", "MS": "The sixth planet in order from the sun. It is one of the five outer planets of the solar system. Its twelve natural satellites include Phoebe and Titan.", "PM": "95", "HN": "95", "MR": "20160617", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018539"}, {"RECTYPE": "D", "MH": "Uranus", "MN": "G01.060.075.730.700.865", "MH_TH": "NLM (1995)", "ST": "T083", "PI": "Planets (1991-1994)", "MS": "The seventh planet in order from the sun. It is one of the five outer planets of the solar system. It has five known natural satellites.", "PM": "95", "HN": "95", "MR": "20160617", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018540"}, {"RECTYPE": "D", "MH": "Neptune", "PRINT ENTRY": "Triton|T083|NAM|REL|NLM (1995)|931202|abcdef", "MN": "G01.060.075.730.700.796", "MH_TH": "NLM (1995)", "ST": "T083", "PI": "Planets (1991-1994)", "MS": "The eighth planet in order from the sun. It is one of the five outer planets of the solar system. Its two natural satellites are Nereid and Triton.", "PM": "95", "HN": "95", "MR": "20160617", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018541"}, {"RECTYPE": "D", "MH": "Pluto", "PRINT ENTRY": "Charon|T083|NAM|REL|NLM (1995)|931202|abcdef", "MN": "G01.060.075.730.600.500", "MH_TH": "NLM (1995)", "ST": "T083", "PI": "Planets (1991-1994)", "MS": "The ninth planet in order from the sun. It is one of the five outer planets of the solar system. Its only natural satellite is Charon.", "PM": "95", "HN": "95", "MR": "20160617", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018542"}, {"RECTYPE": "D", "MH": "Minor Planets", "PRINT ENTRY": "Plutoids|T083|NON|EQV|NLM (2009)|080703|abcdef", "ENTRY": "Plutoid", "MN": "G01.060.075.730.600", "MH_TH": "NLM (1995)", "ST": "T083", "PI": "Solar System (1991-1994)", "MS": "Small solar system planetary bodies including asteroids. Most asteroids are found within the gap lying between the orbits of Mars and Jupiter.", "PM": "95", "HN": "95", "MR": "20210630", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018543"}, {"RECTYPE": "D", "MH": "Weightlessness Countermeasures", "PRINT ENTRY": "Countermeasures, Weightlessness|T061|NON|EQV|NLM (1995)|940110|abcdef", "ENTRY": "Weightlessness Countermeasure", "MN": "E05.974", "FX": "Cardiovascular Deconditioning", "MH_TH": "NLM (1995)", "ST": "T061", "PI": "Space Flight (1966-1994)", "MS": "Techniques and routines designed to prevent or reverse unwanted effects of weightlessness experienced during actual and simulated space flight, including physiologic changes related to removal of gravitational loading. Specific measures include creation of artificial gravity, exercise, low-level lower body negative pressure, and use of anti-deconditioning devices. (From Nicogossian, Space Physiology and Medicine, 2d ed, pp294-297)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "19950609", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018544"}, {"RECTYPE": "D", "MH": "Lactuca", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Lettuce|T002|NON|EQV|NLM (1995)|990101|abcdef", "ENTRY": "Lettuces, Iceberg", "MN": "B01.875.800.575.912.250.100.500", "MH_TH": "NLM (2024)", "ST": "T002", "RN": "txid4235", "RR": "txid4236", "PI": "Plants, Edible (1966-1994)", "MS": "Any of the various plants of the genus Lactuca, especially L. sativa, cultivated for its edible leaves. (From American Heritage Dictionary, 2d ed)", "PM": "1995; use LETTUCE 1995-2023", "HN": "1995; use LETTUCE 1995-2023", "MR": "20230526", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018545"}, {"RECTYPE": "D", "MH": "Hypocotyl", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Hypocotyls|T002|NON|EQV|NLM (1995)|940111|abcdef", "MN": "A18.550.500", "MH_TH": "NLM (1995)", "ST": "T002", "AN": "coordinate with specific plant", "PI": "Plants (1966-1994)", "MS": "The region of the stem beneath the stalks of the seed leaves (cotyledons) and directly above the young root of the embryo plant. It grows rapidly in seedlings showing epigeal germination and lifts the cotyledons above the soil surface. In this region (the transition zone) the arrangement of vascular bundles in the root changes to that of the stem. (From Concise Dictionary of Biology, 1990)", "PM": "95", "HN": "95", "MR": "20090706", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018546"}, {"RECTYPE": "D", "MH": "Plant Stems", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Stems, Plant", "MN": "A18.024.937", "MH_TH": "NLM (1995)", "ST": "T002", "AN": "coord with specific plant; PLANT BARK is also available", "PI": "Plants (1966-1994)", "MS": "Parts of plants that usually grow vertically upwards towards the light and support the leaves, buds, and reproductive structures. (From Concise Dictionary of Biology, 1990)", "PM": "95", "HN": "95", "MR": "20090706", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018547"}, {"RECTYPE": "D", "MH": "Cotyledon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Seed Leaf|T002|NON|EQV|NLM (1995)|931202|abcdef", "ENTRY": "Seed Leave", "MN": "A18.024.875.500", "MH_TH": "NLM (1995)", "ST": "T002", "AN": "coordinate with specific plant", "PI": "Plants (1966-1994)", "MS": "A part of the embryo in a seed plant. The number of cotyledons is an important feature in classifying plants. In seeds without an endosperm, they store food which is used in germination. In some plants, they emerge above the soil surface and become the first photosynthetic leaves. (From Concise Dictionary of Biology, 1990)", "PM": "95", "HN": "95", "MR": "20100625", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018548"}, {"RECTYPE": "D", "MH": "Cryptogenic Organizing Pneumonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Primary Organizing Pneumonia|T047|NON|EQV|NLM (2023)|210826|abcdef", "ENTRY": "Primary Organizing Pneumonias", "MN": "C08.381.495.146.135.140.600.750", "MH_TH": "NLM (2009)", "ST": "T047", "AN": "note entry term BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA: do not confuse with BRONCHIOLITIS OBLITERANS", "PI": "Pneumonia (1985-1993)", "MS": "An interstitial lung disease of unknown etiology, occurring between 21-80 years of age. It is characterized by a dramatic onset of a \"pneumonia-like\" illness with cough, fever, malaise, fatigue, and weight loss. Pathological features include prominent interstitial inflammation without collagen fibrosis, diffuse fibroblastic foci, and no microscopic honeycomb change. There is excessive proliferation of granulation tissue within small airways and alveolar ducts.", "PM": "2009; see BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA 1995-2008", "HN": "2009 (1995)", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018549"}, {"RECTYPE": "D", "MH": "Cephalosporin Resistance", "AQ": "DE EH GE IM PH RE", "ENTRY": "Resistances, Cephalosporin", "MN": "G07.690.773.984.269.347.500.175", "MH_TH": "NLM (1995)", "ST": "T032", "AN": "coord IM with specific cephalosporin (IM)", "PI": "Drug Resistance, Microbial (1977-1994)", "MS": "Non-susceptibility of an organism to the action of the cephalosporins.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018550"}, {"RECTYPE": "D", "MH": "Solanum lycopersicum", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Tomatoes|T168|NON|REL|NLM (1995)|990101|abcdef", "ENTRY": "Tomato|T168|NON|REL|NLM (1995)|940115|abcdef", "MN": "B01.875.800.575.912.250.908.500.725.638", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4081", "PI": "Vegetables (1966-1994)", "MS": "A plant species of the family SOLANACEAE, native of South America, widely cultivated for their edible, fleshy, usually red fruit.", "PM": "2023; SOLANUM LYCOPERSICUM was indexed under LYCOPERSICON ESCULENTUM 2003-2022, and under TOMATOES 1995-2002", "HN": "2023(1965)", "MR": "20230417", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018551"}, {"RECTYPE": "D", "MH": "Daucus carota", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Carrots|T168|NON|NRW|NLM (1995)|990101|abcdef", "ENTRY": "Carrot", "MN": "B01.875.800.575.912.250.075.278", "MH_TH": "NLM (1997)", "ST": "T002", "RN": "txid4039", "RR": "txid4038", "PI": "Vegetables (1966-1994)", "MS": "A plant species of the family APIACEAE that is widely cultivated for the edible yellow-orange root. The plant has finely divided leaves and flat clusters of small white flowers.", "PM": "2003; see CARROTS 1995-2002", "HN": "2003(1995)", "MR": "20210630", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018552"}, {"RECTYPE": "D", "MH": "Cucumis sativus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cucumbers|T168|NON|REL|NLM (1995)|990101|abcdef", "MN": "B01.875.800.575.912.250.300.188.666", "MH_TH": "NLM (1995)", "ST": "T002", "RN": "txid3659", "PI": "Vegetables (1966-1994)", "MS": "A creeping annual plant species of the CUCURBITACEAE family. It has a rough succulent, trailing stem and hairy leaves with three to five pointed lobes.", "PM": "2002; see CUCUMBERS 1995-2001", "HN": "2002(1995)", "MR": "20210630", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018553"}, {"RECTYPE": "D", "MH": "Avena", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Oats|T002|T168|NON|EQV|NLM (1995)|990101|abbcdef", "ENTRY": "Oats, Cultivated", "MN": "B01.875.800.575.912.250.822.060", "MH_TH": "NLM (2016)", "ST": "T168", "RN": "txid4496", "RR": "txid4498", "PI": "Cereals (1966-1994)", "MS": "Oats, genus of the family POACEAE.", "PM": "2016; see AVENA SATIVA 2003-2015, OATS 1995-2002, CEREALS 1985-1994, GRAIN 1963-1984", "HN": "2016; use AVENA SATIVA 2003-2015, OATS 1995-2002, CEREALS 1985-1994, GRAIN 1963-1984", "MR": "20210630", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018554"}, {"RECTYPE": "D", "MH": "Crops, Agricultural", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Agricultural Crops|T002|T168|NON|EQV|NLM (1995)|940114|abbcdef", "ENTRY": "Agricultural Crop", "MN": "J02.500.300", "MH_TH": "NLM (1995)", "ST": "T168", "MS": "Cultivated plants or agricultural produce such as grain, vegetables, or fruit. (From American Heritage Dictionary, 1982)", "PM": "95", "HN": "95", "MR": "20210630", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018556"}, {"RECTYPE": "D", "MH": "United States National Aeronautics and Space Administration", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "National Aeronautics and Space Administration|T092|NAM|EQV|NLM (1995)|931203|abcdef", "MN": "N03.540.348.500.500.984", "MH_TH": "NLM (1995)", "ST": "T092", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.; CATALOGER: Use NAF entry", "MS": "An independent Federal agency established in 1958. It conducts research for the solution of problems of flight within and outside the Earth's atmosphere and develops, constructs, tests, and operates aeronautical and space vehicles. (From U.S. Government Manual, 1993)", "PM": "95", "HN": "95", "MR": "20150629", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018557"}, {"RECTYPE": "D", "MH": "Exobiology", "DE": "EXOBIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Space Biology|T091|NON|EQV|NLM (2020)|190514|abcdef", "ENTRY": "Space Biologies", "MN": "H01.158.273.295", "FX": "Extraterrestrial Environment", "MH_TH": "NLM (1995)", "ST": "T091", "AN": "the discipline (education, history, etc) only; may also be used for articles about the possibility of extraterrestrial life", "MS": "The interdisciplinary science that studies evolutionary biology, including the origin and evolution of the major elements required for life, their processing in the interstellar medium and in protostellar systems. This field also includes the study of chemical evolution and the subsequent interactions between evolving biota and planetary evolution as well as the field of biology that deals with the study of extraterrestrial life.", "PM": "95", "HN": "95", "MR": "20190708", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018559"}, {"RECTYPE": "D", "MH": "Space Simulation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Orbital Simulation|T062|NON|NRW|NLM (1995)|931203|abcdef", "ENTRY": "Space Simulations", "MN": "N06.230.150.440", "FX": "Weightlessness Simulation", "MH_TH": "NLM (1995)", "ST": "T075", "AN": "to test space systems or components by approximating the space environment", "MS": "An environment simulating one or more parameters of the space environment, applied in testing space systems or components. Often, a closed chamber is used, capable of approximating the vacuum and normal environments of space. (From NASA Thesaurus, 1988) This also includes simulated EXTRAVEHICULAR ACTIVITY studies in atmosphere exposure chambers or water tanks.", "PM": "95", "HN": "95", "MR": "20080708", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018561"}, {"RECTYPE": "D", "MH": "Disease Transmission, Infectious", "AQ": "CL EC ES HI LJ PC SN VE", "PRINT ENTRY": "Person-to-Person Transmission|T046|NON|NRW|NLM (2021)|200422|abcdef", "ENTRY": "Transmissions, Community", "MN": "N06.850.335", "FX": "Fomites", "MH_TH": "NLM (2009)", "ST": "T046", "AN": "general or unspecified; prefer /transm with specific diseases", "PI": "Communicable Diseases/transmission (1974-1994)", "MS": "The transmission of infectious disease or pathogens. When transmission is within the same species, the mode can be horizontal or vertical (INFECTIOUS DISEASE TRANSMISSION, VERTICAL).", "PM": "2009; see DISEASE TRANSMISSION (1995-2008)", "HN": "2009 (1995)", "MR": "20210630", "DA": "19940125", "DC": "1", "DX": "19950101", "UI": "D018562"}, {"RECTYPE": "D", "MH": "Disease Notification", "DE": "DIS NOTIF", "AQ": "EC HI LJ MT SN ST", "PRINT ENTRY": "Notification, Disease|T061|NON|EQV|NLM (1995)|931207|NOTIF DIS|abcdefv", "ENTRY": "Reportings, Infectious Disease", "MN": "N06.850.780.200.262", "FX": "Mandatory Reporting", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "for reporting occur of contagious dis: do not confuse with MANDATORY REPORTING, reporting of \"suspected incidence of abuse & neglect\"; IM GEN only; NIM with specific dis IM", "PI": "Communicable Disease Control (1966-1994)", "MS": "Notification or reporting by a physician or other health care provider of the occurrence of specified contagious diseases such as tuberculosis and HIV infections to designated public health agencies. The United States system of reporting notifiable diseases evolved from the Quarantine Act of 1878, which authorized the US Public Health Service to collect morbidity data on cholera, smallpox, and yellow fever; each state in the US has its own list of notifiable diseases and depends largely on reporting by the individual health care provider. (From Segen, Dictionary of Modern Medicine, 1992)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018563"}, {"RECTYPE": "D", "MH": "Food-Drug Interactions", "AQ": "EH GE IM PH RE", "PRINT ENTRY": "Food Interactions|T070|NON|NRW|NLM (1995)|931208|abcdef", "ENTRY": "Interactions, Food-Drug", "MN": "G07.690.773.968.511", "MH_TH": "NLM (1995)", "ST": "T070", "AN": "IM; coord with specific food (IM) + specific drug (IM) with pertinent qualif", "PI": "Drug Interactions (1972-1994)", "MS": "The pharmacological result, either desirable or undesirable, of drugs interacting with components of the diet. (From Stedman, 25th ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018565"}, {"RECTYPE": "D", "MH": "Pregnancy, High-Risk", "DE": "PREGN HIGH RISK", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "High-Risk Pregnancy|T047|NON|EQV|NLM (1995)|931208|HIGH RISK PREGN|abcdefv", "ENTRY": "Pregnancy, High Risk", "MN": "G08.686.784.769.500", "FX": "Pregnancy Complications", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Pregnancy Complications (1966-1994)", "MS": "Pregnancy in which the mother and/or FETUS are at greater than normal risk of MORBIDITY or MORTALITY. Causes include inadequate PRENATAL CARE, previous obstetrical history (ABORTION, SPONTANEOUS), pre-existing maternal disease, pregnancy-induced disease (GESTATIONAL HYPERTENSION), and MULTIPLE PREGNANCY, as well as advanced maternal age above 35.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20180701", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018566"}, {"RECTYPE": "D", "MH": "Breast Neoplasms, Male", "DE": "BREAST NEOPL MALE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Neoplasms, Breast, Male|T191|NON|EQV|NLM (1995)|940509|NEOPL BREAST MALE|abcdefv", "ENTRY": "Tumors, Male Breast", "MN": "C17.800.090.500.260", "MH_TH": "NLM (1995)", "ST": "T191", "AN": "human only; for animal, see note at BREAST NEOPLASMS; coordinate IM with histological type of neoplasm (IM); check tags HUMANS & MALE", "PI": "Breast Neoplasms (1966-1994)", "MS": "Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018567"}, {"RECTYPE": "D", "MH": "Crown-Rump Length", "ENTRY": "Lengths, Crown-Rump", "MN": "N06.850.505.200.100.400", "MH_TH": "NLM (1995)", "ST": "T060", "MS": "In utero measurement corresponding to the sitting height (crown to rump) of the fetus. Length is considered a more accurate criterion of the age of the fetus than is the weight. The average crown-rump length of the fetus at term is 36 cm. (From Williams Obstetrics, 18th ed, p91)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018568"}, {"RECTYPE": "D", "MH": "Risk Assessment", "DE": "RISK ASSESS", "AQ": "EC EH HI LJ MT SN ST TD", "PRINT ENTRY": "Risk-Benefit Assessment|T062|NON|NRW|NLM (1998)|961029|RISK BENEFIT ASSESS|abcdefv", "ENTRY": "Risk-Benefit Assessments", "MN": "N06.850.520.830.600.800.715", "MH_TH": "POPLINE (1991)", "ST": "T062", "AN": "usually NIM", "PI": "Risk Factors (1992-1994)", "MS": "The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018570"}, {"RECTYPE": "D", "MH": "Sentinel Surveillance", "AQ": "VE", "PRINT ENTRY": "Sentinel Health Event|T081|NON|NRW|NLM (1995)|931210|abcdef", "ENTRY": "Surveillance, Syndromic", "MN": "N06.850.780.675.650", "MH_TH": "NLM (1995)", "ST": "T057", "PI": "Population Surveillance (1983-1994)", "MS": "Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort such as in a geographic area or population subgroup to estimate trends in a larger population. (From Last, Dictionary of Epidemiology, 2d ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20230414", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018571"}, {"RECTYPE": "D", "MH": "Disease-Free Survival", "DE": "DIS FREE SURVIVAL", "ENTRY": "Survival, Disease Free", "MN": "N06.850.520.830.998.300", "FX": "Progression-Free Survival", "MH_TH": "NLM (1995)", "ST": "T081", "AN": "usually NIM; coordinate with specific disease /ther or more specific qualifier ", "PI": "Prognosis (1980-1994)", "MS": "Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190530", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018572"}, {"RECTYPE": "D", "MH": "Home Care Agencies", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Home Health Care Agencies|T093|NON|NRW|NLM (1995)|931213|abcdef", "ENTRY": "Home Health Agency", "MN": "N03.540.483", "MH_TH": "NLM (1995)", "ST": "T093", "AN": "public or private agencies; coord IM with specific home care (IM)", "PI": "Home Care Services (1978-1994)", "MS": "Public or private organizations that provide, either directly or through arrangements with other organizations, home health services in the patient's home. (Hospital Administration Terminology, 2d ed)", "OL": "use HOME CARE SERVICES to search HOME HEALTH AGENCIES 1978-94", "PM": "95; HOME HEALTH AGENCIES was see HOME CARE SERVICES 1978-94", "HN": "95; HOME HEALTH AGENCIES was see HOME CARE SERVICES 1978-94", "MR": "19991103", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018574"}, {"RECTYPE": "D", "MH": "Home Care Services, Hospital-Based", "DE": "HOME CARE SERV HOSP BASED", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Hospital-Based Home Care|T058|NON|EQV|NLM (1995)|931213|HOSP BASED HOME CARE|abcdefv", "ENTRY": "Hospital-Based Home Cares", "MN": "N02.421.143.524.403", "MH_TH": "NLM (1995)", "ST": "T058", "PI": "Home Care Services (1967-1994)", "MS": "Hospital-sponsored provision of health services, such as nursing, therapy, and health-related homemaker or social services, in the patient's home. (Hospital Administration Terminology, 2d ed)", "PM": "95", "HN": "95", "MR": "20150629", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018575"}, {"RECTYPE": "D", "MH": "Home Health Aides", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Homemaker-Home Health Aides|T097|NON|EQV|NLM (1995)|940401|abcdef", "ENTRY": "Homemaker-Home Health Aide", "MN": "N02.360.067.350", "MH_TH": "NLM (1995)", "ST": "T097", "AN": "coord IM with specific home health care (IM)", "PI": "Nurses' Aides (1966-1994)", "MS": "Persons who assist ill, elderly, or disabled persons in the home, carrying out personal care and housekeeping tasks. (From Slee & Slee, Health Care Terms. 2d ed, p202)", "PM": "95", "HN": "95", "MR": "20180629", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018576"}, {"RECTYPE": "D", "MH": "Homebound Persons", "AQ": "CL ED HI LJ PX RH SN", "PRINT ENTRY": "Shut-Ins|T101|NON|EQV|NLM (1995)|931213|abcdef", "ENTRY": "Shut-In", "MN": "M01.276", "MH_TH": "NLM (1995)", "ST": "T101", "AN": "IM; homebound elderly: coord IM with AGED; AGED, 80 AND OVER or FRAIL ELDERLY (IM) only when aged is point of article", "PI": "Disabled (1983-1994)", "MS": "Those unable to leave home without exceptional effort and support; patients (in this condition) who are provided with or are eligible for home health services, including medical treatment and personal care. Persons are considered homebound even if they may be infrequently and briefly absent from home if these absences do not indicate an ability to receive health care in a professional's office or health care facility. (From Facts on File Dictionary of Health Care Management, 1988, p309)", "PM": "95", "HN": "95", "MR": "20010725", "DA": "19940606", "DC": "1", "DX": "19950101", "UI": "D018577"}, {"RECTYPE": "D", "MH": "Hospital-Physician Relations", "DE": "HOSP PHYSICIAN RELAT", "PRINT ENTRY": "Physician-Hospital Relations|T058|NON|EQV|NLM (1995)|931213|PHYSICIAN HOSP RELAT|abcdefv", "ENTRY": "Relations, Physician-Hospital", "MN": "N04.452.822.379", "MH_TH": "NLM (1995)", "ST": "T058", "PI": "Physicians (1966-1994)", "MS": "Includes relationships between hospitals, their governing boards, and administrators in regard to physicians, whether or not the physicians are members of the medical staff or have medical staff privileges.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190709", "DA": "19940527", "DC": "1", "DX": "19950101", "UI": "D018578"}, {"RECTYPE": "D", "MH": "Patient Selection", "AQ": "ES", "PRINT ENTRY": "Selection Criteria|T080|NON|REL|NLM (1995)|931214|abcdef", "ENTRY": "Volunteers Selection, Research", "MN": "N04.590.731", "FX": "Health Care Rationing", "MH_TH": "NLM (1995)", "ST": "T062", "MS": "Criteria and standards used for the determination of the appropriateness of the inclusion of patients with specific conditions in proposed treatment plans and the criteria used for the inclusion of subjects in various clinical trials and other research protocols.", "PM": "1995; for SELECTION FOR TREATMENT see HEALTH CARE RATIONING 1991-2000", "HN": "1995; for SELECTION FOR TREATMENT use HEALTH CARE RATIONING 1991-2000", "MR": "20181011", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018579"}, {"RECTYPE": "D", "MH": "Mandatory Testing", "AQ": "EC ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Mandatory Screening|T060|T064|NON|EQV|NLM (1995)|931214|abbcdef", "ENTRY": "Testing, Mandatory", "MN": "N06.850.780.500.412", "FX": "Substance Abuse Detection", "MH_TH": "BIOETHICS (1995)", "ST": "T064", "AN": "for prev of commun dis; IM; coord with specific dis or population group (IM)", "PI": "specific infectious disease/prevention & control (1989-1994)", "MS": "Testing or screening required by federal, state, or local law or other agencies for the diagnosis of specified conditions. It is usually limited to specific populations such as categories of health care providers, members of the military, and prisoners or to specific situations such as premarital examinations or donor screening.", "PM": "95", "HN": "95", "MR": "20080708", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018580"}, {"RECTYPE": "D", "MH": "Technology Transfer", "DE": "TECHNOL TRANSFER", "ENTRY": "Transfers, Technology", "MN": "L01.143.320.800", "MH_TH": "NLM (1995)", "ST": "T170", "PI": "Technology, Medical (1976-1994)", "MS": "Spread and adoption of inventions and techniques from one geographic area to another, from one discipline to another, or from one sector of the economy to another. For example, improvements in medical equipment may be transferred from industrial countries to developing countries, advances arising from aerospace engineering may be applied to equipment for persons with disabilities, and innovations in science arising from government research are made available to private enterprise.", "PM": "95", "HN": "95", "MR": "20150616", "DA": "19940701", "DC": "1", "DX": "19950101", "UI": "D018581"}, {"RECTYPE": "D", "MH": "Sick Leave", "AQ": "CL EC HI LJ SN TD", "PRINT ENTRY": "Sick Days|T078|NON|NRW|NLM (1995)|931214|abcdef", "ENTRY": "Sick Day", "MN": "N04.452.677.800.662", "MH_TH": "NLM (1995)", "ST": "T078", "AN": "permitted absence for sickness, often paid leave", "PI": "Absenteeism (1966-1994)", "MS": "An absence from work permitted because of illness or the number of days per year for which an employer agrees to pay employees who are sick. (Webster's New Collegiate Dictionary, 1981)", "PM": "95", "HN": "95", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018582"}, {"RECTYPE": "D", "MH": "Pliability", "AQ": "DE PH RE", "PRINT ENTRY": "Flexibility|T080|NON|EQV|NLM (1995)|931214|abcdef", "MN": "G01.374.705", "FX": "Range of Motion, Articular", "MH_TH": "NLM (1995)", "ST": "T080", "AN": "for non-biological materials only; JOINT FLEXIBILITY see RANGE OF MOTION, ARTICULAR is available for flexibility of joints", "MS": "The quality or state of being able to be bent or creased repeatedly. (From Webster, 3d ed)", "PM": "95", "HN": "95", "MR": "20080708", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018583"}, {"RECTYPE": "D", "MH": "Physician Self-Referral", "AQ": "ES LJ SN TD", "PRINT ENTRY": "Self-Referral, Physician|T057|NON|EQV|NLM (1995)|931214|abcdef", "ENTRY": "Self-Referrals, Physician", "MN": "N05.350.225.500", "MH_TH": "BIOETHICS (1995)", "ST": "T057", "PI": "Referral and Consultation (1983-1994)", "MS": "Referral by physicians to testing or treatment facilities in which they have financial interest. The practice is regulated by the Ethics in Patient Referrals Act of 1989.", "PM": "95", "HN": "95", "MR": "20190709", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018584"}, {"RECTYPE": "D", "MH": "Battered Women", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Women, Battered|T098|NON|EQV|NLM (1995)|931214|abcdef", "ENTRY": "Woman, Battered|T098|NON|EQV|NLM (1995)|931214|abcdef", "MN": "M01.975.155", "FX": "Spouse Abuse", "MH_TH": "NLM (1995)", "ST": "T098", "AN": "prefer SPOUSE ABUSE for battering of wives; check tags HUMANS & FEMALE", "MS": "Women who are physically and mentally abused over an extended period, usually by a husband or other dominant male figure. Characteristics of the battered woman syndrome are helplessness, constant fear, and a perceived inability to escape. (From American Heritage Dictionary of the English Language, 3d ed)", "PM": "95", "HN": "95", "MR": "20150623", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018585"}, {"RECTYPE": "D", "MH": "Bone Banks", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Bone Bank", "MN": "N02.278.065.900.205", "MH_TH": "NLM (1995)", "ST": "T093", "PI": "Tissue Banks (1966-1994)", "MS": "Centers for acquiring, characterizing, and storing bones or bone tissue for future use.", "PM": "95", "HN": "95", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018586"}, {"RECTYPE": "D", "MH": "Oocyte Donation", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ovum Donation|T061|NON|BRD|NLM (1995)|940303|abcdef", "ENTRY": "Ovum Donations", "MN": "E05.820.800.968", "FX": "Directed Tissue Donation", "MH_TH": "NLM (1995)", "ST": "T061", "PI": "Tissue Donors (1983-1994)", "MS": "Transfer of preovulatory oocytes from donor to a suitable host. Oocytes are collected, fertilized in vitro, and transferred to a host that can be human or animal.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018587"}, {"RECTYPE": "D", "MH": "Fee-for-Service Plans", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Reimbursement, Fee-for-Service|T081|NON|NRW|NLM (1995)|931214|REIMBURSEMENT FEE FOR SERV|abcdefv", "ENTRY": "Services, Fees for", "MN": "N04.452.758.745.225", "MH_TH": "NLM (1995)", "ST": "T081", "PI": "Fees, Medical (1969-1994)", "MS": "Method of charging whereby a physician or other practitioner bills for each encounter or service rendered. In addition to physicians, other health care professionals are reimbursed via this mechanism. Fee-for-service plans contrast with salary, per capita, and prepayment systems, where the payment does not change with the number of services actually used or if none are used. (From Discursive Dictionary of Health Care, 1976)", "OL": "use FEES, MEDICAL to search FEE FOR SERVICE, MEDICAL 1982-94", "PM": "95; FEE FOR SERVICE, MEDICAL was see FEES, MEDICAL 1982-94", "HN": "95; FEE FOR SERVICE, MEDICAL was see FEES, MEDICAL 1982-94", "MR": "19991108", "DA": "19940706", "DC": "1", "DX": "19950101", "UI": "D018588"}, {"RECTYPE": "D", "MH": "Gastroparesis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gastric Stasis|T047|NON|EQV|NLM (1995)|931214|abcdef", "ENTRY": "Stasis, Gastric", "MN": "C23.888.592.636.263", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Stomach Diseases (1966-1994)", "MS": "Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018589"}, {"RECTYPE": "D", "MH": "Uterine Monitoring", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tocography|T060|NON|EQV|NLM (1995)|931215|TOCOGR|abcdefv", "ENTRY": "Uterine Monitorings", "MN": "E01.370.520.860", "MH_TH": "NLM (1995)", "ST": "T060", "PI": "Uterine Contraction (1976-1994)", "MS": "Measurement or recording of contraction activity of the uterine muscle. It is used to determine progress of LABOR, OBSTETRIC and assess status of pregnancy. It is also used in conjunction with FETAL MONITORING to determine fetal response to stress of maternal uterine contractions.", "OL": "use CARDIOTOCOGRAPHY to search TOCODYNAMOMETRY & TOCOGRAPHY 1989-94", "PM": "95; TOCODYNAMOMETRY & TOCOGRAPHY were see CARDIOTOCOGRAPHY 1989-94", "HN": "95; TOCODYNAMOMETRY & TOCOGRAPHY were see CARDIOTOCOGRAPHY 1989-94", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018590"}, {"RECTYPE": "D", "MH": "Cross-Over Studies", "ENTRY": "Trials, Crossover", "MN": "N06.850.520.445.150", "MH_TH": "NLM (1995)", "ST": "T062", "AN": "IM general only; when pertinent add CLINICAL TRIAL (PT) or RANDOMIZED CONTROLLED TRIAL (PT)", "MS": "Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018592"}, {"RECTYPE": "D", "MH": "Human Body", "PRINT ENTRY": "Human Figure|T016|NON|EQV|BIOETHICS (1999)|NLM (1995)|931215|abcdeef", "ENTRY": "Parts, Body", "MN": "K01.093.378", "MH_TH": "NLM (1995)", "ST": "T016", "AN": "the human body as a whole, viewed from an artistic, cultural, historical, or social perspective", "MS": "The human being as a non-anatomical and non-zoological entity. The emphasis is on the philosophical or artistic treatment of the human being, and includes lay and social attitudes toward the body in history. (From J. Cassedy, NLM History of Medicine Division)", "PM": "95", "HN": "95", "MR": "20040713", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018594"}, {"RECTYPE": "D", "MH": "Colonialism", "AQ": "CL HI", "MN": "I01.696.116", "MH_TH": "POPLINE (1986)", "ST": "T078", "AN": "IM; specify geog & hist period", "MS": "The aggregate of various economic, political, and social policies by which an imperial power maintains or extends its control over other areas or peoples. It includes the practice of or belief in acquiring and retaining colonies. The emphasis is less on its identity as an ideological political system than on its designation in a period of history. (Webster, 3d ed; from Dr. J. Cassedy, NLM History of Medicine Division)", "OL": "use POLITICAL SYSTEMS to search COLONIALISM 1990-94", "PM": "95; was see POLITICAL SYSTEMS 1990-94", "HN": "95; was see POLITICAL SYSTEMS 1990-94", "MR": "19991103", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018595"}, {"RECTYPE": "D", "MH": "Hinduism", "AQ": "HI PX", "ENTRY": "Ethics, Hindu", "MN": "K01.844.231", "FX": "Medicine, Ayurvedic", "MH_TH": "POPLINE (1978)", "ST": "T078", "AN": "IM; specify geog if pertinent", "PI": "Religion (1966-1994)", "MS": "A complex body of social, cultural, and religious beliefs and practices evolved in and largely confined to the Indian subcontinent and marked by a caste system, an outlook tending to view all forms and theories as aspects of one eternal being and truth, and the practice of the way of works, the way of knowledge, or the way of devotion as a means of release from the round of rebirths. (From Webster, 3d ed)", "PM": "95", "HN": "95", "MR": "19991103", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018596"}, {"RECTYPE": "D", "MH": "Saints", "AQ": "HI", "ENTRY": "Saint", "MN": "K01.844.188.715", "MH_TH": "NLM (1995)", "ST": "T077", "AN": "IM; coord with RELIGION AND MEDICINE (IM) if pertinent + specific med aspect (IM); TN H: form of Saint names as subject name", "PI": "Religion and Medicine (1966-1994)", "MS": "Persons officially recognized or acknowledged as pre-eminent for consecration, holiness, and piety, especially through canonization by a branch of the Christian church. (From Webster, 3d ed)", "PM": "95", "HN": "95", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018597"}, {"RECTYPE": "D", "MH": "Minisatellite Repeats", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Variable Tandem Repeat|T114|T123|NON|NRW|NLM (2021)|191119|abbcdef", "ENTRY": "VNTR Regions", "MN": "G05.360.340.024.850.550", "FX": "DNA Fingerprinting", "MH_TH": "NLM (1995)", "ST": "T123", "PI": "Repetitive Sequences, Nucleic Acid (1985-1994)", "MS": "Tandem arrays of moderately repetitive, short (10-60 bases) DNA sequences which are found dispersed throughout the GENOME, at the ends of chromosomes (TELOMERES), and clustered near telomeres. Their degree of repetition is two to several hundred at each locus. Loci number in the thousands but each locus shows a distinctive repeat unit.", "PM": "1997; see VARIABLE NUMBER OF TANDEM REPEATS 1995-1996", "HN": "1997(1995)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018598"}, {"RECTYPE": "D", "MH": "Witchcraft", "AQ": "HI PX", "PRINT ENTRY": "Sorcery|T078|NON|NRW|NLM (1995)|931216|abcdef", "ENTRY": "Sorceries", "MN": "I01.076.201.450.897.439.925", "MH_TH": "NLM (1995)", "ST": "T078", "AN": "IM; MAGIC is also available", "PI": "Magic (1966-1994)", "MS": "An act of employing sorcery (the use of power gained from the assistance or control of spirits), especially with malevolent intent, and the exercise of supernatural powers and alleged intercourse with the devil or a familiar. (From Webster, 3d ed)", "PM": "95", "HN": "95", "MR": "20010725", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018599"}, {"RECTYPE": "D", "MH": "Teratology", "DE": "TERATOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Teratologies", "MN": "H01.158.273.200.350.500", "FX": "Teratogenesis", "MH_TH": "NLM (1995)", "ST": "T090", "AN": "the discipline only (education, history, etc); corresponding disease term is CONGENITAL ABNORMALITIES or specifics; for \"monsters\" in the historical literature, use ABNORMALITIES, SEVERE TERATOID", "MS": "A branch of embryology for the study of congenital malformations and developmental abnormalities.", "PM": "95", "HN": "95", "MR": "20130708", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018600"}, {"RECTYPE": "D", "MH": "King's Evil", "AQ": "HI", "ENTRY": "Kings Evils", "MN": "C01.150.252.410.040.552.846.617.475.500", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "= scrofula in hist articles only: differentiate from SCROFULA see TUBERCULOSIS, LYMPH NODE which is restricted to scrofula in modern clin med", "PI": "Tuberculosis, Lymph Node (1966-1994)", "MS": "The historic designation for scrofula (TUBERCULOSIS, LYMPH NODE). The disease is so called from the belief that it could be healed by the touch of a king. This term is used only for historical articles using the name \"king's evil\", and is to be differentiated from scrofula as lymph node tuberculosis in modern clinical medicine. (From Webster, 3d ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018601"}, {"RECTYPE": "D", "MH": "Milk Sickness", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sickness, Milk", "MN": "C25.723.756.600", "MH_TH": "NLM (1995)", "ST": "T037", "AN": "a form of plant pois: see MeSH definition", "PI": "Plant Poisoning (1966-1994)", "MS": "An acute, often fatal disease caused by the ingestion of milk, milk products, or the flesh of cattle or sheep which have a disease known as trembles. It is marked by weakness, anorexia, vomiting, constipation, and sometimes muscular tremors. It is caused by poisoning by white snakeroot (Eupatorium rugosum) and the rayless goldenrod (Haplopappus heterophyllus). (From Dorland, 27th ed)", "OL": "use PLANT POISONING to search MILK SICKNESS 1966-94", "PM": "95; was see PLANT POISONING 1979-94; was see under PLANT POISONING 1968-78; was heading 1963-67", "HN": "95; was see PLANT POISONING 1979-94; was see under PLANT POISONING 1968-78; was heading 1963-67", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018602"}, {"RECTYPE": "D", "MH": "Epitope Mapping", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Mappings, Epitope", "MN": "E05.601.690.300", "MH_TH": "NLM (1995)", "ST": "T063", "PI": "Antigenic Determinants (1982-1994)", "MS": "Methods used for studying the interactions of antibodies with specific regions of protein antigens. Important applications of epitope mapping are found within the area of immunochemistry.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018604"}, {"RECTYPE": "D", "MH": "Spontaneous Combustion", "AQ": "HI", "PRINT ENTRY": "Preternatural Human Combustibility|T067|NON|REL|NLM (1995)|931217|abcdef", "ENTRY": "Spontaneous Combustions", "MN": "N06.230.216.750", "MH_TH": "NLM (1995)", "ST": "T067", "AN": "material or human: read MeSH definition; only /hist", "MS": "A circumstance where a substance or organism takes fire and burns without an exogenous source. Spontaneous human combustion differs from preternatural human combustibility in that in the latter, some spark or trivial flame sets the fire and the body tissues, which have a greatly enhanced inflammability, continue to undergo incineration without any external heat source or combustible materials. (Bergman NA. Spontaneous human combustion: its role in literature and science. Pharos 1988;Fall;51(4):18-21)", "PM": "95", "HN": "95", "MR": "20160617", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018605"}, {"RECTYPE": "D", "MH": "Pregnancy Reduction, Multifetal", "DE": "PREGN REDUCTION MULTIFETAL", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Fetal Termination, Selective|T061|NON|NRW|NLM (1995)|931217|abcdef", "ENTRY": "Terminations, Selective Fetal", "MN": "E04.520.050.600", "FX": "Pregnancy, Multiple", "MH_TH": "NLM (1995)", "ST": "T061", "PI": "Pregnancy, Multiple (1984-1994)", "MS": "Selective abortion of one or more embryos or fetuses in a multiple gestation pregnancy. The usual goal is to improve the outcome for the remaining embryos or fetuses.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20150701", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018607"}, {"RECTYPE": "D", "MH": "Ultrasonography, Doppler", "DE": "ULTRASONOGR DOPPLER", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Doppler Ultrasonography|T060|EPO|EQV|NLM (1995)|931217|DOPPLER ULTRASONOGR|abcdefv", "ENTRY": "Ultrasounds, Doppler", "MN": "E01.370.350.850.850", "MH_TH": "NLM (1995)", "ST": "T060", "AN": "general or unspecified; prefer specifics", "PI": "Ultrasonography (1985-1994)", "MS": "Ultrasonography applying the Doppler effect, with frequency-shifted ultrasound reflections produced by moving targets (usually red blood cells) in the bloodstream along the ultrasound axis in direct proportion to the velocity of movement of the targets, to determine both direction and velocity of blood flow. (Stedman, 25th ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018608"}, {"RECTYPE": "D", "MH": "Tibet", "AQ": "EH EP", "MN": "Z01.252.474.164.900", "MH_TH": "NLM (1995)", "ST": "T083", "AN": "ancient & modern", "PI": "China (1970-1994)", "MS": "An autonomous region located in central Asia, within China.", "OL": "use CHINA to search TIBET 1975-94", "HN": "95; was see CHINA 1975-94", "MR": "20100625", "DA": "19940614", "DC": "4", "DX": "19950101", "UI": "D018609"}, {"RECTYPE": "D", "MH": "Heart Bypass, Right", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Right Heart Bypass|T061|NON|EQV|NLM (1995)|931217|abcdef", "ENTRY": "Shunts, Cavopulmonary", "MN": "E04.928.220.370", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "a form of heart surg; permanent: differentiate from HEART BYPASS, LEFT, temporary, a form of extracorp circ, & from CARDIOPULMONARY BYPASS, another type of extracorp circ", "MS": "Diversion of the flow of blood from the entrance to the right atrium directly to the pulmonary arteries, avoiding the right atrium and right ventricle (Dorland, 28th ed). This a permanent procedure often performed to bypass a congenitally deformed right atrium or right ventricle.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018610"}, {"RECTYPE": "D", "MH": "Heart Bypass, Left", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Left Heart Bypass|T061|NON|EQV|NLM (1995)|931217|abcdef", "ENTRY": "Left Heart Bypasses", "MN": "E04.292.465", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "temporary, a form of extracorp circ diverting blood from left atrium: differentiate from HEART BYPASS, RIGHT, a permanent form of heart surg, & from CARDIOPULMONARY BYPASS, another type of extracorp circ diverting blood from right atrium", "MS": "Diversion of the flow of blood from the pulmonary veins directly to the aorta, avoiding the left atrium and the left ventricle (Dorland, 27th ed). This is a temporary procedure usually performed to assist other surgical procedures.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018611"}, {"RECTYPE": "D", "MH": "Byzantium", "AQ": "EH EP", "PRINT ENTRY": "Byzantine Empire|T083|NAM|EQV|NLM (1995)|931217|abcdef", "MN": "Z01.586.035.175", "MH_TH": "NLM (1995)", "ST": "T083", "AN": "the ancient city or empire: note X ref", "MS": "An ancient city, the site of modern Istanbul. From the 4th to 15th centuries the empire extended from southeastern Europe to western Asia, reaching its greatest extent under Justinian (527-565). By about 1000 A.D. it comprised the southern Balkans, Greece, Asia Minor, and parts of southern Italy. The capture of Constantinople in 1453 marked the formal end of the Byzantine Empire. (From Webster's New Geographical Dictionary, 1988)", "HN": "95", "DA": "19940419", "DC": "4", "DX": "19950101", "UI": "D018612"}, {"RECTYPE": "D", "MH": "Microscopy, Confocal", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Microscopy, Confocal, Laser Scanning|T059|NON|NRW|NLM (1995)|931229|abcdef", "ENTRY": "Scanning Microscopy, Laser", "MN": "E05.595.395", "MH_TH": "NLM (1995)", "ST": "T059", "AN": "NIM", "PI": "Microscopy, Fluorescence (1985-1994)", "MS": "A light microscopic technique in which only a small spot is illuminated and observed at a time. An image is constructed through point-by-point scanning of the field in this manner. Light sources may be conventional or laser, and fluorescence or transmitted observations are possible.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018613"}, {"RECTYPE": "D", "MH": "Sweating Sickness", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sudor Anglicus|T046|T184|EPO|EQV|NLM (1995)|931217|abbcdef", "ENTRY": "Sickness, Sweating", "MN": "C23.888.119.344.672", "MH_TH": "NLM (1995)", "ST": "T184", "AN": "a hist epidemic dis", "MS": "A clinical condition characterized by fever and profuse sweating and associated with high mortality. It occurred in epidemic form five times in the fifteenth and sixteenth centuries in England, first in 1485 and last in 1551, specially during the summer and early autumn, attacking the relatively affluent adult male population. The etiology was unknown.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018614"}, {"RECTYPE": "D", "MH": "Ultrasonography, Doppler, Color", "DE": "ULTRASONOGR DOPPLER COLOR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Ultrasonography, Color Doppler|T060|EPO|EQV|NLM (1995)|931220|ULTRASONOGR COLOR DOPPLER|abcdefv", "ENTRY": "Ultrasonography, Doppler Color|T060|EPO|EQV|NLM (1995)|931220|abcdef", "MN": "E01.370.350.850.850.850.850", "MH_TH": "NLM (1995)", "ST": "T060", "PI": "Ultrasonography (1985-1994)", "MS": "Ultrasonography applying the Doppler effect, with the superposition of flow information as colors on a gray scale in a real-time image. This type of ultrasonography is well-suited to identifying the location of high-velocity flow (such as in a stenosis) or of mapping the extent of flow in a certain region.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160317", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018615"}, {"RECTYPE": "D", "MH": "Ultrasonography, Doppler, Duplex", "DE": "ULTRASONOGR DOPPLER DUPLEX", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Ultrasonography, Duplex Doppler|T060|EPO|EQV|NLM (1995)|931220|ULTRASONOGR DUPLEX DOPPLER|abcdefv", "ENTRY": "Ultrasonography, Doppler Duplex|T060|EPO|EQV|NLM (1995)|931220|abcdef", "MN": "E01.370.350.850.850.850", "MH_TH": "NLM (1995)", "ST": "T060", "PI": "Ultrasonography (1984-1994)", "MS": "Ultrasonography applying the Doppler effect combined with real-time imaging. The real-time image is created by rapid movement of the ultrasound beam. A powerful advantage of this technique is the ability to estimate the velocity of flow from the Doppler shift frequency.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160317", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018616"}, {"RECTYPE": "D", "MH": "Ultrasonography, Doppler, Pulsed", "DE": "ULTRASONOGR DOPPLER PULSED", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Ultrasonography, Pulsed Doppler|T060|EPO|EQV|NLM (1995)|931220|ULTRASONOGR PULSED DOPPLER|abcdefv", "ENTRY": "Ultrasonography, Doppler Pulsed|T060|EPO|EQV|NLM (1995)|931220|abcdef", "MN": "E01.370.350.850.850.860", "MH_TH": "NLM (1995)", "ST": "T060", "PI": "Ultrasonography (1985-1994)", "MS": "Ultrasonography applying the Doppler effect, with velocity detection combined with range discrimination. Short bursts of ultrasound are transmitted at regular intervals and the echoes are demodulated as they return.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160317", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018617"}, {"RECTYPE": "D", "MH": "Echocardiography, Doppler, Color", "DE": "ECHOCARDIOGR DOPPLER COLOR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Echocardiography, Color Flow|T060|NON|EQV|NLM (1995)|940214|ECHOCARDIOGR COLOR FLOW|abcdefv", "ENTRY": "Flow Echocardiography, Color", "MN": "E01.370.370.380.220.220.220", "MH_TH": "NLM (1995)", "ST": "T060", "PI": "Echocardiography, Doppler (1989-1994)", "MS": "Echocardiography applying the Doppler effect, with the superposition of flow information as colors on a gray scale in a real-time image.", "OL": "use ECHOCARDIOGRAPHY, DOPPLER to search ECHOCARDIOGRAPHY, DOPPLER, COLOR 1989-94", "PM": "95; was ECHOCARDIOGRAPHY, DOPPLER COLOR see ECHOCARDIOGRAPHY, DOPPLER 1989-94", "HN": "95; was ECHOCARDIOGRAPHY, DOPPLER COLOR see ECHOCARDIOGRAPHY, DOPPLER 1989-94", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018618"}, {"RECTYPE": "D", "MH": "Echocardiography, Doppler, Pulsed", "DE": "ECHOCARDIOGR DOPPLER PULSED", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Echocardiography, Pulsed Doppler|T060|EPO|EQV|NLM (1995)|931220|ECHOCARDIOGR PULSED DOPPLER|abcdefv", "ENTRY": "Pulsed Echocardiography, Doppler|T060|EPO|EQV|NLM (1995)|931220|PULSED ECHOCARDIOGR DOPPLER|abcdefv", "MN": "E01.370.370.380.220.220.225", "MH_TH": "NLM (1995)", "ST": "T060", "PI": "Echocardiography, Doppler (1989-1994)", "MS": "Echocardiography applying the Doppler effect, with velocity detection combined with range discrimination. Short bursts of ultrasound are transmitted at regular intervals and the echoes are demodulated as they return.", "OL": "use ECHOCARDIOGRAPHY, DOPPLER to search ECHOCARDIOGRAPHY, DOPPLER, PULSED 1989-94", "PM": "95; was ECHOCARDIOGRAPHY, PULSED DOPPLER see ECHOCARDIOGRAPHY, DOPPLER 1989-94", "HN": "95; was ECHOCARDIOGRAPHY, PULSED DOPPLER see ECHOCARDIOGRAPHY, DOPPLER 1989-94", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018619"}, {"RECTYPE": "D", "MH": "PrPSc Proteins", "DE": "PRPSC", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO PY RE SD ST TO TU UL UR", "PRINT ENTRY": "Scrapie PrP|T116|EQV|NLM (1995)|940203|abdef", "ENTRY": "PrP res", "MN": "D12.776.785.340.750", "MH_TH": "NLM (1995)", "ST": "T116", "RN": "0", "AN": "PrPSc stands for PRion Protein SCrapie; do not confuse with PRPC PROTEINS", "PI": "Viral Proteins (1989-1991)", "MS": "Abnormal isoform of PRION PROTEINS resulting from a posttranslational modification of the cellular prion protein (PRPC PROTEINS). PrPSc are disease-specific proteins seen in certain human and animal neurodegenerative diseases (PRION DISEASES).", "OL": "use PRIONS to search SCRAPIE AGENT, SCRAPIE PRION, & SCRAPIE VIRUS 1966-94, and RIDA VIRUS 1976-91; use PRPSC PROTEINS (NM) to search SCRAPIE PRP 1988-94", "PM": "95; SCRAPIE AGENT was see PRIONS 1992-94, was heading 1987-91, was SCRAPIE PRION 1986, was SCRAPIE VIRUS 1966-85; SCRAPIE PRP was indexed under PRIONS 1992-94 & VIRAL PROTEINS 1989-91; SCRAPIE VIRUS was see PRIONS 1992-94, was see SCRAPIE AGENT 1987-91, was see SCRAPIE PRION 1986, was heading 1966-85; RIDA VIRUS was see SCRAPIE AGENT 1976-91", "HN": "95; SCRAPIE AGENT was see PRIONS 1992-94, was heading 1987-91, was SCRAPIE PRION 1986, was SCRAPIE VIRUS 1966-85; SCRAPIE PRP was NM 1988-94; SCRAPIE VIRUS was see PRIONS 1992-94, was see SCRAPIE AGENT 1987-91, was see SCRAPIE PRION 1986, was heading 1966-85; RIDA VIRUS was see SCRAPIE AGENT 1976-91", "MR": "20160613", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018620"}, {"RECTYPE": "D", "MH": "PrPC Proteins", "DE": "PRPC", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO PY RE SD ST TO TU UL UR", "PRINT ENTRY": "Scrapie Amyloid Precursor Protein|T116|NON|EQV|NLM (1995)|931222|abcdef", "ENTRY": "PrP sen", "MN": "D12.776.785.340.500", "MH_TH": "NLM (1995)", "ST": "T116", "RN": "0", "AN": "PrPC stands for PRion Protein Cellular; do not confuse with PRPSC PROTEINS which are scrapie prion proteins", "PI": "Prions (1992-1994)", "MS": "Normal cellular isoform of PRION PROTEINS encoded by a chromosomal gene and found in normal and scrapie-infected brain tissue, and other normal tissue. PrPC are protease-sensitive proteins whose function is unknown. Posttranslational modification of PrPC into PrPSC leads to infectivity.", "OL": "use PRPC PROTEINS (NM) to search SCRAPIE AMYLOID PRECURSOR PROTEIN 1989-94", "PM": "95; SCRAPIE AMYLOID PRECURSOR PROTEIN was indexed under PRIONS & PROTEIN PRECURSORS 1992-94 and under VIRAL PROTEINS 1989-91", "HN": "95; SCRAPIE AMYLOID PRECURSOR PROTEIN was NM 1989-94", "MR": "20160613", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018621"}, {"RECTYPE": "D", "MH": "PrP 27-30 Protein", "DS": "PRP PROTEIN 027 030", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO PY RE SD ST TO TU UL UR", "PRINT ENTRY": "Scrapie-Associated Fibrils|T116|NON|EQV|NLM (1995)|931221|SCRAPIE ASSOC FIBRILS|abcdefv", "ENTRY": "Scrapie PrP 27 30 Protein", "MN": "D12.776.785.340.750.700", "MH_TH": "NLM (1995)", "ST": "T116", "RN": "105268-27-7", "AN": "protease-resistant core of PRPSC proteins; PRP stands for Prion Protein; /pathogen permitted", "PI": "Viral Proteins (1985-1991)", "MS": "Protease-resistant core of PrPSc, the abnormal isoform of PRION PROTEINS. PrP 27-30 is produced by limited proteolysis of the N-terminus of PrPSc.", "OL": "use PRIONS to search SCRAPIE-ASSOCIATED FIBRILS 1987-94; use PRP 27-30 PROTEIN (NM) to search SCRAPIE PRP 27-30 PROTEIN 1985-94 & SCRAPIE ASSOCIATED FIBRIL-PROTEIN 1984-94", "PM": "95; SCRAPIE-ASSOCIATED FIBRILS was see PRIONS 1992-94, was see SCRAPIE AGENT 1987-91; SCRAPIE PRP 27-30 PROTEIN was indexed under PRIONS 1992-94 & VIRAL PROTEINS 1985-91; SCRAPIE ASSOCIATED FIBRIL-PROTEIN was indexed under NERVE TISSUE PROTEINS 1984-94", "HN": "95; SCRAPIE-ASSOCIATED FIBRILS was see PRIONS 1992-94, was see SCRAPIE AGENT 1987-91; SCRAPIE PRP 27-30 PROTEIN was NM 1985-94; SCRAPIE ASSOCIATED FIBRIL-PROTEIN was NM 1984-94", "MR": "20160527", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018622"}, {"RECTYPE": "D", "MH": "Microscopy, Atomic Force", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Scanning Force Microscopy|T059|NON|EQV|NLM (1999)|980521|abcdef", "ENTRY": "Scanning Force Microscopies", "MN": "E05.595.666.400", "FX": "Microscopy, Scanning Tunneling", "MH_TH": "NLM (1995)", "ST": "T059", "PI": "Microscopy, Scanning Tunneling (1988-1994)", "MS": "A type of scanning probe microscopy in which a probe systematically rides across the surface of a sample being scanned in a raster pattern. The vertical position is recorded as a spring attached to the probe rises and falls in response to peaks and valleys on the surface. These deflections produce a topographic map of the sample.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20040707", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018625"}, {"RECTYPE": "D", "MH": "Retroelements", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Ty1 Transposon|T114|T123|NRW|NLM (1999)|980317|TY TRANSPOSON 001|abbdefs", "ENTRY": "Ty1 Transposons", "MN": "G05.360.340.024.425.800", "FX": "Mutagenesis, Insertional", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "PI": "DNA Insertion Elements (1985-1994)", "MS": "Elements that are transcribed into RNA, reverse-transcribed into DNA and then inserted into a new site in the genome. Long terminal repeats (LTRs) similar to those from retroviruses are contained in retrotransposons and retrovirus-like elements. Retroposons, such as LONG INTERSPERSED NUCLEOTIDE ELEMENTS and SHORT INTERSPERSED NUCLEOTIDE ELEMENTS do not contain LTRs.", "PM": "99; see RETROTRANSPOSONS 1995-98; for MOBILE DISPERSED GENETIC ELEMENTS see DNA INSERTION ELEMENTS 1982-98; for TY1 TRANSPOSON see DNA INSERTION ELEMENTS 1988-98", "HN": "99(95); for MOBILE DISPERSED GENETIC ELEMENTS use DNA TRANSPOSABLE ELEMENTS 1982-98; for TY1 TRANSPOSON use DNA TRANSPOSABLE ELEMENTS 1988-98", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018626"}, {"RECTYPE": "D", "MH": "Gene Dosage", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Gene Copy Number|T081|NON|EQV|NLM (1995)|940201|abcdef", "ENTRY": "Numbers, Gene Copy", "MN": "G05.380.350", "FX": "DNA Copy Number Variations", "MH_TH": "NLM (1995)", "ST": "T081", "AN": "do not confuse with DOSAGE COMPENSATION, GENETIC", "MS": "The number of copies of a given gene present in the cell of an organism. An increase in gene dosage (by GENE DUPLICATION for example) can result in higher levels of gene product formation. GENE DOSAGE COMPENSATION mechanisms result in adjustments to the level GENE EXPRESSION when there are changes or differences in gene dosage.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018628"}, {"RECTYPE": "D", "MH": "Spectrometry, Mass, Secondary Ion", "DE": "SPECTROMETRY MASS SECOND ION", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Spectroscopy, Mass, Secondary Ion|T059|NON|EQV|NLM (1995)|940104|SPECTROSCOPY MASS SECOND ION|abcdefv", "ENTRY": "Secondary Ion Mass Spectroscopy Microscopy|T059|NON|EQV|NLM (1995)|940131|SECOND ION MASS SPECTROSCOPY MICROSCOPY|abcdefv", "MN": "E05.196.566.760", "MH_TH": "NLM (1995)", "ST": "T059", "AN": "for SIMS microscopy, coordinate with type of microscopy", "PI": "Spectrum Analysis, Mass (1976-1994)", "MS": "A mass-spectrometric technique that is used for microscopic chemical analysis. A beam of primary ions with an energy of 5-20 kiloelectronvolts (keV) bombards a small spot on the surface of the sample under ultra-high vacuum conditions. Positive and negative secondary ions sputtered from the surface are analyzed in a mass spectrometer in regards to their mass-to-charge ratio. Digital imaging can be generated from the secondary ion beams and their intensity can be measured. Ionic images can be correlated with images from light or other microscopy providing useful tools in the study of molecular and drug actions.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19940512", "DC": "1", "DX": "19950101", "UI": "D018629"}, {"RECTYPE": "D", "MH": "Vitreoretinopathy, Proliferative", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vitreoretinopathy Neovascular Inflammatories", "MN": "C11.768.890", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Vitreous Body (1981-1994)", "MS": "Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20150625", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018630"}, {"RECTYPE": "D", "MH": "ras Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ras Protein|T116|T126|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "ras Gene Products", "MN": "D12.776.476.338.400.500", "FX": "Genes, ras", "MH_TH": "NLM (1995)", "ST": "T126", "RN": "EC 3.6.5.2", "AN": "ras derived from \"Rat Sarcoma\"", "MS": "Small, monomeric GTP-binding proteins encoded by ras genes (GENES, RAS). The protooncogene-derived protein, PROTO-ONCOGENE PROTEIN P21(RAS), plays a role in normal cellular growth, differentiation and development. The oncogene-derived protein ONCOGENE PROTEIN P21(RAS) can play a role in aberrant cellular regulation during neoplastic cell transformation (CELL TRANSFORMATION, NEOPLASTIC). This enzyme was formerly listed as EC 3.6.1.47.", "PM": "95", "HN": "95", "MR": "20210521", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018631"}, {"RECTYPE": "D", "MH": "Mice, Inbred SENCAR", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "SENCAR Mouse, Inbred", "MN": "B01.050.150.900.649.313.992.635.505.500.400.600", "MH_TH": "NLM (1995)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal", "PI": "Mice (1981-1994)", "MS": "Mice selectively bred for hypersusceptibility to two-stage chemical skin carcinogenesis. They are also hypersusceptible to UV radiation tumorigenesis with single high-dose, but not chronic low-dose, exposures. SENCAR (SENsitive to CARcinogenesis) mice are used in research as an animal model for tumor production.", "PM": "95", "HN": "95", "MR": "20200902", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018632"}, {"RECTYPE": "D", "MH": "Pulmonary Atresia", "DE": "PULM ATRESIA", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulmonary Valve Atresia|T019|NON|EQV|NLM (1995)|940311|PULM VALVE ATRESIA|abcdefv", "ENTRY": "Valve Atresias, Pulmonary", "MN": "C16.131.240.850.906", "MH_TH": "NLM (1995)", "ST": "T019", "PI": "Pulmonary Valve/abnormalities (1966-1994)", "MS": "A congenital heart defect characterized by the narrowing or complete absence of the opening between the RIGHT VENTRICLE and the PULMONARY ARTERY. Lacking a normal PULMONARY VALVE, unoxygenated blood in the right ventricle can not be effectively pumped into the lung for oxygenation. Clinical features include rapid breathing, CYANOSIS, right ventricle atrophy, and abnormal heart sounds (HEART MURMURS).", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018633"}, {"RECTYPE": "D", "MH": "Veterinarians", "AQ": "CL EC ES HI LJ OG PX SD SN ST TD", "ENTRY": "Veterinarian", "MN": "N02.360.905", "FX": "Animal Technicians", "EC": "education:Education, Veterinary", "MH_TH": "NLM (1995)", "ST": "T097", "AN": "IM", "PI": "Veterinary Medicine (1966-1994)", "MS": "Individuals with a degree in veterinary medicine that provides them with training and qualifications to treat diseases and injuries of animals.", "PM": "95", "HN": "95", "MR": "20180629", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018634"}, {"RECTYPE": "D", "MH": "Rescue Work", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Work, Rescue", "MN": "N06.230.100.350", "FX": "Relief Work", "MH_TH": "NLM (1995)", "ST": "T057", "AN": "not restricted to med emerg; not restricted to organized services", "PI": "Emergency Medical Services (1968-1994)", "MS": "Activities devoted to freeing persons or animals from danger to life or well-being in accidents, fires, bombings, floods, earthquakes, other disasters and life-threatening conditions. While usually performed by team efforts, rescue work is not restricted to organized services.", "PM": "95", "HN": "95", "MR": "20080708", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018635"}, {"RECTYPE": "D", "MH": "Hypoplastic Left Heart Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Left Heart Syndrome, Hypoplastic|T019|T047|NON|EQV|NLM (1995)|940131|abbcdef", "ENTRY": "Left Heart Hypoplasia Syndrome|T019|T047|NON|EQV|NLM (2008)|060908|abbcdef", "MN": "C16.131.240.400.625", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Heart Defects, Congenital (1966-1994)", "MS": "A condition caused by underdevelopment of the whole left half of the heart. It is characterized by hypoplasia of the left cardiac chambers (HEART ATRIUM; HEART VENTRICLE), the AORTA, the AORTIC VALVE, and the MITRAL VALVE. Severe symptoms appear in early infancy when DUCTUS ARTERIOSUS closes.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018636"}, {"RECTYPE": "D", "MH": "Contact Lens Solutions", "DE": "CONTACT LENS SOL", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Disinfectants, Contact Lens|T121|NON|NRW|NLM (1995)|940107|abcdef", "ENTRY": "Solutions, Contact Lens", "MN": "D27.720.274.150", "MH_TH": "NLM (1995)", "ST": "T120", "RN": "0", "PI": "Solutions (1966-1994)", "MS": "Sterile solutions used to clean and disinfect contact lenses.", "PM": "95", "HN": "95", "MR": "20030709", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018639"}, {"RECTYPE": "D", "MH": "Stomatognathic System Abnormalities", "DE": "STOMATOGNATHIC SYSTEM ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stomatognathic System Abnormality", "MN": "C16.131.850", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "general or unspecified; prefer specifics or specific organ /abnorm", "PI": "Mouth/abnormalities (1966-1974)", "MS": "Congenital structural abnormalities of the mouth and jaws, including the dentition.", "PM": "98", "HN": "98; use explode 1995-97", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19940603", "DC": "1", "DX": "19980101", "UI": "D018640"}, {"RECTYPE": "D", "MH": "Arab World", "AQ": "HI", "MN": "I01.076.201.450.226.200", "MH_TH": "NLM (1995)", "ST": "T078", "AN": "note category; lands & peoples under influence of Arab civilization & culture; IM; not restricted to hist articles; do not confuse with ARABIA, a Category Z hist geog term", "MS": "A historical and cultural entity dispersed across a wide geographical area under the administrative, intellectual, social, and cultural domination of the Arab empire. The Arab world, under the impetus of Islam, by the eighth century A.D., extended from Arabia in the Middle East to all of northern Africa, southern Spain, Sardinia, and Sicily. Close contact was maintained with Greek and Jewish culture. While the principal service of the Arabs to medicine was the preservation of Greek culture, the Arabs themselves were the originators of algebra, chemistry, geology, and many of the refinements of civilization. (From A. Castiglioni, A History of Medicine, 2d ed, p260; from F. H. Garrison, An Introduction to the History of Medicine, 4th ed, p126)", "PM": "95", "HN": "95", "MR": "19950608", "DA": "19940622", "DC": "1", "DX": "19950101", "UI": "D018643"}, {"RECTYPE": "D", "MH": "Roman World", "AQ": "HI", "PRINT ENTRY": "Roman Empire|T078|NAM|NRW|NLM (1996)|940711|abcdef", "MN": "I01.076.201.450.226.800.500", "MH_TH": "NLM (1995)", "ST": "T078", "AN": "note category; lands & peoples under influence of Roman civilization & culture; do not confuse with ROME which is used for the ancient & modern city or with HOLY ROMAN EMPIRE", "MS": "A historical and cultural entity dispersed across a wide geographical area under the political domination and influence of ancient Rome, bringing to the conquered people the Roman civilization and culture from 753 B.C. to the beginning of the imperial rule under Augustus in 27 B.C. The early city built on seven hills grew to conquer Sicily, Sardinia, Carthage, Gaul, Spain, Britain, Greece, Asia Minor, etc., and extended ultimately from Mesopotamia to the Atlantic. Roman medicine was almost entirely in Greek hands, but Rome, with its superior water system, remains a model of sanitation and hygiene. (From A. Castiglioni, A History of Medicine, 2d ed pp196-99; from F. H. Garrison, An Introduction to the History of Medicine, 4th ed, pp107-120)", "PM": "95", "HN": "95", "MR": "20110624", "DA": "19940622", "DC": "1", "DX": "19950101", "UI": "D018644"}, {"RECTYPE": "D", "MH": "Greek World", "AQ": "HI", "MN": "I01.076.201.450.226.800.250", "MH_TH": "NLM (1995)", "ST": "T078", "AN": "note category; lands & peoples under influence of Greek civilization & culture; IM; do not confuse with GREECE, a Category Z term for ancient & modern Greece", "MS": "A historical and cultural entity dispersed across a wide geographical area under the influence of Greek civilization, culture, and science. The Greek Empire extended from the Greek mainland and the Aegean islands from the 16th century B.C., to the Indus Valley in the 4th century under Alexander the Great, and to southern Italy and Sicily. Greek medicine began with Homeric and Aesculapian medicine and continued unbroken to Hippocrates (480-355 B.C.). The classic period of Greek medicine was 460-136 B.C. and the Graeco-Roman period, 156 B.C.-576 A.D. (From A. Castiglioni, A History of Medicine, 2d ed; from F. H. Garrison, An Introduction to the History of Medicine, 4th ed)", "PM": "95", "HN": "95", "MR": "19960610", "DA": "19940622", "DC": "1", "DX": "19950101", "UI": "D018645"}, {"RECTYPE": "D", "MH": "Absinthe", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "MN": "J02.200.100.100", "MH_TH": "NLM (1995)", "ST": "T168", "AN": "an alcoholic beverage", "MS": "An extract of absinthium and other bitter herbs, containing 60% alcohol. Prolonged ingestion causes nervousness, convulsions, trismus, amblyopia, optic neuritis, and mental deterioration. (Dorland, 27th ed)", "PM": "95", "HN": "95", "MR": "20190708", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018646"}, {"RECTYPE": "D", "MH": "Amber", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D20.215.721.500.109", "MH_TH": "NLM (1995)", "ST": "T109", "RN": "0", "PI": "Resins (1969-1994)", "MS": "A yellowish fossil resin, the gum of several species of coniferous trees, found in the alluvial deposits of northeastern Germany. It is used in molecular biology in the analysis of organic matter fossilized in amber.", "PM": "95", "HN": "95", "MR": "20160322", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018647"}, {"RECTYPE": "D", "MH": "Ambergris", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D20.080", "FX": "Sperm Whale", "MH_TH": "NLM (1995)", "ST": "T109", "RN": "0", "MS": "A gray substance found in the GASTROINTESTINAL TRACT of the SPERM WHALE.", "PM": "1995", "HN": "1995", "MR": "20050630", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018648"}, {"RECTYPE": "D", "MH": "Ocimum basilicum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE ST TO UL VI", "PRINT ENTRY": "Sweet Basil|T002|NON|EQV|NLM (1999)|980413|abcdef", "ENTRY": "basilicums, Ocimum", "MN": "B01.875.800.575.912.250.583.520.647.500", "MH_TH": "NLM (1995)", "ST": "T002", "RN": "txid39350", "MS": "A plant species of the genus OCIMUM, family LAMIACEAE. It is a condiment with carminative properties.", "PM": "2003; see BASIL 1995-2002", "HN": "2003(1995)", "MR": "20210630", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018649"}, {"RECTYPE": "D", "MH": "Arnica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Leopards Bane|T002|NON|NRW|NLM (1998)|961106|abcdef", "ENTRY": "montanas, Arnica", "MN": "B01.875.800.575.912.250.100.075", "MH_TH": "NLM (1995)", "ST": "T002", "RN": "txid4246", "RR": "txid436207", "AN": "for Traumeel or homeopathic or 30x dilution coord with HOMEOPATHY (IM)", "PI": "Plants, Medicinal (1966-1984)", "MS": "A plant genus of the family ASTERACEAE. The dried flower heads of Arnica montana are used externally as a counterirritant and tincture for sprains and bruises, either as crude extract or in homeopathic dilution (HOMEOPATHY). Arnica contains volatile oils (OILS, VOLATILE), arnicin, arnisterol, FLAVONOIDS; TANNINS; and resin. The common name of Wolf's Bane is similar to the common name for ACONITUM.", "OL": "use PLANT EXTRACTS (NM) to search ARNICA 1985-94", "PM": "95; ARNICA was indexed under PLANT EXTRACTS 1985-94", "HN": "95; was ARNICA (NM) 1985-94", "MR": "20210630", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018650"}, {"RECTYPE": "D", "MH": "Cichorium intybus", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Chicory|T002|T168|NON|EQV|NLM (1995)|990101|abbcdef", "MN": "B01.875.800.575.912.250.100.200", "MH_TH": "NLM (1995)", "ST": "T168", "RN": "txid13427", "MS": "A thick-rooted perennial native to Europe but widely grown for its young leaves used as salad greens and for its roots, dried and ground-roasted, used to flavor or adulterate coffee. (From Webster, 3d ed)", "PM": "1995; use CHICORY 1995-2023", "HN": "1995; use CHICORY 1995-2023", "MR": "20230526", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018651"}, {"RECTYPE": "D", "MH": "Hemlock", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Hemlocks", "MN": "B01.875.800.575.912.250.075.388", "MH_TH": "NLM (1995)", "ST": "T002", "AN": "for hemlock tree use TSUGA; GEN or unspecified; prefer specifics: CONIUM or CICUTA", "PI": "Plant Poisoning (1966-1994)", "MS": "Any of several poisonous plants, commonly called poison hemlock, of the CICUTA or CONIUM genus. The hemlock tree (TSUGA) is completely unrelated being a coniferous tree of the pine family.", "PM": "95", "HN": "95", "MR": "20210630", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018652"}, {"RECTYPE": "D", "MH": "Juniperus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Juniper|T002|NON|NRW|NLM (1995)|990101|abcdef", "ENTRY": "virginianas, Juniperus", "MN": "B01.875.800.575.912.625.750.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13100", "RR": "txid69008", "AN": "note entry terms WESTERN CEDAR, and EASTERN RED CEDAR: check text to distinguish from other cedar terms in MeSH", "PI": "Trees (1969-1994)", "MS": "A plant genus of the family CUPRESSACEAE. The species are slow growing coniferous evergreen trees or shrubs.", "PM": "1995; see TREES 1986-1994, see JUNIPERUS 1963-1985; JUNIPERUS OXYCEDRUS was indexed under ALLERGENS 1998-2001", "HN": "1995, 1963-1985; use TREES 1986-1994; for JUNIPERUS OXYCEDRUS use JUNIPERUS OXYCEDRUS (NM) 1998-2001", "MR": "20210630", "DA": "19940527", "DC": "1", "DX": "19950101", "UI": "D018653"}, {"RECTYPE": "D", "MH": "Lymphocyte Count", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Total Lymphocyte Count|T034|T081|NON|EQV|NLM (1995)|940113|abbcdef", "ENTRY": "Total Lymphocyte Counts", "MN": "G09.188.105.595.500", "MH_TH": "NLM (1995)", "ST": "T081", "AN": "usually NIM; coord with specific lymphocyte (IM) but note that CD4 LYMPHOCYTE COUNT is available; coord with disease /blood or disease /immunol, not /physiopathol", "PI": "Leukocyte Count (1968-1994)", "MS": "The number of LYMPHOCYTES per unit volume of BLOOD.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018655"}, {"RECTYPE": "D", "MH": "Muscle Fibers, Fast-Twitch", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Muscle Fibers, White|T025|NON|NRW|NLM (1996)|950428|abcdef", "ENTRY": "White Muscle Fibers", "MN": "A11.620.249.400", "MH_TH": "NLM (1995)", "ST": "T025", "MS": "Skeletal muscle fibers characterized by their expression of the Type II MYOSIN HEAVY CHAIN isoforms which have high ATPase activity and effect several other functional properties - shortening velocity, power output, rate of tension redevelopment. Several fast types have been identified.", "PM": "95", "HN": "95", "MR": "20081016", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018656"}, {"RECTYPE": "D", "MH": "Muscle Fibers, Slow-Twitch", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Muscle Fibers, Type I|T025|NON|EQV|NLM (1996)|950202|abcdef", "ENTRY": "Slow-Twitch Muscle Fibers", "MN": "A11.620.249.700", "MH_TH": "NLM (1995)", "ST": "T025", "MS": "Skeletal muscle fibers characterized by their expression of the Type I MYOSIN HEAVY CHAIN isoforms which have low ATPase activity and effect several other functional properties - shortening velocity, power output, rate of tension redevelopment.", "PM": "95", "HN": "95", "MR": "20081016", "DA": "19940607", "DC": "1", "DX": "19950101", "UI": "D018657"}, {"RECTYPE": "D", "MH": "Ventricular Septal Rupture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ventricular Septal Perforation|T047|NON|NRW|NLM (1995)|940118|abcdef", "ENTRY": "Ventricular Septal Ruptures", "MN": "C14.280.470.475.900", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Rupture, Spontaneous (1968-1977)", "MS": "Laceration or tearing of the VENTRICULAR SEPTUM, usually caused by MYOCARDIAL INFARCTION.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160602", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018658"}, {"RECTYPE": "D", "MH": "Blood Pressure Monitoring, Ambulatory", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Monitoring, Ambulatory Blood Pressure|T060|NON|EQV|NLM (1995)|940118|abcdef", "ENTRY": "Self Blood Pressure Monitoring|T060|NON|NRW|NLM (2009)|071128|abcdef", "MN": "E01.370.520.500.100", "MH_TH": "NLM (1995)", "ST": "T060", "PI": "Blood Pressure Monitors (1990-1994)", "MS": "Method in which repeated blood pressure readings are made while the patient undergoes normal daily activities. It allows quantitative analysis of the high blood pressure load over time, can help distinguish between types of HYPERTENSION, and can assess the effectiveness of antihypertensive therapy.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018660"}, {"RECTYPE": "D", "MH": "Mycoplasma penetrans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.645", "MH_TH": "NLM (1995)", "ST": "T007", "RN": "txid28227", "AN": "infection: coord IM with MYCOPLASMA INFECTIONS (IM)", "PI": "Mycoplasma (1992-1994)", "MS": "A species of gram-negative, facultatively anaerobic bacteria. This organism shows remarkable pathobiologic properties: it adheres to cell surfaces, deeply penetrates into the cell, and strongly adsorbs human red blood cells and human CD4+ lymphocytes and monocytes. M. penetrans was first isolated from the urogenital tract of patients with AIDS and high frequencies of antibodies to it are seen in HIV-infected patients.", "PM": "95", "HN": "95", "MR": "20200813", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018661"}, {"RECTYPE": "D", "MH": "Fundoplication", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Nissen Operation|T061|EPO|EQV|NLM (1995)|940121|abcdef", "ENTRY": "Operation, Nissen", "MN": "E04.210.390", "MH_TH": "NLM (1995)", "ST": "T061", "PI": "Gastroesophageal Reflux/surgery (1968-1994)", "MS": "Mobilization of the lower end of the esophagus and plication of the fundus of the stomach around it (fundic wrapping) in the treatment of GASTROESOPHAGEAL REFLUX that may be associated with various disorders, such as hiatal hernia. (From Dorland, 28th ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018662"}, {"RECTYPE": "D", "MH": "Adrenergic Agents", "DE": "ADREN AGENTS", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sympathetic Transmitter Releasers|T121|NON|NRW|NLM (1996)|950530|SYMPATHETIC TRANSM RELEASERS|abcdefv", "ENTRY": "Transmitter Releasers, Sympathetic", "MN": "D27.505.696.577.050", "FX": "Sympathomimetics", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "note entry term ADRENERGIC EFFECT: use only for the adrenergic effect of a chemical substance", "PI": "Sympathomimetics (1977-1994)", "MS": "Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.", "OL": "use SYMPATHOMIMETICS to search SYMPATHETIC TRANSMITTER RELEASERS 1976-94, ADRENERGIC AGENTS 1977-94 & ADRENOMIMETICS 1975-94; use SYMPATHOLYTICS to search ADRENOLYTICS 1975-94", "PM": "95; was see SYMPATHOMIMETICS 1977-94; ADRENERGIC NEURON AGENTS was heading 1995; ADRENERGIC NEUROHUMOR DEPLETERS, ADRENERGIC RELEASE INHIBITORS, ADRENERGIC SYNTHESIS INHIBITORS, & SYMPATHETIC TRANSMITTER RELEASERS were see ADRENERGIC NEURON AGENTS 1995; SYMPATHETIC TRANSMITTER RELEASERS was see SYMPATHOMIMETICS 1976-94; ADRENOLYTICS was see SYMPATHOLYTICS 1975-94; ADRENOMIMETICS was see SYMPATHOMIMETICS 1975-94", "HN": "95; was see SYMPATHOMIMETICS 1977-94; ADRENERGIC NEURON AGENTS was heading 1995; ADRENERGIC NEUROHUMOR DEPLETERS, ADRENERGIC RELEASE INHIBITORS, ADRENERGIC SYNTHESIS INHIBITORS, & SYMPATHETIC TRANSMITTER RELEASERS were see ADRENERGIC NEURON AGENTS 1995; SYMPATHETIC TRANSMITTER RELEASERS was see SYMPATHOMIMETICS 1976-94; ADRENOLYTICS was see SYMPATHOLYTICS 1975-94; ADRENOMIMETICS was see SYMPATHOMIMETICS 1975-94", "MR": "20200527", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018663"}, {"RECTYPE": "D", "MH": "Interleukin-12", "DS": "INTERLEUKIN 012", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Natural Killer Cell Stimulatory Factor|T116|T129|NON|EQV|NLM (1995)|940124|NKSF|abbcdefv", "ENTRY": "Interleukin 12 p70", "MN": "D23.529.374.465.512", "PA": "Angiogenesis Inhibitors", "FX": "Ustekinumab", "MH_TH": "NLM (1995)", "ST": "T129", "RN": "187348-17-0", "PI": "Interleukins (1991-1994)", "MS": "A heterodimeric cytokine that plays a role in innate and adaptive immune responses. Interleukin-12 is a 70 kDa protein that is composed of covalently linked 40 kDa and 35 kDa subunits. It is produced by DENDRITIC CELLS; MACROPHAGES and a variety of other immune cells and plays a role in the stimulation of INTERFERON-GAMMA production by T-LYMPHOCYTES and NATURAL KILLER CELLS.", "PM": "1995; INTERLEUKIN 12 was indexed under INTERLEUKINS 1991-1994; INTERLEUKIN-12 P70 was indexed under INTERLEUKIN-12 2003-2006", "HN": "1995 (1991)", "MR": "20181010", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018664"}, {"RECTYPE": "D", "MH": "Ureteroscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Ureteroscopic Surgical Procedures|T060|T061|NON|NRW|NLM (2000)|991103|URETEROSCOPIC SURG PROCEDURES|abbcdefv", "ENTRY": "Ureteroscopies", "MN": "E04.950.774.840", "FX": "Ureteroscopes", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "/ instrum permitted but consider also URETEROSCOPES", "PI": "Endoscopy (1970-1994)", "MS": "Endoscopic examination, therapy or surgery of the ureter.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018666"}, {"RECTYPE": "D", "MH": "Tilt-Table Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tilt Table Test", "MN": "E01.370.370.750", "MH_TH": "NLM (1995)", "ST": "T060", "AN": "coordinate with HEAD-DOWN TILT if pertinent", "PI": "Posture (1985-1994)", "MS": "A standard and widely accepted diagnostic test used to identify patients who have a vasodepressive and/or cardioinhibitory response as a cause of syncope. (From Braunwald, Heart Disease, 7th ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018667"}, {"RECTYPE": "D", "MH": "Muntjacs", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Muntiacus|T015|NON|EQV|NLM (1995)|940124|abcdef", "ENTRY": "Muntjak", "MN": "B01.050.150.900.649.313.500.380.373.322", "MH_TH": "NLM (1995)", "ST": "T015", "RN": "txid9885", "PI": "Deer (1970-1994)", "MS": "A genus, Muntiacus, of the deer family (Cervidae) comprising six species living in China, Tibet, Nepal, India, the Malay Peninsula, and neighboring island countries. They are usually found in forests and areas of dense vegetation, usually not far from water. They emit a deep barklike sound which gives them the name \"barking deer.\" If they sense a predator they will \"bark\" for an hour or more. They are hunted for their meat and skins; they thrive in captivity and are found in many zoos. The Indian muntjac is believed to have the lowest chromosome number in mammals and cell lines derived from them figure widely in chromosome and DNA studies. (From Walker's Mammals of the World, 5th ed., p1366)", "PM": "95", "HN": "95", "MR": "20200813", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018668"}, {"RECTYPE": "D", "MH": "Monitoring, Ambulatory", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Outpatient Monitoring|T060|NON|EQV|NLM (1995)|940125|abcdef", "MN": "E01.370.520.500", "MH_TH": "NLM (1995)", "ST": "T060", "PI": "Monitoring, Physiologic (1966-1994)", "MS": "The use of electronic equipment to observe or record physiologic processes while the patient undergoes normal daily activities.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018670"}, {"RECTYPE": "D", "MH": "Needle-Exchange Programs", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Syringe-Exchange Programs|T061|NON|EQV|NLM (1995)|940125|abcdef", "ENTRY": "Syringe Exchange Programs", "MN": "N02.421.726.708", "FX": "Substance Abuse Treatment Centers", "MH_TH": "NLM (1995)", "ST": "T061", "PI": "Syringes (1985-1994)", "MS": "Organized services for exchange of sterile needles and syringes used for injections as a potential means of reducing the transmission of infectious diseases.", "PM": "95", "HN": "95", "MR": "20200617", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018671"}, {"RECTYPE": "D", "MH": "Community Health Planning", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Population-Based Planning|T078|NON|BRD|NLM (1995)|940125|abcdef", "ENTRY": "Systems, Community Health", "MN": "N03.349.650.185", "FX": "Community Health Services", "MH_TH": "NLM (1995)", "ST": "T058", "AN": "specify geog", "MS": "Planning that has the goals of improving health, improving accessibility to health services, and promoting efficiency in the provision of services and resources on a comprehensive basis for a whole community. (From Facts on File Dictionary of Health Care Management, 1988, p299)", "PM": "95", "HN": "95", "MR": "19991103", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018672"}, {"RECTYPE": "D", "MH": "Nutrition Policy", "AQ": "EC HI LJ TD", "PRINT ENTRY": "Food Policy|T170|NON|NRW|NLM (1995)|940405|abcdef", "ENTRY": "Policy, Nutrition", "MN": "N03.623.500.608.428.650", "MH_TH": "NLM (1995)", "ST": "T170", "PI": "Health Policy (1980-1994)", "MS": "Guidelines and objectives pertaining to food supply and nutrition including recommendations for healthy diet.", "PM": "95", "HN": "95", "MR": "20130708", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018673"}, {"RECTYPE": "D", "MH": "Adrenergic Antagonists", "DE": "ADREN ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiadrenergic Agents|T121|NON|EQV|NLM (1995)|940426|abcdef", "ENTRY": "Receptor Blockaders, Adrenergic", "MN": "D27.505.696.577.050.200", "FX": "Sympatholytics", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "do not confuse with ADRENERGIC AGONISTS", "PI": "Sympatholytics (1982-1994)", "MS": "Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE.", "OL": "use SYMPATHOLYTICS to search ADRENERGIC-BLOCKING AGENTS 1978-94 & ANTIADRENERGIC AGENTS 1975-94", "PM": "95; ADRENERGIC-BLOCKING AGENTS was see SYMPATHOLYTICS 1978-94; ANTIADRENERGIC AGENTS was see SYMPATHOLYTICS 1975-94", "HN": "95; ADRENERGIC-BLOCKING AGENTS was see SYMPATHOLYTICS 1978-94; ANTIADRENERGIC AGENTS was see SYMPATHOLYTICS 1975-94", "MR": "20050630", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018674"}, {"RECTYPE": "D", "MH": "Toxicity Tests", "DE": "TOX TESTS", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Toxicity Test", "MN": "E05.940", "MH_TH": "NLM (1995)", "ST": "T060", "AN": "general or unspecified; prefer specifics; used for tests of drugs, food, environ pollutants, etc.; when the test itself is emphasized; coord IM with substance /tox (IM); toxic eff of a specific substance equals specific substance /tox", "PI": "specific substance/toxicity (1966-1994)", "MS": "An array of tests used to determine the toxicity of a substance to living systems. These include tests on clinical drugs, foods, and environmental pollutants.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018675"}, {"RECTYPE": "D", "MH": "Tooth Injuries", "DE": "TOOTH INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tooth Injury", "MN": "C26.900", "MH_TH": "NLM (1995)", "ST": "T037", "AN": "general or unspecified; prefer specifics or /inj with specific tooth, as CUSPID /inj", "PI": "Tooth/injuries (1966-1994)", "MS": "Traumatic or other damage to teeth including fractures (TOOTH FRACTURES) or displacements (TOOTH LUXATION).", "OL": "use TOOTH INJURIES to search TOOTH/injuries 1966-94", "PM": "95; was TOOTH/injuries 1966-94", "HN": "95; was TOOTH/injuries 1966-94", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19940628", "DC": "1", "DX": "19950101", "UI": "D018677"}, {"RECTYPE": "D", "MH": "Cholinergic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nicotinic Agents|T121|NON|NRW|NLM (1995)|940406|abcdef", "ENTRY": "Effects, Nicotinic", "MN": "D27.505.696.577.120", "FX": "Bungarotoxins", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; note entry term CHOLINERGIC EFFECT: use only for the cholinergic effect of a chemical substance", "MS": "Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage.", "OL": "use PARASYMPATHOMIMETICS to search CHOLINERGIC AGENTS 1975-94, CHOLINOMIMETICS 1974-94, & MUSCARINIC AGENTS 1969-94; use GANGLIONIC STIMULANTS to search NICOTINIC AGENTS 1978-94", "PM": "95; was see PARASYMPATHOMIMETICS 1975-94; NICOTINIC AGENTS was see GANGLIONIC STIMULANTS 1978-94; CHOLINOMIMETICS was see PARASYMPATHOMIMETICS 1974-94; MUSCARINIC AGENTS was see PARASYMPATHOMIMETICS 1969-94", "HN": "95; was see PARASYMPATHOMIMETICS 1975-94; NICOTINIC AGENTS was see GANGLIONIC STIMULANTS 1978-94; CHOLINOMIMETICS was see PARASYMPATHOMIMETICS 1974-94; MUSCARINIC AGENTS was see PARASYMPATHOMIMETICS 1969-94", "MR": "20200527", "DA": "19940629", "DC": "1", "DX": "19950101", "UI": "D018678"}, {"RECTYPE": "D", "MH": "Cholinergic Agonists", "DE": "CHOLINERGIC AG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acetylcholine Agonists|T121|NON|EQV|NLM (1995)|940502|ACETYLCHOLINE AGON|abcdefv", "ENTRY": "Agonists, Cholinergic", "MN": "D27.505.696.577.120.140", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Acetylcholine/pharmacology (1967-1994)", "MS": "Drugs that bind to and activate cholinergic receptors.", "PM": "95", "HN": "95", "MR": "20050630", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018679"}, {"RECTYPE": "D", "MH": "Cholinergic Antagonists", "DE": "CHOLINERGIC ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cholinolytics|T121|NON|EQV|NLM (1995)|940406|abcdef", "ENTRY": "Receptor Antagonists, Cholinergic", "MN": "D27.505.696.577.120.200", "FX": "Anticholinergic Syndrome", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "/adv eff: consider also ANTICHOLINERGIC SYNDROME", "MS": "Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists.", "OL": "use PARASYMPATHOLYTICS to search CHOLINERGIC-BLOCKING AGENTS 1966-94 & CHOLINOLYTICS & ANTICHOLINERGIC AGENTS 1975-94", "PM": "95; CHOLINERGIC-BLOCKING AGENTS was see PARASYMPATHOLYTICS 1963-94; CHOLINOLYTICS & ANTICHOLINERGIC AGENTS were see PARASYMPATHOLYTICS 1975-94", "HN": "95; CHOLINERGIC-BLOCKING AGENTS was see PARASYMPATHOLYTICS 1963-94; CHOLINOLYTICS & ANTICHOLINERGIC AGENTS were see PARASYMPATHOLYTICS 1975-94", "MR": "20200527", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018680"}, {"RECTYPE": "D", "MH": "Anesthetics, General", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "General Anesthetics|T121|NON|EQV|NLM (1995)|940126|abcdef", "ENTRY": "Anesthetic, General", "MN": "D27.505.954.427.210.100.035", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "see note at ANESTHETICS", "PI": "Anesthetics (1966-1994)", "MS": "Agents that induce various degrees of analgesia; depression of consciousness, circulation, and respiration; relaxation of skeletal muscle; reduction of reflex activity; and amnesia. There are two types of general anesthetics, inhalation and intravenous. With either type, the arterial concentration of drug required to induce anesthesia varies with the condition of the patient, the desired depth of anesthesia, and the concomitant use of other drugs. (From AMA Drug Evaluations Annual, 1994, p.173)", "PM": "95", "HN": "95", "MR": "20200527", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018681"}, {"RECTYPE": "D", "MH": "GABA Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "gamma-Aminobutyric Acid Agents|T121|NON|EQV|NLM (1995)|940513|abcdef", "ENTRY": "gamma Aminobutyric Acid Agents", "MN": "D27.505.696.577.240", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; note entry term GABA EFFECT: use only for the GABA effect of a chemical substance", "PI": "GABA/pharmacology (1972-1994)", "MS": "Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.", "PM": "95", "HN": "95", "MR": "20110624", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018682"}, {"RECTYPE": "D", "MH": "Excitatory Amino Acid Agents", "DE": "EXCITATORY AA AGENTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glutamate Agents|T121|NON|NRW|NLM (1995)|940503|abcdef", "ENTRY": "Agents, Glutamatergic", "MN": "D27.505.696.577.190", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "exogenous: do not confuse with EXCITATORY AMINO ACIDS which are endogenous; general or unspecified; prefer specifics; note entry term EXCITATORY AMINO ACID EFFECT: use only for the excitatory amino acid effect of a chemical substance", "MS": "Drugs used for their actions on any aspect of excitatory amino acid neurotransmitter systems. Included are drugs that act on excitatory amino acid receptors, affect the life cycle of excitatory amino acid transmitters, or affect the survival of neurons using excitatory amino acids.", "PM": "95", "HN": "95", "MR": "20130709", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018683"}, {"RECTYPE": "D", "MH": "Glycine Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Glycine", "MN": "D27.505.696.577.300", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "note entry term GLYCINE EFFECT: use only for the glycine effect of a chemical substance", "PI": "Glycine/pharmacology (1968-1994)", "MS": "Substances used for their pharmacological actions on glycinergic systems. Glycinergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.", "PM": "95", "HN": "95", "MR": "20110624", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018684"}, {"RECTYPE": "D", "MH": "Anesthetics, Inhalation", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Inhalation Anesthetics|T121|NON|EQV|NLM (1995)|940402|abcdef", "ENTRY": "Gases, Anesthetic", "MN": "D27.505.954.427.210.100.035.060", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "see note at ANESTHETICS", "PI": "Anesthetics (1966-1994)", "MS": "Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173)", "PM": "95", "HN": "95", "MR": "20200527", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018685"}, {"RECTYPE": "D", "MH": "Anesthetics, Intravenous", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Intravenous Anesthetics|T121|NON|EQV|NLM (1995)|940526|abcdef", "ENTRY": "Anesthetic, Intravenous", "MN": "D27.505.954.427.210.100.035.075", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "see note at ANESTHETICS", "PI": "Anesthetics (1968-1994)", "MS": "Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174)", "PM": "95", "HN": "95", "MR": "20200527", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018686"}, {"RECTYPE": "D", "MH": "Antidepressive Agents, Second-Generation", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Second-Generation Antidepressive Agents|T121|NON|EQV|NLM (1995)|940126|abcdef", "ENTRY": "Second-Generation Antidepressive Drugs", "MN": "D27.505.954.427.700.122.050", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "PI": "Antidepressive Agents (1977-1994)", "MS": "A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake.", "PM": "95", "HN": "95", "MR": "20140625", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018687"}, {"RECTYPE": "D", "MH": "Neospora", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Neospora caninum|T204|NON|NRW|NLM (1995)|940224|abcdef", "ENTRY": "caninums, Neospora", "MN": "B01.043.075.189.250.750.550", "MH_TH": "NLM (1995)", "ST": "T204", "RN": "txid29175", "RR": "txid29176", "AN": "do not confuse with NEUROSPORA, a fungus; infection: coordinate IM with COCCIDIOSIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Protozoa (1989-1991)", "MS": "A genus of protozoan parasites of the subclass COCCIDIA. Its species are parasitic in dogs, cattle, goats, and sheep, among others. N. caninum, a species that mainly infects dogs, is intracellular in neural and other cells of the body, multiplies by endodyogeny, has no parasitophorous vacuole, and has numerous rhoptries. It is known to cause lesions in many tissues, especially the brain and spinal cord as well as abortion in the expectant mother.", "PM": "95", "HN": "95", "MR": "20200813", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018688"}, {"RECTYPE": "D", "MH": "Sensory System Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "System Drugs, Sensory", "MN": "D27.505.696.663.850", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics ", "MS": "Drugs that act on neuronal sensory receptors resulting in an increase, decrease, or modification of afferent nerve activity. (From Smith and Reynard, Textbook of Pharmacology, 1991, p367)", "PM": "98", "HN": "98; use explode 1995-97", "MR": "20080710", "DA": "19940603", "DC": "1", "DX": "19980101", "UI": "D018689"}, {"RECTYPE": "D", "MH": "Excitatory Amino Acid Agonists", "DE": "EXCITATORY AA AG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glutamate Agonists|T121|NON|NRW|NLM (1995)|940214|GLUTAMATE AGON|abcdefv", "ENTRY": "Agonists, Glutamate", "MN": "D27.505.696.577.190.200", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "note entry term GLUTAMATE AGONISTS: do not coordinate with GLUTAMATES", "PI": "Glutamates/pharmacology (1966-1994)", "MS": "Drugs that bind to and activate excitatory amino acid receptors.", "PM": "95", "HN": "95", "MR": "20050630", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018690"}, {"RECTYPE": "D", "MH": "Excitatory Amino Acid Antagonists", "DE": "EXCITATORY AA ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glutamate Receptor Antagonist|T121|NON|EQV|NLM (2022)|200917|abcdef", "ENTRY": "Receptor Antagonists, Glutamate", "MN": "D27.505.696.577.190.300", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "PI": "Glutamates/antagonists & inhibitors (1968-1994)", "MS": "Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.", "PM": "95", "HN": "95", "MR": "20210630", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018691"}, {"RECTYPE": "D", "MH": "Antimanic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Antimanic", "MN": "D27.505.954.427.700.872.025", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "note entry term ANTIMANIC EFFECT: use only for the antimanic effect of a chemical substance", "PI": "Bipolar Disorder/prevention & control (1968-1994)", "MS": "Agents that are used to treat bipolar disorders or mania associated with other affective disorders.", "PM": "95", "HN": "95", "MR": "20140625", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018692"}, {"RECTYPE": "D", "MH": "Neuroprotective Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neuroprotective Drug|T121|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Effects, Neuroprotective", "MN": "D27.505.954.427.575", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "note entry term NEUROPROTECTIVE EFFECT: use only for the neuroprotective effect of a chemical substance", "MS": "Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.", "PM": "95", "HN": "95", "MR": "20200527", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018696"}, {"RECTYPE": "D", "MH": "Nootropic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Procognitive Agent|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Enhancers, Cognitive", "MN": "D27.505.954.427.637", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "PI": "Psychotropic Drugs (1989-1994)", "MS": "Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms.", "OL": "use PSYCHOTROPIC DRUGS to search NOOTROPIC DRUGS 1990-94", "PM": "95; NOOTRPIC DRUGS was see PSYCHOTROPIC DRUGS 1990-94", "HN": "95; NOOTRPIC DRUGS was see PSYCHOTROPIC DRUGS 1990-94", "MR": "20200527", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018697"}, {"RECTYPE": "D", "MH": "Glutamic Acid", "AQ": "AA AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Potassium Glutamate|T116|NON|NRW|FDA SRS (2014)|NLM (1995)|940127|abcdeef", "ENTRY": "L-Glutamate, Aluminum", "MN": "D12.125.427.300", "FX": "Receptors, Glutamate", "EC": "antagonists & inhibitors:Excitatory Amino Acid Antagonists", "MH_TH": "USAN (19XX)", "ST": "T123", "N1": "L-Glutamic acid", "RN": "3KX376GY7L", "RR": "B5ZC7FHO6O", "MS": "A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM.", "PM": "1995; GLUTAMIC ACID was indexed under GLUTAMATES 1981-1994; for POTASSIUM GLUTAMATE and ALUMINUM L-GLUTAMATE see GLUTAMATES 1995-2013", "HN": "1995; for POTASSIUM GLUTAMATE and ALUMINUM L-GLUTAMATE use GLUTAMATES 1995-2013", "MR": "20130708", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018698"}, {"RECTYPE": "D", "MH": "Coated Vesicles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Vesicles, Coated", "MN": "A11.284.430.214.190.875.190.880.180", "MH_TH": "NLM (1995)", "ST": "T026", "AN": "general or unspecified; prefer specifics", "PI": "Coated Pits, Cell-Membrane (1983-1994)", "MS": "Vesicles formed when cell-membrane coated pits (COATED PITS, CELL-MEMBRANE) invaginate and pinch off. The outer surface of these vesicles are covered with a lattice-like network of coat proteins, such as CLATHRIN, coat protein complex proteins, or CAVEOLINS.", "PM": "95", "HN": "95", "MR": "20030709", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018699"}, {"RECTYPE": "D", "MH": "Pleurodesis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E02.319.694", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "instillation of a drug or other agent into pleural space to seal pleural fistula, effusion, etc.; IM; coord with dis /ther & specific drug /admin (IM) if pertinent", "PI": "Pleura (1976-1994)", "MS": "The production of adhesions between the parietal and visceral pleura. The procedure is used in the treatment of bronchopleural fistulas, malignant pleural effusions, and pneumothorax and often involves instillation of chemicals or other agents into the pleural space causing, in effect, a pleuritis that seals the air leak. (From Fishman, Pulmonary Diseases, 2d ed, p2233 & Dorland, 27th ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018700"}, {"RECTYPE": "D", "MH": "Mononegavirales Infections", "DE": "MONONEGAVIRALES INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Mononegavirales Infection", "MN": "C01.925.782.580", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Infections with viruses of the order MONONEGAVIRALES. The concept includes FILOVIRIDAE INFECTIONS; PARAMYXOVIRIDAE INFECTIONS; and RHABDOVIRIDAE INFECTIONS.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018701"}, {"RECTYPE": "D", "MH": "Filoviridae Infections", "DE": "FILOVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Filovirus", "MN": "C01.925.782.580.250", "MH_TH": "NLM (1995)", "ST": "T047", "MS": "Infections with viruses of the family FILOVIRIDAE. The infections in humans consist of a variety of clinically similar viral hemorrhagic fevers but the natural reservoir host is unknown.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018702"}, {"RECTYPE": "D", "MH": "Founder Effect", "DE": "FOUNDER EFF", "ENTRY": "Founder Effects", "MN": "G05.285", "MH_TH": "NLM (1995)", "ST": "T067", "PI": "Pedigree (1983-1994)", "MS": "A phenomenon that is observed when a small subgroup of a larger POPULATION establishes itself as a separate and isolated entity. The subgroup's GENE POOL carries only a fraction of the genetic diversity of the parental population resulting in an increased frequency of certain diseases in the subgroup, especially those diseases known to be autosomal recessive.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018703"}, {"RECTYPE": "D", "MH": "Orthodontic Retainers", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Retainers, Orthodontic|T074|NON|EQV|NLM (1995)|940128|abcdef", "ENTRY": "Retainer, Orthodontic", "MN": "E06.658.453.637", "MH_TH": "NLM (1995)", "ST": "T074", "PI": "Orthodontic Appliances (1966-1994)", "MS": "Orthodontic appliances, fixed or removable, used to maintain teeth in corrected positions during the period of functional adaptation following corrective treatment. These appliances are also used to maintain the positions of the teeth and jaws gained by orthodontic procedures. (From Zwemer, Boucher's Clinical Dental Terminology, 4th ed, p263)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018704"}, {"RECTYPE": "D", "MH": "Volcanic Eruptions", "AQ": "AE AN CL EC ES HI LJ SN", "PRINT ENTRY": "Volcanic Gases|T131|NON|NRW|NLM (1995)|940128|abcdef", "ENTRY": "Gases, Volcanic", "MN": "G01.311.955", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "specify geographic term if pertinent", "PI": "Natural Disasters (1982-1994)", "MS": "The ash, dust, gases, and lava released by volcanic explosion. The gases are volatile matter composed principally of about 90% water vapor, and carbon dioxide, sulfur dioxide, hydrogen, carbon monoxide, and nitrogen. The ash or dust is pyroclastic ejecta and lava is molten extrusive material consisting mainly of magnesium silicate. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "PM": "2009; see VOLCANIC ERUPTION 1995-2008, see NATURAL DISASTERS 1982-1994", "HN": "2009 (1995); use NATURAL DISASTERS 1982-1994", "MR": "20180630", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018707"}, {"RECTYPE": "D", "MH": "Picobirnavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Picotrinaviruses", "MN": "B04.970.610", "MH_TH": "NLM (1995)", "ST": "T005", "RN": "txid104394", "AN": "an unclassified RNA virus; from pico (tiny) + bi(segmented) + RNA virus; infection: coord IM with RNA VIRUS INFECTIONS (IM)", "PI": "RNA Viruses (1988-1994)", "MS": "Unclassified, bisegmented, double-stranded RNA virus isolated from the feces of humans and other animals. Some reports associate it with gastroenteritis in humans.", "PM": "95", "HN": "95", "MR": "20200902", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018708"}, {"RECTYPE": "D", "MH": "Statistics, Nonparametric", "DE": "STATIST NONPARAMETRIC", "PRINT ENTRY": "Wilcoxon Rank Test|T081|EPO|NRW|NLM (1995)|940325|abcdef", "ENTRY": "U Test, Mann-Whitney", "MN": "N06.850.520.830.995", "MH_TH": "NLM (1995)", "ST": "T081", "AN": "usually NIM", "PI": "Statistics (1966-1994)", "MS": "A class of statistical methods applicable to a large set of probability distributions used to test for correlation, location, independence, etc. In most nonparametric statistical tests, the original scores or observations are replaced by another variable containing less information. An important class of nonparametric tests employs the ordinal properties of the data. Another class of tests uses information about whether an observation is above or below some fixed value such as the median, and a third class is based on the frequency of the occurrence of runs in the data. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1284; Corsini, Concise Encyclopedia of Psychology, 1987, p764-5)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018709"}, {"RECTYPE": "D", "MH": "Pain Clinics", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Pain Relief Units|T093|NON|EQV|NLM (1995)|940129|abcdef", "ENTRY": "Units, Pain Relief", "MN": "N04.452.442.452.422.527.600", "MH_TH": "NLM (1995)", "ST": "T093", "AN": "for diag & ther; coord IM with specific dis (IM) if pertinent", "PI": "Pain (1966-1994)", "MS": "Facilities providing diagnostic, therapeutic, and palliative services for patients with severe chronic pain. These may be free-standing clinics or hospital-based and serve ambulatory or inpatient populations. The approach is usually multidisciplinary. These clinics are often referred to as \"acute pain services\". (From Br Med Bull 1991 Jul;47(3):762-85)", "PM": "95", "HN": "95", "MR": "20190709", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018710"}, {"RECTYPE": "D", "MH": "Analgesics, Non-Narcotic", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nonopioid Analgesics|T121|NON|EQV|NLM (1995)|940131|abcdef", "ENTRY": "Opioid Analgesic, Non", "MN": "D27.505.954.427.040.100", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "PI": "Analgesics (1966-1994)", "MS": "A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS.", "OL": "use ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL to search ANTIPYRETICS 1978-94; use ANALGESICS 1966-77", "PM": "95; ANTIPYRETICS was see ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1990-94; was see ANALGESICS, ANTI-INFAMMATORY 1978-89; was see ANALGESICS AND ANTIPYRETICS 1975-77; was see under ANALGESICS AND ANTIPYRETICS 1963-74", "HN": "95; ANTIPYRETICS was see ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1990-94; was see ANALGESICS, ANTI-INFAMMATORY 1978-89; was see ANALGESICS AND ANTIPYRETICS 1975-77; was see under ANALGESICS AND ANTIPYRETICS 1963-74", "MR": "20210630", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018712"}, {"RECTYPE": "D", "MH": "Prevotella intermedia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Bacteroides intermedius|T007|NON|EQV|NLM (1995)|940131|abcdef", "MN": "B03.440.425.410.194.640.375", "MH_TH": "NLM (1995)", "ST": "T007", "RN": "txid28131", "AN": "infection: coord IM with BACTEROIDACEAE INFECTIONS (IM)", "PI": "Bacteroides (1979-1994)", "MS": "A species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium is a common commensal in the gingival crevice and is often isolated from cases of gingivitis and other purulent lesions related to the mouth.", "PM": "95", "HN": "95", "MR": "20200813", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018713"}, {"RECTYPE": "D", "MH": "Radiotherapy, Adjuvant", "DE": "RADIOTHER ADJUVANT", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Radiotherapies, Adjuvant", "MN": "E02.815.600", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "almost never IM; coord with dis /radiother (IM) + specific radiother (IM) + specific surg or chemother to which this is adjuvant (IM)", "PI": "specific neoplasms/radiotherapy (1966-1994)", "MS": "Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018714"}, {"RECTYPE": "D", "MH": "Microscopy, Video", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Videomicroscopy|T059|NON|EQV|NLM (1995)|940201|abcdef", "ENTRY": "Videomicroscopies", "MN": "L01.462.500.847.823.475", "MH_TH": "NLM (1995)", "ST": "T059", "AN": "NIM", "PI": "Microscopy (1974-1994)", "MS": "Microscopy in which television cameras are used to brighten magnified images that are otherwise too dark to be seen with the naked eye. It is used frequently in TELEPATHOLOGY.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19940416", "DC": "1", "DX": "19950101", "UI": "D018715"}, {"RECTYPE": "D", "MH": "Molecular Mimicry", "DE": "MOL MIMICRY", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Mimicry, Molecular|T044|NON|EQV|NLM (1995)|940201|MIMICRY MOL|abcdefv", "ENTRY": "Molecular Mimicries", "MN": "G16.012.750.500", "MH_TH": "NLM (1995)", "ST": "T044", "PI": "Amino Acid Sequence (1980-1994)", "MS": "The structure of one molecule that imitates or simulates the structure of a different molecule.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018716"}, {"RECTYPE": "D", "MH": "Purple Membrane", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Purple Membranes", "MN": "A20.871", "FX": "Bacteriorhodopsins", "MH_TH": "NLM (1995)", "ST": "T026", "PI": "Cell Membrane (1971-1978)", "MS": "Functionally and structurally differentiated, purple-pigmented regions of the cytoplasmic membrane of some strains of Halobacterium halobium. The membrane develops under anaerobic conditions and is made almost entirely of the purple pigment BACTERIORHODOPSINS. (From Singleton & Sainsbury Dictionary of Microbiology and Molecular Biology, 2d ed)", "OL": "use BACTERIORHODOPSIN to search PURPLE MEMBRANE 1976-94", "PM": "95; was see BACTERIORHODOPSIN 1976-94", "HN": "95; was see BACTERIORHODOPSIN 1976-94", "MR": "20090706", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018717"}, {"RECTYPE": "D", "MH": "Home Infusion Therapy", "DE": "HOME INFUSION THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Therapy, Home Infusion|T061|NON|EQV|NLM (1995)|940331|THER HOME INFUSION|abcdefv", "ENTRY": "Therapy, Outpatient Infusion|T061|NON|BRD|NLM (1995)|940331|THER OUTPATIENT INFUSION|abcdefv", "MN": "N02.421.143.524.436", "FX": "Parenteral Nutrition, Home", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "coordinate with specific type of infusion or infusion therapy ", "MS": "Use of any infusion therapy on an ambulatory, outpatient, or other non-institutionalized basis.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018718"}, {"RECTYPE": "D", "MH": "Receptor, ErbB-2", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "neu Proto-Oncogene Protein|T116|T126|T192|NON|EQV|NLM (2000)|991104|abbbcdef", "ENTRY": "neu Proto Oncogene Protein", "MN": "D23.101.140.642", "FX": "Trastuzumab", "MH_TH": "NLM (2015)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Proto-Oncogene Proteins (1986-1994)", "MS": "A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and  heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member.", "PM": "2019; for ERB-B2 RECEPTOR TYROSINE KINASES see ERBB RECEPTORS 2017-2019; see PROTO-ONCOGENE PROTEINS C-ERBB-2 1995-1999; for PROTO-ONCOGENE PROTEIN ERBB-2 see EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE 1994, PROTO-ONCOGENE PROTEINS 1986-1994, and PHOSPHOPROTEINS 1985;", "HN": "2019 (1995)", "MR": "20210621", "DA": "19991104", "DC": "1", "DX": "19950101", "UI": "D018719"}, {"RECTYPE": "D", "MH": "Prevotella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.194.640", "MH_TH": "NLM (1995)", "ST": "T007", "RN": "txid838", "AN": "\u00e0infection: coord IM with BACTEROIDACEAE INFECTIONS (IM); named for the French microbiologist A. R. Pr\u00e9vot, pioneer in anaerobic microbiol", "PI": "Bacteroides (1990-1994)", "MS": "A genus of gram-negative, anaerobic, nonsporeforming, nonmotile rods. Organisms of this genus had originally been classified as members of the BACTEROIDES genus but overwhelming biochemical and chemical findings in 1990 indicated the need to separate them from other Bacteroides species, and hence, this new genus was established.", "PM": "95", "HN": "95", "MR": "20200813", "DA": "19940706", "DC": "1", "DX": "19950101", "UI": "D018720"}, {"RECTYPE": "D", "MH": "Muscarinic Agonists", "DE": "MUSCARINIC AG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cholinergic Agonists, Muscarinic|T121|NON|EQV|NLM (1995)|940204|CHOLINERGIC AG MUSCARINIC|abcdefv", "ENTRY": "Muscarinic Cholinergic Agonists", "MN": "D27.505.696.577.120.140.500", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "MS": "Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate.", "PM": "95", "HN": "95", "MR": "20140612", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018721"}, {"RECTYPE": "D", "MH": "Nicotinic Agonists", "DE": "NICOTINIC AG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cholinergic Agonists, Nicotinic|T121|NON|EQV|NLM (1995)|940204|CHOLINERGIC AG NICOTINIC|abcdefv", "ENTRY": "Nicotinic Cholinergic Agonists", "MN": "D27.505.696.577.120.140.700", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "MS": "Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission.", "PM": "95", "HN": "95", "MR": "20140613", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018722"}, {"RECTYPE": "D", "MH": "Bethanechol", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "PMS Bethanechol Chloride", "MN": "D02.675.276.148.100", "PA": "Parasympathomimetics", "EC": "analogs & derivatives:Bethanechol Compounds", "MH_TH": "NLM (1995)", "ST": "T121", "N1": "1-Propanaminium, 2-((aminocarbonyl)oxy)-N,N,N-trimethyl-", "RN": "004F72P8F4", "RR": "H4QBZ2LO84", "MS": "A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.", "OL": "use BETHANECHOL (NM) to search BETHANECHOL 1981-94; use BETHANECHOL COMPOUNDS to search BETHANECHOL 1966-67 (as Prov 1966-67)", "PM": "95; BETHANECHOL was indexed under BETHANECHOL COMPOUNDS 1981-94", "HN": "95; was BETHANECHOL (NM) 1981-94; was heading 1964-67 (Prov)", "MR": "20170117", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018723"}, {"RECTYPE": "D", "MH": "Spinacia oleracea", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Spinach|T168|NON|REL|NLM (1995)|990101|abcdef", "MN": "B01.875.800.575.912.250.200.800", "MH_TH": "NLM (1995)", "ST": "T002", "RN": "txid3562", "AN": "water spinach (Ipomoea aquatica): index IPOMOEA", "PI": "Vegetables (1966-1994)", "MS": "A widely cultivated plant, native to Asia, having succulent, edible leaves eaten as a vegetable. (From American Heritage Dictionary, 1982)", "PM": "2005; see SPINACH 1995-2004", "HN": "2005(1995)", "MR": "20210630", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018724"}, {"RECTYPE": "D", "MH": "Tar-Water", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Tar Water", "MN": "D20.749.850", "MH_TH": "NLM (1995)", "ST": "T109", "RN": "0", "AN": "infusion of tar in water; in hist articles", "MS": "A cold infusion of tar in water, formerly regarded as a cure-all. (Webster, 3d ed)", "PM": "95", "HN": "95", "MR": "20030709", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018725"}, {"RECTYPE": "D", "MH": "Anti-Dyskinesia Agents", "DS": "ANTIDYSKINESIA AGENTS", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Movement Disorder Agents|T121|NON|EQV|NLM (1995)|940505|abcdef", "ENTRY": "Disorder Agents, Movement", "MN": "D27.505.954.427.090", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "PI": "Antiparkinson Agents (1976-1994)", "MS": "Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias.", "PM": "95", "HN": "95", "MR": "20140625", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018726"}, {"RECTYPE": "D", "MH": "Muscarinic Antagonists", "DE": "MUSCARINIC ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Muscarinic Antagonist|T121|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Muscarinic Antagonists, Cholinergic", "MN": "D27.505.696.577.120.200.500", "FX": "Parasympatholytics", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "PI": "Parasympatholytics (1966-1994)", "MS": "Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.", "OL": "use PARASYMPATHOLYTICS to search ANTIMUSCARINIC AGENTS 1969-94", "PM": "95; ANTIMUSCARINIC AGENTS was see PARASYMPATHOLYTICS 1969-94", "HN": "95; ANTIMUSCARINIC AGENTS was see PARASYMPATHOLYTICS 1969-94", "MR": "20200527", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018727"}, {"RECTYPE": "D", "MH": "Entorhinal Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Entorhinal Area|T023|NON|EQV|NLM (1995)|940208|abcdef", "ENTRY": "Secondary Olfactory Cortices", "MN": "A08.186.211.200.885.287.750.562", "FX": "Perforant Pathway", "MH_TH": "NLM (1995)", "ST": "T023", "PI": "Limbic System (1969-1994)", "MS": "Cerebral cortex region on the medial aspect of the PARAHIPPOCAMPAL GYRUS, immediately caudal to the OLFACTORY CORTEX of the uncus. The entorhinal cortex is the origin of the major neural fiber system afferent to the HIPPOCAMPAL FORMATION, the so-called PERFORANT PATHWAY.", "PM": "95", "HN": "95", "MR": "20210701", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018728"}, {"RECTYPE": "D", "MH": "Fontan Procedure", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Hemi-Fontan Procedure|T061|EPO|NRW|NLM (1999)|980203|abcdef", "ENTRY": "Shunt, Bidirectional Cavopulmonary", "MN": "E04.928.220.560.500", "MH_TH": "NLM (1995)", "ST": "T061", "PI": "Heart Defects, Congenital/surgery (1977-1994)", "MS": "A procedure in which total right atrial or total caval blood flow is channeled directly into the pulmonary artery or into a small right ventricle that serves only as a conduit. The principal congenital malformations for which this operation is useful are TRICUSPID ATRESIA and single ventricle with pulmonary stenosis.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190222", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018729"}, {"RECTYPE": "D", "MH": "Infant Behavior", "AQ": "CL DE EH ES PH PX RE", "PRINT ENTRY": "Behavior, Infant|T055|NON|EQV|NLM (1995)|940208|abcdef", "MN": "F01.145.179.500", "MH_TH": "NLM (1995)", "ST": "T055", "AN": "check also tag INFANT or INFANT, NEWBORN but see note there", "PI": "specific infant heading (1967-1994)", "MS": "Any observable response or action of a neonate or infant up through the age of 23 months.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20020702", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018730"}, {"RECTYPE": "D", "MH": "Forensic Anthropology", "DE": "FORENSIC ANTHROPOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Human Identification|T060|NON|NRW|NLM (1995)|940209|abcdef", "ENTRY": "Identifications, Human", "MN": "I01.198.780.750", "MH_TH": "NLM (1995)", "ST": "T091", "AN": "restrict to identification of skeletal remains; human identification by teeth: index FORENSIC DENTISTRY and specific dental heading ", "PI": "Forensic Medicine (1966-1994)", "MS": "Scientific study of human skeletal remains with the express purpose of identification. This includes establishing individual identity, trauma analysis, facial reconstruction, photographic superimposition, determination of time interval since death, and crime-scene recovery. Forensic anthropologists do not certify cause of death but provide data to assist in determination of probable cause. This is a branch of the field of physical anthropology and qualified individuals are certified by the American Board of Forensic Anthropology. (From Am J Forensic Med Pathol 1992 Jun;13(2):146)", "PM": "95", "HN": "95", "MR": "20200409", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018732"}, {"RECTYPE": "D", "MH": "Nicotinic Antagonists", "DE": "NICOTINIC ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Antagonists, Nicotinic", "MN": "D27.505.696.577.120.200.700", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "PI": "Neuromuscular Blocking Agents (1975-1994)", "MS": "Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses.", "PM": "95", "HN": "95", "MR": "20180701", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018733"}, {"RECTYPE": "D", "MH": "Genes, erbB-2", "DS": "GENES ERBB 002", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "erbB-2 Genes|T028|EQV|NLM (1995)|940411|ERBB GENES 002|abdefs", "ENTRY": "neu Genes", "MN": "G05.360.340.024.340.375.500.791.295.305", "FX": "Receptor, ErbB-2", "MH_TH": "NLM (1995)", "ST": "T028", "AN": "in titles & translations spell as erbB-2; GENES, ERBB-1 is also available", "PI": "Proto-Oncogenes (1986-1994)", "MS": "The erbB-2 gene is a proto-oncogene that codes for the erbB-2 receptor (RECEPTOR, ERBB-2), a protein with structural features similar to the epidermal growth factor receptor. Its name originates from the viral oncogene homolog (v-erbB) which is a truncated form of the chicken erbB gene found in the avian erythroblastosis virus. Overexpression and amplification of the gene is associated with a significant number of adenocarcinomas. The human c-erbB-2 gene is located at 17q21.2.", "PM": "1995", "HN": "1995", "CATSH": "CAT LIST", "MR": "20180612", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018734"}, {"RECTYPE": "D", "MH": "DNA Adducts", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA Adduct|T114|T123|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Adducts, DNA", "MN": "G05.200.104", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "PI": "DNA (1976-1994)", "MS": "The products of chemical reactions that result in the addition of extraneous chemical groups to DNA.", "PM": "95", "HN": "95", "MR": "20200527", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018736"}, {"RECTYPE": "D", "MH": "Hand Strength", "AQ": "PH", "PRINT ENTRY": "Hand Grip Strength|T081|NON|EQV|NLM (2022)|210125|abcdef", "ENTRY": "Strength, Hand Grip", "MN": "G11.427.560.500", "MH_TH": "NLM (1995)", "ST": "T081", "PI": "Hand/physiology (1966-1994)", "MS": "Force exerted when gripping or grasping.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20210326", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018737"}, {"RECTYPE": "D", "MH": "Hexamethonium", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Monotartrate, Hexamethonium", "MN": "D02.675.276.558.592.500", "PA": "Nicotinic Antagonists", "EC": "analogs & derivatives:Hexamethonium Compounds", "MH_TH": "NLM (1995)", "ST": "T121", "N1": "1,6-hexanediaminium, N,N,N,N',N',N'-hexamethyl-", "RN": "3C9PSP36Z2", "RR": "TIV4Q933FU", "PI": "Hexamethonium Compounds (1980-1994)", "MS": "A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.", "OL": "use HEXAMETHONIUM (NM) to search HEXAMETHONIUM 1980-94", "PM": "95; HEXAMETHONIUM was indexed under HEXAMETHONIUM COMPOUNDS 1980-94", "HN": "95; was HEXAMETHONIUM (NM) 1980-94", "MR": "20130708", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018738"}, {"RECTYPE": "D", "MH": "Oncogene Proteins v-erbB", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-erbB Proteins|T116|EQV|NLM (1995)|940209|abdef", "ENTRY": "v erbB Proteins", "MN": "D12.776.964.775.750.883", "MH_TH": "NLM (1995)", "ST": "T116", "RN": "0", "AN": "coordinate with specific virus", "PI": "Oncogene Proteins, Viral (1988-1994)", "MS": "Transforming proteins encoded by erbB oncogenes from the avian erythroblastosis virus. The protein is a truncated form of the EGF receptor (RECEPTOR, EPIDERMAL GROWTH FACTOR) whose kinase domain is constitutively activated by deletion of the ligand-binding domain.", "OL": "use ONCOGENE PROTEINS V-ERBB (NM) to search ONCOGENE PROTEINS ERBB 1987-94", "PM": "95; ONCOGENE PROTEINS ERBB was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-94 & VIRAL PROTEINS 1987-89", "HN": "95; was ONCOGENE PROTEINS ERBB (NM) 1987-94", "MR": "20050630", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018739"}, {"RECTYPE": "D", "MH": "Genetic Heterogeneity", "DE": "GENET HETEROGENEITY", "AQ": "DE HI RE", "ENTRY": "Heterogeneities, Genetic", "MN": "G05.365.331", "MH_TH": "NLM (1995)", "ST": "T032", "MS": "The presence of apparently similar characters for which the genetic evidence indicates that different genes or different genetic mechanisms are involved in different pedigrees. In clinical settings genetic heterogeneity refers to the presence of a variety of genetic defects which cause the same disease, often due to mutations at different loci on the same gene, a finding common to many human diseases including ALZHEIMER DISEASE; CYSTIC FIBROSIS; LIPOPROTEIN LIPASE DEFICIENCY, FAMILIAL; and POLYCYSTIC KIDNEY DISEASES. (Rieger, et al., Glossary of Genetics: Classical and Molecular, 5th ed; Segen, Dictionary of Modern Medicine, 1992)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018740"}, {"RECTYPE": "D", "MH": "Replication Origin", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "ori Region|T114|T123|NON|EQV|NLM (1995)|940309|abbcdef", "ENTRY": "ori Regions", "MN": "G05.360.340.024.745.725", "MH_TH": "NLM (1995)", "ST": "T123", "PI": "DNA Replication (1969-1994)", "MS": "A unique DNA sequence of a replicon at which DNA REPLICATION is initiated and proceeds bidirectionally or unidirectionally. It contains the sites where the first separation of the complementary strands occurs, a primer RNA is synthesized, and the switch from primer RNA to DNA synthesis takes place. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018741"}, {"RECTYPE": "D", "MH": "DNA, Chloroplast", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chloroplast DNA|T114|EQV|NLM (1995)|940210|abdef", "ENTRY": "DNAs, Chloroplast", "MN": "D13.444.308.435.275", "FX": "Genes, Chloroplast", "MH_TH": "NLM (1995)", "ST": "T114", "RN": "0", "AN": "IM; coord with PLANTS; ALGAE; or specific plant or alga IM; /drug eff /ultrastruct permitted", "PI": "DNA (1966-1994)", "MS": "Deoxyribonucleic acid that makes up the genetic material of CHLOROPLASTS.", "PM": "95", "HN": "95", "MR": "20110624", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018742"}, {"RECTYPE": "D", "MH": "Perinatal Care", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Care, Perinatal", "MN": "N02.421.585.703", "MH_TH": "NLM (1995)", "ST": "T058", "AN": "from 28th wk of pregn through 7 days after birth; care of fetus & neonate: differentiate from PRENATAL CARE & POSTNATAL CARE which are care of the mother; check the tags FEMALE & PREGNANCY & INFANT, NEWBORN if relevant", "MS": "The care of women and a fetus or newborn given before, during, and after delivery from the 28th week of gestation through the 7th day after delivery.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018743"}, {"RECTYPE": "D", "MH": "DNA, Plant", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Plant DNA|T114|EQV|NLM (1995)|940210|abdef", "MN": "D13.444.308.435", "MH_TH": "NLM (1995)", "ST": "T114", "RN": "0", "AN": "IM; coord with specific plant (IM or NIM); /drug eff /ultrastruct permitted", "PI": "specific plant (1966-1994)", "MS": "Deoxyribonucleic acid that makes up the genetic material of plants.", "PM": "95", "HN": "95", "MR": "19950608", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018744"}, {"RECTYPE": "D", "MH": "Genome, Plant", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Plant Genome|T028|NON|EQV|NLM (1995)|940210|abcdef", "ENTRY": "Plant Genomes", "MN": "G05.360.340.365", "FX": "Genes, Plant", "MH_TH": "NLM (1995)", "ST": "T028", "AN": "coordinate IM with specific plant /genet (IM)", "PI": "specific plant (1973-1994)", "MS": "The genetic complement of a plant (PLANTS) as represented in its DNA.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018745"}, {"RECTYPE": "D", "MH": "Systemic Inflammatory Response Syndrome", "DE": "SYSTEMIC INFLAMM RESPONSE SYNDROME", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Sepsis Syndrome|T047|NON|EQV|NLM (1995)|990101|abcdef", "ENTRY": "Syndromes, Sepsis", "MN": "C23.550.835.900", "FX": "Sepsis-Associated Encephalopathy", "MH_TH": "NLM (1995)", "ST": "T047", "MS": "A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever >38 degrees C or HYPOTHERMIA <36 degrees C; (2) TACHYCARDIA >90 beat/minute; (3) tachypnea >24 breaths/minute; (4) LEUKOCYTOSIS >12,000 cells/cubic mm or 10% immature forms. While usually related to infection, SIRS can also be associated with noninfectious insults such as TRAUMA; BURNS; or PANCREATITIS. If infection is involved, a patient with SIRS is said to have SEPSIS.", "PM": "2007; see SEPSIS SYNDROME 1995-2006", "HN": "2007 (1995)", "CATSH": "CAT LIST", "MR": "20200713", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018746"}, {"RECTYPE": "D", "MH": "RNA, Chloroplast", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chloroplast RNA|T114|EQV|NLM (1995)|940210|abdef", "MN": "D13.444.735.635.575", "MH_TH": "NLM (1995)", "ST": "T114", "RN": "0", "PI": "RNA (1966-1994)", "MS": "Ribonucleic acid in chloroplasts having regulatory and catalytic roles as well as involvement in protein synthesis.", "PM": "95", "HN": "95", "MR": "20150629", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018747"}, {"RECTYPE": "D", "MH": "RNA, Plant", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Plant RNA|T114|EQV|NLM (1995)|940210|abdef", "MN": "D13.444.735.635", "MH_TH": "NLM (1995)", "ST": "T114", "RN": "0", "AN": "IM; coord with specific plant (IM or NIM); /drug eff /ultrastruct permitted", "PI": "specific plant (1966-1994)", "MS": "Ribonucleic acid in plants having regulatory and catalytic roles as well as involvement in protein synthesis.", "PM": "95", "HN": "95", "MR": "19950608", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018749"}, {"RECTYPE": "D", "MH": "6-Cyano-7-nitroquinoxaline-2,3-dione", "DS": "CYANONITROQUINOXALINEDIONE 06 07 02 03", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "CNQX|T109|T121|ABB|EQV|FDA SRS (2014)|NLM (1995)|940210|abbcdeef", "ENTRY": "FG9065", "MN": "D03.633.100.857.160", "PA": "Excitatory Amino Acid Antagonists", "MH_TH": "NLM (1995)", "ST": "T121", "N1": "6-Quinoxalinecarbonitrile, 1,2,3,4-tetrahydro-7-nitro-2,3-dioxo-", "RN": "6OTE87SCCW", "RR": "128129-45-3 (1,4-dihydro-2,3-dihydroxy-7-nitro-6-quinoxalinecarbonitrile)", "MS": "A potent excitatory amino acid antagonist with a preference for non-NMDA iontropic receptors. It is used primarily as a research tool.", "OL": "use 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE (NM) to search FG 9065 1988-94", "PM": "95; FG 9065 was indexed under QUINOXALINES 1988-94", "HN": "95; was FG 9065 (NM) 1988-94", "MR": "20160527", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018750"}, {"RECTYPE": "D", "MH": "Diet, Fat-Restricted", "AQ": "AE CL EC EH HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Fat-Restricted Diet|T061|NON|EQV|NLM (1995)|940405|abcdef", "ENTRY": "Low-Fat Diets", "MN": "G07.203.650.240.260", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "IM; coord with dis /diet ther (IM)", "PI": "Dietary Fats (1966-1994)", "MS": "A diet that contains limited amounts of fat with less than 30% of calories from all fats and less than 10% from saturated fat. Such a diet is used in control of HYPERLIPIDEMIAS. (From Bondy et al, Metabolic Control and Disease, 8th ed, pp468-70; Dorland, 27th ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018752"}, {"RECTYPE": "D", "MH": "Diet, Protein-Restricted", "AQ": "AE CL EC EH HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Protein-Restricted Diet|T061|NON|EQV|NLM (1995)|940210|abcdef", "ENTRY": "Protein-Restricted Diets", "MN": "G07.203.650.240.280", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "IM; coord with dis /diet ther (IM)", "PI": "Dietary Proteins (1966-1994)", "MS": "A diet that contains limited amounts of protein. It is prescribed in some cases to slow the progression of renal failure. (From Segen, Dictionary of Modern Medicine, 1992)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018753"}, {"RECTYPE": "D", "MH": "Ventricular Dysfunction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ventricular Dysfunctions", "MN": "C14.280.945", "MH_TH": "NLM (1995)", "ST": "T046", "AN": "general or unspecified: prefer VENTRICULAR DYSFUNCTION, LEFT or VENTRICULAR DYSFUNCTION, RIGHT", "MS": "A condition in which HEART VENTRICLES exhibit impaired function.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19940228", "DC": "1", "DX": "19950101", "UI": "D018754"}, {"RECTYPE": "D", "MH": "GABA Agonists", "DE": "GABA AG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "gamma-Aminobutyric Acid Agonists|T121|NON|EQV|NLM (1995)|940214|GAMMA AMINOBUTYRIC ACID AG|abcdefv", "ENTRY": "gamma Aminobutyric Acid Agonists", "MN": "D27.505.696.577.240.200", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "note specifics; do not confuse with GABA ANTAGONISTS", "MS": "Endogenous compounds and drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors (RECEPTORS, GABA).", "PM": "95", "HN": "95", "MR": "20100625", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018755"}, {"RECTYPE": "D", "MH": "GABA Antagonists", "DE": "GABA ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "gamma-Aminobutyric Acid Antagonists|T121|NON|EQV|NLM (1995)|940214|GAMMA AMINOBUTYRIC ACID ANTAG|abcdefv", "ENTRY": "gamma Aminobutyric Acid Antagonists", "MN": "D27.505.696.577.240.300", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "note specifics; do not confuse with GABA AGONISTS", "PI": "GABA/antagonists & inhibitors (1974-1994)", "MS": "Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS.", "PM": "95", "HN": "95", "MR": "20100625", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018756"}, {"RECTYPE": "D", "MH": "GABA Modulators", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "gamma-Aminobutyric Acid Modulators|T121|NON|EQV|NLM (1995)|940513|abcdef", "ENTRY": "gamma Aminobutyric Acid Modulators", "MN": "D27.505.696.577.240.500", "FX": "Hypnotics and Sedatives", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here.", "PM": "95", "HN": "95", "MR": "20050630", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018757"}, {"RECTYPE": "D", "MH": "Stimulants, Historical", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tonics, Historical|T121|NON|NRW|NLM (2009)|080214|abcdef", "ENTRY": "Historical Tonics", "MN": "D27.505.954.888", "MH_TH": "NLM (2007)", "ST": "T121", "RN": "0", "AN": "historical articles & historical contexts only: do not confuse with CNS, ganglionic or cardiac stimulants; do not confuse entry term Tonics, Historical with CARDIOTONIC AGENTS", "MS": "Agents or remedies that historically have produced stimulation or excited functional activity.", "PM": "2007; see STIMULANTS (HISTORICAL) 1995-2006", "HN": "2007 (1995)", "MR": "20080708", "DA": "19940419", "DC": "1", "DX": "19950101", "UI": "D018758"}, {"RECTYPE": "D", "MH": "Adrenergic Uptake Inhibitors", "DE": "ADREN UPTAKE INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adrenergic Reuptake Inhibitors|T121|NON|EQV|NLM (1995)|940214|ADREN REUPTAKE INHIB|abcdefv", "ENTRY": "Uptake Inhibitors, Adrenergic|T121|NON|EQV|NLM (1995)|940531|UPTAKE INHIB ADREN|abcdefv", "MN": "D27.505.696.577.600.050", "FX": "Dopamine Uptake Inhibitors", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "MS": "Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.", "PM": "95", "HN": "95", "MR": "20140625", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018759"}, {"RECTYPE": "D", "MH": "Multiple Endocrine Neoplasia Type 1", "DE": "MULTIPLE ENDOCRINE NEOPL TYPE 1", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Wermer Syndrome|T191|EPO|EQV|NLM (1995)|ORD (2010)|940215|abcdeef", "ENTRY": "Neoplasms, Multiple Endocrine Type I|T191|NON|EQV|NLM (1995)|940215|abcdef", "MN": "C19.344.400.500", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with specific endocrine/neoplasm pre-coordinates (IM) + specific histological type (IM) if pertinent", "PI": "Multiple Endocrine Neoplasia (1972-1994)", "MS": "A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13).", "OL": "use MULTIPLE ENDOCRINE NEOPLASIA to search MEA I, MEN I, & WERMER SYNDROME 1983-94", "PM": "95; MEA I, MEN I, & WERMER SYNDROME were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94", "HN": "95; MEA I, MEN I, & WERMER SYNDROME were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018761"}, {"RECTYPE": "D", "MH": "Muscle Fatigue", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Fatigue, Muscle|T042|NON|EQV|NLM (1995)|940216|abcdef", "ENTRY": "Fatigue, Muscular", "MN": "G11.427.550", "MH_TH": "NLM (1995)", "ST": "T042", "AN": "note category", "PI": "specific muscle (1966-1994)", "MS": "A state arrived at through prolonged and strong contraction of a muscle. Studies in athletes during prolonged submaximal exercise have shown that muscle fatigue increases in almost direct proportion to the rate of muscle glycogen depletion. Muscle fatigue in short-term maximal exercise is associated with oxygen lack and an increased level of blood and muscle lactic acid, and an accompanying increase in hydrogen-ion concentration in the exercised muscle.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018763"}, {"RECTYPE": "D", "MH": "Dopamine Uptake Inhibitors", "DE": "DOPAMINE UPTAKE INHIB", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dopamine Reuptake Inhibitors|T121|NON|EQV|NLM (1995)|940531|DOPAMINE REUPTAKE INHIB|abcdefv", "ENTRY": "Uptake Inhibitors, Dopamine|T121|NON|EQV|NLM (1995)|940321|UPTAKE INHIB DOPAMINE|abcdefv", "MN": "D27.505.696.577.600.220", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "PI": "Neurotransmitter Uptake Inhibitors (1985-1994)", "MS": "Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.", "PM": "95", "HN": "95", "MR": "20050630", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018765"}, {"RECTYPE": "D", "MH": "Arthralgia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polyarthralgia|T047|NON|REL|NLM (1995)|940301|abcdef", "ENTRY": "Polyarthralgias", "MN": "G11.561.790.444.350", "MH_TH": "NLM (1995)", "ST": "T184", "AN": "non-inflamm joint pain: do not confuse with ARTHRITIS which is inflamm; term used more in foreign lit than in Amer; coord IM with specific joint (IM)", "PI": "Pain (1967-1994)", "MS": "Pain in the joint.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018771"}, {"RECTYPE": "D", "MH": "Dental Marginal Adaptation", "AQ": "CL ST", "PRINT ENTRY": "Marginal Adaptation, Dental|T061|NON|EQV|NLM (1995)|940301|MARGINAL ADAPTATION DENT|abcdefv", "ENTRY": "Marginal Adaptations, Dental", "MN": "E06.780.620", "MH_TH": "NLM (2010)", "ST": "T061", "PI": "Dental Restoration, Permanent (1967-1994)", "MS": "The degree of approximation or fit of filling material or dental prosthetic to the tooth surface. A close marginal adaptation and seal at the interface is important for successful dental restorations.", "PM": "1995", "HN": "1995", "CATSH": "CAT LIST", "MR": "20230705", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018772"}, {"RECTYPE": "D", "MH": "Genes, erbB-1", "DS": "GENES ERBB 001", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "v-erbB Genes|T028|NRW|NLM (1995)|940404|abdef", "ENTRY": "v-erbB Oncogene", "MN": "G05.360.340.024.340.375.500.791.295.300", "FX": "Oncogene Proteins v-erbB", "MH_TH": "NLM (1995)", "ST": "T028", "AN": "spell in titles & translations as erbB-1; GENES, ERBB-2 is also available", "PI": "Proto-Oncogenes (1985-1994)", "MS": "The proto-oncogene c-erbB-1 codes for the epidermal growth factor receptor. Its name originates from the viral homolog v-erbB which was isolated from an avian erythroblastosis virus (AEV) where it was contained as a fragment of the chicken c-ErbB-1 gene lacking the amino-terminal ligand-binding domain. Overexpression of erbB-1 genes occurs in a wide range of tumors, commonly squamous carcinomas of various sites and less commonly adenocarcinomas. The human c-erbB-1 gene is located in the chromosomal region 7p14 and 7p12.", "PM": "1995", "HN": "1995", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018773"}, {"RECTYPE": "D", "MH": "Oncogene Proteins v-erbA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-erbA Proteins|T116|EQV|NLM (1995)|940301|abdef", "ENTRY": "v erbA Proteins", "MN": "D12.776.964.775.750.882", "MH_TH": "NLM (1995)", "ST": "T116", "RN": "0", "PI": "Retroviridae Proteins, Oncogenic (1990-1994)", "MS": "Transforming proteins encoded by erbA oncogenes from the avian erythroblastosis virus. They are truncated versions of c-erbA, the thyroid hormone receptor (RECEPTORS, THYROID HORMONE) that have retained both the DNA-binding and hormone-binding domains. Mutations in the hormone-binding domains abolish the transcriptional activation function. v-erbA acts as a dominant repressor of c-erbA, inducing transformation by disinhibiting proliferation.", "OL": "use ONCOGENE PROTEINS V-ERBA (NM) to search ONCOGENE PROTEIN ERBA 1987-94", "PM": "95; ONCOGENE PROTEIN ERBA was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-94 & RETROVIRIDAE PROTEINS 1987-89", "HN": "95; was ONCOGENE PROTEIN ERBA (NM) 1987-94", "MR": "20180701", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018774"}, {"RECTYPE": "D", "MH": "Bone Demineralization Technique", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Techniques, Bone Demineralization", "MN": "E05.118", "MH_TH": "NLM (1995)", "ST": "T059", "AN": "a histol technique; do not confuse with BONE DEMINERALIZATION, PATHOLOGIC, a metab bone dis", "MS": "Removal of mineral constituents or salts from bone or bone tissue. Demineralization is used as a method of studying bone strength and bone chemistry.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018775"}, {"RECTYPE": "D", "MH": "Genes, erbA", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "v-erbA Genes|T028|NRW|NLM (1995)|940404|abdef", "ENTRY": "v-erbA Oncogene", "MN": "G05.360.340.024.340.375.500.791.290", "FX": "Receptors, Thyroid Hormone", "MH_TH": "NLM (1995)", "ST": "T028", "AN": "erbA stands for \"ERythroBlastosis virus, Avian\"; GENES, ERBB & its specifics are also available; in titles & translations spell as erbA", "PI": "Proto-Oncogenes (1987-1994)", "MS": "Genes related to the erbA DNA sequence that was first isolated from the avian erythroblastosis virus (ERYTHROBLASTOSIS VIRUS, AVIAN), v-erbA. In cells, erbA genes encode thyroid hormone receptors (RECEPTORS, THYROID HORMONE). Two distinct c-erbA genes have been identified: erbA-alpha located at 17q21; and erbA-beta located at 3p24. Truncations at the N- and C-terminals of erbA result in products resembling v-erbA. Truncations affect hormone responsiveness but not DNA binding capacity.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018776"}, {"RECTYPE": "D", "MH": "Multiple Chemical Sensitivity", "DE": "MULTIPLE CHEM SENSITIVITY", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Idiopathic Environmental Intolerances|T047|NON|EQV|NLM (2003)|020312|IDIOPATHIC ENVIR INTOLERANCES|abcdefv", "ENTRY": "Intolerances, Idiopathic Environmental", "MN": "C21.223.500", "FX": "Persian Gulf Syndrome", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "coord IM with specific chemical IM or NIM if discussed", "PI": "Occupational Diseases (1987-1994)", "MS": "An acquired disorder characterized by recurrent symptoms, referable to multiple organ systems, occurring in response to demonstrable exposure to many chemically unrelated compounds at doses below those established in the general population to cause harmful effects. (Cullen MR. The worker with multiple chemical sensitivities: an overview. Occup Med 1987;2(4):655-61)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018777"}, {"RECTYPE": "D", "MH": "Hantavirus Infections", "DE": "HANTAVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Orthohantavirus Infections|T047|NON|EQV|NLM (2023)|220712|abcdef", "ENTRY": "Orthohantavirus Infection", "MN": "C01.925.782.147.420", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Bunyaviridae Infections (1984-1994)", "MS": "Infections with viruses of the genus ORTHOHANTAVIRUS. This is associated with at least four clinical syndromes: HEMORRHAGIC FEVER WITH RENAL SYNDROME caused by viruses of the Hantaan group; a milder form of HFRS caused by SEOUL VIRUS; nephropathia epidemica caused by PUUMALA VIRUS; and HANTAVIRUS PULMONARY SYNDROME caused by SIN NOMBRE VIRUS.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20220715", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018778"}, {"RECTYPE": "D", "MH": "Body Surface Potential Mapping", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Body Surface Mapping|T060|NON|EQV|NLM (1995)|940308|abcdef", "ENTRY": "Surface Mappings, Body", "MN": "E01.370.405.240.850.100", "MH_TH": "NLM (1995)", "ST": "T060", "AN": "an ECG & vectorcardiogr technique: do not confuse with BODY SURFACE AREA, an anthropometric method", "PI": "Vectorcardiography (1978-1994)", "MS": "Recording of regional electrophysiological information by analysis of surface potentials to give a complete picture of the effects of the currents from the heart on the body surface. It has been applied to the diagnosis of old inferior myocardial infarction, localization of the bypass pathway in Wolff-Parkinson-White syndrome, recognition of ventricular hypertrophy, estimation of the size of a myocardial infarct, and the effects of different interventions designed to reduce infarct size. The limiting factor at present is the complexity of the recording and analysis, which requires 100 or more electrodes, sophisticated instrumentation, and dedicated personnel. (Braunwald, Heart Disease, 4th ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018780"}, {"RECTYPE": "D", "MH": "Tension-Type Headache", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tension-Vascular Headache|T047|NON|REL|NLM (2000)|991103|abcdef", "ENTRY": "Tension-Vascular Headaches", "MN": "C10.228.140.546.399.875", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Headache (1966-1994)", "MS": "A common primary headache disorder, characterized by a dull, non-pulsatile, diffuse, band-like (or vice-like) PAIN of mild to moderate intensity in the HEAD; SCALP; or NECK. The subtypes are classified by frequency and severity of symptoms. There is no clear cause even though it has been associated with MUSCLE CONTRACTION and stress. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)", "PM": "2006; see TENSION HEADACHE 1995-2005", "HN": "2006 (1995)", "CATSH": "CAT LIST", "MR": "20080710", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018781"}, {"RECTYPE": "D", "MH": "Maze Learning", "AQ": "DE PH RE", "ENTRY": "Maze Tests", "MN": "F02.463.425.874.500", "MH_TH": "NLM (1995)", "ST": "T041", "PI": "Learning (1966-1994)", "MS": "Learning the correct route through a maze to obtain reinforcement. It is used for human or animal populations. (Thesaurus of Psychological Index Terms, 6th ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20200225", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018782"}, {"RECTYPE": "D", "MH": "Impotence, Vasculogenic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Venous Leakage, Penile|T047|NON|NRW|NLM (1995)|940308|abcdef", "ENTRY": "Venogenic Impotence", "MN": "C12.200.294.214.500", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Penis/blood supply (1985-1994)", "MS": "Inability to achieve and maintain an erection (ERECTILE DYSFUNCTION) due to defects in the arterial blood flow to the PENIS, defect in venous occlusive function allowing blood drainage (leakage) from the erectile tissue (corpus cavernosum penis), or both.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018783"}, {"RECTYPE": "D", "MH": "Abdominal Abscess", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Abscess, Intra-Abdominal|T047|NON|EQV|NLM (1995)|940308|abcdef", "ENTRY": "Intra-Abdominal Abscesses", "MN": "C01.830.025.020", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "for coordination see note on ABSCESS ", "PI": "Abscess (1966-1994)", "MS": "An abscess located in the abdominal cavity, i.e., the cavity between the diaphragm above and the pelvis below. (From Dorland, 27th ed)", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018784"}, {"RECTYPE": "D", "MH": "Tricuspid Atresia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tricuspid Valve Atresia|T019|NON|EQV|NLM (1995)|940311|abcdef", "ENTRY": "Valve Atresias, Tricuspid", "MN": "C16.131.240.400.920", "FX": "Fontan Procedure", "MH_TH": "ORD (2010)", "ST": "T019", "PI": "Tricuspid Valve/abnormalities (1966-1994)", "MS": "Absence of the orifice between the RIGHT ATRIUM and RIGHT VENTRICLE, with the presence of an atrial defect through which all the systemic venous return reaches the left heart. As a result, there is left ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR) because the right ventricle is absent or not functional.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018785"}, {"RECTYPE": "D", "MH": "Bone Substitutes", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Bone Replacement Materials|T122|NON|EQV|NLM (1995)|940310|abcdef", "ENTRY": "Substitute, Bone", "MN": "J01.637.051.130.325", "MH_TH": "NLM (1995)", "ST": "T122", "RN": "0", "AN": "IM; coord with specific bone (IM) if relevant + substitute material (IM) if significant", "MS": "Synthetic or natural materials for the replacement of bones or bone tissue. They include hard tissue replacement polymers, natural coral, hydroxyapatite, beta-tricalcium phosphate, and various other biomaterials. The bone substitutes as inert materials can be incorporated into surrounding tissue or gradually replaced by original tissue.", "PM": "95", "HN": "95", "MR": "20060705", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018786"}, {"RECTYPE": "D", "MH": "Radiation Oncology", "DE": "RAD ONCOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Therapeutic Radiology|T091|NON|NRW|NLM (1995)|940310|THER RADIOL|abcdefv", "MN": "H02.403.740.650", "MH_TH": "NLM (1995)", "ST": "T091", "AN": "do not confuse entry term THERAPEUTIC RADIOLOGY (a specialty) with RADIOTHERAPY (a therapeutic technique)", "PI": "Neoplasms/radiotherapy (1975-1994)", "MS": "A subspecialty of medical oncology and radiology concerned with the radiotherapy of cancer.", "PM": "95", "HN": "95", "MR": "20090706", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018787"}, {"RECTYPE": "D", "MH": "Radioactive Hazard Release", "AQ": "CL EC HI LJ MO PC PX SN TD", "PRINT ENTRY": "Radiation Accidents|T068|NON|NRW|NLM (1995)|940310|RAD ACCIDENTS|abcdefv", "ENTRY": "Releases, Radioactive Hazard", "MN": "N06.850.135.848", "FX": "Radiation Injuries", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "for release resulting in disaster, coordinate with DISASTERS; for deliberate release of radioactive material, coordinate RADIOACTIVE HAZARD RELEASE with TERRORISM; specify geographic location; note entry term ACCIDENTS, RADIATION: do not index here for radiation injuries during radiotherapy or radiodiagnosis: index under specific radiotherapy or radiodiagnosis heading + RADIATION INJURIES", "PI": "Radiation Injuries (1966-1994)", "MS": "Uncontrolled release of radioactive material from its containment. This either threatens to, or does, cause exposure to a radioactive hazard. Such an incident may occur accidentally or deliberately.", "PM": "2009; see Accidents, Radiation 1995-2008", "HN": "2009(1995)", "MR": "20130709", "DA": "19940630", "DC": "1", "DX": "19950101", "UI": "D018788"}, {"RECTYPE": "D", "MH": "CD4 Lymphocyte Count", "DS": "CD 004 LYMPHOCYTE COUNT", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "T4 Lymphocyte Count|T059|EQV|NLM (1995)|940331|LYMPHOCYTE COUNT T 004|abdefs", "ENTRY": "T4 Lymphocyte Counts", "MN": "G09.188.105.595.500.150", "MH_TH": "NLM (1995)", "ST": "T059", "AN": "usually NIM; coord with disease /immunol, not /physiopathol", "PI": "Leukocyte Count (1988-1994)", "MS": "The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018791"}, {"RECTYPE": "D", "MH": "Encephalitis, Viral", "DE": "ENCEPH VIRAL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Viral Encephalitis|T047|NON|EQV|NLM (1995)|940316|VIRAL ENCEPH|abcdefv", "ENTRY": "Viral Infectious Encephalomyelitis", "MN": "C10.586.250.520.750", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "coordinate IM with specific virus infection term (IM)", "PI": "Encephalitis (1966-1994)", "MS": "Inflammation of brain parenchymal tissue as a result of viral infection. Encephalitis may occur as primary or secondary manifestation of TOGAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; BUNYAVIRIDAE INFECTIONS; PICORNAVIRIDAE INFECTIONS; PARAMYXOVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RETROVIRIDAE INFECTIONS; and ARENAVIRIDAE INFECTIONS.", "PM": "1995", "HN": "1995", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018792"}, {"RECTYPE": "D", "MH": "Interleukin-13", "DS": "INTERLEUKIN 013", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "IL-13|T116|T129|ABB|EQV|NLM (1995)|940317|IL 013|abbcdefs", "ENTRY": "Interleukin 13|T116|T129|NON|EQV|NLM (1995)|940412|abbcdef", "MN": "D23.529.374.465.513", "MH_TH": "NLM (1995)", "ST": "T129", "RN": "0", "PI": "Interleukins (1993-1994)", "MS": "A cytokine synthesized by T-LYMPHOCYTES that produces proliferation, immunoglobulin isotype switching, and immunoglobulin production by immature B-LYMPHOCYTES. It appears to play a role in regulating inflammatory and immune responses.", "OL": "use INTERLEUKIN-13 (NM) to search INTERLEUKIN 13 1993-94", "PM": "95; INTERLEUKIN 13 was indexed under INTERLEUKINS 1993-94", "HN": "95; was INTERLEUKIN 13 (NM) 1993-94", "MR": "20060705", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018793"}, {"RECTYPE": "D", "MH": "Problem-Based Learning", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Experiential Learning|T065|NON|REL|NLM (1995)|940318|abcdef", "ENTRY": "Problem-Based Curriculum", "MN": "I02.903.565", "MH_TH": "NLM (1995)", "ST": "T065", "AN": "a teaching method in the curriculum: do not confuse with PROBLEM SOLVING, a type of learning", "PI": "Teaching (1975-1994)", "MS": "Instructional use of examples or cases to teach using problem-solving skills and critical thinking.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20050727", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018794"}, {"RECTYPE": "D", "MH": "Device Approval", "AQ": "LJ ST", "PRINT ENTRY": "New Device Approval|T064|NON|NRW|NLM (1995)|940318|abcdef", "ENTRY": "Processes, Device Approval", "MN": "N06.850.210.275", "MH_TH": "NLM (1995)", "ST": "T064", "AN": "by a govt regulatory agency, not restricted to FDA", "PI": "Consumer Product Safety (1966-1994)", "MS": "Process that is gone through in order for a device to receive approval by a government regulatory agency. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance. It is not restricted to FDA.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018795"}, {"RECTYPE": "D", "MH": "Immunoconjugates", "AQ": "AD AE AN BL CF CH CL DE EC GE HI IM IP ME PD PK PO RE TO TU UL UR", "PRINT ENTRY": "Radioimmunoconjugates|T121|T129|NON|NRW|NLM (1995)|940318|abbcdef", "ENTRY": "Drug Conjugate, Antibody", "MN": "D27.505.696.477.266", "MH_TH": "NLM (1995)", "ST": "T129", "RN": "0", "PI": "Immunotoxins (1987-1994)", "MS": "Combinations of diagnostic or therapeutic substances linked with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; or ANTIGENS. Often the diagnostic or therapeutic substance is a radionuclide. These conjugates are useful tools for specific targeting of DRUGS and RADIOISOTOPES in the CHEMOTHERAPY and RADIOIMMUNOTHERAPY of certain cancers.", "PM": "95", "HN": "95", "MR": "20210630", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018796"}, {"RECTYPE": "D", "MH": "Cell Cycle Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "cdc Proteins|T116|T123|EQV|NLM (1995)|940321|abbdef", "ENTRY": "Cell Cycle Regulatory Proteins", "MN": "D12.776.167", "FX": "Protein Kinases", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "PI": "Cell Division (1966-1994)", "MS": "Proteins that control the CELL DIVISION CYCLE. This family of proteins includes a wide variety of classes, including CYCLIN-DEPENDENT KINASES, mitogen-activated kinases, CYCLINS, and PHOSPHOPROTEIN PHOSPHATASES as well as their putative substrates such as chromatin-associated proteins, CYTOSKELETAL PROTEINS, and TRANSCRIPTION FACTORS.", "PM": "95", "HN": "95", "MR": "20110624", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018797"}, {"RECTYPE": "D", "MH": "Anemia, Iron-Deficiency", "DE": "ANEMIA IRON DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Iron-Deficiency Anemia|T047|NON|EQV|NLM (1995)|940321|IRON DEFIC ANEMIA|abcdefv", "ENTRY": "Iron Deficiency Anemias", "MN": "C18.452.565.400.500", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Anemia, Hypochromic (1966-1994)", "MS": "Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.", "OL": "use ANEMIA, HYPOCHROMIC to search IRON DEFICIENCY ANEMIA 1970-94", "PM": "95; IRON DEFICIENCY ANEMIA was see ANEMIA, HYPOCHROMIC 1970-94", "HN": "95; IRON DEFICIENCY ANEMIA was see ANEMIA, HYPOCHROMIC 1970-94", "CATSH": "CAT LIST", "MR": "20230226", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018798"}, {"RECTYPE": "D", "MH": "Intercellular Adhesion Molecule-1", "DS": "INTERCELLULAR ADHESION MOLECULE 001", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "ICAM-1|T116|T129|ABB|EQV|NLM (1995)|940322|ICAM 001|abbcdefs", "ENTRY": "Intercellular Adhesion Molecule 1", "MN": "D23.050.301.350.450", "MH_TH": "NLM (1995)", "ST": "T129", "N1": "Glycoprotein ICAM 1 (human clone pHRVr1 deblocked protein moiety reduced)", "RN": "126547-89-5", "PI": "Cell Adhesion Molecules (1989-1994)", "MS": "A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue.", "PM": "1995; INTERCELLULAR ADHESION MOLECULE-1 was indexed under CELL ADHESION MOLECULES 1989-94", "HN": "1995; use INTERCELLULAR ADHESION MOLECULE 1 1989-94", "MR": "20230316", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018799"}, {"RECTYPE": "D", "MH": "Thy-1 Antigens", "DS": "THY ANTIGENS 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD90 Antigens|T116|T129|EQV|NLM (1996)|950126|CD 090 ANTIGENS|abbdefs", "ENTRY": "Thy 1.2 Antigen", "MN": "D23.101.100.894.123", "MH_TH": "NLM (1995)", "ST": "T129", "RN": "0", "PI": "Membrane Proteins (1979-1982)", "MS": "A group of differentiation surface antigens, among the first to be discovered on thymocytes and T-lymphocytes. Originally identified in the mouse, they are also found in other species including humans, and are expressed on brain neurons and other cells.", "PM": "2018; see ANTIGENS, THY-1 1995-2017 and THY-1 ANTIGEN 1979-94; THY-1 ANTIGENS was indexed under MEMBRANE GLYCOPROTEINS 1983-94; under ANTIGENS, SURFACE 1981-94; under MEMBRANE PROTEINS 1979-82; and under ANTIGENS 1979-80", "HN": "2018 (1995)", "MR": "20230316", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018800"}, {"RECTYPE": "D", "MH": "CD2 Antigens", "DS": "CD 002 ANTIGENS", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "T11 Erythrocyte-Binding Glycoprotein|T116|T129|T192|EQV|NLM (1995)|940328|T AAG ERYTHROCYTE BINDING GLYCOPROTEIN 011|abbbdefs", "ENTRY": "T11 Erythrocyte Binding Glycoprotein", "MN": "D23.101.100.894.090", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (1995)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1989-1994)", "MS": "Glycoprotein members of the immunoglobulin superfamily which participate in T-cell adhesion and activation. They are expressed on most peripheral T-lymphocytes, natural killer cells, and thymocytes, and function as co-receptors or accessory molecules in the T-cell receptor complex.", "PM": "2018; see ANTIGENS, CD2 1995-2017; CD2 ANTIGENS was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE and RECEPTORS, IMMUNOLOGIC 1989-94; under ANTIGENS, DIFFERENTIATION 1988; and under CARRIER PROTEINS 1985-88", "HN": "2018 (1985); use T11 ERYTHROCYTE-BINDING GLYCOPROTEIN 1985-94", "MR": "20170602", "DA": "19940527", "DC": "1", "DX": "19950101", "UI": "D018801"}, {"RECTYPE": "D", "MH": "Patient-Centered Care", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Person-Centered Care|T058|NON|EQV|NLM (2022)|210321|abcdef", "ENTRY": "Person-Centered Cares", "MN": "N04.590.233.727.407", "MH_TH": "NLM (1995)", "ST": "T058", "AN": "institutional & administrative management: do not confuse with PATIENT CARE PLANNING involving individual patient", "MS": "Design of patient care wherein institutional resources and personnel are organized around patients rather than around specialized departments. (From Hospitals 1993 Feb 5;67(3):14)", "PM": "95", "HN": "95", "MR": "20210706", "DA": "19940701", "DC": "1", "DX": "19950101", "UI": "D018802"}, {"RECTYPE": "D", "MH": "Models, Economic", "DE": "MODELS ECON", "PRINT ENTRY": "Economic Models|T081|T170|NON|EQV|NLM (1995)|940323|ECON MODELS|abbcdefv", "ENTRY": "Model, Economic|T081|T170|NON|EQV|NLM (1995)|940323|MODEL ECON|abbcdefv", "MN": "N06.850.520.830.500.600", "MH_TH": "NLM (1995)", "ST": "T170", "PI": "Economics (1994)", "MS": "Statistical models of the production, distribution, and consumption of goods and services, as well as of financial considerations. For the application of statistics to the testing and quantifying of economic theories MODELS, ECONOMETRIC is available.", "OL": "use ECONOMICS to search MODELS, ECONOMIC and ECONOMIC MODELS 1994", "PM": "95; was see ECONOMICS 1994; ECONOMIC MODELS was see ECONOMICS 1994", "HN": "95; was see ECONOMICS 1994; ECONOMIC MODELS was see ECONOMICS 1994", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018803"}, {"RECTYPE": "D", "MH": "Hantavirus Pulmonary Syndrome", "DE": "HANTAVIRUS PULM SYNDROME", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Hantavirus Pulmonary Syndromes", "MN": "C08.618.846.450", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "causes resp failure", "PI": "Bunyaviridae Infections (1993-1994)", "MS": "Acute respiratory illness in humans caused by the SIN NOMBRE VIRUS whose primary rodent reservoir is the deer mouse Peromyscus maniculatus. First identified in the southwestern United States, this syndrome is characterized most commonly by fever, myalgias, headache, cough, and rapid respiratory failure.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20190529", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018804"}, {"RECTYPE": "D", "MH": "Sepsis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Pyohemia|T033|T047|NON|REL|NLM (2010)|081121|abbcdef", "ENTRY": "Septicemias", "MN": "C23.550.470.790.500", "MH_TH": "NLM (1995)", "ST": "T047", "AN": "SEPSIS SYNDROME see SYSTEMIC INFLAMMATORY RESPONSE SYNDROME is also available", "PI": "specific infection (1966-1994)", "MS": "Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.", "PM": "1995; for SEPTICEMIA see SEPTICEMIA 1966-2006", "HN": "1995", "CATSH": "CAT LIST", "MR": "20200206", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018805"}, {"RECTYPE": "D", "MH": "APACHE", "PRINT ENTRY": "Acute Physiology and Chronic Health Evaluation|T080|T081|NON|EQV|NLM (1995)|940324|ACUTE PHYSIOL CHRONIC HEALTH EVALUATION|abbcdefv", "ENTRY": "APACHE III|T080|T081|ABB|NRW|NLM (1995)|940324|abbcdef", "MN": "N06.850.520.308.980.438.475.364.500.250", "MH_TH": "NLM (1995)", "ST": "T081", "PI": "Severity of Illness Index (1986-1994)", "MS": "An acronym for Acute Physiology and Chronic Health Evaluation, a scoring system using routinely collected data and providing an accurate, objective description for a broad range of intensive care unit admissions, measuring severity of illness in critically ill patients.", "PM": "95", "HN": "95", "MR": "20170630", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018806"}, {"RECTYPE": "D", "MH": "Polymorphism, Single-Stranded Conformational", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Single-Stranded Conformational Polymorphism|T034|NON|EQV|NLM (1995)|940425|abcdef", "ENTRY": "Single-Stranded Conformational Polymorphisms", "MN": "G05.365.795.600", "MH_TH": "NLM (1995)", "ST": "T034", "AN": "POLYMORPHISM, SINGLE NUCLEOTIDE is also available", "PI": "Polymorphism (Genetics) (1990-1994)", "MS": "Variation in a population's DNA sequence that is detected by determining alterations in the conformation of denatured DNA fragments. Denatured DNA fragments are allowed to renature under conditions that prevent the formation of double-stranded DNA and allow secondary structure to form in single stranded fragments. These fragments are then run through polyacrylamide gels to detect variations in the secondary structure that is manifested as an alteration in migration through the gels.", "PM": "1995", "HN": "1995", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018807"}, {"RECTYPE": "D", "MH": "Transcription Factor AP-1", "DS": "TRANSCRIPTION FACTOR AP 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "AP-1 Enhancer-Binding Protein|T116|T123|EQV|NLM (1995)|940324|AP ENHANCER BINDING PROTEIN 001|abbdefs", "ENTRY": "Transcription Factor AP 1", "MN": "D12.776.930.127.875", "FX": "Proto-Oncogene Proteins c-jun", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1988-1994)", "MS": "A multiprotein complex composed of the products of c-jun and c-fos proto-oncogenes. These proteins must dimerize in order to bind to the AP-1 recognition site, also known as the TPA-responsive element (TRE). AP-1 controls both basal and inducible transcription of several genes.", "OL": "use PROTO-ONCOGENE PROTEINS C-JUN to search TRANSCRIPTION FACTOR, AP-1 & AP-1 ENHANCER-BINDING PROTEIN 1992-94", "PM": "95; was TRANSCRIPTION FACTOR, AP-1 see PROTO-ONCOGENE PROTEINS C-JUN 1992-94; AP-1 ENHANCER-BINDING PROTEIN was see PROTO-ONCOGENE PROTEINS C-JUN 1992-94", "HN": "95; was TRANSCRIPTION FACTOR, AP-1 see PROTO-ONCOGENE PROTEINS C-JUN 1992-94; AP-1 ENHANCER-BINDING PROTEIN was see PROTO-ONCOGENE PROTEINS C-JUN 1992-94", "MR": "20050630", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018808"}, {"RECTYPE": "D", "MH": "Proliferating Cell Nuclear Antigen", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "PCNA|T116|T123|ABB|EQV|NLM (1995)|940325|abbcdef", "MN": "D23.101.140.600", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "PI": "Nucleoproteins (1983-1987)", "MS": "Nuclear antigen with a role in DNA synthesis, DNA repair, and cell cycle progression. PCNA is required for the coordinated synthesis of both leading and lagging strands at the replication fork during DNA replication. PCNA expression correlates with the proliferation activity of several malignant and non-malignant cell types.", "OL": "use PROLIFERATING CELL NUCLEAR ANTIGEN (NM) to search PROLIFERATING CELL NUCLEAR ANTIGEN 1983-94", "PM": "95; PROLIFERATING CELL NUCLEAR ANTIGEN was indexed under NUCLEAR PROTEINS 1988-94 & NUCLEOPROTEINS 1983-87", "HN": "95; was PROLIFERATING CELL NUCLEAR ANTIGEN (NM) 1983-94", "MR": "20150619", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018809"}, {"RECTYPE": "D", "MH": "Magnetic Resonance Angiography", "DE": "MR ANGIOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "MRI Angiography|T060|EQV|NLM (1995)|940330|MRI ANGIOGR|abdefv", "ENTRY": "Magnetic Resonance Angiographies", "MN": "E01.370.370.050.500", "MH_TH": "NLM (1995)", "ST": "T060", "AN": "coordinate with disease /diag", "PI": "Nuclear Magnetic Resonance (1983-1987)", "MS": "Non-invasive method of vascular imaging and determination of internal anatomy without injection of contrast media or radiation exposure. The technique is used especially in CEREBRAL ANGIOGRAPHY as well as for studies of other vascular structures.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018810"}, {"RECTYPE": "D", "MH": "Maternal Exposure", "AQ": "AE CL EC ES HI LJ PC SN ST", "ENTRY": "Maternal Exposures", "MN": "N06.850.460.350.145", "FX": "Prenatal Exposure Delayed Effects", "MH_TH": "NLM (1995)", "ST": "T037", "AN": "restrict to exposure to environ or environ factors", "PI": "Environmental Exposure (1967-1994)", "MS": "Exposure of the female parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring. It includes pre-conception maternal exposure.", "PM": "95", "HN": "95", "MR": "20080708", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018811"}, {"RECTYPE": "D", "MH": "Paternal Exposure", "AQ": "AE CL EC ES HI LJ PC SN ST", "ENTRY": "Paternal Exposures", "MN": "N06.850.460.350.700", "FX": "Maternal Exposure", "MH_TH": "NLM (1995)", "ST": "T037", "AN": "restrict to exposure to environ or environ factors", "PI": "Environmental Exposure (1967-1994)", "MS": "Exposure of the male parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring.", "PM": "95", "HN": "95", "MR": "20080708", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018812"}, {"RECTYPE": "D", "MH": "Multiple Endocrine Neoplasia Type 2a", "DE": "MULTIPLE ENDOCRINE NEOPL TYPE 2A", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Sipple Syndrome|T191|EPO|EQV|NLM (1995)|OMIM (2013)|ORD (2010)|940401|abcdeeef", "ENTRY": "Pheochromocytoma And Amyloid Producing Medullary Thyroid Carcinoma", "MN": "C19.344.400.505", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with specific endocrine/neoplasm pre-coordinates (IM) + specific histological type (IM) if pertinent", "PI": "Multiple Endocrine Neoplasia (1966-1994)", "MS": "A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma (CARCINOMA, MEDULLARY) of the THYROID GLAND, and usually with the co-occurrence of PHEOCHROMOCYTOMA, producing CALCITONIN and ADRENALINE, respectively. Less frequently, it can occur with hyperplasia or adenoma of the PARATHYROID GLANDS. This disease is due to gain-of-function mutations of the MEN2 gene on CHROMOSOME 10 (Locus: 10q11.2), also known as the RET proto-oncogene that encodes a RECEPTOR PROTEIN-TYROSINE KINASE. It is an autosomal dominant inherited disease.", "OL": "use MULTIPLE ENDOCRINE NEOPLASIA to search MEA II, MEN II, & SIPPLE SYNDROME 1983-94", "PM": "95; MEA II, MEN II, & SIPPLE SYNDROME were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94", "HN": "95; MEA II, MEN II, & SIPPLE SYNDROME were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018813"}, {"RECTYPE": "D", "MH": "Multiple Endocrine Neoplasia Type 2b", "DE": "MULTIPLE ENDOCRINE NEOPL TYPE 2B", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Neoplasms, Multiple Endocrine Type 2b|T191|NON|EQV|NLM (1995)|940401|NEOPLASMS MULTIPLE ENDOCRINE TYPE 002 B|abcdefs", "ENTRY": "Wagenmann Froboese Syndrome", "MN": "C19.344.400.510", "MH_TH": "NLM (1995)", "ST": "T191", "AN": "coordinate IM with specific endocrine/neoplasm pre-coordinates (IM) + specific histological type (IM) if pertinent", "PI": "Multiple Endocrine Neoplasia (1975-1994)", "MS": "Similar to MEN2A, it is also caused by mutations of the MEN2 gene, also known as the RET proto-oncogene. Its clinical symptoms include medullary carcinoma (CARCINOMA, MEDULLARY) of THYROID GLAND and PHEOCHROMOCYTOMA of ADRENAL MEDULLA (50%). Unlike MEN2a, MEN2b does not involve PARATHYROID NEOPLASMS. It can be distinguished from MEN2A by its neural abnormalities such as mucosal NEUROMAS on EYELIDS; LIP; and TONGUE, and ganglioneuromatosis of GASTROINTESTINAL TRACT leading to MEGACOLON. It is an autosomal dominant inherited disease.", "PM": "1995; MEA III & MEN III see NEOPLASMS, MULTIPLE ENDOCRINE 1983-1994", "HN": "1995; MEA III & MEN III see NEOPLASMS, MULTIPLE ENDOCRINE 1983-1994", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018814"}, {"RECTYPE": "D", "MH": "Genes, erbB", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "erbB-3 Genes|T028|NRW|NLM (1995)|940404|ERBB GENES 003|abdefs", "ENTRY": "erbB-3 Gene", "MN": "G05.360.340.024.340.375.500.791.295", "MH_TH": "NLM (1995)", "ST": "T028", "AN": "spell in titles & translations as erbB; GENES, ERBB-1 & GENES, ERBB-2 are also available", "PI": "Proto-Oncogenes (1992-1994)", "MS": "Retrovirus-associated DNA sequences (erbB) originally isolated from, or related to, the avian erythroblastosis virus (AEV). These genes code for the epidermal growth factor receptor (EGFR) family of receptors which is important in the control of normal cell proliferation and in the pathogenesis of human cancer. The genes include erbB-1 (GENES, ERBB-1), erbB-2 (GENES, ERBB-2), and erbB-3, all of which show abnormalities of expression in various human neoplasms.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19940523", "DC": "1", "DX": "19950101", "UI": "D018815"}, {"RECTYPE": "D", "MH": "Genes, cdc", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "cdc Genes|T028|EQV|NLM (1995)|940405|abdef", "ENTRY": "cdc Gene", "MN": "G05.360.340.024.340.220", "FX": "Cell Cycle Proteins", "MH_TH": "NLM (1995)", "ST": "T028", "MS": "Genes that code for proteins that regulate the CELL DIVISION CYCLE. These genes form a regulatory network that culminates in the onset of MITOSIS by activating the p34cdc2 protein (PROTEIN P34CDC2).", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018816"}, {"RECTYPE": "D", "MH": "N-Methyl-3,4-methylenedioxyamphetamine", "DS": "METHYLMETHYLENEDIOXYAMPHETAMINE N 03 04", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylenedioxymethamphetamine|T109|T121|T131|NON|EQV|FDA SRS (2014)|NLM (1995)|940405|abbbcdeef", "ENTRY": "N Methyl 3,4 methylenedioxyamphetamine Hydrochloride", "MN": "D02.092.471.683.152.670", "PA": "Serotonin Agents", "MH_TH": "NLM (1995)", "ST": "T131", "N1": "1,3-Benzodioxole-5-ethanamine, N,alpha-dimethyl-", "RN": "KE1SEN21RM", "RR": "64057-70-1 (HCl)", "PI": "3,4-Methylenedioxyamphetamine/analogs & derivatives (1984-1994)", "MS": "An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.", "OL": "use N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE (NM) to search N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE 1984-94", "PM": "95; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE was indexed under 3,4-METHYLENEDIOXYAMPHETAMINE/analogs & derivatives 1984-94", "HN": "95; was N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE (NM) 1984-94", "MR": "20130708", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018817"}, {"RECTYPE": "D", "MH": "Fenoldopam", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SKF82526J", "MN": "D03.633.100.079.300", "PA": "Vasodilator Agents", "MH_TH": "NLM (1995)", "ST": "T121", "N1": "1H-3-Benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-", "RN": "INU8H2KAWG", "RR": "HA3R0MY016", "PI": "SK&F-38393/analogs & derivatives (1989-1994)", "MS": "A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.", "OL": "use FENOLDOPAM (NM) to search FENOLDOPAM 1982-94", "PM": "95; FENOLDOPAM was indexed under SK&F-38393/analogs & derivatives 1989-94 & BENZAZEPINES 1982-89", "HN": "95; was FENOLDOPAM (NM) 1982-94", "MR": "20160531", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018818"}, {"RECTYPE": "D", "MH": "Dipeptidyl Peptidase 4", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dipeptidyl-Peptidase IV|T116|T126|T129|NON|EQV|NLM (1995)|940406|abbbcdef", "ENTRY": "Dipeptidyl Peptidase IV", "MN": "D23.101.100.894.160", "EC": "antagonists & inhibitors:Dipeptidyl-Peptidase IV Inhibitors", "MH_TH": "NLM (2011)", "ST": "T129", "RN": "EC 3.4.14.5", "PI": "Dipeptidyl Peptidases (1980-1994)", "MS": "A serine protease that catalyses the release of an N-terminal dipeptide. Several biologically-active peptides have been identified as dipeptidyl peptidase 4 substrates including INCRETINS; NEUROPEPTIDES; and CHEMOKINES. The protein is also found bound to ADENOSINE DEAMINASE on the T-CELL surface and is believed to play a role in T-cell activation.", "PM": "2011; see CD26 ANTIGEN 1995-2010; CD26 ANTIGEN was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1990-1994; DIPEPTIDYL PEPTIDASE IV was indexed under DIPEPTIDYL PEPTIDASES 1980-1994", "HN": "2011(1998)", "MR": "20170524", "DA": "19940527", "DC": "1", "DX": "19950101", "UI": "D018819"}, {"RECTYPE": "D", "MH": "CD18 Antigens", "DS": "CD 018 ANTIGENS", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Integrin beta2|T116|T129|T192|NON|EQV|NLM (1996)|950125|INTEGRIN BETA A 02|abbbcdefs", "ENTRY": "p150,95 beta Subunit", "MN": "D23.101.100.894.118", "FX": "Macrophage-1 Antigen", "MH_TH": "NLM (1995)", "ST": "T192", "RN": "0", "PI": "Receptors, Leukocyte-Adhesion (1989-1991)", "MS": "Cell-surface glycoprotein beta-chains that are non-covalently linked to specific alpha-chains of the CD11 family of leukocyte-adhesion molecules (RECEPTORS, LEUKOCYTE-ADHESION). A defect in the gene encoding CD18 causes LEUKOCYTE-ADHESION DEFICIENCY SYNDROME.", "PM": "2018; see ANTIGENS, CD18 1995-2017, INTEGRIN BETA2 1994-95, and CD18 ANTIGEN 1986-94; CD18 ANTIGENS was indexed under ANTIGENS, CD 1990-94; RECEPTORS, LEUKOCYTE-ADHESION 1989-91; MEMBRANE GLYCOPROTEINS 1986-89; & MEMBRANE PROTEINS 1986-87; INTEGRIN BETA2 was indexed under INTEGRINS 1994-95", "HN": "2018 (1986)", "MR": "20230316", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018821"}, {"RECTYPE": "D", "MH": "alpha-Endorphin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Endorphin, alpha|T116|T123|NON|EQV|NLM (1995)|940407|abbcdef", "ENTRY": "alpha Endorphin", "MN": "D12.776.631.650.575.241.040", "PA": "Neurotransmitter Agents", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "61512-76-3", "PI": "Opioid Peptides (1980-1994)", "MS": "An endogenous opioid peptide derived from BETA-LIPOTROPIN of the pro-opiomelanocortin (POMC) system. It is the 16-amino acid sequence of the N-terminal of BETA-ENDORPHIN and differs from GAMMA-ENDORPHIN by one amino acid (beta-endorphin 1-17).", "OL": "use ALPHA-ENDORPHIN (NM) to search ALPHA-ENDORPHIN 1980-94", "PM": "95; ALPHA-ENDORPHIN was indexed under ENDORPHINS 1980-94", "HN": "95; was ALPHA-ENDORPHIN (NM) 1980-94", "MR": "20151123", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018822"}, {"RECTYPE": "D", "MH": "gamma-Endorphin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Endorphin, gamma|T116|T123|NON|EQV|NLM (1995)|940407|abbcdef", "ENTRY": "gamma Endorphin", "MN": "D12.776.631.650.575.241.540", "PA": "Neurotransmitter Agents", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "61512-77-4", "PI": "Opioid Peptides (1980-1994)", "MS": "An endogenous opioid peptide derived from BETA-LIPOTROPIN of the pro-opiomelanocortin (POMC) system. It is the 17-amino acid sequence of the N-terminal of BETA-ENDORPHIN and differs from ALPHA-ENDORPHIN by one amino acid (beta-endorphin 1-16).", "OL": "use GAMMA-ENDORPHIN (NM) to search GAMMA-ENDORPHIN 1980-94", "PM": "95; GAMMA-ENDORPHIN was indexed under ENDORPHINS 1980-94", "HN": "95; was GAMMA-ENDORPHIN (NM) 1980-94", "MR": "20151123", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018823"}, {"RECTYPE": "D", "MH": "CD13 Antigens", "DS": "CD 013 ANTIGENS", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Membrane Alanyl Aminopeptidase|T116|T126|T129|NON|EQV|NLM (1995)|940428|abbbcdef", "ENTRY": "Protein, ANPEP", "MN": "D23.101.100.894.113", "MH_TH": "NLM (1995)", "ST": "T129", "RN": "EC 3.4.11.2", "RR": "EC 3.4.11.2", "PI": "Antigens, Differentiation, Myelomonocytic (1989-1994)", "MS": "Zinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide.", "PM": "2018; see ANTIGENS, CD13 1995-2017, CD13 ANTIGEN 1988-94, and ALANINE AMINOPEPTIDASE 1975-94; CD13 ANTIGENS was indexed under ANTIGENS, CD 1991-94; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; and ANTIGENS, DIFFERENTIATION 1988; ALANINE AMINOPEPIDASE was indexed under AMINOPEPTIDASES 1981-94 and under ALANINE 1975-80", "HN": "2018 (1975)", "MR": "20210701", "DA": "19940527", "DC": "1", "DX": "19950101", "UI": "D018826"}, {"RECTYPE": "D", "MH": "Carcinoma, Lewis Lung", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SC SU TH UL UR VI", "ENTRY": "Lung Carcinoma, Lewis", "MN": "C04.619.230", "MH_TH": "NLM (1995)", "ST": "T191", "PI": "Lung Neoplasms (1972-1994)", "MS": "A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.", "PM": "95", "HN": "95", "CATSH": "CAT LIST", "MR": "20030730", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018827"}, {"RECTYPE": "D", "MH": "Immunoglobulins, Thyroid-Stimulating", "DE": "IG THYROID STIMULATING", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Thyroid-Stimulating Immunoglobulins|T116|T129|NON|EQV|NLM (1995)|940408|THYROID STIMULATING IG|abbcdefv", "ENTRY": "Thyroid Stimulating, Ig", "MN": "D12.776.377.715.548.114.323.480", "PA": "Immunologic Factors", "FX": "Receptors, Thyrotropin", "MH_TH": "NLM (1995)", "ST": "T129", "RN": "0", "PI": "Autoantibodies (1969-1994)", "MS": "Autoantibodies that bind to the thyroid-stimulating hormone (TSH) receptor (RECEPTORS, THYROTROPIN) on thyroid epithelial cells. The autoantibodies mimic TSH causing an unregulated production of thyroid hormones characteristic of GRAVES DISEASE.", "OL": "use IMMUNOGLOBULINS, THYROID-STIMULATING (NM) to search THYROID-STIMULATING IMMUNOGLOBULIN 1977-94", "PM": "95; THYROID-STIMULATING IMMUNOGLOBULIN was indexed under AUTOANTIBODIES 1977-94 & IGG 1977-90", "HN": "95; was THYROID-STIMULATING IMMUNOGLOBULIN (NM) 1977-94", "MR": "20220413", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018828"}, {"RECTYPE": "D", "MH": "Adhesins, Bacterial", "DE": "ADHESINS BACT", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Fimbrial Adhesins|T116|T129|NON|NRW|NLM (1995)|940413|abbcdef", "ENTRY": "Bacterial Adhesin|T116|T129|NON|EQV|NLM (1995)|940408|BACT ADHESIN|abbcdefv", "MN": "D23.050.161.050", "FX": "Biofilms", "MH_TH": "NLM (1995)", "ST": "T129", "RN": "0", "AN": "coordinate IM with specific bacterium (IM) but note that ADHESINS, ESCHERICHIA COLI is available; do not confuse with BACTERIAL ADHESION; do not confuse with BIOFILMS", "PI": "specific Adhesins (1975-1994)", "MS": "Cell-surface components or appendages of bacteria that facilitate adhesion (BACTERIAL ADHESION) to other cells or to inanimate surfaces. Most fimbriae (FIMBRIAE, BACTERIAL) of gram-negative bacteria function as adhesins, but in many cases it is a minor subunit protein at the tip of the fimbriae that is the actual adhesin. In gram-positive bacteria, a protein or polysaccharide surface layer serves as the specific adhesin. What is sometimes called polymeric adhesin (BIOFILMS) is distinct from protein adhesin.", "PM": "95", "HN": "95", "MR": "20220413", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018829"}, {"RECTYPE": "D", "MH": "Adhesins, Escherichia coli", "DE": "ADHESINS E COLI", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Escherichia coli Adhesins|T116|T129|NON|EQV|NLM (1995)|940421|E COLI ADHESINS|abbcdefv", "ENTRY": "Escherichia coli Adhesin", "MN": "D23.050.161.050.040", "MH_TH": "NLM (1995)", "ST": "T129", "RN": "0", "PI": "Bacterial Proteins (1982-1988)", "MS": "Thin, filamentous protein structures, including proteinaceous capsular antigens (fimbrial antigens), that mediate adhesion of E. coli to surfaces and play a role in pathogenesis. They have a high affinity for various epithelial cells.", "OL": "use ADHESINS, ESCHERICHIA COLI (NM) to search ADHESIN, E COLI 1982-94", "PM": "95; ADHESIN, E COLI was indexed under ANTIGENS, BACTERIAL 1982-94, BACTERIAL OUTER MEMBRANE PROTEINS 1985-94, & BACTERIAL PROTEINS 1982-88", "HN": "95; was ADHESIN, E COLI (NM) 1982-94", "MR": "20220413", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018830"}, {"RECTYPE": "D", "MH": "Molecular Chaperones", "DE": "MOL CHAPERONES", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chaperones, Molecular|T116|T123|NON|EQV|NLM (1995)|940411|CHAPERONES MOL|abbcdefv", "ENTRY": "Molecular Chaperone|T116|T123|NON|EQV|NLM (1995)|940411|MOL CHAPERONE|abbcdefv", "MN": "D12.776.580", "FX": "Heat-Shock Proteins", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Proteins (1987-1994)", "MS": "A family of cellular proteins that mediate the correct assembly or disassembly of polypeptides and their associated ligands. Although they take part in the assembly process, molecular chaperones are not components of the final structures.", "PM": "95", "HN": "95", "MR": "20090706", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018832"}, {"RECTYPE": "D", "MH": "Chaperonins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chaperonin Complex|T116|T126|NON|NRW|NLM (2021)|191230|abbcdef", "ENTRY": "Complex, Chaperonin", "MN": "D12.776.580.216.210", "MH_TH": "NLM (1995)", "ST": "T126", "RN": "EC 3.6.1.-", "AN": "general or unspecified; prefer specifics", "PI": "Proteins (1989-1994)", "MS": "A family of multisubunit protein complexes that form into large cylindrical structures which bind to and encapsulate non-native proteins. Chaperonins utilize the energy of ATP hydrolysis to enhance the efficiency of PROTEIN FOLDING reactions and thereby help proteins reach their functional conformation. The family of chaperonins is split into GROUP I CHAPERONINS, and GROUP II CHAPERONINS, with each group having its own repertoire of protein subunits and subcellular preferences.", "OL": "use CHAPERONINS (NM) to search CHAPERONIN FAMILY 1989-94", "PM": "95; CHAPERONIN FAMILY was indexed under PROTEINS 1989-94", "HN": "95; was CHAPERONIN FAMILY (NM) 1989-94", "MR": "20200527", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018833"}, {"RECTYPE": "D", "MH": "Chaperonin 60", "DS": "CHAPERONIN 060", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "hsp60 Family|T116|T123|EQV|NLM (1995)|940425|HSP 060 FAMILY|abbdefs", "ENTRY": "Heat Shock Proteins 60", "MN": "D12.776.580.216.210.590.750", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "AN": "coordinate with MITOCHONDRIAL PROTEINS or BACTERIAL PROTEINS if pertinent", "PI": "Heat-Shock Proteins (1989-1994)", "MS": "A group I chaperonin protein that forms the barrel-like structure of the chaperonin complex. It is an oligomeric protein with a distinctive structure of fourteen subunits, arranged in two rings of seven subunits each. The protein was originally studied in BACTERIA where it is commonly referred to as GroEL protein.", "PM": "1995; CHAPERONIN 60 was indexed under BACTERIAL PROTEINS & HEAT-SHOCK PROTEINS 1989-1994; HEAT-SHOCK PROTEIN 60 was indexed under HEAT-SHOCK PROTEINS 1993-1994; HSP60 PROTEIN was indexed under HEAT-SHOCK PROTEINS 1989-1994; for GROEL PROTEIN see GROEL PROTEIN 1995-2009", "HN": "1995(1989)", "MR": "20160115", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018834"}, {"RECTYPE": "D", "MH": "Chaperonin 10", "DS": "CHAPERONIN 010", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "hsp10 Family|T116|T123|EQV|NLM (1995)|940429|HSP 010 FAMILY|abbdefs", "ENTRY": "Heat Shock Proteins 10", "MN": "D12.776.580.216.210.590.500", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "PI": "Heat-Shock Proteins (1989-1994)", "MS": "A group I chaperonin protein that forms a lid-like structure which encloses the non-polar cavity of the chaperonin complex. The protein was originally studied in BACTERIA where it is commonly referred to as GroES protein.", "PM": "1995; CHAPERONIN 10 was indexed under HEAT-SHOCK PROTEINS 1989-1994; HEAT-SHOCK PROTEIN 10 was indexed under HEAT-SHOCK PROTEINS 1993-1994; for GROES PROTEIN see GROES PROTEIN 1995-2009", "HN": "1995(1989)", "MR": "20090706", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018835"}, {"RECTYPE": "D", "MH": "Inflammation Mediators", "DE": "INFLAMM MEDIATORS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mediators of Inflammation|T121|NON|EQV|NLM (1995)|940421|MEDIATORS INFLAMM|abcdefv", "ENTRY": "Mediators, Inflammation", "MN": "D23.469", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "AN": "do not confuse with ANTI-INFLAMMATORY AGENTS", "MS": "The endogenous compounds that mediate inflammation (AUTACOIDS) and related exogenous compounds including the synthetic prostaglandins (PROSTAGLANDINS, SYNTHETIC).", "PM": "95", "HN": "95", "MR": "20050630", "DA": "19940601", "DC": "1", "DX": "19950101", "UI": "D018836"}, {"RECTYPE": "D", "MH": "HSP70 Heat-Shock Proteins", "DS": "HSP 070 HEAT SHOCK PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heat-Shock Proteins 70|T116|T123|NON|EQV|NLM (1995)|990101|HEAT SHOCK PROTEINS 070|abbcdefs", "ENTRY": "Heat-Shock Proteins, HSP70", "MN": "D12.776.580.216.375", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "coordinate with MITOCHONDRIAL PROTEINS or BACTERIAL PROTEINS if pertinent", "MS": "A class of MOLECULAR CHAPERONES found in both prokaryotes and in several compartments of eukaryotic cells. These proteins can interact with polypeptides during a variety of assembly processes in such a way as to prevent the formation of nonfunctional structures.", "PM": "2006; see HEAT SHOCK PROTEINS 70 1995-2005, see HEAT-SHOCK PROTEINS 1990-1994", "HN": "2006(1990); use HEAT-SHOCK PROTEINS 1990-1994", "MR": "20150415", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018840"}, {"RECTYPE": "D", "MH": "HSP90 Heat-Shock Proteins", "DS": "HSP 090 HEAT SHOCK PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heat-Shock Proteins 90|T116|T123|NON|EQV|NLM (1995)|990101|HEAT SHOCK PROTEINS 090|abbcdefs", "ENTRY": "Heat-Shock Proteins, HSP90", "MN": "D12.776.580.216.380", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Heat-Shock Proteins (1986-1994)", "MS": "A class of MOLECULAR CHAPERONES whose members act in the mechanism of SIGNAL TRANSDUCTION by STEROID RECEPTORS.", "PM": "2006; see HEAT-SHOCK PROTEINS 90 1995-2005, see HEAT-SHOCK PROTEINS 1990-1994", "HN": "2006(1994); use HEAT-SHOCK PROTEINS 1990-1994", "MR": "20090706", "DA": "19940527", "DC": "1", "DX": "19950101", "UI": "D018841"}, {"RECTYPE": "D", "MH": "Republic of North Macedonia", "AQ": "EH EP", "PRINT ENTRY": "North Macedonia|T083|NON|EQV|NLM (2020)|190307|abcdef", "ENTRY": "Republic of Macedonia|T083|NAM|EQV|NLM (2020)|181010|abcdef", "MN": "Z01.542.248.750", "MH_TH": "NLM (2020)", "ST": "T083", "AN": "note entry terms: do not confuse with MACEDONIA (GREECE) see GREECE", "MS": "Country in Europe, east of Albania and north of Greece. The capital is Skopje. In June, 2018 agreement was reached to establish the new name Republic of North Macedonia.which became effective February 2019.", "HN": "2020 (1995); was MACEDONIA (REPUBLIC) 1995-2019; for MACEDONIA (YUGOSLAVIA), use YUGOSLAVIA 1994", "MR": "20220708", "DA": "19940531", "DC": "4", "DX": "19950101", "UI": "D018843"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "cdk Proteins|T116|T123|NON|EQV|NLM (1995)|940428|abbcdef", "ENTRY": "Protein Kinase, Cyclin-Dependent", "MN": "D12.776.476.563.646.500", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "EC 2.7.11.22", "PI": "Protein Kinases (1992-1994)", "MS": "Protein kinases that control cell cycle progression in all eukaryotes and require physical association with CYCLINS to achieve full enzymatic activity. Cyclin-dependent kinases are regulated by phosphorylation and dephosphorylation events.", "PM": "95", "HN": "95", "MR": "20210521", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018844"}, {"RECTYPE": "D", "MH": "CD11 Antigens", "DS": "CD 011 ANTIGENS", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Antigens, CD11|T116|T129|T192|NON|EQV|NLM (1995)|990101|ANTIGENS CD 011|abbbcdefs", "ENTRY": "CD11 Antigen|T116|T129|T192|EQV|NLM (1995)|940429|abbbdef", "MN": "D23.050.301.350.074", "MH_TH": "NLM (1995)", "ST": "T192", "RN": "0", "PI": "Antigens, Differentiation (1988-1991)", "MS": "A group of three different integrin alpha chains (CD11a, CD11b, CD11c) that are associated with an invariant integrin beta-2 chain (CD18 ANTIGENS). The three resulting leukocyte-adhesion molecules (RECEPTORS, LEUKOCYTE ADHESION) are LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGE-1 ANTIGEN; and ANTIGEN, P150,95.", "PM": "2018; see ANTIGENS, CD11 1995-2017; CD11 ANTIGENS was indexed under ANTIGENS, CD 1990-94 and ANTIGENS, DIFFERENTIATION 1988-91", "HN": "2018 (1988)", "MR": "20230316", "DA": "19940531", "DC": "1", "DX": "19950101", "UI": "D018845"}, {"RECTYPE": "D", "MH": "Excitatory Amino Acids", "DE": "EXCITATORY AA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amino Acids, Excitatory|T116|NON|EQV|NLM (1995)|940504|AA EXCITATORY|abcdefv", "ENTRY": "Amino Acid, Excitatory", "MN": "D12.125.427", "PA": "Neurotransmitter Agents", "FX": "Receptors, Glutamate", "MH_TH": "NLM (1995)", "ST": "T116", "RN": "0", "AN": "endogenous: do not confuse with EXCITATORY AMINO ACID AGENTS which are exogenous; GEN or unspecified; prefer specifics", "PI": "Amino Acids (1966-1994)", "MS": "Endogenous amino acids released by neurons as excitatory neurotransmitters. Glutamic acid is the most common excitatory neurotransmitter in the brain. Aspartic acid has been regarded as an excitatory transmitter for many years, but the extent of its role as a transmitter is unclear.", "PM": "95", "HN": "95", "MR": "20190524", "DA": "19940603", "DC": "1", "DX": "19950101", "UI": "D018846"}, {"RECTYPE": "D", "MH": "Opioid Peptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Opiates, Endogenous|T123|NON|BRD|NLM (1995)|940505|abcdef", "ENTRY": "Peptides, Opioid", "MN": "D12.776.631.650.575", "PA": "Neurotransmitter Agents", "FX": "Receptors, Opioid", "MH_TH": "NLM (1995)", "ST": "T123", "RN": "0", "PI": "Endorphins (1978-1994)", "MS": "The endogenous peptides with opiate-like activity. The three major classes currently recognized are the ENKEPHALINS, the DYNORPHINS, and the ENDORPHINS. Each of these families derives from different precursors, proenkephalin, prodynorphin, and PRO-OPIOMELANOCORTIN, respectively. There are also at least three classes of OPIOID RECEPTORS, but the peptide families do not map to the receptors in a simple way.", "OL": "use ENDORPHINS to search OPIOID PEPTIDES 1982-94 & OPIATES, ENDOGENOUS 1980-94", "PM": "95; OPIOID PEPTIDES was see ENDORPHINS 1982-94; OPIATES, ENDOGENOUS was see ENDORPHINS 1980-94", "HN": "95; OPIOID PEPTIDES was see ENDORPHINS 1982-94; OPIATES, ENDOGENOUS was see ENDORPHINS 1980-94", "MR": "20160705", "DA": "19940616", "DC": "1", "DX": "19950101", "UI": "D018847"}, {"RECTYPE": "D", "MH": "Controlled Clinical Trial", "MN": "V03.175.250.500", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific controlled clinical trial; a different heading CONTROLLED CLINICAL TRIALS AS TOPIC is used for general design, methodology, economics, etc. of clinical trials", "MS": "A work that reports on a clinical trial involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicine, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trial is characterized as a RANDOMIZED CONTROLLED TRIAL.", "HN": "2008(1995)", "MR": "20150415", "DA": "19950623", "DC": "2", "DX": "19960101", "UI": "D018848"}, {"RECTYPE": "D", "MH": "Controlled Clinical Trials as Topic", "AQ": "CL EC ES HI IS LJ MT PX SN ST VE", "ENTRY": "Clinical Trials, Controlled as Topic|T061|T062|T170|NON|EQV|NLM (2008)|070625|abbbcdef", "MN": "N06.850.520.450.250.250.365", "FX": "Control Groups", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "for general design, methodology, economics, etc. of clinical trials; a different heading CONTROLLED CLINICAL TRIAL is used for reports of a specific clinical trial", "PI": "Clinical Trials (1980-1994)", "MS": "Works about clinical trials involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicines, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trials are characterized as RANDOMIZED CONTROLLED TRIALS AS TOPIC.", "PM": "2008; see CONTROLLED CLINICAL TRIALS 1995-2007,was see CLINICAL TRIALS 1980-1994", "HN": "2008(1995); use CLINICAAL TRIALS 1980-1984", "CATSH": "CAT LIST", "MR": "20180702", "DA": "19940630", "DC": "1", "DX": "19950101", "UI": "D018849"}, {"RECTYPE": "D", "MH": "Managed Competition", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Health Plans, Accountable|T093|NON|REL|NLM (1996)|940714|abcdef", "ENTRY": "Plans, Accountable Health", "MN": "N03.219.521.576.343.820", "MH_TH": "NLM (1996)", "ST": "T058", "AN": "restrict to health insurance; do not confuse with MANAGED CARE PROGRAMS", "PI": "Managed Care Programs (1992-1995)", "MS": "A strategy for purchasing health care in a manner which will obtain maximum value for the price for the purchasers of the health care and the recipients. The concept was developed primarily by Alain Enthoven of Stanford University and promulgated by the Jackson Hole Group. The strategy depends on sponsors for groups of the population to be insured. The sponsor, in some cases a health alliance, acts as an intermediary between the group and competing provider groups (accountable health plans). The competition is price-based among annual premiums for a defined, standardized benefit package. (From Slee and Slee, Health Care Reform Terms, 1993)", "PM": "96", "HN": "96", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018854"}, {"RECTYPE": "D", "MH": "Single-Payer System", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Single-Payer Plan|T058|NON|NRW|NLM (1996)|940712|abcdef", "ENTRY": "Systems, Single-Payer", "MN": "N03.349.550.805", "MH_TH": "NLM (1996)", "ST": "T058", "AN": "a type of organized health-care financing", "PI": "Insurance, Health (1992-1995)", "MS": "An approach to health care financing with only one source of money for paying health care providers. The scope may be national (the Canadian System), state-wide, or community-based. The payer may be a governmental unit or other entity such as an insurance company. The proposed advantages include administrative simplicity for patients and providers, and resulting significant savings in overhead costs. (From Slee and Slee, Health Care Reform Terms, 1993, p106)", "PM": "96", "HN": "96", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018855"}, {"RECTYPE": "D", "MH": "Cystitis, Interstitial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Interstitial Cystitis|T047|NON|EQV|NLM (1996)|940914|abcdef", "ENTRY": "Pain Syndrome, Bladder", "MN": "C12.950.829.495.500", "MH_TH": "NLM (1996)", "ST": "T047", "AN": "usually chronic so do not coordinate with CHRONIC DISEASE", "PI": "Cystitis (1966-1995)", "MS": "A condition with recurring discomfort or pain in the URINARY BLADDER and the surrounding pelvic region without an identifiable disease. Severity of pain in interstitial cystitis varies greatly and often is accompanied by increased urination frequency and urgency.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018856"}, {"RECTYPE": "D", "MH": "Food Packaging", "AQ": "CL EC ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Packaging, Food|T073|NON|EQV|NLM (1996)|940712|abcdef", "ENTRY": "Food Container", "MN": "J01.576.761.400", "FX": "Food Storage", "MH_TH": "NLM (1996)", "ST": "T073", "AN": "includes containers, packaging methods, packaging materials; IM; coord with specific food (IM); FOOD LABELING is also available", "PI": "Food Technology (1975-1995)", "MS": "Containers, packaging, and packaging materials for processed and raw foods and beverages. It includes packaging intended to be used for storage and also used for preparation of foods such as microwave food containers versus COOKING AND EATING UTENSILS. Packaging materials may be intended for food contact or designated non-contact, for example, shipping containers. FOOD LABELING is also available.", "PM": "96", "HN": "96", "MR": "20110624", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018857"}, {"RECTYPE": "D", "MH": "Germinal Center", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Germinal Centers", "MN": "A15.382.520.604.412.500", "MH_TH": "NLM (1996)", "ST": "T026", "PI": "Lymphoid Tissue (1966-1995)", "MS": "The activated center of a lymphoid follicle in secondary lymphoid tissue where B-LYMPHOCYTES are stimulated by antigens and helper T cells (T-LYMPHOCYTES, HELPER-INDUCER) are stimulated to generate memory cells.", "PM": "96", "HN": "96", "MR": "20150622", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018858"}, {"RECTYPE": "D", "MH": "Hair Follicle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Hair Follicles", "MN": "A17.815.250.500", "FX": "Folliculitis", "MH_TH": "NLM (1996)", "ST": "T017", "PI": "Hair (1966-1995)", "MS": "A tube-like invagination of the EPIDERMIS from which the hair shaft develops and into which SEBACEOUS GLANDS open. The hair follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. (Stedman, 26th ed) Follicles of very long hairs extend into the subcutaneous layer of tissue under the SKIN.", "PM": "96", "HN": "96", "MR": "20130708", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018859"}, {"RECTYPE": "D", "MH": "Sneddon Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sneddon-Champion Syndrome|T047|EPO|EQV|NLM (1996)|940712|abcdef", "ENTRY": "Syndrome, Sneddon-Champion", "MN": "C17.800.862.775", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "do not confuse with SNEDDON-WILKINSON DISEASE see SKIN DISEASES, VESICULOBULLOUS", "PI": "Skin Diseases, Vascular (1993-1995)", "MS": "A systemic non-inflammatory arteriopathy primarily of middle-aged females characterized by the association of LIVEDO RETICULARIS, multiple thrombotic CEREBRAL INFARCTION; CORONARY DISEASE, and HYPERTENSION. Elevation of antiphospholipid antibody titers (see also ANTIPHOSPHOLIPID SYNDROME), cardiac valvulopathy, ISCHEMIC ATTACK, TRANSIENT; SEIZURES; DEMENTIA; and chronic ischemia of the extremities may also occur. Pathologic examination of affected arteries reveals non-inflammatory adventitial fibrosis, thrombosis, and changes in the media (From Jablonski, Dictionary of Syndromes & Eponymic Diseases, 2d ed; Adams et al., Principles of Neurology, 6th ed, p861; Arch Neurol 1997 Jan;54(1):53-60). Mutations in the CECR1 gene (ADA2 protein, human) are associated with Sneddon syndrome.", "PM": "1996", "HN": "1996", "CATSH": "CAT LIST", "MR": "20230605", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018860"}, {"RECTYPE": "D", "MH": "Merkel Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Merkel's Receptor|T025|EPO|EQV|NLM (1996)|941025|MERKELS RECEPT|abcdefv", "ENTRY": "Receptors, Merkels", "MN": "A11.671.650.915.750.425", "FX": "Carcinoma, Merkel Cell", "MH_TH": "NLM (1996)", "ST": "T025", "MS": "Modified epidermal cells located in the stratum basale. They are found mostly in areas where sensory perception is acute, such as the fingertips. Merkel cells are closely associated with an expanded terminal bulb of an afferent myelinated nerve fiber. Do not confuse with Merkel's corpuscle which is a combination of a neuron and an epidermal cell.", "OL": "use MECHANORECEPTORS to search MERKEL'S RECEPTOR 1994-95", "PM": "96; MERKEL'S RECEPTOR was see MECHANORECEPTORS 1994-95", "HN": "96; MERKEL'S RECEPTOR was see MECHANORECEPTORS 1994-95", "MR": "20200527", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018862"}, {"RECTYPE": "D", "MH": "Cultural Diversity", "PRINT ENTRY": "Pluralism|T077|NON|BRD|NLM (1996)|940713|abcdef", "ENTRY": "Pluralisms", "MN": "I01.880.853.100.450", "FX": "Ethical Relativism", "MH_TH": "NLM (1996)", "ST": "T077", "AN": "IM; coord with specific ethnic, racial, religious or other cultural aspect (IM); specify geog if pertinent", "PI": "Culture (1975-1995)", "MS": "Coexistence of numerous distinct ethnic, racial, religious, or cultural groups within one social unit, organization, or population. (From American Heritage Dictionary, 2d college ed., 1982, p955)", "PM": "96", "HN": "96", "MR": "20010725", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018864"}, {"RECTYPE": "D", "MH": "Dental Research", "DE": "DENT RESEARCH", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Research, Dental|T062|NON|EQV|NLM (1996)|940713|RESEARCH DENT|abcdefv", "MN": "H02.163.090", "MH_TH": "NLM (1996)", "ST": "T062", "AN": "dent research as a field; avoid since most dental articles indexed contribute to \"dental research\"; IM general only on dent research as a field; NIM for status or progress of research in a special dent field or subject (IM); /methods: consider also RESEARCH DESIGN; DF: DENT RESEARCH", "PI": "Research (1966-1995)", "MS": "The study of laws, theories, and hypotheses through a systematic examination of pertinent facts and their interpretation in the field of dentistry. (From Jablonski, Illustrated Dictionary of Dentistry, 1982, p674)", "PM": "96", "HN": "96", "MR": "20100625", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018865"}, {"RECTYPE": "D", "MH": "Insurance, Disability", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Disability Insurance|T058|NON|EQV|NLM (1996)|940714|abcdef", "MN": "N03.219.521.576.300", "MH_TH": "NLM (1996)", "ST": "T058", "AN": "IM; coord with specific disability if pertinent (IM); specific geog if possible", "PI": "Workers' Compensation (1993-1995)", "MS": "Insurance designed to compensate persons who lose wages because of illness or injury; insurance providing periodic payments that partially replace lost wages, salary, or other income when the insured is unable to work because of illness, injury, or disease. Individual and group disability insurance are two types of such coverage. (From Facts on File Dictionary of Health Care Management, 1988, p207)", "PM": "96", "HN": "96", "MR": "19991103", "DA": "19950606", "DC": "1", "DX": "19960101", "UI": "D018868"}, {"RECTYPE": "D", "MH": "Heat-Shock Response", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Heat-Shock Reaction|T040|NON|EQV|NLM (1996)|940714|abcdef", "ENTRY": "Stress, Heat Shock", "MN": "G07.775.500", "FX": "Heat-Shock Proteins", "MH_TH": "NLM (1996)", "ST": "T040", "MS": "A sequence of responses that occur when an organism is exposed to excessive heat. In humans, an increase in skin temperature triggers muscle relaxation, sweating, and vasodilation.", "PM": "1996", "HN": "1996", "CATSH": "CAT LIST", "MR": "20180228", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018869"}, {"RECTYPE": "D", "MH": "Endoplasmic Reticulum, Rough", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Endoplasmic Reticulum, Granular|T026|NON|EQV|NLM (1996)|940714|abcdef", "ENTRY": "Rough Endoplasmic Reticulum", "MN": "A11.284.430.214.190.875.811.740.300", "MH_TH": "NLM (1996)", "ST": "T026", "AN": "ENDOPLASMIC RETICULUM, SMOOTH is also available", "PI": "Endoplasmic Reticulum (1966-1995)", "MS": "A type of endoplasmic reticulum (ER) where polyribosomes are present on the cytoplasmic surfaces of the ER membranes. This form of ER is prominent in cells specialized for protein secretion and its principal function is to segregate proteins destined for export or intracellular utilization.", "PM": "96", "HN": "96", "MR": "20030709", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018870"}, {"RECTYPE": "D", "MH": "Endoplasmic Reticulum, Smooth", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Endoplasmic Reticulum, Agranular|T026|NON|EQV|NLM (1996)|940714|abcdef", "ENTRY": "Smooth Endoplasmic Reticulum", "MN": "A11.284.430.214.190.875.248.310", "MH_TH": "NLM (1996)", "ST": "T026", "PI": "Endoplasmic Reticulum (1966-1995)", "MS": "A type of endoplasmic reticulum lacking associated ribosomes on the membrane surface. It exhibits a wide range of specialized metabolic functions including supplying enzymes for steroid synthesis, detoxification, and glycogen breakdown. In muscle cells, smooth endoplasmic reticulum is called SARCOPLASMIC RETICULUM.", "PM": "96", "HN": "96", "MR": "20030709", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018871"}, {"RECTYPE": "D", "MH": "Pregnancy Rate", "DE": "PREGN RATE", "AQ": "EH TD", "ENTRY": "Rates, Live-Birth Pregnancy", "MN": "N06.850.520.308.985.775", "MH_TH": "NLM (1996)", "ST": "T081", "PI": "Pregnancy (1967-1995)", "MS": "The ratio of the number of conceptions (CONCEPTION) including LIVE BIRTH; STILLBIRTH; and fetal losses, to the mean number of females of reproductive age in a population during a set time period.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20170703", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018873"}, {"RECTYPE": "D", "MH": "Spheroids, Cellular", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Spheroids, Multicellular", "MN": "A11.251.800", "MH_TH": "NLM (2004)", "ST": "T025", "AN": "do not confuse with \"spheroid bodies\" referring to axons in neuropathol; if tumor spheroids coordinate with TUMOR CELLS, CULTURED", "PI": "Tumor Cells, Cultured (1988-1995)", "MS": "Spherical, heterogeneous aggregates of proliferating, quiescent, and necrotic cells in culture that retain three-dimensional architecture and tissue-specific functions. The ability to form spheroids is a characteristic trait of CULTURED TUMOR CELLS derived from solid TUMORS. Cells from normal tissues can also form spheroids. They represent an in-vitro model for studies of the biology of both normal and malignant cells. (From Bjerkvig, Spheroid Culture in Cancer Research, 1992, p4)", "PM": "2004(1996); see SPHEROIDS 1996-2003", "HN": "2004(1996)", "MR": "20030709", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018874"}, {"RECTYPE": "D", "MH": "Vocabulary, Controlled", "AQ": "HI", "PRINT ENTRY": "Thesaurus|T170|NON|NRW|NLM (1996)|940714|abcdef", "ENTRY": "Vocabularies, Controlled", "MN": "L01.462.750.245.945", "MH_TH": "NLM (1996)", "ST": "T170", "PI": "Subject Headings (1989-1995)", "MS": "A specified list of terms with a fixed and unalterable meaning, and from which a selection is made when CATALOGING; ABSTRACTING AND INDEXING; or searching BOOKS; JOURNALS AS TOPIC; and other documents. The control is intended to avoid the scattering of related subjects under different headings (SUBJECT HEADINGS). The list may be altered or extended only by the publisher or issuing agency. (From Harrod's Librarians' Glossary, 7th ed, p163)", "PM": "96", "HN": "96", "MR": "20220712", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018875"}, {"RECTYPE": "D", "MH": "Environmental Illness", "DE": "ENVIR ILLNESS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypersensitivity, Environmental|T047|NON|EQV|NLM (1996)|940715|HYPERSENSITIVITY ENVIR|abcdefv", "ENTRY": "Illnesses, Environmental|T047|NON|EQV|NLM (1996)|950324|ILLNESSES ENVIR|abcdefv", "MN": "C21.223", "MH_TH": "NLM (1996)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with specific disease or source of illness; not for diseases caused by environmental pollution: index under specific disease and ENVIRONMENTAL POLLUTION or specific environmental pollutant ", "MS": "A polysymptomatic condition believed by clinical ecologists to result from immune dysregulation induced by common foods, allergens, and chemicals, resulting in various physical and mental disorders. The medical community has remained largely skeptical of the existence of this \"disease\", given the plethora of symptoms attributed to environmental illness, the lack of reproducible laboratory abnormalities, and the use of unproven therapies to treat the condition. (From Segen, Dictionary of Modern Medicine, 1992)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19950519", "DC": "1", "DX": "19960101", "UI": "D018876"}, {"RECTYPE": "D", "MH": "Sick Building Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Sick House", "MN": "C21.223.750", "MH_TH": "NLM (1996)", "ST": "T047", "PI": "Occupational Diseases (1984-1989)", "MS": "A group of symptoms that are two- to three-fold more common in those who work in large, energy-efficient buildings, associated with an increased frequency of headaches, lethargy, and dry skin. Clinical manifestations include hypersensitivity pneumonitis (ALVEOLITIS, EXTRINSIC ALLERGIC); allergic rhinitis (RHINITIS, ALLERGIC, PERENNIAL); ASTHMA; infections, skin eruptions, and mucous membrane irritation syndromes. Current usage tends to be less restrictive with regard to the type of building and delineation of complaints. (From Segen, Dictionary of Modern Medicine, 1992)", "OL": "use AIR POLLUTION, INDOOR to search SICK BUILDING SYNDROME 1992-95; use ENVIRONMENTAL EXPOSURE 1990-91", "PM": "96; was see AIR POLLUTION, INDOOR 1992-95, was see ENVIRONMENTAL EXPOSURE 1990-91", "HN": "96; was see AIR POLLUTION, INDOOR 1992-95, was see ENVIRONMENTAL EXPOSURE 1990-91", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018877"}, {"RECTYPE": "D", "MH": "Limb Buds", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Buds, Limb", "MN": "A16.567", "MH_TH": "NLM (2008)", "ST": "T018", "AN": "coordinate with specific limb with /embryol if pertinent", "MS": "Distinct regions of mesenchymal outgrowth at both flanks of an embryo during the SOMITE period. Limb buds, covered by ECTODERM, give rise to forelimb, hindlimb, and eventual functional limb structures. Limb bud cultures are used to study CELL DIFFERENTIATION; ORGANOGENESIS; and MORPHOGENESIS.", "PM": "2008; see LIMB BUD 1996-2007", "HN": "2008 (1996)", "MR": "20070709", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018878"}, {"RECTYPE": "D", "MH": "Ventricular Premature Complexes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ventricular Ectopic Beats|T046|NON|EQV|NLM (1996)|940718|abcdef", "ENTRY": "Ventricular Extrasystoles", "MN": "C23.550.073.325.800", "MH_TH": "NLM (1996)", "ST": "T046", "PI": "Cardiac Complexes, Premature (1966-1995)", "MS": "A type of cardiac arrhythmia with premature contractions of the HEART VENTRICLES. It is characterized by the premature QRS complex on ECG that is of abnormal shape and great duration (generally >129 msec). It is the most common form of all cardiac arrhythmias. Premature ventricular complexes have no clinical significance except in concurrence with heart diseases.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19950609", "DC": "1", "DX": "19960101", "UI": "D018879"}, {"RECTYPE": "D", "MH": "Atrial Premature Complexes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Premature Supraventricular Beats|T047|NON|EQV|NLM (1996)|940718|abcdef", "ENTRY": "Supraventricular Beats, Premature", "MN": "C23.550.073.325.050", "MH_TH": "NLM (1996)", "ST": "T047", "PI": "Cardiac Complexes, Premature (1967-1995)", "MS": "A type of cardiac arrhythmia with premature atrial contractions or beats caused by signals originating from ectopic atrial sites. The ectopic signals may or may not conduct to the HEART VENTRICLES. Atrial premature complexes are characterized by premature P waves on ECG which are different in configuration from the P waves generated by the normal pacemaker complex in the SINOATRIAL NODE.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018880"}, {"RECTYPE": "D", "MH": "Suburban Health", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "ENTRY": "Health, Suburban", "MN": "N01.400.548.813", "MH_TH": "NLM (1996)", "ST": "T078", "AN": "specify geog", "PI": "Urban Health (1971-1979)", "MS": "The status of health in suburban populations.", "PM": "96", "HN": "96", "MR": "20180623", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018881"}, {"RECTYPE": "D", "MH": "Heat Stress Disorders", "DE": "HEAT STRESS DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Heat Syncope|T037|NON|NRW|NLM (2021)|191219|abcdef", "ENTRY": "Syncope, Heat", "MN": "C26.522", "MH_TH": "NLM (1996)", "ST": "T037", "AN": "general or unspecified; prefer specifics; restrict to humans and vertebrates; not for microorganisms or plants", "PI": "Stress (1966-1995)", "MS": "A group of conditions that develop due to overexposure or overexertion in excessive environmental heat.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018882"}, {"RECTYPE": "D", "MH": "Heat Stroke", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stroke, Heat", "MN": "C26.522.500", "MH_TH": "NLM (1996)", "ST": "T037", "AN": "SUNSTROKE is also available", "PI": "Heat Exhaustion (1966-1995)", "MS": "A condition caused by the failure of body to dissipate heat in an excessively hot environment or during PHYSICAL EXERTION in a hot environment. Contrast to HEAT EXHAUSTION, the body temperature in heat stroke patient is dangerously high with red, hot skin accompanied by DELUSIONS; CONVULSIONS; or COMA. It can be a life-threatening emergency and is most common in infants and the elderly.", "PM": "1996; for HYPERTHERMIA see FEVERS 1984-2020", "HN": "1996; for HYPERTHERMIA use FEVERS 1984-2020", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018883"}, {"RECTYPE": "D", "MH": "Ixodes", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Western Blacklegged Tick|T204|NON|NRW|NLM (2024)|230411|abcdef", "ENTRY": "Western Blacklegged Ticks", "MN": "B01.050.500.131.166.132.832.400.425", "MH_TH": "NLM (1996)", "ST": "T204", "RN": "txid6944", "RR": "txid6945", "AN": "infestation: coordinate IM with TICK INFESTATIONS (IM)", "PI": "Ticks (1966-1995)", "MS": "The largest genus of TICKS in the family IXODIDAE, containing over 200 species. Many infest humans and other mammals and several are vectors of diseases such as LYME DISEASE; ENCEPHALITIS, TICK-BORNE; and KYASANUR FOREST DISEASE.", "PM": "96", "HN": "96", "MR": "20230601", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D018884"}, {"RECTYPE": "D", "MH": "Aphasia, Conduction", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Dysphasia, Conduction|T048|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Dysphasias, Conduction", "MN": "C23.888.592.604.150.500.800.100.111", "MH_TH": "NLM (1996)", "ST": "T048", "PI": "Aphasia, Wernicke (1980-1995)", "MS": "A type of fluent aphasia characterized by an impaired ability to repeat one and two word phrases, despite retained comprehension. This condition is associated with dominant hemisphere lesions involving the arcuate fasciculus (a white matter projection between Broca's and Wernicke's areas) and adjacent structures. Like patients with Wernicke aphasia (APHASIA, WERNICKE), patients with conduction aphasia are fluent but commit paraphasic errors during attempts at written and oral forms of communication. (From Adams et al., Principles of Neurology, 6th ed, p482; Brain & Bannister, Clinical Neurology, 7th ed, p142; Kandel et al., Principles of Neural Science, 3d ed, p848)", "PM": "1996", "HN": "1996", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018886"}, {"RECTYPE": "D", "MH": "Landau-Kleffner Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Aphasia, Acquired Epileptic|T048|NON|EQV|NLM (1996)|940719|abcdef", "ENTRY": "Syndrome, Landau-Kleffner", "MN": "C10.228.140.490.493.500", "FX": "Aphasia", "MH_TH": "ORD (2010)", "ST": "T048", "PI": "Epilepsy (1982-1995)", "MS": "A syndrome characterized by the onset of isolated language dysfunction in otherwise normal children (age of onset 4-7 years) and epileptiform discharges on ELECTROENCEPHALOGRAPHY. Seizures, including atypical absence (EPILEPSY, ABSENCE), complex partial (EPILEPSY, COMPLEX PARTIAL), and other types may occur. The electroencephalographic abnormalities and seizures tend to resolve by puberty. The language disorder may also resolve although some individuals are left with severe language dysfunction, including APHASIA and auditory AGNOSIA. (From Menkes, Textbook of Child Neurology, 5th ed, pp749-50; J Child Neurol 1997 Nov;12(8):489-495).", "PM": "1996", "HN": "1996", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018887"}, {"RECTYPE": "D", "MH": "Aphasia, Primary Progressive", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Mesulam Syndrome|T048|EPO|EQV|NLM (1996)|940826|abcdef", "ENTRY": "Syndrome, Mesulam's", "MN": "F03.615.400.125", "MH_TH": "ORD (2010)", "ST": "T048", "AN": "a clinical entity: do not confuse with descriptions of the progression of aphasia in case reports", "PI": "Aphasia (1982-1995)", "MS": "A progressive form of dementia characterized by the global loss of language abilities and initial preservation of other cognitive functions. Fluent and nonfluent subtypes have been described. Eventually a pattern of global cognitive dysfunction, similar to ALZHEIMER DISEASE, emerges. Pathologically, there are no Alzheimer or PICK DISEASE like changes, however, spongiform changes of cortical layers II and III are present in the TEMPORAL LOBE and FRONTAL LOBE. (From Brain 1998 Jan;121(Pt 1):115-26)", "PM": "1996", "HN": "1996", "CATSH": "CAT LIST", "MR": "20150630", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018888"}, {"RECTYPE": "D", "MH": "Ilizarov Technique", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Technique, Ilizarov", "MN": "E04.555.120.380", "FX": "Osteogenesis, Distraction", "MH_TH": "NLM (1996)", "ST": "T061", "PI": "Orthopedic Fixation Devices (1971-1995)", "MS": "A bone fixation technique using an external fixator (FIXATORS, EXTERNAL) for lengthening limbs, correcting pseudarthroses and other deformities, and assisting the healing of otherwise hopeless traumatic or pathological fractures and infections, such as chronic osteomyelitis. The method was devised by the Russian orthopedic surgeon Gavriil Abramovich Ilizarov (1921-1992). (From Bull Hosp Jt Dis 1992 Summer;52(1):1)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018889"}, {"RECTYPE": "D", "MH": "Chemoprevention", "DE": "CHEMOPREV", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Chemoprophylaxis|T061|NON|EQV|NLM (1996)|940720|abcdef", "MN": "E02.319.162", "FX": "Secondary Prevention", "MH_TH": "NLM (1996)", "ST": "T061", "AN": "IM general or unspecified only; prefer specific chemotherapeutic agent /ther use and disease /prev", "PI": "specific disease/prevention & control (1966-1995)", "MS": "The use of chemical compounds to prevent the development of a specific disease.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018890"}, {"RECTYPE": "D", "MH": "Dentate Gyrus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Gyrus Dentatus|T023|NON|EQV|NLM (1996)|950104|abcdef", "ENTRY": "Sector CA4, Hippocampal", "MN": "A08.186.211.200.885.287.500.345.200", "MH_TH": "NLM (1996)", "ST": "T023", "PI": "Hippocampus (1966-1995)", "MS": "GRAY MATTER situated above the GYRUS HIPPOCAMPI. It is composed of three layers. The molecular layer is continuous with the HIPPOCAMPUS in the hippocampal fissure. The granular layer consists of closely arranged spherical or oval neurons, called GRANULE CELLS, whose AXONS pass through the polymorphic layer ending on the DENDRITES of PYRAMIDAL CELLS in the hippocampus.", "PM": "1996", "HN": "1996", "MR": "20180630", "DA": "19950217", "DC": "1", "DX": "19960101", "UI": "D018891"}, {"RECTYPE": "D", "MH": "Proton-Motive Force", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "pH gradient|T081|NON|NRW|NLM (2003)|020311|abcdef", "ENTRY": "pH, delta", "MN": "G03.295.770", "FX": "Proton Pumps", "MH_TH": "NLM (1996)", "ST": "T044", "MS": "Energy that is generated by the transfer of protons or electrons across an energy-transducing membrane and that can be used for chemical, osmotic, or mechanical work. Proton-motive force can be generated by a variety of phenomena including the operation of an electron transport chain, illumination of a PURPLE MEMBRANE, and the hydrolysis of ATP by a proton ATPase. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed, p171)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018892"}, {"RECTYPE": "D", "MH": "Bronchoalveolar Lavage", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Lung Lavage|T060|T061|NON|EQV|NLM (1996)|940901|abbcdef", "ENTRY": "Lung Lavages", "MN": "E05.927.100", "MH_TH": "NLM (1996)", "ST": "T061", "AN": "an irrigation technique: do not confuse with BRONCHOALVEOLAR LAVAGE FLUID, the washings obtained by lavage", "PI": "Irrigation (1977-1995)", "MS": "Washing out of the lungs with saline or mucolytic agents for diagnostic or therapeutic purposes. It is very useful in the diagnosis of diffuse pulmonary infiltrates in immunosuppressed patients.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018893"}, {"RECTYPE": "D", "MH": "Reverse Transcriptase Inhibitors", "DE": "REVERSE TRANSCRIPTASE INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Reverse Transcriptase Inhibitor|T121|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Transcriptase Inhibitor, Reverse", "MN": "D27.505.954.122.388.308", "MH_TH": "NLM (1996)", "ST": "T121", "RN": "0", "PI": "RNA-Directed DNA Polymerase/antagonists & inhibitors (1972-1995)", "MS": "Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template.", "PM": "96", "HN": "96", "MR": "20200527", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018894"}, {"RECTYPE": "D", "MH": "Microsatellite Repeats", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Tetranucleotide Repeats|T114|T123|NON|NRW|NLM (1996)|940728|abbcdef", "ENTRY": "Tetranucleotide Repeat", "MN": "G05.360.340.024.850.500", "FX": "Microsatellite Instability", "MH_TH": "NLM (1996)", "ST": "T123", "PI": "Repetitive Sequences, Nucleic Acid (1991-1995)", "MS": "A variety of simple repeat sequences that are distributed throughout the GENOME. They are characterized by a short repeat unit of 2-8 basepairs that is repeated up to 100 times. They are also known as short tandem repeats (STRs).", "PM": "1996; for SIMPLE REPETITIVE SEQUENCE see MINISATELLITE REPEATS 1999-2011, see REPETITIVE SEQUENCE, NUCLEIC ACID 1990-1998", "HN": "1996; for SIMPLE REPETITIVE SEQUENCE use MINISATELLITE REPEATS 1999-2011, use REPETITIVE SEQUENCE, NUCLEIC ACID 1990-1998", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018895"}, {"RECTYPE": "D", "MH": "CpG Islands", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "CpG-Rich Islands|T114|T123|EQV|NLM (1996)|940901|abbdef", "ENTRY": "Islands, CpG-Rich", "MN": "G05.360.340.024.159", "MH_TH": "NLM (1996)", "ST": "T123", "PI": "Dinucleoside Phosphates (1989-1995)", "MS": "Areas of increased density of the dinucleotide sequence cytosine--phosphate diester--guanine. They form stretches of DNA several hundred to several thousand base pairs long. In humans there are about 45,000 CpG islands, mostly found at the 5' ends of genes. They are unmethylated except for those on the inactive X chromosome and some associated with imprinted genes.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018899"}, {"RECTYPE": "D", "MH": "Dinucleotide Repeats", "AQ": "DE ES GE IM PH RE", "ENTRY": "Dinucleotide Repeat", "MN": "G05.360.340.024.850.500.150", "MH_TH": "NLM (1996)", "ST": "T123", "PI": "Repetitive Sequences, Nucleic Acid (1989-1995)", "MS": "The most common of the microsatellite tandem repeats (MICROSATELLITE REPEATS) dispersed in the euchromatic arms of chromosomes. They consist of two nucleotides repeated in tandem; guanine and thymine, (GT)n, is the most frequently seen.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018900"}, {"RECTYPE": "D", "MH": "Peroxisomal Disorders", "DE": "PEROXISOMAL DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperpipecolic Acidemia|T047|NON|NRW|NLM (1996)|OMIM (2013)|ORD (2010)|940816|abcdeeef", "ENTRY": "Single Peroxisomal Dysfunctions", "MN": "C18.452.648.663", "MH_TH": "NLM (1996)", "ST": "T047", "AN": "general or unspecified; prefer specifics; do not confuse entry term ADRENOLEUKODYSTROPHY, NEONATAL with ADRENOLEUKODYSTROPHY", "PI": "Metabolism, Inborn Errors (1988-1995)", "MS": "A heterogeneous group of inherited metabolic disorders marked by absent or dysfunctional PEROXISOMES. Peroxisomal enzymatic abnormalities may be single or multiple. Biosynthetic peroxisomal pathways are compromised, including the ability to synthesize ether lipids and to oxidize long-chain fatty acid precursors. Diseases in this category include ZELLWEGER SYNDROME; INFANTILE REFSUM DISEASE; rhizomelic chondrodysplasia (CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC); hyperpipecolic acidemia; neonatal adrenoleukodystrophy; and ADRENOLEUKODYSTROPHY (X-linked). Neurologic dysfunction is a prominent feature of most peroxisomal disorders.", "PM": "1996", "HN": "1996", "CATSH": "CAT LIST", "MR": "20150608", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018901"}, {"RECTYPE": "D", "MH": "Chondrodysplasia Punctata, Rhizomelic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rhizomelic Chondrodysplasia Punctata|T047|NON|EQV|GHR (2014)|NLM (1996)|940819|RCDP|abcdeefv", "ENTRY": "Rhizomelic Chondrodysplasia Punctatas", "MN": "C18.452.648.663.265", "MH_TH": "NLM (1996)", "ST": "T047", "AN": "a form of osteochondrodysplasia with stippled epiphyses; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES", "PI": "Chondrodysplasia Punctata (1971-1995)", "MS": "An autosomal recessive form of CHONDRODYSPLASIA PUNCTATA characterized by defective plasmalogen biosynthesis and impaired peroxisomes. Patients have shortened proximal limbs and severely disturbed endochondral bone formation. The metabolic defects associated with the impaired peroxisomes are present only in the rhizomelic form of chondrodysplasia punctata. (From Scriver et al, Metabolic Basis of Inherited Disease, 6th ed, p1497)", "PM": "1996", "HN": "1996", "CATSH": "CAT LIST", "MR": "20150608", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018902"}, {"RECTYPE": "D", "MH": "Photorefractive Keratectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Photorefractive Keratectomies", "MN": "E04.540.825.437.500", "FX": "Lasers, Excimer", "MH_TH": "NLM (2005)", "ST": "T061", "AN": "often abbreviated PRK; coordinate with EXCIMER LASER", "PI": "Laser Surgery (1987-1995)", "MS": "A type of refractive surgery of the CORNEA to correct MYOPIA and ASTIGMATISM. An EXCIMER LASER is used directly on the surface of the EYE to remove some of the CORNEAL EPITHELIUM thus reshaping the anterior curvature of the cornea.", "PM": "2008; see KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LASER 1996-2007", "HN": "2008 (1996)", "CATSH": "CAT LIST", "MR": "20170620", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018903"}, {"RECTYPE": "D", "MH": "Antineoplastic Agents, Alkylating", "DE": "ANTINEOPL AGENTS ALKYLATING", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alkylating Agents, Antineoplastic|T121|NON|EQV|NLM (1996)|940826|ALKYLATING AGENTS ANTINEOPL|abcdefv", "ENTRY": "Drugs, Antineoplastic Alkylating", "MN": "D27.888.569.035.035", "MH_TH": "NLM (1996)", "ST": "T121", "RN": "0", "PI": "Antineoplastic Agents (1966-1995)", "MS": "A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026)", "PM": "96", "HN": "96", "MR": "20140625", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018906"}, {"RECTYPE": "D", "MH": "Privacy", "AQ": "LJ PX", "PRINT ENTRY": "Public Law 93-579|T089|NON|REL|NLM (1999)|980330|PUBLIC LAW 093 579|abcdefs", "ENTRY": "Public Law 93 579", "MN": "N03.706.615.862", "FX": "Self Disclosure", "MH_TH": "BIOETHICS (1974)", "ST": "T078", "AN": "a civil right to freedom from intrusion in one's private affairs; note X ref, a Federal statute; privacy of patient data or records: index under CONFIDENTIALITY", "MS": "The state of being free from intrusion or disturbance in one's private life or affairs. (Random House Unabridged Dictionary, 2d ed, 1993)", "OL": "use CIVIL RIGHTS to search PRIVACY 1980-95", "PM": "96; PRIVACY ACT was see CIVIL RIGHTS 1980-95", "HN": "96; PRIVACY ACT was see CIVIL RIGHTS 1980-95", "MR": "20090706", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018907"}, {"RECTYPE": "D", "MH": "Muscle Weakness", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Weaknesses, Muscular", "MN": "C23.888.592.608.593", "FX": "Asthenia", "MH_TH": "NLM (1996)", "ST": "T184", "AN": "general or unspecified as a clinical state or clinical manifestation; specific muscular or neuromuscular diseases of which this is a manifestation are also available; do not confuse \"myasthenia\" (my-, muscle and asthenia, weakness) in foreign titles with \"muscle weakness\": it is more likely to refer to MYASTHENIA GRAVIS; do not confuse with MUSCLE HYPOTONIA or MUSCLE FATIGUE", "PI": "Muscular Diseases (1966-1995)", "MS": "A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018908"}, {"RECTYPE": "D", "MH": "src Homology Domains", "DE": "SRC HOMOL DOMAINS", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "SH3 Domain|T082|T087|NRW|NLM (1996)|940830|SH Z 003 DOMAIN|abbdefs", "ENTRY": "src Homology Domain", "MN": "G02.111.570.820.709.275.750.500.750", "MH_TH": "NLM (1996)", "ST": "T087", "PI": "Sequence Homology, Amino Acid (1993-1995)", "MS": "Regions of AMINO ACID SEQUENCE similarity in the SRC-FAMILY TYROSINE KINASES that fold into specific functional tertiary structures. The SH1 domain is a CATALYTIC DOMAIN. SH2 and SH3 domains are protein interaction domains. SH2 usually binds PHOSPHOTYROSINE-containing proteins and SH3 interacts with CYTOSKELETAL PROTEINS.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19950106", "DC": "1", "DX": "19960101", "UI": "D018909"}, {"RECTYPE": "D", "MH": "Video Games", "AQ": "AE CL EC ES HI LJ PX SD SN ST TD", "ENTRY": "Video Game", "MN": "L01.224.900.930", "MH_TH": "NLM (1996)", "ST": "T073", "PI": "Play and Playthings (1983-1995)", "MS": "A form of interactive entertainment in which the player controls electronically generated images that appear on a video display screen. This includes video games played in the home on special machines or home computers, and those played in arcades.", "OL": "use PLAY AND PLAYTHINGS to search VIDEO GAMES 1984-95", "PM": "96; was see PLAY AND PLAYTHINGS 1984-95", "HN": "96; was see PLAY AND PLAYTHINGS 1984-95", "MR": "20180629", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018910"}, {"RECTYPE": "D", "MH": "Trinucleotide Repeats", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Triplet Repeats|T114|T123|NON|EQV|NLM (1996)|940914|abbcdef", "ENTRY": "Triplet Repeat", "MN": "G05.360.340.024.850.500.850", "MH_TH": "NLM (1996)", "ST": "T123", "PI": "Repetitive Sequences, Nucleic Acid (1989-1995)", "MS": "Microsatellite repeats consisting of three nucleotides dispersed in the euchromatic arms of chromosomes.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018911"}, {"RECTYPE": "D", "MH": "Arabs", "AQ": "CL ED GE HI LJ PX SN", "PRINT ENTRY": "Palestinians|T098|NON|NRW|NLM (1996)|941017|abcdef", "ENTRY": "People, Bedouin", "MN": "M01.686.461.125", "FX": "Islam", "MH_TH": "NLM (1996)", "ST": "T098", "AN": "specify geog if relevant", "MS": "Members of a Semitic people inhabiting the Arabian peninsula or other countries of the Middle East and North Africa. The term may be used with reference to ancient, medieval, or modern ethnic or cultural groups. (From Random House Unabridged Dictionary, 2d ed)", "PM": "96", "HN": "96", "MR": "20230531", "DA": "19950106", "DC": "1", "DX": "19960101", "UI": "D018912"}, {"RECTYPE": "D", "MH": "Event-Related Potentials, P300", "DE": "EVENT RELAT POTENTIALS P300", "DS": "EVENT RELATED POTENTIALS P 300", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "P300 Event-Related Potentials|T042|T060|EQV|NLM (1996)|940902|P A 300 EVENT RELATED POTENTIALS|P300 EVENT RELAT POTENTIALS|abbdefsv", "ENTRY": "P3b Event-Related Potential", "MN": "G11.561.200.500.350", "MH_TH": "NLM (1996)", "ST": "T060", "PI": "specific Evoked Potentials (1980-1995)", "MS": "A late-appearing component of the event-related potential. P300 stands for a positive deflection in the event-related voltage potential at 300 millisecond poststimulus. Its amplitude increases with unpredictable, unlikely, or highly significant stimuli and thereby constitutes an index of mental activity. (From Campbell, Psychiatric Dictionary, 6th ed)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018913"}, {"RECTYPE": "D", "MH": "Cells, Immobilized", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Immobilized Cells|T025|NON|EQV|NLM (1996)|940902|abcdef", "ENTRY": "Immobilized Cell", "MN": "A11.270", "MH_TH": "NLM (1996)", "ST": "T025", "MS": "Microbial, plant, or animal cells which are immobilized by attachment to solid structures, usually a column matrix. A common use of immobilized cells is in biotechnology for the bioconversion of a substrate to a particular product. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)", "PM": "96", "HN": "96", "DA": "19950106", "DC": "1", "DX": "19960101", "UI": "D018914"}, {"RECTYPE": "D", "MH": "Root Canal Preparation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Endodontics Access Cavity Preparation|T061|NON|NRW|NLM (2023)|211013|abcdef", "ENTRY": "Root Canal Preparations", "MN": "E06.931.625", "MH_TH": "NLM (1996)", "ST": "T061", "AN": "/instrum: reamers & broaches go here", "PI": "Root Canal Therapy (1966-1995)", "MS": "Various preparatory steps prior to ROOT CANAL THERAPY by extirpation of diseased pulp and preparation of access cavity to receive the sealing material.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20220708", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018915"}, {"RECTYPE": "D", "MH": "Blood-Aqueous Barrier", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Aqueous-Blood Barrier|T042|NON|EQV|NLM (2004)|030317|abcdef", "ENTRY": "Blood-Aqueous Barriers", "MN": "A09.371.894.030", "FX": "Capillary Permeability", "MH_TH": "NLM (1996)", "ST": "T042", "AN": "coord IM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM)", "PI": "Aqueous Humor (1966-1995)", "MS": "The selectively permeable barrier, in the EYE, formed by the nonpigmented layer of the EPITHELIUM of the CILIARY BODY, and the ENDOTHELIUM of the BLOOD VESSELS of the IRIS. TIGHT JUNCTIONS joining adjacent cells keep the barrier between cells continuous.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20030709", "DA": "19950106", "DC": "1", "DX": "19960101", "UI": "D018916"}, {"RECTYPE": "D", "MH": "Optic Neuropathy, Ischemic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Posterior Ischemic Optic Neuropathy|T047|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Optic Nerve Ischemias", "MN": "C14.907.601", "MH_TH": "NLM (1996)", "ST": "T047", "PI": "Optic Nerve Diseases (1976-1995)", "MS": "Ischemic injury to the OPTIC NERVE which usually affects the OPTIC DISK (optic neuropathy, anterior ischemic) and less frequently the retrobulbar portion of the nerve (optic neuropathy, posterior ischemic). The injury results from occlusion of arterial blood supply which may result from TEMPORAL ARTERITIS; ATHEROSCLEROSIS; COLLAGEN DISEASES; EMBOLISM; DIABETES MELLITUS; and other conditions. The disease primarily occurs in the sixth decade or later and presents with the sudden onset of painless and usually severe monocular visual loss. Anterior ischemic optic neuropathy also features optic disk edema with microhemorrhages. The optic disk appears normal in posterior ischemic optic neuropathy. (Glaser, Neuro-Ophthalmology, 2nd ed, p135)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19950106", "DC": "1", "DX": "19960101", "UI": "D018917"}, {"RECTYPE": "D", "MH": "Phacoemulsification", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Phacoemulsifications", "MN": "E04.943.875", "MH_TH": "NLM (1996)", "ST": "T061", "PI": "Cataract Extraction (1970-1995)", "MS": "A procedure for removal of the crystalline lens in cataract surgery in which an anterior capsulectomy is performed by means of a needle inserted through a small incision at the temporal limbus, allowing the lens contents to fall through the dilated pupil into the anterior chamber where they are broken up by the use of ultrasound and aspirated out of the eye through the incision. (Cline, et al., Dictionary of Visual Science, 4th ed & In Focus 1993;1(1):1)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20110624", "DA": "19950106", "DC": "1", "DX": "19960101", "UI": "D018918"}, {"RECTYPE": "D", "MH": "Neovascularization, Physiologic", "DE": "NEOVASC PHYSIOL", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Angiogenesis, Physiologic|T039|NON|EQV|NLM (1996)|950105|ANGIOGENESIS PHYSIOL|abcdefv", "ENTRY": "Physiological Neovascularization", "MN": "G09.330.630", "FX": "Vascular Remodeling", "MH_TH": "NLM (1996)", "ST": "T039", "AN": "coordinate with organ / blood supply; NEOVASCULARIZATION, PATHOLOGIC is also available; do not confuse with COLLATERAL CIRCULATION: circulation through secondary channels after obstruction of a principal vessel", "MS": "The development of new BLOOD VESSELS during the restoration of BLOOD CIRCULATION during the healing process.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20230522", "DA": "19950106", "DC": "1", "DX": "19960101", "UI": "D018919"}, {"RECTYPE": "D", "MH": "Coculture Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Cocultivation|T059|NON|EQV|NLM (1996)|940908|abcdef", "ENTRY": "Cocultures", "MN": "E05.481.500.374", "FX": "Tumor Cells, Cultured", "MH_TH": "NLM (2005)", "ST": "T059", "AN": "NIM; specify cell or tissue & infecting organism if relevant, probably NIM", "PI": "Tissue Culture (1974-1995)", "MS": "A technique of culturing mixed cell types in vitro to allow their synergistic or antagonistic interactions, such as on CELL DIFFERENTIATION or APOPTOSIS. Coculture can be of different types of cells, tissues, or organs from normal or disease states.", "PM": "2005; see COCULTURE 1996-2004", "HN": "2005 (1996)", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19950106", "DC": "1", "DX": "19960101", "UI": "D018920"}, {"RECTYPE": "D", "MH": "Leukostasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Leukostasis Syndrome|T047|NON|EQV|NLM (1996)|941130|abcdef", "ENTRY": "Syndromes, Leukostasis", "MN": "C15.378.553.560", "MH_TH": "NLM (1996)", "ST": "T047", "AN": "note category: abnorm intravasc leukocyte aggreg", "MS": "Abnormal intravascular leukocyte aggregation and clumping often seen in leukemia patients. The brain and lungs are the two most commonly affected organs. This acute syndrome requires aggressive cytoreductive modalities including chemotherapy and/or leukophoresis. It is differentiated from LEUKEMIC INFILTRATION which is a neoplastic process where leukemic cells invade organs.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "DA": "19950106", "DC": "1", "DX": "19960101", "UI": "D018921"}, {"RECTYPE": "D", "MH": "HL-60 Cells", "DS": "HL CELLS 060", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "HL60 Cell", "MN": "A11.627.340.360.500", "MH_TH": "NLM (1996)", "ST": "T025", "AN": "almost always NIM with no subheadings; check HUMAN; do not routinely add LEUKEMIA, PROMYELOCYTIC, ACUTE", "PI": "Tumor Cells, Cultured (1987-1995)", "MS": "A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. (From Hay et al., American Type Culture Collection, 7th ed, pp127-8)", "PM": "96", "HN": "96", "MR": "20050701", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018922"}, {"RECTYPE": "D", "MH": "Persian Gulf Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gulf War Syndrome|T047|EPO|EQV|NLM (1996)|940927|abcdef", "ENTRY": "Syndrome, Persian Gulf", "MN": "I01.880.735.950.500.951.500.500", "FX": "Open Waste Burning", "MH_TH": "NLM (1996)", "ST": "T047", "AN": "coord IM with specific dis or manifest (IM)", "MS": "Unexplained symptoms reported by veterans of the Persian Gulf War with Iraq in 1991. The symptoms reported include fatigue, skin rash, muscle and joint pain, headaches, loss of memory, shortness of breath, gastrointestinal and respiratory symptoms, and extreme sensitivity to commonly occurring chemicals. (Nature 1994 May 5;369(6475):8)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20230526", "DA": "19941227", "DC": "1", "DX": "19960101", "UI": "D018923"}, {"RECTYPE": "D", "MH": "Vascular Capacitance", "AQ": "DE ES GE IM PH RE", "ENTRY": "Capacitance, Vascular", "MN": "G09.330.380.906", "FX": "Vascular Resistance", "MH_TH": "NLM (1996)", "ST": "T033", "AN": "do not confuse with VASCULAR RESISTANCE, opposition to blood flow in a vasc bed", "PI": "Vascular Resistance (1967-1995)", "MS": "The measure of a BLOOD VESSEL's ability to increase the volume of BLOOD it holds without a large increase in BLOOD PRESSURE. The vascular capacitance is equal to the change in volume divided by the change in pressure.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19950222", "DC": "1", "DX": "19960101", "UI": "D018924"}, {"RECTYPE": "D", "MH": "Chemokines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Intercrines|T116|T129|NON|EQV|NLM (1996)|941003|abbcdef", "ENTRY": "Cytokine, Chemotactic", "MN": "D23.529.374.200", "FX": "Chemotaxis, Leukocyte", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "AN": "chemokines stands for CHEMOtactic cytoKINES; general or unspecified; prefer specifics", "PI": "Cytokines (1992-1995)", "MS": "Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; (CHEMOKINES, C); CC; (CHEMOKINES, CC); and CXC; (CHEMOKINES, CXC); according to variations in a shared cysteine motif.", "PM": "96", "HN": "96", "MR": "20200409", "DA": "19950217", "DC": "1", "DX": "19960101", "UI": "D018925"}, {"RECTYPE": "D", "MH": "Anti-Allergic Agents", "DS": "ANTIALLERGIC AGENTS", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiallergic Drug|T121|NON|EQV|NLM (2021)|200117|abcdef", "ENTRY": "Drugs, Antiallergic", "MN": "D27.505.954.016", "FX": "Histamine H1 Antagonists", "MH_TH": "NLM (1996)", "ST": "T121", "RN": "0", "AN": "consider also HYPERSENSITIVITY /drug ther", "PI": "Histamine H1 Antagonists (1966-1995)", "MS": "Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)", "PM": "96", "HN": "96", "MR": "20200527", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018926"}, {"RECTYPE": "D", "MH": "Anti-Asthmatic Agents", "DS": "ANTIASTHMATIC AGENTS", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiasthmatic Drug|T121|NON|EQV|NLM (2021)|200417|abcdef", "ENTRY": "Drugs, Antiasthmatic", "MN": "D27.505.954.796.050", "MH_TH": "NLM (1996)", "ST": "T121", "RN": "0", "AN": "consider also ASTHMA /drug ther", "PI": "Asthma/drug therapy (1966-1995)", "MS": "Drugs that are used to treat asthma.", "PM": "96", "HN": "96", "MR": "20200527", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018927"}, {"RECTYPE": "D", "MH": "Immunity, Mucosal", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Mucosal Immunity|T042|NON|EQV|NLM (1996)|941019|abcdef", "ENTRY": "Mucosal Immune Responses", "MN": "G12.450.573", "FX": "Immunoglobulin A, Secretory", "MH_TH": "NLM (1996)", "ST": "T042", "PI": "Mucous Membrane/immunology (1970-1995)", "MS": "Nonsusceptibility to the pathogenic effects of foreign microorganisms or antigenic substances as a result of antibody secretions of the mucous membranes. Mucosal epithelia in the gastrointestinal, respiratory, and reproductive tracts produce a form of IgA (IMMUNOGLOBULIN A, SECRETORY) that serves to protect these ports of entry into the body.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19950217", "DC": "1", "DX": "19960101", "UI": "D018928"}, {"RECTYPE": "D", "MH": "Cell Culture Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Culture Techniques, Cell", "MN": "E05.481.500.249", "FX": "Cells, Cultured", "MH_TH": "NLM (2005)", "ST": "T062", "AN": "note category: do not confuse with CELLS, CULTURED", "PI": "Tissue Culture (1966-1995)", "MS": "Methods for maintaining or growing CELLS in vitro.", "PM": "2005; see CELL CULTURE 1996-2004", "HN": "2005 (1996)", "CATSH": "CAT LIST", "MR": "20150706", "DA": "19950106", "DC": "1", "DX": "19960101", "UI": "D018929"}, {"RECTYPE": "D", "MH": "Antineoplastic Agents, Hormonal", "DE": "ANTINEOPL AGENTS HORMONAL", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hormonal Antineoplastic Agents|T121|NON|EQV|NLM (1996)|941024|HORMONAL ANTINEOPL AGENTS|abcdefv", "ENTRY": "Hormonal Drugs, Antineoplastic", "MN": "D27.505.954.248.169", "MH_TH": "NLM (1996)", "ST": "T121", "RN": "0", "AN": "consider also NEOPLASMS, HORMONE-DEPENDENT /drug ther", "PI": "Antineoplastic Agents (1966-1995)", "MS": "Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)", "PM": "96", "HN": "96", "MR": "20050630", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018931"}, {"RECTYPE": "D", "MH": "Chemokine CCL2", "DS": "CHEMOKINE CCL 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Monocyte Chemotactic Protein-1|T116|T129|NON|EQV|NLM (1996)|941025|MONOCYTE CHEMOTACTIC PROTEIN 001|abbcdefs", "ENTRY": "Monocyte Chemotactic Protein 1", "MN": "D23.529.374.200.110.990.500", "MH_TH": "NLM (2007)", "ST": "T129", "RN": "0", "PI": "Glycoproteins (1988-1990)", "MS": "A chemokine that is a chemoattractant for MONOCYTES and may also cause cellular activation of specific functions related to host defense. It is produced by LEUKOCYTES of both monocyte and lymphocyte lineage and by FIBROBLASTS during tissue injury. It has specificity for CCR2 RECEPTORS.", "PM": "2007; see MONOCYTE CHEMOATTRACTANT PROTEIN-1 1996-2006; MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR was indexed under CHEMOTACTIC FACTORS 1991-1995 & GLYCOPROTEINS 1988-1990", "HN": "2007(1989)", "MR": "20151123", "DA": "19950221", "DC": "1", "DX": "19960101", "UI": "D018932"}, {"RECTYPE": "D", "MH": "Pili, Sex", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Sex Pili|T026|NON|EQV|NLM (1995)|941025|abcdef", "ENTRY": "Pilus, Sex", "MN": "A20.867", "FX": "Conjugation, Genetic", "MH_TH": "NLM (1995)", "ST": "T026", "AN": "do not confuse with COMMON PILI see FIMBRIAE, BACTERIAL", "PI": "specific bacteria/ultrastructure (1975-1979)", "MS": "Filamentous or elongated proteinaceous structures which extend from the cell surface in gram-negative bacteria that contain certain types of conjugative plasmid. These pili are the organs associated with genetic transfer and have essential roles in conjugation. Normally, only one or a few pili occur on a given donor cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed, p675) This preferred use of \"pili\" refers to the sexual appendage, to be distinguished from bacterial fimbriae (FIMBRIAE, BACTERIAL), also known as common pili, which are usually concerned with adhesion.", "PM": "95", "HN": "95", "MR": "20090706", "DA": "19941025", "DC": "1", "DX": "19950101", "UI": "D018933"}, {"RECTYPE": "D", "MH": "Fournier Gangrene", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fournier's Gangrene|T047|EPO|EQV|NLM (1996)|990101|abcdef", "ENTRY": "Gangrene, Fournier's", "MN": "C12.200.294.229", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coordinate IM with specific site or organ/diseases term (IM) or with specific bacterial infection (IM) only if particularly discussed", "PI": "Gangrene (1966-1995)", "MS": "An acute necrotic infection of the SCROTUM; PENIS; or PERINEUM. It is characterized by scrotum pain and redness with rapid progression to gangrene and sloughing of tissue. Fournier gangrene is usually secondary to perirectal or periurethral infections associated with local trauma, operative procedures, or urinary tract disease.", "PM": "2000; see FOURNIER'S GANGRENE 1996-1999", "HN": "2000(1996)", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19950217", "DC": "1", "DX": "19960101", "UI": "D018934"}, {"RECTYPE": "D", "MH": "Hepatitis C Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Hepatitis Non A, Non B Antigen", "MN": "D23.050.327.495.505", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Antigens, Viral (1984-1995)", "MS": "Antigens of the virions of HEPACIVIRUS, their surface, core, or other associated antigens.", "OL": "use HEPATITIS C ANTIGENS (NM) to search HEPATITIS NON-A, NON-B ANTIGEN 1984-95", "PM": "96; HEPATITIS NON-A, NON-B ANTIGEN was indexed under ANTIGENS, VIRAL 1984-95", "HN": "96; was HEPATITIS NON-A, NON-B ANTIGEN (NM) 1984-95", "MR": "20220413", "DA": "19950217", "DC": "1", "DX": "19960101", "UI": "D018936"}, {"RECTYPE": "D", "MH": "Hepatitis C Antibodies", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "HCV Antibodies|T129|EQV|NLM (1996)|941026|abdef", "ENTRY": "Anti Hepatitis C Virus Antibodies", "MN": "D12.776.377.715.548.114.254.450.510", "PA": "Immunologic Factors", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Hepatitis Antibodies (1992-1995)", "MS": "Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins.", "OL": "use HEPATITIS C ANTIBODIES (NM) to search HEPATITIS C VIRUS ANTIBODIES 1992-95", "PM": "96; HEPATITIS C VIRUS ANTIBODIES was indexed under HEPATITIS ANTIBODIES 1992-95", "HN": "96; was HEPATITIS C VIRUS ANTIBODIES (NM) 1992-95", "MR": "20050630", "DA": "19950217", "DC": "1", "DX": "19960101", "UI": "D018937"}, {"RECTYPE": "D", "MH": "Caco-2 Cells", "DS": "CACO CELLS 002", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cells, Caco-2", "MN": "A11.436.140", "MH_TH": "NLM (1996)", "ST": "T025", "AN": "Caco stands for adenoCArcinoma of the COlon; almost always NIM with no subheadings; check HUMAN; do not routinely add ADENOCARCINOMA or COLONIC NEOPLASMS", "PI": "Tumor Cells, Cultured (1988-1995)", "MS": "Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells, such as ENTEROCYTES. These cells are valuable in vitro tools for studies related to intestinal cell function and differentiation.", "PM": "96", "HN": "96", "MR": "20030709", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D018938"}, {"RECTYPE": "D", "MH": "Holistic Nursing", "DE": "HOLISTIC NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Nursing, Holistic|T058|T091|NON|EQV|NLM (1996)|941027|NURS HOLISTIC|abbcdefv", "MN": "N02.421.533.282", "MH_TH": "NLM (1996)", "ST": "T091", "PI": "Philosophy, Nursing (1971-1995)", "MS": "A philosophy of nursing practice that takes into account total patient care, considering the physical, emotional, social, economic, and spiritual needs of patients, their response to their illnesses, and the effect of illness on patients' abilities to meet self-care needs. (From Mosby's Medical, Nursing, & Allied Health Dictionary, 4th ed, p745)", "PM": "96", "HN": "96", "MR": "20150629", "DA": "19950217", "DC": "1", "DX": "19960101", "UI": "D018939"}, {"RECTYPE": "D", "MH": "Elasmobranchii", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Elasmobranchs|T013|NON|EQV|NLM (1996)|941031|abcdef", "ENTRY": "Elasmobranchius", "MN": "B01.050.150.900.493.370", "MH_TH": "NLM (1996)", "ST": "T013", "RN": "txid7778", "AN": "general or unspecified; prefer specifics", "PI": "Fishes (1966-1995)", "MS": "A subclass of cartilaginous fish comprising the SHARKS; rays; skates (SKATES (FISH);), and sawfish. Elasmobranchs are typically predaceous, relying more on smell (the olfactory capsules are relatively large) than sight (the eyes are relatively small) for obtaining their food.", "PM": "1996", "HN": "1996", "MR": "20200813", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018940"}, {"RECTYPE": "D", "MH": "Antigens, CD19", "DS": "ANTIGENS CD 019", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "CD19 Antigens|T116|T129|EQV|NLM (1996)|941101|CD 019 ANTIGENS|abbdefs", "ENTRY": "Antigen, CD19", "MN": "D23.101.100.150.119", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Antigens, Surface (1987-1988)", "MS": "Differentiation antigens expressed on B-lymphocytes and B-cell precursors. They are involved in regulation of B-cell proliferation.", "OL": "use ANTIGENS, CD19 (NM) to search B CELL ANTIGEN CD19 1987-95", "PM": "96; B CELL ANTIGEN CD19 was indexed under ANTIGENS, CD 1990-95; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-95; & ANTIGENS, SURFACE 1987-88", "HN": "96; was B CELL ANTIGEN CD19 (NM) 1987-95", "MR": "20160309", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018941"}, {"RECTYPE": "D", "MH": "Macrolides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Macrolide|T109|NON|EQV|NLM (2021)|191129|abcdef", "MN": "D04.345.674.500", "MH_TH": "NLM (1996)", "ST": "T109", "RN": "0", "MS": "A group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties.", "PM": "96", "HN": "96", "MR": "20200527", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018942"}, {"RECTYPE": "D", "MH": "Anthracyclines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Anthracycline|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D09.408.051.059", "MH_TH": "NLM (1996)", "ST": "T109", "RN": "0", "MS": "Organic compounds that have a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.", "PM": "96", "HN": "96", "MR": "20200527", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018943"}, {"RECTYPE": "D", "MH": "Monocyte Chemoattractant Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Monocyte Chemotactic Proteins|T116|T129|NON|EQV|NLM (1996)|941117|abbcdef", "ENTRY": "Protein, Monocyte Chemotactic", "MN": "D23.529.374.200.110.990", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Chemotactic Factors (1991-1995)", "MS": "Chemokines that are chemoattractants for monocytes. These CC chemokines (cysteines adjacent) number at least three including CHEMOKINE CCL2.", "PM": "96", "HN": "96", "MR": "20210630", "DA": "19950221", "DC": "1", "DX": "19960101", "UI": "D018945"}, {"RECTYPE": "D", "MH": "Chemokine CCL5", "DS": "CHEMOKINE CCL 005", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RANTES|T116|T129|ACR|EQV|NLM (1996)|990101|abbcdef", "ENTRY": "T-Cell RANTES Protein", "MN": "D23.529.374.200.110.250", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "PI": "Lymphokines (1988-1995)", "MS": "A CC-type chemokine that is a chemoattractant for EOSINOPHILS; MONOCYTES; and LYMPHOCYTES. It is a potent and selective eosinophil chemotaxin that is stored in and released from PLATELETS and activated T-LYMPHOCYTES. Chemokine CCL5 is specific for CCR1 RECEPTORS; CCR3 RECEPTORS; and CCR5 RECEPTORS. The acronym RANTES refers to Regulated on Activation, Normal T Expressed and Secreted.", "PM": "2008; see RANTES 1996-2007; RANTES PROTEIN, T-CELL was indexed under LYMPHOKINES 1988-95; RANTES PROTEIN, MURINE was indexed under LYMPHOKINES 1992-95", "HN": "2008(1996)", "MR": "20070709", "DA": "19950221", "DC": "1", "DX": "19960101", "UI": "D018946"}, {"RECTYPE": "D", "MH": "Samoa", "AQ": "EH EP", "PRINT ENTRY": "Samoan Islands|T083|NAM|EQV|NLM (1996)|941121|abcdef", "ENTRY": "Samoa Islands|T083|NAM|EQV|NLM (1996)|941121|abcdef", "MN": "Z01.639.760.815.800", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "an island group in Polynesia; AMERICAN SAMOA & INDEPENDENT STATE OF SAMOA are also available", "PI": "Western Samoa (1968-1995)", "MS": "A group of islands in the southwest central Pacific, divided into AMERICAN SAMOA and the INDEPENDENT STATE OF SAMOA (Western Samoa). First European contact was made in 1722 by Jacob Roggeveen, a Dutchman. In 1768 they were named Navigators Islands by Louis de Bougainville. The present name may derive from that of a local chieftain or from a local word meaning place of the moa, a now-extinct island bird. (From Webster's New Geographical Dictionary, 1988, p1061 & Room, Brewer's Dictionary of Names, 1992, p481)", "OL": "use WESTERN SAMOA to search SAMOA 1994-95", "HN": "96; was see WESTERN SAMOA 1994-95", "MR": "20120703", "DA": "19950608", "DC": "4", "DX": "19960101", "UI": "D018947"}, {"RECTYPE": "D", "MH": "American Samoa", "AQ": "EH EP", "PRINT ENTRY": "Eastern Samoa|T083|NAM|EQV|NLM (1996)|941121|abcdef", "MN": "Z01.639.760.815.800.100", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island group in Samoa; admin by US Dept of Interior", "PI": "Western Samoa (1968-1995)", "MS": "A group of islands of SAMOA, in the southwest central Pacific. Its capital is Pago Pago. The islands were ruled by native chiefs until about 1869. An object of American interest beginning in 1839, Pago Pago and trading and extraterritorial rights were granted to the United States in 1878. The United States, Germany, and England administered the islands jointly 1889-99, but in 1899 they were granted to the United States by treaty. The Department of the Interior has administered American Samoa since 1951. (From Webster's New Geographical Dictionary, 1988, p44)", "OL": "use WESTERN SAMOA to search AMERICAN SAMOA 1976-95", "HN": "96; was see WESTERN SAMOA 1976-95", "MR": "20120703", "DA": "19950608", "DC": "4", "DX": "19960101", "UI": "D018948"}, {"RECTYPE": "D", "MH": "Antigens, CD1", "DS": "ANTIGENS CD 001", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "CD1 Antigens|T116|T129|EQV|NLM (1996)|941121|CD 001 ANTIGENS|abbdefs", "ENTRY": "Antigen, CD1", "MN": "D23.101.100.894.080", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "AN": "T-lymphocyte differentiation antigens; but read MeSH definition", "PI": "T-Lymphocytes (1988)", "MS": "Glycoproteins expressed on cortical thymocytes and on some dendritic cells and B-cells. Their structure is similar to that of MHC Class I and their function has been postulated as similar also. CD1 antigens are highly specific markers for human LANGERHANS CELLS.", "OL": "use ANTIGENS, CD1 (NM) to search CD1 ANTIGENS 1988-95", "PM": "96; CD1 ANTIGENS was indexed under ANTIGENS, CD 1990-95; ANTIGENS, DIFFERENTIATION 1988-91; & T-LYMPHYCYTES 1988", "HN": "96; was CD1 ANTIGENS (NM) 1988-95", "MR": "20060705", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018949"}, {"RECTYPE": "D", "MH": "Lipopolysaccharide Receptors", "DE": "LIPOPOLYSACCHARIDE RECEPT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "sCD14|T116|NON|REL|NLM (2021)|200218|abcdef", "ENTRY": "CD14, Soluble", "MN": "D23.101.100.900.045", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "AN": "myelomonocytic differentiation antigen", "PI": "Receptors, Immunologic (1983-1995)", "MS": "Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including MONOCYTES; MACROPHAGES; and some GRANULOCYTES. They function as receptors for the complex of lipopolysaccharide (LPS) and LPS-binding protein.", "PM": "2018; see ANTIGENS, CD14 1995-2017; LIPOPOLYSACCHARIDE RECEPTORS was indexed under ANTIGENS, CD 1990-95; under ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-95; and under ANTIGENS, DIFFERENTIATION 1988; LIPOGLYCAN RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1983-95", "HN": "2018 (1983)", "MR": "20230316", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018950"}, {"RECTYPE": "D", "MH": "Antigens, CD20", "DS": "ANTIGENS CD 020", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "CD20 Antigens|T116|T129|EQV|NLM (1996)|941121|CD 020 ANTIGENS|abbdefs", "ENTRY": "Antigen, CD20", "MN": "D23.101.100.150.120", "FX": "Rituximab", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Antigens, Differentiation, B-Lymphocyte (1988-1995)", "MS": "Unglycosylated phosphoproteins expressed only on B-cells. They are regulators of transmembrane Ca2+ conductance and thought to play a role in B-cell activation and proliferation.", "PM": "1996; see CD20 ANTIGEN 1988-1995; ANTIGENS, CD20 was indexed under ANTIGENS, CD 1990-95 and under ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-95", "HN": "1996; use CD20 ANTIGEN 1988-95", "MR": "20170531", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018951"}, {"RECTYPE": "D", "MH": "Antigens, CD34", "DS": "ANTIGENS CD 034", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "CD34 Antigens|T116|T129|EQV|NLM (1996)|941121|CD 034 ANTIGENS|abbdefs", "ENTRY": "Antigen, CD34", "MN": "D23.101.100.110.134", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "AN": "differentiation antigens", "PI": "Antigens, Differentiation (1988-1991)", "MS": "Glycoproteins found on immature hematopoietic cells and endothelial cells. They are the only molecules to date whose expression within the blood system is restricted to a small number of progenitor cells in the bone marrow.", "OL": "use ANTIGENS, CD34 (NM) to search CD34 ANTIGEN 1988-95", "PM": "96; CD34 ANTIGEN was indexed under ANTIGENS, CD 1990-95 & ANTIGENS, DIFFERENTIATION 1988-91", "HN": "96; was CD34 ANTIGEN (NM) 1988-95", "MR": "20050630", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018952"}, {"RECTYPE": "D", "MH": "Kinesiology, Applied", "DE": "KINESIOL APPLIED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Applied Kinesiology|T057|T091|NON|EQV|NLM (1996)|941201|APPLIED KINESIOL|abbcdefv", "MN": "E02.831.535.867.344", "MH_TH": "NLM (1996)", "ST": "T091", "AN": "do not confuse with KINESIS; KINETICS or KINESTHESIS ", "MS": "The study of muscles and the movement of the human body. In holistic medicine it is the balance of movement and the interaction of a person's energy systems. Applied kinesiology is the name given by its inventor, Dr. George Goodheart, to the system of applying muscle testing diagnostically and therapeutically to different aspects of health care. (Thorsons Introductory Guide to Kinesiology, 1992, p13)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19950221", "DC": "1", "DX": "19960101", "UI": "D018953"}, {"RECTYPE": "D", "MH": "Drugs, Essential", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Essential Drugs", "MN": "D26.355", "FX": "Formularies as Topic", "MH_TH": "NLM (1996)", "ST": "T121", "RN": "0", "PI": "Drugs (1978-1995)", "MS": "Drugs considered essential to meet the health needs of a population as well as to control drug costs.", "PM": "1996", "HN": "1996", "MR": "20140616", "DA": "19950217", "DC": "1", "DX": "19960101", "UI": "D018954"}, {"RECTYPE": "D", "MH": "CD36 Antigens", "DS": "CD 036 ANTIGENS", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Thrombospondin Receptors|T116|T129|T192|NON|EQV|NLM (1996)|941122|THROMBOSPONDIN RECEPT|abbbcdefv", "ENTRY": "SR BI Receptor", "MN": "D12.776.543.750.710.450.750.625.249", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "MS": "Leukocyte differentiation antigens and major platelet membrane glycoproteins present on MONOCYTES; ENDOTHELIAL CELLS; PLATELETS; and mammary EPITHELIAL CELLS. They play major roles in CELL ADHESION; SIGNAL TRANSDUCTION; and regulation of angiogenesis. CD36 is a receptor for THROMBOSPONDINS and can act as a scavenger receptor that recognizes and transports oxidized LIPOPROTEINS and FATTY ACIDS.", "PM": "2018; see ANTIGENS, CD36 1996-2017; CD36 ANTIGENS was indexed under ANTIGENS, CD 1990-1995; and under ANTIGENS, DIFFERENTIATION 1989-1991; CD36 ANTIGEN (COLLAGEN TYPE I RECEPTOR, THROMBSPONDIN RECEPTOR) was indexed under ANTIGENS, CD36 2004; ORGANIC ANION TRANSPORTERS 1996-2004 and under MEMBRANE GLYCOPROTEINS 1996-2004; SCAVENGER RECEPTORS, CLASS B, TYPE I was indexed under RECEPTORS, IMMUNOLOGIC 2005", "HN": "2018 (1996)", "MR": "20230316", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018955"}, {"RECTYPE": "D", "MH": "CD5 Antigens", "DS": "CD 005 ANTIGENS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antigens, CD5|T116|T129|ACX|EQV|NLM (1996)|990101|ANTIGENS CD 005|abbcdefs", "ENTRY": "Leu 1 Antigen", "MN": "D23.101.100.894.101", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Antigens, Differentiation (1990-1991)", "MS": "Glycoproteins expressed on all mature T-cells, thymocytes, and a subset of mature B-cells. Antibodies specific for CD5 can enhance T-cell receptor-mediated T-cell activation. The B-cell-specific molecule CD72 is a natural ligand for CD5. (From Abbas et al., Cellular and Molecular Immunology, 2d ed, p156)", "PM": "2018; see ANTIGENS, CD5 1996-2017 and CD5 ANTIGEN 1988-1995; CD5 ANTIGENS was indexed under ANTIGENS, CD 1990-95; and under ANTIGENS, DIFFERENTIATION 1990-91", "HN": "2018 (1988)", "MR": "20170602", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018956"}, {"RECTYPE": "D", "MH": "CD59 Antigens", "DS": "CD 059 ANTIGENS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protectin|T116|T129|NON|EQV|NLM (2000)|991104|abbcdef", "ENTRY": "Membrane Inhibitor of Reactive Lysis|T116|T129|NON|EQV|NLM (1996)|941123|MIRL|abbcdefv", "MN": "D12.776.543.550.418.140", "PA": "Complement Inactivating Agents", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Membrane Glycoproteins (1989-1995)", "MS": "Small glycoproteins found on both hematopoietic and non-hematopoietic cells. CD59 restricts the cytolytic activity of homologous complement by binding to C8 and C9 and blocking the assembly of the membrane attack complex. (From Barclay et al., The Leukocyte Antigen FactsBook, 1993, p234)", "PM": "2018; see ANTIGENS, CD59 1996-2017 and CD59 ANTIGEN 1989-1995; CD59 ANTIGEN was indexed under ANTIGENS, CD 1990-1995; under MEMBRANE GLYCOPROTEINS 1989-1995; and under ANTIGENS, DIFFERENTIATION 1989-1991; MEMBRANE ATTACK COMPLEX INHIBITION FACTOR was indexed under PROTEINS 1992-1997 and under BLOOD PROTEINS 1990-1991; PROTECTIN was indexed under ION CHANNELS 1996-1999", "HN": "2018 (1990); for PROTECTIN use CATIONIC PROTEIN, URATE-CALCIUM OXALATE STONE 1996-1999", "MR": "20230316", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018957"}, {"RECTYPE": "D", "MH": "CD55 Antigens", "DS": "CD 055 ANTIGENS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Decay-Accelerating Factor|T116|T129|NON|EQV|NLM (1996)|941123|abbcdef", "ENTRY": "Decay-Accelerating Factor, Complement", "MN": "D12.776.543.550.418.130", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Membrane Proteins (1985-1992)", "MS": "GPI-linked membrane proteins broadly distributed among hematopoietic and non-hematopoietic cells. CD55 prevents the assembly of C3 CONVERTASE or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex.", "PM": "2018; see ANTIGENS, CD55 1996-2017 and DECAY-ACCELERATING FACTOR 1985-95; DECAY-ACCELERATING FACTOR was indexed under ANTIGENS, CD 1990-95; under MEMBRANE GLYCOPROTEINS 1988-95; under MEMBRANE PROTEINS 1985-92; and under BLOOD PROTEINS 1985-86", "HN": "2018 (1985)", "MR": "20230316", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018958"}, {"RECTYPE": "D", "MH": "CD57 Antigens", "DS": "CD 057 ANTIGENS", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antigens, CD57|T116|T129|ACX|EQV|NLM (1996)|990101|ANTIGENS CD 057|abbcdefs", "ENTRY": "Leu 7 Antigen", "MN": "D23.101.100.894.157", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "AN": "T-lymphocyte differentiation antigens", "PI": "Antigens, Differentiation, T-Lymphocyte (1989-1993)", "MS": "Oligosaccharide antigenic determinants found principally on NK CELLS and T-CELLS. They are expressed at high levels in terminally differentiated or senescent cells with reduced proliferative capacity; however, their role in the immune response is poorly understood.", "PM": "2018; see ANTIGENS, CD57 1996-2017 and HNK-1 ANTIGEN 1989-95; HNK-1 ANTIGEN was indexed under ANTIGENS, CD 1990-95; under ANTIGENS DIFFERENTIATION, T-LYMPHOCYTE 1989-95; and under ANTIGENS, DIFFERENTIATION 1989-93", "HN": "2018 (1989)", "MR": "20170602", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018959"}, {"RECTYPE": "D", "MH": "Hyaluronan Receptors", "DE": "HYALURONAN RECEPT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Hyaluronan|T116|T129|T192|NON|EQV|NLM (1996)|950419|RECEPT HYALURONAN|abbbcdefv", "ENTRY": "Receptor, Hyaluronan", "MN": "D23.050.301.350.625.144", "FX": "Blood Group Antigens", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "PI": "Receptors, Lymphocyte Homing (1991-1995)", "MS": "Acidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary THYMOCYTES; GRANULOCYTES; MACROPHAGES; erythrocytes, and fibroblasts. Their interaction with HYALURONIC ACID mediates binding of lymphocytes to high endothelial VENULES.", "PM": "2018; see ANTIGENS, CD44 1996-2017 and HYALURONIC ACID BINDING PROTEIN 1980-95; HYALURONAN RECEPTORS was indexed under CARRIER PROTEINS 1980-95; and under RECEPTORS, LYPHOCYTE HOMING 1991-95", "HN": "2018 (1996); for CD44 ANTIGENS use RECEPTORS, LYMPHOCYTE HOMING 1991-93", "MR": "20230316", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018960"}, {"RECTYPE": "D", "MH": "Educational Technology", "DE": "EDUC TECHNOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Technology, Educational|T065|NON|EQV|NLM (1996)|950103|TECHNOL EDUC|abcdefv", "ENTRY": "Technologies, Instructional", "MN": "J01.897.280", "FX": "Teaching Materials", "MH_TH": "NLM (1996)", "ST": "T065", "AN": "coordinate with field or medium of education ", "MS": "Systematic identification, development, organization, or utilization of educational resources and the management of these processes. It is occasionally used also in a more limited sense to describe the use of equipment-oriented techniques or audiovisual aids in educational settings. (Thesaurus of ERIC Descriptors, December 1993, p132)", "PM": "96", "HN": "96", "MR": "20190524", "DA": "19950317", "DC": "1", "DX": "19960101", "UI": "D018961"}, {"RECTYPE": "D", "MH": "Phlebotomy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Venipuncture|T058|NON|REL|NLM (1996)|941128|abcdef", "ENTRY": "Venipunctures", "MN": "E05.200.998.110.625", "FX": "Leeching", "MH_TH": "NLM (1996)", "ST": "T061", "AN": "for historical articles & historical contexts use BLOODLETTING", "PI": "Bloodletting (1966-1995)", "MS": "The techniques used to draw blood from a vein for diagnostic purposes or for treatment of certain blood disorders such as erythrocytosis, hemochromatosis, polycythemia vera, and porphyria cutanea tarda.", "PM": "1996; see BLOODLETTING 1987-1995; VENESECTION see BLOODLETTING 1987-1995; VENIPUNCTURE see BLOODLETTING 1989-1995", "HN": "1996; use BLOODLETTING 1987-1995; VENESECTION use BLOODLETTING 1987-1995; VENIPUNCTURE use BLOODLETTING 1989-1995", "CATSH": "CAT LIST", "MR": "20220711", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D018962"}, {"RECTYPE": "D", "MH": "Hepatitis Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Antigens, Hepatitis|T129|NON|EQV|NLM (1996)|941129|abcdef", "MN": "D23.050.327.495", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Antigens from any of the hepatitis viruses including surface, core, and other associated antigens.", "PM": "96", "HN": "96", "MR": "20220413", "DA": "19950222", "DC": "1", "DX": "19960101", "UI": "D018963"}, {"RECTYPE": "D", "MH": "Frameshifting, Ribosomal", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Ribosomal Frameshifting|T045|NON|EQV|NLM (1996)|941202|abcdef", "ENTRY": "Translational Frameshifting", "MN": "G05.308.215", "FX": "Frameshift Mutation", "MH_TH": "NLM (1996)", "ST": "T045", "AN": "do not confuse with FRAMESHIFT MUTATION, non-physiol insertion or deletion of coding sequence nucleotides", "PI": "Translation, Genetic (1979-1995)", "MS": "A directed change in translational READING FRAMES that allows the production of a single protein from two or more OVERLAPPING GENES. The process is programmed by the nucleotide sequence of the MRNA and is sometimes also affected by the secondary or tertiary mRNA structure. It has been described mainly in VIRUSES (especially RETROVIRUSES); RETROTRANSPOSONS; and bacterial insertion elements but also in some cellular genes.", "OL": "use FRAMESHIFT MUTATION to search RIBOSOMAL FRAMESHIFT 1991-95", "PM": "96; was RIBOSOMAL FRAMESHIFT see FRAMESHIFT MUTATION 1991-95", "HN": "96; was RIBOSOMAL FRAMESHIFT see FRAMESHIFT MUTATION 1991-95", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19950222", "DC": "1", "DX": "19960101", "UI": "D018965"}, {"RECTYPE": "D", "MH": "Library Materials", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Materials, Library", "MN": "L01.583.420", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "print & non-print materials in libraries: not restricted to books", "MS": "Print and non-print materials collected, processed, and stored by libraries. They comprise books, periodicals, pamphlets, reports, microforms, maps, manuscripts, motion pictures, and all other forms of audiovisual records. (Harrod, The Librarians' Glossary, 4th ed, p497)", "PM": "96", "HN": "96", "MR": "20180629", "DA": "19950222", "DC": "1", "DX": "19960101", "UI": "D018966"}, {"RECTYPE": "D", "MH": "Risperidone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R64766", "MN": "D03.383.742.698.685", "PA": "Serotonin Antagonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6 ,7,8,9-tetrahydro-2-methyl-", "RN": "L6UH7ZF8HC", "RR": "106266-06-2 (Risperidone)", "PI": "Piperidines (1988-1995)", "MS": "A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.", "OL": "use RISPERIDONE (NM) to search RISPERIDONE 1988-95", "PM": "96; RISPERIDONE was indexed under ISOXAZOLES & PIPERIDINES 1988-95", "HN": "96; was RISPERIDONE (NM) 1988-95", "MR": "20160531", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018967"}, {"RECTYPE": "D", "MH": "CD58 Antigens", "DS": "CD 058 ANTIGENS", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Lymphocyte Function Associated Antigen-3|T116|T129|T192|NON|EQV|NLM (1996)|950309|LYMPHOCYTE FUNCTION ASSOCIATED 03 ANTIGEN|LYMPHOCYTE FUNCTION ASSOC ANTIGEN 3|abbbcdefsv", "ENTRY": "Lymphocyte Function Associated Antigen 3", "MN": "D12.776.543.550.158", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "AN": "differentiation antigens", "PI": "Membrane Glycoproteins (1988-1995)", "MS": "Glycoproteins with a wide distribution on hematopoietic and non-hematopoietic cells and strongly expressed on MACROPHAGES. CD58 mediates cell adhesion by binding to CD2; (CD2 ANTIGENS); and this enhances antigen-specific T-cell activation.", "PM": "2018; see ANTIGENS, CD58 1996-2017; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3 was indexed under ANTIGENS, CD 1990-95; under ANTIGENS DIFFERENTIATION 1990-91; under MEMBRANE GLYCOPROTEINS 1988-95; and under ANTIGENS, SURFACE 1988-92", "HN": "2018 (1988); use LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3 1988-95", "MR": "20230316", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018968"}, {"RECTYPE": "D", "MH": "Insulin-Like Growth Factor Binding Proteins", "DS": "INSULIN LIKE GROWTH FACTOR 99 BINDING PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Somatomedin-Binding Proteins|T116|T123|NON|EQV|NLM (1996)|941208|abbcdef", "ENTRY": "Somatomedin Binding Proteins", "MN": "D12.776.157.420", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Carrier Proteins (1980-1995)", "MS": "A family of soluble proteins that bind insulin-like growth factors and modulate their biological actions at the cellular level. (Int J Gynaecol Obstet 1992;39(1):3-9)", "PM": "2005; see INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS 1996-2004; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-1995", "HN": "2005(1996)", "MR": "20200527", "DA": "19950616", "DC": "1", "DX": "19960101", "UI": "D018969"}, {"RECTYPE": "D", "MH": "Insulin-Like Growth Factor Binding Protein 1", "DS": "INSULIN LIKE GROWTH FACTOR 01 BINDING PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "IGFBP-1|T116|T123|ABB|EQV|NLM (1996)|941208|IGFBP 01|abbcdefs", "ENTRY": "Insulin Like Growth Factor Binding Protein 1", "MN": "D12.776.157.420.250", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1992-1995)", "MS": "One of the six homologous proteins that specifically bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions. The function of this protein is not completely defined. However, several studies demonstrate that it inhibits IGF binding to cell surface receptors and thereby inhibits IGF-mediated mitogenic and cell metabolic actions. (Proc Soc Exp Biol Med 1993;204(1):4-29)", "PM": "2005; see INSULIN-LIKE-GROWTH-FACTOR-BINDING PROTEIN-1 1996-2005; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1 was indexed under CARRIER PROTEINS 1992-95", "HN": "2005(1992)", "MR": "20130709", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018970"}, {"RECTYPE": "D", "MH": "Insulin-Like Growth Factor Binding Protein 2", "DS": "INSULIN LIKE GROWTH FACTOR 02 BINDING PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "IGFBP-2|T116|T123|EQV|NLM (1996)|941208|IGFBP 02|abbdefs", "ENTRY": "Insulin Like Growth Factor Binding Protein 2", "MN": "D12.776.157.420.260", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1991-1995)", "MS": "One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level.", "OL": "use INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2 (NM) to search INSULIN LIKE GROWTH FACTOR-BINDING PROTEIN-2 1991-95", "PM": "96; INSULIN LIKE GROWTH FACTOR-BINDING PROTEIN-2 was indexed under CARRIER PROTEINS 1991-95", "HN": "96; was INSULIN LIKE GROWTH FACTOR-BINDING PROTEIN-2 (NM) 1991-95", "MR": "20040707", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018971"}, {"RECTYPE": "D", "MH": "Insulin-Like Growth Factor Binding Protein 3", "DS": "INSULIN LIKE GROWTH FACTOR 03 BINDING PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "IGFBP-3|T116|T123|ABB|EQV|NLM (1996)|941208|IGFBP 03|abbcdefs", "ENTRY": "Protein 3, IGF-Binding", "MN": "D12.776.157.420.270", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1980-1995)", "MS": "One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level.", "OL": "use INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEINS (NM) to search INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 1980-95", "PM": "96; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-95", "HN": "96; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 was SY to INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS 1980-95", "MR": "20160628", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018972"}, {"RECTYPE": "D", "MH": "Intellectual Property", "ENTRY": "Property, Intellectual", "MN": "N03.706.535.518", "MH_TH": "NLM (1996)", "ST": "T170", "AN": "specify geographic term if pertinent", "PI": "Patents (1992-1995)", "MS": "Property, such as patents, trademarks, and copyright, that results from creative effort. The Patent and Copyright Clause (Art. 1, Sec. 8, cl. 8) of the United States Constitution provides for promoting the progress of science and useful arts by securing for limited times to authors and inventors, the exclusive right to their respective writings and discoveries. (From Black's Law Dictionary, 5th ed, p1014)", "PM": "96", "HN": "96", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018973"}, {"RECTYPE": "D", "MH": "Insulin-Like Growth Factor Binding Protein 4", "DS": "INSULIN LIKE GROWTH FACTOR 04 BINDING PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "IGFBP-4|T116|T123|ABB|EQV|NLM (1996)|941208|IGFBP 04|abbcdefs", "ENTRY": "Insulin Like Growth Factor Binding Protein 4", "MN": "D12.776.157.420.280", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1991-1995)", "MS": "One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level.", "PM": "2005; see INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEIN 4 1996-2005; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4 was indexed under CARRIER PROTEINS 1991-95", "HN": "2005(1991)", "MR": "20040920", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018974"}, {"RECTYPE": "D", "MH": "Insulin-Like Growth Factor Binding Protein 5", "DS": "INSULIN LIKE GROWTH FACTOR 05 BINDING PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "IGFBP-5|T116|T123|ABB|EQV|NLM (1996)|941208|IGFBP 05|abbcdefs", "ENTRY": "Insulin Like Growth Factor Binding Protein 5", "MN": "D12.776.157.420.290", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1991-1995)", "MS": "One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level.", "PM": "2005; see INSULIN-LIKE GROWTH-FACTOR-BINDING-PROTEIN-5 1996-2004; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-5 was indexed under CARRIER PROTEINS 1991-1995", "HN": "2005(1991)", "MR": "20040707", "DA": "19950616", "DC": "1", "DX": "19960101", "UI": "D018975"}, {"RECTYPE": "D", "MH": "Insulin-Like Growth Factor Binding Protein 6", "DS": "INSULIN LIKE GROWTH FACTOR 06 BINDING PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "IGFBP-6|T116|T123|ABB|EQV|NLM (1996)|941208|IGFBP 06|abbcdefs", "ENTRY": "Insulin Like Growth Factor Binding Protein 6", "MN": "D12.776.157.420.300", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1992-1995)", "MS": "One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level.", "PM": "2005; see INSULIN-LIKE-GROWTH-FACTOR-BINDING PROTEIN 6 1996-2004; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6 was indexed under CARRIER PROTEINS 1992-1995", "HN": "2005(1992)", "MR": "20040707", "DA": "19950616", "DC": "1", "DX": "19960101", "UI": "D018976"}, {"RECTYPE": "D", "MH": "Micronutrients", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Micronutrient", "MN": "J02.500.681.500", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "AN": "coordinate with specific micronutrient if pertinent ", "PI": "Trace Elements (1966-1995)", "MS": "Essential dietary elements or organic compounds that are required in only small quantities for normal physiologic processes to occur.", "OL": "use TRACE ELEMENTS to search MICRONUTRIENTS 1994-95", "PM": "96; was see TRACE ELEMENTS 1994-95", "HN": "96; was see TRACE ELEMENTS 1994-95", "MR": "20190705", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D018977"}, {"RECTYPE": "D", "MH": "Molting", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Ecdysis|T040|NON|EQV|NLM (1996)|941212|abcdef", "ENTRY": "Moultings", "MN": "G07.345.500.550.750", "FX": "Ecdysterone", "MH_TH": "NLM (1996)", "ST": "T040", "MS": "Periodic casting off FEATHERS; HAIR; or cuticle. Molting is a process of sloughing or desquamation, especially the shedding of an outer covering and the development of a new one. This phenomenon permits growth in ARTHROPODS, skin renewal in AMPHIBIANS and REPTILES, and the shedding of winter coats in BIRDS and MAMMALS.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20160617", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D018978"}, {"RECTYPE": "D", "MH": "Myositis, Inclusion Body", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myopathy, Inclusion Body, Sporadic|T047|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Myositides, Inclusion Body", "MN": "C10.668.491.562.500", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not coord with INCLUSION BODIES but coord with INCLUSION BODIES, VIRAL if relevant (IM or NIM)", "PI": "Myositis (1968-1995)", "MS": "Progressive myopathies characterized by the presence of inclusion bodies on muscle biopsy. Sporadic and hereditary forms have been described. The sporadic form is an acquired, adult-onset inflammatory vacuolar myopathy affecting proximal and distal muscles. Familial forms usually begin in childhood and lack inflammatory changes. Both forms feature intracytoplasmic and intranuclear inclusions in muscle tissue. (Adams et al., Principles of Neurology, 6th ed, pp1409-10)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D018979"}, {"RECTYPE": "D", "MH": "Williams Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Contiguous Gene Syndrome, Williams|T047|EPO|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Williams Beuren Syndrome", "MN": "C16.320.180.970", "FX": "Intellectual Disability", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with Williams-Campbell syndrome, a congenital cartilage deficiency", "PI": "Aortic Valve Stenosis (1969-1995)", "MS": "A disorder caused by hemizygous microdeletion of about 28 genes on chromosome 7q11.23, including the ELASTIN gene. Clinical manifestations include SUPRAVALVULAR AORTIC STENOSIS; MENTAL RETARDATION; elfin facies; impaired visuospatial constructive abilities; and transient HYPERCALCEMIA in infancy. The condition affects both sexes, with onset at birth or in early infancy.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20200228", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D018980"}, {"RECTYPE": "D", "MH": "Congenital Disorders of Glycosylation", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Glycoprotein Syndrome, Carbohydrate-Deficient|T047|NON|EQV|NLM (1996)|941212|GLYCOPROTEIN SYNDROME CARB DEFIC|abcdefv", "ENTRY": "Syndromes, Carbohydrate-Deficient Glycoprotein", "MN": "C18.452.648.202.125", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Glycoproteins (1977-1995)", "MS": "A genetically heterogeneous group of heritable disorders resulting from defects in protein N-glycosylation.", "PM": "2011; CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME (1996-2010)", "HN": "2011(1996)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D018981"}, {"RECTYPE": "D", "MH": "DNA Footprinting", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Footprints, DNA|T034|REL|NLM (1996)|941214|abdef", "ENTRY": "Footprintings, DNA", "MN": "E05.393.300", "MH_TH": "NLM (1996)", "ST": "T063", "AN": "DNA FINGERPRINTING is available", "MS": "A method for determining the sequence specificity of DNA-binding proteins. DNA footprinting utilizes a DNA damaging agent (either a chemical reagent or a nuclease) which cleaves DNA at every base pair. DNA cleavage is inhibited where the ligand binds to DNA. (from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D018983"}, {"RECTYPE": "D", "MH": "Epitopes, T-Lymphocyte", "DS": "EPITOPES LYMPHOCYTE T", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "T-Lymphocyte Epitopes|T129|EQV|NLM (1996)|941214|LYMPHOCYTE EPITOPES T|abdefs", "ENTRY": "T Lymphocyte Epitopes", "MN": "D23.050.550.402", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Epitopes (1983-1995)", "MS": "Antigenic determinants recognized and bound by the T-cell receptor. Epitopes recognized by the T-cell receptor are often located in the inner, unexposed side of the antigen, and become accessible to the T-cell receptors after proteolytic processing of the antigen.", "PM": "96", "HN": "96", "MR": "20050630", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D018984"}, {"RECTYPE": "D", "MH": "Epitopes, B-Lymphocyte", "DS": "EPITOPES LYMPHOCYTE B", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "B-Lymphocyte Epitopes|T129|EQV|NLM (1996)|941214|LYMPHOCYTE EPITOPES B|abdefs", "ENTRY": "Epitopes, B-Cell", "MN": "D23.050.550.395", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Epitopes (1987-1995)", "MS": "Antigenic determinants recognized and bound by the B-cell receptor. Epitopes recognized by the B-cell receptor are located on the surface of the antigen.", "PM": "96", "HN": "96", "MR": "20050630", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018985"}, {"RECTYPE": "D", "MH": "Motor Vehicles", "AQ": "CL EC ES HI LJ SN ST", "PRINT ENTRY": "Tanks|T073|NON|NRW|NLM (2020)|190503|abcdef", "ENTRY": "Vehicles, Motor", "MN": "J01.937.500", "FX": "Accidents, Traffic", "MH_TH": "NLM (1996)", "ST": "T073", "AN": "general or unspecified; prefer specifics ", "PI": "specific vehicles (1966-1995)", "MS": "AUTOMOBILES, trucks, buses, or similar engine-driven conveyances. (From Random House Unabridged Dictionary, 2d ed)", "PM": "96", "HN": "96", "MR": "20190503", "DA": "19950620", "DC": "1", "DX": "19960101", "UI": "D018986"}, {"RECTYPE": "D", "MH": "Salivary Ducts", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Whartons Duct", "MN": "A14.549.760.640", "MH_TH": "NLM (1996)", "ST": "T023", "AN": "diseases of salivary ducts: coordinate with SALIVARY GLAND DISEASES; diseases of ducts of a specific salivary gland: coordinate with specific salivary gland disease or specific salivary gland and SALIVARY GLAND DISEASES", "PI": "Salivary Glands (1966-1995)", "MS": "Any of the ducts which transport saliva. Salivary ducts include the parotid duct, the major and minor sublingual ducts, and the submandibular duct.", "PM": "96", "HN": "96", "MR": "20160809", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D018987"}, {"RECTYPE": "D", "MH": "Bacterial Translocation", "DE": "BACT TRANSLOCATION", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Translocation, Bacterial|T040|NON|EQV|NLM (1996)|941221|TRANSLOCATION BACT|abcdefv", "MN": "G06.099.114", "MH_TH": "NLM (1996)", "ST": "T040", "AN": "coordinate IM with specific bacterium /physiol (IM)", "PI": "Cell Movement (1972-1995)", "MS": "The passage of viable bacteria from the GASTROINTESTINAL TRACT to extra-intestinal sites, such as the mesenteric lymph node complex, liver, spleen, kidney, and blood. Factors that promote bacterial translocation include overgrowth with gram-negative enteric bacilli, impaired host immune defenses, and injury to the INTESTINAL MUCOSA resulting in increased intestinal permeability. Bacterial translocation from the lung to the circulation is also possible and sometimes accompanies MECHANICAL VENTILATION.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20160115", "DA": "19950629", "DC": "1", "DX": "19960101", "UI": "D018988"}, {"RECTYPE": "D", "MH": "Myelin Proteolipid Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proteolipid Protein, Myelin|T116|T123|NON|EQV|NLM (1996)|950126|abbcdef", "ENTRY": "Proteolipid Protein, Folch-PI", "MN": "D12.776.816.500", "FX": "Pelizaeus-Merzbacher Disease", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "AN": "/biosyn /drug eff /physiol /ultrastruct permitted", "PI": "Myelin Proteins (1979-1995)", "MS": "A myelin protein that is the major component of the organic solvent extractable lipoprotein complexes of whole brain. It has been the subject of much study because of its unusual physical properties. It remains soluble in chloroform even after essentially all of its bound lipids have been removed. (From Siegel et al., Basic Neurochemistry, 4th ed, p122)", "OL": "use MYELIN PROTEOLIPID PROTEIN (NM) to search FOLCH-PI PROTEOLIPID PROTEIN 1981-95", "PM": "96; FOLCH-PI PROTEOLIPID PROTEIN was indexed under MYELIN PROTEINS 1979-95", "HN": "96; was FOLCH-PI PROTEOLIPID PROTEIN (NM) 1979-95", "MR": "20151124", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018991"}, {"RECTYPE": "D", "MH": "Myelin-Associated Glycoprotein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Small Myelin Associated Glycoprotein Isoform", "MN": "D12.776.631.580.500", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "AN": "do not confuse with MYELIN-OLIGODENDROCYTE GLYCOPROTEIN or OLIGODENDROCYTE-MYELIN GLYCOPROTEIN", "PI": "Myelin Proteins (1982-1995)", "MS": "A myelin protein found in the periaxonal membrane of both the central and peripheral nervous systems myelin sheaths. It binds to cells surface receptors found on AXONS and may regulate cellular interactions between MYELIN and AXONS.", "PM": "1996; see PLEURAL GLYCOPROTEINS 1982-95; PLEURAL GLYCOPROTEINS was indexed under MYELIN PROTEINS 1982-95", "HN": "1996; use PLEURAL GLYCOPROTEINS 1982-95", "MR": "20230316", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018992"}, {"RECTYPE": "D", "MH": "Myelin P0 Protein", "DS": "MYELIN P PROTEIN 000", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "P0 Protein|T116|T123|NON|EQV|NLM (1996)|941223|P A 000 PROTEIN|abbcdefs", "ENTRY": "Zero, Myelin Protein", "MN": "D23.050.301.350.250.500", "FX": "Charcot-Marie-Tooth Disease", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "PI": "Myelin Proteins (1981-1995)", "MS": "A protein that accounts for more than half of the peripheral nervous system myelin protein. The extracellular domain of this protein is believed to engage in adhesive interactions and thus hold the myelin membrane compact. It can behave as a homophilic adhesion molecule through interactions with its extracellular domains. (From J Cell Biol 1994;126(4):1089-97)", "OL": "use MYELIN P0 PROTEIN (NM) to search PROTEIN ZERO, PERIPHERAL NERVE MYELIN 1981-95", "PM": "96; PROTEIN ZERO, PERIPHERAL NERVE MYELIN was indexed under MYELIN PROTEINS 1981-95", "HN": "96; was PROTEIN ZERO, PERIPHERAL NERVE MYELIN (NM) 1981-95", "MR": "20230316", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018993"}, {"RECTYPE": "D", "MH": "Myosin Light Chains", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myosin Alkali Light Chains|T116|T123|NON|NRW|NLM (1996)|950214|abbcdef", "ENTRY": "Light Chains, Myosin", "MN": "D12.776.220.525.475.200", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "PI": "Myosin (1969-1995)", "MS": "The smaller subunits of MYOSINS that bind near the head groups of MYOSIN HEAVY CHAINS. The myosin light chains have a molecular weight of about 20 KDa and there are usually one essential and one regulatory pair of light chains associated with each heavy chain. Many myosin light chains that bind calcium are considered \"calmodulin-like\" proteins.", "PM": "1996; for MYOSIN LIGHT CHAIN see MYOSINS 1982-1995; for MYOSIN ALKALI LIGHT CHAINS see MYOSINS 1990-1995", "HN": "1996; for MYOSIN LIGHT CHAIN use MYOSINS 1982-1995; for MYOSIN ALKALI LIGHT CHAINS use MYOSINS 1990-1995", "MR": "20130709", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018994"}, {"RECTYPE": "D", "MH": "Myosin Heavy Chains", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Heavy Chains, Myosin", "MN": "D12.776.220.525.475.100", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "EC 3.6.4.1", "PI": "Myosin (1971-1995)", "MS": "The larger subunits of MYOSINS. The heavy chains have a molecular weight of about 230 kDa and each heavy chain is usually associated with a dissimilar pair of MYOSIN LIGHT CHAINS. The heavy chains possess actin-binding and ATPase activity.", "PM": "1996; for MYOSIN HEAVY CHAIN see MYOSINS 1982-1995", "HN": "1996; for MYOSIN HEAVY CHAIN use MYOSINS 1982-1995", "MR": "20130708", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018995"}, {"RECTYPE": "D", "MH": "Myelin P2 Protein", "DS": "MYELIN P PROTEIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "P2 Protein, Myelin", "MN": "D12.776.631.580.560", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "PI": "Myelin Proteins (1980-1981)", "MS": "A positively charged protein found in peripheral nervous system MYELIN. Sensitive immunological techniques have demonstrated that P2 is expressed in small amounts of central nervous system myelin sheaths of some species. It is an antigen for experimental allergic neuritis (NEURITIS, EXPERIMENTAL ALLERGIC), the peripheral nervous system counterpart of experimental allergic encephalomyelitis. (From Siegel et al., Basic Neurochemistry, 5th ed, p133)", "OL": "use MYELIN P2 PROTEIN (NM) to search MYELIN P2 PROTEINS 1980-95", "PM": "96; MYELIN P2 PROTEINS was indexed under ENCEPHALITOGENIC BASIC PROTEINS 1982-95 & MYELIN PROTEINS 1980-81", "HN": "96; was MYELIN P2 PROTEINS (NM) 1980-95", "MR": "20151124", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D018996"}, {"RECTYPE": "D", "MH": "Chorionic Gonadotropin, beta Subunit, Human", "DE": "CHORIONIC GONADOTROPIN BETA SUBUNIT HUMAN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Human Chorionic Gonadotropin, beta Subunit|T116|T125|NON|EQV|NLM (1996)|950424|HUMAN CHORIONIC GONADOTROPIN BETA SUBUNIT|abbcdefv", "ENTRY": "HCG beta", "MN": "D23.101.175", "MH_TH": "NLM (1996)", "ST": "T125", "RN": "0", "PI": "Peptide Fragments (1977-1995)", "MS": "The beta subunit of human CHORIONIC GONADOTROPIN. Its structure is similar to the beta subunit of LUTEINIZING HORMONE, except for the additional 30 amino acids at the carboxy end with the associated carbohydrate residues. HCG-beta is used as a diagnostic marker for early detection of pregnancy, spontaneous abortion (ABORTION, SPONTANEOUS); ECTOPIC PREGNANCY; HYDATIDIFORM MOLE; CHORIOCARCINOMA; or DOWN SYNDROME.", "OL": "use CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN (NM) to search HCG-BETA 1978-95", "PM": "96; HCG-BETA was indexed under GONADOTROPINS, CHORIONIC & PEPTIDE FRAGMENTS 1977-95", "HN": "96; was HCG-BETA (NM) 1977-95", "MR": "20150619", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018997"}, {"RECTYPE": "D", "MH": "Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "WGA-HRP|T116|T126|T130|ABB|EQV|NLM (1996)|941227|WGA HRP|abbbcdefv", "ENTRY": "Wheat Germ Agglutinin Horseradish Peroxidase Conjugate", "MN": "D12.776.765.678.968.900", "PA": "Molecular Probes", "MH_TH": "NLM (1996)", "ST": "T130", "RN": "0", "PI": "Wheat Germ Agglutinins (1987-1995)", "MS": "The lectin wheatgerm agglutinin conjugated to the enzyme HORSERADISH PEROXIDASE. It is widely used for tracing neural pathways.", "OL": "use WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE (NM) to search WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE 1986-95", "PM": "96; WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE was indexed under HORSERADISH PEROXIDASE 1986-95, WHEAT GERM AGGLUTININS 1987-95, & LECTINS 1986", "HN": "96; was WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE (NM) 1986-95", "MR": "20050630", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D018998"}, {"RECTYPE": "D", "MH": "Charybdotoxin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ChTX|T116|T123|ABB|EQV|NLM (1996)|941228|abbcdef", "ENTRY": "Toxin, Quinquestriatus", "MN": "D23.946.833.065.830.150", "PA": "Neurotoxins", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "115422-61-2", "RR": "95751-30-7 (unknown MF)", "PI": "Scorpion Venoms (1984-1995)", "MS": "A 37-amino acid residue peptide isolated from the scorpion Leiurus quinquestriatus hebraeus. It is a neurotoxin that inhibits calcium activated potassium channels.", "OL": "use CHARYBDOTOXIN (NM) to search QUINQUESTRIATUS TOXIN 1984-95", "PM": "96; QUINQUESTRIATUS TOXIN was indexed under SCORPION VENOMS 1984-95", "HN": "96; was QUINQUESTRIATUS TOXIN (NM) 1984-95", "MR": "20150331", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D018999"}, {"RECTYPE": "D", "MH": "Phosphotyrosine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Tyrosine O phosphate", "MN": "D12.125.740.740", "MH_TH": "NLM (1996)", "ST": "T123", "N1": "L-tyrosine, dihydrogen phosphate (ester)", "RN": "21820-51-9", "AN": "an amino acid; /biosyn /drug eff /physiol permitted", "PI": "Tyrosine/analogs & derivatives (1980-1995)", "MS": "An amino acid that occurs in endogenous proteins. Tyrosine phosphorylation and dephosphorylation plays a role in cellular signal transduction and possibly in cell growth control and carcinogenesis.", "OL": "use PHOSPHOTYROSINE (NM) to search PHOSPHOTYROSINE 1980-95", "PM": "96; PHOSPHOTYROSINE was indexed under TYROSINE/analogs & derivatives 1980-95", "HN": "96; was PHOSPHOTYROSINE (NM) 1980-95", "MR": "20010725", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019000"}, {"RECTYPE": "D", "MH": "Nitric Oxide Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NO Synthase|T116|T126|EQV|NLM (1996)|941228|abbdef", "ENTRY": "Synthase, Nitric Oxide", "MN": "D08.811.682.664.500.772", "MH_TH": "NLM (2006)", "ST": "T126", "N1": "L-Arginine,NADPH:oxygen oxidoreductase (nitric-oxide-forming)", "RN": "EC 1.14.13.39", "AN": "general; prefer specifics", "MS": "An NADPH-dependent enzyme that catalyzes the conversion of L-ARGININE and OXYGEN to produce CITRULLINE and NITRIC OXIDE.", "PM": "2006; see NITRIC-OXIDE SYNTHASE 1996-2005, NITRIC OXIDE SYNTHASE was indexed under AMINO ACID OXIDOREDUCTASES 1990-1995", "HN": "2006(1990)", "MR": "20050630", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019001"}, {"RECTYPE": "D", "MH": "CD56 Antigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD56 Antigens|T116|T129|EQV|NLM (1996)|941228|CD 056 ANTIGENS|abbdefs", "ENTRY": "NKH 1 Antigen", "MN": "D23.101.100.894.156", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "AN": "for hematodermic CD4/CD56 neoplasm use LYMPHOMA, NON-HODGKIN", "PI": "Antigens, Differentiation, T-Lymphocyte (1988-1995)", "MS": "The 140 kDa isoform of NCAM (neural cell adhesion molecule) containing a transmembrane domain and short cytoplasmic tail. It is expressed by all lymphocytes mediating non-MHC restricted cytotoxicity and is present on some neural tissues and tumors.", "PM": "2018; see ANTIGENS, CD56 1996-2017 and NKH-1 ANTIGEN 1988-95; NKH-1 ANTIGEN was indexed under ANTIGENS, CD 1990-95; and under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-95", "HN": "2018 (1988)", "MR": "20230316", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019002"}, {"RECTYPE": "D", "MH": "Deoxyribonuclease HpaII", "DE": "HPAII", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endonuclease HpaII|T116|T126|EQV|NLM (1996)|941229|abbdef", "ENTRY": "Endonuclease, HapII", "MN": "D08.811.277.352.355.325.300.260.300", "MH_TH": "NLM (1996)", "ST": "T126", "RN": "EC 3.1.21.-", "PI": "Deoxyribonucleases, Type II Site-Specific (1989-1995)", "MS": "One of the Type II site-specific deoxyribonucleases (EC 3.1.21.4). It recognizes and cleaves the sequences C/CGG and GGC/C at the slash. HpaII is from Haemophilus parainfluenzae. Several isoschizomers have been identified. EC 3.1.21.-.", "OL": "use DEOXYRIBONUCLEASE HPAII (NM) to search ENDODEOXYRIBONUCLEASE HPAII 1980-95", "PM": "96; ENDODEOXYRIBONUCLEASE HPAII was indexed under DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC 1989-95 & DNA RESTRICTION ENZYMES 1980-88", "HN": "96; was ENDODEOXYRIBONUCLEASE HPAII (NM) 1980-95", "MR": "20030709", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D019003"}, {"RECTYPE": "D", "MH": "Galanin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Galanin (1-30)|T116|T123|NON|NRW|NLM (2008)|061130|abbcdef", "MN": "D12.776.631.650.250", "FX": "Receptors, Galanin", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "88813-36-9", "PI": "Peptides (1984-1995)", "MS": "A neuropeptide of 29-30 amino acids depending on the species. Galanin is widely distributed throughout the BRAIN; SPINAL CORD; and INTESTINES. There are various subtypes of GALANIN RECEPTORS implicating roles of galanin in regulating FOOD INTAKE; pain perception; memory; and other neuroendocrine functions.", "PM": "1996; GALANIN was indexed under PEPTIDES 1984-1995; GALANIN (1-30) was indexed under PEPTIDE FRAGMENTS & GALANIN 1997-2007", "HN": "1996 (1984)", "MR": "20151123", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D019004"}, {"RECTYPE": "D", "MH": "Cystic Fibrosis Transmembrane Conductance Regulator", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CFTR Protein|T116|T123|EQV|NLM (1996)|941229|abbdef", "ENTRY": "Protein, CFTR", "MN": "D12.776.543.585.450.074.500.500.500.500", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "126880-72-6", "PI": "Membrane Proteins (1989-1995)", "MS": "A chloride channel that regulates secretion in many exocrine tissues. Abnormalities in the CFTR gene have been shown to cause cystic fibrosis. (Hum Genet 1994;93(4):364-8)", "OL": "use CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (NM) to search CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR 1989-95", "PM": "96; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR was indexed under MEMBRANE PROTEINS 1989-95", "HN": "96; was CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (NM) 1989-95", "MR": "20160701", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D019005"}, {"RECTYPE": "D", "MH": "Neural Cell Adhesion Molecules", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neural Cell Adhesion Molecule|T116|T123|NON|EQV|NLM (1996)|950525|abbcdef", "ENTRY": "Cell Adhesion Molecules, Neural|T116|T123|NON|EQV|NLM (1996)|950525|abbcdef", "MN": "D23.050.301.350.250.520", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "AN": "NCAM: note entry term NEURAL CELL ADHESION MOLECULE but do not confuse this entry term with NEURONAL CELL ADHESION MOLECULES see CELL ADHESION MOLECULES, NEURONAL", "PI": "Cell Adhesion Molecules, Neuronal (1990-1995)", "MS": "Cell adhesion molecule involved in a diverse range of contact-mediated interactions among neurons, astrocytes, oligodendrocytes, and myotubes. It is widely but transiently expressed in many tissues early in embryogenesis. Four main isoforms exist, including CD56; (CD56 ANTIGEN); but there are many other variants resulting from alternative splicing and post-translational modifications. (From Pigott & Power, The Adhesion Molecule FactsBook, 1993, pp115-119)", "PM": "96", "HN": "96", "MR": "20230316", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019006"}, {"RECTYPE": "D", "MH": "P-Selectin", "DS": "SELECTIN P", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Platelet alpha-Granule Membrane Protein|T116|T123|T129|NON|EQV|NLM (1996)|950103|abbbcdef", "ENTRY": "Selectin, P", "MN": "D23.050.301.350.700.775", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Platelet Membrane Glycoproteins (1986-1995)", "MS": "Cell adhesion molecule and CD antigen that mediates the adhesion of neutrophils and monocytes to activated platelets and endothelial cells.", "PM": "1996; PLATELET ALPHA-GRANULE MEMBRANE PROTEIN was indexed under PLATELET MEMBRANE GLYCOPROTEINS 1986-95 & MEMBRANE PROTEINS 1985-86", "HN": "1996", "MR": "20230316", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D019007"}, {"RECTYPE": "D", "MH": "Drug Resistance, Neoplasm", "DE": "DRUG RESISTANCE NEOPL", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Drug Resistance, Antineoplastic|T042|NON|EQV|NLM (1996)|950103|DRUG RESISTANCE ANTINEOPL|abcdefv", "ENTRY": "Resistance, Antineoplastic Drug|T042|NON|EQV|NLM (1996)|950103|RESISTANCE ANTINEOPL DRUG|abcdefv", "MN": "G07.690.773.984.395", "MH_TH": "NLM (1996)", "ST": "T042", "PI": "Drug Resistance (1972-1995)", "MS": "Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D019008"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-kit", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p145(c-kit)|T116|T126|T129|T192|EQV|NLM (1996)|950103|P A 145 C KIT|abbbbdefs", "ENTRY": "p145c kit", "MN": "D12.776.624.664.700.183", "FX": "Piebaldism", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptors, Colony-Stimulating Factor (1991-1995)", "MS": "A protein-tyrosine kinase receptor that is specific for STEM CELL FACTOR. This interaction is crucial for the development of hematopoietic, gonadal, and pigment stem cells. Genetic mutations that disrupt the expression of PROTO-ONCOGENE PROTEINS C-KIT are associated with PIEBALDISM, while overexpression or constitutive activation of the c-kit protein-tyrosine kinase is associated with tumorigenesis.", "PM": "2000; see PROTO-ONCOGENE PROTEINS C-KIT 1999-1996; PROTO-ONCOGENE PROTEIN KIT (now PROTO-ONCOGENE PROTEIN C-KIT) was indexed under RECEPTOR PROTEIN-TYROSINE KINASE 1994-1995; RECEPTORS, COLONY-STIMULATING FACTOR 1991-1995; & PROTO-ONCOGENE PROTEINS 1989-1995", "HN": "2000(1996); use PROTO-ONCOGENE PROTEIN c-KIT (NM) 1989-1995", "MR": "20210521", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019009"}, {"RECTYPE": "D", "MH": "Vascular Cell Adhesion Molecule-1", "DS": "VASCULAR CELL ADHESION MOLECULE 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "VCAM-1|T116|T129|ABB|EQV|NLM (1996)|950105|VCAM 001|abbcdefs", "ENTRY": "Vascular Cell Adhesion Molecule 1", "MN": "D23.050.301.350.920", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Cell Adhesion Molecules (1990-1995)", "MS": "Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation. (From Pigott & Power, The Adhesion Molecule FactsBook, 1993, p154)", "PM": "1996; see VASCULAR CELL ADHESION MOLECULE and INDUCIBLE CELL ADHESION MOLECULE 110 1990-1995; VASCULAR CELL ADHESION MOLECULE and INDUCIBLE CELL ADHESION MOLECULE 110 were indexed under CELL ADHESION MOLECULES 1990-95", "HN": "1996", "MR": "20230316", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019010"}, {"RECTYPE": "D", "MH": "Antigens, CD7", "DS": "ANTIGENS CD 007", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "CD7 Antigens|T129|EQV|NLM (1996)|950105|CD 007 ANTIGENS|abdefs", "ENTRY": "Antigen, CD7", "MN": "D23.101.100.894.107", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "AN": "T-lymphocyte differentiation antigens", "PI": "Antigens, Differentiation, T-Lymphocyte (1988-1995)", "MS": "Differentiation antigens expressed on pluripotential hematopoietic cells, most human thymocytes, and a major subset of peripheral blood T-lymphocytes. They have been implicated in integrin-mediated cellular adhesion and as signalling receptors on T-cells.", "PM": "1996; ANTIGENS, CD7 was indexed under ANTIGENS, CD 1990-95 and under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-95", "HN": "1996; use CD7 ANTIGEN 1988-95", "MR": "20170524", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019011"}, {"RECTYPE": "D", "MH": "Integrin beta1", "DS": "INTEGRIN BETA A 01", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "CD29 Antigens|T116|T129|EQV|NLM (1996)|950105|CD 029 ANTIGENS|abbdefs", "ENTRY": "Integrin, beta1", "MN": "D12.776.543.750.705.408.200.500", "FX": "Receptors, Very Late Antigen", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Integrins (1990-1995)", "MS": "Integrin beta chain expressed as a heterodimer that is non-covalently associated with specific alpha-chains of the CD49 family (CD49a-f). It is expressed on resting and activated leukocytes and is a marker for all of the very late activation antigens on cells. (from: Barclay et al., The Leukocyte Antigen FactsBook, 1993, p164)", "PM": "2018; see ANTIGENS, CD29 1996-2017; INTEGRIN BETA1 was indexed under INTEGRINS 1991-95; CD29 ANTIGEN was indexed under ANTIGENS, CD and INTEGRINS 1990-95; and under ANTIGENS, DIFFERENTIATION 1990-91; CDW29 ANTIGEN was indexed under ANTIGENS, CD 1990-95; and under ANTIGENS, DIFFERENTIATION 1988-91", "HN": "2018 (1990); use ANTIGENS, CD29 1996-2017; use INTEGRIN BETA1 1991-95; use CD29 ANTIGEN 1990-95; use CDW29 ANTIGEN (NM) 1988-95", "MR": "20170524", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019012"}, {"RECTYPE": "D", "MH": "CD40 Antigens", "DS": "CD 040 ANTIGENS", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 5|T116|T129|T192|NON|EQV|NLM (2005)|040206|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 05|abbbcdefs", "ENTRY": "Receptor, TNFRSF5", "MN": "D23.101.100.150.140", "FX": "CD40 Ligand", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "PI": "Antigens, Differentiation, B-Lymphocyte (1988-1995)", "MS": "Members of the tumor necrosis factor receptor superfamily with specificity for CD40 LIGAND. They are found on mature B-LYMPHOCYTES, some EPITHELIAL CELLS; and lymphoid DENDRITIC CELLS. Evidence suggests that CD40-dependent activation of B-cells is important for generation of memory B-cells within the germinal centers. Mutations in the CD40 antigen gene result in HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 3. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.", "PM": "2018; see ANTIGENS, CD40 1996-2017, CD40 ANTIGEN 1989-95, and CDW40 ANTIGEN 1988-95; CD40 ANTIGEN was indexed under ANTIGENS, CD 1990-95; and under ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1989-95; CDW40 ANTIGEN was indexed under ANTIGENS, CD 1990-95; and under ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-95", "HN": "2018 (1988)", "MR": "20200327", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019013"}, {"RECTYPE": "D", "MH": "fas Receptor", "DE": "FAS RECEPT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "fas Receptors|T116|T129|T192|NON|EQV|NLM (2000)|991104|abbbcdef", "ENTRY": "Receptor, fas", "MN": "D12.776.543.750.705.852.760.195", "FX": "Autoimmune Lymphoproliferative Syndrome", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "0", "PI": "Antigens, Surface (1989-1995)", "MS": "A tumor necrosis factor receptor subtype found in a variety of tissues and on activated LYMPHOCYTES. It has specificity for FAS LIGAND and plays a role in regulation of peripheral immune responses and APOPTOSIS. Multiple isoforms of the protein exist due to multiple ALTERNATIVE SPLICING. The activated receptor signals via a conserved death domain that associates with specific TNF RECEPTOR-ASSOCIATED FACTORS in the CYTOPLASM. Mutations in the CD95 gene are associated with cases of autoimmune lymphoproliferative syndrome.", "PM": "2018; see ANTIGENS, CD95 1989-2017; FAS ANTIGEN was indexed under ANTIGENS, SURFACE 1989-1995; FAS RECEPTOR was indexed under RECEPTORS, TUMOR NECROSIS FACTOR 1998-1999", "HN": "2018 (1989)", "MR": "20170524", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019014"}, {"RECTYPE": "D", "MH": "Geologic Sediments", "DE": "GEOL SEDIMENTS", "AQ": "AN CH CL MI PS VI", "PRINT ENTRY": "Sediments, Marine|T070|NON|NRW|NLM (1996)|950109|abcdef", "ENTRY": "Snow, Marine Oil", "MN": "G16.500.320", "MH_TH": "NLM (1996)", "ST": "T070", "MS": "A mass of organic or inorganic solid fragmented material, or the solid fragment itself, that comes from the weathering of rock and is carried by, suspended in, or dropped by air, water, or ice. It refers also to a mass that is accumulated by any other natural agent and that forms in layers on the earth's surface, such as sand, gravel, silt, mud, fill, or loess. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1689)", "PM": "96", "HN": "96", "MR": "20190222", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D019015"}, {"RECTYPE": "D", "MH": "Mineral Fibers", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Vitreous Fibers, Synthetic", "MN": "D01.578.500", "FX": "Pneumoconiosis", "MH_TH": "NLM (1996)", "ST": "T197", "RN": "0", "PI": "Minerals (1966-1995)", "MS": "Long, pliable, cohesive natural or manufactured filaments of various lengths. They form the structure of some minerals. The medical significance lies in their potential ability to cause various types of PNEUMOCONIOSIS (e.g., ASBESTOSIS) after occupational or environmental exposure. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p708)", "PM": "96", "HN": "96", "MR": "20170224", "DA": "19950629", "DC": "1", "DX": "19960101", "UI": "D019016"}, {"RECTYPE": "D", "MH": "Eritrea", "AQ": "EH EP", "MN": "Z01.058.290.120.292", "MH_TH": "NLM (1996)", "ST": "T083", "PI": "Ethiopia (1966-1995)", "MS": "A country of eastern Africa, west of the Red Sea, bordered west and northwest by SUDAN, and south by ETHIOPIA. Its capital is Asmara.", "HN": "96; was see ETHIOPIA 1975-95", "MR": "20130709", "DA": "19950526", "DC": "4", "DX": "19960101", "UI": "D019017"}, {"RECTYPE": "D", "MH": "Imagery, Psychotherapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Psychotherapy Imagery|T061|NON|EQV|NLM (2020)|190118|abcdef", "ENTRY": "Therapy, Directed Reverie", "MN": "F04.754.462", "MH_TH": "NLM (2020)", "ST": "T061", "PI": "Relaxation Techniques (1980-1995)", "MS": "The use of mental images produced by the imagination as a form of psychotherapy. It can be classified by the modality of its content: visual, verbal, auditory, olfactory, tactile, gustatory, or kinesthetic. Common themes derive from nature imagery (e.g., forests and mountains), water imagery (e.g., brooks and oceans), travel imagery, etc. Imagery is used in the treatment of mental disorders and in helping patients cope with other diseases. Imagery often forms a part of HYPNOSIS, of AUTOGENIC TRAINING, of RELAXATION TECHNIQUES, and of BEHAVIOR THERAPY. (From Encyclopedia of Human Behavior, vol. 4, pp29-30, 1994)", "PM": "2020; was IMAGERY (PSYCHOTHERAPY) 1996-2019", "HN": "2020 (1996); was IMAGERY (PSYCHOTHERAPY) 1996-2019", "CATSH": "CAT LIST", "MR": "20190118", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D019018"}, {"RECTYPE": "D", "MH": "Directed Molecular Evolution", "DE": "DIRECTED MOL EVOLUTION", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Molecular Evolution, Directed|T062|NON|EQV|NLM (1996)|950330|MOL EVOLUTION DIRECTED|abcdefv", "ENTRY": "Molecular Evolutions, Laboratory", "MN": "E05.393.420.175", "FX": "Protein Engineering", "MH_TH": "NLM (1996)", "ST": "T062", "PI": "Evolution (1978-1995)", "MS": "The techniques used to produce molecules exhibiting properties that conform to the demands of the experimenter. These techniques combine methods of generating structural changes with methods of selection. They are also used to examine proposed mechanisms of evolution under in vitro selection conditions.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019020"}, {"RECTYPE": "D", "MH": "Natural History", "DE": "NATURAL HIST", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "History, Natural", "MN": "K01.400.703", "MH_TH": "NLM (1996)", "ST": "T090", "AN": "restrict to the history of science: not for the \"natural history\" or natural course or develop of a disease", "PI": "Science (1976-1984)", "MS": "A former branch of knowledge embracing the study, description, and classification of natural objects (as animals, plants, and minerals) and thus including the modern sciences of zoology, botany, and mineralogy insofar as they existed at that time. In the 17th, 18th, and 19th centuries it was much used for the generalized pursuit of certain areas of science. (Webster, 3d ed; from Dr. James H. Cassedy, NLM History of Medicine Division)", "PM": "96", "HN": "96", "MR": "20190524", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019021"}, {"RECTYPE": "D", "MH": "Almshouses", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Almshouse", "MN": "J03.340.030", "MH_TH": "NLM (1996)", "ST": "T093", "AN": "historical contexts only", "MS": "Privately endowed or publicly funded institutions receiving and supporting the aged or infirm poor. They sometimes functioned as centers of health care before the establishment of formal hospitals.", "PM": "96", "HN": "96", "MR": "20191118", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019022"}, {"RECTYPE": "D", "MH": "Stethoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Stethoscope", "MN": "E07.230.750", "MH_TH": "NLM (1996)", "ST": "T074", "PI": "Heart Auscultation/instrumentation (1966-1995)", "MS": "Instruments intended to detect and study sound produced by the heart, lungs, or other parts of the body. (from UMDNS, 1999)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019023"}, {"RECTYPE": "D", "MH": "Barber Surgeons", "DE": "BARBER SURG", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Surgeon, Barber", "MN": "N02.360.810.910.500", "MH_TH": "NLM (1996)", "ST": "T097", "PI": "Surgery/history (1966-1995)", "MS": "In the late Middle Ages barbers who also let blood, sold unguents, pulled teeth, applied cups, and gave enemas. They generally had the right to practice surgery. By the 18th century barbers continued to practice minor surgery and dentistry and many famous surgeons acquired their skill in the shops of barbers. (From Castiglioni, A History of Medicine, 2d ed, pp402, 568, 658)", "PM": "96", "HN": "96", "MR": "20180629", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019024"}, {"RECTYPE": "D", "MH": "Medicine Chests", "DE": "MED CHESTS", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Medicine Chest|T073|NON|EQV|NLM (1996)|950113|MED CHEST|abcdefv", "MN": "E07.546", "MH_TH": "NLM (1996)", "ST": "T073", "AN": "do not confuse with the modern medicine cabinet: read MeSH definition; may be used for doctor's bags; often in hist contexts so check hist tags", "MS": "Boxes in which physicians kept their drugs and other medications, medical instruments and supplies, manuals, etc. As a carrying case or convenient storage receptacle, or a kind of portable pharmacy, the medicine chest was indispensable to the itinerant physician. The chest was usually larger and sturdier than a doctor's kit or bag.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20040728", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D019026"}, {"RECTYPE": "D", "MH": "Magnetic Resonance Imaging, Cine", "DE": "MRI CINE", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Cine Magnetic Resonance Imaging|T060|NON|EQV|NLM (1996)|950117|abcdef", "ENTRY": "MRIs, Cine", "MN": "E01.370.350.825.500.510", "MH_TH": "NLM (1996)", "ST": "T060", "AN": "for dis & organ coords see note on MAGNETIC RESONANCE IMAGING", "PI": "Magnetic Resonance Imaging (1988-1995)", "MS": "A type of imaging technique used primarily in the field of cardiology. By coordinating the fast gradient-echo MRI sequence with retrospective ECG-gating, numerous short time frames evenly spaced in the cardiac cycle are produced. These images are laced together in a cinematic display so that wall motion of the ventricles, valve motion, and blood flow patterns in the heart and great vessels can be visualized.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019028"}, {"RECTYPE": "D", "MH": "Palau", "AQ": "EH EP", "MN": "Z01.639.760.680.717", "MH_TH": "POPLINE (1983)", "ST": "T083", "PI": "Micronesia (1970-1995)", "MS": "A republic consisting of a group of about 100 islands and islets in the western Pacific Ocean. Its capital is Koror. Under Spain it was administered as a part of the Caroline Islands but was sold to Germany in 1899. Seized by Japan in 1914, it was taken by the Allies in World War II in 1944. In 1947 it became part of the U.S. Trust Territory of the Pacific Islands, became internally self-governing in 1980, obtained independent control over its foreign policy (except defense) in 1986, and achieved total independence October 1, 1994. (Webster's New Geographical Dictionary, 1988, p915; telephone communication with Randy Flynn, Board on Geographic Names, 17 January 1995)", "OL": "use MICRONESIA to search PALAU 1995 & PAULAU 1994", "HN": "96; was see MICRONESIA 1995; was PAULAU see MICRONESIA 1994", "MR": "20120703", "DA": "19950526", "DC": "4", "DX": "19960101", "UI": "D019029"}, {"RECTYPE": "D", "MH": "Receptors, Vitronectin", "DE": "RECEPT VITRONECTIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Vitronectin Receptors", "MN": "D12.776.543.750.705.408.460.870", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "AN": "do not confuse with VITRONECTIN RECEPTOR see INTEGRIN ALPHAVBETA3", "PI": "Receptors, Immunologic (1987-1992)", "MS": "Receptors such as INTEGRIN ALPHAVBETA3 that bind VITRONECTIN with high affinity and play a role in cell migration. They also bind FIBRINOGEN; VON WILLEBRAND FACTOR; osteopontin; and THROMBOSPONDINS.", "OL": "use RECEPTORS, VITRONECTIN (NM) to search VITRONECTIN RECEPTOR 1985-95", "PM": "96; VITRONECTIN RECEPTOR was indexed under INTEGRINS & RECEPTORS, CYTOADHESIN 1990-95; RECEPTORS, IMMUNOLOGIC 1987-92; & RECEPTORS, ENDOGENOUS SUBSTANCES 1985-86", "HN": "96; was VITRONECTIN RECEPTOR (NM) 1985-95", "MR": "20150629", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D019030"}, {"RECTYPE": "D", "MH": "Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization|T062|NON|EQV|NLM (1996)|950119|abcdef", "ENTRY": "Matrix Assisted Laser Desorption Ionization Mass Spectrometry", "MN": "E05.196.566.755", "MH_TH": "NLM (1996)", "ST": "T062", "PI": "Spectrum Analysis, Mass (1989-1995)", "MS": "A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample-matrix mixture into free (gas phase) matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced, and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019032"}, {"RECTYPE": "D", "MH": "Delivery of Health Care, Integrated", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Integrated Health Care Systems|T058|NON|REL|NLM (1996)|950123|abcdef", "ENTRY": "Systems, Integrated Delivery", "MN": "N05.300.262", "MH_TH": "NLM (1996)", "ST": "T058", "AN": "specify geog if pertinent", "PI": "Delivery of Health Care (1985-1995)", "MS": "A health care system which combines physicians, hospitals, and other medical services with a health plan to provide the complete spectrum of medical care for its customers. In a fully integrated system, the three key elements - physicians, hospital, and health plan membership - are in balance in terms of matching medical resources with the needs of purchasers and patients. (Coddington et al., Integrated Health Care: Reorganizing the Physician, Hospital and Health Plan Relationship, 1994, p7)", "PM": "96", "HN": "96", "MR": "20180629", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019033"}, {"RECTYPE": "D", "MH": "CD-I", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Compact Disk Interactive|T073|T170|NON|EQV|NLM (1996)|950119|abbcdef", "ENTRY": "Interactive Compact Disks", "MN": "L01.462.500.820.090.898.800.250.100", "MH_TH": "NLM (1996)", "ST": "T170", "PI": "Compact Disks (1993-1995)", "MS": "An optical disk storage system used on specialized players that combine the functions of computer and CD player in a self-contained box, designed to be connected to a television set and a home stereo for video and sound output. The player is controlled with a hand-held remote unit resembling a television remote control. (J Allied Health 1993 Winter;22(1):131-8)", "PM": "96", "HN": "96", "MR": "20220712", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019034"}, {"RECTYPE": "D", "MH": "Rural Health Services", "DE": "RURAL HEALTH SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Service, Rural Health", "MN": "N02.421.816", "FX": "Suburban Health Services", "MH_TH": "NLM (1996)", "ST": "T058", "AN": "coordinate with specific health service ", "PI": "Rural Population (1968-1995)", "MS": "Health services, public or private, in rural areas. The services include the promotion of health and the delivery of health care.", "PM": "96", "HN": "96", "MR": "20150629", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019035"}, {"RECTYPE": "D", "MH": "Suburban Health Services", "DE": "SUBURBAN HEALTH SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Suburban Health Service", "MN": "N02.421.908", "FX": "Rural Health Services", "MH_TH": "NLM (1996)", "ST": "T058", "AN": "IM; coord with specific health serv (IM)", "PI": "Suburban Population (1979-1995)", "MS": "Health services, public or private, in suburban areas. The services include the promotion of health and the delivery of health care.", "PM": "96", "HN": "96", "MR": "20150629", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019036"}, {"RECTYPE": "D", "MH": "Urban Health Services", "DE": "URBAN HEALTH SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Urban Health Service", "MN": "N02.421.914", "MH_TH": "NLM (1996)", "ST": "T058", "AN": "IM; coord with specific health serv (IM); SUBURBAN HEALTH SERVICES is also available", "PI": "Urban Population (1968-1995)", "MS": "Health services, public or private, in urban areas. The services include the promotion of health and the delivery of health care.", "PM": "96", "HN": "96", "MR": "20190524", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019037"}, {"RECTYPE": "D", "MH": "Platelet Glycoprotein GPIb-IX Complex", "DE": "GPIB IX", "DS": "PLATELET GLYCOPROTEIN GPIB VIIII COMPLEX", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Platelet Membrane Glycoprotein V|T116|T129|T192|NON|REL|NLM (1996)|950120|abbbcdef", "ENTRY": "Platelet Glycoprotein GPIb IX Complex", "MN": "D12.776.543.750.705.675.568", "EC": "deficiency:Bernard-Soulier Syndrome", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "PI": "Platelet Membrane Glycoproteins (1987-1995)", "MS": "Platelet membrane glycoprotein complex essential for normal platelet adhesion and clot formation at sites of vascular injury. It is composed of three polypeptides, GPIb alpha, GPIb beta, and GPIX. Glycoprotein Ib functions as a receptor for von Willebrand factor and for thrombin. Congenital deficiency of the GPIb-IX complex results in Bernard-Soulier syndrome. The platelet glycoprotein GPV associates with GPIb-IX and is also absent in Bernard-Soulier syndrome.", "OL": "use PLATELET MEMBRANE GLYCOPROTEINS to search PLATELET MEMBRANE GLYCOPROTEIN IB 1987-95", "PM": "96; PLATELET MEMBRANE GLYCOPROTEIN IB was see PLATELET MEMBRANE GLYCOPROTEINS 1987-95", "HN": "96; PLATELET MEMBRANE GLYCOPROTEIN IB was see PLATELET MEMBRANE GLYCOPROTEINS 1987-95", "MR": "20230316", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019038"}, {"RECTYPE": "D", "MH": "Platelet Glycoprotein GPIIb-IIIa Complex", "DE": "GPIIB IIIA", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Integrin alphaIIbbeta3|T116|T129|T192|NON|EQV|NLM (1996)|950419|INTEGRIN ALPHA A 02B BETA 03|abbbcdefs", "ENTRY": "beta-3, Integrin alpha-IIb", "MN": "D12.776.543.750.705.675.784", "FX": "Thrombasthenia", "EC": "deficiency:Thrombasthenia", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "PI": "Platelet Membrane Glycoproteins (1987-1995)", "MS": "Platelet membrane glycoprotein complex important for platelet adhesion and aggregation. It is an integrin complex containing INTEGRIN ALPHAIIB and INTEGRIN BETA3 which recognizes the arginine-glycine-aspartic acid (RGD) sequence present on several adhesive proteins. As such, it is a receptor for FIBRINOGEN; VON WILLEBRAND FACTOR; FIBRONECTIN; VITRONECTIN; and THROMBOSPONDINS. A deficiency of GPIIb-IIIa results in GLANZMANN THROMBASTHENIA.", "PM": "1996; see PLATELET MEMBRANE GLYCOPROTEINS 1987-95; INTEGRIN ALPHAIIBBETA3 was indexed under INTEGRINS 1992-95", "HN": "1996(1987); use INTEGRIN ALPHAIIBBETA3 (NM) 1992-1995", "MR": "20230316", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019039"}, {"RECTYPE": "D", "MH": "E-Selectin", "DS": "SELECTIN E", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "LECAM-2|T116|T129|T192|ABB|EQV|NLM (1996)|950309|LECAM 002|abbbcdefs", "ENTRY": "Selectin, E", "MN": "D23.050.301.350.700.300", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "PI": "Cell Adhesion Molecules (1989-1995)", "MS": "Cell adhesion molecule and CD antigen that mediates neutrophil, monocyte, and memory T-cell adhesion to cytokine-activated endothelial cells. E-selectin recognizes sialylated carbohydrate groups related to the Lewis X or Lewis A family.", "PM": "1996; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1 was indexed under CELL ADHESION MOLECULES 1989-95", "HN": "1996; use ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1 1989-95", "MR": "20230316", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019040"}, {"RECTYPE": "D", "MH": "L-Selectin", "DS": "SELECTIN L", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "LECAM-1|T116|T129|T192|ABB|EQV|NLM (1996)|950309|LECAM 001|abbbcdefs", "ENTRY": "Selectin, L", "MN": "D23.050.301.350.700.510", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "126880-86-2", "PI": "Cell Adhesion Molecules (1989-1995)", "MS": "Cell adhesion molecule and CD antigen that serves as a homing receptor for lymphocytes to lymph node high endothelial venules.", "PM": "1996; LEUKOCYTE ADHESION MOLECULE, LAM-1 was indexed under CELL ADHESION MOLECULES 1989-95", "HN": "1996", "MR": "20230316", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019041"}, {"RECTYPE": "D", "MH": "Muscle Neoplasms", "DE": "MUSCLE NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Muscle Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Neoplasm, Muscle", "MN": "C05.651.494", "MH_TH": "NLM (1996)", "ST": "T191", "AN": "neopl located in muscles: do not confuse with NEOPLASMS, MUSCLE TISSUE, neopl composed of muscle tissue; coord IM with specific muscle (IM) and histol type of neopl (IM)", "PI": "Soft Tissue Neoplasms (1969-1995)", "MS": "Tumors or cancer located in muscle tissue or specific muscles. They are differentiated from NEOPLASMS, MUSCLE TISSUE which are neoplasms composed of skeletal, cardiac, or smooth muscle tissue, such as MYOSARCOMA or LEIOMYOMA.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019042"}, {"RECTYPE": "D", "MH": "Vascular Neoplasms", "DE": "VASCULAR NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Vascular Neoplasm", "MN": "C14.907.936", "MH_TH": "NLM (1996)", "ST": "T191", "AN": "do not confuse with NEOPLASMS, VASCULAR TISSUE, neoplasms composed of vascular tissue; coordinate IM with specific vessel (IM) and histologic type of neoplasm (IM)", "PI": "Vascular Diseases (1968-1995)", "MS": "Neoplasms located in the vasculature system, such as ARTERIES and VEINS. They are differentiated from neoplasms of vascular tissue (NEOPLASMS, VASCULAR TISSUE), such as ANGIOFIBROMA or HEMANGIOMA.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20070709", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019043"}, {"RECTYPE": "D", "MH": "Image Cytometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Cytometry, Image|T059|NON|EQV|NLM (1996)|950126|abcdef", "ENTRY": "Image Cytometries", "MN": "E05.242.386.400", "MH_TH": "NLM (1996)", "ST": "T059", "AN": "a cytophotometry technique", "PI": "Image Processing, Computer-Assisted (1987-1995)", "MS": "A technique encompassing morphometry, densitometry, neural networks, and expert systems that has numerous clinical and research applications and is particularly useful in anatomic pathology for the study of malignant lesions. The most common current application of image cytometry is for DNA analysis, followed by quantitation of immunohistochemical staining.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019044"}, {"RECTYPE": "D", "MH": "Bone Marrow Neoplasms", "DE": "BONE MARROW NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Neoplasm, Bone Marrow", "MN": "C15.378.400.200", "MH_TH": "NLM (1996)", "ST": "T191", "AN": "neoplasms located in bone marrow: do not confuse with neoplasms composed of bone marrow cells (like myeloma);  coordinate with histological type of neoplasm", "PI": "Bone Marrow/pathology (1968-1995)", "MS": "Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20050720", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D019046"}, {"RECTYPE": "D", "MH": "Phantoms, Imaging", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Radiologic Phantoms|T073|NON|NRW|NLM (1996)|950330|RADIOL PHANTOMS|abcdefv", "ENTRY": "Phantom, Imaging", "MN": "E07.671", "MH_TH": "NLM (1996)", "ST": "T073", "AN": "IM or NIM; coord with specific technique /instrum (IM)", "MS": "Devices or objects in various imaging techniques used to visualize or enhance visualization by simulating conditions encountered in the procedure. Phantoms are used very often in procedures employing or measuring x-irradiation or radioactive material to evaluate performance. Phantoms often have properties similar to human tissue. Water demonstrates absorbing properties similar to normal tissue, hence water-filled phantoms are used to map radiation levels. Phantoms are used also as teaching aids to simulate real conditions with x-ray or ultrasonic machines. (From Iturralde, Dictionary and Handbook of Nuclear Medicine and Clinical Imaging, 1990)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20040713", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019047"}, {"RECTYPE": "D", "MH": "Prostatic Intraepithelial Neoplasia", "DE": "PROSTATIC INTRAEPITHELIAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Neoplasia, Prostatic Intraepithelial|T191|NON|EQV|NLM (1996)|950126|NEOPL PROSTATIC INTRAEPITHELIAL|abcdefv", "ENTRY": "Prostatic Neoplasia, Intraepithelial", "MN": "C04.557.470.200.240.500", "MH_TH": "NLM (1996)", "ST": "T191", "AN": "coordinate with PROSTATIC NEOPLASMS ", "PI": "Prostatic Neoplasms (1989-1995)", "MS": "A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D019048"}, {"RECTYPE": "D", "MH": "Developed Countries", "AQ": "CL EC HI SN", "PRINT ENTRY": "Industrialized Countries|T080|NON|EQV|NLM (1996)|950130|abcdef", "ENTRY": "Nations, Industrialized", "MN": "I01.615.500.250", "MH_TH": "NLM (1996)", "ST": "T080", "AN": "use with caution: follow text of author; do not confuse with DEVELOPING COUNTRIES; IM; specify country or countries if relevant", "PI": "specific country (1966-1995)", "MS": "Countries that have reached a level of economic achievement through an increase of production, per capita income and consumption, and utilization of natural and human resources.", "PM": "96", "HN": "96", "MR": "20040713", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019049"}, {"RECTYPE": "D", "MH": "Acupressure", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Zhi Ya|T061|NON|NRW|NLM (2002)|010406|abcdef", "MN": "E02.831.535.867.880.500", "MH_TH": "NLM (1996)", "ST": "T061", "PI": "Pressure (1983-1995)", "MS": "A type of massage in which finger pressure on specific body sites is used to promote healing, relieve fatigue, etc. Although the anatomical locations are the same as the ACUPUNCTURE POINTS used in ACUPUNCTURE THERAPY (hence acu-), no needle or other acupuncture technique is employed in acupressure. (From Random House Unabridged Dictionary, 2d ed). Shiatsu is a modern outgrowth that focuses more on prevention than healing.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019050"}, {"RECTYPE": "D", "MH": "Rhizotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Rhizotomies", "MN": "E04.525.210.815", "MH_TH": "NLM (1996)", "ST": "T061", "PI": "Spinal Nerve Roots/surgery (1970-1995)", "MS": "Surgical interruption of a spinal or cranial nerve root. (From Dorland, 28th ed)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20170705", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019051"}, {"RECTYPE": "D", "MH": "Depression, Postpartum", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Postpartum Dysphoria|T048|NON|NRW|NLM (2023)|210910|abcdef", "ENTRY": "Post Partum Dysphoria", "MN": "F03.600.300.350", "MH_TH": "NLM (1996)", "ST": "T048", "AN": "coordinate with specific psychiatric disease if relevant; check the tag FEMALE", "PI": "Puerperal Disorders (1966-1995)", "MS": "Depression in POSTPARTUM WOMEN, usually within four weeks after giving birth (PARTURITION). The degree of depression ranges from mild transient depression to neurotic or psychotic depressive disorders. (From DSM-IV, p386)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20211018", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019052"}, {"RECTYPE": "D", "MH": "HIV Enteropathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "HIV-Associated Enteropathy|T047|EQV|NLM (1996)|950202|HIV ASSOC ENTEROPATHY|abdefv", "ENTRY": "Idiopathic AIDS Enteropathies", "MN": "C20.673.480.480", "MH_TH": "NLM (1996)", "ST": "T047", "MS": "A syndrome characterized by chronic, well-established DIARRHEA (greater than one month in duration) without an identified infectious cause after thorough evaluation, in an HIV-positive individual. It is thought to be due to direct or indirect effects of HIV on the enteric mucosa. HIV enteropathy is a diagnosis of exclusion and can be made only after other forms of diarrheal illness have been ruled out. (Harrison's Principles of Internal Medicine, 13th ed, pp1607-8; Haubrich et al., Bockus Gastroenterology, 5th ed, p1155)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D019053"}, {"RECTYPE": "D", "MH": "Evoked Potentials, Motor", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Motor Evoked Potentials|T042|T060|NON|EQV|NLM (1996)|950202|abbcdef", "ENTRY": "Potentials, Motor Evoked", "MN": "G11.561.200.500.385", "MH_TH": "NLM (1996)", "ST": "T060", "PI": "Evoked Potentials (1966-1995)", "MS": "The electrical response evoked in a muscle or motor nerve by electrical or magnetic stimulation. Common methods of stimulation are by transcranial electrical and TRANSCRANIAL MAGNETIC STIMULATION. It is often used for monitoring during neurosurgery.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20160120", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019054"}, {"RECTYPE": "D", "MH": "No-Observed-Adverse-Effect Level", "DE": "NO OBSERVED ADV EFF LEVEL", "PRINT ENTRY": "No-Observed-Effect Level|T060|NON|BRD|NLM (1996)|950202|NO OBSERVED EFF LEVEL|abcdefv", "ENTRY": "Tolerable Daily Intakes", "MN": "G07.690.936.750", "MH_TH": "NLM (1996)", "ST": "T081", "AN": "coordinate NIM with specific drug / tox (IM)", "PI": "specific drug /toxicity (1983-1995)", "MS": "The highest dosage administered that does not produce toxic effects.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019055"}, {"RECTYPE": "D", "MH": "Receptors, Polymeric Immunoglobulin", "DE": "RECEPT POLY IG", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Polymeric Immunoglobulin Receptors|T116|T129|T192|NON|EQV|NLM (1996)|950321|POLY IG RECEPT|abbbcdefv", "ENTRY": "Receptor, Polymeric Immunoglobulin", "MN": "D12.776.543.750.705.871.700", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "PI": "Secretory Component (1992-1995)", "MS": "Specialized Fc receptors (RECEPTORS, FC) for polymeric immunoglobulins, which mediate transcytosis of polymeric IMMUNOGLOBULIN A and IMMUNOGLOBULIN M into external secretions. They are found on the surfaces of epithelial cells and hepatocytes. After binding to IMMUNOGLOBULIN A, the receptor-ligand complex undergoes endocytosis, transport by vesicle, and secretion into the lumen by exocytosis. Before release, the part of the receptor (SECRETORY COMPONENT) that is bound to IMMUNOGLOBULIN A is proteolytically cleaved from its transmembrane tail. (From Rosen et al., The Dictionary of Immunology, 1989)", "PM": "96", "HN": "96", "MR": "20180701", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019056"}, {"RECTYPE": "D", "MH": "Quality-Adjusted Life Years", "PRINT ENTRY": "Quality-Adjusted Life Year|T079|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Years, Adjusted Life", "MN": "N06.850.520.308.985.450.875", "MH_TH": "BIOETHICS (1990)", "ST": "T079", "PI": "Quality of Life (1991-1995)", "MS": "A measurement index derived from a modification of standard life-table procedures and designed to take account of the quality as well as the duration of survival. This index can be used in assessing the outcome of health care procedures or services. (BIOETHICS Thesaurus, 1994)", "PM": "96", "HN": "96", "MR": "20210701", "DA": "19950620", "DC": "1", "DX": "19960101", "UI": "D019057"}, {"RECTYPE": "D", "MH": "Community Networks", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Community Health Networks|T058|NON|REL|NLM (1996)|950530|abcdef", "ENTRY": "Networks, Community Health", "MN": "N02.421.143.202", "MH_TH": "NLM (1996)", "ST": "T054", "AN": "IM", "PI": "Community Health Services (1980-1995)", "MS": "Organizations and individuals cooperating together toward a common goal at the local or grassroots level.", "PM": "96", "HN": "96", "MR": "20150626", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019058"}, {"RECTYPE": "D", "MH": "Minimally Invasive Surgical Procedures", "DE": "MINIMAL INVASIVE SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Minimally Invasive|T061|NON|EQV|NLM (1996)|990101|SURG PROCEDURES MINIMAL INVASIVE|abcdefv", "ENTRY": "Surgery, Minimally Invasive", "MN": "E04.502", "MH_TH": "NLM (1996)", "ST": "T061", "AN": "IM general only", "PI": "Surgery, Laparoscopic (1990-1995)", "MS": "Procedures that avoid use of open, invasive surgery in favor of closed or local surgery. These generally involve use of laparoscopic devices and remote-controlled manipulation of instruments with indirect observation of the surgical field through an endoscope or similar device.", "PM": "2015; see SURGICAL PROCEDURES, MINIMALLY INVASIVE 1998-2014; see SURGERY, MINIMALLY INVASIVE 1996-1997", "HN": "2015 (1996)", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019060"}, {"RECTYPE": "D", "MH": "src-Family Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "src-Family Tyrosine Kinase|T116|T126|NON|EQV|NLM (2021)|191122|abbcdef", "ENTRY": "src Protein-Tyrosine Kinases", "MN": "D12.776.476.568.800", "FX": "src Homology Domains", "MH_TH": "NLM (1996)", "ST": "T126", "RN": "EC 2.7.10.2", "PI": "Protein-Tyrosine Kinase (1986-1995)", "MS": "A PROTEIN-TYROSINE KINASE family that was originally identified by homology to the Rous sarcoma virus ONCOGENE PROTEIN PP60(V-SRC). They interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. Oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.", "PM": "96", "HN": "96", "MR": "20210521", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019061"}, {"RECTYPE": "D", "MH": "Cell Adhesion Molecules, Neuron-Glia", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ng-CAM|T116|T123|ABB|EQV|NLM (1996)|950206|abbcdef", "ENTRY": "Neuron Glia Cell Adhesion Molecules", "MN": "D23.050.301.350.250.150", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "AN": "do not confuse with CELL ADHESION MOLECULES, NEURONAL", "PI": "Cell Adhesion Molecules, Neuronal (1990-1995)", "MS": "Cell adhesion molecules that mediate neuron-neuron adhesion and neuron-astrocyte adhesion. They are expressed on neurons and Schwann cells, but not astrocytes and are involved in neuronal migration, neurite fasciculation, and outgrowth. Ng-CAM is immunologically and structurally distinct from NCAM.", "OL": "use CELL ADHESION MOLECULES, NEURONAL to search NEURON-GLIA ADHESION MOLECULES 1990-95", "PM": "96; was NEURON-GLIA ADHESION MOLECULES see CELL ADHESION MOLECULES, NEURONAL 1990-95", "HN": "96; was NEURON-GLIA ADHESION MOLECULES see CELL ADHESION MOLECULES, NEURONAL 1990-95", "MR": "20230316", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019062"}, {"RECTYPE": "D", "MH": "Tenascin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tenascin-C|T116|T123|NON|EQV|NLM (1996)|950206|abbcdef", "ENTRY": "Tenascin C", "MN": "D12.776.860.300.850", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "PI": "Proteins (1986-1989)", "MS": "Hexameric extracellular matrix glycoprotein transiently expressed in many developing organs and often re-expressed in tumors. It is present in the central and peripheral nervous systems as well as in smooth muscle and tendons. (From Kreis & Vale, Guidebook to the Extracellular Matrix and Adhesion Proteins, 1993, p93)", "OL": "use TENASCIN (NM) to search TENASCIN 1986-95", "PM": "96; TENASCIN was indexed under CELL ADHESION MOLECULES, NEURONAL & EXTRACELLULAR MATRIX PROTEINS 1990-95; PROTEINS & GLYCOPROTEINS 1986-89", "HN": "96; was TENASCIN (NM) 1986-95", "MR": "20010725", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019063"}, {"RECTYPE": "D", "MH": "Product Packaging", "AQ": "CL EC ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Product Containers|T073|NON|BRD|NLM (1996)|950330|abcdef", "ENTRY": "Product Packagings", "MN": "J01.576.761", "MH_TH": "NLM (1996)", "ST": "T068", "AN": "includes containers, packaging methods, packaging materials; IM; coord with specific product (IM); FOOD PACKAGING & DRUG PACKAGING are also available", "MS": "Form in which product is processed or wrapped and labeled. PRODUCT LABELING is also available.", "PM": "96", "HN": "96", "MR": "20040730", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019064"}, {"RECTYPE": "D", "MH": "Virus Assembly", "AQ": "DE GE IM PH RE", "ENTRY": "Assembly, Virus", "MN": "G06.920.925.950", "MH_TH": "NLM (1996)", "ST": "T045", "AN": "coordinate with specific virus /physiol", "PI": "Virus Replication (1986-1995)", "MS": "The assembly of VIRAL STRUCTURAL PROTEINS and nucleic acid (VIRAL DNA or VIRAL RNA) to form a VIRUS PARTICLE.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20200622", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019065"}, {"RECTYPE": "D", "MH": "Facies", "MN": "E01.370.600.230", "MH_TH": "NLM (1996)", "ST": "T032", "AN": "do not confuse with FACIAL EXPRESSION, a psychol response; coord IM with assoc dis (IM)", "MS": "The appearance of the face that is often characteristic of a disease or pathological condition, as the elfin facies of WILLIAMS SYNDROME or facies of DOWN SYNDROME. (Random House Unabridged Dictionary, 2d ed)", "OL": "use FACIAL EXPRESSION to search FACIES 1966-73", "PM": "96; was see under FACIAL EXPRESSION 1963-73", "HN": "96; was see under FACIAL EXPRESSION 1963-73", "CATSH": "CAT LIST", "MR": "20220818", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019066"}, {"RECTYPE": "D", "MH": "Antibody-Dependent Enhancement", "AQ": "DE GE IM PH RE", "ENTRY": "Enhancement, Antibody-Dependent", "MN": "G12.113", "MH_TH": "NLM (1996)", "ST": "T049", "AN": "enhancement of viral infectivity: read MeSH definition", "MS": "Enhancement of viral infectivity caused by non-neutralizing antibodies. There are at least two mechanisms known to account for this: mediation by Fc receptors (RECEPTORS, FC) or by complement receptors (RECEPTORS, COMPLEMENT). Either the virus is complexed with antiviral IMMUNOGLOBULIN G and binds to Fc receptors, or virus is coated with antiviral IMMUNOGLOBULIN M and binds to complement receptors.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20160209", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019067"}, {"RECTYPE": "D", "MH": "Bryopsida", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Physcomitrella|T002|NON|NRW|NLM (1996)|950321|abcdef", "ENTRY": "True Mosses", "MN": "B01.875.800.575.137.500", "MH_TH": "NLM (2004)", "ST": "T002", "RR": "txid3224", "AN": "entry term MOSSES, TRUE: check MeSH for other moss term", "PI": "Plants (1966-1995)", "MS": "A class of plants within the Bryophyta comprising the mosses, which are found in both damp (including freshwater) and drier situations. Mosses possess erect or prostrate leafless stems, which give rise to leafless stalks bearing capsules. Spores formed in the capsules are released and grow to produce new plants. (Concise Dictionary of Biology, 1990). Many small plants bearing the name moss are in fact not mosses. The \"moss\" found on the north side of trees is actually a green alga (CHLOROPHYTA). Irish moss is really a red alga (RHODOPHYTA). Beard lichen (beard moss), Iceland moss, oak moss, and reindeer moss are actually LICHENS. Spanish moss is a common name for both LICHENS and an air plant (TILLANDSIA usneoides) of the pineapple family. Club moss is an evergreen herb of the family LYCOPODIACEAE.", "PM": "2004; see MOSSES 1996-2003", "HN": "2004(1996)", "MR": "20210630", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019068"}, {"RECTYPE": "D", "MH": "Cell Respiration", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Respiration, Cell|T043|NON|EQV|NLM (1996)|950213|abcdef", "ENTRY": "Respiration, Cellular", "MN": "G04.270", "FX": "Oxygen Consumption", "MH_TH": "NLM (1996)", "ST": "T043", "AN": "NIM; not for micro-organisms; for plant resp, coord NIM with PLANTS /metab (IM) or specific plant /metab (IM); CELL HYPOXIA is also available", "PI": "Oxygen Consumption (1966-1995)", "MS": "The metabolic process of all living cells (animal and plant) in which oxygen is used to provide a source of energy for the cell.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20160502", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019069"}, {"RECTYPE": "D", "MH": "Cell Lineage", "AQ": "DE GE IM PH RE", "ENTRY": "Lineages, Cell", "MN": "G08.686.784.170.104.249", "FX": "Cell Differentiation", "MH_TH": "NLM (1996)", "ST": "T078", "AN": "not for microorganisms; do not confuse with CELL LINE which is derived from cultured cells", "PI": "Cell Differentiation (1969-1995)", "MS": "The developmental history of specific differentiated cell types as traced back to the original STEM CELLS in the embryo.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20160125", "DA": "19950524", "DC": "1", "DX": "19960101", "UI": "D019070"}, {"RECTYPE": "D", "MH": "Persia", "AQ": "EH EP", "PRINT ENTRY": "Persian Empire|T083|NAM|EQV|NLM (1996)|950215|abcdef", "MN": "Z01.586.035.725", "MH_TH": "NLM (1996)", "ST": "T083", "AN": "use PERSIA through 1934; use IRAN starting with1935", "MS": "An ancient civilization, known as early as 2000 B.C. The Persian Empire was founded by Cyrus the Great (550-529 B.C.) and for 200 years, from 550 to 331 B.C., the Persians ruled the ancient world from India to Egypt. The territory west of India was called Persis by the Greeks who later called the entire empire Persia. In 331 B.C. the Persian wars against the Greeks ended disastrously under the counterattacks by Alexander the Great. The name Persia in modern times for the modern country was changed to Iran in 1935. (From Webster's New Geographical Dictionary, 1988, p546 & Asimov, Words on the Map, 1962, p176)", "HN": "96", "MR": "20150629", "DA": "19950605", "DC": "4", "DX": "19960101", "UI": "D019071"}, {"RECTYPE": "D", "MH": "Antibiotic Prophylaxis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Premedication, Antibiotic|T061|NON|EQV|NLM (1998)|960815|abcdef", "ENTRY": "Prophylaxis, Antibiotic", "MN": "E02.319.703.150", "MH_TH": "NLM (1996)", "ST": "T061", "AN": "IM; coord with specific antibiotic /ther use (IM)", "PI": "Surgical Wound Infection (1966-1995)", "MS": "Use of antibiotics before, during, or after a diagnostic, therapeutic, or surgical procedure to prevent infectious complications.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20050630", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019072"}, {"RECTYPE": "D", "MH": "HT29 Cells", "DS": "HT 29 CELLS", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "HT29 Cell", "MN": "A11.436.365", "MH_TH": "NLM (1996)", "ST": "T025", "AN": "almost always NIM with no subheadings; check HUMAN; do not routinely add ADENOCARCINOMA or COLONIC NEOPLASMS", "PI": "Tumor Cells, Cultured (1988-1995)", "MS": "Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells such as the GOBLET CELLS.", "PM": "96", "HN": "96", "MR": "20030709", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D019073"}, {"RECTYPE": "D", "MH": "Epigastric Arteries", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Epigastric Artery", "MN": "A07.015.114.330", "MH_TH": "NLM (1996)", "ST": "T023", "AN": "nothing to do with stomach or gastric: read MeSH definition", "PI": "Abdominal Muscles/blood supply (1966-1995)", "MS": "Inferior and external epigastric arteries arise from external iliac; superficial from femoral; superior from internal thoracic. They supply the abdominal muscles, diaphragm, iliac region, and groin. The inferior epigastric artery is used in coronary artery bypass grafting and myocardial revascularization.", "PM": "96", "HN": "96", "MR": "20180630", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019074"}, {"RECTYPE": "D", "MH": "Electrophoresis, Capillary", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Zone Electrophoresis, Capillary", "MN": "E05.301.300.190", "MH_TH": "NLM (1996)", "ST": "T059", "AN": "capillary refers to the size of the chambers used for the electrophoresis; NIM", "PI": "Electrophoresis/methods (1980-1995)", "MS": "A highly-sensitive (in the picomolar range, which is 10,000-fold more sensitive than conventional electrophoresis) and efficient technique that allows separation of PROTEINS; NUCLEIC ACIDS; and CARBOHYDRATES. (Segen, Dictionary of Modern Medicine, 1992)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019075"}, {"RECTYPE": "D", "MH": "Transgenes", "AQ": "DE ES GE IM PH RE", "ENTRY": "Transgenes, Recombinant", "MN": "G05.360.340.024.340.825", "FX": "Plants, Genetically Modified", "MH_TH": "NLM (1996)", "ST": "T028", "MS": "Genes that are introduced into an organism using GENE TRANSFER TECHNIQUES.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019076"}, {"RECTYPE": "D", "MH": "Helix-Turn-Helix Motifs", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "HTH Motifs|T082|NON|EQV|NLM (2000)|991105|abcdef", "ENTRY": "Motifs, Helix Turn Helix", "MN": "G02.111.570.820.709.275.500.360.360", "MH_TH": "NLM (1996)", "ST": "T082", "AN": "do not confuse with HELIX-LOOP-HELIX MOTIFS", "PI": "Helix-Loop-Helix Motifs (1994-1995)", "MS": "The first DNA-binding protein motif to be recognized. Helix-turn-helix motifs were originally identified in bacterial proteins but have since been found in hundreds of DNA-BINDING PROTEINS from both eukaryotes and prokaryotes. They are constructed from two alpha helices connected by a short extended chain of amino acids, which constitute the \"turn.\" The two helices are held at a fixed angle, primarily through interactions between the two helices. (From Alberts et al., Molecular Biology of the Cell, 3d ed, p408-9)", "OL": "use HELIX-LOOP-HELIX MOTIFS to search HELIX-TURN-HELIX MOTIFS 1994-95", "PM": "96; was see HELIX-LOOP-HELIX MOTIFS 1994-95", "HN": "96; was see HELIX-LOOP-HELIX MOTIFS 1994-95", "CATSH": "CAT LIST", "MR": "20160531", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019077"}, {"RECTYPE": "D", "MH": "Cafe-au-Lait Spots", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spots, Cafe-au-Lait", "MN": "C23.888.885.250", "MH_TH": "NLM (1996)", "ST": "T047", "AN": "a pigmentation disord; spell in titles & translations with hyphens & accent: caf\u00e9-au-lait", "PI": "Pigmentation Disorders (1966-1995)", "MS": "Light brown pigmented macules associated with NEUROFIBROMATOSIS and Albright's syndrome (see FIBROUS DYSPLASIA, POLYOSTOTIC).", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20160701", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019080"}, {"RECTYPE": "D", "MH": "O Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "O-Specific Polysaccharides|T109|T129|EQV|NLM (1996)|950223|abbdef", "ENTRY": "Polysaccharides, O-Specific", "MN": "D23.946.123.329.500.600", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "PI": "Polysaccharides, Bacterial (1993-1995)", "MS": "The lipopolysaccharide-protein somatic antigens, usually from gram-negative bacteria, important in the serological classification of enteric bacilli. The O-specific chains determine the specificity of the O antigens of a given serotype. O antigens are the immunodominant part of the lipopolysaccharide molecule in the intact bacterial cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)", "OL": "use O ANTIGENS (NM) to search O ANTIGEN, BACTERIAL 1981-95", "PM": "96; O ANTIGEN, BACTERIAL was indexed under POLYSACCHARIDES, BACTERIAL 1993-95 & ANTIGENS, BACTERIAL 1981-92", "HN": "96; was O ANTIGEN, BACTERIAL (NM) 1981-95", "MR": "20220523", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019081"}, {"RECTYPE": "D", "MH": "Smith-Lemli-Opitz Syndrome", "AQ": "BL CF CI CL DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, SLO", "MN": "C18.452.648.925.875", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Abnormalities, Multiple (1967-1995)", "MS": "An autosomal recessive disorder of CHOLESTEROL metabolism. It is caused by a deficiency of 7-dehydrocholesterol reductase, the enzyme that converts 7-dehydrocholesterol to cholesterol, leading to an abnormally low plasma cholesterol. This syndrome is characterized by multiple CONGENITAL ABNORMALITIES, growth deficiency, and INTELLECTUAL DISABILITY.", "PM": "1996", "HN": "1996", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019082"}, {"RECTYPE": "D", "MH": "Mediterranean Region", "AQ": "EH EP", "MN": "Z01.542.580", "MH_TH": "NLM (1996)", "ST": "T083", "AN": "the countries & people of the region in general or unspecified; prefer specific islands or countries", "MS": "The Mediterranean Sea, the Mediterranean islands, and the countries bordering on the sea collectively.", "HN": "96", "MR": "20160707", "DA": "19950605", "DC": "4", "DX": "19960101", "UI": "D019083"}, {"RECTYPE": "D", "MH": "Fluorescent Antibody Technique, Indirect", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Immunofluorescence Technique, Indirect|T059|NON|EQV|NLM (1996)|950302|abcdef", "ENTRY": "Indirect Immunofluorescences", "MN": "E05.478.583.375.310", "MH_TH": "NLM (1996)", "ST": "T059", "AN": "usually NIM; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT is also available", "PI": "Fluorescent Antibody Technique (1966-1995)", "MS": "A form of fluorescent antibody technique commonly used to detect serum antibodies and immune complexes in tissues and microorganisms in specimens from patients with infectious diseases. The technique involves formation of an antigen-antibody complex which is labeled with fluorescein-conjugated anti-immunoglobulin antibody. (From Bennington, Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019084"}, {"RECTYPE": "D", "MH": "Fluorescent Antibody Technique, Direct", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Immunofluorescence Technique, Direct|T059|NON|EQV|NLM (1996)|950302|abcdef", "ENTRY": "Immunofluorescences, Direct", "MN": "E05.478.583.375.300", "MH_TH": "NLM (1996)", "ST": "T059", "AN": "usually NIM; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT is also available", "PI": "Fluorescent Antibody Technique (1966-1995)", "MS": "A form of fluorescent antibody technique utilizing a fluorochrome conjugated to an antibody, which is added directly to a tissue or cell suspension for the detection of a specific antigen. (Bennington, Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20150622", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019085"}, {"RECTYPE": "D", "MH": "Bridged Bicyclo Compounds, Heterocyclic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Heterocyclic Cpds, Bicyclic|T109|EQV|NLM (1996)|950303|HETEROCYCLIC COMPOUNDS BICYCLIC|HETEROCYCLIC CPDS BICYCLIC|abdefsv", "ENTRY": "Heterocyclic Compounds, Bicyclic", "MN": "D03.605.084", "FX": "Bridged Bicyclo Compounds", "MH_TH": "NLM (2017)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Bicyclo Compounds (1975-1995)", "MS": "Heterocyclic compounds that contain two rings that share two non-adjacent atoms in common.", "PM": "2017; see BICYCLIC COMPOUND, HETEROCYCLIC 1997-2016", "HN": "2017(1996)", "MR": "20160609", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D019086"}, {"RECTYPE": "D", "MH": "Selectins", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Selectin|T116|T123|NON|EQV|NLM (2021)|200227|abbcdef", "MN": "D23.050.301.350.700", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Cell Adhesion Molecules (1990-1995)", "MS": "Transmembrane proteins consisting of a lectin-like domain, an epidermal growth factor-like domain, and a variable number of domains that are homologous to complement regulatory proteins. They are important cell adhesion molecules which help LEUKOCYTES attach to VASCULAR ENDOTHELIUM.", "PM": "1996", "HN": "1996", "MR": "20230316", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019087"}, {"RECTYPE": "D", "MH": "Stem Cell Factor", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "c-kit Ligand|T116|T123|EQV|NLM (1996)|950310|abbdef", "ENTRY": "c kit Ligand", "MN": "D23.529.374.410.800", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "PI": "Hematopoietic Cell Growth Factors (1990-1995)", "MS": "A hematopoietic growth factor and the ligand of the cell surface c-kit protein (PROTO-ONCOGENE PROTEINS C-KIT). It is expressed during embryogenesis and is a growth factor for a number of cell types including the MAST CELLS and the MELANOCYTES in addition to the HEMATOPOIETIC STEM CELLS.", "OL": "use STEM CELL FACTOR (NM) to search MAST CELL GROWTH FACTOR 1990-95", "PM": "96; MAST CELL GROWTH FACTOR was indexed under HEMATOPOIETIC CELL GROWTH FACTORS 1990-95", "HN": "96; was MAST CELL GROWTH FACTOR (NM) 1990-95", "MR": "20060705", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019089"}, {"RECTYPE": "D", "MH": "Case Management", "AQ": "CL EC ES HI LJ OG SN ST TD", "MN": "N04.590.233.624.250", "FX": "Managed Care Programs", "MH_TH": "NLM (1996)", "ST": "T057", "AN": "all health professionals' activities to insure coord of services for the patient", "PI": "Patient Care Planning (1980-1995)", "MS": "A traditional term for all the activities which a physician or other health care professional normally performs to insure the coordination of the medical services required by a patient. It also, when used in connection with managed care, covers all the activities of evaluating the patient, planning treatment, referral, and follow-up so that care is continuous and comprehensive and payment for the care is obtained. (From Slee & Slee, Health Care Terms, 2nd ed)", "PM": "96", "HN": "96", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019090"}, {"RECTYPE": "D", "MH": "Critical Pathways", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Clinical Pathways|T058|NON|EQV|NLM (1996)|950313|CLIN PATHWAYS|abcdefv", "ENTRY": "Pathway, Critical", "MN": "N04.590.233.624.625", "MH_TH": "NLM (1996)", "ST": "T058", "AN": "schedules in patient care for coordinated treatment", "PI": "Patient Care Planning (1991-1995)", "MS": "Schedules of medical and nursing procedures, including diagnostic tests, medications, and consultations designed to effect an efficient, coordinated program of treatment. (From Mosby's Medical, Nursing & Allied Health Dictionary, 4th ed)", "PM": "96", "HN": "96", "MR": "20210601", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019091"}, {"RECTYPE": "D", "MH": "Conization", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Conisation|T060|NON|EQV|NLM (1996)|950313|abcdef", "ENTRY": "Conizations", "MN": "E05.242.384.100.160", "MH_TH": "NLM (1996)", "ST": "T060", "AN": "not restricted to cervical biopsy; coord IM with organ /pathol (IM) or organ /surg (IM)", "PI": "Cervix Uteri/surgery (1966-1995)", "MS": "The excision of a cone of tissue, especially of the CERVIX UTERI.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20150601", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019092"}, {"RECTYPE": "D", "MH": "Circumcision, Female", "AQ": "AE CL EC ED EH ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Infibulation|T054|NON|NRW|NLM (1996)|950313|abcdef", "ENTRY": "Infibulations", "MN": "I01.076.201.450.199", "MH_TH": "NLM (1996)", "ST": "T054", "PI": "Circumcision (1990-1995)", "MS": "A general term encompassing three types of excision of the external female genitalia - Sunna, clitoridectomy, and infibulation. It is associated with severe health risks and has been declared illegal in many places, but continues to be widely practiced in a number of countries, particularly in Africa.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19950607", "DC": "1", "DX": "19960101", "UI": "D019093"}, {"RECTYPE": "D", "MH": "Dental Prosthesis, Implant-Supported", "DE": "DENT PROSTHESIS IMPLANT SUP", "AQ": "AE CL EC ES HI IS MI MO MT NU PS PX SN ST TD VE VI", "PRINT ENTRY": "Implant-Supported Dental Prosthesis|T074|NON|EQV|NLM (1996)|950313|IMPLANT SUP DENT PROSTHESIS|abcdefv", "ENTRY": "Prosthesis, Implant-Supported Dental", "MN": "E07.695.190.185", "MH_TH": "NLM (1996)", "ST": "T074", "PI": "Dental Implants (1990-1995)", "MS": "A prosthesis that gains its support, stability, and retention from a substructure that is implanted under the soft tissues of the basal seat of the device and is in contact with bone. (From Boucher's Clinical Dental Terminology, 4th ed)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19950629", "DC": "1", "DX": "19960101", "UI": "D019094"}, {"RECTYPE": "D", "MH": "Point-of-Care Systems", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Point of Care Technology|T058|NON|REL|NLM (1996)|950313|POINT OF CARE TECHNOL|abcdefv", "ENTRY": "Technology, Bedside", "MN": "N04.590.874", "FX": "Medical Order Entry Systems", "MH_TH": "NLM (1996)", "ST": "T058", "MS": "Laboratory and other services provided to patients at the bedside. These include diagnostic and laboratory testing using automated information entry.", "PM": "96", "HN": "96", "MR": "20190709", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019095"}, {"RECTYPE": "D", "MH": "Vitronectin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serum Spreading Factor|T116|T123|NON|NRW|NLM (2024)|230522|abbcdef", "MN": "D12.776.860.300.920", "MH_TH": "NLM (1996)", "ST": "T123", "RN": "0", "AN": "a glycoprotein", "PI": "Glycoproteins (1978-1995)", "MS": "A blood plasma glycoprotein that mediates cell adhesion and interacts with proteins of the complement, coagulation, and fibrinolytic cascade. (From Segen, Dictionary of Modern Medicine, 1992)", "OL": "use VITRONECTIN (NM) to search VITRONECTIN 1980-95", "PM": "96; VITRONECTIN was indexed under GLYCOPROTEINS 1978-95", "HN": "96; was VITRONECTIN (NM) 1978-95", "MR": "20230526", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019096"}, {"RECTYPE": "D", "MH": "Spin Trapping", "AQ": "IS MT", "ENTRY": "Trappings, Spin", "MN": "E05.196.885", "MH_TH": "NLM (1996)", "ST": "T059", "AN": "a method for detecting free radicals", "PI": "Spin Labels (1975-1995)", "MS": "A technique for detecting short-lived reactive FREE RADICALS in biological systems by providing a nitrone or nitrose compound for an addition reaction to occur which produces an ELECTRON SPIN RESONANCE SPECTROSCOPY-detectable aminoxyl radical. In spin trapping, the compound trapping the radical is called the spin trap and the addition product of the radical is identified as the spin adduct. (Free Rad Res Comm 1990;9(3-6):163)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019097"}, {"RECTYPE": "D", "MH": "Telomerase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcriptase, Telomerase Reverse", "MN": "D12.776.664.962.500.921", "FX": "Telomere Homeostasis", "MH_TH": "NLM (1996)", "ST": "T126", "RN": "EC 2.7.7.49", "RR": "EC 2.7.7.49", "PI": "DNA Nucleotidylexotransferase (1989-1995)", "MS": "An essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic CHROMOSOMES.", "PM": "1996; see DNA NUCLEOTIDYLEXOTRANSFERASE 1989-1995; TELOMERASE REVERSE TRANSCRIPTASE was indexed under DNA-BINDING PROTEINS & TELOMERASE 2000-2006, & under FUNGAL PROTEINS 1997, & under PROTEINS 1997-1999", "HN": "1996(1989); use DNA NUCLEOTIDYLEXOTRANSFERASE 1989-1995", "MR": "20170629", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019098"}, {"RECTYPE": "D", "MH": "Infant, Very Low Birth Weight", "DE": "INFANT VLBW", "AQ": "BL CF GD IM ME PH PX UR", "ENTRY": "Very-Low-Birth-Weight Infants", "MN": "M01.060.703.520.460.600", "MH_TH": "NLM (1996)", "ST": "T101", "AN": "check the tag INFANT, NEWBORN", "PI": "Infant, Premature (1970-1974)", "MS": "An infant whose weight at birth is less than 1500 grams (3.3 lbs), regardless of gestational age.", "PM": "96", "HN": "96", "MR": "20020703", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019102"}, {"RECTYPE": "D", "MH": "Random Amplified Polymorphic DNA Technique", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "RAPD-PCR|T059|T063|ABB|EQV|NLM (1996)|950317|abbcdef", "ENTRY": "RAPD Techniques", "MN": "E05.601.700", "FX": "Genetic Markers", "MH_TH": "NLM (1996)", "ST": "T063", "PI": "Polymerase Chain Reaction (1991-1995)", "MS": "Technique that utilizes low-stringency polymerase chain reaction (PCR) amplification with single primers of arbitrary sequence to generate strain-specific arrays of anonymous DNA fragments. RAPD technique may be used to determine taxonomic identity, assess kinship relationships, analyze mixed genome samples, and create specific probes.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20150623", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019105"}, {"RECTYPE": "D", "MH": "Postoperative Hemorrhage", "DE": "POSTOP HEMORRHAGE", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Postoperative|T033|T046|NON|EQV|NLM (1996)|950317|HEMORRHAGE POSTOP|abbcdefv", "ENTRY": "Postoperative Blood Loss", "MN": "C23.550.767.850", "MH_TH": "NLM (1996)", "ST": "T046", "AN": "IM; do not confuse with BLOOD LOSS, SURGICAL which is perioperative; coord with specific type of hemorrhage (IM) or specific type of surg (IM); see note on HEMORRHAGE for additional instructions on coords", "PI": "specific hemorrhage terms (1966-1995)", "MS": "Hemorrhage following any surgical procedure. It may be immediate or delayed and is not restricted to the surgical wound.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019106"}, {"RECTYPE": "D", "MH": "Tight Junctions", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Occluding Junctions|T030|NON|EQV|NLM (1996)|950317|abcdef", "ENTRY": "Zonula Occluden", "MN": "A11.284.149.165.420.820", "MH_TH": "NLM (1996)", "ST": "T030", "PI": "Intercellular Junctions (1970-1995)", "MS": "Cell-cell junctions that seal adjacent epithelial cells together, preventing the passage of most dissolved molecules from one side of the epithelial sheet to the other. (Alberts et al., Molecular Biology of the Cell, 2nd ed, p22)", "OL": "use INTERCELLULAR JUNCTIONS to search TIGHT JUNCTIONS 1995", "PM": "96; was see INTERCELLULAR JUNCTIONS 1995", "HN": "96; was see INTERCELLULAR JUNCTIONS 1995", "MR": "20030709", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019108"}, {"RECTYPE": "D", "MH": "Meteoroids", "PRINT ENTRY": "Meteors|T072|NON|REL|NLM (1996)|950530|abcdef", "ENTRY": "Meteoroid", "MN": "G01.060.075.500", "MH_TH": "NLM (1996)", "ST": "T072", "PI": "Solar System (1995)", "MS": "Any solid objects moving in interplanetary space that are smaller than a planet or asteroid but larger than a molecule. Meteorites are any meteoroid that has fallen to a planetary surface. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "OL": "use SOLAR SYSTEM to search METEOROIDS 1995", "PM": "96; was see SOLAR SYSTEM 1995", "HN": "96; was see SOLAR SYSTEM 1995", "MR": "20160617", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019110"}, {"RECTYPE": "D", "MH": "Condoms, Female", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Single-Use Internal Condom|T074|NON|EQV|NLM (2020)|181119|abcdef", "ENTRY": "Single-Use Internal Condoms", "MN": "E07.190.250.260", "MH_TH": "NLM (1996)", "ST": "T074", "MS": "A soft, loose-fitting polyurethane sheath, closed at one end, with flexible rings at both ends. The device is inserted into the vagina by compressing the inner ring and pushing it in. Properly positioned, the ring at the closed end covers the cervix, and the sheath lines the walls of the vagina. The outer ring remains outside the vagina, covering the labia. (Med Lett Drugs Ther 1993 Dec 24;35(12):123)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20190114", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019111"}, {"RECTYPE": "D", "MH": "Teleradiology", "DE": "TELERADIOL", "AQ": "CL EC ES HI IS LJ MT OG SN ST TD", "MN": "N04.590.374.800.700", "MH_TH": "NLM (1996)", "ST": "T066", "PI": "Telemedicine (1993-1995)", "MS": "The electronic transmission of radiological images from one location to another for the purposes of interpretation and/or consultation. Users in different locations may simultaneously view images with greater access to secondary consultations and improved continuing education. (From American College of Radiology, ACR Standard for Teleradiology, 1994, p3)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20220712", "DA": "19950606", "DC": "1", "DX": "19960101", "UI": "D019112"}, {"RECTYPE": "D", "MH": "Telepathology", "DE": "TELEPATHOL", "AQ": "CL EC ES HI IS LJ MT OG SN ST TD", "MN": "N04.590.374.800.600", "MH_TH": "NLM (1996)", "ST": "T066", "PI": "Telemedicine (1993-1995)", "MS": "Transmission and interpretation of tissue specimens via remote telecommunication, generally for the purpose of diagnosis or consultation but may also be used for continuing education.", "PM": "96", "HN": "96", "MR": "20220712", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019113"}, {"RECTYPE": "D", "MH": "Remote Consultation", "AQ": "CL EC ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Teleconsultation|T060|T066|NON|REL|NLM (1996)|950329|abbcdef", "ENTRY": "Teleconsultations", "MN": "N04.590.374.800.550", "FX": "Distance Counseling", "MH_TH": "NLM (1996)", "ST": "T066", "AN": "usually for diagnosis & therapy but not restricted to medicine", "PI": "Telemedicine (1993-1995)", "MS": "Consultation via electronic or other non-face-to-face interaction between the patient and physician.", "PM": "96", "HN": "96", "MR": "20230602", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019114"}, {"RECTYPE": "D", "MH": "Fasciitis, Necrotizing", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Necrotizing Fascitis", "MN": "C05.321.550", "MH_TH": "ORD (2010)", "ST": "T184", "AN": "coordinate IM with specific bacterial infection term (IM), often Streptococcal infection caused by Streptococcus pyogenes", "PI": "Necrosis (1969-1995)", "MS": "A fulminating bacterial infection of the deep layers of the skin and FASCIA. It can be caused by many different organisms, with STREPTOCOCCUS PYOGENES being the most common.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019115"}, {"RECTYPE": "D", "MH": "Burkholderia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.688.100", "MH_TH": "NLM (1996)", "ST": "T007", "RN": "txid32008", "PI": "Pseudomonadaceae (1992-1995)", "MS": "A genus of gram-negative, aerobic, rod-shaped bacteria originally classified as members of the PSEUDOMONADACEAE.", "PM": "96", "HN": "96", "MR": "20200813", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019117"}, {"RECTYPE": "D", "MH": "Burkholderia Infections", "DE": "BURKHOLDERIA INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Sepsis, Burkholderia cepacia", "MN": "C01.150.252.400.170", "MH_TH": "NLM (1996)", "ST": "T047", "AN": "gram-neg bact infect; coord IM with species (IM)", "PI": "Pseudomonas Infections (1992-1995)", "MS": "Infections with bacteria of the genus BURKHOLDERIA.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019121"}, {"RECTYPE": "D", "MH": "Meditation", "AQ": "HI MT PX", "PRINT ENTRY": "Transcendental Meditation|T041|NON|NRW|NLM (1996)|950403|abcdef", "ENTRY": "Meditation, Transcendental", "MN": "F04.754.137.750.500", "FX": "Yoga", "MH_TH": "NLM (1996)", "ST": "T041", "AN": "a relaxation technique", "PI": "Yoga (1966-1975)", "MS": "A state of consciousness in which the individual eliminates environmental stimuli from awareness so that the mind can focus on a single thing, producing a state of relaxation and relief from stress. A wide variety of techniques are used to clear the mind of stressful outside interferences. It includes meditation therapy. (Mosby's Medical, Nursing, and Allied Health Dictionary, 4th ed)", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D019122"}, {"RECTYPE": "D", "MH": "Therapeutic Touch", "DE": "THER TOUCH", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Reiki|T061|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Touch, Therapeutic|T061|NON|EQV|NLM (1996)|950406|TOUCH THER|abcdefv", "MN": "E02.190.901.830", "MH_TH": "NLM (1996)", "ST": "T061", "AN": "coord IM with disease /ther (IM); do not confuse with MASSAGE or other MUSCULOSKELETAL MANIPULATIONS", "PI": "Touch (1975-1995)", "MS": "Placing of the hands of the healer upon the person to be cured with the intent of spiritual energetic healing.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20130709", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D019124"}, {"RECTYPE": "D", "MH": "United States Social Security Administration", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Social Security Administration (U.S.)|T092|NAM|EQV|NLM (1996)|950405|abcdef", "ENTRY": "Social Security Administration, United States|T092|NAM|EQV|NLM (1996)|950406|SOCIAL SECURITY ADMIN UNITED STATES|abcdefv", "MN": "N03.540.348.500.500.999", "MH_TH": "NLM (1996)", "ST": "T092", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.; CATALOGER: Use NAF entry", "PI": "Social Security (1966-1995)", "MS": "An independent agency within the Executive Branch of the United States Government. It administers a national social insurance program whereby employees, employers, and the self-employed pay contributions into pooled trust funds. Part of the contributions go into a separate hospital insurance trust fund for workers at age 65 to provide help with medical expenses. Other programs include the supplemental social security income program for the aged, blind, and disabled and the Old Age Survivors and Disability Insurance Program. It became an independent agency March 31, 1995. It had previously been part of the Department of Health, Education, and Welfare, later the Department of Health and Human Services. (From United States Government Manual, 1994-95)", "PM": "96", "HN": "96", "MR": "20150629", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019131"}, {"RECTYPE": "D", "MH": "Antibodies, Blocking", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Enhancing Antibodies|T129|NON|NRW|NLM (1996)|950413|abcdef", "MN": "D12.776.377.715.548.114.143", "PA": "Immunologic Factors", "MH_TH": "NLM (1996)", "ST": "T129", "RN": "0", "MS": "Antibodies that inhibit the reaction between ANTIGEN and other antibodies or sensitized T-LYMPHOCYTES (e.g., antibodies of the IMMUNOGLOBULIN G class that compete with IGE antibodies for antigen, thereby blocking an allergic response). Blocking antibodies that bind tumors and prevent destruction of tumor cells by CYTOTOXIC T-LYMPHOCYTES have also been called enhancing antibodies. (Rosen et al., Dictionary of Immunology, 1989)", "PM": "96", "HN": "96", "MR": "20050630", "DA": "19950606", "DC": "1", "DX": "19960101", "UI": "D019138"}, {"RECTYPE": "D", "MH": "Tumor Escape", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Tumor Immune Evasion|T046|NON|EQV|NLM (2010)|090605|abcdef", "ENTRY": "Tumor Immune Evasions", "MN": "G12.900", "FX": "Immune Tolerance", "MH_TH": "NLM (1996)", "ST": "T046", "AN": "entry term IMMUNE EVASION, TUMOR: IMMUNE EVASION is also available", "MS": "The ability of tumors to evade destruction by the IMMUNE SYSTEM. Theories concerning possible mechanisms by which this takes place involve both cellular immunity (IMMUNITY, CELLULAR) and humoral immunity (ANTIBODY FORMATION), and also costimulatory pathways related to CD28 ANTIGENS and B7-1 ANTIGEN.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20200205", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019139"}, {"RECTYPE": "D", "MH": "Dental Care for Children", "DE": "DENT CARE CHILDREN", "AQ": "AE CL EC ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Dentistry for Children|T058|NON|EQV|NLM (1996)|950501|DENT CHILDREN|abcdefv", "ENTRY": "Children, Dentistry for", "MN": "N02.421.240.190.215", "MH_TH": "NLM (1996)", "ST": "T058", "AN": "= professional care by a professional; do not confuse with PEDIATRIC DENTISTRY, the specialty; check tag CHILD", "PI": "Pediatric Dentistry (1966-1995)", "MS": "The giving of attention to the special dental needs of children, including the prevention of tooth diseases and instruction in dental hygiene and dental health. The dental care may include the services provided by dental specialists.", "OL": "use PEDIATRIC DENTISTRY to search DENTISTRY FOR CHILDREN 1995", "PM": "96; DENTISTRY FOR CHILDREN was see PEDIATRIC DENTISTRY 1995", "HN": "96; DENTISTRY FOR CHILDREN was see PEDIATRIC DENTISTRY 1995", "CATSH": "CAT LIST", "MR": "20150629", "DA": "19950608", "DC": "1", "DX": "19960101", "UI": "D019140"}, {"RECTYPE": "D", "MH": "Respiratory System Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Respiratory Stimulants|T121|NON|NRW|NLM (1996)|950509|abcdef", "ENTRY": "Stimulants, Respiratory", "MN": "D27.505.954.796", "MH_TH": "NLM (1996)", "ST": "T121", "RN": "0", "PI": "Respiration/drug effects (1968-1995)", "MS": "Drugs used for their effects on the respiratory system.", "PM": "96", "HN": "96", "MR": "20210630", "DA": "19950526", "DC": "1", "DX": "19960101", "UI": "D019141"}, {"RECTYPE": "D", "MH": "Hemorrhagic Fever, Ebola", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Ebolavirus Infection|T047|NON|EQV|NLM (2020)|181105|abcdef", "ENTRY": "Virus Infection, Ebola", "MN": "C01.925.782.580.250.400", "FX": "Marburg Virus Disease", "MH_TH": "NLM (1996)", "ST": "T047", "PI": "Hemorrhagic Fevers, Viral (1978-1995)", "MS": "A highly fatal, acute hemorrhagic fever caused by EBOLAVIRUS.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20190529", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019142"}, {"RECTYPE": "D", "MH": "Evolution, Molecular", "DE": "EVOLUTION MOL", "PRINT ENTRY": "Molecular Evolution|T070|NON|EQV|NLM (1996)|950601|MOL EVOLUTION|abcdefv", "ENTRY": "Evolution, Genetic", "MN": "G16.075.250", "FX": "Directed Molecular Evolution", "MH_TH": "NLM (1996)", "ST": "T070", "PI": "Evolution (1966-1995)", "MS": "The process of cumulative change at the level of DNA; RNA; and PROTEINS, over successive generations.", "PM": "96", "HN": "96", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19950605", "DC": "1", "DX": "19960101", "UI": "D019143"}, {"RECTYPE": "D", "MH": "Rehabilitation Nursing", "DE": "REHABIL NURS", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Nursing, Rehabilitation|T058|T091|NON|EQV|NLM (1997)|950707|NURS REHABIL|abbcdefv", "ENTRY": "Rehabilitation Nursings", "MN": "N02.421.533.889", "MH_TH": "NLM (1997)", "ST": "T091", "PI": "Specialties, Nursing (1993-1996)", "MS": "A nursing specialty involved in the diagnosis and treatment of human responses of individuals and groups to actual or potential health problems with the characteristics of altered functional ability and altered life-style.", "PM": "97", "HN": "97", "MR": "20150708", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019145"}, {"RECTYPE": "D", "MH": "Hypermedia", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Hypertext|T170|NON|REL|NLM (1997)|950707|abcdef", "ENTRY": "Hypermedium|T170|NON|EQV|NLM (1997)|950918|abcdef", "MN": "L01.224.900.590", "MH_TH": "NLM (1997)", "ST": "T170", "AN": "a type of computer software", "PI": "Computer-Assisted Instruction (1993-1996)", "MS": "Computerized compilations of information units (text, sound, graphics, and/or video) interconnected by logical nonlinear linkages that enable users to follow optimal paths through the material and also the systems used to create and display this information. (From Thesaurus of ERIC Descriptors, 1994)", "PM": "97", "HN": "97", "MR": "20170703", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019146"}, {"RECTYPE": "D", "MH": "Vomeronasal Organ", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Vomeronasal System|T022|NON|REL|NLM (1997)|950714|abcdef", "ENTRY": "Vomeronasale, Organum", "MN": "A09.531.940", "MH_TH": "NLM (1997)", "ST": "T023", "MS": "An accessory chemoreceptor organ that is separated from the main OLFACTORY MUCOSA. It is situated at the base of nasal septum close to the VOMER and NASAL BONES. It forwards chemical signals (such as PHEROMONES) to the CENTRAL NERVOUS SYSTEM, thus influencing reproductive and social behavior. In humans, most of its structures except the vomeronasal duct undergo regression after birth.", "PM": "97", "HN": "97", "MR": "20180629", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019147"}, {"RECTYPE": "D", "MH": "Neuromuscular Blockade", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Blockade, Neuromuscular", "MN": "E05.635", "FX": "Neuromuscular Blocking Agents", "MH_TH": "NLM (1997)", "ST": "T062", "AN": "to produce muscle relaxation during surg & in various exper procedures; differentiate from NERVE BLOCK: read MeSH definitions", "PI": "Neuromuscular Junction/drug effects (1966-1996)", "MS": "The intentional interruption of transmission at the NEUROMUSCULAR JUNCTION by external agents, usually neuromuscular blocking agents. It is distinguished from NERVE BLOCK in which nerve conduction (NEURAL CONDUCTION) is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce MUSCLE RELAXATION as an adjunct to anesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anesthesia but is grouped here with anesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019148"}, {"RECTYPE": "D", "MH": "Bioreactors", "AQ": "AE CL EC ES HI MI PS SD SN ST VE VI", "ENTRY": "Fermentor", "MN": "J01.897.120.115", "FX": "Recombinant Proteins", "MH_TH": "NLM (1997)", "ST": "T072", "PI": "Biotechnology (1987-1996)", "MS": "Tools or devices for generating products using the synthetic or chemical conversion capacity of a biological system. They can be classical fermentors, cell culture perfusion systems, or enzyme bioreactors. For production of proteins or enzymes, recombinant microorganisms such as bacteria, mammalian cells, or insect or plant cells are usually chosen.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19960212", "DC": "1", "DX": "19970101", "UI": "D019149"}, {"RECTYPE": "D", "MH": "Neuroaxonal Dystrophies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Seitelberger's Disease|T047|EPO|NRW|GHR (2014)|NLM (1997)|ORD (2010)|950717|SEITELBERGERS DIS|abcdeeefv", "ENTRY": "Seitelbergers Disease", "MN": "C10.228.140.744", "MH_TH": "NLM (1997)", "ST": "T047", "MS": "A nonspecific term referring both to the pathologic finding of swelling of distal portions of axons in the brain and to disorders which feature this finding. Neuroaxonal dystrophy is seen in various genetic diseases, vitamin deficiencies, and aging. Infantile neuroaxonal dystrophy is an autosomal recessive disease characterized by arrested psychomotor development at 6 months to 2 years of age, ataxia, brain stem dysfunction, and quadriparesis. Juvenile and adult forms also occur. Pathologic findings include brain atrophy and widespread accumulation of axonal spheroids throughout the neuroaxis, peripheral nerves, and dental pulp. (From Davis & Robertson, Textbook of Neuropathology, 2nd ed, p927)", "PM": "1997", "HN": "1997", "CATSH": "CAT LIST", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019150"}, {"RECTYPE": "D", "MH": "Peptide Library", "PRINT ENTRY": "Random Peptide Library|T116|T130|NON|NRW|NLM (1997)|950718|abbcdef", "ENTRY": "Synthetic Peptide Libraries", "MN": "G05.360.325.640", "FX": "Combinatorial Chemistry Techniques", "MH_TH": "NLM (1997)", "ST": "T130", "RN": "0", "PI": "Peptides (1990-1996)", "MS": "A collection of cloned peptides, or chemically synthesized peptides, frequently consisting of all possible combinations of amino acids making up an n-amino acid peptide.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19960212", "DC": "1", "DX": "19970101", "UI": "D019151"}, {"RECTYPE": "D", "MH": "Paracentesis", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Paracenteses", "MN": "E05.200.998.329", "FX": "Douglas' Pouch", "MH_TH": "NLM (1997)", "ST": "T058", "PI": "Suction (1977-1996)", "MS": "A procedure in which fluid is withdrawn from a body cavity or organ via a trocar and cannula, needle, or other hollow instrument.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20150626", "DA": "19960212", "DC": "1", "DX": "19970101", "UI": "D019152"}, {"RECTYPE": "D", "MH": "Protein Splicing", "AQ": "DE ES GE IM PH RE", "ENTRY": "Splicings, Protein", "MN": "G05.308.670.600.700", "FX": "Inteins", "MH_TH": "NLM (1997)", "ST": "T045", "PI": "Protein Processing, Post-Translational (1990-1996)", "MS": "The excision of in-frame internal protein sequences (INTEINS) of a precursor protein, coupled with ligation of the flanking sequences (EXTEINS). Protein splicing is an autocatalytic reaction and results in the production of two proteins from a single primary translation product: the intein and the mature protein.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19960212", "DC": "1", "DX": "19970101", "UI": "D019154"}, {"RECTYPE": "D", "MH": "Veterinary Drugs", "DE": "VET DRUGS", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Drugs, Veterinary|T121|NON|EQV|NLM (1997)|950721|DRUGS VET|abcdefv", "ENTRY": "Veterinary Pharmaceuticals|T121|NON|EQV|NLM (1997)|960209|VET PHARM|abcdefv", "MN": "D26.939", "MH_TH": "NLM (1997)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specific drug /ther use with required animal disease term with /drug ther", "MS": "Drugs used by veterinarians in the treatment of animal diseases. The veterinarian's pharmacological armamentarium is the counterpart of drugs treating human diseases, with dosage and administration adjusted to the size, weight, disease, and idiosyncrasies of the species. In the United States most drugs are subject to federal regulations with special reference to the safety of drugs and residues in edible animal products.", "PM": "97", "HN": "97", "MR": "20040713", "DA": "19960212", "DC": "1", "DX": "19970101", "UI": "D019155"}, {"RECTYPE": "D", "MH": "Indian Ocean", "AQ": "EH EP", "PRINT ENTRY": "Red Sea|T083|NAM|NRW|NLM (1997)|950721|abcdef", "MN": "Z01.756.342", "MH_TH": "NLM (1997)", "ST": "T083", "MS": "A body of water covering approximately one-fifth of the total ocean area of the earth, extending amidst Africa in the west, Australia in the east, Asia in the north, and Antarctica in the south. Including the Red Sea and the Persian Gulf, it constitutes the third largest ocean after the ATLANTIC OCEAN and the PACIFIC OCEAN. (New Encyclopaedia Britannica Micropaedia, 15th ed, 1990, p289)", "HN": "97", "MR": "20100625", "DA": "19960610", "DC": "4", "DX": "19970101", "UI": "D019156"}, {"RECTYPE": "D", "MH": "Ischemic Preconditioning, Myocardial", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Myocardial Preconditioning|T061|NON|EQV|NLM (1997)|950724|abcdef", "ENTRY": "Preconditioning, Myocardial Ischemic", "MN": "E05.516.325", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "do not coordinate with MYOCARDIAL ISCHEMIA or MYOCARDIAL REPERFUSION unless particularly discussed", "MS": "Exposure of myocardial tissue to brief, repeated periods of vascular occlusion in order to render the myocardium resistant to the deleterious effects of ISCHEMIA or REPERFUSION. The period of pre-exposure and the number of times the tissue is exposed to ischemia and reperfusion vary, the average being 3 to 5 minutes.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20020703", "DA": "19960212", "DC": "1", "DX": "19970101", "UI": "D019157"}, {"RECTYPE": "D", "MH": "N-Acetylneuraminic Acid", "DS": "ACETYLNEURAMINIC ACID N", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sialic Acid|T109|T123|NON|EQV|FDA SRS (2014)|NLM (1997)|950726|abbcdeef", "ENTRY": "N Acetylneuraminic Acid", "MN": "D09.811.589.668.030", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "GZP2782OP0", "RR": "131-48-6 (N-Acetylneuraminic Acid)", "AN": "do not confuse with N-ACETYLNEURAMINIC ACIDS see SIALIC ACIDS; do not confuse entry term SIALIC ACID with SIALIC ACIDS", "PI": "Sialic Acids (1981-1996)", "MS": "An N-acyl derivative of neuraminic acid. N-acetylneuraminic acid occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria. (From Dorland, 28th ed, p1518)", "OL": "use N-ACETYLNEURAMINIC ACID (NM) to search N-ACETYLNEURAMINIC ACID 1981-96", "PM": "97; N-ACETYLNEURAMINIC ACID was indexed under SIALIC ACIDS 1981-96", "HN": "97; was N-ACETYLNEURAMINIC ACID (NM) 1981-96", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019158"}, {"RECTYPE": "D", "MH": "Nonheme Iron Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Iron Proteins, Non-Heme|T116|T123|NON|EQV|NLM (1997)|960306|abbcdef", "ENTRY": "Proteins, Nonheme Iron", "MN": "D12.776.556.579.374", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Metalloproteins (1983-1996)", "MS": "Proteins, usually acting in oxidation-reduction reactions, containing iron but no porphyrin groups. (Lehninger, Principles of Biochemistry, 1993, pG-10)", "OL": "use NONHEME IRON PROTEINS (NM) to search NON-HEME IRON PROTEINS 1980-96", "PM": "97; NON-HEME IRON PROTEINS was indexed under METALLOPROTEINS 1983-96 & IRON 1978-82", "HN": "97; was NON-HEME IRON PROTEINS (NM) 1978-96", "MR": "20050630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019159"}, {"RECTYPE": "D", "MH": "Endosonography", "DE": "ENDOSONOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Ultrasonography, Endoscopic|T060|NON|NRW|NLM (1997)|950906|ULTRASONOGR ENDOSCOPIC|abcdefv", "ENTRY": "Ultrasonographies, Endoscopic", "MN": "E01.370.350.850.280", "MH_TH": "NLM (1997)", "ST": "T060", "AN": "coordinate with organ or disease /diag image; do not index ENDOSCOPY or specific endoscopic technique unless also discussed", "PI": "specific endoscopic technique (1984-1996)", "MS": "Ultrasonography of internal organs using an ultrasound transducer sometimes mounted on a fiberoptic endoscope. In endosonography the transducer converts electronic signals into acoustic pulses or continuous waves and acts also as a receiver to detect reflected pulses from within the organ. An audiovisual-electronic interface converts the detected or processed echo signals, which pass through the electronics of the instrument, into a form that the technologist can evaluate. The procedure should not be confused with ENDOSCOPY which employs a special instrument called an endoscope. The \"endo-\" of endosonography refers to the examination of tissue within hollow organs, with reference to the usual ultrasonography procedure which is performed externally or transcutaneously.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20160419", "DA": "19960212", "DC": "1", "DX": "19970101", "UI": "D019160"}, {"RECTYPE": "D", "MH": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Statins, HMG-CoA|T121|NON|EQV|NLM (2003)|020103|abcdef", "ENTRY": "Statins, HMG CoA", "MN": "D27.505.954.557.500.202.370", "FX": "Hydroxymethylglutaryl CoA Reductases", "MH_TH": "NLM (1997)", "ST": "T121", "RN": "0", "PI": "Hydroxymethylglutaryl CoA Reductases/antagonists & inhibitors (1976-1996)", "MS": "Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis.", "PM": "98; see HMG-COA REDUCTASE INHIBITORS 1997; for HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS see HMG-COA REDUCTASE INHIBITORS 1997", "HN": "98", "MR": "20200527", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019161"}, {"RECTYPE": "D", "MH": "Anesthetics, Combined", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Combined Anesthetics", "MN": "D27.505.954.427.210.100.017", "MH_TH": "NLM (1997)", "ST": "T121", "RN": "0", "AN": "coordinate IM with specific anesthetics (IM) using the same qualifiers", "PI": "Anesthetics (1970-1996)", "MS": "The use of two or more chemicals simultaneously or sequentially to induce anesthesia. The drugs need not be in the same dosage form.", "PM": "97", "HN": "97", "MR": "20140625", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019162"}, {"RECTYPE": "D", "MH": "Reducing Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Reductants|T130|NON|EQV|NLM (1997)|960208|abcdef", "ENTRY": "Agents, Reducing", "MN": "D27.720.470.410.690", "MH_TH": "NLM (1997)", "ST": "T130", "RN": "0", "PI": "Oxidation-Reduction (1967-1996)", "MS": "Materials that add an electron to an element or compound, that is, decrease the positiveness of its valence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "PM": "97", "HN": "97", "MR": "20200527", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019163"}, {"RECTYPE": "D", "MH": "Liver, Artificial", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Bioartificial Liver|T074|NON|EQV|NLM (1997)|950802|abcdef", "ENTRY": "Livers, Bioartificial", "MN": "E07.858.082.620", "MH_TH": "NLM (1997)", "ST": "T074", "PI": "Artificial Organs (1972-1996)", "MS": "Devices for simulating the activities of the liver. They often consist of a hybrid between both biological and artificial materials.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19960212", "DC": "1", "DX": "19970101", "UI": "D019164"}, {"RECTYPE": "D", "MH": "Appetite Stimulants", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Stimulants, Appetite", "MN": "D27.505.954.427.220.050", "MH_TH": "NLM (1997)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Anorexia/drug therapy (1975-1996)", "MS": "Agents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and AIDS.", "PM": "97", "HN": "97", "MR": "20050630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019167"}, {"RECTYPE": "D", "MH": "Portasystemic Shunt, Transjugular Intrahepatic", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "TIPSS|T061|ABB|EQV|NLM (1997)|960620|abcdef", "ENTRY": "Transjugular Intrahepatic Portasystemic Shunt|T061|NON|EQV|NLM (1997)|951020|TIPS|abcdefv", "MN": "E04.100.814.868.937.830", "MH_TH": "NLM (1997)", "ST": "T061", "PI": "Portasystemic Shunt, Surgical (1987-1996)", "MS": "A type of surgical portasystemic shunt to reduce portal hypertension with associated complications of esophageal varices and ascites. It is performed percutaneously through the jugular vein and involves the creation of an intrahepatic shunt between the hepatic vein and portal vein. The channel is maintained by a metallic stent. The procedure can be performed in patients who have failed sclerotherapy and is an additional option to the surgical techniques of portocaval, mesocaval, and splenorenal shunts. It takes one to three hours to perform. (JAMA 1995;273(23):1824-30)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20200527", "DA": "19960620", "DC": "1", "DX": "19970101", "UI": "D019168"}, {"RECTYPE": "D", "MH": "Jurkat Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Jurkat Cell", "MN": "A15.382.490.555.567.569.440", "MH_TH": "NLM (1997)", "ST": "T025", "AN": "almost always NIM with no subheadings; check HUMAN;do not routinely add LEUKEMIA, T-CELL", "PI": "Cells, Cultured (1982-1996)", "MS": "A CELL LINE derived from human T-CELL LEUKEMIA and used to determine the mechanism of differential susceptibility to anti-cancer drugs and radiation.", "PM": "97", "HN": "97", "MR": "20040713", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019169"}, {"RECTYPE": "D", "MH": "Somites", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Somite", "MN": "A16.504.660.750", "MH_TH": "NLM (1997)", "ST": "T018", "PI": "Mesoderm (1966-1996)", "MS": "Paired, segmented masses of MESENCHYME located on either side of the developing spinal cord (neural tube). Somites derive from PARAXIAL MESODERM and continue to increase in number during ORGANOGENESIS. Somites give rise to SKELETON (sclerotome); MUSCLES (myotome); and DERMIS (dermatome).", "PM": "97", "HN": "97", "MR": "20070709", "DA": "19960212", "DC": "1", "DX": "19970101", "UI": "D019170"}, {"RECTYPE": "D", "MH": "Transplantation Conditioning", "DE": "TRANSPL CONDITIONING", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Conditioning, Transplantation|T061|NON|EQV|NLM (1997)|951129|CONDITIONING TRANSPL|abcdefv", "ENTRY": "Transplantation Conditionings", "MN": "E05.478.610.800", "FX": "Transplantation", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "coord IM with organ /transpl (IM) or precoord organ/transpl term (IM) (e.g., bone marrow transpl conditioning: coord IM with BONE MARROW TRANSPLANTATION (IM); hematopoietic stem cell transpl conditioning: coord IM with HEMATOPOIETIC STEM CELL TRANSPLANTATION (IM) ); myeloablative therapy or conditioning goes here", "MS": "Preparative treatment of transplant recipient with various conditioning regimens including radiation, immune sera, chemotherapy, and/or immunosuppressive agents, prior to transplantation. Transplantation conditioning is very common before bone marrow transplantation.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20190524", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019172"}, {"RECTYPE": "D", "MH": "DNA Methylation", "AQ": "DE GE IM PH RE", "ENTRY": "Methylations, DNA", "MN": "G05.206", "FX": "Gene Silencing", "MH_TH": "NLM (1997)", "ST": "T045", "PI": "Methylation (1966-1996)", "MS": "Addition of methyl groups to DNA. DNA methyltransferases (DNA methylases) perform this reaction using S-ADENOSYLMETHIONINE as the methyl group donor.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019175"}, {"RECTYPE": "D", "MH": "Potyviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Tritimovirus|T005|NON|NRW|NLM (2007)|050902|abcdef", "ENTRY": "Tritimoviruses", "MN": "B04.820.578.782", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid39729", "RR": "txid39731", "MS": "A family of RNA plant viruses with flexuous, filamentous particles and consisting of six genera: POTYVIRUS; Ipomovirus; Macluravirus; Rymovirus; Tritimovirus; and Bymovirus. All members of the family form cytoplasmic cylindrical inclusion bodies during infection.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019176"}, {"RECTYPE": "D", "MH": "Bromoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Anulaviruses", "MN": "B04.820.578.282", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid39740", "RR": "txid413970", "AN": "coord IM with specific plant /virol", "MS": "A family of RNA plant viruses with a wide host range in crops and horticultural species. All viruses are readily transmitted by mechanical means and some by insects and pollen. The genera include: ALFAMOVIRUS; BROMOVIRUS; CUCUMOVIRUS; ILARVIRUS; and OLEAVIRUS.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019177"}, {"RECTYPE": "D", "MH": "Alfamovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Alfamoviruses", "MN": "B04.820.578.282.050", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid12320", "AN": "a genus of mosaic viruses; from ALFAlfa MOsaic virus; coord IM with specific plant /virol (IM or NIM)", "MS": "A genus of the family BROMOVIRIDAE with a wide host range. Transmission is by aphids and the type species is ALFALFA MOSAIC VIRUS.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019178"}, {"RECTYPE": "D", "MH": "Ilarvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Tobacco streak virus|T005|NON|NRW|NLM (2002)|010416|abcdef", "ENTRY": "Tobacco streak viruses", "MN": "B04.820.578.282.400", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid12316", "RR": "txid12317", "AN": "coord IM with specific plant /virol or tree /virol", "MS": "A genus of the family BROMOVIRIDAE which infects mainly woody plants. Species are divided into ten subgroups. Tobacco streak virus is the type species.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019179"}, {"RECTYPE": "D", "MH": "Secoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Comoviridae|T005|NON|REL|NLM (1997)|990101|abcdef", "ENTRY": "Comovirinae|T005|NON|NRW|NLM (2018)|161028|abcdef", "MN": "B04.820.578.813", "MH_TH": "NLM (2018)", "ST": "T005", "RN": "txid675072", "RR": "txid675075", "AN": "a family of plant viruses", "MS": "A family of non-enveloped RNA plant viruses, transmitted by biological vectors and experimentally by mechanical inoculation. Subfamily Comovirinae includes all members of old taxonomic family Comoviridae: COMOVIRUS; FABAVIRUS; and NEPOVIRUS.", "PM": "2018; Comoviridae was heading 1997-2017", "HN": "2018", "MR": "20200902", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019180"}, {"RECTYPE": "D", "MH": "Fabavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Fabaviruses", "MN": "B04.820.578.813.250", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid12269", "AN": "a genus of plant viruses; from FABA (Latin for bean) virus; coord IM with specific plant /virol (IM or NIM)", "MS": "A genus of the family COMOVIRIDAE with a wide host range among dicotyledons and some monocotyledons. They are transmitted nonpersistently by aphids. The type species is broad bean wilt virus 1.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019181"}, {"RECTYPE": "D", "MH": "Tombusviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Panicovirus|T005|NON|NRW|NLM (2002)|010514|abcdef", "ENTRY": "Umbraviruses", "MN": "B04.820.578.968", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid39738", "RR": "txid47669", "MS": "A family of RNA plant viruses infecting dicotyledons. Transmission is mainly by mechanical inoculation and through propagative plant material. All species elicit formation of multivesicular inclusion bodies. There are at least eight genera: Aureusvirus, Avenavirus, CARMOVIRUS, Dianthovirus, Machlomovirus, Necrovirus, Panicovirus, and TOMBUSVIRUS.", "PM": "97", "HN": "97", "MR": "20200902", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019183"}, {"RECTYPE": "D", "MH": "Carmovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Turnip crinkle virus|T005|NON|NRW|NLM (2007)|060407|abcdef", "ENTRY": "crinkle viruses, Turnip", "MN": "B04.820.578.968.150", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid11985", "RR": "txid11988", "MS": "A genus in the family TOMBUSVIRIDAE mostly found in temperate regions. Some species infecting legumes (FABACEAE) are reported from tropical areas. Most viruses are soil-borne, but some are transmitted by the fungus Olpidium radicale and others by beetles. Carnation mottle virus is the type species.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019184"}, {"RECTYPE": "D", "MH": "Notophthalmus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.090.608.700.500", "MH_TH": "NLM (1997)", "ST": "T011", "RN": "txid8315", "AN": "a genus of newts", "MS": "A genus of newts of the Salamandridae family found in North America in areas east of the 100th meridian. A common species is NOTOPHTHALMUS VIRIDESCENS.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960212", "DC": "1", "DX": "19970101", "UI": "D019185"}, {"RECTYPE": "D", "MH": "Mandibular Advancement", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Advancement, Mandibular", "MN": "E06.658.280", "FX": "Malocclusion", "MH_TH": "NLM (1997)", "ST": "T061", "PI": "Mandible/surgery (1973-1996)", "MS": "Moving a retruded mandible forward to a normal position. It is commonly performed for malocclusion and retrognathia. (From Jablonski's Dictionary of Dentistry, 1992)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019186"}, {"RECTYPE": "D", "MH": "Cadmium Compounds", "DE": "CADMIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Cadmium", "MN": "D01.142", "MH_TH": "NLM (1997)", "ST": "T197", "RN": "0", "PI": "Cadmium (1966-1996)", "MS": "Inorganic compounds that contain cadmium as an integral part of the molecule.", "PM": "97", "HN": "97", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019187"}, {"RECTYPE": "D", "MH": "Organ Preservation Solutions", "DE": "ORGAN PRESERVATION SOL", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tissue Preservation Solutions|T120|NON|EQV|NLM (2003)|011016|abcdef", "ENTRY": "Solutions, Tissue Preservation", "MN": "D26.776.675", "FX": "Cryoprotective Agents", "MH_TH": "NLM (1997)", "ST": "T120", "RN": "0", "AN": "coord with specific chem components of solution (IM) + specific organ or tissue (IM with no qualif)", "PI": "Tissue Preservation (1969-1974)", "MS": "Solutions used to store organs and minimize tissue damage, particularly while awaiting implantation.", "PM": "97", "HN": "97", "MR": "20040729", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019188"}, {"RECTYPE": "D", "MH": "Iron Metabolism Disorders", "DE": "IRON METAB DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Metabolism Disorders, Iron", "MN": "C18.452.565", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Iron/metabolism (1966-1996)", "MS": "Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization. (From Mosby's Medical, Nursing, & Allied Health Dictionary, 4th ed)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "DA": "19960212", "DC": "1", "DX": "19970101", "UI": "D019189"}, {"RECTYPE": "D", "MH": "Iron Overload", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Overload, Iron", "MN": "C18.452.565.500", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "disord of iron metab", "PI": "Iron/metabolism (1966-1995)", "MS": "An excessive accumulation of iron in the body due to a greater than normal absorption of iron from the gastrointestinal tract or from parenteral injection. This may arise from idiopathic hemochromatosis, excessive iron intake, chronic alcoholism, certain types of refractory anemia, or transfusional hemosiderosis. (From Churchill's Illustrated Medical Dictionary, 1989)", "OL": "use HEMOSIDEROSIS to search IRON OVERLOAD 1996", "PM": "97; was see HEMOSIDEROSIS 1996", "HN": "97; was see HEMOSIDEROSIS 1996", "CATSH": "CAT LIST", "DA": "19960212", "DC": "1", "DX": "19970101", "UI": "D019190"}, {"RECTYPE": "D", "MH": "Sequiviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.578.829", "MH_TH": "NLM (1997)", "ST": "T005", "AN": "a family of plant viruses", "MS": "A family of monopartite RNA plant viruses resembling picornaviruses and containing two genera: SEQUIVIRUS and WAIKAVIRUS. Transmission is by aphids or leafhoppers and requires a helper protein.", "PM": "97", "HN": "97", "MR": "20200902", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019191"}, {"RECTYPE": "D", "MH": "Sequivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Parsnip yellow fleck virus|T005|NON|NRW|NLM (2002)|010514|abcdef", "MN": "B04.820.578.829.750", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid12057", "RR": "txid12777", "AN": "coord IM with specific plant /virol (IM or NIM)", "MS": "A genus of plant viruses in the family SEQUIVIRIDAE. Transmission is by APHIDS but depends on the presence of a helper protein encoded by the Anthriscus yellow virus, a WAIKAVIRUS. The type species is Parsnip yellow fleck virus (parsnip serotype).", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019192"}, {"RECTYPE": "D", "MH": "Waikavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Rice tungro spherical virus|T005|NON|NRW|NLM (1997)|950908|abcdef", "ENTRY": "Waikaviruses", "MN": "B04.820.578.829.900", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid12050", "RR": "txid51354", "AN": "coord IM with specific plant (often RICE) /virol", "MS": "A genus of plant viruses in the family SEQUIVIRIDAE. Transmission is by leafhoppers or APHIDS and depends on a self-encoded helper protein. The type species is Rice tungro spherical virus.", "PM": "97", "HN": "97", "MR": "20200902", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019193"}, {"RECTYPE": "D", "MH": "Ischemic Preconditioning", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Preconditioning, Ischemic", "MN": "E05.516", "FX": "Ischemic Postconditioning", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "coordinate IM with tissue / blood supply (IM); ISCHEMIC PRECONDITIONING, MYOCARDIAL is also available", "MS": "A technique in which tissue is rendered resistant to the deleterious effects of prolonged ISCHEMIA and REPERFUSION by prior exposure to brief, repeated periods of vascular occlusion. (Am J Physiol 1995 May;268(5 Pt 2):H2063-7, Abstract)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19960212", "DC": "1", "DX": "19970101", "UI": "D019194"}, {"RECTYPE": "D", "MH": "Badnavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Badnaviruses", "MN": "B04.715.102.074", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid10652", "AN": "from BAcilliform DNA virus", "MS": "A genus of DNA plant viruses with bacilliform morphology. Transmission in clonally-propagated plants is by vegetative propagation of infected plant materials. Transmission in nature is by mealybugs, seeds, and pollen. The type species is Commelina yellow mottle virus.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019195"}, {"RECTYPE": "D", "MH": "Totiviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.223.750", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid11006", "AN": "a family of RNA viruses infecting fungi & protozoa; coord IM with specific fungus /virol (IM or NIM) or specific protozoon /virol (IM or NIM)", "MS": "A family of RNA viruses that infect fungi and protozoa. There are three genera: TOTIVIRUS; GIARDIAVIRUS; and LEISHMANIAVIRUS.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019196"}, {"RECTYPE": "D", "MH": "Totivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.223.750.800", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid11007", "AN": "a genus of the family Totiviridae infecting fungi; coord IM with specific fungus /virol (IM or NIM)", "MS": "A genus of RNA fungi viruses in the family TOTIVIRIDAE. Some of the viruses contain additional satellite RNA or defective RNA. Transmission occurs during cell division, sporogenesis and cell fusion. The type species is Saccharomyces cerevisiae virus L-A.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019197"}, {"RECTYPE": "D", "MH": "Giardiavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Giardiaviruses", "MN": "B04.820.223.750.400", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid11011", "AN": "a genus of the family Totiviridae; infects the protozoan Giardia lamblia; coord IM with GIARDIA LAMBLIA /virol (IM)", "PI": "RNA Viruses (1991-1996)", "MS": "A genus of RNA protozoan viruses of the family TOTIVIRIDAE. It infects many isolates of the flagellated protozoan human parasite G. lamblia, but does not seem to be associated with the virulence of the parasite. The type species is Giardia lamblia virus.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019198"}, {"RECTYPE": "D", "MH": "Leishmaniavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Leishmaniaviruses", "MN": "B04.820.223.750.500", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid39755", "AN": "a genus of the family Totiviridae; infects the protozoan Leishmania; coord IM with specific Leishmania /virol (IM)", "PI": "RNA Viruses (1988-1996)", "MS": "A genus of RNA protozoan viruses of the family TOTIVIRIDAE. Several different strains of Leishmania are infected by a variety of viral species. The type species is Leishmania RNA virus 1-1.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019199"}, {"RECTYPE": "D", "MH": "Astroviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.578.250", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid39733", "MS": "A family of RNA viruses with two genera: MAMASTROVIRUS and AVASTROVIRUS. They cause GASTROENTERITIS in humans and also infect other vertebrates.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019200"}, {"RECTYPE": "D", "MH": "Aquabirnavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Aquabirnaviruses", "MN": "B04.820.223.500.050", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid39750", "AN": "a genus of the family Birnaviridae; infection: coord IM with BIRNAVIRIDAE INFECTIONS (IM)", "MS": "A genus of RNA viruses in the family BIRNAVIRIDAE infecting fish, mollusks, and crustaceans. It is transmitted both vertically and horizontally with no known vectors. The natural hosts are salmonids and the type species is INFECTIOUS PANCREATIC NECROSIS VIRUS.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019201"}, {"RECTYPE": "D", "MH": "Avibirnavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Avibirnaviruses", "MN": "B04.820.223.500.060", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid39751", "AN": "a genus of the family Birnaviridae; infection: coord IM with BIRNAVIRIDAE INFECTIONS (IM)", "MS": "A genus of RNA viruses in the family BIRNAVIRIDAE infecting birds. It is transmitted horizontally with no known vectors. The type species is INFECTIOUS BURSAL DISEASE VIRUS.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019202"}, {"RECTYPE": "D", "MH": "Entomobirnavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Entomobirnaviruses", "MN": "B04.820.223.500.200", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid39752", "AN": "a genus of the family Birnaviridae; infection: coord IM with BIRNAVIRIDAE INFECTIONS (IM)", "MS": "A genus of RNA viruses of the family BIRNAVIRIDAE infecting fruitflies. Transmission is horizontal and there are no known vectors. Drosophila melanogaster is the natural host and the type species is Drosophila X virus.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019203"}, {"RECTYPE": "D", "MH": "GTP-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Guanine Nucleotide Regulatory Proteins|T116|T126|NON|EQV|NLM (1997)|950913|GUANINE NUCLEOTIDE REG PROTEINS|abbcdefv", "ENTRY": "Proteins, GTP-Regulatory", "MN": "D12.776.476.338", "MH_TH": "NLM (1997)", "ST": "T126", "RN": "EC 3.6.1.-", "AN": "general or unspecified; prefer specifics; GTP stands for Guanosine TriPhosphate", "MS": "Regulatory proteins that act as molecular switches. They control a wide range of biological processes including: receptor signaling, intracellular signal transduction pathways, and protein synthesis. Their activity is regulated by factors that control their ability to bind to and hydrolyze GTP to GDP. EC 3.6.1.-.", "PM": "1997; see G-PROTEINS 1985-1996; for G-PROTEINS see G-PROTEINS 1992-1999; for GUANINE NUCLEOTIDE REGULATORY PROTEINS see G-PROTEINS 1992-1996; for GTP-REGULATORY PROTEINS see G-PROTEINS 1985-1996", "HN": "1997(1985)", "MR": "20210521", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019204"}, {"RECTYPE": "D", "MH": "GTP-Binding Protein alpha Subunits, Gs", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "G-Protein, Stimulatory Gs|T116|T126|ABX|EQV|NLM (1997)|990101|G PROTEIN STIM GS|abbcdefv", "ENTRY": "alpha Gs", "MN": "D12.776.543.325.100.400", "FX": "Pseudopseudohypoparathyroidism", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.6.5.1", "PI": "G-Proteins (1985-1996)", "MS": "A family of heterotrimeric GTP-binding protein alpha subunits that activate ADENYLYL CYCLASES.", "PM": "2003; see G-PROTEIN, STIMULATORY GS 1997-2003; STIMULATORY GTP-BINDNG PROTEIN, ALPHA SUBUNIT was indexed under G-PROTEIN, STIMULATORY GS 1997-2003 & under G-PROTEINS 1996", "HN": "2003(1997); for STIMULATORY GTP-BINDING PROTEIN, ALPHA SUBUNIT use G-PROTEIN, GS FAMILY (NM) 1996-2003", "MR": "20210521", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019205"}, {"RECTYPE": "D", "MH": "GTP-Binding Protein alpha Subunits, Gi-Go", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gi, Inhibitory G-Protein|T116|T126|ABX|NRW|NLM (1997)|950913|GI INHIB G PROTEIN|abbcdefv", "ENTRY": "alpha Subunit, Gi", "MN": "D12.776.543.325.100.200", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.6.5.1", "RR": "EC 3.6.5.1", "PI": "G-Proteins (1985-1996)", "MS": "A family of heterotrimeric GTP-binding protein alpha subunits that were originally identified by their ability to inhibit ADENYLYL CYCLASES. Members of this family can couple to beta and gamma G-protein subunits that activate POTASSIUM CHANNELS. The Gi-Go part of the name is also spelled Gi/Go.", "PM": "2004; see G-PROTEIN, INHBITORY GI 1997-2003; GUANINE NUCLEOTIDE-BINDING PROTEIN GO was indexed under HETEROTRIMERIC GTP-BINDING PROTEINS 2000-2003 & GTP-BINDING PROTEINS 1991-1999", "HN": "2004(1997); for GUANINE NUCLEOTIDE-BINDING PROTEIN GO use GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO (NM) 1997-2003", "MR": "20210521", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019206"}, {"RECTYPE": "D", "MH": "beta Carotene", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Betacarotene|T109|T121|T127|NON|EQV|FDA SRS (2014)|INN (19XX)|NLM (1997)|950913|abbbcdeeef", "ENTRY": "MaxCaro", "MN": "D23.767.261.050", "MH_TH": "USP (19XX)", "ST": "T127", "RN": "01YAE03M7J", "RR": "7235-40-7 (beta Carotene)", "PI": "Carotene (1980-1996)", "MS": "A carotenoid that is a precursor of VITAMIN A. Beta carotene is administered to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria (PORPHYRIA, ERYTHROPOIETIC).", "OL": "use BETA CAROTENE (NM) to search BETA-CAROTENE 1980-96", "PM": "97; BETA-CAROTENE was indexed under CAROTENE 1980-96", "HN": "97; was BETA-CAROTENE (NM) 1980-96", "MR": "20160701", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019207"}, {"RECTYPE": "D", "MH": "Brain-Derived Neurotrophic Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "BDNF|T116|T123|ABB|EQV|NLM (1997)|950913|abbcdef", "ENTRY": "Neurotrophic Factor, Brain-Derived", "MN": "D23.529.850.100", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1986-1996)", "MS": "A member of the nerve growth factor family of trophic factors. In the brain BDNF has a trophic action on retinal, cholinergic, and dopaminergic neurons, and in the peripheral nervous system it acts on both motor and sensory neurons. (From Kendrew, The Encyclopedia of Molecular Biology, 1994)", "OL": "use BRAIN-DERIVED NEUROTROPHIC FACTOR (NM) to search BRAIN-DERIVED NEUROTROPHIC FACTOR 1986-96", "PM": "97; BRAIN-DERIVED NEUROTROPHIC FACTOR was indexed under NERVE TISSUE PROTEINS 1986-96", "HN": "97; was BRAIN-DERIVED NEUROTROPHIC FACTOR 1986-96", "MR": "20151123", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019208"}, {"RECTYPE": "D", "MH": "Troponin C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Troponin-C|T116|T123|NON|EQV|NLM (1997)|950913|abbcdef", "MN": "D12.776.220.525.825.900", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "AN": "TROPONIN I & TROPONIN T are also available", "PI": "Troponin (1980-1996)", "MS": "A TROPONIN complex subunit that binds calcium and help regulate calcium-dependent muscle contraction. There are two troponin C subtypes: troponin C1 and C2. Troponin C1 is skeletal and cardiac type whereas troponin C2 is skeletal type. Troponin C1 is a BIOMARKER for damaged or injured CARDIAC MYOCYTES and mutations in troponin C1 gene are associated with FAMILIAL HYPERTROPHIC CARDIOMYOPATHY.", "OL": "use TROPONIN C (NM) to search TROPONIN C 1980-96", "PM": "97; TROPONIN C was indexed under TROPONIN 1980-96 & MUSCLE PROTEINS 1975-79", "HN": "97; was TROPONIN C (NM) 1975-96", "MR": "20160701", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019209"}, {"RECTYPE": "D", "MH": "Troponin I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Troponin-I|T116|T123|NON|EQV|NLM (1997)|950913|abbcdef", "MN": "D12.776.220.525.825.925", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "AN": "TROPONIN C & TROPONIN T are also available", "PI": "Troponin (1979-1996)", "MS": "A TROPONIN complex subunit that inhibits ACTOMYOSIN ATPASE activity thereby disrupting ACTIN and MYOSIN interaction. There are three troponin I subtypes: troponin I1, I2 and I3. Troponin I3 is cardiac-specific whereas troponin I1 and I2 are skeletal subtypes. Troponin I3 is a BIOMARKER for damaged or injured CARDIAC MYOCYTES and mutations in troponin I3 gene are associated with FAMILIAL HYPERTROPHIC CARDIOMYOPATHY.", "OL": "use TROPONIN I (NM) to search TROPONIN I 1980-96", "PM": "97; TROPONIN I was indexed under TROPONIN 1979-96 & MUSCLE PROTEINS 1975-78", "HN": "97; was TROPONIN I (NM) 1975-96", "MR": "20160706", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019210"}, {"RECTYPE": "D", "MH": "Roseolovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Guinea pig cytomegalovirus|T005|NON|NRW|NLM (2002)|010122|abcdef", "ENTRY": "cytomegaloviruses, Guinea pig", "MN": "B04.280.382.150.750", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid40272", "RR": "txid33706", "MS": "A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, whose viruses have been isolated from lymphocytes. HERPESVIRUS 6, HUMAN is the type species.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019211"}, {"RECTYPE": "D", "MH": "Multimedia", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Multimedium|T170|NON|EQV|NLM (1997)|950918|abcdef", "MN": "L01.462.500.820.090.633", "MH_TH": "NLM (1997)", "ST": "T170", "AN": "restrict to a combination of audiovisual aids: do not use for a multiplicity of media such as newspapers, radio, TV", "PI": "Computer-Assisted Instruction (1993-1996)", "MS": "Materials, frequently computer applications, that combine some or all of text, sound, graphics, animation, and video into integrated packages. (Thesaurus of ERIC Descriptors, 1994)", "PM": "97", "HN": "97", "MR": "20220712", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019212"}, {"RECTYPE": "D", "MH": "Rubulavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Rubulaviruses", "MN": "B04.820.480.937.600.650.750", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid39744", "MS": "A genus of the family PARAMYXOVIRIDAE (subfamily PARAMYXOVIRINAE) where all the species have hemagglutinin and neuraminidase activities but lack a C protein. MUMPS VIRUS is the type species.", "PM": "1997", "HN": "1997", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019213"}, {"RECTYPE": "D", "MH": "Gingival Overgrowth", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Overgrowths, Gingival", "MN": "C07.465.714.258.428", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Gingival Hypertrophy (1992-1996)", "MS": "Excessive growth of the gingiva either by an increase in the size of the constituent cells (GINGIVAL HYPERTROPHY) or by an increase in their number (GINGIVAL HYPERPLASIA). (From Jablonski's Dictionary of Dentistry, 1992, p574)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019214"}, {"RECTYPE": "D", "MH": "Biography", "ENTRY": "Historical Biography|T170|NON|NRW|NLM (1997)|951129|abcdef", "MN": "V02.530.150", "FX": "Biobibliography", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Check appropriate century tags. Biographies as a subject are indexed under the main heading BIOGRAPHIES AS TOPIC. CATALOGER: Use for individual and collective biographies. For autobiographies, use the Publication Type AUTOBIOGRAPHY ", "PI": "Historical Biography [Publication Type] (1966-1996)", "MS": "Works consisting of an account of the events, works, and achievements, personal and professional, during a person's life.", "MR": "20190710", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019215"}, {"RECTYPE": "D", "MH": "Metals, Heavy", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "PRINT ENTRY": "Heavy Metals|T196|NON|EQV|NLM (1997)|950920|abcdef", "ENTRY": "Metal, Heavy", "MN": "D01.552.544", "EC": "poisoning:Heavy Metal Poisoning", "MH_TH": "NLM (1997)", "ST": "T196", "RN": "0", "AN": "general; prefer specifics", "PI": "Metals or specifics (1966-1996)", "MS": "Metals with high specific gravity, typically larger than 5. They have complex spectra, form colored salts and double salts, have a low electrode potential, are mainly amphoteric, yield weak bases and weak acids, and are oxidizing or reducing agents (From Grant & Hackh's Chemical Dictionary, 5th ed)", "OL": "pre-explosion - METALS, HEAVY (PX)", "PM": "97", "HN": "97", "MR": "20200527", "DA": "19960620", "DC": "1", "DX": "19970101", "UI": "D019216"}, {"RECTYPE": "D", "MH": "Tooth Attrition", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dental Attrition|T047|NON|EQV|NLM (1997)|950920|DENT ATTRITION|abcdefv", "ENTRY": "Wears, Occlusal", "MN": "C07.793.818.249", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "do not confuse with TOOTH EROSION or TOOTH ABRASION", "PI": "Tooth Abrasion (1966-1996)", "MS": "The wearing away of a tooth as a result of tooth-to-tooth contact, as in mastication, occurring only on the occlusal, incisal, and proximal surfaces. It is chiefly associated with aging. It is differentiated from TOOTH ABRASION (the pathologic wearing away of the tooth substance by friction, as brushing, bruxism, clenching, and other mechanical causes) and from TOOTH EROSION (the loss of substance caused by chemical action without bacterial action). (Jablonski, Dictionary of Dentistry, 1992, p86)", "PM": "1997; for DENTAL ATTRITION see TOOTH ABRASION 1976-1996", "HN": "1997; for DENTAL ATTRITION use TOOTH ABRASION 1976-1996", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019217"}, {"RECTYPE": "D", "MH": "Erythrovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Simian parvovirus|T005|NON|NRW|NLM (2002)|010312|abcdef", "ENTRY": "Erythroviruses", "MN": "B04.280.580.650.200", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid40121", "RR": "txid31598", "AN": "infection: coordinate with PARVOVIRIDAE INFECTIONS", "MS": "A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, and containing the type species PARVOVIRUS B19, HUMAN.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019218"}, {"RECTYPE": "D", "MH": "Parvovirinae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Tetraparvoviruses", "MN": "B04.280.580.650", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid40119", "RR": "txid1511911", "AN": "a subfamily of the family Parvoviridae; infection: coord IM with PARVOVIRIDAE INFECTIONS (IM)", "MS": "A subfamily of DNA vertebrate viruses, in the family PARVOVIRIDAE. There are three genera: PARVOVIRUS; ERYTHROVIRUS; and DEPENDOVIRUS.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019219"}, {"RECTYPE": "D", "MH": "High-Energy Shock Waves", "AQ": "AE TU", "PRINT ENTRY": "Shockwaves, Ultrasonic|T070|NON|REL|UNK (19XX)|860620|abcdef", "ENTRY": "Waves, Ultrasonic Shock", "MN": "G01.750.770.776.891.500", "FX": "Sonication", "MH_TH": "NLM (1997)", "ST": "T070", "PI": "Lithotripsy (1993-1996)", "MS": "High-amplitude compression waves, across which density, pressure, and particle velocity change drastically. The mechanical force from these shock waves can be used for mechanically disrupting tissues and deposits.", "PM": "1997; for SHOCKWAVES, ULTRASONIC see ULTRASONICS 1987-2009", "HN": "1997; for SHOCKWAVES, ULTRASONIC use ULTRASONICS 1987-2009", "MR": "20150622", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019220"}, {"RECTYPE": "D", "MH": "Mandatory Reporting", "AQ": "ES HI", "PRINT ENTRY": "Abuse Reporting|T064|NON|BRD|NLM (1997)|950928|abcdef", "ENTRY": "Reporting, Mandatory", "MN": "N03.706.657.249", "FX": "Parental Notification", "MH_TH": "NLM (1997)", "ST": "T064", "PI": "Elder Abuse/legislation & jurisprudence (1984-1996)", "MS": "A legal requirement that designated types of information acquired by professionals or institutions in the course of their work be reported to appropriate authorities.", "PM": "97", "HN": "97", "MR": "20120703", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019221"}, {"RECTYPE": "D", "MH": "Mind-Body Relations, Metaphysical", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Mind-Body Relations (Non-Physiology)|T041|NON|EQV|NLM (1997)|951017|MIND BODY RELAT NON PHYSIOL|abcdefv", "ENTRY": "Soul-Body Relation", "MN": "F02.463.509", "FX": "Psychophysiology", "MH_TH": "NLM (2011)", "ST": "T041", "AN": "important in alternative medicine; do not confuse with MIND-BODY RELATIONS (PHYSIOLOGY) see PSYCHOPHYSIOLOGY where emphasis is on physiology", "PM": "2011; 1997-2010 see Mind-Body Relations (Metaphysics)", "HN": "2011; 1997-2010 use Mind-Body Relations (Metaphysics)", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019222"}, {"RECTYPE": "D", "MH": "Densovirinae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Pefudensovirus|T005|NON|NRW|NLM (2007)|050825|abcdef", "ENTRY": "Penstyldensoviruses", "MN": "B04.525.150", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid40120", "RR": "txid40122", "AN": "coord IM with specific arthropod /virol or insect /virol (IM); do not confuse entry term INFECTIOUS HYPODERMAL AND HEMATOPOIETIC NECROSIS VIRUS see DENSOVIRINAE with INFECTIOUS HEMATOPOIETIC NECROSIS VIRUS", "MS": "A subfamily of DNA arthropod viruses, in the family PARVOVIRIDAE. The host range includes members of Dictyoptera; DIPTERA; LEPIDOPTERA; Odonata; and ORTHOPTERA. There are three genera: DENSOVIRUS, Iteravirus, and Brevidensovirus. Densovirus-like viruses also infect and multiply in crabs and shrimp.", "PM": "97", "HN": "97", "MR": "20200902", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019223"}, {"RECTYPE": "D", "MH": "Temporomandibular Joint Disc", "DE": "TMJ DISC", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Temporomandibular Joint Disk|T030|NON|EQV|NLM (1997)|990101|TMJ DISK|abcdefv", "ENTRY": "Temporomandibular Joint Disks", "MN": "A14.907.900", "MH_TH": "NLM (2012)", "ST": "T030", "AN": "disc displacement: coordinate with JOINT DISLOCATIONS", "PI": "Temporomandibular Joint (1966-1996)", "MS": "A plate of fibrous tissue that divides the temporomandibular joint into an upper and lower cavity. The disc is attached to the articular capsule and moves forward with the condyle in free opening and protrusion. (Boucher's Clinical Dental Terminology, 4th ed, p92)", "PM": "2012; see TEMPOROMANDIBULAR JOINT DISK (1997-2011)", "HN": "2012 (1997)", "MR": "20160706", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019224"}, {"RECTYPE": "D", "MH": "Oral Ulcer", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mouth Ulcer|T047|NON|EQV|NLM (1997)|951005|abcdef", "ENTRY": "Ulcers, Oral", "MN": "C07.465.672", "FX": "Stomatitis, Aphthous", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "coord IM with cause (IM) if pertinent; not a synonym for STOMATITIS, APHTHOUS", "PI": "Ulcer (1966-1996)", "MS": "A loss of mucous substance of the mouth showing local excavation of the surface, resulting from the sloughing of inflammatory necrotic tissue. It is the result of a variety of causes, e.g., denture irritation, aphthous stomatitis (STOMATITIS, APHTHOUS); NOMA; necrotizing gingivitis (GINGIVITIS, NECROTIZING ULCERATIVE); TOOTHBRUSHING; and various irritants. (From Jablonski, Dictionary of Dentistry, 1992, p842)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20050715", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019226"}, {"RECTYPE": "D", "MH": "Tooth Apex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Apical Foramen|T023|NON|NRW|NLM (1998)|960723|abcdef", "ENTRY": "Foramen, Apical", "MN": "A14.549.167.900.750.700", "FX": "Apicoectomy", "MH_TH": "NLM (1997)", "ST": "T023", "AN": "dis: coord IM with TOOTH DISEASES (IM); /surg: consider also APICOECTOMY; apical foramen goes here", "PI": "Tooth Root (1975-1996)", "MS": "The tip or terminal end of the root of a tooth. (Jablonski, Dictionary of Dentistry, 1992, p62)", "OL": "use TOOTH ROOT to search TOOTH APEX 1969-96", "PM": "97; was see TOOTH ROOT 1975-96; was see under TOOTH ROOT 1969-74", "HN": "97; was see TOOTH ROOT 1975-96; was see under TOOTH ROOT 1969-74", "MR": "20030709", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019227"}, {"RECTYPE": "D", "MH": "Tooth Crown", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tooth Crowns", "MN": "A14.549.167.900.710", "MH_TH": "NLM (1997)", "ST": "T023", "AN": "anatomical crown: do not confuse with CROWNS or its X ref DENTAL CROWNS (Cat E6), prosthetic restorations; coord IM with specific tooth (IM) if pertinent", "PI": "specific tooth (1966-1996)", "MS": "The upper part of the tooth, which joins the lower part of the tooth (TOOTH ROOT) at the cervix (TOOTH CERVIX) at a line called the cementoenamel junction. The entire surface of the crown is covered with enamel which is thicker at the extremity and becomes progressively thinner toward the cervix. (From Jablonski, Dictionary of Dentistry, 1992, p216)", "PM": "97", "HN": "97", "MR": "20030709", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019228"}, {"RECTYPE": "D", "MH": "Dentition, Permanent", "PRINT ENTRY": "Dentition, Secondary|T023|NON|EQV|NLM (1997)|951006|abcdef", "ENTRY": "Secondary Dentition", "MN": "A14.549.167.237", "MH_TH": "NLM (1997)", "ST": "T023", "AN": "differentiate from TOOTH ", "PI": "Dentition (1966-1996)", "MS": "The 32 teeth of adulthood that either replace or are added to the complement of deciduous teeth. (Boucher's Clinical Dental Terminology, 4th ed)", "PM": "97", "HN": "97", "MR": "20030709", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019229"}, {"RECTYPE": "D", "MH": "Dental Audit", "DE": "DENT AUDIT", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Dental Audits|T058|NON|EQV|NLM (1997)|951020|DENT AUDITS|abcdefv", "MN": "N05.700.175.250", "MH_TH": "NLM (1997)", "ST": "T058", "PI": "Medical Audit (1980-1996)", "MS": "A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of dental care.", "PM": "97", "HN": "97", "MR": "20070709", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019230"}, {"RECTYPE": "D", "MH": "Tooth Preparation, Prosthodontic", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tooth Preparations, Prosthodontic", "MN": "E06.931.750", "FX": "Dental Cavity Preparation", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "restrict to prep procedures for prostheses; DENTAL CAVITY PREPARATION (for fillings & inlays) & ROOT CANAL PREPARATION are also available", "PI": "specific dental procedure (1966-1996)", "MS": "The selected form given to a natural tooth when it is reduced by instrumentation to receive a prosthesis (e.g., artificial crown or a retainer for a fixed or removable prosthesis). The selection of the form is guided by clinical circumstances and physical properties of the materials that make up the prosthesis. (Boucher's Clinical Dental Terminology, 4th ed, p239)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019231"}, {"RECTYPE": "D", "MH": "Dental Restoration Failure", "DE": "DENT RESTORATION FAILURE", "AQ": "CL EC SN VE", "PRINT ENTRY": "Dental Prosthesis Failure|T067|NON|NRW|NLM (1997)|960423|DENT PROSTHESIS FAILURE|abcdefv", "ENTRY": "Restoration Failures, Dental|T067|NON|EQV|NLM (1997)|951012|RESTORATION FAILURES DENT|abcdefv", "MN": "E06.780.346.725", "MH_TH": "NLM (1997)", "ST": "T067", "AN": "coordinate IM with specific type of dental restoration or prosthesis (IM)", "MS": "Inability or inadequacy of a dental restoration or prosthesis to perform as expected.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20230705", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019232"}, {"RECTYPE": "D", "MH": "Retreatment", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Retreatments", "MN": "E02.887", "FX": "Reoperation", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "NIM; coord with specific type of ther (IM) + specific disease /ther (or other ther qualif) (IM)", "MS": "The therapy of the same disease in a patient, with the same agent or procedure repeated after initial treatment, or with an additional or alternate measure or follow-up. It does not include therapy which requires more than one administration of a therapeutic agent or regimen. Retreatment is often used with reference to a different modality when the original one was inadequate, harmful, or unsuccessful.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019233"}, {"RECTYPE": "D", "MH": "Dentinal Fluid", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Fluids, Dentinal", "MN": "A12.383.250", "MH_TH": "NLM (1997)", "ST": "T031", "AN": "dentin lymph or transudate", "PI": "Dentin (1966-1996)", "MS": "The lymph or fluid of dentin. It is a transudate of extracellular fluid, mainly cytoplasm of odontoblastic processes, from the dental pulp via the dentinal tubules. It is also called dental lymph. (From Stedman, 26th ed, p665)", "PM": "97", "HN": "97", "DA": "19960618", "DC": "1", "DX": "19970101", "UI": "D019234"}, {"RECTYPE": "D", "MH": "Ephemerovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Ephemeroviruses", "MN": "B04.820.480.937.750.250", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid32613", "MS": "A genus of the family RHABDOVIRIDAE which primarily infect cattle. EPHEMERAL FEVER VIRUS, BOVINE is the type species.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019235"}, {"RECTYPE": "D", "MH": "Tooth Cervix", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cervix Dentis|T023|NON|EQV|NLM (1997)|951018|abcdef", "ENTRY": "Junctions, Cementoenamel", "MN": "A14.549.167.900.700", "MH_TH": "NLM (1997)", "ST": "T023", "AN": "IM; coord with specific tooth (IM) if pertinent", "MS": "The constricted part of the tooth at the junction of the crown and root or roots. It is often referred to as the cementoenamel junction (CEJ), the line at which the cementum covering the root of a tooth and the enamel of the tooth meet. (Jablonski, Dictionary of Dentistry, 1992, p530, p433)", "PM": "97", "HN": "97", "MR": "20190524", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019237"}, {"RECTYPE": "D", "MH": "Practice Patterns, Dentists'", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Practice Patterns, Dental|T057|NON|EQV|NLM (1997)|951020|PRACTICE PATTERNS DENT|abcdefv", "ENTRY": "Practice Patterns, Dentist's", "MN": "N05.300.580", "MH_TH": "NLM (2016)", "ST": "T057", "PI": "Professional Practice (1987-1995)", "MS": "Patterns of practice in dentistry related to diagnosis and treatment.", "PM": "2016; see Dentist's Practice Patterns 1997-2015", "HN": "2016 (1997)", "MR": "20150630", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019239"}, {"RECTYPE": "D", "MH": "Corticoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "PM2 Bacteriophage|T005|NON|NRW|NLM (1997)|960325|PM BACTERIOPHAGE 002|abcdefs", "ENTRY": "PM2 Bacteriophages", "MN": "B04.123.210", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid10659", "RR": "txid10661", "AN": "coord with specific bacterium /virol", "MS": "A family of icosahedral, lipid-containing, non-enveloped bacteriophages containing one genus (Corticovirus).", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019240"}, {"RECTYPE": "D", "MH": "Fuselloviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Sulfolobus virus 1|T005|NON|NRW|NLM (1997)|951020|SULFOLOBUS VIRUS 001|abcdefs", "ENTRY": "Betafuselloviruses", "MN": "B04.280.224", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid10474", "RR": "txid244589", "AN": "coord with specific Archaea /virol", "MS": "A family of lemon-shaped DNA viruses infecting ARCHAEA.", "PM": "97", "HN": "97", "MR": "20200902", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019241"}, {"RECTYPE": "D", "MH": "Oral Medicine", "DE": "ORAL MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD VE", "PRINT ENTRY": "Stomatology|T091|NON|EQV|NLM (1997)|951023|STOMATOL|abcdefv", "ENTRY": "Medicine, Oral|T091|NON|EQV|NLM (1997)|960422|MED ORAL|abcdefv", "MN": "H02.163.670", "FX": "Oral Manifestations", "MH_TH": "NLM (1997)", "ST": "T091", "PI": "Dentistry (1966-1996)", "MS": "A branch of dentistry dealing with diseases of the oral and paraoral structures and the oral management of systemic diseases. (Hall, What is Oral Medicine, Anyway? Clinical Update: National Naval Dental Center, March 1991, p7-8)", "OL": "use DENTISTRY to search ORAL MEDICINE 1980-96 & STOMATOLOGY 1989-96", "PM": "97; was see DENTISTRY 1980-96; STOMATOLOGY was see DENTISTRY 1989-96", "HN": "97; was see DENTISTRY 1980-96; STOMATOLOGY was see DENTISTRY 1989-96", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019242"}, {"RECTYPE": "D", "MH": "Enamel Microabrasion", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Microabrasion, Enamel|T061|NON|EQV|NLM (1997)|960423|abcdef", "ENTRY": "Microabrasions, Enamel|T061|NON|EQV|NLM (1997)|960423|abcdef", "MN": "E06.420.500", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "to remove surface discoloration", "PI": "Tooth Discoloration/therapy (1989-1996)", "MS": "Mechanical removal of a small amount of tooth structure (not more than a few tenths of a millimeter in depth) to eliminate superficial enamel discoloration defects not successfully removed by bleaching techniques. A common abrasive is a mixture of pumice and hydrochloric acid.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019243"}, {"RECTYPE": "D", "MH": "RNA, Satellite", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Satellite RNA|T114|EQV|NLM (1997)|951024|abdef", "ENTRY": "RNAs, Satellite", "MN": "D13.444.735.721", "FX": "Satellite Viruses", "MH_TH": "NLM (1997)", "ST": "T114", "RN": "0", "AN": "RNA molecules acting as molecular parasites of various RNA plant viruses; coord IM with specific plant virus /genet (IM or NIM) but note that CUCUMBER MOSAIC VIRUS SATELLITE is available", "PI": "RNA, Viral (1974-1996)", "MS": "Small, linear single-stranded RNA molecules functionally acting as molecular parasites of certain RNA plant viruses. Satellite RNAs exhibit four characteristic traits: (1) they require helper viruses to replicate; (2) they are unnecessary for the replication of helper viruses; (3) they are encapsidated in the coat protein of the helper virus; (4) they have no extensive sequence homology to the helper virus. Thus they differ from SATELLITE VIRUSES which encode their own coat protein, and from the genomic RNA; (=RNA, VIRAL); of satellite viruses. (From Maramorosch, Viroids and Satellites, 1991, p143)", "OL": "use RNA, SATELLITE (NM) to search SATELLITE RNA 1981-96", "PM": "97; SATELLITE RNA was indexed under RNA 1981-96", "HN": "97; was SATELLLITE RNA (NM) 1981-96", "MR": "20010725", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019244"}, {"RECTYPE": "D", "MH": "Compressive Strength", "AQ": "DE PH RE", "ENTRY": "Strengths, Compressive", "MN": "G01.374.180", "MH_TH": "NLM (1997)", "ST": "T081", "AN": "do not confuse with TENSILE STRENGTH", "MS": "The maximum compression a material can withstand without failure. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed, p427)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19960620", "DC": "1", "DX": "19970101", "UI": "D019245"}, {"RECTYPE": "D", "MH": "Tooth Preparation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tooth Preparations", "MN": "E06.931", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "general or unspecified; prefer specifics; coordinate with specific dental procedure ", "MS": "Procedures carried out with regard to the teeth or tooth structures preparatory to specified dental therapeutic and surgical measures.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20100625", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019246"}, {"RECTYPE": "D", "MH": "HIV Wasting Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wasting Syndrome, HIV|T047|NON|EQV|NLM (1997)|951031|abcdef", "ENTRY": "Wasting Syndrome, AIDS", "MN": "C20.673.480.520", "MH_TH": "NLM (1997)", "ST": "T047", "PI": "HIV Infections (1991-1996)", "MS": "Involuntary weight loss of greater than 10 percent associated with intermittent or constant fever and chronic diarrhea or fatigue for more than 30 days in the absence of a defined cause other than HIV infection. A constant feature is major muscle wasting with scattered myofiber degeneration. A variety of etiologies, which vary among patients, contributes to this syndrome. (From Harrison's Principles of Internal Medicine, 13th ed, p1611).", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019247"}, {"RECTYPE": "D", "MH": "Jaw Fixation Techniques", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "PRINT ENTRY": "Maxillomandibular Fixation|T061|NON|NRW|NLM (1997)|951101|abcdef", "ENTRY": "Techniques, Jaw Fixation", "MN": "E06.645.440", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "coord IM with MANDIBLE /surg or MAXILLA /surg (IM); MANDIBULAR ADVANCEMENT is also available", "MS": "The stable placement of surgically induced fractures of the mandible or maxilla through the use of elastics, wire ligatures, arch bars, or other splints. It is used often in the cosmetic surgery of retrognathism and prognathism. (From Dorland, 28th ed, p636)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "19970620", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019248"}, {"RECTYPE": "D", "MH": "Dental Implants, Single-Tooth", "DE": "DENT IMPLANTS SINGLE TOOTH", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Single-Tooth Implants|T074|NON|EQV|NLM (1997)|951101|abcdef", "ENTRY": "Single-Tooth Implant", "MN": "E07.695.190.183.185", "MH_TH": "NLM (1997)", "ST": "T074", "PI": "Dental Implants (1990-1996)", "MS": "Devices, usually alloplastic, surgically inserted into or onto the jawbone, which support a single prosthetic tooth and serve either as abutments or as cosmetic replacements for missing teeth.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019250"}, {"RECTYPE": "D", "MH": "Nucleocapsid", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nucleocapsids", "MN": "A21.249.500", "FX": "Nucleocapsid Proteins", "MH_TH": "NLM (1997)", "ST": "T116", "AN": "a protein-nucleic acid complex of a virion", "PI": "Viral Proteins (1966-1985)", "MS": "A protein-nucleic acid complex which forms part or all of a virion. It consists of a CAPSID plus enclosed nucleic acid. Depending on the virus, the nucleocapsid may correspond to a naked core or be surrounded by a membranous envelope.", "OL": "use NUCLEOCAPSID (NM) to search VIRAL N PROTEIN 1983-96", "PM": "97; VIRAL N PROTEIN was indexed under VIRAL CORE PROTEINS 1986-96, CAPSID 1983-96, and VIRAL PROTEINS 1983-85", "HN": "97; was VIRAL N PROTEIN (NM) 1983-96", "MR": "20200622", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019251"}, {"RECTYPE": "D", "MH": "Radiography, Dental, Digital", "DE": "RADIOGR DENT DIGITAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Digital Radiography, Dental|T060|NON|EQV|NLM (1997)|960524|DIGITAL RADIOGR DENT|abcdefv", "ENTRY": "Visualices", "MN": "E06.342.764.716", "MH_TH": "NLM (1997)", "ST": "T060", "PI": "Radiography, Dental (1989-1996)", "MS": "A rapid, low-dose, digital imaging system using a small intraoral sensor instead of radiographic film, an intensifying screen, and a charge-coupled device. It presents the possibility of reduced patient exposure and minimal distortion, although resolution and latitude are inferior to standard dental radiography. A receiver is placed in the mouth, routing signals to a computer which images the signals on a screen or in print. It includes digitizing from x-ray film or any other detector. (From MEDLINE abstracts; personal communication from Dr. Charles Berthold, NIDR)", "PM": "98; see RADIOVISIOGRAPHY, DENTAL 1997", "HN": "98(97)", "CATSH": "CAT LIST", "MR": "20160322", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019252"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-bcl-2", "DS": "PROTO ONCOGENE PROTEINS C BCL 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-bcl-2 Proteins|T116|T123|EQV|NLM (1997)|951102|C BCL PROTEINS 002|abbdefs", "ENTRY": "c-bcl-2, Proto-Oncogene Proteins", "MN": "D12.776.624.664.700.169", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "PI": "Proto-Oncogene Proteins (1989-1996)", "MS": "Membrane proteins encoded by the BCL-2 GENES and serving as potent inhibitors of cell death by APOPTOSIS. The proteins are found on mitochondrial, microsomal, and NUCLEAR MEMBRANE sites within many cell types. Overexpression of bcl-2 proteins, due to a translocation of the gene, is associated with follicular lymphoma.", "OL": "use PROTO-ONCOGENE PROTEINS C-BCL-2 (NM) to search PROTO-ONCOGENE PROTEIN BCL-2 1989-96", "PM": "97; PROTO-ONCOGENE PROTEIN BCL-2 was indexed under PROTO-ONCOGENE PROTEINS 1989-96", "HN": "97; was PROTO-ONCOGENE PROTEIN BCL-2 (NM) 1989-96", "MR": "20151124", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019253"}, {"RECTYPE": "D", "MH": "Genes, bcl-2", "DS": "GENES BCL 002", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "c-bcl-2 Genes|T028|NRW|NLM (1997)|951102|C BCL GENES 002|abdefs", "ENTRY": "c-bcl-2 Proto-Oncogene", "MN": "G05.360.340.024.340.375.500.791.150", "FX": "Proto-Oncogene Proteins c-bcl-2", "MH_TH": "NLM (1997)", "ST": "T028", "AN": "bcl stands for \"B-Cell Leukemia\"", "PI": "Proto-Oncogenes (1988-1996)", "MS": "The B-cell leukemia/lymphoma-2 genes, responsible for blocking apoptosis in normal cells, and associated with follicular lymphoma when overexpressed. Overexpression results from the t(14;18) translocation. The human c-bcl-2 gene is located at 18q24 on the long arm of chromosome 18.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20080708", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019254"}, {"RECTYPE": "D", "MH": "NADPH Oxidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NADPH Oxidase|T116|T126|ACX|EQV|NLM (1997)|990101|abbcdef", "ENTRY": "Oxidases, NADPH", "MN": "D12.776.543.653", "FX": "Granulomatous Disease, Chronic", "MH_TH": "NLM (2018)", "ST": "T126", "RN": "EC 1.6.3.-", "PI": "Oxidoreductases (1972-1978)", "MS": "A family of membrane-associated flavoprotein NADPH-dependent oxidoreductases that catalyze the univalent reduction of OXYGEN to create SUPEROXIDES. Structurally, they are characterized by six N-terminal transmembrane ALPHA-HELICES, a FLAVIN-ADENINE DINUCLEOTIDE (FAD)-binding region, and a C-terminal NADPH-binding region. They are expressed primarily by EPITHELIAL CELLS in gut, kidney, colon, and smooth muscle tissues, as well as GRANULOCYTES and function to transfer electrons across membranes to molecular oxygen. Defects in the production of superoxide ions by some NADPH oxidases result in GRANULOMATOUS DISEASE, CHRONIC.", "PM": "2018; see NADPH OXIDASE 1997-2017; NAD(P)H OXIDASE was indexed under NADH, NADPH OXIDOREDUCTASES 2000-2005; NADPH OXIDASE was indexed under NADH, NADPH OXIDOREDUCTASES 1979-1996, NADP 1972-1980 & OXIDOREDUCTASES 1972-1978", "HN": "2018 (1997)", "MR": "20180612", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019255"}, {"RECTYPE": "D", "MH": "Cadmium Chloride", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "CdCl2|T131|T197|ABB|EQV|NLM (1997)|951108|abbcdef", "ENTRY": "Dichloride, Cadmium", "MN": "D01.210.450.150.125", "MH_TH": "NLM (1997)", "ST": "T197", "N1": "Cadmium chloride (CdCl2)", "RN": "J6K4F9V3BA", "RR": "10108-64-2 (Cadmium Chloride)", "PI": "Chlorides (1980-1996)", "MS": "A cadmium halide in the form of colorless crystals, soluble in water, methanol, and ethanol. It is used in photography, in dyeing, and calico printing, and as a solution to precipitate sulfides. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "OL": "use CADMIUM CHLORIDE (NM) to search CADMIUM CHLORIDE 1980-96", "PM": "97; CADMIUM CHLORIDE was indexed under CADMIUM & CHLORIDES 1980-96", "HN": "97; was CADMIUM CHLORIDE (NM) 1980-96", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019256"}, {"RECTYPE": "D", "MH": "Quinpirole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Quinpirole Monohydrochloride|T109|T121|NRW|NLM (1999)|990913|abbdef", "MN": "D03.633.300.802", "PA": "Dopamine Agonists", "MH_TH": "NLM (1997)", "ST": "T121", "N1": "1H-Pyrazolo(3,4-g)quinoline, 4,4a,5,6,7,8,8a,9-octahydro-5-propyl-, (4aR-trans)-", "RN": "20OP60125T", "RR": "T6I2W5V2K1", "PI": "Ergolines (1981-1996)", "MS": "A dopamine D2/D3 receptor agonist.", "OL": "use QUINPIROLE (NM) to search QUINPIROLE 1981-96", "PM": "97; QUINPIROLE was indexed under ERGOLINES 1981-96", "HN": "97; was QUINPIROLE (NM) 1981-96", "MR": "20160531", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019257"}, {"RECTYPE": "D", "MH": "Saquinavir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro 318959", "MN": "D03.633.100.810.900", "PA": "HIV Protease Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "L3JE09KZ2F", "RR": "UHB9Z3841A", "PI": "Quinolines (1993-1996)", "MS": "An HIV protease inhibitor which acts as an analog of an HIV protease cleavage site. It is a highly specific inhibitor of HIV-1 and HIV-2 proteases, and also inhibits CYTOCHROME P-450 CYP3A.", "OL": "use SAQUINAVIR (NM) to search SAQUINAVIR 1990-96", "PM": "97; SAQUINAVIR was indexed under ISOQUINOLINES & QUINOLINES 1993-96 and HIV PROTEASE/antagonists & inhibitors 1990-92", "HN": "97; was SAQUINAVIR (NM) 1990-96", "MR": "20160531", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019258"}, {"RECTYPE": "D", "MH": "Lamivudine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lamivudine, (+-)-trans-|T114|NON|NRW|NLM (2023)|210817|abcdef", "ENTRY": "Lamivudine, 3TC", "MN": "D13.570.685.245.500.950.500", "PA": "Reverse Transcriptase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "2T8Q726O95", "RR": "H6S9D88T3D", "PI": "Zalcitabine/analogs & derivatives (1993-1996)", "MS": "A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease.", "OL": "use LAMIVUDINE (NM) to search LAMIVUDINE 1991-96", "PM": "97; LAMIVUDINE was indexed under ZALCITABINE/analogs & derivatives 1993-96 and CYTOSINE/analogs & derivatives 1991-92", "HN": "97; was LAMIVUDINE (NM) 1991-96", "MR": "20211018", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019259"}, {"RECTYPE": "D", "MH": "Expressed Emotion", "AQ": "CL DE ES PH RE", "ENTRY": "Expressed Emotions", "MN": "F01.829.197", "MH_TH": "NLM (1997)", "ST": "T041", "AN": "negative emotions like anger & hostility: coord IM with specific emotion (IM) if relevant", "PI": "Emotions (1966-1996)", "MS": "A measurement of collective behavior and attitudes that exist towards a specific person\u2014a measurement of the social environment or social relationships of an individual.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20190705", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019260"}, {"RECTYPE": "D", "MH": "Epithalamus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "MN": "A08.186.211.200.317.200", "MH_TH": "NLM (1997)", "ST": "T023", "MS": "The dorsal posterior subdivision of the diencephalon. The epithalamus is generally considered to include the habenular nuclei (HABENULA) and associated fiber bundles, the PINEAL BODY, and the epithelial roof of the third ventricle. The anterior and posterior paraventricular nuclei of the thalamus are included with the THALAMIC NUCLEI although they develop from the same pronuclear mass as the epithalamic nuclei and are sometimes considered part of the epithalamus.", "PM": "97", "HN": "97", "MR": "20180630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019261"}, {"RECTYPE": "D", "MH": "Habenula", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nucleus, Habenular", "MN": "A08.186.211.200.317.200.360", "MH_TH": "NLM (1997)", "ST": "T023", "PI": "Thalamus (1966-1996)", "MS": "A small protuberance at the dorsal, posterior corner of the wall of the THIRD VENTRICLE, adjacent to the dorsal THALAMUS and PINEAL BODY. It contains the habenular nuclei and is a major part of the epithalamus.", "PM": "97", "HN": "97", "MR": "20180701", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019262"}, {"RECTYPE": "D", "MH": "Dysthymic Disorder", "DE": "DYSTHYMIC DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Persistent Depressive Disorder, Dysthymia|T048|NON|EQV|NLM (2021)|200612|abcdef", "ENTRY": "Dysthymic Disorders", "MN": "F03.600.300.400", "MH_TH": "NLM (1997)", "ST": "T048", "PI": "Depressive Disorder (1981-1996)", "MS": "Chronically depressed mood that occurs for most of the day more days than not for at least 2 years. The required minimum duration in children to make this diagnosis is 1 year. During periods of depressed mood, at least 2 of the following additional symptoms are present: poor appetite or overeating, insomnia or hypersomnia, low energy or fatigue, low self-esteem, poor concentration or difficulty making decisions, and feelings of hopelessness. (DSM-IV)", "OL": "use DEPRESSIVE DISORDER to search DYSTHYMIC DISORDER 1981-96", "PM": "97; was see DEPRESSIVE DISORDER 1981-96", "HN": "97; was see DEPRESSIVE DISORDER 1981-96", "CATSH": "CAT LIST", "MR": "20210512", "DA": "19960618", "DC": "1", "DX": "19970101", "UI": "D019263"}, {"RECTYPE": "D", "MH": "Adoptive Transfer", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Adoptive Cell Transfer|T061|NON|NRW|NLM (1997)|951121|abcdef", "ENTRY": "Cell Transfers, Adoptive", "MN": "E05.478.550.520.050", "MH_TH": "NLM (1997)", "ST": "T061", "PI": "Immunotherapy, Adoptive (1991-1996)", "MS": "Form of passive immunization where previously sensitized immunologic agents (cells or serum) are transferred to non-immune recipients. When transfer of cells is used as a therapy for the treatment of neoplasms, it is called adoptive immunotherapy (IMMUNOTHERAPY, ADOPTIVE).", "OL": "use IMMUNOTHERAPY, ADOPTIVE to search ADOPTIVE CELL TRANSFER 1991-96; use IMMUNIZATION, PASSIVE 1983-90", "PM": "97; was ADOPTIVE CELL TRANSFER see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90", "HN": "97; was ADOPTIVE CELL TRANSFER see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90", "CATSH": "CAT LIST", "MR": "20090706", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019264"}, {"RECTYPE": "D", "MH": "Spectroscopy, Near-Infrared", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Spectrometry, Near-Infrared|T059|T060|NON|EQV|NLM (1997)|960322|abbcdef", "ENTRY": "Spectroscopy, Near Infrared", "MN": "E05.196.867.851", "MH_TH": "NLM (1997)", "ST": "T060", "AN": "usually NIM", "PI": "Spectrophotometry, Infrared (1991-1996)", "MS": "A noninvasive technique that uses the differential absorption properties of hemoglobin and myoglobin to evaluate tissue oxygenation and indirectly can measure regional hemodynamics and blood flow. Near-infrared light (NIR) can propagate through tissues and at particular wavelengths is differentially absorbed by oxygenated vs. deoxygenated forms of hemoglobin and myoglobin. Illumination of intact tissue with NIR allows qualitative assessment of changes in the tissue concentration of these molecules. The analysis is also used to determine body composition.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20040802", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019265"}, {"RECTYPE": "D", "MH": "Iron, Dietary", "AQ": "AD AE AG AI AN BL CF CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dietary Iron|T197|NON|EQV|NLM (1997)|951122|abcdef", "MN": "D01.490.600", "EC": "chemistry:Iron:chemistry", "MH_TH": "NLM (1997)", "ST": "T197", "RN": "0", "AN": "/\u200cadv \u200ceff: coordinate with disease  /etiol, not  \u200c/\u200cchem\u200c ind;  \u200c/\u200cther \u200cuse: coordinate with disease  \u200c/\u200cdiet \u200cther ", "PI": "Iron (1966-1996)", "MS": "Iron or iron compounds in FOOD AND BEVERAGES or DIETARY SUPPLEMENTS. Iron is important in OXYGEN transport and the synthesis of the iron-porphyrin proteins such as HEMOGLOBIN; MYOGLOBIN; and CYTOCHROMES. Insufficient amounts of dietary iron can lead to IRON DEFICIENCIES.", "PM": "97", "HN": "97", "MR": "20211227", "DA": "19960619", "DC": "1", "DX": "19970101", "UI": "D019266"}, {"RECTYPE": "D", "MH": "Hemagglutinin Glycoproteins, Influenza Virus", "DE": "HGIV", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "MN": "D12.776.964.970.880.345.500", "PA": "Hemagglutinins", "MH_TH": "NLM (1997)", "ST": "T129", "RN": "0", "PI": "Hemagglutinins, Viral (1983-1996)", "MS": "Membrane glycoproteins from influenza viruses which are involved in hemagglutination, virus attachment, and envelope fusion. Fourteen distinct subtypes of HA glycoproteins and nine of NA glycoproteins have been identified from INFLUENZA A VIRUS; no subtypes have been identified for Influenza B or Influenza C viruses.", "OL": "use HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS (NM) to search HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS 1980-96", "PM": "97; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS was indexed under HEMAGGLUTININS, VIRAL 1983-96 & GLYCOPROTEINS 1980-82", "HN": "97; was HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS (NM) 1980-96", "MR": "20180630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019267"}, {"RECTYPE": "D", "MH": "Antibodies, Antineutrophil Cytoplasmic", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "p-ANCA|T129|NRW|NLM (1997)|951122|abdef", "ENTRY": "p ANCA", "MN": "D23.101.050", "PA": "Immunologic Factors", "MH_TH": "NLM (1997)", "ST": "T129", "RN": "0", "AN": "do not coordinate with ANTIBODY FORMATION for /biosyn;", "PI": "Autoantibodies (1991-1996)", "MS": "Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for GRANULOMATOSIS WITH POLYANGIITIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA (perinuclear), and atypical ANCA.", "OL": "use ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC (NM) to search C-ANCA 1991-96", "PM": "97; C-ANCA was indexed under AUTOANTIBODIES 1991-96", "HN": "97; was C-ANCA (NM) 1991-96", "MR": "20220413", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019268"}, {"RECTYPE": "D", "MH": "Phosphatidylinositol 4,5-Diphosphate", "DS": "PHOSPHATIDYLINOSITOL DIPHOSPHATE 04 05", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PtdInsP2|T109|T123|ABB|EQV|NLM (1998)|970113|PTDINS P 02|abbcdefs", "ENTRY": "Phosphatidylinositol 4,5 Diphosphate", "MN": "D10.570.755.375.760.400.942.625.900", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "PI": "Phosphatidylinositols (1981-1993)", "MS": "A phosphoinositide present in all eukaryotic cells, particularly in the plasma membrane. It is the major substrate for receptor-stimulated phosphoinositidase C, with the consequent formation of inositol 1,4,5-triphosphate and diacylglycerol, and probably also for receptor-stimulated inositol phospholipid 3-kinase. (Kendrew, The Encyclopedia of Molecular Biology, 1994)", "OL": "use PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE (NM) to search PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE 1981-96", "PM": "97; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE was indexed under PHOSPHATIDYLINOSITOL PHOSPHATES 1994-96 & PHOSPHOINOSITIDES 1981-93", "HN": "97; see PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE (NM) 1981-96", "MR": "20100625", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019269"}, {"RECTYPE": "D", "MH": "Fructosamine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "D Isoglucosamine", "MN": "D09.067.342.300", "MH_TH": "NLM (1997)", "ST": "T109", "RN": "4429-04-3", "RR": "27968-74-7 (cpd w/o isomeric designation)", "PI": "Hexosamines (1983-1996)", "MS": "An amino sugar formed when glucose non-enzymatically reacts with the N-terminal amino group of proteins. The fructose moiety is derived from glucose by the \"classical\" Amadori rearrangement.", "OL": "use FRUCTOSAMINE (NM) to search FRUCTOSAMINE 1983-96", "PM": "97; FRUCTOSAMINE was indexed under HEXOSAMINES 1983-96", "HN": "97; was FRUCTOSAMINE (NM) 1983-96", "MR": "20040727", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019270"}, {"RECTYPE": "D", "MH": "Hypoxanthine", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.633.100.759.758.399.475", "EC": "analogs & derivatives:Hypoxanthines", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "2TN51YD919", "RR": "68-94-0 (Hypoxanthine)", "AN": "do not confuse with HYPOXANTHINES", "PI": "Hypoxanthines (1981-1996)", "MS": "A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.", "OL": "use HYPOXANTHINE (NM) to search HYPOXANTHINE 1981-96", "PM": "97; HYPOXANTHINE was indexed under HYPOXANTHINES 1981-96", "HN": "97; was HYPOXANTHINE (NM) 1981-96", "MR": "20160531", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019271"}, {"RECTYPE": "D", "MH": "Leukocyte Elastase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polymorphonuclear Leukocyte Elastase|T116|T126|NON|EQV|NLM (1997)|951124|abbcdef", "ENTRY": "Leukocyte Elastase, Polymorphonuclear", "MN": "D08.811.277.656.959.350.560.500", "MH_TH": "NLM (1997)", "ST": "T126", "RN": "EC 3.4.21.37", "RR": "9004-06-2 (CAS RN)", "PI": "Pancreatopeptidase (1988-1996)", "MS": "An enzyme that catalyzes the hydrolysis of proteins, including elastin. It cleaves preferentially bonds at the carboxyl side of Ala and Val, with greater specificity for Ala. EC 3.4.21.37.", "OL": "use LEUKOCYTE ELASTASE (NM) to search LEUKOCYTE ELASTASE 1988-96", "PM": "97; LEUKOCYTE ELASTASE was indexed under PANCREATOPEPTIDASE 1988-96", "HN": "97; was LEUKOCYTE ELASTASE (NM) 1988-96", "MR": "20090706", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019272"}, {"RECTYPE": "D", "MH": "Botulinum Toxins, Type A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Botulinum Toxin Type A|T116|T121|T126|T131|NON|EQV|NLM (1997)|990101|abbbbcdef", "ENTRY": "Toxin, Botulinum A", "MN": "D23.946.123.179.050", "PA": "Neurotoxins", "MH_TH": "NLM (2011)", "ST": "T131", "RN": "EC 3.4.24.69", "RR": "E211KPY694", "AN": "/antag permitted but consider also BOTULINUM ANTITOXIN", "PI": "Botulinum Toxins (1982-1996)", "MS": "A serotype of botulinum toxins that has specificity for cleavage of SYNAPTOSOMAL-ASSOCIATED PROTEIN 25.", "PM": "2011; see BOTULINUM TOXIN TYPE A 1997-2010, see BOTULINUM TOXINS 1983-1996, ONABOTULINUMTOXINA was indexed BOTULINIUM TOXINS, TYPE A 1997-2018", "HN": "2011 (1997)", "MR": "20200527", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019274"}, {"RECTYPE": "D", "MH": "Radiopharmaceuticals", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Radiopharmaceutical|T121|T130|NON|EQV|NLM (2021)|191219|abbcdef", "MN": "D27.720.470.410.650", "MH_TH": "NLM (1997)", "ST": "T130", "RN": "0", "PI": "specific chemical (1966-1996)", "MS": "Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)", "PM": "97", "HN": "97", "MR": "20200527", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019275"}, {"RECTYPE": "D", "MH": "Glycocalyx", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Cell Coat|T026|NON|EQV|NLM (1997)|951129|abcdef", "ENTRY": "Coats, Cell", "MN": "A11.284.149.165.355", "MH_TH": "NLM (1997)", "ST": "T026", "AN": "a carbohydrate-rich zone on cell surface", "PI": "Polysaccharides (1976-1996)", "MS": "The carbohydrate-rich zone on the cell surface. This zone can be visualized by a variety of stains as well as by its affinity for lectins. Although most of the carbohydrate is attached to intrinsic plasma membrane molecules, the glycocalyx usually also contains both glycoproteins and proteoglycans that have been secreted into the extracellular space and then adsorbed onto the cell surface. (Alberts et al., Molecular Biology of the Cell, 3d ed, p502)", "PM": "97; GLYCOCALYX was indexed under GLYCOPROTEINS & POLYSACCHARIDES 1976-96", "HN": "97; was GLYCOCALYX (NM) 1976-96", "MR": "20000622", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019276"}, {"RECTYPE": "D", "MH": "Entropy", "ENTRY": "Entropies", "MN": "G01.906.345", "MH_TH": "NLM (1997)", "ST": "T170", "PI": "Thermodynamics (1966-1996)", "MS": "The measure of that part of the heat or energy of a system which is not available to perform work. Entropy increases in all natural (spontaneous and irreversible) processes. (From Dorland, 28th ed)", "PM": "97", "HN": "97", "MR": "20080708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019277"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 3", "DS": "MATRIX METALLOPROTEINASE 003", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transin|T116|T126|NON|EQV|NLM (1997)|951129|abbcdef", "ENTRY": "Metalloproteinase, MMP3", "MN": "D12.776.467.836.200", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (1997)", "ST": "T126", "RN": "EC 3.4.24.17", "PI": "Peptide Peptidohydrolases (1985-1987)", "MS": "An extracellular endopeptidase of vertebrate tissues similar to MATRIX METALLOPROTEINASE 1. It digests PROTEOGLYCAN; FIBRONECTIN; COLLAGEN types III, IV, V, and IX, and activates procollagenase. (Enzyme Nomenclature, 1992)", "PM": "2007; see STROMELYSIN 1 1997-2006; MATRIX METALLOPROTEINASE 3 was indexed under METALLOPROTEINASES 1988-1996 & PEPTIDE PEPTIDOHYDROLASES 1985-1987", "HN": "2007(1997)", "MR": "20210521", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019278"}, {"RECTYPE": "D", "MH": "Resin Cements", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Cements, Resin", "MN": "J01.637.051.720.716.822.730", "MH_TH": "NLM (1997)", "ST": "T122", "RN": "0", "PI": "Dental Cements (1974-1996)", "MS": "Dental cements composed either of polymethyl methacrylate or dimethacrylate, produced by mixing an acrylic monomer liquid with acrylic polymers and mineral fillers. The cement is insoluble in water and is thus resistant to fluids in the mouth, but is also irritating to the dental pulp. It is used chiefly as a luting agent for fabricated and temporary restorations. (Jablonski's Dictionary of Dentistry, 1992, p159)", "PM": "97", "HN": "97", "MR": "20060705", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019279"}, {"RECTYPE": "D", "MH": "Branchio-Oto-Renal Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Branchio-Otorenal Dysplasia|T047|NON|EQV|GHR (2014)|NLM (1997)|951129|abcdeef", "ENTRY": "Syndrome, BOF", "MN": "C16.320.180.090", "MH_TH": "NLM (1997)", "ST": "T047", "PI": "Chromosome Abnormalities (1966-1996)", "MS": "An autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to Mondini type cochlear defect and stapes fixation. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20190517", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019280"}, {"RECTYPE": "D", "MH": "Dimerization", "ENTRY": "Dimerizations", "MN": "G03.230", "FX": "Protein Multimerization", "MH_TH": "NLM (1997)", "ST": "T070", "AN": "coordinate with substance but note PROTEIN DIMERIZATION see PROTEIN MULTIMERIZATION is available", "MS": "The process by which two molecules of the same chemical composition form a condensation product or polymer.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20160623", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019281"}, {"RECTYPE": "D", "MH": "Wasting Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Wasting Disease|T047|NON|EQV|NLM (1997)|951129|WASTING DIS|abcdefv", "ENTRY": "Wasting Syndromes", "MN": "C18.654.940", "FX": "Cachexia", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "human or animal; do not confuse with CACHEXIA: do not make diagnoses, use words of text; HIV WASTING SYNDROME is also available", "MS": "A condition of involuntary weight loss of greater then 10% of baseline body weight. It is characterized by atrophy of muscles and depletion of lean body mass. Wasting is a sign of MALNUTRITION as a result of inadequate dietary intake, malabsorption, or hypermetabolism.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019282"}, {"RECTYPE": "D", "MH": "Pancreatitis, Acute Necrotizing", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pancreatitis Necrotizing|T047|NON|EQV|NLM (2020)|190618|abcdef", "ENTRY": "Pancreatitis, Hemorrhagic Necrotic", "MN": "C06.689.750.650", "MH_TH": "NLM (1997)", "ST": "T047", "PI": "Pancreatitis (1990-1996)", "MS": "A severe form of acute INFLAMMATION of the PANCREAS characterized by one or more areas of NECROSIS in the pancreas with varying degree of involvement of the surrounding tissues or organ systems. Massive pancreatic necrosis may lead to DIABETES MELLITUS, and malabsorption.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20200110", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019283"}, {"RECTYPE": "D", "MH": "Thapsigargin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.663.500.750.888", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1997)", "ST": "T109", "RN": "67526-95-8", "PI": "Terpenes (1979-1996)", "MS": "A sesquiterpene lactone found in roots of THAPSIA. It inhibits SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES.", "OL": "use THAPSIGARGIN (NM) to search THAPSIGARGIN 1980-96", "PM": "97; THAPSIGARGIN was indexed under TERPENES 1979-96", "HN": "97; was THAPSIGARGIN (NM) 1979-96", "MR": "20190705", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019284"}, {"RECTYPE": "D", "MH": "Endopeptidase K", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proteinase K|T116|T126|NON|EQV|NLM (1997)|951205|abbcdef", "ENTRY": "Proteinase, Tritirachium Alkaline", "MN": "D08.811.277.656.959.350.247", "MH_TH": "NLM (1997)", "ST": "T126", "RN": "EC 3.4.21.64", "PI": "Serine Proteinases (1988-1996)", "MS": "An enzyme that catalyzes the hydrolysis of keratin, and of other proteins with subtilisin-like specificity. It hydrolyses peptide amides. Endopeptidase K is from the mold Tritirachium album Limber. (Enzyme Nomenclature, 1992) EC 3.4.21.64.", "OL": "use ENDOPEPTIDASE K (NM) to search ENDOPEPTIDASE K 1980-96", "PM": "97; ENDOPEPTIDASE K was indexed under SERINE PROTEINASES 1988-96 & PEPTIDE PEPTIDOHYDROLASES 1979-87", "HN": "97; was ENDOPEPTIDASE K (NM) 1979-96", "MR": "20090706", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019286"}, {"RECTYPE": "D", "MH": "Zinc Sulfate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Zinc", "MN": "D01.975.987", "PA": "Astringents", "MH_TH": "NLM (1997)", "ST": "T197", "N1": "Sulfuric acid, Zinc salt (1:1)", "RN": "7733-02-0", "RR": "7446-20-0 (heptahydrate)", "PI": "Zinc Compounds (1994-1996)", "MS": "A compound given in the treatment of conditions associated with zinc deficiency such as acrodermatitis enteropathica. Externally, zinc sulfate is used as an astringent in lotions and eye drops. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)", "OL": "use ZINC SULFATE (NM) to search ZINC SULFATE 1980-96", "PM": "97; ZINC SULFATE was indexed under ZINC COMPOUNDS 1994-96, SULFATES 1979-96, & ZINC 1979-93", "HN": "97; was ZINC SULFATE (NM) 1979-96", "MR": "20010725", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019287"}, {"RECTYPE": "D", "MH": "Herpesvirus 8, Human", "DE": "HHV 8", "DS": "HERPESVIRUS HUMAN 08", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Kaposi Sarcoma-Associated Herpesvirus|T005|EPO|EQV|NLM (1997)|951205|KAPOSI SARCOMA ASSOC HERPESVIRUS|abcdefv", "ENTRY": "Sarcoma-Associated Herpesviruses, Kaposi's", "MN": "B04.613.204.500.700.330", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid37296", "AN": "infection: coord IM with HERPESVIRIDAE INFECTIONS (IM) or KAPOSI SARCOMA if so specified by author", "MS": "A species in the genus RHADINOVIRUS, subfamily GAMMAHERPESVIRINAE, isolated from patients with AIDS-related and \"classical\" Kaposi sarcoma.", "PM": "2002; see HERPESVIRUS, KAPOSI SARCOMA-ASSOCIATED 1998-2001, see HERPESVIRUS, KAPOSI'S SARCOMA-ASSOCIATED 1997; KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS was KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS 1997", "HN": "2002(1997)", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019288"}, {"RECTYPE": "D", "MH": "Pyruvic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyruvate|T109|T123|NON|NRW|FDA SRS (2014)|NLM (1997)|951205|abbcdeef", "ENTRY": "Acid, Pyruvic", "MN": "D02.241.755.812.800", "MH_TH": "NLM (1997)", "ST": "T109", "RN": "8558G7RUTR", "RR": "127-17-3 (Pyruvic Acid)", "AN": "do not confuse entry term PYRUVATE with PYRUVATES", "PI": "Pyruvates (1981-1996)", "MS": "An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)", "OL": "use PYRUVIC ACID (NM) to search PYRUVIC ACID 1981-96", "PM": "97; PYRUVIC ACID was indexed under PYRUVATES 1981-96", "HN": "97; was PYRUVIC ACID (NM) 1981-96", "MR": "20160701", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019289"}, {"RECTYPE": "D", "MH": "Megestrol Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NuMegestrol", "MN": "D04.210.500.745.432.531.500", "PA": "Appetite Stimulants", "MH_TH": "USP (19XX)", "ST": "T125", "N1": "Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-", "RN": "TJ2M0FR8ES", "RR": "51154-23-5 (Megestrol Acetate)", "PI": "Megestrol/analogs & derivatives (1980-1996)", "MS": "Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)", "PM": "97", "HN": "97;", "MR": "20170524", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019290"}, {"RECTYPE": "D", "MH": "Skull Base", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cranial Base|T023|T029|NON|EQV|NLM (1997)|951206|abbcdef", "ENTRY": "Base, Skull", "MN": "A02.835.232.781.750", "MH_TH": "NLM (1997)", "ST": "T029", "AN": "general or unspecified; prefer specifics; SKULL BASE NEOPLASMS is available", "PI": "Skull (1966-1996)", "MS": "The inferior region of the skull consisting of an internal (cerebral), and an external (basilar) surface.", "PM": "97", "HN": "97", "MR": "20180629", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019291"}, {"RECTYPE": "D", "MH": "Skull Base Neoplasms", "DE": "SKULL BASE NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Skull Base Neoplasm", "MN": "C05.116.231.754.829", "MH_TH": "NLM (1997)", "ST": "T191", "AN": "coordinate with specific histological type of neoplasm", "PI": "Skull Neoplasms (1966-1996)", "MS": "Neoplasms of the base of the skull specifically, differentiated from neoplasms of unspecified sites or bones of the skull (SKULL NEOPLASMS).", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20000622", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019292"}, {"RECTYPE": "D", "MH": "Xanthomatosis, Cerebrotendinous", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Van Bogaert-Scherer-Epstein Disease|T047|EPO|EQV|GHR (2014)|NLM (1997)|951206|VAN BOGAERT SCHERER EPSTEIN DIS|abcdeefv", "ENTRY": "Xanthomatoses, Cerebrotendinous", "MN": "C18.452.648.398.925", "MH_TH": "NLM (1997)", "ST": "T047", "PI": "Xanthomatosis (1968-1996)", "MS": "An autosomal recessive lipid storage disorder due to mutation of the gene CYP27A1 encoding a CHOLESTANETRIOL 26-MONOOXYGENASE. It is characterized by large deposits of CHOLESTEROL and CHOLESTANOL in various tissues resulting in xanthomatous swelling of tendons, early CATARACT, and progressive neurological symptoms.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20210630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019294"}, {"RECTYPE": "D", "MH": "Computational Biology", "DE": "COMPUTATIONAL BIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Molecular Biology, Computational|T091|NON|NRW|NLM (1997)|960322|MOL BIOL COMPUTIONAL|abcdefv", "ENTRY": "Molecular Biologies, Computational", "MN": "L01.313.124", "FX": "Medical Informatics", "MH_TH": "NLM (1997)", "ST": "T091", "AN": "use for the discipline and as a coordinate for bioinformatics studies", "PI": "Molecular Biology (1992-1996)", "MS": "A field of biology concerned with the development of techniques for the collection and manipulation of biological data, and the use of such data to make biological discoveries or predictions. This field encompasses all computational methods and theories for solving biological problems including manipulation of models and datasets.", "PM": "97", "HN": "97", "MR": "20140616", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019295"}, {"RECTYPE": "D", "MH": "Capnography", "DE": "CAPNOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Capnographies", "MN": "E01.370.386.700.150", "MH_TH": "NLM (1997)", "ST": "T060", "PI": "Carbon Dioxide (1966-1996)", "MS": "Continuous recording of the carbon dioxide content of expired air.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "19991103", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019296"}, {"RECTYPE": "D", "MH": "2,4-Dinitrophenol", "DS": "DINITROPHENOL 02 04", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2,4-DNP|T109|T130|ABB|EQV|NLM (1997)|960122|DNP 02 04|abbcdefs", "ENTRY": "2,4 Dinitrophenol", "MN": "D02.640.743.304.250", "PA": "Uncoupling Agents", "MH_TH": "NLM (1997)", "ST": "T130", "RN": "Q13SKS21MN", "RR": "51-28-5 (2,4-Dinitrophenol)", "PI": "Dinitrophenols (1980-1996)", "MS": "A toxic dye, chemically related to trinitrophenol (picric acid), used in biochemical studies of oxidative processes where it uncouples oxidative phosphorylation. It is also used as a metabolic stimulant. (Stedman, 26th ed)", "OL": "use 2,4-DINITROPHENOL (NM) to search 2,4-DINITROPHENOL 1980-96", "PM": "97; 2,4-DINITROPHENOL was indexed under DINITROPHENOLS 1980-96", "HN": "97; was 2,4-DINITROPHENOL (NM) 1980-96", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019297"}, {"RECTYPE": "D", "MH": "Glucose-6-Phosphate", "DS": "GLUCOSE PHOSPHATE A 06", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Glucose 6 Phosphate", "MN": "D09.894.417.448.500", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "56-73-5", "PI": "Glucosephosphates (1981-1996)", "MS": "An ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. (Stedman, 26th ed)", "OL": "use GLUCOSE-6-PHOSPHATE (NM) to search GLUCOSE-6-PHOSPHATE 1981-96", "PM": "97; GLUCOSE-6-PHOSPHATE was indexed under GLUCOSEPHOSPHATES 1981-96", "HN": "97; was GLUCOSE-6-PHOSPHATE (NM) 1981-96", "MR": "20040707", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019298"}, {"RECTYPE": "D", "MH": "Decompression, Surgical", "DE": "DECOMPRESSION SURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Decompressions", "MN": "E04.188", "MH_TH": "NLM (1997)", "ST": "T061", "PI": "specific disease/surgery (1966-1996)", "MS": "A surgical operation for the relief of pressure in a body compartment or on a body part. (From Dorland, 28th ed)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019299"}, {"RECTYPE": "D", "MH": "Medical Errors", "DE": "MED ERR", "AQ": "AE CL EC ES HI LJ MO NU PC PX SN TD VE", "PRINT ENTRY": "Surgical Errors|T080|NON|NRW|NLM (1997)|960122|SURG ERR|abcdefv", "ENTRY": "Wrong-Site Surgeries", "MN": "N02.421.450", "FX": "Patient Harm", "MH_TH": "NLM (1997)", "ST": "T080", "AN": "coordinate with specific disease or procedure; do not confuse with MALPRACTICE", "MS": "Errors or mistakes committed by health professionals which result in harm to the patient. They include errors in diagnosis (DIAGNOSTIC ERRORS), errors in the administration of drugs and other medications (MEDICATION ERRORS), errors in the performance of surgical procedures, in the use of other types of therapy, in the use of equipment, and in the interpretation of laboratory findings. Medical errors are differentiated from MALPRACTICE in that the former are regarded as honest mistakes or accidents while the latter is the result of negligence, reprehensible ignorance, or criminal intent.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019300"}, {"RECTYPE": "D", "MH": "Oleic Acid", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oleate|T109|T121|T123|NON|NRW|FDA SRS (2014)|NLM (1997)|951207|abbbcdeef", "ENTRY": "cis 9 Octadecenoic Acid", "MN": "D10.251.355.325.600.525", "EC": "analogs & derivatives:Oleic Acids", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "2UMI9U37CP", "RR": "112-80-1 (Oleic Acid)", "AN": "do not confuse with OLEIC ACIDS", "PI": "Oleic Acids (1981-1996)", "MS": "An unsaturated fatty acid that is the most widely distributed and abundant fatty acid in nature. It is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent. (Stedman, 26th ed)", "OL": "use OLEIC ACID (NM) to search OLEIC ACID 1981-96", "PM": "97; OLEIC ACID was indexed under OLEIC ACIDS 1981-96", "HN": "97; was OLEIC ACID (NM) 1981-96", "MR": "20160610", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019301"}, {"RECTYPE": "D", "MH": "HIV Envelope Protein gp160", "DE": "GP160", "DS": "HIV ENVELOPE PROTEIN GP 160", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gp160(HIV)|T116|T123|EQV|NLM (1997)|951208|GP 160 HIV|abbdefs", "ENTRY": "gp160, HTLV-III", "MN": "D12.776.964.970.880.325.164.374", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "PI": "Viral Envelope Proteins (1988-1989)", "MS": "An envelope protein of the human immunodeficiency virus that is encoded by the HIV env gene. It has a molecular weight of 160,000 kDa and contains numerous glycosylation sites. It serves as a precursor for both the HIV ENVELOPE PROTEIN GP120 and the HIV ENVELOPE PROTEIN GP41.", "OL": "use HIV ENVELOPE PROTEIN GP160 (NM) to search HIV ENVELOPE PROTEIN GP160 1988-96", "PM": "97; HIV ENVELOPE PROTEIN GP160 was indexed under GENE PRODUCTS, ENV & PROTEIN PRECURSORS 1990-96 and RETROVIRIDAE PROTEINS & VIRAL ENVELOPE PROTEINS 1988-89", "HN": "97; was HIV ENVELOPE PROTEIN GP160 (NM) 1988-96", "MR": "20070709", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019302"}, {"RECTYPE": "D", "MH": "Multilingualism", "PRINT ENTRY": "Bilingualism|T171|NON|REL|NLM (1997)|951208|abcdef", "MN": "L01.559.423.452", "MH_TH": "NLM (1997)", "ST": "T171", "PI": "Language (1968-1996)", "MS": "The ability to speak, read, or write several languages or many languages with some facility. Bilingualism is the most common form. (From Random House Unabridged Dictionary, 2d ed)", "PM": "97", "HN": "97", "MR": "20170708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019303"}, {"RECTYPE": "D", "MH": "Ethinyl Estradiol-Norgestrel Combination", "DE": "EEN COMBINATION", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Norgestrel-Ethinyl Estradiol Combination|T109|T121|T125|NON|EQV|NLM (1997)|951208|abbbcdef", "ENTRY": "TrisistoneR", "MN": "D06.472.334.851.437.968.500.250", "PA": "Contraceptives, Postcoital, Synthetic", "MH_TH": "NLM (1997)", "ST": "T125", "RN": "8056-51-7", "PI": "Norgestrel (1972-1996)", "MS": "ETHINYL ESTRADIOL and NORGESTREL given in fixed proportions.", "OL": "use ETHINYL ESTRADIOL-NORGESTREL COMBINATION (NM) to search STEDIRIL 1980-96", "PM": "97; STEDIRIL was indexed under NORGESTREL & ETHINYL ESTRADIOL 1972-96, CONTRACEPTIVES, ORAL, COMBINED 1976-82, & CONTRACEPTIVES, ORAL 1972-77", "HN": "97; was STEDIRIL (NM) 1972-96", "MR": "20190705", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019304"}, {"RECTYPE": "D", "MH": "Epilepsy, Rolandic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sylvian Epilepsy|T047|EPO|EQV|NLM (2000)|991104|abcdef", "ENTRY": "Temporal-Central Focal Epilepsies", "MN": "C10.228.140.490.493.250", "MH_TH": "NLM (1997)", "ST": "T047", "PI": "Epilepsy, Partial (1986-1996)", "MS": "An autosomal dominant inherited partial epilepsy syndrome with onset between age 3 and 13 years. Seizures are characterized by PARESTHESIA and tonic or clonic activity of the lower face associated with drooling and DYSARTHRIA. In most cases, affected children are neurologically and developmentally normal. (From Epilepsia 1998 39;Suppl 4:S32-S41)", "PM": "1997", "HN": "1997", "CATSH": "CAT LIST", "MR": "20170224", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019305"}, {"RECTYPE": "D", "MH": "Artemisia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Wormwood|T002|NON|EQV|NLM (1997)|960325|abcdef", "ENTRY": "vulgaris, Artemisia", "MN": "B01.875.800.575.912.250.100.100", "MH_TH": "NLM (1997)", "ST": "T002", "RN": "txid4219", "RR": "txid86306", "AN": "note entry term WORMSEED, LEVANT: WORMSEED see CHENOPODIUM AMBROSIOIDES is also available;", "MS": "A plant genus of the family ASTERACEAE with strong-smelling foliage. It is a source of SANTONIN and other cytotoxic TERPENES.", "PM": "97", "HN": "97", "MR": "20210630", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019306"}, {"RECTYPE": "D", "MH": "1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine", "DE": "IQSMP", "DS": "ISOQUINOLINESULFONYL METHYLPIPERAZINE 01 05 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "H-7|T109|T121|NON|EQV|NLM (1997)|960111|H A 07|abbcdefs", "ENTRY": "H 7", "MN": "D03.633.100.531.400", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1997)", "ST": "T121", "N1": "Piperazine, 1-(5-isoquinolinylsulfonyl)-2-methyl-, (2S-(1(R*(R*)), 2alpha, 3abeta, 7abeta))-", "RN": "84477-87-2", "PI": "Piperazines (1985-1996)", "MS": "A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.", "OL": "use 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE (NM) to search 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE 1985-96", "PM": "97; 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE was indexed under ISOQUINOLINES & PIPERAZINES 1985-96", "HN": "97; was 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE (NM) 1985-96", "MR": "20170410", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019307"}, {"RECTYPE": "D", "MH": "Palmitic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hexadecanoic Acid|T109|NON|EQV|FDA SRS (2014)|NLM (1997)|960408|abcdeef", "ENTRY": "Palmitate, Sodium", "MN": "D10.251.694.750", "PA": "Enzyme Inhibitors", "EC": "analogs & derivatives:Palmitic Acids", "MH_TH": "USAN (19XX)", "ST": "T109", "RN": "2V16EO95H1", "RR": "JQ43KP6296", "AN": "do not confuse with PALMITIC ACIDS", "PI": "Palmitic Acids (1981-1996)", "MS": "A common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.", "OL": "use PALMITIC ACID (NM) to search PALMITIC ACIDS 1981-96; use PALMITIC ACIDS to search HEXADECANOIC ACID 1975-96", "PM": "97; PALMITIC ACID was indexed under PALMITIC ACIDS 1981-96; HEXADECANOIC ACID was see PALMITIC ACIDS 1975-96", "HN": "97; was PALMITIC ACID (NM) 1981-96; HEXADECANOIC ACID was see PALMITIC ACIDS 1975-96", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019308"}, {"RECTYPE": "D", "MH": "Epstein-Barr Virus Nuclear Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Epstein-Barr Virus Nuclear Antigen|T116|T129|NON|EQV|NLM (2022)|200908|abbcdef", "ENTRY": "Nuclear Antigens, EBV", "MN": "D23.050.327.300", "MH_TH": "NLM (1997)", "ST": "T129", "RN": "0", "PI": "DNA-Binding Proteins (1993-1996)", "MS": "Nuclear antigens encoded by VIRAL GENES found in HUMAN HERPESVIRUS 4. At least six nuclear antigens have been identified.", "OL": "use EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS (NM) to search EBV-ASSOCIATED NUCLEAR ANTIGEN 1980-96", "PM": "97; EBV-ASSOCIATED NUCLEAR ANTIGEN was indexed under ANTIGENS, VIRAL 1979-96 and DNA-BINDING PROTEINS 1993-96", "HN": "97; was EBV-ASSOCIATED NUCLEAR ANTIGEN (NM) 1979-96", "MR": "20220413", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019309"}, {"RECTYPE": "D", "MH": "Pseudolymphoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lymphoid Hyperplasia, Reactive|T047|NON|EQV|NLM (1997)|960111|abcdef", "ENTRY": "Reactive Lymphoid Hyperplasias", "MN": "C15.604.613", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "non-neoplastic; coord IM with organ/dis (IM)", "PI": "Lymphoma, Small Lymphocytic (1990-1996)", "MS": "A group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma. Pseudolymphoma is characterized by a benign infiltration of lymphoid cells or histiocytes which microscopically resembles a malignant lymphoma. (From Dorland, 28th ed & Stedman, 26th ed)", "OL": "use LYMPHOMA, SMALL LYMPHOCYTIC to search LYMPHOCYTOMA 1991-96", "PM": "97; LYMPHOCYTOMA was see LYMPHOMA, SMALL LYMPHOCYTIC 1991-96", "HN": "97; LYMPHOCYTOMA was see LYMPHOMA, SMALL LYMPHOCYTIC 1991-96", "CATSH": "CAT LIST", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019310"}, {"RECTYPE": "D", "MH": "Staurosporine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-|T109|NON|EQV|NLM (2020)|190201|abcdef", "MN": "D03.633.300.148.750", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1997)", "ST": "T109", "RN": "H88EPA0A3N", "RR": "62996-74-1 (Staurosporine)", "PI": "Alkaloids (1977-1996)", "MS": "An indolocarbazole that is a potent PROTEIN KINASE C inhibitor which enhances cAMP-mediated responses in human neuroblastoma cells. (Biochem Biophys Res Commun 1995;214(3):1114-20)", "OL": "use STAUROSPORINE (NM) to search STAUROSPORINE 1980-96", "PM": "97; STAUROSPORINE was indexed under ALKALOIDS 1977-96", "HN": "97; was STAUROSPORINE (NM) 1977-96", "MR": "20200527", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019311"}, {"RECTYPE": "D", "MH": "BRCA1 Protein", "DS": "BRCA PROTEIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Breast Cancer 1 Gene Product|T116|T123|NON|EQV|NLM (2002)|001220|abbcdef", "ENTRY": "Ring Finger Protein 53|T116|T123|NON|EQV|NLM (2017)|151026|abbcdef", "MN": "D12.776.930.137", "FX": "Hereditary Breast and Ovarian Cancer Syndrome", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1994-1996)", "MS": "The phosphoprotein encoded by the BRCA1 gene (GENE, BRCA1). It contains an N-terminal RING FINGER DOMAIN and is a PROTEIN PHOSPHATASE 1 regulatory subunit. In normal cells the BRCA1 protein is localized in the nucleus, whereas in the majority of breast cancer cell lines and in malignant pleural effusions from breast cancer patients, it is localized mainly in the cytoplasm. (Science 1995;270(5237):713,789-91)", "OL": "use BRCA1 PROTEIN (NM) to search BRCA1 PROTEIN 1994-96", "PM": "97; BCRA1 PROTEIN was indexed under NEOPLASM PROTEINS & TRANSCRIPTION FACTORS 1994-96", "HN": "97; was BRCA1 PROTEIN (NM) 1994-96", "MR": "20151123", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019313"}, {"RECTYPE": "D", "MH": "Dehydroepiandrosterone Sulfate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DHEA Sulfate|T109|T121|T123|EQV|FDA SRS (2014)|NLM (1997)|960118|abbbdeef", "ENTRY": "Sulfate, Prasterone", "MN": "D06.472.334.851.968.952.300", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "57B09Q7FJR", "RR": "651-48-9 (Dehydroepiandrosterone Sulfate)", "PI": "Sulfuric Acids (1978-1980)", "MS": "The circulating form of a major C19 steroid produced primarily by the ADRENAL CORTEX. DHEA sulfate serves as a precursor for TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE.", "OL": "use DEHYDROEPIANDROSTERONE SULFATE (NM) to search DEHYDROEPIANDROSTERONE SULFATE 1980-96", "PM": "97; DEHYDROEPIANDROSTERONE SULFATE was indexed under PRASTERONE/analogs & derivatives 1978-96 & SULFURIC ACIDS 1978-80", "HN": "97; was DEHYDROEPIANDROSTERONE SULFATE (NM) 1978-96", "MR": "20160528", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019314"}, {"RECTYPE": "D", "MH": "Retrobulbar Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Retrobulbar|T033|T046|NON|EQV|NLM (1997)|951214|abbcdef", "ENTRY": "Retrobulbar Hemorrhages", "MN": "C23.550.414.960", "MH_TH": "NLM (1997)", "ST": "T046", "AN": "do not confuse with EYE HEMORRHAGE or its specifics, hemorrh of eye tissue", "MS": "Hemorrhage within the orbital cavity, posterior to the eyeball.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "19991228", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019315"}, {"RECTYPE": "D", "MH": "Porcine respiratory and reproductive syndrome virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Swine Infertility and Respiratory Syndrome Virus|T005|NON|EQV|NLM (1997)|990101|abcdef", "ENTRY": "Swine Infertility Respiratory Syndrome Virus|T005|NON|EQV|NLM (1997)|960326|abcdef", "MN": "B04.820.578.500.080.500.800", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid28344", "RR": "txid11049", "PI": "Togaviridae (1992)", "MS": "A species of ARTERIVIRUS causing reproductive and respiratory disease in pigs. The European strain is called Lelystad virus. Airborne transmission is common.", "PM": "2002; see SWINE INFERTILITY AND RESPIRATORY SYNDROME VIRUS 1997-2001", "HN": "2002 (1997)", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019316"}, {"RECTYPE": "D", "MH": "Evidence-Based Medicine", "DE": "EVIDENCE BASED MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Medicine, Evidence-Based|T091|NON|EQV|NLM (1997)|960318|MED EVIDENCE BASED|abcdefv", "ENTRY": "Medicine, Evidence Based", "MN": "N05.300.319", "FX": "Evidence-Based Nursing", "MH_TH": "NLM (1997)", "ST": "T091", "MS": "An approach of practicing medicine with the goal to improve and evaluate patient care. It requires the judicious integration of best research evidence with the patient's values to make decisions about medical care. This method is to help physicians make proper diagnosis, devise best testing plan, choose best treatment and methods of disease prevention, as well as develop guidelines for large groups of patients with the same disease. (from JAMA 296 (9), 2006)", "PM": "97", "HN": "97", "MR": "20230405", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019317"}, {"RECTYPE": "D", "MH": "Porcine Reproductive and Respiratory Syndrome", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Swine Infertility and Respiratory Syndrome|T047|NON|EQV|NLM (1997)|951214|abcdef", "ENTRY": "Swine Disease, Mystery", "MN": "C22.905.700", "MH_TH": "NLM (1997)", "ST": "T047", "PI": "Swine Diseases (1991-1996)", "MS": "A syndrome characterized by outbreaks of late term abortions, high numbers of stillbirths and mummified or weak newborn piglets, and respiratory disease in young unweaned and weaned pigs. It is caused by PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS. (Radostits et al., Veterinary Medicine, 8th ed, p1048)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019318"}, {"RECTYPE": "D", "MH": "Okadaic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ocadaic Acid|T109|T131|NON|EQV|NLM (1997)|960130|abbcdef", "MN": "D23.946.580.800.750", "PA": "Ionophores", "MH_TH": "NLM (1997)", "ST": "T131", "RN": "1W21G5Q4N2", "RR": "78111-17-8 (Okadaic Acid)", "PI": "Ethers, Cyclic (1982-1996)", "MS": "A specific inhibitor of phosphoserine/threonine protein phosphatase 1 and 2a. It is also a potent tumor promoter. It is produced by DINOFLAGELLATES and causes diarrhetic SHELLFISH POISONING.", "OL": "use OKADAIC ACID (NM) to search OKADAIC ACID 1982-96", "PM": "97; OKADAIC ACID was indexed under ETHERS, CYCLIC 1982-96", "HN": "97; was OKADAIC ACID (NM) 1982-96", "MR": "20230607", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019319"}, {"RECTYPE": "D", "MH": "Embolism, Paradoxical", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Paradoxical Embolisms", "MN": "C14.907.355.590.400", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "coordinate IM with specific vessels or vascular disease (IM), often PULMONARY EMBOLISM or FORAMEN OVALE, PATENT", "PI": "specific embolisms (1975-1996)", "MS": "Blockage of an artery due to passage of a clot (THROMBUS) from a systemic vein to a systemic artery without its passing through the lung which acts as a filter to remove blood clots from entering the arterial circulation. Paradoxical embolism occurs when there is a defect that allows a clot to cross directly from the right to the left side of the heart as in the cases of ATRIAL SEPTAL DEFECTS or open FORAMEN OVALE. Once in the arterial circulation, a clot can travel to the brain, block an artery, and cause a STROKE.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20150608", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019320"}, {"RECTYPE": "D", "MH": "omega-N-Methylarginine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "NG-Monomethyl-L-Arginine|T116|T123|EQV|FDA SRS (2014)|NLM (1997)|960603|NG MONOMETHYL L ARGININE|abbdeefs", "ENTRY": "omega N Methylarginine", "MN": "D12.125.142.087.500", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "27JT06E6GR", "RR": "17035-90-4 (omega-N-Methylarginine)", "PI": "Arginine/analogs & derivatives (1979-1996)", "MS": "A competitive inhibitor of nitric oxide synthetase.", "OL": "use OMEGA-N-METHYLARGININE to search OMEGA-N-METHYLARGININE 1980-96", "PM": "97; OMEGA-N-METHYLARGININE was indexed under ARGININE/analogs & derivatives 1979-96", "HN": "97; was OMEGA-N-METHYLARGININE 1979-96", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019323"}, {"RECTYPE": "D", "MH": "beta-Naphthoflavone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "5,6-Benzoflavone|T109|T121|NON|EQV|NLM (1997)|951220|BENZOFLAVONE 05 06|abbcdefs", "ENTRY": "beta Naphthoflavone", "MN": "D03.633.100.150.266.450.175.100", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1997)", "ST": "T121", "RN": "6051-87-2", "PI": "Naphthalenes (1973-1980)", "MS": "A polyaromatic hydrocarbon inducer of P4501A1 and P4501A2 cytochromes. (Proc Soc Exp Biol Med 1994 Dec:207(3):302-308)", "OL": "use BETA-NAPHTHOFLAVONE (NM) to search BETA-NAPHTHOFLAVONE 1980-96", "PM": "97; BETA-NAPHTHOFLAVONE was indexed under BENZOFLAVONES 1981-96, NAPHTHALENES 1973-80, & FLAVONES 1973-80", "HN": "97; was BETA-NAPHTHOFLAVONE (NM) 1973-96", "MR": "20160531", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019324"}, {"RECTYPE": "D", "MH": "3-O-Methylglucose", "DS": "METHYLGLUCOSE O 03", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "3-O-Methyl-D-Glucose|T109|T121|T130|NON|EQV|NLM (1997)|960110|METHYL GLUCOSE O 03 D|abbbcdefs", "ENTRY": "3 O Methylglucose", "MN": "D09.408.514.622.500", "MH_TH": "NLM (1997)", "ST": "T130", "N1": "D-glucose, 3-O-methyl-", "RN": "146-72-5", "PI": "Methylglucosides (1981-1996)", "MS": "A non-metabolizable glucose analogue that is not phosphorylated by hexokinase. 3-O-Methylglucose is used as a marker to assess glucose transport by evaluating its uptake within various cells and organ systems. (J Neurochem 1993;60(4):1498-504)", "OL": "use 3-O-METHYLGLUCOSE (NM) to search 3-O-METHYLGLUCOSE 1981-96", "PM": "97; 3-O-METHYLGLUCOSE was indexed under METHYLGLUCOSIDES 1981-96", "HN": "97; was 3-O-METHYLGLUCOSE (NM) 1981-96", "MR": "20040707", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019325"}, {"RECTYPE": "D", "MH": "17-alpha-Hydroxyprogesterone", "DS": "ALPHA HYDROXYPROGESTERONE 17", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "17-Hydroxyprogesterone|T109|T121|T125|NON|EQV|NLM (1997)|990101|HYDROXYPROGESTERONE 17|abbbcdefs", "ENTRY": "17 alpha Hydroxyprogesterone", "MN": "D06.472.334.851.687.750.478.400", "MH_TH": "NLM (2004)", "ST": "T125", "N1": "Pregn-4-ene-3,20-dione, 17-hydroxy-", "RN": "68-96-2", "RR": "604-10-4 ((9 beta, 10 alpha)-isomer)", "PI": "Hydroxyprogesterones (1975-1996)", "MS": "A metabolite of PROGESTERONE with a hydroxyl group at the 17-alpha position. It serves as an intermediate in the biosynthesis of HYDROCORTISONE and GONADAL STEROID HORMONES.", "PM": "2004; see 17-HYDROXYPROGESTERONE 1997-2003; 17-HYDROXYPROGESTERONE was indexed under HYDROXYPROGESTERONES 1982-1996, under HYDROXYPROGESTERONES 1975-1982", "HN": "2004 (1997); use 17-HYDROXYPROGESTERONE (NM) 1982-1996, use HYDROXYPROGESTERONES 1975-1982", "MR": "20160527", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019326"}, {"RECTYPE": "D", "MH": "Copper Sulfate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cupric Sulfate|T197|NON|EQV|FDA SRS (2014)|NLM (1997)|USP (19XX)|960111|abcdeeef", "ENTRY": "Vitriol, Blue", "MN": "D01.875.800.800.850.150", "PA": "Emetics", "MH_TH": "NLM (1997)", "ST": "T197", "RN": "LRX7AJ16DT", "RR": "7758-98-7 (Copper Sulfate)", "PI": "Sulfates (1969-1982)", "MS": "A sulfate salt of copper. It is a potent emetic and is used as an antidote for poisoning by phosphorus. It also can be used to prevent the growth of algae.", "OL": "use COPPER SULFATE (NM) to search COPPER SULFATE 1980-96", "PM": "97; COPPER SULFATE was indexed under COPPER 1969-96 & SULFATES 1969-82", "HN": "97; was COPPER SULFATE (NM) 1969-96", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019327"}, {"RECTYPE": "D", "MH": "Buthionine Sulfoximine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfoximine, Buthionine", "MN": "D12.125.166.676.620.125", "PA": "Radiation-Sensitizing Agents", "MH_TH": "NLM (1997)", "ST": "T131", "N1": "Butanoic acid, 2-amino-4-(S-butylsulfonimidoyl)-", "RN": "5072-26-4", "PI": "Methionine Sulfoximine (1979-1996)", "MS": "A synthetic amino acid that depletes glutathione by irreversibly inhibiting gamma-glutamylcysteine synthetase. Inhibition of this enzyme is a critical step in glutathione biosynthesis. It has been shown to inhibit the proliferative response in human T-lymphocytes and inhibit macrophage activation. (J Biol Chem 1995;270(33):1945-7)", "OL": "use BUTHIONINE SULFOXIMINE (NM) to search BUTHIONINE SULFOXIMINE 1980-96", "PM": "97; BUTHIONINE SULFOXIMINE was indexed under METHIONINE SULFOXIMINE 1979-96", "HN": "97: was BUTHIONINE SULFOXIMINE (NM) 1979-96", "MR": "20050630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019328"}, {"RECTYPE": "D", "MH": "Idazoxan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RX781094", "MN": "D03.633.100.355", "PA": "Adrenergic alpha-2 Receptor Antagonists", "MH_TH": "NLM (1997)", "ST": "T121", "RN": "Y310PA316B", "RR": "79944-58-4 (Idazoxan)", "PI": "Imidazoles (1982-1996)", "MS": "A benzodioxane-linked imidazole that has alpha-2 adrenoceptor antagonist activity.", "OL": "use IDAZOXAN (NM) to search IDAZOXAN 1982-96", "PM": "97; IDAZOXAN was indexed under DIOXANES & IMIDAZOLES 1982-96 and DIOXINS 1982-84", "HN": "97; was IDAZOXAN (NM) 1982-96", "MR": "20160531", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019329"}, {"RECTYPE": "D", "MH": "NG-Nitroarginine Methyl Ester", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "NG-Nitro-L-Arginine Methyl Ester|T116|T123|NON|EQV|FDA SRS (2014)|NLM (1997)|960105|NG NITROARGININE METHYL ESTER L|abbcdeefs", "ENTRY": "NG Nitroarginine Methyl Ester, D Orn Isomer", "MN": "D12.125.095.104.525", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "V55S2QJN2X", "RR": "51298-62-5 (mono-HCl, L-Orn-isomer)", "PI": "Arginine/analogs & derivatives (1990-1996)", "MS": "A non-selective inhibitor of nitric oxide synthase. It has been used experimentally to induce hypertension.", "OL": "use NG-NITROARGININE METHYL ESTER (NM) to search N(G)-NITROARGININE METHYL ESTER 1990-96", "PM": "97; N(G)-NITROARGININE METHYL ESTER was indexed under ARGININE/analogs & derivatives 1990-96", "HN": "97; was N(G)-NITROARGININE METHYL ESTER (NM) 1990-96", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019331"}, {"RECTYPE": "D", "MH": "Endothelin-1", "DS": "ENDOTHELIN 01", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Proendothelin 1 Precursor", "MN": "D23.529.400.225", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "RR": "122462-75-3", "AN": "/drug eff permitted", "PI": "Endothelins (1991-1996)", "MS": "A 21-amino acid peptide produced in a variety of tissues including endothelial and vascular smooth-muscle cells, neurons and astrocytes in the central nervous system, and endometrial cells. It acts as a modulator of vasomotor tone, cell proliferation, and hormone production. (N Eng J Med 1995;333(6):356-63)", "PM": "2004; see ENDOTHELINS 1991-1996; BIG ENDOTHELIN was indexed under ENDTHELINS & PROTEIN PRECUSORS 1991-2003; under PEPTIDES 1990; PREPROENDOTHELIN was indexed under ENDOTHELINS & PROTEIN PRECUSORS 1989-2003", "HN": "2004(1997); use ENDOTHELINS 1991-96; for BIG ENDOTHELIN use ENDOTHELIN-1 (NM) 1990-2003; for PREPROENDOLTHELIN use ENDOTHELINS-1 (NM) 1989-2003", "MR": "20150626", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019332"}, {"RECTYPE": "D", "MH": "Endothelin-2", "DS": "ENDOTHELIN 02", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Endothelin 2", "MN": "D23.529.400.235", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "PI": "Endothelins (1991-1996)", "MS": "A 21-amino acid peptide produced predominantly within the kidney and intestine, with smaller amounts produced in the myocardium, placenta, and uterus, but the cells of origin are not clear. Endothelin-2 has no unique physiologic functions, as compared with endothelin-1. (N Eng J Med 1995;333(6):356-63)", "OL": "use ENDOTHELINS to search ENDOTHELIN-2 1991-96", "PM": "97; was see ENDOTHELINS 1991-96", "HN": "97; was see ENDOTHELINS 1991-96", "MR": "20150626", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019333"}, {"RECTYPE": "D", "MH": "Endothelin-3", "DS": "ENDOTHELIN 03", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Endothelin-3, Big", "MN": "D23.529.400.245", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "RR": "129774-03-4", "PI": "Endothelins (1991-1996)", "MS": "A 21-amino acid peptide that circulates in the plasma, but its source is not known. Endothelin-3 has been found in high concentrations in the brain and may regulate important functions in neurons and astrocytes, such as proliferation and development. It also is found throughout the gastrointestinal tract and in the lung and kidney. (N Eng J Med 1995;333(6):356-63)", "PM": "1997; see ENDOTHELINS 1991-1996; BIG ENDOTHELIN 3 was indexed under ENDOTHELINS & PROTEIN PRECURSORS 1993-2003", "HN": "1997; use ENDOTHELINS 1991-1996; for BIG ENDOTHELIN 3 use ENDOTHELIN-3 (NM) 1993-2003", "MR": "20070709", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019334"}, {"RECTYPE": "D", "MH": "Nitroarginine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "NOARG|T109|T121|ABB|EQV|NLM (1997)|960116|abbcdef", "ENTRY": "omega-Nitro-L-Arginine, N", "MN": "D12.125.095.104.587", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1997)", "ST": "T121", "RN": "2149-70-4", "AN": "an enzyme inhib", "PI": "Arginine/analogs & derivatives (1990-1996)", "MS": "An inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in brain energy and ammonia metabolites. (Neurochem Res 1995:200(4):451-6)", "OL": "use NITROARGININE (NM) to search NITROARGININE 1990-96", "PM": "97; NITROARGININE was indexed under ARGININE/analogs & derivatives 1990-96", "HN": "97; was NITROARGININE (NM) 1990-96", "MR": "20010725", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019335"}, {"RECTYPE": "D", "MH": "Cognitive Science", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sciences, Cognitive", "MN": "F04.096.628.255", "MH_TH": "NLM (1997)", "ST": "T091", "PI": "Cognition (1981-1996)", "MS": "The study of the precise nature of different mental tasks and the operations of the brain that enable them to be performed, engaging branches of psychology, computer science, philosophy, and linguistics. (Random House Unabridged Dictionary, 2d ed)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019336"}, {"RECTYPE": "D", "MH": "Hematologic Neoplasms", "DE": "HEMATOL NEOPL", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Hematopoietic Neoplasms|T191|NON|NRW|NLM (1997)|960117|HEMATOPOIETIC NEOPL|abcdefv", "ENTRY": "Neoplasm, Hematopoietic", "MN": "C15.378.400", "FX": "Lymphoma", "MH_TH": "NLM (1997)", "ST": "T191", "AN": "general or unspecified only;  consider instead LEUKEMIA or LYMPHOMA or their specifics and  do not coordinate here", "PI": "specific lymphomas (1968-1996)", "MS": "Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20220523", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019337"}, {"RECTYPE": "D", "MH": "Polypharmacy", "DE": "POLYPHARM", "AQ": "EC HI LJ PC SN TD", "ENTRY": "Polymedication|T061|NON|EQV|NLM (2018)|160902|abcdef", "MN": "N05.300.150.395.450.188.500", "FX": "Drug Therapy, Combination", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "note category: do not confuse with POLYPHARMACOLOGY, the design or use of drugs acting on multiple targets or pathways or with PHARMACOLOGY, the discipline or with DRUG COMBINATIONS or with POLYCHEMOTHERAPY see DRUG THERAPY, COMBINATION", "MS": "The use of multiple drugs administered to the same patient, most commonly seen in elderly patients. It includes also the administration of excessive medication. Since in the United States most drugs are dispensed as single-agent formulations, polypharmacy, though using many drugs administered to the same patient, must be differentiated from DRUG COMBINATIONS, single preparations containing two or more drugs as a fixed dose, and from DRUG THERAPY, COMBINATION, two or more drugs administered separately for a combined effect. (From Segen, Dictionary of Modern Medicine, 1992)", "PM": "1997; for OVERMEDICATION see MEDICAL OVERUSE  2016-2021", "HN": "1997; for OVERMEDICATION use MEDICAL OVERUSE  2016-2021", "CATSH": "CAT LIST", "MR": "20210312", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019338"}, {"RECTYPE": "D", "MH": "Port-Wine Stain", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nevus Flammeus|T019|NON|EQV|NLM (1997)|960117|abcdef", "ENTRY": "Stains, Port-Wine", "MN": "C17.800.804.675", "MH_TH": "OMIM (2013)", "ST": "T019", "AN": "distinguish from HEMANGIOMA, CAPILLARY", "MS": "A vascular malformation of developmental origin characterized pathologically by ectasia of superficial dermal capillaries, and clinically by persistent macular erythema. In the past, port wine stains have frequently been termed capillary hemangiomas, which they are not; unfortunately this confusing practice persists: HEMANGIOMA, CAPILLARY is neoplastic, a port-wine stain is non-neoplastic. Port-wine stains vary in color from fairly pale pink to deep red or purple and in size from a few millimeters to many centimeters in diameter. The face is the most frequently affected site and they are most often unilateral. (From Rook et al., Textbook of Dermatology, 5th ed, p483)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20120703", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019339"}, {"RECTYPE": "D", "MH": "Osteotomy, Le Fort", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Le Fort Osteotomy", "MN": "E06.645.575", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "Le Fort I: coordinate with MAXILLA /surg for maxillary advancement; Le Fort II: coordinate with MAXILLARY FRACTURES /surg; Le Fort III: coordinate with MAXILLARY FRACTURES /surg or CRANIOFACIAL DYSOSTOSIS /surg or other related facial abnormality /surg ", "PI": "Osteotomy (1971-1996)", "MS": "Transverse sectioning and repositioning of the maxilla. There are three types: Le Fort I osteotomy for maxillary advancement or the treatment of maxillary fractures; Le Fort II osteotomy for the treatment of maxillary fractures; Le Fort III osteotomy for the treatment of maxillary fractures with fracture of one or more facial bones. Le Fort III is often used also to correct craniofacial dysostosis and related facial abnormalities. (From Dorland, 28th ed, p1203 & p662)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20060705", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019340"}, {"RECTYPE": "D", "MH": "Aromatherapy", "DE": "AROMATHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapies, Aroma", "MN": "F04.754.035", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "use of essential oils to treat dis in alternative med; coord IM with disease /ther (IM) and specific plant or essential oil /ther use (IM) if available and if pertinent", "PI": "Oils, Volatile (1986-1996)", "MS": "The use of fragrances and essences from plants to affect or alter a person's mood or behavior and to facilitate physical, mental, and emotional well-being. The chemicals comprising essential oils in plants has a host of therapeutic properties and has been used historically in Africa, Asia, and India. Its greatest application is in the field of alternative medicine. (From Random House Unabridged Dictionary, 2d ed; from Dr. Atiba Vheir, Dove Center, Washington, D.C.)", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20010725", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019341"}, {"RECTYPE": "D", "MH": "Acetic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vinegar|T109|T121|T130|NON|NRW|FDA SRS (2014)|NLM (1997)|960123|abbbcdeef", "ENTRY": "Glacial, Acetic Acid", "MN": "D10.251.400.045.500", "PA": "Indicators and Reagents", "EC": "analogs & derivatives:Acetates", "MH_TH": "NLM (1997)", "ST": "T130", "RN": "Q40Q9N063P", "RR": "64-19-7 (Acetic Acid)", "PI": "Acetic Acids (1981-1996)", "MS": "Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed)", "OL": "use ACETIC ACID (NM) to search ACETIC ACID GLACIAL 1981-1996", "PM": "1997; ACETIC ACID GLACIAL was indexed under ACETIC ACIDS 1981-1996", "HN": "1997; was ACETIC ACID GLACIAL (NM) 1981-1996", "MR": "20180521", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019342"}, {"RECTYPE": "D", "MH": "Citric Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Citrate|T109|NON|NRW|FDA SRS (2014)|NLM (1997)|960123|abcdeef", "ENTRY": "Uralyt U|T109|T121|TRD|NRW|NLM (1997)|960123|abbcdef", "MN": "D02.241.081.901.434.249", "PA": "Calcium Chelating Agents", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "2968PHW8QP", "RR": "XF417D3PSL", "AN": "do not confuse entry term CITRATE with CITRATES", "PI": "Citrates (1979-1996)", "MS": "A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.", "PM": "1997; CITRIC ACID was indexed under CITRATES 1979-1996", "HN": "1997 (1979)", "MR": "20180301", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019343"}, {"RECTYPE": "D", "MH": "Lactic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lactate|T109|NON|NRW|NLM (1997)|960123|abcdef", "ENTRY": "Lactate, Ammonium", "MN": "D02.241.511.459.450", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "33X04XA5AT", "RR": "F9S9FFU82N", "AN": "do not confuse entry term LACTATE with LACTATES", "PI": "Lactates (1981-1996)", "MS": "A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)", "OL": "use LACTIC ACID (NM) to search LACTIC ACID 1981-96", "PM": "97; LACTIC ACID was indexed under LACTATES 1981-96", "HN": "97; was LACTIC ACID (NM) 1981-96", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019344"}, {"RECTYPE": "D", "MH": "Zinc Acetate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Zinc Acetate, Anhydrous", "MN": "D02.241.081.018.165.750", "EC": "analogs & derivatives:Acetates", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "FM5526K07A", "RR": "H2ZEY72PME", "PI": "Acetic Acids (1981-1996)", "MS": "A salt produced by the reaction of zinc oxide with acetic acid and used as an astringent, styptic, and emetic.", "PM": "1997; ZINC ACETATE was indexed under ACETIC ACIDS 1981-1996", "HN": "1997 (1981)", "MR": "20180301", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019345"}, {"RECTYPE": "D", "MH": "Sodium Acetate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium Acetate, Anhydrous|T109|T121|REL|NLM (1999)|990913|abbdef", "MN": "D02.241.081.018.165.500", "EC": "analogs & derivatives:Acetates", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "4550K0SC9B", "RR": "NVG71ZZ7P0", "PI": "Acetic Acids (1981-1996)", "MS": "The trihydrate sodium salt of acetic acid, which is used as a source of sodium ions in solutions for dialysis and as a systemic and urinary alkalizer, diuretic, and expectorant.", "PM": "1997; SODIUM ACETATE was indexed under ACETIC ACIDS 1981-1996", "HN": "1997 (1981)", "MR": "20180301", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019346"}, {"RECTYPE": "D", "MH": "Potassium Acetate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acetate, Potassium", "MN": "D02.241.081.018.165.249", "EC": "analogs & derivatives:Acetates", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "M911911U02", "RR": "127-08-2 (Potassium Acetate)", "PI": "Acetic Acids (1981-1996)", "MS": "A potassium salt used to replenish ELECTROLYTES, for restoration of WATER-ELECTROLYTE BALANCE, as well as a urinary and systemic alkalizer, which can be administered orally or by intravenous infusion. Formerly, it was used in DIURETICS and EXPECTORANTS.", "OL": "use ACETIC ACID (NM) to search POTASSIUM ACETATE 1981-96", "PM": "97; POTASSIUM ACETATE was indexed under ACETIC ACIDS 1981-96", "HN": "97; POTASSIUM ACETATE was SY to ACETIC ACID GLACIAL (NM) 1981-96", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019347"}, {"RECTYPE": "D", "MH": "Empiricism", "AQ": "HI", "MN": "K01.752.667.400", "MH_TH": "NLM (1997)", "ST": "T078", "MS": "One of the principal schools of medical philosophy in ancient Greece and Rome. It developed in Alexandria between 270 and 220 B.C., the only one to have any success in reviving the essentials of the Hippocratic concept. The Empiricists declared that the search for ultimate causes of phenomena was vain, but they were active in endeavoring to discover immediate causes. The \"tripod of the Empirics\" was their own chance observations (experience), learning obtained from contemporaries and predecessors (experience of others), and, in the case of new diseases, the formation of conclusions from other diseases which they resembled (analogy). Empiricism enjoyed sporadic continuing popularity in later centuries up to the nineteenth. (From Castiglioni, A History of Medicine, 2d ed, p186; Dr. James H. Cassedy, NLM History of Medicine Division)", "PM": "97", "HN": "97", "MR": "19991108", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019348"}, {"RECTYPE": "D", "MH": "Roseolovirus Infections", "DE": "ROSEOLOVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Roseolovirus Infection", "MN": "C01.925.256.466.850", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "caused by a genus of the family Herpesviridae", "MS": "Infection with ROSEOLOVIRUS, the most common in humans being EXANTHEMA SUBITUM, a benign disease of infants and young children.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019349"}, {"RECTYPE": "D", "MH": "Astroviridae Infections", "DE": "ASTROVIRIDAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Astroviridae", "MN": "C01.925.782.105", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "caused by MAMASTROVIRUS", "MS": "Infections with ASTROVIRIDAE, causing gastroenteritis in human infants, calves, lambs, and piglets.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019350"}, {"RECTYPE": "D", "MH": "Rubulavirus Infections", "DE": "RUBULAVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Rubulavirus Infection", "MN": "C01.925.782.580.600.680", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "general or unspecified; prefer specifics; do not confuse with RUBELLA VIRUS infections (equals RUBELLA)", "MS": "Infections with viruses of the genus RUBULAVIRUS, family PARAMYXOVIRIDAE.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20190617", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019351"}, {"RECTYPE": "D", "MH": "Censuses", "AQ": "HI", "ENTRY": "Methods, Census", "MN": "N06.850.505.400.225", "MH_TH": "NLM (1997)", "ST": "T081", "AN": "for modern & hist censuses; IM; specify geog", "PI": "Demography (1966-1996)", "MS": "Enumerations of populations usually recording identities of all persons in every place of residence with age or date of birth, sex, occupation, national origin, language, marital status, income, relation to head of household, information on the dwelling place, education, literacy, health-related data (e.g., permanent disability), etc. The census or \"numbering of the people\" is mentioned several times in the Old Testament. Among the Romans, censuses were intimately connected with the enumeration of troops before and after battle and probably a military necessity. (From Last, A Dictionary of Epidemiology, 3d ed; Garrison, An Introduction to the History of Medicine, 4th ed, p66, p119)", "OL": "use DEMOGRAPHY to search CENSUS 1990-96", "PM": "97; CENSUS was see DEMOGRAPHY 1990-96", "HN": "97; CENSUS was see DEMOGRAPHY 1990-96", "MR": "20080708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019352"}, {"RECTYPE": "D", "MH": "Endemic Diseases", "DE": "ENDEMIC DIS", "AQ": "CL EC ES HI LJ PC SN VE", "ENTRY": "Endemic Disease", "MN": "N06.850.392", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "note category; do not confuse with epidemic diseases (= EPIDEMICS ); coordinate with specific disease /epidemiol & specify geographic location if pertinent", "PI": "specific disease/epidemiology (1966-1996)", "MS": "The constant presence of diseases or infectious agents within a given geographic area or population group. It may also refer to the usual prevalence of a given disease with such area or group. It includes holoendemic and hyperendemic diseases. A holoendemic disease is one for which a high prevalent level of infection begins early in life and affects most of the child population, leading to a state of equilibrium such that the adult population shows evidence of the disease much less commonly than do children (malaria in many communities is a holoendemic disease). A hyperendemic disease is one that is constantly present at a high incidence and/or prevalence rate and affects all groups equally. (Last, A Dictionary of Epidemiology, 3d ed, p53, 78, 80)", "PM": "97", "HN": "97", "MR": "20190524", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019353"}, {"RECTYPE": "D", "MH": "Sodium Lactate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Lactate, Sodium", "MN": "D02.241.511.459.800", "EC": "analogs & derivatives:Lactates", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "TU7HW0W0QT", "RR": "72-17-3 (Sodium Lactate)", "PI": "Lactates (1981-1996)", "MS": "The sodium salt of racemic or inactive lactic acid. It is a hygroscopic agent used intravenously as a systemic and urinary alkalizer.", "OL": "use LACTIC ACID (NM) to search SODIUM LACTATE 1981-96", "PM": "97; LACTIC ACID was indexed under LACTATES 1981-96", "HN": "97; SODIUM LACTATE was SY to LACTIC ACID (NM) 1981-96", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019354"}, {"RECTYPE": "D", "MH": "Calcium Citrate", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Citrates, Calcium", "MN": "D02.241.081.901.434.249.500", "PA": "Food Additives", "EC": "analogs & derivatives:Citrates", "MH_TH": "USP (19XX)", "ST": "T123", "RN": "MLM29U2X85", "RR": "5785-44-4 (Calcium Citrate)", "PI": "Citrates (1979-1996)", "MS": "A colorless crystalline or white powdery organic, tricarboxylic acid occurring in plants, especially citrus fruits, and used as a flavoring agent, as an antioxidant in foods, and as a sequestrating agent. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)", "OL": "use CITRIC ACID (NM) to search CALCIUM CITRATE 1980-96", "PM": "97; CALCIUM CITRATE was indexed under CITRATES 1979-96", "HN": "97; CALCIUM CITRATE was SY to CITRIC ACID (NM) 1979-96", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019355"}, {"RECTYPE": "D", "MH": "Grave Robbing", "AQ": "ES HI LJ", "ENTRY": "Robbing, Grave", "MN": "I01.198.240.385", "MH_TH": "NLM (1997)", "ST": "T055", "AN": "usually in historical contexts; check appropriate history tags if pertinent", "MS": "Stealing of corpses after burial, especially for medical dissection. In the late 18th and early 19th centuries, in the absence of laws governing the acquisition of dissecting material for the study of anatomy, the needs of anatomy classes were met by surreptitious methods: body-snatching and grave robbing. (Random House Unabridged Dictionary, 2d ed; from Garrison, An Introduction to the History of Medicine, 4th ed, p447; from Castiglioni, A History of Medicine, 2d ed, p676)", "PM": "97", "HN": "97", "MR": "20150701", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019356"}, {"RECTYPE": "D", "MH": "Potassium Citrate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Citrate, Potassium", "MN": "D02.241.081.901.434.249.750", "PA": "Expectorants", "EC": "analogs & derivatives:Citrates", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "EE90ONI6FF", "RR": "866-84-2 (anhydrous)", "PI": "Citrates (1979-1996)", "MS": "A powder that dissolves in water, which is administered orally, and is used as a diuretic, expectorant, systemic alkalizer, and electrolyte replenisher.", "OL": "use CITRIC ACID (NM) to search POTASSIUM CITRATE 1980-96", "PM": "97; POTASSIUM CITRATE was indexed under CITRATES 1979-96", "HN": "97; POTASSIUM CITRATE was SY to CITRIC ACID (NM) 1979-96", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019357"}, {"RECTYPE": "D", "MH": "Fat Substitutes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Artificial Fats|T109|NON|EQV|NLM (1997)|960125|abcdef", "ENTRY": "Substitutes, Fat", "MN": "J02.500.514.500.350", "MH_TH": "NLM (1997)", "ST": "T109", "RN": "0", "AN": "coordinate with specific substitute if pertinent", "PI": "Proteins (1990-1993)", "MS": "Compounds used in food or in food preparation to replace dietary fats. They may be carbohydrate-, protein-, or fat-based. Fat substitutes are usually lower in calories but provide the same texture as fats.", "OL": "use FAT SUBSTITUTES (NM) to search FAT SUBSTITUTES 1990-96", "PM": "97; FAT SUBSTITUTES was indexed under DIETARY PROTEINS 1994-96 & PROTEINS 1990-93", "HN": "97; was FAT SUBSTITUTES (NM) 1990-96", "MR": "20170628", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019358"}, {"RECTYPE": "D", "MH": "Knowledge", "PRINT ENTRY": "Epistemology|T170|NON|NRW|NLM (1997)|960126|abcdef", "MN": "K01.468", "MH_TH": "NLM (2000)", "ST": "T170", "AN": "restrict to knowledge as an abstract or philosophical concept, as \"transmission of knowledge\"; do not use as coordinate for knowledge of specific subjects as \"fuller use of our knowledge about children\"; will figure largely in historical articles & historical contexts; \"medical knowledge\" is probably MEDICINE & not here", "MS": "The body of truths or facts accumulated in the course of time, the cumulated sum of information, its volume and nature, in any civilization, period, or country.", "PM": "97", "HN": "97", "MR": "20170630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019359"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2B1", "DS": "CYTOCHROME P 450 CYP 002 B 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pentoxyresorufin O-Dealkylase|T116|T126|NON|EQV|NLM (1997)|960207|abbcdef", "ENTRY": "Pentoxyresorufin O Dealkylase", "MN": "D12.776.422.220.453.491.313", "MH_TH": "NLM (1997)", "ST": "T126", "RN": "EC 1.14.14.1", "AN": "do not confuse with other cytochrome P-450 CYP's", "PI": "Oxidoreductases (1985-1996)", "MS": "A major cytochrome P-450 enzyme which is inducible by PHENOBARBITAL in both the LIVER and SMALL INTESTINE. It is active in the metabolism of compounds like pentoxyresorufin, TESTOSTERONE, and ANDROSTENEDIONE. This enzyme, encoded by CYP2B1 gene, also mediates the activation of CYCLOPHOSPHAMIDE and IFOSFAMIDE to MUTAGENS.", "OL": "use CYTOCHROME P-450 CYP2B1 (NM) to search PENTOXYRESORUFIN O-DEALKYLASE 1985-96", "PM": "97; PENTOXYRESORUFIN O-DEALKYLASE was indexed under CYTOCHROME P-450 & OXIDOREDUCTASES 1985-96", "HN": "97; was PENTOXYRESORUFIN O-DEALKYLASE (NM) 1985-96", "MR": "20160527", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019362"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP1A1", "DS": "CYTOCHROME P 450 CYP 001 A 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ethoxyresorufin O-Deethylase|T116|T126|NON|EQV|NLM (1997)|960207|abbcdef", "ENTRY": "Cytochrome P 450 CYP1A1", "MN": "D12.776.422.220.453.100.500", "MH_TH": "NLM (1997)", "ST": "T126", "RN": "EC 1.14.14.1", "AN": "do not confuse with other cytochrome P-450 CYP's", "PI": "Oxidoreductases (1980-1996)", "MS": "A liver microsomal cytochrome P-450 monooxygenase capable of biotransforming xenobiotics such as polycyclic hydrocarbons and halogenated aromatic hydrocarbons into carcinogenic or mutagenic compounds. They have been found in mammals and fish. This enzyme, encoded by CYP1A1 gene, can be measured by using ethoxyresorufin as a substrate for the ethoxyresorufin O-deethylase activity.", "OL": "use CYTOCHROME P-450 CYP1A1 (NM) to search ETHOXYRESORUFIN O-DEETHYLASE 1980-96", "PM": "97; ETHOXYRESORUFIN O-DEETHYLASE was indexed under CYTOCHROME P-450 1982-96, OXIDOREDUCTASES 1980-96, & OXAZINES 1979-81", "HN": "97; was ETHOXYRESORUFIN O-DEETHYLASE (NM) 1979-96", "MR": "20160527", "DA": "19960624", "DC": "1", "DX": "19970101", "UI": "D019363"}, {"RECTYPE": "D", "MH": "Humoralism", "MN": "K01.752.667.750", "MH_TH": "NLM (1997)", "ST": "T078", "MS": "An ancient Greek medical theory that health and illness result from a balance or imbalance of body fluids or \"humors\". The humors are blood, phlegm, yellow bile, and black bile.", "PM": "97", "HN": "97", "MR": "19991103", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019364"}, {"RECTYPE": "D", "MH": "Metaphor", "ENTRY": "Metaphors", "MN": "K01.752.798.500", "MH_TH": "NLM (2001)", "ST": "T078", "AN": "IM; coord with object of comparison (IM)", "MS": "The application of a concept to that which it is not literally the same but which suggests a resemblance and comparison. Medical metaphors were widespread in ancient literature; the description of a sick body was often used by ancient writers to define a critical condition of the State, in which one corrupt part can ruin the entire system. (From Med Secoli Arte Sci, 1990;2(3):abstract 331)", "PM": "97", "HN": "97", "MR": "20060705", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019365"}, {"RECTYPE": "D", "MH": "Western World", "AQ": "HI", "MN": "I01.076.201.450.226.800", "MH_TH": "NLM (1997)", "ST": "T078", "AN": "note category; refers usually to Europe & the Americas; IM; specify Category Z continent or country if relevant", "MS": "A historical and cultural entity dispersed across the wide geographical area of Europe, as opposed to the East, Asia, and Africa. The term was used by scholars through the late medieval period. Thereafter, with the impact of colonialism and the transmission of cultures, Western World was sometimes expanded to include the Americas. (Dr. James H. Cassedy, NLM History of Medicine Division)", "PM": "97", "HN": "97", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019366"}, {"RECTYPE": "D", "MH": "Medicine, Unani", "DE": "MED UNANI", "AQ": "AE EC HI IS MT PX SN ST TD", "ENTRY": "Unani Medicine|T091|NON|EQV|NLM (1997)|960318|UNANI MED|abcdefv", "MN": "I01.076.201.450.654.510.500", "MH_TH": "NLM (1997)", "ST": "T091", "AN": "specify geographic term only if relevant", "MS": "A modified Greco-Arabic medical system. It reflects Arabic medicine blending with Greek philosophy, science, and medicine.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "MR": "20180629", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019367"}, {"RECTYPE": "D", "MH": "Nature", "MN": "K01.637", "MH_TH": "NLM (1997)", "ST": "T078", "AN": "restrict to Nature as an abstract or philosophical concept, as \"von Humboldt's Views of Nature\" or \"the laws of nature\"; not for \"the nature of science\" or \"the nature of psychoanalytic theory\"", "MS": "The system of all phenomena in space and time; the totality of physical reality. It is both a scientific and philosophic concept appearing in all historic eras. (Webster 2d; Dr. James H. Cassedy, NLM History of Medicine Division)", "PM": "97", "HN": "97", "MR": "20080708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019368"}, {"RECTYPE": "D", "MH": "Life", "MN": "K01.752.400", "MH_TH": "NLM (1997)", "ST": "T078", "PI": "Philosophy, Medical (1966-1996)", "MS": "The state that distinguishes organisms from inorganic matter, manifested by growth, metabolism, reproduction, and adaptation. It includes the course of existence, the sum of experiences, the mode of existing, or the fact of being. Over the centuries inquiries into the nature of life have crossed the boundaries from philosophy to biology, forensic medicine, anthropology, etc., in creative as well as scientific literature. (Random House Unabridged Dictionary, 2d ed; Dr. James H. Cassedy, NLM History of Medicine Division)", "PM": "97", "HN": "97", "MR": "20020703", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019369"}, {"RECTYPE": "D", "MH": "Observation", "AQ": "MT", "MN": "E05.581.249", "MH_TH": "NLM (2003)", "ST": "T062", "AN": "do not confuse with the Publication Type OBSERVATIONAL STUDY or with OBSERVATIONAL STUDY AS TOPIC; use only as a scientific method, as \"Langerhans, a genius at observation\", \"the father of clinical observation\"; not for \"electron microscopy observations on Pleistocene tissues\" or \"historical observations on dental care\" or \"observations on difficult children\" or \"diagnostic observations on hypertension\"", "MS": "The act of regarding attentively and studying facts and occurrences, gathering data through analyzing, measuring, and drawing conclusions, with the purpose of applying the observed information to theoretical assumptions. Observation as a scientific method in the acquisition of knowledge began in classical antiquity; in modern science and medicine its greatest application is facilitated by modern technology. Observation is one of the components of the research process.", "PM": "97", "HN": "97", "MR": "20130708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019370"}, {"RECTYPE": "D", "MH": "Topography, Medical", "DE": "TOPOGR MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Medical Topography|T077|NON|EQV|NLM (1997)|960129|MED TOPOGR|abcdefv", "MN": "H02.403.352.500", "FX": "Geographic Mapping", "MH_TH": "NLM (1997)", "ST": "T077", "MS": "The systematic surveying, mapping, charting, and description of specific geographical sites, with reference to the physical features that were presumed to influence health and disease. Medical topography should be differentiated from EPIDEMIOLOGY in that the former emphasizes geography whereas the latter emphasizes disease outbreaks.", "PM": "97", "HN": "97", "MR": "20120703", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019371"}, {"RECTYPE": "D", "MH": "Orphanages", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Orphanage", "MN": "J03.775.640", "MH_TH": "NLM (1997)", "ST": "T092", "MS": "Institutions for the housing and care of orphans, foundlings, and abandoned children. They have existed as such since the medieval period but the heading is applicable to such usage also in modern parlance.", "PM": "97", "HN": "97", "MR": "20160613", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019372"}, {"RECTYPE": "D", "MH": "12-Hydroxy-5,8,10,14-eicosatetraenoic Acid", "DS": "HYDROXYEICOSATETRAENOIC ACID 12 05 08 10 14", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "12-S-Hydroxyeicosatetraenoic Acid|T109|T123|NON|NRW|NLM (1997)|960227|HYDROXYEICOSATETRAENOIC ACID 12 S|abbcdefs", "ENTRY": "Acid, 12-S-Hydroxyeicosatetraenoic", "MN": "D10.251.355.310.166.550.425", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "59985-28-3", "PI": "Hydroxyeicosatetraenoic Acids (1985-1996)", "MS": "A lipoxygenase metabolite of ARACHIDONIC ACID. It is a highly selective ligand used to label mu-opioid receptors in both membranes and tissue sections. The 12-S-HETE analog has been reported to augment tumor cell metastatic potential through activation of protein kinase C. (J Pharmacol Exp Ther 1995; 274(3):1545-51; J Natl Cancer Inst 1994; 86(15):1145-51)", "OL": "use 12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID (NM) to search 12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID 1980-96", "PM": "97; 12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID was indexed under HYDROXYEICOSATETRAENOIC ACIDS 1985-96, ARACHIDONIC ACIDS 1975-84, HYDROXY ACIDS 1976-80, & FATTY ALCOHOLS 1975-76", "HN": "97; was 12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID (NM) 1975-96", "MR": "20150622", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019377"}, {"RECTYPE": "D", "MH": "Teriparatide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "hPTH (1-34)|T116|T121|EQV|NLM (1997)|960131|HPTH 001 034|abbdefs", "ENTRY": "Teriparatide Acetate|T116|T121|NON|NRW|FDA SRS (2014)|NLM (2014)|USAN (1986)|960131|abbcdeeef", "MN": "D12.644.548.587.850", "PA": "Bone Density Conservation Agents", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "10T9CSU89I", "RR": "9959P4V12N", "PI": "Peptide Fragments (1978-1996)", "MS": "A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)", "OL": "use TERIPARATIDE (NM) to search PARATHYROID HORMONE PEPTIDE (1-34) 1978-96", "PM": "97; PARATHYROID HORMONE PEPTIDE (1-34) was indexed under PARATHYROID HORMONES & PEPTIDE FRAGMENTS 1978-96", "HN": "97; was PARATHYROID HORMONE PEPTIDE (1-34) (NM) 1978-96", "MR": "20180702", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019379"}, {"RECTYPE": "D", "MH": "Anti-HIV Agents", "DS": "ANTIHIV AGENTS", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Anti-HIV Drug|T121|NON|EQV|NLM (2022)|200727|abcdef", "ENTRY": "Drugs, Anti-HIV", "MN": "D27.505.954.122.388.077.088", "MH_TH": "NLM (1997)", "ST": "T121", "RN": "0", "AN": "consider also AIDS /drug ther; may be used for articles on simian acquired immunodefic syndrome & simian immunodefic virus", "PI": "Antiviral Agents (1985-1996)", "MS": "Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.", "PM": "97", "HN": "97", "MR": "20210630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019380"}, {"RECTYPE": "D", "MH": "Human Growth Hormone", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Somatropin (Human)|T116|T121|T125|NON|EQV|NLM (2003)|020129|abbbcdef", "ENTRY": "Growth Hormone, Human", "MN": "D12.644.548.691.525.425.875", "MH_TH": "NLM (1997)", "ST": "T125", "N1": "Somatotropin (human)", "RN": "12629-01-5", "AN": "GROWTH HORMONE, unspecified is also available; despite entry term, coordinate with RECOMBINANT PROTEINS for recombinant human growth hormone", "PI": "Somatotropin (1976-1996)", "MS": "A 191-amino acid polypeptide hormone secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR), also known as GH or somatotropin. Synthetic growth hormone, termed somatropin, has replaced the natural form in therapeutic usage such as treatment of dwarfism in children with growth hormone deficiency.", "PM": "2003; see SOMATROPIN 1997-2002; SEROSTIM was indexed under SOMATOTROPINS, RECOMBINANT 1996-2002; NORDITROPIN was indexed under SOMATOTROPIN & RECOMBINANT PROTEINS 1992-1996", "HN": "2003 (1997); for SEROSTIM use SOMATOTROPINS, RECOMBINANT (NM) 1996-2002; use NORDITROPIN (NM) 1992-1996", "MR": "20160701", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019382"}, {"RECTYPE": "D", "MH": "Nucleic Acid Synthesis Inhibitors", "DE": "NUCLEIC ACID SYN INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "RNA Synthesis Inhibitors|T121|T123|NRW|NLM (1997)|960202|RNA SYN INHIB|abbdefv", "ENTRY": "Synthesis Inhibitors, RNA", "MN": "D27.505.519.389.675", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "AN": "coordinate IM with DNA /biosyn (IM) or RNA  /biosyn (IM) or specifc DNA or RNA / biosyn (IM)", "PI": "RNA (1966-1996)", "MS": "Compounds that inhibit cell production of DNA or RNA.", "PM": "97", "HN": "97", "MR": "20200527", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019384"}, {"RECTYPE": "D", "MH": "Alendronate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MK217", "MN": "D02.705.429.500.100", "PA": "Bone Density Conservation Agents", "MH_TH": "USAN (1990)", "ST": "T121", "RN": "X1J18R4W8P", "RR": "66376-36-1 (Alendronate)", "PI": "Diphosphonates (1987-1996)", "MS": "A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.", "PM": "1997; ALENDRONATE was indexed under DIPHOSPHONATES 1987-1996", "HN": "1997 (1987)", "MR": "20180228", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019386"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP1A2", "DS": "CYTOCHROME P 450 CYP 001 A 002", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phenacetin O-Dealkylase|T116|T126|NON|EQV|NLM (1997)|960207|abbcdef", "ENTRY": "Phenacetin O Dealkylase", "MN": "D12.776.422.220.453.100.750", "FX": "Cytochrome P-450 CYP1A2 Inducers", "EC": "antagonists & inhibitors:Cytochrome P-450 CYP1A2 Inhibitors", "MH_TH": "NLM (1997)", "ST": "T126", "RN": "EC 1.14.14.1", "AN": "do not confuse with other cytochrome P-450 CYP's", "PI": "Phenacetin (1976-1980)", "MS": "A cytochrome P450 enzyme subtype that has specificity for relatively planar heteroaromatic small molecules, such as CAFFEINE and ACETAMINOPHEN.", "OL": "use CYTOCHROME P-450 CYP1A2 (NM) to search PHENACETIN O-DEALKYLASE 1980-96", "PM": "97; PHENACETIN O-DEALKYLASE was indexed under OXIDOREDUCTASES 1980-96, CYTOCHROME P-450 1976-96, & PHENACETIN 1976-80", "HN": "97; was PHENACETIN O-DEALKYLASE (NM) 1976-96", "MR": "20160527", "DA": "19960624", "DC": "1", "DX": "19970101", "UI": "D019388"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2D6", "DS": "CYTOCHROME P 450 CYP 002 D 006", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Debrisoquine Hydroxylase|T116|T126|NON|EQV|NLM (1997)|960207|abbcdef", "ENTRY": "P450 2D6, Cytochrome", "MN": "D12.776.422.220.453.491.368", "EC": "antagonists & inhibitors:Cytochrome P-450 CYP2D6 Inhibitors", "MH_TH": "NLM (1997)", "ST": "T126", "RN": "EC 1.14.14.1", "PI": "Hydroxylases (1979-1996)", "MS": "A cytochrome P450 enzyme that catalyzes the hydroxylation of many drugs and environmental chemicals, such as DEBRISOQUINE; ADRENERGIC RECEPTOR ANTAGONISTS; and TRICYCLIC ANTIDEPRESSANTS. This enzyme is deficient in up to 10 percent of the Caucasian population.", "OL": "use CYTOCHROME P-450 CYP2D6 (NM) to search DEBRISOQUINE 4-HYDROXYLASE 1982-96", "PM": "97; DEBRISOQUINE 4-HYDROXYLASE was indexed under CYTOCHROME P-450 & HYDROXYLASES 1982-96", "HN": "97; was DEBRISOQUINE 4-HYDROXYLASE (NM) 1982-96", "MR": "20160527", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019389"}, {"RECTYPE": "D", "MH": "Arrestins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.543.090", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "AN": "regulatory proteins; do not confuse with ARRESTIN", "PI": "Eye Proteins (1992-1996)", "MS": "Regulatory proteins that down-regulate phosphorylated G-protein membrane receptors, including rod and cone photoreceptors and adrenergic receptors.", "PM": "97", "HN": "97", "MR": "20160418", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019390"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2E1", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dimethylnitrosamine N-Demethylase|T116|T126|NON|EQV|NLM (1997)|960208|DMN DEMETHYLASE|abbcdefv", "ENTRY": "N Nitrosodimethylamine Demethylase", "MN": "D12.776.422.220.453.491.375", "EC": "antagonists & inhibitors:Cytochrome P-450 CYP2E1 Inhibitors", "MH_TH": "NLM (1997)", "ST": "T126", "RN": "EC 1.14.13.-", "AN": "do not confuse with other cytochrome P-450 CYP's", "PI": "Oxidoreductases, N-Demethylating (1975-1996)", "MS": "An ethanol-inducible cytochrome P450 enzyme that metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Substrates include ETHANOL; INHALATION ANESTHETICS; BENZENE; ACETAMINOPHEN and other low molecular weight compounds. CYP2E1 has been used as an enzyme marker in the study of alcohol abuse.", "OL": "use CYTOCHROME P-450 CYP2E1 (NM) to search DIMETHYLNITROSAMINE N-DEMETHYLASE 1980-96 & 4-NITROPHENOL-2-HYDROXYLASE 1984-96", "PM": "97; DIMETHYLNITROSAMINE N-DEMETHYLASE was indexed under CYTOCHROME P-450 & OXIDOREDUCTASES, N-DEMETHYLATING 1975-96, NITROSAMINES 1972-76, & OXIDOREDUCTASES 1972-74; 4-NITROPHENOL-2-HYDROXYLASE was indexed under CYTOCHROME P-450 & HYDROXYLASES 1984-96", "HN": "97; was DIMETHYLNITROSAMIME N-DEMETHYLASE (NM) 1972-96 & was 4-NITROPHENOL-2-HYDROXYLASE (NM) 1984-96", "MR": "20160527", "DA": "19960624", "DC": "1", "DX": "19970101", "UI": "D019392"}, {"RECTYPE": "D", "MH": "Arrestin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "S-Antigen, Retinal|T116|T129|NON|EQV|NLM (1997)|960208|abbcdef", "ENTRY": "S Antigen, Retinal", "MN": "D23.050.301.280", "MH_TH": "NLM (1997)", "ST": "T129", "RN": "0", "AN": "an eye protein; do not confuse with ARRESTINS", "PI": "Eye Proteins (1983-1996)", "MS": "A 48-Kd protein of the outer segment of the retinal rods and a component of the phototransduction cascade. Arrestin quenches G-protein activation by binding to phosphorylated photolyzed rhodopsin. Arrestin causes experimental autoimmune uveitis when injected into laboratory animals.", "OL": "use ARRESTIN (NM) to search S ANTIGEN, RETINAL 1981-96", "PM": "97; S ANTIGEN, RETINAL was indexed under ANTIGENS & EYE PROTEINS 1981-96", "HN": "97; was S ANTIGEN, RETINAL (NM) 1981-96", "MR": "20160418", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019393"}, {"RECTYPE": "D", "MH": "Ki-67 Antigen", "DS": "KI ANTIGEN 67", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "MIB-1 Antigen|T116|T129|NON|EQV|NLM (2003)|011206|abbcdef", "ENTRY": "MIB 1 Antigen", "MN": "D23.101.140.400", "MH_TH": "NLM (1997)", "ST": "T129", "RN": "0", "PI": "Nuclear Proteins (1992-1996)", "MS": "A CELL CYCLE and tumor growth marker which can be readily detected using IMMUNOCYTOCHEMISTRY methods. Ki-67 is a nuclear antigen present only in the nuclei of cycling cells.", "OL": "use KI-67 ANTIGEN (NM) to search ANTIGEN KI67 1988-96", "PM": "97; ANTIGEN KI67 was indexed under NEOPLASM PROTEINS 1994-96, NUCLEAR PROTEINS 1992-96 & ANTIGENS, SURFACE 1988-91", "HN": "97; was ANTIGEN KI67 (NM) 1988-96", "MR": "20210305", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019394"}, {"RECTYPE": "D", "MH": "Tissue Polypeptide Antigen", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "TPA Antigen|T116|T129|EQV|NLM (1997)|960213|abbdef", "ENTRY": "Antigen, Tissue Polypeptide", "MN": "D23.101.140.880", "FX": "Keratins", "MH_TH": "NLM (1997)", "ST": "T129", "RN": "0", "PI": "Peptides (1978-1996)", "MS": "Serological tumor marker composed of a molecular complex of cytokeratins 8, 18, and 19. It is used in the diagnosis and staging of bronchogenic carcinoma.", "OL": "use TISSUE POLYPEPTIDE ANTIGEN (NM) to search TISSUE PEPTIDE ANTIGEN 1980-96", "PM": "97; TISSUE POLYPEPTIDE ANTIGEN was indexed under PEPTIDES 1978-96", "HN": "97; was TISSUE POLYPEPTIDE ANTIGEN (NM) 1978-96", "MR": "20150619", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019396"}, {"RECTYPE": "D", "MH": "Pancreas, Artificial", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Artificial Pancreas|T074|NON|EQV|NLM (1997)|960213|abcdef", "MN": "E07.858.082.760", "MH_TH": "NLM (1997)", "ST": "T074", "AN": "device simulating pancreas activity", "PI": "Artificial Organs (1972-1996)", "MS": "Devices for simulating the activity of the pancreas. They can be either electromechanical, consisting of a glucose sensor, computer, and insulin pump or bioartificial, consisting of isolated islets of Langerhans in an artificial membrane.", "PM": "97", "HN": "97", "CATSH": "CAT LIST", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019397"}, {"RECTYPE": "D", "MH": "Genes, BRCA1", "DS": "GENES BRCA 001", "AQ": "DE PH RE", "PRINT ENTRY": "BRCA1 Gene|T028|EQV|NLM (1997)|960216|BRCA GENE A 001|abdefs", "ENTRY": "Gene, BRCA1", "MN": "G05.360.340.024.340.415.400.100", "FX": "BRCA1 Protein", "MH_TH": "NLM (1997)", "ST": "T028", "AN": "BRCA stands for \"BReast CAncer\"", "PI": "Genes, Suppressor, Tumor (1993-1996)", "MS": "A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human CHROMOSOME 17 at locus 17q21. Mutations of this gene are associated with the formation of HEREDITARY BREAST AND OVARIAN CANCER SYNDROME. It encodes a large nuclear protein that is a component of DNA repair pathways.", "PM": "97", "HN": "97", "MR": "20140606", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019398"}, {"RECTYPE": "D", "MH": "Tobacco mosaic satellite virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Tobacco Mosaic Virus Satellite|T005|NON|EQV|NLM (1997)|990101|abcdef", "MN": "B04.265.658.850", "MH_TH": "NLM (2002)", "ST": "T005", "PI": "Satellite Viruses (1989-1996)", "MS": "A spherical RNA satellite virus which requires an obligatory helper TOBACCO MOSAIC VIRUS for replication.", "PM": "2002; see TOBACCO MOSAIC VIRUS SATELLITE 1997-2001", "HN": "2002 (1997)", "MR": "20200902", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019400"}, {"RECTYPE": "D", "MH": "Cucumber Mosaic Virus Satellite", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cucumber Mosaic Virus Satellite RNA|T114|EQV|NLM (1997)|960403|abdef", "MN": "D13.444.735.721.250", "MH_TH": "NLM (1997)", "ST": "T114", "RN": "0", "AN": "satellite RNA, not a satellite virus", "PI": "RNA, Viral (1983-1996)", "MS": "A satellite RNA (not a satellite virus) which has several types. Different cucumoviruses can act as helper viruses for different types.", "PM": "97", "HN": "97", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019401"}, {"RECTYPE": "D", "MH": "Macrophage Inflammatory Proteins", "DE": "MACROPHAGE INFLAMM PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Macrophage Inflammatory Protein|T116|T129|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Protein-1, Macrophage Inflammatory", "MN": "D23.529.374.200.600", "MH_TH": "NLM (1997)", "ST": "T129", "RN": "0", "MS": "Heparin-binding proteins that exhibit a number of inflammatory and immunoregulatory activities. Originally identified as secretory products of MACROPHAGES, these chemokines are produced by a variety of cell types including NEUTROPHILS; FIBROBLASTS; and EPITHELIAL CELLS. They likely play a significant role in respiratory tract defenses.", "PM": "1997; for MACROPHAGE INFLAMMATORY PROTEIN-1 see MACROPHAGE INFLAMMATORY PROTEIN-1 1997-2007", "HN": "1997", "MR": "20200527", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019402"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP11B2", "DS": "CYTOCHROME P 450 CYP 011 B 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Steroid 18-Hydroxylase|T116|T126|NON|EQV|NLM (1997)|960222|STEROID HYDROXYLASE 018|abbcdefs", "ENTRY": "Steroid 18 Hydroxylase", "MN": "D12.776.422.220.453.915.050", "MH_TH": "NLM (1997)", "ST": "T126", "RN": "EC 1.14.15.4", "RR": "EC 1.14.15.4", "AN": "/antag: coordinate with CYTOCHROME P-450 ENZYME INHIBITORS", "PI": "Steroid Hydroxylases (1979-1993)", "MS": "A mitochondrial cytochrome P450 enzyme that catalyzes the 18-hydroxylation of steroids in the presence of molecular oxygen and NADPH-specific flavoprotein. This enzyme, encoded by CYP11B2 gene, is important in the conversion of CORTICOSTERONE to 18-hydroxycorticosterone and the subsequent conversion to ALDOSTERONE.", "PM": "2015; see ALDOSTERONE SYNTHASE 2003-2014; see CYTOCHROME P-450 CYP11B2 1977-2002; for STEROID 18-HYDROXYLASE see CYTOCHROME P-450 1984-1996, see STEROID 11-HYDROXYLASE 1994-1996, see STEROID HYDROXYLASES 1979-1993, & see DESOXYCORTICOSTERONE 1979-1982", "HN": "2015 (1979)", "MR": "20200622", "DA": "19960624", "DC": "1", "DX": "19970101", "UI": "D019405"}, {"RECTYPE": "D", "MH": "Platelet Endothelial Cell Adhesion Molecule-1", "DS": "PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PECAM-1|T116|T129|ABB|EQV|NLM (1997)|960223|PECAM 001|abbcdefs", "ENTRY": "Platelet Endothelial Cell Adhesion Molecule 1", "MN": "D23.101.100.900.131", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (1997)", "ST": "T129", "RN": "0", "PI": "Membrane Glycoproteins (1990-1994)", "MS": "A cell adhesion molecule, composed of a series of Ig-like domains, and expressed on virtually all MONOCYTES; PLATELETS; and GRANULOCYTES. PECAM-1 is highly expressed on endothelial cells and concentrated at the junctions between them. It is essential for TRANSENDOTHELIAL MIGRATION of leukocytes and removal of apoptotic cells by PHAGOCYTES.", "PM": "2018; see ANTIGENS, CD31 1997-2017 and CD31 ANTIGEN 1990-1996; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE-1 was indexed under CELL ADHESION MOLECULES 1995-96; under ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1990-96; and under MEMBRANE GLYCOPROTEINS 1990-94", "HN": "2018 (1990)", "MR": "20230316", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019408"}, {"RECTYPE": "D", "MH": "Interleukin-15", "DS": "INTERLEUKIN 015", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "IL-15|T116|T129|ABB|EQV|NLM (1997)|960223|IL 015|abbcdefs", "ENTRY": "Interleukin 15|T116|T129|NON|EQV|NLM (1997)|960306|abbcdef", "MN": "D23.529.374.465.515", "MH_TH": "NLM (1997)", "ST": "T129", "RN": "0", "PI": "Interleukins (1994-1996)", "MS": "Cytokine that stimulates the proliferation of T-LYMPHOCYTES and shares biological activities with IL-2. IL-15 also can induce proliferation and differentiation of B-LYMPHOCYTES.", "OL": "use INTERLEUKIN-15 (NM) to search INTERLEUKIN 15 1994-96", "PM": "97; INTERLEUKIN 15 was indexed under INTERLEUKINS 1994-96", "HN": "97; was INTERLEUKIN 15 (NM) 1994-96", "MR": "20060705", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019409"}, {"RECTYPE": "D", "MH": "Interleukin-16", "DS": "INTERLEUKIN 016", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lymphocyte Chemoattractant Factor|T116|T129|NON|EQV|NLM (1997)|960223|abbcdef", "ENTRY": "Interleukin 16", "MN": "D23.529.374.465.516", "MH_TH": "NLM (1997)", "ST": "T129", "RN": "0", "PI": "Lymphokines (1987-1996)", "MS": "A cytokine produced by activated T-LYMPHOCYTES that stimulates the migration of CD4-POSITIVE LYMPHOCYTES and monocytes. It has been reported to suppress HIV replication.", "OL": "use INTERLEUKIN-16 (NM) to search LYMPHOCYTE CHEMOATTRACTANT FACTOR 1987-96", "PM": "97; LYMPHOCYTE CHEMOATTRACTANT FACTOR was indexed under LYMPHOKINES 1987-96", "HN": "97; was LYMPHOCYTE CHEMOATTRACTANT FACTOR (NM) 1987-96", "MR": "20060705", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019410"}, {"RECTYPE": "D", "MH": "Clinical Laboratory Techniques", "DE": "CLIN LABORATORY TECHNIQUES", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Clinical Laboratory Testing|T059|NON|REL|NLM (2022)|200930|abcdef", "ENTRY": "Testing, Clinical Laboratory", "MN": "E05.200", "FX": "Medical Laboratory Science", "MH_TH": "NLM (2000)", "ST": "T058", "AN": "general or unspecified; prefer specifics", "MS": "Techniques used to carry out clinical investigative procedures in the diagnosis and therapy of disease.", "PM": "2000; see TECHNOLOGY, MEDICAL LABORATORY 1997-1999; for LABORATORY DIAGNOSIS see LABORATORY TECHNIQUES AND PROCEDURES 1998-2011, see DIAGNOSIS, LABORATORY 1963-1997; for LABORATORY EXAMINATIONS AND DIAGNOSES see LABORATORY TECHNIQUES AND PROCEDURES 1981-2011; for DIAGNOSES AND LABORATORY EXAMINATIONS see LABORATORY TECHNIQUES AND PROCEDURES 1993-2011", "HN": "2000 (1997)", "MR": "20210630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019411"}, {"RECTYPE": "D", "MH": "Anatomy, Cross-Sectional", "DE": "ANAT CROSS SECTION", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Anatomy, Sectional|T091|NON|EQV|NLM (1997)|960226|ANAT SECTION|abcdefv", "ENTRY": "Cross Sectional Anatomy", "MN": "H01.158.100.185", "FX": "Ultrasonography", "MH_TH": "NLM (2005)", "ST": "T091", "AN": "coordinate with organ/anat (IM)", "MS": "Descriptive anatomy based on three-dimensional imaging (IMAGING, THREE-DIMENSIONAL) of the body, organs, and structures using a series of computer multiplane sections, displayed by transverse, coronal, and sagittal analyses. It is essential to accurate interpretation by the radiologist of such techniques as ultrasonic diagnosis, MAGNETIC RESONANCE IMAGING, and computed tomography (TOMOGRAPHY, X-RAY COMPUTED). (From Lane & Sharfaei, Modern Sectional Anatomy, 1992, Preface)", "PM": "97", "HN": "97", "MR": "20080708", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019412"}, {"RECTYPE": "D", "MH": "Qi", "AQ": "HI", "PRINT ENTRY": "Vital Energy (Philosophy)|T078|NON|EQV|NLM (1997)|960226|abcdef", "ENTRY": "Life Breath (Philosophy)", "MN": "K01.752.730", "FX": "Yin-Yang", "MH_TH": "NLM (1997)", "ST": "T078", "AN": "Qi defic goes here", "MS": "The vital life force in the body, supposedly able to be regulated by acupuncture. It corresponds roughly to the Greek pneuma, the Latin spiritus, and the ancient Indian prana. The concept of life-breath or vital energy was formulated as an indication of the awareness of man, originally directed externally toward nature or society but later turned inward to the self or life within. (From Comparison between Concepts of Life-Breath in East and West, 15th International Symposium on the Comparative History of Medicine - East and West, August 26-September 3, 1990, Shizuoka, Japan, pp. ix-x)", "PM": "2002; see CH'I 1997-2002", "HN": "2002(1997)", "MR": "20090706", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019413"}, {"RECTYPE": "D", "MH": "Chlorobi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Green Sulfur Bacteria|T007|NON|EQV|NLM (1997)|990101|GREEN SULFUR BACT|abcdefv", "MN": "B03.250", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid1090", "RR": "txid191412", "PI": "Bacteria (1990-1996)", "MS": "A phylum of anoxygenic, phototrophic bacteria including the family Chlorobiaceae. They occur in aquatic sediments, sulfur springs, and hot springs and utilize reduced sulfur compounds instead of oxygen.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019414"}, {"RECTYPE": "D", "MH": "Torque", "ENTRY": "Torques", "MN": "G01.374.860.500", "MH_TH": "NLM (1997)", "ST": "T067", "AN": "a principle of mechanics; not restricted to space flight", "MS": "The rotational force about an axis that is equal to the product of a force times the distance from the axis where the force is applied.", "PM": "97", "HN": "97", "MR": "20160617", "DA": "19960620", "DC": "1", "DX": "19970101", "UI": "D019415"}, {"RECTYPE": "D", "MH": "Head Movements", "AQ": "DE PH RE", "ENTRY": "Movements, Head", "MN": "G11.427.410.478", "MH_TH": "NLM (1997)", "ST": "T040", "AN": "note HEAD BANGING see STEREOTYPED BEHAVIOR", "PI": "Movement (1966-1996)", "MS": "Voluntary or involuntary motion of head that may be relative to or independent of body; includes animals and humans.", "PM": "97", "HN": "97", "MR": "20160630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019416"}, {"RECTYPE": "D", "MH": "Hindlimb Suspension", "AQ": "AE ES IS LJ MT PH PX SN ST VE", "PRINT ENTRY": "Tail Suspension|T062|NON|REL|NLM (1997)|960227|abcdef", "ENTRY": "Unloadings, Skeletal", "MN": "N06.230.150.440.950.400", "MH_TH": "NLM (1997)", "ST": "T062", "PI": "Immobilization (1966-1996)", "MS": "Technique for limiting use, activity, or movement by immobilizing or restraining animal by suspending from hindlimbs or tails. This immobilization is used to simulate some effects of reduced gravity and study weightlessness physiology.", "PM": "97", "HN": "97", "MR": "20180629", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019417"}, {"RECTYPE": "D", "MH": "Evolution, Chemical", "DE": "EVOLUTION CHEM", "PRINT ENTRY": "Chemical Evolution|T067|NON|EQV|NLM (1997)|960227|CHEM EVOLUTION|abcdefv", "ENTRY": "Evolutions, Chemical", "MN": "G02.225", "FX": "Organelle Biogenesis", "MH_TH": "NLM (1997)", "ST": "T067", "PI": "Biogenesis (1993-1996)", "MS": "Chemical and physical transformation of the biogenic elements from their nucleosynthesis in stars to their incorporation and subsequent modification in planetary bodies and terrestrial biochemistry. It includes the mechanism of incorporation of biogenic elements into complex molecules and molecular systems, leading up to the origin of life.", "PM": "97", "HN": "97", "MR": "20160617", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019418"}, {"RECTYPE": "D", "MH": "Evolution, Planetary", "PRINT ENTRY": "Planetary Evolution|T067|NON|EQV|NLM (1997)|960227|abcdef", "MN": "G01.311.290", "MH_TH": "NLM (1997)", "ST": "T067", "PI": "Planets (1993-1996)", "MS": "Creation and development of bodies within solar systems, includes study of early planetary geology.", "PM": "97", "HN": "97", "MR": "20160617", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019419"}, {"RECTYPE": "D", "MH": "Dietary Sucrose", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sucrose, Dietary|T109|T168|NON|EQV|NLM (1997)|960301|abbcdef", "ENTRY": "Table Sugars", "MN": "J02.500.514.500.400.700.750.250", "PA": "Sweetening Agents", "MH_TH": "NLM (1997)", "ST": "T168", "RN": "0", "AN": "/adv eff: coordinate with disease /etiol, not /chem ind; /ther use: coordinate with specific disease /diet ther", "PI": "Sucrose (1966-1996)", "MS": "Sucrose present in the diet. It is added to food and drinks as a sweetener.", "PM": "97", "HN": "97", "MR": "20170628", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019422"}, {"RECTYPE": "D", "MH": "Shamanism", "AQ": "HI", "MN": "I01.076.201.450.654.830", "FX": "Traditional Medicine Practitioners", "MH_TH": "NLM (1997)", "ST": "T078", "AN": "a form of traditional medicine; specify geog; not for African witch doctors: use instead MEDICINE, AFRICAN TRADITIONAL", "PI": "Medicine, Traditional (1970-1996)", "MS": "An intermediate stage between polytheism and monotheism, which assumes a \"Great Spirit\", with lesser deities subordinated. With the beginnings of shamanism there was the advent of the medicine man or witch doctor, who assumed a supervisory relation to disease and its cure. Formally, shamanism is a religion of Ural-Altaic peoples of Northern Asia and Europe, characterized by the belief that the unseen world of gods, demons, ancestral spirits is responsive only to shamans. The Indians of North and South America entertain religious practices similar to the Ural-Altaic shamanism. The word shaman comes from the Tungusic (Manchuria and Siberia) saman, meaning Buddhist monk. The SHAMAN handles disease almost entirely by psychotherapeutic means; he frightens away the demons of disease by assuming a terrifying mien. (From Garrison, An Introduction to the History of Medicine, 4th ed, p22; from Webster, 3d ed)", "PM": "97", "HN": "97", "MR": "20220712", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019423"}, {"RECTYPE": "D", "MH": "Dominica", "AQ": "EH EP", "MN": "Z01.639.880.262", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "an island in the West Indies; do not confuse with DOMINICAN REPUBLIC, also in the West Indies", "PI": "West Indies (1968-1996)", "MS": "An island republic of the West Indies. Its capital is Roseau. It was discovered in 1493 by Columbus and held at different times by the French and the British in the 18th century. A member of the West Indies Federation, it achieved internal self-government in 1967 but became independent in 1978. It was named by Columbus who discovered it on Sunday, Domingo in Spanish, from the Latin Dominica dies, the Lord's Day. (From Webster's New Geographical Dictionary, 1988, p338 & Room, Brewer's Dictionary of Names, 1992, p151)", "HN": "97", "MR": "20120703", "DA": "19960626", "DC": "4", "DX": "19970101", "UI": "D019424"}, {"RECTYPE": "D", "MH": "Grenada", "AQ": "EH EP", "MN": "Z01.639.880.362", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "an island in the West Indies; do not confuse with GRENADINES see SAINT VINCENT AND THE GRENADINES, also in the West Indies", "PI": "West Indies (1969-1996)", "MS": "An island of the West Indies. Its capital is St. George's. It was discovered in 1498 by Columbus who called it Concepcion. It was held at different times by the French and the British during the 18th century. The British suppressed a native uprising in 1795. It was an associate state of Great Britain 1967-74 but became an independent nation within the British Commonwealth in 1974. The original name referred to the Feast of the Immaculate Conception but it was later renamed for the Spanish kingdom of Granada. (From Webster's New Geographical Dictionary, 1988, p467 & Room, Brewer's Dictionary of Names, 1992, p219)", "HN": "97", "MR": "20120703", "DA": "19960626", "DC": "4", "DX": "19970101", "UI": "D019425"}, {"RECTYPE": "D", "MH": "Integrases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Integrase|T116|T126|NON|EQV|NLM (1997)|990101|abbcdef", "MN": "D08.811.739.500", "EC": "antagonists & inhibitors:Integrase Inhibitors", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.7.7.-", "RR": "52350-85-3 (CAS RN)", "AN": "HIV INTEGRASE is also available", "PI": "Viral Proteins (1980-1987)", "MS": "Recombinases that insert exogenous DNA into the host genome. Examples include proteins encoded by the POL GENE of RETROVIRIDAE and also by temperate BACTERIOPHAGES, the best known being BACTERIOPHAGE LAMBDA.", "PM": "2004; see INTEGRASE 1997-2003; INTEGRASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1974-96, DNA UNWINDING PROTEINS 1974-87, VIRAL PROTEINS 1980-87, & COLIPHAGES/enzymology 1974-80", "HN": "2004(1997); use INTEGRASE (NM) 1974-1996", "MR": "20030709", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019426"}, {"RECTYPE": "D", "MH": "HIV Integrase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Integration Protein, HIV", "MN": "D12.776.964.970.600.850.375.545.500", "EC": "antagonists & inhibitors:HIV Integrase Inhibitors", "MH_TH": "NLM (1997)", "ST": "T126", "RN": "EC 2.7.7.-", "PI": "DNA Nucleotidyltransferases (1993-1996)", "MS": "Enzyme of the HUMAN IMMUNODEFICIENCY VIRUS that is required to integrate viral DNA into cellular DNA in the nucleus of a host cell. HIV integrase is a DNA nucleotidyltransferase encoded by the pol gene.", "OL": "use INTEGRASE (NM) to search HIV INTEGRASE 1993-96", "PM": "97; HIV INTEGRASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1993-96", "HN": "97; HIV INTEGRASE was SY to INTEGRASE (NM) 1993-96", "MR": "20200622", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019427"}, {"RECTYPE": "D", "MH": "HIV Integrase Inhibitors", "DE": "HIV INTEGRASE INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Integrase Inhibitors, HIV|T121|EQV|NLM (1997)|960306|INTEGRASE INHIB HIV|abdefv", "ENTRY": "Inhibitors, HIV Integrase", "MN": "D27.505.954.122.388.077.088.314", "MH_TH": "NLM (1997)", "ST": "T121", "RN": "0", "PI": "DNA Nucleotidyltransferases/antagonists & inhibitors (1994-1996)", "MS": "Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA.", "PM": "97", "HN": "97", "MR": "20140625", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019428"}, {"RECTYPE": "D", "MH": "Integrase Inhibitors", "DE": "INTEGRASE INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Integrase Inhibitor|T121|T123|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Inhibitor, Integrase", "MN": "D27.505.519.389.375", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "PI": "DNA Nucleotidyltransferases/antagonists & inhibitors (1993-1996)", "MS": "Compounds which inhibit or antagonize biosynthesis or actions of integrase.", "PM": "97", "HN": "97", "MR": "20200527", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019429"}, {"RECTYPE": "D", "MH": "Guadeloupe", "AQ": "EH EP", "MN": "Z01.639.880.393", "MH_TH": "POPLINE (1978)", "ST": "T083", "AN": "two islands in the West Indies separated by a narrow channel", "PI": "West Indies (1966-1996)", "MS": "The name of two islands of the West Indies, separated by a narrow channel. Their capital is Basse-Terre. They were discovered by Columbus in 1493, occupied by the French in 1635, held by the British at various times between 1759 and 1813, transferred to Sweden in 1813, and restored to France in 1816. Its status was changed from colony to a French overseas department in 1946. Columbus named it in honor of the monastery of Santa Maria de Guadalupe in Spain. (From Webster's New Geographical Dictionary, 1988, p470 & Room, Brewer's Dictionary of Names, 1992, p221)", "HN": "97", "MR": "20120703", "DA": "19960626", "DC": "4", "DX": "19970101", "UI": "D019430"}, {"RECTYPE": "D", "MH": "Saint Lucia", "AQ": "EH EP", "ENTRY": "St. Lucia|T083|NAM|EQV|NLM (1997)|960305|ST LUCIA|abcdefv", "MN": "Z01.639.880.825", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "an island in the West Indies", "PI": "West Indies (1966-1996)", "MS": "An independent state in the West Indies. Its capital is Castries. It was probably discovered by Columbus in 1502 and first settled by the English in 1605. Contended for by the French and English in the 17th century, it was regarded as neutral in 1748 but changed hands many times in the wars of the 19th century. It became a self-governing state in association with Great Britain in 1967 and achieved independence in 1979. Columbus named it for the day on which he discovered it, the feast of St. Lucy, a Sicilian virgin martyr. (From Webster's New Geographical Dictionary, 1988, p1051 & Room, Brewer's Dictionary of Names, 1992, p477)", "HN": "97", "MR": "20120703", "DA": "19960610", "DC": "4", "DX": "19970101", "UI": "D019431"}, {"RECTYPE": "D", "MH": "Falkland Islands", "AQ": "EH EP", "PRINT ENTRY": "Malvinas|T083|NAM|EQV|NLM (1997)|960301|abcdef", "MN": "Z01.639.040.695", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "a Brit colony in the Atlantic Islands", "PI": "Atlantic Islands (1982-1996)", "MS": "A British colony in the Atlantic Islands, comprising two principal islands, East Falkland and West Falkland. Its capital is Stanley. Discovered in 1592, it was not occupied until the French settled there briefly in 1764. Later the English settled there but were expelled by the Spanish in 1770. The Falklands were claimed by Argentina but were occupied in 1833 by the British who, after an April 1982 invasion by Argentina, regained them in June. The islands were named by British Captain John Strong in 1690 for the fifth Viscount Falkland who financed Strong's expedition. The Spanish name for the islands, Malvinas, is from the French Malouins, inhabitants of St. Malo who attempted to colonize the islands in 1764. (From Webster's New Geographical Dictionary, 1988, p389 & Room, Brewer's Dictionary of Names, 1992, p182)", "HN": "97", "MR": "20120703", "DA": "19960626", "DC": "4", "DX": "19970101", "UI": "D019432"}, {"RECTYPE": "D", "MH": "Chickenpox Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Varicella Vaccine|T121|T129|NON|EQV|NLM (1997)|960301|abbcdef", "ENTRY": "Varicella Vaccine, Oka", "MN": "D20.215.894.899.290.130", "MH_TH": "NLM (1997)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1970-1996)", "MS": "A live, attenuated varicella virus vaccine used for immunization against chickenpox. It is recommended for children between the ages of 12 months and 13 years.", "OL": "use CHICKENPOX VACCINE (NM) to search VARICELLA VACCINE 1985-96", "PM": "97; VARICELLA VACCINE was indexed under VIRAL VACCINES 1985-96", "HN": "97; was VARICELLA VACCINE (NM) 1985-96", "MR": "20050630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019433"}, {"RECTYPE": "D", "MH": "Guernsey", "AQ": "EH EP", "ENTRY": "Guernsey Island|T083|NAM|EQV|NLM (1997)|960304|abcdef", "MN": "Z01.542.363.161.500", "MH_TH": "NLM (1997)", "ST": "T083", "AN": "one of the Channel Islands", "PI": "Channel Islands (1967-1996)", "MS": "The second largest of the Channel Islands in the English Channel. It covers about 30 square miles and is where the Guernsey breed of cattle originated. The name is Scandinavian, Grani's island (ey means island). (From Webster's New Geographical Dictionary, 1988, p474 & Room, Brewer's Dictionary of Names, 1992, p222)", "OL": "use CHANNEL ISLANDS to search GUERNSEY ISLAND 1975-96", "HN": "97; GUERNSEY ISLAND was see CHANNEL ISLANDS 1975-96", "MR": "20160711", "DA": "19960626", "DC": "4", "DX": "19970101", "UI": "D019435"}, {"RECTYPE": "D", "MH": "Saint Vincent and the Grenadines", "DE": "ST VINCENT", "AQ": "EH EP", "PRINT ENTRY": "Grenadines|T083|NAM|NRW|NLM (1997)|960313|abcdef", "ENTRY": "St. Vincent and the Grenadines|T083|NAM|EQV|NLM (1997)|960305|abcdef", "MN": "Z01.639.880.862", "MH_TH": "POPLINE (1983)", "ST": "T083", "AN": "self-governing islands in the West Indies; do not confuse entry term GRENADINES with GRENADA, also in the West Indies", "PI": "West Indies (1969-1996)", "MS": "A self-governing state of the Windward Islands in the West Indies, comprising Saint Vincent and the northern islets of the Grenadines. Its capital is Kingstown. It is one of the original homes of the Carib Indians supposed to have been sighted by Columbus in 1498. It was in English hands from 1627 till held by the French 1779-83. Saint Vincent subsequently became a British possession and, with other nearby British territories, was administered by the Governor of the Windward Islands till 1959. It attained a measure of independence in 1969 but achieved full independence as Saint Vincent and the Grenadines in 1979. Saint Vincent was the 4th century Spanish martyr on whose feast day Columbus discovered the island. Grenadines is derived from the Spanish kingdom of Granada. (From Webster's New Geographical Dictionary, 1988, p1054 & The Europa World Year Book 1993, p2441)", "HN": "97", "MR": "20190524", "DA": "19960610", "DC": "4", "DX": "19970101", "UI": "D019436"}, {"RECTYPE": "D", "MH": "Saint Kitts and Nevis", "DE": "SAINT KITTS", "AQ": "EH EP", "PRINT ENTRY": "Nevis|T083|NAM|NRW|NLM (1997)|960304|abcdef", "ENTRY": "St. Kitts and Nevis|T083|NAM|EQV|NLM (1997)|960305|ST KITTS|abcdefv", "MN": "Z01.639.880.787", "MH_TH": "POPLINE (1993)", "ST": "T083", "AN": "an independent federation in the West Indies", "PI": "West Indies (1966-1996)", "MS": "An independent federation of the Leeward Islands in the West Indies, consisting of Saint Christopher, Nevis, and Sombrero. Its capital is Basseterre. It was discovered by Columbus in 1493, settled by the British in 1625, the first of the Leeward Islands to be colonized by them. It was held jointly by the French and English 1628-1713, but returned to Great Britain by the Treaty of Utrecht in 1713. It was held by the French 1782-83. Under the British for the next 200 years, it gained its independence in 1983. (From Webster's New Geographical Dictionary, 1988, p1045; Embassy, telephone 202-686-2636)", "HN": "97", "MR": "20120703", "DA": "19960626", "DC": "4", "DX": "19970101", "UI": "D019437"}, {"RECTYPE": "D", "MH": "Ritonavir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ABT538", "MN": "D03.383.129.708.653", "PA": "HIV Protease Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "O3J8G9O825", "PI": "Valine/analogs & derivatives (1996)", "MS": "An HIV protease inhibitor that works by interfering with the reproductive cycle of HIV. It also inhibits CYTOCHROME P-450 CYP3A.", "OL": "use RITONAVIR (NM) to search ABT 538 1995-96", "PM": "97; ABT 538 was indexed under THIAZOLES & VALINE/analogs & derivatives 1996 & HIV PROTEASE INHIBITORS 1995", "HN": "97; was ABT 538 (NM) 1995-96", "MR": "20160701", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019438"}, {"RECTYPE": "D", "MH": "Chromaffin Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Chromaffin Cell", "MN": "A11.299", "MH_TH": "NLM (1997)", "ST": "T025", "AN": "located in adrenal medulla & sympath paraganglia; store epinephrine", "PI": "Enterochromaffin Cells (1977-1995)", "MS": "Cells that store epinephrine secretory vesicles. During times of stress, the nervous system signals the vesicles to secrete their hormonal content. Their name derives from their ability to stain a brownish color with chromic salts. Characteristically, they are located in the adrenal medulla and paraganglia (PARAGANGLIA, CHROMAFFIN) of the sympathetic nervous system.", "PM": "97", "HN": "97", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019439"}, {"RECTYPE": "D", "MH": "Anti-Obesity Agents", "DS": "ANTIOBESITY AGENTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Weight-Loss Drug|T121|NON|REL|NLM (2022)|200727|abcdef", "ENTRY": "Weight Loss Drugs", "MN": "D27.505.954.203", "MH_TH": "NLM (1997)", "ST": "T121", "RN": "0", "PI": "Obesity/drug therapy (1992-1996)", "MS": "Agents that increase energy expenditure and weight loss by neural and metabolic regulation.", "PM": "97", "HN": "97", "MR": "20210630", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019440"}, {"RECTYPE": "D", "MH": "Plant Epidermis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Epidermis, Plant|T002|NON|EQV|NLM (1997)|960305|abcdef", "ENTRY": "Plant Epidermi", "MN": "A18.024.750", "MH_TH": "NLM (1997)", "ST": "T002", "AN": "outer integument of plants; IM; coord with specific plant if pertinent (IM)", "PI": "Plants (1966-1996)", "MS": "A thin layer of cells forming the outer integument of seed plants and ferns. (Random House Unabridged Dictionary, 2d ed)", "PM": "97", "HN": "97", "MR": "20090706", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019441"}, {"RECTYPE": "D", "MH": "Space Suits", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Flight Suits|T073|NON|REL|NLM (1997)|960305|abcdef", "ENTRY": "Suits, Space", "MN": "J01.637.708.560.875.700", "MH_TH": "NLM (1997)", "ST": "T073", "AN": "GRAVITY SUITS is also available", "PI": "G Suits (1975-1996)", "MS": "Pressure suits for wear in space or at very low ambient pressures within the atmosphere, designed to permit the wearer to leave the protection of a pressurized cabin. (NASA Thesaurus, 1994)", "PM": "97", "HN": "97", "MR": "20220714", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019442"}, {"RECTYPE": "D", "MH": "Cosmic Dust", "AQ": "AE AN", "PRINT ENTRY": "Interstellar Dust|T167|NON|EQV|NLM (1997)|960305|abcdef", "ENTRY": "Interstellar Dusts", "MN": "G16.500.275.240.200", "MH_TH": "NLM (1997)", "ST": "T167", "RN": "0", "MS": "Finely divided solid matter with particle sizes smaller than a micrometeorite, thus with diameters much smaller than a millimeter, moving in interplanetary space. (NASA Thesaurus, 1994)", "PM": "97", "HN": "97", "MR": "20160617", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019443"}, {"RECTYPE": "D", "MH": "Vaccines, DNA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaccines, Recombinant DNA|T114|T121|T129|EQV|NLM (1997)|960307|abbbdef", "ENTRY": "Vaccines, Naked DNA", "MN": "D23.050.865.450.250", "MH_TH": "NLM (1997)", "ST": "T129", "RN": "0", "PI": "Vaccines, Synthetic (1986-1996)", "MS": "Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers.", "PM": "97", "HN": "97", "MR": "20210630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019444"}, {"RECTYPE": "D", "MH": "Solar Activity", "PRINT ENTRY": "Sunspots|T070|NON|NRW|NLM (1997)|960306|abcdef", "ENTRY": "Sunspot", "MN": "G01.060.800", "FX": "Solar Energy", "MH_TH": "NLM (1997)", "ST": "T070", "PI": "Solar Energy (1990-1996)", "MS": "Any type of variation in the appearance of energy output of the sun. (NASA Thesaurus, 1994)", "PM": "97", "HN": "97", "MR": "20160617", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019445"}, {"RECTYPE": "D", "MH": "Endotoxemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Endotoxemias", "MN": "C23.550.470.790.500.100.275", "FX": "Shock, Septic", "MH_TH": "NLM (1997)", "ST": "T033", "AN": "coordinate with specific bacterial infection heading or specific bacterium if precoordinated bacterial infection heading is not in MeSH; do not use /blood to cover -emia ", "PI": "Toxemia (1966-1996)", "MS": "A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.", "PM": "97", "HN": "97", "MR": "20190617", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019446"}, {"RECTYPE": "D", "MH": "Ethnobotany", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.158.273.118.299", "FX": "Phytotherapy", "MH_TH": "NLM (1997)", "ST": "T090", "AN": "specialty; coordinate with geographic term or ethnic group if pertinent; coordinate NIM with specific drug or plant (IM) for ethnobotany aspects of the plant", "PI": "Plants, Medicinal (1970-1996)", "MS": "The study of plant lore and agricultural customs of a people. In the fields of ETHNOMEDICINE and ETHNOPHARMACOLOGY, the emphasis is on traditional medicine and the existence and medicinal uses of PLANTS and PLANT EXTRACTS and their constituents, both historically and in modern times.", "PM": "97", "HN": "97", "MR": "20080708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019448"}, {"RECTYPE": "D", "MH": "Pouchitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ileitis, Pouch", "MN": "C06.405.469.420.520.500", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "do not index under PROCTOCOLECTOMY, RESTORATIVE unless particularly discussed", "PI": "Proctocolectomy, Restorative (1992-1996)", "MS": "Acute INFLAMMATION in the INTESTINAL MUCOSA of the continent ileal reservoir (or pouch) in patients who have undergone ILEOSTOMY and restorative proctocolectomy (PROCTOCOLECTOMY, RESTORATIVE).", "PM": "97", "HN": "97", "MR": "20030709", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019449"}, {"RECTYPE": "D", "MH": "Genes, MDR", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Multidrug Resistance Gene|T028|NON|EQV|NLM (1997)|960307|abcdef", "ENTRY": "Resistance Genes, Multidrug", "MN": "G05.360.340.024.340.645.500", "FX": "Drug Resistance, Multiple", "MH_TH": "NLM (1997)", "ST": "T028", "PI": "Multigene Family (1989-1996)", "MS": "Genes for MEMBRANE TRANSPORT PROTEINS that confer resistance to toxic compounds. Several superfamilies of these multidrug export proteins are known and found in both prokaryotes and eukaryotes.", "PM": "97", "HN": "97", "MR": "20180716", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019450"}, {"RECTYPE": "D", "MH": "Information Management", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Management, Information", "MN": "L01.399", "MH_TH": "NLM (1997)", "ST": "T057", "MS": "Management of the acquisition, organization, storage, retrieval, and dissemination of information. (From Thesaurus of ERIC Descriptors, 1994)", "PM": "97", "HN": "97", "MR": "19970620", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019451"}, {"RECTYPE": "D", "MH": "Terminally Ill", "AQ": "CL HI LJ PX SN", "ENTRY": "Ill, Terminally", "MN": "M01.873", "MH_TH": "NLM (1997)", "ST": "T101", "PI": "Terminal Care (1966-1996)", "MS": "Persons with an incurable or irreversible illness at the end stage that will result in death within a short time. (From O'Leary et al., Lexikon: Dictionary of Health Care Terms, Organizations, and Acronyms for the Era of Reform, 1994, p780)", "PM": "97", "HN": "97", "MR": "19980611", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019452"}, {"RECTYPE": "D", "MH": "Escherichia coli O157", "DS": "ESCHERICHIA COLI O 157", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Escherichia coli O157-H7|T007|NRW|NLM (1997)|960307|ESCHERICHIA COLI O 157 H 007|abdefs", "MN": "B03.660.250.150.180.100.800.250.500", "MH_TH": "NLM (1997)", "ST": "T007", "RN": "txid1045010", "RR": "txid83334", "AN": "infection: coordinate IM with ESCHERICHIA COLI INFECTIONS (IM); consider also HEMOLYTIC-UREMIC SYNDROME; in titles & translations use O157 (the letter O), not 0157 (the number zero)", "PI": "Escherichia coli (1977-1996)", "MS": "A verocytotoxin-producing serogroup belonging to the O subfamily of Escherichia coli which has been shown to cause severe food-borne disease. A strain from this serogroup, serotype H7, which produces SHIGA TOXINS, has been linked to human disease outbreaks resulting from contamination of foods by E. coli O157 from bovine origin.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960614", "DC": "1", "DX": "19970101", "UI": "D019453"}, {"RECTYPE": "D", "MH": "Chronotherapy", "DE": "CHRONOTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Chronotherapies", "MN": "E02.168", "FX": "Circadian Rhythm", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "coordinate with type of therapy but do not coordinate with CIRCADIAN RHYTHM; SLEEP PHASE CHRONOTHERAPY and DRUG CHRONOTHERAPY are also available", "PI": "Circadian Rhythm (1972-1996)", "MS": "The adaptation of therapeutic approaches such as pharmacological (DRUG CHRONOTHERAPY), surgical, radiological, or physical to the known variations in biological RHYTHMICITY, such as CIRCADIAN RHYTHMS. The treatment is aimed at supporting normal rhythms, or modifying the timing of therapy to achieve maximal efficacy and minimal adverse effect.", "PM": "97", "HN": "97", "MR": "20100625", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019454"}, {"RECTYPE": "D", "MH": "Self Psychology", "DE": "SELF PSYCHOL", "PRINT ENTRY": "Psychology, Self|T078|NON|EQV|NLM (1997)|960308|PSYCHOL SELF|abcdefv", "MN": "F02.739.794.837", "FX": "Narcissism", "MH_TH": "NLM (1997)", "ST": "T078", "AN": "do not confuse with SELF CONCEPT", "PI": "Psychoanalytic Theory (1966-1996)", "MS": "Psychoanalytic theory focusing on interpretation of behavior in reference to self. (From APA, Thesaurus of Psychological Terms, 1994) This elaboration of the psychoanalytic concepts of narcissism and the self, was developed by Heinz Kohut, and stresses the importance of the self-awareness of excessive needs for approval and self-gratification.", "PM": "97", "HN": "97", "MR": "19970620", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019455"}, {"RECTYPE": "D", "MH": "Health Transition", "ENTRY": "Transitions, Health", "MN": "N06.850.650", "MH_TH": "NLM (1997)", "ST": "T068", "AN": "demogr & epidemiol changes in health picture in a population", "MS": "Demographic and epidemiologic changes that have occurred in the last five decades in many developing countries and that are characterized by major growth in the number and proportion of middle-aged and elderly persons and in the frequency of the diseases that occur in these age groups. The health transition is the result of efforts to improve maternal and child health via primary care and outreach services and such efforts have been responsible for a decrease in the birth rate; reduced maternal mortality; improved preventive services; reduced infant mortality, and the increased life expectancy that defines the transition. (From Ann Intern Med 1992 Mar 15;116(6):499-504)", "PM": "97", "HN": "97", "MR": "20080708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019456"}, {"RECTYPE": "D", "MH": "Chromosome Breakage", "AQ": "DE RE", "ENTRY": "Chromosome Breakages", "MN": "G05.365.590.175.175", "FX": "Chromosome Breakpoints", "MH_TH": "NLM (1997)", "ST": "T049", "PI": "Chromosome Abnormalities (1966-1996)", "MS": "A type of chromosomal aberration involving DNA BREAKS. Chromosome breakage can result in CHROMOSOMAL TRANSLOCATION; CHROMOSOME INVERSION; or SEQUENCE DELETION.", "PM": "97", "HN": "97", "MR": "20230526", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019457"}, {"RECTYPE": "D", "MH": "Insurance Coverage", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Insurance Status|T078|NON|EQV|NLM (1997)|960311|abcdef", "ENTRY": "Status, Insurance", "MN": "N03.219.521.576.265", "MH_TH": "NLM (1997)", "ST": "T078", "AN": "coord IM with specific type of insurance (IM); not restricted to health insurance; specify geog if pertinent; UNIVERSAL HEALTH INSURANCE (restricted to health insurance) is also available", "PI": "Insurance, Health (1966-1996)", "MS": "Generally refers to the amount of protection available and the kind of loss which would be paid for under an insurance contract with an insurer. (Slee & Slee, Health Care Terms, 2d ed)", "PM": "97", "HN": "97", "MR": "20180713", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019458"}, {"RECTYPE": "D", "MH": "Urothelium", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Epithelium, Urinary Tract", "MN": "A10.272.850", "MH_TH": "NLM (1997)", "ST": "T024", "AN": "coordinate with specific urinary tract organ but not with URINARY TRACT", "PI": "Epithelium (1967-1996)", "MS": "The epithelial lining of the URINARY TRACT.", "PM": "97", "HN": "97", "MR": "20100625", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019459"}, {"RECTYPE": "D", "MH": "Tobacco Industry", "DE": "TOBACCO INDUST", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Tobacco Industries", "MN": "J01.576.655.968", "MH_TH": "NLM (1997)", "ST": "T092", "PI": "Tobacco (1966-1996)", "MS": "The aggregate business enterprise of agriculture, manufacture, and distribution related to tobacco and tobacco-derived products.", "PM": "97", "HN": "97", "MR": "20140612", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019460"}, {"RECTYPE": "D", "MH": "Employee Retirement Income Security Act", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "United States Employee Retirement Income Security Act|T089|NON|EQV|NLM (2002)|001204|abcdef", "ENTRY": "Public Law 93 406", "MN": "N04.452.677.800.325.300", "MH_TH": "NLM (1997)", "ST": "T089", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "PI": "Insurance, Health (1975-1990)", "MS": "A 1974 Federal act which preempts states' rights with regard to workers' pension benefits and employee benefits. It does not affect the benefits and rights of employees whose employer is self-insured. (From Slee & Slee, Health Care Reform Terms, 1993)", "PM": "97", "HN": "97", "MR": "20150605", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019461"}, {"RECTYPE": "D", "MH": "Syncope, Vasovagal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Syncope, Vasodepressor|T047|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Vasovagal Syncopes", "MN": "C23.888.592.604.359.800.600.500", "MH_TH": "NLM (1997)", "ST": "T047", "PI": "Syncope (1968-1996)", "MS": "Loss of consciousness due to a reduction in blood pressure that is associated with an increase in vagal tone and peripheral vasodilation.", "PM": "1997", "HN": "1997", "MR": "20080708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019462"}, {"RECTYPE": "D", "MH": "Mice, Inbred MRL lpr", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "MRL lpr Mouse", "MN": "B01.050.150.900.649.313.992.635.505.500.400.555", "MH_TH": "NLM (1997)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal ", "PI": "Mice (1981-1996)", "MS": "A mouse substrain that is genetically predisposed to the development of systemic lupus erythematosus-like syndrome, which has been found to be clinically similar to the human disease. It has been determined that this mouse strain carries a mutation in the fas gene. Also, the MRL/lpr is a useful model to study behavioral and cognitive deficits found in autoimmune diseases and the efficacy of immunosuppressive agents.", "PM": "97", "HN": "97", "MR": "20200902", "DA": "19960619", "DC": "1", "DX": "19970101", "UI": "D019463"}, {"RECTYPE": "D", "MH": "Tax Exemption", "AQ": "CL EC HI LJ ST TD", "ENTRY": "Tax Exemptions", "MN": "N03.219.900.940", "MH_TH": "NLM (1997)", "ST": "T089", "AN": "coord IM with subject of tax (IM); specify geog", "PI": "Taxes (1986-1996)", "MS": "Status not subject to taxation; as the income of a philanthropic organization. Tax-exempt organizations may also qualify to receive tax-deductible donations if they are considered to be nonprofit corporations under Section 501(c)3 of the United States Internal Revenue Code.", "PM": "97", "HN": "97", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019464"}, {"RECTYPE": "D", "MH": "Craniofacial Abnormalities", "DE": "CRANIOFACIAL ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Craniofacial Abnormality", "MN": "C16.131.621.207", "MH_TH": "NLM (1997)", "ST": "T019", "AN": "general or unspecified; prefer specifics", "PI": "Skull/abnormalities (1966-1996)", "MS": "Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones.", "PM": "97", "HN": "97", "MR": "19991103", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019465"}, {"RECTYPE": "D", "MH": "Glare", "AQ": "AE", "MN": "G14.400", "MH_TH": "NLM (1997)", "ST": "T070", "PI": "Light (1966-1996)", "MS": "Relatively bright light, or the dazzling sensation of relatively bright light, which produces unpleasantness or discomfort, or which interferes with optimal VISION, OCULAR. (Cline et al., Dictionary of Visual Science, 4th ed)", "PM": "97", "HN": "97", "MR": "20150331", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019466"}, {"RECTYPE": "D", "MH": "Subacute Care", "AQ": "CL EC ES HI LJ MT OG PX SN ST TD", "ENTRY": "Sub Acute Care", "MN": "N02.421.585.850", "MH_TH": "NLM (1997)", "ST": "T058", "PI": "Progressive Patient Care (1993-1996)", "MS": "Medical and skilled nursing services provided to patients who are not in an acute phase of an illness but who require a level of care higher than that provided in a long-term care setting. (JCAHO, Lexikon, 1994)", "PM": "97", "HN": "97", "MR": "20160309", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019467"}, {"RECTYPE": "D", "MH": "Disease Management", "DE": "DIS MANAGEMENT", "ENTRY": "Managements, Disease", "MN": "N04.590.607", "MH_TH": "NLM (1997)", "ST": "T058", "AN": "selection of appropriate dis ther processes in relation to cost and clin outcome", "PI": "Patient Care Planning (1992-1996)", "MS": "A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596)", "PM": "97", "HN": "97", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019468"}, {"RECTYPE": "D", "MH": "Indinavir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfate, Indinavir", "MN": "D03.383.725.385", "PA": "HIV Protease Inhibitors", "MH_TH": "USAN (1997)", "ST": "T121", "RN": "5W6YA9PKKH", "RR": "771H53976Q", "PI": "Pyridines (1994-1996)", "MS": "A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.", "OL": "use INDINAVIR (NM) to search INDINAVIR 1994-96", "PM": "97; INDINAVIR was indexed under PYRIDINES 1994-96", "HN": "97; was INDINAVIR (NM) 1994-96", "MR": "20160531", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019469"}, {"RECTYPE": "D", "MH": "Biolistics", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Particle-Mediated Epidermal Delivery of DNA|T061|NON|NRW|NLM (2008)|061109|abcdef", "ENTRY": "Gene-Gun Techniques", "MN": "E05.393.350.100", "MH_TH": "NLM (1997)", "ST": "T063", "PI": "Genetic Techniques (1990-1995)", "MS": "Techniques where DNA is delivered directly into organelles at high speed using projectiles coated with nucleic acid, shot from a helium-powered gun (gene gun). One of these techniques involves immunization by DNA VACCINES, which delivers DNA-coated gold beads to the epidermis.", "PM": "97", "HN": "97", "MR": "20080708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019470"}, {"RECTYPE": "D", "MH": "Elementary Particle Interactions", "PRINT ENTRY": "Particle Interactions, Elementary|T070|NON|EQV|NLM (1997)|960312|abcdef", "ENTRY": "Particle Interaction, Elementary", "MN": "G01.238", "MH_TH": "NLM (1997)", "ST": "T070", "AN": "a concept in nuclear physics; sub-atomic particles only", "MS": "The interactions of particles responsible for their scattering and transformations (decays and reactions). Because of interactions, an isolated particle may decay into other particles. Two particles passing near each other may transform, perhaps into the same particles but with changed momenta (elastic scattering) or into other particles (inelastic scattering). Interactions fall into three groups: strong, electromagnetic, and weak. (From McGraw-Hill Encyclopedia of Science & Technology, 7th ed)", "PM": "97", "HN": "97", "MR": "20160617", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019471"}, {"RECTYPE": "D", "MH": "Universal Health Insurance", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Universal Coverage|T078|NON|EQV|NLM (1997)|990101|abcdef", "ENTRY": "Insurance, Universal Health", "MN": "N03.219.521.576.265.500", "MH_TH": "NLM (2019)", "ST": "T078", "MS": "Health insurance coverage for all persons in a state or country, rather than for some subset of the population. It may extend to the unemployed as well as to the employed; to aliens as well as to citizens; for pre-existing conditions as well as for current illnesses; for mental as well as for physical conditions.", "PM": "2019; see Universal Coverage 1997-2018", "HN": "2019(1997)", "MR": "20190705", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019472"}, {"RECTYPE": "D", "MH": "Transcription Factors, TFII", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TFII Transcription Factors|T116|T123|EQV|NLM (1997)|960313|abbdef", "MN": "D12.776.930.930.875", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1979-1996)", "MS": "The so-called general transcription factors that bind to RNA POLYMERASE II and that are required to initiate transcription. They include TFIIA; TFIIB; TFIID; TFIIE; TFIIF; TFIIH; TFII-I; and TFIIJ. In vivo they apparently bind in an ordered multi-step process and/or may form a large preinitiation complex called RNA polymerase II holoenzyme.", "PM": "97", "HN": "97", "MR": "20050630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019473"}, {"RECTYPE": "D", "MH": "Transcription Factors, TFIII", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TFIII Transcription Factors|T116|T123|NON|EQV|NLM (1997)|960313|abbcdef", "ENTRY": "Factors, TFIII Transcription", "MN": "D12.776.930.930.937", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1983-1996)", "MS": "Factors that bind to RNA POLYMERASE III and aid in transcription. They include the assembly factors TFIIIA and TFIIIC and the initiation factor TFIIIB. All combine to form a preinitiation complex at the promotor that directs the binding of RNA POLYMERASE III.", "PM": "97", "HN": "97", "MR": "20050630", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019474"}, {"RECTYPE": "D", "MH": "Camphor 5-Monooxygenase", "DS": "CAMPHOR MONOOXYGENASE 005", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochrome P-450(cam)|T116|T126|EQV|NLM (1997)|960314|CYTOCHROME P 450 CAM|abbdefs", "ENTRY": "Cytochrome P 450 cam", "MN": "D12.776.422.220.453.012", "MH_TH": "NLM (1997)", "ST": "T126", "RN": "EC 1.14.15.1", "RR": "9030-82-4 (CAS RN)", "PI": "Hydroxylases (1973-1996)", "MS": "A soluble cytochrome P-450 enzyme that catalyzes camphor monooxygenation in the presence of putidaredoxin, putidaredoxin reductase, and molecular oxygen. This enzyme, encoded by the CAMC gene also known as CYP101, has been crystallized from bacteria and the structure is well defined. Under anaerobic conditions, this enzyme reduces the polyhalogenated compounds bound at the camphor-binding site.", "OL": "use CAMPHOR 5-MONOOXYGENASE (NM) to search CAMPHOR-5-MONOOXYGENASE 1980-96", "PM": "97; CAMPHOR-5-MONOOXYGENASE was indexed under CYTOCHROME P-450 & HYDROXYLASES 1973-96, & CAMPHOR 1973-82", "HN": "97; was CAMPHOR-5-MONOOXYGENASE (NM) 1973-96", "MR": "20160527", "DA": "19960624", "DC": "1", "DX": "19970101", "UI": "D019475"}, {"RECTYPE": "D", "MH": "Insect Proteins", "AQ": "AD AE AG AI AN BI BL CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Insect Protein|T116|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Proteins, Insect", "MN": "D12.776.093.500", "MH_TH": "NLM (1997)", "ST": "T116", "RN": "0", "AN": "/drug eff /ultrastruct permitted; /physiol permitted for function within the insect; coord IM with specific protein (IM) + specific insect (IM)", "PI": "specific insect (1966-1996)", "MS": "Proteins found in any species of insect.", "PM": "97", "HN": "97", "MR": "20200527", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019476"}, {"RECTYPE": "D", "MH": "Portrait", "PRINT ENTRY": "Portraits|T170|NON|EQV|NLM (2008)|070626|abcdef", "MN": "V02.700.600", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "this heading is used as a Publication Type; used for individual or group portraits in an article; portraits as a subject are indexed under the main heading PORTRAITS AS TOPIC", "MS": "Work consisting of graphic representations, especially of the face, of real persons, usually posed, living or dead. They are pictures whose purpose is the portrayal of an individual or group of individuals, not pictures which merely include people as part of an event or scene. (From Thesaurus for Graphic Materials II, p540, 1995)", "HN": "2008(1997)", "MR": "20180702", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019477"}, {"RECTYPE": "D", "MH": "Academic Dissertation", "PRINT ENTRY": "Theses|T073|T170|NON|BRD|NLM (2008)|070621|abbcdef", "MN": "V02.050", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Academic dissertations as a subject are indexed under the main heading ACADEMIC DISSERTATIONS AS TOPIC. INDEXER: Do not use; CATALOGER: Use only for dissertations in clinical medical research.", "MS": "Work consisting of formal presentations made usually to fulfill requirements for an academic degree.", "HN": "2008(1997)", "MR": "20180701", "DA": "19960620", "DC": "2", "DX": "19970101", "UI": "D019478"}, {"RECTYPE": "D", "MH": "Account Book", "PRINT ENTRY": "Account Books|T170|NON|EQV|NLM (1997)|960502|abcdef", "MN": "V02.060", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Account books as a subject are indexed under the main heading ACCOUNTING. INDEXER: Do not use", "MS": "Book in which personal or commercial accounts of financial transactions are recorded. (From Random House Unabridged Dictionary, 2d ed)", "HN": "2008(1997)", "MR": "20180701", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019479"}, {"RECTYPE": "D", "MH": "Advertisement", "PRINT ENTRY": "Advertisements|T170|NON|EQV|NLM (2008)|070621|abcdef", "MN": "V02.355.249", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Publication Types BROADSIDE & POSTER & PROSPECTUSES are also available. Advertisements as a subject are indexed under the main heading ADVERTISING. INDEXER: Do not use", "MS": "Work consisting of publicly distributed notices, usually as paid announcements in mass media such as newspapers, magazines, or on billboards. They include those in motion picture, television advertising, radio, or electronic media.", "HN": "2008(1997)", "MR": "20190710", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019480"}, {"RECTYPE": "D", "MH": "Almanac", "PRINT ENTRY": "Almanacs|T170|NON|EQV|NLM (2008)|070621|abcdef", "MN": "V02.110", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Almanacs as a subject are indexed under the main heading ALMANACS AS TOPIC. INDEXER: Do not use", "MS": "Work consisting of a calendar of days, weeks, and months, together with information such as astronomical data, various statistics, etc. (From Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed)", "HN": "2008(1997)", "MR": "20180701", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019482"}, {"RECTYPE": "D", "MH": "Disintegrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Disintegrin|T116|T123|NON|EQV|NLM (2021)|200506|abbcdef", "MN": "D12.644.138", "PA": "Platelet Aggregation Inhibitors", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "AN": "polypeptides from snake venom; platelet aggregation inhib", "PI": "Venoms (1992-1994)", "MS": "A family of polypeptides purified from snake venoms, which contain the arginine-glycine-aspartic acid (RGD) sequence. The RGD tripeptide binds to integrin receptors and thus competitively inhibits normal integrin-ligand interactions. Disintegrins thus block adhesive functions and act as platelet aggregation inhibitors.", "OL": "use DISINTEGRINS (NM) to search DISINTEGRINS 1992-96", "PM": "97; DISINTEGRINS was indexed under PEPTIDES 1992-96 & VENOMS 1992-94", "HN": "97; was DISINTEGRINS (NM) 1992-96", "MR": "20200527", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019483"}, {"RECTYPE": "D", "MH": "Address", "PRINT ENTRY": "Addresses|T170|NON|EQV|NLM (1997)|960502|abcdef", "MN": "V02.070", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "this heading is used as a Publication Type; do not confuse with Publication Type LECTURE which is usually for classroom instruction.", "MS": "Work consisting of speeches, orations, or written statements, usually formal, directed to a particular group of persons. These are different from a LECTURE that is usually delivered to classes for instructional purposes.", "HN": "2019(1997); was ADDRESSES 1966-2019", "MR": "20190705", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019484"}, {"RECTYPE": "D", "MH": "Bone Morphogenetic Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Morphogenetic Proteins, Bone", "MN": "D23.529.942.200", "MH_TH": "NLM (1997)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "PI": "Proteins (1981-1996)", "MS": "Bone-growth regulatory factors that are members of the transforming growth factor-beta superfamily of proteins. They are synthesized as large precursor molecules which are cleaved by proteolytic enzymes. The active form can consist of a dimer of two identical proteins or a heterodimer of two related bone morphogenetic proteins.", "OL": "use BONE MORPHOGENETIC PROTEINS (NM) to search BONE MORPHOGENETIC PROTEIN 1981-96", "PM": "97; BONE MORPHOGENETIC PROTEIN was indexed under PROTEINS 1981-96", "HN": "97; was BONE MORPHOGENETIC PROTEIN (NM) 1981-96", "MR": "20080708", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019485"}, {"RECTYPE": "D", "MH": "Animation", "MN": "V02.120", "MH_TH": "NLM (1997)", "ST": "T170", "AN": "This heading is used as a Publication Type. Animation as a subject is indexed under the main heading MOTION PICTURES. INDEXER: Do not use ", "MS": "A film or video wholly or partially created by photographing drawings, sculptures, or other inanimate things in sequence to create the illusion of motion. Animations are also generated by computers. (From Moving Image Materials: Genre Terms, 1988)", "HN": "2008(1997)", "MR": "20150605", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019486"}, {"RECTYPE": "D", "MH": "Annual Report", "MN": "V02.130", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Annual reports as a subject are indexed under the main heading ANNUAL REPORTS AS TOPIC. INDEXER: Do not use; CATALOGER: Use for serial publications only ", "MS": "Annual statements concerning the administrative and operational functions of an institution or organization.", "HN": "2008(1997)", "MR": "20190705", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019487"}, {"RECTYPE": "D", "MH": "Architectural Drawing", "PRINT ENTRY": "Architectural Drawings|T170|NON|EQV|NLM (1997)|960502|abcdef", "MN": "V02.140", "FX": "Drawing", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Architectural drawings as a subject are indexed under the main heading ARCHITECTURE. INDEXER: Do not use", "MS": "Work consisting of drawings of architecture and architectural projects, whether the project was executed or not. (Art & Architecture Thesaurus, 1990, v.2)", "HN": "2008(1997)", "MR": "20180702", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019488"}, {"RECTYPE": "D", "MH": "Book Illustrations", "MN": "V01.185", "FX": "Pictorial Work", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. Book illustrations as a subject are indexed under the main heading BOOKS, ILLUSTRATED. INDEXER: Do not use. CATALOGER: Use only for images originally published in a book.  ", "MS": "Works consisting of photographs, prints, drawings, portraits, plates, diagrams, facsimiles, maps, tables, or other representations or systematic arrangements of data designed to elucidate or decorate the contents of a publication. (From The ALA Glossary of Library and Information Science, 1983, p114)", "HN": "2008(1997)", "MR": "20180716", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019489"}, {"RECTYPE": "D", "MH": "Broadside", "PRINT ENTRY": "Broadsides|T170|NON|EQV|NLM (2008)|070622|abcdef", "MN": "V02.200", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. Broadsides as a subject are indexed under the main heading BROADSIDES AS TOPIC. Publication Types ADVERTISEMENT & POSTER are also available. INDEXER: Do not use", "MS": "Work consisting of published pieces of paper or other material, usually printed on one side and intended to be read unfolded and usually intended to be posted, publicly distributed, or sold, e.g., proclamations, handbills, newssheets, etc. (From Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed)", "HN": "2008(1997)", "MR": "20180713", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019490"}, {"RECTYPE": "D", "MH": "Bookplate", "PRINT ENTRY": "Bookplates|T073|T170|NON|EQV|NLM (2008)|070622|abbcdef", "ENTRY": "Book Plates|T073|T170|NON|EQV|NLM (2008)|070622|abbcdef", "MN": "V01.195", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "This heading is used as a Publication Type. Bookplates as a subject are indexed under the main heading BOOKPLATES AS TOPIC. INDEXER: Do not use", "MS": "Works consisting of book owner's identification labels. They are usually intended for attaching inside a book or similar object. (From Thesaurus for Graphic Materials II: Genre and Physical Characteristic Terms, 1995)", "HN": "2008(1997)", "MR": "20190705", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019491"}, {"RECTYPE": "D", "MH": "Caricature", "PRINT ENTRY": "Caricatures|T170|NON|EQV|NLM (2008)|070622|abcdef", "MN": "V02.700.074", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Caricatures as a subject are indexed under the main heading CARICATURES AS TOPIC. Publication Type CARTOON is also available. INDEXER: Do not use", "MS": "Work portraying in a critical or facetious way a real individual or group, or a figure representing a social, political, ethnic, or racial type. The effect is usually achieved through distortion or exaggeration of characteristics. (Genre Terms: A Thesaurus for Use in Rare Book and Special Collection Cataloguing, 2d ed)", "HN": "2008(1997)", "MR": "20180713", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019492"}, {"RECTYPE": "D", "MH": "Cartoon", "PRINT ENTRY": "Cartoons|T170|NON|EQV|NLM (2008)|070623|abcdef", "MN": "V02.700.149", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Cartoons as a subject are indexed under the main heading CARTOONS AS TOPIC; Publication Type CARICATURE is also available; INDEXER: Do not use", "MS": "Image used to comment on such things as contemporary events, social habits, or political trends; usually executed in a broad or abbreviated manner.", "HN": "2008(1997)", "MR": "20180713", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019493"}, {"RECTYPE": "D", "MH": "Catalog", "PRINT ENTRY": "Catalogs|T073|T170|NON|EQV|NLM (2008)|070624|abbcdef", "MN": "V02.240", "FX": "Union List", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Catalogs as a subject are indexed under the main heading CATALOGS AS TOPIC. INDEXER: Do not use", "MS": "Work consisting of bibliographic records, created according to specific and uniform principles of construction and under the control of an authority file, which describe the materials contained in a collection, library, or group of libraries. Catalogs include also lists of materials prepared for a particular purpose, such as exhibition catalogs, sales catalogs, garden catalogs, medical supply catalogs. (From The ALA Glossary of Library and Information Sciences, 1983)", "HN": "2008(1997)", "MR": "20190711", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019494"}, {"RECTYPE": "D", "MH": "Cancer Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaccines, Tumor|T116|T121|T129|NON|EQV|NLM (1997)|960321|abbbcdef", "ENTRY": "Vaccine, Tumor", "MN": "D20.215.894.200", "MH_TH": "NLM (1997)", "ST": "T129", "RN": "0", "AN": "coord IM with specific cancer histol type (IM) + organ/neopl precoord (IM)", "PI": "Vaccines (1971-1996)", "MS": "Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced.", "PM": "97", "HN": "97", "MR": "20200527", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019496"}, {"RECTYPE": "D", "MH": "Diary", "PRINT ENTRY": "Diaries|T170|NON|EQV|NLM (1997)|960502|abcdef", "MN": "V02.305", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Diaries as a subject are indexed under the main heading DIARIES AS TOPIC. INDEXER: Do not use", "MS": "Work consisting of records, usually private, of writers' experiences, observations, feelings, attitudes, etc. They may also be works marked in calendar order in which to note appointments and the like. (From Random House Unabridged Dictionary, 2d ed)", "HN": "2008(1997)", "MR": "20180702", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019497"}, {"RECTYPE": "D", "MH": "Documentaries and Factual Films", "MN": "V02.315", "MH_TH": "NLM (1997)", "ST": "T170", "AN": "This heading is used as a Publication Type. For documentaries, motion pictures and films as a subject, index under the main heading MOTION PICTURES. INDEXER: Do not use ", "MS": "Works consisting of films, videos, and programs which depict actual persons or actual events. They do not include frank historical re-creations and do not attempt to judge the truth of the depiction in a film purporting to be factual or documentary in character. (From Moving Image Materials: Genre Terms, 1988)", "HN": "2008(1997)", "MR": "20150605", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019499"}, {"RECTYPE": "D", "MH": "Encyclopedia", "PRINT ENTRY": "Encyclopedias|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V02.350", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Encyclopedias as a subject are indexed under the main heading ENCYCLOPEDIAS AS TOPIC. INDEXER: Do not use", "MS": "Work containing informational articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject.", "HN": "2008(1997)", "MR": "20190705", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019500"}, {"RECTYPE": "D", "MH": "Ephemera", "MN": "V02.355", "MH_TH": "NLM (1997)", "ST": "T170", "AN": "This heading is used as a Publication Type. Ephemera as a subject are indexed under the main heading for the specific type of ephemeron such as ADVERTISING AS TOPIC; CORRESPONDENCE AS TOPIC; PAMPHLETS; etc. INDEXER: Do not use", "MS": "Works consisting of transient everyday items, usually printed on paper, that are produced for a specific limited use and then often thrown away. (From Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed & The ALA Glossary of Library and Information Science, 1983)", "HN": "2008(1997)", "MR": "20150605", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019502"}, {"RECTYPE": "D", "MH": "Eulogy", "PRINT ENTRY": "Eulogies|T170|NON|EQV|NLM (1997)|960502|abcdef", "MN": "V02.375", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Do not confuse with Publication Type FUNERAL SERMON for eulogies delivered at funeral services. INDEXER: Do not use", "MS": "Work consisting of speeches or writings in praise of a person or thing, especially a set oration in honor of a deceased person. They differ from FUNERAL SERMON which are delivered at ceremonies for the deceased prior to their burial or cremation. (From Random House Unabridged Dictionary, 2d ed)", "HN": "2008(1997)", "MR": "20180713", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019504"}, {"RECTYPE": "D", "MH": "Funeral Sermon", "PRINT ENTRY": "Funeral Sermons|T170|NON|EQV|NLM (1997)|960502|abcdef", "MN": "V02.375.400", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Funeral sermons as a subject are indexed under the main heading FUNERAL RITES. INDEXER: Do not use", "MS": "Work consisting of sermons delivered at ceremonies for a dead person prior to burial or cremation. (From Random House Unabridged Dictionary, 2d ed)", "HN": "2008(1997)", "MR": "20180701", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019505"}, {"RECTYPE": "D", "MH": "Guidebook", "PRINT ENTRY": "Guidebooks|T073|T170|NON|EQV|NLM (1997)|960502|abbcdef", "MN": "V02.510", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Handbooks for travelers; INDEXER: Do not use", "MS": "Work consisting of publications for travelers that give information about a city, region, or country, or similar handbooks about buildings, museums, etc. (The ALA Glossary of Library and Information Science, 1983)", "HN": "2008(1997)", "MR": "20180702", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019508"}, {"RECTYPE": "D", "MH": "Herbal", "PRINT ENTRY": "Herbals|T073|T170|NON|EQV|NLM (2008)|070625|abbcdef", "MN": "V02.695.500", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Herbals as a subject are index under the main heading HERBALS AS TOPIC. INDEXER: Do not use", "MS": "Work such as books on herbs or plants usually describing their medicinal value. (Random House Unabridged Dictionary, 2d ed)", "HN": "2008(1997)", "MR": "20180702", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019509"}, {"RECTYPE": "D", "MH": "Pancreatitis, Alcoholic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Alcoholic Pancreatitis|T047|NON|EQV|NLM (1997)|960325|abcdef", "MN": "C25.775.100.087.730", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "usually chronic so do not coord with CHRONIC DISEASE", "PI": "Pancreatitis (1966-1996)", "MS": "Acute or chronic INFLAMMATION of the PANCREAS due to excessive ALCOHOL DRINKING. Alcoholic pancreatitis usually presents as an acute episode but it is a chronic progressive disease in alcoholics.", "PM": "97", "HN": "97", "MR": "20130708", "DA": "19960619", "DC": "1", "DX": "19970101", "UI": "D019512"}, {"RECTYPE": "D", "MH": "Feminism", "AQ": "CL HI", "PRINT ENTRY": "Feminist Ethics|T078|NON|REL|BIOETHICS (1995)|960325|abcdef", "ENTRY": "Ethics, Feminist", "MN": "K01.752.566.479.174.700", "MH_TH": "POPLINE (1994)", "ST": "T078", "PI": "Women's Rights (1977-1996)", "MS": "The theory of the political, economic, and social equality of the sexes and organized activity on behalf of women's rights and interests. (Webster New Collegiate Dictionary, 1981)", "OL": "use WOMEN'S RIGHTS to search FEMINISM 1994-96", "PM": "97; was see WOMEN'S RIGHTS 1994-96", "HN": "97; was see WOMEN'S RIGHTS 1994-96", "MR": "20160608", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019513"}, {"RECTYPE": "D", "MH": "Instructional Film and Video", "PRINT ENTRY": "Instructional Films and Videos|T170|NON|EQV|NLM (2011)|100510|abcdef", "ENTRY": "Video-Audio Demonstration|T078|NON|NRW|NLM (2011)|100426|abcdef", "MN": "V02.575", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "This heading is used as a Publication Type. Restrict to instruction by motion pictures & video, not by lectures, classroom or printed matter. Instructional films and videos as a subject are indexed under the main heading MOTION PICTURES. INDEXER: Do not use ", "MS": "Works consisting of nonfiction films and video designed to teach, instruct, or train. (From Moving Image Materials: Genre Terms, 1988)", "HN": "2011; was INSTRUCTION 2008(1997)", "MR": "20191031", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019514"}, {"RECTYPE": "D", "MH": "Orthodontic Space Closure", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Space Closure, Orthodontic|T061|NON|EQV|NLM (1997)|960325|abcdef", "ENTRY": "Space Closures, Orthodontic", "MN": "E06.658.578.229", "MH_TH": "NLM (1997)", "ST": "T061", "PI": "Tooth Movement (1993-1996)", "MS": "Therapeutic closure of spaces caused by the extraction of teeth, the congenital absence of teeth, or the excessive space between teeth.", "PM": "97", "HN": "97", "DA": "19960624", "DC": "1", "DX": "19970101", "UI": "D019516"}, {"RECTYPE": "D", "MH": "Unedited Footage", "ENTRY": "Outtakes|T170|NON|NRW|NLM (1997)|960514|abcdef", "MN": "V02.940", "MH_TH": "NLM (1997)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use  ", "MS": "Work consisting of untitled raw motion picture and video footage which has not been edited or assembled into a finished work. (From: Moving Image Materials: Genre Terms, 1988)", "HN": "2008(1997)", "MR": "20150605", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019517"}, {"RECTYPE": "D", "MH": "Postprandial Period", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Postcibal Period|T079|NON|EQV|NLM (1997)|960325|abcdef", "ENTRY": "Postprandial Periods", "MN": "G10.261.700", "MH_TH": "NLM (1997)", "ST": "T079", "PI": "Food (1966-1996)", "MS": "The time frame after a meal or FOOD INTAKE.", "PM": "97", "HN": "97", "MR": "20080708", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019518"}, {"RECTYPE": "D", "MH": "Poster", "PRINT ENTRY": "Posters|T170|NON|EQV|NLM (1997)|960502|abcdef", "MN": "V02.355.500", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. not for poster presentations at meetings; The Publication Types ADVERTISEMENT & BROADSIDE are also available. Posters as a subject are indexed under the main heading POSTERS AS TOPIC. INDEXER: Do not use", "MS": "Work consisting of single or multi-sheet notices made to attract attention to events, activities, causes, goods, or services. They are for posting, usually in a public place and are chiefly pictorial. They are intended to make an immediate impression from a distance. Posters do not include poster presentations at conferences and meetings. (From Thesaurus for Graphic Materials II: Genre and Physical Characteristic Headings, 1995)", "HN": "2008(1997)", "MR": "20180713", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019519"}, {"RECTYPE": "D", "MH": "Living Donors", "AQ": "CL ED ES HI LJ PX SD SN", "PRINT ENTRY": "Donors, Living|T098|NON|EQV|NLM (1997)|960325|abcdef", "ENTRY": "Living Donor", "MN": "M01.898.656", "MH_TH": "NLM (1997)", "ST": "T098", "AN": "coord IM with precoord organ/transpl heading (IM) or specific organ or tissue /transpl (IM) if precoord transpl heading is not in MeSH", "PI": "Tissue Donors (1990-1996)", "MS": "Non-cadaveric providers of organs for transplant to related or non-related recipients.", "PM": "97", "HN": "97", "MR": "20021031", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019520"}, {"RECTYPE": "D", "MH": "Body Patterning", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Polarity of Development|T040|NON|NRW|NLM (1997)|960611|abcdef", "ENTRY": "Specification, Embryonic Pattern", "MN": "G07.345.500.100", "MH_TH": "NLM (1997)", "ST": "T044", "PI": "Morphogenesis (1986-1996)", "MS": "The processes occurring in early development that direct morphogenesis. They specify the body plan ensuring that cells will proceed to differentiate, grow, and diversify in size and shape at the correct relative positions. Included are axial patterning, segmentation, compartment specification, limb position, organ boundary patterning, blood vessel patterning, etc.", "PM": "97", "HN": "97", "MR": "20160115", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019521"}, {"RECTYPE": "D", "MH": "Vaginal Discharge", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vaginal Discharges", "MN": "C12.100.250.894.700", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "note category; nonbloody; IM; coord with cause of discharge (IM)", "PI": "Vaginal Diseases (1966-1996)", "MS": "A common gynecologic disorder characterized by an abnormal, nonbloody discharge from the genital tract.", "PM": "97", "HN": "97", "MR": "20210630", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019522"}, {"RECTYPE": "D", "MH": "Sermon", "PRINT ENTRY": "Sermons|T170|NON|EQV|NLM (1997)|960502|abcdef", "MN": "V02.070.750", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. The Publication Type FUNERAL SERMON is also available. INDEXER: Do not use", "MS": "Work consisting of discourses for the purpose of religious instruction or exhortation, especially one based on a text of Scripture and delivered by a member of the clergy, as part of a religious service. (From: Random House Unabridged Dictionary, 2d ed)", "HN": "2008(1997)", "MR": "20180713", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019523"}, {"RECTYPE": "D", "MH": "Price List", "PRINT ENTRY": "Price Lists|T170|NON|EQV|NLM (1997)|960502|abcdef", "MN": "V02.240.500", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use", "MS": "Work consisting of lists giving the prices of items for sale, including drugs, equipment, books, etc. Price lists are less detailed than catalogs and not as long.", "HN": "2008(1997)", "MR": "20180702", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019525"}, {"RECTYPE": "D", "MH": "Prospectus", "PRINT ENTRY": "Prospectuses|T170|NON|EQV|NLM (1997)|960502|abcdef", "ENTRY": "Prospectuse|T170|NON|EQV|NLM (2019)|180702|abcdef", "MN": "V02.355.775", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "This heading is used as a Publication Type. Prospectuses as a subject are indexed under the main heading ADVERTISING. INDEXER: Do not use", "MS": "Work consisting of advertisements separately printed and distributed by a publisher to describe and solicit orders for a recent or forthcoming publication. In the case of books, they may include sample pages. (From: ALA Glossary of Library and Information Science, 1983)", "HN": "2008(1997)", "MR": "20190710", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019527"}, {"RECTYPE": "D", "MH": "Lecture Note", "PRINT ENTRY": "Lecture Notes|T170|NON|EQV|NLM (1997)|960502|abcdef", "MN": "V02.607", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use", "MS": "Work consisting of notes taken at the delivery or reading of a speech before an audience or class, usually given to instruct. (From Random House Unabridged Dictionary, 2d ed)", "HN": "2008(1997)", "MR": "20180702", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019528"}, {"RECTYPE": "D", "MH": "Sexuality", "AQ": "CL DE EH ES HI PH PX RE SN", "MN": "G08.686.867", "FX": "Psychosexual Development", "MH_TH": "NLM (1997)", "ST": "T053", "AN": "human only", "PI": "Sex Behavior (1974-1996)", "MS": "The sexual functions, activities, attitudes, and orientations of an individual. Sexuality, male or female, becomes evident at PUBERTY under the influence of gonadal steroids (TESTOSTERONE or ESTRADIOL), and social effects.", "PM": "1997; see SEX BEHAVIOR 1978-1996", "HN": "1997; use SEX BEHAVIOR 1978-1996", "MR": "20080708", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019529"}, {"RECTYPE": "D", "MH": "Lecture", "PRINT ENTRY": "Lectures|T170|NON|EQV|NLM (1997)|960502|abcdef", "MN": "V02.533", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. usually for instruction; Do not confuse with the Publication Type ADDRESS. CATALOGER: Publication Type LECTURE NOTE is also available", "MS": "Work consisting of speeches read or delivered before an audience or class, especially for instruction or to set forth some subject. They are differentiated from an ADDRESS which are less didactic and more informational, entertaining, inspirational, or polemic. (From Random House Unabridged Dictionary, 2d ed)", "HN": "2019(1997); was LECTURES", "MR": "20190708", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019531"}, {"RECTYPE": "D", "MH": "Map", "PRINT ENTRY": "Maps|T073|T170|NON|EQV|NLM (2008)|070530|abbcdef", "MN": "V02.700.450", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Use for geographic atlases. Do not also use the publication type ATLASES. Maps as a subject are indexed under the main heading MAPS AS TOPIC. INDEXER: Do not use", "MS": "Works consisting of representations, normally to scale and on a flat medium, of a selection of material or abstract features on the surface of the earth. They may be used also in delineating the heavens and celestial bodies. (From Anglo-American Cataloguing Rules, 2d ed, p619)", "HN": "2008 (1997)", "MR": "20190528", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019532"}, {"RECTYPE": "D", "MH": "Streptococcus oralis", "DE": "STREP ORALIS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872.875.600", "MH_TH": "NLM (1997)", "ST": "T007", "RN": "txid1303", "AN": "infection: coordinate with STREPTOCOCCAL INFECTIONS ", "PI": "Streptococcus (1983-1996)", "MS": "A species of gram-positive, coccoid bacteria that is numerous in the mouth and throat. It is a common cause of endocarditis and is also implicated in dental plaque formation.", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019533"}, {"RECTYPE": "D", "MH": "Shoulder Impingement Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subacromial Impingement Syndrome|T047|NON|NRW|NLM (1997)|960326|abcdef", "ENTRY": "Subacromial Impingement Syndromes", "MN": "C26.803.500", "MH_TH": "NLM (1997)", "ST": "T047", "PI": "Joint Diseases (1982-1996)", "MS": "Compression of the ROTATOR CUFF tendons and subacromial bursa between the HUMERAL HEAD and  the ACROMION of the SCAPULA. This condition is associated with subacromial BURSITIS, as well as rotator cuff (largely supraspinatus) and bicipital tendon INFLAMMATION.", "PM": "97", "HN": "97", "MR": "20190222", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019534"}, {"RECTYPE": "D", "MH": "Mycoplasma hominis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.400", "MH_TH": "NLM (1997)", "ST": "T007", "RN": "txid2098", "AN": "infection: coord IM with MYCOPLASMA INFECTIONS (IM)", "PI": "Mycoplasma (1966-1996)", "MS": "A common inhabitant of the vagina and cervix and a potential human pathogen, causing infections of the male and female reproductive tracts. It has also been associated with respiratory disease and pharyngitis. (From Dorland, 28th ed)", "PM": "97", "HN": "97", "MR": "20200813", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019535"}, {"RECTYPE": "D", "MH": "Health Care Surveys", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "PRINT ENTRY": "National Hospital Discharge Survey|T058|NON|NRW|NLM (1997)|960326|abcdef", "ENTRY": "Surveys, Healthcare", "MN": "N06.850.520.308.980.344", "MH_TH": "NLM (1997)", "ST": "T062", "AN": "do not confuse with HEALTH SURVEYS: health care surveys are on health services provided, health surveys are on health statist; specify geog if pertinent", "MS": "Statistical measures of utilization and other aspects of the provision of health care services including hospitalization and ambulatory care.", "PM": "97", "HN": "97", "MR": "20150622", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019538"}, {"RECTYPE": "D", "MH": "Pharmacopoeia", "PRINT ENTRY": "Pharmacopoeias|T170|NON|EQV|NLM (2008)|070626|abcdef", "MN": "V02.695", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Pharmacopoeias as a subject are indexed under the main heading PHARMACOPOEIAS AS TOPIC. INDEXER: Do not use", "MS": "Authoritative work containing lists of drugs and preparations, their description, formulation, analytic composition, main chemical properties, standards for strength, purity, and dosage, chemical tests for determining identity, etc. They have the status of a standard.", "HN": "2008(1997)", "MR": "20181116", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019539"}, {"RECTYPE": "D", "MH": "Area Under Curve", "PRINT ENTRY": "AUC|T081|ABB|EQV|NLM (1997)|960326|abcdef", "ENTRY": "Under Curves, Area", "MN": "N06.850.520.830.200", "MH_TH": "NLM (1997)", "ST": "T081", "MS": "A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. (From Winslade, Dictionary of Clinical Research, 1992)", "PM": "97", "HN": "97", "MR": "20160616", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019540"}, {"RECTYPE": "D", "MH": "Program", "PRINT ENTRY": "Programs|T170|NON|EQV|NLM (1997)|960502|abcdef", "MN": "V02.355.750", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use", "MS": "Works consisting of lists of the events, pieces, performers, speakers, etc., of an entertainment, ceremony, or the like. (From: Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloging, 2d ed)", "HN": "2008(1997)", "MR": "20190705", "DA": "19960621", "DC": "2", "DX": "19970101", "UI": "D019542"}, {"RECTYPE": "D", "MH": "Equipment Failure Analysis", "DE": "EQUIPMENT FAILURE ANAL", "AQ": "EC IS MT SN ST", "PRINT ENTRY": "Prosthesis Failure Analysis|T080|NON|NRW|NLM (1997)|960326|PROSTHESIS FAILURE ANAL|abcdefv", "ENTRY": "Prosthesis Failure Analyses", "MN": "E05.325.192", "MH_TH": "NLM (1997)", "ST": "T080", "AN": "coordinate with specific equipment or specific technique / instrum", "PI": "Equipment and Supplies (1993-1996)", "MS": "The evaluation of incidents involving the loss of function of a device. These evaluations are used for a variety of purposes such as to determine the failure rates, the causes of failures, costs of failures, and the reliability and maintainability of devices.", "PM": "97", "HN": "97", "MR": "20090706", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019544"}, {"RECTYPE": "D", "MH": "Intuition", "AQ": "CL DE ES PH RE", "MN": "F02.463.188.675", "MH_TH": "NLM (1997)", "ST": "T041", "AN": "knowing without conscious reasoning", "PI": "Consciousness (1966-1996)", "MS": "Knowing or understanding without conscious use of reasoning. (Thesaurus of ERIC Descriptors, 1994)", "PM": "97", "HN": "97", "MR": "19970620", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019545"}, {"RECTYPE": "D", "MH": "Couples Therapy", "DE": "COUPLES THER", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapy, Couples", "MN": "F04.754.864.581.136", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "a psychother technique for unmarried couples: for married couples index under MARITAL THERAPY", "PI": "Psychotherapy (1990-1996)", "MS": "Psychotherapy used for either unmarried couples or married couples, of mixed or same sex.", "PM": "97", "HN": "97", "MR": "20180525", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019546"}, {"RECTYPE": "D", "MH": "Neck Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neckache|T184|NON|EQV|NLM (1997)|960327|abcdef", "ENTRY": "Posterior Neck Pains", "MN": "C23.888.592.612.553", "MH_TH": "NLM (1997)", "ST": "T184", "PI": "Pain (1966-1996)", "MS": "Discomfort or more intense forms of pain that are localized to the cervical region. This term generally refers to pain in the posterior or lateral regions of the neck.", "PM": "1997", "HN": "1997", "MR": "20170620", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019547"}, {"RECTYPE": "D", "MH": "Crime Victims", "AQ": "CL EC ED HI LJ PX RH SN", "PRINT ENTRY": "Victimization|T068|NON|REL|NLM (1997)|960327|abcdef", "ENTRY": "Victims, Crime", "MN": "M01.135", "FX": "Violence", "MH_TH": "NLM (1997)", "ST": "T098", "AN": "coord IM with specific crime if pertinent (IM)", "PI": "Crime (1986-1996)", "MS": "Individuals subjected to and adversely affected by criminal activity. (APA, Thesaurus of Psychological Index Terms, 1994)", "PM": "97", "HN": "97", "MR": "19970620", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019548"}, {"RECTYPE": "D", "MH": "Environmental Medicine", "DE": "ENVIR MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Environmental|T091|NON|EQV|NLM (1997)|960327|MED ENVIR|abcdefv", "MN": "N06.850.420", "MH_TH": "NLM (1997)", "ST": "T091", "PI": "Environmental Health (1990-1996)", "MS": "Medical specialty concerned with environmental factors that may impinge upon human disease, and development of methods for the detection, prevention, and control of environmentally related disease.", "PM": "97", "HN": "97", "MR": "20090706", "DA": "19960624", "DC": "1", "DX": "19970101", "UI": "D019550"}, {"RECTYPE": "D", "MH": "Dental Disinfectants", "DE": "DENT DISINFECTANTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Disinfectants, Dental|T121|NON|EQV|NLM (1997)|960327|DISINFECTANTS DENT|abcdefv", "MN": "D27.720.274.300", "MH_TH": "NLM (1997)", "ST": "T121", "RN": "0", "PI": "Disinfectants (1967-1996)", "MS": "Chemicals especially for use on instruments to destroy pathogenic organisms. (Boucher, Clinical Dental Terminology, 4th ed)", "PM": "97", "HN": "97", "MR": "20030709", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019551"}, {"RECTYPE": "D", "MH": "Infection Control, Dental", "DE": "INFECT CONTROL DENT", "AQ": "EC HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Dental Infection Control|T058|NON|EQV|NLM (1997)|960327|DENT INFECT CONTROL|abcdefv", "ENTRY": "Infection Controls, Dental", "MN": "N06.850.780.200.450.500", "MH_TH": "NLM (1997)", "ST": "T058", "AN": "prevention of infection in dental health facilities, not prevention of tooth infection in the mouth ", "PI": "Infection Control (1990-1996)", "MS": "Efforts to prevent and control the spread of infections within dental health facilities or those involving provision of dental care.", "PM": "97", "HN": "97", "MR": "20080708", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019552"}, {"RECTYPE": "D", "MH": "Tooth, Nonvital", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tooth, Pulpless|T047|NON|EQV|NLM (1997)|960327|abcdef", "ENTRY": "Tooth, Endodontically Treated", "MN": "C07.793.237.910", "MH_TH": "NLM (1997)", "ST": "T047", "AN": "a devitalized tooth: note X ref", "MS": "A tooth from which the dental pulp has been removed or is necrotic. (Boucher, Clinical Dental Terminology, 4th ed)", "PM": "97", "HN": "97", "MR": "19970620", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019553"}, {"RECTYPE": "D", "MH": "Dental Restoration Wear", "DE": "DENT RESTORATION WEAR", "AQ": "AE CL PX SN", "PRINT ENTRY": "Occlusal Wear, Restoration|T070|NON|EQV|NLM (1997)|960327|abcdef", "ENTRY": "Wear, Denture", "MN": "E06.780.346.737.125", "MH_TH": "NLM (1997)", "ST": "T070", "PI": "Surface Properties (1986-1996)", "MS": "Occlusal wear of the surfaces of restorations and surface wear of dentures.", "PM": "97", "HN": "97", "MR": "20150622", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019554"}, {"RECTYPE": "D", "MH": "Physician-Nurse Relations", "DE": "PHYSICIAN NURSE RELAT", "PRINT ENTRY": "Nurse-Physician Relations|T054|NON|EQV|NLM (1997)|960418|NURSE PHYSICIAN RELAT|abcdefv", "ENTRY": "Relationships, Physician Nurse", "MN": "F01.829.401.205.500", "MH_TH": "NLM (1997)", "ST": "T054", "AN": "coordinate with medical & nursing specialties if pertinent", "PI": "Physicians (1966-1996)", "MS": "The reciprocal interaction of physicians and nurses.", "PM": "97", "HN": "97", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019555"}, {"RECTYPE": "D", "MH": "COS Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cells, COS-7", "MN": "A11.329.228.220", "MH_TH": "NLM (1997)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMALS & add CHLOROCEBUS AETHIOPS (NIM)", "PI": "Cell Line (1983-1996)", "MS": "CELL LINES derived from the CV-1 cell line by transformation with a replication origin defective mutant of SV40 VIRUS, which codes for wild type large T antigen (ANTIGENS, POLYOMAVIRUS TRANSFORMING). They are used for transfection and cloning. (The CV-1 cell line was derived from the kidney of an adult male African green monkey (CHLOROCEBUS AETHIOPS).)", "PM": "97", "HN": "97", "MR": "20190710", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019556"}, {"RECTYPE": "D", "MH": "Dermatitis, Perioral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Perioral Dermatitis|T047|NON|EQV|NLM (1997)|960328|abcdef", "ENTRY": "Perioral Dermatitides", "MN": "C17.800.271.250", "MH_TH": "NLM (1997)", "ST": "T047", "PI": "Facial Dermatoses (1968-1996)", "MS": "A papular eruption of unknown etiology that progresses to residual papular erythema and scaling usually confined to the area of the mouth, and almost exclusively occurring in young women. It may also be localized or extend to involve the eyelids and adjacent glabella area of the forehead (periocular dermatitis). (Dorland, 28th ed)", "PM": "97", "HN": "97", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019557"}, {"RECTYPE": "D", "MH": "Occlusal Adjustment", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Occlusal Equilibration|T061|NON|EQV|NLM (1997)|960329|abcdef", "ENTRY": "Occlusal Adjustments", "MN": "E06.658.578.200", "MH_TH": "NLM (1997)", "ST": "T061", "AN": "grinding of occlusal surfaces of teeth to achieve optimal occlusion", "PI": "Dental Occlusion, Balanced (1993-1996)", "MS": "Selective grinding of occlusal surfaces of the teeth in an effort to eliminate premature contacts and occlusal interferences; to establish optimal masticatory effectiveness, stable occlusal relationships, direction of main occlusal forces, and efficient multidirectional patterns, to improve functional relations and to induce physiologic stimulation of the masticatory system; to eliminate occlusal trauma; to eliminate abnormal muscle tension; to aid in the stabilization of orthodontic results; to treat periodontal and temporomandibular joint problems; and in restorative procedures. (From Jablonski, Dictionary of Dentistry, 1992)", "OL": "use DENTAL OCCLUSION, BALANCED to search OCCLUSAL ADJUSTMENT 1969-96", "PM": "97; OCCLUSAL EQUILIBRATION was see DENTAL OCCLUSION, BALANCED 1975-96; was see under DENTAL OCCLUSION, BALANCED 1969-74", "HN": "97; OCCLUSAL EQUILIBRATION was see DENTAL OCCLUSION, BALANCED 1975-96; was see under DENTAL OCCLUSION, BALANCED 1969-74", "MR": "20040729", "DA": "19960613", "DC": "1", "DX": "19970101", "UI": "D019558"}, {"RECTYPE": "D", "MH": "Capillary Leak Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Systemic Capillary Leak Syndrome|T047|NON|EQV|NLM (1997)|960329|abcdef", "ENTRY": "Capillary Leak Syndromes", "MN": "C14.907.218", "FX": "Multiple Organ Failure", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Capillary Permeability (1972-1996)", "MS": "A condition characterized by recurring episodes of fluid leaking from capillaries into extra-vascular compartments causing hematocrit to rise precipitously. If not treated, generalized vascular leak can lead to generalized EDEMA; SHOCK; cardiovascular collapse; and MULTIPLE ORGAN FAILURE.", "PM": "1997", "HN": "1997", "MR": "20100625", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019559"}, {"RECTYPE": "D", "MH": "Echocardiography, Three-Dimensional", "DE": "ECHOCARDIOGR THREE DIMENSIONAL", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Three-Dimensional Echocardiographies", "MN": "E01.370.370.380.220.230", "MH_TH": "NLM (1997)", "ST": "T060", "AN": "ECHOCARDIOGRAPHY, FOUR-DIMENSIONAL is also available", "PI": "Echocardiography (1974-1996)", "MS": "Echocardiography amplified by the addition of depth to the conventional two-dimensional ECHOCARDIOGRAPHY visualizing only the length and width of the heart. Three-dimensional ultrasound imaging was first described in 1961 but its application to echocardiography did not take place until 1974. (Mayo Clin Proc 1993;68:221-40)", "PM": "97", "HN": "97", "MR": "20100625", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019560"}, {"RECTYPE": "D", "MH": "Echocardiography, Four-Dimensional", "DE": "ECHOCARDIOGR FOUR DIMENSIONAL", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Four-Dimensional Echocardiographies", "MN": "E01.370.370.380.220.230.230", "MH_TH": "NLM (1997)", "ST": "T060", "AN": "ECHOCARDIOGRAPHY, THREE-DIMENSIONAL is also available", "PI": "Echocardiography (1993-1996)", "MS": "Dynamic three-dimensional echocardiography using the added dimension of time to impart the cinematic perception of motion. (Mayo Clin Proc 1993;68:221-40)", "PM": "97", "HN": "97", "MR": "20100625", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019561"}, {"RECTYPE": "D", "MH": "Viral Load", "AQ": "CL DE EC ES GE HI IM IS MT PH RE SN ST TD VE", "PRINT ENTRY": "Virus Titer|T081|NON|REL|NLM (2010)|090204|abcdef", "ENTRY": "Titer, Virus", "MN": "G06.920.850", "MH_TH": "NLM (1997)", "ST": "T081", "MS": "The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression.", "PM": "97", "HN": "97", "MR": "20110624", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019562"}, {"RECTYPE": "D", "MH": "Mechanics", "MN": "H01.671.515", "FX": "Biomechanical Phenomena", "MH_TH": "NLM (1997)", "ST": "T070", "AN": "the discipline (education, history, etc) only; use MECHANICAL PHENOMENA or specifics treed under it for mechanical properties and processes of materials", "PI": "Physics (1966-1996)", "MS": "The branch of physics which deals with the motions of material bodies, including kinematics, dynamics, and statics. When the laws of mechanics are applied to living structures, as to the locomotor system, it is referred to as BIOMECHANICAL PHENOMENA. (From Dorland, 28th ed)", "PM": "97", "HN": "97", "MR": "20130710", "DA": "19960620", "DC": "1", "DX": "19970101", "UI": "D019563"}, {"RECTYPE": "D", "MH": "Unnecessary Procedures", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Unnecessary Surgery|T061|NON|NRW|NLM (1997)|960424|UNNECESSARY SURG|abcdefv", "ENTRY": "Unnecessary Procedure", "MN": "N05.300.150.395.450.500", "MH_TH": "NLM (1997)", "ST": "T058", "MS": "Diagnostic, therapeutic, and investigative procedures prescribed and performed by health professionals, the results of which do not justify the benefits or hazards and costs to the patient.", "PM": "97", "HN": "97", "MR": "20150626", "DA": "19960610", "DC": "1", "DX": "19970101", "UI": "D019564"}, {"RECTYPE": "D", "MH": "Metals, Light", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Light Metals|T196|NON|EQV|NLM (1997)|960507|abcdef", "MN": "D01.552.547", "MH_TH": "NLM (1997)", "ST": "T196", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Metals or specifics (1966-1996)", "MS": "Metals with low specific gravity, typically smaller than 5, characterized by a single valence (1, 2, or 3), a simple spectrum, strong electromotive force (positive), and colorless compounds. (From Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "1997", "HN": "1997", "MR": "20180228", "DA": "19960620", "DC": "1", "DX": "19970101", "UI": "D019565"}, {"RECTYPE": "D", "MH": "Back Injuries", "DE": "BACK INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injury, Back", "MN": "C26.117", "FX": "Spinal Injuries", "MH_TH": "NLM (1998)", "ST": "T037", "AN": "general or unspecified; coordinate with specific injury or specific region; do not confuse with SPINAL INJURIES which refers to vertebrae only", "PI": "Back/injuries (1966-1997)", "MS": "General or unspecified injuries to the posterior part of the trunk. It includes injuries to the muscles of the back.", "PM": "98", "HN": "98", "MR": "20100625", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019567"}, {"RECTYPE": "D", "MH": "Lung, Hyperlucent", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thorax, Hyperlucent|T047|NON|EQV|NLM (1998)|961106|abcdef", "ENTRY": "Unilateral Hyperlucent Lungs", "MN": "C08.381.570", "MH_TH": "NLM (1998)", "ST": "T047", "PI": "Pulmonary Emphysema (1966-1997)", "MS": "A lung with reduced markings on its chest radiograph and increased areas of transradiancy (hyperlucency). A hyperlucent lung is usually associated with pulmonary emphysema or PNEUMOTHORAX.", "PM": "98", "HN": "98", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019568"}, {"RECTYPE": "D", "MH": "Hemifacial Spasm", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spasm, Hemifacial|T033|NON|EQV|NLM (1998)|960701|abcdef", "ENTRY": "Unilateral Facial Spasms", "MN": "C23.888.592.608.750.400", "MH_TH": "NLM (1998)", "ST": "T033", "PI": "Spasm (1966-1997)", "MS": "Recurrent clonic contraction of facial muscles, restricted to one side. It may occur as a manifestation of compressive lesions involving the seventh cranial nerve (FACIAL NERVE DISEASES), during recovery from BELL PALSY, or in association with other disorders. (From Adams et al., Principles of Neurology, 6th ed, p1378)", "PM": "1998", "HN": "1998", "MR": "19991213", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019569"}, {"RECTYPE": "D", "MH": "Inhalation Exposure", "AQ": "AE AN CL EC ES HI LJ PC SN ST", "ENTRY": "Inhalation Exposures", "MN": "N06.850.460.350.112", "MH_TH": "NLM (1998)", "ST": "T037", "AN": "may or may not result in a disease; coord IM with specific inhalant (IM)", "PI": "Occupational Exposure (1991-1997)", "MS": "The exposure to potentially harmful chemical, physical, or biological agents by inhaling them.", "PM": "98", "HN": "98", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019570"}, {"RECTYPE": "D", "MH": "Arrhythmogenic Right Ventricular Dysplasia", "DE": "ARVD", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ventricular Dysplasia, Right, Arrhythmogenic|T019|T047|NON|EQV|GHR (2014)|NLM (1998)|960924|abbcdeef", "ENTRY": "Arrhythmogenic Right Ventricular Cardiomyopathy Dysplasia", "MN": "C16.131.240.400.145", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Tachycardia, Ventricular (1993-1997)", "MS": "A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.", "PM": "98", "HN": "98", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019571"}, {"RECTYPE": "D", "MH": "Retinal Neoplasms", "DE": "RETINAL NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumor, Retinal", "MN": "C11.768.717", "FX": "Retinoblastoma", "MH_TH": "NLM (1998)", "ST": "T191", "AN": "coordinate IM with histologic type of neoplasm (IM) but majority will be RETINOBLASTOMA", "PI": "Retinoblastoma (1968-1997)", "MS": "Tumors or cancer of the RETINA.", "PM": "1998", "HN": "1998", "MR": "20090706", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019572"}, {"RECTYPE": "D", "MH": "Epithelium, Corneal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Epithelium, Anterior Corneal|T024|NON|EQV|NLM (1998)|960925|abcdef", "MN": "A10.272.510", "MH_TH": "NLM (1998)", "ST": "T024", "AN": "do not confuse with ENDOTHELIUM, CORNEAL; do not confuse entry term ANTERIOR CORNEAL EPITHELIUM with ANTERIOR CHAMBER EPITHELIUM see ENDOTHELIUM, CORNEAL", "PI": "Epithelium (1966-1997)", "MS": "Stratified squamous epithelium that covers the outer surface of the CORNEA. It is smooth and contains many free nerve endings.", "PM": "98", "HN": "98", "MR": "19991103", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019573"}, {"RECTYPE": "D", "MH": "Optic Nerve Neoplasms", "DE": "OPTIC NERVE NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Optic Nerve Sheath Tumors|T191|NON|NRW|NLM (2000)|991104|abcdef", "ENTRY": "Optic Nerve Neoplasm", "MN": "C11.640.544", "MH_TH": "NLM (1998)", "ST": "T191", "AN": "coordinate IM with histologic type of neoplasm (IM)", "PI": "Optic Nerve Diseases (1978-1997)", "MS": "Benign and malignant neoplasms that arise from the optic nerve or its sheath. OPTIC NERVE GLIOMA is the most common histologic type. Optic nerve neoplasms tend to cause unilateral visual loss and an afferent pupillary defect and may spread via neural pathways to the brain.", "PM": "98", "HN": "98", "MR": "20150623", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019574"}, {"RECTYPE": "D", "MH": "Blindness, Cortical", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Psychic Denial of Blindness|T047|NON|REL|NLM (2000)|991103|abcdef", "ENTRY": "Transient Antons Syndrome", "MN": "C23.888.592.763.941.162.250", "MH_TH": "NLM (1998)", "ST": "T047", "PI": "Blindness (1966-1997)", "MS": "Total loss of vision in all or part of the visual field due to bilateral OCCIPITAL LOBE (i.e., VISUAL CORTEX) damage or dysfunction. Anton syndrome is characterized by the psychic denial of true, organic cortical blindness. (Adams et al., Principles of Neurology, 6th ed, p460)", "PM": "1998", "HN": "1998", "MR": "20100625", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019575"}, {"RECTYPE": "D", "MH": "Porpoises", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Spectacled Porpoise|T015|NON|NRW|NLM (2006)|041210|abcdef", "ENTRY": "Spectacled Porpoises", "MN": "B01.050.150.900.649.313.875.566", "MH_TH": "NLM (1997)", "ST": "T015", "RN": "txid9740", "RR": "txid9744", "PI": "Dolphins (1967-1997)", "MS": "Mammals of the family Phocoenidae comprising four genera found in the North Pacific Ocean and both sides of the North Atlantic Ocean and in various other seas. They differ from DOLPHINS in that porpoises have a blunt snout and a rather stocky body while dolphins have a beak-like snout and a slender, streamlined body. They usually travel in small groups. (From Walker's Mammals of the World, 5th ed, pp1003-4)", "PM": "98; see DOLPHINS 1968-97", "HN": "98; use DOLPHINS 1968-97", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019576"}, {"RECTYPE": "D", "MH": "Mole Rats", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Heterocephalus|T015|NON|NRW|NLM (1998)|960701|abcdef", "ENTRY": "Rats, Mole", "MN": "B01.050.150.900.649.313.992.600", "MH_TH": "NLM (1998)", "ST": "T015", "RR": "txid10180", "AN": "NIM when experimental animal", "PI": "Rodentia (1968-1997)", "MS": "Any of several burrowing rodents of the families MURIDAE and Bathyergidae, found in eastern Europe, Africa, and Asia. They have short limbs, small eyes with permanently closed lids, and no tail. Three genera SPALAX (Muridae), Heterocephalus (Bathyergidae) and Cryptomys (Bathyergidae) are used frequently as experimental animals in biomedical research. (From Walker's Mammals of the World, 6th ed)", "PM": "98", "HN": "98", "MR": "20200902", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019577"}, {"RECTYPE": "D", "MH": "Multiple System Atrophy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Multisystemic Atrophies", "MN": "C10.574.928.625", "FX": "Shy-Drager Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "a specific neurodegenerative syndrome complex; not for atrophy in other systems", "PI": "Shy-Drager Syndrome (1981-1997)", "MS": "A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92)", "PM": "1998", "HN": "1998", "MR": "20190517", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019578"}, {"RECTYPE": "D", "MH": "Neocortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Substantia Corticali", "MN": "A08.186.211.200.885.287.500.420", "MH_TH": "NLM (1998)", "ST": "T023", "PI": "specific part of brain (1966-1997)", "MS": "The largest portion of the CEREBRAL CORTEX in which the NEURONS are arranged in six layers in the mammalian brain: molecular, external granular, external pyramidal, internal granular, internal pyramidal and multiform layers.", "PM": "98", "HN": "98", "MR": "20180701", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019579"}, {"RECTYPE": "D", "MH": "Perforant Pathway", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Perforating Fasciculus|T023|NON|EQV|NLM (1998)|960917|abcdef", "ENTRY": "Perforant Pathways", "MN": "A08.612.600", "FX": "Mossy Fibers, Hippocampal", "MH_TH": "NLM (1998)", "ST": "T023", "PI": "Neural Pathways (1977-1997)", "MS": "A pathway of fibers that originates in the lateral part of the ENTORHINAL CORTEX, perforates the SUBICULUM of the HIPPOCAMPUS, and runs into the stratum moleculare of the hippocampus, where these fibers synapse with others that go to the DENTATE GYRUS where the pathway terminates. It is also known as the perforating fasciculus.", "PM": "98", "HN": "98", "MR": "20180701", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019580"}, {"RECTYPE": "D", "MH": "Neuropil", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Neuropils", "MN": "A11.671.685", "FX": "Mushroom Bodies", "MH_TH": "NLM (1998)", "ST": "T026", "AN": "do not confuse with NEUROPIL THREADS, abnormal neuronal structures", "MS": "A dense intricate feltwork of interwoven fine glial processes, fibrils, synaptic terminals, axons, and dendrites interspersed among the nerve cells in the gray matter of the central nervous system.", "PM": "98", "HN": "98", "MR": "20120927", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019581"}, {"RECTYPE": "D", "MH": "Dose Fractionation, Radiation", "PRINT ENTRY": "Radiotherapy Dose Fractionation|T061|NON|EQV|NLM (1998)|960801|RADIOTHER DOSE FRACTIONATION|abcdefv", "ENTRY": "Radiotherapy Dose Fractionations", "MN": "E02.815.639.200", "MH_TH": "NLM (2019)", "ST": "T061", "MS": "Administration of the total dose of radiation (RADIATION DOSAGE) in parts, at timed intervals.", "PM": "2019; see Dose Fractionation 2008-2018", "HN": "2019(2008)", "MR": "20180228", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019583"}, {"RECTYPE": "D", "MH": "Hot Flashes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Flashes, Hot", "MN": "C23.888.475", "MH_TH": "NLM (1998)", "ST": "T184", "AN": "do not confuse with FLUSHING", "PI": "Menopause (1972-1997)", "MS": "A sudden, temporary sensation of heat predominantly experienced by some women during MENOPAUSE. (Random House Unabridged Dictionary, 2d ed)", "PM": "98", "HN": "98", "MR": "19991108", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019584"}, {"RECTYPE": "D", "MH": "Intracranial Hypotension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intracranial Hypotension, Spontaneous|T047|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Spontaneous Intracranial Hypotension", "MN": "C10.228.140.638", "FX": "Hypovolemia", "MH_TH": "NLM (1998)", "ST": "T047", "AN": "do not confuse with INTRACRANIAL HYPERTENSION; coord IM with disease /physiopathol (IM) causing or caused by intracranial hypotension", "PI": "Intracranial Pressure (1967-1997)", "MS": "Reduction of CEREBROSPINAL FLUID pressure characterized clinically by ORTHOSTATIC HEADACHE and occasionally by an ABDUCENS NERVE PALSY; HEARING LOSS; NAUSEA; neck stiffness, and other symptoms. This condition may be spontaneous or secondary to CEREBROSPINAL FLUID LEAK; SPINAL PUNCTURE; NEUROSURGICAL PROCEDURES; DEHYDRATION; UREMIA; trauma (see also CRANIOCEREBRAL TRAUMA); and other processes. Chronic hypotension may be associated with subdural hematomas (see HEMATOMA, SUBDURAL) or hygromas. (From Semin Neurol 1996 Mar;16(1):5-10; Adams et al., Principles of Neurology, 6th ed, pp637-8)", "PM": "1998", "HN": "1998", "MR": "20160701", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019585"}, {"RECTYPE": "D", "MH": "Intracranial Hypertension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pressure, Elevated Intracranial", "MN": "C10.228.140.631", "FX": "Hydrocephalus", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with INTRACRANIAL HYPOTENSION; coord IM with disease /physiopathol (IM) causing or caused by intracranial hypertension", "PI": "Pseudotumor Cerebri (1966-1997)", "MS": "Increased pressure within the cranial vault. This may result from several conditions, including HYDROCEPHALUS; BRAIN EDEMA; intracranial masses; severe systemic HYPERTENSION; PSEUDOTUMOR CEREBRI; and other disorders.", "PM": "1998", "HN": "1998", "MR": "20090706", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019586"}, {"RECTYPE": "D", "MH": "Dietary Supplements", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Neutraceuticals|T168|NON|REL|NLM (2007)|051117|abcdef", "ENTRY": "Supplements, Herbal", "MN": "J02.500.456", "FX": "Functional Food", "MH_TH": "NLM (1998)", "ST": "T168", "AN": "do not confuse with FOOD, FORTIFIED or FOOD, FORMULATED or FOOD ADDITIVES or FUNCTIONAL FOOD; coordinate IM with specific nutrient if relevant (IM)", "PI": "Food, Fortified (1972-1997)", "MS": "Products in capsule, tablet or liquid form that provide dietary ingredients, and that are intended to be taken by mouth to increase the intake of nutrients.  Dietary supplements can include macronutrients, such as proteins, carbohydrates, and fats; and/or MICRONUTRIENTS, such as VITAMINS; MINERALS; and PHYTOCHEMICALS.", "OL": "use FOOD, FORTIFIED to search DIETARY SUPPLEMENTATION 1995-97 & FOOD, SUPPLEMENTED 1975-97", "PM": "98; DIETARY SUPPLEMENTATION was see FOOD, FORTIFIED 1995-97; FOOD, SUPPLEMENTED was see FOOD, FORTIFIED 1975-97", "HN": "98; DIETARY SUPPLEMENTATION was see FOOD, FORTIFIED 1995-97; FOOD, SUPPLEMENTED was see FOOD, FORTIFIED 1975-97", "MR": "20170113", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019587"}, {"RECTYPE": "D", "MH": "Aging, Premature", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Premature Aging|T046|T184|NON|EQV|NLM (1998)|960820|abbcdef", "MN": "C23.888.069", "MH_TH": "NLM (1998)", "ST": "T184", "AN": "unspecified with relation to age; in children, consider PROGERIA; in adults, consider PROGERIA, ADULT see WERNER SYNDROME", "PI": "Werner Syndrome (1971-1997)", "MS": "Changes in the organism associated with senescence, occurring at an accelerated rate.", "PM": "98", "HN": "98", "MR": "19991108", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019588"}, {"RECTYPE": "D", "MH": "Tooth Components", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tooth Component", "MN": "A14.549.167.900", "MH_TH": "NLM (1998)", "ST": "T023", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "PI": "specific tooth structure (1966-1997)", "MS": "The anatomical components of a tooth, its tissues, and correlated parts.", "PM": "98", "HN": "98", "MR": "20150605", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019589"}, {"RECTYPE": "D", "MH": "Nucleocapsid Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Viral Nucleoproteins|T116|T123|NON|NRW|NLM (2021)|200422|abbcdef", "ENTRY": "Proteins, Viral N", "MN": "D12.776.964.970.600", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "PI": "Viral Proteins (1970-1985)", "MS": "Viral proteins found in either the NUCLEOCAPSID or the viral core (VIRAL CORE PROTEINS).", "OL": "use NUCLEOCAPSID to search NUCLEOCAPSID PROTEINS 1997", "PM": "98; was see NUCLEOCAPSID 1997", "HN": "98; was see NUCLEOCAPSID 1997", "MR": "20200622", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019590"}, {"RECTYPE": "D", "MH": "Pseudophakia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.681", "MH_TH": "NLM (1998)", "ST": "T033", "AN": "do not confuse with PSEUDOAPHAKIA see CATARACT", "PI": "Lenses, Intraocular (1979-1997)", "MS": "Presence of an intraocular lens after cataract extraction.", "PM": "98", "HN": "98", "MR": "19991103", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019591"}, {"RECTYPE": "D", "MH": "Severe Dengue", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Hemorrhagic Fever, Dengue|T047|NON|EQV|NLM (1998)|960823|abcdef", "ENTRY": "Severe Dengues", "MN": "C01.925.782.417.214.200", "MH_TH": "NLM (2014)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "PI": "Dengue (1966-1997)", "MS": "A virulent form of dengue characterized by THROMBOCYTOPENIA and an increase in vascular permeability (grades I and II) and distinguished by a positive pain test (e.g., TOURNIQUET PAIN TEST). When accompanied by SHOCK (grades III and IV), it is called dengue shock syndrome.", "OL": "use DENGUE to search DENGUE HEMORRHAGIC FEVER & DENGUE SHOCK SYNDROME 1997, & HEMORRHAGIC FEVER, DENGUE 1977-97", "PM": "98; was see DENGUE 1997; DENGUE SHOCK SYNDROME was see DENGUE 1997; HEMORRHAGIC FEVER, DENGUE was see DENGUE 1977-97", "HN": "98; was see DENGUE 1997; DENGUE SHOCK SYNDROME was see DENGUE 1997; HEMORRHAGIC FEVER, DENGUE was see DENGUE 1977-97", "MR": "20230601", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019595"}, {"RECTYPE": "D", "MH": "Wolves", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Canis simensis|T015|NON|NRW|NLM (2005)|030807|abcdef", "ENTRY": "Wolf, Red", "MN": "B01.050.150.900.649.313.750.250.216.900", "MH_TH": "NLM (1998)", "ST": "T015", "RR": "txid9612", "PI": "Carnivora (1966-1997)", "MS": "Any of several large carnivorous mammals of the family CANIDAE that usually hunt in packs.", "PM": "98", "HN": "98", "MR": "20200902", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019596"}, {"RECTYPE": "D", "MH": "Flax", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Linum|T002|NON|EQV|NLM (1998)|960925|abcdef", "ENTRY": "usitatissimums, Linum", "MN": "B01.875.800.575.912.250.859.797.620.500", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid4005", "RR": "txid4006", "AN": "despite entry term FLAXSEED, coord IM with SEEDS (IM)", "MS": "A plant genus of the family LINACEAE that is cultivated for its fiber (manufactured into linen cloth). It contains a trypsin inhibitor and the seed is the source of LINSEED OIL.", "PM": "98", "HN": "98", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019597"}, {"RECTYPE": "D", "MH": "Mossy Fibers, Hippocampal", "AQ": "AB AH BS CH DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hippocampal Mossy Fibers|T023|NON|EQV|NLM (1998)|960826|abcdef", "ENTRY": "Mossy Fiber, Hippocampal", "MN": "A11.671.501.145.438", "FX": "Perforant Pathway", "MH_TH": "NLM (1998)", "ST": "T023", "AN": "do not confuse with MOSSY FIBERS, CEREBELLAR see NERVE FIBERS", "PI": "Nerve Fibers (1978-1997)", "MS": "Axons of certain cells in the DENTATE GYRUS. They project to the polymorphic layer of the dentate gyrus and to the proximal dendrites of PYRAMIDAL CELLS of the HIPPOCAMPUS. These mossy fibers should not be confused with mossy fibers that are cerebellar afferents (see NERVE FIBERS).", "PM": "98", "HN": "98", "MR": "20220708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019599"}, {"RECTYPE": "D", "MH": "Neuropil Threads", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Neuropil Thread", "MN": "A11.671.685.550", "MH_TH": "NLM (1998)", "ST": "T020", "AN": "do not confuse with NEUROPIL, a \"felt\" of interwoven neuronal components & neuroglia", "MS": "Abnormal structures located chiefly in distal dendrites and, along with NEUROFIBRILLARY TANGLES and SENILE PLAQUES, constitute the three morphological hallmarks of ALZHEIMER DISEASE. Neuropil threads are made up of straight and paired helical filaments which consist of abnormally phosphorylated microtubule-associated tau proteins. It has been suggested that the threads have a major role in the cognitive impairment seen in Alzheimer disease.", "PM": "98", "HN": "98", "MR": "20120927", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019600"}, {"RECTYPE": "D", "MH": "Pacific States", "AQ": "EH EP", "MN": "Z01.107.567.875.580", "MH_TH": "NLM (1998)", "ST": "T083", "AN": "index specific states as needed but use PACIFIC STATES when text uses the term & when the region is the intent of the author; CATALOGER: Use for 4 or more states", "MS": "The geographic designation for states bordering on or located in the Pacific Ocean. The states so designated are Alaska, California, Hawaii, Oregon, and Washington. (U.S. Geologic Survey telephone communication)", "HN": "98", "MR": "20150605", "DA": "19970620", "DC": "4", "DX": "19980101", "UI": "D019601"}, {"RECTYPE": "D", "MH": "Food and Beverages", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Food And Beverage|T168|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Beverages, Food And", "MN": "J02", "RH": "J2 - FOOD AND BEVERAGES", "MH_TH": "NLM (1998)", "ST": "T168", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Edible or potable substances.", "HN": "98", "MR": "20200527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019602"}, {"RECTYPE": "D", "MH": "Thermoplasmales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Picrophilus|T194|NON|NRW|NLM (1998)|961001|abcdef", "ENTRY": "Thermoplasmatales|T194|NON|EQV|NLM (1998)|961001|abcdef", "MN": "B02.200.850", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2301", "RR": "txid46631", "AN": "an order of the kingdom of Euryarchaeota, of the domain of Archaea", "MS": "An order of aerobic, thermophilic archaea, in the kingdom EURYARCHAEOTA, characterized by the absence of a cell wall. Two genera have been described: THERMOPLASMA and Picrophilus.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019603"}, {"RECTYPE": "D", "MH": "Euryarchaeota", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Thermoplasmata|T194|NON|NRW|NLM (2004)|020930|abcdef", "ENTRY": "Methanobacteria|T194|NON|NRW|UNK (19XX)|780130|abcdef", "MN": "B02.200", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid28890", "RR": "txid183988", "AN": "do not confuse entry term METHANOBACTERIA (a class name) with METHANOBACTERIUM, the genus", "MS": "A phylum of ARCHAEA comprising at least seven classes: Methanobacteria, Methanococci, Halobacteria (extreme halophiles), Archaeoglobi (sulfate-reducing species), Methanopyri, and the thermophiles: Thermoplasmata, and Thermococci.", "PM": "1998; for METHANOBACTERIA see METHANOGENS 1979-2003", "HN": "1998", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019605"}, {"RECTYPE": "D", "MH": "Phosphoamino Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Amino Acids, Phosphorus|T116|NON|EQV|NLM (1998)|961003|abcdef", "ENTRY": "Phosphorus Amino Acids", "MN": "D12.125.740", "MH_TH": "NLM (1998)", "ST": "T116", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Amino Acids (1966-1997)", "MS": "Amino acids that contain phosphorus as an integral part of the molecule.", "PM": "98", "HN": "98", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019606"}, {"RECTYPE": "D", "MH": "Brassicaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cruciferae|T002|NON|EQV|NLM (1998)|990101|abcdef", "ENTRY": "Moricandias", "MN": "B01.875.800.575.912.250.157", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid3700", "RR": "txid180539", "MS": "A plant family of the order Capparales, subclass Dilleniidae, class Magnoliopsida. They are mostly herbaceous plants with peppery-flavored leaves, due to gluconapin (GLUCOSINOLATES) and its hydrolysis product butenylisotrhiocyanate. The family includes many plants of economic importance that have been extensively altered and domesticated by humans. Flowers have 4 petals. Podlike fruits contain a number of seeds. Cress is a general term used for many in the Brassicacea family. Rockcress is usually ARABIS; Bittercress is usually CARDAMINE; Yellowcress is usually RORIPPA; Pennycress is usually THLASPI; Watercress refers to NASTURTIUM; or RORIPPA or TROPAEOLUM; Gardencress refers to LEPIDIUM; Indiancress refers to TROPAEOLUM.", "PM": "2003; see CRUCIFERAE 1998-2002", "HN": "2003(1998)", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019607"}, {"RECTYPE": "D", "MH": "Archaeoglobales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Archaeoglobaceae|T194|NON|NRW|NLM (1998)|961003|abcdef", "MN": "B02.200.080", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2231", "RR": "txid2232", "AN": "an order of the kingdom of Euryarchaeota, of the domain of Archaea", "MS": "An order of extremely thermophilic, sulfate-reducing archaea, in the kingdom EURYARCHAEOTA. The single family Archaeoglobaceae contains one genus ARCHAEOGLOBUS.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019608"}, {"RECTYPE": "D", "MH": "Archaeoglobus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.080.080", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2233", "AN": "a genus of archaea, extremely thermophilic", "MS": "A genus of extremely thermophilic, sulfate-reducing archaea, in the family Archaeoglobaceae.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019609"}, {"RECTYPE": "D", "MH": "Cytoprotection", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Cell Protection|T039|NON|EQV|NLM (1998)|961003|abcdef", "ENTRY": "Protection, Cell", "MN": "G07.690.773.500", "MH_TH": "NLM (1998)", "ST": "T039", "AN": "coordinate with specific agent and specific cell", "MS": "The process by which chemical compounds provide protection to cells against harmful agents.", "PM": "98", "HN": "98", "MR": "20150629", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019610"}, {"RECTYPE": "D", "MH": "Archaeoglobus fulgidus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.080.080.100", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2234", "AN": "a species of archaea", "PI": "Archaea (1991-1997)", "MS": "A species of extremely thermophilic, sulfur-reducing archaea. It grows at a maximum temperature of 95 degrees C. in marine or deep-sea geothermal areas.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019611"}, {"RECTYPE": "D", "MH": "Fagopyrum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fagopyrum tataricum|T002|NON|NRW|NLM (1998)|961003|abcdef", "ENTRY": "Buckwheats", "MN": "B01.875.800.575.912.250.825.333", "MH_TH": "NLM (2006)", "ST": "T002", "RN": "txid3616", "RR": "txid62330", "MS": "A plant genus of the family POLYGONACEAE that is used as an EDIBLE GRAIN. Although the seeds are used as cereal, the plant is not one of the cereal grasses (POACEAE).", "PM": "2006; see BARLEY 1998-2005", "HN": "2006(1998)", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019612"}, {"RECTYPE": "D", "MH": "Haloarcula", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.400.400.400", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2237", "AN": "a genus of archaea \"found in neutral saline environments\"", "PI": "Archaea (1990-1997)", "MS": "A genus of HALOBACTERIACEAE distinguished from other genera in the family by the presence of specific derivatives of TGD-2 polar lipids. Haloarcula are found in neutral saline environments such as salt lakes, marine salterns, and saline soils.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019613"}, {"RECTYPE": "D", "MH": "Haloarcula marismortui", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Halobacterium marismortui|T194|NON|EQV|NLM (1998)|961004|HALOBACT MARISMORTUI|abcdefv", "MN": "B02.200.400.400.400.410", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2238", "AN": "a species of halophilic archaea; marismortui is Latin for Dead Sea", "PI": "Halobacterium (1990-1997)", "MS": "A species of halophilic archaea distinguished by its production of acid from sugar. This species was previously called Halobacterium marismortui.", "PM": "98; HALOBACTERIUM MARISMORTUI was see HALOBACTERIUM 1992-97", "HN": "98; HALOBACTERIUM MARISMORTUI was see HALOBACTERIUM 1992-97", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019614"}, {"RECTYPE": "D", "MH": "Crenarchaeota", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.075", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid28889", "AN": "a kingdom of the domain Archaea", "PI": "Archaea (1990-1997)", "MS": "A kingdom in the domain ARCHAEA comprised of thermoacidophilic, sulfur-dependent organisms. The two orders are SULFOLOBALES and THERMOPROTEALES.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970702", "DC": "1", "DX": "19980101", "UI": "D019615"}, {"RECTYPE": "D", "MH": "Thoracic Surgical Procedures", "DE": "THORACIC SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Thoracic Surgical Procedure|T061|NON|EQV|NLM (1998)|961021|THORACIC SURG PROCEDURE|abcdefv", "MN": "E04.928", "FX": "Thoracic Surgery", "MH_TH": "NLM (1998)", "ST": "T061", "AN": "note category: do not confuse with THORACIC SURGERY, the surg specialty; GEN or unspecified; prefer specifics", "PI": "Thorax/surgery (1966-1979)", "MS": "Surgery performed on the thoracic organs, most commonly the lungs and the heart.", "PM": "98", "HN": "98", "MR": "20190524", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019616"}, {"RECTYPE": "D", "MH": "Halobacterium salinarum", "DE": "HALOBACT SALINARUM", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Halobacterium halobium|T194|NON|EQV|NLM (1992)|990101|HALOBACT HALOBIUM|abcdefv", "MN": "B02.200.400.400.410.450", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2242", "PI": "Halobacterium halobium (1993-1997)", "MS": "A species of halophilic archaea found in salt lakes. Some strains form a PURPLE MEMBRANE under anaerobic conditions.", "PM": "2003; see HALOBACTERIUM SALINARIUM 1998-2002; for HALOBACTERIUM HALOBIUM see HALOBACTERIA HALOBIUM 1992-2003", "HN": "2003 (1998)", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019617"}, {"RECTYPE": "D", "MH": "Thermoproteales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.075.800", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2266", "AN": "an order of the kingdom of Crenarchaeota, of the domain Archaea", "PI": "Archaea (1980-1997)", "MS": "An order of CRENARCHAEOTA comprised of rod, disc, or spherical shaped, nonseptate, anaerobic, extreme thermophiles and found in solfataric hot waters, mud holes, and superheated submarine environments.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970702", "DC": "1", "DX": "19980101", "UI": "D019619"}, {"RECTYPE": "D", "MH": "Desulfurococcaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Thermosphaera|T194|NON|NRW|NLM (2004)|020910|abcdef", "MN": "B02.075.200.500", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2272", "RR": "txid54258", "MS": "A family of archaea, in the order DESULFUROCOCCALES, consisting of anaerobic cocci which utilize peptides, proteins or carbohydrates facultatively by sulfur respiration or fermentation. There are eight genera: AEROPYRUM, Desulfurococcus, Ignicoccus, Staphylothermus, Stetteria, Sulfophoboccus, Thermodiscus, and Thermosphaera. (From Bergey's Manual of Systematic Bacteriology, 2d ed)", "PM": "1998", "HN": "1998", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019620"}, {"RECTYPE": "D", "MH": "Haloferax", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.400.400.440", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2251", "AN": "a genus of Halobacteriaceae, extremely halophilic", "PI": "Halobacteriaceae (1990-1997)", "MS": "A genus of extremely halophilic HALOBACTERIACEAE which are chemoheterotropic and strictly aerobic. They are found in neutral saline environments such as salt lakes (especially the Dead Sea) and marine salterns.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019621"}, {"RECTYPE": "D", "MH": "Haloferax volcanii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.400.400.440.900", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2246", "AN": "a species of Haloferax found in the Dead Sea; volcanii refers to B.E. Volcani, discoverer of life in the Dead Sea", "PI": "Halobacteriaceae (1992-1997)", "MS": "A species of halophilic archaea found in the Dead Sea.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019622"}, {"RECTYPE": "D", "MH": "Haloferax mediterranei", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.400.400.440.500", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2252", "AN": "a species of Haloferax of the family Halobacteriaceae", "MS": "A species of halophilic archaea found in the Mediterranean Sea. It produces bacteriocins active against a range of other halobacteria.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019623"}, {"RECTYPE": "D", "MH": "Thermoproteaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.075.800.800", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2267", "MS": "A family of THERMOPROTEALES consisting of variable length rigid rods without septa. They grow either chemolithoautotrophically or by sulfur respiration. The four genera are: PYROBACULUM; THERMOPROTEUS; Caldivirga; and Thermocladium. (From Bergey's Manual of Systematic Bacteriology, 2d ed)", "PM": "1998", "HN": "1998", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019624"}, {"RECTYPE": "D", "MH": "Halococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.400.400.420", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2249", "AN": "a genus of Halobacteriaceae, extremely halophilic", "MS": "A genus of extremely halophilic HALOBACTERIACEAE with coccoid cells occurring singly or as pairs, tetrads, or irregular clusters. They are found in neutral salt lakes, marine salterns, saline soils and seawater.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019625"}, {"RECTYPE": "D", "MH": "Natronobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.400.400.550", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2256", "AN": "natrono- refers to its presence in SODA LAKES & soda soils", "PI": "Halobacteriaceae (1993-1997)", "MS": "A genus of rod-shaped, extremely halophilic HALOBACTERIACEAE which grows in alkaline conditions. They are strictly aerobic and some strains are motile. Natronobacterium is found in soda lakes, alkaline salterns, and soda soils.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019633"}, {"RECTYPE": "D", "MH": "Natronococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.400.400.560", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid29287", "AN": "natrono- refers to its presence in SODA LAKES & soda soils", "PI": "Archaea (1992-1997)", "MS": "A genus of coccoid, extremely halophilic HALOBACTERIACEAE which grows in alkaline conditions. They are nonmotile and strictly aerobic and are found in soda lakes, alkaline salterns, and soda soils.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019634"}, {"RECTYPE": "D", "MH": "Neurosurgical Procedures", "DE": "NEUROSURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedure, Neurologic", "MN": "E04.525", "FX": "Neurosurgery", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Neurosurgery (1966-1997)", "MS": "Surgery performed on the nervous system or its parts.", "PM": "98", "HN": "98", "MR": "20120703", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019635"}, {"RECTYPE": "D", "MH": "Neurodegenerative Diseases", "DE": "NEURODEGENERATIVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Degenerative Diseases, Nervous System|T047|NON|EQV|NLM (2000)|991103|DEGENERATIVE DIS NERVOUS SYSTEM|abcdefv", "ENTRY": "Neurologic Disorders, Degenerative", "MN": "C10.574", "MH_TH": "NLM (1998)", "ST": "T047", "AN": "general or unspecified; prefer specifics; /genet: consider also HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM", "MS": "Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.", "PM": "98", "HN": "98", "MR": "19991103", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019636"}, {"RECTYPE": "D", "MH": "Orthopedic Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgery, Orthopedic|T091|NON|NRW|NLM (1993)|911209|abcdef", "ENTRY": "Surgical Procedures, Orthopedic", "MN": "E04.555", "FX": "Orthopedics", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Orthopedics (1966-1997)", "MS": "Procedures used to treat and correct deformities, diseases, and injuries to the MUSCULOSKELETAL SYSTEM, its articulations, and associated structures.", "PM": "98", "HN": "98", "MR": "20190705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019637"}, {"RECTYPE": "D", "MH": "Methanomicrobiaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Methanoplanus|T194|NON|NRW|NLM (2004)|020930|abcdef", "MN": "B02.200.705.500", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2194", "RR": "txid81416", "MS": "A family of anaerobic METHANOMICROBIALES whose cells are coccoid to straight or slightly curved rods. There are six genera.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019638"}, {"RECTYPE": "D", "MH": "Methanospirillum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Methanospirillaceae|T194|NON|BRD|NLM (2004)|020930|abcdef", "MN": "B02.200.705.750", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2202", "RR": "txid196137", "PI": "Methanogens (1976-1997)", "MS": "The sole genus in the family Methanospirillaceae whose organisms are progressively motile by means of polar, tufted flagella. They have been isolated from sewage-sludge and pear waste digesters as well as marine and non-marine habitats.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019639"}, {"RECTYPE": "D", "MH": "Methanosarcinales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Methanosaetaceae|T194|NON|NRW|NLM (2004)|020930|abcdef", "MN": "B02.200.765", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid94695", "RR": "txid143067", "MS": "An order of anaerobic methanogens in the kingdom EURYARCHAEOTA. There are two families: METHANOSARCINACEAE and Methanosaetaceae.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019640"}, {"RECTYPE": "D", "MH": "DNA, Archaeal", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Archaeal DNA|T114|EQV|NLM (1998)|961009|abdef", "MN": "D13.444.308.180", "MH_TH": "NLM (1998)", "ST": "T114", "RN": "0", "AN": "IM; coord with specific archaeon (IM); /drug eff /ultrastruct permitted", "PI": "DNA, Bacterial (1979-1997)", "MS": "Deoxyribonucleic acid that makes up the genetic material of archaea.", "PM": "98", "HN": "98", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019641"}, {"RECTYPE": "D", "MH": "RNA, Archaeal", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Archaeal RNA|T114|EQV|NLM (1998)|961009|abdef", "MN": "D13.444.735.300", "MH_TH": "NLM (1998)", "ST": "T114", "RN": "0", "AN": "IM; coord with specific archaeon (IM); /drug eff /ultrastruct permitted", "PI": "RNA, Bacterial (1983-1997)", "MS": "Ribonucleic acid in archaea having regulatory and catalytic roles as well as involvement in protein synthesis.", "PM": "98", "HN": "98", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019642"}, {"RECTYPE": "D", "MH": "Arthroplasty, Replacement", "DE": "ARTHROPLASTY REPLACE", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Joint Prosthesis Implantation|T061|NON|EQV|NLM (1998)|961212|abcdef", "ENTRY": "Total Joint Replacements", "MN": "E04.650.110", "FX": "Joint Prosthesis", "MH_TH": "NLM (1998)", "ST": "T061", "AN": "general; note specifics", "PI": "specific joint (1966-1970)", "MS": "Partial or total replacement of a skeletal joint.", "PM": "98; see JOINT PROSTHESIS 1979-97", "HN": "98; use JOINT PROSTHESIS 1979-97", "MR": "20220406", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019643"}, {"RECTYPE": "D", "MH": "Arthroplasty, Replacement, Hip", "DE": "ARTHROPLASTY REPLACE HIP", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Total Hip Arthroplasty|T061|NON|NRW|NLM (2021)|191122|abcdef", "ENTRY": "Total Hip Replacements", "MN": "E04.650.110.110", "FX": "Hip Prosthesis", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Prostheses and Implants (1966-1970)", "MS": "Replacement of the hip joint.", "PM": "98; see HIP PROSTHESIS 1980-97", "HN": "98; use HIP PROSTHESIS 1980-97", "MR": "20220406", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019644"}, {"RECTYPE": "D", "MH": "Arthroplasty, Replacement, Knee", "DE": "ARTHROPLASTY REPLACE KNEE", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Knee Replacement, Total|T061|NON|EQV|NLM (1998)|961010|KNEE REPLACE TOTAL|abcdefv", "ENTRY": "Total Knee Arthroplasty", "MN": "E04.650.110.115", "FX": "Knee Prosthesis", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Prostheses and Implants (1966-1970)", "MS": "Replacement of the knee joint.", "PM": "98; see KNEE PROSTHESIS 1980-97; for KNEE REPLACEMENT, TOTAL see KNEE PROSTHESIS 1992-97", "HN": "98; use KNEE PROSTHESIS 1980-97; for KNEE REPLACEMENT, TOTAL use KNEE PROSTHESIS 1992-97", "MR": "20220406", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019645"}, {"RECTYPE": "D", "MH": "Decompression, Explosive", "AQ": "PC", "ENTRY": "Explosive Decompression", "MN": "G01.374.715.250.500", "MH_TH": "NLM (1998)", "ST": "T067", "PI": "Decompression (1981-1997)", "MS": "A sudden loss of pressure in a pressurized cabin, cockpit, or the like, so rapid as to be explosive. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "PM": "98; see DECOMPRESSION 1981-97, see ATMOSPHERIC PRESSURE 1975-80", "HN": "98; use DECOMPRESSION 1981-97, use ATMOSPHERIC PRESSURE 1975-80; use DECOMPRESSION 1964-74", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019646"}, {"RECTYPE": "D", "MH": "Oral Surgical Procedures", "DE": "ORAL SURG PROCEDURES", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Maxillofacial Procedures|T061|NON|NRW|NLM (1998)|961010|abcdef", "ENTRY": "Procedures, Maxillofacial", "MN": "E06.645", "FX": "Surgery, Oral", "MH_TH": "NLM (1998)", "ST": "T061", "AN": "cranio-maxillo-facial surgical procedures do not go here unless clearly dental; use instead specific anatomical terms /surg or specific surgical procedure if pertinent", "PI": "Surgery, Oral (1966-1997)", "MS": "Surgical procedures used to treat disease, injuries, and defects of the oral and maxillofacial region.", "PM": "98", "HN": "98", "MR": "20141203", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019647"}, {"RECTYPE": "D", "MH": "Foods, Specialized", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Specialized Foods", "MN": "J02.500.525", "MH_TH": "NLM (1998)", "ST": "T168", "AN": "general or unspecified; prefer specifics", "MS": "Foods and beverages prepared for use to meet specific needs such as infant foods.", "PM": "98", "HN": "98", "MR": "20141014", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019648"}, {"RECTYPE": "D", "MH": "Food Industry", "DE": "FOOD INDUST", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Industry, Food", "MN": "J01.576.423", "MH_TH": "NLM (1998)", "ST": "T057", "AN": "general or unspecified; prefer specifics", "MS": "The industry concerned with processing, preparing, preserving, distributing, and serving of foods and beverages.", "PM": "98", "HN": "98", "MR": "20190524", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019649"}, {"RECTYPE": "D", "MH": "Hematopoietic Stem Cell Mobilization", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Stem Cell Mobilization|T061|NON|EQV|NLM (1998)|961011|abcdef", "ENTRY": "Mobilization, Stem Cell", "MN": "E02.095.410", "FX": "Hematopoietic Stem Cell Transplantation", "MH_TH": "NLM (1998)", "ST": "T061", "AN": "note category; \"release of stem cells from bone marrow into peripheral blood circ\" prior to stem cell transpl", "PI": "Hematopoietic Stem Cells (1990-1997)", "MS": "The release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of leukapheresis, prior to stem cell transplantation. Hematopoietic growth factors or chemotherapeutic agents often are used to stimulate the mobilization.", "PM": "98", "HN": "98", "MR": "20040727", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019650"}, {"RECTYPE": "D", "MH": "Plastic Surgery Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Reconstructive Surgical Procedures, Cosmetic|T061|NON|NRW|NLM (2000)|991103|RECONSTRUCTIVE SURG PROCEDURES COSMETIC|abcdefv", "ENTRY": "Surgical Procedures, Plastic", "MN": "E04.617", "FX": "Surgery, Plastic", "MH_TH": "NLM (2023)", "ST": "T061", "AN": "do not confuse with SURGERY, PLASTIC, the specialty", "PI": "Surgery, Plastic (1966-1997)", "MS": "Procedures used to reconstruct, restore, or improve defective, damaged, or missing structures.", "PM": "2023; see RECONSTRUCTIVE SURGICAL PROCEDURES 1998-2022", "HN": "2023 (1998)", "MR": "20220406", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019651"}, {"RECTYPE": "D", "MH": "Extraction and Processing Industry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "J01.576.655.875", "MH_TH": "NLM (1998)", "ST": "T057", "AN": "indust removal of raw materials from the earth & conversion into refined products", "MS": "The industry concerned with the removal of raw materials from the Earth's crust and with their conversion into refined products.", "PM": "98", "HN": "98", "MR": "19991228", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019652"}, {"RECTYPE": "D", "MH": "Myeloablative Agonists", "DE": "MYELOABLATIVE AG", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Agonists, Myeloablative", "MN": "D27.505.954.248.589", "MH_TH": "NLM (1998)", "ST": "T121", "RN": "0", "MS": "Agents that destroy bone marrow activity. They are used to prepare patients for BONE MARROW TRANSPLANTATION or STEM CELL TRANSPLANTATION.", "PM": "98", "HN": "98", "MR": "20050630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019653"}, {"RECTYPE": "D", "MH": "Lens Implantation, Intraocular", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Lens Implantations, Intraocular", "MN": "E04.540.825.600", "FX": "Pseudophakia", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Lenses, Intraocular (1979-1997)", "MS": "Insertion of an artificial lens to replace the natural CRYSTALLINE LENS after CATARACT EXTRACTION or to supplement the natural lens which is left in place.", "PM": "98; was see LENSES, INTRAOCULAR 1979-97", "HN": "98; was see LENSES, INTRAOCULAR 1979-97", "MR": "20070709", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019654"}, {"RECTYPE": "D", "MH": "Quantitative Trait, Heritable", "ENTRY": "Traits, Heritable Quantitative", "MN": "G05.420.720", "FX": "Quantitative Trait Loci", "MH_TH": "NLM (2003)", "ST": "T032", "PI": "Phenotype (1968-1997)", "MS": "A characteristic showing quantitative inheritance such as SKIN PIGMENTATION in humans. (From A Dictionary of Genetics, 4th ed)", "PM": "1998; see QUANTITATIVE TRAIT 1998-2002", "HN": "1998", "MR": "20110624", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019655"}, {"RECTYPE": "D", "MH": "Loss of Heterozygosity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Heterozygosity, Loss of|T045|T049|NON|EQV|NLM (1998)|961202|abbcdef", "ENTRY": "Heterozygosity Loss", "MN": "G05.365.590.029.530", "FX": "Hemizygote", "MH_TH": "NLM (1998)", "ST": "T049", "AN": "do not confuse entry term ALLELIC LOSS with ALLELIC IMBALANCE", "PI": "Heterozygote (1983-1997)", "MS": "The loss of one allele at a specific locus, caused by a deletion mutation; or loss of a chromosome from a chromosome pair, resulting in abnormal HEMIZYGOSITY. It is detected when heterozygous markers for a locus appear monomorphic because one of the ALLELES was deleted.", "PM": "98", "HN": "98", "MR": "20100625", "DA": "19970714", "DC": "1", "DX": "19980101", "UI": "D019656"}, {"RECTYPE": "D", "MH": "Solanaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Dunalia|T002|NON|NRW|NLM (2004)|030417|abcdef", "ENTRY": "Dunalias", "MN": "B01.875.800.575.912.250.908.500", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid4070", "RR": "txid362344", "MS": "A plant family of the order SOLANALES, class MAGNOLIOPSIDA. Among the most noted are POTATOES; TOMATOES; CAPSICUM (green and red peppers); TOBACCO; and BELLADONNA.", "PM": "98", "HN": "98", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019657"}, {"RECTYPE": "D", "MH": "Linaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.797.620", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid4004", "AN": "prefer specific plant", "MS": "A plant family in the order Linales. These plants have simple leaves and regular flowers housing a compound ovary. Stamens are usually fused by their filaments.", "PM": "98", "HN": "98", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019658"}, {"RECTYPE": "D", "MH": "Asteraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Viguiera|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "fluctuan, Enhydra", "MN": "B01.875.800.575.912.250.100", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid4210", "RR": "txid98683", "AN": "note entry term ENHYDRA FLUCTUANS: do not confuse with the sea otter ENHYDRA LUTRIS see OTTERS", "MS": "A large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of \"daisy\" refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.", "PM": "1998; for DORONICUM see ARNICA 1996-2002", "HN": "1998; for DORONICUM use ARNICA 1996-2002", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019659"}, {"RECTYPE": "D", "MH": "Malvaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Waltheria|T002|NON|NRW|NLM (2003)|020328|abcdef", "ENTRY": "Mallow Families", "MN": "B01.875.800.575.912.250.859.821.500", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid3629", "RR": "txid93803", "MS": "The mallow family of the order MALVALES, subclass Dilleniidae, class Magnoliopsida. The common names of hollyhock and mallow are used for several genera of Malvaceae.", "PM": "98", "HN": "98", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019660"}, {"RECTYPE": "D", "MH": "Apiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Umbelliferae|T002|NON|EQV|NLM (1998)|961021|abcdef", "ENTRY": "Smyrniums", "MN": "B01.875.800.575.912.250.075", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid4037", "RR": "txid52507", "AN": "prefer specific plant", "MS": "A large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.", "PM": "98", "HN": "98", "MR": "20230609", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019661"}, {"RECTYPE": "D", "MH": "Cucurbitaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Melothria|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Melothrias", "MN": "B01.875.800.575.912.250.300", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid3650", "RR": "txid386191", "MS": "The gourd plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. It is sometimes placed in its own order, Cucurbitales. 'Melon' generally refers to CUCUMIS; CITRULLUS; or MOMORDICA.", "PM": "1998; for MELONS see CUCUMIS 2002-2004", "HN": "1998; for MELONS use CUCUMIS 2002-2004", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019662"}, {"RECTYPE": "D", "MH": "Chenopodiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Suaeda|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Suaedas", "MN": "B01.875.800.575.912.250.200", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid1804623", "RR": "txid46108", "MS": "The goosefoot plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. It includes beets and chard (BETA VULGARIS), as well as SPINACH, and salt tolerant plants.", "PM": "98", "HN": "98", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019663"}, {"RECTYPE": "D", "MH": "Polygonaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.825", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid3615", "AN": "FAGOPYRUM & RHEUM are also available; prefer specific plant", "MS": "The only family of the buckwheat order (Polygonales) of dicotyledonous flowering plants. It has 40 genera of herbs, shrubs, and trees.", "PM": "1998", "HN": "1998", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019664"}, {"RECTYPE": "D", "MH": "Euphorbiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Spondianthus|T002|NON|NRW|NLM (2003)|011011|abcdef", "MN": "B01.875.800.575.912.250.859.797.438", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid3977", "RR": "txid300959", "MS": "The spurge family of flowering plants in the order Malpighiales. The family consists of annual and perennial herbs and woody shrubs or trees. Members contain securinine.", "PM": "98", "HN": "98", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019665"}, {"RECTYPE": "D", "MH": "Rubiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Schumanniophyton|T002|NON|NRW|NLM (2003)|010927|abcdef", "ENTRY": "Schumanniophytons", "MN": "B01.875.800.575.912.250.456.937", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid24966", "RR": "txid60057", "AN": "do not confuse entry term CRUCIATA with crucifers (BRASSICACEAE)", "MS": "The Madder plant family of the order Gentianales (formerly Rubiales), subclass Asteridae, class Magnoliopsida includes important medicinal plants that provide QUININE; IPECAC; and COFFEE. They have opposite leaves and interpetiolar stipules.", "PM": "1998", "HN": "1998", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019666"}, {"RECTYPE": "D", "MH": "Liliaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Family, Lily", "MN": "B01.875.800.575.912.250.618.875.500", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid4677", "MS": "A monocot family within the order Liliales.", "PM": "98", "HN": "98", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019668"}, {"RECTYPE": "D", "MH": "Embryophyta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Land Plants|T002|NON|EQV|NLM (2011)|091028|abcdef", "ENTRY": "Plants, Land", "MN": "B01.875.800.575", "MH_TH": "NLM (2011)", "ST": "T002", "RN": "txid3193", "AN": "general or unspecified; prefer specifics", "MS": "Higher plants that live primarily in terrestrial habitats, although some are secondarily aquatic. Most obtain their energy from PHOTOSYNTHESIS. They comprise the vascular and non-vascular plants.", "PM": "2011; see PLANT FAMILIES AND GROUPS 1998-2010", "HN": "2011 (1998)", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019669"}, {"RECTYPE": "D", "MH": "Genes, T-Cell Receptor", "DE": "GENES T CELL RECEPT", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "TcR Genes|T028|EQV|NLM (1998)|961023|abdef", "ENTRY": "TcR Gene", "MN": "G05.360.340.024.340.475", "FX": "Receptors, Antigen, T-Cell", "MH_TH": "NLM (1998)", "ST": "T028", "AN": "general or unspecified; prefer specifics", "MS": "DNA sequences, in cells of the T-lymphocyte lineage, that code for T-cell receptors. The TcR genes are formed by somatic rearrangement (see GENE REARRANGEMENT, T-LYMPHOCYTE and its children) of germline gene segments, and resemble Ig genes in their mechanisms of diversity generation and expression.", "PM": "98", "HN": "98", "MR": "20180630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019672"}, {"RECTYPE": "D", "MH": "Genes, T-Cell Receptor alpha", "DE": "GENES T CELL RECEPT ALPHA", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "TcR alpha Genes|T028|EQV|NLM (1998)|961023|abdef", "ENTRY": "TcR alpha Gene", "MN": "G05.360.340.024.340.475.050", "FX": "Receptors, Antigen, T-Cell, alpha-beta", "MH_TH": "NLM (1998)", "ST": "T028", "PI": "Receptors, Antigen, T-Cell/genetics (1985-1991)", "MS": "DNA sequences encoding the alpha chain of the T-cell receptor. The genomic organization of the TcR alpha genes is essentially the same in all species and is similar to the organization of Ig genes.", "PM": "98", "HN": "98", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019673"}, {"RECTYPE": "D", "MH": "Genes, T-Cell Receptor beta", "DE": "GENES T CELL RECEPT BETA", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "TcR beta Genes|T028|EQV|NLM (1998)|961023|abdef", "ENTRY": "TcR beta Gene", "MN": "G05.360.340.024.340.475.080", "FX": "Receptors, Antigen, T-Cell, alpha-beta", "MH_TH": "NLM (1998)", "ST": "T028", "PI": "Receptors, Antigen, T-Cell/genetics (1984-1991)", "MS": "DNA sequences encoding the beta chain of the T-cell receptor. The genomic organization of the TcR beta genes is essentially the same in all species and is similar to the organization of Ig genes.", "PM": "98", "HN": "98", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019674"}, {"RECTYPE": "D", "MH": "Genes, T-Cell Receptor gamma", "DE": "GENES T CELL RECEPT GAMMA", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "TcR gamma Genes|T028|EQV|NLM (1998)|961023|abdef", "ENTRY": "TcR gamma Gene", "MN": "G05.360.340.024.340.475.400", "FX": "Receptors, Antigen, T-Cell, gamma-delta", "MH_TH": "NLM (1998)", "ST": "T028", "PI": "Receptors, Antigen, T-Cell/genetics (1985-1991)", "MS": "DNA sequences encoding the gamma chain of the T-cell receptor. The human gamma-chain locus is organized similarly to the TcR beta-chain locus.", "PM": "98", "HN": "98", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019675"}, {"RECTYPE": "D", "MH": "Genes, T-Cell Receptor delta", "DE": "GENES T CELL RECEPT DELTA", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "TcR delta Genes|T028|EQV|NLM (1998)|961023|abdef", "ENTRY": "TcR delta Gene", "MN": "G05.360.340.024.340.475.240", "FX": "Receptors, Antigen, T-Cell, gamma-delta", "MH_TH": "NLM (1998)", "ST": "T028", "PI": "Receptors, Antigen, T-Cell/genetics (1987-1991)", "MS": "DNA sequences encoding the delta chain of the T-cell receptor. The delta-chain locus is located entirely within the alpha-chain locus.", "PM": "98", "HN": "98", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019676"}, {"RECTYPE": "D", "MH": "Artificial Gene Fusion", "AQ": "DE MT RE", "ENTRY": "Gene Fusions, Artificial", "MN": "E05.393.220.250", "FX": "Recombinant Fusion Proteins", "MH_TH": "NLM (2006)", "ST": "T063", "AN": "GENE FUSION is also available", "PI": "Cloning, Molecular (1980-1997)", "MS": "The in vitro fusion of GENES by RECOMBINANT DNA techniques to analyze protein behavior or GENE EXPRESSION REGULATION, or to merge protein functions for specific medical or industrial uses.", "PM": "2006; see GENE FUSION 1998-2005; see CLONING, MOLECULAR 1988-1997", "HN": "2006 (1998)", "MR": "20050630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019677"}, {"RECTYPE": "D", "MH": "Kininogen, High-Molecular-Weight", "DE": "KININOGEN HMW", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "High-Molecular-Weight Kininogen|T116|T123|NON|EQV|NLM (1998)|961025|HMW KININOGEN|abbcdefv", "ENTRY": "Kininogens, High-Molecular-Weight", "MN": "D23.529.812.654.350", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "PI": "Kininogens (1974-1997)", "MS": "A plasma protein, molecular weight of 110 kD, that normally exists in plasma in a 1:1 complex with PREKALLIKREIN. HMWK is split by plasma kallikrein to produce BRADYKININ. The complex is a cofactor in the activation of coagulation factor XII. The product of this reaction, XIIa, in turn activates prekallikrein to KALLIKREINS. (From Stedman, 26th ed)", "PM": "98; see KININOGENS 1989-97", "HN": "98; use KININOGENS 1989-97", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019679"}, {"RECTYPE": "D", "MH": "Trinucleotide Repeat Expansion", "AQ": "DE ES GE IM PH RE", "ENTRY": "Trinucleotide Repeats, Expanded", "MN": "G05.558.220.865", "FX": "Myotonic Dystrophy", "MH_TH": "NLM (1998)", "ST": "T086", "PI": "Repetitive Sequences, Nucleic Acid (1981-1997)", "MS": "An increased number of contiguous trinucleotide repeats in the DNA sequence from one generation to the next. The presence of these regions is associated with diseases such as FRAGILE X SYNDROME and MYOTONIC DYSTROPHY. Some CHROMOSOME FRAGILE SITES are composed of sequences where trinucleotide repeat expansion occurs.", "PM": "99; see DNA SEQUENCE, UNSTABLE 1998", "HN": "99(98)", "MR": "20160617", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019680"}, {"RECTYPE": "D", "MH": "Penetrance", "MN": "G05.695.650", "FX": "Genes, Modifier", "MH_TH": "NLM (1998)", "ST": "T081", "AN": "frequency a gene or gene combination is manifested in the phenotype", "PI": "Phenotype (1968-1997)", "MS": "The percent frequency with which a dominant or homozygous recessive gene or gene combination manifests itself in the phenotype of the carriers. (From Glossary of Genetics, 5th ed)", "PM": "98", "HN": "98", "MR": "20110624", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019683"}, {"RECTYPE": "D", "MH": "Magnoliopsida", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Angiosperms|T002|NON|EQV|NLM (1998)|990101|abcdef", "ENTRY": "Vahliale", "MN": "B01.875.800.575.912.250", "MH_TH": "NLM (2018)", "ST": "T002", "RN": "txid3398", "PI": "Flowers/Embryology (2008)", "MS": "A class of vascular plants which produce flowers and seeds. They include monocotyledons, dicotyledons, and about 80% of all known plant species.", "PM": "2018; see ANGIOSPERMS 1997-2017", "HN": "2018(1998)", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019684"}, {"RECTYPE": "D", "MH": "Rosales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pittosporum|T002|NON|NRW|NLM (2003)|020327|abcdef", "ENTRY": "Rosale", "MN": "B01.875.800.575.912.250.859.937", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid3744", "RR": "txid23129", "MS": "An order of the class MAGNOLIOPSIDA. Its members include some of the most known ornamental and edible plants of temperate zones including roses, apples, cherries, and peaches.", "PM": "1998", "HN": "1998", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019685"}, {"RECTYPE": "D", "MH": "Lamiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tetradenia|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Tetradenias", "MN": "B01.875.800.575.912.250.583.520", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid4136", "RR": "txid587665", "MS": "The mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).", "PM": "1998", "HN": "1998", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019686"}, {"RECTYPE": "D", "MH": "Uterine Inversion", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Uterus Inversion", "MN": "C12.100.250.852.726", "MH_TH": "NLM (1998)", "ST": "T047", "AN": "do not confuse with UTERINE PROLAPSE", "PI": "Uterine Prolapse (1966-1992)", "MS": "A complication of OBSTETRIC LABOR in which the corpus of the UTERUS is forced completely or partially through the UTERINE CERVIX. This can occur during the late stages of labor and is associated with IMMEDIATE POSTPARTUM HEMORRHAGE.", "PM": "98; was see UTERINE DISEASES 1993-97", "HN": "98; was see UTERINE DISEASES 1993-97", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019687"}, {"RECTYPE": "D", "MH": "Gram-Negative Oxygenic Photosynthetic Bacteria", "DE": "GRAM NEG OXYGENIC PHOTOSYN BACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gram Negative Oxygenic Photosynthetic Bacteria|T007|EPO|EQV|NLM (1998)|970210|abcdef", "MN": "B03.440.475", "MH_TH": "NLM (1998)", "ST": "T007", "AN": "general or unspecified; prefer specifics", "PI": "Cyanobacteria (1970-1997)", "MS": "Widely distributed unicellular or multicellular bacteria. The CYANOBACTERIA use chlorophyll a and phycobilins for oxygenic photosynthesis while genera in the Prochlorales use both chlorophyll a and b but not phycobilins.", "PM": "98", "HN": "98", "MR": "20200902", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019688"}, {"RECTYPE": "D", "MH": "Technetium Tc 99m Exametazime", "DS": "TECHNETIUM TC EXAMETAZIME 099M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Technetium Tc 99m Hexamethylpropyleneamine Oxime|T109|T130|EQV|NLM (1998)|970128|TECHNETIUM TC HEXAMETHYLPROPYLENEAMINE OXIME 099M|TC HMPAO|abbdefsv", "ENTRY": "Technetium Tc 99m Hexamethylpropylene amine Oxime", "MN": "D02.691.825.562", "PA": "Radiopharmaceuticals", "MH_TH": "USAN (1989)", "ST": "T130", "RN": "3B744AG22N", "RR": "100504-35-6", "AN": "for routine use as label, use no qualifiers", "PI": "Oximes (1985-1997)", "MS": "A gamma-emitting RADIONUCLIDE IMAGING agent used in the evaluation of regional cerebral blood flow and in non-invasive dynamic biodistribution studies and MYOCARDIAL PERFUSION IMAGING. It has also been used to label leukocytes in the investigation of INFLAMMATORY BOWEL DISEASES.", "PM": "98; TECHNETIUM TC 99M EXAMETAZINE was indexed under ORGANOTECHNETIUM COMPOUNDS 1990-97, OXIMES 1985-97, & ORGANOMETALLIC COMPOUNDS 1985-89", "HN": "98; see TECHNETIUM TC 99M EXAMETAZIME (NM) 1985-97", "MR": "20150527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019690"}, {"RECTYPE": "D", "MH": "Prochloron", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.655.620", "MH_TH": "NLM (1998)", "ST": "T007", "RN": "txid1214", "MS": "A genus of PROCHLOROPHYTES containing unicellular, spherical bacteria without a mucilaginous sheath. They are found almost exclusively as extracellular symbionts of colonial ASCIDIANS on subtropical or tropical marine shores.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019691"}, {"RECTYPE": "D", "MH": "Prochlorothrix", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.655.640", "MH_TH": "NLM (1998)", "ST": "T007", "RN": "txid1222", "PI": "Cyanobacteria (1985-1997)", "MS": "A genus of PROCHLOROPHYTES occurring in unbranched chains of indefinite length and containing both chlorophylls a and b.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019692"}, {"RECTYPE": "D", "MH": "Hepatitis, Autoimmune", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Autoimmune Hepatitis|T047|NON|EQV|NLM (1998)|ORD (2010)|961107|abcdeef", "ENTRY": "Hepatitis, Autoimmune Chronic", "MN": "C20.111.567", "MH_TH": "NLM (1998)", "ST": "T047", "PI": "Hepatitis (1967-1997)", "MS": "A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.", "PM": "1998", "HN": "1998", "MR": "20180630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019693"}, {"RECTYPE": "D", "MH": "Hepatitis B, Chronic", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Chronic Hepatitis B|T047|NON|EQV|NLM (1998)|961104|abcdef", "ENTRY": "Hepatitis B Virus Infection, Chronic|T047|NON|EQV|NLM (2018)|160930|abcdef", "MN": "C23.550.291.500.477.500", "MH_TH": "NLM (1998)", "ST": "T047", "PI": "Hepatitis, Chronic (1983-1997)", "MS": "INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.", "PM": "98", "HN": "98", "MR": "20210312", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019694"}, {"RECTYPE": "D", "MH": "Glycyrrhizic Acid", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glycyrrhizin|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1998)|961105|abbcdeef", "ENTRY": "Glycyrrhizinate, Dipotassium", "MN": "D02.455.849.919.530.466", "PA": "Anti-Inflammatory Agents", "MH_TH": "NLM (1998)", "ST": "T121", "N1": "alpha-D-glucopyranosiduronic acid, (3 beta,20 beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-", "RN": "6FO62043WK", "RR": "CA2Y0FE3FX", "AN": "do not confuse with GLYCYRRHETINIC ACID", "PI": "Glycyrrhiza (1976-1985)", "MS": "A widely used anti-inflammatory agent isolated from the licorice root. It is metabolized to GLYCYRRHETINIC ACID, which inhibits 11-BETA-HYDROXYSTEROID DEHYDROGENASES and other enzymes involved in the metabolism of CORTICOSTEROIDS. Therefore, glycyrrhizic acid, which is the main and sweet component of licorice, has been investigated for its ability to cause hypermineralocorticoidism with sodium retention and potassium loss, edema, increased blood pressure, as well as depression of the renin-angiotensin-aldosterone system.", "PM": "98; GLYCYRRHIZIC ACID was indexed under GLYCYRRHETINIC ACID 1979-97, GLYCYRRHIZA 1976-79, GLUCOSIDURONATES 1976-79, & ENOXOLONE 1977-79", "HN": "98; see GLYCYRRHIZIC ACID (NM) 1976-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019695"}, {"RECTYPE": "D", "MH": "Peptidylprolyl Isomerase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Prolyl Isomerase|T116|T126|NON|EQV|NLM (1998)|961106|abbcdef", "ENTRY": "cis-trans-Isomerase, Peptidyl-Prolyl", "MN": "D08.811.399.325.500", "MH_TH": "NLM (1998)", "ST": "T126", "N1": "Peptidylproline cis-trans-isomerase", "RN": "EC 5.2.1.8", "PI": "Carrier Proteins (1984-1997)", "MS": "An enzyme that catalyzes the isomerization of proline residues within proteins. EC 5.2.1.8.", "PM": "98; PEPTIDYLPROLYL ISOMERASE was indexed under CARRIER PROTEINS & AMINO ACID ISOMERASES 1984-97", "HN": "98; use PEPTIDYLPROLYL ISOMERASE (NM) 1984-97", "MR": "20030709", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019696"}, {"RECTYPE": "D", "MH": "Onions", "AQ": "AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI", "PRINT ENTRY": "Leeks|T002|T168|NON|REL|NLM (1998)|961106|abbcdef", "ENTRY": "Onion", "MN": "B01.875.800.575.912.250.618.100.050.060.600", "MH_TH": "NLM (1998)", "ST": "T168", "RR": "txid4681", "PI": "Plants (1966-1985)", "MS": "Herbaceous biennial plants and their edible bulbs, belonging to the Allium genus.", "PM": "98; was see ALLIUM 1986-97", "HN": "98; was see ALLIUM 1986-97", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019697"}, {"RECTYPE": "D", "MH": "Hepatitis C, Chronic", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Chronic Hepatitis C|T047|NON|EQV|NLM (1998)|961106|abcdef", "MN": "C23.550.291.500.477.750", "MH_TH": "NLM (1998)", "ST": "T047", "PI": "Hepatitis, Chronic (1984-1997)", "MS": "INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.", "PM": "98", "HN": "98", "MR": "20210312", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019698"}, {"RECTYPE": "D", "MH": "Thrombospondins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Thrombospondin|T116|T123|NON|EQV|NLM (1998)|961108|abbcdef", "MN": "D12.776.543.550.895", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "AN": "membrane glycoproteins; THROMBOSPONDIN 1 is also available", "PI": "Platelet Membrane Glycoproteins (1992-1993)", "MS": "A family of related, adhesive glycoproteins which are synthesized, secreted, and incorporated into the extracellular matrix of a variety of cells, including alpha granules of platelets following thrombin activation and endothelial cells. They interact with a number of BLOOD COAGULATION FACTORS and anticoagulant factors. Five distinct forms have been identified, thrombospondin 1, -2, -3, -4, and cartilage oligomeric matrix protein (COMP). They are involved in cell adhesion, platelet aggregation, cell proliferation, angiogenesis, tumor metastasis, VASCULAR SMOOTH MUSCLE growth, and tissue repair.", "PM": "98; THROMBOSPONDIN was indexed under MEMBRANE GLYCOPROTEINS 1989-97, PLATELET MEMBRANE GLYCOPROTEINS 1992-93, & GLYCOPROTEINS 1981-89", "HN": "98; see THROMBOSPONDINS (NM) 1981-97", "MR": "20230316", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019699"}, {"RECTYPE": "D", "MH": "Thrombospondin 1", "DS": "THROMBOSPONDIN 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TSP-1|T116|T123|ABB|EQV|NLM (1998)|970307|TSP 01|abbcdefs", "MN": "D12.776.543.550.895.800", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "AN": "a membrane glycoprotein", "PI": "Platelet Membrane Glycoproteins (1991-1993)", "MS": "An extracellular matrix glycoprotein from platelets and a variety of normal and transformed cells of both mesenchymal and epithelial origin. Thrombospondin-1 is believed to play a role in cell migration and proliferation, during embryogenesis and wound repair. Also, it has been studied for its use as a potential regulator of tumor growth and metastasis.", "PM": "98; THROMBOSPONDIN 1 was indexed under MEMBRANE GLYCOPROTEINS 1993-97& PLATELET MEMBRANE GLYCOPROTEINS 1991-93", "HN": "98; see THROMBOSPONDIN (NM) 1991-97", "MR": "20230316", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019700"}, {"RECTYPE": "D", "MH": "Hepatitis D, Chronic", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Delta Hepatitis, Chronic|T047|NON|EQV|NLM (1998)|970131|abcdef", "ENTRY": "Hepatitis, Chronic Delta", "MN": "C23.550.291.500.477.875", "MH_TH": "NLM (1998)", "ST": "T047", "PI": "Hepatitis, Viral, Human (1983-1986)", "MS": "INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS in conjunction with HEPATITIS B VIRUS and lasting six months or more.", "PM": "98", "HN": "98", "MR": "20210312", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019701"}, {"RECTYPE": "D", "MH": "Calcineurin", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Phosphatase-2B|T116|T126|NON|EQV|NLM (1998)|970130|PROTEIN PHOSPHATASE B 02|abbcdefs", "ENTRY": "Protein Phosphatase 2B", "MN": "D12.776.476.559.150", "EC": "antagonists & inhibitors:Calcineurin Inhibitors", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 3.1.3.16", "PI": "Phosphoprotein Phosphatase (1988-1997)", "MS": "A CALCIUM and CALMODULIN-dependent serine/threonine protein phosphatase that is composed of the calcineurin A catalytic subunit and the calcineurin B regulatory subunit. Calcineurin has been shown to dephosphorylate a number of phosphoproteins including HISTONES; MYOSIN LIGHT CHAIN; and the regulatory subunits of CAMP-DEPENDENT PROTEIN KINASES. It is involved in the regulation of signal transduction and is the target of an important class of immunophilin-immunosuppressive drug complexes.", "PM": "98; CALCINEURIN was indexed under PHOSPHOPROTEIN PHOSPHATASE 1988-97 & CALMODULIN-BINDING PROTEINS 1986-97; CALCINEURIN B (now CALCINEURIN) was indexed under CALCIUM-BINDING PROTEINS 1994-97", "HN": "98; see CALCINEURIN (NM) 1987-97", "MR": "20210520", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019703"}, {"RECTYPE": "D", "MH": "Protein Disulfide-Isomerases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Disulfide-Isomerase|T116|T126|NON|EQV|NLM (1998)|990101|abbcdef", "ENTRY": "Trypanothione Glutathione Thioltransferase", "MN": "D08.811.399.475.800.550", "FX": "Procollagen-Proline Dioxygenase", "MH_TH": "NLM (2009)", "ST": "T126", "N1": "Protein disulfide-isomerase", "RN": "EC 5.3.4.1", "RR": "37318-49-3 (CAS RN)", "MS": "Sulfur-sulfur bond isomerases that catalyze the rearrangement of disulfide bonds within proteins during folding. Specific protein disulfide-isomerase isoenzymes also occur as subunits of PROCOLLAGEN-PROLINE DIOXYGENASE.", "PM": "2008; see PROTEIN DISULFIDE-ISOMERASE 1998-2008; PROTEIN DISULFIDE-ISOMERASE was indexed under ISOMERASES 1977-1997, DISULFIDES 1974-1982, & PROTEINS 1974-1979", "HN": "2008(1998);", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019704"}, {"RECTYPE": "D", "MH": "Excitatory Postsynaptic Potentials", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "EPSP|T042|ABB|EQV|NLM (1998)|970512|abcdef", "ENTRY": "Potentials, Excitatory Postsynaptic", "MN": "G11.561.830.750.199", "MH_TH": "NLM (1998)", "ST": "T042", "AN": "for miniature end plate potentials or miniature excitatory postsynaptic potentials coordinate with MINIATURE POSTSYNAPTIC POTENTIALS", "PI": "Evoked Potentials (1967-1997)", "MS": "Depolarization of membrane potentials at the SYNAPTIC MEMBRANES of target neurons during neurotransmission. Excitatory postsynaptic potentials can singly or in summation reach the trigger threshold for ACTION POTENTIALS.", "PM": "98", "HN": "98", "MR": "20160623", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019706"}, {"RECTYPE": "D", "MH": "Receptors, Chemokine", "DE": "RECEPT CHEMOKINE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Chemokine Receptors|T116|T129|T192|NON|EQV|NLM (1998)|961119|CHEMOKINE RECEPT|abbbcdefv", "ENTRY": "Receptor, Chemokine", "MN": "D12.776.543.750.705.852.125", "MH_TH": "NLM (1998)", "ST": "T192", "RN": "0", "PI": "Receptors, Cytokine (1993-1997)", "MS": "Cell surface glycoproteins that bind to chemokines and thus mediate the migration of pro-inflammatory molecules. The receptors are members of the seven-transmembrane G protein-coupled receptor family. Like the CHEMOKINES themselves, the receptors can be divided into at least three structural branches: CR, CCR, and CXCR, according to variations in a shared cysteine motif.", "PM": "1998", "HN": "1998", "MR": "20200527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019707"}, {"RECTYPE": "D", "MH": "Korarchaeota", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.500", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid51967", "MS": "A kingdom in the domain ARCHAEA, comprising thermophilic organisms from terrestrial hot springs that are among the most primitive of all life forms. They have undergone comparatively little evolutionary change since the last common ancestor of all extant life.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019708"}, {"RECTYPE": "D", "MH": "Thermococcales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.825", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2258", "AN": "an order of the kingdom of Euryarchaeota, of the domain of Archaea", "MS": "An order of strictly anaerobic, thermophilic archaea, in the kingdom EURYARCHAEOTA. Members exhibit heterotropic growth by sulfur respiration. There is a single family THERMOCOCCACEAE.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019709"}, {"RECTYPE": "D", "MH": "Thermococcaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.825.800", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2259", "AN": "a family of the order Thermococcales", "MS": "A family of anaerobic THERMOCOCCALES found in hot environments. There are two genera: PYROCOCCUS and THERMOCOCCUS.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019710"}, {"RECTYPE": "D", "MH": "Pyrococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.825.800.650", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2260", "AN": "a genus of archaea found in heated seawaters; THERMOCOCCUS, found in heated seawater, is also available", "PI": "Archaea (1989-1997)", "MS": "A genus of strictly anaerobic ultrathermophilic archaea, in the family THERMOCOCCACEAE, occurring in heated seawaters. They exhibit heterotrophic growth at an optimum temperature of 100 degrees C.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019711"}, {"RECTYPE": "D", "MH": "Thermococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.825.800.800", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2263", "AN": "a genus of archaea found in heated sea flows; PYROCOCCUS, found in heated seawater, is also available", "PI": "Archaea (1988-1997)", "MS": "A genus of extremely thermophilic heterotrophic archaea, in the family THERMOCOCCACEAE, occurring in heated sea flows. They are anaerobic chemoorganotropic sulfidogens.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019712"}, {"RECTYPE": "D", "MH": "Receptors, CCR5", "DE": "RECEPT CCR5", "DS": "RECEPTORS CCR 005", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD195 Antigens|T116|T192|ABX|EQV|NLM (2008)|061201|CD 195 ANTIGENS|abbcdefs", "ENTRY": "Receptor, CCR5", "MN": "D12.776.543.750.830.700.605", "EC": "antagonists & inhibitors:CCR5 Receptor Antagonists", "MH_TH": "NLM (1998)", "ST": "T192", "RN": "0", "PI": "Receptors, HIV (1997)", "MS": "CCR receptors with specificity for CHEMOKINE CCL3; CHEMOKINE CCL4; and CHEMOKINE CCL5. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; MACROPHAGES; MAST CELLS; and NK CELLS. The CCR5 receptor is used by the HUMAN IMMUNODEFICIENCY VIRUS to infect cells.", "PM": "1998; CC CHEMOKINE RECEPTOR 5 (now RECEPTORS, CCR5) was indexed under RECEPTORS, HIV 1997 & RECEPTORS, CYTOKINE 1996-97", "HN": "1998; use RECEPTORS, CCR5 (NM) 1996-97", "MR": "20170524", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019713"}, {"RECTYPE": "D", "MH": "Tissue Inhibitor of Metalloproteinases", "DE": "TISSUE INHIB METALLOPROTEINASES", "DS": "TISSUE INHIBITOR 99 OF METALLOPROTEINASES", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tissue Inhibitor of Metalloproteinase|T116|T121|T123|NON|EQV|NLM (2021)|200220|abbbcdef", "ENTRY": "Proteins, TIMP", "MN": "D12.776.815.875", "PA": "Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Glycoproteins (1980-1990)", "MS": "A family of secreted protease inhibitory proteins that regulates the activity of SECRETED MATRIX METALLOENDOPEPTIDASES. They play an important role in modulating the proteolysis of EXTRACELLULAR MATRIX, most notably during tissue remodeling and inflammatory processes.", "PM": "98; COLLAGENASE INHIBITOR (now TISSUE INHIBITOR OF METALLOPROTEINASES) was indexed under GLYCOPROTEINS 1989-97 & ENZYME INHIBITORS 1980-90", "HN": "98; see TISSUE INHIBITOR OF METALLOPROTEINASES (NM) 1980-97", "MR": "20220712", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019714"}, {"RECTYPE": "D", "MH": "Tissue Inhibitor of Metalloproteinase-1", "DE": "TISSUE INHIB METALLOPROTEINASE 1", "DS": "TISSUE INHIBITOR 01 OF METALLOPROTEINASE", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TIMP-1|T116|T123|ABB|EQV|NLM (1998)|961118|TIMP 01|abbcdefs", "ENTRY": "Tissue Inhibitor of Metalloproteinase 1", "MN": "D12.776.815.875.450", "PA": "Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "PI": "Glycoproteins (1990-1997)", "MS": "A member of the family of TISSUE INHIBITOR OF METALLOPROTEINASES. It is a N-glycosylated protein, molecular weight 28 kD, produced by a vast range of cell types and found in a variety of tissues and body fluids. It has been shown to suppress metastasis and inhibit tumor invasion in vitro.", "PM": "98; COLLAGENASE INHIBITOR (now TISSUE-INHIBITOR OF METALLOPROTEINASE-1) was indexed under GLYCOPROTEINS 1990-97", "HN": "98; see TISSUE-INHIBITOR OF METALLOPROTEINASE-1 (NM) 1980-97", "MR": "20220712", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019715"}, {"RECTYPE": "D", "MH": "Tissue Inhibitor of Metalloproteinase-2", "DE": "TISSUE INHIB METALLOPROTEINASE 2", "DS": "TISSUE INHIBITOR 02 OF METALLOPROTEINASE", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TIMP-2|T116|T121|T123|ABB|EQV|NLM (1998)|961118|TIMP 02|abbbcdefs", "ENTRY": "Tissue Inhibitor of Metalloproteinase 2", "MN": "D12.776.815.875.500", "PA": "Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "127497-59-0", "PI": "Proteins (1990-1997)", "MS": "A member of the family of TISSUE INHIBITOR OF METALLOPROTEINASES. It is a 21-kDa nonglycosylated protein found in tissue fluid and is secreted as a complex with progelatinase A by human fibroblast and uncomplexed from alveolar macrophages. An overexpression of TIMP-2 has been shown to inhibit invasive and metastatic activity of tumor cells and decrease tumor growth in vivo.", "PM": "1998; TISSUE INHIBITOR OF METALLOPROTEINASE 2 was indexed under PROTEINS 1990-97 & NEOPLASM PROTEINS 1989-1993", "HN": "1998; see TISSUE INHIBITOR OF METALLOPROTEINASE-2 (NM) 1989-1997", "MR": "20220712", "DA": "19970630", "DC": "1", "DX": "19980101", "UI": "D019716"}, {"RECTYPE": "D", "MH": "Tissue Inhibitor of Metalloproteinase-3", "DE": "TISSUE INHIB METALLOPROTEINASE 3", "DS": "TISSUE INHIBITOR 03 OF METALLOPROTEINASE", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tissue Inhibitor of Metalloproteinase 3", "MN": "D12.776.815.875.550", "PA": "Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "PI": "Proteins (1995-1997)", "MS": "A member of the family of tissue inhibitor of metalloproteinases. Mutations of the gene for TIMP3 PROTEIN causes Sorsby fundus dystrophy.", "PM": "1998; TISSUE INHIBITOR OF METALLOPROTEINASE 3 was indexed under PROTEINS 1995-97 & NEOPLASM PROTEINS 1992-1995", "HN": "1998; see TISSUE INHIBITOR OF METALLOPROTEINASE-3 (NM) 1992-1997", "MR": "20220712", "DA": "19970630", "DC": "1", "DX": "19980101", "UI": "D019717"}, {"RECTYPE": "D", "MH": "Receptors, CXCR4", "DE": "RECEPT CXCR4", "DS": "RECEPTORS CXCR 004", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Fusin|T116|T192|NON|EQV|NLM (1998)|961119|abbcdef", "ENTRY": "Receptor, CXCR4", "MN": "D12.776.543.750.830.700.650", "MH_TH": "NLM (1998)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1994-1997)", "MS": "CXCR receptors with specificity for CXCL12 CHEMOKINE. The receptors may play a role in HEMATOPOIESIS regulation and can also function as coreceptors for the HUMAN IMMUNODEFICIENCY VIRUS.", "PM": "1998; FUSIN was indexed under RECEPTORS, HIV 1997 and MEMBRANE PROTEINS 1996-97; LESTR RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1994-97", "HN": "1998; use RECEPTORS, CXCR4 1994-97", "MR": "20170524", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019718"}, {"RECTYPE": "D", "MH": "Diagnostic Equipment", "DE": "DIAG EQUIPMENT", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Equipments, Diagnostic", "MN": "E07.230", "MH_TH": "NLM (1998)", "ST": "T074", "MS": "Nonexpendable items used in examination.", "PM": "98", "HN": "98", "MR": "20150605", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019719"}, {"RECTYPE": "D", "MH": "Otoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Otoscope|T074|NON|EQV|NLM (2003)|020311|abcdef", "MN": "E07.230.550", "FX": "Otoscopy", "MH_TH": "NLM (1998)", "ST": "T074", "PI": "Otolaryngology/instrumentation (1968-1997)", "MS": "Instruments designed to inspect or auscultate the ear. They are designed primarily to examine the outer ear canal and tympanic membrane by means of light and air under moderate pressure, as with a pneumatic otoscope. (UMDNS, 1999)", "PM": "98", "HN": "98", "MR": "20020703", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019720"}, {"RECTYPE": "D", "MH": "Ophthalmoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Funduscopes|T074|NON|EQV|NLM (1998)|961120|abcdef", "ENTRY": "Ophthalmoscope", "MN": "E07.230.540", "MH_TH": "NLM (1998)", "ST": "T074", "PI": "Ophthalmoscopy/instrumentation (1966-1997)", "MS": "Devices for examining the interior of the eye, permitting the clear visualization of the structures of the eye at any depth. (UMDNS, 1999)", "PM": "98", "HN": "98", "MR": "19991103", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019721"}, {"RECTYPE": "D", "MH": "Sphygmomanometers", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Sphygmomanometer", "MN": "E07.230.740", "MH_TH": "NLM (1998)", "ST": "T074", "PI": "Blood Pressure Determination/instrumentation (1966-1997)", "MS": "Instruments for measuring arterial blood pressure consisting of an inflatable cuff, inflating bulb, and a gauge showing the blood pressure. (Stedman, 26th ed)", "PM": "98", "HN": "98", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019722"}, {"RECTYPE": "D", "MH": "Endoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Endoscope", "MN": "E07.858.240", "FX": "Endoscopy", "MH_TH": "NLM (1998)", "ST": "T074", "AN": "general or unspecified; prefer specifics", "PI": "Sigmoidoscopy/instrumentation (1966-1997)", "MS": "Instruments for the visual examination of interior structures of the body. There are rigid endoscopes and flexible fiberoptic endoscopes for various types of viewing in ENDOSCOPY.", "PM": "98", "HN": "98", "MR": "20100625", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019723"}, {"RECTYPE": "D", "MH": "Presumed Consent", "AQ": "ES HI LJ", "ENTRY": "Consent, Presumed", "MN": "N03.706.535.664", "MH_TH": "NLM (1999)", "ST": "T089", "PI": "Informed Consent (1986-1998)", "MS": "An institutional policy of granting authority to health personnel to perform procedures on patients or to remove organs from cadavers for transplantation unless an objection is registered by family members or by the patient prior to death. This also includes emergency care of minors without prior parental consent.", "PM": "99", "HN": "99", "MR": "20021031", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D019724"}, {"RECTYPE": "D", "MH": "Patient Self-Determination Act", "AQ": "CL EC ES HI OG SN ST TD", "PRINT ENTRY": "United States Patient Self-Determination Act|T089|NON|EQV|NLM (2002)|001205|abcdef", "ENTRY": "United States Patient Self Determination Act", "MN": "N03.706.615.808", "FX": "Advance Directives", "MH_TH": "NLM (1999)", "ST": "T089", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "MS": "The purpose of this 1990 federal act is to assure that individuals receiving health care services will be given an opportunity to participate in and direct health care decisions affecting themselves. Under this act, hospitals, health care agencies, and health maintenance organizations are responsible for developing patient information for distribution. The information must include patients' rights, advance directives, living wills, ethics committees' consultation and education functions, limited medical treatment (support/comfort care only), mental health treatment, resuscitation, restraints, surrogate decision making and transfer of care. (from JCAHO, Lexicon, 1994)", "PM": "99", "HN": "99", "MR": "20160628", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D019726"}, {"RECTYPE": "D", "MH": "Proxy", "AQ": "CL HI LJ PX SN", "PRINT ENTRY": "Patient Agent|T096|NON|NRW|NLM (1999)|961120|abcdef", "ENTRY": "Proxies", "MN": "M01.380.600", "FX": "Treatment Refusal", "MH_TH": "NLM (1999)", "ST": "T096", "MS": "A person authorized to decide or act for another person, for example, a person having durable power of attorney.", "PM": "99", "HN": "99", "MR": "19991103", "DA": "19980618", "DC": "1", "DX": "19990101", "UI": "D019727"}, {"RECTYPE": "D", "MH": "Kininogen, Low-Molecular-Weight", "DE": "KININOGEN LMW", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Low-Molecular-Weight Kininogen|T116|T123|NON|EQV|NLM (1998)|961120|LMW KININOGEN|abbcdefv", "ENTRY": "Kininogens, Low-Molecular-Weight", "MN": "D23.529.812.654.400", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "PI": "Kininogens (1975-1997)", "MS": "A protein, molecular weight 50 kD, located in various normal tissues. Upon cleavage by KALLIKREINS, it forms KALLIDIN. Kallidin, in turn, is converted into BRADYKININ. (From Stedman, 25th ed)", "PM": "98; see KININOGENS 1989-97", "HN": "98; use KININOGENS 1989-97", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019728"}, {"RECTYPE": "D", "MH": "Carbon-Oxygen Ligases", "DE": "C O LIGASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ligases, Carbon-Oxygen", "MN": "D08.811.464.263", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 6.1.-", "AN": "do not confuse with CARBON-OXYGEN LYASES", "MS": "Enzymes that catalyze the joining of two molecules by the formation of a carbon-oxygen bond. EC 6.1.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019729"}, {"RECTYPE": "D", "MH": "Carbon-Sulfur Ligases", "DE": "C S LIGASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ligases, Carbon-Sulfur", "MN": "D08.811.464.267", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 6.2.-", "MS": "Enzymes that catalyze the joining of two molecules by the formation of a carbon-sulfur bond. EC 6.2.", "PM": "98", "HN": "98", "MR": "20180630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019730"}, {"RECTYPE": "D", "MH": "Carbon-Nitrogen Ligases", "DE": "C N LIGASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ligases, Carbon-Nitrogen", "MN": "D08.811.464.259", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 6.3.-", "MS": "Enzymes that catalyze the joining of two molecules by the formation of a carbon-nitrogen bond. EC 6.3.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019731"}, {"RECTYPE": "D", "MH": "Amide Synthases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthases, Amide", "MN": "D08.811.464.259.200", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 6.3.1.-", "MS": "Enzymes that catalyze the joining of either ammonia or an amide with another molecule, in which the linkage is in the form of a carbon-nitrogen bond. EC 6.3.1.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019732"}, {"RECTYPE": "D", "MH": "Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor", "DE": "C N LIGASES GLN DONOR", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Carbon Nitrogen Ligases with Glutamine as Amide N Donor", "MN": "D08.811.464.259.400", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 6.3.5.-", "MS": "Enzymes that catalyze the joining of glutamine-derived ammonia and another molecule. The linkage is in the form of a carbon-nitrogen bond. EC 6.3.5.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019733"}, {"RECTYPE": "D", "MH": "Carbon-Carbon Ligases", "DE": "C C LIGASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ligases, Carbon-Carbon", "MN": "D08.811.464.257", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 6.4.-", "MS": "Enzymes that catalyze the joining of two molecules by the formation of a carbon-carbon bond. These are the carboxylating enzymes and are mostly biotinyl-proteins. EC 6.4.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019735"}, {"RECTYPE": "D", "MH": "Prostheses and Implants", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD UL VE VI", "PRINT ENTRY": "Prosthetic Implant|T074|NON|EQV|NLM (2022)|201022|abcdef", "ENTRY": "Implants, Prosthetic", "MN": "E07.695", "FX": "Prosthesis Retention", "MH_TH": "NLM (1998)", "ST": "T074", "AN": "general or unspecified; prefer specifics; coordinate with prosthetic or implant material if pertinent; adv eff: consider PROSTHESIS-RELATED INFECTIONS; BIOPROSTHESIS is also available", "PI": "specific prosthesis (1966-1997)", "MS": "Artificial substitutes for body parts, and materials inserted into tissue for functional, cosmetic, or therapeutic purposes. Prostheses can be functional, as in the case of artificial arms and legs, or cosmetic, as in the case of an artificial eye. Implants, all surgically inserted or grafted into the body, tend to be used therapeutically. IMPLANTS, EXPERIMENTAL is available for those used experimentally.", "PM": "1998; IMPLANTS, ARTIFICIAL was heading 1981-1997; PROSTHESIS was heading 1963-1997", "HN": "1998", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019736"}, {"RECTYPE": "D", "MH": "Transplants", "AQ": "AB AH BS CH CL CY DE DG EC EM EN GD HI IM IN IR ME MI PA PH PP PS RE SD SN ST SU TR UL VI", "PRINT ENTRY": "Tissue Transplants|T024|NON|NRW|NLM (1998)|961125|abcdef", "ENTRY": "Transplants, Tissue", "MN": "A01.941", "FX": "Bioprosthesis", "MH_TH": "NLM (1998)", "ST": "T025", "AN": "use for the transplant itself: use TRANSPLANTATION for the surgical procedure; note specifics; coordinate IM with organ / transpl (IM) or precoordinated organ / transplantation term (IM)", "MS": "Organs, tissues, or cells taken from the body for grafting into another area of the same body or into another individual.", "PM": "98; ORGAN TRANSPLANTS was see ORGAN TRANSPLANTATION 1991-97, was see TRANSPLANTATION 1990", "HN": "98; ORGAN TRANSPLANTS was see ORGAN TRANSPLANTATION 1991-97, was see TRANSPLANTATION 1990", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019737"}, {"RECTYPE": "D", "MH": "Surgically-Created Structures", "DE": "SURG CREATED STRUCTURES", "AQ": "AE BS CL EC ES HI IM IR MI PA PH PS SD SN ST TD VE VI", "ENTRY": "Surgically Created Structures", "MN": "E07.862", "MH_TH": "NLM (1998)", "ST": "T017", "AN": "general or unspecified; prefer specifics; coordinate with organ or tissue /surg or specific surgical procedure ", "MS": "Organs or parts of organs surgically formed from nearby tissue to function as substitutes for diseased or surgically removed tissue.", "PM": "98", "HN": "98", "MR": "20190524", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019738"}, {"RECTYPE": "D", "MH": "Skeletal Muscle Ventricle", "AQ": "AE BS CL EC ES HI IM IR MI PA PH PS SD SN ST TD VE VI", "ENTRY": "Ventricles, Skeletal Muscle", "MN": "E07.862.700", "FX": "Cardiomyoplasty", "MH_TH": "NLM (1998)", "ST": "T074", "AN": "autol skeletal musc wrapped around heart & electrically stimulated to provide mechanical heart assist", "PI": "Muscles (1989-1994)", "MS": "Autologous skeletal muscle that is wrapped around the heart and electrically stimulated in order to provide mechanical heart assistance. The latissimus dorsi muscle is commonly used to form this ventricle that functions to independently augment cardiac performance by pumping in series with the heart.", "PM": "98; was see CARDIOMYOPLASTY 1995-97", "HN": "98; was see CARDIOMYOPLASTY 1995-97", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019739"}, {"RECTYPE": "D", "MH": "Haemophilus influenzae type b", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Hib|T007|ABB|EQV|NLM (1998)|961122|abcdef", "MN": "B03.660.250.550.290.330.150", "FX": "Meningitis, Haemophilus", "MH_TH": "NLM (1998)", "ST": "T007", "AN": "infection: coordinate with HAEMOPHILUS INFECTIONS or MENINGITIS, HAEMOPHILUS; HAEMOPHILUS VACCINES is available ", "PI": "Haemophilus influenzae (1966-1997)", "MS": "A type of H. influenzae isolated most frequently from biotype I. Prior to vaccine availability, it was a leading cause of childhood meningitis.", "PM": "98", "HN": "98", "MR": "20200902", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019741"}, {"RECTYPE": "D", "MH": "Chemokines, CC", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Chemokines|T116|T129|NON|EQV|NLM (1998)|961122|abbcdef", "ENTRY": "beta Chemokines", "MN": "D23.529.374.200.110", "MH_TH": "NLM (1998)", "ST": "T129", "RN": "0", "AN": "do not confuse with CHEMOKINES, C or CHEMOKINES, CXC", "PI": "Cytokines (1992-1995)", "MS": "Group of chemokines with adjacent cysteines that are chemoattractants for lymphocytes, monocytes, eosinophils, basophils but not neutrophils.", "PM": "98", "HN": "98", "MR": "20200527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019742"}, {"RECTYPE": "D", "MH": "Chemokines, CXC", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-Chemokines|T116|T129|NON|EQV|NLM (1998)|961122|abbcdef", "ENTRY": "alpha Chemokines", "MN": "D23.529.374.200.120", "MH_TH": "NLM (1998)", "ST": "T129", "RN": "0", "AN": "do not confuse with CHEMOKINES, C or CHEMOKINES, CC", "PI": "Cytokines (1993-1997)", "MS": "Group of chemokines with paired cysteines separated by a different amino acid. CXC chemokines are chemoattractants for neutrophils but not monocytes.", "PM": "98", "HN": "98", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019743"}, {"RECTYPE": "D", "MH": "Chemokines, C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gamma-Chemokines|T116|T129|NON|EQV|NLM (1998)|961122|abbcdef", "ENTRY": "gamma Chemokines", "MN": "D23.529.374.200.100", "MH_TH": "NLM (1998)", "ST": "T129", "RN": "0", "AN": "do not confuse with CHEMOKINES, CC or CHEMOKINES, CXC", "PI": "Cytokines (1995)", "MS": "Group of chemokines without adjacent cysteines that are chemoattractants for lymphocytes only.", "PM": "98", "HN": "98", "MR": "20070709", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019744"}, {"RECTYPE": "D", "MH": "cis-trans-Isomerases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "cis-trans-Isomerase|T116|T126|NON|EQV|NLM (2022)|200824|abbcdef", "ENTRY": "cis-trans Isomerases", "MN": "D08.811.399.325", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 5.2.-", "PI": "Isomerases (1966-1997)", "MS": "Enzymes that catalyze the rearrangement of geometry about double bonds. EC 5.2.", "PM": "98", "HN": "98", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019745"}, {"RECTYPE": "D", "MH": "Intramolecular Oxidoreductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidoreductases, Intramolecular", "MN": "D08.811.399.475", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 5.3.-", "MS": "Enzymes of the isomerase class that catalyze the oxidation of one part of a molecule with a corresponding reduction of another part of the same molecule. They include enzymes converting aldoses to ketoses (ALDOSE-KETOSE ISOMERASES), enzymes shifting a carbon-carbon double bond (CARBON-CARBON DOUBLE BOND ISOMERASES), and enzymes transposing S-S bonds (SULFUR-SULFUR BOND ISOMERASES). (From Enzyme Nomenclature, 1992) EC 5.3.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019746"}, {"RECTYPE": "D", "MH": "Aldose-Ketose Isomerases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ketose-Aldose Isomerases|T116|T126|NON|EQV|NLM (1998)|970411|abbcdef", "ENTRY": "Ketose Aldose Isomerases", "MN": "D08.811.399.475.200", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 5.3.1.-", "MS": "Enzymes that catalyze the interconversion of aldose and ketose compounds.", "PM": "98", "HN": "98", "MR": "20110624", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019747"}, {"RECTYPE": "D", "MH": "Carbon-Carbon Double Bond Isomerases", "DE": "C C DOUBLE BOND ISOMERASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Carbon Carbon Double Bond Isomerases", "MN": "D08.811.399.475.400", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 5.3.3.-", "PI": "Isomerases (1980-1997)", "MS": "Enzymes that catalyze the shifting of a carbon-carbon double bond from one position to another within the same molecule. EC 5.3.3.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019748"}, {"RECTYPE": "D", "MH": "Sulfur-Sulfur Bond Isomerases", "DE": "S S BOND ISOMERASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sulfur Sulfur Bond Isomerases", "MN": "D08.811.399.475.800", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 5.3.4.-", "PI": "Isomerases (1977-1997)", "MS": "Enzymes that catalyze the transposition of a sulfur-sulfur bond. EC 5.3.4.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970714", "DC": "1", "DX": "19980101", "UI": "D019749"}, {"RECTYPE": "D", "MH": "Intramolecular Transferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mutases|T116|T126|NON|EQV|NLM (1998)|970307|abbcdef", "ENTRY": "Transferases, Intramolecular", "MN": "D08.811.399.520", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 5.4.-", "MS": "Enzymes of the isomerase class that catalyze the transfer of acyl-, phospho-, amino- or other groups from one position within a molecule to another. EC 5.4.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019751"}, {"RECTYPE": "D", "MH": "Intramolecular Lyases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lyases, Intramolecular", "MN": "D08.811.399.430", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 5.5.-", "PI": "Isomerases (1990-1997)", "MS": "Enzymes of the isomerase class that catalyze reactions in which a group can be regarded as eliminated from one part of a molecule, leaving a double bond, while remaining covalently attached to the molecule. (From Enzyme Nomenclature, 1992) EC 5.5.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019753"}, {"RECTYPE": "D", "MH": "Carbon-Carbon Lyases", "DE": "C C LYASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lyases, Carbon-Carbon", "MN": "D08.811.520.224", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 4.1.-", "MS": "Enzymes that catalyze the cleavage of a carbon-carbon bond by means other than hydrolysis or oxidation. This subclass contains the DECARBOXYLASES, the ALDEHYDE-LYASES, and the OXO-ACID-LYASES. EC 4.1.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019755"}, {"RECTYPE": "D", "MH": "Carbon-Oxygen Lyases", "DE": "C O LYASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lyases, Carbon-Oxygen", "MN": "D08.811.520.241", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 4.2.-", "MS": "Enzymes that catalyze the cleavage of a carbon-oxygen bond by means other than hydrolysis or oxidation. EC 4.2.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019757"}, {"RECTYPE": "D", "MH": "Carbon-Nitrogen Lyases", "DE": "C N LYASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lyases, Carbon-Nitrogen", "MN": "D08.811.520.232", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 4.3.-", "PI": "Lyases (1966-1997)", "MS": "Enzymes that catalyze the cleavage of a carbon-nitrogen bond by means other than hydrolysis or oxidation. Subclasses are the AMMONIA-LYASES, the AMIDINE-LYASES, the amine-lyases, and other carbon-nitrogen lyases. EC 4.3.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019759"}, {"RECTYPE": "D", "MH": "Amidine-Lyases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Amidine Lyases", "MN": "D08.811.520.232.300", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 4.3.2.-", "PI": "Lyases (1966-1997)", "MS": "These enzymes catalyze the elimination of ammonia from amidines with the formation of a double bond. EC 4.3.2.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019760"}, {"RECTYPE": "D", "MH": "Phosphorus-Oxygen Lyases", "DE": "P O LYASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphorus Oxygen Lyases", "MN": "D08.811.520.650", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 4.6.-", "MS": "Enzymes that catalyze the cleavage of a phosphorus-oxygen bond by means other than hydrolysis or oxidation. EC 4.6.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019761"}, {"RECTYPE": "D", "MH": "Heparin Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heparinase I|T116|T126|NON|EQV|NLM (1998)|961127|abbcdef", "ENTRY": "Lyase, Heparin", "MN": "D08.811.520.241.700.512", "MH_TH": "NLM (1998)", "ST": "T126", "N1": "heparin lyase", "RN": "EC 4.2.2.7", "PI": "Polysaccharide-Lyases (1975-1997)", "MS": "An enzyme of the isomerase class that catalyzes the eliminative cleavage of polysaccharides containing 1,4-linked D-glucuronate or L-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-D-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-D-gluc-4-enuronosyl groups at their non-reducing ends. (From Enzyme Nomenclature, 1992) EC 4.2.2.7.", "PM": "98; HEPARIN LYASE was indexed under POLYSACCHARIDE-LYASES 1975-97, HEPARIN 1973-82 & LYASES 1973-79", "HN": "98; use HEPARIN LYASE (NM) 1973-97", "MR": "20160628", "DA": "19970625", "DC": "1", "DX": "19980101", "UI": "D019763"}, {"RECTYPE": "D", "MH": "Phosphoenolpyruvate Carboxykinase (ATP)", "DE": "PEP CARBOXYKINASE ATP", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Trypanosoma cruzi PEPCK|T116|T126|NRW|NLM (1998)|961127|abbdef", "ENTRY": "Phosphoenolpyruvate Carboxykinase, ATP-Dependent", "MN": "D08.811.520.224.125.500", "MH_TH": "NLM (1998)", "ST": "T126", "N1": "ATP:oxaloacetate carboxy-lyase (transphosphorylating)", "RN": "EC 4.1.1.49", "AN": "do not confuse with PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP)", "PI": "Phosphoenolpyruvate Carboxykinase (GTP) (1994-1997)", "MS": "An enzyme of the lyase class that catalyzes the conversion of ATP and oxaloacetate to ADP, phosphoenolpyruvate, and carbon dioxide. The enzyme is found in some bacteria, yeast, and Trypanosoma, and is important for the photosynthetic assimilation of carbon dioxide in some plants. EC 4.1.1.49.", "PM": "1998; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP) was indexed under PHOSPHOENOLPYRUVATE CARBOXYKINASES 1994-1997", "HN": "1998; use PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP) (NM) 1994-1997", "MR": "20030725", "DA": "19970702", "DC": "1", "DX": "19980101", "UI": "D019764"}, {"RECTYPE": "D", "MH": "Chondroitin ABC Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chondroitinase ABC|T116|T126|NON|EQV|NLM (1998)|961127|abbcdef", "ENTRY": "Chondroitin Sulfate ABC Endolyase", "MN": "D08.811.520.241.700.350.500.500", "MH_TH": "NLM (1998)", "ST": "T126", "N1": "chondroitin ABC lyase", "RN": "EC 4.2.2.20", "AN": "do not confuse with CHONDROITIN LYASES", "MS": "An enzyme that catalyzes the eliminative degradation of polysaccharides containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups. (Enzyme Nomenclature, 1992)", "PM": "98; see CHONDROITIN LYASES 1975-97", "HN": "98; use CHONDROITIN LYASES 1975-97", "MR": "20090706", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019765"}, {"RECTYPE": "D", "MH": "Genes, Archaeal", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Archaeal Genes|T028|NON|EQV|NLM (1998)|961202|abcdef", "ENTRY": "Gene, Archaeal", "MN": "G05.360.340.358.050.500", "FX": "Genome, Archaeal", "MH_TH": "NLM (1998)", "ST": "T028", "AN": "coordinate IM with specific archaeon /genet (IM)", "PI": "Genes, Bacterial (1984-1997)", "MS": "The functional genetic units of ARCHAEA.", "PM": "98", "HN": "98", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019766"}, {"RECTYPE": "D", "MH": "Maxillofacial Abnormalities", "DE": "MAXILLOFACIAL ABNORM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Maxillofacial Abnormality", "MN": "C16.131.850.500", "MH_TH": "NLM (1998)", "ST": "T019", "AN": "general or unspecified; prefer specifics involving both the maxilla and the face: not a substitute for MAXILLA /abnorm or FACE /abnorm or FACIAL BONES /abnorm", "PI": "Maxilla/abnormalities (1968-1997)", "MS": "Congenital structural deformities, malformations, or other abnormalities of the maxilla and face or facial bones.", "PM": "98", "HN": "98", "MR": "19991103", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019767"}, {"RECTYPE": "D", "MH": "Lauraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.595.400", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid3433", "MS": "A family of mainly aromatic evergreen plants in the order Laurales. The laurel family includes 2,200 species in 45 genera and from these are derived medicinal extracts, essential oils, camphor and other products.", "PM": "98", "HN": "98", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019770"}, {"RECTYPE": "D", "MH": "Axotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Axotomies", "MN": "E04.525.210.158", "MH_TH": "NLM (1998)", "ST": "T062", "AN": "NIM when an experimental technique; coordinate with specific neuron or specific nerve or specific organ /innerv with probably /physiol in experimental studies or /surg in therapeutic studies", "PI": "Neurons (1968-1997)", "MS": "Transection or severing of an axon. This type of denervation is used often in experimental studies on neuronal physiology and neuronal death or survival, toward an understanding of nervous system disease.", "PM": "98", "HN": "98", "MR": "20170705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019771"}, {"RECTYPE": "D", "MH": "Topotecan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SKF104864A", "MN": "D03.132.151.850", "PA": "Topoisomerase I Inhibitors", "MH_TH": "NLM (1998)", "ST": "T121", "RN": "7M7YKX2N15", "RR": "956S425ZCY", "PI": "Camptothecin/analogs & derivatives (1991-1997)", "MS": "An antineoplastic agent used to treat ovarian cancer. It works by inhibiting DNA TOPOISOMERASES, TYPE I.", "PM": "98; TOPOTECAN was indexed under CAMPTOTHECIN/analogs & derivatives 1991-97", "HN": "98; use TOPOTECAN (NM) 1991-97", "MR": "20170117", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019772"}, {"RECTYPE": "D", "MH": "Epiretinal Membrane", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Surface-Wrinkling Retinopathy|T020|NON|EQV|NLM (2022)|210428|abcdef", "ENTRY": "Surface-Wrinkling Retinopathies", "MN": "C11.768.328", "MH_TH": "NLM (1998)", "ST": "T020", "AN": "note category: a retinal disease", "PI": "Retinal Diseases (1976-1997)", "MS": "A membrane on the vitreal surface of the retina resulting from the proliferation of one or more of three retinal elements: (1) fibrous astrocytes; (2) fibrocytes; and (3) RETINAL PIGMENT EPITHELIUM. Localized epiretinal membranes may occur at the posterior pole of the eye without clinical signs or may cause marked loss of vision as a result of covering, distorting, or detaching the FOVEA CENTRALIS. Epiretinal membranes may cause vascular leakage and secondary retinal edema. In younger individuals some membranes appear to be developmental in origin and occur in otherwise normal eyes. The majority occur in association with RETINAL HOLES, ocular concussions, retinal inflammation, or after ocular surgery. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p291)", "PM": "98", "HN": "98", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019773"}, {"RECTYPE": "D", "MH": "Blood Coagulation Factor Inhibitors", "DE": "BLOOD COAG FACTOR INHIB", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Blood Coagulation Factor Inhibitor|T123|NON|EQV|NLM (2022)|201013|abcdef", "ENTRY": "Inhibitors, Coagulation Factor, Blood|T123|NON|EQV|NLM (1998)|961216|INHIB COAG FACTORS BLOOD|abcdefv", "MN": "D23.113", "PA": "Anticoagulants", "FX": "Blood Coagulation Factors", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "MS": "Substances, usually endogenous, that act as inhibitors of blood coagulation. They may affect one or multiple enzymes throughout the process. As a group, they also inhibit enzymes involved in processes other than blood coagulation, such as those from the complement system, fibrinolytic enzyme system, blood cells, and bacteria.", "PM": "98", "HN": "98", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019774"}, {"RECTYPE": "D", "MH": "Salmonella enterica", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.710.160", "MH_TH": "NLM (1998)", "ST": "T007", "RN": "txid28901", "PI": "Salmonella (1980-1997)", "MS": "A subgenus of Salmonella containing several medically important serotypes. The habitat for the majority of strains is warm-blooded animals.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019779"}, {"RECTYPE": "D", "MH": "Technetium Tc 99m Lidofenin", "DS": "TECHNETIUM TC LIDOFENIN 099M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "99mTc-Lidofenin|T109|T130|EQV|NLM (1998)|961216|TC LIDOFENIN 099M|abbdefs", "ENTRY": "Technetium Tc 99m 2,6 Dimethyl Iminodiacetic Acid", "MN": "D12.125.072.401.900", "PA": "Radiopharmaceuticals", "MH_TH": "USP (19XX)", "ST": "T130", "RN": "6433TZJ6TQ", "AN": "for routine use as label, use no qualifiers", "PI": "Organotechnetium Compounds (1990-1997)", "MS": "A nontoxic radiopharmaceutical that is used in RADIONUCLIDE IMAGING for the clinical evaluation of hepatobiliary disorders in humans.", "PM": "98; TECHNETIUM TC 99M LIDOFENIN was indexed under IMINO ACIDS 1977-97, ORGANOTECHNETIUM COMPOUNDS 1990-97, ORGANOMETALLIC COMPOUNDS 1977-89, ACETANILIDE/analogs & derivatives 1978-89, & LIDOCAINE/analogs & derivatives 1978-80", "HN": "98; use TECHNETIUM TC 99M LIDOFENIN (NM) 1977-97", "MR": "20150527", "DA": "19970702", "DC": "1", "DX": "19980101", "UI": "D019780"}, {"RECTYPE": "D", "MH": "Corneal Topography", "DE": "CORNEAL TOPOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Videokeratography|T060|NON|REL|NLM (1999)|980305|abcdef", "ENTRY": "Videokeratographies", "MN": "E01.370.380.150", "FX": "Aberrometry", "MH_TH": "NLM (1998)", "ST": "T060", "PI": "Cornea/pathology (1983-1997)", "MS": "The measurement of curvature and shape of the anterior surface of the cornea using techniques such as keratometry, keratoscopy, photokeratoscopy, profile photography, computer-assisted image processing and videokeratography. This measurement is often applied in the fitting of contact lenses and in diagnosing corneal diseases or corneal changes including keratoconus, which occur after keratotomy and keratoplasty.", "PM": "98", "HN": "98", "MR": "20090706", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019781"}, {"RECTYPE": "D", "MH": "Riluzole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RP54274", "MN": "D03.633.100.185.611", "PA": "Neuroprotective Agents", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "7LJ087RS6F", "RR": "1744-22-5 (Riluzole)", "PI": "Thiazoles (1986-1997)", "MS": "A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.", "PM": "98; RILUZOLE was indexed under THIAZOLES 1986-97", "HN": "98; use RILUZOLE (NM) 1986-97", "MR": "20170524", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019782"}, {"RECTYPE": "D", "MH": "Technetium Tc 99m Dimercaptosuccinic Acid", "DE": "TC DMSA", "DS": "TECHNETIUM TC DIMERCAPTOSUCCINIC ACID 099M", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "99mTc-Dimercaptosuccinic Acid|T109|T130|EQV|NLM (1998)|970110|TC DIMERCAPTOSUCCINIC ACID 099M|abbdefs", "ENTRY": "Technetium 99m Dimercaptosuccinic Acid", "MN": "D02.886.489.750.725", "PA": "Radiopharmaceuticals", "MH_TH": "NLM (1998)", "ST": "T130", "RN": "494JNQ8L28", "RR": "65438-08-6 (Technetium Tc 99m Dimercaptosuccinic Acid)", "AN": "for routine use as label, use no qualifiers", "PI": "Sulfhydryl Compounds (1977-1989)", "MS": "A nontoxic radiopharmaceutical that is used in the diagnostic imaging of the renal cortex.", "PM": "98; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID was indexed under SUCCIMER 1980-97, ORGANOTECHNETIUM COMPOUNDS 1990-97, SULFHYDRYL COMPOUNDS 1977-89, ORGANOMETALLIC COMOUNDS 1977-89, & SUCCINATES 1977-79", "HN": "98; use TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID (NM) 1980-97", "MR": "20150605", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019783"}, {"RECTYPE": "D", "MH": "Technetium Tc 99m Diethyl-iminodiacetic Acid", "DE": "TC EHIDA", "DS": "TECHNETIUM TC DIETHYL IMINODIACETIC ACID 099M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Technetium Tc 99m Diethyl IDA|T109|T130|EQV|NLM (1998)|970612|TECHNETIUM TC DIETHYL IDA 099M|abbdefs", "ENTRY": "Technetium Tc 99m Diethylacetanitanildo IDA", "MN": "D12.125.072.401.830", "PA": "Radiopharmaceuticals", "MH_TH": "NLM (1998)", "ST": "T130", "RN": "0", "AN": "for routine use as label, use no qualifiers", "PI": "Organotechnetium Compounds (1990-1997)", "MS": "A nontoxic radiopharmaceutical that is used in the clinical evaluation of hepatobiliary disorders in humans.", "PM": "98; TECHNETIUM TC 99M DIETHYL IDA (now TECHNETIUM TC 99M DIETHYL-IMINODIACETIC ACID) was indexed under IMINO ACIDS 1977-97, ORGANOTECHNETIUM COMPOUNDS 1990-97, ORGANOMETALLIC COMPOUNDS 1977-89, LIDOCAINE/analogs & derivatives 1979-80, & ACETANILIDES 1977-79", "HN": "98; use TECHNETIUM TC 99M DIETHYL-IMINODIACETIC ACID (NM) 1977-97", "MR": "20150605", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019784"}, {"RECTYPE": "D", "MH": "Technetium Tc 99m Disofenin", "DE": "TC DISIDA", "DS": "TECHNETIUM TC DISOFENIN 099M", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Technetium 99m Disofenin", "MN": "D12.125.072.401.840", "PA": "Radiopharmaceuticals", "MH_TH": "USP (19XX)", "ST": "T130", "RN": "QTJ2VIW97T", "AN": "for routine use as label, use no qualifiers", "PI": "Organotechnetium Compounds (1990-1997)", "MS": "A radiopharmaceutical used extensively in cholescintigraphy for the evaluation of hepatobiliary diseases. (From Int Jrnl Rad Appl Inst 1992;43(9):1061-4)", "PM": "98; TECHNETIUM TC 99M DISOFENIN was indexed under ORGANOTECHNETIUM COMPOUNDS 1990-97, IMINO ACIDS 1980-97, & ORGANOMETALLIC COMPOUNDS 1980-89", "HN": "98; use TECHNETIUM TC 99M DISOFENIN (NM) 1980-97", "MR": "20150605", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019785"}, {"RECTYPE": "D", "MH": "Gadolinium DTPA", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gd-DTPA|T109|T130|NON|EQV|NLM (1998)|961217|abbcdef", "ENTRY": "Gd DTPA", "MN": "D02.257.141", "PA": "Contrast Media", "MH_TH": "NLM (1998)", "ST": "T130", "RN": "K2I13DR72L", "RR": "RH248G8V27", "PI": "Organometallic Compounds (1987-1997)", "MS": "A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see PENTETIC ACID), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)", "PM": "98; GADOLINIUM DTPA was indexed under DTPA/analogs & derivatives 1994-97, ORGANOMETALLIC COMPOUNDS 1987-97, and DTPA 1987-93; GADOPENTETATE DIMEGLUMINE (now GADOLINIUM DTPA) was indexed under DTPA/analogs & derivatives 1994-97, ORGANOMETALLIC COMPOUNDS 1987-97, MEGLUMINE 1987-97, DRUG COMBINATIONS 1987-97, & DTPA 1987-93", "HN": "98; use GADOLINIUM DTPA (NM) 1987-97", "MR": "20190705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019786"}, {"RECTYPE": "D", "MH": "Linoleic Acid", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Linoleate|T109|T123|NON|REL|FDA SRS (2014)|NLM (1998)|961217|abbcdeef", "ENTRY": "Acid, 9,12-Octadecadienoic", "MN": "D10.251.355.343.500.500", "EC": "analogs & derivatives:Linoleic Acids", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "9KJL21T0QJ", "RR": "822-17-3 (Na salt(Z,Z)-isomer)", "AN": "LINOLEIC ACIDS and LINOLEIC ACIDS, CONJUGATED are also available", "PI": "Linoleic Acids (1981-1997)", "MS": "A doubly unsaturated fatty acid, occurring widely in plant glycosides. It is an essential fatty acid in mammalian nutrition and is used in the biosynthesis of prostaglandins and cell membranes. (From Stedman, 26th ed)", "PM": "98; LINOLEIC ACID was indexed under LINOLEIC ACIDS 1981-97 & FATTY ACIDS, UNSATURATED 1981-83", "HN": "98; use LINOLEIC ACID (NM) 1981-97", "MR": "20160701", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019787"}, {"RECTYPE": "D", "MH": "Fluorodeoxyglucose F18", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fludeoxyglucose F 18|T109|T130|ABX|EQV|FDA SRS (2014)|NLM (1998)|USAN (19XX)|USP (19XX)|990101|FLUDEOXYGLUCOSE F 018|abbcdeeeefs", "ENTRY": "Fluorodeoxyglucose, 18F", "MN": "D09.254.229.500", "PA": "Radiopharmaceuticals", "MH_TH": "NLM (2005)", "ST": "T130", "RN": "0Z5B2CJX4D", "RR": "83903-67-7 (14C-labeled cpd)", "PI": "Deoxyglucose/analogs & derivatives (1978-1997)", "MS": "The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)", "PM": "2005; see FLUDEOXYGLUCOSE F 18 1998-2004; FLUDEOXYGLUCOSE F 18 was indexed under DEOXYGLUCOSE/analogs & derivatives 1978-1997", "HN": "2005(1978)", "MR": "20190701", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019788"}, {"RECTYPE": "D", "MH": "Tetraethylammonium", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetraethylammonium Ion|T109|T121|NON|EQV|NLM (1998)|970102|abbcdef", "ENTRY": "Ion, Tetraethylammonium", "MN": "D02.675.276.787.500", "PA": "Potassium Channel Blockers", "EC": "analogs & derivatives:Tetraethylammonium Compounds", "MH_TH": "NLM (1998)", "ST": "T121", "RN": "66-40-0", "RR": "RA8VU41B1F", "PI": "Tetraethylammonium Compounds (1980-1997)", "MS": "A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)", "PM": "98; TETRAETHYLAMMONIUM was indexed under TETRAETHYLAMMONIUM COMPOUNDS 1980-97", "HN": "98; use TETRAETHYLAMMONIUM (NM) 1980-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019789"}, {"RECTYPE": "D", "MH": "Guanidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Guanidinium Chloride|T109|T123|NON|NRW|NLM (1998)|961218|abbcdef", "ENTRY": "Sulfate, Guanidine", "MN": "D02.078.370.472", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "JU58VJ6Y3B", "RR": "B542239A4E", "PI": "Guanidines (1974-1997)", "MS": "A strong organic base existing primarily as guanidium ions at physiological pH. It is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. (From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed) It is also used in the treatment of myasthenia and as a fluorescent probe in HPLC.", "PM": "98; GUANIDINE was indexed under GUANIDINES 1974-97", "HN": "98; use GUANIDINE (NM) 1974-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019791"}, {"RECTYPE": "D", "MH": "Fluorescein", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sodium Fluorescein|T109|T121|NON|NRW|NLM (1998)|961218|abbcdef", "ENTRY": "Sodium, Fluorescein", "MN": "D04.711.347.390", "PA": "Fluorescent Dyes", "EC": "analogs & derivatives:Fluoresceins", "MH_TH": "USP (19XX)", "ST": "T130", "RN": "TPY09G7XIR", "RR": "93X55PE38X", "PI": "Fluoresceins (1969-1997)", "MS": "A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium such as the aqueous humor.", "PM": "98; see FLUORESCEINS 1969-97", "HN": "98; see FLUORESCEIN (NM) 1981-97", "MR": "20160531", "DA": "19970702", "DC": "1", "DX": "19980101", "UI": "D019793"}, {"RECTYPE": "D", "MH": "2,3-Diphosphoglycerate", "DS": "DIPHOSPHOGLYCERATE 002 003", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2,3-Diphosphoglyceric Acid|T109|T123|NON|BRD|NLM (1998)|961220|DIPHOSPHOGLYCERIC ACID 02 03|abbcdefs", "ENTRY": "2,3-Bisphosphate, Glycerate", "MN": "D09.811.366.388.175", "EC": "analogs & derivatives:Diphosphoglyceric Acids", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "138-81-8", "RR": "14438-19-8 ((D)-isomer)", "PI": "Diphosphoglyceric Acids (1980-1997)", "MS": "A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508)", "PM": "98; 2,3-DIPHOSPHOGLYCERATE was indexed under DIPHOSPHOGLYCERIC ACIDS 1980-97", "HN": "98; use 2,3-DIPHOSPHOGLYCERATE (NM) 1980-97", "MR": "20120703", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019794"}, {"RECTYPE": "D", "MH": "15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid", "DS": "HYDROXYEPOXYMETHANO PROSTA DIENOIC ACID ALPHA ALPHA 015 011 09 05 013", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "U 46619", "MN": "D23.469.700.630.500", "PA": "Vasoconstrictor Agents", "MH_TH": "NLM (1998)", "ST": "T121", "N1": "5-Heptenoic Acid, 7-(6-(3-Hydroxy-1-Ocentyl)-2-Oxabicyclo(2.2.1)hept-5-yl)-, (1R-(1alpha,4alpha,5 beta(Z),6alpha(1E,3S*)))-", "RN": "76898-47-0", "RR": "87421-95-2 (1R-(1alpha,4alpha,5beta(Z),6alpha(1E,3R*)))-isomer", "PI": "Thromboxane A2/analogs & derivatives (1983-1997)", "MS": "A stable prostaglandin endoperoxide analog which serves as a thromboxane mimetic. Its actions include mimicking the hydro-osmotic effect of VASOPRESSIN and activation of TYPE C PHOSPHOLIPASES. (From J Pharmacol Exp Ther 1983;224(1): 108-117; Biochem J 1984;222(1):103-110)", "PM": "1998; 15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID was indexed under PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC 1978-97 & THROMBOXANE A2/analogs & derivatives 1983-97; (15S)HYDROXY-9ALPHA,11ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID and 9,11-EPOXYMETHANO-PGH2 were indexed under PROSTAGLANDINS H 1993-2003 & PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC 1986-1992", "HN": "1998; use 15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID (NM) 1977-1997; for (15S)HYDROXY-9ALPHA,11ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID and 9,11-EPOXYMETHANO-PGH2 use PROSTAGLANDIN H2 (NM) 1992-2003", "MR": "20230226", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019796"}, {"RECTYPE": "D", "MH": "3-Iodobenzylguanidine", "DS": "IODOBENZYLGUANIDINE 03", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "MIBG|T109|T121|T130|ABB|EQV|FDA SRS (2014)|NLM (1998)|961219|abbbcdeef", "ENTRY": "meta Iodobenzylguanidine", "MN": "D02.455.526.581.496.300", "PA": "Radiopharmaceuticals", "MH_TH": "NLM (1998)", "ST": "T130", "RN": "35MRW7B4AD", "RR": "Q461L7AK4R", "PI": "Iodobenzenes (1983-1997)", "MS": "A guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors. The radiolabeled forms are used as antineoplastic agents and radioactive imaging agents. (Merck Index, 12th ed) MIBG serves as a neuron-blocking agent which has a strong affinity for, and retention in, the adrenal medulla and also inhibits ADP-ribosyltransferase.", "PM": "98; 3-IODOBENZYLGUANIDINE was indexed under IODOBENZENES 1983-97 & GUANIDINES 1980-82", "HN": "98; use 3-IODOBENZYLGUANIDINE (NM) 1980-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019797"}, {"RECTYPE": "D", "MH": "Neopterin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone|T109|T123|NON|EQV|NLM (1998)|961219|AMINOTRIHYDROXYPROPYL PTERIDINONE 002 006 001 001 003 004 003 H|abbcdefs", "ENTRY": "Umanopterin|T109|T123|NON|NRW|NLM (1998)|961223|abbcdef", "MN": "D08.211.090.500", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "670-65-5", "RR": "7204-22-0 ((R*,R*)-isomer)", "PI": "Biopterin/analogs & derivatives (1977-1997)", "MS": "A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of BIOPTERINS.", "PM": "98; NEOPTERIN was indexed under BIOPTERIN/analogs & derivatives 1977-97", "HN": "98; use NEOPTERIN (NM) 1979-97", "MR": "20230727", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019798"}, {"RECTYPE": "D", "MH": "Phenol", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phenolate, Sodium", "MN": "D02.455.426.559.389.657.595", "PA": "Sclerosing Solutions", "EC": "analogs & derivatives:Phenols", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "339NCG44TV", "RR": "4NC0T56V35", "PI": "Phenols (1969-1997)", "MS": "An antiseptic and disinfectant aromatic alcohol.", "PM": "1998; PHENOL was indexed under PHENOLS 1969-1997; for CARBOL see PHENOLS 1982-2012", "HN": "1998", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019800"}, {"RECTYPE": "D", "MH": "Succinic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Succinate|T109|T121|NON|NRW|NLM (1998)|961226|abbcdef", "ENTRY": "Succinate, Potassium", "MN": "D02.241.081.337.759.625", "EC": "analogs & derivatives:Succinates", "MH_TH": "NLM (1998)", "ST": "T121", "RN": "AB6MNQ6J6L", "RR": "DTZ9PEC9JL", "PI": "Succinates (1981-1997)", "MS": "A water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. (Hawley's Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851)", "PM": "98; SUCCINIC ACID was indexed under SUCCINATES 1981-97", "HN": "98; use SUCCINIC ACID (NM) 1981-97", "MR": "20180629", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019802"}, {"RECTYPE": "D", "MH": "Glutathione Disulfide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "GSSG|T116|T123|ABB|EQV|NLM (1998)|961226|abbcdef", "ENTRY": "Oxidized Glutathione", "MN": "D12.644.456.448.500", "MH_TH": "NLM (1998)", "ST": "T123", "N1": "Bis(gamma-Glutamyl-L-cysteinylglycine) Disulfide", "RN": "ULW86O013H", "RR": "40055-98-9 (ion(1-))", "PI": "Glutathione/analogs & derivatives (1979-1997)", "MS": "A GLUTATHIONE dimer formed by a disulfide bond between the cysteine sulfhydryl side chains during the course of being oxidized.", "PM": "1998; GLUTATHIONE DISULFATE was indexed under GLUTATHIONE/analogs & derivatives 1980-1997", "HN": "1998(1997)", "MR": "20210304", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019803"}, {"RECTYPE": "D", "MH": "Mesalamine", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mesalazine|T116|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|NLM (1998)|961226|abbcdeeeef", "ENTRY": "meta Aminosalicylic Acid", "MN": "D02.455.426.559.389.657.410.595.100.540", "PA": "Anti-Inflammatory Agents, Non-Steroidal", "EC": "analogs & derivatives:Aminosalicylic Acids", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "4Q81I59GXC", "RR": "89-57-6 (Mesalamine)", "PI": "Aminosalicylic Acids (1981-1997)", "MS": "An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)", "PM": "98; MESALAMINE was indexed under AMINOSALICYLIC ACIDS 1981-97", "HN": "98; use MESALAMINE (NM) 1981-97", "MR": "20170117", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019804"}, {"RECTYPE": "D", "MH": "alpha-Methyltyrosine", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "alpha-Methyl-p-tyrosine|T116|T121|NON|EQV|NLM (1998)|961227|abbcdef", "ENTRY": "alpha-methyl- DL-Tyrosine", "MN": "D12.125.072.050.875.485.050", "PA": "Enzyme Inhibitors", "EC": "analogs & derivatives:Methyltyrosines", "MH_TH": "NLM (1998)", "ST": "T121", "RN": "658-48-0", "RR": "X88TTO174Z", "PI": "Methyltyrosines (1979-1997)", "MS": "An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)", "PM": "98; ALPHA-METHYLTYROSINE was indexed under METHYLTYROSINES 1979-97", "HN": "98; use ALPHA-METHYLTYROSINE (NM) 1979-97", "MR": "20160701", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019805"}, {"RECTYPE": "D", "MH": "Cromakalim", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Levcromakalim|T109|T121|NON|NRW|BAN (19XX)|FDA SRS (2014)|INN (19XX)|USAN (1993)|961227|abbcdeeeef", "ENTRY": "BRL38227", "MN": "D03.633.100.150.455", "PA": "Vasodilator Agents", "MH_TH": "NLM (1998)", "ST": "T121", "N1": "2H-1-Benzopyran-6-carbonitrile, 3,4-dihydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-, trans-(+-)-", "RN": "0G4X367WA3", "RR": "RW7PN4BLDJ", "PI": "Pyrroles (1986-1997)", "MS": "A potassium-channel opening vasodilator that has been investigated in the management of hypertension. It has also been tried in patients with asthma. (Martindale, The Extra Pharmacopoeia, 30th ed, p352)", "PM": "98; CROMAKALIM was indexed under BENZOPYRANS & PYRROLES 1986-97", "HN": "98; use CROMAKALIM (NM) 1986-97", "MR": "20160528", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019806"}, {"RECTYPE": "D", "MH": "Iodoacetic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Monosodium Iodoacetate|T109|NON|NRW|NLM (2022)|200923|abcdef", "ENTRY": "Iodoacetate, Sodium", "MN": "D02.455.526.581.247.500", "PA": "Enzyme Inhibitors", "EC": "analogs & derivatives:Iodoacetates", "MH_TH": "NLM (1998)", "ST": "T130", "N1": "Acetic acid, iodo-", "RN": "WF5188V710", "RR": "64-69-7 (Iodoacetic Acid)", "PI": "Iodoacetates (1980-1998)", "MS": "A derivative of ACETIC ACID that contains one IODINE atom attached to its methyl group.", "PM": "1999; IODOACETIC ACID was indexed under IODOACETATES 1980-1998, for SODIUM IODOACETATE see IODOACETATES 1998-2012", "HN": "1999; use IODOACETIC ACID (NM) 1980-1998", "MR": "20210630", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D019807"}, {"RECTYPE": "D", "MH": "Losartan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Salt, Losartan Monopotassium", "MN": "D03.383.129.617.467", "PA": "Antihypertensive Agents", "FX": "Valsartan", "MH_TH": "NLM (1998)", "ST": "T121", "RN": "JMS50MPO89", "RR": "3ST302B24A", "PI": "Tetrazoles (1990-1997)", "MS": "An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.", "PM": "98; LOSARTAN was indexed under IMIDAZOLES 1990-97, TETRAZOLES 1990-97, & BIPHENYL COMPOUNDS 1990-97", "HN": "98; use LOSARTAN (NM) 1990-97", "MR": "20160531", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019808"}, {"RECTYPE": "D", "MH": "Streptavidin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Strepavidin|T116|T123|T130|NON|EQV|NLM (1998)|961230|abbbcdef", "MN": "D12.776.097.835", "PA": "Indicators and Reagents", "MH_TH": "NLM (1998)", "ST": "T130", "RN": "9013-20-1", "PI": "Bacterial Proteins (1980-1997)", "MS": "A 60-kDa extracellular protein of Streptomyces avidinii with four high-affinity biotin binding sites. Unlike AVIDIN, streptavidin has a near neutral isoelectric point and is free of carbohydrate side chains.", "PM": "98; STREPTAVIDIN was indexed under BACTERIAL PROTEINS 1980-97", "HN": "98; use STREPTAVIDIN (NM) 1980-97", "MR": "20040707", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019809"}, {"RECTYPE": "D", "MH": "Sodium Azide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "NaN3|T121|T130|T131|T197|ABB|EQV|NLM (1998)|961231|NAN 003|abbbbcdefs", "ENTRY": "Azide, Sodium", "MN": "D01.857.462", "PA": "Vasodilator Agents", "MH_TH": "NLM (1998)", "ST": "T197", "RN": "968JJ8C9DV", "RR": "26628-22-8 (Sodium Azide)", "PI": "Nitrogen (1975-1976)", "MS": "A cytochrome oxidase inhibitor which is a nitridizing agent and an inhibitor of terminal oxidation. (From Merck Index, 12th ed)", "PM": "98; SODIUM AZIDE was indexed under AZIDES 1977-97 & NITROGEN 1975-76", "HN": "98; use SODIUM AZIDE (NM) 1979-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019810"}, {"RECTYPE": "D", "MH": "Hydroxylamine", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydroxylammonium Chloride|T197|NON|NRW|FDA SRS (2014)|NLM (1998)|970507|abcdeef", "MN": "D01.625.062.437", "EC": "analogs & derivatives:Hydroxylamines", "MH_TH": "NLM (1998)", "ST": "T197", "RN": "2FP81O2L9Z", "RR": "7803-49-8 (Hydroxylamine)", "AN": "HYDROXYLAMINES is also available", "PI": "Hydroxylamines (1976-1997)", "MS": "A colorless inorganic compound (HONH2) used in organic synthesis and as a reducing agent, due to its ability to donate nitric oxide.", "PM": "1998; HYDROXYLAMINE was indexed under HYDROXYLAMINES 1976-1997", "HN": "1998 (1980)", "MR": "20180301", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019811"}, {"RECTYPE": "D", "MH": "Heparan Sulfate Proteoglycans", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Heparan Sulfate Proteoglycan|T116|T123|NON|EQV|NLM (1998)|990101|abbcdef", "ENTRY": "Sulfate Proteoglycans, Heparan", "MN": "D12.776.395.650.350", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "AN": "do not confuse with HEPARAN SULFATE see HEPARITIN SULFATE", "PI": "Proteoglycans (1982-1997)", "MS": "Ubiquitous macromolecules associated with the cell surface and extracellular matrix of a wide range of cells of vertebrate and invertebrate tissues. They are essential cofactors in cell-matrix adhesion processes, in cell-cell recognition systems, and in receptor-growth factor interactions. (From Cancer Metastasis Rev 1996; 15(2): 177-86; Hepatology 1996; 24(3): 524-32)", "PM": "2006; HEPARAN SULFATE PROTEOGLYCAN was indexed under PROTEOGLYCANS 1982-1997, HEPARITIN SULFATE 1982-1997, & PROTEOCHONDROITIN SULFATES 1982-1992", "HN": "2006(1982)", "MR": "20230316", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019812"}, {"RECTYPE": "D", "MH": "1,2-Dimethylhydrazine", "DS": "DIMETHYLHYDRAZINE 01 02", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "sym Dimethylhydrazine", "MN": "D02.442.600.400.200", "PA": "Mutagens", "EC": "analogs & derivatives:Dimethylhydrazines", "MH_TH": "NLM (1998)", "ST": "T131", "RN": "IX068S9745", "RR": "540-73-8 (1,2-Dimethylhydrazine)", "PI": "Dimethylhydrazines (1977-1997)", "MS": "A DNA alkylating agent that has been shown to be a potent carcinogen and is widely used to induce colon tumors in experimental animals.", "PM": "98; 1,2-DIMETHYLHYDRAZINE was indexed under DIMETHYLHYDRAZINES 1980-97", "HN": "98; use 1,2-DIMETHYLHYDRAZINE (NM) 1980-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019813"}, {"RECTYPE": "D", "MH": "Myristic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Myristate|T109|T123|NON|NRW|NLM (1998)|970327|abbcdef", "ENTRY": "Acid, Tetradecanoic", "MN": "D10.251.640.630", "EC": "analogs & derivatives:Myristates", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0I3V7S25AW", "RR": "544-63-8 (Myristic Acid)", "PI": "Myristic Acids (1982-1997)", "MS": "A saturated 14-carbon fatty acid occurring in most animal and vegetable fats, particularly butterfat and coconut, palm, and nutmeg oils. It is used to synthesize flavor and as an ingredient in soaps and cosmetics. (From Dorland, 28th ed)", "PM": "98; MYRISTIC ACID was indexed under MYRISTIC ACIDS 1982-97", "HN": "98; use MYRISTIC ACID (NM) 1982-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019814"}, {"RECTYPE": "D", "MH": "Oxalic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxalate, Sodium", "MN": "D02.241.081.337.593.750", "PA": "Reducing Agents", "EC": "analogs & derivatives:Oxalates", "MH_TH": "NLM (1998)", "ST": "T130", "N1": "Ethanedioic acid", "RN": "9E7R5L6H31", "RR": "LC7F2W7I5B", "PI": "Oxalates (1979-1998)", "MS": "A strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent.", "PM": "1999; for ALUMINUM OXALATE, CHROMIUM OXALATE, DIPOTASSIUM OXALATE, POTASSIUM CHROMIUM OXALATE, and SODIUM OXALATE see OXALATES 1992-2012; for AMMONIUM OXALATE, CHROMIUM (2+) OXALATE, CHROMIUM (3+) OXALATE (3:2), DIAMMONIUM OXALATE, DILITHIUM OXALATE, DISODIUM OXALATE, IRON (2+) OXALATE (1:1), IRON (3+) OXALATE, IRON OXALATE, MAGNESIUM OXALATE (1:1), MANGANESE (2+) OXALATE (1:1), MONOAMMONIUM OXALATE, MONOPOTASSIUM OXALATE, MONOSODIUM OXALATE, POTASSIUM OXALATE, and POTASSIUM OXALATE (2:1) see OXALATES 1999-2012; OXALIC ACID was indexed under OXALATES 1981-1998", "HN": "1999; for ALUMINUM OXALATE, CHROMIUM OXALATE, DIPOTASSIUM OXALATE, POTASSIUM CHROMIUM OXALATE, and SODIUM OXALATE use OXALATES 1992-2012; for AMMONIUM OXALATE, CHROMIUM (2+) OXALATE, CHROMIUM (3+) OXALATE (3:2), DIAMMONIUM OXALATE, DILITHIUM OXALATE, DISODIUM OXALATE, IRON (2+) OXALATE (1:1), IRON (3+) OXALATE, IRON OXALATE, MAGNESIUM OXALATE (1:1), MANGANESE (2+) OXALATE (1:1), MONOAMMONIUM OXALATE, MONOPOTASSIUM OXALATE, MONOSODIUM OXALATE, POTASSIUM OXALATE, and POTASSIUM OXALATE (2:1) use OXALATES 1999-2012", "MR": "20180629", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D019815"}, {"RECTYPE": "D", "MH": "Benzoic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Benzoate, Potassium", "MN": "D02.455.426.559.389.127.117", "PA": "Food Preservatives", "EC": "analogs & derivatives:Benzoates", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzoic acid", "RN": "8SKN0B0MIM", "RR": "763YQN2K7K", "AN": "BENZOIC ACIDS see BENZOATES is also available", "PI": "Benzoates (1966-1998)", "MS": "A fungistatic compound that is widely used as a food preservative. It is conjugated to GLYCINE in the liver and excreted as hippuric acid.", "PM": "1999; BENZOIC ACID was indexed under BENZOATES 1980-1998; for POTASSIUM BENZOATE see BENZOATES 1999-2012", "HN": "1999; for POTASSIUM BENZOATE use BENZOATES 1999-2012", "MR": "20160701", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D019817"}, {"RECTYPE": "D", "MH": "Clavulanic Acid", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Clavulanate|T109|T195|NON|NRW|FDA SRS (2014)|NLM (1998)|970327|abbcdeef", "ENTRY": "Potassium, Clavulanate", "MN": "D03.633.100.300.374.160", "PA": "beta-Lactamase Inhibitors", "EC": "analogs & derivatives:Clavulanic Acids", "MH_TH": "NLM (1998)", "ST": "T195", "N1": "4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, (2R-(2alpha,3Z,5alpha))", "RN": "23521W1S24", "RR": "Q42OMW3AT8", "PI": "Lactams (1976-1982)", "MS": "A beta-lactam antibiotic produced by the actinobacterium Streptomyces clavuligerus. It is a suicide inhibitor of bacterial beta-lactamase enzymes. Administered alone, it has only weak antibacterial activity against most organisms, but given in combination with other beta-lactam antibiotics it prevents antibiotic inactivation by microbial lactamase.", "PM": "98; CLAVULANIC ACID was indexed under CLAVULANIC ACIDS 1978-97 & LACTAMS 1976-82", "HN": "98; use CLAVULANIC ACID (NM) 1980-97", "MR": "20180629", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019818"}, {"RECTYPE": "D", "MH": "Budesonide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tarpeyo|T109|T121|TRD|NRW|NLM (2023)|211216|abbcdef", "ENTRY": "Rhinocort|T109|T121|TRD|NRW|NLM (1998)|970102|abbcdef", "MN": "D04.210.500.745.745.654.105", "PA": "Glucocorticoids", "MH_TH": "USAN (1979)", "ST": "T121", "N1": "Pregna-1,4-diene-3,20-dione,16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)-", "RN": "51333-22-3", "RR": "51372-29-3 ((R)-isomer)", "PI": "Pregnenediones (1979-1997)", "MS": "A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS.", "PM": "98; BUDESONIDE was indexed under PREGNENEDIONES 1979-97", "HN": "98; use BUDESONIDE (NM) 1979-97", "MR": "20220714", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019819"}, {"RECTYPE": "D", "MH": "Xanthine", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.759.758.824.938", "EC": "analogs & derivatives:Xanthines", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "1AVZ07U9S7", "RR": "69-89-6 (Xanthine)", "AN": "a specific chem: do not confuse with XANTHINES or XANTHENES", "PI": "Xanthines (1980-1997)", "MS": "A purine base found in most body tissues and fluids, certain plants, and some urinary calculi. It is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine. The methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects. (Dorland, 28th ed)", "PM": "98; XANTHINE was indexed under XANTHINES 1981-97", "HN": "98; use XANTHINE (NM) 1980-97", "MR": "20160601", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019820"}, {"RECTYPE": "D", "MH": "Simvastatin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MK733", "MN": "D04.615.638.400.900", "PA": "Hypolipidemic Agents", "FX": "Rosuvastatin Calcium", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "AGG2FN16EV", "RR": "79902-63-9 (Simvastatin)", "PI": "Naphthalenes (1986-1987)", "MS": "A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL CHOLESTEROL.", "PM": "98; SIMVASTATIN was indexed under LOVASTATIN/analogs & derivatives 1988-97 & NAPHTHALENES 1986-87", "HN": "98; use SIMVASTATIN (NM) 1986-97", "MR": "20170117", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019821"}, {"RECTYPE": "D", "MH": "beta-MSH", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta Intermedin|T116|T121|T123|T125|NON|EQV|NLM (2020)|190222|abbbbcdef", "ENTRY": "beta Melanotropin", "MN": "D12.776.631.650.460.075", "PA": "Hormones", "MH_TH": "UNK (19XX)", "ST": "T125", "RN": "0", "MS": "An 18-amino acid peptide that is the C-terminal fragment of gamma-lipotropin which is the N-terminal fragment of BETA-LIPOTROPIN. Beta-MSH is shown to regulate skin pigmentation, steroid production, and feeding.", "PM": "1998", "HN": "1998", "MR": "20190408", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D019824"}, {"RECTYPE": "D", "MH": "gamma-MSH", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Melanocyte-Stimulating Hormone, gamma|T116|T121|T125|NON|EQV|NLM (2007)|060110|abbbcdef", "ENTRY": "gamma3 MSH", "MN": "D12.776.631.650.460.115", "PA": "Hormones", "MH_TH": "UNK (19XX)", "ST": "T125", "RN": "0", "MS": "An 11-amino acid peptide derived from the N-terminal fragment of pro-opiomelanocortin (POMC). Gamma-MSH stimulates adrenal steroidogenesis and has an regulatory role in the cardiovascular and the renal systems.", "PM": "1998; N-POMC was indexed under PEPTIDE FRAGMENTS & PRO-OPIOMELANOCORTIN 1981-2006", "HN": "1998 (1981)", "MR": "20151123", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D019825"}, {"RECTYPE": "D", "MH": "Cholic Acid", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cholbam|T109|T121|T123|TRD|REL|NLM (2021)|191004|abbbcdef", "MN": "D04.210.500.221.430.130", "EC": "analogs & derivatives:Cholic Acids", "MH_TH": "NLM (1998)", "ST": "T123", "N1": "Cholan-24-oic acid, 3,7,12-trihydroxy-, (3-alpha, 5-beta, 7-alpha, 12-alpha)-", "RN": "G1JO7801AE", "RR": "81-25-4 (Cholic Acid)", "AN": "CHOLIC ACIDS is available", "PI": "Cholic Acids (1978-1998)", "MS": "A major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion.", "PM": "99; CHOLIC ACID was indexed under CHOLIC ACIDS 1983-98", "HN": "99; use CHOLIC ACID (NM) 1981-98", "MR": "20200110", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D019826"}, {"RECTYPE": "D", "MH": "Nevirapine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hemihydrate, Nevirapine", "MN": "D03.383.725.506", "PA": "Reverse Transcriptase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-", "RN": "99DK7FVK1H", "RR": "B7XF2TD73C", "PI": "Pyridines (1993-1997)", "MS": "A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.", "PM": "98", "HN": "98", "MR": "20160531", "DA": "19970722", "DC": "1", "DX": "19980101", "UI": "D019829"}, {"RECTYPE": "D", "MH": "Adenosine-5'-(N-ethylcarboxamide)", "DS": "ADENOSINE ETHYLCARBOXAMIDE 05 N", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "NECA|T114|T121|EQV|NLM (1998)|970110|abbdef", "ENTRY": "N6 Ethyl carboxamido Adenosine", "MN": "D13.570.800.096.250", "PA": "Vasodilator Agents", "MH_TH": "NLM (1998)", "ST": "T121", "RN": "35920-39-9", "PI": "Adenosine/analogs & derivatives (1980-1997)", "MS": "A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase activity.", "PM": "98; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE) was indexed under ADENOSINE/analogs & derivatives 1980-97", "HN": "98; use ADENOSINE-5'-(N-ETHYLCARBOXAMIDE) (NM) 1980-97", "MR": "20160527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019830"}, {"RECTYPE": "D", "MH": "Sodium-Calcium Exchanger", "DE": "NA CA EXCHANGER", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sodium-Calcium Carrier|T116|T123|NON|EQV|NLM (1998)|970110|abbcdef", "ENTRY": "Sodium Calcium Exchanger", "MN": "D12.776.543.585.450.162.442", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1980-1993)", "MS": "An electrogenic ion exchange protein that maintains a steady level of calcium by removing an amount of calcium equal to that which enters the cells. It is widely distributed in most excitable membranes, including the brain and heart.", "PM": "98; SODIUM-CALCIUM CARRIER (now SODIUM-CALCIUM EXCHANGER) was indexed under CARRIER PROTEINS 1980-97; CALCIUM-SODIUM ANTIPORTER was indexed under ANTIPORTERS 1993-97, CARRIER PROTEINS & MEMBRANE PROTEINS 1980-93", "HN": "98; use SODIUM-CALCIUM EXCHANGER (NM) 1980-97", "MR": "20050630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019831"}, {"RECTYPE": "D", "MH": "N-Methylscopolamine", "DS": "METHYLSCOPOLAMINE N", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nitrate, N-Methylscopolamine", "MN": "D03.605.869.822.550", "PA": "Parasympatholytics", "MH_TH": "NLM (1998)", "ST": "T109", "RN": "VDR09VTQ8U", "RR": "RTN51LK7WL", "PI": "Scopolamine Derivatives (1972-1997)", "MS": "A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors.", "PM": "98; N-METHYLSCOPOLAMINE was indexed under SCOPOLAMINE DERIVATIVES 1972-97", "HN": "98; use N-METHYLSCOPOLAMINE (NM) 1980-97", "MR": "20160531", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019832"}, {"RECTYPE": "D", "MH": "Genistein", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Genestein|T109|T123|NON|EQV|NLM (1998)|970113|abbcdef", "MN": "D03.633.100.150.266.450.400.375", "PA": "Protein Kinase Inhibitors", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "DH2M523P0H", "RR": "446-72-0 (Genistein)", "PI": "Isoflavones (1976-1997)", "MS": "An isoflavonoid derived from soy products. It inhibits PROTEIN-TYROSINE KINASE and topoisomerase-II (DNA TOPOISOMERASES, TYPE II); activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 PHASE arrest in human and murine cell lines and inhibits PROTEIN-TYROSINE KINASE.", "PM": "98; GENISTEIN was indexed under ISOFLAVONES 1976-97", "HN": "98; use GENISTEIN (NM) 1980-97", "MR": "20160531", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019833"}, {"RECTYPE": "D", "MH": "FMRFamide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Phe Met Arg Phe amide", "MN": "D12.776.631.650.235", "PA": "Membrane Transport Modulators", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "64190-70-1", "RR": "84413-35-4 ((D-phenylalaninamide)-isomer)", "PI": "Oligopeptides (1978-1986)", "MS": "A molluscan neuroactive peptide which induces a fast excitatory depolarizing response due to direct activation of amiloride-sensitive SODIUM CHANNELS. (From Nature 1995; 378(6558): 730-3)", "PM": "98; FMRFAMIDE was indexed under NEUROPEPTIDES 1987-97, NERVE TISSUE PROTEINS 1986-87, & OLIGOPEPTIDES 1978-86", "HN": "98; use FMRFAMIDE (NM) 1978-97", "MR": "20151123", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019835"}, {"RECTYPE": "D", "MH": "Preimplantation Diagnosis", "DE": "PREIMPLANTATION DIAG", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Preimplantation Genetic Diagnosis|T060|NON|EQV|NLM (1998)|970113|PREIMPLANTATION GENETIC DIAG|abcdefv", "ENTRY": "Screenings, Preimplantation", "MN": "E01.370.378.625", "FX": "Prenatal Diagnosis", "MH_TH": "BIOETHICS (1991)", "ST": "T060", "AN": "preimplanation refers to ovum implantation; check tags HUMANS or ANIMALS & FEMALE & PREGNANCY", "PI": "Prenatal Diagnosis (1987-1997)", "MS": "Determination of the nature of a pathological condition or disease in the OVUM; ZYGOTE; or BLASTOCYST prior to implantation. CYTOGENETIC ANALYSIS is performed to determine the presence or absence of genetic disease.", "PM": "98", "HN": "98", "MR": "20110624", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019836"}, {"RECTYPE": "D", "MH": "Ryanodine Receptor Calcium Release Channel", "DE": "RYANODINE RECEPT CALCIUM RELEASE CHANNEL", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ryanodine Receptors|T116|T192|NON|BRD|NLM (1998)|970113|RYANODINE RECEPT|abbcdefv", "ENTRY": "Receptors, Ryanodine", "MN": "D12.776.543.585.400.150.800", "EC": "antagonists & inhibitors:Calcium Channel Blockers", "MH_TH": "NLM (1998)", "ST": "T192", "RN": "0", "PI": "Receptors, Cholinergic (1985-1992)", "MS": "A tetrameric calcium release channel in the SARCOPLASMIC RETICULUM membrane of SMOOTH MUSCLE CELLS, acting oppositely to SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES. It is important in skeletal and cardiac excitation-contraction coupling and studied by using RYANODINE. Abnormalities are implicated in CARDIAC ARRHYTHMIAS and MUSCULAR DISEASES.", "PM": "98; CALCIUM-RYANODINE RECEPTOR COMPLEX (now RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL) was indexed under CALCIUM CHANNELS 1988-97, MUSCLE PROTEINS 1993-97, & RECEPTORS, CHOLINERGIC 1985-92", "HN": "98; use RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL (NM) 1985-97", "MR": "20160701", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019837"}, {"RECTYPE": "D", "MH": "Neck Injuries", "DE": "NECK INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neck Injury", "MN": "C26.700", "MH_TH": "NLM (1998)", "ST": "T037", "AN": "general or unspecified; prefer specifics; restrict to injury of soft tissue; injury of cervical vertebrae equals CERVICAL VERTEBRAE /inj; coordinate with specific injury ", "PI": "Neck/injuries (1966-1997)", "MS": "General or unspecified injuries to the neck. It includes injuries to the skin, muscles, and other soft tissues of the neck.", "PM": "98", "HN": "98", "MR": "20190524", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019838"}, {"RECTYPE": "D", "MH": "2-Propanol", "DS": "PROPANOL 02", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isopropyl Alcohol|T109|NON|EQV|FDA SRS (2014)|NLM (1998)|USP (19XX)|970115|abcdeeef", "ENTRY": "Alcohol, Rubbing", "MN": "D02.033.755.615", "PA": "Solvents", "EC": "analogs & derivatives:Propanols", "MH_TH": "NLM (1998)", "ST": "T109", "RN": "ND2M416302", "RR": "67-63-0 (2-Propanol)", "PI": "1-Propanol (1975-1997)", "MS": "An isomer of 1-PROPANOL. It is a colorless liquid having disinfectant properties. It is used in the manufacture of acetone and its derivatives and as a solvent. Topically, it is used as an antiseptic.", "PM": "98", "HN": "98", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019840"}, {"RECTYPE": "D", "MH": "Defecography", "DE": "DEFECOGR", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Defecographies", "MN": "E01.370.350.700.715.250", "MH_TH": "NLM (1998)", "ST": "T060", "PI": "Fecal Incontinence (1978-1997)", "MS": "Radiographic examination of the process of defecation after the instillation of a CONTRAST MEDIA into the rectum.", "PM": "98", "HN": "98", "MR": "19991103", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019841"}, {"RECTYPE": "D", "MH": "Ciliary Arteries", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ciliary Artery", "MN": "A07.015.114.248", "MH_TH": "NLM (1998)", "ST": "T023", "MS": "Three groups of arteries found in the eye which supply the iris, pupil, sclera, conjunctiva, and the muscles of the iris.", "PM": "98", "HN": "98", "MR": "20180630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019842"}, {"RECTYPE": "D", "MH": "Archaeal Proteins", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Gene Products, Archaeal|T116|NON|EQV|NLM (1998)|970116|abcdef", "ENTRY": "Gene Proteins, Archaeal", "MN": "D12.776.090", "MH_TH": "NLM (1998)", "ST": "T116", "RN": "0", "AN": "/drug eff /ultrastruct permitted; /physiol permitted for function within the archaeon; coord IM with specific protein (IM) + specific archaeon (IM)", "PI": "Bacterial Proteins (1994-1997)", "MS": "Proteins found in any species of archaeon.", "PM": "98", "HN": "98", "MR": "20050630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019843"}, {"RECTYPE": "D", "MH": "Antibodies, Archaeal", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Archaeal Antibodies|T129|NON|EQV|NLM (1998)|970116|abcdef", "MN": "D12.776.377.715.548.114.107", "PA": "Immunologic Factors", "MH_TH": "NLM (1998)", "ST": "T129", "RN": "0", "AN": "coordinate IM with specific archaeon /immunol (IM); do not coordinate with ANTIBODY FORMATION for /biosyn", "PI": "Antibodies, Bacterial (1984-1997)", "MS": "Immunoglobulins produced in a response to ARCHAEAL ANTIGENS.", "PM": "98", "HN": "98", "MR": "20100625", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019844"}, {"RECTYPE": "D", "MH": "Antigens, Archaeal", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Archaeal Antigens|T129|NON|EQV|NLM (1998)|970116|abcdef", "MN": "D23.050.140", "MH_TH": "NLM (1998)", "ST": "T129", "RN": "0", "AN": "coord IM with specific archaeon /immunol (IM)", "PI": "Antigens, Bacterial (1981-1997)", "MS": "Substances of archaeal origin that have antigenic activity.", "PM": "98", "HN": "98", "MR": "20050630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019845"}, {"RECTYPE": "D", "MH": "Miller Fisher Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ophthalmoplegia, Ataxia and Areflexia Syndrome|T047|NON|EQV|NLM (2000)|991108|abcdef", "ENTRY": "Syndrome, Miller-Fisher", "MN": "C20.111.258.750.400.500", "MH_TH": "NLM (1998)", "ST": "T047", "AN": "entry term FISHER SYNDROME: do not confuse with the Fisher one-and-a-half syndrome, an eye movement disorder caused by a brain stem lesion", "PI": "Reflex, Abnormal (1966-1997)", "MS": "A variant of the GUILLAIN-BARRE SYNDROME characterized by the acute onset of oculomotor dysfunction, ataxia, and loss of deep tendon reflexes with relative sparing of strength in the extremities and trunk. The ataxia is produced by peripheral sensory nerve dysfunction and not by cerebellar injury. Facial weakness and sensory loss may also occur. The process is mediated by autoantibodies directed against a component of myelin found in peripheral nerves. (Adams et al., Principles of Neurology, 6th ed, p1313; Neurology 1987 Sep;37(9):1493-8)", "PM": "1998", "HN": "1998", "MR": "20220523", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019846"}, {"RECTYPE": "D", "MH": "Chromosomes, Archaeal", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "ENTRY": "Chromosome, Archaeal", "MN": "G05.360.162.167", "MH_TH": "NLM (1998)", "ST": "T026", "PI": "Chromosomes, Bacterial (1989-1997)", "MS": "Structures within the nucleus of archaeal cells consisting of or containing DNA, which carry genetic information essential to the cell.", "PM": "98", "HN": "98", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019847"}, {"RECTYPE": "D", "MH": "Gene Expression Regulation, Archaeal", "DE": "GENE EXPRESSION REG ARCHAEAL", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Regulation of Gene Expression, Archaeal|T045|NON|EQV|NLM (1998)|970117|REG GENE EXPRESSION ARCHAEAL|abcdefv", "ENTRY": "Regulation, Gene Expression, Archaeal|T045|NON|EQV|NLM (1998)|970117|abcdef", "MN": "G05.308.290", "MH_TH": "NLM (1998)", "ST": "T045", "AN": "coordinate with specific archaeon /genet           ", "PI": "Gene Expression Regulation, Bacterial (1990-1997)", "MS": "Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in archaea.", "PM": "98", "HN": "98", "MR": "20180630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019848"}, {"RECTYPE": "D", "MH": "Sex Determination Processes", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Sex Determination Genetics|T045|NON|EQV|NLM (2011)|100108|abcdef", "ENTRY": "Processes, Sex Determination", "MN": "G08.686.841.437", "FX": "Sex Preselection", "MH_TH": "NLM (2011)", "ST": "T045", "AN": "do not confuse with SEX DETERMINATION ANALYSIS which is validation of sex by examination of gonads or genetic tests; natural sex reversal processes go here (note entry terms PROTANDRY and PROTOGYNY); HERMAPHRODITIC ORGANISMS is also available", "PI": "Sex Determination (Analysis) (1966-1997)", "MS": "The mechanisms by which the SEX of an individual's GONADS are fixed.", "PM": "2011; see SEX DETERMINATION (GENETICS) 1998-2010", "HN": "2011 (1998)", "MR": "20160617", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019849"}, {"RECTYPE": "D", "MH": "Heptanol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "n-Heptanol|T109|NON|EQV|FDA SRS (2014)|NLM (1998)|970220|HEPTANOL N|abcdeefs", "ENTRY": "n Heptanol", "MN": "D10.289.500", "MH_TH": "NLM (1998)", "ST": "T109", "N1": "1-Heptanol", "RN": "8JQ5607IO5", "RR": "111-70-6 (Heptanol)", "PI": "Alcohols (1980-1997)", "MS": "A colorless liquid with a fragrant odor. It is used as an intermediate, solvent and in cosmetics.", "PM": "98; N-HEPTANOL was indexed under ALCOHOLS 1980-97", "HN": "98; use HEPTANOL (NM) 1980-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019850"}, {"RECTYPE": "D", "MH": "Thrombophilia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypercoagulability|T047|NON|EQV|NLM (1999)|980123|abcdef", "ENTRY": "Thrombophilias", "MN": "C15.378.925", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Thrombosis (1966-1997)", "MS": "A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.", "PM": "98", "HN": "98", "MR": "20120703", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019851"}, {"RECTYPE": "D", "MH": "Diacylglycerol Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Diglyceride Kinase|T116|T126|NON|EQV|NLM (1998)|970124|abbcdef", "ENTRY": "gamma, DGK", "MN": "D08.811.913.696.620.200", "MH_TH": "NLM (1998)", "ST": "T126", "N1": "ATP:1,2-diacylglycerol 3-phosphotransferase", "RN": "EC 2.7.1.107", "PI": "Phosphotransferases (Alcohol Group Acceptor) (1994-1997)", "MS": "An enzyme of the transferase class that uses ATP to catalyze the phosphorylation of diacylglycerol to a phosphatidate. EC 2.7.1.107.", "PM": "98; DIACYLGLYCEROL KINASE was indexed under PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR) 1994-97, PHOSPHOTRANSFERASES, ATP 1975-93, DIGLYCERIDES 1975-80, and GLYCERIDES & PHOSPHOTRANSFERASES 1973-74", "HN": "98; use DIACYLGLYCEROL KINASE (NM) 1980-97", "MR": "20220714", "DA": "19970702", "DC": "1", "DX": "19980101", "UI": "D019852"}, {"RECTYPE": "D", "MH": "O(6)-Methylguanine-DNA Methyltransferase", "DS": "METHYLGUANINE DNA METHYLTRANSFERASE O 06", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "O(6)-Methylguanine Methyltransferase|T116|T126|NON|EQV|NLM (1998)|970520|METHYLGUANINE METHYLTRANSFERASE O 06|abbcdefs", "ENTRY": "S-Methyltransferase, Methylated-DNA-Protein-Cysteine", "MN": "D08.811.913.555.500.800.650", "MH_TH": "NLM (1998)", "ST": "T126", "N1": "DNA-6-O-methylguanine:protein-L-cysteine S-methyltransferase", "RN": "EC 2.1.1.63", "RR": "77271-19-3 (CAS RN)", "PI": "Methyltransferases (1978-1997)", "MS": "An enzyme that transfers methyl groups from O(6)-methylguanine, and other methylated moieties of DNA, to a cysteine residue in itself, thus repairing alkylated DNA in a single-step reaction. EC 2.1.1.63.", "PM": "98; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1978-97 & DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1978-82", "HN": "98; use O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE (NM) 1980-97", "MR": "20040729", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019853"}, {"RECTYPE": "D", "MH": "Ethylene Glycol", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Glycol, Monoethylene", "MN": "D02.033.455.250.268", "EC": "analogs & derivatives:Ethylene Glycols", "MH_TH": "NLM (1998)", "ST": "T131", "RN": "FC72KVT52F", "RR": "107-21-1 (Ethylene Glycol)", "AN": "ETHYLENE GLYCOLS also available", "PI": "Ethylene Glycols (1982-1997)", "MS": "A colorless, odorless, viscous dihydroxy alcohol. It has a sweet taste, but is poisonous if ingested. Ethylene glycol is the most important glycol commercially available and is manufactured on a large scale in the United States. It is used as an antifreeze and coolant, in hydraulic fluids, and in the manufacture of low-freezing dynamites and resins.", "PM": "98; ETHYLENE GLYCOL was indexed under ETHYLENE GLYCOLS 1982-97", "HN": "98; use ETHYLENE GLYCOL (NM) 1982-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019855"}, {"RECTYPE": "D", "MH": "Ethanolamine", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2-Aminoethanol|T109|NON|EQV|FDA SRS (2014)|NLM (1998)|970127|AMINOETHANOL 02|abcdeefs", "ENTRY": "2 Aminoethanol", "MN": "D02.092.063.291.375", "EC": "analogs & derivatives:Ethanolamines", "MH_TH": "NLM (1998)", "ST": "T109", "RN": "5KV86114PT", "RR": "141-43-5 (Ethanolamine)", "AN": "ETHANOLAMINES also available", "PI": "Ethanolamines (1973-1997)", "MS": "A viscous, hygroscopic amino alcohol with an ammoniacal odor. It is widely distributed in biological tissue and is a component of lecithin. It is used as a surfactant, fluorimetric reagent, and to remove CO2 and H2S from natural gas and other gases.", "PM": "98; ETHANOLAMINE was indexed under ETHANOLAMINES 1973-97", "HN": "98; use ETHANOLAMINE (NM) 1980-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019856"}, {"RECTYPE": "D", "MH": "Osteogenesis, Distraction", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Distraction Osteogenesis|T061|NON|EQV|NLM (1998)|970130|abcdef", "ENTRY": "Osteogeneses, Distraction", "MN": "E04.555.120.690", "FX": "Ilizarov Technique", "MH_TH": "NLM (1998)", "ST": "T061", "AN": "bone lengthening by gradual distraction; not restricted to long bones", "PI": "Osteogenesis (1985-1997)", "MS": "Bone lengthening by gradual mechanical distraction. An external fixation device produces the distraction across the bone plate. The technique was originally applied to long bones but in recent years the method has been adapted for use with mandibular implants in maxillofacial surgery.", "PM": "98", "HN": "98", "DA": "19970625", "DC": "1", "DX": "19980101", "UI": "D019857"}, {"RECTYPE": "D", "MH": "Enteroendocrine Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Intestinal Secretin Cells|T025|NON|NRW|NLM (2006)|041025|abcdef", "ENTRY": "Secretin Cells, Intestinal", "MN": "A11.436.294", "FX": "APUD Cells", "MH_TH": "NLM (1998)", "ST": "T025", "PI": "Endocrine Glands (1973-1997)", "MS": "Cells found throughout the lining of the GASTROINTESTINAL TRACT that contain and secrete regulatory PEPTIDE HORMONES and/or BIOGENIC AMINES.", "PM": "2006; see ENDOCRINE CELLS OF GUT 1998-2005", "HN": "2006 (1998)", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019858"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-met", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "met Proto-Oncogene Proteins|T116|T126|T192|ABX|EQV|NLM (2006)|050422|abbbcdef", "ENTRY": "met Proto Oncogene Proteins", "MN": "D12.776.624.664.700.186", "MH_TH": "NLM (1998)", "ST": "T192", "RN": "EC 2.7.10.1", "MS": "Cell surface protein-tyrosine kinase receptors for HEPATOCYTE GROWTH FACTOR. They consist of an extracellular alpha chain which is disulfide-linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and sites critical for the regulation of kinase activity. Mutations in the c-met proto-oncogene are associated with papillary renal carcinoma and other neoplasia.", "PM": "2006; see PROTO-ONCOGENE PROTEIN C-MET 2000-2005, see PROTO-ONCOGENE PROTEINS C-MET 1998-1999; PROTO-ONCOGENE PROTEIN C-MET was indexed under RECEPTOR PROTEIN-TYROSINE KINASE 1994-1997 & PROTO-ONCOGENE PROTEINS 1989-1993", "HN": "2006, 1998-1999", "MR": "20210521", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019859"}, {"RECTYPE": "D", "MH": "Lymphocyte Specific Protein Tyrosine Kinase p56(lck)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p56 lck|T116|T126|ABB|EQV|NLM (1998)|970205|P A 056 LCK|abbcdefs", "ENTRY": "lck, Proto-Oncogene Protein", "MN": "D12.776.624.664.700.128", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.7.10.2", "PI": "src-Family Kinases (1996-1997)", "MS": "This enzyme is a lymphoid-specific src family tyrosine kinase that is critical for T-cell development and activation. Lck is associated with the cytoplasmic domains of CD4, CD8 and the beta-chain of the IL-2 receptor, and is thought to be involved in the earliest steps of TCR-mediated T-cell activation.", "PM": "98; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK) was indexed under SRC-FAMILY KINASES 1996-97 & PROTEIN-TYROSINE KINASE 1988-95", "HN": "98; use LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK) (NM) 1988-97", "MR": "20210521", "DA": "19970702", "DC": "1", "DX": "19980101", "UI": "D019860"}, {"RECTYPE": "D", "MH": "Enterochromaffin-like Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "ECL Cells|T025|EQV|NLM (1998)|970205|abdef", "ENTRY": "Enterochromaffin-like Cell", "MN": "A11.436.294.047", "FX": "Enterochromaffin Cells", "MH_TH": "NLM (1998)", "ST": "T025", "PI": "Gastric Mucosa (1967-1971)", "MS": "Neuroendocrine cells in the glands of the GASTRIC MUCOSA. They produce HISTAMINE and peptides such as CHROMOGRANINS. ECL cells respond to GASTRIN by releasing histamine which acts as a paracrine stimulator of the release of HYDROCHLORIC ACID from the GASTRIC PARIETAL CELLS.", "PM": "98", "HN": "98", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019861"}, {"RECTYPE": "D", "MH": "Zingiberales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Zingiberale", "MN": "B01.875.800.575.912.250.618.937", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid4618", "MS": "An order of herbaceous tropical perennials which include the banana (MUSACEAE) and GINGER (ZINGIBERACEAE) family.", "PM": "1998", "HN": "1998", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019862"}, {"RECTYPE": "D", "MH": "Gastrin-Secreting Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Gastrin Cells|T025|NON|EQV|NLM (1998)|970206|abcdef", "ENTRY": "Gastrin-Secreting Cell", "MN": "A11.436.294.055", "MH_TH": "NLM (2006)", "ST": "T025", "PI": "Pyloric Antrum (1972-1997)", "MS": "Endocrine cells which secrete GASTRIN, a peptide that induces GASTRIC ACID secretion. They are found predominantly in the GASTRIC GLANDS of PYLORIC ANTRUM in the STOMACH, but can also be found in the DUODENUM, nervous and other tissues.", "PM": "2006; see G CELLS 1998-2005", "HN": "2006 (1998)", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019863"}, {"RECTYPE": "D", "MH": "Somatostatin-Secreting Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "delta Cells|T025|NON|EQV|NLM (2006)|041101|abcdef", "ENTRY": "delta Cells, Pancreatic", "MN": "A11.436.294.950", "MH_TH": "NLM (2006)", "ST": "T025", "AN": "/transpl: if from pancreas, coordinate with ISLETS OF LANGERHANS TRANSPLANTATION", "PI": "Pancreas/cytology (1968-1989)", "MS": "Endocrine cells found throughout the GASTROINTESTINAL TRACT and in islets of the PANCREAS. D cells secrete SOMATOSTATIN that acts in both an endocrine and paracrine manner. Somatostatin acts on a variety of tissues including the PITUITARY GLAND; gastrointestinal tract; pancreas; and KIDNEY by inhibiting the release of hormones, such as GROWTH HORMONE; GASTRIN; INSULIN; and RENIN.", "PM": "2006, see D CELLS 1998-2005; for PANCREATIC DELTA CELLS see ISLETS OF LANGERHANS 1991-1997", "HN": "2006 (1998); for PANCREATIC DELTA CELLS use ISLETS OF LANGERHANS 1991-1997", "MR": "20180701", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019864"}, {"RECTYPE": "D", "MH": "Anti-Glomerular Basement Membrane Disease", "DE": "ANTI GLOMERULAR BASEMENT MEMBRANE DIS", "DS": "ANTIGLOMERULAR BASEMENT MEMBRANE DISEASE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Goodpasture Syndrome|T047|NON|EQV|NLM (1965)|OMIM (2013)|ORD (2010)|990101|abcdeeef", "ENTRY": "Syndrome, Goodpasture's", "MN": "C20.111.190", "FX": "Glomerular Basement Membrane", "MH_TH": "NLM (1998)", "ST": "T047", "MS": "An autoimmune disease of the KIDNEY and the LUNG. It is characterized by the presence of circulating autoantibodies targeting the epitopes in the non-collagenous domains of COLLAGEN TYPE IV in the basement membranes of kidney glomeruli (KIDNEY GLOMERULUS) and lung alveoli (PULMONARY ALVEOLI), and the subsequent destruction of these basement membranes. Clinical features include pulmonary alveolar hemorrhage and glomerulonephritis.", "PM": "1998; for GOODPASTURE SYNDROME see GOODPASTURE SYNDROME 1965-2006", "HN": "1998", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019867"}, {"RECTYPE": "D", "MH": "Kanamycin Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neomycin Phosphotransferase|T116|T126|NON|EQV|NLM (1998)|970206|abbcdef", "ENTRY": "Transferase, Kanamycin-Neomycin Phosphate", "MN": "D08.811.913.696.620.475", "MH_TH": "NLM (1998)", "ST": "T126", "N1": "ATP:kanamycin 3'-O-phosphotransferase", "RN": "EC 2.7.1.95", "RR": "62213-36-9 (CAS RN)", "PI": "Phosphotransferases (Alcohol Group Acceptor) (1994-1997)", "MS": "A class of enzymes that inactivate aminocyclitol-aminoglycoside antibiotics (AMINOGLYCOSIDES) by regiospecific PHOSPHORYLATION of the 3' and/or 5' hydroxyl.", "PM": "98; KANAMYCIN KINASE was indexed under PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR) 1994-97, PHOSPHOTRANSFERASES, ATP 1976-93 & KANAMYCIN 1976-80", "HN": "98; use KANAMYCIN KINASE (NM) 1980-97", "MR": "20040707", "DA": "19970702", "DC": "1", "DX": "19980101", "UI": "D019868"}, {"RECTYPE": "D", "MH": "Phosphatidylinositol 3-Kinases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PtdIns 3-Kinase|T116|T126|EQV|NLM (1998)|970611|PTDINS KINASE 03|abbdefs", "ENTRY": "PtdIns 3 Kinases", "MN": "D12.776.476.556", "EC": "antagonists & inhibitors:Phosphoinositide-3 Kinase Inhibitors", "MH_TH": "NLM (2011)", "ST": "T126", "RN": "EC 2.7.1.-", "AN": "note specifics including PHOSPHATIDYLINOSITOL 3-KINASE are available", "PI": "Phosphotransferases (Alcohol Group Acceptor) (1994-1997)", "MS": "Phosphotransferases that catalyzes the conversion of 1-phosphatidylinositol to 1-phosphatidylinositol 3-phosphate. Many members of this enzyme class are involved in RECEPTOR MEDIATED SIGNAL TRANSDUCTION and regulation of vesicular transport with the cell. Phosphatidylinositol 3-Kinases have been classified both according to their substrate specificity and their mode of action within the cell.", "PM": "2011; see 1-PHOSPHATIDYLINOSITOL 3-KINASE 1998-2010; 1-PHOSPHATIDYLINOSITOL 3-KINASE was indexed under PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR) 1994-97 & PHOSPHOTRANSFERASES, ATP 1988-93", "HN": "2011(1998)", "MR": "20210521", "DA": "19970702", "DC": "1", "DX": "19980101", "UI": "D019869"}, {"RECTYPE": "D", "MH": "1-Phosphatidylinositol 4-Kinase", "DS": "PHOSPHATIDYLINOSITOL KINASE 01 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PtdIns 4-Kinase|T116|T126|EQV|NLM (1998)|970207|PTDINS KINASE 04|abbdefs", "ENTRY": "PtdIns 4 Kinase", "MN": "D08.811.913.696.620.550", "MH_TH": "NLM (1998)", "ST": "T126", "N1": "ATP:1-phosphatidyl-1D-myo-inositol-4-phosphotransferase", "RN": "EC 2.7.1.67", "RR": "37205-54-2 (CAS RN)", "PI": "Phosphotransferases, ATP (1974-1993)", "MS": "An enzyme that catalyzes the conversion of phosphatidylinositol (PHOSPHATIDYLINOSITOLS) to phosphatidylinositol 4-phosphate, the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate.", "PM": "98; 1-PHOSPHATIDYLINOSITOL 4-KINASE was indexed under PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR) 1994-97, PHOSPHATIDYLINOSITOLS 1980-82, PHOSPHOTRANSFERASES, ATP 1974-93, & PHOSPHOINOSITIDES 1974-75", "HN": "98; use 1-PHOSPHATIDYLINOSITOL 4-KINASE (NM) 1980-97", "MR": "20030709", "DA": "19970702", "DC": "1", "DX": "19980101", "UI": "D019870"}, {"RECTYPE": "D", "MH": "Dyskeratosis Congenita", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Zinsser-Cole-Engman Syndrome|T019|T047|EPO|NRW|GHR (2014)|NLM (1998)|OMIM (2013)|970210|abbcdeeef", "ENTRY": "Zinsser Cole Engman Syndrome", "MN": "C17.800.827.235", "MH_TH": "NLM (1998)", "ST": "T047", "MS": "A predominantly X-linked recessive syndrome characterized by a triad of reticular skin pigmentation, nail dystrophy and leukoplakia of mucous membranes. Oral and dental abnormalities may also be present. Complications are a predisposition to malignancy and bone marrow involvement with pancytopenia. (from Int J Paediatr Dent 2000 Dec;10(4):328-34) The X-linked form is also known as Zinsser-Cole-Engman syndrome and involves the gene which encodes a highly conserved protein called dyskerin.", "PM": "98", "HN": "98", "MR": "20190617", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019871"}, {"RECTYPE": "D", "MH": "Chief Cells, Gastric", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Gastric Chief Cells|T025|NON|EQV|NLM (1998)|970211|abcdef", "ENTRY": "Zymogenic Cells, Gastric", "MN": "A11.436.150", "MH_TH": "NLM (1998)", "ST": "T025", "PI": "Gastric Mucosa (1966-1997)", "MS": "Epithelial cells that line the basal half of the GASTRIC GLANDS. Chief cells synthesize and export an inactive enzyme PEPSINOGEN which is converted into the highly proteolytic enzyme PEPSIN in the acid environment of the STOMACH.", "PM": "98", "HN": "98", "MR": "20050630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019872"}, {"RECTYPE": "D", "MH": "Schnitzler Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C20.683.780.640.700", "MH_TH": "NLM (1998)", "ST": "T047", "MS": "An extremely rare condition manifested as monoclonal IMMUNOGLOBULIN M dysproteinemia without features of lymphoproliferative disease, but with chronic urticaria, fever of unknown origin, disabling bone pain, hyperostosis, and increased erythrocyte sedimentation rate.", "PM": "98", "HN": "98", "MR": "20010807", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019873"}, {"RECTYPE": "D", "MH": "One-Carbon Group Transferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Single-Carbon Group Transferases|T116|T126|NON|EQV|NLM (1998)|970513|abbcdef", "ENTRY": "Transferases, Single-Carbon Group", "MN": "D08.811.913.555", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.1.-", "MS": "A subclass of transferases that transfer chemical groups containing a single carbon. These include the METHYLTRANSFERASES, the HYDROXYMETHYL AND FORMYL TRANSFERASES, the CARBOXYL AND CARBAMOYL TRANSFERASES, and the AMIDINOTRANSFERASES. EC 2.1.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019875"}, {"RECTYPE": "D", "MH": "Sports Equipment", "AQ": "AE CL EC ES HI LJ SN ST", "PRINT ENTRY": "Athletic Equipment|T073|NON|EQV|NLM (1998)|970211|abcdef", "ENTRY": "Equipment, Sports", "MN": "J01.637.825", "FX": "Protective Devices", "MH_TH": "NLM (1998)", "ST": "T073", "AN": "coord IM with specific sport (IM); for protective equipment coord with PROTECTIVE DEVICES (IM) or specific protective device (IM)", "PI": "specific sport (1966-1997)", "MS": "Equipment required for engaging in a sport (such as balls, bats, rackets, skis, skates, ropes, weights) and devices for the protection of athletes during their performance (such as masks, gloves, mouth pieces).", "PM": "98", "HN": "98", "MR": "20180629", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019876"}, {"RECTYPE": "D", "MH": "Hydroxymethyl and Formyl Transferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transhydroxymethylase|T116|T126|NON|NRW|NLM (2021)|191120|abbcdef", "ENTRY": "Transferases, Hydroxymethyl", "MN": "D08.811.913.555.400", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.1.2.-", "MS": "Enzymes that catalyze the transfer of hydroxymethyl or formyl groups. EC 2.1.2.", "PM": "98", "HN": "98", "MR": "20200527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019877"}, {"RECTYPE": "D", "MH": "Carboxyl and Carbamoyl Transferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carboxyltransferase|T116|T126|NON|NRW|NLM (2021)|191120|abbcdef", "ENTRY": "Transferases, Carboxyl", "MN": "D08.811.913.555.275", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.1.3.-", "PI": "Transferases (1969-1997)", "MS": "A group of enzymes that catalyze the transfer of carboxyl- or carbamoyl- groups. EC 2.1.3.", "PM": "98", "HN": "98", "MR": "20200527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019878"}, {"RECTYPE": "D", "MH": "Paneth Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Paneth Cell|T025|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Cells, Paneth", "MN": "A11.436.700", "MH_TH": "NLM (1998)", "ST": "T025", "PI": "Intestine, Small (1966-1997)", "MS": "Differentiated epithelial cells of the INTESTINAL MUCOSA, found in the basal part of the intestinal crypts of Lieberkuhn. Paneth cells secrete GROWTH FACTORS, digestive enzymes such as LYSOZYME and antimicrobial peptides such as cryptdins (ALPHA-DEFENSINS) into the crypt lumen.", "PM": "98", "HN": "98", "MR": "20200527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019879"}, {"RECTYPE": "D", "MH": "Aldehyde-Ketone Transferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transferases, Aldehyde-Ketone", "MN": "D08.811.913.200", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.2.-", "PI": "Transferases (1971-1997)", "MS": "Enzymes that catalyze the transfer of aldehyde or ketone residues. EC 2.2.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019880"}, {"RECTYPE": "D", "MH": "Aminoacyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.913.050.200", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.3.2.-", "PI": "Acyltransferases (1967-1997)", "MS": "Enzymes that catalyze the transfer of an aminoacyl group from donor to acceptor resulting in the formation of an ester or amide linkage. EC 2.3.2.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019881"}, {"RECTYPE": "D", "MH": "Blepharoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Blepharoplasties", "MN": "E04.617.275.090", "FX": "Blepharoptosis", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Eyelids/surgery (1966-1997)", "MS": "Plastic surgery of the eyelid. (Cline et al., Dictionary of Visual Science, 4th ed)", "PM": "98", "HN": "98", "MR": "20220406", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019882"}, {"RECTYPE": "D", "MH": "Alkyl and Aryl Transferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aryltransferases|T116|T126|NON|NRW|NLM (1998)|970501|abbcdef", "MN": "D08.811.913.225", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.5.-", "PI": "Transferases (1976-1997)", "MS": "A somewhat heterogeneous class of enzymes that catalyze the transfer of alkyl or related groups (excluding methyl groups). EC 2.5.", "PM": "98", "HN": "98", "MR": "20210630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019883"}, {"RECTYPE": "D", "MH": "Nitrogenous Group Transferases", "DE": "N GROUP TRANSFERASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transferases, Nitrogenous Group", "MN": "D08.811.913.477", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.6.-", "MS": "Enzymes that catalyze the transfer of nitrogenous groups, primarily amino groups, from a donor, generally an amino acid, to an acceptor, usually a 2-oxoacid. EC 2.6.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019884"}, {"RECTYPE": "D", "MH": "Sulfur Group Transferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transferases, Sulfur Group", "MN": "D08.811.913.817", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.8.-", "PI": "Transferases (1970-1997)", "MS": "Enzymes that catalyze the transfer of sulfur atoms (2.8.1), sulfur groups (2.8.2) or coenzyme A (2.8.3). EC 2.8.", "PM": "98", "HN": "98", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019885"}, {"RECTYPE": "D", "MH": "Gastrin-Releasing Peptide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gastrin-Releasing Peptide (1-27)|T116|T123|T125|NON|EQV|NLM (1998)|970417|GASTRIN RELEASING PEPTIDE A 001 027|abbbcdefs", "ENTRY": "Gastrin Releasing Peptide", "MN": "D12.776.631.650.315", "PA": "Gastrointestinal Agents", "MH_TH": "NLM (1998)", "ST": "T125", "RN": "80043-53-4", "PI": "Peptides (1978-1997)", "MS": "Neuropeptide and gut hormone that helps regulate GASTRIC ACID secretion and motor function. Once released from nerves in the antrum of the STOMACH, the neuropeptide stimulates release of GASTRIN from the GASTRIN-SECRETING CELLS.", "PM": "98; GASTRIN RELEASING PEPTIDE was indexed under PEPTIDES 1978-97", "HN": "98; use GASTRIN-RELEASING PEPTIDE (NM) 1980-97", "MR": "20151123", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019886"}, {"RECTYPE": "D", "MH": "Peanut Agglutinin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peanut Lectin|T116|T123|T130|NON|EQV|NLM (1998)|970212|abbbcdef", "ENTRY": "Lectin, Peanut", "MN": "D12.776.765.678.625", "MH_TH": "NLM (1998)", "ST": "T130", "RN": "0", "PI": "Lectins (1979-1997)", "MS": "Lectin purified from peanuts (ARACHIS HYPOGAEA). It binds to poorly differentiated cells and terminally differentiated cells and is used in cell separation techniques.", "PM": "98; PEANUT AGGLUTININ was indexed under LECTINS 1979-97", "HN": "98; use PEANUT AGGLUTININ (NM) 1979-97", "MR": "20030709", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019887"}, {"RECTYPE": "D", "MH": "Nelfinavir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfonate, Nelfinavir Monomethane", "MN": "D03.633.100.531.520", "PA": "HIV Protease Inhibitors", "MH_TH": "NLM (1998)", "ST": "T121", "RN": "HO3OGH5D7I", "RR": "98D603VP8V", "PI": "Sulfonic Acids (1995-1997)", "MS": "A potent HIV protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children.", "PM": "98; NELFINAVIR MESYLATE (now NELFINAVIR) was indexed under ISOQUINOLINES 1997; AG 1343 (now NELFINAVIR) was indexed under ISOQUINOLINES & SULFONIC ACIDS 1995-97", "HN": "98; use NELFINAVIR (NM) 1995-97", "MR": "20170524", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019888"}, {"RECTYPE": "D", "MH": "Leukopoiesis", "AQ": "DE ES GE IM PH RE", "MN": "G09.188.343.597", "MH_TH": "NLM (1998)", "ST": "T042", "PI": "Leukocytes (1966-1997)", "MS": "The process of generating white blood cells (LEUKOCYTES) from the pluripotent HEMATOPOIETIC STEM CELLS of the BONE MARROW. There are two significant pathways to generate various types of leukocytes: MYELOPOIESIS, in which leukocytes in the blood are derived from MYELOID STEM CELLS, and LYMPHOPOIESIS, in which leukocytes of the lymphatic system (LYMPHOCYTES) are generated from lymphoid stem cells.", "PM": "98", "HN": "98", "MR": "20160617", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019891"}, {"RECTYPE": "D", "MH": "eIF-2 Kinase", "DS": "EIF 02 A KINASE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p68 Kinase|T116|T126|NON|EQV|NLM (1998)|970213|P A 068 KINASE|abbcdefs", "ENTRY": "eRF, eIF 2 Recycling Factor", "MN": "D12.776.476.563.300", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Protein-Serine-Threonine Kinases (1993-1997)", "MS": "A dsRNA-activated cAMP-independent protein serine/threonine kinase that is induced by interferon. In the presence of dsRNA and ATP, the kinase autophosphorylates on several serine and threonine residues. The phosphorylated enzyme catalyzes the phosphorylation of the alpha subunit of EUKARYOTIC INITIATION FACTOR-2, leading to the inhibition of protein synthesis.", "PM": "98; EIF-2 KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES 1993-97 & PROTEIN KINASES 1980-93", "HN": "98; use EIF-2 KINASE (NM) 1980-97", "MR": "20210521", "DA": "19970702", "DC": "1", "DX": "19980101", "UI": "D019892"}, {"RECTYPE": "D", "MH": "Ribosomal Protein S6 Kinases", "DS": "RIBOSOMAL PROTEIN KINASES S 06", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "S6 Kinase|T116|T126|NON|EQV|NLM (1998)|970214|S A 006 KINASE|abbcdefs", "ENTRY": "S6 H4 Kinase", "MN": "D12.776.476.563.862", "FX": "Ribosomal Protein S6", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Protein-Serine-Threonine Kinases (1993-1997)", "MS": "A family of protein serine/threonine kinases which act as intracellular signalling intermediates. Ribosomal protein S6 kinases are activated through phosphorylation in response to a variety of HORMONES and INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS. Phosphorylation of RIBOSOMAL PROTEIN S6 by enzymes in this class results in increased expression of 5' top MRNAs. Although specific for RIBOSOMAL PROTEIN S6 members of this class of kinases can act on a number of substrates within the cell. The immunosuppressant SIROLIMUS inhibits the activation of ribosomal protein S6 kinases.", "PM": "2003; see RIBOSOMAL PROTEIN S6 KINASE 1998-2002; RIBOSOMAL PROTEIN S6 KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES 1993-1997 & PROTEIN KINASES 1985-1992", "HN": "2003(1998); use RIBOSOMAL PROTEIN S6 KINASES (NM) 1985-1997", "MR": "20210610", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019893"}, {"RECTYPE": "D", "MH": "Peptide YY", "AQ": "AD AE AG AI AN BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PYY Peptide|T116|T125|EQV|NLM (1998)|970214|abbdef", "ENTRY": "Peptide, PYY", "MN": "D12.644.548.595", "MH_TH": "NLM (1998)", "ST": "T125", "RN": "106388-42-5", "PI": "Peptides (1982-1997)", "MS": "A 36-amino acid peptide produced by the L cells of the distal small intestine and colon. Peptide YY inhibits gastric and pancreatic secretion.", "PM": "98; PEPTIDE YY was indexed under PEPTIDES 1982-97", "HN": "98; use PEPTIDE YY (NM) 1982-97", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019894"}, {"RECTYPE": "D", "MH": "Transposases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transposase|T116|T126|NON|EQV|NLM (1998)|990101|abbcdef", "MN": "D08.811.913.696.445.825", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.7.7.-", "PI": "Nucleotidyltransferases (1981-1995)", "MS": "Enzymes that recombine DNA segments by a process which involves the formation of a synapse between two DNA helices, the cleavage of single strands from each DNA helix and the ligation of a DNA strand from one DNA helix to the other. The resulting DNA structure is called a Holliday junction which can be resolved by DNA REPLICATION or by HOLLIDAY JUNCTION RESOLVASES.", "PM": "2004; TRANSPOSASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1996-1997 & NUCLEOTIDYLTRANSFERASES 1981-1995", "HN": "2004(1998); use TRANSPOSASE (NM) 1981-1997", "MR": "20050718", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019895"}, {"RECTYPE": "D", "MH": "alpha 1-Antitrypsin Deficiency", "DE": "ALPHA 1 ANTITRYPSIN DEFIC", "DS": "ALPHA ANTITRYPSIN DEFICIENCY 01", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "alpha 1-Antitrypsin Deficiencies", "MN": "C23.550.325.500.500", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "Pi or PiZZ goes here + PHENOTYPE", "PI": "alpha 1-Antitrypsin/deficiency (1975-1997)", "MS": "Deficiency of the protease inhibitor ALPHA 1-ANTITRYPSIN that manifests primarily as PULMONARY EMPHYSEMA and LIVER CIRRHOSIS.", "PM": "98", "HN": "98", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019896"}, {"RECTYPE": "D", "MH": "Periplasm", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Spaces, Periplasmic", "MN": "A11.284.295.680", "MH_TH": "NLM (1998)", "ST": "T026", "MS": "The space between the inner and outer membranes of a cell that is shared with the cell wall.", "PM": "98", "HN": "98", "MR": "20000622", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019897"}, {"RECTYPE": "D", "MH": "Autocrine Communication", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Autocrine Signaling|T043|NON|EQV|NLM (1998)|970512|abcdef", "ENTRY": "Signalings, Autocrine", "MN": "G04.085.100", "MH_TH": "NLM (1998)", "ST": "T043", "MS": "Mode of communication wherein a bound hormone affects the function of the cell type that produced the hormone.", "PM": "98", "HN": "98", "MR": "20160115", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019898"}, {"RECTYPE": "D", "MH": "Paracrine Communication", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Paracrine Signaling|T043|NON|EQV|NLM (1998)|970512|abcdef", "ENTRY": "Signalings, Paracrine", "MN": "G04.085.600", "FX": "Intercellular Signaling Peptides and Proteins", "MH_TH": "NLM (1998)", "ST": "T043", "MS": "Cellular signaling in which a factor secreted by a cell affects other cells in the local environment. This term is often used to denote the action of INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS on surrounding cells.", "PM": "98", "HN": "98", "MR": "20160617", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019899"}, {"RECTYPE": "D", "MH": "3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer", "DS": "DICHLOROMETHYLPYRROLIDINYLCYCLOHEXYL BENZENEACETAMIDE 003 004 N N 002 001", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzeneacetamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, (trans)-Isomer|T109|T121|NON|EQV|NLM (2002)|000921|abbcdef", "ENTRY": "U50488", "MN": "D03.383.773.170", "PA": "Antihypertensive Agents", "MH_TH": "NLM (2002)", "ST": "T121", "RN": "67198-13-4", "RR": "83913-06-8 (mesylate, (trans)-(+-)-isomer)", "PI": "Pyrrolidines (1982-1997)", "MS": "A non-peptide, kappa-opioid receptor agonist which has also been found to stimulate the release of adrenocorticotropin (ADRENOCORTICOTROPIC HORMONE) via the release of hypothalamic arginine vasopressin (ARGININE VASOPRESSIN) and CORTICOTROPIN-RELEASING HORMONE. (From J Pharmacol Exp Ther 1997;280(1):416-21)", "PM": "2002; see U-50488 1998-2001; U-50488 (now 3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER) was indexed under PYRROLIDINES 1982-97", "HN": "2002(1998); use 3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER (NM) 1982-97", "MR": "20160527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019900"}, {"RECTYPE": "D", "MH": "Locus Control Region", "AQ": "DE ES GE IM PH RE", "ENTRY": "Regions, Locus Control", "MN": "G05.360.340.024.380.249", "MH_TH": "NLM (1998)", "ST": "T123", "MS": "A regulatory region first identified in the human beta-globin locus but subsequently found in other loci. The region is believed to regulate GENETIC TRANSCRIPTION by opening and remodeling CHROMATIN structure. It may also have enhancer activity.", "PM": "98", "HN": "98", "MR": "20090714", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019901"}, {"RECTYPE": "D", "MH": "Chondrocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Chondroblasts|T025|NON|REL|NLM (1999)|980225|abcdef", "ENTRY": "Chondrocyte", "MN": "A11.329.171", "MH_TH": "NLM (1998)", "ST": "T025", "PI": "Cartilage (1966-1997)", "MS": "Polymorphic cells that form cartilage.", "PM": "98", "HN": "98", "MR": "19991103", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019902"}, {"RECTYPE": "D", "MH": "Polymethyl Methacrylate", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polymethylmethacrylate|T109|T122|NON|EQV|NLM (1998)|970620|abbcdef", "ENTRY": "Syndiostatic Polymethyl Methacrylate", "MN": "J01.637.051.720.716.822.111.650.605.500", "PA": "Vasodilator Agents", "MH_TH": "NLM (1998)", "ST": "T122", "RN": "9011-14-7", "RR": "9008-29-1 (plexiglass)", "PI": "Polymers (1974-1980)", "MS": "Polymerized methyl methacrylate monomers which are used as sheets, moulding, extrusion powders, surface coating resins, emulsion polymers, fibers, inks, and films (From International Labor Organization, 1983). This material is also used in tooth implants, bone cements, and hard corneal contact lenses.", "PM": "98; METHYLMETHACRYLATE (now POLYMETHYL METHACRYLATE) was indexed under METHYLMETHACRYLATES 1974-97 and POLYMERS 1974-80; for POLYMETHYLMETHACRYLATE see METHYLMETHACRYLATES 1981-97", "HN": "98; use METHYLMETHACRYLATE (NM) 1977-97; for POLYMETHYLMETHACRYLATE use METHYLMETHACRYLATES 1981-97", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019904"}, {"RECTYPE": "D", "MH": "Benzyl Alcohol", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Alcohol, Benzyl", "MN": "D02.455.426.559.389.140.200.100", "PA": "Anesthetics, Local", "EC": "analogs & derivatives:Benzyl Alcohols", "MH_TH": "USAN (19XX)", "ST": "T109", "RN": "LKG8494WBH", "RR": "100-51-6 (Benzyl Alcohol)", "AN": "BENZYL ALCOHOLS also available", "PI": "Benzyl Alcohols (1981-1997)", "MS": "A colorless liquid with a sharp burning taste and slight odor. It is used as a local anesthetic and to reduce pain associated with LIDOCAINE injection. Also, it is used in the manufacture of other benzyl compounds, as a pharmaceutic aid, and in perfumery and flavoring.", "PM": "98; BENZYL ALCOHOL was indexed under BENZYL ALCOHOLS 1981-97", "HN": "98; use BENZYL ALCOHOL (NM) 1981-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019905"}, {"RECTYPE": "D", "MH": "Nuclear Magnetic Resonance, Biomolecular", "DE": "NMR BIOMOLECULAR", "AQ": "AE CL HI IS MT TU", "PRINT ENTRY": "Protein NMR Spectroscopy|T063|NRW|NLM (1998)|970221|abdef", "ENTRY": "Spectroscopy, Protein NMR", "MN": "E05.196.867.519.550", "MH_TH": "NLM (1998)", "ST": "T063", "PI": "Nuclear Magnetic Resonance (1994-1997)", "MS": "NMR spectroscopy on small- to medium-size biological macromolecules. This is often used for structural investigation of proteins and nucleic acids, and often involves more than one isotope.", "PM": "98", "HN": "98", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019906"}, {"RECTYPE": "D", "MH": "Mycobacterium fortuitum", "DE": "MYCOBACT FORTUITUM", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.552.552.720.325", "MH_TH": "NLM (1998)", "ST": "T007", "RN": "txid1766", "AN": "infection: coordinate with MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS ", "PI": "Mycobacterium, Atypical (1977-1997)", "MS": "A rapid-growing, nonphotochromogenic species that is potentially pathogenic, producing lesions of lung, bone, or soft tissue following trauma. It has been found in soil and in injection sites of humans, cattle, and cold-blooded animals. (Dorland, 28th ed)", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019907"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-raf", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-raf Proteins|T116|T126|NON|EQV|NLM (1998)|970224|abbcdef", "ENTRY": "raf 1 Kinase", "MN": "D12.776.624.664.700.204.500", "FX": "Oncogene Proteins v-raf", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Proto-Oncogene Proteins (1986-1997)", "MS": "A ubiquitously expressed raf kinase subclass that plays an important role in SIGNAL TRANSDUCTION. The c-raf Kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1 and MAP KINASE KINASE 2.", "PM": "1998; PROTO-ONCOGENE PROTEIN MIL (now PROTO-ONCOGENE PROTEINS C-RAF) was indexed under PROTEIN-SERINE-THEONINE KINASES 1993-1997 & PROTO-ONCOGENE PROTEINS 1986-1997; CRAF1 KINASE was indexed under PROTO-ONCOGENE PROTEINS C-RAF 1993-2004", "HN": "1998 (1986)", "MR": "20210521", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019908"}, {"RECTYPE": "D", "MH": "Mycobacterium kansasii", "DE": "MYCOBACT KANSASII", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.552.552.720.400", "MH_TH": "NLM (1998)", "ST": "T007", "RN": "txid1768", "AN": "infection: coord IM with MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS (IM)", "PI": "Mycobacterium, Atypical (1977-1997)", "MS": "A slow-growing, photochromogenic species that is the etiologic agent of a tuberculosis-like disease in humans and is frequently isolated from human pulmonary secretions or tubercles. The incidence of infection is sharply increased among immunocompromised individuals. (Dorland, 28th ed)", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019909"}, {"RECTYPE": "D", "MH": "Mycobacterium marinum", "DE": "MYCOBACT MARINUM", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.552.552.720.500", "MH_TH": "NLM (1998)", "ST": "T007", "RN": "txid1781", "AN": "infection: coordinate with MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS ", "PI": "Mycobacterium, Atypical (1977-1997)", "MS": "A moderate-growing, photochromogenic species found in aquariums, diseased fish, and swimming pools. It is the cause of cutaneous lesions and granulomas (swimming pool granuloma) in humans. (Dorland, 28th ed)", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019910"}, {"RECTYPE": "D", "MH": "Mycobacterium ulcerans", "DE": "MYCOBACT ULCERANS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mycobacterium buruli|T007|NON|EQV|NLM (1998)|970224|MYCOBACT BURULI|abcdefv", "MN": "B03.510.460.400.410.552.552.720.700", "MH_TH": "NLM (1998)", "ST": "T007", "RN": "txid1809", "PI": "Mycobacterium, Atypical (1977-1997)", "MS": "A slow-growing mycobacterium that infects the skin and subcutaneous tissues, giving rise to indolent BURULI ULCER.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019911"}, {"RECTYPE": "D", "MH": "Mycobacterium xenopi", "DE": "MYCOBACT XENOPI", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.552.552.720.950", "MH_TH": "NLM (1998)", "ST": "T007", "RN": "txid1789", "AN": "infection: coordinate with MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS ", "PI": "Mycobacterium, Atypical (1977-1997)", "MS": "A slow-growing, scotochromogenic species occurring usually harmlessly in human secretions but occasionally associated with chronic pulmonary disease. (Dorland, 28th ed)", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019912"}, {"RECTYPE": "D", "MH": "Nuclear Localization Signals", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nuclear Localization Signal|T087|NON|EQV|NLM (1998)|990101|abcdef", "ENTRY": "Signals, Nuclear Localization", "MN": "G02.111.570.060.670.610", "FX": "Active Transport, Cell Nucleus", "MH_TH": "NLM (2006)", "ST": "T087", "RN": "0", "MS": "Short, predominantly basic amino acid sequences identified as nuclear import signals for some proteins. These sequences are believed to interact with specific receptors at the NUCLEAR PORE.", "PM": "1998; NUCLEAR LOCALIZATION SIGNAL PEPTIDE was indexed under NUCLEAR PROTEINS 1990-2000", "HN": "1998; for NUCLEAR LOCALIZATION SIGNAL PEPTIDE use NUCLEAR LOCALIZATION SIGNAL (NM) 1990-2000", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019913"}, {"RECTYPE": "D", "MH": "Taq Polymerase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Taq DNA Polymerase|T116|T126|EQV|NLM (1998)|970224|abbdef", "ENTRY": "aquaticus Polymerase, Thermus", "MN": "D08.811.913.696.445.308.300.875", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.7.7.-", "PI": "DNA-Directed DNA Polymerase (1989-1997)", "MS": "A heat stable DNA-DIRECTED DNA POLYMERASE from the bacteria Thermus aquaticus. It is widely used for the amplification of genes through the process of POLYMERASE CHAIN REACTION. EC 2.7.7.-.", "PM": "98; TAQ POLYMERASE was indexed under DNA POLYMERASES 1989-97", "HN": "98; use TAQ POLYMERASE (NM) 1989-97", "MR": "20030709", "DA": "19970702", "DC": "1", "DX": "19980101", "UI": "D019914"}, {"RECTYPE": "D", "MH": "DNA Primase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Primase|T116|T126|NON|EQV|NLM (1998)|970424|abbcdef", "ENTRY": "T7 gene 4 protein", "MN": "D08.811.913.696.445.735.270.375", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.7.7.-", "RR": "64885-96-7 (CAS RN)", "PI": "RNA Nucleotidyltransferases (1978-1997)", "MS": "A single-stranded DNA-dependent RNA polymerase that functions to initiate, or prime, DNA synthesis by synthesizing oligoribonucleotide primers. EC 2.7.7.-.", "PM": "98; DNA PRIMASE was indexed under RNA NUCLEOTIDYLTRANSFERASES 1978-97 & DNA 1978-82", "HN": "98; use DNA PRIMASE (NM) 1980-97", "MR": "20030725", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019915"}, {"RECTYPE": "D", "MH": "Choline-Phosphate Cytidylyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CTP Phosphocholine Cytidylyltransferase|T116|T126|EQV|NLM (1998)|970224|abbdef", "ENTRY": "Transferase, Phosphorylcholine Cytidyl", "MN": "D08.811.913.696.445.184", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.7.7.15", "RR": "9026-34-0 (CAS RN)", "PI": "Nucleotidyltransferases (1975-1997)", "MS": "An enzyme that catalyzes the transfer of cytidylate (CMP) to choline phosphate to form CDPcholine. It is the rate-limiting enzyme in the choline pathway for the biosynthesis of phosphatidylcholine. Its activity is increased by glucocorticoids. EC 2.7.7.15.", "PM": "98; CHOLINE-PHOSPHATE CYTIDYLTRANSFERASE was indexed under CYTOSINE NUCLEOTIDES & CHOLINE 1975-77, CYTIDINE DIPHOSPHATE CHOLINE 1977-81 & NUCLEOTIDYLTRANSFERASES 1975-97", "HN": "98; use CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE (NM) 1980-97", "MR": "20060705", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019916"}, {"RECTYPE": "D", "MH": "Blood Vessel Prosthesis Implantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Prosthesis Implantation, Vascular", "MN": "E04.650.200", "FX": "Blood Vessel Prosthesis", "MH_TH": "NLM (1998)", "ST": "T061", "AN": "coordinate with specific blood vessel / transplantation", "PI": "Blood Vessel Prosthesis (1966-1997)", "MS": "Surgical insertion of BLOOD VESSEL PROSTHESES to repair injured or diseased blood vessels.", "PM": "98", "HN": "98", "MR": "20100625", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019917"}, {"RECTYPE": "D", "MH": "Heart Valve Prosthesis Implantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Implantation, Heart Valve Prosthesis|T061|NON|EQV|NLM (1998)|970224|abcdef", "MN": "E04.928.220.410", "FX": "Heart Valve Prosthesis", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Heart Valve Prosthesis (1966-1997)", "MS": "Surgical insertion of synthetic material to repair injured or diseased heart valves.", "PM": "98", "HN": "98", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019918"}, {"RECTYPE": "D", "MH": "Prosthesis Implantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Prosthesis Implantations", "MN": "E04.650", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "specific prosthesis (1966-1997)", "MS": "Surgical insertion of a prosthesis.", "PM": "98", "HN": "98", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019919"}, {"RECTYPE": "D", "MH": "Photoaffinity Labels", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Labels, Photoaffinity", "MN": "D27.720.470.410.080.600", "MH_TH": "NLM (1998)", "ST": "T130", "RN": "0", "PI": "Affinity Labels (1975-1997)", "MS": "Biologically active molecules which are covalently bound to the enzymes or binding proteins normally acting on them. Binding occurs due to activation of the label by ultraviolet light. These labels are used primarily to identify binding sites on proteins.", "PM": "98", "HN": "98", "MR": "20030709", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019920"}, {"RECTYPE": "D", "MH": "Biotinylation", "AQ": "CL DE EC GE HI IS MT PH RE SN ST TD VE", "ENTRY": "Biotinylations", "MN": "G03.162", "MH_TH": "NLM (1998)", "ST": "T059", "MS": "Incorporation of biotinyl groups into molecules.", "PM": "98", "HN": "98", "MR": "20160502", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019921"}, {"RECTYPE": "D", "MH": "GAP-43 Protein", "DS": "GAP A 043 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neuromodulin|T116|T123|NON|EQV|NLM (1998)|970225|abbcdef", "ENTRY": "Phosphoprotein B 50", "MN": "D12.776.631.400", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1986-1997)", "MS": "A nervous tissue specific protein which is highly expressed in NEURONS during development and NERVE REGENERATION. It has been implicated in neurite outgrowth, long-term potentiation, SIGNAL TRANSDUCTION, and NEUROTRANSMITTER release. (From Neurotoxicology 1994;15(1):41-7) It is also a substrate of PROTEIN KINASE C.", "PM": "98; NERVE GROWTH CONE MEMBRANE PROTEIN GAP-43 (now GAP-43 PROTEIN) was indexed under NERVE TISSUE PROTEINS 1986-97, MEMBRANE GLYCOPROTEINS 1988-97, CALMODULIN-BINDING PROTEINS 1986-92, & MEMBRANE PROTEINS 1986-89.", "HN": "98; use GAP-43 PROTEIN (NM) 1986-97", "MR": "20230316", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019922"}, {"RECTYPE": "D", "MH": "Capsulorhexis", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Capsulorrhexis|T061|NON|EQV|NLM (1998)|970226|abcdef", "MN": "E04.540.825.249.352", "FX": "Lens Capsule, Crystalline", "MH_TH": "NLM (1998)", "ST": "T061", "AN": "do not coordinate with PHACOEMULSIFICATION unless particularly discussed", "PI": "Phacoemulsification (1996-1997)", "MS": "The making of a continuous circular tear in the anterior capsule during cataract surgery in order to allow expression or phacoemulsification of the nucleus of the lens. (Dorland, 28th ed)", "PM": "98", "HN": "98", "MR": "20070709", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019923"}, {"RECTYPE": "D", "MH": "Embryo Disposition", "AQ": "AE CL EC ES HI IS LJ MO NU PX SN ST TD VE", "ENTRY": "Embryo Donations", "MN": "E05.820.240", "MH_TH": "NLM (1997)", "ST": "T062", "AN": "mammalian only", "MS": "Utilization or disposal of an embryo that is fertilized but not immediately transplanted and resulting course of action.", "PM": "99", "HN": "99", "MR": "20120703", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D019924"}, {"RECTYPE": "D", "MH": "Cyclin A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenovirus E1A-Associated Protein p60|T116|T123|NON|EQV|NLM (1998)|970226|ADENOVIRUS E01A ASSOCIATED PROTEIN P 060|abbcdefs", "ENTRY": "Cyclins, Type A", "MN": "D12.776.476.262.100", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "PI": "Invertebrate Hormones (1986-1990)", "MS": "A cyclin subtype that has specificity for CDC2 PROTEIN KINASE and CYCLIN-DEPENDENT KINASE 2. It plays a role in progression of the CELL CYCLE through G1/S and G2/M phase transitions.", "PM": "98; see CYCLINS 1993-97", "HN": "98; use CYCLINS 1993-97", "MR": "20151123", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019925"}, {"RECTYPE": "D", "MH": "Cyclin B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cyclins, Type B", "MN": "D12.776.476.262.120", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "PI": "Invertebrate Hormones (1989-1990)", "MS": "A cyclin subtype that is transported into the CELL NUCLEUS at the end of the G2 PHASE. It stimulates the G2/M phase transition by activating CDC2 PROTEIN KINASE.", "PM": "98; see CYCLINS 1993-97; CDC13 PROTEIN (now CYCLIN B) was indexed under CYCLINS 1993-97", "HN": "98; use CYCLINS & CYCLIN B (NM) 1993-97", "MR": "20151123", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019926"}, {"RECTYPE": "D", "MH": "Cyclin E", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.262.180", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "0", "PI": "Cyclins (1991-1997)", "MS": "A 50-kDa protein that complexes with CYCLIN-DEPENDENT KINASE 2 in the late G1 phase of the cell cycle.", "PM": "98", "HN": "98", "MR": "20151123", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019927"}, {"RECTYPE": "D", "MH": "Breast Implantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Breast Prosthesis Implantation|T061|NON|EQV|NLM (1998)|970227|abcdef", "ENTRY": "Prosthesis Implantations, Breast", "MN": "E04.650.210", "FX": "Breast Implants", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Prostheses and Implants (1967-1994)", "MS": "Surgical insertion of an inert sac filled with silicone or other material to augment the female form cosmetically.", "PM": "98", "HN": "98", "MR": "20220406", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019928"}, {"RECTYPE": "D", "MH": "Cochlear Implantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Cochlear Prosthesis Implantation|T061|NON|EQV|NLM (1998)|970227|abcdef", "ENTRY": "Prosthesis Implantations, Cochlear", "MN": "E04.650.220", "FX": "Cochlear Implants", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Prostheses and Implants (1966-1979)", "MS": "Surgical insertion of an electronic hearing device (COCHLEAR IMPLANTS) with electrodes to the COCHLEAR NERVE in the inner ear to create sound sensation in patients with residual nerve fibers.", "PM": "98", "HN": "98", "MR": "20020703", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019929"}, {"RECTYPE": "D", "MH": "Mandibular Prosthesis Implantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Prosthesis Implantations, Mandibular", "MN": "E06.645.510.500", "FX": "Mandibular Prosthesis", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Prostheses and Implants (1966)", "MS": "Surgical insertion of an appliance for the replacement of areas of the mandible.", "PM": "98", "HN": "98", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019930"}, {"RECTYPE": "D", "MH": "Maxillofacial Prosthesis Implantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Prosthesis Implantations, Maxillofacial", "MN": "E06.645.510", "FX": "Maxillofacial Prosthesis", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Prostheses and Implants (1966)", "MS": "Surgical insertion of an appliance for the replacement of areas of the maxilla, mandible, and face. When only portions of the mandible are replaced, it is referred to as MANDIBULAR PROSTHESIS IMPLANTATION.", "PM": "98", "HN": "98", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019931"}, {"RECTYPE": "D", "MH": "Ossicular Replacement", "DE": "OSSICULAR REPLACE", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Ossicular Prosthesis Implantation|T061|NON|EQV|NLM (1998)|970227|abcdef", "ENTRY": "Replacements, Ossicular", "MN": "E04.650.600", "FX": "Ossicular Prosthesis", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Prostheses and Implants (1966-1986)", "MS": "Surgical insertion of an implant to replace one or more of the ear ossicles.", "PM": "98", "HN": "98", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019933"}, {"RECTYPE": "D", "MH": "International Normalized Ratio", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "INR|T081|ABB|EQV|NLM (1998)|970401|abcdef", "ENTRY": "Ratios, International Normalized", "MN": "E05.200.625.115.320", "FX": "Blood Coagulation", "MH_TH": "NLM (1998)", "ST": "T081", "AN": "note short X ref", "MS": "System established by the World Health Organization and the International Committee on Thrombosis and Hemostasis for monitoring and reporting blood coagulation tests. Under this system, results are standardized using the International Sensitivity Index for the particular test reagent/instrument combination used.", "PM": "98", "HN": "98", "MR": "20110624", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019934"}, {"RECTYPE": "D", "MH": "Penile Implantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Penile Prosthesis Implantation|T061|NON|EQV|NLM (1998)|970227|abcdef", "ENTRY": "Prosthesis Implantations, Penile", "MN": "E04.950.774.860.620", "FX": "Penile Prosthesis", "MH_TH": "NLM (1998)", "ST": "T061", "PI": "Prostheses and Implants (1966-1989)", "MS": "Surgical insertion of cylindric hydraulic devices for the treatment of organic ERECTILE DYSFUNCTION.", "PM": "98", "HN": "98", "MR": "20070711", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019935"}, {"RECTYPE": "D", "MH": "Probiotics", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Probiotic|T007|NON|EQV|NLM (2017)|150917|abcdef", "MN": "J02.500.456.500", "MH_TH": "NLM (1998)", "ST": "T007", "AN": "Do not confuse with PREBIOTICS", "MS": "Live microbial DIETARY SUPPLEMENTS which beneficially affect the host animal by improving its intestinal microbial balance. Antibiotics and other related compounds are not included in this definition. In humans, lactobacilli are commonly used as probiotics, either as single species or in mixed culture with other bacteria. Other genera that have been used are bifidobacteria and streptococci. (J. Nutr. 1995;125:1401-12)", "PM": "98", "HN": "98", "MR": "20151009", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019936"}, {"RECTYPE": "D", "MH": "Diagnostic Techniques and Procedures", "DE": "DIAG TECHNIQUES PROCEDURES", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "PRINT ENTRY": "Diagnostic Testing|T060|NON|EQV|NLM (2021)|200103|abcdef", "ENTRY": "Testing, Diagnostic", "MN": "E01.370", "FX": "Sensitivity and Specificity", "MH_TH": "NLM (1998)", "ST": "T060", "AN": "general: prefer specifics", "PI": "Diagnosis (1966-1997)", "MS": "Methods, procedures, and tests performed to diagnose disease, disordered function, or disability.", "PM": "98", "HN": "98", "MR": "20200609", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019937"}, {"RECTYPE": "D", "MH": "Cyclin D1", "DS": "CYCLIN D 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-bcl-1 Proteins|T116|T123|EQV|NLM (1998)|970227|C BCL PROTEINS 001|abbdefs", "ENTRY": "c-bcl-1, Proto-Oncogene Proteins", "MN": "D12.776.624.664.700.100", "FX": "Lymphoma, Mantle-Cell", "MH_TH": "NLM (1998)", "ST": "T123", "RN": "136601-57-5", "PI": "Proto-Oncogene Proteins (1990-1997)", "MS": "Protein encoded by the bcl-1 gene which plays a critical role in regulating the cell cycle. Overexpression of cyclin D1 is the result of bcl-1 rearrangement, a t(11;14) translocation, and is implicated in various neoplasms.", "PM": "98; PRAD1 PROTEIN (now CYCLIN D1) was indexed under CYCLINS & ONCOGENE PROTEINS 1991-97; PROTO-ONCOGENE PROTEIN BCL-1 (now CYCLIN D1) was indexed under PROTO-ONCOGENE PROTEINS 1990-97", "HN": "98; use CYCLIN D1 (NM) 1990-97", "MR": "20151123", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019938"}, {"RECTYPE": "D", "MH": "Genes, bcl-1", "DS": "GENES BCL 001", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "c-bcl-1 Genes|T028|NRW|NLM (1998)|970227|C BCL GENES 001|abdefs", "ENTRY": "c-bcl-1 Proto-Oncogene", "MN": "G05.360.340.024.340.375.500.791.148", "FX": "Lymphoma, Mantle-Cell", "MH_TH": "NLM (1998)", "ST": "T028", "AN": "bcl stands for \"B-Cell Leukemia\"", "PI": "Proto-Oncogenes (1990-1997)", "MS": "The B-cell leukemia/lymphoma-1 genes, associated with various neoplasms when overexpressed. Overexpression results from the t(11;14) translocation, which is characteristic of mantle zone-derived B-cell lymphomas. The human c-bcl-1 gene is located at 11q13 on the long arm of chromosome 11.", "PM": "98", "HN": "98", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019940"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase Inhibitor p16", "DS": "CYCLIN DEPENDENT KINASE INHIBITOR P 016", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, INK4A", "MN": "D12.776.624.776.355.200", "FX": "Tumor Suppressor Protein p14ARF", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1994-1997)", "MS": "A product of the p16 tumor suppressor gene (GENES, P16). It is also called INK4 or INK4A because it is the prototype member of the INK4 CYCLIN-DEPENDENT KINASE INHIBITORS. This protein is produced from the alpha mRNA transcript of the p16 gene. The other gene product, produced from the alternatively spliced beta transcript, is TUMOR SUPPRESSOR PROTEIN P14ARF. Both p16 gene products have tumor suppressor functions.", "PM": "1998; see PROTEIN P16; CDK4-ASSOCIATED PROTEIN P16 was indexed under CARRIER PROTEINS 1994-1997; P16(INK4A) was indexed under CARRIER PROTEINS 2000-2001", "HN": "2006(1994)", "MR": "20151123", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019941"}, {"RECTYPE": "D", "MH": "Genes, p16", "DS": "GENES P 016", "AQ": "DE ES PH RE", "PRINT ENTRY": "p16INK4 Genes|T028|EQV|NLM (1998)|970228|P A 016 INK 004 GENES|abdefs", "ENTRY": "p16INK4A Genes", "MN": "G05.360.340.024.340.415.400.375", "FX": "Tumor Suppressor Protein p14ARF", "MH_TH": "NLM (1998)", "ST": "T028", "PI": "Genes, Suppressor, Tumor (1994-1997)", "MS": "Tumor suppressor genes located on human chromosome 9 in the region 9p21. This gene is either deleted or mutated in a wide range of malignancies. (From Segen, Current Med Talk, 1995) Two alternatively spliced gene products are encoded by p16: CYCLIN-DEPENDENT KINASE INHIBITOR P16 and TUMOR SUPPRESSOR PROTEIN P14ARF.", "PM": "98", "HN": "98", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019942"}, {"RECTYPE": "D", "MH": "Amino Acid Substitution", "AQ": "DE GE IM PH RE", "ENTRY": "Substitutions, Amino Acid", "MN": "G05.558.109", "FX": "Mutation, Missense", "MH_TH": "NLM (1998)", "ST": "T063", "PI": "Amino Acid Sequence (1966-1997)", "MS": "The naturally occurring or experimentally induced replacement of one or more AMINO ACIDS in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish, enhance, or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.", "PM": "98", "HN": "98", "MR": "20160115", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019943"}, {"RECTYPE": "D", "MH": "Propylene Glycol", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "1,2-Propanediol|T109|NON|EQV|FDA SRS (2014)|NLM (1998)|970228|PROPANEDIOL 01 02|abcdeefs", "ENTRY": "Monohydrate, Propylene Glycol", "MN": "D02.033.455.706.725", "PA": "Solvents", "EC": "analogs & derivatives:Propylene Glycols", "MH_TH": "USP (19XX)", "ST": "T109", "RN": "6DC9Q167V3", "RR": "63180-48-3 (monohydrate)", "AN": "PROPYLENE GLYCOLS is also available", "PI": "Propylene Glycols (1972-1997)", "MS": "A clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations.", "PM": "98; PROPYLENE GLYCOL was indexed under PROPANEDIOLS 1972-97", "HN": "98; use PROPYLENE GLYCOL (NM) 1980-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019946"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-6", "DE": "RECEPT IL 6", "DS": "RECEPTORS INTERLEUKIN 006", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, IL-6|T116|T192|EQV|NLM (1998)|970228|RECEPTORS IL 006|RECEPT IL6|abbdefsv", "ENTRY": "Receptors, Interleukin 6", "MN": "D12.776.543.750.705.852.420.400", "MH_TH": "NLM (1998)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (1994-1997)", "MS": "Cell surface receptors that are specific for INTERLEUKIN-6. They are present on T-LYMPHOCYTES, mitogen-activated B-LYMPHOCYTES, and peripheral MONOCYTES. The receptors are heterodimers of the INTERLEUKIN-6 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR GP130.", "PM": "98; INTERLEUKIN 6 RECEPTOR (now RECEPTORS, INTERLEUKIN-6) was indexed under RECEPTORS, INTERLEUKIN 1994-97, ANTIGENS, CD 1989-97, & RECEPTORS, IMMUNOLOGIC 1988-93", "HN": "98; use RECEPTORS, INTERLEUKIN-6 (NM) 1988-97", "MR": "20200527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019947"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-4", "DE": "RECEPT IL 4", "DS": "RECEPTORS INTERLEUKIN 004", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, IL-4|T116|T192|EQV|NLM (1998)|970228|RECEPTORS IL 004|RECEPT IL4|abbdefsv", "ENTRY": "Receptors, Interleukin 4", "MN": "D12.776.543.750.705.852.420.360", "MH_TH": "NLM (1998)", "ST": "T192", "RN": "0", "AN": "RECEPTORS, INTERLEUKIN-4 TYPE I and RECEPTORS, INTERLEUKIN-4 TYPE II are also available", "PI": "Receptors, Mitogen (1986-1994)", "MS": "Receptors present on a wide variety of hematopoietic and non-hematopoietic cell types that are specific for INTERLEUKIN-4. They are involved in signaling a variety of immunological responses related to allergic INFLAMMATION including the differentiation of TH2 CELLS and the regulation of IMMUNOGLOBULIN E production. Two subtypes of receptors exist and are referred to as the TYPE I INTERLEUKIN-4 RECEPTOR and the TYPE II INTERLEUKIN-4 RECEPTOR. Each receptor subtype is defined by its unique subunit composition.", "PM": "1998; RECEPTORS, INTERLEUKIN-4 was indexed under RECEPTORS, INTERLEUKIN 1994-97, ANTIGENS, CD 1990-97, and RECEPTORS, MITOGEN 1986-94", "HN": "1998(1986)", "MR": "20200527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019948"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase 1", "DS": "MITOGEN ACTIVATED PROTEIN KINASE 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p42(Mitogen-Activated Protein Kinase)|T116|T126|NON|EQV|NLM (1998)|970303|P A 042 MITOGEN ACTIVATED PROTEIN KINASE|abbcdefs", "ENTRY": "Mitogen Activated Protein Kinase 2", "MN": "D12.776.476.563.567.249.500", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 2.7.11.24", "AN": "Don't confuse MAP Kinase 2 with MAP KINASE KINASES referred to as MAP2 Kinases", "PI": "Protein-Tyrosine Kinase (1992-1997)", "MS": "A proline-directed serine/threonine protein kinase which mediates signal transduction from the cell surface to the nucleus. Activation of the enzyme by phosphorylation leads to its translocation into the nucleus where it acts upon specific transcription factors. p40 MAPK and p41 MAPK are isoforms.", "PM": "2000; see P42 MAP KINASE 2000-2004, see P42(MAPK) KINASE 1998-1999; P42(MAPK) KINASE was indexed under CALMODULIN-DEPENDENT PROTEIN KINASES 1994-1997, PROTEIN-TYROSINE KINASE 1992-1997, PROTEIN-SERINE-THREONINE KINASES 1993-1995 & PROTEIN KINASES 1992; ERK2 BRAIN KINASE PK40 was indexed under PROTEIN-SERINE-THREONINE KINASES 1995-1999; ERK2 was indexed under CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE 1998-1999, CALMODULIN-DEPENDENT KINASES 1994-1997, PROTEIN-SERINE-THREONINE KINASES 1992-1993 & PROTEIN KINASES 1992; ERK2 MBP-KINASE was indexed under CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE 1998-1999 & CALMODULIN-DEPENDENT KINASES 1994-1997", "HN": "2005(1992)", "MR": "20210521", "DA": "19970702", "DC": "1", "DX": "19980101", "UI": "D019950"}, {"RECTYPE": "D", "MH": "DNA Polymerase beta", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA Polymerase IV|T116|T126|EQV|NLM (1998)|970522|DNA POLYMERASE 04|abbdefs", "ENTRY": "Polymerase IV, DNA", "MN": "D08.811.913.696.445.308.300.112", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.7.7.7", "PI": "DNA Polymerase I (1981-1997)", "MS": "A DNA repair enzyme that catalyzes DNA synthesis during base excision DNA repair.", "PM": "1998; see DNA POLYMERASE I 1981-1997", "HN": "1998; use DNA POLYMERASE I 1981-1997", "MR": "20200622", "DA": "19970625", "DC": "1", "DX": "19980101", "UI": "D019951"}, {"RECTYPE": "D", "MH": "Neurobehavioral Manifestations", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Signs and Symptoms, Neurobehavioral|T184|NON|EQV|NLM (2000)|991103|abcdef", "ENTRY": "Symptoms, Cognitive", "MN": "F01.700", "MH_TH": "NLM (2000)", "ST": "T184", "AN": "not used for indexing", "MS": "Signs and symptoms of higher cortical dysfunction caused by organic conditions. These include certain behavioral alterations and impairments of skills involved in the acquisition, processing, and utilization of knowledge or information.", "PM": "2000; see COGNITIVE SYMPTOMS 1998-1999", "HN": "2000(1998)", "MR": "20010725", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019954"}, {"RECTYPE": "D", "MH": "Conduct Disorder", "DE": "CONDUCT DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Callous-Unemotional Traits|T048|NON|NRW|NLM (2021)|191018|abcdef", "ENTRY": "Conduct Disorders", "MN": "F03.625.094.300", "FX": "Antisocial Personality Disorder", "MH_TH": "NLM (1998)", "ST": "T048", "MS": "A repetitive and persistent pattern of behavior in which the basic rights of others or major age-appropriate societal norms or rules are violated. These behaviors include aggressive conduct that causes or threatens physical harm to other people or animals, nonaggressive conduct that causes property loss or damage, deceitfulness or theft, and serious violations of rules. The onset is before age 18. (From DSM-IV, 1994)", "PM": "98", "HN": "98", "MR": "20200206", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019955"}, {"RECTYPE": "D", "MH": "Stereotypic Movement Disorder", "DE": "STEREOTYPIC MOVEMENT DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Movement Disorder, Stereotypic|T048|NON|EQV|NLM (1998)|970527|MOVEMENT DIS STEREOTYPIC|abcdefv", "ENTRY": "Stereotypic Movement Disorders", "MN": "F03.625.984", "FX": "Stereotyped Behavior", "MH_TH": "NLM (1998)", "ST": "T048", "MS": "Motor behavior that is repetitive, often seemingly driven, and nonfunctional. This behavior markedly interferes with normal activities or results in severe bodily self-injury. The behavior is not due to the direct physiological effects of a substance or a general medical condition. (DSM-IV, 1994)", "PM": "98; for HEAD BANGING & BODY ROCKING see STEREOTYPED BEHAVIOR 1981-97", "HN": "98; for HEAD BANGING & BODY ROCKING use STEREOTYPED BEHAVIOR 1981-97", "MR": "20150630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019956"}, {"RECTYPE": "D", "MH": "Motor Skills Disorders", "DE": "MOTOR SKILLS DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Developmental Coordination Disorder|T047|NON|NRW|NLM (1998)|970314|DEVELOPMENTAL COORDINATION DIS|abcdefv", "ENTRY": "Motor Skills Disorder", "MN": "F03.625.813", "MH_TH": "NLM (1998)", "ST": "T048", "MS": "Marked impairments in the development of motor coordination such that the impairment interferes with activities of daily living. (From DSM-V)", "PM": "98", "HN": "98", "MR": "20150102", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019957"}, {"RECTYPE": "D", "MH": "Attention Deficit and Disruptive Behavior Disorders", "DE": "ATTENTION DEFICIT DISRUPTIVE BEHAVIOR", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Disruptive Behavioral Disorder|T048|NON|NRW|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Disruptive Behavioral Disorders", "MN": "F03.625.094", "FX": "Problem Behavior", "MH_TH": "NLM (1998)", "ST": "T046", "MS": "Includes two similar disorders: oppositional defiant disorder and CONDUCT DISORDERS. Symptoms occurring in children with these disorders include: defiance of authority figures, angry outbursts, and other antisocial behaviors.", "PM": "98", "HN": "98", "MR": "20230405", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019958"}, {"RECTYPE": "D", "MH": "Feeding and Eating Disorders of Childhood", "DE": "FEEDING EATING DIS CHILD", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Childhood Eating and Feeding Disorders|T048|NON|EQV|NLM (1998)|970516|CHILD EATING FEEDING DIS|abcdefv", "MN": "F03.400.500", "MH_TH": "NLM (1998)", "ST": "T048", "MS": "Mental disorders related to feeding and eating usually diagnosed in infancy or early childhood.", "PM": "98", "HN": "98", "MR": "20181005", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019959"}, {"RECTYPE": "D", "MH": "Elimination Disorders", "DE": "ELIMINATION DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Elimination Disorder", "MN": "F03.388", "MH_TH": "NLM (1998)", "ST": "T048", "MS": "Excretory-related psychiatric disorders usually diagnosed in infancy or childhood.", "PM": "98", "HN": "98", "MR": "20150706", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019960"}, {"RECTYPE": "D", "MH": "Reactive Attachment Disorder", "DE": "REACTIVE ATTACHMENT DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Reactive Attachment Disorders", "MN": "F03.625.937", "MH_TH": "NLM (1998)", "ST": "T055", "MS": "Markedly disturbed and developmentally inappropriate social relatedness that begins before age 5 and is associated with grossly pathological child care. The child may persistently fail to initiate and respond to social interactions in a developmentally appropriate way (inhibited type) or there may be a pattern of diffuse attachments with nondiscriminate sociability (disinhibited type). (From DSM-V)", "PM": "98", "HN": "98", "MR": "20150210", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019962"}, {"RECTYPE": "D", "MH": "Clinical Chemistry Tests", "DE": "CLIN CHEM TESTS", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Chemistry Tests, Clinical|T059|NON|EQV|NLM (1998)|970410|CHEM TESTS CLIN|abcdefv", "ENTRY": "Tests, Clinical Chemistry|T059|NON|EQV|NLM (1998)|970321|TESTS CLIN CHEM|abcdefv", "MN": "E05.200.124", "FX": "Chemistry, Clinical", "MH_TH": "NLM (1998)", "ST": "T059", "AN": "general or unspecified; prefer specifics", "PI": "Chemistry, Clinical (1966-1997)", "MS": "Laboratory tests demonstrating the presence of physiologically significant substances in the blood, urine, tissue, and body fluids with application to the diagnosis or therapy of disease.", "PM": "98", "HN": "98", "MR": "20190524", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019963"}, {"RECTYPE": "D", "MH": "Mood Disorders", "DE": "MOOD DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Affective Disorders|T048|NON|EQV|NLM (1998)|970523|AFFECTIVE DIS|abcdefv", "ENTRY": "Mood Disorder", "MN": "F03.600", "MH_TH": "NLM (1998)", "ST": "T048", "AN": "human only; do not confuse with AFFECTIVE SYMPTOMS: read MeSH definitions & follow text", "MS": "Those disorders that have a disturbance in mood as their predominant feature.", "PM": "98; see AFFECTIVE DISORDERS 1981-97", "HN": "98(81)", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019964"}, {"RECTYPE": "D", "MH": "Neurocognitive Disorders", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Psychoses, Traumatic|T048|NON|NRW|NLM (1979)|970523|abcdef", "ENTRY": "Traumatic Psychoses", "MN": "F03.615", "MH_TH": "NLM (2016)", "ST": "T048", "MS": "Diagnoses of DEMENTIA and AMNESTIC DISORDER are subsumed here. (DSM-5)", "PM": "2016; see ORGANIC MENTAL DISORDERS 1981-97; see MENTAL DISORDERS 1969-80; see PSYCHOSES, ORGANIC 1996-80; see PSYCHOSES, TRAUMATIC 1963-78; see ORGANIC MENTAL DISORDERS, PSYCHOTIC", "HN": "2016(1963) for NON PSYCHOTIC BRAIN SYNDROME use MENTAL DISORDERS 1969-74", "MR": "20211202", "DA": "19970707", "DC": "1", "DX": "19980101", "UI": "D019965"}, {"RECTYPE": "D", "MH": "Substance-Related Disorders", "DE": "SUBSTANCE RELATED DIS", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Substance Use Disorders|T048|NON|REL|NLM (1981)|970611|SUBSTANCE USE DIS|abcdefv", "ENTRY": "Use, Substance", "MN": "F03.900", "FX": "Psychoses, Alcoholic", "MH_TH": "NLM (1998)", "ST": "T048", "AN": "general or unspecified; prefer specifics; /diag: consider SUBSTANCE ABUSE DETECTION; SOCIAL DETERMINANTS OF HEALTH is available", "MS": "Disorders related to substance use or abuse.", "PM": "2018; see ORGANIC MENTAL DISORDERS, SUBSTANCE-INDUCED 1981-97; see SUBSTANCE ABUSE 1981-97; see DRUG ABUSE 1968-80; see DRUG ADDICTION 1963-75; for PRESCRIPTION DRUG ABUSE see PRESCRIPTION DRUG MISUSE 2016-2017", "HN": "2018 (1963); for PRESCRIPTION DRUG ABUSE use PRESCRIPTION DRUG MISUSE 2016-2017", "MR": "20210512", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019966"}, {"RECTYPE": "D", "MH": "Schizophrenia Spectrum and Other Psychotic Disorders", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Schizophrenia and Disorders with Psychotic Features|T048|NON|EQV|NLM (1998)|990101|SCHIZOPHRENIA DIS PSYCHOTIC|abcdefv", "MN": "F03.700", "MH_TH": "NLM (2016)", "ST": "T048", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Marked disorders of thought (delusions, hallucinations, or other thought disorder accompanied by disordered affect or behavior), and deterioration from a previous level of functioning. Individuals have one o more of the following symptoms: delusions, hallucinations, and disorganized speech. (from DSM-5)", "PM": "2015", "HN": "2015(1998)", "MR": "20160531", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019967"}, {"RECTYPE": "D", "MH": "Sexual and Gender Disorders", "DE": "SEXUAL GENDER DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "MN": "F03.835.750", "MH_TH": "NLM (1999)", "ST": "T048", "AN": "general or unspecified; prefer specifics", "MS": "Mental disorders related to sexual dysfunction, paraphilias, and gender identity disorders.", "PM": "98", "HN": "98", "MR": "20150630", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019968"}, {"RECTYPE": "D", "MH": "Amphetamine-Related Disorders", "DE": "AMPHETAMINE RELATED DIS", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Amphetamine Dependence|T048|NON|NRW|NLM (1999)|980303|abcdef", "ENTRY": "Disorders, Amphetamine-Related", "MN": "F03.900.225", "MH_TH": "NLM (1999)", "ST": "T048", "MS": "Disorders related or resulting from use of amphetamines.", "PM": "98", "HN": "98", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019969"}, {"RECTYPE": "D", "MH": "Cocaine-Related Disorders", "DE": "COCAINE RELATED DIS", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Cocaine Dependence|T048|NON|NRW|NLM (1999)|980303|abcdef", "ENTRY": "Disorders, Cocaine-Related", "MN": "F03.900.300", "MH_TH": "NLM (1998)", "ST": "T048", "MS": "Disorders related or resulting from use of cocaine.", "PM": "98", "HN": "98", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019970"}, {"RECTYPE": "D", "MH": "Alcohol-Related Disorders", "DE": "ALCOHOL RELATED DIS", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Alcohol Problem|T047|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Disorder, Alcohol-Related", "MN": "F03.900.100", "FX": "Substance-Related Disorders", "MH_TH": "NLM (1998)", "ST": "T047", "MS": "Disorders related to or resulting from abuse or misuse of alcohol.", "PM": "98", "HN": "98", "MR": "20210512", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019973"}, {"RECTYPE": "D", "MH": "Pan paniscus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Pygmy Chimpanzee|T015|NON|EQV|NLM (1998)|970321|abcdef", "ENTRY": "Pygmy Chimpanzees", "MN": "B01.050.150.900.649.313.988.400.112.400.600", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9597", "AN": "diseases: coordinate with APE DISEASES + specific disease /vet ", "PI": "Pongidae (1966-1971)", "MS": "The pygmy chimpanzee, a species of the genus Pan, family HOMINIDAE. Its common name is Bonobo, which was once considered a separate genus by some; others considered it a subspecies of PAN TROGLODYTES. Its range is confined to the forests of the central Zaire basin. Despite its name, it is often of equal size to P. troglodytes.", "PM": "98", "HN": "98", "MR": "20200813", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019974"}, {"RECTYPE": "D", "MH": "Cloning, Organism", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Human Cloning|T062|NON|NRW|NLM (1998)|970327|abcdef", "ENTRY": "Organism Clonings", "MN": "E05.820.180", "FX": "Reproduction, Asexual", "MH_TH": "NLM (1998)", "ST": "T062", "AN": "check tags HUMANS or ANIMALS; differentiate from CLONING, MOLECULAR and CLONE CELLS", "PI": "Reproduction Techniques (1994-1997)", "MS": "The formation of one or more genetically identical organisms derived by vegetative reproduction from a single cell. The source nuclear material can be embryo-derived, fetus-derived, or taken from an adult somatic cell.", "PM": "98", "HN": "98", "MR": "20150623", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019976"}, {"RECTYPE": "D", "MH": "Amoxicillin-Potassium Clavulanate Combination", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Potassium Clavulanate-Amoxicillin Combination|T109|T195|NON|EQV|NLM (1998)|970404|abbcdef", "ENTRY": "Potassium Clavulanate Amoxicillin Combination", "MN": "D26.310.102", "MH_TH": "NLM (1998)", "ST": "T195", "RN": "74469-00-4", "RR": "79198-29-1 (parent)", "PI": "Lactams (1981-1982)", "MS": "A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate.", "PM": "1998; BRL 25000 (now AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION) was indexed under ANTIBIOTICS, COMBINED 1989-1997 AMOXICILLIN & CLAVULANIC ACIDS 1981-1997, DRUG COMBINATIONS 1981-1988, & LACTAMS 1981-1982", "HN": "1998; use AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION (NM) 1981-1997", "MR": "20180409", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019980"}, {"RECTYPE": "D", "MH": "Health Care Sector", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Healthcare Industry|T093|NON|REL|NLM (1998)|970617|HEALTHCARE INDUST|abcdefv", "ENTRY": "Sectors, Healthcare", "MN": "N03.219.650", "FX": "Marketing of Health Services", "MH_TH": "NLM (1998)", "ST": "T078", "MS": "Economic sector concerned with the provision, distribution, and consumption of health care services and related products.", "PM": "98", "HN": "98", "MR": "20180629", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019981"}, {"RECTYPE": "D", "MH": "Organizational Case Studies", "DE": "ORGAN CASE STUDIES", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Management Case Studies|T058|T170|NON|REL|NLM (1998)|970407|abbcdef", "ENTRY": "Studies, Organizational Case", "MN": "N05.715.360.455", "MH_TH": "NLM (1998)", "ST": "T170", "AN": "excludes clinical studies", "MS": "Descriptions and evaluations of specific health care organizations.", "PM": "98", "HN": "98", "MR": "20180629", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019982"}, {"RECTYPE": "D", "MH": "Guideline Adherence", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Protocol Compliance|T058|NON|NRW|NLM (1998)|970407|abcdef", "ENTRY": "Compliance, Protocol", "MN": "N05.715.360.395", "FX": "Advance Directive Adherence", "MH_TH": "NLM (1998)", "ST": "T064", "AN": "by organization, health facility or facility personnel; coord with GUIDELINES AS TOPIC or PRACTICE GUIDELINES AS TOPIC if pertinent; for patient adherence to guidelines of care use PATIENT COMPLIANCE", "MS": "Conformity in fulfilling or following official, recognized, or institutional requirements, guidelines, recommendations, protocols, pathways, or other standards.", "PM": "98", "HN": "98", "MR": "20070711", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019983"}, {"RECTYPE": "D", "MH": "Quality Indicators, Health Care", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Quality Indicator, Healthcare", "MN": "N05.715.760", "FX": "Benchmarking", "MH_TH": "NLM (1998)", "ST": "T080", "MS": "Norms, criteria, standards, and other direct qualitative and quantitative measures used in determining the quality of health care.", "PM": "98", "HN": "98", "MR": "20190530", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019984"}, {"RECTYPE": "D", "MH": "Benchmarking", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Metrics|T080|T081|NON|REL|NLM (2020)|190320|abbcdef", "ENTRY": "Healthcare Benchmarking", "MN": "N05.715.360.650.150", "FX": "Quality Indicators, Health Care", "MH_TH": "NLM (1998)", "ST": "T081", "MS": "Method of measuring performance against established standards of best practice.", "PM": "98", "HN": "98", "MR": "20190530", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019985"}, {"RECTYPE": "D", "MH": "Persons With Hearing Impairments", "AQ": "CL HI LJ PX RH SN", "PRINT ENTRY": "Hearing Impaired Persons|T101|NON|EQV|NLM (1998)|990101|abcdef", "ENTRY": "Persons, Hearing Impaired", "MN": "M01.150.750", "FX": "Deafness", "EC": "education:Education of Hearing Disabled", "MH_TH": "NLM (1998)", "ST": "T101", "MS": "Persons with any degree of loss of hearing that has an impact on their activities of daily living or that requires special assistance or intervention.", "PM": "98", "HN": "98", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019986"}, {"RECTYPE": "D", "MH": "Visually Impaired Persons", "AQ": "CL HI LJ PX RH SN", "PRINT ENTRY": "Visually Disabled Persons|T101|NON|EQV|NLM (2024)|230426|abcdef", "ENTRY": "Visually Impaired Person", "MN": "M01.150.850", "FX": "Deaf-Blind Disorders", "EC": "education:Education of Visually Disabled", "MH_TH": "NLM (1998)", "ST": "T101", "MS": "Persons with loss of vision such that there is an impact on activities of daily living.", "PM": "98", "HN": "98", "MR": "20230622", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019987"}, {"RECTYPE": "D", "MH": "Disabled Children", "AQ": "CL ED HI LJ PX RH SN", "PRINT ENTRY": "Handicapped Children|T101|NON|EQV|NLM (1998)|970407|abcdef", "ENTRY": "Disabled Child", "MN": "M01.150.200", "MH_TH": "NLM (1998)", "ST": "T101", "AN": "coord with type of disability if given (e.g. HEARING IMPAIRED PERSONS) + appropriate check tag", "MS": "Children with mental or physical disabilities that interfere with usual activities of daily living and that may require accommodation or intervention.", "PM": "98", "HN": "98", "MR": "20020703", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019988"}, {"RECTYPE": "D", "MH": "Persons with Mental Disabilities", "AQ": "CL HI LJ PX RH SN", "PRINT ENTRY": "Persons with Intellectual Disability|T101|NON|EQV|NLM (2021)|200317|abcdef", "ENTRY": "Persons, Mentally Disabled", "MN": "M01.150.600", "FX": "Intellectual Disability", "EC": "education:Education of Intellectually Disabled", "MH_TH": "NLM (2021)", "ST": "T101", "MS": "Persons diagnosed as having significantly lower than average intelligence and considerable problems in adapting to everyday life or lacking independence in regard to activities of daily living.", "PM": "98", "HN": "98", "MR": "20200618", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019989"}, {"RECTYPE": "D", "MH": "Perioperative Care", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Care, Perioperative", "MN": "N02.421.585.722", "MH_TH": "NLM (1998)", "ST": "T058", "AN": "do not confuse with PEROPERATIVE CARE see INTRAOPERATIVE CARE", "MS": "Interventions to provide care prior to, during, and immediately after surgery.", "PM": "98", "HN": "98", "MR": "20181012", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019990"}, {"RECTYPE": "D", "MH": "Database", "ENTRY": "Data Base|T170|NON|EQV|NLM (2008)|070705|abcdef", "MN": "V02.300", "MH_TH": "NLM (1998)", "ST": "T170", "AN": "This heading is used as a Publication Type. Databases as a subject are indexed under the main heading DATABASES AS TOPIC;  or DATABASES, BIBLIOGRAPHIC; or DATABASES, FACTUAL; etc. INDEXER: Do not use", "MS": "A structured file of information or a set of logically related data stored and retrieved using computer-based means.", "HN": "2008(1998)", "MR": "20190705", "DA": "19970715", "DC": "2", "DX": "19980101", "UI": "D019991"}, {"RECTYPE": "D", "MH": "Databases as Topic", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Databanks as Topic|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "L01.470.750", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "general or unspecified; prefer specifics; do not confuse with Publication Type DATABASE", "PI": "Information Systems (1966-1997)", "MS": "Works on organized collections of records, standardized in format and content, that are stored in any of a variety of computer-readable modes.", "PM": "2008; see DATABASES 1998-2007; for DATABASES see INFORMATION SYSTEMS 1994-1996; for DATABANKS see DATABASES, FACTUAL 1991-2001, see INFORMATION SYSTEMS 1982-1990", "HN": "2008(1998); for DATABASES use INFORMATION SYSTEMS 1994-1996; for DATABANKS use DATABASES, FACTUAL 1991-2001; DATA BANKS was see INFORMATION SYSTEMS 1982-90", "MR": "20170630", "DA": "19970626", "DC": "1", "DX": "19980101", "UI": "D019992"}, {"RECTYPE": "D", "MH": "Laboratory Chemicals", "DE": "LABORATORY CHEM", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Chemicals, Laboratory|T120|NON|EQV|NLM (1998)|970521|CHEM LABORATORY|abcdefv", "MN": "D27.720.470", "MH_TH": "NLM (1998)", "ST": "T120", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Chemicals necessary to perform experimental and/or investigative procedures and for the preparation of drugs and other chemicals.", "PM": "98", "HN": "98", "MR": "20030709", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019995"}, {"RECTYPE": "D", "MH": "Racemases and Epimerases", "DE": "RACEMASES EPIMERASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Racemases|T116|T126|NON|NRW|NLM (1998)|970414|abbcdef", "ENTRY": "Epimerases and Racemases|T116|T126|NON|EQV|NLM (1998)|970414|abbcdef", "MN": "D08.811.399.894", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 5.1.-", "MS": "Enzymes that catalyze inversion of the configuration around an asymmetric carbon in a substrate having one (racemase) or more (epimerase) center(s) of asymmetry. (Dorland, 28th ed) EC 5.1.", "OL": "search ISOMERASES 1966-74", "PM": "98; see RACEMASES 1991-97, see EPIMERASES 1991-97, see ISOMERASES 1975-90", "HN": "98(75)", "MR": "20200527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019998"}, {"RECTYPE": "D", "MH": "Pharmaceutical Solutions", "DE": "PHARM SOL", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Solutions, Pharmaceutic", "MN": "D27.720.752", "FX": "Solutions", "MH_TH": "NLM (1998)", "ST": "T121", "RN": "0", "AN": "IM general only; coordinate NIM with specific drug in solution (IM)", "PI": "Solutions (1970-1997)", "MS": "Homogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents. For reasons of their ingredients, method of preparation, or use, they do not fall into another group of products.", "PM": "98", "HN": "98", "MR": "20140617", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D019999"}, {"RECTYPE": "D", "MH": "Decision Support Systems, Clinical", "DE": "DECISION SUPPORT SYSTEMS CLIN", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Clinical Decision Support Systems|T170|NON|EQV|NLM (1998)|970418|CLIN DECISION SUPPORT SYSTEMS|abcdefv", "ENTRY": "Supports, Clinical Decision", "MN": "L01.313.500.750.300.190", "MH_TH": "NLM (1998)", "ST": "T170", "MS": "Computer-based information systems used to integrate clinical and patient information and provide support for decision-making in patient care.", "PM": "98", "HN": "98", "MR": "20200527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D020000"}, {"RECTYPE": "D", "MH": "1-Butanol", "DS": "BUTANOL 001", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "n-Butanol|T109|NON|EQV|FDA SRS (2014)|NLM (1998)|970424|BUTANOL N|abcdeefs", "ENTRY": "n Butyl Alcohol", "MN": "D10.289.110.175", "EC": "analogs & derivatives:Butanols", "MH_TH": "NLM (1998)", "ST": "T109", "RN": "8PJ61P6TS3", "RR": "71-36-3 (1-Butanol)", "AN": "BUTANOLS is also available", "PI": "Butanols (1980-1997)", "MS": "A four carbon linear hydrocarbon that has a hydroxy group at position 1.", "PM": "98; N-BUTYL ALCOHOL (now 1-BUTANOL) was indexed under ALCOHOLS, BUTYL 1980-97", "HN": "98; use 1-BUTANOL (NM) 1980-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D020001"}, {"RECTYPE": "D", "MH": "tert-Butyl Alcohol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "tertiary Butyl Alcohol", "MN": "D10.289.110.855", "MH_TH": "NLM (1998)", "ST": "T109", "RN": "MD83SFE959", "RR": "75-65-0 (tert-Butyl Alcohol)", "PI": "Butanols (1981-1997)", "MS": "An isomer of butanol that contains a tertiary butyl group that consists of three methyl groups, each separately attached to a central (tertiary) carbon.", "PM": "98; TERT-BUTYL ALCOHOL was indexed under ALCOHOLS, BUTYL 1981-97", "HN": "98; use TERT-BUTYL ALCOHOL (NM) 1981-97", "MR": "20151008", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D020002"}, {"RECTYPE": "D", "MH": "1-Octanol", "DS": "OCTANOL 01", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "n-Octanol|T109|NON|EQV|FDA SRS (2014)|NLM (1998)|970428|OCTANOL N|abcdeefs", "ENTRY": "n Octyl Alcohol", "MN": "D10.289.600.610", "PA": "Solvents", "EC": "analogs & derivatives:Octanols", "MH_TH": "NLM (1998)", "ST": "T109", "RN": "NV1779205D", "RR": "111-87-5 (1-Octanol)", "AN": "OCTANOLS is also available", "PI": "Octanols (1981-1997)", "MS": "A colorless, slightly viscous liquid used as a defoaming or wetting agent. It is also used as a solvent for protective coatings, waxes, and oils, and as a raw material for plasticizers. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)", "PM": "98; 1-OCTANOL was indexed under ALCOHOLS, OCTYL 1981-97", "HN": "98; use 1-OCTANOL (NM) 1981-97", "MR": "20130708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D020003"}, {"RECTYPE": "D", "MH": "Propanols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Alcohols, Propyl|T109|NON|EQV|NLM (1998)|970428|abcdef", "ENTRY": "Propyl Alcohols", "MN": "D02.033.755", "MH_TH": "NLM (1998)", "ST": "T109", "RN": "0", "MS": "Isomeric forms and derivatives of PROPANOL (C3H7OH).", "PM": "98", "HN": "98", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D020005"}, {"RECTYPE": "D", "MH": "Implants, Experimental", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Implant, Experimental", "MN": "E07.695.340", "MH_TH": "NLM (1998)", "ST": "T074", "PI": "Prostheses and Implants (1966-1997)", "MS": "Artificial substitutes for body parts and materials inserted into organisms during experimental studies.", "PM": "98", "HN": "98", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D020007"}, {"RECTYPE": "D", "MH": "Delavirdine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "U90152S", "MN": "D03.633.100.473.250", "PA": "Reverse Transcriptase Inhibitors", "MH_TH": "NLM (1998)", "ST": "T121", "N1": "Piperazine, 1-(3-((1-methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)-", "RN": "DOL5F9JD3E", "RR": "421105KRQE", "PI": "Piperazines (1993-1997)", "MS": "A potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1.", "PM": "98; DELAVIRDINE was indexed under PIPERAZINES & INDOLES 1993-97", "HN": "98; use DELAVIRDINE (NM) 1993-97", "MR": "20170524", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D020008"}, {"RECTYPE": "D", "MH": "Heterosexuality", "AQ": "CL DE EH ES HI PH PX RE SN", "ENTRY": "Heterosexual", "MN": "G08.686.867.400", "MH_TH": "NLM (1998)", "ST": "T054", "MS": "The sexual attraction or relationship between members of the opposite SEX.", "PM": "98; see SEXUALITY 1997; see SEX BEHAVIOR 1990-96", "HN": "98; use SEXUALITY 1997; use SEX BEHAVIOR 1990-96", "MR": "20080708", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D020010"}, {"RECTYPE": "D", "MH": "Protective Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Protective Drug|T120|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Drugs, Protective", "MN": "D27.720.799", "MH_TH": "NLM (1998)", "ST": "T120", "RN": "0", "AN": "general; prefer specific groups of protective agents", "MS": "Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent.", "PM": "98", "HN": "98", "MR": "20200527", "DA": "19970620", "DC": "1", "DX": "19980101", "UI": "D020011"}, {"RECTYPE": "D", "MH": "Calcium Signaling", "DE": "CA SIGNALING", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Calcium Waves|T043|NON|NRW|NLM (1999)|980114|CA WAVES|abcdefv", "ENTRY": "Waves, Calcium", "MN": "G04.835.800.100", "FX": "Inositol 1,4,5-Trisphosphate", "MH_TH": "NLM (1998)", "ST": "T043", "AN": "calcium mobilization in context of signal transduction goes here, in other cases index CALCIUM/metab", "PI": "Signal Transduction (1989-1998)", "MS": "Signal transduction mechanisms whereby calcium mobilization (from outside the cell or from intracellular storage pools) to the cytoplasm is triggered by external stimuli. Calcium signals are often seen to propagate as waves, oscillations, spikes, sparks, or puffs. The calcium acts as an intracellular messenger by activating calcium-responsive proteins.", "PM": "99", "HN": "99", "MR": "20160502", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020013"}, {"RECTYPE": "D", "MH": "K562 Cells", "DS": "K A 562 CELLS", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cells, K562", "MN": "A11.443.240.497.480", "MH_TH": "NLM (1999)", "ST": "T025", "AN": "almost always NIM with no subheadings; check HUMAN; do not routinely add ERYTHROLEUKEMIA", "PI": "Tumor Cells, Cultured (1988-1998)", "MS": "An ERYTHROLEUKEMIA cell line derived from a CHRONIC MYELOID LEUKEMIA patient in BLAST CRISIS.", "PM": "99", "HN": "99", "MR": "20080708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020014"}, {"RECTYPE": "D", "MH": "Activated Protein C Resistance", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "APC Resistance|T049|EQV|NLM (1999)|OMIM (2013)|980313|abdeef", "ENTRY": "Resistance, APC", "MN": "C16.320.099.037", "FX": "Protein C Deficiency", "MH_TH": "OMIM (2013)", "ST": "T049", "PI": "Protein C (1993-1998)", "MS": "A hemostatic disorder characterized by a poor anticoagulant response to activated protein C (APC). The activated form of Factor V (Factor Va) is more slowly degraded by activated protein C. Factor V Leiden mutation (R506Q) is the most common cause of APC resistance.", "PM": "99", "HN": "99", "MR": "20120703", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020016"}, {"RECTYPE": "D", "MH": "Sexual Dysfunctions, Psychological", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Sexual Aversion Disorder|T048|NON|NRW|NLM (1998)|970714|SEXUAL AVERSION DIS|abcdefv", "ENTRY": "Sexual Dysfunction, Psychological", "MN": "F03.835", "MH_TH": "NLM (1998)", "ST": "T048", "MS": "Disturbances in sexual desire and the psychophysiologic changes that characterize the sexual response cycle and cause marked distress and interpersonal difficulty. (APA, DSM-IV, 1994)", "PM": "99; see SEXUAL DYSFUNCTIONS 1998; see PSYCHOSEXUAL DISORDERS was heading 1981-98; for FRIGIDITY see FRIGIDITY 1966-97; for PSYCHOSEXUAL DISORDERS see PSYCHOSEXUAL DISORDERS 1981-97", "HN": "99(81)", "MR": "20150630", "DA": "19970714", "DC": "1", "DX": "19980101", "UI": "D020018"}, {"RECTYPE": "D", "MH": "Neurocysticercosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Neurocoenurosis|T047|NON|EQV|NLM (2021)|200506|abcdef", "ENTRY": "Neurocysticercoses", "MN": "C10.228.228.205.250.550", "FX": "Taenia", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent; coordinate with specific site/disease term if pertinent", "PI": "Cysticercosis (1966-1998)", "MS": "Infection of the brain, spinal cord, or perimeningeal structures with the larval forms of the genus TAENIA (primarily T. solium in humans). Lesions formed by the organism are referred to as cysticerci. The infection may be subacute or chronic, and the severity of symptoms depends on the severity of the host immune response and the location and number of lesions. SEIZURES represent the most common clinical manifestation although focal neurologic deficits may occur. (From Joynt, Clinical Neurology, 1998, Ch27, pp46-50)", "PM": "1999", "HN": "1999", "MR": "20200622", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020019"}, {"RECTYPE": "D", "MH": "Genetic Predisposition to Disease", "DE": "GENET PREDISPOSITION DIS", "AQ": "CL EH EM EP ET GE HI PC PX", "PRINT ENTRY": "Genetic Susceptibility|T032|NON|EQV|NLM (1999)|971205|GENET SUSCEPTIBILITY|abcdefv", "ENTRY": "Susceptibilities, Genetic", "MN": "G05.380.355", "FX": "Genetic Testing", "EC": "diagnosis:Genetic Testing", "MH_TH": "NLM (1999)", "ST": "T032", "AN": "latent susceptibility to disease only: coordinate with specific disease/genet; for positive genetic predisposition (like longevity) use specific trait/genet", "PI": "specific disease/genetics (1966-1998)", "MS": "A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.", "PM": "99", "HN": "99", "MR": "20110624", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020022"}, {"RECTYPE": "D", "MH": "Leukotriene Antagonists", "DE": "LEUKOTRIENE ANTAG", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Leukotriene Receptor Antagonists|T121|NON|EQV|NLM (1999)|970903|LEUKOTRIENE RECEPT ANTAG|abcdefv", "ENTRY": "Receptor Antagonist, Leukotriene", "MN": "D27.505.696.399.450.565", "PA": "Anti-Asthmatic Agents", "MH_TH": "NLM (1999)", "ST": "T121", "RN": "0", "MS": "A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.", "PM": "99", "HN": "99", "MR": "20200527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020024"}, {"RECTYPE": "D", "MH": "Peroxisome Proliferators", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Proliferators, Peroxisome", "MN": "D27.888.569.100.675", "FX": "Peroxisome Proliferator-Activated Receptors", "MH_TH": "NLM (1999)", "ST": "T131", "RN": "0", "PI": "Liver Neoplasms, Experimental (1986-1998)", "MS": "A class of nongenotoxic CARCINOGENS that induce the production of hepatic PEROXISOMES and induce hepatic neoplasms after long-term administration.", "PM": "99", "HN": "99", "MR": "20040707", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020025"}, {"RECTYPE": "D", "MH": "Pyrococcus furiosus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.825.800.650.300", "MH_TH": "NLM (1999)", "ST": "T194", "RN": "txid2261", "AN": "a species of archaea", "PI": "Archaea (1989-1998)", "MS": "A species of strictly anaerobic, hyperthermophilic archaea which lives in geothermally-heated marine sediments. It exhibits heterotropic growth by fermentation or sulfur respiration.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020027"}, {"RECTYPE": "D", "MH": "Base Pairing", "AQ": "DE ES GE PH RE", "PRINT ENTRY": "Base Pair|T044|T114|NON|EQV|NLM (1999)|970916|abbcdef", "ENTRY": "Base Pairings", "MN": "G05.360.580.100", "FX": "Base Pair Mismatch", "MH_TH": "NLM (1999)", "ST": "T114", "AN": "coord with DNA or RNA or specific", "PI": "Nucleic Acid Conformation (1972-1998)", "MS": "Pairing of purine and pyrimidine bases by HYDROGEN BONDING in double-stranded DNA or RNA.", "PM": "99; see BASE COMPOSITION 1980-98", "HN": "99; use BASE COMPOSITION 1980-98", "MR": "20160115", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020029"}, {"RECTYPE": "D", "MH": "Nitric Oxide Donors", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nitric Oxide Donor|T121|NON|EQV|NLM (2021)|200225|abcdef", "ENTRY": "Oxide Donors, Nitric", "MN": "D27.505.954.411.590", "FX": "Nitric Oxide", "MH_TH": "NLM (1999)", "ST": "T121", "RN": "0", "PI": "Nitric Oxide (1990-1998)", "MS": "A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81)", "PM": "99", "HN": "99", "MR": "20200527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020030"}, {"RECTYPE": "D", "MH": "Epstein-Barr Virus Infections", "DE": "EPSTEIN BARR VIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "EBV Infections|T047|EQV|NLM (1999)|970916|EBV INFECT|abdefv", "ENTRY": "Virus Infections, Epstein-Barr", "MN": "C01.925.928.313", "MH_TH": "NLM (1999)", "ST": "T047", "PI": "Herpesviridae Infections (1970-1998)", "MS": "Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).", "PM": "99", "HN": "99", "MR": "20190617", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020031"}, {"RECTYPE": "D", "MH": "Tyrphostins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tyrphostin|T121|NON|EQV|NLM (2021)|200330|abcdef", "MN": "D03.633.100.857.885", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (1999)", "ST": "T121", "RN": "0", "PI": "Protein-Tyrosine Kinase/antagonists & inhibitors (1989-1998)", "MS": "A family of synthetic protein tyrosine kinase inhibitors. They selectively inhibit receptor autophosphorylation and are used to study receptor function.", "PM": "99", "HN": "99", "MR": "20200527", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020032"}, {"RECTYPE": "D", "MH": "Protein Isoforms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Splice Variants, Protein|T116|NON|NRW|NLM (2007)|060307|abcdef", "ENTRY": "Variants, Protein Splice", "MN": "D12.776.800", "FX": "RNA Splice Sites", "MH_TH": "NLM (1999)", "ST": "T116", "RN": "0", "AN": "IM general only; coordinate NIM with specific protein (IM); for enzymes use ISOENZYMES", "MS": "Different forms of a protein that may be produced from different GENES, or from the same gene by ALTERNATIVE SPLICING.", "PM": "99", "HN": "99", "MR": "20200527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020033"}, {"RECTYPE": "D", "MH": "Silicone Gels", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Gels, Silicone", "MN": "J01.637.051.720.900.850.905", "FX": "Breast Implants", "MH_TH": "NLM (1999)", "ST": "T122", "RN": "0", "AN": "silicones in breast implants probably goes here unless specified as elastomers (SILICONE ELASTOMERS); for prosthetic implants do not use /ther use", "PI": "Silicones (1970-1998)", "MS": "Synthetic organosiloxane gels that are formed from synthetic polymers of silicone oxide with organic sidechains (polydimethylsiloxane) by lengthening the polymer chains. Unlike silicone elastomers, they are not treated with amorphous silica. They are used as fillers in breast implants.", "PM": "99", "HN": "99", "MR": "20190627", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020034"}, {"RECTYPE": "D", "MH": "Holoenzymes", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Holoenzyme|T116|T126|NON|EQV|NLM (2021)|191119|abbcdef", "MN": "D08.811.255", "MH_TH": "NLM (1999)", "ST": "T126", "RN": "0", "AN": "IM GEN only; coord NIM with specific enzyme (IM)", "PI": "Coenzymes (1966-1998)", "MS": "Catalytically active enzymes that are formed by the combination of an apoenzyme (APOENZYMES) and its appropriate cofactors and prosthetic groups.", "PM": "99; see COENZYMES 1996-98", "HN": "99; use COENZYMES 1996-98", "MR": "20200527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020035"}, {"RECTYPE": "D", "MH": "Onygenales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Ajellomyces|T004|NON|NRW|NLM (1999)|970925|abcdef", "ENTRY": "Onygenale", "MN": "B01.300.107.650", "FX": "Chrysosporium", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid33183", "MS": "An order of fungi in the phylum ASCOMYCOTA containing many medically important species. There are four families and mitosporic (anamorphic) forms are prominent.", "PM": "99", "HN": "99", "MR": "20200902", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020036"}, {"RECTYPE": "D", "MH": "Sordariales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Sordariale", "MN": "B01.300.107.800", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid5139", "MS": "An order of fungi in the phylum ASCOMYCOTA that includes many valuable experimental organisms. There are eight families and very few anamorphic forms.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020037"}, {"RECTYPE": "D", "MH": "RNA, Spliced Leader", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Trans-Spliced Leader Sequences|T086|NON|NRW|NLM (1999)|980114|abcdef", "ENTRY": "Trans Spliced Leader Sequences", "MN": "D13.444.735.790.552.968", "FX": "Trans-Splicing", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "0", "AN": "do not confuse with LEADER SEQUENCES, MRNA see 5' UNTRANSLATED REGION", "PI": "Signal Peptides (1987-1998)", "MS": "The small RNAs which provide spliced leader sequences, SL1, SL2, SL3, SL4 and SL5 (short sequences which are joined to the 5' ends of pre-mRNAs by TRANS-SPLICING). They are found primarily in primitive eukaryotes (protozoans and nematodes).", "PM": "99", "HN": "99", "MR": "20100625", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020038"}, {"RECTYPE": "D", "MH": "Trans-Splicing", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Trans RNA Splicing|T044|NON|EQV|NLM (1999)|980114|abcdef", "ENTRY": "Trans-Splicings, RNA", "MN": "G05.308.700.700.750", "FX": "RNA, Spliced Leader", "MH_TH": "NLM (1999)", "ST": "T044", "AN": "note category: a physiol process taking place within the cell nucleus; do not confuse with DNA, RECOMBINANT; CLONING, MOLECULAR; or GENETIC ENGINEERING", "PI": "RNA Splicing (1982-1998)", "MS": "The joining of RNA from two different genes. One type of trans-splicing is the \"spliced leader\" type (primarily found in protozoans such as trypanosomes and in lower invertebrates such as nematodes) which results in the addition of a capped, noncoding, spliced leader sequence to the 5' end of mRNAs. Another type of trans-splicing is the \"discontinuous group II introns\" type (found in plant/algal chloroplasts and plant mitochondria) which results in the joining of two independently transcribed coding sequences. Both are mechanistically similar to conventional nuclear pre-mRNA cis-splicing. Mammalian cells are also capable of trans-splicing.", "PM": "99", "HN": "99", "MR": "20160701", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020040"}, {"RECTYPE": "D", "MH": "Histiocytic Necrotizing Lymphadenitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lymphadenitis, Histiocytic Necrotizing|T047|NON|EQV|NLM (1999)|980310|abcdef", "ENTRY": "Nosocomial Kikuchis Disease", "MN": "C15.604.315.300", "MH_TH": "NLM (1999)", "ST": "T047", "PI": "Lymphadenitis (1983-1998)", "MS": "Development of lesions in the lymph node characterized by infiltration of the cortex or paracortex by large collections of proliferating histiocytes and complete or, more often, incomplete necrosis of lymphoid tissue.", "PM": "1999", "HN": "1999", "MR": "20090706", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020042"}, {"RECTYPE": "D", "MH": "Genes, Essential", "AQ": "DE ES GE IM PH RE", "ENTRY": "Housekeeping Genes", "MN": "G05.360.340.024.340.270", "MH_TH": "NLM (1999)", "ST": "T028", "AN": "coord NIM with specific genes", "MS": "Those genes found in an organism which are necessary for its viability and normal function.", "PM": "99", "HN": "99", "MR": "20110624", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020043"}, {"RECTYPE": "D", "MH": "Pfiesteria piscicida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "piscicida, Pfiesteria", "MN": "B01.043.214.600", "MH_TH": "NLM (1999)", "ST": "T204", "RN": "txid71001", "AN": "infection: coordinate with PROTOZOAN INFECTIONS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent ", "PI": "Dinoflagellida (1998)", "MS": "A dinoflagellate with a life cycle that includes numerous flagellated, amoeboid, and encysted stages. Both the flagellated and amoeboid forms produce toxins which cause open wounds on fish. Pfiesteria piscicida feeds on tissue sloughed from these wounds, as well as on bacteria and algae. It is found in Atlantic estuaries of the United States.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020045"}, {"RECTYPE": "D", "MH": "Rectocele", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Rectoceles", "MN": "C23.300.707.984", "MH_TH": "NLM (1999)", "ST": "T047", "PI": "Rectal Diseases (1966-1998)", "MS": "Herniation of the RECTUM into the VAGINA.", "PM": "99", "HN": "99", "MR": "20150626", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020047"}, {"RECTYPE": "D", "MH": "Blattellidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "German Cockroachs", "MN": "B01.050.500.131.617.140.100", "MH_TH": "NLM (1999)", "ST": "T204", "RN": "txid1049651", "AN": "for killing Blattellidae with insecticides, see note at INSECTICIDES", "PI": "Cockroaches (1965-1998)", "MS": "A family of insects in the order Dictyoptera (COCKROACHES), including genera Blattella, Parcoblatta, and Symploce.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020048"}, {"RECTYPE": "D", "MH": "Isoptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Termites|T204|NON|EQV|NLM (1999)|971023|abcdef", "ENTRY": "Termite", "MN": "B01.050.500.131.617.485", "MH_TH": "NLM (1999)", "ST": "T204", "RN": "txid1912919", "AN": "do not use /drug eff for insecticides: TN 111", "PI": "Insects (1966-1998)", "MS": "An order of insects, restricted mostly to the tropics, containing at least eight families. A few species occur in temperate regions of North America.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020049"}, {"RECTYPE": "D", "MH": "Mantodea", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Praying Mantis|T204|NON|NRW|NLM (1999)|971023|abcdef", "ENTRY": "Praying Manti", "MN": "B01.050.500.131.617.720.500.750", "MH_TH": "NLM (1999)", "ST": "T204", "RN": "txid7504", "RR": "txid7507", "AN": "do not use /drug eff for insecticides: TN 111", "PI": "Orthoptera (1981-1998)", "MS": "An order of insects, comprising a single family (Mantidae), restricted almost entirely to the tropics. Only one species, the praying mantis (Mantis religiosa), is found in temperate habitats.", "PM": "99; for MANTIDS & PRAYING MANTIS see ORTHOPTERA 1986-98", "HN": "99; for MANTIDS & PRAYING MANTIS use ORTHOPTERA 1986-98", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020050"}, {"RECTYPE": "D", "MH": "N-Acetylgalactosamine-4-Sulfatase", "DS": "ACETYLGALACTOSAMINE SULFATASE N 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Arylsulfatase B|T116|T126|NON|EQV|NLM (1999)|971028|abbcdef", "ENTRY": "Sulphatase, N-Acetylgalactosamine-4-sulphate", "MN": "D08.811.277.352.827.180.175.060", "EC": "deficiency:Mucopolysaccharidosis VI", "MH_TH": "NLM (1999)", "ST": "T126", "N1": "N-Acetyl-D-Galactosamine-4-sulfate 4-sulfohydrolase", "RN": "EC 3.1.6.12", "PI": "Sulfatases (1988-1998)", "MS": "An arylsulfatase that catalyzes the hydrolysis of the 4-sulfate groups of the N-acetyl-D-galactosamine 4-sulfate units of chondroitin sulfate and dermatan sulfate. A deficiency of this enzyme is responsible for the inherited lysosomal disease, Maroteaux-Lamy syndrome (MUCOPOLYSACCHARIDOSIS VI). EC 3.1.6.12.", "PM": "99; for ARYLSULFATASE B see CHONDRO-4-SULFATASE 1975-98; N-ACETYLGALACTOSAMINE-4-SULFATE SULFATASE (now N-ACETYLGALACTOSAMINE-4-SULFATASE) was indexed under SULFATASES 1988-98", "HN": "99; for ARYLSULFATASE B use CHONDRO-4-SULFATASE 1975-98; use N-ACETYLGALACTOSAMINE-4-SULFATASE (NM) 1988-98", "MR": "20160628", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020051"}, {"RECTYPE": "D", "MH": "Styrene", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Styrene Monomer|T109|T131|NON|EQV|NLM (1999)|971029|abbcdef", "ENTRY": "Monomer, Styrene", "MN": "D02.455.426.559.389.150.750.800", "EC": "analogs & derivatives:Styrenes", "MH_TH": "NLM (1999)", "ST": "T131", "N1": "Benzene, ethenyl-", "RN": "44LJ2U959V", "RR": "100-42-5 (Styrene)", "AN": "STYRENES is also available", "PI": "Styrenes (1981-1998)", "MS": "A colorless, toxic liquid with a strong aromatic odor. It is used to make rubbers, polymers and copolymers, and polystyrene plastics.", "PM": "99; STYRENE was indexed under STYRENES 1981-98", "HN": "99; use STYRENE (NM) 1981-98", "MR": "20130708", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020058"}, {"RECTYPE": "D", "MH": "Cathepsin E", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteinase, Slow Moving", "MN": "D08.811.277.656.300.048.185", "MH_TH": "NLM (1999)", "ST": "T126", "RN": "EC 3.4.23.34", "PI": "Cathepsins (1980-1998)", "MS": "An aspartic endopeptidase that is similar in structure to CATHEPSIN D. It is found primarily in the cells of the immune system where it may play a role in processing of CELL SURFACE ANTIGENS.", "PM": "99; CATHEPSIN E & ERYTHROCYTE MEMBRANE ASPARTIC PROTEINASE were indexed under CATHEPSINS 1980-98", "HN": "99; use CATHEPSIN E (NM) 1980-98", "MR": "20090706", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020059"}, {"RECTYPE": "D", "MH": "Phthirus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Crab Lice|T204|NON|NRW|NLM (1999)|971031|abcdef", "ENTRY": "Louses, Crab", "MN": "B01.050.500.131.617.690.060.730", "MH_TH": "NLM (1999)", "ST": "T204", "RN": "txid121227", "RR": "txid121228", "AN": "do not use /drug eff for insecticides: TN 111", "PI": "Lice (1965-1998)", "MS": "Lice of the genus Phthirus, family Pediculidae. Phthirus pubis, the crab louse, is usually acquired by sexual contact or contact with infected objects. It is found most frequently in the pubic hair, but also on eyebrows, eyelashes, or on the axillary hairs.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020061"}, {"RECTYPE": "D", "MH": "Heteroptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Heteropteras", "MN": "B01.050.500.131.617.412.420", "MH_TH": "NLM (1999)", "ST": "T204", "RN": "txid33345", "PI": "Insects (1965-1974)", "MS": "A suborder of HEMIPTERA, called true bugs, characterized by the possession of two pairs of wings. It includes the medically important families CIMICIDAE and REDUVIIDAE. (From Dorland, 28th ed)", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020062"}, {"RECTYPE": "D", "MH": "Cimicidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.412.420.150", "MH_TH": "NLM (1999)", "ST": "T204", "RN": "txid30078", "AN": "do not use /drug eff for insecticides: TN 111", "PI": "Hemiptera (1986-1998)", "MS": "A family of wingless, blood-sucking insects of the suborder HETEROPTERA, including the bedbugs and related forms. Cimex (BEDBUGS), Heamatosiphon, and Oeciacus are medically important genera. (From Dorland, 28th ed)", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020063"}, {"RECTYPE": "D", "MH": "Reduviidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Assassin Bugs|T204|NON|EQV|NLM (1999)|971103|abcdef", "ENTRY": "Bugs, Assassin", "MN": "B01.050.500.131.617.412.420.700", "MH_TH": "NLM (1999)", "ST": "T204", "RN": "txid27479", "AN": "do not use /drug eff for insecticides: TN 111", "PI": "Triatominae (1979-1998)", "MS": "A family of winged insects of the suborder HETEROPTERA, called assassin bugs, because most prey on other insects. However one subfamily, TRIATOMINAE, attacks humans and other vertebrates and transmits Chagas disease.", "PM": "99; see TRIATOMINAE 1979-98", "HN": "99; use TRIATOMINAE 1979-98", "MR": "20200813", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020064"}, {"RECTYPE": "D", "MH": "Hepatopulmonary Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Hepatopulmonary", "MN": "C08.381.385", "MH_TH": "NLM (1999)", "ST": "T047", "PI": "Liver Diseases (1982-1998)", "MS": "A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation (HYPOXEMIA) in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL).", "PM": "99", "HN": "99", "MR": "20080708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020065"}, {"RECTYPE": "D", "MH": "Merozoite Surface Protein 1", "DS": "MEROZOITE SURFACE PROTEIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "MSP1|T116|T129|ABB|EQV|NLM (1999)|971107|MSP 001|abbcdefs", "ENTRY": "Surface Protein-1, Merozoite", "MN": "D23.050.293.500", "MH_TH": "NLM (1999)", "ST": "T129", "RN": "0", "AN": "coord IM with specific PLASMODIUM species", "PI": "Protozoan Proteins (1990-1998)", "MS": "A surface protein found on Plasmodium species which induces a T-cell response. The antigen is polymorphic, sharing amino acid sequence homology among PLASMODIUM FALCIPARUM; PLASMODIUM CHABAUDI; PLASMODIUM VIVAX; and PLASMODIUM YOELII.", "PM": "99; PLASMODIUM FALCIPARUM MEROZOITE PRECURSOR SURFACE COAT PROTEIN (now MEROZOITE SURFACE PROTEIN 1) was indexed under PROTOZOAN PROTEINS 1990-98 and ANTIGENS, PROTOZOAN 1987-89", "HN": "99; use PLASMODIUM FALCIPARUM MEROZOITE PRECURSOR SURFACE COAT PROTEIN (NM) 1987-98", "MR": "20220523", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020066"}, {"RECTYPE": "D", "MH": "Zygosaccharomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Zygosaccharomyce", "MN": "B01.300.107.795.990", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid4953", "PI": "Saccharomycetales (1986-1998)", "MS": "A genus of ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020068"}, {"RECTYPE": "D", "MH": "Shoulder Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Shoulder Pains", "MN": "G11.561.790.444.350.500", "MH_TH": "NLM (1999)", "ST": "T184", "PI": "Pain (1966-1998)", "MS": "Unilateral or bilateral pain of the shoulder. It is often caused by physical activities such as work or sports participation, but may also be pathologic in origin.", "PM": "99", "HN": "99", "MR": "20170620", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020069"}, {"RECTYPE": "D", "MH": "Cervical Ripening", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "ENTRY": "Ripenings, Cervical", "MN": "G08.686.784.769.326.100", "MH_TH": "NLM (1999)", "ST": "T061", "PI": "Cervix Uteri (1976-1998)", "MS": "A change in the CERVIX UTERI with respect to its readiness to relax. The cervix normally becomes softer, more flexible, more distensible, and shorter in the final weeks of PREGNANCY. These cervical changes can also be chemically induced (LABOR, INDUCED).", "PM": "99", "HN": "99", "MR": "20160616", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020070"}, {"RECTYPE": "D", "MH": "Interspersed Repetitive Sequences", "DE": "INTERSPERSED REPET SEQ", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Repetitive Sequences, Interspersed|T114|T123|NON|EQV|NLM (1999)|980410|REPET SEQ INTERSPERSED|abbcdefv", "ENTRY": "Sequences, Interspersed Repetitive", "MN": "G05.360.340.024.425", "FX": "Mutagenesis, Insertional", "MH_TH": "NLM (1999)", "ST": "T123", "AN": "general or unspecified; prefer specifics", "PI": "Repetitive Sequences, Nucleic Acid (1981-1998)", "MS": "Copies of transposable elements interspersed throughout the genome, some of which are still active and often referred to as \"jumping genes\". There are two classes of interspersed repetitive elements. Class I elements (or RETROELEMENTS - such as retrotransposons, retroviruses, LONG INTERSPERSED NUCLEOTIDE ELEMENTS and SHORT INTERSPERSED NUCLEOTIDE ELEMENTS) transpose via reverse transcription of an RNA intermediate. Class II elements (or DNA TRANSPOSABLE ELEMENTS - such as transposons, Tn elements, insertion sequence elements and mobile gene cassettes of bacterial integrons) transpose directly from one site in the DNA to another.", "PM": "99; for MOBILE GENETIC ELEMENTS see DNA INSERTION ELEMENTS 1986-98; for SELFISH DNA see DNA (1983-2003)", "HN": "99; for MOBILE GENETIC ELEMENTS use DNA TRANSPOSABLE ELEMENTS 1986-98; for SELFISH DNA use DNA (1983-2003)", "MR": "20080708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020071"}, {"RECTYPE": "D", "MH": "Polyporales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Aphyllophorales|T004|NON|EQV|NLM (1999)|990101|abcdef", "ENTRY": "Polyporale", "MN": "B01.300.179.120", "MH_TH": "NLM (2005)", "ST": "T004", "RN": "txid5303", "MS": "An order of fungi in the phylum BASIDIOMYCOTA having macroscopic basidiocarps. The members are characterized by their saprophytic activities as decomposers, particularly in the degradation of CELLULOSE and LIGNIN. A large number of species in the order have been used medicinally. (From Alexopoulos, Introductory Mycology, 4th ed, pp504-68)", "PM": "2005; see APHYLLPHORALES 1999-2004", "HN": "2005 (1999)", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020072"}, {"RECTYPE": "D", "MH": "Gravidity", "AQ": "DE GE IM PH RE", "ENTRY": "Primigravidities", "MN": "N06.850.490.812.250", "FX": "Parity", "MH_TH": "NLM (1999)", "ST": "T081", "AN": "human & animal; do not confuse with PARITY", "PI": "Pregnancy (1966-1998)", "MS": "The number of pregnancies, complete or incomplete, experienced by a female. It is different from PARITY, which is the number of offspring borne. (From Stedman, 26th ed)", "PM": "99", "HN": "99", "MR": "20160617", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020073"}, {"RECTYPE": "D", "MH": "Lentinula", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Lentinus|T004|NON|EQV|NLM (1999)|990101|abcdef", "ENTRY": "Lentinulas", "MN": "B01.300.179.100.515", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid5352", "PI": "Polyporaceae (1985-1998)", "MS": "A genus of fungi of the family Tricholomataceae, order AGARICALES. The commonly known SHIITAKE MUSHROOMS are Lentinula edodes (also seen as Lentinus edodes).", "PM": "2005; see LENTINUS 1999-2004, see POLYPORACEAE 1986-98", "HN": "2005 (1999); use POLYPORACEAE 1986-98", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020074"}, {"RECTYPE": "D", "MH": "Phanerochaete", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Sporotrichum pruinosum|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Phanerochaete chrysosporium|T004|NON|NRW|NLM (1999)|980409|abcdef", "MN": "B01.300.179.120.570", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid5305", "RR": "txid5306", "PI": "Basidiomycota (1978-1998)", "MS": "A genus of fungi in the family Corticiaceae, order Stereales, that degrades lignin. The white-rot fungus Phanerochaete chrysosporium is a frequently used species in research.", "PM": "99", "HN": "99", "MR": "20200527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020075"}, {"RECTYPE": "D", "MH": "Pleurotus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Shimeji Mushrooms|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Shimeji Mushroom", "MN": "B01.300.179.100.650", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid5320", "RR": "txid5322", "PI": "Polyporaceae (1988-1998)", "MS": "A genus of basidiomycetous fungi, family Pleurotaceae, order AGARICALES, that grows on logs or tree stumps in shelflike layers. The species P. ostreatus, the oyster mushroom, is a choice edible species and is the most frequently encountered member of the genus in eastern North America. (Alexopoulos et al., Introductory Mycology, 4th ed, p531)", "PM": "99", "HN": "99", "MR": "20200527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020076"}, {"RECTYPE": "D", "MH": "Endogenous Retroviruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Retroviruses, Endogenous|T005|NON|EQV|NLM (1999)|980413|abcdef", "ENTRY": "Retroviruses, Human Endogenous", "MN": "G05.360.340.024.425.800.175", "FX": "Proviruses", "MH_TH": "NLM (1999)", "ST": "T005", "RR": "txid206037", "PI": "Retroelements (1995-1998)", "MS": "Retroviruses that have integrated into the germline (PROVIRUSES) that have lost infectious capability but retained the capability to transpose.", "PM": "99", "HN": "99", "MR": "20200902", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020077"}, {"RECTYPE": "D", "MH": "Neurogenic Inflammation", "DE": "NEUROGENIC INFLAMM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neurogenic Inflammations", "MN": "C23.550.470.448", "FX": "Neuroimmunomodulation", "MH_TH": "NLM (1999)", "ST": "T037", "PI": "Inflammation (1967-1998)", "MS": "Inflammation caused by an injurious stimulus of peripheral neurons and resulting in release of neuropeptides which affect vascular permeability and help initiate proinflammatory and immune reactions at the site of injury.", "PM": "99", "HN": "99", "MR": "19991103", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020078"}, {"RECTYPE": "D", "MH": "Terminal Repeat Sequences", "DE": "TERMINAL REPEAT SEQ", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "R Repetitive Sequence|T114|NON|NRW|NLM (1999)|980319|R REPET SEQ|abcdefv", "ENTRY": "Terminal Repeats, Long", "MN": "G05.360.080.708.850", "MH_TH": "NLM (1999)", "ST": "T114", "PI": "Repetitive Sequences, Nucleic Acid (1981-1998)", "MS": "Nucleotide sequences repeated on both the 5' and 3' ends of a sequence under consideration. For example, the hallmarks of a transposon are that it is flanked by inverted repeats on each end and the inverted repeats are flanked by direct repeats. The Delta element of Ty retrotransposons and LTRs (long terminal repeats) are examples of this concept.", "PM": "99; for DELTA ELEMENTS see DNA INSERTION ELEMENTS 1988-98; for INVERTED TERMINAL REPEAT see REPETITIVE SEQUENCE, NUCLEIC ACID 1988-98; for LONG TERMINAL REPEAT, TERMINAL REPEAT & R REPETITIVE SEQUENCE see REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98", "HN": "99; for DELTA ELEMENTS use DNA TRANSPOSABLE ELEMENTS 1988-98; for INVERTED TERMINAL REPEAT use REPETITIVE SEQUENCE, NUCLEIC ACID 1988-98; for LONG TERMINAL REPEAT, TERMINAL REPEAT & R REPETITIVE SEQUENCE use REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98", "MR": "20180701", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020079"}, {"RECTYPE": "D", "MH": "Tandem Repeat Sequences", "DE": "TANDEM REPEAT SEQ", "AQ": "DE GE IM PH RE", "ENTRY": "Tandem Repeats, Direct", "MN": "G05.360.340.024.850", "MH_TH": "NLM (1999)", "ST": "T123", "PI": "Repetitive Sequences, Nucleic Acid (1981-1998)", "MS": "Copies of DNA sequences which lie adjacent to each other in the same orientation (direct tandem repeats) or in the opposite direction to each other (INVERTED TANDEM REPEATS).", "PM": "99; for TANDEM REPEAT see REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98", "HN": "99; for TANDEM REPEAT use REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98", "MR": "20080708", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020080"}, {"RECTYPE": "D", "MH": "Phyllachorales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Glomerella|T004|NON|NRW|NLM (1999)|971124|abcdef", "ENTRY": "Phyllachorale", "MN": "B01.300.107.715", "FX": "Colletotrichum", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid5135", "RR": "txid5455", "MS": "An order of fungi in the phylum ASCOMYCOTA characterized by stromatic perithecial forms in most species. Notable genera are Magnaporthe and Glomerella, the latter having the anamorph (mitosporic form) COLLETOTRICHUM.", "PM": "99", "HN": "99", "MR": "20211018", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020081"}, {"RECTYPE": "D", "MH": "Magnaporthe", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Magnaporthes", "MN": "B01.300.107.575", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid148303", "PI": "Ascomycota (1990-1998)", "MS": "A genus of FUNGI, in the family Magnaporthaceae of uncertain position (incertae sedis). It is best known for its species, M. grisea, which is one of the most popular experimental organisms of all fungal plant pathogens. Its anamorph is PYRICULARIA GRISEA.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020082"}, {"RECTYPE": "D", "MH": "Acquired Hyperostosis Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "SAPHO Syndrome|T047|EQV|NLM (1999)|ORD (2010)|980121|abdeef", "ENTRY": "Syndromes, SAPHO", "MN": "C05.116.099.708.025", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Syndrome consisting of SYNOVITIS; ACNE CONGLOBATA; PALMOPLANTAR PUSTULOSIS; HYPEROSTOSIS; and OSTEITIS. The most common site of the disease is the upper anterior chest wall, characterized by predominantly osteosclerotic lesions, hyperostosis, and arthritis of the adjacent joints. The association of sterile inflammatory bone lesions and neutrophilic skin eruptions is indicative of this syndrome.", "PM": "99", "HN": "99", "MR": "20150622", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020083"}, {"RECTYPE": "D", "MH": "Long Interspersed Nucleotide Elements", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Long Interspersed DNA Sequence Elements|T114|T123|EQV|NLM (1999)|971125|abbdef", "ENTRY": "Sequences, LINE Repeat", "MN": "G05.360.340.024.425.800.400", "MH_TH": "NLM (1999)", "ST": "T123", "PI": "Repetitive Sequences, Nucleic Acid (1981-1998)", "MS": "Highly repeated sequences, 6K-8K base pairs in length, which contain RNA polymerase II promoters. They also have an open reading frame that is related to the reverse transcriptase of retroviruses but they do not contain LTRs (long terminal repeats). Copies of the LINE 1 (L1) family form about 15% of the human genome. The jockey elements of Drosophila are LINEs.", "PM": "99", "HN": "99", "MR": "20080708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020084"}, {"RECTYPE": "D", "MH": "Neocallimastigales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Sphaeromonas|T004|NON|NRW|NLM (1999)|971125|abcdef", "ENTRY": "Sphaeromona", "MN": "B01.300.665.600", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid29006", "RR": "txid4823", "MS": "An order of fungi in the phylum NEOCALLIMASTIGOMYCOTA comprising anaerobic chytrids that inhabit the RUMEN; and CECUM of herbivorous animals. Genera (all in the lone family Neocallimastigaceae) include NEOCALLIMASTIX, Orpinomyces, PIROMYCES, Anaeromyces, Cyllamyces, and Caecomyces.", "PM": "2009; see NEOCALLIMASTICALES 1999-2008", "HN": "2009 (1999)", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020085"}, {"RECTYPE": "D", "MH": "Short Interspersed Nucleotide Elements", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Short Interspersed DNA Sequence Elements|T114|T123|EQV|NLM (1999)|971125|abbdef", "MN": "G05.360.340.024.425.800.800", "MH_TH": "NLM (1999)", "ST": "T123", "PI": "Repetitive Sequences, Nucleic Acid (1981-1998)", "MS": "Highly repeated sequences, 100-300 bases long, which contain RNA polymerase III promoters. The primate Alu (ALU ELEMENTS) and the rodent B1 SINEs are derived from 7SL RNA, the RNA component of the signal recognition particle. Most other SINEs are derived from tRNAs including the MIRs (mammalian-wide interspersed repeats).", "PM": "99", "HN": "99", "MR": "20200527", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020086"}, {"RECTYPE": "D", "MH": "Alu Elements", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Alu-Like Repetitive Sequence|T114|T123|REL|NLM (1999)|980319|ALU LIKE REPET SEQ|abbdefv", "ENTRY": "Sequences, Alu Repetitive", "MN": "G05.360.340.024.425.800.800.050", "FX": "Mutagenesis, Insertional", "MH_TH": "NLM (1999)", "ST": "T123", "PI": "Repetitive Sequences, Nucleic Acid (1981-1998)", "MS": "The Alu sequence family (named for the restriction endonuclease cleavage enzyme Alu I) is the most highly repeated interspersed repeat element in humans (over a million copies). It is derived from the 7SL RNA component of the SIGNAL RECOGNITION PARTICLE and contains an RNA polymerase III promoter. Transposition of this element into coding and regulatory regions of genes is responsible for many heritable diseases.", "PM": "99; see REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98; for ALU REPETITIVE SEQUENCE, ALU FAMILY, and ALU-LIKE REPETITIVE SEQUENCE see REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98", "HN": "99; use REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98; for ALU REPETITIVE SEQUENCE, ALU FAMILY, and ALU-LIKE REPETITIVE SEQUENCE use REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98", "MR": "20080708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020087"}, {"RECTYPE": "D", "MH": "Neocallimastix", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Neocallimastices", "MN": "B01.300.665.600.600", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid4756", "PI": "Fungi (1975-1998)", "MS": "A genus of fungi in the family Neocallimasticaceae, order NEOCALLIMASTIGALES. They contain polyflagellate zoospores and grow on a range of simple and complex carbohydrates in the rumen of sheep and cattle.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020088"}, {"RECTYPE": "D", "MH": "Piromyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Piromonas|T004|NON|EQV|NLM (1999)|971125|abcdef", "ENTRY": "Piromyce", "MN": "B01.300.665.600.675", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid4821", "PI": "Fungi (1992-1998)", "MS": "A genus of fungi in the family Neocallimasticaceae, order NEOCALLIMASTICALES, containing uniflagellate zoospores.", "PM": "1999; for PIROMONAS see NEOCALLIMASTICALES 1999-2004", "HN": "1999; for PIROMONAS use NEOCALLIMASTICALES 1999-2004", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020089"}, {"RECTYPE": "D", "MH": "Chromosome Segregation", "AQ": "DE GE IM PH RE", "ENTRY": "Segregations, Chromosome", "MN": "G05.113.220.625", "MH_TH": "NLM (1999)", "ST": "T045", "MS": "The orderly segregation of CHROMOSOMES during MEIOSIS or MITOSIS.", "PM": "99", "HN": "99", "MR": "20160115", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020090"}, {"RECTYPE": "D", "MH": "Entomophthorales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Zoophthora|T004|NON|NRW|NLM (1999)|971126|abcdef", "ENTRY": "Zoophthoras", "MN": "B01.300.300.300", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid4857", "RR": "txid4859", "AN": "infection: coord IM with ZYGOMYCOSIS (IM)", "PI": "Zygomycota (1976-1998)", "MS": "An order of fungi comprising mostly insect pathogens, though some infect mammals including humans. Strict host specificity make these fungi a focus of many biological control studies.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020091"}, {"RECTYPE": "D", "MH": "Conidiobolus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.300.300.150", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid34487", "AN": "infection: coord IM with ZYGOMYCOSIS (IM)", "PI": "Zygomycota (1976-1998)", "MS": "A genus of fungi in the family Ancylistaceae, order ENTOMOPHTHORALES, characterized by the presence of small nuclei with a prominent central nucleolus in interphase. They are commonly found in the soil but also infect termites, aphids, and sometimes, though rarely, mammals including humans. (Alexopoulos et al, Introductory Mycology, 4th ed, pp159-60)", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020092"}, {"RECTYPE": "D", "MH": "Cunninghamella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Cunninghamellas", "MN": "B01.300.300.500.150", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid4852", "AN": "infection: coordinate IM with MUCORMYCOSIS (IM)", "MS": "A genus of zygomycetous fungi of the family Cunninghamellaceae, order MUCORALES. Some species cause systemic infections in humans.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020093"}, {"RECTYPE": "D", "MH": "Mortierella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Mortierellas", "MN": "B01.300.300.500.480", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid4855", "AN": "infection: coord IM with MUCORMYCOSIS (IM)", "PI": "Mucorales (1973-1998)", "MS": "A genus of zygomycetous fungi of the family Mortierellaceae, order MUCORALES. Its species are abundant in soil and can cause rare infections in humans and animals. Mortierella alpinais is used for production of arachidonic acid.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020094"}, {"RECTYPE": "D", "MH": "Absidia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Absidias", "MN": "B01.300.300.500.030", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid4828", "AN": "infection: coord IM with MUCORMYCOSIS (IM)", "PI": "Mucorales (1975-1998)", "MS": "A genus of zygomycetous fungi, family Mucoraceae, order MUCORALES, which sometimes causes infection in humans.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020095"}, {"RECTYPE": "D", "MH": "Zygomycosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Phycomycosis|T047|NON|REL|NLM (1999)|971128|abcdef", "ENTRY": "Zygomycoses", "MN": "C01.150.703.980", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "fungus dis caused by various Zygomycetes; for dis caused by Mucorales, MUCORMYCOSIS is available", "PI": "Mycoses (1976-1991)", "MS": "Infection in humans and animals caused by fungi in the class Zygomycetes. It includes MUCORMYCOSIS and entomophthoramycosis. The latter is a tropical infection of subcutaneous tissue or paranasal sinuses caused by fungi in the order Entomophthorales. Phycomycosis, closely related to zygomycosis, describes infection with members of Phycomycetes, an obsolete classification.", "PM": "99; see MUCORMYCOSIS 1989-98", "HN": "99; use MUCORMYCOSIS 1989-98", "MR": "20190617", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020096"}, {"RECTYPE": "D", "MH": "Natriuretic Peptide, Brain", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nesiritide|T116|T123|NON|EQV|NLM (2004)|020813|abbcdef", "ENTRY": "Ventricular Natriuretic Peptide, B type", "MN": "D12.776.631.590", "PA": "Natriuretic Agents", "MH_TH": "NLM (1999)", "ST": "T123", "N1": "Natriuretic factor, brain", "RN": "114471-18-0", "PI": "Nerve Tissue Proteins (1988-1998)", "MS": "A PEPTIDE that is secreted by the BRAIN and the HEART ATRIA, stored mainly in cardiac ventricular MYOCARDIUM. It can cause NATRIURESIS; DIURESIS; VASODILATION; and inhibits secretion of RENIN and ALDOSTERONE. It improves heart function. It contains 32 AMINO ACIDS.", "PM": "1999; BRAIN NATRIURETIC PEPTIDE was indexed under NERVE TISSUE PROTEINS 1988-1998; NATRIURETIC PEPTIDE TYPE-B was indexed under ATRIAL NATRIURETIC FACTOR 1994-2003; NESIRITIDE was indexed under NATRIURETIC HORMONE 2003; VENTRICULAR NATRIURETIC PEPTIDE, B-TYPE was indexed under ATRIAL NATRIURETIC FACTOR 1994-2003.", "HN": "1999, use BRAIN NATRIURETIC PEPTIDE (NM) 1988-1998; use NATRIURETIC PEPTIDE, BRAIN (NM) for NATRIURETIC PEPTIDE TYPE-B 1994-2003; use NATRIURETIC PEPTIDE, BRAIN (NM) for NESIRITIDE 2003; for VENTRICULAR NATRIURETIC PEPTIDE, B-TYPE use NATRIURETIC PEPTIDE, BRAIN (NM) 1994-2003.", "MR": "20151124", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020097"}, {"RECTYPE": "D", "MH": "Natriuretic Peptide, C-Type", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "C-Type Natriuretic Peptide|T116|T123|NON|EQV|NLM (1999)|971201|abbcdef", "ENTRY": "Peptide-53, C-Type Natriuretic", "MN": "D12.644.548.585.750", "PA": "Natriuretic Agents", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "127869-51-6", "PI": "Proteins (1995-1998)", "MS": "A PEPTIDE of 22 amino acids, derived mainly from cells of VASCULAR ENDOTHELIUM. It is also found in the BRAIN, major endocrine glands, and other tissues. It shares structural homology with ATRIAL NATRIURETIC FACTOR. It has vasorelaxant activity thus is important in the regulation of vascular tone and blood flow. Several high molecular weight forms containing the 22 amino acids have been identified.", "PM": "99; C-TYPE NATRIURETIC PEPTIDE was indexed under PROTEINS 1995-98 & NERVE TISSUE PROTEINS 1990-94", "HN": "99; use C-TYPE NATRIURETIC PEPTIDE (NM) 1990-98", "MR": "20060705", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020098"}, {"RECTYPE": "D", "MH": "Coated Materials, Biocompatible", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Surface Coated Materials", "MN": "J01.637.051.130.420", "MH_TH": "NLM (1999)", "ST": "T122", "RN": "0", "AN": "coord with specific coating material", "PI": "Biocompatible Materials (1967-1998)", "MS": "Biocompatible materials usually used in dental and bone implants that enhance biologic fixation, thereby increasing the bond strength between the coated material and bone, and minimize possible biological effects that may result from the implant itself.", "PM": "99", "HN": "99", "MR": "20060705", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020099"}, {"RECTYPE": "D", "MH": "Hydrogels", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Patterned Hydrogels|T122|NON|NRW|NLM (2020)|190220|abcdef", "ENTRY": "Hydrogel, Patterned", "MN": "D26.255.165.320.375", "MH_TH": "NLM (1999)", "ST": "T122", "RN": "0", "AN": "HYDROGEL, POLYETHYLENE GLYCOL DIMETHACRYLATE is also available", "PI": "Biocompatible Materials (1975-1998)", "MS": "Water swollen, rigid, 3-dimensional network of cross-linked, hydrophilic macromolecules, 20-95% water. They are used in paints, printing inks, foodstuffs, pharmaceuticals, and cosmetics. (Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "99", "HN": "99", "MR": "20190429", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020100"}, {"RECTYPE": "D", "MH": "Acrosome Reaction", "AQ": "DE GE IM PH RE", "ENTRY": "Reactions, Acrosome", "MN": "G08.686.784.277.800.100", "FX": "Acrosome", "MH_TH": "NLM (1999)", "ST": "T043", "PI": "Spermatozoa (1966-1974)", "MS": "Changes that occur to liberate the enzymes of the ACROSOME of a sperm (SPERMATOZOA). Acrosome reaction allows the sperm to penetrate the ZONA PELLUCIDA and enter the OVUM during FERTILIZATION.", "PM": "99", "HN": "99", "MR": "20160602", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020101"}, {"RECTYPE": "D", "MH": "Mycobacterium smegmatis", "DE": "MYCOBACT SMEGMATIS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.552.552.720.662", "MH_TH": "NLM (1999)", "ST": "T007", "RN": "txid1772", "AN": "infection: coordinate with MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS", "PI": "Mycobacterium (1966-1998)", "MS": "A rapid-growing, nonphotochromogenic species of MYCOBACTERIUM originally isolated from human smegma and found also in soil and water. (From Dorland, 28th ed)", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020102"}, {"RECTYPE": "D", "MH": "Rhizomucor", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Rhizomucors", "MN": "B01.300.300.500.795", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid4838", "AN": "infection: coord IM with MUCORMYCOSIS (IM)", "PI": "Mucorales (1983-1998)", "MS": "A genus of zygomycetous fungi of the family Mucoraceae, order MUCORALES.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020103"}, {"RECTYPE": "D", "MH": "Immunophilins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Immunophilin|T116|T126|T192|NON|EQV|NLM (2021)|200311|abbbcdef", "ENTRY": "Neurophilins|T116|T192|NON|REL|NLM (2004)|021105|abbcdef", "MN": "D12.776.827.344", "MH_TH": "NLM (1999)", "ST": "T192", "RN": "EC 5.2.1.8", "RR": "EC 5.2.1.8", "AN": "don't confuse entry term NEUROPHILINS with NEUROPILINS", "PI": "Immunosuppressive Agents (1990-1998)", "MS": "Members of a family of highly conserved proteins which are all cis-trans peptidyl-prolyl isomerases (PEPTIDYLPROLYL ISOMERASE). They bind the immunosuppressant drugs CYCLOSPORINE; TACROLIMUS and SIROLIMUS. They possess rotamase activity, which is inhibited by the immunosuppressant drugs that bind to them.", "PM": "2004; NEUROPHILIN was indexed under LYMPHOKINES 1974-2003; ENDOTHELIAL GROWTH FACTORS 1991-2003 & INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2002", "HN": "2004(1999); for NEUROPHILIN use VASCULAR ENDOTHELIAL GROWTH FACTOR (NM) 1997-2003", "MR": "20230526", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020104"}, {"RECTYPE": "D", "MH": "Milrinone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Win47203", "MN": "D03.383.725.050.085.543", "PA": "Vasodilator Agents", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "(3,4'-Bipyridine)-5-carbonitrile, 6-dihydro-2-methyl-6-oxo-", "RN": "JU9YAX04C7", "RR": "9K8XR81MO8", "PI": "Pyridones (1983-1998)", "MS": "A positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase type 3 activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the inotropic potency of amrinone.", "PM": "99; MILRINONE was indexed under PYRIDONES 1983-98", "HN": "99; use MILRINONE (NM) 1983-98", "MR": "20170524", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020105"}, {"RECTYPE": "D", "MH": "Acrylamide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.241.081.069.094.015", "EC": "analogs & derivatives:Acrylamides", "MH_TH": "NLM (1999)", "ST": "T131", "RN": "20R035KLCI", "RR": "79-06-1 (Acrylamide)", "AN": "ACRYLAMIDES is also available", "PI": "Acrylamides (1982-1998)", "MS": "A colorless, odorless, highly water soluble vinyl monomer formed from the hydration of acrylonitrile. It is primarily used in research laboratories for electrophoresis, chromatography, and electron microscopy and in the sewage and wastewater treatment industries.", "PM": "99; ACRYLAMIDE was indexed under ACRYLAMIDES 1982-98", "HN": "99; use ACRYLAMIDE (NM) 1982-98", "MR": "20130708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020106"}, {"RECTYPE": "D", "MH": "Troponin T", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Troponin-T|T116|T123|NON|EQV|NLM (1999)|971203|abbcdef", "MN": "D12.776.220.525.825.962", "FX": "Cardiomyopathy, Hypertrophic, Familial", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "0", "AN": "TROPONIN C & TROPONIN I are also available", "PI": "Troponin (1981-1998)", "MS": "A TROPONIN complex subunit that binds to TROPOMYOSIN. There are three troponin T subtypes: troponin T1, T2 and T3. Troponin T2 is cardiac-specific whereas troponin T2 and T3 are skeletal subtypes. Troponin T2 is a BIOMARKER for damaged or injured CARDIAC MYOCYTES and mutations in troponin T2 gene are associated with FAMILIAL HYPERTROPHIC CARDIOMYOPATHY.", "PM": "99; TROPONIN T was indexed under TROPONIN 1981-98", "HN": "99; use TROPONIN T (NM) 1981-98", "MR": "20160701", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020107"}, {"RECTYPE": "D", "MH": "Nicorandil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "2-Nicotinamidoethyl Nitrate|T109|T121|NON|EQV|NLM (1999)|971204|NICOTINAMIDOETHYL NITRATE 02|abbcdefs", "ENTRY": "SG75", "MN": "D03.383.725.547.530.498", "PA": "Vitamin B Complex", "MH_TH": "USAN (1981)", "ST": "T121", "N1": "3-Pyridinecarboxamide, N-(2-(Nitroxy)ethyl)-", "RN": "260456HAM0", "RR": "65141-46-0 (Nicorandil)", "PI": "Nitrates (1978-1982)", "MS": "A derivative of the NIACINAMIDE that is structurally combined with an organic nitrate. It is a potassium-channel opener that causes vasodilatation of arterioles and large coronary arteries. Its nitrate-like properties produce venous vasodilation through stimulation of guanylate cyclase.", "PM": "99; NICORANDIL was indexed under NIACINAMIDE 1983-98 & NITRATES 1978-82", "HN": "99; use NICORANDIL (NM) 1978-98", "MR": "20170524", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020108"}, {"RECTYPE": "D", "MH": "Devazepide", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MK329", "MN": "D03.633.100.079.080.070.200", "PA": "Hormone Antagonists", "MH_TH": "USAN (1989)", "ST": "T121", "N1": "1H-Indole-2-carboxamide, N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-, (S)-", "RN": "JE6P7QY7NH", "RR": "103420-77-5 (Devazepide)", "PI": "Benzodiazepinones (1986-1998)", "MS": "A derivative of benzodiazepine that acts on the cholecystokinin A (CCKA) receptor to antagonize CCK-8's (SINCALIDE) physiological and behavioral effects, such as pancreatic stimulation and inhibition of feeding.", "PM": "99; DEVAZEPIDE was indexed under BENZODIAZEPINONES 1986-98", "HN": "99; use DEVAZEPIDE (NM) 1986-98", "MR": "20160528", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020109"}, {"RECTYPE": "D", "MH": "Pinacidil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Anhydrous, Pinacidil", "MN": "D02.078.370.729", "PA": "Vasodilator Agents", "MH_TH": "USAN (1984)", "ST": "T121", "N1": "Guanidine, N''-cyano-N-4-pyridinyl-N'-(1,2,2-trimethylpropylmonohydrate), (+-)-", "RN": "7B0ZZH8P2W", "RR": "85371-64-8 (Pinacidil)", "PI": "Pyridines (1980-1982)", "MS": "A guanidine that opens POTASSIUM CHANNELS producing direct peripheral vasodilatation of the ARTERIOLES. It reduces BLOOD PRESSURE and peripheral resistance and produces fluid retention. (Martindale The Extra Pharmacopoeia, 31st ed)", "PM": "99; PINACIDIL was indexed under GUANIDINES 1983-98 & PYRIDINES 1980-82", "HN": "99; use PINACIDIL (NM) 1980-98", "MR": "20130708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020110"}, {"RECTYPE": "D", "MH": "Chlorodiphenyl (54% Chlorine)", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Aroclor-1254|T109|T131|TRD|NRW|NLM (1999)|971205|abbcdef", "MN": "D02.455.526.439.785.292.077", "PA": "Antithyroid Agents", "EC": "analogs & derivatives:Aroclors", "MH_TH": "NLM (2009)", "ST": "T131", "RN": "11097-69-1", "AN": "AROCLORS is also available", "PI": "Aroclors (1980-1998)", "MS": "A mixture of polychlorinated biphenyls that induces hepatic microsomal UDP-glucuronyl transferase activity towards thyroxine.", "PM": "2009; AROCLOR 1254 was indexed under AROCLORS 1980-1998", "HN": "2009(1980)", "MR": "20160701", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020111"}, {"RECTYPE": "D", "MH": "Rhodamine 123", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.953.600.500", "PA": "Fluorescent Dyes", "FX": "ATP Binding Cassette Transporter, Subfamily B, Member 1", "MH_TH": "NLM (1999)", "ST": "T130", "N1": "Xanthylium, 3,6-diamino-9-(2-(methoxycarbonyl)phenyl)-, chloride", "RN": "1N3CZ14C5O", "RR": "62669-70-9 (Rhodamine 123)", "PI": "Rhodamines (1982-1998)", "MS": "A fluorescent probe with low toxicity which is a potent substrate for ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 and the bacterial multidrug efflux transporter. It is used to assess mitochondrial bioenergetics in living cells and to measure the efflux activity of ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 in both normal and malignant cells. (Leukemia 1997;11(7):1124-30)", "PM": "99; RHODAMINE 123 was indexed under RHODAMINES 1982-98", "HN": "99; use RHODAMINE 123 (NM) 1982-98", "MR": "20180713", "DA": "19980720", "DC": "1", "DX": "19990101", "UI": "D020112"}, {"RECTYPE": "D", "MH": "Phenolphthalein", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Thalinol|T109|T121|TRD|NRW|US|041021|abbcdef", "MN": "D02.455.426.559.389.657.625.555", "PA": "Indicators and Reagents", "EC": "analogs & derivatives:Phenolphthaleins", "MH_TH": "USP (19XX)", "ST": "T130", "N1": "1(3H)-Isobenzofuranone, 3,3-bis(4-hydroxyphenyl)-", "RN": "6QK969R2IF", "RR": "77-09-8 (Phenolphthalein)", "AN": "PHENOLPHTHALEINS is also available", "PI": "Phenolphthaleins (1983-1998)", "MS": "An acid-base indicator which is colorless in acid solution, but turns pink to red as the solution becomes alkaline. It is used medicinally as a cathartic.", "PM": "99; PHENOLPHTHALEIN was indexed under PHENOLPHTHALEINS 1983-98", "HN": "99; use PHENOLPHTHALEIN (NM) 1983-98", "MR": "20160701", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020113"}, {"RECTYPE": "D", "MH": "Rickettsia conorii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.875.650.650.180", "MH_TH": "NLM (1999)", "ST": "T007", "RN": "txid781", "PI": "Rickettsia (1976-1998)", "MS": "A species of gram-negative, aerobic bacteria that is the etiologic agent of BOUTONNEUSE FEVER. It resembles RICKETTSIA RICKETTSII but is antigenically distinct and less virulent for animals and man. (From Bergey's Manual of Systematic Bacteriology, vol 1)", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020114"}, {"RECTYPE": "D", "MH": "Pepsinogen C", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Progastricsin|T116|T123|NON|EQV|NLM (1999)|971208|abbcdef", "MN": "D12.776.811.243.509.725", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "61536-72-9", "PI": "Pepsinogens (1972-1998)", "MS": "This is one of the 2 related pepsinogen systems in humans. It is found in prostate and seminal fluid whereas PEPSINOGEN A is not.", "PM": "99", "HN": "99; use PEPSINOGENS 1987-98", "MR": "20190530", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020115"}, {"RECTYPE": "D", "MH": "Pepsinogen A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Uropepsinogen|T116|T123|NON|EQV|NLM (1999)|971208|abbcdef", "MN": "D12.776.811.243.509.700", "MH_TH": "NLM (1999)", "ST": "T123", "N1": "Pepsinogen A", "RN": "9001-10-9", "PI": "Pepsinogens (1980-1998)", "MS": "This is one of 2 related pepsinogen systems in humans and is also known as pepsinogen. (The other is PEPSINOGEN C.) This includes isozymogens Pg1-Pg5 (pepsinogens 1-5, group I or products of PGA1-PGA5 genes). This is the main pepsinogen found in urine.", "PM": "99; for PEPSINOGEN see PEPSINOGEN 1972-98; UROPEPSINOGEN was indexed under PEPSINOGEN 1978-98", "HN": "99; for PEPSINOGEN use PEPSINOGENS 1972-98; for UROPEPSINOGEN use PEPSINOGEN A (NM) 1978-98", "MR": "20190530", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020116"}, {"RECTYPE": "D", "MH": "Cisapride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "R51619", "MN": "D03.383.621.135", "PA": "Serotonin Receptor Agonists", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Benzamide, 4-amino-5-chloro-N-(1-(3-(4-fluorophenoxy)propyl)-3-methoxy -4-piperidinyl)-2-methoxy-, cis-", "RN": "UVL329170W", "RR": "81098-60-4 (Cisapride)", "PI": "Piperidines (1984-1998)", "MS": "A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)", "PM": "99; CISAPRIDE was indexed under PIPERIDINES 1984-98", "HN": "99; use CISAPRIDE (NM) 1984-98", "MR": "20180705", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020117"}, {"RECTYPE": "D", "MH": "Cupriavidus necator", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Wautersia eutropha|T007|NON|EQV|NLM (2006)|040817|abcdef", "ENTRY": "Alcaligenes eutropha|T007|NON|EQV|NLM (1999)|980130|abcdef", "MN": "B03.660.075.090.688.200.200", "MH_TH": "NLM (2007)", "ST": "T007", "RN": "txid106590", "PI": "Alcaligenes (1995-1998)", "MS": "A gram-negative, facultatively chemoautotrophic bacterium, formerly called Wautersia eutropha, found in water and soil.", "PM": "2007; see Wautersia eutropha 2006, see RALSTONIA EUTROPHA 1999-2005", "HN": "2007 (1999)", "MR": "20200813", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020118"}, {"RECTYPE": "D", "MH": "Iodocyanopindolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "ICYP|T109|T130|ABB|EQV|NLM (1999)|971209|abbcdef", "ENTRY": "I Cyanopindolol", "MN": "D02.092.063.624.698.699.420", "PA": "Adrenergic beta-Antagonists", "MH_TH": "NLM (1999)", "ST": "T130", "N1": "1H-Indole-2-carbonitrile, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-3-iodo-", "RN": "83498-72-0", "PI": "Pindolol/analogs & derivatives (1981-1998)", "MS": "A highly selective and specific beta antagonist that is used to characterize beta-adrenoceptors.", "PM": "99; IODOCYANOPINDOLOL was indexed under PINDOLOL/analogs & derivatives 1981-98", "HN": "99; use IODOCYANOPINDOLOL (NM) 1981-98", "MR": "20130708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020120"}, {"RECTYPE": "D", "MH": "5' Untranslated Regions", "DS": "UNTRANSLATED REGIONS 005", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "mRNA Leader Sequences|T114|T123|EQV|NLM (1999)|980410|MRNA LEADER SEQ|abbdefv", "ENTRY": "mRNA Sequences, Leader", "MN": "G05.360.340.024.340.137.910.885", "FX": "5' Flanking Region", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "0", "AN": "do not confuse with RNA, SPLICED LEADER; do not confuse with 5' FLANKING REGION", "PI": "RNA, Messenger (1975-1998)", "MS": "The sequence at the 5' end of the messenger RNA that does not code for product. This sequence contains the ribosome binding site and other transcription and translation regulating sequences.", "PM": "99", "HN": "99", "MR": "20090706", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020121"}, {"RECTYPE": "D", "MH": "tert-Butylhydroperoxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "tert-Butyl Hydroperoxide|T109|T130|NON|EQV|FDA SRS (2014)|NLM (1999)|971210|abbcdeef", "ENTRY": "tertiary Butylhydroperoxide", "MN": "D02.389.593.374.925", "MH_TH": "NLM (1999)", "ST": "T130", "N1": "Hydroperoxide, 1,1-dimethylethyl", "RN": "955VYL842B", "RR": "75-91-2 (tert-Butylhydroperoxide)", "PI": "Peroxides (1976-1998)", "MS": "A direct-acting oxidative stress-inducing agent used to examine the effects of oxidant stress on Ca(2+)-dependent signal transduction in vascular endothelial cells. It is also used as a catalyst in polymerization reactions and to introduce peroxy groups into organic molecules.", "PM": "99; TERT-BUTYLHYDROPEROXIDE was indexed under PEROXIDES 1976-98", "HN": "99; use TERT-BUTYLHYDROPEROXIDE (NM) 1980-98", "MR": "20230226", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020122"}, {"RECTYPE": "D", "MH": "Sirolimus", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rapamycin|T109|T195|NON|EQV|FDA SRS (2014)|NLM (1999)|971210|abbcdeef", "ENTRY": "I2190A", "MN": "D02.540.505.760", "PA": "Immunosuppressive Agents", "MH_TH": "USAN (19XX)", "ST": "T195", "RN": "W36ZG6FT64", "RR": "53123-88-9 (Sirolimus)", "PI": "Polyenes (1976-1998)", "MS": "A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.", "PM": "99; RAPAMYCIN (now SIROLIMUS) was indexed under POLYENES 1976-98", "HN": "99; use SIROLIMUS (NM) 1980-97", "MR": "20160701", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020123"}, {"RECTYPE": "D", "MH": "Thermotoga maritima", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.748.500", "MH_TH": "NLM (1999)", "ST": "T007", "RN": "txid2336", "PI": "Gram-Negative Anaerobic Bacteria (1988-1998)", "MS": "A rod-shaped bacterium surrounded by a sheath-like structure which protrudes balloon-like beyond the ends of the cell. It is thermophilic, with growth occurring at temperatures as high as 90 degrees C. It is isolated from geothermally heated marine sediments or hot springs. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020124"}, {"RECTYPE": "D", "MH": "Mutation, Missense", "AQ": "DE ES GE IM PH RE", "ENTRY": "Mutations, Missense", "MN": "G05.365.590.650", "FX": "Point Mutation", "MH_TH": "NLM (1999)", "ST": "T045", "PI": "Amino Acid Sequence (1966-1998)", "MS": "A mutation in which a codon is mutated to one directing the incorporation of a different amino acid. This substitution may result in an inactive or unstable product. (From A Dictionary of Genetics, King & Stansfield, 5th ed)", "PM": "99", "HN": "99", "MR": "20080708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020125"}, {"RECTYPE": "D", "MH": "Brefeldin A", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NSC89671", "MN": "D02.540.576.500.875", "PA": "Protein Synthesis Inhibitors", "MH_TH": "NLM (1999)", "ST": "T195", "N1": "4H-Cyclopent(f)oxacyclotridecin-4-one,1,6,7,8,9,11a-beta,12,13,14,14a-alpha-decahydro-1-beta-13-alpha-dihydroxy-6-beta-methyl-", "RN": "20350-15-6", "PI": "Cyclopentanes (1974-1998)", "MS": "A fungal metabolite which is a macrocyclic lactone exhibiting a wide range of antibiotic activity.", "PM": "99; BREFELDIN A was indexed under CYCLOPENTANES 1974-98", "HN": "99; use BREFELDIN A (NM) 1980-98", "MR": "20150622", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020126"}, {"RECTYPE": "D", "MH": "Recovery of Function", "AQ": "DE ES GE IM PH RE", "ENTRY": "Function Recovery", "MN": "G16.757", "FX": "Remission, Spontaneous", "MH_TH": "NLM (1999)", "ST": "T184", "MS": "A partial or complete return to the normal or proper physiologic activity of an organ or part following disease or trauma.", "PM": "99", "HN": "99", "MR": "20160531", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020127"}, {"RECTYPE": "D", "MH": "Inhibitory Concentration 50", "DS": "INHIBITORY CONCENTRATION 050", "PRINT ENTRY": "IC50|T081|ABB|EQV|NLM (1999)|971215|IC 050|abcdefs", "ENTRY": "Concentration 50, Inhibitory", "MN": "G07.690.936.563", "FX": "Microbial Sensitivity Tests", "MH_TH": "NLM (1999)", "ST": "T081", "AN": "do not confuse with LETHAL DOSE 50, determined in animals", "PI": "Cell Survival/drug effects (1971-1998)", "MS": "The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture.", "PM": "99", "HN": "99", "MR": "20160628", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020128"}, {"RECTYPE": "D", "MH": "Bacterial Chromatophores", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Chromatophores, Bacterial|T026|NON|EQV|NLM (1999)|980618|abcdef", "ENTRY": "Chromatophore, Bacterial", "MN": "A20.374", "MH_TH": "NLM (1999)", "ST": "T026", "MS": "Organelles of phototrophic bacteria which contain photosynthetic pigments and which are formed from an invagination of the cytoplasmic membrane.", "PM": "1999; see PHOTOTROPHIC BACTERIA or specifics & CHROMATOPHORES 1966-1998", "HN": "1999(1966)", "MR": "20090706", "DA": "19980618", "DC": "1", "DX": "19990101", "UI": "D020130"}, {"RECTYPE": "D", "MH": "Genes, Duplicate", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Duplicate Genes|T028|NON|EQV|NLM (1999)|971215|abcdef", "ENTRY": "Gene, Duplicate", "MN": "G05.360.340.024.340.250", "FX": "Multigene Family", "MH_TH": "NLM (1999)", "ST": "T028", "AN": "coord with specific gene or gene product; do not confuse with GENE DUPLICATION", "MS": "Two identical genes showing the same phenotypic action but localized in different regions of a chromosome or on different chromosomes. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)", "PM": "99", "HN": "99", "MR": "20080708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020131"}, {"RECTYPE": "D", "MH": "Anticipation, Genetic", "DE": "ANTICIPATION GENET", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Genetic Anticipation|T032|NON|EQV|NLM (1999)|980130|GENET ANTICIPATION|abcdefv", "MN": "G05.420.040", "FX": "Trinucleotide Repeat Expansion", "MH_TH": "NLM (1999)", "ST": "T032", "MS": "The apparent tendency of certain diseases to appear at earlier AGE OF ONSET and with increasing severity in successive generations. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)", "PM": "99", "HN": "99", "MR": "20160701", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020132"}, {"RECTYPE": "D", "MH": "Reverse Transcriptase Polymerase Chain Reaction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Polymerase Chain Reaction, Reverse Transcriptase|T063|NON|EQV|NLM (1999)|980130|abcdef", "ENTRY": "Transcriptase PCR, Reverse", "MN": "E05.393.620.500.725", "FX": "RNA-Directed DNA Polymerase", "MH_TH": "NLM (1999)", "ST": "T063", "AN": "RT-PCR in the literature probably goes here not under REAL-TIME POLYMERASE CHAIN REACTION; check text", "PI": "RNA-Directed DNA Polymerase (1991-1998)", "MS": "A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.", "PM": "99", "HN": "99", "MR": "20110624", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020133"}, {"RECTYPE": "D", "MH": "Catalytic Domain", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Reactive Site|T082|T169|NON|NRW|UNK (19XX)|740329|abbcdef", "ENTRY": "Subunits, Catalytic", "MN": "G02.111.570.820.709.275.750.188", "MH_TH": "NLM (1999)", "ST": "T087", "PI": "Amino Acid Sequence (1975-1998)", "MS": "The region of an enzyme that interacts with its substrate to cause the enzymatic reaction.", "PM": "1999; for ACTIVE SITE or REACTIVE SITE see BINDING SITE 1975-2008", "HN": "1999; for ACTIVE SITE or REACTIVE SITE use BINDING SITE 1975-2008", "MR": "20160527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020134"}, {"RECTYPE": "D", "MH": "Peptide Nucleic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Nucleic Acid|T114|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Nucleic Acids, Peptide", "MN": "D13.695.578.424.550", "MH_TH": "NLM (1999)", "ST": "T114", "RN": "0", "PI": "Peptides (1993-1998)", "MS": "DNA analogs containing neutral amide backbone linkages composed of aminoethyl glycine units instead of the usual phosphodiester linkage of deoxyribose groups. Peptide nucleic acids have high biological stability and higher affinity for complementary DNA or RNA sequences than analogous DNA oligomers.", "PM": "99", "HN": "99", "MR": "20200527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020135"}, {"RECTYPE": "D", "MH": "Hydrogel, Polyethylene Glycol Dimethacrylate", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "PEGDMA Hydrogels", "MN": "J01.637.051.720.741.485", "EC": "analogs & derivatives:Hydrogels", "MH_TH": "NLM (2018)", "ST": "T122", "N1": "Poly(oxy-1,2-ethanediyl),alpha-(2-methyl-1-oxo-2-propenyl)-omega-((2-methyl-1-oxo-2 propenyl)oxy)-", "RN": "25852-47-5", "PI": "Polyethylene Glycols (1981-1998)", "MS": "A network of cross-linked hydrophilic macromolecules used in biomedical applications fabricated by photopolymerization of polyethylene glycol dimethacrylate. Its general formulae is C3H5C(O)(OCH2CH2)nOC(O)C3H5 where n denotes a number of average polyglycol (OCH2CH2) repeats.", "PM": "2018; was HYDROGEL 1998-2017; see under HYDROGEL (NM) 1981-1997", "HN": "2018(1998); was HYDROGEL 1998-2017; use under HYDROGEL (NM) 1981-1997", "MR": "20190625", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020136"}, {"RECTYPE": "D", "MH": "Base Pair Mismatch", "AQ": "DE ES GE IM PH RE", "ENTRY": "Mismatches, Base Pair", "MN": "G05.365.590.060", "FX": "Nucleic Acid Heteroduplexes", "MH_TH": "NLM (1999)", "ST": "T049", "MS": "The presence of an uncomplimentary base in double-stranded DNA caused by spontaneous deamination of cytosine or adenine, mismatching during homologous recombination, or errors in DNA replication. Multiple, sequential base pair mismatches lead to formation of heteroduplex DNA; (NUCLEIC ACID HETERODUPLEXES).", "PM": "99", "HN": "99", "MR": "20230526", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020137"}, {"RECTYPE": "D", "MH": "Hyperhomocysteinemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperhomocysteinemias", "MN": "C18.654.521.500.133.699.418", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Homocysteine/blood (1991-1998)", "MS": "Condition in which the plasma levels of homocysteine and related metabolites are elevated (>13.9 \u03bcmol/l). Hyperhomocysteinemia can be familial or acquired. Development of the acquired hyperhomocysteinemia is mostly associated with vitamins B and/or folate deficiency (e.g., PERNICIOUS ANEMIA, vitamin malabsorption). Familial hyperhomocysteinemia often results in a more severe elevation of total homocysteine and excretion into the urine, resulting in HOMOCYSTINURIA. Hyperhomocysteinemia is a risk factor for cardiovascular and neurodegenerative diseases, osteoporotic fractures and complications during pregnancy.", "PM": "1999", "HN": "1999", "MR": "20090706", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020138"}, {"RECTYPE": "D", "MH": "Gastroschisis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Gastroschises", "MN": "C23.300.707.374.500", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with HERNIA, UMBILICAL", "PI": "Abdominal Muscles/abnormalities (1966-1998)", "MS": "A congenital defect with major fissure in the ABDOMINAL WALL lateral to, but not at, the UMBILICUS. This results in the extrusion of VISCERA. Unlike OMPHALOCELE, herniated structures in gastroschisis are not covered by a sac or PERITONEUM.", "PM": "1999", "HN": "1999", "MR": "20120703", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020139"}, {"RECTYPE": "D", "MH": "Lysosomal Storage Diseases, Nervous System", "DE": "LYSOSOMAL STORAGE DIS NERVOUS SYSTEM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nervous System Lysosomal Storage Diseases|T047|NON|EQV|NLM (2000)|991012|NERVOUS SYSTEM LYSOSOMAL STORAGE DIS|abcdefv", "ENTRY": "Nervous System Lysosomal Enzyme Disorders|T047|NON|EQV|NLM (2000)|991012|NERVOUS SYSTEM LYSOSOMAL ENZYME DIS|abcdefv", "MN": "C18.452.648.595.554", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Sphingolipidoses (1974-1999)", "MS": "A group of enzymatic disorders affecting the nervous system and to a variable degree the skeletal system, lymphoreticular system, and other organs. The conditions are marked by an abnormal accumulation of catabolic material within lysosomes.", "PM": "2000", "HN": "2000", "MR": "20060705", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020140"}, {"RECTYPE": "D", "MH": "Hemostatic Disorders", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vascular Hemostatic Disorders|T047|NON|EQV|NLM (1999)|990101|VASCULAR HEMOSTATIC DIS|abcdefv", "ENTRY": "Vascular Hemostatic Disorder", "MN": "C15.378.463.515", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "Pathological processes involving the integrity of blood circulation. Hemostasis depends on the integrity of BLOOD VESSELS, blood fluidity, and BLOOD COAGULATION. Majority of the hemostatic disorders are caused by disruption of the normal interaction between the VASCULAR ENDOTHELIUM, the plasma proteins (including BLOOD COAGULATION FACTORS), and PLATELETS.", "PM": "2008; use VASCULAR HEMOSTATIC DISORDERS 1999-2007", "HN": "2008 (1999)", "MR": "20100625", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020141"}, {"RECTYPE": "D", "MH": "Gangliosidoses, GM2", "DS": "GANGLIOSIDOSES GM 02", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "G(M2) Gangliosidoses|T047|NON|EQV|NLM (2000)|991012|GM GANGLIOSIDOSES 02|abcdefs", "ENTRY": "Gangliosidosis, GM2", "MN": "C18.452.648.595.554.825.300.300", "FX": "beta-N-Acetylhexosaminidases", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Tay-Sachs Disease (1966-1999)", "MS": "A group of recessively inherited diseases characterized by the intralysosomal accumulation of G(M2) GANGLIOSIDE in the neuronal cells. Subtypes include mutations of enzymes in the BETA-N-ACETYLHEXOSAMINIDASES system or G(M2) ACTIVATOR PROTEIN leading to disruption of normal degradation of GANGLIOSIDES, a subclass of ACIDIC GLYCOSPHINGOLIPIDS.", "PM": "2007; see GANGLIOSIDOSES GM2 2000-2006", "HN": "2007 (2000)", "MR": "20210701", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020143"}, {"RECTYPE": "D", "MH": "Basal Ganglia Cerebrovascular Disease", "DE": "BASAL GANGLIA CEREBROVASCULAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lenticulostriate Vasculopathy|T047|NON|NRW|NLM (2008)|060727|abcdef", "ENTRY": "Vasculopathy, Lenticulostriate", "MN": "C14.907.253.061", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coordinate IM with specific disease and site (IM) if applicable", "PI": "Cerebrovascular Disorders (1966-1999)", "MS": "A pathological condition caused by impaired blood flow in the basal regions of cerebral hemispheres (BASAL GANGLIA), such as INFARCTION; HEMORRHAGE; or ISCHEMIA in vessels of this brain region including the lateral lenticulostriate arteries. Primary clinical manifestations include involuntary movements (DYSKINESIAS) and muscle weakness (HEMIPARESIS).", "PM": "2000", "HN": "2000", "MR": "20070709", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020144"}, {"RECTYPE": "D", "MH": "Basal Ganglia Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Basal Ganglia|T046|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Hemorrhage, Basal Ganglionic", "MN": "C23.550.414.913.100.200", "MH_TH": "NLM (2000)", "ST": "T046", "AN": "coordinate IM with site (IM) if given; PUTAMINAL HEMORRHAGE is also available", "PI": "Cerebrovascular Disorders (1966-1999)", "MS": "Bleeding within the subcortical regions of cerebral hemispheres (BASAL GANGLIA). It is often associated with HYPERTENSION or ARTERIOVENOUS MALFORMATIONS. Clinical manifestations may include HEADACHE; DYSKINESIAS; and HEMIPARESIS.", "PM": "2000", "HN": "2000", "MR": "20070709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020145"}, {"RECTYPE": "D", "MH": "Putaminal Hemorrhage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Putamen|T046|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Putamen Hemorrhage", "MN": "C23.550.414.913.100.200.500", "FX": "Putamen", "MH_TH": "NLM (2000)", "ST": "T046", "PI": "Putamen (1976-1999)", "MS": "Intracranial bleeding into the PUTAMEN, a BASAL GANGLIA nucleus. This is associated with HYPERTENSION and lipohyalinosis of small blood vessels in the putamen. Clinical manifestations vary with the size of hemorrhage, but include HEMIPARESIS; HEADACHE; and alterations of consciousness.", "PM": "2000", "HN": "2000", "MR": "20070709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020146"}, {"RECTYPE": "D", "MH": "Coagulation Protein Disorders", "DE": "COAG PROTEIN DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Blood Coagulation Factor Deficiencies|T047|NON|EQV|NLM (1999)|980313|BLOOD COAG FACTOR DEFIC|abcdefv", "ENTRY": "Proteins Disorders, Coagulation", "MN": "C15.378.100.141", "MH_TH": "NLM (1999)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with coagulation factor ", "PI": "Blood Coagulation Disorders (1966-1998)", "MS": "Hemorrhagic and thrombotic disorders resulting from abnormalities or deficiencies of coagulation proteins.", "PM": "99", "HN": "99", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020147"}, {"RECTYPE": "D", "MH": "Butyric Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dibutyrate, Magnesium", "MN": "D10.251.400.143.500", "PA": "Histamine Antagonists", "EC": "analogs & derivatives:Butyrates", "MH_TH": "NLM (1999)", "ST": "T109", "N1": "Butanoic Acid", "RN": "107-92-6", "RR": "556-45-6", "PI": "Butyric Acids (1981-1998)", "MS": "A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.", "PM": "99; BUTYRIC ACID was indexed under BUTYRIC ACIDS 1981-98", "HN": "99; use BUTYRIC ACID (NM) 1981-98", "MR": "20130708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020148"}, {"RECTYPE": "D", "MH": "Manganese Poisoning", "DE": "MANGANESE POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neurotoxicity Syndrome, Manganese|T037|NON|EQV|NLM (2000)|991012|NEUROTOX SYNDROME MANGANESE|abcdefv", "ENTRY": "Syndromes, Manganese Neurotoxicity", "MN": "C25.723.522.813", "FX": "Parkinson Disease", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "coord IM with specific manganese cpd (IM) if given", "PI": "Parkinson Disease (1966-1999)", "MS": "Manganese poisoning is associated with chronic inhalation of manganese particles by individuals who work with manganese ore. Clinical features include CONFUSION; HALLUCINATIONS; and an extrapyramidal syndrome (PARKINSON DISEASE, SECONDARY) that includes rigidity; DYSTONIA; retropulsion; and TREMOR. (Adams, Principles of Neurology, 6th ed, p1213)", "PM": "2000", "HN": "2000", "MR": "20170620", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020149"}, {"RECTYPE": "D", "MH": "Chorea Gravidarum", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Choreoathetosis, Pregnancy-Associated|T047|NON|EQV|NLM (2000)|991012|CHOREOATHETOSIS PREGNANCY ASSOC|abcdefv", "ENTRY": "Pregnancy-Induced Choreas", "MN": "C12.050.703.141", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY", "PI": "Pregnancy Complications/diagnosis (1966-1999)", "MS": "A rare movement disorder developed during PREGNANCY, characterized by involuntary jerky motion (CHOREA) and inability to maintain stable position of body parts (ATHETOSIS). RHEUMATIC FEVER and collagen vascular disorders are frequently associated with this disease. Chorea may vary from mild to severe and occurs in approximately 1 per 2,000 to 3,000 pregnancies. (From Md Med J 1997 Sep;46(8):436-9)", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020150"}, {"RECTYPE": "D", "MH": "Protein C Deficiency", "DE": "PROTEIN C DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Protein C Deficiencies", "MN": "C16.320.099.690", "FX": "Activated Protein C Resistance", "MH_TH": "NLM (1999)", "ST": "T047", "PI": "Protein C (1987-1998)", "MS": "An absence or deficiency in PROTEIN C which leads to impaired regulation of blood coagulation. It is associated with an increased risk of severe or premature thrombosis. (Stedman's Med. Dict., 26th ed.)", "PM": "99", "HN": "99", "MR": "20130708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020151"}, {"RECTYPE": "D", "MH": "Antithrombin III Deficiency", "DE": "ANTITHROMBIN III DEFIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Deficiency, Antithrombin 3", "MN": "C16.320.099.075", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Antithrombins/deficiency (1971-1978)", "MS": "An absence or reduced level of Antithrombin III leading to an increased risk for thrombosis.", "PM": "99", "HN": "99", "MR": "20130708", "DA": "19980618", "DC": "1", "DX": "19990101", "UI": "D020152"}, {"RECTYPE": "D", "MH": "3-Hydroxybutyric Acid", "DS": "HYDROXYBUTYRIC ACID A 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Hydroxybutyrate|T109|T123|NON|NRW|NLM (1999)|980122|abbcdef", "ENTRY": "beta Hydroxybutyric Acid", "MN": "D10.251.400.143.781.500", "EC": "analogs & derivatives:Hydroxybutyrates", "MH_TH": "NLM (1999)", "ST": "T109", "N1": "Butanoic acid, 3-hydroxy-", "RN": "TZP1275679", "RR": "300-85-6 (3-Hydroxybutyric Acid)", "PI": "Hydroxybutyrates (1966-1998)", "MS": "BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.", "PM": "99; 3-HYDROXYBUTYRIC ACID was indexed under HYDROXYBUTYRATES 1966-98", "HN": "99; use 3-HYDROXYBUTYRIC ACID (NM) 1980-98", "MR": "20151020", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020155"}, {"RECTYPE": "D", "MH": "Salicylic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ortho Hydroxybenzoic Acid", "MN": "D02.455.426.559.389.657.410.595.608", "PA": "Keratolytic Agents", "EC": "analogs & derivatives:Salicylates", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "O414PZ4LPZ", "RR": "69-72-7 (Salicylic Acid)", "AN": "SALICYLIC ACIDS see SALICYLATES is also available", "PI": "Salicylic Acids (1981-1998)", "MS": "A compound obtained from the bark of the white willow and wintergreen leaves. It has bacteriostatic, fungicidal, and keratolytic actions.", "PM": "99; SALICYLIC ACID was indexed under SALICYLIC ACIDS 1981-98", "HN": "99; use SALICYLIC ACID (NM) 1981-98", "MR": "20130708", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020156"}, {"RECTYPE": "D", "MH": "Amino Acid Transport Disorders, Inborn", "DE": "AA TRANSPORT DIS INBORN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Transport Disorders, Amino Acid, Inborn|T047|NON|EQV|NLM (2000)|991012|TRANSPORT DIS AA INBORN|abcdefv", "ENTRY": "Inherited Amino Acid Transport Disorders|T047|NON|EQV|NLM (2000)|991012|INHERITED AA TRANSPORT DIS|abcdefv", "MN": "C18.452.648.151", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Brain Diseases, Metabolic (1977-1999)", "MS": "Disorders characterized by defective transport of amino acids across cell membranes. These include deficits in transport across brush-border epithelial cell membranes of the small intestine (MICROVILLI) and KIDNEY TUBULES; transport across the basolateral membrane; and transport across the membranes of intracellular organelles. (From Nippon Rinsho 1992 Jul;50(7):1587-92)", "PM": "2000", "HN": "2000", "MR": "20060705", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020157"}, {"RECTYPE": "D", "MH": "Hyperglycinemia, Nonketotic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nonketotic Hyperglycinemia|T047|NON|EQV|GHR (2014)|NLM (2000)|ORD (2010)|991012|abcdeeef", "ENTRY": "Nonketotic Hyperglycinemias", "MN": "C18.452.648.189.375", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "Do not confuse with HYPERGLYCEMIC HYPEROSMOLAR NONKETOTIC COMA", "PI": "Amino Acid Metabolism, Inborn Errors (1966-1998)", "MS": "An autosomal recessive metabolic disorder caused by deficiencies in the mitochondrial GLYCINE cleavage system.", "PM": "2000", "HN": "2000", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020158"}, {"RECTYPE": "D", "MH": "Citrullinemia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Deficiency Disease, Argininosuccinic Acid Synthase|T047|NON|EQV|NLM (2000)|991012|DEFIC DIS ARGININOSUCCINIC ACID SYNTHASE|abcdefv", "ENTRY": "Type I Citrullinemias", "MN": "C18.452.648.189.937.374", "FX": "Argininosuccinate Synthase", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Argininosuccinate Synthase/deficiency (1975-1999)", "MS": "A group of diseases related to a deficiency of the enzyme ARGININOSUCCINATE SYNTHASE which causes an elevation of serum levels of CITRULLINE. In neonates, clinical manifestations include lethargy, hypotonia, and SEIZURES. Milder forms also occur. Childhood and adult forms may present with recurrent episodes of intermittent weakness, lethargy, ATAXIA, behavioral changes, and DYSARTHRIA. (From Menkes, Textbook of Child Neurology, 5th ed, p49)", "PM": "2000", "HN": "2000", "MR": "20200527", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020159"}, {"RECTYPE": "D", "MH": "Sodium Benzoate", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Benzoate, Sodium", "MN": "D02.455.426.559.389.127.117.500", "PA": "Food Preservatives", "EC": "analogs & derivatives:Benzoates", "MH_TH": "USAN (1989)", "ST": "T109", "N1": "Benzoic acid, sodium salt", "RN": "OJ245FE5EU", "RR": "532-32-1 (Sodium Benzoate)", "PI": "Benzoates (1980-1998)", "MS": "The sodium salt of BENZOIC ACID. It is used as an antifungal preservative in pharmaceutical preparations and foods. It may also be used as a test for liver function.", "PM": "99; SODIUM BENZOATE was indexed under BENZOATES 1980-98", "HN": "99; for SODIUM BENZOATE use BENZOIC ACID (NM) 1980-98", "MR": "20130708", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020160"}, {"RECTYPE": "D", "MH": "Physical Chromosome Mapping", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Physical Mapping (Genetics)|T063|NON|EQV|NLM (1999)|980306|abcdef", "ENTRY": "Physical Mappings (Genetics)", "MN": "E05.393.183.620", "MH_TH": "NLM (1999)", "ST": "T063", "PI": "Chromosome Mapping (1968-1998)", "MS": "Mapping of the linear order of genes on a chromosome with units indicating their distances by using methods other than genetic recombination. These methods include nucleotide sequencing, overlapping deletions in polytene chromosomes, and electron micrography of heteroduplex DNA. (From King & Stansfield, A Dictionary of Genetics, 5th ed)", "PM": "99; for PHYSICAL MAPPING (GENETICS) see RESTRICTION MAPPING 1997-98", "HN": "99; for PHYSICAL MAPPING (GENETICS) use RESTRICTION MAPPING 1997-98", "MR": "19991103", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020161"}, {"RECTYPE": "D", "MH": "Hyperargininemia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Argininemia|T047|NON|EQV|GHR (2014)|NLM (2000)|OMIM (2013)|ORD (2010)|991012|abcdeeeef", "ENTRY": "Hyperargininemias", "MN": "C18.452.648.189.937.437", "FX": "Arginase", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Amino Acid Metabolism, Inborn Errors (1966-1999)", "MS": "A rare autosomal recessive disorder of the urea cycle. It is caused by a deficiency of the hepatic enzyme ARGINASE. Arginine is elevated in the blood and cerebrospinal fluid, and periodic HYPERAMMONEMIA may occur. Disease onset is usually in infancy or early childhood. Clinical manifestations include seizures, microcephaly, progressive mental impairment, hypotonia, ataxia, spastic diplegia, and quadriparesis. (From Hum Genet 1993 Mar;91(1):1-5; Menkes, Textbook of Child Neurology, 5th ed, p51)", "PM": "2000", "HN": "2000", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020162"}, {"RECTYPE": "D", "MH": "Ornithine Carbamoyltransferase Deficiency Disease", "DE": "ORNITHINE CARBAMOYLTRANSFERASE DEFIC DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ornithine Transcarbamylase Deficiency Disease|T047|NON|EQV|NLM (2000)|991012|ORNITHINE TRANSCARBAMYLASE DEFIC DIS|abcdefv", "ENTRY": "Ornithine Transcarbamylase Deficiencies", "MN": "C18.452.648.189.937.500", "FX": "Ornithine Carbamoyltransferase", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Ornithine Carbamoyltransferase/deficiency (1966-1999)", "MS": "An inherited urea cycle disorder associated with deficiency of the enzyme ORNITHINE CARBAMOYLTRANSFERASE, transmitted as an X-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. (Menkes, Textbook of Child Neurology, 5th ed, pp49-50)", "PM": "2000", "HN": "2000", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020163"}, {"RECTYPE": "D", "MH": "Chemical Actions and Uses", "MN": "D27", "RH": "D27 - CHEMICAL ACTIONS AND USES", "MH_TH": "NLM (1999)", "ST": "T120", "RN": "0", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "A group of pharmacologic activities, effects on living systems and the environment, and modes of employment of drugs and chemicals. They are broken into actions, which describe their effects, and uses, which describe how they are employed.", "PM": "99", "HN": "99", "MR": "20150605", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020164"}, {"RECTYPE": "D", "MH": "Carbamoyl-Phosphate Synthase I Deficiency Disease", "DE": "CARBAMOYL PHOSPHATE SYNTHASE I DEFIC DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperammonemia Due to Carbamoyl Phosphate Synthetase 1 Deficiency|T047|NON|REL|NLM (2010)|ORD (2010)|090205|abcdeef", "ENTRY": "Carbamyl Phosphate Synthetase I Deficiency Disease", "MN": "C18.452.660.097", "FX": "Carbamoyl-Phosphate Synthase (Ammonia)", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "consider also CARBAMOYL-PHOSPHATE SYNTHASE (AMMONIA)/defic", "PI": "Metabolism, Inborn Errors (1970-1974)", "MS": "A urea cycle disorder manifesting in infancy as lethargy, emesis, seizures, alterations of muscle tone, abnormal eye movements, and an elevation of serum ammonia. The disorder is caused by a reduction in the activity of hepatic mitochondrial CARBAMOYL-PHOSPHATE SYNTHASE (AMMONIA). (Menkes, Textbook of Child Neurology, 5th ed, pp50-1)", "PM": "2000", "HN": "2000", "MR": "20160226", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020165"}, {"RECTYPE": "D", "MH": "Hyperlysinemias", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Saccharopine Dehydrogenase Deficiency Disease|T047|NON|NRW|GHR (2014)|NLM (2000)|991012|SACCHAROPINE DEHYDROGENASE DEFIC DIS|abcdeefv", "ENTRY": "With Hyperammonemias, Hyperlysinuria", "MN": "C18.452.648.189.380", "FX": "Saccharopine Dehydrogenases", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Lysine/metabolism (1966-1999)", "MS": "A group of inherited metabolic disorders which have in common elevations of serum LYSINE levels. Enzyme deficiencies of alpha-aminoadipic semialdehyde dehydrogenase and the SACCHAROPINE DEHYDROGENASES have been associated with hyperlysinemia. Clinical manifestations include mental retardation, recurrent emesis, hypotonia, lethargy, diarrhea, and developmental delay. (From Menkes, Textbook of Child Neurology, 5th ed, p56)", "PM": "2000", "HN": "2000", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020167"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter, Subfamily B, Member 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "P-Glycoprotein 1|T116|NON|NRW|NLM (2024)|230322|abcdef", "ENTRY": "Translocase ABCB1, ATP-Dependent", "MN": "D12.776.543.585.450.074.500.500.250.125", "FX": "Drug Resistance, Multiple", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "AN": "note entry term: ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B is also available", "PI": "P-Glycoprotein (1995-1998)", "MS": "A 170-kDa transmembrane glycoprotein from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS. It serves as an ATP-dependent efflux pump for a variety of chemicals, including many ANTINEOPLASTIC AGENTS. Overexpression of this glycoprotein is associated with multidrug resistance (see DRUG RESISTANCE, MULTIPLE).", "PM": "2019; see ATP-BINDING CASSETTE, SUB-FAMILY B, MEMBER 1 2018; see P-GLYCOPROTEIN 1995-2017;  ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY B, MEMBER 1 was indexed under P-GLYCOPROTEIN 1995-1998; under CARRIER PROTEINS & MEMBRANE GLYCOPROTEINS 1980-1994; under GLYCOPROTEINS 1980-1987; and under MEMBRANE PROTEINS 1980-1982", "HN": "2019 (1995)", "MR": "20230425", "DA": "19980720", "DC": "1", "DX": "19990101", "UI": "D020168"}, {"RECTYPE": "D", "MH": "Caspases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Caspase|T116|T126|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D12.776.476.075.405", "FX": "Apoptosis", "EC": "antagonists & inhibitors:Caspase Inhibitors", "MH_TH": "NLM (1999)", "ST": "T126", "RN": "EC 3.4.22.-", "AN": "CASPASES, EFFECTOR and CASPASES, INITIATOR and specifics are available", "PI": "Cysteine Proteinases (1997-1998)", "MS": "A family of intracellular CYSTEINE ENDOPEPTIDASES that play a role in regulating INFLAMMATION and APOPTOSIS. They specifically cleave peptides at a CYSTEINE amino acid that follows an ASPARTIC ACID residue. Caspases are activated by proteolytic cleavage of a precursor form to yield large and small subunits that form the enzyme. Since the cleavage site within precursors matches the specificity of caspases, sequential activation of precursors by activated caspases can occur.", "PM": "99", "HN": "99", "MR": "20210521", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020169"}, {"RECTYPE": "D", "MH": "Caspase 1", "DS": "CASPASE 001", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Interleukin-1beta Converting Enzyme|T116|T126|NON|EQV|NLM (1999)|980116|INTERLEUKIN 001 BETA CONVERTING ENZYME|abbcdefs", "ENTRY": "beta-Converting Enzyme, IL-1", "MN": "D12.776.476.075.405.550.100", "FX": "Interleukin-1", "EC": "antagonists & inhibitors:Caspase Inhibitors", "MH_TH": "NLM (1999)", "ST": "T126", "RN": "EC 3.4.22.36", "PI": "Metalloproteinases (1989-1994)", "MS": "A long pro-domain caspase that has specificity for the precursor form of INTERLEUKIN-1BETA. It plays a role in INFLAMMATION by catalytically converting the inactive forms of CYTOKINES such as interleukin-1beta to their active, secreted form. Caspase 1 is referred as interleukin-1beta converting enzyme and is frequently abbreviated ICE.", "PM": "99; INTERLEUKIN 1BETA CONVERTING ENZYME (now CASPASE 1) was indexed under CYSTEINE PROTEINASES 1995-98 & METALLOPROTEINASES 1989-94", "HN": "99; use CASPASE 1 (NM) 1989-98", "MR": "20210521", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020170"}, {"RECTYPE": "D", "MH": "Botrytis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Botryti", "MN": "B01.300.381.128", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid33196", "PI": "Mitosporic Fungi (1965-1998)", "MS": "A mitosporic Leotiales fungal genus of plant pathogens. It has teleomorphs in the genus Botryotina.", "PM": "99; see HYPHOMYCETES 1986-98, see MONILIALES 1975-85", "HN": "99; use MITOSPORIC FUNGI 1975-98", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020171"}, {"RECTYPE": "D", "MH": "Verticillium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Verticilliums", "MN": "B01.300.381.950", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid5106", "PI": "Mitosporic Fungi (1966-1998)", "MS": "A mitosporic fungal genus commonly isolated from soil. Some species are the cause of wilt diseases in many different plants.", "PM": "99; see HYPHOMYCETES 1986-98, see MONILIALES 1975-85", "HN": "99; use MITOSPORIC FUNGI 1975-98", "MR": "20200813", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020172"}, {"RECTYPE": "D", "MH": "Tyrosinemias", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tyrosine Transaminase Deficiency Disease|T047|NON|NRW|NLM (2000)|991012|TYROSINE TRANSAMINASE DEFIC DIS|abcdefv", "ENTRY": "Tyrosinoses, Oculocutaneous Type", "MN": "C18.452.648.189.875", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "note X refs: consider also TYROSINE TRANSAMINASE /defic or other enzymes /defic", "PI": "Amino Acid Metabolism, Inborn Errors (1967-1999)", "MS": "A group of disorders which have in common elevations of tyrosine in the blood and urine secondary to an enzyme deficiency. Type I tyrosinemia features episodic weakness, self-mutilation, hepatic necrosis, renal tubular injury, and seizures and is caused by a deficiency of the enzyme fumarylacetoacetase. Type II tyrosinemia features INTELLECTUAL DISABILITY, painful corneal ulcers, and keratoses of the palms and plantar surfaces and is caused by a deficiency of the enzyme TYROSINE TRANSAMINASE. Type III tyrosinemia features INTELLECTUAL DISABILITY and is caused by a deficiency of the enzyme 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE. (Menkes, Textbook of Child Neurology, 5th ed, pp42-3)", "PM": "2000", "HN": "2000", "MR": "20160628", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020176"}, {"RECTYPE": "D", "MH": "Idiopathic Hypersomnia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Idiopathic CNS Hypersomnolence|T047|ACX|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Idiopathic Hypersomnolences", "MN": "F03.870.400.800.200.400", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Disorders of Excessive Somnolence (1975-1999)", "MS": "A sleep disorder of central nervous system origin characterized by prolonged nocturnal sleep and periods of daytime drowsiness. Affected individuals experience difficulty with awakening in the morning and may have associated sleep drunkenness, automatic behaviors, and memory disturbances. This condition differs from narcolepsy in that daytime sleep periods are longer, there is no association with CATAPLEXY, and the multiple sleep latency onset test does not record sleep-onset rapid eye movement sleep. (From Chokroverty, Sleep Disorders Medicine, 1994, pp319-20; Psychiatry Clin Neurosci 1998 Apr:52(2):125-129)", "PM": "2020; see Hypersomnolence, Idiopathic 2000-2019", "HN": "2020; was Hypersomnolence, Idiopathic 2000-2019", "MR": "20190222", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020177"}, {"RECTYPE": "D", "MH": "Sleep Disorders, Circadian Rhythm", "DE": "SLEEP DIS CIRCADIAN RHYTHM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sleep-Wake Schedule Disorder|T048|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Sleep Wake Schedule Disorders", "MN": "F03.870.400.200", "FX": "Work Schedule Tolerance", "MH_TH": "NLM (2000)", "ST": "T048", "MS": "Dyssomnias associated with disruption of the normal 24 hour sleep wake cycle secondary to travel (e.g., JET LAG SYNDROME), shift work, or other causes.", "PM": "2000", "HN": "2000", "MR": "20200527", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020178"}, {"RECTYPE": "D", "MH": "Jet Lag Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Time Zone Change Syndrome|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Time Zone Syndromes", "MN": "I03.883.855.500", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Sleep Disorders (1974-1999)", "MS": "A chronobiologic disorder resulting from rapid travel across a number of time zones, characterized by insomnia or hypersomnolence, fatigue, behavioral symptoms, headaches, and gastrointestinal disturbances. (From Cooper, Sleep, 1994, pp593-8)", "PM": "2000", "HN": "2000", "MR": "20170710", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020179"}, {"RECTYPE": "D", "MH": "Heteroduplex Analysis", "DE": "HETERODUPLEX ANAL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Heteroduplex Analyses", "MN": "E05.393.661.250", "FX": "Nucleic Acid Heteroduplexes", "MH_TH": "NLM (1999)", "ST": "T063", "PI": "Nucleic Acid Hybridization (1973-1979)", "MS": "A method of detecting gene mutation by mixing PCR-amplified mutant and wild-type DNA followed by denaturation and reannealing. The resultant products are resolved by gel electrophoresis, with single base substitutions detectable under optimal electrophoretic conditions and gel formulations. Large base pair mismatches may also be analyzed by using electron microscopy to visualize heteroduplex regions.", "PM": "99", "HN": "99", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020180"}, {"RECTYPE": "D", "MH": "Sleep Apnea, Obstructive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Upper Airway Resistance Sleep Apnea Syndrome|T047|NON|REL|NLM (2000)|991012|abcdef", "ENTRY": "Sleep Apneas, Obstructive", "MN": "C10.886.425.800.750.850", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Sleep Apnea Syndromes (1980-1999)", "MS": "A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac arrhythmias and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. (From Adams et al., Principles of Neurology, 6th ed, p395)", "PM": "2000", "HN": "2000", "MR": "20151020", "DA": "19991109", "DC": "1", "DX": "20000101", "UI": "D020181"}, {"RECTYPE": "D", "MH": "Sleep Apnea, Central", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sleep-Disordered Breathing, Central|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Sleep-Disordered Breathings, Central", "MN": "C10.886.425.800.750.800", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Sleep Apnea Syndromes (1980-1999)", "MS": "A condition associated with multiple episodes of sleep apnea which are distinguished from obstructive sleep apnea (SLEEP APNEA, OBSTRUCTIVE) by the complete cessation of efforts to breathe. This disorder is associated with dysfunction of central nervous system centers that regulate respiration.", "PM": "2000; for CENTRAL ALVEOLAR HYPOVENTILATION SYNDROME see SLEEP DISORDERS, INTRINSIC 2000-2012", "HN": "2000; for CENTRAL ALVEOLAR HYPOVENTILATION SYNDROME use SLEEP DISORDERS, INTRINSIC 2000-2012", "MR": "20130708", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020182"}, {"RECTYPE": "D", "MH": "Nocturnal Paroxysmal Dystonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sleep-Related Dystonia|T047|NON|EQV|NLM (2000)|991012|SLEEP RELAT DYSTONIA|abcdefv", "ENTRY": "Sleep-Related Dystonias", "MN": "F03.870.664.627", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Sleep Disorders (1981-1999)", "MS": "A parasomnia characterized by paroxysmal episodes of choreoathetotic, ballistic, dystonic movements, and semipurposeful activity. The episodes occur during non-rapid eye movement sleep and typically recur several times per night. (Neurology 1992 Jul;42(7 Suppl 6):61-67; Adams et al., Principles of Neurology, 6th ed, p391)", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020183"}, {"RECTYPE": "D", "MH": "Night Terrors", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sleep Terrors|T048|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Terrors, Sleep", "MN": "F03.870.664.635.600", "MH_TH": "UNK (19XX)", "ST": "T048", "PI": "Sleep Disorders (1969-1999)", "MS": "A disorder characterized by incomplete arousals from sleep associated with behavior suggesting extreme fright. This condition primarily affects children and young adults and the individual generally has no recall of the event. Episodes tend to occur during stage III or IV. SOMNAMBULISM is frequently associated with this condition. (Adams et al., Principles of Neurology, 6th ed, p391)", "PM": "2000; see SLEEP DISORDERS 1981-1999; for SLEEP TERROR DISORDER see SLEEP DISORDERS 1981-1999", "HN": "2000; use SLEEP DISORDERS 1981-1999; for SLEEP TERROR DISORDER use SLEEP DISORDERS 1981-1999", "MR": "20010725", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020184"}, {"RECTYPE": "D", "MH": "Sleep Bruxism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nocturnal Teeth Grinding Disorder|T047|T184|NON|EQV|NLM (2000)|991012|NOCTURNAL TEETH GRINDING DIS|abbcdefv", "ENTRY": "Sleep-Related Bruxisms", "MN": "F03.870.664.637", "MH_TH": "NLM (2000)", "ST": "T184", "AN": "BRUXISM is also available", "PI": "Bruxism (1965-1999)", "MS": "A sleep disorder characterized by grinding and clenching of the teeth and forceful lateral or protrusive jaw movements. Sleep bruxism may be associated with TOOTH INJURIES; TEMPOROMANDIBULAR JOINT DISORDERS; sleep disturbances; and other conditions.", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020186"}, {"RECTYPE": "D", "MH": "REM Sleep Behavior Disorder", "DE": "REM SLEEP BEHAVIOR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rapid Eye Movement Sleep Behavior Disorder|T047|NON|EQV|NLM (2000)|991012|RAPID EYE MOVEMENT SLEEP BEHAVIOR DIS|abcdefv", "ENTRY": "REM Behavior Disorders", "MN": "F03.870.664.633.700", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Sleep, REM (1987-1999)", "MS": "A disorder characterized by episodes of vigorous and often violent motor activity during REM sleep (SLEEP, REM). The affected individual may inflict self injury or harm others, and is difficult to awaken from this condition. Episodes are usually followed by a vivid recollection of a dream that is consistent with the aggressive behavior. This condition primarily affects adult males. (From Adams et al., Principles of Neurology, 6th ed, p393)", "PM": "2000", "HN": "2000", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020187"}, {"RECTYPE": "D", "MH": "Sleep Paralysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paralysis, Sleep|T046|NON|EQV|NLM (2000)|991012|abcdef", "MN": "F03.870.664.633.800", "MH_TH": "NLM (2000)", "ST": "T046", "PI": "Sleep Disorders (1965-1999)", "MS": "A common condition characterized by transient partial or total paralysis of skeletal muscles and areflexia that occurs upon awakening from sleep or less often while falling asleep. Stimuli such as touch or sound may terminate the episode, which usually has a duration of seconds to minutes. This condition may occur in normal subjects or be associated with NARCOLEPSY; CATAPLEXY; and hypnagogic HALLUCINATIONS. The pathophysiology of this condition is closely related to the normal hypotonia that occur during REM sleep. (From Adv Neurol 1995;67:245-271)", "PM": "2000", "HN": "2000", "MR": "20040802", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020188"}, {"RECTYPE": "D", "MH": "Nocturnal Myoclonus Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sleep Myoclonus Syndrome|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Syndromes, Sleep Myoclonus", "MN": "C10.886.659.618", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Myoclonus (1966-1999)", "MS": "Excessive periodic leg movements during sleep that cause micro-arousals and interfere with the maintenance of sleep. This condition induces a state of relative sleep deprivation which manifests as excessive daytime hypersomnolence. The movements are characterized by repetitive contractions of the tibialis anterior muscle, extension of the toe, and intermittent flexion of the hip, knee and ankle. (Adams et al., Principles of Neurology, 6th ed, p387)", "PM": "2000", "HN": "2000", "MR": "20010725", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020189"}, {"RECTYPE": "D", "MH": "Myoclonic Epilepsy, Juvenile", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Juvenile Myoclonic Epilepsy|T047|NON|EQV|GHR (2014)|NLM (2000)|ORD (2010)|991012|abcdeeef", "ENTRY": "Myoclonic Juvenile Epilepsy", "MN": "C10.228.140.490.493.063.670", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Myoclonus (1975-1999)", "MS": "A disorder characterized by the onset of myoclonus in adolescence, a marked increase in the incidence of absence seizures (see EPILEPSY, ABSENCE), and generalized major motor seizures (see EPILEPSY, TONIC-CLONIC). The myoclonic episodes tend to occur shortly after awakening. Seizures tend to be aggravated by sleep deprivation and alcohol consumption. Hereditary and sporadic forms have been identified. (From Adams et al., Principles of Neurology, 6th ed, p323)", "PM": "2000", "HN": "2000", "MR": "20181010", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020190"}, {"RECTYPE": "D", "MH": "Myoclonic Epilepsies, Progressive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "May-White Syndrome|T047|EPO|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Syndromes, Myoclonus-Nephropathy", "MN": "C10.228.140.490.493.063.650", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Myoclonus (1968-1999)", "MS": "A heterogeneous group of primarily familial EPILEPSY disorders characterized by myoclonic seizures, tonic-clonic seizures, ataxia, progressive intellectual deterioration, and neuronal degeneration. These include LAFORA DISEASE; MERRF SYNDROME; NEURONAL CEROID-LIPOFUSCINOSIS; sialidosis (see MUCOLIPIDOSES), and UNVERRICHT-LUNDBORG SYNDROME.", "PM": "2000; see Epilepsy, Myoclonic 1977-1999", "HN": "2000; use Epilepsy, Myoclonic 1977-1999", "MR": "20170224", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020191"}, {"RECTYPE": "D", "MH": "Lafora Disease", "DE": "LAFORA DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Progressive Myoclonic Epilepsy, Lafora Type|T047|EPO|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Lafora Myoclonic Epilepsy", "MN": "C16.320.400.480", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Epilepsy (1966-1976)", "MS": "A form of stimulus sensitive MYOCLONIC EPILEPSY inherited as an autosomal recessive condition. The most common presenting feature is a single seizure in the second decade of life. This is followed by progressive myoclonus, myoclonic seizures, tonic-clonic seizures, focal occipital seizures, intellectual decline, and severe motor and coordination impairments. Most affected individuals do not live past the age of 25 years. Concentric amyloid (Lafora) bodies are found in neurons, liver, skin, bone, and muscle (From Menkes, Textbook of Childhood Neurology, 5th ed, pp111-110).", "PM": "2000; see Epilepsy, Myoclonic 1977-1999", "HN": "2000; use Epilepsy, Myoclonic 1977-1999", "MR": "20170224", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020192"}, {"RECTYPE": "D", "MH": "Unverricht-Lundborg Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mediterranean Myoclonic Epilepsy|T047|EPO|EQV|GHR (2014)|NLM (2000)|991012|abcdeef", "ENTRY": "Unverricht-Lundborg Diseases", "MN": "C16.320.400.940", "FX": "Cystatin B", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Myoclonus (1965-1976)", "MS": "An autosomal recessive condition characterized by recurrent myoclonic and generalized seizures, ATAXIA, slowly progressive intellectual deterioration, DYSARTHRIA, and intention tremor. Myoclonic seizures are severe and continuous, and tend to be triggered by movement, stress, and sensory stimuli. The age of onset is between 8 and 13 years, and the condition is relatively frequent in the Baltic region, especially Finland. (From Menkes, Textbook of Child Neurology, 5th ed, pp109-110)", "PM": "2000; for LUNDBORG-UNVERRICHT SYNDROME see EPILEPSY, MYOCLONIC 1977-1999", "HN": "2000; for LUNDBORG-UNVERRICHT SYNDROME use EPILEPSY, MYOCLONIC 1977-1999", "MR": "20170224", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020194"}, {"RECTYPE": "D", "MH": "Epilepsy, Reflex", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Reflex Epilepsy, Reading|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Writing-Induced Reflex Epilepsies", "MN": "C10.228.140.490.450", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coord with stimulus which precipitates the seizures/adv eff if permitted", "PI": "Epilepsy (1965-1999)", "MS": "A subtype of epilepsy characterized by seizures that are consistently provoked by a certain specific stimulus. Auditory, visual, and somatosensory stimuli as well as the acts of writing, reading, eating, and decision making are examples of events or activities that may induce seizure activity in affected individuals. (From Neurol Clin 1994 Feb;12(1):57-8)", "PM": "2000", "HN": "2000", "MR": "20120703", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020195"}, {"RECTYPE": "D", "MH": "Trauma, Nervous System", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nervous System Injuries|T037|NON|EQV|NLM (2000)|991012|NERVOUS SYSTEM INJ|abcdefv", "ENTRY": "Neurotmeses", "MN": "C26.915", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "general: prefer specific precoordinated site/injuries term or site/inj", "PI": "Spinal Cord Injuries (1996-1999)", "MS": "Traumatic injuries to the brain, cranial nerves, spinal cord, autonomic nervous system, or neuromuscular system, including iatrogenic injuries induced by surgical procedures.", "PM": "2000", "HN": "2000", "MR": "20160505", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020196"}, {"RECTYPE": "D", "MH": "Head Injuries, Penetrating", "DE": "HEAD INJ PENETRATING", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Missile Injuries, Penetrating, Head|T037|NON|NRW|NLM (2000)|991012|MISSILE INJ PENETRATING HEAD|abcdefv", "ENTRY": "Traumas, Penetrating Head", "MN": "C26.986.500", "MH_TH": "NLM (2000)", "ST": "T037", "PI": "Wounds, Penetrating (1971-1999)", "MS": "Head injuries which feature compromise of the skull and dura mater. These may result from gunshot wounds (WOUNDS, GUNSHOT), stab wounds (WOUNDS, STAB), and other forms of trauma.", "PM": "2000", "HN": "2000", "MR": "20150622", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020197"}, {"RECTYPE": "D", "MH": "Intracranial Hemorrhage, Traumatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Traumatic Intracranial Hemorrhage|T037|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Traumatic Intracranial Hemorrhages", "MN": "C26.915.300.490", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "BRAIN HEMORRHAGE, TRAUMATIC and specifics are available", "PI": "Cerebral Hemorrhage (1966-1999)", "MS": "Bleeding within the SKULL induced by penetrating and nonpenetrating traumatic injuries, including hemorrhages into the tissues of CEREBRUM; BRAIN STEM; and CEREBELLUM; as well as into the epidural, subdural and subarachnoid spaces of the MENINGES.", "PM": "2000", "HN": "2000", "MR": "20150622", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020198"}, {"RECTYPE": "D", "MH": "Hematoma, Subdural, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subdural Hematoma, Acute|T020|T037|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Subdural Hematomas, Acute", "MN": "C26.915.300.490.450.050", "MH_TH": "NLM (2000)", "ST": "T037", "PI": "Hematoma, Subdural (1965-1999)", "MS": "Accumulation of blood in the SUBDURAL SPACE with acute onset of neurological symptoms. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.", "PM": "2000", "HN": "2000", "MR": "20150622", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020199"}, {"RECTYPE": "D", "MH": "Hematoma, Subdural, Chronic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subdural Hematoma, Chronic|T020|T037|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Subdural Hematomas, Chronic", "MN": "C26.915.300.490.450.120", "MH_TH": "NLM (2000)", "ST": "T037", "PI": "Hematoma, Subdural (1966-1999)", "MS": "Accumulation of blood in the SUBDURAL SPACE with delayed onset of neurological symptoms. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.", "PM": "2000", "HN": "2000", "MR": "20210312", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020200"}, {"RECTYPE": "D", "MH": "Brain Hemorrhage, Traumatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Traumatic Brain Hemorrhage|T037|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Traumatic Cerebellar Hemorrhages", "MN": "C26.915.300.490.150", "FX": "Brain Contusion", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "coordinate with specific site if pertinent, but note specifics", "PI": "Cerebral Hemorrhage (1964-1999)", "MS": "Bleeding within the brain as a result of penetrating and nonpenetrating CRANIOCEREBRAL TRAUMA. Traumatically induced hemorrhages may occur in any area of the brain, including the CEREBRUM; BRAIN STEM (see BRAIN STEM HEMORRHAGE, TRAUMATIC); and CEREBELLUM.", "PM": "2000", "HN": "2000", "MR": "20160120", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020201"}, {"RECTYPE": "D", "MH": "Cerebral Hemorrhage, Traumatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intracerebral Hemorrhage, Traumatic|T037|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Traumatic Intracerebral Hemorrhages", "MN": "C26.915.300.490.150.300", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "coordinate with specific site if pertinent", "PI": "Cerebral Hemorrhage (1966-1999)", "MS": "Bleeding into one or both CEREBRAL HEMISPHERES due to TRAUMA. Hemorrhage may involve any part of the CEREBRAL CORTEX and the BASAL GANGLIA. Depending on the severity of bleeding, clinical features may include SEIZURES; APHASIA; VISION DISORDERS; MOVEMENT DISORDERS; PARALYSIS; and COMA.", "PM": "2000", "HN": "2000", "MR": "20150622", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020202"}, {"RECTYPE": "D", "MH": "Brain Stem Hemorrhage, Traumatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pontine Hemorrhage, Traumatic|T037|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Traumatic Pontine Hemorrhage", "MN": "C26.915.300.490.150.200", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "coordinate with site", "PI": "Cerebral Hemorrhage (1968-1999)", "MS": "Bleeding into structures of BRAIN STEM, including the MIDBRAIN; PONS; or MEDULLA OBLONGATA, as the result of CRANIOCEREBRAL TRAUMA. DIFFUSE AXONAL INJURY is commonly associated. Clinical manifestations may include OCULAR MOTILITY DISORDERS; ATAXIA; PARALYSIS; PERSISTENT VEGETATIVE STATE; and COMA.", "PM": "2000", "HN": "2000", "MR": "20150622", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020203"}, {"RECTYPE": "D", "MH": "Skull Fracture, Depressed", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Skull Fracture, Compound Depressed|T037|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Skull Fractures, Depressed", "MN": "C26.915.300.745.350", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "coordinate with specific bone in the skull /inj if pertinent ", "PI": "Skull Fractures (1965-1999)", "MS": "A skull fracture characterized by inward depression of a fragment or section of cranial bone, often compressing the underlying dura mater and brain. Depressed cranial fractures which feature open skin wounds that communicate with skull fragments are referred to as compound depressed skull fractures.", "PM": "2000", "HN": "2000", "MR": "20150623", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020204"}, {"RECTYPE": "D", "MH": "Skull Fracture, Basilar", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Battle Sign|T184|EPO|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Skull Fractures, Frontobasilar", "MN": "C26.915.300.745.300", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "coordinate with specific bone in the skull /inj if pertinent ", "PI": "Temporal Bone (1966-1999)", "MS": "Fractures which extend through the base of the SKULL, usually involving the PETROUS BONE. Battle's sign (characterized by skin discoloration due to extravasation of blood into the subcutaneous tissue behind the ear and over the mastoid process), CRANIAL NEUROPATHIES, TRAUMATIC; CAROTID-CAVERNOUS SINUS FISTULA; and CEREBROSPINAL FLUID OTORRHEA are relatively frequent sequelae of this condition. (Adams et al., Principles of Neurology, 6th ed, p876)", "PM": "2000", "HN": "2000", "MR": "20150623", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020205"}, {"RECTYPE": "D", "MH": "Subarachnoid Hemorrhage, Traumatic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Traumatic Subarachnoid Hemorrhage|T037|T046|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Traumatic Subarachnoid Hemorrhages", "MN": "C26.915.300.490.700", "MH_TH": "NLM (2000)", "ST": "T046", "PI": "Subarachnoid Hemorrhage (1965-1999)", "MS": "Bleeding into the SUBARACHNOID SPACE due to CRANIOCEREBRAL TRAUMA. Minor hemorrhages may be asymptomatic; moderate to severe hemorrhages may be associated with INTRACRANIAL HYPERTENSION and VASOSPASM, INTRACRANIAL.", "PM": "2000", "HN": "2000", "MR": "20150623", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020206"}, {"RECTYPE": "D", "MH": "Coma, Post-Head Injury", "DE": "COMA POST HEAD INJ", "DS": "COMA POSTHEAD INJURY", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Coma, Post-Traumatic|T047|NON|EQV|NLM (2000)|991012|COMA POSTTRAUMATIC|abcdefs", "ENTRY": "Traumatic Coma", "MN": "C26.915.300.350", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Coma (1965-1999)", "MS": "Prolonged unconsciousness from which the individual cannot be aroused, associated with traumatic injuries to the BRAIN. This may be defined as unconsciousness persisting for 6 hours or longer. Coma results from injury to both cerebral hemispheres or the RETICULAR FORMATION of the BRAIN STEM. Contributing mechanisms include DIFFUSE AXONAL INJURY and BRAIN EDEMA. (From J Neurotrauma 1997 Oct;14(10):699-713)", "PM": "2000", "HN": "2000", "MR": "20150622", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020207"}, {"RECTYPE": "D", "MH": "Brain Injury, Chronic", "DE": "BRAIN INJ CHRONIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Chronic Brain Injuries", "MN": "C26.915.300.200.200", "MH_TH": "NLM (2000)", "ST": "T037", "PI": "Brain Damage, Chronic (1965-1999)", "MS": "Conditions characterized by persistent brain damage or dysfunction as sequelae of cranial trauma. This disorder may result from DIFFUSE AXONAL INJURY; INTRACRANIAL HEMORRHAGES; BRAIN EDEMA; and other conditions. Clinical features may include DEMENTIA; focal neurologic deficits; PERSISTENT VEGETATIVE STATE; AKINETIC MUTISM; or COMA.", "PM": "2000", "HN": "2000", "MR": "20210312", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020208"}, {"RECTYPE": "D", "MH": "Cranial Nerve Injuries", "DE": "CRANIAL NERVE INJ", "DS": "CRANIAL NERVE Z INJURIES", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Traumatic Cranial Neuropathy", "MN": "C26.915.300.400", "FX": "Vestibulocochlear Nerve Diseases", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "general or unspecified; prefer specifics", "MS": "Dysfunction of one or more cranial nerves causally related to a traumatic injury. Penetrating and nonpenetrating CRANIOCEREBRAL TRAUMA; NECK INJURIES; and trauma to the facial region are conditions associated with cranial nerve injuries.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020209"}, {"RECTYPE": "D", "MH": "Central Cord Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Central Spinal Cord Syndrome|T037|NON|EQV|NLM (2000)|991012|abcdef", "MN": "C26.819.339", "FX": "Spinal Cord Ischemia", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "coord IM with specific vertebrae (NIM) to locate site on spinal cord", "PI": "Spinal Diseases (1971-1999)", "MS": "A syndrome associated with traumatic injury to the cervical or upper thoracic regions of the spinal cord characterized by weakness in the arms with relative sparing of the legs and variable sensory loss. This condition is associated with ischemia, hemorrhage, or necrosis involving the central portions of the spinal cord. Corticospinal fibers destined for the legs are spared due to their more external location in the spinal cord. This clinical pattern may emerge during recovery from spinal shock. Deficits may be transient or permanent.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020210"}, {"RECTYPE": "D", "MH": "Autonomic Dysreflexia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spinal Autonomic Dysreflexia|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Spinal Autonomic Dysreflexias", "MN": "C10.900.850.250", "FX": "Reflex, Abnormal", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Spinal Cord Injuries (1973-1999)", "MS": "A syndrome associated with damage to the spinal cord above the mid thoracic level (see SPINAL CORD INJURIES) characterized by a marked increase in the sympathetic response to minor stimuli such as bladder or rectal distention. Manifestations include HYPERTENSION; TACHYCARDIA (or reflex bradycardia); FEVER; FLUSHING; and HYPERHIDROSIS. Extreme hypertension may be associated with a STROKE. (From Adams et al., Principles of Neurology, 6th ed, pp538 and 1232; J Spinal Cord Med 1997;20(3):355-60)", "PM": "2000", "HN": "2000", "MR": "20070710", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020211"}, {"RECTYPE": "D", "MH": "Carotid Artery Injuries", "DE": "CAROTID ARTERY INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Trauma, Carotid Artery|T037|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Traumatic Carotid Arteriopathy", "MN": "C26.915.200.200", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "coordinate IM with specific carotid artery (IM) if pertinent", "PI": "Carotid Artery Diseases (1965-1999)", "MS": "Damages to the CAROTID ARTERIES caused either by blunt force or penetrating trauma, such as CRANIOCEREBRAL TRAUMA; THORACIC INJURIES; and NECK INJURIES. Damaged carotid arteries can lead to CAROTID ARTERY THROMBOSIS; CAROTID-CAVERNOUS SINUS FISTULA; pseudoaneurysm formation; and INTERNAL CAROTID ARTERY DISSECTION. (From Am J Forensic Med Pathol 1997, 18:251; J Trauma 1994, 37:473)", "PM": "2000; for CAROTID PSEUDOANEURYSM see CAROTID-CAVERNOUS SINUS FISTULA 2000-2007", "HN": "2000; for CAROTID PSEUDOANEURYSM use CAROTID-CAVERNOUS SINUS FISTULA 2000-2007", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020212"}, {"RECTYPE": "D", "MH": "Cerebrovascular Trauma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vascular Injury, Brain|T037|NON|EQV|NLM (2000)|991012|VASCULAR INJ BRAIN|abcdefv", "ENTRY": "Vascular Traumas, Brain", "MN": "C26.915.200", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "general or unspecified only: prefer specific vessel/inj", "PI": "Cerebrovascular Disorders (1964-1999)", "MS": "Penetrating and nonpenetrating traumatic injuries to an extracranial or intracranial blood vessel that supplies the brain. This includes the CAROTID ARTERIES; VERTEBRAL ARTERIES; MENINGEAL ARTERIES; CEREBRAL ARTERIES; veins, and venous sinuses.", "PM": "2000", "HN": "2000", "MR": "20160226", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020214"}, {"RECTYPE": "D", "MH": "Carotid Artery, Internal, Dissection", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Internal Carotid Artery Dissection|T037|T047|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Dissection, Internal Carotid Artery|T037|T047|NON|EQV|NLM (2000)|991012|abbcdef", "MN": "C26.915.200.200.500", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Carotid Artery Diseases (1969-1999)", "MS": "The splitting of the vessel wall in one or both (left and right) internal carotid arteries (CAROTID ARTERY, INTERNAL). Interstitial hemorrhage into the media of the vessel wall can lead to occlusion of the internal carotid artery and aneurysm formation.", "PM": "2000", "HN": "2000", "MR": "20220523", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020215"}, {"RECTYPE": "D", "MH": "Carotid-Cavernous Sinus Fistula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Traumatic Carotid-Cavernous Sinus Fistula|T037|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Traumatic Carotid Cavernous Sinus Fistula", "MN": "C26.915.200.200.550", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Cavernous Sinus (1964-1999)", "MS": "An acquired or spontaneous abnormality in which there is communication between CAVERNOUS SINUS, a venous structure, and the CAROTID ARTERIES. It is often associated with HEAD TRAUMA, specifically basilar skull fractures (SKULL FRACTURE, BASILAR). Clinical signs often include VISION DISORDERS and INTRACRANIAL HYPERTENSION.", "PM": "2000", "HN": "2000", "MR": "20230405", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020216"}, {"RECTYPE": "D", "MH": "Vertebral Artery Dissection", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dissecting Vertebral Artery Aneurysm|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Vertebral Artery Dissections", "MN": "C26.915.200.600", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Vertebral Artery (1975-1999)", "MS": "Splitting of the vessel wall in the VERTEBRAL ARTERY. Interstitial hemorrhage into the media of the vessel wall can lead to occlusion of the vertebral artery, aneurysm formation, or THROMBOEMBOLISM. Vertebral artery dissection is often associated with TRAUMA and injuries to the head-neck region but can occur spontaneously.", "PM": "2000", "HN": "2000", "MR": "20220523", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020217"}, {"RECTYPE": "D", "MH": "Response Elements", "AQ": "DE ES GE IM PH RE", "ENTRY": "Response Element", "MN": "G05.360.340.024.340.137.750.680.765", "MH_TH": "NLM (1999)", "ST": "T123", "PI": "Regulatory Sequences, Nucleic Acid (1988-1998)", "MS": "Nucleotide sequences, usually upstream, which are recognized by specific regulatory transcription factors, thereby causing gene response to various regulatory agents. These elements may be found in both promoter and enhancer regions.", "PM": "99", "HN": "99", "MR": "20080708", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020218"}, {"RECTYPE": "D", "MH": "Chondrogenesis", "AQ": "DE GE IM PH RE", "MN": "G11.427.578.180", "MH_TH": "NLM (1999)", "ST": "T042", "PI": "Cartilage/embryology (1966-1998)", "MS": "The formation of cartilage. This process is directed by CHONDROCYTES which continually divide and lay down matrix during development. It is sometimes a precursor to OSTEOGENESIS.", "PM": "99", "HN": "99", "MR": "20160209", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020219"}, {"RECTYPE": "D", "MH": "Facial Nerve Injuries", "DE": "FACIAL NERVE INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Marginal Mandibular Nerve Injury|T037|NON|NRW|NLM (2020)|190416|abcdef", "ENTRY": "Traumatic Facial Neuropathy", "MN": "C26.915.300.400.300", "MH_TH": "NLM (2000)", "ST": "T037", "PI": "Facial Paralysis (1965-1999)", "MS": "Traumatic injuries to the facial nerve. This may result in FACIAL PARALYSIS, decreased lacrimation and salivation, and loss of taste sensation in the anterior tongue. The nerve may regenerate and reform its original pattern of innervation, or regenerate aberrantly, resulting in inappropriate lacrimation in response to gustatory stimuli (e.g., \"crocodile tears\") and other syndromes.", "PM": "2000", "HN": "2000", "MR": "20190517", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020220"}, {"RECTYPE": "D", "MH": "Optic Nerve Injuries", "DE": "OPTIC NERVE INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Second Cranial Nerve Trauma|T037|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Traumatic Optic Neuropathy", "MN": "C26.915.300.400.650", "FX": "Craniocerebral Trauma", "MH_TH": "NLM (2000)", "ST": "T037", "PI": "Optic Nerve Diseases (1976-1999)", "MS": "Injuries to the optic nerve induced by a trauma to the face or head. These may occur with closed or penetrating injuries. Relatively minor compression of the superior aspect of orbit may also result in trauma to the optic nerve. Clinical manifestations may include visual loss, PAPILLEDEMA, and an afferent pupillary defect.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020221"}, {"RECTYPE": "D", "MH": "Abducens Nerve Injury", "DE": "ABDUCENS NERVE INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sixth-Nerve Palsy, Traumatic|T037|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Traumatic Sixth-Nerve Palsies", "MN": "C26.915.300.400.100", "MH_TH": "NLM (2000)", "ST": "T037", "PI": "Ophthalmoplegia (1966-1999)", "MS": "Traumatic injury to the abducens, or sixth, cranial nerve. Injury to this nerve results in lateral rectus muscle weakness or paralysis. The nerve may be damaged by closed or penetrating CRANIOCEREBRAL TRAUMA or by facial trauma involving the orbit.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020222"}, {"RECTYPE": "D", "MH": "Chromosome Painting", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Paintings, Chromosome", "MN": "E05.393.661.475.350.125", "MH_TH": "NLM (1999)", "ST": "T063", "PI": "In Situ Hybridization, Fluorescence (1993-1998)", "MS": "A technique for visualizing CHROMOSOME ABERRATIONS using fluorescently labeled DNA probes which are hybridized to chromosomal DNA. Multiple fluorochromes may be attached to the probes. Upon hybridization, this produces a multicolored, or painted, effect with a unique color at each site of hybridization. This technique may also be used to identify cross-species homology by labeling probes from one species for hybridization with chromosomes from another species.", "PM": "99", "HN": "99", "MR": "20110624", "DA": "19980618", "DC": "1", "DX": "19990101", "UI": "D020223"}, {"RECTYPE": "D", "MH": "Expressed Sequence Tags", "DE": "EXPRESSED SEQ TAGS", "AQ": "CH ME", "PRINT ENTRY": "ESTs|T114|T130|ABB|EQV|NLM (1999)|980410|abbcdef", "ENTRY": "Tags, Expressed Sequence", "MN": "G05.360.340.024.340.137.275", "FX": "Sequence Tagged Sites", "MH_TH": "NLM (1999)", "ST": "T130", "AN": "do not confuse with SEQUENCE TAGGED SITES", "PI": "Gene Expression (1991-1998)", "MS": "Partial cDNA (DNA, COMPLEMENTARY) sequences that are unique to the cDNAs from which they were derived.", "PM": "99", "HN": "99", "MR": "20080708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020224"}, {"RECTYPE": "D", "MH": "Sagittal Sinus Thrombosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombosis, Sagittal Sinus|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Thromboses, Sagittal Sinus", "MN": "C14.907.355.590.213.350.500.750", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Sinus Thrombosis, Intracranial (1968-1999)", "MS": "Formation or presence of a blood clot (THROMBUS) in the SUPERIOR SAGITTAL SINUS or the inferior sagittal sinus. Sagittal sinus thrombosis can result from infections, hematological disorders, CRANIOCEREBRAL TRAUMA; and NEUROSURGICAL PROCEDURES. Clinical features are primarily related to the increased intracranial pressure causing HEADACHE; NAUSEA; and VOMITING. Severe cases can evolve to SEIZURES or COMA.", "PM": "2000", "HN": "2000", "MR": "20150608", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020225"}, {"RECTYPE": "D", "MH": "Cavernous Sinus Thrombosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombosis, Cavernous Sinus|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Thromboses, Cavernous Sinus", "MN": "C14.907.355.590.213.350.500.375", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Sinus Thrombosis, Intracranial (1966-1999)", "MS": "Formation or presence of a blood clot (THROMBUS) in the CAVERNOUS SINUS of the brain. Infections of the paranasal sinuses and adjacent structures, CRANIOCEREBRAL TRAUMA, and THROMBOPHILIA are associated conditions. Clinical manifestations include dysfunction of cranial nerves III, IV, V, and VI, marked periorbital swelling, chemosis, fever, and visual loss. (From Adams et al., Principles of Neurology, 6th ed, p711)", "PM": "2000", "HN": "2000", "MR": "20230824", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020226"}, {"RECTYPE": "D", "MH": "Lateral Sinus Thrombosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Transverse Sinus Thrombosis|T047|NON|EQV|NLM (2008)|060814|abcdef", "ENTRY": "Transverse Sinus Thromboses", "MN": "C14.907.355.590.213.350.500.562", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Sinus Thrombosis, Intracranial (1968-1999)", "MS": "Formation or presence of a blood clot (THROMBUS) in the LATERAL SINUSES. This condition is often associated with ear infections (OTITIS MEDIA or MASTOIDITIS) without antibiotic treatment. In developed nations, lateral sinus thrombosis can result from CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; NEUROSURGICAL PROCEDURES; THROMBOPHILIA; and other conditions. Clinical features include HEADACHE; VERTIGO; and increased intracranial pressure.", "PM": "2000", "HN": "2000", "MR": "20150608", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020227"}, {"RECTYPE": "D", "MH": "Pharmacologic Actions", "PRINT ENTRY": "Pharmacologic Action|T070|NON|EQV|NLM (2022)|201005|abcdef", "ENTRY": "Actions, Pharmacologic", "MN": "D27.505", "FX": "Pharmacological and Toxicological Phenomena", "MH_TH": "NLM (1999)", "ST": "T070", "RN": "0", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "A broad category of chemical actions and uses that result in the prevention, treatment, cure or diagnosis of disease. Included here are drugs and chemicals that act by altering normal body functions, such as the REPRODUCTIVE CONTROL AGENTS and ANESTHETICS. Effects of chemicals on the environment are also included.", "PM": "2004; see CHEMICAL ACTIONS 1999-2003", "HN": "2004(1999)", "MR": "20210630", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020228"}, {"RECTYPE": "D", "MH": "Serotonin Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Serotonin", "MN": "C25.100.875", "FX": "Serotonin", "MH_TH": "NLM (1999)", "ST": "T037", "PI": "Serotonin Uptake Inhibitors/adverse effects (1993-1998)", "MS": "An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.", "PM": "99", "HN": "99", "MR": "20220718", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020230"}, {"RECTYPE": "D", "MH": "Colletotrichum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Colletotrichums", "MN": "B01.300.381.235", "FX": "Phyllachorales", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid5455", "PI": "Mitosporic Fungi (1973-1998)", "MS": "A genus of mitosporic Phyllachoraceae fungi which contains at least 40 species of plant parasites. They have teleomorphs in the genus Glomerella (see PHYLLACHORALES).", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020231"}, {"RECTYPE": "D", "MH": "Kluver-Bucy Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Temporal Lobectomy Behavior Syndrome|T048|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Syndrome, Kluver-Bucy", "MN": "F03.615.400.431", "MH_TH": "ORD (2010)", "ST": "T048", "PI": "Temporal Lobe (1966-1999)", "MS": "A neurobehavioral syndrome associated with bilateral medial temporal lobe dysfunction. Clinical manifestations include oral exploratory behavior; tactile exploratory behavior; hypersexuality; BULIMIA; MEMORY DISORDERS; placidity; and an inability to recognize objects or faces. This disorder may result from a variety of conditions, including CRANIOCEREBRAL TRAUMA; infections; ALZHEIMER DISEASE; PICK DISEASE OF THE BRAIN; and CEREBROVASCULAR DISORDERS.", "PM": "2000", "HN": "2000", "MR": "20150622", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020232"}, {"RECTYPE": "D", "MH": "Gait Disorders, Neurologic", "DE": "GAIT DIS NEUROLOGIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ambulation Disorders, Neurologic|T047|NON|EQV|NLM (2000)|991012|AMBULATION DIS NEUROLOGIC|abcdefv", "ENTRY": "Widebased Gait", "MN": "C23.888.592.413", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "LAMENESS, ANIMAL is also available", "PI": "Gait (1965-1999)", "MS": "Gait abnormalities that are a manifestation of nervous system dysfunction. These conditions may be caused by a wide variety of disorders which affect motor control, sensory feedback, and muscle strength including: CENTRAL NERVOUS SYSTEM DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; or MUSCULAR DISEASES.", "PM": "2000", "HN": "2000", "MR": "20010725", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020233"}, {"RECTYPE": "D", "MH": "Gait Ataxia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cerebellar Gait|T033|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Sensory Gait Ataxias", "MN": "C23.888.592.413.450", "MH_TH": "NLM (2000)", "ST": "T033", "PI": "Gait (1966-1999)", "MS": "Impairment of the ability to coordinate the movements required for normal ambulation (WALKING) which may result from impairments of motor function or sensory feedback. This condition may be associated with BRAIN DISEASES (including CEREBELLAR DISEASES and BASAL GANGLIA DISEASES); SPINAL CORD DISEASES; or PERIPHERAL NERVOUS SYSTEM DISEASES.", "PM": "2000", "HN": "2000", "MR": "20050630", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020234"}, {"RECTYPE": "D", "MH": "Gait Apraxia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dyspraxia of Gait|T048|T184|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Gait Dyspraxias", "MN": "F01.700.875.350.600", "MH_TH": "NLM (2000)", "ST": "T184", "PI": "Gait (1965-1999)", "MS": "Impaired ambulation not attributed to sensory impairment or motor weakness. FRONTAL LOBE disorders; BASAL GANGLIA DISEASES (e.g., PARKINSONIAN DISORDERS); DEMENTIA, MULTI-INFARCT; ALZHEIMER DISEASE; and other conditions may be associated with gait apraxia.", "PM": "2000", "HN": "2000", "MR": "20150622", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020235"}, {"RECTYPE": "D", "MH": "Amnesia, Transient Global", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Transient Global Amnesia|T048|NON|EQV|NLM (2000)|ORD (2010)|991012|abcdeef", "ENTRY": "TGAs (Transient Global Amnesia)", "MN": "F03.615.200.800", "MH_TH": "NLM (2000)", "ST": "T048", "AN": "AMNESIA, GLOBAL see AMNESIA is also available", "PI": "Memory (1966-1999)", "MS": "A syndrome characterized by a transient loss of the ability to form new memories. It primarily occurs in middle aged or elderly individuals, and episodes may last from minutes to hours. During the period of amnesia, immediate and recent memory abilities are impaired, but the level of consciousness and ability to perform other intellectual tasks are preserved. The condition is related to bilateral dysfunction of the medial portions of each TEMPORAL LOBE. Complete recovery normally occurs, and recurrences are unusual. (From Adams et al., Principles of Neurology, 6th ed, pp429-30)", "PM": "2000", "HN": "2000", "MR": "20150630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020236"}, {"RECTYPE": "D", "MH": "Alexia, Pure", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Pure Alexia|T048|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Word Blindnesses, Pure", "MN": "F03.615.700.500", "MH_TH": "NLM (2000)", "ST": "T048", "AN": "ALEXIA see DYSLEXIA is also available", "PI": "Dyslexia, Acquired (1966-1999)", "MS": "Loss of the power to comprehend written materials despite preservation of the ability to write (i.e., alexia without agraphia). This condition is generally attributed to lesions that \"disconnect\" the visual cortex of the non-dominant hemisphere from language centers in the dominant hemisphere. This may occur when a dominant visual cortex injury is combined with underlying white matter lesions that involve crossing fibers from the occipital lobe of the opposite hemisphere. (From Adams et al., Principles of Neurology, 6th ed, p483)", "PM": "2000", "HN": "2000", "MR": "20150630", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020237"}, {"RECTYPE": "D", "MH": "Prosopagnosia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Facial Recognition Agnosia|T048|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Recognition Agnosias, Facial", "MN": "F01.700.750.100.650", "FX": "Facial Recognition", "MH_TH": "NLM (2000)", "ST": "T048", "PI": "Vision Disorders (1967-1999)", "MS": "The inability to recognize a familiar face or to learn to recognize new faces. This visual agnosia is most often associated with lesions involving the junctional regions between the temporal and occipital lobes. The majority of cases are associated with bilateral lesions, however unilateral damage to the right occipito-temporal cortex has also been associated with this condition. (From Cortex 1995 Jun;31(2):317-29).", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020238"}, {"RECTYPE": "D", "MH": "Receptor Cross-Talk", "DE": "RECEPT CROSS TALK", "AQ": "DE ES IM PH RE", "ENTRY": "Cross-Talk, Receptor", "MN": "G04.794", "FX": "Signal Transduction", "MH_TH": "NLM (1999)", "ST": "T044", "PI": "Signal Transduction (1989-1998)", "MS": "The simultaneous or sequential binding of multiple cell surface receptors to different ligands resulting in coordinated stimulation or suppression of signal transduction.", "PM": "99", "HN": "99", "MR": "20160617", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020239"}, {"RECTYPE": "D", "MH": "Apraxia, Ideomotor", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Ideomotor Apraxia|T048|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Transcortical Apraxias", "MN": "F01.700.875.350.200", "MH_TH": "NLM (2000)", "ST": "T048", "PI": "Apraxias (1968-1999)", "MS": "A form of apraxia characterized by an acquired inability to carry out a complex motor activity despite the ability to mentally formulate the action. This condition has been attributed to a disruption of connections between the dominant parietal cortex and supplementary and premotor cortical regions in both hemispheres. (From Adams et al., Principles of Neurology, 6th ed, p57)", "PM": "2000", "HN": "2000", "MR": "20090706", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020240"}, {"RECTYPE": "D", "MH": "Encephalomyelitis, Western Equine", "DE": "ENCEPH WESTERN EQUINE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Western Equine Encephalitis|T047|NON|EQV|NLM (2000)|ORD (2010)|991012|WESTERN EQUINE ENCEPH|abcdeefv", "ENTRY": "Western Equine Encephalomyelitis", "MN": "C10.586.500.406.250", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Encephalomyelitis, Equine (1966-1999)", "MS": "A form of arboviral encephalitis (which primarily affects horses) endemic to western and central regions of NORTH AMERICA. The causative organism (ENCEPHALOMYELITIS VIRUS, WESTERN EQUINE) may be transferred to humans via the bite of mosquitoes (CULEX tarsalis and others). Clinical manifestations include headache and influenza-like symptoms followed by alterations in mentation, SEIZURES, and COMA. DEATH occurs in a minority of cases. Survivors may recover fully or be left with residual neurologic dysfunction, including PARKINSONISM, POSTENCEPHALITIC. (From Joynt, Clinical Neurology, 1996, Ch26, pp8-9)", "PM": "2000", "HN": "2000", "MR": "20230601", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020241"}, {"RECTYPE": "D", "MH": "Encephalomyelitis, Eastern Equine", "DE": "ENCEPH EASTERN EQUINE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Eastern Equine Encephalomyelitis|T047|NON|EQV|NLM (2000)|991012|EASTERN EQUINE ENCEPH|abcdefv", "ENTRY": "Equine Encephalomyelitis, Eastern", "MN": "C10.586.500.406.200", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "human & animal; if in horses, coordinate ENCEPHALOMYELITIS, EASTERN, EQUINE /vet  with HORSE DISEASES ", "PI": "Encephalomyelitis, Equine (1966-1999)", "MS": "A form of arboviral encephalitis (primarily affecting equines) endemic to eastern regions of North America. The causative organism (ENCEPHALOMYELITIS VIRUS, EASTERN EQUINE) may be transmitted to humans via the bite of AEDES mosquitoes. Clinical manifestations include the acute onset of fever, HEADACHE, altered mentation, and SEIZURES followed by coma. The condition is fatal in up to 50% of cases. Recovery may be marked by residual neurologic deficits and EPILEPSY. (From Joynt, Clinical Neurology, 1996, Ch26, pp9-10)", "PM": "2000", "HN": "2000", "MR": "20230601", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020242"}, {"RECTYPE": "D", "MH": "Infarction, Anterior Cerebral Artery", "DE": "INFARCT ACA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stroke, Anterior Cerebral Artery|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Infarcts, ACA", "MN": "C23.550.717.489.250.200.400", "FX": "Infarction", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Infarction (1966-1978)", "MS": "NECROSIS occurring in the ANTERIOR CEREBRAL ARTERY system, including branches such as Heubner's artery. These arteries supply blood to the medial and superior parts of the CEREBRAL HEMISPHERE, Infarction in the anterior cerebral artery usually results in sensory and motor impairment in the lower body.", "PM": "2000", "HN": "2000", "MR": "20190702", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020243"}, {"RECTYPE": "D", "MH": "Infarction, Middle Cerebral Artery", "DE": "INFARCT MCA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombotic Infarction, Middle Cerebral Artery|T047|NON|NRW|NLM (2000)|991012|THROMBOTIC INFARCT MIDDLE CEREBRAL ARTERY|abcdefv", "ENTRY": "MCA Infarcts", "MN": "C23.550.717.489.250.200.450", "FX": "Infarction", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Infarction (1966-1978)", "MS": "NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.", "PM": "2000", "HN": "2000", "MR": "20190702", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020244"}, {"RECTYPE": "D", "MH": "p-Chloromercuribenzoic Acid", "DS": "CHLOROMERCURIBENZOIC ACID P", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PCMB|T109|T130|ABB|EQV|NLM (1999)|980203|abbcdef", "ENTRY": "para Chloromercuribenzoate", "MN": "D02.691.750.740.644.261.275", "PA": "Sulfhydryl Reagents", "EC": "analogs & derivatives:Chloromercuribenzoates", "MH_TH": "NLM (1999)", "ST": "T130", "N1": "(4-carboxylatophenyl)chloromercurate(1-), hydrogen", "RN": "59-85-8", "AN": "CHLOROMERCURIBENZOATES is also available", "PI": "Chloromercuribenzoates (1980-1998)", "MS": "An organic mercurial used as a sulfhydryl reagent.", "PM": "99; 4-CHLOROMERCURIBENZOIC ACID (now P-CHLOROMERCURIBENZOIC ACID) was indexed under CHLOROMERCURIBENZOATES 1980-98", "HN": "99; use P-CHLOROMERCURIBENZOIC ACID (NM) 1980-98", "MR": "20120703", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020245"}, {"RECTYPE": "D", "MH": "Venous Thrombosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombosis, Venous|T046|NON|EQV|NLM (1999)|980203|abcdef", "ENTRY": "Venous Thrombosis, Deep", "MN": "C14.907.355.830.925", "MH_TH": "NLM (1999)", "ST": "T046", "AN": "general: prefer specifics; coordinate IM with specific vein (IM)", "PI": "Thrombophlebitis (1963-1998)", "MS": "The formation or presence of a blood clot (THROMBUS) within a vein.", "PM": "99; see THROMBOPHLEBITIS 1963-98", "HN": "99; use THROMBOPHLEBITIS 1963-98", "MR": "20150618", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020246"}, {"RECTYPE": "D", "MH": "Myofunctional Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Oral Myotherapy|T061|NON|EQV|NLM (1999)|980521|abcdef", "ENTRY": "Therapy, Myofunctional", "MN": "E06.603", "FX": "Facial Muscles", "MH_TH": "NLM (1999)", "ST": "T061", "MS": "Training or retraining of the buccal, facial, labial, and lingual musculature in toothless conditions; DEGLUTITION DISORDERS; TEMPOROMANDIBULAR JOINT DISORDERS; MALOCCLUSION; and ARTICULATION DISORDERS.", "PM": "99", "HN": "99", "MR": "20160701", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020247"}, {"RECTYPE": "D", "MH": "Hormone Replacement Therapy", "DE": "HORMONE REPLACE THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Replacement Therapy, Hormone|T061|NON|EQV|NLM (1999)|980330|REPLACE THER HORMONE|abcdefv", "ENTRY": "Therapies, Hormone Replacement", "MN": "E02.319.452", "MH_TH": "NLM (1999)", "ST": "T061", "AN": "coord IM with specific hormone /ther use; ESTROGEN REPLACEMENT THERAPY is also available", "PI": "Estrogen Replacement Therapy (1990-1998)", "MS": "Therapeutic use of hormones to alleviate the effects of hormone deficiency.", "PM": "99", "HN": "99", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020249"}, {"RECTYPE": "D", "MH": "Postoperative Nausea and Vomiting", "DE": "POSTOP NAUSEA VOMITING", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "PONV|T046|T184|EQV|NLM (1999)|980206|abbdef", "ENTRY": "Postoperative Emeses", "MN": "C23.888.821.937.059", "MH_TH": "NLM (1999)", "ST": "T184", "PI": "Vomiting (1966-1998)", "MS": "Emesis and queasiness occurring after anesthesia.", "PM": "99", "HN": "99", "MR": "20030709", "DA": "19980616", "DC": "1", "DX": "19990101", "UI": "D020250"}, {"RECTYPE": "D", "MH": "Gastric Antral Vascular Ectasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Watermelon Stomach|T020|T047|NON|EQV|NLM (1999)|ORD (2010)|980206|abbcdeef", "ENTRY": "Watermelon Stomachs", "MN": "C14.907.075.280", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Angiodysplasia (1992-1998)", "MS": "A distinct vascular lesion in the PYLORIC ANTRUM that is characterized by tortuous dilated blood vessels (ectasia) radiating outward from the PYLORUS. The vessel pattern resembles the stripes on the surface of a watermelon. This lesion causes both acute and chronic GASTROINTESTINAL HEMORRHAGE.", "PM": "99", "HN": "99", "MR": "20090706", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020252"}, {"RECTYPE": "D", "MH": "Tooth Ankylosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dentoalveolar Ankylosis|T047|NON|EQV|NLM (1999)|980209|abcdef", "ENTRY": "Tooth Ankyloses", "MN": "C07.793.710", "MH_TH": "NLM (1999)", "ST": "T047", "PI": "Tooth Diseases (1968-1998)", "MS": "Solid fixation of a tooth resulting from fusion of the cementum and alveolar bone, with obliteration of the periodontal ligament. It is uncommon in the deciduous dentition and very rare in permanent teeth. (Jablonski's Dictionary of Dentistry, 1992)", "PM": "99", "HN": "99", "MR": "20120703", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020254"}, {"RECTYPE": "D", "MH": "Vitreous Detachment", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Posterior Vitreous Detachment|T047|NON|NRW|NLM (1999)|980209|abcdef", "ENTRY": "Vitreous Detachments, Posterior", "MN": "C11.980", "MH_TH": "NLM (1999)", "ST": "T047", "PI": "Vitreous Body (1968-1998)", "MS": "Detachment of the corpus vitreum (VITREOUS BODY) from its normal attachments, especially the retina, due to shrinkage from degenerative or inflammatory conditions, trauma, myopia, or senility.", "PM": "99", "HN": "99", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020255"}, {"RECTYPE": "D", "MH": "Choroidal Neovascularization", "DE": "CHOROIDAL NEOVASC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neovascularization, Choroidal|T033|T046|NON|EQV|NLM (1999)|980327|NEOVASC CHOROIDAL|abbcdefv", "ENTRY": "Choroidal Neovascularizations", "MN": "C23.550.589.500.145", "MH_TH": "NLM (1999)", "ST": "T046", "PI": "Neovascularization, Pathologic (1980-1998)", "MS": "A pathological process consisting of the formation of new blood vessels in the CHOROID.", "PM": "99", "HN": "99", "MR": "19991103", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020256"}, {"RECTYPE": "D", "MH": "Ventricular Remodeling", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Myocardial Remodeling, Ventricular|T042|NON|EQV|NLM (1999)|980527|abcdef", "ENTRY": "Ventricular Remodelings, Left", "MN": "G09.330.955.975", "MH_TH": "NLM (1999)", "ST": "T042", "PI": "Heart Ventricle (1984-1998)", "MS": "The geometric and structural changes that the HEART VENTRICLES undergo, usually following MYOCARDIAL INFARCTION. It comprises expansion of the infarct and dilatation of the healthy ventricle segments. While most prevalent in the left ventricle, it can also occur in the right ventricle.", "PM": "99", "HN": "99", "MR": "20160622", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020257"}, {"RECTYPE": "D", "MH": "Neurotoxicity Syndromes", "DE": "NEUROTOX SYNDROMES", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Poisoning, Nervous System|T037|NON|EQV|NLM (2000)|991012|POIS NERVOUS SYSTEM|abcdefv", "ENTRY": "Toxic Encephalopathy", "MN": "C25.723.705", "MH_TH": "ORD (2010)", "ST": "T037", "MS": "Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.", "PM": "2000", "HN": "2000", "MR": "20220714", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020258"}, {"RECTYPE": "D", "MH": "Heavy Metal Poisoning, Nervous System", "DE": "HEAVY METAL POIS NERVOUS SYSTEM", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Poisoning, Heavy Metals, Nervous System|T037|NON|EQV|NLM (2000)|991012|POIS HEAVY METALS NERVOUS SYSTEM|abcdefv", "MN": "C10.720.475", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "general or unspecified; prefer specifics", "PI": "Metals, Heavy/poisoning (1997-1999)", "MS": "Conditions associated with damage or dysfunction of the nervous system caused by exposure to heavy metals, which may cause a variety of central, peripheral, or autonomic nervous system injuries.", "PM": "2000", "HN": "2000", "MR": "19991216", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020260"}, {"RECTYPE": "D", "MH": "Arsenic Poisoning", "DE": "ARSENIC POIS", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Arsenical Neurotoxicity", "MN": "C25.723.098", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "coord IM with specific arsenic cpd (IM) if given", "PI": "Arsenicals/poisoning (1966-1999)", "MS": "Disorders associated with acute or chronic exposure to compounds containing ARSENIC (ARSENICALS) which may be fatal. Acute oral ingestion is associated with gastrointestinal symptoms and an encephalopathy which may manifest as SEIZURES, mental status changes, and COMA. Chronic exposure is associated with mucosal irritation, desquamating rash, myalgias, peripheral neuropathy, and white transverse (Mees) lines in the fingernails. (Adams et al., Principles of Neurology, 6th ed, p1212)", "PM": "2000", "HN": "2000", "MR": "20170620", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020261"}, {"RECTYPE": "D", "MH": "Mercury Poisoning, Nervous System", "DE": "MERCURY POIS NERVOUS SYSTEM", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Poisoning, Mercury, Neurologic|T037|NON|EQV|NLM (2000)|991012|POIS MERCURY NEUROLOGIC|abcdefv", "ENTRY": "System Mercurialism, Nervous", "MN": "C25.723.522.875.500", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "coord IM with specific mercury cpd (IM) if given", "PI": "Mercury Poisoning (1966-1999)", "MS": "Neurologic disorders associated with exposure to inorganic and organic forms of MERCURY. Acute intoxication may be associated with gastrointestinal disturbances, mental status changes, and PARAPARESIS. Chronic exposure to inorganic mercury usually occurs in industrial workers, and manifests as mental confusion, prominent behavioral changes (including psychosis), DYSKINESIAS, and NEURITIS. Alkyl mercury poisoning may occur through ingestion of contaminated seafood or grain, and its characteristic features include POLYNEUROPATHY; ATAXIA; vision loss; NYSTAGMUS, PATHOLOGIC; and DEAFNESS. (From Joynt, Clinical Neurology, 1997, Ch20, pp10-15)", "PM": "2000; for MINAMATA DISEASE see MERCURY POISONING 1977-1999", "HN": "2000; for MINAMATA DISEASE use MERCURY POISONING 1977-1999", "MR": "20170620", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020262"}, {"RECTYPE": "D", "MH": "Lead Poisoning, Nervous System", "DE": "LEAD POIS NERVOUS SYSTEM", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Poisoning, Lead, Neurologic|T037|NON|EQV|NLM (2000)|991012|POIS LEAD NEUROLOGIC|abcdefv", "ENTRY": "Syndromes, Lead Neurotoxicity", "MN": "C25.723.522.750.500", "MH_TH": "NLM (2000)", "ST": "T037", "PI": "Lead Poisoning (1966-1999)", "MS": "Injury to the nervous system secondary to exposure to lead compounds. Two distinct clinical patterns occur in children (LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD) and adults (LEAD POISONING, NERVOUS SYSTEM, ADULT). In children, lead poisoning typically produces an encephalopathy. In adults, exposure to toxic levels of lead is associated with a peripheral neuropathy.", "PM": "2000", "HN": "2000", "MR": "20170620", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020263"}, {"RECTYPE": "D", "MH": "Lead Poisoning, Nervous System, Childhood", "DE": "LEAD POIS NERVOUS SYSTEM CHILDHOOD", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Poisoning, Lead, Neurologic, Childhood|T037|NON|EQV|NLM (2000)|991012|POIS LEAD NEUROLOGIC CHILDHOOD|abcdefv", "ENTRY": "Saturnism, Childhood Neurologic", "MN": "C25.723.522.750.500.700", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "includes infant as well as child; coord with specific nervous system symptoms if emphasized", "PI": "Lead Poisoning (1966-1999)", "MS": "Neurologic disorders occurring in children following lead exposure. The most frequent manifestation of childhood lead toxicity is an encephalopathy associated with chronic ingestion of lead that usually presents between the ages of 1 and 3 years. Clinical manifestations include behavioral changes followed by lethargy; CONVULSIONS; HALLUCINATIONS; DELIRIUM; ATAXIA; and vomiting. Elevated intracranial pressure (HYPERTENSION, INTRACRANIAL) and CEREBRAL EDEMA may occur. (From Adams et al., Principles of Neurology, 6th ed, p1210-2)", "PM": "2000", "HN": "2000", "MR": "20170620", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020264"}, {"RECTYPE": "D", "MH": "Lead Poisoning, Nervous System, Adult", "DE": "LEAD POIS NERVOUS SYSTEM ADULT", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Poisoning, Lead, Neurologic, Adult|T037|NON|EQV|NLM (2000)|991012|POIS LEAD NEUROLOGIC ADULT|abcdefv", "ENTRY": "Saturnism, Adult Neurologic", "MN": "C25.723.522.750.500.400", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "includes adolescent as well as adult; coord with specific nervous system symptoms if emphasized", "PI": "Lead Poisoning (1966-1999)", "MS": "Neurologic conditions in adults associated with acute or chronic exposure to lead or any of its salts. The most common lead related neurologic syndrome in adults consists of a polyneuropathy involving motor fibers. This tends to affect distal nerves and may present as wrist drop due to RADIAL NEUROPATHY. Additional features of chronic lead exposure include ANEMIA; CONSTIPATION; colicky abdominal pain; a bluish lead line of the gums; interstitial nephritis (NEPHRITIS, INTERSTITIAL); and saturnine gout. An encephalopathy may rarely occur. (From Adams et al., Principles of Neurology, 6th ed, p1212)", "PM": "2000", "HN": "2000", "MR": "20170620", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020265"}, {"RECTYPE": "D", "MH": "Radiotherapy, Conformal", "DE": "RADIOTHER CONFORMAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Conformal Radiotherapy|T061|NON|EQV|NLM (1999)|980211|CONFORMAL RADIOTHER|abcdefv", "ENTRY": "Three-Dimensional Conformal Radiotherapies", "MN": "L01.313.500.750.100.710.600.550", "FX": "Radiotherapy Planning, Computer-Assisted", "MH_TH": "NLM (1999)", "ST": "T061", "PI": "Radiotherapy, Computer-Assisted (1988-1998)", "MS": "A therapy using IONIZING RADIATION where there is improved dose homogeneity within the tumor and reduced dosage to uninvolved structures. The precise shaping of dose distribution is achieved via the use of computer-controlled multileaf collimators.", "PM": "99", "HN": "99", "MR": "20160120", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020266"}, {"RECTYPE": "D", "MH": "MPTP Poisoning", "DE": "MPTP POIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "MPTP Neurotoxicity Syndrome|T037|NON|EQV|NLM (2000)|991012|MPTP NEUROTOX SYNDROME|abcdefv", "ENTRY": "Poisoning, MPTP", "MN": "C25.723.705.400", "FX": "1-Methyl-4-phenylpyridinium", "MH_TH": "NLM (2000)", "ST": "T037", "AN": "not for animal models of Parkinson disease induced by MPTP: index MPTP-INDUCED EXPERIMENTAL PARKINSONISM ", "PI": "Parkinson Disease, Secondary (1983-1999)", "MS": "A condition caused by the neurotoxin MPTP which causes selective destruction of nigrostriatal dopaminergic neurons. Clinical features include irreversible parkinsonian signs including rigidity and bradykinesia (PARKINSON DISEASE, SECONDARY). MPTP toxicity is also used as an animal model for the study of PARKINSON DISEASE. (Adams et al., Principles of Neurology, 6th ed, p1072; Neurology 1986 Feb;36(2):250-8)", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020267"}, {"RECTYPE": "D", "MH": "Alcohol-Induced Disorders, Nervous System", "DE": "ALCOHOL IND DIS NERVOUS SYSTEM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ethanol-Induced Nervous System Disorders|T047|NON|EQV|NLM (2000)|991012|ETHANOL IND NERVOUS SYSTEM DIS|abcdefv", "ENTRY": "Nervous System Disorders, Ethanol Induced", "MN": "C25.775.100.087.193", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Alcoholism (1966-1999)", "MS": "Acute and chronic neurologic disorders associated with the various neurologic effects of ETHANOL. Primary sites of injury include the brain and peripheral nerves.", "PM": "2000", "HN": "2000", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020268"}, {"RECTYPE": "D", "MH": "Alcoholic Neuropathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polyneuropathy, Alcoholic|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Polyneuropathy, Alcohol-Related Autonomic", "MN": "C25.775.100.087.193.400", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Peripheral Nervous System Diseases/etiology (1966-1999)", "MS": "A condition where damage to the peripheral nervous system (including the peripheral elements of the autonomic nervous system) is associated with chronic ingestion of alcoholic beverages. The disorder may be caused by a direct effect of alcohol, an associated nutritional deficiency, or a combination of factors. Clinical manifestations include variable degrees of weakness; ATROPHY; PARESTHESIAS; pain; loss of reflexes; sensory loss; diaphoresis; and postural hypotension. (From Arch Neurol 1995;52(1):45-51; Adams et al., Principles of Neurology, 6th ed, p1146)", "PM": "2000", "HN": "2000", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020269"}, {"RECTYPE": "D", "MH": "Alcohol Withdrawal Seizures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Status Epilepticus, Alcohol Withdrawal-Induced|T047|NON|NRW|NLM (2000)|991012|STATUS EPILEPTICUS ALCOHOL WITHDRAWAL IND|abcdefv", "ENTRY": "Withdrawal-Induced Seizures, Alcohol", "MN": "C25.775.835.500", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "ALCOHOL WITHDRAWAL DELIRIUM is available", "PI": "Psychoses, Alcoholic (1966-1999)", "MS": "A condition where seizures occur in association with ethanol abuse (ALCOHOLISM) without other identifiable causes. Seizures usually occur within the first 6-48 hours after the cessation of alcohol intake, but may occur during periods of alcohol intoxication. Single generalized tonic-clonic motor seizures are the most common subtype, however, STATUS EPILEPTICUS may occur. (Adams et al., Principles of Neurology, 6th ed, p1174)", "PM": "2000", "HN": "2000", "MR": "20170224", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020270"}, {"RECTYPE": "D", "MH": "Heredodegenerative Disorders, Nervous System", "DE": "HEREDODEGENERATIVE DIS NERVOUS SYSTEM", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neurodegenerative Diseases, Hereditary|T047|NON|EQV|NLM (2000)|991012|NEURODEGENERATIVE DIS HEREDITARY|abcdefv", "ENTRY": "Neurodegenerative Hereditary Diseases", "MN": "C16.320.400", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "Inherited disorders characterized by progressive atrophy and dysfunction of anatomically or physiologically related neurologic systems.", "PM": "2000", "HN": "2000", "MR": "20010725", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020271"}, {"RECTYPE": "D", "MH": "Orbital Implants", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Orbital Implant", "MN": "E07.695.540", "FX": "Eye, Artificial", "MH_TH": "NLM (1999)", "ST": "T074", "PI": "Prostheses and Implants (1966-1998)", "MS": "Rounded objects made of coral, teflon, or alloplastic polymer and covered with sclera, and which are implanted in the orbit following enucleation. An artificial eye (EYE, ARTIFICIAL) is usually attached to the anterior of the orbital implant for cosmetic purposes.", "PM": "99", "HN": "99", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020273"}, {"RECTYPE": "D", "MH": "Autoimmune Diseases of the Nervous System", "DE": "AUTOIMMUNE DIS NERVOUS SYSTEM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nervous System Autoimmune Diseases|T047|NON|EQV|NLM (2000)|991012|NERVOUS SYSTEM AUTOIMMUNE DIS|abcdefv", "ENTRY": "Neurologic Autoimmune Disease", "MN": "C20.111.258", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Autoimmune Diseases (1966-1999)", "MS": "Disorders caused by cellular or humoral immune responses primarily directed towards nervous system autoantigens. The immune response may be directed towards specific tissue components (e.g., myelin) and may be limited to the central nervous system (e.g., MULTIPLE SCLEROSIS) or the peripheral nervous system (e.g., GUILLAIN-BARRE SYNDROME).", "PM": "2000", "HN": "2000", "MR": "20211018", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020274"}, {"RECTYPE": "D", "MH": "Guillain-Barre Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polyradiculoneuropathy, Acute Inflammatory|T047|NON|NRW|NLM (2000)|991012|POLYRADICULONEUROPATHY ACUTE INFLAMM|abcdefv", "ENTRY": "Syndrome, Landry-Guillain-Barre", "MN": "C23.550.291.500.829.313", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "do not confuse entry term POLYRADICULONEUROPATHY, ACUTE INFLAMMATORY with POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY see POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING", "PI": "Polyradiculoneuropathy (1966-1999)", "MS": "An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. (From Adams et al., Principles of Neurology, 6th ed, pp1312-1314)", "PM": "2000; see POLYRADICULONEURITIS 1979-1999", "HN": "2000; use POLYRADICULONEUROPATHY 1979-1999", "MR": "20220419", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020275"}, {"RECTYPE": "D", "MH": "HIV Long-Term Survivors", "AQ": "CL HI LJ PX SN", "PRINT ENTRY": "Long-Term Survivors, HIV|T101|ABX|EQV|NLM (1999)|980212|abcdef", "ENTRY": "Long-Term Survivors, HIV-1", "MN": "M01.860.400", "MH_TH": "NLM (1999)", "ST": "T101", "MS": "Persons who have experienced prolonged survival of HIV infection. This includes the full spectrum of untreated, HIV-infected long-term asymptomatics to those with AIDS who have survived due to successful treatment.", "PM": "99", "HN": "99", "MR": "20210701", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020276"}, {"RECTYPE": "D", "MH": "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating", "DE": "POLYRADICULONEUROPATHY CHRONIC INFLAMM DEMYELINATING", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "CIDP|T047|ACR|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Polyradiculopathy, Chronic Inflammatory", "MN": "C23.550.291.500.813", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "do not confuse entry term CHRONIC INFLAMMATORY POLYRADICULONEUROPATHY with POLYRADICULONEUROPATHY, ACUTE INFLAMMATORY see GUILLAIN-BARRE SYNDROME", "PI": "Polyradiculopathy (1975-1999)", "MS": "A slowly progressive autoimmune demyelinating disease of peripheral nerves and nerve roots. Clinical manifestations include weakness and sensory loss in the extremities and enlargement of peripheral nerves. The course may be relapsing-remitting or demonstrate a step-wise progression. Protein is usually elevated in the spinal fluid and cranial nerves are typically spared. GUILLAIN-BARRE SYNDROME features a relatively rapid progression of disease which distinguishes it from this condition. (Adams et al., Principles of Neurology, 6th ed, p1337)", "PM": "2000", "HN": "2000", "MR": "20210312", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020277"}, {"RECTYPE": "D", "MH": "Demyelinating Autoimmune Diseases, CNS", "DE": "DEMYELINATING AUTOIMMUNE DIS CNS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spinal Cord Demyelinating Autoimmune Diseases|T047|NON|NRW|NLM (2000)|991012|SPINAL CORD DEMYELINATING AUTOIMMUNE DIS|abcdefv", "ENTRY": "Demyelinating Disease, Autoimmune, CNS|T047|NON|EQV|NLM (2000)|991012|DEMYELINATING DIS AUTOIMMUNE CNS|abcdefv", "MN": "C20.111.258.250", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "for central nervous system diseases only; for demyelinating diseases of the peripheral nervous system consider POLYRADICULONEURITIS; GUILLAIN-BARRE SYNDROME; and CHRONIC INFLAMMATORY POLYRADICULONEUROPATHY; for demyelinating autoimmune diseases of the brain or spinal cord not otherwise specified coord with BRAIN DISEASES or SPINAL CORD DISEASES", "MS": "Conditions characterized by loss or dysfunction of myelin (see MYELIN SHEATH) in the brain, spinal cord, or optic nerves secondary to autoimmune mediated processes. This may take the form of a humoral or cellular immune response directed toward myelin or OLIGODENDROGLIA associated autoantigens.", "PM": "2000", "HN": "2000", "MR": "20130708", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020278"}, {"RECTYPE": "D", "MH": "Hereditary Central Nervous System Demyelinating Diseases", "DE": "HEREDITARY CNS DEMYELINATING DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Demyelinating Diseases, Central Nervous System, Hereditary|T047|NON|EQV|NLM (2000)|991012|DEMYELINATING DIS CNS HEREDITARY|abcdefv", "ENTRY": "Hereditary Demyelinating Diseases, Central Nervous System|T047|NON|EQV|NLM (2000)|991012|HEREDITARY DEMYELINATING DIS CNS|abcdefv", "MN": "C18.452.648.189.362", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "Inherited conditions characterized by a loss of MYELIN in the central nervous system.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020279"}, {"RECTYPE": "D", "MH": "Sertraline", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ratio Sertraline", "MN": "D04.615.638.845.800", "PA": "Selective Serotonin Reuptake Inhibitors", "MH_TH": "NLM (1999)", "ST": "T121", "N1": "1-Naphthalenamine,1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-, (1S-cis)-", "RN": "QUC7NX6WMB", "RR": "UTI8907Y6X", "PI": "1-Naphthylamine/analogs & derivatives (1983-1998)", "MS": "A selective serotonin uptake inhibitor that is used in the treatment of depression.", "PM": "99; SERTRALINE was indexed under 1-NAPHTHYLAMINE/analogs & derivatives 1983-98", "HN": "99; use SERTRALINE (NM) 1983-98", "MR": "20220718", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020280"}, {"RECTYPE": "D", "MH": "Photoreceptors, Microbial", "DE": "PHOTORECEPT MICROBIAL", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "ENTRY": "Microbial Photoreceptors", "MN": "D12.776.752", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "0", "AN": "coord with specific organism", "MS": "Light absorbing proteins and protein prosthetic groups found in certain microorganisms. Some microbial photoreceptors initiate specific chemical reactions which signal a change in the environment, while others generate energy by pumping specific ions across a cellular membrane.", "PM": "99", "HN": "99", "MR": "20050630", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020283"}, {"RECTYPE": "D", "MH": "Cryoelectron Microscopy", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Electron Cryomicroscopy|T059|NON|EQV|NLM (1999)|980213|abcdef", "ENTRY": "Microscopy, Cryoelectron", "MN": "E05.595.402.150", "MH_TH": "NLM (1999)", "ST": "T059", "PI": "Microscopy, Electron (1986-1998)", "MS": "Electron microscopy involving rapid freezing of the samples. The imaging of frozen-hydrated molecules and organelles permits the best possible resolution closest to the living state, free of chemical fixatives or stains.", "PM": "99", "HN": "99", "MR": "20040707", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020285"}, {"RECTYPE": "D", "MH": "Pericytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Rouget Cells|T025|EPO|EQV|NLM (1999)|980213|abcdef", "ENTRY": "Pericyte", "MN": "A16.504.660.600", "MH_TH": "NLM (1999)", "ST": "T025", "PI": "Capillaries (1970-1998)", "MS": "Unique slender cells with multiple processes extending along the capillary vessel axis and encircling the vascular wall, also called mural cells. Pericytes are imbedded in the BASEMENT MEMBRANE shared with the ENDOTHELIAL CELLS of the vessel. Pericytes are important in maintaining vessel integrity, angiogenesis, and vascular remodeling.", "PM": "99", "HN": "99", "MR": "20180701", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020286"}, {"RECTYPE": "D", "MH": "In Situ Nick-End Labeling", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "TUNEL|T063|ABB|EQV|NLM (1999)|980213|abcdef", "ENTRY": "Nick End Labelling, In Situ", "MN": "E05.393.475", "FX": "Comet Assay", "MH_TH": "NLM (1999)", "ST": "T063", "PI": "Apoptosis (1994-1998)", "MS": "An in situ method for detecting areas of DNA which are nicked during APOPTOSIS. Terminal deoxynucleotidyl transferase is used to add labeled dUTP, in a template-independent manner, to the 3 prime OH ends of either single- or double-stranded DNA. The terminal deoxynucleotidyl transferase nick end labeling, or TUNEL, assay labels apoptosis on a single-cell level, making it more sensitive than agarose gel electrophoresis for analysis of DNA FRAGMENTATION.", "PM": "99", "HN": "99", "MR": "20060705", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020287"}, {"RECTYPE": "D", "MH": "Papilloma, Choroid Plexus", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Choroid Plexus Papilloma|T191|NON|EQV|NLM (2000)|OMIM (2013)|ORD (2010)|991012|abcdeeef", "ENTRY": "Papillomas, Choroid Plexus", "MN": "C10.551.240.250.200.200.500", "MH_TH": "NLM (1994)", "ST": "T191", "PI": "Glioma (1994-1999)", "MS": "A usually benign neoplasm that arises from the cuboidal epithelium of the choroid plexus and takes the form of an enlarged CHOROID PLEXUS, which may be associated with oversecretion of CSF. The tumor usually presents in the first decade of life with signs of increased intracranial pressure including HEADACHES; ATAXIA; DIPLOPIA; and alterations of mental status. In children it is most common in the lateral ventricles and in adults it tends to arise in the fourth ventricle. Malignant transformation to choroid plexus carcinomas may rarely occur. (Adams et al., Principles of Neurology, 6th ed, p667; DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2072)", "PM": "2000; see GLIOMA 1994-1999", "HN": "2000; use GLIOMA 1994-1999", "MR": "20120703", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020288"}, {"RECTYPE": "D", "MH": "Vasculitis, Central Nervous System", "DE": "VASCULITIS CNS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Secondary CNS Vasculitis|T047|NON|NRW|NLM (2000)|991012|SECOND CNS VASCULITIS|abcdefv", "ENTRY": "Vasculitis, Secondary CNS", "MN": "C20.111.258.962", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Cerebrovascular Disorders (1966-1999)", "MS": "Inflammation of blood vessels within the central nervous system. Primary vasculitis is usually caused by autoimmune or idiopathic factors, while secondary vasculitis is caused by existing disease process. Clinical manifestations are highly variable but include HEADACHE; SEIZURES; behavioral alterations; INTRACRANIAL HEMORRHAGES; TRANSIENT ISCHEMIC ATTACK; and BRAIN INFARCTION. (From Adams et al., Principles of Neurology, 6th ed, pp856-61)", "PM": "2000", "HN": "2000", "MR": "20090706", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020293"}, {"RECTYPE": "D", "MH": "Myasthenic Syndromes, Congenital", "DE": "MYASTHENIC SYNDROMES CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Slow-Channel Congenital Myasthenic Syndrome|T047|NON|NRW|NLM (2021)|191122|abcdef", "ENTRY": "Syndromes, Congenital Myasthenic", "MN": "C16.320.590", "FX": "Myasthenia Gravis", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "do not confuse with MYASTHENIA GRAVIS, NEONATAL, a transient condition seen in neonates born to myasthenic mothers", "PI": "Myasthenia Gravis/congenital (1970-1999)", "MS": "A heterogeneous group of disorders characterized by a congenital defect in neuromuscular transmission at the NEUROMUSCULAR JUNCTION. This includes presynaptic, synaptic, and postsynaptic disorders (that are not of autoimmune origin). The majority of these diseases are caused by mutations of various subunits of the nicotinic acetylcholine receptor (RECEPTORS, NICOTINIC) on the postsynaptic surface of the junction. (From Arch Neurol 1999 Feb;56(2):163-7)", "PM": "2000", "HN": "2000", "MR": "20200527", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020294"}, {"RECTYPE": "D", "MH": "Brain Stem Neoplasms", "DE": "BRAIN STEM NEOPL", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pontine Neoplasms|T191|NON|NRW|NLM (2000)|991012|PONTINE NEOPL|abcdefv", "ENTRY": "Tumors, Pontine", "MN": "C10.551.240.250.400.200", "MH_TH": "NLM (2000)", "ST": "T191", "AN": "coord IM with histol type of neopl (IM)", "PI": "Brain Stem (1966-1999)", "MS": "Benign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies (see CRANIAL NERVE DISEASES), NAUSEA, hemiparesis (see HEMIPLEGIA), and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.", "PM": "2000", "HN": "2000", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020295"}, {"RECTYPE": "D", "MH": "Animals, Congenic", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Congenic Animals", "MN": "B01.050.050.199.520.040", "MH_TH": "NLM (1999)", "ST": "T010", "AN": "coordinate with specific congenic animal; NIM when experimental animal", "MS": "Animals that are produced through selective breeding to eliminate genetic background differences except for a single or few specific loci.  They are used to investigate the contribution of genetic background differences to PHENOTYPE.", "PM": "99", "HN": "99", "MR": "20200902", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020296"}, {"RECTYPE": "D", "MH": "Mice, Congenic", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Congenic Mice", "MN": "B01.050.150.900.649.313.992.635.505.500.150", "MH_TH": "NLM (1999)", "ST": "T015", "AN": "NIM when exper animal; check tag MICE", "PI": "Mice (1966-1998)", "MS": "Mouse strains constructed to possess identical genotypes except for a difference at a single gene locus.", "PM": "99", "HN": "99", "MR": "20200902", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020297"}, {"RECTYPE": "D", "MH": "U937 Cells", "DS": "U A 937 CELLS", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "U937 Cell", "MN": "A11.627.635.675.750.500", "MH_TH": "NLM (1999)", "ST": "T025", "AN": "almost always NIM with no subheadings; check HUMAN; do not routinely add LYMPHOMA, LARGE B-CELL, DIFFUSE", "PI": "Cell Line (1981-1998)", "MS": "A human cell line established from a diffuse histiocytic lymphoma (HISTIOCYTIC LYMPHOMA, DIFFUSE) and displaying many monocytic characteristics. It serves as an in vitro model for MONOCYTE and MACROPHAGE differentiation.", "PM": "99", "HN": "99", "MR": "20080708", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020298"}, {"RECTYPE": "D", "MH": "Intracranial Hemorrhage, Hypertensive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intracerebral Hemorrhage, Hypertensive|T046|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Intracranial Hypertensive Hemorrhages", "MN": "C14.907.253.573.350", "MH_TH": "NLM (2000)", "ST": "T046", "PI": "Hypertension/complications (1972-1999)", "MS": "Bleeding within the SKULL that is caused by systemic HYPERTENSION, usually in association with INTRACRANIAL ARTERIOSCLEROSIS. Hypertensive hemorrhages are most frequent in the BASAL GANGLIA; CEREBELLUM; PONS; and THALAMUS; but may also involve the CEREBRAL CORTEX, subcortical white matter, and other brain structures.", "PM": "2000", "HN": "2000", "MR": "20070709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020299"}, {"RECTYPE": "D", "MH": "Intracranial Hemorrhages", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hemorrhage, Intracranial|T046|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Posterior Fossa Hemorrhages", "MN": "C23.550.414.913", "MH_TH": "NLM (2000)", "ST": "T046", "PI": "Cerebral Hemorrhage (1966-1999)", "MS": "Bleeding within the SKULL, including hemorrhages in the brain and the three membranes of MENINGES. The escape of blood often leads to the formation of HEMATOMA in the cranial epidural, subdural, and subarachnoid spaces.", "PM": "2000", "HN": "2000", "MR": "20070709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020300"}, {"RECTYPE": "D", "MH": "Vasospasm, Intracranial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intracranial Vasospasm|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Vasospasms, Intracranial", "MN": "C14.907.253.951", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Ischemic Attack, Transient (1966-1999)", "MS": "Constriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN).", "PM": "2000; for CEREBRAL VASOSPASM see CEREBRAL ISCHEMIA, TRANSIENT 1966-1999", "HN": "2000; for CEREBRAL VASOSPASM use CEREBRAL ISCHEMIA, TRANSIENT 1966-1999", "MR": "20070709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020301"}, {"RECTYPE": "D", "MH": "Weibel-Palade Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Weibel Palade Bodies", "MN": "A11.284.430.214.190.875.190.190.950", "FX": "von Willebrand Factor", "MH_TH": "NLM (1999)", "ST": "T026", "PI": "Organelles (1981-1998)", "MS": "Rod-shaped storage granules for VON WILLEBRAND FACTOR specific to endothelial cells.", "PM": "99", "HN": "99", "MR": "20030709", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020302"}, {"RECTYPE": "D", "MH": "Rats, Inbred Dahl", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Dahl Salt-Sensitive Rats|T015|EPO|NRW|NLM (1999)|980219|abcdef", "ENTRY": "Salt-Sensitive Rats, Dahl", "MN": "B01.050.150.900.649.313.992.635.505.700.400.165", "MH_TH": "NLM (1999)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal ", "PI": "Rats, Inbred Strains (1982-1998)", "MS": "Inbred rats derived from Sprague-Dawley rats and used for the study of salt-dependent hypertension. Salt-sensitive and salt-resistant strains have been selectively bred to show the opposite genetically determined blood pressure responses to excess sodium chloride ingestion.", "PM": "99", "HN": "99", "MR": "20200902", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020303"}, {"RECTYPE": "D", "MH": "Raptors", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Birds of Prey|T012|NON|EQV|NLM (1999)|980219|abcdef", "ENTRY": "Raptor", "MN": "B01.050.150.900.248.815", "MH_TH": "NLM (1999)", "ST": "T012", "PI": "Birds (1984-1998)", "MS": "BIRDS that hunt and kill other animals, especially higher vertebrates, for food. They include the FALCONIFORMES order, or diurnal birds of prey, comprised of EAGLES, falcons, HAWKS, and others, as well as the STRIGIFORMES order, or nocturnal birds of prey, which includes OWLS.", "PM": "99", "HN": "99", "MR": "20200902", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020304"}, {"RECTYPE": "D", "MH": "Strigiformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Owls|T012|NON|EQV|NLM (1999)|990101|abcdef", "ENTRY": "Owls, Great Horned", "MN": "B01.050.150.900.248.815.550", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid30458", "RR": "txid56313", "PI": "Birds (1966-1998)", "MS": "An order of BIRDS with the common name owls characterized by strongly hooked beaks, sharp talons, large heads, forward facing eyes, and facial disks. While considered nocturnal RAPTORS, some owls do hunt by day.", "PM": "2005; see OWLS 1999-2004", "HN": "2005 (1999)", "MR": "20200902", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020305"}, {"RECTYPE": "D", "MH": "Tuberculosis, Central Nervous System", "DE": "TUBERCULOSIS CNS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Central Nervous System Tuberculosis|T047|NON|EQV|NLM (2000)|991012|CNS TUBERCULOSIS|abcdefv", "MN": "C10.228.228.180.850", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Tuberculosis, Meningeal (1966-1999)", "MS": "Tuberculosis of the brain, spinal cord, or meninges (TUBERCULOSIS, MENINGEAL), most often caused by MYCOBACTERIUM TUBERCULOSIS and rarely by MYCOBACTERIUM BOVIS. The infection may be limited to the nervous system or coexist in other organs (e.g., TUBERCULOSIS, PULMONARY). The organism tends to seed the meninges causing a diffuse meningitis and leads to the formation of TUBERCULOMA, which may occur within the brain, spinal cord, or perimeningeal spaces. Tuberculous involvement of the vertebral column (TUBERCULOSIS, SPINAL) may result in nerve root or spinal cord compression. (From Adams et al., Principles of Neurology, 6th ed, pp717-20)", "PM": "2000", "HN": "2000", "MR": "20211018", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020306"}, {"RECTYPE": "D", "MH": "Eagles", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Haliaeetus leucocephalus|T012|NON|NRW|NLM (2021)|210331|abcdef", "ENTRY": "Eagle, Bald", "MN": "B01.050.150.900.248.815.350.200", "MH_TH": "NLM (1999)", "ST": "T012", "RR": "txid8968", "PI": "Birds (1970-1998)", "MS": "Large members of the FALCONIFORMES order of birds, family Accipitridae, most especially the genera Aquila, Haliaeetus, Harpia, and Circaetus. They are characterized by their powerful talons, which carry long, curved, pointed claws and by their opposable hindtoe.", "PM": "1999", "HN": "1999", "MR": "20210331", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020307"}, {"RECTYPE": "D", "MH": "Songbirds", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Wrens|T012|NON|NRW|NLM (2005)|031029|abcdef", "ENTRY": "Wren", "MN": "B01.050.150.900.248.620.750", "FX": "High Vocal Center", "MH_TH": "NLM (1999)", "ST": "T012", "RR": "txid9183", "AN": "prefer specifics; entry term EREMOPHILA ALPESTRIS: EREMOPHILA PLANT, and EREMOPHILUS MUTISII see CATFISHES are also available", "PI": "Birds (1966-1998)", "MS": "PASSERIFORMES of the suborder, Oscines, in which the flexor tendons of the toes are separate, and the lower syrinx has 4 to 9 pairs of tensor muscles inserted at both ends of the tracheal half rings. They include many commonly recognized birds such as CROWS; FINCHES; robins; SPARROWS; and SWALLOWS.", "PM": "1999", "HN": "1999", "MR": "20200902", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020308"}, {"RECTYPE": "D", "MH": "Struthioniformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Ostriches|T012|NON|EQV|NLM (1999)|990101|abcdef", "MN": "B01.050.150.900.248.600.800", "MH_TH": "NLM (1999)", "ST": "T012", "RN": "txid8798", "AN": "OSTRICH, AMERICAN see RHEIFORMES is available", "PI": "Birds (1968-1998)", "MS": "An order of flightless birds comprising the ostriches, which naturally inhabit open, low rainfall areas of Africa.", "PM": "2005; see OSTRICHES 1999-2004", "HN": "2005 (1999)", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020310"}, {"RECTYPE": "D", "MH": "Rheiformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Rheas|T012|NON|EQV|NLM (1999)|990101|abcdef", "ENTRY": "Ostrichs, American", "MN": "B01.050.150.900.248.600.750", "MH_TH": "NLM (1999)", "ST": "T012", "RN": "txid8792", "RR": "txid8797", "AN": "note entry term OSTRICH, AMERICAN: OSTRICHES see STRUTHIONIFORMES is available", "PI": "Birds (1971-1998)", "MS": "An order of large, long-necked, long-legged, flightless birds, found in South America. Known as rheas, they are sometimes called American ostriches, though they are in a separate order from true OSTRICHES.", "PM": "2005; see RHEAS 1999-2004", "HN": "2005 (1999)", "MR": "20200813", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020311"}, {"RECTYPE": "D", "MH": "Dromaiidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Emus|T012|NON|EQV|NLM (1999)|990101|abcdef", "ENTRY": "Emu|T012|NON|NRW|NLM (2005)|030813|abcdef", "MN": "B01.050.150.900.248.600.200", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid8788", "RR": "txid8790", "PI": "Birds (1973-1998)", "MS": "A family of flightless, running BIRDS, in the order Casuariiformes. The emu is the only surviving member of the family. They naturally inhabit forests, open plains, and grasslands in Australia.", "PM": "2005; see EMUS 1999", "HN": "2005 (1999)", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020312"}, {"RECTYPE": "D", "MH": "Specialty Uses of Chemicals", "ENTRY": "Specialty Chemicals and Products|T067|NON|EQV|NLM (1974)|990101|SPECIALTY CHEM PRODUCTS|abcdefv", "MN": "D27.720", "MH_TH": "NLM (2004)", "ST": "T067", "RN": "0", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Uses of chemicals in a research, industrial, or household setting. This does not include PHARMACOLOGIC ACTIONS.", "PM": "2004; see USES OF CHEMICALS AND DRUGS 1999-2003 and SPECIALTY CHEMICALS AND PRODUCTS 1975-2003", "HN": "2004(1999)", "MR": "20150605", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020313"}, {"RECTYPE": "D", "MH": "Central Nervous System Fungal Infections", "DE": "CNS FUNGAL INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Mycoses, Central Nervous System|T047|NON|EQV|NLM (2000)|991012|MYCOSES CNS|abcdefv", "ENTRY": "Infections, CNS Fungal", "MN": "C10.228.228.198", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coord IM with precoord fungal infection (IM) and specific site/dis term (IM) if pertinent", "MS": "MYCOSES of the brain, spinal cord, and meninges which may result in ENCEPHALITIS; MENINGITIS, FUNGAL; MYELITIS; BRAIN ABSCESS; and EPIDURAL ABSCESS. Certain types of fungi may produce disease in immunologically normal hosts, while others are classified as opportunistic pathogens, causing illness primarily in immunocompromised individuals (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME).", "PM": "2000", "HN": "2000", "MR": "20190702", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020314"}, {"RECTYPE": "D", "MH": "Latex Hypersensitivity", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rubber Allergy|T047|NON|EQV|NLM (1999)|980519|abcdef", "ENTRY": "Rubber Latex Allergies", "MN": "C20.543.764", "FX": "Rubber", "MH_TH": "NLM (1999)", "ST": "T047", "AN": "coordinate with HYPERSENSITIVITY, IMMEDIATE or HYPERSENSITIVITY, DELAYED if pertinent", "PI": "Rubber (1986-1998)", "MS": "Allergic reaction to products containing processed natural rubber latex such as rubber gloves, condoms, catheters, dental dams, balloons, and sporting equipment. Both T-cell mediated (HYPERSENSITIVITY, DELAYED) and IgE antibody-mediated (HYPERSENSITIVITY, IMMEDIATE) allergic responses are possible. Delayed hypersensitivity results from exposure to antioxidants present in the rubber; immediate hypersensitivity results from exposure to a latex protein.", "PM": "2002; see LATEX ALLERGY 1999-2001", "HN": "2002", "MR": "20220712", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020315"}, {"RECTYPE": "D", "MH": "Salmo salar", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Salmon, Atlantic|T013|NON|EQV|NLM (1999)|980220|abcdef", "ENTRY": "Salmons, Atlantic", "MN": "B01.050.150.900.493.817.750.705.790", "MH_TH": "NLM (1999)", "ST": "T013", "RN": "txid8030", "PI": "Salmonidae (1969-1971)", "MS": "A commercially important species of SALMON in the family SALMONIDAE, order SALMONIFORMES, which occurs in the North Atlantic.", "PM": "1999", "HN": "1999", "MR": "20200813", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020317"}, {"RECTYPE": "D", "MH": "Rats, Long-Evans", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Long-Evans Rat|T015|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Rats, Long Evans", "MN": "B01.050.150.900.649.313.992.635.505.700.500", "FX": "Rats, Inbred OLETF", "MH_TH": "NLM (1999)", "ST": "T015", "AN": "NIM when exper animal; check tag RATS", "PI": "Rats (1968-1998)", "MS": "An outbred strain of rats developed in 1915 by crossing several Wistar Institute white females with a wild gray male. Inbred strains have been derived from this original outbred strain, including Long-Evans cinnamon rats (RATS, INBRED LEC) and Otsuka-Long-Evans-Tokushima Fatty rats (RATS, INBRED OLETF), which are models for Wilson's disease and non-insulin dependent diabetes mellitus, respectively.", "PM": "99", "HN": "99", "MR": "20200902", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020318"}, {"RECTYPE": "D", "MH": "Oligodeoxyribonucleotides, Antisense", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antisense Oligodeoxyribonucleotides|T114|T123|T130|NON|EQV|NLM (1999)|980220|abbbcdef", "ENTRY": "Oligodeoxyribonucleotides, Anti-Sense", "MN": "D27.720.470.530.600.150.640.640", "MH_TH": "NLM (1999)", "ST": "T130", "RN": "0", "PI": "Oligonucleotides, Antisense (1991-1998)", "MS": "Short fragments of DNA that are used to alter the function of target RNAs or DNAs to which they hybridize.", "PM": "99; see OLIGONUCLEOTIDES, ANTISENSE 1991-98", "HN": "99; was OLIGONUCLEOTIDES, ANTISENSE 1991-98", "MR": "20030709", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020319"}, {"RECTYPE": "D", "MH": "Oligoribonucleotides, Antisense", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antisense Oligoribonucleotides|T114|T123|T130|NON|EQV|NLM (1999)|980220|abbbcdef", "ENTRY": "Oligoribonucleotides, Anti-Sense", "MN": "D27.720.470.530.600.150.760.645", "MH_TH": "NLM (1999)", "ST": "T130", "RN": "0", "PI": "RNA, Antisense (1991-1998)", "MS": "Short fragments of RNA that are used to alter the function of target RNAs or DNAs to which they hybridize.", "PM": "99; see OLIGONUCLEOTIDES, ANTISENSE 1991-98", "HN": "99; was OLIGONUCLEOTIDES, ANTISENSE 1991-98", "MR": "20030709", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020320"}, {"RECTYPE": "D", "MH": "Tics", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tic, Vocal|T184|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Vocal Tics", "MN": "C23.888.592.350.700", "FX": "Tourette Syndrome", "MH_TH": "NLM (2000)", "ST": "T184", "AN": "TIC DISORDERS is available", "PI": "Tic Disorders (1966-1999)", "MS": "Habitual, repeated, rapid contraction of certain muscles, resulting in stereotyped individualized actions that can be voluntarily suppressed for only brief periods. They often involve the face, vocal cords, neck, and less often the extremities. Examples include repetitive throat clearing, vocalizations, sniffing, pursing the lips, and excessive blinking. Tics tend to be aggravated by emotional stress. When frequent they may interfere with speech and INTERPERSONAL RELATIONS. Conditions which feature frequent and prominent tics as a primary manifestation of disease are referred to as TIC DISORDERS. (From Adams et al., Principles of Neurology, 6th ed, pp109-10)", "PM": "2000", "HN": "2000", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020323"}, {"RECTYPE": "D", "MH": "Amnesia, Anterograde", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Post-Ictal Memory Loss|T048|NON|NRW|NLM (2000)|991012|POSTICTAL MEMORY LOSS|abcdefs", "ENTRY": "Post-Ictal Memory Losses", "MN": "F03.615.200.137", "MH_TH": "NLM (2000)", "ST": "T048", "PI": "Amnesia (1967-1999)", "MS": "Loss of the ability to form new memories beyond a certain point in time. This condition may be organic or psychogenic in origin. Organically induced anterograde amnesia may follow CRANIOCEREBRAL TRAUMA; SEIZURES; ANOXIA; and other conditions which adversely affect neural structures associated with memory formation (e.g., the HIPPOCAMPUS; FORNIX (BRAIN); MAMMILLARY BODIES; and ANTERIOR THALAMIC NUCLEI). (From Memory 1997 Jan-Mar;5(1-2):49-71)", "PM": "2000", "HN": "2000", "MR": "20150630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020324"}, {"RECTYPE": "D", "MH": "Migraine with Aura", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Migraine, Classic|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Prolonged Aura Migraine", "MN": "C10.228.140.546.399.750.250", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Migraine (1966-1999)", "MS": "A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)", "PM": "2006; use CLASSIC MIGRAINE 2000-2005; for COMPLICATED MIGRAINE see MIGRAINE 2000-2005", "HN": "2006 (2000); for COMPLICATED MIGRAINE use MIGRAINE 2000-2005", "MR": "20130708", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020325"}, {"RECTYPE": "D", "MH": "Migraine without Aura", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Migraine, Common|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Migraines, Common", "MN": "C10.228.140.546.399.750.450", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Migraine (1966-1999)", "MS": "Recurrent unilateral pulsatile headaches, not preceded or accompanied by an aura, in attacks lasting 4-72 hours. It is characterized by PAIN of moderate to severe intensity; aggravated by physical activity; and associated with NAUSEA and / or PHOTOPHOBIA and PHONOPHOBIA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)", "PM": "2006; see COMMON MIGRAINE 2000-2005", "HN": "2006 (2000)", "MR": "20050630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020326"}, {"RECTYPE": "D", "MH": "Glaucoma Drainage Implants", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Krupin Valves|T074|EPO|NRW|NLM (1999)|980224|abcdef", "ENTRY": "Valves, Krupin", "MN": "E07.695.250", "MH_TH": "NLM (1999)", "ST": "T074", "MS": "Devices, usually incorporating unidirectional valves, which are surgically inserted in the sclera to maintain normal intraocular pressure.", "PM": "99; for AQUEOUS SHUNTS see MOLTENO IMPLANTS 1995-98", "HN": "99; for AQUEOUS SHUNTS use MOLTENO IMPLANTS 1995-98", "MR": "20200527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020327"}, {"RECTYPE": "D", "MH": "Essential Tremor", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Familial Tremor|T047|NON|NRW|GHR (2014)|NLM (2000)|991012|abcdeef", "ENTRY": "Tremors, Familial", "MN": "C10.228.662.350", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Tremor (1966-1999)", "MS": "A relatively common disorder characterized by a fairly specific pattern of tremors which are most prominent in the upper extremities and neck, inducing titubations of the head. The tremor is usually mild, but when severe may be disabling. An autosomal dominant pattern of inheritance may occur in some families (i.e., familial tremor). (Mov Disord 1988;13(1):5-10)", "PM": "2000", "HN": "2000", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020329"}, {"RECTYPE": "D", "MH": "Bell Palsy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Herpetic Facial Paralysis|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Paralysis, Idiopathic Facial", "MN": "C10.292.319.250", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Facial Paralysis (1966-1999)", "MS": "A syndrome characterized by the acute onset of unilateral FACIAL PARALYSIS which progresses over a 2-5 day period. Weakness of the orbicularis oculi muscle and resulting incomplete eye closure may be associated with corneal injury. Pain behind the ear often precedes the onset of paralysis. This condition may be associated with HERPESVIRUS 1, HUMAN infection of the facial nerve. (Adams et al., Principles of Neurology, 6th ed, p1376)", "PM": "2000; for BELL'S PALSY see Facial Paralysis 1966-1999", "HN": "2000; for BELL'S PALSY use Facial Paralysis 1966-1999", "MR": "20190617", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020330"}, {"RECTYPE": "D", "MH": "Mobius Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Moebius Syndromes", "MN": "C16.614.595", "FX": "Facial Paralysis", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Facial Paralysis (1966-1999)", "MS": "A syndrome of congenital facial paralysis, frequently associated with abducens palsy and other congenital abnormalities including lingual palsy, clubfeet, brachial disorders, cognitive deficits, and pectoral muscle defects. Pathologic findings are variable and include brain stem nuclear aplasia, facial nerve aplasia, and facial muscle aplasia, consistent with a multifactorial etiology. (Adams et al., Principles of Neurology, 6th ed, p1020)", "PM": "2000: see FACIAL PARALYSIS 1997-1999", "HN": "2000; use FACIAL PARALYSIS 1997-1999", "MR": "20220419", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020331"}, {"RECTYPE": "D", "MH": "Rats, Inbred LEC", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rats, Inbred Long-Evans Cinnamon|T015|EPO|EQV|NLM (1999)|980224|abcdef", "ENTRY": "Rats, Long-Evans Cinnamon", "MN": "B01.050.150.900.649.313.992.635.505.700.400.275", "FX": "Rats, Long-Evans", "MH_TH": "NLM (1999)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal ", "PI": "Rats (1989-1998)", "MS": "A cinnamon-colored strain of Long-Evans rats which carries a mutation causing fulminant hepatitis and jaundice, with an associated gross accumulation of copper in the liver. This strain is a model for Wilson's Disease (see HEPATOLENTICULAR DEGENERATION).", "PM": "99", "HN": "99", "MR": "20200902", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020332"}, {"RECTYPE": "D", "MH": "Tolosa-Hunt Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tolosa Hunt Syndrome", "MN": "C11.590.905", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Ophthalmoplegia (1973-1999)", "MS": "An idiopathic syndrome characterized by the formation of granulation tissue in the anterior cavernous sinus or superior orbital fissure, producing a painful ophthalmoplegia. (Adams et al., Principles of Neurology, 6th ed, p271)", "PM": "2000; see OPHTHALMOPLEGIA 1981-1999", "HN": "2000; use OPHTHALMOPLEGIA 1981-1999", "MR": "20230405", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020333"}, {"RECTYPE": "D", "MH": "Rats, Inbred OLETF", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Otsuka-Long-Evans-Tokushima Rats|T015|EPO|EQV|NLM (1999)|980224|abcdef", "ENTRY": "Rats, Otsuka-Long-Evans-Tokushima Fatty", "MN": "B01.050.150.900.649.313.992.635.505.700.400.290", "FX": "Rats, Long-Evans", "MH_TH": "NLM (1999)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal; a model for DIABETES MELLITUS, TYPE 2 not DIABETES MELLITUS, EXPERIMENTAL", "PI": "Rats (1993-1998)", "MS": "An inbred strain of Long-Evans rats that develops hyperglycemia, hyperinsulinemia, and mild obesity, mostly in males, that resembles non-insulin-dependent diabetes mellitus in humans. It was developed from outbred Long-Evans stock in 1983.", "PM": "99", "HN": "99", "MR": "20200902", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020334"}, {"RECTYPE": "D", "MH": "Paraparesis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spinal Paraparesis", "MN": "C23.888.592.643.500", "MH_TH": "NLM (2000)", "ST": "T184", "PI": "Paresis (1967-1999)", "MS": "Mild to moderate loss of bilateral lower extremity motor function, which may be a manifestation of SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; MUSCULAR DISEASES; INTRACRANIAL HYPERTENSION; parasagittal brain lesions; and other conditions.", "PM": "2000", "HN": "2000", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020335"}, {"RECTYPE": "D", "MH": "Paraparesis, Spastic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spastic Paraparesis|T184|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Spastic Parapareses", "MN": "C23.888.592.643.500.500", "MH_TH": "UNK (19XX)", "ST": "T184", "AN": "do not confuse with PARAPARESIS, TROPICAL SPASTIC caused by HUMAN T-LYMPHOTROPIC VIRUS 1", "PI": "Paraparesis (1966-1999)", "MS": "Mild or moderate loss of motor function accompanied by spasticity in the lower extremities. This condition is a manifestation of CENTRAL NERVOUS SYSTEM DISEASES that cause injury to the motor cortex or descending motor pathways.", "PM": "2000", "HN": "2000", "MR": "20050801", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020336"}, {"RECTYPE": "D", "MH": "Vestibular Neuronitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuronitis, Vestibular|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Vestibulopathy, Recurrent", "MN": "C10.292.910.850", "FX": "Neuritis", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Neuritis (1968-1999)", "MS": "Idiopathic inflammation of the VESTIBULAR NERVE, characterized clinically by the acute or subacute onset of VERTIGO; NAUSEA; and imbalance. The COCHLEAR NERVE is typically spared and HEARING LOSS and TINNITUS do not usually occur. Symptoms usually resolve over a period of days to weeks. (Adams et al., Principles of Neurology, 6th ed, p304)", "PM": "2000", "HN": "2000", "MR": "20070709", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020338"}, {"RECTYPE": "D", "MH": "Optic Nerve Glioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Malignant Astrocytoma, Optic Nerve|T191|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Optic Nerve Gliomas", "MN": "C11.640.544.500", "MH_TH": "NLM (2000)", "ST": "T191", "PI": "Orbital Neoplasms (1966-1999)", "MS": "Glial cell derived tumors arising from the optic nerve, usually presenting in childhood.", "PM": "2000", "HN": "2000", "MR": "20150623", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020339"}, {"RECTYPE": "D", "MH": "Tobacco Use Cessation", "AQ": "EC EH HI MT PX SN", "PRINT ENTRY": "Smokeless Tobacco Cessation|T055|NON|NRW|NLM (1999)|980225|abcdef", "ENTRY": "Cessations, Tobacco Use", "MN": "F01.145.488.750", "FX": "Tobacco Use Cessation Devices", "MH_TH": "NLM (1999)", "ST": "T055", "AN": "SMOKING CESSATION is also available", "MS": "Ending the TOBACCO habits of smoking, chewing, or snuff use.", "PM": "99", "HN": "99", "MR": "20180716", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020340"}, {"RECTYPE": "D", "MH": "Absorbable Implants", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Implants, Absorbable|T074|NON|EQV|NLM (1999)|980225|abcdef", "ENTRY": "Implants, Biodegradable", "MN": "E07.695.025", "MH_TH": "NLM (1999)", "ST": "T074", "AN": "coord with substance if emphasized", "MS": "Implants constructed of materials designed to be absorbed by the body without producing an immune response. They are usually composed of plastics and are frequently used in orthopedics and orthodontics.", "PM": "99", "HN": "99", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020341"}, {"RECTYPE": "D", "MH": "Finite Element Analysis", "DE": "FINITE ELEMENT ANAL", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Finite Element Analyses", "MN": "E05.355", "MH_TH": "NLM (1999)", "ST": "T062", "PI": "Models, Theoretical (1969-1986)", "MS": "A computer based method of simulating or analyzing the behavior of structures or components.", "PM": "99", "HN": "99", "MR": "20080708", "DA": "19980612", "DC": "1", "DX": "19990101", "UI": "D020342"}, {"RECTYPE": "D", "MH": "Hypertensive Encephalopathy", "DE": "HYPERTENSIVE ENCEPH", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Encephalopathy, Hypertensive|T047|NON|EQV|NLM (2000)|991012|ENCEPH HYPERTENSIVE|abcdefv", "MN": "C10.228.140.631.500", "FX": "Hypertension, Malignant", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Hypertension/complications (1966-1999)", "MS": "Brain dysfunction or damage resulting from sustained MALIGNANT HYPERTENSION. When BLOOD PRESSURE exceeds the limits of cerebral autoregulation, cerebral blood flow is impaired (BRAIN ISCHEMIA). Clinical manifestations include HEADACHE; NAUSEA; VOMITING; SEIZURES; altered mental status (in some cases progressing to COMA); PAPILLEDEMA; and RETINAL HEMORRHAGE.", "PM": "2000", "HN": "2000", "MR": "20070709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020343"}, {"RECTYPE": "D", "MH": "Enterocolitis, Necrotizing", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Necrotizing Enterocolitis|T047|NON|EQV|NLM (2004)|ORD (2010)|021219|abcdeef", "MN": "C06.405.469.363.700", "FX": "Typhlitis", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Enterocolitis, Pseudomembranous (1966-1998)", "MS": "ENTEROCOLITIS with extensive ulceration (ULCER) and NECROSIS. It is observed primarily in LOW BIRTH WEIGHT INFANT.", "PM": "99; see ENTEROCOLITIS, PSEUDOMEMBRANOUS 1980-98", "HN": "99; use ENTEROCOLITIS, PSEUDOMEMBRANOUS 1980-98", "MR": "20090706", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020345"}, {"RECTYPE": "D", "MH": "Aquaporins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Water Channels|T116|T123|NON|EQV|NLM (1999)|980225|abbcdef", "ENTRY": "Proteins, Water Channel", "MN": "D12.776.543.585.400.730.040", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "PI": "Water/metabolism (1976-1998)", "MS": "A class of porins that allow the passage of WATER and other small molecules across CELL MEMBRANES.", "PM": "99", "HN": "99", "MR": "20200527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020346"}, {"RECTYPE": "D", "MH": "Lithiasis", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Calculosis|T046|NON|EQV|NLM (1999)|980225|abcdef", "ENTRY": "Lithiases", "MN": "C23.550.537", "FX": "Calculi", "MH_TH": "NLM (1999)", "ST": "T046", "AN": "prefer specifics; coord IM with organ /disease term (IM)", "MS": "A condition characterized by the formation of CALCULI and concretions in the hollow organs or ducts of the body. They occur most often in the gallbladder, kidney, and lower urinary tract.", "PM": "99", "HN": "99", "MR": "19991108", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020347"}, {"RECTYPE": "D", "MH": "Surface Plasmon Resonance", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Surface Plasmon Resonances", "MN": "E05.601.043.700", "MH_TH": "NLM (1999)", "ST": "T063", "AN": "do not confuse with plasmon, extrachromosomal genetic material", "PI": "Biosensing Techniques (1991-1998)", "MS": "A biosensing technique in which biomolecules capable of binding to specific analytes or ligands are first immobilized on one side of a metallic film. Light is then focused on the opposite side of the film to excite the surface plasmons, that is, the oscillations of free electrons propagating along the film's surface. The refractive index of light reflecting off this surface is measured. When the immobilized biomolecules are bound by their ligands, an alteration in surface plasmons on the opposite side of the film is created which is directly proportional to the change in bound, or adsorbed, mass. Binding is measured by changes in the refractive index. The technique is used to study biomolecular interactions, such as antigen-antibody binding.", "PM": "99", "HN": "99", "MR": "20150623", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020349"}, {"RECTYPE": "D", "MH": "Graft vs Tumor Effect", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Graft vs Neoplasm Effect|T042|NON|EQV|NLM (1999)|980406|GRAFT VS NEOPL EFFECT|abcdefv", "ENTRY": "Responses, Graft-vs-Tumor", "MN": "G12.875.402.320", "MH_TH": "NLM (1999)", "ST": "T042", "PI": "Graft vs Host Reaction (1973-1998)", "MS": "Immunological rejection of tumor tissue/cells following bone marrow transplantation.", "PM": "99", "HN": "99", "MR": "20160623", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020350"}, {"RECTYPE": "D", "MH": "Cholates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cholate|T109|T121|T123|NON|NRW|NLM (1999)|980227|abbbcdef", "MN": "D04.210.500.221.430.130.330", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "0", "AN": "SODIUM CHOLATE is available", "MS": "Salts and esters of CHOLIC ACID.", "PM": "99; CHOLATE was indexed under CHOLIC ACIDS 1983-98", "HN": "99; for CHOLATE use CHOLIC ACIDS (NM) 1981-98", "MR": "20160528", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020355"}, {"RECTYPE": "D", "MH": "Selenomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Selenomonas ruminantium|T007|NON|NRW|NLM (1999)|980227|abcdef", "MN": "B03.440.425.410.800.877", "MH_TH": "NLM (1999)", "ST": "T007", "RN": "txid970", "RR": "txid971", "AN": "infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Gram-Negative Anaerobic Bacteria (1978-1998)", "MS": "Curved bacteria, usually crescent-shaped rods, with ends often tapered, occurring singly, in pairs, or short chains. They are non-encapsulated, non-sporing, motile, and ferment glucose. Selenomonas are found mainly in the human buccal cavity, the rumen of herbivores, and the cecum of pigs and several rodents. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020357"}, {"RECTYPE": "D", "MH": "Sodium Cholate", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Choleate, Sodium", "MN": "D04.210.500.221.430.130.330.850", "EC": "analogs & derivatives:Cholates", "MH_TH": "NLM (1999)", "ST": "T123", "N1": "Cholan-24-oic acid, 3,7,12-trihydroxy-, monosodium salt,(3alpha,5beta,7alpha,12alpha)-", "RN": "NU3Y4CCH8Z", "RR": "361-09-1 (Sodium Cholate)", "AN": "CHOLATES is available", "PI": "Cholic Acids (1978-1998)", "MS": "A trihydroxy bile salt that is used as a digestive aid in dietary supplements. It is used in culture media and in conjunction with PAPAIN and PANCREATIN.", "PM": "99; SODIUM CHOLATE was indexed under CHOLIC ACIDS 1983-98", "HN": "99; use SODIUM CHOLATE (NM) 1981-98", "MR": "20160531", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020358"}, {"RECTYPE": "D", "MH": "Neoadjuvant Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Neoadjuvant Treatment|T061|NON|EQV|NLM (1999)|980227|abcdef", "ENTRY": "Treatment, Neoadjuvant Systemic", "MN": "E02.186.450", "MH_TH": "NLM (1999)", "ST": "T061", "PI": "Combined Modality Therapy (1984-1998)", "MS": "Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, IMMUNOTHERAPY, HYPERTHERMIA, INDUCED etc.) that is given before the main therapy.", "PM": "99", "HN": "99", "MR": "20220714", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020360"}, {"RECTYPE": "D", "MH": "Paraneoplastic Syndromes, Nervous System", "DE": "PARANEOPL SYNDROMES NERVOUS SYSTEM", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paraneoplastic Encephalomyelitis|T047|NON|NRW|NLM (2000)|991012|PARANEOPL ENCEPH|abcdefv", "ENTRY": "Syndromes, Paraneoplastic Neurologic", "MN": "C10.574.781", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Paraneoplastic Syndromes (1980-1999)", "MS": "Degenerative or inflammatory conditions affecting the central or peripheral nervous system that develop in association with a systemic neoplasm without direct invasion by tumor. They may be associated with circulating antibodies that react with the affected neural tissue. (Intern Med 1996 Dec;35(12):925-9)", "PM": "2000", "HN": "2000", "MR": "20110624", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020361"}, {"RECTYPE": "D", "MH": "Paraneoplastic Cerebellar Degeneration", "DE": "PARANEOPL CEREBELLAR DEGENERATION", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paraneoplastic Cerebellar Degeneration, Anti-Yo-Associated|T047|NON|NRW|NLM (2000)|991012|PARANEOPL CEREBELLAR DEGENERATION ANTI YO ASSOC|abcdefv", "ENTRY": "Paraneoplastic Cerebellar Syndromes", "MN": "C10.574.781.700", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coord with precoord organ/neopl term + histol type", "PI": "Paraneoplastic Syndromes (1980-1999)", "MS": "Cerebellar degeneration associated with a remote neoplasm. Clinical manifestations include progressive limb and GAIT ATAXIA; DYSARTHRIA; and NYSTAGMUS, PATHOLOGIC. The histologic type of the associated neoplasm is usually carcinoma or lymphoma. Pathologically the cerebellar cortex and subcortical nuclei demonstrate diffuse degenerative changes. Anti-Purkinje cell antibodies (anti-Yo) are found in the serum of approximately 50% of affected individuals. (Adams et al., Principles of Neurology, 6th ed, p686)", "PM": "2000", "HN": "2000", "MR": "20090706", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020362"}, {"RECTYPE": "D", "MH": "Limbic Encephalitis", "DE": "LIMBIC ENCEPH", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paraneoplastic Limbic Encephalitis|T047|NON|EQV|NLM (2000)|991012|PARANEOPL LIMBIC ENCEPH|abcdefv", "ENTRY": "Limbic Encephalitis, Paraneoplastic", "MN": "C10.586.250.525", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Paraneoplastic Syndromes (1980-1999)", "MS": "A paraneoplastic syndrome marked by degeneration of neurons in the LIMBIC SYSTEM. Clinical features include HALLUCINATIONS, loss of EPISODIC MEMORY; ANOSMIA; AGEUSIA; TEMPORAL LOBE EPILEPSY; DEMENTIA; and affective disturbance (depression). Circulating anti-neuronal antibodies (e.g., anti-Hu; anti-Yo; anti-Ri; and anti-Ma2) and small cell lung carcinomas or testicular carcinoma are frequently associated with this syndrome.", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020363"}, {"RECTYPE": "D", "MH": "Paraneoplastic Polyneuropathy", "DE": "PARANEOPL POLYNEUROPATHY", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Polyneuropathy, Paraneoplastic|T047|NON|EQV|NLM (2000)|991012|POLYNEUROPATHY PARANEOPL|abcdefv", "ENTRY": "Polyneuropathies, Paraneoplastic", "MN": "C10.668.829.800.662", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Peripheral Nervous System Diseases/etiology (1968-1999)", "MS": "A diffuse or multifocal peripheral neuropathy related to the remote effects of a neoplasm, most often carcinoma or lymphoma. Pathologically, there are inflammatory changes in peripheral nerves. The most common clinical presentation is a symmetric distal mixed sensorimotor polyneuropathy. (Adams et al., Principles of Neurology, 6th ed, p1334)", "PM": "2000", "HN": "2000", "MR": "20000622", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020364"}, {"RECTYPE": "D", "MH": "RNA Helicases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Helicases, RNA", "MN": "D08.811.913.696.445.735.720", "MH_TH": "NLM (1999)", "ST": "T126", "RN": "EC 3.6.4.13", "PI": "RNA Nucleotidyltransferases (1989-1998)", "MS": "A family of proteins that promote unwinding of RNA during splicing and translation.", "PM": "99; RNA HELICASE was indexed under RNA NUCLEOTIDYLTRANSFERASES 1992-98", "HN": "99; for RNA HELICASE use RNA HELICASES 1989-98", "MR": "20130708", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020365"}, {"RECTYPE": "D", "MH": "Methylmethacrylate", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Methylmethacrylate Methyl Monomer|T109|T122|NON|EQV|NLM (1999)|980317|abbcdef", "ENTRY": "Zimmer Bone Cements", "MN": "J01.637.051.720.716.822.111.650.605.450", "PA": "Bone Cements", "MH_TH": "NLM (1999)", "ST": "T122", "N1": "2-Propenoic acid, 2-methyl- methyl ester", "RN": "196OC77688", "RR": "80-62-6 (Methylmethacrylate)", "AN": "POLYMETHYL METHACRYLATE is available", "PI": "Methylmethacrylates (1974-1998)", "MS": "The methyl ester of methacrylic acid. It polymerizes easily to form POLYMETHYL METHACRYLATE. It is used as a bone cement.", "PM": "99; METHYLMETHACRYLATE was indexed under METHYLMETHACRYLATES 1974-98", "HN": "99; use METHYLMETHACRYLATE (NM) 1980-98", "MR": "20150623", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020366"}, {"RECTYPE": "D", "MH": "Iofetamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "N-Isopropyl-p-iodoamphetamine|T109|T130|NON|EQV|NLM (1999)|980310|ISOPROPYL IODOAMPHETAMINE N P|abbcdefs", "ENTRY": "N Isopropyl p iodoamphetamine", "MN": "D02.092.471.683.152.535", "PA": "Radiopharmaceuticals", "MH_TH": "NLM (1999)", "ST": "T130", "N1": "Benzeneethanamine, 4-iodo-alpha-methyl-N-(1-methylethyl)-", "RN": "C2A5X08042", "RR": "R5O1XB5L3M", "PI": "Amphetamines (1980-1998)", "MS": "An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.", "PM": "99; IOFETAMINE was indexed under AMPHETAMINES 1980-98", "HN": "99; use IOFETAMINE (NM) 1980-98", "MR": "20130708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020367"}, {"RECTYPE": "D", "MH": "Bradyrhizobium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.035.090", "MH_TH": "NLM (1999)", "ST": "T007", "RN": "txid374", "PI": "Rhizobium (1985-1998)", "MS": "A genus of gram-negative, aerobic, rod-shaped bacteria usually containing granules of poly-beta-hydroxybutyrate. They characteristically invade the root hairs of leguminous plants and act as intracellular symbionts.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020369"}, {"RECTYPE": "D", "MH": "Osteoarthritis, Knee", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Osteoarthritis of the Knee|T047|NON|EQV|NLM (2020)|190124|abcdef", "ENTRY": "Knee Osteoarthritis", "MN": "C05.799.613.500", "MH_TH": "NLM (1999)", "ST": "T047", "PI": "Osteoarthritis (1965-1998)", "MS": "Noninflammatory degenerative disease of the knee joint consisting of three large categories: conditions that block normal synchronous movement, conditions that produce abnormal pathways of motion, and conditions that cause stress concentration resulting in changes to articular cartilage. (Crenshaw, Campbell's Operative Orthopaedics, 8th ed, p2019)", "PM": "99", "HN": "99", "MR": "20190222", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020370"}, {"RECTYPE": "D", "MH": "Pelizaeus-Merzbacher Disease", "DE": "PELIZAEUS MERZBACHER DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cockayne-Pelizaeus-Merzbacher Disease|T047|EPO|NRW|GHR (2014)|NLM (2000)|991012|COCKAYNE PELIZAEUS MERZBACHER DIS|abcdeefv", "ENTRY": "Transitional Pelizaeus Merzbacher Disease", "MN": "C18.452.648.189.362.775", "FX": "Myelin Proteolipid Protein", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Multiple Sclerosis (1966-1999)", "MS": "A rare, slowly progressive disorder of myelin formation. Subtypes are referred to as classic, congenital, transitional, and adult forms of this disease. The classic form is X-chromosome linked, has its onset in infancy and is associated with a mutation of the proteolipid protein gene. Clinical manifestations include TREMOR, spasmus nutans, roving eye movements, ATAXIA, spasticity, and NYSTAGMUS, CONGENITAL. Death occurs by the third decade of life. The congenital form has similar characteristics but presents early in infancy and features rapid disease progression. Transitional and adult subtypes have a later onset and less severe symptomatology. Pathologic features include patchy areas of demyelination with preservation of perivascular islands (trigoid appearance). (From Menkes, Textbook of Child Neurology, 5th ed, p190)", "PM": "2000; see CEREBRAL SCLEROSIS, DIFFUSE 1979-1999", "HN": "2000; use CEREBRAL SCLEROSIS, DIFFUSE 1979-1999", "MR": "20160226", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020371"}, {"RECTYPE": "D", "MH": "Dexfenfluramine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Dexfenfluramine", "MN": "D02.092.471.683.338", "PA": "Serotonin Receptor Agonists", "MH_TH": "NLM (1999)", "ST": "T121", "N1": "Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (S)-", "RN": "E35R3G56OV", "RR": "PM28L0FHNP", "PI": "Fenfluramine (1986-1998)", "MS": "The S-isomer of FENFLURAMINE. It is a serotonin agonist and is used as an anorectic. Unlike fenfluramine, it does not possess any catecholamine agonist activity.", "PM": "99", "HN": "99", "MR": "20160701", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020372"}, {"RECTYPE": "D", "MH": "Chromatography, Micellar Electrokinetic Capillary", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Micellar Electrokinetic Capillary Chromatography|T059|NON|EQV|NLM (1999)|980303|MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGR|abcdefv", "MN": "E05.196.181.500", "FX": "Electrophoresis, Capillary", "MH_TH": "NLM (1999)", "ST": "T059", "AN": "do not confuse with capillary gas chromatography (= CHROMATOGRAPHY, GAS)", "PI": "Electrophoresis, Capillary (1996-1998)", "MS": "A hybrid separation technique combining both chromatographic and electrophoretic separation principles. While the method was invented to separate neutral species, it can also be applied to charged molecules such as small peptides.", "PM": "99", "HN": "99", "DA": "19980618", "DC": "1", "DX": "19990101", "UI": "D020374"}, {"RECTYPE": "D", "MH": "Education, Distance", "DE": "EDUC DISTANCE", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Distance Learning|T065|NON|NRW|NLM (1999)|980304|abcdef", "ENTRY": "Online Educations", "MN": "I02.195", "FX": "Computer Communication Networks", "MH_TH": "NLM (1999)", "ST": "T065", "AN": "do not confuse with COMPUTER-ASSISTED INSTRUCTION", "MS": "Education via communication media (correspondence, radio, television, computer networks) with little or no in-person face-to-face contact between students and teachers. (ERIC Thesaurus, 1997)", "PM": "99; for CORRESPONDENCE COURSES see EDUCATION 1978-98", "HN": "99; for CORRESPONDENCE COURSES see EDUCATION 1978-98", "MR": "20170630", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020375"}, {"RECTYPE": "D", "MH": "Dichelobacter nodosus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Dichelobacter|T007|NON|BRD|NLM (2004)|030102|abcdef", "MN": "B03.660.250.080.550", "FX": "Foot Rot", "MH_TH": "NLM (1999)", "ST": "T007", "RN": "txid870", "RR": "txid869", "AN": "infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS and FOOT ROT or DIGITAL DERMATITIS if pertinent", "PI": "Bacteroides (1991-1998)", "MS": "A gram-negative, obligate anaerobe of the family Cardiobacteriaceae. It has polar fimbriae and is the causative agent of FOOT ROT and DIGITAL DERMATITIS. It is the lone species in the genus Dichelobacter.", "PM": "99", "HN": "99", "MR": "20200813", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020376"}, {"RECTYPE": "D", "MH": "Self Efficacy", "ENTRY": "Efficacy, Self", "MN": "F01.752.747.792.700", "MH_TH": "NLM (1999)", "ST": "T041", "PI": "Self Concept (1969-1998)", "MS": "Cognitive mechanism based on expectations or beliefs about one's ability to perform actions necessary to produce a given effect. It is also a theoretical component of behavior change in various therapeutic treatments. (APA, Thesaurus of Psychological Index Terms, 1994)", "PM": "99", "HN": "99", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020377"}, {"RECTYPE": "D", "MH": "Confined Spaces", "PRINT ENTRY": "Unventilated Spaces|T072|NON|REL|NLM (1999)|980522|abcdef", "ENTRY": "Unventilated Space", "MN": "N06.230.074", "FX": "Ventilation", "MH_TH": "NLM (1999)", "ST": "T072", "AN": "do not use with claustrophobia", "MS": "A space which has limited openings for entry and exit combined with unfavorable natural ventilation such as CAVES, refrigerators, deep tunnels, pipelines, sewers, silos, tanks, vats, mines, deep trenches or pits, vaults, manholes, chimneys, etc.", "PM": "99", "HN": "99", "MR": "20110624", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020378"}, {"RECTYPE": "D", "MH": "Risk Adjustment", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Case-Mix Adjustment|T081|NON|REL|NLM (1999)|980305|abcdef", "ENTRY": "Risk Adjustments", "MN": "N05.715.360.750.625.700.690.800", "MH_TH": "NLM (1999)", "ST": "T081", "MS": "The use of severity-of-illness measures, such as age, to estimate the risk (measurable or predictable chance of loss, injury or death) to which a patient is subject before receiving some health care intervention. This adjustment allows comparison of performance and quality across organizations, practitioners, and communities. (from JCAHO, Lexikon, 1994)", "PM": "99", "HN": "99", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020379"}, {"RECTYPE": "D", "MH": "Needs Assessment", "DE": "NEEDS ASSESS", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Educational Needs Assessment|T057|NON|NRW|NLM (1999)|980518|EDUC NEEDS ASSESS|abcdefv", "ENTRY": "Needs Assessments, Healthcare", "MN": "N05.300.537", "MH_TH": "NLM (1999)", "ST": "T081", "MS": "Systematic identification of a population's needs or the assessment of individuals to determine the proper level of services needed.", "PM": "99; ASSESSMENT OF HEALTH CARE NEEDS & DETERMINATION OF HEALTH CARE NEEDS see HEALTH SERVICES NEEDS AND DEMAND 1980-98", "HN": "99; ASSESSMENT OF HEALTH CARE NEEDS & DETERMINATION OF HEALTH CARE NEEDS use HEALTH SERVICES NEEDS AND DEMAND 1980-98", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020380"}, {"RECTYPE": "D", "MH": "Interleukin-17", "DS": "INTERLEUKIN 017", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "IL-17|T116|T129|ABB|EQV|NLM (1999)|980306|IL 017|abbcdefs", "ENTRY": "Interleukin 25", "MN": "D23.529.374.465.517", "MH_TH": "NLM (1999)", "ST": "T129", "RN": "0", "PI": "Interleukins (1995-1998)", "MS": "A proinflammatory cytokine produced primarily by T-LYMPHOCYTES or their precursors. Several subtypes of interleukin-17 have been identified, each of which is a product of a unique gene.", "PM": "1999; INTERLEUKIN 17 was indexed under INTERLEUKINS 1996-1998; INTERLEUKIN-17E was indexed under INTERLEUKIN-17 & CYTOKINES 2001-2006; INTERLEUKIN-17B was indexed under INTERLEUKIN-17 2002-2006", "HN": "1999(1996)", "MR": "20130708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020381"}, {"RECTYPE": "D", "MH": "Interleukin-18", "DS": "INTERLEUKIN 018", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Interferon-gamma-Inducing Factor|T116|T129|NON|EQV|NLM (1999)|980306|IGIF|abbcdefv", "ENTRY": "Interleukin 18", "MN": "D23.529.374.465.518", "MH_TH": "NLM (1999)", "ST": "T129", "RN": "0", "PI": "Cytokines (1995-1998)", "MS": "A cytokine which resembles IL-1 structurally and IL-12 functionally. It enhances the cytotoxic activity of NK CELLS and CYTOTOXIC T-LYMPHOCYTES, and appears to play a role both as neuroimmunomodulator and in the induction of mucosal immunity.", "PM": "99; INTERFERON-GAMMA INDUCING FACTOR (now INTERLEUKIN-18) was indexed under CYTOKINES 1995-98", "HN": "99; use INTERLEUKIN-18 (NM) 1995-98", "MR": "20060705", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020382"}, {"RECTYPE": "D", "MH": "Neutral Glycosphingolipids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Glycosphingolipids, Neutral", "MN": "D10.570.877.360.612", "MH_TH": "NLM (1999)", "ST": "T109", "RN": "0", "PI": "Glycosphingolipids (1975-1998)", "MS": "A subclass of GLYCOSPHINGOLIPIDS containing one or more sugars within their head group connected directly to a ceramide moiety. They consist of monoglycosyl-, and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides.", "PM": "99", "HN": "99", "MR": "20040707", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020383"}, {"RECTYPE": "D", "MH": "Acidic Glycosphingolipids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Glycosphingolipids, Acidic", "MN": "D10.570.877.360.025", "MH_TH": "NLM (1999)", "ST": "T109", "RN": "0", "PI": "Glycosphingolipids (1983-1998)", "MS": "A subclass of GLYCOSPHINGOLIPIDS containing large polar heads made up of several sugar units. One or more of their terminal sugar units are bound to a negatively charged molecule at pH 7. Members of this class include: GANGLIOSIDES, uronoglycosphingolipids, SULFOGLYCOSPHINGOLIPIDS, phosphoglycosphingolipids, and phosphonoglycosphingolipids.", "PM": "99", "HN": "99", "MR": "20040707", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020384"}, {"RECTYPE": "D", "MH": "Myokymia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Myokymias, Generalized", "MN": "C23.888.592.608.650", "MH_TH": "UNK (19XX)", "ST": "T184", "AN": "consider also FASCICULATION; for continuous myokymia use ISAACS SYNDROME", "PI": "Fasciculation (1985-1999)", "MS": "Successive and rapid contractions of motor units associated with chronic nerve injury. The discharges arise from the peripheral aspects of regenerating nerves, and clinically impart a nearly continuous undulation of the body surface overlying the muscle. (Adams et al., Principles of Neurology, 6th ed, p1491)", "PM": "2000; see FASCICULATION 1985-1999", "HN": "2000; use FASCICULATION 1985-1999", "MR": "20090706", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020385"}, {"RECTYPE": "D", "MH": "Isaacs Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pseudomyotonia|T047|NON|REL|NLM (2000)|991012|abcdef", "ENTRY": "Neuromyotonia, Acquired", "MN": "C10.668.829.425", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Fasciculation (1995-1999)", "MS": "A rare neuromuscular disorder with onset usually in late childhood or early adulthood, characterized by intermittent or continuous widespread involuntary muscle contractions; FASCICULATION; hyporeflexia; MUSCLE CRAMP; MUSCLE WEAKNESS; HYPERHIDROSIS; TACHYCARDIA; and MYOKYMIA. Involvement of pharyngeal or laryngeal muscles may interfere with speech and breathing. The continuous motor activity persists during sleep and general anesthesia (distinguishing this condition from STIFF-PERSON SYNDROME). Familial and acquired (primarily autoimmune) forms have been reported. (From Ann NY Acad Sci 1998 May 13;841:482-496; Adams et al., Principles of Neurology, 6th ed, p1491)", "PM": "2000; for ISAACS' SYNDROME see FASCICULATION 1995-1999", "HN": "2000; for ISAACS' SYNDROME use FASCICULATION 1995-1999", "MR": "20190517", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020386"}, {"RECTYPE": "D", "MH": "Food Chain", "PRINT ENTRY": "Saprophytic Chain|T070|NON|NRW|NLM (1999)|980309|abcdef", "ENTRY": "Webs, Food", "MN": "N06.230.124.250", "MH_TH": "NLM (1999)", "ST": "T070", "MS": "The sequence of transfers of matter and energy from organism to organism in the form of FOOD. Food chains intertwine locally into a food web because most organisms consume more than one type of animal or plant. PLANTS, which convert SOLAR ENERGY to food by PHOTOSYNTHESIS, are the primary food source. In a predator chain, a plant-eating animal is eaten by a larger animal. In a parasite chain, a smaller organism consumes part of a larger host and may itself be parasitized by smaller organisms. In a saprophytic chain, microorganisms live on dead organic matter.", "PM": "99", "HN": "99", "MR": "20150623", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020387"}, {"RECTYPE": "D", "MH": "Muscular Dystrophy, Duchenne", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "PRINT ENTRY": "Muscular Dystrophy, Pseudohypertrophic|T047|NON|EQV|GHR (2014)|NLM (2000)|991012|abcdeef", "ENTRY": "Pseudohypertrophic Muscular Dystrophy", "MN": "C16.320.577.300", "FX": "Dystrophin", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Muscular Dystrophies (1966-1999)", "MS": "An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)", "PM": "2000; see MUSCULAR DYSTROPHIES 1980-1999; for MUSCULAR DYSTROPHY, BECKER & BECKER MUSCULAR DYSTROPHY see MUSCULAR DYSTROPHIES 1991-1999", "HN": "2000; use MUSCULAR DYSTROPHIES 1980-1999; for MUSCULAR DYSTROPHY, BECKER & BECKER MUSCULAR DYSTROPHY use MUSCULAR DYSTROPHIES 1991-1999", "MR": "20130708", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020388"}, {"RECTYPE": "D", "MH": "Muscular Dystrophy, Emery-Dreifuss", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "PRINT ENTRY": "Emery-Dreifuss Syndrome|T047|EPO|EQV|GHR (2014)|NLM (2000)|991012|abcdeef", "ENTRY": "Scapuloperoneal Myopathy, MYH7 Related", "MN": "C16.320.577.350", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Muscular Dystrophies (1966-1999)", "MS": "A heterogenous group of inherited muscular dystrophy without the involvement of nervous system. The disease is characterized by MUSCULAR ATROPHY; MUSCLE WEAKNESS; CONTRACTURE of the elbows; ACHILLES TENDON; and posterior cervical muscles; with or without cardiac features. There are several INHERITANCE PATTERNS including X-linked (X CHROMOSOME), autosomal dominant (for LMNA-associated type see AUTOSOMAL EMERY-DREIFUSS MUSCULAR DYSTROPHY), and autosomal recessive gene mutations.", "PM": "2000; for MUSCULAR DYSTROPHY, SCAPULOPERONEAL see MUSCULAR DYSTROPHIES 2000-2004", "HN": "2000; for MUSCULAR DYSTROPHY, SCAPULOPERONEAL use MUSCULAR DYSTROPHIES 2000-2004", "MR": "20200221", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020389"}, {"RECTYPE": "D", "MH": "Tooth Socket", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Dental Alveolus|T023|NON|EQV|NLM (1999)|980309|abcdef", "ENTRY": "Tooth Sockets", "MN": "A14.549.167.646.094.800", "MH_TH": "NLM (1999)", "ST": "T023", "PI": "Alveolar Process (1966-1998)", "MS": "A hollow part of the alveolar process of the MAXILLA or MANDIBLE where each tooth fits and is attached via the periodontal ligament.", "PM": "99", "HN": "99", "MR": "20180629", "DA": "19980618", "DC": "1", "DX": "19990101", "UI": "D020390"}, {"RECTYPE": "D", "MH": "Muscular Dystrophy, Facioscapulohumeral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "PRINT ENTRY": "Landouzy-Dejerine Dystrophy|T047|NON|EQV|GHR (2014)|NLM (2000)|991012|abcdeef", "ENTRY": "Muscular Dystrophies, Facioscapulohumeral", "MN": "C16.320.577.400", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Muscular Dystrophies (1966-1999)", "MS": "An autosomal dominant degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. The onset of symptoms usually occurs in the first or second decade of life. Affected individuals usually present with impairment of upper extremity elevation. This tends to be followed by facial weakness, primarily involving the orbicularis oris and orbicularis oculi muscles. (Neuromuscul Disord 1997;7(1):55-62; Adams et al., Principles of Neurology, 6th ed, p1420)", "PM": "2000", "HN": "2000", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020391"}, {"RECTYPE": "D", "MH": "Entopeduncular Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Nucleus Entopeduncularis|T023|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Nucleus, Entopeduncular", "MN": "A08.186.211.200.317.800.240", "FX": "Globus Pallidus", "MH_TH": "NLM (2000)", "ST": "T023", "AN": "for non-primates medial globus pallidus is ENTOPEDUNCULAR NUCLEUS", "PI": "Globus Pallidus (1967-1999)", "MS": "A portion of the nucleus of ansa lenticularis located medial to the posterior limb of the internal capsule, along the course of the ansa lenticularis and the inferior thalamic peduncle or as a separate nucleus within the internal capsule adjacent to the medial GLOBUS PALLIDUS (NeuroNames, http://rprcsgi.rprc. washington.edu/neuronames/ (September 28, 1998)). In non-primates, the entopeduncular nucleus is analogous to both the medial globus pallidus and the entopeduncular nucleus of human.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020392"}, {"RECTYPE": "D", "MH": "Manipulation, Spinal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Spinal Manipulation|T061|NON|EQV|NLM (1999)|980309|abcdef", "ENTRY": "Manipulation, Lumbar", "MN": "E02.831.535.867.466", "MH_TH": "NLM (1999)", "ST": "T061", "PI": "Manipulation, Orthopedic (1966-1998)", "MS": "Adjustment and manipulation of the vertebral column.", "PM": "1999", "HN": "1999", "MR": "20160531", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020393"}, {"RECTYPE": "D", "MH": "Vault Ribonucleoprotein Particles", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vault RNP Particles|T116|T123|EQV|NLM (1999)|980410|abbdef", "ENTRY": "Vault Ribonucleoprotein Particle", "MN": "D12.776.664.962.500.937", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1986-1998)", "MS": "Large cytoplasmic ribonucleoprotein particles that have an eight-fold symmetry with a central pore and petal-like structure giving the appearance of an octagonal dome. (The Dictionary of Cell Biology, Lackie and Dow, 2nd ed.)", "PM": "99", "HN": "99", "MR": "20210701", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020394"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-7", "DE": "RECEPT IL 7", "DS": "RECEPTORS INTERLEUKIN 007", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, IL-7|T116|T192|EQV|NLM (1999)|980309|RECEPTORS IL 007|RECEPT IL7|abbdefsv", "ENTRY": "Receptors, Interleukin 7", "MN": "D12.776.543.750.705.852.420.420", "MH_TH": "NLM (1999)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (1994-1998)", "MS": "Cell surface receptors that are specific for INTERLEUKIN-7. They are present on T-LYMPHOCYTES and B-LYMPHOCYTE precursors. The receptors are heterodimeric proteins consisting of the INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR COMMON BETA SUBUNIT.", "PM": "1999; INTERLEUKIN 7 RECEPTOR (now RECEPTORS, INTERLEUKIN-7) was indexed under RECEPTORS, INTERLEUKIN 1994-98, ANTIGENS, CD 1991-98, & RECEPTORS, IMMUNOLOGIC 1990-93", "HN": "1999; use RECEPTORS, INTERLEUKIN-7 (NM) 1990-98", "MR": "20170524", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020395"}, {"RECTYPE": "D", "MH": "Goblet Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Goblet Cell", "MN": "A11.436.298", "MH_TH": "NLM (1999)", "ST": "T025", "MS": "A glandular epithelial cell or a unicellular gland. Goblet cells secrete MUCUS. They are scattered in the epithelial linings of many organs, especially the SMALL INTESTINE and the RESPIRATORY TRACT.", "PM": "99", "HN": "99", "MR": "20210510", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020397"}, {"RECTYPE": "D", "MH": "Medicare Part C", "DE": "MEDICARE C", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Medicare Plus Choice|T089|NON|EQV|NLM (1999)|980310|abcdef", "ENTRY": "Programs, Medicare+Choice (US)", "MN": "N03.706.615.420.249", "MH_TH": "NLM (1999)", "ST": "T089", "AN": "specify state if given; CATALOGER: Coordinate with specific NAF entry if applicable", "MS": "The Balanced Budget Act (BBA) of 1997 establishes a Medicare+Choice program under part C of Title XVIII, Section 4001, of the Social Security Act. Under this program, an eligible individual may elect to receive Medicare benefits through enrollment in a Medicare+Choice plan. Beneficiaries may choose to use private pay options, establish medical savings accounts, use managed care plans, or join provider-sponsored plans.", "PM": "99", "HN": "99", "MR": "20150605", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020398"}, {"RECTYPE": "D", "MH": "Practice Management", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Practice Management Services|T057|NON|NRW|NLM (1999)|980515|PRACTICE MANAGEMENT SERV|abcdefv", "ENTRY": "Service, Practice Management", "MN": "N04.452.758.708", "MH_TH": "NLM (1999)", "ST": "T057", "MS": "Business management of medical, dental and veterinary practices that may include capital financing, utilization management, and arrangement of capitation agreements with other parties.", "PM": "99", "HN": "99", "MR": "20140616", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020399"}, {"RECTYPE": "D", "MH": "Provider-Sponsored Organizations", "DE": "PROVIDER SPONSORED ORGAN", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Provider-Sponsored Organization", "MN": "N05.300.262.600", "MH_TH": "NLM (1999)", "ST": "T093", "MS": "Entities sponsored by local hospitals, physician groups, and other licensed providers which are affiliated through common ownership or control and share financial risk whose purpose is to deliver health care services.", "PM": "99", "HN": "99", "MR": "19991103", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020400"}, {"RECTYPE": "D", "MH": "Primed In Situ Labeling", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "PRINS|T063|ABB|EQV|NLM (1999)|980310|abcdef", "MN": "E05.393.661.475.680", "MH_TH": "NLM (1999)", "ST": "T063", "PI": "In Situ Hybridization, Fluorescence (1993-1998)", "MS": "A technique that labels specific sequences in whole chromosomes by in situ DNA chain elongation or PCR (polymerase chain reaction).", "PM": "99", "HN": "99", "MR": "20110624", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020401"}, {"RECTYPE": "D", "MH": "Medical Savings Accounts", "DE": "MED SAVINGS ACCOUNTS", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Savings Accounts, Medical|T064|NON|EQV|NLM (1999)|980406|SAVINGS ACCOUNTS MED|abcdefv", "ENTRY": "Medical Savings Account", "MN": "N03.219.559.500", "MH_TH": "NLM (1999)", "ST": "T064", "MS": "Tax-exempt trusts or custodial accounts established by individuals with financial institutions for saving money for future medical expenses.", "PM": "99", "HN": "99", "MR": "20180227", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020402"}, {"RECTYPE": "D", "MH": "Patient Freedom of Choice Laws", "AQ": "CL EC ES HI OG SN ST TD", "PRINT ENTRY": "Selective Provider Restrictions|T089|NON|EQV|NLM (1999)|980310|abcdef", "ENTRY": "Selective Provider Restriction", "MN": "N04.590.374.410.700", "MH_TH": "NLM (1999)", "ST": "T089", "MS": "Laws requiring patients under managed care programs to receive services from the physician or other provider of their choice. Any willing provider laws take many different forms, but they typically prohibit managed-care organizations from having a closed panel of physicians, hospitals, or other providers.", "PM": "99", "HN": "99", "MR": "20090706", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020403"}, {"RECTYPE": "D", "MH": "Glycerophospholipids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphoglycerides|T109|T123|NON|EQV|NLM (1999)|980310|abbcdef", "MN": "D10.570.755.375.760.400", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "0", "PI": "Phosphatidic Acids (1977-1998)", "MS": "Derivatives of phosphatidic acid in which the hydrophobic regions are composed of two fatty acids and a polar alcohol is joined to the C-3 position of glycerol through a phosphodiester bond. They are named according to their polar head groups, such as phosphatidylcholine and phosphatidylethanolamine.", "PM": "99; for PHOSPHOGLYCERIDES see GLYCEROPHOSPHATES 1977-98", "HN": "99; for PHOSPHOGLYCERIDES use GLYCEROPHOSPHATES 1977-98", "MR": "20200527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020404"}, {"RECTYPE": "D", "MH": "Dermis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Corium|T024|NON|EQV|NLM (1999)|980310|abcdef", "MN": "A17.815.180", "MH_TH": "NLM (1999)", "ST": "T024", "PI": "Skin (1966-1998)", "MS": "A layer of vascularized connective tissue underneath the EPIDERMIS. The surface of the dermis contains innervated papillae. Embedded in or beneath the dermis are SWEAT GLANDS; HAIR FOLLICLES; and SEBACEOUS GLANDS.", "PM": "99", "HN": "99", "MR": "20020703", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020405"}, {"RECTYPE": "D", "MH": "Medicare Payment Advisory Commission", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "MEDPAC|T097|ABB|EQV|NLM (1999)|980311|abcdef", "MN": "N03.219.521.710.305.200.500", "FX": "Prospective Payment Assessment Commission", "MH_TH": "NLM (1999)", "ST": "T097", "AN": "CATALOGER: Use NAF entry", "MS": "The Commission was created by the Balanced Budget Act of 1997 under Title XVIII. It is specifically charged to review the effect of Medicare+Choice under Medicare Part C and to review payment policies under Parts A and B. It is also generally charged to evaluate the effect of prospective payment policies and their impact on health care delivery in the US. The former Prospective Payment Assessment Commission (ProPAC) and the Physician Payment Review Commission (PPRC) were merged to form MEDPAC.", "PM": "99", "HN": "99", "MR": "20150605", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020406"}, {"RECTYPE": "D", "MH": "Internet", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "World Wide Web|T073|T170|NON|EQV|NLM (1999)|980515|abbcdef", "ENTRY": "Wide Web, World", "MN": "L01.224.230.110.500", "FX": "Cloud Computing", "MH_TH": "NLM (1999)", "ST": "T170", "PI": "Computer Communication Networks (1996-1998)", "MS": "A loose confederation of computer communication networks around the world. The networks that make up the Internet are connected through several backbone networks. The Internet grew out of the US Government ARPAnet project and was designed to facilitate information exchange.", "PM": "99; use COMPUTER COMMUNICATION NETWORKS 1996-98", "HN": "99; see COMPUTER COMMUNICATION NETWORKS 1996-98", "MR": "20170703", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020407"}, {"RECTYPE": "D", "MH": "Health Insurance Portability and Accountability Act", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "United States Health Insurance Portability and Accountability Act|T089|NON|EQV|NLM (2002)|001204|abcdef", "ENTRY": "Public Law 104 191", "MN": "N03.706.615.273", "MH_TH": "NLM (1999)", "ST": "T089", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "MS": "Public Law 104-91 enacted in 1996, was designed to improve the efficiency and effectiveness of the healthcare system, protect health insurance coverage for workers and their families, and to protect individual personal health information.", "PM": "99", "HN": "99", "MR": "20150605", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020408"}, {"RECTYPE": "D", "MH": "Molecular Motor Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Motility Proteins|T116|NON|NRW|NLM (2007)|051220|abcdef", "ENTRY": "Proteins, Motility", "MN": "D08.811.277.040.025.193", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "Proteins that are involved in or cause CELL MOVEMENT such as the rotary structures (flagellar motor) or the structures whose movement is directed along cytoskeletal filaments (MYOSIN; KINESIN; and DYNEIN motor families).", "PM": "2007; see MOLECULAR MOTORS 1999-2006", "HN": "2007(1999)", "MR": "20060705", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020409"}, {"RECTYPE": "D", "MH": "Activated-Leukocyte Cell Adhesion Molecule", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Neurolin|T116|T129|NON|REL|NLM (1999)|980311|abbcdef", "ENTRY": "Zebrafish Alcam protein", "MN": "D23.050.301.350.250.150.050", "MH_TH": "NLM (1999)", "ST": "T129", "RN": "0", "PI": "Nerve Tissue Proteins (1991-1998)", "MS": "Cell adhesion molecule expressed on activated leukocytes, fibroblasts, and neurons. It is a ligand for CD6. ALCAM-CD6 interactions may play a role in the binding of T and B cells to activated leukocytes.", "PM": "1999; CD6 LIGAND was indexed under GLYCOPROTEINS 1995-98; KG-CAM was indexed under CELL ADHESION MOLECULES, NEURON-GLIA 1996-98; and CELL ADHESION MOLECULES 1994-95; NEUROLIN was indexed under CELL ADHESION MOLECULES, NEURONAL 1992-98; all are now ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE", "HN": "1999 (1990)", "MR": "20230316", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020410"}, {"RECTYPE": "D", "MH": "Oligonucleotide Array Sequence Analysis", "DE": "OLIGONUCLEOTIDE ARRAY SEQ ANAL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "cDNA Microarrays|T074|T075|NON|REL|NLM (2001)|991201|abbcdef", "ENTRY": "cDNA Microarray", "MN": "E05.601.640", "FX": "Oligonucleotide Probes", "MH_TH": "NLM (1999)", "ST": "T063", "PI": "Nucleic Acid Hybridization (1993-1998)", "MS": "Hybridization of a nucleic acid sample to a very large set of OLIGONUCLEOTIDE PROBES, which have been attached individually in columns and rows to a solid support, to determine a BASE SEQUENCE, or to detect variations in a gene sequence, GENE EXPRESSION, or for GENE MAPPING.", "PM": "99", "HN": "99", "MR": "20220408", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020411"}, {"RECTYPE": "D", "MH": "Multifactorial Inheritance", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Polygenic Traits|T045|NON|REL|NLM (1999)|980312|abcdef", "ENTRY": "Traits, Polygenic", "MN": "G05.420.590", "FX": "Quantitative Trait, Heritable", "MH_TH": "NLM (1999)", "ST": "T045", "PI": "specific disease /genetics (1967-1998)", "MS": "A pattern of inheritance of a trait that includes the contributions from more than one gene.", "PM": "99", "HN": "99", "MR": "20171213", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020412"}, {"RECTYPE": "D", "MH": "3' Untranslated Regions", "DS": "UNTRANSLATED REGIONS 003", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "3'UTR|T114|T123|EQV|NLM (1999)|980312|UTR 003|abbdefs", "ENTRY": "Untranslated Regions, 3'", "MN": "G05.360.340.024.340.137.910.880", "FX": "3' Flanking Region", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "0", "AN": "do not confuse with 3' FLANKING REGION", "PI": "RNA, Messenger (1975-1998)", "MS": "The sequence at the 3' end of messenger RNA that does not code for product. This region contains transcription and translation regulating sequences.", "PM": "99", "HN": "99", "MR": "20090706", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020413"}, {"RECTYPE": "D", "MH": "Risk Sharing, Financial", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Financial Risk Sharing|T058|NON|EQV|NLM (1999)|980312|abcdef", "ENTRY": "Sharings, Financial Risk", "MN": "N04.452.871.800", "FX": "Managed Care Programs", "MH_TH": "NLM (1999)", "ST": "T058", "PI": "Risk Management (1995-1998)", "MS": "Any system which allows payors to share some of the financial risk associated with a particular patient population with providers. Providers agree to adhere to fixed fee schedules in exchange for an increase in their payor base and a chance to benefit from cost containment measures. Common risk-sharing methods are prospective payment schedules (PROSPECTIVE PAYMENT SYSTEM), capitation (CAPITATION FEES), diagnosis-related fees (DIAGNOSIS-RELATED GROUPS), and pre-negotiated fees.", "PM": "99", "HN": "99", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020414"}, {"RECTYPE": "D", "MH": "Personnel Downsizing", "AQ": "CL EC ES HI LJ MT OG PX SD SN ST TD", "PRINT ENTRY": "Staff Downsizing|T057|NON|EQV|NLM (1999)|980312|abcdef", "ENTRY": "Downsizing, Personnel", "MN": "N04.452.677.450", "MH_TH": "NLM (1999)", "ST": "T057", "PI": "Personnel Management (1990-1998)", "MS": "Reducing staff to cut costs or to achieve greater efficiency.", "PM": "99", "HN": "99", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020415"}, {"RECTYPE": "D", "MH": "Outsourced Services", "DE": "OUTSOURCED SERV", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Services, Outsourced|T057|NON|EQV|NLM (1999)|980312|SERV OUTSOURCED|abcdefv", "ENTRY": "Outsourced Service", "MN": "N03.219.463.100.600", "MH_TH": "NLM (1999)", "ST": "T057", "PI": "Contract Services (1996-1998)", "MS": "Organizational activities previously performed internally that are provided by external agents.", "PM": "99", "HN": "99", "MR": "19991103", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020416"}, {"RECTYPE": "D", "MH": "Nystagmus, Congenital", "DE": "NYSTAGMUS CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Congenital Nystagmus|T019|T047|NON|EQV|NLM (2000)|991012|CONGEN NYSTAGMUS|abbcdefv", "MN": "C16.614.643", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "do not use /congen; do not coord with INFANT, NEWBORN, DISEASES", "PI": "Nystagmus, Pathologic (1966-1999)", "MS": "Nystagmus present at birth or caused by lesions sustained in utero or at the time of birth. It is usually pendular, and is associated with ALBINISM and conditions characterized by early loss of central vision. Inheritance patterns may be X-linked, autosomal dominant, or recessive. (Adams et al., Principles of Neurology, 6th ed, p275)", "PM": "2000", "HN": "2000", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020417"}, {"RECTYPE": "D", "MH": "Algal Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gene Products, Algal|T116|NON|EQV|NLM (1999)|980313|abcdef", "ENTRY": "Proteins, Algal", "MN": "D12.776.037", "MH_TH": "NLM (1999)", "ST": "T116", "RN": "0", "AN": "coord IM with specific protein (IM) + specific alga (IM)", "PI": "Fungi (1963-1998)", "MS": "Proteins found in any species of algae.", "PM": "99", "HN": "99", "MR": "20200527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020418"}, {"RECTYPE": "D", "MH": "Photoreceptor Cells, Vertebrate", "DE": "PHOTORECEPT CELLS VERTEBRATE", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Rods and Cones|T025|NON|EQV|NLM (1999)|980317|RODS CONES|abcdefv", "ENTRY": "Vertebrate Photoreceptor Cell", "MN": "A11.671.650.915.937.670", "MH_TH": "NLM (2009)", "ST": "T025", "PI": "Photoreceptors (1971-1998)", "MS": "Specialized PHOTOTRANSDUCTION neurons in the vertebrates, such as the RETINAL ROD CELLS and the RETINAL CONE CELLS. Non-visual photoreceptor neurons have been reported in the deep brain, the PINEAL GLAND and organs of the circadian system.", "PM": "2009; see PHOTORECEPTORS, VERTEBRATE 1999-2008; see PHOTORECEPTORS 1997-1998; for RODS AND CONES see PHOTORECEPTORS 1997-1998, see RODS AND CONES 1966-1996; for RETINAL PHOTORECEPTORS see PHOTORECEPTORS 1997-2008", "HN": "2009 (1999); use PHOTORECEPTORS 1997-1998; for RODS AND CONES use PHOTORECEPTORS 1966-1998; for RETINAL PHOTORECEPTORS use PHOTORECEPTORS 1997-2008", "MR": "20080708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020419"}, {"RECTYPE": "D", "MH": "Cyst Fluid", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Fluids, Cyst", "MN": "A12.383.200", "MH_TH": "NLM (1999)", "ST": "T031", "AN": "breast cyst fluid: coord NIM with FIBROCYSTIC BREAST DISEASE (IM)", "PI": "Exudates and Transudates (1969-1998)", "MS": "Liquid material found in epithelial-lined closed cavities or sacs.", "PM": "99", "HN": "99", "MR": "20150623", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020420"}, {"RECTYPE": "D", "MH": "Vagus Nerve Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tenth Cranial Nerve Diseases|T047|NON|EQV|NLM (2000)|991012|TENTH CRANIAL NERVE DIS|abcdefv", "ENTRY": "Vagus Neuropathies", "MN": "C10.292.887", "FX": "Cranial Nerve Injuries", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "PI": "Vocal Cord Paralysis (1966-1999)", "MS": "Diseases of the tenth cranial nerve, including brain stem lesions involving its nuclei (solitary, ambiguus, and dorsal motor), nerve fascicles, and intracranial and extracranial course. Clinical manifestations may include dysphagia, vocal cord weakness, and alterations of parasympathetic tone in the thorax and abdomen.", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020421"}, {"RECTYPE": "D", "MH": "Mononeuropathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mononeuropathy Multiplex|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Syndromes, Mononeuropathy Multiplex", "MN": "C10.668.829.500", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Peripheral Nervous System Diseases (1968-1999)", "MS": "Disease or trauma involving a single peripheral nerve in isolation, or out of proportion to evidence of diffuse peripheral nerve dysfunction. Mononeuropathy multiplex refers to a condition characterized by multiple isolated nerve injuries. Mononeuropathies may result from a wide variety of causes, including ISCHEMIA; traumatic injury; compression; CONNECTIVE TISSUE DISEASES; CUMULATIVE TRAUMA DISORDERS; and other conditions.", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020422"}, {"RECTYPE": "D", "MH": "Median Neuropathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Median Nerve Diseases|T047|NON|EQV|NLM (2000)|991012|MEDIAN NERVE DIS|abcdefv", "ENTRY": "Proximal Median Neuropathy", "MN": "C10.668.829.500.500", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "pronator nerve syndrome: coordinate with NERVE COMPRESSION SYNDROMES", "PI": "Median Nerve (1967-1999)", "MS": "Disease involving the median nerve, from its origin at the BRACHIAL PLEXUS to its termination in the hand. Clinical features include weakness of wrist and finger flexion, forearm pronation, thenar abduction, and loss of sensation over the lateral palm, first three fingers, and radial half of the ring finger. Common sites of injury include the elbow, where the nerve passes through the two heads of the pronator teres muscle (pronator syndrome) and in the carpal tunnel (CARPAL TUNNEL SYNDROME).", "PM": "2000", "HN": "2000", "MR": "20180226", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020423"}, {"RECTYPE": "D", "MH": "Ulnar Neuropathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ulnar Nerve Diseases|T047|NON|EQV|NLM (2000)|991012|ULNAR NERVE DIS|abcdefv", "ENTRY": "Ulnar Neuropathy", "MN": "C10.668.829.500.850", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Ulnar Nerve (1966-1999)", "MS": "Disease involving the ULNAR NERVE from its origin in the BRACHIAL PLEXUS to its termination in the hand. Clinical manifestations may include PARESIS or PARALYSIS of wrist flexion, finger flexion, thumb adduction, finger abduction, and finger adduction. Sensation over the medial palm, fifth finger, and ulnar aspect of the ring finger may also be impaired. Common sites of injury include the AXILLA, cubital tunnel at the ELBOW, and Guyon's canal at the wrist. (From Joynt, Clinical Neurology, 1995, Ch51 pp43-5)", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020424"}, {"RECTYPE": "D", "MH": "Radial Neuropathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Saturday Night Palsy|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Wrist Drop", "MN": "C10.668.829.500.650", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Peripheral Nervous System Diseases (1966-1999)", "MS": "Disease involving the RADIAL NERVE. Clinical features include weakness of elbow extension, elbow flexion, supination of the forearm, wrist and finger extension, and thumb abduction. Sensation may be impaired over regions of the dorsal forearm. Common sites of compression or traumatic injury include the AXILLA and radial groove of the HUMERUS.", "PM": "2000", "HN": "2000", "MR": "20190705", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020425"}, {"RECTYPE": "D", "MH": "Sciatic Neuropathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sciatic Nerve Diseases|T047|NON|EQV|NLM (2000)|991012|SCIATIC NERVE DIS|abcdefv", "ENTRY": "Sciatic Neuropathies", "MN": "C10.668.829.500.675", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Sciatic Nerve (1966-1999)", "MS": "Disease or damage involving the SCIATIC NERVE, which divides into the PERONEAL NERVE and TIBIAL NERVE (see also PERONEAL NEUROPATHIES and TIBIAL NEUROPATHY). Clinical manifestations may include SCIATICA or pain localized to the hip, PARESIS or PARALYSIS of posterior thigh muscles and muscles innervated by the peroneal and tibial nerves, and sensory loss involving the lateral and posterior thigh, posterior and lateral leg, and sole of the foot. The sciatic nerve may be affected by trauma; ISCHEMIA; COLLAGEN DISEASES; and other conditions. (From Adams et al., Principles of Neurology, 6th ed, p1363)", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020426"}, {"RECTYPE": "D", "MH": "Peroneal Neuropathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuropathy, Superficial Peroneal|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Superficial Peroneal Neuropathy", "MN": "C10.668.829.500.600", "FX": "Leg Injuries", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Sciatic Nerve (1966-1999)", "MS": "Disease involving the common PERONEAL NERVE or its branches, the deep and superficial peroneal nerves. Lesions of the deep peroneal nerve are associated with PARALYSIS of dorsiflexion of the ankle and toes and loss of sensation from the web space between the first and second toe. Lesions of the superficial peroneal nerve result in weakness or paralysis of the peroneal muscles (which evert the foot) and loss of sensation over the dorsal and lateral surface of the leg. Traumatic injury to the common peroneal nerve near the head of the FIBULA is a relatively common cause of this condition. (From Joynt, Clinical Neurology, 1995, Ch51, p31)", "PM": "2000", "HN": "2000", "MR": "20180614", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020427"}, {"RECTYPE": "D", "MH": "Femoral Neuropathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuropathy, Femoral|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Neuritis, Femoral", "MN": "C10.668.829.500.200", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Peripheral Nervous System Diseases (1966-1999)", "MS": "Disease involving the femoral nerve. The femoral nerve may be injured by ISCHEMIA (e.g., in association with DIABETIC NEUROPATHIES), nerve compression, trauma, COLLAGEN DISEASES, and other disease processes. Clinical features include MUSCLE WEAKNESS or PARALYSIS of hip flexion and knee extension, ATROPHY of the QUADRICEPS MUSCLE, reduced or absent patellar reflex, and impaired sensation over the anterior and medial thigh.", "PM": "2000; for MERALGIA PARESTHETICA see NERVE COMPRESSION SYNDROMES 2010-2018", "HN": "2000; for MERALGIA PARESTHETICA use NERVE COMPRESSION SYNDROMES 2010-2018", "MR": "20180228", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020428"}, {"RECTYPE": "D", "MH": "Tibial Neuropathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tibial Nerve Diseases|T047|NON|EQV|NLM (2000)|991012|TIBIAL NERVE DIS|abcdefv", "ENTRY": "Tibial Neuropathy, Posterior", "MN": "C10.668.829.500.700", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Peripheral Nervous System Diseases (1968-1999)", "MS": "Disease of the TIBIAL NERVE (also referred to as the posterior tibial nerve). The most commonly associated condition is the TARSAL TUNNEL SYNDROME. However, LEG INJURIES; ISCHEMIA; and inflammatory conditions (e.g., COLLAGEN DISEASES) may also affect the nerve. Clinical features include PARALYSIS of plantar flexion, ankle inversion and toe flexion as well as loss of sensation over the sole of the foot. (From Joynt, Clinical Neurology, 1995, Ch51, p32)", "PM": "2000", "HN": "2000", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020429"}, {"RECTYPE": "D", "MH": "Cubital Tunnel Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tunnel Syndromes, Cubital", "MN": "C26.844.150.957.200", "MH_TH": "NLM (1994)", "ST": "T047", "PI": "Ulnar Nerve (1969-1999)", "MS": "Compression of the ULNAR NERVE in the cubital tunnel, which is formed by the two heads of the flexor carpi ulnaris muscle, humeral-ulnar aponeurosis, and medial ligaments of the elbow. This condition may follow trauma or occur in association with processes which produce nerve enlargement or narrowing of the canal. Manifestations include elbow pain and PARESTHESIA radiating distally, weakness of ulnar innervated intrinsic hand muscles, and loss of sensation over the hypothenar region, fifth finger, and ulnar aspect of the ring finger. (Joynt, Clinical Neurology, 1995, Ch51, p43)", "PM": "2000; for CUBITAL TUNNEL SYNDROME see ULNAR NERVE COMPRESSION SYNDROME 1994-1999", "HN": "2000; for CUBITAL TUNNEL SYNDROME use ULNAR NERVE COMPRESSION SYNDROMES 1994-1999", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020430"}, {"RECTYPE": "D", "MH": "Olfactory Nerve Diseases", "DE": "OLFACTORY NERVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "First Cranial Nerve Diseases|T047|NON|EQV|NLM (2000)|991012|FIRST CRANIAL NERVE DIS|abcdefv", "ENTRY": "Olfactory Nerve Disease", "MN": "C10.292.650", "FX": "Olfaction Disorders", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "PI": "Olfactory Nerve (1963-1999)", "MS": "Diseases of the first cranial (olfactory) nerve, which usually feature anosmia or other alterations in the sense of smell and taste. Anosmia may be associated with NEOPLASMS; CENTRAL NERVOUS SYSTEM INFECTIONS; CRANIOCEREBRAL TRAUMA; inherited conditions; toxins; METABOLIC DISEASES; tobacco abuse; and other conditions. (Adams et al., Principles of Neurology, 6th ed, pp229-31)", "PM": "2000", "HN": "2000", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020431"}, {"RECTYPE": "D", "MH": "Trochlear Nerve Diseases", "DE": "TROCHLEAR NERVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fourth Cranial Nerve Diseases|T047|NON|EQV|NLM (2000)|991012|FOURTH CRANIAL NERVE DIS|abcdefv", "ENTRY": "Trochlear Neuropathies", "MN": "C10.292.850", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "PI": "Trochlear Nerve (1965-1999)", "MS": "Diseases of the fourth cranial (trochlear) nerve or its nucleus in the midbrain. The nerve crosses as it exits the midbrain dorsally and may be injured along its course through the intracranial space, cavernous sinus, superior orbital fissure, or orbit. Clinical manifestations include weakness of the superior oblique muscle which causes vertical DIPLOPIA that is maximal when the affected eye is adducted and directed inferiorly. Head tilt may be seen as a compensatory mechanism for diplopia and rotation of the visual axis. Common etiologies include CRANIOCEREBRAL TRAUMA and INFRATENTORIAL NEOPLASMS.", "PM": "2000", "HN": "2000", "MR": "20010725", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020432"}, {"RECTYPE": "D", "MH": "Trigeminal Nerve Diseases", "DE": "TRIGEMINAL NERVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Raeder Paratrigeminal Syndrome|T047|EPO|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Trigeminal Neuropathies, Idiopathic", "MN": "C10.292.319.625.700", "FX": "Cranial Nerve Injuries", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "PI": "Trigeminal Neuralgia (1966-1999)", "MS": "Diseases of the trigeminal nerve or its nuclei, which are located in the pons and medulla. The nerve is composed of three divisions: ophthalmic, maxillary, and mandibular, which provide sensory innervation to structures of the face, sinuses, and portions of the cranial vault. The mandibular nerve also innervates muscles of mastication. Clinical features include loss of facial and intra-oral sensation and weakness of jaw closure. Common conditions affecting the nerve include brain stem ischemia, INFRATENTORIAL NEOPLASMS, and TRIGEMINAL NEURALGIA.", "PM": "2000", "HN": "2000", "MR": "20150601", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020433"}, {"RECTYPE": "D", "MH": "Abducens Nerve Diseases", "DE": "ABDUCENS NERVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sixth Cranial Nerve Disorders|T047|NON|EQV|NLM (2000)|991012|SIXTH CRANIAL NERVE DIS|abcdefv", "ENTRY": "Sixth Nerve Palsies", "MN": "C10.292.150", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Peripheral Nervous System Diseases (1968-1980)", "MS": "Diseases of the sixth cranial (abducens) nerve or its nucleus in the pons. The nerve may be injured along its course in the pons, intracranially as it travels along the base of the brain, in the cavernous sinus, or at the level of superior orbital fissure or orbit. Dysfunction of the nerve causes lateral rectus muscle weakness, resulting in horizontal diplopia that is maximal when the affected eye is abducted and ESOTROPIA. Common conditions associated with nerve injury include INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; ISCHEMIA; and INFRATENTORIAL NEOPLASMS.", "PM": "2000", "HN": "2000", "MR": "20180521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020434"}, {"RECTYPE": "D", "MH": "Glossopharyngeal Nerve Diseases", "DE": "GLOSSOPHARYNGEAL NERVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ninth Cranial Nerve Diseases|T047|NON|EQV|NLM (2000)|991012|NINTH CRANIAL NERVE DIS|abcdefv", "ENTRY": "Neuralgias, Glossopharyngeal", "MN": "C10.292.450", "FX": "Cranial Nerve Injuries", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "PI": "Glossopharyngeal Nerve (1965-1980)", "MS": "Diseases of the ninth cranial (glossopharyngeal) nerve or its nuclei in the medulla. The nerve may be injured by diseases affecting the lower brain stem, floor of the posterior fossa, jugular foramen, or the nerve's extracranial course. Clinical manifestations include loss of sensation from the pharynx, decreased salivation, and syncope. Glossopharyngeal neuralgia refers to a condition that features recurrent unilateral sharp pain in the tongue, angle of the jaw, external auditory meatus and throat that may be associated with SYNCOPE. Episodes may be triggered by cough, sneeze, swallowing, or pressure on the tragus of the ear. (Adams et al., Principles of Neurology, 6th ed, p1390)", "PM": "2000", "HN": "2000", "MR": "20030725", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020435"}, {"RECTYPE": "D", "MH": "Accessory Nerve Diseases", "DE": "ACCESSORY NERVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spinal Accessory Nerve Diseases|T047|NON|EQV|NLM (2000)|991012|SPINAL ACCESSORY NERVE DIS|abcdefv", "ENTRY": "Accessory Nerve Disease", "MN": "C10.292.175", "FX": "Cranial Nerve Injuries", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "PI": "Cranial Nerve Diseases (1981-1999)", "MS": "Diseases of the eleventh cranial (spinal accessory) nerve. This nerve originates from motor neurons in the lower medulla (accessory portion of nerve) and upper spinal cord (spinal portion of nerve). The two components of the nerve join and exit the skull via the jugular foramen, innervating the sternocleidomastoid and trapezius muscles, which become weak or paralyzed if the nerve is injured. The nerve is commonly involved in MOTOR NEURON DISEASE, and may be injured by trauma to the posterior triangle of the neck.", "PM": "2000", "HN": "2000", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020436"}, {"RECTYPE": "D", "MH": "Hypoglossal Nerve Diseases", "DE": "HYPOGLOSSAL NERVE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Twelfth Cranial Nerve Diseases|T047|NON|EQV|NLM (2000)|991012|TWELFTH CRANIAL NERVE DIS|abcdefv", "ENTRY": "Palsy, Hypoglossal Nerve", "MN": "C10.292.525", "FX": "Cranial Nerve Injuries", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)", "PI": "Peripheral Nervous System Diseases (1966-1980)", "MS": "Diseases of the twelfth cranial (hypoglossal) nerve or nuclei. The nuclei and fascicles of the nerve are located in the medulla, and the nerve exits the skull via the hypoglossal foramen and innervates the muscles of the tongue. Lower brain stem diseases, including ischemia and MOTOR NEURON DISEASES may affect the nuclei or nerve fascicles. The nerve may also be injured by diseases of the posterior fossa or skull base. Clinical manifestations include unilateral weakness of tongue musculature and lingual dysarthria, with deviation of the tongue towards the side of weakness upon attempted protrusion.", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020437"}, {"RECTYPE": "D", "MH": "Growth Cones", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Growth Cone", "MN": "A11.671.501.145.375", "FX": "Neurites", "MH_TH": "NLM (1999)", "ST": "T026", "PI": "Neurites (1991-1998)", "MS": "Bulbous enlargement of the growing tip of nerve axons and dendrites. They are crucial to neuronal development because of their pathfinding ability and their role in synaptogenesis.", "PM": "99", "HN": "99", "MR": "20220708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020439"}, {"RECTYPE": "D", "MH": "Gene Duplication", "AQ": "DE GE IM PH RE", "ENTRY": "Gene Duplications", "MN": "G05.558.320", "FX": "Segmental Duplications, Genomic", "MH_TH": "NLM (1999)", "ST": "T045", "AN": "do not confuse with GENES, DUPLICATE", "PI": "Multigene Family (1987-1998)", "MS": "Processes occurring in various organisms by which new genes are copied. Gene duplication may result in a MULTIGENE FAMILY; supergenes or PSEUDOGENES.", "PM": "99; see MULTIGENE FAMILY 1987-98", "HN": "99; use MULTIGENE FAMILY 1987-98", "MR": "20160617", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020440"}, {"RECTYPE": "D", "MH": "Ginkgo biloba", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Maidenhair Tree|T002|NON|EQV|NLM (1999)|980317|abcdef", "ENTRY": "bilobas, Ginkgo", "MN": "B01.875.800.575.912.125", "MH_TH": "NLM (1999)", "ST": "T002", "RN": "txid3311", "RR": "txid58021", "PI": "Gymnosperms (1998)", "MS": "The only specie of the genus Ginkgo, family Ginkgoacea. It is the source of extracts of medicinal interest, especially Egb 761. Ginkgo may refer to the genus or species.", "PM": "99; for GINKGOPHYTA use GYMNOSPERMS 1998", "HN": "99; for GINKGOPHYTA see GYMNOSPERMS 1998", "MR": "20210630", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020441"}, {"RECTYPE": "D", "MH": "Poloxamer", "AQ": "AA AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Poloxamers|T109|T121|NON|BRD|NLM (1999)|980317|abbcdef", "ENTRY": "Poloxamer 407s", "MN": "J01.637.051.720.741.667", "PA": "Surface-Active Agents", "MH_TH": "USAN (1971)", "ST": "T109", "N1": "alpha-Hydro-omega-hydroxypoly(oxyethylene)a-poly(oxopropylene)b-poly(oxyethylene)a block copolymer", "RN": "106392-12-5", "PI": "Poloxalene (1976-1998)", "MS": "A nonionic polyoxyethylene-polyoxypropylene block co-polymer with the general formula HO(C2H4O)a(-C3H6O)b(C2H4O)aH. It is available in different grades which vary from liquids to solids. It is used as an emulsifying agent, solubilizing agent, surfactant, and wetting agent for antibiotics. Poloxamer is also used in ointment and suppository bases and as a tablet binder or coater. (Martindale The Extra Pharmacopoeia, 31st ed)", "PM": "99; for POLOXAMERS see POLOXALENE 1974-98", "HN": "99; for POLOXAMERS use POLOXALENE 1974-98", "MR": "20200527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020442"}, {"RECTYPE": "D", "MH": "Practice Valuation and Purchase", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Purchase, Medical Practice|T081|NON|NRW|NLM (1999)|980317|PURCHASE MED PRACTICE|abcdefv", "ENTRY": "Practice Purchase, Medical", "MN": "N04.452.758.708.600", "FX": "Ownership", "MH_TH": "NLM (1999)", "ST": "T081", "PI": "Practice Management, Medical (1975-1998)", "MS": "Determination of economic value of an established health care provider practice including value of patient lists, equipment, and other assets, and process of buying or selling rights to said practice.", "PM": "99", "HN": "99", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020443"}, {"RECTYPE": "D", "MH": "Reimbursement, Disproportionate Share", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Disproportionate Share Reimbursement|T064|NON|EQV|NLM (1999)|980317|abcdef", "ENTRY": "Share Reimbursements, Disproportionate", "MN": "N03.219.521.710.305.290", "MH_TH": "NLM (1999)", "ST": "T064", "AN": "specify geog", "MS": "Payments that include adjustments to reflect the costs of uncompensated care and higher costs for inpatient care for certain populations receiving mandated services. MEDICARE and MEDICAID include provisions for this type of reimbursement.", "PM": "99", "HN": "99", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020444"}, {"RECTYPE": "D", "MH": "Hospitalists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Hospitalist", "MN": "N02.360.810.580", "FX": "Hospital Medicine", "MH_TH": "NLM (1999)", "ST": "T097", "MS": "Physicians who are employed to work exclusively in hospital settings, primarily for managed care organizations. They are the attending or primary responsible physician for the patient during hospitalization.", "PM": "99", "HN": "99", "MR": "20180629", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020445"}, {"RECTYPE": "D", "MH": "Fitness Centers", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Wellness Centers|T093|NON|REL|NLM (1999)|980318|abcdef", "ENTRY": "Wellness Center", "MN": "N02.278.207", "MH_TH": "NLM (1999)", "ST": "T093", "MS": "Facilities having programs intended to promote and maintain a state of physical well-being for optimal performance and health.", "PM": "99", "HN": "99", "MR": "20200708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020446"}, {"RECTYPE": "D", "MH": "Parasomnias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sleep Drunkenness|T048|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Sleep Sensory Paroxysms", "MN": "F03.870.664", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "do not confuse x-ref BENIGN NEONATAL SLEEP MYOCLONUS with MYOCLONUS, NOCTURNAL and MYOCLONUS, SLEEP see MYOCLONUS", "PI": "Somnambulism (1979-1980)", "MS": "Movements or behaviors associated with sleep, sleep stages, or partial arousals from sleep that may impair sleep maintenance. Parasomnias are generally divided into four groups: arousal disorders, sleep-wake transition disorders, parasomnias of REM sleep, and nonspecific parasomnias. (From Thorpy, Sleep Disorders Medicine, 1994, p191)", "PM": "2000", "HN": "2000", "MR": "20030722", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020447"}, {"RECTYPE": "D", "MH": "Ericales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Theales|T002|NON|EQV|NLM (1999)|990101|abcdef", "ENTRY": "Theale", "MN": "B01.875.800.575.912.250.341", "MH_TH": "NLM (2018)", "ST": "T002", "RN": "txid41945", "MS": "A large and diverse order of dicotyledonous flowering plants in the subclass DILLENIIDAE. Most members have weakly fused petals and radially symmetric flowers which form fruit capsules and thin seed coats. Members also contain IRIDOIDS, compounds which protect against herbivores. Common examples of the ericales are economically important species such as TEA, PERSIMMON, BLUEBERRY, BRAZIL NUTS,  azalea, CRANBERRIES, and RHODODENDRON.", "PM": "2018; see THEALES 1998-2017", "HN": "2018(1998)", "MR": "20210630", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020448"}, {"RECTYPE": "D", "MH": "Repetitive Sequences, Amino Acid", "DE": "REPET SEQ AA", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Amino Acid Repeat Sequence|T087|NON|EQV|NLM (1999)|980319|AA REPEAT SEQ|abcdefv", "ENTRY": "Amino Acid Repetitive Seq|T087|NON|EQV|NLM (1999)|980319|AA REPET SEQ|abcdefv", "MN": "G02.111.570.820.709.275.875", "MH_TH": "NLM (1999)", "ST": "T087", "PI": "Repetitive Sequences, Nucleic Acid (1981-1998)", "MS": "A sequential pattern of amino acids occurring more than once in the same protein sequence. There often is some sequence variation between the repeated segments. Many PROTEIN DOMAINS are constituted from repeats.", "PM": "99", "HN": "99", "MR": "20160527", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020449"}, {"RECTYPE": "D", "MH": "Heavy Ions", "AQ": "AE CL HI", "PRINT ENTRY": "Ions, Heavy|T196|NON|EQV|NLM (1999)|980319|abcdef", "ENTRY": "Ion, Heavy", "MN": "G01.249.467", "EC": "therapeutic use:Heavy Ion Radiotherapy", "MH_TH": "NLM (1999)", "ST": "T196", "AN": "coordinate with specific element if pertinent", "PI": "Protons (1977-1998)", "MS": "Positively-charged atomic nuclei that have been stripped of their electrons. These particles have one or more units of electric charge and a mass exceeding that of the Helium-4 nucleus (alpha particle).", "PM": "99", "HN": "99", "MR": "20180206", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020450"}, {"RECTYPE": "D", "MH": "Contig Mapping", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Mapping, Contig", "MN": "E05.393.260", "MH_TH": "NLM (1999)", "ST": "T063", "MS": "Overlapping of cloned or sequenced DNA to construct a continuous region of a gene, chromosome or genome.", "PM": "99", "HN": "99", "MR": "20000622", "DA": "19980618", "DC": "1", "DX": "19990101", "UI": "D020451"}, {"RECTYPE": "D", "MH": "Journalism", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "MN": "L01.737.498", "MH_TH": "NLM (1999)", "ST": "T057", "PI": "Journalism (1994-1997)", "MS": "The collection, preparation, and distribution of news and related commentary and feature materials through such media as pamphlets, newsletters, newspapers, magazines, radio, motion pictures, television, and books. While originally applied to the reportage of current events in printed form, specifically newspapers, with the advent of radio and television the use of the term has broadened to include all printed and electronic communication dealing with current affairs.", "PM": "99; JOURNALISM was heading 1994-97", "HN": "99; see JOURNALISM, MEDICAL 1994-97", "MR": "20000622", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020452"}, {"RECTYPE": "D", "MH": "Sirenia", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "MN": "B01.050.150.900.649.313.250.750", "MH_TH": "NLM (1999)", "ST": "T015", "RN": "txid9774", "PI": "Mammals (1966-1998)", "MS": "An order of heavy-bodied, slow-moving, completely aquatic, herbivorous mammals. The body is fusiform, plump, and hairless, except for bristles on the snout. Hindlimbs are absent, the forelimbs are modified to flippers, and the tail is a horizontal fluke. (From Scott, Concise Encyclopedia Biology, 1996)", "PM": "99; see MAMMALS 1998; see SIRENIA 1963-67", "HN": "99; 63-97; use MAMMALS 1998; use SIRENIA 1963-67", "MR": "20210630", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020453"}, {"RECTYPE": "D", "MH": "Dugong", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Sea Cows|T015|NON|NRW|NLM (1999)|980327|abcdef", "ENTRY": "Sea Cow", "MN": "B01.050.150.900.649.313.250.750.125", "MH_TH": "NLM (1999)", "ST": "T015", "RN": "txid29136", "RR": "txid29137", "PI": "Mammals (1968-1998)", "MS": "A genus of the order Sirenia characterized by a notched tail, the presence of nasal bones and a long nasal cavity, and large columnar teeth lacking enamel. Dugongs inhabit the coastal waters of the Indian Ocean, Red Sea, and the Malay Archipelago. (From Scott, Concise Encyclopedia Biology, 1996)", "PM": "99; for DUGONGS & SEA COWS see MAMMALS 1998", "HN": "99; for DUGONGS & SEA COWS use MAMMALS 1998", "MR": "20210630", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020454"}, {"RECTYPE": "D", "MH": "Trichechus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Manatees|T015|NON|EQV|NLM (1999)|980327|abcdef", "ENTRY": "Manatee", "MN": "B01.050.150.900.649.313.250.750.750", "MH_TH": "NLM (1999)", "ST": "T015", "RN": "txid9776", "PI": "Mammals (1977-1998)", "MS": "A genus of the order Sirenia comprising what are commonly called manatees. The distinguishing characteristics include a tail that is not notched, a short nasal cavity, the absence of nasal bones, and enamel-covered teeth. Members of this genus are found in marine bays and/or sluggish rivers, usually in turbid water. (From Scott, Concise Encyclopedia Biology, 1996)", "PM": "99; for MANATEES see MAMMALS 1998", "HN": "99; for MANATEES use MAMMALS 1998", "MR": "20210630", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020455"}, {"RECTYPE": "D", "MH": "Trichechus inunguis", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Manatee, Brazilian|T015|NON|EQV|NLM (1999)|980327|abcdef", "ENTRY": "Manatees, Brazilian", "MN": "B01.050.150.900.649.313.250.750.750.350", "MH_TH": "NLM (1999)", "ST": "T015", "RN": "txid9777", "PI": "Pinnipedia (1986)", "MS": "Member of the genus Trichechus found in the Amazon and Orinoco drainages of northeastern South America. (From Scott, Concise Encyclopedia Biology, 1996)", "PM": "99", "HN": "99", "MR": "20210630", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020456"}, {"RECTYPE": "D", "MH": "Trichechus manatus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "West Indian Manatee|T015|NON|EQV|NLM (1999)|980327|abcdef", "ENTRY": "West Indian Manatees", "MN": "B01.050.150.900.649.313.250.750.750.500", "MH_TH": "NLM (1999)", "ST": "T015", "RN": "txid9778", "PI": "Mammals (1977-1998)", "MS": "Member of the genus Trichechus inhabiting the coast and coastal rivers of the southeastern United States as well as the West Indies and the adjacent mainland from Vera Cruz, Mexico to northern South America. (From Scott, Concise Encyclopedia Biology, 1996)", "PM": "99", "HN": "99", "MR": "20210630", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020457"}, {"RECTYPE": "D", "MH": "Third-Party Consent", "AQ": "ES HI LJ SN", "PRINT ENTRY": "Spousal Consent|T078|NON|NRW|BIOETHICS (1997)|NLM (1999)|POPLINE (1993)|980406|abcdeeef", "ENTRY": "Consents, Community", "MN": "N03.706.535.489.635", "FX": "Treatment Refusal", "MH_TH": "NLM (1999)", "ST": "T078", "AN": "do not confuse with THIRD-PARTY PAYMENTS see INSURANCE, HEALTH, REIMBURSEMENT", "PI": "Informed Consent (1979-1998)", "MS": "Informed consent given by someone other than the patient or research subject.", "PM": "1999; use INFORMED CONSENT for SPOUSAL CONSENT 1979-1998", "HN": "1999; use INFORMED CONSENT for SPOUSAL CONSENT 1979-1998", "MR": "20021031", "DA": "19980618", "DC": "1", "DX": "19990101", "UI": "D020458"}, {"RECTYPE": "D", "MH": "Genes, rRNA", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "rRNA Genes|T028|EQV|NLM (1999)|980410|abdef", "ENTRY": "rRNA Gene", "MN": "G05.360.340.024.340.645.750", "FX": "rRNA Operon", "MH_TH": "NLM (1999)", "ST": "T028", "PI": "rRNA Operon (1988-1998)", "MS": "Genes, found in both prokaryotes and eukaryotes, which are transcribed to produce the RNA which is incorporated into RIBOSOMES. Prokaryotic rRNA genes are usually found in OPERONS dispersed throughout the GENOME, whereas eukaryotic rRNA genes are clustered, multicistronic transcriptional units.", "PM": "99; see rRNA OPERON 1988-98; for rRNA GENES see rRNA OPERON 1988-98", "HN": "99; use rRNA OPERON 1988-98; for rRNA GENES use rRNA OPERON 1988-98", "MR": "20080708", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020459"}, {"RECTYPE": "D", "MH": "Melanosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Melanosome", "MN": "A11.436.613.560", "MH_TH": "NLM (1999)", "ST": "T026", "PI": "Melanocytes (1979-1998)", "MS": "Melanin-containing organelles found in melanocytes and melanophores.", "PM": "99", "HN": "99", "MR": "20180630", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020460"}, {"RECTYPE": "D", "MH": "Madurella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Streptotrix mycetomatis|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Madurellas", "MN": "B01.300.381.515", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid100815", "RR": "txid100816", "PI": "Mitosporic Fungi (1963-1998)", "MS": "A mitosporic fungal genus that causes MYCETOMA in humans. Madurella grisea and M. mycetomatis are the etiological agents.", "PM": "99; see HYPHOMYCETES 1986-98, see MADURELLA 1963-85", "HN": "99, 63-85; use MITOSPORIC FUNGI 1963-98", "MR": "20200527", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020461"}, {"RECTYPE": "D", "MH": "Gliocladium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gliocladiums", "MN": "B01.300.381.385", "MH_TH": "NLM (1999)", "ST": "T004", "RN": "txid62887", "PI": "Mitosporic Fungi (1975-1998)", "MS": "A mitosporic fungal genus occurring in soil or decaying plant matter. It is structurally similar to Penicillium.", "PM": "99; see HYPHOMYCETES 1986-98, see MONILIALES 1975-85", "HN": "99; use MITOSPORIC FUNGI 1975-98", "MR": "20200813", "DA": "19980618", "DC": "1", "DX": "19990101", "UI": "D020462"}, {"RECTYPE": "D", "MH": "Abbreviations", "PRINT ENTRY": "Acronym|T170|NON|NRW|NLM (2021)|191121|abcdef", "ENTRY": "Acronyms|T170|NON|NRW|NLM (2008)|070629|abcdef", "MN": "V02.025", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works consisting of lists of shortened forms of written words or phrases used for brevity. Acronyms are included here. Abbreviations as a subject are indexed under the main heading ABBREVIATIONS AS TOPIC; INDEXER: Do not use", "MS": "Works consisting of lists of shortened forms of written words or phrases used for brevity. Acronyms are included here.", "HN": "2008(1999)", "MR": "20200527", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020463"}, {"RECTYPE": "D", "MH": "Anecdotes", "MN": "V02.115", "FX": "Wit and Humor", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. Anecdotes as a subject are indexed under the main heading ANECDOTES AS TOPIC. INDEXER: Do not use", "MS": "Works consisting of brief accounts or narratives of incidents or events.", "HN": "2008(1999)", "MR": "20180716", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020465"}, {"RECTYPE": "D", "MH": "Atlas", "PRINT ENTRY": "Atlases|T073|T170|NON|EQV|NLM (2008)|070530|abbcdef", "MN": "V02.150", "FX": "Pictorial Work", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use; CATALOGER: Use for collections of illustrative plates, charts, etc. and for items in which there are both illustrations and text, even when the text predominates, when the purpose of the text is to explain the illustrations. Do not use for geographic atlases or MAP. Use instead the Publication Type MAP.", "MS": "Work consisting of collections of illustrative plates, charts, etc., usually with explanatory captions.", "HN": "2008(1999)", "MR": "20190710", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020466"}, {"RECTYPE": "D", "MH": "Biobibliography", "MN": "V02.165.500", "FX": "Biography", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. It is used for works consisting of the biographical information of a person as well as substantial list of bibliography by the person. Biobibliography as a subject is indexed under the main heading BIOGRAPHIES AS TOPIC; INDEXER: Do not use ", "MS": "Works consisting of biographical information as well as lists of the writings of those persons.", "HN": "2008(1999)", "MR": "20200527", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020467"}, {"RECTYPE": "D", "MH": "Chart", "PRINT ENTRY": "Charts|T170|NON|EQV|NLM (2008)|070624|abcdef", "MN": "V02.245", "FX": "Tables", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Charts as a subject are indexed under the main heading STATISTICS AS TOPIC. INDEXER: Do not use; CATALOGER: Use for single chart only", "MS": "Work consisting of information presented in graphic form, for example, graphs or diagrams.", "HN": "2008(1999)", "MR": "20190711", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020468"}, {"RECTYPE": "D", "MH": "Chronology", "MN": "V02.250", "FX": "Tables", "MH_TH": "NLM (2008)", "ST": "T170", "MS": "Works consisting of lists of events arranged in chronological order.", "HN": "2008(1963)", "MR": "20190711", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020469"}, {"RECTYPE": "D", "MH": "Collected Work", "PRINT ENTRY": "Collected Works|T170|NON|EQV|NLM (2008)|070624|abcdef", "MN": "V02.260", "FX": "Essay", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use", "MS": "Work consisting of collections of previously published works.", "HN": "2008(1999)", "MR": "20190711", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020470"}, {"RECTYPE": "D", "MH": "Collection", "MN": "V02.265", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Collections as a subject are indexed under the main heading COLLECTIONS AS TOPIC. INDEXER: Do not use ", "MS": "Items gathered and assembled in some order to facilitate access or use.", "HN": "2008(1999)", "MR": "20180629", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020471"}, {"RECTYPE": "D", "MH": "Drawing", "PRINT ENTRY": "Drawings|T073|T170|NON|EQV|NLM (2008)|070625|abbcdef", "MN": "V02.700.300", "FX": "Atlas", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Drawings as a subject are indexed under the main heading ART. INDEXER: Do not use ", "MS": "Work consisting of graphic representations of objects or ideas by lines.", "HN": "2008(1999)", "MR": "20180702", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020472"}, {"RECTYPE": "D", "MH": "Essay", "PRINT ENTRY": "Essays|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V02.365", "FX": "Collected Work", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "CATALOGER: Do not use", "MS": "Short literary prose composition, usually dealing with a single theme.", "HN": "2020; see ESSAYS 2008-2019 and COLLECTED WORK 1999-2007", "MR": "20190528", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020474"}, {"RECTYPE": "D", "MH": "Examination Questions", "ENTRY": "Examination Question|T170|NON|EQV|NLM (2019)|180702|abcdef", "MN": "V02.395", "FX": "Problems and Exercises", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use", "MS": "Work consisting of compilations of questions and answers pertaining to a particular subject, used for study and review.", "HN": "2008(1999)", "MR": "20190705", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020475"}, {"RECTYPE": "D", "MH": "Exhibition", "PRINT ENTRY": "Exhibit|T170|NON|EQV|NLM (2020)|190704|abcdef", "MN": "V02.415", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Use for works describing an exhibition. Use the main heading EXHIBITIONS AS TOPIC with the Publication Type CATALOG for exhibition catalogs. Exhibitions as a subject are indexed under the main heading EXHIBITIONS AS TOPIC. INDEXER: Do not use ", "MS": "Objects publicly displayed.", "HN": "2008(1999)", "MR": "20190710", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020476"}, {"RECTYPE": "D", "MH": "Form", "PRINT ENTRY": "Forms|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V02.460", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Forms as a subject are indexed under the main heading FORMS AS TOPIC. INDEXER: Do not use. CATALOGER: Use for single forms or works consisting of multiple forms", "MS": "Document used for acquiring particular information or for presenting particular information in a prescribed sequence and format, often with blank spaces or lines or other methods to prompt for insertion of the requested information.", "HN": "2008(1999)", "MR": "20190307", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020478"}, {"RECTYPE": "D", "MH": "Handbook", "PRINT ENTRY": "Handbooks|T073|T170|NON|EQV|NLM (2008)|070625|abbcdef", "MN": "V02.520", "FX": "Resource Guide", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type; INDEXER: Do not use", "MS": "Work consisting of concise reference works in which facts and information pertaining to a certain subject or field are arranged for ready reference and consultation rather than for continuous reading and study.", "HN": "2008(1999)", "MR": "20180702", "DA": "19980608", "DC": "2", "DX": "19990101", "UI": "D020479"}, {"RECTYPE": "D", "MH": "Wit and Humor", "PRINT ENTRY": "Humor|T170|NON|REL|NLM (2008)|070626|abcdef", "MN": "V02.540", "FX": "Anecdotes", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Works on Wit and Humor as a subject are indexed  under the main heading WIT AND HUMOR AS TOPIC. INDEXER: Do not use", "HN": "2008(1999)", "MR": "20180630", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020480"}, {"RECTYPE": "D", "MH": "Index", "PRINT ENTRY": "Indexes|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V02.550", "FX": "Resource Guide", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use", "MS": "Work providing an analytical subject approach to materials in a field of knowledge.", "HN": "2008(1999)", "MR": "20180702", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020481"}, {"RECTYPE": "D", "MH": "Juvenile Literature", "MN": "V02.725.500", "FX": "Popular Work", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use", "MS": "Works produced for children through age 15 or through the ninth grade.", "HN": "2008(1999)", "MR": "20180716", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020482"}, {"RECTYPE": "D", "MH": "Laboratory Manual", "PRINT ENTRY": "Laboratory Manuals|T170|NON|EQV|NLM (2008)|070626|abcdef", "MN": "V02.605", "FX": "Handbook", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Laboratory manuals as a subject are indexed under the main heading MANUALS AS TOPIC. INDEXER: Do not use", "MS": "Work containing concise background information and directions for activities, including conducting experiments or diagnostic tests in the laboratory.", "HN": "2008(1999)", "MR": "20180702", "DA": "19980608", "DC": "2", "DX": "19990101", "UI": "D020484"}, {"RECTYPE": "D", "MH": "Legislation", "MN": "V02.620", "FX": "Legal Case", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. CATALOGER: Use when 20% or more of the content consists of the text of laws, statutes, ordinances, or government regulations. Do not use for works that are merely discussion of law, etc. Legislation as a subject is indexed under the main heading LEGISLATION AS TOPIC", "MS": "Works consisting of the text of proposed or enacted legislation that may be in the form of bills, laws, statutes, ordinances, or government regulations.", "HN": "2008(1999)", "MR": "20180716", "DA": "19980610", "DC": "2", "DX": "19990101", "UI": "D020485"}, {"RECTYPE": "D", "MH": "Manuscript", "PRINT ENTRY": "Manuscripts|T170|NON|EQV|NLM (2008)|070626|abcdef", "MN": "V02.630", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Manuscripts as a subject are indexed under the main heading MANUSCRIPTS AS TOPIC. INDEXER: Do not use", "MS": "Work written by hand, as one written before the invention or adoption of printing.", "HN": "2008(1999)", "MR": "20180702", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020486"}, {"RECTYPE": "D", "MH": "Nurses Instruction", "PRINT ENTRY": "Nurses' Instruction|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V02.668", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use; CATALOGER: Use for background material on diseases and other topics written for a nursing audience, which do not include specific nursing procedures. For works which include nursing procedures, use instead an appropriate main heading qualified by the topical subheading nursing, or coordinate with the main heading NURSING CARE or another appropriate nursing term.", "MS": "Work consisting of materials developed for a nursing audience.", "HN": "2008(1999)", "MR": "20180702", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020488"}, {"RECTYPE": "D", "MH": "Outline", "PRINT ENTRY": "Outlines|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V02.670", "MH_TH": "OBSSR (2016)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use", "MS": "Work consisting of brief statements of the principal elements of a subject, usually arranged by heads and subheads.", "HN": "2008(1999)", "MR": "20180702", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020489"}, {"RECTYPE": "D", "MH": "Patent", "PRINT ENTRY": "Patents|T073|T170|NON|EQV|NLM (2008)|070626|abbcdef", "MN": "V02.675", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Patents as a subject are indexed under the main heading PATENTS AS TOPIC; INDEXER: Do not use", "MS": "Work consisting of documents granted by a government giving exclusive rights to an inventor or assignee to manufacture, use, or sell an invention for a certain number of years.", "HN": "2008(1999)", "MR": "20180702", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020490"}, {"RECTYPE": "D", "MH": "Periodical", "PRINT ENTRY": "Periodicals|T170|NON|EQV|NLM (2008)|070626|abcdef", "ENTRY": "Newspapers|T170|NON|NRW|NLM (2016)|150528|abcdef", "MN": "V02.690", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Periodicals as a subject are indexed under the main heading PERIODICALS AS TOPIC. Newspapers as a subject are indexed under the main heading NEWSPAPERS AS TOPIC. INDEXER: Do not use ", "MS": "Publication intended to be issued on an ongoing basis, generally more frequently than annually, containing separate articles, stories, or writings.", "HN": "2008(1999)", "MR": "20200527", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020492"}, {"RECTYPE": "D", "MH": "Autobiography", "PRINT ENTRY": "Autobiographies|T170|NON|EQV|NLM (1995)|931126|abcdef", "MN": "V02.530.150.750.100", "FX": "Biography", "MH_TH": "NLM (1966)", "ST": "T170", "AN": "This heading is used as a Publication Type. used for autobiographies of persons; includes memoirs; Autobiographies as a subject are indexed under the main heading AUTOBIOGRAPHIES AS TOPIC. CATALOGER: Use for single as well as for collections of autobiographical accounts and personal reminiscences. ", "MS": "Self-described narratives of a person's life.", "MR": "20190710", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020493"}, {"RECTYPE": "D", "MH": "Phrases", "ENTRY": "Phrase|T170|NON|EQV|NLM (2019)|180702|abcdef", "MN": "V02.699", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use", "MS": "Work consisting of common terms, phrases, idioms, and typical conversations, e.g., between health professional and patients. These are often intended for use by non-native speakers of a language.", "HN": "2008(1999)", "MR": "20190705", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020494"}, {"RECTYPE": "D", "MH": "Pictorial Work", "PRINT ENTRY": "Pictorial Works|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V02.700", "FX": "Caricature", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Pictorial Works as a subject are indexed under the main heading PICTORIAL WORKS AS TOPIC. INDEXER: Do not use ", "MS": "Work consisting exclusively or mainly of pictures but not technical drawings.", "HN": "2008(1999)", "MR": "20180702", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020495"}, {"RECTYPE": "D", "MH": "Popular Work", "PRINT ENTRY": "Popular Works|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V02.725", "FX": "Juvenile Literature", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use", "MS": "Work written for non-professional or lay audiences.", "HN": "2008(1999)", "MR": "20180702", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020496"}, {"RECTYPE": "D", "MH": "Problems and Exercises", "MN": "V02.734", "FX": "Examination Questions", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use", "MS": "Works consisting of collections of practice questions and drills, generally for instructional or review use.", "HN": "2008(1999)", "MR": "20190711", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020497"}, {"RECTYPE": "D", "MH": "Programmed Instruction", "MN": "V02.735", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. Programmed instructions as a subject are indexed under the main heading PROGRAMMED INSTRUCTIONS AS TOPIC. INDEXER: Do not use ", "MS": "Works consisting of sequenced self-correction texts.", "HN": "2008(1999)", "MR": "20190710", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020498"}, {"RECTYPE": "D", "MH": "Statistics", "PRINT ENTRY": "Statistic|T170|NON|EQV|NLM (2021)|191120|abcdef", "MN": "V02.925", "FX": "Tables", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. Statistics as a subject is indexed under the main heading STATISTICS AS TOPIC. INDEXER: Do not use; CATALOGER: Use when 20% or more of the content consists of statistical data. If presented in tabular form use also the Publication Type TABLES.", "MS": "Works consisting of presentations of numerical data on particular subjects.", "HN": "2008(1999)", "MR": "20200527", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020500"}, {"RECTYPE": "D", "MH": "Tables", "ENTRY": "Table|T170|NON|EQV|NLM (2019)|180702|abcdef", "MN": "V02.930", "FX": "Statistics", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use; CATALOGER: Use when 20% or more of the content is presented in tabular form. For statistical data presented in tabular form use also the Publication Type STATISTICS.", "MS": "Presentations of data in tabular form.", "HN": "2008(1999)", "MR": "20190705", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020501"}, {"RECTYPE": "D", "MH": "Terminology", "ENTRY": "Nomenclature|T170|NON|NRW|NLM (2008)|070626|abcdef", "MN": "V02.938", "FX": "Dictionary", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. Terminology as a subject is indexed under the main heading TERMINOLOGY AS TOPIC. INDEXER: Do not use", "MS": "Work consisting of lists of the technical terms or expressions used in a specific field. These lists may or may not be formally adopted or sanctioned by usage.", "HN": "2008(1999)", "MR": "20180701", "DA": "19980611", "DC": "2", "DX": "19990101", "UI": "D020502"}, {"RECTYPE": "D", "MH": "Union List", "PRINT ENTRY": "Union Lists|T170|NON|EQV|NLM (2008)|070626|abcdef", "MN": "V02.945", "FX": "Catalog", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use", "MS": "Works consisting of records of the holdings or items owned by two or more libraries.", "HN": "2008(1999)", "MR": "20190705", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020503"}, {"RECTYPE": "D", "MH": "Abstracts", "PRINT ENTRY": "Abstract|T170|NON|EQV|NLM (2021)|191115|abcdef", "MN": "V02.035", "FX": "Resource Guide", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use; CATALOGER: Use for annotated bibliographies. Do not also use Publication Type BIBLIOGRAPHY. Do not use for meeting abstracts. Use instead Publication Type CONGRESS. Abstracts as a subject are indexed under the main heading ABSTRACTING AND INDEXING ", "MS": "Works consisting of lists of publications on a subject and that provide full annotated bibliographical information together with substantive summaries or condensations of the facts, ideas, or opinions presented in each publication listed. (From LC Subject Cataloging Manual)", "HN": "2008(1999)", "MR": "20200527", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020504"}, {"RECTYPE": "D", "MH": "Collected Correspondence", "MN": "V02.260.260", "FX": "Letter", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. Correspondence as a subject is indexed under the main heading CORRESPONDENCE AS TOPIC. INDEXER: Do not use", "MS": "Written communication between persons or between institutions or organizations.", "HN": "2008(1999)", "MR": "20190705", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020505"}, {"RECTYPE": "D", "MH": "Untranslated Regions", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "UTRs|T114|T123|ABB|EQV|NLM (1999)|980515|abbcdef", "ENTRY": "Untranslated Region", "MN": "G05.360.340.024.340.137.910", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "0", "PI": "RNA, Messenger (1975-1998)", "MS": "The parts of the messenger RNA sequence that do not code for product, i.e. the 5' UNTRANSLATED REGIONS and 3' UNTRANSLATED REGIONS.", "PM": "99", "HN": "99", "MR": "20090706", "DA": "19980611", "DC": "1", "DX": "19990101", "UI": "D020506"}, {"RECTYPE": "D", "MH": "Resource Guide", "PRINT ENTRY": "Resource Guides|T170|NON|EQV|NLM (2008)|070626|abcdef", "ENTRY": "Source Guides|T170|NON|REL|NLM (2008)|070626|abcdef", "MN": "V02.750", "FX": "Index", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use", "MS": "Work listing and describing various sources of information, from multiple media or in different formats, on a given subject.", "HN": "2008(1999)", "MR": "20180702", "DA": "19980603", "DC": "2", "DX": "19990101", "UI": "D020507"}, {"RECTYPE": "D", "MH": "Fungi, Unclassified", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "sedis Fungus, incertae", "MN": "B01.300.300", "MH_TH": "NLM (1999)", "ST": "T004", "AN": "author will state \"unclassified\"; do not confuse with fungi \"unnamed\" or unspecified by author (= probably FUNGI); general: avoid; infections by unclassified fungi: coordinate IM with MYCOSES or specific mycosis (IM)", "MS": "Fungi whose taxonomic relationships have not been authoritatively established.", "PM": "99", "HN": "99", "MR": "20200902", "DA": "19980610", "DC": "1", "DX": "19990101", "UI": "D020508"}, {"RECTYPE": "D", "MH": "Neuromuscular Junction Diseases", "DE": "NEUROMUSCULAR JUNCTION DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neuromuscular Transmission Disorder", "MN": "C10.668.758", "FX": "Channelopathies", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Neuromuscular Junction (1966-1999)", "MS": "Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions.", "PM": "2000", "HN": "2000", "MR": "20060705", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020511"}, {"RECTYPE": "D", "MH": "Myopathy, Central Core", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Shy-Magee Syndrome|T047|EPO|EQV|GHR (2014)|NLM (1994)|920810|abcdeef", "ENTRY": "Syndrome, Shy-Magee", "MN": "C10.668.491.550.300", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Muscular Atrophy (1963-1999)", "MS": "An inherited congenital myopathic condition characterized by weakness and hypotonia in infancy and delayed motor development. Muscle biopsy reveals a condensation of myofibrils and myofibrillar material in the central portion of each muscle fiber. (Adams et al., Principles of Neurology, 6th ed, p1452)", "PM": "2000; for CENTRAL CORE DISEASE & SHY-MAGEE SYNDROME see NEMALINE MYOPATHY 1994-1999", "HN": "2000; for CENTRAL CORE DISEASE & SHY-MAGEE SYNDROME use NEMALINE MYOPATHY 1994-1999", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020512"}, {"RECTYPE": "D", "MH": "Paralysis, Hyperkalemic Periodic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paralysis, Periodic, Hyperkalemic, Familial|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Disease, Gamstorp", "MN": "C18.452.648.618.711.600", "FX": "NAV1.4 Voltage-Gated Sodium Channel", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Paralyses, Familial Periodic (1966-1999)", "MS": "An autosomal dominant familial disorder which presents in infancy or childhood and is characterized by episodes of weakness associated with hyperkalemia. During attacks, muscles of the lower extremities are initially affected, followed by the lower trunk and arms. Episodes last from 15-60 minutes and typically occur after a period of rest following exercise. A defect in skeletal muscle sodium channels has been identified as the cause of this condition. Normokalemic periodic paralysis is a closely related disorder marked by a lack of alterations in potassium levels during attacks of weakness. (Adams et al., Principles of Neurology, 6th ed, p1481)", "PM": "2000", "HN": "2000", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020513"}, {"RECTYPE": "D", "MH": "Hypokalemic Periodic Paralysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Primary Hypokalemic Periodic Paralysis|T047|NON|EQV|GHR (2014)|NLM (2000)|991012|abcdeef", "ENTRY": "Periodic Paralysis- Hypokalemics", "MN": "C18.452.648.618.711.550", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Paralyses, Familial Periodic (1965-1999)", "MS": "An autosomal dominant familial disorder characterized by recurrent episodes of skeletal muscle weakness associated with falls in serum potassium levels. The condition usually presents in the first or second decade of life with attacks of trunk and leg paresis during sleep or shortly after awakening. Symptoms may persist for hours to days and generally are precipitated by exercise or a meal high in carbohydrates. (Adams et al., Principles of Neurology, 6th ed, p1483)", "PM": "2000", "HN": "2000", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020514"}, {"RECTYPE": "D", "MH": "Brachial Plexus Neuropathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Klumpke Paralysis|T037|EPO|NRW|NLM (2000)|ORD (2010)|991012|abcdeef", "ENTRY": "Plexus Neuropathy, Brachial", "MN": "C10.668.829.100", "FX": "Brachial Plexus Neuritis", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Peripheral Nervous System Diseases (1975-1999)", "MS": "Diseases of the cervical (and first thoracic) roots, nerve trunks, cords, and peripheral nerve components of the BRACHIAL PLEXUS. Clinical manifestations include regional pain, PARESTHESIA; MUSCLE WEAKNESS, and decreased sensation (HYPESTHESIA) in the upper extremity. These disorders may be associated with trauma (including BIRTH INJURIES); THORACIC OUTLET SYNDROME; NEOPLASMS; NEURITIS; RADIOTHERAPY; and other conditions. (From Adams et al., Principles of Neurology, 6th ed, pp1351-2)", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020516"}, {"RECTYPE": "D", "MH": "Atrial Appendage", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Heart Atrium Appendage|T023|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Heart Atrium Appendages", "MN": "A07.541.358.100", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Heart Atrium (1966-1999)", "MS": "Ear-shaped appendage of either atrium of the heart. (Dorland, 28th ed)", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020517"}, {"RECTYPE": "D", "MH": "Focal Nodular Hyperplasia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperplasia, Focal Nodular|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Hyperplasias, Focal Nodular", "MN": "C06.552.270", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Liver Neoplasms (1968-1999)", "MS": "Solitary or multiple benign hepatic vascular tumors, usually occurring in women of 20-50 years of age. The nodule, poorly encapsulated, consists of a central stellate fibrous scar and normal liver elements such as HEPATOCYTES, small BILE DUCTS, and KUPFFER CELLS among the intervening fibrous septa. The pale colored central scar represents large blood vessels with hyperplastic fibromuscular layer and narrowing lumen.", "PM": "2000", "HN": "2000", "MR": "20040707", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020518"}, {"RECTYPE": "D", "MH": "Pericardiocentesis", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Pericardiocenteses", "MN": "E05.200.998.329.620", "FX": "Pericardial Effusion", "MH_TH": "NLM (2000)", "ST": "T061", "PI": "Punctures (1969-1999)", "MS": "Puncture and aspiration of fluid from the PERICARDIUM.", "PM": "2000", "HN": "2000", "MR": "20150622", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020519"}, {"RECTYPE": "D", "MH": "Brain Infarction", "DE": "BRAIN INFARCT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Venous Infarction, Brain|T047|NON|NRW|NLM (2000)|991012|VENOUS INFARCT BRAIN|abcdefv", "ENTRY": "Venous Infarctions, Brain", "MN": "C23.550.717.489.250", "FX": "Infarction", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Intracranial Embolism and Thrombosis (1966-1999)", "MS": "Tissue NECROSIS in any area of the brain, including the CEREBRAL HEMISPHERES, the CEREBELLUM, and the BRAIN STEM. Brain infarction is the result of a cascade of events initiated by inadequate blood flow through the brain that is followed by HYPOXIA and HYPOGLYCEMIA in brain tissue. Damage may be temporary, permanent, selective or pan-necrosis.", "PM": "2000", "HN": "2000", "MR": "20190628", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020520"}, {"RECTYPE": "D", "MH": "Stroke", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH UR VE VI", "PRINT ENTRY": "Vascular Accident, Brain|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Vascular Accidents, Brain", "MN": "C14.907.253.855", "EC": "rehabilitation:Stroke Rehabilitation", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "note entry term APOPLEXY: PITUITARY APOPLEXY is also available", "PI": "Intracranial Embolism and Thrombosis (1965-1999)", "MS": "A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)", "PM": "2008; see CEREBROVASCULAR ACCIDENT 2000-2007; see CEREBROVASCULAR DISORDERS 1963-1999; for APOPLEXY see CEREBROVASCULAR DISORDERS 1963-1999", "HN": "2008 (2000); use CEREBROVASCULAR DISEASES 1963-1999; for APOPLEXY use CEREBROVASCULAR DISORDERS 1963-1999", "MR": "20160613", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020521"}, {"RECTYPE": "D", "MH": "Lymphoma, Mantle-Cell", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Mantle-Zone Lymphoma|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Small-Cell Lymphomas, Centrocytic", "MN": "C20.683.515.761.480.525", "FX": "Genes, bcl-1", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Lymphoma, Non-Hodgkin (1992-1999)", "MS": "A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1).", "PM": "2000; for LYMPHOMA, LYMPHOCYTIC, DIFFUSE, INTERMEDIATE; LYMPHOCYTIC LYMPHOMA, DIFFUSE, POORLY-DIFFERENTIATED; LYMPHOMA, CENTROCYTIC SMALL-CELL; LYMPHOMA, LYMPHOCYTIC, DIFFUSE, POORLY-DIFFERENTIATED; & LYMPHOMA, SMALL-CELL, CENTROCYTIC see LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE 1991-1999", "HN": "2000; for LYMPHOMA, LYMPHOCYTIC, DIFFUSE, INTERMEDIATE; LYMPHOCYTIC LYMPHOMA, DIFFUSE, POORLY-DIFFERENTIATED; LYMPHOMA, CENTROCYTIC SMALL-CELL; LYMPHOMA, LYMPHOCYTIC, DIFFUSE, POORLY-DIFFERENTIATED; & LYMPHOMA, SMALL-CELL, CENTROCYTIC use LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE 1991-1999", "MR": "20180629", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020522"}, {"RECTYPE": "D", "MH": "Chemokines, CX3C", "DS": "CHEMOKINES CXXXC", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CX3C Chemokines|T116|T129|NON|EQV|NLM (2000)|991012|CXXXC CHEMOKINES|abbcdefs", "MN": "D23.529.374.200.130", "MH_TH": "NLM (2000)", "ST": "T129", "RN": "0", "PI": "Chemokines (1997-1999)", "MS": "Group of chemokines with the first two cysteines separated by three amino acids. CX3C chemokines are chemotactic for natural killer cells, monocytes, and activated T-cells.", "PM": "2000", "HN": "2000", "MR": "20070709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020523"}, {"RECTYPE": "D", "MH": "Thylakoids", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Thylakoid Membrane|T026|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Thylakoid Membranes", "MN": "A11.284.430.214.190.875.700.140.800", "FX": "Photosystem II Protein Complex", "MH_TH": "NLM (2000)", "ST": "T026", "PI": "Chloroplasts (1969-1999)", "MS": "Membranous cisternae of the CHLOROPLAST containing photosynthetic pigments, reaction centers, and the electron-transport chain. Each thylakoid consists of a flattened sac of membrane enclosing a narrow intra-thylakoid space (Lackie and Dow, Dictionary of Cell Biology, 2nd ed). Individual thylakoids are interconnected and tend to stack to form aggregates called grana. They are found in cyanobacteria and all plants.", "PM": "2000; for GRANA see CHLOROPLASTS 1979-1999", "HN": "2000; for GRANA use CHLOROPLASTS 1979-1999", "MR": "20030709", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020524"}, {"RECTYPE": "D", "MH": "Xenodiagnosis", "DE": "XENODIAG", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Xenodiagnoses", "MN": "E05.200.875.985", "MH_TH": "NLM (2000)", "ST": "T060", "AN": "permitted with parasitic diseases as well as microbial infections", "PI": "specific disease/diagnosis (1967-1999)", "MS": "A method for diagnosing a disease in one organism by inoculating the putative causative organism in a second animal of a different species. It has been used for the detection of parasites (Trypanosoma cruzi and Trichinella spiralis) when peripheral blood smears are negative. (Segen, Current Med Talk, 1995)", "PM": "2000", "HN": "2000", "MR": "20110624", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020525"}, {"RECTYPE": "D", "MH": "Brain Stem Infarctions", "DE": "BRAIN STEM INFARCT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Weber Syndrome|T047|EPO|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Syndrome, Millard-Gublar", "MN": "C23.550.717.489.250.100", "FX": "Infarction", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Infarction (1971-1999)", "MS": "Infarctions that occur in the BRAIN STEM which is comprised of the MIDBRAIN; PONS; and MEDULLA OBLONGATA. There are several named syndromes characterized by their distinctive clinical manifestations and specific sites of ischemic injury.", "PM": "2000", "HN": "2000", "MR": "20190628", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020526"}, {"RECTYPE": "D", "MH": "Microscopy, Scanning Probe", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Scanning Probe Microscopy|T059|NON|EQV|NLM (2000)|991012|abcdef", "MN": "E05.595.666", "MH_TH": "NLM (1999)", "ST": "T059", "PI": "Microscopy, Atomic Force (1999)", "MS": "Scanning microscopy in which a very sharp probe is employed in close proximity to a surface, exploiting a particular surface-related property. When this property is local topography, the method is atomic force microscopy (MICROSCOPY, ATOMIC FORCE), and when it is local conductivity, the method is scanning tunneling microscopy (MICROSCOPY, SCANNING TUNNELING).", "PM": "2000; see MICROSCOPY, ATOMIC FORCE 1999", "HN": "2000; use MICROSCOPY, ATOMIC FORCE 1999", "MR": "20040707", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020527"}, {"RECTYPE": "D", "MH": "Multiple Sclerosis, Chronic Progressive", "DE": "MS CHRONIC PROGRESSIVE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Multiple Sclerosis, Remittent Progressive|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Secondary Progressive Multiple Sclerosis|T047|NON|NRW|NLM (2000)|991012|SECOND PROGRESSIVE MULTIPLE SCLEROSIS|abcdefv", "MN": "C23.550.291.500.625", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Multiple Sclerosis (1973-1999)", "MS": "A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing remitting form. If the clinical course is free of distinct remissions, it is referred to as primary progressive multiple sclerosis. When the progressive decline is punctuated by acute exacerbations, it is referred to as progressive relapsing multiple sclerosis. The term secondary progressive multiple sclerosis is used when relapsing remitting multiple sclerosis evolves into the chronic progressive form. (From Ann Neurol 1994;36 Suppl:S73-S79; Adams et al., Principles of Neurology, 6th ed, pp903-914)", "PM": "2000", "HN": "2000", "MR": "20210312", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020528"}, {"RECTYPE": "D", "MH": "Multiple Sclerosis, Relapsing-Remitting", "DE": "MS RELAPSING REMITTING", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Relapsing-Remitting Multiple Sclerosis|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Remitting Relapsing Multiple Sclerosis", "MN": "C20.111.258.250.500.600", "FX": "Myelitis, Transverse", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Multiple Sclerosis (1978-1999)", "MS": "The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020529"}, {"RECTYPE": "D", "MH": "Subthalamus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Nucleus of Field H|T023|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Thalamicus, Fasciculus", "MN": "A08.186.211.200.317.800", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Thalamus (1981-1999)", "MS": "A transition zone in the anterior part of the diencephalon interposed between the thalamus, hypothalamus, and tegmentum of the mesencephalon. Components of the subthalamus include the SUBTHALAMIC NUCLEUS, zona incerta, nucleus of field H, and the nucleus of ansa lenticularis. The latter contains the ENTOPEDUNCULAR NUCLEUS.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020530"}, {"RECTYPE": "D", "MH": "Subthalamic Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Nucleus Subthalamicus|T023|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Subthalamicus, Nucleus", "MN": "A08.186.211.200.317.800.800", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Thalamic Nuclei (1972-1999)", "MS": "Lens-shaped structure on the inner aspect of the INTERNAL CAPSULE. The SUBTHALAMIC NUCLEUS and pathways traversing this region are concerned with the integration of somatic motor function.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020531"}, {"RECTYPE": "D", "MH": "Basal Nucleus of Meynert", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Nucleus Basalis of Meynert|T023|NON|EQV|UNK (19XX)|830615|abcdef", "ENTRY": "Nucleus, Basal Magnocellular", "MN": "A08.186.211.200.885.287.249.880.100", "MH_TH": "UNK (19XX)", "ST": "T023", "PI": "Substantia Innominata (1984-1999)", "MS": "A group of nerve cells in the SUBSTANTIA INNOMINATA that has wide projections to the NEOCORTEX and is rich in ACETYLCHOLINE and CHOLINE ACETYLTRANSFERASE. In PARKINSON DISEASE and ALZHEIMER DISEASE the nucleus undergoes degeneration.", "PM": "2000; see SUBSTANTIA INNOMINATA 1984-1999; for NUCLEUS BASALIS OF MEYNERT & NUCLEUS BASALIS MAGONCELLULARIS see SUBSTANTIA INNOMINATA 1984-1999; for BASAL MAGNOCELLULAR NUCLEUS see ISLANDS OF CALLEJA 2015", "HN": "2000; use SUBSTANTIA INNOMINATA 1984-1999; for NUCLEUS BASALIS OF MEYNERT & NUCLEUS BASALIS MAGNOCELLULARIS use SUBSTANTIA INNOMINATA 1984-1999; for BASAL MAGNOCELLULAR NUCLEUS use ISLANDS OF CALLEJA 2015", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020532"}, {"RECTYPE": "D", "MH": "Angiogenesis Inhibitors", "DE": "ANGIOGENESIS INHIB", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neovascularization Inhibitors|T121|T123|NON|EQV|NLM (2000)|991012|NEOVASC INHIB|abbcdefv", "ENTRY": "Inhibitors, Angiogenesis Factor", "MN": "D27.505.954.248.025", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "AN": "note entry term ANTI-ANGIOGENESIS EFFECT: use only for the anti-angiogenesis effect of a chemical substance", "PI": "Neovascularization, Pathologic (1980-1999)", "MS": "Agents and endogenous substances that antagonize or inhibit the development of new blood vessels.", "PM": "2000; ANGIOGENSIS FACTOR INHIBITORS was indexed under PROTEINS 1981-2003", "HN": "2004(2000); for ANGIOGENESIS FACTOR INHIBITORS use ANGIOGENESIS INHIBITORS (NM) 1981-2003", "MR": "20200527", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020533"}, {"RECTYPE": "D", "MH": "Parahippocampal Gyrus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hippocampal Gyrus|T023|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Presubiculums", "MN": "A08.186.211.200.885.287.500.382.750", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Hippocampus (1969-1999)", "MS": "A convolution on the inferior surface of each cerebral hemisphere, lying between the hippocampal and collateral sulci.", "PM": "2000", "HN": "2000", "MR": "20210701", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020534"}, {"RECTYPE": "D", "MH": "Video-Assisted Surgery", "DE": "VIDEO ASSISTED SURG", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgery, Video-Assisted|T061|NON|EQV|NLM (2000)|991012|SURG VIDEO ASSISTED|abcdefv", "ENTRY": "Video-Assisted Surgeries", "MN": "E04.502.250.950", "FX": "Video Recording", "MH_TH": "NLM (2000)", "ST": "T061", "PI": "Video Recording or specifics (1975-1999)", "MS": "Endoscopic surgical procedures performed with visualization via video transmission. When real-time video is combined interactively with prior CT scans or MRI images, this is called image-guided surgery (see SURGERY, COMPUTER-ASSISTED).", "PM": "2000", "HN": "2000", "MR": "20010725", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020535"}, {"RECTYPE": "D", "MH": "Enzyme Activators", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Activators of Enzymes|T121|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Enzymes Activators", "MN": "D27.505.519.374", "FX": "Enzyme Activation", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Enzyme Activation/drug effects (1976-1999)", "MS": "Compounds or factors that act on a specific enzyme to increase its activity.", "PM": "2000", "HN": "2000", "MR": "20140625", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020536"}, {"RECTYPE": "D", "MH": "RNA, Small Nucleolar", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "snoRNA|T114|T123|NON|EQV|NLM (2000)|991012|abbcdef", "MN": "D13.444.735.790.552.937.800", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "RNA, Small Nuclear (1986-1999)", "MS": "Small nuclear RNAs that are involved in the processing of pre-ribosomal RNA in the nucleolus. Box C/D containing snoRNAs (U14, U15, U16, U20, U21 and U24-U63) direct site-specific methylation of various ribose moieties. Box H/ACA containing snoRNAs (E2, E3, U19, U23, and U64-U72) direct the conversion of specific uridines to pseudouridine. Site-specific cleavages resulting in the mature ribosomal RNAs are directed by snoRNAs U3, U8, U14, U22 and the snoRNA components of RNase MRP and RNase P.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020537"}, {"RECTYPE": "D", "MH": "Sequence Analysis, Protein", "DE": "SEQ ANAL PROTEIN", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Sequence Determination, Protein|T059|T063|NON|NRW|NLM (2000)|991012|SEQ DETERMINATION PROTEIN|abbcdefv", "ENTRY": "Sequencing, Protein", "MN": "E05.393.760.705", "FX": "Molecular Sequence Annotation", "MH_TH": "NLM (2000)", "ST": "T063", "AN": "coordinate with specific protein (or protein group or peptide) with /chem", "PI": "Sequence Analysis (1993-1999)", "MS": "A process that includes the determination of AMINO ACID SEQUENCE of a protein (or peptide, oligopeptide or peptide fragment) and the information analysis of the sequence.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020539"}, {"RECTYPE": "D", "MH": "Metencephalon", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Metencephalons", "MN": "A08.186.211.132.810.428", "MH_TH": "UNK (19XX)", "ST": "T023", "PI": "Pons (1987-1999)", "MS": "The anterior portion of the developing hindbrain. It gives rise to the CEREBELLUM and the PONS.", "PM": "2000; see PONS 1987-1999", "HN": "2000; use PONS 1987-1999", "MR": "20150623", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020540"}, {"RECTYPE": "D", "MH": "Coiled Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Cajal Bodies|T026|EPO|EQV|NLM (2022)|201124|abcdef", "ENTRY": "Coiled Body", "MN": "A11.284.430.106.279.345.574.500", "MH_TH": "NLM (2000)", "ST": "T026", "PI": "Ribonucleoproteins, Small Nuclear (1993-1999)", "MS": "A distinct subnuclear domain enriched in splicesomal snRNPs (RIBONUCLEOPROTEINS, SMALL NUCLEAR) and p80-coilin.", "PM": "2000", "HN": "2000", "MR": "20210305", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020541"}, {"RECTYPE": "D", "MH": "Third Ventricle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ventricles, Third", "MN": "A08.186.211.140.840", "FX": "Cerebral Ventriculography", "MH_TH": "NLM (2000)", "ST": "T030", "PI": "Cerebral Ventricles (1965-1999)", "MS": "A narrow cleft inferior to the CORPUS CALLOSUM, within the DIENCEPHALON, between the paired thalami. Its floor is formed by the HYPOTHALAMUS, its anterior wall by the lamina terminalis, and its roof by EPENDYMA. It communicates with the FOURTH VENTRICLE by the CEREBRAL AQUEDUCT, and with the LATERAL VENTRICLES by the interventricular foramina.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020542"}, {"RECTYPE": "D", "MH": "Proteome", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "ENTRY": "Proteomes|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "MN": "D12.776.817", "FX": "Genome", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "AN": "coord with precoord organism protein + organism", "MS": "The protein complement of an organism coded for by its genome.", "PM": "2000", "HN": "2000", "MR": "20050630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020543"}, {"RECTYPE": "D", "MH": "Graft vs Leukemia Effect", "AQ": "DE GE IM PH RE", "ENTRY": "Responses, Graft-vs-Leukemia", "MN": "G12.875.402.320.320", "MH_TH": "NLM (1999)", "ST": "T042", "PI": "Graft vs Tumor Effect (1999)", "MS": "Immunological rejection of leukemia cells following bone marrow transplantation.", "PM": "2000; see GRAFT VS TUMOR EFFECT 1999", "HN": "2000; use GRAFT VS TUMOR EFFECT 1999", "MR": "20160623", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020544"}, {"RECTYPE": "D", "MH": "Respiratory Mucosa", "DE": "RESP MUCOSA", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Respiratory Epithelium|T024|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Mucosa, Respiratory", "MN": "A10.615.550.760", "MH_TH": "NLM (2000)", "ST": "T024", "PI": "Respiratory System or specifics (1966-1999)", "MS": "The mucous membrane lining the RESPIRATORY TRACT, including the NASAL CAVITY; the LARYNX; the TRACHEA; and the BRONCHI tree. The respiratory mucosa consists of various types of epithelial cells ranging from ciliated columnar to simple squamous, mucous GOBLET CELLS, and glands containing both mucous and serous cells.", "PM": "2000", "HN": "2000", "MR": "20050630", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020545"}, {"RECTYPE": "D", "MH": "Fourth Ventricle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ventricolos, Quarto", "MN": "A08.186.211.140.500", "FX": "Cerebral Ventriculography", "MH_TH": "NLM (2000)", "ST": "T030", "PI": "Cerebral Ventricles (1965-1999)", "MS": "An irregularly shaped cavity in the RHOMBENCEPHALON, located between the MEDULLA OBLONGATA; the PONS; and the isthmus in front, and the CEREBELLUM behind. It is continuous with the central canal of the cord below and with the CEREBRAL AQUEDUCT above, and through its lateral and median apertures it communicates with the SUBARACHNOID SPACE.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020546"}, {"RECTYPE": "D", "MH": "Lateral Ventricles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Zones, Subventricular", "MN": "A08.186.211.140.650", "FX": "Cerebral Ventriculography", "MH_TH": "NLM (2000)", "ST": "T030", "PI": "Cerebral Ventricles (1965-1999)", "MS": "Cavity in each of the CEREBRAL HEMISPHERES derived from the cavity of the embryonic NEURAL TUBE. They are separated from each other by the SEPTUM PELLUCIDUM, and each communicates with the THIRD VENTRICLE by the foramen of Monro, through which also the choroid plexuses (CHOROID PLEXUS) of the lateral ventricles become continuous with that of the third ventricle.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020547"}, {"RECTYPE": "D", "MH": "GTP Phosphohydrolase Activators", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "GTPase Activators|T121|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Activators, Small GTPase", "MN": "D27.505.519.374.200", "MH_TH": "NLM (2000)", "ST": "T121", "RN": "0", "PI": "GTP Phosphohydrolase/metabolism (1976-1999)", "MS": "Agents and factors that activate GTP phosphohydrolase activity.", "PM": "2000", "HN": "2000", "MR": "20140625", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020549"}, {"RECTYPE": "D", "MH": "Pulse Therapy, Drug", "DE": "PULSE THER DRUG", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Drug Pulse Therapy|T079|NON|EQV|NLM (2000)|991012|DRUG PULSE THER|abcdefv", "ENTRY": "Therapy, Pulse Drug", "MN": "E02.319.283.600", "MH_TH": "NLM (2000)", "ST": "T079", "AN": "coord NIM with drug /admin (IM)", "PI": "Drug Administration Schedule (1978-1999)", "MS": "Administration of high doses of pharmaceuticals over short periods of time.", "PM": "2000", "HN": "2000", "MR": "20190524", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020551"}, {"RECTYPE": "D", "MH": "Comet Assay", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Gel Electrophoresis, Single-Cell|T063|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Single-Cell Gel Electrophoresis", "MN": "E05.940.560.150", "FX": "DNA Damage", "MH_TH": "NLM (2000)", "ST": "T063", "PI": "Mutagenicity Tests (1992-1999)", "MS": "A genotoxicological technique for measuring DNA damage in an individual cell using single-cell gel electrophoresis. Cell DNA fragments assume a \"comet with tail\" formation on electrophoresis and are detected with an image analysis system. Alkaline assay conditions facilitate sensitive detection of single-strand damage.", "PM": "2000", "HN": "2000", "MR": "20080708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020552"}, {"RECTYPE": "D", "MH": "Sperm Injections, Intracytoplasmic", "DE": "SPERM INJECT INTRACYTOPLASMIC", "AQ": "AE CL DE EC ES HI IS LJ MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Intracytoplasmic Sperm Injections|T061|NON|EQV|NLM (2000)|991012|INTRACYTOPLASMIC SPERM INJECT|abcdefv", "ENTRY": "Sperm Injection, Intracytoplasmic", "MN": "E05.820.800.750.700", "FX": "Infertility, Male", "MH_TH": "NLM (2000)", "ST": "T061", "PI": "Microinjections (1994-1999)", "MS": "An assisted fertilization technique consisting of the microinjection of a single viable sperm into an extracted ovum. It is used principally to overcome low sperm count, low sperm motility, inability of sperm to penetrate the egg, or other conditions related to male infertility (INFERTILITY, MALE).", "PM": "2000", "HN": "2000", "MR": "20010725", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020554"}, {"RECTYPE": "D", "MH": "GTP-Binding Protein Regulators", "DE": "GTP BINDING PROTEIN REG", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Regulators, G-Protein Signaling|T116|T123|NON|EQV|NLM (2000)|991012|REG G PROTEIN SIGNALING|abbcdefv", "ENTRY": "Signaling Regulators, G-Protein", "MN": "D12.776.476.325", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "AN": "do not confuse with RGS PROTEINS", "PI": "Proteins (1978-1999)", "MS": "Proteins that regulate the signaling activity of GTP-BINDING PROTEINS. They are divided into three categories depending upon whether they stimulate GTPase activity (GTPASE-ACTIVATING PROTEINS), inhibit release of GDP; (GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS); or exchange GTP for GDP; (GUANINE NUCLEOTIDE EXCHANGE FACTORS).", "PM": "2000", "HN": "2000", "MR": "20151123", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020555"}, {"RECTYPE": "D", "MH": "Neutrophil Infiltration", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Neutrophil Recruitment|T039|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Recruitment, Neutrophil", "MN": "G12.632", "FX": "Leukemic Infiltration", "MH_TH": "NLM (2000)", "ST": "T039", "PI": "Neutrophils (1969-1999)", "MS": "The diffusion or accumulation of neutrophils in tissues or cells in response to a wide variety of substances released at the sites of inflammatory reactions.", "PM": "2000", "HN": "2000", "MR": "20160623", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020556"}, {"RECTYPE": "D", "MH": "Neurolinguistic Programming", "ENTRY": "Programming, Neurolinguistic", "MN": "L01.559.598.628.550", "FX": "Psychotherapy", "MH_TH": "NLM (2000)", "ST": "T170", "MS": "A set of models of how communication impacts and is impacted by subjective experience. Techniques are generated from these models by sequencing of various aspects of the models in order to change someone's internal representations. Neurolinguistic programming is concerned with the patterns or programming created by the interactions among the brain, language, and the body, that produce both effective and ineffective behavior.", "PM": "2000", "HN": "2000", "MR": "20170703", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020557"}, {"RECTYPE": "D", "MH": "GTP Phosphohydrolases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Guanosinetriphosphatases|T116|T126|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Triphosphate Phosphohydrolases, Guanosine", "MN": "D08.811.277.040.330", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.1.-", "AN": "GTP PHOSPHOHYDROLASE ACTIVATORS is available", "MS": "Enzymes that hydrolyze GTP to GDP. EC 3.6.1.-.", "PM": "2000; for GUANOSINE TRIPHOSPHATE PHOSPHOHYDROLASES, GTP PHOSPHOHYDROLASE AND GUANOSINETRIPHOSPHATASES see GTP PHOSPHOHYDROLASE 1975-1999; for GTPASE see GTP PHOSPHOHYDROLASE 1977-1999", "HN": "2000(1975)", "MR": "20210304", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020558"}, {"RECTYPE": "D", "MH": "Monomeric GTP-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ras-Related GTPases|T116|T126|NON|NRW|NLM (2000)|991012|RAS RELAT GTPASES|abbcdefv", "ENTRY": "ras Related GTPases", "MN": "D12.776.476.338.400", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "Heterotrimeric GTP-Binding Proteins (1985-1996)", "MS": "A class of monomeric, low molecular weight (20-25 kDa) GTP-binding proteins that regulate a variety of intracellular processes. The GTP bound form of the protein is active and limited by its inherent GTPase activity, which is controlled by an array of GTPase activators, GDP dissociation inhibitors, and guanine nucleotide exchange factors. This enzyme was formerly listed as EC 3.6.1.47", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020559"}, {"RECTYPE": "D", "MH": "Proteobacteria", "DE": "PROTEOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Purple Bacteria|T007|NON|EQV|NLM (2004)|021021|PURPLE BACT|abcdefv", "MN": "B03.660", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid1224", "MS": "A phylum of bacteria consisting of the purple bacteria and their relatives which form a branch of the eubacterial tree. This group of predominantly gram-negative bacteria is classified based on homology of equivalent nucleotide sequences of 16S ribosomal RNA or by hybridization of ribosomal RNA or DNA with 16S and 23S ribosomal RNA.", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020560"}, {"RECTYPE": "D", "MH": "Alphaproteobacteria", "DE": "ALPHAPROTEOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "alpha Proteobacteria|T007|NON|EQV|NLM (2000)|991012|ALPHA PROTEOBACT|abcdefv", "ENTRY": "Proteobacteria alpha|T007|NON|EQV|NLM (2000)|991012|PROTEOBACT ALPHA|abcdefv", "MN": "B03.660.050", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid28211", "MS": "A class in the phylum PROTEOBACTERIA comprised mostly of two major phenotypes: purple non-sulfur bacteria and aerobic bacteriochlorophyll-containing bacteria.", "PM": "2004; see ALPHA PROTEOBACTERIA 2000-2003", "HN": "2004 (2000)", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020561"}, {"RECTYPE": "D", "MH": "Betaproteobacteria", "DE": "BETAPROTEOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "beta Proteobacteria|T007|NON|EQV|NLM (2000)|991012|BETA PROTEOBACT|abcdefv", "ENTRY": "Proteobacteria beta|T007|NON|EQV|NLM (2000)|991012|PROTEOBACT BETA|abcdefv", "MN": "B03.660.075", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid28216", "MS": "A class in the phylum PROTEOBACTERIA comprised of chemoheterotrophs and chemoautotrophs which derive nutrients from decomposition of organic material.", "PM": "2004; see BETA PROTEOBACTERIA 2000-2003", "HN": "2004 (2000)", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020562"}, {"RECTYPE": "D", "MH": "Gammaproteobacteria", "DE": "GAMMAPROTEOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "gamma Proteobacteria|T007|NON|EQV|NLM (2000)|991012|GAMMA PROTEOBACT|abcdefv", "ENTRY": "Proteobacteria gamma|T007|NON|EQV|NLM (2000)|991012|PROTEOBACT GAMMA|abcdefv", "MN": "B03.660.250", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid1236", "MS": "A group of the proteobacteria comprised of facultatively anaerobic and fermentative gram-negative bacteria.", "PM": "2004; use GAMMA PROTEOBACTERIA 2000-2003", "HN": "2004 (2000)", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020563"}, {"RECTYPE": "D", "MH": "Deltaproteobacteria", "DE": "DELTAPROTEOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "delta Proteobacteria|T007|NON|EQV|NLM (2000)|991012|DELTA PROTEOBACT|abcdefv", "ENTRY": "Proteobacteria delta|T007|NON|EQV|NLM (2000)|991012|PROTEOBACT DELTA|abcdefv", "MN": "B03.660.125", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid28221", "PI": "Gram-negative Anaerobic Bacteria (1995-1999)", "MS": "A group of PROTEOBACTERIA represented by morphologically diverse, anaerobic sulfidogens. Some members of this group are considered bacterial predators, having bacteriolytic properties.", "PM": "2004; see delta Proteobacteria 2000-2003", "HN": "2004 (2000)", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020564"}, {"RECTYPE": "D", "MH": "Epsilonproteobacteria", "DE": "EPSILONPROTEOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "epsilon Proteobacteria|T007|NON|EQV|NLM (2000)|991012|EPSILON PROTEOBACT|abcdefv", "ENTRY": "Proteobacteria epsilon|T007|NON|EQV|NLM (2000)|991012|PROTEOBACT EPSILON|abcdefv", "MN": "B03.660.150", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid29547", "PI": "Bacteria/classification (1994-1999)", "MS": "A group of proteobacteria consisting of chemoorganotrophs usually associated with the DIGESTIVE SYSTEM of humans and animals.", "PM": "2004; see episilon Proteobacteria 2000-2004", "HN": "2004 (2000)", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020565"}, {"RECTYPE": "D", "MH": "Dendritic Cells, Follicular", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Follicular Dendritic Cells|T025|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Follicular Dendritic Cell", "MN": "A15.382.520.604.412.500.200", "MH_TH": "UNK (19XX)", "ST": "T025", "AN": "DENDRITIC CELLS is also available", "PI": "Lymph Nodes (1980-1986)", "MS": "Non-hematopoietic cells, with extensive dendritic processes, found in the primary and secondary follicles of lymphoid tissue (the B cell zones). They are different from conventional DENDRITIC CELLS associated with T-CELLS. They are derived from MESENCHYMAL STEM CELLS and are negative for class II MHC antigen and do not process or present antigen like the conventional dendritic cells do. Instead, follicular dendritic cells have FC RECEPTORS and C3B RECEPTORS that hold antigen in the form of ANTIGEN-ANTIBODY COMPLEXES on their surfaces for long periods for recognition by B-CELLS.", "PM": "2000; see DENDRITIC CELLS 1987-1999", "HN": "2000; use DENDRITIC CELLS 1987-1999", "MR": "20150622", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020566"}, {"RECTYPE": "D", "MH": "Fetal Weight", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Body Weight, Fetal|T032|T081|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Weights, Fetal", "MN": "G08.686.280", "FX": "Birth Weight", "MH_TH": "NLM (2000)", "ST": "T081", "AN": "mammalian only", "PI": "Fetus (1965-1999)", "MS": "The weight of the FETUS in utero. It is usually estimated by various formulas based on measurements made during PRENATAL ULTRASONOGRAPHY.", "PM": "2000", "HN": "2000", "MR": "20220712", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020567"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-rel", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rel Proto-Oncogene Proteins|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "rel Proto Oncogene Proteins", "MN": "D12.776.930.730", "FX": "I-kappa B Proteins", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Proto-Oncogene Proteins (1988-1999)", "MS": "Cellular DNA-binding proteins encoded by the rel gene (GENES, REL). They are expressed predominately in hematopoietic cells and may play a role in lymphocyte differentiation. Rel frequently combines with other related proteins (NF-KAPPA B, I-kappa B, relA) to form heterodimers that regulate transcription. Rearrangement or overexpression of c-rel can cause tumorigenesis.", "PM": "2000; PROTO-ONCOGENE PROTEIN C-REL was indexed under PROTO-ONCOGENE PROTEINS 1988-1999", "HN": "2000; use PROTO-ONCOGENE PROTEINS C-REL (NM) 1988-1999", "MR": "20150629", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020569"}, {"RECTYPE": "D", "MH": "Genes, myb", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "v-myb Genes|T028|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "v-myb Oncogene", "MN": "G05.360.340.024.340.375.500.791.418", "MH_TH": "UNK (19XX)", "ST": "T028", "PI": "Oncogenes (1983-1999)", "MS": "Retrovirus-associated DNA sequences (v-myb) originally isolated from the avian myeloblastosis and E26 leukemia viruses. The proto-oncogene c-myb codes for a nuclear protein involved in transcriptional regulation and appears to be essential for hematopoietic cell proliferation. The human myb gene is located at 6q22-23 on the short arm of chromosome 6. This is the point of break in translocations involved in T-cell acute lymphatic leukemia and in some ovarian cancers and melanomas. (From Ibelgaufts, Dictionary of Cytokines, 1995).", "PM": "2000; use ONCOGENES 1985-1999", "HN": "2000; use ONCOGENES 1985-1999", "MR": "20080708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020570"}, {"RECTYPE": "D", "MH": "Genes, sis", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "v-sis Genes|T028|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "v-sis Oncogene", "MN": "G05.360.340.024.340.375.500.791.560", "FX": "Proto-Oncogene Proteins c-sis", "MH_TH": "UNK (19XX)", "ST": "T028", "PI": "Oncogenes (1983-1999)", "MS": "Retrovirus-associated DNA sequences (v-sis) originally isolated from the simian sarcoma virus (SSV). The proto-oncogene c-sis codes for a growth factor which is the B chain of PLATELET-DERIVED GROWTH FACTOR. v-sis or overexpression of c-sis causes tumorigenesis. The human sis gene is located at 22q12.3-13.1 on the long arm of chromosome 22.", "PM": "2000; see ONCOGENES 1988-1999", "HN": "2000; use ONCOGENES 1988-1999", "MR": "20080708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020571"}, {"RECTYPE": "D", "MH": "Oncogene Proteins v-rel", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-rel Proteins|T116|T129|T192|NON|EQV|NLM (2000)|991012|abbbcdef", "ENTRY": "v-rel, Oncogene Proteins", "MN": "D12.776.964.775.750.925", "FX": "Genes, rel", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "0", "PI": "Retroviridae Proteins, Oncogenic (1990-1999)", "MS": "Transforming proteins coded by rel oncogenes. The v-rel protein competes with rel-related proteins and probably transforms cells by acting as a dominant negative version of c-rel. This results in the induction of a broad range of leukemias and lymphomas.", "PM": "2000; ONCOGENE PROTEIN REL was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1999 & RETROVIRIDAE PROTEINS 1988-1989", "HN": "2000; use ONCOGENE PROTEINS V-REL (NM) 1988-1999", "MR": "20050630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020572"}, {"RECTYPE": "D", "MH": "Genes, rel", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "v-rel Genes|T028|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "v-rel Oncogene", "MN": "G05.360.340.024.340.375.500.791.552", "FX": "Proto-Oncogene Proteins c-rel", "MH_TH": "UNK (19XX)", "ST": "T028", "PI": "Oncogenes (1983-1999)", "MS": "Family of retrovirus-associated DNA sequences (v-rel) originally isolated from an avian reticuloendotheliosis virus strain. The proto-oncogene rel (c-rel) codes for a subcellular (nuclear and cytoplasmic) transcription factor that has a role in lymphocyte differentiation. Translocation or overexpression of c-rel or competition from v-rel causes oncogenesis. The human rel gene is located at 2p12-13 on the short arm of chromosome 2.", "PM": "2000; see ONCOGENES 1988-1999", "HN": "2000; use ONCOGENES 1988-1999", "MR": "20080708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020573"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-sis", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "sis Proto-Oncogene Proteins|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "sis, Proto-Oncogene Proteins", "MN": "D23.529.910.650", "FX": "Genes, sis", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Proto-Oncogene Proteins (1987-1999)", "MS": "Cellular DNA-binding proteins encoded by the sis gene (GENES, SIS). c-sis proteins make up the B chain of PLATELET-DERIVED GROWTH FACTOR. Overexpression of c-sis causes tumorigenesis.", "PM": "2000; PROTO-ONCOGENE PROTEIN SIS was indexed under PROTO-ONCOGENE PROTEINS 1987-1999 & PLATELET-DERIVED GROWTH FACTOR 1990-1999", "HN": "2000; use PROTO-ONCOGENE PROTEINS C-SIS (NM) 1987-1999", "MR": "20060705", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020574"}, {"RECTYPE": "D", "MH": "Oncogene Proteins v-sis", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-sis Proteins|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "v-sis, Oncogene Proteins", "MN": "D12.776.964.775.750.935", "FX": "Genes, sis", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Viral Proteins (1983-1985)", "MS": "Transforming proteins coded by sis oncogenes. Transformation of cells by v-sis is related to its interaction with the PDGF receptor and also its ability to alter other transcription factors.", "PM": "2000; ONCOGENE PROTEINS SIS was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1999; RETROVIRIDAE PROTEINS 1986-1989; & VIRAL PROTEINS 1983-1985", "HN": "2000; use ONCOGENE PROTEINS V-SIS (NM) 1983-1999", "MR": "20050630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020575"}, {"RECTYPE": "D", "MH": "Gluconobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Gluconobacter suboxydans|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.050.755.050.415", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid441", "AN": "do not confuse entry term GLUCONOBACTER SUBOXYDANS with GLUCONOBACTER OXYDANS", "MS": "A genus of gram-negative, rod-shaped to ellipsoidal bacteria occurring singly or in pairs and found in flowers, soil, honey bees, fruits, cider, beer, wine, and vinegar. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200902", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020576"}, {"RECTYPE": "D", "MH": "Wolbachia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.500.762", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid953", "PI": "Rickettsiaceae (1976-1999)", "MS": "A genus of bacteria which comprises a heterogenous group of gram-negative small rods and coccoid forms associated with arthropods. (From Bergey's Manual of Systematic Bacteriology, vol 1, 1984)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020577"}, {"RECTYPE": "D", "MH": "Sphingomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.800.750", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid13687", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "MS": "A genus of gram-negative, aerobic, rod-shaped bacteria characterized by an outer membrane that contains glycosphingolipids but lacks lipopolysaccharide. They have the ability to degrade a broad range of substituted aromatic compounds.", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020578"}, {"RECTYPE": "D", "MH": "Sinorhizobium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.662.835", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid28105", "MS": "A genus of gram-negative, aerobic, nonsporeforming rods which usually contain granules of poly-beta-hydroxybutyrate. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020579"}, {"RECTYPE": "D", "MH": "Methylobacterium", "DE": "METHYLOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.500.500", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid407", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Methylococcaceae (1998-1999)", "MS": "A genus of gram-negative, aerobic, facultatively methylotrophic rods occurring singly or occasionally in rosettes. Members of this genus are usually motile and are isolated from soil, dust, fresh water, lake sediments, leaf surfaces, rice, air, and hospital environments. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020580"}, {"RECTYPE": "D", "MH": "Methylosinus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.512.500", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid425", "PI": "Methylococcaceae (1975-1999)", "MS": "A genus of gram-negative rods which form exospores and are obligate methanotrophs.", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020581"}, {"RECTYPE": "D", "MH": "Hyphomicrobium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Hyphomicrobium methylovorum|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.050.350.400", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid81", "RR": "txid84", "PI": "Budding and Appendaged Bacteria (1998-1999)", "MS": "A genus of rod-shaped, oval, or bean-shaped bacteria found in soil and fresh water. Polar prosthecae are present and cells reproduce by budding at the tips of the prosthecae. Cells of this genus are aerobic and grow best with one-carbon compounds. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020582"}, {"RECTYPE": "D", "MH": "Azorhizobium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.350.080", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid6", "PI": "Rhizobiaceae/genetics (1988-1996)", "MS": "A genus of gram-negative, rod-shaped, obligate aerobes which are motile by peritrichous flagella on solid medium and one lateral flagellum in liquid medium. Under microaerobic conditions Azorhizobium fixes nitrogen. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020583"}, {"RECTYPE": "D", "MH": "Xanthobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Xanthobacter flavus|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.050.350.950", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid279", "RR": "txid281", "PI": "Gram-Negative Aerobic Bacteria (1985-1999)", "MS": "A genus of gram-negative, aerobic, rod-shaped bacteria found in wet soil containing decaying organic material and in water. Cells tend to be pleomorphic if grown on media containing succinate or coccoid if grown in the presence of an alcohol as the sole carbon source. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020584"}, {"RECTYPE": "D", "MH": "Comamonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Comamonas terrigena|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.075.090.766.150", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid283", "RR": "txid32013", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "MS": "A genus of gram-negative, straight or slightly curved rods which are motile by polar flagella and which accumulate poly-beta-hydroxybutyrate within the cells.", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020585"}, {"RECTYPE": "D", "MH": "Thiocapsa", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.110.750", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid1056", "PI": "Chromatiaceae (1988-1999)", "MS": "A genus of anoxygenic, photosynthetic, nonmotile, spherical to slightly ovoid bacterial cells occurring singly, or in aggregates of two or four, and usually surrounded with slime. It is found in stagnant water, mud of ponds, estuaries, and microbial mats of salt marshes. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020586"}, {"RECTYPE": "D", "MH": "Ectothiorhodospira", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.145.500", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid1051", "MS": "A genus of vibrioid or rod-shaped cells which are motile by polar flagella. Internal photosynthetic membranes are present as lamellar stacks and contain bacteriochlorophyll a or b and carotenoids. Growth occurs photoautotrophically under anaerobic conditions. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020587"}, {"RECTYPE": "D", "MH": "Stenotrophomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.915.750", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid40323", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Xanthomonas (1993-1999)", "MS": "A genus of gram-negative, aerobic, motile, rod-shaped bacteria formerly classified as part of the genus XANTHOMONAS.", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020588"}, {"RECTYPE": "D", "MH": "Vitreoscilla", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Vitreoscilla stercoraria|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.075.525.900", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid59", "RR": "txid61", "MS": "A genus of gram-negative, aerobic or microaerophilic, colorless filaments. It is nonfruiting, motile by gliding, and found in freshwater sediments and cow dung. One species (V. stercoraria) is considered morphologically to be a streptobacillus. That species is strictly aerobic and produces a homodimeric bacterial hemoglobin, especially under oxygen-limited growth conditions. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020589"}, {"RECTYPE": "D", "MH": "Alteromonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.021.020", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid226", "PI": "Gram-Negative Aerobic Bacteria (1977-1999)", "MS": "A genus of gram-negative, straight or curved rods which are motile by means of a single, polar flagellum. Members of this genus are found in coastal waters and the open ocean. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020591"}, {"RECTYPE": "D", "MH": "Shewanella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.021.755", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid22", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Gram-Negative Facultatively Anaerobic Rods (1995-1999)", "MS": "A genus of gram-negative, facultatively anaerobic rods. It is a saprophytic, marine organism which is often isolated from spoiling fish.", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020592"}, {"RECTYPE": "D", "MH": "Xenorhabdus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Xenorhabdus nematophilus subsp. nematophilus|T007|NON|NRW|NLM (2021)|190919|abcdef", "ENTRY": "Xenorhabdus nematophilus|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.250.150.910", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid626", "RR": "txid628", "AN": "XENORHABDUS LUMINESCENS see PHOTORHABDUS is also available", "PI": "Enterobacteriaceae (1983-1999)", "MS": "A genus of gram-negative, facultatively anaerobic rod-shaped cells which are motile by peritrichous flagella. Late in the growth cycle, spheroplasts or coccoid bodies occur, resulting from disintegration of the cell wall. The natural habitat is the intestinal lumen of certain nematodes. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020593"}, {"RECTYPE": "D", "MH": "Edwardsiella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.160", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid635", "AN": "infection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)", "PI": "Enterobacteriaceae (1969-1999)", "MS": "A genus of small, straight gram-negative rods which are facultatively anaerobic, chemoorganotrophic, and usually motile by peritrichous flagella. Members of this genus are usually found in the intestines of cold-blooded animals and in fresh water. They are pathogenic for eels, CATFISHES, and other animals and are rare opportunistic pathogens for humans. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020594"}, {"RECTYPE": "D", "MH": "Hafnia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.280", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid568", "AN": "infection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)", "PI": "Enterobacteriaceae (1966-1999)", "MS": "A genus of straight, gram-negative bacterial rods which are facultatively anaerobic and motile by peritrichous flagella. This genus is found in human and animal feces, soil, water, and dairy products. It is an opportunistic pathogen in humans. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020595"}, {"RECTYPE": "D", "MH": "Morganella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.500", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid581", "AN": "infection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)", "PI": "Enterobacteriaceae (1974-1999)", "MS": "A genus of gram-negative, facultatively anaerobic, straight rods which are motile by peritrichous flagella. These organisms are chemoorganotrophic and have both a respiratory and fermentative type of metabolism. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020596"}, {"RECTYPE": "D", "MH": "Stigmatella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.125.500.710", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid40", "PI": "Myxococcales (1978-1999)", "MS": "A genus of the MYXOCOCCALES having vegetative cells which are straight rods with tapered ends and myxospores which are short and somewhat crooked. Fruiting bodies consist of spherical, ovoid, or club-shaped sporangioles on stalks. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020597"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-myb", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "myb Proto-Oncogene Proteins|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "myb, Proto-Oncogene Proteins", "MN": "D12.776.930.725", "FX": "Genes, myb", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Trans-Activators (1990-1999)", "MS": "Cellular DNA-binding proteins encoded by the myb gene (GENES, MYB). They are expressed in a wide variety of cells including thymocytes and lymphocytes, and regulate cell differentiation. Overexpression of myb is associated with autoimmune diseases and malignancies.", "PM": "2000; PROTO-ONCOGENE PROTEIN MYB was indexed under PROTO-ONCOGENE PROTEINS 1986-1990 & TRANS-ACTIVATORS 1990-1999", "HN": "2000; use PROTO-ONCOGENE PROTEINS C-MYB (NM) 1986-1999", "MR": "20150629", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020598"}, {"RECTYPE": "D", "MH": "Azorhizobium caulinodans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.350.080.100", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid7", "PI": "Rhizobiaceae/genetics (1988-1999)", "MS": "A species of AZORHIZOBIUM which forms nodules on the roots of the tropical legume Sesbania rostrata. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200128", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020599"}, {"RECTYPE": "D", "MH": "Gluconobacter oxydans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.755.050.415.550", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid442", "AN": "do not confuse with GLUCONOBACTER SUBOXYDANS see GLUCONOBACTER", "PI": "Pseudomonadaceae (1976-1992)", "MS": "A rod-shaped to ellipsoidal, gram-negative bacterium which oxidizes ethanol to acetic acid and prefers sugar-enriched environments. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020600"}, {"RECTYPE": "D", "MH": "Methylobacterium extorquens", "DE": "METHYLOBACT EXTORQUENS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.500.500.150", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid408", "PI": "Gram-Negative Aerobic Bacteria (1989-1999)", "MS": "A species of METHYLOBACTERIUM which can utilize acetate, ethanol, or methylamine as a sole carbon source. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020601"}, {"RECTYPE": "D", "MH": "Methylosinus trichosporium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.512.500.750", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid426", "MS": "A species of METHYLOSINUS which is capable of degrading trichloroethylene and other organic pollutants.", "PM": "2000", "HN": "2000", "MR": "20200128", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020602"}, {"RECTYPE": "D", "MH": "Comamonas testosteroni", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pseudomonas testosteroni|T007|NON|EQV|NLM (2000)|991012|abcdef", "MN": "B03.660.075.090.766.150.750", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid285", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "MS": "A species of gram-negative, aerobic rods formerly called Pseudomonas testosteroni. It is differentiated from other Comamonas species by its ability to assimilate testosterone and to utilize phenylacetate or maleate as carbon sources.", "PM": "2000", "HN": "2000", "MR": "20200128", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020604"}, {"RECTYPE": "D", "MH": "Delftia acidovorans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pseudomonas acidovorans|T007|NON|EQV|NLM (2000)|991012|abcdef", "MN": "B03.660.075.090.766.170.030", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid80866", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "MS": "A species of gram-negative rod-shaped bacteria found ubiquitously and formerly called Comamonas acidovorans and Pseudomonas acidovorans. It is the type species of the genus DELFTIA.", "PM": "2004; see COMAMONAS ACIDOVORANS 2000-2003", "HN": "2004 (2000)", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020605"}, {"RECTYPE": "D", "MH": "Stigmatella aurantiaca", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Chondromyces aurantiacus|T007|NON|EQV|NLM (2021)|190918|abcdef", "MN": "B03.660.125.500.710.050", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid41", "PI": "Myxococcales (1978-1999)", "MS": "A species of STIGMATELLA usually isolated from rotting wood. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200128", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020606"}, {"RECTYPE": "D", "MH": "Halorhodospira halophila", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Ectothiorhodospira halophila|T007|NON|EQV|NLM (2000)|991012|abcdef", "MN": "B03.660.250.145.750", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid1053", "MS": "A species of Halorhodospira distinguished by its ability to grow optimally in an environment of 15-20% salinity. It was formerly called Ectothiorhodospira halophila.", "PM": "2004; see ECTOTHIORHODOSPIRA HALOPHILA 2000-2003", "HN": "2004 (2000)", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020607"}, {"RECTYPE": "D", "MH": "Ectothiorhodospira shaposhnikovii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Ectothiorhodospira vacuolata|T007|NON|EQV|NLM (2000)|991012|abcdef", "MN": "B03.660.250.145.500.720", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid1054", "MS": "A species of ECTOTHIORHODOSPIRA distinguished by its ability to utilize nitrate. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000; for ECTOTHIORHODOSPIRA VACUOLATA see ECTOTHIORHODOSPIRA 2000-2005", "HN": "2000; for ECTOTHIORHODOSPIRA VACUOLATA use ECTOTHIORHODOSPIRA 2000-2005", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020608"}, {"RECTYPE": "D", "MH": "Edwardsiella tarda", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Paracolobactrum anguillimortiferum|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.150.160.750", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid636", "AN": "infection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)", "PI": "Enterobacteriaceae (1966-1999)", "MS": "A species of EDWARDSIELLA distinguished by its hydrogen sulfide production. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200128", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020609"}, {"RECTYPE": "D", "MH": "Edwardsiella ictaluri", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.160.340", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid67780", "AN": "infection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)", "PI": "Enterobacteriaceae (1984-1999)", "MS": "A species of EDWARDSIELLA distinguished by its nonmotility. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020610"}, {"RECTYPE": "D", "MH": "Hafnia alvei", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.280.050", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid569", "AN": "infection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)", "PI": "Enterobacteriaceae (1969-1999)", "MS": "The type species for the genus HAFNIA. It is distinguished from other biochemically similar bacteria by its lack of acid production on media containing sucrose. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020611"}, {"RECTYPE": "D", "MH": "Morganella morganii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Salmonella morgani|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.150.500.500", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid582", "AN": "infection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)", "PI": "Proteus (1975-1987)", "MS": "A species of MORGANELLA formerly classified as a Proteus species. It is found in the feces of humans, dogs, other mammals, and reptiles. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200128", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020613"}, {"RECTYPE": "D", "MH": "Shewanella putrefaciens", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pseudomonas putrefaciens|T007|NON|EQV|NLM (2021)|190918|abcdef", "MN": "B03.660.250.021.755.750", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid24", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Gram-Negative Facultatively Anaerobic Rods (1995-1999)", "MS": "A species of SHEWANELLA noted for its ability to reduce iron and manganese anaerobically.", "PM": "2000", "HN": "2000", "MR": "20200128", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020614"}, {"RECTYPE": "D", "MH": "Stenotrophomonas maltophilia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Xanthomonas maltophilia|T007|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Pseudomonas maltophilia|T007|NON|EQV|NLM (2015)|130905|abcdef", "MN": "B03.660.250.915.750.500", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid40324", "AN": "infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Xanthomonas (1995-1999)", "MS": "A species of STENOTROPHOMONAS, formerly called Xanthomonas maltophilia, which reduces nitrate. It is a cause of hospital-acquired ocular and lung infections, especially in those patients with cystic fibrosis and those who are immunosuppressed.", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020615"}, {"RECTYPE": "D", "MH": "Thiocapsa roseopersicina", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.110.750.660", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid1058", "PI": "Chromatiaceae (1976-1999)", "MS": "A species of THIOCAPSA which is facultatively aerobic and chemotrophic and which can utilize thiosulfate. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020616"}, {"RECTYPE": "D", "MH": "Methylococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.500.500", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid413", "PI": "Methylococcaceae (1978-1999)", "MS": "A genus of gram-negative, aerobic, spherical cells usually occurring in pairs. The resting stage is considered a cyst. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020618"}, {"RECTYPE": "D", "MH": "Methylococcus capsulatus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.500.500.100", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid414", "PI": "Methylococcaceae (1978-1999)", "MS": "A species of METHYLOCOCCUS which forms capsules and is capable of autotrophic carbon dioxide fixation. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200128", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020619"}, {"RECTYPE": "D", "MH": "Methylomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.500.505", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid416", "PI": "Methylococcaceae (1976-1999)", "MS": "A genus of gram-negative, aerobic, straight, curved, or branched rods which are motile by a single polar flagellum. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020620"}, {"RECTYPE": "D", "MH": "Ochrobactrum anthropi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.070.700.650", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid529", "AN": "infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS", "MS": "A species of gram-negative, obligately aerobic rods. Motility occurs by peritrichous flagella. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200128", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020621"}, {"RECTYPE": "D", "MH": "Afipia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Afipia felis|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.050.035.040", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid1033", "RR": "txid1035", "AN": "infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM) or CAT-SCRATCH DISEASE (IM) if pertinent", "PI": "Gram-Negative Bacteria (1992-1999)", "MS": "A genus of gram-negative, oxidase-positive, nonfermentative rods which are motile by means of a single flagellum. Afipia felis and BARTONELLA HENSELAE are causative agents of CAT-SCRATCH DISEASE. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020622"}, {"RECTYPE": "D", "MH": "Rhodomicrobium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rhodomicrobium vannielii|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.050.350.675", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid1068", "RR": "txid1069", "PI": "Rhodospirillaceae (1978-1999)", "MS": "A genus, in the family HYPHOMICROBIACEAE, comprised of ovoid-shaped bacteria with polar growth and a characteristic vegetative growth cycle. Cells grow preferably photoheterotrophically under anaerobic conditions in the light, but will also grow under microaerobic or aerobic conditions in the dark. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2004; see RHODOMICROBIUM VANNIELII 2000-2003", "HN": "2004 (2000)", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020623"}, {"RECTYPE": "D", "MH": "Oxalobacter formigenes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Oxalobacter|T007|NON|BRD|NLM (2004)|021113|abcdef", "MN": "B03.660.075.090.883.600", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid847", "RR": "txid846", "PI": "Gram-Negative Anaerobic Bacteria (1996-1999)", "MS": "The sole species of the genus Oxalobacter consisting of straight or curved gram-negative rods with rounded ends. Cells are nonmotile, nonsporing, and use oxylates as the only source of CARBON and energy, with formate and CARBON DIOXIDE as end products. They are isolated from lake sediments and from the rumen or large bowel of humans and animals. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020624"}, {"RECTYPE": "D", "MH": "Taylorella equigenitalis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.344.800.200", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid29575", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Haemophilus (1986-1999)", "MS": "A species of bacteria which is comprised of gram-negative rods which often approach a spherical shape. They are nonmotile and microaerophilic. They are considered parasites of horses and are pathogenic for mares. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020625"}, {"RECTYPE": "D", "MH": "Oncogene Proteins v-myb", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-myb Proteins|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "v-myb, Oncogene Proteins", "MN": "D12.776.964.775.750.903", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Retroviridae Proteins, Oncogenic (1990-1999)", "MS": "Transforming proteins coded by myb oncogenes. Transformation of cells by v-myb in conjunction with v-ets is seen in the avian E26 leukemia virus.", "PM": "2000; ONCOGENE PROTEINS MYB was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1999 & RETROVIRIDAE PROTEINS 1986-1989", "HN": "2000; use ONCOGENE PROTEINS V-MYB (NM) 1986-1999", "MR": "20050630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020626"}, {"RECTYPE": "D", "MH": "Azoarcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.655.070", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid12960", "PI": "Gram-Negative Facultatively Anaerobic Rods (1994-1999)", "MS": "A genus of gram-negative, facultatively anaerobic bacteria including species which are often associated with grasses (POACEAE) and which fix nitrogen as well as species which anaerobically degrade toluene and other mono-aromatic hydrocarbons.", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020627"}, {"RECTYPE": "D", "MH": "Thauera", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Thauera aromatica|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.075.655.800", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid33057", "RR": "txid59405", "MS": "A genus of gram-negative, rod-shaped bacteria able to anaerobically oxidize and degrade toluene.", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020628"}, {"RECTYPE": "D", "MH": "Methylophilus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.495.520", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid16", "MS": "A genus of straight or slightly curved gram-negative rods occurring singly or in pairs and isolated from sludge, mud, and river and pond water. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020629"}, {"RECTYPE": "D", "MH": "Methylophilus methylotrophus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Methylotrophus methylophilus|T007|NON|EQV|NLM (2021)|190918|abcdef", "MN": "B03.660.075.495.520.500", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid17", "PI": "Gram-Negative Bacteria (1992-1997)", "MS": "A species of METHYLOPHILUS which is motile by single flagella. In addition to growth on methanol as a sole carbon source, growth also occurs on glucose. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200128", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020630"}, {"RECTYPE": "D", "MH": "Methylobacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.495.500", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid404", "MS": "A genus of short, aerobic, gram-negative rods which are obligate methylotrophs, growing on one-carbon compounds other than methane. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020631"}, {"RECTYPE": "D", "MH": "Halomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Halomonas elongata|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.250.350.500", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid2745", "RR": "txid2746", "MS": "A genus of gram-negative, rod-shaped or pleomorphic bacteria which are halotolerant. Members of this genus are capable of growth in sodium chloride concentrations of up to 20% or more. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020632"}, {"RECTYPE": "D", "MH": "Cellvibrio", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Cellvibrio mixtus|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.250.580.100", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid10", "RR": "txid39650", "MS": "A genus of aerobic, gram-negative, motile, slightly curved, rod-shaped bacteria. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020633"}, {"RECTYPE": "D", "MH": "Buchnera", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Buchnera aphidicola|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.250.150.047", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid32199", "RR": "txid9", "PI": "Aphids/microbiology (1993-1999)", "MS": "A genus of gram-negative bacteria which are obligately intracellular endosymbionts of APHIDS. The bacteria are found within specialized cells in the aphid body cavity.", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020635"}, {"RECTYPE": "D", "MH": "Pantoea", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pantoea agglomerans|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.250.150.540", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid53335", "RR": "txid549", "AN": "infection: coordinate IM with ENTEROBACTERIACEAE INFECTIONS (IM)", "MS": "A genus of gram-negative, facultatively anaerobic, straight rods which are motile by peritrichous flagella. Most strains produce a yellow pigment. This organism is isolated from plant surfaces, seeds, soil, and water, as well as from animals and human wounds, blood, and urine. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020636"}, {"RECTYPE": "D", "MH": "Photorhabdus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Xenorhabdus luminescens|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.250.150.545", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid29487", "RR": "txid29488", "PI": "Enterobacteriaceae (1994-1999)", "MS": "A genus of gram-negative bacteria existing symbiotically with nematodes of the family Heterorhabditidae (see RHABDITOIDEA). These nematodes infect a variety of soil-dwelling insects. Upon entering an insect host, the nematode releases Photorhabdus from its intestinal tract and the bacterium establishes a lethal septicemia in the insect.", "PM": "2000; for XENORHABDUS LUMINESCENS see XENORHABDUS 2001-2002", "HN": "2000; for XENORHABDUS LUMINESCENS use XENORHABDUS 2001-2002", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020637"}, {"RECTYPE": "D", "MH": "Rahnella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rahnella aquatilis|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.250.150.655", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid34037", "RR": "txid34038", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Enterobacteriaceae (1980-1999)", "MS": "A genus of gram-negative, facultatively anaerobic, small, rod-shaped bacteria occurring in fresh water.", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020638"}, {"RECTYPE": "D", "MH": "Lawsonia Bacteria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Lawsonia intracellularis|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.125.460", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid41707", "RR": "txid29546", "AN": "infection: coord IM with DESULFOVIBRIONACEAE INFECTIONS (IM)", "PI": "Gram-Negative Bacteria (1996-1999)", "MS": "A genus of gram-negative, obligate intracellular bacteria causing a proliferative enteritis in animals, especially pigs, deer, horses, and rabbits.", "PM": "2003; see LAWSONIA 2000-2003", "HN": "2003(2000)", "MR": "20200813", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020639"}, {"RECTYPE": "D", "MH": "Arcobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Arcobacter butzleri|T007|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B03.660.150.050", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid28196", "RR": "txid28197", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Campylobacter (1992-1999)", "MS": "A genus of gram-negative, aerotolerant, spiral-shaped bacteria isolated from water and associated with diarrhea in humans and animals.", "PM": "2000", "HN": "2000", "MR": "20200813", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020640"}, {"RECTYPE": "D", "MH": "Polymorphism, Single Nucleotide", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Single Nucleotide Polymorphism|T086|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Single Nucleotide Polymorphisms", "MN": "G05.365.795.598", "MH_TH": "NLM (2000)", "ST": "T086", "AN": "do not confuse with POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL", "PI": "Polymorphism (Genetics) (1991-1999)", "MS": "A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.", "PM": "2000", "HN": "2000", "MR": "20080708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020641"}, {"RECTYPE": "D", "MH": "Acatalasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypocatalasemia|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Takaharas Disease", "MN": "C18.452.648.663.050", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Catalase (1965-1999)", "MS": "A rare autosomal recessive disorder resulting from the absence of CATALASE activity. Though usually asymptomatic, a syndrome of oral ulcerations and gangrene may be present.", "PM": "2000", "HN": "2000", "MR": "20150608", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020642"}, {"RECTYPE": "D", "MH": "Anterior Thalamic Nuclei", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Anteroventral Thalamic Nucleus|T023|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Thalamus, Anterior", "MN": "A08.186.211.200.317.826.701.080", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Thalamic Nuclei (1971-1999)", "MS": "Three nuclei located beneath the dorsal surface of the most rostral part of the thalamus. The group includes the anterodorsal nucleus, anteromedial nucleus, and anteroventral nucleus. All receive connections from the MAMILLARY BODY and BRAIN FORNIX, and project fibers to the CINGULATE BODY.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020643"}, {"RECTYPE": "D", "MH": "Midline Thalamic Nuclei", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Rhomboid Thalamic Nucleus|T023|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Thalamus, Nucleus Reuniens", "MN": "A08.186.211.200.317.826.701.500", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Thalamic Nuclei (1971-1999)", "MS": "Small, nonspecific nerve cells scattered in the periventricular GRAY MATTER, separating the medial part of the thalamus from the EPENDYMA of the THIRD VENTRICLE. The group includes the paraventricular nucleus, paratenial nucleus, reuniens nucleus, rhomboidal nucleus, and subfascular nucleus.", "PM": "2000", "HN": "2000", "MR": "20180701", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020644"}, {"RECTYPE": "D", "MH": "Mediodorsal Thalamic Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Medial Dorsal Nucleus|T023|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Thalamus, Nucleus Dorsomedialis", "MN": "A08.186.211.200.317.826.701.490", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Thalamus (1967-1973)", "MS": "The largest of the medial nuclei of the thalamus. It makes extensive connections with most of the other thalamic nuclei.", "PM": "2000", "HN": "2000", "MR": "20180701", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020645"}, {"RECTYPE": "D", "MH": "Intralaminar Thalamic Nuclei", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Rostral Intralaminar Nuclei|T023|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Thalamus, Nucleus Parafascicularis", "MN": "A08.186.211.200.317.826.701.460", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Thalamus (1966-1970)", "MS": "Cell groups within the internal medullary lamina of the THALAMUS. They include a rostral division comprising the paracentral, central lateral, central dorsal, and central medial nuclei, and a caudal division composed of the centromedian and parafascicular nuclei.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020646"}, {"RECTYPE": "D", "MH": "Lateral Thalamic Nuclei", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Lateral Posterior Thalamic Nucleus|T023|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Thalamic Nucleus, Laterodorsal", "MN": "A08.186.211.200.317.826.701.485", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Thalamic Nuclei (1971-1999)", "MS": "A narrow strip of cell groups on the dorsomedial surface of the thalamus. It includes the lateral dorsal nucleus, lateral posterior nucleus, and the PULVINAR.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020647"}, {"RECTYPE": "D", "MH": "Peptide Elongation Factor 1", "DS": "PEPTIDE ELONGATION FACTOR AAA 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Elongation Factor 1gamma|T116|T126|NON|NRW|NLM (2000)|991012|ELONGATION FACTOR A 001 GAMMA|abbcdefs", "ENTRY": "EF 1gamma", "MN": "D12.776.835.700.350.101", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "0", "PI": "Peptide Elongation Factors (1973-1999)", "MS": "Peptide elongation factor 1 is a multisubunit protein that is responsible for the GTP-dependent binding of aminoacyl-tRNAs to eukaryotic ribosomes. The alpha subunit (EF-1alpha) binds aminoacyl-tRNA and transfers it to the ribosome in a process linked to GTP hydrolysis. The beta and delta subunits (EF-1beta, EF-1delta) are involved in exchanging GDP for GTP. The gamma subunit (EF-1gamma) is a structural component.", "PM": "2000; ELONGATION FACTOR 1 was indexed under PEPTIDE ELONGATION FACTORS 1980-1999; ELONGATION FACTOR 1GAMMA was indexed under PEPTIDE ELONGATION FACTORS 1994-1999", "HN": "2000; for ELONGATION FACTOR 1 use PEPTIDE ELONGATION FACTOR 1 (NM) 1980-1999; for ELONGATION FACTOR 1GAMMA use PEPTIDE ELONGATION FACTOR 1 (NM) 1994-1999", "MR": "20210521", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020648"}, {"RECTYPE": "D", "MH": "Pulvinar", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Oral Pulvinar Nucleus|T023|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Thalamus, Pulvinar", "MN": "A08.186.211.200.317.826.701.485.600", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Thalamus (1965-1970)", "MS": "Large mass of nuclei forming the most caudal portion of the THALAMUS and overhanging the GENICULATE BODIES and the dorsolateral surface of the MIDBRAIN. It is divided into four parts: the lateral, medial, inferior, and oral pulvinar nuclei.", "PM": "2000", "HN": "2000", "MR": "20180701", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020649"}, {"RECTYPE": "D", "MH": "Combinatorial Chemistry Techniques", "DE": "COMB CHEM", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Techniques, Combinatorial Chemistry|T062|NON|EQV|NLM (2000)|991012|TECHNIQUES COMBINATORIAL CHEM|abcdefv", "ENTRY": "Technique, Combinatorial Chemistry|T062|NON|EQV|NLM (2000)|991012|TECHNIQUE COMBINATORIAL CHEM|abcdefv", "MN": "J01.897.836.249.249", "FX": "Peptide Library", "MH_TH": "NLM (2000)", "ST": "T062", "PI": "specific chemical /chemistry (1992-1999)", "MS": "A technology, in which sets of reactions for solution or solid-phase synthesis, is used to create molecular libraries for analysis of compounds on a large scale.", "PM": "2000", "HN": "2000", "MR": "20160617", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020650"}, {"RECTYPE": "D", "MH": "Ventral Thalamic Nuclei", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Ventral Posteromedial Thalamic Nucleus|T023|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Ventrolateralis Thalamus, Nucleus", "MN": "A08.186.211.200.317.826.701.900", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Thalamus (1965-1970)", "MS": "A large group of nuclei lying between the internal medullary lamina and the INTERNAL CAPSULE. It includes the ventral anterior, ventral lateral, and ventral posterior nuclei.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020651"}, {"RECTYPE": "D", "MH": "Peptide Elongation Factor 2", "DS": "PEPTIDE ELONGATION FACTOR AAA 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Elongation Factor 2|T116|T126|NON|EQV|NLM (2000)|991012|ELONGATION FACTOR A 002|abbcdefs", "ENTRY": "EF 2", "MN": "D12.776.835.700.350.102", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "0", "PI": "Peptide Elongation Factors (1980-1999)", "MS": "Peptide Elongation Factor 2 catalyzes the translocation of peptidyl-tRNA from the A site to the P site of eukaryotic ribosomes by a process linked to the hydrolysis of GTP to GDP.", "PM": "2000; ELONGATION FACTOR 2 was indexed under PEPTIDE ELONGATION FACTORS 1980-1999", "HN": "2000; for ELONGATION FACTOR 2 use PEPTIDE ELONGATION FACTOR 2 (NM) 1980-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020652"}, {"RECTYPE": "D", "MH": "Peptide Elongation Factor G", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "fusA Protein|T116|T126|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "EF G", "MN": "D12.776.835.700.350.200", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "0", "PI": "Peptide Elongation Factors (1980-1999)", "MS": "Peptide Elongation Factor G catalyzes the translocation of peptidyl-tRNA from the A to the P site of bacterial ribosomes by a process linked to hydrolysis of GTP to GDP.", "PM": "2000; Elongation Factor G was indexed under PEPTIDE ELONGATION FACTORS 1980-1999", "HN": "2000; for ELONGATION FACTOR G use PEPTIDE ELONGATION FACTOR G (NM) 1980-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020653"}, {"RECTYPE": "D", "MH": "Posterior Thalamic Nuclei", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Suprageniculate Thalamic Nucleus|T023|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Thalamus Posterior Nucleus", "MN": "A08.186.211.200.317.826.701.700", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Thalamic Nuclei (1973-1999)", "MS": "A transitional diencephalic zone of the thalamus consisting of complex and varied cells lying caudal to the VENTRAL POSTEROLATERAL NUCLEUS, medial to the rostral part of the PULVINAR, and dorsal to the MEDIAL GENICULATE BODY. It contains the limitans, posterior, suprageniculate, and submedial nuclei.", "PM": "2000", "HN": "2000", "MR": "20180701", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020656"}, {"RECTYPE": "D", "MH": "Guanine Nucleotide Exchange Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Guanine Nucleotide Releasing Factors|T116|T126|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Reversing Factors, GDP-GTP", "MN": "D12.776.476.325.300", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "0", "PI": "Proteins (1978-1999)", "MS": "Protein factors that promote the exchange of GTP for GDP bound to GTP-BINDING PROTEINS.", "PM": "2000; GUANINE-NUCLEOTIDE-RELEASING FACTOR was indexed under PROTEINS 1978-1999; GDP-GTP EXCHANGE PROTEIN was indexed under G-PROTEINS 1994-1999; GDP DISSOCIATION FACTOR was indexed under G-PROTEINS 1996-1999", "HN": "2000; use GUANINE NUCLEOTIDE EXCHANGE FACTORS (NM) 1978-1999; for GDP-GTP EXCHANGE PROTEIN use RAB3 GTP-BINDING PROTEINS (NM) 1994-1999; for GDP DISSOCIATION FACTOR use RAP GTP-BINDING PROTEINS (NM) 1996-1999", "MR": "20151123", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020662"}, {"RECTYPE": "D", "MH": "ras Guanine Nucleotide Exchange Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rasGEFs|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "ras GEFs", "MN": "D12.776.476.325.300.700", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Proteins (1979-1999)", "MS": "A family of GUANINE NUCLEOTIDE EXCHANGE FACTORS that are specific for RAS PROTEINS.", "PM": "2000; RAS GUANINE NUCLEOTIDE EXCHANGE FACTOR was indexed under PROTEINS 1995-1999", "HN": "2000; for RAS GUANINE NUCLEOTIDE EXCHANGE FACTOR use RAS GUANINE NUCLEOTIDE EXCHANGE FACTORS (NM) 1995-1999", "MR": "20151124", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020663"}, {"RECTYPE": "D", "MH": "Son of Sevenless Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SOS Proteins|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Sevenless Protein Son", "MN": "D12.776.476.325.300.700.700", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "AN": "not for proteins involved in SOS RESPONSE (GENETICS); SOS PROTEIN see SON OF SEVENLESS PROTEIN, DROSOPHILA is also available", "PI": "Proteins (1978-1999)", "MS": "A class of RAS GUANINE NUCLEOTIDE EXCHANGE FACTORS that are genetically related to the Son of Sevenless gene from DROSOPHILA. Sevenless refers to genetic mutations in DROSOPHILA that cause loss of the R7 photoreceptor which is required to see UV light.", "PM": "2000; SON OF SEVENLESS PROTEIN was indexed under MEMBRANE PROTEINS 1992-1999", "HN": "2000; use SON OF SEVENLESS PROTEINS (NM) 1992-1999", "MR": "20151124", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020664"}, {"RECTYPE": "D", "MH": "Septum of Brain", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Septal Region|T023|NON|REL|NLM (2000)|991012|abcdef", "ENTRY": "Region, Septal", "MN": "A08.186.211.200.885.750", "MH_TH": "NLM (2000)", "ST": "T023", "AN": "SEPTUM PELLUCIDUM is also available", "PI": "Septum Pellucidum (1972-1999)", "MS": "GRAY MATTER structures of the telencephalon and LIMBIC SYSTEM in the brain, but containing widely varying definitions among authors. Included here is the cortical septal area, subcortical SEPTAL NUCLEI, and the SEPTUM PELLUCIDUM.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020665"}, {"RECTYPE": "D", "MH": "ras-GRF1", "DS": "RAS GRF 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "cdc25 Guanine Nucleotide Exchange Factor|T116|T123|NON|EQV|NLM (2000)|991012|CDC 025 GUANINE NUCLEOTIDE EXCHANGE FACTOR|abbcdefs", "ENTRY": "ras GRF1", "MN": "D12.776.476.325.300.700.500", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "AN": "note: GRF1 is an acronym for several proteins that are not Guanine Nucleotide Releasing Factors; do not confuse with CDC25 PHOSPHATASES", "PI": "Proteins (1981-1999)", "MS": "A guanine nucleotide exchange factor that is expressed primarily in neuronal tissue and may be specific for the Ha-ras homolog of the RAS PROTEINS.", "PM": "2000; RAS-GRF1 was indexed under CELL CYCLE PROTEINS 1996-1999 & under PROTEINS 1992-1995; RAS-GRF was indexed under PROTEINS 1995-1999", "HN": "2000; use RAS-GRF1 (NM) 1992-1999; for RAS-GRF use RAS-GRF1 (NM) 1995-1999;", "MR": "20151124", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020666"}, {"RECTYPE": "D", "MH": "Diagonal Band of Broca", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Broca Diagonal Band", "MN": "A08.186.211.200.885.380", "MH_TH": "NLM (2000)", "ST": "T023", "AN": "do not confuse with NUCLEUS OF DIAGONAL BAND see SEPTAL NUCLEI", "MS": "Cholinergic bundle of nerve fibers posterior to the anterior perforated substance. It interconnects the paraterminal gyrus in the septal area with the hippocampus and lateral olfactory area.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020667"}, {"RECTYPE": "D", "MH": "rap GTP-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ras-Related rap Proteins|T116|T126|ABX|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "ras-Related rap Protein", "MN": "D12.776.476.338.400.475", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1989-1999)", "MS": "A family of MONOMERIC GTP-BINDING PROTEINS that are related to RAS PROTEINS.This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RAS-RELATED RAP PROTEINS (now RAP GTP-BINDING PROTEINS) was indexed under G-PROTEINS 1988-1999", "HN": "2000; use RAP GTP-BINDING PROTEINS (NM) 1988-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020668"}, {"RECTYPE": "D", "MH": "Fetoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Embryoscopes|T074|NON|REL|NLM (2000)|991012|abcdef", "ENTRY": "Fetoscope", "MN": "E07.858.240.280", "FX": "Fetoscopy", "MH_TH": "NLM (2000)", "ST": "T074", "PI": "Fetoscopy/instrumentation (1977-1999)", "MS": "Endoscopes for viewing the embryo, fetus and amniotic cavity.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020669"}, {"RECTYPE": "D", "MH": "Islands of Calleja", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Terminalis, Insulae", "MN": "A08.186.211.200.885.287.750.656.500", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Olfactory Pathways (1973-1999)", "MS": "Aggregations of GRANULE CELLS in the dorsal aspect of the OLFACTORY TUBERCLE and within the Island of Calleja Magna that lies between the BRAIN SEPTUM and the NUCLEUS ACCUMBENS.", "PM": "2000", "HN": "2000", "MR": "20210701", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020670"}, {"RECTYPE": "D", "MH": "Posterior Horn Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Neurons, Posterior Horn|T023|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Posterior Horn Neurons", "MN": "A11.671.650.675", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Spinal Cord (1967-1999)", "MS": "Neurons in the SPINAL CORD DORSAL HORN whose cell bodies and processes are confined entirely to the CENTRAL NERVOUS SYSTEM. They receive collateral or direct terminations of dorsal root fibers. They send their axons either directly to ANTERIOR HORN CELLS or to the WHITE MATTER ascending and descending longitudinal fibers.", "PM": "2000", "HN": "2000", "MR": "20140620", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020671"}, {"RECTYPE": "D", "MH": "I-kappa B Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "IkB DNA Binding Proteins", "MN": "D12.776.930.326", "FX": "Proto-Oncogene Proteins c-rel", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Proto-Oncogene Proteins (1993-1998)", "MS": "A family of inhibitory proteins which bind to the REL PROTO-ONCOGENE PROTEINS and modulate their activity. In the CYTOPLASM, I-kappa B proteins bind to the transcription factor NF-KAPPA B. Cell stimulation causes its dissociation and translocation of active NF-kappa B to the nucleus.", "PM": "2000; see I KAPPA B 2000-2005, I KAPPA B PROTEINS was indexed under PROTO-ONCOGENE PROTEINS 1993-1998 & DNA-BINDING PROTEINS 1998-1999", "HN": "2006(2000)", "MR": "20170630", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020672"}, {"RECTYPE": "D", "MH": "Protein Renaturation", "AQ": "DE RE", "PRINT ENTRY": "Renaturation, Protein|T067|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Renaturations, Protein", "MN": "G02.111.688.501.500", "MH_TH": "NLM (2000)", "ST": "T067", "PI": "Protein Folding (1993-1999)", "MS": "The reconstitution of a protein's activity following denaturation.", "PM": "2000", "HN": "2000", "MR": "20180702", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020673"}, {"RECTYPE": "D", "MH": "Peroxisomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Peroxisome", "MN": "A11.284.430.214.190.875.190.190.755.600", "FX": "Peroxisome Proliferators", "MH_TH": "UNK (19XX)", "ST": "T026", "PI": "Microbodies (1975-1999)", "MS": "Microbodies which occur in animal and plant cells and in certain fungi and protozoa. They contain peroxidase, catalase, and allied enzymes. (From Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2nd ed)", "PM": "2000; see MICROBODIES 1976-1999", "HN": "2000; use MICROBODIES 1976-1999", "MR": "20030709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020675"}, {"RECTYPE": "D", "MH": "Glyoxysomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Glyoxysome", "MN": "A11.284.430.214.190.875.190.190.755.250", "MH_TH": "NLM (2000)", "ST": "T026", "PI": "Microbodies (1982-1999)", "MS": "Microbodies which occur in plant cells, and in some eukaryotic microorganisms, and which contain enzymes of the glyoxylate cycle. (Singleton and Stainsbury, Dictionary of Microbiology and Molecular Biology, 2nd ed)", "PM": "2000", "HN": "2000", "MR": "20030709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020676"}, {"RECTYPE": "D", "MH": "Angioscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Angioscope", "MN": "E07.858.240.040", "FX": "Angioscopy", "MH_TH": "NLM (2000)", "ST": "T074", "PI": "Endoscopes (1998-1999)", "MS": "Endoscopes used for viewing the interior of blood vessels.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020677"}, {"RECTYPE": "D", "MH": "Microscopic Angioscopy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Capillaroscopy|T060|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Videocapillaroscopies", "MN": "E05.595.185.500", "MH_TH": "NLM (2000)", "ST": "T060", "PI": "Angioscopy (1993-1999)", "MS": "The noninvasive microscopic examination of the microcirculation, commonly done in the nailbed or conjunctiva. In addition to the capillaries themselves, observations can be made of passing blood cells or intravenously injected substances. This is not the same as endoscopic examination of blood vessels (ANGIOSCOPY).", "PM": "2000", "HN": "2000", "MR": "20150625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020678"}, {"RECTYPE": "D", "MH": "Arthroscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Arthroscope", "MN": "E07.858.240.060", "FX": "Arthroscopy", "MH_TH": "NLM (2000)", "ST": "T074", "PI": "Endoscopes (1998-1999)", "MS": "Endoscopes for visualizing the interior of a joint.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020679"}, {"RECTYPE": "D", "MH": "Bronchoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Bronchoscope", "MN": "E07.858.240.090", "FX": "Bronchoscopy", "MH_TH": "NLM (2000)", "ST": "T074", "PI": "Endoscopes (1998-1999)", "MS": "Endoscopes for the visualization of the interior of the bronchi.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020680"}, {"RECTYPE": "D", "MH": "Colposcopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Colposcope", "MN": "E07.858.240.170", "FX": "Colposcopy", "MH_TH": "NLM (2000)", "ST": "T074", "PI": "Endoscopes (1998-1999)", "MS": "Instruments inserted into the vagina for examination of the tissues of the vagina and cervix by means of a magnifying lens.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020681"}, {"RECTYPE": "D", "MH": "Cefixime", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "FR17027", "MN": "D03.633.100.300.249.190.190.115", "MH_TH": "USP (19XX)", "ST": "T195", "N1": "5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid,7-(((2-amino-4-thiazolyl)((carboxymethoxy)imino)acetyl)amino)3-ethenyl-8-oxo-, trihydrate, (6R-(6alpha,7beta(Z)))-", "RN": "97I1C92E55", "RR": "XZ7BG04GJX", "PI": "Cephalosporins (1984-1985)", "MS": "A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.", "PM": "2000; FK 027 (now CEFIXIME) was indexed under CEFOTAXIME/*analogs & derivatives 1986-1999 and under CEPHALOSPORINS 1984-1985", "HN": "2000 (1984)", "MR": "20230821", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020682"}, {"RECTYPE": "D", "MH": "Culdoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Culdoscope|T074|NON|EQV|NLM (2000)|991012|abcdef", "MN": "E07.858.240.180", "FX": "Culdoscopy", "MH_TH": "NLM (1979)", "ST": "T074", "PI": "Culdoscopy (1978-1999)", "MS": "Endoscopic instruments used for viewing the rectovaginal pouch and pelvic viscera.", "PM": "2000; for CULDOSCOPE see CULDOSCOPY 1979-1999", "HN": "2000; for CULDOSCOPE use CULDOSCOPY 1979-1999", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020683"}, {"RECTYPE": "D", "MH": "Cystoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Cystoscope", "MN": "E07.858.240.190", "FX": "Cystoscopy", "MH_TH": "NLM (1998)", "ST": "T074", "PI": "Endoscopes (1998-1999)", "MS": "Endoscopes for visual examination of the urinary bladder.", "PM": "2000; see ENDOSCOPES 1998-1999", "HN": "2000; use ENDOSCOPES 1998-1999", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020684"}, {"RECTYPE": "D", "MH": "Colonoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Colonoscope", "MN": "E07.858.240.260.160", "FX": "Colonoscopy", "MH_TH": "NLM (1998)", "ST": "T074", "PI": "Endoscopes (1998-1999)", "MS": "Specially designed endoscopes for visualizing the interior surface of the colon.", "PM": "2000; see ENDOSCOPES 1998-1999", "HN": "2000; use ENDOSCOPES 1998-1999", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020685"}, {"RECTYPE": "D", "MH": "cdc25 Phosphatases", "DS": "CDC 025 PHOSPHATASES", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphatases, cdc25", "MN": "D12.776.476.564.250.100", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.48", "AN": "do not confuse with CDC25 GUANINE NUCLEOTIDE EXCHANGE FACTOR", "PI": "Phosphoprotein Phosphatase (1996-1999)", "MS": "A subclass of dual specificity phosphatases that play a role in the progression of the CELL CYCLE. They dephosphorylate and activate CYCLIN-DEPENDENT KINASES.", "PM": "2008; see CDC25 PHOSPHATASE 2000-2008; CDC25 PROTEIN (now CDC25 PHOSPHATASE) was indexed under CELL CYCLE PROTEINS 1995-1999 & PHOSPHOPROTEIN PHOSPHATASES 1996-1999; CDC25A PHOSPHATASE & CDC25B PHOSPHATASE were indexed under CDC25 PHOSPHATASES 1999-2007; CDC25C PHOSPHATASE was indexed under CDC25 PHOSPHATASES & CELL CYCLE PROTEINS 2000-2007, under PHOSPHOPROTEIN PHOSPHATASE 1996-1999 & under PROTEINS 1993-1995", "HN": "2008(1995)", "MR": "20210521", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020687"}, {"RECTYPE": "D", "MH": "Exopeptidases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Exoproteases|T116|T126|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Exoprotease|T116|T126|NON|EQV|NLM (2000)|991012|abbcdef", "MN": "D08.811.277.656.350", "EC": "antagonists & inhibitors:Protease Inhibitors", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.4.-", "PI": "Peptide Hydrolases (1977-1999)", "MS": "A sub-class of PEPTIDE HYDROLASES that act only near the ends of polypeptide chains.", "PM": "2000; EXOPROTEASES (now EXOPEPTIDASES) was indexed under PEPTIDE HYDROLASES 1977-1999", "HN": "2000; use EXOPEPTIDASES (NM) 1977-1999", "MR": "20090706", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020689"}, {"RECTYPE": "D", "MH": "GTPase-Activating Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "GAP Proteins|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "GTPase Activating Proteins", "MN": "D12.776.476.325.150", "PA": "GTP Phosphohydrolase Activators", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Proteins (1989-1999)", "MS": "Proteins that activate the GTPase of specific GTP-BINDING PROTEINS.", "PM": "2000; GTPASE-ACTIVATING PROTEIN (now GTPase-ACTIVATING PROTEINS) was indexed under PROTEINS 1988-1999", "HN": "2000; use GTPASE-ACTIVATING PROTEINS (NM) 1988-1999", "MR": "20151123", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020690"}, {"RECTYPE": "D", "MH": "rab GTP-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rab GTPases|T116|T126|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "rab GTP Binding Proteins", "MN": "D12.776.476.338.400.400", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1989-1999)", "MS": "A large family of MONOMERIC GTP-BINDING PROTEINS that play a key role in cellular secretory and endocytic pathways.", "PM": "2000", "HN": "2000", "MR": "20210521", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020691"}, {"RECTYPE": "D", "MH": "rab3 GTP-Binding Proteins", "DS": "RAB A 003 GTP BINDING PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "rab3 GTP Binding Proteins", "MN": "D12.776.476.338.400.400.100", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1989-1999)", "MS": "A genetically related subfamily of RAB GTP-BINDING PROTEINS involved in calcium-dependent EXOCYTOSIS. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RAB3 PROTEIN (now RAB3 GTP-BINDING PROTEINS) was indexd under G-PROTEINS 1990-1999", "HN": "2000(1990)", "MR": "20210427", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020692"}, {"RECTYPE": "D", "MH": "rab2 GTP-Binding Protein", "DS": "RAB A 002 GTP BINDING PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "rab2 GTP Binding Protein", "MN": "D12.776.476.338.400.400.050", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1992-1999)", "MS": "A protein involved in transport between the ENDOPLASMIC RETICULUM and the GOLGI APPARATUS. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RAB2 PROTEIN (now RAB2 GTP-BINDING PROTEIN) was indexed under G-PROTEINS 1991-1999", "HN": "2000; use RAB2 GTP-BINDING PROTEIN (NM) 1991-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020693"}, {"RECTYPE": "D", "MH": "Sigmoidoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Sigmoidoscope", "MN": "E07.858.240.260.160.800", "FX": "Sigmoidoscopy", "MH_TH": "NLM (1998)", "ST": "T074", "PI": "Sigmoidoscopy/instrumentation (1966-1999)", "MS": "Endoscopes for examining the interior of the sigmoid colon.", "PM": "2000; see ENDOSCOPY 1998-1999", "HN": "2000; use ENDOSCOPY 1998-1999", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020694"}, {"RECTYPE": "D", "MH": "rab4 GTP-Binding Proteins", "DS": "RAB A 004 GTP BINDING PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rab4A GTP-Binding Protein|T116|T126|ABX|NRW|NLM (2000)|991012|RAB A 004A GTP BINDING PROTEIN|abbcdefs", "ENTRY": "rab4A GTP Binding Protein", "MN": "D12.776.476.338.400.400.150", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1992-1999)", "MS": "A genetically related subfamily of RAB GTP-BINDING PROTEINS involved in recycling of proteins such as cell surface receptors from early endosomes to the cell surface. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RAB4 PROTEIN (now RAB4 GTP-BINDING PROTEINS) was indexed under G-PROTEINS 1991-1999", "HN": "2000; use RAB4 GTP-BINDING PROTEINS (NM) 1991-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020695"}, {"RECTYPE": "D", "MH": "rab5 GTP-Binding Proteins", "DS": "RAB A 005 GTP BINDING PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rab5A GTP-Binding Protein|T116|T126|ABX|NRW|NLM (2000)|991012|RAB A 005A GTP BINDING PROTEIN|abbcdefs", "ENTRY": "rab5A GTP Binding Protein", "MN": "D12.776.476.338.400.400.200", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1992-1999)", "MS": "A genetically related subfamily of RAB GTP-BINDING PROTEINS involved in transport from the cell membrane to early endosomes. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RAB5 PROTEIN (now RAB5 GTP-BINDING PROTEINS) was indexed under G-PROTEINS 1991-1999", "HN": "2000; use RAB5 GTP-BINDING PROTEINS (NM) 1991-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020696"}, {"RECTYPE": "D", "MH": "Duodenoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Duodenoscope", "MN": "E07.858.240.260.200", "FX": "Duodenoscopy", "MH_TH": "NLM (2000)", "ST": "T074", "PI": "Endoscopes (1998-1999)", "MS": "Endoscopes for examining the interior of the duodenum.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020698"}, {"RECTYPE": "D", "MH": "Gastroscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Gastroscope", "MN": "E07.858.240.260.320", "FX": "Gastroscopy", "MH_TH": "NLM (1998)", "ST": "T074", "PI": "Gastroscopy/instrumentation (1966-1999)", "MS": "Endoscopes used for examining the interior of the stomach.", "PM": "2000; see ENDOSCOPES 1998-1999", "HN": "2000; use ENDOSCOPES 1998-1999", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020699"}, {"RECTYPE": "D", "MH": "Proctoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Rectoscopes|T074|NON|REL|NLM (2024)|221006|abcdef", "ENTRY": "Proctoscope|T074|NON|EQV|NLM (2000)|991012|abcdef", "MN": "E07.858.240.260.680", "FX": "Proctoscopy", "MH_TH": "NLM (1979)", "ST": "T074", "PI": "Proctoscopy/instrumentation (1966-1999)", "MS": "Endoscopes for visual examination of the RECTUM and ANUS.", "PM": "2000; for PROCTOSCOPE see PROCTOSCOPY 1979-1999", "HN": "2000; for PROCTOSCOPE use PROCTOSCOPY 1979-1999", "MR": "20221215", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020700"}, {"RECTYPE": "D", "MH": "Esophagoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Esophagoscope", "MN": "E07.858.240.260.260", "FX": "Esophagoscopy", "MH_TH": "NLM (2000)", "ST": "T074", "PI": "Esophagoscopy/instrumentation (1966-1999)", "MS": "Endoscopes for examining the interior of the esophagus.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020701"}, {"RECTYPE": "D", "MH": "Hysteroscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Uteroscopes|T074|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Uteroscope", "MN": "E07.858.240.390", "FX": "Hysteroscopy", "MH_TH": "NLM (2000)", "ST": "T074", "PI": "Hysteroscopy/instrumentation (1990-1999)", "MS": "Endoscopes for examining the interior of the uterus.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020702"}, {"RECTYPE": "D", "MH": "ras GTPase-Activating Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ras-GAPs|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "ras GTPase Activating Proteins", "MN": "D12.776.476.325.150.500", "PA": "GTP Phosphohydrolase Activators", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Proteins (1995-1999)", "MS": "PROTEINS that specifically activate the GTP-phosphohydrolase activity of RAS PROTEINS.", "PM": "2000; RAS-GAP was indexed under PROTEINS 1995-1999", "HN": "2000; for RAS-GAP use RAS GTPASE-ACTIVATING PROTEINS (NM) 1995-1999", "MR": "20151124", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020703"}, {"RECTYPE": "D", "MH": "Laryngoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Laryngoscope", "MN": "E07.858.240.525", "FX": "Laryngoscopy", "MH_TH": "NLM (2000)", "ST": "T074", "PI": "Laryngoscopy/instrumentation (1966-1999)", "MS": "Endoscopes for examining the interior of the larynx.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020704"}, {"RECTYPE": "D", "MH": "Laparoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Peritoneoscopes|T074|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Peritoneoscope", "MN": "E07.858.240.520", "FX": "Laparoscopy", "MH_TH": "NLM (1998)", "ST": "T074", "PI": "Laparoscopy/instrumentation (1966-1999)", "MS": "ENDOSCOPES for examining the abdominal and pelvic organs in the peritoneal cavity.", "PM": "2000; see ENDOSCOPES 1998-1999", "HN": "2000; use ENDOSCOPES 1998-1999", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020706"}, {"RECTYPE": "D", "MH": "Mediastinoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Mediastinoscope", "MN": "E07.858.240.565", "FX": "Mediastinoscopy", "MH_TH": "NLM (2000)", "ST": "T074", "PI": "Mediastinoscopy/instrumentation (1974-1999)", "MS": "Endoscopes for examining tissue of the anterior superior mediastinum.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020707"}, {"RECTYPE": "D", "MH": "Thoracoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Thoracoscope", "MN": "E07.858.240.850", "FX": "Thoracoscopy", "MH_TH": "NLM (2000)", "ST": "T074", "PI": "Thoracoscopy/instrumentation (1966-1999)", "MS": "Endoscopes for examining the pleural cavity.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020708"}, {"RECTYPE": "D", "MH": "Ureteroscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Ureteroscope", "MN": "E07.858.240.895", "FX": "Ureteroscopy", "MH_TH": "NLM (2000)", "ST": "T074", "PI": "Ureteroscopy/instrumentation (1995-1999)", "MS": "Endoscopes for examining the interior of the ureter.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020709"}, {"RECTYPE": "D", "MH": "RGS Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Regulators of G-Protein Signaling Proteins|T116|T126|NON|EQV|NLM (2000)|991012|REGULAT OF G PROTEIN SIGNALING PROTEINS|abbcdefv", "ENTRY": "Regulators of G Protein Signaling Proteins", "MN": "D12.776.476.325.150.750", "PA": "GTP Phosphohydrolase Activators", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "0", "AN": "do not confuse with GTP-BINDING PROTEIN REGULATORS; not the same as RGS tripeptide", "PI": "Proteins (1989-1999)", "MS": "A large family of evolutionarily conserved proteins that function as negative regulators of HETEROTRIMERIC GTP-BINDING PROTEINS. RGS PROTEINS act by increasing the GTPase activity of the G alpha subunit of a heterotrimeric GTP-binding protein, causing it to revert to its inactive (GDP-bound) form.", "PM": "2000; RGS PROTEIN (G-PROTEIN SIGNALING) was indexed under PROTEINS 1997-1999", "HN": "2000; for RGS PROTEIN (G-PROTEIN SIGNALING) use GTPASE-ACTIVATING PROTEINS (NM) 1997-1999", "MR": "20151124", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020710"}, {"RECTYPE": "D", "MH": "Threshold Limit Values", "PRINT ENTRY": "Short-Term Exposure Limit|T089|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "TLV-TWAs", "MN": "N06.850.460.350.600.807", "FX": "Maximum Allowable Concentration", "MH_TH": "UNK (19XX)", "ST": "T089", "MS": "Standards for limiting worker exposure to airborne contaminants. They are the maximum concentration in air at which it is believed that a particular substance will not produce adverse health effects with repeated daily exposure. It can be a time-weighted average (TLV-TWA), a short-term value (TLV-STEL), or an instantaneous value (TLV-Ceiling). They are expressed either as parts per million (ppm) or milligram per cubic meter (mg/m3).", "PM": "2000; see MAXIMUM PERMISSIBLE EXPOSURE LEVEL 1976-1999; for TLV see MAXIMUM PERMISSIBLE EXPOSURE LEVEL 1976-1999", "HN": "2000; use MAXIMUM ALLOWABLE CONCENTRATION 1976-1999; for TLV use MAXIMUM ALLOWABLE CONCENTRATION 1976-1999", "MR": "20080708", "DA": "19991109", "DC": "1", "DX": "20000101", "UI": "D020711"}, {"RECTYPE": "D", "MH": "Fornix, Brain", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Fimbria, Brain|T023|NON|NRW|NLM (2008)|061004|abcdef", "ENTRY": "Hippocampus, Commissura", "MN": "A08.186.211.200.885.287.500.345.600", "MH_TH": "NLM (2008)", "ST": "T023", "PI": "Hippocampus (1966-1999)", "MS": "Heavily myelinated fiber bundle of the TELENCEPHALON projecting from the hippocampal formation to the HYPOTHALAMUS. Some authorities consider the fornix part of the LIMBIC SYSTEM. The fimbria starts as a flattened band of axons arising from the subiculum and HIPPOCAMPUS, which then thickens to form the fornix.", "PM": "2008; see FORNIX (BRAIN) 2000-2007; for FIMBRIA OF HIPPOCAMPUS see under HIPPOCAMPUS 2000-2014 now HIPPOCAMPAL FORMATION", "HN": "2008 (2000)", "MR": "20180630", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020712"}, {"RECTYPE": "D", "MH": "Vancomycin Resistance", "AQ": "DE EH GE IM PH RE", "MN": "G07.690.773.984.269.347.984", "MH_TH": "NLM (2000)", "ST": "T032", "PI": "Vancomycin/pharmacology (1973-1999)", "MS": "Nonsusceptibility of bacteria to the action of VANCOMYCIN, an inhibitor of cell wall synthesis.", "PM": "2000", "HN": "2000", "MR": "20150629", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020713"}, {"RECTYPE": "D", "MH": "Maximum Tolerated Dose", "PRINT ENTRY": "Maximally Tolerated Dose|T081|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Tolerated Doses, Maximum", "MN": "G07.690.936.625", "MH_TH": "NLM (2000)", "ST": "T081", "MS": "The highest dose of a biologically active agent given during a chronic study that will not reduce longevity from effects other than carcinogenicity. (from Lewis Dictionary of Toxicology, 1st ed)", "PM": "2000", "HN": "2000", "MR": "20150629", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020714"}, {"RECTYPE": "D", "MH": "Eukaryotic Initiation Factor-2B", "DS": "EUKARYOTIC INITIATION FACTOR 02 B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Initiation Factor EIF-2B|T116|T123|ACX|EQV|NLM (2003)|020412|PEPTIDE INITIATION FACTOR EIF 02 B|abbcdefs", "ENTRY": "Peptide Initiation Factor EIF 2B", "MN": "D12.776.835.725.868.374", "FX": "Leukoencephalopathies", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Proteins (1983-1999)", "MS": "A guanine nucleotide exchange factor that acts to restore EUKARYOTIC INITIATION FACTOR-2 to its GTP bound form.", "PM": "2003; see EIF-2B 2000-2002; EIF-2B was indexed under PROTEINS 1992-1999", "HN": "2003(2000); use EUKARYOTIC INITIATION FACTOR-2B (NM) 1992-1999", "MR": "20150622", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020717"}, {"RECTYPE": "D", "MH": "Ribonucleoproteins, Small Nucleolar", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "snoRNP|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Ribonucleoprotein, Small Nucleolar", "MN": "D12.776.664.962.500.875.590", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins, Small Nuclear (1993-1999)", "MS": "Nucleolar RNA-protein complexes that function in pre-ribosomal RNA processing.", "PM": "2000", "HN": "2000", "MR": "20200527", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020718"}, {"RECTYPE": "D", "MH": "Glucuronides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glucuronide|T109|T123|NON|EQV|NLM (2021)|191115|abbcdef", "MN": "D09.811.922.162.750", "FX": "Uridine Diphosphate Glucuronic Acid", "MH_TH": "UNK (19XX)", "ST": "T123", "RN": "0", "MS": "Glycosides of GLUCURONIC ACID formed by the reaction of URIDINE DIPHOSPHATE GLUCURONIC ACID with certain endogenous and exogenous substances. Their formation is important for the detoxification of drugs, steroid excretion and BILIRUBIN metabolism to a more water-soluble compound that can be eliminated in the URINE and BILE.", "PM": "2000; see GLUCURONATES 1977-1999", "HN": "2000; use GLUCURONATES 1977-1999", "MR": "20200527", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020719"}, {"RECTYPE": "D", "MH": "Myasthenia Gravis, Autoimmune, Experimental", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Passive Transfer Experimental Autoimmune Myasthenia Gravis|T050|NON|NRW|NLM (2000)|991012|PASSIVE TRANSFER EXPER AUTOIMMUNE MYASTHENIA GRAVIS|abcdefv", "ENTRY": "Myasthenias, Experimental", "MN": "E05.598.500.500.750", "MH_TH": "NLM (2005)", "ST": "T050", "PI": "Myasthenia Gravis (1968-1999)", "MS": "Any autoimmune animal disease model used in the study of MYASTHENIA GRAVIS. Injection with purified neuromuscular junction acetylcholine receptor (AChR) (see RECEPTORS, CHOLINERGIC) components results in a myasthenic syndrome that has acute and chronic phases. The motor endplate pathology, loss of acetylcholine receptors, presence of circulating anti-AChR antibodies, and electrophysiologic changes make this condition virtually identical to human myasthenia gravis. Passive transfer of AChR antibodies or lymphocytes from afflicted animals to normals induces passive transfer experimental autoimmune myasthenia gravis. (From Joynt, Clinical Neurology, 1997, Ch 54, p3)", "PM": "2005; see MYASTHENIA GRAVIS, EXPERIMENTAL AUTOIMMUNE 2000-2004", "HN": "2005 (2000)", "MR": "20190222", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020720"}, {"RECTYPE": "D", "MH": "Nervous System Autoimmune Disease, Experimental", "DE": "NERVOUS SYSTEM AUTOIMMUNE DIS EXPER", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myositis, Experimental Autoimmune|T050|NON|NRW|NLM (2000)|991012|MYOSITIS EXPER AUTOIMMUNE|abcdefv", "ENTRY": "Experimental Myositis, Autoimmune", "MN": "E05.598.500.500", "MH_TH": "NLM (2005)", "ST": "T050", "AN": "coordinate with specific autoimmune disease but note specifics indented here", "PI": "Disease Models, Animal (1967-1999)", "MS": "Experimental animal models for human AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM. They include GUILLAIN-BARRE SYNDROME (see NEURITIS, AUTOIMMUNE, EXPERIMENTAL); MYASTHENIA GRAVIS (see MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL); and MULTIPLE SCLEROSIS (see ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL).", "PM": "2005; see DISEASE MODELS, AUTOIMMUNE, NERVOUS SYSTEM 2000-2004", "HN": "2005 (2000)", "MR": "20040713", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020721"}, {"RECTYPE": "D", "MH": "Glucuronic Acid", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glucuronate|T109|T123|NON|NRW|NLM (2000)|991104|abbcdef", "ENTRY": "Glucuronate, Monosodium", "MN": "D09.811.922.162.500", "FX": "Glucuronides", "EC": "analogs & derivatives:Glucuronates", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "8A5D83Q4RW", "RR": "7182-77-6", "AN": "for glycoside-linked compounds use GLUCURONIDES", "PI": "Glucuronates (1981-1999)", "MS": "A sugar acid formed by the oxidation of the C-6 carbon of GLUCOSE. In addition to being a key intermediate metabolite of the uronic acid pathway, glucuronic acid also plays a role in the detoxification of certain drugs and toxins by conjugating with them to form GLUCURONIDES.", "PM": "2000; for GLUCURONATE see GLUCURONIC ACID 2000-2012, GLUCURONIC ACID was indexed under GLUCURONATES 1981-1999", "HN": "2000; for GLUCURONATE use GLUCURONIC ACID 2000-2012", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020723"}, {"RECTYPE": "D", "MH": "Elastomers", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Synthetic Rubber|T073|T109|NON|NRW|NLM (2000)|991103|abbcdef", "ENTRY": "Synthetic Rubbers", "MN": "J01.637.412", "FX": "Elastin", "MH_TH": "UNK (19XX)", "ST": "T122", "RN": "0", "AN": "SILICONE ELASTOMERS is available", "MS": "A generic term for all substances having the properties of stretching under tension, high tensile strength, retracting rapidly, and recovering their original dimensions fully. They are generally POLYMERS.", "PM": "2000; for SYNTHETIC RUBBER see RUBBER 2000-2006; for ELASTOMERS see RUBBER 1981-1999", "HN": "2000; for SYNTHETIC RUBBER use RUBBER 2000-2006; for ELASTOMERS use RUBBER 1981-1999", "MR": "20060705", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020724"}, {"RECTYPE": "D", "MH": "ral GTP-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ral A GTP-Binding Protein|T116|T126|NON|NRW|NLM (2000)|991012|abbcdef", "ENTRY": "ral GTP Binding Proteins", "MN": "D12.776.476.338.400.450", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1994-1999)", "MS": "A family of ubiquitously expressed MONOMERIC GTP-BINDING PROTEINS that are involved in intracellular signal transduction. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RAL PROTEIN & RAL A PROTEIN were indexed under G-PROTEINS 1993-1999", "HN": "2000; use RAL GTP-BINDING PROTEINS (NM) 1993-1999; for RAL A PROTEIN use RAL GTP-BINDING PROTEINS (NM) 1993-1999", "MR": "20210521", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020725"}, {"RECTYPE": "D", "MH": "ral Guanine Nucleotide Exchange Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ralGDS|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "ral GDS", "MN": "D12.776.476.325.300.600", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "G-Proteins (1997-1999)", "MS": "A guanine nucleotide exchange factor that stimulates the dissociation of GDP from RAL GTP-BINDING PROTEINS. It also has GDP exchange activity towards other MONOMERIC GTP-BINDING PROTEINS.", "PM": "2000; RAL-GUANINE NUCLEOTIDE EXCHANGE FACTOR was indexed under G-PROTEINS 1997-1999", "HN": "2000; for RAL-GUANINE NUCLEOTIDE EXCHANGE FACTOR use RAL-GUANINE NUCLEOTIDE EXCHANGE FACTOR 1997-1999", "MR": "20151124", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020726"}, {"RECTYPE": "D", "MH": "ADP-Ribosylation Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "ADP Ribosylation Factors", "MN": "D12.776.476.338.400.100", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1985-1999)", "MS": "MONOMERIC GTP-BINDING PROTEINS that were initially recognized as allosteric activators of the MONO(ADP-RIBOSE) TRANSFERASE of the CHOLERA TOXIN catalytic subunit. They are involved in vesicle trafficking and activation of PHOSPHOLIPASE D. This enzyme was formerly listed as EC 3.6.1.47", "PM": "2000; ARF PROTEIN COFACTOR (now ADP-RIBOSYLATION FACTORS) was indexed under G-PROTEINS 1984-1999", "HN": "2000; use ADP-RIBOSYLATION FACTORS (NM) 1984-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020727"}, {"RECTYPE": "D", "MH": "Transurethral Resection of Prostate", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "VLAP|T061|ACR|NRW|NLM (2003)|011221|abcdef", "ENTRY": "Transurethral Ultrasound Guided Laser Induced Prostatectomy", "MN": "E04.950.774.860.625.750", "MH_TH": "NLM (1999)", "ST": "T061", "AN": "coordinate with specific ablation technique if pertinent", "PI": "Prostatectomy (1966-1999)", "MS": "Removal of all or part of the PROSTATE, often using a cystoscope and/or resectoscope passed through the URETHRA.", "PM": "2000; see PROSTATECTOMY 1999; for PROSTATECTOMY, TRANSURETHRAL see PROSTATECTOMY 1992-1999", "HN": "2000; use PROSTATECTOMY 1999; for PROSTATECTOMY, TRANSURETHRAL use PROSTATECTOMY 1992-1999", "MR": "20080708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020728"}, {"RECTYPE": "D", "MH": "p120 GTPase Activating Protein", "DS": "P A 120 GTPASE ACTIVATING PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p125-GAP Protein|T116|T123|NON|EQV|NLM (2000)|991012|P A 125 GAP PROTEIN|abbcdefs", "ENTRY": "p125 GAP Protein", "MN": "D12.776.476.325.150.500.500", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Proteins (1989-1999)", "MS": "A 120-kDa RAS GTPase-activating protein that binds to tyrosine phosphoproteins through its SH2 domains. The 100-kDa RNA-splicing variant (p100 GAP protein) is expressed in placenta.", "PM": "2000; P120-GAP PROTEIN was indexed under PROTEINS 1994-1999; P100-GAP PROTEIN was indexed under PROTEINS 1995-1999; P120RASGAP & P125 GAP were indexed under PROTEINS 1996-1999", "HN": "2000; for P120-GAP PROTEIN use GTPASE ACTIVATING PROTEINS (NM) 1994-1999; for P100-GAP PROTEIN use GTPASE ACTIVATING PROTEINS (NM) 1995-1999; for P120RASGAP & P125 GAP use GTPASE ACTIVATING PROTEINS (NM) 1996-1999", "MR": "20151124", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020729"}, {"RECTYPE": "D", "MH": "Guanine Nucleotide Dissociation Inhibitors", "DE": "GUANINE NUCLEOTIDE DISSOCIATION INHIB", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "GDP Dissociation Inhibitors|T116|T123|ABX|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Inhibitors, GDP Dissociation", "MN": "D12.776.476.325.225", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "G-Proteins (1992-1999)", "MS": "Protein factors that inhibit the dissociation of GDP from GTP-BINDING PROTEINS.", "PM": "2000; GDP DISSOCIATION INHIBITOR was indexed under GAUNINE NUCLEOTIDE DISSOCIATION INHIBITORS 2000-2012", "HN": "2000; for GDP DISSOCIATION INHIBITOR use RHO-SPECIFIC GUANIN NUCLEOTIDE DISSOCIATION INHIBITORS 2000-2012", "MR": "20151123", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020730"}, {"RECTYPE": "D", "MH": "Keratomileusis, Laser In Situ", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Laser In Situ Keratomileusis|T061|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Laser Intrastromal Keratomileuses", "MN": "E04.540.825.437.374", "MH_TH": "NLM (2000)", "ST": "T061", "AN": "coordinate with specific LASER when discussed", "PI": "Cornea/surgery (1995-1999)", "MS": "A surgical procedure to correct MYOPIA by CORNEAL STROMA subtraction. It involves the use of a microkeratome to make a lamellar dissection of the CORNEA creating a flap with intact CORNEAL EPITHELIUM. After the flap is lifted, the underlying midstroma is reshaped with an EXCIMER LASER and the flap is returned to its original position.", "PM": "2000", "HN": "2000", "MR": "20170620", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020731"}, {"RECTYPE": "D", "MH": "Cytogenetic Analysis", "DE": "CYTOGENET ANAL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Molecular Cytogenetic Techniques|T063|NON|EQV|NLM (2000)|991012|MOL CYTOGENET TECHNIQUES|abcdefv", "ENTRY": "Techniques, Molecular Cytogenetic", "MN": "E05.393.285", "FX": "Molecular Diagnostic Techniques", "MH_TH": "NLM (2000)", "ST": "T063", "PI": "Genetic Techniques (1967-1999)", "MS": "Examination of CHROMOSOMES to diagnose, classify, screen for, or manage genetic diseases and abnormalities. Following preparation of the sample, KARYOTYPING is performed and/or the specific chromosomes are analyzed.", "PM": "2000", "HN": "2000", "MR": "20150601", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020732"}, {"RECTYPE": "D", "MH": "RNA, Small Cytoplasmic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "scRNA|T114|T123|NON|EQV|NLM (2000)|991012|abbcdef", "MN": "D13.444.735.790.552.750", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "RNA or specifics (1980-1999)", "MS": "Small RNAs found in the cytoplasm usually complexed with proteins in scRNPs (RIBONUCLEOPROTEINS, SMALL CYTOPLASMIC).", "PM": "2000; SMALL CYTOPLASMIC RNA was indexed under RNA (NM) 1984-1999; for 7S RNA see RNA, SMALL NUCLEAR 1993-1999", "HN": "2000; for SMALL CYTOPLASMIC RNA use RNA, SMALL CYTOPLASMIC (NM) 1984-1999; for 7S RNA use RNA, SMALL NUCLEAR 1993-1999", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020733"}, {"RECTYPE": "D", "MH": "Parkinsonian Disorders", "DE": "PARKINSONIAN DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ramsay Hunt Paralysis Syndrome|T047|EPO|REL|NLM (1992)|901126|abcdef", "ENTRY": "Recessive Parkinsonism, Autosomal", "MN": "C10.228.662.600", "FX": "Striatonigral Degeneration", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "Gen: prefer specifics; do not confuse entry term RAMSAY HUNT PARALYSIS SYNDROME with RAMSAY HUNT AURICULAR SYNDROME see HERPES ZOSTER OTICUS or RAMSAY HUNT CEREBELLAR SYNDROME see MYOCLONIC CEREBELLAR DYSSYNERGIA", "PI": "Parkinson Disease (1966-1999)", "MS": "A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.", "PM": "2000; for PARKINSONISM see PARKINSON DISEASE 1978-1999; for PARKINSONIAN SYNDROME see PARKINSON DISEASE, SECONDARY 1974-1999: for RAMSAY HUNT PARALYSIS SYNDROME see PARKINSON DISEASE 1992-1999", "HN": "2000; for PARKINSONISM use PARKINSON DISEASE 1978-1999; for PARKINSONIAN SYNDROME use PARKINSON DISEASE, SECONDARY 1974-1999; for RAMSAY HUNT PARALYSIS SYNDROME use PARKINSON DISEASE 1992-1999", "MR": "20190705", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020734"}, {"RECTYPE": "D", "MH": "Guanine Nucleotide-Releasing Factor 2", "DS": "GUANINE NUCLEOTIDE RELEASING FACTOR 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Guanine Nucleotide Exchange Factor C3G|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "GRF 2", "MN": "D12.776.476.325.300.300", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Proteins (1997-1999)", "MS": "A 145-kDa guanine nucleotide exchange factor that is specific for rap1 and ras GTP-BINDING PROTEINS. It associates with SH3 domains of the crk family of signaling proteins.", "PM": "2000; GRF2 PROTEIN, MAMMALIAN was indexed under PROTEINS 1995-1999; C3G PROTEIN was indexed under PROTEINS 1997-1999", "HN": "2000; use GUANINE NUCLEOTIDE EXCHANGE FACTORS (NM) 1997-1999", "MR": "20151123", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020735"}, {"RECTYPE": "D", "MH": "Ribonucleoproteins, Small Cytoplasmic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "scRNP|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "MN": "D12.776.664.962.500.750", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1982-1999)", "MS": "Complexes of scRNA (RNA, SMALL CYTOPLASMIC) and protein found in the cytoplasm. An example is SIGNAL RECOGNITION PARTICLE.", "PM": "2000", "HN": "2000", "MR": "20050630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020736"}, {"RECTYPE": "D", "MH": "Leptin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Obese Protein|T116|T125|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Gene Product, Obese", "MN": "D23.529.024.500", "MH_TH": "NLM (2000)", "ST": "T125", "RN": "0", "PI": "Proteins (1995-1999)", "MS": "A 16-kDa peptide hormone secreted from WHITE ADIPOCYTES. Leptin serves as a feedback signal from fat cells to the CENTRAL NERVOUS SYSTEM in regulation of food intake, energy balance, and fat storage.", "PM": "2000; OB PROTEIN (now LEPTIN) was indexed under PROTEINS 1995-1999", "HN": "2000; use LEPTIN (NM) 1995-1999", "MR": "20070709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020738"}, {"RECTYPE": "D", "MH": "Brain Diseases, Metabolic, Inborn", "DE": "BRAIN DIS METAB INBORN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Metabolic Diseases, Inborn, Brain|T047|NON|EQV|NLM (2000)|991012|METAB DIS INBORN BRAIN|abcdefv", "ENTRY": "Metabolic Disorders, Familial, Brain|T047|NON|NRW|NLM (2000)|991012|abcdef", "MN": "C18.452.648.189", "FX": "Intellectual Disability", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "general or unspecified, prefer specifics", "PI": "Metabolism, Inborn Errors (1972-1999)", "MS": "Brain disorders resulting from inborn metabolic errors, primarily from enzymatic defects which lead to substrate accumulation, product reduction, or increase in toxic metabolites through alternate pathways. The majority of these conditions are familial, however spontaneous mutation may also occur in utero.", "PM": "2000", "HN": "2000", "MR": "20110705", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020739"}, {"RECTYPE": "D", "MH": "Chimerin Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chimaerin Proteins|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Proteins, Chimaerin", "MN": "D12.776.631.124", "PA": "GTP Phosphohydrolase Activators", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Proteins (1996-1999)", "MS": "A family of GTPASE-ACTIVATING PROTEINS that are specific for RAC GTP-BINDING PROTEINS.", "PM": "2000", "HN": "2000", "MR": "20151123", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020740"}, {"RECTYPE": "D", "MH": "rho GTP-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rho Small GTP-Binding Proteins|T116|T126|ABX|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "rho Small GTP Binding Proteins", "MN": "D12.776.476.338.400.700", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1993-1999)", "MS": "A large family of MONOMERIC GTP-BINDING PROTEINS that are involved in regulation of actin organization, gene expression and cell cycle progression. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; P21 (RHO)PROTEIN (now RHO GTP-BINDING PROTEINS) was indexed under PROTEINS 1992-1999", "HN": "2000; use RHO GTP-BINDING PROTEINS (NM) 1992-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020741"}, {"RECTYPE": "D", "MH": "rhoA GTP-Binding Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rho12 GTP-Binding Protein|T116|T126|ABX|EQV|NLM (2000)|991012|RHO A 012 GTP BINDING PROTEIN|abbcdefs", "ENTRY": "rhoA GTP Binding Protein", "MN": "D12.776.476.338.400.700.200", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1991-1999)", "MS": "A RHO GTP-BINDING PROTEIN involved in regulating signal transduction pathways that control assembly of focal adhesions and actin stress fibers. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RHOA P21 PROTEIN (now RHOA GTP-BINDING PROTEIN) was indexed under G-PROTEINS 1991-1999", "HN": "2000(1991)", "MR": "20210427", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020742"}, {"RECTYPE": "D", "MH": "rhoB GTP-Binding Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "arh6 GTP-Binding Protein|T116|T126|ABX|EQV|NLM (2000)|991012|ARH A 006 GTP BINDING PROTEIN|abbcdefs", "ENTRY": "rhoB GTP Binding Protein", "MN": "D12.776.476.338.400.700.300", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1989-1999)", "MS": "A GTP-BINDING PROTEIN involved in regulating a signal transduction pathway that controls assembly of focal adhesions and actin stress fibers. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RHOB P20 PROTEIN (now RHOB GTP-BINDING PROTEIN) was indexed under G-PROTEINS 1988-1999", "HN": "2000; use RHOB GTP-BINDING PROTEIN (NM) 1988-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020743"}, {"RECTYPE": "D", "MH": "rac GTP-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rac Proteins|T116|T126|ABX|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "rac GTP Binding Proteins", "MN": "D12.776.476.338.400.700.100", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "Proteins (1989-1999)", "MS": "A sub-family of RHO GTP-BINDING PROTEINS that is involved in regulating the organization of cytoskeletal filaments. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RAC PROTEINS was indexed under G-Proteins 1991-1999 & Proteins 1989-1990; RAC G PROTEIN was indexed under GTP PHOSPHOHYDROLASE 1998-1999", "HN": "2000; for RAC PROTEINS use RAC GTP-BINDING PROTEINS (NM) 1989-1999; for RAC G PROTEIN use RAC GTP-BINDING PROTEINS (NM) 1998-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020744"}, {"RECTYPE": "D", "MH": "Genome, Archaeal", "AQ": "DE GE IM PH RE", "ENTRY": "Genomes, Archaeal", "MN": "G05.360.340.358.050", "FX": "Genes, Archaeal", "MH_TH": "NLM (2000)", "ST": "T028", "AN": "coordinate IM with specific archaeon/genet(IM)", "PI": "Genome, Bacterial (1994-1999)", "MS": "The genetic complement of an archaeal organism (ARCHAEA) as represented in its DNA.", "PM": "2000", "HN": "2000", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020745"}, {"RECTYPE": "D", "MH": "Calcium Channels, L-Type", "DE": "VDCC L", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Receptors, Dihydropyridine|T116|T123|NON|NRW|NLM (2000)|991012|RECEPT DIHYDROPYRIDINE|abbcdefv", "ENTRY": "VDCC, L-Type", "MN": "D12.776.543.585.400.150.400", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Muscle Proteins (1993-1999)", "MS": "Long-lasting voltage-gated CALCIUM CHANNELS found in both excitable and non-excitable tissue. They are responsible for normal myocardial and vascular smooth muscle contractility. Five subunits (alpha-1, alpha-2, beta, gamma, and delta) make up the L-type channel. The alpha-1 subunit is the binding site for calcium-based antagonists. Dihydropyridine-based calcium antagonists are used as markers for these binding sites.", "PM": "2000; DIHYDROPYRIDINE RECEPTOR (now L-TYPE CALCIUM CHANNELS) was indexed under CALCIUM CHANNELS & MUSCLE PROTEINS 1993-1999", "HN": "2000; use L-TYPE CALCIUM CHANNELS (NM) 1993-1999", "MR": "20210630", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020746"}, {"RECTYPE": "D", "MH": "Calcium Channels, T-Type", "DE": "CA CHANNELS T TYPE", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transient-Type Calcium Channels|T116|T123|NON|EQV|NLM (2000)|991012|TRANSIENT TYPE CA CHANNELS|abbcdefv", "ENTRY": "VDCC, T-Type", "MN": "D12.776.543.585.400.150.720", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Calcium Channels (1989-1999)", "MS": "A heterogenous group of transient or low voltage activated type CALCIUM CHANNELS. They are found in cardiac myocyte membranes, the sinoatrial node, Purkinje cells of the heart and the central nervous system.", "PM": "2000; CALCIUM CHANNEL (T-TYPE) was indexed under CALCIUM CHANNELS 1999", "HN": "2000; use CALCIUM CHANNELS, T-TYPE (NM) 1999", "MR": "20160701", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020747"}, {"RECTYPE": "D", "MH": "Mibefradil", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ro 405967", "MN": "D04.615.638.960.585", "PA": "Vasodilator Agents", "MH_TH": "NLM (2000)", "ST": "T121", "N1": "(1S,2S)-(2-((3-(2-benzimidazolyl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate", "RN": "27B90X776A", "RR": "842TUP3PQ8", "PI": "Tetrahydronaphthalenes (1989-1999)", "MS": "A benzimidazoyl-substituted tetraline that selectively binds and inhibits CALCIUM CHANNELS, T-TYPE.", "PM": "2000; MIBEFRADIL was indexed under BENZIMIDAZOLES & TETRAHYDRONAPHTHALENS 1989-1999", "HN": "2000; use MIBEFRADIL 1989-1999", "MR": "20170524", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020748"}, {"RECTYPE": "D", "MH": "Alcohol-Induced Disorders", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Alcohol-Induced Disorder", "MN": "C25.775.100.087", "MH_TH": "NLM (2000)", "ST": "T048", "MS": "Disorders stemming from the misuse and abuse of alcohol.", "PM": "2000", "HN": "2000", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020751"}, {"RECTYPE": "D", "MH": "Neurocutaneous Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Phakomatoses|T191|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Syndromes, Neuroectodermal Dysplasia", "MN": "C17.800.827.250.712", "MH_TH": "NLM (2000)", "ST": "T191", "AN": "for neurocutaneous melanosis, coord with MELANOSIS", "PI": "Skin Diseases (1967-1999)", "MS": "A group of disorders characterized by ectodermal-based malformations and neoplastic growths in the skin, nervous system, and other organs.", "PM": "2000", "HN": "2000", "MR": "20150618", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020752"}, {"RECTYPE": "D", "MH": "Spinocerebellar Ataxias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spinocerebellar Atrophies|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Syndrome, Wadia-Swami", "MN": "C16.320.400.780.875", "FX": "Ataxins", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "SPINOCEREBELLAR ATAXIA TYPE 3 see MACHADO-JOSEPH DISEASE is available", "PI": "Spinocerebellar Degenerations (1987-1999)", "MS": "A group of predominately late-onset, cerebellar ataxias which have been divided into multiple subtypes based on clinical features and genetic mapping. Progressive ataxia is a central feature of these conditions, and in certain subtypes POLYNEUROPATHY; DYSARTHRIA; visual loss; and other disorders may develop. (From Joynt, Clinical Neurology, 1997, Ch65, pp 12-17; J Neuropathol Exp Neurol 1998 Jun;57(6):531-43)", "PM": "2000; see SPINOCEREBELLAR DEGENERATION 1987-1999", "HN": "2000; use SPINOCEREBELLAR DEGENERATION 1987-1999", "MR": "20210510", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020754"}, {"RECTYPE": "D", "MH": "Coat Protein Complex I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "COPI Protein|T116|T123|ACX|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "COP-I|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "MN": "D12.776.543.990.300", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "AN": "for alpha, beta, delta, and epsilon-COP see COATOMER PROTEIN", "PI": "Membrane Proteins (1995-1999)", "MS": "A protein complex comprised of COATOMER PROTEIN and ADP RIBOSYLATION FACTOR 1. It is involved in transport of vesicles between the ENDOPLASMIC RETICULUM and the GOLGI APPARATUS.", "PM": "2000; COPI PROTEIN (now COAT PROTEIN PROTEIN COMPLEX I) was indexed under MEMBRANE PROTEINS 1994-1999", "HN": "2000; use COATOMER PROTEIN (NM) 1994-1999", "MR": "20020703", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020755"}, {"RECTYPE": "D", "MH": "Coatomer Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "zeta COP", "MN": "D12.776.543.990.300.300", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "RR": "134548-78-0", "PI": "Membrane Proteins (1995-1999)", "MS": "A 700-kDa cytosolic protein complex consisting of seven equimolar subunits (alpha, beta, beta', gamma, delta, epsilon and zeta). COATOMER PROTEIN and ADP-RIBOSYLATION FACTOR 1 are principle components of COAT PROTEIN COMPLEX I and are involved in vesicle transport between the ENDOPLASMIC RETICULUM and the GOLGI APPARATUS.", "PM": "2000; COATOMER PROTEIN & COATOMER SUBUNIT EPSILON-COP were indexed under MEMBRANE PROTEINS 1994-1999; RET1 PROTEIN & ZETA-COP were indexed under MEMBRANE PROTEINS 1995-1999; DELTA-COP PROTEIN & HEP-COP PROTEIN were indexed under MEMBRANE PROTEINS 1996-1999; BETA-COP was indexed under MEMBRANE PROTEINS 1991-1999; ARCN1 PROTEIN was indexed under PROTEINS 1995-1999; P102 PROTEIN (GOLGI) was indexed under MEMBRANE PROTEINS 1993-1999;", "HN": "2000; for COATOMER PROTEIN & COATOMER SUBUNIT EPSILON-COP use COATOMER PROTEIN (NM) 1994-1999; for ACRN1 PROTEIN, & RET1 PROTEIN use COATOMER PROTEIN (NM) 1995-1999; for BETA-COP use COATOMER PROTEIN (NM) 1991-1999; for P102 PROTEIN (GOLGI) use COATOMER PROTEIN (NM) 1993-1999; for ZETA-COP use RHOB GTP-BINDING PROTEIN (NM) 1995-1999", "MR": "20040707", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020756"}, {"RECTYPE": "D", "MH": "Amaurosis Fugax", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Monocular Blindness, Transient|T184|NON|EQV|NLM (2000)|ORD (2010)|991012|abcdeef", "ENTRY": "Transient Monocular Blindness", "MN": "C23.888.592.763.941.162.125", "MH_TH": "ORD (2010)", "ST": "T184", "PI": "Vision Disorders (1967-1999)", "MS": "Transient complete or partial monocular blindness due to retinal ischemia. This may be caused by emboli from the CAROTID ARTERY (usually in association with CAROTID STENOSIS) and other locations that enter the central RETINAL ARTERY. (From Adams et al., Principles of Neurology, 6th ed, p245)", "PM": "2000", "HN": "2000", "MR": "20090706", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020757"}, {"RECTYPE": "D", "MH": "Spinal Cord Vascular Diseases", "DE": "SPINAL CORD VASCULAR DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Posterior Spinal Artery Syndrome|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Hematomyelias", "MN": "C14.907.790", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Vascular Diseases (1965-1999)", "MS": "Pathological processes involving any of the BLOOD VESSELS feeding the SPINAL CORD, such as the anterior and paired posterior spinal arteries or their many branches. Disease processes may include ATHEROSCLEROSIS; EMBOLISM; and ARTERIOVENOUS MALFORMATIONS leading to ISCHEMIA or HEMORRHAGE into the spinal cord (hematomyelia).", "PM": "2000", "HN": "2000", "MR": "20070709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020758"}, {"RECTYPE": "D", "MH": "Anterior Spinal Artery Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anterior Spinal Artery Dissection|T047|NON|REL|NLM (2000)|991012|abcdef", "ENTRY": "Syndrome, Anterior Spinal Artery|T047|NON|EQV|NLM (2000)|991012|abcdef", "MN": "C14.907.790.550.100", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Thrombosis/etiology (1968-1999)", "MS": "Ischemia or infarction of the spinal cord in the distribution of the anterior spinal artery, which supplies the ventral two-thirds of the spinal cord. This condition is usually associated with ATHEROSCLEROSIS of the aorta and may result from dissection of an AORTIC ANEURYSM or rarely dissection of the anterior spinal artery. Clinical features include weakness and loss of pain and temperature sensation below the level of injury, with relative sparing of position and vibratory sensation. (From Adams et al., Principles of Neurology, 6th ed, pp1249-50)", "PM": "2000", "HN": "2000", "MR": "20150622", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020759"}, {"RECTYPE": "D", "MH": "Spinal Cord Ischemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spinal Cord Ischemias", "MN": "C14.907.790.550", "FX": "Central Cord Syndrome", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Spinal Cord/blood supply (1966-1999)", "MS": "Reduced blood flow to the spinal cord which is supplied by the anterior spinal artery and the paired posterior spinal arteries. This condition may be associated with ARTERIOSCLEROSIS, trauma, emboli, diseases of the aorta, and other disorders. Prolonged ischemia may lead to INFARCTION of spinal cord tissue.", "PM": "2000", "HN": "2000", "MR": "20070709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020760"}, {"RECTYPE": "D", "MH": "rab1 GTP-Binding Proteins", "DS": "RAB A 001 GTP BINDING PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rab1A GTP-Binding Protein|T116|T126|ABX|NRW|NLM (2000)|991012|RAB A 001A GTP BINDING PROTEIN|abbcdefs", "ENTRY": "rab1A GTP Binding Protein", "MN": "D12.776.476.338.400.400.025", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1990-1999)", "MS": "A genetically related subfamily of RAB GTP-BINDING PROTEINS involved in vesicle transport between the ENDOPLASMIC RETICULUM and the GOLGI APPARATUS and through early Golgi compartments. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RAB1A PROTEIN was indexed under G-PROTEINS 1992-1999", "HN": "2000; for RAB1A PROTEIN use RAB1 GTP-BINDING PROTEINS (NM) 1992-1999", "MR": "20210521", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020761"}, {"RECTYPE": "D", "MH": "Infarction, Posterior Cerebral Artery", "DE": "INFARCT PCA", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombotic Infarction, Posterior Cerebral Artery|T047|NON|NRW|NLM (2000)|991012|THROMBOTIC INFARCT POSTERIOR CEREBRAL ARTERY|abcdefv", "ENTRY": "PCA Infarcts", "MN": "C23.550.717.489.250.200.475", "FX": "Infarction", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Cerebral Arterial Diseases (1966-1999)", "MS": "NECROSIS induced by ISCHEMIA in the POSTERIOR CEREBRAL ARTERY distribution system which supplies portions of the BRAIN STEM; the THALAMUS; TEMPORAL LOBE, and OCCIPITAL LOBE. Depending on the size and location of infarction, clinical features include OLFACTION DISORDERS and visual problems (AGNOSIA; ALEXIA; HEMIANOPSIA).", "PM": "2000", "HN": "2000", "MR": "20190702", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020762"}, {"RECTYPE": "D", "MH": "Pathological Conditions, Anatomical", "DE": "PATHOL CONDITIONS ANATOM", "ENTRY": "Pathological Condition, Anatomical", "MN": "C23.300", "MH_TH": "NLM (2000)", "ST": "T046", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "An abnormal structural condition of the human body, usually macroscopic, that is common to a variety of different diseases.", "PM": "2000", "HN": "2000", "MR": "20150605", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020763"}, {"RECTYPE": "D", "MH": "cdc42 GTP-Binding Protein", "DS": "CDC 042 GTP BINDING PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p21 cdc42|T116|T126|ABX|EQV|NLM (2000)|991012|P A 021 CDC 042|abbcdefs", "ENTRY": "cdc42, p21", "MN": "D12.776.476.338.400.700.050", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "AN": "CDC42 GTP-BINDING PROTEIN, SACCHAROMYCES CEREVISIAE is also available", "PI": "G-Proteins (1991-1999)", "MS": "A member of the Rho family of MONOMERIC GTP-BINDING PROTEINS. It is associated with a diverse array of cellular functions including cytoskeletal changes, filopodia formation and transport through the GOLGI APPARATUS. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; G25K PROTEIN (now CDC42 GTP-BINDING PROTEIN) was indexed under G-PROTEINS 1991-1999", "HN": "2000; use CDC42 GTP-BINDING PROTEIN (NM) 1991-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020764"}, {"RECTYPE": "D", "MH": "Intracranial Arterial Diseases", "DE": "INTRACRANIAL ARTERIAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Brain Diseases, Arterial|T047|NON|NRW|NLM (2000)|991012|BRAIN DIS ARTERIAL|abcdefv", "ENTRY": "Intracranial Arterial Disorder", "MN": "C14.907.253.560", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Cerebrovascular Disorders/complications (1965-1999)", "MS": "Pathological conditions involving ARTERIES in the skull, such as arteries supplying the CEREBRUM, the CEREBELLUM, the BRAIN STEM, and associated structures. They include atherosclerotic, congenital, traumatic, infectious, inflammatory, and other pathological processes.", "PM": "2000", "HN": "2000", "MR": "20070709", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020765"}, {"RECTYPE": "D", "MH": "Intracranial Embolism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Embolism, Intracranial|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Embolus, Cerebral", "MN": "C14.907.355.590.213.300", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Intracranial Embolism and Thrombosis (1965-1999)", "MS": "Blocking of a blood vessel in the SKULL by an EMBOLUS which can be a blood clot (THROMBUS) or other undissolved material in the blood stream. Most emboli are of cardiac origin and are associated with HEART DISEASES. Other non-cardiac sources of emboli are usually associated with VASCULAR DISEASES.", "PM": "2000; for CEREBRAL EMBOLISM see CEREBRAL EMBOLISM AND THROMBOSIS 1991-1999", "HN": "2000; for CEREBRAL EMBOLISM use INTRACRANIAL EMBOLISM AND THROMBOSIS 1991-1999", "MR": "20150608", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020766"}, {"RECTYPE": "D", "MH": "Intracranial Thrombosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thrombosis, Intracranial|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Thrombus, Cerebral", "MN": "C14.907.355.590.213.350", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Intracranial Embolism and Thrombosis (1965-1999)", "MS": "Formation or presence of a blood clot (THROMBUS) in a blood vessel within the SKULL. Intracranial thrombosis can lead to thrombotic occlusions and BRAIN INFARCTION. The majority of the thrombotic occlusions are associated with ATHEROSCLEROSIS.", "PM": "2000; for CEREBRAL THROMBOSIS see INTRACRANIAL EMBOLISM AND THROMBOSIS 1991-1999", "HN": "2000; for CEREBRAL THROMBOSIS use INTRACRANIAL EMBOLISM AND THROMBOSIS 1991-1999", "MR": "20150608", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020767"}, {"RECTYPE": "D", "MH": "Middle Cerebral Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cerebral Artery, Middle|T023|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Middle Cerebral Arteries", "MN": "A07.015.114.228.550", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Cerebral Arteries (1966-1999)", "MS": "The largest of the cerebral arteries. It trifurcates into temporal, frontal, and parietal branches supplying blood to most of the parenchyma of these lobes in the CEREBRAL CORTEX. These are the areas involved in motor, sensory, and speech activities.", "PM": "2000", "HN": "2000", "MR": "20180701", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020768"}, {"RECTYPE": "D", "MH": "Posterior Cerebral Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cerebral Artery, Posterior|T023|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Posterior Cerebral Arteries", "MN": "A07.015.114.228.700", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Cerebral Arteries (1966-1999)", "MS": "Artery formed by the bifurcation of the BASILAR ARTERY. Branches of the posterior cerebral artery supply portions of the OCCIPITAL LOBE; PARIETAL LOBE; inferior temporal gyrus, brainstem, and CHOROID PLEXUS.", "PM": "2000", "HN": "2000", "MR": "20180701", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020769"}, {"RECTYPE": "D", "MH": "Compomers", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Polyacid-Modified Composite Resins|T109|T122|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Resins, Polyacid-Modified Composite", "MN": "J01.637.051.720.716.822.308.300", "MH_TH": "NLM (2000)", "ST": "T122", "RN": "0", "PI": "Glass Ionomer Cements (1994-1999)", "MS": "Composite materials composed of an ion-leachable glass embedded in a polymeric matrix. They differ from GLASS IONOMER CEMENTS in that partially silanized glass particles are used to provide a direct bond to the resin matrix and the matrix is primarily formed by a light-activated, radical polymerization reaction.", "PM": "2000", "HN": "2000", "MR": "20200527", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020770"}, {"RECTYPE": "D", "MH": "Anterior Cerebral Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cerebral Artery, Anterior|T023|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Cerebral Arteries, Anterior", "MN": "A07.015.114.228.100", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Cerebral Arteries (1966-1999)", "MS": "Artery formed by the bifurcation of the internal carotid artery (CAROTID ARTERY, INTERNAL). Branches of the anterior cerebral artery supply the CAUDATE NUCLEUS; INTERNAL CAPSULE; PUTAMEN; SEPTAL NUCLEI; GYRUS CINGULI; and surfaces of the FRONTAL LOBE and PARIETAL LOBE.", "PM": "2000", "HN": "2000", "MR": "20180630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020771"}, {"RECTYPE": "D", "MH": "Internal Capsule", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Internas, Capsula", "MN": "A08.612.435", "MH_TH": "NLM (2000)", "ST": "T023", "MS": "WHITE MATTER pathway, flanked by nuclear masses, consisting of both afferent and efferent fibers projecting between the WHITE MATTER and the BRAINSTEM. It consists of three distinct parts: an anterior limb, posterior limb, and genu.", "PM": "2000", "HN": "2000", "MR": "20180702", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020772"}, {"RECTYPE": "D", "MH": "Headache Disorders", "DE": "HEADACHE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chronic Headache|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Syndrome, Headache", "MN": "C10.228.140.546", "FX": "Headache", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Headache (1978-1999)", "MS": "Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS (based on characteristics of their headache symptoms) and SECONDARY HEADACHE DISORDERS (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)", "PM": "2000", "HN": "2000", "MR": "20050630", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020773"}, {"RECTYPE": "D", "MH": "Pick Disease of the Brain", "DE": "PICK DIS OF THE BRAIN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Lobar Atrophy of the Brain|T047|NON|EQV|NLM (2010)|ORD (2010)|090504|abcdeef", "ENTRY": "Picks Disease", "MN": "F03.615.400.380.299.500", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Dementia (1966-1999)", "MS": "A rare form of DEMENTIA that is sometimes familial. Clinical features include APHASIA; APRAXIA; CONFUSION; ANOMIA; memory loss; and personality deterioration. This pattern is consistent with the pathologic findings of circumscribed atrophy of the poles of the FRONTAL LOBE and TEMPORAL LOBE. Neuronal loss is maximal in the HIPPOCAMPUS, entorhinal cortex, and AMYGDALA. Some ballooned cortical neurons contain argentophylic (Pick) bodies. (From Brain Pathol 1998 Apr;8(2):339-54; Adams et al., Principles of Neurology, 6th ed, pp1057-9)", "PM": "2000; for PICKS DISEASE OF BRAIN see DEMENTIA 1992-1999", "HN": "2000; for PICKS DISEASE OF BRAIN use DEMENTIA 1992-1999", "MR": "20150623", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020774"}, {"RECTYPE": "D", "MH": "Thoracic Surgery, Video-Assisted", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Video-Assisted Thoracic Surgery|T061|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Video-Assisted Thoracoscopic Surgeries", "MN": "E04.928.752.830", "FX": "Video Recording", "MH_TH": "NLM (2000)", "ST": "T061", "PI": "Video Recording (1993-1999)", "MS": "Endoscopic surgery of the pleural cavity performed with visualization via video transmission.", "PM": "2000", "HN": "2000", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020775"}, {"RECTYPE": "D", "MH": "Endoscopes, Gastrointestinal", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Gastrointestinal Endoscopes|T074|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Gastrointestinal Endoscope", "MN": "E07.858.240.260", "FX": "Endoscopy, Gastrointestinal", "MH_TH": "NLM (2000)", "ST": "T074", "PI": "Gastroscopy/instrumentation (1966-1990)", "MS": "Instruments for the visual examination of the interior of the gastrointestinal tract.", "PM": "2000", "HN": "2000", "MR": "20100625", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020776"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 2", "DS": "MATRIX METALLOPROTEINASE 002", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gelatinase A|T116|T126|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Metalloproteinase, MMP2", "MN": "D12.776.467.836.150", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.24", "PI": "Metalloendopeptidases (1992-1999)", "MS": "A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain.", "PM": "2000; see GELATINASE A 2000-2006; MATRIX METALLOPROTEINASE 2 was indexed under GELATINASES & METALLOPROTEINASES 1992-1999", "HN": "2007(2000)", "MR": "20210521", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020778"}, {"RECTYPE": "D", "MH": "Sinus Pericranii", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C16.131.666.190.800", "MH_TH": "NLM (2000)", "ST": "T020", "PI": "Hemangioma (1971-1999)", "MS": "Rare vascular anomaly involving a communication between the intracranial and extracranial venous circulation via diploe, the central spongy layer of cranial bone. It is often characterized by dilated venous structures on the scalp due to abnormal drainage from the intracranial venous sinuses. Sinus pericranii can be congenital or traumatic in origin.", "PM": "2000", "HN": "2000", "MR": "20070709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020779"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 9", "DS": "MATRIX METALLOPROTEINASE 009", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Gelatinase B|T116|T126|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Metalloproteinase, MMP9", "MN": "D12.776.467.836.350", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.35", "PI": "Collagenases (1989-1999)", "MS": "An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V.", "PM": "2007; see GELATINASE B 2000-2006; MATRIX METALLOPROTEINASE 9 was indexed under COLLAGENASES 1989-1999", "HN": "2007(2000)", "MR": "20210521", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020780"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 1", "DS": "MATRIX METALLOPROTEINASE 001", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Interstitial Collagenase|T116|T126|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Promatrixmetalloproteinase 1", "MN": "D12.776.467.836.100", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.7", "PI": "Collagenases (1991-1999)", "MS": "A member of the metalloproteinase family of enzymes that is principally responsible for cleaving FIBRILLAR COLLAGEN. It can degrade interstitial collagens, types I, II and III.", "PM": "2007; see INTERSTITIAL COLLAGENASE 2000-2006; PRO-MATRIX METALLOPROTEINASE 1 was indexed under ENZYME PRECURSORS & COLLAGENASES 1995-2006", "HN": "2007(2000)", "MR": "20210521", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020781"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Matrix Metalloproteinase|T116|T126|NON|EQV|NLM (2021)|191113|abbcdef", "ENTRY": "Metalloproteinases, Matrix", "MN": "D08.811.277.656.675.374.525", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.4.24.-", "AN": "general or unspecified; prefer specifics", "PI": "Metalloendopeptidases (1988-1999)", "MS": "A family of zinc-dependent metalloendopeptidases that is involved in the degradation of EXTRACELLULAR MATRIX components.", "PM": "2000", "HN": "2000", "MR": "20200527", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020782"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 7", "DS": "MATRIX METALLOPROTEINASE 007", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Matrilysin|T116|T126|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Metalloproteinase-7, Matrix", "MN": "D12.776.467.836.250", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.23", "PI": "Metalloendopeptidases (1992-1999)", "MS": "The smallest member of the MATRIX METALLOPROTEINASES. It plays a role in tumor progression.", "PM": "2000; see MATRILYSIN 2000-2006; MATRIX METALLOPROTEINASE 7 was indexed under METALLOPROTEINASES 1992-1999", "HN": "2007(2000)", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020783"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 8", "DS": "MATRIX METALLOPROTEINASE 008", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neutrophil Collagenase|T116|T126|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Metalloproteinase-8, Matrix", "MN": "D12.776.467.836.300", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.34", "PI": "Collagenases (1992-1999)", "MS": "A member of the MATRIX METALLOPROTEINASES that cleaves triple-helical COLLAGEN types I, II, and III.", "PM": "2000; see NEUTROPHIL COLLAGENASE 2000-2006; MATRIX METALLOPROTEINASE 8 was indexed under COLLAGENASES 1992-1999", "HN": "2007(2000)", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020784"}, {"RECTYPE": "D", "MH": "Central Nervous System Vascular Malformations", "DE": "CNS VASCULAR MALFORMATIONS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vascular Malformations, Central Nervous System|T190|NON|EQV|NLM (2000)|991012|VASCULAR MALFORMATIONS CNS|abcdefv", "ENTRY": "Vascular Malformations, CNS", "MN": "C16.131.666.190", "MH_TH": "NLM (2000)", "ST": "T190", "AN": "do not confuse entry terms CAPILLARY TELANGIECTASIA, BRAIN and PONTINE CAPILLARY TELANGIECTASIAS with TELANGIECTASIS", "PI": "Veins/abnormalities (1966-1999)", "MS": "Congenital, inherited, or acquired abnormalities involving ARTERIES; VEINS; or venous sinuses in the BRAIN; SPINAL CORD; and MENINGES.", "PM": "2000", "HN": "2000", "MR": "20200527", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020785"}, {"RECTYPE": "D", "MH": "Hemangioma, Cavernous, Central Nervous System", "DE": "HEMANGIOMA CAVERNOUS CNS", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Cerebral Cavernous Hemangioma|T191|NON|NRW|GHR (2014)|NLM (2000)|ORD (2010)|991012|abcdeeef", "ENTRY": "Malformations, Familial Cavernous", "MN": "C16.131.666.190.200", "MH_TH": "NLM (2000)", "ST": "T191", "AN": "coordinate IM with CENTRAL NERVOUS SYSTEM NEOPLASMS or specifics (IM)", "PI": "Hemangioma, Cavernous (1966-1999)", "MS": "A vascular anomaly composed of a collection of large, thin walled tortuous VEINS that can occur in any part of the central nervous system but lack intervening nervous tissue. Familial occurrence is common and has been associated with a number of genes mapped to 7q, 7p and 3q. Clinical features include SEIZURES; HEADACHE; STROKE; and progressive neurological deficit.", "PM": "2000", "HN": "2000", "MR": "20230405", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020786"}, {"RECTYPE": "D", "MH": "Central Nervous System Venous Angioma", "DE": "CNS VENOUS ANGIOMA", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Venous Angioma, Central Nervous System|T019|NON|EQV|NLM (2000)|991012|VENOUS ANGIOMA CNS|abcdefv", "ENTRY": "Venous Angiomas, Intracranial", "MN": "C16.131.666.190.100", "MH_TH": "NLM (2000)", "ST": "T019", "PI": "Intracranial Arteriovenous Malformations (1978-1999)", "MS": "A vascular anomaly characterized by a radial or wedge-shaped arrangement of dilated VEINS draining into a larger vein in the brain, spinal cord, or the meninges. Veins in a venous angioma are surrounded by normal nervous tissue, unlike a CENTRAL NERVOUS SYSTEM CAVERNOUS HEMANGIOMA that lacks intervening nervous tissue. Drainage of venous angioma is fully integrated with the body's venous system, therefore, in most cases there is no clinical signs and rare bleeding.", "PM": "2000", "HN": "2000", "MR": "20190429", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020787"}, {"RECTYPE": "D", "MH": "Bardet-Biedl Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Laurence-Moon-Bardet-Biedl Syndrome|T019|T047|EPO|EQV|GHR (2014)|NLM (2000)|991012|abbcdeef", "ENTRY": "Syndrome, Laurence-Moon-Bardet-Biedl", "MN": "C16.320.184.125", "FX": "Intellectual Disability", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "note entry term: do not confuse with LAURENCE-MOON SYNDROME", "PI": "Bardet-Biedl Syndrome (1966-1999)", "MS": "An autosomal recessive disorder characterized by RETINITIS PIGMENTOSA; POLYDACTYLY; OBESITY; MENTAL RETARDATION; hypogenitalism; renal dysplasia; and short stature. This syndrome has been distinguished as a separate entity from LAURENCE-MOON SYNDROME. (From J Med Genet 1997 Feb;34(2):92-8)", "PM": "2000", "HN": "2000", "MR": "20180615", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020788"}, {"RECTYPE": "D", "MH": "Cathepsin C", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dipeptidyl Peptidase I|T116|T126|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Dipeptidyl Transferase|T116|T126|NON|EQV|NLM (2000)|991012|abbcdef", "MN": "D08.811.277.656.350.350.100", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.4.14.1", "PI": "Dipeptidyl Peptidases (1984-1999)", "MS": "A papain-like cysteine protease that has specificity for amino terminal dipeptides. The enzyme plays a role in the activation of several pro-inflammatory serine proteases by removal of their aminoterminal inhibitory dipeptides. Genetic mutations that cause loss of cathepsin C activity in humans are associated with PAPILLON-LEFEVRE DISEASE.", "PM": "2010; see DIPEPTIDYL PEPTIDASE I 2000-2009; DIPEPTIDYL PEPTIDASE I was indexed under DIPEPTIDYL PEPTIDASES 1984-1999; CATHEPSINS 1981-1984", "HN": "2010(1981)", "MR": "20100625", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020789"}, {"RECTYPE": "D", "MH": "Diabetes Insipidus, Neurogenic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vasopressin Deficiency|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef", "MN": "C19.700.159.750", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "do not confuse with DIABETES INSIPIDUS, NEPHROGENIC", "PI": "Diabetes Insipidus (1966-1999)", "MS": "A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS).", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020790"}, {"RECTYPE": "D", "MH": "Venombin A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.656.959.350.955", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.4.21.74", "MS": "A thrombin-like enzyme from the venom of snakes of the viper/rattlesnake group. Species variants of the enzyme include ANCROD (Agkistrodon rhodostoma (Malayan pit viper)); BATROXOBIN from Bothrops atrox; and crotalase from Crotalus adamanteus (Eastern diamondback rattlesnake). EC 3.4.21.74.", "PM": "2000", "HN": "2000", "MR": "20090706", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020791"}, {"RECTYPE": "D", "MH": "Salivary Calculi", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Calculi, Salivary|T031|T046|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Calculus, Salivary", "MN": "C23.300.175.700", "MH_TH": "NLM (2000)", "ST": "T046", "AN": "chem composition of calculi: use/chem; /ultrastruc permitted", "PI": "Salivary Duct Calculi (1965-1999)", "MS": "The presence of calculi in a salivary duct or gland.", "PM": "2000", "HN": "2000", "MR": "20060705", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020792"}, {"RECTYPE": "D", "MH": "Gatekeeping", "AQ": "CL EC ES HI LJ OG SN ST TD", "MN": "N04.452.758.849.350", "MH_TH": "BIOETHICS (1999)", "ST": "T058", "PI": "Referral and Consultation (1990-1999)", "MS": "The controlling of access to health services, usually by primary care providers; often used in managed care settings to reduce utilization of expensive services and reduce referrals. (From BIOETHICS Thesaurus, 1999)", "PM": "2000", "HN": "2000", "MR": "20030722", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020793"}, {"RECTYPE": "D", "MH": "Receptor Protein-Tyrosine Kinases", "DE": "RPTK", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tyrosine Kinase Receptors|T116|T126|T192|NON|EQV|NLM (2000)|991012|TYROSINE KINASE RECEPT|abbbcdefv", "ENTRY": "Receptors, Protein Tyrosine Kinase", "MN": "D12.776.543.750.630", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "specific receptors (1983-1993)", "MS": "A class of cellular receptors that have an intrinsic PROTEIN-TYROSINE KINASE activity.", "PM": "2000; for RECEPTOR PROTEIN-TYROSINE KINASE see RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999", "HN": "2000", "MR": "20210521", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020794"}, {"RECTYPE": "D", "MH": "Photophobia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Light Sensitivity|T184|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Sensitivity, Light", "MN": "C23.888.592.763.941.661", "MH_TH": "NLM (2000)", "ST": "T184", "PI": "Vision Disorders (1968-1999)", "MS": "Abnormal sensitivity to light. This may occur as a manifestation of EYE DISEASES; MIGRAINE; SUBARACHNOID HEMORRHAGE; MENINGITIS; and other disorders. Photophobia may also occur in association with DEPRESSION and other MENTAL DISORDERS.", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020795"}, {"RECTYPE": "D", "MH": "Receptor, Platelet-Derived Growth Factor alpha", "DS": "RECEPTOR PLATELET DERIVED GROWTH ALPHA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Receptor, PDGF alpha|T116|T126|T192|NON|EQV|NLM (2000)|991012|RECEPT PDGF ALPHA|abbbcdefv", "ENTRY": "Platelet Derived Growth Factor alpha Receptor", "MN": "D12.776.543.750.750.400.630.300", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptors, Platelet-Derived Growth Factor (1994-1999)", "MS": "A PDGF receptor that binds specifically to both PDGF-A chains and PDGF-B chains. It contains a protein-tyrosine kinase activity that is involved in SIGNAL TRANSDUCTION.", "PM": "2000; PLATELET-DERIVED GROWTH FACTOR ALPHA RECEPTOR (now RECEPTOR, PDGF ALPHA) was indexed under RECEPTORS, PLATELET-DERIVED GROWTH FACTOR 1994-1999", "HN": "2000; use RECEPTOR, PDGF ALPHA (NM) 1994-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020796"}, {"RECTYPE": "D", "MH": "Receptor, Platelet-Derived Growth Factor beta", "DS": "RECEPTOR PLATELET DERIVED GROWTH BETA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Receptor, PDGF beta|T116|T126|T192|NON|EQV|NLM (2000)|991012|RECEPT PDGF BETA|abbbcdefv", "ENTRY": "beta, PDGFR", "MN": "D12.776.543.750.750.400.630.400", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptors, Platelet-Derived Growth Factor (1994-1999)", "MS": "A PDGF receptor that binds specifically to the PDGF-B chain. It contains a protein-tyrosine kinase activity that is involved in SIGNAL TRANSDUCTION.", "PM": "2000; PLATELET-DERIVED GROWTH FACTOR BETA RECEPTOR (now RECEPTOR PDGF BETA) was indexed under RECEPTORS, PLATELET-DERIVED GROWTH FACTOR 1994-1999", "HN": "2000; use RECEPTOR, PDGF BETA (NM) 1994-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020797"}, {"RECTYPE": "D", "MH": "Two-Hybrid System Techniques", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "PRINT ENTRY": "Yeast Two-Hybrid System Techniques|T063|NON|NRW|NLM (2008)|061115|abcdef", "ENTRY": "n-Hybrid System Technique", "MN": "E05.601.870", "FX": "Blotting, Far-Western", "MH_TH": "NLM (2000)", "ST": "T063", "MS": "Screening techniques first developed in yeast to identify genes encoding interacting proteins. Variations are used to evaluate interplay between proteins and other molecules. Two-hybrid techniques refer to analysis for protein-protein interactions, one-hybrid for DNA-protein interactions, three-hybrid interactions for RNA-protein interactions or ligand-based interactions. Reverse n-hybrid techniques refer to analysis for mutations or other small molecules that dissociate known interactions.", "PM": "2000", "HN": "2000", "MR": "20150623", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020798"}, {"RECTYPE": "D", "MH": "Pancrelipase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ku Zyme", "MN": "D20.777.500.745", "PA": "Gastrointestinal Agents", "MH_TH": "USP (19XX)", "ST": "T126", "RN": "53608-75-6", "PI": "Pancreatin (1970-1979)", "MS": "A preparation of hog pancreatic enzymes standardized for lipase content.", "PM": "2000; for PANCREASE see PANCREATIN 1989-1999; PANCRELIPSASE was indexed under LIPASE & PANCREATIC EXTRACTS 1980-1999 & PANCREATIN 1970-1979", "HN": "2000; for PANCREASE use PANCREATIN 1989-1999; use PANCRELIPASE (NM) 1970-1999", "MR": "20160701", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020799"}, {"RECTYPE": "D", "MH": "Receptor, Nerve Growth Factor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Nerve Growth Factor Receptor, Low-Affinity|T116|T192|NON|EQV|NLM (2000)|991012|NERVE GROWTH FACTOR RECEPT LOW AFFINITY|abbcdefv", "ENTRY": "p75, Neurotropin Receptor", "MN": "D12.776.543.750.750.400.550.500", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "0", "AN": "do not confuse with RECEPTORS, NERVE GROWTH FACTOR", "MS": "A low affinity receptor that binds NERVE GROWTH FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; and neurotrophin 4.", "PM": "2000; NERVE GROWTH FACTOR RECEPTOR P75 (now RECEPTOR, NERVE GROWTH FACTOR) was indexed under RECEPTORS, NERVE GROWTH FACTOR 1994-1999; P75 NEUROTROPHIN RECEPTOR was indexed under RECEPTORS, NERVE GROWTH FACTOR 2000-2005", "HN": "2000(1994)", "MR": "20050630", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020800"}, {"RECTYPE": "D", "MH": "Receptor, Ciliary Neurotrophic Factor", "DE": "RECEPT CILIARY NEUROTROPHIC FACTOR", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Ciliary Neurotrophic Factor Receptor|T116|T192|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Receptor, CNTF", "MN": "D12.776.543.750.750.400.550.250", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "0", "PI": "Receptors, Nerve Growth Factor (1995-1999)", "MS": "Cell surface receptors for CILIARY NEUROTROPHIC FACTOR. They are heterotrimeric proteins formed by the association of the CILIARY NEUROTROPHIC FACTOR RECEPTOR ALPHA SUBUNIT with the LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR GP130. Although the receptor regulates neuronal development, it is structurally similar to the cytokine receptor for INTERLEUKIN-6; (RECEPTORS, INTERLEUKIN-6).", "PM": "2000; CILIARY NEUROTROPHIC FACTOR RECEPTOR (now RECEPTOR, CILIARY NEUROTROPHIC FACTOR) was indexed under RECEPTORS, NERVE GROWTH FACTOR 1995-1999, RECEPTOR PROTEIN-TYROSINE KINASE 1997-1999, RECEPTORS, GROWTH FACTOR 1993-1994, & RECEPTORS, ENDOGENOUS SUBSTANCES 1991-1999", "HN": "2000; use RECEPTOR, CILIARY NEUROTROPHIC FACTOR (NM) 1991-1999", "MR": "20090714", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020801"}, {"RECTYPE": "D", "MH": "Epidural Abscess", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Spinal Epidural Abscess|T047|NON|NRW|NLM (2023)|210827|abcdef", "ENTRY": "Intracranial Extradural Abscesses", "MN": "C10.228.228.709.350", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coordinate with site + precoordinated organism/infection term + specific CENTRAL NERVOUS SYSTEM infection term ", "PI": "Spinal Cord Diseases (1967-1999)", "MS": "Circumscribed collections of suppurative material occurring in the spinal or intracranial EPIDURAL SPACE. The majority of epidural abscesses occur in the spinal canal and are associated with OSTEOMYELITIS of a vertebral body; ANALGESIA, EPIDURAL; and other conditions. Clinical manifestations include local and radicular pain, weakness, sensory loss, URINARY INCONTINENCE, and FECAL INCONTINENCE. Cranial epidural abscesses are usually associated with OSTEOMYELITIS of a cranial bone, SINUSITIS, or OTITIS MEDIA. (From Adams et al., Principles of Neurology, 6th ed, p710 and pp1240-1; J Neurol Neurosurg Psychiatry 1998 Aug;65(2):209-12)", "PM": "2000", "HN": "2000", "MR": "20211018", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020802"}, {"RECTYPE": "D", "MH": "Encephalitis, Herpes Simplex", "DE": "ENCEPH HERPES SIMPLEX", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Meningoencephalitis, Herpes Simplex Virus|T047|NON|BRD|NLM (2000)|991012|MENINGOENCEPH HERPES SIMPLEX VIRUS|abcdefv", "ENTRY": "Meningoencephalitis, Herpetic", "MN": "C10.586.250.520.750.350", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coord IM with specific SIMPLEXVIRUS if given", "MS": "An acute (or rarely chronic) inflammatory process of the brain caused by SIMPLEXVIRUS infections which may be fatal. The majority of infections are caused by human herpesvirus 1 (HERPESVIRUS 1, HUMAN) and less often by human herpesvirus 2 (HERPESVIRUS 2, HUMAN). Clinical manifestations include FEVER; HEADACHE; SEIZURES; HALLUCINATIONS; behavioral alterations; APHASIA; hemiparesis; and COMA. Pathologically, the condition is marked by a hemorrhagic necrosis involving the medial and inferior TEMPORAL LOBE and orbital regions of the FRONTAL LOBE. (From Adams et al., Principles of Neurology, 6th ed, pp751-4)", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020803"}, {"RECTYPE": "D", "MH": "Encephalitis, Varicella Zoster", "DE": "ENCEPH VARICELLA ZOSTER", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Varicella Encephalitis|T047|NON|EQV|NLM (2000)|991012|VARICELLA ENCEPH|abcdefv", "ENTRY": "Zoster Encephalitis, Varicella", "MN": "C10.586.250.520.750.400", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Herpes Zoster (1966-1999)", "MS": "Inflammation of brain tissue caused by infection with the varicella-zoster virus (HERPESVIRUS 3, HUMAN). This condition is associated with immunocompromised states, including the ACQUIRED IMMUNODEFICIENCY SYNDROME. Pathologically, the virus tends to induce a vasculopathy and infect oligodendrocytes and ependymal cells, leading to CEREBRAL INFARCTION, multifocal regions of demyelination, and periventricular necrosis. Manifestations of varicella encephalitis usually occur 5-7 days after onset of HERPES ZOSTER and include HEADACHE; VOMITING; lethargy; focal neurologic deficits; FEVER; and COMA. (From Joynt, Clinical Neurology, 1996, Ch 26, pp29-32; Hum Pathol 1996 Sep;27(9):927-38)", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020804"}, {"RECTYPE": "D", "MH": "Central Nervous System Viral Diseases", "DE": "CNS VIRAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Viral Diseases, Central Nervous System|T047|NON|EQV|NLM (2000)|991012|VIRAL DIS CNS|abcdefv", "ENTRY": "Viral Diseases, CNS", "MN": "C10.228.228.245", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coordinate with specific virus disease and specific site/disease term if pertinent", "PI": "Virus Diseases (1966-1999)", "MS": "Viral infections of the brain, spinal cord, meninges, or perimeningeal spaces.", "PM": "2000", "HN": "2000", "MR": "20190611", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020805"}, {"RECTYPE": "D", "MH": "Central Nervous System Bacterial Infections", "DE": "CNS BACT INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Bacterial Infections, Central Nervous System|T047|NON|EQV|NLM (2000)|991012|BACTERIAL INFECT CNS|abcdefv", "ENTRY": "Infections, Bacterial, Central Nervous System|T047|NON|EQV|NLM (2000)|991012|INFECT BACTERIAL CNS|abcdefv", "MN": "C10.228.228.180", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coord IM with precoord bacterial infection (IM) and specific site/dis term (IM) if pertinent", "PI": "Meningitis (1967-1999)", "MS": "Bacterial infections of the brain, spinal cord, and meninges, including infections involving the perimeningeal spaces.", "PM": "2000", "HN": "2000", "MR": "20190617", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020806"}, {"RECTYPE": "D", "MH": "Central Nervous System Parasitic Infections", "DE": "CNS PARASITIC INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Parasitic Infections, Central Nervous System|T047|NON|EQV|NLM (2000)|991012|PARASITIC INFECT CNS|abcdefv", "ENTRY": "Parasitic Infections, CNS", "MN": "C10.228.228.205", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coord IM with precoord parasitic infection (IM) and site/dis term (IM) if pertinent", "PI": "Parasitic Diseases (1966-1999)", "MS": "Infections of the brain, spinal cord, and meninges caused by parasites.", "PM": "2000", "HN": "2000", "MR": "20190702", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020807"}, {"RECTYPE": "D", "MH": "Central Nervous System Protozoal Infections", "DE": "CNS PROTOZOAL INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Protozoal Infections, Central Nervous System|T047|NON|EQV|NLM (2000)|991012|PROTOZOAL INFECT CNS|abcdefv", "ENTRY": "Sappinia diploidea Meningoencephalitides", "MN": "C10.228.228.205.300", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coordinate with specific protozoan infection and specific site/disease term if pertinent", "PI": "Amebiasis (1966-1999)", "MS": "Infections of the brain, spinal cord, or meninges by single celled organisms of the former subkingdom known as protozoa. The central nervous system may be the primary or secondary site of protozoal infection. These diseases may occur as OPPORTUNISTIC INFECTIONS or arise in immunocompetent hosts.", "PM": "2000", "HN": "2000", "MR": "20190611", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020808"}, {"RECTYPE": "D", "MH": "Central Nervous System Helminthiasis", "DE": "CNS HELMINTHIASIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Helminthiasis, Central Nervous System|T047|NON|EQV|NLM (2000)|991012|HELMINTHIASIS CNS|abcdefv", "ENTRY": "Helminthiasis, Cerebral", "MN": "C10.228.228.205.250", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Helminthiasis (1968-1999)", "MS": "Infections of the BRAIN; SPINAL CORD; or MENINGES caused by HELMINTHS (parasitic worms).", "PM": "2000", "HN": "2000", "MR": "20190611", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020809"}, {"RECTYPE": "D", "MH": "Biomedical Technology", "DE": "BIOMED TECHNOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Health Technology|T058|NON|NRW|NLM (1998)|970613|HEALTH TECHNOL|abcdefv", "ENTRY": "Technology, Health Care|T058|NON|NRW|NLM (1998)|970613|TECHNOL HEALTH CARE|abcdefv", "MN": "J01.897.120.050", "FX": "Medical Informatics", "MH_TH": "NLM (1991)", "ST": "T058", "PI": "Technology, Medical (1991-1999)", "MS": "The application of technology to the solution of medical problems.", "PM": "2000; see TECHNOLOGY, MEDICAL 1991-1999; HEALTH CARE TECHNOLOGY & HEALTH TECHNOLOGY use TECHNOLOGY, MEDICAL (1998-1999)", "HN": "2000; use TECHNOLOGY, MEDICAL 1991 - 1999", "MR": "20210304", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020811"}, {"RECTYPE": "D", "MH": "Receptor, trkC", "DE": "RECEPT TRKC", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "trkC Receptor|T116|T126|T192|NON|EQV|NLM (2000)|991012|TRKC RECEPT|abbbcdefv", "ENTRY": "TRKC, Protein-Tyrosine Kinase", "MN": "D12.776.543.750.750.400.550.700", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptors, Nerve Growth Factor (1995-1999)", "MS": "A protein-tyrosine kinase receptor that is specific for NEUROTROPHIN 3. It is widely expressed in nervous tissue and may play a role in mediating the effects of NEUROTROPHIN 3 on the proliferation and differentiation of NEURONS.", "PM": "2000; TRKC PROTEIN (now RECEPTOR, TYPE 3 NEUROTROPHIC TYROSINE KINASE) was indexed under RECEPTORS, NERVE GROWTH FACTOR 1995-1999, RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999, RECEPTORS, GROWTH FACTOR 1993-1994, MEMBRANE GLYCOPROTEINS 1991-1993 & PROTEIN-TYROSINE KINASE 1991-1993", "HN": "2000; use RECEPTOR, TYPE 3 NEUROTROPHIC TYROSINE KINASE (NM) 1991-1999", "MR": "20210521", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020812"}, {"RECTYPE": "D", "MH": "Receptor, trkB", "DE": "RECEPT TRKB", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "trkB Receptor|T116|T126|T192|NON|EQV|NLM (2000)|991012|TRKB RECEPT|abbbcdefv", "ENTRY": "Receptor, NTRK2", "MN": "D12.776.543.750.750.400.550.600", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptors, Nerve Growth Factor (1994-1999)", "MS": "A protein-tyrosine kinase receptor that is specific for BRAIN-DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; neurotrophin 4 and neurotrophin 5. It is widely expressed in nervous tissue and plays a role in mediating the effects of neurotrophins on growth and differentiation of neuronal cells.", "PM": "2000; TRKB(GP145) PROTEIN was indexed under RECEPTORS, NERVE GROWTH FACTOR & RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999, and under MEMBRANE GLYCOPROTEINS, PROTEIN-TYROSINE KINASE & RECEPTORS, GROWTH FACTOR 1990-1999; BDNF RECEPTOR was indexed under RECEPTORS, NERVE GROWTH FACTOR & RECEPTOR PROTEIN-TYROSINE KINASE 1995-1999", "HN": "2000; for TRKB(GP145) PROTEIN use RECEPTOR, TYPE 2 NEUROTROPHIC TYROSINE KINASE (NM) 1990-1999; for BDNF RECEPTOR use RECEPTOR, TYPE 2 NEUROTROPHIC TYROSINE KINASE (NM) 1995-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020813"}, {"RECTYPE": "D", "MH": "Meningitis, Escherichia coli", "DE": "MENINGITIS E COLI", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Escherichia coli Meningitis|T047|NON|EQV|NLM (2000)|991012|E COLI MENINGITIS|abcdefv", "ENTRY": "Meningitides, Escherichia coli", "MN": "C10.586.625.280.350", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Meningitis, Bacterial (1966-1999)", "MS": "A form of gram-negative meningitis that tends to occur in neonates, in association with anatomical abnormalities (which feature communication between the meninges and cutaneous structures) or as OPPORTUNISTIC INFECTIONS in association with IMMUNOLOGIC DEFICIENCY SYNDROMES. In premature neonates the clinical presentation may be limited to ANOREXIA; VOMITING; lethargy; or respiratory distress. Full-term infants may have as additional features FEVER; SEIZURES; and bulging of the anterior fontanelle. (From Menkes, Textbook of Child Neurology, 5th ed, pp398-400)", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020814"}, {"RECTYPE": "D", "MH": "Polyproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polyprotein|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "MN": "D12.776.775", "MH_TH": "UNK (19XX)", "ST": "T123", "RN": "0", "MS": "Proteins which are synthesized as a single polymer and then cleaved into several distinct proteins.", "PM": "2000; see PROTEINS 1988-1999", "HN": "2000; use PROTEINS 1988-1999", "MR": "20200527", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020815"}, {"RECTYPE": "D", "MH": "Amino Acid Motifs", "DE": "AA MOTIFS", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Supersecondary Protein Structure|T082|NON|BRD|NLM (2000)|991012|SUPERSECOND PROTEIN STRUCTURE|abcdefv", "ENTRY": "Supersecondary Protein Structures", "MN": "G02.111.570.820.709.600.500", "FX": "Conserved Sequence", "MH_TH": "NLM (2000)", "ST": "T082", "AN": "IM general only; coordinate NIM with specific protein", "MS": "Three-dimensional protein structural elements that are composed of a combination of secondary structures. They include HELIX-LOOP-HELIX MOTIFS and ZINC FINGERS. Motifs are typically the most conserved regions of PROTEIN DOMAINS and are critical for domain function. However, the same motif may occur in proteins or enzymes with different functions.", "PM": "2000", "HN": "2000", "MR": "20190429", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020816"}, {"RECTYPE": "D", "MH": "Asperger Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Syndrome, Asperger's", "MN": "F03.625.164.113.250", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Autistic Disorder (1981-1999)", "MS": "A disorder beginning in childhood whose essential features are persistent impairment in reciprocal social communication and social interaction, and restricted, repetitive patterns of behavior, interests, or activities. These symptoms may limit or impair everyday functioning. (From DSM-5)", "PM": "2000", "HN": "2000", "MR": "20170620", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020817"}, {"RECTYPE": "D", "MH": "Neuroschistosomiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Schistosomiasis, Central Nervous System|T047|NON|EQV|NLM (2000)|991012|SCHISTOSOMIASIS CNS|abcdefv", "ENTRY": "Schistosomal Myeloradiculopathies", "MN": "C10.228.228.205.250.600", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent; coordinate IM with precoordinated organism/infection (IM) and specific site/disease term (IM) if pertinent", "PI": "Schistosomiasis (1965-1999)", "MS": "SCHISTOSOMIASIS of the brain, spinal cord, or meninges caused by infections with trematodes of the genus SCHISTOSOMA (primarily SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; and SCHISTOSOMA HAEMATOBIUM in humans). S. japonicum infections of the nervous system may cause an acute meningoencephalitis or a chronic encephalopathy. S. mansoni and S. haematobium nervous system infections are associated with acute transverse myelitis involving the lower portions of the spinal cord. (From Joynt, Clinical Neurology, 1998, Ch27, pp61-2)", "PM": "2000", "HN": "2000", "MR": "20190611", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020818"}, {"RECTYPE": "D", "MH": "Perimeningeal Infections", "DE": "PERIMENINGEAL INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Perimeningeal Infection", "MN": "C10.228.228.709", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coord IM with specific infection term (IM)", "MS": "Infectious processes, including abscesses, effusions, and empyemas which occur in the epidural or subdural spaces surrounding the brain and spinal cord.", "PM": "2000", "HN": "2000", "MR": "20190617", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020819"}, {"RECTYPE": "D", "MH": "Dyskinesias", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Orofacial Dyskinesia|T047|NON|NRW|NLM (2000)|991109|abcdef", "ENTRY": "Tardive Oral Dyskinesias", "MN": "C23.888.592.350", "FX": "Movement Disorders", "EC": "chemically induced:Dyskinesia, Drug-Induced", "MH_TH": "UNK (19XX)", "ST": "T184", "AN": "DYSKINESIA SYNDROMES see MOVEMENT DISORDERS is also available", "PI": "Movement Disorders (1966-1999)", "MS": "Abnormal involuntary movements which primarily affect the extremities, trunk, or jaw that occur as a manifestation of an underlying disease process. Conditions which feature recurrent or persistent episodes of dyskinesia as a primary manifestation of disease may be referred to as dyskinesia syndromes (see MOVEMENT DISORDERS). Dyskinesias are also a relatively common manifestation of BASAL GANGLIA DISEASES.", "PM": "2000; for LINGUAL-FACIAL-BUCCAL DYSKINESIA see MOVEMENT DISORDERS 2000-2016;  for ORAL DYSKINESIA see MOVEMENT DISORDERS 2000-2017", "HN": "2000; for LINGUAL-FACIAL-BUCCAL DYSKINESIA use MOVEMENT DISORDERS 2000-2016; for ORAL DYSKINESIA use MOVEMENT DISORDERS 2000-2017", "MR": "20170405", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020820"}, {"RECTYPE": "D", "MH": "Dystonic Disorders", "DE": "DYSTONIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Writer's Cramp|T047|T184|NON|NRW|NLM (2000)|991012|abbcdef", "ENTRY": "Writers Cramp", "MN": "C10.228.662.300", "FX": "Dystonia", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "DYSTONIA is also available", "PI": "Dystonia (1966-1999)", "MS": "Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.", "PM": "2000", "HN": "2000", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020821"}, {"RECTYPE": "D", "MH": "ADP-Ribosylation Factor 1", "DS": "ADP RIBOSYLATION FACTOR A 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ARF 1 Protein|T116|T126|NON|EQV|NLM (2000)|991012|ARF A 01 PROTEIN|abbcdefs", "ENTRY": "Protein, ARF1", "MN": "D12.776.543.990.300.150", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1993-1999)", "MS": "ADP-RIBOSYLATION FACTOR 1 is involved in regulating intracellular transport by modulating the interaction of coat proteins with organelle membranes in the early secretory pathway. It is a component of COAT PROTEIN COMPLEX I. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; ADP RIBOSYLATION FACTOR 1 (now ADP-RIBOSYLATION FACTOR 1) was indexed under G-PROTEINS 1993-1999", "HN": "2000; use ADP-RIBOSYLATION FACTOR 1 (NM) 1993-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020823"}, {"RECTYPE": "D", "MH": "Spinocerebellar Tracts", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Tracts, Spinocerebellar", "MN": "A08.612.220.725", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Neural Pathways (1967-1999)", "MS": "Fibers that arise from cell groups within the spinal cord and pass directly to the cerebellum. They include the anterior, posterior, and rostral spinocerebellar tracts, and the cuneocerebellar tract. (From Parent, Carpenter's Human Neuroanatomy, 9th ed, p607)", "PM": "2000", "HN": "2000", "MR": "20040713", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020824"}, {"RECTYPE": "D", "MH": "T-Box Domain Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "T Box Domain Proteins", "MN": "D12.776.930.850", "MH_TH": "NLM (2000)", "ST": "T116", "RN": "0", "PI": "Transcription Factors (1996-1999)", "MS": "Proteins containing a region of conserved sequence, about 200 amino acids long, which encodes a particular sequence specific DNA binding domain (the T-box domain). These proteins are transcription factors that control developmental pathways. The prototype of this family is the mouse Brachyury (or T) gene product.", "PM": "2000", "HN": "2000", "MR": "20050630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020825"}, {"RECTYPE": "D", "MH": "rab3A GTP-Binding Protein", "DS": "RAB A 003A GTP BINDING PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "smg25a GTP Binding Protein|T116|T126|ABX|EQV|NLM (2000)|991012|SMG A 025A GTP BINDING PROTEIN|abbcdefs", "ENTRY": "rab3A GTP Binding Protein", "MN": "D12.776.476.338.400.400.100.500", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1992-1999)", "MS": "The most abundant member of the RAB3 GTP-BINDING PROTEINS. It is involved in calcium-dependent EXOCYTOSIS and is localized to neurons and neuroendocrine cells. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RAB3A PROTEIN was indexed under G-PROTEINS 1992-1999", "HN": "2000; for RAB3A PROTEIN see RAB3 GTP-BINDING PROTEINS (NM) 1992-1999;", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020826"}, {"RECTYPE": "D", "MH": "rap1 GTP-Binding Proteins", "DS": "RAP 001 GTP BINDING PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "smg p21 GTP-Binding Protein|T116|T126|ABX|NRW|NLM (2000)|991012|SMG P A 021 GTP BINDING PROTEIN|abbcdefs", "ENTRY": "smg p21 GTP Binding Protein", "MN": "D12.776.476.338.400.475.100", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1991-1999)", "MS": "A genetically related subfamily of RAP GTP-BINDING PROTEINS that share homology with RAS PROTEINS. They bind to Ras effectors but do not activate them, therefore they may antagonize the effects of RAS PROTEINS. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RAP1A PROTEIN, K-REV-1 PROTEIN & SMG P21A were indexed under G-PROTEINS 1991-1999", "HN": "2000; for RAP1A PROTEIN, K-REV-1 PROTEIN & SMG P21A use RAP GTP-BINDING PROTEINS (NM) 1991-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020827"}, {"RECTYPE": "D", "MH": "Pseudobulbar Palsy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spastic Bulbar Palsy|T033|T047|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Syndromes, Pseudobulbar", "MN": "C23.888.592.636.711", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Paralysis (1982-1999)", "MS": "A syndrome characterized by DYSARTHRIA, dysphagia, dysphonia, impairment of voluntary movements of tongue and facial muscles, and emotional lability. This condition is caused by diseases that affect the motor fibers that travel from the cerebral cortex to the lower BRAIN STEM (i.e., corticobulbar tracts); including MULTIPLE SCLEROSIS; MOTOR NEURON DISEASE; and CEREBROVASCULAR DISORDERS. (From Adams et al., Principles of Neurology, 6th ed, p489)", "PM": "2000; for PSEUDOBULBAR PARALYSIS and PARALYSIS, PSEUDOBULBAR see PARALYSIS 1985-1999", "HN": "2000; for PSEUDOBULBAR PARALYSIS and PARALYSIS, PSEUDOBULBAR use PARALYSIS 1985-1999", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020828"}, {"RECTYPE": "D", "MH": "Equisetum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Horsetail|T002|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Horsetails", "MN": "B01.875.800.575.175", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid3257", "RR": "txid3256", "PI": "Plants, Medicinal (1976-1999)", "MS": "The only living genus of the order Equisetales, class Equisetopsida (Sphenopsida), division Equisetophyta (Sphenophyta); distantly related to ferns. It grows in moist places. The hollow, jointed, ridged stems contain SILICATES.", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020829"}, {"RECTYPE": "D", "MH": "rac1 GTP-Binding Protein", "DS": "RAC 001 GTP BINDING PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TC-25 GTP-Binding Protein|T116|T126|ABX|EQV|NLM (2000)|991012|TC A 025 GTP BINDING PROTEIN|abbcdefs", "ENTRY": "ras Related C3 Botulinum Toxin Substrate 1", "MN": "D12.776.476.338.400.700.100.500", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.2", "PI": "G-Proteins (1991-1999)", "MS": "A rac GTP-binding protein involved in regulating actin filaments at the plasma membrane. It controls the development of filopodia and lamellipodia in cells and thereby influences cellular motility and adhesion. It is also involved in activation of NADPH OXIDASES. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RAC1 GENE PRODUCT was indexed under G-PROTEINS 1991-1999 & PROTEINS 1989-1990", "HN": "2000; for RAC1 GENE PRODUCT use RAC GTP-BINDING PROTEINS (NM) 1989-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020830"}, {"RECTYPE": "D", "MH": "Acupuncture, Ear", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ear Acupuncture|T061|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Ear Acupunctures", "MN": "E02.190.204.500", "MH_TH": "NLM (2000)", "ST": "T061", "AN": "AURICULOTHERAPY is also available", "PI": "Acupuncture Therapy (1989-1999)", "MS": "Acupuncture therapy by inserting needles in the ear. It is used to control pain and for treating various ailments.", "PM": "2000", "HN": "2000", "MR": "20080708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020831"}, {"RECTYPE": "D", "MH": "EF Hand Motifs", "AQ": "DE GE IM PH RE", "ENTRY": "Motifs, EF Hand", "MN": "G02.111.570.820.709.275.500.360.240", "FX": "Calbindins", "MH_TH": "NLM (2000)", "ST": "T082", "MS": "Calcium-binding motifs composed of two helices (E and F) joined by a loop. Calcium is bound by the loop region. These motifs are found in many proteins that are regulated by calcium.", "PM": "2000", "HN": "2000", "MR": "20160527", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020832"}, {"RECTYPE": "D", "MH": "Diffuse Axonal Injury", "DE": "DIFFUSE AXONAL INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Axonal Injury, Diffuse|T037|NON|EQV|NLM (2000)|991012|AXONAL INJ DIFFUSE|abcdefv", "ENTRY": "Injury, Diffuse Axonal", "MN": "C26.915.300.200.188.500", "MH_TH": "NLM (2000)", "ST": "T037", "PI": "Brain Injuries (1982-1999)", "MS": "A relatively common sequela of blunt head injury, characterized by a global disruption of axons throughout the brain. Associated clinical features may include NEUROBEHAVIORAL MANIFESTATIONS; PERSISTENT VEGETATIVE STATE; DEMENTIA; and other disorders.", "PM": "2000", "HN": "2000", "MR": "20160120", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020833"}, {"RECTYPE": "D", "MH": "Ethnopharmacology", "DE": "ETHNOPHARMACOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "I01.076.201.450.654.252", "FX": "Plants, Medicinal", "MH_TH": "NLM (2000)", "ST": "T091", "AN": "specialty; coordinate with geographic term or ethnic group if pertinent; coordinate NIM with specific drug or plant (IM) for ethnopharmacologic aspects of the drug or plant", "PI": "Pharmacology (1983-1999)", "MS": "The study of the actions and properties of medicinal agents, often derived from PLANTS, indigenous to populations or ETHNICITY.", "PM": "2000", "HN": "2000", "MR": "20210712", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020834"}, {"RECTYPE": "D", "MH": "Medicine, Kampo", "AQ": "AE EC HI IS MT PX SN ST TD", "PRINT ENTRY": "Kampo Medicine|T058|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Medicine, Kanpo", "MN": "I01.076.201.450.654.558.600", "FX": "Medicine, Chinese Traditional", "MH_TH": "NLM (2000)", "ST": "T058", "AN": "coord with DRUGS, CHINESE HERBAL or MATERIA MEDICA if pertinent; MEDICINE, CHINESE TRADITIONAL is also available", "PI": "Medicine, Chinese Traditional (1994-1999)", "MS": "System of herbal medicine practiced in Japan by both herbalists and practitioners of modern medicine. Kampo originated in China and is based on Chinese herbal medicine (MEDICINE, CHINESE TRADITIONAL).", "PM": "2000; for KAMPO & KAMPO use MEDICINE, CHINESE TRADITIONAL 1994-1999", "HN": "2000; for KAMPO & KANPO use MEDICINE, CHINESE TRADITIONAL 1994-1999", "MR": "20180629", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020835"}, {"RECTYPE": "D", "MH": "Protein Structure, Quaternary", "AQ": "DE GE PH RE", "PRINT ENTRY": "Quaternary Protein Structure|T082|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Quaternary Protein Structures", "MN": "G02.111.570.820.709.550", "FX": "Multiprotein Complexes", "MH_TH": "NLM (1993)", "ST": "T082", "AN": "for multimeric proteins; for the 3-dimensional shape of a single polypeptide chain use PROTEIN CONFORMATION", "PI": "Protein Conformation (1972-1999)", "MS": "The characteristic 3-dimensional shape and arrangement of multimeric proteins (aggregates of more than one polypeptide chain).", "PM": "2000; see PROTEIN CONFORMATION (1993-1999)", "HN": "2000; use PROTEIN CONFORMATION (1993-1999)", "MR": "20150623", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020836"}, {"RECTYPE": "D", "MH": "SOS1 Protein", "DS": "SOS PROTEIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Son of Sevenless Homolog 1|T116|T123|NON|EQV|NLM (2000)|991012|SON OF SEVENLESS HOMOLOG A 001|abbcdefs", "ENTRY": "mSOS1 Protein|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "MN": "D12.776.476.325.300.700.700.630", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Repressor Proteins (1992-1999)", "MS": "A mammalian homolog of the DROSOPHILA SON OF SEVENLESS PROTEIN. It is a guanine nucleotide exchange factor for RAS PROTEINS.", "PM": "2000; SOS1 PROTEIN was indexed under REPRESSOR PROTEINS 1993-1999; MSOS1 PROTEIN was indexed under PROTEINS 1993-1999", "HN": "2000; use SOS1 PROTEIN (NM) 1992-1999; for MSOS1 PROTEIN use GUANINE NUCLEOTIDE EXCHANGE FACTORS (NM) 1996-1999", "MR": "20151124", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020837"}, {"RECTYPE": "D", "MH": "Calendula", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Calendula officinalis|T002|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "officinalis, Calendula", "MN": "B01.875.800.575.912.250.100.141", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid41495", "RR": "txid41496", "PI": "Plants, Medicinal (1970-1999)", "MS": "A plant genus of the family ASTERACEAE. Members contain CAROTENOIDS, essential oils (OILS, VOLATILE), flavonoids, mucilage, SAPONINS, and STEROLS. The plants are used both topically and internally. The common name of Marigold is also used for TAGETES.", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020838"}, {"RECTYPE": "D", "MH": "Son of Sevenless Protein, Drosophila", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SOS Protein|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "SOS Protein, Drosophila", "MN": "D12.776.476.325.300.700.700.600", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "AN": "SON OF SEVENLESS PROTEINS is also available", "PI": "Membrane Proteins (1992-1999)", "MS": "A guanine nucleotide exchange factor from DROSOPHILA. Sevenless refers to genetic mutations in DROSOPHILA that cause loss of the R7 photoreceptor which is required to see UV light.", "PM": "2000; SOS PROTEIN was indexed under MEMBRANE PROTEINS 1995-1999", "HN": "2000; for SOS PROTEIN use SON OF SEVENLESS PROTEINS 1995-1999", "MR": "20151124", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020839"}, {"RECTYPE": "D", "MH": "Tissue Kallikreins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "hK2 Kallikrein|T116|T126|NON|NRW|NLM (2000)|991012|HK 002 KALLIKREIN|abbcdefs", "ENTRY": "Specific Kallikrein, Prostate", "MN": "D23.101.140.870", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.4.21.35", "AN": "do not confuse PROSTATE SPECIFIC KALLIKREIN with PROSTATE SPECIFIC ANTIGEN", "PI": "Kallikreins (1983-1999)", "MS": "A family of trypsin-like SERINE ENDOPEPTIDASES that are expressed in a variety of cell types including human prostate epithelial cells. They are formed from tissue prokallikrein by action with TRYPSIN. They are highly similar to PROSTATE-SPECIFIC ANTIGEN.", "PM": "2000; TISSUE KALLIKREIN was indexed under KALLIKREIN 1983-1999 & PEPTIDE PEPTIDOHYDROLASES 1982-1983", "HN": "2000; use TISSUE KALLIKREIN (NM) 1983-1999", "MR": "20150619", "DA": "19991109", "DC": "1", "DX": "20000101", "UI": "D020840"}, {"RECTYPE": "D", "MH": "Plasma Kallikrein", "AQ": "AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kallikrein, Serum", "MN": "D08.811.277.656.959.350.442.700", "PA": "Coagulants", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.4.21.34", "PI": "Kallikreins (1965-1999)", "MS": "A peptidohydrolytic enzyme that is formed from PREKALLIKREIN by FACTOR XIIA. It activates FACTOR XII; FACTOR VII; and PLASMINOGEN. It is selective for both ARGININE and to a lesser extent LYSINE bonds. EC 3.4.21.34.", "PM": "2000", "HN": "2000", "MR": "20090706", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020842"}, {"RECTYPE": "D", "MH": "Chamomile", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Oils, Chamomile", "MN": "B01.875.800.575.912.250.100.195", "MH_TH": "NLM (2000)", "ST": "T002", "AN": "prefer specific plant", "PI": "Plants, Medicinal (1965-1999)", "MS": "Common name for several daisy-like plants (MATRICARIA; TRIPLEUROSPERMUM; ANTHEMIS; CHAMAEMELUM) native to Europe and Western Asia, now naturalized in the United States and Australia.", "PM": "2000; CHAMOMILE was indexed under FLAVONES 1989-1999 & OILS, VOLATILE 1981-1999", "HN": "2000", "MR": "20210630", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020843"}, {"RECTYPE": "D", "MH": "Comfrey", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Symphytum officinale|T002|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "officinales, Symphytum", "MN": "B01.875.800.575.912.250.150.210", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid278672", "PI": "Plants, Medicinal (1967-1999)", "MS": "Perennial herb Symphytum officinale, in the family Boraginaceae, used topically for wound healing. It contains ALLANTOIN, carotene, essential oils (OILS, VOLATILE); GLYCOSIDES; mucilage, resin, SAPONINS; TANNINS; triterpenoids, VITAMIN B12, and ZINC. Comfrey also contains PYRROLIZIDINE ALKALOIDS and is hepatotoxic if ingested.", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020844"}, {"RECTYPE": "D", "MH": "Selective Estrogen Receptor Modulators", "DE": "SELECTIVE ESTROGEN RECEPT MODULATORS", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "SERMs|T121|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Selective Estrogen Receptor Modulator|T121|NON|EQV|NLM (2000)|991012|abcdef", "MN": "D27.505.696.399.450.360.827", "FX": "Bone Density Conservation Agents", "MH_TH": "NLM (2000)", "ST": "T121", "RN": "0", "AN": "do not confuse with ESTROGEN RECEPTOR MODULATORS", "PI": "Receptors, Estrogen (1996-1999)", "MS": "A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63)", "PM": "2000", "HN": "2000", "MR": "20130709", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020845"}, {"RECTYPE": "D", "MH": "cdc42 GTP-Binding Protein, Saccharomyces cerevisiae", "DS": "CDC 042 GTP BINDING PROTEIN SACCHAROMYCES CEREVISIAE", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "cdc42 Protein, Yeast|T116|T126|ACX|BRD|NLM (2000)|991012|CDC 042 PROTEIN YEAST|abbcdefs", "ENTRY": "cdc42 GTP Binding Protein, Yeast", "MN": "D12.776.476.338.400.700.060", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.5.2", "RR": "EC 3.6.5.2", "AN": "CDC42 GTP-BINDING PROTEIN is also available", "PI": "G-Proteins (1996-1999)", "MS": "A member of the Rho family of MONOMERIC GTP-BINDING PROTEINS from SACCHAROMYCES CEREVISIAE. It is involved in morphological events related to the cell cycle. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2002; CDC42 PROTEIN, FUNGAL (now CDC42 GTP-BINDING PROTEIN, SACCHAROMYCES CEREVISIAE) was indexed under CELL CYCLE PROTEINS & G-PROTEINS 1996-1999 & FUNGAL PROTEINS 1991-1995", "HN": "2002(2000); use CDC42 GTP-BINDING PROTEIN, SACCHAROMYCES CEREVISIAE (NM) 1991-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020846"}, {"RECTYPE": "D", "MH": "Estrogen Receptor Modulators", "DE": "ESTROGEN RECEPT MODULATORS", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiestrogens|T121|NON|EQV|UNK (19XX)|770517|abcdef", "ENTRY": "Receptor Modulators, Estrogen", "MN": "D27.505.696.399.450.360", "FX": "Estrogens", "MH_TH": "NLM (2000)", "ST": "T121", "RN": "0", "AN": "do not confuse with SELECTIVE ESTROGEN RECEPTOR MODULATORS", "MS": "Substances that possess antiestrogenic actions but can also produce estrogenic effects as well. They act as complete or partial agonist or as antagonist. They can be either steroidal or nonsteroidal in structure.", "PM": "2000; see ESTROGEN ANTAGONISTS 1978-1999", "HN": "2000; use ESTROGEN ANTAGONISTS 1978-1999", "MR": "20030709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020847"}, {"RECTYPE": "D", "MH": "Chimerin 1", "DS": "CHIMERIN A 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rhoGAP2 Protein|T116|T123|NON|EQV|NLM (2000)|991012|RHOGAP PROTEIN 002|abbcdefs", "ENTRY": "n Chimaerin", "MN": "D12.776.631.124.200", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1991-1999)", "MS": "A GTPase activating protein that is specific for RAC GTP-BINDING PROTEINS. It is expressed primarily in the brain and may be involved in signal transduction. The alternatively spliced form of CHIMERIN 1 (alpha-2 Chimerin) contains an additional src homology domain and is expressed in both the brain and testes.", "PM": "2000; N-CHIMAERIN (now CHIMERIN 1) was indexed under NERVE TISSUE PROTEINS 1990-1999; ALPHA1-CHIMAERIN was indexed under PROTEINS 1996-1999", "HN": "2000; use CHIMERIN 1 (NM) 1990-1999; for ALPHA1-CHIMAERIN use GTPASE-ACTIVATING PROTEINS (NM) 1996-1999", "MR": "20151123", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020848"}, {"RECTYPE": "D", "MH": "Raloxifene Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Raloxifene|T109|T121|NON|BRD|FDA SRS (2014)|INN (19XX)|NLM (2000)|991012|abbcdeeef", "ENTRY": "LY156758", "MN": "D02.455.426.559.389.150.700.900.775", "PA": "Selective Estrogen Receptor Modulators", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "4F86W47BR6", "RR": "YX9162EO3I", "PI": "Piperidines (1983-1999)", "MS": "A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.", "PM": "2000; LY 139481 (now RALOXIFENE) was indexed under PIPERIDINES 1983-1999", "HN": "2000; use RALOXIFENE (NM) 1983-1999", "MR": "20150708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020849"}, {"RECTYPE": "D", "MH": "Lyme Neuroborreliosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Peripheral Nervous System Lyme Disease|T047|NON|NRW|NLM (2000)|991012|PERIPHERAL NERVOUS SYSTEM LYME DIS|abcdefv", "ENTRY": "Polyradiculopathy, Lyme", "MN": "C10.228.228.180.437", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coord IM with Borrelia (IM) + specific site/dis term (IM) if pertinent", "PI": "Lyme Disease (1984-1999)", "MS": "Nervous system infections caused by tick-borne spirochetes of the BORRELIA BURGDORFERI GROUP. The disease may affect elements of the central or peripheral nervous system in isolation or in combination. Common clinical manifestations include a lymphocytic meningitis, cranial neuropathy (most often a facial neuropathy), POLYRADICULOPATHY, and a mild loss of memory and other cognitive functions. Less often more extensive inflammation involving the central nervous system (encephalomyelitis) may occur. In the peripheral nervous system, B. burgdorferi infection is associated with mononeuritis multiplex and polyradiculoneuritis. (From J Neurol Sci 1998 Jan 8;153(2):182-91)", "PM": "2000", "HN": "2000", "MR": "20190617", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020852"}, {"RECTYPE": "D", "MH": "AT Rich Sequence", "DE": "AT RICH SEQ", "AQ": "DE ES GE IM PH RE", "ENTRY": "Sequences, AT Rich", "MN": "G05.360.080.040", "FX": "GC Rich Sequence", "MH_TH": "NLM (2000)", "ST": "T123", "PI": "Thymine (1971-1987)", "MS": "A nucleic acid sequence that contains an above average number of ADENINE and THYMINE bases.", "PM": "2000", "HN": "2000", "MR": "20080708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020856"}, {"RECTYPE": "D", "MH": "Hallux Limitus", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Limitus, Hallux", "MN": "C26.558.300.500", "MH_TH": "NLM (2000)", "ST": "T020", "PI": "Foot Diseases (1997)", "MS": "A bony proliferation and articular degeneration of the first METATARSOPHALANGEAL JOINT that is characterized by pain and a progressive decrease in the dorsiflexion range of motion.", "PM": "2000", "HN": "2000", "MR": "20160226", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020857"}, {"RECTYPE": "D", "MH": "Tissue and Organ Harvesting", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Tissue Harvesting|T061|T062|NON|NRW|NLM (2000)|991012|abbcdef", "ENTRY": "Retrievals, Organ", "MN": "E04.936.537", "FX": "Tissue and Organ Procurement", "MH_TH": "NLM (2005)", "ST": "T062", "AN": "sperm collection goes here", "MS": "The procedure of removing TISSUES, organs, or specimens from DONORS for reuse, such as TRANSPLANTATION.", "PM": "2005; see TISSUE HARVESTING 2000-2004", "HN": "2005 (2000)", "MR": "20110624", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020858"}, {"RECTYPE": "D", "MH": "Hallux Rigidus", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Rigidus, Hallux", "MN": "C05.550.450", "MH_TH": "NLM (2000)", "ST": "T020", "PI": "Metatarsophalangeal Joint (1983-1999)", "MS": "A condition caused by degenerative arthritis (see OSTEOARTHRITIS) of the METATARSOPHALANGEAL JOINT of the great toe and characterized by pain and limited dorsiflexion, but relatively unrestricted plantar flexion.", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020859"}, {"RECTYPE": "D", "MH": "Subtilisin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.656.959.350.787.805", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.4.21.62", "AN": "SUBTILISINS is also available", "PI": "Subtilisins (1973-1999)", "MS": "A serine endopeptidase isolated from Bacillus subtilis. It hydrolyzes proteins with broad specificity for peptide bonds, and a preference for a large uncharged residue in P1. It also hydrolyzes peptide amides. (From Enzyme Nomenclature, 1992) EC 3.4.21.62.", "PM": "2000", "HN": "2000", "MR": "20090706", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020860"}, {"RECTYPE": "D", "MH": "GC Rich Sequence", "DE": "GC RICH SEQ", "AQ": "DE ES GE IM PH RE", "ENTRY": "Sequences, GC Rich", "MN": "G05.360.080.380", "FX": "Isochores", "MH_TH": "NLM (2000)", "ST": "T123", "PI": "Dinucleoside Phosphates (1989-1999)", "MS": "A nucleic acid sequence that contains an above average number of GUANINE and CYTOSINE bases.", "PM": "2000", "HN": "2000", "MR": "20080708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020862"}, {"RECTYPE": "D", "MH": "Central Nervous System Cysts", "DE": "CNS CYSTS", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Suprasellar Cyst|T191|NON|NRW|UNK (19XX)|740329|abcdef", "ENTRY": "Suprasellar Cysts", "MN": "C16.131.666.142", "MH_TH": "NLM (2000)", "ST": "T191", "AN": "coord with organ neopl site", "MS": "Congenital or acquired cysts of the brain, spinal cord, or meninges which may remain stable in size or undergo progressive enlargement.", "PM": "2000; for SUPRASELLAR CYST see CRANIOPHARYNGIOMA 1966-1999", "HN": "2000; for SUPRASELLAR CYST use CRANIOPHARYNGIOMA 1966-1999", "MR": "20200527", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020863"}, {"RECTYPE": "D", "MH": "Calcium Channels, N-Type", "DE": "VDCC N", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neural-Type Calcium Channels|T116|T123|NON|EQV|NLM (2000)|991012|NEURAL TYPE CA CHANNELS|abbcdefv", "ENTRY": "VDCC, N-Type", "MN": "D12.776.543.585.400.150.585", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Calcium Channels (1990-1999)", "MS": "CALCIUM CHANNELS that are concentrated in neural tissue. Omega toxins inhibit the actions of these channels by altering their voltage dependence.", "PM": "2000", "HN": "2000", "MR": "20160701", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020864"}, {"RECTYPE": "D", "MH": "Calcium Channels, P-Type", "DE": "VDCC P", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Purkinje-Type Calcium Channels|T116|T123|NON|EQV|NLM (2000)|991012|PURKINJE TYPE CA CHANNELS|abbcdefv", "ENTRY": "VDCC, P-Type", "MN": "D12.776.543.585.400.150.585.792", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Calcium Channels (1991-1999)", "MS": "CALCIUM CHANNELS located within the PURKINJE CELLS of the cerebellum. They are involved in stimulation-secretion coupling of neurons.", "PM": "2000; P-TYPE VDCC was indexed under CALCIUM CHANNELS 1999", "HN": "2000; for P-TYPE VDCC use VOLTAGE-DEPENDENT CALCIUM CHANNEL (P-Q TYPE) (NM) 1999", "MR": "20160701", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020865"}, {"RECTYPE": "D", "MH": "omega-Conotoxin GVIA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE TO TU UR", "ENTRY": "toxin, omega-Conus geographus", "MN": "D23.946.833.590.162.720.700", "PA": "Neurotoxins", "MH_TH": "NLM (2000)", "ST": "T131", "RN": "92078-76-7", "PI": "Peptides (1994-1999)", "MS": "A neurotoxic peptide, which is a cleavage product (VIa) of the omega-Conotoxin precursor protein contained in venom from the marine snail, CONUS geographus. It is an antagonist of CALCIUM CHANNELS, N-TYPE.", "PM": "2000; CONUS GEOGRAPHUS TOXIN (now OMEGA-CONOTOXIN GVIA) was indexed under PEPTIDES 1994-1999 & MOLLUSK VENOMS 1984-1993", "HN": "2000; use OMEGA-CONOTOXIN GVIA (NM) 1984-1999", "MR": "20050630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020866"}, {"RECTYPE": "D", "MH": "omega-Agatoxin IVA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE TO TU UR", "PRINT ENTRY": "omega-Aga-IVA|T116|T123|T131|NON|EQV|NLM (2000)|991012|abbbcdef", "ENTRY": "omega Agatoxin IVA", "MN": "D23.946.833.065.870.324.500", "PA": "Neurotoxins", "MH_TH": "NLM (2000)", "ST": "T131", "RN": "0", "PI": "Spider Venoms (1992-1999)", "MS": "A neuropeptide toxin from the venom of the funnel web spider, Agelenopsis aperta. It inhibits CALCIUM CHANNELS, P-TYPE by altering the voltage-dependent gating so that very large depolarizations are needed for channel opening. It also inhibits CALCIUM CHANNELS, Q-TYPE.", "PM": "2000; OMEGA-AGATOXIN IVA was indexed under SPIDER VENOMS 1992-1999", "HN": "2000; use OMEGA-AGATOXIN IVA (NM) 1992-1999", "MR": "20150618", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020867"}, {"RECTYPE": "D", "MH": "Gene Silencing", "AQ": "DE ES IM PH RE", "PRINT ENTRY": "Gene Inactivation|T045|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Silencing, Gene", "MN": "G05.308.203.374", "FX": "DNA Methylation", "MH_TH": "NLM (2000)", "ST": "T045", "PI": "Gene Expression Regulation (1981-1999)", "MS": "Interruption or suppression of the expression of a gene at transcriptional or translational levels.", "PM": "2000", "HN": "2000", "MR": "20160617", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020868"}, {"RECTYPE": "D", "MH": "Gene Expression Profiling", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "mRNA Differential Display|T059|T063|NON|REL|NLM (2001)|991208|abbcdef", "ENTRY": "mRNA Differential Displays", "MN": "E05.393.332", "FX": "Transcriptome", "MH_TH": "NLM (2000)", "ST": "T063", "AN": "do not confuse with DNA PROFILING see DNA FINGERPRINTING", "MS": "The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell.", "PM": "2000", "HN": "2000", "MR": "20220408", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020869"}, {"RECTYPE": "D", "MH": "RNA Stability", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "mRNA Transcript Degradation|T044|ACX|REL|NLM (2004)|021011|abcdef", "ENTRY": "Transcript Degradation, mRNA", "MN": "G02.111.780", "FX": "RNA Cleavage", "MH_TH": "NLM (2000)", "ST": "T080", "AN": "coordinate with specific RNA if pertinent", "MS": "The extent to which an RNA molecule retains its structural integrity and resists degradation by RNASE, and base-catalyzed HYDROLYSIS, under changing in vivo or in vitro conditions.", "PM": "2000", "HN": "2000", "MR": "20110624", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020871"}, {"RECTYPE": "D", "MH": "Enkephalin, Ala(2)-MePhe(4)-Gly(5)-", "DS": "ENKEPHALIN ALA MEPHE GLY 02 04 05", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DAMGO|T116|T121|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "RX 783006", "MN": "D12.776.631.650.575.281.075", "PA": "Neurotransmitter Agents", "MH_TH": "NLM (2000)", "ST": "T121", "N1": "L-Phenylalaninamide, L-tyrosyl-D-alanylglycyl-N-(2-hydroxyethyl)-nalpha-methyl-", "RN": "100929-53-1", "PI": "Enkephalins (1981-1999)", "MS": "An enkephalin analog that selectively binds to the MU OPIOID RECEPTOR. It is used as a model for drug permeability experiments.", "PM": "2000; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- was indexed under ENKEPHALINS 1981-1999", "HN": "2000; use ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- (NM) 1981-1999", "MR": "20151123", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020875"}, {"RECTYPE": "D", "MH": "Device Removal", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Removals, Device", "MN": "E04.199", "MH_TH": "POPLINE (1999)", "ST": "T061", "MS": "Removal of an implanted therapeutic or prosthetic device.", "PM": "2000", "HN": "2000", "MR": "20020703", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020878"}, {"RECTYPE": "D", "MH": "Neuromuscular Manifestations", "PRINT ENTRY": "Muscle Disease Manifestations|T184|NON|NRW|NLM (2000)|991012|MUSCLE DIS MANIFESTATIONS|abcdefv", "ENTRY": "Neuromuscular Manifestation", "MN": "C23.888.592.608", "MH_TH": "NLM (2000)", "ST": "T184", "AN": "not used for indexing", "MS": "Signs and symptoms associated with diseases of the muscle, neuromuscular junction, or peripheral nerves.", "PM": "2000", "HN": "2000", "MR": "20030722", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020879"}, {"RECTYPE": "D", "MH": "Neuregulins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neuregulin|T116|T125|NON|EQV|NLM (2021)|191231|abbcdef", "ENTRY": "Neuronal Differentiation Factor, Cholinergic|T116|T125|NON|NRW|NLM (2000)|991012|abbcdef", "MN": "D23.529.850.550", "FX": "Receptor, ErbB-2", "MH_TH": "NLM (2000)", "ST": "T125", "RN": "0", "PI": "Glycoproteins (1986-1999)", "MS": "A family of peptides originally found as factors that stimulate the phosphorylation of the erbB-2 receptor (RECEPTORS, ERBB-2). Multiple variant forms of NEUREGULINS occur due to alternative splicing of their mRNAs. The NEUREGULINS include products from the three known genes (NGR1; NGR2 and NGR3).", "PM": "2000; NEURONAL DIFFERENTIATION FACTOR, CHOLINERGIC (now NEUREGULINS) was indexed under GLYCOPROTEINS 1986-1999", "HN": "2000; use NEUREGULINS (NM) 1986-1999", "MR": "20200527", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020880"}, {"RECTYPE": "D", "MH": "Enkephalin, D-Penicillamine (2,5)-", "DS": "ENKEPHALIN PENICILLAMINE D 02 05", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DPDPE|T116|T121|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "L-Pen5-Enkephalin D-Pen2", "MN": "D12.776.631.650.575.281.600", "PA": "Neurotransmitter Agents", "MH_TH": "NLM (2000)", "ST": "T121", "RN": "88373-73-3", "RR": "88381-28-6 (all L, D-valyl-isomer)", "PI": "Enkephalins (1983-1999)", "MS": "A disulfide opioid pentapeptide that selectively binds to the DELTA OPIOID RECEPTOR. It possesses antinociceptive activity.", "PM": "2000; ENKEPHALIN, PEN(2,5)- (now ENKEPHALIN, D-PENICILLAMINE (2,5)-) was indexed under ENKEPHALINS 1983-1999", "HN": "2000; use ENKEPHALIN, D-PENICILLAMINE (2,5)- (NM) 1983-1999", "MR": "20151123", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020881"}, {"RECTYPE": "D", "MH": "Hysterotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Hysterotomies", "MN": "E04.520.365", "MH_TH": "NLM (1979)", "ST": "T061", "PI": "Uterus/surgery (1966-1999)", "MS": "An incision in the uterus, performed through either the abdomen or the vagina.", "PM": "2000", "HN": "2000", "MR": "19991228", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020883"}, {"RECTYPE": "D", "MH": "Colpotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Vaginotomies", "MN": "E04.950.300.220", "MH_TH": "POPLINE (1978)", "ST": "T061", "PI": "Vagina/surgery (1978-1999)", "MS": "An incision in the vagina.", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020884"}, {"RECTYPE": "D", "MH": "Ribonucleoprotein, U7 Small Nuclear", "DS": "RIBONUCLEOPROTEINS U 007 SMALL NUCLEAR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "U7 snRNP|T116|T123|NON|EQV|NLM (1993)|920325|SNRNP U 007|abbcdefs", "MN": "D12.776.664.962.500.875.625", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins, Small Nuclear (1993-1999)", "MS": "This ribonucleoprotein particle, composed of U7 snRNA, Sm core protein, and U7 snRNP-specific proteins, is involved in the 3'end processing of histone premessenger RNAs.", "PM": "2000; for U7 SNRNP, U7 SMALL NUCLEAR RIBONUCLEARPROTEINS and SMALL NUCLEAR RIBONUCLEARPROTEINS, U7 see RIBONUCLEOPROTEINS, SMALL NUCLEAR 1993-1999", "HN": "2000; for U7 SNRNP, U7 SMALL NUCLEAR RIBONUCLEARPROTEINS and SMALL NUCLEAR RIBONUCLEARPROTEINS, U7 use RIBONUCLEOPROTEINS, SMALL NUCLEAR 1993-1999", "MR": "20210304", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020885"}, {"RECTYPE": "D", "MH": "Somatosensory Disorders", "DE": "SOMATOSENSORY DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thermal Sensation Disorders|T047|NON|NRW|NLM (2000)|991012|THERMAL SENSATION DIS|abcdefv", "ENTRY": "Thermal Sensation Disorder", "MN": "C23.888.592.763.770", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Sensation Disorders (1966-1999)", "MS": "Disorders of sensory information received from superficial and deep regions of the body. The somatosensory system conveys neural impulses which pertain to proprioception, tactile sensation, thermal sensation, pressure sensation, and pain. PERIPHERAL NERVOUS SYSTEM DISEASES; SPINAL CORD DISEASES; and BRAIN DISEASES may be associated with impaired or abnormal somatic sensation.", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020886"}, {"RECTYPE": "D", "MH": "Selenious Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Selenite|T121|T197|NON|REL|FDA SRS (2014)|NLM (1994)|921228|abbcdeef", "ENTRY": "Acid, Selenous", "MN": "D01.810.900", "PA": "Trace Elements", "MH_TH": "USP (19XX)", "ST": "T197", "N1": "Selenium dioxide, monohydrated", "RN": "F6A27P4Q4R", "RR": "KXO0259XJ1", "PI": "Selenium Compounds (1994-1999)", "MS": "A selenium compound with the molecular formula H2SO3. It used as a source of SELENIUM, especially for patients that develop selenium deficiency following prolonged PARENTERAL NUTRITION.", "PM": "2000; SELENIOUS ACID was indexed under SELENIUM COMPOUNDS 1994-1999, SELENIUM 1974-1993, & OXIDES 1974-1979", "HN": "2000; use SELENIOUS ACID (NM) 1974-1999", "MR": "20130708", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020887"}, {"RECTYPE": "D", "MH": "Vigabatrin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "gamma-Vinyl-gamma-Aminobutyric Acid|T116|T121|T123|NON|EQV|NLM (2000)|991012|abbbcdef", "ENTRY": "gamma Vinyl gamma Aminobutyric Acid", "MN": "D12.125.190.350.900", "PA": "GABA Agents", "MH_TH": "USAN (1985)", "ST": "T123", "N1": "4-Amino-5-hexenoic Acid", "RN": "GR120KRT6K", "RR": "60643-86-9 (Vigabatrin)", "PI": "GABA/analogs & derivatives (1994-1999)", "MS": "An analogue of GAMMA-AMINOBUTYRIC ACID. It is an irreversible inhibitor of 4-AMINOBUTYRATE TRANSAMINASE, the enzyme responsible for the catabolism of GAMMA-AMINOBUTYRIC ACID and is used as an anticonvulsant. (From Martindale The Extra Pharmacopoeia, 31st ed)", "PM": "2000; VIGABATRIN was indexed under GABA/analogs & derivatives 1994-1999, AMINOCAPROIC ACIDS 1981-1994, & GABA/analogs 1979-1980", "HN": "2000; use VIGABATRIN 1977-1999", "MR": "20180521", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020888"}, {"RECTYPE": "D", "MH": "Rolipram", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ZK62711", "MN": "D03.383.773.812.785", "PA": "Phosphodiesterase 4 Inhibitors", "MH_TH": "USAN (1980)", "ST": "T121", "N1": "Pyrrolidone, 4-(3-cyclopentyloxy-4-methoxyphenyl)-2-", "RN": "K676NL63N7", "RR": "61413-54-5 (Rolipram)", "PI": "Pyrrolidinones (1983-1999)", "MS": "A phosphodiesterase 4 inhibitor with antidepressant properties.", "PM": "2000; ROLIPRAM was indexed under PYRROLIDINONES 1983-1999 & CYCLOPENTANES 1979-1982", "HN": "2000; use ROLIPRAM (NM) 1979-1999", "MR": "20160531", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020889"}, {"RECTYPE": "D", "MH": "Neuregulin-1", "DS": "NEUREGULIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "neu Differentiation Factor|T116|T123|NON|NRW|NLM (2000)|991012|abbcdef", "ENTRY": "Neuregulin 1", "MN": "D23.529.850.550.750", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "0", "AN": "do not confuse entry term GLIAL GROWTH FACTOR with GLIA MATURATION FACTOR", "PI": "Nerve Tissue Proteins (1980-1999)", "MS": "A peptide factor originally identified by its ability to stimulate the phosphorylation the erbB-2 receptor (RECEPTOR, ERBB-2). It is a ligand for the erbB-3 receptor (RECEPTOR, ERBB-3) and the erbB-4 receptor. Variant forms of NEUREGULIN-1 occur through alternative splicing of its mRNA.", "PM": "2000; NEUREGULIN-1 was indexed under GLYCOPROTEINS 1993-1999; GLIAL GROWTH FACTOR was indexed under NERVE TISSUE PROTEINS 1980-1999", "HN": "2000; use NEUREGULIN-1 (NM) 1993-1999; for GLIAL GROWTH FACTOR use GLIA MATURATION FACTOR (NM) 1980-1999", "MR": "20151124", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020890"}, {"RECTYPE": "D", "MH": "Raclopride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "FLB472", "MN": "D02.455.426.559.389.127.250.937", "PA": "Dopamine Antagonists", "MH_TH": "NLM (2000)", "ST": "T121", "N1": "Benzamide, 3,5-dichloro-N-((1-ethyl-2-pyrrolidinyl)-methyl)-2-hydroxy-6-methoxy-", "RN": "430K3SOZ7G", "RR": "97849-54-2 (C11)", "PI": "Salicylamides (1987-1999)", "MS": "A substituted benzamide that has antipsychotic properties. It is a dopamine D2 receptor (see RECEPTORS, DOPAMINE D2) antagonist.", "PM": "2000; RACLOPRIDE was indexed under SALICYLAMIDES 1987-1999 & BENZAMIDES 1985-1986", "HN": "2000; use RACLOPRIDE 1985-1999", "MR": "20130708", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020891"}, {"RECTYPE": "D", "MH": "Receptor, ErbB-3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "erbB-3 Protein|T116|T126|T192|ABX|EQV|NLM (2000)|991012|ERBB PROTEIN 003|abbbcdefs", "ENTRY": "erbB-3, Proto-Oncogene Proteins", "MN": "D23.101.140.721", "FX": "Genes, erbB", "MH_TH": "NLM (2015)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptor, Epidermal Growth Factor (1990-1999)", "MS": "A cell surface protein-tyrosine kinase receptor that is specific for NEUREGULINS. It has extensive homology to and can heterodimerize with the EGF RECEPTOR and the ERBB-2 RECEPTOR. Overexpression of the erbB-3 receptor is associated with TUMORIGENESIS.", "PM": "2000; PROTO-ONCOGENE PROTEIN ERBB-3 (now RECEPTOR, ERBB-3) was indexed under EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE 1993-1999 & PROTO-ONCOGENE PROTEINS 1990-1999", "HN": "2000; use RECEPTOR, ERBB-3 (NM) 1990-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020893"}, {"RECTYPE": "D", "MH": "Microfibrils", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Microfibril", "MN": "A11.284.295.310.560", "MH_TH": "NLM (2000)", "ST": "T031", "MS": "Components of the extracellular matrix consisting primarily of fibrillin. They are essential for the integrity of elastic fibers.", "PM": "2000", "HN": "2000", "MR": "20000622", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020894"}, {"RECTYPE": "D", "MH": "Enterocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Enterocyte", "MN": "A11.436.290", "MH_TH": "NLM (2000)", "ST": "T025", "PI": "Intestinal Mucosa (1968-1999)", "MS": "Absorptive cells in the lining of the INTESTINAL MUCOSA. They are differentiated EPITHELIAL CELLS with apical MICROVILLI facing the intestinal lumen. Enterocytes are more abundant in the SMALL INTESTINE than in the LARGE INTESTINE. Their microvilli greatly increase the luminal surface area of the cell by 14- to 40 fold.", "PM": "2000", "HN": "2000", "MR": "20050630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020895"}, {"RECTYPE": "D", "MH": "Hypovolemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypovolemics", "MN": "C23.550.455", "FX": "Shock", "MH_TH": "NLM (2000)", "ST": "T046", "PI": "Blood Volume (1966-1999)", "MS": "An abnormally low volume of blood circulating through the body. It may result in hypovolemic shock (see SHOCK).", "PM": "2000", "HN": "2000", "MR": "20160701", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020896"}, {"RECTYPE": "D", "MH": "Organizers, Embryonic", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Spemann Organizer|T018|EPO|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Spemanns Organizer", "MN": "A16.675", "FX": "Embryonic Induction", "MH_TH": "NLM (2000)", "ST": "T018", "PI": "Embryonic Induction (1990-1999)", "MS": "Cells in certain regions of an embryo that self-regulate embryonic development. These organizers have been found in dorsal and ventral poles of GASTRULA embryos, including Spemann organizer in amphibians, and Hensen node in chicken and mouse. These organizer cells communicate with each other via a network of secreted signaling proteins, such as BONE MORPHOGENETIC PROTEINS and their antagonists (chordin and noggin).", "PM": "2000", "HN": "2000", "MR": "20070709", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020897"}, {"RECTYPE": "D", "MH": "Echinacea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rudbeckia purpurea|T002|NON|NRW|NLM (2003)|020110|abcdef", "ENTRY": "Purple Coneflowers, Pale", "MN": "B01.875.800.575.912.250.100.310", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid53747", "RR": "txid53751", "AN": "do not confuse with ECHINOIDEA see SEA URCHINS; note entry term CONEFLOWER, PURPLE:  CONEFLOWER, PRAIRIE see RATIBIDA and CONEFLOWER, ORANGE see RUDBECKIA are also available", "PI": "Plants, Medicinal (1967-1999)", "MS": "A genus of perennial herbs used topically and internally. It contains echinacoside, GLYCOSIDES; INULIN; isobutyl amides, resin, and SESQUITERPENES.", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020900"}, {"RECTYPE": "D", "MH": "Kava", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Piper methysticum|T002|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "methysticums, Piper", "MN": "B01.875.800.575.912.250.812.666.249", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid130404", "PI": "Plants, Medicinal (1967-1999)", "MS": "Dried rhizome and roots of Piper methysticum, a shrub native to Oceania and known for its anti-anxiety and sedative properties. Heavy usage results in some adverse effects. It contains ALKALOIDS; LACTONES; kawain, methysticin, mucilage, STARCH, and yangonin. Kava is also the name of the pungent beverage prepared from the plant's roots.", "PM": "2000; KAVA was indexed under PLANT EXTRACTS 1981-1999", "HN": "2000", "MR": "20210630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020901"}, {"RECTYPE": "D", "MH": "Hypericum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "St. Johns Wort|T002|EPO|NRW|NLM (1999)|980318|ST JOHNS WORT|abcdefv", "ENTRY": "perforatums, Hypericum", "MN": "B01.875.800.575.912.250.859.625.500", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid55962", "RR": "txid65561", "PI": "Theales (1999)", "MS": "Genus of perennial plants in the family CLUSIACEAE (sometimes classified as Hypericaceae). Herbal and homeopathic preparations are used for depression, neuralgias, and a variety of other conditions. Hypericum contains flavonoids; GLYCOSIDES; mucilage, TANNINS; volatile oils (OILS, ESSENTIAL), hypericin and hyperforin.", "PM": "2000; for Hypericum & St. Johns Wort see THEALES 1999;", "HN": "2000; for Hypericum & St. Johns Wort use THEALES 1999", "MR": "20210630", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020902"}, {"RECTYPE": "D", "MH": "Tanacetum parthenium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Feverfew|T002|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Feverfews", "MN": "B01.875.800.575.912.250.100.874.500", "FX": "Parthenium hysterophorus", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid127999", "PI": "Sesquiterpenes (1977-1999)", "MS": "An aromatic perennial plant species that has been used to treat migraines, arthritis, and as a febrifuge. It contains TANNINS, volatile oils (OILS, ESSENTIAL), and sesquiterpene lactones, especially parthenolide.", "PM": "2003; see FEVERFEW 2000-2002, see SESQUITERPENES 1986-1999", "HN": "2003(2000)", "MR": "20230531", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020903"}, {"RECTYPE": "D", "MH": "Glia Maturation Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glia Maturation Factor beta|T116|T123|NON|NRW|NLM (2000)|991012|abbcdef", "ENTRY": "Maturation Factor-beta, Glia", "MN": "D23.529.850.325", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "AN": "do not confuse with GLIAL GROWTH FACTOR see NEUREGULIN-1", "PI": "Nerve Tissue Proteins (1977-1999)", "MS": "A factor identified in the brain that influences the growth and differentiation of NEURONS and NEUROGLIA. Glia maturation factor beta is the 17-kDa polypeptide product of the GMFB gene and is the principal component of GLIA MATURATION FACTOR.", "PM": "2000; GLIAL MATURATION FACTOR (now GLIA MATURATION FACTOR) was indexed under NERVE TISSUE PROTEINS 1977-1999", "HN": "2000; use GLIAL MATURATION FACTOR (NM) 1977-1999", "MR": "20151123", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020904"}, {"RECTYPE": "D", "MH": "Air Abrasion, Dental", "DE": "AIR ABRASION DENT", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Dental Air Abrasion|T061|NON|EQV|NLM (2000)|991012|DENT AIR ABRASION|abcdefv", "ENTRY": "Dental Air Abrasions", "MN": "E06.020", "MH_TH": "NLM (2000)", "ST": "T061", "PI": "Dental Cavity Preparation (1996-1999)", "MS": "A technique using a pneumatic, high-pressure stream of aluminum oxide to remove DENTAL ENAMEL; DENTIN; and restorative materials from teeth. In contrast to using DENTAL HIGH-SPEED EQUIPMENT, this method usually requires no dental anesthesia (ANESTHESIA, DENTAL) and reduces risks of tooth chipping and microfracturing. It is used primarily for routine DENTAL CAVITY PREPARATION.", "PM": "2000", "HN": "2000", "MR": "20010725", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020906"}, {"RECTYPE": "D", "MH": "Calcium Channels, Q-Type", "DE": "VDCC Q", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Q-Type Calcium Channels|T116|T123|NON|EQV|NLM (2000)|991012|Q TYPE CA CHANNELS|abbcdefv", "ENTRY": "VDCC, Q-Type", "MN": "D12.776.543.585.400.150.585.826", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Calcium Channels (1994-1999)", "MS": "CALCIUM CHANNELS located in the neurons of the brain.", "PM": "2000; Q-TYPE VDCC was indexed under CALCIUM CHANNELS 1999", "HN": "2000; for Q-TYPE VDCC use VOLTAGE-DEPENDENT CALCIUM CHANNELS (P-Q TYPE) (NM) 1999", "MR": "20160701", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020907"}, {"RECTYPE": "D", "MH": "Calcium Channels, R-Type", "DE": "VDCC R", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "R-Type Calcium Channels|T116|T123|NON|EQV|NLM (2000)|991012|R TYPE CA CHANNELS|abbcdefv", "ENTRY": "VDCC, R-Type", "MN": "D12.776.543.585.400.150.585.867", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Calcium Channels (1992-1999)", "MS": "CALCIUM CHANNELS located in the neurons of the brain. They are inhibited by the marine snail toxin, omega conotoxin MVIIC.", "PM": "2000", "HN": "2000", "MR": "20160701", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020908"}, {"RECTYPE": "D", "MH": "Acarbose", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Precose|T109|T121|TRD|NRW|US|020717|abbcdef", "MN": "D09.698.629.802.100", "PA": "Glycoside Hydrolase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "D-glucose, O-4,6-dideoxy-4-(((1S-(1 alpha,4 alpha,5 beta,6 alpha))-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyr anosyl-(1-4)-", "RN": "T58MSI464G", "RR": "56180-94-0 (Acarbose)", "PI": "Trisaccharides (1980-1999)", "MS": "An inhibitor of ALPHA-GLUCOSIDASES that retards the digestion and absorption of DIETARY CARBOHYDRATES in the SMALL INTESTINE.", "PM": "2000; ACARBOSE was indexed under TRISACCHARIDES 1980-1999, CYCLOHEXANOLS 1979-1981, & POLYSACCHARIDES 1978-1979", "HN": "2000; use ACARBOSE (NM) 1979-1999", "MR": "20170117", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020909"}, {"RECTYPE": "D", "MH": "Ketorolac", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.473.420.485", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "NLM (2000)", "ST": "T121", "N1": "1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro", "RN": "YZI5105V0L", "RR": "74103-06-3 ((+-)-isomer)", "AN": "KETOROLAC TROMETHAMINE is available", "PI": "Tolmetin/analogs & derivatives (1983-1999)", "MS": "A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is an NSAID and is used principally for its analgesic activity. (From Martindale The Extra Pharmacopoeia, 31st ed)", "PM": "2000; KETOROLAC was indexed under TOLMETIN/analogs & derivatives 1983-1999", "HN": "2000; use KETOROLAC (NM) 1983-1999", "MR": "20160531", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020910"}, {"RECTYPE": "D", "MH": "Ketorolac Tromethamine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Toradol|T109|T121|TRD|NRW|NLM (2000)|991012|abbcdef", "MN": "D03.633.100.473.420.742", "PA": "Cyclooxygenase Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro, (+/-)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol(1:1)", "RN": "4EVE5946BQ", "RR": "74103-07-4 (Ketorolac Tromethamine)", "AN": "KETOROLAC is also available", "PI": "Tromethamine (1986-1999)", "MS": "A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity.", "PM": "2000; KETOROLAC TROMETHAMINE was indexed under TOLMETIN/analogs & derivatives & TROMETHAMINE 1986-1999", "HN": "2000; use KETOROLAC TROMETHAMINE (NM) 1986-1999", "MR": "20180410", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020911"}, {"RECTYPE": "D", "MH": "Moclobemide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "von ct, Moclobemid", "MN": "D02.455.426.559.389.127.250.875", "PA": "Monoamine Oxidase Inhibitors", "MH_TH": "USAN (1987)", "ST": "T121", "N1": "Benzamide, 4-Chloro-N-(2-(4-morpholinyl)ethyl)-", "RN": "PJ0Y7AZB63", "RR": "71320-77-9 (Moclobemide)", "PI": "Benzamides (1982-1999)", "MS": "A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.", "PM": "2000; MOCLOBEMIDE was indexed under BENZAMIDES 1982-1999", "HN": "2000; use MOCLOBEMIDE (NM) 1982-1999", "MR": "20160701", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020912"}, {"RECTYPE": "D", "MH": "Perindopril", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "S9490", "MN": "D03.633.100.473.766", "PA": "Antihypertensive Agents", "MH_TH": "USAN (1988)", "ST": "T121", "N1": "1H-Indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-", "RN": "Y5GMK36KGY", "RR": "99149-83-4 (cpd with unspecified MF)", "PI": "Indoles (1985-1999)", "MS": "An angiotensin-converting enzyme inhibitor. It is used in patients with hypertension and heart failure.", "PM": "2000; see INDOLES 1985-1999", "HN": "2000; use PERINDOPRIL (NM) 1985-1999", "MR": "20160531", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020913"}, {"RECTYPE": "D", "MH": "Myopathies, Structural, Congenital", "DE": "MYOPATHIES STRUCTURAL CONGEN", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tubular Aggregate Myopathy|T047|NON|NRW|NLM (2000)|OMIM (2013)|ORD (2010)|991012|abcdeeef", "ENTRY": "X-Linked Myotubular Myopathies", "MN": "C10.668.491.550", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Neuromuscular Diseases (1976-1999)", "MS": "A heterogeneous group of diseases characterized by the early onset of hypotonia, developmental delay of motor skills, non-progressive weakness. Each of these disorders is associated with a specific histologic muscle fiber abnormality.", "PM": "2000", "HN": "2000", "MR": "20190705", "DA": "19991109", "DC": "1", "DX": "20000101", "UI": "D020914"}, {"RECTYPE": "D", "MH": "Korsakoff Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Wernicke-Korsakoff Syndrome|T048|NON|EQV|NLM (2000)|OMIM (2013)|ORD (2010)|991012|abcdeeef", "ENTRY": "Wernicke-Korsakoff Syndromes", "MN": "F01.700.625.400", "MH_TH": "UNK (19XX)", "ST": "T048", "MS": "An acquired cognitive disorder characterized by inattentiveness and the inability to form short term memories. This disorder is frequently associated with chronic ALCOHOLISM; but it may also result from dietary deficiencies; CRANIOCEREBRAL TRAUMA; NEOPLASMS; CEREBROVASCULAR DISORDERS; ENCEPHALITIS; EPILEPSY; and other conditions. (Adams et al., Principles of Neurology, 6th ed, p1139)", "PM": "2000; see ALCOHOL AMNESTIC DISORDER 1963-1999; for KORSAKOFF PSYCHOSIS see ALCOHOL AMNESTIC DISORDER 1980-1999", "HN": "2000; use ALCOHOL AMNESTIC DISORDER 1963-1999; for KORSAKOFF PSYCHOSIS use ALCOHOL AMNESTIC DISORDER 1980-1999", "MR": "20170620", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020915"}, {"RECTYPE": "D", "MH": "Conotoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE TO TU UR", "PRINT ENTRY": "mu-Conotoxins|T116|T123|T131|NON|NRW|NLM (2000)|991012|abbbcdef", "ENTRY": "mu Conotoxins", "MN": "D23.946.833.590.162", "PA": "Neurotoxins", "MH_TH": "NLM (2000)", "ST": "T131", "RN": "0", "AN": "OMEGA-CONOTOXINS and OMEGA-CONOTOXIN GVIA are available", "PI": "Mollusk Venoms (1986-1999)", "MS": "Peptide neurotoxins from the marine fish-hunting snails of the genus CONUS. They contain 13 to 29 amino acids which are strongly basic and are highly cross-linked by disulfide bonds. There are three types of conotoxins, omega-, alpha-, and mu-. OMEGA-CONOTOXINS inhibit voltage-activated entry of calcium into the presynaptic membrane and therefore the release of ACETYLCHOLINE. Alpha-conotoxins inhibit the postsynaptic acetylcholine receptor. Mu-conotoxins prevent the generation of muscle action potentials. (From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed)", "PM": "2000", "HN": "2000", "MR": "20050630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020916"}, {"RECTYPE": "D", "MH": "Receptor, trkA", "DE": "RECEPT TRKA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "trkA Receptor|T116|T126|T192|NON|EQV|NLM (2000)|991012|TRKA RECEPT|abbbcdefv", "ENTRY": "trk, Proto-Oncogene Protein", "MN": "D12.776.543.750.750.400.550.550", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptors, Nerve Growth Factor (1994-1999)", "MS": "A protein-tyrosine kinase receptor that is specific for NERVE GROWTH FACTOR; NEUROTROPHIN 3; neurotrophin 4, neurotrophin 5. It plays a crucial role in pain sensation and thermoregulation in humans. Gene mutations that cause loss of receptor function are associated with CONGENITAL INSENSITIVITY TO PAIN WITH ANHIDROSIS, while gene rearrangements that activate the protein-tyrosine kinase function are associated with tumorigenesis.", "PM": "2000; PROTO-ONCOGENE PROTEIN TRK (now RECEPTOR, TYPE 1 NEUROTROPHIC TYROSINE KINASE) was indexed under PROTO-ONCOGENE PROTEINS 1990-1999, RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999 & RECEPTORS, NERVE GROWTH FACTOR 1994-1999", "HN": "2000; use RECEPTOR, TYPE 1 NEUROTROPHIC TYROSINE KINASE(NM) 1990-1999", "MR": "20210521", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020917"}, {"RECTYPE": "D", "MH": "Complex Regional Pain Syndromes", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pain Syndromes, Regional Complex|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "CRPS (Complex Regional Pain Syndromes)|T047|NON|EQV|NLM (2000)|991012|abcdef", "MN": "C10.668.829.250", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Reflex Sympathetic Dystrophy (1995-1999)", "MS": "Conditions characterized by pain involving an extremity or other body region, HYPERESTHESIA, and localized autonomic dysfunction following injury to soft tissue or nerve. The pain is usually associated with ERYTHEMA; SKIN TEMPERATURE changes, abnormal sudomotor activity (i.e., changes in sweating due to altered sympathetic innervation) or edema. The degree of pain and other manifestations is out of proportion to that expected from the inciting event. Two subtypes of this condition have been described: type I; (REFLEX SYMPATHETIC DYSTROPHY) and type II; (CAUSALGIA). (From Pain 1995 Oct;63(1):127-33)", "PM": "2000", "HN": "2000", "MR": "20230316", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020918"}, {"RECTYPE": "D", "MH": "Sleep Disorders, Intrinsic", "DE": "SLEEP DIS INTRINSIC", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intrinsic Sleep Disorders|T047|NON|EQV|NLM (2000)|991012|INTRINSIC SLEEP DIS|abcdefv", "ENTRY": "Sleep State Misperceptions", "MN": "F03.870.400.800", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "Dyssomnias (i.e., insomnias or hypersomnias) associated with dysfunction of internal sleep mechanisms or secondary to a sleep-related medical disorder (e.g., sleep apnea, post-traumatic sleep disorders, etc.). (From Thorpy, Sleep Disorders Medicine, 1994, p187)", "PM": "2000", "HN": "2000", "MR": "20120703", "DA": "19991109", "DC": "1", "DX": "20000101", "UI": "D020919"}, {"RECTYPE": "D", "MH": "Dyssomnias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sleep Disorders, Extrinsic|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Syndromes, Nocturnal Eating-Drinking", "MN": "F03.870.400", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Circadian Rhythm (1966-1999)", "MS": "A broad category of sleep disorders characterized by either hypersomnolence or insomnia. The three major subcategories include intrinsic (i.e., arising from within the body) (SLEEP DISORDERS, INTRINSIC), extrinsic (secondary to environmental conditions or various pathologic conditions), and disturbances of circadian rhythm. (From Thorpy, Sleep Disorders Medicine, 1994, p187)", "PM": "2000", "HN": "2000", "MR": "20160303", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020920"}, {"RECTYPE": "D", "MH": "Sleep Arousal Disorders", "DE": "SLEEP AROUSAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Confusional Arousals|T048|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Sleep Arousal Disorder", "MN": "F03.870.664.635", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Sleep Disorders (1968-1999)", "MS": "Sleep disorders characterized by impaired arousal from the deeper stages of sleep (generally stage III or IV sleep).", "PM": "2000", "HN": "2000", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020921"}, {"RECTYPE": "D", "MH": "Sleep-Wake Transition Disorders", "DE": "SLEEP WAKE TRANSITION DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Somnolescent Starts|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Transitional Disorders, Sleep Wake", "MN": "F03.870.664.700", "MH_TH": "NLM (2000)", "ST": "T048", "PI": "Sleep Initiation and Maintenance Disorders (1986-1999)", "MS": "Parasomnias characterized by behavioral abnormalities that occur during the transition between wakefulness and sleep (or between sleep and wakefulness).", "PM": "2000", "HN": "2000", "MR": "20030722", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020922"}, {"RECTYPE": "D", "MH": "REM Sleep Parasomnias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sleep-Related Painful Erections|T047|NON|NRW|NLM (2000)|991012|SLEEP RELAT PAINFUL ERECTIONS|abcdefv", "ENTRY": "Sleep-Related Painful Erection", "MN": "F03.870.664.633", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "do not confuse with REM SLEEP BEHAVIOR DISORDER", "PI": "Sleep, REM (1986-1999)", "MS": "Abnormal behavioral or physiologic events that are associated with REM sleep, including REM SLEEP BEHAVIOR DISORDER.", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020923"}, {"RECTYPE": "D", "MH": "Urological Manifestations", "ENTRY": "Urological Manifestation", "MN": "C23.888.942", "FX": "Urination Disorders", "MH_TH": "NLM (2000)", "ST": "T184", "AN": "not used in indexing", "MS": "Clinical disturbances of the urinary system.", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020924"}, {"RECTYPE": "D", "MH": "Hypoxia-Ischemia, Brain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ischemic-Hypoxic Encephalopathy|T047|NON|NRW|NLM (2000)|991012|ISCHEMIC HYPOXIC ENCEPH|abcdefv", "ENTRY": "Ischemic-Hypoxic Encephalopathies", "MN": "C23.888.852.079.797.500", "FX": "Hypoxia", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Cerebrovascular Disorders (1971-1999)", "MS": "A disorder characterized by a reduction of oxygen in the blood combined with reduced blood flow (ISCHEMIA) to the brain from a localized obstruction of a cerebral artery or from systemic hypoperfusion. Prolonged hypoxia-ischemia is associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; BRAIN EDEMA; COMA; and other conditions.", "PM": "2000", "HN": "2000", "MR": "20200527", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020925"}, {"RECTYPE": "D", "MH": "Medetomidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "MPV785", "MN": "D03.383.129.308.521", "PA": "Hypnotics and Sedatives", "MH_TH": "NLM (2000)", "ST": "T121", "N1": "IH-Imidazole, 4(1-(2,3-dimethylphenyl)ethyl)-", "RN": "MR15E85MQM", "RR": "BH210P244U", "PI": "Imidazoles (1986-1999)", "MS": "An agonist of RECEPTORS, ADRENERGIC ALPHA-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of DEXMEDETOMIDINE.", "PM": "2000; MEDETOMIDINE was indexed under IMIDAZOLES 1986-1999", "HN": "2000; use MEDETOMIDINE (NM) 1986-1999", "MR": "20160531", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020926"}, {"RECTYPE": "D", "MH": "Dexmedetomidine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sileo|T109|TRD|NRW|NLM (2024)|221025|abcdef", "ENTRY": "MPV1440", "MN": "D03.383.129.308.245", "PA": "Hypnotics and Sedatives", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "1H-Imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)-, (R)-", "RN": "67VB76HONO", "RR": "113775-47-6 (Dexmedetomidine)", "PI": "Imidazoles (1990-1999)", "MS": "An imidazole derivative that is an agonist of ADRENERGIC ALPHA-2 RECEPTORS. It is closely related to MEDETOMIDINE, which is the racemic form of this compound.", "PM": "2000; MEDETOMIDINE (now DEXMEDETOMIDINE) was indexed under IMIDAZOLES 1990-1999", "HN": "2000; use DEXMEDETOMIDINE (NM) 1990-1999", "MR": "20230531", "DA": "19991109", "DC": "1", "DX": "20000101", "UI": "D020927"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mitogen-Activated Protein Kinase|T116|T126|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Protein Kinases, Mitogen-Activated", "MN": "D12.776.476.563.567", "FX": "MAP Kinase Signaling System", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 2.7.11.24", "PI": "Protein-Tyrosine Kinase (1989-1999)", "MS": "A superfamily of PROTEIN SERINE-THREONINE KINASES that are activated by diverse stimuli via protein kinase cascades. They are the final components of the cascades, activated by phosphorylation by MITOGEN-ACTIVATED PROTEIN KINASE KINASES, which in turn are activated by mitogen-activated protein kinase kinase kinases (MAP KINASE KINASE KINASES).", "PM": "2000; for EXTRACELLULAR SIGNAL-REGULATED KINASES see CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE 1994-1999", "HN": "2000; for EXTRACELLULAR SIGNAL-REGULATED KINASES use CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE 1994-1999", "MR": "20210712", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020928"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mitogen-Activated Protein Kinase Kinase|T116|T126|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Mitogen Activated Protein Kinase Kinases", "MN": "D12.776.476.568.200", "FX": "MAP Kinase Signaling System", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 2.7.12.2", "RR": "EC 2.7.12.2", "PI": "Protein-Tyrosine Kinase (1989-1999)", "MS": "A dual-specific protein kinase family whose members are components in protein kinase cascades activated by diverse stimuli. These MAPK kinases phosphorylate MITOGEN-ACTIVATED PROTEIN KINASES and are themselves phosphorylated by MAP KINASE KINASE KINASES. JNK kinases (also known as SAPK kinases) are a subfamily.", "PM": "2000; MAP KINASE KINASE and MAPKK (now MITOGEN-ACTIVATED KINASE KINASES) were indexed under PROTEIN KINASES 1992-1999; MAP-ERK KINASE (now MITOGEN-ACTIVATED KINASE KINASES) was indexed under PROTEIN-TYROSINE KINASE 1992-1999", "HN": "2000; for MAP-ERK KINASE use MEK1 PROTEIN (NM) 1992-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020929"}, {"RECTYPE": "D", "MH": "MAP Kinase Kinase Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mitogen-Activated Protein Kinase Kinase Kinase|T116|T126|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Mitogen Activated Protein Kinase Kinase Kinases", "MN": "D12.776.476.563.554", "FX": "MAP Kinase Signaling System", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 2.7.11.25", "RR": "EC 2.7.11.25", "PI": "Protein-Tyrosine Kinase (1989-1999)", "MS": "Mitogen-activated protein kinase kinase kinases (MAPKKKs) are serine-threonine protein kinases that initiate protein kinase signaling cascades. They phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES; (MAPKKs) which in turn phosphorylate MITOGEN-ACTIVATED PROTEIN KINASES; (MAPKs).", "PM": "2000; MAP KINASE KINASE KINASE (now MAP KINASE KINASE KINASES) was indexed under PROTEIN-SERINE-THREONINE KINASES 1992-1999", "HN": "2000; use MAP KINASE KINASE KINASE 1992-1999", "MR": "20210422", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020930"}, {"RECTYPE": "D", "MH": "ran GTP-Binding Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ran Protein|T116|T123|ABX|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "ras Related Nuclear Protein", "MN": "D12.776.660.768", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "EC 3.6.5.2", "PI": "Nuclear Proteins (1991-1999)", "MS": "A monomeric GTP-binding protein involved in nucleocytoplasmic transport of proteins into the nucleus and RNA into the cytoplasm. This enzyme was formerly listed as EC 3.6.1.47.", "PM": "2000; RAN PROTEIN (now RAN GTP-BINDING PROTEIN) was indexed under NUCLEAR PROTEINS 1991-1999", "HN": "2000; use RAN GTP-BINDING PROTEIN (NM) 1991-1999", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020931"}, {"RECTYPE": "D", "MH": "Nerve Growth Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nerve Growth Factor gamma Subunit|T116|T123|NON|NRW|NLM (2000)|991012|abbcdef", "ENTRY": "beta Nerve Growth Factor", "MN": "D23.529.850.437", "MH_TH": "UNK (19XX)", "ST": "T123", "RN": "9061-61-4", "AN": "NERVE GROWTH FACTORS is also available", "PI": "Nerve Growth Factors (1980-1999)", "MS": "NERVE GROWTH FACTOR is the first of a series of neurotrophic factors that were found to influence the growth and differentiation of sympathetic and sensory neurons. It is comprised of alpha, beta, and gamma subunits. The beta subunit is responsible for its growth stimulating activity.", "PM": "2000; see NERVE GROWTH FACTORS 1980-1999, see NERVE GROWTH FACTOR 1966-1979", "HN": "2000; use NERVE GROWTH FACTORS 1966-1999", "MR": "20151124", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020932"}, {"RECTYPE": "D", "MH": "Neurotrophin 3", "DS": "NEUROTROPHIN 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nerve Growth Factor 2|T116|T123|NON|EQV|NLM (1992)|910115|NERVE GROWTH FACTOR A 002|abbcdefs", "MN": "D23.529.850.775", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Nerve Growth Factors (1990-1999)", "MS": "A neurotrophic factor involved in regulating the survival of visceral and proprioceptive sensory neurons. It is closely homologous to nerve growth factor beta and BRAIN-DERIVED NEUROTROPHIC FACTOR.", "PM": "2000; NEUROTROPHIN 3 was indexed under NERVE GROWTH FACTORS 1990-1999; for NERVE GROWTH FACTOR 2 see NERVE GROWTH FACTORS 1992-1999", "HN": "2000; use NEUROTROPHIN 3 (NM) 1990-1999; for NERVE GROWTH FACTOR 2 use NERVE GROWTH FACTORS 1992-1999", "MR": "20151124", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020933"}, {"RECTYPE": "D", "MH": "Ciliary Neurotrophic Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CNTF|T116|T123|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Neurotrophic Factor, Ciliary", "MN": "D23.529.850.212", "FX": "Receptor, Ciliary Neurotrophic Factor", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1980-1999)", "MS": "A neurotrophic factor that promotes the survival of various neuronal cell types and may play an important role in the injury response in the nervous system.", "PM": "2000; CILIARY NEUROTROPHIC FACTOR was indexed under NERVE TISSUE PROTEINS 1980-1999", "HN": "2000; use CILIARY NEUROTROPHIC FACTOR (NM) 1980-1999", "MR": "20151123", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020934"}, {"RECTYPE": "D", "MH": "MAP Kinase Signaling System", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "MAP Kinase Signaling Pathways|T043|T044|NON|REL|NLM (2000)|991012|abbcdef", "ENTRY": "p38 Kinase Pathways", "MN": "G04.835.560", "FX": "Mitogen-Activated Protein Kinases", "MH_TH": "NLM (2000)", "ST": "T044", "PI": "Protein-Tyrosine Kinase (1989-1999)", "MS": "An intracellular signaling system involving the mitogen-activated protein kinase cascades (three-membered protein kinase cascades). Various upstream activators, which act in response to extracellular stimuli, trigger the cascades by activating the first member of a cascade, MAP KINASE KINASE KINASES; (MAPKKKs). Activated MAPKKKs phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES which in turn phosphorylate the MITOGEN-ACTIVATED PROTEIN KINASES; (MAPKs). The MAPKs then act on various downstream targets to affect gene expression. In mammals, there are several distinct MAP kinase pathways including the ERK (extracellular signal-regulated kinase) pathway, the SAPK/JNK (stress-activated protein kinase/c-jun kinase) pathway, and the p38 kinase pathway. There is some sharing of components among the pathways depending on which stimulus originates activation of the cascade.", "PM": "2000", "HN": "2000", "MR": "20220614", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020935"}, {"RECTYPE": "D", "MH": "Epilepsy, Benign Neonatal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neonatal Convulsions, Benign|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Seizures, Benign Familial Neonatal Infantile", "MN": "C16.614.258", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Epilepsy (1968-1999)", "MS": "A condition marked by recurrent seizures that occur during the first 4-6 weeks of life despite an otherwise benign neonatal course. Autosomal dominant familial and sporadic forms have been identified. Seizures generally consist of brief episodes of tonic posturing and other movements, apnea, eye deviations, and blood pressure fluctuations. These tend to remit after the 6th week of life. The risk of developing epilepsy at an older age is moderately increased in the familial form of this disorder. (Neurologia 1996 Feb;11(2):51-5)", "PM": "2000", "HN": "2000", "MR": "20181010", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020936"}, {"RECTYPE": "D", "MH": "Epilepsy, Partial, Sensory", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sensory Epilepsy|T047|NON|REL|NLM (2000)|991012|abcdef", "ENTRY": "Visual Partial Seizures", "MN": "C10.228.140.490.360.275", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Epilepsy (1966-1976)", "MS": "A disorder characterized by recurrent focal onset seizures which have sensory (i.e., olfactory, visual, tactile, gustatory, or auditory) manifestations. Partial seizures that feature alterations of consciousness are referred to as complex partial seizures (EPILEPSY, COMPLEX PARTIAL).", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020937"}, {"RECTYPE": "D", "MH": "Epilepsy, Partial, Motor", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Seizure Disorder, Partial, Motor|T047|NON|EQV|NLM (2000)|991012|SEIZURE DIS PARTIAL MOTOR|abcdefv", "ENTRY": "Versive Seizure", "MN": "C10.228.140.490.360.272", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Epilepsies, Partial (1977-1999)", "MS": "A disorder characterized by recurrent localized paroxysmal discharges of cerebral neurons that give rise to seizures that have motor manifestations. The majority of partial motor seizures originate in the FRONTAL LOBE (see also EPILEPSY, FRONTAL LOBE). Motor seizures may manifest as tonic or clonic movements involving the face, one limb or one side of the body. A variety of more complex patterns of movement, including abnormal posturing of extremities, may also occur.", "PM": "2000", "HN": "2000", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020938"}, {"RECTYPE": "D", "MH": "Zingiber officinale", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ginger|T002|NON|EQV|NLM (1993)|970206|abcdef", "ENTRY": "Gingers", "MN": "B01.875.800.575.912.250.618.937.900.444", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid94328", "PI": "Zingiberales (1998-1999)", "MS": "Deciduous plant rich in volatile oil (OILS, VOLATILE). It is used as a flavoring agent and has many other uses both internally and topically.", "PM": "2000; use ZINGIBERALES 1998-1999, use SPICES 1993-1997; use GINGER 2000-2023", "HN": "2000; use ZINGIBERALES 1998-1999, use SPICES 1993-1997; use GINGER 2000-2023", "MR": "20230526", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020939"}, {"RECTYPE": "D", "MH": "Reishi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Ganoderma lucidum|T004|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Lingzhi|T004|NON|EQV|NLM (2016)|141204|abcdef", "MN": "B01.300.179.120.760.338.700", "FX": "Drugs, Chinese Herbal", "MH_TH": "NLM (2000)", "ST": "T004", "RN": "txid5315", "PI": "Basidiomycota (1979-1999)", "MS": "A mushroom, Ganoderma lucidum, of the POLYPORALES order of basidiomycetous fungi. It has long been used in traditional Chinese medicine in various forms.", "PM": "2000; LINGZHI was indexed under DRUGS, CHINESE HERBAL 1981-2015", "HN": "2000", "MR": "20200527", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020940"}, {"RECTYPE": "D", "MH": "Myasthenia Gravis, Neonatal", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neonatal Myasthenia Gravis|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Myasthenia Gravis, Antenatal", "MN": "C20.111.258.500.650", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Myasthenia Gravis (1965-1999)", "MS": "A disorder of neuromuscular transmission that occurs in a minority of newborns born to women with myasthenia gravis. Clinical features are usually present at birth or develop in the first 3 days of life and consist of hypotonia and impaired respiratory, suck, and swallowing abilities. This condition is associated with the passive transfer of acetylcholine receptor antibodies through the placenta. In the majority of infants the myasthenic weakness resolves (i.e., transient neonatal myasthenia gravis) although this disorder may rarely continue beyond the neonatal period (i.e., persistent neonatal myasthenia gravis). (From Menkes, Textbook of Child Neurology, 5th ed, p823; Neurology 1997 Jan;48(1):50-4)", "PM": "2000", "HN": "2000", "MR": "20190222", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020941"}, {"RECTYPE": "D", "MH": "Shiitake Mushrooms", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE TU UL VI", "PRINT ENTRY": "Lentinus edodes|T002|NON|EQV|NLM (1999)|980409|abcdef", "ENTRY": "Shiitake Mushroom", "MN": "B01.300.179.100.515.810", "MH_TH": "NLM (1999)", "ST": "T002", "RN": "txid5353", "PI": "Lentinus (1999)", "MS": "Mushrooms in the order AGARICALES containing B vitamins, cortinelin, and the polysaccharide LENTINAN.", "PM": "2000; see LENTINUS 1999", "HN": "2000; use LENTINUS 1999", "MR": "20200527", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020942"}, {"RECTYPE": "D", "MH": "AIDS Arteritis, Central Nervous System", "DE": "AIDS ARTERITIS CNS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "HIV-Associated Vasculitis of the Central Nervous System|T047|ACX|REL|NLM (2000)|991012|HIV ASSOC VASCULITIS CNS|abcdefv", "ENTRY": "Vasculitis, HIV-Associated CNS", "MN": "C20.673.480.048", "FX": "Acquired Immunodeficiency Syndrome", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Vasculitis (1987-1999)", "MS": "Inflammation of ARTERIES in the CENTRAL NERVOUS SYSTEM that occurs in patients with ACQUIRED IMMUNODEFICIENCY SYNDROME or AIDS-RELATED OPPORTUNISTIC INFECTIONS.", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020943"}, {"RECTYPE": "D", "MH": "Silybum marianum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Milk Thistle|T002|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Thistles, Milk", "MN": "B01.875.800.575.912.250.100.525", "FX": "Silymarin", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid92921", "PI": "Plants, Medicinal (1968-1999)", "PM": "2000; use MILK THISTLE 2000-2023", "HN": "2000; use MILK THISTLE 2000-2023", "MR": "20230526", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020944"}, {"RECTYPE": "D", "MH": "Lupus Vasculitis, Central Nervous System", "DE": "LUPUS VASCULITIS CNS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuropsychiatric Systemic Lupus Erythematosus|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Meningoencephalitis, Lupus", "MN": "C20.111.590.750", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Lupus Erythematosus, Systemic (1965-1999)", "MS": "Central nervous system vasculitis that is associated with SYSTEMIC LUPUS ERYTHEMATOSUS. Clinical manifestations may include DEMENTIA; SEIZURES; CRANIAL NERVE DISEASES; HEMIPARESIS; BLINDNESS; DYSPHASIA; and other neurological disorders.", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020945"}, {"RECTYPE": "D", "MH": "Taxus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Taxus brevifolia|T002|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "brevifolia, Taxus", "MN": "B01.875.800.575.912.625.937.500", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid25628", "RR": "txid46220", "PI": "Trees (1965-1999)", "MS": "Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL).", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020946"}, {"RECTYPE": "D", "MH": "Tea Tree Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Melaleuca alternifolia Oil|T109|T121|T123|NON|EQV|NLM (2000)|991012|abbbcdef", "ENTRY": "Oil, Tea Tree", "MN": "D20.215.784.750.940", "PA": "Anti-Infective Agents, Local", "MH_TH": "NLM (2000)", "ST": "T123", "N1": "Oils, tea-tree", "RN": "68647-73-4", "RR": "VIF565UC2G", "PI": "Plant Oils (1990-1999)", "MS": "Essential oil extracted from MELALEUCA ALTERNIFOLIA (tea tree). It is used as a topical antimicrobial due to the presence of terpineol.", "PM": "2000; TEA TREE OIL was indexed under OILS, VOLATILE & PLANT OILS 1993-1999", "HN": "2000; use TEA TREE OIL (NM) 1993-1999", "MR": "20210326", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020947"}, {"RECTYPE": "D", "MH": "Cat's Claw", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Uncaria tomentosa|T002|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "tomentosas, Uncaria", "MN": "B01.875.800.575.912.250.456.937.909.500", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid128375", "PI": "Plants, Medicinal (1985-1999)", "MS": "A vine (Uncaria tomentosa) indigenous to the Amazon rainforest whose name is derived from its hook-like thorns. It contains oxindole alkaloids and glycosides and has many medicinal uses.", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020948"}, {"RECTYPE": "D", "MH": "Usnea", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Usnea barbata|T004|NON|NRW|NLM (2000)|991012|abcdef", "MN": "B01.300.340.458.500", "MH_TH": "NLM (2000)", "ST": "T004", "RN": "txid86620", "RR": "txid192174", "PI": "Lichens (1967-1999)", "MS": "A genus of lichen-forming fungi containing usnic acid and mucilage. Usnea barbata is used in HERBAL MEDICINE.", "PM": "2000", "HN": "2000", "MR": "20200527", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020949"}, {"RECTYPE": "D", "MH": "Vitex", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Vitex agnus-castus|T002|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Vitex agnus castus", "MN": "B01.875.800.575.912.250.583.520.987", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid54476", "RR": "txid54477", "PI": "Plants, Medicinal (1970-1999)", "MS": "A genus of trees in the Lamiaceae family containing assorted flavonoids with possible analgesic and antineoplastic properties. The fruit of these trees is used in herbal preparations.", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020950"}, {"RECTYPE": "D", "MH": "Neuroaspergillosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Neuroaspergilloses", "MN": "C10.228.228.198.750", "FX": "Cranial Nerve Diseases", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "coord IM with species (IM) and specific site/dis term (IM) if pertinent", "PI": "Aspergillosis (1966-1999)", "MS": "Infections of the nervous system caused by fungi of the genus ASPERGILLUS, most commonly ASPERGILLUS FUMIGATUS. Aspergillus infections may occur in immunocompetent hosts, but are more prevalent in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES. The organism may spread to the nervous system from focal infections in the lung, mastoid region, sinuses, inner ear, bones, eyes, gastrointestinal tract, and heart. Sinus infections may be locally invasive and enter the intracranial compartment, producing MENINGITIS, FUNGAL; cranial neuropathies; and abscesses in the frontal lobes of the brain. (From Joynt, Clinical Neurology, 1998, Ch 27, pp62-3)", "PM": "2000", "HN": "2000", "MR": "20190617", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020953"}, {"RECTYPE": "D", "MH": "Single-Parent Family", "AQ": "EH PX SN", "PRINT ENTRY": "One-Parent Family|T099|NON|EQV|UNK (19XX)|861231|abcdef", "ENTRY": "Single-Parent Families", "MN": "N06.850.505.400.400.580.875", "FX": "Single Parent", "MH_TH": "UNK (19XX)", "ST": "T099", "PI": "Single Parent (1989-1999)", "MS": "A household that includes children and is headed by one adult parent.", "PM": "2000; see SINGLE PARENT 1989-1999", "HN": "2000; use SINGLE PARENT 1989-1999", "MR": "20220413", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020954"}, {"RECTYPE": "D", "MH": "Striatonigral Degeneration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Striatonigral Degenerations", "MN": "C10.228.662.550.800", "FX": "Parkinsonian Disorders", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Substantia Nigra (1970-1999)", "MS": "A sporadic neurodegenerative disease with onset in middle-age characterized clinically by Parkinsonian features (e.g., MUSCLE RIGIDITY; HYPOKINESIA; stooped posture) and HYPOTENSION. This condition is considered a clinical variant of MULTIPLE SYSTEM ATROPHY. Pathologic features include a prominent loss of neurons in the zona compacta of the SUBSTANTIA NIGRA and PUTAMEN. (From Adams et al., Principles of Neurology, 6th ed, p1075-6)", "PM": "2000; see MULTIPLE SYSTEM ATROPHY 1998-1999", "HN": "2000; use MULTIPLE SYSTEM ATROPHY 1998-1999", "MR": "20190517", "DA": "19991104", "DC": "1", "DX": "20000101", "UI": "D020955"}, {"RECTYPE": "D", "MH": "Nunavut", "AQ": "EH EP", "MN": "Z01.107.567.176.614", "MH_TH": "NLM (2000)", "ST": "T083", "MS": "A self-governing territory formed from the central and eastern portions of the Northwest Territories. It was officially established April 1, 1999. The capital is Iqaluit.", "HN": "2000", "MR": "20030722", "DA": "19991103", "DC": "4", "DX": "20000101", "UI": "D020957"}, {"RECTYPE": "D", "MH": "Australian Capital Territory", "AQ": "EH EP", "MN": "Z01.678.100.373.500", "MH_TH": "NLM (2000)", "ST": "T083", "PI": "Australia (1990-1999)", "MS": "A territory of Australia consisting of Canberra, the national capital and surrounding land. It lies geographically within NEW SOUTH WALES and was established by law in 1988.", "HN": "2000", "MR": "20150623", "DA": "19991103", "DC": "4", "DX": "20000101", "UI": "D020958"}, {"RECTYPE": "D", "MH": "Polyethylene", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polythene|T109|T122|NON|EQV|NLM (2000)|991012|abbcdef", "ENTRY": "Polyethylene, Low-Density", "MN": "J01.637.051.720.716.507.500", "MH_TH": "POPLINE (1978)", "ST": "T122", "N1": "Ethene, homopolymer", "RN": "9002-88-4", "AN": "POLYETHYLENES is available", "PI": "Polypropylenes (1983-1999)", "MS": "A vinyl polymer made from ethylene. It can be branched or linear. Branched or low-density polyethylene is tough and pliable but not to the same degree as linear polyethylene. Linear or high-density polyethylene has a greater hardness and tensile strength. Polyethylene is used in a variety of products, including implants and prostheses.", "PM": "2000; POLYTHENE was indexed under POLYETHYLENES & POLYPROPYLENES 1983-1999 & POLYMERS 1978-1982", "HN": "2000; for POLYTHENE use PLASTIPORE (NM) 1978-1999", "MR": "20130709", "DA": "19991109", "DC": "1", "DX": "20000101", "UI": "D020959"}, {"RECTYPE": "D", "MH": "omega-Conotoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE TO TU UR", "ENTRY": "omega Conotoxins", "MN": "D23.946.833.590.162.720", "PA": "Neurotoxins", "MH_TH": "NLM (2000)", "ST": "T131", "RN": "0", "PI": "Peptides (1992-1999)", "MS": "A family of structurally related neurotoxic peptides from mollusk venom that inhibit voltage-activated entry of calcium into the presynaptic membrane. They selectively inhibit N-, P-, and Q-type calcium channels.", "PM": "2000", "HN": "2000", "MR": "20050630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020960"}, {"RECTYPE": "D", "MH": "Lewy Body Disease", "DE": "LEWY BODY DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Diffuse Lewy Body Disease|T047|EPO|EQV|NLM (1992)|OMIM (2013)|ORD (2010)|901101|DIFFUSE LEWY BODY DIS|abcdeeefv", "ENTRY": "Lewy Body Type Senile Dementia|T047|EPO|EQV|NLM (2000)|991012|abcdef", "MN": "F03.615.400.512", "FX": "Lewy Bodies", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "LEWY BODY PARKINSON DISEASE see PARKINSON DISEASE is also available", "PI": "Parkinson Disease, Secondary (1984-1999)", "MS": "A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)", "PM": "2000; see PARKINSON DISEASE 1992-1999; for DIFFUSE LEWY BODY DISEASE & LEWY BODY DISEASE, DIFFUSE see PARKINSON DISEASE 1992-1999", "HN": "2000; use PARKINSON DISEASE 1992-1999; for DIFFUSE LEWY BODY DISEASE & LEWY BODY DISEASE, DIFFUSE use PARKINSON DISEASE 1992-1999", "MR": "20190517", "DA": "19991108", "DC": "1", "DX": "20000101", "UI": "D020961"}, {"RECTYPE": "D", "MH": "Heterotrimeric GTP-Binding Proteins", "DE": "HET G PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heterotrimeric GTP-Binding Protein|T116|T126|NON|EQV|NLM (2022)|200928|abbcdef", "ENTRY": "Protein, Heterotrimeric GTP-Binding", "MN": "D12.776.543.325", "MH_TH": "NLM (2000)", "ST": "T126", "RN": "EC 3.6.5.1", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Cell Surface (1973-1984)", "MS": "GTP-BINDING PROTEINS that contain three non-identical subunits. They are found associated with members of the seven transmembrane domain superfamily of G-PROTEIN-COUPLED RECEPTORS. Upon activation the GTP-BINDING PROTEIN ALPHA SUBUNIT of the complex dissociates leaving a dimer of a GTP-BINDING PROTEIN BETA SUBUNIT bound to a GTP-BINDING PROTEIN GAMMA SUBUNIT.", "PM": "2000", "HN": "2000", "MR": "20210630", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020962"}, {"RECTYPE": "D", "MH": "GTP Phosphohydrolase-Linked Elongation Factors", "DE": "GTPASE LINKED EF", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Guanosinetriphosphatase-Linked Elongation Factors|T123|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "Guanosinetriphosphatase Linked Elongation Factors", "MN": "D12.776.835.700.350", "MH_TH": "NLM (2000)", "ST": "T123", "RN": "EC 3.6.1.-", "PI": "Phosphoric Monoester Hydrolases (1969-1974)", "MS": "Factors that utilize energy from the hydrolysis of GTP to GDP for peptide chain elongation. EC 3.6.1.-.", "PM": "2000; see GTP PHOSPHOHYDROLASE 1975-1999", "HN": "2000(1975)", "MR": "20210521", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020963"}, {"RECTYPE": "D", "MH": "Embryo Loss", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Embryo Resorption|T040|T046|NON|NRW|NLM (1975)|990101|abbcdef", "ENTRY": "Resorption, Embryo", "MN": "C23.550.260.440", "FX": "Fetal Death", "MH_TH": "NLM (2000)", "ST": "T046", "MS": "Early pregnancy loss during the EMBRYO, MAMMALIAN stage of development. In the human, this period comprises the second through eighth week after fertilization.", "PM": "2000; see EMBRYO RESORPTION 1991-1999", "HN": "2000(1991)", "MR": "20210630", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020964"}, {"RECTYPE": "D", "MH": "Muscular Disorders, Atrophic", "DE": "MUSCULAR DIS ATROPHIC", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Atrophy, Spinopontine|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Spinopontine Atrophies", "MN": "C10.668.491.175", "FX": "Muscular Atrophy", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Muscular Atrophy (1966-1999)", "MS": "Disorders characterized by an abnormal reduction in muscle volume due to a decrease in the size or number of muscle fibers. Atrophy may result from diseases intrinsic to muscle tissue (e.g., MUSCULAR DYSTROPHY) or secondary to PERIPHERAL NERVOUS SYSTEM DISEASES that impair innervation to muscle tissue (e.g., MUSCULAR ATROPHY, SPINAL).", "PM": "2000; for SPINAL AND BULBAR MUSCULAR ATROPHY, see BULBO-SPINAL ATROPHY, X-LINKED 2010-2012", "HN": "2000", "MR": "20180629", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020966"}, {"RECTYPE": "D", "MH": "Myotonic Disorders", "DE": "MYOTONIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paramyotonia Congenita|T047|NON|NRW|GHR (2014)|NLM (2000)|ORD (2010)|991012|PARAMYOTONIA CONGEN|abcdeeefv", "ENTRY": "Von Eulenberg Disease", "MN": "C10.668.491.606", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Myotonic Dystrophy (1965-1999)", "MS": "Diseases characterized by MYOTONIA, which may be inherited or acquired. Myotonia may be restricted to certain muscles (e.g., intrinsic hand muscles) or occur as a generalized condition.", "PM": "2000", "HN": "2000", "MR": "20150706", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020967"}, {"RECTYPE": "D", "MH": "Brachial Plexus Neuritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Shoulder-Girdle Neuropathy|T047|NON|EQV|UNK (19XX)|880414|abcdef", "ENTRY": "Syndrome, Parsonage-Turner", "MN": "C10.668.829.650.250", "FX": "Brachial Plexus Neuropathies", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Neuritis (1965-1999)", "MS": "A syndrome associated with inflammation of the BRACHIAL PLEXUS. Clinical features include severe pain in the shoulder region which may be accompanied by MUSCLE WEAKNESS and loss of sensation in the upper extremity. This condition may be associated with VIRUS DISEASES; IMMUNIZATION; SURGERY; heroin use (see HEROIN DEPENDENCE); and other conditions. The term brachial neuralgia generally refers to pain associated with brachial plexus injury. (From Adams et al., Principles of Neurology, 6th ed, pp1355-6)", "PM": "2000; for CERVICO-BRACHIAL NEURALGIA see CERVICO-BRACHIAL NEURALGIA 1965-1999; for BRACHIAL NEURALGIA; NEURALGIC AMYOTROPHY; PARSONAGE-TURNER SYNDROME; & SHOULDER-GIRDLE NEUROPATHY see CERVICO-BRACHIAL NEURALGIA 1988-1999; for BRACHIAL NEURALGIA see CERVICO-BRACHIAL NEURALGIA 1988-1999", "HN": "2000; for CERVICO-BRACHIAL NEURALGIA use BRACHIAL PLEXUS NEURITIS 1965-1999; for BRACHIAL NEURALGIA; NEURALGIC AMYOTROPHY; PARSONAGE-TURNER SYNDROME; & SHOULDER-GIRDLE NEUROPATHY use BRACHIAL PLEXUS NEURITIS 1989-1999; for BRACHIAL NEURALGIA use CERVICO-BRACHIAL NEURALGIA 1988-1999", "MR": "20130708", "DA": "19991105", "DC": "1", "DX": "20000101", "UI": "D020968"}, {"RECTYPE": "D", "MH": "Disease Attributes", "ENTRY": "Disease Attribute", "MN": "C23.550.291", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Clinical characteristics of disease or illness.", "PM": "2000", "HN": "2000", "MR": "20150605", "DA": "19991103", "DC": "1", "DX": "20000101", "UI": "D020969"}, {"RECTYPE": "D", "MH": "Placental Circulation", "DE": "PLACENTAL CIRC", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Uteroplacental Circulation|T042|NON|NRW|NLM (1995)|990101|UTEROPLACENTAL CIRC|abcdefv", "ENTRY": "Uteroplacental Blood Flows", "MN": "G09.330.100.749", "FX": "Maternal-Fetal Exchange", "MH_TH": "NLM (2001)", "ST": "T042", "PI": "Placenta/blood supply (1966-2000)", "MS": "The circulation of BLOOD, of both the mother and the FETUS, through the PLACENTA.", "PM": "2001; for UTEROPLACENTAL CIRCULATION see UTEROPLACENTAL CIRCULATION 1995-2000", "HN": "2001(1995)", "MR": "20200221", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021041"}, {"RECTYPE": "D", "MH": "Liquid Ventilation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Total Liquid Ventilation|T061|NON|NRW|NLM (2001)|991130|abcdef", "ENTRY": "Ventilation, Total Liquid", "MN": "E02.880.820.525", "FX": "Ventilators, Mechanical", "MH_TH": "NLM (2001)", "ST": "T061", "AN": "/instrum: consider also VENTILATORS, MECHANICAL", "PI": "Respiration, Artificial (1974-2000)", "MS": "Artificial respiration (RESPIRATION, ARTIFICIAL) using an oxygenated fluid.", "PM": "2001", "HN": "2001", "MR": "20100625", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D021061"}, {"RECTYPE": "D", "MH": "Chronobiology Disorders", "DE": "CHRONOBIOL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Circadian Rhythm Disorders|T047|NON|NRW|NLM (2000)|991012|CIRCADIAN RHYTHM DIS|abcdefv", "ENTRY": "Dysregulation, Circadian", "MN": "C10.281", "FX": "Smith-Magenis Syndrome", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "Disruptions of the rhythmic cycle of bodily functions or activities.", "PM": "2001; see SLEEP DISORDERS, CIRCADIAN RHYTHM 2000", "HN": "2001; use SLEEP DISORDERS, CIRCADIAN RHYTHM 2000", "MR": "20100625", "DA": "20000705", "DC": "1", "DX": "20010101", "UI": "D021081"}, {"RECTYPE": "D", "MH": "Radiation Hybrid Mapping", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Radiation Hybrids|T025|NON|REL|NLM (2001)|991201|abcdef", "ENTRY": "Radiation Hybrid Map", "MN": "E05.393.183.620.405", "MH_TH": "NLM (2001)", "ST": "T063", "PI": "Physical Chromosome Mapping (1999-2000)", "MS": "A method for ordering genetic loci along CHROMOSOMES. The method involves fusing irradiated donor cells with host cells from another species. Following cell fusion, fragments of DNA from the irradiated cells become integrated into the chromosomes of the host cells. Molecular probing of DNA obtained from the fused cells is used to determine if two or more genetic loci are located within the same fragment of donor cell DNA.", "PM": "2001", "HN": "2001", "MR": "20130709", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021101"}, {"RECTYPE": "D", "MH": "Branched DNA Signal Amplification Assay", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "bDNA Assays", "MN": "E05.601.300", "MH_TH": "NLM (2001)", "ST": "T063", "PI": "Molecular Probe Techniques (1991-2000)", "MS": "A molecular probe technique that utilizes branched DNA (bDNA) as a means to amplify the hybridization signal. One end of the bDNA molecule is designed to bind a specific target, while the other end of the bDNA molecule contains many branches of DNA that are designed to bind a probe used for signal detection.", "PM": "2001", "HN": "2001", "MR": "20150622", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D021121"}, {"RECTYPE": "D", "MH": "Protein Subunits", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Protomers|T116|NON|BRD|NLM (2003)|020125|abcdef", "ENTRY": "Subunits, Protein", "MN": "D12.776.813", "MH_TH": "NLM (2001)", "ST": "T116", "RN": "0", "PI": "Protein Conformation (1972-2000)", "MS": "Single chains of amino acids that are the units of multimeric PROTEINS. Multimeric proteins can be composed of identical or non-identical subunits. One or more monomeric subunits may compose a protomer which itself is a subunit structure of a larger assembly.", "PM": "2001", "HN": "2001", "MR": "20030725", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021122"}, {"RECTYPE": "D", "MH": "Nucleic Acid Amplification Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "RNA Amplification Techniques|T063|ACX|NRW|NLM (2001)|991202|abcdef", "ENTRY": "Techniques, RNA Amplification", "MN": "E05.393.620", "MH_TH": "NLM (2001)", "ST": "T063", "PI": "Gene Amplification (1980-2000)", "MS": "Laboratory techniques that involve the in-vitro synthesis of many copies of DNA or RNA from one original template.", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D021141"}, {"RECTYPE": "D", "MH": "Self-Sustained Sequence Replication", "DE": "SELF SUSTAINED SEQ REPLICATION", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Nucleic Acid Sequence-Based Amplification|T063|NON|EQV|NLM (2001)|991202|NUCLEIC ACID SEQ BASED AMPLIFICATION|abcdefv", "ENTRY": "Sequence Replications, Self-Sustained", "MN": "E05.393.620.700", "MH_TH": "NLM (2001)", "ST": "T063", "MS": "An isothermal in-vitro nucleotide amplification process. The process involves the concomitant action of a RNA-DIRECTED DNA POLYMERASE, a ribonuclease (RIBONUCLEASES), and DNA-DIRECTED RNA POLYMERASES to synthesize large quantities of sequence-specific RNA and DNA molecules.", "PM": "2001", "HN": "2001", "MR": "20060705", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D021161"}, {"RECTYPE": "D", "MH": "Egg Hypersensitivity", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypersensitivity, Egg|T047|NON|EQV|NLM (2002)|991202|abcdef", "ENTRY": "Hypersensitivities, Egg", "MN": "C20.543.480.370.150", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "coord IM with specific egg component /adv eff (IM) if pertinent", "PI": "Food Hypersensitivity (1965-2001)", "MS": "Allergic reaction to eggs that is triggered by the immune system.", "PM": "2002", "HN": "2002", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D021181"}, {"RECTYPE": "D", "MH": "Wheat Hypersensitivity", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypersensitivity, Wheat|T047|NON|EQV|NLM (2002)|991202|abcdef", "ENTRY": "Wheat Hypersensitivities", "MN": "C20.543.480.370.850", "FX": "Celiac Disease", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "differentiate from CELIAC DISEASE", "PI": "Wheat (1967-2001)", "MS": "Allergic reaction to wheat that is triggered by the immune system.", "PM": "2002", "HN": "2002", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D021182"}, {"RECTYPE": "D", "MH": "Peanut Hypersensitivity", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Peanut Allergy|T047|NON|EQV|NLM (2002)|991202|abcdef", "ENTRY": "Peanut Allergies", "MN": "C20.543.480.370.572.750", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "NUT HYPERSENSITIVITY is also available", "PI": "Food Hypersensitivity (1966-2001)", "MS": "Allergic reaction to peanuts that is triggered by the immune system.", "PM": "2002", "HN": "2002", "MR": "20170620", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D021183"}, {"RECTYPE": "D", "MH": "Nut Hypersensitivity", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tree Nut Hypersensitivity|T047|NON|EQV|NLM (2001)|991202|abcdef", "ENTRY": "Tree Nut Hypersensitivities", "MN": "C20.543.480.370.572.500", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "PEANUT HYPERSENSITIVITY is also available", "PI": "Nuts (1968-2001)", "MS": "Allergic reaction to tree nuts that is triggered by the immune system.", "PM": "2002", "HN": "2002", "MR": "20170620", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D021184"}, {"RECTYPE": "D", "MH": "Spectrometry, Mass, Electrospray Ionization", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Electrospray Ionization Mass Spectrometry|T059|NON|EQV|NLM (2001)|991206|abcdef", "ENTRY": "Spectrometry, ESI Mass", "MN": "E05.196.566.600", "MH_TH": "NLM (2001)", "ST": "T059", "PI": "Spectrum Analysis, Mass (1985-2000)", "MS": "A mass spectrometry technique used for analysis of nonvolatile compounds such as proteins and macromolecules. The technique involves preparing electrically charged droplets from analyte molecules dissolved in solvent. The electrically charged droplets enter a vacuum chamber where the solvent is evaporated. Evaporation of solvent reduces the droplet size, thereby increasing the coulombic repulsion within the droplet. As the charged droplets get smaller, the excess charge within them causes them to disintegrate and release analyte molecules. The volatilized analyte molecules are then analyzed by mass spectrometry.", "PM": "2001", "HN": "2001", "MR": "20060705", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021241"}, {"RECTYPE": "D", "MH": "Parasitic Sensitivity Tests", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Tests, Parasitic Sensitivity", "MN": "E05.337.550.700", "MH_TH": "NLM (2001)", "ST": "T059", "AN": "IM when general; NIM with specific drug (IM) & specific parasite (IM); MICROBIAL SENSITIVITY TESTS is also available", "PI": "Parasitology (1967-2000)", "MS": "Tests that demonstrate the relative effectiveness of chemotherapeutic agents against specific parasites.", "PM": "2001", "HN": "2001", "MR": "20110624", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021261"}, {"RECTYPE": "D", "MH": "Quantitative Structure-Activity Relationship", "PRINT ENTRY": "Structure Activity Relationship, Quantitative|T081|NON|EQV|NLM (2001)|991207|abcdef", "ENTRY": "Structure-Activity Relationships, Quantitative", "MN": "G07.690.773.997.500", "MH_TH": "NLM (2001)", "ST": "T081", "PI": "Structure-Activity Relationship (1972-2000)", "MS": "A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds.", "PM": "2001", "HN": "2001", "MR": "20150629", "DA": "20000627", "DC": "1", "DX": "20010101", "UI": "D021281"}, {"RECTYPE": "D", "MH": "Antifreeze Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thermal Hysteresis Protein|T116|T123|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Proteins, Thermal Hysteresis", "MN": "D12.776.053", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Peptides (1980-1982)", "MS": "Proteins that bind to ice and modify the growth of ice crystals. They perform a cryoprotective role in a variety of organisms.", "PM": "2001; ANTIFREEZE GLYCOPROTEINS (now ANTIFREEZE PROTEINS) was indexed under GLYCOPROTEINS 1983-2000 & PEPTIDES 1980-1982", "HN": "2001; use ANTIFREEZE PROTEINS (NM) 1980-2000", "MR": "20200527", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D021301"}, {"RECTYPE": "D", "MH": "Antifreeze Proteins, Type IV", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Type IV Fish Antifreeze Proteins|T116|T123|NON|NRW|NLM (2001)|991207|abbcdef", "MN": "D12.776.053.500", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "PI": "Peptides (1980-1982)", "MS": "A subclass of ANTIFREEZE PROTEINS that contain four amphipathic alpha-helices folded into an antiparallel helix bundle.", "PM": "2001; ANTIFREEZE GLYCOPROTEINS, TYPE IV was indexed under GLYCOPROTEINS 1997-2000", "HN": "2001; use ANTIFREEZE PROTEINS (NM) 1997-2000", "MR": "20050630", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D021302"}, {"RECTYPE": "D", "MH": "Antifreeze Proteins, Type I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Type I Fish Antifreeze Proteins|T116|T123|NON|NRW|NLM (2001)|991207|abbcdef", "MN": "D12.776.053.100", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "MS": "A subclass of ANTIFREEZE PROTEINS that are 3-5 kDa in size and contain a single alanine-rich amphipathic alpha-helix.", "PM": "2001", "HN": "2001", "MR": "20050630", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D021322"}, {"RECTYPE": "D", "MH": "Antifreeze Proteins, Type II", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Type II Fish Antifreeze Proteins|T116|T123|NON|NRW|NLM (2001)|991207|abbcdef", "MN": "D12.776.053.200", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "MS": "A subclass of ANTIFREEZE PROTEINS that have a cystine-rich globular structure of approximately 14 kD.", "PM": "2001", "HN": "2001", "MR": "20050630", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D021341"}, {"RECTYPE": "D", "MH": "Antifreeze Proteins, Type III", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Type III Fish Antifreeze Proteins|T116|T123|NON|NRW|NLM (2001)|991207|abbcdef", "MN": "D12.776.053.350", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "MS": "A subclass of ANTIFREEZE PROTEINS that are globular, 6.5 kDa in size and contain compact beta-sheet structures.", "PM": "2001", "HN": "2001", "MR": "20050630", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D021343"}, {"RECTYPE": "D", "MH": "Scaphoid Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Navicular Bone of Hand|T023|NON|EQV|NLM (2001)|991207|abcdef", "ENTRY": "Scaphoid Bones", "MN": "A02.835.232.087.319.150.750", "MH_TH": "NLM (2001)", "ST": "T023", "PI": "Wrist Joint (1966-1971)", "MS": "The bone which is located most lateral in the proximal row of CARPAL BONES.", "PM": "2001", "HN": "2001", "MR": "20180629", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021361"}, {"RECTYPE": "D", "MH": "Palate, Hard", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Palatine Bone|T023|NON|NRW|NLM (1998)|960719|abcdef", "ENTRY": "Palates, Hard", "MN": "A14.549.617.660", "MH_TH": "NLM (1998)", "ST": "T023", "PI": "Palate (1966-2000)", "MS": "The anteriorly located rigid section of the PALATE.", "PM": "2001; see PALATE 1998-2000", "HN": "2001; use PALATE 1998-2000", "MR": "20180629", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021362"}, {"RECTYPE": "D", "MH": "Protein Transport", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Vesicular Protein Transport|T043|NON|NRW|NLM (2001)|991208|abcdef", "ENTRY": "Traffickings, Protein", "MN": "G03.143.700", "FX": "Protein Sorting Signals", "MH_TH": "NLM (2001)", "ST": "T043", "AN": "coordinate NIM with specific protein /metab or /pharmacokin ", "PI": "Proteins/metabolism (1964-2000)", "MS": "The process of moving proteins from one cellular compartment (including extracellular) to another by various sorting and transport mechanisms such as gated transport, protein translocation, and vesicular transport.", "PM": "2001", "HN": "2001", "MR": "20190530", "DA": "20000705", "DC": "1", "DX": "20010101", "UI": "D021381"}, {"RECTYPE": "D", "MH": "Protein Sorting Signals", "AQ": "DE ES GE PH RE", "PRINT ENTRY": "Leader Signal Peptides|T116|T123|NON|NRW|UNK (19XX)|850606|abbcdef", "ENTRY": "Sorting Signals, Protein", "MN": "G02.111.570.060.670", "FX": "Signal Recognition Particle", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "MS": "Amino acid sequences found in transported proteins that selectively guide the distribution of the proteins to specific cellular compartments.", "PM": "2001; see Signal Peptides 1986-2000", "HN": "2001(1986)", "MR": "20080708", "DA": "20000706", "DC": "1", "DX": "20010101", "UI": "D021382"}, {"RECTYPE": "D", "MH": "Carcinoma, Pancreatic Ductal", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pancreatic Ductal Carcinoma|T191|NON|EQV|NLM (2001)|000411|abcdef", "ENTRY": "Pancreatic Ductal Carcinomas", "MN": "C19.344.421.750", "MH_TH": "NLM (2001)", "ST": "T191", "AN": "coordinate IM with PANCREATIC NEOPLASMS (IM)", "PI": "Pancreatic Neoplasms (1966-2000)", "MS": "Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.", "PM": "2001", "HN": "2001", "MR": "20120703", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021441"}, {"RECTYPE": "D", "MH": "Animals, Outbred Strains", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Strains, Outbred Animal", "MN": "B01.050.050.284", "MH_TH": "NLM (2001)", "ST": "T008", "AN": "IM GEN or unspecified; coord NIM with specific animal probably NIM", "MS": "Animals that are generated from breeding two genetically dissimilar strains of the same species.", "PM": "2001", "HN": "2001", "MR": "20200902", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D021461"}, {"RECTYPE": "D", "MH": "Flank Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Right Flank Pains", "MN": "C23.888.592.612.386", "MH_TH": "NLM (2001)", "ST": "T184", "PI": "Pain (1966-2000)", "MS": "Pain emanating from below the RIBS and above the ILIUM.", "PM": "2001", "HN": "2001", "MR": "20170620", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021501"}, {"RECTYPE": "D", "MH": "Ribotyping", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Ribotypes", "MN": "E05.393.290.765", "MH_TH": "NLM (2001)", "ST": "T063", "PI": "RNA, Ribosomal (1991-2000)", "MS": "RESTRICTION FRAGMENT LENGTH POLYMORPHISM analysis of rRNA genes that is used for differentiating between species or strains.", "PM": "2001", "HN": "2001", "MR": "20110624", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021521"}, {"RECTYPE": "D", "MH": "Bioartificial Organs", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Organs, Bioartificial", "MN": "E07.858.082.212", "MH_TH": "NLM (2001)", "ST": "T074", "MS": "Artificial organs that are composites of biomaterials and cells. The biomaterial can act as a membrane (container) as in BIOARTIFICIAL LIVER or a scaffold as in bioartificial skin.", "PM": "2001", "HN": "2001", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021522"}, {"RECTYPE": "D", "MH": "Sea Bream", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Sparus aurata|T013|NON|EQV|NLM (2001)|991220|abcdef", "ENTRY": "Seabreams, Gilthead", "MN": "B01.050.150.900.493.602.750", "MH_TH": "NLM (2001)", "ST": "T013", "RN": "txid8175", "PI": "Perciformes (1987-2000)", "MS": "A species of PERCIFORMES commonly used in saline aquaculture.", "PM": "2001", "HN": "2001", "MR": "20200813", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021541"}, {"RECTYPE": "D", "MH": "Amino Acids, Neutral", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neutral Amino Acids|T116|T123|NON|EQV|NLM (2001)|991220|abbcdef", "ENTRY": "Acids, Neutral Amino", "MN": "D12.125.154", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "MS": "Amino acids with uncharged R groups or side chains.", "PM": "2001", "HN": "2001", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D021542"}, {"RECTYPE": "D", "MH": "Active Transport, Cell Nucleus", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Nucleocytoplasmic Transport|T043|NON|EQV|NLM (2003)|011127|abcdef", "ENTRY": "Transports, Nucleo-cytoplasmic", "MN": "G03.143.700.100", "FX": "Nucleocytoplasmic Transport Proteins", "MH_TH": "NLM (2001)", "ST": "T043", "AN": "IM general only; coordinate NIM with CELL NUCLEUS /metab (IM) + substance /metab (IM)", "PI": "Cell Nucleus/ME (1982-2000)", "MS": "Gated transport mechanisms by which proteins or RNA are moved across the NUCLEAR MEMBRANE.", "PM": "2001", "HN": "2001", "MR": "20160502", "DA": "20000705", "DC": "1", "DX": "20010101", "UI": "D021581"}, {"RECTYPE": "D", "MH": "trans-Golgi Network", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "trans-Golgi Region|T026|NON|REL|NLM (2001)|000222|abcdef", "ENTRY": "trans-Golgi Regions", "MN": "A11.284.430.214.190.875.336.850", "MH_TH": "NLM (2001)", "ST": "T026", "PI": "Golgi Apparatus (1986-2000)", "MS": "A network of membrane compartments, located at the cytoplasmic side of the GOLGI APPARATUS, where proteins and lipids are sorted for transport to various locations in the cell or cell membrane.", "PM": "2001", "HN": "2001", "MR": "20030709", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021601"}, {"RECTYPE": "D", "MH": "Imaging, Three-Dimensional", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Imaging, Three-Dimensional, Computer Assisted|T060|T062|NON|NRW|NLM (2001)|000228|abbcdef", "ENTRY": "Three-Dimensional Imagings, Computer-Assisted", "MN": "L01.224.308.410", "MH_TH": "NLM (2001)", "ST": "T062", "MS": "The process of generating three-dimensional images by electronic, photographic, or other methods. For example, three-dimensional images can be generated by assembling multiple tomographic images with the aid of a computer, while photographic 3-D images (HOLOGRAPHY) can be made by exposing film to the interference pattern created when two laser light sources shine on an object.", "PM": "2000", "HN": "2000", "MR": "20220415", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021621"}, {"RECTYPE": "D", "MH": "Recognition, Psychology", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Recognition (Psychology)|T041|NON|EQV|NLM (1998)|960710|abcdef", "ENTRY": "Recognition, Psychological", "MN": "F02.463.425.540.706", "MH_TH": "NLM (2020)", "ST": "T041", "MS": "The knowledge or perception that someone or something present has been previously encountered.", "PM": "2020; was RECOGNITION (PSYCHOLOGY) 2001-2019; see MEMORY 1998-2000", "HN": "2020 (1998); was RECOGNITION (PSYCHOLOGY) 2001-2019; use MEMORY 1998-2000", "MR": "20190118", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021641"}, {"RECTYPE": "D", "MH": "Management Service Organizations", "DE": "MANAGEMENT SERV ORGAN", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Service Organizations, Management", "MN": "N04.452.758.372", "MH_TH": "NLM (1996)", "ST": "T092", "MS": "Voluntarily-formed groups of healthcare professionals who join for common management services and other benefits such as collective bargaining agreements with reimbursement agents. The physical assets of a practice are controlled by the MSO which also provides billing, collections, and similar services. The practitioner retains control of patient records and management of patient care.", "HN": "2001; use HOSPITAL-PHYSICIAN JOINT VENTURES 1996-2000", "MR": "20040728", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021661"}, {"RECTYPE": "D", "MH": "Scedosporium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Scedosporium inflatum|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Scedosporiums", "MN": "B01.300.381.785", "MH_TH": "NLM (2001)", "ST": "T004", "RN": "txid41687", "RR": "txid563466", "PI": "Pseudallescheria (1982-2000)", "MS": "A mitosporic fungal genus previously called Monosporium. Teleomorphs include PSEUDALLESCHERIA.", "PM": "2001; for MONOSPORIUM APIOSPERMUM see PSEUDALLESCHERIA 1986-2000", "HN": "2001", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021681"}, {"RECTYPE": "D", "MH": "Sentinel Lymph Node Biopsy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Lymph Node Biopsy, Sentinel|T060|NON|EQV|NLM (2001)|000229|abcdef", "MN": "E05.242.384.100.580", "FX": "Sentinel Lymph Node", "MH_TH": "NLM (2001)", "ST": "T060", "PI": "Biopsy (1966-2000)", "MS": "A diagnostic procedure used to determine whether LYMPHATIC METASTASIS has occurred. The SENTINEL LYMPH NODE is the first lymph node to receive drainage from a neoplasm.", "PM": "2001", "HN": "2001", "MR": "20160120", "DA": "20000705", "DC": "1", "DX": "20010101", "UI": "D021701"}, {"RECTYPE": "D", "MH": "Balloon Occlusion", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Balloon Tamponade|T061|NON|REL|UNK (19XX)|870316|abcdef", "ENTRY": "Tamponades, Balloon", "MN": "E05.157.063", "FX": "Blood Vessel Prosthesis Implantation", "MH_TH": "NLM (2001)", "ST": "T061", "AN": "coordinate IM with disease/ther (IM), not /surg", "PI": "Embolization, Therapeutic (1975-2000)", "MS": "Use of a balloon CATHETER to block the flow of blood through an artery or vein.", "PM": "2001", "HN": "2001", "MR": "20150622", "DA": "20000627", "DC": "1", "DX": "20010101", "UI": "D021721"}, {"RECTYPE": "D", "MH": "Eimeriida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Eimeriidas", "MN": "B01.043.075.189.250", "MH_TH": "NLM (2001)", "ST": "T204", "AN": "infection: coordinate IM with COCCIDIOSIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "An order of parasitic organisms in the class COCCIDIA. Families include CRYPTOSPORIDIIDAE; EIMERIIDAE; and SARCOCYSTIDAE.", "PM": "2001", "HN": "2001", "MR": "20200902", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021741"}, {"RECTYPE": "D", "MH": "Cryptosporidiidae", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.043.075.189.250.150", "MH_TH": "NLM (2001)", "ST": "T204", "RN": "txid35082", "AN": "infection: coordinate IM with COCCIDIOSIS; coord with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A family of parasitic organisms in the order EIMERIIDA. CRYPTOSPORIDIUM is the most important genus.", "PM": "2001", "HN": "2001", "MR": "20200813", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021742"}, {"RECTYPE": "D", "MH": "Eimeriidae", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.043.075.189.250.250", "MH_TH": "NLM (2001)", "ST": "T204", "RN": "txid5799", "AN": "infection: coordinate IM with COCCIDIOSIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Coccidia (1980-2000)", "MS": "A large family of parasites in the order EIMERIIDA. They cause COCCIDIOSIS in a number of vertebrates including humans.", "PM": "2001", "HN": "2001", "MR": "20200813", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021743"}, {"RECTYPE": "D", "MH": "Cyclospora", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Cyclosporas", "MN": "B01.043.075.189.250.250.200", "MH_TH": "NLM (2001)", "ST": "T204", "RN": "txid44417", "PI": "Eucoccidiida (1990-2000)", "MS": "A genus of coccidian parasites in the family EIMERIIDAE. Cyclospora cayetanensis is pathogenic in humans, probably transmitted via the fecal-oral route, and causes nausea and diarrhea.", "PM": "2001", "HN": "2001", "MR": "20200813", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021744"}, {"RECTYPE": "D", "MH": "Sarcocystidae", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.043.075.189.250.750", "MH_TH": "NLM (2001)", "ST": "T204", "RN": "txid5809", "AN": "infection: coordinate with COCCIDIOSIS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A family of parasitic organisms in the order EIMERIIDAE. They form tissue-cysts in their intermediate hosts, ultimately leading to pathogenesis in the final hosts that includes various mammals (including humans) and birds. The most important genera include NEOSPORA; SARCOCYSTIS; and TOXOPLASMA.", "PM": "2001; for BESNOITIA see EIMERIINA 1992-2000", "HN": "2001; for BESNOITIA use EIMERIIDA 1992-2000", "MR": "20210510", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021745"}, {"RECTYPE": "D", "MH": "Multicystic Dysplastic Kidney", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Renal Dysplasias, Multicystic", "MN": "C16.131.939.629", "MH_TH": "NLM (2001)", "ST": "T047", "AN": "do not confuse with POLYCYSTIC KIDNEY DISEASES, a genetic defect", "PI": "Polycystic Kidney Diseases (1966-2000)", "MS": "A nongenetic defect due to malformation of the KIDNEY which appears as a bunch of grapes with multiple renal cysts but lacking the normal renal bean shape, and the collection drainage system. This condition can be detected in-utero with ULTRASONOGRAPHY.", "PM": "2001", "HN": "2001", "MR": "20210630", "DA": "20000627", "DC": "1", "DX": "20010101", "UI": "D021782"}, {"RECTYPE": "D", "MH": "Zygapophyseal Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Facet Joint|T030|NON|EQV|NLM (2001)|000113|abcdef", "ENTRY": "Zygapophysial Joints", "MN": "A02.835.583.979", "MH_TH": "NLM (2001)", "ST": "T030", "PI": "Joints (1966-2000)", "MS": "The joint that occurs between facets of the interior and superior articular processes of adjacent VERTEBRAE.", "PM": "2001", "HN": "2001", "MR": "20150622", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021801"}, {"RECTYPE": "D", "MH": "Communicable Diseases, Emerging", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Infectious Diseases, Emerging|T047|NON|EQV|NLM (2001)|000114|abcdef", "ENTRY": "Reemerging Infectious Diseases", "MN": "C23.550.291.531.750", "FX": "Zoonoses", "MH_TH": "NLM (2001)", "ST": "T047", "PI": "Communicable Diseases (1966-2000)", "MS": "Infectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode.", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021821"}, {"RECTYPE": "D", "MH": "Safe Sex", "AQ": "CL DE EH HI PH PX RE SN", "PRINT ENTRY": "Responsible Sex|T054|NON|EQV|NLM (2001)|000114|abcdef", "ENTRY": "Sex, Safe", "MN": "F01.145.802.845", "FX": "Sex Education", "MH_TH": "NLM (2001)", "ST": "T054", "PI": "Sex Behavior (1966-2000)", "MS": "Sexual behavior that prevents or reduces the spread of SEXUALLY TRANSMITTED DISEASES or PREGNANCY.", "PM": "2001", "HN": "2001", "MR": "20080708", "DA": "20000627", "DC": "1", "DX": "20010101", "UI": "D021841"}, {"RECTYPE": "D", "MH": "Microsporidia, Unclassified", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Microsporidium|T204|NON|NRW|NLM (2001)|000118|abcdef", "ENTRY": "Unclassified Microsporidias", "MN": "B01.300.360.520", "MH_TH": "NLM (2001)", "ST": "T204", "RN": "txid67676", "RR": "txid144516", "AN": "index here if the author uses the term microsporidium or \"unclassifed microsporidia\"; index MICROSPORIDIA if the author uses \"microsporidia\" as a general term for the phylum; infection: coordinate IM with MICROSPORIDIOSIS (IM); coordinate with specific fungal term (ANTIGENS, FUNGAL, etc) if pertinent", "MS": "Includes newly defined organisms as well as some that will never be classified to the genus and/or species level because of loss of the specimen or other information.", "PM": "2001", "HN": "2001", "MR": "20200813", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021861"}, {"RECTYPE": "D", "MH": "Enterocytozoon", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Enterocytozoon bienusi|T204|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Enterocytozoons", "MN": "B01.300.360.500.500.100.200", "MH_TH": "NLM (2001)", "ST": "T204", "RN": "txid27971", "RR": "txid31281", "AN": "infection: coordinate with MICROSPORIDIOSIS; coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc.) if pertinent", "PI": "Microsporida (1992-2000)", "MS": "A genus of parasitic FUNGI in the family Enterocytozoonidae, which infects humans. Enterocytozoon bieneusi has been found in the intestines of patients with AIDS.", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021862"}, {"RECTYPE": "D", "MH": "Vittaforma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Nosema corneum|T004|NON|NRW|NLM (2001)|000118|abcdef", "ENTRY": "Vittaformas", "MN": "B01.300.360.500.500.100.900", "MH_TH": "NLM (2001)", "ST": "T004", "RN": "txid42398", "RR": "txid42399", "AN": "infection: coordinate with MICROSPORIDIOSIS; coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc.) if pertinent", "PI": "Microsporida (1995-2000)", "MS": "A genus of parasitic FUNGI in the family Nosematidae that infects humans. Vittaforma corneae has been isolated from AIDS patients.", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021863"}, {"RECTYPE": "D", "MH": "Pleistophora", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Pleistophoras", "MN": "B01.300.360.500.500.600.650", "MH_TH": "NLM (2001)", "ST": "T204", "RN": "txid35233", "AN": "infection: coordinate IM with MICROSPORIDIOSIS (IM); coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc) if pertinent", "PI": "Protozoa (1968-1980)", "MS": "A genus of parasitic FUNGI in the family Pleistophoridae that infects humans.", "PM": "2001", "HN": "2001", "MR": "20200813", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021864"}, {"RECTYPE": "D", "MH": "Isosporiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Isosporiases", "MN": "C01.610.752.250.410", "MH_TH": "NLM (2001)", "ST": "T047", "AN": "/drug ther: consider also COCCIDIOSTATS", "PI": "Coccidiosis (1978-2000)", "MS": "Infection with parasitic protozoa of the genus ISOSPORA, producing intestinal disease. It is caused by ingestion of oocysts and can produce tissue cysts.", "PM": "2001", "HN": "2001", "MR": "20190617", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021865"}, {"RECTYPE": "D", "MH": "Cyclosporiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Cyclospora", "MN": "C01.610.752.250.280", "MH_TH": "NLM (2001)", "ST": "T047", "PI": "Coccidiosis (1993-2000)", "MS": "Infection with parasitic protozoa of the genus CYCLOSPORA. It is distributed globally and causes a diarrheal illness. Transmission is waterborne.", "PM": "2001", "HN": "2001", "MR": "20190617", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021866"}, {"RECTYPE": "D", "MH": "DNA, Catalytic", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Deoxyribozymes|T114|T126|NON|EQV|NLM (2001)|000120|abbcdef", "ENTRY": "Deoxyribozyme|T114|T126|NON|EQV|NLM (2001)|abbcde", "MN": "D13.444.308.243", "MH_TH": "NLM (2001)", "ST": "T126", "RN": "0", "PI": "DNA, Single-Stranded (1997-2000)", "MS": "Molecules of DNA that possess enzymatic activity.", "PM": "2001; Deoxyribozyme (now DNA, CATALYTIC) was indexed under DNA, SINGLE-STRANDED 1997-2000", "HN": "2001; use DNA, CATALYTIC (NM) 1997-2000", "MR": "20050713", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021881"}, {"RECTYPE": "D", "MH": "DNA, Intergenic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Spacer DNA|T114|T123|ACX|NRW|NLM (2001)|000120|abbcdef", "ENTRY": "Spacer DNAs", "MN": "G05.360.340.024.220", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "AN": "note that DNA, RIBOSOMAL SPACER is available", "PI": "DNA or specifics (1984-2000)", "MS": "Any of the DNA in between gene-coding DNA, including untranslated regions, 5' and 3' flanking regions, INTRONS, non-functional pseudogenes, and non-functional repetitive sequences. This DNA may or may not encode regulatory functions.", "PM": "2001", "HN": "2001", "MR": "20080708", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021901"}, {"RECTYPE": "D", "MH": "Enterobacter aerogenes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Klebsiella mobilis|T007|NON|EQV|NLM (2021)|190913|abcdef", "ENTRY": "Klebsiella mobilus|T007|NON|EQV|NLM (2001)|000120|abcdef", "MN": "B03.660.250.150.170.049", "FX": "Klebsiella pneumoniae", "MH_TH": "NLM (2001)", "ST": "T007", "RN": "txid548", "AN": "infection: coordinate with ENTEROBACTERIACEAE INFECTIONS", "PI": "Klebsiella pneumoniae (1992-2000)", "MS": "Gram-negative, capsulated, gas-producing rods found widely in nature. Both motile and non-motile strains exist. The species is closely related to KLEBSIELLA PNEUMONIAE and is frequently associated with nosocomial infections", "PM": "2001; for AEROBACTER AEROGENES see KLEBSIELLA PNEUMONIAE 1992-2000, ENTEROBACTER 1976-1991, & AEROBACTER AEROGENES 1963-1975", "HN": "2001; for AEROBACTER AEROGENES use KLEBSIELLA PNEUMONIAE 1992-2000 & ENTEROBACTER 1963-1991", "MR": "20200206", "DA": "20000627", "DC": "1", "DX": "20010101", "UI": "D021902"}, {"RECTYPE": "D", "MH": "DNA, Ribosomal Spacer", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ribosomal Spacer DNA|T114|T123|NON|EQV|NLM (2001)|000224|abbcdef", "ENTRY": "Spacer DNA, Ribosomal", "MN": "D13.444.308.475.230", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "AN": "DNA, RIBOSOMAL and DNA, SPACER see DNA, INTERGENIC are also available", "PI": "RNA, Ribosomal (1984-2000)", "MS": "The intergenic DNA segments that are between the ribosomal RNA genes (internal transcribed spacers) and between the tandemly repeated units of rDNA (external transcribed spacers and nontranscribed spacers).", "PM": "2001", "HN": "2001", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021903"}, {"RECTYPE": "D", "MH": "Aortic Stenosis, Supravalvular", "DE": "AORTIC STENOSIS SUPRAVALV", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Supravalvular Aortic Stenosis|T047|NON|EQV|GHR (2014)|NLM (2001)|OMIM (2013)|000228|SUPRAVALV AORTIC STENOSIS|abcdeeefv", "ENTRY": "Supravalvular Stenoses, Aortic", "MN": "C14.280.955.249.535", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Aortic Valve Stenosis (1965-2000)", "MS": "A pathological constriction occurring in the region above the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.", "PM": "2001; see AORTIC VALVE STENOSIS 1980-2000", "HN": "2001; use AORTIC VALVE STENOSIS 1980-2000", "MR": "20200228", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D021921"}, {"RECTYPE": "D", "MH": "Discrete Subaortic Stenosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subaortic Stenosis, Discrete|T047|NON|EQV|NLM (2001)|000228|abcdef", "ENTRY": "Subaortic Stenoses, Discrete", "MN": "C14.280.955.249.070.210", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Aortic Valve Stenosis (1972-2000)", "MS": "A type of constriction that is caused by the presence of a fibrous ring (discrete type) below the AORTIC VALVE, anywhere between the aortic valve and the MITRAL VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.", "PM": "2001; see AORTIC VALVE STENOSIS 1986-2000", "HN": "2001; use AORTIC VALVE STENOSIS 1986-2000", "MR": "20200228", "DA": "20000706", "DC": "1", "DX": "20010101", "UI": "D021922"}, {"RECTYPE": "D", "MH": "Caveolae", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Caveolas", "MN": "A11.284.430.214.190.875.190.880.180.160", "FX": "Caveolins", "MH_TH": "NLM (2001)", "ST": "T026", "PI": "Cell Membrane (1971-2000)", "MS": "Endocytic/exocytic CELL MEMBRANE STRUCTURES rich in glycosphingolipids, cholesterol, and lipid-anchored membrane proteins that function in ENDOCYTOSIS (potocytosis), transcytosis, and SIGNAL TRANSDUCTION. Caveolae assume various shapes from open pits to closed vesicles. Caveolar coats are composed of CAVEOLINS.", "PM": "2001", "HN": "2001", "MR": "20130709", "DA": "20000627", "DC": "1", "DX": "20010101", "UI": "D021941"}, {"RECTYPE": "D", "MH": "Cell Membrane Structures", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Structures, Cell Membrane", "MN": "A11.284.149.165", "MH_TH": "NLM (2001)", "ST": "T026", "AN": "general or unspecified; prefer specifics", "MS": "Structures which are part of the CELL MEMBRANE or have cell membrane as a major part of their structure.", "PM": "2001", "HN": "2001", "DA": "20000705", "DC": "1", "DX": "20010101", "UI": "D021961"}, {"RECTYPE": "D", "MH": "Membrane Microdomains", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Lipid Rafts, Cell Membrane|T026|NON|EQV|NLM (2001)|000128|abcdef", "ENTRY": "Sphingolipid-Cholesterol Raft", "MN": "A11.284.149.165.570", "MH_TH": "NLM (2001)", "ST": "T026", "PI": "Cell Membrane (1981-2000)", "MS": "Detergent-insoluble CELL MEMBRANE components. They are enriched in SPHINGOLIPIDS and CHOLESTEROL and clustered with glycosyl-phosphatidylinositol (GPI)-anchored proteins.", "PM": "2001", "HN": "2001", "MR": "20040707", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D021962"}, {"RECTYPE": "D", "MH": "Cell-Matrix Junctions", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Cell-Matrix Adhesions|T026|NON|EQV|NLM (2001)|000508|abcdef", "ENTRY": "Junctions, Cell-Matrix", "MN": "A11.284.149.165.165", "FX": "Cell Adhesion", "MH_TH": "NLM (2001)", "ST": "T026", "PI": "Extracellular Matrix (1991-2000)", "MS": "Specialized areas at the CELL MEMBRANE where a cell attaches to the EXTRACELLULAR MATRIX or other substratum.", "PM": "2001", "HN": "2001", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D021982"}, {"RECTYPE": "D", "MH": "Cyclophilins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cyclosporin-Binding Proteins|T116|T126|T192|NON|EQV|NLM (2001)|000131|abbbcdef", "ENTRY": "Proteins, Cyclosporin-Binding", "MN": "D12.776.827.344.300", "MH_TH": "NLM (2001)", "ST": "T192", "RN": "EC 5.2.1.-", "PI": "Peptidylprolyl Isomerase (1998-2000)", "MS": "A family of peptidyl-prolyl cis-trans isomerases that bind to CYCLOSPORINS and regulate the IMMUNE SYSTEM. EC 5.2.1.-", "PM": "2001; see PEPTIDYLPROLYL ISOMERASE 1998-2000, was indexed under CARRIER PROTEINS & AMINO ACID ISOMERASES 1984-1997", "HN": "2001; use PEPTIDYLPROLYL ISOMERASE 1998-2000 & PEPTIDYLPROLYL ISOMERASE (NM) 1984-1997", "MR": "20230526", "DA": "20000705", "DC": "1", "DX": "20010101", "UI": "D021983"}, {"RECTYPE": "D", "MH": "Cyclophilin A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptidyl-Prolyl cis-trans Isomerase A|T116|T126|T192|NON|EQV|NLM (2001)|000131|PEPTIDYL PROYL CIS TRANS Z ISOMERASE|abbbcdefs", "MN": "D12.776.827.344.300.500", "MH_TH": "NLM (1998)", "ST": "T192", "RN": "EC 5.2.1.-", "PI": "Peptidylprolyl Isomerase (1998-2000)", "MS": "A 17-KDa cytoplasmic PEPTIDYLPROLYL ISOMERASE involved in immunoregulation. It is a member of the cyclophilin family of proteins that binds to CYCLOSPORINE.", "PM": "2001; see PEPTIDYLPROLYL ISOMERASE 1998-2000, was indexed under CARRIER PROTEINS & AMINO ACID ISOMERASES 1984-1997", "HN": "2001; use PEPTIDYLPROLYL ISOMERASE 1998-2000 & PEPTIDYLPROLYL ISOMERASE (NM) 1984-1997", "MR": "20230526", "DA": "20000705", "DC": "1", "DX": "20010101", "UI": "D021984"}, {"RECTYPE": "D", "MH": "Focal Adhesions", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Focal Contacts|T026|NON|EQV|NLM (2001)|000131|abcdef", "ENTRY": "Plaques, Adhesion", "MN": "A11.284.149.165.165.285", "FX": "Cell Adhesion", "MH_TH": "NLM (2001)", "ST": "T026", "PI": "Extracellular Matrix (1986-2000)", "MS": "An anchoring junction of the cell to a non-cellular substrate. It is composed of a specialized area of the plasma membrane where bundles of the ACTIN CYTOSKELETON terminate and attach to the transmembrane linkers, INTEGRINS, which in turn attach through their extracellular domains to EXTRACELLULAR MATRIX PROTEINS.", "PM": "2001", "HN": "2001", "MR": "20110701", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022001"}, {"RECTYPE": "D", "MH": "Hemidesmosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Hemidesmosome", "MN": "A11.284.149.165.165.360", "MH_TH": "NLM (2001)", "ST": "T026", "PI": "Desmosomes (1972-2000)", "MS": "An anchoring junction of the cell to a non-cellular substrate, similar in morphology to halves of DESMOSOMES. They are composed of specialized areas of the plasma membrane where INTERMEDIATE FILAMENTS bind on the cytoplasmic face to the transmembrane linkers, INTEGRINS, via intracellular attachment proteins, while the extracellular domain of the integrins binds to EXTRACELLULAR MATRIX PROTEINS.", "PM": "2001", "HN": "2001", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022002"}, {"RECTYPE": "D", "MH": "Cell Nucleus Structures", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Structures, Cell Nucleus", "MN": "A11.284.430.106.279", "MH_TH": "NLM (2001)", "ST": "T026", "AN": "general or unspecified; prefer specifics", "PI": "Cell Nucleus/UL (1966-2000)", "MS": "Structures that are part of or contained in the CELL NUCLEUS.", "PM": "2001", "HN": "2001", "MR": "20030709", "DA": "20000705", "DC": "1", "DX": "20010101", "UI": "D022003"}, {"RECTYPE": "D", "MH": "Chromosome Structures", "DE": "CHROMOSOME STRUCT", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "ENTRY": "Structures, Chromosome", "MN": "G05.360.160", "MH_TH": "NLM (2001)", "ST": "T026", "AN": "general or unspecified; prefer specifics", "PI": "Chromosomes/UL (1975-2000)", "MS": "Structures which are contained in or part of CHROMOSOMES.", "PM": "2001", "HN": "2001", "MR": "20080708", "DA": "20000705", "DC": "1", "DX": "20010101", "UI": "D022004"}, {"RECTYPE": "D", "MH": "Adherens Junctions", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Zonula Adherens|T026|NON|REL|NLM (2001)|000202|abcdef", "ENTRY": "Junctions, Adherens", "MN": "A11.284.149.165.420.020", "MH_TH": "NLM (2001)", "ST": "T026", "PI": "Intercellular Junctions (1984-2000)", "MS": "Anchoring points where the CYTOSKELETON of neighboring cells are connected to each other. They are composed of specialized areas of the plasma membrane where bundles of the ACTIN CYTOSKELETON attach to the membrane through the transmembrane linkers, CADHERINS, which in turn attach through their extracellular domains to cadherins in the neighboring cell membranes. In sheets of cells, they form into adhesion belts (zonula adherens) that go all the way around a cell.", "PM": "2001", "HN": "2001", "MR": "20110701", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022005"}, {"RECTYPE": "D", "MH": "Tacrolimus Binding Proteins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Rapamycin Binding Proteins|T116|T126|NON|REL|NLM (2001)|abbcde", "ENTRY": "Rotamase, FKBP", "MN": "D12.776.827.344.700", "MH_TH": "NLM (2022)", "ST": "T192", "RN": "EC 5.2.1.-", "RR": "EC 5.2.1.8", "PI": "Tacrolimus Binding Proteins/chemistry/genetics/*pharmacology (2000-2021)", "MS": "A family of immunophilin proteins that bind to the immunosuppressive drugs TACROLIMUS (also known as FK506) and SIROLIMUS.", "PM": "2001; FK 506 BINDING PROTEIN (now TACROLIMUS BINDING PROTEINS) was indexed under IMMUNOPHILINS 1999-2000 & under CARRIER PROTEINS, DNA-BINDING PROTEINS, & HEAT SHOCK PROTEINS 1991-1998", "HN": "2001 (2000)", "MR": "20230526", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022021"}, {"RECTYPE": "D", "MH": "Nuclear Pore", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Pores, Nuclear", "MN": "A11.284.430.106.279.692.630", "MH_TH": "UNK (19XX)", "ST": "T026", "PI": "Nuclear Membrane (1977-2000)", "MS": "An opening through the NUCLEAR ENVELOPE formed by the nuclear pore complex which transports nuclear proteins or RNA into or out of the CELL NUCLEUS and which, under some conditions, acts as an ion channel.", "PM": "2001; see NUCLEAR MEMBRANE 1977-2000", "HN": "2001; use NUCLEAR ENVELOPE 1977-2000", "MR": "20030709", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022022"}, {"RECTYPE": "D", "MH": "Euchromatin", "AQ": "CH CL DE EN GE IM IP ME MI PA PH PS RE TR UL VI", "ENTRY": "Euchromatins", "MN": "G05.360.160.180.270", "MH_TH": "NLM (2001)", "ST": "T028", "RN": "0", "PI": "Chromatin (1971-2000)", "MS": "Chromosome regions that are loosely packaged and more accessible to RNA polymerases than HETEROCHROMATIN. These regions also stain differentially in CHROMOSOME BANDING preparations.", "PM": "2001; EUCHROMATIN was indexed under CHROMATIN 1981-2000", "HN": "2001; use EUCHROMATIN (NM) 1981-2000", "MR": "20080708", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022041"}, {"RECTYPE": "D", "MH": "Tacrolimus Binding Protein 1A", "DS": "TACROLIMUS BINDING PROTEIN 001 A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "FKBP12|T116|T126|T192|NON|EQV|NLM (2001)|abbbcde", "ENTRY": "Macrophilin 12", "MN": "D12.776.827.344.700.500", "MH_TH": "NLM (2001)", "ST": "T192", "RN": "EC 5.2.1.-", "PI": "Immunophilins (1999-2000)", "MS": "A 12-KDa tacrolimus binding protein that is found associated with and may modulate the function of calcium release channels. It is a peptidyl-prolyl cis/trans isomerase which is inhibited by both tacrolimus (commonly called FK506) and SIROLIMUS.", "PM": "2001; FK 506 BINDING PROTEIN (now TACROLIMUS BINDING PROTEINS) was indexed under IMMUNOPHILINS 1999-2000 & under HEAT-SHOCK PROTEINS, DNA-BINDING PROTEINS, & CARRIER PROTEINS 1991-1998", "HN": "2001; use TACROLIMUS BINDING PROTEINS (NM) 1991-2000", "MR": "20230526", "DA": "20000623", "DC": "1", "DX": "20010101", "UI": "D022061"}, {"RECTYPE": "D", "MH": "Electrophysiologic Techniques, Cardiac", "DE": "ELECTROPHYSIOL TECHNIQUES CARDIAC", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Electrophysiologic Study, Cardiac|T060|NON|NRW|NLM (2001)|000204|ELECTROPHYSIOL STUDY CARDIAC|abcdefv", "ENTRY": "Transesophageal Electrophysiological Studies", "MN": "E01.370.405.267", "FX": "Cardiac Electrophysiology", "MH_TH": "NLM (2001)", "ST": "T061", "PI": "Electrophysiology (1970-2000)", "MS": "Methods to induce and measure electrical activities at specific sites in the heart to diagnose and treat problems with the heart's electrical system.", "PM": "2001", "HN": "2001", "MR": "20080708", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022062"}, {"RECTYPE": "D", "MH": "Cell Surface Extensions", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Cell Membrane Protrusions|T026|NON|EQV|NLM (2001)|000308|abcdef", "ENTRY": "Surface Protrusions, Cell", "MN": "A11.284.180", "MH_TH": "NLM (2001)", "ST": "T026", "AN": "general or unspecified; prefer specifics", "MS": "Specialized structures of the cell that extend the cell membrane and project out from the cell surface.", "PM": "2001", "HN": "2001", "MR": "20150622", "DA": "20000627", "DC": "1", "DX": "20010101", "UI": "D022081"}, {"RECTYPE": "D", "MH": "Cellular Structures", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Structures, Cellular", "MN": "A11.284", "MH_TH": "NLM (2001)", "ST": "T026", "AN": "general or unspecified; prefer specifics", "MS": "Components of a cell.", "PM": "2001", "HN": "2001", "DA": "20000705", "DC": "1", "DX": "20010101", "UI": "D022082"}, {"RECTYPE": "D", "MH": "Cytoplasmic Structures", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Structures, Cytoplasmic", "MN": "A11.284.430.214.190", "MH_TH": "NLM (2001)", "ST": "T026", "AN": "general or unspecified; prefer specifics", "MS": "Components of the cytoplasm excluding the CYTOSOL.", "PM": "2001", "HN": "2001", "MR": "20030709", "DA": "20000705", "DC": "1", "DX": "20010101", "UI": "D022083"}, {"RECTYPE": "D", "MH": "Microtubule-Organizing Center", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Microtubule-Organizing Centers", "MN": "A11.284.430.214.190.750.585", "MH_TH": "NLM (1995)", "ST": "T026", "PI": "Microtubules (1973-2000)", "MS": "An amorphous region of electron dense material in the cytoplasm from which the MICROTUBULES polymerization is nucleated. The pericentriolar region of the CENTROSOME which surrounds the CENTRIOLES is an example.", "PM": "2001; see CENTROSOME 1993-2000", "HN": "2001; use CENTROSOME 1993-2000", "MR": "20030709", "DA": "20000706", "DC": "1", "DX": "20010101", "UI": "D022101"}, {"RECTYPE": "D", "MH": "Cholera Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cholera Vaccine|T121|T129|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Vaccines, Cholera", "MN": "D20.215.894.135.225", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "MS": "Vaccines or candidate vaccines used to prevent infection with VIBRIO CHOLERAE. The original cholera vaccine consisted of killed bacteria, but other kinds of vaccines now exist.", "PM": "2001; see CHOLERA VACCINE 1965-2000", "HN": "2001", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022121"}, {"RECTYPE": "D", "MH": "Anthrax Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaccines, Anthrax|T121|T129|NON|EQV|NLM (2001)|000505|abbcdef", "ENTRY": "Vaccine, Anthrax", "MN": "D20.215.894.135.063", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "MS": "Vaccines or candidate vaccines used to prevent ANTHRAX.", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022122"}, {"RECTYPE": "D", "MH": "Lyme Disease Vaccines", "DE": "LYME DIS VACCINES", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaccines, Lyme Disease|T121|T129|NON|EQV|NLM (2001)|000505|VACCINES LYME DIS|abbcdefv", "ENTRY": "Vaccine, Lyme Disease", "MN": "D20.215.894.135.492", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Bacterial Vaccines (1992-2000)", "MS": "Vaccines or candidate vaccines used to prevent LYME DISEASE.", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022123"}, {"RECTYPE": "D", "MH": "Hyperammonemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.550.421", "MH_TH": "NLM (2001)", "ST": "T046", "PI": "Ammonia (1966-2000)", "MS": "Elevated level of AMMONIA in the blood. It is a sign of defective CATABOLISM of AMINO ACIDS or ammonia to UREA.", "PM": "2001", "HN": "2001", "MR": "20060705", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022124"}, {"RECTYPE": "D", "MH": "Lacerations", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Laceration", "MN": "C26.540", "MH_TH": "NLM (2001)", "ST": "T037", "PI": "Wounds and Injuries (1966-2000)", "MS": "Torn, ragged, mangled wounds.", "PM": "2001", "HN": "2001", "MR": "20100625", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022125"}, {"RECTYPE": "D", "MH": "Access to Information", "AQ": "ES HI LJ PX", "PRINT ENTRY": "Public Access to Information|T169|NON|REL|NLM (2008)|061220|abcdef", "ENTRY": "Requests, FOIA", "MN": "L01.737.030", "MH_TH": "NLM (2001)", "ST": "T169", "MS": "Individual's rights to obtain and use information collected or generated by others.", "PM": "2001", "HN": "2001", "MR": "20130709", "DA": "20010727", "DC": "1", "DX": "20020101", "UI": "D022126"}, {"RECTYPE": "D", "MH": "Jaagsiekte sheep retrovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Ovine pulmonary adenocarcinoma virus|T005|NON|EQV|NLM (2002)|010428|abcdef", "ENTRY": "sheep retrovirus, Jaagsiekte", "MN": "B04.820.650.124.400", "MH_TH": "NLM (2001)", "ST": "T005", "RN": "txid11746", "PI": "Retroviruses, Type D (1989-2000)", "MS": "A BETARETROVIRUS that causes pulmonary adenomatosis in sheep (PULMONARY ADENOMATOSIS, OVINE).", "PM": "2007; see OVINE PULMONARY ADENOCARCINOMA VIRUS 2002-2006, see JAAGSIEKTE SHEEP RETROVIRUS 2001", "HN": "2007, 2001", "MR": "20200813", "DA": "20000628", "DC": "1", "DX": "20010101", "UI": "D022141"}, {"RECTYPE": "D", "MH": "Secretory Vesicles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Zymogen Granules|T026|NON|NRW|NLM (2001)|000414|abcdef", "ENTRY": "Zymogen Granule", "MN": "A11.284.430.214.190.875.190.880.810", "FX": "Exosomes", "MH_TH": "NLM (2001)", "ST": "T026", "AN": "for zymogen granules coord with ENZYME PRECURSORS + specific enzyme", "PI": "Cytoplasmic Granules (1976-2000)", "MS": "Vesicles derived from the GOLGI APPARATUS containing material to be released at the cell surface.", "PM": "2001; see CYTOPLASMIC GRANULES 1980-2000", "HN": "2001; use CYTOPLASMIC GRANULES 1980-2000", "MR": "20210305", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022142"}, {"RECTYPE": "D", "MH": "Family Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursings, Family-Centered", "MN": "H02.478.676.218", "MH_TH": "NLM (2001)", "ST": "T058", "PI": "Nursing Care (1991-2000)", "MS": "The provision of care involving the nursing process, to families and family members in health and illness situations. From Lippincott Manual of Nursing Practice. 6th ed.", "PM": "2001", "HN": "2001", "MR": "20140616", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022143"}, {"RECTYPE": "D", "MH": "Transport Vesicles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Endocytic Vesicles|T026|NON|NRW|NLM (2001)|000209|abcdef", "ENTRY": "Vesicles, Transport", "MN": "A11.284.430.214.190.875.190.880", "FX": "Biological Transport", "MH_TH": "NLM (2001)", "ST": "T026", "PI": "Biological Transport (1989-2000)", "MS": "Vesicles that are involved in shuttling cargo from the interior of the cell to the cell surface, from the cell surface to the interior, across the cell or around the cell to various locations.", "PM": "2001", "HN": "2001", "MR": "20030709", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022161"}, {"RECTYPE": "D", "MH": "Cytoplasmic Vesicles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Vesicles, Cytoplasmic", "MN": "A11.284.430.214.190.875.190", "MH_TH": "NLM (2001)", "ST": "T026", "MS": "Membrane-limited structures derived from the plasma membrane or various intracellular membranes which function in storage, transport or metabolism.", "PM": "2001", "HN": "2001", "MR": "20030709", "DA": "20000706", "DC": "1", "DX": "20010101", "UI": "D022162"}, {"RECTYPE": "D", "MH": "Clathrin-Coated Vesicles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Vesicles, Clathrin-Coated", "MN": "A11.284.430.214.190.875.190.880.180.170", "MH_TH": "NLM (2001)", "ST": "T026", "PI": "Coated Vesicles (1995-2000)", "MS": "Vesicles formed when cell-membrane coated pits (COATED PITS, CELL-MEMBRANE) invaginate and pinch off. The outer surface of these vesicles is covered with a lattice-like network of the protein CLATHRIN. Shortly after formation, however, the clathrin coat is removed and the vesicles are referred to as ENDOSOMES.", "PM": "2001", "HN": "2001", "MR": "20030709", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022163"}, {"RECTYPE": "D", "MH": "COP-Coated Vesicles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Coatomer-Coated Vesicles|T026|NON|NRW|NLM (2001)|000210|abcdef", "ENTRY": "Vesicles, Coatomer-Coated", "MN": "A11.284.430.214.190.875.190.880.180.180", "MH_TH": "NLM (2001)", "ST": "T026", "PI": "Coated Vesicles (1995-2000)", "MS": "TRANSPORT VESICLES formed when cell-membrane coated pits (COATED PITS, CELL-MEMBRANE) invaginate and pinch off. The outer surface of these vesicles is covered with a lattice-like network of COP (coat protein complex) proteins, either COPI or COPII. COPI coated vesicles transport backwards from the cisternae of the GOLGI APPARATUS to the rough endoplasmic reticulum (ENDOPLASMIC RETICULUM, ROUGH), while COPII coated vesicles transport forward from the rough endoplasmic reticulum to the Golgi apparatus.", "PM": "2001", "HN": "2001", "MR": "20030709", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022181"}, {"RECTYPE": "D", "MH": "Chromosomes, Artificial", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Artificial Chromosomes|T075|NON|EQV|NLM (2001)|000210|abcdef", "ENTRY": "Chromosome, Artificial", "MN": "G05.360.337.249", "MH_TH": "NLM (2001)", "ST": "T075", "AN": "coord with specific organism /genet only if particularly discussed; for insertion of the artificial chromosome, coord with GENE TRANSFER TECHNIQUES", "PI": "Chromosomes (1992-2000)", "MS": "DNA constructs that are composed of, at least, elements such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, that are required for successful replication, propagation to and maintenance in progeny cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.", "PM": "2001", "HN": "2001", "MR": "20130709", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022201"}, {"RECTYPE": "D", "MH": "Chromosomes, Artificial, Bacterial", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Bacterial Artificial Chromosomes|T075|NON|EQV|NLM (2001)|000210|BACT ARTIFICIAL CHROMOSOMES|abcdefv", "ENTRY": "Chromosome, Bacterial Artificial", "MN": "G05.360.337.249.170", "MH_TH": "NLM (2002)", "ST": "T075", "AN": "coord with specific bacterium /genet only if particularly discussed", "PI": "Chromosomes, Bacterial (1994-2000)", "MS": "DNA constructs that are composed of, at least, a REPLICATION ORIGIN, for successful replication, propagation to and maintenance as an extra chromosome in bacteria. In addition, they can carry large amounts (about 200 kilobases) of other sequence for a variety of bioengineering purposes.", "PM": "2002; see CHROMOSOMES, BACTERIAL ARTIFICIAL 2001", "HN": "2002(2001)", "MR": "20130709", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022202"}, {"RECTYPE": "D", "MH": "Chromosomes, Artificial, Mammalian", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Mammalian Artificial Chromosomes|T075|NON|EQV|NLM (2001)|000210|abcdef", "ENTRY": "Mammalian Artificial Chromosome", "MN": "G05.360.337.249.190", "MH_TH": "NLM (2002)", "ST": "T075", "AN": "coord with specific animal /genet only if particularly discussed", "PI": "Chromosomes (1994-2000)", "MS": "DNA constructs that are composed of, at least, all elements, such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, that are required for successful replication, propagation to and maintainance in progeny mammalian cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.", "PM": "2002; see CHROMOSOMES, MAMMALIAN ARTIFICIAL 2001", "HN": "2002(2001)", "MR": "20130709", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022221"}, {"RECTYPE": "D", "MH": "Chromosomes, Artificial, Human", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Human Artificial Chromosomes|T075|NON|EQV|NLM (2001)|000210|abcdef", "ENTRY": "Human Artificial Chromosome", "MN": "G05.360.337.249.190.117", "MH_TH": "NLM (2002)", "ST": "T075", "AN": "coord with specific human chromosome /genet only if particularly discussed", "PI": "Chromosomes (1992-2000)", "MS": "DNA constructs that are composed of, at least, all elements, such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, required for successful replication, propagation to and maintainance in progeny human cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.", "PM": "2002; see CHROMOSOMES, HUMAN ARTIFICIAL 2001", "HN": "2002(2001)", "MR": "20130709", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022222"}, {"RECTYPE": "D", "MH": "Vaccines, Subunit", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Subunit Vaccine|T121|T129|NON|EQV|NLM (2021)|191126|abbcdef", "ENTRY": "Vaccine, Subunit", "MN": "D20.215.894.860", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "IM general only; coord NIM with specific vaccine (IM)", "PI": "Vaccines, Synthetic (1978-2000)", "MS": "Vaccines consisting of one or more antigens that stimulate a strong immune response. They are purified from microorganisms or produced by recombinant DNA techniques, or they can be chemically synthesized peptides.", "PM": "2001", "HN": "2001", "MR": "20230522", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022223"}, {"RECTYPE": "D", "MH": "Parainfluenza Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Parainfluenza", "MN": "D20.215.894.899.500", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "coord IM with specific parainfluenza virus /immunol (IM)", "PI": "Viral Vaccines (1964-2000)", "MS": "Vaccines or candidate vaccines used to prevent infection with parainfluenza viruses in humans and animals.", "PM": "2001", "HN": "2001", "MR": "20050630", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022241"}, {"RECTYPE": "D", "MH": "Pneumococcal Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pneumococcal Vaccine|T121|T129|NON|EQV|NLM (2021)|191129|abbcdef", "ENTRY": "Vaccines, Pneumococcal", "MN": "D20.215.894.135.750.600", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Bacterial Vaccines (1965-2000)", "MS": "Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE.", "PM": "2001; PNEUMOVAX (now PNEUMOCOCCAL VACCINES) was indexed under BACTERIAL VACCINES 1983-2000 & POLYSACCHARIDES, BACTERIAL 1978-1982", "HN": "2001; use PNEUMOCOCCAL VACCINES (NM) to search PNEUMOVAX 1978-2000", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022242"}, {"RECTYPE": "D", "MH": "Rotavirus Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rotavirus Vaccine|T121|T129|NON|EQV|NLM (2021)|191227|abbcdef", "ENTRY": "Vaccines, Rotavirus", "MN": "D20.215.894.899.760", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1979-2000)", "MS": "Vaccines or candidate vaccines used to prevent infection with ROTAVIRUS.", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022243"}, {"RECTYPE": "D", "MH": "Respiratory Syncytial Virus Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Respiratory Syncytial Virus Vaccine|T121|T129|NON|EQV|NLM (2021)|191122|abbcdef", "ENTRY": "Vaccines, RSV", "MN": "D20.215.894.899.730", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1966-2000)", "MS": "Vaccines or candidate vaccines used to prevent infection with RESPIRATORY SYNCYTIAL VIRUSES.", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022261"}, {"RECTYPE": "D", "MH": "Shigella Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Shigella", "MN": "D20.215.894.135.720", "FX": "Shigella dysenteriae", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "coord IM with specific Shigella species /immunol (IM)", "PI": "Bacterial Vaccines (1967-2000)", "MS": "Vaccines or candidate vaccines used to prevent bacillary dysentery (DYSENTERY, BACILLARY) caused by species of SHIGELLA.", "PM": "2001", "HN": "2001", "MR": "20050630", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022281"}, {"RECTYPE": "D", "MH": "Vaccines, Acellular", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acellular Vaccine|T121|T129|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Vaccine, Acellular", "MN": "D20.215.894.860.900", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "IM general only; coord NIM with specific vaccine (IM)", "MS": "Vaccines that are produced by using only the antigenic part of the disease causing organism. They often require a \"booster\" every few years to maintain their effectiveness.", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022282"}, {"RECTYPE": "D", "MH": "Herpesvirus Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Herpesvirus", "MN": "D20.215.894.899.290", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "coord IM with specific herpesvirus /immunol (IM) but note specifics", "PI": "Viral Vaccines (1965-2000)", "MS": "Vaccines or candidate vaccines used to prevent infection by any virus from the family HERPESVIRIDAE.", "PM": "2001", "HN": "2001", "MR": "20050630", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022283"}, {"RECTYPE": "D", "MH": "Herpes Simplex Virus Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "HSV Vaccines|T121|T129|ACX|EQV|NLM (2001)|000217|abbcdef", "ENTRY": "Vaccines, Simplexvirus", "MN": "D20.215.894.899.290.400", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "coord IM with specific simplexvirus /immunol (IM)", "PI": "Viral Vaccines (1973-2000)", "MS": "Vaccines or candidate vaccines used to prevent infection with viruses from the genus SIMPLEXVIRUS. This includes vaccines for HSV-1 and HSV-2.", "PM": "2001", "HN": "2001", "MR": "20050630", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022301"}, {"RECTYPE": "D", "MH": "Japanese Encephalitis Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Japanese Encephalitis Vaccine|T121|T129|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Vaccines, Japanese Encephalitis", "MN": "D20.215.894.899.320", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "vaccines to prevent infections caused by ENCEPHALITIS VIRUS, JAPANESE only, not ENCEPHALITIS VIRUSES, JAPANESE.", "PI": "Viral Vaccines (1966-2000)", "MS": "Vaccines or candidate vaccines used to prevent infection with Japanese B encephalitis virus (ENCEPHALITIS VIRUS, JAPANESE).", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022321"}, {"RECTYPE": "D", "MH": "Yellow Fever Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccine, Yellow Fever", "MN": "D20.215.894.899.970", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1965-2000)", "MS": "Vaccine used to prevent YELLOW FEVER. It consists of a live attenuated 17D strain of the YELLOW FEVER VIRUS.", "PM": "2001", "HN": "2001", "MR": "20050630", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022341"}, {"RECTYPE": "D", "MH": "Escherichia coli Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "E coli Vaccines|T121|T129|NON|EQV|NLM (2001)|000407|abbcdef", "ENTRY": "Vaccines, Escherichia coli", "MN": "D20.215.894.135.390", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Bacterial Vaccines (1971-2000)", "MS": "Vaccines or candidate vaccines used to prevent or treat both enterotoxigenic and enteropathogenic Escherichia coli infections.", "PM": "2001; ESCHERICHIA COLI VACCINE was indexed under BACTERIAL VACCINES 1983-2000", "HN": "2001; use ESCHERICHIA COLI VACCINES (NM) to search ESCHERICHIA COLI VACCINE 1983-2000", "MR": "20050630", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022361"}, {"RECTYPE": "D", "MH": "Hepatitis A Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Hepatovirus", "MN": "D20.215.894.899.955.395", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Viral Hepatitis Vaccines (1987-2000)", "MS": "Vaccines or candidate vaccines used to prevent infection with hepatitis A virus (HEPATOVIRUS).", "PM": "2001; Hepatitis A Vaccine was indexed under VIRAL HEPATITIS VACCINES 1992-2000", "HN": "2001; use HEPATITIS A VACCINES (NM) to search HEPATITIS A VACCINE 1992-2000", "MR": "20050630", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022362"}, {"RECTYPE": "D", "MH": "Meningococcal Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Meningococcal", "MN": "D20.215.894.135.500", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Bacterial Vaccines (1965-2000)", "MS": "Vaccines or candidate vaccines used to prevent infection with NEISSERIA MENINGITIDIS.", "PM": "2001; MENINGOCOCCAL VACCINE was indexed under BACTERIAL VACCINES 1983-2000", "HN": "2001; use MENINGOCOCCAL VACCINES (NM) to search MENINGOCOCCAL VACCINE 1983-2000", "MR": "20160701", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022401"}, {"RECTYPE": "D", "MH": "Pseudorabies Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Pseudorabies", "MN": "D20.215.894.899.632", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1971-2000)", "MS": "Vaccines or candidate vaccines used to prevent PSEUDORABIES (Aujeszky's disease), a herpesvirus of swine and other animals.", "PM": "2001; PSUEDORABIES VACCINE was indexed under VIRAL VACCINES 1992-2000 & VACCINES, ATTENUATED 1992-1993", "HN": "2001; use PSEUDORABIES VACCINES (NM) to search PSEUDORABIES VACCINE 1992-2000", "MR": "20050630", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022421"}, {"RECTYPE": "D", "MH": "Diphtheria-Tetanus Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DT Vaccine|T121|T129|ACX|EQV|NLM (2001)|abbcde", "ENTRY": "Vaccine, Diphtheria-Tetanus", "MN": "D20.215.894.815.320", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES and DIPHTHERIA-TETANUS-PERTUSSIS VACCINE are also available", "PI": "Vaccines, Combined (1994-2000)", "MS": "A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine (DIPHTHERIA-TETANUS-PERTUSSIS VACCINE) when PERTUSSIS VACCINE is contraindicated.", "PM": "2001; DT VACCINE (now DIPHTHERIA-TETANUS VACCINE) was indexed under DIPHTHERIA TOXOID & TETANUS TOXOID 1983-2000; VACCINES, COMBINED 1994-2000; and DRUG COMBINATIONS 1983-1995", "HN": "2001; use DIPHTHERIA-TETANUS VACCINE (NM) to search DT VACCINE 1983-2000", "MR": "20130709", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022422"}, {"RECTYPE": "D", "MH": "Myeloid Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Myeloid Cell", "MN": "A11.627", "MH_TH": "NLM (2001)", "ST": "T025", "MS": "The classes of BONE MARROW-derived blood cells in the monocytic series (MONOCYTES and their precursors) and granulocytic series (GRANULOCYTES and their precursors).", "PM": "2001", "HN": "2001", "MR": "20030709", "DA": "20000706", "DC": "1", "DX": "20010101", "UI": "D022423"}, {"RECTYPE": "D", "MH": "Caveolins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Caveolin|T116|T123|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Proteins, Caveolin", "MN": "D12.776.543.990.100", "FX": "Caveolae", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1992-2000)", "MS": "The main structural proteins of CAVEOLAE. Several distinct genes for caveolins have been identified.", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022461"}, {"RECTYPE": "D", "MH": "Vaccines, Edible", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Edible Vaccines", "MN": "D23.050.865.915", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "IM general only; coord NIM with specific vaccine (IM)", "MS": "Vaccines or candidate vaccines derived from edible plants. Transgenic plants (PLANTS, TRANSGENIC) are used as recombinant protein production systems and the edible plant tissue functions as an oral vaccine.", "PM": "2001", "HN": "2001", "MR": "20050630", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022462"}, {"RECTYPE": "D", "MH": "Cytomegalovirus Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cytomegalovirus Vaccine|T121|T129|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Vaccines, Cytomegalovirus", "MN": "D20.215.894.899.120", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1974-2000)", "MS": "Vaccines or candidate vaccines used to prevent infection with CYTOMEGALOVIRUS.", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022482"}, {"RECTYPE": "D", "MH": "Marek Disease Vaccines", "DE": "MAREK DIS VACCINES", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Marek's Disease", "MN": "D20.215.894.899.290.500", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1970-2000)", "MS": "Vaccines or candidate vaccines used to prevent MAREK DISEASE, an avian disease caused by a herpesvirus.", "PM": "2001", "HN": "2001", "MR": "20050630", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022501"}, {"RECTYPE": "D", "MH": "Stress Fibers", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Stress Fibre", "MN": "A11.284.430.214.190.750.050.830", "MH_TH": "NLM (2001)", "ST": "T026", "PI": "Cytoskeleton (1978-2000)", "MS": "Bundles of actin filaments (ACTIN CYTOSKELETON) and myosin-II that span across the cell attaching to the cell membrane at FOCAL ADHESIONS and to the network of INTERMEDIATE FILAMENTS that surrounds the nucleus.", "PM": "2001", "HN": "2001", "MR": "20110701", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022502"}, {"RECTYPE": "D", "MH": "Ligase Chain Reaction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Reactions, Ligase Chain", "MN": "E05.393.620.311", "FX": "Polymerase Chain Reaction", "MH_TH": "NLM (2001)", "ST": "T063", "PI": "Gene Amplification (1980-2000)", "MS": "A DNA amplification technique based upon the ligation of OLIGONUCLEOTIDE PROBES. The probes are designed to exactly match two adjacent sequences of a specific target DNA. The chain reaction is repeated in three steps in the presence of excess probe: (1) heat denaturation of double-stranded DNA, (2) annealing of probes to target DNA, and (3) joining of the probes by thermostable DNA ligase. After the reaction is repeated for 20-30 cycles the production of ligated probe is measured.", "PM": "2001", "HN": "2001", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022521"}, {"RECTYPE": "D", "MH": "Streptococcal Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Streptococcal", "MN": "D20.215.894.135.750", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "coord IM with specific Streptococcus species /immunol (IM)", "PI": "Bacterial Vaccines (1970-2000)", "MS": "Vaccines or candidate vaccines used to prevent STREPTOCOCCAL INFECTIONS.", "PM": "2001", "HN": "2001", "MR": "20050630", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022541"}, {"RECTYPE": "D", "MH": "Measles-Mumps-Rubella Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "MMR Vaccine|T121|T129|ACX|EQV|NLM (2001)|abbcde", "ENTRY": "Vaccine, Mumps-Measles-Rubella", "MN": "D20.215.894.899.779.500", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Rubella Vaccine (1986-2000)", "MS": "A combined vaccine used to prevent MEASLES; MUMPS; and RUBELLA.", "PM": "2001; MEASLES, MUMPS, RUBELLA VACCINE was indexed under MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE, & VACCINES, COMBINED 1986-2000 and under DRUG COMBINATIONS 1986-1995", "HN": "2001; use MEASLES-MUMPS-RUBELLA VACCINE (NM) to search MEASLES, MUMPS, RUBELLA VACCINE 1986-2000", "MR": "20150623", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022542"}, {"RECTYPE": "D", "MH": "Advanced Cardiac Life Support", "AQ": "AE CL EC ED ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Life Support, Advanced Cardiac|T061|NON|EQV|NLM (2001)|000310|abcdef", "MN": "N02.421.585.440.028", "FX": "Heart Arrest", "MH_TH": "NLM (2001)", "ST": "T061", "PI": "Resuscitation (1971-1991)", "MS": "The use of sophisticated methods and equipment to treat cardiopulmonary arrest. Advanced Cardiac Life Support (ACLS) includes the use of specialized equipment to maintain the airway, early defibrillation and pharmacological therapy.", "PM": "2001", "HN": "2001", "MR": "20150706", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022561"}, {"RECTYPE": "D", "MH": "Salmonella Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaccines, Salmonella|T121|T129|NON|EQV|NLM (2001)|000504|abbcdef", "ENTRY": "Vaccines, Salmonellosis", "MN": "D20.215.894.135.685", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "coord IM with specific Salmonella species /immunol (IM) but note TYPHOID-PARATYPHOID VACCINES is also available", "PI": "Bacterial Vaccines (1968-2000)", "MS": "Vaccines or candidate vaccines used to prevent infection with SALMONELLA. This includes vaccines used to prevent TYPHOID FEVER or PARATYPHOID FEVER; (TYPHOID-PARATYPHOID VACCINES), and vaccines used to prevent nontyphoid salmonellosis.", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022562"}, {"RECTYPE": "D", "MH": "Vaccines, Marker", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Marker Vaccines|T121|T129|NON|EQV|NLM (2001)|000313|abbcdef", "ENTRY": "Vaccine, Marker", "MN": "D20.215.894.845", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "IM general only; coord NIM with specific vaccine (IM)", "MS": "Vaccines used in conjunction with diagnostic tests to differentiate vaccinated animals from carrier animals. Marker vaccines can be either a subunit or a gene-deleted vaccine.", "PM": "2001", "HN": "2001", "MR": "20210630", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022581"}, {"RECTYPE": "D", "MH": "Shiga Toxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vero Toxins|T109|T131|NON|EQV|NLM (2001)|000315|abbcdef", "ENTRY": "Toxins, Vero", "MN": "D23.946.330.575", "PA": "Protein Synthesis Inhibitors", "FX": "Dysentery", "MH_TH": "NLM (2001)", "ST": "T131", "RN": "0", "AN": "SHIGA TOXIN is also available", "PI": "Bacterial Toxins (1980-2000)", "MS": "A class of toxins that inhibit protein synthesis by blocking the interaction of ribosomal RNA; (RNA, RIBOSOMAL) with PEPTIDE ELONGATION FACTORS. They include SHIGA TOXIN which is produced by SHIGELLA DYSENTERIAE and a variety of shiga-like toxins that are produced by pathologic strains of ESCHERICHIA COLI such as ESCHERICHIA COLI O157.", "PM": "2001; VERO CYTOTOXIN, VERO CELL CYTOTOXIN, VERO TOXIN & VERO TOXIN were indexed under BACTERIAL TOXINS 1980-2000", "HN": "2001; for VERO CYTOTOXIN, VERO CELL CYTOTOXIN, VERO TOXIN & VERO TOXIN use SHIGA-LIKE TOXIN I (NM) 1980-2000", "MR": "20180629", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022603"}, {"RECTYPE": "D", "MH": "Shiga Toxin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Stx Protein, Shigella dysenteria|T109|T131|NON|EQV|NLM (2001)|000314|abbcdef", "ENTRY": "Toxin, Shigella", "MN": "D23.946.330.575.100", "FX": "Shigella dysenteriae", "MH_TH": "NLM (2001)", "ST": "T131", "RN": "75757-64-1", "AN": "SHIGA TOXINS is available", "PI": "Bacterial Toxins (1980-2000)", "MS": "A toxin produced by SHIGELLA DYSENTERIAE. It is the prototype of class of toxins that inhibit protein synthesis by blocking the interaction of ribosomal RNA; (RNA, RIBOSOMAL) with PEPTIDE ELONGATION FACTORS.", "PM": "2001; SHIGA TOXIN was indexed under BACTERIAL TOXINS 1980-2000", "HN": "2001; use SHIGA TOXINS (NM) 1980-2000", "MR": "20200527", "DA": "20000627", "DC": "1", "DX": "20010101", "UI": "D022621"}, {"RECTYPE": "D", "MH": "Shiga Toxin 1", "DS": "SHIGA TOXIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Shiga Like Toxin I", "MN": "D23.946.330.575.120", "FX": "Shiga-Toxigenic Escherichia coli", "MH_TH": "NLM (2001)", "ST": "T131", "RN": "0", "PI": "Bacterial Toxins (1980-2000)", "MS": "A toxin produced by certain pathogenic strains of ESCHERICHIA COLI such as ESCHERICHIA COLI O157. It is closely related to SHIGA TOXIN produced by SHIGELLA DYSENTERIAE.", "PM": "2008; see SHIGA-LIKE TOXIN 1 2001-2007, see BACTERIAL TOXINS 1997-2000; SHIGA-LIKE TOXIN 1 was indexed under BACTERIAL TOXINS 1984-2000", "HN": "2008 (1984)", "MR": "20180629", "DA": "20000627", "DC": "1", "DX": "20010101", "UI": "D022622"}, {"RECTYPE": "D", "MH": "Shiga Toxin 2", "DS": "SHIGA TOXIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SLT II", "MN": "D23.946.330.575.124", "FX": "Shiga-Toxigenic Escherichia coli", "MH_TH": "NLM (2001)", "ST": "T131", "RN": "0", "PI": "Bacterial Toxins (1980-2000)", "MS": "A toxin produced by certain pathogenic strains of ESCHERICHIA COLI such as ESCHERICHIA COLI O157. It shares 50-60% homology with SHIGA TOXIN and SHIGA TOXIN 1.", "PM": "2008; see SHIGA-LIKE TOXIN II 2001-2007, see BACTERIAL TOXINS 1997-2000; SHIGA-LIKE TOXIN II was indexed under BACTERIAL TOXINS 1988-2000", "HN": "2008 (1988)", "MR": "20180629", "DA": "20000627", "DC": "1", "DX": "20010101", "UI": "D022641"}, {"RECTYPE": "D", "MH": "Vaccines, Contraceptive", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Contraceptive Vaccines|T121|T129|NON|EQV|POPLINE (1994)|950322|abbcdef", "ENTRY": "Vaccine, Contraceptive", "MN": "D20.215.894.818", "FX": "Contraception, Immunologic", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Vaccines (1977-2000)", "MS": "Vaccines or candidate vaccines used to prevent conception.", "PM": "2001; see CONTRACEPTION, IMMUNOLOGIC 1996-2000", "HN": "2001; use CONTRACEPTION, IMMUNOLOGIC 1996-2000", "MR": "20210304", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022642"}, {"RECTYPE": "D", "MH": "RNA, Untranslated", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Untranslated RNA", "MN": "D13.444.735.790", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "AN": "general: prefer specifics; do not confuse with RNA, MESSENGER, STORED", "MS": "RNA which does not code for protein but has some enzymatic, structural or regulatory function. Although ribosomal RNA (RNA, RIBOSOMAL) and transfer RNA (RNA, TRANSFER) are also untranslated RNAs they are not included in this scope.", "PM": "2001", "HN": "2001", "MR": "20110624", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022661"}, {"RECTYPE": "D", "MH": "Diphtheria-Tetanus-acellular Pertussis Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diphtheria-Tetanus-acellular Pertussis Vaccine|T121|T129|NON|EQV|NLM (2022)|200831|abbcdef", "ENTRY": "Vaccines, Diphtheria-Tetanus-acellular Pertussis", "MN": "D20.215.894.860.900.267", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "DIPHTHERIA-TETANUS VACCINE and DIPHTHERIA-TETANUS-PERTUSSIS VACCINE are also available", "PI": "Diphtheria-Tetanus-Pertussis Vaccine (1996-2000)", "MS": "Combined vaccines consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and an acellular form of PERTUSSIS VACCINE. At least five different purified antigens of B. pertussis have been used in various combinations in these vaccines.", "PM": "2001; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINE was indexed under DIPHTHERIA-TETANUS-PERTUSSIS VACCINE 1997-2000", "HN": "2001; use DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES (NM) to search DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINE 1997-2000", "MR": "20210630", "DA": "20000628", "DC": "1", "DX": "20010101", "UI": "D022681"}, {"RECTYPE": "D", "MH": "Virosomes", "AQ": "AA AD AE AG AI BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Virosome", "MN": "J01.637.087.500.900", "FX": "Vaccines, Virosome", "MH_TH": "NLM (2001)", "ST": "T116", "RN": "0", "AN": "when used as a vehicle in drug ther, index specific drug /admin (IM) + VIROSOMES (NIM without qualif)", "PI": "Liposomes (1975-2000)", "MS": "Semi-synthetic complex derived from nucleic-acid free viral particles. They are essentially reconstituted viral coats, where the infectious nucleocapsid is replaced by a compound of choice. Virosomes retain their fusogenic activity and thus deliver the incorporated compound (antigens, drugs, genes) inside the target cell. They can be used for vaccines (VACCINES, VIROSOME), drug delivery, or gene transfer.", "PM": "2001", "HN": "2001", "MR": "20060705", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022701"}, {"RECTYPE": "D", "MH": "Receptors, Adrenergic, beta-3", "DE": "RECEPT ADREN BETA 3", "DS": "RECEPTORS ADRENERGIC BETA 3", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "beta-3 Adrenergic Receptors|T116|T192|NON|EQV|NLM (2001)|000317|BETA ADRENERGIC RECEPTORS 03|BETA 3 ADREN RECEPT|abbcdefsv", "ENTRY": "beta-3 Receptors, Adrenergic", "MN": "D12.776.543.750.720.330.300.340.300", "EC": "antagonists & inhibitors:Adrenergic beta-3 Receptor Antagonists", "MH_TH": "NLM (2001)", "ST": "T192", "RN": "0", "PI": "Receptors, Adrenergic, beta (1977-2000)", "MS": "A subclass of beta-adrenergic receptors (RECEPTORS, ADRENERGIC, BETA). The beta-3 adrenergic receptors are the predominant beta-adrenergic receptor type expressed in white and brown ADIPOCYTES and are involved in modulating ENERGY METABOLISM and THERMOGENESIS.", "PM": "2001; ADRENERGIC BETA-3 RECEPTOR now RECEPTORS, ADRENERGIC, BETA-3 was indexed under RECEPTORS, ADRENERGIC, BETA 1977-2000", "HN": "2001; use RECEPTORS, ADRENERGIC, BETA-3 (NM) 1977-2000", "MR": "20200527", "DA": "20000623", "DC": "1", "DX": "20010101", "UI": "D022702"}, {"RECTYPE": "D", "MH": "Vaccines, Virosome", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Virosome Vaccines", "MN": "D23.050.865.940", "FX": "Virosomes", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "AN": "IM general only; coord NIM with specific vaccine (IM)", "MS": "Vaccines using VIROSOMES as the antigen delivery system that stimulates the desired immune response.", "PM": "2001", "HN": "2001", "MR": "20050630", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022721"}, {"RECTYPE": "D", "MH": "Thermogenesis", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Heat Production|T040|NON|EQV|UNK (19XX)|740329|abcdef", "ENTRY": "Thermogenesis, Nonshivering", "MN": "G16.012.500.535.778", "MH_TH": "NLM (2001)", "ST": "T040", "PI": "Body Temperature Regulation (1966-2000)", "MS": "The generation of heat in order to maintain body temperature. The uncoupled oxidation of fatty acids contained within brown adipose tissue and SHIVERING are examples of thermogenesis in MAMMALS.", "PM": "2001; for HEAT PRODUCTION see BODY TEMPERATURE REGULATION 1975-2000", "HN": "2001; for HEAT PRODUCTION use BODY TEMPERATURE REGULATION 1975-2000", "MR": "20160701", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022722"}, {"RECTYPE": "D", "MH": "Gene Transfer, Horizontal", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Recombination, Interspecies|T045|NON|NRW|NLM (2004)|021010|abcdef", "ENTRY": "Lateral Gene Transfers", "MN": "G05.728.390", "MH_TH": "NLM (2001)", "ST": "T045", "AN": "note category: do not confuse with GENE TRANSFER TECHNIQUES", "MS": "The naturally occurring transmission of genetic information between organisms, related or unrelated, circumventing parent-to-offspring transmission. Horizontal gene transfer may occur via a variety of naturally occurring processes such as GENETIC CONJUGATION; GENETIC TRANSDUCTION; and TRANSFECTION. It may result in a change of the recipient organism's genetic composition (TRANSFORMATION, GENETIC).", "PM": "2001", "HN": "2001", "MR": "20160617", "DA": "20000706", "DC": "1", "DX": "20010101", "UI": "D022761"}, {"RECTYPE": "D", "MH": "CCAAT-Enhancer-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "C-EBP Proteins|T116|T123|ACX|EQV|NLM (2001)|000321|abbcdef", "ENTRY": "Nuclear Protein, C-EBP", "MN": "D12.776.930.127.124", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Nuclear Proteins (1991-2000)", "MS": "A class of proteins that were originally identified by their ability to bind the DNA sequence CCAAT. The typical CCAAT-enhancer binding protein forms dimers and consists of an activation domain, a DNA-binding basic region, and a leucine-rich dimerization domain (LEUCINE ZIPPERS). CCAAT-BINDING FACTOR is structurally distinct type of CCAAT-enhancer binding protein consisting of a trimer of three different subunits.", "PM": "2001; C-EBP NUCLEAR PROTEIN was indexed under DNA-BINDING PROTEINS & NUCLEAR PROTEINS 1989-2000; CCAAT SEQUENCE-SPECIFIC DNA-BINDING PROTEINS was indexed under DNA-BINDING PROTEINS 1988-2000", "HN": "2001; for C-EBP NUCLEAR PROTEIN use CCAAT-ENHANCER-BINDING PROTEINS (NM) 1989-2000; for CCAAT SEQUENCE-SPECIFIC DNA-BINDING PROTEINS use CCAAT-ENHANCER BINDING PROTEINS 1988-2000", "MR": "20130709", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022762"}, {"RECTYPE": "D", "MH": "CCAAT-Enhancer-Binding Protein-alpha", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "C-EBP alpha|T116|T123|ACX|EQV|NLM (2001)|000321|abbcdef", "ENTRY": "CCAAT Enhancer Binding Protein alpha", "MN": "D12.776.930.127.124.500", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "PI": "Nuclear Proteins (1990-2000)", "MS": "A CCAAT-enhancer-binding protein found in LIVER; ADIPOSE TISSUE; INTESTINES; LUNG; ADRENAL GLANDS; PLACENTA; OVARY and peripheral blood mononuclear cells (LEUKOCYTES, MONONUCLEAR). Experiments with knock-out mice have demonstrated that CCAAT-enhancer binding protein-alpha is essential for the functioning and differentiation of HEPATOCYTES and ADIPOCYTES.", "PM": "2001; C-EBPALPHA was indexed under NUCLEAR PROTEINS & DNA-BINDING PROTEINS 1996-2000", "HN": "2001; C-EBPALPHA use CCAAT-ENHANCER-BINDING PROTEINS (NM) 1996-2000", "MR": "20050630", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022763"}, {"RECTYPE": "D", "MH": "Hepatocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Hepatic Cells|T025|NON|EQV|NLM (2001)|000320|abcdef", "ENTRY": "Hepatocyte", "MN": "A11.436.348", "MH_TH": "NLM (2001)", "ST": "T025", "PI": "Liver (1966-2000)", "MS": "The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.", "PM": "2001", "HN": "2001", "MR": "20080708", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022781"}, {"RECTYPE": "D", "MH": "CCAAT-Enhancer-Binding Protein-beta", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NF-IL6|T116|T123|ABB|EQV|NLM (2001)|abbcde", "ENTRY": "Transcription Factor, LAP", "MN": "D12.776.930.127.124.750", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "PI": "Nuclear Proteins (1994-2000)", "MS": "A CCAAT-enhancer-binding protein found in LIVER; INTESTINES; LUNG and ADIPOSE TISSUE. It is an important mediator of INTERLEUKIN-6 signaling.", "PM": "2001; C-EBP BETA (now CCAAT-ENHANCER-BINDING PROTEIN-BETA) was indexed under DNA-BINDING PROTEINS and NUCLEAR PROTEINS 1994-2000; LIVER-ENRICHED INHIBITING PROTEIN was indexed under REPRESSOR PROTEINS 1995-2000", "HN": "2001; use CCAAT-ENHANCER-BINDING PROTEINS (NM) 1994-2000; for LIVER-ENRICHED INHIBITING PROTEIN use CCAAT-ENHANCER-BINDING PROTEIN-BETA (NM) 1995-2000;", "MR": "20050711", "DA": "20000623", "DC": "1", "DX": "20010101", "UI": "D022782"}, {"RECTYPE": "D", "MH": "Torque teno virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Transfusion-Transmitted Virus|T005|NON|EQV|NLM (2001)|000320|abcdef", "ENTRY": "viruses, SEN", "MN": "B04.280.038.500", "MH_TH": "NLM (2005)", "ST": "T005", "RN": "txid68887", "RR": "txid136966", "AN": "a specific virus, not any virus transmitted by transfusion; infection: coord IM with DNA VIRUS INFECTIONS (IM)", "PI": "Hepatitis Viruses (1998-1999)", "MS": "A species of non-enveloped DNA virus in the genus ANELLOVIRUS, associated with BLOOD TRANSFUSIONS; and HEPATITIS. However, no etiological role has been found for TTV in hepatitis.", "PM": "2006; see TRANSFUSION-ASSOCIATED VIRUS 2001-2005", "HN": "2006 (2001)", "MR": "20200813", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022783"}, {"RECTYPE": "D", "MH": "Complementarity Determining Regions", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Third Complementarity-Determining Regions", "MN": "G02.111.570.060.425.160", "FX": "Receptors, Antigen, T-Cell", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Immunoglobulin Variable Region (1982-2000)", "MS": "Three regions (CDR1; CDR2 and CDR3) of amino acid sequence in the IMMUNOGLOBULIN VARIABLE REGION that are highly divergent. Together the CDRs from the light and heavy immunoglobulin chains form a surface that is complementary to the antigen. These regions are also present in other members of the immunoglobulin superfamily, for example, T-cell receptors (RECEPTORS, ANTIGEN, T-CELL).", "PM": "2001; for COMPLEMENTARITY DETERMINING REGION and HYPERVARIABLE REGION see IMMUNOGLOBULIN VARIABLE REGION 1988-2000; COMPLEMENTARITY-DETERMINING REGION 3 was indexed under COMPLEMENTARITY DETERMINING REGIONS 1998-2005", "HN": "2001; for COMPLEMENTARITY DETERMINING REGION and HYPERVARIABLE REGION use IMMUNOGLOBULIN VARIABLE REGION 1988-2000", "MR": "20110624", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022801"}, {"RECTYPE": "D", "MH": "RNA Splice Sites", "AQ": "DE ES GE PH RE", "PRINT ENTRY": "Splice Donor Site|T086|T114|T123|NON|NRW|NLM (2001)|000323|abbbcdef", "ENTRY": "Splice Sites, Cryptic", "MN": "G05.360.340.024.340.137.800", "FX": "RNA Splicing", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "PI": "RNA Splicing (1982-2000)", "MS": "Nucleotide sequences located at the ends of EXONS and recognized in pre-messenger RNA by SPLICEOSOMES. They are joined during the RNA SPLICING reaction, forming the junctions between exons.", "PM": "2001", "HN": "2001", "MR": "20120703", "DA": "20000623", "DC": "1", "DX": "20010101", "UI": "D022821"}, {"RECTYPE": "D", "MH": "Hermanski-Pudlak Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hermansky Pudlak Syndrome", "MN": "C18.452.648.100.102.100.400", "MH_TH": "NLM (1991)", "ST": "T047", "PI": "Albinism, Oculocutaneous (1990-2000)", "MS": "Syndrome characterized by the triad of oculocutaneous albinism (ALBINISM, OCULOCUTANEOUS); PLATELET STORAGE POOL DEFICIENCY; and lysosomal accumulation of ceroid lipofuscin.", "PM": "2001", "HN": "2001", "MR": "20160701", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022861"}, {"RECTYPE": "D", "MH": "Trihalomethanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trihalomethane|T109|NON|EQV|UNK (19XX)|840919|abcdef", "MN": "D02.455.526.913", "MH_TH": "NLM (2001)", "ST": "T109", "RN": "0", "PI": "Freons (1984-2000)", "MS": "Methanes substituted with three halogen atoms, which may be the same or different.", "PM": "2001; see CHLOROFLUOROCARBONS, METHANE 1984-2000", "HN": "2001; use CHLOROFLUOROCARBONS, METHANE 1984-2000", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D022882"}, {"RECTYPE": "D", "MH": "Unpublished Work", "PRINT ENTRY": "Unpublished Works|T170|NON|EQV|NLM (2008)|070626|abcdef", "ENTRY": "Unpublished Documents|T170|NON|NRW|NLM (2008)|070626|abcdef", "MN": "V02.950", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. CATALOGER: Used by collaborating partners only", "MS": "Work that has not been formally published.", "HN": "2008(2000)", "MR": "20180702", "DA": "20000331", "DC": "2", "DX": "20000331", "UI": "D022902"}, {"RECTYPE": "D", "MH": "Government Publication", "ENTRY": "Government Document|T170|NON|EQV|NLM (2019)|180702|abcdef", "MN": "V02.500", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "This heading is used as a Publication Type. Government publications as a subject are indexed under the main heading GOVERNMENT PUBLICATIONS AS TOPIC. CATALOGER: Used by collaborating partners only ", "MS": "Work consisting of publications issued by local, regional, or national governments or by their agencies or subdivisions.", "HN": "2019(2000)", "MR": "20190705", "DA": "20000331", "DC": "2", "DX": "20000331", "UI": "D022903"}, {"RECTYPE": "D", "MH": "Book Review", "PRINT ENTRY": "Book Reviews|T170|NON|EQV|NLM (2008)|070622|abcdef", "MN": "V02.180", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. INDEXER: Do not use ", "MS": "Work consisting of critical analyses of books or other monographic works.", "HN": "2008(2000)", "MR": "20180702", "DA": "20000331", "DC": "2", "DX": "20000331", "UI": "D022921"}, {"RECTYPE": "D", "MH": "Fictional Work", "PRINT ENTRY": "Fictional Works|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V02.450", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type.  Fictional works as a subject are indexed under the main heading FICTIONAL WORKS AS TOPIC. INDEXER: Do not use ", "MS": "Work consisting of creative writing, not presented as factual.", "HN": "2008(2000)", "MR": "20180702", "DA": "20000331", "DC": "2", "DX": "20000331", "UI": "D022922"}, {"RECTYPE": "D", "MH": "Textbook", "PRINT ENTRY": "Textbooks|T170|NON|EQV|NLM (2008)|070626|abcdef", "MN": "V02.660.500", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Textbooks as a subject are indexed under the main heading TEXTBOOKS AS TOPIC. CATALOGER: Used by collaborating partners only", "MS": "Book intended for use in the study of specific subjects, containing systematic presentation of the principles and essential knowledge of the subjects.", "HN": "2008(2000)", "MR": "20180702", "DA": "20000331", "DC": "2", "DX": "20000331", "UI": "D022923"}, {"RECTYPE": "D", "MH": "Allelic Imbalance", "AQ": "DE ES GE IM PH RE", "ENTRY": "Imbalances, Allelic", "MN": "G05.365.590.029", "MH_TH": "NLM (2001)", "ST": "T049", "AN": "do not confuse with ALLELIC LOSS see LOSS OF HETEROZYGOSITY", "MS": "A situation where one member (allele) of a gene pair is lost (LOSS OF HETEROZYGOSITY) or amplified.", "PM": "2001", "HN": "2001", "MR": "20080708", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D022981"}, {"RECTYPE": "D", "MH": "Transplantation Tolerance", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Graft Tolerance|T040|NON|NRW|NLM (2001)|000613|abcdef", "ENTRY": "Tolerance, Transplantation", "MN": "G12.535.425.955", "FX": "Graft Survival", "MH_TH": "NLM (2001)", "ST": "T040", "PI": "Immune Tolerance (1967-2000)", "MS": "An induced state of non-reactivity to grafted tissue from a donor organism that would ordinarily trigger a cell-mediated or humoral immune response.", "PM": "2001", "HN": "2001", "MR": "20160623", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D023001"}, {"RECTYPE": "D", "MH": "Xenograft Model Antitumor Assays", "AQ": "EC HI IS MT SN ST VE", "PRINT ENTRY": "Xenograft Antitumor Assays|T059|NON|EQV|NLM (2001)|000410|abcdef", "ENTRY": "Xenograft Assays, Tumor", "MN": "E05.624.850", "MH_TH": "NLM (2001)", "ST": "T059", "MS": "In vivo methods of screening investigative anticancer drugs, biologic response modifiers or radiotherapies. Human tumor tissue or cells are transplanted into mice or rats followed by tumor treatment regimens. A variety of outcomes are monitored to assess antitumor effectiveness.", "PM": "2001; for TUMOR XENOGRAFT ASSAY see SUBRENAL CAPSULE ASSAY 1988-2000", "HN": "2001; for TUMOR XENOGRAFT ASSAY use SUBRENAL CAPSULE ASSAY 1988-2000", "MR": "20210304", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D023041"}, {"RECTYPE": "D", "MH": "Gene Order", "AQ": "DE ES GE IM PH RE", "ENTRY": "Positions, Gene", "MN": "G05.340", "FX": "Genetic Linkage", "MH_TH": "NLM (2001)", "ST": "T044", "PI": "Chromosome Mapping (1965-2000)", "MS": "The sequential location of genes on a chromosome.", "PM": "2001", "HN": "2001", "MR": "20100625", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D023061"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-8A", "DE": "RECEPT IL 8A", "DS": "RECEPTORS INTERLEUKIN 008A", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, CXCR1|T116|T129|T192|ABX|EQV|NLM (2001)|000412|RECEPTORS CXCR 001|RECEPT CXCR1|abbbcdefsv", "ENTRY": "Receptors, MDNCF", "MN": "D12.776.543.750.705.852.420.421.500", "MH_TH": "NLM (2001)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (1994-2000)", "MS": "High-affinity G-protein-coupled receptors for INTERLEUKIN-8 present on NEUTROPHILS; MONOCYTES; and BASOPHILS.", "PM": "2001; INTERLEUKIN 8 RECEPTOR was indexed under RECEPTORS, INTERLEUKIN 1994-2000, ANTIGENS, CD 1989-2000, & RECEPTORS, IMMUNOLOGIC 1989-1993", "HN": "2001; use RECEPTORS, INTERLEUKIN-8A (NM) to search INTERLEUKIN 8 RECEPTOR 1989-2000", "MR": "20170524", "DA": "20000623", "DC": "1", "DX": "20010101", "UI": "D023062"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-8B", "DE": "RECEPT IL 8B", "DS": "RECEPTORS INTERLEUKIN 008B", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, CXCR2|T116|T129|T192|ABX|EQV|NLM (2001)|000412|RECEPTORS CXCR 002|RECEPT CXCR2|abbbcdefsv", "ENTRY": "Receptors, Interleukin 8B", "MN": "D12.776.543.750.705.852.420.421.750", "MH_TH": "NLM (2001)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (1994-2000)", "MS": "High-affinity G-protein-coupled receptors for INTERLEUKIN-8 present on NEUTROPHILS; MONOCYTES; and T-LYMPHOCYTES. These receptors also bind several other CXC CHEMOKINES.", "PM": "2001; for INTERLEUKIN-8 RECEPTOR TYPE B see RECEPTORS, INTERLEUKIN-8B 1994-2000; RECEPTORS, INTERLEUKIN-8B was indexed under RECEPTORS, CHEMOKINE 1998-2000, and under RECEPTORS, INTERLEUKIN 1994-2000", "HN": "2001; for INTERLEUKIN-8 RECEPTOR TYPE B use RECEPTORS, INTERLEUKIN-8B 1994-2000", "MR": "20200527", "DA": "20000623", "DC": "1", "DX": "20010101", "UI": "D023063"}, {"RECTYPE": "D", "MH": "CCAAT-Binding Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CCAAT-Binding Factor, C-Subunit|T116|T123|NON|NRW|NLM (2001)|000420|abbcdef", "ENTRY": "Transcription Factor, CCAAT-Binding", "MN": "D12.776.930.127.124.249", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "PI": "DNA-Binding Proteins (1988-2000)", "MS": "A heterotrimeric DNA-binding protein that binds to CCAAT motifs in the promoters of eukaryotic genes. It is composed of three subunits: A, B and C.", "PM": "2001; CCAAT-BINDING FACTOR was indexed under DNA-BINDING PROTEINS 1988-2000", "HN": "2001; use CCAAT-ENHANCER-BINDING PROTEINS (NM) 1988-2000", "MR": "20050630", "DA": "20000623", "DC": "1", "DX": "20010101", "UI": "D023081"}, {"RECTYPE": "D", "MH": "Defensins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Defensin|T116|T121|T129|NON|EQV|NLM (2021)|191129|abbbcdef", "MN": "D12.776.543.695.054.200", "PA": "Anti-Infective Agents", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Proteins (1998-2000)", "MS": "Family of antimicrobial peptides that have been identified in humans, animals, and plants. They are thought to play a role in host defenses against infections, inflammation, wound repair, and acquired immunity.", "PM": "2001; DEFENSINS was indexed under PROTEINS 1999-2000 & BLOOD PROTEINS 1985-1998", "HN": "2000(1985)", "MR": "20210507", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023082"}, {"RECTYPE": "D", "MH": "beta-Defensins", "DE": "BETA DE", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Defensin|T116|T121|T129|NON|EQV|NLM (2021)|191115|abbbcdef", "ENTRY": "beta Defensins", "MN": "D12.776.543.695.054.200.075", "PA": "Anti-Infective Agents", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Proteins (1993-2000)", "MS": "DEFENSINS found mainly in epithelial cells.", "PM": "2001", "HN": "2001", "MR": "20210510", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023083"}, {"RECTYPE": "D", "MH": "alpha-Defensins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "alpha-Defensin|T116|T121|T129|NON|EQV|NLM (2021)|191115|abbbcdef", "ENTRY": "alpha Defensins", "MN": "D12.776.543.695.054.200.050", "PA": "Anti-Infective Agents", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Anti-Infective Agents (1997-2000)", "MS": "DEFENSINS found in azurophilic granules of neutrophils and in the secretory granules of intestinal PANETH CELLS.", "PM": "2001", "HN": "2001", "MR": "20210510", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D023084"}, {"RECTYPE": "D", "MH": "Anoikis", "AQ": "DE ES GE IM PH RE", "MN": "G04.146.954.035.060", "MH_TH": "NLM (2001)", "ST": "T043", "PI": "Apoptosis (1994-2000)", "MS": "APOPTOSIS triggered by loss of contact with the EXTRACELLULAR MATRIX.", "PM": "2001", "HN": "2001", "MR": "20190530", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D023102"}, {"RECTYPE": "D", "MH": "RNA, Messenger, Stored", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stored Messenger RNA|T114|T123|ACX|EQV|NLM (2001)|000501|abbcdef", "ENTRY": "mRNA, Stored", "MN": "D13.444.735.544.527", "MH_TH": "NLM (2001)", "ST": "T123", "RN": "0", "AN": "do not confuse with RNA, UNTRANSLATED", "PI": "RNA, Messenger (1966-2000)", "MS": "Messenger RNA that is stored in a masked state for translation at a later time. Distinguish from RNA, UNTRANSLATED which refers to non-messenger RNA, i.e. RNA that does not code for protein.", "PM": "2001", "HN": "2001", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023121"}, {"RECTYPE": "D", "MH": "Herpesvirus 4, Equid", "DS": "HERPESVIRUS EQUID 04", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Equine Rhinopneumonitis Virus|T005|NON|EQV|NLM (1994)|930302|abcdef", "ENTRY": "Rhinopneumonitis Viruses, Equine", "MN": "B04.280.382.100.900.440", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid10331", "AN": "infection: coordinate IM with HERPESVIRIDAE INFECTIONS (IM) ", "PI": "Varicellovirus (1994-2000)", "MS": "A species of VARICELLOVIRUS and the chief cause of rhinopneumonitis in horses.", "PM": "2001; see VARICELLOVIRUS 1994-2000; for EQUINE RHINOPNEUMONITIS VIRUS see HERPESVIRUS 1, EQUID 1994-2000, EQUINE RHINOPNEUMONITIS VIRUS 1991-1993, HERPESVIRIDAE 1981-1990, & HERPESVIRUSES 1975-1980", "HN": "2001; use VARICELLOVIRUS 1994-2000; for EQUINE RHINOPNEUMONITIS VIRUS use HERPESVIRUS 1, EQUID 1994-2000, EQUINE RHINOPNEUMONITIS VIRUS 1973-1993", "MR": "20200813", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023141"}, {"RECTYPE": "D", "MH": "Antimicrobial Cationic Peptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Microbicidal Cationic Proteins|T116|T121|T129|NON|EQV|NLM (2001)|abbbcde", "ENTRY": "Proteins, Microbicidal Cationic", "MN": "D12.776.543.695.054", "PA": "Anti-Infective Agents", "FX": "Blood Bactericidal Activity", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "PI": "Proteins (1981-2000)", "MS": "Small cationic peptides that are an important component, in most species, of early innate and induced defenses against invading microbes. In animals they are found on mucosal surfaces, within phagocytic granules, and on the surface of the body. They are also found in insects and plants. Among others, this group includes the DEFENSINS, protegrins, tachyplesins, and thionins. They displace DIVALENT CATIONS from phosphate groups of MEMBRANE LIPIDS leading to disruption of the membrane.", "PM": "2001; MICROBICIDAL CATIONIC PROTEINS (now ANTIMICROBIAL CATIONIC PEPTIDES) was indexed under PROTEINS 1981-2000", "HN": "2001; use ANTIMICROBIAL CATIONIC PEPTIDES (NM) to search MICROBICIDAL CATIONIC PROTEINS 1981-2000", "MR": "20210510", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D023181"}, {"RECTYPE": "D", "MH": "CD40 Ligand", "DS": "CD 040 LIGAND", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Ligand Superfamily Member 5|T116|T129|NON|EQV|NLM (2007)|051130|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 005|abbcdefs", "ENTRY": "gp39 Antigen, T Cell", "MN": "D23.529.374.750.124", "FX": "CD40 Antigens", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "147205-72-9", "PI": "Membrane Glycoproteins (1992-2000)", "MS": "A membrane glycoprotein and differentiation antigen expressed on the surface of T-cells that binds to CD40 ANTIGENS on B-LYMPHOCYTES and induces their proliferation. Mutation of the gene for CD40 ligand is a cause of HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1.", "PM": "2001; CD40 LIGAND was indexed under MEMBRANE GLYCOPROTEINS 1992-2000", "HN": "2001(2000)", "MR": "20230316", "DA": "20000623", "DC": "1", "DX": "20010101", "UI": "D023201"}, {"RECTYPE": "D", "MH": "Antiretroviral Therapy, Highly Active", "DE": "ANTIRETROVIRAL THER HIGHLY ACTIVE", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Highly Active Antiretroviral Therapy|T061|NON|EQV|NLM (2001)|000421|HIGHLY ACTIVE ANTIRETROVIRAL THER|abcdefv", "ENTRY": "Therapy, Combination Antiretroviral", "MN": "E02.319.310.075", "FX": "Anti-HIV Agents", "MH_TH": "NLM (2001)", "ST": "T061", "AN": "IM when general; NIM when with specific drugs", "PI": "Drug Therapy, Combination (1997-2000)", "MS": "Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.", "PM": "2001", "HN": "2001", "MR": "20210701", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D023241"}, {"RECTYPE": "D", "MH": "Glasgow Outcome Scale", "AQ": "EC HI SN ST TD VE", "ENTRY": "Scale, Glasgow Outcome", "MN": "N05.715.360.300.715.500.800.335", "MH_TH": "NLM (1990)", "ST": "T170", "PI": "Outcome and Process Assessment (Health Care) (1981-1989)", "MS": "A scale that assesses the outcome of serious craniocerebral injuries, based on the level of regained social functioning.", "PM": "2001; see GLASGOW COMA SCALE 1990-2000", "HN": "2001; use GLASGOW COMA SCALE 1990-2000", "MR": "20180629", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023261"}, {"RECTYPE": "D", "MH": "Genomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Structural Genomics|T091|NON|NRW|NLM (2022)|210514|abcdef", "ENTRY": "Genomics, Structural", "MN": "H01.158.273.343.350", "FX": "Sequence Analysis, DNA", "MH_TH": "NLM (2001)", "ST": "T091", "AN": "paleogenomics: coordinate with PALEONTOLOGY", "MS": "The systematic study of the complete DNA sequences (GENOME) of organisms. Included is construction of complete genetic, physical, and transcript maps, and the analysis of this structural genomic information on a global scale such as in GENOME WIDE ASSOCIATION STUDIES.", "PM": "2001", "HN": "2001", "MR": "20210707", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023281"}, {"RECTYPE": "D", "MH": "Nuclease Protection Assays", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Nuclease Protection Assay", "MN": "E05.393.600", "MH_TH": "NLM (2001)", "ST": "T063", "MS": "Techniques for measuring specific nucleic acid interaction with another nucleic acid or with a protein by digestion of the non-interacting nucleic acid by various nucleases. After all non-interacting regions are eliminated by nuclease digestion, the protected nucleic acid that remains is analyzed. DNA FOOTPRINTING utilizes this technique to analyze the DNA contact sites of DNA-BINDING PROTEINS.", "PM": "2001", "HN": "2001", "MR": "20130709", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D023282"}, {"RECTYPE": "D", "MH": "Protein Footprinting", "AQ": "AE CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Footprints, Protein|T034|NON|REL|NLM (2001)|000515|abcdef", "ENTRY": "Protein Footprint", "MN": "E05.393.760.705.685.690", "MH_TH": "NLM (2001)", "ST": "T063", "MS": "A method for determining points of contact between interacting proteins or binding sites of proteins to nucleic acids. Protein footprinting utilizes a protein cutting reagent or protease. Protein cleavage is inhibited where the proteins, or nucleic acids and protein, contact each other. After completion of the cutting reaction, the remaining peptide fragments are analyzed by electrophoresis.", "PM": "2001", "HN": "2001", "MR": "20020703", "DA": "20000706", "DC": "1", "DX": "20010101", "UI": "D023302"}, {"RECTYPE": "D", "MH": "Oxazolidinones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxazolidinone|T109|T121|NON|EQV|NLM (2021)|200113|abbcdef", "ENTRY": "Oxazolidin 2 one", "MN": "D03.383.129.462.600", "PA": "Protein Synthesis Inhibitors", "MH_TH": "NLM (2001)", "ST": "T121", "RN": "0", "RR": "497-25-6", "PI": "Oxazoles (1995-2000)", "MS": "Derivatives of oxazolidin-2-one. They represent an important class of synthetic antibiotic agents.", "PM": "2001; 1,3-OXAZOLIDINE-2-ONE (now OXAZOLIDIONES) was indexed under OXAZOLES 1995-2000", "HN": "2001; use OXAZOLIDINONES (NM) 1995-2000", "MR": "20200527", "DA": "20000623", "DC": "1", "DX": "20010101", "UI": "D023303"}, {"RECTYPE": "D", "MH": "Poliovirus Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Poliovirus Vaccine|T121|T129|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Vaccines, Poliovirus", "MN": "D20.215.894.899.623", "MH_TH": "NLM (2001)", "ST": "T129", "RN": "0", "MS": "Vaccines used to prevent POLIOMYELITIS. They include inactivated (POLIOVIRUS VACCINE, INACTIVATED) and oral vaccines (POLIOVIRUS VACCINE, ORAL).", "PM": "2001", "HN": "2001", "MR": "20200527", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023321"}, {"RECTYPE": "D", "MH": "Chills", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.208", "FX": "Shivering", "MH_TH": "NLM (1997)", "ST": "T184", "PI": "Shivering (1977-2000)", "MS": "The sudden sensation of being cold. It may be accompanied by SHIVERING.", "PM": "2001; see SHIVERING 1977-2000", "HN": "2001; use SHIVERING 1977-2000", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023341"}, {"RECTYPE": "D", "MH": "Validation Study", "PRINT ENTRY": "Validation Studies|T170|NON|EQV|NLM (2008)|070620|abcdef", "MN": "V03.950", "FX": "Clinical Trial", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "This heading is used as a Publication Type for original report of the conduct or results of a specific validation study. A different heading VALIDATION STUDIES AS TOPIC is used for general design, methodology, economics, etc. of validation studies. ", "MS": "Works consisting of research using processes by which the reliability and relevance of a procedure for a specific purpose are established.", "HN": "2008(2001)", "MR": "20220714", "DA": "20000622", "DC": "2", "DX": "20010101", "UI": "D023361"}, {"RECTYPE": "D", "MH": "Evaluation Study", "PRINT ENTRY": "Evaluation Studies|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V03.400", "FX": "Validation Study", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific evaluation study; a different heading EVALUATION STUDIES AS TOPIC is used for general design, methodology, economics, etc. of evaluation studies", "MS": "Works consisting of studies determining the effectiveness or utility of processes, personnel, and equipment.", "HN": "2008(2001)", "MR": "20190705", "DA": "20000622", "DC": "2", "DX": "20010101", "UI": "D023362"}, {"RECTYPE": "D", "MH": "Endpoint Determination", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Endpoint Assay|T062|NON|REL|NLM (2001)|000509|abcdef", "ENTRY": "Point Determinations, End", "MN": "E05.315", "MH_TH": "NLM (2001)", "ST": "T062", "PI": "Biological Assay (1980-2000)", "MS": "Establishment of the level of a quantifiable effect indicative of a biologic process. The evaluation is frequently to detect the degree of toxic or therapeutic effect.", "PM": "2001", "HN": "2001", "MR": "20090706", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D023381"}, {"RECTYPE": "D", "MH": "Toxicity Tests, Acute", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Acute Toxicity Tests|T060|NON|EQV|NLM (2001)|000509|abcdef", "ENTRY": "Toxicity Test, Acute", "MN": "E05.940.790", "MH_TH": "NLM (2001)", "ST": "T060", "AN": "TOXICITY TESTS, SUBACUTE is also available", "PI": "specific substance/toxicity (1966-1994)", "MS": "Experiments designed to determine the potential toxic effects of one-time, short-term exposure to a chemical or chemicals.", "PM": "2012; see ACUTE TOXICITY TESTS 2001-2011", "HN": "2012 (2001)", "MR": "20130709", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D023382"}, {"RECTYPE": "D", "MH": "Animal Use Alternatives", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Animal Research Alternatives|T059|NON|EQV|NLM (2023)|210809|abcdef", "ENTRY": "Use Alternatives, Animal", "MN": "E05.017.080", "FX": "Animal Welfare", "MH_TH": "NLM (2001)", "ST": "T059", "PI": "Animal Testing Alternatives (1985-2000)", "MS": "Alternatives to the use of animals in research, testing, and education. The alternatives may include reduction in the number of animals used, replacement of animals with a non-animal model or with animals of a species lower phylogenetically, or refinement of methods to minimize pain and distress of animals used.", "PM": "2001", "HN": "2001", "MR": "20211128", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D023401"}, {"RECTYPE": "D", "MH": "Models, Animal", "PRINT ENTRY": "Laboratory Animal Models|T008|NON|NRW|NLM (2001)|000510|abcdef", "ENTRY": "Models, Laboratory Animal", "MN": "E05.598", "FX": "Animal Experimentation", "MH_TH": "NLM (2001)", "ST": "T008", "MS": "Non-human animals, selected because of specific characteristics, for use in experimental research, teaching, or testing.", "PM": "2001", "HN": "2001", "MR": "20030709", "DA": "20000621", "DC": "1", "DX": "20010101", "UI": "D023421"}, {"RECTYPE": "D", "MH": "Skin Irritancy Tests", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Tests, Skin Irritancy", "MN": "E05.940.790.500", "MH_TH": "NLM (2001)", "ST": "T081", "MS": "Tests or bioassays that measure the skin sensitization potential of various chemicals.", "PM": "2001", "HN": "2001", "MR": "20110624", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023422"}, {"RECTYPE": "D", "MH": "Local Lymph Node Assay", "ENTRY": "LLNA|T081|ACR|EQV|NLM (2001)|000510|abcdef", "MN": "E05.478.594.890.450", "MH_TH": "NLM (2001)", "ST": "T081", "MS": "The local lymph node assay (LLNA) is an alternative method for the identification of chemicals that have the ability to cause skin sensitization and allergic contact dermatitis. Endpoints have been established so fewer animals are required and less painful procedures are used.", "PM": "2001", "HN": "2001", "MR": "20110624", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023441"}, {"RECTYPE": "D", "MH": "Myeloid Progenitor Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Stem Cells, Myeloid|T025|NON|EQV|NLM (2001)|000511|abcdef", "ENTRY": "Units, Granulocyte-Erythroid-Macrophage-Megakaryocyte Colony-Forming", "MN": "A15.378.316.378.590", "MH_TH": "NLM (2001)", "ST": "T025", "PI": "Hematopoietic Stem Cells (1978-2000)", "MS": "Stem cells derived from HEMATOPOIETIC STEM CELLS. Derived from these myeloid progenitor cells are the MEGAKARYOCYTES; ERYTHROID CELLS; MYELOID CELLS; and some DENDRITIC CELLS.", "PM": "2001", "HN": "2001", "MR": "20160610", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023461"}, {"RECTYPE": "D", "MH": "Terrorism", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Terrorism, Radioactive", "MN": "I01.880.735.900.800", "MH_TH": "UNK (19XX)", "ST": "T054", "PI": "Violence (1976-2000)", "MS": "The use or threatened use of force or violence against persons or property in violation of criminal laws for purposes of intimidation, coercion, or ransom, in support of political or social objectives.", "PM": "2001; see VIOLENCE 1981-2000", "HN": "2001; use VIOLENCE 1981-2000", "MR": "20090706", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023481"}, {"RECTYPE": "D", "MH": "Bioterrorism", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Biological Terrorism|T052|NON|EQV|NLM (2001)|000602|abcdef", "ENTRY": "Terrorism, Biological", "MN": "I01.880.735.950.500.226.100", "MH_TH": "NLM (2001)", "ST": "T052", "PI": "Violence (1996-2000)", "MS": "The use of biological agents in TERRORISM. This includes the malevolent use of BACTERIA; VIRUSES; or other BIOLOGICAL TOXINS against people, ANIMALS; or PLANTS.", "PM": "2001", "HN": "2001", "MR": "20220523", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023482"}, {"RECTYPE": "D", "MH": "Chlamydophila", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.190.190.230", "MH_TH": "NLM (2001)", "ST": "T007", "MS": "A genus of the family CHLAMYDIACEAE comprising gram-negative non CHLAMYDIA TRACHOMATIS-like species infecting vertebrates. Chlamydophila do not produce detectable quantities of glycogen. The type species is CHLAMYDOPHILA PSITTACI.", "PM": "2001", "HN": "2001", "MR": "20200902", "DA": "20000623", "DC": "1", "DX": "20010101", "UI": "D023501"}, {"RECTYPE": "D", "MH": "Chlamydia muridarum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.190.190.190.500", "MH_TH": "NLM (2001)", "ST": "T007", "RN": "txid83560", "AN": "infection: coord IM with CHLAMYDIA INFECTIONS (IM); index also PNEUMONIA, BACTERIAL if pertinent", "PI": "Chlamydia trachomatis (1980-2000)", "MS": "Species of CHLAMYDIA causing pneumonitis in mice and hamsters. These isolates formerly belonged to CHLAMYDIA TRACHOMATIS.", "PM": "2001", "HN": "2001", "MR": "20200813", "DA": "20000623", "DC": "1", "DX": "20010101", "UI": "D023502"}, {"RECTYPE": "D", "MH": "Chlamydophila Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Chlamydophila", "MN": "C01.150.252.400.210.250", "MH_TH": "NLM (2001)", "ST": "T047", "MS": "Infections with bacteria of the genus CHLAMYDOPHILA.", "PM": "2001", "HN": "2001", "MR": "20190617", "DA": "20000622", "DC": "1", "DX": "20010101", "UI": "D023521"}, {"RECTYPE": "D", "MH": "HIV Fusion Inhibitors", "DE": "HIV FUSION INHIB", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "HIV Fusion Protein Inhibitor|T121|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Inhibitor, HIV Fusion", "MN": "D27.505.954.122.388.538.500", "FX": "Membrane Fusion", "MH_TH": "NLM (2002)", "ST": "T121", "RN": "0", "PI": "Anti-HIV Agents (1998-2001)", "MS": "Inhibitors of the fusion of HIV to host cells, preventing viral entry. This includes compounds that block attachment of HIV ENVELOPE PROTEIN GP120 to CD4 RECEPTORS.", "PM": "2002", "HN": "2002", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023581"}, {"RECTYPE": "D", "MH": "Alzheimer Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vaccines, Alzheimer", "MN": "D20.215.894.067", "MH_TH": "NLM (2002)", "ST": "T129", "RN": "0", "PI": "Vaccines (1999-2001)", "MS": "Vaccines or candidate vaccines used to prevent or treat ALZHEIMER DISEASE.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023582"}, {"RECTYPE": "D", "MH": "Archaeal Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, Archaeal", "MN": "B04.100", "MH_TH": "NLM (2002)", "ST": "T005", "AN": "coord with specific Archaea /virol", "PI": "Archaea/virology (1996-2001)", "MS": "Viruses whose hosts are in the domain ARCHAEA.", "PM": "2002", "HN": "2002", "MR": "20200902", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023641"}, {"RECTYPE": "D", "MH": "Rudiviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Sulfolobus virus SIRV-2|T005|ACX|NRW|NLM (2002)|010309|abcdef", "ENTRY": "Sulfolobus virus SIRV 2", "MN": "B04.280.775", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid157897", "RR": "txid187213", "AN": "coordinate with specific Archaea /virol", "PI": "DNA Viruses (1999-2001)", "MS": "Family of rod-shaped DNA viruses infecting ARCHAEA. They lack viral envelopes or lipids.", "PM": "2002", "HN": "2002", "MR": "20220708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023642"}, {"RECTYPE": "D", "MH": "Lipothrixviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Gammalipothrixviruses", "MN": "B04.280.450", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid10477", "RR": "txid564646", "MS": "Family of enveloped, lipid-containing, filamentous DNA viruses that infect ARCHAEA.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023643"}, {"RECTYPE": "D", "MH": "Guttaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Sulfolobus virus SNDV|T005|ACX|NRW|NLM (2002)|001214|abcdef", "ENTRY": "Viruses, Sulfolobus SNDV-like", "MN": "B04.280.362", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid324686", "AN": "coord with specific Archaea /virol", "MS": "Family of archaeal viruses with a single genus: Sulfolobus SNDV-like Viruses.", "PM": "2002", "HN": "2002", "MR": "20200902", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023644"}, {"RECTYPE": "D", "MH": "Esociformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.493.385", "MH_TH": "NLM (2002)", "ST": "T013", "RN": "txid8007", "MS": "An order of fishes native to North America and Northern Eurasia, consisting of two families: ESOCIDAE (pikes) and UMBRIDAE (mudminnows).", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023661"}, {"RECTYPE": "D", "MH": "Cichlids", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Tilapia nilotica|T013|NON|NRW|NLM (1993)|911120|abcdef", "ENTRY": "Fish, Cichlid", "MN": "B01.050.150.900.493.602.200", "MH_TH": "NLM (2002)", "ST": "T013", "RN": "txid8113", "RR": "txid8128", "AN": "note entry terms TILAPIA NILOTICA, and NILE TILAPIA; TILAPIA is also available", "PI": "Perches (1986-2001)", "MS": "Common name for perch-like fish of the family Cichlidae, belonging to the suborder Labroidei, order PERCIFORMES.", "PM": "2002; see PERCHES 1987-2001; for TILAPIA NILOTICA use TILAPIA 1992-2001", "HN": "2002; use PERCHES 1987-2001; for TILAPIA NILOTICA use TILAPIA 1992-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023681"}, {"RECTYPE": "D", "MH": "Smegmamorpha", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Swamp Eels|T013|NON|NRW|NLM (2002)|000804|abcdef", "ENTRY": "Swamp Eel", "MN": "B01.050.150.900.493.850", "MH_TH": "NLM (2002)", "ST": "T013", "RR": "txid8189", "AN": "note entry term SWAMP EELS; EELS is also available", "MS": "Group of fish under the superorder Acanthopterygii, separate from the PERCIFORMES, which includes swamp eels, mullets, sticklebacks, seahorses, spiny eels, rainbowfishes, and KILLIFISHES. The name is derived from the six taxa which comprise the group. (From http://www.nanfa.org/articles/Elassoma/elassoma.htm, 8/4/2000)", "PM": "2002; for STICKLEBACKS see FISHES 1975-2001; for MULLETS see PERCIFORMES 1987-2001", "HN": "2002; for STICKLEBACKS use FISHES 1975-2001; for MULLETS use PERCIFORMES 1987-2001", "MR": "20200902", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023701"}, {"RECTYPE": "D", "MH": "Gymnotiformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Gymnotidae|T013|NON|NRW|NLM (2002)|001023|abcdef", "ENTRY": "Gymnotids", "MN": "B01.050.150.900.493.378.430", "MH_TH": "NLM (2002)", "ST": "T013", "RN": "txid8002", "RR": "txid36703", "MS": "An order of neotropical electric fish found chiefly in the waters of South America. They continually emit weak electric discharges, which they use in object location and communication. A most popular species of research interest is the electric eel, ELECTROPHORUS electricus.", "PM": "2002; for GYMNOTID see ELECTRIC FISH 1987-2001", "HN": "2002; for GYMNOTID use ELECTRIC FISH 1987-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023702"}, {"RECTYPE": "D", "MH": "Tetraodontiformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Pufferfish|T013|NON|NRW|NLM (2002)|000807|abcdef", "ENTRY": "Fish, Puffer", "MN": "B01.050.150.900.493.875", "MH_TH": "NLM (2002)", "ST": "T013", "RN": "txid31022", "RR": "txid31031", "PI": "Fishes (1981-2001)", "MS": "A small order of primarily marine fish containing 340 species. Most have a rotund or box-like shape. TETRODOTOXIN is found in their liver and ovaries.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023721"}, {"RECTYPE": "D", "MH": "Takifugu", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Torafugu|T013|NON|NRW|NLM (2002)|000807|abcdef", "MN": "B01.050.150.900.493.875.800", "MH_TH": "NLM (2002)", "ST": "T013", "RN": "txid31032", "RR": "txid31033", "PI": "Fishes, Poisonous (1993-2001)", "MS": "A genus of pufferfish commonly used for research.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023741"}, {"RECTYPE": "D", "MH": "Beloniformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Needlefishes|T013|NON|NRW|NLM (2002)|000807|abcdef", "ENTRY": "Needlefish|T013|NON|NRW|NLM (2002)|000807|abcdef", "MN": "B01.050.150.900.493.850.139", "MH_TH": "NLM (2002)", "ST": "T013", "RN": "txid76071", "RR": "txid94935", "PI": "Fishes (1974-2001)", "MS": "An order of fish in the group SMEGMAMORPHA, comprising adrianichthyids, medakas (ORYZIAS), needlefishes, halfbeaks, and flying fishes.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023761"}, {"RECTYPE": "D", "MH": "Fundulidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Killifish, Gulf|T013|NON|NRW|NLM (2002)|000808|abcdef", "ENTRY": "Topminnows|T013|NON|EQV|NLM (2002)|000808|abcdef", "MN": "B01.050.150.900.493.850.280.214", "MH_TH": "NLM (2002)", "ST": "T013", "RN": "txid28756", "RR": "txid8077", "PI": "Killifish (1976-2001)", "MS": "Family of small, surface-dwelling fish that inhabit fresh and brackish waters, and coastal marine areas.", "PM": "2002", "HN": "2002", "MR": "20230226", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023781"}, {"RECTYPE": "D", "MH": "Directly Observed Therapy", "AQ": "CL DE ES PH RE", "ENTRY": "Therapy, Directly Observed", "MN": "N05.300.150.800.500.600.500.500", "FX": "Patient Compliance", "MH_TH": "NLM (2002)", "ST": "T061", "PI": "Patient Compliance (1992-2001)", "MS": "A treatment method in which patients are under direct observation when they take their medication or receive their treatment. This method is designed to reduce the risk of treatment interruption and to ensure patient compliance.", "PM": "2002", "HN": "2002", "MR": "20200228", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023801"}, {"RECTYPE": "D", "MH": "Cerclage, Cervical", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Cerclage of Uterine Cervix|T061|NON|EQV|NLM (2002)|000915|abcdef", "ENTRY": "Uterine Cervix Cerclage", "MN": "E04.520.100", "MH_TH": "NLM (2002)", "ST": "T061", "PI": "Cervix Incompetence (1973-2001)", "MS": "The surgical closure of the incompetent cervix uteri with suture material.", "PM": "2002", "HN": "2002", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D023802"}, {"RECTYPE": "D", "MH": "Limb Salvage", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Salvage, Limb", "MN": "E04.617.350", "MH_TH": "NLM (2002)", "ST": "T061", "PI": "Reconstructive Surgical Procedure (1999-2001)", "MS": "An alternative to AMPUTATION, SURGICAL in patients with neoplasms, ischemia, fractures, and other limb-threatening conditions. Generally, sophisticated surgical procedures such as vascular surgery and reconstruction are used to salvage diseased limbs.", "PM": "2002", "HN": "2002", "MR": "20220715", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023821"}, {"RECTYPE": "D", "MH": "Tissue Engineering", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "ENTRY": "Engineering, Tissue", "MN": "J01.293.069.249.500", "FX": "Tissue Therapy, Historical", "MH_TH": "NLM (2002)", "ST": "T061", "PI": "Tissue Culture (1967-2001)", "MS": "Generating tissue in vitro for clinical applications, such as replacing wounded tissues or impaired organs. The use of TISSUE SCAFFOLDING enables the generation of complex multi-layered tissues and tissue structures.", "PM": "2002", "HN": "2002", "MR": "20220708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023822"}, {"RECTYPE": "D", "MH": "Rhinometry, Acoustic", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Acoustic Rhinometry|T060|NON|EQV|NLM (2002)|000818|abcdef", "MN": "E01.370.386.870", "MH_TH": "NLM (2002)", "ST": "T060", "PI": "Diagnosis (1989-2001)", "MS": "Diagnostic measurement of the nose and its cavity through acoustic reflections. Used to measure nasal anatomical landmarks, nasal septal deviation, and nasal airway changes in response to allergen provocation tests (NASAL PROVOCATION TESTS).", "PM": "2002", "HN": "2002", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023842"}, {"RECTYPE": "D", "MH": "Photography, Dental", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Photography, Intraoral|T060|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Photographies, Intraoral", "MN": "E06.342.488", "MH_TH": "NLM (2002)", "ST": "T060", "PI": "Photography (1969-1999)", "MS": "Photographic techniques used in ORTHODONTICS; DENTAL ESTHETICS; and patient education.", "PM": "2002; for PHOTOGRAPHY, INTRAORAL see PHOTOGRAPHY, INTRAORAL (2000-2001)", "HN": "2002", "MR": "20070711", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023861"}, {"RECTYPE": "D", "MH": "Colonography, Computed Tomographic", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Virtual Colonoscopy|T060|NON|EQV|NLM (2002)|000823|abcdef", "ENTRY": "Colonography, CT", "MN": "E01.370.372.230", "FX": "Tomography, X-Ray Computed", "MH_TH": "NLM (2002)", "ST": "T060", "PI": "Tomography, X-Ray Computed (1994-2001)", "MS": "A non-invasive imaging method that uses computed tomographic data combined with specialized imaging software to examine the colon.", "PM": "2002", "HN": "2002", "MR": "20080708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023881"}, {"RECTYPE": "D", "MH": "Dominance, Ocular", "AQ": "DE ES GE PH RE", "PRINT ENTRY": "Eye Dominance|T042|NON|EQV|NLM (2002)|001207|abcdef", "ENTRY": "Ocular Dominance", "MN": "G14.264", "MH_TH": "NLM (2002)", "ST": "T042", "PI": "Dominance, Cerebral (1967-2001)", "MS": "The functional superiority and preferential use of one eye over the other. The term is usually applied to superiority in sighting (VISUAL PERCEPTION) or motor task but not difference in VISUAL ACUITY or dysfunction of one of the eyes. Ocular dominance can be modified by visual input and NEUROTROPHIC FACTORS.", "PM": "2002", "HN": "2002", "MR": "20080708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023882"}, {"RECTYPE": "D", "MH": "Chromosome Pairing", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Synapsis|T043|T045|NON|EQV|NLM (2002)|000823|abbcdef", "ENTRY": "Chromosome Pairings", "MN": "G05.113.220.781.906.250", "FX": "Crossing Over, Genetic", "MH_TH": "NLM (2002)", "ST": "T045", "AN": "do not confuse SYNAPSIS with SYNAPSES (neuron cell junctions)", "MS": "The alignment of CHROMOSOMES at homologous sequences.", "PM": "2002", "HN": "2002", "MR": "20160115", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023902"}, {"RECTYPE": "D", "MH": "Coronary Restenosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Restenosis, Coronary", "MN": "C14.907.585.250.285.200", "FX": "No-Reflow Phenomenon", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "Recurrence (1983-2001)", "MS": "Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.", "PM": "2002", "HN": "2002", "MR": "20090706", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023903"}, {"RECTYPE": "D", "MH": "Coronary Stenosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stenosis, Coronary Artery", "MN": "C14.907.585.250.285", "FX": "Constriction, Pathologic", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Coronary Disease (1965-2001)", "MS": "Narrowing or constriction of a coronary artery.", "PM": "2002; see CORONARY DISEASE 1995-2001", "HN": "2002; use CORONARY DISEASE 1995-2001", "MR": "20070709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023921"}, {"RECTYPE": "D", "MH": "Gonadal Dysgenesis, 46,XX", "DS": "GONADAL DYSGENESIS AAA", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pure Gonadal Dysgenesis, 46,XX|T019|T047|NON|NRW|NLM (2011)|100217|abbcdef", "MN": "C19.391.119.309.193", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "Sex Differentiation Disorders (1966-1979)", "MS": "The 46,XX gonadal dysgenesis may be sporadic or familial. Familial XX gonadal dysgenesis is transmitted as an autosomal recessive trait and its locus was mapped to chromosome 2. Mutation in the gene for the FSH receptor (RECEPTORS, FSH) was detected. Sporadic XX gonadal dysgenesis is heterogeneous and has been associated with trisomy-13 and trisomy-18. These phenotypic females are characterized by a normal stature, sexual infantilism, bilateral streak gonads, amenorrhea, elevated plasma LUTEINIZING HORMONE and FSH concentration.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D023961"}, {"RECTYPE": "D", "MH": "Sarcoma, Myeloid", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sarcoma, Granulocytic|T191|NON|REL|NLM (2002)|ORD (2010)|000908|abcdeef", "ENTRY": "Sarcomas, Myeloid", "MN": "C15.378.508.539.775", "MH_TH": "NLM (2008)", "ST": "T191", "PI": "Leukemia, Myeloid (1966-2001)", "MS": "An extramedullary tumor of immature MYELOID CELLS or MYELOBLASTS. Granulocytic sarcoma usually occurs with or follows the onset of ACUTE MYELOID LEUKEMIA.", "PM": "2008; see SARCOMA, MYELOID 2002-2007", "HN": "2008 (2002)", "MR": "20230531", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D023981"}, {"RECTYPE": "D", "MH": "HMGN Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleosomal Binding Proteins|T116|T123|NON|EQV|NLM (2002)|000911|abbcdef", "ENTRY": "Binding Proteins, Nucleosomal", "MN": "D12.776.664.235.400.400", "FX": "Nucleosomes", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nucleoproteins (1966-1981)", "MS": "A family of HIGH MOBILITY GROUP PROTEINS that bind to NUCLEOSOMES.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024001"}, {"RECTYPE": "D", "MH": "HMGB Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HMG-Box Proteins|T116|T123|ACX|EQV|NLM (2002)|000911|abbcdef", "ENTRY": "HMG Box Proteins", "MN": "D12.776.664.235.400.600", "FX": "HMG-Box Domains", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nucleoproteins (1966-1981)", "MS": "A family of sequence-related proteins similar to HMGB1 PROTEIN that contains specific HMG-BOX DOMAINS.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024002"}, {"RECTYPE": "D", "MH": "HMGA Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HMG-AT-Hook Proteins|T116|T123|NON|EQV|NLM (2002)|000911|abbcdef", "ENTRY": "HMG AT Proteins", "MN": "D12.776.664.235.400.500", "FX": "AT-Hook Motifs", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nucleoproteins (1966-1981)", "MS": "Proteins containing AT-HOOK MOTIFS that are rich in arginine and glycine residues. They bind to the minor grove of AT-rich regions of DNA.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024003"}, {"RECTYPE": "D", "MH": "Fibril-Associated Collagens", "DE": "FIBRIL ASSOC COLLAGENS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fibril Associated Collagens With Interrupted Triple Helices", "MN": "D12.776.860.300.250.400.550", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "do not confuse with FIBRILLAR COLLAGENS or MICROFIBRIL COLLAGEN HEMOSTAT see COLLAGEN; precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1992-2001)", "MS": "A family of non-fibrillar collagens that interact with FIBRILLAR COLLAGENS. They contain short triple helical domains interrupted by short non-helical domains and do not form into collagen fibrils.", "PM": "2002", "HN": "2002", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024021"}, {"RECTYPE": "D", "MH": "Fibrillar Collagens", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Collagens, Fibrillar", "MN": "D12.776.860.300.250.300", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics; do not confuse with FIBRIL-ASSOCIATED COLLAGENS or MICROFIBRIL COLLAGEN HEMOSTAT; precusors: coordinate with PROCOLLAGEN ", "PI": "Collagen (1966-2001)", "MS": "A family of structurally related collagens that form the characteristic collagen fibril bundles seen in CONNECTIVE TISSUE.", "PM": "2002", "HN": "2002", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024022"}, {"RECTYPE": "D", "MH": "Non-Fibrillar Collagens", "DS": "NONFIBRILLAR COLLAGENS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Short-Chain Collagens|T116|T123|NON|EQV|NLM (2002)|000912|abbcdef", "ENTRY": "Short Chain Collagens", "MN": "D12.776.860.300.250.400", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "precusors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1966-2001)", "MS": "A family of structurally-related short-chain collagens that do not form large fibril bundles.", "PM": "2002", "HN": "2002", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024041"}, {"RECTYPE": "D", "MH": "Collagen Type I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Collagen, Type I", "MN": "D12.776.860.300.250.300.100", "FX": "Osteogenesis Imperfecta", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "AN": "precursors: coordinate with PROCOLLAGEN ", "PI": "Collagen (1966-2001)", "MS": "The most common form of fibrillar collagen. It is a major constituent of bone (BONE AND BONES) and SKIN and consists of a heterotrimer of two alpha1(I) and one alpha2(I) chains.", "PM": "2002; see COLLAGEN 1966-2001; for ALPHA-2 TYPE 1 COLLAGEN see COLLAGEN 1987-2001; for PROCOLLAGEN TYPE I see PROCOLLAGEN 1986-2001; for TYPE I PROCOLLAGEN & PRO ALPHA 2 COLLAGEN see PROCOLLAGEN 1982-2001; for PRO ALPHA 1 COLLAGEN see PROCOLLAGEN 1988-2001", "HN": "2002; use COLLAGEN 1966-2001; for ALPHA-2 TYPE 1 COLLAGEN use COLLAGEN 1987-2001; for PROCOLLAGEN TYPE I use PROCOLLAGEN 1986-2001; for TYPE I PROCOLLAGEN & PRO ALPHA 2 COLLAGEN use PROCOLLAGEN 1982-2001; for PRO ALPHA 1 COLLAGEN use PROCOLLAGEN 1988-2001", "MR": "20210701", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024042"}, {"RECTYPE": "D", "MH": "Collagen Type II", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Procollagen, Type II", "MN": "D12.776.860.300.250.300.200", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1977-2001)", "MS": "A fibrillar collagen found predominantly in CARTILAGE and vitreous humor. It consists of three identical alpha1(II) chains.", "PM": "2002; see COLLAGEN 1990-2001; for PROCOLLAGEN TYPE II see PROCOLLAGEN 1984-2001", "HN": "2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE II use PROCOLLAGEN 1982-2001", "MR": "20160628", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024043"}, {"RECTYPE": "D", "MH": "Collagen Type III", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Collagen, Type III", "MN": "D12.776.860.300.250.300.300", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "AN": "precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1974-2001)", "MS": "A fibrillar collagen consisting of three identical alpha1(III) chains that is widely distributed in many tissues containing COLLAGEN TYPE I. It is particularly abundant in BLOOD VESSELS and may play a role in tissues with elastic characteristics.", "PM": "2002; see COLLAGEN 1990-2001; for PROCOLLAGEN TYPE III see PROCOLLAGEN 1990-2001", "HN": "2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE III use PROCOLLAGEN 1990-2001", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024061"}, {"RECTYPE": "D", "MH": "Collagen Type V", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "V Procollagen, Type", "MN": "D12.776.860.300.250.300.400", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1993-2001)", "MS": "A fibrillar collagen found widely distributed as a minor component in tissues that contain COLLAGEN TYPE I and COLLAGEN TYPE III. It is a heterotrimeric molecule composed of alpha1(V), alpha2(V) and alpha3(V) subunits. Several forms of collagen type V exist depending upon the composition of the subunits that form the trimer.", "PM": "2002; see COLLAGEN 1990-2001; for PROCOLLAGEN TYPE V see PROCOLLAGEN 1983-2001", "HN": "2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE V use PROCOLLAGEN 1983-2001", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024062"}, {"RECTYPE": "D", "MH": "Collagen Type IX", "DS": "COLLAGEN TYPE VXXXX", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Type IX, Procollagen", "MN": "D12.776.860.300.250.400.550.200", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1990-2001)", "MS": "A fibril-associated collagen usually found crosslinked to the surface of COLLAGEN TYPE II fibrils. It is a heterotrimer containing alpha1(IX), alpha2(IX) and alpha3(IX) subunits.", "PM": "2002; see COLLAGEN 1990-2001", "HN": "2002; use COLLAGEN 1990-2001", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024081"}, {"RECTYPE": "D", "MH": "Collagen Type XII", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Type XII, Procollagen", "MN": "D12.776.860.300.250.400.550.300", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "AN": "precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1987-2001)", "MS": "A fibril-associated collagen found in many tissues bearing high tensile stress, such as TENDONS and LIGAMENTS. It is comprised of a trimer of three identical alpha1(XII) chains.", "PM": "2002; see COLLAGEN 1992-2001", "HN": "2002; use COLLAGEN 1992-2001", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024082"}, {"RECTYPE": "D", "MH": "Mitochondrial Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proteins, Mitochondrial|T116|T123|NON|EQV|NLM (2002)|000912|abbcdef", "ENTRY": "Protein, Mitochondrial", "MN": "D12.776.575", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Mitochondria (1965-2001)", "MS": "Proteins encoded by the mitochondrial genome or proteins encoded by the nuclear genome that are imported to and resident in the MITOCHONDRIA.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024101"}, {"RECTYPE": "D", "MH": "Collagen Type VIII", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Type VIII, Procollagen", "MN": "D12.776.860.300.250.400.400", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1985-2001)", "MS": "A non-fibrillar collagen originally found in DESCEMET MEMBRANE. It is expressed in endothelial cell layers and in tissues undergoing active remodeling. It is heterotrimer comprised of alpha1(VIII) and alpha2(VIII) chains.", "PM": "2002; see COLLAGEN 1985-2001", "HN": "2002; use COLLAGEN 1985-2001", "MR": "20050701", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024102"}, {"RECTYPE": "D", "MH": "Collagen Type X", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Type X, Procollagen", "MN": "D12.776.860.300.250.400.500", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1990-2001)", "MS": "A non-fibrillar collagen found primarily in terminally differentiated hypertrophic CHONDROCYTES. It is a homotrimer of three identical alpha1(X) subunits.", "PM": "2002; see COLLAGEN 1990-2001", "HN": "2002; use COLLAGEN 1990-2001", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024121"}, {"RECTYPE": "D", "MH": "Collagen Type IV", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Procollagen, Type IV", "MN": "D12.776.860.300.250.400.100", "FX": "Porencephaly", "MH_TH": "NLM (1988)", "ST": "T123", "RN": "0", "AN": "precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1978-2001)", "MS": "A non-fibrillar collagen found in the structure of BASEMENT MEMBRANE. Collagen type IV molecules assemble to form a sheet-like network which is involved in maintaining the structural integrity of basement membranes. The predominant form of the protein is comprised of two alpha1(IV) subunits and one alpha2(IV) subunit, however, at least six different alpha subunits can be incorporated into the heterotrimer.", "PM": "2002; see COLLAGEN 1990-2001; for PROCOLLAGEN TYPE IV see PROCOLLAGEN 1982-2001; for 7S COLLAGEN see COLLAGEN 1982-2001", "HN": "2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE IV use PROCOLLAGEN 1982-2001; for 7S COLLAGEN use COLLAGEN 1982-2001", "MR": "20140613", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024141"}, {"RECTYPE": "D", "MH": "Collagen Type VI", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Procollagen, Type VI", "MN": "D12.776.860.300.250.400.200", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1985-2001)", "MS": "A non-fibrillar collagen that forms a network of MICROFIBRILS within the EXTRACELLULAR MATRIX of CONNECTIVE TISSUE. The alpha subunits of collagen type VI assemble into antiparallel, overlapping dimers which then align to form tetramers.", "PM": "2002; see COLLAGEN 1990-2001", "HN": "2002; use COLLAGEN 1990-2001", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024142"}, {"RECTYPE": "D", "MH": "Collagen Type VII", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Type VII, Procollagen", "MN": "D12.776.860.300.250.400.300", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "AN": "precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1990-2001)", "MS": "A non-fibrillar collagen involved in anchoring the epidermal BASEMENT MEMBRANE to underlying tissue. It is a homotrimer comprised of C-terminal and N-terminal globular domains connected by a central triple-helical region.", "PM": "2002; see COLLAGEN 1990-2001", "HN": "2002; use COLLAGEN 1990-2001", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024143"}, {"RECTYPE": "D", "MH": "Collagen Type XI", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Procollagen, Type XI", "MN": "D12.776.860.300.250.300.500", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "AN": "precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1992-2001)", "MS": "A fibrillar collagen found primarily in interstitial CARTILAGE. Collagen type XI is heterotrimer containing alpha1(XI), alpha2(XI) and alpha3(XI) subunits.", "PM": "2002; see COLLAGEN 1992-2001", "HN": "2002; use COLLAGEN 1992-2001", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024161"}, {"RECTYPE": "D", "MH": "Second-Look Surgery", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgery, Second Look", "MN": "E04.708", "FX": "Reoperation", "MH_TH": "NLM (1992)", "ST": "T061", "PI": "Reoperation (1983-2001)", "MS": "A followup operation to examine the outcome of the previous surgery and other treatments, such as chemotherapy or radiation therapy.", "PM": "2002", "HN": "2002", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024162"}, {"RECTYPE": "D", "MH": "Collagen Type XIII", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Procollagen, Type XIII", "MN": "D12.776.860.300.250.400.525", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "AN": "precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Collagen (1992-2001)", "MS": "A non-fibrillar collagen found as a ubiquitously expressed membrane- associated protein. Type XIII collagen contains both collagenous and non-collagenous domains along with a transmembrane domain within its N-terminal region.", "PM": "2002; see COLLAGEN (1992-2001)", "HN": "2002; use COLLAGEN (1992-2001)", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024181"}, {"RECTYPE": "D", "MH": "Uniparental Disomy", "AQ": "CI CY DE DI ET GE IM PA PP RE UL", "PRINT ENTRY": "Uniparental Isodisomy|T049|NON|NRW|NLM (2002)|000913|abcdef", "ENTRY": "Uniparental Isodisomies", "MN": "G05.365.590.175.935", "MH_TH": "ORD (2010)", "ST": "T049", "PI": "Chromosome Abnormalities (1980-2001)", "MS": "The presence in a cell of two paired chromosomes from the same parent, with no chromosome of that pair from the other parent. This chromosome composition stems from non-disjunction (NONDISJUNCTION, GENETIC) events during MEIOSIS. The disomy may be composed of both homologous chromosomes from one parent (heterodisomy) or a duplicate of one chromosome (isodisomy).", "PM": "2002", "HN": "2002", "MR": "20090706", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024182"}, {"RECTYPE": "D", "MH": "Bystander Effect", "AQ": "DE ES GE IM PH RE", "ENTRY": "Suppression, Bystander", "MN": "G04.085.155", "MH_TH": "NLM (2002)", "ST": "T043", "AN": "note category: cell physiol context only", "MS": "The result of a positive or negative response (to drugs, for example) in one cell being passed onto other cells via the GAP JUNCTIONS or the intracellular milieu.", "PM": "2002", "HN": "2002", "MR": "20160115", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024201"}, {"RECTYPE": "D", "MH": "Electrophoretic Mobility Shift Assay", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Mobility Shift Assay|T059|NON|EQV|NLM (2002)|000914|abcdef", "ENTRY": "Techniques, EMSA Electrophoretic", "MN": "E05.196.401.500", "MH_TH": "NLM (2002)", "ST": "T059", "AN": "coordinate with the specific type of electrophoresis used", "PI": "Electrophoresis or specifics (1976-2001)", "MS": "An electrophoretic technique for assaying the binding of one compound to another. Typically one compound is labeled to follow its mobility during electrophoresis. If the labeled compound is bound by the other compound, then the mobility of the labeled compound through the electrophoretic medium will be retarded.", "PM": "2002", "HN": "2002", "MR": "20060705", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D024202"}, {"RECTYPE": "D", "MH": "Antineoplastic Protocols", "AQ": "CL ST", "PRINT ENTRY": "Cancer Treatment Protocols|T061|NON|EQV|NLM (2002)|000803|abcdef", "ENTRY": "Treatment Protocols, Cancer", "MN": "N05.715.360.330.125.500", "MH_TH": "NLM (2002)", "ST": "T061", "AN": "coord with COMBINED MODALITY THERAPY if pertinent", "PI": "Antineoplastic Combined Chemotherapy Protocols (1983-2001)", "MS": "Clinical protocols used to inhibit the growth or spread of NEOPLASMS.", "PM": "2002", "HN": "2002", "MR": "20180630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024221"}, {"RECTYPE": "D", "MH": "HMGN1 Protein", "DS": "HMGN Q 001 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HMG 14 Protein|T116|T123|ACX|EQV|UNK (19XX)|840530|HMG Q 014 PROTEIN|abbcdefs", "ENTRY": "Nonhistone Chromosomal Protein HMG 14", "MN": "D12.776.664.235.400.400.200", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nucleoproteins (1966-1981)", "MS": "An evolutionarily-conserved 10-kDa nuclear protein that binds NUCLEOSOMES and may be involved in the process of CHROMATIN unfolding.", "PM": "2002; for HMG 14 PROTEIN see HIGH MOBILITY GROUP PROTEINS 1985-2001", "HN": "2002; for HMG 14 PROTEIN use HIGH MOBILITY GROUP PROTEINS 1985-2001", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024241"}, {"RECTYPE": "D", "MH": "HMGN2 Protein", "DS": "HMGN Q 002 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HMG 17 Protein|T116|T123|EQV|UNK (19XX)|840530|HMG Q 017 PROTEIN|abbdefs", "ENTRY": "Nucleosomal Binding Protein 2, High Mobility Group|T116|T123|NON|EQV|NLM (2002)|010309|abbcdef", "MN": "D12.776.664.235.400.400.300", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nucleoproteins (1966-1981)", "MS": "An evolutionarily conserved 9-KDa nuclear protein that binds NUCLEOSOMES and may be involved in the process of CHROMATIN unfolding.", "PM": "2002; for HMG 17 & HMG 17 PROTEIN see HIGH MOBILITY GROUP PROTEINS 1985-2001", "HN": "2002; for HMG 17 & HMG 17 PROTEIN use HIGH MOBILITY GROUP PROTEINS 1985-2001", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024242"}, {"RECTYPE": "D", "MH": "HMGB1 Protein", "DS": "HMGB Q 001 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HMG1|T116|T123|ACX|EQV|NLM (1992)|910318|HMG Q 001|abbcdefs", "ENTRY": "p30, Heparin-Binding Protein", "MN": "D12.776.664.235.400.600.300", "FX": "HMG-Box Domains", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nucleoproteins (1966-1981)", "MS": "A 24-kDa HMGB protein that binds to and distorts the minor grove of DNA.", "PM": "2002; for HMG 1 PROTEIN see HIGH MOBILITY GROUP PROTEINS 1985-2001; for HMG1 use HIGH MOBILITY GROUP PROTEINS 1992-2001; AMPHOTERIN was indexed under HIGH MOBILITY GROUP PROTEINS 1991-2001 & CARRIER PROTEINS 1991-2001", "HN": "2002; for HMG 1 PROTEIN use HIGH MOBILITY GROUP PROTEINS 1985-2001; for HMG1 use HIGH MOBILITY GROUP PROTEINS 1992-2001; for AMPHOTERIN use HMGB1 PROTEIN (NM) 1991-2001", "MR": "20160630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024243"}, {"RECTYPE": "D", "MH": "HMGB2 Protein", "DS": "HMGB Q 002 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HMG2|T116|T123|ACX|EQV|NLM (1992)|910318|HMG Q 002|abbcdefs", "ENTRY": "High-Mobility Group (Nonhistone Chromosomal) Protein 2|T116|T123|NON|EQV|NLM (2002)|000919|abbcdef", "MN": "D12.776.664.235.400.600.600", "FX": "HMG-Box Domains", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nucleoproteins (1966-1981)", "MS": "A 23-kDa HMG-box protein that binds to and distorts the minor grove of DNA.", "PM": "2002; for HMG 2 PROTEIN see HIGH MOBILITY GROUP PROTEINS 1985-2001; for HMG 2 & HMG2 see HIGH MOBILITY GROUP PROTEINS 1992-2001", "HN": "2002; for HMG 2 PROTEIN use HIGH MOBILITY GROUP PROTEINS 1985-2001; for HMG 2 & HMG2 use HIGH MOBILITY GROUP PROTEINS 1992-2001", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024261"}, {"RECTYPE": "D", "MH": "Genes, sry", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Sex-Related Gene On Y|T028|NON|EQV|NLM (2002)|000921|SEX RELAT GENE ON Y|abcdefv", "ENTRY": "sry Genes", "MN": "G05.360.340.024.340.450", "FX": "Sex Determination Processes", "MH_TH": "NLM (2003)", "ST": "T028", "PI": "Sex Determination (Genetics) (1998-2001)", "MS": "The primary testis-determining gene in mammalians, located on the Y CHROMOSOME. It codes for a high mobility group box transcription factor (TRANSCRIPTION FACTORS) which initiates the development of the TESTES from the embryonic GONADS.", "PM": "2002", "HN": "2002", "MR": "20100628", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024282"}, {"RECTYPE": "D", "MH": "Plant Bark", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tree Bark|T002|NON|NRW|NLM (2002)|000921|abcdef", "ENTRY": "Tree Barks", "MN": "A18.024.750.200", "MH_TH": "NLM (2002)", "ST": "T002", "MS": "The outer layer of the woody parts of plants.", "PM": "2002", "HN": "2002", "MR": "20090706", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024301"}, {"RECTYPE": "D", "MH": "zeta Carotene", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Carotene, zeta", "MN": "D23.767.261.925", "PA": "Antioxidants", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Carotenoids (1986-2001)", "MS": "A carotenoid produced in most carotenogenic organisms. It is one of several sequentially synthesized molecules that are precursors to BETA CAROTENE.", "PM": "2002; for ZETA-CAROTENE see CAROTENE 1988-2001", "HN": "2002; for ZETA-CAROTENE use CAROTENOIDS 1988-2001", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024321"}, {"RECTYPE": "D", "MH": "Amino Acids, Aromatic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aromatic Amino Acids|T116|NON|EQV|NLM (2002)|000926|abcdef", "ENTRY": "Aromatic Amino Acid", "MN": "D12.125.072.050", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "PI": "specific amino acid (1965-2001)", "MS": "Amino acids containing an aromatic side chain.", "PM": "2002", "HN": "2002", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024322"}, {"RECTYPE": "D", "MH": "Xanthophylls", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Carotenoids, Xanthophyll", "MN": "D23.767.261.887", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Lutein (1965-2001)", "MS": "Oxygenated forms of carotenoids. They are usually derived from alpha and beta carotene.", "PM": "2002", "HN": "2002", "MR": "20190705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024341"}, {"RECTYPE": "D", "MH": "Amino Acids, Acidic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acidic Amino Acids|T116|NON|EQV|NLM (2002)|000926|abcdef", "ENTRY": "Acidic Amino Acid", "MN": "D12.125.067", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "PI": "specific amino acids (1970-2001)", "MS": "Amino acids with side chains that are negatively charged at physiological pH.", "PM": "2002", "HN": "2002", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024342"}, {"RECTYPE": "D", "MH": "Open Bite", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Bite, Open", "MN": "C07.793.494.825", "MH_TH": "NLM (1997)", "ST": "T190", "PI": "Malocclusion (1965-2001)", "MS": "A condition in which certain opposing teeth fail to establish occlusal contact when the jaws are closed.", "PM": "2002", "HN": "2002", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024343"}, {"RECTYPE": "D", "MH": "Amino Acids, Basic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Basic Amino Acids|T116|NON|EQV|NLM (2002)|000926|abcdef", "ENTRY": "Amino Acid, Basic", "MN": "D12.125.068", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "PI": "specific amino acids (1969-2001)", "MS": "Amino acids with side chains that are positively charged at physiological pH.", "PM": "2002", "HN": "2002", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024361"}, {"RECTYPE": "D", "MH": "Advance Directive Adherence", "AQ": "CL EC ES HI LJ OG PX SN ST TD", "PRINT ENTRY": "Directive Adherence|T058|NON|BRD|NLM (2002)|010611|abcdef", "ENTRY": "Directive Compliance, Advance", "MN": "N05.715.360.317", "FX": "Resuscitation Orders", "MH_TH": "NLM (2002)", "ST": "T058", "PI": "Advance Directives (1991-2001)", "MS": "Compliance by health personnel or proxies with the stipulations of ADVANCE DIRECTIVES (or similar directives such as RESUSCITATION ORDERS) when patients are unable to direct their own care.", "PM": "2002", "HN": "2002", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024362"}, {"RECTYPE": "D", "MH": "Transcription Initiation Site", "AQ": "DE ES PH RE", "ENTRY": "Transcription Start Sites", "MN": "G05.360.340.024.340.137.750.840", "MH_TH": "NLM (2002)", "ST": "T123", "PI": "Transcription, Genetic (1974-2001)", "MS": "The first nucleotide of a transcribed DNA sequence where RNA polymerase (DNA-DIRECTED RNA POLYMERASE) begins synthesizing the RNA transcript.", "PM": "2002", "HN": "2002", "MR": "20080708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024363"}, {"RECTYPE": "D", "MH": "Professional Role", "AQ": "HI PX", "ENTRY": "Roles, Professional", "MN": "F01.829.316.616.625", "MH_TH": "NLM (2002)", "ST": "T054", "MS": "The expected function of a member of a particular profession.", "PM": "2002", "HN": "2002", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024382"}, {"RECTYPE": "D", "MH": "Carbonic Anhydrase I", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Carbonic Anhydrase I Hiroshima 1", "MN": "D08.811.520.241.300.150.100", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 4.2.1.-", "AN": "/antag: coord with CARBONIC ANHYDRASE INHIBITORS", "PI": "Carbonic Anhydrases (1965-2001)", "MS": "A cytosolic carbonic anhydrase isoenzyme primarily expressed in ERYTHROCYTES, vascular endothelial cells, and the gastrointestinal mucosa. EC 4.2.1.-", "PM": "2002; see CARBONIC DEHYDATASE 1992-2001 & CARBONIC ANHYDRASE 1983-1991; for CA I HIROSHIMA-1, CARBONIC ANHYDRASE B see CARBONIC DEHYDRATASE 1992-2001 & CARBONIC ANHYDRASE 1983-2001; for CARBONIC ANHYDRASE ISOENZYME B see CARBONIC DEHYDRATASE 1992-2001 & CARBONIC ANHYDRASE 1984-2001", "HN": "2002; use CARBONIC ANHYDRASES 1983-2001; for CA I HIROSHIMA-1 & CARBONIC ANHYDRASE B use CARBONIC ANHYDRASES 1983-2001; for CARBONIC ANHYDRASE ISOENZYME B use CARBONIC ANHYDRASES 1984-2001", "MR": "20030709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024401"}, {"RECTYPE": "D", "MH": "Carbonic Anhydrase II", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Carbonic Anhydrase Isoenzyme C|T116|T126|NON|EQV|UNK (19XX)|811102|abbcdef", "MN": "D08.811.520.241.300.150.200", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 4.2.1.-", "AN": "/antag: coord with CARBONIC ANHYDRASE INHIBITORS", "PI": "Carbonic Anhydrases (1967-2001)", "MS": "A cytosolic carbonic anhydrase isoenzyme found widely distributed in cells of almost all tissues. Deficiencies of carbonic anhydrase II produce a syndrome characterized by OSTEOPETROSIS, renal tubular acidosis (ACIDOSIS, RENAL TUBULAR) and cerebral calcification. EC 4.2.1.-", "PM": "2002; see CARBONIC DEHYDATASE 1992-2001 & CARBONIC ANHYDRASE 1983-1991; for CARBONIC ANHYDRASE C see CARBONIC DEHYDATASE 1992-2001 & CARBONIC ANHYDRASE 1984-1991; for CARBONIC ANHYDRASE ISOENZYME C see CARBONIC DEHYDATASE 1992-2001 & CARBONIC ANHYDRASE 1983-1991", "HN": "2002; use CARBONIC ANHYDRASES 1983-2001; for CARBONIC ANHYDRASE C use CARBONIC ANHYDRASES 1984-2001; for CARBONIC ANHYDRASE ISOENZYME C use CARBONIC ANHDYRASES 1983-2001", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024402"}, {"RECTYPE": "D", "MH": "Carbonic Anhydrase III", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Muscle-Specific Carbonic Anhydrase", "MN": "D08.811.520.241.300.150.300", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 4.2.1.-", "AN": "/antag: coord with CARBONIC ANHYDRASE INHIBITORS", "PI": "Carbonic Anhydrases (1972-2001)", "MS": "A cytosolic carbonic anhydrase isoenzyme primarily expressed in skeletal muscle (MUSCLES, SKELETAL). EC 4.2.1.-", "PM": "2002; see CARBONIC DEHYDATASE 1992-2001 & CARBONIC ANHYDRASE 1983-1991", "HN": "2002; use CARBONIC ANHYDRASES 1983-2001", "MR": "20030709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024403"}, {"RECTYPE": "D", "MH": "Carbonic Anhydrase V", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Carbonic Anhydrase Isozyme V|T116|T126|NON|EQV|NLM (2002)|000928|abbcdef", "MN": "D08.811.520.241.300.150.500", "MH_TH": "NLM (1992)", "ST": "T126", "RN": "EC 4.2.1.-", "AN": "/antag: coord with CARBONIC ANHYDRASE INHIBITORS", "PI": "Carbonic Anhydrases (1992-2001)", "MS": "A carbonic anhydrase isoenzyme found in MITOCHONDRIA where it provides bicarbonate ions that are components in the urea cycle and in GLUCONEOGENESIS.", "PM": "2002; see CARBONIC DEHYDATASE 1992-2001", "HN": "2002; use CARBONIC ANHYDRASES 1992-2001", "MR": "20030709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024404"}, {"RECTYPE": "D", "MH": "Gastroepiploic Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Gastroepiploic Arteries", "MN": "A07.015.114.379", "MH_TH": "NLM (2002)", "ST": "T023", "PI": "Stomach/blood supply (1967-2001)", "MS": "Abdominal artery that follows the curvature of the stomach. The right gastroepiploic artery is frequently used in CORONARY ARTERY BYPASS GRAFTING; MYOCARDIAL REVASCULARIZATION, and other vascular reconstruction.", "PM": "2002", "HN": "2002", "MR": "20180630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024405"}, {"RECTYPE": "D", "MH": "Aneugens", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Aneugen|T120|NON|EQV|NLM (2021)|200227|abcdef", "ENTRY": "Polyploidy Inducing Agents", "MN": "D27.888.569.468.060", "FX": "Aneuploidy", "MH_TH": "NLM (2002)", "ST": "T120", "RN": "0", "PI": "Mutagens (1988-2001)", "MS": "Agents which affect CELL DIVISION and the MITOTIC SPINDLE APPARATUS resulting in the loss or gain of whole CHROMOSOMES, thereby inducing an ANEUPLOIDY.", "PM": "2002", "HN": "2002", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024422"}, {"RECTYPE": "D", "MH": "Aspartate Aminotransferase, Mitochondrial", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glutamate Oxaloacetate Transaminase-2|T116|T126|NON|EQV|NLM (2002)|001002|GLUTAMATE OXALOACETATE TRANS 002|abbcdefs", "ENTRY": "Transaminase-2, Glutamate Oxaloacetate", "MN": "D08.811.913.477.700.225.500", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 2.6.1.-", "AN": "ASPARTATE AMINOTRANSFERASE, CYTOPLASMIC is also available", "PI": "Aspartate Aminotransferases (1968-2001)", "MS": "An aspartate aminotransferase found in MITOCHONDRIA.", "PM": "2002", "HN": "2002", "MR": "20050708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024442"}, {"RECTYPE": "D", "MH": "Aspartate Aminotransferase, Cytoplasmic", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glutamate Oxaloacetate-Transaminase-1|T116|T126|NON|EQV|NLM (2002)|001002|GLUTAMATE OXALOACETATE TRANS 001|abbcdefs", "ENTRY": "Oxaloacetate-Transaminase-1, Glutamate", "MN": "D08.811.913.477.700.225.249", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 2.6.1.-", "AN": "ASPARTATE AMINOTRANSFERASE, MITOCHONDRIAL is also available", "PI": "Aspartate Aminotransferases (1972-2001)", "MS": "An aspartate aminotransferase found in the CYTOPLASM.", "PM": "2002", "HN": "2002", "MR": "20050708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024443"}, {"RECTYPE": "D", "MH": "Myosin Type I", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myosin IB|T116|T126|NON|NRW|UNK (19XX)|860929|abbcdef", "MN": "D12.776.220.525.475.470", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "PI": "Myosins (1987-2001)", "MS": "A subclass of myosins found generally associated with actin-rich membrane structures such as filopodia. Members of the myosin type I family are ubiquitously expressed in eukaryotes. The heavy chains of myosin type I lack coiled-coil forming sequences in their tails and therefore do not dimerize.", "PM": "2002; for MYOSIN IA & MYOSIN IB see MYOSIN 1988-2001", "HN": "2002; for MYOSIN IA & MYOSIN IB use MYOSINS 1988-2001", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024461"}, {"RECTYPE": "D", "MH": "Myosin Type II", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myosin II|T116|T126|NON|EQV|UNK (19XX)|820204|abbcdef", "MN": "D12.776.220.525.475.475", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "AN": "general or unspecified; prefer specifics", "PI": "Myosins (1973-2001)", "MS": "The subfamily of myosin proteins that are commonly found in muscle fibers. Myosin II is also involved a diverse array of cellular functions including cell division, transport within the GOLGI APPARATUS, and maintaining MICROVILLI structure.", "PM": "2002; for MYOSIN II see MYOSIN 1983-2001", "HN": "2002; for MYOSIN II use MYOSINS 1983-2001", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024462"}, {"RECTYPE": "D", "MH": "Vitamin K 2", "DS": "VITAMIN K A 02", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Menaquinone|T109|T121|T127|NON|EQV|UNK (19XX)|780516|abbbcdef", "ENTRY": "Vitamin K2|T109|T121|T127|NON|EQV|NLM (2002)|001003|abbbcdef", "MN": "D04.615.638.721.374.844", "PA": "Vitamins", "MH_TH": "NLM (2002)", "ST": "T127", "RN": "11032-49-8", "AN": "deficiency: coordinate VITAMIN K 2 (IM) with VITAMIN K DEFICIENCY (IM)", "PI": "Vitamin K (1965-2001)", "MS": "A group of substances similar to VITAMIN K 1 which contains a ring of 2-methyl-1,4-naphthoquinione and an isoprenoid side chain of varying number of isoprene units. In vitamin K 2, each isoprene unit contains a double bond. They are produced by bacteria including the normal intestinal flora.", "PM": "2002; see VITAMIN K 1965-2001", "HN": "2002; use VITAMIN K 1965-2001", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024482"}, {"RECTYPE": "D", "MH": "Vitamin K 3", "DS": "VITAMIN K A 03", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Menadione|T109|T121|T127|NON|EQV|FDA SRS (2014)|UNK (19XX)|USP (19XX)|750716|abbbcdeeef", "ENTRY": "Sodium Bisulfite, Menadione", "MN": "D04.615.638.721.374.922", "PA": "Vitamins", "MH_TH": "NLM (2002)", "ST": "T127", "RN": "723JX6CXY5", "RR": "6XF3C2HK77", "AN": "deficiency: coordinate VITAMIN K 3 (IM) with VITAMIN K DEFICIENCY (IM)", "PI": "Vitamin K (1965-2001)", "MS": "A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.", "PM": "2002; see VITAMIN K 1965-2001", "HN": "2002; use VITAMIN K 1965-2001", "MR": "20130708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024483"}, {"RECTYPE": "D", "MH": "Nonmuscle Myosin Type IIB", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Non-Muscle Myosin Type IIB|T116|T126|NON|EQV|NLM (2002)|001004|abbcdef", "ENTRY": "Non Muscle Myosin Type IIB", "MN": "D12.776.220.525.475.475.500", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "PI": "Myosin (1982-2001)", "MS": "A nonmuscle isoform of myosin type II found predominantly in neuronal tissue.", "PM": "2002", "HN": "2002; for MYOSIN B use MYOSINS 1982-2001", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024501"}, {"RECTYPE": "D", "MH": "alpha-Tocopherol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "d alpha Tocopheryl Acetate", "MN": "D03.633.100.150.909.750.249", "PA": "Vitamins", "MH_TH": "UNK (19XX)", "ST": "T127", "RN": "H4N855PNZ1", "RR": "N9PR3490H9", "AN": "deficiency: coordinate ALPHA-TOCOPHEROL with VITAMIN E DEFICIENCY", "PI": "Vitamin E (1965-2001)", "MS": "A natural tocopherol and one of the most potent antioxidant tocopherols. It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. It has four methyl groups on the 6-chromanol nucleus. The natural d form of alpha-tocopherol is more active than its synthetic dl-alpha-tocopherol racemic mixture.", "PM": "2002; see VITAMIN E 1966-2001; ALPHA-TOCOPHEROL SUCCINATE was indexed under VITAMIN E 1985-2008; ALPHA-TOCOPHEROL ACETATE was indexed under ALPHA-TOCOPHEROL 1980-2008, for TOCOPHEROL ACETATE, D-ALPHA-TOCOPHEROL ACETATE, and TOCOPHEROL SUCCINATE see TOCOPHEROLS 2008-2013", "HN": "2002; use VITAMIN E 1966-2001; for ALPHA-TOCOPHEROL SUCCINATE use VITAMIN E 1982-2007; for TOCOPHEROL ACETATE, D-ALPHA-TOCOPHEROL ACETATE, and TOCOPHEROL SUCCINATE use TOCOPHEROLS 2008-2013", "MR": "20180702", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024502"}, {"RECTYPE": "D", "MH": "beta-Tocopherol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta Tocopherol", "MN": "D03.633.100.150.909.750.374", "PA": "Vitamins", "MH_TH": "UNK (19XX)", "ST": "T127", "RN": "9U6A490501", "AN": "deficiency: coordinate BETA-TOCOPHEROL with VITAMIN E DEFICIENCY", "PI": "Vitamin E (1971-2001)", "MS": "A natural tocopherol with less antioxidant activity than alpha-tocopherol. It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. As in GAMMA-TOCOPHEROL, it also has three methyl groups on the 6-chromanol nucleus but at different sites.", "PM": "2002; see VITAMIN E 1966-2001", "HN": "2002; use VITAMIN E 1966-2001", "MR": "20160531", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024503"}, {"RECTYPE": "D", "MH": "gamma-Tocopherol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "3,4-Dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol|T109|T121|T127|NON|EQV|NLM (2009)|080701|abbbcdef", "MN": "D03.633.100.150.909.750.500", "PA": "Vitamins", "MH_TH": "UNK (19XX)", "ST": "T127", "RN": "8EF1Z1238F", "AN": "deficiency: coordinate GAMMA-TOCOPHEROL with VITAMIN E DEFICIENCY", "PI": "Vitamin E (1969-2001)", "MS": "A natural tocopherol with less antioxidant activity than ALPHA-TOCOPHEROL. It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. As in BETA-TOCOPHEROL, it also has three methyl groups on the 6-chromanol nucleus but at different sites.", "PM": "2002; see VITAMIN E 1966-2001", "HN": "2002; use VITAMIN E 1966-2001", "MR": "20160531", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024504"}, {"RECTYPE": "D", "MH": "Tocopherols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tocopherol|T121|T127|NON|EQV|FDA SRS (2018)|JAN (19XX)|UNK (19XX)|790525|abbcdeeef", "ENTRY": "VitaminE EVIMIRALE", "MN": "D03.633.100.150.909.750", "PA": "Vitamins", "MH_TH": "UNK (19XX)", "ST": "T127", "RN": "R0ZB2556P8", "RR": "1406-66-2", "AN": "deficiency: coordinate TOCOPHEROLS with VITAMIN E DEFICIENCY", "PI": "Vitamin E (1963-2001)", "MS": "A collective name for a group of closely related lipids that contain substitutions on the 2H-1-benzopyran-6-ol nucleus and a long hydrocarbon chain of isoprenoid units. They are antioxidants by virtue of the phenolic hydrogen. Tocopherols react with the most reactive form of oxygen and protect unsaturated fatty acids from oxidation.", "PM": "2002; see VITAMIN E 1966-2001; TOCOPHEROL SUCCINATE was indexed under VITAMIN E 1982-2008; TOCOPEHROL ACETATE was indexed under ALPHA TOCOPHEROL 1980-2008", "HN": "2002; use VITAMIN E 1966-2001", "MR": "20170524", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024505"}, {"RECTYPE": "D", "MH": "5' Flanking Region", "DS": "FLANKING REGION 005", "AQ": "DE GE IM PH RE", "ENTRY": "Sequences, 5' Flanking", "MN": "G05.360.340.024.340.137.295", "FX": "5' Untranslated Regions", "MH_TH": "NLM (2002)", "ST": "T123", "AN": "do not confuse with 5' UNTRANSLATED REGIONS", "MS": "The region of DNA which borders the 5' end of a transcription unit and where a variety of regulatory sequences are located.", "PM": "2002", "HN": "2002", "MR": "20090706", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024506"}, {"RECTYPE": "D", "MH": "Nonmuscle Myosin Type IIA", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myosin Type IIA, Non-Muscle|T116|T126|NON|EQV|NLM (2002)|001030|abbcdef", "ENTRY": "Non muscle Myosin Type IIA", "MN": "D12.776.220.525.475.475.249", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "PI": "Myosin (1997-2001)", "MS": "A nonmuscle isoform of myosin type II found predominantly in platelets, lymphocytes, neutrophils and brush border enterocytes.", "PM": "2002", "HN": "2002", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024507"}, {"RECTYPE": "D", "MH": "Tocotrienols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tocotrienol|T109|T121|T127|NON|EQV|NLM (2002)|001004|abbbcdef", "MN": "D03.633.100.150.909.875", "PA": "Vitamins", "MH_TH": "NLM (2002)", "ST": "T127", "RN": "0", "AN": "deficiency: coordinate TOCOTRIENOLS with VITAMIN E DEFICIENCY", "PI": "Vitamin E (1969-2001)", "MS": "Natural analogs of TOCOPHEROLS exhibiting antioxidant activity. These tocol derivatives and isomers contain a benzopyran ring and an unsaturated isoprenoid side chain.", "PM": "2002; see VITAMIN E 1966-2001", "HN": "2002; use VITAMIN E 1966-2001", "MR": "20160601", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024508"}, {"RECTYPE": "D", "MH": "3' Flanking Region", "DS": "FLANKING REGION 003", "AQ": "DE GE IM PH RE", "ENTRY": "Sequences, 3' Flanking", "MN": "G05.360.340.024.340.137.290", "FX": "3' Untranslated Regions", "MH_TH": "NLM (2002)", "ST": "T123", "AN": "do not confuse with 3' UNTRANSLATED REGIONS", "MS": "The region of DNA which borders the 3' end of a transcription unit and where a variety of regulatory sequences are located.", "PM": "2002", "HN": "2002", "MR": "20090706", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D024509"}, {"RECTYPE": "D", "MH": "Muscle Development", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Myogenesis|T042|NON|NRW|NLM (2002)|001004|abcdef", "ENTRY": "Development, Muscular", "MN": "G11.427.578.590", "MH_TH": "NLM (2002)", "ST": "T042", "AN": "coord with specific muscle term if pertinent", "MS": "Developmental events leading to the formation of adult muscular system, which includes differentiation of the various types of muscle cell precursors, migration of myoblasts, activation of myogenesis and development of muscle anchorage.", "PM": "2002", "HN": "2002", "MR": "20160623", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024510"}, {"RECTYPE": "D", "MH": "Mushroom Bodies", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Pedunculata, Corpora", "MN": "A13.641", "FX": "Neuropil", "MH_TH": "NLM (2002)", "ST": "T023", "PI": "Brain (1970-2001)", "MS": "Prominent lobed neuropils found in ANNELIDA and all ARTHROPODS except crustaceans. They are thought to be involved in olfactory learning and memory.", "PM": "2002", "HN": "2002", "MR": "20120703", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024521"}, {"RECTYPE": "D", "MH": "Genes, BRCA2", "DS": "GENES BRCA 002", "AQ": "DE ES PH RE", "PRINT ENTRY": "BRCA2 Gene|T028|ACX|EQV|NLM (2002)|001020|BRCA GENE A 002|abcdefs", "ENTRY": "Gene, BRCA2", "MN": "G05.360.340.024.340.415.400.105", "FX": "BRCA2 Protein", "MH_TH": "NLM (2002)", "ST": "T028", "AN": "BRCA stands for \"BReast CAncer\"", "PI": "Genes, Tumor Suppressor (1995-2001)", "MS": "A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human chromosome 13 at locus 13q12.3. Mutations in this gene predispose humans to breast and ovarian cancer. It encodes a large, nuclear protein that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev 2000;14(11):1400-6)", "PM": "2002", "HN": "2002", "MR": "20080708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024522"}, {"RECTYPE": "D", "MH": "Batrachoidiformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Toadfishes|T013|NON|EQV|NLM (2002)|001006|abcdef", "MN": "B01.050.150.900.493.039", "MH_TH": "NLM (2002)", "ST": "T013", "RN": "txid8064", "RR": "txid8067", "MS": "An order of bottom fishes with short, small, spinous dorsal fins. It is comprised of one family (Batrachoididae) and about 70 species.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024541"}, {"RECTYPE": "D", "MH": "Hyperotreti", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Hyperotretus", "MN": "B01.050.500.272.400", "MH_TH": "NLM (2002)", "ST": "T008", "RN": "txid117565", "MS": "A group of invertebrate chordates (CHORDATA, NONVERTEBRATE) in the subphylum Craniota. They include the single order Myxiniformes, which comprise various HAGFISHES.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D024561"}, {"RECTYPE": "D", "MH": "Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)", "DS": "GLYCERALDEHYDEPHOSPHATE DE PHO A 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphorylating Glyceraldehyde 3 Phosphate Dehydrogenase", "MN": "D08.811.682.657.163.750.350", "MH_TH": "NLM (1999)", "ST": "T126", "RN": "EC 1.2.1.12", "AN": "do not confuse with Glyceraldehyde 3 Phosphate-Dehydrogenase (NADP+)(Phosphorylating)", "PI": "Glyceraldehyde-3-Phosphate Dehydrogenases (1972-2001)", "MS": "An NAD-dependent glyceraldehyde-3-phosphate dehydrogenase found in the cytosol of eucaryotes. It catalyses the dehydrogenation and phosphorylation of GLYCERALDEHYDE 3-PHOSPHATE to 3-phospho-D-glyceroyl phosphate, which is an important step in the GLYCOLYSIS pathway.", "PM": "2002; see GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001", "HN": "2002; use GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024581"}, {"RECTYPE": "D", "MH": "Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+)", "DS": "GLYCERALDEHYDEPHOSPHATE DE NADP A 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NADP-Dependent Glyceraldehyde 3-Phosphate-Dehydrogenase", "MN": "D08.811.682.657.163.750.250", "MH_TH": "NLM (1999)", "ST": "T126", "RN": "EC 1.2.1.9", "AN": "do not confuse with Glyceraldehyde 3 Phosphate-Dehydrogenase (NADP+)(Phosphorylating)", "PI": "Glyceraldehyde-3-Phosphate Dehydrogenases (1965-2001)", "MS": "An NADP-dependent, non-phosphorylating aldehyde dehydrogenase that catalyzes the irreversible oxidation of GLYCERALDEHYDE 3-PHOSPHATE to 3-phosphoglycerate. It is found in the cytosol of a wide variety of organisms.", "PM": "2002; see GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001", "HN": "2002; use GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024601"}, {"RECTYPE": "D", "MH": "Glyceraldehyde-3-Phosphate Dehydrogenase (NADP+)(Phosphorylating)", "DS": "GLYCERALDEHYDEPHOSPHATE DE NADP P 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glyceraldehyde-3-Phosphate Dehydrogenase, NADP-Dependent, Phosphorylating|T116|T126|NON|EQV|NLM (2002)|001013|abbcdef", "MN": "D08.811.682.657.163.750.300", "MH_TH": "NLM (1999)", "ST": "T126", "RN": "EC 1.2.1.13", "AN": "do not confuse with Glyceraldehyde 3 Phosphate Dehydrogenase (NADP+) or Glyceraldehyde-3-Phosphate-Dehydrogenase (Phosphorylating)", "PI": "Glyceraldehyde-3-Phosphate Dehydrogenases (1972-2001)", "MS": "A phosphorylating glyceraldehyde-3-phosphate dehydrogenase found in the CHLOROPLASTS of higher plants. This enzyme exists as an A2B2 heterotetramer and transfers hydrogen to NADP. It plays an important role in catalyzing the reductive step of the Calvin cycle.", "PM": "2002; see GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (NADP+) (PHOSPHORYLATING) was indexed under GLYCERALDEHYDEPHOSPHATE DEHYDROGENASE 1991-1998 & ALDEHYDE OXIDOREDUCTASES 1991-1994", "HN": "2002; use GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001; use GLYCERALDEHYDEPHOSPHATE DEHYDROGENASES (NM) 1991-1998", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024602"}, {"RECTYPE": "D", "MH": "Potassium Channels, Voltage-Gated", "DE": "K CHANNELS VOLTAGE GATED", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Voltage-Gated Potassium Channels|T116|T123|NON|EQV|NLM (2002)|001020|VOLTAGE GATED K CHANNELS|abbcdefv", "ENTRY": "Voltage Gated Potassium Channels", "MN": "D12.776.543.585.400.750.900", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Potassium Channels (1981-2001)", "MS": "Potassium channel whose permeability to ions is extremely sensitive to the transmembrane potential difference. The opening of these channels is induced by the membrane depolarization of the ACTION POTENTIAL.", "PM": "2002", "HN": "2002", "MR": "20160701", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D024642"}, {"RECTYPE": "D", "MH": "Potassium Channels, Inwardly Rectifying", "DE": "K CHANNELS INWARDLY RECTIFYING", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Inward Rectifier Potassium Channels|T116|T123|NON|EQV|NLM (2002)|001023|abbcdef", "ENTRY": "Channel, IRK1", "MN": "D12.776.543.585.400.750.450", "FX": "Congenital Hyperinsulinism", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Potassium Channels (1989-2001)", "MS": "Potassium channels where the flow of K+ ions into the cell is greater than the outward flow.", "PM": "2002; INWARD RECTIFIER POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, INWARDLY RECTIFYING 2003-2005, POTASSIUM CHANNELS 1999-2002, & MEMBRANE PROTEINS 1993", "HN": "2002", "MR": "20180630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024661"}, {"RECTYPE": "D", "MH": "Potassium Channels, Calcium-Activated", "DE": "K CHANNELS CA ACTIVATED", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Calcium-Activated Potassium Channels|T116|T123|NON|EQV|NLM (2002)|001024|CA ACTIVATED K CHANNELS|abbcdefv", "ENTRY": "Potassium Channels, Calcium Dependent", "MN": "D12.776.543.585.400.750.150", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Potassium Channels (1988-2001)", "MS": "Potassium channels whose activation is dependent on intracellular calcium concentrations.", "PM": "2002", "HN": "2002", "MR": "20160701", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024681"}, {"RECTYPE": "D", "MH": "BRCA2 Protein", "DS": "BRCA PROTEIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fanconi Anemia Complementation Group D1 Protein|T116|T123|NON|EQV|NLM (2006)|050426|FANCONI ANEMIA COMPLEMENTATION GROUP D 01 PROTEIN|abbcdefs", "ENTRY": "Fanconi Anemia Group D1 Protein|T116|T123|NON|EQV|NLM (2006)|050426|abbcdef", "MN": "D12.776.660.105", "FX": "Hereditary Breast and Ovarian Cancer Syndrome", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1995-2001)", "MS": "A large, nuclear protein, encoded by the BRCA2 gene (GENE, BRCA2). Mutations in this gene predispose humans to breast and ovarian cancer. The BRCA2 protein is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev. 2000;14(11):1400-6)", "PM": "2002; BCRA2 PROTEIN was indexed under NEOPLASM PROTEINS & TRANSCRIPTION FACTORS 1995-2001", "HN": "2002; use BRCA2 PROTEIN (NM) 1995-2001", "MR": "20110624", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024682"}, {"RECTYPE": "D", "MH": "Potassium Channels, Tandem Pore Domain", "DE": "K CHANNELS TANDEM PORE DOMAIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tandem Pore Domain Potassium Channels|T116|T123|NON|EQV|NLM (2002)|001026|TANDEM PORE DOMAIN K CHANNELS|abbcdefv", "ENTRY": "Leak Potassium Channels", "MN": "D12.776.543.585.400.750.850", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Potassium Channels (1995-2001)", "MS": "Potassium channels that contain two pores in tandem. They are responsible for baseline or leak currents and may be the most numerous of all K channels.", "PM": "2002", "HN": "2002", "MR": "20160701", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024683"}, {"RECTYPE": "D", "MH": "Myosin Type V", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myosin V|T116|T126|NON|EQV|NLM (2002)|001024|abbcdef", "ENTRY": "Myosin V p190", "MN": "D12.776.220.525.475.750", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "AN": "do not confuse with MYOSIN V1 and MYOSIN V3 see VENTRICULAR MYOSINS", "PI": "Nerve Tissue Proteins (1993-2001)", "MS": "A subclass of myosin involved in organelle transport and membrane targeting. It is abundantly found in nervous tissue and neurosecretory cells. The heavy chains of myosin V contain unusually long neck domains that are believed to aid in translocating molecules over large distances.", "PM": "2002", "HN": "2002; for MYOSIN-V P190 use CHICKEN BRAIN MYOSIN-V P190 (NM) 1993-2001", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024701"}, {"RECTYPE": "D", "MH": "E-Box Elements", "AQ": "DE ES GE IM PH RE", "ENTRY": "Sites, E-Box", "MN": "G05.360.340.024.340.137.750.249.240", "MH_TH": "NLM (2002)", "ST": "T123", "MS": "DNA locations with the consensus sequence CANNTG. ENHANCER ELEMENTS may contain multiple copies of this element. E-boxes play a regulatory role in the control of transcription. They bind with basic helix-loop-helix (bHLH) type TRANSCRIPTION FACTORS. Binding specificity is determined by the specific bHLH heterodimer or homodimer combination and by the specific nucleotides at the 3rd and 4th position of the E-box sequence.", "PM": "2002", "HN": "2002", "MR": "20090714", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024721"}, {"RECTYPE": "D", "MH": "Cardiac Myosins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myosins, Cardiac|T116|T126|NON|EQV|NLM (2002)|001228|abbcdef", "ENTRY": "Myosins, Cardiac Muscle", "MN": "D12.776.220.525.475.475.124", "FX": "Cardiomyopathy, Hypertrophic, Familial", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "PI": "Myosins (1973-2001)", "MS": "Myosin type II isoforms found in cardiac muscle.", "PM": "2002", "HN": "2002", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024722"}, {"RECTYPE": "D", "MH": "Ventricular Myosins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta-Myosin, Ventricular Cardiac", "MN": "D12.776.220.525.475.475.124.500", "FX": "Cardiomyopathy, Hypertrophic, Familial", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "AN": "do not confuse entry terms MYOSIN V1, and MYOSIN V3 with MYOSIN TYPE V", "PI": "Myosins (1976-2001)", "MS": "Isoforms of MYOSIN TYPE II, specifically found in the ventricular muscle of the HEART. Defects in the genes encoding ventricular myosins result in FAMILIAL HYPERTROPHIC CARDIOMYOPATHY.", "PM": "2002", "HN": "2002; for MYOSIN V1 & MYOSIN V3 use MYOSINS 1988-2001", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024723"}, {"RECTYPE": "D", "MH": "Cardiomyopathy, Hypertrophic, Familial", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Familial Hypertrophic Cardiomyopathy|T047|NON|EQV|NLM (2002)|ORD (2010)|001030|abcdeef", "ENTRY": "Ventricular Hypertrophies, Hereditary", "MN": "C16.320.160", "FX": "Ventricular Myosins", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "Cardiomyopathy, Hypertrophic/genetics (1983-2001)", "MS": "An autosomal dominant inherited form of HYPERTROPHIC CARDIOMYOPATHY. It results from any of more than 50 mutations involving genes encoding contractile proteins such as VENTRICULAR MYOSINS; cardiac TROPONIN T; ALPHA-TROPOMYOSIN.", "PM": "2002", "HN": "2002", "MR": "20200228", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024741"}, {"RECTYPE": "D", "MH": "HMG-Box Domains", "AQ": "DE GE IM PH RE", "ENTRY": "High Mobility Group Box Domains", "MN": "G02.111.570.820.709.275.750.235", "MH_TH": "NLM (2002)", "ST": "T087", "AN": "HIGH MOBILITY GROUP PROTEINS is also available", "PI": "High Mobility Group Proteins (1991-2001)", "MS": "DNA-binding domains present in proteins of the HMG-box superfamily including the archetypal HMGB PROTEINS, a number of sequence specific TRANSCRIPTION FACTORS, and other DNA-BINDING PROTEINS. The domains consist of 70-80 amino acids that form an L-shaped fold from three alpha-helical segments. The domain has the capacity to recognize and/or induce specific DNA structures and effect the accessibility of the DNA to other proteins involved in transcription, recombination, or DNA repair. (Note that not all HIGH MOBILITY GROUP PROTEINS contain this domain.)", "PM": "2002", "HN": "2002", "MR": "20160531", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D024742"}, {"RECTYPE": "D", "MH": "Atrial Myosins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myosins, Atrial|T116|T126|NON|EQV|NLM (2002)|001228|abbcdef", "ENTRY": "Myosin, Atrial", "MN": "D12.776.220.525.475.475.124.249", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "PI": "Myosins (1979-2001)", "MS": "Myosin type II isoforms specifically found in the atrial muscle of the heart.", "PM": "2002", "HN": "2002", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024743"}, {"RECTYPE": "D", "MH": "Skeletal Muscle Myosins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Myosins, Skeletal Muscle|T116|T126|NON|EQV|NLM (2002)|001228|abbcdef", "MN": "D12.776.220.525.475.475.750", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "PI": "Myosins (1970-2001)", "MS": "Myosin type II isoforms found in skeletal muscle.", "PM": "2002", "HN": "2002", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024744"}, {"RECTYPE": "D", "MH": "Smooth Muscle Myosins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myosins, Smooth Muscle|T116|T126|NON|EQV|NLM (2002)|001228|abbcdef", "MN": "D12.776.220.525.475.475.875", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "PI": "Myosins (1971-2001)", "MS": "Myosin type II isoforms found in smooth muscle.", "PM": "2002", "HN": "2002", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024745"}, {"RECTYPE": "D", "MH": "AT-Hook Motifs", "AQ": "DE GE IM PH RE", "ENTRY": "Motifs, AT-Hook", "MN": "G02.111.570.820.709.275.500.050", "MH_TH": "NLM (2002)", "ST": "T087", "PI": "DNA-Binding Proteins (1994-2001)", "MS": "DNA-binding motifs, first described in one of the HMGA PROTEINS: HMG-I(Y) PROTEIN. They consist of positively charged sequences of nine amino acids centered on the invariant tripeptide glycine-arginine-proline. They act to fasten the protein to an AT RICH SEQUENCE in the DNA.", "PM": "2002", "HN": "2002", "MR": "20160527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024761"}, {"RECTYPE": "D", "MH": "Leeching", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Leech Therapy|T061|NON|EQV|NLM (2002)|001031|LEECH THER|abcdefv", "MN": "E02.596", "FX": "Leeches", "MH_TH": "NLM (2002)", "ST": "T061", "PI": "Leeches (1965-2001)", "MS": "The application of LEECHES to the body to draw blood for therapeutic purposes. Such medicinal leeching, an ancient medical practice, is still being used in microsurgery and the treatment of venous congestion or occlusion.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024763"}, {"RECTYPE": "D", "MH": "Hirudin Therapy", "DE": "HIRUDIN THER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E02.319.913.500", "FX": "Leeching", "MH_TH": "NLM (2002)", "ST": "T061", "AN": "coord IM with disease/drug ther (IM)", "PI": "Hirudin (1968-2001)", "MS": "Use of HIRUDINS as an anticoagulant in the treatment of cardiological and hematological disorders.", "PM": "2002", "HN": "2002", "MR": "20150623", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D024764"}, {"RECTYPE": "D", "MH": "Tauopathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tauopathy|T047|NON|EQV|NLM (2002)|010111|abcdef", "MN": "C10.574.945", "FX": "tau Proteins", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "tau Proteins (1997-2001)", "MS": "Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.", "PM": "2002", "HN": "2002", "MR": "20050707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024801"}, {"RECTYPE": "D", "MH": "Nurse's Role", "AQ": "HI PX", "ENTRY": "Roles, Nurses'", "MN": "N05.300.100.337", "MH_TH": "NLM (2002)", "ST": "T054", "MS": "The expected function of a member of the nursing profession.", "PM": "2002", "HN": "2002", "MR": "20180629", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024802"}, {"RECTYPE": "D", "MH": "Biomedical Enhancement", "DE": "BIOMED ENHANCEMENT", "AQ": "EC ES HI MT SN ST", "PRINT ENTRY": "Enhancement, Biomedical|T061|NON|EQV|NLM (2002)|001113|ENHANCEMENT BIOMED|abcdefv", "ENTRY": "Technology, Enhancement", "MN": "J01.897.120.050.250", "MH_TH": "NLM (2002)", "ST": "T061", "MS": "The use of technology-based interventions to improve functional capacities rather than to treat disease.", "PM": "2002", "HN": "2002", "MR": "20200609", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024803"}, {"RECTYPE": "D", "MH": "Metabolic Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Reaven Syndrome X|T047|EPO|EQV|NLM (1998)|960718|abcdef", "ENTRY": "X Syndrome, Metabolic", "MN": "C18.452.625", "FX": "Microvascular Angina", "MH_TH": "NLM (2018)", "ST": "T047", "PI": "Syndrome X (1996-2001)", "MS": "A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.", "PM": "2018; see METABOLIC SYNDROME X 2002-2017; for REAVEN SYNDROME X see INSULIN RESISTANCE 1998-2001", "HN": "2018 (2002); for REAVEN SYNDROME X use INSULIN RESISTANCE 1998-2001", "MR": "20200228", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024821"}, {"RECTYPE": "D", "MH": "Fluoroquinolones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fluoroquinolone|T109|T121|NON|EQV|NLM (2021)|191121|abbcdef", "MN": "D03.633.100.810.835.322", "PA": "Nucleic Acid Synthesis Inhibitors", "MH_TH": "NLM (2002)", "ST": "T121", "RN": "0", "PI": "Quinolones (1987-2001)", "MS": "A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.", "PM": "2002", "HN": "2002", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024841"}, {"RECTYPE": "D", "MH": "Genetic Enhancement", "DE": "GENET ENHANCEMENT", "AQ": "EC ES HI LJ MT SN ST", "ENTRY": "Genetic Enhancements|T061|T063|NON|EQV|NLM (2002)|010613|GENET ENHANCEMENTS|abbcdefv", "MN": "J01.897.120.050.250.500", "MH_TH": "NLM (2002)", "ST": "T063", "AN": "not for therapeutic procedures (=GENE THERAPY)", "PI": "Genetic Engineering (1996-2001)", "MS": "The use of genetic methodologies to improve functional capacities of an organism rather than to treat disease.", "PM": "2002; see GENE ENGINEERING 1997-2001", "HN": "2002; use GENE ENGINEERING 1997-2001", "MR": "20200609", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024861"}, {"RECTYPE": "D", "MH": "Oxyphil Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Oxyphil Cell|T025|NON|EQV|NLM (2021)|200526|abcdef", "ENTRY": "Cells, Oxyphil", "MN": "A11.690", "FX": "Adenoma, Oxyphilic", "MH_TH": "NLM (2002)", "ST": "T025", "PI": "Thyroid Neoplasms (1992-2001)", "MS": "Large cells with small irregular nuclei and dense acidophilic granules due to the presence of abundant MITOCHONDRIA. Oxyphil cells, also known as oncocytes, are found in oncocytomas of the kidney, salivary glands, and endocrine glands. In the thyroid gland, oxyphil cells are known as Hurthle cells and Askenazy cells.", "PM": "2002", "HN": "2002", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024862"}, {"RECTYPE": "D", "MH": "Drug Resistance, Bacterial", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Antibiotic Resistance, Bacterial|T032|NON|NRW|NLM (2002)|010125|abcdef", "ENTRY": "Antibacterial Drug Resistance|T032|NON|EQV|NLM (2002)|001113|abcdef", "MN": "G07.690.773.984.269.347", "FX": "Tuberculosis, Multidrug-Resistant", "MH_TH": "NLM (2002)", "ST": "T032", "AN": "general or unspecified; prefer specifics", "PI": "Drug Resistance, Microbial (1968-2001)", "MS": "The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).", "PM": "2002", "HN": "2002", "MR": "20150629", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024881"}, {"RECTYPE": "D", "MH": "Drug Resistance, Viral", "AQ": "DE GE IM PH RE", "ENTRY": "Drug Resistances, Viral", "MN": "G07.690.773.984.269.420", "MH_TH": "NLM (2002)", "ST": "T032", "PI": "Drug Resistance, Microbial (1968-2001)", "MS": "The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation.", "PM": "2002", "HN": "2002", "MR": "20150629", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024882"}, {"RECTYPE": "D", "MH": "Drug Resistance, Multiple, Bacterial", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Multidrug Resistance, Bacterial|T032|NON|EQV|NLM (2024)|230414|abcdef", "ENTRY": "Resistance, Bacterial Multidrug", "MN": "G07.690.773.984.300.500", "FX": "Tuberculosis, Multidrug-Resistant", "MH_TH": "NLM (2002)", "ST": "T032", "PI": "Drug Resistance, Multiple (1994-2001)", "MS": "The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).", "PM": "2002", "HN": "2002", "MR": "20230703", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024901"}, {"RECTYPE": "D", "MH": "Drug Resistance, Multiple, Viral", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Multidrug Resistance, Viral|T032|NON|EQV|NLM (2024)|230414|abcdef", "ENTRY": "Viral Multidrug Resistances", "MN": "G07.690.773.984.300.750", "MH_TH": "NLM (2002)", "ST": "T032", "PI": "Drug Resistance, Multiple (1994-2001)", "MS": "The ability of viruses to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance phenotype may be attributed to multiple gene mutation.", "PM": "2002", "HN": "2002", "MR": "20230414", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024921"}, {"RECTYPE": "D", "MH": "Starch Phosphorylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphorylase, Starch", "MN": "D08.811.913.400.450.460.400.374", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 2.4.1.-", "PI": "Phosphorylases (1973-2001)", "MS": "An enzyme of the PHOSPHORYLASES family that catalyzes the degradation of starch, a mixture of unbranched AMYLOSE and branched AMYLOPECTIN compounds. This phosphorylase from plants is the counterpart of GLYCOGEN PHOSPHORYLASE in animals that catalyzes the reaction of inorganic phosphate on the terminal alpha-1,4-glycosidic bond at the non-reducing end of glucans resulting in the release of glucose-1-phosphate.", "PM": "2002", "HN": "2002", "MR": "20030709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024941"}, {"RECTYPE": "D", "MH": "Glycogen Phosphorylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphorylase, Glycogen", "MN": "D08.811.913.400.450.460.400.186", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.4.1.-", "AN": "general or unspecified; prefer specifics", "PI": "Phosphorylases (1972-2001)", "MS": "An enzyme that catalyzes the degradation of GLYCOGEN in animals by releasing glucose-1-phosphate from the terminal alpha-1,4-glycosidic bond. This enzyme exists in two forms: an active phosphorylated form ( PHOSPHORYLASE A) and an inactive un-phosphorylated form (PHOSPHORYLASE B). Both a and b forms of phosphorylase exist as homodimers. In mammals, the major isozymes of glycogen phosphorylase are found in muscle, liver and brain tissue.", "PM": "2002", "HN": "2002", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024981"}, {"RECTYPE": "D", "MH": "Glycogen Phosphorylase, Muscle Form", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myophosphorylase|T116|T126|NON|EQV|UNK (19XX)|800804|abbcdef", "ENTRY": "Myophosphorylase a and b|T116|T126|NON|EQV|NLM (2000)|991108|abbcdef", "MN": "D08.811.913.400.450.460.400.186.312", "FX": "Glycogen Storage Disease Type V", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 2.4.1.-", "PI": "Phosphorylases (1979-2001)", "MS": "An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in muscle. Mutation of the gene coding this enzyme is the cause of McArdle disease (GLYCOGEN STORAGE DISEASE TYPE V).", "PM": "2002", "HN": "2002", "MR": "20030709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D024982"}, {"RECTYPE": "D", "MH": "Glycogen Phosphorylase, Liver Form", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glycogen Phosphorylase b, Liver Form|T116|T126|NON|NRW|NLM (2002)|010213|abbcdef", "MN": "D08.811.913.400.450.460.400.186.124", "FX": "Glycogen Storage Disease Type VI", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 2.4.1.-", "PI": "Phosphorylases (1972-2001)", "MS": "An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in liver tissue. Mutation of the gene coding this enzyme on chromosome 14 is the cause of GLYCOGEN STORAGE DISEASE TYPE VI.", "PM": "2002", "HN": "2002", "MR": "20030709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025001"}, {"RECTYPE": "D", "MH": "Glycogen Phosphorylase, Brain Form", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glycogen Phosphorylase b, Brain Form|T116|T126|NON|NRW|NLM (2002)|010213|abbcdef", "MN": "D08.811.913.400.450.460.400.186.061", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 2.4.1.-", "PI": "Phosphorylases (1978-2001)", "MS": "An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in brain tissue.", "PM": "2002", "HN": "2002", "MR": "20030709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025002"}, {"RECTYPE": "D", "MH": "Cementogenesis", "AQ": "DE GE IM PH RE", "MN": "G07.345.500.325.377.124", "FX": "Dental Cementum", "MH_TH": "NLM (2002)", "ST": "T042", "PI": "Dental Cementum (1967-2001)", "MS": "The formation of DENTAL CEMENTUM, a bone-like material that covers the root of the tooth.", "PM": "2002", "HN": "2002", "MR": "20160115", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025021"}, {"RECTYPE": "D", "MH": "Animal Migration", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Migration, Animal|T053|NON|EQV|NLM (2002)|001122|abcdef", "ENTRY": "Migrations, Animal", "MN": "F01.145.113.069.500", "FX": "Homing Behavior", "MH_TH": "NLM (2002)", "ST": "T053", "PI": "Behavior, Animal (1966-2001)", "MS": "Periodic movements of animals in response to seasonal changes or reproductive instinct. Hormonal changes are the trigger in at least some animals. Most migrations are made for reasons of climatic change, feeding, or breeding.", "PM": "2002", "HN": "2002", "MR": "20120703", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025041"}, {"RECTYPE": "D", "MH": "Amacrine Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cells, Amacrine", "MN": "A11.671.650.850.500", "MH_TH": "NLM (2002)", "ST": "T025", "PI": "Retina/cytology (1966-2001)", "MS": "INTERNEURONS of the vertebrate RETINA. They integrate, modulate, and interpose a temporal domain in the visual message presented to the RETINAL GANGLION CELLS, with which they synapse in the inner plexiform layer.", "PM": "2002", "HN": "2002", "MR": "20080708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025042"}, {"RECTYPE": "D", "MH": "Dinosaurs", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Dinosaur", "MN": "B01.050.150.900.833.150", "MH_TH": "NLM (2002)", "ST": "T014", "RN": "txid436486", "PI": "Reptiles (1966-2001)", "MS": "General name for two extinct orders of reptiles from the Mesozoic era: Saurischia and Ornithischia.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025061"}, {"RECTYPE": "D", "MH": "Yarrowia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Yarrowias", "MN": "B01.300.930.980", "MH_TH": "NLM (2002)", "ST": "T004", "RN": "txid4951", "RR": "txid4952", "PI": "Yeasts (1980-2001)", "MS": "A genus of ascomycetous yeast in the family Dipodascaceae, order SACCHAROMYCETALES.", "PM": "2002", "HN": "2002", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025062"}, {"RECTYPE": "D", "MH": "Chromosome Disorders", "DE": "CHROMOSOME DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chromosome Abnormality Disorders|T047|NON|EQV|NLM (2002)|001124|CHROMOSOME ABNORM DIS|abcdefv", "ENTRY": "Disorders, Chromosome", "MN": "C16.320.180", "FX": "Genetics, Medical", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate with specific numbered chromosome", "PI": "Chromosome Abnormalities (1964-2001)", "MS": "Clinical conditions caused by an abnormal chromosome constitution in which there is extra or missing chromosome material (either a whole chromosome or a chromosome segment). (from Thompson et al., Genetics in Medicine, 5th ed, p429)", "PM": "2002", "HN": "2002; see CHROMOSOMAL ABNORMALITIES 1978-1995", "MR": "20090706", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025063"}, {"RECTYPE": "D", "MH": "Sex Chromosome Disorders", "DE": "SEX CHROMOSOME DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sex Chromosome Abnormality Disorders|T047|NON|EQV|NLM (2002)|010123|SEX CHROMOSOME ABNORM DIS|abcdefv", "ENTRY": "Sex Chromosome Disorder", "MN": "C16.320.180.830", "FX": "Sex Chromosome Aberrations", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "general or unspecified; prefer specifics; coordinate IM with specific sex chromosome (IM)", "PI": "Sex Chromosome Abnormalities (1971-2001)", "MS": "Clinical conditions caused by an abnormal sex chromosome constitution (SEX CHROMOSOME ABERRATIONS), in which there is extra or missing sex chromosome material (either a whole chromosome or a chromosome segment).", "PM": "2002", "HN": "2002", "MR": "20100625", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025064"}, {"RECTYPE": "D", "MH": "Borrelia burgdorferi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Lyme Disease Spirochete|T007|NON|EQV|NLM (2002)|001124|abcdef", "MN": "B03.851.595.193.150.125", "MH_TH": "NLM (2002)", "ST": "T007", "RN": "txid139", "AN": "infection: coord IM with LYME DISEASE or specifics (IM); BORRELIA BURGDORFERI GROUP is also available", "PI": "Borrelia burgdorferi Group (1990-2001)", "MS": "A specific species of bacteria, part of the BORRELIA BURGDORFERI GROUP, whose common name is Lyme disease spirochete.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025065"}, {"RECTYPE": "D", "MH": "Vitamin B 6", "DS": "VITAMIN B A 06", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Vitamin B6|T109|T127|NON|EQV|NLM (1990)|890413|abbcdef", "MN": "D03.383.725.676.925", "PA": "Vitamin B Complex", "EC": "deficiency:Vitamin B 6 Deficiency", "MH_TH": "UNK (19XX)", "ST": "T127", "RN": "8059-24-3", "AN": "/ther use: coordinate with disease /drug ther, not /diet ther", "PI": "Pyridoxine (1965-2001)", "MS": "VITAMIN B 6 refers to several PICOLINES (especially PYRIDOXINE; PYRIDOXAL; & PYRIDOXAMINE) that are efficiently converted by the body to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, and aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into PYRIDOXAMINE phosphate. Although pyridoxine and Vitamin B 6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990). Most of vitamin B6 is eventually degraded to PYRIDOXIC ACID and excreted in the urine.", "PM": "2002; see PYRIDOXINE 1963-2001", "HN": "2002; use PYRIDOXINE 1963-2001", "MR": "20160601", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025101"}, {"RECTYPE": "D", "MH": "Myosin Type III", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myosin III|T116|T126|NON|EQV|NLM (2002)|001129|abbcdef", "MN": "D12.776.220.525.475.612", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "RR": "EC 2.7.1.-", "PI": "Myosins (1998-2001)", "MS": "A subclass of myosins originally found in the photoreceptor of DROSOPHILA. The heavy chains can occur as two alternatively spliced isoforms of 132 and 174 KDa. The amino terminal of myosin type III is highly unusual in that it contains a protein kinase domain which may be an important component of the visual process.", "PM": "2002", "HN": "2002", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025102"}, {"RECTYPE": "D", "MH": "Myosin Type IV", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myosin IV|T116|T126|NON|EQV|NLM (2002)|001129|abbcdef", "ENTRY": "Type IV, Myosin", "MN": "D12.776.220.525.475.681", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "PI": "Myosins (1990-2001)", "MS": "A subclass of myosin found in ACANTHAMOEBA. It is a non-filamentous myosin containing a single 180-kDa myosin heavy chain.", "PM": "2002", "HN": "2002", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025121"}, {"RECTYPE": "D", "MH": "Drug Resistance, Fungal", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Antibiotic Resistance, Fungal|T032|NON|NRW|NLM (2002)|010125|abcdef", "ENTRY": "Resistance, Antifungal Drug", "MN": "G07.690.773.984.269.383", "MH_TH": "NLM (2002)", "ST": "T032", "PI": "Drug Resistance, Microbial (1966-2001)", "MS": "The ability of fungi to resist or to become tolerant to chemotherapeutic agents, antifungal agents, or antibiotics. This resistance may be acquired through gene mutation.", "PM": "2002", "HN": "2002", "MR": "20150630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025141"}, {"RECTYPE": "D", "MH": "ATP Synthetase Complexes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ATP Synthetase Complex|T116|T126|ACX|EQV|NLM (2002)|abbcde", "ENTRY": "ATP ADP Kinase", "MN": "D08.811.913.696.650.150", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 2.7.4.-", "PI": "Phosphotransferases (Phosphate Group Acceptor) (1994-2001)", "MS": "Multisubunit enzyme complexes that synthesize ADENOSINE TRIPHOSPHATE from energy sources such as ions traveling through channels.", "PM": "2002; ATP SYNTHETASE COMPLEX was indexed under MULTIENZYME COMPLEXES 1980-2001, PHOSPHOTRANSFERASES (PHOSPHATE GROUP ACCEPTOR) 1994-2001, PHOSPHOTRANSFERASES, ATP 1977-1993, PHOSPHOTRANSFERASES 1972-1976 & ATP 1972-1976", "HN": "2002; use ATP SYNTHETASE COMPLEXES (NM) 1980-2001", "MR": "20050707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025181"}, {"RECTYPE": "D", "MH": "Molecular Diagnostic Techniques", "DE": "MOL DIAG TECHNIQUES", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Molecular Testing|T063|NON|EQV|NLM (2021)|200103|abcdef", "ENTRY": "Testing, Molecular Diagnostic", "MN": "E05.393.520", "FX": "Molecular Probes", "MH_TH": "NLM (2002)", "ST": "T063", "AN": "coordinate with specific technique", "MS": "MOLECULAR BIOLOGY techniques used in the diagnosis of disease.", "PM": "2002; for MOLECULAR DIAGNOSTIC TESTING see CYTOGENETIC ANALYSIS 2000-2001", "HN": "2002; for MOLECULAR DIAGNOSTIC TESTING use CYTOGENETIC ANALYSIS 2000-2001", "MR": "20200609", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025202"}, {"RECTYPE": "D", "MH": "Phosphofructokinase-1, Muscle Type", "DS": "PHOSPHOFRUCTOKINASE 01 MUSCLE TYPE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "6-Phosphofructokinase, Muscle Type|T116|T126|NON|EQV|NLM (2002)|001204|PHOSPHOFRUCTOKINASE 06 MUSCLE TYPE|abbcdefs", "ENTRY": "Phosphofructokinase 1, Muscle Type", "MN": "D08.811.913.696.620.225.850.500.500", "EC": "deficiency:Glycogen Storage Disease Type VII", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 2.7.1.-", "PI": "6-Phosphofructokinase (1977-2001)", "MS": "An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. In humans, PHOSPHOFRUCTOKINASE-1 in muscle exists as the homotetramer of M subunits. Defects in this muscle enzyme cause GLYCOGEN STORAGE DISEASE TYPE VII, also known as Tarui's disease.", "PM": "2002", "HN": "2002", "MR": "20050725", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025203"}, {"RECTYPE": "D", "MH": "Phosphofructokinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphofructokinase|T116|T126|NON|EQV|NLM (2021)|200113|abbcdef", "MN": "D08.811.913.696.620.225.850", "MH_TH": "NLM (1993)", "ST": "T126", "RN": "EC 2.7.1 -", "PI": "Phosphofructokinase-1 (1964-2001)", "MS": "Allosteric enzymes that regulate glycolysis and gluconeogenesis. These enzymes catalyze phosphorylation of fructose-6-phosphate to either fructose-1,6-bisphosphate (PHOSPHOFRUCTOKINASE-1 reaction), or to fructose-2,6-bisphosphate (PHOSPHOFRUCTOKINASE-2 reaction).", "PM": "2002; see 6-PHOSPHOFRUCTOKINASE 1993-2001, use PHOSPHOFRUCTOKINASE 1965-1992", "HN": "2002; use 6-PHOSPHOFRUCTOKINASE 1993-2001, use PHOSPHOFRUCTOKINASE 1965-1992", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025221"}, {"RECTYPE": "D", "MH": "Chloroplast Proton-Translocating ATPases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chloroplast Coupling Factor|T116|T126|NON|EQV|UNK (19XX)|830616|abbcdef", "ENTRY": "Synthases, Chloroplast ATP", "MN": "D12.776.765.199.750.374", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.3.-", "PI": "Proton-Translocating ATPases (1978-2001)", "MS": "Proton-translocating ATPases which produce ADENOSINE TRIPHOSPHATE in plants. They derive energy from light-driven reactions that develop high concentrations of protons within the membranous cisternae (THYLAKOIDS) of the CHLOROPLASTS.", "PM": "2002; for CHLOROPLAST COUPLING FACTOR see H(+)-TRANSPORTING ATP SYNTHASE 1993-2001, ADENOSINE TRIPHOSPHATASE F1 1984-92 ADENOSINE TRIPHOSPHATASE F1 1983 & CHLOROPLAST COUPLING FACTOR 1978-1983; for CF1 ATPASE, COUPLING FACTOR 0 & COUPLING FACTOR 1 see H(+)-TRANSPORTING ATP SYNTHASE 1993-2001, ADENOSINE TRIPHOSPHATASE F1 1984-92 & ADENOSINE TRIPHOSPHATASE F1 1983", "HN": "2002; for CHLOROPLAST COUPLING FACTOR use PROTON TRANSLOCATING ATPASES 1978-2001; for CF1 ATPASE, COUPLING FACTOR 0 & COUPLING FACTOR 1 use PROTON TRANSLOCATING ATPASES 1983-2001", "MR": "20160115", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025222"}, {"RECTYPE": "D", "MH": "Spondylarthritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spinal Arthritis|T047|NON|EQV|NLM (2002)|001205|abcdef", "ENTRY": "Spondylarthritides", "MN": "C05.550.114.865", "FX": "Spondylitis, Ankylosing", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "coordinate with specific vertebra", "PI": "Spondylitis, Ankylosing (1966-2001)", "MS": "Inflammation of the joints of the SPINE, the intervertebral articulations.", "PM": "2002", "HN": "2002", "MR": "20080708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025241"}, {"RECTYPE": "D", "MH": "Spondylarthropathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Bechterew", "MN": "C05.550.114.865.800", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "coordinate with specific vertebra", "PI": "Spondylitis, Ankylosing (1977-2001)", "MS": "Heterogeneous group of arthritic diseases sharing clinical and radiologic features. They are associated with the HLA-B27 ANTIGEN and some with a triggering infection. Most involve the axial joints in the SPINE, particularly the SACROILIAC JOINT, but can also involve asymmetric peripheral joints. Subsets include ANKYLOSING SPONDYLITIS; REACTIVE ARTHRITIS; PSORIATIC ARTHRITIS; and others.", "PM": "2002", "HN": "2002", "MR": "20120703", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D025242"}, {"RECTYPE": "D", "MH": "Bacterial Proton-Translocating ATPases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proton-Translocating ATPases, Bacterial", "MN": "D12.776.543.585.450.250.875.500.249", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "AN": "coord with specific bacterium /enzymol", "PI": "Proton-Translocating ATPases (1983-2001)", "MS": "Membrane-bound proton-translocating ATPases that serve two important physiological functions in bacteria. One function is to generate ADENOSINE TRIPHOSPHATE by utilizing the energy provided by an electrochemical gradient of protons across the cellular membrane. A second function is to counteract a loss of the transmembrane ion gradient by pumping protons at the expense of adenosine triphosphate hydrolysis.", "PM": "2002", "HN": "2002", "MR": "20110701", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025243"}, {"RECTYPE": "D", "MH": "Mitochondrial Proton-Translocating ATPases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Respiratory Complex V|T116|T126|NON|EQV|NLM (2022)|210521|abbcdef", "ENTRY": "Proton-Translocating ATPases, Mitochondrial", "MN": "D12.776.575.750.625", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.3.-", "PI": "Proton-Translocating ATPases (1979-2001)", "MS": "Proton-translocating ATPases responsible for ADENOSINE TRIPHOSPHATE synthesis in the MITOCHONDRIA. They derive energy from the respiratory chain-driven reactions that develop high concentrations of protons within the intermembranous space of the mitochondria.", "PM": "2002", "HN": "2002", "MR": "20210707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025261"}, {"RECTYPE": "D", "MH": "Vacuolar Proton-Translocating ATPases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Vacuolar H+ ATPase", "MN": "D12.776.543.585.450.250.875.500.875", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 3.6.1.-", "PI": "Proton-Translocating ATPases (1984-2001)", "MS": "Proton-translocating ATPases that are involved in acidification of a variety of intracellular compartments.", "PM": "2002; for VACUOLAR H+-ATPASES see VACUOLAR PROTEIN-TRANSLOCATION ATPASES 2002-2006, PROTON-TRANSLOCATION ATPASES 1992-2001 & ADENOSINETRIPHOSPHATASE 1992-1996", "HN": "2002", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025262"}, {"RECTYPE": "D", "MH": "Mycelium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Myceliums", "MN": "A19.687", "MH_TH": "NLM (2002)", "ST": "T004", "AN": "coord with specific fungus", "MS": "The body of a fungus which is made up of HYPHAE.", "PM": "2002", "HN": "2002", "MR": "20090706", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025282"}, {"RECTYPE": "D", "MH": "Hyphae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Hyphas", "MN": "A19.687.400", "MH_TH": "NLM (2002)", "ST": "T004", "AN": "coord with specific fungus", "MS": "Microscopic threadlike filaments in FUNGI that are filled with a layer of protoplasm. Collectively, the hyphae make up the MYCELIUM.", "PM": "2002", "HN": "2002", "MR": "20090706", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025301"}, {"RECTYPE": "D", "MH": "Surgery, Computer-Assisted", "DE": "SURG COMPUTER ASSISTED", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Navigation|T061|NON|NRW|NLM (2021)|200421|abcdef", "ENTRY": "Surgery, Image Guided", "MN": "E04.749", "FX": "Therapy, Computer-Assisted", "MH_TH": "NLM (2002)", "ST": "T061", "PI": "Therapy, Computer-Assisted (1988-2001)", "MS": "Surgical procedures conducted with the aid of computers. Used in various types of surgery for implant placement and instrument guidance. Image-guided surgery interactively combines prior CT scans or MRI images with real-time video.", "PM": "2002", "HN": "2002", "MR": "20200609", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025321"}, {"RECTYPE": "D", "MH": "Principal Component Analysis", "DE": "PRINCIPAL COMPONENT ANAL", "AQ": "CL HI MT ST", "ENTRY": "Principal Component Analyses", "MN": "E05.318.740.562", "MH_TH": "NLM (2002)", "ST": "T081", "MS": "Mathematical procedure that transforms a number of possibly correlated variables into a smaller number of uncorrelated variables called principal components.", "PM": "2002", "HN": "2002", "MR": "20080708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025341"}, {"RECTYPE": "D", "MH": "Streptogramins", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Streptogramin|T116|T195|NON|EQV|NLM (1994)|921203|abbcdef", "MN": "D12.644.641.802", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1994)", "ST": "T195", "RN": "0", "PI": "Virginiamycin (1992-2001)", "MS": "A class of natural cyclic peptide antibiotics produced by certain subspecies of STREPTOMYCES. They include two structurally unrelated components, STREPTOGRAMIN GROUP A and STREPTOGRAMIN GROUP B, which generally act synergistically to inhibit bacterial growth.", "PM": "2002; see VIRGINIAMYCIN 1994-2001, see STREPTOGRAMINS 1981-1993", "HN": "2002, 1981-1993; use VIRGINIAMYCIN 1994-2001", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025361"}, {"RECTYPE": "D", "MH": "Streptogramin Group A", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Streptogramin, Group A", "MN": "D12.644.641.802.500", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (2002)", "ST": "T195", "RN": "0", "AN": "STREPTOGRAMIN A is also available", "PI": "Virginiamycin (1986-2001)", "MS": "A structural subclass of streptogramins that includes molecules containing unsaturated macrocyclic lactones with approximate molecular weight of 500 KDa.", "PM": "2002", "HN": "2002", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025362"}, {"RECTYPE": "D", "MH": "Rhinomanometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E05.559.740", "MH_TH": "NLM (2002)", "ST": "T060", "PI": "Manometry (1970-2001)", "MS": "Technique for measuring air pressure and the rate of airflow in the nasal cavity during respiration.", "PM": "2002", "HN": "2002", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025363"}, {"RECTYPE": "D", "MH": "Streptogramin A", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Virginiamycin Factor M1|T116|T195|NON|EQV|FDA SRS (2014)|NLM (1991)|900409|VIRGINIAMYCIN FACTOR M01|abbcdeefs", "ENTRY": "Virginiamycin M1|T116|T195|NON|EQV|FDA SRS (2014)|NLM (2002)|001117|abbcdeef", "MN": "D12.644.641.802.875.500", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1991)", "ST": "T195", "N1": "8,9,14,15,24,25-Hexahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone", "RN": "8W4UOL59AZ", "RR": "21411-53-0 (Streptogramin A)", "PI": "Virginiamycin (1991-2001)", "MS": "A specific streptogramin group A antibiotic produced by Streptomyces graminofaciens and other bacteria.", "PM": "2002; see VIRGINIAMYCIN 1991-2001; for STAPHYLOMYCIN M1, PRISTAMYCIN IIA & VIRGINIAMYCIN FACTOR M1 see VIRGINIAMYCIN 1991-2001", "HN": "2002; use VIRGINIAMYCIN 1991-2001; for STAPHYLOMYCIN M1, PRISTAMYCIN IIA & VIRGINIAMYCIN FACTOR M1 use VIRGINIAMYCIN 1991-2001", "MR": "20130708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025364"}, {"RECTYPE": "D", "MH": "Streptogramin B", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vernamycin Balpha|T116|T129|NON|EQV|NLM (2002)|001211|abbcdef", "MN": "D12.644.641.802.750.500", "MH_TH": "NLM (1991)", "ST": "T129", "N1": "4-(4-(Dimethylamino)-N-methyl-L-phenylalanine)virginiamycin S1", "RN": "3131-03-1", "PI": "Virginiamycin (1986-2001)", "MS": "A specific streptogramin group B antibiotic produced by Streptomyces graminofaciens and other bacteria.", "PM": "2002; see VIRGINIAMYCIN 1991-2001; for PRISTINAMYCIN IA see VIRGINIAMYCIN 1991-2001", "HN": "2002; use VIRGINIAMYCIN 1991-2001; for PRISTINAMYCIN IA use VIRGINIAMYCIN 1991-2001", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025381"}, {"RECTYPE": "D", "MH": "Streptogramin Group B", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Streptogramin, Group B", "MN": "D12.644.641.802.750", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (2002)", "ST": "T129", "RN": "0", "AN": "STREPTOGRAMIN B is available", "PI": "Virginiamycin (1986-2001)", "MS": "A structural subclass of streptogramins. They are cyclic hexadepsipeptides with approximate molecular weight of 800 that contain a characteristic 3-hydroxy picolinoyl exocyclic component.", "PM": "2002", "HN": "2002", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025382"}, {"RECTYPE": "D", "MH": "Echocardiography, Stress", "DE": "ECHOCARDIOGR STRESS", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "PRINT ENTRY": "Stress Echocardiography|T060|NON|EQV|NLM (2002)|010309|STRESS ECHOCARDIOGR|abcdefv", "ENTRY": "Stress Echocardiography, Dobutamine", "MN": "E01.370.370.380.220.228", "FX": "Exercise Test", "MH_TH": "NLM (2002)", "ST": "T060", "PI": "Exercise Test (1983-2001)", "MS": "A method of recording heart motion and internal structures by combining ultrasonic imaging with exercise testing (EXERCISE TEST) or pharmacologic stress.", "PM": "2002", "HN": "2002", "MR": "20100625", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025401"}, {"RECTYPE": "D", "MH": "Dihydroergocornine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dihydroergocornine Mesylate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1992)|910314|abbcdeef", "ENTRY": "Monomesylate, Dihydroergocornine", "MN": "D03.633.400.562.150", "PA": "Dopamine Agonists", "FX": "Dihydroergotoxine", "MH_TH": "NLM (1992)", "ST": "T123", "N1": "Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-2',5'alpha-bis(1-methylethyl)-", "RN": "IK4C1OC8NE", "RR": "42RX8KPW29", "PI": "Dihydroergotoxine (1991-2001)", "MS": "A 9,10alpha-dihydro derivative of ERGOTAMINE that contains isopropyl sidechains at the 2' and 5' positions of the molecule.", "PM": "2002; see DIHYDROERGOTOXINE 1992-2001; for DIHYDROERGOCORNINE MESYLATE see ERGOLOID MESYLATES 1991-2001", "HN": "2002, 1977-1991; use DIHYDROERGOTOXINE 1992-2001; for DIHYDROERGOCORNINE MESYLATE use ERGOLOID MESYLATES 1991-2001", "MR": "20160531", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025441"}, {"RECTYPE": "D", "MH": "Dihydroergocristine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dihydroergocristine Mesylate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1992)|910314|abbcdeef", "ENTRY": "Monomesylate, Dihydroergocristine", "MN": "D03.633.400.562.200", "PA": "Vasodilator Agents", "FX": "Dihydroergotoxine", "MH_TH": "NLM (1992)", "ST": "T121", "N1": "Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(phenylmethyl)-", "RN": "05D48LUM4Z", "RR": "DS7CL18UAM", "PI": "Ergoloid Mesylates (1973-1974)", "MS": "A 9,10alpha-dihydro derivative of ERGOTAMINE that contains an isopropyl sidechain at the 2' position of the molecule.", "PM": "2002; see DIHYDROERGOTOXINE 1975-2001, for DIHYDROERGOCRISTINE MESYLATE see ERGOLOID MESYLATES 1991-2001", "HN": "2002, 1975-1991; use DIHYDROERGOTOXINE 1992-2001, for DIHYDROERGOCRISTINE MESYLATE use ERGOLOID MESYLATES 1977-2001", "MR": "20170524", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025442"}, {"RECTYPE": "D", "MH": "Dihydroergocryptine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dihydroergocryptine Mesylate|T109|T121|NON|NRW|NLM (1992)|910314|abbcdef", "ENTRY": "Monomesylate, Dihydroergokryptine", "MN": "D03.633.400.562.250", "PA": "Vasodilator Agents", "FX": "Dihydroergotoxine", "MH_TH": "NLM (1992)", "ST": "T121", "N1": "Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-5'alpha-isobutyl-2'-isopropyl", "RN": "67V3FSL2GL", "RR": "29261-93-6 (Dihydroergocryptine mesylate)", "PI": "Dihydroergotoxine (1991-2001)", "MS": "A 9,10alpha-dihydro derivative of ERGOTAMINE that contains an isopropyl sidechain at the 2' position and an alpha-isobutyl sidechain at 5'alpha position of the molecule.", "PM": "2002; see DIHYDROERGOTOXINE 1991-2001; for DIHYDROERGOCRYPTINE MESYLATE see ERGOLOID MESYLATES 1991-2001", "HN": "2002, 1971-1991; use DIHYDROERGOTOXINE 1992-2001; for DIHYDROERGOCRYPTINE MESYLATE use ERGOLOID MESYLATES 1991-2001", "MR": "20170524", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025443"}, {"RECTYPE": "D", "MH": "Feedback, Physiological", "AQ": "DE PH RE", "PRINT ENTRY": "Feedback, Biochemical|T067|NON|NRW|NLM (2002)|001218|abcdef", "ENTRY": "Stimulations, Biochemical Feedback", "MN": "G07.410.732", "FX": "Signal Transduction", "MH_TH": "NLM (2010)", "ST": "T067", "PI": "Feedback (1964-2001)", "MS": "A mechanism of communication with a physiological system for homeostasis, adaptation, etc. Physiological feedback is mediated through extensive feedback mechanisms that use physiological cues as feedback loop signals to control other systems.", "PM": "2002", "HN": "2002", "MR": "20170630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D025461"}, {"RECTYPE": "D", "MH": "Phosphofructokinase-2", "DS": "PHOSPHOFRUCTOKINASE 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fructose-2,6-bisphosphatase|T116|T126|NON|NRW|NLM (2002)|FRUCTOSE BISPHOSPHATASE 02 06|abbcdes", "ENTRY": "Phosphofructokinase 2", "MN": "D08.811.913.696.620.225.850.750", "FX": "Phosphofructokinase-1", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 2.7.1.105", "RR": "EC 3.1.3.46", "PI": "Phosphotransferases (1981-2001)", "MS": "An allosteric enzyme that regulates glycolysis and gluconeogenesis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-2,6-bisphosphate, an allosteric effector for the other 6-phosphofructokinase, PHOSPHOFRUCTOKINASE-1. Phosphofructokinase-2 is bifunctional: the dephosphorylated form is a kinase and the phosphorylated form is a phosphatase that breaks down fructose-2,6-bisphosphate to yield fructose-6-phosphate.", "PM": "2002; 6-PHOSPHOFRUCTO-2-KINASE was indexed under PHOSPHOTRANSFERASES (NM) 1993-2001, under PHOSPHOTRANSFERASES, ATP (NM) 1981-1993; FRUCTOSE-2,6-BISPHOSPATASE was indexed under PHOSPHORIC MONOESTER HYDROLASES (NM) 1983-2001; 6-PHOSPHOFRUCTO-2-KINASE-FRUCTOSE-2,6-BISPHOSPHATASE was indexed under FRUCTOSE-BISPHOSPHATASE (NM) 1990-2001, under MULTIENZYME COMPLEXES (NM) 1990-2001, under PHOSPHOFRUCTOKINASE-1 (NM) 1990-2001", "HN": "2002; for 6-PHOSPHOFRUCTO-2-KINASE use PHOSPHOTRANSFERASES (NM) 1993-2001, use PHOSPHOTRANSFERASES, ATP (NM) 1981-1993; for FRUCTOSE-2,6-BISPHOSPATASE use PHOSPHORIC MONOESTER HYDROLASES (NM) 1983-2001; for 6-PHOSPHOFRUCTO-2-KINASE-FRUCTOSE-2,6-BISPHOSPHATASE use FRUCTOSE-BISPHOSPHATASE (NM) 1990-2001, use MULTIENZYME COMPLEXES (NM) 1990-2001, use PHOSPHOFRUCTOKINASE-1 (NM) 1990-2001", "MR": "20130708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025481"}, {"RECTYPE": "D", "MH": "Phosphofructokinase-1, Liver Type", "DS": "PHOSPHOFRUCTOKINASE 01 LIVER TYPE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "6-Phosphofructokinase, Liver Type|T116|T126|NON|EQV|NLM (2002)|001219|PHOSPHOFRUCTOKINASE 06 LIVER TYPE|abbcdefs", "ENTRY": "Phosphofructokinase 1, Liver Type", "MN": "D08.811.913.696.620.225.850.500.249", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 2.7.1.-", "PI": "6-Phosphofructokinase (1977-2001)", "MS": "An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. In human liver, the 6-phosphofructose-1-kinase exists as the homotetramer of L subunits.", "PM": "2002", "HN": "2002", "MR": "20040713", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025501"}, {"RECTYPE": "D", "MH": "Phosphofructokinase-1, Type C", "DS": "PHOSPHOFRUCTOKINASE 01 TYPE C", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "6-Phosphofructokinase, Platelet Type|T116|T126|NON|EQV|NLM (2002)|001219|PHOSPHOFRUCTOKINASE 06 PLATELET TYPE|abbcdefs", "ENTRY": "Phosphofructokinase 1, Type C", "MN": "D08.811.913.696.620.225.850.500.750", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 2.7.1.-", "PI": "6-Phosphofructokinase (1977-2001)", "MS": "An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. In the humans, 6-phosphofructose-1-kinase isozyme C is found in platelets, brain, heart, kidney, colon and testis. This isozyme C can exist as the homotetramer of C subunits (P subunits), or heterotetramer of C type and L type subunits.", "PM": "2002", "HN": "2002", "MR": "20030709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025502"}, {"RECTYPE": "D", "MH": "Tumor Suppressor Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Suppressor Protein|T116|T123|NON|EQV|NLM (2022)|201006|abbcdef", "ENTRY": "Suppressor Protein, Tumor", "MN": "D12.776.624.776", "FX": "Genes, Tumor Suppressor", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "MS": "Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025521"}, {"RECTYPE": "D", "MH": "Bacteriophage N4", "DS": "BACTERIOPHAGE N 004", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Phage N4|T005|NON|EQV|NLM (1994)|930113|PHAGE N 004|abcdefs", "ENTRY": "Phages, N4", "MN": "B04.280.090.700.065", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10752", "PI": "Podoviridae (1993-2001)", "MS": "A species in the genus N4-like viruses, in the family PODOVIRIDAE, that infects E. coli.", "PM": "2002; see PODOVIRIDAE 1994-2001", "HN": "2002; use PODOVIRIDAE 1994-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025522"}, {"RECTYPE": "D", "MH": "Bacteriophage HK022", "DS": "BACTERIOPHAGE HK 022", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Enterobacteria phage HK022|T005|NON|EQV|NLM (2002)|001214|abcdef", "ENTRY": "HK022, Enterobacteria phage", "MN": "B04.280.090.800.200", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10742", "PI": "Coliphages (1976-2001)", "MS": "A tentative species in the genus lambda-like viruses, family SIPHOVIRIDAE.", "PM": "2002; see BACTERIOPHAGE LAMBDA 1994-2001", "HN": "2002; use BACTERIOPHAGE LAMBDA 1994-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025523"}, {"RECTYPE": "D", "MH": "Bacteriochlorophyll A", "AQ": "AD AE AG AI AN BI CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU", "MN": "D12.776.752.249.500", "MH_TH": "UNK (19XX)", "ST": "T123", "RN": "0", "PI": "Bacteriochlorophylls (1982-2001)", "MS": "A specific bacteriochlorophyll that is similar in structure to chlorophyll a.", "PM": "2002; see BACTERIOCHLOROPHYLLS 1991-2001; see CHLOROPHYLL 1983-1990", "HN": "2002; use BACTERIOCHLOROPHYLLS 1983-2001", "MR": "20090715", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025541"}, {"RECTYPE": "D", "MH": "Neurofibromin 1", "DS": "NEUROFIBROMIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neurofibromatosis Type 1 Protein|T116|T123|NON|EQV|NLM (2002)|NEUROFIBROMATOSIS TYPE PROTEIN 001|abbcdes", "ENTRY": "NF1 GAP Related Protein", "MN": "D12.776.624.776.610", "FX": "Neurofibromatosis 1", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Proteins (1990-1999)", "MS": "A protein found most abundantly in the nervous system. Defects or deficiencies in this protein are associated with NEUROFIBROMATOSIS 1, Watson syndrome, and LEOPARD syndrome. Mutations in the gene (GENE, NEUROFIBROMATOSIS 1) affect two known functions: regulation of ras-GTPase and tumor suppression.", "PM": "2002", "HN": "2002", "MR": "20151124", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025542"}, {"RECTYPE": "D", "MH": "Bacteriophage IKe", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Phage IKe|T005|NON|EQV|NLM (1994)|930113|abcdef", "ENTRY": "Phages, IKe", "MN": "B04.280.400.400.240", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10867", "AN": "coord with specific bacterium /virol", "PI": "Inovirus (1993-2001)", "MS": "A species of filamentous phage in the genus INOVIRUS, family INOVIRIDAE. They are specific for enterobacteria that contain an IncN plasmid.", "PM": "2002; see INOVIRUS 1994-2001", "HN": "2002; use INOVIRUS 1994-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025543"}, {"RECTYPE": "D", "MH": "Bacteriophage Pf1", "DS": "BACTERIOPHAGE PF 001", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Pseudomonas phage Pf1|T005|NON|EQV|NLM (2002)|001215|PSEUDOMONAS PHAGE PF 001|abcdefs", "ENTRY": "Phages, Pf1", "MN": "B04.280.400.400.300", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid2011081", "AN": "coord with specific Pseudomonas /virol", "PI": "Inovirus (1993-2001)", "MS": "A species of filamentous Pseudomonas phage in the genus INOVIRUS, family INOVIRIDAE.", "PM": "2002; see INOVIRUS 1994-2001", "HN": "2002; use INOVIRUS 1994-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025561"}, {"RECTYPE": "D", "MH": "Neurofibromin 2", "DS": "NEUROFIBROMIN 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Schwannomin|T116|T123|EPO|EQV|NLM (2002)|001221|abbcdef", "ENTRY": "Protein, Schwannomin", "MN": "D12.776.624.776.612", "FX": "Neurofibromatosis 2", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Neoplasm Proteins (1993-2001)", "MS": "A membrane protein homologous to the ERM (Ezrin-Radixin-Moesin) family of cytoskeleton-associated proteins which regulate physical properties of membranes. Alterations in neurofibromin 2 are the cause of NEUROFIBROMATOSIS 2.", "PM": "2002; SCHWANNOMIN PROTEIN was indexed under MEMBRANE PROTEINS 1993-2001", "HN": "2002; for SCHWANNOMIN PROTEIN use NEUROFIBROMIN 2 (NM) 1993-2001", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025581"}, {"RECTYPE": "D", "MH": "Adenomatous Polyposis Coli Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.624.776.010", "FX": "Genes, APC", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Neoplasm Proteins (1993-1994)", "MS": "A negative regulator of beta-catenin signaling which is mutant in ADENOMATOUS POLYPOSIS COLI and GARDNER SYNDROME.", "PM": "2002", "HN": "2002; use ADENOMATOUS POLYPOSIS COLI PROTEIN (NM) 1993-2001", "MR": "20170524", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025601"}, {"RECTYPE": "D", "MH": "Halorhodopsins", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Halorhodopsin|T116|T126|NON|EQV|NLM (2002)|abbcde", "ENTRY": "9 cis Halorhodopsin", "MN": "D12.776.752.812.500", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "0", "PI": "Bacteriorhodopsins (1981-2001)", "MS": "Light driven chloride ion pumps that are ubiquitously found in halophilic archaea (HALOBACTERIALES).", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D025602"}, {"RECTYPE": "D", "MH": "Sensory Rhodopsins", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Sensory Rhodopsin|T116|T123|NON|EQV|NLM (2021)|200623|abbcdef", "ENTRY": "Rhodopsins, Sensory", "MN": "D12.776.752.812.750", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "do not confuse with RHODOPSIN", "PI": "Bacteriorhodopsin (1988-2001)", "MS": "Photosensory rhodopsins found in microorganisms such as HALOBACTERIA. They convert light signals into biochemical information that regulates certain cellular functions such as flagellar motor activity.", "PM": "2002", "HN": "2002", "MR": "20200625", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025603"}, {"RECTYPE": "D", "MH": "Rhodopsins, Microbial", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Microbial Rhodopsin|T116|T123|NON|EQV|NLM (2021)|200225|abbcdef", "ENTRY": "Rhodopsins, Bacterial", "MN": "D12.776.752.812", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "Do not confuse entry term BACTERIAL RHODOPSINS with BACTERIORHODOPSINS", "MS": "Rhodopsin molecules found in microorganisms such as ARCHAEA and PROTEOBACTERIA.", "PM": "2002", "HN": "2002", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025604"}, {"RECTYPE": "D", "MH": "Bacteriophage PRD1", "DS": "BACTERIOPHAGE PRD 001", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Phage PRD1|T005|NON|EQV|NLM (2002)|001227|PHAGE PRD 001|abcdefs", "ENTRY": "PRD1, Phage", "MN": "B04.123.900.150", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid10658", "PI": "Bacteriophages (1974-2001)", "MS": "Bacteriophage and type species in the genus Tectivirus, family TECTIVIRIDAE. They are specific for Gram-negative bacteria.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025622"}, {"RECTYPE": "D", "MH": "Tobacco necrosis satellite virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Tobacco Necrosis Virus Satellite|T005|NON|EQV|NLM (2002)|001228|abcdef", "MN": "B04.265.658.860", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid12881", "PI": "Satellite Viruses (1968-2001)", "MS": "An icosahedral RNA satellite virus which requires an obligatory Tobacco necrosis virus (see NECROVIRUS) for its replication.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025641"}, {"RECTYPE": "D", "MH": "Adenoviruses, Porcine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Porcine Adenoviruses|T005|NON|EQV|NLM (2002)|010620|abcdef", "ENTRY": "Porcine Adenovirus", "MN": "B04.280.030.500.675", "MH_TH": "NLM (2002)", "ST": "T005", "AN": "infection: coord IM with ADENOVIRIDAE INFECTIONS (IM)", "PI": "Mastadenovirus (1993-2001)", "MS": "Species of the genus MASTADENOVIRUS, causing neurological disease in pigs.", "PM": "2002", "HN": "2002", "MR": "20200902", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D025662"}, {"RECTYPE": "D", "MH": "Fowl adenovirus A", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Fowl Adenovirus 1|T005|NON|NRW|NLM (1994)|921105|FOWL ADENOVIRUS 001|abcdefs", "ENTRY": "Viruses, CELO", "MN": "B04.280.030.100.250", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid190061", "RR": "txid10553", "AN": "infection: coord IM with ADENOVIRIDAE INFECTIONS (IM)", "MS": "The type species of the genus AVIADENOVIRUS, family ADENOVIRIDAE, an oncogenic virus of birds. This is also called CELO virus for chick embryo lethal orphan virus.", "PM": "2002; for FOWL ADENOVIRUS 1 see AVIADENOVIRUS 1994-2001; for CELO VIRUS see AVIADENOVIRUS 1978-2001, see ADENOVIRUSES 1975-1976", "HN": "2002; for FOWL ADENOVIRUS 1 use AVIADENOVIRUS 1994-2001; for CELO VIRUS use AVIADENOVIRUS 1978-2001, use ADENOVIRUSES 1975-1976", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025681"}, {"RECTYPE": "D", "MH": "Nanovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Subterranean clover stunt virus|T005|NON|NRW|NLM (2002)|010102|abcdef", "ENTRY": "Nanoviruses", "MN": "B04.970.540", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid104766", "RR": "txid36772", "PI": "Plant Viruses (1999-2001)", "MS": "A genus in the family NANOVIRIDAE containing multiple circular single-stranded DNA molecules. The type species is Subterranean clover stunt virus.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025682"}, {"RECTYPE": "D", "MH": "Asfarviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Asfivirus|T005|NON|NRW|NLM (2002)|010103|abcdef", "ENTRY": "Asfiviruses", "MN": "B04.280.049", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid137992", "RR": "txid39743", "AN": "infection: coord IM with DNA VIRUS INFECTIONS (IM)", "MS": "A family of double-stranded DNA viruses containing one genus Asfivirus. It is the source of AFRICAN SWINE FEVER.", "PM": "2002; for AFRICAN SWINE FEVER-LIKE VIRUSES see AFRICAN SWINE FEVER-LIKE VIRUSES 1997-2001", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025701"}, {"RECTYPE": "D", "MH": "WT1 Proteins", "DS": "WT PROTEINS 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, WT1", "MN": "D12.776.624.776.960", "FX": "Wilms Tumor", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1991-2001)", "MS": "Isoforms encoded by the WT1 Wilms tumor suppressor gene (GENES, WILMS TUMOR) and produced by alternative splicings. They are zinc finger-containing transcription factors involved in both transactivation and repression, and are critical for normal development and function of the urogenital tract.", "PM": "2002; WT1 PROTEIN was indexed as DNA-BINDING PROTEINS and TRANSCRIPTION FACTORS 1991-2001", "HN": "2002; for WT1 PROTEIN use WT1 PROTEINS (NM) 1991-2001", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025721"}, {"RECTYPE": "D", "MH": "Granulovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Granulosis Viruses|T005|NON|EQV|NLM (1991)|900424|abcdef", "ENTRY": "granulovirus, Cydia pomonella", "MN": "B04.525.100.249", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid558017", "RR": "txid28289", "AN": "coord with specific insect /virol", "PI": "Baculoviridae (1995-2001)", "MS": "Granulovirus is the common name for Betabaculovirus, a genus of the family BACULOVIRIDAE, characterized by ovocylindrical occlusion bodies. The type species is Cydia pomonella granulovirus.", "PM": "2002; see BACULOVIRIDAE 1997-2001; for GRANULOSIS VIRUSES see BACULOVIRIDAE 1991-2001", "HN": "2002; use BACULOVIRIDAE 1997-2001; for GRANULOSIS VIRUSES use BACULOVIRIDAE 1991-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025722"}, {"RECTYPE": "D", "MH": "HMGA1a Protein", "DS": "HMGA Q 001A PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HMG I-Type Protein|T116|T123|NON|EQV|NLM (2002)|HMG Q I TYPE PROTEIN|abbcdes", "ENTRY": "Phosphoprotein, HMG I-Y", "MN": "D12.776.664.235.400.500.100", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "124544-67-8", "PI": "High Mobility Group Proteins (1993-2001)", "MS": "An 11-kDa AT-hook motif-containing (AT-HOOK MOTIFS) protein that binds to the minor grove of AT-rich regions of DNA. It is the full-length product of the alternatively-spliced HMGA1 gene and may function as an architectural chromatin binding protein that is involved in transcriptional regulation.", "PM": "2002; HMG I-TYPE PROTEIN was indexed under HIGH MOBILITY GROUP PROTEINS & TRANSCRIPTION FACTORS 1993-2001", "HN": "2002; for HMG I-TYPE PROTEIN use HMGA1A PROTEIN (NM) 1993-2001", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025741"}, {"RECTYPE": "D", "MH": "HMGA1b Protein", "DS": "HMGA Q 001B PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "AT Hook 1b Protein, High Mobility Group", "MN": "D12.776.664.235.400.500.200", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "124543-08-4", "PI": "Transcription Factors (1993-2001)", "MS": "An AT-hook motif-containing protein (AT-HOOK MOTIFS) that binds to the minor grove of AT-rich regions of DNA. It is a truncated form of HMGA1a protein that is produced by alternative-splicing of the HMGA1 gene. It may function as an architectural chromatin binding protein that is involved in transcriptional regulation.", "PM": "2002; HMGY PROTEIN was indexed under HIGH MOBILITY GROUP PROTEINS & TRANSCRIPTION FACTORS 1993-2001", "HN": "2002; for HMGY PROTEIN use HMGA1B PROTEIN (NM) 1993-2001", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025742"}, {"RECTYPE": "D", "MH": "HMGA2 Protein", "DS": "HMGA Q 002 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HMG I-C Protein|T116|T123|ACX|EQV|NLM (2002)|000518|abbcdef", "ENTRY": "HMGI C Protein", "MN": "D12.776.664.235.400.500.600", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "High Mobility Group Proteins (1992-2001)", "MS": "An AT-hook-containing (AT-HOOK MOTIFS) nuclear protein that is expressed predominantly in proliferating and undifferentiated mesenchymal cells.", "PM": "2002; HMG I-C PROTEIN was indexed under HIGH MOBILITY GROUP PROTEINS 1993-2001, under TRANSCRIPTION FACTORS 1993-2001; HMGI-C PROTEIN was indexed under HIGH MOBILITY GROUP PROTEINS 1992-2001", "HN": "2002; for HMG I-C PROTEIN use HMGA1A PROTEIN (NM) 1993-2001; for HMGI-C PROTEIN use HMGA2 PROTEIN (NM) 1992-2001", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025743"}, {"RECTYPE": "D", "MH": "Mikamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Mikamycins|T116|T195|NON|EQV|NLM (1991)|900409|abbcdef", "MN": "D12.644.641.802.249", "PA": "Anti-Bacterial Agents", "MH_TH": "UNK (19XX)", "ST": "T195", "RN": "0", "PI": "Virginiamycin (1991-2001)", "MS": "An antibiotic complex originally isolated from Streptomyces mitakaenis. It contains two principle ingredients: STREPTOGRAMIN A (mikamycin A) and STREPTOGRAMIN B (mikamycin B).", "PM": "2002; see VIRGINIAMYCIN 1991-2001, see VIRGINIAMYCINS 1981-1990 , see MIKAMYCINS 1975-1980", "HN": "2002(1975); use VIRGINIAMYCIN 1981-2001", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025761"}, {"RECTYPE": "D", "MH": "Pristinamycin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "RP7293|T116|T121|LAB|NRW|NLM (1998)|970205|abbcdef", "MN": "D12.644.641.802.374", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1994)", "ST": "T195", "RN": "0", "PI": "Virginiamycin (1994-2001)", "MS": "An antibiotic mixture originally isolated from Streptomyces pristinaspiralis. It is a mixture of compounds from STREPTOGRAMIN GROUP A: pristinamycin IIA and IIB and from STREPTOGRAMIN GROUP B: pristinamycin IA, pristinamycin IB, pristinamycin IC.", "PM": "2002; see VIRGINIAMYCIN 1994-2001, see PRISTINAMYCINS 1981-1993; for RP7293 and RP 7293 see VIRGINIAMYCIN 1998-2001", "HN": "2002; use VIRGINIAMYCIN 1994-2001; for RP7293 and RP 7293 use VIRGINIAMYCIN 1998-2001", "MR": "20160701", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025762"}, {"RECTYPE": "D", "MH": "Vernamycin B", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D12.644.641.802.812", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1994)", "ST": "T195", "RN": "0", "PI": "Virginiamycin (1993-2001)", "MS": "An antibiotic mixture originally isolated from Streptomyces loidensis. It contains a mixture of compounds belonging to STREPTOGRAMIN GROUP A and STREPTOGRAMIN GROUP B.", "PM": "2002; see VIRGINIAMYCIN 1994-2001", "HN": "2002; use VIRGINIAMYCIN 1994-2001", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025763"}, {"RECTYPE": "D", "MH": "HMGA1c Protein", "DS": "HMGA Q 001C PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "AT Hook 1c Protein, High Mobility Group", "MN": "D12.776.664.235.400.500.300", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "High Mobility Group Proteins (1995-2001)", "MS": "An AT-hook-containing (AT-HOOK MOTIFS) nuclear protein that may be involved in retinoid-dependent transcriptional activity.", "PM": "2002", "HN": "2002", "MR": "20111212", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025764"}, {"RECTYPE": "D", "MH": "HMGB3 Protein", "DS": "HMGB Q 003 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HMG2a|T116|T123|ACR|EQV|NLM (2002)|000919|HMG Q 002A|abbcdefs", "ENTRY": "HMG2a Protein|T116|T123|NON|EQV|NLM (2002)|000919|abbcdef", "MN": "D12.776.664.235.400.600.800", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "High Mobility Group Proteins (1998-2001)", "MS": "An HMG-box domain (HMG-BOX DOMAINS) found highly expressed in embryonic tissue and in placenta.", "PM": "2002", "HN": "2002", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025765"}, {"RECTYPE": "D", "MH": "Hydroxymethylglutaryl-CoA Reductases, NAD-Dependent", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HMG CoA Reductases, NAD-Dependent|T116|T126|NON|EQV|NLM (2002)|010108|abbcdef", "ENTRY": "NAD-Dependent Hydroxymethylglutaryl-CoA Reductases", "MN": "D08.811.682.047.820.150.415.250", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 1.1.1.88", "AN": "do not confuse with HYDROXYMETHYLGLUTARYL-COA-REDUCTASES, NADP-DEPENDENT", "PI": "Hydroxymethylglutaryl CoA Reductases (1989-2001)", "MS": "Specific hydroxymethylglutaryl CoA reductases that utilize the cofactor NAD. This class of enzymes performs a catabolic role in microorganisms such as Pseudomonas mevalonii where it oxidatively acetylates MEVALONIC ACID to form 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A and NADH.", "PM": "2002", "HN": "2002", "MR": "20130708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025781"}, {"RECTYPE": "D", "MH": "Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hydroxymethylglutaryl-CoA-Reductase (NADP)|T116|T126|NON|EQV|NLM (2002)|abbcde", "ENTRY": "NADP-dependent Hydroxymethylglutaryl-CoA-Reductases", "MN": "D08.811.682.047.820.150.415.750", "EC": "antagonists & inhibitors:Hydroxymethylglutaryl-CoA Reductase Inhibitors", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 1.1.1.34", "RR": "9028-35-7 (CRN)", "AN": "do not confuse with HYDROXYMETHYLGLUTARYL-COA REDUCTASES, NAD-DEPENDENT", "PI": "Hydroxymethylglutaryl CoA Reductases (1987-2001)", "MS": "Specific hydroxymethylglutaryl CoA reductases that utilize the cofactor NAD. In liver enzymes of this class are involved in cholesterol biosynthesis.", "PM": "2002; hydroxymethylglutaryl-CoA-reductase (NADP) now HYDROXYMETHYLGLUTARYL-COA-REDUCTASES, NADP-DEPENDENT was indexed under HYDROXYMETHYLGLUTARYL COA REDUCTASES 1981-2001", "HN": "2002; use HYDROXYMETHYLGLUTARYL COA REDUCTASES (NM) 1981-2001", "MR": "20130708", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D025782"}, {"RECTYPE": "D", "MH": "Ubiquitin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Human Ubiquitin", "MN": "D12.776.947.500", "MH_TH": "NLM (1985)", "ST": "T123", "RN": "0", "RR": "79586-22-4 (human)", "AN": "UBIQUITINS is also available", "PI": "Ubiquitins (1985-2001)", "MS": "A highly conserved 76-amino acid peptide universally found in eukaryotic cells that functions as a marker for intracellular PROTEIN TRANSPORT and degradation. Ubiquitin becomes activated through a series of complicated steps and forms an isopeptide bond to lysine residues of specific proteins within the cell. These \"ubiquitinated\" proteins can be recognized and degraded by proteosomes or be transported to specific compartments within the cell.", "PM": "2002; see UBIQUITINS (1985-2001)", "HN": "2002; use UBIQUITINS (1985-2001)", "MR": "20150605", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025801"}, {"RECTYPE": "D", "MH": "Electric Capacitance", "AQ": "AE CL HI TU", "PRINT ENTRY": "Capacitance, Electrical|T081|NON|EQV|NLM (2002)|010606|abcdef", "ENTRY": "Capacitance, Electric", "MN": "G01.358.500.249.270", "MH_TH": "NLM (1995)", "ST": "T081", "PI": "Electric Conductivity (1968-2001)", "MS": "The ability of a substrate to retain an electrical charge.", "PM": "2002; see ELECTRIC CONDUCTIVITY 1968-2001", "HN": "2002; use ELECTRIC CONDUCTIVITY 1968-2001", "MR": "20110624", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025802"}, {"RECTYPE": "D", "MH": "Tumor Suppressor Protein p14ARF", "DS": "TUMOR SUPPRESSOR PROTEIN P 014 ARF", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p14ARF Protein|T116|T123|ACX|EQV|NLM (2002)|010108|P A 014ARF PROTEIN|abbcdefs", "ENTRY": "p14ARF|T116|T123|ACX|EQV|NLM (2002)|abbcde", "MN": "D12.776.624.776.772", "FX": "Genes, p16", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A gene product of the p16 tumor suppressor gene (GENES, P16). It antagonizes the function of MDM2 PROTEIN (which regulates P53 TUMOR SUPPRESSOR PROTEIN by targeting it for degradation). p14ARF is produced from the beta mRNA transcript of the p16 gene. The other gene product, produced from the alternatively spliced alpha transcript, is CYCLIN-DEPENDENT KINASE INHIBITOR P16. Both p16 gene products have tumor suppressor functions.", "PM": "2002; TUMOR SUPPRESSOR PROTEIN P14ARF was indexed under P14ARF PROTEIN 2002-2005, & under PROTEINS 1996-2001", "HN": "2002(1996)", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025803"}, {"RECTYPE": "D", "MH": "Polyubiquitin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.947.500.500", "MH_TH": "NLM (2002)", "ST": "T123", "N1": "Ubiquitin, poly-", "RN": "120904-94-1", "PI": "Ubiquitins (1994-2001)", "MS": "An oligomer formed from the repetitive linking of the C-terminal glycine of one UBIQUITIN molecule via an isopeptide bond to a lysine residue on a second ubiquitin molecule. It is structurally distinct from UBIQUITIN C, which is a single protein containing a tandemly arrayed ubiquitin peptide sequence.", "PM": "2002; POLYUBIQUITIN was indexed under UBIQUITIN & BIOPOLYMERS 1994-2001, and under POLYMERS 1991-1993", "HN": "2002; use POLYUBIQUITIN (NM) 1991-2001", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025821"}, {"RECTYPE": "D", "MH": "Ubiquitin C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Polyubiquitin Gene Product|T116|T123|NON|EQV|NLM (2002)|010109|abbcdef", "MN": "D12.776.947.500.750", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Ubiquitins (1994-2001)", "MS": "A single protein comprised of tandem repeats of the UBIQUITIN 78-amino acid sequence. It is a product of the polyubiquitin gene which contains multiple copies of the ubiquitin coding sequence. Proteolytic processing of ubiquitin C results in the formation of individual ubiquitin molecules. This protein is distinct from POLYUBIQUITIN, which is a protein formed through isopeptide linkage of multiple ubiquitin species.", "PM": "2002", "HN": "2002", "MR": "20050803", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025822"}, {"RECTYPE": "D", "MH": "Small Ubiquitin-Related Modifier Proteins", "DE": "SMALL UBIQUITIN RELAT MODIFIER PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SUMO Proteins|T116|T123|ACX|EQV|NLM (2002)|010110|abbcdef", "ENTRY": "Ubiquitin Related Modifier Protein, Small", "MN": "D12.776.947.249", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Ubiquitins (1996-2001)", "MS": "A class of structurally related proteins of 12-20 kDa in size. They covalently modify specific proteins in a manner analogous to UBIQUITIN.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025841"}, {"RECTYPE": "D", "MH": "SUMO-1 Protein", "DS": "SUMO PROTEIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sentrin 1|T116|T123|NON|EQV|NLM (2002)|010110|SENTRIN 001|abbcdefs", "ENTRY": "Ubiquitin like 1 Gene Product", "MN": "D12.776.947.249.500", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Ubiquitins (1996-2001)", "MS": "A 1.5-kDa small ubiquitin-related modifier protein that can covalently bind via an isopeptide link to a number of cellular proteins. It may play a role in intracellular protein transport and a number of other cellular processes.", "PM": "2002; PIC 1 PROTEIN (now SUMO-1 PROTEIN) was indexed under UBIQUITIN 1996-2001", "HN": "2002; use SUMO-1 PROTEIN (NM) 1996-2001", "MR": "20040707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025842"}, {"RECTYPE": "D", "MH": "Blood Coagulation Disorders, Inherited", "DE": "BLOOD COAG DIS INHERITED", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Inherited Coagulation Disorders|T047|NON|EQV|NLM (2002)|010111|INHERITED COAG DIS|abcdefv", "ENTRY": "Inherited Coagulation Disorder", "MN": "C16.320.099", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "Blood Coagulation Disorders (1995-2001)", "MS": "Hemorrhagic and thrombotic disorders that occur as a consequence of inherited abnormalities in blood coagulation.", "PM": "2002", "HN": "2002", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025861"}, {"RECTYPE": "D", "MH": "Herpesvirus 5, Bovine", "DS": "HERPESVIRUS BOVINE 05", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, Bovine Encephalitis", "MN": "B04.280.382.100.900.410", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid35244", "AN": "infection: coord IM with HERPESVIRIDAE INFECTIONS (IM) + MENINGOENCEPHALITIS (IM) + ENCEPHALITIS, VIRAL (IM)", "PI": "Herpesviridae (1982-2001)", "MS": "A species of VARICELLOVIRUS that causes a fatal MENINGOENCEPHALITIS in calves.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025881"}, {"RECTYPE": "D", "MH": "Carboxypeptidase B2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thrombin-Activatable Fibrinolysis Inhibitor|T116|T126|NON|EQV|NLM (2002)|abbcde", "ENTRY": "Thrombin Activatable Fibrinolysis Inhibitor", "MN": "D08.811.277.656.837.092", "MH_TH": "NLM (2015)", "ST": "T126", "RN": "EC 3.4.17.20", "PI": "Lysine Carboxypeptidase (1994-2001)", "MS": "A carboxypeptidase that removes C-terminal lysine or arginine from peptides and proteins. Carboxypeptidase B2 (CPB2) is released into the circulation as a proenzyme which is activated by the THROMBIN-THROMBOMODULIN complex. Activated CPB2 is involved in modulating a variety of processes by cleaving and inactivating various circulating proteins and peptides that are its substrates including FIBRIN; KININS; and ANAPHYLATOXINS.", "PM": "2015; see CARBOXYPEPTIDASE U 2002-2014; CARBOXYPEPTIDASE U (NM) was indexed under CARBOXYPEPTIDASES 1994-2001; for ARGININE CARBOXYPEPTIDASE see LYSINE CARBOXYPEPTIDASE 1997-2001", "HN": "2015 (2002); use CARBOXYPEPTIDASE U (NM) 1994-2001 and LYSINE CARBOXYPEPTIDASE 1997-2001", "MR": "20140606", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025901"}, {"RECTYPE": "D", "MH": "Iltovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Laryngotracheitis-like Viruses, Infectious", "MN": "B04.280.382.100.374", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid180255", "AN": "infection: coordinate IM with HERPESVIRIDAE INFECTIONS (IM)", "MS": "A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, with a single species: HERPESVIRUS 1, GALLID.", "PM": "2002; see INFECTIOUS LARYNGOTRACHEITIS-LIKE VIRUSES 2002-2006", "HN": "2007 (2002)", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025921"}, {"RECTYPE": "D", "MH": "Mardivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Marek Disease-like Viruses|T005|EPO|EQV|NLM (2002)|010116|abcdef", "ENTRY": "Mareks Disease-like Viruses", "MN": "B04.280.382.100.562", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid180252", "MS": "A genus in the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, associated with malignancy in birds.", "PM": "2007; see MAREK'S DISEASE-LIKE VIRUSES 2002-2006", "HN": "2007 (2002)", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025922"}, {"RECTYPE": "D", "MH": "Chromatography, Supercritical Fluid", "DE": "CHROMATOGR SUPERCRITICAL FLUID", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Supercritical Fluid Extraction|T059|NON|REL|NLM (2002)|010116|abcdef", "ENTRY": "Fluid Extraction, Supercritical", "MN": "E05.196.181.750", "MH_TH": "NLM (2002)", "ST": "T059", "PI": "Chromatography (1976-2001)", "MS": "A CHROMATOGRAPHY method using supercritical fluid, usually carbon dioxide under very high pressure (around 73 atmospheres or 1070 psi at room temperature) as the mobile phase. Other solvents are sometimes added as modifiers. This is used both for analytical (SFC) and extraction (SFE) purposes.", "PM": "2002", "HN": "2002", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025924"}, {"RECTYPE": "D", "MH": "Protein Interaction Mapping", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Protein Interaction Mappings", "MN": "E05.601.690", "FX": "Protein Interaction Maps", "MH_TH": "NLM (2002)", "ST": "T063", "PI": "Protein Binding (1993-2001)", "MS": "Methods for determining interaction between PROTEINS.", "PM": "2002", "HN": "2002", "MR": "20150623", "DA": "20010806", "DC": "1", "DX": "20020101", "UI": "D025941"}, {"RECTYPE": "D", "MH": "Oligosaccharides, Branched-Chain", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Branched-Chain Oligosaccharides|T109|NON|EQV|NLM (2002)|010312|abcdef", "MN": "D09.698.629.553", "MH_TH": "NLM (2002)", "ST": "T109", "RN": "0", "PI": "Oligosaccharides (1977-2001)", "MS": "Oligosaccharides containing various types of glycosidic linkages that yield branching or antennae. The number of antennae (such as bi-, tri-, tetra-, or penta-antennary) in the oligosaccharides on the PROTEOGLYCANS; GLYCOPROTEINS; or LIPOPOLYSACCHARIDES contribute to their biological activities, such as receptor binding and metabolism.", "PM": "2002", "HN": "2002", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025942"}, {"RECTYPE": "D", "MH": "Herpesvirus 3, Gallid", "DS": "HERPESVIRUS GALLID 03", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Marek's Disease Virus Serotype 2|T005|EPO|EQV|NLM (2002)|010119|MAREKS DISEASE VIRUS SEROTYPE 002|MAREKS DIS VIRUS SEROTYPE 2|abcdefsv", "ENTRY": "Marek Disease Herpesvirus 2|T005|EPO|EQV|NLM (2002)|010118|MAREK DIS HERPESVIRUS 2|abcdefv", "MN": "B04.280.382.100.562.405", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid35250", "MS": "A species in the genus MAREK'S DISEASE-LIKE VIRUSES, in the family HERPESVIRIDAE, infecting chickens.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025961"}, {"RECTYPE": "D", "MH": "Septo-Optic Dysplasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Septooptic Dysplasia|T047|NON|EQV|GHR (2014)|NLM (2010)|OMIM (2013)|ORD (2010)|090514|abcdeeeef", "ENTRY": "Septooptic Dysplasias", "MN": "C16.131.666.763.500", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Septum Pellucidum (1972-2001)", "MS": "A condition resulting from congenital malformations involving the brain. The syndrome of septo-optic dysplasia combines hypoplasia or agenesis of the SEPTUM PELLUCIDUM; CORPUS CALLOSUM and the OPTIC NERVE. The extent of the abnormalities can vary. Septo-optic dysplasia is often associated with abnormalities of the HYPOTHALAMUS and other diencephalic structures, and HYPOPITUITARISM.", "PM": "2002", "HN": "2002", "MR": "20220419", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025962"}, {"RECTYPE": "D", "MH": "Hip Injuries", "DE": "HIP INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Injuries, Hip|T037|NON|EQV|NLM (2002)|010312|INJ HIP|abcdefv", "MN": "C26.531", "MH_TH": "NLM (2002)", "ST": "T037", "PI": "Hip/injuries (1966-2001)", "MS": "General or unspecified injuries involving the hip.", "PM": "2002", "HN": "2002", "MR": "20100625", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D025981"}, {"RECTYPE": "D", "MH": "Herpesvirus 1, Meleagrid", "DS": "HERPESVIRUS MELEAGRID 001", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Marek's Disease Virus Serotype 3|T005|EPO|EQV|NLM (2002)|010119|MAREKS DISEASE VIRUS SEROTYPE 003|MAREKS DIS VIRUS SEROTYPE 3|abcdefsv", "ENTRY": "Turkey Herpesviruses", "MN": "B04.280.382.100.562.550", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid37108", "PI": "Herpesviridae (1971-2001)", "MS": "A species in the genus MAREK'S DISEASE-LIKE VIRUSES, in the family HERPESVIRIDAE, infecting turkeys.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026002"}, {"RECTYPE": "D", "MH": "Herpesvirus 4, Bovine", "DS": "HERPESVIRUS BOVINE 04", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Movar viruses", "MN": "B04.613.204.500.700.300", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid10385", "AN": "infection: coord IM with HERPESVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "PI": "Herpesviridae (1982-1993)", "MS": "A species in the genus RHADINOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting cattle.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026021"}, {"RECTYPE": "D", "MH": "Permethrin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclopropanecarboxylic Acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (3-phenoxyphenyl)methyl ester|T109|T121|NON|EQV|NLM (2020)|190627|abbcdef", "ENTRY": "trans permethrin", "MN": "D02.455.849.575.188.750.636", "PA": "Insecticides", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "509F88P9SZ", "RR": "61949-77-7 ((trans)-isomer)", "PI": "Pyrethrum (1975-1977)", "MS": "A pyrethroid insecticide commonly used in the treatment of LICE INFESTATIONS and SCABIES.", "PM": "2002; PERMETHRIN was indexed under PYRETHRINS 1978-2001 & PYRETHRUM 1975-1977", "HN": "2002; use PYMETHRIN (NM) 1975-2001", "MR": "20190703", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026023"}, {"RECTYPE": "D", "MH": "Singlet Oxygen", "AQ": "AD AE AG AN BL CF CH CL EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Oxygen, Singlet", "MN": "D02.389.593.500", "PA": "Oxidants", "MH_TH": "NLM (2002)", "ST": "T196", "RN": "17778-80-2", "PI": "Oxygen (1967-2001)", "MS": "An excited state of molecular oxygen generated photochemically or chemically. Singlet oxygen reacts with a variety of biological molecules such as NUCLEIC ACIDS; PROTEINS; and LIPIDS; causing oxidative damages.", "PM": "2002; SINGLET OXYGEN was indexed under OXYGEN 1974-2001", "HN": "2002; use OXYGEN (NM) 1974-2001", "MR": "20230226", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026082"}, {"RECTYPE": "D", "MH": "Indole Alkaloids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Indole Alkaloid|T109|T121|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Alkaloids, Indole", "MN": "D03.633.100.496.500.500", "MH_TH": "NLM (2002)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Indoles (1966-2001)", "MS": "Group of alkaloids containing a benzylpyrrole group (derived from TRYPTOPHAN).", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026121"}, {"RECTYPE": "D", "MH": "Factor XIIIa", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Plasma Transglutaminase|T116|NON|NRW|NLM (1990)|890425|abcdef", "ENTRY": "Transglutaminase, Plasma", "MN": "D23.119.475.500", "FX": "Factor XIII Deficiency", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "EC 2.3.2.13", "AN": "distinguish entry term PLASMA TRANSGLUTAMINASE from TRANSGLUTAMINASES", "PI": "Transglutaminases (1990-2001)", "MS": "Activated form of FACTOR XIII, a transglutaminase, which stabilizes the formation of the fibrin polymer (clot) culminating the blood coagulation cascade.", "PM": "2002; see PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 1990-2001", "HN": "2002; use TRANSGLUTAMINASE 1990-2001", "MR": "20190705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026122"}, {"RECTYPE": "D", "MH": "Drug Resistance, Multiple, Fungal", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Multidrug Resistance, Fungal|T032|NON|EQV|NLM (2002)|010214|abcdef", "ENTRY": "Multiple Antifungal Drug Resistance|T032|NON|EQV|NLM (2002)|010124|abcdef", "MN": "G07.690.773.984.300.625", "MH_TH": "NLM (2002)", "ST": "T032", "PI": "Drug Resistance, Multiple (1994-2001)", "MS": "The ability of fungi to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance phenotype may be attributed to multiple gene mutations.", "PM": "2002", "HN": "2002", "MR": "20230405", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026141"}, {"RECTYPE": "D", "MH": "MADS Domain Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Deficiens-Agamous-Like Proteins|T116|T123|NON|NRW|NLM (2002)|abbcde", "ENTRY": "Proteins, Agamous-Related", "MN": "D12.776.930.397", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "note X refs; AGAMOUS PROTEIN, ARABIDOPSIS and DEFICIENS PROTEIN are also available", "PI": "Transcription Factors (1995-2001)", "MS": "A superfamily of proteins that share a highly conserved MADS domain sequence motif. The term MADS refers to the first four members which were MCM1 PROTEIN; AGAMOUS 1 PROTEIN; DEFICIENS PROTEIN; and SERUM RESPONSE FACTOR. Many MADS domain proteins have been found in species from all eukaryotic kingdoms. They play an important role in development, especially in plants where they have an important role in flower development.", "PM": "2002; DEFICIENS-AGAMOUS-LIKE PROTEINS was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1995-2001", "HN": "2002; for DEFICIENS-AGAMOUS-LIKE PROTEINS use MADS DOMAIN PROTEINS 1995-2001", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026161"}, {"RECTYPE": "D", "MH": "Musculoskeletal Manipulations", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Reflexology|T091|NON|NRW|NLM (1990)|890207|REFLEXOL|abcdefv", "ENTRY": "Therapy, Manual", "MN": "E02.831.535.867", "MH_TH": "NLM (2002)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "MS": "Various manipulations of body tissues, muscles and bones by hands or equipment to improve health and circulation, relieve fatigue, promote healing.", "PM": "2002; for Craniosacral Massage and Rolfing see Massage 2002-2019; for Reflexology 1990-2019 see Massage; Bodywork see Massage 2011-2019", "HN": "2002; for Craniosacral Massage and Rolfing use Massage 2002-2019; for Reflexology 1990-2019 use Massage; Bodywork use Massage 2011-2019", "MR": "20190701", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026201"}, {"RECTYPE": "D", "MH": "Exercise Movement Techniques", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Training, Pilates", "MN": "E02.779.474", "FX": "Sports", "MH_TH": "NLM (2002)", "ST": "T061", "MS": "Methods or programs of physical activities which can be used to promote, maintain, or restore the physical and physiological well-being of an individual.", "PM": "2002", "HN": "2002", "MR": "20180629", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026241"}, {"RECTYPE": "D", "MH": "Diazepam Binding Inhibitor", "DS": "DIAZEPAM BINDING INHIB", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acyl-CoA-Binding Protein|T116|T123|NON|EQV|NLM (2002)|abbcde", "ENTRY": "Protein, Acyl-CoA-Binding", "MN": "D12.644.136", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Neuropeptides (1987-1992)", "MS": "An 86-amino acid polypeptide, found in central and peripheral tissues, that displaces diazepam from the benzodiazepine recognition site on the gamma-aminobutyric acid receptor (RECEPTORS, GABA). It also binds medium- and long-chain acyl-CoA esters and serves as an acyl-CoA transporter. This peptide regulates lipid metabolism.", "PM": "2002; DIAZEPAM BINDING INHIBITOR was indexed under CARRIER PROTEINS 1984-2001", "HN": "2002; use DIAZEPAM BINDING INHIBITOR (NM) 1984-2001", "MR": "20110624", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026261"}, {"RECTYPE": "D", "MH": "DEFICIENS Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DEFA Protein|T116|T123|ACX|EQV|NLM (2002)|010129|abbcdef", "MN": "D12.776.930.397.374", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "DEFICIENS-AGAMOUS-LIKE PROTEINS see MADS DOMAIN PROTEINS is also available", "PI": "Homeodomain Proteins (1997-2001)", "MS": "DEFICIENS is a homeotic gene involved in the genetic control of Antirrhinum majus flower development. Its protein is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.", "PM": "2002; DEFICIENS PROTEIN was indexed under HOMEODOMAIN PROTEINS 1996-2001", "HN": "2002; use DEFICIENS PROTEIN (NM) 1996-2001", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026281"}, {"RECTYPE": "D", "MH": "Manipulation, Osteopathic", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Osteopathic Manipulation|T061|NON|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Treatments, Osteopathic Manipulative", "MN": "E02.831.535.867.444", "FX": "Manipulation, Orthopedic", "MH_TH": "NLM (2002)", "ST": "T061", "AN": "do not confuse with OSTEOPATHIC MEDICINE, the specialty", "PI": "Manipulation, Orthopedic (1986-2001)", "MS": "Musculoskeletal manipulation based on the principles of OSTEOPATHIC MEDICINE developed in 1874 by Dr Andrew Taylor Still.", "PM": "2002; see MANIPULATION, ORTHOPEDIC 1987-2001", "HN": "2002; use MANIPULATION, ORTHOPEDIC 1987-2001", "MR": "20180629", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026301"}, {"RECTYPE": "D", "MH": "Tai Ji", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Taijiquan|T056|NON|EQV|NLM (2002)|010406|abcdef", "ENTRY": "Quan, Tai Ji", "MN": "I03.450.642.845.560.500", "MH_TH": "NLM (2002)", "ST": "T056", "AN": "do not confuse with 'Taiji study' carried out in that region of Japan; do not confuse with Japanese interpretation of \"Taiji\" which means 'embryo' or 'fetus'", "PI": "Martial Arts (1996-2001)", "MS": "One of the MARTIAL ARTS and also a form of meditative exercise using methodically slow circular stretching movements and positions of body balance.", "PM": "2002; see MARTIAL ARTS 1996-2001", "HN": "2002; use MARTIAL ARTS 1996-2001", "MR": "20160531", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026302"}, {"RECTYPE": "D", "MH": "Piperaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.812", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid16739", "AN": "prefer specific plant", "PI": "Spices (1993-2001)", "MS": "A family of flowering plants in the order Piperales best known for the black pepper widely used in SPICES, and for KAVA and Betel used for neuroactive properties.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026321"}, {"RECTYPE": "D", "MH": "Myristica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Nutmeg|T168|NON|REL|NLM (1993)|920302|abcdef", "MN": "B01.875.800.575.912.250.765.500", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid51088", "RR": "txid51089", "AN": "for food coordinate with SPICES", "PI": "Spices (1993-2001)", "MS": "A plant genus in the MYRISTICACEAE family. The seed is used as a spice and used for antimicrobial and psychoactive effects. Myristicin, SAFROLE, and methyleugenol are key components.", "PM": "2019; see SPICES 1993-2001; see CONDIMENTS 1963-82; see HALLUCINOGENS 1975-77", "HN": "2019(2002); use SPICES 1993-2001", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D026323"}, {"RECTYPE": "D", "MH": "Myristicaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.765", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid22274", "AN": "prefer specific plant", "PI": "Spices (1993-2001)", "MS": "A family of flowering plants in the order Magnoliales. Many of the species are tropical and have fragrant wood and leaves.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D026324"}, {"RECTYPE": "D", "MH": "Minichromosome Maintenance 1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor MCM1|T116|T123|ABX|EQV|NLM (2002)|abbcde", "MN": "D12.776.930.397.750", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1993-2001)", "MS": "A sequence-specific DNA-binding protein that plays an essential role as a global regulator of yeast cell cycle control. It contains a 56 amino acid MADS-box domain within the N-terminal of the protein and is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.", "PM": "2013; see MCM1 PROTEIN 2002-2013, MCM1 PROTEIN (now MINICHROMOSOME MAINTENANCE 1 PROTEIN) was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1993-2001 & FUNGAL PROTEINS 1992", "HN": "2013(2002);", "MR": "20130708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026341"}, {"RECTYPE": "D", "MH": "AGAMOUS Protein, Arabidopsis", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Arabidopsis AGAMOUS Protein", "MN": "D12.776.930.397.249", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "AGAMOUS-LIKE PROTEINS see MADS DOMAIN PROTEINS is also available", "PI": "Transcription Factors (1993-2001)", "MS": "A plant homeotic protein involved in the development of stamens and carpels of Arabidopsis thaliana. It is a DNA-binding protein that contains the MADS-box domain. It is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.", "PM": "2002; AGAMOUS PROTEIN was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1993-2001", "HN": "2002; use AGAMOUS PROTEIN (NM) 1993-2001", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026342"}, {"RECTYPE": "D", "MH": "Reactive Nitrogen Species", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Species, Reactive Nitrogen", "MN": "D02.654.846", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nitroso Compounds (1992-2001)", "MS": "Nitrogenous products of NITRIC OXIDE synthases, ranging from NITRIC OXIDE to NITRATES. These reactive nitrogen intermediates also include the inorganic PEROXYNITROUS ACID and the organic S-NITROSOTHIOLS.", "PM": "2002", "HN": "2002", "MR": "20230226", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026361"}, {"RECTYPE": "D", "MH": "Serum Response Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "c fos Serum Response Factor", "MN": "D12.776.930.397.875", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nuclear Proteins (1988-2001)", "MS": "A MADS domain-containing transcription factor that binds to the SERUM RESPONSE ELEMENT in the promoter-enhancer region of many genes. It is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.", "PM": "2002; SERUM RESPONSE FACTOR was indexed under NUCLEAR PROTEINS 1988-2001 & DNA-BINDING PROTEINS 1992-2001", "HN": "2002; use SERUM RESPONSE FACTOR (NM) 1988-2001", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026362"}, {"RECTYPE": "D", "MH": "S-Nitrosothiols", "DS": "NITROSOTHIOLS S", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "S-Nitrosothiol|T109|T121|T123|NON|EQV|NLM (2002)|010208|abbbcdef", "MN": "D02.886.489.650", "PA": "Vasodilator Agents", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nitroso Compounds (1992-2001)", "MS": "A group of organic sulfur-containing nitrites, alkyl thionitrites. S-Nitrosothiols include compounds such as S-NITROSO-N-ACETYLPENICILLAMINE and S-NITROSOGLUTATHIONE.", "PM": "2002", "HN": "2002", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026403"}, {"RECTYPE": "D", "MH": "Sensory Art Therapies", "DE": "SENSORY ART THER", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Therapies, Sensory Art", "MN": "E02.190.888", "FX": "Psychotherapy", "MH_TH": "NLM (2002)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "MS": "Therapies using arts or directed at the senses.", "PM": "2002", "HN": "2002", "MR": "20180629", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026421"}, {"RECTYPE": "D", "MH": "S-Nitrosoglutathione", "DS": "NITROSOGLUTATHIONE S", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "S-Nitroso-GSH|T109|T121|T123|ABX|EQV|NLM (2002)|NITROSO GSH S|abbbcdes", "MN": "D12.644.456.448.750", "PA": "Vasodilator Agents", "MH_TH": "NLM (2002)", "ST": "T123", "N1": "glycine, N-(N-L-gamma-glutamyl-S-nitroso-L-cysteinyl)-", "RN": "57564-91-7", "PI": "Nitroso Compounds (1980-2001)", "MS": "A sulfur-containing alkyl thionitrite that is one of the NITRIC OXIDE DONORS.", "PM": "2002; S-NITROSOGLUTATHIONE was indexed under NITROSO COMPOUNDS 1980-2001, GLUTATHIONE 1980-2001", "HN": "2002; use S-NITROSOGLUTATHIONE (NM) 1980-2001", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026422"}, {"RECTYPE": "D", "MH": "S-Nitroso-N-Acetylpenicillamine", "DS": "NITROSOACETYLPENICILLAMINE S N", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "SNAP (NO donor)|T109|T121|T123|ACR|EQV|NLM (2002)|abbbcde", "MN": "D12.125.166.786.500", "PA": "Vasodilator Agents", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "79032-48-7", "PI": "Penicillamine (1984-2001)", "MS": "A sulfur-containing alkyl thionitrite that is one of the NITRIC OXIDE DONORS.", "PM": "2002; S-NITROSO-N-ACETYLPENICILLAMINE was indexed under PENICILLAMINE 1984-2001", "HN": "2002; use S-NITROSO-N-ACETYLPENICILLAMINE (NM) 1984-2001", "MR": "20060705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026423"}, {"RECTYPE": "D", "MH": "Mind-Body Therapies", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Therapy, Mind-Body", "MN": "E02.190.525", "FX": "Spiritual Therapies", "MH_TH": "NLM (2009)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "MS": "Treatment methods or techniques which are based on the knowledge of mind and body interactions. These techniques can be used to reduce the feeling of tension and effect of stress, and to enhance the physiological and psychological well-being of an individual.", "PM": "2009; see MIND-BODY AND RELAXATION TECHNIQUES 2002-2008; for RELAXATION TECHNIQUES see RELAXATION TECHNIQUES 1991-2008, see RELAXATION TECHNICS 1976-1990", "HN": "2009 (2002); for RELAXATION TECHNIQUES use MUSCULAR RELAXATION TECHNIQUES 1991-2008, use RELAXATION TECHNIQUES 1976-1990", "MR": "20180629", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026441"}, {"RECTYPE": "D", "MH": "Spiritual Therapies", "DE": "SPIRITUAL THER", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Spiritual Healing|T061|NON|NRW|UNK (19XX)|830504|abcdef", "ENTRY": "Spiritual Healings", "MN": "E02.190.901", "FX": "Spirituality", "MH_TH": "NLM (2002)", "ST": "T061", "MS": "Mystical, religious, or spiritual practices performed for health benefit.", "PM": "2002", "HN": "2002", "MR": "20190705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026443"}, {"RECTYPE": "D", "MH": "Ecdysteroids", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Ecdysteroid|T109|T125|NON|EQV|NLM (2002)|010208|abbcdef", "MN": "D23.704.500.143", "MH_TH": "NLM (2002)", "ST": "T125", "RN": "0", "PI": "Steroids (1992-2001)", "MS": "Steroids that bring about MOLTING or ecdysis in insects. Ecdysteroids include the endogenous insect hormones (ECDYSONE and ECDYSTERONE) and the insect-molting hormones found in plants, the phytoecdysteroids. Phytoecdysteroids are natural insecticides.", "PM": "2002; ECDYSTEROIDS was indexed under STEROIDS 1992-2001and INVERTEBRATE HORMONES 1976-1995", "HN": "2002; use ECDYSTEROIDS (NM) 1976-2001", "MR": "20160531", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026461"}, {"RECTYPE": "D", "MH": "Blotting, Far-Western", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Far-Western Blotting|T059|T063|NON|EQV|NLM (2002)|010313|abbcdef", "ENTRY": "West-Western Blottings", "MN": "E05.601.690.149", "FX": "Two-Hybrid System Techniques", "MH_TH": "NLM (2002)", "ST": "T063", "PI": "Protein Binding (1996-2001)", "MS": "A method that is derived from western blotting (BLOTTING, WESTERN) and is used to detect protein-protein interactions. The blotted proteins are probed with a non-antibody protein which can then be tagged with a labeled antibody.", "PM": "2002", "HN": "2002", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026481"}, {"RECTYPE": "D", "MH": "Blotting, Southwestern", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Southwestern Blotting|T059|T063|NON|EQV|NLM (2002)|010308|abbcdef", "ENTRY": "Southwestern Blottings", "MN": "E05.601.225", "MH_TH": "NLM (2002)", "ST": "T063", "PI": "DNA-Binding Proteins (1989-2001)", "MS": "A method that is used to detect DNA-protein interactions. Proteins are separated by electrophoresis and blotted onto a nitrocellulose membrane similar to Western blotting (BLOTTING, WESTERN) but the proteins are identified when they bind labeled DNA PROBES (as with Southern blotting (BLOTTING, SOUTHERN)) instead of antibodies.", "PM": "2002", "HN": "2002", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026501"}, {"RECTYPE": "D", "MH": "LDL-Receptor Related Proteins", "DE": "LDL RECEPT RELAT PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Low Density Lipoprotein-Related Proteins|T116|T123|NON|EQV|NLM (2002)|010209|LOW DENSITY LIPOPROTEIN RELAT PROTEINS|abbcdefv", "ENTRY": "Low Density Lipoprotein Related Proteins", "MN": "D12.776.543.750.710.450.500", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Receptors, Immunologic (1990-2001)", "MS": "A family of proteins that share sequence similarity with the low density lipoprotein receptor (RECEPTORS, LDL).", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026502"}, {"RECTYPE": "D", "MH": "Low Density Lipoprotein Receptor-Related Protein-1", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "alpha-2-Macroglobulin Receptor|T116|T192|NON|EQV|NLM (2002)|ALPHA MACROGLOBULIN RECEPTOR 002|ALPHA 2 MACROGLOBULIN RECEPT|abbcdesv", "ENTRY": "alpha2 Macroglobulin Signaling Receptor", "MN": "D12.776.543.750.710.450.500.100", "FX": "Apolipoproteins E", "MH_TH": "NLM (2012)", "ST": "T192", "RN": "0", "PI": "Receptors, Lipoprotein (1994-2001)", "MS": "A LDL-receptor related protein involved in clearance of chylomicron remnants and of activated ALPHA-MACROGLOBULINS from plasma.", "PM": "2012; see LDL-RECEPTOR RELATED PROTEIN 1 2002-2011; ALPHA-2-MACROGLOBULIN RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1981-2000; APOLIPOPROTEIN E RECEPTOR was indexed under RECEPTORS, LIPOPROTEIN 1994-2001 & RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1993", "HN": "2012(2002)", "MR": "20170524", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026503"}, {"RECTYPE": "D", "MH": "Heymann Nephritis Antigenic Complex", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Nephritis Antigen, Heyman|T116|T129|EPO|EQV|NLM (2002)|abbcde", "ENTRY": "Receptor Associated Protein, Heymann Nephritis", "MN": "D23.050.422.500", "FX": "Glomerulonephritis", "MH_TH": "NLM (2002)", "ST": "T129", "RN": "0", "AN": "HEYMANN NEPHRITIS ANTIGEN GP330 see LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-2 is also available", "PI": "Membrane Glycoproteins (1989-2001)", "MS": "A complex of antigenic proteins obtained from the brush border of kidney tubules. It contains two principal components LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-2 and LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN. The name of this complex is derived from researcher, Dr. Walter Heymann, who developed an experimental model of membranous glomerulonephritis (GLOMERULONEPHRITIS) by injecting this antigenic complex into rats to induce an autoimmune response.", "PM": "2002; NEPHRITIS ANTIGEN, HEYMAN now HEYMANN NEPHRITIS ANTIGENIC COMPLEX was indexed under MEMBRANE GLYCOPROTEINS 1989-2001 & under ANTIGENS, SURFACE 1986-1988", "HN": "2002; use HEYMANN NEPHRITIS ANTIGENIC COMPLEX (NM) 1983-2001", "MR": "20110701", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026541"}, {"RECTYPE": "D", "MH": "Low Density Lipoprotein Receptor-Related Protein-2", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Megalin|T116|T192|NON|EQV|NLM (2002)|abbcde", "ENTRY": "Low Density Lipoprotein Receptor Related Protein 2", "MN": "D23.050.422.500.500", "MH_TH": "NLM (2012)", "ST": "T192", "RN": "0", "AN": "note entry term Heymann Nephritis Antigen GP330: HEYMANN NEPHRITIS ANTIGENIC COMPLEX is also available", "PI": "Membrane Glycoproteins (1989-2001)", "MS": "An LDL-RECEPTOR RELATED PROTEIN found in the neuroepithelium and in proximal tubular cells of the kidney. It is considered a multiligand receptor in that it binds to a variety of ligands with relatively high affinity and may function in mediating the uptake and lysosomal degradation of macromolecules such as: LIPOPROTEINS; ENDOPEPTIDASES; and PROTEASE INHIBITORS.", "PM": "2012; see LDL-RECEPTOR RELATED PROTEIN 2 2002-2011; HEYMAN'S NEPHRITIS ANTIGEN GP330 was indexed under MEMBRANE GLYCOPROTEINS 1989-2001 & ANTIGENS, SURFACE 1986-1988; ANTIGEN GP330, NEPHRITIS was indexed under MEMBRANE GLYCOPROTEINS 1989-2001& ANTIGENS, SURFACE 1988; RENAL GLYCOPROTEIN GP330 was indexed under MEMBRANE GLYCOPROTEINS 1991-2001; GP330 ANTIGEN was indexed under MEMBRANE GLYCOPROTEINS 1991-2001; LPR-2 was indexed under MEMBRANE GLYCOPROTEINS 1996-2001; LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEINS 2 was indexed under MEMBRANE GLYCOPROTEINS 1994-2001; MEGALIN was indexed under MEMBRANE GLYCOPROTEINS 1995-2001", "HN": "2012(2002)", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026561"}, {"RECTYPE": "D", "MH": "LDL-Receptor Related Protein-Associated Protein", "DE": "LDL RECEPT RELAT PROTEIN ASSOCIAT PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha2 Macroglobulin Receptor Associated Protein", "MN": "D23.050.422.500.750", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Receptors, Immunologic (1997-2001)", "MS": "A membrane protein found in the rough endoplasm reticulum (ENDOPLASMIC RETICULUM, ROUGH) that binds to LDL-RECEPTOR RELATED PROTEINS. It may function to prevent ligand binding of receptors during protein processing events within endosomal compartments.", "PM": "2002; HEPARIN-BINDING PROTEIN 44, 39-KDA RECEPTOR-ASSOCIATED PROTEIN & 39KDA-RAP were indexed under CARRIER PROTEINS & GLYCOPROTEINS 1992-2001; ALPHA2-MACROGLOBULIN RECEPTOR-ASSOCIATED PROTEIN & ALPHA2-MRAP were indexed under CARRIER PROTEINS & GLYCOPROTEINS 1994-2001; LDL RECEPTOR-ASSOCIATED PROTEIN was indexed under MEMBRANE GLYCOPROTEINS 1997-2001; LPRAP1 GENE PRODUCT was indexed under RECEPTORS, IMMUNOLOGIC 1997-2001", "HN": "2002; for HEPARIN-BINDING PROTEIN 44, 39-KDA RECEPTOR-ASSOCIATED PROTEIN & 39KDA-RAP use LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN (NM) 1992-2001; for ALPHA2-MACROGLOBULIN RECEPTOR-ASSOCIATED PROTEIN & ALPHA2-MRAP use LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN (NM) 1994-2001; for LDL RECEPTOR-ASSOCIATED PROTEIN use HEYMANN NEPHRITIS ANTIGEN COMPLEX (NM) 1997-2001; for LPRAP1 GENE PRODUCT use LDL-RECEPTOR RELATED PROTEIN 1 (NM) 1997-2001", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026563"}, {"RECTYPE": "D", "MH": "Isoaspartic Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "beta Aspartic Acid", "MN": "D12.125.119.170.275", "MH_TH": "NLM (1993)", "ST": "T123", "RN": "0", "PI": "Aspartic Acid (1984-2001)", "MS": "An ASPARTIC ACID residue in polypeptide chains that is linked at the beta-carboxyl group instead of at the normal, alpha-carboxyl group, polypeptide linkage. It is a result of the spontaneous decomposition of aspartic acid or ASPARAGINE residues.", "PM": "2002; see ASPARTIC ACID 1993-2001", "HN": "2002; use ASPARTIC ACID 1993-2001", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026581"}, {"RECTYPE": "D", "MH": "Protein D-Aspartate-L-Isoaspartate Methyltransferase", "DS": "PROTEIN ASPARTATE ISOASPARTATE METHYLTRANSFERASE D L", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein-L-Isoaspartate-D-Aspartate-O-Methyltransferase|T116|T126|NON|EQV|NLM (2002)|010530|PROTEIN ISOASPARTATE ASPARTATE METHYLTRANSFERASE L D O|abbcdefs", "ENTRY": "Protein beta Aspartate Methyltransferase", "MN": "D08.811.913.555.500.800.800.700", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 2.1.1.77", "PI": "Protein Methyltransferases (1984-2001)", "MS": "A PROTEIN O-METHYLTRANSFERASE that recognizes and catalyzes the methyl esterification of ISOASPARTIC ACID and D-ASPARTIC ACID residues in peptides and proteins. It initiates the repair of proteins damaged by the spontaneous decomposition of normal L-aspartic acid and L-asparagine residues.", "PM": "2002; PROTEIN-D-ASPARTATE METHYLTRANSFERASE (now PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE) was indexed under PROTEIN METHYLTRANSFERASES 1984-2001", "HN": "2002; use PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE (NM) 1984-2001", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026601"}, {"RECTYPE": "D", "MH": "Nitrergic Neurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Nitroxidergic Neurons|T025|NON|EQV|NLM (2002)|010212|abcdef", "ENTRY": "Neuron, Nitroxidergic", "MN": "A11.671.738", "MH_TH": "NLM (2002)", "ST": "T025", "PI": "Neurons (1992-2001)", "MS": "Nerve cells where transmission is mediated by NITRIC OXIDE.", "PM": "2002", "HN": "2002", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026602"}, {"RECTYPE": "D", "MH": "D-Aspartic Acid", "DS": "ASPARTIC ACID D", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "D-Aspartate|T116|T123|NON|NRW|NLM (2002)|010212|ASPARATE D|abbcdefs", "ENTRY": "D Aspartic Acid", "MN": "D12.125.119.170.150", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "4SR0Q8YD1X", "RR": "1783-96-6 (D-Aspartic Acid)", "PI": "Aspartic Acid (1966-2001)", "MS": "The D-isomer of ASPARTIC ACID.", "PM": "2002", "HN": "2002", "MR": "20130708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026603"}, {"RECTYPE": "D", "MH": "Clinical Trials Data Monitoring Committees", "DE": "CLIN TRIALS DATA MONITORING COMMITTEES", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Safety Monitoring Boards|T097|NON|EQV|BIOETHICS (2000)|010611|abcdef", "ENTRY": "Safety Monitoring Board", "MN": "N05.700.685.149", "FX": "Research Design", "MH_TH": "NLM (2002)", "ST": "T097", "PI": "Professional Staff Committees (1991-2001)", "MS": "Committees established to review interim data and efficacy outcomes in clinical trials. The findings of these committees are used in deciding whether a trial should be continued as designed, changed, or terminated. Government regulations regarding federally-funded research involving human subjects (the \"Common Rule\") require (45 CFR 46.111) that research ethics committees reviewing large-scale clinical trials monitor the data collected using a mechanism such as a data monitoring committee. FDA regulations (21 CFR 50.24) require that such committees be established to monitor studies conducted in emergency settings.", "PM": "2002", "HN": "2002", "MR": "20090715", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026661"}, {"RECTYPE": "D", "MH": "Vitamin B 6 Deficiency", "DS": "VITAMIN B A 06 DEFICIENCY", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pyridoxine Deficiency|T047|NON|NRW|NLM (1966)|ORD (2010)|990101|PYRIDOXINE DEFIC|abcdeefv", "ENTRY": "Vitamin Deficiencies, B6", "MN": "C18.654.521.500.133.699.901", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "Pyridoxine Deficiency (1963-2001)", "MS": "A nutritional condition produced by a deficiency of VITAMIN B 6 in the diet, characterized by dermatitis, glossitis, cheilosis, and stomatitis. Marked deficiency causes irritability, weakness, depression, dizziness, peripheral neuropathy, and seizures. In infants and children typical manifestations are diarrhea, anemia, and seizures. Deficiency can be caused by certain medications, such as isoniazid.", "PM": "2000; for PYRIDOXINE DEFICIENCY see PYRIDOXINE DEFICIENCY 1963-2001", "HN": "2000", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026681"}, {"RECTYPE": "D", "MH": "Advisory Committees", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Task Force", "MN": "N03.706.742.500", "FX": "Ethics Committees", "MH_TH": "NLM (1992)", "ST": "T064", "AN": "coord IM with specific activity or agency (IM) + geog if pertinent", "PI": "Public Policy (1981-2001)", "MS": "Groups set up to advise governmental bodies, societies, or other institutions on policy. (Bioethics Thesaurus)", "PM": "2002", "HN": "2002", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026683"}, {"RECTYPE": "D", "MH": "Personal Autonomy", "PRINT ENTRY": "Autonomy, Personal|T078|NON|EQV|NLM (2002)|910726|abcdef", "ENTRY": "Self Determination|T078|NON|REL|NLM (2002)|890502|abcdef", "MN": "N05.350.958.650", "FX": "Self Concept", "MH_TH": "NLM (2002)", "ST": "T078", "PI": "Freedom (1974-2001)", "MS": "Self-directing freedom and especially moral independence. An ethical principle holds that the autonomy of persons ought to be respected. (Bioethics Thesaurus)", "PM": "2002; for SELF DETERMINATION see FREEDOM 1990-2001", "HN": "2002; for SELF DETERMINATION use FREEDOM 1990-2001", "MR": "20150623", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026684"}, {"RECTYPE": "D", "MH": "Beneficence", "ENTRY": "Nonmaleficence|T078|NON|REL|BIOETHICS (1974)|010214|abcdef", "MN": "N05.350.958.500", "FX": "Paternalism", "MH_TH": "NLM (2002)", "ST": "T078", "PI": "Altruism (1974-2001)", "MS": "The state or quality of being kind, charitable, or beneficial. (from American Heritage Dictionary of the English Language, 4th ed). The ethical principle of BENEFICENCE requires producing net benefit over harm. (Bioethics Thesaurus)", "PM": "2002; see ALTRUISM 1978-2001", "HN": "2002; use ALTRUISM 1978-2001", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026686"}, {"RECTYPE": "D", "MH": "Bioethical Issues", "AQ": "HI LJ ST", "ENTRY": "Issues, Bioethical", "MN": "N05.350.100", "FX": "Patient Rights", "MH_TH": "NLM (2002)", "ST": "T078", "AN": "used for discussions of several specific issues that fall within the domain of BIOETHICS but not for discussions of the field or discipline as such; BIOETHICS is available for the specialty and BIOETHICISTS see ETHICISTS is available for the person", "PI": "Bioethics (1974-2001)", "MS": "Clusters of topics that fall within the domain of BIOETHICS, the field of study concerned with value questions that arise in biomedicine and health care delivery.", "PM": "2002; see BIOETHICS 1978-2001", "HN": "2002; use BIOETHICS 1978-2001", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026688"}, {"RECTYPE": "D", "MH": "Ethical Analysis", "DE": "ETHICAL ANAL", "AQ": "MT", "ENTRY": "Ethical Analyses", "MN": "N05.350.244", "MH_TH": "NLM (2002)", "ST": "T078", "PI": "Ethics (1979-2001)", "MS": "The use of systematic methods of ethical examination, such as CASUISTRY or ETHICAL THEORY, in reasoning about moral problems.", "PM": "2002; see ETHICS 1979-2001", "HN": "2002; use ETHICS 1978-2001", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026689"}, {"RECTYPE": "D", "MH": "Ethics, Clinical", "DE": "ETHICS CLIN", "AQ": "ED HI", "ENTRY": "Clinical Ethics|T078|NON|EQV|NLM (2002)|010214|CLIN ETHICS|abcdefv", "MN": "N05.350.340.162", "FX": "Ethics Consultation", "MH_TH": "NLM (2002)", "ST": "T078", "AN": "general; prefer specifics such as ETHICS, MEDICAL for ethics in relation to the physician. Do not use routinely; reserve for discussions of clinical ethics as a topic in its own right; specify geographic term if pertinent", "PI": "Ethics, Medical (1992-2001)", "MS": "The identification, analysis, and resolution of moral problems that arise in the care of patients. (Bioethics Thesaurus)", "PM": "2002; see ETHICS, MEDICAL 1993-2001", "HN": "2002; use ETHICS, MEDICAL 1993-2001", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026690"}, {"RECTYPE": "D", "MH": "Paternalism", "AQ": "ES", "MN": "F01.829.547", "FX": "Personal Autonomy", "MH_TH": "NLM (2002)", "ST": "T054", "AN": "do not confuse with FATHERS or PATERNITY", "MS": "Interference with the FREEDOM or PERSONAL AUTONOMY of another person, with justifications referring to the promotion of the person's good or the prevention of harm to the person. (from Cambridge Dictionary of Philosophy, 1995); more generally, not allowing a person to make decisions on his or her own behalf.", "PM": "2002", "HN": "2002", "MR": "20021031", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026706"}, {"RECTYPE": "D", "MH": "Value of Life", "AQ": "EC", "PRINT ENTRY": "Life Valuation, Economic|T081|NON|NRW|UNK (19XX)|820428|LIFE VALUATION ECON|abcdefv", "ENTRY": "Valuations, Economic Life", "MN": "K01.752.400.900", "FX": "Social Values", "MH_TH": "NLM (2002)", "ST": "T080", "AN": "entry term ECONOMIC VALUE OF LIFE: coord with /econ + specific economics tern", "PI": "Quality of Life (1976-2001)", "MS": "The intrinsic moral worth ascribed to a living being. (Bioethics Thesaurus)", "PM": "2002; for ECONOMIC VALUE OF LIFE & LIFE VALUATION, ECONOMIC see ECONOMIC VALUE OF LIFE 1991-2001; see ECONOMICS 1983-1990", "HN": "2002", "MR": "20020703", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026712"}, {"RECTYPE": "D", "MH": "RNA 3' End Processing", "DS": "RNA END PROCESSING 003", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "3' End Processing, RNA|T044|ABX|EQV|NLM (2002)|010312|END PROCESSING RNA 003|abcdefs", "MN": "G05.308.700.225", "MH_TH": "NLM (2002)", "ST": "T044", "PI": "RNA Processing, Post-Transcriptional (1984-2001)", "MS": "The steps that generate the 3' ends of mature RNA molecules. For most mRNAs (RNA, MESSENGER), 3' end processing referred to as POLYADENYLATION includes the addition of POLY A.", "PM": "2002", "HN": "2002", "MR": "20160623", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026721"}, {"RECTYPE": "D", "MH": "Polyadenylation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Polyadenylations", "MN": "G05.308.700.225.710", "MH_TH": "NLM (2002)", "ST": "T044", "PI": "RNA, Messenger/metabolism (1974-2001)", "MS": "The addition of a tail of polyadenylic acid (POLY A) to the 3' end of mRNA (RNA, MESSENGER). Polyadenylation involves recognizing the processing site signal, (AAUAAA), and cleaving of the mRNA to create a 3' OH terminal end to which poly A polymerase (POLYNUCLEOTIDE ADENYLYLTRANSFERASE) adds 60-200 adenylate residues. The 3' end processing of some messenger RNAs, such as histone mRNA, is carried out by a different process that does not include the addition of poly A as described here.", "PM": "2002", "HN": "2002", "MR": "20160623", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026723"}, {"RECTYPE": "D", "MH": "Ethical Review", "DE": "ETHICAL REV", "AQ": "CL EC HI LJ ST", "ENTRY": "Review, Ethical", "MN": "N05.350.250", "FX": "Peer Review", "MH_TH": "NLM (2002)", "ST": "T062", "PI": "Ethics (1979-2001)", "MS": "A formal process of examination of patient care or research proposals for conformity with ethical standards. The review is usually conducted by an organized clinical or research ethics committee (CLINICAL ETHICS COMMITTEES or RESEARCH ETHICS COMMITTEES), sometimes by a subset of such a committee, an ad hoc group, or an individual ethicist (ETHICISTS).", "PM": "2002; see ETHICS 1993-2001", "HN": "2002; use ETHICS 1993-2001", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026724"}, {"RECTYPE": "D", "MH": "Physical Therapy Modalities", "DE": "PHYSICAL THER TECHNIQUES", "AQ": "AE CL EC ED ES HI IS LJ MO NU OG PX SN ST TD VE", "PRINT ENTRY": "Physiotherapy (Techniques)|T061|NON|EQV|NLM (2003)|020221|PHYSIOTHER PRACTICE|abcdefv", "ENTRY": "Therapy, Physical", "MN": "E02.831.535", "FX": "Postoperative Care", "MH_TH": "NLM (2006)", "ST": "T061", "AN": "general or unspecified; prefer specifics; do not confuse with the specialty PHYSICAL THERAPY SPECIALTY", "MS": "Therapeutic modalities frequently used in PHYSICAL THERAPY SPECIALTY by PHYSICAL THERAPISTS or physiotherapists to promote, maintain, or restore the physical and physiological well-being of an individual.", "PM": "2006; see PHYSICAL THERAPY TECHNIQUES 2002-2005, see PHYSICAL THERAPY 1963-2001", "HN": "2006 (2002)", "MR": "20200206", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026741"}, {"RECTYPE": "D", "MH": "Physical Therapy Specialty", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapy Specialty, Physical", "MN": "H02.010.625", "MH_TH": "NLM (2012)", "ST": "T091", "AN": "use for the specialty only; use MUSCULOSKELETAL MANIPULATIONS or PHYSICAL THERAPY MODALITIES or their specifics for therapy", "PI": "Physical Therapy Techniques (1963-2001)", "MS": "The auxiliary health profession by which PHYSICAL THERAPISTS make use of PHYSICAL THERAPY MODALITIES to prevent, correct, and alleviate movement dysfunction of anatomic or physiological origin.", "PM": "2012; see PHYSICAL THERAPY (SPECIALTY) 2002-2011, see PHYSICAL THERAPY 1963-2001", "HN": "2012 (1963)", "MR": "20160701", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026761"}, {"RECTYPE": "D", "MH": "Maize streak virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Maize streak viruses", "MN": "B04.715.270.500", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid10821", "PI": "Plant Viruses (1984-1993)", "MS": "The type species of genus Mastrevirus, family GEMINIVIRIDAE.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026762"}, {"RECTYPE": "D", "MH": "Mandragora", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mandrake, European|T002|NON|EQV|NLM (1997)|960415|abcdef", "ENTRY": "vernali, Mandragora", "MN": "B01.875.800.575.912.250.908.500.347", "MH_TH": "NLM (1997)", "ST": "T002", "RN": "txid24647", "AN": "do not confuse entry term MANDRAKE, EUROPEAN with MANDRAKE, AMERICAN see PODOPHYLLUM", "PI": "Plants, Toxic (1997-2001)", "MS": "Plants of the Mandragora genus in the SOLANACEAE family, including Mandragora officinarum L. and Mandragora vernalis Bertol (sometimes called Atropa mandragora). They contain TROPANES that are anticholinergic (CHOLINERGIC ANTAGONISTS). Mandrake may also refer to PODOPHYLLUM.", "PM": "2002, 1963-1991; see PLANTS, TOXIC 1986-1990; for MANDRAKE, EUROPEAN see PLANTS, TOXIC 1997-2001; see MANDRAGORA 1986-96", "HN": "2002, 1963-1996; use PLANTS, TOXIC 1997-2001; for MANDRAKE, EUROPEAN use PLANTS, TOXIC 1986-2001", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D026781"}, {"RECTYPE": "D", "MH": "Synteny", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Conserved Synteny|T044|NON|NRW|NLM (2002)|010216|abcdef", "ENTRY": "Synteny, Conserved", "MN": "G05.810.550.830", "FX": "Genetic Linkage", "MH_TH": "NLM (2001)", "ST": "T044", "PI": "specific Chromosome Mapping (1971-2001)", "MS": "The presence of two or more genetic loci on the same chromosome. Extensions of this original definition refer to the similarity in content and organization between chromosomes, of different species for example.", "PM": "2002; see LINKAGE(GENETICS) 2001", "HN": "2002; use LINKAGE(GENETICS) 2001", "MR": "20100625", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026801"}, {"RECTYPE": "D", "MH": "Ethicists", "AQ": "ED HI LJ PX SD SN ST", "PRINT ENTRY": "Bioethicists|T097|NON|NRW|NLM (2002)|010612|abcdef", "ENTRY": "Ethics Consultant", "MN": "N05.350.262", "FX": "Ethics, Clinical", "MH_TH": "NLM (2002)", "ST": "T097", "PI": "Ethics (1979-2001)", "MS": "Persons trained in philosophical or theological ethics who work in clinical, research, public policy, or other settings where they bring their expertise to bear on the analysis of ethical dilemmas in policies or cases. (Bioethics Thesaurus)", "PM": "2002; see ETHICS 1993-2001", "HN": "2002; use ETHICS 1993-2001", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026822"}, {"RECTYPE": "D", "MH": "Ornithodoros", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Ticks, Relapsing Fever|T204|NON|EQV|NLM (2002)|010220|abcdef", "ENTRY": "Tick, Relapsing Fever", "MN": "B01.050.500.131.166.132.832.100.700", "MH_TH": "NLM (2002)", "ST": "T204", "RN": "txid6937", "AN": "infestation: coord IM with TICK INFESTATIONS (IM)", "PI": "Ticks (1964-2001)", "MS": "A genus of softbacked TICKS, in the family ARGASIDAE, serving as the vector of BORRELIA, causing RELAPSING FEVER, and of the AFRICAN SWINE FEVER VIRUS.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026861"}, {"RECTYPE": "D", "MH": "Argasidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Ticks, Softbacked|T204|NON|EQV|NLM (2002)|010220|abcdef", "ENTRY": "Tick, Softbacked", "MN": "B01.050.500.131.166.132.832.100", "MH_TH": "NLM (2002)", "ST": "T204", "RN": "txid6936", "AN": "infestation: coord IM with TICK INFESTATIONS (IM)", "PI": "Ticks (1964-2001)", "MS": "A family of softbacked TICKS, in the subclass ACARI. Genera include ARGAS and ORNITHODOROS among others.", "PM": "2002", "HN": "2002", "MR": "20230405", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026862"}, {"RECTYPE": "D", "MH": "Ixodidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Ticks, Hardbacked|T204|NON|EQV|NLM (2002)|010220|abcdef", "ENTRY": "Ticks, Hard", "MN": "B01.050.500.131.166.132.832.400", "MH_TH": "NLM (2002)", "ST": "T204", "RN": "txid6939", "AN": "infestation: coord IM with TICK INFESTATIONS (IM)", "PI": "Ticks (1965-2001)", "MS": "A family of hardbacked TICKS, in the subclass ACARI. Genera include DERMACENTOR and IXODES among others.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026863"}, {"RECTYPE": "D", "MH": "Argas", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Arga", "MN": "B01.050.500.131.166.132.832.100.100", "MH_TH": "NLM (2002)", "ST": "T204", "RN": "txid34601", "AN": "infestation: coord IM with TICK INFESTATIONS (IM)", "PI": "Ticks (1965-2001)", "MS": "A genus of softbacked TICKS in the family ARGASIDAE. Most infect birds or bats but a few parasitize terrestrial mammals.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026864"}, {"RECTYPE": "D", "MH": "Acupuncture", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Pharmacopuncture|T091|NON|NRW|NLM (2017)|160518|abcdef", "MN": "H02.004", "FX": "Acupuncture Therapy", "MH_TH": "NLM (2002)", "ST": "T091", "AN": "use for the discipline only; do not confuse with ACUPUNCTURE THERAPY", "PI": "Acupuncture Therapy/trends (1978-2001)", "MS": "The occupational discipline of the traditional Chinese methods of ACUPUNCTURE THERAPY for treating disease by inserting needles along specific pathways or meridians.", "PM": "2002", "HN": "2002", "MR": "20160705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026881"}, {"RECTYPE": "D", "MH": "Manipulation, Chiropractic", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Spinal Adjustment, Chiropractic|T061|NON|NRW|NLM (2002)|010523|abcdef", "ENTRY": "Spinal Adjustments, Chiropractic", "MN": "E02.190.599.233", "FX": "Manipulation, Osteopathic", "MH_TH": "NLM (1992)", "ST": "T061", "AN": "do not confuse with CHIROPRACTIC, the specialty", "PI": "Manipulation, Spinal (1999-2001)", "MS": "Procedures used by chiropractors to treat neuromusculoskeletal complaints.", "PM": "2002; MANIPULATION, CHIROPRACTIC see CHIROPRACTIC 1992-1998", "HN": "2002; MANIPULATION, CHIROPRACTIC see CHIROPRACTIC 1992-1998", "MR": "20090706", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026882"}, {"RECTYPE": "D", "MH": "Membrane Transport Proteins", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Permease|T116|T126|NON|NRW|NLM (2021)|200113|abbcdef", "ENTRY": "Transporters, Membrane", "MN": "D12.776.543.585", "FX": "Protein Translocation Systems", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Permeases (1968-2001)", "MS": "Membrane proteins whose primary function is to facilitate the transport of molecules across a biological membrane. Included in this broad category are proteins involved in active transport (BIOLOGICAL TRANSPORT, ACTIVE), facilitated transport and ION CHANNELS.", "PM": "2002; for BIOLOGICAL PUMP & METABOLIC PUMP see BIOLOGICAL TRANSPORT ACTIVE 1991-2001", "HN": "2002; for BIOLOGICAL PUMP & METABOLIC PUMP use BIOLOGICAL TRANSPORT ACTIVE 1991-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026901"}, {"RECTYPE": "D", "MH": "Potassium Channel Blockers", "DE": "K CHANNEL BLOCK", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Potassium Channel Blocker|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Channel Blocker, Potassium", "MN": "D27.505.954.411.645", "FX": "Vasodilator Agents", "MH_TH": "NLM (2002)", "ST": "T121", "RN": "0", "PI": "Potassium Channels/antagonists & inhibitors (1988-2001)", "MS": "A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS.", "PM": "2002", "HN": "2002", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026902"}, {"RECTYPE": "D", "MH": "Amino Acid Transport Systems", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Amino Acid Transporters|T116|T123|NON|EQV|NLM (2002)|010223|abbcdef", "ENTRY": "Transporters, Amino Acid", "MN": "D12.776.543.585.200", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Permeases (1981-2001)", "MS": "Cellular proteins and protein complexes that transport amino acids across biological membranes.", "PM": "2002; AMINO ACID PERMEASE was indexed under PERMEASES 1981-2001; AMINO ACID TRANSPORTER was indexed under CARRIER PROTEINS 1987-2001", "HN": "2002; for AMINO ACID PERMEASE use AMINO ACID TRANSPORT SYSTEMS (NM) 1981-2001; for AMINO ACID TRANSPORTER use AMINO ACID TRANSPORT SYSTEMS (NM) 1987-2001", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026905"}, {"RECTYPE": "D", "MH": "Amino Acid Transport Systems, Neutral", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Zwitterionic Amino Acid Transport Systems|T116|T123|NON|EQV|NLM (2002)|010227|abbcdef", "ENTRY": "Na+ Independent Neutral Amino Acid Transporter", "MN": "D12.776.543.585.200.500", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1992-2001)", "MS": "Amino acid transporter systems capable of transporting neutral amino acids (AMINO ACIDS, NEUTRAL).", "PM": "2002; NA+-INDEPENDENT NEUTRAL AMINO ACID TRANSPORTER was indexed under CARRIER PROTEINS 1992-2001", "HN": "2002; for NA+-INDEPENDENT NEUTRAL AMINO ACID TRANSPORTER use AMINO ACID TRANSPORT SYSTEMS 1992-2001", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026921"}, {"RECTYPE": "D", "MH": "Amino Acid Transport Systems, Acidic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Anionic Amino Acid Transport Systems|T116|T123|NON|EQV|NLM (2002)|010223|abbcdef", "ENTRY": "Anionic Amino Acid Transporters|T116|T123|NON|EQV|NLM (2002)|010223|abbcdef", "MN": "D12.776.543.585.200.249", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1981-2001)", "MS": "Amino acid transporter systems capable of transporting acidic amino acids (AMINO ACIDS, ACIDIC).", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026922"}, {"RECTYPE": "D", "MH": "Amino Acid Transport Systems, Basic", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cationic Amino Acid Transporter|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Cationic Amino Acid Transporters|T116|T123|NON|EQV|NLM (2002)|010223|abbcdef", "MN": "D12.776.543.585.200.374", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1992-2001)", "MS": "Amino acid transporter systems capable of transporting basic amino acids (AMINO ACIDS, BASIC).", "PM": "2002; CATIONIC AMINO ACID TRANSPORTER, MAMMALIAN (now AMINO ACID TRANSPORT SYTEMS, BASIC) was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 1992-2001", "HN": "2002; use AMINO ACID TRANSPORT SYSTEMS, BASIC (NM) 1992-2001", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026923"}, {"RECTYPE": "D", "MH": "Amino Acid Transport System A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, System A", "MN": "D12.776.543.585.200.500.100", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (2000-2001)", "MS": "A sodium-dependent neutral amino acid transporter that accounts for most of the sodium-dependent neutral amino acid uptake by mammalian cells. The preferred substrates for this transporter system include ALANINE; SERINE; and GLUTAMINE.", "PM": "2002; AMINO ACID TRANSPORTER A was indexed under CARRIER PROTEINS 2000-2001", "HN": "2002; for AMINO ACID TRANSPORTER A use AMINO ACID TRANSPORT SYSTEMS (NM) 2000-2001", "MR": "20050707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026924"}, {"RECTYPE": "D", "MH": "Sodium Channel Blockers", "DE": "NA CHANNEL BLOCK", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sodium Channel Inhibitor|T121|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Inhibitors, Sodium Channel", "MN": "D27.505.954.411.720", "FX": "Anti-Arrhythmia Agents", "MH_TH": "NLM (2002)", "ST": "T121", "RN": "0", "AN": "coordinate with DIURETICS if pertinent", "PI": "Sodium Channels/antagonists & inhibitors (1988-2001)", "MS": "A class of drugs that act by inhibition of sodium influx through cell membranes. Blockade of sodium channels slows the rate and amplitude of initial rapid depolarization, reduces cell excitability, and reduces conduction velocity.", "PM": "2002", "HN": "2002", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026941"}, {"RECTYPE": "D", "MH": "DNA Topoisomerases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Topoisomerases, DNA", "MN": "D08.811.399.403", "EC": "antagonists & inhibitors:Topoisomerase Inhibitors", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 5.99.1.-", "PI": "DNA Topoisomerase (ATP-Hydrolysing) (1979-2001)", "MS": "Enzymes that regulate the topology of DNA by actions such as breaking, relaxing, passing, and rejoining strands of DNA in cells. These enzymes are important components of the DNA replication system. They are classified by their substrate specificities. DNA TOPOISOMERASE I enzymes act on a single strand of DNA. DNA TOPOISOMERASE II enzymes act on double strands of DNA.", "PM": "2002", "HN": "2002", "MR": "20100625", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026942"}, {"RECTYPE": "D", "MH": "Amino Acid Transport System ASC", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "System ASC Transporter Proteins|T116|T123|NON|EQV|NLM (2002)|010510|abbcdef", "MN": "D12.776.543.585.200.500.200", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Biological Transport (1980-2001)", "MS": "A ubiquitous sodium-dependent neutral amino acid transporter. The preferred substrates for this transporter system include ALANINE; SERINE; and CYSTEINE.", "PM": "2002", "HN": "2002", "MR": "20050707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026962"}, {"RECTYPE": "D", "MH": "Urtica dioica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Stinging Nettle|T002|NON|EQV|NLM (2002)|010226|abcdef", "ENTRY": "dioica, Urtica", "MN": "B01.875.800.575.912.250.859.937.937.888", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3501", "MS": "A plant species of the genus Urtica, family URTICACEAE. Roots have been used to treat PROSTATIC HYPERPLASIA. Leaves are edible after the stinging quality is eliminated by brief heating.", "PM": "2002; see HAMAMELIDAE 1999-2001", "HN": "2002; use HAMAMELIDAE 1999-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D026982"}, {"RECTYPE": "D", "MH": "Urticaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Myrianthus|T002|NON|NRW|NLM (2003)|011003|abcdef", "MN": "B01.875.800.575.912.250.859.937.937", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3499", "RR": "txid1317685", "MS": "The nettles plant family of the order ROSALES, superorder ROSANAE, and class MAGNOLIOPSIDA. Many have stinging hairs on stems and leaves with flowers that are small and greenish in leaf axils. The fruit is dry and one-seeded.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027003"}, {"RECTYPE": "D", "MH": "Somatic Hypermutation, Immunoglobulin", "DE": "SOMATIC HYPERMUTATION IG", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Immunoglobulin Somatic Hypermutation|T045|NON|EQV|NLM (2002)|010314|abcdef", "ENTRY": "Somatic Hypermutations, Immunoglobulin", "MN": "G12.500.780", "FX": "Gene Rearrangement, B-Lymphocyte", "MH_TH": "NLM (2002)", "ST": "T045", "PI": "Mutation (1981-2001)", "MS": "A programmed mutation process whereby changes are introduced to the nucleotide sequence of immunoglobulin gene DNA during development.", "PM": "2002", "HN": "2002", "MR": "20160623", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027041"}, {"RECTYPE": "D", "MH": "Chromosomes, Artificial, P1 Bacteriophage", "DS": "CHROMOSOMES ARTIFICIAL BACTERIOPHAGE P 001", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "P1 Bacteriophage Artificial Chromosomes|T075|NON|EQV|NLM (2002)|010226|P A 001 BACTERIOPHAGE ARTIFICIAL CHROMOSOMES|abcdefs", "ENTRY": "P1-Derived Artificial Chromosome", "MN": "G05.360.337.249.195", "MH_TH": "NLM (2002)", "ST": "T075", "MS": "DNA constructs that are derived from the DNA of BACTERIOPHAGE P1. They can carry large amounts (about 100-300 kilobases) of other sequence for a variety of bioengineering purposes.", "PM": "2002", "HN": "2002", "MR": "20080708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027042"}, {"RECTYPE": "D", "MH": "Amino Acid Transport System L", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, System L", "MN": "D12.776.543.585.200.500.500", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1999-2001)", "MS": "A sodium-independent neutral amino acid transporter system with specificity for large amino acids. One of the functions of the transporter system is to supply large neutral amino acids to the brain.", "PM": "2002; LARGE NEUTRAL AMINO ACID TRANSPORTER (LNAA) was indexed under CARRIER PROTEINS 1999-2001", "HN": "2002; for LARGE NEUTRAL AMINO ACID TRANSPORTER (LNAA) use AMINO ACID TRANSPORT SYSTEMS (NM) 1999-2001", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027062"}, {"RECTYPE": "D", "MH": "DNA Gyrase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA Gyrase B Subunit|T116|T126|ABX|NRW|NLM (2002)|abbcde", "ENTRY": "GyrB Protein|T116|T126|ABX|NRW|NLM (2014)|130516|abbcdef", "MN": "D12.776.097.237", "EC": "antagonists & inhibitors:Topoisomerase II Inhibitors", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 5.99.1.3", "PI": "DNA, Circular (1976-1977)", "MS": "A bacterial DNA topoisomerase II that catalyzes ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. Gyrase binds to DNA as a heterotetramer consisting of two A and two B subunits. In the presence of ATP, gyrase is able to convert the relaxed circular DNA duplex into a superhelix. In the absence of ATP, supercoiled DNA is relaxed by DNA gyrase.", "PM": "2002; see DNA TOPOISOMERASE (ATP-HYDROLYZING) 1994-2001, see DNA GYRASE 1980-1993; GYRA PROTEIN was indexed under DNA TOPOISOMERASE (ATP-HYDROLYZING) (NM) 1992-2001; GYRB PROTEIN was indexed under DNA TOPOISOMERASE (ATP-HYDROLYZING) (NM) 1991-2001", "HN": "2002; use DNA TOPOISOMERASE (ATP-HYDROLYZING) 1994-2001, use DNA GYRASE 1980-1993; for GYRA PROTEIN use DNA TOPOISOMERASE (ATP-HYDROLYZING) (NM) 1992-2001; GYRB PROTEIN use DNA TOPOISOMERASE (ATP-HYDROLYZING) (NM) 1991-2001", "MR": "20130708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027081"}, {"RECTYPE": "D", "MH": "DNA Topoisomerase IV", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "parE Protein|T116|T126|NON|NRW|NLM (2002)|abbcde", "ENTRY": "Topoisomerase IV, DNA", "MN": "D12.776.097.256", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 5.99.1.-", "PI": "DNA Topoisomerase (ATP-Hydrolysing) (1991-2001)", "MS": "A bacterial DNA topoisomerase II that catalyzes ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. Topoisomerase IV binds to DNA as a heterotetramer consisting 2 parC and 2 parE subunits. Topoisomerase IV is a decatenating enzyme that resolves interlinked daughter chromosomes following DNA replication.", "PM": "2002; DNA TOPOISOMERASE IV was indexed under TYPE II DNA TOPOISOMERASE 1991-2001", "HN": "2002; use DNA TOPOISOMERASE IV (NM) 1991-2001", "MR": "20100625", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027101"}, {"RECTYPE": "D", "MH": "Satellite Cells, Perineuronal", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Perineuronal Satellite Cells|T025|NON|EQV|NLM (1994)|921203|abcdef", "ENTRY": "Satellite Cell, Perineuronal", "MN": "A11.650.775", "MH_TH": "NLM (2002)", "ST": "T025", "MS": "The non-neuronal cells that surround the neuronal cell bodies of the GANGLIA. They are distinguished from the perineuronal satellite oligodendrocytes (OLIGODENDROGLIA) found in the central nervous system.", "PM": "2002", "HN": "2002", "MR": "20020703", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027161"}, {"RECTYPE": "D", "MH": "Amino Acid Transport System y+", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "y+ Transporter, System", "MN": "D12.776.543.585.937.375", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1975-2001)", "MS": "A sodium-independent, basic amino acid transport system with a high-affinity for LYSINE; ARGININE; and ORNITHINE.", "PM": "2002", "HN": "2002", "MR": "20151123", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027182"}, {"RECTYPE": "D", "MH": "Cationic Amino Acid Transporter 1", "DS": "CATIONIC AMINO ACID TRANSPORTER 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CAT-1 Transporter|T116|T192|ACX|EQV|NLM (2002)|CAT TRANSPORTER 001|abbcdes", "ENTRY": "Transporter, SLC7A1", "MN": "D12.776.543.585.937.375.200", "MH_TH": "NLM (2002)", "ST": "T192", "RN": "0", "PI": "Membrane Proteins (1992-2001)", "MS": "A high-affinity, low capacity system y+ amino acid transporter found ubiquitously. It has specificity for the transport of ARGININE; LYSINE; and ORNITHINE. It may also act as an ecotropic leukemia retroviral receptor.", "PM": "2002; ATRC1 was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 1992-2001; CAT-1 TRANSPORTER was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 1996-2001", "HN": "2002; for ATRC1 use BASIC AMINO ACID TRANSPORT SYSTEMS (NM) 1992-2001; for CAT-1 TRANSPORTER use BASIC AMINO ACID TRANSPORT SYSTEMS (NM) 1996-2001", "MR": "20151123", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D027201"}, {"RECTYPE": "D", "MH": "Cationic Amino Acid Transporter 2", "DS": "CATIONIC AMINO ACID TRANSPORTER 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CAT-2 Transporter|T116|T123|ACX|EQV|NLM (2002)|010228|CAT TRANSPORTER 002|abbcdefs", "ENTRY": "Transporter, CAT-2B", "MN": "D12.776.543.585.937.375.300", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1996-2001)", "MS": "A high-affinity, low capacity system y+ amino acid transporter with strong similarity to CATIONIC AMINO ACID TRANSPORTER 1. The two isoforms of the protein, CAT-2A and CAT-2B, exist due to alternative mRNA splicing. The transporter has specificity for the transport of ARGININE; LYSINE; and ORNITHINE.", "PM": "2002; CAT-2 GENE PRODUCT was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 1996-2001", "HN": "2002; for CAT2 GENE PRODUCT use BASIC AMINO ACID TRANSPORT SYSTEMS (NM) 1996-2001", "MR": "20151123", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027202"}, {"RECTYPE": "D", "MH": "Amino Acid Transport System y+L", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "y+L Transporter, System", "MN": "D12.776.543.585.937.313", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Amino Acids/metabolism (1992-2001)", "MS": "A leucine-sensitive amino acid transport system with high affinity for basic amino acids( AMINO ACIDS, BASIC).", "PM": "2002", "HN": "2002", "MR": "20151123", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027241"}, {"RECTYPE": "D", "MH": "Fusion Regulatory Protein-1", "DS": "FUSION REGULATORY PROTEIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD98 Antigens|T116|T129|ABX|EQV|NLM (2002)|CD 098 ANTIGENS|abbcdes", "ENTRY": "Transport Proteins, CD98", "MN": "D12.776.543.585.937.313.500", "MH_TH": "NLM (2002)", "ST": "T129", "RN": "0", "PI": "Carrier Proteins (1996-2001)", "MS": "A heterodimeric protein that is a cell surface antigen associated with lymphocyte activation. The initial characterization of this protein revealed one identifiable heavy chain (FUSION REGULATORY PROTEIN 1, HEAVY CHAIN) and an indeterminate smaller light chain. It is now known that a variety of light chain subunits (FUSION REGULATORY PROTEIN 1, LIGHT CHAINS) can dimerize with the heavy chain. Depending upon its light chain composition a diverse array of functions can be found for this protein. Functions include: type L amino acid transport, type y+L amino acid transport and regulation of cellular fusion.", "PM": "2018; see ANTIGENS, CD98 1988-2017; FUSION REGULATORY PROTEIN-1 was indexed under CARRIER PROTEINS 1996-2001; under ANTIGENS CD 1996-2001; and under ANTIGENS, SURFACE 1989-1995", "HN": "2018 (1988)", "MR": "20170524", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027261"}, {"RECTYPE": "D", "MH": "Fusion Regulatory Protein 1, Heavy Chain", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD98 Antigens Heavy Chain|T116|T123|ACX|EQV|NLM (2002)|010417|CD 098 ANTIGENS HEAVY CHAIN|abbcdefs", "ENTRY": "FRP 1 Heavy Chain", "MN": "D12.776.543.585.937.313.500.250", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1996-2001)", "MS": "A transmembrane glycoprotein subunit that can dimerize with a variety of light chain subunits such as SLC7A5; SLC7A6, and 4F2 LIGHT CHAINS. This protein subunit serves a diverse array of functions including amino acid transport and cell fusion. Its function is altered depending which of the light chain subunits it interacts with.", "PM": "2018; see ANTIGENS, CD98 2002-2017; 4F2 ANTIGEN, HEAVY CHAIN was indexed under CARRIER PROTEINS and ANTIGENS, CD 1996-2001", "HN": "2018 (2002)", "MR": "20170524", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027282"}, {"RECTYPE": "D", "MH": "Large Neutral Amino Acid-Transporter 1", "DS": "LARGE NEUTRAL AMINO ACID TRANS 001", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Solute Carrier Family-7 (Cationic Amino Acid Transporter, y+ System), Member 5|T116|T123|NON|EQV|NLM (2002)|010227|abbcdef", "ENTRY": "Membrane Protein, E16", "MN": "D12.776.543.585.937.313.500.625.500", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1995-2001)", "MS": "A CD98 antigen light chain that when heterodimerized with CD98 antigen heavy chain (FUSION REGULATORY PROTEIN-1 HEAVY CHAIN) forms a protein that mediates sodium-independent L-type amino acid transport.", "PM": "2002;  for MEMBRANE PROTEIN E16 see LARGE NEUTRAL AMINO ACID-TRANSPORTER 1 1995-2001; for LAT1 PROTEIN see AMINO ACID TRANSPORT SYSTEMS 1999-2001; for SLC7A5 see BASIC AMINO ACID TRANSPORT SYSTEMS 1999-2001; MEMBRANE PROTEIN E16 was indexed under MEMBRANE PROTEINS 1995-2001; LAT1 PROTEIN was indexed under CARRIER PROTEINS 1999-2001; SCL7A5 was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 1999-2001", "HN": "2002; for MEMBRANE PROTEIN E16 use LARGE NEUTRAL AMINO ACID-TRANSPORTER 1 1995-2001; for LAT1 PROTEIN use AMINO ACID TRANSPORT SYSTEMS 1999-2001; for SLC7A5 use BASIC AMINO ACID TRANSPORT SYSTEMS 1999-2001", "MR": "20170713", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027283"}, {"RECTYPE": "D", "MH": "Fusion Regulatory Protein 1, Light Chains", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD98 Antigens Light Chain|T116|T129|NON|EQV|NLM (2002)|010417|CD 098 ANTIGENS LIGHT CHAIN|abbcdefs", "ENTRY": "CD98 Antigen Light Chain|T116|T129|NON|EQV|NLM (2002)|010417|abbcdef", "MN": "D12.776.543.585.937.313.500.625", "MH_TH": "NLM (2018)", "ST": "T129", "RN": "0", "PI": "Carrier Proteins (1996-2001)", "MS": "A family of light chains that bind to FUSION REGULATORY PROTEIN 1, HEAVY CHAIN to form a heterodimer. They convey functional specificity to the protein.", "PM": "2018; see ANTIGENS, CD98 LIGHT CHAINS 2002-2017", "HN": "2018 (2002)", "MR": "20170524", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027301"}, {"RECTYPE": "D", "MH": "Anion Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Anion Pumps|T116|T123|NON|NRW|NLM (1994)|930211|abbcdef", "ENTRY": "Pumps, Anion", "MN": "D12.776.543.585.450.074", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "ORGANIC ANION TRANSPORTERS is also available", "PI": "Membrane Proteins (1980-1982)", "MS": "Membrane proteins whose primary function is to facilitate the transport of negatively charged molecules (anions) across a biological membrane.", "PM": "2002; ANION TRANSPORT PROTEINS was indexed under CARRIER PROTEINS 1983-2001 & MEMBRANE PROTEINS 1980-1982; for ANION PUMP & ANION PUMPS use ION PUMPS 1992-2001", "HN": "2002; use ANION TRANSPORT PROTEINS (NM) 1980-2001; for ANION PUMP & ANION PUMPS use ION PUMPS 1992-2001", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027321"}, {"RECTYPE": "D", "MH": "Amino Acid Transport System X-AG", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glutamate-Aspartate Transporter|T116|T123|NON|NRW|NLM (2002)|abbcde", "ENTRY": "Transporters, GLAST Glutamate-Aspartate", "MN": "D12.776.543.585.937.250", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Glycoproteins (1979-1995)", "MS": "A family of POTASSIUM and SODIUM-dependent acidic amino acid transporters that demonstrate a high affinity for GLUTAMIC ACID and ASPARTIC ACID. Several variants of this system are found in neuronal tissue.", "PM": "2002; GLUTAMATE TRANSLOCASE was indexed under ABC TRANSPORTERS 1996-2001, under GLYCOPROTEINS 1979-1995 & under GLUTAMATES/me 1979-1989; GLUTAMATE TRANSPORTER was indexed under ABC TRANSPORTERS 1996-2001, under GLYCOPROTEINS 1989-1995 & under GLUTAMATES/me 1989; GLUTAMATE TRANSPORT GLYCOPROTEIN was indexed under ABC TRANSPORTERS 1996-2001 & under GLYCOPROTEINS 1990-1995; GLUTAMATE-ASPARTATE TRANSPORTER", "HN": "2002; for GLUTAMATE TRANSLOCASE use AMINO ACID TRANSPORT SYSTEM X-AG (NM) 1979-2001; for GLUTAMATE TRANSPORTER use AMINO ACID TRANSPORT SYSTEM X-AG 1989-2001; for GLUTAMATE TRANSPORT GLYCOPROTEIN use AMINO ACID TRANSPORT SYSTEM X-AG 1990-2001; for GLUTAMATE-ASPARTATE TRANSPORTER use AMINO ACID TRANSPORT SYSTEM X-AG (NM) 1997-2001", "MR": "20151123", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027322"}, {"RECTYPE": "D", "MH": "Excitatory Amino Acid Transporter 1", "DS": "EXCITATORY AMINO ACID TRANSPORTER 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, SLC1A3", "MN": "D12.776.543.585.937.250.500.500", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Glycoproteins (1989-1995)", "MS": "A glial type glutamate plasma membrane transporter protein found predominately in ASTROCYTES. It is also expressed in HEART and SKELETAL MUSCLE and in the PLACENTA.", "PM": "2002", "HN": "2002", "MR": "20151123", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027341"}, {"RECTYPE": "D", "MH": "Excitatory Amino Acid Transporter 2", "DS": "EXCITATORY AMINO ACID TRANSPORTER 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, SLC1A2", "MN": "D12.776.543.585.937.250.500.750", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Receptors, Neurotransmitter (1995-2001)", "MS": "A glutamate plasma membrane transporter protein found in ASTROCYTES and in the LIVER.", "PM": "2002; EXCITATORY AMINO ACID TRANSPORTER 2 was indexed under RECEPTORS, NEUROTRANSMITTER 1995-2001; GLUTAMATE TRANSPORTER was indexed under ABC TRANSPORTERS 1996-2001", "HN": "2002; use EXCITATORY AMINO ACID TRANSPORTER 2 (NM) 1995-2001; for GLUT-1 GLUTAMATE TRANSPORTER use AMINO ACID TRANSPORT SYSTEM X-AG (NM) 1996-2001", "MR": "20151123", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027342"}, {"RECTYPE": "D", "MH": "Rhizome", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Rhizomes|T002|NON|EQV|NLM (2017)|151119|abcdef", "MN": "A18.400.750", "MH_TH": "NLM (2002)", "ST": "T002", "AN": "coord with specific Plant", "MS": "Root-like underground horizontal stem of plants that produces shoots above and roots below. Distinguished from true roots which don't have buds and nodes. Similar to true roots in being underground and thickened by storage deposits.", "PM": "2002", "HN": "2002", "MR": "20160617", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027343"}, {"RECTYPE": "D", "MH": "Organic Anion Transporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Organic Anion Transporter|T116|T123|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Transporters, Organic Anion", "MN": "D12.776.543.585.450.074.500", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "ANION TRANSPORT PROTEINS is also available", "PI": "Ion Pumps (1994-2001)", "MS": "Proteins involved in the transport of organic anions. They play an important role in the elimination of a variety of endogenous substances, xenobiotics and their metabolites from the body.", "PM": "2002", "HN": "2002;", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027361"}, {"RECTYPE": "D", "MH": "Organic Anion Transport Protein 1", "DS": "ORGANIC ANION TRANSPORTER 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p Aminohippurate Transporter", "MN": "D12.776.543.585.937.719", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1997-2001)", "MS": "A polyspecific transporter for organic cations found primarily in the kidney. It mediates the coupled exchange of alpha-ketoglutarate with organic ions such as P-AMINOHIPPURIC ACID.", "PM": "2002; OAT1 PROTEIN, P-AMINOHIPPURATE TRANSPORTER & RENAL PAN TRANSPORTER were indexed under CARRIER PROTEINS 2000-2001", "HN": "2002; for OAT1 PROTEIN, P-AMINOHIPPURATE TRANSPORTER & RENAL PAN TRANSPORTER use ANION TRANSPORT PROTEINS 2000-2001", "MR": "20151124", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027362"}, {"RECTYPE": "D", "MH": "Liver-Specific Organic Anion Transporter 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Organic Anion Transport Polypeptide C|T116|T123|ACX|EQV|NLM (2002)|010306|abbcdef", "ENTRY": "Transporter, SLC21A6", "MN": "D12.776.543.585.937.901", "MH_TH": "NLM (2019)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1999-2001)", "MS": "An organic anion transporter found in human and mouse liver. It is capable of transporting a variety organic anions and mediates sodium-independent uptake of bile in the liver.", "PM": "2019; see SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 1B1 2017-2018; see LIVER-SPECIFIC ORGANIC ANION TRANSPORTER, LST-1 2002-2016; LIVER-SPECIFIC ORGANIC ANION TRANSPORTER, LST-1 was indexed under CARRIER PROTEINS 1999-2001; OATP2 & OATP2 PROTEIN were indexed under CARRIER PROTEINS 2000-2001", "HN": "2019(2002); use SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 1B1 2017-2018; for LIVER-SPECIFIC ORGANIC ANION TRANSPORTER, LST-1 use ANION TRANSPORT PROTEINS (NM) 1999-2001; for OATP2 & OATP2 PROTEIN use ANION TRANSPORT PROTEINS (NM) 2000-2001", "MR": "20190705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027381"}, {"RECTYPE": "D", "MH": "Polyomaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Gammapolyomaviruses", "MN": "B04.613.204.670", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid151341", "RR": "txid1891716", "MS": "A family of small, non-enveloped DNA viruses, infecting mainly MAMMALS.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027382"}, {"RECTYPE": "D", "MH": "Papillomaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.613.204.655", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid151340", "AN": "infection: coordinate with PAPILLOMAVIRUS INFECTIONS", "MS": "A family of small, non-enveloped DNA viruses infecting birds and most mammals, especially humans. They are grouped into multiple genera, but the viruses are highly host-species specific and tissue-restricted. They are commonly divided into hundreds of papillomavirus \"types\", each with specific gene function and gene control regions, despite sequence homology. Human papillomaviruses are found in the genera ALPHAPAPILLOMAVIRUS; BETAPAPILLOMAVIRUS; GAMMAPAPILLOMAVIRUS; and MUPAPILLOMAVIRUS.", "PM": "2002; for HUMAN PAPILLOMA VIRUS see ALPHAPAPILLOMAVIRUS 2021-2022", "HN": "2002; for HUMAN PAPILLOMA VIRUS use ALPHAPAPILLOMAVIRUS 2021-2022", "MR": "20220523", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027383"}, {"RECTYPE": "D", "MH": "Oncogene Proteins v-raf", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-mil Protein|T116|T123|NON|REL|NLM (2002)|abbcde", "ENTRY": "v-raf, Oncogene Proteins", "MN": "D12.776.964.775.750.920", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 2.7.11.1", "RR": "EC 2.7.11.1", "PI": "Retroviridae Proteins, Oncogenic (1989-2001)", "MS": "A family of transforming proteins isolated from retroviruses such as MOUSE SARCOMA VIRUSES. They are viral-derived members of the raf-kinase family of serine-theonine kinases.", "PM": "2002; ONCOGENE PROTEIN MIL was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-2001 and RETROVIRIDAE PROTEINS 1986-1989", "HN": "2002; for ONCOGENE PROTEIN MIL use ONCOGENE PROTEINS V-RAF (NM) 1986-2001", "MR": "20210521", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027384"}, {"RECTYPE": "D", "MH": "Persea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Avocado|T168|NON|NRW|NLM (1998)|961206|abcdef", "ENTRY": "americana, Persea", "MN": "B01.875.800.575.912.250.595.400.650", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3434", "RR": "txid3435", "PI": "Lauraceae (1998-2001)", "MS": "A plant genus in the LAURACEAE family. The tree, Persea americana Mill., is known for the Avocado fruit, the food of commerce.", "PM": "2002; see LAURACEAE 1998-2001", "HN": "2002; use LAURACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027421"}, {"RECTYPE": "D", "MH": "Umbellularia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "California Bay Laurel|T002|NAM|NRW|NLM (2002)|010306|abcdef", "ENTRY": "Umbellularias", "MN": "B01.875.800.575.912.250.595.400.825", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3437", "AN": "do not confuse entry term BAY LAUREL, CALIFORNIA with BAY LAUREL see LAURUS", "MS": "A plant genus in the LAURACEAE family. The tree, Umbellularia californica (Hook. & Arn.) Nutt., is known for aromatic leaves used in SPICES having a similar flavor to LAURUS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027422"}, {"RECTYPE": "D", "MH": "Cinnamomum camphora", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Camphor Tree|T002|NON|EQV|NLM (2002)|010306|abcdef", "ENTRY": "camphoras, Cinnamomum", "MN": "B01.875.800.575.912.250.595.400.149.249", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid13429", "PI": "Lauraceae (1996-2001)", "MS": "A tree, Cinnamomum camphora (L.) J. Presl, known as the source of CAMPHOR.", "PM": "2002; see LAURACEAE 1998-2001", "HN": "2002; use LAURACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027423"}, {"RECTYPE": "D", "MH": "Cinnamomum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cinnamomums", "MN": "B01.875.800.575.912.250.595.400.149", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13428", "PI": "Lauraceae (1996-2001)", "MS": "A plant genus in the LAURACEAE family. The bark of the trees is used in FOLK MEDICINE and FLAVORING AGENTS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027424"}, {"RECTYPE": "D", "MH": "Multidrug Resistance-Associated Proteins", "DE": "MULTIDRUG RESISTANCE ASSOC PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Multidrug Resistance-Associated Protein|T116|T123|NON|EQV|NLM (2002)|abbcde", "ENTRY": "Resistance-Associated Protein, Multidrug", "MN": "D12.776.543.585.450.074.500.500.500", "FX": "Drug Resistance, Multiple", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "P-Glycoprotein (1987-2001)", "MS": "A sequence-related subfamily of ATP-BINDING CASSETTE TRANSPORTERS that actively transport organic substrates. Although considered organic anion transporters, a subset of proteins in this family have also been shown to convey drug resistance to neutral organic drugs. Their cellular function may have clinical significance for CHEMOTHERAPY in that they transport a variety of ANTINEOPLASTIC AGENTS. Overexpression of proteins in this class by NEOPLASMS is considered a possible mechanism in the development of multidrug resistance (DRUG RESISTANCE, MULTIPLE). Although similar in function to P-GLYCOPROTEINS, the proteins in this class share little sequence homology to the ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 family of proteins.", "PM": "2002; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN was indexed under ABC TRANSPORTERS 1994-2001; MOAT PROTEIN & MULTISPECIFIC ORGANIC ANION TRANSPORTER were indexed under CARRIER PROTEINS 1995-2001", "HN": "2002; use MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS (NM) 1994-2001; for MOAT PROTEIN & MULTISPECIFIC ORGANIC ANION TRANSPORTER use ANION TRANSPORT PROTEINS 1995-2001", "MR": "20180713", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027425"}, {"RECTYPE": "D", "MH": "Sassafras", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Sassafras officinale|T002|NON|NRW|NLM (2002)|010306|abcdef", "MN": "B01.875.800.575.912.250.595.400.737", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid46944", "RR": "txid46945", "MS": "A plant genus in the LAURACEAE family. The tree bark has been used medicinally. Drinks called sarsaparilla and root beer have been prepared from Sassafras and SMILAX ORNATA (Jamaican sarsaparilla).", "PM": "2002; see LAURACEAE 1996-2001", "HN": "2002; use LAURACEAE 1996-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027441"}, {"RECTYPE": "D", "MH": "Laurus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bay Leaf|T168|NON|REL|NLM (2002)|010306|abcdef", "ENTRY": "Leaf, Bay", "MN": "B01.875.800.575.912.250.595.400.399", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid85222", "RR": "txid85223", "AN": "do not confuse entry term BAY LAUREL with BAY LAUREL, CALIFORNIA see UMBELLULARIA", "PI": "Lauraceae (1998-2001)", "MS": "A plant genus in the LAURACEAE family. Laurus nobilis L. leaves are known for use in SPICES, having a similar flavor as UMBELLULARIA.", "PM": "2002; see LAURACEAE 1998-2001", "HN": "2002; use LAURACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027442"}, {"RECTYPE": "D", "MH": "Lindera", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Spicebush|T002|NON|NRW|NLM (2002)|010306|abcdef", "ENTRY": "benzoins, Lindera", "MN": "B01.875.800.575.912.250.595.400.524", "FX": "Benzoic Acid", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid55957", "RR": "txid55958", "MS": "A plant genus in the LAURACEAE family. Lindera benzoin is a source of a balsamic resin called benzoin which is up to 1/3 BENZOIC ACID. This should not be confused with the chemical BENZOIN or the plant STYRAX BENZOIDES.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027443"}, {"RECTYPE": "D", "MH": "Ocotea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "bullata, Ocotea", "MN": "B01.875.800.575.912.250.595.400.587", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid63801", "RR": "txid128657", "MS": "A plant genus in the LAURACEAE family. The common name of stinkwood is also used for Zieria (RUTACEAE).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027444"}, {"RECTYPE": "D", "MH": "Beta vulgaris", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Chard|T168|NON|REL|NLM (1998)|961107|abcdef", "ENTRY": "vulgari, Beta", "MN": "B01.875.800.575.912.250.200.399", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid161934", "PI": "Chenopodiaceae (1998-2001)", "MS": "A species of the Beta genus. Cultivars are used as a source of beets (root) or chard (leaves).", "PM": "2002; see CHENOPODIACEAE 1998-2001", "HN": "2002; use CHENOPODIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027461"}, {"RECTYPE": "D", "MH": "Chenopodium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Goosefoot|T002|NON|NRW|NLM (1998)|961206|abcdef", "ENTRY": "Goosefoots", "MN": "B01.875.800.575.912.250.198.500.100.666", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3558", "RR": "txid66214", "MS": "A plant genus in the CHENOPODIACEAE family.", "PM": "2002; for GOOSEFOOT see CHENOPODIACEAE 1998-2001", "HN": "2002; for GOOSEFOOT use CHENOPODIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027462"}, {"RECTYPE": "D", "MH": "Chenopodium album", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lamb's Quarters|T002|NON|EQV|NLM (2002)|010306|abcdef", "ENTRY": "album, Chenopodium", "MN": "B01.875.800.575.912.250.198.500.100.666.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3559", "PI": "Chenopodiaceae (1998-2001)", "MS": "A plant species in the CHENOPODIUM genus known for edible greens.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027463"}, {"RECTYPE": "D", "MH": "Chenopodium ambrosioides", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Wormseed|T002|NON|EQV|NLM (2002)|010306|abcdef", "ENTRY": "ambrosioide, Chenopodium", "MN": "B01.875.800.575.912.250.198.500.100.666.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid330163", "MS": "A plant species of the genus Chenopodium known for toxicity to intestinal worms and other simple organisms.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027464"}, {"RECTYPE": "D", "MH": "Chenopodium quinoa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Quinoa|T168|NON|NRW|NLM (2002)|010306|abcdef", "ENTRY": "quinoa, Chenopodium", "MN": "B01.875.800.575.912.250.198.500.100.666.875", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid63459", "MS": "A species of the Chenopodium genus which is the source of edible seed called quinoa. It contains makisterone A and other STEROIDS, some having ECDYSTEROID activity on insects.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027465"}, {"RECTYPE": "D", "MH": "Atriplex", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Saltbush|T002|NON|EQV|NLM (2002)|010306|abcdef", "ENTRY": "Saltbushs", "MN": "B01.875.800.575.912.250.198.500.100.232", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3550", "MS": "A plant genus in the CHENOPODIACEAE family.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027466"}, {"RECTYPE": "D", "MH": "Bassia scoparia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Summer cypress|T002|NON|EQV|NLM (2002)|010306|abcdef", "ENTRY": "scoparia, Kochia", "MN": "B01.875.800.575.912.250.200.299", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid83154", "AN": "do not confuse entry term BURNINGBUSH (BASSIA) with BURNINGBUSH (EUONYMUS) see EUONYMUS", "MS": "A plant species of the family CHENOPODIACEAE. It is a source of furonaphthoquinones. The common name of burning bush is also used with the unrelated EUONYMUS sieboldianus.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D027467"}, {"RECTYPE": "D", "MH": "Crepis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hawk's Beard|T002|NON|EQV|NLM (2002)|010307|abcdef", "ENTRY": "capillaris, Crepis", "MN": "B01.875.800.575.912.250.100.255", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid13464", "RR": "txid13465", "MS": "A plant genus in the ASTERACEAE family.", "PM": "2002; see ASTERACEAE 1998-2001, see HERBS 1995-1997", "HN": "2002; use ASTERACEAE 1998-2001, use HERBS 1995-1997", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027468"}, {"RECTYPE": "D", "MH": "Araliaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Umbrella Tree|T002|NON|NRW|NLM (2003)|010824|abcdef", "ENTRY": "Umbrella Trees", "MN": "B01.875.800.575.912.250.087", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4050", "RR": "txid46414", "AN": "prefer specific plant", "MS": "The ginseng plant family of the order Apiales, subclass Rosidae, class Magnoliopsida. Leaves are generally alternate, large, and compound. Flowers are five-parted and arranged in compound flat-topped umbels. The fruit is a berry or (rarely) a drupe (a one-seeded fruit). It is well known for plant preparations used as adaptogens (immune support and anti-fatigue).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027481"}, {"RECTYPE": "D", "MH": "Monocarboxylic Acid Transporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pyruvate Transporter|T116|T123|NON|NRW|NLM (1986)|181204|abbcdef", "ENTRY": "Transporters, Monocarboxylic Acid", "MN": "D12.776.543.585.450.074.500.300", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "coordinate with MITOCHONDRIAL PROTEINS if from MITOCHONDRIA", "PI": "Ion Pumps (1994-2001)", "MS": "A family of proteins involved in the transport of monocarboxylic acids such as LACTIC ACID and PYRUVIC ACID across cellular membranes.", "PM": "2020; PYRUVATE TRANSPORT PROTEIN was indexed under MEMBRANE TRANSPORT PROTEINS 2002-2019, and under CARRIER PROTEINS 1986-2001; MONOCARBOXYLIC ACID TRANSPORT PROTEIN was indexed under CARRIER PROTEINS 1997-2001; ERYTHROCYTE LACTATE TRANSPORTER was indexed under CARRIER PROTEINS 1995-2001; LACTATE TRANSLOCASE & LACTATE TRANSPORTER were indexed under CARRIER PROTEINS 1991-2001; MONOCARBOXYLATE TRANSLOCATOR was indexed under CARRIER PROTEINS 1991-2001", "HN": "2020 (2002)", "MR": "20190116", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027501"}, {"RECTYPE": "D", "MH": "Nepeta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Catnip|T002|NON|EQV|NLM (1998)|961107|abcdef", "ENTRY": "cataria, Nepeta", "MN": "B01.875.800.575.912.250.583.520.538", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid39172", "RR": "txid39347", "PI": "Plants (1969-2001)", "MS": "A genus of the LAMIACEAE family. It is known for its mild calming effect and for the way cats are attracted to the aroma.", "PM": "2002; see LAMIACEAE 1998-2001", "HN": "2002; use LAMIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027521"}, {"RECTYPE": "D", "MH": "Marrubium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Horehound, Woolly|T002|NON|NRW|NLM (2003)|010831|abcdef", "ENTRY": "vulgares, Marrubium", "MN": "B01.875.800.575.912.250.583.520.465", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid41229", "RR": "txid41230", "AN": "entry term HOREHOUND: HOREHOUND, BLACK see BALLOTA and HOREHOUND, WATER see LYCOPUS are also available", "PI": "Plants, Medicinal (1966-2001)", "MS": "A plant genus of the LAMIACEAE family that contains marrubiin (a labdane diterpene). It is known as a traditional medicinal for sore throat.", "PM": "2002; see LAMIACEAE 1998-2001", "HN": "2002; use LAMIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027522"}, {"RECTYPE": "D", "MH": "Lavandula", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lavender|T002|NON|EQV|NLM (1998)|961107|abcdef", "ENTRY": "Lavenders", "MN": "B01.875.800.575.912.250.583.520.428", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid39169", "RR": "txid39329", "PI": "Plants, Medicinal (1969-2001)", "MS": "A plant genus of the LAMIACEAE family.", "PM": "2002; see LAMIACEAE 1998-2001", "HN": "2002; use LAMIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027523"}, {"RECTYPE": "D", "MH": "Mentha", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mint|T002|NON|EQV|NLM (1998)|961107|abcdef", "ENTRY": "Mints", "MN": "B01.875.800.575.912.250.583.520.483", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid21819", "PI": "Plants, Medicinal (1968-2001)", "MS": "Mentha is a genus of the mint family (LAMIACEAE). It is known for species having characteristic flavor and aroma.", "PM": "2002; see LAMIACEAE 1998-2001", "HN": "2002; use LAMIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027541"}, {"RECTYPE": "D", "MH": "Rosmarinus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "officinalis, Rosmarinus", "MN": "B01.875.800.575.912.250.583.520.757", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid39177", "RR": "txid39367", "PI": "Plants, Medicinal (1967-2001)", "MS": "A plant genus of the LAMIACEAE family. It is known as a spice and medicinal plant.", "PM": "2002; see LAMIACEAE 1998-2001", "HN": "2002; use LAMIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027542"}, {"RECTYPE": "D", "MH": "Salvia officinalis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "officinalis, Salvia", "MN": "B01.875.800.575.912.250.583.520.922.770", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid38868", "PI": "Plants, Medicinal (1966-2001)", "MS": "A plant species of the Salvia genus known as a spice and medicinal plant.", "PM": "2002; see LAMIACEAE 1998-2001", "HN": "2002; use LAMIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027543"}, {"RECTYPE": "D", "MH": "Salvia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Salvias", "MN": "B01.875.800.575.912.250.583.520.922", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid21880", "PI": "Plants, Medicinal (1966-2001)", "MS": "A genus in the mint family (LAMIACEAE).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027544"}, {"RECTYPE": "D", "MH": "Salvia miltiorrhiza", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Danshen|T002|NON|EQV|NLM (2002)|010307|abcdef", "ENTRY": "Salvias, Chinese", "MN": "B01.875.800.575.912.250.583.520.922.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid226208", "PI": "Plants, Medicinal (1977-2001)", "MS": "A plant species which is known as an Oriental traditional medicinal plant.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D027561"}, {"RECTYPE": "D", "MH": "Cannabaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.937.055", "MH_TH": "NLM (1999)", "ST": "T002", "RN": "txid3481", "PI": "Cannabis (1978-2001)", "MS": "A plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. It is most notable for the members, Cannabis and Hops.", "PM": "2002; see Cannabis 1999-2001", "HN": "2002; use Cannabis 1999-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027581"}, {"RECTYPE": "D", "MH": "Humulus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hops|T002|NON|EQV|NLM (2002)|010308|abcdef", "ENTRY": "Humulus lupulus|T002|NON|NRW|NLM (2016)|150325|abcdef", "MN": "B01.875.800.575.912.250.859.937.055.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3484", "RR": "txid3486", "PI": "Plants, Medicinal (1974-2001)", "MS": "A plant genus in the CANNABACEAE family. Best known for the buds of Humulus lupulus L. used in BEER.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027582"}, {"RECTYPE": "D", "MH": "Polyomavirus Infections", "DE": "POLYOMAVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Polyomavirus Infection", "MN": "C01.925.256.721", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "DNA Virus Infections (1992-2001)", "MS": "Infections with POLYOMAVIRUS, which are often cultured from the urine of kidney transplant patients. Excretion of BK VIRUS is associated with ureteral strictures and CYSTITIS, and that of JC VIRUS with progressive multifocal leukoencephalopathy (LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL).", "PM": "2002", "HN": "2002", "MR": "20190617", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027601"}, {"RECTYPE": "D", "MH": "Serum Response Element", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Response Element, Serum|T114|T123|NON|EQV|NLM (2002)|010309|abbcdef", "ENTRY": "Elements, Serum Response", "MN": "G05.360.340.024.340.137.750.680.765.800", "MH_TH": "NLM (2002)", "ST": "T123", "PI": "Serum Response Factor (1988-2001)", "MS": "A DNA sequence that is found in the promoter region of many growth-related genes. The regulatory transcription factor SERUM RESPONSE FACTOR binds to and regulates the activity of genes containing this element.", "PM": "2002; SERUM RESPONSE ELEMENT was indexed under DNA-BINDING PROTEINS and NUCLEAR PROTEINS 1988-2001", "HN": "2002; use SERUM RESPONSE FACTOR (NM) 1988-2001", "MR": "20080708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027602"}, {"RECTYPE": "D", "MH": "Iridaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Moraea|T002|NON|NRW|NLM (2003)|020326|abcdef", "MN": "B01.875.800.575.912.250.618.100.400", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid26339", "RR": "txid58963", "MS": "A plant family of the Asparagales order. Comprised of perennial herbs with BULBS, corms, or RHIZOMES and grass-like leaves with bisexual flowers that have 2 whorls of petaloid tepals which are usually showy.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027621"}, {"RECTYPE": "D", "MH": "Crocus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Saffron Crocus|T002|NON|NRW|NLM (2002)|010412|abcdef", "ENTRY": "Saffrons", "MN": "B01.875.800.575.912.250.618.100.400.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid58949", "RR": "txid82528", "PI": "Plants (1969-2001)", "MS": "A plant genus, in the IRIDACEAE family, known as a source of Saffron.", "PM": "2002; for SAFFRON see Liliaceae 1998-2001", "HN": "2002; for SAFFRON use Liliaceae 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027622"}, {"RECTYPE": "D", "MH": "Yucca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Yuccas", "MN": "B01.875.800.575.912.250.618.100.060.980", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid39550", "RR": "txid55960", "PI": "Plants (1965-2001)", "MS": "A genus (and common name) in the Asparagaceae family. It is known for SAPONINS in the root that are used in SOAPS.", "PM": "2002; see Liliaceae 1998-2001", "HN": "2002; use Liliaceae 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027623"}, {"RECTYPE": "D", "MH": "Laughter Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Yoga, Laughter", "MN": "E02.190.525.311", "FX": "Wit and Humor as Topic", "MH_TH": "NLM (2002)", "ST": "T061", "PI": "Wit and Humor (1963-2001)", "MS": "Therapeutic use of humor and laughter to improve emotional well being and health.", "PM": "2002", "HN": "2002", "MR": "20190705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027641"}, {"RECTYPE": "D", "MH": "Eclecticism, Historical", "AQ": "CL ED ES HI PX SN TD", "ENTRY": "Historical Eclecticism", "MN": "E02.190.755.624", "MH_TH": "NLM (2002)", "ST": "T078", "MS": "A system of medicine, most popular in the 19th century, that advocates the use of indigenous plants in the treatment of specific signs and symptoms.", "PM": "2002", "HN": "2002", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027681"}, {"RECTYPE": "D", "MH": "Cation Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cation Pumps|T116|T123|NON|NRW|NLM (1994)|930211|abbcdef", "ENTRY": "Pumps, Cation", "MN": "D12.776.543.585.450.250", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Ion Pumps (1992-2001)", "MS": "Membrane proteins whose primary function is to facilitate the transport of positively charged molecules (cations) across a biological membrane.", "PM": "2002; for CATION PUMPS & CATION PUMP see ION PUMPS 1992-2001", "HN": "2002; for CATION PUMPS & CATION PUMP use ION PUMPS 1992-2001", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027682"}, {"RECTYPE": "D", "MH": "Organic Cation Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Membrane Transport-Proteins, Organic Cation|T116|T123|NON|EQV|NLM (2002)|010314|MEMBRANE TRANSPORT PROTEINS CATION ORGANIC|abbcdefs", "MN": "D12.776.543.585.937.701", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Ion Pumps (1992-2001)", "MS": "A family of proteins involved in the transport of organic cations. They play an important role in the elimination of a variety of endogenous substances, xenobiotics, and their metabolites from the body.", "PM": "2002", "HN": "2002", "MR": "20170524", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027701"}, {"RECTYPE": "D", "MH": "Organic Cation Transporter 1", "DS": "ORGANIC CATION TRANSPORTER 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, SLC22A1", "MN": "D12.776.543.585.937.701.500", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1995-2001)", "MS": "An organic cation transporter found in kidney. It is localized to the basal lateral membrane and is likely to be involved in the renal secretion of organic cations.", "PM": "2002; OCT1 PROTEIN now ORGANIC CATION TRANSPORTER 1 was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 1995-2001", "HN": "2002; use ORGANIC CATION TRANSPORTER 1 (NM) 1995-2001", "MR": "20170524", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027702"}, {"RECTYPE": "D", "MH": "Amaranthaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Pfaffias", "MN": "B01.875.800.575.912.250.198.500.100", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3563", "RR": "txid240008", "AN": "general or unspecified; prefer specifics", "MS": "A family of flowering plants in the order Caryophyllales, with about 60 genera and more than 800 species of plants, with a few shrubs, trees, and vines. The leaves usually have nonindented edges.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027703"}, {"RECTYPE": "D", "MH": "Amaranthus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Amaranth Plant|T002|NON|EQV|NLM (2002)|010314|abcdef", "ENTRY": "Redroot Pigweeds", "MN": "B01.875.800.575.912.250.198.500.100.130", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3564", "RR": "txid124763", "AN": "entry term REDROOT PIGWEED: REDROOT see SANGUINARIA is also available; AMARANTH DYE is also available", "PI": "Phytotherapy (1981-2001)", "MS": "A plant genus, in the family AMARANTHACEAE, best known as a source of high-protein grain crops and of Red Dye No. 2 (AMARANTH DYE). Tumbleweed sometimes refers to Amaranthus but more often refers to SALSOLA.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027721"}, {"RECTYPE": "D", "MH": "Convolvulaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Turbina|T002|NON|NRW|NLM (2003)|010829|abcdef", "ENTRY": "Turbinas", "MN": "B01.875.800.575.912.250.238", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4118", "RR": "txid89667", "MS": "The morning glory family of flowering plants, of the order Solanales, which includes about 50 genera and at least 1,400 species. Leaves are alternate and flowers are funnel-shaped. Most are twining and erect herbs, with a few woody vines, trees, and shrubs.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027722"}, {"RECTYPE": "D", "MH": "Ipomoea batatas", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yam, Pseudo|T168|NON|REL|NLM (2002)|010314|abcdef", "ENTRY": "batatas, Ipomoea", "MN": "B01.875.800.575.912.250.238.500.500", "FX": "Dioscorea", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid4120", "PI": "Solanaceae (1998-2001)", "MS": "A plant species of the genus IPOMOEA, family CONVOLVULACEAE. Some cultivars are sweet and edible whereas bitter varieties are a source of SAPONINS. This sweet potato is sometimes referred to as a yam (DIOSCOREA).", "PM": "2002; see Solanaceae 1998-2001", "HN": "2002; use Solanaceae 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027723"}, {"RECTYPE": "D", "MH": "Reproductive Techniques, Assisted", "DE": "REPRODUCTIVE TECHNIQUES ASSIST", "AQ": "AE CL EC ES HI IS LJ MO NU PX SN ST TD VE", "PRINT ENTRY": "Reproductive Technology, Assisted|T061|T062|NON|BRD|NLM (2002)|010314|REPRODUCTIVE TECHNOLOGY ASSIST|abbcdefv", "ENTRY": "Technology, Assisted Reproductive", "MN": "E05.820.800", "MH_TH": "NLM (2002)", "ST": "T061", "AN": "usually for humans; may be used for animals if specified; otherwise use BREEDING or its specifics; REPRODUCTIVE TECHNIQUES is also available", "PI": "Reproduction Techniques (1989-2001)", "MS": "Clinical and laboratory techniques used to enhance fertility in humans and animals.", "PM": "2002", "HN": "2002", "MR": "20050706", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027724"}, {"RECTYPE": "D", "MH": "Ipomoea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Water Spinach|T002|NON|NRW|NLM (2021)|200227|abcdef", "MN": "B01.875.800.575.912.250.238.500", "FX": "Dioscorea", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4119", "RR": "txid89636", "MS": "A plant genus in the family CONVOLVULACEAE best known for morning glories (a common name also used with CONVOLVULUS) and sweet potato.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027741"}, {"RECTYPE": "D", "MH": "Dioscorea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yam|T168|NON|REL|NLM (1998)|961107|abcdef", "ENTRY": "Yaos, Shan", "MN": "B01.875.800.575.912.250.325.500", "FX": "Ipomoea", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4672", "RR": "txid569628", "AN": "do not confuse entry term YAM with PSEUDO-YAM see IPOMOEA BATATAS", "PI": "Liliaceae (1998-2001)", "MS": "A plant genus best known for edible underground tubers. Yam may also refer to a moist variety of sweet potato, IPOMOEA BATATAS.", "PM": "2002; see Liliaceae 1998-2001", "HN": "2002; use Liliaceae 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027742"}, {"RECTYPE": "D", "MH": "Dioscoreaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Taccas", "MN": "B01.875.800.575.912.250.325", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4671", "RR": "txid44981", "MS": "The yam plant family, of the order Liliales, has thick roots or tubers and net-veined, heart-shaped leaves that sometimes are lobed.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027743"}, {"RECTYPE": "D", "MH": "Tamus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bryony, Black|T002|NON|EQV|NLM (2002)|010522|abcdef", "ENTRY": "communis, Tamus", "MN": "B01.875.800.575.912.250.325.750", "MH_TH": "NLM (2002)", "ST": "T002", "RR": "txid55634", "PI": "Plants, Medicinal (1968-2001)", "MS": "A plant genus of the DIOSCOREACEAE plant family.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027744"}, {"RECTYPE": "D", "MH": "Asparagus Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Asparagus", "MN": "B01.875.800.575.912.250.618.100.060.063", "MH_TH": "NLM (1998)", "ST": "T002", "RR": "txid4686", "PI": "Liliaceae (1998-2001)", "MS": "A plant genus in the family Asparagaceae that contains ECDYSTEROIDS and is an ingredient of Siotone. The shoots are used as a vegetable and the roots are used in FOLK MEDICINE.", "PM": "2002; see Liliaceae 1998-2001", "HN": "2002; use Liliaceae 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027761"}, {"RECTYPE": "D", "MH": "Lilium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lily|T002|NON|EQV|NLM (1998)|961107|abcdef", "ENTRY": "Liliums", "MN": "B01.875.800.575.912.250.618.875.500.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4688", "PI": "Liliaceae (1998-2001)", "MS": "A plant genus in the family LILIACEAE generally growing in temperate areas. The word lily is also used in the common names of many plants of other genera that resemble true lilies. True lilies are erect perennial plants with leafy stems, scaly bulbs, usually narrow leaves, and solitary or clustered flowers.", "PM": "2002; see Liliaceae 1998-2001", "HN": "2002; use Liliaceae 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027762"}, {"RECTYPE": "D", "MH": "Shallots", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Allium ascalonicum|T002|NON|REL|NLM (1998)|961106|abcdef", "ENTRY": "Shallot|T002|T168|NON|EQV|NLM (2002)|010412|abbcdef", "MN": "B01.875.800.575.912.250.618.100.050.060.800", "MH_TH": "NLM (1998)", "ST": "T168", "RN": "txid28911", "RR": "txid1476995", "PI": "Allium (1998-2001)", "MS": "Mildly aromatic herb in the Allium genus used in SPICES.", "PM": "2002; see Allium 1998-2001", "HN": "2002; use Allium 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027781"}, {"RECTYPE": "D", "MH": "Chive", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Allium schoenoprasum|T168|NON|EQV|NLM (2002)|010314|abcdef", "ENTRY": "Chives, Chinese", "MN": "B01.875.800.575.912.250.618.100.050.060.149", "MH_TH": "NLM (1998)", "ST": "T168", "RN": "txid74900", "RR": "txid4683", "PI": "Allium (1998-2001)", "MS": "A plant in the genus ALLIUM, similar to ONIONS.", "PM": "2002; see Allium 1998-2001", "HN": "2002; use Allium 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027782"}, {"RECTYPE": "D", "MH": "Galanthus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Snowdrops|T002|NON|NRW|NLM (2002)|010314|abcdef", "ENTRY": "Snowdrop", "MN": "B01.875.800.575.912.250.618.100.050.295", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4669", "RR": "txid4670", "PI": "Plants, Medicinal (1965-2001)", "MS": "A plant genus in the family  Amaryllidaceae. Galanthus nivalis L. is the source of GALANTHAMINE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027801"}, {"RECTYPE": "D", "MH": "Hypoxis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Hypoxis rooperi|T002|NON|NRW|NLM (2002)|010314|abcdef", "MN": "B01.875.800.575.912.250.618.100.230.395", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid16123", "PI": "Plants, Medicinal (1978-2001)", "MS": "Hypoxis is a plant genus in the family Hypoxidaceae (sometimes classified as LILIACEAE).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027802"}, {"RECTYPE": "D", "MH": "Phaseolus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tepary Bean|T168|NON|REL|NLM (2002)|010314|abcdef", "ENTRY": "vulgaris, Phaseolus", "MN": "B01.875.800.575.912.250.401.649", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid3883", "RR": "txid3885", "PI": "Fabaceae (1978-2001)", "MS": "A plant genus in the family FABACEAE which is the source of edible beans and the lectin PHYTOHEMAGGLUTININS.", "PM": "2002; see LEGUMES 1978-2001", "HN": "2002; use FABACEAE 1978-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027805"}, {"RECTYPE": "D", "MH": "Lens Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lentils|T168|NON|REL|UNK (19XX)|770426|abcdef", "ENTRY": "culinari, Lens", "MN": "B01.875.800.575.912.250.401.450", "MH_TH": "NLM (2005)", "ST": "T002", "RN": "txid3863", "RR": "txid3864", "PI": "Fabaceae (1978-2001)", "MS": "A plant genus of the FABACEAE family known for the seeds used as food.", "PM": "2005; see LENTILS 2001-2004; see FABACEAE 1978-2001", "HN": "2005(2002); use FABACEAE 1978-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027806"}, {"RECTYPE": "D", "MH": "Lathyrus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.401.375", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid3853", "PI": "Fabaceae (1978-2001)", "MS": "A plant genus in the family FABACEAE known for LATHYRISM poisoning.", "PM": "2002; see FABACEAE 1986-2001", "HN": "2002; use FABACEAE 1986-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027807"}, {"RECTYPE": "D", "MH": "Rutaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Zieria|T002|NON|NRW|NLM (2003)|011203|abcdef", "ENTRY": "Zierias", "MN": "B01.875.800.575.912.250.875", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid23513", "RR": "txid77014", "AN": "unspecified FAGARA goes here: note FAGARA HORRIDA see GLEDITSIA and FAGARA BONINENSIS, FAGARA RHETZA, FAGARA XANTHOXYLOIDES and FAGARA ZANTHOXYLOIDES see ZANTHOXYLUM are also available", "PI": "Plants, Medicinal (1966-2001)", "MS": "A plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027821"}, {"RECTYPE": "D", "MH": "Myrtaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Mirtaceae|T002|NON|EQV|NLM (2004)|030417|abcdef", "MN": "B01.875.800.575.912.250.773", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3931", "PI": "Plants, Medicinal (1968-2001)", "MS": "The myrtle plant family of the order Myrtales. It includes several aromatic medicinal plants such as EUCALYPTUS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027822"}, {"RECTYPE": "D", "MH": "Rhamnaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ventilago|T002|NON|NRW|NLM (2003)|020327|abcdef", "ENTRY": "Alphitonia|T002|NON|NRW|NLM (2003)|020327|abcdef", "MN": "B01.875.800.575.912.250.859.937.437", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3608", "RR": "txid48243", "AN": "prefer specific plant", "PI": "Plants, Medicinal (1968-2001)", "MS": "The buckthorn plant family, of the order Rhamnales, includes some species with edible fruits and some that are medicinal.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027823"}, {"RECTYPE": "D", "MH": "Rosaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Serviceberry|T002|NON|NRW|NLM (2003)|010924|abcdef", "ENTRY": "Serviceberries", "MN": "B01.875.800.575.912.250.859.937.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3745", "RR": "txid48230", "AN": "prefer specific plant", "PI": "Plants, Medicinal (1966-2001)", "MS": "The rose plant family in the order ROSALES and class Magnoliopsida. They are generally woody plants. A number of the species of this family contain cyanogenic compounds.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027824"}, {"RECTYPE": "D", "MH": "Crataegus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hawthorn|T002|NON|NRW|NLM (1999)|980316|abcdef", "ENTRY": "Hawthorns", "MN": "B01.875.800.575.912.250.859.937.500.177", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid23159", "RR": "txid298643", "PI": "Rosales (1988-2001)", "MS": "A genus in the family ROSACEAE of shrubs and small trees native to the North Temperate Zone. It is best known for a traditional medication for the heart.", "PM": "2002; see Rosales 1998-2001; see PLANTS, MEDICINAL 1986-1997; for HAWTHORN see ROSALES 1998-2001", "HN": "2002; use Rosales 1998-2001, use PLANTS, MEDICINAL 1986-1997; for HAWTHORN use ROSALES 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027825"}, {"RECTYPE": "D", "MH": "Rosa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rosehips|T017|NON|NRW|NLM (2002)|010314|abcdef", "ENTRY": "Roses", "MN": "B01.875.800.575.912.250.859.937.500.750", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid3764", "PI": "Rosales (1998-2001)", "MS": "A plant genus in the family ROSACEAE and order Rosales. This should not be confused with the genus RHODIOLA which is sometimes called roseroot.", "PM": "2002; see Rosales 1988-2001, see PLANTS, MEDICINAL 1986-1997", "HN": "2002; use Rosales 1998-2001, use PLANTS, MEDICINAL 1986-1997", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027826"}, {"RECTYPE": "D", "MH": "Pimenta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pimenta pseudocaryophyllus|T002|NON|NRW|NLM (2021)|200203|abcdef", "ENTRY": "Pimentas", "MN": "B01.875.800.575.912.250.773.777", "MH_TH": "NLM (2022)", "ST": "T002", "RN": "txid260138", "RR": "txid375273", "PI": "Rosales (1998-2001)", "MS": "A plant genus in the family MYRTACEAE, order Myrtales, subclass Rosidae. It is best known for allspice from the dried berry of PIMENTA dioica.", "PM": "2021; see Pimenta 2002-2020, Rosales 1998-2001, SPICES 1993-1997", "HN": "2021; use Pimenta 2002-2020, Rosales 1998-2001, SPICES 1993-1997", "MR": "20210712", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027841"}, {"RECTYPE": "D", "MH": "Syzygium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Clove|T168|NON|NRW|NLM (1993)|970206|abcdef", "ENTRY": "Trees, Java Plum", "MN": "B01.875.800.575.912.250.773.900", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid178174", "RR": "txid334497", "PI": "Rosales (1998-2001)", "MS": "A plant genus in the family Myrtaceae. It is known for cloves, which is the flower bud of Syzygium aromaticum and is the source of an oil rich in EUGENOL.", "PM": "2016; see EUGENIA 2005-2015, see CLOVE 2002-2004; for CLOVE see ROSALES 1988-2001, for CLOVE see SPICES 1993-1997", "HN": "2016 (2002); for CLOVE use ROSALES 1988-2001, for CLOVE use SPICES 1993-1997", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027842"}, {"RECTYPE": "D", "MH": "Vitis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Raisins|T168|NON|REL|NLM (2002)|010524|abcdef", "ENTRY": "Raisin", "MN": "B01.875.800.575.912.250.965.500", "FX": "Wine", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3603", "RR": "txid29760", "PI": "Rosales (1998-2001)", "MS": "A plant genus in the family Vitaceae. It is a woody vine cultivated worldwide. It is best known for grapes, the edible fruit and used to make WINE and raisins.", "PM": "2002; for GRAPES see Rosales 1988-2001, see FRUIT 1983-1997, see GRAPES 1963-1982", "HN": "2002; for GRAPES use Rosales 1998-2001, use FRUIT 1983-1997, use GRAPES 1963-1982", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027843"}, {"RECTYPE": "D", "MH": "Vitaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.965", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3602", "AN": "prefer specific plant", "PI": "Plants, Medicinal (1966-2001)", "MS": "A plant family of the order Rhamnales, subclass Rosidae, class Magnoliopsida, best known for the VITIS genus, the source of grapes.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027844"}, {"RECTYPE": "D", "MH": "Malus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Apple|T168|NON|REL|NLM (1983)|970206|abcdef", "ENTRY": "Trees, Apple", "MN": "B01.875.800.575.912.250.859.937.500.444", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3749", "RR": "txid3750", "PI": "Rosales (1998-2001)", "MS": "A plant genus in the family ROSACEAE, order Rosales, subclass Rosidae. It is best known as a source of the edible fruit (apple) and is cultivated in temperate climates worldwide.", "PM": "2002; for APPLE see Rosales 1988-2001, see FRUIT 1963-1997", "HN": "2002; for APPLE use Rosales 1998-2001, use FRUIT 1963-1997", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027845"}, {"RECTYPE": "D", "MH": "Prunus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Chokecherry Tree|T002|NON|NRW|NLM (2002)|010315|abcdef", "ENTRY": "Trees, Chokecherry", "MN": "B01.875.800.575.912.250.859.937.500.625", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3754", "RR": "txid133204", "PI": "Rosales (1998-2001)", "MS": "A plant genus in the family ROSACEAE, order Rosales, subclass Rosidae. It is best known as a source of edible fruits such as apricot, plum, peach, cherry, and almond.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027861"}, {"RECTYPE": "D", "MH": "Agave", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Maguey|T002|NON|NRW|NLM (2003)|010823|abcdef", "ENTRY": "Plants, Century", "MN": "B01.875.800.575.912.250.618.100.060.032", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid39509", "RR": "txid39510", "AN": "entry term CENTURY PLANT: CENTAURIUM is also available", "PI": "Plants, Medicinal (1966-2001)", "MS": "A genus known for fibers obtained from their leaves: sisal from A. sisalana, henequen from A. fourcroyoides and A. cantala, or Manila-Maguey fiber from A. cantala. Some species provide a sap that is fermented to an intoxicating drink, called pulque in Mexico. Some contain agavesides.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D027882"}, {"RECTYPE": "D", "MH": "Astragalus Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Milk Vetch|T002|NON|NRW|NLM (2002)|010315|MILKVETCH|abcdefv", "ENTRY": "Wooly Locoweeds", "MN": "B01.875.800.575.912.250.401.087", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid20400", "MS": "A plant genus in the family FABACEAE, subfamily Papilionaceae, order Fabales, subclass Rosidae. Many of the species are associated with poisoning of grazing animals. Some of the species are used medicinally.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027883"}, {"RECTYPE": "D", "MH": "Astragalus gummifer", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "gummifers, Astragalus", "MN": "B01.875.800.575.912.250.401.087.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid339493", "MS": "Astragalus gummifer Labill. is the source of gum TRAGACANTH.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027884"}, {"RECTYPE": "D", "MH": "Astragalus propinquus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Astragalus membranaceus|T002|NON|REL|NLM (2002)|010315|abcdef", "ENTRY": "Astragalus mongholicus|T002|NON|REL|NLM (2019)|180206|abcdef", "MN": "B01.875.800.575.912.250.401.087.750", "MH_TH": "NLM (2019)", "ST": "T002", "RN": "txid158324", "RR": "txid649199", "PI": "Plants, Medicinal (1979-2001)", "MS": "A plant species of the Astragalus genus which is source of Huang qi preparation used in TRADITIONAL CHINESE MEDICINE.", "PM": "2019; see ASTRAGALUS MEMBRANACEUS 2002-2018", "HN": "2019(2002)", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027885"}, {"RECTYPE": "D", "MH": "Acanthaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thunbergia|T002|NON|NRW|NLM (2003)|010823|abcdef", "ENTRY": "Hygrophila|T002|NON|NRW|NLM (2004)|030417|abcdef", "MN": "B01.875.800.575.912.250.583.040", "FX": "Petunia", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4185", "RR": "txid23945", "MS": "A plant family of the order Lamiales. It is characterized by simple leaves in opposite pairs, cystoliths (enlarged cells containing crystals of calcium carbonate), and bilaterally symmetrical and bisexual flowers that are usually crowded together. The common name for Ruellia of wild petunia is easily confused with PETUNIA.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D027901"}, {"RECTYPE": "D", "MH": "Justicia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Malabar-nut|T002|NON|NRW|NLM (2002)|010315|abcdef", "ENTRY": "Malabar-nuts", "MN": "B01.875.800.575.912.250.583.040.650", "MH_TH": "NLM (2016)", "ST": "T002", "RN": "txid4190", "RR": "txid141317", "PI": "Plants, Medicinal (1968-2001)", "MS": "A plant genus in the family ACANTHACEAE. Adhatoda vasica Nees is a source of vasicine.", "PM": "2016; see ADHATODA (2002-2015)", "HN": "2016 (2002)", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027902"}, {"RECTYPE": "D", "MH": "Caprifoliaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.328.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4200", "MS": "A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027922"}, {"RECTYPE": "D", "MH": "Sambucus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Elderberry|T002|NON|NRW|NLM (2002)|010412|abcdef", "ENTRY": "Plants, Elder", "MN": "B01.875.800.575.912.250.328.500.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4201", "RR": "txid57008", "PI": "Plants, Medicinal (1968-2001)", "MS": "A plant genus in the family CAPRIFOLIACEAE known for elderberries.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027923"}, {"RECTYPE": "D", "MH": "Sambucus nigra", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Elder, European|T002|NON|EQV|NLM (2002)|010412|abcdef", "ENTRY": "European Elders", "MN": "B01.875.800.575.912.250.328.500.500.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4202", "PI": "Protein Synthesis Inhibitors (1999-2001)", "MS": "A plant species in the genus SAMBUCUS, known for the elderberry fruit. The plant is also a source of Sambucus nigra lectins and ribosome-inactivating protein.", "PM": "2002; SAMBUCUS NIGRA was indexed under SAMBUCUS RIBOSOME-INACTIVATING PROTEIN (NM) 1999-2001", "HN": "2002; use SAMBUCUS RIBOSOME-INACTIVATING PROTEIN (NM) 1999-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027924"}, {"RECTYPE": "D", "MH": "Viburnum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Highbush Cranberry|T002|NON|EQV|NLM (2002)|010315|abcdef", "ENTRY": "Viburnums", "MN": "B01.875.800.575.912.250.328.500.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4204", "PI": "Plants (1966-2001)", "MS": "A plant genus in the family CAPRIFOLIACEAE. The common name derives from its traditional use for menstrual cramps. It is a source of viburnine, valerianic acid, vibsanin, and ursolic acid. Note that true cranberry is VACCINIUM MACROCARPON.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027925"}, {"RECTYPE": "D", "MH": "Anacardiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Spondias|T002|NON|NRW|NLM (2003)|010823|abcdef", "ENTRY": "Spondia", "MN": "B01.875.800.575.912.250.044", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4011", "RR": "txid43860", "AN": "prefer specific plant", "MS": "The sumac plant family in the order Sapindales, subclass Rosidae, class Magnoliopsida. They are tropical and subtropical trees, shrubs, and woody vines that have resin ducts in the bark. The sap of many of the species is irritating to the skin.", "PM": "2002", "HN": "2002", "MR": "20220413", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027926"}, {"RECTYPE": "D", "MH": "Pistacia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pistachio|T002|T168|NON|REL|NLM (2002)|010315|abbcdef", "ENTRY": "Trees, Pistachio Nut", "MN": "B01.875.800.575.912.250.044.555", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid55512", "RR": "txid55513", "PI": "Nuts (1972-2001)", "MS": "A plant genus in the ANACARDIACEAE family known for species that produce pistachio nuts (Pistacia vera) and GUM MASTIC (Pistacia lentiscus). Several of the species have the common name Pistachio.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027927"}, {"RECTYPE": "D", "MH": "Potassium-Hydrogen Antiporters", "AQ": "AD AE AG AI BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Potassium Hydrogen Exchanger", "MN": "D12.776.543.585.450.162.276", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1982-1993)", "MS": "Membrane proteins that allow the exchange of hydrogen ions for potassium ions across the cellular membrane. The action of these antiporters influences intracellular pH and potassium ion homeostasis.", "PM": "2002; POTASSIUM-HYDROGEN ANTIPORTER (now POTASSIUM-HYDROGEN ANTIPORTERS) was indexed under ANTIPORTERS 1994-2001 & under CARRIER PROTEINS (1982-1993)", "HN": "2002; use POTASSIUM-HYDROGEN ANTIPORTERS 1982-2001", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027961"}, {"RECTYPE": "D", "MH": "Chloride-Bicarbonate Antiporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, AE", "MN": "D12.776.543.585.937.776.249", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1984-1993)", "MS": "Electroneutral chloride bicarbonate exchangers that allow the exchange of BICARBONATE IONS exchange for CHLORIDE IONS across the cellular membrane. The action of specific antiporters in this class serve important functions such as allowing the efficient exchange of bicarbonate across red blood cell membranes as they passage through capillaries and the reabsorption of bicarbonate ions by the kidney.", "PM": "2002; CHLORIDE-BICARBONATE EXCHANGER (now CHLORIDE-BICARBONATE ANTIPORTERS) was indexed under ANTIPORTERS 1994-2001 & under CARRIER PROTEINS 1984-1993", "HN": "2002; use CHLORIDE-BICARBONATE ANTIPORTERS (NM) 1984-2001", "MR": "20190524", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027963"}, {"RECTYPE": "D", "MH": "Symporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Symporter|T116|T123|NON|EQV|NLM (2021)|191122|abbcdef", "ENTRY": "Co Transporters", "MN": "D12.776.543.585.450.625", "FX": "Ion Transport", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1981-2001)", "MS": "Membrane transporters that co-transport two or more dissimilar molecules in the same direction across a membrane. Usually the transport of one ion or molecule is against its electrochemical gradient and is \"powered\" by the movement of another ion or molecule with its electrochemical gradient.", "PM": "2002", "HN": "2002", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027981"}, {"RECTYPE": "D", "MH": "Sodium-Bicarbonate Symporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SLC4A5 Protein|T116|T123|ABX|NRW|NLM (2014)|130404|abbcdef", "ENTRY": "k NBC3 Protein", "MN": "D12.776.543.585.937.776.500", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1986-2001)", "MS": "Proteins that cotransport sodium ions and bicarbonate ions across cellular membranes.", "PM": "2002; SODIUM BICARBONATE SYMPORT (now SODIUM-BICARBONATE SYMPORTERS) was indexed under CARRIER PROTEINS 1986-2001", "HN": "2002; use SODIUM-BICARBONATE SYMPORTERS (NM) 1986-2001", "MR": "20190524", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027982"}, {"RECTYPE": "D", "MH": "Aralia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Spikenard|T002|NON|EQV|NLM (2002)|010319|abcdef", "ENTRY": "hispidas, Aralia", "MN": "B01.875.800.575.912.250.087.249", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13340", "RR": "txid51236", "AN": "note entry term BRISTLY SARSAPARILLA: SARSAPARILLA see SMILAX and SARSAPARILLA, EAST INDIAN see HEMIDESMUS are also available", "MS": "A plant genus in the family Araliaceae.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D027983"}, {"RECTYPE": "D", "MH": "Eleutherococcus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Siberian Ginseng|T002|NON|NRW|NLM (2002)|010319|abcdef", "ENTRY": "Siberian Ginsengs", "MN": "B01.875.800.575.912.250.087.374", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid50304", "RR": "txid82096", "AN": "note entry term SIBERIAN GINSENG: do not confuse with GINSENG see PANAX", "PI": "Plant Extracts (1987-2001)", "MS": "A plant genus in the family ARALIACEAE, order Apiales, subclass Rosidae. It is best known as an adaptogen and a substitute for PANAX GINSENG.", "PM": "2002; ELEUTHEROCOCC (now ELEUTHEROCOCCUS) was indexed under PLANT EXTRACTS 1987-2001", "HN": "2002; use ELEUTHEROCOCC (NM) 1987-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028001"}, {"RECTYPE": "D", "MH": "Oplopanax", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ginseng, Alaskan|T002|NON|NRW|NLM (2002)|010412|abcdef", "ENTRY": "Oplopanaxs", "MN": "B01.875.800.575.912.250.087.450", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid133947", "RR": "txid182917", "PI": "Plants, Medicinal (1983-2001)", "MS": "A plant genus in the family ARALIACEAE, order Apiales, subclass Rosidae. It is the source of cirensenosides (triterpenoid saponins).", "PM": "2002; for ECHINOPANAX see GINSENG 1984-2001", "HN": "2002; for ECHINOPANAX use GINSENG 1984-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028002"}, {"RECTYPE": "D", "MH": "Sodium-Potassium-Chloride Symporters", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sodium-Potassium-Chloride Cotransporters|T116|T123|NON|EQV|NLM (2002)|010319|abbcdef", "ENTRY": "Symporter, NaK2Cl", "MN": "D12.776.543.585.937.875", "EC": "antagonists & inhibitors:Sodium Potassium Chloride Symporter Inhibitors", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1984-2001)", "MS": "A subclass of symporters that specifically transport SODIUM; POTASSIUM and CHLORIDE ions across cellular membranes in a tightly coupled electroneutrality process.", "PM": "2002; SODIUM, POTASSIUM, CHLORIDE-COTRANSPORTER was indexed under CARRIER PROTEINS 1984-2001", "HN": "2002; use SODIUM-POTASSIUM-CHLORIDE COTRANSPORTERS 1984-2001", "MR": "20230405", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028021"}, {"RECTYPE": "D", "MH": "Low-Level Light Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Photobiomodulation|T061|NON|EQV|NLM (2024)|221027|abcdef", "ENTRY": "Therapy, Photobiomodulation", "MN": "E02.774.500", "MH_TH": "NLM (2016)", "ST": "T061", "AN": "coordinate IM with disease /radiother (IM) + specific type of laser /ther use (IM) if pertinent", "PI": "specific disease/radiotherapy (1985-2001)", "MS": "Treatment using irradiation with light of low power intensity so that the effects are a response to the light and not due to heat. A variety of light sources, especially low-power lasers are used.", "PM": "2002", "HN": "2002", "MR": "20230609", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028022"}, {"RECTYPE": "D", "MH": "Arecaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pijiguao|T002|NON|NRW|NLM (2003)|010824|abcdef", "ENTRY": "Pijiguaos", "MN": "B01.875.800.575.912.250.093", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4710", "RR": "txid93296", "AN": "prefer specific plant", "MS": "The palm family of order Arecales, subclass Arecidae, class Liliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028023"}, {"RECTYPE": "D", "MH": "Serenoa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sabal|T002|NON|EQV|NLM (2002)|010319|abcdef", "ENTRY": "serrulatas, Sabal", "MN": "B01.875.800.575.912.250.093.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4721", "RR": "txid4722", "PI": "Plants, Medicinal (1969-2001)", "MS": "A plant genus in the family ARECACEAE, order Arecales, subclass Arecidae. The fruit or the extract (Permixon) is used for PROSTATIC HYPERPLASIA.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028024"}, {"RECTYPE": "D", "MH": "Centella", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mandukaparni|T002|NON|NRW|NLM (2003)|020103|abcdef", "ENTRY": "kola, Gotu", "MN": "B01.875.800.575.912.250.075.180", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid43068", "RR": "txid48106", "AN": "for Cola or Kola see COLA; BITTER KOLA see GARCINIA KOLA is also available", "PI": "Plants, Medicinal (1967-2001)", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028041"}, {"RECTYPE": "D", "MH": "Pimpinella", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pimpinella anisum|T168|NON|NRW|NLM (2002)|010320|abcdef", "ENTRY": "anisums, Pimpinella", "MN": "B01.875.800.575.912.250.075.798", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid40958", "RR": "txid40880", "AN": "distinguish from Star Anise (ILLICIUM)", "PI": "Anise (2001-2002)", "MS": "A plant genus in the family APIACEAE (Umbelliferae) that is used in SPICES and is a source of anethole.", "PM": "2003; see ANISE 2001-2002, see APIACEAE 1988-2001", "HN": "2003; use APIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028042"}, {"RECTYPE": "D", "MH": "Phosphate-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphate Binding Protein|T116|T123|NON|EQV|NLM (2022)|201022|abbcdef", "ENTRY": "Protein, Phosphate Binding", "MN": "D12.776.157.648", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "do not confuse with PHOSPHATE TRANSPORT PROTEINS", "PI": "Carrier Proteins (1980-2001)", "MS": "Proteins that bind to and are involved in the metabolism of phosphate ions.", "PM": "2002; PHOSPHATE-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-2001", "HN": "2002; use PHOSPHATE-BINDING PROTEINS (NM) 1980-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028044"}, {"RECTYPE": "D", "MH": "Phosphate Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporters, Phosphate", "MN": "D12.776.543.585.450.074.750", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "do not confuse with PHOSPHATE-BINDING PROTEINS", "PI": "Carrier Proteins (1991-2001)", "MS": "Membrane proteins that are involved in the active transport of phosphate.", "PM": "2002; PHOSPHATE TRANSPORT PROTEINS & PHOSPHATE TRANSPORTER were indexed under CARRIER PROTEINS 1991-2001; INORGANIC PHOSPHATE TRANSPORTER was indexed under CARRIER PROTEINS 1999-2001", "HN": "2002; for PHOSPHATE TRANSPORT PROTEINS & PHOSPHATE TRANSPORTER use PHOSPHATE BINDING PROTEINS (NM) 1991-2001; for INORGANIC PHOSPHATE TRANSPORTER use PHOSPHATE BINDING PROTEINS (NM) 1999-2001", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028061"}, {"RECTYPE": "D", "MH": "Proton-Phosphate Symporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Symporters, Proton-Phosphate", "MN": "D12.776.543.585.450.625.249", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1991-2001)", "MS": "Proteins that cotransport hydrogen ions and phosphate ions across cellular membranes.", "PM": "2002; H+-PI SYMPORTER was indexed under CARRIER PROTEINS 1991-2001; PROTON-PHOSPHATE SYMPORTER was indexed under CARRIER PROTEINS 1991-2001", "HN": "2002; for H+-PI SYMPORTER use PHOSPHATE-BINDING PROTEINS 1991-2001; for PROTON-PHOSPHATE SYMPORTER use PHOSPHATE-BINDING PROTEINS 1991-2001", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028081"}, {"RECTYPE": "D", "MH": "Boraginaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tournefortia|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Tournefortias", "MN": "B01.875.800.575.912.250.150", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid21571", "RR": "txid89629", "MS": "The Borage plant family is in the class Magnoliopsida, subclass Asteridae, order Lamiales. It is characterized by hairy foliage, usually alternate and simple; flowers are funnel-shaped or tubular. Some of the species contain PYRROLIZIDINE ALKALOIDS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028082"}, {"RECTYPE": "D", "MH": "Scrophulariaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.583.800", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4149", "MS": "The figwort plant family of the order Lamiales. The family is characterized by bisexual flowers with tubular corollas (fused petals) that are bilaterally symmetrical (two-lips) and have four stamens in most, two of which are usually shorter.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028083"}, {"RECTYPE": "D", "MH": "Clusiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rheedia|T002|NON|NRW|NLM (2003)|020404|abcdef", "ENTRY": "Waika Plums", "MN": "B01.875.800.575.912.250.859.625", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid55961", "RR": "txid999533", "AN": "prefer specific plant", "PI": "Theales (1999-2001)", "MS": "The mangosteen plant family (sometimes classified as Guttiferae; also known as Hypericaceae) of the order THEALES, subclass Dilleniidae, class Magnoliopsida. It includes trees and shrubs with resinous, sticky sap, usually with broad-ended, oblong, leathery leaves with a strong, central vein, flowers with many stamens.", "PM": "2002; see Theales 1989-2001", "HN": "2002; use Theales 1999-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028084"}, {"RECTYPE": "D", "MH": "Papaveraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.836.500", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid3465", "AN": "prefer specific plant", "PI": "Papaver (1998-2001)", "MS": "The poppy plant family of the order Papaverales, subclass Magnoliidae, class Magnoliopsida. These have bisexual, regular, cup-shaped flowers with one superior pistil and many stamens; 2 or 3 conspicuous, separate sepals and a number of separate petals. The fruit is a capsule. Leaves are usually deeply cut or divided into leaflets.", "PM": "2002; see Papaver 1998-2001", "HN": "2002; use Papaver 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028101"}, {"RECTYPE": "D", "MH": "Canarypox virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Canarypox viruses", "MN": "B04.280.650.160.100.149", "MH_TH": "NLM (1996)", "ST": "T005", "RN": "txid44088", "AN": "infection: coord IM with POXVIRIDAE INFECTIONS (IM)", "PI": "Poxviridae (1991-1993)", "MS": "A species of AVIPOXVIRUS, subfamily CHORDOPOXVIRINAE. Canarypox virus vectors are used in vaccine and immunotherapy research.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028121"}, {"RECTYPE": "D", "MH": "Berberidaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.125", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid41773", "MS": "The Barberry plant family of the order Ranunculales, subclass Magnoliidae, class Magnoliopsida. The shrubs have spiny leaves.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028141"}, {"RECTYPE": "D", "MH": "Berberis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Barberry|T002|NON|EQV|NLM (2003)|011115|abcdef", "ENTRY": "Berberi", "MN": "B01.875.800.575.912.250.125.249", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid22774", "AN": "Entry term BARBERRY: HOLLYLEAVED BARBERRY see MAHONIA is also available; BAYBERRY see MYRICA is also available", "PI": "Plants, Medicinal (1966-2001)", "MS": "A plant genus in the family BERBERIDACEAE. The common names of Barberry or Oregon Grape are also used for MAHONIA. The similar-named Bayberry is the unrelated MYRICA. Oregon Grape was classified by Pursh as a Berberis but Nuttall claimed it is different enough to call it a new genus, MAHONIA. Botanists insist on this name while horticulturists stay with Mahonia. They are shrubs with yellow wood and usually three-branched spines at the base of leafstalks. Flowers are yellow, six-petaled and fruit is a berry with one to several seeds. Members contain BERBERINE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028142"}, {"RECTYPE": "D", "MH": "Mahonia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Barberry, Hollyleaved|T002|NON|NRW|NLM (2003)|010824|abcdef", "ENTRY": "aquifolium, Mahonia", "MN": "B01.875.800.575.912.250.125.374", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid2750454", "RR": "txid203270", "PI": "Plants, Medicinal (1966-2001)", "MS": "A plant genus in the family BERBERIDACEAE. Oregon Grape was discovered in North America and classified by Pursh as a BERBERIS but Nuttall claimed it is different enough to call it a new genus, MAHONIA. Now botanists insist on Berberis while horticulturists stay with this genus. It is a source of BERBERINE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028143"}, {"RECTYPE": "D", "MH": "Podophyllum peltatum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mandrake, American|T002|NON|EQV|UNK (19XX)|850514|abcdef", "ENTRY": "Mayapples", "MN": "B01.875.800.575.912.250.125.500.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid35933", "AN": "do not confuse entry term MANDRAKE, AMERICAN with MANDRAKE, EUROPEAN see MANDRAGORA", "PI": "Podophyllum (1985-2001)", "MS": "A plant of the genus PODOPHYLLUM, family BERBERIDACEAE (sometimes classified as Podophyllaceae) which is the source of PODOPHYLLIN and of PODOPHYLLOTOXIN that inhibits DNA TOPOISOMERASES, TYPE II. It is different from the European mandrake, MANDRAGORA.", "PM": "2002; for MANDRAKE, AMERICAN see Podophyllum 1985-2001", "HN": "2002; for MANDRAKE, AMERICAN use Podophyllum 1985-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028144"}, {"RECTYPE": "D", "MH": "Caulophyllum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cohosh, Blue|T002|NON|NRW|NLM (2002)|010320|abcdef", "ENTRY": "thalictroides, Caulophyllum", "MN": "B01.875.800.575.912.250.125.311", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid46962", "RR": "txid46963", "PI": "Plants, Medicinal (1967-2001)", "MS": "A plant genus of the family BERBERIDACEAE (sometimes classified as Leonticaceae), most notably Caulophyllum thalictroides (L.) Michx.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028145"}, {"RECTYPE": "D", "MH": "Valerianaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Centranthus|T002|NON|NRW|NLM (2003)|011003|abcdef", "MN": "B01.875.800.575.912.250.328.937", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid19944", "RR": "txid42331", "MS": "The Valerian plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida that is characterized by 3-5-lobed tubular flowers, often spurred at the base and clustered in tight heads.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028161"}, {"RECTYPE": "D", "MH": "Heliotropium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Heliotrope, True|T002|NON|EQV|NLM (2002)|010321|abcdef", "ENTRY": "True Heliotropes", "MN": "B01.875.800.575.912.250.150.444", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid21621", "AN": "note entry term HELIOTROPE, TRUE: HELIOTROPE, GARDEN see VALERIAN is also available", "PI": "Valerian (1986-2001)", "MS": "A plant genus in the family Boraginaceae, order Lamiales, subclass Asteridae. This is the True Heliotrope that should not be confused with an unrelated plant sometimes called Garden Heliotrope (VALERIAN).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D028162"}, {"RECTYPE": "D", "MH": "Viscaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Korthalsella|T002|NON|NRW|NLM (2003)|011003|abcdef", "ENTRY": "Korthalsellas", "MN": "B01.875.800.575.912.250.735.888", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid1003255", "RR": "txid35999", "AN": "prefer specific plant", "PI": "Viscum (1965-2001)", "MS": "The Christmas Mistletoe plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. They are parasitic primarily on coniferous trees forming a drooping evergreen bush of leathery leaves on tree branches. The berries are sticky and toxic.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028163"}, {"RECTYPE": "D", "MH": "Viscum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Viscums", "MN": "B01.875.800.575.912.250.884.916", "MH_TH": "NLM (1966)", "ST": "T002", "RN": "txid3971", "AN": "VISCUM LEUCARPUM see PHORADENDRON is also available", "PI": "Mistletoe (1963-2001)", "MS": "A plant genus in the family VISCACEAE, order Santalales, subclass Rosidae, class Magnoliopsida. Species of this genus contain cytotoxic LECTINS. The common name of MISTLETOE is used for many species of this and the LORANTHACEAE families.", "PM": "2002; see MISTLETOE 1963-2001", "HN": "2002; use MISTLETOE 1963-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028181"}, {"RECTYPE": "D", "MH": "Viscum album", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mistletoe, European|T002|EPO|EQV|NLM (2003)|011003|abcdef", "ENTRY": "albums, Viscum", "MN": "B01.875.800.575.912.250.884.916.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3972", "AN": "entry term MISTLETOE, EUROPEAN: several mistletoe terms are available, check text and MeSH; Christmas mistletoe goes here", "PI": "Viscum (1963-2001)", "MS": "A plant species of the family VISCACEAE, order Santalales, subclass Rosidae. This is the traditional mistletoe of literature and Christmas. Members contain viscotoxin (5 kDa basic polypeptides related to thionins), beta-galactoside- and N-acetyl-D-galactosamine-specific lectin II (60 kDa), and polysaccharides. Mistletoe lectin I is a type 2 ribosome-inactivating protein. Commercial extracts include Plenosol, Eurixor, Helixor Isorel, Iscador, and NSC 635089 (ANTINEOPLASTIC AGENTS, PHYTOGENIC).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028182"}, {"RECTYPE": "D", "MH": "Loranthaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Taxillus|T002|NON|NRW|NLM (2003)|011003|abcdef", "ENTRY": "cuneifolia, Ligaria", "MN": "B01.875.800.575.912.250.735.249", "FX": "Phoradendron", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3963", "RR": "txid50164", "AN": "entry term MISTLETOE, ARGENTINE: several mistletoe terms are available, check text and MeSH", "PI": "Mistletoe (1963-2001)", "MS": "The showy mistletoe plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. This includes parasitic tropical plants with haustoria connecting to the hosts. The leaves are opposite and thick. The flowers (4-7) have both calyx and corolla. The fruit is a berry with one seed.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028183"}, {"RECTYPE": "D", "MH": "Phoradendron", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mistletoe, American|T002|EPO|NRW|NLM (2003)|011003|abcdef", "ENTRY": "leucarpums, Viscum", "MN": "B01.875.800.575.912.250.884.333", "FX": "Loranthaceae", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3967", "RR": "txid3970", "AN": "entry term MISTLETOE, AMERICAN: several mistletoe terms are available, check text and MeSH", "PI": "Viscum (1963-2001)", "MS": "A plant genus in the family VISCACEAE, order Santalales, subclass Rosidae. Members contain phoratoxin and oleanane TRITERPENES.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028184"}, {"RECTYPE": "D", "MH": "Pinaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.625.875", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3318", "PI": "Trees (1965-2001)", "MS": "A plant family of the order Pinales, class Pinopsida, division Tracheophyta, known for the various conifers.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028201"}, {"RECTYPE": "D", "MH": "Abies", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fir, Balsam|T002|NON|NRW|NLM (2003)|011203|abcdef", "ENTRY": "balsameas, Abies", "MN": "B01.875.800.575.912.625.875.033", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3319", "RR": "txid90345", "AN": "note entry term: DOUGLAS FIR see PSEUDOTSUGA is also available", "PI": "Trees (1966-2001)", "MS": "A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. Balm of Gilead is a common example.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028202"}, {"RECTYPE": "D", "MH": "Cedrus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cedar Tree|T002|NON|EQV|NLM (2002)|010321|abcdef", "ENTRY": "Trees, Cedar", "MN": "B01.875.800.575.912.625.875.222", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3321", "AN": "note entry term CEDAR TREE; restrict to genus CEDRUS; do not use for other genera referred to as cedar in the literature; check MeSH for other cedar terms", "PI": "Trees (1965-2001)", "MS": "A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. It is the source of cedarwood oil. Cedar ordinarily refers to this but also forms part of the name of plants in other genera.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028203"}, {"RECTYPE": "D", "MH": "Larix", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tamarack|T002|NON|EQV|NLM (2002)|010321|abcdef", "ENTRY": "Tamaracks", "MN": "B01.875.800.575.912.625.875.444", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3325", "PI": "Trees (1965-2001)", "MS": "A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028221"}, {"RECTYPE": "D", "MH": "Picea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Spruce Tree|T002|NON|EQV|NLM (2002)|010321|abcdef", "ENTRY": "Trees, Spruce", "MN": "B01.875.800.575.912.625.875.755", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3328", "PI": "Trees (1965-2001)", "MS": "A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are evergreen, pyramidal trees with whorled branches and thin, scaly bark. Each of the linear, spirally arranged leaves are joined near the stem on a separate woody base.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028222"}, {"RECTYPE": "D", "MH": "Pinus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pine Tree|T002|NON|EQV|NLM (2002)|010321|abcdef", "ENTRY": "Trees, Pine", "MN": "B01.875.800.575.912.625.875.777", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3337", "RR": "txid71647", "PI": "Trees (1965-2001)", "MS": "A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are evergreen trees mainly in temperate climates.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028223"}, {"RECTYPE": "D", "MH": "Pseudotsuga", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fir, Douglas|T002|NON|NRW|NLM (2002)|010321|abcdef", "ENTRY": "Pseudotsugas", "MN": "B01.875.800.575.912.625.875.984", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3356", "RR": "txid3357", "AN": "note entry term: FIR TREE see ABIES is also available", "PI": "Trees (1965-2001)", "MS": "A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are coniferous evergreen trees with long, flat, spirally arranged needles that grow directly from the branch.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028224"}, {"RECTYPE": "D", "MH": "Tsuga", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hemlock Tree|T002|NON|EQV|NLM (2002)|010321|abcdef", "ENTRY": "Tsugas", "MN": "B01.875.800.575.912.625.875.992", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3358", "AN": "distinguish from hemlock plants (CICUTA or CONIUM)", "MS": "A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are coniferous evergreen trees and should not be confused with hemlock plants (CICUTA and CONIUM).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028225"}, {"RECTYPE": "D", "MH": "Amyloidosis, Familial", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Amyloidosis, Hereditary|T047|NON|EQV|NLM (2002)|ORD (2010)|010321|abcdeef", "ENTRY": "Hereditary Amyloidosis", "MN": "C18.452.845.500.075", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "Amyloidosis (1966-2001)", "MS": "Diseases in which there is a familial pattern of AMYLOIDOSIS.", "PM": "2002", "HN": "2002", "MR": "20170620", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028226"}, {"RECTYPE": "D", "MH": "Amyloid Neuropathies, Familial", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Familial Amyloid Polyneuropathies|T047|NON|EQV|NLM (1994)|ORD (2010)|920928|abcdeef", "ENTRY": "Wohlwill Corino Andrade Syndrome", "MN": "C18.452.845.500.075.050", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Peripheral Nervous System Diseases (1967-1993)", "MS": "Inherited disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. The different clinical types based on symptoms correspond to the presence of a variety of mutations in several different proteins including transthyretin (PREALBUMIN); APOLIPOPROTEIN A-I; and GELSOLIN.", "PM": "2002; see AMYLOID NEUROPATHIES 1994-2001; for FAMILIAL AMYLOID POLYNEUROPATHIES see AMYLOID NEUROPATHIES 1994-2001", "HN": "2002; use AMYLOID NEUROPATHIES 1994-2001; for FAMILIAL AMYLOID POLYNEUROPATHIES use AMYLOID NEUROPATHIES 1994-2001", "MR": "20180228", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028227"}, {"RECTYPE": "D", "MH": "Camellia sinensis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thea sinensis|T002|NON|EQV|NLM (1999)|980515|abcdef", "ENTRY": "sinensis, Thea", "MN": "B01.875.800.575.912.250.341.998.500.500", "FX": "Tea", "MH_TH": "NLM (1999)", "ST": "T002", "RN": "txid4442", "AN": "for the beverage, use TEA", "PI": "Theales (1999-2001)", "MS": "Camellia sinensis L. (formerly Thea sinensis) is an evergreen Asiatic shrub of the THEACEAE family. The infusion of leaves of this plant is used as Oriental TEA which contains CAFFEINE; THEOPHYLLINE; and epigallocatechin gallate.", "PM": "2002; see TEA 1999-2001", "HN": "2002; use TEA 1999-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028241"}, {"RECTYPE": "D", "MH": "Theaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gordonia Plant|T002|NON|NRW|NLM (2003)|011030|abcdef", "ENTRY": "Plants, Gordonia", "MN": "B01.875.800.575.912.250.341.998", "MH_TH": "NLM (1999)", "ST": "T002", "RN": "txid27065", "RR": "txid79255", "AN": "prefer specific plant", "PI": "Theales (1999-2001)", "MS": "A plant family of the order THEALES, subclass Dilleniidae, class Magnoliopsida, best known for CAMELLIA SINENSIS, which is the source of Oriental TEA.", "PM": "2002; see Theales 1999-2001", "HN": "2002; use Theales 1999-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028242"}, {"RECTYPE": "D", "MH": "Cerebral Amyloid Angiopathy, Familial", "DE": "CEREBRAL AMYLOID ANGIOPATHY FAMILIAL", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cerebral Amyloid Angiopathy, Cst3 Related", "MN": "C18.452.845.500.100.160", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Cerebrovascular Disorders (1974-1991)", "MS": "A familial disorder marked by AMYLOID deposits in the walls of small and medium sized blood vessels of CEREBRAL CORTEX and MENINGES.", "PM": "2002; for CEREBRAL AMYLOID ANGIOPATHY, FAMILIAL see CEREBRAL AMYLOID ANGIOPATHY 2000-2001", "HN": "2002; for CEREBRAL AMYLOID ANGIOPATHY, FAMILIAL use CEREBRAL AMYLOID ANGIOPATHY 2000-2001", "MR": "20170620", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028243"}, {"RECTYPE": "D", "MH": "Camellia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thea|T002|NON|EQV|NLM (1999)|980515|abcdef", "ENTRY": "Theas", "MN": "B01.875.800.575.912.250.341.998.500", "MH_TH": "NLM (1999)", "ST": "T002", "RN": "txid4441", "PI": "Theales (1999-2001)", "MS": "A plant genus in the family THEACEAE, order ERICALES best known for CAMELLIA SINENSIS which is the source of Oriental TEA.", "PM": "2002; for CAMELLIA & THEA see Theales 1999-2001, see TEA 1986-1998", "HN": "2002; for CAMELLIA & THEA use Theales 1999-2001, use TEA 1986-1998", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028244"}, {"RECTYPE": "D", "MH": "Chelidonium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Celandine|T002|NON|EQV|NLM (2002)|010322|abcdef", "ENTRY": "Chelidoniums", "MN": "B01.875.800.575.912.250.836.500.249", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid71250", "PI": "Papaver (1998-2001)", "MS": "A plant genus in the family PAPAVERACEAE, order Papaverales, subclass Magnoliidae.", "PM": "2002; see PAPAVER 1998-2001, see PLANTS, MEDICINAL 1986-1997", "HN": "2002; use PAPAVER 1998-2001, use PLANTS, MEDICINAL 1986-1997", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028281"}, {"RECTYPE": "D", "MH": "Feline Panleukopenia Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Infectious Enteritis Virus, Feline|T005|NON|EQV|UNK (19XX)|741211|INFECT ENTERITIS VIRUS FELINE|abcdefv", "ENTRY": "Viruses, Feline Panleukopenia", "MN": "B04.280.580.650.600.325", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10786", "RR": "txid10785", "PI": "Parvovirus, Feline (1975-2001)", "MS": "A species of PARVOVIRUS infecting cats with a highly contagious enteric disease. Host range variants include mink enteritis virus, canine parvovirus (PARVOVIRUS, CANINE), and raccoon parvovirus. After infecting their new hosts, many of these viruses have further evolved and are now considered distinct species.", "PM": "2016; see Feline panleukopenia virus 2002-2015, PARVOVIRUS, FELINE 1994-2001, FELINE INFECTIOUS ENTERITIS VIRUS 1991-1993, PARVOVIRIDAE 1981-1990, PARVOVIRUSES 1975-1980; for PARVOVIRUS, FELINE see PARVOVIRUS, FELINE 1994-2006", "HN": "2016; use Feline panleukopenia virus 2002-2015, PARVOVIRUS, FELINE 1994-2001, FELINE INFECTIOUS ENTERITIS VIRUS 1991-1993, PARVOVIRIDAE 1981-1990, PARVOVIRUSES 1975-1980; for PARVOVIRUS, FELINE use PARVOVIRUS, FELINE 1994-2006", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028301"}, {"RECTYPE": "D", "MH": "Plant Preparations", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Herbal Preparations|T121|NON|EQV|NLM (2002)|010524|abcdef", "ENTRY": "Preparation, Plant", "MN": "D20.215.784", "MH_TH": "NLM (2002)", "ST": "T121", "RN": "0", "AN": "coordinate with specific plant and PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM or NIM with phytotherapy (IM) + disease / drug ther (IM)", "MS": "Material prepared from plants.", "PM": "2002", "HN": "2002", "MR": "20150623", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028321"}, {"RECTYPE": "D", "MH": "Inhibin-beta Subunits", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Activin-beta Subunits|T116|T123|NON|EQV|NLM (2002)|010322|abbcdef", "ENTRY": "beta Inhibin Polypeptide", "MN": "D12.776.395.439.500", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "93443-12-0", "PI": "Peptides (1984-2001)", "MS": "They are glycopeptides and subunits in INHIBINS and ACTIVINS. Inhibins and activins belong to the transforming growth factor beta superfamily.", "PM": "2002", "HN": "2002", "MR": "20230316", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028322"}, {"RECTYPE": "D", "MH": "Parvovirus, Porcine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Porcine Parvoviruses", "MN": "B04.280.580.650.600.690", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid10796", "AN": "infection: coord IM with PARVOVIRIDAE INFECTIONS (IM)", "PI": "Parvovirus (1994-2001)", "MS": "A species of PARVOVIRUS causing reproductive failure in pigs.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028323"}, {"RECTYPE": "D", "MH": "Activins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, FSH-Releasing", "MN": "D12.776.395.022", "MH_TH": "NLM (2002)", "ST": "T125", "RN": "104625-48-1", "PI": "Inhibin (1986-2001)", "MS": "Activins are produced in the pituitary, gonads, and other tissues. By acting locally, they stimulate pituitary FSH secretion and have diverse effects on cell differentiation and embryonic development. Activins are glycoproteins that are hetero- or homodimers of INHIBIN-BETA SUBUNITS.", "PM": "2002; ACTIVIN was indexed under INHIBIN 1987-2001", "HN": "2002; use ACTIVINS (NM) 1987-2001", "MR": "20230316", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028341"}, {"RECTYPE": "D", "MH": "Mitochondrial Diseases", "DE": "MITOCHONDRIAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Respiratory Chain Deficiencies, Mitochondrial|T047|NON|NRW|NLM (2002)|010323|RESPIRATORY CHAIN DEFIC MITOCHONDRIAL|abcdefv", "ENTRY": "Phosphorylation Deficiency, Oxidative", "MN": "C18.452.660", "MH_TH": "NLM (2000)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Mitochondrial Myopathies (1992-2001)", "MS": "Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.", "PM": "2002; see MITOCHONDRIAL MYOPATHIES 2000-2001", "HN": "2002; use MITOCHONDRIAL MYOPATHIES 2000-2001", "MR": "20230405", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D028361"}, {"RECTYPE": "D", "MH": "Nidovirales", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Nidoviruses|T005|NON|EQV|NLM (2009)|070921|abcdef", "ENTRY": "Nidovirus", "MN": "B04.820.578.500", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid76804", "RR": "txid1312872", "MS": "An order comprising three families of eukaryotic viruses possessing linear, nonsegmented, positive sense RNA genomes. The families are Mesoniviridae; CORONAVIRIDAE; ARTERIVIRIDAE; and RONIVIRIDAE.", "PM": "2002", "HN": "2002", "MR": "20200902", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028381"}, {"RECTYPE": "D", "MH": "Arteriviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.578.500.080", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid76803", "AN": "infection: coord IM with RNA VIRUS INFECTIONS (IM)", "MS": "A family of viruses, of the order NIDOVIRALES, containing spherical virions. In contrast to CORONAVIRIDAE, no protruding spikes are obvious on the surface.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028382"}, {"RECTYPE": "D", "MH": "Isoprostanes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Isoprostane|T109|T123|NON|EQV|NLM (2002)|010327|abbcdef", "MN": "D10.251.355.411", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Lipid Peroxides (1992-2001)", "MS": "A series of prostaglandin-like compounds that are produced by the attack of free-radical species on unsaturated fatty acids, especially ARACHIDONIC ACID, of cellular MEMBRANES. Once cleaved from the lipid membrane by the action of phospholipases they can circulate into various bodily fluids and eventually be excreted. Although these compounds resemble enzymatically synthesized prostaglandins their stereoisometric arrangement is usually different than the \"naturally occurring\" compounds.", "PM": "2002", "HN": "2002", "MR": "20150622", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D028421"}, {"RECTYPE": "D", "MH": "F2-Isoprostanes", "DS": "F A 02 ISOPROSTANES", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "F2 Isoprostanes", "MN": "D10.251.355.411.500", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Dinoprost (1994-2001)", "MS": "Isoprostanes derived from the free radical oxidation of ARACHIDONIC ACID. Although similar in structure to enzymatically synthesized prostaglandin F2alpha (DINOPROST), they occur through non-enzymatic oxidation of cell membrane lipids.", "PM": "2002; F2-ISOPROSTANE (now F2-ISOPROSTANES) was indexed under DINOPROST 1994-2001", "HN": "2002; use F2-ISOPROSTANES (NM) 1994-2001", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028441"}, {"RECTYPE": "D", "MH": "Zygophyllaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.987", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid43873", "AN": "prefer specific plant", "PI": "Plants, Medicinal (1971-2001)", "MS": "A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida which is a small family of small trees and shrubs growing in arid and warm regions.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028461"}, {"RECTYPE": "D", "MH": "Cucumis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cucumi", "MN": "B01.875.800.575.912.250.300.188", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3655", "PI": "Cucurbitaceae (1996-2001)", "MS": "A plant genus of the family CUCURBITACEAE, order Violales, subclass Dilleniidae best known for cucumber (CUCUMIS SATIVUS) and cantaloupe (CUCUMIS MELO). Watermelon is a different genus, CITRULLUS. Bitter melon may refer to MOMORDICA or this genus.", "PM": "2002; see CUCURBITACEAE 1996-2001", "HN": "2002; use CUCURBITACEAE 1996-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028462"}, {"RECTYPE": "D", "MH": "Cucumis melo", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cantaloupes|T002|NON|NRW|NLM (2002)|010328|abcdef", "ENTRY": "melos, Cucumis", "MN": "B01.875.800.575.912.250.300.188.444", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3656", "PI": "Melons (1995-2001)", "MS": "A plant species of the family CUCURBITACEAE, order Violales, subclass Dilleniidae known for the melon fruits with reticulated (net) surface including cantaloupes, honeydew, casaba, and Persian melons.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028463"}, {"RECTYPE": "D", "MH": "Cucurbita", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Squashes|T168|NON|REL|NLM (1998)|961021|abcdef", "ENTRY": "Squashe", "MN": "B01.875.800.575.912.250.300.222", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3660", "PI": "Cucurbitaceae (1998-2001)", "MS": "A plant genus of the family CUCURBITACEAE, order Violales, subclass Dilleniidae, which includes pumpkin, gourd and squash.", "PM": "2002; for PUMPKINS & SQUASHES see CUCURBITACEAE 1998-2001", "HN": "2002; for PUMPKINS & SQUASHES use CUCURBITACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028464"}, {"RECTYPE": "D", "MH": "Euphorbia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Spurge|T002|NON|NRW|NLM (1998)|961209|abcdef", "ENTRY": "Spurges", "MN": "B01.875.800.575.912.250.859.797.438.333", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3990", "RR": "txid318062", "AN": "note entry term SPURGE: restrict to EUPHORBIA; SPURGE, JAPANESE see PACHYSANDRA is also available", "PI": "Euphorbiaceae (1998-2001)", "MS": "A large plant genus of the family EUPHORBIACEAE, order Euphorbiales, subclass Rosidae. They have a milky sap and a female flower consisting of a single pistil surrounded by numerous male flowers of one stamen each. Euphorbia hirta is rarely called milkweed but that name is normally used for ASCLEPIAS.", "PM": "2002; for SPURGE see EUPHORBIACEAE 1998-2001", "HN": "2002; for SPURGE use EUPHORBIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028481"}, {"RECTYPE": "D", "MH": "Hevea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rubber Tree|T002|NON|REL|NLM (1998)|961021|abcdef", "ENTRY": "brasiliensis, Hevea", "MN": "B01.875.800.575.912.250.859.797.438.399", "FX": "Rubber", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3980", "RR": "txid3981", "AN": "do not confuse with FICUS which is sometimes called rubberplant", "PI": "Euphorbiaceae (1998-2001)", "MS": "A plant genus of the family EUPHORBIACEAE, order Euphorbiales, subclass Rosidae. Commercial natural RUBBER is mainly obtained from Hevea brasiliensis but also from some other plants.", "PM": "2002; for RUBBER TREE see EUPHORBIACEAE 1998-2001", "HN": "2002; for RUBBER TREE use EUPHORBIACEAE 1998-2001", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D028482"}, {"RECTYPE": "D", "MH": "Abelmoschus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Okra|T168|NON|NRW|NLM (1998)|961107|abcdef", "ENTRY": "Okras", "MN": "B01.875.800.575.912.250.859.821.500.100", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid183218", "RR": "txid455045", "PI": "Malvaceae (1996-2001)", "MS": "A plant genus of the family MALVACEAE, order Malvales, subclass Dilleniidae, of which okra is best known example.", "PM": "2002; for OKRA see MALVACEAE 1996-2001", "HN": "2002; for OKRA use MALVACEAE 1996-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028483"}, {"RECTYPE": "D", "MH": "Malva", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Malvas", "MN": "B01.875.800.575.912.250.859.821.500.555", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid96479", "PI": "Malvaceae (1996-2001)", "MS": "A plant genus of the family MALVACEAE, order Malvales, subclass Dilleniida. The common name of 'Mallow' may sometimes get confused with other plants.", "PM": "2002; see MALVACEAE 1996-2001", "HN": "2002; use MALVACEAE 1996-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028501"}, {"RECTYPE": "D", "MH": "Polygonum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Smartweed|T002|NON|NRW|NLM (2002)|010328|abcdef", "ENTRY": "Smartweeds", "MN": "B01.875.800.575.912.250.825.437", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid46786", "PI": "Polygonaceae (1998-2001)", "MS": "A plant genus of the family POLYGONACEAE that is an ingredient of Shou-Wu-Pian, a Chinese herbal preparation (DRUGS, CHINESE HERBAL). The common name of black bindweed also refers to TAMUS or Fallopia (use POLYGONACEAE).", "PM": "2002, 1963-1985; see POLYGONACEAE 1998-2001, see PLANTS, MEDICINAL 1986-1997", "HN": "2002, 1963-1985; use POLYGONACEAE 1998-2001, use PLANTS, MEDICINAL 1986-1997", "MR": "20210520", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028502"}, {"RECTYPE": "D", "MH": "Cephaelis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "ipecacuanhas, Cephaelis", "MN": "B01.875.800.575.912.250.456.937.200", "FX": "Ipecac", "MH_TH": "NLM (1999)", "ST": "T002", "RN": "txid189135", "RR": "txid77880", "PI": "Rubiaceae (1999-2001)", "MS": "A plant genus of the family RUBIACEAE, order Rubiales, subclass Asteridae. Cephaelis ipecacuanha is the source of IPECAC.", "PM": "2002; see RUBIACEAE 1999-2001; see IPECAC 1977-1998; for URAGOGA see RUBIACEAE 1999-2001, see IPECAC 1977-1998", "HN": "2002; use RUBIACEAE 1999-2001; use IPECAC 1977-1998; for URAGOGA use RUBIACEAE 1999-2001, use IPECAC 1977-1998", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028503"}, {"RECTYPE": "D", "MH": "Musa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Banana Plant|T002|NON|EQV|NLM (2002)|010525|abcdef", "ENTRY": "Plants, Banana", "MN": "B01.875.800.575.912.250.618.937.555.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4640", "RR": "txid4641", "AN": "Plantain, the banana-like fruit and green plantain flour go here; the medicinal herb referred to by the common name plantain probably goes under PLANTAGO", "PI": "Zingiberales (1998-2001)", "MS": "A plant genus of the family Musaceae, order Zingiberales, subclass Zingiberidae, class Liliopsida.", "PM": "2002; for BANANA see ZINGIBERALES 1998-2001; see FRUIT 1983-1997", "HN": "2002; for BANANA use ZINGIBERALES 1998-2001; use FRUIT 1983-1997", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028521"}, {"RECTYPE": "D", "MH": "Musaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618.937.555", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid4637", "AN": "prefer specific plant", "PI": "Zingiberales (1998-2001)", "MS": "A plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida best known for banana (MUSA). The slender false trunk, formed by leaf sheaths of the spirally arranged leaves, may rise to 15 meters (50 feet). There is a crown of large leaves at the top.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028522"}, {"RECTYPE": "D", "MH": "Elettaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cardamon|T002|NON|NRW|NLM (2002)|010328|abcdef", "ENTRY": "cardamomums, Amomum", "MN": "B01.875.800.575.912.250.618.937.900.333", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid105180", "RR": "txid105181", "AN": "entry term AMOMUM CARDAMOMUM: AMOMUM is also available", "PI": "Zingiberales (1998-2001)", "MS": "A plant genus of the family ZINGIBERACEAE, order Zingiberales, subclass Zingiberidae. Elettaria cardamomum (L.) Maton is the source of Cardamom used in SPICES.", "PM": "2002; for CARDAMON see ZINGIBERALES 1998-2001", "HN": "2002; for CARDAMON use ZINGIBERALES 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028523"}, {"RECTYPE": "D", "MH": "Anethum graveolens", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Weeds, Dill", "MN": "B01.875.800.575.912.250.075.077", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid40922", "PI": "Apiaceae (1998-2001)", "MS": "Anethum graveolens L. is a plant species of the family APIACEAE. The leaves are considered as a spice (SPICES).", "PM": "2002; for DILL PLANT see APIACEAE 1998-2001", "HN": "2002; for DILL PLANT use APIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028524"}, {"RECTYPE": "D", "MH": "Coriandrum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Coriander|T168|NON|REL|NLM (1998)|961206|abcdef", "ENTRY": "sativums, Coriandrum", "MN": "B01.875.800.575.912.250.075.211", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4046", "RR": "txid4047", "PI": "Apiaceae (1998-2001)", "MS": "A plant genus of the family APIACEAE. The leaves are the source of cilantro and the seeds are the source of coriander, both of which are used in SPICES.", "PM": "2002; see APIACEAE 1998-2001", "HN": "2002; use APIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028526"}, {"RECTYPE": "D", "MH": "Cuminum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cumin|T168|NON|REL|NLM (1998)|961106|abcdef", "ENTRY": "cyminums, Cuminum", "MN": "B01.875.800.575.912.250.075.233", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid52461", "RR": "txid52462", "PI": "Apiaceae (1998-2001)", "MS": "A plant genus of the family APIACEAE. The seed is used in SPICES.", "PM": "2002; for CUMIN see APIACEAE 1998-2001", "HN": "2002; for CUMIN use APIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028527"}, {"RECTYPE": "D", "MH": "Petroselinum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Parsley|T168|NON|REL|NLM (1998)|961106|abcdef", "ENTRY": "crispum, Petroselinum", "MN": "B01.875.800.575.912.250.075.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4042", "RR": "txid4043", "PI": "Apiaceae (1998-2001)", "MS": "A plant genus of the family APIACEAE used for flavoring food.", "PM": "2002; for PARSLEY see APIACEAE 1998-2001", "HN": "2002; for PARSLEY use APIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028528"}, {"RECTYPE": "D", "MH": "Pastinaca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Parsnips|T168|NON|REL|NLM (1998)|961106|abcdef", "ENTRY": "sativas, Pastinaca", "MN": "B01.875.800.575.912.250.075.625", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4040", "RR": "txid4041", "PI": "Apiaceae (1998-2001)", "MS": "A plant genus of the family APIACEAE. The roots are used as food.", "PM": "2002; for PARSNIPS see APIACEAE 1998-2001", "HN": "2002; for PARSNIPS use APIACEAE 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028529"}, {"RECTYPE": "D", "MH": "Transition Elements", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Elements, Transition", "MN": "D01.268.956", "MH_TH": "NLM (2002)", "ST": "T196", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Elements with partially filled d orbitals. They constitute groups 3-12 of the periodic table of elements.", "PM": "2002", "HN": "2002", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028561"}, {"RECTYPE": "D", "MH": "Lanthanoid Series Elements", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lanthanoids|T196|NON|EQV|NLM (2002)|010330|abcdef", "ENTRY": "Elements, Lanthanoid Series", "MN": "D01.552.550.399", "MH_TH": "NLM (2002)", "ST": "T196", "RN": "0", "MS": "Elements of the lanthanoid series including atomic number 57 (LANTHANUM) through atomic number 71 (LUTETIUM).", "PM": "2002; for LANTHANIDES see METALS, RARE EARTH 1976-2001", "HN": "2002; for LANTHANIDES use METALS, RARE EARTH 1976-2001", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028581"}, {"RECTYPE": "D", "MH": "Euthanasia, Active", "AQ": "CL ES HI LJ MT PX SN ST TD VE", "ENTRY": "Active Euthanasia|T052|NON|EQV|BIOETHICS (1974)|NLM (2002)|770329|abcdeef", "MN": "N02.421.585.905.199.500", "FX": "Suicide, Assisted", "MH_TH": "NLM (2002)", "ST": "T052", "AN": "human only", "PI": "Euthanasia (1974-2001)", "MS": "The act or practice of killing for reasons of mercy, i.e., in order to release a person or animal from incurable disease, intolerable suffering, or undignified death. (from Beauchamp and Walters, Contemporary Issues in Bioethics, 5th ed)", "PM": "2002", "HN": "2002", "MR": "20150629", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028601"}, {"RECTYPE": "D", "MH": "Mentally Ill Persons", "AQ": "CL HI LJ PX SN", "PRINT ENTRY": "Mental Patients|T101|NON|EQV|POPLINE (1978)|781226|abcdef", "ENTRY": "Persons, Mentally Ill", "MN": "M01.150.725", "FX": "Mental Disorders", "MH_TH": "NLM (2002)", "ST": "T101", "PI": "Mental Disorders (1974-2001)", "MS": "Persons with psychiatric illnesses or diseases, particularly psychotic and severe mood disorders.", "PM": "2002", "HN": "2002", "MR": "20020703", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028642"}, {"RECTYPE": "D", "MH": "Complicity", "PRINT ENTRY": "Moral Complicity|T078|NON|NRW|BIOETHICS (1992)|NLM (1993)|920414|abcdeef", "MN": "N05.350.219", "FX": "Professional Misconduct", "MH_TH": "NLM (2002)", "ST": "T078", "PI": "Morals (1992-2001)", "MS": "Association with or participation in an act that is, or is perceived to be, criminal or immoral. One is complicitous when one promotes or unduly benefits from practices or institutions that are morally or legally suspect.", "PM": "2002; for MORAL COMPLICITY see MORALS 1993-2001", "HN": "2002; for MORAL COMPLICITY use MORALS 1993-2001", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028661"}, {"RECTYPE": "D", "MH": "Principle-Based Ethics", "AQ": "HI", "ENTRY": "Principle-Based Ethic", "MN": "N05.350.958", "FX": "Ethical Theory", "MH_TH": "NLM (2002)", "ST": "T078", "PI": "Ethics (1974-2001)", "MS": "An approach to ethics that focuses on theories of the importance of general principles such as respect for autonomy, beneficence/nonmaleficence, and justice.", "PM": "2002; see ETHICS 1999-2001", "HN": "2002; use ETHICS 1999-2001", "MR": "20150623", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028662"}, {"RECTYPE": "D", "MH": "Ethical Theory", "AQ": "CL HI", "ENTRY": "Utilitarianisms", "MN": "N05.350.256", "FX": "Principle-Based Ethics", "MH_TH": "NLM (2002)", "ST": "T078", "PI": "Ethics (1974-2001)", "MS": "A philosophically coherent set of propositions (for example, utilitarianism) which attempts to provide general norms for the guidance and evaluation of moral conduct. (from Beauchamp and Childress, Principles of Biomedical Ethics, 4th ed)", "PM": "2002; see ETHICS 1993-2001", "HN": "2002; use ETHICS 1993-2001", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028663"}, {"RECTYPE": "D", "MH": "Moral Obligations", "ENTRY": "Obligations, Moral", "MN": "K01.752.566.869.500", "MH_TH": "NLM (2002)", "ST": "T078", "PI": "Social Responsibility (1977-2001)", "MS": "Duties that are based in ETHICS, rather than in law.", "PM": "2002; see SOCIAL RESPONSIBILITY 1978-2001", "HN": "2002; use SOCIAL RESPONSIBILITY 1978-2001", "MR": "20150623", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028681"}, {"RECTYPE": "D", "MH": "National Socialism", "AQ": "HI", "ENTRY": "Socialism, National", "MN": "I01.696.586", "FX": "Holocaust", "MH_TH": "NLM (2002)", "ST": "T078", "AN": "specify geog", "PI": "Political Systems (1976-2001)", "MS": "The doctrines and policies of the Nazis or the National Social German Workers party, which ruled Germany under Adolf Hitler from 1933-1945. These doctrines and policies included racist nationalism, expansionism, and state control of the economy. (from Columbia Encyclopedia, 6th ed. and American Heritage College Dictionary, 3d ed.)", "PM": "2002; for NAZISM see POLITICAL SYSTEMS 1990-2001", "HN": "2002; for NAZISM use POLITICAL SYSTEMS 1990-2001", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028683"}, {"RECTYPE": "D", "MH": "Patient Rights", "AQ": "CL ES HI LJ ST TD", "PRINT ENTRY": "Right to Treatment|T078|NON|NRW|BIOETHICS (1974)|770317|abcdef", "ENTRY": "Treatments, Right to", "MN": "N03.706.437.650", "FX": "Patient Advocacy", "MH_TH": "NLM (2002)", "ST": "T078", "AN": "general or unspecified; prefer specifics", "PI": "Patient Advocacy (1974-2001)", "MS": "Fundamental claims of patients, as expressed in statutes, declarations, or generally accepted moral principles. (Bioethics Thesaurus) The term is used for discussions of patient rights as a group of many rights, as in a hospital's posting of a list of patient rights.", "PM": "2002; for PATIENT ADVOCACY 1978-2001; for RIGHT TO TREATMENT see PATIENT ADVOCACY 1978-2001", "HN": "2002; use PATIENT ADVOCACY 1978-2001; for RIGHT TO TREATMENT use PATIENT ADVOCACY 1978-2001", "MR": "20030709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028701"}, {"RECTYPE": "D", "MH": "Virtues", "ENTRY": "Virtue", "MN": "K01.752.566.934", "FX": "Social Values", "MH_TH": "NLM (2002)", "ST": "T078", "AN": "for \"virtue theory,\" coordinate with ETHICAL THEORY", "PI": "Social Values (1976-2001)", "MS": "Character traits that are considered to be morally praiseworthy. (Bioethics Thesaurus)", "PM": "2002; see SOCIAL VALUES 1987-2001", "HN": "2002; use SOCIAL VALUES 1987-2001", "MR": "20150623", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028722"}, {"RECTYPE": "D", "MH": "Personhood", "MN": "N05.350.917", "FX": "Human Characteristics", "MH_TH": "NLM (2002)", "ST": "T078", "AN": "do not confuse with INDIVIDUALITY", "PI": "Individuality (1974-2001)", "MS": "The state or condition of being a human individual accorded moral and/or legal rights. Criteria to be used to determine this status are subject to debate, and range from the requirement of simply being a human organism to such requirements as that the individual be self-aware and capable of rational thought and moral agency.", "PM": "2002; see INDIVIDUALITY 1995-2001", "HN": "2002; use INDIVIDUALITY 1995-2001", "MR": "20200618", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028723"}, {"RECTYPE": "D", "MH": "Theology", "DE": "THEOL", "AQ": "ED HI", "MN": "K01.844.949", "MH_TH": "NLM (2002)", "ST": "T078", "PI": "Religion (1974-2001)", "MS": "The study of religion and religious belief, or a particular system or school of religious beliefs and teachings (from online Cambridge Dictionary of American English, 2000 and WordNet: An Electronic Lexical Database, 1997)", "PM": "2002; see RELIGION 1978-2001", "HN": "2002; use RELIGION 1978-2001", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028725"}, {"RECTYPE": "D", "MH": "Ethics Committees, Clinical", "DE": "ETHICS COMMITTEES CLIN", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Hospital Ethics Committees|T097|NON|EQV|NLM (2002)|010404|HOSP ETHICS COMMITTEES|abcdefv", "MN": "N05.700.685.300.500", "FX": "Ethics, Clinical", "MH_TH": "NLM (1994)", "ST": "T097", "AN": "distinguish from ETHICS COMMITTEES, RESEARCH", "PI": "Ethics Committees (1979-2001)", "MS": "Hospital or other institutional ethics committees established to consider the ethical dimensions of patient care. Distinguish from ETHICS COMMITTEES, RESEARCH, which are established to monitor the welfare of patients or healthy volunteers participating in research studies.", "PM": "2002", "HN": "2002", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028741"}, {"RECTYPE": "D", "MH": "Professional Misconduct", "AQ": "CL ES HI LJ PX SN TD", "PRINT ENTRY": "Misconduct, Professional|T080|NON|EQV|NLM (2002)|010619|abcdef", "ENTRY": "Unprofessional Behaviors", "MN": "N05.350.979", "FX": "Retrospective Moral Judgment", "MH_TH": "NLM (2002)", "ST": "T080", "AN": "SCIENTIFIC MISCONDUCT is also available", "PI": "Malpractice (1974-2001)", "MS": "Violation of laws, regulations, or professional standards.", "PM": "2002", "HN": "2002", "MR": "20150612", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028743"}, {"RECTYPE": "D", "MH": "Ethics Committees, Research", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Institutional Review Boards|T097|NON|EQV|NLM (2002)|810519|INSTITUTIONAL REV BOARDS|abcdefv", "ENTRY": "Committees, Research Ethics", "MN": "N05.700.685.300.750", "FX": "Clinical Trials Data Monitoring Committees", "MH_TH": "BIOETHICS (1974)", "ST": "T097", "AN": "coord with geographic term", "PI": "Professional Staff Committees (1981-2001)", "MS": "Hospital or other institutional committees established to protect the welfare of research subjects. Federal regulations (the \"Common Rule\" (45 CFR 46)) mandate the use of these committees to monitor federally-funded biomedical and behavioral research involving human subjects.", "PM": "2002; for INSTITUTIONAL REVIEW BOARD see PROFESSIONAL STAFF COMMITTEES 1982-2001", "HN": "2002; for INSTITUTIONAL REVIEW BOARD use PROFESSIONAL STAFF COMMITTEES 1982-2001", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028744"}, {"RECTYPE": "D", "MH": "Withholding Treatment", "AQ": "EC ES HI LJ SN ST TD", "PRINT ENTRY": "Withdrawing Care|T052|T078|NON|REL|NLM (1999)|980323|abbcdef", "ENTRY": "Withholding Treatments", "MN": "N02.421.585.952", "FX": "Resuscitation Orders", "MH_TH": "NLM (2002)", "ST": "T058", "AN": "human only; EUTHANASIA, PASSIVE: do not coord with WITHHOLDING TREATMENT unless particularly discussed", "MS": "Withholding or withdrawal of a particular treatment or treatments, often (but not necessarily) life-prolonging treatment, from a patient or from a research subject as part of a research protocol. The concept is differentiated from REFUSAL TO TREAT, where the emphasis is on the health professional's or health facility's refusal to treat a patient or group of patients when the patient or the patient's representative requests treatment. Withholding of life-prolonging treatment is usually indexed only with EUTHANASIA, PASSIVE, unless the distinction between withholding and withdrawing treatment, or the issue of withholding palliative rather than curative treatment, is discussed.", "PM": "2002; for WITHDRAWING CARE see EUTHANASIA, PASSIVE 1999-2001", "HN": "2002; for WITHDRAWING CARE use EUTHANASIA, PASSIVE 1999-2001", "MR": "20150629", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028761"}, {"RECTYPE": "D", "MH": "Ethical Relativism", "AQ": "HI", "ENTRY": "Relativism, Ethical", "MN": "N05.350.247", "FX": "Retrospective Moral Judgment", "MH_TH": "NLM (2002)", "ST": "T078", "PI": "Ethics (1979-2001)", "MS": "The philosophical view that conceptions of truth and moral values are not absolute but are relative to the persons or groups holding them. (from American Heritage Dictionary of the English Language, 4th ed)", "PM": "2002", "HN": "2002", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028781"}, {"RECTYPE": "D", "MH": "Nuclear Pore Complex Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleoporins|T116|T123|NON|EQV|NLM (2002)|010406|abbcdef", "ENTRY": "Nucleoporin|T116|T123|NON|EQV|NLM (2002)|010406|abbcdef", "MN": "D12.776.543.585.750.625", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nuclear Proteins (1991-2001)", "MS": "Proteins that form the structure of the NUCLEAR PORE. They are involved in active, facilitated and passive transport of molecules in and out of the CELL NUCLEUS.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028861"}, {"RECTYPE": "D", "MH": "Karyopherins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Karyopherin|T116|T123|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Transportins|T116|T123|NON|EQV|NLM (2002)|010406|abbcdef", "MN": "D12.776.660.502", "FX": "Active Transport, Cell Nucleus", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Receptors, Cytoplasmic and Nuclear (1995-2001)", "MS": "A family of proteins involved in NUCLEOCYTOPLASMIC TRANSPORT. Karyopherins are heteromeric molecules composed of two major types of components, ALPHA KARYOPHERINS and BETA KARYOPHERINS, that function together to transport molecules through the NUCLEAR PORE COMPLEX. Several other proteins such as RAN GTP BINDING PROTEIN and CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN bind to karyopherins and participate in the transport process.", "PM": "2002; IMPORTIN (now KARYOPHERINS) was indexed under NUCLEAR PROTEINS 1995-2001; TRANSPORTIN (now KARYOPHERINS) was indexed under NUCLEAR PROTEINS & RECEPTORS, CYTOPLASMIC AND NUCLEAR 1995-2001", "HN": "2002; use KARYOPHERINS (NM) 1995-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028884"}, {"RECTYPE": "D", "MH": "alpha Karyopherins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "receptor, NLS", "MN": "D12.776.660.502.100", "FX": "Nuclear Localization Signals", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nuclear Proteins (1994-2001)", "MS": "Nucleocytoplasmic transport molecules that bind to the NUCLEAR LOCALIZATION SIGNALS of cytoplasmic molecules destined to be imported into the CELL NUCLEUS. Once attached to their cargo they bind to BETA KARYOPHERINS and are transported through the NUCLEAR PORE COMPLEX. Inside the CELL NUCLEUS alpha karyopherins dissociate from beta karypherins and their cargo. They then form a complex with CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN and RAN GTP-BINDING PROTEIN which is exported to the CYTOPLASM.", "PM": "2002; KARYOPHERIN ALPHA (now ALPHA KARYOPHERINS) was indexed under NUCLEAR PROTEINS 1994-2001; IMPORTIN-ALPHA was indexed under NUCLEAR PROTEINS 1995-2001; NLS-BINDING PROTEIN, NLSBP & NUCLEAR LOCALIZATION SIGNAL-BINDING PROTEIN were indexed under NUCLEAR PROTEINS & PHOSPHOPROTEINS 1992-2001", "HN": "2002; use ALPHA KARYOPHERINS (NM) 1994-2001; for IMPORTIN-ALPHA use KARYOPHERINS 1995-2001; for NLS-BINDING PROTEIN, NLSBP & NUCLEAR LOCALIZATION SIGNAL-BINDING PROTEIN use NOPP140 (NM) 1992-2001", "MR": "20050712", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028901"}, {"RECTYPE": "D", "MH": "Biotinidase Deficiency", "DE": "BIOTINIDASE DEFIC", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Multiple Carboxylase Deficiency, Late-Onset|T047|NON|EQV|GHR (2014)|NLM (2002)|OMIM (2013)|010407|MULTIPLE CARBOXYLASE DEFIC LATE ONSET|abcdeeefv", "ENTRY": "Multiple Carboxylase Deficiency, Late Onset", "MN": "C18.452.648.202.720.100", "FX": "Biotin", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Amidohydrolases/deficiency (1983-2001)", "MS": "The late onset form of MULTIPLE CARBOXYLASE DEFICIENCY (deficiency of the activities of biotin-dependent enzymes propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, and PYRUVATE CARBOXYLASE) due to a defect or deficiency in biotinidase which is essential for recycling BIOTIN.", "PM": "2002", "HN": "2002", "MR": "20130708", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D028921"}, {"RECTYPE": "D", "MH": "Holocarboxylase Synthetase Deficiency", "DE": "HOLOCARBOXYLASE SYNTHETASE DEFIC", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Multiple Carboxylase Deficiency, Neonatal Form|T047|NON|EQV|GHR (2014)|NLM (2002)|OMIM (2013)|010407|MULTIPLE CARBOXYLASE DEFIC NEONATAL FORM|abcdeeefv", "ENTRY": "Holocarboxylase Synthetase Deficiencies", "MN": "C18.452.648.202.720.380", "FX": "Biotin", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "The neonatal form of MULTIPLE CARBOXYLASE DEFICIENCY that is caused by a defect or deficiency in holocarboxylase synthetase. HLCS is the enzyme that covalently links biotin to the biotin dependent carboxylases (propionyl-CoA-carboxylase, pyruvate carboxylase, and beta-methylcrotonyl-CoA carboxylase).", "PM": "2002", "HN": "2002", "MR": "20130708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028922"}, {"RECTYPE": "D", "MH": "Coronavirus 229E, Human", "DS": "CORONAVIRUS HUMAN A 229 E", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Human Coronavirus 229E|T005|NON|EQV|NLM (2002)|150623|HUMAN CORONAVIRUS A 229 E|abcdefs", "MN": "B04.820.578.500.540.150.075.750", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11137", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS + COMMON COLD if appropriate", "PI": "Coronavirus (1993-2001)", "MS": "A species in the genus CORONAVIRUS causing the common cold and possibly nervous system infections in humans. It lacks hemagglutinin-esterase.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028941"}, {"RECTYPE": "D", "MH": "beta Karyopherins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Karyopherin-beta|T116|T123|NON|EQV|NLM (2002)|010423|abbcdef", "ENTRY": "nuclear protein, p92", "MN": "D12.776.660.502.500", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nuclear Proteins (1995-2001)", "MS": "Nucleocytoplasmic transport molecules that bind to ALPHA KARYOPHERINS in the CYTOSOL and are involved in transport of molecules through the NUCLEAR PORE COMPLEX. Once inside the CELL NUCLEUS beta karyopherins interact with RAN GTP-BINDING PROTEIN and dissociate from alpha karyopherins. Beta karyopherins bound to RAN GTP-BINDING PROTEIN are then re-transported to the cytoplasm where hydrolysis of the GTP of RAN GTP-BINDING PROTEIN causes release of karyopherin beta.", "PM": "2002; KARYOPHERIN BETA & IMPORTIN-BETA were indexed under NUCLEAR PROTEINS 1995-2001", "HN": "2002; use BETA KARYOPHERINS (NM) 1995-2001; for IMPORTIN-BETA use KARYOPHERINS (NM) 1995-2001", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028961"}, {"RECTYPE": "D", "MH": "Coronavirus OC43, Human", "DS": "CORONAVIRUS HUMAN OC 043", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Human Coronavirus OC43|T005|ACX|EQV|NLM (2002)|150623|HUMAN CORONAVIRUS OC 043|abcdefs", "MN": "B04.820.578.500.540.150.113.500.500", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid31631", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS and COMMON COLD if appropriate ", "PI": "Coronavirus (1993-2001)", "MS": "A species in the genus CORONAVIRUS causing the common cold and possibly nervous system infections in humans. It contains hemagglutinin-esterase.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028962"}, {"RECTYPE": "D", "MH": "Bornaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Bornaviruses", "MN": "B04.820.480.937.149", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid178830", "RR": "txid186458", "AN": "infection: coord IM with MONONEGAVIRALES INFECTIONS (IM)", "MS": "A family in the order MONONEGAVIRALES comprising one genus Bornavirus. This family has a unique form of mRNA processing: replication and transcription takes place in the nucleus.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D028981"}, {"RECTYPE": "D", "MH": "Herbal Medicine", "DE": "HERBAL MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Medicine, Herbal|T091|NON|EQV|NLM (2002)|010412|MED HERBAL|abcdefv", "ENTRY": "Medicine, Hawaiian Herbal", "MN": "H02.628.190", "FX": "Traditional Medicine Practitioners", "MH_TH": "NLM (2002)", "ST": "T091", "AN": "specialty only; do not confuse with PHYTOTHERAPY", "PI": "Phytotherapy (1989-2001)", "MS": "The study of medicines derived from botanical sources.", "PM": "2002", "HN": "2002", "MR": "20220712", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029001"}, {"RECTYPE": "D", "MH": "Steam Bath", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Sweat Lodge|T056|T061|NON|NRW|NLM (2002)|010410|abbcdef", "ENTRY": "Saunas, Finnish", "MN": "E02.565.640", "MH_TH": "NLM (2002)", "ST": "T061", "PI": "Baths, Finnish (1963-2001)", "MS": "Therapy of sitting in a hot steamy room followed by a cool bath or shower.", "PM": "2002; see BATHS, FINNISH 1963-2001", "HN": "2002(1963)", "MR": "20210304", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029002"}, {"RECTYPE": "D", "MH": "Peste-des-Petits-Ruminants", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "ENTRY": "Peste des Petits Ruminants", "MN": "C22.706", "MH_TH": "NLM (1998)", "ST": "T047", "PI": "Rinderpest (1971-2001)", "MS": "A highly fatal contagious disease of goats and sheep caused by PESTE-DES-PETITS-RUMINANTS VIRUS. The disease may be acute or subacute and is characterized by stomatitis, conjunctivitis, diarrhea, and pneumonia.", "PM": "2002; see RINDERPEST 1998-2001", "HN": "2002; use RINDERPEST 1998-2001", "MR": "20190617", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029021"}, {"RECTYPE": "D", "MH": "Acoraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.010", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid42228", "AN": "prefer specific plant", "MS": "A plant family of the order Arales, subclass Arecidae, class Liliopsida (monocot).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029022"}, {"RECTYPE": "D", "MH": "Acorus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sedge, Sweet|T002|NON|NRW|NLM (2002)|010522|abcdef", "ENTRY": "Sweet Sedges", "MN": "B01.875.800.575.912.250.010.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4464", "RR": "txid55184", "AN": "note entry terms CALAMUS ROOT and ACORUS CALAMUS: do not confuse with the genus CALAMUS", "PI": "Plants, Medicinal (1966-2001)", "MS": "A plant genus of the family ACORACEAE, order Arales, subclass Arecidae most notable for Acorus calamus L. root which contains asarone and has been used in TRADITIONAL MEDICINE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029023"}, {"RECTYPE": "D", "MH": "Marburgvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Ravn Virus|T005|NON|NRW|NLM (2024)|230214|abcdef", "ENTRY": "Virus, Ravn", "MN": "B04.820.480.937.300.650", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid186537", "RR": "txid11269", "MS": "A genus in the family FILOVIRIDAE consisting of one species (Lake Victoria marburgvirus) with several strains. The genus shows no antigenic cross-reactivity with EBOLAVIRUS.", "PM": "2007; use MARBURG-LIKE VIRUSES 2002-2006; for LAKE VICTORIA MARBURGVIRUS see MARBURG VIRUS 1991-2001, see RHABDOVIRIDAE 1981-1990, see RHABDOVIRUSES 1978-1980, see RNA VIRUSES 1975-1977", "HN": "2007 (2002); for LAKE VICTORIA MARBURGVIRUS use MARBURG-LIKE VIRUSES 1991-2001, use RHABDOVIRIDAE 1981-1990, use RHABDOVIRUSES 1978-1980, see RNA VIRUSES 1975-1977", "MR": "20230405", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029024"}, {"RECTYPE": "D", "MH": "Actinidiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.341.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3623", "AN": "prefer specific plant", "MS": "A plant family of the order Theales, subclass Dilleniidae, class Magnoliopsida. It is best known for Kiwi fruit (ACTINIDIA).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029041"}, {"RECTYPE": "D", "MH": "Actinidia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Kiwi Plant|T002|NON|EQV|NLM (2002)|010411|abcdef", "ENTRY": "deliciosas, Actinidia", "MN": "B01.875.800.575.912.250.341.500.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3624", "RR": "txid3627", "MS": "A plant species of the family ACTINIDIACEAE, order ERICALES.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029042"}, {"RECTYPE": "D", "MH": "Ebolavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Ebola Virus, Zaire|T005|EPO|NRW|NLM (2002)|010411|abcdef", "ENTRY": "Viruses, Ebola", "MN": "B04.820.480.937.300.200", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid186536", "RR": "txid128951", "MS": "A genus in the family FILOVIRIDAE consisting of several distinct species of Ebolavirus, each containing separate strains. These viruses cause outbreaks of a contagious, hemorrhagic disease (HEMORRHAGIC FEVER, EBOLA) in humans, usually with high mortality.", "PM": "2007; see EBOLA-LIKE VIRUSES 2002-2006", "HN": "2007 (2002)", "MR": "20200902", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029043"}, {"RECTYPE": "D", "MH": "Achyranthes", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Achyranthe", "MN": "B01.875.800.575.912.250.198.500.100.100", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid169205", "MS": "A plant genus of the family AMARANTHACEAE, order Caryophyllales, which has been used in traditional medicine (MEDICINE, CHINESE TRADITIONAL).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029044"}, {"RECTYPE": "D", "MH": "Rhus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sumac|T002|NON|EQV|NLM (2002)|010411|abcdef", "ENTRY": "Sumacs", "MN": "B01.875.800.575.912.250.044.666", "MH_TH": "NLM (1993)", "ST": "T002", "RN": "txid4012", "PI": "Toxicodendron (1993-2001)", "MS": "A plant genus of the family Anacardiaceae, order Sapindales, subclass Rosidae. It is a source of gallotannin (TANNIC ACID) and of somewhat edible fruit. Do not confuse with TOXICODENDRON which used to be part of this genus.", "PM": "2002; see TOXICODENDRON 1993-2001, see RHUS 1963-1992", "HN": "2002; use TOXICODENDRON 1993-2001, use RHUS 1963-1992", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029045"}, {"RECTYPE": "D", "MH": "Annonaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Porcelia|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Yingzhaos", "MN": "B01.875.800.575.912.250.065", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid22140", "RR": "txid306974", "MS": "The custard-apple plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. Some members provide large pulpy fruits and commercial timber. Leaves and wood are often fragrant. Leaves are simple, with smooth margins, and alternately arranged in two rows along the stems.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029061"}, {"RECTYPE": "D", "MH": "Apocynaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rhazya|T002|NON|NRW|NLM (2003)|020404|abcdef", "ENTRY": "Gongronema|T002|NON|NRW|NLM (2004)|030417|abcdef", "MN": "B01.875.800.575.912.250.456.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4056", "RR": "txid84860", "MS": "The dogbane family of the order Gentianales.  Members of the family have milky, often poisonous juice, smooth-margined leaves, and flowers in clusters.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029062"}, {"RECTYPE": "D", "MH": "Aquifoliaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.084", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4294", "AN": "prefer specific plant", "MS": "The holly plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029063"}, {"RECTYPE": "D", "MH": "Araceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Symplocarpus|T002|NON|NRW|NLM (2003)|010824|abcdef", "ENTRY": "stratiote, Pistia", "MN": "B01.875.800.575.912.250.618.050.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4454", "RR": "txid78383", "MS": "A plant family of the order ALISMATALES. Many members contain OXALIC ACID and calcium oxalate (OXALATES).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029064"}, {"RECTYPE": "D", "MH": "Aristolochiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.096", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid16727", "AN": "prefer specific plant", "MS": "A plant family of the order Aristolochiales subclass Magnoliidae class Magnoliopsida. They are mostly tropical woody vines and a few temperate-zone species. The flowers are 3-parted; some species lack petals while others are large and foul smelling.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029065"}, {"RECTYPE": "D", "MH": "Balsaminaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.341.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid25692", "MS": "A plant family of the order Geraniales (or Ericales in APG system), subclass Rosidae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029068"}, {"RECTYPE": "D", "MH": "Impatiens", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Touch-me-not|T002|NON|NRW|NLM (2002)|010411|abcdef", "ENTRY": "balsamina, Impatiens", "MN": "B01.875.800.575.912.250.341.750.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid35939", "RR": "txid63779", "MS": "A plant genus of subsucculent annual or perennial plants in the family BALSAMINACEAE, order Geraniales.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029069"}, {"RECTYPE": "D", "MH": "Sendai virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hemagglutinating Virus of Japan|T005|EPO|EQV|NLM (1997)|950920|abcdef", "ENTRY": "Japan Hemagglutinating Virus", "MN": "B04.820.480.937.600.650.700.800", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid11191", "AN": "infection: coordinate IM with RESPIROVIRUS INFECTIONS (IM)", "PI": "Respirovirus (1965-2001)", "MS": "The type species of RESPIROVIRUS in the subfamily PARAMYXOVIRINAE. It is the murine version of HUMAN PARAINFLUENZA VIRUS 1, distinguished by host range.", "PM": "2002; see PARAMYXOVIRUS 1997-2001, see PARAINFLUENZA VIRUS TYPE 1 1977-1996, see SENDAI VIRUS 1964-1976; for SHIPPING FEVER VIRUS see PARAMYXOVIRUS 1997-2001, see PARAINFLUENZA VIRUS TYPE 3 1976-1996", "HN": "2002; use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 1 1977-1996, use SENDAI VIRUS 1964-1976; for SHIPPING FEVER VIRUS use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 3 1976-1996", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029082"}, {"RECTYPE": "D", "MH": "Parainfluenza Virus 3, Bovine", "DS": "PARAINFLUENZA VIRUS BOVINE 003", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Shipping Fever Virus|T005|NON|EQV|NLM (1997)|950920|abcdef", "ENTRY": "Shipping Fever Viruses", "MN": "B04.820.480.937.600.650.700.700", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid11215", "AN": "infection: coord IM with RESPIROVIRUS INFECTIONS (IM) but consider also PASTEURELLOSIS, PNEUMONIC", "PI": "Respirovirus (1965-2001)", "MS": "A species of RESPIROVIRUS, subfamily PARAMYXOVIRINAE, most often seen in conjunction with a secondary infection of MANNHEIMIA HAEMOLYTICA resulting in pneumonic pasteurellosis (PASTEURELLOSIS, PNEUMONIC).", "PM": "2002; see PARAMYXOVIRUS 1997-2001, see PARAINFLUENZA VIRUS TYPE 3 1976-1996", "HN": "2002; use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 3 1976-1996", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029101"}, {"RECTYPE": "D", "MH": "Metapneumovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Rhinotracheitis Virus, Turkey|T005|NON|NRW|NLM (1994)|930209|abcdef", "ENTRY": "Metapneumoviruses, Human", "MN": "B04.820.480.937.600.670.500", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid162387", "RR": "txid38525", "AN": "infection: coord IM with PARAMYXOVIRIDAE INFECTIONS (IM)", "MS": "A genus of the subfamily PNEUMOVIRINAE, containing two members: Turkey rhinotracheitis virus and a human Metapneumovirus. Virions lack HEMAGGLUTININ and NEURAMINIDASE.", "PM": "2002; for RHINOTRACHEITIS VIRUS, TURKEY see PNEUMOVIRUS 1994-2001", "HN": "2002; for RHINOTRACHEITIS VIRUS, TURKEY use PNEUMOVIRUS 1994-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029121"}, {"RECTYPE": "D", "MH": "Murine pneumonia virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Pneumonia Virus of Mice|T005|NON|EQV|NLM (1994)|930209|abcdef", "ENTRY": "pneumonia viruses, Murine", "MN": "B04.820.480.937.600.670.600.550", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11263", "AN": "infection: coord IM with PNEUMOVIRUS INFECTIONS; index also PNEUMONIA, VIRAL if pertinent", "PI": "Pneumovirus (1994-2001)", "MS": "A species of the genus PNEUMOVIRUS causing pneumonia in mice.", "PM": "2002; see PNEUMOVIRUS 1994-2001", "HN": "2002; use PNEUMOVIRUS 1994-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029122"}, {"RECTYPE": "D", "MH": "Novirhabdovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hirame rhabdovirus|T005|EPO|NRW|NLM (2002)|010413|abcdef", "ENTRY": "Novirhabdoviruses", "MN": "B04.820.480.937.750.600", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid186778", "RR": "txid1980915", "AN": "infection: coord IM with RHABDOVIRIDAE INFECTIONS (IM)", "MS": "A genus in the family RHABDOVIRIDAE, infecting numerous species of fish with broad geographic distribution. The type species is INFECTIOUS HEMATOPOIETIC NECROSIS VIRUS.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029141"}, {"RECTYPE": "D", "MH": "Infectious hematopoietic necrosis virus", "DE": "INFECT HEMATOPOIETIC NECROSIS VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "IHNV|T005|ACR|EQV|NLM (2002)|010413|abcdef", "MN": "B04.820.480.937.750.600.400", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11290", "AN": "do not confuse with INFECTIOUS HYPODERMAL AND HEMATOPOIETIC NECROSIS VIRUS see DENSOVIRINAE; infection: coord IM with RHABDOVIRIDAE INFECTIONS (IM)", "PI": "Rhabdoviridae (1981-2001)", "MS": "The type species of NOVIRHABDOVIRUS, in the family RHABDOVIRIDAE. It is a major pathogen of TROUT and SALMON.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029142"}, {"RECTYPE": "D", "MH": "Oleavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Olive latent virus 2|T005|NON|NRW|NLM (2002)|010413|OLIVE LATENT VIRUS 002|abcdefs", "ENTRY": "Oleaviruses", "MN": "B04.820.578.282.700", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid154322", "RR": "txid33773", "AN": "coord IM with speciic plant /virol", "PI": "Bromoviridae (1997-2001)", "MS": "A genus in the family BROMOVIRIDAE containing one species: Olive latent virus 2.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029161"}, {"RECTYPE": "D", "MH": "Spirituality", "PRINT ENTRY": "Spiritual Sensitivity|T078|NON|EQV|NLM (2023)|211108|abcdef", "ENTRY": "Spiritualities", "MN": "K01.844.664.500", "FX": "Spiritual Therapies", "MH_TH": "NLM (2002)", "ST": "T078", "MS": "Sensitivity or attachment to religious values, or to things of the spirit as opposed to material or worldly interests. (from Merriam-Webster's Collegiate Dictionary, 10th ed, and Oxford English Dictionary, 2nd ed)", "PM": "2002", "HN": "2002", "MR": "20220712", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029181"}, {"RECTYPE": "D", "MH": "Hamamelidaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.475", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid42216", "AN": "general or unspecified; prefer specifics; for therapy, coordinate with PLANT PREPARATIONS or specifics and PHYTOTHERAPY and disease /drug ther", "MS": "A plant family of the order Hamamelidales, subclass Hamamelidae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029201"}, {"RECTYPE": "D", "MH": "Faith Healing", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Prayer Healing|T061|NON|NRW|NLM (1996)|950404|abcdef", "ENTRY": "Healing, Prayer", "MN": "E02.190.901.155", "MH_TH": "UNK (19XX)", "ST": "T061", "PI": "Mental Healing (1983-2001)", "MS": "The use of faith and spirit to cure disease.", "PM": "2002; see MENTAL HEALING 1983-2001", "HN": "2002; use MENTAL HEALING 1983-2001", "MR": "20180629", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029221"}, {"RECTYPE": "D", "MH": "Piper nigrum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "White Pepper|T168|NON|NRW|NLM (1998)|970206|abcdef", "ENTRY": "Pepper, White", "MN": "B01.875.800.575.912.250.812.666.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13216", "AN": "see entry terms at CAPSICUM for other types of pepper", "MS": "A plant species in the PIPERACEAE plant family. It is a common spice on foods and is used medicinally to increase gastrointestinal assimilation of other supplements and drugs. Piperine is a key component. Black pepper is picked unripe and heaped for a few days to ferment. White Pepper is the ripe fruit dehulled by maceration in water.", "PM": "2002; for BLACK PEPPER see BLACK PEPPER 2001-2015; for WHITE PEPPER see SPICES 1998-2001", "HN": "2002; for BLACK PEPPER use SPICES 1993-2001; for WHITE PEPPER use SPICES 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029222"}, {"RECTYPE": "D", "MH": "Ascoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Ascovirus|T005|NON|NRW|NLM (2002)|010416|abcdef", "ENTRY": "Toursvirus|T005|NON|NRW|NLM (2018)|161028|abcdef", "MN": "B04.525.045", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid43682", "RR": "txid43680", "PI": "Insect Viruses (1990-2001)", "MS": "A family of insect viruses causing disease in lepidopterous larvae, most commonly from species of the owlet moth family Noctuidae.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029223"}, {"RECTYPE": "D", "MH": "Optic Atrophy, Autosomal Dominant", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Optic Atrophy, Hereditary, Autosomal Dominant|T047|NON|EQV|GHR (2014)|NLM (2002)|010516|abcdeef", "ENTRY": "Optic Atrophy, Kjer-Type", "MN": "C18.452.660.665", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Optic Atrophy, Hereditary (1989-2001)", "MS": "Dominant optic atrophy is a hereditary optic neuropathy causing decreased visual acuity, color vision deficits, a centrocecal scotoma, and optic nerve pallor (Hum. Genet. 1998; 102: 79-86). Mutations leading to this condition have been mapped to the OPA1 gene at chromosome 3q28-q29. OPA1 codes for a dynamin-related GTPase that localizes to mitochondria.", "PM": "2002; see OPTIC ATROPHIES, HEREDITARY 2000-2001", "HN": "2002; use OPTIC ATROPHIES, HEREDITARY 2000-2001", "MR": "20130708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029241"}, {"RECTYPE": "D", "MH": "Optic Atrophy, Hereditary, Leber", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Leber Hereditary Optic Atrophy|T047|EPO|EQV|GHR (2014)|NLM (1999)|980413|abcdeef", "ENTRY": "Optic Neuroretinopathy, Hereditary", "MN": "C18.452.660.670", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "Optic Atrophy/genetics (1977-1988)", "MS": "A maternally linked genetic disorder that presents in mid-life as acute or subacute central vision loss leading to central scotoma and blindness. The disease has been associated with missense mutations in the mtDNA, in genes for Complex I, III, and IV polypeptides, that can act autonomously or in association with each other to cause the disease. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim/, MIM#535000 (April 17, 2001))", "PM": "2002; see OPTIC ATROPHIES, HEREDITARY 1999-2001", "HN": "2002; use OPTIC ATROPHIES, HEREDITARY 1999-2001", "MR": "20130708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029242"}, {"RECTYPE": "D", "MH": "Sin Nombre virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Muerto Canyon Virus|T005|EPO|EQV|NLM (1995)|940307|abcdef", "MN": "B04.820.480.750.440.700", "MH_TH": "NLM (2001)", "ST": "T005", "RN": "txid1980491", "PI": "Hantavirus (1994-2001)", "MS": "A species of ORTHOHANTAVIRUS which emerged in the Four Corners area of the United States in 1993. It causes a serious, often fatal pulmonary illness (HANTAVIRUS PULMONARY SYNDROME) in humans. Transmission is by inhaling aerosolized rodent secretions that contain virus particles, carried especially by deer mice (PEROMYSCUS maniculatus) and pinyon mice (P. truei).", "PM": "2002; see HANTAVIRUS 1995-2001", "HN": "2002; use HANTAVIRUS 1995-2001", "MR": "20220715", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029261"}, {"RECTYPE": "D", "MH": "Puumala virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.480.750.440.600", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid1980486", "AN": "infection: coord IM with HEMORRHAGIC FEVER WITH RENAL SYNDROME (IM)", "PI": "Hantavirus (1985-2001)", "MS": "A species of ORTHOHANTAVIRUS causing nephropathia epidemica, a mild form of HEMORRHAGIC FEVER WITH RENAL SYNDROME. It is found in most of Europe and especially in Finland, along with its carrier rodent, the bank vole (Clethrionomys glareolus).", "PM": "2002; see HANTAVIRUS 1994-2001", "HN": "2002; use HANTAVIRUS 1994-2001", "MR": "20220715", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029262"}, {"RECTYPE": "D", "MH": "Seoul virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.480.750.440.690", "MH_TH": "NLM (1992)", "ST": "T005", "RN": "txid1980490", "AN": "infection: coord IM with HEMORRHAGIC FEVER WITH RENAL SYNDROME (IM)", "PI": "Hantavirus (1993-2001)", "MS": "A species of ORTHOHANTAVIRUS causing a less severe form of HEMORRHAGIC FEVER WITH RENAL SYNDROME in Asia (primarily Korea and Japan). It is transmitted by rats, especially Rattus rattus and R. norvegicus.", "PM": "2002; see HANTAVIRUS 1992-2001", "HN": "2002; use HANTAVIRUS 1992-2001", "MR": "20220715", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029263"}, {"RECTYPE": "D", "MH": "Nairobi sheep disease virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Ganjam virus|T005|NON|REL|NLM (2002)|010418|abcdef", "MN": "B04.820.480.750.565.600", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid194540", "RR": "txid1980521", "PI": "Nairovirus (1996-2001)", "MS": "A species of NAIROVIRUS, transmitted by the ixodid ticks and producing a lethal gastroenteritis in sheep and goats. Though a major veterinary pathogen, its effect on humans has not been firmly established.", "PM": "2002; for DUGBE VIRUS see NAIROVIRUS 1994-2017", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029281"}, {"RECTYPE": "D", "MH": "Patient Education Handout", "ENTRY": "Consumer Information Handout|T170|NON|REL|NLM (2008)|070626|abcdef", "MN": "V02.725.750", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "this heading is used as a Publication Type", "MS": "Works consisting of a handout or self-contained informative material used to explain a procedure or a condition or the contents of a specific article in a biomedical journal and written in non-technical language for the patient or consumer.", "HN": "2008(2002)", "MR": "20070709", "DA": "20010725", "DC": "2", "DX": "20020101", "UI": "D029282"}, {"RECTYPE": "D", "MH": "Sandfly fever Naples virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Toscana virus|T005|EPO|NRW|NLM (2002)|010418|abcdef", "MN": "B04.820.480.750.710.750", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid206160", "RR": "txid206161", "AN": "do not confuse with SANDFLY FEVER SICILIAN VIRUS see PHLEBOVIRUS; infection: coord IM with PHLEBOTOMUS FEVER (IM) or if not so specified coord with BUNYAVIRIDAE INFECTIONS (IM)", "PI": "Phlebovirus (1977-2001)", "MS": "A species in the genus PHLEBOVIRUS causing PHLEBOTOMUS FEVER, an influenza-like illness. Related serotypes include Toscana virus and Tehran virus.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029301"}, {"RECTYPE": "D", "MH": "Lagovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.578.298.500", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid95339", "AN": "infection: coordinate IM with CALICIVIRIDAE INFECTIONS (IM)", "MS": "A genus of the family CALICIVIRIDAE, associated with infections in rabbits and hares, responsible for epidemics with high mortality. RABBIT HEMORRHAGIC DISEASE VIRUS is the type species.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029321"}, {"RECTYPE": "D", "MH": "Norovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Small Round-Structured Viruses|T005|NON|REL|NLM (1992)|901004|SRSV|abcdefv", "ENTRY": "Small Round Structured Viruses", "MN": "B04.820.578.298.550", "MH_TH": "NLM (2004)", "ST": "T005", "RN": "txid142786", "AN": "infection: coord IM with CALICIVIRIDAE INFECTIONS + probably GASTROENTERITIS (IM)", "MS": "A genus in the family CALICIVIRIDAE, associated with epidemic GASTROENTERITIS in humans. The type species, NORWALK VIRUS, contains multiple strains.", "PM": "2004; see NORWALK-LIKE VIRUSES 2002-2003; for SMALL ROUND-STRUCTURED VIRUSES see NORWALK VIRUS 1992-2001", "HN": "2004 (2002); for SMALL ROUND-STRUCTURED VIRUSES use NORWALK VIRUS 1992-2001", "MR": "20200902", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029322"}, {"RECTYPE": "D", "MH": "Sapovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Sapporo-like Viruses|T005|NON|EQV|NLM (2002)|010419|abcdef", "ENTRY": "Sapporo like Viruses", "MN": "B04.820.578.298.775", "MH_TH": "NLM (2004)", "ST": "T005", "RN": "txid95341", "RR": "txid95342", "AN": "infection: coord IM with CALICIVIRIDAE INFECTIONS + probably GASTROENTERITIS (IM)", "MS": "A genus of the family CALICIVIRIDAE associated with worldwide sporadic outbreaks of GASTROENTERITIS in humans. The first recorded outbreak was in human infants in Sapporo, Japan in 1977. The genus is comprised of a single species, Sapporo virus, containing multiple strains.", "PM": "2004; see SAPPORO-LIKE VIRUSES 2002-2003", "HN": "2004 (2002)", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029341"}, {"RECTYPE": "D", "MH": "Vesivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Vesiviruses", "MN": "B04.820.578.298.887", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid95337", "AN": "infection: coord IM with CALICIVIRIDAE INFECTIONS (IM)", "MS": "A genus of the family CALICIVIRIDAE comprised of species infecting a wide range of organisms. Most members of this genus can be readily propagated in cell culture (as opposed to other genera of Caliciviridae). The type species is VESICULAR EXANTHEMA OF SWINE VIRUS.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029342"}, {"RECTYPE": "D", "MH": "Organic Anion Transporters, Sodium-Independent", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sodium Independent Organic Anion Transporters", "MN": "D12.776.543.585.450.074.500.875", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Ion Pumps (1994-2001)", "MS": "A subclass of ORGANIC ANION TRANSPORTERS that do not rely directly or indirectly upon sodium ion gradients for the transport of organic ions.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029362"}, {"RECTYPE": "D", "MH": "Organic Anion Transporters, Sodium-Dependent", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Organic Anion Transporters, Sodium Dependent", "MN": "D12.776.543.585.450.074.500.812", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Ion Pumps (1994-2001)", "MS": "A subclass of ORGANIC ANION TRANSPORTERS whose transport of organic anions is driven either directly or indirectly by a gradient of sodium ions.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029363"}, {"RECTYPE": "D", "MH": "Tenuivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Rice stripe virus|T005|NON|NRW|NLM (2002)|010419|abcdef", "ENTRY": "Tenuiviruses", "MN": "B04.820.480.984", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid12329", "RR": "txid12331", "AN": "coord IM with specific plant /virol", "PI": "RNA Viruses (1995-2001)", "MS": "A genus of RNA plant viruses as yet unassigned to any family. Plant hosts are all in the family Poaceae. Each species is transmitted by a particular species of planthopper. The type species is Rice stripe virus.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029364"}, {"RECTYPE": "D", "MH": "Organic Anion Transporters, ATP-Dependent", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Organic Anion Transporters, ATP Dependent", "MN": "D12.776.543.585.450.074.500.500", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Ion Pumps (1994-2001)", "MS": "A subclass of ORGANIC ANION TRANSPORTERS whose transport of organic anions is linked directly to the hydrolysis of ATP. The subclass includes those ATP-BINDING CASSETTE TRANSPORTERS that transport organic ions.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029365"}, {"RECTYPE": "D", "MH": "Closteroviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Velariviruses", "MN": "B04.820.578.313", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid69973", "RR": "txid1513308", "AN": "coord IM with specific plant /virol", "MS": "A family of plant viruses containing the largest single-stranded RNA genomes. Infections typically involve yellowing and necrosis, particularly affecting the phloem.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029381"}, {"RECTYPE": "D", "MH": "Dicarboxylic Acid Transporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dicarboxylate-Binding Protein|T116|T123|NON|EQV|NLM (2002)|abbcde", "ENTRY": "Transporters, Dicarboxylic Acid", "MN": "D12.776.543.585.450.074.500.149", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Ion Pumps (1994-2001)", "MS": "A family of organic anion transporters that specifically transport DICARBOXYLIC ACIDS such as alpha-ketoglutaric acid across cellular membranes.", "PM": "2002; DICARBOXYLATE TRANSPORT PROTEIN (now DICARBOXYLIC ACID TRANSPORTERS) was indexed under CARRIER PROTEINS 1981-2001", "HN": "2002; use DICARBOXYLIC ACID TRANSPORTERS (NM) 1981-2001", "MR": "20110624", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029382"}, {"RECTYPE": "D", "MH": "Crinivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Lettuce infectious yellows virus|T005|NON|NRW|NLM (2002)|010419|abcdef", "ENTRY": "Criniviruses", "MN": "B04.820.578.313.175", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid67753", "RR": "txid31713", "AN": "coord IM with specific plant /virol", "MS": "A genus of plant viruses in the family CLOSTEROVIRIDAE. Transmission is by whiteflies. Lettuce infectious yellows virus is the type species.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029383"}, {"RECTYPE": "D", "MH": "Betulaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ostrya|T002|NON|NRW|NLM (2003)|010828|abcdef", "ENTRY": "Ostryopses", "MN": "B01.875.800.575.912.250.859.750.200", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3514", "RR": "txid78606", "AN": "general or unspecified; prefer specifics", "MS": "A plant family of the order Fagales, subclass Hamamelidae, class Magnoliopsida. They have simple, serrate, alternate leaves. Male flowers are borne in long, pendulous catkins; the female in shorter, pendulous or erect catkins. The fruit is usually a small nut or a short-winged samara.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029401"}, {"RECTYPE": "D", "MH": "Bignoniaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Tecoma|T002|NON|NRW|NLM (2004)|030417|abcdef", "MN": "B01.875.800.575.912.250.583.080", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid24079", "RR": "txid69903", "MS": "A plant family of the order Lamiales. The family is characterized by oppositely paired, usually compound leaves and bell- or funnel-shaped, bisexual flowers having a five-lobed calyx and corolla.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029402"}, {"RECTYPE": "D", "MH": "Burseraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.162", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4014", "MS": "A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. They are resinous trees and shrubs with alternate leaves composed of many leaflets.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029403"}, {"RECTYPE": "D", "MH": "Activin Receptors", "DE": "ACTIVIN RECEPT", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Activin Receptor-Like Kinases|T116|T126|T192|NON|EQV|NLM (2002)|010329|ACTIVIN RECEPT LIKE KINASES|abbbcdefv", "ENTRY": "Receptors, Activin", "MN": "D12.776.543.750.750.400.820.500", "MH_TH": "NLM (2002)", "ST": "T192", "RN": "EC 2.7.11.30", "PI": "Receptors, Cell Surface (1989-1992)", "MS": "Receptors for ACTIVINS are membrane protein kinases belonging to the family of PROTEIN-SERINE-THREONINE KINASES, thus also named activin receptor-like kinases (ALK's). Activin receptors also bind TRANSFORMING GROWTH FACTOR BETA. As those transmembrane receptors of the TGF-beta superfamily (RECEPTORS, TRANSFORMING GROWTH FACTOR BETA), ALK's consist of two different but related protein kinases, Type I and Type II. Activins initiate cellular signal transduction by first binding to the type II receptors (ACTIVIN RECEPTORS, TYPE II ) which then recruit and phosphorylate the type I receptors (ACTIVIN RECEPTORS, TYPE I ) with subsequent activation of the type I kinase activity.", "PM": "2002; ACTIVIN RECEPTORS was indexed under RECEPTORS, GROWTH FACTOR 1991-2002", "HN": "2002(1991)", "MR": "20210421", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029404"}, {"RECTYPE": "D", "MH": "GB virus A", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Pegivirus A|T005|NON|EQV|NLM (2021)|200605|abcdef", "ENTRY": "GBV-A|T005|ABB|EQV|NLM (1997)|960216|abcdef", "MN": "B04.820.578.344.588.500", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid1307800", "AN": "infection: coordinate with FLAVIVIRIDAE INFECTIONS", "PI": "Hepatitis Agents, GB (1998-2001)", "MS": "A species of virus in the family FLAVIVIRIDAE, that have been identified in at least six species of New World monkeys. They do not cause HEPATITIS in the host or other susceptible species.", "PM": "2002; see HEPATITIS AGENTS, GB 1997-2001", "HN": "2002; use HEPATITIS AGENTS, GB 1997-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029405"}, {"RECTYPE": "D", "MH": "GB virus B", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "GBV-B|T005|ABB|EQV|NLM (1997)|960216|abcdef", "MN": "B04.820.578.344.475.405", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid39113", "AN": "infection: coord IM with FLAVIVIRIDAE INFECTIONS (IM) + HEPATITIS, VIRAL, HUMAN (IM) or HEPATITIS, VIRAL, ANIMAL (IM)", "PI": "Hepatitis Agents, GB (1999-2001)", "MS": "A species of virus (tentatively placed in the genus HEPACIVIRUS) in the family FLAVIVIRIDAE, that was recovered from a tamarin monkey, but may have been of human origin. It causes HEPATITIS in several species of New World monkeys.", "PM": "2002; see HEPATITIS AGENTS, GB 1997-2001", "HN": "2002; use HEPATITIS AGENTS, GB 1997-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029406"}, {"RECTYPE": "D", "MH": "GB virus C", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Pegivirus C|T005|NON|EQV|NLM (2021)|200605|abcdef", "ENTRY": "Pegivirus-1, Human", "MN": "B04.820.578.344.588.750", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid54290", "AN": "infection: coordinate with FLAVIVIRIDAE INFECTIONS + HEPATITIS, VIRAL, HUMAN or HEPATITIS, VIRAL, ANIMAL if pertinent", "PI": "Hepatitis Agents, GB (1996-2001)", "MS": "A species of virus in the family FLAVIVIRIDAE. It is genetically heterogeneous, of human origin, and transmitted by blood or blood products. Despite its alternate name (Hepatitis G virus), its pathogenicity remains controversial.", "PM": "2002; see HEPATITIS AGENTS, GB 1997-2001", "HN": "2002; use HEPATITIS AGENTS, GB 1997-2001", "MR": "20210316", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029407"}, {"RECTYPE": "D", "MH": "Cactaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cactus|T002|NON|EQV|NLM (2002)|010521|abcdef", "MN": "B01.875.800.575.912.250.198.500.200", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3593", "MS": "The cactus plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. Cacti are succulent perennial plants well adapted to dry regions.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029421"}, {"RECTYPE": "D", "MH": "Campanulaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Campanula|T002|NON|NRW|NLM (2003)|010925|abcdef", "ENTRY": "Campanulas", "MN": "B01.875.800.575.912.250.171", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4381", "RR": "txid82270", "AN": "general or unspecified; prefer specifics", "MS": "A plant family of the order Campanulales, subclass Asteridae, class Magnoliopsida", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029422"}, {"RECTYPE": "D", "MH": "Pulmonary Disease, Chronic Obstructive", "DE": "PULM DIS CHRONIC OBSTRUCTIVE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chronic Obstructive Pulmonary Diseases|T047|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Chronic Airflow Obstructions", "MN": "C23.550.291.500.875", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "LUNG DISEASES, OBSTRUCTIVE is also available", "PI": "Pulmonary Emphysema (1965-1971)", "MS": "A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.", "PM": "2002; see LUNG DISEASES, OBSTRUCTIVE 1984-2001", "HN": "2002; use LUNG DISEASES, OBSTRUCTIVE 1984-2001", "MR": "20210312", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029424"}, {"RECTYPE": "D", "MH": "Carica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Papaya|T168|NON|REL|NLM (2002)|010420|abcdef", "ENTRY": "papaya, Carica", "MN": "B01.875.800.575.912.250.192.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3648", "RR": "txid3649", "MS": "A plant genus of the family Caricaceae, order Violales, subclass Dilleniidae, class Magnoliopsida. It is the source of edible fruit and PAPAIN.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029441"}, {"RECTYPE": "D", "MH": "Sialic Acid Storage Disease", "DE": "SIALIC ACID STORAGE DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sialuria, Infantile Form|T047|NON|NRW|NLM (2002)|OMIM (2013)|ORD (2010)|010420|abcdeeef", "ENTRY": "Sialurias, Infantile Form", "MN": "C18.452.648.595.554.810", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Lysosomal Storage Diseases (1991-2001)", "MS": "Autosomal recessive neurodegenerative disorders caused by lysosomal membrane transport defects that result in accumulation of free sialic acid (N-ACETYLNEURAMINIC ACID) within the lysosomes. The two main clinical phenotypes, which are allelic variants of the SLC17A5 gene, are ISSD, a severe infantile form, or Salla disease, a slowly progressive adult form, named for the geographic area in Finland where the kindred first studied resided.", "PM": "2002", "HN": "2002", "MR": "20130708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029461"}, {"RECTYPE": "D", "MH": "Bronchitis, Chronic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Chronic Bronchitis|T047|NON|EQV|NLM (2002)|010423|abcdef", "MN": "C23.550.291.500.875.750", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "BRONCHITIS is also available", "PI": "Bronchitis (1965-2001)", "MS": "A subcategory of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. The disease is characterized by hypersecretion of mucus accompanied by a chronic (more than 3 months in 2 consecutive years) productive cough. Infectious agents are a major cause of chronic bronchitis.", "PM": "2002", "HN": "2002", "MR": "20210312", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029481"}, {"RECTYPE": "D", "MH": "Parainfluenza Virus 4, Human", "DS": "PARAINFLUENZA VIRUS HUMAN 004", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human parainfluenza virus 4|T005|NON|EQV|NLM (2002)|010413|HUMAN PARAINFLUENZA VIRUS 004|abcdefs", "MN": "B04.820.480.937.600.650.750.717", "MH_TH": "NLM (1997)", "ST": "T005", "RN": "txid1979161", "AN": "infection: coord IM with RUBULAVIRUS INFECTIONS (IM)", "PI": "Rubulavirus (1997-2001)", "MS": "A species of RUBULAVIRUS causing endemic upper respiratory infections in children. It produces only a mild clinical disease and often goes undetected.", "PM": "2002; see RUBULAVIRUS 1997-2001, see PARAINFLUENZA VIRUSES 1994-1996", "HN": "2002; use RUBULAVIRUS 1997-2001, use PARAINFLUENZA VIRUSES 1994-1996", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029482"}, {"RECTYPE": "D", "MH": "Hamamelis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Witch Hazel|T002|NON|NRW|NLM (2002)|010423|abcdef", "ENTRY": "virginianas, Hamamelis", "MN": "B01.875.800.575.912.250.475.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4395", "RR": "txid4397", "AN": "do not confuse with HAMELIA;", "MS": "A plant genus of the family Hamamelidaceae, order Hamamelidales. It is known for the astringent (ASTRINGENTS) extract of leaves and bark used in over the counter preparations. This should not be confused with the similar named Hamelia genus (RUBIACEAE).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029501"}, {"RECTYPE": "D", "MH": "Anemia, Hypoplastic, Congenital", "DE": "ANEMIA HYPOPLASTIC CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hypoplastic Anemia, Congenital|T047|NON|EQV|NLM (1992)|910131|HYPOPLASTIC ANEMIA CONGEN|abcdefv", "ENTRY": "Hypoplastic Anemias, Congenital", "MN": "C16.320.077", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Fanconi Anemia (1992-2001)", "MS": "An inborn condition characterized by deficiencies of red cell precursors that sometimes also includes LEUKOPENIA and THROMBOCYTOPENIA.", "PM": "2002;see FANCONI ANEMIA 1992-2001", "HN": "2002; use FANCONI ANEMIA 1992-2001", "MR": "20230226", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029502"}, {"RECTYPE": "D", "MH": "Anemia, Diamond-Blackfan", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Diamond-Blackfan Anemia|T047|EPO|EQV|GHR (2014)|NLM (1992)|OMIM (2013)|ORD (2010)|910109|abcdeeeef", "ENTRY": "Inherited Erythroblastopenias", "MN": "C16.320.077.090", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Fanconi Anemia (1992-2001)", "MS": "A rare congenital hypoplastic anemia that usually presents early in infancy. The disease is characterized by a moderate to severe macrocytic anemia, occasional neutropenia or thrombocytosis, a normocellular bone marrow with erythroid hypoplasia, and an increased risk of developing leukemia. (Curr Opin Hematol 2000 Mar;7(2):85-94)", "PM": "2002; see FANCONI ANEMIA 1992-2001", "HN": "2002; use FANCONI ANEMIA 1992-2001", "MR": "20230226", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029503"}, {"RECTYPE": "D", "MH": "Alphainfluenzavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Influenzavirus A|T005|NON|EQV|NLM (2002)|010423|abcdef", "ENTRY": "Alphainfluenzaviruses", "MN": "B04.820.480.968.405", "MH_TH": "NLM (2024)", "ST": "T005", "RN": "txid197911", "PI": "Orthomyxoviridae (1997-2001)", "MS": "A genus in the family ORTHOMYXOVIRIDAE causing influenza and other diseases in humans and animals. It contains many strains as well as antigenic subtypes of the integral membrane proteins hemagglutinin (VIRAL HEMAGGLUTININS) and NEURAMINIDASE. The type species is INFLUENZA A VIRUS.", "PM": "2024; see INFLUENZAVIRUS A 2002-2023", "HN": "2002", "MR": "20230405", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029521"}, {"RECTYPE": "D", "MH": "Hydrophyllaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.531", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4130", "AN": "prefer specific plant", "MS": "The waterleaf plant family of the order Solanales, subclass Asteridae, class Magnoliopsida. They have alternate leaves, regular flowers with five-lobed corollas (united petals), and a one- or two-celled ovary.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029522"}, {"RECTYPE": "D", "MH": "Illicium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Star Anise|T002|NON|NRW|NLM (2002)|010423|abcdef", "ENTRY": "Illicium verum|T002|NON|NRW|NLM (2002)|010423|abcdef", "MN": "B01.875.800.575.912.250.103.500.250", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13097", "RR": "txid124794", "AN": "note entry term STAR ANISE:  ANISE see PIMPINELLA is also available", "MS": "A plant genus of the family SCHISANDRACEAE, order AUSTROBAILEYALES, class MAGNOLIOPSIDA. They have evergreen, aromatic leaves and bisexual flowers. The female portion of the flower consists of 7 to 15 carpels.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029523"}, {"RECTYPE": "D", "MH": "Betainfluenzavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Influenzavirus B|T005|NON|EQV|NLM (2002)|010423|abcdef", "ENTRY": "Betainfluenzaviruses", "MN": "B04.820.480.968.407", "MH_TH": "NLM (2024)", "ST": "T005", "RN": "txid197912", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans or ORTHOMYXOVIRIDAE INFECTIONS (IM) in animals; INFLUENZA B VIRUS is also available", "PI": "Orthomyxoviridae (1997-2001)", "MS": "A genus of the family ORTHOMYXOVIRUS causing HUMAN INFLUENZA and other diseases primarily in humans. In contrast to INFLUENZAVIRUS A, no distinct antigenic subtypes of hemagglutinin (VIRAL HEMAGGLUTININ) and NEURAMINIDASE are recognized. The type species is INFLUENZA B VIRUS.", "PM": "2002; see INFLUENZAVIRUS B 2002-2023", "HN": "2002", "MR": "20230405", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029524"}, {"RECTYPE": "D", "MH": "Juglandaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.750.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid16714", "MS": "The walnut plant family of the order Juglandales, subclass Hamamelidae, class Magnoliopsida. They are mainly temperate zone trees.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029525"}, {"RECTYPE": "D", "MH": "Loganiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Spigelias", "MN": "B01.875.800.575.912.250.456.875", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid26468", "RR": "txid26495", "MS": "A plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida. They have leaflike appendages at the base of the leafstalks, have terminal flower clusters. Petals have four or five overlapping lobes and the fruit is a capsule containing winged or wingless seeds.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029541"}, {"RECTYPE": "D", "MH": "Lycopodiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Moss, Club|T002|NON|EQV|NLM (2003)|011004|abcdef", "ENTRY": "Mosses, Club", "MN": "B01.875.800.575.525", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3250", "AN": "note entry terms: do not confuse with the true MOSSES", "MS": "The club-moss plant family of the order Lycopodiales, class Lycopodiopsida, division Lycopodiophyta, subkingdom TRACHEOPHYTA. The common name of clubmoss applies to several genera of this family. Despite the name this is not one of the true mosses (BRYOPSIDA ).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029542"}, {"RECTYPE": "D", "MH": "Nucleocytoplasmic Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transport Proteins, Nucleocytoplasmic", "MN": "D12.776.543.585.750", "FX": "Active Transport, Cell Nucleus", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Nuclear Proteins (1980-2001)", "MS": "Proteins involved in the process of transporting molecules in and out the cell nucleus. Included here are: NUCLEOPORINS, which are membrane proteins that form the NUCLEAR PORE COMPLEX; KARYOPHERINS, which carry molecules through the nuclear pore complex; and proteins that play a direct role in the transport of karyopherin complexes through the nuclear pore complex.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D029543"}, {"RECTYPE": "D", "MH": "Foot-and-Mouth Disease Virus", "DE": "FOOT MOUTH DIS VIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Foot-and-Mouth Disease Viruses", "MN": "B04.820.578.750.070.250", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12110", "PI": "Aphthovirus (1964-2001)", "MS": "The type species of APHTHOVIRUS, causing FOOT-AND-MOUTH DISEASE in cloven-hoofed animals. Several different serotypes exist.", "PM": "2002, 1963-1993; see APHTHOVIRUS 1994-2001", "HN": "2002, 1963-1993; use APHTHOVIRUS 1994-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029544"}, {"RECTYPE": "D", "MH": "Lythraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Punicaceae|T002|NON|NRW|NLM (2003)|010919|abcdef", "MN": "B01.875.800.575.912.250.859.833.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3928", "MS": "The loosestrife plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. Members are mainly herbs and many of them contain ALKALOIDS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029561"}, {"RECTYPE": "D", "MH": "Magnoliaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Michelias", "MN": "B01.875.800.575.912.250.685", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3401", "RR": "txid13611", "MS": "A plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. They are trees and shrubs having an elongated conelike floral axis with fragrant flowers that have six tepals (sepals and petals that are not distinctly different) and many spirally arranged stamens.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029562"}, {"RECTYPE": "D", "MH": "Cellular Apoptosis Susceptibility Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Importin alpha Export Receptor CAS", "MN": "D12.776.543.585.750.200", "FX": "Apoptosis", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "MS": "A nucleocytoplasmic transport protein that binds to ALPHA KARYOPHERINS and RAN GTP BINDING PROTEIN inside the CELL NUCLEUS and participates in their export into CYTOPLASM. It is also associated with the regulation of APOPTOSIS and microtubule assembly.", "PM": "2002; CELLULAR APOPTOSIS SUSCEPTABILITY PROTEIN was indexed under PROTEINS 1995-2001", "HN": "2002; use CELLULAR APOPTOSIS SUSCEPTABILITY PROTEIN (NM) 1995-2001", "MR": "20050707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029563"}, {"RECTYPE": "D", "MH": "Malpighiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cherry, Acerola|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "glabras, Malpighia", "MN": "B01.875.800.575.912.250.859.797.690", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4268", "RR": "txid71611", "AN": "prefer specific plant", "MS": "A plant family of the order Polygalales, subclass Rosidae class, Magnoliopsida that are mostly shrubs and small trees. Many of the members contain indole alkaloids.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029581"}, {"RECTYPE": "D", "MH": "Meliaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Trichilia|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Turraeas", "MN": "B01.875.800.575.912.250.715", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid43707", "RR": "txid43908", "MS": "The mahogany plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029582"}, {"RECTYPE": "D", "MH": "Menispermaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Triclisia|T002|NON|NRW|NLM (2003)|010917|abcdef", "ENTRY": "Triclisias", "MN": "B01.875.800.575.912.250.725", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3455", "RR": "txid461644", "AN": "prefer specific plant", "MS": "A plant family of the order Ranunculales, subclass Magnoliidae, class Magnoliopsida. Members are mostly vines and shrubs and they contain isoquinoline alkaloids, some of which have been used as arrow poisons.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029583"}, {"RECTYPE": "D", "MH": "Prostatic Secretory Proteins", "DE": "PROSTATIC SECRET PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Secretory Proteins, Prostatic", "MN": "D12.776.869.250.249", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Prostate-Specific Antigen (1987-2001)", "MS": "Proteins secreted by the prostate gland. The major secretory proteins from the human prostate gland include PROSTATE-SPECIFIC ANTIGEN, prostate-specific acid phosphatase, prostate-specific membrane antigen, and prostate-specific protein-94.", "PM": "2002", "HN": "2002", "MR": "20220708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029584"}, {"RECTYPE": "D", "MH": "Monimiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hortonia|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Hortonias", "MN": "B01.875.800.575.912.250.595.600", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid22063", "RR": "txid74874", "MS": "A plant family of the order Laurales, subclass Magnoliidae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029585"}, {"RECTYPE": "D", "MH": "Moraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Dorstenia|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Plants, Castilla", "MN": "B01.875.800.575.912.250.859.937.406", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3487", "RR": "txid194260", "AN": "prefer specific plant", "MS": "The mulberry plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. They have milky latex and small, petalless male or female flowers.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029586"}, {"RECTYPE": "D", "MH": "Moringa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Moringas", "MN": "B01.875.800.575.912.250.752", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3734", "AN": "prefer specific plant", "MS": "A plant genus of the family Moringaceae, order Capparales, subclass Dilleniidae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029587"}, {"RECTYPE": "D", "MH": "Moringa oleifera", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Drumsticktree|T002|NON|EQV|NLM (2002)|010424|abcdef", "ENTRY": "oleifera, Moringa", "MN": "B01.875.800.575.912.250.752.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3735", "MS": "A plant species of the family Moringaceae, order Capparales, subclass Dilleniidae. It is a source of niaziminin and hypotensive thiocarbamate glycosides.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D029588"}, {"RECTYPE": "D", "MH": "Seminal Plasma Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.869.250", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "PI": "Proteins (1980-2001)", "MS": "Proteins found in SEMEN. Major seminal plasma proteins are secretory proteins from the male sex accessory glands, such as the SEMINAL VESICLES and the PROSTATE. They include the seminal vesicle-specific antigen, an ejaculate clotting protein; and the PROSTATE-SPECIFIC ANTIGEN, a protease and an esterase.", "PM": "2002; SEMINAL PLASMA PROTEINS was indexed under PROTEINS 1979-2001", "HN": "2002; use SEMINAL PLASMA PROTEINS (NM) 1979-2001", "MR": "20220708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029589"}, {"RECTYPE": "D", "MH": "Myricaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fern, Sweet|T002|NON|NRW|NLM (2003)|010917|abcdef", "ENTRY": "Sweet Ferns", "MN": "B01.875.800.575.912.250.859.750.700", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid26766", "RR": "txid26768", "MS": "A plant family of the order Myricales, subclass Hamamelidae, class Magnoliopsida. They are trees and shrubs having aromatic leaves that often have yellow glandular dots on the surface. Single-seeded fruits are often covered with waxy granules, bumps, or layers. The flowers are small, greenish, and inconspicuous.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029590"}, {"RECTYPE": "D", "MH": "Oleaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Myxopyrum|T002|NON|NRW|NLM (2004)|030417|abcdef", "MN": "B01.875.800.575.912.250.583.640", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4144", "RR": "txid126535", "MS": "A plant family of the order Lamiales. The leaves are usually opposite and the flowers usually have four sepals, four petals, two stamens, and two fused carpels that form a single superior ovary.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029592"}, {"RECTYPE": "D", "MH": "Jervell-Lange Nielsen Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Cardio-Auditory-Syncope", "MN": "C16.131.240.400.715.440", "FX": "KCNQ1 Potassium Channel", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Long QT Syndrome (1986-2001)", "MS": "A form of long QT syndrome that is associated with congenital deafness. It is characterized by abnormal cardioelectrophysiology involving the VOLTAGE-GATED POTASSIUM CHANNEL. It results from mutation of KCNQ1 gene (Subtype 1 or JLN1) or the KCNE1 gene (Subtype 2 or JLN2).", "PM": "2002; see LONG QT SYNDROME 1986-2001", "HN": "2002; use LONG QT SYNDROME 1986-2001", "MR": "20190705", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029593"}, {"RECTYPE": "D", "MH": "Onagraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ludwigia|T002|NON|NRW|NLM (2003)|010917|abcdef", "ENTRY": "Ludwigias", "MN": "B01.875.800.575.912.250.786", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3934", "RR": "txid13118", "MS": "The evening primrose plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. Flower parts are mostly in fours and the ovary is inferior.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029594"}, {"RECTYPE": "D", "MH": "Orchidaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Phalaenopsis|T002|NON|NRW|NLM (2004)|030417|abcdef", "ENTRY": "Orchid Families", "MN": "B01.875.800.575.912.250.618.100.640", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4747", "RR": "txid45173", "MS": "A plant family of the order Asparagales. All members of the orchid family have the same bilaterally symmetrical flower structure, with three sepals, but the flowers vary greatly in color and shape.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029595"}, {"RECTYPE": "D", "MH": "Paeonia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Shakuyaku|T002|NON|NRW|NLM (2002)|010424|abcdef", "ENTRY": "Shakuyakus", "MN": "B01.875.800.575.912.250.791", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13625", "MS": "A plant genus of the family Paeoniaceae, order Dilleniales, subclass Dilleniidae, class Magnoliopsida. These perennial herbs are up to 2 m (6') tall. Leaves are alternate and are divided into three lobes, each lobe being further divided into three smaller lobes. The large flowers are symmetrical, bisexual, have 5 sepals, 5 petals (sometimes 10), and many stamens.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029596"}, {"RECTYPE": "D", "MH": "Romano-Ward Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ward-Romano Syndrome|T047|EPO|EQV|GHR (2014)|NLM (2002)|OMIM (2013)|ORD (2010)|010424|abcdeeeef", "ENTRY": "Ward Romano Syndrome", "MN": "C23.550.073.547.720", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Long QT Syndrome (1985-2001)", "MS": "A form of long QT syndrome that is without congenital deafness. It is caused by mutation of the KCNQ1 gene which encodes a protein in the VOLTAGE-GATED POTASSIUM CHANNEL.", "PM": "2002; see LONG QT SYNDROME 1986-2001", "HN": "2002; use LONG QT SYNDROME 1986-2001", "MR": "20170620", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029597"}, {"RECTYPE": "D", "MH": "Passiflora", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Passionfruit|T168|NON|NRW|NLM (2002)|010424|abcdef", "ENTRY": "Purple Passionflowers", "MN": "B01.875.800.575.912.250.803.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3684", "RR": "txid78168", "MS": "A plant genus of the family Passifloraceae, order Violales, subclass Dilleniidae, class Magnoliopsida. They are vines with ornamental flowers and edible fruit.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029598"}, {"RECTYPE": "D", "MH": "Pedaliaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.583.690", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4180", "MS": "The sesame family of the order Lamiales that are mainly herbs and shrubs growing in warm regions.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029601"}, {"RECTYPE": "D", "MH": "Phytolaccaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Rivinas", "MN": "B01.875.800.575.912.250.198.500.875", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3525", "RR": "txid46141", "AN": "prefer specific plant", "MS": "The pokeweed plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. The leaves are alternate, simple and smooth-edged and the flowers are in spikes or panicles and are usually bisexual.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029602"}, {"RECTYPE": "D", "MH": "Phytolacca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Phytolaccas", "MN": "B01.875.800.575.912.250.198.500.875.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3526", "AN": "prefer specific plant", "MS": "A plant genus of the family PHYTOLACCACEAE, order Caryophyllales.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029603"}, {"RECTYPE": "D", "MH": "Phytolacca americana", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pokeweed|T002|NON|EQV|NLM (2002)|010424|abcdef", "ENTRY": "Pokeweeds", "MN": "B01.875.800.575.912.250.198.500.875.500.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3527", "MS": "A plant species of the family PHYTOLACCACEAE. The root has been used in traditional medicine and contains POKEWEED MITOGENS, triterpene glycosides, and antiviral protein.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029604"}, {"RECTYPE": "D", "MH": "Phytolacca dodecandra", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Endod|T002|NON|EQV|NLM (2002)|010424|abcdef", "ENTRY": "dodecandras, Phytolacca", "MN": "B01.875.800.575.912.250.198.500.875.500.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid29724", "MS": "A plant species of the family PHYTOLACCACEAE. The root has been used in traditional medicine and contains SAPONINS used to poison SNAILS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029605"}, {"RECTYPE": "D", "MH": "Plumbaginaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Plumbago|T002|NON|NRW|NLM (2003)|010918|abcdef", "ENTRY": "Plumbago zeylanica|T002|NON|NRW|NLM (2017)|150903|abcdef", "MN": "B01.875.800.575.912.250.198.500.937", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4437", "RR": "txid76149", "MS": "A plant family of the order Plumbaginales, subclass Caryophyllidae, class Magnoliopsida of shrubs and herbs. Some members contain ANTHOCYANINS and NAPHTHOQUINONES.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029606"}, {"RECTYPE": "D", "MH": "Seminal Vesicle Secretory Proteins", "DE": "SEMINAL VESICLE SECRET PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Seminal Vesicle Clotting Proteins|T116|T123|NON|NRW|NLM (2002)|010426|abbcdef", "ENTRY": "Vesicle Proteins, Seminal", "MN": "D12.776.869.250.500", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "PI": "Proteins (1980-2001)", "MS": "The secretory proteins of the seminal vesicles are proteins and enzymes that are important in the rapid clotting of the ejaculate. The major clotting protein is seminal vesicle-specific antigen. Many of these seminal vesicle proteins are under androgen regulation, and are substrates for the prostatic enzymes, such as the PROSTATE-SPECIFIC ANTIGEN, a protease and an esterase.", "PM": "2002; SEMINAL VESICLE CLOTTING PROTEIN was indexed under PROTEINS 1987-2001", "HN": "2002; for SEMINAL VESICLE CLOTTING PROTEIN use SEMINAL VESICAL SECRETORY PROTEINS (NM) 1987-2001", "MR": "20220708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029607"}, {"RECTYPE": "D", "MH": "Polygalaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.844", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4274", "MS": "A plant family of the order Polygalales, subclass Rosidae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029608"}, {"RECTYPE": "D", "MH": "Polypodiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gusuibu|T002|NON|NRW|NLM (2003)|020328|abcdef", "ENTRY": "Gusuibus", "MN": "B01.875.800.575.912.063.700", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3275", "RR": "txid187348", "MS": "The fern plant family of the order Polypodiales, class Filicopsida, division Pteridophyta, subkingdom TRACHEOPHYTA.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029621"}, {"RECTYPE": "D", "MH": "Portulacaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Montia|T002|NON|NRW|NLM (2003)|010919|abcdef", "ENTRY": "Montias", "MN": "B01.875.800.575.912.250.198.500.984", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3581", "RR": "txid46145", "MS": "A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. There are no true petals; each flower has two to six sepals. They produce betacyanin and betaxanthin pigments and lack anthocyanins.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029622"}, {"RECTYPE": "D", "MH": "Primulaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Myrsinaceae|T002|NON|EQV|NLM (2002)|010424|abcdef", "ENTRY": "Oncostemon|T002|NON|NRW|NLM (2004)|030417|abcdef", "MN": "B01.875.800.575.912.250.341.984", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4335", "RR": "txid59969", "MS": "A plant family of the order ERICALES, class MAGNOLIOPSIDA, with flowers having both stamens and pistil, producing encapsulated fruits.", "PM": "2019; for MYRSINACEAE, AEGICERAS, and ONCOSTEMON, see MYRSINACEAE 2002-2018", "HN": "2019(2002)", "MR": "20220413", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029623"}, {"RECTYPE": "D", "MH": "Ferns", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Blechnum|T002|NON|NRW|NLM (2003)|020328|abcdef", "ENTRY": "Fern", "MN": "B01.875.800.575.912.063", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid241806", "RR": "txid29605", "AN": "prefer specific plant", "MS": "Seedless nonflowering plants of the class Filicinae. They reproduce by spores that appear as dots on the underside of feathery fronds. In earlier classifications the Pteridophyta included the club mosses, horsetails, ferns, and various fossil groups. In more recent classifications, pteridophytes and spermatophytes (seed-bearing plants) are classified in the Subkingdom TRACHEOPHYTA (also known as Tracheophyta).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029624"}, {"RECTYPE": "D", "MH": "Pteridaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cheilanthes|T002|NON|NRW|NLM (2004)|030417|abcdef", "ENTRY": "Cheilanthe", "MN": "B01.875.800.575.912.063.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13819", "RR": "txid37456", "MS": "A plant family of the order Polypodiales, class Filicopsida, division Pteridophyta (FERNS).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029625"}, {"RECTYPE": "D", "MH": "Ranunculaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Isopyrum|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Isopyrums", "MN": "B01.875.800.575.912.250.836.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3440", "RR": "txid78477", "MS": "The buttercup plant family of the order RANUNCULALES, class MAGNOLIOPSIDA. The leaves are usually alternate and stalkless. The flowers usually have two to five free sepals and may be radially symmetrical or irregular.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029626"}, {"RECTYPE": "D", "MH": "Crassulaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tylecodon|T002|NON|NRW|NLM (2003)|020327|abcdef", "ENTRY": "Tylecodons", "MN": "B01.875.800.575.912.250.859.937.249", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3781", "RR": "txid91163", "AN": "prefer specific plant", "MS": "The stonecrop plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida that grow in warm, dry regions. The leaves are thick. The flower clusters are red, yellow, or white.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029627"}, {"RECTYPE": "D", "MH": "Hydrangeaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.937.374", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid23097", "MS": "A plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029628"}, {"RECTYPE": "D", "MH": "Santalaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Toadflax, Bastard|T002|NON|NRW|NLM (2003)|010928|abcdef", "ENTRY": "Toadflaxs, Bastard", "MN": "B01.875.800.575.912.250.884", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3958", "RR": "txid50118", "AN": "X ref Toadflax, Bastard: Toadflax see LINARIA is also available", "MS": "A plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. They are parasites that form connections (haustoria) to their hosts to obtain water and nutrients. The one-seeded fruit may be surrounded by a brightly colored nut-like structure.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029630"}, {"RECTYPE": "D", "MH": "Sapindaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Xanthoceras|T002|NON|NRW|NLM (2003)|010928|abcdef", "MN": "B01.875.800.575.912.250.885", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid23672", "RR": "txid99657", "MS": "The soapberry plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Some members contain SAPONINS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029631"}, {"RECTYPE": "D", "MH": "Sapotaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tieghemella|T002|NON|NRW|NLM (2004)|030417|abcdef", "ENTRY": "Tieghemellas", "MN": "B01.875.800.575.912.250.339.485", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3737", "RR": "txid85883", "AN": "prefer specific plant", "MS": "A plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida that are tropical trees which have elongate latex cells. Several members bear sweet edible fruits and produce triterpenoid saponins.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029632"}, {"RECTYPE": "D", "MH": "Schisandraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.103.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid16733", "MS": "A plant family of the order AUSTROBAILEYALES, class MAGNOLIOPSIDA.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029633"}, {"RECTYPE": "D", "MH": "Simaroubaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Simaba|T002|NON|NRW|NLM (2003)|020328|abcdef", "ENTRY": "Simabas", "MN": "B01.875.800.575.912.250.898", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid23808", "RR": "txid459142", "AN": "prefer specific plant", "MS": "A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Leaves are alternate and compound. Most have small flowers, bitter bark, and fleshy fruits that are sometimes winged. Members contain QUASSINS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029641"}, {"RECTYPE": "D", "MH": "Smilacaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618.875.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4703", "MS": "A plant family of the order Liliales, subclass Liliidae, class Liliopsida (monocotyledon).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029642"}, {"RECTYPE": "D", "MH": "Styracaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.341.996", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid20008", "MS": "A plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029644"}, {"RECTYPE": "D", "MH": "Thymelaeaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thymelaea|T002|NON|NRW|NLM (2021)|190823|abcdef", "ENTRY": "Thymelaeas", "MN": "B01.875.800.575.912.250.932", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid39987", "RR": "txid699056", "AN": "prefer specific plant", "MS": "A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. They are mainly trees and shrubs. Many members contain mucilage and COUMARINS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029645"}, {"RECTYPE": "D", "MH": "Tiliaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.938", "MH_TH": "NLM (2002)", "ST": "T002", "MS": "A plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029646"}, {"RECTYPE": "D", "MH": "Turnera", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Damiana|T002|NON|NRW|NLM (2002)|010424|abcdef", "ENTRY": "Damianas", "MN": "B01.875.800.575.912.250.803.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid45183", "RR": "txid329212", "MS": "A plant genus of the family Passifloraceae.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029647"}, {"RECTYPE": "D", "MH": "Verbenaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.583.990", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid21910", "AN": "prefer specific plant", "MS": "A plant family of the order Lamiales, subclass Asteridae, class Magnoliopsida. The leaves are opposite or whorled. The flowers are aggregated in spikes, clusters, or racemes.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029648"}, {"RECTYPE": "D", "MH": "Violaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hybanthus|T002|NON|NRW|NLM (2004)|030417|abcdef", "MN": "B01.875.800.575.912.250.859.797.962", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid24921", "RR": "txid97457", "MS": "A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029649"}, {"RECTYPE": "D", "MH": "Enterovirus, Bovine", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Enteroviruses, Bovine", "MN": "B04.820.578.750.284.200", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid12064", "AN": "infection: coord IM with ENTEROVIRUS INFECTIONS (IM)", "PI": "Enterovirus (1965-2001)", "MS": "A species in the family ENTEROVIRUS infecting cattle.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029650"}, {"RECTYPE": "D", "MH": "Alnus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Alder|T002|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "Alders", "MN": "B01.875.800.575.912.250.859.750.200.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3515", "MS": "A plant genus of the family BETULACEAE that is distinguished from birch (BETULA) by its usually stalked winter buds and by cones that remain on the branches after the small, winged nutlets are released.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029661"}, {"RECTYPE": "D", "MH": "Betula", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Birch|T002|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "Birchs", "MN": "B01.875.800.575.912.250.859.750.200.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3504", "MS": "A plant genus of the family BETULACEAE. The tree has smooth, resinous, varicolored or white bark, marked by horizontal pores (lenticels), which usually peels horizontally in thin sheets.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D029662"}, {"RECTYPE": "D", "MH": "Tabebuia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pau d'arco|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "d'arco, Pau", "MN": "B01.875.800.575.912.250.583.080.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid39256", "RR": "txid429709", "MS": "A plant genus of the family BIGNONIACEAE that is a source of lapachol and beta-lapachone.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029663"}, {"RECTYPE": "D", "MH": "Arabidopsis Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Arabidopsis thaliana Proteins|T116|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "thaliana Proteins, Arabidopsis", "MN": "D12.776.765.149", "FX": "Arabidopsis", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "PI": "Plant Proteins (1994-2001)", "MS": "Proteins that originate from plants species belonging to the genus ARABIDOPSIS. The most intensely studied species of Arabidopsis, Arabidopsis thaliana, is commonly used in laboratory experiments.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029681"}, {"RECTYPE": "D", "MH": "Amsinckia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Amsinckias", "MN": "B01.875.800.575.912.250.150.122", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid255583", "MS": "A plant genus of the family BORAGINACEAE. Members contain PYRROLIZIDINE ALKALOIDS. The common name of burweed is also used for Triumfetta (TILIACEAE).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029682"}, {"RECTYPE": "D", "MH": "Borago", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Borage|T002|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "Borages", "MN": "B01.875.800.575.912.250.150.188", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13362", "RR": "txid13363", "MS": "A plant genus of the family BORAGINACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029683"}, {"RECTYPE": "D", "MH": "Lithospermum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Puccoon|T002|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "Puccoons", "MN": "B01.875.800.575.912.250.150.501", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid21634", "MS": "A plant genus of the family BORAGINACEAE. Members contain lithospermans and lithospermic acid.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029684"}, {"RECTYPE": "D", "MH": "Pulmonaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lungwort|T002|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "Pulmonarias", "MN": "B01.875.800.575.912.250.150.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid136615", "MS": "A plant genus of the family BORAGINACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029685"}, {"RECTYPE": "D", "MH": "Lepidium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Maca|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "meyenii, Lepidium", "MN": "B01.875.800.575.912.250.157.600", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid19205", "RR": "txid153348", "MS": "A plant genus of the family BRASSICACEAE growing in Peru mountains. It is the source of maca root.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029686"}, {"RECTYPE": "D", "MH": "Capsella", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Shepherd's Purse|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "bursa-pastoris, Capsella", "MN": "B01.875.800.575.912.250.157.244", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3718", "RR": "txid3719", "MS": "A plant genus of the family CRUCIFERAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029687"}, {"RECTYPE": "D", "MH": "Brassica napus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Turnip|T002|NON|EQV|NLM (1998)|961107|abcdef", "ENTRY": "Turnips", "MN": "B01.875.800.575.912.250.157.200.249", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3708", "RR": "txid3709", "PI": "Brassica (1998-2001)", "MS": "A plant species of the family BRASSICACEAE best known for the edible roots.", "PM": "2002; for RAPESEED see BRASSICA RAPA 2002-2019 and BRASSICA 1977-2001", "HN": "2002; for RAPESEED use BRASSICA RAPA 2002-2019 and BRASSICA 1977-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029688"}, {"RECTYPE": "D", "MH": "Saccharomyces cerevisiae Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Baker's Yeast Proteins|T116|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "S cerevisiae Proteins|T116|ABX|EQV|NLM (2002)|010425|abcdef", "MN": "D12.776.354.750", "FX": "Saccharomyces cerevisiae", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "AN": "coordinate IM with specific protein (IM)", "PI": "Fungal Proteins (1973-2001)", "MS": "Proteins obtained from the species SACCHAROMYCES CEREVISIAE. The function of specific proteins from this organism are the subject of intense scientific interest and have been used to derive basic understanding of the functioning similar proteins in higher eukaryotes.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029701"}, {"RECTYPE": "D", "MH": "Schizosaccharomyces pombe Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fission Yeast Proteins|T116|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "S pombe Proteins|T116|ACX|EQV|NLM (2002)|010511|abcdef", "MN": "D12.776.354.875", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "AN": "coord IM with specific protein (IM)", "PI": "Fungal Proteins (1973-2001)", "MS": "Proteins obtained from the species Schizosaccharomyces pombe. The function of specific proteins from this organism are the subject of intense scientific interest and have been used to derive basic understanding of the functioning similar proteins in higher eukaryotes.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029702"}, {"RECTYPE": "D", "MH": "Drosophila Proteins", "AQ": "AD AE AG AI AN BI BL CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Drosophila melanogaster Proteins|T116|T123|NON|NRW|NLM (2002)|010425|abbcdef", "ENTRY": "melanogaster Proteins, Drosophila", "MN": "D12.776.093.500.462", "FX": "Drosophila melanogaster", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "coord IM with specific protein (IM)", "PI": "Insect Proteins (1997-2001)", "MS": "Proteins that originate from insect species belonging to the genus DROSOPHILA. The proteins from the most intensely studied species of Drosophila, DROSOPHILA MELANOGASTER, are the subject of much interest in the area of MORPHOGENESIS and development.", "PM": "2002", "HN": "2002", "MR": "20150618", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D029721"}, {"RECTYPE": "D", "MH": "Brassica rapa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Wild Turnip|T002|NON|EQV|NLM (2020)|190124|abcdef", "ENTRY": "Wild Turnips", "MN": "B01.875.800.575.912.250.157.200.277", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3711", "PI": "Brassica (1977-2001)", "MS": "A subspecies of Brassica that includes rape mustard. It is cultivated for the seed and used as animal feed.", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029741"}, {"RECTYPE": "D", "MH": "Caenorhabditis elegans Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "C elegans Proteins|T116|NON|EQV|NLM (2002)|010425|abcdef", "MN": "D12.776.419.500", "FX": "Caenorhabditis elegans", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "AN": "coord IM with specific protein (IM)", "PI": "Helminth Proteins (1990-2001)", "MS": "Proteins from the nematode species CAENORHABDITIS ELEGANS. The proteins from this species are the subject of scientific interest in the area of multicellular organism MORPHOGENESIS.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029742"}, {"RECTYPE": "D", "MH": "Boswellia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Boswellia serrata|T002|NON|NRW|NLM (2002)|010425|abcdef", "MN": "B01.875.800.575.912.250.162.111", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid80276", "RR": "txid613112", "MS": "A plant genus of the family BURSERACEAE used medicinally since ancient times. It is a source of salai guggal (the gum resin), boswellic acid (ursane type TRITERPENES), and FRANKINCENSE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029743"}, {"RECTYPE": "D", "MH": "Commiphora", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Myrrh, Bisabol|T002|NON|NRW|NLM (2003)|010829|abcdef", "ENTRY": "Tree, Common Myrrh", "MN": "B01.875.800.575.912.250.162.166", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid43868", "RR": "txid318982", "MS": "A plant genus of the family BURSERACEAE which is a source of gugulipid and guggulu extract. Balm of Gilead is a common name more often referring to POPULUS and sometimes to ABIES.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029744"}, {"RECTYPE": "D", "MH": "Codonopsis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Dang Shen|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "Shens, Dang", "MN": "B01.875.800.575.912.250.171.200", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid16399", "MS": "A plant genus of the family CAMPANULACEAE. The common name of bellflower may sometimes be confused with other plants in the family that have similar appearance.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029745"}, {"RECTYPE": "D", "MH": "Lobelia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "laxifloras, Lobelia", "MN": "B01.875.800.575.912.250.171.600", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4382", "RR": "txid308559", "MS": "A plant genus of the family CAMPANULACEAE used medicinally and is a source of LOBELINE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029746"}, {"RECTYPE": "D", "MH": "Opuntia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Prickly-pear Cactus|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "Prickly pear Cactus", "MN": "B01.875.800.575.912.250.198.500.200.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid106975", "RR": "txid371859", "MS": "A plant genus of the family CACTACEAE. Species with cylindrical joints are called Cholla; flat jointed ones are Prickly-pear.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029747"}, {"RECTYPE": "D", "MH": "Caryophyllaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Spergularias", "MN": "B01.875.800.575.912.250.198.500.250", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3568", "RR": "txid3579", "MS": "A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. The species are diverse in appearance and habitat; most have swollen leaf and stem joints.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029748"}, {"RECTYPE": "D", "MH": "Dianthus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Carnation|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "Carnations", "MN": "B01.875.800.575.912.250.198.500.250.222", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3569", "RR": "txid3570", "MS": "A plant genus of the family CARYOPHYLLACEAE. Members contain dianthins, which are ribosome inactivating proteins.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029749"}, {"RECTYPE": "D", "MH": "Saponaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "officinali, Saponaria", "MN": "B01.875.800.575.912.250.198.500.250.611", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3571", "RR": "txid3572", "MS": "A plant species of the family CARYOPHYLLACEAE. It is a source of SAPONINS. The common name \"Soapwort\" is also used with VACCARIA. The common name of \"Bouncing Bet\" is occasionally used with VIOLA.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029750"}, {"RECTYPE": "D", "MH": "Silene", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Catchfly, Pink|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "Silenes", "MN": "B01.875.800.575.912.250.198.500.250.655", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3573", "MS": "A plant genus of the family CARYOPHYLLACEAE. The common name of campion is also used with LYCHNIS. The common name of 'pink' can be confused with other plants.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029751"}, {"RECTYPE": "D", "MH": "Stellaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Common Chickweeds", "MN": "B01.875.800.575.912.250.198.500.250.827", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13273", "RR": "txid13274", "MS": "A plant genus of the family Caryophyllaceae.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029752"}, {"RECTYPE": "D", "MH": "Celastraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Glyptopetalum|T002|NON|NRW|NLM (2003)|010829|abcdef", "ENTRY": "Kokoonas", "MN": "B01.875.800.575.912.250.859.500.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4305", "RR": "txid123559", "MS": "A plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029753"}, {"RECTYPE": "D", "MH": "Catha", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Khat|T002|NON|NRW|NLM (2003)|abcde", "ENTRY": "edulis, Catha", "MN": "B01.875.800.575.912.250.859.500.750.155", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid123403", "RR": "txid123405", "MS": "A plant genus of the family CELASTRACEAE. The leafy stems of khat are chewed by some individuals for stimulating effect. Members contain ((+)-norpseudoephedrine), cathionine, cathedulin, cathinine & cathidine.", "PM": "2002; MIRAA was indexed under PLANT EXTRACTS 1981-2002", "HN": "2002; for MIRAA use MIRAA (NM) 1981-2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029754"}, {"RECTYPE": "D", "MH": "Maytenus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.500.750.577", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid123430", "MS": "A plant genus of the family CELASTRACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029755"}, {"RECTYPE": "D", "MH": "Euonymus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Spindletree|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "Spindletrees", "MN": "B01.875.800.575.912.250.859.500.750.366", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4306", "RR": "txid344450", "AN": "distinguish from BURNINGBUSH (BASSIA)", "MS": "A plant genus of the family CELASTRACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029756"}, {"RECTYPE": "D", "MH": "Tripterygium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tripterygium wilfordii|T002|NON|NRW|NLM (2002)|abcde", "ENTRY": "wilfordius, Tripterygium", "MN": "B01.875.800.575.912.250.859.500.750.788", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid123484", "RR": "txid458696", "MS": "A plant genus of the family CELASTRACEAE that is a source of triterpenoids and diterpene epoxides such as triptolide.", "PM": "2002; TRIPTERYGIUM was indexed under DRUGS, CHINESE HERBAL 1985-2001", "HN": "2002; for TRIPTERYGIUM WILFORDII use TRIPTERYGIUM (NM) 1985-2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029757"}, {"RECTYPE": "D", "MH": "Cistus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.204.177", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid69451", "MS": "A plant genus of the family CISTACEAE. The common name of rock rose is also sometimes used with the closely related Helianthemum genus (CISTACEAE).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029758"}, {"RECTYPE": "D", "MH": "Calophyllum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Punna|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "Punnas", "MN": "B01.875.800.575.912.250.859.250", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid73121", "MS": "A plant genus of the family CLUSIACEAE. Members contain costatolide, calanolides and 4-phenylfuranocoumarins (FUROCOUMARINS).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029759"}, {"RECTYPE": "D", "MH": "Garcinia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Garcinias", "MN": "B01.875.800.575.912.250.859.625.333", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid58227", "AN": "prefer specific plant", "MS": "A plant genus of the family CLUSIACEAE. Members contain XANTHONES.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029760"}, {"RECTYPE": "D", "MH": "Garcinia cambogia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Citrin Fruit|T002|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "cambogia, Mangostana", "MN": "B01.875.800.575.912.250.859.625.333.200", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid1220707", "MS": "A plant species of the family CLUSIACEAE. It is a source of hydroxycitric acid.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029761"}, {"RECTYPE": "D", "MH": "Garcinia mangostana", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mangosteen|T002|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "mangostana, Garcinia", "MN": "B01.875.800.575.912.250.859.625.333.600", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid58228", "MS": "A plant genus of the family CLUSIACEAE. It is the source of the mangosteen fruit.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029762"}, {"RECTYPE": "D", "MH": "Garcinia kola", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Kola, Bitter|T002|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "kola, Garcinia", "MN": "B01.875.800.575.912.250.859.625.333.400", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid469930", "AN": "for Kola or Cola see COLA; GOTU KOLA see CENTELLA is also available", "MS": "A plant species of the family CLUSIACEAE. The common name of 'Bitter Kola' is sometimes also used to refer to COLA.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029763"}, {"RECTYPE": "D", "MH": "Combretaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.228", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3954", "MS": "A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. They are mostly trees and shrubs growing in warm areas.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029764"}, {"RECTYPE": "D", "MH": "Combretum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Combretums", "MN": "B01.875.800.575.912.250.228.166", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid99434", "MS": "A plant genus of the family COMBRETACEAE. Triterpenes and combretastatin have been identified in members of this genus.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029765"}, {"RECTYPE": "D", "MH": "Terminalia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Myrobalans|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "Trees, Arjuna", "MN": "B01.875.800.575.912.250.228.583", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid39992", "RR": "txid172200", "MS": "A plant genus of the family COMBRETACEAE. Members contain arjunin, an ellagitannin (TANNINS).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029766"}, {"RECTYPE": "D", "MH": "Cornaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.250", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid42219", "MS": "A plant family of the order Cornales, subclass Rosidae, class Magnoliopsida that is a loose grouping of woody ornamentals: 11 of its 14 genera have been placed in single families by some authorities. Some botanists combine members of NYSSACEAE into this family.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029767"}, {"RECTYPE": "D", "MH": "Cornus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Dogwood|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "Fructus, Corni", "MN": "B01.875.800.575.912.250.250.299", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4281", "MS": "A plant genus of the family CORNACEAE. It is widely cultivated for the attractive flowers.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029768"}, {"RECTYPE": "D", "MH": "Camptotheca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Camptothecas", "MN": "B01.875.800.575.912.250.778.188", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid16921", "MS": "A plant genus of the family NYSSACEAE (sometimes classified in the CORNACEAE family). It is a source of CAMPTOTHECIN.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029769"}, {"RECTYPE": "D", "MH": "Costus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "spicatus, Costus", "MN": "B01.875.800.575.912.250.618.937.124", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4631", "RR": "txid328782", "AN": "do not confuse with SAUSSUREA COSTUS see SAUSSUREA", "MS": "A plant genus of the family Costaceae (sometimes classified in Zingiberaceae), order Zingiberales, subclass Zingiberidae, class Liliopsida (monocotyledons). It is a source of SAPONINS and furostanol glycosides.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029770"}, {"RECTYPE": "D", "MH": "Rhodiola", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Roseroot|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "Roseroots", "MN": "B01.875.800.575.912.250.859.937.249.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid202994", "RR": "txid242839", "AN": "do not confuse entry term ROSEROOT with ROSE see ROSA", "MS": "A plant genus of the family CRASSULACEAE. Members contain rhodioloside. This roseroot is unrelated to the familiar rose (ROSA). Some species in this genus are called stonecrop which is also a common name for SEDUM.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029771"}, {"RECTYPE": "D", "MH": "Bryonia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bryony|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "dioicas, Bryonia", "MN": "B01.875.800.575.912.250.300.093", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3651", "RR": "txid3652", "AN": "do not confuse entry term BRYONY with BLACK BRYONY see TAMUS", "MS": "A plant genus of the family CUCURBITACEAE that is the source of bryodin 1 (a ribosome-inactivating protein).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029772"}, {"RECTYPE": "D", "MH": "Citrullus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Watermelon|T168|NON|REL|NLM (2002)|010425|abcdef", "ENTRY": "Watermelons", "MN": "B01.875.800.575.912.250.300.140", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3653", "RR": "txid260674", "MS": "A plant genus of the family CUCURBITACEAE known for the edible fruit.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029773"}, {"RECTYPE": "D", "MH": "Gynostemma", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "pentaphyllum, Gynostemma", "MN": "B01.875.800.575.912.250.300.444", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid182083", "RR": "txid182084", "MS": "A plant genus of the family CUCURBITACEAE. It is a source of gypenosides and triterpenoid SAPONINS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029774"}, {"RECTYPE": "D", "MH": "Momordica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Momordicas", "MN": "B01.875.800.575.912.250.300.655", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3671", "MS": "A plant genus of the family CUCURBITACEAE. It is a source of momordin.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029775"}, {"RECTYPE": "D", "MH": "Luffa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Momordica luffa|T002|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "luffa, Momordica", "MN": "B01.875.800.575.912.250.300.522", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3669", "MS": "A plant genus of the family CUCURBITACEAE known for the fruit which is the source of the luffa sponge and the seeds which contain luffin.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029776"}, {"RECTYPE": "D", "MH": "Momordica charantia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Karela|T002|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "charantias, Momordica", "MN": "B01.875.800.575.912.250.300.655.249", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3673", "MS": "A plant species of the family CUCURBITACEAE. It is a source of ribosome-inactivating proteins and triterpene glycosides.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029777"}, {"RECTYPE": "D", "MH": "Trichosanthes", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Snake Gourd|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "kirilowius, Trichosanthes", "MN": "B01.875.800.575.912.250.300.827", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3676", "RR": "txid3677", "MS": "A plant species of the family CUCURBITACEAE that is a source of TRICHOSANTHIN (a ribosomal inhibitory protein).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029778"}, {"RECTYPE": "D", "MH": "Cupressaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Taxodiaceae|T002|NON|EQV|NLM (2003)|011004|abcdef", "MN": "B01.875.800.575.912.625.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3367", "RR": "txid13386", "MS": "A plant family of the order Pinales, class Pinopsida, division Tracheophyta. They are mainly resinous, aromatic evergreen trees.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029779"}, {"RECTYPE": "D", "MH": "Chamaecyparis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lawson's False Cypress|T002|EPO|NRW|NLM (2002)|010425|abcdef", "ENTRY": "thyoides, Chamaecyparis", "MN": "B01.875.800.575.912.625.750.199", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13414", "RR": "txid85954", "AN": "note X refs containing cedar and cypress: check text to distinguish from other cedar and cypress terms in MeSH", "MS": "A plant genus of the family CUPRESSACEAE which should not be confused with other cedar and cypress trees of THUJA or CUPRESSUS genera.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029780"}, {"RECTYPE": "D", "MH": "Cupressus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cypress|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "Cypresses", "MN": "B01.875.800.575.912.625.750.266", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13468", "AN": "entry term CYPRESS: check text; restrict to genus CUPRESSUS; do not use for other genera referred to as cyprus in the literature; check MeSH for other cypress terms", "MS": "A plant genus of the family CUPRESSACEAE. Cypress ordinarily refers to this but also forms part of the name of plants in other genera.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029781"}, {"RECTYPE": "D", "MH": "Libocedrus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.625.750.599", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13594", "MS": "A plant genus of the family CUPRESSACEAE. The common name of 'Cedar' makes this easily confused with other trees using that name including cedrus, JUNIPERUS; and CHAMAECYPARIS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029782"}, {"RECTYPE": "D", "MH": "Thuja", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cedar, Western Red|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "plicata, Thuja", "MN": "B01.875.800.575.912.625.750.799", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3315", "RR": "txid58046", "AN": "entry term CEDAR, WESTERN RED: do not confuse with other cedar terms in MeSH", "MS": "A plant genus of the family CUPRESSACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029783"}, {"RECTYPE": "D", "MH": "Cycas", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Palm, False Sago|T002|NON|EQV|NLM (2003)|011004|abcdef", "ENTRY": "Sago Palms, False", "MN": "B01.875.800.575.156.199", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3395", "MS": "A plant genus of the family Cycadaceae, order Cycadales, class Cycadopsida, division CYCADOPHYTA of palm-like trees. It is a source of CYCASIN, the beta-D-glucoside of methylazoxymethanol.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029784"}, {"RECTYPE": "D", "MH": "Cyperaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.312", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4609", "MS": "The sedge plant family of the order Cyperales, subclass Commelinidae, class Liliopsida (monocotyledons)", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029785"}, {"RECTYPE": "D", "MH": "Cyperus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yellow Nutgrass|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "Yellow Nutgrasses", "MN": "B01.875.800.575.912.250.312.199", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4610", "RR": "txid1053340", "MS": "A plant genus of the family CYPERACEAE. SESQUITERPENES are found in some of the species.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029786"}, {"RECTYPE": "D", "MH": "Drosera", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sundew|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "Sundews", "MN": "B01.875.800.575.912.250.198.500.350.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4363", "AN": "coordinate with CARNIVOROUS PLANT if pertinent", "MS": "A plant genus of the family Droseraceae, order Nepenthales, subclass Dilleniidae, class Magnoliopsida, that contains naphthoquinone glucosides. The name sundew is rarely used for PYROLA.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029787"}, {"RECTYPE": "D", "MH": "Diospyros", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sapote, Black|T002|NON|NRW|NLM (2003)|010829|abcdef", "ENTRY": "digynas, Diospyros", "MN": "B01.875.800.575.912.250.341.875.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13492", "RR": "txid110741", "MS": "A plant genus of the family EBENACEAE, order Ebenales, subclass Dilleniidae, class Magnoliopsida best known for the edible fruit and the antibacterial activity and compounds of the wood.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029788"}, {"RECTYPE": "D", "MH": "Ephedra", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Ephedras", "MN": "B01.875.800.575.156.577.222", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3387", "MS": "A plant genus of the family Ephedraceae, order Ephedrales, class Gnetopsida, division Gnetophyta.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029789"}, {"RECTYPE": "D", "MH": "Ephedra sinica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Muzei Ma Huang|T002|NON|REL|NLM (2024)|230426|abcdef", "ENTRY": "Ma-Huang, Cao", "MN": "B01.875.800.575.156.577.222.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid33152", "RR": "txid173280", "MS": "A plant species of the family Ephedraceae, order Ephedrales, class Gnetopsida, division Gnetophyta. It is a source of EPHEDRINE and other alkaloids.", "PM": "2002", "HN": "2002", "MR": "20230531", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029790"}, {"RECTYPE": "D", "MH": "Ericaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.341.937", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4345", "MS": "The heath plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida that are generally shrubs or small trees. Leaves are alternate, simple, and leathery; flowers are symmetrical with a 4- or 5-parted corolla of partly fused petals.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029791"}, {"RECTYPE": "D", "MH": "Arctostaphylos", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Uva-ursi|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "uva-ursi, Arctostaphylos", "MN": "B01.875.800.575.912.250.341.937.099", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid83607", "RR": "txid84009", "MS": "A plant genus of the family ERICACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029792"}, {"RECTYPE": "D", "MH": "Rhododendron", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Rhododendrons", "MN": "B01.875.800.575.912.250.341.937.549", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4346", "MS": "A plant genus of the family ERICACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029793"}, {"RECTYPE": "D", "MH": "Ledum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Wild Rosemary|T002|NON|NRW|NLM (2002)|010425|abcdef", "ENTRY": "palustre, Ledum", "MN": "B01.875.800.575.912.250.341.937.324", "MH_TH": "NLM (2002)", "ST": "T002", "RR": "txid49605", "MS": "A plant genus of the family ERICACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029794"}, {"RECTYPE": "D", "MH": "Calluna", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Scotch Heather|T002|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "Scotch Heathers", "MN": "B01.875.800.575.912.250.341.937.211", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13384", "MS": "A plant genus of the family ERICACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029795"}, {"RECTYPE": "D", "MH": "Vaccinium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Vacciniums", "MN": "B01.875.800.575.912.250.341.937.774", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13749", "MS": "A plant genus of the family ERICACEAE known for species with edible fruits.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029796"}, {"RECTYPE": "D", "MH": "Huckleberry Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Huckleberry", "MN": "B01.875.800.575.912.250.341.937.774.500", "MH_TH": "NLM (2002)", "ST": "T002", "MS": "Several plant species of the genus VACCINIUM known for the edible huckleberry fruit.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029797"}, {"RECTYPE": "D", "MH": "Blueberry Plants", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Blueberry Plant|T002|NON|EQV|NLM (2002)|010425|abcdef", "ENTRY": "Plants, Blueberry", "MN": "B01.875.800.575.912.250.341.937.774.249", "MH_TH": "NLM (2017)", "ST": "T002", "RR": "txid69266", "MS": "Several species of the genus Vaccinium which produce the edible blueberry fruit.", "PM": "2017; see BLUEBERRY PLANT 2002-2016", "HN": "2017 (2002)", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029798"}, {"RECTYPE": "D", "MH": "Vaccinium macrocarpon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cranberry|T168|NON|REL|NLM (2002)|010425|abcdef", "ENTRY": "macrocarpon, Vaccinium", "MN": "B01.875.800.575.912.250.341.937.774.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13750", "MS": "A plant species of the family VACCINIUM known for the sour fruit which is sometimes used for urinary tract infections.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029799"}, {"RECTYPE": "D", "MH": "Vaccinium myrtillus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Whortleberry|T168|NON|REL|NLM (2002)|010425|abcdef", "ENTRY": "bracteatums, Vaccinium", "MN": "B01.875.800.575.912.250.341.937.774.875", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid180763", "RR": "txid276782", "MS": "A plant species of the family VACCINIUM.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029800"}, {"RECTYPE": "D", "MH": "Vaccinium vitis-idaea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lingonberry|T168|NON|REL|NLM (2002)|010426|abcdef", "ENTRY": "vitis-idaeas, Vaccinium", "MN": "B01.875.800.575.912.250.341.937.774.937", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid180772", "MS": "A plant species of the genus VACCINIUM.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029801"}, {"RECTYPE": "D", "MH": "Croton", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Crotons", "MN": "B01.875.800.575.912.250.859.797.438.199", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid100370", "MS": "A plant genus of the family EUPHORBIACEAE. The common name of dragon's blood is also used for DRACAENA and Daemonorops (ARECACEAE). CROTON TIGLIUM is the source of CROTON OIL.", "PM": "2002", "HN": "2002", "MR": "20220523", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029802"}, {"RECTYPE": "D", "MH": "Phyllanthus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bahupatra|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "nirurius, Phyllanthus", "MN": "B01.875.800.575.912.250.859.797.438.622", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid58880", "RR": "txid296034", "MS": "A plant genus of the family EUPHORBIACEAE. Bahupatra (MEDICINE, AYURVEDIC) is prepared from this.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029803"}, {"RECTYPE": "D", "MH": "Enterovirus A, Human", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human Enterovirus 71|T005|NON|NRW|NLM (2008)|070403|HUMAN ENTEROVIRUS 071|abcdefs", "ENTRY": "Human Enterovirus A|T005|NON|EQV|NLM (2002)|150623|abcdef", "MN": "B04.820.578.750.284.180", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid138948", "RR": "txid39054", "AN": "infection: coordinate IM with ENTEROVIRUS INFECTIONS (IM) or COXSACKIEVIRUS INFECTIONS (IM) or specifics; follow text", "MS": "A species of ENTEROVIRUS infecting humans and containing 10 serotypes, mostly coxsackieviruses.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029821"}, {"RECTYPE": "D", "MH": "Enterovirus B, Human", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Pleurodynia Virus|T005|NON|NRW|UNK (19XX)|771205|abcdef", "ENTRY": "Viruses, Coxsackie A9", "MN": "B04.820.578.750.284.182", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid138949", "RR": "txid12075", "MS": "A species of ENTEROVIRUS infecting humans and containing 36 serotypes. It is comprised of all the echoviruses and a few coxsackieviruses, including all of those previously named coxsackievirus B.", "PM": "2002; for COXSACKIEVIRUSES B see COXSACKIEVIRUSES B 1994-2001, see COXSACKIE B VIRUSES 1979-1993; for PLEURODYNIA VIRUS see COXSACKIE VIRUSES 1963-1978; for ECHOVIRUSES see ECHOVIRUSES 1966-2001; for COXSACKIE A9 VIRUS see COXSACKIEVIRUSES A 1979-2001", "HN": "2002; for COXSACKIE A9 VIRUS see ENTEROVIRUSES 1979-2001", "MR": "20200902", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029822"}, {"RECTYPE": "D", "MH": "Phyllanthus emblica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mirobalanus embilica|T002|NON|EQV|NLM (2002)|010426|abcdef", "ENTRY": "officinali, Emblica", "MN": "B01.875.800.575.912.250.859.797.438.622.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid296036", "MS": "A plant species of the family EUPHORBIACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029842"}, {"RECTYPE": "D", "MH": "Suregada", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Suregada multiflora|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "multifloras, Suregada", "MN": "B01.875.800.575.912.250.859.797.438.825", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid314340", "RR": "txid3979", "MS": "A plant genus of the family EUPHORBIACEAE that contains gelonin, a ribosome-inactivating protein.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029843"}, {"RECTYPE": "D", "MH": "Amphibian Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.045", "FX": "Amphibians", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "AN": "coord IM with specific protein (IM) + specific amphibian (IM)", "MS": "Proteins obtained from species in the class of AMPHIBIANS.", "PM": "2002", "HN": "2002", "MR": "20080709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029845"}, {"RECTYPE": "D", "MH": "Senna Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Indian Senna|T002|NON|NRW|NLM (2024)|220808|abcdef", "ENTRY": "Senna, Indian", "MN": "B01.875.800.575.912.250.401.718", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid53922", "RR": "txid72402", "AN": "note entry terms: CASSIA and CASSIA TREE see CINNAMOMUM AROMATICUM are also available; SENNA EXTRACT is also available", "MS": "A plant genus of the family FABACEAE. SENNA EXTRACT is obtained from members of this genus. Members contain ANTHRAQUINONES and have been an ingredient in laxatives (CATHARTICS). Many species of the CASSIA genus have been reclassified into this genus. This bush should not be confused with the Cassia tree (CINNAMOMUM).", "PM": "2002", "HN": "2002", "MR": "20230226", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029846"}, {"RECTYPE": "D", "MH": "Tamarindus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tamarind|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "indicas, Tamarindus", "MN": "B01.875.800.575.912.250.401.875", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid58859", "RR": "txid58860", "MS": "A plant genus of the family FABACEAE known for its sour fruit.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029861"}, {"RECTYPE": "D", "MH": "Prosopis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mesquite|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "Prosopi", "MN": "B01.875.800.575.912.250.401.702", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid35715", "MS": "A plant genus of the family FABACEAE that is a source of prosopis gum.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029862"}, {"RECTYPE": "D", "MH": "Cicer", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Garbanzo|T168|NON|REL|NLM (2002)|010426|abcdef", "ENTRY": "arietinum, Cicer", "MN": "B01.875.800.575.912.250.401.150", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3826", "RR": "txid3827", "MS": "A plant genus of the family FABACEAE known for the edible beans.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029863"}, {"RECTYPE": "D", "MH": "Crotalaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rattlepod Chipilin|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "Rattlepod Chipilins", "MN": "B01.875.800.575.912.250.401.175", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3828", "MS": "A plant genus of the family FABACEAE that contains crotalarin.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029864"}, {"RECTYPE": "D", "MH": "Cytisus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Broom, Scotch|T002|NON|EQV|NLM (2003)|010830|abcdef", "ENTRY": "Scotch Brooms", "MN": "B01.875.800.575.912.250.401.187", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3833", "RR": "txid3835", "AN": "entry term BROOM, DESERT: several other Broom terms are also available; check text and MeSH", "MS": "A plant genus of the family FABACEAE that is sometimes called broom because of the shape of the plant. Members produce SPARTEINE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029865"}, {"RECTYPE": "D", "MH": "Derris", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "urucus, Lonchocarpus", "MN": "B01.875.800.575.912.250.401.191", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid53864", "RR": "txid185716", "AN": "entry term PONGAMIA ULIGINOSA: Pongamia unspecified, PONGAMIA see FABACEAE is available", "MS": "A plant genus of the family FABACEAE. The root is a source of rotenoids (ROTENONE) and flavonoids. Some species of Pongamia have been reclassified to this genus and some to MILLETTIA. Some species of Deguelia have been reclassified to this genus.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029866"}, {"RECTYPE": "D", "MH": "Xenopus Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Xenopus laevis Proteins|T116|NON|NRW|NLM (2002)|010426|abcdef", "MN": "D12.776.045.500", "FX": "Xenopus laevis", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "AN": "coord IM with specific protein", "MS": "Proteins obtained from various species of Xenopus. Included here are proteins from the African clawed frog (XENOPUS LAEVIS). Many of these proteins have been the subject of scientific investigations in the area of MORPHOGENESIS and development.", "PM": "2002", "HN": "2002", "MR": "20130709", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029867"}, {"RECTYPE": "D", "MH": "Galega", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rue, Goat's|T002|NON|NRW|NLM (2003)|010926|abcdef", "ENTRY": "orientalis, Galega", "MN": "B01.875.800.575.912.250.401.250", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid47100", "RR": "txid47654", "MS": "A plant genus of the family FABACEAE that contains galegine (GUANIDINES). Most of the other species have been reclassified to TEPHROSIA; a few to ASTRAGALUS PLANT; and INDIGOFERA.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029881"}, {"RECTYPE": "D", "MH": "Glycyrrhiza uralensis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gan zao|T002|NON|EQV|NLM (2002)|010426|abcdef", "ENTRY": "zaos, Gan", "MN": "B01.875.800.575.912.250.401.300.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid74613", "MS": "A plant species of the family FABACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029882"}, {"RECTYPE": "D", "MH": "Indigofera", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Indigoferas", "MN": "B01.875.800.575.912.250.401.337", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid20685", "MS": "A plant genus of the family FABACEAE. The common name of indigo also refers to Baptisia or Amorpha genera (FABACEAE).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029883"}, {"RECTYPE": "D", "MH": "Lespedeza", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Clover, Bush|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "Lespedezas", "MN": "B01.875.800.575.912.250.401.525", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid53892", "AN": "note entry term BUSH CLOVER: SWEET CLOVER see MELILOTUS; CLOVER see MEDICAGO; and RED CLOVER see TRIFOLIUM are also available", "MS": "A plant genus of the family FABACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029884"}, {"RECTYPE": "D", "MH": "Maackia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "amurensis, Maackia", "MN": "B01.875.800.575.912.250.401.581", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid37500", "RR": "txid37501", "MS": "A plant genus of the family FABACEAE. It contains a hemagglutinin.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029901"}, {"RECTYPE": "D", "MH": "Medicago", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Clover|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "Medicagos", "MN": "B01.875.800.575.912.250.401.590", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3877", "AN": "note entry term CLOVER: BUSH CLOVER see LESPEDEZA; SWEET CLOVER see MELILOTUS; and RED CLOVER see TRIFOLIUM are also available", "MS": "A plant genus of the family FABACEAE. It is distinct from Sweet Clover (MELILOTUS), from Bush Clover (LESPEDEZA), and from Red Clover (TRIFOLIUM).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029902"}, {"RECTYPE": "D", "MH": "Melilotus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sweet Clover|T002|NON|EQV|NLM (2002)|010426|abcdef", "ENTRY": "Yellow Sweetclovers", "MN": "B01.875.800.575.912.250.401.592", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid47081", "RR": "txid47083", "AN": "note entry term SWEET CLOVER: CLOVER see MEDICAGO; BUSH CLOVER see LESPEDEZA; and RED CLOVER see TRIFOLIUM are also available", "MS": "A plant genus of the family FABACEAE. Molded yellow sweet clover hay, in which the coumarin of sweet clover is converted to DICOUMAROL, is the causative agent of a hemorrhagic disorder in cattle - \"hemorrhagic sweet clover disease\" and featured in the history of anticoagulant drug development.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029903"}, {"RECTYPE": "D", "MH": "Myroxylon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Myroxylon balsamum|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "balsamum, Myroxylon", "MN": "B01.875.800.575.912.250.401.601", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid53905", "RR": "txid53906", "MS": "A plant genus of the family FABACEAE that is a source of aromatic resinous balsams (Balsam of Tolu and Balsam of Peru) used in perfumery and as a constituent in cough syrups and lozenge.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029904"}, {"RECTYPE": "D", "MH": "Pachyrhizus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Jicama|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "Yam Beans", "MN": "B01.875.800.575.912.250.401.611", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid109170", "RR": "txid205481", "AN": "PACHYRHIZUS THUNBERGIANUS see PUERARIA; YAM see DIOSCOREA; YAM BEAN, AFRICAN see SPHENOSTYLIS; PSEUDO-YAM see IPOMOEA BATATAS", "MS": "A plant genus of the family FABACEAE. Some Pachyrhizus have been reclassified to PUERARIA. Do not confuse with yam (IPOMOEA; or DIOSCOREA) or African yam bean (SPHENOSTYLIS).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029905"}, {"RECTYPE": "D", "MH": "Physostigma", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Calabar Bean|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "venenosums, Physostigma", "MN": "B01.875.800.575.912.250.401.694", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid271806", "RR": "txid271807", "MS": "A plant genus of the family FABACEAE that is a source of PHYSOSTIGMINE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029906"}, {"RECTYPE": "D", "MH": "Psoralea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Psoraleas", "MN": "B01.875.800.575.912.250.401.710", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid100167", "MS": "A plant genus of the family FABACEAE that is a source of psoralen (FICUSIN).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029907"}, {"RECTYPE": "D", "MH": "Pueraria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pachyrhizus thunbergianus|T002|NON|NRW|NLM (2003)|010830|abcdef", "ENTRY": "tuberosa, Pueraria", "MN": "B01.875.800.575.912.250.401.714", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3892", "RR": "txid457826", "MS": "A plant genus of the family FABACEAE a common weed of the southeast US. There has been folk use for alcoholism and liver protection. It contains puerarin, kakkalide, daidzein (isoflavonoids), and kudzusaponins (oleanene-type triterpene glycosides).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029908"}, {"RECTYPE": "D", "MH": "Sophora", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mescal Bean Plant|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "Sophoras", "MN": "B01.875.800.575.912.250.401.734", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3896", "MS": "A plant genus of the family FABACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029909"}, {"RECTYPE": "D", "MH": "Trigonella", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fenugreek|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "foenum-graecum, Trigonella", "MN": "B01.875.800.575.912.250.401.937", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid78532", "RR": "txid78534", "MS": "A plant genus of the family FABACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029910"}, {"RECTYPE": "D", "MH": "Caesalpinia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Brazilwood|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "Caesalpinias", "MN": "B01.875.800.575.912.250.401.093", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid53845", "RR": "txid372551", "AN": "CAT'S CLAW is also available", "MS": "A plant genus of the family FABACEAE. The common name of \"Bird-Of-Paradise\" is also used for other plants such as Heliconia (HELICONIACEAE) and Strelitzia (STRELITZIACEAE) and some birds. The common name of \"Cat's-Claw\" is more often used with UNCARIA. The common name of \"Pernambuco\" also refers to a state in Brazil. Furanoditerpenoid lactones and caesalpin are produced by members of this genus.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029911"}, {"RECTYPE": "D", "MH": "Abrus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Precatory Bean Plant|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "Precatory Bean Plants", "MN": "B01.875.800.575.912.250.401.012", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3815", "RR": "txid3816", "MS": "A plant genus of the family FABACEAE whose members contain the highly toxic compound ABRIN.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029912"}, {"RECTYPE": "D", "MH": "Trifolium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Red Clover|T002|NON|NRW|NLM (2010)|090701|abcdef", "ENTRY": "repen, Trifolium", "MN": "B01.875.800.575.912.250.401.906", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3898", "RR": "txid57577", "AN": "note entry term RED CLOVER: CLOVER see MEDICAGO; BUSH CLOVER see LESPEDEZA; and SWEET CLOVER see MELILOTUS are also available", "MS": "A plant genus of the family FABACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029921"}, {"RECTYPE": "D", "MH": "Fish Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fish Protein|T116|T123|NON|EQV|NLM (2021)|200225|abbcdef", "ENTRY": "Proteins, Fish", "MN": "D12.776.325", "FX": "Fishes", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "AN": "coorrd IM with specific protein (IM) + specific fish (IM)", "MS": "Proteins obtained from species of fish (FISHES).", "PM": "2002", "HN": "2002", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029941"}, {"RECTYPE": "D", "MH": "Zebrafish Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Zebra Fish Proteins|T116|NON|EQV|NLM (2002)|010426|abcdef", "MN": "D12.776.325.500", "FX": "Zebrafish", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "AN": "coord IM with specific protein (IM)", "MS": "Proteins obtained from the ZEBRAFISH. Many of the proteins in this species have been the subject of studies involving basic embryological development (EMBRYOLOGY).", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029961"}, {"RECTYPE": "D", "MH": "Fagaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.750.300", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3503", "AN": "prefer specific plant;", "MS": "A plant family of the order Fagales subclass Hamamelidae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029962"}, {"RECTYPE": "D", "MH": "Quercus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Oak Tree|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "Trees, Oak", "MN": "B01.875.800.575.912.250.859.750.300.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3511", "RR": "txid58334", "MS": "A plant genus of the family FAGACEAE that is a source of TANNINS. Do not confuse with Holly (ILEX).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029963"}, {"RECTYPE": "D", "MH": "Fagus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Beech|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "Beechs", "MN": "B01.875.800.575.912.250.859.750.300.249", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid21024", "MS": "A plant genus of the family FAGACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029964"}, {"RECTYPE": "D", "MH": "Gentianaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Canscoras", "MN": "B01.875.800.575.912.250.456.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid21472", "RR": "txid82702", "MS": "A plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029965"}, {"RECTYPE": "D", "MH": "Centaurium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "minus, Centaurium", "MN": "B01.875.800.575.912.250.456.750.188", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid50750", "RR": "txid172057", "MS": "A plant genus of the family GENTIANACEAE. Triterpene lactones and other compounds have been isolated from species of this genus. The common name of century plant has also been used for the AGAVE genus.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D029966"}, {"RECTYPE": "D", "MH": "Swertia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Swertias", "MN": "B01.875.800.575.912.250.456.750.594", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid39241", "RR": "txid137887", "MS": "A plant genus of the family GENTIANACEAE. It is a source of swertiapuniside and IRIDOID GLYCOSIDES.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029967"}, {"RECTYPE": "D", "MH": "Escherichia coli Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "E coli Proteins|T116|ACX|EQV|NLM (2002)|010426|abcdef", "MN": "D12.776.097.275", "FX": "Escherichia coli", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "PI": "Bacterial Proteins (1994-2001)", "MS": "Proteins obtained from ESCHERICHIA COLI.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029968"}, {"RECTYPE": "D", "MH": "Angelica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Angelicas", "MN": "B01.875.800.575.912.250.075.088", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid40948", "MS": "A plant genus of the family Apiaceae.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029969"}, {"RECTYPE": "D", "MH": "Angelica archangelica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "archangelicas, Angelica", "MN": "B01.875.800.575.912.250.075.088.077", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid40949", "MS": "A plant species of the family Apiaceae that contains COUMARINS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029970"}, {"RECTYPE": "D", "MH": "Angelica sinensis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "sinenses, Angelica", "MN": "B01.875.800.575.912.250.075.088.538", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid165353", "MS": "A plant species of the family APIACEAE that is the source of dong quai.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029971"}, {"RECTYPE": "D", "MH": "Bupleurum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Saiko|T002|NON|NRW|NLM (2002)|abcde", "ENTRY": "Hare's Ears", "MN": "B01.875.800.575.912.250.075.144", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid46366", "MS": "A plant genus of the family APIACEAE that is the source of bupleurum root and of bupleurotoxin and is an ingredient of sho-saiko-to.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029972"}, {"RECTYPE": "D", "MH": "Carum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Caraway|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "copticum, Carum", "MN": "B01.875.800.575.912.250.075.166", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid48031", "RR": "txid48032", "MS": "A plant genus of the family Apiaceae. The seeds are used as flavoring.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029974"}, {"RECTYPE": "D", "MH": "Cicuta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Water Hemlock|T002|NON|EQV|NLM (2002)|010426|abcdef", "ENTRY": "virosas, Cicuta", "MN": "B01.875.800.575.912.250.075.190", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid48035", "RR": "txid48109", "PI": "Hemlock (1995-2001)", "MS": "A plant genus of the family APIACEAE. It is a source of cicutoxin.", "PM": "2002; for CICUTA MAJOR & CICUTA VIROSA see HEMLOCK 1995-2001", "HN": "2002; for CICUTA MAJOR & CICUTA VIROSA use HEMLOCK 1995-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029981"}, {"RECTYPE": "D", "MH": "Conium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Poison Hemlock|T002|NON|EQV|NLM (2002)|010426|abcdef", "ENTRY": "maculatums, Conium", "MN": "B01.875.800.575.912.250.075.205", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13446", "RR": "txid13447", "AN": "note entry term POISON HEMLOCK: use only for this plant and not for poisoning by other HEMLOCK plants", "PI": "Hemlock (1995-2001)", "MS": "A plant genus of the family APIACEAE that is a source of coniine.", "PM": "2002; for CONIUM MACULATUM see HEMLOCK 1995-2001", "HN": "2002; for CONIUM MACULATUM use HEMLOCK 1995-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D029982"}, {"RECTYPE": "D", "MH": "Foeniculum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fennel|T168|NON|REL|NLM (2003)|010824|abcdef", "ENTRY": "vulgares, Foeniculum", "MN": "B01.875.800.575.912.250.075.333", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid48037", "RR": "txid2849586", "AN": "entry term FENNEL: FENNEL, DOG see ANTHEMIS are also available", "MS": "A plant genus of the family APIACEAE used in SPICES.", "PM": "2002", "HN": "2002", "MR": "20211018", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030001"}, {"RECTYPE": "D", "MH": "Heracleum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Heracleums", "MN": "B01.875.800.575.912.250.075.411", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid40917", "MS": "A plant genus of the family APIACEAE. Members contain COUMARINS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030002"}, {"RECTYPE": "D", "MH": "Levisticum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lovage|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "officinales, Levisticum", "MN": "B01.875.800.575.912.250.075.488", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid48041", "RR": "txid48042", "AN": "note entry term ALPINE LOVAGE: LOVAGE see LIGUSTICUM is also available", "MS": "A plant genus of the family APIACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030003"}, {"RECTYPE": "D", "MH": "Ligusticum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lovage, Alpine|T002|NON|EQV|NLM (2002)|010515|abcdef", "ENTRY": "Lovages, Alpine", "MN": "B01.875.800.575.912.250.075.511", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid49551", "AN": "note entry term ALPINE LOVAGE: LOVAGE see LEVISTICUM is also available", "MS": "A plant genus of the family APIACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030004"}, {"RECTYPE": "D", "MH": "Sanicula", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sanicle|T002|NON|EQV|NLM (2002)|010426|abcdef", "ENTRY": "Saniculas", "MN": "B01.875.800.575.912.250.075.875", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13665", "AN": "do not confuse with other snakeroots such as ASARUM; ARISTOLOCHIA; and Polygala", "MS": "A plant genus of the family Apiaceae. Commonly called snakeroot but that name is used for many other plants such as ASARUM; ARISTOLOCHIA; and Polygala.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030005"}, {"RECTYPE": "D", "MH": "Amsonia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "elliptica, Amsonia", "MN": "B01.875.800.575.912.250.456.500.088", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid141529", "RR": "txid403098", "MS": "A plant genus of the family APOCYNACEAE. Species of this genus contain YOHIMBINE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030006"}, {"RECTYPE": "D", "MH": "Nerium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Oleander|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "oleanders, Nerium", "MN": "B01.875.800.575.912.250.456.500.432", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid63461", "RR": "txid63479", "MS": "A plant genus of the family APOCYNACEAE. It is a very poisonous plant that contains cardioactive agents.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030007"}, {"RECTYPE": "D", "MH": "Catharanthus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Vinca rosea|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "rosea, Vinca", "MN": "B01.875.800.575.912.250.456.500.260", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4057", "RR": "txid4058", "MS": "A plant genus of the family Apocynaceae. It is the source of VINCA ALKALOIDS, used in leukemia chemotherapy.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030008"}, {"RECTYPE": "D", "MH": "Aspidosperma", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Brazilian Box Tree|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "Trees, Brazilian Box", "MN": "B01.875.800.575.912.250.456.500.174", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid84858", "MS": "A plant genus of the family APOCYNACEAE. It contains ellipticine.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030009"}, {"RECTYPE": "D", "MH": "Apocynum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Dogbane|T002|NON|EQV|NLM (2002)|010426|abcdef", "ENTRY": "Poacynums", "MN": "B01.875.800.575.912.250.456.500.131", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid13338", "RR": "txid13339", "MS": "A plant genus of the family APOCYNACEAE. On rare occasions it is called Milkweed, but should not be confused with true Milkweed (ASCLEPIAS).", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030010"}, {"RECTYPE": "D", "MH": "Ochrosia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "ellipticas, Ochrosia", "MN": "B01.875.800.575.912.250.456.500.604", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid141590", "RR": "txid141591", "MS": "A plant genus of the family Apocynaceae. Species of this genus contain 9-methoxyellipticine (ELLIPTICINES) which is the basis of one of the classes of ANTINEOPLASTIC AGENTS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030011"}, {"RECTYPE": "D", "MH": "Gentiana", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gentian|T002|NON|EQV|NLM (1998)|961206|abcdef", "ENTRY": "Yellow Gentians", "MN": "B01.875.800.575.912.250.456.750.391", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid21496", "RR": "txid38851", "AN": "do not confuse with GENTIAN VIOLET", "MS": "A plant genus of the family Gentianaceae whose members contain SECOIRIDOIDS and have been used in TRADITIONAL MEDICINE for suppressing INFLAMMATION.", "PM": "2003; see GENTIAN 2002, see RAUWOLFIA 1998-2001", "HN": "2003 (2002); use RAUWOLFIA 1998-2001", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030012"}, {"RECTYPE": "D", "MH": "Strophanthus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.456.500.833", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid52858", "MS": "A plant genus of the family APOCYNACEAE that contains OUABAIN cardiac glycosides.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030013"}, {"RECTYPE": "D", "MH": "Tabernaemontana", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tabernaemontaneae|T002|NON|REL|NLM (2021)|190820|abcdef", "ENTRY": "Tabernaemontanas", "MN": "B01.875.800.575.912.250.456.500.888", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid52860", "RR": "txid167497", "MS": "A plant genus of the family APOCYNACEAE that contains bisindole alkaloids and IBOGAINE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030014"}, {"RECTYPE": "D", "MH": "Enterovirus C, Human", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Coxsackievirus A24, Human|T005|NON|NRW|NLM (2002)|010426|COXSACKIEVIRUS A 024 HUMAN|abcdefs", "ENTRY": "A24 Variant, Coxsackievirus", "MN": "B04.820.578.750.284.184", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid138950", "RR": "txid12089", "AN": "infection: coord IM with ENTEROVIRUS INFECTIONS (IM) or COXSACKIEVIRUS INFECTIONS (IM), follow text", "MS": "A species of ENTEROVIRUS infecting humans and containing 11 serotypes, all coxsackieviruses.", "PM": "2002; for COXSACKIE A24 VARIANT VIRUS see COXSACKIEVIRUSES A 1992-2001", "HN": "2002; for COXSACKIE A24 VARIANT VIRUS use ENTEROVIRUS 1992-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030015"}, {"RECTYPE": "D", "MH": "Enterovirus D, Human", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human Enterovirus D|T005|NON|EQV|NLM (2023)|210812|abcdef", "ENTRY": "Human Enterovirus 70", "MN": "B04.820.578.750.284.188", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid138951", "RR": "txid42789", "AN": "infection: coordinate with ENTEROVIRUS INFECTIONS  ", "MS": "A species of ENTEROVIRUS infecting humans and consisting of 2 serotypes: Human enterovirus 68 and Human enterovirus 70.", "PM": "2002; for ENTEROVIRUS-70 see ENTEROVIRUS 1992-2001", "HN": "2002; for ENTEROVIRUS-70 use ENTEROVIRUS 1992-2001", "MR": "20211018", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030016"}, {"RECTYPE": "D", "MH": "Ilex", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Winterberry|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "verticillatas, Ilex", "MN": "B01.875.800.575.912.250.084.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4295", "RR": "txid185559", "AN": "entry term HOLLY: restrict to ILEX; SEA HOLLY see ERYNGIUM is also available; entry term ALDER, BLACK: ALDER see ALNUS is also available", "MS": "A plant genus of the family AQUIFOLIACEAE. The common name of 'holly' usually refers to this genus but may sometimes refer to similar looking plants of the MAHONIA or QUERCUS genus.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030017"}, {"RECTYPE": "D", "MH": "Ilex guayusa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Guayusa|T002|NON|EQV|NLM (2002)|010426|abcdef", "ENTRY": "guayusa, Ilex", "MN": "B01.875.800.575.912.250.084.500.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid185514", "MS": "A plant species of the family AQUIFOLIACEAE known for ritual use by Amazonian Jivaro Indians.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030018"}, {"RECTYPE": "D", "MH": "Ilex paraguariensis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yerba Mate|T002|NON|EQV|NLM (2002)|010426|abcdef", "ENTRY": "paraguarienses, Ilex", "MN": "B01.875.800.575.912.250.084.500.750", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid185542", "MS": "A plant species of the family AQUIFOLIACEAE. An infusion of the leaves is commonly drunk in South America for stimulating effect in much the same manner as coffee is in other cultures.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030019"}, {"RECTYPE": "D", "MH": "Ilex vomitoria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yaupon|T002|NON|EQV|NLM (2002)|010426|abcdef", "ENTRY": "vomitoria, Ilex", "MN": "B01.875.800.575.912.250.084.500.875", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4297", "MS": "A plant species of the family AQUIFOLIACEAE. It has been used to induce vomiting in purification rites.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030020"}, {"RECTYPE": "D", "MH": "Pinellia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rhizoma Pinelliae|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "ternatas, Pinellia", "MN": "B01.875.800.575.912.250.618.050.750.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid199219", "RR": "txid199225", "MS": "A plant genus of the family ARACEAE that contains pinellian (an acidic polysaccharide). The plant is an ingredient of some traditional Asian medicinal mixtures including sho-saiko-to, saiko-keishi-to, and banxia houpu decoction.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030021"}, {"RECTYPE": "D", "MH": "Aristolochia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Dutchman's Pipe|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "Pipes, Dutchman's", "MN": "B01.875.800.575.912.250.096.211", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid12947", "RR": "txid12949", "MS": "A plant genus of the family ARISTOLOCHIACEAE. Species of this genus have been used in traditional medicine but they contain aristolochic acid which is associated with nephropathy. These are sometimes called 'snakeroot' but that name is also used with a number of other plants such as POLYGALA; SANICULA; ASARUM; ARISTOLOCHIA; AGERATINA; and others.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030022"}, {"RECTYPE": "D", "MH": "Asarum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Wild Ginger|T002|NON|NRW|NLM (2002)|010426|abcdef", "ENTRY": "canadense, Asarum", "MN": "B01.875.800.575.912.250.096.233", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid16728", "RR": "txid28498", "AN": "snakeroot may or may not go here, check text; note entry term WILD GINGER: GINGER is also available", "MS": "A plant genus of the family ARISTOLOCHIACEAE which was used medicinally by North American Indians. The common name of 'snakeroot' is also used for many other plants, including SANICULA; or ARISTOLOCHIA; or Polygala.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030023"}, {"RECTYPE": "D", "MH": "Curcuma", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Zedoary zedoaria|T002|NON|NRW|NLM (2003)|020328|abcdef", "ENTRY": "zedoaria, Zedoary", "MN": "B01.875.800.575.912.250.618.937.900.166", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid99568", "RR": "txid136224", "AN": "entry term TUMERIC: TURMERIC YELLOW see CURCUMIN is also available", "MS": "A plant genus of the family ZINGIBERACEAE that contains CURCUMIN and curcuminoids.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030024"}, {"RECTYPE": "D", "MH": "Hepatitis A virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Hepatitis A viruses", "MN": "B04.820.578.750.400.410", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid12092", "PI": "Hepatovirus (1964-2001)", "MS": "A species in the genus HEPATOVIRUS containing one serotype and two strains: HUMAN HEPATITIS A VIRUS and Simian hepatitis A virus causing hepatitis in humans (HEPATITIS A) and primates, respectively.", "PM": "2002, 1977-1993; see HEPATOVIRUS 1994-2001", "HN": "2002, 1977-1993; use HEPATOVIRUS 1994-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030041"}, {"RECTYPE": "D", "MH": "Parechovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Ljungan virus|T005|NON|NRW|NLM (2007)|050902|abcdef", "ENTRY": "parechovirus, Human", "MN": "B04.820.578.750.700", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid138954", "RR": "txid39085", "AN": "infection: coordinate IM with PICORNAVIRIDAE INFECTIONS (IM)", "MS": "A genus in the family PICORNAVIRIDAE infecting humans and rodents. The type species is Human parechovirus.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030061"}, {"RECTYPE": "D", "MH": "Palyam Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Kasba virus|T005|NON|NRW|NLM (2002)|010427|abcdef", "MN": "B04.820.223.719.550.750", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid40059", "RR": "txid1565589", "AN": "infection: coord IM with REOVIRIDAE INFECTIONS (IM)", "PI": "Reoviridae (1988-1993)", "MS": "A species of ORBIVIRUS infecting cattle and sheep. It is transmitted by culicine mosquitoes and gnats (CULICOIDES).", "PM": "2002; see ORBIVIRUS 1994-2001", "HN": "2002; use ORBIVIRUS 1994-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030081"}, {"RECTYPE": "D", "MH": "Orthoreovirus, Avian", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Avian orthoreovirus|T005|NON|EQV|NLM (2002)|010428|abcdef", "ENTRY": "Reoviruses, Avian", "MN": "B04.820.223.719.590.500", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid38170", "AN": "infection: coord IM with REOVIRIDAE INFECTIONS (IM)", "PI": "Reoviridae (1967-1994)", "MS": "A species of ORTHOREOVIRUS infecting birds, with outcomes ranging from inapparent to lethal depending on the virus strain and age of the host bird. This species does not infect mammals.", "PM": "2002; see ORTHOREOVIRUS 1997-2001", "HN": "2002; use ORTHOREOVIRUS 1997-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030101"}, {"RECTYPE": "D", "MH": "Orthoreovirus, Mammalian", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Reovirus 2|T005|NON|NRW|NLM (1994)|930310|REOVIRUS 002|abcdefs", "ENTRY": "Orthoreoviruses, Mammalian", "MN": "B04.820.223.719.590.550", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid351073", "RR": "txid538121", "AN": "infection: coordinate IM with REOVIRIDAE INFECTIONS (IM)", "MS": "A species of ORTHOREOVIRUS infecting mammals (other than baboons). There are four serotypes. In humans they are generally benign but may sometimes cause upper respiratory tract illness or enteritis in infants and children. MAMMALIAN ORTHOREOVIRUS 3 is a very pathogenic virus in laboratory rodents.", "PM": "2002; for REOVIRUS 1 & REOVIRUS 2 see ORTHOREOVIRUS 1994-2001", "HN": "2002; for REOVIRUS 1 & REOVIRUS 2 use ORTHOREOVIRUS 1994-2001", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030102"}, {"RECTYPE": "D", "MH": "Betaretrovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Type D Retroviruses|T005|NON|NRW|NLM (1994)|930223|abcdef", "ENTRY": "Type D Retrovirus", "MN": "B04.820.650.124", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid140052", "AN": "infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "MS": "A genus of the family RETROVIRIDAE consisting of viruses with either type B or type D morphology. This includes a few exogenous, vertically transmitted and endogenous viruses of mice (type B) and some primate and sheep viruses (type D). MAMMARY TUMOR VIRUS, MOUSE is the type species.", "PM": "2002; for RETROVIRUSES TYPE D see RETROVIRUSES TYPE D 1999-2001, see RETROVIRUSES, TYPE D 1994-1998, see ONCOVIRUSES, TYPE D 1991-1993; for FIBROBLAST VIRUS, HUMAN, PERMANENT see RETROVIRUSES TYPE D 1994-2001, see FIBROBLAST VIRUS, HUMAN, PERMANENT 1991-1993; for RETROVIRUSES TYPE B, MAMMALIAN see RETROVIRUSES TYPE D MAMMALIAN 1994-2001, see ONCOVIRUSES TYPE B, MAMMALIAN 1994-1996, see MAMMARY CANCER VIRUS 1991-1993; for TYPE B ONCOVIRUSES MAMMALIAN see MAMMARY CANCER VIRUS 1991-1993", "HN": "2002", "MR": "20200902", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030121"}, {"RECTYPE": "D", "MH": "Feedback, Psychological", "DE": "FEEDBACK PSYCHOL", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Psychological Feedback|T067|NON|EQV|NLM (2002)|010430|PSYCHOL FEEDBACK|abcdefv", "ENTRY": "Psychological Feedbacks", "MN": "F04.754.308", "MH_TH": "NLM (2002)", "ST": "T067", "AN": "BIOFEEDBACK, PSYCHOLOGY is also available", "PI": "Feedback (1965-2001)", "MS": "A mechanism of information stimulus and response that may control subsequent behavior, cognition, perception, or performance. (From APA Thesaurus of Psychological Index Terms, 8th ed.)", "PM": "2002", "HN": "2002", "MR": "20170630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030141"}, {"RECTYPE": "D", "MH": "Avian Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Bird Proteins|T116|NON|EQV|NLM (2002)|010501|abcdef", "ENTRY": "Proteins, Bird", "MN": "D12.776.095", "FX": "Birds", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "AN": "coord IM with specific protein (IM) + specific bird (IM)", "MS": "Proteins obtained from species of BIRDS.", "PM": "2002", "HN": "2002", "MR": "20200527", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030161"}, {"RECTYPE": "D", "MH": "Reptilian Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reptile Proteins|T116|NON|EQV|NLM (2002)|010501|abcdef", "MN": "D12.776.831", "FX": "Reptiles", "MH_TH": "NLM (2002)", "ST": "T116", "RN": "0", "AN": "coord IM with specific protein (IM) + specific reptile (IM)", "MS": "Proteins obtained from species of REPTILES.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030162"}, {"RECTYPE": "D", "MH": "Vitamin D Response Element", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Response Element, Vitamin D|T114|T123|NON|EQV|NLM (2002)|010504|abbcdef", "MN": "G05.360.340.024.340.137.750.680.765.920", "MH_TH": "NLM (1992)", "ST": "T123", "PI": "Vitamin D (1989-2001)", "MS": "A DNA sequence that is found in the promoter region of vitamin D regulated genes. Vitamin D receptor (RECEPTOR, CALCITRIOL) binds to and regulates the activity of genes containing this element.", "PM": "2002; 2002; see VITAMIN D-BINDING PROTEIN 1992-2001", "HN": "2002; was VITAMIN D-BINDING PROTEIN 1992-2001", "MR": "20080708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030181"}, {"RECTYPE": "D", "MH": "Activin Receptors, Type I", "DE": "ACTIVIN RECEPT TYPE I", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Activin Receptor-Like Kinases, Type I|T116|T126|T192|NON|EQV|NLM (2002)|010523|ACTIVIN RECEPT LIKE KINASES TYPE I|abbbcdefv", "ENTRY": "Activin Receptor Like Kinases, Type I", "MN": "D12.776.543.750.750.400.820.500.500", "MH_TH": "NLM (2002)", "ST": "T192", "RN": "EC 2.7.11.30", "PI": "Receptors, Growth Factor (1995-2001)", "MS": "One of the two types of ACTIVIN RECEPTORS or activin receptor-like kinases (ALK'S). There are several type I activin receptors. The major active ones are ALK-2 (ActR-IA) and ALK-4 (ActR-IB).", "PM": "2002; ACTIVIN RECEPTOR TYPE I was indexed under RECEPTORS, GROWTH FACTOR 1997-2001", "HN": "2002; use ACTIVIN RECEPTORS, TYPE I (NM) 1997-2001", "MR": "20210520", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030201"}, {"RECTYPE": "D", "MH": "Cola", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Nuts, Kola", "MN": "B01.875.800.575.912.250.859.821.500.212", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid82456", "RR": "txid93760", "AN": "do not confuse with the cola beverage;  GOTU KOLA see CENTELLA and  BITTER KOLA see GARCINIA KOLA are also available", "MS": "A plant genus of the family STERCULIACEAE. This is the source of the kola nut which contains CAFFEINE and is used in popular beverages.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030221"}, {"RECTYPE": "D", "MH": "Diarrhea Virus 1, Bovine Viral", "DS": "DIARRHEA VIRUS BOVINE VIRAL 001", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Bovine viral diarrhea virus 1|T005|NON|EQV|NLM (2002)|010510|BOVINE VIRAL DIARRHEA VIRUS 001|abcdefs", "ENTRY": "Bovine Viral Diarrhea Virus Type 1|T005|NON|EQV|NLM (2002)|010510|abcdef", "MN": "B04.820.578.344.700.150.100", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11099", "AN": "infection: coord IM with BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE (IM) or PESTIVIRUS INFECTIONS (IM) if not in cattle", "MS": "A species of PESTIVIRUS causing systemic infections (BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE) in cattle and some other cloven-hoofed animals. There are several strains and two biotypes: cytopathic (rare) and non-cytopathic. Infections range from clinically inapparent to severe, but do not correlate with biotypes.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030241"}, {"RECTYPE": "D", "MH": "Diarrhea Virus 2, Bovine Viral", "DS": "DIARRHEA VIRUS BOVINE VIRAL 002", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Bovine viral diarrhea virus 2|T005|NON|EQV|NLM (2002)|010510|BOVINE VIRAL DIARRHEA VIRUS 002|abcdefs", "ENTRY": "Bovine Viral Diarrhea Virus Type 2|T005|NON|EQV|NLM (2002)|010510|abcdef", "MN": "B04.820.578.344.700.150.120", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid54315", "MS": "A species of PESTIVIRUS causing systemic infections including BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE and BOVINE HEMORRHAGIC SYNDROME in cattle and some other cloven-hoofed animals. There are several strains and two biotypes: cytopathic (rare) and non-cytopathic. The severity of disease appears to be strain dependent. Cytopathogenic effects do not correlate with virulence as non-cytopathic BVDV-2 is associated only with Hemorrhagic Disease, Bovine.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030242"}, {"RECTYPE": "D", "MH": "Hemorrhagic Syndrome, Bovine", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Bovine Hemorrhagic Syndrome|T047|NON|EQV|NLM (2002)|010510|abcdef", "MN": "C22.196.400", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "Bovine Virus Diarrhea-Mucosal Disease (1995-2001)", "MS": "Clinically severe acute disease of cattle caused by noncytopathic forms of Bovine viral diarrhea virus 2 (DIARRHEA VIRUS 2, BOVINE VIRAL). Outbreaks are characterized by high morbidity and high mortality.", "PM": "2002", "HN": "2002", "MR": "20190617", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030243"}, {"RECTYPE": "D", "MH": "Primate T-lymphotropic virus 1", "DS": "PRIMATE LYMPHOTROPIC VIRUS T 001", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "T-Lymphotropic Virus 1, Primate|T005|NON|EQV|NLM (2002)|010511|LYMPHOTROPIC VIRUS PRIMATE T 001|abcdefs", "ENTRY": "T Lymphotropic Virus 1, Primate", "MN": "B04.820.650.200.725", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid194440", "AN": "infection: coord IM with DELTARETROVIRUS INFECTIONS + TUMOR VIRUS INFECTIONS (IM) if pertinent", "MS": "A species in the family DELTARETROVIRUS comprising strains of different host species but arising from the same geographic origin. They include HUMAN T-LYMPHOTROPIC VIRUS 1 and SIMIAN T-LYMPHOTROPIC VIRUS 1.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030261"}, {"RECTYPE": "D", "MH": "Soybean Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Soybean Protein|T116|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Soybean Proteins, Dietary", "MN": "J02.500.850.800.500.750", "FX": "Glycine max", "MH_TH": "NLM (1997)", "ST": "T116", "RN": "0", "MS": "Proteins which are present in or isolated from SOYBEANS.", "PM": "2002; see SOY PROTEINS (1997-2001)", "HN": "2002(1997)", "MR": "20230727", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030262"}, {"RECTYPE": "D", "MH": "Primate T-lymphotropic virus 2", "DS": "PRIMATE LYMPHOTROPIC VIRUS T 002", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "T-Lymphotropic Virus 2, Primate|T005|NON|EQV|NLM (2002)|010511|LYMPHOTROPIC VIRUS PRIMATE T 002|abcdefs", "ENTRY": "T-lymphotropic virus-PP, Simian", "MN": "B04.820.650.200.730", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid194441", "AN": "infection: coordinate IM with DELTARETROVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) if pertinent", "MS": "A species in the family DELTARETROVIRUS, comprising strains from different host species but arising from the same geographic origin. They include HUMAN T-LYMPHOTROPIC VIRUS 2; SIMIAN T-LYMPHOTROPIC VIRUS 2; and Simian T-lymphotropic virus - PP.", "PM": "2002", "HN": "2002", "MR": "20200902", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030263"}, {"RECTYPE": "D", "MH": "Simian T-lymphotropic virus 2", "DS": "SIMIAN LYMPHOTROPIC VIRUS T 002", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "STLV-2|T005|ACR|EQV|NLM (2002)|010511|STLV 002|abcdefs", "ENTRY": "Simian T lymphotropic virus 2", "MN": "B04.820.650.805.855", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid33748", "AN": "infection: coord IM with DELTARETROVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) if pertinent", "PI": "Simian T-lymphotropic virus 1 (1998-2001)", "MS": "A strain of PRIMATE T-LYMPHOTROPIC VIRUS 2 isolated from Congolese bonobos (PAN PANISCUS).", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030281"}, {"RECTYPE": "D", "MH": "Primate T-lymphotropic virus 3", "DS": "PRIMATE LYMPHOTROPIC VIRUS T 003", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Primate T lymphotropic virus 3", "MN": "B04.820.650.200.735", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid194443", "AN": "infection: coordinate IM with DELTARETROVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) if pertinent", "PI": "Simian T-lymphotropic virus 1 (1999-2001)", "MS": "A species of DELTARETROVIRUS that includes the strains SIMIAN T-LYMPHOTROPIC VIRUS 3 and HUMAN T-LYMPHOTROPIC VIRUS 3.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030282"}, {"RECTYPE": "D", "MH": "Epsilonretrovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Walleye epidermal hyperplasia virus 2|T005|NON|NRW|NLM (2002)|010511|WALLEYE EPIDERMAL HYPERPLASIA 002 VIRUS|abcdefs", "ENTRY": "Epsilonretroviruses", "MN": "B04.820.650.260", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid153137", "RR": "txid64462", "AN": "infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS if pertinent + FISH DISEASES (IM) (see note there)", "PI": "Retroviridae (1995-2001)", "MS": "A genus in the family RETROVIRIDAE infecting fish. Species include Walleye dermal sarcoma virus, Walleye epidermal hyperplasia virus 1, and Walleye epidermal hyperplasia virus 2.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030283"}, {"RECTYPE": "D", "MH": "Activin Receptors, Type II", "DE": "ACTIVIN RECEPT TYPE II", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Activin Receptor Like Kinases, Type II|T116|T126|T192|NON|EQV|NLM (2002)|010523|ACTIVIN RECEPT LIKE KINASES TYPE II|abbbcdefv", "ENTRY": "Activin Receptors Type II|T116|T126|T192|NON|EQV|NLM (2002)|abbbcde", "MN": "D12.776.543.750.750.400.820.500.750", "MH_TH": "NLM (2002)", "ST": "T192", "RN": "EC 2.7.11.30", "PI": "Receptors, Growth Factor (1994-2001)", "MS": "One of the two types of ACTIVIN RECEPTORS. They are membrane protein kinases belonging to the family of PROTEIN SERINE-THREONINE KINASES. The major type II activin receptors are ActR-IIA and ActR-IIB.", "PM": "2002; ACTIVIN RECEPTOR TYPE II was indexed under RECEPTORS, GROWTH FACTORS 1991-2001", "HN": "2002; use ACTIVIN RECEPTORS, TYPE II (NM) 1991-2001", "MR": "20210712", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030301"}, {"RECTYPE": "D", "MH": "Denys-Drash Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Drash Syndrome|T019|T191|EPO|EQV|NLM (2010)|OMIM (2013)|ORD (2010)|090608|abbcdeeef", "ENTRY": "Syndrome, Drash", "MN": "C19.391.119.096.562", "FX": "Genes, Wilms Tumor", "MH_TH": "ORD (2010)", "ST": "T191", "PI": "Pseudohermaphroditism (1991-2001)", "MS": "A disorder of sex development characterized by UROGENITAL ABNORMALITIES; GONADAL DYSGENESIS; and WILMS TUMOR. It is caused by a mutation in the Wilms tumor suppressor gene (GENES, WILMS TUMOR) on chromosome 11.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D030321"}, {"RECTYPE": "D", "MH": "Nidovirales Infections", "DE": "NIDOVIRALES INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C01.925.782.600", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "MS": "Infections with viruses of the order NIDOVIRALES. The concept includes ARTERIVIRUS INFECTIONS and CORONAVIRIDAE INFECTIONS.", "PM": "2002", "HN": "2002", "MR": "20190617", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030341"}, {"RECTYPE": "D", "MH": "Genetic Diseases, Inborn", "DE": "GENET DIS INBORN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hereditary Diseases|T047|NON|NRW|POPLINE (1978)|990101|HEREDITARY DIS|abcdefv", "ENTRY": "Single-Gene Defect", "MN": "C16.320", "FX": "Genetics, Medical", "MH_TH": "NLM (2002)", "ST": "T047", "AN": "general; prefer /genet with specific diseases", "MS": "Diseases that are caused by genetic mutations present during embryo or fetal development, although they may be observed later in life. The mutations may be inherited from a parent's genome or they may be acquired in utero.", "PM": "2002; for HEREDITARY DISEASES see HEREDITARY DISEASES 1968-2001", "HN": "2002", "MR": "20160609", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030342"}, {"RECTYPE": "D", "MH": "Papillomavirus Infections", "DE": "PAPILLOMAVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Papillomavirus Infections, Human", "MN": "C23.550.291.531.937.640.500", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "Tumor Virus Infections (1966-1993)", "MS": "Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.", "PM": "2002", "HN": "2002", "MR": "20220712", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030361"}, {"RECTYPE": "D", "MH": "Nodaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Betanodavirus|T005|NON|NRW|NLM (2002)|010516|abcdef", "MN": "B04.820.578.625", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid12283", "RR": "txid143920", "AN": "infection: coord IM with RNA VIRUS INFECTIONS (IM) + FISH DISEASES (IM) (see note there); in insects: coord IM with specific insect /virol", "PI": "RNA Viruses (1996-2001)", "MS": "A family of RNA viruses infecting INSECTA and fish. There are two genera: Alphanodavirus and Betanodavirus.", "PM": "2002", "HN": "2002", "MR": "20200813", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030381"}, {"RECTYPE": "D", "MH": "Cytochrome-c Oxidase Deficiency", "DE": "CYTOCHROME C OXIDASE DEFIC", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Oxidase Deficiency, Cytochrome-c", "MN": "C18.452.660.195", "FX": "Electron Transport Complex IV", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "Leigh Disease (1997-2001)", "MS": "A disease that results from a congenital defect in ELECTRON TRANSPORT COMPLEX IV. Defects in ELECTRON TRANSPORT COMPLEX IV can be caused by mutations in the SURF1, SCO2, COX10, or SCO1 genes. ELECTRON TRANSPORT COMPLEX IV deficiency caused by mutation in SURF1 manifests itself as LEIGH DISEASE; that caused by mutation in SCO2 as fatal infantile cardioencephalomyopathy; that caused by mutation in COX10 as tubulopathy and leukodystrophy; and that caused by mutation in SCO1 as early-onset hepatic failure and neurologic disorder. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM#220110, May 17, 2001)", "PM": "2002", "HN": "2002", "MR": "20130708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030401"}, {"RECTYPE": "D", "MH": "Peroxynitrous Acid", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Peroxynitrite|T123|T197|NON|NRW|NLM (2002)|abbcde", "ENTRY": "Peroxynitrous Acids", "MN": "D02.389.508.750", "MH_TH": "NLM (2002)", "ST": "T197", "RN": "14691-52-2", "RR": "19059-14-4 (peroxynitrite)", "PI": "Nitrates (1990-2001)", "MS": "A potent oxidant synthesized by the cell during its normal metabolism. Peroxynitrite is formed from the reaction of two free radicals, NITRIC OXIDE and the superoxide anion (SUPEROXIDES).", "PM": "2002; PEROXYNITRITE was indexed under NITRATES 1990-2001", "HN": "2002; for PEROXYNITRITE use PEROXYNITROUS ACID (NM) 1990-2001", "MR": "20230226", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030421"}, {"RECTYPE": "D", "MH": "Saussurea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Aucklandia lappa|T002|NON|NRW|NLM (2022)|210520|abcdef", "ENTRY": "Saussurea lappa|T002|NON|NRW|NLM (2002)|010522|abcdef", "MN": "B01.875.800.575.912.250.100.700", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid41629", "RR": "txid324593", "AN": "do not confuse entry term SAUSSUREA COSTUS with COSTUS", "MS": "A plant genus of the family ASTERACEAE, order Asterales, subclass Asteridae. It is a source of costus root oil and should not be confused with the genus COSTUS.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030441"}, {"RECTYPE": "D", "MH": "Pyruvate Dehydrogenase (Lipoamide)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pyruvate Dehydrogenase E1", "MN": "D08.811.682.657.350.875", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 1.2.4.1", "RR": "9014-20-4 (CRN)", "PI": "Pyruvate Dehydrogenase Complex (1983-2001)", "MS": "The E1 component of the multienzyme PYRUVATE DEHYDROGENASE COMPLEX. It is composed of 2 alpha subunits (pyruvate dehydrogenase E1 alpha subunit) and 2 beta subunits (pyruvate dehydrogenase E1 beta subunit).", "PM": "2002; PYRUVATE DEHYDROGENASE (LIPOAMIDE) was indexed under PYRUVATE DEHYDROGENASE COMPLEX 1983-2001", "HN": "2002; use PYRUVATE DEHYDROGENASE (LIPOAMIDE) (NM) 1983-2001", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030481"}, {"RECTYPE": "D", "MH": "Epididymal Secretory Proteins", "DE": "EPIDIDYMAL SECRET PROTEINS", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Androgen-Dependent Epididymal Secretory Proteins|T116|T123|NON|NRW|NLM (2002)|010524|ANDROGEN DEPENDENT EPIDIDYMAL SECRET PROTEINS|abbcdefv", "ENTRY": "Androgen-Dependent Epididymal Secretory Protein|T116|T123|NON|NRW|NLM (2002)|abbcde", "MN": "D12.776.298", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "PI": "Proteins (1968-2000)", "MS": "Proteins secreted by the epididymal epithelium. These proteins are both tissue- and species-specific. They are important molecular agents in the process of sperm maturation.", "PM": "2002; ANDROGEN-DEPENDENT EPIDIDYMAL SECRETORY PROTEIN was indexed under METALLOPROTEINS 1987-2001, TESTICULAR HORMONES 1987-2001", "HN": "2002; use EPIDIDYMAL SECRETORY PROTEINS (NM) 1987-2001", "MR": "20050630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030501"}, {"RECTYPE": "D", "MH": "Zingiberaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Renealmia|T002|NON|NRW|NLM (2003)|020328|abcdef", "ENTRY": "Renealmias", "MN": "B01.875.800.575.912.250.618.937.900", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid4642", "RR": "txid97748", "AN": "prefer specific plant", "PI": "Zingiberales (1997-2001)", "MS": "A plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).", "PM": "2002; see ZINGIBERALES 1997-2001", "HN": "2002; use ZINGIBERALES 1997-2001", "MR": "20210630", "DA": "20010803", "DC": "1", "DX": "20020101", "UI": "D030521"}, {"RECTYPE": "D", "MH": "Databases, Genetic", "DE": "DATABASES GENET", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Online Mendelian Inheritance In Man|T170|NON|NRW|NLM (2002)|010628|abcdef", "ENTRY": "Sequence Databases, Genetic", "MN": "L01.470.750.750.325", "FX": "Genetic Testing", "MH_TH": "NLM (2002)", "ST": "T170", "AN": "DATABASES, NUCLEIC ACID and DATABASES, PROTEIN are also available", "MS": "Databases devoted to knowledge about specific genes and gene products.", "PM": "2002", "HN": "2002", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030541"}, {"RECTYPE": "D", "MH": "Databases, Nucleic Acid", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "RNA Databases|T170|ACX|NRW|NLM (2002)|010530|abcdef", "ENTRY": "Sequence Databases, RNA", "MN": "L01.470.750.750.325.630", "FX": "Genetic Testing", "MH_TH": "NLM (2002)", "ST": "T170", "MS": "Databases containing information about NUCLEIC ACIDS such as BASE SEQUENCE; SNPS; NUCLEIC ACID CONFORMATION; and other properties. Information about the DNA fragments kept in a GENE LIBRARY or GENOMIC LIBRARY is often maintained in DNA databases.", "PM": "2002; for DNA DATABANKS see DATABASES, FACTUAL 1994-2001", "HN": "2002; for DNA DATABANKS use DATABASES, FACTUAL 1994-2001", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030561"}, {"RECTYPE": "D", "MH": "Databases, Protein", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "SWISS-PROT|T170|NON|NRW|NLM (2002)|010629|abcdef", "ENTRY": "Structure Databases, Protein", "MN": "L01.470.750.750.325.710", "MH_TH": "NLM (2002)", "ST": "T170", "PI": "Information Systems (1987-1990)", "MS": "Databases containing information about PROTEINS such as AMINO ACID SEQUENCE; PROTEIN CONFORMATION; and other properties.", "PM": "2002", "HN": "2002", "MR": "20150622", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030562"}, {"RECTYPE": "D", "MH": "Cistaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Helianthemum|T002|NON|NRW|NLM (2003)|010829|abcdef", "ENTRY": "Roses, Rock", "MN": "B01.875.800.575.912.250.204", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid69450", "RR": "txid69453", "MS": "A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. The common name of rock rose is used with several plants of this family.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030601"}, {"RECTYPE": "D", "MH": "Genetic Privacy", "DE": "GENET PRIVACY", "AQ": "EC ES HI LJ OG PX ST TD", "PRINT ENTRY": "Personal Genetic Information|T034|NON|REL|NLM (2002)|010615|PERSONAL GENET INFORMATION|abcdefv", "ENTRY": "Privacy, Genetic", "MN": "N03.706.535.230.320", "FX": "Pedigree", "MH_TH": "NLM (2002)", "ST": "T078", "PI": "Privacy (1995-2001)", "MS": "The protection of genetic information about an individual, family, or population group, from unauthorized disclosure.", "PM": "2002", "HN": "2002", "MR": "20090707", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030661"}, {"RECTYPE": "D", "MH": "Ficus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rubberplant|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Rubberplants", "MN": "B01.875.800.575.912.250.859.937.406.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3493", "AN": "entry term RUBBERPLANT: RUBBER TREE see HEVEA is also available", "MS": "A plant genus of the family MORACEAE. It is the source of the familiar fig fruit and the latex from this tree contains FICAIN.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030681"}, {"RECTYPE": "D", "MH": "Nyssaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.778", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4289", "MS": "The sour gum family of the order Cornales.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030701"}, {"RECTYPE": "D", "MH": "Nymphaeaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Lily Family, Water", "MN": "B01.875.800.575.912.250.776", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4410", "MS": "The water lily plant family of aquatic, rhizomatous herbs in the class Magnoliopsida.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030702"}, {"RECTYPE": "D", "MH": "Nymphaea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Water Lily|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Waterlily|T002|NON|EQV|NLM (2003)|010917|abcdef", "MN": "B01.875.800.575.912.250.776.500", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid4418", "RR": "txid264924", "AN": "note entry term NYMPHAEA LOTUS: use LOTUS for Lotus species in the family FABACEAE", "MS": "A plant genus of the family NYMPHAEACEAE.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030721"}, {"RECTYPE": "D", "MH": "Carbonic Anhydrase IV", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Anhydrase 4, Carbonic", "MN": "D12.776.543.550.418.160", "MH_TH": "NLM (2002)", "ST": "T126", "RN": "EC 4.2.1.-", "AN": "/antag: coord with CARBONIC ANHYDRASE INHIBITORS", "PI": "Carbonic Anhydrases (1990-2001)", "MS": "A membrane-bound carbonic anhydrase found in lung capillaries and kidney.", "PM": "2002", "HN": "2002", "MR": "20230316", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030741"}, {"RECTYPE": "D", "MH": "Estrous Cycle", "AQ": "BL CF DE GE IM ME PH RE UR", "ENTRY": "Estrous Cycles", "MN": "G08.686.195", "MH_TH": "UNK (19XX)", "ST": "T040", "AN": "non-primate mammals only; humans & other primates, use MENSTRUAL CYCLE", "PI": "Estrus (1964-2001)", "MS": "The period of cyclic physiological and behavior changes in non-primate female mammals that exhibit ESTRUS. The estrous cycle generally consists of 4 or 5 distinct periods corresponding to the endocrine status (PROESTRUS; ESTRUS; METESTRUS; DIESTRUS; and ANESTRUS).", "PM": "2002; see ESTRUS 1975-2001", "HN": "2002; use ESTRUS 1975-2001", "MR": "20080708", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030762"}, {"RECTYPE": "D", "MH": "Organisms, Genetically Modified", "DE": "ORGANISMS GENET MODIFIED", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Transgenic Organisms|T001|NON|NRW|BIOETHICS (1997)|NLM (1999)|980206|abcdeef", "ENTRY": "Organisms, Genetically Engineered|T001|NON|EQV|NLM (2019)|180523|abcdef", "MN": "B05.620", "FX": "Transgenes", "MH_TH": "NLM (2002)", "ST": "T001", "AN": "general or unspecified; prefer specifics", "PI": "Genetic Engineering (1989-2001)", "MS": "Organisms whose GENOME has been changed by a GENETIC ENGINEERING technique.", "PM": "2002; ORGANISMS, TRANSGENIC was heading 1999-2001", "HN": "2002", "MR": "20180629", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030781"}, {"RECTYPE": "D", "MH": "Animals, Genetically Modified", "DE": "ANIMALS GENET MODIFIED", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Transgenic Animals|T008|NON|NRW|BIOETHICS (1990)|870508|abcdef", "ENTRY": "Transgenic Founder Animals", "MN": "B05.620.136", "FX": "Transgenes", "MH_TH": "NLM (2002)", "ST": "T008", "AN": "coord with specific animal /genet", "MS": "ANIMALS whose GENOME has been altered by GENETIC ENGINEERING, or their offspring.", "PM": "2002; ANIMALS, TRANSGENIC was heading 1988-2001", "HN": "2002", "MR": "20200902", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030801"}, {"RECTYPE": "D", "MH": "Plants, Genetically Modified", "DE": "PLANTS GENET MODIFIED", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Transgenic Plants|T002|NON|NRW|NLM (1992)|901115|abcdef", "ENTRY": "Transgenic Plant", "MN": "B05.620.600", "FX": "Transgenes", "MH_TH": "NLM (2002)", "ST": "T002", "AN": "coordinate with specific plant /genet", "PI": "Plants, Transgenic (1992-2001)", "MS": "PLANTS, or their progeny, whose GENOME has been altered by GENETIC ENGINEERING.", "PM": "2002; PLANTS, TRANSGENIC as heading 1992-2001", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030821"}, {"RECTYPE": "D", "MH": "Food, Genetically Modified", "DE": "FOOD GENET MODIFIED", "AQ": "AE CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Genetically Modified Food|T168|NON|EQV|NLM (2002)|010614|GENET MODIFIED FOOD|abcdefv", "ENTRY": "Genetically Modified Foods", "MN": "J02.500.518", "FX": "Plants, Genetically Modified", "MH_TH": "NLM (2002)", "ST": "T168", "AN": "coord with specific food", "MS": "Food derived from genetically modified organisms (ORGANISMS, GENETICALLY MODIFIED).", "PM": "2002", "HN": "2002", "MR": "20141014", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030841"}, {"RECTYPE": "D", "MH": "Capitalism", "MN": "I01.696.100", "MH_TH": "POPLINE (1984)", "ST": "T078", "AN": "specify geog", "PI": "Political Systems (1990-2001)", "MS": "A political and economic system characterized by individual rights, by private or corporate ownership of capital goods, and by prices, production, and the distribution of goods that are determined mainly by competition in a free market. (From Merriam-Webster's Collegiate Dictionary, 10th ed)", "PM": "2002; see POLITICAL SYSTEMS 1990-2001", "HN": "2002; use POLITICAL SYSTEMS 1990-2001", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030861"}, {"RECTYPE": "D", "MH": "Disclosure", "AQ": "ES HI LJ SN ST TD", "PRINT ENTRY": "Information Disclosure|T055|NON|EQV|BIOETHICS (2000)|010612|abcdef", "ENTRY": "Financial Disclosures", "MN": "L01.143.335", "FX": "Patient Access to Records", "MH_TH": "BIOETHICS (1989)", "ST": "T055", "AN": "TRUTH DISCLOSURE is also available", "PI": "Truth Disclosure (1977-2001)", "MS": "Revealing of information, by oral or written communication.", "PM": "2002; see TRUTH DISCLOSURE 1978-2001; for WHISTLEBLOWING see TRUTH DISCLOSURE 1997-2001", "HN": "2002; use TRUTH DISCLOSURE 1978-2001; for WHISTLEBLOWING use TRUTH DISCLOSURE 1997-2001", "MR": "20120703", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030881"}, {"RECTYPE": "D", "MH": "Erythroxylaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.346", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid22118", "MS": "A plant family of the order Linales, subclass Rosidae, class Magnoliopsida best known for the coca plant.", "PM": "2002", "HN": "2002", "MR": "20210630", "DA": "20010725", "DC": "1", "DX": "20020101", "UI": "D030921"}, {"RECTYPE": "D", "MH": "Acro-Osteolysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Acro-Osteolysis Syndrome", "MN": "C05.116.264.579.052", "FX": "Osteolysis, Essential", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Osteolysis, Essential (1972-2002)", "MS": "A condition with congenital and acquired forms causing recurrent ulcers in the fingers and toes. The congenital form exhibits autosomal dominant inheritance; the acquired form is found in workers who handle VINYL CHLORIDE. When acro-osteolysis is accompanied by generalized OSTEOPOROSIS and skull deformations, it is called HAJDU-CHENEY SYNDROME.", "PM": "2003", "HN": "2003", "MR": "20120703", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D030981"}, {"RECTYPE": "D", "MH": "Aceraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618.050.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid910345", "AN": "prefer specific plant", "MS": "A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Leaves are opposite and usually toothed or lobed. The fruit, a samara (a winged nutlet), splits into two (rarely three) winged, one-seeded parts. This family is widely distributed in the Northern Hemisphere.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031001"}, {"RECTYPE": "D", "MH": "Acer", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Elder, Box|T002|NON|NRW|NLM (2003)|010823|abcdef", "ENTRY": "saccharums, Acer", "MN": "B01.875.800.575.912.250.885.056", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4022", "RR": "txid4024", "MS": "A plant genus of the family SAPINDACEAE, best known for trees with palmately lobed leaves.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031002"}, {"RECTYPE": "D", "MH": "Adoxaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Muskroot|T002|NON|NRW|NLM (2003)|010823|abcdef", "ENTRY": "Muskroots", "MN": "B01.875.800.575.912.250.328.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4206", "RR": "txid4207", "MS": "A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. Members of this family are sometimes classified in CAPRIFOLIACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031003"}, {"RECTYPE": "D", "MH": "Anacardium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cashew|T168|NON|REL|NLM (2003)|010823|abcdef", "ENTRY": "occidentales, Anacardium", "MN": "B01.875.800.575.912.250.044.277", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid171928", "RR": "txid171929", "MS": "A plant genus of the family ANACARDIACEAE. This is the source of the familiar cashew nuts, which are heat treated to remove the irritant toxin. Cashew nut shell liquid (frequently abbreviated as CNSL) is a major source of alkenyl phenolic compounds, especially ANACARDIC ACIDS, cardol, and cardanol.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031021"}, {"RECTYPE": "D", "MH": "Mangifera", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mango|T168|NON|REL|NLM (2003)|010823|abcdef", "ENTRY": "indicas, Mangifera", "MN": "B01.875.800.575.912.250.044.416", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid23461", "RR": "txid29780", "MS": "A plant genus of the family ANACARDIACEAE best known for the edible fruit.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031022"}, {"RECTYPE": "D", "MH": "Semecarpus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "anacardiums, Semecarpus", "MN": "B01.875.800.575.912.250.044.705", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid173682", "RR": "txid289767", "MS": "A plant genus of the family ANACARDIACEAE that is the source of anacarcin forte. The nut milk extract is cytotoxic.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031023"}, {"RECTYPE": "D", "MH": "Annona", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cherimoya|T002|NON|NRW|NLM (2003)|010824|abcdef", "ENTRY": "cherimolia, Annona", "MN": "B01.875.800.575.912.250.065.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13336", "RR": "txid49314", "MS": "A plant genus of the family ANNONACEAE. It has edible fruit and seeds which contain acetogenins and benzoquinazoline and other alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031041"}, {"RECTYPE": "D", "MH": "Asimina", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pawpaw|T002|NON|EQV|NLM (2003)|010824|abcdef", "ENTRY": "Pawpaws", "MN": "B01.875.800.575.912.250.065.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid12952", "MS": "A plant genus of the family ANNONACEAE. It has edible fruit and seeds which contain asitrocin, asitrilobins, and other tetrahydrofuran acetogenins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031042"}, {"RECTYPE": "D", "MH": "Guatteria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Guatterias", "MN": "B01.875.800.575.912.250.065.875", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid295145", "MS": "A plant genus of the family ANNONACEAE. Members contain asarone, isoguattouregidine (an isoquinoline alkaloid), norlaureline, puterine, noraporphine alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031043"}, {"RECTYPE": "D", "MH": "Polyalthia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Polyalthias", "MN": "B01.875.800.575.912.250.065.937", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid105756", "MS": "A plant genus of the family ANNONACEAE. Members contain 8-oxopolyalthiaine.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031044"}, {"RECTYPE": "D", "MH": "Rollinia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Rollinias", "MN": "B01.875.800.575.912.250.065.968", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid301698", "MS": "A plant genus of the family ANNONACEAE. Members contain aporphines, acetogenins and rollinone.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031045"}, {"RECTYPE": "D", "MH": "Uvaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Uvarias", "MN": "B01.875.800.575.912.250.065.984", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid174969", "MS": "A plant genus of the family ANNONACEAE. Members contain uvarigrin, uvarigrandin, chamuvaritin and other acetogenins and benzylisoquinoline alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031046"}, {"RECTYPE": "D", "MH": "Cnidium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "monnierus, Cnidium", "MN": "B01.875.800.575.912.250.075.199", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid48110", "RR": "txid94007", "MS": "A plant genus of the family APIACEAE. Members contain osthol.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031048"}, {"RECTYPE": "D", "MH": "Eryngium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Holly, Sea|T002|NON|EQV|NLM (2003)|010824|abcdef", "ENTRY": "Sea Hollies", "MN": "B01.875.800.575.912.250.075.294", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43070", "AN": "Holly see ILEX is also available", "MS": "A plant genus of the family APIACEAE. Members contain SAPONINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031049"}, {"RECTYPE": "D", "MH": "Oenanthe", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Dropwort, Water|T002|NON|EQV|NLM (2003)|010824|abcdef", "ENTRY": "Water Dropworts", "MN": "B01.875.800.575.912.250.075.568", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid48043", "AN": "entry term WATER DROPWORT: DROPWORT see FILIPENDULA is also available", "MS": "A plant genus of the family APIACEAE that is sometimes called Hemlock Water Dropwort but should not be confused with HEMLOCK. It contains enanthotoxin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031050"}, {"RECTYPE": "D", "MH": "Alstonia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Pines, Milky", "MN": "B01.875.800.575.912.250.456.500.043", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid52821", "RR": "txid52822", "MS": "A plant genus of the family APOCYNACEAE. Members contain echitovenidine, echitamine, venenatine (an indole alkaloid), and anti-inflammatory triterpenoids", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031051"}, {"RECTYPE": "D", "MH": "Thevetia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Oleander Tree, Yellow|T002|NON|NRW|NLM (2003)|010824|abcdef", "ENTRY": "peruviana, Thevetia", "MN": "B01.875.800.575.912.250.456.500.944", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid45319", "RR": "txid52862", "AN": "Oleander see NERIUM is also available", "MS": "A plant genus of the family APOCYNACEAE. Members contain thevetin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031052"}, {"RECTYPE": "D", "MH": "Vinca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Periwinkle|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Periwinkles, Lesser", "MN": "B01.875.800.575.912.250.456.500.972", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid60092", "RR": "txid60093", "AN": "VINCA ROSEA  see CATHARANTHUS is also available", "MS": "A plant genus of the family Apocynaceae.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031053"}, {"RECTYPE": "D", "MH": "Alocasia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Taro, Giant|T002|NON|NRW|NLM (2003)|010824|abcdef", "ENTRY": "macrorrhizas, Alocasia", "MN": "B01.875.800.575.912.250.618.050.750.066", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4455", "RR": "txid4456", "MS": "A plant genus of the family ARACEAE. Members contain beta-glucosidases and trypsin inhibitors.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031055"}, {"RECTYPE": "D", "MH": "Amorphophallus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Konjac|T002|NON|NRW|NLM (2003)|010824|abcdef", "ENTRY": "konjac, Amorphophallus", "MN": "B01.875.800.575.912.250.618.050.750.077", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid74663", "RR": "txid78372", "MS": "A plant genus of the family ARACEAE. Members contain konjac glucomannan (MANNANS) and SEROTONIN.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031056"}, {"RECTYPE": "D", "MH": "Arisaema", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Jack-in-the-Pulpit|T002|NON|NRW|NLM (2003)|010824|abcdef", "ENTRY": "triphyllum, Arisaema", "MN": "B01.875.800.575.912.250.618.050.750.088", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid50230", "RR": "txid78371", "MS": "A plant genus of the family ARACEAE. It has a stemless, tuberous root.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031057"}, {"RECTYPE": "D", "MH": "Arum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Arums", "MN": "B01.875.800.575.912.250.618.050.750.109", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4457", "MS": "A plant genus of the family ARACEAE. The name derived from ar (fire in Arabic) due to the irritating sap. Flower is a spathe.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031058"}, {"RECTYPE": "D", "MH": "Calla Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Calla", "MN": "B01.875.800.575.912.250.618.050.750.177", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid45006", "MS": "A plant genus of the family ARACEAE. Calla Lily (Callalily) also refers to the ZANTEDESCHIA. There is no relationship with CALLA ANTIGEN.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031059"}, {"RECTYPE": "D", "MH": "Colocasia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Taro|T168|NON|REL|NLM (2003)|010824|abcdef", "ENTRY": "Taros", "MN": "B01.875.800.575.912.250.618.050.750.199", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4459", "RR": "txid4460", "MS": "A plant genus of the family ARACEAE. Members contain acrid calcium oxalate and LECTINS. Polynesians prepare the root into poi. Common names of Taro and Coco Yam (Cocoyam) may be confused with other ARACEAE; XANTHOSOMA; or with common yam (DIOSCOREA).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031060"}, {"RECTYPE": "D", "MH": "Cyrtosperma", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Taro, Giant Swamp|T002|NON|EQV|NLM (2003)|010824|abcdef", "ENTRY": "Taros, Giant Swamp", "MN": "B01.875.800.575.912.250.618.050.750.211", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39258", "MS": "A plant genus of the family ARACEAE that may be confused with other ARACEAE having similar common names.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031061"}, {"RECTYPE": "D", "MH": "Philodendron", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Philodendrons", "MN": "B01.875.800.575.912.250.618.050.750.488", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid71613", "MS": "A plant genus of the family ARACEAE. As a houseplant it sometimes poisons children and animals.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031062"}, {"RECTYPE": "D", "MH": "Xanthosoma", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Zanthosoma|T002|NON|EQV|NLM (2003)|010824|abcdef", "ENTRY": "sagittifollium, Xanthosoma", "MN": "B01.875.800.575.912.250.618.050.750.944", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid15105", "RR": "txid28478", "MS": "A plant genus of the family ARACEAE. The common names of 'Coco Yam' (Cocoyam) or 'Elephant's Ear' may be confused with COLOCASIA and other ARACEAE or with common yam (DIOSCOREA). It contains LECTINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031063"}, {"RECTYPE": "D", "MH": "Zantedeschia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Zantedeschias", "MN": "B01.875.800.575.912.250.618.050.750.972", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid69720", "MS": "A plant genus of the family ARACEAE. The common name of Calla Lily or Callalily also refers to the Calla genus (CALLA PLANT).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031064"}, {"RECTYPE": "D", "MH": "Calamus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Palm, Rattan|T002|NON|EQV|NLM (2003)|010824|abcdef", "ENTRY": "Rattan Palms", "MN": "B01.875.800.575.912.250.093.188", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4711", "AN": "CALAMUS ROOT see ACORUS is also available", "MS": "A plant genus of the family ARECACEAE that should not be confused with ACORUS CALAMUS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031081"}, {"RECTYPE": "D", "MH": "Marsdenia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Condurango|T002|NON|NRW|NLM (2003)|010824|abcdef", "ENTRY": "tenacissimas, Marsdenia", "MN": "B01.875.800.575.912.250.456.500.411", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid141490", "RR": "txid1925545", "MS": "A plant genus of the family ASCLEPIADACEAE. Members contain pregnane glycosides (marsdekoiside & marstomentosides, maryal) and hainaneosides (SAPONINS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031101"}, {"RECTYPE": "D", "MH": "Hemidesmus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sarsaparilla, East Indian|T002|EPO|NRW|NLM (2003)|010824|abcdef", "ENTRY": "East Indian Sarsaparilla", "MN": "B01.875.800.575.912.250.456.500.341", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid63475", "RR": "txid63476", "AN": "note entry term BRISTLY SARSAPARILLA: SARSAPARILLA see SMILAX and SARSAPARILLA, EAST INDIAN see HEMIDESMUS are also available", "MS": "A plant genus of the family Apocynaceae. It is a source of PREGNANES and is sometimes an adulterant of commercial sarsaparilla (SMILAX).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031102"}, {"RECTYPE": "D", "MH": "Gymnema", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "alternifoliums, Gymnema", "MN": "B01.875.800.575.912.250.456.500.336", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4067", "MS": "A plant genus of the family ASCLEPIADACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031103"}, {"RECTYPE": "D", "MH": "Gymnema sylvestre", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gurmar|T002|NON|EQV|NLM (2003)|abcde", "ENTRY": "sylvestre, Gymnema", "MN": "B01.875.800.575.912.250.456.500.336.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4068", "MS": "A plant species of the genus GYMNEMA that contains gymnemic acid (triterpene SAPONINS) which affects blood sugar level, and gurmarin protein. The common name of Gurmar should not be confused with Guar (CYAMOPSIS).", "PM": "2003; GURMAR was indexed under PLANT EXTRACTS 1984-2002", "HN": "2003; for GURMAR use GURMAR (NM) 1984-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031104"}, {"RECTYPE": "D", "MH": "Cynanchum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cynanchums", "MN": "B01.875.800.575.912.250.456.500.325", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid126747", "AN": "CYNANCHUM INDICUM see TYLOPHORA is also available", "MS": "A plant genus of the family ASCLEPIADACEAE. Members contain steroidal glycosides and cytotoxic phenanthroindolizidine N-oxide alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031105"}, {"RECTYPE": "D", "MH": "Cryptolepis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cryptolepses", "MN": "B01.875.800.575.912.250.456.500.303", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid165212", "MS": "A plant genus of the family ASCLEPIADACEAE. Members contain the alkaloids quindoline, CSA-3, cryptolepine, and neocryptolepine.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031106"}, {"RECTYPE": "D", "MH": "Calotropis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "proceras, Calotropis", "MN": "B01.875.800.575.912.250.456.500.217", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4065", "RR": "txid4066", "MS": "A plant genus of the family ASCLEPIADACEAE. The downy akund floss fiber from the seeds is used like kapok.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031107"}, {"RECTYPE": "D", "MH": "Asclepias", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Milkweed, Common|T002|NON|EQV|NLM (2003)|010824|abcdef", "ENTRY": "Milkweeds, Common", "MN": "B01.875.800.575.912.250.456.500.153", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid21199", "AN": "for ASCLEPIAS ASTHMATICA see TYLOPHORA is also available", "MS": "A plant genus of the family ASCLEPIADACEAE. This is the true milkweed; APOCYNUM & EUPHORBIA hirta are rarely called milkweed. Asclepias asthmatica has been changed to TYLOPHORA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031108"}, {"RECTYPE": "D", "MH": "Periploca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.456.500.691", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid63484", "AN": "PERIPLOCA INDICA see HEMIDESMUS is also available", "MS": "A plant genus of the family Apocynaceae. It is a source of periplocosides (pregnane steroid glycosides).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031109"}, {"RECTYPE": "D", "MH": "Tylophora", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "indicum, Cynanchum", "MN": "B01.875.800.575.912.250.456.500.958", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid52863", "RR": "txid63500", "MS": "A plant genus of the family ASCLEPIADACEAE. Members contain phenanthro-indolizidine alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031110"}, {"RECTYPE": "D", "MH": "Balanophoraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thonningia|T002|NON|NRW|NLM (2003)|010824|abcdef", "ENTRY": "Thonningias", "MN": "B01.875.800.575.912.250.106", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid25673", "RR": "txid1003263", "MS": "A plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. They are root parasites lacking CHLOROPHYLL.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031111"}, {"RECTYPE": "D", "MH": "Begoniaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Begonia|T002|NON|NRW|NLM (2003)|010824|abcdef", "ENTRY": "Begonias", "MN": "B01.875.800.575.912.250.118", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3680", "RR": "txid3681", "MS": "A plant family of the order Violales (by some in Begoniales), subclass Dilleniidae, class Magnoliopsida. Members are found throughout tropical and warm temperate habitats. Most are perennial herbs with monoecious flowers (both sexes on the same plant). Fruits are usually capsules containing many tiny seeds.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031112"}, {"RECTYPE": "D", "MH": "Mannheimia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Pasteurella granulomatis|T007|NON|NRW|NLM (2003)|011011|abcdef", "MN": "B03.660.250.550.500", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid75984", "RR": "txid85404", "AN": "infection: coord IM with PASTEURELLACEAE INFECTIONS (IM)", "MS": "Genus of bacteria in the family PASTEURELLACEAE, comprising multiple species that do not ferment trehalose. Species include MANNHEIMIA HAEMOLYTICA; M. glucosida, M. granulomatis, M. ruminalis, and M. varigena.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031121"}, {"RECTYPE": "D", "MH": "Pseudoalteromonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.021.600", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid53246", "PI": "Gram-Negative Aerobic Bacteria (1995-2002)", "MS": "A genus of GRAM-NEGATIVE AEROBIC BACTERIA of marine origin. Many species were formerly classified under ALTEROMONAS.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031161"}, {"RECTYPE": "D", "MH": "Achillea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yarrow|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "millefolium, Achillea", "MN": "B01.875.800.575.912.250.100.037", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13328", "RR": "txid13329", "MS": "A plant genus of the family ASTERACEAE that has long been used in folk medicine for treating wounds.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031162"}, {"RECTYPE": "D", "MH": "Ageratum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Ageratums", "MN": "B01.875.800.575.912.250.100.056", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid55597", "MS": "A plant genus of the family ASTERACEAE that contains PYRROLIZIDINE ALKALOIDS. Yellow vein disease of Ageratum is caused by a viral DNA complex of a begomovirus (GEMINIVIRIDAE).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031163"}, {"RECTYPE": "D", "MH": "Ambrosia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Short Ragweed|T002|NON|NRW|NLM (2024)|230417|abcdef", "ENTRY": "Short Ragweeds", "MN": "B01.875.800.575.912.250.100.065", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4211", "RR": "txid4214", "MS": "A plant genus of the family ASTERACEAE. The POLLEN is one cause of HAYFEVER.", "PM": "2003", "HN": "2003", "MR": "20230531", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031164"}, {"RECTYPE": "D", "MH": "Ammi", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "visnagas, Ammi", "MN": "B01.875.800.575.912.250.075.039", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid48025", "RR": "txid1053409", "MS": "A plant genus of the family APIACEAE that is the primary plant source of KHELLIN.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031165"}, {"RECTYPE": "D", "MH": "Anthemis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mayweed, Stinking|T002|NON|NRW|NLM (2003)|010828|abcdef", "ENTRY": "cotulas, Anthemis", "MN": "B01.875.800.575.912.250.100.071", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid99027", "RR": "txid158220", "AN": "note entry terms; distinguish from related plants that have similar names; ANTHEMIS NOBILIS see CHAMAEMELUM is also available", "MS": "A plant genus of the family ASTERACEAE that is similar to MATRICARIA but this has tiny chaffy bract scales between each pair of florets. Members contain sesquiterpene lactones. Other plants with similar common names include FERULA; FOENICULUM; MATRICARIA; CHAMAEMELUM and TRIPLEUROSPERMUM.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031166"}, {"RECTYPE": "D", "MH": "Chamaemelum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Chamomile, Roman|T002|EPO|NRW|NLM (2003)|010828|abcdef", "ENTRY": "nobilis, Anthemis", "MN": "B01.875.800.575.912.250.100.192", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid99036", "RR": "txid99037", "AN": "X refs: distinguish from related plants with similar common names; check text and MeSH", "MS": "A plant genus of the family ASTERACEAE that is used in folk medicine as CHAMOMILE. Other plants with similar common names include MATRICARIA; TRIPLEUROSPERMUM and ANTHEMIS.", "PM": "2003; for CHAMAEMELUM NOBILE see CHAMOMILE 1999-2002", "HN": "2003; for CHAMAEMELUM NOBILE use CHAMOMILE 1999-2002", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031167"}, {"RECTYPE": "D", "MH": "Matricaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pineapple Weed|T002|NON|NRW|NLM (2003)|010828|abcdef", "ENTRY": "recutitas, Matricaria", "MN": "B01.875.800.575.912.250.100.509", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid56016", "RR": "txid98504", "AN": "X refs: distinguish from related plants with similar common names; check text and MeSH; for Matricaria parthenium use TANACETUM; MATRICARIA PERFORATA see TRIPLEUROSPERMUM is also available", "PI": "Chamomile (1999-2002)", "MS": "A plant genus of the family ASTERACEAE. M. chamomilla appears similar to Anthemis but this flower disk is conical and hollow and lacks chaffy bract scales and the odor is weaker. The common name of 'manzanilla' is confused with other meanings of the word. 'Matricaria chamomilla sensu' is classified by some as Tripleurospermum perforata. Other plants with similar common names include CHAMAEMELUM; TRIPLEUROSPERMUM and ANTHEMIS.", "PM": "2003; for MATRICARIA CHAMOMILLA see CHAMOMILE 1999-2002", "HN": "2003; for MATRICARIA CHAMOMILLA use CHAMOMILE 1999-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031168"}, {"RECTYPE": "D", "MH": "Tripleurospermum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tripleurosperum perforatum|T002|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "perforatums, Tripleurosperum", "MN": "B01.875.800.575.912.250.100.937", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid99107", "RR": "txid99108", "AN": "X refs: distinguish from related plants with similar common names; check text and MeSH", "PI": "Chamomile (1999-2002)", "MS": "A plant genus of the family ASTERACEAE. It is easily confused with related plants with similar common names of Chamomile and Mayweed (MATRICARIA; CHAMAEMELUM; and ANTHEMIS).", "PM": "2003; for MATRICARIA PERFORATA see CHAMOMILE 1999-2002", "HN": "2003; for MATRICARIA PERFORATA use CHAMOMILE 1999-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031169"}, {"RECTYPE": "D", "MH": "Arctium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gobou|T002|NON|NRW|NLM (2003)|010828|abcdef", "ENTRY": "Plants, Burdock", "MN": "B01.875.800.575.912.250.100.072", "FX": "Rheum", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4216", "RR": "txid4217", "MS": "A plant genus of the family ASTERACEAE. Arctiin (LIGNANS) is in the seed.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031170"}, {"RECTYPE": "D", "MH": "Artemisia absinthium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "absinthiums, Artemisia", "MN": "B01.875.800.575.912.250.100.100.099", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid72332", "MS": "A plant species of the genus ARTEMISIA, family ASTERACEAE that has been used in ABSINTHE. The oil contains neurotoxic 1-thujone and d-isothujone.", "PM": "2003; see ARTEMISIA 1998-2002", "HN": "2003; use ARTEMISIA 1998-2002", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031171"}, {"RECTYPE": "D", "MH": "Artemisia annua", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Wormwoods, Sweet", "MN": "B01.875.800.575.912.250.100.100.144", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid35608", "PI": "Artemisia (1996-2002)", "MS": "A plant species of the genus ARTEMISIA, family ASTERACEAE. It is the source of the antimalarial artemisinin (ANTIMALARIALS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031172"}, {"RECTYPE": "D", "MH": "Aster Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Aster", "MN": "B01.875.800.575.912.250.100.111", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41479", "MS": "A plant genus of the family ASTERACEAE. This plant should not be confused with microtubule asters (MICROTUBULES) nor with aster yellows phytoplasma (mycoplasma-like organisms).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031173"}, {"RECTYPE": "D", "MH": "Atractylodes", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Jutsu|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "lanceas, Atractylodes", "MN": "B01.875.800.575.912.250.100.126", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41485", "RR": "txid41486", "MS": "A plant genus of the family ASTERACEAE. Members contain hinesol and atractylon. Atractylodes rhizome is Byaku-jutsu. A. lancea rhizome is So-jutsu.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031174"}, {"RECTYPE": "D", "MH": "Baccharis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Willow, Water|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Willows, Water", "MN": "B01.875.800.575.912.250.100.133", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41487", "AN": "entry term BROOM, DESERT: several other Broom terms are also available; check text and MeSH", "MS": "A plant genus of the family ASTERACEAE. Other plants called broom include CYTISUS; SPARTIUM; and BROMUS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031175"}, {"RECTYPE": "D", "MH": "Bidens", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Beggarticks|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "pilosa, Bidens", "MN": "B01.875.800.575.912.250.100.137", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid42336", "RR": "txid42337", "MS": "A plant genus of the family ASTERACEAE. Members contain bidensyneosides (polyacetylene glucosides).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031176"}, {"RECTYPE": "D", "MH": "Carduus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thistle, Plumeless|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Thistles, Plumeless", "MN": "B01.875.800.575.912.250.100.168", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid92905", "AN": "CARDUUS MARIANUS see MILK THISTLE is also available", "MS": "A plant genus of the family ASTERACEAE. Members contain arctiin and onopordopicrin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031177"}, {"RECTYPE": "D", "MH": "Carthamus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thistle, Distaff|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Thistles, Distaff", "MN": "B01.875.800.575.912.250.100.181", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4221", "MS": "A plant genus of the family ASTERACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031178"}, {"RECTYPE": "D", "MH": "Centaurea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yellow Star Thistle|T002|NON|NRW|NLM (2022)|210625|abcdef", "ENTRY": "Yellow Star Thistles", "MN": "B01.875.800.575.912.250.100.188", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41503", "RR": "txid72152", "AN": "other 'thistle' plants are also available", "MS": "A plant genus of the family ASTERACEAE. Members contain 5-methyl-8-hydroxycoumarin. The common name of centaury is more often used for CENTAURIUM", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031179"}, {"RECTYPE": "D", "MH": "Cirsium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thistle, Yellowspine|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "arvenses, Cirsium", "MN": "B01.875.800.575.912.250.100.227", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41549", "RR": "txid41550", "AN": "other 'thistle' plants are also available", "MS": "A plant genus of the family ASTERACEAE. Members contain pectolinarin (a flavonoid glycoside).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031180"}, {"RECTYPE": "D", "MH": "Cnicus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.100.241", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid50281", "AN": "other 'thistle' plants are also available", "MS": "A plant genus of the family ASTERACEAE. CENTAUREA BENEDICTA which is also known as Cnicus benedictus contains CNICIN.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031181"}, {"RECTYPE": "D", "MH": "Echinops Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thistle, Globe|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "grijisii, Echinops", "MN": "B01.875.800.575.912.250.100.317", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid32194", "RR": "txid1804979", "AN": "other 'thistle' plants are also available", "MS": "A plant genus of the family ASTERACEAE. Members contain a pseudoguaiane sesquiterpene. San-fang-feng is the root of E. grijisii used in DRUGS, CHINESE HERBAL.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031182"}, {"RECTYPE": "D", "MH": "Onopordum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thistle, Cotton|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Thistles, Cotton", "MN": "B01.875.800.575.912.250.100.562", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid92914", "AN": "other 'thistle' plants are also available", "MS": "A plant genus of the family ASTERACEAE. Members contain eudesmane and elemane SESQUITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031183"}, {"RECTYPE": "D", "MH": "Sonchus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thistle, Sow|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "arvensis, Sonchus", "MN": "B01.875.800.575.912.250.100.833", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid50190", "RR": "txid50192", "AN": "other 'thistle' plants are also available", "MS": "A plant genus of the family ASTERACEAE. Sesquiterpene lactone glucosides (SESQUITERPENES) have been found in it.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031184"}, {"RECTYPE": "D", "MH": "Scolymus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thistle, Golden|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Thistles, Golden", "MN": "B01.875.800.575.912.250.100.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid114286", "AN": "other 'thistle' plants are also available; do not confuse with CYNARA SCOLYMUS; Common Salsify see TRAGOPOGON is also available", "MS": "A plant genus of the family ASTERACEAE with a name that is similar to CYNARA SCOLYMUS. Members contain taraxasteryl acetate.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031185"}, {"RECTYPE": "D", "MH": "Scorzonera", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Salsify, Black|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Scorzoneras", "MN": "B01.875.800.575.912.250.100.775", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid114288", "MS": "A plant genus of the family ASTERACEAE. INULIN and SESQUITERPENES have been found in it.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031186"}, {"RECTYPE": "D", "MH": "Carthamus tinctorius", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Safflower|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Safflowers", "MN": "B01.875.800.575.912.250.100.181.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4222", "MS": "A plant genus of the family ASTERACEAE. Oil from the seed (SAFFLOWER OIL) is an important food oil of commerce.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031187"}, {"RECTYPE": "D", "MH": "Tragopogon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Salsify, Yellow|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "pratensis, Tragopogon", "MN": "B01.875.800.575.912.250.100.916", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13730", "RR": "txid41653", "MS": "A plant genus of the family ASTERACEAE. The root and shoots have been used for food.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031188"}, {"RECTYPE": "D", "MH": "Chrysanthemum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Chrysanthemums", "MN": "B01.875.800.575.912.250.100.206", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid13422", "AN": "CHRYSANTHEMUM PARTHENIUM see TANACETUM PARTHENIUM is also available", "PI": "Pyrethrum (1977-2002)", "MS": "A plant genus of the family ASTERACEAE. The common names of daisy or marguerite are easily confused with other plants. Some species in this genus have been reclassified to TANACETUM.", "PM": "2003; see PYRETHRUM 1977-2002", "HN": "2003; use PYRETHRUM 1977-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031202"}, {"RECTYPE": "D", "MH": "Tanacetum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "vulgares, Tanacetum", "MN": "B01.875.800.575.912.250.100.874", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid99105", "RR": "txid128002", "AN": "TANACETUM CINERARIIFOLIUM and TANACETUM COCCINEUM see CHRYSANTHEMUM CINERARIIFOLIUM are also available", "MS": "A plant genus of the family ASTERACEAE. Some species of the CHRYSANTHEMUM and the old Pyrethrum genera have been reclassified to this genus. The common name of tansy usually refers to this but also forms part of the common name of other plants such as Tansy Ragwort (SENECIO) and Tansyaster (HAPLOPAPPUS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031203"}, {"RECTYPE": "D", "MH": "Caloric Restriction", "AQ": "AE CL EC EH ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Calorie Restricted Diet|T061|T081|NON|EQV|NLM (2021)|OBSSR (2021)|200612|abbcdeef", "ENTRY": "Restriction, Caloric", "MN": "G07.203.650.240.340.150", "MH_TH": "NLM (2003)", "ST": "T081", "AN": "coordinate with specific disease /diet ther if pertinent", "MS": "Reduction in caloric intake without reduction in adequate nutrition. In experimental animals, caloric restriction has been shown to extend lifespan and enhance other physiological variables.", "PM": "2003", "HN": "2003", "MR": "20210512", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031204"}, {"RECTYPE": "D", "MH": "Taraxacum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Dandelion|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Dandelions", "MN": "B01.875.800.575.912.250.100.895", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid49743", "RR": "txid50225", "MS": "A plant genus of the family Asteraceae. Members contain chicoric and chlorogenic acids and germacrane- and eudesmane-type SESQUITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031205"}, {"RECTYPE": "D", "MH": "Haplopappus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tansyaster|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Tansyasters", "MN": "B01.875.800.575.912.250.100.358", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid71051", "MS": "A plant genus of the family ASTERACEAE. Many of the member species have been reclassified to other genera such as Machaeranthera, Isocoma, Ericameria, etc. Ingestion of the plant has been associated with MILK SICKNESS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031206"}, {"RECTYPE": "D", "MH": "Tussilago", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Coltsfoot|T002|NON|NRW|NLM (2003)|010828|abcdef", "ENTRY": "farfaras, Tussilago", "MN": "B01.875.800.575.912.250.100.958", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid118777", "RR": "txid118778", "MS": "A plant genus of the family ASTERACEAE. Flower buds contain farfaratin (SESQUITERPENES) and bisabolene epoxide.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031207"}, {"RECTYPE": "D", "MH": "Verbesina", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Verbesinas", "MN": "B01.875.800.575.912.250.100.979", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41660", "MS": "A plant genus of the family ASTERACEAE. Members contain galegine (GUANIDINES).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031208"}, {"RECTYPE": "D", "MH": "Wedelia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Wedelias", "MN": "B01.875.800.575.912.250.100.989", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid183097", "MS": "A plant genus of the family ASTERACEAE. Members contain wedelolactone and wedeloside.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031209"}, {"RECTYPE": "D", "MH": "Xanthium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cocklebur, Spiny|T002|NON|NRW|NLM (2003)|010828|abcdef", "ENTRY": "spinosums, Xanthium", "MN": "B01.875.800.575.912.250.100.994", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid36590", "RR": "txid1053410", "MS": "A plant genus of the family ASTERACEAE. The name \"prickly burweed\" is sometimes used but causes confusion with AMSINCKIA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031210"}, {"RECTYPE": "D", "MH": "Corylus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hazelnut|T168|NON|NRW|NLM (2003)|010828|abcdef", "ENTRY": "Hazelnuts|T168|NON|NRW|NLM (2003)|010925|abcdef", "MN": "B01.875.800.575.912.250.859.750.200.875", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13450", "MS": "A plant genus of the family BETULACEAE known for the edible nuts.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031211"}, {"RECTYPE": "D", "MH": "Bixaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Kondagogu|T002|NON|NRW|NLM (2003)|010828|abcdef", "ENTRY": "Kondagogus", "MN": "B01.875.800.575.912.250.146", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid66670", "RR": "txid66674", "MS": "A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. Bixa contains bixin. Cochlospermum contains arjunolic acid and gum kondagogu (POLYSACCHARIDES).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031212"}, {"RECTYPE": "D", "MH": "Cordia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Manjack|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Manjacks", "MN": "B01.875.800.575.912.250.150.327", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid79331", "MS": "A plant genus of the family BORAGINACEAE. Members contain TRITERPENES and naphthoxirene.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031213"}, {"RECTYPE": "D", "MH": "Arabis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cress, Rock|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Rock Cresses", "MN": "B01.875.800.575.912.250.157.150", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid50451", "MS": "A plant genus of the family BRASSICACEAE. Member species are ornamentals grown for their numerous small white, yellow, pink, or purplish flowers.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031214"}, {"RECTYPE": "D", "MH": "Armoracia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Horseradish|T168|NON|REL|NLM (2003)|010828|abcdef", "ENTRY": "Horseradishs", "MN": "B01.875.800.575.912.250.157.175", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3703", "RR": "txid3704", "AN": "note entry term HORSERADISH: HORSERADISH, JAPANESE see WASABIA is also available", "MS": "A plant genus of the family BRASSICACEAE known for the root used in hot SPICES. It is also the source of HORSERADISH PEROXIDASE which is widely used in laboratories.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031215"}, {"RECTYPE": "D", "MH": "Barbarea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rocket, Yellow|T002|NON|NRW|NLM (2003)|010828|abcdef", "ENTRY": "vulgari, Barbarea", "MN": "B01.875.800.575.912.250.157.187", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid50457", "RR": "txid50459", "MS": "A plant genus of the family BRASSICACEAE. Members contain glucobrassicin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031216"}, {"RECTYPE": "D", "MH": "Cardamine", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cress, Meadow|T002|NON|NRW|NLM (2003)|010828|abcdef", "ENTRY": "pratenses, Cardamine", "MN": "B01.875.800.575.912.250.157.255", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid50460", "RR": "txid50465", "MS": "A plant genus of the family BRASSICACEAE that is low-growing in damp meadows of the Northern Hemisphere and has pinnately divided leaves and small white to rose flowers.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031217"}, {"RECTYPE": "D", "MH": "Crambe Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "abyssinicas, Crambe", "MN": "B01.875.800.575.912.250.157.277", "MH_TH": "NLM (2005)", "ST": "T002", "RN": "txid3720", "RR": "txid3721", "AN": "do not confuse with CRAMBE SPONGE, an invertebrate", "MS": "A plant genus of the family BRASSICACEAE. Members contain crambin.", "PM": "2005; see CRAMBE 2003-2004", "HN": "2005 (2003)", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031218"}, {"RECTYPE": "D", "MH": "Isatis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Woad|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "Woads", "MN": "B01.875.800.575.912.250.157.438", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid161755", "MS": "A plant genus of the family BRASSICACEAE that is an ingredient of the preparation PC-SPES that is used to treat PROSTATIC HYPERPLASIA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031219"}, {"RECTYPE": "D", "MH": "Lepidium sativum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pepperweed|T002|NON|EQV|NLM (2003)|010828|abcdef", "ENTRY": "sativum, Lepidium", "MN": "B01.875.800.575.912.250.157.600.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid33125", "MS": "A plant species of the genus LEPIDIUM, family BRASSICACEAE that is a fast-growing, often weedy native of western Asia. It is widely grown, especially in its curl-leaved form, and used as a garnish", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031220"}, {"RECTYPE": "D", "MH": "Knee Dislocation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Knee Dislocations", "MN": "C26.558.554.500", "MH_TH": "NLM (2003)", "ST": "T037", "AN": "do not confuse with PATELLAR DISLOCATION, which is displacement of the patella (knee cap) from the femoral groove", "PI": "Knee Joint (1966-2002)", "MS": "Slippage of the FEMUR off the TIBIA.", "PM": "2003", "HN": "2003", "MR": "20170705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031221"}, {"RECTYPE": "D", "MH": "Patellar Dislocation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Patellar Dislocations", "MN": "C26.558.554.750", "MH_TH": "NLM (2003)", "ST": "T037", "AN": "do not confuse with KNEE DISLOCATION, which is slippage of the femur off the tibia", "PI": "Patella (1965-2002)", "MS": "Displacement of the PATELLA from the femoral groove.", "PM": "2003", "HN": "2003", "MR": "20170705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031222"}, {"RECTYPE": "D", "MH": "Nasturtium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "officinales, Nasturtium", "MN": "B01.875.800.575.912.250.157.644", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid65947", "RR": "txid65948", "AN": "NASTURTIUM, GARDEN see TROPAEOLUM is also available", "MS": "A plant genus of the family BRASSICACEAE. Nasturtium is also used as a common name for TROPAEOLUM. The common name of watercress is also used for RORIPPA & TROPAEOLUM. This is the most popular of the edible cresses, is a hardy creeping perennial plant, native to Europe but extensively naturalized elsewhere in moist places.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031223"}, {"RECTYPE": "D", "MH": "Raphanus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Radish|T002|NON|EQV|NLM (2003)|010829|abcdef", "ENTRY": "Radish, Wild", "MN": "B01.875.800.575.912.250.157.711", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3725", "RR": "txid3726", "MS": "A plant genus of the family BRASSICACEAE known for its peppery red root.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031224"}, {"RECTYPE": "D", "MH": "Rorippa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cress, Yellow|T002|NON|EQV|NLM (2003)|010829|abcdef", "ENTRY": "Yellow Cresses", "MN": "B01.875.800.575.912.250.157.744", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid50495", "AN": "RORIPPA NASTURTIUM-AQUATICUM see NASTURTIUM is also available", "MS": "A plant genus of the family BRASSICACEAE that includes several marshy plants. The common name of watercress is also used for NASTURTIUM & TROPAEOLUM.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031225"}, {"RECTYPE": "D", "MH": "Sinapis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "White Mustards", "MN": "B01.875.800.575.912.250.157.811", "FX": "Mustard Plant", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid3727", "RR": "txid3728", "PI": "Mustard (1985-2002)", "MS": "A plant genus of the family Brassicaceae. The common name of mustard may refer to MUSTARD PLANT (BRASSICA JUNCEA or BRASSICA NIGRA).", "PM": "2003; see MUSTARD 1985-2002; for BRASSICA ALBA see MUSTARD PLANT 2003-2016", "HN": "2003; use MUSTARD 1985-2002;  for BRASSICA ALBA use MUSTARD PLANT 2003-2016", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031226"}, {"RECTYPE": "D", "MH": "Thlaspi", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "arvenses, Thlaspi", "MN": "B01.875.800.575.912.250.157.905", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13287", "RR": "txid13288", "MS": "A plant genus of the family BRASSICACEAE that is grown in rock gardens. T. arvense is grown for its large, round ornamental seed pods. The common name of pennycress usually refers to this genus but may also refer to the genus Microthlaspi.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031227"}, {"RECTYPE": "D", "MH": "Wasabia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Horseradish, Japanese|T002|NON|EQV|NLM (2003)|010829|abcdef", "ENTRY": "Wasabias", "MN": "B01.875.800.575.912.250.157.952", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid98005", "AN": "HORSERADISH see ARMORACIA is also available", "MS": "A plant genus of the family BRASSICACEAE used for its hot peppery root.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031228"}, {"RECTYPE": "D", "MH": "Bromeliaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.159", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4613", "MS": "A plant family of the order Bromeliales, subclass Zingiberidae, class Liliopsida (monocotyledons).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031229"}, {"RECTYPE": "D", "MH": "Ananas", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pineapple|T168|NON|REL|NLM (2003)|010829|abcdef", "ENTRY": "Pineapples", "MN": "B01.875.800.575.912.250.159.099", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4614", "RR": "txid4615", "MS": "A plant genus of the family BROMELIACEAE known for the edible fruit that is the source of BROMELAINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031230"}, {"RECTYPE": "D", "MH": "Bromelia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Bromelias", "MN": "B01.875.800.575.912.250.159.244", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4616", "MS": "A plant genus of the family BROMELIACEAE. Members contain karatasin and balansain (ENDOPEPTIDASES) and BROMELAINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031231"}, {"RECTYPE": "D", "MH": "Tillandsia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Tillandsias", "MN": "B01.875.800.575.912.250.159.622", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid15170", "MS": "A plant genus of the family BROMELIACEAE. Members contain 3-methoxy-5-hydroxyflavonols.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031232"}, {"RECTYPE": "D", "MH": "Bursera", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gumbo Limbo|T002|NON|NRW|NLM (2003)|010829|abcdef", "ENTRY": "simaruba, Bursera", "MN": "B01.875.800.575.912.250.162.138", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4015", "RR": "txid80326", "MS": "A plant genus of the family BURSERACEAE. Members contain a PODOPHYLLOTOXIN.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031233"}, {"RECTYPE": "D", "MH": "Buxaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sarcococca|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Sarcococcas", "MN": "B01.875.800.575.912.250.165", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4000", "RR": "txid108422", "MS": "A plant family of the order Euphorbiales, subclass Rosidae, class Magnoliopsida. Leaves are alternate, simple, and leathery. Fruits are one- or two-seeded capsules or drupes (stony-pitted fleshy fruits).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031234"}, {"RECTYPE": "D", "MH": "Buxus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Boxwood|T002|NON|EQV|NLM (2003)|010829|abcdef", "ENTRY": "Boxwoods", "MN": "B01.875.800.575.912.250.165.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4001", "MS": "A plant genus of the family BUXACEAE. Members contain steroidal alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031235"}, {"RECTYPE": "D", "MH": "Pachysandra", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Spurge, Japanese|T002|NON|EQV|NLM (2003)|010829|abcdef", "ENTRY": "Spurges, Japanese", "MN": "B01.875.800.575.912.250.165.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid74824", "AN": "SPURGE see EUPHORBIA is also available", "MS": "A plant genus of the family BUXACEAE that should not be confused with common spurge (EUPHORBIA).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031236"}, {"RECTYPE": "D", "MH": "Calycanthaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.595.200", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3427", "MS": "A plant family of the order Laurales, subclass Magnoliidae, class Magnoliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031237"}, {"RECTYPE": "D", "MH": "Platycodon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bellflower, Chinese|T002|NON|EQV|NLM (2003)|010829|abcdef", "ENTRY": "grandiflorum, Platycodon", "MN": "B01.875.800.575.912.250.171.800", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid94285", "RR": "txid94286", "MS": "A plant genus of the family CAMPANULACEAE that contains platycodin and other triterpenoid SAPONINS. It is a constituent of kikyo-to (MEDICINE, KAMPO).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031238"}, {"RECTYPE": "D", "MH": "Lonicera", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Honeysuckle|T002|NON|EQV|NLM (2003)|010829|abcdef", "ENTRY": "Loniceras", "MN": "B01.875.800.575.912.250.328.750.388", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid49606", "MS": "A plant genus of the family CAPRIFOLIACEAE. Members contain iridoid glucosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031239"}, {"RECTYPE": "D", "MH": "Symphoricarpos", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Symphoricarpo", "MN": "B01.875.800.575.912.250.328.750.625", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13701", "MS": "A plant genus of the family CAPRIFOLIACEAE. The common name of \"snowberry\" is also used for GAULTHERIA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031240"}, {"RECTYPE": "D", "MH": "Caricaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.192", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3647", "AN": "prefer specific plant", "MS": "A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031241"}, {"RECTYPE": "D", "MH": "Agrostemma", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Corncockle|T002|NON|EQV|NLM (2003)|010829|abcdef", "ENTRY": "Corncockles", "MN": "B01.875.800.575.912.250.198.500.250.055", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39847", "MS": "A plant genus of the family CARYOPHYLLACEAE that contains ALLANTOIN and a ribosome-inactivating protein.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031242"}, {"RECTYPE": "D", "MH": "Arenaria Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Arenaria", "MN": "B01.875.800.575.912.250.198.500.250.077", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3577", "MS": "A plant genus of the family CARYOPHYLLACEAE. The common name of sandwort is used with other plants. Do not confuse with Arenaria bird or with other genera which use arenaria as the species name such as Mya arenaria (softshell clam) or Meloidogyne arenaria, or Ammophila arenaria (marram grass).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031243"}, {"RECTYPE": "D", "MH": "Lychnis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Lychni", "MN": "B01.875.800.575.912.250.198.500.250.416", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid265240", "MS": "A plant genus of the family CARYOPHYLLACEAE. The common name \"Campion\" is also used with SILENE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031244"}, {"RECTYPE": "D", "MH": "Vaccaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Vaccarias", "MN": "B01.875.800.575.912.250.198.500.250.913", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39247", "MS": "A plant genus of the family CARYOPHYLLACEAE. The common name \"Soapwort\" is also used with SAPONARIA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031245"}, {"RECTYPE": "D", "MH": "Celastrus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.500.750.199", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid85180", "MS": "A plant genus of the family CELASTRACEAE that contains insecticidal sesquiterpenoids and celastrus oil.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031247"}, {"RECTYPE": "D", "MH": "Salsola", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tumbleweed|T002|NON|EQV|NLM (2003)|010829|abcdef", "ENTRY": "Tumbleweeds", "MN": "B01.875.800.575.912.250.198.500.100.833", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid151233", "MS": "A plant genus of the family CHENOPODIACEAE. The extract may be called lochein. Tumbleweed may occasionally refer to AMARANTHUS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031248"}, {"RECTYPE": "D", "MH": "Erdheim-Chester Disease", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Granulomatosis, Lipid|T047|NON|EQV|NLM (2003)|010829|abcdef", "ENTRY": "Lipid Granulomatosis", "MN": "C15.604.250.410.224", "MH_TH": "NLM (2003)", "ST": "T047", "PI": "Xanthomatosis (1979-2002)", "MS": "A rare form of non-Langerhans-cell histiocytosis (HISTIOCYTOSIS, NON-LANGERHANS-CELL) with onset in middle age. The systemic disease is characterized by infiltration of lipid-laden macrophages, multinucleated giant cells, an inflammatory infiltrate of lymphocytes and histiocytes in the bone marrow, and a generalized sclerosis of the long bones.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031249"}, {"RECTYPE": "D", "MH": "Clethraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sweetpepperbush|T002|NON|NRW|NLM (2003)|010829|abcdef", "ENTRY": "Sweetpepperbushs", "MN": "B01.875.800.575.912.250.339.218", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid16611", "RR": "txid13434", "MS": "A plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031250"}, {"RECTYPE": "D", "MH": "Clusia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Clusias", "MN": "B01.875.800.575.912.250.859.625.249", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid72403", "MS": "A plant genus of the family CLUSIACEAE. Members contain benzophenones.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031251"}, {"RECTYPE": "D", "MH": "Mammea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Mammeas", "MN": "B01.875.800.575.912.250.859.625.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid180118", "MS": "A plant genus of the family CLUSIACEAE. Members contain xanthones and BENZOPHENONES. The common name of Mamey is also used with POUTERIA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031252"}, {"RECTYPE": "D", "MH": "Calystegia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bindweed, False|T002|NON|EQV|NLM (2003)|010829|abcdef", "ENTRY": "False Bindweeds", "MN": "B01.875.800.575.912.250.238.249", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid47518", "MS": "A plant genus of the family CONVOLVULACEAE. Members contain calystegine and calystegins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031253"}, {"RECTYPE": "D", "MH": "Convolvulus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bindweed, Field|T002|NON|EQV|NLM (2003)|010829|abcdef", "ENTRY": "Field Bindweeds", "MN": "B01.875.800.575.912.250.238.374", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4122", "MS": "A plant genus of the family CONVOLVULACEAE. The common name of morning glory also refers to IPOMOEA. The common name of bindweed also refers to IPOMOEA; CALYSTEGIA; or POLYGONUM.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031254"}, {"RECTYPE": "D", "MH": "Carex Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Carex", "MN": "B01.875.800.575.912.250.312.099", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13398", "MS": "A plant genus of the family CYPERACEAE. The seed contains oligostilbenes (STILBENES).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031255"}, {"RECTYPE": "D", "MH": "Eleocharis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Water Chestnut, Chinese|T002|EPO|EQV|NLM (2003)|010829|abcdef", "ENTRY": "Water Chestnuts", "MN": "B01.875.800.575.912.250.312.299", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid46324", "MS": "A plant genus of the family CYPERACEAE. Corm of Eleocharis species (e.g., Eleocharis dulcis) is edible and commonly referred to as \"water chestnut\" which sometimes also referred to fruits of unrelated plant genus TRAPA (e.g., invasive aquatic plant TRAPA NATANS).", "PM": "2003", "HN": "2003", "MR": "20230226", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031256"}, {"RECTYPE": "D", "MH": "Droseraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Venus Flytrap|T002|NON|NRW|NLM (2003)|010829|abcdef", "ENTRY": "Venus Flytraps", "MN": "B01.875.800.575.912.250.198.500.350", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4360", "RR": "txid4361", "AN": "entry term VENUS FLYTRAP: FLYTRAP see SARRACENIACEAE is also available; coordinate with CARNIVOROUS PLANT if pertinent ", "MS": "A plant family of the order Nepenthales, subclass Dilleniidae, class Magnoliopsida, notable for leaves with sticky gland-tipped hairs that entrap insects.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031257"}, {"RECTYPE": "D", "MH": "Poult Enteritis Mortality Syndrome", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Spiking Mortality Syndrome|T047|NON|EQV|NLM (2003)|010829|abcdef", "ENTRY": "Mortality Syndrome, Spiking", "MN": "C22.131.728.650", "FX": "Enteritis, Transmissible, of Turkeys", "MH_TH": "NLM (2003)", "ST": "T047", "AN": "don't forget TURKEYS (NIM)", "PI": "Poultry Diseases (1991-2002)", "MS": "An acute, transmissible, infectious disease associated with high MORTALITY and MORBIDITY in young turkeys (poults). It is characterized by DIARRHEA; ANOREXIA; growth depression, and immune dysfunction. The cause is unknown but astroviruses (AVASTROVIRUS) and coronaviruses (CORONAVIRUS, TURKEY) have been isolated from diseased poults and are thought to cause the enteritis and increased susceptibility to bacterial infections.", "PM": "2003", "HN": "2003", "MR": "20190617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031261"}, {"RECTYPE": "D", "MH": "Ebenaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Euclea|T002|NON|NRW|NLM (2003)|010829|abcdef", "ENTRY": "Eucleas", "MN": "B01.875.800.575.912.250.341.875", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid19955", "RR": "txid85201", "MS": "A small plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida. Members contain NAPHTHOQUINONES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031262"}, {"RECTYPE": "D", "MH": "Elaeagnaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Shepherdia|T002|NON|NRW|NLM (2003)|010830|abcdef", "ENTRY": "Shepherdias", "MN": "B01.875.800.575.912.250.859.937.280", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid25996", "RR": "txid36904", "MS": "A plant family of the order Rhamnales, subclass Rosidae class Magnoliopsida. The plants have a characteristic silvery or rusty-colored sheen, caused by tiny distinctive scales. Flowers have a tubular structure of four sepals. Root nodules host the Frankia (ACTINOMYCETES) nitrogen-fixing symbionts.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031263"}, {"RECTYPE": "D", "MH": "Hippophae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sea Buckthorn|T002|NON|EQV|NLM (2003)|010830|abcdef", "ENTRY": "Sea Buckthorns", "MN": "B01.875.800.575.912.250.859.937.280.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid48233", "RR": "txid193516", "MS": "A plant genus of the family ELAEAGNACEAE. Linoleic (18:2n-6) and alpha-linolenic acids (18:3n-3) comprised about 70% of seed oil fatty acids. This is unrelated to 'artificial sea buckthorn oil'. This genus does not belong to the buckthorn family (RHAMNACEAE).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031281"}, {"RECTYPE": "D", "MH": "Gaultheria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Gaultherias", "MN": "B01.875.800.575.912.250.341.937.267", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13538", "MS": "A plant genus of the family ERICACEAE. The common name of \"wintergreen\" is also used for PYROLA and \"snowberry\" is also used for SYMPHORICARPOS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031282"}, {"RECTYPE": "D", "MH": "Eucommiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Du-zhong|T002|NON|NRW|NLM (2003)|010830|abcdef", "ENTRY": "ulmoide, Eucommia", "MN": "B01.875.800.575.912.250.348", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4390", "RR": "txid4392", "MS": "A plant family of the order Eucommiales, subclass Hamamelidae, class Magnoliopsida (some botanists have classified this in the order Hamamelidales or Urticales). Eucomia is an elmlike tree of central and eastern China. Leaves are alternate; deciduous flowers are solitary and unisexual and lack petals and sepals. The male flowers have 6 to 10 stamens and female flowers have one ovary of two carpels, one of which aborts during development so the fruit (a dry, winged structure) contains only one seed. The latex is a source of RUBBER. Tochu tea is an aqueous extract of Eucommia ulmoides leaves and a popular beverage in Japan. (Mutat Res 1997 Jan 15;388(1):7-20).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031283"}, {"RECTYPE": "D", "MH": "Aleurites", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tung|T002|NON|EQV|NLM (2003)|010830|abcdef", "ENTRY": "Tungs", "MN": "B01.875.800.575.912.250.859.797.438.077", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid123497", "MS": "A plant genus of the family EUPHORBIACEAE that is the source of tung oil and a phorbol diester (PHORBOL ESTERS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031284"}, {"RECTYPE": "D", "MH": "Hippomane", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Manchineel|T002|NON|EQV|NLM (2003)|010830|abcdef", "ENTRY": "Manchineels", "MN": "B01.875.800.575.912.250.859.797.438.461", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid316843", "MS": "A plant genus of the family EUPHORBIACEAE. The trees contain hippomanin A and the latex is a skin irritant.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031285"}, {"RECTYPE": "D", "MH": "Jatropha", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Spurge, Nettle|T002|NON|EQV|NLM (2003)|010830|abcdef", "ENTRY": "Spurges, Nettle", "MN": "B01.875.800.575.912.250.859.797.438.488", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3995", "RR": "txid180498", "MS": "A plant genus of the family EUPHORBIACEAE. Members contain jatrophone and other diterpenes.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031286"}, {"RECTYPE": "D", "MH": "Sapium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Sapiums", "MN": "B01.875.800.575.912.250.859.797.438.737", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid139771", "MS": "A plant genus of the family EUPHORBIACEAE that contains bukittinggine and PHORBOL ESTERS.", "PM": "2003", "HN": "2003", "MR": "20220413", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031287"}, {"RECTYPE": "D", "MH": "Chamaecrista", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pea, Sensitive|T002|NON|EQV|NLM (2003)|010830|abcdef", "ENTRY": "Sensitive Peas", "MN": "B01.875.800.575.912.250.401.125", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid53853", "MS": "A plant genus of the family FABACEAE. Some species were reclassified from CASSIA and Senna.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031288"}, {"RECTYPE": "D", "MH": "Albizzia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Silktree|T002|NON|EQV|NLM (2003)|010830|abcdef", "ENTRY": "Silktrees", "MN": "B01.875.800.575.912.250.401.051", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3812", "MS": "A plant genus of the family FABACEAE that contains julibroside (triterpenoid saponins).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031289"}, {"RECTYPE": "D", "MH": "Butea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Buteas", "MN": "B01.875.800.575.912.250.401.090", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid12979", "MS": "A plant genus of the family FABACEAE that contains butrin and isobutrin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031290"}, {"RECTYPE": "D", "MH": "Castanospermum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Castanospermums", "MN": "B01.875.800.575.912.250.401.112", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid24961", "MS": "A plant genus of the family FABACEAE that contains castanospermines, swainsonine, and triterpenoid saponins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031291"}, {"RECTYPE": "D", "MH": "Clitoria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Clitorias", "MN": "B01.875.800.575.912.250.401.162", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43365", "MS": "A plant genus of the family FABACEAE that contains ternatins (anthocyanins) and preternatins, antifungal proteins, stigmast-4-ene-3,6-dione, and clitoriacetal (ROTENONE).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031292"}, {"RECTYPE": "D", "MH": "Cyamopsis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Guar|T002|NON|EQV|NLM (2003)|010830|abcdef", "ENTRY": "tetragonoloba, Cyamopsis", "MN": "B01.875.800.575.912.250.401.181", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3831", "RR": "txid3832", "MS": "A plant genus of the family FABACEAE that is the source of guar gum.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031293"}, {"RECTYPE": "D", "MH": "Dolichos", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Dolicho", "MN": "B01.875.800.575.912.250.401.196", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3839", "MS": "A plant genus of the family FABACEAE that contains LECTINS. Many members have been reclassified into other genera of the FABACEAE family.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031294"}, {"RECTYPE": "D", "MH": "Griffonia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Griffonias", "MN": "B01.875.800.575.912.250.401.318", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3849", "MS": "A plant genus of the family FABACEAE. Members contain Griffonia simplicifolia agglutin-I and griffonin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031295"}, {"RECTYPE": "D", "MH": "Laburnum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Golden Chain|T002|NON|EQV|NLM (2003)|010830|abcdef", "ENTRY": "laburnums, Cytisus", "MN": "B01.875.800.575.912.250.401.356", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3851", "RR": "txid49828", "AN": "INDIAN LABURNUM see CASSIA is also available", "MS": "A plant genus of the family FABACEAE named after the drooping clusters of flowers.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031296"}, {"RECTYPE": "D", "MH": "Lupinus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lupine|T002|NON|EQV|NLM (2003)|010830|abcdef", "ENTRY": "Lupines", "MN": "B01.875.800.575.912.250.401.571", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3869", "MS": "A plant genus of the family FABACEAE that is a source of SPARTEINE, lupanine and other lupin alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031297"}, {"RECTYPE": "D", "MH": "Mimosa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Mimosas", "MN": "B01.875.800.575.912.250.401.596", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid21013", "MS": "A plant genus of the family FABACEAE that contains kukulkanin, a CHALCONE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031298"}, {"RECTYPE": "D", "MH": "Mucuna", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cowitch|T002|NON|EQV|NLM (2003)|010830|abcdef", "ENTRY": "Velvet Beans", "MN": "B01.875.800.575.912.250.401.598", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid40336", "MS": "A plant genus of the family FABACEAE that is the source of mucuna gum.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031299"}, {"RECTYPE": "D", "MH": "Retinal Vasculitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vasculitis, Retinal|T047|NON|EQV|NLM (2003)|010830|abcdef", "MN": "C14.907.940.815", "FX": "Retinitis", "MH_TH": "NLM (2003)", "ST": "T047", "PI": "Vasculitis (1966-2002)", "MS": "Inflammation of the retinal vasculature with various causes including infectious disease; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE SCLEROSIS; BEHCET SYNDROME; and CHORIORETINITIS.", "PM": "2003", "HN": "2003", "MR": "20050719", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031300"}, {"RECTYPE": "D", "MH": "Robinia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Locust, Black|T002|NON|NRW|NLM (2003)|010831|abcdef", "ENTRY": "pseudoacacia, Robinia", "MN": "B01.875.800.575.912.250.401.716", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid35937", "RR": "txid35938", "MS": "A plant genus of the family FABACEAE that contains linarin (acaciin) and LECTINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031301"}, {"RECTYPE": "D", "MH": "Spartium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Broom, Spanish|T002|NON|EQV|NLM (2003)|010831|abcdef", "ENTRY": "junceums, Spartium", "MN": "B01.875.800.575.912.250.401.812", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid49842", "RR": "txid49843", "AN": "entry term BROOM, SPANISH: several other Broom terms are also available; check text and MeSH", "MS": "A plant genus of the family FABACEAE that is a source of SPARTEINE. Do not confuse with Broom or Scotch Broom (CYTISUS) or Butcher's Broom (RUSCUS) or Desert Broom (BACCHARIS) or Brome (BROMUS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031302"}, {"RECTYPE": "D", "MH": "Sphenostylis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yam Bean, African|T002|EPO|NRW|NLM (2003)|010831|abcdef", "ENTRY": "stenocarpas, Sphenostylis", "MN": "B01.875.800.575.912.250.401.843", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid92479", "RR": "txid92480", "MS": "A plant genus of the family FABACEAE that contains LECTINS and raffinose oligosaccharides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031303"}, {"RECTYPE": "D", "MH": "Tephrosia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Tephrosias", "MN": "B01.875.800.575.912.250.401.890", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid47097", "MS": "A plant genus of the family FABACEAE that contains tephrorin, tephrosone, and C-prenylflavonoids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031304"}, {"RECTYPE": "D", "MH": "Tetrapleura", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Tetrapleuras", "MN": "B01.875.800.575.912.250.401.898", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid148727", "MS": "A plant genus of the family FABACEAE. Members contain molluscicidal triterpene glycosides (TRITERPENES).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031305"}, {"RECTYPE": "D", "MH": "Vicia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Vetch|T002|NON|EQV|NLM (2003)|010831|abcdef", "ENTRY": "Vicias", "MN": "B01.875.800.575.912.250.401.968", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3904", "AN": "do not confuse entry term VETCH with milkvetch see ASTRAGALUS PLANT;", "MS": "A plant genus of the family FABACEAE that is widely used as ground cover and forage and known for the edible beans, VICIA FABA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031306"}, {"RECTYPE": "D", "MH": "Vicia faba", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Horsebean|T002|NON|EQV|NLM (2003)|010831|abcdef", "ENTRY": "fabas, Vicia", "MN": "B01.875.800.575.912.250.401.968.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3906", "MS": "A plant species of the genus VICIA, family FABACEAE. The edible beans are well known but they cause FAVISM in some individuals with GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY. This plant contains vicine, convicine, Vicia lectins, unknown seed protein, AAP2 transport protein, and Vicia faba DNA-binding protein 1.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031307"}, {"RECTYPE": "D", "MH": "Salicaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Flacourtiaceae|T002|NON|EQV|NLM (2003)|010831|abcdef", "MN": "B01.875.800.575.912.250.859.797.875", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid3688", "MS": "A plant family of the order MALPIGHIALES, superorder ROSANAE, class MAGNOLIOPSIDA. The leaves are alternate and simple, and staminate (male) flowers consist of one to several stamens; pistillate (female) flowers consist of a single-chambered ovary with several ovules that produce silky seeds.", "PM": "2019; see FLACOURTIACEAE 2001-2017", "HN": "2019(2001)", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031308"}, {"RECTYPE": "D", "MH": "Ryania", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Ryanias", "MN": "B01.875.800.575.912.250.859.797.875.455", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid312403", "RR": "txid312404", "MS": "A plant genus of the family Salicaceae that is the source of RYANODINE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031309"}, {"RECTYPE": "D", "MH": "Fumariaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.836.500.469", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3462", "AN": "prefer specific plant;", "MS": "The fumitory, or bleeding-heart plant family of the order Papaverales, subclass Magnoliidae, class Magnoliopsida. Flowers are bisexual, with two small sepals and four petals, one pistil and six stamens.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031310"}, {"RECTYPE": "D", "MH": "Corydalis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fumewort|T002|NON|EQV|NLM (2003)|010831|abcdef", "ENTRY": "Fumeworts", "MN": "B01.875.800.575.912.250.836.500.312", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3463", "MS": "A plant genus of the family FUMARIACEAE (classified by some in PAPAVERACEAE) that contains isoquinoline alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031311"}, {"RECTYPE": "D", "MH": "Fumaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Fumitories", "MN": "B01.875.800.575.912.250.836.500.437", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid200992", "RR": "txid200993", "MS": "A plant genus of the family FUMARIACEAE that contains fumariline and other isoquinoline alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031312"}, {"RECTYPE": "D", "MH": "Gentianella", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hercumpuri|T002|NON|EQV|NLM (2003)|010831|abcdef", "ENTRY": "Hercumpurus", "MN": "B01.875.800.575.912.250.456.750.492", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid49959", "PI": "Plants, Medicinal (1999-2002)", "MS": "A plant genus of the family GENTIANACEAE that contains nitiol (a C25 sesterterpenoid) & nitidasin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031313"}, {"RECTYPE": "D", "MH": "Geraniaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.462", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4027", "AN": "prefer specific plant;", "MS": "A plant family of the order Geraniales, subclass Rosidae, class Magnoliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031314"}, {"RECTYPE": "D", "MH": "Geranium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Geraniums", "MN": "B01.875.800.575.912.250.462.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4028", "MS": "A plant genus of the family GERANIACEAE. Geranium is also used as a common name for PELARGONIUM.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031315"}, {"RECTYPE": "D", "MH": "Pelargonium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Pelargoniums", "MN": "B01.875.800.575.912.250.462.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4030", "MS": "A plant genus of the family GERANIACEAE. The common name of geranium is also used for the GERANIUM genus.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031316"}, {"RECTYPE": "D", "MH": "Liquidambar", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sweetgum|T002|NON|NRW|NLM (2003)|010831|abcdef", "ENTRY": "Trees, Sweet Gum", "MN": "B01.875.800.575.912.250.475.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4398", "RR": "txid4400", "MS": "A plant genus of the family HAMAMELIDACEAE. The sap is a source of storax, which should not be confused with the similar named STYRAX genus.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031317"}, {"RECTYPE": "D", "MH": "Hippocastanaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.885.278", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid910346", "AN": "prefer specific plant", "MS": "A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida.", "PM": "2003", "HN": "2003", "MR": "20220603", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031318"}, {"RECTYPE": "D", "MH": "Aesculus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Red Chestnuts", "MN": "B01.875.800.575.912.250.885.278.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43363", "RR": "txid43364", "MS": "A plant genus of the family HIPPOCASTANACEAE (or SAPINDACEAE by some) that contains antimicrobial protein 1 and escin. A. hippocastanum is used in folk medicine for treating chronic venous insufficiency.", "PM": "2003", "HN": "2003", "MR": "20220714", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031319"}, {"RECTYPE": "D", "MH": "Hippocrateaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hippocratea|T002|NON|NRW|NLM (2003)|010831|abcdef", "ENTRY": "Hippocrateas", "MN": "B01.875.800.575.912.250.517", "MH_TH": "NLM (2003)", "ST": "T002", "RR": "txid4317", "MS": "A plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida. The Hippocratea genus contains friedelanes, triterpenoid quinone, and hippocrateine I.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031320"}, {"RECTYPE": "D", "MH": "Hydrocharitaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thalassia|T002|NON|NRW|NLM (2003)|011227|abcdef", "ENTRY": "Thalassias", "MN": "B01.875.800.575.912.250.618.050.875", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid26319", "RR": "txid55495", "MS": "A plant family of the order Hydrocharitales, subclass ALISMATIDAE, class Liliopsida (monocotyledons).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031321"}, {"RECTYPE": "D", "MH": "Eriodictyon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yerba Santa|T002|NON|NRW|NLM (2003)|010831|abcdef", "ENTRY": "californicums, Eriodictyon", "MN": "B01.875.800.575.912.250.150.415", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4131", "RR": "txid4132", "MS": "A plant genus of the family HYDROPHYLLACEAE that has a characteristic strong smell.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031322"}, {"RECTYPE": "D", "MH": "Iris Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Iris", "MN": "B01.875.800.575.912.250.618.100.400.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid26378", "MS": "A plant genus of the family IRIDACEAE that contains IRIP, a type-1 ribosome-inactivating protein, and iridals (TRITERPENES).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031323"}, {"RECTYPE": "D", "MH": "Juglans", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Walnut|T002|NON|EQV|NLM (2003)|010831|abcdef", "ENTRY": "Walnuts, English", "MN": "B01.875.800.575.912.250.859.750.500.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid16718", "RR": "txid51240", "MS": "A plant genus of the family JUGLANDACEAE that provides the familiar walnut.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031324"}, {"RECTYPE": "D", "MH": "Carya", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pecans|T168|NON|REL|NLM (2003)|010926|abcdef", "ENTRY": "illinoenses, Carya", "MN": "B01.875.800.575.912.250.859.750.500.249", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13402", "RR": "txid32201", "MS": "A plant genus of the family JUGLANDACEAE that bears edible nuts.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031325"}, {"RECTYPE": "D", "MH": "Krameriaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rhatany|T002|NON|NRW|NLM (2003)|abcde", "ENTRY": "Rhatanies", "MN": "B01.875.800.575.912.250.572", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid66687", "RR": "txid66688", "MS": "A plant family of the order Polygalales, subclass Rosidae, class Magnoliopsida.", "PM": "2003; RHATANY was indexed under TANNINS 1992-2002", "HN": "2003; for RHATANY use KRAMERIACEAE 1992-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031326"}, {"RECTYPE": "D", "MH": "Agastache", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hyssop, Giant|T002|NON|EQV|NLM (2003)|010831|abcdef", "ENTRY": "Hyssops, Giant", "MN": "B01.875.800.575.912.250.583.520.049", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39130", "MS": "A plant genus of the family LAMIACEAE that contains tilianin, agastanol, and agastaquinone (a cytotoxic diterpenoid quinone).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031327"}, {"RECTYPE": "D", "MH": "Ajuga", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bugle|T002|NON|EQV|NLM (2003)|010831|abcdef", "ENTRY": "Bugles", "MN": "B01.875.800.575.912.250.583.520.051", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid38595", "MS": "A plant genus of the family LAMIACEAE that contains cyasterone, ajugasterone, 20-hydroxyecdysone, 8-acetylharpagide (an iridoid glycoside).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031328"}, {"RECTYPE": "D", "MH": "Ballota", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Horehound, Black|T002|NON|EQV|NLM (2003)|010831|abcdef", "ENTRY": "Horehounds, Black", "MN": "B01.875.800.575.912.250.583.520.075", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid155228", "PI": "Plants, Medicinal (1998-2002)", "MS": "A plant genus of the family LAMIACEAE that contains phenylpropanoids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031329"}, {"RECTYPE": "D", "MH": "Coleus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.583.520.166", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid587658", "MS": "A plant genus of the family Lamiaceae. The species of Coleus should be distinguished from PLECTRANTHUS BARBATUS - which is also known as Coleus forskohlii.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031330"}, {"RECTYPE": "D", "MH": "Hyptis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Hypti", "MN": "B01.875.800.575.912.250.583.520.297", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid204122", "MS": "A plant genus of the family LAMIACEAE that contains 5-methoxydehydropodophyllotoxin (a PODOPHYLLOTOXIN) and other LIGNANS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031331"}, {"RECTYPE": "D", "MH": "Leonurus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Motherwort|T002|NON|EQV|NLM (2003)|010831|abcdef", "ENTRY": "Motherworts", "MN": "B01.875.800.575.912.250.583.520.446", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4137", "MS": "A plant genus of the family LAMIACEAE that contains leonurine.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031332"}, {"RECTYPE": "D", "MH": "Lycopus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Horehound, Water|T002|NON|EQV|NLM (2003)|010831|abcdef", "ENTRY": "Water Horehounds", "MN": "B01.875.800.575.912.250.583.520.455", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid260602", "RR": "txid1620142", "MS": "A plant genus of the family LAMIACEAE that contains rosmarinic acid and isopimarane diterpenoids and has been used in folk medicine for HYPERTHYROIDISM.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031333"}, {"RECTYPE": "D", "MH": "Melissa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "officinalis, Melissa", "MN": "B01.875.800.575.912.250.583.520.474", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39170", "RR": "txid39338", "MS": "A plant genus of the family LAMIACEAE. The common names of beebalm or lemonbalm are also used for MONARDA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031334"}, {"RECTYPE": "D", "MH": "Mentha pulegium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pulegium vulgare|T002|NON|EQV|NLM (2003)|010831|abcdef", "ENTRY": "vulgare, Pulegium", "MN": "B01.875.800.575.912.250.583.520.483.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid294739", "MS": "A plant genus of the family LAMIACEAE that contains pulegone. Do not confuse with 'American false pennyroyal' (HEDEOMA).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031335"}, {"RECTYPE": "D", "MH": "Hedeoma", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pennyroyal, American False|T002|NON|NRW|NLM (2003)|010831|abcdef", "ENTRY": "pulegioides, Melissa", "MN": "B01.875.800.575.912.250.583.520.231", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid313681", "RR": "txid1547260", "AN": "entry term PENNYROYAL, AMERICAN FALSE: PENNYROYAL, EUROPEAN see MENTHA PULEGIUM is also available", "MS": "A plant genus of the family LAMIACEAE that is closely related to the European pennyroyal (MENTHA PULEGIUM).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031336"}, {"RECTYPE": "D", "MH": "Mentha spicata", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Spearmint|T002|NON|EQV|NLM (2003)|010831|abcdef", "ENTRY": "spicata, Mentha", "MN": "B01.875.800.575.912.250.583.520.483.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid29719", "MS": "A plant genus of the family LAMIACEAE having characteristic flavor.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031337"}, {"RECTYPE": "D", "MH": "Monarda", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Monardas", "MN": "B01.875.800.575.912.250.583.520.510", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39171", "MS": "A plant genus of the family LAMIACEAE. The common names of beebalm or lemonbalm are also used for MELISSA. The common name of bergamot is also used for Citrus bergamia (CITRUS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031338"}, {"RECTYPE": "D", "MH": "Ocimum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "gratissimum, Ocimum", "MN": "B01.875.800.575.912.250.583.520.647", "MH_TH": "NLM (1999)", "ST": "T002", "RN": "txid39173", "RR": "txid204144", "PI": "Ocimum basilicum (1998-2002)", "MS": "A plant genus of the family Lamiaceae which occurs in tropical and warm temperate regions worldwide. It includes the aromatic herb OCIMUM BASILICUM (Sweet Basil) and the MEDICINAL PLANT Ocimum tenuiflorum (Holy Basil).", "PM": "2003; see OCIMUM BASILICUM 1998-2002", "HN": "2003; use OCIMUM BASILICUM 1998-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031339"}, {"RECTYPE": "D", "MH": "Origanum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Oregano Plant|T002|NON|BRD|NLM (2003)|010831|abcdef", "ENTRY": "Sweet Marjorams", "MN": "B01.875.800.575.912.250.583.520.702", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39174", "RR": "txid452416", "MS": "A plant genus of the family Lamiaceae that is the source of familiar seasonings, oregano and marjoram.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031341"}, {"RECTYPE": "D", "MH": "Orthosiphon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Teas, Java", "MN": "B01.875.800.575.912.250.583.520.729", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid204150", "RR": "txid260636", "MS": "A plant genus of the family LAMIACEAE that contains pimarane-type diterpenes. Several species of Orthosiphon are also called Java tea.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031342"}, {"RECTYPE": "D", "MH": "Perilla", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.583.520.743", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid48385", "MS": "A plant genus of the family LAMIACEAE that is a source of perilla alcohol and the oil is rich in alpha-linolenic acid (alpha-18:3).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031343"}, {"RECTYPE": "D", "MH": "Perilla frutescens", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "frutescen, Perilla", "MN": "B01.875.800.575.912.250.583.520.743.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid48386", "MS": "A plant genus of the family LAMIACEAE that is an ingredient of Banxia Houpu (DRUGS, CHINESE HERBAL).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031344"}, {"RECTYPE": "D", "MH": "Phlomis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Phlomi", "MN": "B01.875.800.575.912.250.583.520.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid316257", "MS": "A plant genus of the family LAMIACEAE that contains phlorigidosides, iridoid glucosides and megastigmane glycosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031345"}, {"RECTYPE": "D", "MH": "Plectranthus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "barbatus, Plectranthus", "MN": "B01.875.800.575.912.250.583.520.753", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41227", "RR": "txid41228", "MS": "A plant genus of the family LAMIACEAE that contains eudesmane sesquiterpenes and antimicrobial abietane diterpenoids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031346"}, {"RECTYPE": "D", "MH": "Prunella", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Xiakucao|T002|NON|NRW|NLM (2003)|010831|abcdef", "ENTRY": "vulgaris, Prunella", "MN": "B01.875.800.575.912.250.583.520.755", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39176", "RR": "txid39358", "MS": "A plant genus of the family LAMIACEAE. Members contain TRITERPENES. Heal all is another common name.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031347"}, {"RECTYPE": "D", "MH": "Satureja", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Savory Plant|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Savory Plants", "MN": "B01.875.800.575.912.250.583.520.935", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid49986", "MS": "A plant genus of the family LAMIACEAE used to flavor food.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031362"}, {"RECTYPE": "D", "MH": "Scutellaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Skullcap", "MN": "B01.875.800.575.912.250.583.520.942", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4139", "MS": "A plant genus of the family Lamiaceae used in folk medicine.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031363"}, {"RECTYPE": "D", "MH": "Scutellaria baicalensis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Skullcap, Baikal|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Scutellariae radix|T002|NON|EQV|NLM (2003)|010904|abcdef", "MN": "B01.875.800.575.912.250.583.520.942.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid65409", "MS": "A plant species of the genus Scutellaria, family LAMIACEAE, that contains skullcap flavone and is used in CHINESE HERBAL DRUGS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031364"}, {"RECTYPE": "D", "MH": "Sideritis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ironwort|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Sideritides", "MN": "B01.875.800.575.912.250.583.520.945", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid155231", "MS": "A plant genus of the family LAMIACEAE that contains isoscutellarein-7-O-(allosyl(1-2)glucoside).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031365"}, {"RECTYPE": "D", "MH": "Stachys", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Nettle, Hedge|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Stachy", "MN": "B01.875.800.575.912.250.583.520.947", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid53171", "MS": "A plant genus of the family LAMIACEAE that has a characteristic odor.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031366"}, {"RECTYPE": "D", "MH": "Teucrium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Germander|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "poliums, Teucrium", "MN": "B01.875.800.575.912.250.583.520.948", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid21896", "RR": "txid53176", "MS": "A plant genus of the family Lamiaceae. Members contain teuscordonin. There have been reports of hepatotoxicity by this genus.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031367"}, {"RECTYPE": "D", "MH": "Zoster Sine Herpete", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Zoster Sine Eruptione|T047|NON|EQV|NLM (2003)|010904|abcdef", "MN": "C01.925.256.466.930.750.970", "MH_TH": "NLM (2003)", "ST": "T047", "PI": "Herpes Zoster Ophthalmicus (1995-2002)", "MS": "HERPES ZOSTER but without eruption of vesicles. Patients exhibit the characteristic pain minus the skin rash, sometimes making diagnosis difficult.", "PM": "2003", "HN": "2003", "MR": "20190617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031368"}, {"RECTYPE": "D", "MH": "Cryptocarya", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cryptocaryas", "MN": "B01.875.800.575.912.250.595.400.177", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid22027", "MS": "A plant genus of the family LAURACEAE. Members contain cryptofolione, caryachine, grandisin and other compounds. Some PEUMUS species have been reclassified as CRYPTOCARYA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031369"}, {"RECTYPE": "D", "MH": "Lecythidaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.341.968", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3642", "MS": "A plant family of the order Lecythidales, subclass Dilleniidae, class Magnoliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031381"}, {"RECTYPE": "D", "MH": "Barringtonia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Barringtonias", "MN": "B01.875.800.575.912.250.341.968.099", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid79556", "MS": "A plant genus of the family Lecythidaceae. Members contain nasimalun A and B (neo-clerodane diterpenoids).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031382"}, {"RECTYPE": "D", "MH": "Bertholletia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Brazil Nuts|T168|EPO|REL|NLM (2003)|010904|abcdef", "ENTRY": "excelsas, Bertholletia", "MN": "B01.875.800.575.912.250.341.968.133", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3644", "RR": "txid3645", "MS": "A plant genus of the family Lecythidaceae which is the source of edible Brazil nuts.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031383"}, {"RECTYPE": "D", "MH": "Polygonatum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Solomon Seal|T002|EPO|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Solomons Seal", "MN": "B01.875.800.575.912.250.618.100.060.650", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid16195", "AN": "note entry term SOLOMON'S SEAL: SOLOMON SEAL, FALSE see MAIANTHEMUM is also available", "MS": "A plant genus of the family Asparagaceae. Members contain benzoquinones, steroidal saponin, and ribosome-inactivating proteins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031384"}, {"RECTYPE": "D", "MH": "Maianthemum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Solomon Seal, False|T002|EPO|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Seal, False Solomon", "MN": "B01.875.800.575.912.250.618.100.060.560", "MH_TH": "NLM (2017)", "ST": "T002", "RN": "txid16150", "AN": "SMILACINA, FALSE and SOLOMON SEAL see POLYGONATUM is also available", "MS": "A plant genus of the family Asparagaceae. The cluster of flowers at the end of the stalk distinguishes this plant from \"true\" Solomon's seal (POLYGONATUM), which has flowers that grow along the stem.", "PM": "2017; see SMILACINA 2003-2016", "HN": "2017 (2003)", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031401"}, {"RECTYPE": "D", "MH": "Alstroemeria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lily, Peruvian|T002|EPO|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Peruvian Lily", "MN": "B01.875.800.575.912.250.618.875.088", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid56741", "MS": "A plant genus of the family Alstroemeriaceae. Members contain allergens, tuliposide A and tulipalin A.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031402"}, {"RECTYPE": "D", "MH": "Anemarrhena", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Anemarrhenae|T002|NON|EQV|NLM (2003)|020326|abcdef", "MN": "B01.875.800.575.912.250.618.100.060.048", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid59044", "MS": "A plant genus of the family Asparagaceae. Members contain anemarans (POLYSACCHARIDES), hinokiresinol, mangiferin (a xanthone), and timosaponin (a steroidal saponin).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031403"}, {"RECTYPE": "D", "MH": "Camassia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Camas|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Cama", "MN": "B01.875.800.575.912.250.618.100.060.125", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39523", "MS": "A plant genus of the family Asparagaceae that contains steroidal SAPONINS and should not be confused with death camas (ZIGADENUS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031404"}, {"RECTYPE": "D", "MH": "Convallaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lily-of-the-Valley|T002|NON|NRW|NLM (2003)|010904|abcdef", "ENTRY": "Lily-of-the-Valleys", "MN": "B01.875.800.575.912.250.618.100.060.188", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid16053", "RR": "txid32189", "MS": "A plant genus of the family Asparagaceae that contains CARDIAC GLYCOSIDES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031405"}, {"RECTYPE": "D", "MH": "Cordyline", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618.100.060.195", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39500", "MS": "A plant genus of the family Asparagaceae that contains spirostanol & furostanol SAPONINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031406"}, {"RECTYPE": "D", "MH": "Crinum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618.100.050.178", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid16055", "MS": "A plant genus of the family Amaryllidaceae that contains ALKALOIDS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031407"}, {"RECTYPE": "D", "MH": "Curculigo", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618.100.230.190", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4675", "MS": "A plant genus of the family Hypoxidaceae that contains curculin and cycloartane saponins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031408"}, {"RECTYPE": "D", "MH": "Dracaena", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618.100.060.250", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39502", "MS": "A plant genus of the family Asparagaceae. The common name of \"dragon's blood\" is also used for CROTON and Daemonorops (ARECACEAE).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031409"}, {"RECTYPE": "D", "MH": "Fritillaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fritillary|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Fritillaries", "MN": "B01.875.800.575.912.250.618.875.500.313", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid59070", "MS": "A plant genus of the family LILIACEAE. Members of this genus produce imperialine, a steroidal alkaloid which acts at muscarinic receptors.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031410"}, {"RECTYPE": "D", "MH": "Hemerocallis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Daylily|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Daylilies", "MN": "B01.875.800.575.912.250.618.100.970.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid16107", "MS": "A plant genus of the family ASPHODELACEAE. Members contain steroidal saponins.", "PM": "2003", "HN": "2003", "MR": "20220715", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031421"}, {"RECTYPE": "D", "MH": "Hosta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Hostas", "MN": "B01.875.800.575.912.250.618.100.060.375", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13090", "MS": "A plant genus of the family Asparagaceae. Members contain steroidal saponins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031422"}, {"RECTYPE": "D", "MH": "Hyacinthus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hyacinth|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Hyacinths", "MN": "B01.875.800.575.912.250.618.100.060.400", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid82024", "AN": "HYACINTH, WATER see EICHHORNIA is also available", "MS": "A plant genus of the family Hyacinthaceae (Asparagaceae). Do not confuse with water hyacinth (EICHHORNIA).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031423"}, {"RECTYPE": "D", "MH": "Liriope Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Liriope spicatum|T002|NON|NRW|NLM (2003)|010904|abcdef", "ENTRY": "Plants, Liriope", "MN": "B01.875.800.575.912.250.618.100.060.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39528", "RR": "txid39529", "MS": "A plant genus of the family Asparagaceae. Members contain ruscogenin. Do not confuse with the Liriope jellyfish (CNIDARIA).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031424"}, {"RECTYPE": "D", "MH": "Plasmodesmata", "AQ": "CH DE DG EN GE IM ME MI PH PS RE UL VI", "MN": "A11.284.149.165.420.625", "MH_TH": "NLM (2003)", "ST": "T002", "PI": "Cell Wall (1967-2002)", "MS": "Membrane-like channels of cytoplasm connecting adjacent plant cells. Plasmodesmata connect through pores in the CELL WALL and associate with the CYTOSKELETON machinery. They are essential for intercellular transport and communication.", "PM": "2003", "HN": "2003", "MR": "20180629", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031425"}, {"RECTYPE": "D", "MH": "Lycoris", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618.100.050.530", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid82236", "MS": "A plant genus of the family Amaryllidaceae. Members contain radiatine, vittatine, haemanthamine, lycorenine, dihydrolycorine, lycorine, lycoricidinol and lycoricidine.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031426"}, {"RECTYPE": "D", "MH": "Narcissus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Daffodil|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Daffodils", "MN": "B01.875.800.575.912.250.618.100.050.600", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4697", "MS": "A plant genus of the family Amaryllidaceae. Members contain ungiminorine and LECTINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031427"}, {"RECTYPE": "D", "MH": "Ophiopogon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Mondo Grasses", "MN": "B01.875.800.575.912.250.618.100.060.600", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid100502", "RR": "txid100506", "MS": "A plant genus of the family Asparagaceae. Members contain steroidal glycosides and provide an ingredient of shengmaisan (DRUGS, CHINESE HERBAL).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031441"}, {"RECTYPE": "D", "MH": "Ornithogalum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Star of Bethlehem|T002|EPO|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Ornithogalums", "MN": "B01.875.800.575.912.250.618.875.500.593", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid51466", "MS": "A plant genus of the family LILIACEAE that contains cholestane glycosides (CHOLESTANES).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031442"}, {"RECTYPE": "D", "MH": "Ruscus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Butcher's Broom|T002|NON|NRW|NLM (2003)|010904|abcdef", "ENTRY": "Butchers Broom", "MN": "B01.875.800.575.912.250.618.100.060.725", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid59066", "RR": "txid59067", "MS": "A plant genus of the family Asparagaceae. This should not be confused with Broom or Scotch Broom (CYTISUS) or Desert Broom (BACCHARIS) or Spanish Broom (SPARTIUM) or Brome (BROMUS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031443"}, {"RECTYPE": "D", "MH": "Sansevieria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618.100.060.800", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13667", "MS": "A plant genus of the family Asparagaceae that contains steroidal SAPONINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031444"}, {"RECTYPE": "D", "MH": "Scilla", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Squills, Siberian", "MN": "B01.875.800.575.912.250.618.100.060.810", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4701", "RR": "txid4702", "MS": "A plant genus of the family Asparagaceae. Members contain the cardiotonic PROSCILLARIDIN. The common name of squill is also used for DRIMIA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031445"}, {"RECTYPE": "D", "MH": "Trillium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Wakerobin|T002|NON|NRW|NLM (2003)|010904|abcdef", "ENTRY": "Wakerobins", "MN": "B01.875.800.575.912.250.618.875.625.860", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid49674", "RR": "txid50545", "MS": "A plant genus of the family Melanthiaceae that is a short plant with a distinct whorl of 3 broad leaves.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031446"}, {"RECTYPE": "D", "MH": "Tulipa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tulip|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Tulips", "MN": "B01.875.800.575.912.250.618.875.500.786", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13305", "MS": "A plant genus of the family LILIACEAE. Members contain tuliposides and tulipalins and have been associated with allergic contact dermatitis in florists.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031447"}, {"RECTYPE": "D", "MH": "Drimia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Urginea|T002|NON|REL|NLM (2003)|010904|abcdef", "ENTRY": "Urginea maritima|T002|NON|NRW|NLM (2003)|010904|abcdef", "MN": "B01.875.800.575.912.250.618.100.060.313", "MH_TH": "NLM (2017)", "ST": "T002", "RN": "txid65772", "RR": "txid82070", "MS": "A plant genus of the family Asparagaceae that contains bufadienolides (BUFANOLIDES). The common name of squill is also used for SCILLA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031448"}, {"RECTYPE": "D", "MH": "Zigadenus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Zygadenus|T002|NON|EQV|NLM (2003)|010904|abcdef", "MN": "B01.875.800.575.912.250.618.875.625.960", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid164831", "RR": "txid164840", "AN": "CAMAS see CAMASSIA is also available", "MS": "A plant genus of the family Melanthiaceae that is fatally toxic to grazing animals. The name is similar to another plant genus CAMASSIA.", "PM": "2003", "HN": "2003", "MR": "20230531", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031449"}, {"RECTYPE": "D", "MH": "Gelsemium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yellow-Jessamine|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Yellow-Jessamines", "MN": "B01.875.800.575.912.250.456.875.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid26478", "MS": "A plant genus of the family LOGANIACEAE (classified by some botanists as Gelsemiaceae). The sometimes used common name of trumpet flower is also used for DATURA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031450"}, {"RECTYPE": "D", "MH": "Strychnos", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Strychno", "MN": "B01.875.800.575.912.250.456.875.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid26496", "AN": "prefer specific plant", "MS": "A plant genus of the family LOGANIACEAE (classified by some botanists as Strychnaceae).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031451"}, {"RECTYPE": "D", "MH": "Strychnos nux-vomica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Strychninetree|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "nux-vomicas, Strychnos", "MN": "B01.875.800.575.912.250.456.875.750.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid28545", "MS": "A plant genus of the genus STRYCHNOS, family LOGANIACEAE that is the source of STRYCHNINE.", "PM": "2003; for NUX-VOMICA see STRYCHNINE 1979-2001, see NUX VOMICA 1963-1978", "HN": "2003; for NUX-VOMICA use STRYCHNINE 1979-2001, use NUX VOMICA 1963-1978", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031461"}, {"RECTYPE": "D", "MH": "Cynomorium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cynomoriums", "MN": "B01.875.800.575.912.250.106.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid51502", "MS": "A plant genus of the family BALANOPHORACEAE. Members contain stigmastanes and ursanes (TRITERPENES) and lignan glucopyranosides (LIGNANS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031482"}, {"RECTYPE": "D", "MH": "Capparaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Crateva|T002|NON|NRW|NLM (2003)|010907|abcdef", "ENTRY": "Cratevas", "MN": "B01.875.800.575.912.250.177", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid301453", "RR": "txid190805", "AN": "entry term CRATEVA: Crateva marmelos see AEGLE MARMELOS is also available", "MS": "A plant family of the order Capparales, subclass Dilleniidae, class Magnoliopsida, that are mostly herbs and shrubs growing in warm arid regions. Several produce GLUCOSINOLATES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031483"}, {"RECTYPE": "D", "MH": "Capparis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Capers|T168|NON|REL|NLM (2003)|010907|abcdef", "ENTRY": "Cappari", "MN": "B01.875.800.575.912.250.177.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13394", "MS": "A plant genus of the family CAPPARACEAE that contains mabinlin, a sweet protein.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031484"}, {"RECTYPE": "D", "MH": "Cleome", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cleomes", "MN": "B01.875.800.575.912.250.177.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid25782", "MS": "A plant genus of the family CAPPARACEAE that contains cleogynol and 15alpha-acetoxycleomblynol (dammaranes) and 1-epibrachyacarpone (a triterpene), and ISOTHIOCYANATES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031485"}, {"RECTYPE": "D", "MH": "Gleditsia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gleditsia japonica|T002|NON|NRW|NLM (2003)|010912|abcdef", "ENTRY": "japonica, Gleditsia", "MN": "B01.875.800.575.912.250.401.275", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid54873", "RR": "txid66093", "AN": "note entry term  FAGARA HORRIDA: FAGARA, unspecified index RUTACEAE", "MS": "A plant genus of the family FABACEAE that contains gleditsiosides (triterpenoid SAPONINS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031501"}, {"RECTYPE": "D", "MH": "Fractionation, Field Flow", "AQ": "IS MT", "PRINT ENTRY": "Sedimentation Field Flow Fractionation|T059|NON|NRW|NLM (2003)|010913|abcdef", "ENTRY": "SdFFF|T059|NON|NRW|NLM (2003)|010913|abcdef", "MN": "E05.196.155.500", "MH_TH": "NLM (2003)", "ST": "T059", "AN": "DOSE FRACTIONATION, RADIATION and CELL FRACTIONATION are also available", "PI": "Fractionation (1980-2002)", "MS": "Separation of molecules and particles by a simultaneous action of carrier liquid flow and focusing field forces (electrical, sedimentation, or thermal), without a stationary phase.", "PM": "2003", "HN": "2003", "MR": "20180713", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031521"}, {"RECTYPE": "D", "MH": "Fluorescence Resonance Energy Transfer", "DE": "FRET", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Forster Resonance Energy Transfer|T059|EPO|EQV|NLM (2008)|060915|abcdef", "MN": "G02.111.255.280", "MH_TH": "NLM (2003)", "ST": "T059", "AN": "coordinate with MICROSCOPY or specifics if appropriate", "PI": "Spectrometry, Fluorescence (1971-2002)", "MS": "A type of FLUORESCENCE SPECTROSCOPY using two FLUORESCENT DYES with overlapping emission and absorption spectra, which is used to indicate proximity of labeled molecules. This technique is useful for studying interactions of molecules and PROTEIN FOLDING.", "PM": "2003", "HN": "2003", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031541"}, {"RECTYPE": "D", "MH": "Lythrum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lythrum virgatum|T002|NON|NRW|NLM (2023)|220120|abcdef", "ENTRY": "Purple Loosestrifes", "MN": "B01.875.800.575.912.250.859.833.500.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13128", "RR": "txid907234", "MS": "A plant genus of the family LYTHRACEAE that contains ALKALOIDS. Common name loosestrife refers to members Lythrum \u200b(purple loosestrife) and LYSIMACHIA (e.g., yellow loosestrife).", "PM": "2003", "HN": "2003", "MR": "20220523", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031561"}, {"RECTYPE": "D", "MH": "Cuphea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cupheas", "MN": "B01.875.800.575.912.250.859.833.500.249", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3929", "MS": "A plant genus of the family LYTHRACEAE. Members contain lauric acid and cuphiin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031562"}, {"RECTYPE": "D", "MH": "Lagerstroemia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Lagerstroemias", "MN": "B01.875.800.575.912.250.859.833.500.374", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid122809", "MS": "A plant genus of the family LYTHRACEAE. Members contain lagertannin and have hypoglycemic effects.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031563"}, {"RECTYPE": "D", "MH": "Lawsonia Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Henna Plant|T002|NON|NRW|NLM (2003)|010914|abcdef", "ENTRY": "inermi, Lawsonia", "MN": "B01.875.800.575.912.250.859.833.500.437", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid141190", "RR": "txid141191", "MS": "A plant genus of the family LYTHRACEAE that is the source of henna and has cytotoxic activity.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031564"}, {"RECTYPE": "D", "MH": "Woodfordia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Woodfordias", "MN": "B01.875.800.575.912.250.859.833.500.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid141188", "MS": "A plant genus of the family LYTHRACEAE. Members contain woodfordins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031565"}, {"RECTYPE": "D", "MH": "Magnolia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sweet Bay|T002|NON|NRW|NLM (2003)|010914|abcdef", "ENTRY": "virginianas, Magnolia", "MN": "B01.875.800.575.912.250.685.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3402", "RR": "txid85864", "MS": "A plant genus of the family MAGNOLIACEAE. The germacranolide sesquiterpene lactones costunolide, parthenolide, and costunolide diepoxide have been isolated from the leaves. Bark contains honokiol and magnolol. Parts are an ingredient of Banxia Houpo Tang.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031566"}, {"RECTYPE": "D", "MH": "Liriodendron", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tulip Tree|T002|NON|NRW|NLM (2003)|010914|abcdef", "ENTRY": "tulipiferas, Liriodendron", "MN": "B01.875.800.575.912.250.685.249", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3413", "RR": "txid3415", "AN": "entry term YELLOW POPLAR: POPLAR, TRUE see POPULUS is also available", "MS": "A plant genus of the family MAGNOLIACEAE. Members include hardwood trees of eastern North America with distinct large tuliplike flowers.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031567"}, {"RECTYPE": "D", "MH": "Banisteriopsis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ayahuasca|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Banisteriopses", "MN": "B01.875.800.575.912.250.859.797.690.099", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid151794", "MS": "A plant genus of the family MALPIGHIACEAE which includes an Amazonian psychoactive plant that contains the beta-carboline harmine and N,N-dimethyltryptamine.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031581"}, {"RECTYPE": "D", "MH": "Galphimia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "glauca, Galphimia", "MN": "B01.875.800.575.912.250.859.797.690.355", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid112832", "RR": "txid212252", "MS": "A plant genus of the family MALPIGHIACEAE. G. glauca is the source of 'Galphimia glauca extract' and contains 'galphimine B' and tetragalloylquinic acid.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031582"}, {"RECTYPE": "D", "MH": "Althaea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Marshmallow|T002|NON|NRW|NLM (2003)|010917|abcdef", "ENTRY": "White Mallows", "MN": "B01.875.800.575.912.250.859.821.500.115", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid145744", "RR": "txid145745", "MS": "A plant genus of the family MALVACEAE known for mucilaginous roots. The common names of hollyhock and mallow are also used for other genera of MALVACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031583"}, {"RECTYPE": "D", "MH": "Hibiscus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Kenaf|T002|NON|NRW|NLM (2003)|010917|abcdef", "ENTRY": "Roselles", "MN": "B01.875.800.575.912.250.859.821.500.288", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid47605", "RR": "txid229543", "MS": "A plant genus of the family MALVACEAE. Members contain CITRIC ACID; MALATES; ANTHOCYANINS; FLAVONOIDS; GLYCOSIDES; DIETARY FIBER; and LIGNANS. Hibiscus sabdariffa is common constituent of HERBAL TEAS. Hibiscus cannabinus is a source of hemp fiber for TEXTILES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031584"}, {"RECTYPE": "D", "MH": "Melia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Melias", "MN": "B01.875.800.575.912.250.715.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43708", "MS": "A plant genus of the family MELIACEAE. Members contain meliavolkinin, melianin C and limonoids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031585"}, {"RECTYPE": "D", "MH": "Melia azedarach", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Chinaberry Tree|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "azedarachs, Melia", "MN": "B01.875.800.575.912.250.715.500.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid155640", "AN": "MELIA AZEDARACH see AZADIRACHTA is also available", "MS": "A plant species of the genus MELIA, family MELIACEAE, which is toxic to insects. The name is very similar to Melia azadirachta (AZADIRACHTA).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031586"}, {"RECTYPE": "D", "MH": "Cedrela", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cedrelas", "MN": "B01.875.800.575.912.250.715.249", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid124946", "MS": "A plant genus of the family MELIACEAE. Members contain cedrelanolide.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031587"}, {"RECTYPE": "D", "MH": "Azadirachta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Neem Tree|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "indicas, Azadirachta", "MN": "B01.875.800.575.912.250.715.124", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid124942", "RR": "txid124943", "AN": "entry term MELIA AZADIRACHTA: MELIA AZEDARACH is also available", "MS": "A plant genus of the family MELIACEAE. Members contain azadirachtin A (a limonoid commonly referred to as azadirachtin) and other TRITERPENES. They have been used in PESTICIDES. The old name of Melia azadirachta is very similar to a related plant, MELIA AZEDARACH.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031601"}, {"RECTYPE": "D", "MH": "Aglaia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Aglaias", "MN": "B01.875.800.575.912.250.715.061", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid201006", "MS": "A plant genus of the family MELIACEAE. Members contain lariciresinol, pregnanes, insecticidal rocaglamide derivatives and other compounds.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031602"}, {"RECTYPE": "D", "MH": "Menispermum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Parilla, Yellow|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "dauricums, Menispermum", "MN": "B01.875.800.575.912.250.725.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid49680", "RR": "txid49683", "MS": "A plant genus of the family MENISPERMACEAE. Members contain dauricine and other ALKALOIDS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031603"}, {"RECTYPE": "D", "MH": "Cyclea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cycleas", "MN": "B01.875.800.575.912.250.725.249", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid152372", "MS": "A plant genus of the family MENISPERMACEAE. Members contain bisbenzylisoquinoline alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031604"}, {"RECTYPE": "D", "MH": "Cocculus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.725.124", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13440", "MS": "A plant genus of the family MENISPERMACEAE. Members contain sinococuline, coccuvine and other ALKALOIDS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031605"}, {"RECTYPE": "D", "MH": "Cissampelos", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cissampelo", "MN": "B01.875.800.575.912.250.725.111", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid108408", "MS": "A plant genus of the family MENISPERMACEAE. Members contain eletefine (a stephaoxocane alkaloid) and tropoloisoquinoline and protoberberine ALKALOIDS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031606"}, {"RECTYPE": "D", "MH": "Stephania", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Stephanias", "MN": "B01.875.800.575.912.250.725.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid147243", "MS": "A plant genus of the family MENISPERMACEAE. Members contain cycleanine.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031607"}, {"RECTYPE": "D", "MH": "Area Postrema", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Zones, Chemoreceptor Trigger", "MN": "A08.713.049.500", "MH_TH": "NLM (2003)", "ST": "T023", "PI": "Medulla Oblongata (1966-2002)", "MS": "A small, rounded eminence on each side of the FOURTH VENTRICLE, which receives nerve fibers from the SOLITARY NUCLEUS; SPINAL CORD; and adjacent areas of the MEDULLA OBLONGATA. The area postrema lies outside the BLOOD-BRAIN BARRIER and its functions include acting as an emetic chemoreceptor.", "PM": "2003", "HN": "2003", "MR": "20150622", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031608"}, {"RECTYPE": "D", "MH": "Stephania tetrandra", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "tetrandras, Stephania", "MN": "B01.875.800.575.912.250.725.750.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid425106", "MS": "A plant species of the genus STEPHANIA, family MENISPERMACEAE, that contains tetrandrine and bisbenzylisoquinoline alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031609"}, {"RECTYPE": "D", "MH": "Tinospora", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Tinosporas", "MN": "B01.875.800.575.912.250.725.875", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41789", "MS": "A plant genus of the family MENISPERMACEAE. Members have been used in AYURVEDIC MEDICINE. Hypoglycemic effect has been reported.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031610"}, {"RECTYPE": "D", "MH": "Peumus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Boldo|T002|NON|NRW|NLM (2003)|010917|abcdef", "ENTRY": "fragrans, Boldea", "MN": "B01.875.800.575.912.250.595.600.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid63802", "RR": "txid63812", "MS": "A plant genus of the family MONIMIACEAE. Members contain boldine ALKALOIDS. Some PEUMUS species have been reclassified as CRYPTOCARYA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031611"}, {"RECTYPE": "D", "MH": "Antiaris", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Antiari", "MN": "B01.875.800.575.912.250.859.937.406.055", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid241856", "MS": "A plant genus of the family MORACEAE. Members have been used as an arrow poison.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031621"}, {"RECTYPE": "D", "MH": "Artocarpus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Jackfruit Plant|T002|NON|NRW|NLM (2024)|230308|abcdef", "ENTRY": "Jackfruits", "MN": "B01.875.800.575.912.250.859.937.406.088", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3488", "RR": "txid3489", "MS": "A plant genus of the family MORACEAE. Puag-haad extract, from A. lakoocha, contains STILBENES and related 4-substituted RESORCINOLS.", "PM": "2003", "HN": "2003", "MR": "20230405", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031622"}, {"RECTYPE": "D", "MH": "Broussonetia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Broussonetias", "MN": "B01.875.800.575.912.250.859.937.406.144", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid66379", "MS": "A plant genus of the family MORACEAE. Members contain PYRROLIDINES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031623"}, {"RECTYPE": "D", "MH": "Maclura", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Osage Orange|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Osage Oranges", "MN": "B01.875.800.575.912.250.859.937.406.599", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3495", "MS": "A plant genus of the family MORACEAE. Members contain maclurin, antifungal chalcones, and other compounds.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031624"}, {"RECTYPE": "D", "MH": "Morus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mulberry|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Mulberries", "MN": "B01.875.800.575.912.250.859.937.406.633", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3497", "MS": "A plant genus of the family MORACEAE that is widely planted for shade.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031625"}, {"RECTYPE": "D", "MH": "Myrica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sweet Gale|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Sweet Gales", "MN": "B01.875.800.575.912.250.859.750.700.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3509", "AN": "entry term BOG MYRTLE: MYRTLE see MYRTUS is also available", "MS": "A plant genus of the family MYRICACEAE. Members contain myricanol. The common name of bayberry is similar to the name barberry which is used for BERBERIS and MAHONIA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031641"}, {"RECTYPE": "D", "MH": "Myoporaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.756", "MH_TH": "NLM (2003)", "ST": "T002", "AN": "prefer specific plant", "MS": "A plant family of the order Scrophulariales, subclass Asteridae, class Magnoliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031642"}, {"RECTYPE": "D", "MH": "Myoporum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Boobialla|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Myoporums", "MN": "B01.875.800.575.912.250.583.800.490", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid57115", "MS": "A plant genus of the family MYOPORACEAE. Members contain dehydrongaione, deisopropylngaione, dehydromyodesmone and other furanoid sesquiterpene essential oils. It is the source of Ngaio oil and ngaione.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031643"}, {"RECTYPE": "D", "MH": "Ardisia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Marlberry|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Marlberries", "MN": "B01.875.800.575.912.250.341.984.324", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13344", "MS": "A plant genus of the family MYRSINACEAE. Members contain ardisiacrispins (oleanane triterpenoid saponins), ardicrenin, and cyclamiretin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031644"}, {"RECTYPE": "D", "MH": "Embelia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Embelias", "MN": "B01.875.800.575.912.250.341.984.662", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid459628", "MS": "A plant genus of the family MYRSINACEAE. Members contain embelin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031645"}, {"RECTYPE": "D", "MH": "Feijoa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pineapple Guava|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Pineapple Guavas", "MN": "B01.875.800.575.912.250.773.522", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid260129", "AN": "GUAVA see PSIDIUM is also available", "MS": "A plant genus of the family MYRTACEAE that is cultivated for the edible fruit, which is different from the ordinary guava (PSIDIUM).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031646"}, {"RECTYPE": "D", "MH": "Psidium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Guava|T168|NON|REL|NLM (2003)|010917|abcdef", "ENTRY": "guajava, Psidium", "MN": "B01.875.800.575.912.250.773.888", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid120289", "RR": "txid120290", "AN": "entry term GUAVA: PINEAPPLE GUAVA see FEIJOA is also available", "MS": "A plant genus of the family MYRTACEAE that bears an edible fruit and contains guavin B and quercetin glycosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031647"}, {"RECTYPE": "D", "MH": "Kunzea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Kanuka|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Kunzeas", "MN": "B01.875.800.575.912.250.773.649", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid106040", "MS": "A plant genus of the family MYRTACEAE. The common name of tea tree more often refers to MELALEUCA or LEPTOSPERMUM.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031648"}, {"RECTYPE": "D", "MH": "Leptospermum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "New Zealand Manuka|T002|EPO|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Zealand Manuka, New", "MN": "B01.875.800.575.912.250.773.713", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid106047", "MS": "A plant genus of the family MYRTACEAE. The common name of tea tree is also used for MELALEUCA and KUNZEA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031649"}, {"RECTYPE": "D", "MH": "Melaleuca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Niaouli|T002|NON|NRW|NLM (2003)|010917|abcdef", "ENTRY": "vindifolias, Melaleuca", "MN": "B01.875.800.575.912.250.773.745", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid164925", "RR": "txid164936", "MS": "A plant genus of the family MYRTACEAE. M. alternifolia foliage is a source of TEA TREE OIL. The common name of tea tree also refers to LEPTOSPERMUM or KUNZEA. M. vindifolia is a source of niaouli oil. M. cajuputi and M. leucadendra are sources of cajuput oil.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031650"}, {"RECTYPE": "D", "MH": "Myrtus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Myrtle|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Myrtles", "MN": "B01.875.800.575.912.250.773.761", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid119948", "AN": "entry term MYRTLE: BOG MYRTLE see MYRICA is also available", "MS": "A plant genus of the family MYRTACEAE. Members contain PHYTOHEMAGGLUTININS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031651"}, {"RECTYPE": "D", "MH": "Nelumbonaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.774", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4429", "AN": "prefer specific plant", "MS": "A plant family of the order Nymphaeales, subclass Magnoliidae, class Magnoliopsida. They are aquatic plants.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031652"}, {"RECTYPE": "D", "MH": "Nelumbo", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Lotus, Sacred", "MN": "B01.875.800.575.912.250.774.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4430", "RR": "txid4432", "AN": "lotus seeds or lotus nuts: coordinate NELUMBO with SEEDS or NUTS", "MS": "A plant genus of the family NELUMBONACEAE. The common name lotus is also used for other plants such as the WATER-LILY, which they resemble, and the unrelated genus Lotus (LOTUS). Nelumbo produce the edible lotus nuts.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031653"}, {"RECTYPE": "D", "MH": "Nuphar", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pond Lily, Yellow|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Yellow Pond Lily", "MN": "B01.875.800.575.912.250.776.488", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4415", "MS": "A plant genus of the family NYMPHAEACEAE. Members contain sesquiterpene thioalkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031654"}, {"RECTYPE": "D", "MH": "Nyssa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tupelo|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Tupelos", "MN": "B01.875.800.575.912.250.778.594", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4290", "MS": "A plant genus of the family Nyssaceae. Named for the water nymph from classical mythology, these species grow in moist habitats and are tolerant of flooding.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031655"}, {"RECTYPE": "D", "MH": "Olacaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ximenia|T002|NON|NRW|NLM (2003)|010917|abcdef", "ENTRY": "Ximenias", "MN": "B01.875.800.575.912.250.780", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3973", "RR": "txid50173", "AN": "prefer specific plant", "MS": "A small plant family of the order Santalales, subclass Rosidae, class Magnoliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031656"}, {"RECTYPE": "D", "MH": "Forsythia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Goldenbells|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Goldenbell", "MN": "B01.875.800.575.912.250.583.640.333", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid55182", "MS": "A plant genus of the family OLEACEAE. Members contain suspensaside.", "PM": "2003", "HN": "2003", "MR": "20230609", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031657"}, {"RECTYPE": "D", "MH": "Olea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Olives|T168|NON|REL|NLM (2003)|011004|abcdef", "ENTRY": "Trees, Olive", "MN": "B01.875.800.575.912.250.583.640.666", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4145", "RR": "txid4146", "AN": "OLIVE, RUSSIAN see ELAEAGNACEAE is also available", "MS": "A plant genus of the family Oleaceae. The olive fruit is the source of OLIVE OIL.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031658"}, {"RECTYPE": "D", "MH": "Ligustrum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Privet|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "lucidus, Ligustri", "MN": "B01.875.800.575.912.250.583.640.499", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13596", "RR": "txid458695", "MS": "A plant genus of the family OLEACEAE. Oleuropein, a phenolic secoiridoid glycoside, is found in the leaves.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031659"}, {"RECTYPE": "D", "MH": "Jasminum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Jasmine|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Jasminums", "MN": "B01.875.800.575.912.250.583.640.416", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4147", "MS": "A plant genus of the family OLEACEAE. Members contain secoiridoid glucosides and this is the source of oil of jasmine.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031660"}, {"RECTYPE": "D", "MH": "Fraxinus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ash, Common|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Trees, Ash", "MN": "B01.875.800.575.912.250.583.640.374", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid38871", "RR": "txid38874", "MS": "A plant genus of the family OLEACEAE. Members contain secoiridoid glucosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031661"}, {"RECTYPE": "D", "MH": "Syringa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Syringas", "MN": "B01.875.800.575.912.250.583.640.833", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid24208", "MS": "A plant genus of the family OLEACEAE. Oleuropein has been identified in the stem bark.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031662"}, {"RECTYPE": "D", "MH": "Clarkia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.786.222", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3935", "MS": "A plant genus, of the family ONAGRACEAE, which is the subject of genetic studies. The floral aroma is attributed to benzenoid esters and benzyl acetate.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031663"}, {"RECTYPE": "D", "MH": "Oenothera", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Oenotheras", "MN": "B01.875.800.575.912.250.786.611", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3939", "MS": "A plant genus of the family ONAGRACEAE. Members contain oenotheins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031664"}, {"RECTYPE": "D", "MH": "Oenothera biennis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Primrose, Evening|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "biennis, Oenothera", "MN": "B01.875.800.575.912.250.786.611.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3942", "MS": "A plant species, of the genus OENOTHERA, family ONAGRACEAE, that is the source of evening primrose oil.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031665"}, {"RECTYPE": "D", "MH": "Epilobium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Epilobiums", "MN": "B01.875.800.575.912.250.786.416", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13054", "MS": "A plant genus of the family ONAGRACEAE. The common name of fireweed is also used with other plants.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031666"}, {"RECTYPE": "D", "MH": "Dendrobium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Dendrobiums", "MN": "B01.875.800.575.912.250.618.100.640.222", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid37818", "MS": "A plant genus of the family ORCHIDACEAE that contains dihydroayapin (COUMARINS) and phenanthraquinones.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031667"}, {"RECTYPE": "D", "MH": "Gastrodia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tien ma|T002|NON|NRW|NLM (2003)|010917|abcdef", "ENTRY": "Gastrodias", "MN": "B01.875.800.575.912.250.618.100.640.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid91200", "RR": "txid91201", "MS": "A plant genus of the family ORCHIDACEAE which depends on the fungus Armillaria mellea to complete its life cycle. It is an ingredient of Zhenxuanyin (DRUGS, CHINESE HERBAL).", "PM": "2003; GASTRODIA ELATA EXTRACT was indexed under DRUGS, CHINESE HERBAL 2002-2004", "HN": "2003(2002)", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031668"}, {"RECTYPE": "D", "MH": "Vanilla", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.618.100.640.888", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid51238", "MS": "A plant genus of the family ORCHIDACEAE that is the source of the familiar flavoring used in foods and medicines (FLAVORING AGENTS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031669"}, {"RECTYPE": "D", "MH": "Orobanchaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Paintbrush, Indian|T002|EPO|NRW|NLM (2003)|010823|abcdef", "ENTRY": "Indian Paintbrush|T002|EPO|NRW|NLM (2003)|010823|abcdef", "MN": "B01.875.800.575.912.250.583.670", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid91896", "RR": "txid46036", "MS": "The broom-rape plant family of the order Lamiales.", "PM": "2003; for CASTILLEJA see ACANTHACEAE 2003-2015", "HN": "2003; for CASTILLEJA use ACANTHACEAE 2003-2015", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031670"}, {"RECTYPE": "D", "MH": "Cistanche", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cistanches", "MN": "B01.875.800.575.912.250.583.670.175", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid87753", "MS": "A plant genus of the family OROBANCHACEAE. Members contain phenylethanoid glycosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031671"}, {"RECTYPE": "D", "MH": "Orobanche", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Broomrape|T002|NON|EQV|NLM (2003)|010917|abcdef", "ENTRY": "Rapes, Broom", "MN": "B01.875.800.575.912.250.583.670.670", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid36747", "AN": "note entry term BROOM RAPE: other broom terms are also available", "MS": "A plant genus of the family OROBANCHACEAE. Lacking chlorophyll, they are nonphotosynthetic parasitic plants. The common name is similar to Broom or Scotch Broom (CYTISUS) or Butcher's Broom (RUSCUS) or Desert Broom (BACCHARIS) or Spanish Broom (SPARTIUM) or Brome (BROMUS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031672"}, {"RECTYPE": "D", "MH": "Pandanaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pandanus|T002|NON|NRW|NLM (2003)|010917|abcdef", "MN": "B01.875.800.575.912.250.792", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4724", "RR": "txid4725", "AN": "prefer specific plant", "MS": "A plant family of the order Pandanales, subclass Arecidae, class Liliopsida (monocotyledons).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031673"}, {"RECTYPE": "D", "MH": "Argemone", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Prickly Poppy|T002|NON|NRW|NLM (2003)|010917|abcdef", "ENTRY": "mexicana, Argemone", "MN": "B01.875.800.575.912.250.836.500.124", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid54795", "RR": "txid54796", "MS": "A plant genus of the family PAPAVERACEAE that contains isoquinoline alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031674"}, {"RECTYPE": "D", "MH": "Eschscholzia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Poppy, California|T002|NON|NRW|NLM (2003)|010917|abcdef", "ENTRY": "californicas, Eschscholzia", "MN": "B01.875.800.575.912.250.836.500.374", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3466", "RR": "txid3467", "MS": "A plant genus of the family PAPAVERACEAE that contains benzo[c]phenanthridine alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031675"}, {"RECTYPE": "D", "MH": "Sanguinaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bloodroot|T002|NON|NRW|NLM (2003)|010918|abcdef", "ENTRY": "Redroots", "MN": "B01.875.800.575.912.250.836.500.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3471", "RR": "txid3472", "AN": "note entry term REDROOT: REDROOT PIGWEED see AMARANTHUS is also available ", "MS": "A plant genus of the family PAPAVERACEAE, a species of which is the source of sanguinarine extract used in MOUTHWASHES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031681"}, {"RECTYPE": "D", "MH": "Passifloraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.803", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3683", "AN": "prefer specific plant", "MS": "A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida that are herbaceous or woody vines, shrubs, and trees, mostly of warm regions. Many have tendrils in leaf axils. Leaves are alternate. Flowers have 3-5 sepals, petals and stamens. Nearly all species have seeds that bear a fleshy appendage called an aril.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031683"}, {"RECTYPE": "D", "MH": "Harpagophytum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Uncaria procumbens|T002|NON|NRW|NLM (2003)|010918|abcdef", "ENTRY": "procumbens, Uncaria", "MN": "B01.875.800.575.912.250.583.690.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4183", "RR": "txid222879", "MS": "A plant genus of the family PEDALIACEAE. Members contain harpagoside.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031684"}, {"RECTYPE": "D", "MH": "Sesamum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sesame|T168|NON|REL|NLM (2003)|010918|abcdef", "ENTRY": "Sesamums", "MN": "B01.875.800.575.912.250.583.690.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4181", "RR": "txid4182", "MS": "A plant genus of the family PEDALIACEAE that is the source of the edible seed and SESAME OIL.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031685"}, {"RECTYPE": "D", "MH": "Tagetes", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Tagete", "MN": "B01.875.800.575.912.250.100.853", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13707", "MS": "A plant genus of the family ASTERACEAE. The common name of marigold is also used for CALENDULA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031686"}, {"RECTYPE": "D", "MH": "Piper", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pepper, Jaborandi|T002|NON|NRW|NLM (2003)|010918|abcdef", "ENTRY": "Pipers", "MN": "B01.875.800.575.912.250.812.666", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13215", "RR": "txid511543", "MS": "A plant genus of the family PIPERACEAE that includes species used for spicy and stimulating qualities.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031701"}, {"RECTYPE": "D", "MH": "Agropyron", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Agropyrons", "MN": "B01.875.800.575.912.250.822.033", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4592", "MS": "A plant genus of the family POACEAE. The common name of wheatgrass is also used for other plants in the family.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031702"}, {"RECTYPE": "D", "MH": "Agrostis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bentgrass|T002|NON|EQV|NLM (2003)|010918|abcdef", "ENTRY": "Bentgrasses", "MN": "B01.875.800.575.912.250.822.044", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid15297", "MS": "A plant genus of the family POACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031703"}, {"RECTYPE": "D", "MH": "Piper betle", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "betles, Piper", "MN": "B01.875.800.575.912.250.812.666.374", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13217", "MS": "A plant genus of the family PIPERACEAE that is indigenous in the Indian Malay region and cultivated in Madagascar, and the West Indies. It contains chavibetol, chavicol and cadinene. The leaf is chewed as a stimulant, antiseptic and sialogogue. The common name of betel is also used for ARECA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031721"}, {"RECTYPE": "D", "MH": "Andropogon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Andropogons", "MN": "B01.875.800.575.912.250.822.055", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid15314", "AN": "ANDROPOGON NARDUS see CYMBOPOGON is also available ", "MS": "A plant genus of the family POACEAE. The common name of bluestem is also used for other plants in this family. Andropogon nardus has been reclassified as CYMBOPOGON nardus and Andropogon zizanioides as Chrysopogon zizanioides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031722"}, {"RECTYPE": "D", "MH": "Bambusa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Bambusas", "MN": "B01.875.800.575.912.250.822.066", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4581", "MS": "A plant genus of the family POACEAE. Young shoots are eaten in Asian foods while the stiff mature stems are used for construction of many things. The common name of bamboo is also used for other genera of Poaceae including Phyllostachys, SASA, and Dendrocalamus.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031723"}, {"RECTYPE": "D", "MH": "Bromus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bromegrass|T002|NON|EQV|NLM (2003)|010918|abcdef", "ENTRY": "Bromes", "MN": "B01.875.800.575.912.250.822.077", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4501", "AN": "do not confuse with Broom terms in MeSH", "MS": "A plant genus of the family POACEAE. The name is similar to Broom or Scotch Broom (CYTISUS) or Butcher's Broom (RUSCUS) or Desert Broom (BACCHARIS) or Spanish Broom (SPARTIUM).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031724"}, {"RECTYPE": "D", "MH": "Cenchrus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sandbur|T002|NON|EQV|NLM (2003)|010918|abcdef", "ENTRY": "Sandburs", "MN": "B01.875.800.575.912.250.822.151", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4583", "MS": "A plant genus of the family POACEAE. The common name of buffelgrass is also used for PENNISETUM.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031741"}, {"RECTYPE": "D", "MH": "Coix", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Job's Tears|T002|EPO|EQV|NLM (2003)|010918|abcdef", "ENTRY": "lachryma-jobus, Coix", "MN": "B01.875.800.575.912.250.822.227", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4504", "RR": "txid4505", "MS": "A plant genus of the family POACEAE. The seed is used in folk medicine (DRUGS, CHINESE HERBAL).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031742"}, {"RECTYPE": "D", "MH": "Cymbopogon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lemongrass|T002|NON|NRW|NLM (2003)|010918|abcdef", "ENTRY": "Lemongrasses", "MN": "B01.875.800.575.912.250.822.266", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid66013", "RR": "txid79840", "MS": "A plant genus of the family POACEAE which is a source of citronella oil and lemongrass oil.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031743"}, {"RECTYPE": "D", "MH": "Cynodon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Grass, Bermuda|T002|NON|EQV|NLM (2003)|010918|abcdef", "ENTRY": "Grasses, Bermuda", "MN": "B01.875.800.575.912.250.822.288", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid15437", "MS": "A plant genus of the family POACEAE that is considered a lawn grass by some and a weed by others. It contains allergen Cyn d 7.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031744"}, {"RECTYPE": "D", "MH": "Dactylis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Orchardgrass|T002|NON|EQV|NLM (2003)|010918|abcdef", "ENTRY": "Orchardgrasses", "MN": "B01.875.800.575.912.250.822.299", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4508", "MS": "A plant genus of the family POACEAE that contains allergen Dac g I.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031745"}, {"RECTYPE": "D", "MH": "Digitaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Grass, Crab|T002|NON|EQV|NLM (2003)|010918|abcdef", "ENTRY": "Grasses, Crab", "MN": "B01.875.800.575.912.250.822.311", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid66017", "MS": "A plant genus of the family POACEAE that many people consider to be a weed.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031746"}, {"RECTYPE": "D", "MH": "Echinochloa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Millet, Japanese|T002|NON|EQV|NLM (2003)|010918|abcdef", "ENTRY": "Millets, Japanese", "MN": "B01.875.800.575.912.250.822.322", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid45618", "MS": "A plant genus of the family POACEAE that is grown mainly as a hay crop.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031747"}, {"RECTYPE": "D", "MH": "Eleusine", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Millet, Koracan|T002|NON|NRW|NLM (2003)|010918|abcdef", "ENTRY": "indicas, Eleusine", "MN": "B01.875.800.575.912.250.822.333", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4510", "RR": "txid4511", "MS": "A plant genus of the family POACEAE. Finger millet or raggee (E. coracana) is an important food grain in southern Asia and parts of Africa.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031748"}, {"RECTYPE": "D", "MH": "Elymus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.822.344", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid15492", "MS": "A plant genus of the family POACEAE. The common name of wild rye is used with some other grasses.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031749"}, {"RECTYPE": "D", "MH": "Eragrostis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Teff|T002|NON|EQV|NLM (2003)|010918|abcdef", "ENTRY": "Teffs", "MN": "B01.875.800.575.912.250.822.355", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid38413", "MS": "A plant genus of the family POACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031750"}, {"RECTYPE": "D", "MH": "Festuca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Festucas", "MN": "B01.875.800.575.912.250.822.427", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4605", "MS": "A plant genus of the family POACEAE. The common name of fescue is also used with some other grasses.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031751"}, {"RECTYPE": "D", "MH": "Holcus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Velvetgrass|T002|NON|EQV|NLM (2003)|010918|abcdef", "ENTRY": "Velvetgrasses", "MN": "B01.875.800.575.912.250.822.463", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid15560", "MS": "A plant genus of the family POACEAE that contains Hol l 1 and Hol l 5 allergens.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031752"}, {"RECTYPE": "D", "MH": "Paspalum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Millet, Kodo|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "Paspalums", "MN": "B01.875.800.575.912.250.822.744", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid147271", "AN": "entry term MILLET, KODO: other millet terms are also available", "MS": "A plant genus of the family POACEAE that is used for forage.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031781"}, {"RECTYPE": "D", "MH": "Pennisetum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Millet, Pearl|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "Pennisetums", "MN": "B01.875.800.575.912.250.822.755", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4541", "MS": "A plant genus of the family POACEAE. The seed is one of the millets used in EDIBLE GRAIN. It contains vitexin. The common name of buffelgrass is also used for CENCHRUS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031782"}, {"RECTYPE": "D", "MH": "Phalaris", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Grass, Canary|T002|NON|EQV|NLM (2003)|011116|abcdef", "ENTRY": "Phalari", "MN": "B01.875.800.575.912.250.822.777", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid15740", "MS": "A plant genus of the family POACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031783"}, {"RECTYPE": "D", "MH": "Phleum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Timothy Grass|T002|NON|EQV|NLM (2003)|011116|abcdef", "ENTRY": "Timothy Grasses", "MN": "B01.875.800.575.912.250.822.788", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid15956", "MS": "A plant genus of the family POACEAE that contains the Phl p 4 allergen.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031784"}, {"RECTYPE": "D", "MH": "Poa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Kentucky Blue Grass|T002|EPO|NRW|NLM (2003)|010919|abcdef", "ENTRY": "pratenses, Poa", "MN": "B01.875.800.575.912.250.822.793", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4544", "RR": "txid4545", "MS": "A plant genus of the family POACEAE that contains the Poa p Ia allergen and allergen C KBGP.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031785"}, {"RECTYPE": "D", "MH": "Saccharum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sugarcane|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "Sugarcanes", "MN": "B01.875.800.575.912.250.822.835", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4546", "RR": "txid62335", "MS": "A plant genus of the family POACEAE widely cultivated in the tropics for the sweet cane that is processed into sugar.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031786"}, {"RECTYPE": "D", "MH": "Sasa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Kumazasa|T002|NON|NRW|NLM (2003)|010919|abcdef", "ENTRY": "kurinenses, Sasa", "MN": "B01.875.800.575.912.250.822.844", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid66037", "MS": "A plant genus of the family POACEAE. Folin is the water-soluble extract from Sasa albomarginata. Sasa kurinensis is an ingredient of Sho-ju-sen, a Japanese herbal medicine.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031787"}, {"RECTYPE": "D", "MH": "Polygala", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Snakeroot, Seneca|T002|NON|NRW|NLM (2003)|010919|abcdef", "ENTRY": "Snakeroots, Seneca", "MN": "B01.875.800.575.912.250.859.844.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4275", "RR": "txid355332", "AN": "other snakeroots are available such as ASARUM; SANICULA; ARISTOLOCHIA; AGERATINA;", "MS": "A plant genus of the family POLYGALACEAE that contains onjisaponins, xanthones, pyrones, and benzophenones. The name is similar to other snakeroots such as ASARUM; SANICULA; ARISTOLOCHIA; AGERATINA; and others.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031801"}, {"RECTYPE": "D", "MH": "Securidaca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Securidacas", "MN": "B01.875.800.575.912.250.859.844.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4277", "MS": "A plant genus of the family POLYGALACEAE that contains securiosides and indole alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031802"}, {"RECTYPE": "D", "MH": "Eriogonum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Buckwheat, Wild|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "Wild Buckwheats", "MN": "B01.875.800.575.912.250.825.306", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid63080", "MS": "A plant genus of the family POLYGONACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031803"}, {"RECTYPE": "D", "MH": "Rumex", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yellow Dock|T002|NON|NRW|NLM (2003)|011005|abcdef", "ENTRY": "Yellow Docks", "MN": "B01.875.800.575.912.250.825.850", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3618", "RR": "txid41241", "MS": "A plant genus of the family POLYGONACEAE that contains patientosides and other naphthalene glycosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031804"}, {"RECTYPE": "D", "MH": "Pontederiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pontederia|T002|NON|NRW|NLM (2003)|010919|abcdef", "ENTRY": "Pontederias", "MN": "B01.875.800.575.912.250.827", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid16367", "RR": "txid16372", "MS": "A plant family of the order Liliales, subclass Liliidae, class Liliopsida (monocotyledons). Most species are perennials, native primarily to tropical America. They have creeping rootstocks, fibrous roots, and leaves in clusters at the base of the plant or borne on branched stems. The fruit is a capsule containing many seeds, or a one-seeded winged structure.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031805"}, {"RECTYPE": "D", "MH": "Eichhornia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Water Hyacinth|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "Water Hyacinths", "MN": "B01.875.800.575.912.250.827.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid44945", "AN": "entry term WATER HYACINTH: HYACINTH see HYACINTHUS is also available", "MS": "A plant genus of the family PONTEDERIACEAE that is used as a biological filter for treating wastewater.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031806"}, {"RECTYPE": "D", "MH": "Potamogetonaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Potamogeton|T002|NON|NRW|NLM (2003)|010919|abcdef", "ENTRY": "Potamogetons", "MN": "B01.875.800.575.912.250.618.050.937", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid16362", "RR": "txid13228", "MS": "A plant family of the order Najadales, subclass Alismatidae, class Liliopsida (monocotyledons).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031821"}, {"RECTYPE": "D", "MH": "Portulaca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Purslane|T002|NON|NRW|NLM (2003)|010919|abcdef", "ENTRY": "oleraceas, Portulaca", "MN": "B01.875.800.575.912.250.198.500.984.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3582", "RR": "txid46147", "MS": "A plant genus of the family PORTULACACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031822"}, {"RECTYPE": "D", "MH": "Anagallis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pimpernel|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "Pimpernels", "MN": "B01.875.800.575.912.250.341.984.099", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4336", "MS": "A plant genus of the family PRIMULACEAE that contains anagallosides, which are molluscacidal triterpenoid saponins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031823"}, {"RECTYPE": "D", "MH": "Cyclamen", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cyclamens", "MN": "B01.875.800.575.912.250.341.984.549", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid59973", "MS": "A plant genus of the family PRIMULACEAE that contains triterpenoid saponins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031824"}, {"RECTYPE": "D", "MH": "Primula", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Primrose|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "veris, Primula", "MN": "B01.875.800.575.912.250.828", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid49647", "RR": "txid170927", "MS": "A plant genus of the family PRIMULACEAE. It can cause CONTACT DERMATITIS. SAPONINS have been identified in the root.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031825"}, {"RECTYPE": "D", "MH": "Pyrolaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.835", "MH_TH": "NLM (2003)", "ST": "T002", "MS": "A plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031827"}, {"RECTYPE": "D", "MH": "Pyrola", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Shinleaf|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "Shinleafs", "MN": "B01.875.800.575.912.250.341.937.437", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13650", "MS": "A plant genus of the family PYROLACEAE. The common name of wintergreen is more often used for GAULTHERIA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031828"}, {"RECTYPE": "D", "MH": "Aconitum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Monkshood|T002|NON|NRW|NLM (2003)|010919|abcdef", "ENTRY": "Radix Aconitus", "MN": "B01.875.800.575.912.250.836.750.022", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid49188", "RR": "txid112591", "MS": "A plant genus of the family RANUNCULACEAE. Members contain a number of diterpenoid alkaloids including: aconitans, hypaconitine, ACONITINE, jesaconitine, ignavine, napelline, and mesaconitine. The common name of Wolfbane is similar to the common name for ARNICA.", "PM": "2003; for ACONITE see ACONITE 1963-2004", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031841"}, {"RECTYPE": "D", "MH": "Actaea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bugbane|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "Bugbanes", "MN": "B01.875.800.575.912.250.836.750.033", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid46988", "AN": "ACTAEA RACEMOSA see CIMICIFUGA is also available", "MS": "A plant genus of the family RANUNCULACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031842"}, {"RECTYPE": "D", "MH": "Adonis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Oxeye Daisy|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "vernali, Adonis", "MN": "B01.875.800.575.912.250.836.750.036", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid46984", "RR": "txid46985", "MS": "A plant genus of the family RANUNCULACEAE. Members contain cardenolide oligoglycosides such as adoniside, adonisidum and alepposide.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031843"}, {"RECTYPE": "D", "MH": "Nigella", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Nigellas", "MN": "B01.875.800.575.912.250.836.750.518", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3443", "MS": "A plant genus of the family RANUNCULACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031844"}, {"RECTYPE": "D", "MH": "Hajdu-Cheney Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Osteolysis, Multicentric|T019|T047|NON|EQV|NLM (2003)|011011|abbcdef", "ENTRY": "Osteolyses, Multicentric", "MN": "C16.320.355", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Osteolysis, Essential (1980-2002)", "MS": "Rare, autosomal dominant syndrome characterized by ACRO-OSTEOLYSIS, generalized OSTEOPOROSIS, and skull deformations.", "PM": "2003; see OSTEOLYSIS, ESSENTIAL 1987-2002", "HN": "2003; use OSTEOLYSIS, ESSENTIAL 1987-2002", "MR": "20130708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031845"}, {"RECTYPE": "D", "MH": "Nigella damascena", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fennel, Wild|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "damascena, Nigella", "MN": "B01.875.800.575.912.250.836.750.518.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3444", "AN": "X ref Fennel, Wild: other fennel terms are also available; check text and MeSH", "MS": "A plant genus of the family RANUNCULACEAE. The name is similar to giant fennel (FERULA), true fennel (FOENICULUM), and dog fennel (ANTHEMIS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031861"}, {"RECTYPE": "D", "MH": "Nigella sativa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Kalonji|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "sativa, Nigella", "MN": "B01.875.800.575.912.250.836.750.518.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid555479", "MS": "A plant genus of the family RANUNCULACEAE that contains alpha-hederin, a triterpene saponin in the seeds, and is the source of black seed oil.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031881"}, {"RECTYPE": "D", "MH": "Delphinium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Larkspur|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "Larkspurs", "MN": "B01.875.800.575.912.250.836.750.277", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid46246", "MS": "A plant genus of the family RANUNCULACEAE. Members contain ACONITINE and other diterpenoid alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031882"}, {"RECTYPE": "D", "MH": "Anemone", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "raddeana, Anemone", "MN": "B01.875.800.575.912.250.836.750.077", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid22868", "RR": "txid387928", "AN": "X ref ANEMONE: venom of Conus anemone use MOLLUSK VENOMS is also available", "MS": "A plant genus of the family RANUNCULACEAE that contains triterpene saponins. The root of Anemone raddeana is the source of a Chinese folk medicine, zhu jie xian fu. The common name of liverwort is also used with other plants. This genus is unrelated to SEA ANEMONES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031883"}, {"RECTYPE": "D", "MH": "Aquilegia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Columbine|T002|NON|EQV|NLM (2003)|010919|abcdef", "ENTRY": "Columbines", "MN": "B01.875.800.575.912.250.836.750.088", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3450", "AN": "AQUILEGIA ADOXOIDES see SEMIAQUILEGIA is also available", "MS": "A plant genus of the family RANUNCULACEAE that contains aquiledine, isoaquiledine and cycloartane-type glycosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031884"}, {"RECTYPE": "D", "MH": "Cimicifuga", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cohosh, Black|T002|NON|NRW|NLM (2003)|010919|abcdef", "ENTRY": "racemosas, Actaea", "MN": "B01.875.800.575.912.250.836.750.182", "MH_TH": "NLM (2003)", "ST": "T002", "RR": "txid64040", "MS": "A plant genus of the family RANUNCULACEAE that contains triterpenoid saponins. Remifemin from C. racemosa is used to suppress LUTEINIZING HORMONE. It is reclassified by some to ACTAEA. The common name of black snakeroot is also used with ASARUM and SANICULA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031885"}, {"RECTYPE": "D", "MH": "Gestational Trophoblastic Disease", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Trophoblastic Neoplasms, Gestational|T191|NON|NRW|NLM (2003)|011009|TROPHOBLASTIC NEOPL GESTATIONAL|abcdefv", "ENTRY": "Trophoblastic Neoplasm, Gestational", "MN": "C12.050.703.720.949.416", "MH_TH": "ORD (2010)", "ST": "T191", "PI": "Trophoblastic Neoplasms (1980-2002)", "MS": "A group of diseases arising from pregnancy that are commonly associated with hyperplasia of trophoblasts (TROPHOBLAST) and markedly elevated human CHORIONIC GONADOTROPIN. They include HYDATIDIFORM MOLE, invasive mole (HYDATIDIFORM MOLE, INVASIVE), placental-site trophoblastic tumor (TROPHOBLASTIC TUMOR, PLACENTAL SITE), and CHORIOCARCINOMA. These neoplasms have varying propensities for invasion and spread.", "PM": "2012; see GESTATIONAL TROPHOBLASTIC NEOPLASMS 2003-2011", "HN": "2012 (2003)", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031901"}, {"RECTYPE": "D", "MH": "Hemorrhagic Septicemia, Viral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "ENTRY": "Viral Hemorrhagic Septicemia", "MN": "C23.550.470.790.500.900.400", "FX": "Hemorrhagic Septicemia", "MH_TH": "NLM (2003)", "ST": "T047", "PI": "Rhabdoviridae Infections (1994-2002)", "MS": "A systemic infection of various salmonid and a few nonsalmonid fishes caused by Viral hemorrhagic septicemia virus (see NOVIRHABDOVIRUS),", "PM": "2003", "HN": "2003", "MR": "20190617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031941"}, {"RECTYPE": "D", "MH": "Cynara", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cardoon|T002|NON|NRW|NLM (2003)|010921|abcdef", "ENTRY": "Cynaras", "MN": "B01.875.800.575.912.250.100.269", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4264", "RR": "txid4265", "MS": "A plant genus of the family ASTERACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031942"}, {"RECTYPE": "D", "MH": "Cynara scolymus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Artichoke|T168|NON|REL|NLM (2003)|010921|abcdef", "ENTRY": "Artichokes", "MN": "B01.875.800.575.912.250.100.269.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid59895", "AN": "SCOLYMUS genus is also available", "MS": "A plant species of the genus CYNARA, family ASTERACEAE. The flower bud is the familiar artichoke eaten as a vegetable.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031943"}, {"RECTYPE": "D", "MH": "Dahlia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Dahlias", "MN": "B01.875.800.575.912.250.100.289", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41562", "AN": "DAHLIA, SEA see COREOPSIS is also available", "MS": "A plant genus of the family ASTERACEAE that contains antifungal plant defensin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031944"}, {"RECTYPE": "D", "MH": "Coreopsis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tickseed|T002|NON|EQV|NLM (2003)|010921|abcdef", "ENTRY": "Tickseeds", "MN": "B01.875.800.575.912.250.100.248", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13448", "AN": "entry term DAHLIA, SEA: DAHLIA also available", "MS": "A plant genus of the family ASTERACEAE that contains phenyl propanoids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031945"}, {"RECTYPE": "D", "MH": "Pulsatilla", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pasqueflower|T002|NON|EQV|NLM (2003)|010921|abcdef", "ENTRY": "Pulsatillas", "MN": "B01.875.800.575.912.250.836.750.666", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid46977", "MS": "A plant genus of the family RANUNCULACEAE. Members contain cernuosides and other oleanane and hederagenin saponins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031946"}, {"RECTYPE": "D", "MH": "Ranunculus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.836.750.733", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3445", "MS": "A plant genus of the family RANUNCULACEAE that contains protoanemonin, anemonin, and ranunculin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031947"}, {"RECTYPE": "D", "MH": "Semiaquilegia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tian kui|T002|NON|EQV|NLM (2003)|010921|abcdef", "ENTRY": "kuus, Tian", "MN": "B01.875.800.575.912.250.836.750.766", "FX": "Aquilegia", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid349365", "RR": "txid349366", "AN": "entry term AQUILEGIA ADOXOIDES: AQUILEGIA is also available", "MS": "A plant genus of the family RANUNCULACEAE that contains griffonilide, lithospermoside, and magnoflorine.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031948"}, {"RECTYPE": "D", "MH": "Thalictrum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rue, Meadow|T002|NON|EQV|NLM (2003)|010921|abcdef", "ENTRY": "Thalictrums", "MN": "B01.875.800.575.912.250.836.750.883", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid46968", "MS": "A plant genus of the family RANUNCULACEAE. Members contain isoquinoline alkaloids and triterpene glycosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031949"}, {"RECTYPE": "D", "MH": "Xanthorhiza", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yellowroot|T002|NON|EQV|NLM (2003)|010921|abcdef", "ENTRY": "Yellowroots", "MN": "B01.875.800.575.912.250.836.750.941", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13761", "MS": "A plant genus of the family RANUNCULACEAE. Members contain isoquinoline alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031950"}, {"RECTYPE": "D", "MH": "Resedaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Reseda|T002|NON|NRW|NLM (2003)|010921|abcdef", "MN": "B01.875.800.575.912.250.859.891", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid26958", "RR": "txid26963", "MS": "A plant family of the order Capparales, subclass Dilleniidae, class Magnoliopsida. It is a small family of herbs and shrubs. Some produce GLUCOSINOLATES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031951"}, {"RECTYPE": "D", "MH": "Ceanothus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.937.437.111", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid22922", "MS": "A plant genus of the family RHAMNACEAE. Root nodules host the Frankia (ACTINOMYCETES) nitrogen-fixing bacteria.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031952"}, {"RECTYPE": "D", "MH": "Colubrina", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Colubrinas", "MN": "B01.875.800.575.912.250.859.937.437.133", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid106663", "MS": "A plant genus of the family RHAMNACEAE. Members contain antifungal jujubogenin saponins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031953"}, {"RECTYPE": "D", "MH": "Choriocarcinoma, Non-gestational", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Non-gestational Choriocarcinoma|T191|NON|EQV|NLM (2003)|010921|abcdef", "ENTRY": "Non-gestational Choriocarcinomas", "MN": "C12.050.703.720.949.208.438", "MH_TH": "NLM (2003)", "ST": "T191", "PI": "Trophoblastic Neoplasms (1986-2002)", "MS": "A highly malignant CHORIOCARCINOMA derived from the non-placental origin such as the totipotent cells in the TESTIS, the OVARY, and the PINEAL GLAND. It produces high levels of CHORIONIC GONADOTROPIN and can metastasize widely through the bloodstream to the lungs, brain, liver, bone, and other viscera by the time of diagnosis.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031954"}, {"RECTYPE": "D", "MH": "Rhamnus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Frangula|T002|NON|REL|NLM (1991)|900518|abcdef", "ENTRY": "Frangulas", "MN": "B01.875.800.575.912.250.859.937.437.316", "MH_TH": "NLM (1986)", "ST": "T002", "RN": "txid3609", "RR": "txid55262", "MS": "A plant genus of the family RHAMNACEAE. This genus is often called buckthorn but should not be confused with HIPPOPHAE or KARWINSKIA. Some RHAMNUS species have been reclassified into this genus. F. purshiana bark is cascara sagrada. Members contain frangulanin, frangulin, and anthraquinones such as EMODIN.", "PM": "1991; see PLANTS, TOXIC 1986-1990, was FRANGULA 2002-2018; for CASCARA SAGRADA see CASCARA 1981-2019", "HN": "2019(1991)", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031955"}, {"RECTYPE": "D", "MH": "Karwinskia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tullidora|T002|NON|NRW|UNK (19XX)|850514|abcdef", "ENTRY": "humboldtiana, Karwinskia", "MN": "B01.875.800.575.912.250.859.937.437.408", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid106682", "RR": "txid106683", "PI": "Rhamnus (1985-2002)", "MS": "A plant genus of the family RHAMNACEAE that contains tullidinol (toxin T-544) and peroxisomicine (toxin T-514). It is sometimes called buckthorn but should not be confused with other plants called that.", "PM": "2003; see RHAMNUS 1985-2002; for Tullidora see RHAMNUS 1986-2002", "HN": "2003; use RHAMNUS 1985-2002; for Tullidora use RHAMNUS 1986-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031956"}, {"RECTYPE": "D", "MH": "Ziziphus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Zizyphus|T002|NON|EQV|NLM (2003)|010921|abcdef", "ENTRY": "Jujubes", "MN": "B01.875.800.575.912.250.859.937.437.833", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid72171", "MS": "A plant genus of the family RHAMNACEAE. Members contain nummularogenin (a spirostane) and is the source of an edible fruit.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031957"}, {"RECTYPE": "D", "MH": "Connaraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rourea|T002|NON|NRW|NLM (2003)|010924|abcdef", "ENTRY": "Roureas", "MN": "B01.875.800.575.912.250.859.937.222", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid25889", "RR": "txid85260", "MS": "A plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida that are tropical plants. The flowers are usually bisexual and have 5 sepals and petals; 5 or 10 stamens; and 1, 4, or usually 5 separate, one-chambered, female ovule-bearing structures (carpels).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031961"}, {"RECTYPE": "D", "MH": "Kalanchoe", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bryophyllum|T002|NON|NRW|NLM (2011)|100607|abcdef", "MN": "B01.875.800.575.912.250.859.937.249.249", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid23012", "RR": "txid92858", "MS": "A plant genus of the family CRASSULACEAE. Members contain bryophyllins (also called bryotoxins) which are bufadienolides (BUFANOLIDES) that have insecticidal activity.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031962"}, {"RECTYPE": "D", "MH": "Sedum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cockscomb, Green|T002|NON|NRW|NLM (2003)|011203|abcdef", "ENTRY": "praealtums, Sedum", "MN": "B01.875.800.575.912.250.859.937.249.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3784", "MS": "A plant genus of the family CRASSULACEAE. Some species in this genus are called stonecrop which is also a common name for RHODIOLA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031963"}, {"RECTYPE": "D", "MH": "Grossulariaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.937.311", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid23066", "AN": "prefer specific plant", "MS": "A plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida. They are deciduous woody shrubs with alternate leaves. The flowers are in terminal racemes with 5 petals and 5 stamens.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031964"}, {"RECTYPE": "D", "MH": "Ribes", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gooseberry|T168|NON|REL|NLM (2003)|010924|abcdef", "ENTRY": "Gooseberries", "MN": "B01.875.800.575.912.250.859.937.311.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3801", "RR": "txid78511", "MS": "Also known as currant, ribes is a member of the family GROSSULARIACEAE. Oil extracted from the seeds contain GAMMA-LINOLENIC ACID.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031965"}, {"RECTYPE": "D", "MH": "Hydrangea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Hydrangeas", "MN": "B01.875.800.575.912.250.859.937.374.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid23109", "MS": "A plant genus of the family HYDRANGEACEAE. Members contain hydrangenol, thunberginols, hydramacrosides A and B, and secoiridoid glucosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031966"}, {"RECTYPE": "D", "MH": "Agrimonia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Agrimony|T002|NON|EQV|NLM (2003)|010924|abcdef", "ENTRY": "pilosa, Agrimonia", "MN": "B01.875.800.575.912.250.859.937.500.033", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid23137", "RR": "txid74656", "MS": "A plant genus of the family ROSACEAE that has been used in folk treatment of diabetes. Members contain agrimoniin (TANNINS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031981"}, {"RECTYPE": "D", "MH": "Alchemilla", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lady's Mantle|T002|NON|EQV|NLM (2003)|010924|abcdef", "ENTRY": "Ladys Mantle", "MN": "B01.875.800.575.912.250.859.937.500.055", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid23138", "MS": "A plant genus of the family ROSACEAE. Members contain esculetin and QUERCETIN.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031982"}, {"RECTYPE": "D", "MH": "Eriobotrya", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Loquats|T168|NON|REL|NLM (2003)|010927|abcdef", "ENTRY": "Trees, Loquat", "MN": "B01.875.800.575.912.250.859.937.500.222", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid23166", "MS": "A plant genus of the family ROSACEAE that is the source of an edible fruit. Members contain TRITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031983"}, {"RECTYPE": "D", "MH": "Filipendula", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Meadowsweet|T002|NON|EQV|NLM (2003)|010924|abcdef", "ENTRY": "Meadowsweets", "MN": "B01.875.800.575.912.250.859.937.500.244", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid23170", "MS": "A plant genus of the family ROSACEAE. Members contain TANNINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031984"}, {"RECTYPE": "D", "MH": "Fragaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Strawberries|T168|NON|REL|NLM (2003)|010924|abcdef", "ENTRY": "Woodland Strawberries", "MN": "B01.875.800.575.912.250.859.937.500.266", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3746", "RR": "txid57918", "MS": "A plant genus of the family ROSACEAE known for the edible fruit.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031985"}, {"RECTYPE": "D", "MH": "Geum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Avens|T002|NON|EQV|NLM (2003)|010924|abcdef", "ENTRY": "Geums", "MN": "B01.875.800.575.912.250.859.937.500.288", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3761", "MS": "A plant genus of the family ROSACEAE. Members contain TRITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031986"}, {"RECTYPE": "D", "MH": "Potentilla", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Silverweed|T002|NON|EQV|NLM (2003)|010924|abcdef", "ENTRY": "Silverweeds", "MN": "B01.875.800.575.912.250.859.937.500.601", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid23204", "MS": "A plant genus of the family ROSACEAE. Members contain procyanidins and TANNINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031987"}, {"RECTYPE": "D", "MH": "Pyrus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pears|T168|NON|REL|NLM (2003)|010924|abcdef", "ENTRY": "Pear", "MN": "B01.875.800.575.912.250.859.937.500.699", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3766", "MS": "A plant genus of the family ROSACEAE known for the edible fruit.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031989"}, {"RECTYPE": "D", "MH": "Quillaja", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Soapbush|T002|NON|NRW|NLM (2003)|010924|abcdef", "ENTRY": "Soapbushs", "MN": "B01.875.800.575.912.250.859.937.500.724", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid23212", "RR": "txid32244", "AN": "do not confuse entry term QUILLAJA SAPONARlA with the genus SAPONARlA;", "MS": "A plant genus of the family ROSACEAE whose members produce SAPONINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031990"}, {"RECTYPE": "D", "MH": "Pyracantha", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Firethorn|T002|NON|EQV|NLM (2003)|010924|abcdef", "ENTRY": "Pyracanthas", "MN": "B01.875.800.575.912.250.859.937.500.693", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid144561", "MS": "A plant genus of the family ROSACEAE widely cultivated as a prickly hedge with bright red berries. Members contain pyracrenic acid (a lupane triterpenoid).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031991"}, {"RECTYPE": "D", "MH": "Spiraea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Spiraeas", "MN": "B01.875.800.575.912.250.859.937.500.808", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid23224", "MS": "A plant genus of the family ROSACEAE. Members contain prunioside, spiramine and other diterpene alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031992"}, {"RECTYPE": "D", "MH": "Sanguisorba", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Burnet|T002|NON|EQV|NLM (2003)|010924|abcdef", "ENTRY": "Sanguisorbas", "MN": "B01.875.800.575.912.250.859.937.500.779", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid57937", "MS": "A plant genus of the family ROSACEAE. Members contain sanguiin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031993"}, {"RECTYPE": "D", "MH": "Sorbus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rowan|T002|NON|EQV|NLM (2003)|010924|abcdef", "ENTRY": "Rowans", "MN": "B01.875.800.575.912.250.859.937.500.793", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid23222", "MS": "A plant genus of the family ROSACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031994"}, {"RECTYPE": "D", "MH": "Saxifragaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Saxifrage|T002|NON|NRW|NLM (2003)|010924|abcdef", "MN": "B01.875.800.575.912.250.859.937.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3792", "RR": "txid3798", "AN": "prefer specific plant", "MS": "The saxifrage plant family of the order SAXIFRAGALES, class Magnoliopsida. The leaves are alternate and sometimes deeply lobed or form rosettes. The flowers have both male and female parts and 4 or 5 sepals and petals; they are usually in branched clusters. The fruit is a capsule with many seeds.", "PM": "2003", "HN": "2003", "MR": "20210520", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D031995"}, {"RECTYPE": "D", "MH": "Heuchera", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Alumroot|T002|NON|EQV|NLM (2003)|010924|abcdef", "ENTRY": "Heucheras", "MN": "B01.875.800.575.912.250.859.937.750.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3794", "MS": "A plant genus of the family SAXIFRAGACEAE with dark green round or heart-shaped leaves and tiny flowers.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D031996"}, {"RECTYPE": "D", "MH": "Delegation, Professional", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Professional Delegation|T077|NON|EQV|NLM (2003)|010926|abcdef", "MN": "N04.590.374.070", "MH_TH": "NLM (2003)", "ST": "T077", "MS": "The process of assigning duties to a subordinate with lesser qualifications.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032022"}, {"RECTYPE": "D", "MH": "Integrons", "AQ": "DE ES GE IM PH RE", "ENTRY": "Integron", "MN": "G02.111.570.080.708.330.200.500", "MH_TH": "NLM (2003)", "ST": "T114", "AN": "do not confuse with INTEGRINS (membrane glycoproteins)", "MS": "DNA elements that include the component genes and insertion site for a site-specific recombination system that enables them to capture mobile gene cassettes.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032023"}, {"RECTYPE": "D", "MH": "Personnel Delegation", "AQ": "OG", "PRINT ENTRY": "Delegation, Personnel|T077|NON|EQV|NLM (2003)|010926|abcdef", "MN": "N04.452.677.445", "MH_TH": "NLM (2003)", "ST": "T077", "MS": "To entrust to the care or management of another, to transfer or to assign tasks within an organizational or administrative unit or structure", "PM": "2003", "HN": "2003", "MR": "20040730", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032024"}, {"RECTYPE": "D", "MH": "Nested Genes", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Genes, Nested|T028|NON|EQV|NLM (2003)|011116|abcdef", "ENTRY": "Nested Gene", "MN": "G05.360.340.024.340.385.600", "MH_TH": "NLM (2003)", "ST": "T028", "AN": "for nested primers use NESTED PCR; (POLYMERASE CHAIN REACTION)", "MS": "Genes whose entire sequences are contained within other genes.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032041"}, {"RECTYPE": "D", "MH": "Galium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cleavers|T002|NON|NRW|NLM (2003)|010927|abcdef", "ENTRY": "Cleaver", "MN": "B01.875.800.575.912.250.456.937.377", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid25168", "RR": "txid29788", "AN": "do not confuse with the element GALLIUM; note entry term BEDSTRAW: for \"smooth bedstraw\" index  CRUCIATA see  RUBIACEAE", "MS": "A genus of herbaceous annual and perennial plants in the family RUBIACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032061"}, {"RECTYPE": "D", "MH": "Gardenia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Gardenias", "MN": "B01.875.800.575.912.250.456.937.388", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43486", "MS": "A plant genus of the family RUBIACEAE. Members contain genepin, from which geniposide is obtained for use as a crosslinking agent in ADHESIVES, and 3-caffeoyl-4-sinapoylquinic acid.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032062"}, {"RECTYPE": "D", "MH": "Hamelia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Hamelias", "MN": "B01.875.800.575.912.250.456.937.404", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43496", "AN": "do not confuse with HAMAMELIS", "MS": "A plant genus of the family RUBIACEAE that has a name very similar to another plant genus, HAMAMELIS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032063"}, {"RECTYPE": "D", "MH": "Hedyotis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Hedyoti", "MN": "B01.875.800.575.912.250.456.937.422", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid58416", "MS": "A plant genus of the family RUBIACEAE. Members contain anthraquinones and iridoids. H. diffusa is used in DRUGS, CHINESE HERBAL.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032064"}, {"RECTYPE": "D", "MH": "Mitragyna", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Mitragynas", "MN": "B01.875.800.575.912.250.456.937.555", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid170021", "RR": "txid170351", "MS": "A plant genus of the family RUBIACEAE. Members contain antimalarial (ANTIMALARIALS) and analgesic (ANALGESICS) indole alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032065"}, {"RECTYPE": "D", "MH": "Morinda", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Noni|T002|NON|NRW|NLM (2003)|010927|abcdef", "ENTRY": "citrifolias, Morinda", "MN": "B01.875.800.575.912.250.456.937.566", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43521", "RR": "txid43522", "MS": "A plant genus of the family RUBIACEAE. Members contain iridoid glycosides and ANTHRAQUINONES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032066"}, {"RECTYPE": "D", "MH": "Oldenlandia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Oldenlandias", "MN": "B01.875.800.575.912.250.456.937.611", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43535", "MS": "A plant genus of the family RUBIACEAE. Some species are used as an ingredient in Chinese and African traditional medicines. Members contain kalata B1, a macrocyclic peptide.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032067"}, {"RECTYPE": "D", "MH": "Pausinystalia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yohimbe|T002|NON|NRW|NLM (2003)|010927|abcdef", "ENTRY": "Yohimbes", "MN": "B01.875.800.575.912.250.456.937.805", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid170025", "RR": "txid170026", "MS": "A plant genus of the family RUBIACEAE. Members produce YOHIMBINE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032068"}, {"RECTYPE": "D", "MH": "Psychotria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Psychotrias", "MN": "B01.875.800.575.912.250.456.937.844", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid25443", "AN": "PSYCHOTRIA IPECACUANHA see CEPHAELIS IPECACUANHA is also available", "MS": "A plant genus of the family RUBIACEAE. Members contain psychotridine and brachycerine (indole alkaloids).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032069"}, {"RECTYPE": "D", "MH": "Uncaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Uncarias", "MN": "B01.875.800.575.912.250.456.937.909", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43574", "AN": "UNCARIA PROCUMBENS see HARPAGOPHYTUM is also available", "MS": "A plant genus of the family RUBIACEAE. Members contain uncarine and other cytotoxic and hypotensive oxindole alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032070"}, {"RECTYPE": "D", "MH": "Casimiroa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Casimiroas", "MN": "B01.875.800.575.912.250.875.155", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid68534", "MS": "A plant genus of the family RUTACEAE. The fruit is edible and the seed has cardiovascular activity.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032081"}, {"RECTYPE": "D", "MH": "Citrus aurantiifolia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Limes|T168|NON|REL|NLM (2003)|010928|abcdef", "ENTRY": "aurantiifolia, Citrus", "MN": "B01.875.800.575.912.250.875.177.077", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid159033", "MS": "A plant species of the genus CITRUS, family RUTACEAE that provides the familiar lime fruit. Its common name of lime is similar to the limetree (TILIA).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032082"}, {"RECTYPE": "D", "MH": "Citrus paradisi", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Toronja|T168|NON|REL|NLM (2003)|010928|abcdef", "ENTRY": "Toronjas", "MN": "B01.875.800.575.912.250.875.177.538", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid37656", "AN": "juices: coordinate with FRUIT AND VEGETABLE JUICES", "MS": "A plant species of the genus CITRUS, family RUTACEAE that produces the familiar grapefruit. There is evidence that grapefruit inhibits CYTOCHROME P-450 CYP3A4, resulting in delayed metabolism and higher blood levels of a variety of drugs.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032083"}, {"RECTYPE": "D", "MH": "Citrus sinensis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Oranges|T168|NON|REL|NLM (2003)|010928|abcdef", "ENTRY": "sinensis, Citrus", "MN": "B01.875.800.575.912.250.875.177.769", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid2711", "AN": "juices: coordinate with FRUIT AND VEGETABLE JUICES", "MS": "A plant species of the genus CITRUS, family RUTACEAE that provides the familiar orange fruit which is also a source of orange oil.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032084"}, {"RECTYPE": "D", "MH": "Isochores", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Isochore", "MN": "G05.360.340.024.430", "FX": "GC Rich Sequence", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Base Composition (1990-2002)", "MS": "Large regions of the GENOME that contain local similarities in BASE COMPOSITION.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032085"}, {"RECTYPE": "D", "MH": "Evodia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Wu Zhu Yu|T121|NON|NRW|NLM (2003)|010928|abcdef", "ENTRY": "ruticarpum, Tetradium", "MN": "B01.875.800.575.912.250.875.333", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid354493", "RR": "txid354523", "MS": "A plant genus of the family RUTACEAE which is used in Chinese medicine (DRUGS, CHINESE HERBAL). Evodiamine and other quinazoline alkaloids (QUINAZOLINES) are obtained from the fruit of E. ruticarpa.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032086"}, {"RECTYPE": "D", "MH": "Murraya", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Murrayas", "MN": "B01.875.800.575.912.250.875.666", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43710", "MS": "A plant genus of the family RUTACEAE. Members contain murrayanine, koenine, isomahanine, kwangsine, siamenol, murrayafoline A, murrayaquinone A and other cytotoxic carbazolequinones.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032101"}, {"RECTYPE": "D", "MH": "Phellodendron", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Corktree|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "Phellodendrons", "MN": "B01.875.800.575.912.250.875.717", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid68553", "MS": "A plant genus of the family RUTACEAE. Members contain BERBERINE, indolopyridoquinazoline and other ALKALOIDS and limonoids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032102"}, {"RECTYPE": "D", "MH": "Pilocarpus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.875.733", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid77016", "MS": "A plant genus of the family RUTACEAE that is the natural source of PILOCARPINE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032103"}, {"RECTYPE": "D", "MH": "Poncirus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Orange, Trifoliate|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "Trifoliate Oranges", "MN": "B01.875.800.575.912.250.875.755", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid37881", "MS": "A plant genus of the family RUTACEAE. Members contain ponfolin, a coumarin (COUMARINS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032104"}, {"RECTYPE": "D", "MH": "Ruta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rue|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "graveolen, Ruta", "MN": "B01.875.800.575.912.250.875.788", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid37564", "RR": "txid452790", "MS": "A plant genus of the family RUTACEAE. Members contain quinoline alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032105"}, {"RECTYPE": "D", "MH": "Zanthoxylum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Xanthoxylum|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "zanthoxyloides, Fagara", "MN": "B01.875.800.575.912.250.875.922", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid67937", "RR": "txid992815", "AN": "note FAGARA entry terms: FAGARA see RUTACEAE and FAGARA HORRIDA see GLEDITSIA are also available", "MS": "A plant genus of the family RUTACEAE. Some members of Zanthoxylum are reclassified from ELEUTHEROCOCCUS, Melicope, and EVODIA. The twigs are used as dental brushing sticks (TOOTHBRUSHING).  Most plants that are called Fagara have been reclassified as Zanthoxylum, however some Fagara were reclassified  to MELICOPE (also in the Rutacea family) or to GLEDITSIA (a genus in the FABACEAE family).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032106"}, {"RECTYPE": "D", "MH": "Populus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Poplar, True|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "nigras, Populus", "MN": "B01.875.800.575.912.250.859.797.875.453", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3689", "RR": "txid73824", "MS": "A plant genus of the family SALICACEAE. Balm of Gilead is a common name used for P. candicans, or P. gileadensis, or P. jackii, and sometimes also used for ABIES BALSAMEA or for COMMIPHORA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032107"}, {"RECTYPE": "D", "MH": "Salix", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Willow|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "Willows, White", "MN": "B01.875.800.575.912.250.859.797.875.833", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid40685", "RR": "txid75704", "MS": "A plant genus of the family Salicaceae. Members contain salicin, which yields SALICYLIC ACID.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032108"}, {"RECTYPE": "D", "MH": "Salvadoraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Salvadora|T002|NON|NRW|NLM (2003)|010928|abcdef", "ENTRY": "Salvadoras", "MN": "B01.875.800.575.912.250.882", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4324", "RR": "txid4325", "MS": "A plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida, a small family growing in the tropics. Members contain piperidine alkaloids and GLUCOSINOLATES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032121"}, {"RECTYPE": "D", "MH": "Pyrularia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Pyrularias", "MN": "B01.875.800.575.912.250.884.666", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3959", "MS": "A plant genus of the family SANTALACEAE. Members contain thionin toxin, which shouldn't be confused with thionine.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032122"}, {"RECTYPE": "D", "MH": "Santalum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sandalwood|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "Santalums", "MN": "B01.875.800.575.912.250.884.833", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid35973", "MS": "A plant genus of the family SANTALACEAE which is the source of sandalwood oil.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032123"}, {"RECTYPE": "D", "MH": "Blighia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Akee|T002|NON|NRW|NLM (2003)|011019|abcdef", "ENTRY": "sapida, Blighia", "MN": "B01.875.800.575.912.250.885.111", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid259380", "RR": "txid259381", "MS": "A plant genus of the family SAPINDACEAE. Members contain hypoglycins and ackee oil.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032124"}, {"RECTYPE": "D", "MH": "Litchi", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Lychee|T002|NON|NRW|NLM (2003)|010928|abcdef", "ENTRY": "chinenses, Litchi", "MN": "B01.875.800.575.912.250.885.444", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid151068", "RR": "txid151069", "MS": "A plant genus of the family SAPINDACEAE that bears sweet fruits. Unusual fatty acids such as cyclopropanoic fatty acids have been identified in the seeds.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032125"}, {"RECTYPE": "D", "MH": "Paullinia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Guarana|T002|NON|NRW|NLM (2003)|010928|abcdef", "ENTRY": "pinnata, Paullinia", "MN": "B01.875.800.575.912.250.885.722", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid290983", "RR": "txid392747", "MS": "A plant genus of the family SAPINDACEAE. The seed of P. cupana is the source of guarana powder which contains 4% CAFFEINE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032126"}, {"RECTYPE": "D", "MH": "Sapindus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Soapberry|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "Soapberries", "MN": "B01.875.800.575.912.250.885.861", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid57654", "MS": "A plant genus of the family SAPINDACEAE that contain SAPONINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032127"}, {"RECTYPE": "D", "MH": "Madhuca", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Madhucas", "MN": "B01.875.800.575.912.250.339.485.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid191069", "MS": "A plant genus of the family SAPOTACEAE that is the source of mahua oil. Members contain oleanene triterpenoid saponins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032128"}, {"RECTYPE": "D", "MH": "Manilkara", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Zapote|T002|NON|NRW|NLM (2003)|010928|abcdef", "ENTRY": "zapotilla, Sapota", "MN": "B01.875.800.575.912.250.339.485.555", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3740", "RR": "txid3741", "MS": "A plant genus of the family SAPOTACEAE that bears sweet fruit.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032129"}, {"RECTYPE": "D", "MH": "Mimusops", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Mimusop", "MN": "B01.875.800.575.912.250.339.485.577", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid233713", "MS": "A plant genus of the family SAPOTACEAE. Members contain triterpenoid saponins. Latex from bark incisions is processed into gutta balata.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032130"}, {"RECTYPE": "D", "MH": "Palaquium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "gutta, Palaquium", "MN": "B01.875.800.575.912.250.339.485.666", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid191073", "RR": "txid1524299", "MS": "A plant genus of the family SAPOTACEAE. Latex from bark incisions is processed into GUTTA-PERCHA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032131"}, {"RECTYPE": "D", "MH": "Pouteria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sapote, Yellow|T002|NON|NRW|NLM (2003)|010928|abcdef", "ENTRY": "sapota, Pouteria", "MN": "B01.875.800.575.912.250.339.485.699", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid85249", "RR": "txid233744", "MS": "A plant genus of the family SAPOTACEAE. Members contain triterpenes. Some species in this genus are called mamey which is also a common name for MAMMEA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032132"}, {"RECTYPE": "D", "MH": "Synsepalum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Miracle Fruit|T002|NON|NRW|NLM (2003)|010928|abcdef", "ENTRY": "dulcificums, Synsepalum", "MN": "B01.875.800.575.912.250.339.485.849", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid233754", "RR": "txid3743", "MS": "A plant genus of the family SAPOTACEAE. Members contain miraculin (also spelled mieraculin), a sweet protein.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032133"}, {"RECTYPE": "D", "MH": "Saururaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Saururus|T002|NON|NRW|NLM (2003)|010928|abcdef", "MN": "B01.875.800.575.912.250.888", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid16748", "RR": "txid13259", "MS": "A plant family of the order Piperales, subclass Magnoliidae class Magnoliopsida. Members contain sauristolactam, and aristololactam BII.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032134"}, {"RECTYPE": "D", "MH": "Kadsura", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Kadsuras", "MN": "B01.875.800.575.912.250.103.500.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid105749", "MS": "A plant genus of the family SCHISANDRACEAE used in folk medicine in a manner similar to SCHISANDRA. Members contain KADSURENONE and KADSURIN.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032135"}, {"RECTYPE": "D", "MH": "Schisandra", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Wuweizi|T121|NON|REL|NLM (2003)|010928|abcdef", "ENTRY": "Starvines, Bay", "MN": "B01.875.800.575.912.250.103.500.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13673", "RR": "txid50507", "MS": "A plant genus of the family Schisandraceae which contain schisandrins (Russian) which are also called gomisins (Japanese) or wuweizins (Chinese). Compounds produced by this genus are very similar in composition and use to that of the related KADSURA plant.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032141"}, {"RECTYPE": "D", "MH": "Antirrhinum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Snapdragon|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "Snapdragons", "MN": "B01.875.800.575.912.250.583.700.067", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4150", "MS": "A plant genus of the family Plantaginaceae. Members contain DEFICIENS PROTEIN.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032161"}, {"RECTYPE": "D", "MH": "Craterostigma", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Resurrection Plant|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "Resurrection Plants", "MN": "B01.875.800.575.912.250.583.300", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4152", "MS": "A plant genus of the order Lamiales, family Linderniaceae.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032181"}, {"RECTYPE": "D", "MH": "Euphrasia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Eyebright|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "Eyebrights", "MN": "B01.875.800.575.912.250.583.670.270", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid46053", "MS": "A plant genus of the family Orobanchaceae used in FOLK REMEDIES for the eyes.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032201"}, {"RECTYPE": "D", "MH": "Linaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Toadflax|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "Toadflaxs", "MN": "B01.875.800.575.912.250.583.700.530", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43170", "AN": "note entry term TOADFLAX: TOADFLAX, BASTARD see SANTALACEAE is also available", "MS": "A plant genus of the family Plantaginaceae. Members contain linarin (also called acaciin).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032221"}, {"RECTYPE": "D", "MH": "Mimulus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Monkeyflower|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "Monkeyflowers", "MN": "B01.875.800.575.912.250.583.580", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4154", "MS": "A plant genus of the family Phrymaceae. Members contain 6-geranylflavanones and mimulone.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032241"}, {"RECTYPE": "D", "MH": "Picrorhiza", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "kurrooas, Picrorhiza", "MN": "B01.875.800.575.912.250.583.700.690", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid195119", "RR": "txid195120", "MS": "A plant genus of the family Plantaginaceae. Members contain scrosides (CINNAMATES) and phenylethanoid glycoside. P. kurrooa is the source of picroliv (a purified iridoid glycoside fraction from the roots having hepatoprotective, anti-inflammatory and antioxidant properties).", "PM": "2003", "HN": "2003", "MR": "20210520", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032261"}, {"RECTYPE": "D", "MH": "Pedicularis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Pediculari", "MN": "B01.875.800.575.912.250.583.670.690", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43174", "MS": "A plant genus of the family Orobanchaceae. Members contain phenylpropanoid glycosides and iridoids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032262"}, {"RECTYPE": "D", "MH": "Penstemon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.583.700.680", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid69923", "MS": "A plant genus of the family Plantaginaceae. Members contain phenylpropanoid and iridoid glycosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032263"}, {"RECTYPE": "D", "MH": "Veronica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Speedwell|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "Veronicas", "MN": "B01.875.800.575.912.250.583.700.925", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4173", "MS": "A plant genus of the family Plantaginaceae. Members contain bis-sesquiterpene and iridoid glucosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032264"}, {"RECTYPE": "D", "MH": "Verbascum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mullein|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "Mulleins", "MN": "B01.875.800.575.912.250.583.800.899", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39257", "RR": "txid90365", "MS": "A plant genus of the family Scrophulariaceae.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032265"}, {"RECTYPE": "D", "MH": "Scrophularia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Figwort Betony|T002|NON|EQV|NLM (2003)|010928|abcdef", "ENTRY": "Scrophularias", "MN": "B01.875.800.575.912.250.583.800.855", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39249", "MS": "A plant genus of the family SCROPHULARIACEAE. Members contain iridoids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032266"}, {"RECTYPE": "D", "MH": "Rehmannia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Foxglove, Chinese|T002|EPO|NRW|NLM (2003)|010928|abcdef", "ENTRY": "Chinese Foxglove", "MN": "B01.875.800.575.912.250.583.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid99299", "RR": "txid99300", "MS": "A plant genus of the family Rehmanniaceae. Members contain catapol, rehmannin and ALKALOIDS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032267"}, {"RECTYPE": "D", "MH": "Ailanthus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tree Of Heaven|T002|NON|NRW|NLM (2003)|010928|abcdef", "ENTRY": "Tree Of Heavens", "MN": "B01.875.800.575.912.250.898.044", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid23809", "RR": "txid2768810", "MS": "A plant genus of the family SIMAROUBACEAE. Members contain ailantinols and other quassinoids.", "PM": "2003", "HN": "2003", "MR": "20230601", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032268"}, {"RECTYPE": "D", "MH": "Brucea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Bruceas", "MN": "B01.875.800.575.912.250.898.111", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43722", "MS": "A plant genus of the family SIMAROUBACEAE. Members contain bruceosides and bruceanols (quassinoids). The astringent seeds have been used to treat dysentery in southeastern Asia.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032269"}, {"RECTYPE": "D", "MH": "Picrasma", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Picrasmas", "MN": "B01.875.800.575.912.250.898.555", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid210333", "MS": "A plant genus of the family SIMAROUBACEAE. Members contain javanicins, picrasinoside and other quassinoids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032270"}, {"RECTYPE": "D", "MH": "Quassia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "amaras, Quassia", "MN": "B01.875.800.575.912.250.898.599", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43724", "RR": "txid43725", "AN": "QUASSIA SIMAROUBA see SIMAROUBA is also available", "MS": "A plant genus of the family SIMAROUBACEAE. Members contain quassinoids. Quassia simarouba has been reclassified as SIMAROUBA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032271"}, {"RECTYPE": "D", "MH": "Simarouba", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Quassia simarouba|T002|NON|NRW|NLM (2003)|010928|abcdef", "ENTRY": "simarouba, Quassia", "MN": "B01.875.800.575.912.250.898.799", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43728", "RR": "txid101569", "AN": "entry term QUASSIA SIMAROUBA: QUASSIA is also available", "MS": "A plant genus of the family SIMAROUBACEAE. Members produce quassinoids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032272"}, {"RECTYPE": "D", "MH": "Smilax", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Zarzaparilla|T002|NON|EQV|NLM (2003)|011001|abcdef", "ENTRY": "Zarzaparillas", "MN": "B01.875.800.575.912.250.618.875.750.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid49656", "RR": "txid1353877", "AN": "note entry term SARSAPARILLA: SARSAPARILLA, EAST INDIAN see HEMIDESMUS and BRISTLY SARSAPARILLA see ARALIA are also available", "MS": "A plant genus of the family SMILACACEAE. Members contain smiglasides (phenylpropanoid glycosides) and steroidal saponins. Commercially it is sometimes adulterated with HEMIDESMUS, which would affect experimental results. Drinks called sarsaparilla and root beer have been prepared from the Smilaz ornata (Jamaican sarsaparilla) and SASSAFRAS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032281"}, {"RECTYPE": "D", "MH": "Atropa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Atropas", "MN": "B01.875.800.575.912.250.908.500.049", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid24609", "AN": "prefer specific plant; ATROPA MANDRAGORA see MANDRAGORA is also available", "MS": "A plant genus of the family SOLANACEAE which contain SOLANACEOUS ALKALOIDS including ATROPINE which is named after this genus.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032282"}, {"RECTYPE": "D", "MH": "Cestrum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Jessamine|T002|NON|EQV|NLM (2003)|011001|abcdef", "ENTRY": "Jessamines", "MN": "B01.875.800.575.912.250.908.500.166", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid103474", "MS": "A plant genus of the family SOLANACEAE. Members contain steroidal saponins and cause CALCINOSIS in grazing livestock due to high levels of 1 ALPHA,25-DIHYDROXYVITAMIN D3.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032301"}, {"RECTYPE": "D", "MH": "Datura", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Daturas", "MN": "B01.875.800.575.912.250.908.500.188", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid4074", "AN": "prefer specific plant", "PI": "Datura stramonium (1974-2002)", "MS": "A plant genus of the family SOLANACEAE. Members contain TROPANES. The common name of trumpet flower is also sometimes used for GELSEMIUM.", "PM": "2003; see DATURA STRAMONIUM 1974-2002", "HN": "2003(1974)", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032302"}, {"RECTYPE": "D", "MH": "Duboisia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Duboisias", "MN": "B01.875.800.575.912.250.908.500.202", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid195735", "MS": "A plant genus of the family SOLANACEAE that is a source of SCOPOLAMINE and other TROPANES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032303"}, {"RECTYPE": "D", "MH": "Hyoscyamus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Henbane|T002|NON|EQV|NLM (2003)|011001|abcdef", "ENTRY": "Henbanes, Black", "MN": "B01.875.800.575.912.250.908.500.274", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4078", "RR": "txid4079", "MS": "A plant genus of the family SOLANACEAE which contains TROPANES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032304"}, {"RECTYPE": "D", "MH": "Lycium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Wolfberry|T168|NON|NRW|NLM (2003)|011001|abcdef", "ENTRY": "Wolfberries", "MN": "B01.875.800.575.912.250.908.500.310", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid24646", "RR": "txid112883", "MS": "A plant genus of the family SOLANACEAE. Members contain CEREBROSIDES and SCOPOLETIN.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032305"}, {"RECTYPE": "D", "MH": "Petunia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Petunias", "MN": "B01.875.800.575.912.250.908.500.448", "FX": "Acanthaceae", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4101", "MS": "A plant genus of the family SOLANACEAE. Members contain steroidal glycosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032306"}, {"RECTYPE": "D", "MH": "Physalis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tomatillo|T168|NON|REL|NLM (2003)|011001|abcdef", "ENTRY": "Tomatillos", "MN": "B01.875.800.575.912.250.908.500.499", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid24663", "RR": "txid374031", "MS": "A plant genus of the family SOLANACEAE. Members contain physalin and withangulatin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032321"}, {"RECTYPE": "D", "MH": "Solanum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Trompillo|T002|NON|EQV|NLM (2003)|011001|abcdef", "ENTRY": "laciniatum, Solanum", "MN": "B01.875.800.575.912.250.908.500.725", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4107", "RR": "txid45835", "AN": "several specific Solanum terms are available; check text and MeSH", "MS": "A plant genus of the family SOLANACEAE. Members contain SOLANACEOUS ALKALOIDS. Some species in this genus are called deadly nightshade which is also a common name for ATROPA BELLADONNA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032322"}, {"RECTYPE": "D", "MH": "Solanum melongena", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Eggplant|T168|NON|REL|NLM (2003)|011001|abcdef", "ENTRY": "melongena, Solanum", "MN": "B01.875.800.575.912.250.908.500.725.666", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4111", "MS": "A plant species of the genus SOLANUM, family SOLANACEAE. The fruit is a large, egg-shaped berry, varying in color from dark purple to red, yellowish, or white. The leaves are large and ovate. The flowers are pendant, violet, and two inches across.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032323"}, {"RECTYPE": "D", "MH": "Solanum nigrum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Nightshade, Black|T002|NON|EQV|NLM (2003)|011001|abcdef", "ENTRY": "nigrums, Solanum", "MN": "B01.875.800.575.912.250.908.500.725.699", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4112", "MS": "A plant species of the genus SOLANUM, family SOLANACEAE that contains steroidal glycosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032324"}, {"RECTYPE": "D", "MH": "Withania", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "somniferas, Withania", "MN": "B01.875.800.575.912.250.908.500.950", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid126908", "RR": "txid126910", "MS": "A plant genus of the family SOLANACEAE. Members contain withanolides. Withania somnifera is the source of ashwagandha and aswal.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032341"}, {"RECTYPE": "D", "MH": "Muscle Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Myocytes|T025|NON|EQV|NLM (2003)|011119|abcdef", "ENTRY": "Myocyte", "MN": "A11.620", "FX": "Myoblasts", "MH_TH": "NLM (2003)", "ST": "T025", "AN": "prefer specifics", "PI": "Muscles/cytology (1965-2002)", "MS": "Mature contractile cells, commonly known as myocytes, that form one of three kinds of muscle. The three types of muscle cells are skeletal (MUSCLE FIBERS, SKELETAL), cardiac (MYOCYTES, CARDIAC), and smooth (MYOCYTES, SMOOTH MUSCLE). They are derived from embryonic (precursor) muscle cells called MYOBLASTS.", "PM": "2003", "HN": "2003", "MR": "20080710", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032342"}, {"RECTYPE": "D", "MH": "Sterculia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Karaya|T002|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "urens, Sterculia", "MN": "B01.875.800.575.912.250.859.821.500.888", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid66667", "RR": "txid482950", "AN": "source of TRAGACANTH, INDIAN see KARAYA GUM; source of true tragacanth is ASTRAGALUS GUMMIFER", "MS": "A plant genus of the family STERCULIACEAE. S. urens is the source of KARAYA GUM which is sometimes called Indian tragacanth, which is different from the true TRAGACANTH which comes from ASTRAGALUS GUMMIFER.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032361"}, {"RECTYPE": "D", "MH": "Styrax", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "benzoide, Styrax", "MN": "B01.875.800.575.912.250.341.996.777", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13699", "RR": "txid153524", "MS": "A plant genus of the family STYRACACEAE. Sap of these Asian trees are a source of a balsam (BALSAMS). This styrax balsam is 3/4 coniferyl benzoate, 1/8 free BENZOIC ACID, along with benzyl cinnamate, vanillin, and TRITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032362"}, {"RECTYPE": "D", "MH": "Tamaricaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tamarix|T002|NON|NRW|NLM (2003)|011003|abcdef", "ENTRY": "Tamarisks", "MN": "B01.875.800.575.912.250.198.500.992", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid63083", "RR": "txid63084", "MS": "A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032363"}, {"RECTYPE": "D", "MH": "Daphne", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Daphnes", "MN": "B01.875.800.575.912.250.932.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid66679", "MS": "A plant genus of the family THYMELAEACEAE. They are evergreen shrubs much cultivated in garden borders and rock gardens in mild climates. Members contain mezerein, flavonoids, and COUMARINS such as daphnetin and daphnin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032364"}, {"RECTYPE": "D", "MH": "Wikstroemia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Wikstroemias", "MN": "B01.875.800.575.912.250.932.909", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid142693", "MS": "A plant genus of the family THYMELAEACEAE. Members contain daphnoretin and wikstroelides and daphnane-type DITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032365"}, {"RECTYPE": "D", "MH": "Corchorus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.859.821.500.228", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid93758", "MS": "A plant genus of the family TILIACEAE. Members contain cycloartane saponins and CARDENOLIDES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032381"}, {"RECTYPE": "D", "MH": "Grewia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Dhaman Tree|T002|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "Trees, Dhaman", "MN": "B01.875.800.575.912.250.859.821.500.266", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid82407", "MS": "A plant genus of the family TILIACEAE. Members contain lupeol and betulin TRITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032382"}, {"RECTYPE": "D", "MH": "Myocytes, Cardiac", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Muscle Cells, Heart|T025|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "Myocyte, Cardiac", "MN": "A11.620.500", "FX": "Myofibrils", "MH_TH": "NLM (2003)", "ST": "T025", "PI": "Myocardium/cytology (1968-2002)", "MS": "Striated muscle cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC).", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032383"}, {"RECTYPE": "D", "MH": "Tilia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Linden|T002|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "Tilias", "MN": "B01.875.800.575.912.250.859.821.500.944", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid64580", "AN": "do not confuse  the  common name Limetree with LIMES see CITRUS AURANTIIFOLIA", "MS": "A plant genus of the family TILIACEAE. Some species in this genus are called Limetree which is nearly the same as the common name for lime (CITRUS AURANTIIFOLIA). Some people are allergic to the POLLEN.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032384"}, {"RECTYPE": "D", "MH": "Triumfetta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "semitrilobas, Triumfetta", "MN": "B01.875.800.575.912.250.859.821.500.972", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid93801", "RR": "txid93802", "MS": "A plant genus of the family TILIACEAE. The common name of burweed is also used for AMSINCKIA. Triumfetta semitriloba is considered a noxious weed.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032385"}, {"RECTYPE": "D", "MH": "Myoblasts, Cardiac", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Myoblast, Cardiac", "MN": "A11.872.620.470", "FX": "Myocytes, Cardiac", "MH_TH": "NLM (2003)", "ST": "T025", "PI": "Myocardium (1969-2002)", "MS": "Precursor cells destined to differentiate into cardiac myocytes (MYOCYTES, CARDIAC).", "PM": "2003", "HN": "2003", "MR": "20160610", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032386"}, {"RECTYPE": "D", "MH": "Tropaeolaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.942", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4018", "AN": "prefer specific plant", "MS": "A plant family of the order Geraniales, subclass Rosidae, class Magnoliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032387"}, {"RECTYPE": "D", "MH": "Tropaeolum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Nasturtium, Garden|T002|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "Tropaeolums", "MN": "B01.875.800.575.912.250.942.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4019", "RR": "txid4020", "AN": "entry term NASTURTIUM, GARDEN: the genus NASTURTIUM is also available", "MS": "A plant genus of the family TROPAEOLACEAE. The common nasturtium is a plant that grows 2.4-3.6 m (8-12 feet) tall and has funnel-shaped flowers that are commonly yellow-orange with red spots or stripes and have a long spur that contains sweet nectar. Some species in this genus are called watercress which is also a common name for RORIPPA and NASTURTIUM.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032388"}, {"RECTYPE": "D", "MH": "Myocytes, Smooth Muscle", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Smooth Muscle Cells|T025|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "Smooth Muscle Myocytes", "MN": "A11.620.520", "FX": "Myoblasts, Smooth Muscle", "MH_TH": "NLM (2003)", "ST": "T025", "PI": "Muscle, Smooth/cytology (1964-2002)", "MS": "Non-striated, elongated, spindle-shaped cells found lining the digestive tract, uterus, and blood vessels. They are derived from specialized myoblasts (MYOBLASTS, SMOOTH MUSCLE).", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032389"}, {"RECTYPE": "D", "MH": "Myoblasts, Smooth Muscle", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Smooth Muscle Myoblasts|T025|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "Smooth Muscle Myoblast", "MN": "A11.872.620.510", "FX": "Myocytes, Smooth Muscle", "MH_TH": "NLM (2003)", "ST": "T025", "MS": "Precursor cells destined to differentiate into smooth muscle myocytes (MYOCYTES, SMOOTH MUSCLE).", "PM": "2003", "HN": "2003", "MR": "20160610", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032390"}, {"RECTYPE": "D", "MH": "Typhaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Typha|T002|NON|NRW|NLM (2003)|011003|abcdef", "ENTRY": "Typhas", "MN": "B01.875.800.575.912.250.948", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4731", "RR": "txid4732", "MS": "A plant family of the order Typhales, subclass Commelinidae, class Liliopsida (monocotyledons) that contains a single genus, Typha, that grows worldwide.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032401"}, {"RECTYPE": "D", "MH": "Boehmeria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ramie|T002|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "Ramies", "MN": "B01.875.800.575.912.250.859.937.937.077", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid83905", "MS": "A plant genus of the family URTICACEAE. Members contain cryptopleurine, beta-sitosterol, daucosterol and 19 alpha-hydroxyursolic acid.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032402"}, {"RECTYPE": "D", "MH": "Parietaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pellitory|T002|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "Pellitories", "MN": "B01.875.800.575.912.250.859.937.937.777", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13186", "MS": "A plant genus of the family URTICACEAE which is the most common cause of pollinosis in Mediterranean countries. It is the source of 'allergen Par o I' and of Pollinex used for DESENSITIZATION, IMMUNOLOGIC.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032403"}, {"RECTYPE": "D", "MH": "Nardostachys", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Nardostachy", "MN": "B01.875.800.575.912.250.328.937.443", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid59169", "MS": "A plant genus of the family VALERIANACEAE. Nardostachysin, nardostachin, nardosinone, valeranone, and patchoulene have been found in this genus. Nardostachys jatamansi is classified by some as Valeriana jatamansi.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032404"}, {"RECTYPE": "D", "MH": "Patrinia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Patrinias", "MN": "B01.875.800.575.912.250.328.937.665", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid59171", "MS": "A plant genus of the family VALERIANACEAE. Members contain ursolic acid and oleanolic acid glycosides, sulfapatrinosides (triterpenoid glycosides), and patriscabrol (iridolactone).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032405"}, {"RECTYPE": "D", "MH": "Valerianella", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cornsalad|T002|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "Valerianellas", "MN": "B01.875.800.575.912.250.328.937.944", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid59165", "MS": "A plant genus of the family VALERIANACEAE. It is sometimes called goosefoot cornsalad but should not be confused with true goosefoot (CHENOPODIUM).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032406"}, {"RECTYPE": "D", "MH": "Avicennia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mangrove, Grey|T002|NON|NRW|NLM (2004)|021227|abcdef", "ENTRY": "marinas, Avicennia", "MN": "B01.875.800.575.912.250.583.040.522", "FX": "Wetlands", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41377", "RR": "txid82927", "AN": "note entry term MANGROVE, GREY: MANGROVE SWAMPS see WETLANDS is also available", "MS": "A plant genus of the family Acanthaceae. Members contain NAPHTHOQUINONES. Black mangroves (common name for the genus) are distinguished from other mangroves by their spike-like aerial roots called pneumatophores that project from the soil or water surrounding the plants.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032407"}, {"RECTYPE": "D", "MH": "Callicarpa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Beautyberries", "MN": "B01.875.800.575.912.250.583.520.098", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid21922", "MS": "A plant genus of the family Lamiaceae. Members contain clerodane DITERPENES and callicarpone.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032408"}, {"RECTYPE": "D", "MH": "Clerodendrum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Clerodendrums", "MN": "B01.875.800.575.912.250.583.520.121", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13432", "MS": "A plant genus of the family Lamiaceae. Inerminosides (iridoid glycosides); colebroside A; STEROIDS; STEROLS; terpenoid glucosides; and abietane DITERPENES have been found in this genus.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032409"}, {"RECTYPE": "D", "MH": "Lantana", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Lantanas", "MN": "B01.875.800.575.912.250.583.990.411", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid87005", "MS": "A plant genus of the family VERBENACEAE. Members contain lantadene and other TRITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032410"}, {"RECTYPE": "D", "MH": "Lippia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Lippias", "MN": "B01.875.800.575.912.250.583.990.433", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid320344", "MS": "A plant genus of the family VERBENACEAE. Lippsidoquinone; TRITERPENES; SESQUITERPENES; and THYMOL have been found in this genus. Plant extracts have cytotoxic activity. It is sometimes called Mexican oregano but that confuses it with real oregano (ORIGANUM).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032411"}, {"RECTYPE": "D", "MH": "Verbena", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Vervain|T002|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "Vervains", "MN": "B01.875.800.575.912.250.583.990.855", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid22002", "MS": "A plant genus of the family VERBENACEAE. Members contain verbenachalcone (dimeric dihydrochalcone), iridoids, and phenylethanoids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032412"}, {"RECTYPE": "D", "MH": "Viola", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Violet|T002|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "Violets", "MN": "B01.875.800.575.912.250.859.797.962.888", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13757", "MS": "A plant genus of the family VIOLACEAE. Some species in this genus are called bouncing bet which is a common name more often used with SAPONARIA OFFICINALIS. Members contain macrocyclic peptides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032413"}, {"RECTYPE": "D", "MH": "Ampelopsis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Porcelainberry Plants", "MN": "B01.875.800.575.912.250.965.044", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid125007", "RR": "txid178805", "MS": "A plant genus of the family VITACEAE. Members contain momordin and SITOSTEROLS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032421"}, {"RECTYPE": "D", "MH": "Cissus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.965.272", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid149357", "MS": "A plant genus of the family VITACEAE. Cissus rufescence gum is considered comparable to TRAGACANTH.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032422"}, {"RECTYPE": "D", "MH": "Winteraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.970", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3417", "AN": "prefer specific plant", "MS": "A plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. The wood lacks water-conducting cells but has acrid sap. The leaves are gland-dotted, leathery, and smooth-margined. The flowers are small, in clusters, with two to six sepals, petals in two or more series, several stamens, and one to several carpels.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032423"}, {"RECTYPE": "D", "MH": "Drimys", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Drimy", "MN": "B01.875.800.575.912.250.970.199", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3418", "MS": "A plant genus of the family WINTERACEAE. They have leathery, elliptic-shaped leaves; red-tinged shoots; and jasmine-scented, cream-colored, 8- to 12-petaled, 2.5-centimeter (1-inch) flowers in clusters.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032424"}, {"RECTYPE": "D", "MH": "Pseudowintera", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Pseudowinteras", "MN": "B01.875.800.575.912.250.970.599", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid22293", "MS": "A plant genus of the family WINTERACEAE. Members contain polygodial.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032425"}, {"RECTYPE": "D", "MH": "Marantaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Thalia|T002|NON|NRW|NLM (2003)|011003|abcdef", "ENTRY": "Thalias", "MN": "B01.875.800.575.912.250.618.937.522", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4619", "RR": "txid4622", "AN": "entry term ARROWROOT: BRAZILIAN ARROWROOT see MANIHOT is also available", "MS": "A plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032426"}, {"RECTYPE": "D", "MH": "Heliconiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Heliconia|T002|NON|NRW|NLM (2003)|011003|abcdef", "ENTRY": "Heliconias", "MN": "B01.875.800.575.912.250.618.937.323", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4652", "RR": "txid4653", "MS": "A plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032427"}, {"RECTYPE": "D", "MH": "Strelitziaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Strelitzia reginae|T002|NON|NRW|NLM (2022)|210518|abcdef", "MN": "B01.875.800.575.912.250.618.937.727", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4660", "RR": "txid4665", "MS": "A plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida. Some species in this genus are called bird-of-paradise (Strelitzia reginae) which is also a common name for CAESALPINIA and Heliconia (HELICONIACEAE).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032428"}, {"RECTYPE": "D", "MH": "Alpinia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Galanga|T002|NON|NRW|NLM (2003)|011003|abcdef", "ENTRY": "galanga, Alpinia", "MN": "B01.875.800.575.912.250.618.937.900.033", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid94326", "RR": "txid94327", "MS": "A plant genus of the family ZINGIBERACEAE. Members contain galangin, yakuchinone-A, and diarylheptanoids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032429"}, {"RECTYPE": "D", "MH": "Balanites", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Balanite", "MN": "B01.875.800.575.912.250.987.088", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid66624", "MS": "A plant genus of the family ZYGOPHYLLACEAE. Feruloyltyramine, balanitoside (a furostanol glycoside), and cytostatic steroidal saponins have been found in this genus. B. aegyptiaca fruit water extract is traditionally used as an anthelmintic in the Sudan.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032430"}, {"RECTYPE": "D", "MH": "Guaiacum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Guaiacums", "MN": "B01.875.800.575.912.250.987.277", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid45188", "PI": "Guaiac (1982-2002)", "MS": "A plant genus of the family ZYGOPHYLLACEAE. GUAIAC is obtained from G. officinale or G. sanctum. Some species in this genus are called lignum vitae which is also a common name for other trees.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032441"}, {"RECTYPE": "D", "MH": "Larrea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gobernadora|T002|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "Bush, Creosote", "MN": "B01.875.800.575.912.250.987.399", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid66635", "RR": "txid66636", "MS": "A plant genus of the family ZYGOPHYLLACEAE. It is sometimes called chaparral but that is a generic word which is used with a number of other plants. Members contain NORDIHYDROGUAIARETIC ACID.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032442"}, {"RECTYPE": "D", "MH": "Peganum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Peganum harmala|T002|NON|NRW|NLM (2017)|150902|abcdef", "MN": "B01.875.800.575.912.250.987.699", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid43877", "RR": "txid43879", "MS": "A plant genus of the family ZYGOPHYLLACEAE. HARMALINE and other ALKALOIDS, phenylpropanoids, and TRITERPENES have been found in plants of this genus.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032443"}, {"RECTYPE": "D", "MH": "Tribulus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Puncture Vine|T002|NON|EQV|NLM (2003)|011003|abcdef", "ENTRY": "terrestri, Tribulus", "MN": "B01.875.800.575.912.250.987.849", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid66647", "RR": "txid210369", "MS": "A plant genus of the family ZYGOPHYLLACEAE. Members contain steroidal saponins. Ingestion by grazing animals causes PHOTOSENSITIVITY DISORDERS called geeldikkop (yellow thick head) in South Africa.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032444"}, {"RECTYPE": "D", "MH": "Zygophyllum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Zygophyllums", "MN": "B01.875.800.575.912.250.987.924", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid66651", "MS": "A plant genus of the family ZYGOPHYLLACEAE. Members contain SAPONINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032445"}, {"RECTYPE": "D", "MH": "Myoblasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Muscle Cells, Embryonic|T025|NON|EQV|NLM (2003)|011116|abcdef", "ENTRY": "Precursor Muscle Cells", "MN": "A11.872.620", "FX": "Muscle Cells", "MH_TH": "NLM (2003)", "ST": "T025", "AN": "prefer specifics", "PI": "Muscles (1966-2002)", "MS": "Embryonic (precursor) cells of the myogenic lineage that develop from the MESODERM. They undergo proliferation, migrate to their various sites, and then differentiate into the appropriate form of myocytes (MYOCYTES, SKELETAL; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE).", "PM": "2003", "HN": "2003", "MR": "20160610", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032446"}, {"RECTYPE": "D", "MH": "Wisteria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "floribundas, Wisteria", "MN": "B01.875.800.575.912.250.401.984", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3921", "RR": "txid3922", "MS": "A plant genus of the family FABACEAE. Members contain wistarin, wisteria lectin and wistariasaponin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032447"}, {"RECTYPE": "D", "MH": "Myoblasts, Skeletal", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Skeletal Myoblasts|T025|NON|EQV|NLM (2003)|011004|abcdef", "ENTRY": "Skeletal Myoblast", "MN": "A11.872.620.500", "FX": "Muscle Fibers, Skeletal", "MH_TH": "NLM (2003)", "ST": "T025", "PI": "Muscles (1969-1994)", "MS": "Precursor cells destined to differentiate into skeletal myocytes (MYOCYTES, SKELETAL).", "PM": "2003", "HN": "2003", "MR": "20160610", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032448"}, {"RECTYPE": "D", "MH": "Canavalia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Canavalias", "MN": "B01.875.800.575.912.250.401.096", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3822", "MS": "A plant genus of the family FABACEAE. Canavalia ensiformis is the source of CONCANAVALIN A.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032449"}, {"RECTYPE": "D", "MH": "Chromosomes, Plant", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "ENTRY": "Plant Chromosomes", "MN": "G05.360.162.560", "MH_TH": "NLM (2003)", "ST": "T026", "PI": "Chromosomes (1973-2002)", "MS": "Complex nucleoprotein structures which contain the genomic DNA and are part of the CELL NUCLEUS of PLANTS.", "PM": "2003", "HN": "2003", "MR": "20090706", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032461"}, {"RECTYPE": "D", "MH": "Cycadopsida", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gymnosperms|T002|NON|EQV|NLM (1998)|990101|abcdef", "ENTRY": "Gymnosperm", "MN": "B01.875.800.575.156", "MH_TH": "NLM (2006)", "ST": "T002", "RN": "txid3296", "RR": "txid3297", "PI": "Gymnosperms (1998-2002)", "MS": "A class of vascular seed plants also known as gymnosperms in the subdivision spermatophytina. They have large cones and pinnate leaves. Examples are pines, spruces, cedars and sequoias.", "PM": "2018; see CYCADOPHYTA 2003-2017; see GYMNOSPERMS 1998-2002", "HN": "2018(2003); use GYMNOSPERMS 1998-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032462"}, {"RECTYPE": "D", "MH": "Zamiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Zamia|T002|NON|NRW|NLM (2003)|011004|abcdef", "ENTRY": "Zamias", "MN": "B01.875.800.575.156.955", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3298", "RR": "txid58032", "MS": "A plant family of the order Cycadales, class Cycadopsida, division CYCADOPHYTA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032481"}, {"RECTYPE": "D", "MH": "Cephalotaxus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Yew, Harrington Plum|T002|NON|NRW|NLM (2003)|011004|abcdef", "ENTRY": "harringtonias, Cephalotaxus", "MN": "B01.875.800.575.912.625.937.250", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid50178", "RR": "txid58029", "MS": "A plant genus of the family TAXACEAE, order Pinales, class Pinopsida, division TRACHEOPHYTA. Members contain homoharringtonine.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032483"}, {"RECTYPE": "D", "MH": "Cryptomeria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cedar, Japanese|T002|EPO|EQV|NLM (2003)|011004|abcdef", "ENTRY": "Japanese Cedar", "MN": "B01.875.800.575.912.625.750.233", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3368", "MS": "A plant genus of the family CUPRESSACEAE which produce POLLEN that is a major ALLERGEN.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032485"}, {"RECTYPE": "D", "MH": "Cunninghamia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fir, Chinese|T002|EPO|NRW|NLM (2003)|011004|abcdef", "ENTRY": "lanceolatas, Cunninghamia", "MN": "B01.875.800.575.912.625.750.250", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid25608", "RR": "txid28977", "MS": "A plant genus of the family TAXODIACEAE. Members contain DITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032486"}, {"RECTYPE": "D", "MH": "Sequoia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Redwood|T002|NON|NRW|NLM (2003)|011004|abcdef", "ENTRY": "Sequoias", "MN": "B01.875.800.575.912.625.750.699", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid25611", "RR": "txid28980", "AN": "SEQUOIA, GIANT see SEQUOIADENDRON is also available", "MS": "A plant family of conifers in the order Pinales. They are very tall trees with a worldwide distribution.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032487"}, {"RECTYPE": "D", "MH": "Sequoiadendron", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sequoia, Giant|T002|NON|EQV|NLM (2003)|011004|abcdef", "ENTRY": "Sequoias, Giant", "MN": "B01.875.800.575.912.625.750.749", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid99813", "AN": "note entry term SEQUOIA, GIANT: SEQUOIA is also available", "MS": "A plant genus of the family CUPRESSACEAE known for tall trees like the SEQUOIA redwoods.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032488"}, {"RECTYPE": "D", "MH": "Taxodium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cypress, Bald|T002|NON|EQV|NLM (2003)|011004|abcdef", "ENTRY": "Taxodiums", "MN": "B01.875.800.575.912.625.750.774", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13282", "MS": "A plant genus of the family CUPRESSACEAE. Members contain taxodione and taxodone, which are diterpenoid quinone methide tumor inhibitors.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032489"}, {"RECTYPE": "D", "MH": "Taxaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Torreya|T002|NON|NRW|NLM (2003)|011004|abcdef", "MN": "B01.875.800.575.912.625.937", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid25623", "RR": "txid50188", "MS": "A plant family of the order Pinales, class Pinopsida, division TRACHEOPHYTA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032490"}, {"RECTYPE": "D", "MH": "Dryopteridaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Onoclea|T002|NON|NRW|NLM (2003)|011004|abcdef", "ENTRY": "Onocleas", "MN": "B01.875.800.575.912.063.222", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid29607", "RR": "txid3280", "MS": "The wood fern plant family of the order Polypodiales, class Filicopsida, division Pteridophyta.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032491"}, {"RECTYPE": "D", "MH": "Dryopteris", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Male Fern|T002|NON|NRW|NLM (2003)|011004|abcdef", "ENTRY": "filix-mas, Dryopteris", "MN": "B01.875.800.575.912.063.222.222", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3287", "RR": "txid3289", "MS": "A plant genus of the family DRYOPTERIDACEAE. Members contain aspidin and filicic acid.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032492"}, {"RECTYPE": "D", "MH": "Polystichum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fern, Giant Holly|T002|NON|EQV|NLM (2003)|011004|abcdef", "ENTRY": "Polystichums", "MN": "B01.875.800.575.912.063.222.611", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3278", "MS": "A plant genus of the family DRYOPTERIDACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032493"}, {"RECTYPE": "D", "MH": "Polypodium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fern, Licorice|T002|NON|EQV|NLM (2003)|011004|abcdef", "ENTRY": "Polypodiums", "MN": "B01.875.800.575.912.063.700.666", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid38352", "MS": "A plant genus of the family POLYPODIACEAE. Members contain polypodoside.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032494"}, {"RECTYPE": "D", "MH": "Pteris", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fern, Brake|T002|NON|EQV|NLM (2003)|011004|abcdef", "ENTRY": "Pteri", "MN": "B01.875.800.575.912.063.750.666", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13820", "AN": "FERN, BRACKEN, PTERIS AQUILINA and PTERIS ESCULENTUM see PTERIDIUM are also available", "MS": "A plant genus of the family PTERIDACEAE. Members contain entkaurane DITERPENES. The name is similar to bracken fern (PTERIDIUM).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032495"}, {"RECTYPE": "D", "MH": "Satellite Cells, Skeletal Muscle", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Skeletal Muscle Satellite Cells|T025|NON|EQV|NLM (2003)|011004|abcdef", "ENTRY": "Satellite Cell, Myogenic", "MN": "A11.872.620.500.700", "MH_TH": "NLM (2003)", "ST": "T025", "PI": "Muscles/cytology (1965-1994)", "MS": "Elongated, spindle-shaped, quiescent myoblasts lying in close contact with adult skeletal muscle. They are thought to play a role in muscle repair and regeneration.", "PM": "2003", "HN": "2003", "MR": "20220523", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032496"}, {"RECTYPE": "D", "MH": "Dennstaedtiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.063.199", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid32084", "MS": "The bracken fern plant family of the order Polypodiales, class Filicopsida, division Pteridophyta.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032497"}, {"RECTYPE": "D", "MH": "Pteridium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Fern, Bracken|T002|NON|EQV|NLM (2003)|011004|abcdef", "ENTRY": "esculentums, Pteris", "MN": "B01.875.800.575.912.063.199.666", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid32100", "RR": "txid32101", "AN": "do not confuse entry term FERN, BRACKEN with FERN, BRAKE see PTERIS", "MS": "A plant genus of the family DENNSTAEDTIACEAE. Members contain ptaquiloside, braxin A1, and braxin B. The name is similar to brake fern (PTERIS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032498"}, {"RECTYPE": "D", "MH": "Huperzia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Huperzias", "MN": "B01.875.800.575.525.333", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid37428", "MS": "A plant genus of the family LYCOPODIACEAE. Members contain huperzine, one of the CHOLINESTERASE INHIBITORS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032501"}, {"RECTYPE": "D", "MH": "Lycopodium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Lycopodiums", "MN": "B01.875.800.575.525.666", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3251", "MS": "A plant genus of the family LYCOPODIACEAE. Members contain ALKALOIDS. Lycopodium oil is obtained from L. clavatum.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032502"}, {"RECTYPE": "D", "MH": "Selaginellaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Spikemoss|T002|NON|NRW|NLM (2003)|011004|abcdef", "ENTRY": "Spikemosses", "MN": "B01.875.800.575.825", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3245", "RR": "txid3246", "MS": "A plant family of the order Selaginellales, class Lycopodiopsida, division Lycopodiophyta, subkingdom TRACHEOPHYTA. Members contain bilobetin. The rarely used common name of resurrection plant is mainly used with CRATEROSTIGMA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032503"}, {"RECTYPE": "D", "MH": "Immunity, Herd", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Population Immunity|T039|NON|EQV|NLM (2024)|230105|abcdef", "ENTRY": "Immunity, Population", "MN": "G12.450.400", "MH_TH": "NLM (2003)", "ST": "T039", "AN": "human & animal", "MS": "The state of a community in which a significant proportion of its population becomes immune to an infectious disease, and the risk of person-to-person transmission decreases. Individuals who are not immune and susceptible are indirectly protected because ongoing disease spread is very small.", "PM": "2003", "HN": "2003", "MR": "20230601", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032521"}, {"RECTYPE": "D", "MH": "Mass Vaccination", "AQ": "AE CL EC EH ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Mass Immunization|T061|NON|EQV|NLM (2003)|011005|abcdef", "ENTRY": "Vaccination, Mass", "MN": "N06.850.780.680.310.890.500", "FX": "Mass Drug Administration", "MH_TH": "NLM (2003)", "ST": "T061", "PI": "Immunization (1967-2002)", "MS": "Administration of a vaccine to large populations in order to elicit IMMUNITY.", "PM": "2010; see MASS IMMUNIZATION 2003-2009", "HN": "2010 (2003)", "MR": "20170224", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032541"}, {"RECTYPE": "D", "MH": "Cotton Fiber", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Fibers, Cotton", "MN": "J01.637.836.299", "FX": "Gossypium", "MH_TH": "NLM (2003)", "ST": "T167", "PI": "Gossypium (1963-2002)", "MS": "A TEXTILE fiber obtained from the pappus (outside the SEEDS) of cotton plant (GOSSYPIUM).", "PM": "2003", "HN": "2003", "MR": "20180702", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032561"}, {"RECTYPE": "D", "MH": "Tuberculosis Vaccines", "AQ": "AA AD AE AG AI BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tuberculosis Vaccine|T121|T129|NON|EQV|NLM (2022)|201006|abbcdef", "ENTRY": "Vaccines, Tuberculosis", "MN": "D20.215.894.135.825", "MH_TH": "UNK (19XX)", "ST": "T129", "RN": "0", "PI": "BCG Vaccine (1966-2002)", "MS": "Vaccines or candidate vaccines used to prevent or treat TUBERCULOSIS.", "PM": "2003, 1965-1978; see BCG VACCINE 1965-2002", "HN": "2003, 1965-1978; use BCG VACCINE 1965-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032581"}, {"RECTYPE": "D", "MH": "Erysimum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Wallflower|T002|NON|EQV|NLM (2003)|011009|abcdef", "ENTRY": "Wallflowers", "MN": "B01.875.800.575.912.250.157.357", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid65352", "MS": "A plant genus of the family BRASSICACEAE. Some members contain CARDIAC GLYCOSIDES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032601"}, {"RECTYPE": "D", "MH": "Caragana", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Peashrub|T002|NON|EQV|NLM (2003)|011009|abcdef", "ENTRY": "Peashrubs", "MN": "B01.875.800.575.912.250.401.098", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid20483", "MS": "A plant genus of the family FABACEAE. Members contain STILBENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032602"}, {"RECTYPE": "D", "MH": "Scopolia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Scopolias", "MN": "B01.875.800.575.912.250.908.500.612", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid221161", "MS": "A plant genus of the family SOLANACEAE after which the compound SCOPOLAMINE got its name.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032603"}, {"RECTYPE": "D", "MH": "Alangiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Alangium|T002|NON|NRW|NLM (2003)|011009|abcdef", "ENTRY": "Alangiums", "MN": "B01.875.800.575.912.250.022", "MH_TH": "NLM (2003)", "ST": "T002", "RR": "txid16896", "MS": "A plant family of the order Cornales, subclass Rosidae, class Magnoliopsida, consisting of slow-growing evergreen trees common in tropical forests of south India and Burma. Members contain tetrahydroisoquinoline-monoterpene and iridoid glycosides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032604"}, {"RECTYPE": "D", "MH": "DNA Shuffling", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Molecular Breeding|T062|NON|EQV|NLM (2003)|011009|abcdef", "ENTRY": "Shufflings, DNA", "MN": "E05.393.420.238", "FX": "Protein Engineering", "MH_TH": "NLM (2003)", "ST": "T062", "MS": "The use of DNA recombination (RECOMBINATION, GENETIC) to prepare a large gene library of novel, chimeric genes from a population of randomly fragmented DNA from related gene sequences.", "PM": "2003", "HN": "2003", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032621"}, {"RECTYPE": "D", "MH": "Eurotiales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Eurotiale", "MN": "B01.300.107.320", "MH_TH": "NLM (2003)", "ST": "T004", "RN": "txid5042", "MS": "An order of fungi in the phylum ASCOMYCOTA characterized by the presence of well defined peridia and cleistothecial asci. Notable anamorphs (mitosporic forms) of Eurotiales include PENICILLIUM and ASPERGILLUS.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032641"}, {"RECTYPE": "D", "MH": "Cordyceps", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Sphaeria sinensis|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Fungus, Caterpillar", "MN": "B01.300.107.501.220", "MH_TH": "NLM (2003)", "ST": "T004", "RN": "txid45234", "RR": "txid73501", "PI": "Ascomycota (1968-2002)", "MS": "A genus of ascomycetous fungi (ASCOMYCOTA), family Clavicipitaceae, order HYPOCREALES, that grows by infecting insect larvae or mature insects with spores that germinate often before the cocoon is formed.", "PM": "2003", "HN": "2003", "MR": "20220523", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032661"}, {"RECTYPE": "D", "MH": "Spectral Karyotyping", "AQ": "IS MT VE", "PRINT ENTRY": "Karyotyping, Spectral|T059|T063|NON|EQV|NLM (2003)|011010|abbcdef", "ENTRY": "Spectral Karyotypings", "MN": "E05.393.661.475.350.125.800", "MH_TH": "NLM (2003)", "ST": "T063", "PI": "Karyotyping (1996-2002)", "MS": "The simultaneous identification of all chromosomes from a cell by fluorescence in situ hybridization (IN SITU HYBRIDIZATION, FLUORESCENCE) with chromosome-specific florescent probes that are discerned by their different emission spectra.", "PM": "2003", "HN": "2003", "MR": "20150601", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032681"}, {"RECTYPE": "D", "MH": "Biomimetics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Mimetics, Biological|T090|NON|EQV|NLM (2003)|020503|MIMETICS BIOL|abcdefv", "ENTRY": "Sciences, Biomimicry", "MN": "J01.897.120.100", "FX": "Biological Mimicry", "MH_TH": "NLM (2003)", "ST": "T090", "AN": "BIOMIMETIC MATERIALS is also available", "MS": "An interdisciplinary field in materials science, ENGINEERING, and BIOLOGY, studying the use of biological principles for synthesis or fabrication of BIOMIMETIC MATERIALS.", "PM": "2003", "HN": "2003", "MR": "20150109", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032701"}, {"RECTYPE": "D", "MH": "Adult Children", "AQ": "CL ED EH HI LJ PX SN", "PRINT ENTRY": "Offspring, Adult|T098|T099|NON|EQV|NLM (2003)|011011|abbcdef", "ENTRY": "Sons, Adult", "MN": "M01.055", "MH_TH": "NLM (2002)", "ST": "T099", "AN": "HUMAN only; use only when the subject of discussion, not as a checktag", "PI": "Family (1974-2002)", "MS": "Children who have reached maturity or the legal age of majority.", "PM": "2003; see FAMILY 2002", "HN": "2003; use FAMILY 2002", "MR": "20140616", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032721"}, {"RECTYPE": "D", "MH": "Advance Care Planning", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Planning, Advance Medical", "MN": "N04.590.233.624.124", "FX": "Terminal Care", "MH_TH": "NLM (1999)", "ST": "T058", "PI": "Advance Directives (1994-2002)", "MS": "Discussions with patients and/or their representatives about the goals and desired direction of the patient's care, particularly end-of-life care, in the event that the patient is or becomes incompetent to make decisions.", "PM": "2003; see ADVANCE DIRECTIVES 1999-2002", "HN": "2003; use ADVANCE DIRECTIVES 1999-2002", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032722"}, {"RECTYPE": "D", "MH": "Monascus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Monascus rubiginosus|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Monascus purpureus|T004|NON|NRW|NLM (2003)|011011|abcdef", "MN": "B01.300.107.320.500", "MH_TH": "NLM (2003)", "ST": "T004", "RN": "txid5097", "RR": "txid5098", "PI": "Ascomycota (1975-2002)", "MS": "A genus in the family Monascaceae, order EUROTIALES. One species, Monascus purpureus, has multiple uses in traditional Chinese medicine (MEDICINE, CHINESE TRADITIONAL).", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032741"}, {"RECTYPE": "D", "MH": "Animal Experimentation", "AQ": "ES HI LJ SN ST", "ENTRY": "Research, Animal", "MN": "H01.770.644.053", "FX": "Models, Animal", "MH_TH": "NLM (2003)", "ST": "T062", "AN": "IM for moral, legal, ethical, social, and religious aspects of experiments on animals; do not routinely add for specific research studies involving animals", "PI": "Animal Welfare (1978-2002)", "MS": "The use of animals as investigational subjects.", "PM": "2003; see ANIMAL WELFARE 1987-2002; for ANIMAL EXPERIMENTS see ANIMAL 1978-2003", "HN": "2003; use ANIMAL WELFARE 1987-2002; for ANIMAL EXPERIMENTS use ANIMALS 1978-2003", "MR": "20100625", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032761"}, {"RECTYPE": "D", "MH": "Autoexperimentation", "AQ": "ES HI LJ", "PRINT ENTRY": "Self-Experimentation|T062|NON|EQV|NLM (2003)|011011|abcdef", "ENTRY": "Self Experimentation", "MN": "H01.770.644.145.365.100", "MH_TH": "NLM (1999)", "ST": "T062", "MS": "Intentionally using oneself as a research subject.", "PM": "2003; see HUMAN EXPERIMENTATION 1999-2002", "HN": "2003; use HUMAN EXPERIMENTATION 1999-2002", "MR": "20150622", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032762"}, {"RECTYPE": "D", "MH": "Behavior Control", "AQ": "CL ES HI LJ MT PX ST", "PRINT ENTRY": "Behavioral Manipulation|T061|T068|NON|EQV|NLM (2003)|020501|abbcdef", "ENTRY": "Manipulation, Behavioral", "MN": "I01.880.630.099", "FX": "Persuasive Communication", "MH_TH": "NLM (2003)", "ST": "T068", "MS": "Manipulation of the behavior of persons or animals by biomedical, physical, psychological, or social means, including for nontherapeutic reasons.", "PM": "2003; see BEHAVIOR 1997-2002", "HN": "2003; use BEHAVIOR 1997-2002", "MR": "20200527", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032763"}, {"RECTYPE": "D", "MH": "Casuistry", "AQ": "HI", "MN": "N05.350.244.150", "MH_TH": "NLM (1992)", "ST": "T078", "AN": "do not confuse with \"casuistics,\" the recording and study of cases of disease, or with CAUSALITY", "PI": "Ethics (1989-2001)", "MS": "A method of ETHICAL ANALYSIS that emphasizes practical problem solving through examining individual cases that are considered to be representative; sometimes used to denote specious argument or rationalization. Differentiate from casuistics, which is the recording and study of cases and disease.", "PM": "2003; see ETHICAL ANALYSIS 2002; see ETHICS 1992-2001", "HN": "2003; use ETHICAL ANALYSIS 2002; use ETHICS 1992-2001", "MR": "20150622", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032764"}, {"RECTYPE": "D", "MH": "Codes of Ethics", "AQ": "CL HI LJ TD", "PRINT ENTRY": "Ethical Oaths|T170|NON|REL|NLM (2003)|011011|abcdef", "ENTRY": "Professional Ethics Codes", "MN": "N05.700.350.324", "MH_TH": "NLM (2003)", "ST": "T170", "AN": "if text of code and issuing organization are present, index also GUIDELINE (PT)", "PI": "Ethics, Professional (1974-2002)", "MS": "Systematic statements of principles or rules of appropriate professional conduct, usually established by professional societies.", "PM": "2003; see ETHICS, PROFESSIONAL 1991-2001", "HN": "2003; use ETHICS, PROFESSIONAL 1991-2001", "MR": "20150622", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032781"}, {"RECTYPE": "D", "MH": "Iridectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Corectomy|T061|NON|EQV|NLM (2003)|011011|abcdef", "ENTRY": "Iridectomies", "MN": "E04.540.480", "MH_TH": "NLM (2003)", "ST": "T061", "PI": "Iris/surgery (1964-2002)", "MS": "Surgical removal of a section of the iris.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032801"}, {"RECTYPE": "D", "MH": "Committee Membership", "ENTRY": "Memberships, Committee", "MN": "N04.452.122", "MH_TH": "NLM (2003)", "ST": "T102", "AN": "coord with specific committee if pertinent", "PI": "Organization and Administration (1990-2002)", "MS": "The composition of a committee; the state or status of being a member of a committee.", "PM": "2003", "HN": "2003", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032802"}, {"RECTYPE": "D", "MH": "Commodification", "MN": "J01.219.187", "MH_TH": "NLM (2000)", "ST": "T067", "PI": "Economics (1986-2002)", "MS": "The social process by which something or someone comes to be regarded and treated as an article of trade or commerce.", "PM": "2003; see ECONOMICS 2001-2002", "HN": "2003; use ECONOMICS 2001-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032821"}, {"RECTYPE": "D", "MH": "Sinomenium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Qing Feng Teng|T002|NON|NRW|NLM (2003)|011011|abcdef", "ENTRY": "acutums, Sinomenium", "MN": "B01.875.800.575.912.250.725.625", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid152362", "RR": "txid152363", "MS": "A plant genus of the family MENISPERMACEAE. Members contain sinomenine, caffeine, 1,7-dimethylxanthine, and other ALKALOIDS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032841"}, {"RECTYPE": "D", "MH": "Emericella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Emericellas", "MN": "B01.300.107.320.200", "MH_TH": "NLM (2003)", "ST": "T004", "RN": "txid5071", "PI": "Ascomycota (1974-2002)", "MS": "A genus in the family Trichocomaceae, order EUROTIALES. The anamorph is ASPERGILLUS.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032842"}, {"RECTYPE": "D", "MH": "Buddleja", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Buddlejas", "MN": "B01.875.800.575.912.250.583.800.124", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid26473", "MS": "A plant genus of the family SCROPHULARIACEAE. Members contain mimengoside B, verbascoside, and phenylethanoids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032861"}, {"RECTYPE": "D", "MH": "Litsea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Litseas", "MN": "B01.875.800.575.912.250.595.400.555", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid22042", "MS": "A plant genus of the family LAURACEAE. Members contain laurotetanine and other APORPHINES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032862"}, {"RECTYPE": "D", "MH": "Comprehension", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Understanding|T041|NON|EQV|NLM (2003)|011011|abcdef", "MN": "F02.463.188.357", "FX": "Mental Recall", "MH_TH": "NLM (1993)", "ST": "T041", "PI": "Mental Processes (1978-1992)", "MS": "The act or fact of grasping the meaning, nature, or importance of; understanding. (American Heritage Dictionary, 4th ed) Includes understanding by a patient or research subject of information disclosed orally or in writing.", "PM": "2003; see COGNITION 1993-2002", "HN": "2003; use COGNITION 1993-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032882"}, {"RECTYPE": "D", "MH": "Talaromyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Talaromyce", "MN": "B01.300.107.320.800", "MH_TH": "NLM (2003)", "ST": "T004", "RN": "txid5094", "PI": "Ascomycota (1965-2002)", "MS": "A fungal genus in the family Trichocomaceae, order EUROTIALES, characterized by loose hyphal fruiting bodies containing spherical asci. Anamorphs include PENICILLIUM and PAECILOMYCES.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032901"}, {"RECTYPE": "D", "MH": "Ganoderma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Ganoderma tsugae|T004|NON|NRW|NLM (2016)|150320|abcdef", "MN": "B01.300.179.120.760.338", "MH_TH": "NLM (2003)", "ST": "T004", "RN": "txid5314", "RR": "txid34467", "PI": "Basidiomycota (1971-2002)", "MS": "A genus of fungi in the family Ganodermataceae, order POLYPORALES, containing a dimitic hyphal system. It causes a white rot and is a wood decomposer. Ganoderma lucidum (REISHI) is used in traditional Chinese medicine (MEDICINE, CHINESE TRADITIONAL).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032902"}, {"RECTYPE": "D", "MH": "Confucianism", "AQ": "HI PX", "MN": "K01.844.799.214", "MH_TH": "NLM (2002)", "ST": "T078", "MS": "A school of thought and set of moral, ethical, and political teachings usually considered to be founded by Confucius in 6th-5th century B.C. China. (from Cambridge Dictionary of Philosophy, 1995)", "PM": "2003; see RELIGIOUS PHILOSOPHIES 2002", "HN": "2003; use RELIGIOUS PHILOSOPHIES 2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032903"}, {"RECTYPE": "D", "MH": "Cinnamomum aromaticum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cassia, Chinese|T002|NON|EQV|NLM (2003)|010904|abcdef", "ENTRY": "Trees, Cassia", "MN": "B01.875.800.575.912.250.595.400.149.124", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid119260", "AN": "note entry terms: do not confuse with CASSIA SENNA, CASSIA ANGUSTIFOLIA or CASSIA OCCIDENTALIS see SENNA PLANT", "MS": "A plant species of the genus CINNAMOMUM that contains CINNAMATES and has been used in traditional Chinese medicine (DRUGS, CHINESE HERBAL).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032904"}, {"RECTYPE": "D", "MH": "Consensus", "ENTRY": "Development, Consensus", "MN": "F02.463.785.373.433", "FX": "Dissent and Disputes", "MH_TH": "NLM (2003)", "ST": "T054", "MS": "General agreement or collective opinion; the judgment arrived at by most of those concerned.", "PM": "2003; see DECISION MAKING 1997-2002", "HN": "2003; use DECISION MAKING 1997-2002", "MR": "20070711", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032921"}, {"RECTYPE": "D", "MH": "Sperm Midpiece", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Sperm Midpieces", "MN": "A11.497.760.450", "MH_TH": "NLM (2003)", "ST": "T026", "PI": "Spermatozoa (1975-2002)", "MS": "The middle piece of the spermatozoon is a highly organized segment consisting of MITOCHONDRIA, the outer dense fibers and the core microtubular structure.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032961"}, {"RECTYPE": "D", "MH": "Consent Forms", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Informed Consent Forms|T073|T170|NON|EQV|NLM (2002)|010614|abbcdef", "ENTRY": "Informed Consent Form", "MN": "N05.715.360.300.715.245", "MH_TH": "NLM (1998)", "ST": "T170", "PI": "Informed Consent (1974-2002)", "MS": "Documents describing a medical treatment or research project, including proposed procedures, risks, and alternatives, that are to be signed by an individual, or the individual's proxy, to indicate his/her understanding of the document and a willingness to undergo the treatment or to participate in the research.", "PM": "2003; see INFORMED CONSENT 1998-2002", "HN": "2003; use INFORMED CONSENT 1998-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032962"}, {"RECTYPE": "D", "MH": "Dehumanization", "ENTRY": "Dehumanisation|T054|T067|NON|EQV|NLM (2003)|011015|abbcdef", "MN": "F01.145.813.191", "MH_TH": "NLM (2003)", "ST": "T067", "MS": "The process by which a person or group of persons comes to be regarded or treated as lacking in human qualities.", "PM": "2003", "HN": "2003", "MR": "20040713", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032981"}, {"RECTYPE": "D", "MH": "Contracts", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Contract", "MN": "N03.706.535.241", "FX": "Contract Services", "MH_TH": "NLM (2003)", "ST": "T170", "AN": "CONTRACT SERVICES is also available", "MS": "Agreements between two or more parties, especially those that are written and enforceable by law (American Heritage Dictionary of the English Language, 4th ed). It is sometimes used to characterize the nature of the professional-patient relationship.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032982"}, {"RECTYPE": "D", "MH": "Setaria Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Setaria italica|T002|NON|NRW|NLM (2003)|011015|abcdef", "ENTRY": "italica, Setaria", "MN": "B01.875.800.575.912.250.822.871", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4554", "RR": "txid4555", "AN": "note X refs: other millet terms are also available", "PI": "Panicum (1990-2002)", "MS": "A plant genus of the family POACEAE. The small pointed seeds are grown for hay in North America and western Europe and important as food in China and other Asian countries.", "PM": "2003; for ITALIAN MILLET see PANICUM 1990-2002", "HN": "2003; for ITALIAN MILLET use PANICUM 1990-2002", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D032983"}, {"RECTYPE": "D", "MH": "Ethics, Research", "AQ": "ED HI", "PRINT ENTRY": "Research Ethics|T078|NON|EQV|NLM (2002)|010405|abcdef", "MN": "N05.350.670", "FX": "Research", "MH_TH": "NLM (2003)", "ST": "T078", "AN": "do not use routinely for ethical issues in research, for which prefer specific topics; reserve for discussions of research ethics as a topic in its own right", "MS": "The moral obligations governing the conduct of research. Used for discussions of research ethics as a general topic.", "PM": "2003; see ETHICS 2002", "HN": "2003; use ETHICS 2002", "MR": "20150622", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D032984"}, {"RECTYPE": "D", "MH": "Directed Tissue Donation", "AQ": "CL EC ES HI LJ SN TD", "PRINT ENTRY": "Directed Donation|T055|NON|EQV|BIOETHICS (1990)|NLM (2003)|900802|abcdeef", "ENTRY": "Tissue Donations, Directed", "MN": "N02.421.911.200", "FX": "Tissue Donors", "MH_TH": "NLM (2003)", "ST": "T055", "PI": "Tissue Donors (1990-2002)", "MS": "Tissue, organ, or gamete donation intended for a designated recipient.", "PM": "2003; see ORGAN PROCUREMENT 2002; see TISSUE DONORS 1992-2001", "HN": "2003; use ORGAN PROCUREMENT 2002; use TISSUE DONORS 1992-2001", "MR": "20180629", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033001"}, {"RECTYPE": "D", "MH": "Duty to Recontact", "AQ": "ES LJ", "PRINT ENTRY": "Recontact|T054|NON|BRD|NLM (2003)|011015|abcdef", "ENTRY": "Recontacts", "MN": "N03.706.535.247", "FX": "Duty to Warn", "MH_TH": "NLM (2003)", "ST": "T078", "MS": "The ethical and/or legal obligation of a health provider or researcher to communicate with a former patient or research subject about advances in research relevant to a treatment or to a genetic or other diagnostic test provided earlier, or about proposed new uses of blood or tissue samples taken in the past for another purpose.", "PM": "2003; see DISCLOSURE 2002", "HN": "2003; use DISCLOSURE 2002", "MR": "20120703", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033002"}, {"RECTYPE": "D", "MH": "Eastern Orthodoxy", "AQ": "HI PX", "PRINT ENTRY": "Russian Orthodoxy|T078|EPO|NRW|NLM (2002)|010215|abcdef", "ENTRY": "Orthodoxy, Syrian", "MN": "K01.844.188.502", "MH_TH": "NLM (2003)", "ST": "T078", "AN": "specify geog if pertinent", "PI": "Christianity (1979-2002)", "MS": "The name given to the religion of the body of modern churches, including among others the Greek and Russian Orthodox, that is derived from the church of the Byzantine Empire, adheres to the Byzantine rite, and acknowledges the honorary primacy of the patriarch of Constantinople. (from American Heritage Dictionary of the English Language, 4th ed)", "PM": "2003", "HN": "2003; for EASTERN ORTHODOX ETHICS use CHRISTIANITY 1992-2002", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033003"}, {"RECTYPE": "D", "MH": "Oxytropis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Locoweed, White|T002|NON|NRW|NLM (2003)|011015|abcdef", "ENTRY": "sericeas, Oxytropis", "MN": "B01.875.800.575.912.250.401.606", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid20802", "RR": "txid90234", "MS": "A plant genus of the family FABACEAE. Members contain SWAINSONINE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033021"}, {"RECTYPE": "D", "MH": "Vicia sativa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Vetch, Common|T002|NON|EQV|NLM (2003)|011015|abcdef", "ENTRY": "sativa, Vicia", "MN": "B01.875.800.575.912.250.401.968.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3908", "MS": "A plant species of the genus VICIA, family FABACEAE. The seed is used for food and contains THIOCYANATES such as prunasin, cyanoalanine, cyanogen, and vicine.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033022"}, {"RECTYPE": "D", "MH": "Foot Joints", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Intermetatarsal Joint|T030|NON|NRW|UNK (19XX)|740330|abcdef", "ENTRY": "Joints, Intermetatarsal", "MN": "A02.835.583.378", "MH_TH": "NLM (2003)", "ST": "T030", "AN": "prefer specifics", "PI": "specific foot joints (1976-2002)", "MS": "The articulations extending from the ANKLE distally to the TOES. These include the ANKLE JOINT; TARSAL JOINTS; METATARSOPHALANGEAL JOINT; and TOE JOINT.", "PM": "2003; for INTERMETATARSAL JOINT see TARSAL JOINTS 1965-2005; for FOOT JOINT see TARSAL JOINTS 1975-2002", "HN": "2003; for INTERMETATARSAL JOINT use TARSAL JOINTS 1965-2005; for FOOT JOINT use TARSAL JOINTS 1975-2002", "MR": "20090706", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033023"}, {"RECTYPE": "D", "MH": "Embryo Research", "AQ": "EC ES HI LJ", "PRINT ENTRY": "Human Embryo Research|T062|NON|EQV|NLM (2003)|011015|abcdef", "ENTRY": "Research, Human Embryo", "MN": "H01.770.644.145.250", "FX": "Stem Cell Research", "MH_TH": "NLM (2003)", "ST": "T062", "AN": "mammalian only; IM for ethical, legal, moral, social, or religious aspects of research on embryos; do not routinely add for research involving embryos; embryonic stem cell research: index EMBRYONIC STEM CELL RESEARCH see STEM CELL RESEARCH + EMBRYONIC STEM CELLS & do not index here", "PI": "Research (1985-2002)", "MS": "Experimentation on, or using the organs or tissues from, a human or other mammalian conceptus during the prenatal stage of development that is characterized by rapid morphological changes and the differentiation of basic structures. In humans, this includes the period from the time of fertilization to the end of the eighth week after fertilization.", "PM": "2003; see RESEARCH 1996-2002", "HN": "2003; use RESEARCH 1996-2002", "MR": "20100625", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033041"}, {"RECTYPE": "D", "MH": "Fetal Research", "AQ": "EC ES HI LJ", "PRINT ENTRY": "Fetal Tissue Research|T062|NON|NRW|NLM (1995)|940315|abcdef", "ENTRY": "Research, Fetal Tissue", "MN": "H01.770.644.145.300", "FX": "Human Experimentation", "MH_TH": "BIOETHICS (1995)", "ST": "T062", "AN": "mammalian only; IM for ethical, legal, moral, social, or religious aspects of research on fetuses; do not routinely add for research involving fetuses; X ref Fetal Cell Research: coord with specific type of cell", "MS": "Experimentation on, or using the organs or tissues from, a human or other mammalian conceptus in the postembryonic period, after the major structures have been outlined. In humans, this corresponds to the period from the third month after fertilization until birth.", "PM": "2003; see RESEARCH 1996-2002; for FETAL TISSUE RESEARCH see RESEARCH 1995-2002", "HN": "2003; use RESEARCH 1996-2002; for FETAL TISSUE RESEARCH use RESEARCH 1995-2002", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033042"}, {"RECTYPE": "D", "MH": "Ethics Consultation", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Ethics Consultations", "MN": "N05.350.250.200", "FX": "Ethics, Clinical", "MH_TH": "NLM (2003)", "ST": "T058", "PI": "Referral and Consultation (1988-2001)", "MS": "Services provided by an individual ethicist (ETHICISTS) or an ethics team or committee (ETHICS COMMITTEES, CLINICAL) to address the ethical issues involved in a specific clinical case. The central purpose is to improve the process and outcomes of patients' care by helping to identify, analyze, and resolve ethical problems.", "PM": "2003; see ETHICAL REVIEW 2002", "HN": "2003; use ETHICAL REVIEW 2002", "MR": "20150622", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033061"}, {"RECTYPE": "D", "MH": "Friends", "AQ": "EH PX", "PRINT ENTRY": "Friendship|T054|NON|REL|NLM (1995)|940125|abcdef", "ENTRY": "Friendships", "MN": "M01.252", "FX": "Interpersonal Relations", "MH_TH": "NLM (2003)", "ST": "T098", "AN": "for Society of Friends, or Quakers, use PROTESTANTISM", "PI": "Interpersonal Relations (1995-2002)", "MS": "Persons whom one knows, likes, and trusts.", "PM": "2003; see INTERPERSONAL RELATIONS 1980-2002", "HN": "2003; use INTERPERSONAL RELATIONS 1980-2002", "MR": "20030725", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033062"}, {"RECTYPE": "D", "MH": "Shear Strength", "AQ": "DE PH RE", "ENTRY": "Strength, Shear", "MN": "G01.374.820", "MH_TH": "NLM (2003)", "ST": "T070", "PI": "Biomechanics (1974-2002)", "MS": "The internal resistance of a material to moving some parts of it parallel to a fixed plane, in contrast to stretching (TENSILE STRENGTH) or compression (COMPRESSIVE STRENGTH). Ionic crystals are brittle because, when subjected to shear, ions of the same charge are brought next to each other, which causes repulsion.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033081"}, {"RECTYPE": "D", "MH": "Euthanasia, Active, Voluntary", "AQ": "ES HI LJ PX SN TD", "PRINT ENTRY": "Voluntary Euthanasia|T052|NON|BRD|BIOETHICS (1974)|770329|abcdef", "MN": "N02.421.585.905.199.500.200", "FX": "Suicide, Assisted", "MH_TH": "NLM (2003)", "ST": "T052", "PI": "Euthanasia (1974-2002)", "MS": "Active euthanasia of a patient at the patient's request and/or with the patient's consent.", "PM": "2003; for VOLUNTARY EUTHANASIA see EUTHANASIA 1978-2002", "HN": "2003; for VOLUNTARY EUTHANASIA use EUTHANASIA 1978-2002", "MR": "20150629", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033101"}, {"RECTYPE": "D", "MH": "Genetic Determinism", "DE": "GENET DETERMINISM", "ENTRY": "Determinism, Genetic", "MN": "F04.096.276.400", "MH_TH": "NLM (2003)", "ST": "T078", "MS": "The theory that human CHARACTER and BEHAVIOR are shaped by the GENES that comprise the individual's GENOTYPE rather than by CULTURE; ENVIRONMENT; and individual choice.", "PM": "2003; see GENETICS, BEHAVIORAL 2002", "HN": "2003; use GENETICS, BEHAVIORAL 2002", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033141"}, {"RECTYPE": "D", "MH": "Genetic Services", "DE": "GENET SERV", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Service, Genetic", "MN": "N02.421.308", "FX": "Prenatal Diagnosis", "MH_TH": "NLM (2003)", "ST": "T058", "PI": "Genetics, Medical (1978-2002)", "MS": "Organized services to provide diagnosis, treatment, and prevention of genetic disorders.", "PM": "2003; see GENETIC COUNSELING 2002, see REPRODUCTION TECHNIQUES 1999-2001", "HN": "2003; use GENETIC COUNSELING 2002, use REPRODUCTION TECHNIQUES 1999-2001", "MR": "20150629", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033142"}, {"RECTYPE": "D", "MH": "Government Regulation", "DE": "GOVERNMENT REG", "AQ": "HI", "ENTRY": "Regulations, Government", "MN": "N03.706.358", "MH_TH": "NLM (2003)", "ST": "T064", "AN": "coord with subject of regulation /legis if pertinent; for government regulation of health facilities, add FACILITY REGULATION AND CONTROL", "PI": "specific heading/legislation & jurisprudence (1974-2002)", "MS": "Exercise of governmental authority to control conduct.", "PM": "2003; see SOCIAL CONTROL, FORMAL 1978-2002", "HN": "2003; use SOCIAL CONTROL, FORMAL 1978-2002", "MR": "20030725", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033161"}, {"RECTYPE": "D", "MH": "Incidental Findings", "ENTRY": "Incidental Finding", "MN": "E01.410", "MH_TH": "NLM (2003)", "ST": "T033", "AN": "HUMAN only", "MS": "Unanticipated information discovered in the course of testing or medical care. Used in discussions of information that may have social or psychological consequences, such as when it is learned that a child's biological father is someone other than the putative father, or that a person tested for one disease or disorder has, or is at risk for, something else.", "PM": "2003", "HN": "2003", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033162"}, {"RECTYPE": "D", "MH": "Information Dissemination", "AQ": "ES HI LJ MT", "ENTRY": "Sharings, Information", "MN": "L01.143.443", "FX": "Information Services", "MH_TH": "NLM (2003)", "ST": "T054", "PI": "Information Services (1968-2002)", "MS": "The circulation or wide dispersal of information.", "PM": "2003; see INFORMATION SERVICES 1978-2002", "HN": "2003; use INFORMATION SERVICES 1978-2002", "MR": "20120703", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033181"}, {"RECTYPE": "D", "MH": "Intention", "ENTRY": "Intentions", "MN": "F02.463.306", "FX": "Goals", "MH_TH": "NLM (2003)", "ST": "T041", "MS": "What a person has in mind to do or bring about.", "PM": "2003; see MOTIVATION 1993-2002", "HN": "2003; use MOTIVATION 1993-2002", "MR": "20080710", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033182"}, {"RECTYPE": "D", "MH": "Interdisciplinary Communication", "ENTRY": "Research, Communication", "MN": "L01.143.865.500", "FX": "Interprofessional Relations", "MH_TH": "NLM (2003)", "ST": "T078", "AN": "use only for communication across disciplines; for relations between individuals in different disciplines, use instead INTERPROFESSIONAL RELATIONS; coord IM with specific disciplines (IM)", "PI": "Interprofessional Relations (1974-2002)", "MS": "Communication, in the sense of cross-fertilization of ideas, involving two or more academic disciplines (such as the disciplines that comprise the cross-disciplinary field of bioethics, including the health and biological sciences, the humanities, and the social sciences and law). Also includes differences in patterns of language usage in different academic or medical disciplines.", "PM": "2003; see INTERPROFESSIONAL RELATIONS 1992-2002", "HN": "2003; use INTERPROFESSIONAL RELATIONS 1992-2002", "MR": "20190705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033183"}, {"RECTYPE": "D", "MH": "Euphausiacea", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Nyctiphanes|T204|NON|NRW|UNK (19XX)|850523|abcdef", "MN": "B01.050.500.131.365.250", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6816", "RR": "txid6818", "AN": "as food, coordinate with SHELLFISH", "PI": "Zooplankton (1983-1985)", "MS": "An order of pelagic, shrimplike CRUSTACEA. Many consume ZOOPLANKTON and a few are predacious. Many antarctic species, such as Euphausia superba, constitute the chief food of other animals.", "PM": "2003; see CRUSTACEA 1990-2002; for EUPHAUSIA & NYCTIPHANES see CRUSTACEA 1986-2002", "HN": "2003; use CRUSTACEA 1990-2002; for EUPHAUSIA & NYCTIPHANES use CRUSTACEA 1986-2002", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033201"}, {"RECTYPE": "D", "MH": "Anostraca", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Shrimp, Fairy|T204|NON|EQV|NLM (2003)|011017|abcdef", "ENTRY": "Shrimps, Fairy", "MN": "B01.050.500.131.365.060", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6659", "AN": "note entry term FAIRY SHRIMP: several other shrimp terms are available; check text and MeSH; as animal and food; as food, coord IM with SHELLFISH (IM); unspecified shrimp as food is probably PENAEIDAE", "PI": "Crustacea (1968-2002)", "MS": "An order of CRUSTACEA comprised of shrimp-like organisms containing body trunks with at least 20 segments. The are commonly used as aquarium food.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033202"}, {"RECTYPE": "D", "MH": "Jehovah's Witnesses", "AQ": "HI PX", "ENTRY": "Witnesses, Jehovah's", "MN": "M01.352", "MH_TH": "NLM (2003)", "ST": "T098", "AN": "specify geographic term if pertinent; CATALOGER: Use NAF entry", "PI": "Christianity (1974-2002)", "MS": "Members of a religious denomination founded in the United States during the late 19th century in which active evangelism is practiced, the imminent approach of the millennium is preached, and war and organized government authority in matters of conscience are strongly opposed (from American Heritage Dictionary of the English Language, 4th ed). Jehovah's Witnesses generally refuse blood transfusions and other blood-based treatments based on religious belief.", "PM": "2003; see CHRISTIANITY 1978-2002", "HN": "2003; use CHRISTIANITY 1978-2002", "MR": "20150605", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033221"}, {"RECTYPE": "D", "MH": "Judicial Role", "AQ": "HI", "PRINT ENTRY": "Judicial Bypass|T064|NON|NRW|NLM (2003)|011018|abcdef", "ENTRY": "Roles, Judicial", "MN": "I01.880.604.583.474", "MH_TH": "NLM (2003)", "ST": "T064", "AN": "use only for discussions of the role of judges or courts in decision making, not routinely for individual court cases", "PI": "Jurisprudence (1975-2002)", "MS": "The kind of action or activity proper to the judiciary, particularly its responsibility for decision making.", "PM": "2003; see JURISPRUDENCE 1978-2002", "HN": "2003; use JURISPRUDENCE 1978-2002", "MR": "20030725", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033222"}, {"RECTYPE": "D", "MH": "Lawyers", "AQ": "CL ED HI LJ PX SN ST", "ENTRY": "Public Defender", "MN": "M01.526.520", "FX": "Jurisprudence", "MH_TH": "NLM (2003)", "ST": "T097", "PI": "Jurisprudence (1964-2002)", "MS": "Persons whose profession is to give legal advice and assistance to clients and represent them in legal matters. (American Heritage Dictionary, 3d ed)", "PM": "2003; see JURISPRUDENCE 1992-2002", "HN": "2003; use JURISPRUDENCE 1992-2002", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033241"}, {"RECTYPE": "D", "MH": "Minors", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Minor", "MN": "M01.416", "FX": "Child", "MH_TH": "NLM (2003)", "ST": "T098", "AN": "check appropriate age check tag; do not routinely add this term; use only when specified by author", "PI": "Child (1965-2002)", "MS": "A person who has not attained the age at which full civil rights are accorded.", "PM": "2003; see ADOLESCENCE 1982-2002", "HN": "2003; use ADOLESCENCE 1982-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033242"}, {"RECTYPE": "D", "MH": "Maternal-Fetal Relations", "DE": "MATERNAL FETAL RELAT", "AQ": "DE EH HI PH PX RE", "PRINT ENTRY": "Mother-Fetus Relationship|T055|NON|EQV|BIOETHICS (1974)|NLM (2003)|011018|abcdeef", "ENTRY": "Relationships, Mother-Fetus", "MN": "F01.829.263.370.290.170.500", "FX": "Pregnant Women", "MH_TH": "NLM (2003)", "ST": "T055", "MS": "The bond or lack thereof between a pregnant woman and her FETUS.", "PM": "2003", "HN": "2003", "MR": "20130708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033261"}, {"RECTYPE": "D", "MH": "Narration", "AQ": "HI", "PRINT ENTRY": "Narrative Ethics|T078|NON|NRW|NLM (1997)|970227|abcdef", "ENTRY": "Narrations", "MN": "N06.850.520.308.502", "FX": "Narrative Therapy", "MH_TH": "NLM (2003)", "ST": "T054", "MS": "The act, process, or an instance of narrating, i.e., telling a story. In the context of MEDICINE or ETHICS, narration includes relating the particular and the personal in the life story of an individual.", "PM": "2003; for NARRATIVE ETHICS see ETHICS 1998-2002", "HN": "2003; for NARRATIVE ETHICS use ETHICS 1998-2002", "MR": "20170703", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033262"}, {"RECTYPE": "D", "MH": "Nontherapeutic Human Experimentation", "DE": "NONTHER HUMAN EXPERIMENTATION", "AQ": "ES HI LJ SN ST", "PRINT ENTRY": "Human Experimentation, Nontherapeutic|T062|NON|EQV|NLM (2003)|020508|HUMAN EXPERIMENTATION NONTHER|abcdefv", "ENTRY": "Experimentation, Nontherapeutic Human", "MN": "H01.770.644.145.365.750", "FX": "Clinical Trials, Phase I as Topic", "MH_TH": "NLM (2003)", "ST": "T062", "AN": "use only when the issue of nontherapeutic research is discussed, including its ethical, legal, psychological, or social implications", "PI": "Human Experimentation (1978-2002)", "MS": "Human experimentation that is not intended to benefit the subjects on whom it is performed. Phase I drug studies (CLINICAL TRIALS, PHASE I AS TOPIC) and research involving healthy volunteers are examples of nontherapeutic human experimentation.", "PM": "2003", "HN": "2003", "MR": "20150623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033281"}, {"RECTYPE": "D", "MH": "Parental Consent", "AQ": "ES HI LJ PX SN", "ENTRY": "Consent, Parental", "MN": "N03.706.535.489.635.500", "FX": "Parents", "MH_TH": "NLM (2003)", "ST": "T078", "PI": "Third-Party Consent (1999-2002)", "MS": "Informed consent given by a parent on behalf of a minor or otherwise incompetent child.", "PM": "2003; see THIRD-PARTY CONSENT 1999-2002", "HN": "2003; use THIRD-PARTY CONSENT 1999-2002", "MR": "20021031", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033282"}, {"RECTYPE": "D", "MH": "Patient Access to Records", "AQ": "EC ES HI LJ PX SN ST TD", "MN": "N03.706.437.650.406", "FX": "Disclosure", "MH_TH": "NLM (2003)", "ST": "T078", "PI": "Patient Rights (2000-2002)", "MS": "The freedom of patients to review their own medical, genetic, or other health-related records.", "PM": "2003; see PATIENT RIGHTS 2002, see PATIENT ADVOCACY 1992-2001", "HN": "2003; use PATIENT RIGHTS 2002, use PATIENT ADVOCACY 1992-2001", "MR": "20060705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033283"}, {"RECTYPE": "D", "MH": "Deciduoma", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Deciduomas", "MN": "A16.710.289.500", "MH_TH": "NLM (1998)", "ST": "T020", "PI": "Pseudopregnancy (1966-2001)", "MS": "An intrauterine mass containing decidual cells (DECIDUA) or with structures resembling the PLACENTA. Deciduomas usually are induced experimentally.", "PM": "2003; see HYPERPLASIA 2002, see DECIDUA 1998-2001", "HN": "2003; use HYPERPLASIA 2002, use DECIDUA 1998-2001", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033301"}, {"RECTYPE": "D", "MH": "Postmodernism", "AQ": "HI", "MN": "K01.752.720", "MH_TH": "NLM (2003)", "ST": "T078", "PI": "Philosophy (1993-2002)", "MS": "A late 20th-century philosophical approach or style of cultural analysis that seeks to reveal the cultural or social construction of concepts conventionally assumed to be natural or universal. (from E.R. DuBose, The Illusion of Trust: Toward a Medical Theological Ethics in the Postmodern Age, Kluwer, 1995)", "PM": "2003; see PHILOSOPHY 2002", "HN": "2003; use PHILOSOPHY 2002", "MR": "20060705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033302"}, {"RECTYPE": "D", "MH": "Protestantism", "AQ": "HI PX", "PRINT ENTRY": "Seventh-Day Adventists|T098|NON|REL|NLM (1994)|920731|abcdef", "ENTRY": "Seventh-Day Adventist", "MN": "K01.844.188.644", "MH_TH": "POPLINE (1978)", "ST": "T078", "AN": "specify geog if pertinent", "PI": "Christianity (1974-2002)", "MS": "The name given to all Christian denominations, sects, or groups rising out of the Reformation. Protestant churches generally agree that the principle of authority should be the Scriptures rather than the institutional church or the pope. (from W.L. Reese, Dictionary of Philosophy and Religion, 1999)", "PM": "2003; see CHRISTIANITY 1978-2002; for SEVENTH-DAY ADVENTISTS see CHRISTIANITY 1994-2002", "HN": "2003; use CHRISTIANITY 1978-2002; for SEVENTH-DAY ADVENTISTS use CHRISTIANITY 1994-2002", "MR": "20130709", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033303"}, {"RECTYPE": "D", "MH": "Amphipoda", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Amphipodas", "MN": "B01.050.500.131.365.055", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6821", "PI": "Crustacea (1965-2002)", "MS": "An order of mostly marine CRUSTACEA containing more than 5500 species in over 100 families. Like ISOPODA, the other large order in the superorder Peracarida, members are shrimp-like in appearance, have sessile compound eyes, and no carapace. But unlike Isopoda, they possess thoracic gills and their bodies are laterally compressed.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033304"}, {"RECTYPE": "D", "MH": "Isopoda", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Isopodas", "MN": "B01.050.500.131.365.400", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid29979", "PI": "Crustacea (1966-2002)", "MS": "One of the largest orders of mostly marine CRUSTACEA, containing over 10,000 species. Like AMPHIPODA, the other large order in the superorder Peracarida, members are shrimp-like in appearance, have sessile compound eyes, and no carapace. But unlike Amphipoda, they possess abdominal pleopods (modified as gills) and their bodies are dorsoventrally flattened.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033321"}, {"RECTYPE": "D", "MH": "Arguloida", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Branchiura (Crustacea)|T204|NON|BRD|NLM (2003)|011019|abcdef", "ENTRY": "Lices, Fish", "MN": "B01.050.500.131.365.070", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6839", "RR": "txid6838", "AN": "do not confuse Branchiura the subclass of CRUSTACEA, with Branchiura a genus of ANNELIDA.", "MS": "An order of CRUSTACEA that are parasitic on freshwater fish.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033341"}, {"RECTYPE": "D", "MH": "Copepoda", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Siphonostomatoida|T204|NON|NRW|NLM (2003)|011019|abcdef", "ENTRY": "salmoni, Lepeophtheirus", "MN": "B01.050.500.131.365.160", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6830", "RR": "txid84308", "PI": "Crustacea (1965-2002)", "MS": "A huge subclass of mostly marine CRUSTACEA, containing over 14,000 species. The 10 orders comprise both planktonic and benthic organisms, and include both free-living and parasitic forms. Planktonic copepods form the principle link between PHYTOPLANKTON and the higher trophic levels of the marine food chains.", "PM": "2003; for Siphonostomatoida see Siphonostomatotoida 2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033342"}, {"RECTYPE": "D", "MH": "Cladocera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Water Flea|T204|NON|EQV|NLM (2003)|011019|abcdef", "ENTRY": "Water Fleas", "MN": "B01.050.500.131.365.150", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6665", "PI": "Crustacea (1968-2002)", "MS": "A suborder of CRUSTACEA, order Diplostraca, comprising the water fleas. They are benthic filter feeders that consume PHYTOPLANKTON. The body is laterally compressed and enclosed in a bivalved carapace, from which the head extends.", "PM": "2003", "HN": "2003", "MR": "20230405", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033361"}, {"RECTYPE": "D", "MH": "Powder Diffraction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Diffraction, Powder", "MN": "E05.196.309.711", "MH_TH": "NLM (2003)", "ST": "T062", "PI": "X-Ray Diffraction (1971-2002)", "MS": "Method of using a polycrystalline powder and Rietveld refinement (LEAST SQUARES ANALYSIS) of X-RAY DIFFRACTION or NEUTRON DIFFRACTION. It circumvents the difficulties of producing single large crystals.", "PM": "2003", "HN": "2003", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033362"}, {"RECTYPE": "D", "MH": "Neutron Diffraction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Neutron Diffractions", "MN": "G02.551", "MH_TH": "NLM (2003)", "ST": "T070", "AN": "for SANS (small angle neutron scattering) coordinate with SCATTERING, SMALL ANGLE", "PI": "Neutrons (1967-2002)", "MS": "The scattering of NEUTRONS by matter, especially crystals, with accompanying variation in intensity due to interference effects. It is useful in CRYSTALLOGRAPHY and POWDER DIFFRACTION.", "PM": "2003", "HN": "2003", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033363"}, {"RECTYPE": "D", "MH": "Decapoda", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sicyonia|T204|NON|NRW|NLM (2003)|011019|abcdef", "ENTRY": "Shrimps, Rock", "MN": "B01.050.500.131.365.190", "MH_TH": "NLM (2020)", "ST": "T204", "RN": "txid6683", "RR": "txid64464", "AN": "as animal & food; as food coordinate with SHELLFISH; note entry term ROCK SHRIMP: several other shrimp terms are available; unspecified shrimp as food is probably PENAEIDAE", "PI": "Crustacea (1966-2002)", "MS": "The largest order of CRUSTACEA, comprising over 10,000 species. They are characterized by three pairs of thoracic appendages modified as maxillipeds, and five pairs of thoracic legs. The order includes the familiar shrimps, crayfish (ASTACOIDEA), true crabs (BRACHYURA), and lobsters (NEPHROPIDAE and PALINURIDAE), among others.", "PM": "2003", "HN": "2020 (2003); was DECAPODA (CRUSTACEA) 2003-2019", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033364"}, {"RECTYPE": "D", "MH": "Anomura", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Paralithodes|T204|NON|NRW|NLM (2003)|011022|abcdef", "ENTRY": "Paralithode", "MN": "B01.050.500.131.365.190.050", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6738", "RR": "txid6746", "PI": "Crustacea (1979-2002)", "MS": "An infraorder of CRUSTACEA, in the order DECAPODA comprising the hermit crabs and characterized by a small fifth pair of legs.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033381"}, {"RECTYPE": "D", "MH": "Microscopy, Acoustic", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Acoustic Microscopy|T060|NON|EQV|NLM (2003)|011022|abcdef", "ENTRY": "Ultrasound Biomicroscopies", "MN": "E05.595.370", "MH_TH": "NLM (2003)", "ST": "T060", "PI": "Microscopy (1972-2002)", "MS": "A scientific tool based on ULTRASONOGRAPHY and used not only for the observation of microstructure in metalwork but also in living tissue. In biomedical application, the acoustic propagation speed in normal and abnormal tissues can be quantified to distinguish their tissue elasticity and other properties.", "PM": "2003", "HN": "2003", "MR": "20040707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033401"}, {"RECTYPE": "D", "MH": "Beginning of Human Life", "AQ": "ES", "ENTRY": "Life Beginning, Human", "MN": "K01.752.400.100", "FX": "Personhood", "MH_TH": "NLM (2003)", "ST": "T080", "AN": "check tag HUMAN; use only for the beginning of life as a philosophical or religious concept; do not confuse with ORIGIN OF LIFE", "MS": "The point at which religious ensoulment or PERSONHOOD is considered to begin.", "PM": "2003; see LIFE 2002", "HN": "2003; use LIFE 2002", "MR": "20150709", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033421"}, {"RECTYPE": "D", "MH": "Andrology", "DE": "ANDROL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.763.500", "FX": "Urology", "MH_TH": "NLM (1992)", "ST": "T091", "AN": "use for the specialty only", "PI": "Infertility, Male (1965-2002)", "MS": "A scientific or medical discipline concerning the study of male reproductive biology, diseases of the male genital organs, and male infertility. Major areas of interest include ENDOCRINOLOGY; SPERMATOGENESIS; SEMEN ANALYSIS; FERTILIZATION; CONTRACEPTION; and CRYOPRESERVATION.", "PM": "2003; see UROLOGY 1992-2002", "HN": "2003; use UROLOGY 1992-2002", "MR": "20160615", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033441"}, {"RECTYPE": "D", "MH": "Hyperuricemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.550.449", "MH_TH": "NLM (2003)", "ST": "T046", "PI": "Uric Acid (1963-2002)", "MS": "Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.", "PM": "2003", "HN": "2003", "MR": "20060705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033461"}, {"RECTYPE": "D", "MH": "Chromosomes, Mammalian", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "ENTRY": "Mammalian Chromosomes", "MN": "G05.360.162.520", "MH_TH": "NLM (2003)", "ST": "T026", "PI": "Chromosomes (1965-2002)", "MS": "Complex nucleoprotein structures which contain the genomic DNA and are part of the CELL NUCLEUS of MAMMALS.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033481"}, {"RECTYPE": "D", "MH": "Crangonidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Crangon|T204|NON|NRW|NLM (2003)|011024|abcdef", "ENTRY": "Crangons", "MN": "B01.050.500.131.365.190.150", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid98081", "RR": "txid98082", "PI": "Crustacea (1969-2002)", "MS": "A family of shrimp in the class CRUSTACEA, order DECAPODA, containing a single genus, Crangon, with multiple species.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033501"}, {"RECTYPE": "D", "MH": "Palinuridae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Spiny Lobsters|T204|NON|EQV|NLM (2003)|011024|abcdef", "ENTRY": "Spiny Lobster", "MN": "B01.050.500.131.365.190.625", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6731", "RR": "txid6734", "PI": "Nephropidae (1971-2002)", "MS": "A family of marine CRUSTACEA, in the order DECAPODA, comprising the clawless lobsters. They are found in tropical and subtropical waters and characterized by short spines along the length of the tail and body.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033521"}, {"RECTYPE": "D", "MH": "Palaemonidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Shrimp, Palaemonid|T204|NON|EQV|NLM (2003)|011025|abcdef", "ENTRY": "Shrimps, Palaemonid", "MN": "B01.050.500.131.365.190.615", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6695", "RR": "txid6696", "AN": "note entry term PALAEMONID SHRIMP: several other shrimp terms are available; check text and MeSH; unspecified shrimp as food is probably PENAEIDAE", "PI": "Crustacea (1968-2002)", "MS": "A family of CRUSTACEA, order DECAPODA, comprising the palaemonid shrimp. Genera include Macrobrachium, Palaemon, and Palaemonetes. Palaemonidae osmoregulate by means of gills.", "PM": "2003", "HN": "2003", "MR": "20200902", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033541"}, {"RECTYPE": "D", "MH": "Pandalidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Shrimp, Pandalid|T204|NON|EQV|NLM (2003)|011025|abcdef", "ENTRY": "Shrimps, Pandalid", "MN": "B01.050.500.131.365.190.635", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6701", "RR": "txid6702", "AN": "note entry term PANDALID SHRIMP: several other shrimp termsare available; check text and MeSH; unspecified shrimp as food is probably PENAEIDAE", "PI": "Crustacea (1967-2002)", "MS": "A family of CRUSTACEA, order DECAPODA, comprising the pandalid shrimp. They are protandric hermaphrodites and can breed in both male and female stages. Many species are commercially harvested in the Pacific Northwest.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033542"}, {"RECTYPE": "D", "MH": "Penaeidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Shrimp, Penaeid|T204|NON|EQV|NLM (2003)|011025|abcdef", "ENTRY": "Shrimps, Penaeid", "MN": "B01.050.500.131.365.190.660", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6685", "RR": "txid32277", "AN": "as animal & food; as food coord IM with SHELLFISH (IM); unspecified shrimp as food probably goes here but note several other shrimp terms in MeSH", "MS": "A family of CRUSTACEA, order DECAPODA, comprising the penaeid shrimp. Species of the genus Penaeus are the most important commercial shrimp throughout the world.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033561"}, {"RECTYPE": "D", "MH": "Stem Cell Transplantation", "DE": "STEM CELL TRANSPL", "AQ": "AE CL EC EH ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Transplantation, Stem Cell|T061|NON|EQV|NLM (1995)|931210|TRANSPL STEM CELL|abcdefv", "ENTRY": "Transplantations, Stem Cell", "MN": "E04.936.225.687", "MH_TH": "NLM (1995)", "ST": "T061", "AN": "general or unspecified only: prefer specifics or /transpl with specific type of stem cell", "PI": "Hematopoietic Stem Cell Transplantation (1981-2002)", "MS": "The transfer of STEM CELLS from one individual to another within the same species (TRANSPLANTATION, HOMOLOGOUS) or between species (XENOTRANSPLANTATION), or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). The source and location of the stem cells determines their potency or pluripotency to differentiate into various cell types.", "PM": "2003; see HEMATOPOIETIC STEM CELL TRANSPLANTATION 1995-2002", "HN": "2003; use HEMATOPOIETIC STEM CELL TRANSPLANTATION 1995-2002", "MR": "20170224", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033581"}, {"RECTYPE": "D", "MH": "Gordonia Bacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Gordona|T007|NON|EQV|NLM (2003)|011030|abcdef", "MN": "B03.510.024.700", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid2053", "AN": "infection: coordinate with ACTINOMYCETALES INFECTIONS", "PI": "Actinomycetales (1971-2002)", "MS": "A genus of gram-positive BACTERIA in the family Gordoniaceae and phylum ACTINOBACTERIA. It is isolated from soil and from sputa of patients with chest disorders. It is also used for biotransformation of natural products. In its most common form, Gordonia bronchialis, it is known as a rare cause of eye infections such as chronic INFECTIOUS ENDOPHTHALMITIS.", "PM": "2003", "HN": "2003", "MR": "20210209", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033601"}, {"RECTYPE": "D", "MH": "Tephritidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Rhagoletis|T204|NON|NRW|NLM (2003)|011114|abcdef", "ENTRY": "Queensland Fruit Fly", "MN": "B01.050.500.131.617.720.500.500.750.850", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid7211", "RR": "txid59916", "PI": "Diptera (1967-2002)", "MS": "A large family of fruit flies in the order DIPTERA, comprising over 4,500 species in about 100 genera. They have patterned wings and brightly colored bodies and are found predominantly in the tropical latitudes.", "PM": "2003", "HN": "2003", "MR": "20230531", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033621"}, {"RECTYPE": "D", "MH": "Ceratitis capitata", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Mediterranean Fruit Fly|T204|NON|EQV|NLM (1995)|940106|abcdef", "ENTRY": "capitatas, Ceratitis", "MN": "B01.050.500.131.617.720.500.500.750.850.150", "MH_TH": "NLM (1995)", "ST": "T204", "RN": "txid7213", "MS": "A species of fruit fly originating in sub-Saharan Africa but widely distributed worldwide. One of the most destructive fruit pests, its larvae feed and develop on many different fruits and some vegetables.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033622"}, {"RECTYPE": "D", "MH": "Millettia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Trees, Indian Beech", "MN": "B01.875.800.575.912.250.401.594", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid53625", "RR": "txid56065", "AN": "note entry term PONGAMIA PINNATA:  PONGAMIA and PONGAMIA ULIGINOSA see DERRIS are also available", "MS": "A plant genus of the family FABACEAE. Members contain ISOFLAVONES, some of which show molluscicidal and schistosomicidal activity. Some species of Pongamia have been reclassified to this genus and some to DERRIS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033641"}, {"RECTYPE": "D", "MH": "Oocysts", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Sporocyst", "MN": "G07.345.500.550.500.675", "MH_TH": "NLM (2003)", "ST": "T025", "MS": "Zygote-containing cysts of sporozoan protozoa. Further development in an oocyst produces small individual infective organisms called SPOROZOITES. Then, depending on the genus, the entire oocyst is called a sporocyst or the oocyst contains multiple sporocysts encapsulating the sporozoites.", "PM": "2003", "HN": "2003", "MR": "20170620", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033661"}, {"RECTYPE": "D", "MH": "Mitochondrial Membrane Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mitochondrial Transport Proteins|T116|T123|NON|EQV|NLM (2024)|230109|abbcdef", "ENTRY": "Transport Proteins, Mitochondrial", "MN": "D12.776.575.750", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "Proteins involved in the transport of specific substances across the membranes of the MITOCHONDRIA.", "PM": "2003", "HN": "2003", "MR": "20230226", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033681"}, {"RECTYPE": "D", "MH": "Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.543.585.625", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A broad class of proteins involved in the transport of nucleobases, NUCLEOSIDES; NUCLEOTIDES; and NUCLEIC ACIDS; across membranes.", "PM": "2003", "HN": "2003", "MR": "20050721", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033701"}, {"RECTYPE": "D", "MH": "Nucleobase Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transport Proteins, Nucleobase", "MN": "D12.776.543.585.625.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "Proteins involved in the transport of nucleobases such as PYRIMIDINES and PURINES across membranes.", "PM": "2003", "HN": "2003", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033702"}, {"RECTYPE": "D", "MH": "Nucleoside Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, Nucleoside", "MN": "D12.776.543.585.625.750", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1983-2002)", "MS": "Proteins involved in the transport of NUCLEOSIDES across cellular membranes.", "PM": "2003; NUCLEOSIDE TRANSPORTER (now NUCLEOSIDE TRANSPORT PROTEINS) was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 1983-2002", "HN": "2003; use NUCLEOSIDE TRANSPORT PROTEINS (NM) 1983-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033703"}, {"RECTYPE": "D", "MH": "Nucleotide Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transport Proteins, Nucleotide", "MN": "D12.776.543.585.625.875", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Mitochondrial ADP, ATP Translocases (1982-2002)", "MS": "Proteins involved in the transport of NUCLEOTIDES across cellular membranes.", "PM": "2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1982-2002", "HN": "2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1982-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033704"}, {"RECTYPE": "D", "MH": "Equilibrative Nucleoside Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Equilibrative Nucleoside Transport Protein|T116|T123|NON|EQV|NLM (2003)|abbcde", "MN": "D12.776.543.585.937.563", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1997-2002)", "MS": "A class of sodium-independent nucleoside transporters that mediate the facilitative transport of NUCLEOSIDES.", "PM": "2003; EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEIN was indexed under CARRIER PROTEINS 1997-2002", "HN": "2003; use EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS (NM) 1997-2002", "MR": "20151123", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033705"}, {"RECTYPE": "D", "MH": "Equilibrative Nucleoside Transporter 1", "DS": "EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Equilibrative Nitrobenzylmercaptopurine Riboside Sensitive Nucleoside Transporter", "MN": "D12.776.543.585.937.563.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Membrane Transport Proteins (2001-2002)", "MS": "A subtype of equilibrative nucleoside transporter proteins that is sensitive to inhibition by 4-nitrobenzylthioinosine.", "PM": "2003; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 was indexed under MEMBRANE TRANSPORT PROTEINS 2001, MEMBRANE PROTEINS & CARRIER PROTEINS 1997-2002", "HN": "2003; use EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 (NM) 1997-2002", "MR": "20151123", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033721"}, {"RECTYPE": "D", "MH": "Equilibrative-Nucleoside Transporter 2", "DS": "EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Solute Carrier-Family 29 (Nucleoside Transporters), Member 2|T116|T123|NON|EQV|NLM (2003)|011107|abbcdef", "MN": "D12.776.543.585.937.563.750", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Membrane Transport Proteins (2002)", "MS": "A subtype of equilibrative nucleoside transporter proteins that is insensitive to inhibition by 4-nitrobenzylthioinosine.", "PM": "2003; EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2 was indexed under MEMBRANE TRANSPORT PROTEINS 2002, CARRIER PROTEINS 1998-2001 & MEMBRANE PROTEINS 1998-2001", "HN": "2003; use EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2 (NM) 1998-2002", "MR": "20151123", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033722"}, {"RECTYPE": "D", "MH": "Adenine Nucleotide Translocator 1", "DS": "ADENINE NUCLEOTIDE TRANSLOCATOR A 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transport Protein, ANT-1", "MN": "D12.776.575.750.500.100", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "0", "PI": "Adenine Nucleotide Translocase (1999-2002)", "MS": "A subtype of mitochondrial ADP, ATP translocase found primarily in heart muscle (MYOCARDIUM) and skeletal muscle (MUSCLE, SKELETAL).", "PM": "2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1999-2002", "HN": "2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1999-2002", "MR": "20160226", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033741"}, {"RECTYPE": "D", "MH": "Adenine Nucleotide Translocator 2", "DS": "ADENINE NUCLEOTIDE TRANSLOCATOR A 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adenine Nucleotide Translocator, Fibroblast Isoform|T116|T123|NON|EQV|NLM (2003)|011107|abbcdef", "ENTRY": "Transport Protein, ANT2", "MN": "D12.776.575.750.500.200", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "0", "PI": "Adenine Nucleotide Translocase (1999-2002)", "MS": "A subtype of mitochondrial ADP, ATP translocase found primarily in FIBROBLASTS.", "PM": "2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1999-2002", "HN": "2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1999-2002", "MR": "20160226", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033742"}, {"RECTYPE": "D", "MH": "Spores, Protozoan", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Spore, Protozoan", "MN": "B05.775.740", "MH_TH": "NLM (2003)", "ST": "T001", "AN": "sporulation: coordinate organism / physiol (IM) + SPORES, PROTOZOAN (NIM)", "MS": "A vegetative stage in the life cycle of sporozoan protozoa. It is characteristic of members of the phyla APICOMPLEXA and MICROSPORIDIA.", "PM": "2003", "HN": "2003", "MR": "20130708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033761"}, {"RECTYPE": "D", "MH": "Adenine Nucleotide Translocator 3", "DS": "ADENINE NUCLEOTIDE TRANSLOCATOR A 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transport Protein, ANT3", "MN": "D12.776.575.750.500.300", "MH_TH": "NLM (1999)", "ST": "T123", "RN": "0", "PI": "Mitochondrial ADP, ATP Translocases (1999-2002)", "MS": "A subtype of mitochondrial ADP, ATP translocase found primarily in the LIVER.", "PM": "2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1999-2002", "HN": "2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1999-2002", "MR": "20160226", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033781"}, {"RECTYPE": "D", "MH": "Iron-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Iron-Binding Protein|T116|T123|NON|EQV|NLM (2022)|200929|abbcdef", "ENTRY": "Protein, Iron-Binding", "MN": "D12.776.556.579", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "Proteins that specifically bind to IRON.", "PM": "2003; IRON-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-2002", "HN": "2003; use IRON-BINDING PROTEINS (NM) 1980-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033862"}, {"RECTYPE": "D", "MH": "Transferrin-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transferrin Binding Proteins", "MN": "D12.776.157.905", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Iron-Binding Proteins (1980-2002)", "MS": "A class of carrier proteins that bind to TRANSFERRIN. Many strains of pathogenic bacteria utilize transferrin-binding proteins to acquire their supply of iron from serum.", "PM": "2003; TRANSFERRIN-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-2002", "HN": "2003; use IRON-BINDING PROTEINS (NM) 1980-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033863"}, {"RECTYPE": "D", "MH": "Transferrin-Binding Protein A", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Transferrin-Binding Protein, Tbp1", "MN": "D12.776.543.750.800.249.500", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Iron-Binding Proteins (1986-2002)", "MS": "A subtype of bacterial transferrin-binding protein found in bacteria. It forms a cell surface receptor complex with TRANSFERRIN-BINDING PROTEIN B.", "PM": "2003; TBP1 PROTEIN (now TRANSFERRIN-BINDING PROTEIN A) was indexed under CARRIER PROTEINS 1986-2002", "HN": "2003; use IRON-BINDING PROTEINS (NM) 1986-2002", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033881"}, {"RECTYPE": "D", "MH": "Transferrin-Binding Protein B", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Transferrin-Binding Protein, TbpB", "MN": "D12.776.543.750.800.249.750", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Iron-Binding Proteins (1986-2002)", "MS": "A subtype of bacterial transferrin-binding protein found in bacteria. It forms a cell surface receptor complex with TRANSFERRIN-BINDING PROTEIN A.", "PM": "2003; TRANSFERRIN-BINDING PROTEIN B was indexed under CARRIER PROTEINS 1986-2002", "HN": "2003; use IRON-BINDING PROTEINS (NM) 1986-2002", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033882"}, {"RECTYPE": "D", "MH": "Bacterial Transferrin Receptor Complex", "DE": "BACT TRANSFERRIN RECEPT COMPLEX", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Transferrin-Binding Protein Complex, Bacterial|T116|T192|NON|EQV|NLM (2003)|011108|TRANSFERRIN BINDING PROTEIN COMPLEX BACT|abbcdefv", "ENTRY": "Transferrin Binding Protein Complex, Bacterial", "MN": "D12.776.543.750.800.249", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Iron-Binding Proteins (1980-2002)", "MS": "A complex of proteins that forms a receptor for TRANSFERRIN in BACTERIA. Many pathogenic bacteria utilize the transferrin-binding complex to acquire their supply of iron from serum.", "PM": "2003", "HN": "2003", "MR": "20160115", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033901"}, {"RECTYPE": "D", "MH": "Periplasmic Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Periplasmic Binding Protein|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Protein, Periplasmic Binding", "MN": "D12.776.157.622", "MH_TH": "UNK (19XX)", "ST": "T123", "RN": "0", "MS": "Periplasmic proteins that scavenge or sense diverse nutrients. In the bacterial environment they usually couple to transporters or chemotaxis receptors on the inner bacterial membrane.", "PM": "2003; see CARRIER PROTEINS 1983-2002", "HN": "2003; use CARRIER PROTEINS 1983-2002", "MR": "20200527", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033902"}, {"RECTYPE": "D", "MH": "Periplasmic Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.765.537", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Proteins (1966-2002)", "MS": "Proteins found in the PERIPLASM of organisms with cell walls.", "PM": "2003", "HN": "2003", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033903"}, {"RECTYPE": "D", "MH": "Vesicular Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transport Proteins, Vesicular", "MN": "D12.776.543.990", "FX": "Transport Vesicles", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "A broad category of proteins involved in the formation, transport and dissolution of TRANSPORT VESICLES. They play a role in the intracellular transport of molecules contained within membrane vesicles. Vesicular transport proteins are distinguished from MEMBRANE TRANSPORT PROTEINS, which move molecules across membranes, by the mode in which the molecules are transported.", "PM": "2003", "HN": "2003", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033921"}, {"RECTYPE": "D", "MH": "Clathrin Heavy Chains", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Heavy Chains, Clathrin", "MN": "D12.776.543.990.200.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "114899-12-6", "PI": "Clathrin (1996-2002)", "MS": "The heavy chain subunits of clathrin.", "PM": "2003; CLATHERIN HEAVY CHAIN was indexed under CLATHRIN 1996-2002", "HN": "2003; use CLATHRIN HEAVY CHAINS (NM) 1996-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033922"}, {"RECTYPE": "D", "MH": "Clathrin Light Chains", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Light Chains, Clathrin", "MN": "D12.776.543.990.200.750", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Clathrin (1986-2002)", "MS": "The light chain subunits of clathrin.", "PM": "2003", "HN": "2003", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D033941"}, {"RECTYPE": "D", "MH": "Adaptor Proteins, Vesicular Transport", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vesicular Transport Adaptor Proteins|T116|T123|NON|EQV|NLM (2005)|040323|abbcdef", "ENTRY": "Protein, Clathrin-Associated", "MN": "D12.776.543.990.150", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Phosphoproteins (1987-2001)", "MS": "A class of proteins involved in the transport of molecules via TRANSPORT VESICLES. They perform functions such as binding to the cell membrane, capturing cargo molecules and promoting the assembly of CLATHRIN. The majority of adaptor proteins exist as multi-subunit complexes, however monomeric varieties have also been found.", "PM": "2005; see ADAPTOR PROTEINS 2002-2004; CLATHRIN ASSEMBLY PROTEINS was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 2001-2002, and under NERVE TISSUE PROTEINS & PHOSPHOPROTEINS 1987-2001", "HN": "2005(1987)", "MR": "20200527", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033942"}, {"RECTYPE": "D", "MH": "Adaptor Protein Complex 1", "DS": "ADAPTOR PROTEIN COMPLEX A 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Clathrin Assembly Protein Complex 1|T116|T123|NON|EQV|NLM (2003)|011109|CLATHRIN ASSEMBLY PROTEIN COMP A 1|abbcdefs", "ENTRY": "Adaptor Related Protein Complex 1", "MN": "D12.776.543.990.150.100", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Phosphoproteins (1998-2001)", "MS": "A clathrin adaptor protein complex primarily involved in clathrin-related transport at the TRANS-GOLGI NETWORK.", "PM": "2003; ADAPTOR PROTEIN COMPLEX 1(AP-1) was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 2001-2002, and under NERVE TISSUE PROTEINS & PHOSPHOPROTEINS 1998-2001; GOLGI ADAPTOR PROTEIN 1 was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 1994-2001", "HN": "2003; for ADAPTOR PROTEIN COMPLEX 1(AP-1) use CLATHRIN ADAPTOR PROTEINS (NM) 1998-2002, for GOLGI ADAPTOR PROTEIN 1 use CLATHRIN ADAPTOR PROTEIN ALPHA SUBUNITS 1994-2002", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033961"}, {"RECTYPE": "D", "MH": "Adaptor Protein Complex 2", "DS": "ADAPTOR PROTEIN COMPLEX A 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Clathrin Assembly Protein Complex 2|T116|T123|NON|EQV|NLM (2003)|011109|CLATHRIN ASSEMBLY PROTEIN COMP A 2|abbcdefs", "ENTRY": "HA 2 Adaptors", "MN": "D12.776.543.990.150.200", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Phosphoproteins (1994-2001)", "MS": "An adaptor protein complex primarily involved in the formation of clathrin-related endocytotic vesicles (ENDOSOMES) at the CELL MEMBRANE.", "PM": "2003; AP-2 PROTEIN COMPLEX, AP-2 ADAPTOR (CLATHRIN-COATED VESICLES), HA-2 ADAPTORS, HYDROXYAPATITE 2 ADAPTORS were indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 2001-2002, and under NERVE TISSUE PROTEINS & PHOSPHOPROTEINS 1994-2001", "HN": "2003; for AP-2 PROTEIN COMPLEX, AP-2 ADAPTOR (CLATHRIN-COATED VESICLES), HA-2 ADAPTORS & HYDROXYAPATITE 2 ADAPTORS use CLATHRIN ADAPTOR PROTEINS (NM) 1994-2002", "MR": "20130709", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033962"}, {"RECTYPE": "D", "MH": "Adaptor Protein Complex 3", "DS": "ADAPTOR PROTEIN COMPLEX A 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Clathrin Assembly Protein Complex 3|T116|T123|NON|EQV|NLM (2003)|011109|abbcdef", "ENTRY": "Adaptor Related Protein Complex 3", "MN": "D12.776.543.990.150.300", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Phosphoproteins (1998-2001)", "MS": "An adaptor protein complex found primarily on perinuclear compartments.", "PM": "2003; AP3 ADAPTOR COMPLEX was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 2001-2002, and under NERVE TISSUE PROTEINS & PHOSPHOPROTEINS 1998-2001", "HN": "2003; for AP3 ADAPTOR COMPLEX use CLATHRIN ADAPTOR PROTEINS (NM) 1998-2002", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033963"}, {"RECTYPE": "D", "MH": "Adaptor Protein Complex 4", "DS": "ADAPTOR PROTEIN COMPLEX A 4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Adaptor-Related Protein Complex 4|T116|T123|NON|EQV|NLM (2003)|010727|abbcdef", "ENTRY": "Adaptor Related Protein Complex 4", "MN": "D12.776.543.990.150.400", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (2001-2002)", "MS": "An adaptor protein complex involved in transport of molecules between the TRANS-GOLGI NETWORK and the endosomal-lysosomal system.", "PM": "2003; AP-4 PROTEIN COMPLEX was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 2001-2002 and under NERVE TISSUE PROTEINS & PHOSPHOPROTEINS 1999-2001", "HN": "2003; for AP-4 PROTEIN COMPLEX use ADAPTOR PROTEINS 1999-2002", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033964"}, {"RECTYPE": "D", "MH": "Adaptor Protein Complex alpha Subunits", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-Adaptins|T116|T123|NON|EQV|NLM (2003)|abbcde", "ENTRY": "alpha Adaptins", "MN": "D12.776.543.990.150.500.100", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1989-2002)", "MS": "A family of large adaptin protein subunits of approximately 100 kDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 2.", "PM": "2003; ALPHA-ADAPTINS (now ADAPTOR PROTEIN COMPLEX ALPHA SUBUNITS) was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 1989-2002", "HN": "2003; use ADAPTOR PROTEIN COMPLEX ALPHA SUBUNITS (NM) 1989-2002", "MR": "20040707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033965"}, {"RECTYPE": "D", "MH": "Adaptor Protein Complex beta Subunits", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Adaptins|T116|T123|NON|EQV|NLM (2003)|abbcde", "ENTRY": "beta Adaptins", "MN": "D12.776.543.990.150.500.200", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Proteins (1990-1994)", "MS": "A family of large adaptin protein complex subunits of approximately 90-130 kDa in size.", "PM": "2003; BETA-ADAPTINS (now ADAPTOR PROTEIN COMPLEX BETA SUBUNITS) was indexed under MEMBRANE PROTEINS 1995-2002, PROTEINS 1990-1994", "HN": "2003; use ADAPTOR PROTEIN COMPLEX BETA SUBUNITS (NM) 1990-2002", "MR": "20040707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033966"}, {"RECTYPE": "D", "MH": "Adaptor Protein Complex delta Subunits", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "delta-Adaptin|T116|T123|NON|EQV|NLM (2003)|abbcde", "ENTRY": "delta Adaptin", "MN": "D12.776.543.990.150.500.300", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1997-2002)", "MS": "A family of large adaptin protein subunits of approximately 130-kDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 3.", "PM": "2003; DELTA-ADAPTIN (now ADAPTOR PROTEIN COMPLEX DELTA SUBUNITS) was indexed under MEMBRANE PROTEINS 1997-2002", "HN": "2003; use ADAPTOR PROTEIN COMPLEX DELTA SUBUNITS (NM) 1997-2002", "MR": "20040707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033981"}, {"RECTYPE": "D", "MH": "Adaptor Protein Complex gamma Subunits", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gamma-Adaptin|T116|T123|NON|EQV|NLM (2003)|abbcde", "ENTRY": "gamma Adaptin", "MN": "D12.776.543.990.150.500.400", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Proteins (1991-1994)", "MS": "A family of large adaptin protein subunits of approximately 90 KDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 1.", "PM": "2003; GAMMA-ADAPTIN (now ADAPTOR PROTEIN COMPLEX GAMMA SUBUNITS) was indexed under MEMBRANE PROTEINS 1995-2002, PROTEINS 1991-1994", "HN": "2003; use ADAPTOR PROTEIN COMPLEX GAMMA SUBUNITS (NM) 1991-2001", "MR": "20040707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033982"}, {"RECTYPE": "D", "MH": "Adaptor Protein Complex mu Subunits", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "mu-Adaptin|T116|T123|NON|EQV|NLM (2003)|011219|abbcdef", "ENTRY": "mu Adaptin", "MN": "D12.776.543.990.150.500.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Adaptor Proteins (1997-2002)", "MS": "A family of medium adaptin protein subunits of approximately 45 KDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 3 and ADAPTOR PROTEIN COMPLEX 4.", "PM": "2003", "HN": "2003", "MR": "20040707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D033983"}, {"RECTYPE": "D", "MH": "Adaptor Protein Complex Subunits", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Clathrin Assembly Protein Subunits|T116|T123|NON|NRW|NLM (2003)|011113|abbcdef", "MN": "D12.776.543.990.150.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "The subunits that make up the large, medium and small chains of adaptor proteins.", "PM": "2003", "HN": "2003", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034001"}, {"RECTYPE": "D", "MH": "Adaptor Protein Complex sigma Subunits", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sigma-Adaptins|T116|T123|NON|EQV|NLM (2003)|011219|abbcdef", "ENTRY": "Sigma Adaptins", "MN": "D12.776.543.990.150.500.750", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Adaptor Proteins (1995-2002)", "MS": "A family of small adaptin protein complex subunits of approximately 19 KDa in size.", "PM": "2003", "HN": "2003", "MR": "20040707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034002"}, {"RECTYPE": "D", "MH": "Auxilins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Auxilin|T116|T123|NON|EQV|NLM (2003)|abbcde", "MN": "D12.776.543.990.049", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1993-2002)", "MS": "A family of proteins that play a role as cofactors in the process of CLATHRIN recycling in cells.", "PM": "2003; AUXILIN was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 1993-2002", "HN": "2003; for AUXILIN use ADAPTOR PROTEINS (NM) 1993-2002", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034021"}, {"RECTYPE": "D", "MH": "Monomeric Clathrin Assembly Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Monomeric Clathrin Adaptor Proteins|T116|T123|NON|EQV|NLM (2003)|011113|abbcdef", "MN": "D12.776.543.990.150.750", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "A subclass of clathrin assembly proteins that occur as monomers.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034041"}, {"RECTYPE": "D", "MH": "Thrombopoiesis", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Megakaryocytopoiesis|T042|NON|REL|NLM (2003)|011113|abcdef", "ENTRY": "Thrombopoieses", "MN": "G09.188.343.798", "MH_TH": "NLM (2003)", "ST": "T042", "PI": "Hematopoiesis (1965-2002)", "MS": "The process of generating thrombocytes (BLOOD PLATELETS) from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW via the MEGAKARYOCYTES. The humoral factor with thrombopoiesis-stimulating activity is designated THROMBOPOIETIN.", "PM": "2003", "HN": "2003", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034061"}, {"RECTYPE": "D", "MH": "Insomnia, Fatal Familial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Fatal Familial Insomnia|T047|NON|EQV|NLM (2003)|OMIM (2013)|ORD (2010)|011113|abcdeeef", "ENTRY": "Insomnias, Fatal Familial", "MN": "C10.886.425.800.800.400", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Sleep Initiation and Maintenance Disorders (1986-1992)", "MS": "An autosomal dominant disorder characterized by degeneration of the THALAMUS and progressive insomnia. It is caused by a mutation in the prion protein (PRIONS).", "PM": "2003; see PRION DISEASES 1993-2002", "HN": "2003; use PRION DISEASES 1993-2002", "MR": "20190617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034062"}, {"RECTYPE": "D", "MH": "Wasting Disease, Chronic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Chronic Wasting Disease|T047|NON|EQV|NLM (2003)|011113|abcdef", "MN": "C23.550.291.500.937", "MH_TH": "NLM (2003)", "ST": "T047", "PI": "Wasting Syndrome (1999-2002)", "MS": "A transmissible spongiform encephalopathy (prion disease) of DEER and elk characterized by chronic weight loss leading to death. It is thought to spread by direct contact between animals or through environmental contamination with the prion protein (PRIONS).", "PM": "2003", "HN": "2003", "MR": "20210312", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034081"}, {"RECTYPE": "D", "MH": "Sporozoites", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Sporozoite", "MN": "G07.345.500.550.500.675.800", "MH_TH": "NLM (2003)", "ST": "T025", "MS": "The product of meiotic division of zygotes in parasitic protozoa comprising haploid cells. These infective cells invade the host and undergo asexual reproduction producing MEROZOITES (or other forms) and ultimately gametocytes.", "PM": "2003", "HN": "2003", "MR": "20170224", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034101"}, {"RECTYPE": "D", "MH": "Reproductive Health Services", "DE": "REPRODUCTIVE HEALTH SERV", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Services, Reproductive Health", "MN": "N02.421.800", "FX": "Reproductive Techniques", "MH_TH": "NLM (2003)", "ST": "T058", "PI": "Family Planning (1983-2002)", "MS": "Health care services related to human REPRODUCTION and diseases of the REPRODUCTIVE SYSTEM. Services are provided to both sexes and usually by physicians in the medical or the surgical specialties such as REPRODUCTIVE MEDICINE; ANDROLOGY; GYNECOLOGY; OBSTETRICS; and PERINATOLOGY.", "PM": "2003", "HN": "2003", "MR": "20170414", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034121"}, {"RECTYPE": "D", "MH": "Hypoalbuminemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C15.378.147.607.500", "MH_TH": "NLM (2003)", "ST": "T184", "PI": "Serum Albumin (1965-2002)", "MS": "A condition in which albumin level in blood (SERUM ALBUMIN) is below the normal range. Hypoalbuminemia may be due to decreased hepatic albumin synthesis, increased albumin catabolism, altered albumin distribution, or albumin loss through the urine (ALBUMINURIA).", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034141"}, {"RECTYPE": "D", "MH": "Pelvic Infection", "DE": "PELVIC INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pelvic Infections", "MN": "C01.635", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Adnexitis (1967-2002)", "MS": "Infection involving the tissues or organs in the PELVIS.", "PM": "2003; see ADNEXITIS 1990-2002", "HN": "2003; use ADNEXITIS 1990-2002", "MR": "20190617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034161"}, {"RECTYPE": "D", "MH": "Epimedium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "sagittatums, Epimedium", "MN": "B01.875.800.575.912.250.125.342", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid63350", "RR": "txid253616", "MS": "A plant genus of the family BERBERIDACEAE which is used in DRUGS, CHINESE HERBAL. Members contain flavonol glycosides including epimedins, icariin and noricariin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034181"}, {"RECTYPE": "D", "MH": "Cuscuta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Dodder|T002|NON|EQV|NLM (2003)|011116|abcdef", "ENTRY": "Dodders", "MN": "B01.875.800.575.912.250.238.437", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4128", "MS": "A plant genus of the family Cuscutaceae. It is a threadlike climbing parasitic plant that is used in DRUGS, CHINESE HERBAL.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034182"}, {"RECTYPE": "D", "MH": "Computers, Handheld", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Personal Digital Assistant|T073|NON|NRW|NLM (2003)|020116|abcdef", "ENTRY": "Tablet Computer", "MN": "L01.224.230.260.550.500", "FX": "Cell Phone", "MH_TH": "NLM (2003)", "ST": "T073", "PI": "Microcomputers (1992-2002)", "MS": "A type of MICROCOMPUTER, sometimes called a personal digital assistant, that is very small and portable and fitting in a hand. They are convenient to use in clinical and other field situations for quick data management. They usually require docking with MICROCOMPUTERS for updates.", "PM": "2003", "HN": "2003", "MR": "20200618", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034201"}, {"RECTYPE": "D", "MH": "Moritella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Vibrio viscosus|T007|NON|NRW|NLM (2003)|011120|abcdef", "MN": "B03.660.250.021.500", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid58050", "RR": "txid80854", "MS": "A genus of gram-negative, curved or straight rod-shaped bacteria, in the family ALTEROMONADACEAE. They are chemo-organotrophic, halophilic, and associated with cold marine habitats.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034221"}, {"RECTYPE": "D", "MH": "Alteromonadaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Idiomarina|T007|NON|NRW|NLM (2007)|060119|abcdef", "MN": "B03.660.250.021", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid72275", "RR": "txid28228", "PI": "Proteobacteria (2001-2002)", "MS": "A family of marine, gram-negative PROTEOBACTERIA including the genera ALTEROMONAS; Colwellia; Idiomarina; MARINOBACTER; MORITELLA; PSEUDOALTEROMONAS; and SHEWANELLA.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034241"}, {"RECTYPE": "D", "MH": "Cyclooctanes", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dibenzocyclooctanes|T109|NON|REL|NLM (2003)|011120|abcdef", "MN": "D02.455.426.392.368.408", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "PI": "Cycloparaffins (1963-2002)", "MS": "A group of compounds with an 8-carbon ring. They may be saturated or unsaturated.", "PM": "2003", "HN": "2003", "MR": "20040707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034242"}, {"RECTYPE": "D", "MH": "Epothilones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Epothilone|T109|NON|EQV|NLM (2003)|011120|abcdef", "MN": "D02.540.576.500.984", "PA": "Tubulin Modulators", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "PI": "Macrolides (1998-2002)", "MS": "A group of 16-member MACROLIDES which stabilize MICROTUBULES in a manner similar to PACLITAXEL. They were originally found in the myxobacterium Sorangium cellulosum, now renamed to Polyangium (MYXOCOCCALES).", "PM": "2003", "HN": "2003", "MR": "20150622", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034261"}, {"RECTYPE": "D", "MH": "Dynamins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "GTPase-Deficient Dynamin|T116|T123|ACX|NRW|NLM (2003)|011126|abbcdef", "ENTRY": "GTPase Deficient Dynamin", "MN": "D12.776.543.990.400", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 3.6.5.5", "AN": "general or unspecified; prefer specifics", "PI": "GTP Phosphohydrolases (1994-2002)", "MS": "A family of high molecular weight GTP phosphohydrolases that play a direct role in vesicle transport. They associate with microtubule bundles (MICROTUBULES) and are believed to produce mechanical force via a process linked to GTP hydrolysis. This enzyme was formerly listed as EC 3.6.1.50.", "PM": "2003; DYNAMIN (now DYNAMINS) was indexed under GTP PHOSPHOHYDROLASES 1 1994-2002 & CA(2+) MG(2+)-ATPASE 1989-1993", "HN": "2003; use DYNAMINS (NM) 1989-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034281"}, {"RECTYPE": "D", "MH": "Dynamin I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dynamin 1", "MN": "D12.776.543.990.400.100", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 3.5.1.50", "PI": "GTP Phosphohydrolases (1994-2002)", "MS": "A subtype of dynamin found primarily in the NEURONS of the brain.", "PM": "2003; DYNAMIN I & DYNAMIN-1 were indexed under GTP PHOSPHOHYDROLASES 1994-2002 & CA(2+) MG(2+)-ATPASE 1989-1993", "HN": "2003; for DYNAMIN I & DYNAMIN-1 use DYNAMINS (NM) 1997-2002", "MR": "20040707", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034284"}, {"RECTYPE": "D", "MH": "Dynamin II", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dynamin, DYNII", "MN": "D12.776.543.990.400.200", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 3.6.5.5", "PI": "GTP Phosphohydrolases (1998-2002)", "MS": "A subtype of dynamin found ubiquitously expressed in a variety of tissues.", "PM": "2003: DYNAMIN-2 was indexed under GTP PHOSPHOHYDROLASES 1998-2002", "HN": "2003; for DYNAMIN-2 use DYNAMINS (NM) 1998-2002", "MR": "20090706", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034285"}, {"RECTYPE": "D", "MH": "Dynamin III", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Testicular Dynamin", "MN": "D12.776.543.990.400.300", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 3.6.5.5", "PI": "GTP Phosphohydrolases (1999-2002)", "MS": "A subtype of dynamin found expressed exclusively in the testis, lung and brain.", "PM": "2003; DYNAMIN III was indexed under GTP PHOSPHOHYDROLASES 1999-2002", "HN": "2003; for DYNAMIN III use DYNAMINS (NM) 1999-2002", "MR": "20090706", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034286"}, {"RECTYPE": "D", "MH": "Deinococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Deinococcus radiodurans|T007|NON|NRW|NLM (2003)|011121|abcdef", "MN": "B03.510.400.200", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid1298", "RR": "txid1299", "PI": "Micrococcus (1983-1999)", "MS": "A genus of gram-positive aerobic cocci found in the soil, that is highly resistant to radiation, especially ionizing radiation (RADIATION, IONIZING). Deinococcus radiodurans is the type species.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034301"}, {"RECTYPE": "D", "MH": "Hyperamylasemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Macroamylasemia|T046|NON|NRW|NLM (2003)|011121|abcdef", "MN": "C23.550.425", "FX": "Amylases", "MH_TH": "NLM (2003)", "ST": "T046", "PI": "Metabolic Diseases (1970-2002)", "MS": "A condition with abnormally elevated level of AMYLASES in the serum. Hyperamylasemia due to PANCREATITIS or other causes may be differentiated by identifying the amylase isoenzymes.", "PM": "2003", "HN": "2003", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034321"}, {"RECTYPE": "D", "MH": "Aristolochic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D04.615.723.089", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "PI": "Phenanthrenes (1965-2002)", "MS": "Nitro-phenanthrenes occurring in ARISTOLOCHIACEAE and other plants. They derive from stephanine (APORPHINES) by oxidative ring cleavage. The nitro group is a reactive alkylator (ALKYLATING AGENTS) that binds to biological macromolecules. Ingestion by humans is associated with nephropathy (NEPHRITIS). There is no relationship to the similar named aristolochene (SESQUITERPENES).", "PM": "2003", "HN": "2003", "MR": "20090820", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034341"}, {"RECTYPE": "D", "MH": "Streptococcus mitis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872.875.500", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid28037", "AN": "infection: coord IM with STREPTOCOCCAL INFECTIONS (IM)", "PI": "Streptococcus (1965-2002)", "MS": "A species of gram-positive, coccoid bacteria commensal in the respiratory tract.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034361"}, {"RECTYPE": "D", "MH": "Striga", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Witchweed|T002|NON|EQV|NLM (2003)|011123|abcdef", "ENTRY": "Witchweeds", "MN": "B01.875.800.575.912.250.583.670.875", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4169", "MS": "A plant genus of the family Orobanchaceae that is parasitic on the roots of other plants. Members contain the flavones, APIGENIN and LUTEOLIN.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034362"}, {"RECTYPE": "D", "MH": "Viridans Streptococci", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Streptococcus Viridans Group|T007|NON|EQV|NLM (2003)|011123|abcdef", "ENTRY": "Streptococcus viridans|T007|NON|REL|NLM (2003)|011123|abcdef", "MN": "B03.510.550.737.872.875", "MH_TH": "NLM (2003)", "ST": "T007", "RR": "txid78535", "AN": "infection: coord IM with STREPTOCOCCAL INFECTIONS (IM)", "PI": "Streptococcus (1967-2002)", "MS": "A large heterogeneous group of mostly alpha-hemolytic streptococci. They colonize the respiratory tract at birth and generally have a low degree of pathogenicity. This group of species includes STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SANGUIS; STREPTOCOCCUS SOBRINUS; and the STREPTOCOCCUS MILLERI GROUP. The latter are often beta-hemolytic and commonly produce invasive pyogenic infections including brain and abdominal abscesses.", "PM": "2003", "HN": "2003", "MR": "20200902", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034363"}, {"RECTYPE": "D", "MH": "Streptococcus milleri Group", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Streptococcus milleri|T007|NON|REL|NLM (2003)|011123|abcdef", "MN": "B03.510.550.737.872.875.475", "MH_TH": "NLM (2003)", "ST": "T007", "RR": "txid33040", "AN": "infection: coord IM with STREPTOCOCCAL INFECTIONS (IM)", "PI": "Streptococcus (1978-2002)", "MS": "A subset of VIRIDANS STREPTOCOCCI, but the species in this group differ in their hemolytic pattern and diseases caused. These species are often beta-hemolytic and produce pyogenic infections.", "PM": "2003", "HN": "2003", "MR": "20200902", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034364"}, {"RECTYPE": "D", "MH": "Streptococcus constellatus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872.875.475.150", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid76860", "AN": "infection: coord IM with STREPTOCOCCAL INFECTIONS (IM)", "PI": "Streptococcus (1979-2002)", "MS": "A species of gram-positive bacteria in the STREPTOCOCCUS MILLERI GROUP. It is commonly found in the oropharnyx flora and has a proclivity for abscess formation in the upper body and respiratory tract.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034365"}, {"RECTYPE": "D", "MH": "Streptococcus anginosus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872.875.475.080", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid1328", "AN": "infection: coordinate with STREPTOCOCCAL INFECTIONS", "MS": "A species of gram-positive bacteria in the STREPTOCOCCUS MILLERI GROUP. It is the most frequently seen isolate of that group, has a proclivity for abscess formation, and is most often isolated from the blood, gastrointestinal, and urogenital tract.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034366"}, {"RECTYPE": "D", "MH": "Streptococcus intermedius", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872.875.475.400", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid1338", "AN": "infection: coord IM with STREPTOCOCCAL INFECTIONS (IM)", "PI": "Streptococcus (1978-2002)", "MS": "A species of gram-positive bacteria in the STREPTOCOCCUS MILLERI GROUP. It is commonly found in the oropharynx flora and has a proclivity for abscess formation, most characteristically in the CENTRAL NERVOUS SYSTEM and LIVER.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034367"}, {"RECTYPE": "D", "MH": "Hearing Loss", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Transitory Hearing Loss|T184|NON|NRW|NLM (2020)|190506|abcdef", "ENTRY": "Transitory Hearing Losses", "MN": "C23.888.592.763.393.341", "MH_TH": "NLM (2000)", "ST": "T184", "AN": "general or unspecified; prefer specifics", "MS": "A general term for the complete or partial loss of the ability to hear from one or both ears.", "PM": "2003; see DEAFNESS 2000-2002; for HYPOACUSIS see HEARING LOSS, PARTIAL 2000-2002", "HN": "2003; use DEAFNESS 2000-2002", "MR": "20190701", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034381"}, {"RECTYPE": "D", "MH": "Ulmaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Zelkova|T002|NON|NRW|NLM (2003)|011126|abcdef", "ENTRY": "Zelkovas", "MN": "B01.875.800.575.912.250.859.937.844", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3474", "RR": "txid45186", "AN": "prefer specific plant", "MS": "A plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. Members are trees and shrubs of temperate regions that have watery sap and alternate leaves which are lopsided at the base. The flowers lack petals.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034401"}, {"RECTYPE": "D", "MH": "Trema", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Tremas", "MN": "B01.875.800.575.912.250.859.937.055.875", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3479", "MS": "A plant genus of the family ULMACEAE. Members contain PHENANTHRENES and COUMARINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034402"}, {"RECTYPE": "D", "MH": "Ulmus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Elm Tree|T002|NON|EQV|NLM (2003)|011126|abcdef", "ENTRY": "Trees, Elm", "MN": "B01.875.800.575.912.250.859.937.844.888", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid24735", "RR": "txid102693", "MS": "A plant genus of the family ULMACEAE that is susceptible to Dutch elm disease which is caused by the ASCOMYCOTA fungus, Ophiostoma.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034403"}, {"RECTYPE": "D", "MH": "Sus scrofa", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Wild Boar|T015|NON|EQV|NLM (2003)|020114|abcdef", "ENTRY": "Wild Boars", "MN": "B01.050.150.900.649.313.500.880.399", "MH_TH": "NLM (2003)", "ST": "T015", "RN": "txid9823", "RR": "txid9825", "AN": "only Sus scrofa; index other species or unspecified swine or pigs under SWINE", "MS": "A species of SWINE, in the family Suidae, comprising a number of subspecies including the domestic pig Sus scrofa domestica.", "PM": "2003", "HN": "2003", "MR": "20230226", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034421"}, {"RECTYPE": "D", "MH": "Heterogeneous-Nuclear Ribonucleoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ribonucleoproteins, Heterogeneous-Nuclear", "MN": "D12.776.664.962.813.750", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1980-2002)", "MS": "A family of ribonucleoproteins that were originally found as proteins bound to nascent RNA transcripts in the form of ribonucleoprotein particles. Although considered ribonucleoproteins they are primarily classified by their protein component. They are involved in a variety of processes such as packaging of RNA and RNA TRANSPORT within the nucleus. A subset of heterogeneous-nuclear ribonucleoproteins are involved in additional functions such as nucleocytoplasmic transport (ACTIVE TRANSPORT, CELL NUCLEUS) of RNA and mRNA stability in the CYTOPLASM.", "PM": "2003; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS was indexed under RIBONUCLEOPROTEINS 1980-2002; INFORMATIN was indexed under RIBONUCLEOPROTEINS 1978-2002", "HN": "2003; use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS (NM) 1980-2002; for INFORMATIN use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS (NM) 1980-2002", "MR": "20230405", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034441"}, {"RECTYPE": "D", "MH": "N-substituted Glycines", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "N-substituted Glycine|T116|NON|EQV|NLM (2003)|011127|abcdef", "ENTRY": "N substituted Glycines", "MN": "D12.644.679.500", "MH_TH": "NLM (2004)", "ST": "T116", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Peptides (1992-2002)", "MS": "AMINO ACIDS composed of GLYCINE substituted at the nitrogen rather than the usual carbon position, resulting in the loss of HYDROGEN BONDING donors. Polymers of these compounds are called PEPTOIDS.", "PM": "2004; see N-SUBSTITUTED GLYCINE 2003", "HN": "2004(2003)", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034442"}, {"RECTYPE": "D", "MH": "RNA Transport", "AQ": "DE ES GE IM PH RE", "ENTRY": "Transport, Ribonucleic Acid", "MN": "G03.143.850", "MH_TH": "NLM (2003)", "ST": "T043", "MS": "The process of moving specific RNA molecules from one cellular compartment or region to another by various sorting and transport mechanisms.", "PM": "2003", "HN": "2003", "MR": "20160701", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034443"}, {"RECTYPE": "D", "MH": "Peptoids", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Peptoid|T116|NON|EQV|NLM (2003)|011127|abcdef", "MN": "D12.644.679", "MH_TH": "NLM (2003)", "ST": "T116", "RN": "0", "PI": "Peptides (1987-2002)", "MS": "Polymers of N-SUBSTITUTED GLYCINES containing chiral centers at the a-position of their side chains. These oligomers lack HYDROGEN BONDING donors, preventing formation of the usual intrachain hydrogen bonds but can form helices driven by the steric influence of chiral side chains.", "PM": "2003", "HN": "2003", "MR": "20030725", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034444"}, {"RECTYPE": "D", "MH": "Ovulation Inhibition", "AQ": "BL CF DE EH ES GE IM ME PH PX RE UR", "ENTRY": "Suppression, Ovulation", "MN": "G08.686.784.690.493", "MH_TH": "NLM (2003)", "ST": "T070", "PI": "Contraceptives, Oral (1964-2002)", "MS": "Blocking the process leading to OVULATION. Various factors are known to inhibit ovulation, such as neuroendocrine, psychological, and pharmacological agents.", "PM": "2003", "HN": "2003", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034445"}, {"RECTYPE": "D", "MH": "Luteinization", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "MN": "G08.686.784.690.355", "MH_TH": "NLM (2003)", "ST": "T038", "PI": "Corpus Luteum (1966-2002)", "MS": "Formation of CORPUS LUTEUM. This process includes capillary invasion of the ruptured OVARIAN FOLLICLE, hypertrophy of the GRANULOSA CELLS and the THECA CELLS, and the production of PROGESTERONE. Luteinization is regulated by LUTEINIZING HORMONE.", "PM": "2003", "HN": "2003", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034461"}, {"RECTYPE": "D", "MH": "Dissent and Disputes", "AQ": "EC HI LJ", "PRINT ENTRY": "Dissent And Dispute|T054|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Professional-Patient Disagreements", "MN": "F02.463.785.373.476", "FX": "Politics", "MH_TH": "NLM (2003)", "ST": "T054", "AN": "do not use for dissent by one author from the opinion of another", "MS": "Differences of opinion or disagreements that may arise, for example, between health professionals and patients or their families, or against a political regime.", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034462"}, {"RECTYPE": "D", "MH": "Heterogeneous-Nuclear Ribonucleoprotein Group A-B", "DS": "HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "hnRNP A-B Proteins|T116|T123|ACX|EQV|NLM (2003)|011127|abbcdef", "ENTRY": "hnRNP A B Proteins", "MN": "D12.776.664.962.813.750.100", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "see SCR for specific hnRNP entries", "PI": "DNA-Binding Proteins (1993-2002)", "MS": "A class of closely related heterogeneous-nuclear ribonucleoproteins of approximately 34-40 kDa in size. Although they are generally found in the nucleoplasm, they also shuttle between the nucleus and the cytoplasm. Members of this class have been found to have a role in mRNA transport, telomere biogenesis and RNA SPLICING.", "PM": "2003; HNRNP A2-B1 was indexed under DNA-BINDING PROTEINS 1993-2001", "HN": "2003; for HNRNP A2-B1 use TELOMERE-BINDING PROTEINS (NM) 1993-2002", "MR": "20230405", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034481"}, {"RECTYPE": "D", "MH": "Heterogeneous-Nuclear Ribonucleoprotein Group C", "DS": "HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "hnRNP C1 C2 Proteins", "MN": "D12.776.664.962.813.750.200", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "see SCR for specific hnRNP entries", "PI": "Ribonucleoproteins (1986-2002)", "MS": "A group of closely related heterogeneous-nuclear ribonucleoproteins of approximately 41-43 kDa in size found in the cell nucleus. Members of this class have been implicated in a variety of processes including splicing, polyadenylation, and nuclear retention of RNA.", "PM": "2003; C-TYPE PROTEIN HNRNP & HNRNP C PROTEIN was indexed under RIBONUCLEOPROTEINS 1992-2002", "HN": "2003; for C-TYPE PROTEIN HNRNP & HNRNP C PROTEIN use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS (NM) 1992-2002", "MR": "20230405", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034482"}, {"RECTYPE": "D", "MH": "Telomere-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Telomere-Binding Protein|T116|T123|NON|EQV|NLM (2022)|201023|abbcdef", "ENTRY": "beta-Subunit Telomer-Binding Protein", "MN": "D12.776.660.235.700", "FX": "Telomere Homeostasis", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "coordinate with MITOCHONDRIAL PROTEINS if from MITOCHONDRIA", "PI": "DNA-Binding Proteins (1991-2002)", "MS": "Proteins that specifically bind to TELOMERES. Proteins in this class include those that perform functions such as telomere capping, telomere maintenance and telomere stabilization.", "PM": "2003; TELOMERE-BINDING PROTEINS was indexed under DNA-BINDING PROTEINS 1991-2002", "HN": "2003; use TELOMERE-BINDING PROTEINS (NM) 1991-2002", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034501"}, {"RECTYPE": "D", "MH": "Heterogeneous-Nuclear Ribonucleoprotein D", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HNRNP D|T116|T123|ACR|EQV|NLM (2003)|011128|abbcdef", "ENTRY": "Ribonucleoprotein D, Heterogeneous-Nuclear", "MN": "D12.776.664.962.813.750.300", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "see SCR for specific hnRNP entries", "PI": "Ribonucleoproteins (1998-2002)", "MS": "A heterogeneous-nuclear ribonucleoprotein that has specificity for AU-rich elements found in the 3'-region of mRNA and may play a role in RNA stability. Several isoforms of hnRNP D protein have been found to occur due to alternative mRNA splicing (RNA SPLICING).", "PM": "2003", "HN": "2003", "MR": "20230405", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034502"}, {"RECTYPE": "D", "MH": "Nuclear Matrix-Associated Proteins", "DE": "NUCLEAR MATRIX ASSOC PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nuclear Scaffold Protein|T116|T123|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Scaffold Proteins, Nuclear", "MN": "D12.776.660.650", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "A broad category of nuclear proteins that are components of or participate in the formation of the NUCLEAR MATRIX.", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034521"}, {"RECTYPE": "D", "MH": "Heterogeneous-Nuclear Ribonucleoprotein Group F-H", "DS": "HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F H", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Heterogeneous Nuclear Ribonucleoprotein H H' F 2H9 Family", "MN": "D12.776.664.962.813.750.400", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "see SCR for specific hnRNP entries", "PI": "Ribonucleoproteins (1994-2002)", "MS": "A group of closely-related heterogeneous-nuclear ribonucleoproteins that are involved in pre-mRNA splicing.", "PM": "2003; HNRNP F was indexed under RIBONUCLEOPROTEINS 1994-2002; HNRNP H was indexed under RIBONUCLEOPROTEINS 1998-2002", "HN": "2003; for HNRNP F use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS 1994-2002; for HNRNP H use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS 1998-2002", "MR": "20230405", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034541"}, {"RECTYPE": "D", "MH": "Sheep, Domestic", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Mouflon|T015|NON|NRW|NLM (2003)|011128|abcdef", "ENTRY": "Mouflons", "MN": "B01.050.150.900.649.313.500.380.791.150", "MH_TH": "NLM (2003)", "ST": "T015", "RN": "txid9940", "RR": "txid9938", "AN": "sheep unspecified goes under SHEEP; SHEEP, BIGHORN is also available", "PI": "Sheep (1965-2002)", "MS": "A species of sheep, Ovis aries, descended from Near Eastern wild forms, especially mouflon.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034561"}, {"RECTYPE": "D", "MH": "Sheep, Bighorn", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rocky Mountain Bighorn Sheep|T010|EPO|NRW|NLM (2003)|020114|abcdef", "ENTRY": "Bighorn Sheep", "MN": "B01.050.150.900.649.313.500.380.791.100", "MH_TH": "NLM (2003)", "ST": "T015", "RN": "txid37174", "PI": "Sheep (1965-2002)", "MS": "A species of sheep, Ovis canadensis, characterized by massive brown horns. There are at least four subspecies and they are all endangered or threatened.", "PM": "2003", "HN": "2003", "MR": "20200902", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034581"}, {"RECTYPE": "D", "MH": "Integumentary System", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Systems, Integumentary", "MN": "A17", "RH": "A17 - ANATOMY-INTEGUMENTARY SYSTEM", "MH_TH": "NLM (2003)", "ST": "T023", "MS": "The outer covering of the body composed of the SKIN and the skin appendages, which are the HAIR, the NAILS; and the SEBACEOUS GLANDS and the SWEAT GLANDS and their ducts.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034582"}, {"RECTYPE": "D", "MH": "Hares", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Lepus|T015|NON|EQV|NLM (2003)|011129|abcdef", "ENTRY": "Jackrabbit", "MN": "B01.050.150.900.649.313.968.400", "MH_TH": "NLM (1995)", "ST": "T015", "RN": "txid9980", "AN": "do not confuse with BELGIAN HARE see RABBITS", "PI": "Rabbits (1964-1974)", "MS": "The genus Lepus, in the family Leporidae, order LAGOMORPHA. Hares are born above ground, fully furred, and with their eyes and ears open. In contrast with RABBITS, hares have 24 chromosome pairs.", "PM": "2003", "HN": "2003", "MR": "20200902", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034621"}, {"RECTYPE": "D", "MH": "RNA Interference", "AQ": "DE IM PH RE", "PRINT ENTRY": "Post-Transcriptional Gene Silencing|T045|NON|EQV|NLM (2003)|011129|POSTTRANSCRIPTIONAL GENE SILENCING|abcdefs", "ENTRY": "Silencing, Post-Transcriptional Gene", "MN": "G05.308.203.374.790", "FX": "RNAi Therapeutics", "MH_TH": "NLM (2003)", "ST": "T045", "MS": "A gene silencing phenomenon whereby specific dsRNAs (RNA, DOUBLE-STRANDED) trigger the degradation of homologous mRNA (RNA, MESSENGER). The specific dsRNAs are processed into SMALL INTERFERING RNA (siRNA) which serves as a guide for cleavage of the homologous mRNA in the RNA-INDUCED SILENCING COMPLEX. DNA METHYLATION may also be triggered during this process.", "PM": "2003", "HN": "2003", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034622"}, {"RECTYPE": "D", "MH": "Heterogeneous-Nuclear Ribonucleoprotein K", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "dC Stretch Binding Protein", "MN": "D12.776.664.962.813.750.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "see SCR for specific hnRNP entries", "PI": "Ribonucleoproteins (1994-2002)", "MS": "A heterogeneous-nuclear ribonucleoprotein found in the CELL NUCLEUS and the CYTOPLASM. Heterogeneous-nuclear ribonucleoprotein K has been implicated in the regulation of gene expression at nearly all levels: GENETIC TRANSCRIPTION; mRNA processing (RNA PROCESSING, POST-TRANSCRIPTIONAL), mRNA transport, mRNA stability, and translation (TRANSLATION, GENETIC). The hnRNP protein has a strong affinity for polypyrimidine-rich RNA and for single-stranded polypyrimidine-rich DNA. Multiple hnRNP K protein isoforms exist due to alternative splicing and display different nucleic-acid-binding properties.", "PM": "2003; DC-STRETCH-BINDING PROTEIN (now HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K) was indexed under DNA-BINDING PROTEINS 1994-2002; HNRNP K was indexed under RIBONUCLEOPROTEINS 1994-2002", "HN": "2003; use HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K (NM) 1994-2002; for HNRNP K use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS (NM) 1994-2002", "MR": "20230405", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034641"}, {"RECTYPE": "D", "MH": "Heterogeneous-Nuclear Ribonucleoprotein L", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ribonucleoprotein L, Heterogeneous-Nuclear", "MN": "D12.776.664.962.813.750.600", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "see SCR for specific hnRNP entries", "PI": "Ribonucleoproteins (2000-2002)", "MS": "A heterogeneous-nuclear ribonucleoprotein found associated with most nascent transcripts, most notably those of the landmark giant loops of amphibian lampbrush chromosomes.", "PM": "2003; HNRNP L was indexed under RIBONUCLEOPROTEINS 2000-2002", "HN": "2003; for HNRNP L use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS (NM) 2000-2002", "MR": "20230405", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034664"}, {"RECTYPE": "D", "MH": "Bacopa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Water Hyssops", "MN": "B01.875.800.575.912.250.583.700.080", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid90645", "MS": "A plant genus of the family Plantaginaceae. Members contain bacopaside, bacopasaponins and other dammarane type jujubogenins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034681"}, {"RECTYPE": "D", "MH": "Church of Jesus Christ of Latter-day Saints", "AQ": "HI PX", "ENTRY": "Mormon", "MN": "K01.844.188.466", "MH_TH": "NLM (2003)", "ST": "T078", "AN": "CATALOGER: Use NAF entry", "MS": "A group of religious bodies tracing their origin to Joseph Smith in 1830 and accepting the Book of Mormon as divine revelation. (from Merriam-Webster's Collegiate Dictionary, 10th ed)", "PM": "2003; for MORMONS see CHRISTIANITY 1977-2002", "HN": "2003; for MORMONS use CHRISTIANITY 1977-2002", "MR": "20150605", "DA": "20020712", "DC": "1", "DX": "20030101", "UI": "D034682"}, {"RECTYPE": "D", "MH": "Mastocytosis, Cutaneous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Skin Mastocytosis|T047|NON|EQV|NLM (2003)|020107|abcdef", "ENTRY": "Skin Mastocytoses", "MN": "C20.762.750.563", "MH_TH": "NLM (2003)", "ST": "T047", "AN": "MACULOPAPULAR CUTANEOUS MASTOCYTOSIS see URTICARIA PIGMENTOSA is also available", "PI": "Urticaria Pigmentosa (1965-2002)", "MS": "Skin lesions due to abnormal infiltration of MAST CELLS. Cutaneous mastocytosis is confined to the skin without the involvement of other tissues or organs, and is mostly found in children. The three major variants are: URTICARIA PIGMENTOSA; diffuse cutaneous mastocytosis; and SOLITARY MASTOCYTOMA OF SKIN.", "PM": "2003; for MASTOCYTOSIS, BULLOUS see URTICARIA PIGMENTOSA 1987-2002; for MASTOCYTOSIS, DIFFUSE CUTANEOUS see URTICARIA PIGMENTOSA 1987-2002", "HN": "2003; for MASTOCYTOSIS, BULLOUS use URTICARIA PIGMENTOSA 1987-2002; for MASTOCYTOSIS, DIFFUSE CUTANEOUS use URTICARIA PIGMENTOSA 1987-2002", "MR": "20210707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034701"}, {"RECTYPE": "D", "MH": "RNA-Binding Protein FUS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "FUS RNA-Binding Protein|T116|T123|ACX|EQV|NLM (2003)|011130|abbcdef", "ENTRY": "RNA-Binding Protein, FUS", "MN": "D12.776.664.962.813.750.902", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1996-2002)", "MS": "A multifunctional heterogeneous-nuclear ribonucleoprotein that may play a role in homologous DNA pairing and recombination. The N-terminal portion of protein is a potent transcriptional activator, while the C terminus is required for RNA binding. The name FUS refers to the fact that genetic recombination events result in fusion oncogene proteins (ONCOGENE PROTEINS, FUSION) that contain the N-terminal region of this protein. These fusion proteins have been found in myxoid liposarcoma (LIPOSARCOMA, MYXOID) and acute myeloid leukemia.", "PM": "2003; FUS PROTEIN & HNRNP P2 were indexed under RIBONUCLEOPROTEINS 1996-2002; TLS PROTEIN was indexed under 1993-2002 RIBONUCLEOPROTEINS", "HN": "2003; for FUS PROTEIN & HNRNP P2 use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS (NM) 1996-2002; for TLS PROTEIN use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS (NM) 1993-2002;", "MR": "20230405", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034702"}, {"RECTYPE": "D", "MH": "Mastocytosis, Systemic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Systemic Mast-Cell Disease|T047|NON|EQV|NLM (2003)|ORD (2010)|020107|abcdeef", "ENTRY": "Systemic Mastocytosis, Indolent", "MN": "C20.762.750.750", "MH_TH": "NLM (2003)", "ST": "T047", "PI": "Mast Cells (1965-2002)", "MS": "A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.", "PM": "2003", "HN": "2003", "MR": "20210707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034721"}, {"RECTYPE": "D", "MH": "Heterogeneous-Nuclear Ribonucleoprotein U", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ribonucleoprotein U, Heterogeneous-Nuclear", "MN": "D12.776.664.962.813.750.800", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "see SCR for specific hnRNP entries", "PI": "Ribonucleoproteins (1992-2002)", "MS": "A heterogeneous-nuclear ribonucleoprotein found associated with the NUCLEAR MATRIX.", "PM": "2003; HNRNP U PROTEIN was indexed under RIBONUCLEOPROTEINS 1992-2002, GRIP120 & SCAFFOLD ATTACHMENT FACTOR A (SAF-A) were indexed under RIBONUCLEOPROTEINS 1998-2002", "HN": "2003; for HNRNP U PROTEIN use HETEROGENEOUS-NUCLEAR RIBONUCLEAR PROTEINS 1992-2002, for GRIP120 & SCAFFOLD ATTACHMENT FACTOR A (SAF-A) use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS (NM) 1998-2002", "MR": "20230405", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034722"}, {"RECTYPE": "D", "MH": "Double Effect Principle", "ENTRY": "Rule, Double Effect", "MN": "N05.350.238", "FX": "Intention", "MH_TH": "NLM (2009)", "ST": "T089", "AN": "note category; use only in the context of ethics", "PI": "Ethics, Medical (1997-2002)", "MS": "Guideline for determining when it is morally permissible to perform an action to pursue a good end with knowledge that the action will also bring about bad results. It generally states that, in cases where a contemplated action has such double effect, the action is permissible only if: it is not wrong in itself; the bad result is not intended; the good result is not a direct causal result of the bad result; and the good result is \"proportionate to\" the bad result. (from Solomon, \"Double Effect,\" in Becker, The Encyclopedia of Ethics, 1992)", "PM": "2009; see DOUBLE EFFECT 2003-2008; see ETHICS 2002", "HN": "2009 (2003); use ETHICS 2002", "MR": "20150622", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034723"}, {"RECTYPE": "D", "MH": "RNA, Small Interfering", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "siRNA, Trans-Acting|T114|ACX|NRW|NLM (2008)|070227|abcdef", "ENTRY": "siRNA, Trans Acting", "MN": "D13.444.735.790.552.875", "FX": "RNA-Induced Silencing Complex", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "Do not confuse with defective interfering RNA (diRNA), a viral RNA of DEFECTIVE VIRUSES.", "MS": "Small double-stranded, non-protein coding RNAs (21-31 nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, Dicer, that generates miRNAs (MICRORNAS). The perfect match of the siRNAs' antisense strand to their target RNAs mediates RNAi by siRNA-guided RNA cleavage. siRNAs fall into different classes including trans-acting siRNA (tasiRNA), repeat-associated RNA (rasiRNA), small-scan RNA (scnRNA), and Piwi protein-interacting RNA (piRNA) and have different specific gene silencing functions.", "PM": "2003; RNA, SMALL INTERFERING was indexed under RNA, UNTRANSLATED 2001-2002", "HN": "2003; use RNA, SMALL INTERFERING (NM) 2001-2002", "MR": "20220708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034741"}, {"RECTYPE": "D", "MH": "Electronic Mail", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Email|T054|T170|NON|EQV|NLM (2003)|011203|abbcdef", "ENTRY": "Mail, Electronic", "MN": "L01.559.423.906.377.333", "MH_TH": "NLM (1996)", "ST": "T170", "PI": "Computer Communication Networks (1995-2002)", "MS": "Messages between computer users via COMPUTER COMMUNICATION NETWORKS. This feature duplicates most of the features of paper mail, such as forwarding, multiple copies, and attachments of images and other file types, but with a speed advantage. The term also refers to an individual message sent in this way.", "PM": "2003; see COMPUTER COMMUNICATION NETWORKS 1996-2002; see OFFICE AUTOMATION 1987-1995", "HN": "2003; use COMPUTER COMMUNICATION NETWORKS 1996-2002; use OFFICE AUTOMATION 1987-1995", "MR": "20220712", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034742"}, {"RECTYPE": "D", "MH": "RNA-Induced Silencing Complex", "DE": "RNA IND SILENCING COMPLEX", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Silencing Complex, RNA-Induced", "MN": "D12.776.664.962.500.906", "FX": "RNA, Small Interfering", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Endoribonucleases (2001-2002)", "MS": "A multicomponent, ribonucleoprotein complex comprised of one of the family of ARGONAUTE PROTEINS and the \"guide strand\" of the one of the 20- to 30-nucleotide small RNAs. RISC cleaves specific RNAs, which are targeted for degradation by homology to these small RNAs. Functions in regulating gene expression are determined by the specific argonaute protein and small RNA including siRNA (RNA, SMALL INTERFERING), miRNA (MICRORNA), or piRNA (PIWI-INTERACTING RNA).", "PM": "2003; RNA-INDUCED SILENCING COMPLEX was indexed under RIBONUCLEOPROTEINS 2001-2002", "HN": "2003; use RNA-INDUCED SILENCING COMPLEX (NM) 2001-2002", "MR": "20110624", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034743"}, {"RECTYPE": "D", "MH": "Heterogeneous-Nuclear Ribonucleoprotein Group M", "DS": "HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN M", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "hnRNP M|T116|T123|ACR|EQV|NLM (2003)|001018|abbcdef", "ENTRY": "Ribonucleoprotein M, Heterogeneous-Nuclear", "MN": "D12.776.664.962.813.750.700", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "see SCR for specific hnRNP entries", "PI": "Nucleoproteins (2000-2002)", "MS": "A group of closely-related 72-74-kDa heterogeneous-nuclear ribonucleoproteins that are involved in RNA SPLICING events.", "PM": "2003; HNRNP M was indexed under NUCLEOPROTEINS 2000-2002", "HN": "2003; for HNRNP M use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS (NM) 2000-2002", "MR": "20230405", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034761"}, {"RECTYPE": "D", "MH": "Celosia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cockscomb, Common|T002|NON|NRW|NLM (2003)|011203|abcdef", "ENTRY": "cristatas, Celosia", "MN": "B01.875.800.575.912.250.198.500.100.333", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid46111", "RR": "txid124768", "AN": "entry term COCKSCOMB, COMMON: COCKSCOMB, GREEN see SEDUM is also available", "MS": "A plant genus of the family AMARANTHACEAE. Young leaves are used as vegetables in Asia. Members contain betacyanins, celogentins, betaxanthin, and celosian.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034762"}, {"RECTYPE": "D", "MH": "Receptors, N-Acetylglucosamine", "DE": "RECEPT N ACETYLGLUCOSAMINE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "N-Acetylglucosamine Receptors|T116|T192|NON|EQV|NLM (2003)|abbcde", "ENTRY": "Receptors, N Acetylglucosamine", "MN": "D12.776.543.750.715", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Receptors, Thyroid Hormone (1988-2002)", "MS": "Cell surface receptors that bind to ACETYLGLUCOSAMINE.", "PM": "2003; N-ACETYLGLUCOSAMIN RECEPTORS was indexed under RECEPTORS, IMMUNOLOGIC & RECEPTORS, THRYOID HORMONE 1988-2002", "HN": "2003; use RECEPTORS, N-ACETYLGLUCOSAMINE (NM) 1988-2002", "MR": "20050721", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034781"}, {"RECTYPE": "D", "MH": "Mastocytoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Mastocytoma, Benign|T191|NON|EQV|UNK (19XX)|860407|abcdef", "ENTRY": "Mastocytomas, Extracutaneous", "MN": "C20.762.750.469", "MH_TH": "NLM (2003)", "ST": "T191", "AN": "unifocal lesion only; multi-focal lesions use MASTOCYTOSIS, CUTANEOUS or MASTOCYTOSIS, SYSTEMIC; MASTOCYTOMA, SKIN is also available", "PI": "Mastocytosis (1985-2002)", "MS": "A solid tumor consisting of a dense infiltration of MAST CELLS. It is generally benign.", "PM": "2003; for MASTOCYTOMA BENIGN see MASTOCYTOSIS 1987-2002", "HN": "2003; for MASTOCYTOMA BENIGN use MASTOCYTOSIS 1987-2002", "MR": "20210707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034801"}, {"RECTYPE": "D", "MH": "RNA-Binding Protein EWS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "RNA Binding Protein EWS", "MN": "D12.776.664.962.813.750.900", "FX": "Zinc Fingers", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1995-2002)", "MS": "A ubiquitous hnRNP protein that contains an RNA RECOGNITION MOTIF and C-terminal ranBP2-type zinc finger. It localizes to the CELL NUCLEUS and CYTOPLASM and is expressed as different isoforms in various tissues, interacting with CALMODULIN and TUMOR SUPPRESSOR PROTEIN P53 to negatively regulate cell growth. Translocations that result in the formation of fusion proteins containing parts of RNA-binding protein EWS are associated with EWING SARCOMA.", "PM": "2003; EWS PROTEIN was indexed under RIBONUCLEOPROTEINS 1995-2002", "HN": "2003; for EWS PROTEIN use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS 1995-2002", "MR": "20230405", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034802"}, {"RECTYPE": "D", "MH": "Commelinaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.233", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4740", "MS": "A plant family of the order Commelinales, subclass Commelinidae, class Liliopsida (monocotyledons) that are often somewhat succulent. The leaves are alternate, simple, parallel-veined, and usually with a closed sheathing base. The flowers are often in cymes and have 3 petals and 3 sepals.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034821"}, {"RECTYPE": "D", "MH": "Commelina", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Dayflower|T002|NON|EQV|NLM (2003)|011204|abcdef", "ENTRY": "Dayflowers", "MN": "B01.875.800.575.912.250.233.222", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4743", "MS": "A plant genus of the family COMMELINACEAE of perennial herbs with blue flowers.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034822"}, {"RECTYPE": "D", "MH": "Tradescantia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Spiderwort|T002|NON|EQV|NLM (2003)|011204|abcdef", "ENTRY": "Tradescantias", "MN": "B01.875.800.575.912.250.233.611", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4741", "MS": "A plant genus of the family COMMELINACEAE that is used in genotoxic bioassays.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034823"}, {"RECTYPE": "D", "MH": "Abdominal Cavity", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "ENTRY": "Cavity, Abdominal", "MN": "A01.923.047.025", "EC": "injuries:Abdominal Injuries", "MH_TH": "NLM (2003)", "ST": "T029", "AN": "prefer specifics; ABDOMEN is also available, use author's language", "PI": "Abdomen (1964-2002)", "MS": "The region in the abdomen extending from the thoracic DIAPHRAGM to the plane of the superior pelvic aperture (pelvic inlet). The abdominal cavity contains the PERITONEUM and abdominal VISCERA, as well as the extraperitoneal space which includes the RETROPERITONEAL SPACE.", "PM": "2003", "HN": "2003", "MR": "20110624", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034841"}, {"RECTYPE": "D", "MH": "Abdominal Wall", "AQ": "AB AH BS DG EM GD IR MI PA PH PP PS RE SU VI", "ENTRY": "Wall, Abdominal", "MN": "A01.923.112.125", "FX": "Abdominal Muscles", "MH_TH": "NLM (1993)", "ST": "T023", "PI": "Abdominal Muscles (1965-2002)", "MS": "The outer margins of the ABDOMEN, extending from the osteocartilaginous thoracic cage to the PELVIS. Though its major part is muscular, the abdominal wall consists of at least seven layers: the SKIN, subcutaneous fat, deep FASCIA; ABDOMINAL MUSCLES, transversalis fascia, extraperitoneal fat, and the parietal PERITONEUM.", "PM": "2003; see ABDOMINAL MUSCLES 1966-1992", "HN": "2003; use ABDOMINAL MUSCLES 1966-1992", "MR": "20210706", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034861"}, {"RECTYPE": "D", "MH": "Nuclear Lamina", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Nuclear Laminas", "MN": "A11.284.835.514.700.500", "MH_TH": "NLM (2003)", "ST": "T026", "MS": "A lattice of fibrils which covers the entire inner surface of the nuclear envelope and interlinks nuclear pores (NUCLEAR PORE).", "PM": "2003", "HN": "2003", "MR": "20030709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034881"}, {"RECTYPE": "D", "MH": "Lamins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lamin|T116|T123|NON|EQV|NLM (2021)|191115|abbcdef", "MN": "D12.776.660.650.875", "FX": "Nuclear Lamina", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific lamins", "MS": "Nuclear matrix proteins that are structural components of the NUCLEAR LAMINA. They are found in most multicellular organisms.", "PM": "2003; LAMINS was indexed under Nuclear Proteins 1988-2002, NUCLEOPROTEINS 1980-1987", "HN": "2003; use LAMINS (NM) 1980-2002", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034882"}, {"RECTYPE": "D", "MH": "Alismataceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Echinodorus|T002|NON|NRW|NLM (2003)|020104|abcdef", "MN": "B01.875.800.575.912.250.618.050.625", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4449", "RR": "txid13047", "AN": "prefer specific plant", "MS": "A plant family of the subclass ALISMATIDAE, class Liliopsida (monocotyledons) of aquatic plants. The flower parts are in threes with 3 green sepals and 3 white or yellow petals.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034901"}, {"RECTYPE": "D", "MH": "Alisma", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Water Plantains, Common", "MN": "B01.875.800.575.912.250.618.050.625.044", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid14999", "RR": "txid15000", "MS": "A plant genus of the family ALISMATACEAE. The flowers have 3 green sepals, 3 yellow and white petals, 6 stamens, and several pistils. Members contain TRITERPENES and SESQUITERPENES. Alisma is a component of tokishakuyakusan. Some species in this genus are called water plantain which is also a common name for other ALISMATACEAE plants.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034902"}, {"RECTYPE": "D", "MH": "Sagittaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Arrowhead|T002|NON|EQV|NLM (2003)|011205|abcdef", "ENTRY": "Sagittarias", "MN": "B01.875.800.575.912.250.618.050.625.777", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4450", "MS": "A plant genus of the family ALISMATACEAE that grows in salty marshes and is used for phytoremediation of oil spills. The unisexual flowers have 3 sepals and 3 petals. Members contain trifoliones (DITERPENES).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034903"}, {"RECTYPE": "D", "MH": "Lamin Type A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lamins, Type A", "MN": "D12.776.660.650.875.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Nuclear Proteins (1991-2002)", "MS": "A subclass of developmentally regulated lamins having a neutral isoelectric point. They are found to disassociate from nuclear membranes during mitosis.", "PM": "2003; LAMIN A was indexed under NUCLEAR PROTEINS 1991-2002", "HN": "2003; for LAMIN A use LAMINS (NM) 1991-2002", "MR": "20180702", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034904"}, {"RECTYPE": "D", "MH": "Lamin Type B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lamin B3|T116|NON|NRW|NLM (2024)|230609|abcdef", "ENTRY": "Type B Lamins|T116|T123|NON|EQV|NLM (2003)|020122|abbcdef", "MN": "D12.776.660.650.875.750", "FX": "Pelger-Huet Anomaly", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Nuclear Proteins (1991-2002)", "MS": "A subclass of ubiquitously-expressed lamins having an acidic isoelectric point. They are found to remain bound to NUCLEAR MEMBRANE during MITOSIS.", "PM": "2003; LAMIN B was indexed under NUCLEAR PROTEINS 1991-2002", "HN": "2003; for LAMIN B use LAMINS (NM) 1991-2002", "MR": "20230609", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034921"}, {"RECTYPE": "D", "MH": "Upper Extremity", "AQ": "AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "Extremity, Upper|T029|NON|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Upper Limbs", "MN": "A01.378.800", "FX": "Bones of Upper Extremity", "EC": "abnormalities:Upper Extremity Deformities, Congenital", "MH_TH": "UNK (19XX)", "ST": "T029", "AN": "prefer specifics", "PI": "Arm (1963-2002)", "MS": "The region of the upper limb in animals, extending from the deltoid region to the HAND, and including the ARM; AXILLA; and SHOULDER.", "PM": "2003; see ARM 1987-2002", "HN": "2003; use ARM 1987-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034941"}, {"RECTYPE": "D", "MH": "Antigens, Nuclear", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Nuclear Antigens|T129|NON|EQV|NLM (2003)|abcde", "ENTRY": "Nuclear Antigens, Extractable", "MN": "D23.050.290", "FX": "Autoantigens", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "AN": "coord NIM with specific antigen/organism heading (IM)", "PI": "Nuclear Proteins (1981-2002)", "MS": "Immunologically detectable substances found in the CELL NUCLEUS.", "PM": "2003; NUCLEAR ANTIGENS was indexed under NUCLEAR PROTEINS 1981-2002", "HN": "2003; use NUCLEAR ANTIGENS (NM) 1981-2002", "MR": "20200527", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D034961"}, {"RECTYPE": "D", "MH": "Integration Host Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Integration Host Factor|T116|T123|NON|EQV|NLM (2003)|abbcde", "ENTRY": "Host Factors, Integration", "MN": "D23.297.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "do not confuse with HOST-DERIVED CELLULAR FACTORS", "PI": "Carrier Proteins (1981-2002)", "MS": "Bacterial proteins that are used by BACTERIOPHAGES to incorporate their DNA into the DNA of the \"host\" bacteria. They are DNA-binding proteins that function in genetic recombination as well as in transcriptional and translational regulation.", "PM": "2003; INTEGRATION HOST FACTOR was indexed under BACTERIAL PROTEINS 1985-2002; HOST FACTOR was indexed under CARRIER PROTEINS 1981-2002", "HN": "2003; use INTEGRATION HOST FACTORS (NM) 1981-2002", "MR": "20100625", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D034982"}, {"RECTYPE": "D", "MH": "Host Factor 1 Protein", "DS": "HOST FACTOR A 01 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "hfq Gene Product|T116|T123|ACX|EQV|NLM (2003)|abbcde", "MN": "D12.776.664.962.249", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1994-2002)", "MS": "An integration host factor that was originally identified as a bacterial protein required for the integration of bacteriophage Q beta (ALLOLEVIVIRUS). Its cellular function may be to regulate mRNA stability and processing in that it binds tightly to poly(A) RNA and interferes with ribosome binding.", "PM": "2003; HFQ GENE PRODUCT & HOST FACTOR 1 were indexed under CARRIER PROTEINS 1994-2002", "HN": "2003; for HFQ GENE PRODUCT & HOST FACTOR 1 use INTEGRATION HOST FACTORS (NM) 1994-2002", "MR": "20040728", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035001"}, {"RECTYPE": "D", "MH": "Lower Extremity", "AQ": "AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "Extremity, Lower|T029|NON|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Lower Limbs", "MN": "A01.378.610", "EC": "abnormalities:Lower Extremity Deformities, Congenital", "MH_TH": "UNK (19XX)", "ST": "T029", "AN": "prefer specifics", "PI": "Leg (1964-2002)", "MS": "The region of the lower limb in animals, extending from the gluteal region to the FOOT, and including the BUTTOCKS; HIP; and LEG.", "PM": "2003; see LEG 1987-2002", "HN": "2003; use LEG 1987-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035002"}, {"RECTYPE": "D", "MH": "Factor For Inversion Stimulation Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Inversion Stimulation Factor|T116|T123|NON|EQV|NLM (2003)|abbcde", "MN": "D12.776.260.246", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1994-2002)", "MS": "A highly abundant DNA binding protein whose expression is strongly correlated with the growth phase of bacteria. The protein plays a role in regulating DNA topology and activation of RIBOSOMAL RNA transcription. It was originally identified as a factor required for inversion stimulation by the Hin recombinase of SALMONELLA and Gin site-specific recombinase of BACTERIOPHAGE MU.", "PM": "2003; INVERSION STIMULATION FACTOR were indexed under CARRIER PROTEINS 1994-2002;", "HN": "2003; for INVERSION STIMULATION FACTOR use INTEGRATION HOST FACTOR (NM) 1994-2002", "MR": "20040707", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035021"}, {"RECTYPE": "D", "MH": "Anonymous Testing", "AQ": "AE CL EC ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Testing, Anonymous", "MN": "N06.850.780.500.162", "FX": "Confidentiality", "MH_TH": "BIOETHICS (1991)", "ST": "T062", "MS": "Testing in which the source of the specimen or the person being tested is not individually identified.", "PM": "2003", "HN": "2003", "MR": "20170630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035041"}, {"RECTYPE": "D", "MH": "Control Groups", "ENTRY": "Groups, Control", "MN": "E05.581.500.149", "FX": "Controlled Clinical Trials as Topic", "MH_TH": "BIOETHICS (1974)", "ST": "T096", "AN": "do not use routinely for the presence of control groups in a study design; reserve for discussions about control groups.", "PI": "Research Design (1973-2002)", "MS": "Groups that serve as a standard for comparison in experimental studies. They are similar in relevant characteristics to the experimental group but do not receive the experimental intervention.", "PM": "2003", "HN": "2003", "MR": "20180629", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035061"}, {"RECTYPE": "D", "MH": "Editorial Policies", "ENTRY": "Policy, Editorial", "MN": "L01.737.484", "MH_TH": "BIOETHICS (1974)", "ST": "T170", "PI": "Publishing (1970-2002)", "MS": "The guidelines and policy statements set forth by the editor(s) or editorial board of a publication.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035081"}, {"RECTYPE": "D", "MH": "Federal Government", "AQ": "HI", "ENTRY": "Government, Federal", "MN": "N03.540.400.750", "MH_TH": "BIOETHICS (1974)", "ST": "T092", "AN": "not restricted to the U.S.; use when legislation or regulation at the national, as opposed to the state, provincial, or local level, is under discussion; specify country", "PI": "Government (1966-2002)", "MS": "The level of governmental organization and function at the national or country-wide level.", "PM": "2003", "HN": "2003", "MR": "20150629", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035082"}, {"RECTYPE": "D", "MH": "Voluntary Programs", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Voluntary Program", "MN": "N04.452.977", "FX": "Mandatory Programs", "MH_TH": "NLM (2003)", "ST": "T058", "MS": "Programs in which participation is not required.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035141"}, {"RECTYPE": "D", "MH": "Bombacaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Quararibea|T002|NON|NRW|NLM (2003)|011210|abcdef", "ENTRY": "Quararibeas", "MN": "B01.875.800.575.912.250.148", "MH_TH": "NLM (2003)", "ST": "T002", "RR": "txid69117", "AN": "prefer specific plant", "MS": "A plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida of tropical trees.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035161"}, {"RECTYPE": "D", "MH": "Adansonia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Baobab|T002|NON|EQV|NLM (2003)|011210|abcdef", "ENTRY": "Baobabs", "MN": "B01.875.800.575.912.250.859.821.500.108", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid69108", "MS": "A plant genus of the family BOMBACACEAE that is used for FOOD and MEDICINE, TRADITIONAL.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035162"}, {"RECTYPE": "D", "MH": "Bombax", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "malabaricum, Salmalia", "MN": "B01.875.800.575.912.250.859.821.500.148", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid45324", "RR": "txid45325", "MS": "A plant genus of the family BOMBACACEAE. The fine silky hairs covering the seeds have been used like kapok (CEIBA) for floatation, stuffing, and insulation.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035163"}, {"RECTYPE": "D", "MH": "Ceiba", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Kapok Tree|T002|NON|NRW|NLM (2003)|011210|abcdef", "ENTRY": "pentandra, Ceiba", "MN": "B01.875.800.575.912.250.859.821.500.180", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid93752", "RR": "txid193163", "MS": "A plant genus of the family BOMBACACEAE. The fine silky hairs covering the seeds have been used for floatation, stuffing, and insulation.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035164"}, {"RECTYPE": "D", "MH": "Transcription Factors, General", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "General Transcription Factors|T116|T123|NON|EQV|NLM (2003)|011210|abbcdef", "ENTRY": "General Transcription Initiation Complex Proteins|T116|T123|NON|REL|NLM (2003)|011213|abbcdef", "MN": "D12.776.930.930", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "Transcription factors that form transcription initiation complexes on DNA, bind to specific DNA-DIRECTED RNA POLYMERASES and are required to initiate transcription. Although their binding may be localized to distinct sequence and structural motifs within the DNA they are considered non-specific with regard to the specific gene being transcribed.", "PM": "2003", "HN": "2003", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035165"}, {"RECTYPE": "D", "MH": "TATA-Box Binding Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TATA-Box-Binding Protein|T116|T123|ACX|EQV|NLM (2003)|abbcde", "ENTRY": "TATA Box Binding Protein", "MN": "D12.776.930.930.875.750.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1992-2002)", "MS": "A general transcription factor that plays a major role in the activation of eukaryotic genes transcribed by RNA POLYMERASES. It binds specifically to the TATA BOX promoter element, which lies close to the position of transcription initiation in RNA transcribed by RNA POLYMERASE II. Although considered a principal component of TRANSCRIPTION FACTOR TFIID it also takes part in general transcription factor complexes involved in RNA POLYMERASE I and RNA POLYMERASE III transcription.", "PM": "2003; TATA-BOX BINDING PROTEIN was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1992-2002", "HN": "2003; use TATA-BOX BINDING PROTEIN (NM) 1992-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035181"}, {"RECTYPE": "D", "MH": "TATA Box Binding Protein-Like Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TBP-Related Factor|T116|T123|ACX|EQV|NLM (2003)|abbcde", "ENTRY": "TLP, TBP-Like", "MN": "D12.776.930.930.812", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "entry term TBP-RELATED FACTOR: see SCR for organism-specific TBP-related factors", "PI": "Transcription Factors (1993-2002)", "MS": "A class of proteins related in structure and function to TATA-BOX BINDING PROTEIN that can take the place of TATA-BOX BINDING PROTEIN in the transcription initiation complex. They are found in most multicellular organisms and may be involved in tissue-specific promoter regulation. They bind to DNA and interact with TATA-BINDING PROTEIN ASSOCIATED FACTORS, however they may lack specificity for the TATA-BOX.", "PM": "2003; TBP-RELATED FACTOR (now TATA-BOX BINDING PROTEIN-LIKE PROTEINS) was indexed under TRANSCRIPTION FACTORS & DNA-BINDING PROTEINS 1993-2002", "HN": "2003; use TATA-BOX BINDING PROTEIN-LIKE PROTEINS (NM) 1993-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035182"}, {"RECTYPE": "D", "MH": "Brachiaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Brachiarias", "MN": "B01.875.800.575.912.250.822.071", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid59786", "MS": "A plant genus of the family POACEAE originating from the savanna of eastern Africa. It is widely grown for livestock forage.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035201"}, {"RECTYPE": "D", "MH": "Plant Components, Aerial", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Aerial Plant Components|T002|NON|EQV|NLM (2003)|011211|abcdef", "ENTRY": "Plant Component, Aerial", "MN": "A18.024", "MH_TH": "NLM (2003)", "ST": "T002", "AN": "coord with specific plant", "MS": "The above-ground plant without the roots.", "PM": "2003", "HN": "2003", "MR": "20090706", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035261"}, {"RECTYPE": "D", "MH": "Cranial Fossa, Anterior", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Olfactory Groove|T030|NON|NRW|NLM (2020)|190412|abcdef", "ENTRY": "Olfactory Grooves", "MN": "A02.835.232.781.750.150", "MH_TH": "NLM (2003)", "ST": "T030", "AN": "NIM when merely locational; neoplasms: coordinate with SKULL BASE NEOPLASMS ", "MS": "The compartment containing the inferior part and anterior extremities of the frontal lobes (FRONTAL LOBE) of the cerebral hemispheres. It is formed mainly by orbital parts of the FRONTAL BONE and the lesser wings of the SPHENOID BONE.", "PM": "2003", "HN": "2003", "MR": "20190521", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035262"}, {"RECTYPE": "D", "MH": "Flowering Tops", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Tops, Flowering", "MN": "A18.024.249", "MH_TH": "NLM (2003)", "ST": "T002", "AN": "coord with specific plant", "MS": "Tops of plants when in flower, including the stems, leaves and blooms.", "PM": "2003", "HN": "2003", "MR": "20090706", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035263"}, {"RECTYPE": "D", "MH": "Flowers", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Plant Style|T002|NON|NRW|NLM (2003)|020307|abcdef", "ENTRY": "Styles, Plant", "MN": "A18.024.249.500", "MH_TH": "NLM (2003)", "ST": "T002", "AN": "coordinate with specific plant", "MS": "The reproductive organs of plants.", "PM": "2003", "HN": "2003", "MR": "20090706", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035264"}, {"RECTYPE": "D", "MH": "Plant Tubers", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tubers, Plant|T002|NON|EQV|NLM (2003)|011211|abcdef", "ENTRY": "Tuber, Plant", "MN": "A18.400.625", "MH_TH": "NLM (2003)", "ST": "T002", "PI": "Plant Roots (1995-2002)", "MS": "An enlarged underground root or stem of some plants. It is usually rich in carbohydrates. Some, such as POTATOES, are important human FOOD. They may reproduce vegetatively from buds.", "PM": "2003", "HN": "2003", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035281"}, {"RECTYPE": "D", "MH": "Cranial Fossa, Middle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Middle Cranial Fossa|T030|NON|EQV|NLM (2003)|011211|abcdef", "ENTRY": "Fossa, Middle Cranial", "MN": "A02.835.232.781.750.165", "MH_TH": "NLM (2003)", "ST": "T030", "AN": "NIM when merely locational; neoplasms: coordinate with SKULL BASE NEOPLASMS ", "MS": "The compartment containing the anterior extremities and half the inferior surface of the temporal lobes (TEMPORAL LOBE) of the cerebral hemispheres. Lying posterior and inferior to the anterior cranial fossa (CRANIAL FOSSA, ANTERIOR), it is formed by part of the TEMPORAL BONE and SPHENOID BONE. It is separated from the posterior cranial fossa (CRANIAL FOSSA, POSTERIOR) by crests formed by the superior borders of the petrous parts of the temporal bones.", "PM": "2003", "HN": "2003", "MR": "20190521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035301"}, {"RECTYPE": "D", "MH": "Telomeric Repeat Binding Protein 1", "DS": "TELOMERIC REPEAT BINDING PROTEIN A 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TRF1 Protein|T116|T123|ACX|EQV|NLM (2003)|TRF A 01 PROTEIN|abbcdes", "ENTRY": "TRF1 Proteins", "MN": "D12.776.664.981.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "DNA-Binding Proteins (1997-2002)", "MS": "A ubiquitously expressed telomere-binding protein that is present at TELOMERES throughout the CELL CYCLE. It is a suppressor of telomere elongation and may be involved in stabilization of telomere length. It is structurally different from TELOMERIC REPEAT BINDING PROTEIN 2 in that it contains acidic N-terminal amino acid residues.", "PM": "2003; TRF1 PROTEIN was indexed under DNA-BINDING PROTEINS 1997-2002", "HN": "2003; for TRF1 PROTEIN use TELOMERE-BINDING PROTEINS (NM) 1997-2002;", "MR": "20210510", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035321"}, {"RECTYPE": "D", "MH": "Melastomataceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Miconia|T002|NON|NRW|NLM (2003)|011211|abcdef", "ENTRY": "Miconias", "MN": "B01.875.800.575.912.250.707", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid39998", "RR": "txid263288", "MS": "A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida composed of tropical plants with parallel-nerved leaves.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035322"}, {"RECTYPE": "D", "MH": "Telomeric Repeat Binding Protein 2", "DS": "TELOMERIC REPEAT BINDING PROTEIN A 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TRF2 Protein|T116|T123|ACX|EQV|NLM (2003)|TRF A 02 PROTEIN|abbcdes", "ENTRY": "Trf2 Gene Products", "MN": "G05.360.160.845.500.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "DNA-Binding Proteins (1998-2002)", "MS": "A ubiquitously expressed telomere-binding protein that is present at TELOMERES throughout the cell cycle. It is a suppressor of telomere elongation and may be involved in stabilization of telomere length. It is structurally different from TELOMERIC REPEAT BINDING PROTEIN 1 in that it contains basic N-terminal amino acid residues.", "PM": "2003; TRF2 PROTEIN (now TELOMERIC REPEAT BINDING PROTEIN 2) was indexed under DNA-BINDING PROTEINS 1998-2002", "HN": "2003; use TELOMERIC REPEAT BINDING PROTEIN 2 (NM) 1998-2002", "MR": "20210510", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035341"}, {"RECTYPE": "D", "MH": "Transcription Factor TFIIIB", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TFIIIB, Transcription Factor", "MN": "D12.776.930.930.937.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1987-2002)", "MS": "One of several general transcription factors that are specific for RNA POLYMERASE III. TFIIIB recruits and positions pol III over the initiation site and remains stably bound to the DNA through multiple rounds of re-initiation by RNA POLYMERASE III.", "PM": "2003; TRANSCRIPTION FACTOR TFIIIB was indexed under TRANSCRIPTION FACTORS 1987-2002", "HN": "2003; use TRANSCRIPTION FACTOR TFIIIB (NM) 1987-2002", "MR": "20050728", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035361"}, {"RECTYPE": "D", "MH": "Transcription Factor TFIID", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor IID|T116|T123|NON|EQV|NLM (2003)|abbcde", "MN": "D12.776.930.930.875.750", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1988-1998)", "MS": "The major sequence-specific DNA-binding component involved in the activation of transcription of RNA POLYMERASE II. It was originally described as a complex of TATA-BOX BINDING PROTEIN and TATA-BINDING PROTEIN ASSOCIATED FACTORS. It is now know that TATA BOX BINDING PROTEIN-LIKE PROTEINS may take the place of TATA-box binding protein in the complex.", "PM": "2003; TRANSCRIPTION FACTOR TFIID was indexed under TRANSCRIPTION FACTORS, TFII 1998-2002, TRANSCRIPTION FACTORS 1999-2002", "HN": "2003; use TRANSCRIPTION FACTOR TFIID (NM) 1988-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035362"}, {"RECTYPE": "D", "MH": "TATA-Binding Protein Associated Factors", "DE": "TATA BINDING PROTEIN ASSOC FACTORS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TBP-Associated Factors|T116|T123|ACX|EQV|NLM (2003)|011213|TBP ASSOC FACTORS|abbcdefv", "ENTRY": "TBP Associated Factors", "MN": "D12.776.930.930.186", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "Factors that associate with TATA-BOX BINDING PROTEIN. Many of them are components of TRANSCRIPTION FACTOR TFIID", "PM": "2003", "HN": "2003", "MR": "20060705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035381"}, {"RECTYPE": "D", "MH": "Conyza", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Horseweed|T002|NON|EQV|NLM (2003)|011212|abcdef", "ENTRY": "Horseweeds", "MN": "B01.875.800.575.912.250.100.244", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41552", "MS": "A plant genus of the family ASTERACEAE. Members contain alkenynes, daucosterol, friedelinol, conyzasaponins and other TRITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035401"}, {"RECTYPE": "D", "MH": "Parotid Region", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Region, Parotid", "MN": "A01.456.505.750", "MH_TH": "NLM (2003)", "ST": "T029", "MS": "The region of the face on either side, around the PAROTID GLAND.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035421"}, {"RECTYPE": "D", "MH": "Pleural Cavity", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Pleural Cavities", "MN": "A01.923.761.800.650", "MH_TH": "NLM (1998)", "ST": "T029", "AN": "PLEURA is also available", "PI": "Pleura (1965-2002)", "MS": "Paired but separate cavity within the THORACIC CAVITY. It consists of the space between the parietal and visceral PLEURA and normally contains a capillary layer of serous fluid that lubricates the pleural surfaces.", "PM": "2003", "HN": "2003", "MR": "20110624", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035422"}, {"RECTYPE": "D", "MH": "Thoracic Cavity", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Cavity, Thoracic", "MN": "A01.923.761.800", "MH_TH": "NLM (2003)", "ST": "T029", "AN": "prefer specifics", "MS": "The region of the thorax that includes the PLEURAL CAVITY and MEDIASTINUM.", "PM": "2003", "HN": "2003", "MR": "20160809", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035423"}, {"RECTYPE": "D", "MH": "Thoracic Wall", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Chest Wall|T023|NON|EQV|NLM (2003)|020212|abcdef", "ENTRY": "Wall, Thoracic", "MN": "A01.923.761.850", "FX": "Respiratory Muscles", "MH_TH": "NLM (2003)", "ST": "T023", "MS": "The outer margins of the thorax containing SKIN, deep FASCIA; THORACIC VERTEBRAE; RIBS; STERNUM; and MUSCLES.", "PM": "2003", "HN": "2003", "MR": "20110624", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035441"}, {"RECTYPE": "D", "MH": "Holarrhena", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Kutaja|T121|NON|REL|NLM (2003)|abcde", "ENTRY": "Kutajas", "MN": "B01.875.800.575.912.250.456.500.346", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid69380", "MS": "A plant genus of the family APOCYNACEAE. Members contain holarrhenine (a steroidal alkaloid) and TRICHOTHECENES.", "PM": "2003; KUTAJA was indexed under ALKALOIDS 1984-2002", "HN": "2003; for KUTAJA use KUTAJA (NM) 1984-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035462"}, {"RECTYPE": "D", "MH": "Pol1 Transcription Initiation Complex Proteins", "DS": "POL 00 TRANSCRIPTION INITIATION COMPLEX PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transcription Factors, TFI|T116|T123|ACX|EQV|NLM (2003)|011213|abbcdef", "ENTRY": "Transcription Factors, RNA Polymerase I|T116|T123|ACX|EQV|NLM (2003)|011213|abbcdef", "MN": "D12.776.930.930.092", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "Factors that form a preinitiation complex at promoters that are specifically transcribed by RNA POLYMERASE I.", "PM": "2003", "HN": "2003", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035463"}, {"RECTYPE": "D", "MH": "Retrospective Moral Judgment", "PRINT ENTRY": "Retrospective Moral Judgement|T078|NON|EQV|NLM (2023)|210819|abcdef", "ENTRY": "Retrospective Moral Judgments", "MN": "N05.350.244.750", "FX": "Professional Misconduct", "MH_TH": "NLM (2002)", "ST": "T078", "PI": "Morals (1997-2002)", "MS": "The application of current standards of morality to past actions, institutions, or persons.", "PM": "2003", "HN": "2003", "MR": "20211202", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035481"}, {"RECTYPE": "D", "MH": "Uncertainty", "MN": "N06.850.520.830.600.900", "MH_TH": "BIOETHICS (1991)", "ST": "T078", "MS": "The condition in which reasonable knowledge regarding risks, benefits, or the future is not available.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035501"}, {"RECTYPE": "D", "MH": "Trust", "AQ": "PX", "MN": "F01.829.401.825", "MH_TH": "BIOETHICS (1974)", "ST": "T055", "PI": "Professional-Patient Relations (1967-2002)", "MS": "Confidence in or reliance on a person or thing.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035502"}, {"RECTYPE": "D", "MH": "Sociobiology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.158.273.866", "FX": "Genetics, Behavioral", "MH_TH": "NLM (2002)", "ST": "T090", "MS": "The comparative study of social organization in animals including humans, especially with regard to its genetic basis and evolutionary history. (Merriam-Webster's Collegiate Dictionary, 10th ed)", "PM": "2003", "HN": "2003", "MR": "20100628", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035503"}, {"RECTYPE": "D", "MH": "Supreme Court Decisions", "AQ": "HI", "PRINT ENTRY": "United States Supreme Court|T092|NON|REL|NLM (2002)|010611|US SUPREME COURT|abcdefv", "ENTRY": "Supreme Court Decision", "MN": "I01.880.604.583.858", "MH_TH": "BIOETHICS (1989)", "ST": "T089", "AN": "US only; for supreme courts of other nations use JURISPRUDENCE", "PI": "Jurisprudence (1974-2002)", "MS": "Decisions made by the United States Supreme Court.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035521"}, {"RECTYPE": "D", "MH": "Transcription Factor TFIIA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TFIIA|T116|T123|ACR|EQV|NLM (2003)|abbcde", "MN": "D12.776.930.930.875.374", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1989-2002)", "MS": "An RNA POLYMERASE II specific transcription factor. It may play a role in transcriptional activation of gene expression by interacting with the TATA-BOX BINDING PROTEIN component of TRANSCRIPTION FACTOR TFIID.", "PM": "2003; TRANSCRIPTION FACTOR TFIIA was indexed under TRANSCRIPTION FACTORS 1989-2002", "HN": "2003; use TRANSCRIPTION FACTOR TFIIA (NM) 1989-2002", "MR": "20050728", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035561"}, {"RECTYPE": "D", "MH": "Transcription Factor TFIIB", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor IIB|T116|T123|ACX|EQV|NLM (2003)|abbcde", "MN": "D12.776.930.930.875.562", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1991-2002)", "MS": "An RNA POLYMERASE II specific transcription factor. It plays a role in assembly of the pol II transcriptional preinitiation complex and has been implicated as a target of gene-specific transcriptional activators.", "PM": "2003; TRANSCRIPTION FACTOR TFIIB was indexed under TRANSCRIPTION FACTORS 1991-2002", "HN": "2003; use TRANSCRIPTION FACTOR TFIIB (NM) 1991-2002", "MR": "20050728", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035581"}, {"RECTYPE": "D", "MH": "Transcription Factor TFIIIA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "5S Gene Specific Transcription Factor", "MN": "D12.776.930.930.937.249", "FX": "RNA, Ribosomal, 5S", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1984-2002)", "MS": "One of several general transcription factors that are specific for RNA POLYMERASE III. It is a zinc finger (ZINC FINGERS) protein and is required for transcription of 5S ribosomal genes.", "PM": "2003; TRANSCRIPTION FACTOR TFIIIA was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1984-2002", "HN": "2003; use TRANSCRIPTION FACTOR TFIIIA (NM) 1984-2002", "MR": "20050728", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035582"}, {"RECTYPE": "D", "MH": "Rare Diseases", "DE": "RARE DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Rare Disease", "MN": "C23.550.291.906", "FX": "Undiagnosed Diseases", "MH_TH": "NLM (2003)", "ST": "T047", "AN": "coordinate with specific disease; index only when discussed as rare disease ", "PI": "Case Report (1965-2002)", "MS": "A large group of diseases which are characterized by a low prevalence in the population. They frequently are associated with problems in diagnosis and treatment.", "PM": "2003", "HN": "2003", "MR": "20190411", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035583"}, {"RECTYPE": "D", "MH": "Transcriptional Elongation Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Elongation Factors, Transcriptional", "MN": "D12.776.930.955", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "Transcription factors whose primary function is to regulate the rate in which RNA is transcribed.", "PM": "2003", "HN": "2003", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035602"}, {"RECTYPE": "D", "MH": "Secularism", "AQ": "HI", "MN": "K01.922", "FX": "Religion", "MH_TH": "NLM (2002)", "ST": "T077", "MS": "Indifference to, or rejection of, RELIGION or religious considerations. (From Merriam-Webster's Collegiate Dictionary, 10th ed)", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035621"}, {"RECTYPE": "D", "MH": "Parental Notification", "DE": "PARENTAL NOTIF", "AQ": "ES HI LJ", "ENTRY": "Parental Notifications", "MN": "I01.880.604.583.080.134.399", "FX": "Parents", "MH_TH": "BIOETHICS (1984)", "ST": "T058", "PI": "Parents (1982-2002)", "MS": "Reporting to parents or guardians about care to be provided to a minor (MINORS).", "PM": "2003", "HN": "2003", "MR": "20120703", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035622"}, {"RECTYPE": "D", "MH": "Chest Wall Oscillation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "High-Frequency Chest Wall Oscillation|T061|NON|NRW|NLM (2003)|011217|abcdef", "ENTRY": "Oscillation, Chest Wall", "MN": "E02.880.130", "MH_TH": "NLM (2003)", "ST": "T061", "PI": "Respiration, Artificial (1985-2002)", "MS": "A respiratory support system used to remove mucus and clear airway by oscillating pressure on the chest.", "PM": "2003", "HN": "2003", "MR": "20060705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035641"}, {"RECTYPE": "D", "MH": "Whistleblowing", "AQ": "ES LJ PX", "ENTRY": "Whistleblowers", "MN": "I01.880.604.583.080.134.900", "MH_TH": "BIOETHICS (1996)", "ST": "T055", "PI": "Truth Disclosure (1994-2002)", "MS": "The reporting of observed or suspected PROFESSIONAL MISCONDUCT or incompetence to appropriate authorities or to the public.", "PM": "2003; see DISCLOSURE 1997-2002", "HN": "2003; use DISCLOSURE 1997-2002", "MR": "20120703", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035642"}, {"RECTYPE": "D", "MH": "Animal Care Committees", "AQ": "CL EC HI LJ OG SN TD", "PRINT ENTRY": "Institutional Animal Care and Use Committee|T097|NON|NRW|NLM (2022)|201007|abcdef", "ENTRY": "IACUCs", "MN": "I01.880.604.100.049", "FX": "Ethics Committees", "MH_TH": "BIOETHICS (1989)", "ST": "T097", "PI": "Animal Welfare (1986-2002)", "MS": "Institutional committees established to protect the welfare of animals used in research and education. The 1971 NIH Guide for the Care and Use of Laboratory Animals introduced the policy that institutions using warm-blooded animals in projects supported by NIH grants either be accredited by a recognized professional laboratory animal accrediting body or establish its own committee to evaluate animal care; the Public Health Service adopted a policy in 1979 requiring such committees; and the 1985 amendments to the Animal Welfare Act mandate review and approval of federally funded research with animals by a formally designated Institutional Animal Care and Use Committee (IACUC).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035661"}, {"RECTYPE": "D", "MH": "Adiantum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Adiantums", "MN": "B01.875.800.575.912.063.750.044", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13817", "MS": "A plant genus of the family Pteridaceae. Members contain TRITERPENES. Some species in this genus are called maidenhair fern which is also a common name occasionally used for Lygodium (FERNS) and POLYPODIUM.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035681"}, {"RECTYPE": "D", "MH": "Gnetophyta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Gnetophytas", "MN": "B01.875.800.575.156.577", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid58022", "PI": "Gymnosperms (1998-2002)", "MS": "A plant division of seed plants containing only a few members.", "PM": "2003; see GYMNOSPERMS 1998-2002", "HN": "2003; use GYMNOSPERMS 1998-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035682"}, {"RECTYPE": "D", "MH": "MicroRNAs", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "stRNA|T114|T123|ACX|NRW|NLM (2003)|011220|abbcdef", "ENTRY": "pri miRNA", "MN": "D13.444.735.790.552.500", "FX": "RNA, Small Interfering", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "RNA, Untranslated (2001-2002)", "MS": "Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.", "PM": "2003; MICRORNAS was indexed under RNA, UNTRANSLATED and RNA, ANTISENSE 2001-2002", "HN": "2003; use MICRORNAS (NM) 2001-2002", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035683"}, {"RECTYPE": "D", "MH": "Gnetum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Gnetums", "MN": "B01.875.800.575.156.577.333", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3380", "MS": "A plant genus of the family Gnetaceae, order Gnetales class Gnetopsida, division GNETOPHYTA. Members contain STILBENES and benzylisoquinoline alkaloids.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035684"}, {"RECTYPE": "D", "MH": "Andrographis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Andrographi", "MN": "B01.875.800.575.912.250.583.040.044", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid175693", "MS": "A plant genus of the family ACANTHACEAE. Members contain andrographolide and other DITERPENES and androechin, a CHALCONE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035685"}, {"RECTYPE": "D", "MH": "Eurycoma", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "longifolia, Eurycoma", "MN": "B01.875.800.575.912.250.898.333", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid458530", "RR": "txid458531", "MS": "A plant genus of the family SIMAROUBACEAE. Members contain quassinoids. There is Malaysian folk use of these plants for male virility.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035701"}, {"RECTYPE": "D", "MH": "Cecropia Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Cecropia", "MN": "B01.875.800.575.912.250.859.937.937.427", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid77071", "MS": "A plant genus of the family CECROPIACEAE. Hypotensive and hypoglycemic effects have been observed in animals after ingesting members of this genus. There is no relation to cecropia moth (Hyalophora cecropia) see MOTHS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035702"}, {"RECTYPE": "D", "MH": "Therapies, Investigational", "DE": "THER INVESTIGATIONAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Investigational Therapies|T061|NON|EQV|BIOETHICS (2000)|010619|INVESTIGATIONAL THER|abcdefv", "ENTRY": "Treatments, Investigational", "MN": "E02.931", "FX": "Clinical Trials as Topic", "MH_TH": "NLM (2003)", "ST": "T061", "MS": "Treatments which are undergoing clinical trials or for which there is insufficient evidence to determine their effects on health outcomes; coverage for such treatments is often denied by health insurers.", "PM": "2003", "HN": "2003", "MR": "20070711", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035703"}, {"RECTYPE": "D", "MH": "Molluginaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Mollugo|T002|NON|NRW|NLM (2003)|011218|abcdef", "ENTRY": "Mollugos", "MN": "B01.875.800.575.912.250.198.500.675", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3590", "RR": "txid3591", "MS": "A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. Some members contain triterpenoid saponins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035704"}, {"RECTYPE": "D", "MH": "Pterocarpus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.401.712", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid100169", "MS": "A plant genus of the family FABACEAE. Members contain TRITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035721"}, {"RECTYPE": "D", "MH": "Aizoaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Trianthema|T002|NON|NRW|NLM (2003)|011218|abcdef", "ENTRY": "Trianthemas", "MN": "B01.875.800.575.912.250.198.500.050", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3542", "RR": "txid45317", "AN": "prefer specific plant", "MS": "A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035722"}, {"RECTYPE": "D", "MH": "Mesembryanthemum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Iceplant|T002|NON|EQV|NLM (2003)|011218|abcdef", "ENTRY": "Plants, Ice", "MN": "B01.875.800.575.912.250.198.500.050.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3543", "MS": "A plant genus of the family AIZOACEAE. It is a native of Africa and widely planted for erosion control to stabilize soil along roadsides and beaches.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035723"}, {"RECTYPE": "D", "MH": "Vernonia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Vernonias", "MN": "B01.875.800.575.912.250.100.984", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13753", "MS": "A plant genus of the family ASTERACEAE. Members contain germacrane and sesquiterpene LACTONES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035741"}, {"RECTYPE": "D", "MH": "Mikania", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Guaco|T002|NON|EQV|NLM (2003)|011218|abcdef", "ENTRY": "Mikanias", "MN": "B01.875.800.575.912.250.100.512", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid102786", "MS": "A plant genus of the family ASTERACEAE. Members contain scandenolide (a sesquiterpene lactone) and germacranolides.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035742"}, {"RECTYPE": "D", "MH": "Wedge Argument", "ENTRY": "Wedge Arguments", "MN": "N05.350.244.875", "MH_TH": "BIOETHICS (1974)", "ST": "T078", "PI": "Ethics (1974-2002)", "MS": "An assertion that an action apparently unobjectionable in itself would set in motion a train of events leading ultimately to an undesirable outcome. (From Cambridge Dictionary of Philosophy, 1995)", "PM": "2003", "HN": "2003", "MR": "20150623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035761"}, {"RECTYPE": "D", "MH": "Siblings", "AQ": "EH PX", "ENTRY": "Sister", "MN": "M01.781", "MH_TH": "NLM (1992)", "ST": "T099", "AN": "use only when the subject of discussion", "PI": "Nuclear Family (1991-2002)", "MS": "Persons or animals having at least one parent in common. (American College Dictionary, 3d ed)", "PM": "2003", "HN": "2003", "MR": "20220413", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035781"}, {"RECTYPE": "D", "MH": "Dalbergia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Dalbergias", "MN": "B01.875.800.575.912.250.401.190", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid53862", "MS": "A plant genus of the family FABACEAE. Members of this genus can cause CONTACT DERMATITIS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035782"}, {"RECTYPE": "D", "MH": "Amomum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Amomums", "MN": "B01.875.800.575.912.250.618.937.900.099", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid188482", "MS": "A plant genus of the family ZINGIBERACEAE. Members contain aculeatin D, beta-sitosterol, and STIGMASTEROL. Some members have been reclassified to ELETTARIA and other ZINGIBERACEAE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035801"}, {"RECTYPE": "D", "MH": "Behavioral Research", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Research, Behavioral", "MN": "H01.770.644.108", "MH_TH": "BIOETHICS (1974)", "ST": "T062", "AN": "behavioral research as a field or the progress or status of behavioral research; do not add routinely for specific studies in behavior: Manual 29.16", "PI": "Research (1968-2002)", "MS": "Research that involves the application of the behavioral and social sciences to the study of the actions or reactions of persons or animals in response to external or internal stimuli. (from American Heritage Dictionary, 4th ed)", "PM": "2003", "HN": "2003", "MR": "20130709", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035841"}, {"RECTYPE": "D", "MH": "Research Subjects", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Subjects, Research", "MN": "M01.774", "FX": "Human Experimentation", "MH_TH": "BIOETHICS (1975)", "ST": "T098", "AN": "IM when ethical, legal, psychological, social or economic aspects of the subjects are discussed", "PI": "Human Experimentation (1975-2002)", "MS": "Persons who are enrolled in research studies or who are otherwise the subjects of research.", "PM": "2003", "HN": "2003", "MR": "20170224", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035842"}, {"RECTYPE": "D", "MH": "Biomedical Research", "DE": "BIOMED RESEARCH", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Medical Research|T062|NON|NRW|NLM (1990)|891204|MED RESEARCH|abcdefv", "ENTRY": "Medicine, Investigative", "MN": "H01.770.644.145", "FX": "Animals, Laboratory", "MH_TH": "BIOETHICS (1974)", "ST": "T062", "AN": "biomedical research as a field or the progress or status of biomedical research; do not add routinely for specific studies in biomedicine", "PI": "Research (1965-2002)", "MS": "Research that involves the application of the natural sciences, especially biology and physiology, to medicine.", "PM": "2003", "HN": "2003", "MR": "20151123", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035843"}, {"RECTYPE": "D", "MH": "Researcher-Subject Relations", "DE": "RESEARCHER SUBJECT RELAT", "AQ": "ES PX", "ENTRY": "Researcher Subject Relationships", "MN": "F01.829.401.650.837", "MH_TH": "NLM (2003)", "ST": "T054", "MS": "Interaction between research personnel and research subjects.", "PM": "2003", "HN": "2003", "MR": "20021031", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035844"}, {"RECTYPE": "D", "MH": "Research Embryo Creation", "AQ": "EC ES HI LJ MT ST", "PRINT ENTRY": "Embryo Creation, Research|T063|NON|EQV|NLM (2003)|020305|abcdef", "ENTRY": "Research Embryo Creations", "MN": "E05.313.750", "MH_TH": "BIOETHICS (1996)", "ST": "T063", "AN": "mammalian only", "PI": "Research (1985-2002)", "MS": "The creation of embryos specifically for research purposes.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035845"}, {"RECTYPE": "D", "MH": "Law Enforcement", "AQ": "CL ES HI MT", "ENTRY": "Enforcement, Law", "MN": "I01.880.604.594", "FX": "Police", "MH_TH": "NLM (1993)", "ST": "T064", "AN": "specify geog", "PI": "Social Control, Formal (1971-2002)", "MS": "Organized efforts to insure obedience to the laws of a community.", "PM": "2003", "HN": "2003", "MR": "20021031", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035846"}, {"RECTYPE": "D", "MH": "Vulnerable Populations", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Disadvantaged Populations|T098|NON|NRW|NLM (2022)|210629|abcdef", "ENTRY": "Vulnerable Population", "MN": "M01.270.992", "MH_TH": "BIOETHICS (1997)", "ST": "T098", "AN": "HUMAN only; for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "Groups of persons whose range of options is severely limited, who are frequently subjected to COERCION in their DECISION MAKING, or who may be compromised in their ability to give INFORMED CONSENT.", "PM": "2003", "HN": "2003", "MR": "20220708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035862"}, {"RECTYPE": "D", "MH": "Moral Development", "ENTRY": "Development, Moral", "MN": "K01.752.566.739", "MH_TH": "BIOETHICS (1986)", "ST": "T061", "PI": "Morals (1969-2002)", "MS": "The process by which individuals internalize standards of right and wrong conduct.", "PM": "2003", "HN": "2003", "MR": "20150623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035863"}, {"RECTYPE": "D", "MH": "Compensation and Redress", "AQ": "ES HI LJ", "PRINT ENTRY": "Compensation|T081|NON|BRD|BIOETHICS (1974)|NLM (1993)|920505|abcdeef", "ENTRY": "Redress and Compensation", "MN": "N03.706.535.125", "FX": "Workers' Compensation", "MH_TH": "NLM (2003)", "ST": "T081", "MS": "Payment, or other means of making amends, for a wrong or injury.", "PM": "2003; for COMPENSATION see ECONOMICS 1993-2002", "HN": "2003; for COMPENSATION use ECONOMICS 1993-2002", "MR": "20021031", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035881"}, {"RECTYPE": "D", "MH": "Hypocrea", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Trichoderma virens|T004|NON|NRW|NLM (2021)|200319|abcdef", "ENTRY": "Pseudohypocreas", "MN": "B01.300.107.501.430", "MH_TH": "NLM (2003)", "ST": "T004", "RR": "txid29875", "PI": "Hypocreales (1993-2002)", "MS": "A genus of fungus in the family Hypocreaceae, order HYPOCREALES. Anamorphs include TRICHODERMA.", "PM": "2003", "HN": "2003", "MR": "20200807", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035901"}, {"RECTYPE": "D", "MH": "Hepatitis A Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Antigens, Hepatitis A", "MN": "D23.050.327.495.249", "FX": "Hepatitis Antibodies", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "AN": "for antigens to human virus, coord IM with HEPATITIS A VIRUS, HUMAN /immunol (IM)", "PI": "Antigens, Viral (1985-2002)", "MS": "Antigens produced by various strains of HEPATITIS A VIRUS such as the human hepatitis A virus (HEPATITIS A VIRUS, HUMAN).", "PM": "2003; HEPATITIS A ANTIGENS was indexed under ANTIGENS, VIRAL 1985-2002", "HN": "2003; use HEPATITIS A ANTIGENS (NM) 1985-2002", "MR": "20220413", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035921"}, {"RECTYPE": "D", "MH": "Hepatitis A Antibodies", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Hepatitis A Virus Antibodies|T116|T129|NON|EQV|NLM (2003)|abbcde", "ENTRY": "Antibodies, Hepatitis A", "MN": "D12.776.377.715.548.114.254.450.251", "PA": "Immunologic Factors", "FX": "Hepatitis A Antigens", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "AN": "for antibodies to human virus, coordinate IM with HEPATITIS A VIRUS, HUMAN /immunol (IM)", "PI": "Hepatitis Antibodies (1985-2002)", "MS": "Antibodies to the HEPATITIS A ANTIGENS including antibodies to envelope, core, and non-structural proteins.", "PM": "2003; HEPATITIS A ANTIBODIES was indexed under HEPATITIS ANTIBODIES 1985-2002, ANTIBODIES, VIRAL 1981-1984", "HN": "2003; use HEPATITIS A ANTIBODIES (NM) 1981-2002", "MR": "20050630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035922"}, {"RECTYPE": "D", "MH": "Hepatitis delta Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "delta Antigen|T129|NON|EQV|NLM (2003)|abcde", "ENTRY": "delta Antigens, Hepatitis", "MN": "D23.050.327.495.752", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "PI": "Hepatitis B Antigens (1981-1987)", "MS": "Antigens produced by various strains of HEPATITIS D VIRUS.", "PM": "2003; HEPATITIS D ANTIGENS (now HEPATITUS DELTA ANTIGENS) was indexed under HEPATITIS ANTIGENS 1996-2002, ANTIGENS, VIRAL 1988-1996 & HEPATITIS B ANTIGENS 1981-1987", "HN": "2003; use HEPATITIS DELTA ANTIGENS (NM) 1981-2002", "MR": "20220413", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035923"}, {"RECTYPE": "D", "MH": "Montanoa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Zoapatle|T002|NON|EQV|NLM (2003)|abcde", "ENTRY": "tomentosa, Montanoa", "MN": "B01.875.800.575.912.250.100.543", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid166981", "RR": "txid167007", "PI": "Oxepins (1980-2002)", "MS": "A plant genus of the family ASTERACEAE. Steroidal activity has been observed in animals. Members of this genus contain sesquiterpene lactones such as tomentosin, OXEPINS such as zoapatanol, and kaurene type DITERPENES.", "PM": "2003; ZOAPATLE was indexed under OXEPINS 1980-2002", "HN": "2003; for ZOAPATLE use MONTANOA (NM) 1980-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035924"}, {"RECTYPE": "D", "MH": "Iron-Regulatory Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Iron Response Protein|T116|T123|NON|EQV|NLM (2022)|201019|abbcdef", "ENTRY": "Response Protein, Iron", "MN": "D12.776.494", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Ribonucleoproteins (1992-2002)", "MS": "Proteins that regulate cellular and organismal iron homeostasis. They play an important biological role by maintaining iron levels that are adequate for metabolic need, but below the toxicity threshold.", "PM": "2003; IRON REGULATORY FACTOR now IRON-REGULATORY PROTEINS was indexed under RNA-BINDING PROTEINS & IRON-SULFUR PROTEINS 1991-2002, CARRIER PROTEINS 1990", "HN": "2003; use IRON-REGULATORY PROTEINS (NM) 1990-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035925"}, {"RECTYPE": "D", "MH": "Hepatophyta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Liverworts|T002|NON|EQV|NLM (2003)|011226|abcdef", "ENTRY": "Liverwort", "MN": "B01.875.800.575.462", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3195", "RR": "txid186782", "MS": "A plant division. They are simple plants that lack vascular tissue and possess rudimentary rootlike organs (rhizoids). Like MOSSES, liverworts have alternation of generations between haploid gamete-bearing forms (gametophytes) and diploid spore-bearing forms (sporophytes).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035926"}, {"RECTYPE": "D", "MH": "Iron Regulatory Protein 1", "DS": "IRON REGULATORY PROTEIN A 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Soluble Aconitase 1", "MN": "D12.776.664.962.374", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "EC 4.2.1.3", "PI": "Ribonucleoproteins (1995-2002)", "MS": "A multifunctional iron-sulfur protein that is both an iron regulatory protein and cytoplasmic form of aconitate hydratase. It binds to iron regulatory elements found on mRNAs involved in iron metabolism and regulates their translation. Its RNA binding ability and its aconitate hydrolase activity are dependent upon availability of IRON.", "PM": "2003; FERRITIN REPRESSOR PROTEIN was indexed under IRON-SULFUR PROTEINS & RNA-BINDING PROTEINS 1991-2002, IRE-BP1, IRON REGULATORY PROTEIN 1, IRP-1 PROTEIN & IRP1 PROTEIN were indexed under IRON-SULFUR PROTEINS & RNA-BINDING PROTEINS 1995-2002", "HN": "2003; for FERRITIN REPRESSOR PROTEIN use IRON-REGULATORY PROTEINS (NM) 1991-2002, for IRE-BP1, IRON REGULATORY PROTEIN 1, IRP-1 PROTEIN & IRP1 PROTEIN use IRON-REGULATORY PROTEINS (NM) 1995-2002", "MR": "20060705", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035941"}, {"RECTYPE": "D", "MH": "Iron Regulatory Protein 2", "DS": "IRON REGULATORY PROTEIN A 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "RNA-binding protein, IRP-2", "MN": "D12.776.664.962.437", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "EC 4.2.1.3", "PI": "Ribonucleoproteins (1995-2002)", "MS": "A multifunctional iron-sulfur protein that is both an iron regulatory protein and cytoplasmic form of aconitate hydratase. It binds to iron regulatory elements found on mRNAs involved in iron metabolism and regulates their translation. Its rate of degradation is increased in the presence of IRON.", "PM": "2003; IRON REGULATORY PROTEIN 2, IRE-BP2 & IRP-2 RNA-BINDING PROTEIN were indexed under RNA-BINDING PROTEINS & IRON-SULFUR PROTEINS 1995-2002", "HN": "2003; for IRON REGULATORY PROTEIN 2, IRE-BP2 & IRP-2 RNA-BINDING PROTEIN use IRON-REGULATORY PROTEINS (NM) 1995-2002", "MR": "20060705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035942"}, {"RECTYPE": "D", "MH": "Alismatales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ruppia|T002|NON|NRW|NLM (2003)|011227|abcdef", "ENTRY": "Ruppias", "MN": "B01.875.800.575.912.250.618.050", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid16360", "RR": "txid55487", "MS": "A plant of the class MAGNOLIOPSIDA. It is a primitive group of mostly aquatic plants.", "PM": "2018; see ALISMATIDAE 2003-2017", "HN": "2018(2003)", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D035961"}, {"RECTYPE": "D", "MH": "Zosteraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Zosteras", "MN": "B01.875.800.575.912.250.618.050.968", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid27254", "RR": "txid27257", "MS": "A plant family of the order Najadales, subclass ALISMATIDAE, class Liliopsida (monocotyledons). This is a group of perennial aquatic herbs with basal leaves.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035962"}, {"RECTYPE": "D", "MH": "Oxocins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxocenes|T109|NON|EQV|NLM (2003)|011227|abcdef", "MN": "D03.383.585", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "MS": "Compounds based on an 8-membered heterocyclic ring including an oxygen. They can be considered medium ring ethers.", "PM": "2003", "HN": "2003", "MR": "20200228", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035964"}, {"RECTYPE": "D", "MH": "Hedera", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ivy, English|T002|EPO|NRW|NLM (2003)|011228|abcdef", "ENTRY": "helices, Hedera", "MN": "B01.875.800.575.912.250.087.412", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4051", "RR": "txid4052", "MS": "A plant genus of the family ARALIACEAE. Members contain hederin (olean-12-ene) type TRITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D035981"}, {"RECTYPE": "D", "MH": "ADP Ribose Transferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NAD+ ADP-Ribosyltransferase|T116|T126|ACX|NRW|NLM (1988)|990101|NAD ADP RIBOSYLTRANSFERASE|abbcdefs", "ENTRY": "Transferases, Mono ADPribose", "MN": "D08.811.913.400.725.115", "FX": "ADP-Ribosylation", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 2.4.2.-", "RR": "EC 2.4.2.31", "MS": "Enzymes that transfer the ADP-RIBOSE group of NAD or NADP to proteins or other small molecules. Transfer of ADP-ribose to water (i.e., hydrolysis) is catalyzed by the NADASES. The mono(ADP-ribose)transferases transfer a single ADP-ribose. POLY(ADP-RIBOSE) POLYMERASES transfer multiple units of ADP-ribose to protein targets, building POLY ADENOSINE DIPHOSPHATE RIBOSE in linear or branched chains.", "PM": "2003; see NAD(P)(+)-ARGININE ADP-RIBOSYLTRANSFERASE 1992-2002, see NAD-ARGININE ADP-RIBOSYLTRANSFERASE 1989-1991; for NAD+ ADP-RIBOSYLTRANSFERASE see NAD+ ADP-RIBOSYLTRANSFERASE 1992-2002, see POLY ADP RIBOSE POLYMERASE 1988-1991; for MONO-ADP-RIBOSYLTRANSFERASE and NAD-ARGININE ADP-RIBOSYLTRANSFERASE and NADP-ARGININE ADP-RIBOSYLTRANSFERASE see NAD(P)(+)-ARGININE ADP-RIBOSYLTRANSFERASE 1992-2002, see NAD-ARGININE ADP-RIBOSYLTRANSFERASE 1989-1991", "HN": "2003; for NAD+ ADP-RIBOSYLTRANSFERASE use POLY(ADP-RIBOSE) POLYMERASES 1988-2002", "MR": "20170414", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036002"}, {"RECTYPE": "D", "MH": "Capsid Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Viral V Proteins|T116|T129|NON|NRW|NLM (2021)|200527|abbcdef", "ENTRY": "V Proteins, Viral", "MN": "D12.776.964.970.600.550", "FX": "Capsid", "MH_TH": "UNK (19XX)", "ST": "T123", "RN": "0", "AN": "CAPSID is also available", "PI": "Capsid (1987-2002)", "MS": "Proteins that form the CAPSID of VIRUSES.", "PM": "2003; see CAPSID 1988-2002", "HN": "2003; use CAPSID 1988-2002", "MR": "20200723", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036022"}, {"RECTYPE": "D", "MH": "Solanum glaucophyllum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "glaucophyllum, Solanum", "MN": "B01.875.800.575.912.250.908.500.725.610", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid52877", "MS": "A plant species of the genus SOLANUM, family SOLANACEAE that causes CALCINOSIS in grazing livestock due to high levels of 1a,25-dihydroxy vitamin D3 (CALCITRIOL).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036061"}, {"RECTYPE": "D", "MH": "Receptors, Eph Family", "DE": "RECEPT EPH FAMILY", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Eph Receptor Tyrosine Kinase|T116|T126|T192|ACX|EQV|NLM (2003)|EPH RECEPT TYROSINE KINASE|abbbcdev", "ENTRY": "Receptors, Ephrin A", "MN": "D12.776.543.750.630.500", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "RR": "EC 2.7.10.1", "PI": "Receptor Protein-Tyrosine Kinases (1994-2002)", "MS": "A large family of receptor protein-tyrosine kinases that are structurally-related. The name of this family of proteins derives from original protein Eph (now called the EPHA1 RECEPTOR), which was named after the cell line it was first discovered in: Erythropoietin-Producing human Hepatocellular carcinoma cell line. Members of this family have been implicated in regulation of cell-cell interactions involved in nervous system patterning and development.", "PM": "2003; EPHRIN B RECEPTORS (now RECEPTORS, EPH FAMILY) was indexed under RECEPTOR PROTEIN TYROSINE KINASES 1999-2002, EPH RECEPTOR TYROSINE KINASE was indexed under RECEPTOR PROTEIN TYROSINE KINASES 1999-2002", "HN": "2003; use RECEPTORS, EPH FAMILY (NM) 1999-2002, for EPH RECEPTOR TYROSINE KINASE use EPHA1 RECEPTOR (NM) 1999-2002;", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036081"}, {"RECTYPE": "D", "MH": "Receptor, EphA1", "DE": "RECEPT EPHA1", "DS": "RECEPTOR EPH A 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EphA1 Receptor|T116|T126|T192|ACX|EQV|NLM (2003)|020103|EPH A 001 RECEPTOR|EPHA1 RECEPT|abbbcdefsv", "ENTRY": "Eph Receptor|T116|T126|T192|ACX|EQV|NLM (2003)|020103|abbbcdef", "MN": "D12.776.543.750.630.500.050", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptor Protein-Tyrosine Kinases (1999-2002)", "MS": "The founding member of the EPH FAMILY RECEPTORS. It was first cloned from an erythropoietin-producing human hepatocellular carcinoma cell line and is highly conserved among many mammalian species. Overproduction of the EphA1 receptor is associated with tumors and tumor cells of epithelial origin. It is also expressed at high levels in LIVER; LUNG; and KIDNEY; which is in contrast to many other members of the Eph receptor that are found primarily in tissues of the nervous system.", "PM": "2003; EPHA1 PROTEIN (now RECEPTOR, EPHA1) were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1999-2002", "HN": "2003; use RECEPTOR, EPHA1 (NM) 1999-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036082"}, {"RECTYPE": "D", "MH": "Atractylis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "gummiferas, Atractylis", "MN": "B01.875.800.575.912.250.100.118", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41483", "MS": "A plant genus of the family ASTERACEAE. Members contain ATRACTYLOSIDE which inhibits ADENINE NUCLEOTIDE TRANSLOCASE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036083"}, {"RECTYPE": "D", "MH": "Callilepis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Impila|T002|NON|NRW|NLM (2003)|020103|abcdef", "ENTRY": "laureola, Callilepis", "MN": "B01.875.800.575.912.250.100.154", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid112344", "RR": "txid112345", "MS": "A plant genus of the family ASTERACEAE. Members contain ATRACTYLOSIDE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036084"}, {"RECTYPE": "D", "MH": "Cord Blood Stem Cell Transplantation", "DE": "CORD BLOOD STEM CELL TRANSPL", "AQ": "AE CL EC EH ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Umbilical Cord Blood Stem Cell Transplantation|T061|NON|EQV|NLM (2003)|011108|UMBILICAL CORD BLOOD STEM CELL TRANSPL|abcdefv", "ENTRY": "Stem Cell Transplantation, Placental Blood|T061|NON|EQV|NLM (2016)|150706|abcdef", "MN": "E04.936.225.687.312", "MH_TH": "NLM (2003)", "ST": "T061", "PI": "Hematopoietic Stem Cell Transplantation (1993-2002)", "MS": "Transplantation of STEM CELLS collected from the fetal blood remaining in the UMBILICAL CORD and the PLACENTA after delivery. Included are the HEMATOPOIETIC STEM CELLS.", "PM": "2003", "HN": "2003", "MR": "20170224", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036101"}, {"RECTYPE": "D", "MH": "Peripheral Blood Stem Cell Transplantation", "DE": "PERIPHERAL BLOOD STEM CELL TRANSPL", "AQ": "AE CL EC EH ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Stem Cell Transplantation, Peripheral|T061|NON|EQV|NLM (1995)|931206|STEM CELL TRANSPL PERIPHERAL|abcdefv", "ENTRY": "Transplantation, Peripheral Stem Cell|T061|NON|EQV|NLM (1995)|931210|TRANSPL PERIPHERAL STEM CELL|abcdefv", "MN": "E04.936.225.687.500.500", "MH_TH": "NLM (2003)", "ST": "T061", "PI": "Hematopoietic Stem Cells/transplantation (1986-1994)", "MS": "Transplantation of PERIPHERAL BLOOD STEM CELLS. It is a less invasive alternative to direct marrow harvesting of hematopoietic stem cells. Enrichment of stem cells in peripheral blood can be achieved by inducing mobilization of stem cells from the BONE MARROW.", "PM": "2003; see HEMATOPOIETIC STEM CELL TRANSPLANTATION 1995-2002", "HN": "2003; use HEMATOPOIETIC STEM CELL TRANSPLANTATION 1995-2002", "MR": "20170224", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036102"}, {"RECTYPE": "D", "MH": "Nanotechnology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Nanotechnologies", "MN": "J01.897.520.600", "FX": "Nanostructures", "MH_TH": "NLM (2003)", "ST": "T090", "PI": "Miniaturization (1994-2001)", "MS": "The development and use of techniques to study physical phenomena and construct structures in the nanoscale size range or smaller.", "PM": "2002", "HN": "2002", "MR": "20050630", "DA": "20020103", "DC": "1", "DX": "20020103", "UI": "D036103"}, {"RECTYPE": "D", "MH": "Receptor, EphA2", "DE": "RECEPT EPHA2", "DS": "RECEPTOR EPH A 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mammary Derived Tyrosine Kinase 2", "MN": "D12.776.543.750.630.500.100", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptor Protein-Tyrosine Kinases (1999-2002)", "MS": "An Eph family receptor found abundantly in tissues of epithelial origin. It is expressed in a diverse array of tissues during embryonic development, suggesting that it may play a role in embryogenesis. In adult tissues high levels of the receptor are expressed in the LUNG; SKIN; SMALL INTESTINE and OVARY.", "PM": "2003; EPHA2 PROTEIN (now RECEPTOR, EPHA2) was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 2001-2002 & MEMBRANE PROTEINS 1990-2000", "HN": "2003; use RECEPTOR, EPHA2 (NM) 1990-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036104"}, {"RECTYPE": "D", "MH": "Receptor, EphA3", "DE": "RECEPT EPHA3", "DS": "RECEPTOR EPH A 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EphA3 Receptor|T116|T126|T192|ACX|EQV|NLM (2003)|020104|EPH A 003 RECEPTOR|EPHA3 RECEPT|abbbcdefsv", "ENTRY": "Eph Receptor, Cek4", "MN": "D12.776.543.750.630.500.150", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "AN": "see SCR for species specific terms", "PI": "Receptor Protein-Tyrosine Kinases (1998-2002)", "MS": "An eph family receptor that is found primarily in adult BRAIN and variety of tissues in the developing embryo tissues. During embryonic development high levels of EphA3 receptor expression is seen in the nervous system and coincides with neuronal cell migration, suggesting a role for this protein in axonal pathfinding.", "PM": "2003; CEK4 RECEPTOR PROTEIN-TYROSINE KINASE (now RECEPTOR, EPHA3 ) were indexed under RECEPTOR PROTEIN TYROSINE KINASES 1999-2002, EPHA3 PROTEIN was indexed under RECEPTOR PROTEIN TYROSINE KINASES 1999-2002", "HN": "2003; use RECEPTOR, EPHA3 (NM) 1999-2002, for EPHA3 PROTEIN use RECEPTOR, EPHA5 (NM) 1999-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036121"}, {"RECTYPE": "D", "MH": "Receptor, EphA4", "DE": "RECEPT EPHA4", "DS": "RECEPTOR EPH A 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EphA4 Receptor|T116|T126|T192|ACX|EQV|NLM (2003)|020104|EPH A 004 RECEPTOR|EPHA4 RECEPT|abbbcdefsv", "ENTRY": "Sek 1 Receptor Tyrosine Kinase", "MN": "D12.776.543.750.630.500.200", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptor Protein-Tyrosine Kinases (1994-2002)", "MS": "An eph family receptor found in variety of tissues including BRAIN. During embryogenesis, EphA4 receptor exhibits a diverse spatial and temporal patterns of expression suggesting its role in multiple developmental processes.", "PM": "2003; EPHA4 RECEPTOR TYROSINE KINASE (now RECEPTOR, EPHA4) was indexed under FETAL PROTEINS & RECEPTOR PROTEIN-TYROSINE KINASES 1999-2002; CEK8 PROTEIN (now RECEPTOR, EPHA4) was indexed under NEUROPEPTIDES & RECEPTOR PROTEIN-TYROSINE KINASES 1999-2002", "HN": "2003; use RECEPTOR, EPHA4 (NM) 1999-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036122"}, {"RECTYPE": "D", "MH": "Receptor, EphA5", "DE": "RECEPT EPHA5", "DS": "RECEPTOR EPH A 005", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EphA5 Receptor|T116|T126|T192|ACX|EQV|NLM (2003)|020104|EPH A 005 RECEPTOR|EPHA5 RECEPT|abbbcdefsv", "ENTRY": "Tyrosine Kinase, bsk", "MN": "D12.776.543.750.630.500.250", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptor Protein-Tyrosine Kinases (1994-2002)", "MS": "An eph family receptor found primarily in differentiated neuronal tissues. Several isoforms of EphA5 receptor occur due to multiple alternative RNA splicing. The protein is prominently expressed in the NEURONS of the LIMBIC SYSTEM during development and throughout adult life, suggesting its role in the plasticity of limbic structure and function.", "PM": "2003; BRAIN-SPECIFIC KINASE & CEK7 PROTEIN (now RECEPTOR, EPHA5) were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2002; EPHA5 PROTEIN (now RECEPTOR, EPHA5 ) were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1998-2002", "HN": "2003; use RECEPTOR, EPHA5 (NM) 1994-2002", "MR": "20210521", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036123"}, {"RECTYPE": "D", "MH": "Receptor, EphA6", "DE": "RECEPT EPHA6", "DS": "RECEPTOR EPH A 006", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EphA6 Receptor|T116|T126|T192|ACX|EQV|NLM (2003)|020104|EPH A 006 RECEPTOR|EPHA6 RECEPT|abbbcdefsv", "ENTRY": "EphA6 Protein|T116|T126|T192|ACX|EQV|NLM (2003)|010420|abbbcdef", "MN": "D12.776.543.750.630.500.300", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptor Protein-Tyrosine Kinases (1994-2002)", "MS": "An eph family receptor that is found in a variety of neuronal regions of the BRAIN. In contrast to the other proteins in this class, it is expressed at higher levels in adult tissues than in embryonic tissues.", "PM": "2003; EHK-2 PROTEIN (now RECEPTOR, EPHA6) was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2002, EPHA6 PROTEIN was indexed under RECEPTOR PROTEIN TYROSINE KINASES 1994-2002", "HN": "2003; use RECEPTOR, EPHA6 (NM) 1994-2002, for EPHA6 PROTEIN use EPHA7 RECEPTOR 1994-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036124"}, {"RECTYPE": "D", "MH": "Receptor, EphA7", "DE": "RECEPT EPHA7", "DS": "RECEPTOR EPH A 007", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EphA7 Receptor|T116|T126|ACX|EQV|NLM (2003)|020104|EPH A 007 RECEPTOR|EPHA7 RECEPT|abbcdefsv", "ENTRY": "Receptor Tyrosine Kinase Cek11|T116|T126|ACX|EQV|NLM (2003)|RECEPT TYROSINE KINASE CEK11|abbcdev", "MN": "D12.776.543.750.630.500.350", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 2.7.10.1", "PI": "Receptor Protein-Tyrosine Kinases (1997-2002)", "MS": "An eph family receptor found widely expressed in embryo tissues, including the NERVOUS SYSTEM. In the BRAIN high levels of EphA7 expression occurs in the anterior tectum, medulla, RHOMBENCEPHALON, and SUBCOMMISSURAL ORGAN. Several isoforms of the protein occur due to multiple alternative spicing of the EphA7 mRNA.", "PM": "2003; RECEPTOR TYROSINE KINASE CEK11 & EPHA7 PROTEIN (now RECEPTOR, EPHA7) were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1997-2002, MDK1 (RTK) & MDK1 GENE PRODUCT were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1997-2002", "HN": "2003; use RECEPTOR, EPHA7 (NM) 1997-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036141"}, {"RECTYPE": "D", "MH": "Mentha piperita", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Peppermint|T002|NON|EQV|NLM (2003)|abcde", "ENTRY": "Peppermints", "MN": "B01.875.800.575.912.250.583.520.483.444", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid34256", "PI": "Plant Extracts (1973-2002)", "MS": "A plant genus of the family LAMIACEAE that is the source of peppermint oil.", "PM": "2003; PEPPERMINT was indexed under PLANT EXTRACTS 1973-2002", "HN": "2003; for PEPPERMINT use MENTHA PIPERITA (NM) 1973-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036142"}, {"RECTYPE": "D", "MH": "Receptor, EphA8", "DE": "RECEPT EPHA8", "DS": "RECEPTOR EPH A 008", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EphA8 Receptor|T116|T126|T192|ACX|EQV|NLM (2003)|020104|EPH A 008 RECEPTOR|EPHA8 RECEPT|abbbcdefsv", "ENTRY": "eph and elk Related Kinase", "MN": "D12.776.543.750.630.500.400", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "MS": "An eph family receptor found exclusively in BRAIN. EphA8 receptors may play a role in the AXONAL GUIDANCE of a subset of tectal commissural NEURONS.", "PM": "2003; EEK PROTEIN (now RECEPTOR, EPHA8 ) was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1991-2002; EPHA8 PROTEIN (now RECEPTOR, EPHA8) was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 2002-2002", "HN": "2003; use RECEPTOR, EPHA8 (NM) 1991-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036143"}, {"RECTYPE": "D", "MH": "Ginsenosides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sanchinosides|T109|NON|EQV|NLM (2003)|020104|abcdef", "MN": "D09.408.782.300", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "MS": "Dammarane type triterpene saponins based mainly on the aglycones, protopanaxadiol and protopanaxatriol.", "PM": "2003; GINSENOSIDES was indexed under SAPONINS 1977-2002", "HN": "2003; for GINSENOSIDES use GINSENOSIDES (NM) 1977-2002", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036145"}, {"RECTYPE": "D", "MH": "Receptor, EphB2", "DE": "RECEPT EPHB2", "DS": "RECEPTOR EPH B 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EphB2 Receptor|T116|T126|T192|ACX|EQV|NLM (2003)|EPH B 002 RECEPTOR|EPHB2 RECEPT|abbbcdesv", "ENTRY": "Receptors, EphB2", "MN": "D12.776.543.750.630.500.500", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptor Protein-Tyrosine Kinases (1995-2002)", "MS": "An eph family receptor found widely expressed in embryonic and adult tissues. High levels of EphB2 receptor are observed in growing AXONS and NERVE FIBERS. Several isoforms of the protein exist due to multiple alternative mRNA splicing.", "PM": "2003; EPHB2-TYROSINE KINASE (now RECEPTOR, EPHB2) was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1995-2002, PROTEIN-TYROSINE KINASE 1992-1994, DRT PROTEIN (now RECEPTOR, EPHB2) was indexed under PROTEIN-TYROSINE KINASE 1996-2002", "HN": "2003; use RECEPTOR, EPHB2 (NM) 1992-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036183"}, {"RECTYPE": "D", "MH": "Receptor, EphB5", "DE": "RECEPT EPHB5", "DS": "RECEPTOR EPH B 005", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EphB5 Receptor|T116|T126|T192|ACX|EQV|NLM (2003)|991215|EPH B 005 RECEPTOR|EPHB5 RECEPT|abbbcdefsv", "ENTRY": "Receptor Tyrosine Kinase Cek9|T116|T126|T192|ACX|EQV|NLM (2003)|RECEPT TYROSINE KINASE CEK9|abbbcdev", "MN": "D12.776.543.750.630.500.875", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptor Protein-Tyrosine Kinases (1993-2002)", "MS": "An eph family receptor found at high levels in adult THYMUS and RETINA. In embryonic tissues it is found in many developing organs.", "PM": "2003; RECEPTOR TYROSINE KINASE CEK9 (now RECEPTOR, EPHB5 ) was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1996-2002", "HN": "2003; use RECEPTOR, EPHB5 (NM) 1996-2002, for EPHB5 RECEPTOR use EPHB2 RECEPTOR (NM) 1999-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036201"}, {"RECTYPE": "D", "MH": "Receptor, EphB3", "DE": "RECEPT EPHB3", "DS": "RECEPTOR EPH B 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EphB3 Receptor|T116|T126|T192|ACX|EQV|NLM (2003)|010915|EPH B 003 RECEPTOR|EPHB3 RECEPT|abbbcdefsv", "ENTRY": "Receptor Tyrosine Kinase HEK2", "MN": "D12.776.543.750.630.500.687", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptor Protein-Tyrosine Kinases (2001-2002)", "MS": "An eph family receptor found in a number of tissues including BRAIN; LUNG; KIDNEY; PANCREAS; INTESTINE; and HEART. During embryogenesis EphB3 receptor is expressed at high levels in the brain.", "PM": "2003; CEK10 PROTEIN (now RECEPTOR, EPHB3) was indexed under PROTEIN-TYROSINE KINASE 1993-2002, EPHB3 RECEPTOR was indexed under RECEPTOR PROTEIN TYROSINE KINASES 2001-2002", "HN": "2003; use RECEPTOR, EPHB3 (NM) 1993-2002; for EPHB3 RECEPTOR use RECEPTORS, EPH FAMILY (NM) 2001-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036223"}, {"RECTYPE": "D", "MH": "Receptor, EphB4", "DE": "RECEPT EPHB4", "DS": "RECEPTOR EPH B 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EphB4 Receptor|T116|T126|T192|ACX|EQV|NLM (2003)|000219|EPH B 004 RECEPTOR|EPHB4 RECEPT|abbbcdefsv", "ENTRY": "Transmembrane Kinase, Hepatoma", "MN": "D12.776.543.750.630.500.781", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptor Protein-Tyrosine Kinases (1994-2002)", "MS": "An eph family receptor found in a variety of adult and embryonic tissues. Unlike the majority of proteins in this class there is little or no expression of EphB4 receptor in the BRAIN. It has been found at high levels in developing mammary glands and in invasive mammary tumors.", "PM": "2003; HEPATOMA TRANSMEMBRANE KINASE (now RECEPTOR, EPHB4) was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2002; EPHB4 RECEPTOR was indexed under RECEPTOR PROTEIN TYROSINE-KINASE 2000-2002", "HN": "2003; use RECEPTOR, EPHB4 (NM) 1994-2002; for EPHB4 RECPTOR use RECEPTORS, EPH FAMILY 2000-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036224"}, {"RECTYPE": "D", "MH": "Receptor, EphB1", "DE": "RECEPT EPHB1", "DS": "RECEPTOR EPH B 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EphB1 Receptor|T116|T126|T192|ACX|EQV|NLM (2003)|000102|EPH B 001 RECEPTOR|EPHB1 RECEPT|abbbcdefsv", "ENTRY": "Neuronally Expressed EPH Related Tyrosine Kinase", "MN": "D12.776.543.750.630.500.450", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptor Protein-Tyrosine Kinases (1997-2002)", "MS": "An eph family receptor found primarily in the nervous system. In the embryonic BRAIN EphB1 receptor expression occurs in the mantle layer and increases with the progression of embryogenesis. In adult brain it is found in the several regions including the CEREBELLUM; CEREBRAL CORTEX; and CAUDATE NUCLEUS; and PUTAMEN.", "PM": "2003; EPHB1 RECEPTOR, ELK PROTEIN EPHT2 PROTEIN & NEURONALLY EXPRESSED EPH-TYROSINE KINASE were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1999-2002", "HN": "2003; for RECEPTOR, EPHB1, ELK PROTEIN EPHT2 PROTEIN & NEURONALLY EXPRESSED EPH-TYROSINE KINASE use RECEPTORS, EPH FAMILY 1999-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036225"}, {"RECTYPE": "D", "MH": "Seedlings", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Seedling|T002|NON|EQV|NLM (1995)|940217|abcdef", "ENTRY": "Sprouted Seed", "MN": "B01.650.819", "FX": "Plant Shoots", "MH_TH": "NLM (1995)", "ST": "T002", "PI": "Plants (1995-2002)", "MS": "Young plants produced at the completion of GERMINATION of SEEDS.", "PM": "2015; see PLANTS 1995-2002", "HN": "2015; 1995", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036226"}, {"RECTYPE": "D", "MH": "Receptor, EphB6", "DE": "RECEPT EPHB6", "DS": "RECEPTOR EPH B 006", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "EphB6 Receptor|T116|T192|ACX|EQV|NLM (2003)|011020|EPH B 006 RECEPTOR|EPHB6 RECEPT|abbcdefsv", "ENTRY": "Receptor EphB6, Ephrin", "MN": "D12.776.543.750.630.500.937", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Receptor Protein-Tyrosine Kinases (2001-2002)", "MS": "An eph family receptor found primarily in BRAIN and THYMUS. The EphB6 receptor is unusual in that its tyrosine kinase domain shares little homology with other members of this class. The unusual tyrosine kinase domain of this receptor appears to result in its lack of tyrosine kinase activity.", "PM": "2003; MEP PROTEIN (now RECEPTOR, EPHB6) was indexed under MEMBRANE PROTEINS 1996-2002, EPHB6 RECEPTOR was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 2001-2002", "HN": "2003; use RECEPTOR, EPHB6 (NM) 1996-2002", "MR": "20160531", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036261"}, {"RECTYPE": "D", "MH": "Empirical Research", "ENTRY": "Research, Empirical", "MN": "H01.770.644.241", "FX": "Data Collection", "MH_TH": "BIOETHICS (1996)", "ST": "T062", "MS": "The study, based on direct observation, use of statistical records, interviews, or experimental methods, of actual practices or the actual impact of practices or policies.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036262"}, {"RECTYPE": "D", "MH": "Genetic Research", "DE": "GENET RESEARCH", "AQ": "EC ES HI LJ", "ENTRY": "Research, Genetic|T062|NON|EQV|NLM (1997)|960321|RESEARCH GENET|abcdefv", "MN": "H01.770.644.145.350", "MH_TH": "BIOETHICS (1995)", "ST": "T062", "AN": "genetic research as a field or the progress or status of genetic research; do not add routinely for specific research studies in genetics", "MS": "Research into the cause, transmission, amelioration, elimination, or enhancement of inherited disorders and traits.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036281"}, {"RECTYPE": "D", "MH": "Qualitative Research", "ENTRY": "Research, Qualitative", "MN": "H01.770.644.241.850", "FX": "Focus Groups", "MH_TH": "NLM (2002)", "ST": "T062", "AN": "coordinate with specific qualitative research method if pertinent", "MS": "Any type of research that employs nonnumeric information to explore individual or group characteristics, producing findings not arrived at by statistical procedures or other quantitative means. (Qualitative Inquiry: A Dictionary of Terms Thousand Oaks, CA: Sage Publications, 1997)", "PM": "2003", "HN": "2003", "MR": "20211202", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036301"}, {"RECTYPE": "D", "MH": "Therapeutic Human Experimentation", "DE": "THER HUMAN EXPERIMENTATION", "AQ": "EC ES HI LJ", "PRINT ENTRY": "Therapeutic Research|T062|NON|EQV|BIOETHICS (1995)|941020|THER RESEARCH|abcdefv", "ENTRY": "Experimentation, Therapeutic Human", "MN": "H01.770.644.145.365.875", "MH_TH": "NLM (2003)", "ST": "T062", "AN": "use only when ethical, legal, psychological, or social issues are discussed", "PI": "Research (1966-2002)", "MS": "Human experimentation that is intended to benefit the subjects on whom it is performed.", "PM": "2003", "HN": "2003", "MR": "20150623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036302"}, {"RECTYPE": "D", "MH": "Intercellular Signaling Peptides and Proteins", "DE": "INTERCELLULAR SIGNALING PEPTIDES PROTEINS", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Paracrine Protein Factors|T116|T123|NON|NRW|NLM (2003)|020107|abbcdef", "ENTRY": "Peptide Factors, Paracrine", "MN": "D23.529", "FX": "Receptors, Growth Factor", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics; coordinate with PARACRINE COMMUNICATION if pertinent; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS is also available", "MS": "Regulatory proteins and peptides that are signaling molecules involved in the process of PARACRINE COMMUNICATION. They are generally considered factors that are expressed by one cell and are responded to by receptors on another nearby cell. They are distinguished from HORMONES in that their actions are local rather than distal.", "PM": "2003; for GROWTH FACTORS see GROWTH SUBSTANCES 1999-2006", "HN": "2003; for GROWTH FACTORS use GROWTH SUBSTANCES 1999-2006", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036341"}, {"RECTYPE": "D", "MH": "Ephrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ephrin|T116|T123|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Receptor Ligands, Eph", "MN": "D23.529.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "Signaling proteins that are ligands for the EPH FAMILY RECEPTORS. They are membrane-bound proteins that are attached to the CELL MEMBRANE either through a GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR or through a transmembrane domain. Many of the ephrins are considered important intercellular signaling molecules that control morphogenic changes during embryogenesis.", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036342"}, {"RECTYPE": "D", "MH": "Pterocarpans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.633.400.748", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "MS": "A group of compounds which can be described as benzo-pyrano-furano-benzenes which can be formed from ISOFLAVONES by internal coupling of the B ring to the 4-ketone position. Members include medicarpin, phaseolin, and pisatin which are found in FABACEAE.", "PM": "2003", "HN": "2003", "MR": "20160531", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036343"}, {"RECTYPE": "D", "MH": "Peptide Hormones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polypeptide Hormones|T116|T123|NON|REL|NLM (2003)|020107|abbcdef", "ENTRY": "Hormones, Polypeptide", "MN": "D12.644.548", "FX": "Receptors, Peptide", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "Hormones synthesized from amino acids. They are distinguished from INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS in that their actions are systemic.", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036361"}, {"RECTYPE": "D", "MH": "Diarylheptanoids", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Linear Diarylheptanoids|T109|NON|NRW|NLM (2020)|190501|abcdef", "ENTRY": "Heptanoids, Diaryl", "MN": "D02.455.426.559.695", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "MS": "A group of compounds consisting of two aryl rings linked by seven carbons (HEPTANES) which may be acyclic (linear) or cyclic. It is a group of secondary metabolites in polyketide synthesis pathway best exemplified by a linear diarylheptanoid CURCUMIN.", "PM": "2003", "HN": "2003", "MR": "20230531", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036381"}, {"RECTYPE": "D", "MH": "Ephrin-A1", "DS": "EPHRIN A 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endothelium Secreted Protein B61|T116|T123|ACX|EQV|NLM (2003)|abbcde", "ENTRY": "RPTK Ligand, Eck", "MN": "D23.529.500.100", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Proteins (1990-2002)", "MS": "An ephrin that was originally identified as the product of an early response gene induced by TUMOR NECROSIS FACTORS. It is linked to the CELL MEMBRANE via a GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR and binds EPHA2 RECEPTOR with high affinity. During embryogenesis high levels of ephrin-A1 are expressed in LUNG; KIDNEY; SALIVARY GLANDS; and INTESTINE.", "PM": "2003; ENDOTHELIUM SECRETED PROTEIN B61 (now Ephrin-A1) was indexed under PROTEINS 1990-2002,", "HN": "2003; use EPHRIN-A1 (NM) 1990-2002", "MR": "20230316", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036382"}, {"RECTYPE": "D", "MH": "Ephrin-A2", "DS": "EPHRIN A 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "RPTK Ligand, Cek7", "MN": "D23.529.500.200", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1998-2002)", "MS": "A GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR-containing ephrin with a high affinity for the EPHA3 RECEPTOR. Early in embryogenesis it is expressed at high levels in the MESENCEPHALON; SOMITES; branchial arches, and LIMB BUDS.", "PM": "2003; LERK-6 PROTEIN (now EPHRIN-A2) was indexed under TRANSCRIPTION FACTORS 1998-2002; EPH LIGAND FAMILY 1 PROTEIN, MAMMALIAN (now EPHRIN-A2) was indexed under TRANSCRIPTION FACTORS 1998-2002, PROTEINS 1994-1997", "HN": "2003; use EPHRIN-A2 (NM) 1994-2002", "MR": "20230316", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036383"}, {"RECTYPE": "D", "MH": "Ephrin-A3", "DS": "EPHRIN A 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "LERK 3 Protein", "MN": "D23.529.500.300", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1995-2002)", "MS": "A GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR containing ephrin with a high affinity for the EPHA3 RECEPTOR; EPHA5 RECEPTOR; EPHA6 RECEPTOR; EPHA7 RECEPTOR; and EPHA8 RECEPTOR. It is found primarily in NERVE TISSUE.", "PM": "2003; LERK-3 PROTEIN (now EPHRIN-A3) was indexed under MEMBRANE PROTEINS 1995-2002", "HN": "2003; use EPHRIN-A3 (NM) 1995-2002", "MR": "20230316", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036384"}, {"RECTYPE": "D", "MH": "Ephrin-A4", "DS": "EPHRIN A 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "LERK 4 Protein", "MN": "D23.529.500.400", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1995-2002)", "MS": "A GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR containing ephrin found in variety of adult tissue such as KIDNEY; LUNG; COLON and OVARY. During embryonic development, ephrin-A4 is expressed in the HIPPOCAMPUS and CEREBRAL CORTEX. It binds preferentially to ephA receptors (EPH FAMILY RECEPTORS) with the exception of the EPHA1 RECEPTOR.", "PM": "2003; LERK-4 PROTEIN (now EPHRIN-A4) was indexed under MEMBRANE PROTEINS 1995-2002", "HN": "2003; use EPHRIN-A4 (NM) 1995-2002", "MR": "20230316", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036385"}, {"RECTYPE": "D", "MH": "Ephrin-A5", "DS": "EPHRIN A 005", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EFNA5|T116|T123|NON|EQV|NLM (2022)|210407|abbcdef", "ENTRY": "REK7 Ligand AL 1", "MN": "D23.529.500.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1995-2002)", "MS": "A GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR containing ephrin found in developing tectum. It has been shown to mediate the bundling of cortical axons and repel the axonal growth of retinal ganglia axons. It is found in a variety of adult tissues of BRAIN; HEART; and KIDNEY.", "PM": "2003; EPHRIN-A5 was indexed under MEMBRANE PROTEINS (1998-2002); REPUSLSIVE AXONAL GUIDANCE PROTEIN was indexed under TRANSCRIPTION FACTORS 1995-2002", "HN": "2003; use EPHRIN-A5 (NM) 1998-2002; for REPUSLSIVE AXONAL GUIDANCE PROTEIN use EPHRIN-A4 (NM) 1995-2002", "MR": "20230316", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036386"}, {"RECTYPE": "D", "MH": "Ephrin-B1", "DS": "EPHRIN B 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "EFNB1|T116|T123|ACR|EQV|NLM (2022)|210407|abbcdef", "ENTRY": "RPTK Ligand, Cek5", "MN": "D23.529.500.600", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Proteins (1994-1997)", "MS": "A transmembrane domain containing ephrin that is specific for EPHB1 RECEPTOR; EPHB2 RECEPTOR and EPHB3 RECEPTOR. It is widely expressed in a variety of developing and adult tissues.", "PM": "2003; EPHRIN-B1 was indexed under MEMBRANE PROTEINS 1998-2002, PROTEINS 1994-1997", "HN": "2003; use EPHRIN-B1 (NM) 1994-2002", "MR": "20210628", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036387"}, {"RECTYPE": "D", "MH": "Ephrin-B2", "DS": "EPHRIN B 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mammalian ELF-2 Protein", "MN": "D23.529.500.700", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "RR": "165945-35-7", "PI": "Membrane Proteins (1995-2002)", "MS": "A transmembrane domain containing ephrin that binds with high affinity to EPHB1 RECEPTOR; EPHB3 RECEPTOR; and EPHB4 RECEPTOR. Expression of ephrin-B2 occurs in a variety of adult tissues. During embryogenesis, high levels of ephrin-B2 is seen in the PROSENCEPHALON; RHOMBENCEPHALON; developing SOMITES; LIMB BUD; and bronchial arches.", "PM": "2003; EPH LIGAND FAMILY 2 PROTEIN, MAMMALIAN (now EPHRIN-B2) was indexed under MEMBRANE PROTEINS 1995-2002; LERK-5 PROTEIN (now EPHRIN-B2) was indexed under MEMBRANE PROTEINS 1996-2002", "HN": "2003; use EPHRIN-B2 (NM) 1995-2002", "MR": "20060705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036388"}, {"RECTYPE": "D", "MH": "Ephrin-B3", "DS": "EPHRIN B 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "LERK 8 Protein", "MN": "D23.529.500.800", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1997-2002)", "MS": "A transmembrane domain containing ephrin. Although originally found to be specific for the EPHB3 RECEPTOR it has since been shown to bind a variety of EPH FAMILY RECEPTORS. During embryogenesis ephrin-B3 is expressed at high levels in the ventral neural tube. In adult tissues, it is found primarily in the BRAIN and HEART.", "PM": "2003; EPHRIN-B3 was indexed under MEMBRANE PROTEINS 1998-2002; LERK-8 PROTEIN (now EPHRIN-B3) was indexed under MEMBRANE PROTEINS 1997-2002", "HN": "2003; use EPHRIN-B3 (NM) 1997-2002", "MR": "20060705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036389"}, {"RECTYPE": "D", "MH": "Toxicity Tests, Chronic", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Chronic Toxicity Tests|T060|NON|EQV|NLM (2003)|020108|abcdef", "ENTRY": "Toxicity Test, Chronic", "MN": "E05.940.800", "MH_TH": "NLM (2003)", "ST": "T060", "AN": "TOXICITY TESTS, SUBCHRONIC is also available", "PI": "Toxicity Tests (1995-2002)", "MS": "Experiments designed to determine the potential toxic effects of a long-term exposure to a chemical or chemicals.", "PM": "2003", "HN": "2003", "MR": "20110624", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036401"}, {"RECTYPE": "D", "MH": "Nerve Fibers, Unmyelinated", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "C Fibers|T023|NRW|UNK (19XX)|760503|abdef", "ENTRY": "Unmyelinated Nerve Fibers", "MN": "A11.671.501.756", "FX": "Gray Matter", "MH_TH": "NLM (2003)", "ST": "T026", "PI": "Nerve Fibers (1976-2002)", "MS": "A class of nerve fibers as defined by their nerve sheath arrangement. The AXONS of the unmyelinated nerve fibers are small in diameter and usually several are surrounded by a single MYELIN SHEATH. They conduct low-velocity impulses, and represent the majority of peripheral sensory and autonomic fibers, but are also found in the BRAIN and SPINAL CORD.", "PM": "2003; for C FIBERS see NERVE FIBERS 1977-2002", "HN": "2003; for C FIBERS use NERVE FIBERS 1977-2002", "MR": "20140610", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036421"}, {"RECTYPE": "D", "MH": "Osmeriformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Smelts|T013|NON|NRW|NLM (2003)|020108|abcdef", "ENTRY": "Smelt", "MN": "B01.050.150.900.493.595", "MH_TH": "NLM (2003)", "ST": "T013", "RN": "txid41711", "RR": "txid8012", "PI": "Fishes (2001-2002)", "MS": "An order of fish including smelts, galaxiids, and salamanderfish.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036441"}, {"RECTYPE": "D", "MH": "Mallotus Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Kamala Tree|T002|NON|NRW|NLM (2003)|020109|abcdef", "ENTRY": "philippensis, Mallotus", "MN": "B01.875.800.575.912.250.859.797.438.505", "MH_TH": "NLM (2003)", "ST": "T002", "RR": "txid316645", "MS": "A plant genus of the family EUPHORBIACEAE. Members contain fredelin type TRITERPENES, mallorepine (a cyano-pyridone), and hydrolyzable TANNINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036461"}, {"RECTYPE": "D", "MH": "Bauhinia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Bauhinias", "MN": "B01.875.800.575.912.250.401.088", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3805", "MS": "A plant genus of the family FABACEAE. Members contain isoacteoside, luteolin, indole-3-carboxylic acid.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036481"}, {"RECTYPE": "D", "MH": "Metered Dose Inhalers", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Spacer Inhalers|T074|NON|REL|NLM (2003)|020315|abcdef", "ENTRY": "Spinhaler", "MN": "E07.605.750", "MH_TH": "NLM (2003)", "ST": "T074", "AN": "do not confuse entry term SPACER INHALERS with INHALATION SPACERS", "PI": "Respiratory Therapy (1980-2002)", "MS": "A small aerosol canister used to release a calibrated amount of medication for inhalation.", "PM": "2003", "HN": "2003", "MR": "20150623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036501"}, {"RECTYPE": "D", "MH": "Infusions, Intralesional", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Intralesional Infusions", "MN": "E02.319.267.510.555", "MH_TH": "NLM (2003)", "ST": "T061", "AN": "do not confuse with INJECTIONS, INTRALESIONAL", "MS": "The administration of medication or fluid directly into localized lesions, by means of gravity flow or INFUSION PUMPS.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036502"}, {"RECTYPE": "D", "MH": "Inhalation Spacers", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Tube Spacers|T074|NON|NRW|NLM (2003)|020109|abcdef", "ENTRY": "Valved Holding Chamber", "MN": "E07.605.750.500", "MH_TH": "NLM (2003)", "ST": "T074", "AN": "do not confuse with SPACER INHALERS see METERED DOSE INHALERS", "PI": "Respiratory Therapy (1979-2002)", "MS": "A variety of devices used in conjunction with METERED DOSE INHALERS. Their purpose is to hold the released medication for inhalation and make it easy for the patients to inhale the metered dose of medication into their lungs.", "PM": "2003", "HN": "2003", "MR": "20150623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036503"}, {"RECTYPE": "D", "MH": "ADP-ribosyl Cyclase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ADP Ribose Cyclase|T116|T126|ACX|EQV|NLM (2003)|abbcde", "ENTRY": "Ribose Cyclase, ADP", "MN": "D08.811.913.400.725.115.660.060", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 3.2.2.5", "RR": "EC 3.2.2.6", "PI": "NAD+ Nucleosidase (1993-2002)", "MS": "A membrane-bound or cytosolic enzyme that catalyzes the synthesis of CYCLIC ADP-RIBOSE (cADPR) from nicotinamide adenine dinucleotide (NAD). This enzyme generally catalyzes the hydrolysis of cADPR to ADP-RIBOSE, as well, and sometimes the synthesis of cyclic ADP-ribose 2' phosphate (2'-P-cADPR) from NADP.", "PM": "2003; ADP-RIBOSYL CYCLASE was indexed under ANTIGENS, DIFFERENTIATION 1988-2002, NUCLEOSIDASES 1988-1997, and NAD+ NUCLEOSIDASES 1998-2002", "HN": "2003; use CD38 ANTIGEN (NM) 1988-2002", "MR": "20130709", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036541"}, {"RECTYPE": "D", "MH": "Tomography, Spiral Computed", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tomography, Helical Computed|T060|NON|EQV|NLM (2003)|020110|abcdef", "ENTRY": "Tomography, Spiral Computerized", "MN": "E01.370.350.825.810.810.800", "MH_TH": "NLM (2003)", "ST": "T060", "AN": "do not confuse with SPIRAL CONE-BEAM COMPUTED TOMOGRAPHY", "PI": "Tomography, X-Ray Computed (1985-2002)", "MS": "Computed tomography where there is continuous X-ray exposure to the patient while being transported in a spiral or helical pattern through the beam of irradiation. This provides improved three-dimensional contrast and spatial resolution compared to conventional computed tomography, where data is obtained and computed from individual sequential exposures.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036542"}, {"RECTYPE": "D", "MH": "Cajanus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pigeonpea Plant|T002|NON|NRW|NLM (2003)|020110|abcdef", "ENTRY": "cajan, Cajanus", "MN": "B01.875.800.575.912.250.401.094", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3820", "RR": "txid3821", "MS": "A plant genus of the family FABACEAE that is used for food in NIGERIA.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036561"}, {"RECTYPE": "D", "MH": "Helichrysum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Helichrysums", "MN": "B01.875.800.575.912.250.100.425", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid59430", "MS": "A plant genus of the family ASTERACEAE. Members contain CHALCONE, helichrysetin, arenarin, and flamin.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036562"}, {"RECTYPE": "D", "MH": "Cyclic ADP-Ribose", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "cADP-Ribose|T114|T123|NON|EQV|NLM (2003)|020625|abbcdef", "ENTRY": "cADP Ribose", "MN": "D13.695.827.708.070.125.195", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "119340-53-3", "PI": "Adenosine Diphosphate Ribose (1989-2002)", "MS": "A pyridine nucleotide that mobilizes CALCIUM. It is synthesized from nicotinamide adenine dinucleotide (NAD) by ADP RIBOSE CYCLASE.", "PM": "2003; CYCLIC ADP-RIBOSE (NM) was indexed under ADENOSINE DIPHOSPHATE RIBOSE 1989-2002", "HN": "2003; use CYCLIC ADP-RIBOSE (NM)1989-2002", "MR": "20160528", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036563"}, {"RECTYPE": "D", "MH": "Ratibida", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Coneflower, Prairie|T002|NON|EQV|NLM (2003)|020110|abcdef", "ENTRY": "Ratibidas", "MN": "B01.875.800.575.912.250.100.631", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid52291", "AN": "entry term CONEFLOWER, PRAIRIE: CONEFLOWER, PURPLE see ECHINACEA, and CONEFLOWER, ORANGE see RUDBECKIA are also available", "MS": "A plant genus of the family ASTERACEAE. Members contain sesquiterpene lactones.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036581"}, {"RECTYPE": "D", "MH": "Rudbeckia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Coneflower, Orange|T002|NON|EQV|NLM (2003)|020110|abcdef", "ENTRY": "Rudbeckias", "MN": "B01.875.800.575.912.250.100.665", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid48209", "AN": "entry term CONEFLOWER, ORANGE: CONEFLOWER, PURPLE see ECHINACEA, and CONEFLOWER, PRAIRIE see RATIBIDA are also available", "MS": "A plant genus of the family ASTERACEAE. Some Rudbeckia species have been reclassified to ECHINACEA; RATIBIDA; or HELIANTHUS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036582"}, {"RECTYPE": "D", "MH": "Eclipta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Ecliptas", "MN": "B01.875.800.575.912.250.100.337", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid53718", "MS": "A plant genus of the family ASTERACEAE. Members contain wedelolactone.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036601"}, {"RECTYPE": "D", "MH": "Eupatorium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Eupatoriums", "MN": "B01.875.800.575.912.250.100.347", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13516", "AN": "EUPATORIUM REBAUDIANUM see STEVIA; EUPATORIUM ODORATUM see CHROMOLAENA and EUPATORIUM ADENOPHORUM see AGERATINA are also available; for other species check plant taxonomy reference: Manual 22.37", "MS": "A plant genus of the family ASTERACEAE. Ingestion has been associated with MILK SICKNESS. The common name of thoroughwort is also used for other plants including CHROMOLAENA; Hebeclinium, and Koanophyllon.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036602"}, {"RECTYPE": "D", "MH": "Ageratina", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Eupatorium adenophorum|T002|NON|NRW|NLM (2003)|020110|abcdef", "ENTRY": "adenophorum, Eupatorium", "MN": "B01.875.800.575.912.250.100.046", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid102749", "RR": "txid176616", "MS": "A plant genus of the family ASTERACEAE. The common name of snakeroot is also used for POLYGALA; SANICULA; ARISTOLOCHIA and others.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036603"}, {"RECTYPE": "D", "MH": "Chromolaena", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Eupatorium odoratum|T002|NON|NRW|NLM (2003)|020110|abcdef", "ENTRY": "odoratums, Eupatorium", "MN": "B01.875.800.575.912.250.100.203", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13420", "RR": "txid103745", "MS": "A plant genus of the family ASTERACEAE. The common name of thoroughwort is also used for other plants including EUPATORIUM; CHROMOLAENA, Hebeclinium and Koanophyllon. Eupolin is the aqueous extract of the leaves.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036604"}, {"RECTYPE": "D", "MH": "Geigeria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Geigerias", "MN": "B01.875.800.575.912.250.100.352", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid56527", "MS": "A plant genus of the family ASTERACEAE that causes vermeersiekte poisoning of sheep in South Africa. Members contain dihydrogriesenin and ivalin (sesquiterpene lactones).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036621"}, {"RECTYPE": "D", "MH": "Gnaphalium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Gnaphaliums", "MN": "B01.875.800.575.912.250.100.355", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid59428", "MS": "A plant genus of the family ASTERACEAE. The common name of cudweed is also used for other plants including Evax, Hesperevax, Pseudognaphalium, and Omalotheca. The common name of everlasting is also used for other plants including Anaphalis, Antennaria, HELICHRYSUM, Gamochaeta, and Pseudognaphalium.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036622"}, {"RECTYPE": "D", "MH": "Grindelia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gumweed|T002|NON|EQV|NLM (2003)|020110|abcdef", "ENTRY": "Gumweeds", "MN": "B01.875.800.575.912.250.100.356", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid71045", "MS": "A plant genus of the family ASTERACEAE. Members contain triterpenoid sapogenins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036623"}, {"RECTYPE": "D", "MH": "Solidago", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Solidago canadensis|T002|NON|NRW|NLM (2024)|230417|abcdef", "ENTRY": "Goldenrods", "MN": "B01.875.800.575.912.250.100.816", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid59293", "RR": "txid59297", "MS": "A plant genus of the family Asteraceae. Goldenrods are often mistaken as being the cause of allergy attacks when it is most often similar looking RAGWEED most accountable. However, goldenrod pollens can cause allergies.", "PM": "2003", "HN": "2003", "MR": "20230531", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036624"}, {"RECTYPE": "D", "MH": "Stevia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sweetleaf|T002|NON|NRW|NLM (2003)|020110|abcdef", "ENTRY": "rebaudianums, Eupatorium", "MN": "B01.875.800.575.912.250.100.843", "PA": "Sweetening Agents", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid55669", "RR": "txid55670", "MS": "A plant genus of the family ASTERACEAE. Members contain stevioside and other sweet diterpene glycosides. The leaf is used for sweetening (SWEETENING AGENTS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036625"}, {"RECTYPE": "D", "MH": "Microscopy, Fluorescence, Multiphoton", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Multiphoton Fluorescence Microscopy|T059|NON|EQV|NLM (2003)|020114|abcdef", "ENTRY": "Multiphoton Excitation Microscopies", "MN": "E05.595.717.250", "MH_TH": "NLM (2003)", "ST": "T059", "PI": "Microscopy, Fluorescence (1996-2002)", "MS": "Fluorescence microscopy utilizing multiple low-energy photons to produce the excitation event of the fluorophore (endogenous fluorescent molecules in living tissues or FLUORESCENT DYES). Multiphoton microscopes have a simplified optical path in the emission side due to the lack of an emission pinhole, which is necessary with normal confocal microscopes. Ultimately this allows spatial isolation of the excitation event, enabling deeper imaging into optically thick tissue, while restricting photobleaching and phototoxicity to the area being imaged.", "PM": "2003", "HN": "2003", "MR": "20170630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036641"}, {"RECTYPE": "D", "MH": "Echium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Echiums", "MN": "B01.875.800.575.912.250.150.385", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid21610", "MS": "A plant genus of the family BORAGINACEAE. Members contain GAMMA-LINOLENIC ACID and PYRROLIZIDINE ALKALOIDS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036661"}, {"RECTYPE": "D", "MH": "Fluorescence Recovery After Photobleaching", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Fluorescence Photobleaching Recovery|T059|NON|EQV|NLM (2003)|020212|abcdef", "ENTRY": "FRAPs (Fluorescence Recovery After Photobleaching)", "MN": "E05.196.712.516.600.393", "MH_TH": "NLM (2003)", "ST": "T059", "PI": "Fluorescence (1976-2002)", "MS": "A method used to study the lateral movement of MEMBRANE PROTEINS and LIPIDS. A small area of a cell membrane is bleached by laser light and the amount of time necessary for unbleached fluorescent marker-tagged proteins to diffuse back into the bleached site is a measurement of the cell membrane's fluidity. The diffusion coefficient of a protein or lipid in the membrane can be calculated from the data. (From Segen, Current Med Talk, 1995).", "PM": "2003", "HN": "2003", "MR": "20040707", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036681"}, {"RECTYPE": "D", "MH": "Limonins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetranortriterpenoids|T109|NON|REL|NLM (2003)|020114|abcdef", "ENTRY": "Tetranortriterpene, Limonoid", "MN": "D02.455.849.919.490", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "PI": "Triterpenes (1974-2002)", "MS": "A group of degraded TRITERPENES in which the four terminal carbons of the C17 side chain have been removed, and the remaining portion often forming C17 furans.", "PM": "2003", "HN": "2003", "MR": "20230531", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036701"}, {"RECTYPE": "D", "MH": "Quassins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Simaroubolides|T109|NON|NRW|NLM (2003)|020125|abcdef", "MN": "D02.455.849.919.570", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "MS": "A group of degraded TRITERPENES which have lost ten carbons (8 from the side chain, C17, and one from C4) so have C20 skeletons which could be misinterpreted as DITERPENES. They especially occur in plants of the SIMAROUBACEAE family.", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036702"}, {"RECTYPE": "D", "MH": "Blastula", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Blastulae|T018|NON|EQV|NLM (2003)|011128|abcdef", "MN": "A16.331.099", "MH_TH": "UNK (19XX)", "ST": "T018", "AN": "non-mammalian only; mammalian, use BLASTOCYST", "PI": "Embryo, Nonmammalian (1975-2002)", "MS": "An early non-mammalian embryo that follows the MORULA stage. A blastula resembles a hollow ball with the layer of cells surrounding a fluid-filled cavity (blastocele). The layer of cells is called BLASTODERM.", "PM": "2003; see BLASTOCYST 1980-2002", "HN": "2003; use BLASTOCYST 1980-2002", "MR": "20070709", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036703"}, {"RECTYPE": "D", "MH": "Scoparia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Scoparia dulcis|T002|NON|NRW|NLM (2003)|020114|abcdef", "MN": "B01.875.800.575.912.250.583.700.850", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid107239", "RR": "txid107240", "MS": "A plant genus of the family Plantaginaceae. Members contain thyrsiflorin and other scopadulane (labdane) type DITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036721"}, {"RECTYPE": "D", "MH": "Plant Tumor-Inducing Plasmids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ti Plasmid|T114|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Tumor-Inducing Plasmids, Plant", "MN": "G05.360.600.550", "FX": "Fimbriae Proteins", "MH_TH": "NLM (2003)", "ST": "T123", "PI": "Plasmids (1976-2002)", "MS": "Plasmids coding for proteins which induce PLANT TUMORS. The most notable example of a plant tumor inducing plasmid is the Ti plasmid found associated with AGROBACTERIUM TUMEFACIENS.", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036741"}, {"RECTYPE": "D", "MH": "Ultrasound, High-Intensity Focused, Transrectal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Transrectal High-Intensity Focused Ultrasound|T061|NON|EQV|NLM (2003)|020115|TRANSRECTAL HIFU|abcdefv", "ENTRY": "Transrectal High Intensity Focused Ultrasound", "MN": "E04.950.774.860.625.875", "MH_TH": "NLM (2003)", "ST": "T061", "PI": "Ultrasonic Therapy (1994-2002)", "MS": "Tissue ablation of the PROSTATE performed by ultrasound from a transducer placed in the RECTUM. The procedure is used to treat prostate cancer (PROSTATIC NEOPLASMS) and benign prostatic hypertrophy (PROSTATIC HYPERPLASIA).", "PM": "2003", "HN": "2003", "MR": "20150626", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036761"}, {"RECTYPE": "D", "MH": "Fimbriae Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Propilin|T116|T123|NON|NRW|NLM (2003)|abbcde", "ENTRY": "Protein Precusors, Fimbriae", "MN": "D12.776.543.100.300", "FX": "Pili, Sex", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "147680-16-8", "AN": "Coordinate with PILI, SEX if involved in BACTERIAL CONJUGATION, otherwise coordinate with FIMBRIAE, BACTERIAL", "MS": "Proteins that are structural components of bacterial fimbriae (FIMBRIAE, BACTERIAL) or sex pili (PILI, SEX).", "PM": "2003; PILIN (now FIMBRIAE PROTEINS) was indexed under MEMBRANE PROTEINS 1977-2002; PROPILIN (now FIMBRIAE PROTEINS) was indexed under BACTERIAL OUTER MEMBRANE PROTEINS & PROTEIN PRECURSORS 1989-2002", "HN": "2003; use FIMBRIAE PROTEINS (NM) 1977-2002", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036781"}, {"RECTYPE": "D", "MH": "Parturition", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "PRINT ENTRY": "Childbirth|T040|NON|NRW|BIOETHICS (1989)|740330|abcdef", "ENTRY": "Parturitions", "MN": "G08.686.784.769.490", "MH_TH": "UNK (19XX)", "ST": "T040", "PI": "Pregnancy (1965-2002)", "MS": "The process of giving birth to one or more offspring.", "PM": "2003", "HN": "2003", "MR": "20160617", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036801"}, {"RECTYPE": "D", "MH": "Endometrial Stromal Tumors", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Endometrial Stromal", "MN": "C12.900.418.875.200.374", "MH_TH": "NLM (2003)", "ST": "T191", "AN": "coordinate IM with ENDOMETRIAL NEOPLASMS (IM); note entry term SARCOMA, ENDOMETRIAL STROMAL, LOW-GRADE: SARCOMA, ENDOMETRIAL STROMAL is also available", "PI": "Uterine Neoplasms (1966-1991)", "MS": "Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036821"}, {"RECTYPE": "D", "MH": "Ciguatera Poisoning", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Ciguatera|T037|NON|EQV|UNK (19XX)|770418|abcdef", "ENTRY": "Poisonings, Ciguatera Fish", "MN": "C25.723.415.246", "MH_TH": "NLM (2003)", "ST": "T037", "PI": "Ciguatoxins (1978-2002)", "MS": "Poisoning caused by ingestion of SEAFOOD containing microgram levels of CIGUATOXINS. The poisoning is characterized by gastrointestinal, neurological and cardiovascular disturbances.", "PM": "2003; use CIGUATOXIN 1978-2002", "HN": "2003; see CIGUATOXINS 1978-2002", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036841"}, {"RECTYPE": "D", "MH": "Delivery, Obstetric", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Obstetric Deliveries", "MN": "E04.520.252", "FX": "Dystocia", "MH_TH": "NLM (2003)", "ST": "T061", "AN": "\"tokolysis\": translate as \"tocolysis\" & index as TOCOLYSIS", "PI": "Pregnancy (1967-1971)", "MS": "Delivery of the FETUS and PLACENTA under the care of an obstetrician or a health worker. Obstetric deliveries may involve physical, psychological, medical, or surgical interventions.", "PM": "2003", "HN": "2003", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036861"}, {"RECTYPE": "D", "MH": "Long-Term Synaptic Depression", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Homosynaptic Depression|T042|NON|REL|NLM (2003)|020117|abcdef", "ENTRY": "Synaptic Depression, Long-Term", "MN": "G11.561.638.355", "MH_TH": "NLM (2003)", "ST": "T042", "AN": "note category: do not confuse with clinical DEPRESSION or DEPRESSIVE DISORDERS", "PI": "Neuronal Plasticity (1985-2002)", "MS": "A persistent activity-dependent decrease in synaptic efficacy between NEURONS. It typically occurs following repeated low-frequency afferent stimulation, but it can be induced by other methods. Long-term depression appears to play a role in MEMORY.", "PM": "2008; see LONG-TERM DEPRESSION (PHYSIOLOGY) 2003-2007", "HN": "2008 (2003)", "MR": "20160623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036881"}, {"RECTYPE": "D", "MH": "Kalopanax", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Kalopanaxs", "MN": "B01.875.800.575.912.250.087.431", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid46398", "MS": "A plant genus of the family ARALIACEAE. Members contain triterpene saponins.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036882"}, {"RECTYPE": "D", "MH": "Petasites", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Coltsfoot, Sweet|T002|NON|EQV|NLM (2003)|020118|abcdef", "ENTRY": "Sweet Coltsfoots", "MN": "B01.875.800.575.912.250.100.596", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid56018", "RR": "txid278673", "MS": "A plant genus of the family ASTERACEAE. Members contain SESQUITERPENES. The common name of sweet coltsfoot is similar to the common name for TUSSILAGO.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036901"}, {"RECTYPE": "D", "MH": "Voacanga", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Voacangas", "MN": "B01.875.800.575.912.250.456.500.986", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid141629", "MS": "A plant genus of the family APOCYNACEAE. Members contain voacangine and other INDOLES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036902"}, {"RECTYPE": "D", "MH": "Aspalathus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rooibos|T002|NON|NRW|NLM (2003)|020118|abcdef", "ENTRY": "Rooibo", "MN": "B01.875.800.575.912.250.401.082", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid70004", "RR": "txid155124", "MS": "A plant genus of the family FABACEAE. It is the source of an herbal tea that is commonly consumed in South Africa. Members contain aspalathin and other polyphenols (PHENOLS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036903"}, {"RECTYPE": "D", "MH": "Leukocyte Rolling", "AQ": "DE ES GE IM PH RE", "ENTRY": "Rolling, Leukocyte", "MN": "G04.198.424.233.500", "MH_TH": "NLM (2003)", "ST": "T043", "PI": "Cell Movement (1991-2002)", "MS": "Movement of tethered, spherical LEUKOCYTES along the endothelial surface of the microvasculature. The tethering and rolling involves interaction with SELECTINS and other adhesion molecules in both the ENDOTHELIUM and leukocyte. The rolling leukocyte then becomes activated by CHEMOKINES, flattens out, and firmly adheres to the endothelial surface in preparation for transmigration through the interendothelial cell junction. (From Abbas, Cellular and Molecular Immunology, 3rd ed)", "PM": "2003", "HN": "2003", "MR": "20160623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036904"}, {"RECTYPE": "D", "MH": "Dictamnus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.875.255", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid77005", "MS": "A plant genus of the family RUTACEAE. Members contain eudesmane type SESQUITERPENES; COUMARINS, and obacunone (a limonoid).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036905"}, {"RECTYPE": "D", "MH": "Achyrocline", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Marcela|T002|NON|EQV|NLM (2003)|020118|abcdef", "ENTRY": "Marcelas", "MN": "B01.875.800.575.912.250.100.041", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid746490", "MS": "A plant genus of the family ASTERACEAE. Members contain TERPENES and achyrofuran, a prenylated dibenzofuran (BENZOFURANS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D036921"}, {"RECTYPE": "D", "MH": "Peperomia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Peperomias", "MN": "B01.875.800.575.912.250.812.332", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13196", "MS": "A plant genus of the family PIPERACEAE. Members contain prenylated quinones.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036941"}, {"RECTYPE": "D", "MH": "Matrix Attachment Region Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "MAR Binding Proteins|T116|T123|NON|EQV|NLM (2003)|020118|abbcdef", "MN": "D12.776.260.532", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "Proteins that bind to the MATRIX ATTACHMENT REGIONS of DNA.", "PM": "2003", "HN": "2003", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036961"}, {"RECTYPE": "D", "MH": "Fasciitis, Plantar", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Plantar Fasciitis|T047|NON|EQV|NLM (2003)|020118|abcdef", "ENTRY": "Policemans Heel", "MN": "C05.360.350", "FX": "Heel Spur", "MH_TH": "NLM (2003)", "ST": "T047", "PI": "Foot Diseases (1974-2002)", "MS": "Inflammation of the plantar fascia (APONEUROSIS) on the bottom of the foot causing heel pain. The etiology of plantar fasciitis remains controversial but is likely to involve a biomechanical imbalance. Though often presenting along with HEEL SPUR, they do not appear to be causally related.", "PM": "2003", "HN": "2003", "MR": "20190222", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036981"}, {"RECTYPE": "D", "MH": "Heel Spur", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Calcaneal Spur|T047|NON|EQV|NLM (2003)|020118|abcdef", "ENTRY": "Spurs, Heel", "MN": "C05.360.400", "FX": "Fasciitis, Plantar", "MH_TH": "NLM (2003)", "ST": "T047", "AN": "do not confuse with HEEL SPUR SYNDROME see FASCIITIS, PLANTAR", "PI": "Exostoses (1970-2002)", "MS": "A bony outgrowth on the lower surface of the CALCANEUS. Though often presenting along with plantar fasciitis (FASCIITIS, PLANTAR), they are not considered causally related.", "PM": "2003", "HN": "2003", "MR": "20090820", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D036982"}, {"RECTYPE": "D", "MH": "Directive Counseling", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Counseling, Prescriptive", "MN": "N02.421.461.363.349", "FX": "Genetic Counseling", "MH_TH": "NLM (2000)", "ST": "T061", "MS": "Counseling during which a professional plays an active role in a client's or patient's decision making by offering advice, guidance, and/or recommendations.", "PM": "2003; see COUNSELING 2001-2002", "HN": "2003; use COUNSELING 2001-2002", "MR": "20150629", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037001"}, {"RECTYPE": "D", "MH": "Thyroid Hormone Receptors alpha", "DE": "THYROID HORMONE RECEPT ALPHA", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "erbA Proto-Oncogene Products|T116|T192|EQV|NLM (1995)|940301|abbdef", "ENTRY": "erbA Proto Oncogene Products", "MN": "D12.776.826.850.500", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Receptors, Thyroid Hormone (1988-2002)", "MS": "High affinity receptors for THYROID HORMONES, especially TRIIODOTHYRONINE. These receptors are usually found in the nucleus where they regulate DNA transcription. They are encoded by the THRA gene (also known as NR1A1, THRA1, ERBA or ERBA1 gene) as several isoforms produced by alternative splicing.", "PM": "2003; see RECEPTORS, THYROID HORMONE 1994-2002", "HN": "2003; use RECEPTORS, THYROID HORMONE 1994-2002", "MR": "20150623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037021"}, {"RECTYPE": "D", "MH": "Posthumous Conception", "AQ": "AE CL EC ES HI LJ PX SN VE", "PRINT ENTRY": "Posthumous Reproduction|T040|NON|REL|BIOETHICS (1999)|991103|abcdef", "ENTRY": "Reproduction, Posthumous", "MN": "E05.820.800.986", "FX": "Fertilization", "MH_TH": "NLM (2003)", "ST": "T061", "AN": "human or animal", "PI": "Reproductive Techniques (1999-2002)", "MS": "Conception after the death of the male or female biological parent through techniques such as the use of gametes that have been stored during his or her lifetime or that were collected immediately after his or her death.", "PM": "2003", "HN": "2003", "MR": "20060705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037022"}, {"RECTYPE": "D", "MH": "United States Government Agencies", "AQ": "CL EC ES HI LJ OG SN ST TD", "MN": "N03.540.348.500.500", "MH_TH": "NLM (2003)", "ST": "T092", "AN": "add UNITED STATES; CATALOGER: Coordinate with specific NAF entry if applicable", "MS": "Agencies of the FEDERAL GOVERNMENT of the United States.", "PM": "2003", "HN": "2003", "MR": "20150629", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037041"}, {"RECTYPE": "D", "MH": "Thyroid Hormone Receptors beta", "DE": "THYROID HORMONE RECEPT BETA", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors beta, Thyroid Hormone|T116|T192|NON|EQV|NLM (2003)|020502|RECEPT BETA THYROID HORMONE|abbcdefv", "ENTRY": "c erbA beta", "MN": "D12.776.826.850.750", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "MS": "High affinity receptors for THYROID HORMONES, especially TRIIODOTHYRONINE. These receptors are usually found in the nucleus where they regulate DNA transcription. They are encoded by the THRB gene (also known as NR1A2, THRB1, or ERBA2 gene) as several isoforms produced by alternative splicing. Mutations in the THRB gene cause THYROID HORMONE RESISTANCE SYNDROME.", "PM": "2003; use RECEPTORS, THYROID HORMONE 1994-2002; THYROID HORMONE RECEPTOR BETA was indexed under RECEPTORS, THYROID HORMONE 2002-2005", "HN": "2003; use RECEPTORS, THYROID HORMONE 1994-2002", "MR": "20150623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037042"}, {"RECTYPE": "D", "MH": "Metatarsalgia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.592.612.540", "MH_TH": "NLM (2003)", "ST": "T184", "AN": "coord with pertinent metatarsal term", "PI": "Pain (1967-2002)", "MS": "Pain in the region of the METATARSUS. It can include pain in the METATARSAL BONES; METATARSOPHALANGEAL JOINT; and/or intermetatarsal joints (TARSAL JOINTS).", "PM": "2003", "HN": "2003", "MR": "20170620", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037061"}, {"RECTYPE": "D", "MH": "Posterior Tibial Tendon Dysfunction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tibialis Posterior Dysfunction|T047|NON|EQV|NLM (2003)|020513|abcdef", "ENTRY": "Dysfunction, Tibialis Posterior", "MN": "C05.360.750", "FX": "Flatfoot", "MH_TH": "NLM (2003)", "ST": "T047", "PI": "Tendons (1989-2002)", "MS": "A condition characterized by a broad range of progressive disorders ranging from TENOSYNOVITIS to tendon rupture with or without hindfoot collapse to a fixed, rigid, FLATFOOT deformity. Pathologic changes can involve associated tendons, ligaments, joint structures of the ANKLE, hindfoot, and midfoot. Posterior tibial tendon dysfunction is the most common cause of acquired flatfoot deformity in adults.", "PM": "2003", "HN": "2003", "MR": "20060705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037081"}, {"RECTYPE": "D", "MH": "Luteinizing Hormone, beta Subunit", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lutropin, beta Subunit|T116|T125|NON|EQV|NLM (2003)|abbcde", "ENTRY": "Lutropin beta", "MN": "D12.644.548.691.525.343.463.500", "MH_TH": "NLM (2003)", "ST": "T125", "RN": "0", "PI": "Luteinizing Hormone (1974-2002)", "MS": "The beta subunit of luteinizing hormone. It is a 15-kDa glycopolypeptide with structure similar to the beta subunit of the placental chorionic gonadatropin (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN) except for the additional 31 amino acids at the C-terminal of CG-beta. Full biological activity of LH requires the non-covalently bound heterodimers of an alpha and a beta subunit. Mutation of the LHB gene causes HYPOGONADISM and infertility.", "PM": "2003; LUTEINIZING HORMONE, BETA SUBUNIT was indexed under LH 1983-2002", "HN": "2003; use LUTEINIZING HORMONE, BETA SUBUNIT (NM) 1983-2002", "MR": "20060705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037101"}, {"RECTYPE": "D", "MH": "Lectins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lectin|T116|T123|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Lectins, Animal", "MN": "D12.776.503", "MH_TH": "NLM (1966)", "ST": "T123", "RN": "0", "PI": "Lectins (1966-2002)", "MS": "Proteins that share the common characteristic of binding to carbohydrates. Some ANTIBODIES and carbohydrate-metabolizing proteins (ENZYMES) also bind to carbohydrates, however they are not considered lectins. PLANT LECTINS are carbohydrate-binding proteins that have been primarily identified by their hemagglutinating activity (HEMAGGLUTININS). However, a variety of lectins occur in animal species where they serve diverse array of functions through specific carbohydrate recognition.", "PM": "2003; ISOLECTIN was indexed under LECTINS 1979-2002", "HN": "2003; for ISOLECTIN use LECTINS (NM) 1979-2002", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037102"}, {"RECTYPE": "D", "MH": "Plant Lectins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Plant Lectin|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Lectin, Plant", "MN": "D12.776.765.678", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Lectins (1963-2002)", "MS": "Protein or glycoprotein substances of plant origin that bind to sugar moieties in cell walls or membranes. Some carbohydrate-metabolizing proteins (ENZYMES) from PLANTS also bind to carbohydrates, however they are not considered lectins. Many plant lectins change the physiology of the membrane of BLOOD CELLS to cause agglutination, mitosis, or other biochemical changes. They may play a role in plant defense mechanisms.", "PM": "2003; see LECTINS 1979-2002, PLANT AGGLUTININS 1963-1978 & PHYTOMITOGENS 1972-1978", "HN": "2003; use LECTINS 1979-2002", "MR": "20210707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037121"}, {"RECTYPE": "D", "MH": "Mandatory Programs", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Programs, Mandatory", "MN": "N04.452.521", "FX": "Voluntary Programs", "MH_TH": "BIOETHICS (1989)", "ST": "T064", "AN": "coord with geographical term and type of program if pertinent", "MS": "Programs in which participation is required.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037141"}, {"RECTYPE": "D", "MH": "Flaveria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Flaverias", "MN": "B01.875.800.575.912.250.100.349", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4223", "MS": "A plant genus of the family ASTERACEAE that is used for experiments in molecular genetic studies in plant physiology and development.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037142"}, {"RECTYPE": "D", "MH": "Galectins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lectins, S-Type|T116|T123|NON|EQV|NLM (2003)|020313|abbcdef", "ENTRY": "beta Galactoside Binding Lectin", "MN": "D12.776.503.307", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "GALECTIN 1 through GALECTIN 4 are available", "PI": "Hemagglutinins (1978-2002)", "MS": "A class of animal lectins that bind specifically to beta-galactoside in a calcium-independent manner. Members of this class are distiguished from other lectins by the presence of a conserved carbohydrate recognition domain. The majority of proteins in this class bind to sugar molecules in a sulfhydryl-dependent manner and are often referred to as S-type lectins, however this property is not required for membership in this class.", "PM": "2003; GALAPTINS (now GALECTINS) was indexed under HEMAGGLUTININS 1978-2002", "HN": "2003; use GALECTINS (NM) 1978-2002", "MR": "20050714", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037161"}, {"RECTYPE": "D", "MH": "Lectins, C-Type", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "C-Type Lectins|T116|T123|ACX|EQV|NLM (2003)|020124|abbcdef", "ENTRY": "Receptors, C Type Lectin", "MN": "D12.776.503.280", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "A class of animal lectins that bind to carbohydrate in a calcium-dependent manner. They share a common carbohydrate-binding domain that is structurally distinct from other classes of lectins.", "PM": "2003; C-TYPE LECTIN (now LECTINS, C-TYPE) was indexed under LECTINS 1997-2002", "HN": "2003; use LECTINS, C-TYPE (NM) 1997-2002", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037181"}, {"RECTYPE": "D", "MH": "T-Cell Antigen Receptor Specificity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "T-Cell Specificity|T044|NON|REL|NLM (2003)|020124|abcdef", "ENTRY": "T Cell Specificity", "MN": "G12.450.900", "FX": "Antibody Specificity", "MH_TH": "NLM (2003)", "ST": "T044", "AN": "T-cell cross-reactivity goes here", "MS": "The property of the T-CELL RECEPTOR which enables it to react with some antigens and not others. The specificity is derived from the structure of the receptor's variable region which has the ability to recognize certain antigens in conjunction with the MAJOR HISTOCOMPATIBILITY COMPLEX molecule.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037182"}, {"RECTYPE": "D", "MH": "Follicle Stimulating Hormone, beta Subunit", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "FSH, beta Subunit|T116|T125|ACX|EQV|NLM (2003)|abbcde", "ENTRY": "FSH beta", "MN": "D12.644.548.691.525.343.288.500", "MH_TH": "NLM (2003)", "ST": "T125", "RN": "0", "PI": "Follicle Stimulating Hormone (1963-2002)", "MS": "The beta subunit of follicle stimulating hormone. It is a 15-kDa glycopolypeptide. Full biological activity of FSH requires the non-covalently bound heterodimers of an alpha and a beta subunit. Mutation of the FSHB gene causes delayed puberty, or infertility.", "PM": "2003; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT was indexed under FOLLICLE STIMULATING HORMONE 2002; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT was indexed under FSH 1963-2001", "HN": "2003; use FOLLICLE STIMULATING HORMONE, BETA SUBUNIT (NM) 1983-2002", "MR": "20120703", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037201"}, {"RECTYPE": "D", "MH": "Collectins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lectins, Collagenous", "MN": "D12.776.503.280.249", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1980-2002)", "MS": "A class of C-type lectins that target the carbohydrate structures found on invading pathogens. Binding of collectins to microorganisms results in their agglutination and enhanced clearance. Collectins form trimers that may assemble into larger oligomers. Each collectin polypeptide chain consists of four regions: a relatively short N-terminal region, a collagen-like region, an alpha-helical coiled-coil region, and carbohydrate-binding region.", "PM": "2003; COLLECTIN (now COLLECTINS) was indexed under CARRIER PROTEINS 1980-2002", "HN": "2003; use COLLECTINS (NM) 1980-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037222"}, {"RECTYPE": "D", "MH": "Mannose-Binding Lectins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mannose Specific Lectin", "MN": "D12.776.503.311", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "MANNOSE-BINDING LECTIN is also available", "PI": "Lectins (1989-2002)", "MS": "A subclass of lectins that are specific for CARBOHYDRATES that contain MANNOSE.", "PM": "2003; MANNOSE-SPECIFIC LECTIN (now MANNOSE-BINDING LECTINS) was indexed under LECTINS 1989-2002", "HN": "2003; use MANNOSE-BINDING LECTINS (NM) 1989-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037241"}, {"RECTYPE": "D", "MH": "Asialoglycoprotein Receptor", "DE": "ASIALOGLYCOPROTEIN RECEPT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Asialoglycoprotein Receptors|T116|T192|NON|EQV|NLM (2003)|abbcde", "ENTRY": "Receptors, Asialoorosomucoid", "MN": "D12.776.543.750.024", "FX": "Asialoglycoproteins", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (1980-2002)", "MS": "A C-type lectin that is a cell surface receptor for ASIALOGLYCOPROTEINS. It is found primarily in the LIVER where it mediates the endocytosis of serum glycoproteins.", "PM": "2003; ASIALOGLYCOPROTEIN RECEPTOR was indexed under RECEPTORS, CELL SURFACE 1980-2002", "HN": "2003; use ASIALOGLYCOPROTEIN RECEPTOR (NM) 1980-2002", "MR": "20050630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037263"}, {"RECTYPE": "D", "MH": "Calnexin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "pp90, Phosphoprotein", "MN": "D12.776.543.162", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "139873-08-8", "PI": "Calcium-Binding Proteins (1991-2002)", "MS": "A lectin found in ENDOPLASMIC RETICULUM membranes that binds to specific N-linked OLIGOSACCHARIDES found on newly synthesized proteins. It may play role in PROTEIN FOLDING or retention and degradation of misfolded proteins in the endoplasmic reticulum.", "PM": "2003; CALNEXIN was indexed under CALCIUM-BINDING PROTEINS 1991-2002", "HN": "2003; use CALNEXIN (NM) 1991-2002", "MR": "20170630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037281"}, {"RECTYPE": "D", "MH": "Calreticulin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Calcium Binding Protein 3", "MN": "D12.776.503.303", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Calcium-Binding Proteins (1990-2002)", "MS": "A multifunctional protein that is found primarily within membrane-bound organelles. In the ENDOPLASMIC RETICULUM it binds to specific N-linked oligosaccharides found on newly-synthesized proteins and functions as a MOLECULAR CHAPERONE that may play a role in PROTEIN FOLDING or retention and degradation of misfolded proteins. In addition calreticulin is a major storage form for CALCIUM and functions as a calcium-signaling molecule that can regulate intracellular calcium HOMEOSTASIS.", "PM": "2003; CALRETICULIN was indexed under CALCIUM-BINDING PROTEINS 1990-2002", "HN": "2003; use CALRETICULIN (NM) 1990-2002", "MR": "20170630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037282"}, {"RECTYPE": "D", "MH": "Ctenophora", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sea Walnuts|T204|NON|EQV|NLM (2003)|020125|abcdef", "ENTRY": "Walnuts, Sea", "MN": "B01.050.500.325", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid10197", "RR": "txid27922", "PI": "Invertebrates (1970-2002)", "MS": "Phylum of marine colenterates characterized by eight comb rows of fused cilia on the body surface. In contrast to CNIDARIA they lack stinging cells, but they are voracious predators and possess sticky cells (colloblasts) for capturing prey. Most species are transparent and many exhibit bioluminescence.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037302"}, {"RECTYPE": "D", "MH": "Thyrotropin, beta Subunit", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thyroid Stimulating Hormone, beta Subunit|T116|T125|NON|EQV|NLM (2003)|020128|abbcdef", "ENTRY": "Thyrotropin beta", "MN": "D12.644.548.691.525.883.500", "MH_TH": "NLM (2003)", "ST": "T125", "RN": "0", "PI": "Thyrotropin (1975-2002)", "MS": "The beta subunit of thyroid stimulating hormone, thyrotropin. It is a 112-amino acid glycopolypeptide of about 16 kD. Full biological activity of TSH requires the non-covalently bound heterodimers of an alpha and a beta subunit.", "PM": "2003; THYROTROPIN, BETA SUBUNIT was indexed under THYROTROPIN 1983-2002", "HN": "2003; use THYROTROPIN, BETA SUBUNIT (NM) 1983-2002", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037322"}, {"RECTYPE": "D", "MH": "Fumonisins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fumonisin|T109|T131|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D23.946.587.385", "PA": "Poisons", "MH_TH": "NLM (2003)", "ST": "T131", "RN": "0", "PI": "Mycotoxins (1992-1997)", "MS": "A group of MYCOTOXINS found in CORN contaminated with FUSARIUM fungus. They are chains of about 20 carbons with acidic ester, acetylamino and sometimes other substituents. They inhibit ceramide synthetase conversion of SPHINGOLIPIDS to CERAMIDES.", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037341"}, {"RECTYPE": "D", "MH": "Pertussis Toxin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pertussigen|T116|T126|T131|NON|EQV|UNK (19XX)|850617|abbbcdef", "ENTRY": "Toxin, Pertussis", "MN": "D23.946.896.980.690", "MH_TH": "UNK (19XX)", "ST": "T131", "RN": "EC 2.4.2.31", "PI": "Virulence Factors, Bordetella (1977-2002)", "MS": "One of the virulence factors produced by BORDETELLA PERTUSSIS. It is a multimeric protein composed of five subunits S1 - S5. S1 contains mono ADPribose transferase activity.", "PM": "2003; see PERTUSSIS TOXINS 1986-2002; for PERTUSSIGEN, ISLET-ACTIVATING PROTEIN, IAP PERTUSSIS TOXIN, and HISTAMINE-SENSITIZING FACTOR see PERTUSSIS TOXINS 1986-2002", "HN": "2003; use VIRULENCE FACTORS, BORDETELLA 1986-2002; for PERTUSSIGEN, ISLET-ACTIVATING PROTEIN, IAP PERTUSSIS TOXIN, and HISTAMINE-SENSITIZING FACTOR use VIRULENCE FACTORS, BORDETELLA 1986-2002", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037342"}, {"RECTYPE": "D", "MH": "Adenylate Cyclase Toxin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Toxin, cyaA", "MN": "D23.946.896.980.040", "MH_TH": "UNK (19XX)", "ST": "T131", "RN": "0", "PI": "Virulence Factors, Bordetella (1984-2002)", "MS": "One of the virulence factors produced by virulent BORDETELLA organisms. It is a bifunctional protein with both ADENYLYL CYCLASES and hemolysin components.", "PM": "2003; see PERTUSSIS TOXINS 1986-2002; CYCLOLYSIN was indexed under BACTERIAL PROTEINS and PROTEIN PRECURSORS 1989-2002", "HN": "2003; use VIRULENCE FACTORS, BORDETELLA 1986-2002; for CYCLOLYSIN use ADENYLATE CYCLASE TOXIN (NM) 1989-2002", "MR": "20150713", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037361"}, {"RECTYPE": "D", "MH": "Scyphozoa", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sea Nettle, West Coast|T204|NON|NRW|NLM (2003)|020129|abcdef", "ENTRY": "fuscescens, Chrysaora", "MN": "B01.050.500.308.690", "MH_TH": "UNK (19XX)", "ST": "T204", "RN": "txid6142", "RR": "txid880219", "AN": "do not confuse the genus Aurelia with the species Paramecium aurelia", "PI": "Cnidaria (1971-2002)", "MS": "The class of true jellyfish, in the phylum CNIDARIA. They are mostly free-swimming marine organisms that go through five stages in their life cycle and exhibit two body forms: polyp and medusa.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037401"}, {"RECTYPE": "D", "MH": "Hydrozoa", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Portuguese Man-of-War|T204|NON|NRW|NLM (1998)|961010|abcdef", "ENTRY": "tetraphyllas, Liriope", "MN": "B01.050.500.308.485", "MH_TH": "NLM (1998)", "ST": "T204", "RN": "txid6074", "RR": "txid37524", "AN": "do not confuse entry term LIRIOPE TETRAPHYLLA with LIRIOPE PLANT", "PI": "Cnidaria (1986-2002)", "MS": "A class in the phylum CNIDARIA which alternates between polyp and medusa forms during their life cycle. There are over 2700 species in five orders.", "PM": "2003; see HYDRA 1997-2000, see CNIDARIA 2001-2002; for PHYSALIA & PORTUGESE MAN-OF-WAR see JELLYFISH 1998-2002", "HN": "2003; use HYDRA 1997-2000, use CNIDARIA 2001-2002; for PHYSALIA & PORTUGESE MAN-OF-WAR use CNIDARIA 1998-2002", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037402"}, {"RECTYPE": "D", "MH": "Anthozoa", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Corals|T204|NON|NRW|NLM (1998)|961010|abcdef", "MN": "B01.050.500.308.237", "FX": "Coral Reefs", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6101", "PI": "Cnidaria (1970-2002)", "MS": "A class in the phylum CNIDARIA, comprised mostly of corals and anemones. All members occur only as polyps; the medusa stage is completely absent.", "PM": "2003; for CORALS see CNIDARIA 1998-2002", "HN": "2003; for CORALS use CNIDARIA 1998-2002", "MR": "20210706", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037421"}, {"RECTYPE": "D", "MH": "Sea Nettle, East Coast", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Chrysaora quinquecirrha|T204|NON|EQV|NLM (2003)|020130|abcdef", "ENTRY": "quinquecirrhas, Chrysaora", "MN": "B01.050.500.308.690.750", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6148", "PI": "Cnidaria (1968-2002)", "MS": "Species of jellyfish, in the family Pelagiidae, order Semaeostomeae, class SCYPHOZOA. Their painful sting is caused by a venom toxic to humans.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037441"}, {"RECTYPE": "D", "MH": "Cubozoa", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sea Wasps|T204|NON|EQV|NLM (2003)|020130|abcdef", "ENTRY": "Wasps, Sea", "MN": "B01.050.500.308.361", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6137", "RR": "txid78581", "PI": "Cnidaria (1968-2002)", "MS": "The class of box jellyfish, in the phylum CNIDARIA, characterized by their cube shape, and considered the most venomous jellyfish.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037462"}, {"RECTYPE": "D", "MH": "Galectin 1", "DS": "GALECTIN A 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lectin, L1-Lac", "MN": "D12.776.503.307.100", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Hemagglutinins (1994-2002)", "MS": "A galectin found abundantly in smooth muscle (MUSCLE, SMOOTH) and SKELETAL MUSCLE and many other tissues. It occurs as a homodimer with two 14-kDa subunits.", "PM": "2003; GALECTIN 1 was indexed under HEMAGLUTININS 1994-2002", "HN": "2003; use GALECTIN 1 (NM) 1994-2002", "MR": "20040707", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037483"}, {"RECTYPE": "D", "MH": "Galectin 2", "DS": "GALECTIN A 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lectin 2, Galactoside-Binding", "MN": "D12.776.503.307.200", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Hemagglutinins (1996-2002)", "MS": "A galectin found preferentially expressed in the gastrointestinal tract. The protein occurs as a homodimer with two 14-kDa subunits.", "PM": "2003; GALECTIN 2 was indexed under HEMAGGLUTININS 1996-2002", "HN": "2003; use GALECTIN 2 (NM) 1996-2002", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037501"}, {"RECTYPE": "D", "MH": "Galectin 3", "DS": "GALECTIN A 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mac-2 Antigen|T116|T129|ACX|EQV|NLM (2003)|MAC ANTIGEN 02|abbcdes", "ENTRY": "Protein, IgE Binding", "MN": "D12.776.503.307.300", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "MS": "A multifunctional galactin initially discovered as a macrophage antigen that binds to IMMUNOGLOBULIN E, and as 29-35-kDa lectin that binds LAMININ. It is involved in a variety of biological events including interactions with galactose-containing glycoconjugates, cell proliferation, CELL DIFFERENTIATION, and APOPTOSIS.", "PM": "2003; MAC-2 ANTIGEN (now GALECTIN 3 ) was indexed under ANTIGENS, DIFFERENTIATION 1994-2002", "HN": "2003; use GALECTIN 3 (NM) 1994-2002", "MR": "20040707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037502"}, {"RECTYPE": "D", "MH": "Virulence Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Virulence Factor|T109|T123|T131|NON|EQV|NLM (2021)|191114|abbbcdef", "ENTRY": "Factors, Virulence", "MN": "D23.946.896", "FX": "Virulence", "MH_TH": "NLM (2003)", "ST": "T131", "RN": "0", "AN": "coord with specific factors if pertinent", "PI": "Virulence (1967-2002)", "MS": "Those components of an organism that determine its capacity to cause disease but are not required for its viability per se. Two classes have been characterized: TOXINS, BIOLOGICAL and surface adhesion molecules that effect the ability of the microorganism to invade and colonize a host. (From Davis et al., Microbiology, 4th ed. p486)", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037521"}, {"RECTYPE": "D", "MH": "Galectin 4", "DS": "GALECTIN A 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lectin, L-36 Lactose-Binding", "MN": "D12.776.503.307.400", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Hemagglutinins (1984-2002)", "MS": "A galectin found in the small and large intestine and the stomach. It occurs as a homodimer with two 36-kDa subunits and is localized to sites of cell adhesion where it may play role in assembly of ADHERENS JUNCTIONS.", "PM": "2003; LACTOSE-BINDING AGGLUTINATION FACTOR was indexed under HEMAGGLUTININS 1984-2002", "HN": "2003; use GALECTIN 4 (NM) 1984-2002", "MR": "20040707", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037541"}, {"RECTYPE": "D", "MH": "Immunoconglutinins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Conglutinins, Immune", "MN": "D12.776.377.715.548.114.323.390", "PA": "Immunologic Factors", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "PI": "Immunoglobulins (1981-2002)", "MS": "Autoantibodies directed against newly-formed EPITOPES created as the COMPLEMENT cascade is activated and the proteins involved change their conformations.", "PM": "2003; IMMUNOCONGLUTININS was indexed under IMMUNGLOBULINS 1981-2002", "HN": "2003; use IMMUNOCONGLUTININS (NM) 1981-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037561"}, {"RECTYPE": "D", "MH": "Complement Pathway, Mannose-Binding Lectin", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Mannose-Binding Lectin Complement Pathway|T044|NON|EQV|NLM (2003)|020201|abcdef", "ENTRY": "Pathways, Mannan-Binding Lectin (Complement Activation)", "MN": "G12.274.849", "FX": "Mannose-Binding Lectin", "MH_TH": "NLM (2003)", "ST": "T044", "PI": "Complement Activation (1989-2002)", "MS": "Complement activation triggered by the interaction of microbial POLYSACCHARIDES with serum MANNOSE-BINDING LECTIN resulting in the activation of MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES. As in the classical pathway, MASPs cleave COMPLEMENT C4 and COMPLEMENT C2 to form C3 CONVERTASE (C4B2A) and the subsequent C5 CONVERTASE (C4B2A3B) leading to cleavage of COMPLEMENT C5 and assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX.", "PM": "2003", "HN": "2003", "MR": "20160623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037582"}, {"RECTYPE": "D", "MH": "Mannose-Binding Lectin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mannose Binding Protein", "MN": "D12.776.503.311.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "MANNOSE-BINDING LECTINS is also available; see SCR for species specific terms; analogs & homologs are not MANNOSE-BINDING LECTINS", "PI": "Carrier Proteins (1990-2002)", "MS": "A specific mannose-binding member of the collectin family of lectins. It binds to carbohydrate groups on invading pathogens and plays a key role in the MANNOSE-BINDING LECTIN COMPLEMENT PATHWAY.", "PM": "2003; MANNOSE-BINDING LECTIN, MANNAN-BINDING PROTEIN & MANNAN-BINDING LECTIN were indexed under CARRIER PROTEINS 1990-2002", "HN": "2003; for MANNOSE-BINDING LECTIN, MANNAN-BINDING PROTEIN & MANNAN-BINDING LECTIN use COLLECTINS 1990-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037601"}, {"RECTYPE": "D", "MH": "Isodon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "rubescens, Rabdosia", "MN": "B01.875.800.575.912.250.583.520.362", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid204130", "RR": "txid587669", "MS": "A plant genus of the family LAMIACEAE used in TRADITIONAL CHINESE MEDICINE.", "PM": "2003; for RABDOSIA see RABDOSIA 2003-2014", "HN": "2003; for RABDOSIA see RABDOSIA 2003-2014", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037602"}, {"RECTYPE": "D", "MH": "Artemisinins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.849.765.211", "PA": "Antimalarials", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "PI": "Sesquiterpenes (1982-2002)", "MS": "A group of SESQUITERPENES and their analogs that contain a peroxide group (PEROXIDES) within an oxepin ring (OXEPINS).", "PM": "2003", "HN": "2003", "MR": "20230320", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037621"}, {"RECTYPE": "D", "MH": "Pulmonary Surfactant-Associated Proteins", "DE": "PULMONARY SURFACTANT ASSOC PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Surfactant-Associated Proteolipid, Pulmonary", "MN": "D12.776.823", "PA": "Pulmonary Surfactants", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Pulmonary Surfactants (1981-2002)", "MS": "Proteins found in the LUNG that act as PULMONARY SURFACTANTS.", "PM": "2003; PULMONARY SURFACTANT-ASSOCIATED PROTEIN (now PULMONARY SURFACTANT-ASSOCIATED PROTEINS) was indexed under PROTEOLIPIDS & PULMONARY SURFACTANTS 1981-2002", "HN": "2003; use PULMONARY SURFACTANT-ASSOCIATED PROTEINS (NM) 1981-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037661"}, {"RECTYPE": "D", "MH": "Pulmonary Surfactant-Associated Protein A", "DE": "PULMONARY SURFACTANT ASSOC PROTEIN A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SP A Protein", "MN": "D12.776.823.100", "PA": "Pulmonary Surfactants", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Pulmonary Surfactants (1991-2002)", "MS": "An abundant pulmonary surfactant-associated protein that binds to a variety of lung pathogens, resulting in their opsinization. It also stimulates MACROPHAGES to undergo PHAGOCYTOSIS of microorganisms. Surfactant protein A contains a N-terminal collagen-like domain and a C-terminal lectin domain that are characteristic of members of the collectin family of proteins.", "PM": "2003; SURFACTANT PROTEIN A & SP-A PROTEIN was indexed under PROTEOLIPIDS & PULMONARY SURFACTANTS 1991-2002", "HN": "2003; for SURFACTANT PROTEIN A & SP-A PROTEIN use PULMONARY SURFACTANT-ASSOCIATED PROTEINS (NM) 1991-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037662"}, {"RECTYPE": "D", "MH": "Pulmonary Surfactant-Associated Protein D", "DE": "PULMONARY SURFACTANT ASSOC PROTEIN D", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Surfactant Protein D|T116|T123|NON|EQV|NLM (2003)|abbcde", "ENTRY": "Surfactant Associated Glycoprotein D", "MN": "D12.776.823.249", "PA": "Pulmonary Surfactants", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Glycoproteins (1990-2002)", "MS": "An abundant pulmonary surfactant-associated protein that binds to a variety of lung pathogens and enhances their opsinization and killing by phagocytic cells. Surfactant protein D contains a N-terminal collagen-like domain and a C-terminal lectin domain that are characteristic of members of the collectin family of proteins.", "PM": "2003; SURFACTANT PROTEIN D (now PULMONARY SURFACTANT-ASSOCIATED PROTEIN D) was indexed under GLYCOPROTEINS 1990-2002", "HN": "2003(1990)", "MR": "20210304", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037663"}, {"RECTYPE": "D", "MH": "Pulmonary Surfactant-Associated Protein B", "DE": "PULMONARY SURFACTANT ASSOC PROTEIN B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pulmonary Surfactant-Associated Protein SP-B|T116|T123|NON|EQV|NLM (2003)|PULMONARY SURFACTANT ASSOC PROTEIN SP B|abbcdev", "ENTRY": "Surfactant Protein SP B", "MN": "D12.776.823.124", "PA": "Pulmonary Surfactants", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Pulmonary Surfactants (1989-2002)", "MS": "A pulmonary surfactant associated-protein that plays an essential role in alveolar stability by lowering the surface tension at the air-liquid interface. Inherited deficiency of pulmonary surfactant-associated protein B is one cause of RESPIRATORY DISTRESS SYNDROME, NEWBORN.", "PM": "2003; PULMONARY SURFACTANT ASSOCIATED PROTEIN SP-B (now PULMONARY SURFACTANT-ASSOCIATED PROTEIN B) was indexed under PROTEOLIPIDS & PULMONARY SURFACTANTS 1989-2002", "HN": "2003; use PULMONARY SURFACTANT-ASSOCIATED PROTEIN B (NM) 1989-2002", "MR": "20050728", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037701"}, {"RECTYPE": "D", "MH": "Pulmonary Surfactant-Associated Protein C", "DE": "PULMONARY SURFACTANT ASSOC PROTEIN C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pulmonary Surfactant-Associated Protein SP-C|T116|T123|ACX|EQV|NLM (2003)|PULMONARY SURFACTANT ASSOC PROTEIN SP C|abbcdev", "ENTRY": "Surfactant Polypeptide SP C", "MN": "D12.776.823.186", "PA": "Pulmonary Surfactants", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Pulmonary Surfactants (1990-2002)", "MS": "A pulmonary surfactant associated protein that plays a role in alveolar stability by lowering the surface tension at the air-liquid interface. It is a membrane-bound protein that constitutes 1-2% of the pulmonary surfactant mass. Pulmonary surfactant-associated protein C is one of the most hydrophobic peptides yet isolated and contains an alpha-helical domain with a central poly-valine segment that binds to phospholipid bilayers.", "PM": "2003; PULMONARY SURFACTANT ASSOCIATED-PROTEIN SP-C (now PULMONARY SURFACTANT-ASSOCIATED PROTEIN C) was indexed under PROTEOLIPIDS & PULMONARY SURFACTANTS 1990-2002", "HN": "2003; use PULMONARY SURFACTANT-ASSOCIATED PROTEIN C (NM) 1990-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037721"}, {"RECTYPE": "D", "MH": "Fullerenes", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Buckyballs|T104|NON|EQV|NLM (2003)|020205|abcdef", "ENTRY": "Fullerene", "MN": "J01.637.512.600.612.350", "MH_TH": "NLM (2003)", "ST": "T104", "RN": "0", "PI": "Carbon (1991-2002)", "MS": "A polyhedral CARBON structure composed of around 60-80 carbon atoms in pentagon and hexagon configuration. They are named after Buckminster Fuller because of structural resemblance to geodesic domes. Fullerenes can be made in high temperature such as arc discharge in an inert atmosphere.", "PM": "2003", "HN": "2003", "MR": "20070709", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037741"}, {"RECTYPE": "D", "MH": "Nanotubes, Carbon", "AQ": "AE AN CH CL EC HI MI PO PS RE SD SN ST TO UL VI", "PRINT ENTRY": "Nanoribbons|T073|NON|NRW|NLM (2011)|100407|abcdef", "ENTRY": "Nanotube, Carbon", "MN": "J01.637.512.850.500", "MH_TH": "NLM (2003)", "ST": "T104", "RN": "0", "PI": "Carbon (1996-2002)", "MS": "Nanometer-sized tubes composed mainly of CARBON. Such nanotubes are used as probes for high-resolution structural and chemical imaging of biomolecules with ATOMIC FORCE MICROSCOPY.", "PM": "2003", "HN": "2003", "MR": "20130709", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037742"}, {"RECTYPE": "D", "MH": "Sirtuins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sirtuin|T116|T126|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Sir2 like Proteins", "MN": "D12.776.476.900", "FX": "Silent Information Regulator Proteins, Saccharomyces cerevisiae", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 3.5.1.-", "PI": "Histone Deacetylase (2000-2002)", "MS": "A homologous family of regulatory enzymes that are structurally related to the protein silent mating type information regulator 2 (Sir2) found in Saccharomyces cerevisiae. Sirtuins contain a central catalytic core region which binds NAD. Several of the sirtuins utilize NAD to deacetylate proteins such as HISTONES and are categorized as GROUP III HISTONE DEACETYLASES. Several other sirtuin members utilize NAD to transfer ADP-RIBOSE to proteins and are categorized as MONO ADP-RIBOSE TRANSFERASES, while a third group of sirtuins appears to have both deacetylase and ADP ribose transferase activities.", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037761"}, {"RECTYPE": "D", "MH": "Hammer Toe Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mallet Toe|T190|NON|NRW|NLM (2003)|020206|abcdef", "ENTRY": "Toes, Mallet", "MN": "C05.330.615", "MH_TH": "NLM (2003)", "ST": "T190", "PI": "Toes/abnormalities (1966-2002)", "MS": "A condition characterized by a series of interrelated digital symptoms and joint changes of the lesser digits and METATARSOPHALANGEAL JOINTS of the FOOT. The syndrome can include some or all of the following conditions: hammer toe, claw toe, mallet toe, overlapping fifth toe, curly toe, EXOSTOSIS; HYPEROSTOSIS; interdigital heloma, or contracted toe.", "PM": "2003", "HN": "2003", "MR": "20160226", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037801"}, {"RECTYPE": "D", "MH": "Casearia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Casearias", "MN": "B01.875.800.575.912.250.859.797.875.250", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid112816", "MS": "A plant genus of the family SALICACEAE. Members contain casearins which are clerodane-type DITERPENES.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037821"}, {"RECTYPE": "D", "MH": "Pregnant Women", "DE": "PREGN WOMEN", "AQ": "ED EH PX", "PRINT ENTRY": "Women, Pregnant|T098|T101|NON|EQV|UNK (19XX)|770317|WOMEN PREGN|abbcdefv", "ENTRY": "Woman, Pregnant", "MN": "M01.975.807", "FX": "Pregnancy", "MH_TH": "BIOETHICS (1974)", "ST": "T101", "AN": "IM as psychological or social entity; /educ consider also PRENATAL EDUCATION", "PI": "Pregnancy (1966-2002)", "MS": "Human females who are pregnant, as cultural, psychological, or sociological entities.", "PM": "2003", "HN": "2003", "MR": "20180630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037841"}, {"RECTYPE": "D", "MH": "Aborted Fetus", "AQ": "AB AH BS CH CY DE DG EM EN IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Fetus, Aborted|T018|NON|EQV|NLM (2003)|020304|abcdef", "ENTRY": "Fetuses, Aborted", "MN": "A16.378.099", "FX": "Abortion, Spontaneous", "MH_TH": "NLM (2003)", "ST": "T018", "PI": "Fetus (1968-2002)", "MS": "A mammalian fetus expelled by INDUCED ABORTION or SPONTANEOUS ABORTION.", "PM": "2003; see FETUS 1978-2002", "HN": "2003; use FETUS 1978-2002", "MR": "20160601", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037881"}, {"RECTYPE": "D", "MH": "Euthanasia, Animal", "AQ": "ES HI LJ MT SN", "PRINT ENTRY": "Animal Euthanasia|T058|NON|EQV|NLM (2003)|020304|abcdef", "ENTRY": "Animal Mercy Killing", "MN": "N02.421.585.905.199.500.750", "FX": "Animal Welfare", "MH_TH": "NLM (2003)", "ST": "T058", "AN": "methods of \"sacrificing\" animals go here if the topic of discussion; for euthanasia of laboratory animals, coordinate with ANIMALS, LABORATORY", "MS": "The killing of animals for reasons of mercy, to control disease transmission or maintain the health of animal populations, or for experimental purposes (ANIMAL EXPERIMENTATION).", "PM": "2003", "HN": "2003", "MR": "20150629", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D037901"}, {"RECTYPE": "D", "MH": "Gift Giving", "AQ": "ES", "PRINT ENTRY": "Gifts, Financial|T071|NON|REL|UNK (19XX)|770505|abcdef", "ENTRY": "Gift, Financial", "MN": "F01.145.813.208", "FX": "Fund Raising", "MH_TH": "NLM (2003)", "ST": "T054", "MS": "The bestowing of tangible or intangible benefits, voluntarily and usually without expectation of anything in return. However, gift giving may be motivated by feelings of ALTRUISM or gratitude, by a sense of obligation, or by the hope of receiving something in return.", "PM": "2003; for GIFTS, FINANCIAL see FUND RAISING 1978-2002", "HN": "2003; for GIFTS, FINANCIAL use FUND RAISING 1978-2002", "MR": "20021031", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037921"}, {"RECTYPE": "D", "MH": "Silencer Elements, Transcriptional", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Transcriptional Silencer Elements|T114|T123|NON|EQV|NLM (2003)|020214|abbcdef", "ENTRY": "Transcriptional Silencer Element", "MN": "G05.360.340.024.815", "MH_TH": "NLM (2003)", "ST": "T123", "MS": "Nucleic acid sequences that are involved in the negative regulation of GENETIC TRANSCRIPTION by chromatin silencing.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037941"}, {"RECTYPE": "D", "MH": "Frullania", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Frullanias", "MN": "B01.875.800.575.462.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid95763", "MS": "A plant genus of the family Jubulaceae, subclass JUNGERMANNIAE. Members contain eudesmane-type sesquiterpene lactones and cause CONTACT DERMATITIS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037961"}, {"RECTYPE": "D", "MH": "Neck Dissection", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Radical Neck Dissection|T061|NON|NRW|NLM (1965)|990101|abcdef", "ENTRY": "Radical Neck Dissections", "MN": "E04.580.411", "MH_TH": "NLM (2003)", "ST": "T061", "PI": "Radical Neck Dissection (1965-2002)", "MS": "Dissection in the neck to remove all disease tissues including cervical LYMPH NODES and to leave an adequate margin of normal tissue. This type of surgery is usually used in tumors or cervical metastases in the head and neck. The prototype of neck dissection is the radical neck dissection described by Crile in 1906.", "PM": "2003; for RADICAL NECK DISSECTION see RADICAL NECK DISSECTION 1965-2002", "HN": "2003; for RADICAL NECK DISSECTION use RADICAL NECK DISSECTION 1965-2002", "MR": "20070709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D037981"}, {"RECTYPE": "D", "MH": "Lymphopoiesis", "AQ": "DE ES GE IM PH RE", "MN": "G09.188.343.597.500", "MH_TH": "NLM (2003)", "ST": "T042", "PI": "Lymphocytes (1965-2002)", "MS": "Formation of LYMPHOCYTES and PLASMA CELLS from the lymphoid stem cells which develop from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW. These lymphoid stem cells differentiate into T-LYMPHOCYTES; B-LYMPHOCYTES; PLASMA CELLS; or NK-cells (KILLER CELLS, NATURAL) depending on the organ or tissues (LYMPHOID TISSUE) to which they migrate.", "PM": "2003", "HN": "2003", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038041"}, {"RECTYPE": "D", "MH": "Myelopoiesis", "AQ": "DE ES GE IM PH RE", "MN": "G09.188.343.597.750", "MH_TH": "NLM (1998)", "ST": "T042", "PI": "Leukopoiesis (1998-2002)", "MS": "Formation of MYELOID CELLS from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW via MYELOID STEM CELLS. Myelopoiesis generally refers to the production of leukocytes in blood, such as MONOCYTES and GRANULOCYTES. This process also produces precursor cells for MACROPHAGE and DENDRITIC CELLS found in the lymphoid tissue.", "PM": "2003; see LEUKOPOIESIS 1998-2002", "HN": "2003; use LEUKOPOIESIS 1998-2002", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038042"}, {"RECTYPE": "D", "MH": "Lower Extremity Deformities, Congenital", "DE": "LOWER EXTREMITY DEFORMITIES CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lower Limb Deformities, Congenital|T019|NON|EQV|NLM (2003)|020212|LOWER LIMB DEFORMITIES CONGEN|abcdefv", "MN": "C16.131.621.585.512", "MH_TH": "NLM (2003)", "ST": "T019", "MS": "Congenital structural abnormalities of the LOWER EXTREMITY.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038061"}, {"RECTYPE": "D", "MH": "Upper Extremity Deformities, Congenital", "DE": "UPPER EXTREMITY DEFORMITES CONGEN", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Upper Limb Deformities, Congenital|T019|NON|EQV|NLM (2003)|020212|UPPER LIMB DEFORMITIES CONGEN|abcdefv", "MN": "C16.131.621.585.988", "MH_TH": "NLM (2003)", "ST": "T019", "MS": "Congenital structural abnormalities of the UPPER EXTREMITY.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038062"}, {"RECTYPE": "D", "MH": "Organogenesis", "AQ": "DE GE IM PH RE", "MN": "G08.686.784.170.450", "MH_TH": "NLM (1995)", "ST": "T038", "AN": "human and animal; mammalian and non-mammalian; coord with specific organ/embryol", "PI": "Pregnancy (1965-2002)", "MS": "Formation of differentiated cells and complicated tissue organization to provide specialized functions.", "PM": "2003; see FETAL DEVELOPMENT 1995-2002", "HN": "2003; use FETAL DEVELOPMENT 1995-2002", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038081"}, {"RECTYPE": "D", "MH": "Insulator Elements", "AQ": "DE ES GE IM PH RE", "ENTRY": "Insulator Element", "MN": "G05.360.340.024.420", "MH_TH": "NLM (2003)", "ST": "T123", "MS": "Nucleic acid regulatory sequences that limit or oppose the action of ENHANCER ELEMENTS and define the boundary between differentially regulated gene loci.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038101"}, {"RECTYPE": "D", "MH": "Inula", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pushkarmula|T002|NON|NRW|NLM (2003)|abcde", "ENTRY": "Pushkarmulas", "MN": "B01.875.800.575.912.250.100.471", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid41589", "RR": "txid55635", "MS": "A plant genus of the family ASTERACEAE. Members contain INULIN, alantol, helenin, alantic acid, and acrid resin.", "PM": "2003; INULA RACEMOSA was indexed under INULIN 1983-2002", "HN": "2003; for INULA RACEMOSA use INULA (NM) 1983-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038143"}, {"RECTYPE": "D", "MH": "Snow Sports", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Sports, Snow", "MN": "I03.450.642.845.787", "MH_TH": "NLM (2003)", "ST": "T056", "AN": "/inj: coord with specific injury (IM)", "PI": "Skiing (1963-2002)", "MS": "Sports activities in the snow.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038161"}, {"RECTYPE": "D", "MH": "FMN Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NAD(P)H-Flavin Oxidoreductase|T116|T126|ACX|EQV|NLM (2003)|abbcde", "ENTRY": "Reductase, NADPH-Flavin", "MN": "D08.811.682.662.171", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.5.1.38", "RR": "EC 1.5.1.41", "PI": "NADH, NADPH Oxidoreductases (1981-2002)", "MS": "An enzyme that utilizes NADH or NADPH to reduce FLAVINS. It is involved in a number of biological processes that require reduced flavin for their functions such as bacterial bioluminescence. Formerly listed as EC 1.6.8.1 and EC 1.5.1.29.", "PM": "2006; see FLAVIN MONONUCLEOTIDE REDUCTASE 2003-2005; FLAVIN MONONUCLEOTIDE REDUCTASE(now FMN REDUCTASE) was indexed under NADH, NADPH OXIDOREDUCTASES 1981-2002 & under FMN 1975-1980", "HN": "2006(1975)", "MR": "20130708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038181"}, {"RECTYPE": "D", "MH": "alpha-Crystallins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Crystallins, alpha|T116|T123|NON|EQV|NLM (2003)|020227|abbcdef", "ENTRY": "alpha Crystallins", "MN": "D12.776.580.157", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Crystallins (1965-2002)", "MS": "A subclass of crystallins that provides the majority of refractive power and translucency to the lens (LENS, CRYSTALLINE) in VERTEBRATES. Alpha-crystallins also act as molecular chaperones that bind to denatured proteins, keep them in solution and thereby maintain the translucency of the lens. The proteins exist as large oligomers that are formed from ALPHA-CRYSTALLIN A CHAIN and ALPHA-CRYSTALLIN B CHAIN subunits.", "PM": "2003; for ALPHA-CRYSTALLIN see CRYSTALLINS 1982-2002", "HN": "2003; for ALPHA-CRYSTALLIN use CRYSTALLINS 1982-2002", "MR": "20050630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038201"}, {"RECTYPE": "D", "MH": "alpha-Crystallin A Chain", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha A-Crystallin|T116|T123|NON|EQV|UNK (19XX)|840919|abbcdef", "ENTRY": "alpha Crystallin, A Subunit", "MN": "D12.776.580.157.149", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Crystallins (1984-2002)", "MS": "One of the subunits of alpha-crystallins. Unlike ALPHA-CRYSTALLIN B CHAIN the expression of ALPHA-CRYSTALLIN A CHAIN is limited primarily to the lens (LENS, CRYSTALLINE).", "PM": "2003; for ALPHA A-CRYSTALLIN see CRYSTALLINS 1986-2002", "HN": "2003; for ALPHA A-CRYSTALLIN use CRYSTALLINS 1986-2002", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038202"}, {"RECTYPE": "D", "MH": "alpha-Crystallin B Chain", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha B-Crystallin|T116|T123|NON|EQV|NLM (1998)|970113|abbcdef", "ENTRY": "alpha Crystallin, B Subunit", "MN": "D12.776.580.157.300", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Crystallins (1985-2002)", "MS": "One of the alpha crystallin subunits. In addition to being expressed in the lens (LENS, CRYSTALLINE), alpha-crystallin B chain has been found in a variety of tissues such as HEART; BRAIN; MUSCLE; and KIDNEY. Accumulation of the protein in the brain is associated with NEURODEGENERATIVE DISEASES such as CREUTZFELDT-JAKOB SYNDROME and ALEXANDER DISEASE.", "PM": "2003; for ALPHA B-CRYSTALLIN see CRYSTALLINS 1998-2002", "HN": "2003; for ALPHA B-CRYSTALLIN use CRYSTALLINS 1998-2002", "MR": "20050715", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038203"}, {"RECTYPE": "D", "MH": "beta-Crystallins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Crystallins, beta|T116|T123|NON|EQV|NLM (2003)|020227|abbcdef", "ENTRY": "beta Crystallins", "MN": "D12.776.306.366.300", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Crystallins (1966-2002)", "MS": "A class of crystallins that provides refractive power and translucency to the lens (LENS, CRYSTALLINE) in VERTEBRATES. Beta-crystallins are similar in structure to GAMMA-CRYSTALLINS in that they both contain Greek key motifs. Beta-crystallins exist as oligomers formed from acidic (BETA-CRYSTALLIN A CHAIN) and basic (BETA-CRYSTALLIN B CHAIN) subunits.", "PM": "2003; for BETA-CRYSTALLIN see CRYSTALLINS 1982-2002", "HN": "2003; for BETA-CRYSTALLIN use CRYSTALLINS 1982-2002", "MR": "20050630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038204"}, {"RECTYPE": "D", "MH": "beta-Crystallin A Chain", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta A-Crystallin|T116|T123|NON|EQV|NLM (2003)|020222|abbcdef", "ENTRY": "beta Crystallin, A Subunit", "MN": "D12.776.306.366.300.100", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Crystallins (1984-2002)", "MS": "The acidic subunit of beta-crystallins.", "PM": "2003", "HN": "2003", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038205"}, {"RECTYPE": "D", "MH": "beta-Crystallin B Chain", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta B-Crystallin|T116|T123|NON|EQV|NLM (2003)|020222|abbcdef", "ENTRY": "beta Crystallin B Chain", "MN": "D12.776.306.366.300.200", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Crystallins (1978-2002)", "MS": "The basic subunit of beta-crystallins.", "PM": "2003; for BETA-CRYSTALLIN BASIC PRINCIPAL POLYPEPTIDE see CRYSTALLINS 1990-2002", "HN": "2003; for BETA-CRYSTALLIN BASIC PRINCIPAL POLYPEPTIDE use CRYSTALLINS 1990-2002", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038206"}, {"RECTYPE": "D", "MH": "delta-Crystallins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Crystallins, delta|T116|T123|NON|EQV|NLM (2003)|020227|abbcdef", "ENTRY": "delta Crystallins", "MN": "D12.776.306.366.310", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Crystallins (1973-2002)", "MS": "A subclass of crystallins found in the lens (LENS, CRYSTALLINE) in BIRDS and REPTILES. They are inactive forms of the enzyme argininosuccinate lyase.", "PM": "2003; for DELTA-CRYSTALLIN see CRYSTALLINS 1981-2002", "HN": "2003; for DELTA-CRYSTALLIN use CRYSTALLINS 1981-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038207"}, {"RECTYPE": "D", "MH": "epsilon-Crystallins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Crystallins, epsilon|T116|T123|NON|EQV|NLM (2003)|020227|abbcdef", "ENTRY": "epsilon Crystallins", "MN": "D12.776.306.366.350", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Crystallins (1982-2002)", "MS": "A group of crystallins that have been found in the lens (LENS, CRYSTALLINE) of DUCKS and CROCODILES. They are inactivated forms of the B chain subunit of lactate dehydrogenase.", "PM": "2003; for EPSILON-CRYSTALLIN see CRYSTALLIN 1988-2002", "HN": "2003; for EPSILON-CRYSTALLIN use CRYSTALLIN 1988-2002", "MR": "20050718", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038221"}, {"RECTYPE": "D", "MH": "gamma-Crystallins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Crystallins, gamma|T116|T123|NON|EQV|NLM (2003)|020227|abbcdef", "ENTRY": "gamma Crystallins", "MN": "D12.776.306.366.850", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Crystallins (1968-2002)", "MS": "A subclass of crystallins that found in the lens (LENS, CRYSTALLINE) of VERTEBRATES. Gamma-crystallins are similar in structure to BETA-CRYSTALLINS in that they both form into a Greek key-like structure. They are composed of monomeric subunits.", "PM": "2003; for GAMMA-CRYSTALLIN see CRYSTALLINS 1983-2002", "HN": "2003; for GAMMA-CRYSTALLIN use CRYSTALLINS 1983-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038222"}, {"RECTYPE": "D", "MH": "Post-Concussion Syndrome", "DS": "POSTCONCUSSION SYNDROME", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Post-Concussive Syndrome|T047|NON|EQV|NLM (2000)|991012|POSTCONCUSSIVE SYNDROME|abcdefs", "ENTRY": "Post-Concussive Syndromes, Chronic", "MN": "C26.974.382.200.500", "MH_TH": "NLM (2003)", "ST": "T047", "PI": "Brain Injury, Chronic (2000-2002)", "MS": "The organic and psychogenic disturbances observed after closed head injuries (HEAD INJURIES, CLOSED). Post-concussion syndrome includes subjective physical complaints (i.e. headache, dizziness), cognitive, emotional, and behavioral changes. These disturbances can be chronic, permanent, or late emerging.", "PM": "2003; see BRAIN INJURY, CHRONIC 2001-2002", "HN": "2003; use BRAIN INJURY, CHRONIC 2001-2002", "MR": "20160225", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038223"}, {"RECTYPE": "D", "MH": "omega-Crystallins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Crystallins, omega|T116|T123|NON|EQV|NLM (2003)|020227|abbcdef", "ENTRY": "omega Crystallins", "MN": "D12.776.306.366.925", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Crystallins (1988-2002)", "MS": "A type of crystallin that has been found in the lens (LENS, CRYSTALLINE) of certain species of MOLLUSCA such as SQUID and OCTOPUS. It is an inactivated form of aldehyde dehydrogenase.", "PM": "2003; for OMEGA-CRYSTALLIN see CRYSTALLINS 1998-2002", "HN": "2003; for OMEGA-CRYSTALLIN use CRYSTALLINS 1998-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038224"}, {"RECTYPE": "D", "MH": "tau-Crystallins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tau-Crystallin|T116|T123|NON|EQV|UNK (19XX)|991012|abbcdef", "ENTRY": "tau Crystallins", "MN": "D12.776.306.366.962", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Crystallins (1985-2002)", "MS": "A type of crystallin that has been found in the lens (LENS, CRYSTALLINE) of certain species of VERTEBRATES. They are inactivated form of PHOSPHOPYRUVATE HYDRATASE.", "PM": "2003; for TAU-CRYSTALLIN see CRYSTALLINS 2001-2002", "HN": "2003; for TAU-CRYSTALLIN use CRYSTALLINS 2001-2002", "MR": "20050718", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038225"}, {"RECTYPE": "D", "MH": "zeta-Crystallins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Crystallins, zeta|T116|T123|NON|EQV|NLM (2003)|020227|abbcdef", "ENTRY": "zeta Crystallins", "MN": "D12.776.306.366.981", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Crystallins (1987-2002)", "MS": "A group of crystallins that have been found in the lens (LENS, CRYSTALLINE) of certain species of VERTEBRATES including GUINEA PIGS; CAMELS; and LLAMAS. They are inactivated forms of NAD(P)H DEHYDROGENASE (QUINONE).", "PM": "2003; for ZETA-CRYSTALLIN see CRYSTALLINS 1989-2002; ZETA-CRYSTALLIN-NADPH OXIDOREDUCTASE was indexed under CRYSTALLINS & NAD(P)H DEHYDROGENASE (QUINONE) 1997-2002", "HN": "2003; for ZETA-CRYSTALLIN use CRYSTALLINS 1989-2002; for ZETA-CRYSTALLIN-NADPH OXIDOREDUCTASE use ZETA-CRYSTALLINS (NM) 1997-2002", "MR": "20050715", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038226"}, {"RECTYPE": "D", "MH": "Alexander Disease", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Alexanders Disease", "MN": "C18.452.648.189.362.312", "FX": "Glial Fibrillary Acidic Protein", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Rare leukoencephalopathy with infantile-onset accumulation of Rosenthal fibers in the subpial, periventricular, and subependymal zones of the brain. Rosenthal fibers are GLIAL FIBRILLARY ACIDIC PROTEIN aggregates found in ASTROCYTES. Juvenile- and adult-onset types show progressive atrophy of the lower brainstem instead. De novo mutations in the GFAP gene are associated with the disease with propensity for paternal inheritance.", "PM": "2003", "HN": "2003", "MR": "20130708", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038261"}, {"RECTYPE": "D", "MH": "Auditory Brain Stem Implants", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Brain Stem Implants, Auditory|T074|NON|EQV|NLM (2003)|020417|abcdef", "ENTRY": "Implants, Auditory Brainstem", "MN": "E07.814.458.074", "FX": "Auditory Brain Stem Implantation", "MH_TH": "NLM (2003)", "ST": "T074", "PI": "Cochlear Implants (1992-2002)", "MS": "Multi-channel hearing devices typically used for patients who have tumors on the COCHLEAR NERVE and are unable to benefit from COCHLEAR IMPLANTS after tumor surgery that severs the cochlear nerve. The device electrically stimulates the nerves of cochlea nucleus in the BRAIN STEM rather than the inner ear as in cochlear implants.", "PM": "2003", "HN": "2003", "MR": "20100625", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038262"}, {"RECTYPE": "D", "MH": "Auditory Brain Stem Implantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Implantation, Auditory Brainstem", "MN": "E04.650.155", "FX": "Auditory Brain Stem Implants", "MH_TH": "NLM (2003)", "ST": "T061", "PI": "Cochlear Implantation (1992-2002)", "MS": "Surgical insertion of an electronic hearing device (AUDITORY BRAIN STEM IMPLANTS) with electrodes to the cochlea nucleus in the BRAIN STEM rather than to the inner ear as in COCHLEAR IMPLANTATION.", "PM": "2003", "HN": "2003", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038263"}, {"RECTYPE": "D", "MH": "Silent Information Regulator Proteins, Saccharomyces cerevisiae", "DE": "SILENT INFORMATION REGULAT PROTEINS SACCH CEREV", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SIR Proteins, S cerevisiae|T116|T123|ACX|EQV|NLM (2003)|020226|SIR PROTEINS SACCH CEREV|abbcdefv", "ENTRY": "Silent Mating Type Information Regulator Protein, S cerevisiae|T116|T123|NON|NRW|NLM (2003)|020226|SILENT MATING TYPE INFORMATION REGULAT PROTEIN SACCH CEREV|abbcdefv", "MN": "D12.776.660.820", "FX": "Sirtuins", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "A set of nuclear proteins in SACCHAROMYCES CEREVISIAE that are required for the transcriptional repression of the silent mating type loci. They mediate the formation of silenced CHROMATIN and repress both transcription and recombination at other loci as well. They are comprised of 4 non-homologous, interacting proteins, Sir1p, Sir2p, Sir3p, and Sir4p. Sir2p, an NAD-dependent HISTONE DEACETYLASE, is the founding member of the family of SIRTUINS.", "PM": "2003", "HN": "2003", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038281"}, {"RECTYPE": "D", "MH": "Virus Inactivation", "AQ": "DE ES RE", "PRINT ENTRY": "Viral Inactivation|T059|NON|EQV|NLM (2003)|020227|abcdef", "ENTRY": "Inactivation, Virus", "MN": "G06.920.872", "FX": "Antiviral Agents", "MH_TH": "NLM (2003)", "ST": "T059", "MS": "Inactivation of viruses by non-immune related techniques. They include extremes of pH, HEAT treatment, ultraviolet radiation, IONIZING RADIATION; DESICCATION; ANTISEPTICS; DISINFECTANTS; organic solvents, and DETERGENTS.", "PM": "2003", "HN": "2003", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038301"}, {"RECTYPE": "D", "MH": "Glycemic Index", "AQ": "DE EH GE IM PH RE", "ENTRY": "Glycemic Indices", "MN": "N06.850.601.750.500", "FX": "Blood Glucose", "MH_TH": "NLM (2003)", "ST": "T081", "AN": "GLYCEMIC LOAD is also available", "PI": "Dietary Carbohydrates (1981-2002)", "PM": "2003", "HN": "2003", "MR": "20150629", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038321"}, {"RECTYPE": "D", "MH": "Glycogen Synthase Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthase Kinase, Glycogen", "MN": "D12.776.476.563.429", "MH_TH": "NLM (1994)", "ST": "T126", "RN": "EC 2.7.11.-", "PI": "Ca(2+)-Calmodulin Dependent Protein Kinase (1973-2002)", "MS": "A class of protein-serine-threonine kinases that was originally found as one of the three types of kinases that phosphorylate GLYCOGEN SYNTHASE. Glycogen synthase kinases along with CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASES and CYCLIC AMP-DEPENDENT PROTEIN KINASES regulate glycogen synthase activity.", "PM": "2003; see CA(2+)-CALMODULIN-DEPENDENT PROTEIN KINASE 1994-2002", "HN": "2003; use CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038341"}, {"RECTYPE": "D", "MH": "Neuronavigation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Stereotaxy, Frameless", "MN": "E05.873.249", "MH_TH": "NLM (2003)", "ST": "T061", "PI": "Stereotaxic Techniques (1995-2002)", "MS": "Intraoperative computer-assisted 3D navigation and guidance system generally used in neurosurgery for tracking surgical tools and localize them with respect to the patient's 3D anatomy. The pre-operative diagnostic scan is used as a reference and is transferred onto the operative field during surgery.", "PM": "2003", "HN": "2003", "MR": "20200609", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038361"}, {"RECTYPE": "D", "MH": "Glycogen Synthase Kinase 3", "DS": "GLYCOGEN SYNTHASE KINASE 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "gsk-3 Gene Product|T116|T126|ACX|EQV|NLM (2003)|abbcde", "MN": "D12.776.476.563.646.625", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 2.7.11.26", "PI": "Ca(2+)-Calmodulin Dependent Protein Kinase (1995-2002)", "MS": "A glycogen synthase kinase that was originally described as a key enzyme involved in glycogen metabolism. It regulates a diverse array of functions such as CELL DIVISION, microtubule function and APOPTOSIS.", "PM": "2003; GLYCOGEN SYNTEHASE KINASE 3 was indexed under CA(2+)-CALMODULIN PROTEIN KINASE 1995-2002", "HN": "2003; use GLYCOGEN SYNTHASE KINASE 3 (NM) 1995-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038362"}, {"RECTYPE": "D", "MH": "Neisseria meningitidis, Serogroup A", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Meningococcus, Serogroup A|T007|NON|EQV|NLM (2003)|020304|abcdef", "ENTRY": "Meningococci, Serogroup A|T007|NON|EQV|NLM (2003)|020304|abcdef", "MN": "B03.660.075.525.520.500.700", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid65699", "AN": "infection: coord IM with MENINGITIS, MENINGOCOCCAL (IM) or, if not meningitis, MENINGOCOCCAL INFECTIONS (IM)", "PI": "Neisseria meningitidis (1965-2002)", "MS": "Strains of Neisseria meningitidis responsible for most outbreaks of meningococcal disease in Western Europe and the United States in the first half of the 20th century. They continue to be a major cause of disease in Asia and Africa, and especially localized epidemics in Sub-Sahara Africa.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038381"}, {"RECTYPE": "D", "MH": "Hemispherectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Hemispherectomy, Total", "MN": "E04.525.160.500", "MH_TH": "NLM (2003)", "ST": "T062", "PI": "Hemiplegia (1965-2002)", "MS": "A neurosurgical procedure that removes or disconnects the epileptogenic CEREBRAL CORTEX of a hemisphere. Hemispherectomy is usually performed for patients with intractable unilateral EPILEPSY due to malformations of cortical development or brain lesions. Depending on the epileptogenic area in the hemisphere, cortical removal can be total or partial.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038421"}, {"RECTYPE": "D", "MH": "Diet, Mediterranean", "AQ": "AE EC EH HI PX SN", "PRINT ENTRY": "Mediterranean Diet|T061|NON|EQV|NLM (2003)|020417|abcdef", "ENTRY": "Mediterranean Diets", "MN": "G07.203.650.240.278.250", "MH_TH": "NLM (2003)", "ST": "T061", "PI": "Diet (1984-2002)", "MS": "A diet typical of the Mediterranean region characterized by a pattern high in fruits and vegetables, EDIBLE GRAIN and bread, potatoes, poultry, beans, nuts, olive oil and fish while low in red meat and dairy and moderate in alcohol consumption.", "PM": "2003", "HN": "2003", "MR": "20221215", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038441"}, {"RECTYPE": "D", "MH": "Proline-Directed Protein Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Proline Kinase", "MN": "D12.776.476.563.646", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 2.7.11.-", "PI": "Protein-Serine-Threonine Kinases (1994-2002)", "MS": "A subclass of protein serine-threonine kinases that phosphorylate proteins on a SERINE or THREONINE residue that is immediately preceding a PROLINE residue.", "PM": "2003; PROTEIN-PROLINE KINASE (now PROLINE-DIRECTED PROTEIN KINASES) was indexed under PROTEIN-SERINE-THREONINE KINASES 1994-2002 & under PROTEIN KINASES 1990-1993", "HN": "2003; use PROLINE-DIRECTED PROTEIN KINASES (NM) 1990-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038461"}, {"RECTYPE": "D", "MH": "Anterior Temporal Lobectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Lobectomy, Anterior Temporal", "MN": "E04.525.044", "FX": "Epilepsy, Temporal Lobe", "MH_TH": "NLM (2003)", "ST": "T062", "PI": "Epilepsy, Temporal Lobe (1965-2002)", "MS": "A neurosurgical procedure that removes the anterior TEMPORAL LOBE including the medial temporal structures of CEREBRAL CORTEX; AMYGDALA; HIPPOCAMPUS; and the adjacent PARAHIPPOCAMPAL GYRUS. This procedure is generally used for the treatment of intractable temporal epilepsy (EPILEPSY, TEMPORAL LOBE).", "PM": "2003", "HN": "2003", "MR": "20170602", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038481"}, {"RECTYPE": "D", "MH": "Tankyrases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tankyrase|T116|T126|NON|EQV|NLM (2021)|200129|abbcdef", "ENTRY": "TRF-1 Interacting, Ankyrin-Related, ADP-Ribose Polymerases|T116|T126|NON|EQV|NLM (2003)|020301|abbcdef", "MN": "D08.811.913.400.725.115.690.840", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 2.4.2.30", "PI": "Poly(ADP-ribose) Polymerases (1998-2002)", "MS": "A group of telomere associated proteins that interact with TRF1 PROTEIN, contain ANKYRIN REPEATS and have poly(ADP-ribose) polymerase activity.", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038501"}, {"RECTYPE": "D", "MH": "Twinning, Monozygotic", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Monozygous Twinning|T040|NON|EQV|NLM (2020)|190315|abcdef", "ENTRY": "Twinning, Monozygous", "MN": "G08.686.784.170.104.625.750", "MH_TH": "NLM (2005)", "ST": "T040", "AN": "TWINS, MONOZYGOTIC is also available", "PI": "Twins (1966-2002)", "MS": "The division of a ZYGOTE into two parts that are each capable of further development into two distinct individuals, both that have the same genetic makeup.", "PM": "2005; see TWINNING 2003-2004; see TWINS 1978-2002", "HN": "2005 (2003); use TWINS 1978-2002", "MR": "20190530", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038522"}, {"RECTYPE": "D", "MH": "Diffusion Magnetic Resonance Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Magnetic Resonance Imaging, Diffusion|T060|NON|EQV|NLM (2003)|020520|abcdef", "ENTRY": "MRI, Diffusion Weighted", "MN": "E01.370.350.825.500.150", "MH_TH": "NLM (2003)", "ST": "T060", "PI": "Magnetic Resonance Spectroscopy (1984-1988)", "MS": "A diagnostic technique that incorporates the measurement of molecular diffusion (such as water or metabolites) for tissue assessment by MRI. The degree of molecular movement can be measured by changes of apparent diffusion coefficient (ADC) with time, as reflected by tissue microstructure. Diffusion MRI has been used to study BRAIN ISCHEMIA and tumor response to treatment.", "PM": "2003", "HN": "2003", "MR": "20040707", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038524"}, {"RECTYPE": "D", "MH": "Neisseria meningitidis, Serogroup B", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Meningococcus, Serogroup B|T007|NON|EQV|NLM (2003)|020304|abcdef", "ENTRY": "Meningococci, Serogroup B|T007|NON|EQV|NLM (2003)|020304|abcdef", "MN": "B03.660.075.525.520.500.710", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid491", "AN": "infection: coord IM with MENINGITIS, MENINGOCOCCAL (IM) or, if not meningitis, MENINGOCOCCAL INFECTIONS (IM)", "PI": "Neisseria meningitidis (1972-2002)", "MS": "Strains of Neisseria meningitidis which are the most common ones causing infections or disease in infants. Serogroup B strains are isolated most frequently in sporadic cases, and are less common in outbreaks and epidemics.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038541"}, {"RECTYPE": "D", "MH": "Neisseria meningitidis, Serogroup C", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Meningococcus, Serogroup C|T007|NON|EQV|NLM (2003)|020304|abcdef", "ENTRY": "Meningococci, Serogroup C|T007|NON|EQV|NLM (2003)|020304|abcdef", "MN": "B03.660.075.525.520.500.720", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid135720", "AN": "infection: coord IM with MENINGITIS, MENINGOCOCCAL (IM) or, if not meningitis, MENINGOCOCCAL INFECTIONS (IM)", "PI": "Neisseria meningitidis (1974-2002)", "MS": "Strains of Neisseria meningitidis responsible for most sporadic cases in teenagers and almost all outbreaks of disease in this age group. These strains are less common in infants.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038542"}, {"RECTYPE": "D", "MH": "Neisseria meningitidis, Serogroup Y", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Meningococcus, Serogroup Y|T007|NON|EQV|NLM (2003)|020304|abcdef", "ENTRY": "Meningococci, Serogroup Y|T007|NON|EQV|NLM (2003)|020304|abcdef", "MN": "B03.660.075.525.520.500.820", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid648194", "AN": "infection: coord IM with MENINGITIS, MENINGOCOCCAL (IM) or, if not meningitis, MENINGOCOCCAL INFECTIONS (IM)", "PI": "Neisseria meningitidis (1974-2002)", "MS": "Strains of Neisseria meningitidis which, in the United States, causes disease in mostly adults and the elderly. Serogroup Y strains are associated with PNEUMONIA.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038581"}, {"RECTYPE": "D", "MH": "Neisseria meningitidis, Serogroup W-135", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Neisseria meningitidis, Serogroup W135|T007|NON|EQV|NLM (2003)|021018|abcdef", "MN": "B03.660.075.525.520.500.800", "MH_TH": "NLM (2003)", "ST": "T007", "AN": "infection: coord IM with MENINGITIS, MENINGOCOCCAL (IM) or, if not meningitis, MENINGOCOCCAL INFECTIONS (IM)", "PI": "Neisseria meningitidis (1976-2002)", "MS": "Strains of Neisseria meningitidis found mostly in Africa.", "PM": "2003", "HN": "2003", "MR": "20200902", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038582"}, {"RECTYPE": "D", "MH": "Ribosomal Protein S6", "DS": "RIBOSOMAL PROTEIN 00 S 06", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein S6, Ribosomal", "MN": "D12.776.835.931", "FX": "Ribosomal Protein S6 Kinases", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Ribosomal Proteins (1981-2002)", "MS": "A ribosomal protein that may play a role in controlling cell growth and proliferation. It is a major substrate of RIBOSOMAL PROTEIN S6 KINASES and plays a role in regulating the translation (TRANSLATION, GENETIC) of RNAs that contain an RNA 5' TERMINAL OLIGOPYRIMIDINE SEQUENCE.", "PM": "2003; RIBOSOMAL PROTEIN S6 was indexed under RIBOSOMAL PROTEINS 1981-2002", "HN": "2003; use RIBOSOMAL PROTEIN S6 (NM) 1981-2002", "MR": "20100625", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038601"}, {"RECTYPE": "D", "MH": "Mice, Biozzi", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Biozzi Mice", "MN": "B01.050.150.900.649.313.992.635.505.500.550.100", "MH_TH": "NLM (2003)", "ST": "T015", "PI": "Mice, Inbred Strains (1972-2002)", "MS": "A strain of mice bred specifically as high or low antibody responders.", "PM": "2003", "HN": "2003", "MR": "20200902", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038602"}, {"RECTYPE": "D", "MH": "Regulatory Sequences, Ribonucleic Acid", "DE": "REG SEQ RIBONUCLEIC ACID", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Ribonucleic Acid Regulatory Sequences|T114|T123|NON|EQV|NLM (2003)|020305|RIBONUCLEIC ACID REG SEQ|abbcdefv", "ENTRY": "Sequences, RNA Regulatory", "MN": "G05.360.080.689.687", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "Sequences within RNA that regulate the processing, stability (RNA STABILITY) or translation (TRANSLATION, GENETIC) of RNA.", "PM": "2003", "HN": "2003", "MR": "20100625", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038621"}, {"RECTYPE": "D", "MH": "Internationality", "AQ": "HI LJ", "ENTRY": "Relations, International", "MN": "I01.615", "MH_TH": "NLM (2003)", "ST": "T078", "AN": "specify geographic term if pertinent", "MS": "The quality or state of relating to or affecting two or more nations. (After Merriam-Webster Collegiate Dictionary, 10th ed)", "PM": "2003", "HN": "2003", "MR": "20090706", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038622"}, {"RECTYPE": "D", "MH": "RNA 5' Terminal Oligopyrimidine Sequence", "DE": "RNA 5 TERMINAL OLIGOPYRIMIDINE SEQ", "DS": "RNA TERMINAL OLIGOPYRIMIDINE SEQUENCE 005", "AQ": "DE ES GE IM PH RE", "ENTRY": "Sequences, 5' TOP", "MN": "G05.360.340.024.340.137.785", "MH_TH": "NLM (2003)", "ST": "T123", "MS": "A regulatory sequence found in the 5' terminal regions of a variety of RNA species. The sequence starts with a CYTIDINE, which is followed by a stretch of 5 to 15 PYRIMIDINE NUCLEOTIDES. Messenger RNA that contains the 5' Terminal Oligo Pyrimidine tract is often referred to as 5' TOP mRNA. The sequence acts as a translational regulator and has been found in mRNAs for PEPTIDE ELONGATION FACTORS and RIBOSOMAL PROTEINS.", "PM": "2003", "HN": "2003", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038641"}, {"RECTYPE": "D", "MH": "Shaken Baby Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C26.915.300.200.825", "FX": "Child Abuse", "MH_TH": "NLM (2003)", "ST": "T037", "PI": "Child Abuse (1984-2002)", "MS": "Brain injuries resulted from vigorous shaking of an infant or young child held by the chest, shoulders, or extremities causing extreme cranial acceleration. It is characterized by the intracranial and intraocular hemorrhages with no evident external trauma. Serious cases may result in death.", "PM": "2003", "HN": "2003", "MR": "20150623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038642"}, {"RECTYPE": "D", "MH": "Follistatin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Activin-Binding Protein|T116|T123|NON|EQV|NLM (2003)|abbcde", "ENTRY": "Activin Binding Protein", "MN": "D12.776.157.247", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Inhibins (1987-2001)", "MS": "A broadly distributed protein that binds directly to ACTIVINS. It functions as an activin antagonist, inhibits FOLLICLE STIMULATING HORMONE secretion, regulates CELL DIFFERENTIATION, and plays an important role in embryogenesis. Follistatin is a single glycosylated polypeptide chain of approximately 37-kDa and is not a member of the inhibin family (INHIBINS). Follistatin also binds and neutralizes many members of the TRANSFORMING GROWTH FACTOR BETA family.", "PM": "2003; was indexed under FOLLISTATIN (NM) 1988-2002", "HN": "2003; use FOLLISTATIN (NM) 1988-2002", "MR": "20040707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038681"}, {"RECTYPE": "D", "MH": "Follistatin-Related Proteins", "DE": "FOLLISTATIN RELAT PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Follistatin Related Proteins", "MN": "D12.776.157.286", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "note species-specific terms in SCR", "PI": "Glycoproteins (2001-2002)", "MS": "Broadly distributed glycoproteins that are homologous to the activin-binding protein, FOLLISTATIN. These follistatin-related proteins are encoded by a number of genes.", "PM": "2003", "HN": "2003", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038702"}, {"RECTYPE": "D", "MH": "Ribosomal Protein S6 Kinases, 90-kDa", "DS": "RIBOSOMAL PROTEIN KINASES S 06 90 KDA", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "MAP-Kinase-Activated Protein Kinase 1|T116|T126|NON|EQV|NLM (2003)|MAP KINASE ACTIVATED PROTEIN KINASE A 01|abbcdes", "ENTRY": "Ribosomal Protein S6 Kinases, 90 kDa", "MN": "D12.776.476.563.862.500", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Ribosomal Protein S6 Kinase (1998-2002)", "MS": "A family of ribosomal protein S6 kinases that are structurally distinguished from RIBOSOMAL PROTEIN S6 KINASES, 70-KDA by their apparent molecular size and the fact they contain two functional kinase domains. Although considered RIBOSOMAL PROTEIN S6 KINASES, members of this family are activated via the MAP KINASE SIGNALING SYSTEM and have been shown to act on a diverse array of substrates that are involved in cellular regulation such as RIBOSOMAL PROTEIN S6 and CAMP RESPONSE ELEMENT-BINDING PROTEIN.", "PM": "2005; see RIBOSOMAL PROTEIN S6 KINASES, 90KD 2003-2004; MAP-KINASE-ACTIVATED KINASE 1 (now RIBOSOMAL PROTEIN S6 KINASES, 90KDa) was indexed under RIBOSOMAL PROTEIN S6 KINASE 1993-2002; for PP90(RSK) & PP90(RSK) see RIBOSOMAL PROTEIN S6 KINASE 1998-2002", "HN": "2005(2002); for PP90(RSK) & PP90(RSK) use RIBOSOMAL PROTEIN S6 KINASES 1998-2002", "MR": "20210610", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038744"}, {"RECTYPE": "D", "MH": "Photobleaching", "AQ": "DE RE", "MN": "G02.740.680", "MH_TH": "NLM (2003)", "ST": "T070", "PI": "Photochemistry (1972-2002)", "MS": "Light-induced change in a chromophore, resulting in the loss of its absorption of light of a particular wave length. The photon energy causes a conformational change in the photoreceptor proteins affecting PHOTOTRANSDUCTION. This occurs naturally in the retina (ADAPTATION, OCULAR) on long exposure to bright light. Photobleaching presents problems when occurring in PHOTODYNAMIC THERAPY, and in FLUORESCENCE MICROSCOPY. On the other hand, this phenomenon is exploited in the technique, FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, allowing measurement of the movements of proteins and LIPIDS in the CELL MEMBRANE.", "PM": "2003", "HN": "2003", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038761"}, {"RECTYPE": "D", "MH": "Ribosomal Protein S6 Kinases, 70-kDa", "DS": "RIBOSOMAL PROTEIN KINASES S 06 70", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p70s6k|T116|T126|ACR|EQV|NLM (1998)|970214|P A 070 S K 06|abbcdefs", "ENTRY": "S6 Kinase, p70", "MN": "D12.776.476.563.862.249", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Ribosomal Protein S6 Kinases (1990-2002)", "MS": "A family of ribosomal protein S6 kinases that are considered the major physiological kinases for RIBOSOMAL PROTEIN S6. Unlike RIBOSOMAL PROTEIN S6 KINASES, 90KDa the proteins in this family are sensitive to the inhibitory effects of RAPAMYCIN and contain a single kinase domain. They are referred to as 70kDa proteins, however ALTERNATIVE SPLICING of mRNAs for proteins in this class also results in 85kDa variants being formed.", "PM": "2005; see RIBOSOMAL PROTEIN S6 KINASES, 70 KD 2003-2004; for P70 S6 KINASE & P70S6K see RIBOSOMAL PROTEIN S6 KINASES 1998-2002", "HN": "2005(2003); for P70 S6 KINASE & P70S6K use RIBOSOMAL PROTEIN S6 KINASES 1998-2002", "MR": "20210610", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038762"}, {"RECTYPE": "D", "MH": "Otoscopy", "AQ": "AE CL EC ES HI MO MT NU PX SN ST TD VE", "MN": "E01.370.382.637", "FX": "Otoscopes", "EC": "instrumentation:Otoscopes", "MH_TH": "NLM (2003)", "ST": "T060", "PI": "Endoscopy (1973-2002)", "MS": "Examination of the EAR CANAL and eardrum with an OTOSCOPE.", "PM": "2003", "HN": "2003", "MR": "20020924", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038781"}, {"RECTYPE": "D", "MH": "International Classification of Diseases", "DE": "INTERNATIONAL CLASS DIS", "AQ": "EC HI ST TD", "PRINT ENTRY": "International Classification of Disease|T170|NON|EQV|NLM (2022)|200929|abcdef", "ENTRY": "ICD 10 Procedure Coding System", "MN": "L01.462.750.245.945.400", "MH_TH": "NLM (2003)", "ST": "T170", "AN": "CATALOGER: Coordinate with specific NAF entry if applicable", "MS": "A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (From ICD-10, p1). The Clinical Modifications, produced by the UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S.", "PM": "2003", "HN": "2003", "MR": "20220712", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038801"}, {"RECTYPE": "D", "MH": "Mycorrhizae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Vesicular-Arbuscular Mycorrhizae|T002|T004|NON|NRW|NLM (2003)|020314|abbcdef", "ENTRY": "Vesicular Arbuscular Mycorrhizae", "MN": "B05.550", "FX": "Symbiosis", "MH_TH": "NLM (2003)", "ST": "T004", "AN": "coordinate with specific plant and specific fungus if pertinent", "MS": "Symbiotic combination (dual organism) of the MYCELIUM of FUNGI with the roots of plants (PLANT ROOTS). The roots of almost all higher plants exhibit this mutually beneficial relationship, whereby the fungus supplies water and mineral salts to the plant, and the plant supplies CARBOHYDRATES to the fungus. There are two major types of mycorrhizae: ectomycorrhizae and endomycorrhizae.", "PM": "2003", "HN": "2003", "MR": "20100625", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038821"}, {"RECTYPE": "D", "MH": "Medicine, Tibetan Traditional", "DE": "MED TIBETAN TRADITIONAL", "AQ": "AE EC HI IS MT PX SN ST TD", "PRINT ENTRY": "Traditional Medicine, Tibetan|T058|EPO|EQV|NLM (2003)|020417|TRADITIONAL MED TIBETAN|abcdefv", "ENTRY": "Traditional Tibetan Medicine", "MN": "I01.076.201.450.654.558.875", "MH_TH": "NLM (2003)", "ST": "T058", "PI": "Medicine, Oriental Traditional (1972-2010)", "MS": "A system of traditional medicine which is based on the beliefs and practices of the Tibetan culture.", "PM": "2003", "HN": "2003", "MR": "20180629", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038861"}, {"RECTYPE": "D", "MH": "Mental Retardation, X-Linked", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "X-Linked Mental Retardation|T048|NON|EQV|NLM (2003)|020315|abcdef", "ENTRY": "X-Linked Mental Retardations", "MN": "C16.320.400.525", "MH_TH": "OMIM (2013)", "ST": "T048", "PI": "Mental Retardation/genetics (1971-2002)", "MS": "A class of genetic disorders resulting in INTELLECTUAL DISABILITY that is associated either with mutations of GENES located on the X CHROMOSOME or aberrations in the structure of the X chromosome (SEX CHROMOSOME ABERRATIONS).", "PM": "2003", "HN": "2003", "MR": "20180630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038901"}, {"RECTYPE": "D", "MH": "Coffin-Lowry Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Coffin-Lowry", "MN": "C16.320.400.525.249", "FX": "Ribosomal Protein S6 Kinases", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Mental Retardation/genetics (1975-2002)", "MS": "A rare, X-linked INTELLECTUAL DISABILITY syndrome that results from mutations in the RIBOSOMAL PROTEIN S6 KINASE gene. Typical manifestations of the disease include an intelligence quotient of less than 50, facial anomalies, and other malformations.", "PM": "2003", "HN": "2003", "MR": "20180630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038921"}, {"RECTYPE": "D", "MH": "Polypyrimidine Tract-Binding Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p57 Cytoplasmic RNA Binding Protein", "MN": "D12.776.664.962.829.250", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "139076-35-0", "PI": "Ribonucleoproteins (1991-2002)", "MS": "A RNA-binding protein that binds to polypyriminidine rich regions in the INTRONS of messenger RNAs. Polypyrimidine tract-binding protein may be involved in regulating the ALTERNATIVE SPLICING of mRNAs since its presence on an intronic RNA region that is upstream of an EXON inhibits the splicing of the exon into the final mRNA product.", "PM": "2003; POLYPYRIMIDINE TRACT-BINDING PROTEIN was indexed under RIBONUCLEOPROTEINS & RNA-BINDING PROTEINS 1991-2002", "HN": "2003; use POLYPYRIMIDINE TRACT-BINDING PROTEIN (NM) 1991-2002", "MR": "20160705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038941"}, {"RECTYPE": "D", "MH": "O-Acetyl-ADP-Ribose", "DS": "ACETYL ADP RIBOSE O", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adenosine-Diphosphate-Ribose, O-Acetyl-|T114|NON|EQV|NLM (2003)|020318|ADENOSINE DIPHOSPHATE RIBOSE ACETYL O|abcdefs", "ENTRY": "O-Acetyl- Adenosine-Diphosphate-Ribose", "MN": "D13.695.827.708.070.125.040", "MH_TH": "NLM (2003)", "ST": "T114", "RN": "0", "MS": "An acetyl ester of ADENOSINE DIPHOSPHATE RIBOSE formed during NAD-dependent deacetylation of proteins by SIRTUINS. The acetate group resides on the ribose ring where nicotinamide was cleaved from NAD during the reaction. Several isomers of O-acetyl-ADP-ribose have been isolated from the reaction.", "PM": "2003; O-ACETYL-ADP-RIBOSE was indexed under ADENOSINE DIPHOSPHATE RIBOSE 2001-2002", "HN": "2003; use O-ACETYL-ADP-RIBOSE (NM) 2001-2002", "MR": "20160531", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038961"}, {"RECTYPE": "D", "MH": "Receptors, Collagen", "DE": "RECEPT COLLAGEN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Collagen Receptors|T116|T192|NON|EQV|NLM (2003)|abbcde", "ENTRY": "Receptor, Collagen", "MN": "D12.776.543.750.685", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Integrins (1983-2002)", "MS": "Cell surface receptors that modulate signal transduction between cells and the EXTRACELLULAR MATRIX. They are found in many cell types and are involved in the maintenance and regulation of cell shape and behavior, including PLATELET ACTIVATION and aggregation, through many different signaling pathways and differences in their affinities for collagen isoforms. Collagen receptors include DISCOIDIN DOMAIN RECEPTORS; INTEGRINS; and GP6, one of the PLATELET MEMBRANE GLYCOPROTEINS.", "PM": "2003; COLLAGEN RECEPTOR was indexed under INTEGRINS 1983-2002", "HN": "2003; use RECEPTORS, COLLAGEN (NM) 1983-2002", "MR": "20160622", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038981"}, {"RECTYPE": "D", "MH": "Integrin alpha2beta1", "DS": "INTEGRIN ALPHA A 02 BETA 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "alpha2beta1, Integrin", "MN": "D12.776.543.750.705.876.280", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Integrins (1994-2002)", "MS": "An integrin found on fibroblasts, platelets, endothelial and epithelial cells, and lymphocytes where it functions as a receptor for COLLAGEN and LAMININ. Although originally referred to as the collagen receptor, it is one of several receptors for collagen. Ligand binding to integrin alpha2beta1 triggers a cascade of intracellular signaling, including activation of p38 MAP kinase.", "PM": "2003; INTEGRIN ALPHA2BETA1 was indexed under INTEGRINS 1994-2002", "HN": "2003; for VLA-2 use COLLAGEN RECEPTORS (NM) 1991-2002; for PLATELET MEMBRANE GLYCOPROTEIN HETERODIMER IA-IIA use COLLAGEN RECEPTORS (NM) 1992-2000; for INTEGRIN ALPHA2BETA1 & CD49B-CD29 use COLLAGEN RECEPTORS (NM) 1994-2002; for ALPHA2BETA1INTEGRIN use COLLAGEN RECEPTORS (NM) 2001-2002", "MR": "20230316", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D038982"}, {"RECTYPE": "D", "MH": "Galactolipids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Galactolipid|T109|NON|EQV|NLM (2021)|200211|abcdef", "ENTRY": "Monogalactolipids|T109|NON|NRW|NLM (2003)|abcde", "MN": "D10.390.355", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "PI": "Glycolipids (1976-2002)", "MS": "A group of GLYCOLIPIDS in which the sugar group is GALACTOSE. They are distinguished from GLYCOSPHINGOLIPIDS in lacking nitrogen. They constitute the majority of MEMBRANE LIPIDS in PLANTS.", "PM": "2003; GALACTOLIPIDS was indexed under GLYCOLIPIDS 1976-2002", "HN": "2003; use GALACTOLIPIDS (NM) 1976-2002", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D038983"}, {"RECTYPE": "D", "MH": "Integrin alpha Chains", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "alpha Integrins|T116|T123|NON|EQV|NLM (2003)|020418|abbcdef", "ENTRY": "alpha Chains, Integrin", "MN": "D12.776.543.750.705.408.100", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Integrins (1966-2002)", "MS": "The alpha subunits of integrin heterodimers (INTEGRINS), which mediate ligand specificity. There are approximately 18 different alpha chains, exhibiting great sequence diversity; several chains are also spliced into alternative isoforms. They possess a long extracellular portion (1200 amino acids) containing a MIDAS (metal ion-dependent adhesion site) motif, and seven 60-amino acid tandem repeats, the last 4 of which form EF HAND MOTIFS. The intracellular portion is short with the exception of INTEGRIN ALPHA4.", "PM": "2003", "HN": "2003", "MR": "20130709", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039001"}, {"RECTYPE": "D", "MH": "Prophages", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Prophage|T005|NON|EQV|NLM (2003)|020318|abcdef", "MN": "B04.123.655", "FX": "Proviruses", "MH_TH": "NLM (2003)", "ST": "T005", "AN": "coord IM with specific bacteriophage (IM)", "PI": "Bacteriophages (1965-2002)", "MS": "Genomes of temperate BACTERIOPHAGES integrated into the DNA of their bacterial host cell. The prophages can be duplicated for many cell generations until some stimulus induces its activation and virulence.", "PM": "2003", "HN": "2003", "MR": "20200902", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039002"}, {"RECTYPE": "D", "MH": "Colonic Pouches", "AQ": "AE BS CL EC ES HI IM IR MI PA PH PS SD SN ST TD VE VI", "PRINT ENTRY": "W-Pouch|T020|NON|NRW|NLM (1992)|910207|abcdef", "ENTRY": "W Pouch", "MN": "E07.862.200", "FX": "Proctocolectomy, Restorative", "MH_TH": "NLM (2003)", "ST": "T017", "PI": "Proctocolectomy, Restorative (1989-2002)", "MS": "Sacs or reservoirs created to function in place of the COLON and/or RECTUM in patients who have undergone restorative proctocolectomy (PROCTOCOLECTOMY, RESTORATIVE).", "PM": "2003; for ILEALANAL POUCHES & ILEAL RESERVOIRS & J-POUCH & KOCH POUCH & W-POUCH see PROCTOCOLECTOMY, RESTORATIVE 1992-2002", "HN": "2003; for ILEALANAL POUCHES & ILEAL RESERVOIRS & J-POUCH & KOCH POUCH & W-POUCH use PROCTOCOLECTOMY, RESTORATIVE 1992-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039021"}, {"RECTYPE": "D", "MH": "Integrin alpha4beta1", "DS": "INTEGRIN ALPHA A 04 BETA 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "alpha4beta1, Integrin Heterodimer", "MN": "D23.050.301.350.625.347", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Receptors, Lymphocyte Homing (1991-2002)", "MS": "Integrin alpha4beta1 is a FIBRONECTIN and VCAM-1 receptor present on LYMPHOCYTES; MONOCYTES; EOSINOPHILS; NK CELLS and thymocytes. It is involved in both cell-cell and cell- EXTRACELLULAR MATRIX adhesion and plays a role in INFLAMMATION, hematopoietic cell homing and immune function, and has been implicated in skeletal MYOGENESIS; NEURAL CREST migration and proliferation, lymphocyte maturation and morphogenesis of the PLACENTA and HEART.", "PM": "2003; INTEGRIN ALPHA4BETA1 was indexed under INTEGRINS and RECEPTORS, LYMPHOCYTE HOMING 1991-2002", "HN": "2003 (1991)", "MR": "20230316", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039041"}, {"RECTYPE": "D", "MH": "Systematized Nomenclature of Medicine", "PRINT ENTRY": "SNOMED|T170|ACR|EQV|NLM (2003)|020320|abcdef", "ENTRY": "SNOMED Clinical Term", "MN": "L01.462.750.245.945.720", "MH_TH": "NLM (2003)", "ST": "T170", "AN": "CATALOGER: Use NAF entry", "PI": "Vocabulary, Controlled (1978-2002)", "MS": "Controlled vocabulary of clinical terms produced by the International Health Terminology Standards Development Organisation (IHTSDO).", "PM": "2003", "HN": "2003", "MR": "20220712", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039061"}, {"RECTYPE": "D", "MH": "Integrin alpha5beta1", "DS": "INTEGRIN ALPHA A 05 BETA 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, VLA-5|T116|T192|ACX|EQV|NLM (1993)|920513|RECEPTORS VLA 05|RECEPT VLA 5|abbcdefsv", "ENTRY": "beta-1, Integrin alpha-5", "MN": "D12.776.543.750.705.876.374", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "AN": "do not confuse entry term FIBRONECTIN RECEPTOR with RECEPTORS, FIBRONECTIN", "PI": "Receptors, Fibronectin (1992-2002)", "MS": "An integrin found in FIBROBLASTS; PLATELETS; MONOCYTES, and LYMPHOCYTES. Integrin alpha5beta1 is the classical receptor for FIBRONECTIN, but it also functions as a receptor for LAMININ and several other EXTRACELLULAR MATRIX PROTEINS.", "PM": "2003; see RECEPTORS, FIBRONECTIN 1992-2002", "HN": "2003; use RECEPTORS, FIBRONECTIN 1992-2002", "MR": "20230316", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039081"}, {"RECTYPE": "D", "MH": "Poly(A)-Binding Proteins", "DS": "POLY A BINDING PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Poly A-Binding Protein|T116|T123|ACX|EQV|NLM (2003)|abbcde", "ENTRY": "Poly A Binding Proteins", "MN": "D12.776.664.962.452", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "RNA-Binding Proteins (1994-2002)", "MS": "Proteins that bind to the 3' polyadenylated region of MRNA. When complexed with RNA the proteins serve an array of functions such as stabilizing the 3' end of RNA, promoting poly(A) synthesis and stimulating mRNA translation.", "PM": "2003; POLY(A)-BINDING PROTEINS was indexed under RNA-BINDING PROTEINS 1994-2002 & under CARRIER PROTEINS 1982-1993", "HN": "2003; use POLY(A)-BINDING PROTEINS (NM) 1982-2002", "MR": "20050630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039102"}, {"RECTYPE": "D", "MH": "Poly(A)-Binding Protein II", "DS": "POLY A BINDING PROTEIN II", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Poly(A) Binding Protein, Nuclear 1|T116|T123|ACX|EQV|NLM (2003)|020322|abbcdef", "MN": "D12.776.664.962.452.500", "FX": "Muscular Dystrophy, Oculopharyngeal", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "RNA-Binding Proteins (1995-2002)", "MS": "A poly(A) binding protein that is involved in promoting the extension of the poly A tails of MRNA. The protein requires a minimum of ten ADENOSINE nucleotides in order for binding to mRNA. Once bound it works in conjunction with CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR to stimulate the rate of poly A synthesis by POLY A POLYMERASE. Once poly-A tails reach around 250 nucleotides in length poly(A) binding protein II no longer stimulates POLYADENYLATION. Mutations within a GCG repeat region in the gene for poly(A) binding protein II have been shown to cause the disease MUSCULAR DYSTROPHY, OCULOPHARYNGEAL.", "PM": "2003; PAB II was indexed under RNA-BINDING PROTEINS 1995-2002; PABP2 GENE PRODUCT & PABP2 PROTEIN were indexed under RNA-BINDING PROTEINS 1999-2002; PABP2 was indexed under RNA-BINDING PROTEINS 2000-2002", "HN": "2003; for PAB II use POLY(A)-BINDING PROTEINS (NM) 1995-2002; for PABP2 GENE PRODUCT & PABP2 PROTEIN use POLY(A)-BINDING PROTEINS (NM) 1999-2002; for PABP2 use POLY(A)-BINDING PROTEINS (NM) 2000-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039103"}, {"RECTYPE": "D", "MH": "RNA 3' Polyadenylation Signals", "DS": "RNA POLYADENYLATION SIGNALS 003", "AQ": "DE ES GE IM PH RE", "ENTRY": "Signals, 3' Polyadenylation", "MN": "G05.360.340.024.340.137.775", "MH_TH": "NLM (2003)", "ST": "T123", "MS": "Sequences found near the 3' end of MESSENGER RNA that direct the cleavage and addition of multiple ADENINE NUCLEOTIDES to the 3' end of mRNA.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039104"}, {"RECTYPE": "D", "MH": "Proteaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Protea Plant|T002|NON|NRW|NLM (2003)|020322|abcdef", "ENTRY": "Protea Plants", "MN": "B01.875.800.575.912.250.831", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4328", "RR": "txid83716", "AN": "prefer specific plant", "MS": "A plant family of the order Proteales, subclass Rosidae class Magnoliopsida. Cluster roots, bottlebrush-like clusters of rootlets which form in response to poor soil, are common in this family.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039105"}, {"RECTYPE": "D", "MH": "Macadamia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Nuts, Macadamia", "MN": "B01.875.800.575.912.250.831.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid4329", "RR": "txid60698", "AN": "coord with FOOD if pertinent", "MS": "A plant genus of the family PROTEACEAE that is the source of edible NUTS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039106"}, {"RECTYPE": "D", "MH": "Integrin alpha6beta1", "DS": "INTEGRIN ALPHA A 06 BETA 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "alpha6beta1, Integrin", "MN": "D12.776.543.750.705.876.500", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Integrins (1992-2002)", "MS": "A cell surface receptor mediating cell adhesion to the EXTRACELLULAR MATRIX and to other cells via binding to LAMININ. It is involved in cell migration, embryonic development, leukocyte activation and tumor cell invasiveness. Integrin alpha6beta1 is the major laminin receptor on PLATELETS; LEUKOCYTES; and many EPITHELIAL CELLS, and ligand binding may activate a number of signal transduction pathways. Alternative splicing of the cytoplasmic domain of the alpha6 subunit (INTEGRIN ALPHA6) results in the formation of A and B isoforms of the heterodimer, which are expressed in a tissue-specific manner.", "PM": "2003; INTEGRIN ALPHA5BETA1 was indexed under INTEGRINS 1992-2002", "HN": "2003; use INTEGRIN ALPHA6BETA1 (NM) 1992-2002", "MR": "20230316", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039121"}, {"RECTYPE": "D", "MH": "Poly(A)-Binding Protein I", "DS": "POLY A BINDING PROTEIN I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p70 Poly(A) Binding Protein|T116|T123|ACX|EQV|NLM (2003)|abbcde", "MN": "D12.776.664.962.452.249", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "RNA-Binding Proteins (1993-2002)", "MS": "A poly(A) binding protein that has a variety of functions such as mRNA stabilization and protection of RNA from nuclease activity. Although poly(A) binding protein I is considered a major cytoplasmic RNA-binding protein it is also found in the CELL NUCLEUS and may be involved in transport of mRNP particles.", "PM": "2003; P70 POLY(A) BINDING PROTEIN was indexed under RNA-BINDING PROTEINS 1999-2002", "HN": "2003; for P70 POLY(A) BINDING PROTEIN use POLY(A)-BINDING PROTEINS (NM) 1999-2002", "MR": "20050721", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039122"}, {"RECTYPE": "D", "MH": "Muscular Dystrophy, Oculopharyngeal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Oculopharyngeal Muscular Dystrophies", "MN": "C16.320.577.450", "FX": "Poly(A)-Binding Protein II", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "/vet: coord with MUSCULAR DYSTROPHY, ANIMAL", "PI": "Muscular Dystrophies (1969-2002)", "MS": "An autosomal dominant hereditary disease that presents in late in life and is characterized by DYSPHAGIA and progressive ptosis of the eyelids. Mutations in the gene for POLY(A)-BINDING PROTEIN II have been associated with oculopharyngeal muscular dystrophy.", "PM": "2003; see MUSCULAR DYSTROPHIES 2001-2002", "HN": "2003; use MUSCULAR DYSTROPHIES 2001-2002", "MR": "20130708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039141"}, {"RECTYPE": "D", "MH": "Integrin alpha6beta4", "DS": "INTEGRIN ALPHA A 06 BETA 04", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "beta4 Integrin, alpha6", "MN": "D12.776.543.750.705.876.750", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Integrins (1988-2002)", "MS": "This intrgrin is a key component of HEMIDESMOSOMES and is required for their formation and maintenance in epithelial cells. Integrin alpha6beta4 is also found on thymocytes, fibroblasts, and Schwann cells, where it functions as a laminin receptor (RECEPTORS, LAMININ) and is involved in wound healing, cell migration, and tumor invasiveness.", "PM": "2003; INTEGRIN ALPHA6BETA4 was indexed under INTEGRINS; & ANTIGENS, SURFACE 1988-2002.", "HN": "2003; use INTEGRIN ALPHA6BETA4 (NM) 1988-2002", "MR": "20130709", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039161"}, {"RECTYPE": "D", "MH": "Steroid 16-alpha-Hydroxylase", "DS": "STEROID HYDROXYLASE ALPHA 016", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochrome P-450(16 alpha)|T116|T126|NON|EQV|NLM (2003)|020325|CYTOCHROME P 450 A 16 ALPHA|abbcdefs", "ENTRY": "Testosterone 16 alpha Hydroxylase", "MN": "D12.776.422.220.453.915.737", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 1.14.14.1", "PI": "Hydroxylases (1966-2002)", "MS": "A liver microsomal cytochrome P450 enzyme that catalyzes the 16-alpha-hydroxylation of a broad spectrum of steroids, fatty acids, and xenobiotics in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme is encoded by a number of genes from several CYP2 subfamilies.", "PM": "2003; PROGESTERONE 16 ALPHA-HYDROXYLASE was indexed under STEROID HYDROXYLASES 1977-2002", "HN": "2003; use PROGESTERONE 16 ALPHA-HYDROXYLASE (NM) 1977-2002", "MR": "20150623", "DA": "20020718", "DC": "1", "DX": "20030101", "UI": "D039181"}, {"RECTYPE": "D", "MH": "Integrin alpha3beta1", "DS": "INTEGRIN ALPHA A 03 BETA 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "alpha3beta1, Integrin", "MN": "D12.776.543.750.705.876.311", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Integrins (1992-2002)", "MS": "Cell surface receptor for LAMININ, epiligrin, FIBRONECTINS, entactin, and COLLAGEN. Integrin alpha3beta1 is the major integrin present in EPITHELIAL CELLS, where it plays a role in the assembly of BASEMENT MEMBRANE as well as in cell migration, and may regulate the functions of other integrins. Two alternatively spliced isoforms of the alpha subunit (INTEGRIN ALPHA3), are differentially expressed in different cell types.", "PM": "2003; INTEGRIN ALPHA3BETA1 was indexed under INTEGRINS 1992-2002", "HN": "2003; use INTEGRIN ALPHA3BETA1 (NM) 1992-2002", "MR": "20160617", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039201"}, {"RECTYPE": "D", "MH": "mRNA Cleavage and Polyadenylation Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polyadenylation Factors|T116|T123|NON|NRW|NLM (2003)|020326|abbcdef", "ENTRY": "Pre mRNA Polyadenylation Factor", "MN": "D12.776.664.962.444", "FX": "RNA Processing, Post-Transcriptional", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "RNA-Binding Proteins (1992-2002)", "MS": "Factors that are involved in directing the cleavage and POLYADENYLATION of the of MESSENGER RNA near the site of the RNA 3' POLYADENYLATION SIGNALS.", "PM": "2003; CLEAVAGE AND POLYADENYLATION FACTOR (now MRNA CLEAVAGE AND POLYADENYLATION FACTORS) was indexed under RNA-BINDING PROTEINS 1992-2002", "HN": "2003; use MRNA CLEAVAGE AND POLYADENYLATION FACTORS (NM) 1992-2002", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039221"}, {"RECTYPE": "D", "MH": "Integrin alpha1beta1", "DS": "INTEGRIN ALPHA A 01 BETA 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "alpha1beta1, Integrin", "MN": "D12.776.543.750.705.876.249", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Integrins (1994-2002)", "MS": "Integrin alpha1beta1 functions as a receptor for LAMININ and COLLAGEN. It is widely expressed during development, but in the adult is the predominant laminin receptor (RECEPTORS, LAMININ) in mature SMOOTH MUSCLE CELLS, where it is important for maintenance of the differentiated phenotype of these cells. Integrin alpha1beta1 is also found in LYMPHOCYTES and microvascular endothelial cells, and may play a role in angiogenesis. In SCHWANN CELLS and neural crest cells, it is involved in cell migration. Integrin alpha1beta1 is also known as VLA-1 and CD49a-CD29.", "PM": "2003; INTEGRIN ALPHA1BETA1 was indexed under INTEGRINS 1994-2002", "HN": "2003; use INTEGRIN ALPHA1BETA1 (NM) 1994-2002", "MR": "20160617", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039222"}, {"RECTYPE": "D", "MH": "Cleavage And Polyadenylation Specificity Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Subunit, CPSF-73-kDa", "MN": "D12.776.664.962.444.240", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "RNA-Binding Proteins (1992-2002)", "MS": "An RNA-binding protein that recognizes the AAUAAA RNA SEQUENCE at the 3' end of MRNA. It contains four subunits of 30, 73, 100 and 160 kDa molecular size and combines with CLEAVAGE STIMULATION FACTOR to form a stable complex with mRNA that directs the 3' cleavage and polyadenylation reaction.", "PM": "2003; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR was indexed under RNA-BINDING PROTEINS 1992-2002", "HN": "2003; for CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR use MRNA CLEAVAGE AND POLYADENYLATION FACTORS (NM) 1992-2002", "MR": "20060705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039223"}, {"RECTYPE": "D", "MH": "Cleavage Stimulation Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CstF Protein|T116|T123|ACX|EQV|NLM (2003)|abbcde", "MN": "D12.776.664.962.444.249", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "RNA-Binding Proteins (1992-2002)", "MS": "A RNA-binding protein that stimulates the cleavage of the 3' end of MRNA near the POLYADENYLATION site. It is a heterotrimer of 55-, 64- and 77-kDa subunits and combines with CLEAVAGE STIMULATION FACTOR to form a stable complex with mRNA that directs the 3' cleavage and polyadenylation reaction.", "PM": "2003; CLEAVAGE STIMULATION FACTOR was indexed under RNA-BINDING PROTEINS 1992-2002", "HN": "2003; for CLEAVAGE STIMULATION FACTOR use MRNA CLEAVAGE AND POLYADENYLATION FACTORS (NM) 1992-2002", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039241"}, {"RECTYPE": "D", "MH": "Eriocaulaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Paepalanthus|T002|NON|NRW|NLM (2003)|020326|abcdef", "MN": "B01.875.800.575.912.250.342", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid26019", "RR": "txid178429", "MS": "A plant family of the order Commelinales, subclass Commelinidae, class Liliopsida (monocotyledons).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039262"}, {"RECTYPE": "D", "MH": "Nyctaginaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bougainvillea|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Bougainvilleas", "MN": "B01.875.800.575.912.250.198.500.750", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3536", "RR": "txid76641", "AN": "prefer specific plant", "MS": "A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039281"}, {"RECTYPE": "D", "MH": "Mirabilis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Mirabili", "MN": "B01.875.800.575.912.250.198.500.750.500", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3537", "AN": "do not confuse with PROTEUS MIRABILIS", "MS": "A plant genus of the family NYCTAGINACEAE. Members contain Mirabilis antiviral protein (a ribosome-inactivating protein).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039282"}, {"RECTYPE": "D", "MH": "Computers, Molecular", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "RNA Computers|T072|ACX|NRW|NLM (2003)|020326|abcdef", "ENTRY": "RNA Computer", "MN": "L01.224.300", "MH_TH": "NLM (2003)", "ST": "T072", "AN": "do not confuse DNA Computers with DNA MICROCHIPS see OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS", "MS": "Computers whose input, output and state transitions are carried out by biochemical interactions and reactions.", "PM": "2003", "HN": "2003", "MR": "20170703", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039301"}, {"RECTYPE": "D", "MH": "Integrin alphaVbeta3", "DS": "INTEGRIN ALPHA V BETA03", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "beta-3, Integrin alpha-v", "MN": "D12.776.543.750.705.675.541", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "AN": "do not confuse entry term VITRONECTIN RECEPTOR with VITRONECTIN RECEPTORS", "MS": "An integrin that binds to a variety of plasma and extracellular matrix proteins containing the conserved RGD amino acid sequence and modulates cell adhesion. Integrin alphavbeta3 is highly expressed in OSTEOCLASTS where it may play role in BONE RESORPTION. It is also abundant in vascular smooth muscle and endothelial cells, and in some tumor cells, where it is involved in angiogenesis and cell migration. Although often referred to as the vitronectin receptor there is more than one receptor for vitronectin (RECEPTORS, VITRONECTIN).", "PM": "2003; see RECEPTORS, VITRONECTIN 1996-2002", "HN": "2003; use RECEPTORS, VITRONECTIN 1996-2002", "MR": "20230316", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039302"}, {"RECTYPE": "D", "MH": "Hydrastis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Goldenseal|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "canadensis, Hydrastis", "MN": "B01.875.800.575.912.250.836.750.397", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13568", "RR": "txid13569", "MS": "A plant genus of the family RANUNCULACEAE. Members contain BERBERINE.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039321"}, {"RECTYPE": "D", "MH": "Helleborus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Hellebore, Stinking|T002|NON|NRW|NLM (2003)|020326|abcdef", "ENTRY": "Stinking Hellebores", "MN": "B01.875.800.575.912.250.836.750.337", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid46995", "RR": "txid46996", "AN": "HELLEBORE, FALSE see VERATRUM is also available", "MS": "A plant genus of the family RANUNCULACEAE. Members contain hellebrin (BUFANOLIDES). The extract is the basis of Boicil preparation used to treat rheumatism. The common name \"black hellebore\" is used for both VERATRUM NIGRUM and Helleborus niger.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039322"}, {"RECTYPE": "D", "MH": "Coptis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Goldthread|T002|NON|EQV|NLM (2003)|020326|abcdef", "ENTRY": "Goldthreads", "MN": "B01.875.800.575.912.250.836.750.229", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3441", "MS": "A plant genus of the family RANUNCULACEAE. Members contain BERBERINE and other isoquinoline ALKALOIDS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039323"}, {"RECTYPE": "D", "MH": "Clematis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Clemati", "MN": "B01.875.800.575.912.250.836.750.205", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3452", "MS": "A plant genus of the family RANUNCULACEAE. Members contain SCOPOLETIN and SAPONINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039324"}, {"RECTYPE": "D", "MH": "Receptors, Fibrinogen", "DE": "RECEPT FIBRINOGEN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Fibrinogen Receptors|T116|T192|NON|EQV|NLM (1996)|950120|FIBRINOGEN RECEPT|abbcdefv", "ENTRY": "Receptor, Fibrinogen", "MN": "D12.776.543.750.705.408.495", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "PI": "Platelet Glycoprotein GPIIb-IIIa Complex (1996-2002)", "MS": "Receptors that bind FIBRINOGEN through distinct adhesive sequences on the fibrinogen molecule. Although MACROPHAGE-1 ANTIGEN is considered an important signaling molecule for fibrinogen interaction, a variety of INTEGRINS from all three major families, (beta1, beta2, and beta3) have been shown to bind fibrinogen.", "PM": "2003; see PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002", "HN": "2003; use PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039341"}, {"RECTYPE": "D", "MH": "RNA Cap-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cap-Binding Proteins, RNA", "MN": "D12.776.664.962.750", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "RNA-Binding Proteins (1981-2002)", "MS": "Proteins that specifically bind to RNA CAPS and form nuclear cap binding protein complexes. In addition to stabilizing the 5' end of mRNAs, they serve a diverse array of functions such as enhancing mRNA transport out of the CELL NUCLEUS and regulating MRNA TRANSLATION in the CYTOPLASM.", "PM": "2003; RNA CAP-BINDING PROTEINS was indexed under RNA-BINDING PROTEINS 1981-2002", "HN": "2003; use RNA CAP-BINDING PROTEINS (NM) 1981-2002", "MR": "20050630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039381"}, {"RECTYPE": "D", "MH": "Maternal Nutritional Physiological Phenomena", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Maternal Nutrition Physiology|T040|T168|NON|EQV|NLM (2007)|051221|abbcdef", "ENTRY": "Physiology, Maternal Nutritional", "MN": "G07.203.650.566", "MH_TH": "NLM (2009)", "ST": "T168", "AN": "PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA is also available", "PI": "Nutrition (1979-2002)", "MS": "Nutrition of a mother which affects the health of the FETUS and INFANT as well as herself.", "PM": "2009; see MATERNAL NUTRITION PHYSIOLOGY 2007-2008, see MATERNAL NUTRITION 2003-2006, see NUTRITION 1979-2002", "HN": "2009 (2003); use NUTRITION 1979-2002", "MR": "20160928", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039382"}, {"RECTYPE": "D", "MH": "Prenatal Nutritional Physiological Phenomena", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Prenatal Nutrition Physiology|T040|NON|EQV|NLM (2007)|051221|abcdef", "ENTRY": "Physiology, Prenatal Nutritional", "MN": "G08.686.784.769.600", "FX": "Prenatal Care", "MH_TH": "NLM (2009)", "ST": "T040", "AN": "check tags FEMALE & PREGNANCY", "PI": "Nutrition (1979-2002)", "MS": "Nutrition of FEMALE during PREGNANCY.", "PM": "2009; see PRENATAL NUTRITION PHYSIOLOGY 2007-2008, see PRENATAL NUTRITION 2003-2006", "HN": "2009 (2003)", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039401"}, {"RECTYPE": "D", "MH": "Integrin alpha2", "DS": "INTEGRIN ALPHA A 02", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "CD49b Antigens|T116|T129|ACX|EQV|NLM (2003)|020415|CD 049B ANTIGENS|abbcdefs", "ENTRY": "alpha2, Integrin", "MN": "D12.776.543.750.705.408.100.350", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "PI": "Integrins (1993-1995)", "MS": "An integrin alpha subunit that primarily combines with INTEGRIN BETA1 to form the INTEGRIN ALPHA2BETA1 heterodimer. It contains a domain which has homology to collagen-binding domains found in von Willebrand factor.", "PM": "2003; INTEGRIN ALPHA2 was indexed under ANTIGENS, CD 1996-2002 and under INTEGRINS 1993-1995", "HN": "2003 (1993)", "MR": "20170524", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039421"}, {"RECTYPE": "D", "MH": "Integrin alpha3", "DS": "INTEGRIN ALPHA A 03", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "CD49c Antigens|T116|T123|ACX|EQV|NLM (2003)|020416|CD 049C ANTIGENS|abbcdefs", "ENTRY": "alpha3, Integrin", "MN": "D12.776.543.750.705.408.100.400", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Integrins (1995-2002)", "MS": "An integrin alpha subunit that occurs as alternatively spliced isoforms. The isoforms are differentially expressed in specific cell types and at specific developmental stages. Integrin alpha3 combines with INTEGRIN BETA1 to form INTEGRIN ALPHA3BETA1 which is a heterodimer found primarily in epithelial cells.", "PM": "2003; INTEGRIN ALPHA3 was indexed under INTEGRINS and ANTIGENS CD 1995-2002", "HN": "2003 (1995)", "MR": "20170524", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039422"}, {"RECTYPE": "D", "MH": "Integrin alpha1", "DS": "INTEGRIN ALPHA A 01", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "CD49a Antigens|T116|T123|ACX|EQV|NLM (2003)|020415|CD 049A ANTIGENS|abbcdefs", "ENTRY": "alpha Subunit, VLA-1", "MN": "D12.776.543.750.705.408.100.300", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Integrins (1994-1995)", "MS": "An integrin alpha subunit that binds COLLAGEN and LAMININ though its I domain. It combines with INTEGRIN BETA1 to form the heterodimer INTEGRIN ALPHA1BETA1.", "PM": "2003; INTEGRIN ALPHA1 was indexed under ANTIGENS, CD 1994-2002", "HN": "2003 (1994)", "MR": "20170524", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039423"}, {"RECTYPE": "D", "MH": "Integrin alpha4", "DS": "INTEGRIN ALPHA A 04", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD49d Antigens|T116|T123|ACX|EQV|NLM (2003)|020416|CD 049D ANTIGENS|abbcdefs", "ENTRY": "Integrin, alpha4", "MN": "D12.776.543.750.705.408.100.450", "FX": "Natalizumab", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "143198-26-9", "PI": "Antigens, CD (1994-2002)", "MS": "An integrin alpha subunit that is unique in that it does not contain an I-domain, and its proteolytic cleavage site is near the middle of the extracellular portion of the polypeptide rather than close to the membrane, as in other integrin alpha subunits.", "PM": "2003; ALPHA4 INTEGRIN (now INTEGRIN ALPHA4) was indexed under ANTIGENS, CD 1994-2002", "HN": "2003 (1994)", "MR": "20170531", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039441"}, {"RECTYPE": "D", "MH": "CD11b Antigen", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Mo1 Antigen|T116|T129|T192|EQV|NLM (1991)|900215|MO ANTIGEN 01|abbbdefs", "ENTRY": "alphaM, Integrin", "MN": "D23.050.301.350.074.049", "MH_TH": "NLM (1995)", "ST": "T192", "RN": "0", "PI": "Macrophage-1 Antigen (1990-2002)", "MS": "A CD antigen that contains a conserved integrin I-domain which is involved in ligand binding. When combined with CD18 the two subunits form MACROPHAGE-1 ANTIGEN.", "PM": "2018; see ANTIGENS, CD11B 2003-2017; for ANTIGENS CD11B and CD11B ANTIGEN see MACROPHAGE-1 ANTIGEN 1995-2002; for M01 ANTIGEN & MO1 GLYCOPROTEIN see MACROPHAGE-1 ANTIGEN 1991-2002", "HN": "2018 (1990); for ANTIGENS CD11B and CD11B ANTIGEN use MACROPHAGE-1 ANTIGEN 1995-2002; for M01 ANTIGEN & MO1 GLYCOPROTEIN use MACROPHAGE-1 ANTIGEN 1991-2002", "MR": "20230316", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039481"}, {"RECTYPE": "D", "MH": "Integrin alpha5", "DS": "INTEGRIN ALPHA A 05", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "CD49e Antigens|T116|T129|ACX|EQV|NLM (2003)|020416|CD 049E ANTIGENS|abbcdefs", "ENTRY": "alphaF, Integrin", "MN": "D12.776.543.750.705.408.100.500", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "PI": "Antigens, CD (1996-2002)", "MS": "This integrin alpha subunit combines with INTEGRIN BETA1 to form a receptor (INTEGRIN ALPHA5BETA1) that binds FIBRONECTIN and LAMININ. It undergoes posttranslational cleavage into a heavy and a light chain that are connected by disulfide bonds.", "PM": "2003; INTEGRIN ALPHA5 was indexed under ANTIGENS, CD 1996-2002", "HN": "2003 (1996)", "MR": "20170524", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039482"}, {"RECTYPE": "D", "MH": "Nuclear Cap-Binding Protein Complex", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nuclear Cap Binding Protein Subunit 1, 80-kDa|T116|T123|NON|NRW|NLM (2003)|020329|abbcdef", "ENTRY": "Nuclear Cap Binding Protein, 80 kDa", "MN": "D12.776.664.962.750.750", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "RNA-Binding Proteins (1981-2002)", "MS": "A heterodimeric protein complex of RNA cap-binding proteins, which binds with high affinity to the 5' MRNA CAP STRUCTURE in the CELL NUCLEUS. The complex contains two subunits, one of 80-kDa molecular weight and another of 20-kDa molecular weight.", "PM": "2003; CBP80 PROTEIN was indexed under RNA-BINDING PROTEINS 1994-2002; CAF20 PROTEIN was indexed under RNA-BINDING PROTEINS 1997-2002; CBP20 PROTEIN was indexed under RNA-BINDING PROTEINS 1996-2002", "HN": "2003; for CBP80 PROTEIN use RNA CAP-BINDING PROTEINS 1994-2002; for CAF20 PROTEIN use RNA CAP-BINDING PROTEINS 1997-2002; for CBP20 PROTEIN use RNA CAP-BINDING PROTEINS 1996-2002", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039502"}, {"RECTYPE": "D", "MH": "Integrin alpha6", "DS": "INTEGRIN ALPHA A 06", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Integrin alpha6B|T116|T123|NON|NRW|NLM (2003)|INTEGRIN ALPHA A 06B|abbcdes", "ENTRY": "alpha6B, Integrin", "MN": "D12.776.543.750.705.408.100.550", "FX": "Integrin alpha6beta4", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Antigens, CD (1994-2002)", "MS": "An integrin alpha subunit that primarily associates with INTEGRIN BETA1 or INTEGRIN BETA4 to form laminin-binding heterodimers. Integrin alpha6 has two alternatively spliced isoforms: integrin alpha6A and integrin alpha6B, which differ in their cytoplasmic domains and are regulated in a tissue-specific and developmental stage-specific manner.", "PM": "2003; INTEGRIN ALPHA6 was indexed under ANTIGENS, CD 1994-2002", "HN": "2003 (1994)", "MR": "20170524", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039503"}, {"RECTYPE": "D", "MH": "CD11c Antigen", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Leu-M5 Antigens|T116|T129|T192|EQV|NLM (1995)|940328|LEU M ANTIGENS 005|abbbdefs", "ENTRY": "alphaX, Integrin", "MN": "D23.050.301.350.275.500", "MH_TH": "NLM (1995)", "ST": "T192", "RN": "0", "PI": "Integrin alphaXbeta2 (1995-2002)", "MS": "An integrin alpha subunit of approximately 150-kDa molecular weight. It is expressed at high levels on monocytes and combines with CD18 ANTIGEN to form the cell surface receptor INTEGRIN ALPHAXBETA2. The subunit contains a conserved I-domain which is characteristic of several of alpha integrins.", "PM": "2018; see ANTIGENS, CD11C 2003-2018; for CD11C ANTIGEN and ANTIGENS, CD11C see COMPLEMENT 4-BINDING PROTEIN 1995-2002", "HN": "2018 (1995); for CD11C ANTIGEN and ANTIGENS, CD11C use INTEGRIN ALPHAXBETA2 1995-2002", "MR": "20230316", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039521"}, {"RECTYPE": "D", "MH": "Eukaryotic Initiation Factor-4E", "DS": "EUKARYOTIC INITIATION FACTOR 04 E", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Initiation Factor EIF-4E|T116|T123|ACX|EQV|NLM (2003)|020412|PEPTIDE INITIATION FACTOR EIF 04 E|abbcdefs", "ENTRY": "Peptide Initiation Factor EIF 4E", "MN": "D12.776.835.725.868.500.750", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Peptide Initiation Factors (1986-2002)", "MS": "A peptide initiation factor that binds specifically to the 5' MRNA CAP STRUCTURE of MRNA in the CYTOPLASM. It is a component of the trimeric complex EIF4F.", "PM": "2003; EIF-4E (now EUKARYOTIC INITIATION FACTOR-4E) was indexed under PEPTIDE INITIATION FACTORS 1986-2002", "HN": "2003; use EUKARYOTIC INITIATION FACTOR-4E (NM) 1986-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039561"}, {"RECTYPE": "D", "MH": "Eukaryotic Initiation Factor-4F", "DS": "EUKARYOTIC INITIATION FACTOR 04 F", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Initiation Factor EIF-4F|T116|T123|ACX|EQV|NLM (2003)|020412|PEPTIDE INITIATION FACTOR EIF 04 F|abbcdefs", "ENTRY": "Protein Initiation Factor EIF 4F", "MN": "D12.776.835.725.868.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Peptide Initiation Factors (1983-2002)", "MS": "A trimeric peptide initiation factor complex that associates with the 5' MRNA cap structure of RNA (RNA CAPS) and plays an essential role in MRNA TRANSLATION. It is composed of EUKARYOTIC INITIATION FACTOR-4A; EUKARYOTIC INITIATION FACTOR-4E; and EUKARYOTIC INITIATION FACTOR-4G.", "PM": "2003; EIF-4F (now EUKARYOTIC INITIATION FACTOR-4F) was indexed under PEPTIDE INITIATION FACTORS 1983-2003", "HN": "2003; use EUKARYOTIC INITIATION FACTOR-4F (NM) 1983-2003", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039562"}, {"RECTYPE": "D", "MH": "Histamine H1 Antagonists, Non-Sedating", "DE": "HISTAMINE H1 ANTAG NON SEDATING", "DS": "HISTAMINE ANTAGONISTS H 001 NON SEDATING", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Third Generation H1 Antagonist|T109|T121|NON|NRW|NLM (2021)|191119|abbcdef", "ENTRY": "Non-Sedating H1 Antihistamines", "MN": "D27.505.696.577.375.425.400.500", "FX": "Anti-Allergic Agents", "MH_TH": "NLM (2003)", "ST": "T121", "RN": "0", "PI": "Histamine H1 Antagonists (1982-2002)", "MS": "A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment.", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039563"}, {"RECTYPE": "D", "MH": "Integrin alphaV", "DS": "INTEGRIN ALPHA V", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "CD51 Antigens|T116|T123|ACX|EQV|NLM (2003)|020416|CD 051 ANTIGENS|abbcdefs", "ENTRY": "alphaV, Integrin", "MN": "D12.776.543.750.705.408.100.900", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "\"V\" in alphaV is the letter not the roman numeral", "PI": "Antigens, CD (1994-2002)", "MS": "An alpha integrin with a molecular weight of 160-kDa that is found in a variety of cell types. It undergoes posttranslational cleavage into a heavy and a light chain that are connected by disulfide bonds. Integrin alphaV can combine with several different beta subunits to form heterodimers that generally bind to RGD sequence-containing extracellular matrix proteins.", "PM": "2003; INTEGRIN ALPHAV was indexed under ANTIGENS, CD 1994-2002", "HN": "2003; use INTEGRIN ALPHAV (NM) 1994-2002", "MR": "20170524", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039564"}, {"RECTYPE": "D", "MH": "Eukaryotic Initiation Factor-4A", "DS": "EUKARYOTIC INITIATION FACTOR 04 A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Initiation Factor EIF-4A|T116|T123|ACX|EQV|NLM (2003)|020412|PEPTIDE INITIATION FACTOR EIF 04 A|abbcdefs", "ENTRY": "Peptide Initiation Factor EIF 4A", "MN": "D12.776.835.725.868.500.500", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "EC 2.7.7.-", "PI": "Peptide Initiation Factors (1980-2002)", "MS": "A component of eukaryotic initiation factor 4F that as an RNA helicase involved in unwinding the secondary structure of the 5' UNTRANSLATED REGION of MRNA. The unwinding facilitates the binding of the 40S ribosomal subunit.", "PM": "2003; EIF-4A (now EUKARYOTIC INITIATION FACTOR-4A) was indexed under PEPTIDE INITIATION FACTORS 1980-2002", "HN": "2003; use EUKARYOTIC INITIATION FACTOR-F4A (NM) 1980-2001", "MR": "20030709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039601"}, {"RECTYPE": "D", "MH": "After-Hours Care", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Practitioner Cooperatives", "MN": "N05.300.049", "FX": "Night Care", "MH_TH": "NLM (2003)", "ST": "T058", "PI": "Telephone (1991-2002)", "MS": "Medical care provided after the regular daily practice schedule of the physicians. Usually it is designed to deliver 24-hour-a-day and 365 day-a-year patient care coverage for emergencies, triage, pediatric care, and hospice care.", "PM": "2003", "HN": "2003", "MR": "20170630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039602"}, {"RECTYPE": "D", "MH": "Eukaryotic Initiation Factor-4G", "DS": "EUKARYOTIC INITIATION FACTOR 04 G", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Initiation Factor EIF-4G|T116|T123|ACX|EQV|NLM (2003)|PEPTIDE INITIATION FACTOR EIF 04 G|abbcdes", "ENTRY": "Peptide Initiation Factor EIF 4G", "MN": "D12.776.835.725.868.500.875", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Peptide Initiation Factors (1997-2002)", "MS": "A component of eukaryotic initiation factor-4F that is involved in multiple protein interactions at the site of translation initiation. Thus it may serve a role in bringing together various initiation factors at the site of translation initiation.", "PM": "2003; EIF-4G (now EUKARYOTIC INITIATION FACTOR-4G) was indexed under PEPTIDE INITIATION FACTORS 1997-2002", "HN": "2003; use EUKARYOTIC INITIATION FACTOR-4G (NM) 1997-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039603"}, {"RECTYPE": "D", "MH": "Answering Services", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Answering Service", "MN": "N05.300.049.500", "MH_TH": "NLM (2003)", "ST": "T066", "PI": "Telephone (1972-2002)", "MS": "Communication services provided by a person or a machine to record and relay the message from the caller.", "PM": "2003", "HN": "2003", "MR": "20220712", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039604"}, {"RECTYPE": "D", "MH": "Eukaryotic Initiation Factor-3", "DS": "EUKARYOTIC INITIATION FACTOR 03", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Initiation Factor EIF-3|T116|T123|ACX|EQV|NLM (2003)|020412|PEPTIDE INITIATION FACTOR EIF 03|abbcdefs", "ENTRY": "Peptide Initiation Factor EIF 3", "MN": "D12.776.835.725.868.437", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Peptide Initiation Factors (1990-2002)", "MS": "A multisubunit eukaryotic initiation factor that contains at least 8 distinct polypeptides. It plays a role in recycling of ribosomal subunits to the site of transcription initiation by promoting the dissociation of non-translating ribosomal subunits. It also is involved in promoting the binding of a ternary complex of EUKARYOTIC INITIATION FACTOR-2; GTP; and INITIATOR TRNA to the 40S ribosomal subunit.", "PM": "2003; EIF-3 (now EUKARYOTIC INITIATION FACTOR-3) was indexed under PEPTIDE INITIATION FACTORS 1990-2002; EUKARYOTIC INITIATION FACTOR 3 P110 (now EUKARYOTIC INITIATION FACTOR-3) was indexed under PEPTIDE INITIATION FACTORS 2000-2002; EUKARYOTIC INITIATION FACTOR 3, SUBUNIT 4 (now EUKARYOTIC INITIATION FACTOR-3) was indexed under PEPTIDE INITIATION FACTORS 1999-2002; INT-6 PROTEIN (now EUKARYOTIC INITIATION FACTOR-3) was indexed under PEPTIDE INITIATION FACTORS 1995-2002", "HN": "2003; use EUKARYOTIC INITIATION FACTOR-3 (NM) 1990-2002", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039621"}, {"RECTYPE": "D", "MH": "Integrin beta Chains", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "beta Integrins|T116|T123|NON|EQV|NLM (2003)|020418|abbcdef", "ENTRY": "beta Chains, Integrin", "MN": "D12.776.543.750.705.408.200", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Integrins (1990-2002)", "MS": "Integrin beta chains combine with integrin alpha chains to form heterodimeric cell surface receptors. Integrins have traditionally been classified into functional groups based on the identity of one of three beta chains present in the heterodimer. The beta chain is necessary and sufficient for integrin-dependent signaling. Its short cytoplasmic tail contains sequences critical for inside-out signaling.", "PM": "2003", "HN": "2003", "MR": "20130709", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039641"}, {"RECTYPE": "D", "MH": "Eukaryotic Initiation Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Translation Initiation Factors, Eukaryotic|T116|T123|NON|EQV|NLM (2003)|020405|abbcdef", "ENTRY": "Initiation Factors, Eukaryotic", "MN": "D12.776.835.725.868", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics; coordinate with MITOCHONDRIAL PROTEINS or CHLOROPLAST PROTEINS if pertinent", "PI": "Peptide Initiation Factors (1973-2002)", "MS": "Peptide initiation factors from eukaryotic organisms. Over twelve factors are involved in PEPTIDE CHAIN INITIATION, TRANSLATIONAL in eukaryotic cells. Many of these factors play a role in controlling the rate of MRNA TRANSLATION.", "PM": "2003", "HN": "2003", "MR": "20110624", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039642"}, {"RECTYPE": "D", "MH": "Integrin beta3", "DS": "INTEGRIN BETA A 03", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Platelet Membrane Glycoprotein IIIa|T116|T123|NON|EQV|NLM (1996)|950120|abbcdef", "ENTRY": "beta3, Integrin", "MN": "D12.776.543.750.705.408.200.750", "FX": "Platelet Glycoprotein GPIIb-IIIa Complex", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Receptors, Endogenous Substances (1989)", "MS": "An integrin beta subunit of approximately 85-kDa in size which has been found in INTEGRIN ALPHAIIB-containing and INTEGRIN ALPHAV-containing heterodimers. Integrin beta3 occurs as three alternatively spliced isoforms, designated beta3A-C.", "PM": "2003; INTEGRIN BETA3 was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1989, INTEGRINS 1990-1995, PLATELET MEMBRANE GLYCOPROTEINS & ANTIGENS, CD 1996-2002; for PLATELET MEMBRANE GLYCPROTEIN IIIA see PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002", "HN": "2003; use INTEGRIN BETA3 (NM) 1989-2002; for PLATELET MEMBRANE GLYCPROTEIN IIIA use PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002", "MR": "20170524", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039661"}, {"RECTYPE": "D", "MH": "Prokaryotic Initiation Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Translation Initiation Factors, Prokaryotic|T116|T123|NON|EQV|NLM (2003)|020405|abbcdef", "ENTRY": "Initiation Factors, Prokaryotic", "MN": "D12.776.835.725.934", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Peptide Initiation Factors (1973-2002)", "MS": "Peptide initiation factors from prokaryotic organisms. Only three factors are needed for translation initiation in prokaryotic organisms, which occurs by a far simpler process than in PEPTIDE CHAIN INITIATION, TRANSLATIONAL of eukaryotic organisms.", "PM": "2003", "HN": "2003", "MR": "20150623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039662"}, {"RECTYPE": "D", "MH": "Integrin beta4", "DS": "INTEGRIN BETA A 04", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "CD104 Antigens|T116|T129|ACX|EQV|NLM (2003)|020418|CD 104 ANTIGENS|abbcdefs", "ENTRY": "beta4, Integrin", "MN": "D12.776.543.750.705.408.200.800", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "PI": "Integrins (1994-2002)", "MS": "Also known as CD104 antigen, this protein is distinguished from other beta integrins by its relatively long cytoplasmic domain (approximately 1000 amino acids vs. approximately 50). Five alternatively spliced isoforms have been described.", "PM": "2003; INTEGRIN BETA4 was indexed under ANTIGENS, CD 1996-2002 & INTEGRINS 1994-1995", "HN": "2003; use INTEGRIN BETA4 (NM) 1994-2002", "MR": "20170524", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039663"}, {"RECTYPE": "D", "MH": "Prokaryotic Initiation Factor-3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Initiation Factor IF-3|T116|T123|ACX|EQV|NLM (2003)|020412|PEPTIDE INITIATION FACTOR IF 03|abbcdefs", "ENTRY": "Prokaryotic Peptide Initiation Factor 3", "MN": "D12.776.835.725.934.750", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Peptide Initiation Factors (1979-2002)", "MS": "A prokaryotic initiation factor that plays a role in recycling of ribosomal subunits for a new round of translational initiation. It binds to 16S RIBOSOMAL RNA and stimulates the dissociation of vacant 70S ribosomes. It may also be involved in the preferential binding of initiator tRNA to the 30S initiation complex.", "PM": "2003; PEPTIDE INITIATION FACTOR 3 (now PROKARYOTIC INITIATION FACTOR-3) was indexed under PEPTIDE INITIATION FACTORS 1979-2002; TIF IF3 & TRANSLATION INITIATION FACTOR 3 were indexed under PEPTIDE INITIATION FACTORS 1994-2002", "HN": "2003; use PROKARYOTIC INITIATION FACTOR-3 (NM) 1979-2002; for TIF IF3 & TRANSLATION INITIATION FACTOR 3 use EUKARYOTIC INITIATION FACTOR-3 (NM) 1994-2002", "MR": "20050711", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039665"}, {"RECTYPE": "D", "MH": "Pyranocoumarins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Calanolides|T109|T121|NON|NRW|NLM (2003)|020402|abbcdef", "MN": "D03.633.100.150.446.853", "MH_TH": "NLM (2003)", "ST": "T121", "RN": "0", "PI": "Coumarins (1977-2002)", "MS": "A type of COUMARINS with added pyran ring(s).", "PM": "2003", "HN": "2003", "MR": "20160531", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039681"}, {"RECTYPE": "D", "MH": "HIV-Associated Lipodystrophy Syndrome", "DE": "HIV ASSOC LIPODYSTROPHY SYNDROME", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lipodystrophy, HIV-Associated", "MN": "C20.673.480.400", "MH_TH": "NLM (2003)", "ST": "T047", "PI": "Lipodystrophy (1998-2002)", "MS": "Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039682"}, {"RECTYPE": "D", "MH": "Current Procedural Terminology", "AQ": "HI", "PRINT ENTRY": "Current Procedural Terminology Code|T170|NON|NRW|NLM (2021)|191121|abcdef", "ENTRY": "Codes, CPT", "MN": "L01.462.750.245.945.160", "MH_TH": "NLM (2003)", "ST": "T170", "AN": "CATALOGER: Use NAF entry", "PI": "Terminology (1970-2002)", "MS": "Descriptive terms and identifying codes for reporting medical services and procedures performed by PHYSICIANS. It is produced by the AMERICAN MEDICAL ASSOCIATION and used in insurance claim reporting for MEDICARE; MEDICAID; and private health insurance programs (From CPT 2002).", "PM": "2003", "HN": "2003", "MR": "20220712", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039702"}, {"RECTYPE": "D", "MH": "Logical Observation Identifiers Names and Codes", "PRINT ENTRY": "LOINC|T170|ACR|EQV|NLM (2003)|020402|abcdef", "MN": "L01.462.750.245.945.500", "MH_TH": "NLM (2003)", "ST": "T170", "PI": "Vocabulary, Controlled (1996-2002)", "MS": "A vocabulary database of universal identifiers for laboratory and clinical test results. Its purpose is to facilitate the exchange and pooling of results for clinical care, outcomes management, and research. It is produced by the Regenstrief Institute. (LOINC and RELMA [Internet]. Indianapolis: The Regenstrief Institute; c1995-2001 [cited 2002 Apr 2]. Available from http://www.regenstrief.org/loinc)", "PM": "2003", "HN": "2003", "MR": "20220712", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039703"}, {"RECTYPE": "D", "MH": "Diagnostic and Statistical Manual of Mental Disorders", "DE": "DIAG STATIST MANUAL MENTAL DIS", "PRINT ENTRY": "DSM-IV|T170|ACR|NRW|NLM (2003)|020515|abcdef", "ENTRY": "DSM-V|T170|ACR|NRW|NLM (2003)|020627|abcdef", "MN": "L01.462.750.245.945.200", "MH_TH": "NLM (2003)", "ST": "T170", "AN": "CATALOGER: Use NAF entry", "PI": "specific mental disorder/diagnosis (1969-2002)", "MS": "Categorical classification of MENTAL DISORDERS based on criteria sets with defining features. It is produced by the American Psychiatric Association. (DSM-IV, page xxii)", "PM": "2003", "HN": "2003", "MR": "20220712", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039721"}, {"RECTYPE": "D", "MH": "Antigens, Dermatophagoides", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "House Dust Mite Antigens|T116|T129|NON|EQV|NLM (2023)|211001|abbcdef", "ENTRY": "Dermatophagoides pteronyssinus Antigens", "MN": "D23.050.181", "FX": "Dust Mite Allergy", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "AN": "coordinate with ALLERGENS if pertinent", "PI": "Dust (1968-2002)", "MS": "Antigens from the house dust mites (DERMATOPHAGOIDES), mainly D. farinae and D. pteronyssinus. They are proteins, found in mite feces or mite extracts, that can cause ASTHMA and other allergic diseases such as perennial rhinitis (RHINITIS, ALLERGIC, PERENNIAL) and atopic dermatitis (DERMATITIS, ATOPIC). More than 11 groups of Dermatophagoides ALLERGENS have been defined. Group I allergens, such as Der f I and Der p I from the above two species, are among the strongest mite immunogens in humans.", "PM": "2003", "HN": "2003", "MR": "20220712", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039741"}, {"RECTYPE": "D", "MH": "Genista", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gorse, Spanish|T002|EPO|NRW|NLM (2003)|020403|abcdef", "ENTRY": "tinctorias, Genista", "MN": "B01.875.800.575.912.250.401.262", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid49818", "RR": "txid49825", "AN": "entry term BROOM, DYERS: several other Broom terms are also available; check text and MeSH", "MS": "A plant genus of the family FABACEAE. The common name of broom may be confused with Scotch Broom (CYTISUS) or Butcher's Broom (RUSCUS) or Desert Broom (BACCHARIS) or Spanish Broom (SPARTIUM) or Brome (BROMUS).", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039761"}, {"RECTYPE": "D", "MH": "Ulex", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Gorse, European|T002|EPO|NRW|NLM (2003)|020403|abcdef", "ENTRY": "jussiaei, Ulex", "MN": "B01.875.800.575.912.250.401.952", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3901", "RR": "txid3902", "MS": "A plant genus of the family FABACEAE (sometimes classified as Papilionaceae). Members contain LECTINS.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039762"}, {"RECTYPE": "D", "MH": "PubMed", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "MN": "L01.470.750.500.650", "FX": "MEDLINE", "MH_TH": "NLM (2003)", "ST": "T170", "AN": "CATALOGER: Use NAF entry", "PI": "MEDLINE (1999-2002)", "MS": "A bibliographic database that includes MEDLINE as its primary subset. It is produced by the National Center for Biotechnology Information (NCBI), part of the NATIONAL LIBRARY OF MEDICINE. PubMed, which is searchable through NLM's Web site, also includes access to additional citations to selected life sciences journals not in MEDLINE, and links to other resources such as the full-text of articles at participating publishers' Web sites, NCBI's molecular biology databases, and PubMed Central.", "PM": "2003", "HN": "2003", "MR": "20180629", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039781"}, {"RECTYPE": "D", "MH": "Monoterpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Monoterpenoid|T109|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Monoterpenoids|T109|NON|EQV|NLM (2003)|020404|abcdef", "MN": "D02.455.849.575", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "PI": "Terpenes (1965-2002)", "MS": "Compounds with a core of 10 carbons generally formed via the mevalonate pathway from the combination of 3,3-dimethylallyl pyrophosphate and isopentenyl pyrophosphate. They are cyclized and oxidized in a variety of ways. Due to the low molecular weight many of them exist in the form of essential oils (OILS, VOLATILE).", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039821"}, {"RECTYPE": "D", "MH": "Iridoids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Secoiridoids|T109|NON|NRW|NLM (2003)|020404|abcdef", "ENTRY": "Derivatives, Iridoid", "MN": "D03.383.663.491", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "PI": "Terpenes (1968-2002)", "MS": "A type of MONOTERPENES, derived from geraniol. They have the general form of cyclopentanopyran, but in some cases, one of the rings is broken as in the case of secoiridoid. They are different from the similarly named iridals (TRITERPENES).", "PM": "2003; IRIDOIDGLUCOSIDES was indexed under GLUCOSIDES 1975-2002", "HN": "2003; for IRIDOIDGLUCOSIDES use IRIDOIDS (NM) 1975-2002", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039823"}, {"RECTYPE": "D", "MH": "Leukocyte L1 Antigen Complex", "DS": "LEUKOCYTE L 001 ANTIGEN COMPLEX", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Leukocyte L1 Protein|T116|T129|NON|EQV|NLM (2003)|LEUKOCYTE L 001 PROTEIN|abbcdes", "ENTRY": "Migratory Inhibitory Factor Related Protein MRP", "MN": "D23.050.301.562", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "PI": "Neural Cell Adhesion Molecules (1996-2002)", "MS": "A member of the S-100 protein family that is present at high levels in the blood and interstitial fluid in several infectious, inflammatory, and malignant disorders, including rheumatoid arthritis, inflammatory bowel disease, and cystic fibrosis. It is a complex of a light chain (CALGRANULIN A) and a heavy chain (CALGRANULIN B). L1 binds calcium through an EF-hand motif, and has been shown to possess antimicrobial activity.", "PM": "2003; L1 ANTIGEN (now LEUKOCYTE L1 ANTIGEN COMPLEX) was indexed under MEMBRANE GLYCOPROTEINS 1984-2002, NEURAL CELL ADHESION MOLECULES 1996-2002, CELL ADHESION MOLECULES, NEURONAL 1992-1995 & ANTIGENS, SURFACE 1984-1991", "HN": "2003; use LEUKOCYTE L1 ANTIGEN COMPLEX (NM) 1984-2002", "MR": "20230609", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039841"}, {"RECTYPE": "D", "MH": "Neural Cell Adhesion Molecule L1", "DS": "NEURAL CELL ADHESION MOLECULE L 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nerve Growth Factor Inducible Large External Glycoprotein", "MN": "D23.050.301.350.250.520.578", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Neural Cell Adhesion Molecules (1996-2002)", "MS": "A member of the immunoglobulin superfamily of neuronal cell adhesion molecules that is required for proper nervous system development. Neural cell adhesion molecule L1 consists of six Ig domains, five fibronectin domains, a transmembrane region and an intracellular domain. Two splicing variants are known: a neuronal form that contains a four-amino acid RSLE sequence in the cytoplasmic domain, and a non-neuronal form that lacks the RSLE sequence. Mutations in the L1 gene result in L1 disease. Neural cell adhesion molecule L1 is predominantly expressed during development in neurons and Schwann cells; involved in cell adhesion, neuronal migration, axonal growth and pathfinding, and myelination.", "PM": "2003; NERVE GROWTH FACTOR-INDUCIBLE LARGE EXTERNAL GLYCOPROTEIN (now NEURAL CELL ADHESION MOLECULE L1) was indexed under MEMBRANE GLYCOPROTEINS 1988-2002 & GLYCOPROTEINS 1983-1987; NEURAL CELL ADHESION MOLECULE L1; F11 GLYCOPROTEIN; CELL ADHESION MOLECULE L1; CAML1 GENE PRODUCT; CELL SURFACE GLYCOPROTEIN L1; L1 CELL ADHESION MOLECULE; L1 CAM & NEURAL ADHESION MOLECULE L1 were indexed under MEMBRANE GLYCOPROTEINS 1992-2002, NEURAL CELL ADHESION MOLECULES 1996-2002, CELL ADHESION MOLECULES, NEURONAL 1992-1995 & ANTIGENS, SURFACE 1984-1991; CALL PROTEIN was indexed under MEMBRANE GLYCOPROTEINS 1999-2002 & NEURAL CELL ADHESION MOLECULES 1999-2002; NILE PROTEIN was indexed under MEMBRANE GLYCOPROTEINS 1992-2002 & NEURAL CELL ADHESION MOLECULES 1996-2002", "HN": "2003; use NEURAL CELL ADHESION MOLECULE L1 (NM) 1983-2002; for NEURAL CELL ADHESION MOLECULE L1; F11 GLYCOPROTEIN; CELL ADHESION MOLECULE L1; CAML1 GENE PRODUCT; CELL SURFACE GLYCOPROTEIN L1; L1 CELL ADHESION MOLECULE; L1 CAM & NEURAL ADHESION MOLECULE L1 use LEUKOCYTE L1 ANTIGEN COMPLEX (NM) 1992-2002; for CALL PROTEIN use LEUKOCYTE L1 ANTIGEN COMPLEX (NM) 1999-2002; for NILE PROTEIN use LEUCKCYTE L1 ANTIGEN COMPLEX (NM) 1996-2002", "MR": "20230316", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039842"}, {"RECTYPE": "D", "MH": "Prokaryotic Initiation Factor-1", "DS": "PROKARYOTIC INITIATION FACTOR 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Initiation Factor IF-1|T116|T123|ACX|EQV|NLM (2003)|020412|PEPTIDE INITIATION FACTOR IF 01|abbcdefs", "ENTRY": "Prokaryotic Peptide Initiation Factor 1", "MN": "D12.776.835.725.934.374", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Peptide Initiation Factors (1978-2002)", "MS": "The smallest of the three prokaryotic initiation factors with a molecular size of approximately 8 kD. It binds near the A-site of the 30S subunit of RIBOSOMES and may play a role in preventing premature addition of aminoacyl-tRNA-linked PEPTIDE ELONGATION FACTOR TU to the ribosome during the initiation of a peptide chain (PEPTIDE CHAIN INITIATION, TRANSLATIONAL).", "PM": "2003; for IF-1see EIF-1 1990-2002", "HN": "2003; for IF-1 use EUKARYOTIC INITIATION FACTOR-1 1990-2002", "MR": "20040730", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039861"}, {"RECTYPE": "D", "MH": "Prokaryotic Initiation Factor-2", "DS": "PROKARYOTIC INITIATION FACTOR 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Initiation Factor IF-2|T116|T123|ACX|EQV|NLM (2003)|PEPTIDE INITIATION FACTOR IF 02|abbcdes", "ENTRY": "Prokaryotic Initiation Factor 2", "MN": "D12.776.835.725.934.562", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Peptide Initiation Factors (1990-2002)", "MS": "The largest of the three prokaryotic initiation factors with a molecular size of approximately 80 kD. It functions in the transcription initiation process by promoting the binding of formylmethionine-tRNA to the P-site of the 30S ribosome and by preventing the incorrect binding of elongator tRNA to the translation initiation site.", "PM": "2003; PROKARYOTIC INITIATION FACTOR-2 was indexed under PEPTIDE INTIATION FACTORS 1990-2002; TRANSLATIONAL INITIATION FACTOR 2 was indexed under PEPTIDE INITIATION FACTORS 1997-2002", "HN": "2003; use PROKARYOTIC INITIATION FACTOR-2 (NM) 1990-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039881"}, {"RECTYPE": "D", "MH": "Totipotent Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Stem Cells, Totipotent|T025|NON|EQV|NLM (2003)|020405|abcdef", "ENTRY": "Totipotent Stem Cell", "MN": "A11.872.870", "MH_TH": "NLM (2003)", "ST": "T025", "AN": "MULTIPOTENT STEM CELLS and PLURIPOTENT STEM CELLS are also available", "MS": "Single cells that have the potential to form an entire organism. They have the capacity to specialize into extraembryonic membranes and tissues, the embryo, and all postembryonic tissues and organs. (Stem Cells: A Primer [Internet]. Bethesda (MD): National Institutes of Health (US); 2000 May [cited 2002 Apr 5]. Available from: http://www.nih.gov/news/stemcell/primer.htm)", "PM": "2003", "HN": "2003", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039901"}, {"RECTYPE": "D", "MH": "Multipotent Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Stem Cells, Multipotent|T025|NON|EQV|NLM (2003)|020405|abcdef", "ENTRY": "Stem Cell, Multipotent", "MN": "A11.872.590", "MH_TH": "NLM (2003)", "ST": "T025", "AN": "TOTIPOTENT STEM CELLS and PLURIPOTENT STEM CELLS are also available", "PI": "Stem Cells or specifics (1982-2002)", "MS": "Specialized stem cells that are committed to give rise to cells that have a particular function; examples are MYOBLASTS; MYELOID PROGENITOR CELLS; and skin stem cells. (Stem Cells: A Primer [Internet]. Bethesda (MD): National Institutes of Health (US); 2000 May [cited 2002 Apr 5]. Available from: http://www.nih.gov/news/stemcell/primer.htm)", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039902"}, {"RECTYPE": "D", "MH": "Actinobacteria", "DE": "ACTINOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Gram-Positive Bacteria, High G+C|T007|NON|EQV|NLM (2003)|020405|GRAM POS BACT HIGH GC|abcdefv", "ENTRY": "High G+C Gram-Positive Bacteria|T007|NON|EQV|NLM (2003)|020405|HIGH GC GRAM POS BACT|abcdefv", "MN": "B03.510.460.400.400.049", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid1760", "MS": "Class of BACTERIA with diverse morphological properties. Strains of Actinobacteria show greater than 80% 16S rDNA/rRNA sequence similarity among each other and also the presence of certain signature nucleotides. (Stackebrandt E. et al, Int. J. Syst. Bacteriol. (1997) 47:479-491)", "PM": "2003; for ACTINOMYCETES see ACTINOMYCETALES 1997-2002, see ACTINOMYCETES 1963-1966", "HN": "2003; for ACTINOMYCETES use ACTINOMYCETALES 1997-2002 & 1963-1966", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039903"}, {"RECTYPE": "D", "MH": "Pluripotent Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Stem Cells, Pluripotent|T025|NON|EQV|NLM (2003)|020405|abcdef", "ENTRY": "Stem Cell, Pluripotent", "MN": "A11.872.700", "MH_TH": "NLM (2003)", "ST": "T025", "AN": "TOTIPOTENT STEM CELLS and MULTIPOTENT STEM CELLS are also available", "PI": "Stem Cells or specifics (1972-2002)", "MS": "Cells that can give rise to cells of the three different GERM LAYERS.", "PM": "2003", "HN": "2003", "MR": "20060705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039904"}, {"RECTYPE": "D", "MH": "Neuropilins", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Neuropilin|T116|T192|NON|EQV|NLM (2003)|abbcde", "MN": "D12.776.543.750.590", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Nerve Tissue Proteins (1998-2002)", "MS": "Neuropilins are 140-kDa vertebrate cell surface receptors that bind neuronal guidance molecules during neural development and axonal outgrowth, and modulate VEGF-mediated angiogenesis. NEUROPILIN-1 and NEUROPILIN-2 differ in their binding specificities, and are distributed complementarily in regions of the developing nervous system. Neuropilins are receptors for secreted CLASS 3 SEMAPHORINS as well as for vascular endothelial growth factors, and may form hetero- or homodimers. They may also interact synergistically with plexins and with VEGF RECEPTORS to form receptor complexes with distinct affinities and specificities. Neuropilin binding specificity is determined by CUB and coagulation-factor-like domains in the extracellular portion of the molecule, while a MAM domain is essential for SIGNAL TRANSDUCTION.", "PM": "2003; NEUROPILIN was indexed under NERVE TISSUE PROTEINS 1998-2002", "HN": "2003; for NEUROPILIN use NEUROPILIN-1 (NM) 1998-2002", "MR": "20160531", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039921"}, {"RECTYPE": "D", "MH": "Bifidobacteriales Infections", "DE": "BIFIDOBACTERIALES INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Bifidobacteriales", "MN": "C01.150.252.410.110", "MH_TH": "NLM (2003)", "ST": "T047", "PI": "Actinomycetales Infections (1984-2002)", "MS": "Infections with BACTERIA of the order Bifidobacteriales. This includes infections in the genera BIFIDOBACTERIUM and GARDNERELLA, in the family Bifidobacteriaceae.", "PM": "2003", "HN": "2003", "MR": "20190617", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D039941"}, {"RECTYPE": "D", "MH": "Neuropilin-1", "DS": "NEUROPILIN 001", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Sema III", "MN": "D12.776.543.750.590.500", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "144713-63-3", "PI": "Nerve Tissue Proteins (1991-2002)", "MS": "A dimeric cell surface receptor involved in angiogenesis (NEOVASCULARIZATION, PHYSIOLOGICAL) and AXONAL GUIDANCE. Neuropilin-1 is a 140-kDa transmembrane protein that binds CLASS 3 SEMAPHORINS, and several other growth factors. Neuropilin-1 forms complexes with plexins or VEGF RECEPTORS; their binding affinity and specificity are determined by the composition of the neuropilin dimer and the identity of other receptors complexed with it. Neuropilin-1 is expressed in distinct patterns during neural development, complementary to those described for NEUROPILIN-2.", "PM": "2003; A5 ANTIGEN (now NEUROPILIN-1) was indexed under NERVE TISSUE PROTEINS 1991-2002", "HN": "2003; use NEUROPILIN-1 (NM) 1991-2002", "MR": "20160705", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039942"}, {"RECTYPE": "D", "MH": "Neuropilin-2", "DS": "NEUROPILIN 002", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Npn 2 Protein", "MN": "D12.776.543.750.590.750", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "0", "PI": "Nerve Tissue Proteins (1998-2002)", "MS": "Transmembrane receptor for CLASS 3 SEMAPHORINS and several vascular endothelial growth factor isoforms. Neuropilin-2 functions either as a homodimer or as a heterodimer with NEUROPILIN-1. The binding affinity of neuropilin-2 varies for different class 3 semaphorin isoforms and is dependent on the composition of the dimer. The protein also forms receptor complexes with plexins and with VEGF RECEPTORS, which alters the binding characteristics of the receptor.", "PM": "2003; NPN-2 PROTEIN was indexed under NERVE TISSUE PROTEINS 1998-2002", "HN": "2003; for NPN-2 PROTEIN use NEUROPILIN-1 1998-2002", "MR": "20160531", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039943"}, {"RECTYPE": "D", "MH": "Semaphorins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Semaphorins, Class V", "MN": "D23.529.923", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "MS": "A family of proteins that mediate AXONAL GUIDANCE. Semaphorins act as repulsive cues for neuronal GROWTH CONES and bind to receptors on their filopodia. At least 20 different molecules have been described and divided into eight classes based on domain organization and species of origin. Classes 1 and 2 are invertebrate, classes 3-7 are vertebrate, and class V are viral. Semaphorins may be secreted (classes 2, 3, and V), transmembrane (classes 1, 4, 5, and 6), or membrane-anchored (class 7). All semaphorins possess a common 500-amino acid extracellular domain which is critical for receptor binding and specificity, and is also found in plexins and scatter factor receptors. Their C termini are class-specific and may contain additional sequence motifs.", "PM": "2003; SEMA 1 & SEMAPHORIN-1 was indexed under CELL ADHESION MOLECULES, NEURONAL 1994-2002", "HN": "2003; for SEMA 1 & SEMAPHORIN-1 use SEMAPHORIN 1A, GRASSHOPPER (NM) 1994-2002", "MR": "20160226", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039961"}, {"RECTYPE": "D", "MH": "Pyroglyphidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Mites, House Dust|T204|NON|EQV|NLM (2003)|020412|abcdef", "ENTRY": "Mites, Housedust", "MN": "B01.050.500.131.166.132.419.600", "FX": "Dust", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6952", "RR": "txid6957", "PI": "Mites (1969-2002)", "MS": "Family of house dust mites, in the superfamily Analgoidea, order Astigmata. They include the genera Dermatophagoides and Euroglyphus.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D039981"}, {"RECTYPE": "D", "MH": "Dermatophagoides farinae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "House Dust Mite, American|T204|EPO|EQV|NLM (2003)|020411|abcdef", "ENTRY": "American House Dust Mite|T204|NON|EQV|NLM (2003)|020411|abcdef", "MN": "B01.050.500.131.166.132.419.600.200", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6954", "PI": "Mites (1968-2002)", "MS": "Species of American house dust mite, in the family PYROGLYPHIDAE.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040001"}, {"RECTYPE": "D", "MH": "Dermatophagoides pteronyssinus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "House Dust Mite, European|T204|EPO|EQV|NLM (2003)|020411|abcdef", "MN": "B01.050.500.131.166.132.419.600.215", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6956", "PI": "Mites (1966-2002)", "MS": "Species of European house dust mite, in the family PYROGLYPHIDAE. It is the most commonly found house dust mite.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040002"}, {"RECTYPE": "D", "MH": "Sarcoptidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.166.132.419.750", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid52281", "AN": "infestation: coord IM with MITE INFESTATIONS (IM)", "PI": "Mites (1965-2002)", "MS": "Family of MITES, in the superfamily Sarcoptoidea, order Astigmata. They are slow moving, obligate PARASITES that infect MAMMALS and BIRDS. The species SARCOPTES SCABIEI causes SCABIES.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040021"}, {"RECTYPE": "D", "MH": "Acaridae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Storage Mites|T204|NON|EQV|NLM (2003)|020412|abcdef", "ENTRY": "Store Product Mites", "MN": "B01.050.500.131.166.132.419.050", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid41442", "PI": "Mites (1967-2002)", "MS": "Family of MITES, in the superfamily Acaroidea, order Astigmata. They are frequently found in cereal-based foodstuffs including GRAIN and FLOUR.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040041"}, {"RECTYPE": "D", "MH": "Psoroptidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Psoroptes ovis|T204|NON|NRW|NLM (2003)|020412|abcdef", "ENTRY": "ovis, Psoroptes", "MN": "B01.050.500.131.166.132.419.575", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid83910", "RR": "txid94638", "AN": "infestation: coord IM with MITE INFESTATIONS (IM)", "PI": "Mites (1966-2002)", "MS": "Family of parasitic MITES, in the superfamily Sarcoptoidea, order Astigmata. Genera include Psoroptes and Chorioptes.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040042"}, {"RECTYPE": "D", "MH": "Eukaryotic Initiation Factor-5", "DS": "EUKARYOTIC INITIATION FACTOR 05", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peptide Initiation Factor EIF-5|T116|T123|ACX|EQV|NLM (2003)|020412|PEPTIDE INITIATION FACTOR EIF 05|abbcdefs", "ENTRY": "Peptide Initiation Factor EIF 5", "MN": "D12.776.835.725.868.750", "PA": "GTP Phosphohydrolase Activators", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Peptide Initiation Factors (1982-2002)", "MS": "A eukaryotic initiation factor that interacts with the 40S initiation complex and promotes the hydrolysis of the bound GTP. The hydrolysis of GTP causes the release of EUKARYOTIC INITIATION FACTOR-2 and EUKARYOTIC INITIATION FACTOR-3 from the 40S subunit and the subsequent joining of the 60S ribosomal subunit to the 40S complex to form the functional 80S initiation complex", "PM": "2003; EIF-5 (now EUKARYOTIC INITIATION FACTOR-5) was indexed under PEPTIDE INITIATION FACTORS 1982-2002", "HN": "2003; use EUKARYOTIC INITIATION FACTOR-5 (NM) 1982-2002", "MR": "20151123", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040061"}, {"RECTYPE": "D", "MH": "Protein Array Analysis", "DE": "PROTEIN ARRAY ANAL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Protein Profiling Chips|T074|T075|NON|REL|NLM (2003)|020412|abbcdef", "ENTRY": "ProteinChips", "MN": "E05.601.680", "FX": "Protein Interaction Mapping", "MH_TH": "NLM (2003)", "ST": "T063", "MS": "Ligand-binding assays that measure protein-protein, protein-small molecule, or protein-nucleic acid interactions using a very large set of capturing molecules, i.e., those attached separately on a solid support, to measure the presence or interaction of target molecules in the sample.", "PM": "2003", "HN": "2003", "MR": "20150626", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040081"}, {"RECTYPE": "D", "MH": "Tetranychidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Spider Mites|T204|NON|EQV|NLM (2003)|020415|abcdef", "ENTRY": "Spider Mite", "MN": "B01.050.500.131.166.132.419.850", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid32262", "PI": "Mites (1966-2002)", "MS": "Family of spider MITES, in the superfamily Tetranychoidea, suborder Trombidiformes.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040102"}, {"RECTYPE": "D", "MH": "Semaphorin-3A", "DS": "SEMAPHORIN A 03A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Collapsin 1", "MN": "D23.529.923.374", "MH_TH": "NLM (2003)", "ST": "T123", "RN": "0", "PI": "Glycoproteins (1993-2002)", "MS": "The prototypical and most well-studied member of the semaphorin family. Semaphorin-3A is an axon-repulsive guidance cue for migrating neurons in the developing nervous system. It has so far been found only in vertebrates, and binds to NEUROPILIN-1/plexin complex receptors on growth cones. Like other class 3 semaphorins, it is a secreted protein.", "PM": "2003; COLLAPSIN (now SEMAPHORIN 3A) was indexed under GLYCOPROTEINS 1993-2002", "HN": "2003; use SEMAPHORIN 3A (NM) 1994-2002", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040121"}, {"RECTYPE": "D", "MH": "Staphylococcaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.790", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid90964", "MS": "Family of gram-positive, facultatively anaerobic bacteria, in the order Bacillales. Genera include Gemella, Macrococcus, Salinicoccus, and STAPHYLOCOCCUS.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040141"}, {"RECTYPE": "D", "MH": "Brevibacterium flavum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.024.250.100", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid92706", "AN": "do not confuse with the genus BREVIBACTERIUM", "PI": "Brevibacterium (1967-2002)", "MS": "A species in the genus CORYNEBACTERIUM, family Corynebacteriaceae, which is used for industrial production of the amino acid LYSINE. It is closely related to Corynebacterium glutamicum.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040142"}, {"RECTYPE": "D", "MH": "Cellulomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.024.213", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid1707", "PI": "Actinomycetales (1974-2002)", "MS": "A genus of aerobic or facultatively anaerobic BACTERIA, in the family Cellulomonadaceae. It is found in the SOIL and capable of hydrolyzing CELLULOSE.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040143"}, {"RECTYPE": "D", "MH": "Frankia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.585.420", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid1854", "PI": "Actinomycetales (1980-2002)", "MS": "Genus of BACTERIA in the family Frankiaceae. They are nitrogen-fixing root-nodule symbionts of many species of woody dicotyledonous plants.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040161"}, {"RECTYPE": "D", "MH": "Genetic Diseases, X-Linked", "DE": "GENET DIS X LINKED", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "X-Linked Genetic Diseases|T047|NON|EQV|NLM (2003)|020520|abcdef", "ENTRY": "X-Linked Genetic Disease", "MN": "C16.320.322", "FX": "Sex Chromosome Disorders", "MH_TH": "NLM (2003)", "ST": "T047", "PI": "specific disease/Genetics (1984-2002)", "MS": "Genetic diseases that are linked to gene mutations on the X CHROMOSOME in humans (X CHROMOSOME, HUMAN) or the X CHROMOSOME in other species. Included here are animal models of human X-linked diseases.", "PM": "2003", "HN": "2003", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040181"}, {"RECTYPE": "D", "MH": "Platelet Membrane Glycoprotein IIb", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Integrin alphaIIb|T116|T129|T192|NON|EQV|NLM (2003)|020418|INTEGRIN ALPHA A 02B|abbbcdefs", "ENTRY": "alphaIIb, Integrin", "MN": "D12.776.543.750.705.408.100.950", "FX": "Platelet Glycoprotein GPIIb-IIIa Complex", "MH_TH": "NLM (1996)", "ST": "T192", "RN": "0", "PI": "Platelet Membrane Glycoproteins (1987-2002)", "MS": "Platelet membrane glycoprotein IIb is an integrin alpha subunit that heterodimerizes with INTEGRIN BETA3 to form PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX. It is synthesized as a single polypeptide chain which is then postranslationally cleaved and processed into two disulfide-linked subunits of approximately 18 and 110 kDa in size.", "PM": "2003; see PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002", "HN": "2003; use PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002", "MR": "20170524", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040201"}, {"RECTYPE": "D", "MH": "Social Marketing", "AQ": "ES", "ENTRY": "Marketing, Social", "MN": "N05.300.430.500.500", "MH_TH": "NLM (1979)", "ST": "T057", "MS": "Use of marketing principles also used to sell products to consumers to promote ideas, attitudes and behaviors. Design and use of programs seeking to increase the acceptance of a social idea or practice by target groups, not for the benefit of the marketer, but to benefit the target audience and the general society.", "PM": "2003; see Marketing of Health Services 1980-2002", "HN": "2003; use Marketing of Health Services 1980-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040241"}, {"RECTYPE": "D", "MH": "Risk Reduction Behavior", "PRINT ENTRY": "Risk Reduction|T061|NON|REL|NLM (2003)|020423|abcdef", "ENTRY": "Risk Reduction Behaviors", "MN": "F01.145.699", "FX": "Risk", "MH_TH": "NLM (1994)", "ST": "T055", "MS": "Reduction of high-risk choices and adoption of low-risk quantity and frequency alternatives.", "PM": "2003; see Health Behavior 1995-2002", "HN": "2003; use Health Behavior 1995-2002", "MR": "20130709", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040242"}, {"RECTYPE": "D", "MH": "Harm Reduction", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Harm Minimization|T061|NON|EQV|NLM (2003)|020423|abcdef", "ENTRY": "Reduction, Harm", "MN": "F01.145.477", "FX": "Risk", "MH_TH": "NLM (2003)", "ST": "T061", "MS": "The application of methods designed to reduce the risk of harm associated with certain behaviors without reduction in frequency of those behaviors. The risk-associated behaviors include ongoing and active addictive behaviors.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040261"}, {"RECTYPE": "D", "MH": "Receptors, Vascular Endothelial Growth Factor", "DE": "RECEPT VASCULAR ENDOTHELIAL GROWTH FACTOR", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, VEGF", "MN": "D12.776.543.750.750.400.910", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "AN": "general; prefer specifics", "PI": "Receptors, Mitogen (1991-1992)", "MS": "A family of closely related RECEPTOR PROTEIN-TYROSINE KINASES that bind vascular endothelial growth factors. They share a cluster of seven extracellular IG-LIKE DOMAINS which are important for ligand binding. They are highly expressed in vascular endothelial cells and are critical for the physiological and pathological growth, development and maintenance of blood and lymphatic vessels.", "PM": "2003; VASCULAR ENDOTHELIAL CELL GROWTH FACTOR RECEPTOR (now RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR) was indexed under RECEPTORS, GROWTH FACTOR 1993-2002, RECEPTORS PROTEIN-TYROSINE KINASES 1994-2002, PROTEIN-TYROSINE KINASE 1993 & RECEPTORS, MITOGEN 1991-1992; ENDOTHELIAL GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, MITOGEN & RECEPTORS, GROWTH FACTOR 1985-2003", "HN": "2003; use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR (NM) 1991-2002; for ENDOTHELIAL GROWTH FACTOR RECEPTOR use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR (NM) 1985-2003", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040262"}, {"RECTYPE": "D", "MH": "Vascular Endothelial Growth Factor Receptor-1", "DE": "VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPT 1", "DS": "VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "VEGFR-1|T116|T126|ACR|EQV|NLM (2003)|VEGFR 01|abbcdes", "ENTRY": "Vascular Endothelial Growth Factor Receptor 1", "MN": "D12.776.543.750.750.400.910.100", "MH_TH": "NLM (2003)", "ST": "T126", "RN": "EC 2.7.10.1", "PI": "Receptors, Growth Factor (1993-2002)", "MS": "A 180-kDa VEGF receptor found primarily in endothelial cells that is essential for vasculogenesis and vascular maintenance. It is also known as Flt-1 (fms-like tyrosine kinase receptor-1). A soluble, alternatively spliced isoform of the receptor may serve as a binding protein that regulates the availability of various ligands for VEGF receptor binding and signal transduction.", "PM": "2003; PROTO-ONCOGENE PROTEIN FLT (now VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1) was indexed under PROTO-ONCOGENE PROTEINS & RECEPTOR PROTEIN-TYROSINE KINASE 1991-2002", "HN": "2003; use VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 (NM) 1990-2002; for FLK-1 RECEPTOR TYROSINE KINASE use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR (NM) 1993-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040281"}, {"RECTYPE": "D", "MH": "Vascular Endothelial Growth Factor Receptor-2", "DE": "VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPT 2", "DS": "VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "VEGFR-2|T116|T192|ACR|EQV|NLM (2003)|VEGFR 02|abbcdes", "ENTRY": "Vascular Endothelial Growth Factor Receptor 2", "MN": "D12.776.543.750.750.400.910.200", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptors, Growth Factor (1993-2002)", "MS": "A 200-230-kDa tyrosine kinase receptor for vascular endothelial growth factors found primarily in endothelial and hematopoietic cells and their precursors. VEGFR-2 is important for vascular and hematopoietic development, and mediates almost all endothelial cell responses to VEGF.", "PM": "2003; VEGFR-2 was indexed under RECEPTORS, PROTEIN-TYROSINE KINASES 1996-2002", "HN": "2003; for FETAL LIVER KINASE-1, KDR TYROSINE KINASE, FLK-1 RECEPTOR TYROSINE KINASE & FLK-1 PROTEIN use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR 1993-2002; for VEGFR-2 use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR 1996-2002", "MR": "20210521", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040301"}, {"RECTYPE": "D", "MH": "Vascular Endothelial Growth Factor Receptor-3", "DE": "VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPT 3", "DS": "VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 03", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "VEGFR-3|T116|T126|T192|ACR|EQV|NLM (2003)|VEGFR 03|abbbcdes", "ENTRY": "Vascular Endothelial Growth Factor Receptor 3", "MN": "D12.776.543.750.750.400.910.300", "MH_TH": "NLM (2003)", "ST": "T192", "RN": "EC 2.7.10.1", "PI": "Receptors, Growth Factor (1995-2002)", "MS": "A vascular endothelial cell growth factor receptor whose expression is restricted primarily to adult lymphatic endothelium. VEGFR-3 preferentially binds the vascular endothelial growth factor C and vascular endothelial growth factor D and may be involved in the control of lymphangiogenesis.", "PM": "2003; FLT4 PROTEIN (now VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3) was indexed under RECEPTOR PROTEIN-TYROSINE KINASE 1994-2002, RECEPTORS, CELL SURFACE 1994-2000 & RECEPTORS, GROWTH FACTOR 1995-2002", "HN": "2003; use VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3 (NM) 1994-2002", "MR": "20210628", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040321"}, {"RECTYPE": "D", "MH": "Genetic Structures", "DE": "GENET STRUCT", "AQ": "DE ES GE IM PH RE", "ENTRY": "Structures, Genetic", "MN": "G05.360", "FX": "Genetics", "MH_TH": "NLM (2003)", "ST": "T028", "AN": "general or unspecified; prefer specifics", "MS": "The biological objects that contain genetic information and that are involved in transmitting genetically encoded traits from one organism to another.", "PM": "2003", "HN": "2003", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040342"}, {"RECTYPE": "D", "MH": "Behavioral Risk Factor Surveillance System", "ENTRY": "Behavior Risk Factor Surveillance System|T058|NON|EQV|NLM (2003)|020424|abcdef", "MN": "N06.850.520.308.980.438.149", "MH_TH": "NLM (2003)", "ST": "T058", "AN": "CATALOGER: Use NAF entry", "PI": "Health Surveys (1985-2002)", "MS": "Telephone surveys are conducted to monitor prevalence of the major behavioral risks among adults associated with premature MORBIDITY and MORTALITY. The data collected is in regard to actual behaviors, rather than on attitudes or knowledge. The Centers for Disease Control and Prevention (CDC) established the Behavioral Risk Factor Surveillance System (BRFSS) in 1984.", "PM": "2003", "HN": "2003", "MR": "20170630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040343"}, {"RECTYPE": "D", "MH": "Healthy People Programs", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Healthy People 2010|T058|NON|NRW|NLM (2003)|020424|abcdef", "ENTRY": "People 2020, Healthy", "MN": "N02.421.726.407.579.300", "MH_TH": "NLM (2003)", "ST": "T058", "AN": "specify geographic term if pertinent; CATALOGER: Coordinate with specific NAF entry if applicable", "PI": "Health Promotion (1990-2002)", "MS": "Healthy People Programs are a set of health objectives to be used by governments, communities, professional organizations, and others to help develop programs to improve health. It builds on initiatives pursued over the past two decades beginning with the 1979 Surgeon General's Report, Healthy People, Healthy People 2000: National Health Promotion and Disease Prevention Objectives, and Healthy People 2010. These established national health objectives and served as the basis for the development of state and community plans. These are administered by the Office of Disease Prevention and Health Promotion (ODPHP). Similar programs are conducted by other national governments.", "PM": "2003", "HN": "2003", "MR": "20170412", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040361"}, {"RECTYPE": "D", "MH": "Geographic Information Systems", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Systems, Global Positioning", "MN": "L01.470.750.750.462", "FX": "Spatial Analysis", "MH_TH": "NLM (2003)", "ST": "T170", "MS": "Computer systems capable of assembling, storing, manipulating, and displaying geographically referenced information, i.e. data identified according to their locations.", "PM": "2003", "HN": "2003", "MR": "20150622", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040362"}, {"RECTYPE": "D", "MH": "American Public Health Association", "DE": "AMERICAN PUBLIC HEALTH ASSOC", "MN": "N03.540.828.052", "MH_TH": "UNK (19XX)", "ST": "T094", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "MS": "Professional organization concerned with issues affecting personal and environmental health, including federal and state funding for health programs, programs related to chronic and infectious diseases, and professional education in public health.", "PM": "2003; see SOCIETIES, SCIENTIFIC 1980-2002", "HN": "2003; use SOCIETIES, SCIENTIFIC 1980-2002", "MR": "20150605", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040363"}, {"RECTYPE": "D", "MH": "Education, Public Health Professional", "DE": "EDUC PUBLIC HEALTH PROFESSIONAL", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Public Health Education for Professionals|T065|NON|EQV|NLM (2003)|020424|PUBLIC HEALTH EDUC PROFESSIONALS|abcdefv", "MN": "I02.358.556", "FX": "Public Health", "MH_TH": "NLM (2003)", "ST": "T065", "MS": "Education and training in PUBLIC HEALTH for the practice of the profession.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040381"}, {"RECTYPE": "D", "MH": "Cell Phone", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "PRINT ENTRY": "Telephone, Cellular|T073|NON|EQV|NLM (2003)|020424|abcdef", "ENTRY": "Transportable Cellular Phones", "MN": "L01.462.500.847.698.300", "FX": "Computers, Handheld", "MH_TH": "NLM (2003)", "ST": "T073", "PI": "Telephone (1991-2002)", "MS": "Analog or digital communications device in which the user has a wireless connection from a telephone to a nearby transmitter. It is termed cellular because the service area is divided into multiple \"cells.\" As the user moves from one cell area to another, the call is transferred to the local transmitter.", "PM": "2018", "HN": "2018 (2003)", "MR": "20220712", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040421"}, {"RECTYPE": "D", "MH": "Health Educators", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Health Educator", "MN": "M01.526.485.410", "MH_TH": "NLM (2003)", "ST": "T097", "MS": "Professionals who plan, organize and direct health education programs for the individual, groups and the community.", "PM": "2003", "HN": "2003", "MR": "20180629", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040441"}, {"RECTYPE": "D", "MH": "Public Health Informatics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Informatics, Public Health", "MN": "L01.313.750", "MH_TH": "NLM (2003)", "ST": "T090", "MS": "The systematic application of information and computer sciences to public health practice, research, and learning.", "PM": "2003", "HN": "2003", "MR": "20090706", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040442"}, {"RECTYPE": "D", "MH": "Students, Public Health", "AQ": "CL HI LJ PX SN", "PRINT ENTRY": "Public Health Students|T097|NON|EQV|NLM (2003)|020425|abcdef", "ENTRY": "Student, Public Health", "MN": "M01.848.769.925", "MH_TH": "NLM (2003)", "ST": "T097", "MS": "Individuals enrolled in a school of PUBLIC HEALTH or a formal educational program in public health.", "PM": "2003", "HN": "2003", "MR": "20150623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040443"}, {"RECTYPE": "D", "MH": "Gene Components", "AQ": "DE ES GE IM PH RE", "ENTRY": "Gene Component", "MN": "G05.360.340.024.340.137", "MH_TH": "NLM (2003)", "ST": "T028", "AN": "general; prefer specifics; do not confuse with GENOME COMPONENTS", "MS": "The parts of the gene sequence that carry out the different functions of the GENES.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040461"}, {"RECTYPE": "D", "MH": "Genome Components", "AQ": "DE ES GE IM PH RE", "ENTRY": "Genome Component", "MN": "G05.360.340.024", "MH_TH": "NLM (2003)", "ST": "T028", "AN": "general; prefer specifics; do not confuse with GENE COMPONENTS", "MS": "The parts of a GENOME sequence that are involved with the different functions or properties of genomes as a whole as opposed to those of individual GENES.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040481"}, {"RECTYPE": "D", "MH": "Calgranulin A", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Myeloid Calcium Binding Protein P8", "MN": "D23.050.301.562.100", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "PI": "Calcium-Binding Proteins (1989-2002)", "MS": "A 10.8-kDa member of the S-100 family of calcium-binding proteins that can form homo- or heterocomplexes with CALGRANULIN B and a variety of other proteins. The calgranulin A/B heterodimer is known as LEUKOCYTE L1 ANTIGEN COMPLEX. Calgranulin A is found in many cell types including GRANULOCYTES; KERATINOCYTES; and myelomonocytes, and has been shown to act as a chemotactic substance for NEUTROPHILS. Because it is present in acute inflammation but absent in chronic inflammation, it is a useful biological marker for a number of pathological conditions.", "PM": "2003; CALGRANULIN A was indexed under CALCIUM-BINDING BINDING PROTEINS 1989-2002; MRP-8 PROTEIN (now CALGRANULIN A) was indexed under ANTIGENS, DIFFERENTIATION & CALCIUM-BINDING PROTEINS 1989-2002", "HN": "2003; use CALGRANULIN A (NM) 1998-2002;", "MR": "20230609", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040501"}, {"RECTYPE": "D", "MH": "Calgranulin B", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Myeloid Calcium Binding Protein p14", "MN": "D23.050.301.562.200", "MH_TH": "NLM (2003)", "ST": "T129", "RN": "0", "PI": "S100 Protein Family (1999-2002)", "MS": "A 13.2-kDa member of the S-100 family of calcium-binding proteins that can form homo- or heterocomplexes with CALGRANULIN A and a variety of other proteins. The calgranulin A/B heterodimer is known as LEUKOCYTE L1 ANTIGEN COMPLEX. Calgranulin B is expressed at high concentrations in GRANULOCYTES during early monocyte differentiation, and serum calgranulin B levels are elevated in many inflammatory disorders such as CYSTIC FIBROSIS.", "PM": "2003; CALGRANULIN B was indexed under CALCIUM-BINDING PROTEINS 1989-2002; MRP-14 PROTEIN was indexed under ANTIGENS, DIFFERENTIATION & NEURONAL PROTEIN S100 1999-2002, CALCIUM-BINDING PROTEINS 1989-1998", "HN": "2003; use CALGRANULIN B (NM) 1989-2002", "MR": "20230609", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040502"}, {"RECTYPE": "D", "MH": "Coffea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Caffea|T002|NON|EQV|UNK (19XX)|850503|abcdef", "ENTRY": "arabicas, Coffea", "MN": "B01.875.800.575.912.250.456.937.275", "FX": "Coffee", "MH_TH": "UNK (19XX)", "ST": "T002", "RN": "txid13442", "RR": "txid13443", "AN": "for the beverage, use COFFEE", "PI": "Coffee (1966-2002)", "MS": "A plant genus of the family RUBIACEAE. It is best known for the COFFEE beverage prepared from the beans (SEEDS).", "PM": "2003; see COFFEE 1986-2002", "HN": "2003; use COFFEE 1986-2002", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040503"}, {"RECTYPE": "D", "MH": "Subcutaneous Tissue", "AQ": "AB AH BS CH DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Hypodermis|T024|NON|EQV|NLM (2003)|020426|abcdef", "ENTRY": "Tissues, Subcutaneous", "MN": "A10.165.887", "MH_TH": "NLM (2003)", "ST": "T024", "MS": "Loose connective tissue lying under the DERMIS, which binds SKIN loosely to subjacent tissues. It may contain a pad of ADIPOCYTES, which vary in number according to the area of the body and vary in size according to the nutritional state.", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040521"}, {"RECTYPE": "D", "MH": "Marketing", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Research, Market", "MN": "J01.219.687", "MH_TH": "POPLINE (1978)", "ST": "T057", "AN": "MARKETING OF HEALTH SERVICES and SOCIAL MARKETING are also available", "PI": "Marketing of Health Services (1979-2002)", "MS": "Activity involved in transfer of goods from producer to consumer or in the exchange of services.", "PM": "2003; see under MARKETING OF HEALTH SERVICES 1979-2002", "HN": "2003; use MARKETING OF HEALTH SERVICES 1979-2002", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040541"}, {"RECTYPE": "D", "MH": "Mechanotransduction, Cellular", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Signal Transduction, Mechanical|T044|NON|EQV|NLM (2003)|020429|abcdef", "ENTRY": "Transduction, Mechanosensory", "MN": "G04.835.580", "FX": "Podosomes", "MH_TH": "NLM (2003)", "ST": "T044", "PI": "Signal Transduction (1973-2002)", "MS": "The process by which cells convert mechanical stimuli into a chemical response. It can occur in both cells specialized for sensing mechanical cues such as MECHANORECEPTORS, and in parenchymal cells whose primary function is not mechanosensory.", "PM": "2003", "HN": "2003", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040542"}, {"RECTYPE": "D", "MH": "Assisted Living Facilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Facility, Assisted Living", "MN": "N02.278.825.187", "MH_TH": "NLM (2003)", "ST": "T093", "MS": "A housing and health care alternative combining independence with personal care. It provides a combination of housing, personalized supportive services and health care designed to meet the needs, both scheduled and unscheduled, of those who need help with activities of daily living. (www.alfa.org)", "PM": "2003", "HN": "2003", "MR": "20160602", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040561"}, {"RECTYPE": "D", "MH": "Inheritance Patterns", "AQ": "DE GE IM PH RE", "ENTRY": "Patterns, Inheritance", "MN": "G05.420", "MH_TH": "NLM (2003)", "ST": "T045", "MS": "The different ways GENES and their ALLELES interact during the transmission of genetic traits that effect the outcome of GENE EXPRESSION.", "PM": "2003", "HN": "2003", "MR": "20160701", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040582"}, {"RECTYPE": "D", "MH": "Quantitative Trait Loci", "AQ": "DE GE IM PH RE", "ENTRY": "Trait Locus, Quantitative", "MN": "G05.360.340.024.380.937", "FX": "Quantitative Trait, Heritable", "MH_TH": "NLM (2003)", "ST": "T028", "MS": "Genetic loci associated with a quantitative trait.", "PM": "2003", "HN": "2003", "MR": "20200205", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040641"}, {"RECTYPE": "D", "MH": "Structural Homology, Protein", "DE": "STRUCT HOMOL PROTEIN", "PRINT ENTRY": "Protein Structural Homology|T081|T082|NON|EQV|NLM (2003)|020528|PROTEIN STRUCT HOMOL|abbcdefv", "ENTRY": "Structural Homologies, Protein", "MN": "G05.820", "FX": "Sequence Homology, Amino Acid", "MH_TH": "NLM (2003)", "ST": "T082", "MS": "The degree of 3-dimensional shape similarity between proteins. It can be an indication of distant AMINO ACID SEQUENCE HOMOLOGY and used for rational DRUG DESIGN.", "PM": "2003", "HN": "2003", "MR": "20150623", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040681"}, {"RECTYPE": "D", "MH": "Stress Disorders, Traumatic, Acute", "DE": "STRESS DIS TRAUMATIC ACUTE", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Stress Disorders, Acute|T048|NON|EQV|NLM (2003)|020225|STRESS DIS ACUTE|abcdefv", "ENTRY": "Stress Disorder, Acute", "MN": "F03.950.750.550", "MH_TH": "NLM (2003)", "ST": "T048", "AN": "STRESS DISORDERS, TRAUMATIC is also available", "PI": "Stress Disorders, Post-Traumatic (1995-2002)", "MS": "A class of traumatic stress disorders that is characterized by the significant dissociative states seen immediately after overwhelming trauma. By definition it cannot last longer than 1 month, if it persists, a diagnosis of post-traumatic stress disorder (STRESS DISORDERS, POST-TRAUMATIC) is more appropriate.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040701"}, {"RECTYPE": "D", "MH": "Genetic Load", "DE": "GENET LOAD", "ENTRY": "Load, Genetic|T081|NON|EQV|NLM (1998)|970522|LOAD GENET|abcdefv", "MN": "G05.350", "FX": "Hybrid Vigor", "MH_TH": "NLM (1998)", "ST": "T081", "MS": "The relative amount by which the average fitness of a POPULATION is lowered, due to the presence of GENES that decrease survival, compared to the GENOTYPE with maximum or optimal fitness. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)", "PM": "2003; see GENETICS, POPULATION 1998-2002", "HN": "2003; use GENETICS, POPULATION 1998-2002", "MR": "20130709", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040741"}, {"RECTYPE": "D", "MH": "Biomimetic Materials", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Biomimetic Devices|T073|NON|REL|NLM (2003)|020503|abcdef", "ENTRY": "Materials, Biomimicry", "MN": "J01.637.087", "FX": "Biocompatible Materials", "MH_TH": "NLM (2003)", "ST": "T073", "AN": "do not confuse with BIOMATERIALS see BIOCOMPATIBLE MATERIALS", "MS": "Materials fabricated by BIOMIMETICS techniques, i.e., based on natural processes found in biological systems.", "PM": "2003", "HN": "2003", "MR": "20210707", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040761"}, {"RECTYPE": "D", "MH": "Human Characteristics", "PRINT ENTRY": "Human Nature|T054|T102|NON|EQV|NLM (2003)|020515|abbcdef", "ENTRY": "Nature, Human", "MN": "F01.510", "FX": "Personhood", "MH_TH": "NLM (2003)", "ST": "T102", "MS": "The fundamental dispositions and traits of humans. (Merriam-Webster's Collegiate Dictionary, 10th ed)", "PM": "2003", "HN": "2003", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040821"}, {"RECTYPE": "D", "MH": "Resource Allocation", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Allocative Efficiency|T052|T081|NON|REL|NLM (2015)|131028|abbcdef", "ENTRY": "Resources Allocation", "MN": "I01.261.750", "MH_TH": "POPLINE (1986)", "ST": "T081", "AN": "for health care resource allocation, use HEALTH CARE RATIONING; use both terms only when a discussion of health care resource allocation is accompanied by a more theoretical discussion of the concept of equity in the distribution of limited resources", "MS": "Societal or individual decisions about the equitable distribution of available resources.", "PM": "2003", "HN": "2003", "MR": "20210326", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040841"}, {"RECTYPE": "D", "MH": "Ethics, Business", "AQ": "ED HI", "PRINT ENTRY": "Ethics, Corporate|T078|NON|NRW|NLM (2003)|020613|abcdef", "ENTRY": "Corporate Ethics|T078|NON|NRW|NLM (2003)|020613|abcdef", "MN": "N05.350.297", "FX": "Industry", "MH_TH": "NLM (2003)", "ST": "T078", "MS": "The moral obligations governing the conduct of commercial or industrial enterprises.", "PM": "2003", "HN": "2003", "MR": "20150622", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040861"}, {"RECTYPE": "D", "MH": "CD11a Antigen", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD11a Antigens|T116|T129|T192|ACX|EQV|NLM (2007)|060623|CD 011A ANTIGENS|abbbcdefs", "ENTRY": "alphaL, Integrin", "MN": "D23.050.301.350.074.024", "MH_TH": "NLM (1995)", "ST": "T192", "RN": "0", "PI": "Lymphocyte Function-Associated Antigen-1 (1995-2002)", "MS": "An alpha-integrin subunit found on lymphocytes, granulocytes, macrophages and monocytes. It combines with the integrin beta2 subunit (CD18 ANTIGEN) to form LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1.", "PM": "2018; see ANTIGENS, CD11A 2003-2017; for CD11A ANTIGEN see LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 195-2002", "HN": "2018 (1995); for CD11a ANTIGEN use LYPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 1995-2002", "MR": "20230316", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040881"}, {"RECTYPE": "D", "MH": "Proteomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Peptidomics|T091|NON|NRW|NLM (2024)|220921|abcdef", "MN": "H01.181.122.738", "MH_TH": "NLM (2003)", "ST": "T091", "PI": "Proteome (2000-2002)", "MS": "The systematic study of the complete complement of proteins (PROTEOME) of organisms.", "PM": "2003", "HN": "2003", "MR": "20230522", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040901"}, {"RECTYPE": "D", "MH": "Stress Disorders, Traumatic", "DE": "TRAUMATIC STRESS DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Traumatic Stress Disorders", "MN": "F03.950.750", "MH_TH": "NLM (2003)", "ST": "T048", "AN": "STRESS DISORDERS, TRAUMATIC, ACUTE is also available", "PI": "Stress, Psychological (1965-2002)", "MS": "Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event, increased arousal, and numbing of responsiveness to or reduced involvement with the external world. Traumatic stress disorders can be further classified by the time of onset and the duration of these symptoms.", "PM": "2003", "HN": "2003", "MR": "20210630", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040921"}, {"RECTYPE": "D", "MH": "Heredity", "AQ": "DE ES GE IM PH RE", "MN": "G05.390", "MH_TH": "UNK (19XX)", "ST": "T044", "AN": "do not confuse with INHERITANCE see WILLS", "MS": "The transmission of traits encoded in GENES from parent to offspring.", "PM": "2003; see GENETICS (1974-2002)", "HN": "2003; use GENETICS (1974-2002)", "MR": "20160617", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040941"}, {"RECTYPE": "D", "MH": "Genetic Drift", "DE": "GENET DRIFT", "PRINT ENTRY": "Evolution, Neutral|T045|NON|REL|NLM (2008)|060711|abcdef", "ENTRY": "Neutral Evolution|T045|NON|REL|NLM (2008)|060711|abcdef", "MN": "G16.075.300", "MH_TH": "UNK (19XX)", "ST": "T045", "PI": "Gene Frequency (1968-2002)", "MS": "The fluctuation of the ALLELE FREQUENCY from one generation to the next.", "PM": "2003; see GENE FREQUENCY 1975-2002", "HN": "2003; use GENE FREQUENCY 1975-2002", "MR": "20210707", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D040961"}, {"RECTYPE": "D", "MH": "Acinetobacter baumannii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Bacterium anitratum|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.530.050.099", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid470", "AN": "infection: coordinate with ACINETOBACTER INFECTIONS", "PI": "Acinetobacter (1988-2002)", "MS": "A species of gram-negative, aerobic bacteria, commonly found in the clinical laboratory, and frequently resistant to common antibiotics.", "PM": "2003", "HN": "2003", "MR": "20200128", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D040981"}, {"RECTYPE": "D", "MH": "Babesia microti", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "microtus, Babesia", "MN": "B01.043.075.600.580.070.550", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid5868", "AN": "infection: coordinate IM with BABESIOSIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Babesia (1969-2002)", "MS": "A species of protozoa infecting humans via the intermediate tick vector IXODES scapularis. The other hosts are the mouse PEROMYSCUS leucopus and meadow vole MICROTUS pennsylvanicus, which are fed on by the tick. Other primates can be experimentally infected with Babesia microti.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D041001"}, {"RECTYPE": "D", "MH": "Brucella canis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Brucella melitensis biovar canis|T007|NON|EQV|NLM (2004)|021017|abcdef", "MN": "B03.660.050.070.100.150", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid36855", "AN": "infection: coord IM with BRUCELLOSIS (IM)", "PI": "Brucella (1968-2002)", "MS": "A species of gram-negative bacteria infecting DOGS, the natural hosts, and causing canine BRUCELLOSIS. It can also cause a mild infection in humans.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D041002"}, {"RECTYPE": "D", "MH": "Brucella suis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Brucella melitensis biovar suis|T007|NON|EQV|NLM (2004)|021017|abcdef", "MN": "B03.660.050.070.100.750", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid29461", "AN": "infection: coordinate with BRUCELLOSIS", "PI": "Brucella (1963-2002)", "MS": "A species of gram-negative bacteria, primarily infecting SWINE, but it can also infect humans, DOGS, and HARES.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D041021"}, {"RECTYPE": "D", "MH": "Candida tropicalis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Procandida tropicalis|T004|NON|EQV|NLM (2021)|200318|abcdef", "MN": "B01.300.930.176.800", "MH_TH": "NLM (2003)", "ST": "T004", "RN": "txid5482", "AN": "infection: coordinate with CANDIDIASIS or its indentions", "PI": "Candida (1964-2002)", "MS": "A species of MITOSPORIC FUNGI that is a major cause of SEPTICEMIA and disseminated CANDIDIASIS, especially in patients with LYMPHOMA; LEUKEMIA; and DIABETES MELLITUS. It is also found as part of the normal human mucocutaneous flora.", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041022"}, {"RECTYPE": "D", "MH": "Citrobacter koseri", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Levinea malonatica|T007|NON|EQV|NLM (2021)|190919|abcdef", "ENTRY": "Citrobacter diversus|T007|NON|EQV|NLM (2003)|020529|abcdef", "MN": "B03.660.250.150.100.475", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid545", "AN": "infection: coordinate with ENTEROBACTERIACEAE INFECTIONS", "PI": "Citrobacter (1973-2002)", "MS": "A species of gram-negative enterobacteria found in WATER; SEWAGE; SOIL; and FOOD. It can be present in any clinical specimen as an opportunistic pathogen.", "PM": "2003", "HN": "2003", "MR": "20200128", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041041"}, {"RECTYPE": "D", "MH": "Ehrlichia canis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.500.287.090", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid944", "AN": "infection: coordinate with EHRLICHIOSIS", "PI": "Ehrlichia (1969-2002)", "MS": "Species of gram-negative bacteria in the family ANAPLASMATACEAE, causing EHRLICHIOSIS in DOGS. The most common vector is the brown dog tick. It can also cause disease in humans.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041061"}, {"RECTYPE": "D", "MH": "Anaplasma phagocytophilum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "HGE Agent|T007|ACX|EQV|NLM (2004)|021025|abcdef", "MN": "B03.660.050.783.500.050.600", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid948", "AN": "infection: coord IM with EHRLICHIOSIS (IM)", "PI": "Ehrlichia (1975-2002)", "MS": "A species of gram-negative bacteria in the genus ANAPLASMA, family ANAPLASMATACEAE, formerly called Ehrlichia phagocytophila or Ehrlichia equi. This organism is tick-borne (IXODES) and causes disease in horses and sheep. In humans, it causes human granulocytic EHRLICHIOSIS.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D041081"}, {"RECTYPE": "D", "MH": "Neorickettsia sennetsu", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Ehrlichia sennetsu|T007|NON|EQV|NLM (2003)|020529|abcdef", "MN": "B03.660.050.783.500.525.720", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid951", "AN": "infection: coord IM with ANAPLASMATACEAE INFECTIONS (IM)", "PI": "Ehrlichia (1985-2002)", "MS": "A species of gram-negative bacteria in the genus NEORICKETTSIA, family ANAPLASMATACEAE, causing Sennetsu fever and found in the ASIA, EASTERN and SOUTHEAST ASIA.", "PM": "2003", "HN": "2003", "MR": "20220715", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041101"}, {"RECTYPE": "D", "MH": "Neorickettsia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Neorickettsia helminthoeca|T007|NON|NRW|NLM (2003)|020529|abcdef", "MN": "B03.660.050.783.500.525", "MH_TH": "UNK (19XX)", "ST": "T007", "RN": "txid33993", "RR": "txid33994", "AN": "infection: coord IM with ANAPLASMATACEAE INFECTIONS (IM)", "PI": "Rickettsiaceae (1969-2002)", "MS": "Genus of gram-negative, intracytoplasmic bacteria that are found primarily in VACUOLES of MONOCYTES in the BLOOD and MACROPHAGES of lymphoid or other tissues of DOGS; HORSES, and humans. (From Int. J. Syst. Evol. Microbiol. (2001) 51:2145-2165)", "PM": "2003, 1963-1981", "HN": "2003, 1963-1981", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041102"}, {"RECTYPE": "D", "MH": "Neorickettsia risticii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Ehrlichia risticii|T007|NON|EQV|NLM (2003)|020529|abcdef", "MN": "B03.660.050.783.500.525.700", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid950", "AN": "infection: coord IM with ANAPLASMATACEAE INFECTIONS (IM)", "PI": "Ehrlichia (1986-2002)", "MS": "A species of gram-negative bacteria in the genus NEORICKETTSIA, family ANAPLASMATACEAE.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041103"}, {"RECTYPE": "D", "MH": "Klebsiella oxytoca", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Bacillus oxytocus perniciosus|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.150.400.580", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid571", "AN": "infection: coordinate with KLEBSIELLA INFECTIONS", "PI": "Klebsiella (1970-2002)", "MS": "A species of gram-negative bacteria causing URINARY TRACT INFECTIONS and SEPTICEMIA.", "PM": "2003", "HN": "2003", "MR": "20200128", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041121"}, {"RECTYPE": "D", "MH": "Plasmodium ovale", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "ovales, Plasmodium", "MN": "B01.043.075.380.611.700", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid36330", "AN": "infection: coordinate with MALARIA; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent ", "PI": "Plasmodium (1966-2002)", "MS": "A species of protozoan parasite causing MALARIA. It is the rarest of the four species of PLASMODIUM infecting humans, but is common in West African countries and neighboring areas.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041122"}, {"RECTYPE": "D", "MH": "Rickettsia akari", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.875.650.650.040", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid786", "AN": "infection: coordinate with SPOTTED FEVER GROUP RICKETTSIOSIS", "PI": "Rickettsia (1972-2002)", "MS": "A species of gram-negative bacteria that causes rickettsialpox. The vector is a mouse mite and the reservoirs are mites and mice.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041141"}, {"RECTYPE": "D", "MH": "Rickettsia felis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.875.650.650.320", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid42862", "AN": "infection: coordinate with RICKETTSIA INFECTIONS", "PI": "Rickettsia (1990-2002)", "MS": "A species of gram-negative bacteria transmitted by the flea Ctenocephalides felis, and known to infect CATS, oppossums, and humans.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041161"}, {"RECTYPE": "D", "MH": "Staphylococcus haemolyticus", "DE": "STAPH HAEMOLYTICUS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.790.750.400", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid1283", "AN": "infection: coord IM with STAPHYLOCOCCAL INFECTIONS (IM)", "PI": "Staphylococcus (1981-2002)", "MS": "A species of STAPHYLOCOCCUS found on the skin of humans (and non-human primates), often causing hospital-acquired infections (CROSS INFECTION).", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041162"}, {"RECTYPE": "D", "MH": "Staphylococcus hominis", "DE": "STAPH HOMINIS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.790.750.425", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid1290", "AN": "infection: coordinate with STAPHYLOCOCCAL INFECTIONS", "PI": "Staphylococcus (1984-2002)", "MS": "A species of STAPHYLOCOCCUS similar to STAPHYLOCOCCUS HAEMOLYTICUS, but containing different esterases. The subspecies Staphylococcus hominis novobiosepticus is highly virulent and novobiocin resistant.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041181"}, {"RECTYPE": "D", "MH": "Taenia solium", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Tapeworm, Pork|T204|NON|EQV|NLM (2003)|020603|abcdef", "ENTRY": "soliums, Taenia", "MN": "B01.050.500.500.736.215.895.775", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6204", "PI": "Taenia (1965-2002)", "MS": "Species of tapeworm in the genus TAENIA, that infects swine. It is acquired by humans through the ingestion of cured or undercooked pork.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041201"}, {"RECTYPE": "D", "MH": "Taenia saginata", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Tapeworm, Beef|T204|NON|EQV|NLM (2003)|020603|abcdef", "ENTRY": "saginata, Taenia", "MN": "B01.050.500.500.736.215.895.643", "MH_TH": "NLM (2003)", "ST": "T204", "RN": "txid6206", "PI": "Taenia (1965-2002)", "MS": "Species of tapeworm in the genus TAENIA, that infects cattle. It is acquired by humans through the ingestion of raw or insufficiently cooked beef.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041202"}, {"RECTYPE": "D", "MH": "Candida glabrata", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Torulopsis glabrata|T004|NON|EQV|NLM (2003)|020604|abcdef", "MN": "B01.300.930.176.400", "MH_TH": "NLM (2003)", "ST": "T004", "RN": "txid5478", "AN": "infection: coordinate with CANDIDIASIS or its indentions ", "PI": "Candida (1967-2002)", "MS": "A species of MITOSPORIC FUNGI commonly found on the body surface. It causes opportunistic infections especially in immunocompromised patients.", "PM": "2003", "HN": "2003", "MR": "20200527", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041221"}, {"RECTYPE": "D", "MH": "Vibrio cholerae O1", "DS": "VIBRIO CHOLERAE O 001", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Vibrio cholerae Serogroup O1|T007|NON|EQV|NLM (2003)|020604|abcdef", "MN": "B03.660.250.830.830.100.151", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid127906", "AN": "infection: coord IM with CHOLERA (IM)", "MS": "Strains of VIBRIO CHOLERAE containing O ANTIGENS group 1. All are CHOLERA-causing strains (serotypes). There are two biovars (biotypes): cholerae and eltor (El Tor).", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041241"}, {"RECTYPE": "D", "MH": "Vibrio cholerae O139", "DS": "VIBRIO CHOLERAE O 139", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Vibrio cholerae Serogroup O139|T007|NON|EQV|NLM (2003)|020604|abcdef", "MN": "B03.660.250.830.830.100.200", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid45888", "AN": "infection: coord IM with CHOLERA (IM)", "PI": "Vibrio cholerae (1993-2002)", "MS": "Strains of VIBRIO CHOLERAE containing O ANTIGENS group 139. This strain emerged in India in 1992 and caused a CHOLERA epidemic.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041242"}, {"RECTYPE": "D", "MH": "Vibrio vulnificus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.830.830.900", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid672", "AN": "infection: coord IM with VIBRIO INFECTIONS (IM)", "PI": "Vibrio (1981-2002)", "MS": "A species of halophilic bacteria in the genus VIBRIO, which lives in warm SEAWATER. It can cause infections in those who eat raw contaminated seafood or have open wounds exposed to seawater.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041261"}, {"RECTYPE": "D", "MH": "Leptospira interrogans serovar australis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.851.475.475.400.050", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid211882", "AN": "do not confuse with the seroGROUP australis, sometimes termed Leptospira australis (index LEPTOSPIRA INTERROGANS); infection: coord IM with probably LEPTOSPIROSIS (IM)", "PI": "Leptospira interrogans (1980-2002)", "MS": "A serovar of the bacterial species LEPTOSPIRA INTERROGANS, characteristically associated with a severe zoonotic disease in humans.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041281"}, {"RECTYPE": "D", "MH": "Leptospira interrogans serovar autumnalis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.851.475.475.400.055", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid174157", "AN": "do not confuse with the seroGROUP autumnalis, sometimes termed Leptospira autumnalis (index LEPTOSPIRA INTERROGANS); infection: coord IM with probably LEPTOSPIROSIS (IM)", "PI": "Leptospira interrogans (1966-2002)", "MS": "A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose primary host is the MOUSE.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041301"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, X", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "X Chromosome, Human|T026|NON|EQV|NLM (2003)|020613|abcdef", "ENTRY": "X Chromosomes, Human", "MN": "G05.360.162.865.982.500", "FX": "Genetic Diseases, X-Linked", "MH_TH": "NLM (2003)", "ST": "T026", "PI": "X Chromosome (1978-2002)", "MS": "The human female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in humans.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041321"}, {"RECTYPE": "D", "MH": "Chromosomes, Human, Y", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Y Chromosome, Human|T026|NON|EQV|NLM (2003)|020613|abcdef", "ENTRY": "Y Chromosomes, Human", "MN": "G05.360.162.865.983.500", "MH_TH": "NLM (2003)", "ST": "T026", "PI": "Y Chromosome (1978-2002)", "MS": "The human male sex chromosome, being the differential sex chromosome carried by half the male gametes and none of the female gametes in humans.", "PM": "2003", "HN": "2003", "MR": "20080708", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041322"}, {"RECTYPE": "D", "MH": "Leptospira interrogans serovar canicola", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Leptospira canicola|T007|NON|EQV|NLM (2017)|151223|abcdef", "MN": "B03.851.475.475.400.150", "MH_TH": "NLM (2009)", "ST": "T007", "RN": "txid211880", "AN": "do not confuse with the SEROGROUP canicola, sometimes termed Leptospira canicola (index LEPTOSPIRA INTERROGANS); infection: coordinate IM with LEPTOSPIROSIS (IM)", "PI": "Leptospira interrogans (1966-2002)", "MS": "A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose natural host is DOGS. The disease is characterized by GASTROENTERITIS, and INTERSTITIAL NEPHRITIS.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041341"}, {"RECTYPE": "D", "MH": "Absorbent Pads", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Underpad", "MN": "E07.325.068", "MH_TH": "NLM (1992)", "ST": "T074", "PI": "Incontinence Pads (1992-2002)", "MS": "Pads made of various materials used for personal hygiene usually for absorbing URINE or FECES. They can be worn as underpants or pants liners by various age groups, from NEWBORNS to the ELDERLY. Absorbent pads can be made of fluff wood pulp and HYDROGEL absorbent covered with viscose rayon, polyester, polypropylene, or POLYETHYLENE coverstock.", "PM": "2003; see INCONTINENCE PADS 1992-2002", "HN": "2003; use INCONTINENCE PADS 1992-2002", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D041342"}, {"RECTYPE": "D", "MH": "Leptospira interrogans serovar hebdomadis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.851.475.475.400.400", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid211881", "AN": "do not confuse with the seroGROUP hebdomadis, sometimes termed Leptospira hebdomadis (index LEPTOSPIRA INTERROGANS); infection: coord IM with probably LEPTOSPIROSIS (IM)", "PI": "Leptospira interrogans (1964-2002)", "MS": "A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose frequent host is CATTLE.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041343"}, {"RECTYPE": "D", "MH": "Pacifiers", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Pacifier", "MN": "E07.490.500", "MH_TH": "UNK (19XX)", "ST": "T073", "PI": "Infant Care (1972-2002)", "MS": "Devices that babies can suck on when they are not feeding. The extra sucking can be comforting to the babies and pacify them. Pacifiers usually are used as a substitute for the thumb in babies who suck on their thumb or fingers almost constantly.", "PM": "2003; see INFANT CARE 1989-2002", "HN": "2003; use INFANT CARE 1989-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041361"}, {"RECTYPE": "D", "MH": "Diapers, Infant", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Diaper Pins|T073|NON|REL|UNK (19XX)|880603|abcdef", "ENTRY": "Pins, Diaper", "MN": "E07.325.068.249", "MH_TH": "UNK (19XX)", "ST": "T073", "PI": "Infant Care (1989-2002)", "MS": "Absorbent pads designed to be worn by infants and very young children.", "PM": "2003; see INFANT CARE 1989-2002", "HN": "2003; use INFANT CARE 1989-2002", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041381"}, {"RECTYPE": "D", "MH": "Diapers, Adult", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Diaper, Adult", "MN": "E07.325.068.124", "MH_TH": "NLM (1992)", "ST": "T074", "PI": "Incontinence Pads (1992-2002)", "MS": "Absorbent pads designed to be worn as underpants or pants liners by adults.", "PM": "2003; see INCONTINENCE PADS 1992-2002", "HN": "2003; use INCONTINENCE PADS 1992-2002", "DA": "20020702", "DC": "1", "DX": "20030101", "UI": "D041382"}, {"RECTYPE": "D", "MH": "Leptospira interrogans serovar icterohaemorrhagiae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.851.475.475.400.420", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid90062", "AN": "do not confuse with the seroGROUP icterohaemorrhagiae, sometimes termed Leptospira icterohaemorrhagiae (index LEPTOSPIRA INTERROGANS); infection: probably WEIL DISEASE or if not coord IM with LEPTOSPIROSIS (IM)", "PI": "Leptospira interrogans (1980-2002)", "MS": "A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose primary host is RATS.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041383"}, {"RECTYPE": "D", "MH": "Leptospira interrogans serovar pomona", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Leptospira pomona|T007|NON|EQV|NLM (2017)|151223|abcdef", "MN": "B03.851.475.475.400.650", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid44276", "AN": "do not confuse with the SEROROUP pomona, sometimes termed Leptospira pomona (index LEPTOSPIRA INTERROGANS); infection: coordinate IM with LEPTOSPIROSIS (IM)", "PI": "Leptospira interrogans (1976-2002)", "MS": "A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose primary hosts include CATTLE and SWINE.", "PM": "2003", "HN": "2003", "MR": "20200813", "DA": "20020703", "DC": "1", "DX": "20030101", "UI": "D041401"}, {"RECTYPE": "D", "MH": "Retinoschisis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "X-Linked Retinoschisis|T047|NON|NRW|GHR (2014)|NLM (2003)|020712|abcdeef", "ENTRY": "X-Linked Retinoschisis, Congenital", "MN": "C11.768.585.865", "FX": "Retinal Detachment", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Retinal Diseases (1970-2002)", "MS": "A vitreoretinal dystrophy characterized by splitting of the neuroretinal layers. It occurs in two forms: degenerative retinoschisis and X chromosome-linked juvenile retinoschisis.", "PM": "2003", "HN": "2003", "MR": "20180630", "DA": "20020718", "DC": "1", "DX": "20030101", "UI": "D041441"}, {"RECTYPE": "D", "MH": "Desulfurococcales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.075.200", "MH_TH": "NLM (2004)", "ST": "T194", "RN": "txid114380", "MS": "An order of CRENARCHAEOTA comprised of irregular coccoid to disc-shaped, hyperthermophiles, and found in submarine hydrothermal systems and solfataric hot springs.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041521"}, {"RECTYPE": "D", "MH": "Aeropyrum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.075.200.500.050", "MH_TH": "NLM (2004)", "ST": "T194", "RN": "txid56635", "PI": "Desulfurococcaceae (2000-2003)", "MS": "A genus of anaerobic, chemolithotropic coccoid ARCHAEA, in the family DESULFUROCOCCACEAE. They live in marine environments.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041522"}, {"RECTYPE": "D", "MH": "Pyrodictiaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pyrolobus|T194|NON|NRW|NLM (2004)|020910|abcdef", "MN": "B02.075.200.650", "MH_TH": "NLM (2004)", "ST": "T194", "RN": "txid2307", "RR": "txid54251", "MS": "A family of archaea, in the order DESULFUROCOCCALES consisting of anaerobic coccoid to disc-shaped cells. They grow either chemolithoautotrophically or by FERMENTATION. Three genera are recognized: Pyrodictium, Hyperthermus, and Pyrolobus.", "PM": "2004; for PYRODICTIUM see DESULFUROCOCCACEAE 1998-2003", "HN": "2004; for PYRODICTIUM use DESULFUROCOCCACEAE 1998-2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041523"}, {"RECTYPE": "D", "MH": "Acidianus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.075.725.725.030", "MH_TH": "NLM (2004)", "ST": "T194", "RN": "txid12914", "PI": "Sulfolobaceae (1996-2003)", "MS": "A genus of facultatively anaerobic coccoid ARCHAEA, in the family SULFOLOBACEAE. Cells are highly irregular in shape and thermoacidophilic. Lithotrophic growth occurs aerobically via sulfur oxidation in some species. Distribution includes solfataric springs and fields, mudholes, and geothermically heated acidic marine environments.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041541"}, {"RECTYPE": "D", "MH": "Thermoproteus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.075.800.800.800", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2270", "PI": "Thermoproteaceae (1998-2003)", "MS": "A genus of obligately anaerobic ARCHAEA, in the family THERMOPROTEACEAE. They are found in acidic hot springs and water holes.", "PM": "2004; see THERMOPROTEACEAE 1998-2003", "HN": "2004; use THERMOPROTEACEAE 1998-2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041542"}, {"RECTYPE": "D", "MH": "Pyrobaculum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.075.800.800.650", "MH_TH": "NLM (1998)", "ST": "T194", "RN": "txid2276", "PI": "Thermoproteaceae (1998-2003)", "MS": "A genus of rod-shaped, almost rectangular ARCHAEA, in the family THERMOPROTEACEAE. Organisms are facultatively aerobic or strictly anaerobic, grow on various organic substrates, and are found in continental solfataras.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041543"}, {"RECTYPE": "D", "MH": "Thermofilaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Thermofilum|T194|NON|NRW|NLM (1998)|961021|abcdef", "MN": "B02.075.800.780", "MH_TH": "NLM (2004)", "ST": "T194", "RN": "txid114378", "RR": "txid2268", "MS": "A family of THERMOPROTEALES consisting of anaerobic, thermoacidophilic thin rods found in solfataric hot springs.", "PM": "2004; for THERMOFILUM see THERMOPROTEALES 1998-2003", "HN": "2004; for THERMOFILUM use THERMOPROTEALES 1998-2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041561"}, {"RECTYPE": "D", "MH": "Methanobrevibacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.492.500.515", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2172", "PI": "Bacteria (1982-2003)", "MS": "A genus of gram-positive, anaerobic, cocci to short rod-shaped ARCHAEA, in the family METHANOBACTERIACEAE, order METHANOBACTERIALES. They are found in the GASTROINTESTINAL TRACT or other anoxic environments.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041581"}, {"RECTYPE": "D", "MH": "Bonamia Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Bonamia spectabilis|T002|NON|NRW|NLM (2004)|020917|abcdef", "ENTRY": "spectabili, Bonamia", "MN": "B01.875.800.575.912.250.238.124", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid142579", "RR": "txid197354", "MS": "A plant genus of the family CONVOLVULACEAE. Members contain bonaspectins (tetrahydrofuran-type sesqui-lignans).", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041601"}, {"RECTYPE": "D", "MH": "Haplosporida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Haplosporidia|T204|NON|EQV|NLM (2004)|021011|abcdef", "ENTRY": "Haplosporidias", "MN": "B01.680.400", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid31291", "RR": "txid126728", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent; entry term BONAMIA OSTREAE: BONAMIA PLANT is also available", "PI": "Protozoa (1988-2003)", "MS": "A phylum of EUKARYOTES in the RHIZARIA group. They are small endoparasites of marine invertebrates. Spores are structurally complex but without polar filaments or tubes.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041602"}, {"RECTYPE": "D", "MH": "Pinus taeda", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Pine, Loblolly|T002|NON|EQV|NLM (2004)|020917|abcdef", "ENTRY": "taeda, Pinus", "MN": "B01.875.800.575.912.625.875.777.888", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid3352", "PI": "Trees (1993-2001)", "MS": "A plant species of the genus PINUS which is the subject of genetic study.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041603"}, {"RECTYPE": "D", "MH": "Pinus ponderosa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ponderosa Pine|T002|NON|EQV|NLM (2004)|020917|abcdef", "ENTRY": "ponderosas, Pinus", "MN": "B01.875.800.575.912.625.875.777.600", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid55062", "PI": "Trees (1972-2001)", "MS": "A plant species of the genus PINUS that contains isocupressic acid.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041604"}, {"RECTYPE": "D", "MH": "Pinus sylvestris", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "sylvestri, Pinus", "MN": "B01.875.800.575.912.625.875.777.744", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid3349", "PI": "Trees (1975-2001)", "MS": "A plant species of the genus PINUS which is the source of pinosylvin. It is sometimes called Scotch pine or Scots pine, which is also a common name for other species of this genus.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041605"}, {"RECTYPE": "D", "MH": "Eremophila Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Eremophila", "MN": "B01.875.800.575.912.250.756.249", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid255893", "AN": "EREMOPHILA ALPESTRIS see SONGBIRDS and EREMOPHILUS MUTISII see CATFISHES are also available; eremophilane compounds (NM) is also available", "MS": "A plant genus of the family MYOPORACEAE. Members have been used in FOLK MEDICINE.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041621"}, {"RECTYPE": "D", "MH": "Tomography, Optical", "DE": "TOMOGR OPTICAL", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Optical Tomography|T060|NON|EQV|NLM (2004)|021011|OPTICAL TOMOGR|abcdefv", "MN": "E05.642.249", "MH_TH": "NLM (2004)", "ST": "T060", "PI": "Tomography (1982-2003)", "MS": "Projection of near-IR light (INFRARED RAYS), in the 700-1000 nm region, across an object in parallel beams to an array of sensitive photodetectors. This is repeated at various angles and a mathematical reconstruction provides three dimensional MEDICAL IMAGING of tissues. Based on the relative transparency of tissues to this spectra, it has been used to monitor local oxygenation, brain and joints.", "PM": "2004", "HN": "2004", "MR": "20130709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041622"}, {"RECTYPE": "D", "MH": "Tomography, Optical Coherence", "DE": "TOMOGR OPTICAL COHERENCE", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tomography, OCT", "MN": "E05.642.249.500", "MH_TH": "NLM (2004)", "ST": "T060", "PI": "Tomography (1991-2003)", "MS": "An imaging method using LASERS that is used for mapping subsurface structure. When a reflective site in the sample is at the same optical path length (coherence) as the reference mirror, the detector observes interference fringes.", "PM": "2004", "HN": "2004", "MR": "20120703", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041623"}, {"RECTYPE": "D", "MH": "Musculoskeletal Development", "AQ": "DE GE IM PH RE", "ENTRY": "System Development, Musculoskeletal", "MN": "G11.427.578", "FX": "Musculoskeletal System", "MH_TH": "NLM (2004)", "ST": "T042", "AN": "general or unspecified; prefer specifics", "PI": "Musculoskeletal System/growth & development (1991-2003)", "MS": "The morphologic and physiological changes of the MUSCLES, bones (BONE AND BONES), and CARTILAGE of the body, i.e., MUSCULOSKELETAL SYSTEM, during the prenatal and postnatal stages of development.", "PM": "2004", "HN": "2004", "MR": "20200629", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041641"}, {"RECTYPE": "D", "MH": "NIH 3T3 Cells", "DS": "NIH T A CELLS 03 03", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "NIH-3T3 Cell", "MN": "A11.329.228.100.550", "MH_TH": "NLM (1992)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMAL & MICE; do not routinely add FIBROBLASTS or EMBRYO, MAMMALIAN", "PI": "Cell Line (1978-1991)", "MS": "A continuous cell line of high contact-inhibition established from NIH Swiss mouse embryo cultures. The cells are useful for DNA transfection and transformation studies. (From ATCC [Internet]. Virginia: American Type Culture Collection; c2002 [cited 2002 Sept 26]. Available from http://www.atcc.org/)", "PM": "2004; see 3T3 CELLS 1992-2003", "HN": "2004; use 3T3 CELLS 1992-2003", "MR": "20130708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041681"}, {"RECTYPE": "D", "MH": "Swiss 3T3 Cells", "DS": "SWISS T A CELLS 03 03", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cells, Swiss 3T3", "MN": "A11.329.228.100.775", "MH_TH": "NLM (2004)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMAL & MICE; do not routinely add FIBROBLASTS or EMBRYO, MAMMALIAN", "PI": "Cell Line (1973-1991)", "MS": "A cell line established in 1962 from disaggregated Swiss albino mouse embryos. This fibroblast cell line is extremely popular in research.", "PM": "2004", "HN": "2004", "MR": "20130708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041701"}, {"RECTYPE": "D", "MH": "BALB 3T3 Cells", "DS": "BALB T A CELLS 03 03", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cells, BALB-c 3T3", "MN": "A11.329.228.100.080", "MH_TH": "NLM (2004)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMALS & MICE; do not routinely add FIBROBLASTS or EMBRYO, MAMMALIAN", "PI": "Cell Line (1969-1991)", "MS": "Cell lines developed from disaggregated BALB/c mouse embryos. They are extremely sensitive to CONTACT INHIBITION, and highly susceptible to transformation by SV40 VIRUS and murine sarcoma virus (SARCOMA VIRUSES, MURINE).", "PM": "2004", "HN": "2004", "MR": "20130708", "DA": "20030730", "DC": "1", "DX": "20040101", "UI": "D041702"}, {"RECTYPE": "D", "MH": "3T3-L1 Cells", "DS": "T AAA A CELLS 03 03 L1", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cells, 3T3-L1", "MN": "A11.329.228.100.775.800", "MH_TH": "NLM (2004)", "ST": "T025", "AN": "check ANIMALS & MICE but do not add FIBROBLASTS nor EMBRYO, MAMMALIAN", "PI": "Cell Line (1991-2003)", "MS": "A continuous cell line that is a substrain of SWISS 3T3 CELLS developed though clonal isolation. The mouse fibroblast cells undergo an adipose-like conversion as they move to a confluent and contact-inhibited state.", "PM": "2004", "HN": "2004", "MR": "20180614", "DA": "20030730", "DC": "1", "DX": "20040101", "UI": "D041721"}, {"RECTYPE": "D", "MH": "Genes, Transgenic, Suicide", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Transgenic Suicide Genes|T028|NON|EQV|NLM (2004)|030307|abcdef", "ENTRY": "Transgenic Suicide Gene", "MN": "G05.360.340.024.340.825.500", "FX": "Genetic Therapy", "MH_TH": "NLM (2004)", "ST": "T028", "MS": "Genes that are used transgenically, i.e., via GENE TRANSFER TECHNIQUES to induce CELL DEATH.", "PM": "2004", "HN": "2004", "MR": "20120705", "DA": "20030725", "DC": "1", "DX": "20040101", "UI": "D041722"}, {"RECTYPE": "D", "MH": "Lower Gastrointestinal Tract", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Gastrointestinal Tract, Lower", "MN": "A03.556.249", "MH_TH": "NLM (2004)", "ST": "T022", "AN": "general or unspecified; prefer specifics", "MS": "The segment of GASTROINTESTINAL TRACT that includes the small intestine below the DUODENUM, and the LARGE INTESTINE.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041741"}, {"RECTYPE": "D", "MH": "Upper Gastrointestinal Tract", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Gastrointestinal Tract, Upper", "MN": "A03.556.875", "MH_TH": "NLM (2004)", "ST": "T022", "AN": "general or unspecified; prefer specifics", "MS": "The segment of GASTROINTESTINAL TRACT that includes the ESOPHAGUS; the STOMACH; and the DUODENUM.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041742"}, {"RECTYPE": "D", "MH": "Herb-Drug Interactions", "AQ": "EH GE IM PH RE", "PRINT ENTRY": "Beneficial Herb-Drug Interactions|T070|NON|NRW|NLM (2020)|190501|abcdef", "ENTRY": "Plant-Drug Interaction", "MN": "G07.690.773.968.755", "MH_TH": "NLM (2004)", "ST": "T070", "AN": "coordinate with specific medicinal herb + specific drug with pertinent qualifiers; use only for  medicinal herb-drug interactions; for non-medicinal herb drug interactions, use FOOD-DRUG INTERACTIONS", "PI": "Drug Interactions (1970-2003)", "MS": "The adverse or beneficial effect of MEDICINAL HERBS on the activity, metabolism, or toxicity of PHARMACEUTICALS.", "PM": "2004", "HN": "2004", "MR": "20190708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041743"}, {"RECTYPE": "D", "MH": "Cholecystolithiasis", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "MN": "C06.130.564.332", "MH_TH": "NLM (2004)", "ST": "T047", "PI": "Cholelithiasis (1965-2003)", "MS": "Presence or formation of GALLSTONES in the GALLBLADDER.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041761"}, {"RECTYPE": "D", "MH": "Jaundice, Obstructive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Jaundice, Mechanical|T184|NON|EQV|UNK (19XX)|880414|abcdef", "ENTRY": "Obstructive Jaundice", "MN": "C23.888.885.375.500", "FX": "Mirizzi Syndrome", "MH_TH": "UNK (19XX)", "ST": "T184", "PI": "Cholestasis (1965-2003)", "MS": "Jaundice, the condition with yellowish staining of the skin and mucous membranes, that is due to impaired BILE flow in the BILIARY TRACT, such as INTRAHEPATIC CHOLESTASIS, or EXTRAHEPATIC CHOLESTASIS.", "PM": "2004; see CHOLESTASIS 1980-2003", "HN": "2004; use CHOLESTASIS 1980-2003", "MR": "20100625", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041781"}, {"RECTYPE": "D", "MH": "Acidiphilium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.755.050.020", "MH_TH": "NLM (2000)", "ST": "T007", "RN": "txid522", "PI": "Gram-Negative Chemolithotrophic Bacteria (1989-1998)", "MS": "A genus in the family ACETOBACTERACEAE consisting of chemoorganotrophic, straight rods with rounded ends. They are aerobic and acidophilic.", "PM": "2004; see Acetobacteraceae 2000-2003", "HN": "2004; use Acetobacteraceae 2000-2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041801"}, {"RECTYPE": "D", "MH": "Gluconacetobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Gluconacetobacter liquefaciens|T007|NON|NRW|NLM (2004)|021004|abcdef", "MN": "B03.660.050.755.050.400", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid89583", "RR": "txid89584", "PI": "Acetobacteraceae (1999-2003)", "MS": "A genus in the family ACETOBACTERACEAE comprised of acetate-oxidizing bacteria.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041821"}, {"RECTYPE": "D", "MH": "Gluconacetobacter xylinus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Acetobacter xylinum|T007|NON|EQV|NLM (2004)|021004|abcdef", "ENTRY": "Gluconacetobacter xylinum|T007|NON|EQV|NLM (2004)|021004|abcdef", "MN": "B03.660.050.755.050.400.500", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid28448", "PI": "Acetobacter (2000-2003)", "MS": "A species of acetate-oxidizing bacteria, formerly known as Acetobacter xylinum.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041822"}, {"RECTYPE": "D", "MH": "Bradyrhizobiaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Nitrobacteraceae|T007|NON|NRW|NLM (1975)|990101|abcdef", "MN": "B03.660.050.035", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid41294", "MS": "A proposed family of bacteria belonging to the alpha-2 subgroup of PROTEOBACTERIA.", "PM": "2004; for NITROBACTERACEAE see NITROBACTERACEAE 1975-2003", "HN": "2004", "MR": "20200902", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041841"}, {"RECTYPE": "D", "MH": "Chloroflexus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.210", "MH_TH": "NLM (1997)", "ST": "T007", "RN": "txid1107", "PI": "Chlorobi (1996-2003)", "MS": "A genus of green nonsulfur bacteria in the family Chloroflexaceae. They are photosynthetic, thermophilic, filamentous gliding bacteria found in hot springs.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041861"}, {"RECTYPE": "D", "MH": "Chloroflexi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Herpetosiphon|T007|NON|NRW|NLM (2004)|021008|abcdef", "ENTRY": "Green Nonsulfur Bacteria|T007|NON|EQV|NLM (2004)|021115|abcdef", "MN": "B03.275", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid200795", "RR": "txid64", "MS": "Phylum of green nonsulfur bacteria including the family Chloroflexaceae, among others.", "PM": "2004; for CHLOROFLEXACEAE see GREEN SULFUR BACTERIA 1997-2003", "HN": "2004; for CHLOROFLEXACEAE use CHLOROBI 1997-2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041862"}, {"RECTYPE": "D", "MH": "Cholecystitis, Acute", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Acute Cholecystitis|T047|NON|EQV|NLM (2004)|021008|abcdef", "MN": "C06.130.564.263.500", "MH_TH": "NLM (2004)", "ST": "T047", "PI": "Cholecystitis (1964-2003)", "MS": "Acute inflammation of the GALLBLADDER wall. It is characterized by the presence of ABDOMINAL PAIN; FEVER; and LEUKOCYTOSIS. Gallstone obstruction of the CYSTIC DUCT is present in approximately 90% of the cases.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041881"}, {"RECTYPE": "D", "MH": "Emphysematous Cholecystitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cholecystitis, Emphysematous|T047|NON|EQV|NLM (2004)|021118|abcdef", "MN": "C06.130.564.263.500.500", "MH_TH": "NLM (2004)", "ST": "T047", "PI": "Cholecystitis (1965-2003)", "MS": "A variant of acute cholecystitis with inflammation of the GALLBLADDER that is characterized by the pockets of gas in the gallbladder wall. It is due to secondary infection caused by gas-forming organisms, and has a high risk of perforation.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041882"}, {"RECTYPE": "D", "MH": "Chlorobium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.275", "MH_TH": "NLM (1997)", "ST": "T007", "RN": "txid1091", "PI": "Chlorobi (1996-2003)", "MS": "A genus of phototrophic, obligately anaerobic bacteria in the family Chlorobiaceae. They are found in hydrogen sulfide-containing mud and water environments.", "PM": "2004; see GREEN SULFUR BACTERIA 1997-2003", "HN": "2004; use CHLOROBI 1997-2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041883"}, {"RECTYPE": "D", "MH": "Stemonaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Stichoneuron|T002|NON|NRW|NLM (2004)|021008|abcdef", "ENTRY": "Stichoneurons", "MN": "B01.875.800.575.912.250.910", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid49662", "RR": "txid85281", "MS": "A small plant family of the order Liliales, subclass Liliidae, class Liliopsida (monocotyledons).", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041901"}, {"RECTYPE": "D", "MH": "Rhodobacteraceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.750", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid31989", "MS": "A family in the order Rhodobacterales, class ALPHAPROTEOBACTERIA.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041902"}, {"RECTYPE": "D", "MH": "Rhodovulum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.750.725", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid34008", "PI": "Rhodobacter (1996-2003)", "MS": "A genus of facultatively or obligately anaerobic marine phototrophic bacteria, in the family RHODOBACTERACEAE.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041903"}, {"RECTYPE": "D", "MH": "Roseobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.750.750", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2433", "MS": "A genus of obligately aerobic marine phototrophic and chemoorganotrophic bacteria, in the family RHODOBACTERACEAE.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041904"}, {"RECTYPE": "D", "MH": "Erythroid Cells", "AQ": "CH CL CY DE EN IM ME MI PA PS RE UL VI", "PRINT ENTRY": "Erythron|T025|NON|REL|NLM (2024)|220907|abcdef", "ENTRY": "Erythroid Cell", "MN": "A11.443", "MH_TH": "NLM (2004)", "ST": "T025", "MS": "The series of cells in the red blood cell lineage at various stages of differentiation.", "PM": "2004", "HN": "2004", "MR": "20230601", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041905"}, {"RECTYPE": "D", "MH": "Hyphomicrobiaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.350", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid45401", "MS": "A family in the order Rhizobiales, class ALPHAPROTEOBACTERIA comprised of many genera of budding or appendaged bacteria.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041921"}, {"RECTYPE": "D", "MH": "Adolescent Development", "AQ": "CL DE PH RE", "ENTRY": "Development, Adolescent", "MN": "G07.345.374.500", "FX": "Adolescent Behavior", "MH_TH": "NLM (2004)", "ST": "T041", "PI": "Adolescence (1965-2003)", "MS": "The continuous sequential physiological and psychological changes during ADOLESCENCE, approximately between the age of 13 and 18.", "PM": "2004", "HN": "2004", "MR": "20160115", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041923"}, {"RECTYPE": "D", "MH": "Milk Substitutes", "AQ": "AD CH CL CS EC ES HI IP IS LJ ME MT PD PK SN ST", "ENTRY": "Milk Substitute", "MN": "J02.200.712", "MH_TH": "NLM (2004)", "ST": "T168", "PI": "Milk (1968-2003)", "MS": "Food BEVERAGES that are used as nutritional substitutes for MILK.", "PM": "2004; see MILK 1998-2003", "HN": "2004; use MILK 1998-2003", "MR": "20141014", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041941"}, {"RECTYPE": "D", "MH": "Soy Milk", "AQ": "AD CH CL CS EC ES HI IP IS LJ ME MT PD PK SN ST", "PRINT ENTRY": "Milk, Soy|T168|NON|EQV|NLM (2004)|021213|abcdef", "ENTRY": "Soy Beverages", "MN": "J02.500.850.800.500.500", "MH_TH": "NLM (2004)", "ST": "T168", "PI": "Milk (1965-2003)", "MS": "A beverage prepared from GLYCINE MAX.", "PM": "2004", "HN": "2004", "MR": "20230727", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041942"}, {"RECTYPE": "D", "MH": "Infant Formula", "AQ": "AE AN CH CL EC HI LJ MI PO PS RE SD SN ST TO VI", "ENTRY": "Infant Formulas", "MN": "J02.500.525.500.500", "MH_TH": "NLM (2004)", "ST": "T168", "AN": "coordinate with major ingredient", "PI": "Milk (1969-2003)", "MS": "Formulations for the nutrition of infants that are substituted for BREAST MILK.", "PM": "2004", "HN": "2004", "MR": "20160928", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041943"}, {"RECTYPE": "D", "MH": "Deuterium Exchange Measurement", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Measurements, Hydrogen-Deuterium Exchange", "MN": "E05.196.344", "MH_TH": "NLM (2004)", "ST": "T059", "PI": "Spectrophotometry (1966-2003)", "MS": "A research technique to measure solvent exposed regions of molecules that is used to provide insight about PROTEIN CONFORMATION.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041961"}, {"RECTYPE": "D", "MH": "Thiotrichaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.770", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid135617", "MS": "A family of colorless sulfur bacteria in the order Thiotrichales, class GAMMAPROTEOBACTERIA.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041962"}, {"RECTYPE": "D", "MH": "Bacteroidetes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Cytophagales|T007|NON|NRW|NLM (1976)|990101|abcdef", "MN": "B03.440.080", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid976", "RR": "txid768507", "MS": "A phylum of bacteria comprising four classes; Bacteroidia, Cytophagia, Flavobacteriia, and Sphingobacteriia.", "PM": "2004; for CYTOPHAGALES use CYTOPHAGALES 1976-2003", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041963"}, {"RECTYPE": "D", "MH": "Cytophagaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Flexibacteraceae|T007|NON|EQV|NLM (2004)|021009|abcdef", "MN": "B03.440.400.425.300", "MH_TH": "NLM (1975)", "ST": "T007", "RN": "txid89373", "MS": "A family of gram-negative, gliding bacteria in the order Cytophagales, class Cytophagia. They are found in SOIL and SEA WATER.", "PM": "2012; see FLEXIBACTERACEAE 2004-2011, see CYTOPHAGACEAE 1975-2003", "HN": "2012 (2004)", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041964"}, {"RECTYPE": "D", "MH": "Flavobacteriaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.400.425.310", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid49546", "MS": "A family of bacteria in the order Sphingobacteriales, class Sphingobacteria. They are gram-negative rods, mostly saprophytic in terrestrial and aquatic habitats.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041965"}, {"RECTYPE": "D", "MH": "Gastrointestinal Tract", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Digestive Tract|T022|NON|EQV|NLM (2004)|021010|abcdef", "ENTRY": "Gastrointestinal Tracts", "MN": "A03.556", "MH_TH": "NLM (2004)", "ST": "T022", "PI": "Gastrointestinal System (1965-2003)", "MS": "Generally refers to the digestive structures stretching from the MOUTH to ANUS, but does not include the accessory glandular organs (LIVER; BILIARY TRACT; PANCREAS).", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D041981"}, {"RECTYPE": "D", "MH": "Ectothiorhodospiraceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.145", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid72276", "MS": "A family in the order Chromatiales, class GAMMAPROTEOBACTERIA. These are haloalkaliphilic, phototrophic bacteria that deposit elemental sulfur outside their cells.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042001"}, {"RECTYPE": "D", "MH": "Chromatin Assembly and Disassembly", "DE": "CHROMATIN ASSEMBLY DISASSEMBLY", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Chromatin Remodeling|T045|NON|NRW|NLM (2004)|021011|abcdef", "ENTRY": "Remodeling, Chromatin", "MN": "G05.308.095", "FX": "Histone Code", "MH_TH": "NLM (2004)", "ST": "T045", "PI": "Chromatin/metabolism (1978-2003)", "MS": "The mechanisms effecting establishment, maintenance, and modification of that specific physical conformation of CHROMATIN determining the transcriptional accessibility or inaccessibility of the DNA.", "PM": "2004", "HN": "2004", "MR": "20160115", "DA": "20030725", "DC": "1", "DX": "20040101", "UI": "D042002"}, {"RECTYPE": "D", "MH": "DNA Packaging", "AQ": "DE ES GE IM PH RE", "ENTRY": "Packaging, DNA", "MN": "G05.213", "MH_TH": "NLM (2004)", "ST": "T045", "MS": "The folding of an organism's DNA molecule into a compact, orderly structure that fits within the limited space of a CELL or VIRUS PARTICLE.", "PM": "2004", "HN": "2004", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042003"}, {"RECTYPE": "D", "MH": "Brucellaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.070", "MH_TH": "UNK (1992)", "ST": "T007", "RN": "txid118882", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Brucella (1972-2003)", "MS": "A family of gram-negative coccoid to rod-shaped bacteria in the order Rhizobiales. They are obligate parasites chiefly of warm-blooded VERTEBRATES. Many are pathogenic.", "PM": "2004; see BRUCELLA 1992-2003, see GRAM-POSITIVE AEROBIC BACTERIA 1976-1991, see BRUCELLACEAE 1975", "HN": "2004, 1975-1991; use BRUCELLA 1992-2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042021"}, {"RECTYPE": "D", "MH": "Ochrobactrum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.070.700", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid528", "AN": "infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS", "PI": "Alphaproteobacteria (2000-2003)", "MS": "A genus of the family BRUCELLACEAE comprising obligately aerobic gram-negative rods with parallel sides and rounded ends.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042041"}, {"RECTYPE": "D", "MH": "Brucella ovis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Brucella melitensis biovar ovis|T007|NON|EQV|NLM (2004)|021017|abcdef", "MN": "B03.660.050.070.100.625", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid236", "AN": "infection: coord IM with BRUCELLOSIS (IM)", "PI": "Brucella (1964-2003)", "MS": "A species of the genus BRUCELLA which are pathogenic to SHEEP.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042061"}, {"RECTYPE": "D", "MH": "Beijerinckiaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Beijerinckia|T007|NON|NRW|NLM (2004)|021017|abcdef", "MN": "B03.660.050.032", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid45404", "RR": "txid532", "MS": "A family of aerobic gram-negative rods that are nitrogen fixers. They are highly viscous, and appear as a semitransparent slime in giant colonies.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042062"}, {"RECTYPE": "D", "MH": "Caulobacteraceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.090", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid76892", "MS": "A family of stalked bacteria that reproduces by budding. There are four genera: CAULOBACTER, Asticcacaulis, Brevundimonas, and Phenylobacterium.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042063"}, {"RECTYPE": "D", "MH": "Azospirillum lipoferum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.755.750.100.510", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid193", "PI": "Azospirillum (1978-2003)", "MS": "A species of gram-negative to gram-variable, nitrogen-fixing bacteria. They are free-living in SOIL or found in association with PLANT ROOTS. It is the type species of the genus AZOSPIRILLUM.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042081"}, {"RECTYPE": "D", "MH": "Methylobacteriaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Roseomonas|T007|NON|NRW|NLM (2004)|021018|abcdef", "MN": "B03.660.050.500", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid119045", "RR": "txid125216", "MS": "A family of gram-negative bacteria in the order Rhizobiales. Genera include METHYLOBACTERIUM, Protomonas, and Roseomonas.", "PM": "2004", "HN": "2004", "MR": "20200902", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042082"}, {"RECTYPE": "D", "MH": "Methylocystaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Methylocystis|T007|NON|NRW|NLM (2004)|021018|abcdef", "MN": "B03.660.050.512", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid31993", "RR": "txid133", "MS": "A family of gram-negative methanotrophs in the order Rhizobiales, distantly related to the nitrogen-fixing and phototrophic bacteria.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042083"}, {"RECTYPE": "D", "MH": "Paracoccus pantotrophus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Thiosphaera pantotropha|T007|NON|EQV|NLM (2004)|021018|abcdef", "MN": "B03.660.050.750.600.600", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid82367", "PI": "Paracoccus (1999-2003)", "MS": "A species of gram-negative, coccoid, mostly chemolithoautotrophic bacteria, in the family RHODOBACTERACEAE. Some strains can grow anaerobically.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042084"}, {"RECTYPE": "D", "MH": "Acalculous Cholecystitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gallbladder Inflammation, Acalculous|T047|NON|EQV|NLM (2004)|021220|GALLBLADDER INFLAMM ACALCULOUS|abcdefv", "ENTRY": "Acalculous Gallbladder Inflammation|T047|NON|EQV|NLM (2004)|021220|ACALCULOUS GALLBLADDER INFLAMM|abcdefv", "MN": "C06.130.564.263.249", "MH_TH": "NLM (2004)", "ST": "T047", "PI": "Cholecystitis (1966-2003)", "MS": "Inflammation of the GALLBLADDER wall in the absence of GALLSTONES.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042101"}, {"RECTYPE": "D", "MH": "Contraception, Barrier", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Barrier Contraception|T061|NON|EQV|NLM (2004)|021022|abcdef", "ENTRY": "Barrier Method, Contraceptive", "MN": "E02.875.194.285", "MH_TH": "NLM (2004)", "ST": "T061", "PI": "Contraceptive Devices (1978-2003)", "MS": "Methods of contraception in which physical, chemical, or biological means are used to prevent the SPERM from reaching the fertilizable OVUM.", "PM": "2004; for BARRIER METHODS see CONTRACEPTION 1988-2003; for VAGINAL BARRIER METHODS see CONTRACEPTION 1993-2003", "HN": "2004; for BARRIER METHODS use CONTRACEPTION 1988-2003; for VAGINAL BARRIER METHODS use CONTRACEPTION 1993-2003", "MR": "20050630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042121"}, {"RECTYPE": "D", "MH": "Rhizobium phaseoli", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.662.670.600", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid396", "PI": "Rhizobium (1969-2003)", "MS": "A species of gram-negative bacteria functioning as a nitrogen inoculum for dry beans, especially species in the genus PHASEOLUS.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042161"}, {"RECTYPE": "D", "MH": "Rhizobium tropici", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.662.670.800", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid398", "PI": "Rhizobium (1991-2003)", "MS": "A species of gram-negative bacteria and an nitrogen inoculum that displays a high intrinsic tolerance to acidity.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042162"}, {"RECTYPE": "D", "MH": "Rhizobium etli", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.662.670.337", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid29449", "PI": "Rhizobium (1993-2003)", "MS": "A species of gram-negative bacteria and nitrogen innoculant of PHASEOLUS VULGARIS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042163"}, {"RECTYPE": "D", "MH": "Sinorhizobium fredii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.662.835.399", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid380", "PI": "Sinorhizobium (1999-2003)", "MS": "A species of gram-negative, aerobic bacteria that is a fast-growing and soybean-nodulating innoculant.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042181"}, {"RECTYPE": "D", "MH": "Rhodospirillum centenum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.755.750.733.150", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid34018", "PI": "Rhodospirillum (1989-2003)", "MS": "A thermotolerant, cyst-forming, anoxygenic photosynthetic species, in the genus RHODOSPIRILLUM.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042182"}, {"RECTYPE": "D", "MH": "Magnetospirillum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.755.750.500", "FX": "Magnetosomes", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid13134", "MS": "A genus of microaerophilic, gram-negative bacteria that forms crystals of the mineral magnetite in special organelles called MAGNETOSOMES.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042201"}, {"RECTYPE": "D", "MH": "Early Diagnosis", "ENTRY": "Disease Early Detection", "MN": "E01.390", "MH_TH": "NLM (2004)", "ST": "T060", "AN": "IM general only", "MS": "Methods to determine in patients the nature of a disease or disorder at its early stage of progression. Generally, early diagnosis improves PROGNOSIS and TREATMENT OUTCOME.", "PM": "2004", "HN": "2004", "MR": "20080708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042241"}, {"RECTYPE": "D", "MH": "Retinoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Retinoscope|T074|NON|EQV|NLM (2004)|021217|abcdef", "MN": "E07.230.540.500", "MH_TH": "NLM (2004)", "ST": "T074", "MS": "Instruments for RETINOSCOPY that determines the refractive state of the EYE, such as the degree of NEARSIGHTEDNESS; FARSIGHTEDNESS; or ASTIGMATISM. In principle, a retinoscope provides a light source to illuminate the RETINA, and then locates the aerial image of the retina in space to obtain an index of the refractive quality of the patient's lens system.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042261"}, {"RECTYPE": "D", "MH": "Retinoscopy", "AQ": "AE CL EC ES HI MO MT NU PX SN ST TD VE", "ENTRY": "Skiascopies", "MN": "E01.370.380.560.500", "FX": "Refraction, Ocular", "EC": "instrumentation:Retinoscopes", "MH_TH": "NLM (2004)", "ST": "T060", "PI": "Refraction, Ocular (1966-2003)", "MS": "An objective determination of the refractive state of the eye (NEARSIGHTEDNESS; FARSIGHTEDNESS; ASTIGMATISM). By using a RETINOSCOPE, the amount of correction and the power of lens needed can be determined.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042262"}, {"RECTYPE": "D", "MH": "Holosporaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Holospora|T007|NON|NRW|NLM (2004)|021025|abcdef", "MN": "B03.660.050.340", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid44746", "RR": "txid44747", "MS": "A family of bacteria comprised of endosymbionts of protozoa.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042281"}, {"RECTYPE": "D", "MH": "Microdissection", "AQ": "AE CL EC ED ES HI IS LJ MO MT SN ST TD VE", "ENTRY": "Microdissections", "MN": "E05.591.560", "FX": "Microsurgery", "MH_TH": "NLM (2004)", "ST": "T062", "PI": "Dissection (1966-2003)", "MS": "The performance of dissections with the aid of a microscope.", "PM": "2004", "HN": "2004", "MR": "20150623", "DA": "20030722", "DC": "1", "DX": "20040101", "UI": "D042282"}, {"RECTYPE": "D", "MH": "Sphingomonadaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Erythrobacter|T007|NON|NRW|NLM (2004)|021028|abcdef", "MN": "B03.660.050.800", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid41297", "RR": "txid1041", "MS": "A family of gram-negative, asporogenous rods or ovoid cells, aerobic or facultative anaerobic chemoorganotrophs. They are commonly isolated from SOIL, activated sludge, or marine environments.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042301"}, {"RECTYPE": "D", "MH": "Anaplasma centrale", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Anaplasma marginale subsp. centrale|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.050.783.500.050.100", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid769", "PI": "Anaplasma (1966-2003)", "MS": "A species of gram-negative bacteria causing mild ANAPLASMOSIS in CATTLE. It also can infect SHEEP and GOATS. It is transmitted by TICKS.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042321"}, {"RECTYPE": "D", "MH": "Anaplasma marginale", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Anaplasma theileri|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.050.783.500.050.500", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid770", "PI": "Anaplasma (1964-2003)", "MS": "A species of gram-negative bacteria and causative agent of severe bovine ANAPLASMOSIS. It is the most pathogenic of the ANAPLASMA species.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042322"}, {"RECTYPE": "D", "MH": "Anaplasma ovis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.783.500.050.575", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid142058", "PI": "Anaplasma (1968-2003)", "MS": "A species of gram-negative bacteria producing mild to severe ANAPLASMOSIS in SHEEP and GOATS, and mild or inapparent infections in DEER and CATTLE.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042323"}, {"RECTYPE": "D", "MH": "Gonadal Hormones", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gonadal Hormone|T125|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Hormones, Gonadal", "MN": "D06.472.334", "MH_TH": "NLM (2004)", "ST": "T125", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Hormones produced by the GONADS, including both steroid and peptide hormones. The major steroid hormones include ESTRADIOL and PROGESTERONE from the OVARY, and TESTOSTERONE from the TESTIS. The major peptide hormones include ACTIVINS and INHIBINS.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042341"}, {"RECTYPE": "D", "MH": "Mammary Glands, Human", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Mammary Lobule, Human", "MN": "A10.336.532", "MH_TH": "NLM (2004)", "ST": "T023", "AN": "for animals use MAMMARY GLANDS, ANIMAL", "PI": "Breast (1965-2003)", "MS": "Glandular tissue in the BREAST of human that is under the influence of hormones such as ESTROGENS; PROGESTINS; and PROLACTIN. In WOMEN, after PARTURITION, the mammary glands secrete milk (MILK, HUMAN) for the nourishment of the young.", "PM": "2004; see BREAST 1975-2003", "HN": "2004; use BREAST 1975-2003", "MR": "20160601", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042361"}, {"RECTYPE": "D", "MH": "Granulocyte Precursor Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Promyelocytes|T025|NON|NRW|UNK (19XX)|840405|abcdef", "ENTRY": "Promyelocyte", "MN": "A15.378.316.378.590.675.500", "FX": "Leukemia, Promyelocytic, Acute", "MH_TH": "NLM (2004)", "ST": "T025", "PI": "Granulocytes or specifics (1975-2003)", "MS": "The cells in the granulocytic series that give rise to mature granulocytes (NEUTROPHILS; EOSINOPHILS; and BASOPHILS). These precursor cells include myeloblasts, promyelocytes, myelocytes and metamyelocytes.", "PM": "2004; for PROMYELOCYTES see GRANULOCYTES 1985-2003", "HN": "2004; for PROMYELOCYTES use GRANULOCYTES 1985-2003", "MR": "20160610", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042381"}, {"RECTYPE": "D", "MH": "Alcaligenaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.344", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid506", "MS": "A family of gram-negative, aerobic, non-spore forming rods or cocci of the order BURKHOLDERIALES, which include . A well-known genera which includes ACHROMOBACTER; ALCALIGENES; and BORDETELLA.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042401"}, {"RECTYPE": "D", "MH": "Achromobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.344.030", "MH_TH": "UNK (19XX)", "ST": "T007", "RN": "txid222", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Alcaligenes (1965-2003)", "MS": "A genus of gram-negative, strictly aerobic, non-spore forming rods. Soil and water are regarded as the natural habitat. They are sometimes isolated from a hospital environment and humans.", "PM": "2004; see ALCALIGENES 1976-2003, see ACROMOBACTER 1963-1975", "HN": "2004, 1963-1975; use ALCALIGENES 1976-2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042402"}, {"RECTYPE": "D", "MH": "Histone Code", "AQ": "DE GE PH RE", "ENTRY": "Modifications, Histone", "MN": "G05.360.360", "FX": "Protein Processing, Post-Translational", "MH_TH": "NLM (2004)", "ST": "T087", "PI": "Histones (2000-2003)", "MS": "The specific patterns of changes made to HISTONES, that are involved in assembly, maintenance, and alteration of chromatin structural states (such as EUCHROMATIN and HETEROCHROMATIN). The changes are made by various histone modification processes that include ACETYLATION; METHYLATION; PHOSPHORYLATION; and UBIQUITINATION.", "PM": "2004", "HN": "2004", "MR": "20200205", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042421"}, {"RECTYPE": "D", "MH": "Achromobacter cycloclastes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.344.030.100", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid223", "AN": "infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS ", "PI": "Alcaligenes (1972-2003)", "MS": "A species of gram negative, aerobic, denitrifying bacteria in the genus ACHROMOBACTER.", "PM": "2004", "HN": "2004", "MR": "20200317", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042422"}, {"RECTYPE": "D", "MH": "Achromobacter denitrificans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Achromobacter xylosoxidans|T007|NON|EQV|NLM (2004)|021105|abcdef", "ENTRY": "Alcaligenes denitrificans subsp. xylosoxydans|T007|NON|NRW|NLM (2004)|021105|abcdef", "MN": "B03.660.075.090.344.030.120", "MH_TH": "NLM (2006)", "ST": "T007", "RN": "txid32002", "RR": "txid85698", "AN": "infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS ", "PI": "Alcaligenes (1971-2003)", "MS": "The type species of gram negative, aerobic bacteria in the genus ACHROMOBACTER. Previously in the genus ALCALIGENES, the classification and nomenclature of this species has been frequently emended. The two subspecies, Achromobacter xylosoxidans subsp. denitrificans and Achromobacter xylosoxidans subsp. xylosoxidans are associated with infections.", "PM": "2006; see ACHROMOBACTER XYLOSOXIDANS 2004-2005", "HN": "2006 (2004)", "MR": "20200902", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042441"}, {"RECTYPE": "D", "MH": "Vascular Endothelial Growth Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "VEGFs|T116|T123|ACR|EQV|NLM (2004)|021106|abbcdef", "MN": "D23.529.100.800", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "PI": "Endothelial Growth Factors (1991-2003)", "MS": "A family of angiogenic proteins that are closely-related to VASCULAR ENDOTHELIAL GROWTH FACTOR A. They play an important role in the growth and differentiation of vascular as well as lymphatic endothelial cells.", "PM": "2004", "HN": "2004", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042442"}, {"RECTYPE": "D", "MH": "Vascular Endothelial Growth Factor A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vascular Endothelial Growth Factor-A|T116|T123|NON|EQV|NLM (2004)|021120|abbcdef", "ENTRY": "Permeability Factor, Vascular", "MN": "D23.529.100.800.200", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Endothelial Growth Factors (2000-2003)", "MS": "The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as \"tumor angiogenesis factor\" and \"vascular permeability factor\". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced.", "PM": "2004; VASCULAR ENDOTHELIAL GROWTH FACTOR was indexed under ENDOTHELIAL GROWTH FACTORS 2000-2002", "HN": "2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR A (NM) 2000-2002", "MR": "20130709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042461"}, {"RECTYPE": "D", "MH": "4-Quinolones", "DS": "QUINOLONES 004", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "4-Quinolone|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "4 Quinolones", "MN": "D03.633.100.810.835.830", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "MS": "QUINOLONES containing a 4-oxo (a carbonyl in the para position to the nitrogen). They inhibit the A subunit of DNA GYRASE and are used as antimicrobials. Second generation 4-quinolones are also substituted with a 1-piperazinyl group at the 7-position and a fluorine at the 6-position.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042462"}, {"RECTYPE": "D", "MH": "Alcaligenes faecalis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.344.050.200", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid511", "PI": "Alcaligenes (1965-2003)", "MS": "The type species of gram negative bacteria in the genus ALCALIGENES, found in soil. It is non-pathogenic, non-pigmented, and used for the production of amino acids.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042481"}, {"RECTYPE": "D", "MH": "Bordetella avium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.344.425.024", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid521", "AN": "infection: coordinate with BORDETELLA INFECTIONS", "PI": "Bordetella (1984-2003)", "MS": "A species of BORDETELLA isolated from the respiratory tracts of TURKEYS and other BIRDS. It causes a highly contagious bordetellosis.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042482"}, {"RECTYPE": "D", "MH": "Bordetella parapertussis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.344.425.590", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid519", "AN": "infection: coordinate with BORDETELLA INFECTIONS", "PI": "Bordetella (1964-2003)", "MS": "A species of BORDETELLA with similar morphology to BORDETELLA PERTUSSIS, but growth is more rapid. It is found only in the RESPIRATORY TRACT of humans.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042483"}, {"RECTYPE": "D", "MH": "Angiogenic Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Angiogenic Protein|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Protein, Angiogenic", "MN": "D23.529.100", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Angiogenesis Modulating Agents (1973-2003)", "MS": "Intercellular signaling peptides and proteins that regulate the proliferation of new blood vessels under normal physiological conditions (ANGIOGENESIS, PHYSIOLOGICAL). Aberrant expression of angiogenic proteins during disease states such as tumorigenesis can also result in PATHOLOGICAL ANGIOGENESIS.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042501"}, {"RECTYPE": "D", "MH": "Taylorella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.344.800", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid29574", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "MS": "A genus of chemoorganotrophic, gram negative rods, in the family ALCALIGENACEAE. They are pathogenic parasites of HORSES.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042502"}, {"RECTYPE": "D", "MH": "Burkholderiaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Ralstoniaceae|T007|NON|NRW|NLM (2004)|021202|abcdef", "MN": "B03.660.075.090.688", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid119060", "MS": "A family of gram negative, aerobic, non-sporeforming, rod-shaped bacteria.", "PM": "2004", "HN": "2004", "MR": "20200902", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042521"}, {"RECTYPE": "D", "MH": "DNA Replication Timing", "AQ": "DE GE IM PH RE", "ENTRY": "Timings, Gene Replication", "MN": "G05.226.760", "FX": "S Phase", "MH_TH": "NLM (2004)", "ST": "T045", "PI": "DNA Replication (1968-2003)", "MS": "The temporal order in which the DNA of the GENOME is replicated.", "PM": "2004", "HN": "2004", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042522"}, {"RECTYPE": "D", "MH": "Intracellular Space", "AQ": "CH DE DG EN GE IM ME MI PH PS RE VI", "ENTRY": "Subcellular Spaces", "MN": "A11.284.430", "FX": "Intracellular Fluid", "MH_TH": "NLM (2004)", "ST": "T030", "MS": "The area within CELLS.", "PM": "2004", "HN": "2004", "MR": "20180629", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042541"}, {"RECTYPE": "D", "MH": "Vascular Endothelial Growth Factor B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "VEGF-B VEGF-Related Protein", "MN": "D23.529.100.800.300", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Endothelial Growth Factors (1996-2003)", "MS": "A vascular endothelial growth factor expressed in a variety of tissues. It binds with high specificity to VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 and NEUROPILIN-1.", "PM": "2004; VASCULAR ENDOTHELIAL GROWTH FACTOR B was indexed under ENDOTHELIAL GROWTH FACTORS 1996-2003", "HN": "2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR B (NM) 1996-2003", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042561"}, {"RECTYPE": "D", "MH": "Intranuclear Space", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Subnuclear Spaces", "MN": "A11.284.430.106.279.345", "FX": "Chromosome Positioning", "MH_TH": "NLM (2004)", "ST": "T030", "MS": "The area within the CELL NUCLEUS.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042581"}, {"RECTYPE": "D", "MH": "Vascular Endothelial Growth Factor C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Vascular Endothelial Growth Factor-C|T116|T123|NON|EQV|NLM (2004)|021120|abbcdef", "MN": "D23.529.100.800.400", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Endothelial Growth Factors (1996-2003)", "MS": "A vascular endothelial growth factor that specifically binds to VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 and VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3. In addition to being an angiogenic factor it can act on LYMPHATIC VESSELS to stimulate LYMPHANGIOGENESIS. It is similar in structure to VASCULAR ENDOTHELIAL GROWTH FACTOR D in that they both contain N- and C-terminal extensions that were not found in other VEGF family members.", "PM": "2004; VASCULAR ENDOTHELIAL GROWTH FACTOR C was indexed under ENDOTHELIAL GROWTH FACTORS 1996-2003", "HN": "2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR C (NM) 1996-2003", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042582"}, {"RECTYPE": "D", "MH": "Lymphangiogenesis", "AQ": "DE GE IM PH RE", "ENTRY": "Lymphangiogeneses", "MN": "G07.345.500.325.377.437", "FX": "Lymphatic Vessels", "MH_TH": "NLM (2004)", "ST": "T067", "MS": "The formation of LYMPHATIC VESSELS.", "PM": "2004", "HN": "2004", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042583"}, {"RECTYPE": "D", "MH": "Lymphatic Vessels", "AQ": "AB AH BS CH CY DE DG EM EN IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Venules, Lymphatic|T023|NON|NRW|NLM (1998)|961011|abcdef", "ENTRY": "Vessels, Lymphatic", "MN": "A15.382.520.301", "EC": "growth & development:Lymphangiogenesis", "MH_TH": "NLM (2004)", "ST": "T023", "AN": "note entry terms VENULES, LYMPHATIC: do not coord with VENULES which are restricted to blood vessels", "MS": "Tubular vessels that are involved in the transport of LYMPH and LYMPHOCYTES.", "PM": "2004; for LYMPHATIC VESSELS, LYMPHATIC CAPILLARIES, LYMPHATIC VENULES & VENULES, POSTCAPILLARY see LYMPHATIC SYSTEM 1997-2002", "HN": "2004; for LYMPHATIC VESSELS, LYMPHATIC CAPILLARIES, LYMPHATIC VENULES & VENULES, POSTCAPILLARY use LYMPHATIC SYSTEM 1997-2002", "MR": "20180206", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042601"}, {"RECTYPE": "D", "MH": "Burkholderia cepacia complex", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.688.100.110", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid87882", "AN": "infection: coord IM with BURKHOLDERIA INFECTIONS (IM)", "PI": "Burkholderia cepacia (1999-2003)", "MS": "A group of phenotypically similar but genotypically distinct species (genomovars) in the genus BURKHOLDERIA. They are found in water, soil, and the rhizosphere of crop plants. They can act as opportunistic human pathogens and as plant growth promoting and biocontrol agents.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042602"}, {"RECTYPE": "D", "MH": "Comamonadaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Hydrogenophaga|T007|NON|NRW|NLM (2004)|021108|abcdef", "MN": "B03.660.075.090.766", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid80864", "RR": "txid47420", "MS": "A family of gram-negative aerobic bacteria in the order BURKHOLDERIALES, encompassing the acidovorans rRNA complex. Some species are pathogenic to PLANTS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042621"}, {"RECTYPE": "D", "MH": "DNA Repeat Expansion", "AQ": "DE ES GE IM PH RE", "ENTRY": "Repeats, Expanded DNA", "MN": "G05.558.220", "FX": "Chromosome Fragility", "MH_TH": "NLM (2004)", "ST": "T086", "PI": "Repetitive Sequences, Nucleic Acid or specifics (1993-2003)", "MS": "An increase number of repeats of a genomic, tandemly repeated DNA sequence from one generation to the next.", "PM": "2004", "HN": "2004", "MR": "20160617", "DA": "20030725", "DC": "1", "DX": "20040101", "UI": "D042622"}, {"RECTYPE": "D", "MH": "Vascular Endothelial Growth Factor D", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "c fos Induced Growth Factor", "MN": "D23.529.100.800.500", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Endothelial Growth Factor (1997-2003)", "MS": "A vascular endothelial growth factor that specifically binds to VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 and VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3. In addition to being an angiogenic factor it can act on LYMPHATIC VESSELS to stimulate LYMPHANGIOGENESIS. It is similar in structure to VASCULAR ENDOTHELIAL GROWTH FACTOR C in that they both contain N- and C-terminal extensions that were not found in other VEGF family members.", "PM": "2004; VASCULAR ENDOTHELIAL GROWTH FACTOR D was indexed under ENDOTHELIAL GROWTH FACTORS 1997-2003", "HN": "2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR D (NM) 1997-2003", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042643"}, {"RECTYPE": "D", "MH": "Vascular Endothelial Growth Factor, Endocrine-Gland-Derived", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endocrine-Gland-Derived Vascular Endothelial Growth Factor|T116|T123|NON|EQV|NLM (2004)|010920|abbcdef", "ENTRY": "Vascular Endothelial Growth Factor, Endocrine Gland Derived", "MN": "D23.529.100.800.600", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Mitogens (2001-2002)", "MS": "A vascular endothelial growth factor whose expression is found largely restricted to the GONADS; ADRENAL CORTEX; and PLACENTA. It has similar biological activity to VASCULAR ENDOTHELIAL GROWTH FACTOR-A.", "PM": "2004; ENDOCRINE-GLAND-DERIVED ENDOTHELIAL GROWTH FACTOR (now VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED) was indexed under ANGIOGENESIS FACTOR & GASTROINTESTINAL HORMONES (2003), under MITOGENS 2001-2002", "HN": "2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED (NM) 2001-2002", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042662"}, {"RECTYPE": "D", "MH": "Angiopoietins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Angiopoietin|T116|T123|NON|EQV|NLM (2021)|191227|abbcdef", "MN": "D23.529.100.100", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "MS": "A family of structurally related angiogenic proteins of approximately 70 kDa in size. They have high specificity for members of the TIE RECEPTOR FAMILY.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042682"}, {"RECTYPE": "D", "MH": "Angiopoietin-1", "DS": "ANGIOPOIETIN 01", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Angiopoietin 1", "MN": "D23.529.100.100.100", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Membrane Glycoproteins (1997-2003)", "MS": "The first to be discovered member of the angiopoietin family. It may play a role in increasing the sprouting and branching of BLOOD VESSELS. Angiopoietin-1 specifically binds to and stimulates the TIE-2 RECEPTOR. Several isoforms of angiopoietin-1 occur due to ALTERNATIVE SPLICING of its mRNA.", "PM": "2004; ANGIOPOIETIN-1 was indexed under MEMBRANE GLYCOPROTEINS 1997-2003 & ANGIOGENESIS FACTOR 2003", "HN": "2004; use ANGIOPOIETIN-1 (NM) 1997-2003", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042683"}, {"RECTYPE": "D", "MH": "Angiopoietin-2", "DS": "ANGIOPOIETIN 02", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Angiopoietin 2|T116|T123|NON|EQV|NLM (2004)|abbcde", "MN": "D23.529.100.100.200", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Proteins (1999-2002)", "MS": "An angiopoietin that is closely related to ANGIOPOIETIN-1. It binds to the TIE-2 RECEPTOR without receptor stimulation and antagonizes the effect of ANGIOPOIETIN-1. However its antagonistic effect may be limited to cell receptors that occur within the vasculature. Angiopoietin-2 may therefore play a role in down-regulation of BLOOD VESSEL branching and sprouting.", "PM": "2004; ANGIOPOIETIN-2 was indexed under PROTEINS 1999-2002 & ANGIOGENESIS FACTOR 2003", "HN": "2004; use ANGIOPOIETIN-2 (NM) 1997-2003", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042702"}, {"RECTYPE": "D", "MH": "Estrogens, Esterified (USP)", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Esterified Estrogens (USP)|T109|T121|T125|NON|EQV|NLM (2004)|021108|abbbcdef", "MN": "D06.472.334.851.437.994", "PA": "Estrogens", "MH_TH": "NLM (2004)", "ST": "T125", "RN": "0", "PI": "Estrogens, Conjugated (1975-2003)", "MS": "A pharmaceutical preparation containing a mixture of esterified estrogens derived from estrogen sulfates, principally from ESTRONE sulfate. Esterified estrogen content should be 75-85% of the estrone sulfate and 6-15% of the EQUILIN sulfate.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042724"}, {"RECTYPE": "D", "MH": "Burkholderia gladioli", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Burkholderia cocovenenans|T007|NON|EQV|NLM (2004)|021108|abcdef", "MN": "B03.660.075.090.688.100.355", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid28095", "AN": "infection: coordinate with BURKHOLDERIA INFECTIONS", "PI": "Burkholderia (1996-2003)", "MS": "A species of gram-negative, aerobic bacteria that acts as both a human and plant pathogen.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042725"}, {"RECTYPE": "D", "MH": "Burkholderia mallei", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pseudomonas mallei|T007|NON|EQV|NLM (2003)|020531|abcdef", "MN": "B03.660.075.090.688.100.477", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid13373", "PI": "Pseudomonas (1983-1997)", "MS": "A species of gram-negative bacteria parasitic on HORSES and DONKEYS causing GLANDERS, which can be transmitted to humans.", "PM": "2004; see PSEUDOMONAS 2003", "HN": "2004; use PSEUDOMONAS 2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042726"}, {"RECTYPE": "D", "MH": "Delftia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.766.170", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid80865", "MS": "A genus of gram-negative, strictly aerobic chemoorganotrophic bacteria, in the family COMAMONADACEAE.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042742"}, {"RECTYPE": "D", "MH": "Leptothrix", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.400.425.481", "MH_TH": "NLM (1997)", "ST": "T007", "RN": "txid88", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Gram-Negative Aerobic Bacteria (1965-2003)", "MS": "A genus of gram-negative, sheathed, rod-shaped bacteria in the order BURKHOLDERIALES.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042743"}, {"RECTYPE": "D", "MH": "Sphaerotilus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.766.750", "MH_TH": "NLM (1997)", "ST": "T007", "RN": "txid34102", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Gram-Negative Aerobic Bacteria (1966-2003)", "MS": "A genus of gram-negative, sheathed, rod-shaped bacteria in the family COMAMONADACEAE. They are closely related to LEPTOTHRIX.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042744"}, {"RECTYPE": "D", "MH": "Methylophilaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.495", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid32011", "MS": "A family of gram-negative bacteria in the order Methylophilales.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042762"}, {"RECTYPE": "D", "MH": "Acidithiobacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.015", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid119977", "PI": "Gammaproteobacteria (2001-2003)", "MS": "A genus of gram-negative rod-shaped bacteria in the class GAMMAPROTEOBACTERIA. They are obligately acidophilic and aerobic, using reduced SULFUR COMPOUNDS to support AUTOTROPHIC GROWTH.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042763"}, {"RECTYPE": "D", "MH": "Receptors, TIE", "DE": "RECEPT TIE", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TIE Receptor Tyrosine Kinases|T116|T192|ACX|EQV|NLM (2004)|020708|TIE RECEPT TYROSINE KINASES|abbcdefv", "ENTRY": "TIE Receptors", "MN": "D12.776.543.750.630.687", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "EC 2.7.10.1", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Cell Surface (1992-1993)", "MS": "A family of structurally-related tyrosine kinase receptors that are expressed predominantly in ENDOTHELIAL CELLS and are essential for development of BLOOD VESSELS (NEOVASCULARIZATION, PHYSIOLOGIC). The name derives from the fact that they are tyrosine kinases that contain Ig and EGF domains.", "PM": "2004; TIE RECEPTOR TYROSINE KINASES (now RECEPTORS, TIE) was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2003; under RECEPTORS, CELL SURFACE & PROTEIN-TYROSINE KINASE 1992-1993", "HN": "2004; use RECEPTORS, TIE (NM) 1999-2003", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042764"}, {"RECTYPE": "D", "MH": "Estrogenic Steroids, Alkylated", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Alkylated Estrogenic Steroids|T109|T121|T125|NON|EQV|NLM (2004)|030609|abbbcdef", "MN": "D06.472.334.851.437.968", "PA": "Estrogens", "MH_TH": "NLM (2004)", "ST": "T125", "RN": "0", "PI": "Ethinyl Estradiol (1968-2003)", "MS": "Estrogenic STEROIDS with aliphatic hydrocarbon chain substitution on C17 or other position. 17-alpha-ALKYLATION renders the molecule more stable, resistant to metabolic degradation, and improves oral efficacy. Examples of synthetic alkyl estrogens include ETHINYL ESTRADIOL and MESTRANOL. Substitutions at other sites generates antiestrogenic and cytotoxic properties.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042782"}, {"RECTYPE": "D", "MH": "Endothelial Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Vascular Endothelial Cell", "MN": "A11.436.275", "FX": "Endothelium", "MH_TH": "NLM (2004)", "ST": "T025", "AN": "coordinate with specific tissue type if pertinent", "PI": "Endothelium (1973-2003)", "MS": "Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer.", "PM": "2004", "HN": "2004", "MR": "20050630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042783"}, {"RECTYPE": "D", "MH": "Receptor, TIE-2", "DE": "RECEPT TIE 2", "DS": "RECEPTOR TIE 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TIE-2 Receptor Tyrosine Kinase|T116|T192|ACX|EQV|NLM (2004)|TIE RECEPTOR TYROSINE KINASE 02|TIE 2 RECEPT TYROSINE KINASE|abbcdesv", "ENTRY": "Tyrosine Kinase, TIE2", "MN": "D12.776.543.750.630.687.500", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "EC 2.7.10.1", "AN": "see SCR for organism-specific terms", "PI": "Receptor Protein-Tyrosine Kinases (1994-2003)", "MS": "A TIE receptor tyrosine kinase that is found almost exclusively on ENDOTHELIAL CELLS. It is required for both normal embryonic vascular development (NEOVASCULARIZATION, PHYSIOLOGIC) and tumor angiogenesis (NEOVASCULARIZATION, PATHOLOGIC).", "PM": "2004; TIE-2 RECEPTOR TYROSINE KINASE (now RECEPTOR TIE-2) was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2004 & under PROTEIN-TYROSINE KINASE 1993", "HN": "2004; use RECEPTOR TIE-2 (NM) 1993-2003", "MR": "20210521", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042787"}, {"RECTYPE": "D", "MH": "Oxalobacteraceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.883", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid75682", "MS": "A family of gram-negative bacteria in the order BURKHOLDERIALES, class BETAPROTEOBACTERIA.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042802"}, {"RECTYPE": "D", "MH": "Herbaspirillum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.883.400", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid963", "PI": "Betaproteobacteria (1998-2003)", "MS": "A genus of gram-negative bacteria in the family OXALOBACTERACEAE, which comprises vibrioid or sometimes helical cells. They are chemoorganotrophic nitrogen fixers and are found free-living in the soil or in association with the roots of members of the GRAMINEAE. (From Bergey's Manual of Determinative Bacteriology, 9th ed)", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042803"}, {"RECTYPE": "D", "MH": "Neisseria cinerea", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Micrococcus cinereus|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.075.525.520.124", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid483", "AN": "infection: coord IM with NEISSERIACEAE INFECTIONS (IM)", "PI": "Neisseria (1980-2003)", "MS": "A species of gram-negative, aerobic bacteria found in the human NASOPHARYNX.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042804"}, {"RECTYPE": "D", "MH": "Neisseria elongata", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.525.520.262", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid495", "AN": "infection: coord IM with NEISSERIACEAE INFECTIONS (IM)", "PI": "Neisseria (1970-2003)", "MS": "A species of gram-negative, aerobic BACTERIA consisting of short chains of rods. It has been isolated from the PHARYNX of healthy individuals and patients with ENDOCARDITIS. There are several recognized subspecies.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042805"}, {"RECTYPE": "D", "MH": "Neisseria lactamica", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Neisseria lactamicus|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.075.525.520.475", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid486", "AN": "infection: coord IM with NEISSERIACEAE INFECTIONS (IM)", "PI": "Neisseria (1973-2003)", "MS": "A species of gram-negative, aerobic BACTERIA commonly found in the NASOPHARYNX of infants and children, but rarely pathogenic. It is the only species to produce acid from LACTOSE.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042806"}, {"RECTYPE": "D", "MH": "Neisseria mucosa", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Diplococcus mucosus|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.075.525.520.520", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid488", "AN": "infection: coord IM with NEISSERIACEAE INFECTIONS (IM)", "PI": "Neisseria (1970-2003)", "MS": "A species of gram-negative, aerobic BACTERIA, found in the human NASOPHARYNX and in the normal flora of the respiratory tissues in DOLPHINS. It is occasionally pathogenic for humans and pathogenic for MICE. (Bergey's Manual of Systemic Bacteriology, 1st edition, p295)", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042807"}, {"RECTYPE": "D", "MH": "Neisseria sicca", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Diplococcus siccus|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.075.525.520.760", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid490", "AN": "infection: coord IM with NEISSERIACEAE INFECTIONS (IM)", "PI": "Neisseria (1966-2003)", "MS": "A species of gram-negative, aerobic BACTERIA found in the human NASOPHARYNX; SALIVA; and SPUTUM.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042808"}, {"RECTYPE": "D", "MH": "Receptor, TIE-1", "DE": "RECEPT TIE 1", "DS": "RECEPTOR TIE 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TIE-1 Receptor Tyrosine Kinase|T116|T192|ACX|EQV|NLM (2004)|020708|TIE RECEPTOR TYROSINE KINASE 01|TIE 1 RECEPT TYROSINE KINASE|abbcdefsv", "ENTRY": "Tyrosine Kinase, TIE1", "MN": "D12.776.543.750.630.687.249", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "EC 2.7.10.1", "AN": "see SCR for organism-specific terms", "PI": "Receptors, Cell Surface (1994-2003)", "MS": "A TIE receptor found predominantly on ENDOTHELIAL CELLS. It is considered essential for vascular development and can form a heterodimer with the TIE-2 RECEPTOR. The TIE-1 receptor may play a role in regulating BLOOD VESSEL stability and maturation.", "PM": "2004; TIE-1 RECEPTOR TYROSINE KINASE & TIE1 TYROSINE KINASE were indexed under RECEPTORS, CELL SURFACE & RECEPTOR PROTEIN-TYROSINE KINASES 1993-2003", "HN": "2004; for TIE-1 RECEPTOR TYROSINE KINASE & TIE1 TYROSINE KINASE use RECEPTOR, TIE-1 (NM) 1993-2003", "MR": "20210521", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042810"}, {"RECTYPE": "D", "MH": "Genomic Instability", "AQ": "DE ES GE IM PH RE", "ENTRY": "Stability, Genomic", "MN": "G05.370", "FX": "DNA Sequence, Unstable", "MH_TH": "NLM (2004)", "ST": "T045", "MS": "An increased tendency of the GENOME to acquire MUTATIONS when various processes involved in maintaining and replicating the genome are dysfunctional.", "PM": "2004", "HN": "2004", "MR": "20160705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042822"}, {"RECTYPE": "D", "MH": "11-beta-Hydroxysteroid Dehydrogenases", "DS": "BETA HYDROXYSTEROID DEHYDROGENASES A 11", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta-Hydroxysteroid Dehydrogenase, 11", "MN": "D08.811.682.047.820.100", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.1.1.146", "RR": "9041-46-7 (CRN)", "PI": "Hydroxysteroid Dehydrogenases (1978-2003)", "MS": "Hydroxysteroid dehydrogenases that catalyzes the reversible conversion of CORTISOL to the inactive metabolite CORTISONE. Enzymes in this class can utilize either NAD or NADP as cofactors.", "PM": "2004; 11BETA-HYDROXYSTEROID DEHYDROGENASE was indexed under HYDROXYSTEROID DEHYDROGENASES 1978-2003", "HN": "2004; use 11-BETA-HYDROXYSTEROID DEHYDROGENASES (NM) 1978-2003", "MR": "20130708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042842"}, {"RECTYPE": "D", "MH": "Glucose 1-Dehydrogenase", "DS": "GLUCOSE DEHYDROGENASE 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glucose 1 Dehydrogenase", "MN": "D08.811.682.047.150.270.500", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.1.1.47", "RR": "9028-53-9 (CRN)", "PI": "Glucose Dehydrogenases (1974-2003)", "MS": "A glucose dehydrogenase that catalyzes the oxidation of beta-D-glucose to form D-glucono-1,5-lactone, using NAD as well as NADP as a coenzyme.", "PM": "2004; GLUCOSE 1-DEHYDROGENASE was indexed under GLUCOSE DEHYDROGENASES 1983-2003", "HN": "2004; use GLUCOSE 1-DEHYDROGENASE (NM) 1983-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042843"}, {"RECTYPE": "D", "MH": "L-Lactate Dehydrogenase (Cytochrome)", "DS": "LACTATE DEHYDROGENASE CYTOCHROME L", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lactic Cytochrome Reductase|T116|T126|NON|EQV|UNK (19XX)|740330|abbcdef", "ENTRY": "Reductase, Lactate Flavocytochrome", "MN": "D08.811.682.047.551.500", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.1.2.3", "RR": "9078-32-4 (CRN)", "AN": "do not confuce with L-LACTATE DEHYDROGENASE", "PI": "L-Lactate Dehydrogenase (1974-2003)", "MS": "A cytochrome form of lactate dehydrogenase found in the MITOCHONDRIA. It catalyzes the oxidation of L-lactate to PYRUVATE with transfer of electrons to CYTOCHROME C. The enzyme utilizes FMN and PROTOHEME IX as cofactors.", "PM": "2004; L-LACTATE DEHYDROGENASE (CYTOCHROME) was indexed under LACTATE DEHYDROGENASE 1981-2003 & under CYTOCHROMES 1974-1980", "HN": "2004; use L-LACTATE DEHYDROGENASE (CYTOCHROME) (NM) 1980-2003", "MR": "20070709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042844"}, {"RECTYPE": "D", "MH": "Laccase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p Diphenol Oxidase", "MN": "D08.811.682.494", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.10.3.2", "RR": "EC 1.10.3.2", "PI": "Oxidoreductases (1980-2003)", "MS": "A copper-containing oxidoreductase enzyme that catalyzes the oxidation of 4-benzenediol to 4-benzosemiquinone. It also has activity towards a variety of O-quinols and P-quinols. It primarily found in FUNGI and is involved in LIGNIN degradation, pigment biosynthesis and detoxification of lignin-derived products.", "PM": "2004; LACCASE was indexed under OXIDOREDUCTASES 1980-2003", "HN": "2004; use LACCASE (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042845"}, {"RECTYPE": "D", "MH": "CDC2-CDC28 Kinases", "DS": "CDC 002 CDC 028 PROTEIN KINASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CDC2-Related Kinases|T116|T126|ACX|NRW|NLM (2004)|021118|CDC 002 RELATED KINASES|abbcdefs", "ENTRY": "CDC28 Related Kinases", "MN": "D12.776.476.563.646.500.500", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.7.11.22", "RR": "EC 2.7.11.22", "AN": "general or unspecified; prefer specifics", "PI": "Cyclin-Dependent Kinases (2000-2003)", "MS": "A family of cell cycle-dependent kinases that are related in structure to CDC28 PROTEIN KINASE, S CEREVISIAE and the CDC2 PROTEIN KINASE found in mammalian species.", "PM": "2004; CDC2-RELATED KINASE was indexed under CYCLIN-DEPENDENT KINASES 2000-2004; CDC2+-CDC28-RELATED PROTEIN KINASE was indexed under CDC28 PROTEIN KINASE 2003; PROTEIN-SERINE-THREONINE KINASES 1992-2002 & PROTEIN KINASES 1991-2003", "HN": "2004; for CDC2-RELATED KINASE use CDC2-CDC28 KINASES (NM) 2000-2004; for CDC2+-CDC28-RELATED PROTEIN KINASE use CDC2-CDC28 KINASES (NM) 1991-2003", "MR": "20210521", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042846"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase 9", "DS": "CYCLIN DEPENDENT KINASE 009", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cdk9 Protein Kinase|T116|T126|ACX|EQV|NLM (2004)|021115|CDK PROTEIN KINASE 009|abbcdefs", "ENTRY": "PITALRE, Cdc2-related Kinase", "MN": "D12.776.930.955.500.500", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.7.11.22", "RR": "EC 2.7.11.23", "AN": "see SCR for organism-specific terms", "MS": "A multifunctional CDC2 kinase-related kinase that plays roles in transcriptional elongation, CELL DIFFERENTIATION, and APOPTOSIS. It is found associated with CYCLIN T and is a component of POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B.", "PM": "2006; see CDK9 PROTEIN KINASE 2004-2005, CDK9 KINASE (now CYCLIN-DEPENDENT KINASE 9) was indexed under CYCLIN-DEPENDENT KINASES 2000-2003, under PROTEIN KINASES 1994-1999", "HN": "2006(1994)", "MR": "20210521", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042863"}, {"RECTYPE": "D", "MH": "Gallstones", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Gallstone|T031|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Calculi, Biliary", "MN": "C23.300.175.525", "MH_TH": "UNK (19XX)", "ST": "T031", "PI": "Common Bile Duct Calculi (1965-2003)", "MS": "Solid crystalline precipitates in the BILIARY TRACT, usually formed in the GALLBLADDER, resulting in the condition of CHOLELITHIASIS. Gallstones, derived from the BILE, consist mainly of calcium, cholesterol, or bilirubin.", "PM": "2004; see CHOLELITHIASIS 1975-2003; for COMMON BILE DUCT CALCULI see COMMON BILE DUCT CALCULI 1963-2003", "HN": "2004; use CHOLELITHIASIS 1975-2003", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042882"}, {"RECTYPE": "D", "MH": "Choledocholithiasis", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Cholelithiasis, Common Bile Duct|T047|NON|EQV|UNK (19XX)|790503|abcdef", "MN": "C06.130.409.267", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Common Bile Duct Calculi (1964-2003)", "MS": "Presence or formation of GALLSTONES in the COMMON BILE DUCT.", "PM": "2004; see COMMON BILE DUCT CALCULI 1980-2003", "HN": "2004; use COMMON BILE DUCT CALCULI 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042883"}, {"RECTYPE": "D", "MH": "Positive Transcriptional Elongation Factor B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "tat Associated Kinase", "MN": "D12.776.930.955.500", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.7.11.-", "PI": "Protein-Serine-Threonine Kinases (1996-2003)", "MS": "A transcriptional elongation factor complex that is comprised of a heterodimer of CYCLIN-DEPENDENT KINASE 9 and one of several CYCLINS including TYPE T CYCLINS and cyclin K. It functions by phosphorylating the carboxy-terminal domain of RNA POLYMERASE II.", "PM": "2004; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B was indexed under PROTEIN-SERINE-THREONINE KINASES 1996-2003", "HN": "2004; use POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B (NM) 1996-2003", "MR": "20210521", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042925"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP4A", "DS": "CYTOCHROME P 450 CYP 004A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lauric Acid Hydroxylase|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "P-450 CYP4A, Cytochrome", "MN": "D12.776.422.220.453.870.500", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.14.15.3", "RR": "9059-16-9 (CRN)", "AN": "/antag: coordinate with CYTOCHROME P-450 ENZYME INHIBITORS", "PI": "Mixed Function Oxygenases (1982-2003)", "MS": "A P450 oxidoreductase that catalyzes the hydroxylation of the terminal carbon of linear hydrocarbons such as OCTANES and FATTY ACIDS in the omega position. The enzyme may also play a role in the oxidation of a variety of structurally unrelated compounds such as XENOBIOTICS, and STEROIDS.", "PM": "2004; see ALKANE 1-MONOXYGENASE 2004-2014; LAURIC ACID HYDROLASE (now ALKANE 1-MONOXYGENASE) was indexed under CYTOCHROME P-450 ENZYME SYSTEM & MIXED FUNCTION OXYGENASES 1982-2003, under LAURIC ACIDS 1979-1981", "HN": "2004(2015)", "MR": "20160527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042926"}, {"RECTYPE": "D", "MH": "Aldehyde Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Aldehyde", "MN": "D08.811.682.657.163.311", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.2.3.1", "RR": "EC 1.2.3.1", "PI": "Oxidoreductases (1979-2003)", "MS": "An aldehyde oxidoreductase expressed predominantly in the LIVER; LUNGS; and KIDNEY. It catalyzes the oxidation of a variety of organic aldehydes and N-heterocyclic compounds to CARBOXYLIC ACIDS, and also oxidizes quinoline and pyridine derivatives. The enzyme utilizes molybdenum cofactor and FAD as cofactors.", "PM": "2004; ALDEHYDE OXIDASE was indexed under ALDEHYDE OXIDOREDUCTASES 1979-2003", "HN": "2004; use ALDEHYDE OXIDASE (NM) 1980-2003", "MR": "20090715", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042931"}, {"RECTYPE": "D", "MH": "3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)", "DS": "METHYL OXOBUTANOATE DEHYDROGENASE LIPOAMIDE 03 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "2-Oxoisovalerate Dehydrogenase (Lipoamide)|T116|T126|NON|EQV|NLM (2004)|OXOISOVALERATE DEHYDROGENASE LIPOAMIDE 02|abbcdes", "ENTRY": "Oxo-Acid Dehydrogenase, Branched-Chain", "MN": "D08.811.682.657.350.760", "FX": "Maple Syrup Urine Disease", "MH_TH": "NLM (2004)", "ST": "T126", "N1": "2-oxoisocaproate dehydrogenase", "RN": "EC 1.2.4.4", "RR": "9082-72-8 (CRN)", "PI": "Multienzyme Complexes (1982-2003)", "MS": "A ketone oxidoreductase that catalyzes the overall conversion of alpha-keto acids to ACYL-CoA and CO2. The enzyme requires THIAMINE DIPHOSPHATE as a cofactor. Defects in genes that code for subunits of the enzyme are a cause of MAPLE SYRUP URINE DISEASE. The enzyme was formerly classified as EC 1.2.4.3.", "PM": "2004; 2-OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE) (now 3-METHYL-2-OXBUTANOATE DEHYDROGENASE (LIPOAMIDE)) was indexed under KETONE OXIDOREDUCTASES & MULTIENZYME COMPLEXES 1982-2003, under AMINO ACIDS, BRANCH-CHAIN 1979-1981, under KETO ACIDS 1973-1981, under CARBOXY-LYASES 1974-1979", "HN": "2004; use 3-METHYL-2-OXBUTANOATE DEHYDROGENASE (LIPOAMIDE) (NM) 1973-2003", "MR": "20130709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042942"}, {"RECTYPE": "D", "MH": "Dihydrouracil Dehydrogenase (NADP)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, Dihydropyrimidine", "MN": "D08.811.682.660.350", "EC": "deficiency:Dihydropyrimidine Dehydrogenase Deficiency", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.3.1.2", "PI": "Uracil (1979)", "MS": "An oxidoreductase involved in pyrimidine base degradation. It catalyzes the catabolism of THYMINE; URACIL and the chemotherapeutic drug, 5-FLUOROURACIL.", "PM": "2004; DIHYDROURACIL DEHYDROGENASE (NADP) was indexed under OXIDOREDUCTASES 1983-2003; & under URACIL 1979", "HN": "2004; use DIHYDROURACIL DEHYDROGENASE (NADP) (NM) 1980-2003", "MR": "20130708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042943"}, {"RECTYPE": "D", "MH": "Cholestenone 5 alpha-Reductase", "DS": "CHOLESTENONE ALPHA REDUCTASE 05", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha-Reductase, Cholestenone 5", "MN": "D08.811.682.660.200", "EC": "analogs & derivatives:5-alpha Reductase Inhibitors", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.3.1.22", "RR": "EC 1.3.1.22", "PI": "Oxidoreductases (1983-2003)", "MS": "An oxidoreductase that catalyzes the conversion of 3-oxo-delta4 steroids into their corresponding 5alpha form. It plays an important role in the conversion of TESTOSTERONE into DIHYDROTESTOSTERONE and PROGESTERONE into DIHYDROPROGESTERONE.", "PM": "2004; CHOLESTENONE 5 ALPHA-REDUCTASE was indexed under OXIDOREDUCTASES 1983-2003 & under CHOLESTENONES 1970-1982", "HN": "2004; use CHOLESTENONE 5 ALPHA-REDUCTASE (NM) 1980-2003", "MR": "20151110", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042944"}, {"RECTYPE": "D", "MH": "Acyl-CoA Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Fatty Acyl-CoA", "MN": "D12.776.331.149", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.3.3.6", "PI": "Peroxidases (1980)", "MS": "An enzyme that catalyzes the first and rate-determining steps of peroxisomal beta-oxidation of fatty acids. It acts on COENZYME A derivatives of fatty acids with chain lengths from 8 to 18, using FLAVIN-ADENINE DINUCLEOTIDE as a cofactor.", "PM": "2004; ACYL-COA OXIDASE was indexed under OXIDOREDUCTASES 1982-2003, under ACYL COENZYME A 1980-1981 & under PEROXIDASES 1980", "HN": "2004; use ACYL-COA OXIDASE (NM) 1979-2003", "MR": "20050630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042962"}, {"RECTYPE": "D", "MH": "Electron Transport Complex II", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Succinate Dehydrogenase (Ubiquinone)|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Succinate Ubiquinone Reductase", "MN": "D12.776.556.579.374.375.141", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.3.5.1", "PI": "Ubiquinone (1972-1978)", "MS": "A flavoprotein oxidase complex that contains iron-sulfur centers. It catalyzes the oxidation of SUCCINATE to fumarate and couples the reaction to the reduction of UBIQUINONE to ubiquinol.", "PM": "2004; SUCCINATE DEHYDROGENASE (UBIQUINONE) was indexed under MULTIENZYME COMPLEXES, OXIDOREDUCTASES & SUCCINATE DEHYDROGENASE 1972-2003; for SUCCINATE-Q OXIDOREDUCTASE see SUCCINATE DEHYDROGENASE 1980-2003", "HN": "2004; use ELECTRON TRANSPORT COMPLEX II (NM) 1980-2003; for SUCCINATE-Q OXIDOREDUCTASE use SUCCINATE DEHYDROGENASE 1980-2003", "MR": "20110624", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042963"}, {"RECTYPE": "D", "MH": "Acyl-CoA Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Palmitoyl CoA Dehydrogenase", "MN": "D12.776.331.099", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.3.8.7", "RR": "EC 1.3.8.9", "AN": "ACYL-COA DEHYDROGENASES and ACYL-COA DEHYDROGENASE, LONG-CHAIN are also available", "PI": "Fatty Acid Desaturases (1982-2003)", "MS": "A flavoprotein oxidoreductase that has specificity for medium-chain fatty acids. It forms a complex with ELECTRON TRANSFERRING FLAVOPROTEINS and conveys reducing equivalents to UBIQUINONE.", "PM": "2004; ACYL-COA DEHYDROGENASE was indexed under FATTY ACID DESATURASES 1982-2003", "HN": "2004; use ACYL-COA DEHYDROGENASE (NM) 1980-2003", "MR": "20130708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042964"}, {"RECTYPE": "D", "MH": "Methylenetetrahydrofolate Reductase (NADPH2)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Methylene-THF Reductase (NADPH)|T116|T126|ABX|EQV|NLM (2004)|abbcde", "ENTRY": "Tetrahydrofolate Reductase, Methylene", "MN": "D12.776.331.775", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.5.1.20", "PI": "Amine Oxidoreductases (1986-2003)", "MS": "A flavoprotein amine oxidoreductase that catalyzes the reversible conversion of 5-methyltetrahydrofolate to 5,10-methylenetetrahydrofolate. This enzyme was formerly classified as EC 1.1.1.171.", "PM": "2004; METHYLENE-THF-REDUCTASE (NADPH) was indexed under AMINE OXIDOREDUCTASES 1986-2003", "HN": "2004; use METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2) (NM) 1986-2003", "MR": "20100625", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042965"}, {"RECTYPE": "D", "MH": "Cytochrome-B(5) Reductase", "DS": "CYTOCHROME B 05 REDUCTASE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase, NADH-Ferrihemoglobin", "MN": "D12.776.331.186", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.6.2.2", "RR": "EC 1.6.2.2", "AN": "/defic: consider also METHEMOGLOBINEMIA", "PI": "Oxidoreductases (1973-1974)", "MS": "A FLAVOPROTEIN oxidoreductase that occurs both as a soluble enzyme and a membrane-bound enzyme due to ALTERNATIVE SPLICING of a single mRNA. The soluble form is present mainly in ERYTHROCYTES and is involved in the reduction of METHEMOGLOBIN. The membrane-bound form of the enzyme is found primarily in the ENDOPLASMIC RETICULUM and outer mitochondrial membrane, where it participates in the desaturation of FATTY ACIDS; CHOLESTEROL biosynthesis and drug metabolism. A deficiency in the enzyme can result in METHEMOGLOBINEMIA.", "PM": "2004; CYTOCHROME B(5)REDUCTASE was indexed under CYTOCHROME REDUCTASES 1975-2003 & under OXIDOREDUCTASES 1973-1974; for METHEMOGLOBIN REDUCTASE see METHEMOGLOBIN REDUCTASE 1991-2003, see NADH, NADPH OXIDOREDUCTASES 1975-1990", "HN": "2004; use CYTOCHROME B(5) REDUCTASE (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042966"}, {"RECTYPE": "D", "MH": "Electron Transport Complex I", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NADH Dehydrogenase (Ubiquinone)|T116|T126|ACX|NRW|NLM (2004)|abbcde", "ENTRY": "Rotenone Sensitive Mitochondrial NADH Ubiquinone Oxidoreductase", "MN": "D12.776.556.579.374.375.140", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 7.1.1.2", "RR": "EC 1.6.5.3", "PI": "NADH, NADPH Oxidoreductases (1992-2003)", "MS": "A flavoprotein and iron sulfur-containing oxidoreductase complex that catalyzes the conversion of UBIQUINONE to ubiquinol. In MITOCHONDRIA the complex also couples its reaction to the transport of PROTONS across the internal mitochondrial membrane. The NADH DEHYDROGENASE component of the complex can be isolated and is listed as EC 1.6.99.3.", "PM": "2004; NADH DEHYDROGENASE (UBIQUINONE) was indexed under NADH, NADPH OXIDOREDUCTASES 1992-2003; for NADH DEHYDROGENASE use NADH DEHYDROGENASE 1990-2003; for UBIQUINONE REDUCTASE see NAD(P)H DEHYDROGENASE (QUINONE) 1992-1999", "HN": "2004; for NADH DEHYDROGENASE (UBIQUINONE) use ELECTRON TRANSPORT COMPLEX I (NM) 1992-2003; for NADH DEHYDROGENASE COMPLEX 1 use NADH DEHYDROGENASE 1989-2003; for UBIQUINONE REDUCTASE use NAD(P)H DEHYDROGENASE (QUINONE) 1992-1999", "MR": "20190705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D042967"}, {"RECTYPE": "D", "MH": "Oligoclonal Bands", "AQ": "AD AE AN BI BL CF CH CL DE DF EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Oligoclonal Immunoglobulins|T034|NON|EQV|NLM (2004)|abcde", "ENTRY": "Immunoglobulin, Oligoclonal", "MN": "D23.101.613", "FX": "Paraproteins", "MH_TH": "NLM (2004)", "ST": "T034", "RN": "0", "PI": "Immunoglobulins (1978-2003)", "MS": "Multiple protein bands serving as markers of specific ANTIBODIES and detected by ELECTROPHORESIS of CEREBROSPINAL FLUID or serum. The bands are most often seen during inflammatory or immune processes and are found in most patients with MULTIPLE SCLEROSIS.", "PM": "2004; OLIGOCLONAL IMMUNOGLOBULINS was indexed under IMMUNOGLOBULINS 1981-2003", "HN": "2004; use OLIGOCLONAL BANDS (NM) 1981-2003", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043025"}, {"RECTYPE": "D", "MH": "Hepatopancreas", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A13.463", "MH_TH": "NLM (1998)", "ST": "T017", "PI": "Pancreas (1964-1997)", "MS": "A primitive form of digestive gland found in marine ARTHROPODS, that contains cells similar to those found in the mammalian liver (HEPATOCYTES), and the PANCREAS.", "PM": "2004; see DIGESTIVE SYSTEM 1998-2003", "HN": "2004; use DIGESTIVE SYSTEM 1998-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043143"}, {"RECTYPE": "D", "MH": "Angiostatic Proteins", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Angiostatic Peptides|T116|T123|NON|NRW|NLM (2004)|021122|abbcdef", "MN": "D23.529.100.450", "PA": "Angiogenesis Inhibitors", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "MS": "Proteins that specifically inhibit the growth of new blood vessels (ANGIOGENESIS, PHYSIOLOGIC).", "PM": "2004", "HN": "2004", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043165"}, {"RECTYPE": "D", "MH": "Spirillaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.710", "MH_TH": "UNK (1992)", "ST": "T007", "RN": "txid119068", "MS": "A family of gram-negative bacteria in the order Nitrosomonadales. It formerly included the genera CAMPYLOBACTER and SPIRILLUM, then was abandoned, and is now reinstated as a family with a single genus SPIRILLUM.", "PM": "2004; see BACTERIA 1992-2003, see SPIRILLACEAE 1975-1991", "HN": "2004, 1975-1991; use BACTERIA 1992-2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043167"}, {"RECTYPE": "D", "MH": "Angiostatins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Angiostatin|T116|T121|NON|EQV|NLM (2004)|abbcde", "MN": "D23.529.100.450.500", "PA": "Antineoplastic Agents", "MH_TH": "NLM (2004)", "ST": "T121", "N1": "Angiostatin", "RN": "86090-08-6", "PI": "Peptide Fragments (1994-2003)", "MS": "Circulating 38-kDa proteins that are internal peptide fragments of PLASMINOGEN. The name derives from the fact that they are potent ANGIOGENESIS INHIBITORS. Angiostatins contain four KRINGLE DOMAINS which are associated with their potent angiostatic activity.", "PM": "2004; ANGIOSTATINS was indexed under PEPTIDE FRAGMENTS & PLASMINOGEN 1994-2003", "HN": "2004; use ANGIOSTATINS (NM) 1994-2003", "MR": "20190530", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043168"}, {"RECTYPE": "D", "MH": "Endostatins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Endostatin|T116|T121|NON|EQV|NLM (2004)|abbcde", "MN": "D23.529.100.450.750", "PA": "Antineoplastic Agents", "MH_TH": "NLM (2004)", "ST": "T121", "RN": "0", "PI": "Peptide Fragments (1997-2003)", "MS": "Angiostatic proteins that are formed from proteolytic cleavage of COLLAGEN TYPE XVIII.", "PM": "2004; ENDOSTATINS was indexed under COLLAGEN and PEPTIDE FRAGMENTS 1997-2003", "HN": "2004; use ENDOSTATINS (NM) 1997-2003", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043169"}, {"RECTYPE": "D", "MH": "Collagen Type XVIII", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Type XVIII, Procollagen", "MN": "D12.776.860.300.250.400.537", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "AN": "precursors: coord IM with PROCOLLAGEN (IM)", "PI": "Peptide Fragments (1997-2003)", "MS": "A non-fibrillar collagen found in BASEMENT MEMBRANE. The C-terminal end of the alpha1 chain of collagen type XVIII contains the ENDOSTATIN peptide, which can be released by proteolytic cleavage.", "PM": "2004; COLLAGEN TYPE XVIII & COLLAGEN XVIII were indexed under COLLAGEN & PEPTIDE FRAGMENTS 1997-2002; COLLAGEN ALPHA1(XVIII) was indexed under COLLAGEN 1994-2002", "HN": "2004; use COLLAGEN TYPE XVIII (NM) 1994-2002", "MR": "20040707", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043170"}, {"RECTYPE": "D", "MH": "Chromosomal Instability", "AQ": "DE ES GE IM PH RE", "ENTRY": "Stability, Chromosome", "MN": "G05.370.180", "MH_TH": "NLM (2004)", "ST": "T045", "PI": "Chromosome Aberrations (1967-2003)", "MS": "An increased tendency to acquire CHROMOSOME ABERRATIONS when various processes involved in chromosome replication, repair, or segregation are dysfunctional.", "PM": "2004", "HN": "2004", "MR": "20080708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043171"}, {"RECTYPE": "D", "MH": "Carboxylesterase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "amidase, Isocarboxazid", "MN": "D08.811.277.352.100.100", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.1.1", "RR": "EC 3.1.1.1", "PI": "Carboxylic Ester Hydrolases (1981-2003)", "MS": "Carboxylesterase is a serine-dependent esterase with wide substrate specificity. The enzyme is involved in the detoxification of XENOBIOTICS and the activation of ester and of amide PRODRUGS.", "PM": "2004; CARBOXYLESTERASE was indexed under CARBOXYLIC ACID ESTERASES 1981-2003", "HN": "2004; use CARBOXYLESTERASE (NM) 1981 - 2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043182"}, {"RECTYPE": "D", "MH": "Irritable Bowel Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Colon, Irritable|T047|NON|EQV|UNK (19XX)|780227|abcdef", "ENTRY": "Syndromes, Irritable Bowel", "MN": "C06.405.469.158.272.608", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Colonic Diseases, Functional (1970-2003)", "MS": "A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.", "PM": "2004; see COLONIC DISEASES, FUNCTIONAL 1979-2003", "HN": "2004; use COLONIC DISEASES, FUNCTIONAL 1979-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043183"}, {"RECTYPE": "D", "MH": "Steroid Metabolism, Inborn Errors", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Steroid Metabolic Diseases, Inborn|T047|NON|EQV|NLM (2004)|030224|abcdef", "MN": "C18.452.648.925", "MH_TH": "NLM (2004)", "ST": "T047", "AN": "coord IM with specific steriod/metab (IM);", "MS": "Errors in metabolic processing of STEROIDS resulting from inborn genetic mutations that are inherited or acquired in utero.", "PM": "2004", "HN": "2004", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043202"}, {"RECTYPE": "D", "MH": "1-Alkyl-2-acetylglycerophosphocholine Esterase", "DS": "ALKYL ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE 01 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Platelet-Activating Factor Hydrolase|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Platelet activating Factor Acetylhydrolase IB", "MN": "D08.811.277.352.100.680.750.937.249", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.1.47", "RR": "EC 3.1.1.47", "AN": "/antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS", "PI": "Phospholipases (1983-2003)", "MS": "A lipoprotein-associated PHOSPHOLIPASE A2 which modulates the action of PLATELET ACTIVATING FACTOR by hydrolyzing the SN-2 ester bond to yield the biologically inactive lyso-platelet-activating factor. It has specificity for phospholipid substrates with short-chain residues at the SN-2 position, but inactive against long-chain phospholipids. Deficiency in this enzyme is associated with many diseases including ASTHMA, and HYPERCHOLESTEROLEMIA.", "PM": "2004; 1-ALKYL-2-ACETYLGLYCEROLPHOSPHOCHOLINE ESTERASE was indexed under PHOSPHOLIPASES A 1983-2003; LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 was indexed under PHOSPHOLIPASES A 2000-2007 & under 1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE 2007", "HN": "2004(1983)", "MR": "20130708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043203"}, {"RECTYPE": "D", "MH": "Mineralocorticoid Excess Syndrome, Apparent", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cortisol 11-beta-Ketoreductase Deficiency|T047|NON|EQV|ORD (2010)|230209|abcdef", "ENTRY": "Deficiency, Cortisol 11-beta-Ketoreductase", "MN": "C18.452.648.925.500", "MH_TH": "NLM (2004)", "ST": "T047", "PI": "Metabolism, Inborn Errors (1977-2003)", "MS": "A hereditary disease characterized by childhood onset HYPERTENSION, hypokalemic alkalosis, and low RENIN and ALDOSTERONE secretion. It results from a defect in the activity of the 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2 enzyme which results in inadequate conversion of CORTISOL to CORTISONE. The build up of unprocessed cortisol to levels that stimulate MINERALOCORTICOID RECEPTORS creates the appearance of having excessive MINERALOCORTICOIDS.", "PM": "2004", "HN": "2004", "MR": "20230405", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043204"}, {"RECTYPE": "D", "MH": "11-beta-Hydroxysteroid Dehydrogenase Type 1", "DS": "BETA HYDROXYSTEROID DEHYDROGENASE A 11 TYPE 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "11beta Hydroxysteroid Dehydrogenase Type 1", "MN": "D08.811.682.047.820.100.300", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.1.1.146", "PI": "Hydroxysteroid Dehydrogenases (1999-2003)", "MS": "A low-affinity 11 beta-hydroxysteroid dehydrogenase found in a variety of tissues, most notably in LIVER; LUNG; ADIPOSE TISSUE; vascular tissue; OVARY; and the CENTRAL NERVOUS SYSTEM. The enzyme acts reversibly and can use either NAD or NADP as cofactors.", "PM": "2004; 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 was indexed under HYDROXYSTEROID DEHYDROGENASES 1999-2003", "HN": "2004; use 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 (NM) 1999-2003", "MR": "20130708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043205"}, {"RECTYPE": "D", "MH": "11-beta-Hydroxysteroid Dehydrogenase Type 2", "DS": "BETA HYDROXYSTEROID DEHYDROGENASE A 11 TYPE 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "11beta Hydroxysteroid Dehydrogenase Type 2", "MN": "D08.811.682.047.820.100.600", "EC": "deficiency:Mineralocorticoid Excess Syndrome, Apparent", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.1.1.146", "PI": "Hydroxysteroid Dehydrogenases (1992-2003)", "MS": "An high-affinity, NAD-dependent 11-beta-hydroxysteroid dehydrogenase that acts unidirectionally to catalyze the dehydrogenation of CORTISOL to CORTISONE. It is found predominantly in mineralocorticoid target tissues such as the KIDNEY; COLON; SWEAT GLANDS; and the PLACENTA. Absence of the enzyme leads to a fatal form of childhood hypertension termed, APPARENT MINERALOCORTICOID EXCESS SYNDROME.", "PM": "2004; 11 BETA-HSD2 was indexed under HYDROXYSTEROID DEHYDROGENASES 1992-2003", "HN": "2004; for 11 BETA-HSD2 use 11 BETA-HYDROXYSTEROID DEHYDROGENASES (NM) 1992-2003", "MR": "20130708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043209"}, {"RECTYPE": "D", "MH": "Exodeoxyribonuclease V", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Deoxyribonuclease, RecBC", "MN": "D08.811.277.352.335.375.750", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.11.5", "RR": "EC 3.1.11.5", "PI": "Exonucleases (1980-1982)", "MS": "An ATP-dependent exodeoxyribonuclease that cleaves in either the 5'- to 3'- or the 3'- to 5'-direction to yield 5'-phosphooligonucleotides. It is primarily found in BACTERIA.", "PM": "2004; EXODEOXYRIBONUCLEASE V was indexed under EXODEOXYRIBONUCLEASES 1983-2003 & under EXONUCLEASES 1980-1982", "HN": "2004; use EXODEOXYRIBONUCLEASE V (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043211"}, {"RECTYPE": "D", "MH": "Ubiquitin Thiolesterase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Uch L1 Protein", "MN": "D12.776.705.937", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.4.19.12", "RR": "EC 3.4.19.12", "PI": "Thiolester Hydrolases (1983-2003)", "MS": "A thioester hydrolase which acts on esters formed between thiols such as DITHIOTHREITOL or GLUTATHIONE and the C-terminal glycine residue of UBIQUITIN.", "PM": "2004; UBIQUITIN THIOLESTERASE was indexed under THIOLESTER HYDROLASES 1983-2003", "HN": "2004; use UBIQUITIN THIOLESTERASE (NM) 1983-2003", "MR": "20220712", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043222"}, {"RECTYPE": "D", "MH": "Deoxyribonuclease IV (Phage T4-Induced)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Redoxyendonuclease|T116|T126|NON|EQV|NLM (2004)|abbcde", "MN": "D08.811.277.352.335.350.275", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.21.2", "PI": "Endodeoxyribonucleases (1987-2003)", "MS": "An enzyme which catalyzes the endonucleolytic cleavage of phosphodiester bonds at purinic or apyrimidinic sites (AP-sites) to produce 5'-Phosphooligonucleotide end products. The enzyme prefers single-stranded DNA (ssDNA) and was formerly classified as EC 3.1.4.30.", "PM": "2004; DEOXYRIBONUCLEASE IV (PHAGE T4-INDUCED) was indexed under ENDODEOXYRIBONUCLEASES 1987-2003", "HN": "2004; use DEOXYRIBONUCLEASE IV (PHAGE T4-INDUCED) (NM) 1987-2002", "MR": "20130709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043223"}, {"RECTYPE": "D", "MH": "Deoxyribonuclease (Pyrimidine Dimer)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Endonuclease, Corrective", "MN": "D08.811.277.352.335.350.137", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.25.1", "RR": "EC 3.1.25.1", "PI": "Endonucleases (1975-1979)", "MS": "An enzyme which catalyzes an endonucleolytic cleavage near PYRIMIDINE DIMERS to produce a 5'-phosphate product. The enzyme acts on the damaged DNA strand, from the 5' side of the damaged site.", "PM": "2004; DEOXYRIBONUCLEASE was indexed under ENDODEOXYRIBONUCLEASES 1983-2003, under ENDONUCLEASES & DEOXYRIBONUCLEASE 1976-1982", "HN": "2004; use DEOXYRIBONUCLEASE (PYRIMIDINE DIMER) (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043224"}, {"RECTYPE": "D", "MH": "DNA Sequence, Unstable", "DE": "DNA SEQ UNSTABLE", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Unstable DNA Sequence|T086|EQV|NLM (1998)|961202|UNSTABLE DNA SEQ|abdefv", "ENTRY": "Sequences, Unstable DNA", "MN": "G05.360.340.024.189", "FX": "Genomic Instability", "MH_TH": "NLM (1999)", "ST": "T086", "MS": "A region of DNA that is highly polymorphic and is prone to strand breaks, rearrangements or other MUTATIONS because of the nature of its sequence. These regions often harbor palindromic, or repetitive sequences (REPETITIVE SEQUENCES, NUCLEIC ACID). Variability in stability of the DNA sequence is seen at CHROMOSOME FRAGILE SITES.", "PM": "2004; see TRINUCLEOTIDE REPEAT EXPANSION 1999-2003", "HN": "2004 (1998); use TRINUCLEOTIDE REPEAT EXPANSION 1998-2003", "MR": "20190701", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043243"}, {"RECTYPE": "D", "MH": "Ribonuclease III", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Enzyme, Dicer", "MN": "D08.811.277.352.700.350.707", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.26.3", "RR": "EC 3.1.26.3", "PI": "Ribonuclease (1979-1982)", "MS": "An endoribonuclease that is specific for double-stranded RNA. It plays a role in POST-TRANSCRIPTIONAL RNA PROCESSING of pre-RIBOSOMAL RNA and a variety of other RNA structures that contain double-stranded regions.", "PM": "2004; RIBONUCLEASE III was indexed under ENDORIBONUCLEASES 1983-2003, under ENDONUCLEASE & RIBONUCLEASE 1979-1982", "HN": "2004; use RIBONUCLEASE III (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043244"}, {"RECTYPE": "D", "MH": "Ribonuclease P", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ribonuclease P, RNA Catalytic Subunit|T114|T126|ACX|NRW|NLM (2004)|030206|abbcdef", "ENTRY": "RNase P|T116|T126|ABX|EQV|NLM (2004)|abbcde", "MN": "D12.776.664.962.500.625", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.26.5", "RR": "EC 3.1.26.5", "PI": "RNA, Catalytic (1991-2003)", "MS": "An RNA-containing enzyme that plays an essential role in tRNA processing by catalyzing the endonucleolytic cleavage of TRANSFER RNA precursors. It removes the extra 5'-nucleotides from tRNA precursors to generate mature tRNA molecules.", "PM": "2004; RIBONUCLEASE P was indexed under ENDORIBONUCLEASES 1983-2003, under RNA, CATALYTIC 1991-2003, under ENDONUCLEASES 1981-1982, & under RIBONUCLEASES 1979-1982", "HN": "2004; use RIBONUCLEASE P (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043262"}, {"RECTYPE": "D", "MH": "Myosin-Light-Chain Phosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Smooth Muscle Phosphatase II", "MN": "D12.776.476.559.475", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.3.53", "RR": "EC 3.1.3.53", "PI": "Phosphoprotein Phosphatase (1980-2003)", "MS": "A phosphoprotein phosphatase that is specific for MYOSIN LIGHT CHAINS. It is composed of three subunits, which include a catalytic subunit, a myosin binding subunit, and a third subunit of unknown function.", "PM": "2004; MYOSIN-LIGHT CHAIN PHOSPHATASE was indexed under PHOSPHOPROTEIN PHOSPHATASE 1980-2003", "HN": "2004; use MYOSIN-LIGHT-CHAIN PHOSPHATASE (NM) 1980-2003", "MR": "20210521", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043263"}, {"RECTYPE": "D", "MH": "Phosphodiesterase I", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphohydrolase, Orthophosphoric Diester", "MN": "D08.811.277.352.640.430", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.4.1", "RR": "9025-82-5 (CRN)", "PI": "Phosphoric Diester Hydrolases (1978-2003)", "MS": "A phosphoric diester hydrolase that removes 5'-nucleotides from the 3'-hydroxy termini of 3'-hydroxy-terminated OLIGONUCLEOTIDES. It has low activity towards POLYNUCLEOTIDES and the presence of 3'-phosphate terminus on the substrate may inhibit hydrolysis.", "PM": "2004; PHOSPHODIESTERASE I was indexed under PHOSPHORIC DIESTER HYDROLASES 1981-2003, under NUCLEOTIDES 1978-1980", "HN": "2004; use PHOSPHODIESTERASE I (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043264"}, {"RECTYPE": "D", "MH": "Phosphatidylinositol Diacylglycerol-Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "1-Phosphatidylinositol Phosphodiesterase|T116|T126|NON|EQV|NLM (2004)|PHOSPHATIDYLINOSITOL PHOSPHODIESTERASE 01|abbcdes", "ENTRY": "Phosphodiesterase, Monophosphatidylinositol", "MN": "D08.811.520.650.800", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 4.6.1.13", "AN": "note X refs: TYPE C PHOSPHOLIPASES is also available", "PI": "Phosphoric Diester Hydrolases (1976-1997)", "MS": "A phosphorus-oxygen lyase found primarily in BACTERIA. The enzyme catalyzes the cleavage of a phosphoester linkage in 1-phosphatidyl-1D-myo-inositol to form 1D-myo-inositol 1,2-cyclic phosphate and diacylglycerol. The enzyme was formerly classified as a phosphoric diester hydrolase (EC 3.1.4.10) and is often referred to as a TYPE C PHOSPHOLIPASES. However it is now known that a cyclic phosphate is the final product of this enzyme and that water does not enter into the reaction.", "PM": "2004; 1-PHOSPHATYDYLINOSITOL-GLYCAN-SPECIFIC PHOSPHOLIPASE C (now PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE) was indexed under PHOSPHOLIPASE C 1998-2003; under PHOSPHORIC DIESTER HYDROLASES 1976-1997 & under PHOSPHATIDYLINOSITOLS 1977-1982", "HN": "2004; use PHOSPHOTIDYLINOSITOL DIACYLGLYCEROL-LYASE (NM) 1980-2003", "MR": "20070711", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043265"}, {"RECTYPE": "D", "MH": "Steryl-Sulfatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sulphatase, Steroid", "MN": "D08.811.277.352.827.070.625", "EC": "deficiency:Ichthyosis, X-Linked", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.6.2", "RR": "9025-62-1 (CRN)", "PI": "Arylsulfatases (1997-2003)", "MS": "An arylsulfatase with high specificity towards sulfated steroids. Defects in this enzyme are the cause of ICHTHYOSIS, X-LINKED.", "PM": "2004; STERYL-SULFATASE was indexed under ARYLSULFATASES 1976-2003", "HN": "2004; use STERYL-SULFATASE (NM) 1980-2003", "MR": "20090706", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043266"}, {"RECTYPE": "D", "MH": "Chromosome Fragile Sites", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Fragile Sites, Chromosome|T086|NON|EQV|UNK (19XX)|810223|abcdef", "ENTRY": "Sites, Chromosome Fragile", "MN": "G05.360.340.024.189.610", "FX": "Fragile X Syndrome", "MH_TH": "NLM (1999)", "ST": "T086", "PI": "Chromosome Fragility (1982-2003)", "MS": "Specific loci that show up during KARYOTYPING as a gap (an uncondensed stretch in closer views) on a CHROMATID arm after culturing cells under specific conditions. These sites are associated with an increase in CHROMOSOME FRAGILITY. They are classified as common or rare, and by the specific culture conditions under which they develop. Fragile site loci are named by the letters \"FRA\" followed by a designation for the specific chromosome, and a letter which refers to which fragile site of that chromosome (e.g. FRAXA refers to fragile site A on the X chromosome. It is a rare, folic acid-sensitive fragile site associated with FRAGILE X SYNDROME.)", "PM": "2004; see CHROMOSOME FRAGILITY 1982-2003", "HN": "2004; use CHROMOSOME FRAGILITY 1982-2003", "MR": "20130709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043283"}, {"RECTYPE": "D", "MH": "Cultured Milk Products", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Products, Fermented Milk", "MN": "J02.500.350.300", "MH_TH": "NLM (2004)", "ST": "T168", "PI": "Milk (1963-2003)", "MS": "Derivatives of milk that are produced by controlled FERMENTATION.", "HN": "2004", "MR": "20210707", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043302"}, {"RECTYPE": "D", "MH": "Aryldialkylphosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Thiolactone Hydrolase, Homocysteine", "MN": "D08.811.277.352.660.500", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.8.1", "RR": "EC 3.1.8.1", "AN": "entry terms PARAOXONASE-1, and PARAOXONASE-2 see SCR for organism specific terms", "PI": "Esterases (1980-2003)", "MS": "An enzyme which catalyzes the hydrolysis of an aryl-dialkyl phosphate to form dialkyl phosphate and an aryl alcohol. It can hydrolyze a broad spectrum of organophosphate substrates and a number of aromatic carboxylic acid esters. It may also mediate an enzymatic protection of LOW DENSITY LIPOPROTEINS against oxidative modification and the consequent series of events leading to ATHEROMA formation. The enzyme was previously regarded to be identical with Arylesterase (EC 3.1.1.2).", "PM": "2004; ARYLDIALKYLPHOSPHATASE was indexed under ESTERASES 1994-2003; PHOSPHORIC MONOESTER HYRDOLASES 1990-1993; PHOSPHOMONOESTERASES 1982-1989", "HN": "2004; use ARYLDIALKYLPHOSPHATASE (NM) 1980 - 2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043303"}, {"RECTYPE": "D", "MH": "Lactase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Galactohydrolase, Lactose", "MN": "D08.811.277.450.410.100.500", "FX": "Lactose Intolerance", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.2.1.108", "PI": "beta-Galactosidase (1990-2003)", "MS": "An enzyme which catalyzes the hydrolysis of LACTOSE to D-GALACTOSE and D-GLUCOSE. Defects in the enzyme cause LACTOSE INTOLERANCE.", "PM": "2004; LACTASE was indexed under BETA-GALACTOSIDASE 1990-2003", "HN": "2004; use LACTASE (NM) 1990-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043322"}, {"RECTYPE": "D", "MH": "alpha-Mannosidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lysosomal alpha-Mannosidase|T116|T126|NON|NRW|NLM (2004)|abbcde", "ENTRY": "alpha-Mannosidase, Neutral", "MN": "D08.811.277.450.625.500", "FX": "alpha-Mannosidosis", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.2.1.24", "RR": "EC 3.2.1.24", "AN": "/DEFIC: consider also ALPHA-MANNOSIDOSIS", "PI": "Mannosidases (1980-2003)", "MS": "An enzyme that catalyzes the HYDROLYSIS of terminal, non-reducing alpha-D-mannose residues in alpha-D-mannosides. The enzyme plays a role in the processing of newly formed N-glycans and in degradation of mature GLYCOPROTEINS. There are multiple isoforms of alpha-mannosidase, each having its own specific cellular location and pH optimum. Defects in the lysosomal form of the enzyme results in a buildup of mannoside intermediate metabolites and the disease ALPHA-MANNOSIDOSIS.", "PM": "2004; ALPHA-MANNOSIDASE was indexed under MANNOSIDASES 1980-2003", "HN": "2004; use ALPHA-MANNOSIDASE (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043323"}, {"RECTYPE": "D", "MH": "beta-Fructofuranosidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-D-Fructofuranosidase|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "beta Fructosidase", "MN": "D08.811.277.450.114", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.2.1.26", "RR": "EC 3.2.1.26", "PI": "Sucrase (1979-2003)", "MS": "A glycoside hydrolase found primarily in PLANTS and YEASTS. It has specificity for beta-D-fructofuranosides such as SUCROSE.", "PM": "2004; BETA-FRUCTOFURANOSIDASE was indexed under GLYCOSIDE HYDROLASES 1983-2003, under SUCRASE 1979-1982, & under FRUCTOSE 1979-1981", "HN": "2004; use BETA-FRUCTOFURANOSIDASE (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043324"}, {"RECTYPE": "D", "MH": "Xylan Endo-1,3-beta-Xylosidase", "DS": "XYLAN ENDO BETA XYLOSIDASE 01 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endo-1,3-beta-Xylanase|T116|T126|NON|EQV|NLM (2004)|ENDO BETA XYLANASE 01 03|abbcdes", "ENTRY": "Xylan Endo 1,3 beta Xylosidase", "MN": "D08.811.277.450.950.500", "FX": "Xylans", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.2.1.32", "RR": "EC 3.2.1.32", "PI": "Xylosidases (1995-2003)", "MS": "A xylosidase that catalyses the random hydrolysis of 1,3-beta-D-xylosidic linkages in 1,3-beta-D-xylans.", "PM": "2004; XYLAN ENDO-1,3-BETA-XYLOSIDASE was indexed under XYLOSIDASES 1995-2003, under GYCOSIDE HYDROLASES 1975-1994, under XYLANS 1979-1982 & under XYLOSE 1975-1979", "HN": "2004; use XYLAN ENDO-1,3-BETA-XYLOSIDASE (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043325"}, {"RECTYPE": "D", "MH": "Glucan 1,3-beta-Glucosidase", "DS": "GLUCAN BETA GLUCOSIDASE 01 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta-D-Glucosidase, Exo-1,3", "MN": "D08.811.277.450.420.200.500", "MH_TH": "NLM (2004)", "ST": "T126", "N1": "exo-1,3-beta-glucanase", "RN": "EC 3.2.1.58", "RR": "EC 3.2.1.58", "PI": "beta-Glucosidase (1979-2003)", "MS": "An exocellulase with specificity for 1,3-beta-D-glucasidic linkages. It catalyzes hydrolysis of beta-D-glucose units from the non-reducing ends of 1,3-beta-D-glucans, releasing GLUCOSE.", "PM": "2004; GLUCAN 1,3-BETA-GLUCOSIDASE was indexed under BETA-GLUCOSIDASE 1979-2003", "HN": "2004; use GLUCAN 1,3-BETA-GLUCOSIDASE (NM) 1979-2003", "MR": "20040727", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043326"}, {"RECTYPE": "D", "MH": "Testosterone Propionate", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Eifelfango, Testosteron Propionat", "MN": "D06.472.334.851.968.984.750", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "Androst-4-en-3-one, 17-(1-oxopropoxy)-(17-beta)-", "RN": "WI93Z9138A", "RR": "57-85-2 (Testosterone Propionate)", "PI": "Testosterone (1965-2003)", "MS": "An ester of TESTOSTERONE with a propionate substitution at the 17-beta position.", "PM": "2004; see TESTOSTERONE 1977-2003", "HN": "2004; use TESTOSTERONE 1977-2003", "MR": "20170524", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043343"}, {"RECTYPE": "D", "MH": "Chordata", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Chordates|T008|NON|EQV|NLM (2004)|021127|abcdef", "ENTRY": "Chordate", "MN": "B01.050.150", "MH_TH": "NLM (2000)", "ST": "T008", "RN": "txid7711", "PI": "Chordata, Nonvertebrate (2000-2003)", "MS": "Phylum in the domain Eukarya, comprised of animals either with fully developed backbones (VERTEBRATES), or those with notochords only during some developmental stage (CHORDATA, NONVERTEBRATE).", "PM": "2004, 1966-1999; see CHORDATA, NON-VERTEBRATE 2000-2003", "HN": "2004, 1966-1999; use CHORDATA, NON-VERTEBRATE 2000-2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043344"}, {"RECTYPE": "D", "MH": "Rhodocyclaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rhodocyclus|T007|NON|NRW|NLM (2004)|021202|abcdef", "MN": "B03.660.075.655", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid75787", "RR": "txid1064", "MS": "A family of gram-negative bacteria in the order Rhodocyclales, class BETAPROTEOBACTERIA. It includes many genera previously assigned to the family PSEUDOMONADACEAE.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043362"}, {"RECTYPE": "D", "MH": "Hydrogenophilaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.400", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid206349", "MS": "A family of gram-negative bacteria in the order Hydrogenophilales, class BETAPROTEOBACTERIA.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043363"}, {"RECTYPE": "D", "MH": "Endo-1,4-beta Xylanases", "DS": "ENDO BETA XYLANASES 01 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endo-1,4-beta-Xylanase|T116|T126|NON|EQV|NLM (2004)|ENDO BETA XYLANASE 01 04|abbcdes", "ENTRY": "Xylanases, Endo-1,4-beta", "MN": "D08.811.277.450.950.249", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.2.1.8", "RR": "EC 3.2.1.8", "PI": "Xylosidases (1995-2003)", "MS": "Enzymes which catalyze the endohydrolysis of 1,4-beta-D-xylosidic linkages in XYLANS.", "PM": "2004; ENDO-1,4 BETA XYLANASES was indexed under XYLOSIDASES 1995-2003, under GLYCOSIDE HYDROLASES 1980-1994 & under XYLANS 1977-1980, XYLANASE B was indexed under XYLOSIDASES 1995-2003 & under GLYCOSIDE HYDROLASES 1990-1994, XYLANASE C was indexed under XYLOSIDASES 1995-2003 & under GLYCOSIDE HYDROLASES 1992-1994, XYLANASE D was indexed under XYLOSIDASES & BETA-GLUCOSIDASE 1995-2003, under GLYCOSIDE HYDROLASES 1993-1994", "HN": "2004; use ENDO-1,4-BETA XYLANASES (NM) 1980-2003; for XYLANASE B use ENDO-1,4-BETA XYLANASES (NM) 1990-2003; for XYLANASE C use ENDO-1,4-BETA XYLANASES (NM) 1992-2003; for XYLANASE D use ENDO-1,4-BETA XYLANASES (NM) 1993-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043364"}, {"RECTYPE": "D", "MH": "Cellulose 1,4-beta-Cellobiosidase", "DS": "CELLULOSE BETA CELLOBIOSIDASE 01 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Exo-Cellobiohydrolase|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Exo Cellobiohydrolase", "MN": "D08.811.277.450.420.200.400", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.2.1.91", "RR": "EC 3.2.1.91", "PI": "Cellulase (1974-2003)", "MS": "An exocellulase with specificity for the hydrolysis of 1,4-beta-D-glucosidic linkages in CELLULOSE and cellotetraose. It catalyzes the hydrolysis of terminal non-reducing ends of beta-D-glucosides with release of CELLOBIOSE.", "PM": "2004; EXO-CELLOBIOHYDROLASE (now CELLULOSE 1,4-BETA-CELLOBIOSIDASE) was indexed under CELLULASE 1974-2003; EXOGLUCANASE II was indexed under BETA-GLUCOSIDASE 1992-2003", "HN": "2004; use CELLULOSE 1,4-BETA-CELLOBIOSIDASE (NM) 1974-2003; for EXOGLUCANASE II use GLUCAN 1,3-BETA-GLUCOSIDASE (NM) 1992-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043366"}, {"RECTYPE": "D", "MH": "Ralstonia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.688.600", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid48736", "AN": "infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Betaproteobacteria (2000-2003)", "MS": "A genus in the family BURKHOLDERIACEAE, comprised of many species. They are associated with a variety of infections including MENINGITIS; PERITONITIS; and URINARY TRACT INFECTIONS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043367"}, {"RECTYPE": "D", "MH": "Ralstonia solanacearum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Pseudomonas solanacearum|T007|NON|EQV|NLM (2004)|021202|abcdef", "MN": "B03.660.075.090.688.600.750", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid305", "PI": "Gram-Negative Aerobic Rods and Cocci (1995-2003)", "MS": "A species of Ralstonia previously classed in the genera PSEUDOMONAS and BURKHOLDERIA. It is an important plant pathogen.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043368"}, {"RECTYPE": "D", "MH": "Nitrosomonadaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.550", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid206379", "MS": "A family of gram-negative nitrifying bacteria, in the order Nitrosomonadales, class BETAPROTEOBACTERIA.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043369"}, {"RECTYPE": "D", "MH": "Nitrosomonas europaea", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.550.500.200", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid915", "PI": "Nitrosomonas (1965-2003)", "MS": "The type species of the genus NITROSOMONAS, a gram-negative chemolithotroph that oxidizes ammonia to nitrite. It is found in soil, sewage, freshwater, and on building walls, and especially in polluted areas where air contains high levels of nitrogen compounds.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043370"}, {"RECTYPE": "D", "MH": "Fatty Acids, Omega-6", "DS": "FATTY ACIDS OMEGA 06", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Omega-6 Fatty Acids|T109|NON|EQV|NLM (2004)|OMEGA FATTY ACIDS 06|abcdes", "ENTRY": "Omega 6 Fatty Acids", "MN": "D10.251.355.343", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "PI": "Fatty Acids, Unsaturated (1980-2003)", "MS": "FATTY ACIDS which have the first unsaturated bond in the sixth position from the omega carbon. A typical American diet tends to contain substantially more omega-6 than OMEGA-3 FATTY ACIDS.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043371"}, {"RECTYPE": "D", "MH": "Gallionellaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Gallionella|T007|NON|NRW|NLM (2004)|021202|abcdef", "MN": "B03.660.075.375", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid90627", "RR": "txid96", "MS": "A family of gram-negative bacteria in the order Nitrosomonadales, class BETAPROTEOBACTERIA. It contains a single genus Gallionella.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043372"}, {"RECTYPE": "D", "MH": "Follicle Stimulating Hormone, Human", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "hFSH|T116|T121|T125|ABX|EQV|NLM (2004)|021202|abbbcdef", "MN": "D06.472.699.631.525.343.288.625", "MH_TH": "NLM (2004)", "ST": "T125", "RN": "0", "AN": "for alpha subunit, coordinate with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; for beta subunit, coordinate with FOLLICLE STIMULATING HORMONE, BETA SUBUNIT", "PI": "Follicle Stimulating Hormone (1966-2003)", "MS": "A major gonadotropin secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and the LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. The alpha subunit is common in the three human pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.", "PM": "2004; see FOLLICLE STIMULATING HORMONE 1987-2003; for ANTHROGON see FOLLICLE STIMULATING HORMONE 1985-2003", "HN": "2004; use FOLLICLE STIMULATING HORMONE 1987-2003; for ANTHROGON use FOLLICLE STIMULATING HORMONE 1985-2003; for FOLLITROPIN-BETA use FOLLICLE STIMULATING HORMONE, BETA SUBUNIT 2003-2012", "MR": "20120703", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043373"}, {"RECTYPE": "D", "MH": "DNA-Formamidopyrimidine Glycosylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Formamidopyrimidine-DNA Glycosylase|T116|T126|ABX|EQV|NLM (2004)|abbcde", "ENTRY": "Formamidopyrimidine DNA Glycosylase", "MN": "D08.811.277.450.430.099.500", "FX": "DNA Repair", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.2.2.23", "PI": "N-Glycosyl Hydrolases (1981-2003)", "MS": "A DNA repair enzyme that is an N-glycosyl hydrolase with specificity for DNA-containing ring-opened N(7)-methylguanine residues.", "PM": "2004; DNA-FORMAIDOPYRIMIDINE GLYCOSYLASE was indexed under N-GLYCOSYL HYDROLASES 1981-2003", "HN": "2004; use DNA-FORMAMIDOPYRIMIDINE GLYCOSYLASE (NM) 1981-2003", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043382"}, {"RECTYPE": "D", "MH": "Adenosylhomocysteinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "S adenosylhomocysteine Synthase", "MN": "D08.811.277.063", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.3.1.1", "RR": "9025-54-1 (CRN)", "PI": "Hydrolases (1976-2003)", "MS": "An enzyme which catalyzes the catabolism of S-ADENOSYLHOMOCYSTEINE to ADENOSINE and HOMOCYSTEINE. It may play a role in regulating the concentration of intracellular adenosylhomocysteine.", "PM": "2004; ADENOSYLHOMOCYSTEINASE was indexed under HYDROLASES 1976-2003", "HN": "2004; use ADENOSYLHOMOCYSTEINASE (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043383"}, {"RECTYPE": "D", "MH": "Glutamyl Aminopeptidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Aminopeptidase, Glutamyl", "MN": "D08.811.277.656.675.555.600", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.4.11.7", "RR": "9074-83-3 (CRN)", "PI": "Aspartic Acid (1978-1980)", "MS": "A ZINC-dependent membrane-bound aminopeptidase that catalyzes the N-terminal peptide cleavage of GLUTAMATE (and to a lesser extent ASPARTATE). The enzyme appears to play a role in the catabolic pathway of the RENIN-ANGIOTENSIN SYSTEM.", "PM": "2004; GLUTAMYL AMINOPEPTIDASE was indexed under AMINOPEPTIDASES 1981-2003 & ASPARTIC ACID 1978-1980", "HN": "2004; use GLUTAMYL AMINPEPTIDASE (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043384"}, {"RECTYPE": "D", "MH": "Cathepsin A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lysosomal Protective Protein|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "beta Galactosidase Protective Protein", "MN": "D08.811.277.656.959.200", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.4.16.5", "PI": "Cathepsins (1965-2003)", "MS": "A carboxypeptidase that catalyzes the release of a C-terminal amino acid with a broad specificity. It also plays a role in the LYSOSOMES by protecting BETA-GALACTOSIDASE and NEURAMINIDASE from degradation. It was formerly classified as EC 3.4.12.1 and EC 3.4.21.13.", "PM": "2010; for CATHEPSIN A see CARBOXYPEPTIDASE C 2004-2009; CATHEPSIN A was indexed under CARBOXYPEPTIDASES 1995-2003", "HN": "2010(1995)", "MR": "20090706", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043402"}, {"RECTYPE": "D", "MH": "Carboxypeptidases A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carboxypeptidase A|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Procarboxypeptidase A2|T116|T123|NON|NRW|NLM (2004)|abbcde", "MN": "D08.811.277.656.675.555.350", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.4.17.1", "RR": "EC 3.4.17.15", "PI": "Carboxypeptidases (1974-2003)", "MS": "Carboxypeptidases that are primarily found the DIGESTIVE SYSTEM that catalyze the release of C-terminal amino acids. Carboxypeptidases A have little or no activity for hydrolysis of C-terminal ASPARTIC ACID; GLUTAMIC ACID; ARGININE; LYSINE; or PROLINE. This enzyme requires ZINC as a cofactor and was formerly listed as EC 3.4.2.1 and EC 3.4.12.2.", "PM": "2004; CARBOXYPEPTIDASES A was indexed under CARBOXYPEPTIDASES 1974-2003; PROCARBOXYPEPTIDASE A was indexed under CARBOXYPEPTIDASES & ENZYME PRECUSORS 1981-2003; PROCARBOXYPEPTIDASE A1 was indexed under CARBOXYPEPTIDASES & ENZYME PRECUSORS 1998-2003; PROCARBOXYPEPTIDASE A2 was indexed under CARBOXYPEPTIDASES & ENZYME PRECUSORS 1998-2003", "HN": "2004; use CARBOXYPEPTIDASES A (NM) 1980-2003, for PROCARBOXYPEPTIDASE A use CARBOXYPEPTIDASE A (NM) 1981-2003; for PROCARBOXYPEPTIDASE A1 use CARBOXYPEPTIDASES A 1998-2003; for PROCARBOXYPEPTIDASES A2 use CARBOXYPEPTIDASES A (NM) 1998-2003", "MR": "20070709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043422"}, {"RECTYPE": "D", "MH": "Carboxypeptidase H", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Carboxypeptidase E|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Enkephalin Synthesizing Carboxypeptidase", "MN": "D08.811.277.656.837.124", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.4.17.10", "PI": "Carboxypeptidases (1982-2003)", "MS": "A ZINC-containing exopeptidase primarily found in SECRETORY VESICLES of endocrine and neuroendocrine cells. It catalyzes the cleavage of C-terminal ARGININE or LYSINE residues from polypeptides and is active in processing precursors of PEPTIDE HORMONES and other bioactive peptides.", "PM": "2004; CARBOXYPETIDASE H was indexed under CARBOXYPEPTIDASES 1982-2003", "HN": "2004; use CARBOXYPEPTIDASE H (NM) 1982-2003", "MR": "20130709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043423"}, {"RECTYPE": "D", "MH": "Carboxypeptidase B", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protaminase|T116|T126|NON|EQV|NLM (2004)|abbcde", "MN": "D08.811.277.656.837.061", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.4.17.2", "RR": "9025-24-5 (CRN)", "PI": "Carboxypeptidases (1974-2003)", "MS": "A ZINC-dependent carboxypeptidase primary found in the DIGESTIVE SYSTEM. The enzyme catalyzes the preferential cleavage of a C-terminal peptidyl-L-lysine or arginine. It was formerly classified as EC 3.4.2.2 and EC 3.4.12.3.", "PM": "2004; CARBOXYPEPTIDASE B was indexed under CARBOXYPEPTIDASES 1974-2003; PROCARBOXYPEPTIDASE B was indexed under CARBOXYPEPTIDASES & ENZYME PRECURSORS 1985-2003", "HN": "2004; use CARBOXYPEPTIDASE B (NM) 1980-2003; for PROCARBOXYPEPTIDASE B use CARBOXYPEPTIDASE B (NM) 1985-2003", "MR": "20040719", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043424"}, {"RECTYPE": "D", "MH": "Glutamate Carboxypeptidase II", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peptidase, N-Acetylaspartylglutamate", "MN": "D08.811.277.656.675.555.500", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.4.17.21", "PI": "Dipeptidases (1988-1998)", "MS": "A metallocarboxypeptidase that is predominantly expressed as a membrane-bound enzyme. It catalyzes the hydrolysis of an unsubstituted, C-terminal glutamyl residue, typically from PTEROYLPOLYGLUTAMIC ACIDS. It was formerly classified as EC 3.4.19.8.", "PM": "2004; GLUTAMATE CARBOXYPEPTIDASE II was indexed under CARBOXYPEPTIDASES 1999-2003 & under DIPEPTIDASES 1988-1998", "HN": "2004; use GLUTAMATE CARBOXYPEPTIDASE II (NM) 1988-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043425"}, {"RECTYPE": "D", "MH": "Proprotein Convertases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proprotein Convertase|T116|T126|NON|EQV|NLM (2004)|030512|abbcdef", "ENTRY": "Subtilisin Like Proprotein Convertases", "MN": "D08.811.277.656.837", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.4.21.-", "RR": "EC 3.4.23.17", "PI": "Subtilisins (2002-2003)", "MS": "Proteolytic enzymes that are involved in the conversion of protein precursors such as peptide prohormones into PEPTIDE HORMONES. Some are ENDOPEPTIDASES, some are EXOPEPTIDASES.", "PM": "2004; PROPROTEIN COVERTASES was indexed under SUBSTILISINS 2002-2003; PRO-OPIOMELANOCORTIN CONVERTING ENZYME was indexed under ASPARTIC ENDOPEPTIDASES 1994-2003, under PEPTIDE PEPTIDOHYDROLASES 1982-1993", "HN": "2004; use PROPROTEIN CONVERTASES (NM) 2002-2003; for PRO-OPIOMELANOCORTIN CONVERTING ENZYME use PROPROTEIN CONVERTASES (NM) 1982-2003", "MR": "20160630", "DA": "20030722", "DC": "1", "DX": "20040101", "UI": "D043484"}, {"RECTYPE": "D", "MH": "Glomus Tympanicum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tympanicum, Glomus", "MN": "A11.671.650.915.500.600.360", "MH_TH": "NLM (1994)", "ST": "T023", "PI": "Paraganglioma, Extra-Adrenal (1965-2003)", "MS": "A highly vascular ovoid body of chemoreceptive tissue lying adjacent to the TYMPANIC CAVITY. It is derived from NEURAL CREST tissue and is considered part of the diffuse neuroendocrine system. It is the site of a rare neoplasm called a GLOMUS TYMPANICUM TUMOR.", "PM": "2004; see PARAGANGLIA, NONCHROMAFFIN 1994-2003", "HN": "2004; use PARAGANGLIA, NONCHROMAFFIN 1994-2003", "MR": "20140613", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043485"}, {"RECTYPE": "D", "MH": "Biotinidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hydrolase, Biocytin", "MN": "D08.811.277.087.200", "FX": "Multiple Carboxylase Deficiency", "EC": "deficiency:Biotinidase Deficiency", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.5.1.12", "RR": "EC 3.5.1.12", "PI": "Amidohydrolases (1983-2003)", "MS": "An enzyme which catalyzes the release of BIOTIN from biocytin. In human, defects in the enzyme are the cause of the organic acidemia MULTIPLE CARBOXYLASE DEFICIENCY or BIOTINIDASE DEFICIENCY.", "PM": "2004; BIOTINIDASE was indexed under AMIDOHYDROLASES 1983 - 2003", "HN": "2004; use BIOTINIDASE (NM) 1983 - 2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043523"}, {"RECTYPE": "D", "MH": "Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glycopeptidase|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Peptide N glycohydrolase F", "MN": "D08.811.277.087.725", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.5.1.52", "RR": "EC 3.5.1.52", "PI": "Amidohydrolases (1979-2003)", "MS": "An amidohydrolase that removes intact asparagine-linked oligosaccharide chains from glycoproteins. It requires the presence of more than two amino-acid residues in the substrate for activity. This enzyme was previously listed as EC 3.2.2.18.", "PM": "2004; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE was indexed under AMIDOHYDROLASES 1983-2003 & GLYCOPEPTIDES 1979-1984", "HN": "2004; use PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE (NM) 1979 - 2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043524"}, {"RECTYPE": "D", "MH": "Cytosine Deaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Deaminase, Cytosine", "MN": "D08.811.277.151.486.625", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.5.4.1", "RR": "9025-05-2 (CRN)", "AN": "see SCR for organism specific terms", "PI": "Nucleoside Deaminases (1978-2003)", "MS": "An enzyme which catalyzes the deamination of CYTOSINE resulting in the formation of URACIL. It can also act on 5-methylcytosine to form THYMIDINE.", "PM": "2004; CYTOSINE DEAMINASE was indexed under NUCLEOSIDE DEAMINASES 1983- 2003 & CYTOSINE 1978-1982", "HN": "2004; use CYTOSINE DEAMINASE (NM) 1983 - 2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043525"}, {"RECTYPE": "D", "MH": "DNA, Z-Form", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Z-DNA|T114|T123|ACR|EQV|UNK (19XX)|840411|abbcdef", "ENTRY": "Z-Form DNA", "MN": "G05.360.580.493", "FX": "DNA, C-Form", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "DNA (1977-2003)", "MS": "A left-handed double helix of DNA. Its name derives from its narrow zigzag structure that is the least twisted and thinnest form of DNA. Z-DNA forming regions within the GENOME may play an important role in GENE EXPRESSION REGULATION.", "PM": "2004; see DNA 1985-2003", "HN": "2004; use DNA 1985-2003", "MR": "20150622", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043542"}, {"RECTYPE": "D", "MH": "Receptors, G-Protein-Coupled", "DE": "RECEPT G PROTEIN COUPLED", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "G-Protein-Coupled Receptors|T116|T192|NON|EQV|NLM (2004)|021206|G PROTEIN COUPLED RECEPT|abbcdefv", "ENTRY": "Receptors, G Protein Coupled", "MN": "D12.776.543.750.695", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Cell Surface (1968-2003)", "MS": "The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043562"}, {"RECTYPE": "D", "MH": "Receptors, Pheromone", "DE": "RECEPT PHEROMONE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Pheromone Receptor|T116|T192|NON|EQV|NLM (2021)|200227|abbcdef", "ENTRY": "Receptor, Pheromone", "MN": "D12.776.543.750.695.660", "MH_TH": "NLM (1991)", "ST": "T192", "RN": "0", "PI": "Chemoreceptors (1991-2003)", "MS": "Cell surface receptors that respond to PHEROMONES.", "PM": "2004; see CHEMORECEPTORS 1991-2003", "HN": "2004; use CHEMORECEPTORS 1991-2003", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043563"}, {"RECTYPE": "D", "MH": "Inorganic Pyrophosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pyrophosphatase, Inorganic|T116|T126|NON|EQV|NLM (2004)|030226|abbcdef", "ENTRY": "Pyrophosphate Energized Inorganic Pyrophosphatase", "MN": "D12.776.543.585.450.250.875.487", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.6.1.1", "RR": "9024-82-2 (CRN)", "PI": "Pyrophosphatases (1980-2003)", "MS": "An enzyme which catalyzes the hydrolysis of diphosphate (DIPHOSPHATES) into inorganic phosphate. The hydrolysis of pyrophosphate is coupled to the transport of HYDROGEN IONS across a membrane.", "PM": "2004; INORGANIC PYROPHOSPHATASE was indexed under PYROPHOSPHATASES 1980-2003", "HN": "2004; use INORGANIC PYROPHOSPHATASE (NM) 1980-2003", "MR": "20130709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043564"}, {"RECTYPE": "D", "MH": "5-alpha-Dihydroprogesterone", "DS": "ALPHA DIHYDROPROGESTERONE 05", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "5beta DHP", "MN": "D06.472.334.851.687.750.070", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "98G4S1OH0Z", "RR": "7350-00-7 (5-beta-Dihydroprogesterone)", "PI": "Progesterone (1974-2003)", "MS": "A biologically active 5-alpha-reduced metabolite of plasma PROGESTERONE. It is the immediate precursor of 5-alpha-pregnan-3-alpha-ol-20-one (ALLOPREGNANOLONE), a neuroactive steroid that binds with GABA(A) RECEPTOR.", "PM": "2004; 3,20-ALLOPREGNANEDIONE was indexed under PREGNANEDIONES (NM) 1971-2003", "HN": "2004; for 3,20-ALLOPREGNANEDIONE use PREGNANEDIONES (NM) 1971-2003", "MR": "20160527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043582"}, {"RECTYPE": "D", "MH": "Nucleoside-Triphosphatase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Triphosphate Phosphohydrolase, Nucleoside", "MN": "D08.811.277.040.465", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.6.1.15", "RR": "EC 3.6.1.15", "PI": "Phosphatases (1973-2003)", "MS": "An enzyme which catalyzes the hydrolysis of nucleoside triphosphates to nucleoside diphosphates. It may also catalyze the hydrolysis of nucleotide triphosphates, diphosphates, thiamine diphosphates and FAD. The nucleoside triphosphate phosphohydrolases I and II are subtypes of the enzyme which are found mostly in viruses.", "PM": "2004; NUCLEOSIDE-TRIPHOSPHATASE was indexed under ACID ANHYDRIDE HYDROLASES 1994-2003, PHOSPHATASES 1973-1993, & NUCLEOTIDES 1973-1993", "HN": "2004; use NUCLEOSIDE-TRIPHOSPHATASE (NM) 1973-2003", "MR": "20130709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043583"}, {"RECTYPE": "D", "MH": "Receptor, Muscarinic M2", "DE": "RECEPT MUSCARINIC M2", "DS": "RECEPTOR MUSCARINIC M 02", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Muscarinic Receptor M2|T116|T192|NON|EQV|NLM (2004)|MUSCARINIC RECEPTOR M 02|MUSCARINIC RECEPT M2|abbcdesv", "ENTRY": "Receptors M2, Muscarinic", "MN": "D12.776.543.750.720.360.500.200", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Muscarinic Receptors (1996-2003)", "MS": "A specific subtype of muscarinic receptor found in the lower BRAIN, the HEART and in SMOOTH MUSCLE-containing organs. Although present in smooth muscle the M2 muscarinic receptor appears not to be involved in contractile responses.", "PM": "2004; MUSCARINIC RECEPTOR M2 was indexed under RECEPTORS, MUSCARINIC 1996-2003", "HN": "2004; use RECEPTOR, MUSCARINIC M2 (NM) 1996-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043585"}, {"RECTYPE": "D", "MH": "Methylmalonyl-CoA Decarboxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Methylmalonyl-Coenzyme A Decarboxylase|T116|T126|NON|EQV|NLM (2024)|220913|abbcdef", "ENTRY": "Methylmalonyl Coenzyme A Decarboxylase", "MN": "D08.811.520.224.125.387", "FX": "Propionic Acidemia", "EC": "deficiency:Propionic Acidemia", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 7.2.4.3", "RR": "37289-44-4 (CRN)", "PI": "Propionates (1984-2003)", "MS": "A carboxy-lyase that catalyzes the DECARBOXYLATION of (S)-2-Methyl-3-oxopropanoyl-CoA to propanoyl-CoA. In microorganisms the reaction can be coupled to the vectorial transport of SODIUM ions across the cytoplasmic membrane.", "PM": "2004; PROPIONYL-COA CARBOXYLASE was indexed under CARBOXY-LYASES 1983-2003 & under PROPIONATES 1975-1982", "HN": "2004; use METHYLMALONYL-COA DECARBOXYLASE (NM) 1980-2003", "MR": "20230226", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043586"}, {"RECTYPE": "D", "MH": "Receptor, Muscarinic M3", "DE": "RECEPT MUSCARINIC M3", "DS": "RECEPTOR MUSCARINIC M 03", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Muscarinic Receptor M3|T116|T192|NON|EQV|NLM (2004)|MUSCARINIC RECEPTOR M 03|MUSCARINIC RECEPT M3|abbcdesv", "ENTRY": "Receptors M3, Muscarinic", "MN": "D12.776.543.750.720.360.500.300", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Muscarinic (1994-2003)", "MS": "A subclass of muscarinic receptor that mediates cholinergic-induced contraction in a variety of SMOOTH MUSCLES.", "PM": "2004; MUSCARINIC RECEPTOR M3 was indexed under RECEPTORS, MUSCARINIC 1994-2003", "HN": "2004; use RECEPTOR, MUSCARINIC M3 (NM) 1994-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043587"}, {"RECTYPE": "D", "MH": "Receptor, Muscarinic M4", "DE": "RECEPT MUSCARINIC M4", "DS": "RECEPTOR MUSCARINIC M 04", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Muscarinic M4|T116|T192|NON|EQV|NLM (2004)|021206|abbcdef", "ENTRY": "Receptors M4, Muscarinic", "MN": "D12.776.543.750.720.360.500.400", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Muscarinic (1996-2003)", "MS": "A specific subtype of muscarinic receptor found in the CORPUS STRIATUM and the LUNG. It has similar receptor binding specificities to MUSCARINIC RECEPTOR M1 and MUSCARINIC RECEPTOR M2.", "PM": "2004; MUSCARINIC RECEPTOR M4 was indexed under RECEPTORS, MUSCARINIC 1996-2003", "HN": "2004; use RECEPTOR, MUSCARINIC M4 (NM) 1996-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043588"}, {"RECTYPE": "D", "MH": "DNA-(Apurinic or Apyrimidinic Site) Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endodeoxyribonuclease (Apurinic or Apyrimidinic)|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Endonuclease, Apurinic DNA", "MN": "D08.811.520.241.225", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 4.2.99.18", "PI": "Carbon-Oxygen Lyases (1978-2003)", "MS": "A DNA repair enzyme that catalyses the excision of ribose residues at apurinic and apyrimidinic DNA sites that can result from the action of DNA GLYCOSYLASES. The enzyme catalyzes a beta-elimination reaction in which the C-O-P bond 3' to the apurinic or apyrimidinic site in DNA is broken, leaving a 3'-terminal unsaturated sugar and a product with a terminal 5'-phosphate. This enzyme was previously listed under EC 3.1.25.2.", "PM": "2004; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE was indexed under CARBON-OXYGEN LYASES 1996-2003, DEOXYRIBONUCLEASES 1978-1982, ENDODEOXYRIBONUCLEASES 1983-1995, ENDONUCLEASES 1978-1982 & LYASES 1978-1980", "HN": "2004; use DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE (NM) 1980-2003", "MR": "20130709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043603"}, {"RECTYPE": "D", "MH": "Glomus Tympanicum Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Glomus Tympanicum", "MN": "C04.557.580.625.650.700.705.360", "MH_TH": "NLM (2004)", "ST": "T191", "AN": "coord IM with EAR NEOPLASMS (IM)", "PI": "Paraganglioma, Extra-Adrenal (1970-2003)", "MS": "A rare PARAGANGLIOMA involving the GLOMUS TYMPANICUM, a collection of chemoreceptor tissue adjacent to the TYMPANIC CAVITY. It can cause TINNITUS and conductive hearing loss (HEARING LOSS, CONDUCTIVE).", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043604"}, {"RECTYPE": "D", "MH": "20-alpha-Hydroxysteroid Dehydrogenase", "DS": "ALPHA HYDROXYSTEROID DEHYDROGENASE 20", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NADPH Dependent 20 alpha Hydroxysteroid Oxidoreductase", "MN": "D08.811.682.047.820.284.750", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.1.1.149", "RR": "9040-08-8 (CRN)", "PI": "Hydroxysteroid Dehydrogenases (1965-1977)", "MS": "An enzymes that catalyzes the reversible reduction-oxidation reaction of 20-alpha-hydroxysteroids, such as from PROGESTERONE to 20-ALPHA-DIHYDROPROGESTERONE.", "PM": "2004; 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE was indexed under 20-HYDROXYSTEROID DEHYDROGENASES (NM) 1982-2003", "HN": "2004; use 20-ALPHA-HYDROXYSTEROID DEHYDROGENASES (NM) 1982-2003", "MR": "20170524", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043607"}, {"RECTYPE": "D", "MH": "Receptor, Muscarinic M5", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Muscarinic Receptors M5|T116|T192|NON|EQV|NLM (2004)|021210|abbcdef", "ENTRY": "Receptors M5, Muscarinic", "MN": "D12.776.543.750.720.360.500.500", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Muscarinic (1996-2003)", "MS": "A specific subtype of muscarinic receptor found in a variety of locations including the SALIVARY GLANDS and the SUBSTANTIA NIGRA and VENTRAL TEGMENTAL AREA of the BRAIN.", "PM": "2004; M5 MUSCARINIC RECEPTOR was indexed under RECEPTORS, MUSCARINIC 1996-2003", "HN": "2004; use RECEPTOR, MUSCARINIC M5 (NM) 1996-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043642"}, {"RECTYPE": "D", "MH": "Receptor, Muscarinic M1", "DE": "RECEPT MUSCARINIC M1", "DS": "RECEPTOR MUSCARINIC M 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Muscarinic Receptor M1|T116|T192|NON|EQV|NLM (2004)|MUSCARINIC RECEPTOR M 01|MUSCARINIC RECEPT M1|abbcdesv", "ENTRY": "Receptors M1, Muscarinic", "MN": "D12.776.543.750.720.360.500.099", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Muscarinic (1996-2003)", "MS": "A specific subtype of muscarinic receptor that has a high affinity for the drug PIRENZEPINE. It is found in the peripheral GANGLIA where it signals a variety of physiological functions such as GASTRIC ACID secretion and BRONCHOCONSTRICTION. This subtype of muscarinic receptor is also found in neuronal tissues including the CEREBRAL CORTEX and HIPPOCAMPUS where it mediates the process of MEMORY and LEARNING.", "PM": "2004; MUSCARINIC RECEPTOR M1 was indexed under RECEPTORS, MUSCARINIC 1996-2003", "HN": "2004; use RECEPTOR, MUSCARINIC M1(NM) 1996-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043643"}, {"RECTYPE": "D", "MH": "Receptor, Adenosine A1", "DE": "RECEPT ADENOSINE A1", "DS": "RECEPTOR ADENOSINE A 01", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Adenosine A1 Receptors|T116|T192|NON|EQV|NLM (2004)|021211|ADENOSINE A 01 RECEPTORS|abbcdefs", "ENTRY": "Receptors, Adenosine A1", "MN": "D12.776.543.750.720.700.700.100", "EC": "antagonists & inhibitors:Adenosine A1 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Purinergic P1 (1994-2003)", "MS": "A subtype of ADENOSINE RECEPTOR that is found expressed in a variety of tissues including the BRAIN and DORSAL HORN NEURONS. The receptor is generally considered to be coupled to the GI, INHIBITORY G-PROTEIN which causes down regulation of CYCLIC AMP.", "PM": "2004; see RECEPTORS, PURINERGIC P1 1994-2003", "HN": "2004; use RECEPTORS, PURINERGIC P1 1994-2003", "MR": "20160701", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043682"}, {"RECTYPE": "D", "MH": "Receptors, Adenosine A2", "DE": "RECEPT ADENOSINE A2", "DS": "RECEPTORS ADENOSINE A 02", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Adenosine A2 Receptors|T116|T192|NON|EQV|NLM (2004)|021211|ADENOSINE A 02 RECEPTORS|ADENOSINE A2 RECEPT|abbcdefsv", "ENTRY": "Receptor, Adenosine A2", "MN": "D12.776.543.750.720.700.700.200", "EC": "antagonists & inhibitors:Adenosine A2 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Purinergic P1 (1994-2003)", "MS": "A subclass of ADENOSINE RECEPTORS that are generally considered to be coupled to the GS, STIMULATORY G-PROTEIN which causes up regulation of CYCLIC AMP.", "PM": "2004; see RECEPTORS, PURINERGIC P1 1994-2003", "HN": "2004; use RECEPTORS, PURINERGIC P1 1994-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043683"}, {"RECTYPE": "D", "MH": "Receptor, Adenosine A3", "DE": "RECEPT ADENOSINE A3", "DS": "RECEPTOR ADENOSINE A 03", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Adenosine A3 Receptors|T116|T192|NON|EQV|NLM (2004)|ADENOSINE A 03 RECEPTORS|abbcdes", "ENTRY": "Receptors, Adenosine A3", "MN": "D12.776.543.750.720.700.700.300", "EC": "antagonists & inhibitors:Adenosine A3 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Purinergic (1997-2003)", "MS": "A subtype of ADENOSINE RECEPTOR that is found expressed in a variety of locations including the BRAIN and endocrine tissues. The receptor is generally considered to be coupled to the GI, INHIBITORY G-PROTEIN which causes down regulation of CYCLIC AMP.", "PM": "2004; ADENOSINE A3 RECEPTOR was indexed under RECEPTORS, PURINERGIC P1 1997-2003", "HN": "2004; use RECEPTOR, ADENOSINE A3 (NM) 1997-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043684"}, {"RECTYPE": "D", "MH": "Receptor, Adenosine A2B", "DE": "RECEPT ADENOSINE A2B", "DS": "RECEPTOR ADENOSINE A 02 B", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Adenosine A2B Receptor|T116|T192|NON|EQV|NLM (2004)|ADENOSINE A 02B RECEPTOR|ADENOSINE A2B RECEPT|abbcdesv", "ENTRY": "Receptors, Adenosine A2B", "MN": "D12.776.543.750.720.700.700.200.200", "EC": "antagonists & inhibitors:Adenosine A2 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Purinergic P1 (1997-2003)", "MS": "A subclass of adenosine A2 receptors found in the CECUM, the COLON, the BLADDER, and a variety of other tissues. It is generally considered to be a low affinity receptor for ADENOSINE that couples to the GS, STIMULATORY G-PROTEIN.", "PM": "2004; ADENOSINE A2B RECEPTOR was indexed under RECEPTORS, PURINERGIC P1 1997-2003", "HN": "2004; use RECEPTOR, ADENSINE A2B (NM) 1997-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043704"}, {"RECTYPE": "D", "MH": "Receptor, Adenosine A2A", "DE": "RECEPT ADENOSINE A2A", "DS": "RECEPTOR ADENOSINE A 02 A", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Adenosine A2A Receptor|T116|T192|NON|EQV|NLM (2004)|ADENOSINE A 02A RECEPTOR|ADENOSINE A2A RECEPT|abbcdesv", "ENTRY": "Receptors, Adenosine A2A", "MN": "D12.776.543.750.720.700.700.200.100", "EC": "antagonists & inhibitors:Adenosine A2 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Purinergic P1 (1994-2003)", "MS": "A subclass of adenosine A2 receptors found in LEUKOCYTES, the SPLEEN, the THYMUS and a variety of other tissues. It is generally considered to be a receptor for ADENOSINE that couples to the GS, STIMULATORY G-PROTEIN.", "PM": "2004; ADENSOSINE A(2A) RECEPTOR was indexed under RECEPTORS, PURINERGIC P1 1994-2003", "HN": "2004; use RECEPTOR, ADENOSINE A2A (NM) 1994-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043705"}, {"RECTYPE": "D", "MH": "Ubiquitin-Protein Ligase Complexes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ubiquitin Protein Ligase Complexes", "MN": "D08.811.464.938", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.3.2.23", "RR": "EC 6.2.1.45", "AN": "UBIQUITIN-PROTEIN LIGASES is also available", "PI": "Ligases (1983-2003)", "MS": "Complexes of enzymes that catalyze the covalent attachment of UBIQUITIN to other proteins by forming a peptide bond between the C-terminal GLYCINE of UBIQUITIN and the alpha-amino groups of LYSINE residues in the protein. The complexes play an important role in mediating the selective-degradation of short-lived and abnormal proteins. The complex of enzymes can be broken down into three components that involve activation of ubiquitin (UBIQUITIN-ACTIVATING ENZYMES), conjugation of ubiquitin to the ligase complex (UBIQUITIN-CONJUGATING ENZYMES), and ligation of ubiquitin to the substrate protein (UBIQUITIN-PROTEIN LIGASES).", "PM": "2004", "HN": "2004", "MR": "20160602", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043743"}, {"RECTYPE": "D", "MH": "Reproductive Behavior", "AQ": "CL DE EH ES HI PH PX RE SN", "ENTRY": "Childlessness, Voluntary", "MN": "G08.686.784.891", "FX": "Sexual Behavior", "MH_TH": "NLM (1980)", "ST": "T055", "AN": "human only; for animals use SEXUAL BEHAVIOR, ANIMAL or REPRODUCTION", "PI": "Sex Behavior (1980-2003)", "MS": "Human behavior or decision related to REPRODUCTION.", "PM": "2004; see SEX BEHAVIOR 1980-2003", "HN": "2004; use SEX BEHAVIOR 1980-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043762"}, {"RECTYPE": "D", "MH": "Receptor, Bradykinin B2", "DE": "RECEPT BRADYKININ B2", "DS": "RECEPTOR BRADYKININ B 02", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Bradykinin Type 2 Receptor|T116|T192|NON|EQV|NLM (2004)|000616|BRADYKININ TYPE 2 RECEPT|abbcdefv", "ENTRY": "Receptors, Bradykinin B2", "MN": "D12.776.543.750.750.555.220.500", "EC": "antagonists & inhibitors:Bradykinin B2 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Bradykinin (1996-2003)", "MS": "A constitutively expressed subtype of bradykinin receptor that may play a role in the acute phase of the inflammatory and pain response. It has high specificity for intact forms of BRADYKININ and KALLIDIN. The receptor is coupled to G-PROTEIN, GQ-G11 ALPHA FAMILY and G-PROTEIN, GI-GO ALPHA FAMILY signaling proteins.", "PM": "2004; BRANDYKININ B2 RECEPTOR & BRADYKININ TYPE 2 RECEPTOR (now RECEPTOR, BRADYKININ B2) were indexed under RECEPTORS, BRADYKININ 1994-2003", "HN": "2004; use RECEPTOR, BRADYKININ B2 (NM) 1994-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043782"}, {"RECTYPE": "D", "MH": "Receptor, Bradykinin B1", "DE": "RECEPT BRADYKININ B 01", "DS": "RECEPTOR BRADYKININ B 01", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Bradykinin B1 Receptor|T116|T192|NON|EQV|NLM (2004)|BRADYKININ B 01 RECEPTOR|BRADYKININ B1 RECEPT|abbcdesv", "ENTRY": "Receptors, Bradykinin B1", "MN": "D12.776.543.750.750.555.220.249", "EC": "antagonists & inhibitors:Bradykinin B1 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Bradykinin (1996-2003)", "MS": "A subtype of BRADYKININ RECEPTOR that is induced in response to INFLAMMATION. It may play a role in chronic inflammation and has a high specificity for KININS lacking the C-terminal ARGININE such as des-Arg(10)-kallidin and des-Arg(9)-bradykinin. The receptor is coupled to G-PROTEIN, GQ-G11 ALPHA FAMILY and G-PROTEIN, GI-GO ALPHA FAMILY signaling proteins.", "PM": "2004; BRADKININ B1 RECEPTOR (now RECEPTOR, BRADYKININ B1) was indexed under RECEPTORS, BRADYKININ 1996-2003", "HN": "2004; use RECEPTOR, BRADYKININ B1 (NM) 1996-2003", "MR": "20160701", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043783"}, {"RECTYPE": "D", "MH": "GTP-Binding Protein alpha Subunits, Gq-G11", "DS": "GTP BINDING PROTEIN ALPHA SUBUNITS GQ G 11", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "G-Protein, Gq-G11 alpha Family|T116|T126|ABX|EQV|NLM (2004)|030123|G PROTEIN GQ G 11 ALPHA FAMILY|abbcdefs", "ENTRY": "alpha11 Protein, G", "MN": "D12.776.543.325.100.300", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.6.5.1", "RR": "EC 3.6.5.1", "PI": "Heterotrimeric GTP-Binding Proteins (2001-2003)", "MS": "A family of heterotrimeric GTP-binding protein alpha subunits that activate TYPE C PHOSPHOLIPASES dependent signaling pathways. The Gq-G11 part of the name is also spelled Gq/G11.", "PM": "2004; G ALPHA Q PROTEIN (now GTP-BINDING PROTEIN ALPHA SUBUNITS GQ-G11) was indexed under HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003; GTP-BINDING PROTEINS 1999-2000", "HN": "2004; use GTP-BINDING PROTEIN ALPHA SUBUNITS GQ-G11(NM) 1999-2003", "MR": "20210521", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043802"}, {"RECTYPE": "D", "MH": "Phenalenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phenylphenalenones|T109|NON|NRW|NLM (2006)|040819|abcdef", "MN": "D04.615.680", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "PI": "Polycyclic Hydrocarbons (1989-2003)", "MS": "A group of AROMATIC HYDROCARBONS that have three rings joined as a triad around a single carbon atom so all three are conjoined, in contrast to a linear arrangement (ANTHRACENES) or angular arrangement (PHENANTHRENES).", "PM": "2004", "HN": "2004", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043803"}, {"RECTYPE": "D", "MH": "Cyclodecanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.426.392.368.242", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "MS": "Compounds with a 10-carbon ring.", "PM": "2004", "HN": "2004", "MR": "20040707", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043822"}, {"RECTYPE": "D", "MH": "Taxoids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Taxoid|T109|NON|EQV|NLM (2021)|191121|abcdef", "MN": "D02.455.849.291.850", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "AN": "ROTAXANES is also available", "PI": "Paclitaxel (1992-2003)", "MS": "A group of diterpenoid CYCLODECANES named for the taxanes that were discovered in the TAXUS tree. The action on MICROTUBULES has made some of them useful as ANTINEOPLASTIC AGENTS.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043823"}, {"RECTYPE": "D", "MH": "Ochnaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sauvagesia|T002|NON|NRW|NLM (2004)|021217|abcdef", "ENTRY": "Sauvagesias", "MN": "B01.875.800.575.912.250.779", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid56627", "RR": "txid58891", "MS": "A plant family of the order THEALES, subclass Dilleniidae, class Magnoliopsida that have evergreen, alternate leaves.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043842"}, {"RECTYPE": "D", "MH": "Leuzea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "carthamoides, Leuzea", "MN": "B01.875.800.575.912.250.100.506", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid145816", "RR": "txid362630", "AN": "X ref RHAPONTICUM: RHEUM RHAPONTICUM is also available", "MS": "A plant genus of the family ASTERACEAE. ECDYSONE has been found in seeds of some members.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043843"}, {"RECTYPE": "D", "MH": "Crown Ethers", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cryptates|T109|NON|NRW|NLM (2004)|021217|abcdef", "ENTRY": "Oxa Thia Crown Ethers", "MN": "D04.345.241.308", "MH_TH": "NLM (1993)", "ST": "T109", "RN": "0", "PI": "Ethers, Cyclic (1974-2003)", "MS": "Macrocyclic polyethers with the repeating unit of (-CH2-CH2-O)n where n is greater than 2 and some oxygens may be replaced by nitrogen, sulfur or phosphorus. These compounds are useful for coordinating CATIONS. The nomenclature uses a prefix to indicate the size of the ring and a suffix for the number of heteroatoms.", "PM": "2004; see ETHERS, CYCLIC 1993-2003; CROWN COMPOUNDS was indexed under ETHERS, CYCLIC 1976-1992", "HN": "2004; use ETHERS, CYCLIC 1993-2003; CROWN COMPOUNDS was NM 1976-1992", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043844"}, {"RECTYPE": "D", "MH": "Rotaxanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pseudorotaxanes|T109|NON|NRW|NLM (2004)|021217|abcdef", "ENTRY": "Rotaxane|T109|T121|NON|EQV|NLM (2004)|020120|abbcdef", "MN": "D02.825", "FX": "Catenanes", "MH_TH": "NLM (2004)", "ST": "T121", "RN": "0", "AN": "coord with specific Cat D chemical structure term if pertinent; TAXANES is also available", "MS": "Complex compounds in which a dumbbell shaped molecule is encircled by a macrocycle. They are named after rota (wheel) and axis (axle). Notation with a prefix is used to indicate the number of interlocked components. They have potential use in NANOTECHNOLOGY. Rotaxanes have been made with CYCLODEXTRINS and CYCLIC ETHERS.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043862"}, {"RECTYPE": "D", "MH": "Catenanes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.251", "FX": "Rotaxanes", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "AN": "coord with specific Cat D chemical structure term if pertinent", "MS": "Complex compounds where two cyclic molecules are interlaced together as links in a chain. They have potential use in NANOTECHNOLOGY.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043863"}, {"RECTYPE": "D", "MH": "DNA, Catenated", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Catenated DNA|T114|ACX|EQV|NLM (2004)|021217|abcdef", "ENTRY": "DNA Catenanes", "MN": "G05.360.580.156.084", "FX": "DNA, Kinetoplast", "MH_TH": "NLM (2004)", "ST": "T114", "RN": "0", "AN": "coord with specific DNA source; DNA, CONCATENATED is also available", "MS": "CIRCULAR DNA that is interlaced together as links in a chain. It is used as an assay for the activity of DNA TOPOISOMERASES. Catenated DNA is attached loop to loop in contrast to CONCATENATED DNA which is attached end to end.", "PM": "2004", "HN": "2004", "MR": "20150622", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043864"}, {"RECTYPE": "D", "MH": "Receptors, Cannabinoid", "DE": "RECEPT CANNABINOID", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Cannabinoid Receptors|T116|T192|NON|EQV|NLM (2004)|CANNABINOID RECEPT|abbcdev", "ENTRY": "Receptor, Cannabinoid", "MN": "D12.776.543.750.695.125", "FX": "Cannabinoids", "EC": "antagonists & inhibitors:Cannabinoid Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "AN": "note specific subtypes", "PI": "Receptors, Drug (1988-2003)", "MS": "A class of G-protein-coupled receptors that are specific for CANNABINOIDS such as those derived from CANNABIS. They also bind a structurally distinct class of endogenous factors referred to as ENDOCANNABINOIDS. The receptor class may play a role in modulating the release of signaling molecules such as NEUROTRANSMITTERS and CYTOKINES.", "PM": "2004; CANNABINOID RECEPTORS was indexed under RECEPTORS, DRUG 1988-2003", "HN": "2004; use RECEPTORS, CANNABINOID (NM) 1988-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043882"}, {"RECTYPE": "D", "MH": "Receptor, Cannabinoid, CB1", "DE": "RECEPT CANNABINOID CB1", "DS": "RECEPTOR CANNABINOID CB 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Cannabinoid Receptor CB1|T116|T192|ABX|EQV|NLM (2004)|021218|CANNABINOID RECEPTOR CB 01|CANNABINOID RECEPT CB1|abbcdefsv", "ENTRY": "Receptor, CB1", "MN": "D12.776.543.750.695.125.100", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Drug (1995-2003)", "MS": "A subclass of cannabinoid receptor found primarily on central and peripheral NEURONS where it may play a role modulating NEUROTRANSMITTER release.", "PM": "2004; CB1 RECEPTOR (now RECEPTOR, CANNABINOID, CB1) was indexed under RECEPTORS, DRUG 1995-2003", "HN": "2004; use RECEPTORS, CANNABINOID (NM) 1995-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043884"}, {"RECTYPE": "D", "MH": "Receptor, Cannabinoid, CB2", "DE": "RECEPT CANNABINOID CB2", "DS": "RECEPTOR CANNABINOID CB 02", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Cannabinoid Receptor CB2|T116|T192|ABX|EQV|NLM (2004)|021218|CANNABINOID RECEPTOR CB 02|CANNABINOID RECEPT CB2|abbcdefsv", "ENTRY": "Receptor, CB2", "MN": "D12.776.543.750.695.125.200", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Receptors, Drug (1995-2003)", "MS": "A subclass of cannabinoid receptor found primarily on immune cells where it may play a role modulating release of CYTOKINES.", "PM": "2004; CB2 RECEPTOR (now RECEPTOR, CANNABINOID, CB2) was indexed under RECEPTORS, DRUG 1995-2003", "HN": "2004; use RECEPTORS, CANNABINOID (NM) 1995-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043885"}, {"RECTYPE": "D", "MH": "Receptor, Cholecystokinin A", "DE": "RECEPT CHOLECYSTOKININ A", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Cholecystokinin A Receptor|T116|T192|NON|EQV|NLM (2004)|CHOLECYSTOKININ A RECEPT|abbcdev", "ENTRY": "Receptor, CCK-A", "MN": "D12.776.543.750.750.555.270.100", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Cholecystokinin (1988-2003)", "MS": "A subtype of cholecystokinin receptor found primarily in the PANCREAS; STOMACH; INTESTINE; and GALLBLADDER. It plays a role in regulating digestive functions such as gallbladder contraction, pancreatic enzyme secretion and absorption in the GASTROINTESTINAL TRACT.", "PM": "2004; CCK-A RECEPTOR (now RECEPTOR, CHOLECTCYSTOKININ A) was indexed under RECEPTORS, CHOLECYSTOKININ 1994-2003", "HN": "2004; use RECEPTOR, CHOLECYSTOKININ A (NM) 1994-2003", "MR": "20160701", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043886"}, {"RECTYPE": "D", "MH": "Receptor, Cholecystokinin B", "DE": "RECEPT CHOLECYSTOKININ B", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Gastrin|T116|T192|NON|EQV|NLM (1993)|920512|RECEPT GASTRIN|abbcdefv", "ENTRY": "Receptors, CCK-B", "MN": "D12.776.543.750.750.555.270.200", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Cholecystokinin (1989-2003)", "MS": "A subtype of cholecystokinin receptor found primarily in the CENTRAL NERVOUS SYSTEM and the GASTRIC MUCOSA. It may play a role as a neuromodulator of dopaminergic neurotransmission the regulation of GASTRIC ACID secretion from GASTRIC PARIETAL CELLS.", "PM": "2004; CCK-B RECEPTOR (now RECEPTOR, CHOLECYSTOKININ B) was indexed under RECEPTORS, CHOLECYSTOKININ 1993-2003", "HN": "2004; use RECEPTOR, CHOLECYSTOKININ B (NM) 1993-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043887"}, {"RECTYPE": "D", "MH": "Pyrococcus horikoshii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.825.800.650.400", "MH_TH": "NLM (2004)", "ST": "T194", "RN": "txid53953", "PI": "Pyrococcus (1998-2003)", "MS": "Anaerobic hyperthermophilic species of ARCHAEA, isolated from hydrothermal fluid samples. It is obligately heterotrophic with coccoid cells that require TRYPTOPHAN for growth.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043902"}, {"RECTYPE": "D", "MH": "Pyrococcus abyssi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.825.800.650.020", "MH_TH": "NLM (2004)", "ST": "T194", "RN": "txid29292", "PI": "Pyrococcus (1998-2003)", "MS": "A species of gram-negative hyperthermophilic ARCHAEA found in deep ocean hydrothermal vents. It is an obligate anaerobe and obligate chemoorganotroph.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043903"}, {"RECTYPE": "D", "MH": "Toxicogenetics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Toxicogenomics|T091|NON|NRW|NLM (2003)|020522|abcdef", "MN": "H02.884.850", "MH_TH": "NLM (2003)", "ST": "T091", "AN": "specialty; prefer specific drug or toxic substance and specific genetic aspect", "PI": "Toxicology (1993-2003)", "MS": "The study of existing genetic knowledge, and the generation of new genetic data, to understand and thus avoid DRUG TOXICITY and adverse effects from toxic substances from the environment.", "PM": "2004; see PHARMACOGENETICS 2003; for TOXICOGENOMICS see PHARMACOGENETICS 2003", "HN": "2004; use PHARMACOGENETICS 2003; for TOXICOGENOMICS use PHARMACOGENETICS 2003", "MR": "20150610", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043922"}, {"RECTYPE": "D", "MH": "Angiogenesis Modulating Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Modulators, Angiogenesis", "MN": "D27.505.696.377.077", "MH_TH": "NLM (2004)", "ST": "T169", "RN": "0", "AN": "general or unspecified; prefer specifics; coordinate with specific agents", "PI": "Angiogenesis Inhibitors (2000-2003)", "MS": "Agents that modulate the PHYSIOLOGIC ANGIOGENESIS process. This is accomplished by endogenous ANGIOGENIC PROTEINS and a variety of other chemicals and pharmaceutical agents.", "PM": "2004", "HN": "2004", "MR": "20140625", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043924"}, {"RECTYPE": "D", "MH": "Angiogenesis Inducing Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Angiogenesis Inducers|T121|NON|EQV|NLM (2004)|021220|abcdef", "ENTRY": "Stimulators, Angiogenesis", "MN": "D27.505.696.377.077.077", "MH_TH": "NLM (2004)", "ST": "T121", "RN": "0", "AN": "note entry term ANGIOGENESIS EFFECT: use only for the angiogenesis effect of a chemical substance", "PI": "Angiogenesis Factor (1973-2003)", "MS": "Agents that induce or stimulate PHYSIOLOGIC ANGIOGENESIS or PATHOLOGIC ANGIOGENESIS.", "PM": "2004; for ANGIOGENESIS FACTOR see ANGIOGENESIS FACTOR 1991-2003, see GROWTH SUBSTANCES 1973-1990", "HN": "2004", "MR": "20140625", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043925"}, {"RECTYPE": "D", "MH": "Nanotubes", "AQ": "AE AN CH CL EC HI MI PO PS RE SD SN ST TO UL VI", "PRINT ENTRY": "Nanorods|T073|NON|REL|NLM (2007)|060322|abcdef", "ENTRY": "Nanotube", "MN": "J01.637.512.850", "FX": "Nanotechnology", "MH_TH": "NLM (2004)", "ST": "T073", "MS": "Nanometer-sized tubes composed of various substances including carbon (CARBON NANOTUBES), boron nitride, or nickel vanadate.", "PM": "2004", "HN": "2004", "MR": "20070709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043942"}, {"RECTYPE": "D", "MH": "Diverticulosis, Colonic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Colonic Diverticulosis|T047|NON|EQV|NLM (2004)|021224|abcdef", "MN": "C06.405.469.158.587", "MH_TH": "NLM (1966)", "ST": "T047", "AN": "do not confuse with DIVERTICULITIS, COLONIC", "PI": "Diverticulum, Colon (1965-2003)", "MS": "A pathological condition characterized by the presence of a number of COLONIC DIVERTICULA in the COLON. Its pathogenesis is multifactorial, including colon aging, motor dysfunction, increases in intraluminal pressure, and lack of dietary fibers.", "PM": "2004, 1963-2000; see DIVERTICULUM, COLON 2001-2003", "HN": "2004, 1963-2000; use DIVERTICULUM, COLON 2001-2003", "MR": "20170224", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043963"}, {"RECTYPE": "D", "MH": "Marsileaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Waterclover|T002|NON|NRW|NLM (2004)|021224|abcdef", "ENTRY": "Waterclovers", "MN": "B01.875.800.575.912.063.461", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid13814", "RR": "txid13815", "MS": "A plant family of the order Hydropteridales, class Filicopsida, division PTERIDOPHYTA. They are aquatic ferns with quatrifoliate leaves resembling four leaf clover, creeping rhizome, and bean shaped sporocarps.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043964"}, {"RECTYPE": "D", "MH": "Rhizophoraceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Rhizophora mangle|T002|NON|NRW|NLM (2004)|021227|abcdef", "ENTRY": "mangle, Rhizophora", "MN": "B01.875.800.575.912.250.859.797.750", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid40029", "RR": "txid61137", "AN": "note entry terms MANGROVE, AMERICAN and MANGROVE, RED: MANGROVE SWAMPS see WETLANDS is also available", "MS": "A plant family of the order Rhizophorales, subclass Rosidae, class Magnoliopsida, that includes mangrove trees.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D043982"}, {"RECTYPE": "D", "MH": "Bryophyta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Musci|T002|NON|NRW|NLM (1996)|950213|abcdef", "ENTRY": "Muscus", "MN": "B01.875.800.575.137", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid3208", "RR": "txid113507", "PI": "Plants (1983-2003)", "MS": "A division of the plant kingdom. Bryophyta contains the subdivision, Musci, which contains the classes: Andreaeopsida, BRYOPSIDA, and SPHAGNOPSIDA.", "PM": "2004; for MUSCI see BRYOPSIDA 1996-2003", "HN": "2004; for MUSCI use BRYOPSIDA 1996-2003", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044002"}, {"RECTYPE": "D", "MH": "Sphagnopsida", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sphagnum|T002|NON|NRW|NLM (1996)|950428|abcdef", "ENTRY": "Sphagnums", "MN": "B01.875.800.575.137.750", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid113508", "RR": "txid13804", "PI": "Bryopsida (1995-2003)", "MS": "A class of BRYOPHYTA which is best known for Sphagnum forming PEAT bogs.", "PM": "2004; for SPHAGNUM see BRYOPSIDA 1996-2003; see PLANTS 1986-1995", "HN": "2004; for SPHAGNUM use BRYOPSIDA 1996-2003, use PLANTS 1986-1995", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044003"}, {"RECTYPE": "D", "MH": "Xanthones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Derivatives, Xanthone", "MN": "D03.633.300.953.852", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "PI": "Xanthenes (1963-2003)", "MS": "A group of XANTHENES that contain a 9-keto OXYGEN.", "PM": "2004", "HN": "2004", "MR": "20160601", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044004"}, {"RECTYPE": "D", "MH": "Tetrahydroisoquinolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetrahydro-Isoquinoline|T109|NON|EQV|NLM (2021)|200210|abcdef", "ENTRY": "Tetrahydro Isoquinolines", "MN": "D03.633.100.531.820", "MH_TH": "NLM (2004)", "ST": "T109", "N1": "Isoquinolines, 1,2,3,4-tetrahydro-", "RN": "0", "PI": "Isoquinolines (1969-2003)", "MS": "A group of ISOQUINOLINES in which the nitrogen containing ring is protonated. They derive from the non-enzymatic Pictet-Spengler condensation of CATECHOLAMINES with ALDEHYDES.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044005"}, {"RECTYPE": "D", "MH": "Receptors, Epoprostenol", "DE": "RECEPT EPOPROSTENOL", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Prostacyclin|T116|T192|NON|EQV|NLM (2004)|021230|RECEPT PROSTACYCLIN|abbcdefv", "ENTRY": "Receptors, Prostaglandins X", "MN": "D12.776.543.750.695.200.700.299", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Prostaglandin (1981-2003)", "MS": "Cell surface receptors for EPOPROSTENOL. They are coupled to HETEROTRIMERIC G-PROTEINS.", "PM": "2004; PROSTACYCLIN RECEPTOR (now RECEPTORS, EPOPROSTENOL) was indexed under RECEPTORS, PROSTAGLANDIN 1981-2002", "HN": "2004; use RECEPTORS, EPOPROSTENOL (NM) 1981-2002", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044006"}, {"RECTYPE": "D", "MH": "Moraxellaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.530", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid468", "MS": "A family of gram-negative, aerobic bacteria in the order Pseudomonadales. Some strains are parasites of the mucosal membranes of animals and humans; others are found in association with food products or in the environment.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044007"}, {"RECTYPE": "D", "MH": "Receptor, Endothelin A", "DE": "RECEPT ENDOTHELIN A", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Endothelin A Receptors|T116|T192|NON|EQV|NLM (2004)|ENDOTHELIN A RECEPT|abbcdev", "ENTRY": "Receptors, Endothelin A", "MN": "D12.776.543.750.750.320.100", "EC": "antagonists & inhibitors:Endothelin A Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Endothelin (1993-2003)", "MS": "A subtype of endothelin receptor found predominantly in the VASCULAR SMOOTH MUSCLE. It has a high affinity for ENDOTHELIN-1 and ENDOTHELIN-2.", "PM": "2004; ENDOTHELIN A RECEPTOR was indexed under RECEPTORS, ENDOTHELIN 1993-2003", "HN": "2004; use RECEPTOR, ENDOTHELIN A (NM) 1993-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044022"}, {"RECTYPE": "D", "MH": "Receptor, Endothelin B", "DE": "RECEPT ENDOTHELIN B", "DS": "RECEPTOR ENDOTHELIN B", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptor, Endothelin B, Type 2|T116|T192|NON|NRW|NLM (2004)|RECEPTOR ENDOTHELIN B TYPE 02|RECEPT ENDOTHELIN B TYPE 2|abbcdesv", "ENTRY": "Receptors, Endothelin B-2", "MN": "D12.776.543.750.750.320.200", "EC": "antagonists & inhibitors:Endothelin B Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Endothelin (1993-2003)", "MS": "A subtype of endothelin receptor found predominantly in the KIDNEY. It may play a role in reducing systemic ENDOTHELIN levels.", "PM": "2004; ENDOTHELIN B RECEPTOR was indexed under RECEPTORS, ENDOTHELIN 1993-2003; ENDOTHELIN B-2 RECEPTOR was indexed under RECEPTORS, ENDOTHELIN 1998-2003", "HN": "2004; use RECEPTOR, ENDOTHELIN B (NM) 1993-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044023"}, {"RECTYPE": "D", "MH": "Tetralones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D04.615.638.960.837", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "PI": "Naphthalenes (1965-2003)", "MS": "A group of TETRAHYDRONAPHTHALENES containing a keto oxygen.", "PM": "2004", "HN": "2004", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044024"}, {"RECTYPE": "D", "MH": "Receptors, Formyl Peptide", "DE": "RECEPT FORMYL PEPTIDE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Chemotactic Peptide Receptor|T116|T192|NON|EQV|NLM (2004)|CHEMOTACTIC PEPTIDE RECEPT|abbcdev", "ENTRY": "fMet Leu Phe Receptor", "MN": "D12.776.543.750.750.340", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Peptide (1980-2003)", "MS": "A family of G-protein-coupled receptors that was originally identified by its ability to bind N-formyl peptides such as N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE. Since N-formyl peptides are found in MITOCHONDRIA and BACTERIA, this class of receptors is believed to play a role in mediating cellular responses to cellular damage and bacterial invasion. However, non-formylated peptide ligands have also been found for this receptor class.", "PM": "2004; CHEMOTACTIC PEPTIDE RECEPTOR (now RECEPTORS, FORMYL PEPTIDE) was indexed under RECEPTORS, IMMUNOLOGIC & RECEPTORS, PEPTIDE 1980-2003", "HN": "2004; use RECEPTORS, FORMYL PEPTIDE (NM) 1980-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044042"}, {"RECTYPE": "D", "MH": "Pectobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.542", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid122277", "AN": "general or unspecified; prefer specifics", "MS": "A genus of gram-negative bacteria in the family ENTEROBACTERIACEAE consisting of species that profusely produce pectinolytic enzymes in plant pathogenesis.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044043"}, {"RECTYPE": "D", "MH": "Aeromonadaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.018.500", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid84642", "AN": "infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "MS": "A family of gram-negative facultatively anaerobic bacteria, ubiquitous in fresh and brackish water, and associated with GASTROINTESTINAL DISEASES.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044044"}, {"RECTYPE": "D", "MH": "Lipoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Lipoxin|T109|T123|NON|EQV|NLM (2004)|030102|abbcdef", "MN": "D10.251.355.255.375", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Hydroxyeicosatetraenoic Acids (1984-2003)", "MS": "Trihydroxy derivatives of eicosanoic acids. They are primarily derived from arachidonic acid, however eicosapentaenoic acid derivatives also exist. Many of them are naturally occurring mediators of immune regulation.", "PM": "2004", "HN": "2004", "MR": "20040728", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044045"}, {"RECTYPE": "D", "MH": "Prostaglandins I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Prostaglandin I|T109|T123|NON|EQV|NLM (1994)|921215|PGI|abbcdefv", "MN": "D23.469.050.175.725.550", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Epoprostenol (1977-2003)", "MS": "A class of cyclic prostaglandins that contain the 6,9-epoxy bond. Endogenous members of this family are biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES.", "PM": "2004; see EPOPROSTENOL 1991-2003, see PROSTGLANDINS X 1984-1990, see PROSTAGLANDINS 1979-1983", "HN": "2004; use EPOPROSTENOL 1979-2003", "MR": "20150608", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044062"}, {"RECTYPE": "D", "MH": "Succinivibrionaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.018.750", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid83763", "AN": "infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Gram-Negative Anaerobic Bacteria (1999-2003)", "MS": "A family of gram-negative, rod-shaped bacteria isolated from the RUMEN of SHEEP and CATTLE and from human FECES. They are chemoorganotrophic and strictly anaerobic.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044063"}, {"RECTYPE": "D", "MH": "Anaerobiospirillum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.018.750.050", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid13334", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "MS": "A genus of gram-negative, spiral-shaped bacteria in the family SUCCINIVIBRIONACEAE. It has been isolated from the THROAT and COLON of beagle dogs and from human FECES.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044064"}, {"RECTYPE": "D", "MH": "Cardiobacteriaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.080", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid868", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "MS": "A family of gram-negative, mostly aerobic bacteria, in the order Cardiobacteriales. There are three genera: CARDIOBACTERIUM; DICHELOBACTER; and Suttonella.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044065"}, {"RECTYPE": "D", "MH": "Cardiobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.080.100", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2717", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM) + ENDOCARDITIS, BACTERIAL if pertinent", "PI": "Gram-Negative Facultatively Anaerobic Rods (1976-2003)", "MS": "A genus of gram-negative, facultatively anaerobic bacteria in the family CARDIOBACTERIACEAE. It is found in the nasal flora of humans and causes ENDOCARDITIS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044066"}, {"RECTYPE": "D", "MH": "Receptors, Lipoxin", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Lipoxin Receptors|T116|T192|NON|EQV|NLM (2004)|030102|abbcdef", "MN": "D12.776.543.750.695.200.575", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "MS": "Cell surface proteins that bind LIPOXINS with high affinity and trigger intracellular changes influencing the behavior of cells.", "PM": "2004", "HN": "2004", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044067"}, {"RECTYPE": "D", "MH": "Citrobacter rodentium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Citrobacter freundii Biotype 4280|T007|NON|EQV|NLM (2001)|991220|abcdef", "MN": "B03.660.250.150.100.737", "MH_TH": "NLM (2001)", "ST": "T007", "RN": "txid67825", "AN": "infection: coordinate with ENTEROBACTERIACEAE INFECTIONS", "PI": "Citrobacter freundii (1995-2003)", "MS": "A species of gram-negative bacteria in the genus CITROBACTER, family ENTEROBACTERIACEAE. As an important pathogen of laboratory mice, it serves as a model for investigating epithelial hyperproliferation and tumor promotion. It was previously considered a strain of CITROBACTER FREUNDII.", "PM": "2004; see CITROBACTER FREUNDII 2001-2003", "HN": "2004; use CITROBACTER FREUNDII 2001-2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044082"}, {"RECTYPE": "D", "MH": "Cronobacter sakazakii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Enterobacter sakazakii|T007|NON|EQV|NLM (2004)|030102|abcdef", "MN": "B03.660.250.150.110.150", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid28141", "AN": "infection: coordinate IM with ENTEROBACTERIACEAE INFECTIONS (IM)", "PI": "Enterobacter (1979-2003)", "MS": "A species of gram-negative bacteria in the genus CHRONOBACTER, found in the environment and in foods.", "PM": "2012; see ENTEROBACTER SAKAZAKII 2004-2011", "HN": "2012 (2004)", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044083"}, {"RECTYPE": "D", "MH": "Erwinia amylovora", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Micrococcus amylovorus|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.150.175.050", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid552", "PI": "Erwinia (1965-2003)", "MS": "A species of gram-negative bacteria, in the genus ERWINIA, causing a necrotic disease of plants.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044084"}, {"RECTYPE": "D", "MH": "Microfluidics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Microfluidic", "MN": "J01.897.520.500.500", "MH_TH": "NLM (2004)", "ST": "T090", "MS": "The study of fluid channels and chambers of tiny dimensions of tens to hundreds of micrometers and volumes of nanoliters or picoliters. This is of interest in biological MICROCIRCULATION and used in MICROCHEMISTRY and INVESTIGATIVE TECHNIQUES.", "PM": "2004", "HN": "2004", "MR": "20130709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044085"}, {"RECTYPE": "D", "MH": "Kluyvera", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.410", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid579", "AN": "infection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)", "PI": "Enterobacteriaceae (1974-2003)", "MS": "A genus of gram-negative, facultatively anaerobic bacteria in the family ENTEROBACTERIACEAE. It is found in FOOD; SOIL; and SEWAGE; and is an opportunistic pathogen of humans.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044086"}, {"RECTYPE": "D", "MH": "Receptor, Anaphylatoxin C5a", "DE": "RECEPT ANAPHYLATOXIN C5A", "DS": "RECEPTOR ANAPHYLATOXIN C 05 A", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptor, Complement 5a|T116|T129|T192|NON|EQV|NLM (2004)|RECEPTOR COMPLEMENT 05 A|RECEPT COMPLEMENT 5A|abbbcdesv", "ENTRY": "Receptors, C5a", "MN": "D12.776.543.750.705.833.550", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Complement (1985-2003)", "MS": "A G-protein-coupled receptor that signals an increase in intracellular calcium in response to the potent ANAPHYLATOXIN peptide COMPLEMENT C5A.", "PM": "2004; COMPLEMENT 5A RECEPTOR (now RECEPTOR, ANAPHYLATOXIN C5A) was indexed under RECEPTORS, COMPLEMENT & ANTIGENS, CD 1985-2003", "HN": "2004; use RECEPTOR, ANAPHYLATOXIN C5A (NM) 1985-2003", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044087"}, {"RECTYPE": "D", "MH": "Receptors, Galanin", "DE": "RECEPT GALANIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Galanin", "MN": "D12.776.543.750.750.555.410", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Neuropeptide (1999-2003)", "MS": "A family of G-protein-coupled receptors that are specific for GALANIN and galanin peptides. They are generally considered to be coupled to the GI, INHIBITORY G-PROTEIN to meditate the neurological effects of galanin. Several subtypes of galanin receptors occur with differing specificities for the full length galanin, galanin peptide fragments, and galanin-like peptide.", "PM": "2004; GALANIN RECEPTOR was indexed under RECEPTORS, NEUROPEPTIDE 1999-2003 & RECEPTORS, GASTROINTESTINAL HORMONE 1987-1998", "HN": "2004; use RECEPTORS, GALANIN (NM) 1999-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044088"}, {"RECTYPE": "D", "MH": "Galanin-Like Peptide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Galanin-Like Protein|T116|T125|NON|EQV|NLM (2004)|000718|abbcdef", "ENTRY": "Galanin Like Protein", "MN": "D12.644.400.275", "MH_TH": "NLM (2004)", "ST": "T125", "RN": "0", "PI": "Nerve Tissue Proteins (2000-2003)", "MS": "A neuropeptide that is highly homologous to GALANIN. It is produced by proteolytic processing of a larger protein that is unrelated to prepro-galanin and preferentially binds to GALANIN-2 RECEPTOR.", "PM": "2004; GALANIN-LIKE PROTEIN (now GALANIN-LIKE PEPTIDE) was indexed under NERVE TISSUE PROTEINS 2000-2003", "HN": "2004; use GALANIN-LIKE PEPTIDE (NM) 2000-2003", "MR": "20050630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044089"}, {"RECTYPE": "D", "MH": "Serratia liquefaciens", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.720.480", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid614", "AN": "infection: coord IM with SERRATIA INFECTIONS (IM)", "PI": "Serratia (1973-2003)", "MS": "A species of gram-negative bacteria in the genus SERRATIA found in plants and the DIGESTIVE TRACT of rodents. It is the most prevalent Serratia species in the natural environment.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044090"}, {"RECTYPE": "D", "MH": "Receptor, Galanin, Type 1", "DE": "RECEPT GALANIN TYPE 1", "DS": "RECEPTOR GALANIN TYPE 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Galanin Receptor 1|T116|T192|NON|EQV|NLM (2004)|030103|GALANIN RECEPTOR 01|GALANIN RECEPT 1|abbcdefsv", "ENTRY": "Receptor, Galanin-1", "MN": "D12.776.543.750.695.315.100", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Neuropeptide (1997-2003)", "MS": "The most abundant galanin receptor subtype. It displays a high affinity for the full-length form of GALANIN.", "PM": "2004; GALANIN-1 RECEPTOR (now RECEPTOR, GALANIN, TYPE 1) was indexed under RECEPTORS, NEUROPEPTIDE 1997-2003", "HN": "2004; use RECEPTOR, GALANIN, TYPE 1 (NM) 1997-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044091"}, {"RECTYPE": "D", "MH": "Receptor, Galanin, Type 2", "DE": "RECEPT GALANIN TYPE 2", "DS": "RECEPTOR GALANIN TYPE 02", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Galanin Receptor 2|T116|T192|NON|EQV|NLM (2004)|030103|GALANIN RECEPTOR 02|GALANIN RECEPT 2|abbcdefsv", "ENTRY": "Receptor, Galanin-2", "MN": "D12.776.543.750.695.315.200", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Neuropeptide (1997-2003)", "MS": "A galanin receptor subtype with broad specificity for full length GALANIN, galanin peptide fragments and GALANIN-LIKE PEPTIDE.", "PM": "2004; GALANIN-2 RECEPTOR (now RECEPTOR, GALANIN, TYPE 2) was indexed under RECEPTORS, NEUROPEPTIDE 1997-2003", "HN": "2004; use RECEPTOR, GALANIN, TYPE 2 (NM) 1997-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044092"}, {"RECTYPE": "D", "MH": "Receptor, Galanin, Type 3", "DE": "RECEPT GALANIN TYPE 3", "DS": "RECEPTOR GALANIN TYPE 03", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Galanin Receptor 3|T116|T192|NON|EQV|NLM (2004)|030103|GALANIN RECEPTOR 03|GALANIN RECEPT 3|abbcdefsv", "ENTRY": "Receptor, Galanin-3", "MN": "D12.776.543.750.695.315.300", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Neuropeptide (1997-2003)", "MS": "A galanin receptor subtype with high affinity for GALANIN-LIKE PEPTIDE and low affinity for full length GALANIN and galanin peptide fragments.", "PM": "2004", "HN": "2004", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044093"}, {"RECTYPE": "D", "MH": "Receptors, Melatonin", "DE": "RECEPT MELATONIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Melatonin Receptors|T116|T192|NON|EQV|NLM (2004)|MELATONIN RECEPT|abbcdev", "ENTRY": "Receptor, Melatonin MT3", "MN": "D12.776.826.590", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Neurohumor (1987-1993)", "MS": "A family of G-protein-coupled receptors that are specific for and mediate the effects of MELATONIN. Activation of melatonin receptors has been associated with decreased intracellular CYCLIC AMP and increased hydrolysis of PHOSPHOINOSITIDES.", "PM": "2004; MELATONIN RECEPTORS was indexed under RECEPTOR, CELL SURFACE & RECEPTORS, CYTOPLASMIC AND NUCLEAR 1984-2003; RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1986; & RECEPTORS, NEUROHUMOR 1987-1993", "HN": "2004; use RECEPTORS, MELATONIN (NM) 1981-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044094"}, {"RECTYPE": "D", "MH": "Proteus penneri", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.590.670", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid102862", "AN": "infection: coord IM with PROTEUS INFECTIONS (IM)", "PI": "Proteus (1982-2003)", "MS": "A genus of gram-negative bacteria isolated from individuals in LONG-TERM CARE facilities and HOSPITALS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044095"}, {"RECTYPE": "D", "MH": "Psychrobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.530.650", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid497", "AN": "infection: coordinate with MORAXELLACEAE INFECTIONS", "MS": "A genus of gram-negative, aerobic bacteria in the family MORAXELLACEAE, associated with processed MEAT; FISH PRODUCTS; and POULTRY PRODUCTS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044096"}, {"RECTYPE": "D", "MH": "Receptors, Melanocortin", "DE": "RECEPT MELANOCORTIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Melanocortin Receptors|T116|T192|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Receptor, Melanocortin|T116|T192|NON|EQV|NLM (2004)|abbcde", "MN": "D12.776.543.750.750.660.285.500", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Receptors, Corticotropin (1994-2003)", "MS": "A family of G-protein-coupled receptors that have specificity for MELANOCYTE-STIMULATING HORMONES and ADRENOCORTICOTROPIC HORMONE. There are several subtypes of melanocortin receptors, each having a distinct ligand specificity profile and tissue localization.", "PM": "2004; MELANOCORTIN RECEPTOR (now RECEPTORS, MELANOCORTIN) was indexed under RECEPTORS, CORTICOTROPIN 1994-2003", "HN": "2004; use RECEPTORS, MELANOCORTIN (NM) 1994-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044101"}, {"RECTYPE": "D", "MH": "Receptor, Melanocortin, Type 1", "DE": "RECEPT MELANOCORTIN TYPE 1", "DS": "RECEPTOR MELANOCORTIN TYPE 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Melanocortin Receptor 1|T116|T192|NON|EQV|NLM (2004)|030113|MELANOCORTIN RECEPTOR 01|MELANOCORTIN RECEPT 1|abbcdefsv", "ENTRY": "Receptor, Melanocyte Melanocortin", "MN": "D12.776.543.750.750.660.285.500.500", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Corticotropin (1999-2003)", "MS": "A melanocortin receptor subtype found primarily in MELANOCYTES. It shows specificity for ALPHA-MSH and ADRENOCORTICOTROPIC HORMONE. Loss of function mutations of the type 1 melanocortin receptor account for the majority of red hair and fair skin recessive traits in human.", "PM": "2004; see MELANOCORTIN-1 RECEPTOR 2002 - 2003", "HN": "2004(2002)", "MR": "20210304", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044102"}, {"RECTYPE": "D", "MH": "Receptor, Melanocortin, Type 2", "DE": "RECEPT MELANOCORTIN TYPE 2", "DS": "RECEPTOR MELANOCORTIN TYPE 02", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Melanocortin Receptor 2|T116|T192|NON|EQV|NLM (2004)|MELANOCORTIN RECEPTOR 02|MELANOCORTIN RECEPT 2|abbcdesv", "ENTRY": "Receptor, Melanocortin 2", "MN": "D12.776.543.750.750.660.285.500.750", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Endogenous Substances (1993)", "MS": "A melanocortin receptor subtype found primarily in the ADRENAL CORTEX. It shows specificity for ADRENOCORTICOTROPIC HORMONE.", "PM": "2004; MELANOCORTIN RECEPTOR 2 was indexed under RECEPTORS, CORTICOTROPIN 1994-2003 & RECEPTORS, ENDOGENOUS SUBSTANCES 1993", "HN": "2004; use RECEPTOR, MELANOCORTIN, TYPE 2 (NM) 1993-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044103"}, {"RECTYPE": "D", "MH": "Receptor, Melanocortin, Type 3", "DE": "RECEPT MELANOCORTIN TYPE 3", "DS": "RECEPTOR MELANOCORTIN TYPE 03", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Melanocortin Receptor 3|T116|T192|NON|EQV|NLM (2004)|MELANOCORTIN RECEPTOR 03|MELANOCORTIN RECEPT 3|abbcdesv", "ENTRY": "Receptor, Melanocortin-3", "MN": "D12.776.543.750.750.660.285.500.875", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Corticotropin (1994-2003)", "MS": "A melanocortin receptor subtype found primarily in BRAIN. It shows specificity for ALPHA-MSH; BETA-MSH; GAMMA-MSH and ADRENOCORTICOTROPIC HORMONE.", "PM": "2004; MELANOCORTIN RECEPTOR 3 was indexed under RECEPTORS, CORTICOTROPIN 1994-2003", "HN": "2004; use RECEPTOR, MELANOCORTIN, TYPE, 3 (NM) 1994-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044104"}, {"RECTYPE": "D", "MH": "Receptor, Melanocortin, Type 4", "DE": "RECEPT MELANOCORTIN TYPE 4", "DS": "RECEPTOR MELANOCORTIN TYPE 04", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Melanocortin Receptor 4|T116|T192|NON|EQV|NLM (2004)|MELANOCORTIN RECEPTOR 04|MELANOCORTIN RECEPT 4|abbcdesv", "ENTRY": "Receptor, Melanocortin 4", "MN": "D12.776.543.750.750.660.285.500.937", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Peptide (1994-2002)", "MS": "A melanocortin receptor subtype found primarily in BRAIN. It shows specificity for ALPHA-MSH; BETA-MSH and ADRENOCORTICOTROPIC HORMONE.", "PM": "2004; MELANOCORTIN RECEPTOR 4 was indexed under RECEPTORS, CORTICOTROPIN 1995-2003; RECEPTORS, PEPTIDE 1994-2002 & RECEPTORS, CELL SURFACE 1993", "HN": "2004; use RECEPTOR, MELANOCORTIN, TYPE 4 (NM) 1993-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044105"}, {"RECTYPE": "D", "MH": "Wigglesworthia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Wigglesworthia glossinidia|T007|NON|NRW|NLM (2004)|030103|abcdef", "MN": "B03.660.250.150.880", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid51228", "RR": "txid51229", "PI": "Enterobacteriaceae (1995-2003)", "MS": "A genus of gram-negative, rod-shaped bacteria in the family ENTEROBACTERIACEAE. They exist only as primary endosymbionts of five species of TSETSE FLIES, found in specialized organelles called mycetomes. The bacteria supply crucial B vitamins (VITAMIN B COMPLEX) which the flies require for fertility.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044106"}, {"RECTYPE": "D", "MH": "Receptor, Melatonin, MT1", "DE": "RECEPT MELATONIN MT1", "DS": "RECEPTOR MELATONIN MT 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Melatonin MT1 Receptor|T116|T192|NON|EQV|NLM (2004)|000426|MELATONIN MT 01 RECEPTOR|MELATONIN MT1 RECEPT|abbcdefsv", "ENTRY": "Receptor, Melatonin MT1", "MN": "D12.776.543.750.695.440.500", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Cytoplasmic and Nuclear (1996-2003)", "MS": "A melatonin receptor subtype that is primarily found in the HYPOTHALAMUS and in the KIDNEY.", "PM": "2004; MEL(1A)-MELATONIN RECEPTOR was indexed under RECEPTORS, CELL SURFACE & RECEPTORS, CYTOPLASMIC AND NUCLEAR 1996-2003", "HN": "2004; for MEL(1A)-MELATONIN RECEPTOR use MELATONIN RECEPTORS (NM) 1996-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044122"}, {"RECTYPE": "D", "MH": "Receptor, Melatonin, MT2", "DE": "RECEPT MELATONIN MT2", "DS": "RECEPTOR MELATONIN MT 02", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Melatonin MT2 Receptor|T116|T192|ACX|EQV|NLM (2004)|000426|MELATONIN MT 02 RECEPTOR|MELATONIN MT2 RECEPT|abbcdefsv", "ENTRY": "Receptor, Melatonin MT2", "MN": "D12.776.543.750.695.440.750", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Cytoplasmic and Nuclear (1996-2003)", "MS": "A melatonin receptor subtype primarily found expressed in the BRAIN and RETINA.", "PM": "2004; MELATONIN 1B RECEPTOR was indexed under RECEPTORS, CELL SURFACE & RECEPTORS, CYTOPLASMIC AND NUCLEAR 1996-2003", "HN": "2004; for MELATONIN 1B RECEPTOR use RECEPTORS, MELATONIN (NM) 1996-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044123"}, {"RECTYPE": "D", "MH": "Yersinia ruckeri", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Yersinia rucker|T007|NON|EQV|NLM (2004)|030106|abcdef", "MN": "B03.660.250.150.950.650", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid29486", "AN": "coordinate IM with YERSINIA INFECTIONS (IM)", "PI": "Yersinia (1979-2003)", "MS": "A species of gram-negative bacteria responsible for red mouth disease in rainbow trout (ONCORHYNCHUS MYKISS). The bacteria is a natural component of fresh water ecosystems in the United States and Canada.", "PM": "2012; see YERSINIA RUCKER 2004-2011", "HN": "2012 (2004)", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044124"}, {"RECTYPE": "D", "MH": "Coxiellaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Rickettsiella|T007|NON|NRW|NLM (2004)|030106|abcdef", "MN": "B03.660.250.132", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid118968", "RR": "txid59195", "MS": "A family of gram-negative bacteria in the order Legionellales. It includes genera COXIELLA and Rickettsiella.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044125"}, {"RECTYPE": "D", "MH": "Epigenesis, Genetic", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Epigenetic Processes|T045|NON|NRW|NLM (2007)|050909|abcdef", "ENTRY": "Processes, Epigenetics", "MN": "G05.308.203", "FX": "Morphogenesis", "MH_TH": "NLM (2004)", "ST": "T045", "MS": "A genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression.", "PM": "2004", "HN": "2004", "MR": "20220712", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044127"}, {"RECTYPE": "D", "MH": "Legionella longbeachae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.460.460.480", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid450", "AN": "infection: coordinate IM with LEGIONELLOSIS (IM)", "PI": "Legionella (1981-2003)", "MS": "A species of gram-negative, aerobic bacteria in the genus LEGIONELLA, first isolated in Long Beach, California. Infection is associated with the use of contaminated potting SOIL.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044128"}, {"RECTYPE": "D", "MH": "Halomonadaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.350", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid28256", "PI": "Gammaproteobacteria (1997-2003)", "MS": "A family of gram-negative, moderately halophilic bacteria in the order Oceanospirillales. Members of the family have been isolated from temperate and Antarctic saline lakes, solar salt facilities, saline soils, and marine environments.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044129"}, {"RECTYPE": "D", "MH": "Oceanospirillaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.540", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid135620", "MS": "A family of gram-negative bacteria in the order Oceanospirillales.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044130"}, {"RECTYPE": "D", "MH": "Actinobacillus equuli", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Shigella viscosa|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.550.050.200", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid718", "AN": "infection: coordinate with ACTINOBACILLUS INFECTIONS", "PI": "Actinobacillus (1971-2003)", "MS": "A genus of gram-negative bacteria in the genus ACTINOBACILLUS, which is pathogenic for HORSES and PIGS.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044131"}, {"RECTYPE": "D", "MH": "Actinobacillus suis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.550.050.700", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid716", "AN": "infection: coord IM with ACTINOBACILLUS INFECTIONS (IM)", "PI": "Actinobacillus (1974-2003)", "MS": "A species of gram-negative bacteria in the genus ACTINOBACILLUS. It is mainly a pathogen of PIGS, but also can infect HORSES.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044132"}, {"RECTYPE": "D", "MH": "Actinobacillus seminis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.550.050.675", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid722", "AN": "infection: coord IM with ACTINOBACILLUS INFECTIONS (IM) + EPIDIDYMITIS (IM) if pertinent", "PI": "Actinobacillus (1966-2003)", "MS": "A species of gram-negative bacteria in the genus ACTINOBACILLUS, which causes EPIDIDYMITIS in SHEEP.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044133"}, {"RECTYPE": "D", "MH": "Haemophilus paragallinarum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Hemophilus paragallinarum|T007|NON|EQV|NLM (2004)|030113|abcdef", "MN": "B03.660.250.550.290.665", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid728", "AN": "infection: coordinate with HAEMOPHILUS INFECTIONS", "PI": "Haemophilus (1977-2003)", "MS": "A species of gram-negative bacteria in the genus HAEMOPHILUS, causing respiratory tract disease in CHICKENS known as infectious coryza.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044134"}, {"RECTYPE": "D", "MH": "Haemophilus parainfluenzae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Hemophilius parainfluenzae|T007|NON|EQV|NLM (2004)|030113|abcdef", "MN": "B03.660.250.550.290.675", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid729", "AN": "infection: coordinate with HAEMOPHILUS INFECTIONS", "PI": "Haemophilus (1966-2003)", "MS": "A species of gram-negative bacteria in the genus HAEMOPHILUS, ubiquitous in the human ORAL CAVITY and PHARYNX. It has low pathogenicity but is occasionally implicated in ENDOCARDITIS in humans.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044135"}, {"RECTYPE": "D", "MH": "Haemophilus paraphrophilus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Hemophilus paraphrophilus|T007|NON|EQV|NLM (2004)|030113|abcdef", "MN": "B03.660.250.550.290.690", "MH_TH": "NLM (2004)", "ST": "T007", "AN": "infection: coordinate with HAEMOPHILUS INFECTIONS", "PI": "Haemophilus (1968-2003)", "MS": "A species of gram-negative bacteria in the genus HAEMOPHILUS, found in the normal flora of the human ORAL CAVITY and PHARYNX. It can cause SUBACUTE BACTERIAL ENDOCARDITIS; and BRAIN ABSCESS, among other conditions.", "PM": "2004", "HN": "2004", "MR": "20200902", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044136"}, {"RECTYPE": "D", "MH": "Haemophilus parasuis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Hemophilus parasuis|T007|NON|EQV|NLM (2004)|030113|abcdef", "MN": "B03.660.250.550.290.700", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid738", "AN": "infection: coordinate with HAEMOPHILUS INFECTIONS", "PI": "Haemophilus (1974-2003)", "MS": "A species of gram-negative bacteria in the genus HAEMOPHILUS found, in the normal upper respiratory tract of SWINE.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044137"}, {"RECTYPE": "D", "MH": "Haemophilus somnus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Hemophilus somnus|T007|NON|EQV|NLM (2004)|030113|abcdef", "MN": "B03.660.250.550.290.750", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid731", "AN": "infection: coordinate with HAEMOPHILUS INFECTIONS", "PI": "Haemophilus (1973-2003)", "MS": "A species of gram-negative bacteria (currently incertae sedis) causing multisystem disease in CATTLE.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044138"}, {"RECTYPE": "D", "MH": "Receptor, Angiotensin, Type 2", "DE": "RECEPT ANGIOTENSIN TYPE 2", "DS": "RECEPTOR ANGIOTENSIN TYPE 02", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptor, Angiotensin II Type 2|T116|T192|NON|EQV|NLM (2004)|RECEPTOR ANGIOTENSIN II TYPE 02|RECEPT ANGIOTENSIN II TYPE 2|abbcdesv", "ENTRY": "Receptor, Angiotensin AT2", "MN": "D12.776.543.750.750.130.875", "EC": "antagonists & inhibitors:Angiotensin II Type 2 Receptor Blockers", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Angiotensin (1996-2003)", "MS": "An angiotensin receptor subtype that is expressed at high levels in fetal tissues. Many effects of the angiotensin type 2 receptor such as VASODILATION and sodium loss are the opposite of that of the ANGIOTENSIN TYPE 1 RECEPTOR.", "PM": "2004; ANGIOTENSIN II TYPE 2 RECEPTOR (now RECEPTOR, ANGIOTENSIN, TYPE 2) was indexed under RECEPTORS, ANGIOTENSIN 1996-2003", "HN": "2004; use RECEPTOR, ANGIOTENSIN, TYPE 2 (NM) 1996-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044139"}, {"RECTYPE": "D", "MH": "Receptor, Angiotensin, Type 1", "DE": "RECEPT ANGIOTENSIN TYPE 1", "DS": "RECEPTOR ANGIOTENSIN TYPE 01", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptor, Angiotensin, Type 1b|T116|T192|NON|NRW|NLM (2004)|030108|RECEPTOR ANGIOTENSIN TYPE 01 B|RECEPT ANGIOTENSIN TYPE 1B|abbcdefsv", "ENTRY": "Receptor, Angiotensin AT1b", "MN": "D12.776.543.750.750.130.750", "EC": "antagonists & inhibitors:Angiotensin II Type 1 Receptor Blockers", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Angiotensin (1996-2003)", "MS": "An angiotensin receptor subtype that is expressed at high levels in a variety of adult tissues including the CARDIOVASCULAR SYSTEM, the KIDNEY, the ENDOCRINE SYSTEM and the NERVOUS SYSTEM. Activation of the type 1 angiotensin receptor causes VASOCONSTRICTION and sodium retention.", "PM": "2004; ANGIOTENSIN II TYPE 1 RECEPTOR (now RECEPTOR, ANGIOTENSIN, TYPE 1) was indexed under RECEPTORS, ANGIOTENSIN 1996-2003; ANGIOTENSIN II TYPE 1A RECEPTOR was indexed under RECEPTORS, ANGIOTENSIN 1995-2003; ANGIOTENSIN II TYPE 1B RECEPTOR was indexed under RECEPTORS, ANGIOTENSIN 1997-2003", "HN": "2004; use RECEPTOR, ANGIOTENSIN, TYPE 1(NM) 1996-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044140"}, {"RECTYPE": "D", "MH": "Pasteurella pneumotropica", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.550.590.650", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid758", "AN": "infection: coordinate with PASTEURELLA INFECTIONS ", "PI": "Pasteurella (1969-2003)", "MS": "A species of gram-negative bacteria in the genus PASTEURELLA, found in the NASOPHARYNX of normal GUINEA PIGS; RATS; HAMSTERS; MICE; DOGS; and CATS. When associated with disease, it is usually a secondary invader. Occasional infections have been reported in humans.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044142"}, {"RECTYPE": "D", "MH": "Piscirickettsiaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Thiomicrospira|T007|NON|NRW|NLM (2004)|030108|abcdef", "MN": "B03.660.250.565", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid135616", "RR": "txid933", "MS": "A family of gram-negative bacteria, in the order Thiotrichales.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044147"}, {"RECTYPE": "D", "MH": "Lymphatic Abnormalities", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lymphatic Abnormality", "MN": "C16.131.482", "MH_TH": "NLM (2004)", "ST": "T020", "MS": "Congenital or acquired structural abnormalities of the lymphatic system (LYMPHOID TISSUE) including the lymph vessels.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044148"}, {"RECTYPE": "D", "MH": "Vibrio alginolyticus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pseudomonas creosotensis|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.830.830.030", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid663", "AN": "infection: coord IM with VIBRIO INFECTIONS (IM)", "PI": "Vibrio (1969-2003)", "MS": "A species of gram-negative, halophilic bacteria, in the genus VIBRIO. It is considered part of normal marine flora and commonly associated with ear infections and superficial wounds exposed to contaminated water sources.", "PM": "2004", "HN": "2004", "MR": "20200206", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044149"}, {"RECTYPE": "D", "MH": "Parathyroid Hormone-Related Protein", "DE": "PARATHYROID HORMONE RELAT PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Parathyroid Hormone Related Protein", "MN": "D23.529.890", "FX": "Receptors, Parathyroid Hormone", "MH_TH": "NLM (2004)", "ST": "T125", "RN": "0", "AN": "see SCR for organism specific terms", "PI": "Proteins (1987-2002)", "MS": "A ubiquitously expressed, secreted protein with bone resorption and renal calcium reabsorption activities that are similar to PARATHYROID HORMONE. It does not circulate in appreciable amounts in normal subjects, but rather exerts its biological actions locally. Overexpression of parathyroid hormone-related protein by tumor cells results in humoral calcemia of malignancy.", "PM": "2004; PARATHYROID HORMONE-RELATED PROTEIN was indexed under PEPTIDE HORMONES 2003; PROTEINS 1987-2002", "HN": "2004; use PARATHYROID HORMONE-RELATED PROTEIN (NM) 1987-2003", "MR": "20180522", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044162"}, {"RECTYPE": "D", "MH": "Vibrio cholerae non-O1", "DS": "VIBRIO CHOLERAE NON O 001", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.830.830.100.075", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid66861", "AN": "infection: coord IM with VIBRIO INFECTIONS (IM)", "PI": "Vibrio cholerae (1981-2003)", "MS": "A strain of the VIBRIO CHOLERAE bacteria belonging to serogroup non-O1, infecting humans and other PRIMATES. It is related to VIBRIO CHOLERAE O1, but causes a disease less severe than CHOLERA. Eating raw shellfish contaminated with the bacteria results in GASTROENTERITIS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044163"}, {"RECTYPE": "D", "MH": "Vibrio mimicus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.830.830.500", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid674", "PI": "Vibrio (1981-2003)", "MS": "A species of gram-negative bacteria in the genus VIBRIO, isolated from SHELLFISH, as well as from human diarrheal stools and ear infections.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044164"}, {"RECTYPE": "D", "MH": "Aliivibrio salmonicida", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Vibrio salmonicida|T007|NON|EQV|NLM (2004)|030108|abcdef", "MN": "B03.660.250.830.050.930", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid40269", "AN": "infection: coordinate with ALIIVIBRIO INFECTIONS + HEMORRHAGIC SEPTICEMIA if pertinent ", "PI": "Vibrio (1987-2003)", "MS": "A species of gram-negative bacteria in the genus ALIIVIBRIO. Aliivibrio salmonicida is the causative agent of cold water vibriosis, a HEMORRHAGIC SEPTICEMIA of ATLANTIC SALMON.", "PM": "2012; see VIBRIO SALMONICIDA 2004-2011", "HN": "2012 (2004)", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044165"}, {"RECTYPE": "D", "MH": "Xanthomonadaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.915", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid32033", "MS": "A family of gram-negative bacteria, in the order Xanthomonadales, pathogenic to plants.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044166"}, {"RECTYPE": "D", "MH": "Xylella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.915.950", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2370", "PI": "Gammaproteobacteria (1997-2003)", "MS": "A genus of gram-negative, aerobic bacteria, in the family XANTHOMONADACEAE. It is found in the xylem of plant tissue.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044167"}, {"RECTYPE": "D", "MH": "Receptor, Parathyroid Hormone, Type 1", "DE": "RECEPT PARATHYROID HORMONE TYPE 1", "DS": "RECEPTOR PARATHYROID HORMONE TYPE 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Parathyroid Hormone Receptor Type 1|T116|T192|NON|EQV|NLM (2004)|030109|PARATHYROID HORMONE RECEPTOR TYPE 01|PARATHYROID HORMONE RECEPT TYPE 1|abbcdefsv", "ENTRY": "Receptor, Parathyroid Hormone", "MN": "D12.776.543.750.750.600.100", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Parathyroid Hormone (1994-2003)", "MS": "A parathyroid hormone receptor subtype that recognizes both PARATHYROID HORMONE and PARATHYROID HORMONE-RELATED PROTEIN. It is a G-protein-coupled receptor that is expressed at high levels in BONE and in KIDNEY.", "PM": "2004; for PARATHYROID HORMONE RECEPTOR see RECEPTORS, PARATHYROID HORMONE 1994-2003; PARATHYROID HORMONE RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1980-1993; PARATHYROID HORMONE-LIKE PEPTIDE RECEPTOR was indexed under RECEPTORS PARATHYROID HORMONE 1994-2003 & RECEPTORS, ENDOGENOUS SUBSTANCES 1991-1993", "HN": "2004; for PARATHYROID HORMONE RECEPTOR use RECEPTORS, PARATHYROID HORMONE 1994-2003 & RECEPTORS, PARATHYROID HORMONE (NM) 1980-1993; for PARATHYROID HORMONE-LIKE PEPTIDE RECEPTOR use RECEPTOR, PARATHYROID HORMONE, TYPE 1 (NM) 1991-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044168"}, {"RECTYPE": "D", "MH": "Receptors, Calcium-Sensing", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Calcium-Sensing Receptor|T116|T192|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Receptors, Calcium Sensing", "MN": "D12.776.543.750.695.115", "FX": "Intracellular Calcium-Sensing Proteins", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "AN": "CALCIUM-BINDING PROTEINS is also available", "PI": "Receptors, Cell Surface (1994-2003)", "MS": "A class of G-protein-coupled receptors that react to varying extracellular CALCIUM levels. Calcium-sensing receptors in the PARATHYROID GLANDS play an important role in the maintenance of calcium HOMEOSTASIS by regulating the release of PARATHYROID HORMONE. They differ from INTRACELLULAR CALCIUM-SENSING PROTEINS which sense intracellular calcium levels.", "PM": "2004; use RECEPTORS, CALCIUM-SENSING (NM) 1994-2003; for CALCIUM RECEPTORS see CALCIUM-BINDING PROTEINS 1982-2003; for RECEPTORS, CALCIUM see CALCIUM-BINDING PROTEINS 1996-2003", "HN": "2004; CALCIUM-SENSING RECEPTOR (now RECEPTORS, CALCIUM-SENSING) was indexed under RECEPTORS, CELL SURFACE; for CALCIUM RECEPTORS use CALCIUM-BINDING PROTEINS 1982-2003; for RECEPTORS, CALCIUM use CALCIUM-BINDING PROTEINS 1996-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044169"}, {"RECTYPE": "D", "MH": "Benzylisoquinolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bisbenzylisoquinolines|T109|NON|NRW|NLM (2004)|030109|abcdef", "ENTRY": "Bis Benzylisoquinolines", "MN": "D03.633.100.531.085", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "MS": "ISOQUINOLINES with a benzyl substituent.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044182"}, {"RECTYPE": "D", "MH": "Receptor, Parathyroid Hormone, Type 2", "DE": "RECEPT PARATHYROID HORMONE TYPE 2", "DS": "RECEPTOR PARATHYROID HORMONE TYPE 02", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Parathyroid Hormone Receptor 2|T116|T192|NON|EQV|NLM (2004)|PARATHYROID HORMONE RECEPTOR 02|PARATHYROID HORMONE RECEPT 2|abbcdesv", "ENTRY": "Receptor, PTH2", "MN": "D12.776.543.750.750.600.200", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Parathyroid Hormone (1996-2003)", "MS": "A parathyroid hormone receptor subtype found in the BRAIN and the PANCREAS. It is a G-protein-coupled receptor with a ligand specificity that varies between homologs from different species.", "PM": "2004; PTH-2 RECEPTOR (now RECEPTOR, PARATHYROID HORMONE, TYPE 2) was indexed under RECEPTORS, PARATHYROID HORMONE 1996-2003", "HN": "2004; use RECEPTOR, PARATHYROID HORMONE, TYPE 2 (NM) 1996-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044183"}, {"RECTYPE": "D", "MH": "Xanthomonas vesicatoria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.915.930.850", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid56460", "PI": "Xanthomonas (1977-2003)", "MS": "A species of gram-negative bacteria, in the genus XANTHOMONAS, causing disease in TOMATO and pepper crops.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044184"}, {"RECTYPE": "D", "MH": "Pseudomonas alcaligenes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.580.590.070", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid43263", "AN": "infection: coord IM with PSEUDOMONAS INFECTIONS (IM)", "PI": "Pseudomonas (1968-2003)", "MS": "A species of gram-negative bacteria in the genus PSEUDOMONAS. It cannot utilize FRUCTOSE; GLUCOSE; or MALTOSE for energy.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044202"}, {"RECTYPE": "D", "MH": "Pseudomonas mendocina", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.580.590.500", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid300", "AN": "infection: coordinate with PSEUDOMONAS INFECTIONS", "PI": "Pseudomonas (1981-2003)", "MS": "A species of gram-negative bacteria in the genus PSEUDOMONAS, which is found in SOIL and WATER.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044203"}, {"RECTYPE": "D", "MH": "Pseudomonas oleovorans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.580.590.570", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid301", "PI": "Pseudomonas (1968-2003)", "MS": "A species of gram-negative bacteria in the genus PSEUDOMONAS. It is isolated from oil-water emulsions used as lubricants and cooling agents in the cutting and grinding of materials.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044204"}, {"RECTYPE": "D", "MH": "Pseudomonas pseudoalcaligenes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.580.590.575", "MH_TH": "NLM (2004)", "ST": "T007", "AN": "infection: coord IM with PSEUDOMONAS INFECTIONS (IM)", "PI": "Pseudomonas (1986-2003)", "MS": "A species of gram-negative bacteria in the genus PSEUDOMONAS. All strains can utilize FRUCTOSE for energy. It is occasionally isolated from humans and some strains are pathogenic to WATERMELON.", "PM": "2004", "HN": "2004", "MR": "20200902", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044205"}, {"RECTYPE": "D", "MH": "Pseudomonas fragi", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pseudomonas fragariae|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.580.590.230", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid296", "PI": "Pseudomonas (1965-2003)", "MS": "A species of gram-negative, aerobic bacteria in the genus PSEUDOMONAS. It has a characteristic strawberry color and is widely distributed in SOIL and WATER.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044206"}, {"RECTYPE": "D", "MH": "Halothiobacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Thiobacillus neapolitanus|T007|NON|NRW|NLM (2004)|030113|abcdef", "MN": "B03.660.250.110.400", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid109262", "RR": "txid927", "MS": "A genus of gram-negative, chemolithoautotrophic bacteria in the family Halothiobacillaceae. Several of its species were reclassified to this genus from THIOBACILLUS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044222"}, {"RECTYPE": "D", "MH": "Pseudomonas stutzeri", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pseudomonas perfectomarinus|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.580.590.750", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid316", "AN": "infection: coord IM with PSEUDOMONAS INFECTIONS (IM)", "PI": "Pseudomonas (1966-2003)", "MS": "A species of gram-negative bacteria in the genus PSEUDOMONAS, containing multiple genomovars. It is distinguishable from other pseudomonad species by its ability to use MALTOSE and STARCH as sole carbon and energy sources. It can degrade ENVIRONMENTAL POLLUTANTS and has been used as a model organism to study denitrification.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044223"}, {"RECTYPE": "D", "MH": "Pseudomonas syringae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pseudomonas syringae subsp. syringae|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.580.590.770", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid317", "PI": "Pseudomonas (1966-2003)", "MS": "A species of gram-negative, fluorescent, phytopathogenic bacteria in the genus PSEUDOMONAS. It is differentiated into approximately 50 pathovars with different plant pathogenicities and host specificities.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044224"}, {"RECTYPE": "D", "MH": "Piscirickettsiaceae Infections", "DE": "PISCIRICKETTSIACEAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Piscirickettsiosis|T047|NON|EQV|NLM (2004)|030113|abcdef", "ENTRY": "Piscirickettsioses", "MN": "C01.150.252.400.719", "MH_TH": "NLM (2004)", "ST": "T047", "PI": "Fish Diseases (1997-2003)", "MS": "Infections with bacteria of the family PISCIRICKETTSIACEAE, causing septicemic disease of salmonid fish (SALMONIDAE). Piscirickettsia-like bacteria are also associated with disease syndromes in non-salmonid fish.", "PM": "2004", "HN": "2004", "MR": "20190617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044225"}, {"RECTYPE": "D", "MH": "Trans Fatty Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Trans Fatty Acid|T109|NON|EQV|NLM (2021)|200106|abcdef", "ENTRY": "Fatty Acids, Trans", "MN": "D10.251.355.920", "FX": "Linoleic Acids, Conjugated", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "AN": "coord with specific fatty acid if pertinent", "PI": "Fatty Acids (1968-2003)", "MS": "UNSATURATED FATTY ACIDS that contain at least one double bond in the trans configuration, which results in a greater bond angle than the cis configuration. This results in a more extended fatty acid chain similar to SATURATED FATTY ACIDS, with closer packing and reduced fluidity. HYDROGENATION of unsaturated fatty acids increases the trans content.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044242"}, {"RECTYPE": "D", "MH": "Linoleic Acids, Conjugated", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Conjugated Linoleic Acid|T109|NON|EQV|NLM (2021)|191129|abcdef", "ENTRY": "Linoleic Acid, Conjugated", "MN": "D10.251.355.343.500.750", "FX": "Trans Fatty Acids", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "AN": "LINOLEIC ACID is also available", "PI": "Linoleic Acid (1992-2003)", "MS": "A collective term for a group of around nine geometric and positional isomers of LINOLEIC ACID in which the trans/cis double bonds are conjugated, where double bonds alternate with single bonds.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044243"}, {"RECTYPE": "D", "MH": "Receptors, Thromboxane A2, Prostaglandin H2", "DE": "RECEPT THROMBOXANE A2 PROSTAGLANDIN H2", "DS": "RECEPTORS THROMBOXANE A 02 PROSTAGLANDIN H 02", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Thromboxane A2, Prostaglandin H2 Receptors|T116|T192|NON|EQV|NLM (2004)|030114|THROMBOXANE A 002 PROSTAGLANDIN H 02 RECEPTORS|THROMBOXANE A2 PROSTAGLANDIN H2 RECEPT|abbcdefsv", "ENTRY": "TXA2 PGH2 Receptors", "MN": "D12.776.543.750.695.200.800.500", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Thromboxane (1992-2003)", "MS": "A subclass of eicosanoid receptors that have specificity for THROMBOXANE A2 and PROSTAGLANDIN H2.", "PM": "2004; for THROMBOXANE A2 RECEPTOR see RECEPTORS, THROMBOXANE 1994-2003; PROSTAGLANDIN H2 RECEPTOR was indexed under RECEPTORS, PROSTAGLANDIN 1985-2003", "HN": "2004; for THROMBOXANE A2 RECEPTOR use RECEPTORS, THROMBOXANE 1994-2003; for PROSTAGLANDIN H2 RECEPTOR use RECEPTORS, TROMBOXANE A2, PROSTAGLANDIN H2 (NM) 1985-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044244"}, {"RECTYPE": "D", "MH": "Prostaglandin H2", "DS": "PROSTAGLANDIN H 02", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "PGH2|T109|ABB|EQV|NLM (2004)|PGH 02|abcdes", "ENTRY": "PGH(2)|T109|ABB|EQV|NLM (2004)|abcde", "MN": "D23.469.050.175.725.025.650.500", "MH_TH": "NLM (2004)", "ST": "T109", "N1": "Prosta-5,13-dien-1-oic acid, 9,11-epidioxy-15-hydroxy-, (5Z,9alpha,11alpha,13E,15S)-", "RN": "42935-17-1", "AN": "/analogs: coord with PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC if pertinent", "PI": "Prostaglandins H (1993-2003)", "MS": "A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins.", "PM": "2004; PROSTAGLANDIN H2 was indexed under PROSTAGLANDINS H 1993-2003 & PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC 1986-1992", "HN": "2004; use PROSTAGLANDIN H2 (NM) 1980-2003", "MR": "20230226", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044262"}, {"RECTYPE": "D", "MH": "Receptors, Serotonin, 5-HT1", "DE": "RECEPT SEROTONIN 5 HT1", "DS": "RECEPTORS SEROTONIN 5 HT 01", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Serotonin Receptors, 5-HT1|T116|T192|ABX|EQV|NLM (2004)|030129|SEROTONIN RECEPTORS 5 HT 01|SEROTONIN RECEPT 5 HT1|abbcdefsv", "ENTRY": "Serotonin, 5 HT1 Receptors", "MN": "D12.776.543.750.720.850.100", "EC": "antagonists & inhibitors:Serotonin 5-HT1 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Serotonin (1993-2003)", "MS": "A subclass of G-protein coupled SEROTONIN receptors that couple preferentially to GI-GO G-PROTEINS resulting in decreased intracellular CYCLIC AMP levels.", "PM": "2004; SEROTONIN 5-HT1 RECEPTOR (now RECEPTORS, SEROTONIN, 5-HT1) was indexed under RECEPTORS, SEROTONIN 1993-2003", "HN": "2004; use RECEPTORS, SEROTONIN, 5-HT1 (NM) 1993-2003", "MR": "20230417", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044263"}, {"RECTYPE": "D", "MH": "Receptor, Serotonin, 5-HT1A", "DE": "RECEPT SEROTONIN 5 HT1A", "DS": "RECEPTOR SEROTONIN 5 HT 01 A", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Serotonin 1A Receptor|T116|T192|NON|EQV|NLM (2004)|SEROTONIN 01 A RECEPTOR|SEROTONIN 1A RECEPT|abbcdesv", "ENTRY": "Serotonin, 5 HT1a Receptor", "MN": "D12.776.543.750.720.850.100.100", "EC": "antagonists & inhibitors:Serotonin 5-HT1 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "112692-38-3", "PI": "Receptors, Serotonin (1993-2003)", "MS": "A serotonin receptor subtype found distributed through the CENTRAL NERVOUS SYSTEM where they are involved in neuroendocrine regulation of ACTH secretion. The fact that this serotonin receptor subtype is particularly sensitive to SEROTONIN RECEPTOR AGONISTS such as BUSPIRONE suggests its role in the modulation of ANXIETY and DEPRESSION.", "PM": "2004; RECEPTOR, SEROTONIN 1A (now RECEPTOR, SEROTONIN, 5-HT1A) was indexed under RECEPTORS, SEROTONIN 1993-2003", "HN": "2004; use RECEPTOR SEROTONIN 5 HT1 SUBCLASS (NM) 1993-2003", "MR": "20160701", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044282"}, {"RECTYPE": "D", "MH": "Receptor, Serotonin, 5-HT1B", "DE": "RECEPT SEROTONIN 5 HT1B", "DS": "RECEPTOR SEROTONIN 5 HT 01 B", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Serotonin 1B Receptor|T116|T192|NON|EQV|NLM (2004)|SEROTONIN 01 B RECEPTOR|SEROTONIN 1B RECEPT|abbcdesv", "ENTRY": "Receptors, Serotonin 1Dbeta", "MN": "D12.776.543.750.720.850.100.150", "EC": "antagonists & inhibitors:Serotonin 5-HT1 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Serotonin (1993-2003)", "MS": "A serotonin receptor subtype found at high levels in the BASAL GANGLIA and the frontal cortex. It plays a role as a terminal autoreceptor that regulates the rate of SEROTONIN release from nerve endings. This serotonin receptor subtype is closely related to and has similar drug binding properties as the 5-HT1D RECEPTOR. It is particularly sensitive to the agonist SUMATRIPTAN and may be involved in mediating the drug's antimigraine effect.", "PM": "2004; SEROTONIN 1B RECEPTOR (now RECEPTOR, SEROTONIN, 5-HT1B) was indexed under RECEPTORS, SEROTONIN 1993-2003; SEROTONIN 1D BETA RECEPTOR (now RECEPTOR, SEROTONIN, 5-HT1B) was indexed under RECEPTORS, SEROTONIN 1995-2003", "HN": "2004; use RECEPTOR, SEROTONIN, 5-HT1B (NM) 1993-2003", "MR": "20160701", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044302"}, {"RECTYPE": "D", "MH": "Malnutrition", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Nutritional Deficiencies", "MN": "C18.654.521", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Nutrition Disorders (1964-2003)", "MS": "An imbalanced nutritional status resulting from insufficient intake of nutrients to meet normal physiological requirement.", "PM": "2004; see NUTRITION DISORDERS 1975-2003", "HN": "2004; use NUTRITION DISORDERS 1975-2003", "MR": "20160630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044342"}, {"RECTYPE": "D", "MH": "Overnutrition", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hypernutrition|T047|NON|EQV|NLM (2015)|140411|abcdef", "MN": "C18.654.726", "FX": "Hyperphagia", "MH_TH": "NLM (2004)", "ST": "T047", "MS": "An imbalanced NUTRITIONAL STATUS resulting from excessive intake of nutrients. Generally, overnutrition generates an energy imbalance between food consumption and energy expenditure leading to disorders such as OBESITY.", "PM": "2004", "HN": "2004", "MR": "20140606", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044343"}, {"RECTYPE": "D", "MH": "Phosphoric Triester Hydrolases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Triester Hydrolases, Phosphoric", "MN": "D08.811.277.352.660", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.8.-", "PI": "Esterases (1980-2003)", "MS": "A class of enzymes that catalyze the hydrolysis of one of the three ester bonds in a phosphotriester-containing compound.", "PM": "2004; PHOSPHOTRIESTERASE was indexed under ESTERASES 1994-2003; PHOSPHORIC MONOESTER HYRDOLASES 1990-1993; PHOSPHOMONOESTERASES 1982-1989", "HN": "2004; for PHOSPHOTRIESTERASE use ARYLDIALKYLPHOSPHATASE (NM) 1980 - 2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044345"}, {"RECTYPE": "D", "MH": "Receptor, Serotonin, 5-HT1D", "DE": "RECEPT SEROTONIN 5 HT1D", "DS": "RECEPTOR SEROTONIN 5 HT 01 D", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Serotonin 1D Receptor|T116|T192|NON|EQV|NLM (2004)|SEROTONIN 01 D RECEPTOR|SEROTONIN 1D RECEPT|abbcdesv", "ENTRY": "Receptors, Serotonin 1D", "MN": "D12.776.543.750.720.850.100.200", "EC": "antagonists & inhibitors:Serotonin 5-HT1 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Serotonin (1996-2003)", "MS": "A serotonin receptor subtype that is localized to the CAUDATE NUCLEUS; PUTAMEN; the NUCLEUS ACCUMBENS; the HIPPOCAMPUS, and the RAPHE NUCLEI. It plays a role as a terminal autoreceptor that regulates the rate of SEROTONIN release from nerve endings. This serotonin receptor subtype is closely related to and has similar drug binding properties as the 5-HT1B RECEPTOR, but is expressed at low levels. It is particularly sensitive to the agonist SUMATRIPTAN and may be involved in mediating the drug's antimigrane effect.", "PM": "2004; SEROTONIN 1D RECEPTOR (now RECEPTOR, SEROTONIN, 5-HT1D) was indexed under RECEPTORS, SEROTONIN 1996-2003; SEROTONIN 1DALPHA RECEPTOR was indexed under RECEPTORS, SEROTONIN 1997-2003;", "HN": "2004; use RECEPTOR, SEROTONIN, 5-HT1D (NM) 1996-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044346"}, {"RECTYPE": "D", "MH": "Sexology", "DE": "SEXOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "F04.096.837", "MH_TH": "NLM (1991)", "ST": "T091", "PI": "Sex Education (1968-2003)", "MS": "This discipline concerns the study of SEXUALITY, and the application of sexual knowledge such as sexual attitudes, psychology, and SEXUAL BEHAVIOR. Scope of application generally includes educational (SEX EDUCATION), clinical (SEX COUNSELING), and other settings.", "PM": "2004; see SEX 1991-2003", "HN": "2004; use SEX 1991-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044347"}, {"RECTYPE": "D", "MH": "Receptors, Serotonin, 5-HT2", "DE": "RECEPT SEROTONIN 5 HT2", "DS": "RECEPTORS SEROTONIN 5 HT 02", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Serotonin Receptors, 5-HT2|T116|T192|NON|EQV|NLM (2004)|030129|SEROTONIN RECEPTORS 5 HT 02|SEROTONIN RECEPT 5 HT2|abbcdefsv", "ENTRY": "Serotonin Receptors, 5 HT2", "MN": "D12.776.543.750.720.850.200", "EC": "antagonists & inhibitors:Serotonin 5-HT2 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Serotonin (1983-2003)", "MS": "A subclass of G-protein coupled SEROTONIN receptors that couple preferentially to the GQ-G11 G-PROTEINS resulting in increased intracellular levels of INOSITOL PHOSPHATES and free CALCIUM.", "PM": "2004; see RECEPTORS, SEROTONIN 1989-2003", "HN": "2004; use RECEPTORS, SEROTONIN 1989-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044348"}, {"RECTYPE": "D", "MH": "Oceania", "AQ": "EH EP", "MN": "Z01.678", "MH_TH": "NLM (2004)", "ST": "T083", "MS": "The islands of the central and South Pacific, including Micronesia, Melanesia, Polynesia, and traditionally Australasia. (Random House Dictionary, 2d ed)", "HN": "2004", "MR": "20090706", "DA": "20030709", "DC": "4", "DX": "20040101", "UI": "D044349"}, {"RECTYPE": "D", "MH": "Australasia", "AQ": "EH EP", "MN": "Z01.678.100", "MH_TH": "NLM (2004)", "ST": "T083", "AN": "do not confuse with AUSTRALIA", "MS": "Australia, New Zealand and neighboring islands in the South Pacific Ocean. (Random House Unabridged Dictionary, 2d ed.)", "HN": "2004", "MR": "20110624", "DA": "20030709", "DC": "4", "DX": "20040101", "UI": "D044362"}, {"RECTYPE": "D", "MH": "Contraception, Postcoital", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Postcoital Fertility Control", "MN": "E02.875.194.540", "FX": "Contraceptives, Postcoital", "MH_TH": "NLM (2004)", "ST": "T061", "AN": "for postcoital douching use CONTRACEPTION, POSTCOITAL and VAGINAL DOUCHING", "PI": "Contraceptives, Postcoital (1974-2003)", "MS": "Means of postcoital intervention to avoid pregnancy, such as the administration of POSTCOITAL CONTRACEPTIVES to prevent FERTILIZATION of an egg or implantation of a fertilized egg (OVUM IMPLANTATION).", "PM": "2004; for FERTILITY CONTROL, POSTCOITAL see CONTRACEPTIVES, POSTCOITAL 1980-2003", "HN": "2004; for FERTILITY CONTROL, POSTCOITAL use CONTRACEPTIVES, POSTCOITAL 1980-2003", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044363"}, {"RECTYPE": "D", "MH": "Vaginal Douching", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Lavage, Vaginal", "MN": "E05.927.852", "FX": "Feminine Hygiene Products", "MH_TH": "NLM (2004)", "ST": "T061", "AN": "for postcoital douching use CONTRACEPTION, POSTCOITAL and VAGINAL DOUCHING", "PI": "Vagina (1973-2003)", "MS": "The washing of the VAGINA cavity or surface with a solution. Agents or drugs can be added to the irrigation solution.", "PM": "2004", "HN": "2004", "MR": "20100625", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044364"}, {"RECTYPE": "D", "MH": "GTP-Binding Protein alpha Subunits, G12-G13", "DS": "GTP BINDING PROTEIN ALPHA SUBUNITS G 12 G 13", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "G13 Protein|T116|T126|ABX|NRW|NLM (2004)|G A 13 PROTEIN|abbcdes", "ENTRY": "alpha13 Protein, G", "MN": "D12.776.543.325.100.100", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.6.5.1", "RR": "EC 3.6.5.1", "PI": "Heterotrimeric GTP-Binding Proteins (2000-2003)", "MS": "A ubiquitously expressed family of heterotrimeric GTP-binding protein alpha subunits that signal through interactions with a variety of second messengers as GTPASE-ACTIVATING PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; and HEAT SHOCK PROTEINS. The G12-G13 part of the name is also spelled G12/G13.", "PM": "2004; G ALPHA12 PROTEIN was indexed under HETEROTRIMERIC GTP-BINDING PROTEINS 2000-2003; G13 PROTEIN was indexed under DNA-BINDING PROTEINS 1996-2003; G(13) PROTEIN was indexed under HETEROTRIMERIC GTP-BINDING PROTEINS 2000-2003 & GTP-BINDING PROTEINS 1998-1999", "HN": "2004; use GTP-BINDING PROTEIN, G12-13 ALPHA SUBUNITS (NM) 1996-2003", "MR": "20210521", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044365"}, {"RECTYPE": "D", "MH": "Transition Temperature", "AQ": "DE RE", "PRINT ENTRY": "Temperature, Transition|T081|NON|EQV|NLM (2005)|031105|abcdef", "ENTRY": "Transition Temperatures", "MN": "G01.906.595.850", "FX": "Phase Transition", "MH_TH": "NLM (2004)", "ST": "T081", "MS": "The temperature at which a substance changes from one state or conformation of matter to another.", "PM": "2004", "HN": "2004", "MR": "20080708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044366"}, {"RECTYPE": "D", "MH": "Phase Transition", "AQ": "DE RE", "ENTRY": "Transitions, Sol-Gel Phase", "MN": "G02.734", "FX": "Transition Temperature", "MH_TH": "NLM (2004)", "ST": "T070", "AN": "note X refs: restrict to physical chemical change; not for physiologic phase transition", "MS": "A change of a substance from one form or state to another.", "PM": "2004", "HN": "2004", "MR": "20160617", "DA": "20030725", "DC": "1", "DX": "20040101", "UI": "D044367"}, {"RECTYPE": "D", "MH": "Population Groups", "AQ": "CL ED EH ES GE HI LJ PX SN", "ENTRY": "Population Group", "MN": "N01.224.708", "MH_TH": "NLM (2004)", "ST": "T098", "AN": "general or unspecified; prefer specifics; Humans only", "MS": "Individuals classified according to their sex, racial and ethnic origin, religion, common place of living, financial or social status, or some other cultural or behavioral attribute.", "PM": "2004", "HN": "2004", "MR": "20230226", "DA": "20030714", "DC": "1", "DX": "20040101", "UI": "D044382"}, {"RECTYPE": "D", "MH": "Black People", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Black Person|T098|NON|EQV|NLM (2023)|220713|abcdef", "ENTRY": "Race, Negroid", "MN": "M01.686.372", "MH_TH": "NLM (2023)", "ST": "T098", "AN": "specify geographic location if pertinent. BLACK OR AFRICAN AMERICAN is available for the United States population groups", "MS": "Persons having origins in any of the black racial groups of AFRICA. Note that OMB category BLACK OR AFRICAN AMERICAN is available for the United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.", "PM": "2023; see AFRICAN CONTINENTAL ANCESTRY GROUP 2004-2021, see BLACKS 2022", "HN": "2023; use AFRICAN CONTINENTAL ANCESTRY GROUP 2004-2021, use BLACKS 2022", "MR": "20220714", "DA": "20030714", "DC": "1", "DX": "20040101", "UI": "D044383"}, {"RECTYPE": "D", "MH": "Ovulation Prediction", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Prediction, Ovulation", "MN": "E05.820.745", "FX": "Ovulation Detection", "MH_TH": "NLM (2004)", "ST": "T060", "PI": "Ovulation Detection (1976-2003)", "MS": "Predicting the time of OVULATION can be achieved by measuring the preovulatory elevation of ESTRADIOL; LUTEINIZING HORMONE or other hormones in BLOOD or URINE. Accuracy of ovulation prediction depends on the completeness of the hormone profiles, and the ability to determine the preovulatory LH peak.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044384"}, {"RECTYPE": "D", "MH": "GTP-Binding Protein alpha Subunits", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Subunit, G-Protein", "MN": "D12.776.543.325.100", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "0", "PI": "Heterotrimeric GTP-Binding Proteins (2000-2003)", "MS": "The GTPase-containing subunits of heterotrimeric GTP-binding proteins. When dissociated from the heterotrimeric complex these subunits interact with a variety of second messenger systems. Hydrolysis of GTP by the inherent GTPase activity of the subunit causes it to revert to its inactive (heterotrimeric) form. The GTP-Binding protein alpha subunits are grouped into families according to the type of action they have on second messenger systems.", "PM": "2004; see HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003", "HN": "2004; use HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003", "MR": "20210521", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044385"}, {"RECTYPE": "D", "MH": "GTP-Binding Protein beta Subunits", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "G-Protein beta Subunit|T116|T123|ABX|EQV|NLM (2001)|000111|abbcdef", "ENTRY": "beta Subunit, G-Protein", "MN": "D12.776.543.325.450", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Heterotrimeric GTP-Binding Proteins (2000-2003)", "MS": "Heterotrimeric GTP-binding protein subunits that tightly associate with GTP-BINDING PROTEIN GAMMA SUBUNITS. A dimer of beta and gamma subunits is formed when the GTP-BINDING PROTEIN ALPHA SUBUNIT dissociates from the GTP-binding protein heterotrimeric complex. The beta-gamma dimer can play an important role in signal transduction by interacting with a variety of second messengers.", "PM": "2004; see HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003", "HN": "2004; use HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003", "MR": "20210521", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044387"}, {"RECTYPE": "D", "MH": "GTP-Binding Protein gamma Subunits", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "G-Protein gamma Subunit|T116|T123|ABX|EQV|NLM (2001)|000111|abbcdef", "ENTRY": "gamma Subunit, G-Protein", "MN": "D12.776.543.325.625", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Heterotrimeric GTP-Binding Proteins (2000-2003)", "MS": "Heterotrimeric GTP-binding protein subunits that tightly associate with GTP-BINDING PROTEIN BETA SUBUNITS. A dimer of beta and gamma subunits is formed when the GTP-BINDING PROTEIN ALPHA SUBUNIT dissociates from the GTP-binding protein heterotrimeric complex. The beta-gamma dimer can play an important role in signal transduction by interacting with a variety of second messengers.", "PM": "2004; see HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003", "HN": "2004; use HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003", "MR": "20210521", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044388"}, {"RECTYPE": "D", "MH": "Receptor, Serotonin, 5-HT2A", "DE": "RECEPT SEROTONIN 5 HT2A", "DS": "RECEPTOR SEROTONIN 5 HT 02 A", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Serotonin 2A Receptor|T116|T192|NON|EQV|NLM (2004)|SEROTONIN 02 A RECEPTOR|SEROTININ 2A RECEPT|abbcdesv", "ENTRY": "Receptors, Serotonin 2A", "MN": "D12.776.543.750.720.850.200.100", "EC": "antagonists & inhibitors:Serotonin 5-HT2 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Serotonin (1994-2003)", "MS": "A serotonin receptor subtype found widely distributed in peripheral tissues where it mediates the contractile responses of variety of tissues that contain SMOOTH MUSCLE. Selective 5-HT2A receptor antagonists include KETANSERIN. The 5-HT2A subtype is also located in BASAL GANGLIA and CEREBRAL CORTEX of the BRAIN where it mediates the effects of HALLUCINOGENS such as LSD.", "PM": "2004; SEROTONIN 2A RECEPTOR (now RECEPTOR, SEROTONIN, 5-HT2A) was indexed under RECEPTORS, SEROTONIN 1994-2003", "HN": "2004; use RECEPTOR, SEROTONIN, 5-HT2A (NM) 1994-2003", "MR": "20160701", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044402"}, {"RECTYPE": "D", "MH": "Receptor, Serotonin, 5-HT2B", "DE": "RECEPT SEROTONIN 5 HT2B", "DS": "RECEPTOR SEROTONIN 5 HT 02 B", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Serotonin 2B Receptor|T116|T192|NON|EQV|NLM (2004)|SEROTONIN 02 B RECEPTOR|SEROTONIN 2B RECEPT|abbcdesv", "ENTRY": "Receptors, Serotonin 2B", "MN": "D12.776.543.750.720.850.200.150", "EC": "antagonists & inhibitors:Serotonin 5-HT2 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Serotonin (1994-2003)", "MS": "A serotonin receptor subtype found in the BRAIN; HEART; LUNGS; PLACENTA and DIGESTIVE SYSTEM organs. A number of functions have been attributed to the action of the 5-HT2B receptor including the development of cardiac myocytes (MYOCYTES, CARDIAC) and the contraction of SMOOTH MUSCLE.", "PM": "2004; SEROTONIN 2B RECEPTOR (now RECEPTOR, SEROTONIN, 5-HT2B) was indexed under RECEPTORS, SEROTONIN 1994-2003", "HN": "2004; use RECEPTOR, SEROTONIN, 5-HT2B (NM) 1994-2003", "MR": "20160701", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044403"}, {"RECTYPE": "D", "MH": "Genomic Islands", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Pathogenicity Islands|T114|T123|NON|NRW|NLM (2004)|030123|abbcdef", "ENTRY": "Symbiosis Islet", "MN": "G05.360.340.024.425.500", "MH_TH": "NLM (2004)", "ST": "T123", "MS": "Distinct units in some bacterial, bacteriophage or plasmid GENOMES that are types of MOBILE GENETIC ELEMENTS. Encoded in them are a variety of fitness conferring genes, such as VIRULENCE FACTORS (in \"pathogenicity islands or islets\"), ANTIBIOTIC RESISTANCE genes, or genes required for SYMBIOSIS (in \"symbiosis islands or islets\"). They range in size from 10 - 500 kilobases, and their GC CONTENT and CODON usage differ from the rest of the genome. They typically contain an INTEGRASE gene, although in some cases this gene has been deleted resulting in \"anchored genomic islands\".", "PM": "2004", "HN": "2004", "MR": "20080708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044404"}, {"RECTYPE": "D", "MH": "Receptor, Serotonin, 5-HT2C", "DE": "RECEPT SEROTONIN 5 HT2C", "DS": "RECEPTOR SEROTONIN 5 HT 02 C", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Serotonin 2C Receptor|T116|T192|NON|EQV|NLM (2004)|SEROTONIN 02 C RECEPTOR|SEROTONIN 2C RECEPT|abbcdesv", "ENTRY": "Receptor, Serotonin 2C", "MN": "D12.776.543.750.720.850.200.200", "EC": "antagonists & inhibitors:Serotonin 5-HT2 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Serotonin (1994-2003)", "MS": "A serotonin receptor subtype found primarily in the CENTRAL NERVOUS SYSTEM and the CHOROID PLEXUS. This receptor subtype is believed to mediate the anorectic action of SEROTONIN, while selective antagonists of the 5-HT2C receptor appear to induce ANXIETY. Several isoforms of this receptor subtype exist, due to adenine deaminase editing of the receptor mRNA.", "PM": "2004; SEROTONIN 2C RECEPTOR (now RECEPTOR, SEROTONIN, 5-HTC) was indexed under RECEPTORS, SEROTONIN 1994-2003", "HN": "2004; use RECEPTOR, SEROTONIN, 5-HT2C (NM) 1994-2003", "MR": "20160701", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044405"}, {"RECTYPE": "D", "MH": "Receptors, Serotonin, 5-HT3", "DE": "RECEPT SEROTONIN 5 HT3", "DS": "RECEPTORS SEROTONIN 5 HT 03", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Serotonin 3 Receptor|T116|T192|NON|EQV|NLM (2004)|SEROTONIN 03 RECEPTOR|SEROTONIN 3 RECEPT|abbcdesv", "ENTRY": "Receptors, Serotonin 3", "MN": "D12.776.543.750.720.850.300", "EC": "antagonists & inhibitors:Serotonin 5-HT3 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Serotonin (1995-2003)", "MS": "A subclass of serotonin receptors that form cation channels and mediate signal transduction by depolarizing the cell membrane. The cation channels are formed from 5 receptor subunits. When stimulated the receptors allow the selective passage of SODIUM; POTASSIUM; and CALCIUM.", "PM": "2004; SEROTONIN 3 RECEPTOR (now RECEPTORS, SEROTONIN, 5-HT3) was indexed under RECEPTORS, SEROTONIN 1995-2003", "HN": "2004; use RECEPTORS, SEROTONIN, 5-HT3 (NM) 1995-2003", "MR": "20160701", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044406"}, {"RECTYPE": "D", "MH": "Receptors, Serotonin, 5-HT4", "DE": "RECEPT SEROTONIN 5 HT4", "DS": "RECEPTORS SEROTONIN 5 HT 04", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Serotonin 4 Receptor|T116|T192|NON|EQV|NLM (2004)|SEROTONIN 04 RECEPTOR|SEROTONIN 4 RECEPT|abbcdesv", "ENTRY": "Receptors, Serotonin 4", "MN": "D12.776.543.750.720.850.400", "EC": "antagonists & inhibitors:Serotonin 5-HT4 Receptor Antagonists", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "158165-40-3", "PI": "Receptors, Serotonin (1995-2003)", "MS": "A subtype of G-protein-coupled SEROTONIN receptors that preferentially couple to GS STIMULATORY G-PROTEINS resulting in increased intracellular CYCLIC AMP. Several isoforms of the receptor exist due to ALTERNATIVE SPLICING of its mRNA.", "PM": "2004; SEROTONIN 4 RECEPTOR (now RECEPTORS, SEROTININ, 5HT4) was indexed under RECEPTORS, SEROTONIN 1995-2003", "HN": "2004; use RECEPTORS, SEROTININ, 5HT4 (NM) 1995-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044422"}, {"RECTYPE": "D", "MH": "Kelp", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.750.600.425", "MH_TH": "NLM (2000)", "ST": "T204", "AN": "coordinate with specific organism if pertinent", "PI": "Seaweed (1971-2003)", "MS": "Large, robust forms of brown algae (PHAEOPHYCEAE) in the order Laminariales. They are a major component of the lower intertidal and sublittoral zones on rocky coasts in temperate and polar waters. Kelp, a kind of SEAWEED, usually refers to species in the genera LAMINARIA or MACROCYSTIS, but the term may also be used for species in FUCUS or Nereocystis.", "PM": "2004; see SEAWEED 2000-2003", "HN": "2004; use SEAWEED 2000-2003", "MR": "20230606", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044423"}, {"RECTYPE": "D", "MH": "Cyanophora", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "paradoxas, Cyanophora", "MN": "B01.350.200", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid2761", "RR": "txid2762", "AN": "do not confuse with the CYANOBACTERIA", "PI": "Cyanobacteria (1980-1988)", "MS": "A genus of primitive plants in the family Cyanophoraceae, class GLAUCOPHYTA. They contain pigmented ORGANELLES (or PLASTIDS) called cyanelles, which have characteristics of both CYANOBACTERIA and CHLOROPLASTS.", "PM": "2004; see ALGAE 1998-2003", "HN": "2004; use ALGAE 1998-2003", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044424"}, {"RECTYPE": "D", "MH": "Nitella", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Nitellas", "MN": "B01.875.800.150.150.575", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid3148", "PI": "Algae, Green (1967-2003)", "MS": "A genus of green plants in the family CHARACEAE, phylum STREPTOPHYTA. They are found in shallow to deep waters of soft water or acid lakes and bogs.", "PM": "2004; see ALGAE, GREEN 1998-2003", "HN": "2004; use ALGAE, GREEN 1998-2003", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044443"}, {"RECTYPE": "D", "MH": "Scenedesmus", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.875.150.800", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid3087", "PI": "Algae, Green (1969-2003)", "MS": "A genus of GREEN ALGAE in the family Scenedesmaceae. It forms colonies of usually four or eight cylindrical cells that are widely distributed in freshwater and SOIL.", "PM": "2004; see ALGAE, GREEN 1998-2003", "HN": "2004; use ALGAE, GREEN 1998-2003", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044444"}, {"RECTYPE": "D", "MH": "Ulva", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sea Lettuces|T002|NON|EQV|NLM (2004)|030701|abcdef", "ENTRY": "Lettuce, Sea", "MN": "B01.875.150.900", "MH_TH": "NLM (2000)", "ST": "T002", "RN": "txid3118", "RR": "txid3119", "PI": "Algae, Green (1969-2003)", "MS": "A genus of GREEN ALGAE in the family Ulvaceae. Commonly known as sea lettuces, they grow attached to rocks and KELP in marine and estuarine waters.", "PM": "2004; see ALGAE, GREEN 2000-2003", "HN": "2004; use ALGAE, GREEN 2000-2003", "MR": "20230606", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044445"}, {"RECTYPE": "D", "MH": "Volvox", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.875.150.950", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid3066", "PI": "Algae, Green (1970-2003)", "MS": "A genus of GREEN ALGAE in the family Volvocaceae. They form spherical colonies of hundreds or thousands of bi-flagellated cells in a semi-transparent gelatinous ball.", "PM": "2004; see ALGAE, GREEN 1998-2003", "HN": "2004; use ALGAE, GREEN 1998-2003", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044446"}, {"RECTYPE": "D", "MH": "Receptors, Proteinase-Activated", "DE": "RECEPT PROTEINASE ACTIVATED", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Proteinase-Activated Receptor|T116|T192|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Receptors, Proteinase Activated", "MN": "D12.776.543.750.792", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Thrombin (1994-2003)", "MS": "A class of receptors that are activated by the action of PROTEINASES. The most notable examples are the THROMBIN RECEPTORS. The receptors contain cryptic ligands that are exposed upon the selective proteolysis of specific N-terminal cleavage sites.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044462"}, {"RECTYPE": "D", "MH": "Receptor, PAR-1", "DS": "RECEPTOR PAR 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Protease-Activated Receptor 1|T116|T192|NON|EQV|NLM (2004)|PROTEASE ACTIVATED RECEPT 1|abbcdev", "ENTRY": "Receptor, PAR1", "MN": "D12.776.543.750.792.500.500", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Thrombin (1997-2003)", "MS": "A thrombin receptor subtype that couples to HETEROTRIMERIC GTP-BINDING PROTEINS resulting in the activation of a variety of signaling mechanisms including decreased intracellular CYCLIC AMP, increased TYPE C PHOSPHOLIPASES and increased PHOSPHOLIPASE A2.", "PM": "2004; PROTEASE-ACTIVATED RECEPTOR-1 (now RECEPTOR, PROTIENASE-ACTIVATED) was indexed under RECEPTORS, THROMBIN 1997-2003", "HN": "2004; use RECEPTOR, PROTEINASE-ACTIVATED 1 (NM) 1997-2003", "MR": "20230316", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044463"}, {"RECTYPE": "D", "MH": "Receptor, PAR-2", "DE": "RECEPT PAR 2", "DS": "RECEPTOR PAR 02", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Proteinase Activated Receptor 2|T116|T192|NON|EQV|NLM (2004)|PROTEINASE ACTIVATED RECEPTOR 02|PROTEINASE ACTIVATED RECEPT 2|abbcdesv", "ENTRY": "Receptors, Trypsin", "MN": "D12.776.543.750.792.249", "MH_TH": "NLM (2004)", "ST": "T192", "RN": "0", "PI": "Receptors, Thrombin (1994-2003)", "MS": "A G-protein-coupled, proteinase-activated receptor that is expressed in a variety of tissues including ENDOTHELIUM; LEUKOCYTES; and the GASTROINTESTINAL TRACT. The receptor is activated by TRYPSIN, which cleaves off the N-terminal peptide from the receptor. The new N-terminal peptide is a cryptic ligand for the receptor. The uncleaved receptor can also be activated by the N-terminal peptide present on the activated THROMBIN RECEPTOR and by small synthetic peptides that contain the unmasked N-terminal sequence.", "PM": "2004; PROTEINASE ACTIVATED RECEPTOR 2 (now RECEPTOR, PAR-2) was indexed under RECEPTORS, THROMBIN 1994-2003; TRYPSIN RECEPTOR (now RECEPTOR, PAR-2) was indexed under RECEPTORS, CELL SURFACE 1986-2003", "HN": "2004; use RECEPTOR, PAR-2 (NM) 1994-2003; for TRYPSIN RECEPTOR use RECEPTOR, PAR-2 (NM) 1986-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044464"}, {"RECTYPE": "D", "MH": "White People", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "White Person|T098|NON|EQV|NLM (2023)|220713|abcdef", "ENTRY": "White Persons", "MN": "M01.686.877", "MH_TH": "NLM (2023)", "ST": "T098", "AN": "specify geographic location if relevant; for the United States populations WHITE is available", "MS": "Persons having origins in any of the white racial groups of  Europe, the Middle East, or North Africa. Note that OMB category WHITE is available for the United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.", "PM": "2023; see CAUCASIAN RACE 1963-1977, WHITES 1978-2003, CAUCASOID RACE 1978-2003, EUROPEAN CONTINENTAL ANCESTRY GROUP 2004-2021, WHITES 2022", "HN": "2023; use CAUCASIAN RACE 1963-1977, WHITES 1978-2003, CAUCASOID RACE 1978-2003, EUROPEAN CONTINENTAL ANCESTRY GROUP 2004-2021, WHITES 2022", "MR": "20230226", "DA": "20030714", "DC": "1", "DX": "20040101", "UI": "D044465"}, {"RECTYPE": "D", "MH": "Asian People", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Asian Person|T098|NON|EQV|NLM (2023)|220713|abcdef", "ENTRY": "Race, Mongoloid", "MN": "M01.686.330", "MH_TH": "NLM (2023)", "ST": "T098", "MS": "Persons having origins in any of the Asian racial groups of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. Note that OMB category ASIAN is available for United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.", "PM": "2023; see MONGOLOID RACE 1966-2003, ASIAN CONTINENTAL ANCESTRY GROUP 2004-2021, ASIANS 2022", "HN": "2023; use MONGOLOID RACE 1966-2003, ASIAN CONTINENTAL ANCESTRY GROUP 2004-2021, ASIANS 2022", "MR": "20220714", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044466"}, {"RECTYPE": "D", "MH": "American Indian or Alaska Native", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Native Americans, Federally-Recognized|T098|NON|BRD|NLM (2021)|220714|abcdef", "ENTRY": "Native, American", "MN": "M01.686.477.625.594.500", "MH_TH": "NLM (2023)", "ST": "T098", "MS": "A person having origins in any of the original peoples of North, South and Central Americas, and who maintains tribal affiliation or community attachment (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the-classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.", "PM": "2004; see AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP 2004-2022", "HN": "2004", "MR": "20220714", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044467"}, {"RECTYPE": "D", "MH": "Native Hawaiian or Other Pacific Islander", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Pacific Island Americans|T098|NON|NRW|NLM (1995)|940208|abcdef", "ENTRY": "Pacific Islander American", "MN": "M01.686.493.500.800.500", "MH_TH": "NLM (2022)", "ST": "T098", "MS": "A person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the-classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.", "PM": "2022", "HN": "2022", "MR": "20220721", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044468"}, {"RECTYPE": "D", "MH": "Racial Groups", "AQ": "CL ED EH GE HI LJ PX SN", "PRINT ENTRY": "Continental Population Groups|T098|NON|REL|NLM (2004)|030129|abcdef", "ENTRY": "Stocks, Racial", "MN": "M01.686.477.625.594", "MH_TH": "NLM (2022)", "ST": "T098", "AN": "general or unspecified; prefer specifics", "MS": "Groups of individuals with similar physical appearances often reinforced by cultural, social and/or linguistic similarities.", "PM": "2022; see RACIAL STOCKS 1968-2003 and CONTINENTAL POPULATION GROUPS 2004-2021", "HN": "2022(1968)", "MR": "20220708", "DA": "20030714", "DC": "1", "DX": "20040101", "UI": "D044469"}, {"RECTYPE": "D", "MH": "Benzeneacetamides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "2-Phenylacetamides|T109|NON|EQV|NLM (2005)|040105|abcdef", "MN": "D02.455.426.559.389.048", "FX": "Acetanilides", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "MS": "Compounds based on benzeneacetamide, that are similar in structure to ACETANILIDES.", "PM": "2004", "HN": "2004", "MR": "20040707", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044482"}, {"RECTYPE": "D", "MH": "Intestinal Polyposis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cronkhite-Canada Syndrome|T047|EPO|NRW|NLM (1996)|OMIM (2013)|950316|abcdeef", "ENTRY": "Polyposis, Intestinal", "MN": "C06.405.469.578", "MH_TH": "NLM (1996)", "ST": "T047", "AN": "INTESTINAL POLYPS is also available; familial: consider also ADENOMATOUS POLYPOSIS COLI", "PI": "Polyps (1966-1973)", "MS": "The growth of INTESTINAL POLYPS. Growth processes include neoplastic (ADENOMA and CARCINOMA) and non-neoplastic (hyperplastic, mucosal, inflammatory, and other polyps).", "PM": "2004; see INTESTINAL POLYPS 1996-2003; for CRONKHITE-CANADA SYNDROME see CHURG-STRAUSS SYNDROME 1992-1995", "HN": "2004; use INTESTINAL POLYPS 1996-2003; for CRONKHITE-CANADA SYNDROME use CHURG-STRAUSS SYNDROME 1992-1995", "MR": "20120703", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044483"}, {"RECTYPE": "D", "MH": "Thymine DNA Glycosylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glycosylase, Thymine Glycol", "MN": "D08.811.277.450.430.099.750", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.2.2.-", "PI": "Endodeoxyribonucleases (1991-2003)", "MS": "An enzyme that removes THYMINE and URACIL bases mispaired with GUANINE through hydrolysis of their N-glycosidic bond. These mispaired nucleotides generally occur through the hydrolytic DEAMINATION of 5-METHYLCYTOSINE to thymine.", "PM": "2004; THYMIDINE DNA GLYCOSYLASE was indexed under ENDODEOXYRIBONUCLEASES 1991-2003", "HN": "2004; use THYMINE DNA GLYCOSYLASE (NM) 1991-2003", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044502"}, {"RECTYPE": "D", "MH": "5-Methylcytosine", "DS": "METHYLCYTOSINE 05", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Monohydrochloride, 5-Methylcytosine", "MN": "D03.383.742.698.421.500", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "6R795CQT4H", "RR": "58366-64-6 (mono-HCl)", "PI": "Cytosine (1970-2003)", "MS": "A methylated nucleotide base found in eukaryotic DNA. In ANIMALS, the DNA METHYLATION of CYTOSINE to form 5-methylcytosine is found primarily in the palindromic sequence CpG. In PLANTS, the methylated sequence is CpNpGp, where N can be any base.", "PM": "2004; 5-METHYLCYTOSINE was indexed under CYTOSINE/AA 1976-2003, under CYTOSINE 1970-1975", "HN": "2004; use 5-METHYLCYTOSINE (NM) 1980-2003", "MR": "20160527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044503"}, {"RECTYPE": "D", "MH": "Enterocolitis, Neutropenic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neutropenic Enterocolitis|T047|NON|EQV|NLM (2004)|030131|abcdef", "MN": "C06.405.469.363.750", "FX": "Typhlitis", "MH_TH": "NLM (2004)", "ST": "T047", "PI": "Enterocolitis, Pseudomembranous (1976-2003)", "MS": "A syndrome characterized by inflammation in the ILEUM, the CECUM, and the ASCENDING COLON. It is observed in cancer patients with CHEMOTHERAPY-induced NEUTROPENIA or in other immunocompromised individuals (IMMUNOCOMPROMISED HOST).", "PM": "2004", "HN": "2004", "MR": "20190617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044504"}, {"RECTYPE": "D", "MH": "Characeae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.150.150", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid3146", "PI": "Plants (1968-1972)", "MS": "Family of slender threadlike aquatic plants, in the order CHARALES, phylum STREPTOPHYTA, that are closely related to LAND PLANTS.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044522"}, {"RECTYPE": "D", "MH": "Chrysophyta", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Golden Algae|T204|NON|EQV|NLM (2011)|091118|abcdef", "ENTRY": "Golden-Brown Algae", "MN": "B01.750.150", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid2825", "PI": "Algae (1969-2003)", "MS": "A family of microscopic freshwater EUKARYOTA, commonly known as golden algae. They share many features with the BROWN ALGAE but are planktonic rather than benthic. Though most are photosynthetic, they are not considered truly autotrophic since they can become facultatively heterotrophic in the absence of adequate light. In this state they can feed on BACTERIA or DIATOMS.", "PM": "2011; see ALGAE, GOLDEN-BROWN 2004-2010", "HN": "2011 (2004)", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044523"}, {"RECTYPE": "D", "MH": "LEOPARD Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Multiple Lentigines", "MN": "C17.800.621.430.530.550.525", "FX": "Noonan Syndrome", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "Syndrome (1971-2003)", "MS": "An autosomal dominant disorder with an acronym of its seven features (LENTIGO; ELECTROCARDIOGRAM abnormalities; ocular HYPERTELORISM; PULMONARY STENOSIS; abnormal genitalia; retardation of growth; and DEAFNESS or SENSORINEURAL HEARING LOSS). This syndrome is caused by mutations of PTPN11 gene encoding the non-receptor PROTEIN TYROSINE PHOSPHATASE, type 11, and is an allelic to NOONAN SYNDROME. Features of LEOPARD syndrome overlap with those of NEUROFIBROMATOSIS 1 which is caused by mutations in the NEUROFIBROMATOSIS 1 GENES.", "PM": "2004; see NEUROFIBROMATOSIS 1 2002 -2003", "HN": "2004; use NEUROFIBROMATOSIS 1 2002 -2003", "MR": "20190705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044542"}, {"RECTYPE": "D", "MH": "RNA, Ribosomal, Self-Splicing", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Self Splicing Ribosomal RNA", "MN": "D13.444.735.686.845", "MH_TH": "NLM (1991)", "ST": "T126", "RN": "0", "PI": "RNA, Catalytic (1991-2003)", "MS": "Components of ribosomal RNA that undergo auto-catalyzed molecular rearrangements of their RNA sequence.", "PM": "2004; see RNA, CATALYTIC 1991-2003", "HN": "2004; use RNA, CATALYTIC 1991-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044563"}, {"RECTYPE": "D", "MH": "Neuroendoscopes", "AQ": "AE CL EC HI MI PS SD SN ST TD VE VI", "ENTRY": "Neuroendoscope|T074|NON|EQV|NLM (2004)|030206|abcdef", "MN": "E07.858.240.707", "FX": "Neuroendoscopy", "MH_TH": "NLM (2004)", "ST": "T074", "PI": "Endoscopes (1990-2003)", "MS": "Instruments for the visual examination of interior structures related to NEUROSURGICAL PROCEDURES. There are two broad categories of neuroendoscopes, the rigid scope and the flexible scope, for various types of procedures.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044582"}, {"RECTYPE": "D", "MH": "Neuroendoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Neuroendoscopies", "MN": "E04.525.562", "FX": "Neuroendoscopes", "MH_TH": "NLM (2004)", "ST": "T061", "AN": "/ instrum permitted but consider also NEUROENDOSCOPES", "PI": "Endoscopy (1995-2003)", "MS": "PROCEDURES that use NEUROENDOSCOPES for disease diagnosis and treatment. Neuroendoscopy, generally an integration of the neuroendoscope with a computer-assisted NEURONAVIGATION system, provides guidance in NEUROSURGICAL PROCEDURES.", "PM": "2004", "HN": "2004", "MR": "20100625", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044583"}, {"RECTYPE": "D", "MH": "Carcinoma, Ductal", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Ductal Carcinomas", "MN": "C04.557.470.615.132", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coord IM with precoord organ/neopl term (IM); CARCINOMA, DUCTAL, BREAST and CARCINOMA, PANCREATIC DUCTAL are also available", "MS": "Malignant neoplasms involving the ductal systems of any of a number of organs, such as the MAMMARY GLANDS, the PANCREAS, the PROSTATE, or the LACRIMAL GLAND.", "PM": "2004, 1963-1993; see CARCINOMA, INFILTRATING DUCT 1994-2003", "HN": "2004, 1963-1993; use CARCINOMA, INFILTRATING DUCT 1994-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044584"}, {"RECTYPE": "D", "MH": "Cellulases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Laminarinase|T116|T126|NON|NRW|UNK (19XX)|741111|abbcdef", "ENTRY": "beta Glucosidases", "MN": "D08.811.277.450.420.200", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.2.1.-", "RR": "EC 3.2.1.91", "AN": "CELLULASE is also available", "PI": "Glucosidases (1966-2003)", "MS": "A family of glycosidases that hydrolyse crystalline CELLULOSE into soluble sugar molecules. Within this family there are a variety of enzyme subtypes with differing substrate specificities that must work together to bring about complete cellulose hydrolysis. They are found in structures called CELLULOSOMES.", "PM": "2004; for BETA-GLUCOSIDASES see BETA-GLUCOSIDASE 1991-2003; for LAMINARINASE use GLUCAN ENDO-1,3-BETA-GLUCOSIDASE 1974-2003; EXO-CELLULASE was indexed under CELLULASE 1991-2003; EXOCELLULASE was indexed under CELLULASE 2001-2003; AVICELASE was indexed under CELLULASE 1996-2003; AVICELASE II was indexed under CELLULASE 1997-2003", "HN": "2004; for BETA-GLUCOSIDASES use BETA-GLUCOSIDASE 1992-2003; for LAMINARINASE use GLUCAN ENDO-1,3-BETA-GLUCOSIDASE 1980-2003; for EXO-CELLULASE use CELLULOSE 1,4-BETA-CELLOBIOSIDASE (NM) 1991-2003; for EXOCELLULASE use CELLULOSE 1,4-BETA-CELLOBIOSIDASE (NM) 2001-2003; for AVICELASE use CELLULOSE 1,4-BETA-CELLOBIOSIDASE (NM) 1996-2003; for AVICELASE II use CELLULOSE 1,4-BETA-CELLOBIOSIDASE (NM) 1997-2003", "MR": "20130709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044602"}, {"RECTYPE": "D", "MH": "Cellulosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cellulosome", "MN": "A11.284.180.120", "MH_TH": "NLM (2004)", "ST": "T017", "MS": "Extracellular structures found in a variety of microorganisms. They contain CELLULASES and play an important role in the digestion of CELLULOSE.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044603"}, {"RECTYPE": "D", "MH": "Dental Pellicle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Salivary Pellicle|T031|NON|EQV|NLM (2004)|030210|abcdef", "ENTRY": "Pellicle, Salivary Acquired", "MN": "A14.549.167.900.255.500", "FX": "Salivary Proteins and Peptides", "MH_TH": "NLM (2004)", "ST": "T031", "MS": "A thin protein film on the surface of DENTAL ENAMEL. It is widely believed to result from the selective adsorption of precursor proteins present in SALIVA onto tooth surfaces, and to reduce microbial adherence to the TEETH.", "PM": "2004", "HN": "2004", "MR": "20080710", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044622"}, {"RECTYPE": "D", "MH": "Nutrition Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Medical Nutrition Therapy|T061|NON|NRW|NLM (2004)|030210|abcdef", "ENTRY": "Therapy, Nutrition", "MN": "E02.642", "MH_TH": "NLM (2004)", "ST": "T061", "AN": "general or unspecified; prefer specifics", "PI": "Nutrition (1974-2003)", "MS": "Improving health status of an individual by adjusting the quantities, qualities, and methods of nutrient intake.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044623"}, {"RECTYPE": "D", "MH": "Glucan 1,4-beta-Glucosidase", "DS": "GLUCAN BETA GLUCOSIDASE 01 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glucohydrolase, 1,4-beta-D-Glucan", "MN": "D08.811.277.450.420.200.550", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.2.1.74", "RR": "37288-52-1 (CRN)", "PI": "beta-Glucosidase (1981-2003)", "MS": "An exocellulase with specificity for the hydrolysis of 1,4-beta-glucosidic linkages of 1,4-beta-D-glucans resulting in successive removal of GLUCOSE units.", "PM": "2004; EXO-1,4-BETA-GLUCOSIDASE was indexed under BETA-GLUCOSIDASE 1981-2003", "HN": "2004; use EXO-1,4-BETA-GLUCOSIDASE (NM) 1981-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044643"}, {"RECTYPE": "D", "MH": "Endo-1,3(4)-beta-Glucanase", "DS": "ENDO BETA GLUCANASE 01 03 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Endo-1,3(4)-B-Glucanase|T116|T126|NON|EQV|NLM (2004)|030210|abbcdef", "ENTRY": "endo-1,3(4)-beta-D-glucanase|T116|T126|NON|EQV|NLM (2005)|abbcde", "MN": "D08.811.277.450.420.200.450", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.2.1.6", "MS": "An endocellulase with specificity for the hydrolysis of 1,3- or 1,4-linkages in beta-D-glucans. This enzyme specifically acts on sites where reducing glucose residues are substituted at the 3 position.", "PM": "2004; ENDO-1,3(4)-BETA-D-GLUCANASE was indexed under GLYCOSIDE HYDROLASES 1993-2003", "HN": "2004", "MR": "20040707", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044644"}, {"RECTYPE": "D", "MH": "Fucus", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Fucus serratus|T204|NON|NRW|NLM (2024)|230322|abcdef", "ENTRY": "Fucus vesiculosus|T204|NON|NRW|NLM (2015)|140213|abcdef", "MN": "B01.750.600.425.250", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid3011", "RR": "txid87148", "PI": "Algae (1965-2003)", "MS": "A genus of BROWN ALGAE in the family Fucaceae. It is found in temperate, marine intertidal areas along rocky coasts and is a source of ALGINATES. Some species of Fucus are referred to as KELP.", "PM": "2004", "HN": "2004", "MR": "20230606", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044645"}, {"RECTYPE": "D", "MH": "Ascophyllum", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Ascophyllum nodosum|T204|NON|NRW|NLM (2024)|230322|abcdef", "MN": "B01.750.600.040", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid52968", "RR": "txid52969", "PI": "Algae (1969-2003)", "MS": "A BROWN ALGAE closely related to FUCUS. It is found attached to rocks and boulders in the middle shore, primarily in the North Atlantic basin.", "PM": "2004", "HN": "2004", "MR": "20230531", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044646"}, {"RECTYPE": "D", "MH": "Sargassum", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.750.600.725", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid3015", "PI": "Seaweed (1974-2003)", "MS": "One of the largest genera of BROWN ALGAE, comprised of more than 150 species found in tropical, subtropical, and temperate zones of both hemispheres. Some species are attached (benthic) but most float in the open sea (pelagic). Sargassum provides a critical habitat for hundreds of species of FISHES; TURTLES; and INVERTEBRATES.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044647"}, {"RECTYPE": "D", "MH": "Undaria", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.750.600.800", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid74380", "PI": "Seaweed (1970-2003)", "MS": "A genus of BROWN ALGAE, in the family Alariaceae, native to Japan, Korea, and China. The edible SEAWEED Undaria pinnatifida is also called wakame.", "PM": "2004", "HN": "2004", "MR": "20230605", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044648"}, {"RECTYPE": "D", "MH": "Macrocystis", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Kelp, Giant|T204|NON|NRW|NLM (2004)|030212|abcdef", "ENTRY": "Giant Kelps", "MN": "B01.750.600.425.750", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid35121", "RR": "txid35122", "MS": "A genus of BROWN ALGAE in the family Lessoniaceae, and one of the major forms of KELP. The species Macrocystis pyrifera, also known as giant kelp, is the largest of the marine algae.", "PM": "2004", "HN": "2004", "MR": "20230606", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044662"}, {"RECTYPE": "D", "MH": "Ochromonas", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Ochromona", "MN": "B01.750.150.600", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid2985", "PI": "Mastigophora (1965-1985)", "MS": "A genus of GOLDEN-BROWN ALGAE in the family Ochromonadaceae, found mostly in freshwater. They bear two unequal FLAGELLA and are heterotrophic.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044663"}, {"RECTYPE": "D", "MH": "Porphyra", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B05.080.750.225.937", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid2784", "PI": "Algae, Red (1976-2003)", "MS": "A genus of RED ALGAE in the family Bangiaceae. It is the most widely consumed SEAWEED in the world and especially in Asia.", "PM": "2004", "HN": "2004", "MR": "20230606", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044664"}, {"RECTYPE": "D", "MH": "Porphyridium", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Porphyridiums", "MN": "B01.715.610", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid2791", "PI": "Algae, Red (1971-2003)", "MS": "A genus of RED ALGAE in the family Porphyridiaceae. A single stellate CHLOROPLAST is present in each cell which has no CELL WALL.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044665"}, {"RECTYPE": "D", "MH": "Colon, Ascending", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Flexure, Hepatic", "MN": "A03.556.249.249.356.333", "MH_TH": "NLM (2004)", "ST": "T023", "PI": "Colonic Diseases (1965-2003)", "MS": "The segment of LARGE INTESTINE between the CECUM and the TRANSVERSE COLON. It passes cephalad from the cecum to the caudal surface of the right lobe of the LIVER where it bends sharply to the left, forming the right colic flexure.", "PM": "2004", "HN": "2004", "MR": "20170418", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044682"}, {"RECTYPE": "D", "MH": "Colon, Descending", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Descending Colon|T023|NON|EQV|NLM (2004)|021219|abcdef", "MN": "A03.556.249.249.356.500", "MH_TH": "NLM (2004)", "ST": "T023", "PI": "Colonic Diseases (1964-2003)", "MS": "The segment of LARGE INTESTINE between TRANSVERSE COLON and the SIGMOID COLON.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044683"}, {"RECTYPE": "D", "MH": "Colon, Transverse", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Flexure, Splenic", "MN": "A03.556.249.249.356.834", "MH_TH": "NLM (2004)", "ST": "T023", "PI": "Colonic Diseases (1964-2003)", "MS": "The segment of LARGE INTESTINE between ASCENDING COLON and DESCENDING COLON. It passes from the RIGHT COLIC FLEXURE across the ABDOMEN, then turns sharply at the left colonic flexure into the descending colon.", "PM": "2004", "HN": "2004", "MR": "20050630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044684"}, {"RECTYPE": "D", "MH": "DNA, A-Form", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DNA, A Form", "MN": "G05.360.580.114", "FX": "Nucleic Acid Conformation", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "DNA (1985-2003)", "MS": "An isoform of DNA that occurs in an environment rich in SODIUM and POTASSIUM ions. It is a right-handed helix with 11 base pairs per turn, a pitch of 0.256 nm per base pair and a helical diameter of 2.3 nm.", "PM": "2004; see DNA 1986-2003", "HN": "2004; use DNA 1986-2003", "MR": "20150622", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044704"}, {"RECTYPE": "D", "MH": "DNA, C-Form", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DNA, C Form", "MN": "G05.360.580.128", "FX": "Nucleic Acid Conformation", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "DNA (1986-2003)", "MS": "An isoform of DNA that occurs under experimental conditions. It is a right-handed helix that is less compact than the B-form of DNA.", "PM": "2004", "HN": "2004", "MR": "20150622", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044705"}, {"RECTYPE": "D", "MH": "Forensic Sciences", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Forensic Mathematics|T090|NON|NRW|NLM (2024)|230504|abcdef", "ENTRY": "Science, Forensic", "MN": "I01.198.780", "MH_TH": "NLM (2004)", "ST": "T090", "PI": "Forensic Medicine (1965-2003)", "MS": "Disciplines that apply sciences to law. Forensic sciences include a wide range of disciplines, such as FORENSIC TOXICOLOGY; FORENSIC ANTHROPOLOGY; FORENSIC MEDICINE; FORENSIC DENTISTRY; and others.", "PM": "2004", "HN": "2004", "MR": "20230531", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044707"}, {"RECTYPE": "D", "MH": "DNA, Concatenated", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DNA, Concatemers|T114|ACX|EQV|NLM (2004)|030224|abcdef", "MN": "G05.360.580.212", "FX": "Tandem Repeat Sequences", "MH_TH": "NLM (2004)", "ST": "T114", "RN": "0", "AN": "coord with specific DNA source; DNA, CATENATED is also available", "MS": "Head to tail array of covalently joined DNA sequences generated by concatenation. Concatenated DNA is attached end to end in contrast to CATENATED DNA which is attached loop to loop.", "PM": "2004", "HN": "2004", "MR": "20150622", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044708"}, {"RECTYPE": "D", "MH": "Forensic Ballistics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Ballistics, Wound|T090|NON|NRW|UNK (19XX)|860623|abcdef", "ENTRY": "Wound Ballistics", "MN": "I01.198.780.760", "FX": "Wounds, Gunshot", "MH_TH": "NLM (2004)", "ST": "T090", "PI": "Wounds, Gunshot (1966-2003)", "MS": "The science of studying projectiles in motion, ballistics, being applied to law. Ballistics on firearm projectiles, such as bullets, include the study of what happens inside the weapon, during the flight of the projectile, and when the projectile strikes the target, such as body tissue.", "PM": "2004; for BALLISTICS, WOUND use WOUNDS, GUNSHOT 1987-2003", "HN": "2004; for BALLISTICS, WOUND see WOUNDS, GUNSHOT 1987-2003", "MR": "20101208", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044709"}, {"RECTYPE": "D", "MH": "Laurencia", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Laurencias", "MN": "B01.715.500", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid99900", "PI": "Algae, Red (1973-2003)", "MS": "A genus of RED ALGAE in the family Rhodomelaceae. Some species are a rich source of chlorine-and bromine-containing metabolites which show significant antibacterial activity.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044722"}, {"RECTYPE": "D", "MH": "Chondrus", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Moss, Irish|T204|NON|NRW|NLM (2004)|030314|abcdef", "ENTRY": "Mosses, Irish", "MN": "B01.715.150", "FX": "Edible Seaweeds", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid2768", "RR": "txid2769", "PI": "Algae, Red (1973-2003)", "MS": "A genus of RED ALGAE, in the family Gigartinaceae. The species Chondrus crispus is a source of CARRAGEENAN.", "PM": "2004", "HN": "2004", "MR": "20230606", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044723"}, {"RECTYPE": "D", "MH": "Gracilaria", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B05.080.750.225.469", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid2774", "PI": "Algae, Red (1976-2003)", "MS": "A genus of RED ALGAE in the family Gracilariaceae. It is a highly commercial SEAWEED and a source of AGAR.", "PM": "2004", "HN": "2004", "MR": "20230606", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044724"}, {"RECTYPE": "D", "MH": "Plocamium", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Plocamiums", "MN": "B01.715.585", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid31451", "PI": "Algae, Red (1977-2003)", "MS": "A genus of RED ALGAE, in the family Plocamiaceae, found in temperate marine environments worldwide. Polyhalogenated monoterpenes of potential medicinal use have been isolated from its species.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044725"}, {"RECTYPE": "D", "MH": "Lagenidium", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Lagenidiums", "MN": "B01.750.580.500", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid4802", "AN": "infection: coordinate IM with INFECTION (IM)", "PI": "Oomycetes (1983-2003)", "MS": "A genus of OOMYCETES in the family Lagenidiaceae. One species (L. giganteum) parasitizes the larval stage of MOSQUITOES and is used in its biological control (PEST CONTROL, BIOLOGICAL); it also causes disease in freshwater FISHES.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044726"}, {"RECTYPE": "D", "MH": "Peronospora", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Peronosporas", "MN": "B01.750.580.710", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid70742", "PI": "Oomycetes (1978-2003)", "MS": "A genus of OOMYCETES in the family Peronosporaceae. Most species are obligatory parasites and many are plant pathogens.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044742"}, {"RECTYPE": "D", "MH": "Achlya", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Achlyas", "MN": "B01.750.580.050", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid4765", "AN": "infection: coordinate IM with INFECTION (IM)", "PI": "Oomycetes (1975-2003)", "MS": "A genus of OOMYCETES in the family Saprolegniaceae. They are pathogens of FISHES and INSECTS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044743"}, {"RECTYPE": "D", "MH": "Aphanomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Aphanomyce", "MN": "B01.750.580.075", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid100860", "AN": "infection: coordinate IM with INFECTION (IM)", "PI": "Oomycetes (1978-2003)", "MS": "A genus of OOMYCETES in the family Saprolegniaceae. It causes root rot in plants and is also a pathogen of FISHES.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044744"}, {"RECTYPE": "D", "MH": "Saprolegnia", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Saprolegnias", "MN": "B01.750.580.825", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid4769", "AN": "infection: coordinate with INFECTIONS", "PI": "Oomycetes (1977-2003)", "MS": "A genus of OOMYCETES in the family Saprolegniaceae. It is a parasite and pathogen of freshwater FISHES.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044762"}, {"RECTYPE": "D", "MH": "Ubiquitin-Conjugating Enzymes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ubiquitin-Conjugating Enzyme|T116|T126|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Ubiquitin Conjugating Enzymes", "MN": "D08.811.464.938.500", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.3.2.23", "RR": "EC 2.3.2.23", "PI": "Ubiquitins (1986-1988)", "MS": "A class of enzymes that form a thioester bond to UBIQUITIN with the assistance of UBIQUITIN-ACTIVATING ENZYMES. They transfer ubiquitin to the LYSINE of a substrate protein with the assistance of UBIQUITIN-PROTEIN LIGASES.", "PM": "2004; UBIQUITIN-CONJUGATING ENZYME E2 ( UBIQUITIN-CONJUGATING ENZYMES) was indexed under LIGASES (1990-2003); HHR6 PROTEIN was indexed under LIGASES 1996-2003", "HN": "2004; use UBIQUITIN-CONJUGATING ENZYMES (NM) 1990-2003", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044763"}, {"RECTYPE": "D", "MH": "Ubiquitin-Activating Enzymes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ubiquitin Activating Enzymes", "MN": "D08.811.464.938.249", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 6.2.1.45", "PI": "Ligases (1983-2003)", "MS": "A class of enzymes that catalyzes the ATP-dependent formation of a thioester bond between itself and UBIQUITIN. It then transfers the activated ubiquitin to one of the UBIQUITIN-PROTEIN LIGASES.", "PM": "2004; UBIQUITIN-ACTIVATING ENZYME was indexed under LIGASES 1983-2003", "HN": "2004; use UBIQUITIN-ACTIVATING ENZYMES (NM) 1983-2003", "MR": "20160602", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044764"}, {"RECTYPE": "D", "MH": "Ubiquitin-Protein Ligases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ubiquitin-Protein Ligase|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Ubiquitin Protein Ligases", "MN": "D08.811.464.938.750", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.3.2.27", "RR": "EC 2.3.2.26", "AN": "UBIQUITIN-PROTEIN LIGASE COMPLEXES is also available", "PI": "Ligases (1983-2003)", "MS": "A diverse class of enzymes that interact with UBIQUITIN-CONJUGATING ENZYMES and ubiquitination-specific protein substrates. Each member of this enzyme group has its own distinct specificity for a substrate and ubiquitin-conjugating enzyme. Ubiquitin-protein ligases exist as both monomeric proteins multiprotein complexes.", "PM": "2004; UBIQUITIN-PROTEIN LIGASE was indexed under LIGASES 1983-2003; E3 UBIQUITIN LIGASE was indexed under LIGASES 1993-2003", "HN": "2004; use UBIQUITIN-PROTEIN LIGASE (NM) 1983-2003", "MR": "20160602", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044767"}, {"RECTYPE": "D", "MH": "F-Box Motifs", "AQ": "DE GE IM PH RE", "ENTRY": "Motifs, F-Box", "MN": "G02.111.570.820.709.275.500.205", "FX": "F-Box Proteins", "MH_TH": "NLM (2004)", "ST": "T087", "MS": "Protein structural motifs that play a role in protein-protein binding. The motifs are comprised of approximately 50 residues. Their name derives from the fact that they were found in cyclin F.", "PM": "2004", "HN": "2004", "MR": "20160527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044782"}, {"RECTYPE": "D", "MH": "F-Box Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "F-Box Protein|T116|NON|EQV|NLM (2021)|200210|abcdef", "ENTRY": "Protein, F-Box Domain", "MN": "D12.776.157.169", "FX": "F-Box Motifs", "MH_TH": "NLM (2004)", "ST": "T116", "RN": "0", "MS": "A family of proteins that share the F-BOX MOTIF and are involved in protein-protein interactions. They play an important role in the process of protein ubiquition by associating with a variety of substrates and then associating into SCF UBIQUITIN LIGASE complexes. They are held in the ubiquitin-ligase complex via binding to SKP DOMAIN PROTEINS.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044783"}, {"RECTYPE": "D", "MH": "Chara", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Charas", "MN": "B01.875.800.150.150.150", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid13778", "PI": "Plants (1969-2003)", "MS": "A genus of green plants in the family CHARACEAE, phylum STREPTOPHYTA. They have a strong garlic-like odor and are an important food source for waterfowl.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044784"}, {"RECTYPE": "D", "MH": "Cryptophyta", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Cryptomonas|T204|NON|NRW|NLM (2004)|030228|abcdef", "ENTRY": "Cryptophytas", "MN": "B01.206", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid3027", "RR": "txid3030", "PI": "Algae (1975-2003)", "MS": "A class of EUKARYOTA (traditionally algae), characterized by biflagellated cells and found in both freshwater and marine environments. Pigmentation varies but only one CHLOROPLAST is present. Unique structures include a nucleomorph and ejectosomes.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044785"}, {"RECTYPE": "D", "MH": "S-Phase Kinase-Associated Proteins", "DE": "S PHASE KINASE ASSOC PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SKP2, p45", "MN": "D12.776.157.743", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Ligases (1983-2003)", "MS": "A family of structurally-related proteins that were originally identified by their ability to complex with cyclin proteins (CYCLINS). They share a common domain that binds specifically to F-BOX MOTIFS. They take part in SKP CULLIN F-BOX PROTEIN LIGASES, where they can bind to a variety of F-BOX PROTEINS.", "PM": "2004; P19(SKP1)PROTEIN and P45(SKP)PROTEIN were indexed under CELL CYCLE PROTEINS 1995-2003", "HN": "2004; use S-PHASE KINASE ASSOCIATED PROTEINS (NM) 1983-2003; for P19(SKP1)PROTEIN and P45(SKP) PROTEIN use S-PHASE KINASE ASSOCIATED PROTEINS (NM) 1995-2003; for P45(SKP) use UBIQUITIN-PROTEIN LIGASES (NM) 1999-2003", "MR": "20050630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044786"}, {"RECTYPE": "D", "MH": "Euglena longa", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Astasia longa|T204|NON|EQV|NLM (2004)|030228|abcdef", "ENTRY": "Genus Astasia|T204|NON|BRD|NLM (2019)|180227|abcdef", "MN": "B01.268.250.320.500", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid3037", "RR": "txid3036", "AN": "infection; coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A species of EUKARYOTES in the phylum EUGLENIDA. It is a colorless heterotrophic flagellate.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044802"}, {"RECTYPE": "D", "MH": "Biodiversity", "PRINT ENTRY": "Biological Diversity|T080|NON|EQV|NLM (2004)|030303|abcdef", "ENTRY": "Diversity, Biological", "MN": "N06.230.124.049", "MH_TH": "NLM (1996)", "ST": "T080", "MS": "The variety of all native living organisms and their various forms and interrelationships.", "PM": "2004; see ECOSYSTEM 1996-2003", "HN": "2004; use ECOSYSTEM 1996-2003", "MR": "20100625", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044822"}, {"RECTYPE": "D", "MH": "Cullin Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cullin|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Cullins|T116|T123|NON|EQV|NLM (2004)|030303|abbcdef", "MN": "D12.776.167.175", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "MS": "A family of structurally related proteins that were originally discovered for their role in cell-cycle regulation in CAENORHABDITIS ELEGANS. They play important roles in regulation of the CELL CYCLE and as components of UBIQUITIN-PROTEIN LIGASES.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044842"}, {"RECTYPE": "D", "MH": "SKP Cullin F-Box Protein Ligases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SCF Ubiquitin Ligase|T116|T126|ABX|EQV|NLM (2004)|abbcde", "ENTRY": "Ubiquitin Ligases, SKP1-Cullin", "MN": "D08.811.464.938.750.750", "FX": "S-Phase Kinase-Associated Proteins", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.3.2.27", "RR": "EC 2.3.2.27", "PI": "Peptide Synthases (1999-2003)", "MS": "A subset of ubiquitin protein ligases that are formed by the association of a SKP DOMAIN PROTEIN, a CULLIN DOMAIN PROTEIN and a F-BOX DOMAIN PROTEIN.", "PM": "2004; SCF UBIQUITIN LIGASE (now SKP CULLIN F-BOX LIGASES) was indexed under PEPTIDE SYNTHASES 1999-2003", "HN": "2004; use SKP CULLIN F-BOX LIGASES (NM) 1999-2003", "MR": "20160602", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044843"}, {"RECTYPE": "D", "MH": "beta-Transducin Repeat-Containing Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Transducin Repeat Containing Proteins", "MN": "D12.776.157.169.500", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "AN": "see SCR for organism specific terms", "MS": "A family of F-box domain proteins that contain sequences that are homologous to the beta subunit of transducin (BETA-TRANSDUCIN). They play an important role in the protein degradation pathway by becoming components of SKP CULLIN F-BOX PROTEIN LIGASES, which selectively act on a subset of proteins including beta-catenin and IkappaBbeta.", "PM": "2004", "HN": "2004", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044844"}, {"RECTYPE": "D", "MH": "Campylobacter hyointestinalis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.150.235.250.500.297", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid198", "AN": "infection: coord IM with CAMPYLOBACTER INFECTIONS (IM)", "PI": "Campylobacter (1983-2003)", "MS": "A species of CAMPYLOBACTER isolated from the INTESTINES of PIGS with proliferative ENTERITIS. It is also found in CATTLE and in CRICETINAE and can cause enteritis in humans.", "PM": "2005; see CAMPYLOBACTER HYOINTESTINAL 2004", "HN": "2005 (2004)", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044862"}, {"RECTYPE": "D", "MH": "Campylobacter lari", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Campylobacter laridis|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.150.235.250.500.450", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid201", "AN": "infection: coord IM with CAMPYLOBACTER INFECTIONS (IM)", "PI": "Campylobacter (1984-2003)", "MS": "A species of thermophilic CAMPYLOBACTER found in healthy seagulls and causing ENTERITIS in humans.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044863"}, {"RECTYPE": "D", "MH": "Glucose Metabolism Disorders", "DE": "GLUCOSE METAB DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Metabolism Disorders, Glucose", "MN": "C18.452.394", "MH_TH": "NLM (2004)", "ST": "T047", "PI": "Glucose (1965-2003)", "MS": "Pathological conditions in which the BLOOD GLUCOSE cannot be maintained within the normal range, such as in HYPOGLYCEMIA and HYPERGLYCEMIA. Etiology of these disorders varies. Plasma glucose concentration is critical to survival for it is the predominant fuel for the CENTRAL NERVOUS SYSTEM.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044882"}, {"RECTYPE": "D", "MH": "Campylobacter rectus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Wolinella recta|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.150.235.250.500.700", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid203", "AN": "infection: coordinate with CAMPYLOBACTER INFECTIONS", "PI": "Campylobacter (1992-2003)", "MS": "A species of CAMPYLOBACTER isolated from cases of human PERIODONTITIS. It is a microaerophile, capable of respiring with OXYGEN.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044883"}, {"RECTYPE": "D", "MH": "Campylobacter sputorum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Vibrio sputorum|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.150.235.250.500.740", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid206", "AN": "infection: coord IM with CAMPYLOBACTER INFECTIONS (IM)", "PI": "Campylobacter (1975-2003)", "MS": "A species of CAMPYLOBACTER comprised of three biovars based on their reaction to CATALASE and UREASE. They have been isolated from humans, CATTLE, and SHEEP.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044884"}, {"RECTYPE": "D", "MH": "Campylobacter upsaliensis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.150.235.250.500.850", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid28080", "AN": "infection: coord IM with CAMPYLOBACTER INFECTIONS (IM)", "PI": "Campylobacter (1989-2003)", "MS": "A species of CAMPYLOBACTER isolated from DOGS; CATS; and humans.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044885"}, {"RECTYPE": "D", "MH": "beta-Mannosidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-D-Mannosidase|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "beta Mannosidase", "MN": "D08.811.277.450.625.750", "FX": "beta-Mannosidosis", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.2.1.25", "RR": "9025-43-8 (CRN)", "AN": "/defic: consider also BETA-MANNOSIDOSIS", "PI": "Mannosidases (1980-2003)", "MS": "An enzyme that catalyzes the hydrolysis of terminal, non-reducing beta-D-mannose residues in beta-D-mannosides. The enzyme plays a role in the lysosomal degradation of the N-glycosylprotein glycans. Defects in the lysosomal form of the enzyme in humans result in a buildup of mannoside intermediate metabolites and the disease BETA-MANNOSIDOSIS.", "PM": "2004; BETA-MANNOSIDASE was indexed under MANNOSIDASES 1980-2003", "HN": "2004; use BETA-MANNOSIDASE (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044902"}, {"RECTYPE": "D", "MH": "Congenital Hyperinsulinism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Persistent Hyperinsulinemia Hypoglycemia of Infancy|T047|NON|EQV|GHR (2014)|NLM (2004)|030306|abcdeef", "ENTRY": "Persistent Hyperinsulinemic Hypoglycemias", "MN": "C18.452.394.984.200", "FX": "Potassium Channels, Inwardly Rectifying", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Hypoglycemia (1977-2003)", "MS": "A familial, nontransient HYPOGLYCEMIA with defects in negative feedback of GLUCOSE-regulated INSULIN release. Clinical phenotypes include HYPOGLYCEMIA; HYPERINSULINEMIA; SEIZURES; COMA; and often large BIRTH WEIGHT. Several sub-types exist with the most common, type 1, associated with mutations on an ATP-BINDING CASSETTE TRANSPORTERS (subfamily C, member 8).", "PM": "2014; see PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY 2004-2013", "HN": "2014(2004)", "MR": "20130708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044903"}, {"RECTYPE": "D", "MH": "Mannosidase Deficiency Diseases", "DE": "MANNOSIDASE DEFIC DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mannosidosis|T047|NON|EQV|GHR (2014)|NLM (1985)|990101|abcdeef", "ENTRY": "Mannosidoses", "MN": "C18.452.648.595.577", "FX": "Mannosidases", "MH_TH": "NLM (2004)", "ST": "T047", "PI": "Mannosidosis (1984-2003)", "MS": "Diseases caused by the loss of one or more enzymes involved in the hydrolysis of mannoside linkages (MANNOSIDASES). The defects in enzyme activity are primarily associated with genetic mutation of the genes that codes for a particular mannosidase isoenzyme.", "PM": "2004; see MANNOSIDOSIS 1984-2003", "HN": "2004; use MANNOSIDOSIS, ALPHA B, LYSOSOMAL 1984-2003", "MR": "20130708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044904"}, {"RECTYPE": "D", "MH": "beta-Mannosidosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mannosidosis, beta A, Lysosomal|T047|NON|EQV|NLM (2004)|OMIM (2013)|ORD (2010)|030307|abcdeeef", "ENTRY": "beta-Mannosidoses", "MN": "C18.452.648.595.577.750", "FX": "beta-Mannosidase", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Mannosidase Deficiency Diseases (1984-2003)", "MS": "An inborn error of metabolism marked by a defect in the lysosomal isoform of BETA-MANNOSIDASE that results in lysosomal accumulation of mannose-rich intermediate metabolites containing 1,4-beta linkages. The human disease occurs through autosomal recessive inheritance and manifests in the form of a variety of symptoms that depend upon the type of gene mutation.", "PM": "2004", "HN": "2004", "MR": "20181102", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044905"}, {"RECTYPE": "D", "MH": "Helicobacter felis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.150.235.500.250.350", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid214", "AN": "infection: coordinate with HELICOBACTER INFECTIONS", "PI": "Helicobacter (1992-2003)", "MS": "A species of HELICOBACTER that colonizes in the STOMACH of laboratory MICE; CATS; and DOGS. It is associated with lymphoid follicular hyperplasia and mild GASTRITIS in CATS.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044922"}, {"RECTYPE": "D", "MH": "Helicobacter hepaticus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.150.235.500.250.410", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid32025", "AN": "infection: coordinate with HELICOBACTER INFECTIONS", "PI": "Helicobacter (1994-2003)", "MS": "A species of HELICOBACTER that colonizes the CECUM and COLON of several strains of MICE, and is associated with HEPATITIS and carcinogenesis.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044923"}, {"RECTYPE": "D", "MH": "Oxidoreductases Acting on CH-CH Group Donors", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidoreductases Acting on CH CH Group Donors", "MN": "D08.811.682.660", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.3.-", "AN": "general or unspecified; prefer specifics", "PI": "Oxidoreductases (1963-2003)", "MS": "A subclass of enzymes which includes all dehydrogenases acting on carbon-carbon bonds. This enzyme group includes all the enzymes that introduce double bonds into substrates by direct dehydrogenation of carbon-carbon single bonds.", "PM": "2004", "HN": "2004", "MR": "20050630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044925"}, {"RECTYPE": "D", "MH": "Butyryl-CoA Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Short Chain Acyl CoA Dehydrogenase", "MN": "D12.776.331.174", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.3.8.1", "RR": "EC 1.3.8.1", "PI": "Oxidoreductases (1974-2003)", "MS": "A flavoprotein oxidoreductase that has specificity for short-chain fatty acids. It forms a complex with ELECTRON-TRANSFERRING FLAVOPROTEINS and conveys reducing equivalents to UBIQUINONE.", "PM": "2004; BUTYL-CAO DEHYDROGENASE was indexed under FATTY ACID DESATURASES 1980-2003; under OXIDOREDUCTASES 1974-1978; under BUTYRATES 1974-1980 & under COENZYME A 1974-1978; SHORT-CHAIN ACETYL-COA DEHYDROGENASE was indexed under FATTY ACID DESATURASES 1981-2003", "HN": "2004; use BUTYRYL-COA DEHYDROGENASE (NM) 1980-2003, for SHORT-CHAIN ACETYL-COA DEHYDROGENASE use ACYL-COA DEHYDROGENASE (NM) 1981-2003", "MR": "20120703", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044926"}, {"RECTYPE": "D", "MH": "Electron-Transferring Flavoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transfer Flavoprotein, Electron", "MN": "D12.776.543.277.500", "FX": "Electron Transport", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Flavoproteins (1983-2003)", "MS": "Flavoproteins that serve as specific electron acceptors for a variety of DEHYDROGENASES. They participate in the transfer of electrons to a variety of redox acceptors that occur in the respiratory chain.", "PM": "2004; ELECTRON-TRANSFERRING FLAVOPROTEINS was indexed under FLAVOPROTEINS 1983-2003", "HN": "2004; use ELECTRON-TRANSFERRING FLAVOPROTEINS (NM) 1983-2003", "MR": "20110624", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044927"}, {"RECTYPE": "D", "MH": "Acyl-CoA Dehydrogenase, Long-Chain", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Long-Chain-Acyl-CoA Dehydrogenase|T116|T126|ABX|EQV|NLM (2004)|abbcde", "ENTRY": "Very Long Chain Acyl CoA Dehydrogenase", "MN": "D12.776.331.102", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.3.8.8", "RR": "EC 1.3.8.8", "AN": "ACYL-COA DEHYDROGENASE is also available", "PI": "Fatty Acid Desaturases (1988-2003)", "MS": "A flavoprotein oxidoreductase that has specificity for long-chain fatty acids. It forms a complex with ELECTRON-TRANSFERRING FLAVOPROTEINS and conveys reducing equivalents to UBIQUINONE.", "PM": "2004; LONG-CHAIN-ACYL-COA DEHYDROGENASE was indexed under FATTY ACID DESATURASES 1988-2003; for DECONOYL COA DEHYDROGENASE see FATTY ACID DESATURASES 1990-2003", "HN": "2004; use LONG-CHAIN-ACYL-COA DEHYDROGENASE (NM) 1988-2003; for DECONOYL COA DEHYDROGENASE use LONG-CHAIN-ACYL-COA DEHYDROGENASE 1990-2003", "MR": "20130708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044942"}, {"RECTYPE": "D", "MH": "Fatty Acid Desaturases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fatty Acid Desaturating Enzymes|T116|T126|NON|EQV|NLM (2004)|030311|abbcdef", "ENTRY": "Reductases, Enoyl CoA", "MN": "D08.811.682.690.708.392", "MH_TH": "NLM (1974)", "ST": "T126", "RN": "EC 1.14.19.-", "PI": "Fatty Acid Desaturases (1974-2003)", "MS": "A family of enzymes that catalyze the stereoselective, regioselective, or chemoselective syn-dehydrogenation reactions. They function by a mechanism that is linked directly to reduction of molecular OXYGEN.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044943"}, {"RECTYPE": "D", "MH": "Acyl-CoA Dehydrogenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenases, Acyl-CoA", "MN": "D08.811.682.660.150", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 1.3.-", "AN": "ACYL-COA DEHYDROGENASE and other specifics are also available", "PI": "Fatty Acid Desaturases (1977-2003)", "MS": "Enzymes that catalyze the first step in the beta-oxidation of FATTY ACIDS.", "PM": "2004; see FATTY ACID DESATURASES 1977-2003", "HN": "2004; use FATTY ACID DESATURASES 1977-2003", "MR": "20050630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044944"}, {"RECTYPE": "D", "MH": "Proanthocyanidins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tannin, Condensed|T109|T121|NON|EQV|NLM (2004)|030625|abbcdef", "ENTRY": "Tannins, Condensed", "MN": "D05.750.078.937.429", "MH_TH": "NLM (2004)", "ST": "T121", "RN": "0", "PI": "Anthocyanidins (1977-2003)", "MS": "Dimers and oligomers of flavan-3-ol units (CATECHIN analogs) linked mainly through C4 to C8 bonds to leucoanthocyanidins. They are structurally similar to ANTHOCYANINS but are the result of a different fork in biosynthetic pathways.", "PM": "2004; PROANTHOCYANIDINS was indexed under ANTHOCYANIDINS 1977-2003", "HN": "2004; use PROANTHOCYANIDIN (NM) 1977-2003", "MR": "20160531", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044945"}, {"RECTYPE": "D", "MH": "Biflavonoids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Biflavonoid|T109|T121|NON|EQV|NLM (2021)|200129|abbcdef", "MN": "D03.633.100.150.266.450.190", "MH_TH": "NLM (2004)", "ST": "T121", "RN": "0", "PI": "Flavones (1970-2003)", "MS": "Dimers (homo and hetero) of FLAVONOIDS.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044946"}, {"RECTYPE": "D", "MH": "Flavonolignans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.633.100.150.266.450.268", "MH_TH": "NLM (2004)", "ST": "T121", "RN": "0", "PI": "Flavones (1974-2003)", "MS": "Heterodimers of FLAVONOIDS bound to LIGNANS.", "PM": "2004", "HN": "2004", "MR": "20160531", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044947"}, {"RECTYPE": "D", "MH": "Flavonols", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "3 hydroxy 4 keto Flavonoids", "MN": "D03.633.100.150.266.450.284", "MH_TH": "NLM (2004)", "ST": "T121", "RN": "0", "MS": "A group of 3-hydroxy-4-keto-FLAVONOIDS.", "PM": "2004; FLAVONOLS was indexed under FLAVONES 1977-2003", "HN": "2004; for FLAVONOLS use FLAVONOLS (NM) 1977-2003", "MR": "20160531", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044948"}, {"RECTYPE": "D", "MH": "Kaempferols", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.633.100.150.266.450.284.388", "MH_TH": "NLM (2004)", "ST": "T121", "RN": "0", "PI": "Flavones (1969-2003)", "MS": "A group of FLAVONOLS based on kaempferol. They are derived from naringenin and can be hydroxylated to QUERCETIN or reduced to leucopelargonidin.", "PM": "2004", "HN": "2004", "MR": "20160531", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044949"}, {"RECTYPE": "D", "MH": "Flavanones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "2 Phenyl Benzopyran 4 Ones", "MN": "D03.633.100.150.266.450.252", "MH_TH": "NLM (2004)", "ST": "T121", "RN": "0", "PI": "Flavones (1965-2003)", "MS": "A group of FLAVONOIDS characterized with a 4-ketone.", "PM": "2004", "HN": "2004", "MR": "20160531", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044950"}, {"RECTYPE": "D", "MH": "Data Compression", "AQ": "CL EC ES HI LJ MT SN ST TD", "ENTRY": "Compression, Image", "MN": "L01.470.500", "FX": "Signal Processing, Computer-Assisted", "MH_TH": "NLM (2004)", "ST": "T066", "MS": "Information application based on a variety of coding methods to minimize the amount of data to be stored, retrieved, or transmitted. Data compression can be applied to various forms of data, such as images and signals. It is used to reduce costs and increase efficiency in the maintenance of large volumes of data.", "PM": "2004", "HN": "2004", "MR": "20170703", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044962"}, {"RECTYPE": "D", "MH": "Biopsy, Fine-Needle", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Aspiration Biopsy, Fine-Needle|T060|NON|NRW|NLM (2004)|030312|abcdef", "ENTRY": "Needle Biopsy, Fine", "MN": "E05.242.384.100.119.500", "MH_TH": "NLM (2004)", "ST": "T060", "AN": "usually NIM with specific organ / pathol + disease /diag and/or /pathol", "PI": "Biopsy, Needle (1972-2003)", "MS": "Using fine needles (finer than 22-gauge) to remove tissue or fluid specimens from the living body for examination in the pathology laboratory and for disease diagnosis.", "PM": "2004", "HN": "2004", "MR": "20161014", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044963"}, {"RECTYPE": "D", "MH": "Cervicoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgeries, Neck Plastic", "MN": "E04.617.152", "MH_TH": "NLM (2004)", "ST": "T061", "AN": "NECK only", "PI": "Surgery, Plastic (1966-2003)", "MS": "PLASTIC SURGERY PROCEDURES in the NECK region to restore or improve form and function.", "PM": "2004", "HN": "2004", "MR": "20220715", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044964"}, {"RECTYPE": "D", "MH": "Anti-Retroviral Agents", "DS": "ANTIRETROVIRAL AGENTS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiretroviral Agent|T121|NON|EQV|NLM (2022)|201007|abcdef", "ENTRY": "Anti Retroviral Agents", "MN": "D27.505.954.122.388.077", "MH_TH": "NLM (2004)", "ST": "T121", "RN": "0", "PI": "Antiviral Agents (1988-2003)", "MS": "Agents used to treat RETROVIRIDAE INFECTIONS.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044966"}, {"RECTYPE": "D", "MH": "Serum", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Serums", "MN": "A15.145.846", "FX": "Plasma", "MH_TH": "NLM (2004)", "ST": "T031", "MS": "The clear portion of BLOOD that is left after BLOOD COAGULATION to remove BLOOD CELLS and clotting proteins.", "PM": "2004", "HN": "2004", "MR": "20180629", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044967"}, {"RECTYPE": "D", "MH": "Regenerative Medicine", "DE": "REGENERATIVE MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Regenerative Medicines", "MN": "H02.403.750", "FX": "Tissue Therapy, Historical", "MH_TH": "NLM (2004)", "ST": "T091", "AN": "use for the specialty only", "MS": "A field of medicine concerned with developing and using strategies aimed at repair or replacement of damaged, diseased, or metabolically deficient organs, tissues, and cells via TISSUE ENGINEERING; CELL TRANSPLANTATION; and ARTIFICIAL ORGANS and BIOARTIFICIAL ORGANS and tissues.", "PM": "2004", "HN": "2004", "MR": "20180629", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044968"}, {"RECTYPE": "D", "MH": "Ochlerotatus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.720.500.500.750.712.500.875.612", "MH_TH": "NLM (2004)", "ST": "T204", "RN": "txid190765", "PI": "Culicidae (1972-2003)", "MS": "A genus of mosquitoes in the family CULICIDAE. A large number of the species are found in the neotropical part of the Americas.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D044969"}, {"RECTYPE": "D", "MH": "3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)", "DS": "ALPHA HYDROXYSTEROID DEHYDROGENASE 03 B SPECIFIC", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidoreductase, 3 alpha-Hydroxysteroid", "MN": "D08.811.682.047.820.186", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.1.1.50", "RR": "EC 1.1.1.50", "PI": "3-Hydroxysteroid Dehydrogenases (1979-2003)", "MS": "A 3-hydroxysteroid dehydrogenase which catalyzes the reversible reduction of the active androgen, DIHYDROTESTOSTERONE to 5 ALPHA-ANDROSTANE-3 ALPHA,17 BETA-DIOL. It also has activity towards other 3-alpha-hydroxysteroids and on 9-, 11- and 15- hydroxyprostaglandins. The enzyme is B-specific in reference to the orientation of reduced NAD or NADPH.", "PM": "2004; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE (B-SPECIFIC) was indexed under 3-HYDROXYSTEROID DEHYDROGENASES 1979-2003; 5 ALPHA-DIHYDROPROGESTERONE 3 ALPHA-HYDROSTEROID OXIDOREDUCTASE was indexed under 3-HYDROXYSTEROID DEHYDROGENASES 1981-2003", "HN": "2004; use 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE (B-SPECIFIC) (NM) 1979-2003", "MR": "20130708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045002"}, {"RECTYPE": "D", "MH": "Lactate Dehydrogenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenases, Lactate", "MN": "D08.811.682.047.551", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.1.-", "AN": "L-LACTATE DEHYDROGENASE and L-LACTATE DEHYDROGENASE (CYTOCHROME) are also available", "PI": "L-Lactate Dehydrogenase (1974-2003)", "MS": "Alcohol oxidoreductases with substrate specificity for LACTIC ACID.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045022"}, {"RECTYPE": "D", "MH": "Pedunculopontine Tegmental Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tegmental Nucleus, Pedunculopontine", "MN": "A08.186.211.132.772.322.500", "MH_TH": "NLM (2004)", "ST": "T023", "PI": "Tegmentum Mesencephali (1980-2003)", "MS": "Dense collection of cells in the caudal pontomesencephalic tegmentum known to play a role in the functional organization of the BASAL GANGLIA and in the modulation of the thalamocortical neuronal system.", "PM": "2004", "HN": "2004", "MR": "20150623", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045042"}, {"RECTYPE": "D", "MH": "Methenyltetrahydrofolate Cyclohydrolase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cyclohydrolase, Methenyltetrahydrofolate", "MN": "D08.811.277.151.418", "FX": "Methylenetetrahydrofolate Dehydrogenase (NADP)", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.5.4.9", "RR": "9027-97-8", "PI": "Tetrahydrofolates (1974-1982)", "MS": "An aminohydrolase that catalyzes the hydrolysis of 5,10-methenyltetrahydrofolate to 10-formyltetrahydrofolate. In most higher eucaryotic organisms this enzyme also includes METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP) and FORMATE-TETRAHYDROFOLATE LIGASE activities.", "PM": "2004; METHENYLTETRAHYDRODROFOLATE CYCLOHYDROLASE was indexed under AMINOHYDROLASES 1983-2003, under TETRAHYDROFOLATES 1974-1982, under HYDROLASES 1974-1977", "HN": "2004; use METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045064"}, {"RECTYPE": "D", "MH": "Methylenetetrahydrofolate Dehydrogenase (NAD+)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "5,10-Methylenetetrahydrofolate-Reductase (NADH)|T116|T126|ABX|EQV|NLM (2004)|METHYLENETETRAHYDROFOLATE REDUCTASE NADH 05 10|abbcdes", "ENTRY": "Oxidoreductase, 5,10-Methylenetetrahydrofolate:NAD", "MN": "D08.811.682.662.217", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.5.1.15", "RR": "82062-90-6", "AN": "do not confuse with METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP)", "PI": "Oxidoreductases (1999-2003)", "MS": "A NAD-dependent oxidoreductase that catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5,10-methenyl-tetrahdyrofolate. It has been found in a variety of microorganisms.", "PM": "2004; see METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1989-2003; 5,10-METHYLENETETRAHYDROFOLATE-REDUCTASE (NADH) was indexed under OXIDOREDUCTASES 1999-2003", "HN": "2004; use METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP) 1989-2003; for 5,10-METHYLENETETRAHYDROFOLATE-REDUCTASE (NADH) use METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NAD+) (NM) 1999-2003;", "MR": "20050630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045102"}, {"RECTYPE": "D", "MH": "5,10-Methylenetetrahydrofolate Reductase (FADH2)", "DS": "METHYLENETETRAHYDROFOLATE REDUCTASE FADH2 05 10", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "5,10-Methylenetetrahydrofolate Reductase (FADH)|T116|T126|ABX|EQV|NLM (2004)|030318|abbcdef", "MN": "D08.811.682.550", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 1.5.1.20", "PI": "Tetrahydrofolates (1974-1982)", "MS": "An FAD-dependent oxidoreductase found primarily in BACTERIA. It is specific for the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. This enzyme was formerly listed as EC 1.1.1.68 and 1.1.99.15.", "PM": "2004; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2) was indexed under OXIDOREDUCTASES 1987-2003, under ALCOHOL OXIDOREDUCTASES 1974-1986, under TETRAHYDROFOLATES 1974-1982 & under FOLIC ACIDS 1970-1973", "HN": "2004; use 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2) (NM) 1980-2003", "MR": "20130709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045103"}, {"RECTYPE": "D", "MH": "Cross-Priming", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Cross-Presentation|T043|NON|REL|NLM (2004)|030319|abcdef", "ENTRY": "Cross Priming", "MN": "G12.565.150", "FX": "Antigen Presentation", "MH_TH": "NLM (2004)", "ST": "T043", "AN": "note category, an immunologic process; do not confuse with cross-modality priming (= probably ASSOCIATION LEARNING or other psychology terms)", "MS": "Class I-restricted activation of CD8-POSITIVE LYMPHOCYTES resulting from ANTIGEN PRESENTATION of exogenous ANTIGENS (cross-presentation). This is in contrast to normal activation of these lymphocytes (direct-priming) which results from presentation of endogenous antigens.", "PM": "2004", "HN": "2004", "MR": "20160623", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045142"}, {"RECTYPE": "D", "MH": "Thiazolidinediones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Glitazones|T109|NON|EQV|NLM (2004)|030321|abcdef", "MN": "D03.383.129.708.933", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "PI": "Thiazoles (1968-2003)", "MS": "THIAZOLES with two keto oxygens. Members are insulin-sensitizing agents which overcome INSULIN RESISTANCE by activation of the peroxisome proliferator activated receptor gamma (PPAR-gamma).", "PM": "2004", "HN": "2004", "MR": "20160601", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045162"}, {"RECTYPE": "D", "MH": "Antibodies, Phospho-Specific", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Phosphorylation State-Specific Antibodies|T116|T129|NON|EQV|NLM (2004)|030321|abbcdef", "ENTRY": "State-Specific Antibodies, Phosphorylation", "MN": "D12.776.377.715.548.114.248", "PA": "Immunologic Factors", "FX": "Antibodies, Antiphospholipid", "MH_TH": "NLM (2004)", "ST": "T129", "RN": "0", "AN": "do not confuse with ANTIBODIES, ANTIPHOSPHOLIPID", "MS": "Antibodies directed against immunogen-coupled phosphorylated PEPTIDES corresponding to amino acids surrounding the PHOSPHORYLATION site. They are used to study proteins involved in SIGNAL TRANSDUCTION pathways. (From Methods Mol Biol 2000; 99:177-89)", "PM": "2004", "HN": "2004", "MR": "20050630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045163"}, {"RECTYPE": "D", "MH": "Mesenchymal Stem Cell Transplantation", "DE": "MESENCHYMAL STEM CELL TRANSPL", "AQ": "AE CL EC EH ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Stem Cell Transplantation, Mesenchymal|T061|NON|EQV|NLM (2004)|030321|STEM CELL TRANSPL MESENCHYMAL|abcdefv", "ENTRY": "Transplantation, Mesenchymal Stem Cell|T061|NON|EQV|NLM (2004)|030321|TRANSPL MESENCHYMAL STEM CELL|abcdefv", "MN": "E04.936.225.687.625", "MH_TH": "NLM (2004)", "ST": "T061", "MS": "Transfer of MESENCHYMAL STEM CELLS between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS).", "PM": "2004", "HN": "2004", "MR": "20170224", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045164"}, {"RECTYPE": "D", "MH": "Testosterone Congeners", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Synthetic Androgen|T121|T125|NON|NRW|NLM (2022)|201007|abbcdef", "ENTRY": "Androgen, Synthetic", "MN": "D06.472.334.851.968", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Androgens (1964-2003)", "MS": "Steroidal compounds related to TESTOSTERONE, the major mammalian male sex hormone. Testosterone congeners include important testosterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with androgenic activities.", "PM": "2004; for ANDROGENS, SYNTHETIC see ANDROGENS, SYNTHETIC 1975-2003", "HN": "2004", "MR": "20220713", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045165"}, {"RECTYPE": "D", "MH": "Estradiol Congeners", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Synthetic Estrogen|T121|NON|NRW|NLM (2021)|191121|abcdef", "ENTRY": "Estrogen, Synthetic", "MN": "D06.472.334.851.437", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics; do not confuse with ESTROGENS, CONJUGATED (USP)", "PI": "Estrogens (1964-2003)", "MS": "Steroidal compounds related to ESTRADIOL, the major mammalian female sex hormone. Estradiol congeners include important estradiol precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with estrogenic activities.", "PM": "2004; for ESTROGENS, SYNTHETIC see ESTROGENS, SYNTHETIC 1975-2003", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045166"}, {"RECTYPE": "D", "MH": "Progesterone Congeners", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Synthetic Progestin|T121|T125|NON|NRW|NLM (2022)|201006|abbcdef", "ENTRY": "Synthetic Progestogens", "MN": "D06.472.334.851.687", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Progestational Hormones (1965-2003)", "MS": "Steroidal compounds related to PROGESTERONE, the major mammalian progestational hormone. Progesterone congeners include important progesterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with progestational activities.", "PM": "2004; for PROGESTATIONAL HORMONES, SYNTHETIC see PROGESTATIONAL HORMONES, SYNTHETIC 1975-2003", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045167"}, {"RECTYPE": "D", "MH": "Severe Acute Respiratory Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Respiratory Syndrome, Severe Acute|T047|NON|EQV|NLM (2003)|030324|abcdef", "ENTRY": "SARS (Severe Acute Respiratory Syndrome)|T047|ABX|EQV|NLM (2015)|131120|abcdef", "MN": "C08.730.730", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with RESPIRATORY DISTRESS SYNDROME, NEWBORN or RESPIRATORY DISTRESS SYNDROME", "MS": "A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.", "PM": "2003", "HN": "2003", "MR": "20200709", "DA": "20030324", "DC": "1", "DX": "20030324", "UI": "D045169"}, {"RECTYPE": "D", "MH": "Matrix Attachment Regions", "AQ": "DE ES GE PH RE", "PRINT ENTRY": "Scaffold Attachment Regions|T114|T123|NON|EQV|NLM (2004)|030324|abbcdef", "ENTRY": "Sequences, MRS", "MN": "G05.360.080.534", "MH_TH": "NLM (2004)", "ST": "T123", "PI": "Nuclear Matrix/metabolism (1990-2003)", "MS": "Regions of the CHROMATIN or DNA that bind to the NUCLEAR MATRIX. They are found in INTERGENIC DNA, especially flanking the 5' ends of genes or clusters of genes. Many of the regions that have been isolated contain a bipartite sequence motif called the MAR/SAR recognition signature sequence that binds to MATRIX ATTACHMENT REGION BINDING PROTEINS.", "PM": "2004", "HN": "2004", "MR": "20111212", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045170"}, {"RECTYPE": "D", "MH": "Fusobacteria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.370", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid32066", "AN": "FUSOBACTERIUM is also available; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Fusobacterium (1965-2003)", "MS": "A phylum of anaerobic, gram-negative bacteria with a chemoorganotrophic heterotrophic metabolism. They are resident flora of the OROPHARYNX.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045182"}, {"RECTYPE": "D", "MH": "Leptotrichia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.535", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid32067", "AN": "infection: coord IM with FUSOBACTERIACEAE INFECTIONS (IM)", "PI": "Bacteroidaceae (1971-2003)", "MS": "A genus of anaerobic, gram-negative bacteria in the family Fusobacteriaceae. Some species cause BACTEREMIA and some intra-amniotic infections.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045183"}, {"RECTYPE": "D", "MH": "Propionigenium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.600", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2332", "AN": "do not confuse with PROPIONIBACTERIUM, a gram-positive bacterium; infection: coord IM with FUSOBACTERIACEAE INFECTIONS (IM)", "MS": "A genus of strictly anaerobic, nonsporeforming gram-negative bacteria in the family Fusobacteriaceae. Species in this genus are popularly used in biochemical research.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045184"}, {"RECTYPE": "D", "MH": "Porphyromonas endodontalis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.194.625.350", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid28124", "AN": "infection: coordinate with BACTEROIDACEAE INFECTIONS", "PI": "Porphyromonas (1993-2003)", "MS": "A species of gram-negative bacteria in the genus PORPHYROMONAS, family Porphyromonadaceae. It is a key pathogen in endodontic infections.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045202"}, {"RECTYPE": "D", "MH": "Electron Transport Chain Complex Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.543.277", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A complex of enzymes and PROTON PUMPS located on the inner membrane of the MITOCHONDRIA and in bacterial membranes. The protein complex provides energy in the form of an electrochemical gradient, which may be used by either MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES or BACTERIAL PROTON-TRANSLOCATING ATPASES.", "PM": "2004", "HN": "2004", "MR": "20110624", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045222"}, {"RECTYPE": "D", "MH": "Prevotella nigrescens", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.194.640.550", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid28133", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Prevotella (1992-2003)", "MS": "A species of gram-negative bacteria in the family Prevotellaceae. It is the species most commonly isolated from endodontic infections (PULPITIS).", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045242"}, {"RECTYPE": "D", "MH": "Prevotella ruminicola", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.194.640.700", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid839", "PI": "Prevotella (1992-2003)", "MS": "A saccharolytic species of gram-negative bacteria in the family Prevotellaceae. It ferments a wide range of CARBOHYDRATES in the RUMEN of animals.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045243"}, {"RECTYPE": "D", "MH": "Rhodothermus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.400.425.710", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid29548", "PI": "Gram-Negative Aerobic Bacteria (1998-2003)", "MS": "A genus of obligately aerobic, thermophilic, gram-negative bacteria in the family Crenotrichaceae. They were isolated from submarine alkaline HOT SPRINGS in Iceland.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045245"}, {"RECTYPE": "D", "MH": "Ornithobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.602", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid28250", "AN": "infection: coord IM with FLAVOBACTERIACEAE INFECTIONS (IM)", "PI": "Gram-Negative Bacteria (1994-2003)", "MS": "A genus of gram-negative, chemoorganotrophic bacteria, in the family FLAVOBACTERIACEAE. It is pathogenic in BIRDS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045246"}, {"RECTYPE": "D", "MH": "Chryseobacterium", "DE": "CHRYSEOBACT", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Flavobacterium meningosepticum|T007|NON|NRW|NLM (1992)|910326|FLAVOBACT MENINGOSEPTICUM|abcdefv", "MN": "B03.440.400.425.310.120", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid59732", "RR": "txid238", "AN": "infection: coordinate with FLAVOBACTERIACEAE INFECTIONS", "PI": "Flavobacterium (1996-2003)", "MS": "A genus of aerobic, gram-negative bacteria in the family FLAVOBACTERIACEAE. Many of its species were formerly in the genus FLAVOBACTERIUM.", "PM": "2004; for FLAVOBACTERIUM MENINGOSEPTICUM see FLAVOBACTERIUM 1992-2003", "HN": "2004; for FLAVOBACTERIUM MENINGOSEPTICUM use FLAVOBACTERIUM 1992-2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045247"}, {"RECTYPE": "D", "MH": "Flexibacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.400.425.300.200", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid992", "AN": "infection: coordinate with CYTOPHAGACEAE INFECTIONS", "PI": "Cytophaga (1974-2003)", "MS": "A genus of gram-negative, chemoorganotrophic bacteria in the family CYTOPHAGACEAE. In some species there is a cyclic change in cell morphology.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045248"}, {"RECTYPE": "D", "MH": "Sphingobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.400.425.745", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid28453", "PI": "Flavobacterium (1987-2003)", "MS": "A genus of gram-negative, chemoorganotrophic bacteria in the family Sphingobacteriaceae. They lack FLAGELLA but some species exhibit sliding motility.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045249"}, {"RECTYPE": "D", "MH": "Reticulocytosis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Reticulocytoses", "MN": "G09.188.760", "FX": "Reticulocyte Count", "MH_TH": "NLM (1994)", "ST": "T184", "PI": "Reticulocytes (1965-2003)", "MS": "An increase in circulating RETICULOCYTES, which is among the simplest and most reliable signs of accelerated ERYTHROCYTE production. Reticulocytosis occurs during active BLOOD regeneration (stimulation of red bone marrow) and in certain types of ANEMIA, particularly CONGENITAL HEMOLYTIC ANEMIA.", "PM": "2004; see RETICULOCYTE COUNT 1994-2003", "HN": "2004; use RETICULOCYTE COUNT 1994-2003", "MR": "20080708", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045262"}, {"RECTYPE": "D", "MH": "Cytochromes a1", "DS": "CYTOCHROMES A 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cytochrome a 1", "MN": "D12.776.422.220.175.500", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "9035-35-2", "PI": "Cytochromes (1980-1993)", "MS": "A subclass of heme a containing cytochromes have a reduced alpha-band absorption of 587-592 nm. They are primarily found in microorganisms.", "PM": "2004; CYTOCHROMES A1 was indexed under CYTOCHROME A 1994-2003 & under CYTOCHROMES 1980-1993", "HN": "2004; use CYTOCHROMES A1 (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045263"}, {"RECTYPE": "D", "MH": "Cytochromes a", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochrome a|T116|T126|NON|EQV|NLM (1994)|990101|abbcdef", "MN": "D12.776.422.220.175.249", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "9035-34-1", "PI": "Cytochromes (1979-1993)", "MS": "A subclass of heme a containing cytochromes that have two imidazole nitrogens as axial ligands and an alpha-band absorption of 605 nm. They are found in a variety of microorganisms and in eucaryotes as a low-spin cytochrome component of MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX IV.", "PM": "2004; see CYTOCROME A GROUP 1994-2004; CYTOCHROME A was indexed under CYTOCHROMES 1979-1993", "HN": "2004; use CYTOCHROME A GROUP 1994-2004, use CYTOCHROME A (NM) 1979-1993", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045264"}, {"RECTYPE": "D", "MH": "Natriuretic Peptides", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Natriuretic Peptide|T116|T125|NON|EQV|NLM (2021)|191129|abbcdef", "ENTRY": "Peptides, Natriuretic", "MN": "D12.644.548.585", "MH_TH": "NLM (2004)", "ST": "T125", "RN": "0", "AN": "general: prefer specifics", "PI": "Peptides (1976-2003)", "MS": "Peptides that regulate the WATER-ELECTROLYTE BALANCE in the body, also known as natriuretic peptide hormones. Several have been sequenced (ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; C-TYPE NATRIURETIC PEPTIDE).", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045265"}, {"RECTYPE": "D", "MH": "Cytochromes a3", "DS": "CYTOCHROMES A 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ferrocytochrome a3|T116|T123|NON|EQV|UNK (19XX)|810424|abbcdef", "MN": "D12.776.422.220.175.600", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Electron Transport Complex IV (1981-2003)", "MS": "A subclass of heme a containing cytochromes with an alpha-band absorption of 605 nm. They are found in a variety of microorganisms and in eukaryotes as a high-spin cytochrome component of MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX IV.", "PM": "2004; for CYTOCHROME A3 see CYTOCHROME-C OXIDASE 1981-2003", "HN": "2004; for CYTOCHROME A3 use MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX IV 1981-2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045266"}, {"RECTYPE": "D", "MH": "Flowmeters", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Flowmeter", "MN": "E07.230.380", "MH_TH": "NLM (1993)", "ST": "T075", "AN": "consider also RHEOLOGY /instrum or LASER-DOPPLER FLOWMETRY /instrum;", "MS": "Devices used to measure the flow of fluids (see RHEOLOGY) or the AIR to measure RESPIRATION.", "PM": "2004; use RHEOLOGY 1993-2003, use FLOWMETERS 1974-1982, use BLOOD FLOW VELOCITY 1963-1971", "HN": "2004, 1974-1992; use RHEOLOGY 1993-2003, use BLOOD FLOW VELOCITY 1963-1971", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045268"}, {"RECTYPE": "D", "MH": "Bilophila", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Bilophila wadsworthia|T007|NON|NRW|NLM (2004)|030401|abcdef", "MN": "B03.660.125.144.500.500", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid35832", "RR": "txid35833", "AN": "infection: coordinate with BILOPHILA INFECTIONS see DESULFOVIBRIONACEAE INFECTIONS ", "PI": "Gram-Negative Anaerobic Bacteria (1989-2000)", "MS": "A genus of gram-negative, anaerobic bacteria in the family DESULFOVIBRIONACEAE. It was originally recovered from infections in patients with gangrenous and PERFORATED APPENDICITIS. It is also associated with ABSCESS; BACTEREMIA; and BILIARY TRACT sepsis.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045282"}, {"RECTYPE": "D", "MH": "Natriuretic Agents", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Natriuretic Hormones|T109|T125|NON|NRW|UNK (19XX)|850308|abbcdef", "ENTRY": "Hormones, Natriuretic", "MN": "D27.505.954.411.455", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "AN": "note entry term NATRIURETIC EFFECT: use only for the natriuretic effect of a chemical substance", "PI": "Natriuresis (1973-1986)", "MS": "Endogenous or exogenous chemicals that regulate the WATER-ELECTROLYTE BALANCE in the body. They consist of peptides and non-peptide compounds.", "PM": "2004; for NATRIURETIC HORMONES see NATRIURETIC HORMONES 1986-2003", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045283"}, {"RECTYPE": "D", "MH": "Desulfovibrio africanus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.900.350.040", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid873", "AN": "infection: coordinate with DESULFOVIBRIONACEAE INFECTIONS", "PI": "Desulfovibrio (1971-2003)", "MS": "A species of gram-negative, anaerobic, sigmoid-shaped bacteria isolated from salt and freshwater in Africa.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045284"}, {"RECTYPE": "D", "MH": "Desulfovibrio desulfuricans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.900.350.150", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid876", "AN": "infection: coordinate with DESULFOVIBRIONACEAE INFECTIONS", "PI": "Desulfovibrio (1966-2003)", "MS": "The type species of gram-negative, anaerobic bacteria of the genus DESULFOVIBRIO. It is found in FRESHWATER; SOIL, and in marine or brackish water.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045285"}, {"RECTYPE": "D", "MH": "Desulfovibrio gigas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.900.350.350", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid879", "AN": "infection: coordinate with DESULFOVIBRIONACEAE INFECTIONS", "PI": "Desulfovibrio (1966-2003)", "MS": "A species of gram-negative, anaerobic, spiral-shaped bacteria originally isolated from a saltwater pond in France. It contains a well-characterized metabolic pathway that enables it to survive transient contacts with OXYGEN.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045286"}, {"RECTYPE": "D", "MH": "Desulfuromonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.900.370", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid890", "MS": "A genus of gram-negative, anaerobic, nonsporeforming bacteria in the family Desulfuromonadaceae. It is found in anoxic marine sediments.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045287"}, {"RECTYPE": "D", "MH": "Geobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.125.305", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid28231", "MS": "A genus of gram-negative, anaerobic, metal-reducing bacteria in the family Geobacteraceae. They have the ability to oxidize a variety of organic compounds, including AROMATIC HYDROCARBONS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045302"}, {"RECTYPE": "D", "MH": "Cytochromes b", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochrome b|T116|T126|NON|EQV|NLM (1983)|990101|abbcdef", "ENTRY": "Apocytochrome b|T116|T123|NON|NRW|NLM (2004)|abbcde", "MN": "D12.776.422.220.187.249", "MH_TH": "NLM (2004)", "ST": "T126", "N1": "cytochrome b", "RN": "9035-37-4", "AN": "do not confuse with CYTOCHROME B GROUP", "PI": "Cytochromes (1966-1982)", "MS": "Cytochromes of the b group that have alpha-band absorption of 563-564 nm. They occur as subunits in MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX III.", "PM": "2004; see CYTOCHROME B GROUP 1983-2003; APOCYTOCHROME B was indexed under APOPROTEINS & CYTOCHROME B 1983-2003 & under CYTOCHROMES 1979-1982", "HN": "2004; use CYTOCHROME B GROUP 1983-2003; for APOCYTOCHROME B use CYTOCHROMES B (NM) 1980-2002", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045303"}, {"RECTYPE": "D", "MH": "Cytochromes c", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ferrocytochrome c|T116|T126|NON|EQV|UNK (19XX)|741125|abbcdef", "ENTRY": "Apocytochrome C|T116|T123|NON|NRW|NLM (2004)|abbcde", "MN": "D12.776.422.220.286.100", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "9007-43-6", "AN": "do not confuse with CYTOCHROME C GROUP", "PI": "Cytochrome c Group (1983-2003)", "MS": "Cytochromes of the c type that are found in eukaryotic MITOCHONDRIA. They serve as redox intermediates that accept electrons from MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX III and transfer them to MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX IV.", "PM": "2004; see CYTOCHROME C 1973-2003; APOCYTOCHROME C was indexed under CYTOCHROME C & APOPROTEINS 1983-2003", "HN": "2004; use CYTOCHROME C GROUP 1973-2003; for APOPCYTOCHROME C use CYTOCHROMES C (NM) 1983-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045304"}, {"RECTYPE": "D", "MH": "Cytochromes c'", "DS": "CYTOCHROMES C0", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ferricytochrome c'|T116|T123|NON|EQV|UNK (19XX)|820603|abbcdef", "MN": "D12.776.422.220.286.150", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Cytochrome c Group (1981-2003)", "MS": "A widely occurring subclass of c type cytochromes which function as electron carriers in the electron transport chain in photosynthetic and denitrifying BACTERIA.", "PM": "2004; see CYTOCHROME C 1982-2003", "HN": "2004; use CYTOCHROME C GROUP 1982-2003", "MR": "20040719", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045305"}, {"RECTYPE": "D", "MH": "Photosynthetic Reaction Center Complex Proteins", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Photosynthetic Reaction Center Complex Protein|T116|T123|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Reaction Centers, Photosynthetic", "MN": "D12.776.765.199.750.750", "FX": "Thylakoids", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Plant Proteins (1966-2003)", "MS": "Protein complexes that take part in the process of PHOTOSYNTHESIS. They are located within the THYLAKOID MEMBRANES of plant CHLOROPLASTS and a variety of structures in more primitive organisms. There are two major complexes involved in the photosynthetic process called PHOTOSYSTEM I and PHOTOSYSTEM II.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045322"}, {"RECTYPE": "D", "MH": "HCT116 Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "HCT116 Cell", "MN": "A11.251.860.180.380", "MH_TH": "NLM (2004)", "ST": "T025", "AN": "almost always NIM with no subheadings; check HUMAN; do not routinely add COLONIC NEOPLASMS", "PI": "Tumor Cells, Cultured (1990-2003)", "MS": "Human COLORECTAL CARCINOMA cell line.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045325"}, {"RECTYPE": "D", "MH": "Photosystem I Protein Complex", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Photosystem I Reaction Center|T116|T126|NON|EQV|NLM (1991)|900220|abbcdef", "ENTRY": "Photosystem I|T116|T126|NON|REL|NLM (2004)|030404|abbcdef", "MN": "D12.776.765.199.750.750.500", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "0", "PI": "Plant Proteins (1966-1990)", "MS": "A large multisubunit protein complex that is found in the THYLAKOID MEMBRANE. It uses light energy derived from LIGHT-HARVESTING PROTEIN COMPLEXES to drive electron transfer reactions that result in either the reduction of NADP to NADPH or the transport of PROTONS across the membrane.", "PM": "2004; for PHOTOSYSTEM I REACTION CENTER see PHOTOSYNTHETIC REACTION CENTER, PLANT 1991-2003", "HN": "2004; for PHOTOSYSTEM I REACTION CENTER use PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1991-2003", "MR": "20160701", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045331"}, {"RECTYPE": "D", "MH": "Photosystem II Protein Complex", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Water Splitting Enzyme of Photosynthesis", "MN": "D12.776.765.199.750.750.750", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "RR": "125389-73-3", "PI": "Plant Proteins (1966-1990)", "MS": "A large multisubunit protein complex found in the THYLAKOID MEMBRANE. It uses light energy derived from LIGHT-HARVESTING PROTEIN COMPLEXES to catalyze the splitting of WATER into DIOXYGEN and of reducing equivalents of HYDROGEN.", "PM": "2004; for PHOTOSYSTEM II REACTION CENTER see PHOTOSYNTHETIC REACTION CENTER, PLANT 1991-2003; WATER-SPLITTING ENZYMES OF PHOTOSYTHESIS was indexed under OXIDOREDUCTASES 1983-2003 & under CHLOROPHYLL & WATER 1972-1982; PHOTOSYSTEM II REACTION CENTER COMPLEX D2 PROTEIN was indexed under PHOTOSYNTHETIC REACTION CENTER, PLANT 1992-2003; D1 PHOTOSYSTEM II PROTEIN, PLANT was indexed under PHOTOSYNTHETIC REACTION CENTER, PLANT 1995-2003, under PHOTOSYNTHETIC REACTION CENTER, BACTERIAL 1994-2001, under PLANT PROTEINS & BACTERIAL PROTEINS 1989-1994 & under FUNGAL PROTEINS 1990-1991", "HN": "2004; for PHOTOSYSTEM II REACTION CENTER use PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1991-2003; for WATER-SPLITTING ENZYME OF PHOTOSYNTHESIS use PHOTOSYSTEM II PROTEIN COMPLEX (NM) 1980-2003; for PHOTOSYSTEM II REACTION CENTER COMPLEX D2 PROTEIN use PHOTOSYSTEM II PROTEIN COMPLEX (NM) 1992-2003; for D1 PHOTOSYSTEM II PROTEIN, PLANT use PHOTOSYSTEM II PROTEIN COMPLEX (NM) 1989-2003;", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045332"}, {"RECTYPE": "D", "MH": "Nanotubes, Peptide", "AQ": "AE AN CH CL EC HI MI PO PS RE SD SN ST TO UL VI", "ENTRY": "Peptide Nanotubes", "MN": "J01.637.512.850.750", "MH_TH": "NLM (2004)", "ST": "T116", "RN": "0", "MS": "NANOTUBES formed from cyclic peptides (PEPTIDES, CYCLIC). Alternating D and L linkages create planar rings that self assemble by stacking into nanotubes. They can form pores through CELL MEMBRANE causing damage to cells.", "PM": "2004", "HN": "2004", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045333"}, {"RECTYPE": "D", "MH": "Light-Harvesting Protein Complexes", "AQ": "AD AE AG AI AN BI CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "ENTRY": "Protein Complexes, Light-Harvesting", "MN": "D12.776.765.199.750.750.490", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Photosynthetic Reaction Center Complex Proteins (1983-2003)", "MS": "Complexes containing CHLOROPHYLL and other photosensitive molecules. They serve to capture energy in the form of PHOTONS and are generally found as components of the PHOTOSYSTEM I PROTEIN COMPLEX or the PHOTOSYSTEM II PROTEIN COMPLEX.", "PM": "2004; for LIGHT-HARVESTING CHLOROPHYLL PROTEIN see PHOTOSYNTHETIC REACTION CENTER, PLANT 1991-2003", "HN": "2004; for LIGHT-HARVESTING CHLOROPHYLL PROTEIN use PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1991-2003", "MR": "20160622", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045342"}, {"RECTYPE": "D", "MH": "Cytochrome b6f Complex", "DS": "CYTOCHROME B 06 F COMPLEX", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cytochrome b6 f", "MN": "D12.776.765.199.750.750.374", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "9035-40-9", "PI": "Cytochrome b Group (1984-2003)", "MS": "A protein complex that includes CYTOCHROME B6 and CYTOCHROME F. It is found in the THYLAKOID MEMBRANE and plays an important role in process of PHOTOSYNTHESIS by transferring electrons from PLASTOQUINONE to PLASTOCYANIN or CYTOCHROME C6. The transfer of electrons is coupled to the transport of PROTONS across the membrane.", "PM": "2004; CYTOCHROME B6F was indexed under CYTOCHROME B 1984-2003", "HN": "2004; use CYTOCHROME B6F COMPLEX (NM) 1984-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045346"}, {"RECTYPE": "D", "MH": "Cytochromes b6", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cytochrome b6|T116|T126|NON|EQV|NLM (2004)|abbcde", "MN": "D12.776.765.199.750.750.374.500", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "0", "RR": "127496-51-9", "PI": "Cytochromes b (1984-2003)", "MS": "Cytochromes of the b group that are found as components of the CYTOCHROME B6F COMPLEX. They contain two non-covalently bound HEME B groups.", "PM": "2004; CYTOCHROME B6 was indexed under CYTOCHROME B 1984-2003; APOCYTOCHROME B6 was indexed under APOPROTEINS & CYTOCHROME B 1991-2003", "HN": "2004; for CYTOCHROME B6 use CYTOCHROME B6F COMPLEX (NM) 1984-2003; for APOPCYTOCHROME B6 use CYTOCHROMES B6 (NM) 1991-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045347"}, {"RECTYPE": "D", "MH": "Cytochromes f", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochrome f|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Apocytochrome f|T116|T123|NON|NRW|NLM (2004)|abbcde", "MN": "D12.776.765.199.750.750.374.750", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "9035-46-5", "PI": "Cytochromes (1980-2003)", "MS": "Cytochromes f are found as components of the CYTOCHROME B6F COMPLEX. They play important role in the transfer of electrons from PHOTOSYSTEM I to PHOTOSYSTEM II.", "PM": "2004; CYTOCHROME F was indexed under CYTOCHROMES 1979-2003; APOCYTOCHROME F was indexed under APOPROTEINS & CYTOCHROMES 1987-2003", "HN": "2004; use CYTOCHROMES F (NM) 1980-2003; for APOCYTOCHROME F use CYTOCHROMES F (NM) 1987-2003", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045348"}, {"RECTYPE": "D", "MH": "Cytochromes c2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochrome c2|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Cytochrome C 2", "MN": "D12.776.422.220.286.300", "MH_TH": "NLM (2004)", "ST": "T126", "N1": "Cytochrome c2", "RN": "9035-43-2", "PI": "Cytochromes (1967-1972)", "MS": "Type C cytochromes that are small (12-14 kD) single-heme proteins. They function as mobile electron carriers between membrane-bound enzymes in photosynthetic BACTERIA.", "PM": "2004; CYTOCHROMES C2 was indexed under CYTOCHROME C 1979-2003", "HN": "2004; use CYTOCHROMES C2 (NM) 1980-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045362"}, {"RECTYPE": "D", "MH": "Pneumocystis carinii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Pneumocystis jirovecii|T004|NON|NRW|NLM (2008)|070430|abcdef", "ENTRY": "Pneumocystis jiroveci|T004|NON|NRW|NLM (2004)|030408|abcdef", "MN": "B01.300.107.730.650", "MH_TH": "NLM (1974)", "ST": "T004", "RN": "txid4754", "RR": "txid42068", "AN": "infection: coordinate with probably PNEUMONIA, PNEUMOCYSTIS  but if not of lungs, coordinate with PNEUMOCYSTIS INFECTIONS + precoordinated organ/disease term", "PI": "Protozoa (1968-1994)", "MS": "The prototype species of PNEUMOCYSTIS infecting the laboratory rat. It was formerly called Pneumocystis carinii f. sp. carinii. Strains that infect humans and cause PNEUMOCYSTIS PNEUMONIA were originally classified as Pneumocystis jirovecii or Pneumocystis carinii f. sp. hominis.", "PM": "2004; see PNEUMOCYSTIS CARINII 1974-2003", "HN": "2004; use PNEUMOCYSTIS 1974-2003", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045363"}, {"RECTYPE": "D", "MH": "Cytochromes c6", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cytochrome c6|T116|T123|NON|EQV|NLM (2004)|abbcde", "MN": "D12.776.422.220.286.600", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Cytochromes (1991-2003)", "MS": "Cytochromes of the c type that are involved in the transfer of electrons from CYTOCHROME B6F COMPLEX and PHOTOSYSTEM I.", "PM": "2004; CYTOCHROME C6 was indexed under CYTOCHROMES 1991-2003", "HN": "2004; for CYTCHROME C6 use CYTOCHROMES F (NM) 1991-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045365"}, {"RECTYPE": "D", "MH": "Pregnancy-Associated alpha 2-Macroglobulins", "DE": "PREGN ASSOCIATED ALPHA 2 MACROGLOBULINS", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha 2-Glucoproteins|T116|T123|NON|NRW|UNK (19XX)|750701|ALPHA GLUCOPROTEINS 02|abbcdefs", "ENTRY": "alpha2 PAG", "MN": "D12.776.780.675", "MH_TH": "UNK (19XX)", "ST": "T123", "RN": "0", "PI": "alpha-Macroglobulins (1976-2003)", "MS": "Large (>160 kDa) glycoproteins with electrophoretic mobility of ALPHA-GLOBULINS, found in high concentration in the plasma of pregnant women but also in a number of species including mouse, rat, and others (ALPHA-MACROGLOBULINS). In humans, they are always present in the circulation and are nonspecific inhibitors of PROTEINASES, similar to COMPLEMENT PROTEINS (C3; C4; C5).", "PM": "2004; see PREGNANCY ZONE PROTEINS 1980-2003; for ALPHA 2-GLUCOPROTEINS see ALPHA-MACROGLOBULINS 1976-2017", "HN": "2018 (2004); for ALPHA 2-GLUCOPROTEINS use ALPHA-MACROGLOBULINS 1976-2017", "MR": "20170629", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045384"}, {"RECTYPE": "D", "MH": "Parainfluenza Virus 5", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Simian Virus 5|T005|NON|EQV|NLM (2004)|130416|abcdef", "MN": "B04.820.480.937.600.650.750.800", "MH_TH": "NLM (2014)", "ST": "T005", "RN": "txid1979162", "AN": "infection: coordinate IM with RUBULAVIRUS INFECTIONS (IM)", "MS": "A species of RUBULAVIRUS originally isolated from cultured primary monkey cells. Its natural host is the DOG in which it causes kennel cough, but it can also infect humans.", "PM": "2004", "HN": "2014; use SIMIAN VIRUS 5 2004-2013", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045402"}, {"RECTYPE": "D", "MH": "Henipavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Henipaviruses", "MN": "B04.820.480.937.600.650.400", "MH_TH": "NLM (2004)", "ST": "T005", "RN": "txid260964", "PI": "Paramyxovirinae (2001-2003)", "MS": "A genus in the subfamily PARAMYXOVIRINAE, family PARAMYXOVIRIDAE. It contains species that infect and cause potentially fatal disease in a number of host species, including humans.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045403"}, {"RECTYPE": "D", "MH": "Hendra Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hendra henipavirus|T005|NON|EQV|NLM (2024)|220912|abcdef", "ENTRY": "Virus, Hendra", "MN": "B04.820.480.937.600.650.400.400", "MH_TH": "NLM (2000)", "ST": "T005", "RN": "txid63330", "AN": "infection: coord IM with HENIPAVIRUS INFECTIONS (IM)", "PI": "Paramyxovirinae (1998-2003)", "MS": "A species of HENIPAVIRUS first identified in Australia in 1994 in HORSES and transmitted to humans. The natural host appears to be fruit bats (PTEROPUS).", "PM": "2004; see PARAMYXOVIRINAE 1994-2003", "HN": "2004; use PARAMYXOVIRINAE 1994-2003", "MR": "20230226", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045404"}, {"RECTYPE": "D", "MH": "Nipah Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Nipah henipavirus|T005|NON|EQV|NLM (2024)|220912|abcdef", "ENTRY": "Virus, Nipah", "MN": "B04.820.480.937.600.650.400.550", "MH_TH": "NLM (2000)", "ST": "T005", "RN": "txid121791", "AN": "infection: coordinate IM with HENIPAVIRUS INFECTIONS (IM)", "PI": "Paramyxovirinae (1999-2003)", "MS": "A species of HENIPAVIRUS, closely related to HENDRA VIRUS, which emerged in Peninsular Malaysia in 1998. It causes a severe febrile VIRAL ENCEPHALITIS in humans and also encephalitis and RESPIRATORY TRACT INFECTIONS in pigs. Fruit bats (PTEROPUS) are the natural host.", "PM": "2004; see PARAMYXOVIRINAE 2000-2003", "HN": "2004; use PARAMYXOVIRINAE 2000-2003", "MR": "20230226", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045405"}, {"RECTYPE": "D", "MH": "Continuous Positive Airway Pressure", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Biphasic Positive Airway Pressure|T061|NON|NRW|NLM (2021)|191018|abcdef", "ENTRY": "Ventilation, nCPAP", "MN": "E02.880.820.790.259", "MH_TH": "NLM (2004)", "ST": "T061", "AN": "BiPAP (BIPHASIC CONTINUOUS POSITIVE AIRWAY PRESSURE) in the literature goes here and BIPAP (BIPHASIC INTERMITTENT POSITIVE AIRWAY PRESSURE) goes under INTERMITTENT POSITIVE-PRESSURE VENTILATION", "PI": "Positive-Pressure Respiration (1971-2003)", "MS": "A technique of respiratory therapy, in either spontaneously breathing or mechanically ventilated patients, in which airway pressure is maintained above atmospheric pressure throughout the respiratory cycle by pressurization of the ventilatory circuit. (On-Line Medical Dictionary [Internet]. Newcastle upon Tyne(UK): The University Dept. of Medical Oncology: The CancerWEB Project; c1997-2003 [cited 2003 Apr 17]. Available from: http://cancerweb.ncl.ac.uk/omd/)", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045422"}, {"RECTYPE": "D", "MH": "Microbubbles", "AQ": "AE CL EC ES HI MI PS SD SN ST TD TU VE VI", "ENTRY": "Microbubble", "MN": "E07.553", "FX": "Microspheres", "MH_TH": "NLM (2004)", "ST": "T074", "AN": "coordinate with CONTRAST MEDIA, specific diagnostic technique or therapeutic technique if pertinent", "PI": "Contrast Media (1973-2003)", "MS": "Small encapsulated gas bubbles (diameters of micrometers) that can be used as CONTRAST MEDIA, and in other diagnostic and therapeutic applications. Upon exposure to sufficiently intense ultrasound, microbubbles will cavitate, rupture, disappear, release gas content. Such characteristics of the microbubbles can be used to enhance diagnostic tests, dissolve blood clots, and deliver drugs or genes for therapy.", "PM": "2004", "HN": "2004", "MR": "20150331", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045423"}, {"RECTYPE": "D", "MH": "Complex Mixtures", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mixtures, Complex|T103|NON|EQV|NLM (2004)|030416|abcdef", "ENTRY": "Mixture, Complex", "MN": "D20", "RH": "D20 - COMPLEX MIXTURES", "FX": "Drug Combinations", "MH_TH": "NLM (2004)", "ST": "T103", "RN": "0", "AN": "GEN only", "MS": "Mixtures of many components in inexact proportions, usually natural, such as PLANT EXTRACTS; VENOMS; and MANURE. These are distinguished from DRUG COMBINATIONS which have only a few components in definite proportions.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045424"}, {"RECTYPE": "D", "MH": "Rotarod Performance Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Test, Rotarod", "MN": "E05.017.449", "MH_TH": "NLM (2004)", "ST": "T062", "PI": "Motor Skills (1967-2003)", "MS": "A performance test based on forced MOTOR ACTIVITY on a rotating rod, usually by a rodent. Parameters include the riding time (seconds) or endurance. Test is used to evaluate balance and coordination of the subjects, particular in experimental animal models for neurological disorders and drug effects.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045442"}, {"RECTYPE": "D", "MH": "Endothelium-Dependent Relaxing Factors", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Endothelium-Derived Relaxing Factor|T123|NON|EQV|NLM (1990)|990101|EDRF|abcdefv", "ENTRY": "Vasodilators, Endothelium-Dependent", "MN": "D27.505.954.411.918.500", "FX": "Nitric Oxide", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Vasodilator Agents (1984-2003)", "MS": "Paracrine substances produced by the VASCULAR ENDOTHELIUM with VASCULAR SMOOTH MUSCLE relaxation (VASODILATION) activities. Several factors have been identified, including NITRIC OXIDE and PROSTACYCLIN.", "PM": "2004; see NITRIC OXIDE 1990-2003", "HN": "2004; use NITRIC OXIDE 1990-2003", "MR": "20130709", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045462"}, {"RECTYPE": "D", "MH": "Avulavirus Infections", "DE": "AVULAVIRUS INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Avulavirus", "MN": "C01.925.782.580.600.080", "MH_TH": "NLM (2004)", "ST": "T047", "MS": "Infections with viruses of the genus AVULAVIRUS, family PARAMYXOVIRIDAE. This includes NEWCASTLE DISEASE and other infections of domestic fowl.", "PM": "2004", "HN": "2004", "MR": "20190617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045463"}, {"RECTYPE": "D", "MH": "Henipavirus Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Virus Infections, Hendra", "MN": "C01.925.782.580.600.400", "MH_TH": "NLM (2004)", "ST": "T047", "MS": "Infections with viruses of the genus HENIPAVIRUS, family PARAMYXOVIRIDAE.", "PM": "2004", "HN": "2004", "MR": "20190617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045464"}, {"RECTYPE": "D", "MH": "Corsiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Arachnitis", "MN": "B01.875.800.575.912.250.618.875.180", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid147240", "RR": "txid179147", "MS": "A plant family of the order Liliales (or by some as Dioscoreales or Burmanniales), subclass Liliidae, class Liliopsida (monocotyledons). They are perennial saprophytic plants obtaining their carbon from FUNGI.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045465"}, {"RECTYPE": "D", "MH": "Dilleniaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Dillenias", "MN": "B01.875.800.575.912.250.318", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid24942", "RR": "txid4377", "MS": "A plant family of the order Dilleniales, subclass Dilleniidae, class Magnoliopsida.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045466"}, {"RECTYPE": "D", "MH": "Elaeocarpaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Elaeocarpus|T002|NON|NRW|NLM (2004)|030417|abcdef", "MN": "B01.875.800.575.912.250.339", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid26000", "RR": "txid26005", "MS": "A plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045467"}, {"RECTYPE": "D", "MH": "Fallopia japonica", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Polygonum cuspidatum|T002|NON|EQV|NLM (2004)|030417|abcdef", "ENTRY": "japonicas, Fallopia", "MN": "B01.875.800.575.912.250.825.359.500", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid488216", "MS": "A plant species of the family POLYGONACEAE. Itadori tea is prepared from the root of this genus.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045468"}, {"RECTYPE": "D", "MH": "Chrysobalanaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Licanias", "MN": "B01.875.800.575.912.250.859.937.110", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid22973", "RR": "txid82154", "MS": "A plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida.", "PM": "2004; see ROSALES 2003-2004", "HN": "2004; use ROSALES 2003-2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045469"}, {"RECTYPE": "D", "MH": "Rubia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "tinctorums, Rubia", "MN": "B01.875.800.575.912.250.456.937.876", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid25473", "RR": "txid339321", "MS": "A plant genus of the family RUBIACEAE. The root is a source of red dyes (madder color and 1,2,4-trihydroxy-9,10-anthracenedione) and ANTHRAQUINONES.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045470"}, {"RECTYPE": "D", "MH": "Aegle", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Aegle marmelos|T002|NON|NRW|NLM (2004)|030417|abcdef", "ENTRY": "marmelos, Crateva", "MN": "B01.875.800.575.912.250.875.077", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid68526", "RR": "txid68527", "AN": "entry term CRATEVA MARMELOS: CRATEVA see CAPPARACEAE is also available", "MS": "A plant genus of the family RUTACEAE.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045471"}, {"RECTYPE": "D", "MH": "Severe acute respiratory syndrome-related coronavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Severe acute respiratory syndrome coronavirus|T005|NON|NRW|NLM (2023)|220712|abcdef", "ENTRY": "Urbani SARS Associated Coronavirus", "MN": "B04.820.578.500.540.150.113.937", "MH_TH": "NLM (2018)", "ST": "T005", "RN": "txid694009", "RR": "txid2901879", "MS": "A species of CORONAVIRUS causing atypical respiratory disease (SEVERE ACUTE RESPIRATORY SYNDROME) in humans. The organism is believed to have first emerged in Guangdong Province, China, in 2002. The natural host is the Chinese horseshoe bat, RHINOLOPHUS sinicus.", "PM": "2023; see SARS Virus 2003-2022", "HN": "2023; use SARS Virus 2003-2022", "MR": "20220712", "DA": "20030417", "DC": "1", "DX": "20030417", "UI": "D045473"}, {"RECTYPE": "D", "MH": "Hot Springs", "AQ": "AN CH MI PS ST VI", "ENTRY": "Warm Spring", "MN": "G16.500.275.260.500", "MH_TH": "NLM (2004)", "ST": "T070", "MS": "Habitat of hot water naturally heated by underlying geologic processes. Surface hot springs have been used for BALNEOLOGY. Underwater hot springs are called HYDROTHERMAL VENTS.", "PM": "2004", "HN": "2004", "MR": "20160705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045482"}, {"RECTYPE": "D", "MH": "Rivers", "AQ": "CH MI PS VI", "ENTRY": "Stream", "MN": "N06.230.232.650", "MH_TH": "NLM (2004)", "ST": "T070", "MS": "Large natural streams of FRESH WATER formed by converging tributaries and which empty into a body of water (lake or ocean).", "PM": "2004", "HN": "2004", "MR": "20120703", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045483"}, {"RECTYPE": "D", "MH": "Helicobacter mustelae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Campylobacter pylori subsp. mustelae|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.150.235.500.250.480", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid217", "AN": "infection: coordinate with HELICOBACTER INFECTIONS", "PI": "Helicobacter (1992-2003)", "MS": "A species of HELICOBACTER commonly associated with STOMACH DISEASES in FERRETS.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045502"}, {"RECTYPE": "D", "MH": "Bartonella bacilliformis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Bartonia bacilliformis|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.050.030.040.080", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid774", "AN": "infection: coordinate with BARTONELLA INFECTIONS", "PI": "Bartonella (1966-2003)", "MS": "The type species of the genus BARTONELLA, a gram-negative bacteria found in humans. It is found in the mountain valleys of Peru, Ecuador, and Southwest Columbia where the sandfly (see PHLEBOTOMUS) vector is present. It causes OROYA FEVER and VERRUGA PERUANA.", "PM": "2004", "HN": "2004", "MR": "20200128", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045503"}, {"RECTYPE": "D", "MH": "Molecular Mechanisms of Pharmacological Action", "PRINT ENTRY": "Pharmacological Mechanisms of Action|T044|NON|EQV|NLM (2008)|061025|abcdef", "MN": "D27.505.519", "FX": "Proteins", "MH_TH": "NLM (2008)", "ST": "T044", "RN": "0", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Pharmacological activities at the molecular level of DRUGS and other exogenous compounds that are used to treat DISEASES and affect normal BIOCHEMISTRY.", "PM": "2004; see MOLECULAR MECHANISMS OF ACTION 2004-2007", "HN": "2008(2004)", "MR": "20150605", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045504"}, {"RECTYPE": "D", "MH": "Physiological Effects of Drugs", "ENTRY": "Physiological Effects, Drug", "MN": "D27.505.696", "MH_TH": "NLM (2004)", "ST": "T039", "RN": "0", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Activities which affect organs and systemic functions without regard to a particular disease.", "PM": "2004", "HN": "2004", "MR": "20150605", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045505"}, {"RECTYPE": "D", "MH": "Therapeutic Uses", "PRINT ENTRY": "Therapeutic Use|T038|NON|EQV|NLM (2021)|200113|abcdef", "ENTRY": "Uses, Therapeutic", "MN": "D27.505.954", "MH_TH": "NLM (2004)", "ST": "T038", "RN": "0", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Uses of chemicals which affect the course of conditions, diseases, syndromes or pathology to benefit the health of an individual.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045506"}, {"RECTYPE": "D", "MH": "Recombinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Resolvases|T116|T126|NON|NRW|NLM (2004)|030429|abbcdef", "MN": "D08.811.739", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "0", "PI": "DNA Nucleotidyltransferases (1986-2003)", "MS": "A broad category of enzymes that are involved in the process of GENETIC RECOMBINATION.", "PM": "2004; RECOMBINASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1986-2003; RESOLVASE was indexed under TRANSPOSASES 1997-2003, under DNA NUCLEOTIDYLTRANSFERASES 1992-1997 & under NUCLEOTIDYLTRANSFERASES 1981-1995", "HN": "2004; use RECOMBINASES (NM) 1986-2003; for RESOLVASE use RECOMBINASES (NM) 1981-2003", "DA": "20030725", "DC": "1", "DX": "20040101", "UI": "D045522"}, {"RECTYPE": "D", "MH": "Phycobilisomes", "AQ": "AD AE AG AI AN BI CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "ENTRY": "Phycobilisome", "MN": "D08.811.600.710.490.500", "MH_TH": "NLM (2004)", "ST": "T026", "RN": "0", "PI": "Proteins (1978-2003)", "MS": "Light energy harvesting structures attached to the THYLAKOID MEMBRANES of CYANOBACTERIA and RED ALGAE. These multiprotein complexes contain pigments (PHYCOBILIPROTEINS) that transfer light energy to chlorophyll a.", "PM": "2004; PHYCOBILISOMES was indexed under PROTEINS 1978-2003", "HN": "2004; use PHYCOBILISOMES (NM) 1980-2003; use PROTEINS 1978-1979", "MR": "20110624", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045524"}, {"RECTYPE": "D", "MH": "PQQ Cofactor", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methoxatin|T109|T123|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Quinone, Pyrroloquinoline", "MN": "D08.211.682", "MH_TH": "NLM (2004)", "ST": "T123", "N1": "1H-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylic acid, 4,5-dihydro-4,5-dioxo-", "RN": "72909-34-3", "MS": "A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.", "PM": "2004; METHOXATIN (now PQQ COFACTOR) was indexed under QUINOLONES 1981-2003", "HN": "2004; use PQQ COFACTOR (NM) 1981-2003", "MR": "20160531", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045542"}, {"RECTYPE": "D", "MH": "Indolequinones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Indole Quinones", "MN": "D03.633.100.473.412", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "AN": "coord with appropriate specific chemical terms if pertinent", "PI": "Indoles (1990-2003)", "MS": "INDOLES which have two keto groups forming QUINONES like structures of the indole aromatic ring.", "PM": "2004", "HN": "2004", "MR": "20160531", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045563"}, {"RECTYPE": "D", "MH": "Transposon Resolvases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Resolvases, Transposon|T116|T126|NON|EQV|NLM (2004)|030604|abbcdef", "ENTRY": "TnpR Protein|T116|T126|NON|EQV|NLM (2004)|abbcde", "MN": "D08.811.913.696.445.837", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.7.7.-", "AN": "Don't confuse with HOLLIDAY JUNCTION RESOLVASES", "PI": "Transposase (1998-2003)", "MS": "Recombinases that involved in the propagation of DNA TRANSPOSONS. They bind to transposon sequences found at two different sites along the same stretch of DNA and bring them into close proximity. The enzymes then catalyze the double strand cleavage, exchange of double strands and rejoining of DNA helices so that the DNA transposon is formed into a circular PLASMID.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045564"}, {"RECTYPE": "D", "MH": "Holliday Junction Resolvases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Resolvases, Holliday Junction|T116|T126|NON|EQV|NLM (2004)|030530|abbcdef", "ENTRY": "Resolvase, Holliday Junction", "MN": "D08.811.739.250", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.21.-", "AN": "do not confuse with TRANSPOSON RESOLVASES", "PI": "Endonucleases (1989-2003)", "MS": "Enzymes that recognize CRUCIFORM DNA structures and introduce paired incisions that help to resolve the structure into two DNA helices.", "PM": "2004; HOLLIDAY JUNCTION RESOLVASES was indexed under ENDONUCLEASES 1989-2003", "HN": "2004; use HOLLIDAY JUNCTION RESOLVASES (NM) 1989-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045565"}, {"RECTYPE": "D", "MH": "DNA, Cruciform", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Junction, Holliday", "MN": "G05.360.580.325", "FX": "Holliday Junction Resolvases", "MH_TH": "NLM (2004)", "ST": "T086", "RN": "0", "MS": "A cross-shaped DNA structure that can be observed under the electron microscope. It is formed by the incomplete exchange of strands between two double-stranded helices or by complementary INVERTED REPEAT SEQUENCES that refold into hairpin loops on opposite strands across from each other.", "PM": "2004;", "HN": "2004;", "MR": "20150622", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045566"}, {"RECTYPE": "D", "MH": "VDJ Recombinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "VDJ Recombinase|T116|T126|ABX|EQV|NLM (2004)|abbcde", "ENTRY": "V D J Recombinase", "MN": "D08.811.913.696.445.950", "FX": "V(D)J Recombination", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 2.7.7.-", "PI": "DNA Nucleotidyltransferases (1986-2003)", "MS": "Recombinases involved in the rearrangement of immunity-related GENES such as IMMUNOGLOBULIN GENES and T-CELL RECEPTOR GENES.", "PM": "2004; VDJ RECOMBINASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1986-2003", "HN": "2004; use VDJ RECOMBINASES (NM) 1986-2003", "MR": "20110624", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045567"}, {"RECTYPE": "D", "MH": "Tetraoxanes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Tetra Oxanes", "MN": "D02.389.593.374.962", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "AN": "coord with appropriate specific chemical terms if pertinent", "MS": "Compounds with two peroxide groups, that is, two pairs of adjacent OXYGEN atoms. They may have activity against PLASMODIUM similar to the ARTEMISININS.", "PM": "2004", "HN": "2004", "MR": "20230226", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045568"}, {"RECTYPE": "D", "MH": "Phytoplasma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.074.575", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid33926", "PI": "Mycoplasma (1996-1998)", "MS": "A genus of minute bacteria in the family ACHOLEPLASMATACEAE that inhabit phloem sieve elements of infected PLANTS and cause symptoms such as yellowing, phyllody, and witches' brooms. Organisms lack a CELL WALL and thus are similar to MYCOPLASMA in animals. They are transmitted by over 100 species of INSECTS especially leafhoppers, planthoppers, and PSYLLIDS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045582"}, {"RECTYPE": "D", "MH": "Chromosome Positioning", "AQ": "DE ES GE IM PH RE", "ENTRY": "Positioning, Chromosome", "MN": "G04.128.180", "FX": "Intranuclear Space", "MH_TH": "NLM (2004)", "ST": "T043", "MS": "The mechanisms of eukaryotic CELLS that place or keep the CHROMOSOMES in a particular SUBNUCLEAR SPACE.", "PM": "2004", "HN": "2004", "MR": "20160115", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045584"}, {"RECTYPE": "D", "MH": "Flap Endonucleases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Flap Endonuclease|T116|T126|NON|EQV|NLM (2022)|201015|abbcdef", "ENTRY": "RTH 1 Nuclease", "MN": "D08.811.277.352.355.325.350", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.-", "PI": "Endodeoxyribonucleases (1994-2003)", "MS": "Endonucleases that remove 5' DNA sequences from a DNA structure called a DNA flap. The DNA flap structure occurs in double-stranded DNA containing a single-stranded break where the 5' portion of the downstream strand is too long and overlaps the 3' end of the upstream strand. Flap endonucleases cleave the downstream strand of the overlap flap structure precisely after the first base-paired nucleotide, creating a ligatable nick.", "PM": "2004; FLAP ENDONUCLEASES was indexed under ENDODEOYRIBONUCLEASES 1994-2003; FEN1 PROTEIN was indexed under EXODEOXYRIBNUCLEASES 1997-2003; RTH-1 NUCLEASE was indexed under EXODEOXYRIBNUCLEASES 1996-2003", "HN": "2004; use FLAP ENDONUCLEASES (NM) 1994-2003; for FEN1 PROTEIN use EXODEOXYRIBONUCLEASE V 1997-2003; for RTH-1 NUCLEASE use EXODEOXYRIBONUCLEASE V 1996-2003", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045585"}, {"RECTYPE": "D", "MH": "Intranuclear Inclusion Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Inclusion Bodies, Intranuclear|T026|NON|EQV|NLM (2004)|030430|abcdef", "ENTRY": "Nuclear Inclusion Body", "MN": "A11.284.420.400", "FX": "Inclusion Bodies, Viral", "MH_TH": "NLM (2004)", "ST": "T026", "PI": "Inclusion Bodies or specifics (1965-2003)", "MS": "Circumscribed masses of foreign or metabolically inactive materials, within the CELL NUCLEUS. Some are VIRAL INCLUSION BODIES.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045586"}, {"RECTYPE": "D", "MH": "Steatorrhea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C18.452.603.887", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Celiac Disease (1964-2003)", "MS": "A condition that is characterized by chronic fatty DIARRHEA, a result of abnormal DIGESTION and/or INTESTINAL ABSORPTION of FATS.", "PM": "2004; see CELIAC DISEASE 1975-2003", "HN": "2004; use CELIAC DISEASE 1975-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045602"}, {"RECTYPE": "D", "MH": "Dioncophyllaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Triphyophyllums", "MN": "B01.875.800.575.912.250.198.500.300", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid63072", "RR": "txid63075", "AN": "coordinate with CARNIVOROUS PLANT if pertinent", "MS": "A plant family of the order Violales, subclass Dilleniidae class Magnoliopsida. Members contain naphthylisoquinolines which inhibit PLASMODIUM.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045603"}, {"RECTYPE": "D", "MH": "Extracellular Fluid", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Interstitial Fluid|T031|NON|NRW|NLM (1993)|911106|abcdef", "ENTRY": "Interstitial Fluids", "MN": "A12.207.270", "MH_TH": "UNK (19XX)", "ST": "T031", "AN": "do not confuse EXTRACELLULAR FLUID with BODY WATER", "PI": "Extracellular Space (1964-2003)", "MS": "The fluid of the body that is outside of CELLS. It is the external environment for the cells.", "PM": "2004; see EXTRACELLULAR SPACE 1975-2003, see BODY FLUIDS 1963-1974", "HN": "2004; use EXTRACELLULAR SPACE 1975-2003, use BODY FLUIDS 1963-1974", "MR": "20040727", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045604"}, {"RECTYPE": "D", "MH": "Entomoplasmataceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Mesoplasma|T007|NON|NRW|NLM (2004)|030502|abcdef", "MN": "B03.440.860.300.250", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid33925", "RR": "txid46239", "MS": "A family of gram-negative, nonhelical, arthropod-associated bacteria in the order Entomoplasmatales. It is comprised of two genera: Entomoplasma and Mesoplasma.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045622"}, {"RECTYPE": "D", "MH": "Mycoplasma capricolum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.210", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2095", "AN": "infection: coordinate with PLEUROPNEUMONIA, CONTAGIOUS", "PI": "Mycoplasma (1974-2003)", "MS": "A genus in the family ENTOMOPLASMATACEAE, order Entomoplasmatales. It is pathogenic to GOATS, causing caprine pleuropneumonia (PLEUROPNEUMONIA, CONTAGIOUS).", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045623"}, {"RECTYPE": "D", "MH": "Spiroplasma citri", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.300.750.625.500", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2133", "PI": "Spiroplasma (1975-2003)", "MS": "The type species of gram-negative bacteria in the genus SPIROPLASMA, family SPIROPLASMATACEAE, causing citrus stubborn disease.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045642"}, {"RECTYPE": "D", "MH": "DNA Repair Enzymes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA Repair Enzyme|T116|T126|NON|EQV|NLM (2022)|200831|abbcdef", "ENTRY": "Repair Enzymes, DNA", "MN": "D08.811.074", "FX": "DNA Repair", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 6.5.1.-", "AN": "general or unspecified; prefer specifics; coordinate with specific enzyme not treed here", "PI": "DNA Ligases (1978-2003)", "MS": "Enzymes that are involved in the reconstruction of a continuous two-stranded DNA molecule without mismatch from a molecule, which contained damaged regions.", "PM": "2004; see DNA LIGASES 1978-2003", "HN": "2004; use DNA LIGASES 1978-2003", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045643"}, {"RECTYPE": "D", "MH": "Mycoplasma agalactiae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.050", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2110", "AN": "infection: coordinate with MYCOPLASMA INFECTIONS", "PI": "Mycoplasma (1967-2003)", "MS": "A species of gram-negative bacteria causing contagious agalactia of SHEEP and GOATS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045644"}, {"RECTYPE": "D", "MH": "Mycoplasma arthritidis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.075", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2111", "AN": "infection: coordinate with MYCOPLASMA INFECTIONS + probably ARTHRITIS, INFECTIOUS", "PI": "Mycoplasma (1967-2003)", "MS": "A species of gram-negative bacteria causing purulent POLYARTHRITIS in RATS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045645"}, {"RECTYPE": "D", "MH": "Mycoplasma bovigenitalium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.195", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2112", "AN": "infection: coordinate with MYCOPLASMA INFECTIONS", "PI": "Mycoplasma (1966-2003)", "MS": "A species of gram-negative bacteria pathogenic to CATTLE.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045646"}, {"RECTYPE": "D", "MH": "DNA Glycosylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DNA N-glycosidase|T116|T126|ABX|EQV|NLM (2004)|abbcde", "ENTRY": "Glycosylases, DNA", "MN": "D08.811.277.450.430.099", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.2.2.-", "PI": "N-Glycosyl Hydrolases (1982-2003)", "MS": "A family of DNA repair enzymes that recognize damaged nucleotide bases and remove them by hydrolyzing the N-glycosidic bond that attaches them to the sugar backbone of the DNA molecule. The process called BASE EXCISION REPAIR can be completed by a DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE which excises the remaining RIBOSE sugar from the DNA.", "PM": "2004; DNA GLYCOSIDASES was indexed under N-GLYCOSIDE HYDROLASES 1982-2003, under GLYCOSIDE HYDROLASES & DNA 1978-1981", "HN": "2004; use DNA GLYCOSIDASES (NM) 1980-2003", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045647"}, {"RECTYPE": "D", "MH": "Dental Etching", "DE": "DENT ETCHING", "AQ": "AE CL EC ES HI IS MT PX SN ST TD VE", "PRINT ENTRY": "Etching, Dental|T061|NON|EQV|UNK (19XX)|760412|ETCHING DENT|abcdefv", "MN": "E06.931.475", "MH_TH": "NLM (1991)", "ST": "T061", "AN": "coord with agent or method", "PI": "Acid Etching, Dental (1977-2003)", "MS": "Preparation of TOOTH surfaces, and of materials bonded to teeth or DENTAL IMPLANTS, with agents and methods which roughen the surface to facilitate adhesion. Agents include phosphoric or other acids (ACID ETCHING, DENTAL) and methods include LASERS.", "PM": "2004; see ACID ETCHING, DENTAL 1977-2003", "HN": "2004; use ACID ETCHING, DENTAL 1977-2003", "MR": "20180629", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045662"}, {"RECTYPE": "D", "MH": "Quantum Dots", "AQ": "AD AE AN CH CL EC HI ME MI PO PS RE SD SN ST TO TU UL VI", "PRINT ENTRY": "Semiconductor Nanocrystals|T073|T130|NON|REL|NLM (2007)|060321|abbcdef", "ENTRY": "Semiconductor Nanoparticle", "MN": "J01.637.512.600.650", "FX": "Semiconductors", "MH_TH": "NLM (2004)", "ST": "T130", "AN": "do not confuse with microscopic fluorescent bar codes which are micrometer sized", "MS": "Nanometer sized fragments of semiconductor crystalline material which emit PHOTONS. The wavelength is based on the quantum confinement size of the dot. They can be embedded in MICROBEADS for high throughput ANALYTICAL CHEMISTRY TECHNIQUES.", "PM": "2004", "HN": "2004", "MR": "20150331", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045663"}, {"RECTYPE": "D", "MH": "Proprotein Convertase 1", "DS": "PROPROTEIN CONVERTASE 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PC1 Prohormone Convertase|T116|T126|ABX|EQV|NLM (2004)|PC 01 PROHORMONE CONVERTASE|abbcdes", "ENTRY": "Prohormone Convertase, PC3", "MN": "D08.811.277.656.959.350.640", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.4.21.93", "PI": "Aspartic Endopeptidases (1991-2003)", "MS": "A CALCIUM-dependent endopeptidase that has specificity for cleavage at ARGININE that is near paired basic residues. It cleaves a variety of prohormones including PRO-OPIOMELANOCORTIN; PRORENIN; proenkephalins; prodynorphin; prosomatostatin; and PROINSULIN.", "PM": "2004; PC1 PROHORMONE CONVERTASE, NEUROENDOCRINE CONVERTASE PC1, PC3 ENDOPROTEASE & PROHORMONE CONVERTASE 1 were indexed under ASPARTIC ENDOPEPTIDASES 1991-2003; PC1 ENDOPROTEASE & PC3 PROHORMONE CONVERTASE were indexed under ASPARTIC ENDOPEPTIDASES 1993-2003; PROPROTEIN CONVERTASE SPC3 was indexed under ASPARTIC ENDOPEPTIDASES 2001-2003; PROINSULIN CONVERTASE 1 was indexed under ASPARTIC ENDOPEPTIDASES 2002-2003;", "HN": "2004; for PC1 PROHORMONE CONVERTASE, NEUROENDOCRINE CONVERTASE PC1, PC3 ENDOPROTEASE, PROHORMONE CONVERTASE 1 use PROPROTEIN CONVERTASE (NM) 1991-2003; for PC1 ENDOPROTEASE & PC3 PROHORMONE CONVERTASE use PROPROTEIN CONVERTASE (NM) 1993-2003; for PROPROTEIN CONVERTASE SPC3 use PROPROTEIN CONVERTASE (NM) 2001-2003; for PROINSULIN CONVERTASE 1 use PROPROTEIN CONVERTASE (NM) 2002-2003", "MR": "20090706", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045664"}, {"RECTYPE": "D", "MH": "Mycoplasma bovis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.200", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid28903", "AN": "infection: coordinate with MYCOPLASMA INFECTIONS", "PI": "Mycoplasma (1971-2003)", "MS": "A species of gram-negative bacteria causing MASTITIS; ARTHRITIS; and RESPIRATORY TRACT DISEASES in CATTLE.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045682"}, {"RECTYPE": "D", "MH": "Furin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dibasic Processing Enzyme|T116|T126|NON|EQV|NLM (2004)|abbcde", "ENTRY": "Processing Enzyme, Dibasic", "MN": "D08.811.277.656.959.350.353", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.4.21.75", "RR": "EC 3.4.21.75", "PI": "Subtilisins (1993-2003)", "MS": "A proprotein convertase with specificity for the proproteins of PROALBUMIN; COMPLEMENT 3C; and VON WILLEBRAND FACTOR. It has specificity for cleavage near paired ARGININE residues that are separated by two amino acids.", "PM": "2004; FURIN was indexed under SUBTILISINS 1993-2003", "HN": "2004; use FURIN (NM) 1993-2003", "MR": "20090706", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045683"}, {"RECTYPE": "D", "MH": "Mycoplasma conjunctivae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.220", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid45361", "AN": "infection: coordinate with MYCOPLASMA INFECTIONS + probably CONJUNCTIVITIS, BACTERIAL or KERATOCONJUNCTIVITIS, INFECTIOUS", "PI": "Mycoplasma (1972-2003)", "MS": "A species of gram-negative bacteria causing CONJUNCTIVITIS and KERATOCONJUNCTIVITIS in SHEEP and GOATS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045684"}, {"RECTYPE": "D", "MH": "Mycoplasma dispar", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.267", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid86660", "AN": "infection: coordinate with PNEUMONIA, MYCOPLASMA /\u200cvet  + CATTLE DISEASES or MYCOPLASMA INFECTIONS /\u200cvet  + CATTLE DISEASES + RESPIRATORY TRACT INFECTIONS /vet", "PI": "Mycoplasma (1970-2003)", "MS": "A species of gram-negative bacteria causing PNEUMONIA, MYCOPLASMA in calves. Mycoplasma dispar also possibly plays a synergistic role with other BACTERIA and VIRUSES to cause other RESPIRATORY TRACT DISEASES in calves.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045685"}, {"RECTYPE": "D", "MH": "Mycoplasma gallisepticum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.345", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2096", "AN": "infection: coord IM with MYCOPLASMA INFECTIONS (IM)", "PI": "Mycoplasma (1965-2003)", "MS": "A species of gram-negative bacteria causing chronic respiratory disease in POULTRY.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045686"}, {"RECTYPE": "D", "MH": "Proprotein Convertase 5", "DS": "PROPROTEIN CONVERTASE 05", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Prohormone Convertase, PC5|T116|T126|ABX|EQV|NLM (2004)|030506|PROHORMONE CONVERTASE PC 05|abbcdefs", "ENTRY": "Proprotein Convertase, PC6A", "MN": "D08.811.277.656.959.350.648", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.4.21.-", "PI": "Subtilisins (1998-2003)", "MS": "A serine endopeptidase found primarily in the EXTRACELLULAR MATRIX. It has specificity for cleavage of a variety of substrates including PRORENIN, pro-membrane type-1 matrix metalloproteinase, and NEURAL CELL ADHESION MOLECULE L1.", "PM": "2004; PC5 PROPROTEIN CONVERTASE (now PREPROTEIN CONVERTASE 5) was indexed under SERINE ENDOPEPTIDASES 1993-1997 & SUBTILISINS 1998-2003", "HN": "2004; use PREPROTEIN CONVERTASE 5 (NM) 1993-2003; for PC6 ENDOPROTEASE use PREPROTEIN CONVERTASE 5 (NM) 1993-2003", "MR": "20160628", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045702"}, {"RECTYPE": "D", "MH": "Emulsifying Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Emulsifying Agent|T167|NON|EQV|NLM (2021)|200511|abcdef", "ENTRY": "Agents, Emulsifying", "MN": "D27.720.877.383", "MH_TH": "UNK (19XX)", "ST": "T167", "RN": "0", "PI": "Excipients (1984-2003)", "MS": "SURFACE-ACTIVE AGENTS that induce a dispersion of undissolved material throughout a liquid.", "PM": "2004; see EXCIPIENTS 1983-2003", "HN": "2004; use EXCIPIENTS 1983-2003", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045703"}, {"RECTYPE": "D", "MH": "Mycoplasma genitalium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.355", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2097", "AN": "infection: coord IM with MYCOPLASMA INFECTIONS (IM)", "PI": "Mycoplasma (1981-2003)", "MS": "A species of gram-negative bacteria originally isolated from urethral specimens of patients with non-gonoccocal URETHRITIS. In primates it exists in parasitic association with ciliated EPITHELIAL CELLS in the genital and respiratory tracts.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045704"}, {"RECTYPE": "D", "MH": "Mycoplasma hyopneumoniae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.420", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2099", "PI": "Mycoplasma (1968-2003)", "MS": "A species of gram-negative bacteria that causes MYCOPLASMA PNEUMONIA OF SWINE. The organism damages the CILIA in the airways of the pig, and thus compromises one of the most effective mechanical barriers against invading pathogens. The resulting weakening of the IMMUNE SYSTEM can encourage secondary infections, leading to porcine respiratory disease complex.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045705"}, {"RECTYPE": "D", "MH": "Proprotein Convertase 2", "DS": "PROPROTEIN CONVERTASE 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Prohormone Convertase, PC2|T116|T123|ABX|EQV|NLM (2004)|030506|PROHORMONE CONVERTASE PC 02|abbcdefs", "ENTRY": "PC2, Endopeptidase", "MN": "D08.811.277.656.959.350.646", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "EC 3.4.21.94", "PI": "Subtilisins (1991-2003)", "MS": "A serine endopeptidase that has specificity for cleavage at ARGININE. It cleaves a variety of prohormones including PRO-OPIOMELANOCORTIN, proluteinizing-hormone-releasing hormone, proenkephalins, prodynorphin, and PROINSULIN.", "PM": "2004; PC2 PROTEIN (now PROPROTEIN CONVERTASE 2) was indexed under SUBTILISINS 1991-2003", "HN": "2004; use PROPROTEIN CONVERTASE 2 (NM) 1991-2003", "MR": "20090706", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045706"}, {"RECTYPE": "D", "MH": "Porcine Respiratory Coronavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Respiratory Coronavirus, Porcine", "MN": "B04.820.578.500.540.150.075.500.500.600", "MH_TH": "NLM (2004)", "ST": "T005", "RN": "txid11146", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS", "PI": "Transmissible gastroenteritis virus (1986-2003)", "MS": "A mutant strain of TRANSMISSIBLE GASTROENTERITIS VIRUS causing mild or subclinical respiratory infections in young SWINE. It may also play a role in post-weaning porcine respiratory disease complex, especially when combined with other respiratory agents.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045722"}, {"RECTYPE": "D", "MH": "Diverticulosis, Esophageal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Esophageal Diverticulosis|T047|NON|EQV|NLM (2004)|030507|abcdef", "MN": "C06.405.205.282.500.438", "FX": "Diverticulum, Esophageal", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Diverticulum, Esophageal (1967-2003)", "MS": "A pathological condition characterized by the presence of a number of ESOPHAGEAL DIVERTICULA in the ESOPHAGUS.", "PM": "2004; see DIVERTICULUM, ESOPHAGEAL 1980-2003", "HN": "2004; use DIVERTICULUM, ESOPHAGEAL 1980-2003", "MR": "20170706", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045723"}, {"RECTYPE": "D", "MH": "Diverticulosis, Stomach", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stomach Diverticulosis|T047|NON|EQV|NLM (2001)|000323|abcdef", "ENTRY": "Gastric Diverticulosis|T047|NON|EQV|NLM (2004)|030507|abcdef", "MN": "C06.405.748.142", "MH_TH": "NLM (2004)", "ST": "T047", "PI": "Diverticulum, Stomach (1968-2003)", "MS": "A pathological condition characterized by the presence of a number of GASTRIC DIVERTICULA in the STOMACH.", "PM": "2004; see DIVERTICULUM, STOMACH 1980-2003", "HN": "2004; use DIVERTICULUM, STOMACH 1980-2003", "MR": "20190617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045724"}, {"RECTYPE": "D", "MH": "Tetrapyrroles", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetrapyrrole|T109|T123|NON|EQV|NLM (2021)|191118|abbcdef", "MN": "D04.345.783", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Pyrroles (1966-2003)", "MS": "Four PYRROLES joined by one-carbon unit linking position 2 of one to position 5 of the next. The conjugated bond system results in PIGMENTATION.", "PM": "2004; TETRAPYRROLES was indexed under PYRROLES 1978-2003", "HN": "2004; use TETRAPYRROLES (NM) 1978-2003", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045725"}, {"RECTYPE": "D", "MH": "Metalloproteases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Metalloproteinases|T116|T126|NON|EQV|NLM (1988)|990101|abbcdef", "ENTRY": "Metallopeptidases|T116|T126|NON|EQV|NLM (2004)|030514|abbcdef", "MN": "D08.811.277.656.675", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 3.4.-", "AN": "general or unspecified; prefer specifics", "PI": "Metalloendopeptidases (1987-2003)", "MS": "Proteases which use a metal, normally ZINC, in the catalytic mechanism. This group of enzymes is inactivated by metal CHELATORS.", "PM": "2004; see METALLOENDOPEPTIDASES 1988-2003", "HN": "2004; use METALLOENDOPEPTIDASES 1988-2003", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045726"}, {"RECTYPE": "D", "MH": "Metalloexopeptidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Metalloexoproteinases|T116|T126|NON|EQV|NLM (2004)|030507|abbcdef", "MN": "D08.811.277.656.675.555", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.4.-", "MS": "EXOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism.", "PM": "2004", "HN": "2004", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045727"}, {"RECTYPE": "D", "MH": "Corrinoids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D04.345.783.437", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "PI": "Porphyrins (1965-2003)", "MS": "Cyclic TETRAPYRROLES based on the corrin skeleton.", "PM": "2004; CORRINOID was indexed under PORPHYRINS 1975-2003", "HN": "2004; use CORRINOIDS (NM) 1975-2003", "MR": "20160528", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045728"}, {"RECTYPE": "D", "MH": "Pneumonia of Swine, Mycoplasmal", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Pneumonia of Swine, Enzootic|T047|NON|EQV|NLM (2004)|030507|abcdef", "ENTRY": "Swine Mycoplasmal Pneumonia", "MN": "C22.905.626", "MH_TH": "NLM (2004)", "ST": "T047", "AN": "do not confuse with PNEUMONIA, MYCOPLASMA", "MS": "A chronic, clinically mild, infectious pneumonia of PIGS caused by MYCOPLASMA HYOPNEUMONIAE. Ninety percent of swine herds worldwide are infected with this economically costly disease that primarily affects animals aged two to six months old. The disease can be associated with porcine respiratory disease complex. PASTEURELLA MULTOCIDA is often found as a secondary infection.", "PM": "2004", "HN": "2004", "MR": "20190617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045729"}, {"RECTYPE": "D", "MH": "Soy Foods", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Tofu|T168|NON|NRW|NLM (2004)|030507|abcdef", "ENTRY": "Vegetable Proteins, Texturized", "MN": "J02.500.850.800.500", "MH_TH": "NLM (2004)", "ST": "T168", "PI": "Soybeans (1963-2003)", "MS": "Foods made from GLYCINE MAX. Soy foods are high in DIETARY PROTEINS and PHYTOESTROGENS such as ISOFLAVONES.", "PM": "2004", "HN": "2004", "MR": "20230727", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045730"}, {"RECTYPE": "D", "MH": "Scleroderma, Diffuse", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Systemic Sclerosis, Progressive", "MN": "C17.800.784.602", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Scleroderma, Systemic (1975-2003)", "MS": "A rapid onset form of SYSTEMIC SCLERODERMA with progressive widespread SKIN thickening over the arms, the legs and the trunk, resulting in stiffness and disability.", "PM": "2004; see SCLERODERMA, SYSTEMIC 1975-2003", "HN": "2004; use SCLERODERMA, SYSTEMIC 1975-2003", "MR": "20110624", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045743"}, {"RECTYPE": "D", "MH": "Cell Line, Tumor", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Tumor Cell Line|T025|NON|EQV|NLM (2004)|030619|abcdef", "ENTRY": "Tumor Cell Lines", "MN": "A11.251.860.180", "MH_TH": "NLM (1992)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMALS or HUMAN; do not routinely add neoplasm term; policy Manual 21.57, 22.26.1, 24.4.5", "PI": "Tumor Cells, Cultured (1988-2003)", "MS": "A cell line derived from cultured tumor cells.", "PM": "2004", "HN": "2004", "DA": "20030730", "DC": "1", "DX": "20040101", "UI": "D045744"}, {"RECTYPE": "D", "MH": "Scleroderma, Limited", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Systemic Sclerodermas, Limited", "MN": "C17.800.784.801", "MH_TH": "NLM (2004)", "ST": "T047", "AN": "do not confuse with SCLERODERMA, LOCALIZED", "PI": "Scleroderma, Systemic (1990-2003)", "MS": "The least progressive form of SYSTEMIC SCLERODERMA with skin thickening restricted to the face, neck and areas distal to the elbows and/or knees, sparing the trunk. The CREST SYNDROME is a form of limited scleroderma.", "PM": "2004", "HN": "2004", "MR": "20090706", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045745"}, {"RECTYPE": "D", "MH": "Enzymes and Coenzymes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Coenzymes and Enzymes", "MN": "D08", "RH": "D8 - ENZYMES AND COENZYMES", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "0", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Biological catalysts and their cofactors.", "PM": "2004", "HN": "2004", "MR": "20150605", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045762"}, {"RECTYPE": "D", "MH": "Hemiterpenes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hemiterpenoids|T109|NON|EQV|NLM (2020)|190227|abcdef", "MN": "D02.455.849.486", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "MS": "Compounds that include a single 2-methyl-1,3-butadiene (also known as isoprene) within their structure.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045782"}, {"RECTYPE": "D", "MH": "Clove Oil", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Oil of Cloves|T109|T121|T122|NON|EQV|UNK (19XX)|830531|abbbcdef", "ENTRY": "Oil, Clove", "MN": "D20.215.784.750.186", "MH_TH": "UNK (19XX)", "ST": "T122", "RN": "0", "PI": "Eugenol (1983-2003)", "MS": "An oil from flower buds of SYZYGIUM trees which contains large amounts of EUGENOL.", "PM": "2004; see EUGENOL 1983-2003", "HN": "2004; use EUGENOL 1983-2003", "MR": "20060705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045783"}, {"RECTYPE": "D", "MH": "Abietanes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Totaranes|T109|NON|NRW|NLM (2020)|190124|abcdef", "ENTRY": "Pimarane Diterpenes", "MN": "D04.615.723.040", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "PI": "Diterpenes (1988-2003)", "MS": "A subclass of  cyclical DITERPENES that contain the abietane ring structure.", "PM": "2020; see DITERPENES, ABIETANE 2014-2019", "HN": "2020 (2004)", "MR": "20210510", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045784"}, {"RECTYPE": "D", "MH": "Diterpenes, Clerodane", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Neoclerodanes|T109|NON|NRW|NLM (2020)|190107|abcdef", "ENTRY": "Diterpenoids, Clerodane", "MN": "D02.455.849.291.325", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "PI": "Diterpenes (1977-2003)", "MS": "A group of DITERPENES cyclized into 2-rings with a side-chain.", "PM": "2004; CLERODANE was indexed under DITERPENES, CLERODANE 2004-2006", "HN": "2004(2002)", "MR": "20230531", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045785"}, {"RECTYPE": "D", "MH": "Diterpenes, Kaurane", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Kaurane Diterpenoids|T109|NON|EQV|NLM (2020)|190501|abcdef", "ENTRY": "Kaurane Diterpenes", "MN": "D02.455.849.291.350", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "PI": "Diterpenes (1976-2003)", "MS": "A group of DITERPENES cyclized into four rings.", "PM": "2004", "HN": "2004", "MR": "20230531", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045786"}, {"RECTYPE": "D", "MH": "Sesquiterpenes, Eudesmane", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Furanoeudesmanes|T109|NON|NRW|NLM (2020)|190522|abcdef", "ENTRY": "Eudesmane Sesquiterpenes", "MN": "D04.663.500", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "PI": "Diterpenes (1977-2003)", "MS": "SESQUITERPENES cyclized into two adjoining cyclohexane rings but with a different configuration from the ARTEMISININS.", "PM": "2004", "HN": "2004", "MR": "20190705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045787"}, {"RECTYPE": "D", "MH": "Sesquiterpenes, Germacrane", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Germacranes|T109|NON|NRW|NLM (2020)|190522|abcdef", "ENTRY": "Germacrane Sesquiterpenes", "MN": "D02.455.849.765.521.750", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "PI": "Diterpenes (1975-2003)", "MS": "SESQUITERPENES cyclized to one 10-carbon ring.", "PM": "2004", "HN": "2004", "MR": "20190705", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045788"}, {"RECTYPE": "D", "MH": "Sesquiterpenes, Guaiane", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Guaiane Sesquiterpene|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Sesquiterpene, Guaiane", "MN": "D04.663.500.750", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "PI": "Sesquiterpenes (1975-2003)", "MS": "SESQUITERPENES cyclized into two adjoining rings, one being 7-carbons and the other is 5-carbons.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045789"}, {"RECTYPE": "D", "MH": "Mycoplasma hyorhinis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.425", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2100", "AN": "infection: coord IM with MYCOPLASMA INFECTIONS (IM)", "PI": "Mycoplasma (1966-2003)", "MS": "A species of gram-negative bacteria and a common inhabitant of the NASAL CAVITY of both healthy and diseased PIGS. It is a common secondary invader in MYCOPLASMAL PNEUMONIA OF SWINE.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045790"}, {"RECTYPE": "D", "MH": "Mycoplasma hyosynoviae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.430", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid29559", "AN": "infection: coordinate with MYCOPLASMA INFECTIONS + probably ARTHRITIS, INFECTIOUS", "PI": "Mycoplasma (1970-2003)", "MS": "A species of gram-negative bacteria isolated from the SYNOVIAL FLUID; LYMPH NODES; and MUCOUS MEMBRANE secretions in diseased SWINE. It causes nonsuppurative ARTHRITIS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045791"}, {"RECTYPE": "D", "MH": "Norisoprenoids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vitispirane|T109|NON|NRW|NLM (2021)|191121|abcdef", "ENTRY": "Nor Isoprenoids", "MN": "D02.455.849.131.309", "MH_TH": "NLM (2004)", "ST": "T109", "RN": "0", "MS": "Thirteen-carbon butene cyclohexene degradation products formed by the cleavage of CAROTENOIDS. They contribute to the flavor of some FRUIT. Ionone should not be confused with the similarly named ionol.", "PM": "2004", "HN": "2004", "MR": "20200527", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045792"}, {"RECTYPE": "D", "MH": "Mycoplasma iowae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.450", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2116", "AN": "infection: coord IM with MYCOPLASMA INFECTIONS (IM)", "PI": "Mycoplasma (1981-2003)", "MS": "A species of gram-negative bacteria causing lesions to AIR SACS and HOCK joints in TURKEYS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045793"}, {"RECTYPE": "D", "MH": "Mycoplasma meleagridis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.570", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid29561", "AN": "infection: coord IM with MYCOPLASMA INFECTIONS (IM)", "PI": "Mycoplasma (1966-2003)", "MS": "A species of gram-negative bacteria producing air sacculitis and skeletal abnormalities in TURKEYS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045794"}, {"RECTYPE": "D", "MH": "Mycoplasma orale", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.630", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2121", "AN": "infection: coord IM with MYCOPLASMA INFECTIONS (IM)", "PI": "Mycoplasma (1968-2003)", "MS": "A species of gram-negative bacteria that is a common inhabitant of the human OROPHARYNX and also cell culture contaminant. It is usually non-pathogenic but it can cause infections in leukemic or immunosuppressed patients.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045795"}, {"RECTYPE": "D", "MH": "Mycoplasma ovipneumoniae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.635", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid29562", "AN": "infection: coord IM with PNEUMONIA, MYCOPLASMA/vet (IM)", "PI": "Mycoplasma (1975-2003)", "MS": "A species of gram-negative bacteria originally isolated from the LUNGS; TRACHEA; and NASAL CAVITY of SHEEP. It causes chronic interstitial pneumonia (PNEUMONIA, MYCOPLASMA) in both SHEEP and GOATS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045802"}, {"RECTYPE": "D", "MH": "Mycoplasma pulmonis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.670", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2107", "AN": "infection: coord IM with MYCOPLASMA INFECTIONS (IM)", "PI": "Mycoplasma (1965-2003)", "MS": "A species of gram-negative bacteria highly pathogenic to RATS and MICE. It is the primary cause of murine respiratory mycoplasmosis.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045803"}, {"RECTYPE": "D", "MH": "Mycoplasma salivarium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.720", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2124", "AN": "infection: coord IM with MYCOPLASMA INFECTIONS (IM)", "PI": "Mycoplasma (1962-2003)", "MS": "A species of gram-negative bacteria strongly implicated in oral infection, PERIODONTAL DISEASES, eye and ear disorders, and SEPTIC ARTHRITIS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045804"}, {"RECTYPE": "D", "MH": "Mycoplasma synoviae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.580.553.553.770", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid2109", "AN": "infection: coordinate with MYCOPLASMA INFECTIONS", "PI": "Mycoplasma (1965-2003)", "MS": "A species of gram-negative bacteria pathogenic to CHICKENS; TURKEYS, and guinea fowls. It causes disease in a wide variety of organs and tissues including JOINTS, tendon sheaths and the RESPIRATORY TRACT.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045805"}, {"RECTYPE": "D", "MH": "Refusal to Participate", "AQ": "EH ES HI LJ PX SN", "ENTRY": "Participate, Refusal to", "MN": "F02.463.785.373.476.850", "FX": "Treatment Refusal", "MH_TH": "NLM (2003)", "ST": "T055", "MS": "Refusal to take part in activities or procedures that are requested or expected of an individual. This may include refusal by HEALTH PERSONNEL to participate in specific medical procedures or refusal by PATIENTS or members of the public to take part in clinical trials or health promotion programs.", "PM": "2004; see DISSENT AND DISPUTES 2003", "HN": "2004; use DISSENT AND DISPUTES 2003", "MR": "20090715", "DA": "20030722", "DC": "1", "DX": "20040101", "UI": "D045808"}, {"RECTYPE": "D", "MH": "Human Rights Abuses", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Rights Abuses, Human", "MN": "I01.880.735.384", "FX": "War Crimes", "MH_TH": "NLM (2004)", "ST": "T068", "PI": "Human Rights (1973-2003)", "MS": "Deliberate maltreatment of groups of humans beings including violations of generally-accepted fundamental rights as stated by the Universal Declaration of Human Rights, adopted and proclaimed by the United Nations General Assembly resolution 217 A (III) of 10 December 1948.", "PM": "2004", "HN": "2004", "MR": "20040713", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045809"}, {"RECTYPE": "D", "MH": "Intestinal Volvulus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Volvulus, Intestinal", "MN": "C23.300.970.500", "MH_TH": "NLM (2004)", "ST": "T047", "PI": "Intestinal Obstruction (1965-2003)", "MS": "A twisting in the intestine (INTESTINES) that can cause INTESTINAL OBSTRUCTION.", "PM": "2004; see INTESTINAL OBSTRUCTION 1975-2003", "HN": "2004; use INTESTINAL OBSTRUCTION 1975-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045822"}, {"RECTYPE": "D", "MH": "Ileus", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C06.405.469.531.492", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "coord IM with specific precoord intestinal dis (IM); PARALYTIC ILEUS see INTESTINAL PSEUDO-OBSTRUCTION is also available", "PI": "Intestinal Obstruction (1968-2003)", "MS": "A condition caused by the lack of intestinal PERISTALSIS or INTESTINAL MOTILITY without any mechanical obstruction. This interference of the flow of INTESTINAL CONTENTS often leads to INTESTINAL OBSTRUCTION. Ileus may be classified into postoperative, inflammatory, metabolic, neurogenic, and drug-induced.", "PM": "2004; see INTESTINAL OBSTRUCTION 1975-2003", "HN": "2004; use INTESTINAL OBSTRUCTION 1975-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045823"}, {"RECTYPE": "D", "MH": "Desulfovibrionaceae Infections", "DE": "DESULFOVIBRIONACEAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Lawsonia Infections|T047|NON|NRW|NLM (2004)|030514|LAWSONIA INFECT|abcdefv", "ENTRY": "Lawsonia Infection", "MN": "C01.150.252.400.260", "MH_TH": "NLM (2004)", "ST": "T047", "MS": "Infections with bacteria of the family Desulfovibrionaceae.", "PM": "2004", "HN": "2004", "MR": "20190617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045824"}, {"RECTYPE": "D", "MH": "Fusobacteriaceae Infections", "DE": "FUSOBACTERIACEAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Fusobacteriaceae", "MN": "C01.150.252.400.388", "MH_TH": "NLM (2004)", "ST": "T047", "MS": "Infections with bacteria of the family Fusobacteriaceae, in the order Fusobacterales, phylum FUSOBACTERIA.", "PM": "2004", "HN": "2004", "MR": "20190617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045825"}, {"RECTYPE": "D", "MH": "Flavobacteriaceae Infections", "DE": "FLAVOBACTERIACEAE INFECT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Flavobacteriaceae", "MN": "C01.150.252.400.349", "MH_TH": "NLM (2004)", "ST": "T047", "MS": "Infections with bacteria of the family FLAVOBACTERIACEAE.", "PM": "2004", "HN": "2004", "MR": "20190617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045826"}, {"RECTYPE": "D", "MH": "Cytophagaceae Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Flexibacteraceae", "MN": "C01.150.252.400.245", "MH_TH": "NLM (2012)", "ST": "T047", "MS": "Infections with bacteria of the family CYTOPHAGACEAE.", "PM": "2012; see FLEXIBACTERACEAE INFECTIONS 2004-2011", "HN": "2012 (2004)", "MR": "20190617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045827"}, {"RECTYPE": "D", "MH": "Moraxellaceae Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Psychobacter Infections|T047|NON|NRW|NLM (2004)|030514|abcdef", "ENTRY": "Psychobacter Infection", "MN": "C01.150.252.400.560", "MH_TH": "NLM (2004)", "ST": "T007", "MS": "Infections with bacteria of the family MORAXELLACEAE.", "PM": "2004", "HN": "2004", "MR": "20190617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045828"}, {"RECTYPE": "D", "MH": "Fibrobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.305.500", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid832", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "MS": "A genus of gram-negative, anaerobic bacteria in the family Fibrobacteraceae, isolated from the human GASTROINTESTINAL TRACT.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045848"}, {"RECTYPE": "D", "MH": "Acidaminococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.073", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid904", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "MS": "A genus of gram-negative bacteria in the family ACIDAMINOCOCCACEAE, isolated from the INTESTINES of PIGS and humans.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045850"}, {"RECTYPE": "D", "MH": "Megasphaera", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.400.500", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid906", "AN": "infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Veillonellaceae (1975-2003)", "MS": "A genus of gram-negative bacteria in the family ACIDAMINOCOCCACEAE, found in the RUMEN of SHEEP and CATTLE, and also in humans.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045851"}, {"RECTYPE": "D", "MH": "Pectinatus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.800.755", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid864", "MS": "A genus of gram-negative bacteria in the family ACIDAMINOCOCCACEAE, isolated from spoiled BEER and pitching yeast.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045852"}, {"RECTYPE": "D", "MH": "Exhalation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Respiratory Expirations", "MN": "G09.772.705.700.275", "FX": "Pulmonary Elimination", "MH_TH": "NLM (2004)", "ST": "T042", "MS": "The act of BREATHING out.", "PM": "2004", "HN": "2004", "MR": "20160617", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045853"}, {"RECTYPE": "D", "MH": "Veillonellaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Acidaminococcaceae|T007|NON|EQV|NLM (2004)|030515|abcdef", "MN": "B03.440.425.410.800", "MH_TH": "NLM (1976)", "ST": "T007", "RN": "txid31977", "MS": "A family of gram-negative bacteria, in the phylum FIRMICUTES.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045854"}, {"RECTYPE": "D", "MH": "Acetobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.024", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid33951", "AN": "do not confuse with ACETOBACTER", "PI": "Gram Positive Rods (1981-2003)", "MS": "A genus of gram-negative bacteria in the family Eubacteriaceae. Species are homoacetogenic, having the ability to use CARBON DIOXIDE as an electron sink, and to reduce it producing acetate as a typical fermentation product.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045855"}, {"RECTYPE": "D", "MH": "Butyrivibrio", "AQ": "CH CL CY DE EN GD GE IM IP ME PY RE UL VI", "MN": "B03.353.625.250", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid830", "AN": "infection: coordinate IM with BACTERIAL INFECTIONS (IM)", "PI": "Gram-Negative Anaerobic Bacteria (1975-2003)", "MS": "A species of anaerobic bacteria, in the family Lachnospiraceae, found in RUMINANTS. It is considered both gram-positive and gram-negative.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045856"}, {"RECTYPE": "D", "MH": "Ruminococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.687", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid1263", "AN": "infection: coordinate IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM)", "PI": "Gram-Positive Cocci (1977-2003)", "MS": "A genus of gram-positive bacteria in the family Lachnospiraceae that inhabits the RUMEN; LARGE INTESTINE; and CECUM of MAMMALS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045857"}, {"RECTYPE": "D", "MH": "Desulfitobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.900.174", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid36853", "MS": "A genus of anaerobic, gram-positive bacteria in the family Peptococcaceae, that reductively dechlorinates CHLOROPHENOLS.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045858"}, {"RECTYPE": "D", "MH": "Desulfotomaculum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.900.300", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid1562", "MS": "A genus of anaerobic bacteria in the family Peptococcaceae, widely distributed in SOIL and the RUMEN of animals. Stains gram-negative but cell wall is gram-positive type.", "PM": "2004", "HN": "2004", "MR": "20200813", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045859"}, {"RECTYPE": "D", "MH": "Sorghum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "halepenses, Sorghum", "MN": "B01.875.800.575.912.250.822.894", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid4557", "RR": "txid4560", "MS": "A plant genus of the family POACEAE. The grain is used for FOOD and for ANIMAL FEED. This should not be confused with KAFFIR LIME or with KEFIR milk product.", "PM": "2004", "HN": "2004", "MR": "20210630", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045868"}, {"RECTYPE": "D", "MH": "Ganglion Cysts", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Myxoid Cyst|T020|NON|EQV|UNK (19XX)|860623|abcdef", "ENTRY": "Myxoid Cysts", "MN": "C17.300.550.274", "MH_TH": "NLM (2004)", "ST": "T020", "AN": "non-neoplastic; SYNOVIAL CYSTS is also available", "PI": "Synovial Cyst (1969-2003)", "MS": "Nodular tumor-like lesions or mucoid flesh, arising from tendon sheaths, LIGAMENTS, or JOINT CAPSULE, especially of the hands, wrists, or feet. They are not true cysts as they lack epithelial wall. They are distinguished from SYNOVIAL CYSTS by the lack of communication with a joint cavity or the SYNOVIAL MEMBRANE.", "PM": "2004; see SYNOVIAL CYST 1969-2003", "HN": "2004; use SYNOVIAL CYST 1969-2003", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045888"}, {"RECTYPE": "D", "MH": "Mpox (monkeypox)", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Monkeypox|T047|NON|EQV|NLM (2004)|030609|abcdef", "ENTRY": "Mpoxs (monkeypox)", "MN": "C22.795.600", "MH_TH": "NLM (2024)", "ST": "T047", "AN": "human & animal; if in animal, use/vet", "PI": "Poxviridae Infections (1967-2003)", "MS": "A viral disease infecting PRIMATES and RODENTS. Its clinical presentation in humans is similar to SMALLPOX including FEVER; HEADACHE; COUGH; and a painful RASH. It is caused by MONKEYPOX VIRUS and is usually transmitted to humans through BITES or via contact with an animal's BLOOD. Interhuman transmission is relatively low (significantly less than smallpox).", "PM": "2023; see MONKEYPOX 2004-2023", "HN": "2023 (2004)", "MR": "20230516", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045908"}, {"RECTYPE": "D", "MH": "Anabolic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Anabolic", "MN": "D27.505.696.399.472.080", "MH_TH": "NLM (2004)", "ST": "T121", "RN": "0", "AN": "note entry term ANABOLIC EFFECT: use only for the anabolic effect of a chemical substance", "MS": "These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power.", "PM": "2004", "HN": "2004", "MR": "20140625", "DA": "20030709", "DC": "1", "DX": "20040101", "UI": "D045930"}, {"RECTYPE": "D", "MH": "Viverridae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Genets|T015|NON|NRW|NLM (1998)|961028|abcdef", "ENTRY": "Civet Cat", "MN": "B01.050.150.900.649.313.750.377.984", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9673", "AN": "note entry terms: CIVET, MALAGASY see EUPLERIDAE and AFRICAN PALM CIVET see NANDINIIDAE are also available", "PI": "Carnivora (1967-2004)", "MS": "The family of civets which are small and medium-sized Old World carnivores, often striped or spotted.", "PM": "2005; see CARNIVORA 1998-2004; for CIVET CATS see CARNIVORA 2004", "HN": "2005; use CARNIVORA 1998-2004; for CIVET CATS use CARNIVORA 2004", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D045949"}, {"RECTYPE": "D", "MH": "Hyaenidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Proteles|T015|NON|NRW|NLM (1998)|961025|abcdef", "ENTRY": "Protele", "MN": "B01.050.150.900.649.313.750.377.937", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9676", "RR": "txid9679", "PI": "Carnivora (1971-2004)", "MS": "A family of large terrestrial carnivores possessing long legs, coarse guard hairs and a bushy tail. It comprises hyenas and aardwolves.", "PM": "2005; see CARNIVORA 1998-2004", "HN": "2005; use CARNIVORA 1998-2004", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D045968"}, {"RECTYPE": "D", "MH": "Mustelidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Wolverines|T015|NON|NRW|NLM (1998)|961008|abcdef", "ENTRY": "Wolverine", "MN": "B01.050.150.900.649.313.750.250.575", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9655", "RR": "txid9658", "PI": "Carnivora (1967-2004)", "MS": "A family of terrestrial carnivores with long, slender bodies, long tails, and anal scent glands. They include badgers, weasels, martens, FERRETS; MINKS; wolverines, polecats, and OTTERS.", "PM": "2005; see CARNIVORA 1998-2004", "HN": "2005; use CARNIVORA 1998-2004", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D045969"}, {"RECTYPE": "D", "MH": "Procyonidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Ringtails|T015|NON|NRW|NLM (2007)|060428|abcdef", "ENTRY": "Ringtail", "MN": "B01.050.150.900.649.313.750.250.623", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9647", "RR": "txid9650", "PI": "Carnivora (1970-2004)", "MS": "A family of long-tailed terrestrial omnivores that includes RACCOONS, ringtails, and coatimundis.", "PM": "2005; see CARNIVORA 1998-2004", "HN": "2005; use CARNIVORA 1998", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D045988"}, {"RECTYPE": "D", "MH": "Felidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Ocelots|T015|NON|NRW|NLM (1998)|961028|abcdef", "ENTRY": "Ocelot", "MN": "B01.050.150.900.649.313.750.377.750", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9681", "RR": "txid61452", "PI": "Carnivora (1966-2004)", "MS": "The cat family in the order CARNIVORA comprised of muscular, deep-chested terrestrial carnivores with a highly predatory lifestyle.", "PM": "2005; see CARNIVORA 1998-2004", "HN": "2005; use CARNIVORA 1998-2004", "MR": "20210510", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D045989"}, {"RECTYPE": "D", "MH": "Felis", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "MN": "B01.050.150.900.649.313.750.377.750.250", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9682", "PI": "Carnivora (1964-2004)", "MS": "Genus in the family FELIDAE comprised of small felines including the domestic cat, Felis catus (CATS) and its ancestor the wild cat, Felis silvestris.", "PM": "2005; see CARNIVORA 1998-2004", "HN": "2005; use CARNIVORA 1998-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D045991"}, {"RECTYPE": "D", "MH": "Lynx", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Bobcats|T015|NON|NRW|NLM (1998)|961028|abcdef", "ENTRY": "Bobcat", "MN": "B01.050.150.900.649.313.750.377.750.500", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid13124", "RR": "txid61384", "PI": "Carnivora (1966-2004)", "MS": "A genus in the family FELIDAE comprising felines with long legs, ear tufts, and a short tail.", "PM": "2005; see CARNIVORA 1998-2004", "HN": "2005; use CARNIVORA 1998-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046008"}, {"RECTYPE": "D", "MH": "Panthera", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Snow Leopards|T015|NON|NRW|NLM (2005)|030805|abcdef", "ENTRY": "Snow Leopard", "MN": "B01.050.150.900.649.313.750.377.750.600", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9688", "RR": "txid9691", "AN": "do not confuse entry term LEOPARD with leopards in other genera", "PI": "Carnivora (1966-2004)", "MS": "Genus in the family FELIDAE comprised of big felines including LIONS; TIGERS; jaguars; and the leopard.", "PM": "2005; see CARNIVORA 1998-2004; for SNOW LEOPARDS see FELIDAE 2005-2021", "HN": "2005; use CARNIVORA 1998-2004; for SNOW LEOPARDS use FELIDAE 2005-2021", "MR": "20210510", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046009"}, {"RECTYPE": "D", "MH": "Tigers", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Panthera tigris|T015|NON|EQV|NLM (2005)|030805|abcdef", "ENTRY": "Tiger", "MN": "B01.050.150.900.649.313.750.377.750.600.800", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9694", "PI": "Carnivora (1963-2004)", "MS": "The species Panthera tigris, a large feline inhabiting Asia. Several subspecies exist including the Siberian tiger and Sumatran tiger.", "PM": "2005; see CARNIVORA 1998-2004", "HN": "2005; use CARNIVORA 1998-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046010"}, {"RECTYPE": "D", "MH": "Puma", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Puma concolor|T015|NON|NRW|NLM (2005)|030805|abcdef", "ENTRY": "Pumas", "MN": "B01.050.150.900.649.313.750.377.750.630", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid146712", "RR": "txid9696", "PI": "Carnivora (1969-2004)", "MS": "A genus in the family FELIDAE comprising one species, Puma concolor. It is a large, long-tailed, feline of uniform color. The names puma, cougar, and mountain lion are used interchangeably for this species. There are more than 20 subspecies.", "PM": "2005; use CARNIVORA 1998-2004", "HN": "2005; use CARNIVORA 1998-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046011"}, {"RECTYPE": "D", "MH": "Canidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Wolf, Maned", "MN": "B01.050.150.900.649.313.750.250.216", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9608", "RR": "txid68728", "PI": "Carnivora (1965-2004)", "MS": "A family of terrestrial carnivores with long snouts and non-retractable claws. Members include COYOTES; DOGS; FOXES; JACKALS; RACCOON DOGS; and WOLVES.", "PM": "2005; see CARNIVORA 1998-2004", "HN": "2005; use CARNIVORA 1998-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046028"}, {"RECTYPE": "D", "MH": "Coyotes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Canis latrans|T015|NON|EQV|NLM (2005)|030806|abcdef", "ENTRY": "Coyote", "MN": "B01.050.150.900.649.313.750.250.216.150", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9614", "PI": "Carnivora (1966-2004)", "MS": "The species Canis latrans in the family CANIDAE, a smaller relative of WOLVES. It is found in the Western hemisphere from Costa Rica to Alaska.", "PM": "2005; see CARNIVORA 1998-2004", "HN": "2005; use CARNIVORA 1998-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046029"}, {"RECTYPE": "D", "MH": "Jackals", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Jackal", "MN": "B01.050.150.900.649.313.750.250.216.400", "MH_TH": "NLM (1998)", "ST": "T015", "PI": "Carnivora (1967-2004)", "MS": "Medium-sized terrestrial carnivores, in the genus Canis, family CANIDAE. Three species are recognized, two found only in Africa and one found in Africa, Europe, and Asia.", "PM": "2005; see CARNIVORA 1998-2004", "HN": "2005; use CARNIVORA 1998-2004", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046030"}, {"RECTYPE": "D", "MH": "Raccoon Dogs", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Nyctereutes|T015|NON|BRD|NLM (1998)|961025|abcdef", "ENTRY": "Raccoon Dog", "MN": "B01.050.150.900.649.313.750.250.216.700", "MH_TH": "NLM (1990)", "ST": "T015", "RN": "txid34880", "RR": "txid34879", "AN": "do not confuse with RACCOONS", "PI": "Carnivora (1974-2004)", "MS": "The lone species in the genus Nyctereutes, family CANIDAE. It is found in the woodland zone from southeastern Siberia to Vietnam and on the main islands of Japan.", "PM": "2005; see CARNIVORA 1990-2004; for NYCTEREUTES see CARNIVORA 1998-2004", "HN": "2005; use CARNIVORA 1990-2004; for NYCTEREUTES use CARNIVORA 1998-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046031"}, {"RECTYPE": "D", "MH": "Microscopy, Energy-Filtering Transmission Electron", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Energy-Filtered Transmission Electron Microscopy|T059|NON|EQV|NLM (2005)|030806|abcdef", "ENTRY": "TEM, Energy-Filtered", "MN": "E05.595.402.580.500", "MH_TH": "NLM (2005)", "ST": "T059", "PI": "Microscopy, Electron (1993-2004)", "MS": "An analytical transmission electron microscopy method using an electron microscope fitted with an energy filtering lens. The method is based on the principle that some of the ELECTRONS passing through the specimen will lose energy when they ionize inner shell electrons of the atoms in the specimen. The amount of energy loss is dependent upon the element. Analysis of the energy loss spectrum (ELECTRON ENERGY-LOSS SPECTROSCOPY) reveals the elemental composition of a specimen. It is used analytically and quantitatively to determine which, how much of, and where specific ELEMENTS are in a sample. For example, it is used for elemental mapping of PHOSPHORUS to trace the strands of NUCLEIC ACIDS in nucleoprotein complexes.", "PM": "2005", "HN": "2005", "MR": "20050721", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046032"}, {"RECTYPE": "D", "MH": "Seals, Earless", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Seals, True|T015|NON|EQV|NLM (2005)|030808|abcdef", "ENTRY": "True Seals", "MN": "B01.050.150.900.649.313.750.250.700", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid9709", "RR": "txid9714", "AN": "seals unspecified goes here; FUR SEALS is also available", "MS": "The family Phocidae, suborder PINNIPEDIA, order CARNIVORA, comprising the true seals. They lack external ears and are unable to use their hind flippers to walk. It includes over 18 species including the harp seal, probably the best known seal species in the world.", "PM": "2005; see SEALS 1975-2004", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046048"}, {"RECTYPE": "D", "MH": "Phoca", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Seal, Harbor|T015|NON|NRW|NLM (2005)|030808|abcdef", "ENTRY": "Seals, Harbor", "MN": "B01.050.150.900.649.313.750.250.700.600", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid9717", "RR": "txid9720", "PI": "Seals, Earless (1975-2004)", "MS": "A genus in the family of EARLESS SEALS (Phocidae) and collectively the most abundant PINNIPEDS in the Northern Hemisphere.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046049"}, {"RECTYPE": "D", "MH": "Caulerpa", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "taxifolia, Caulerpa", "MN": "B01.875.150.300", "MH_TH": "NLM (2005)", "ST": "T002", "RN": "txid76312", "RR": "txid76313", "PI": "Algae, Green (1971-2004)", "MS": "A genus of toxic marine GREEN ALGAE found throughout tropical and subtropical seas. One species, Caulerpa taxifolia, is highly invasive and produces the poison caulerpenyne, deadly to marine organisms though not humans.", "PM": "2005", "HN": "2005", "MR": "20210630", "DA": "20040719", "DC": "1", "DX": "20050101", "UI": "D046068"}, {"RECTYPE": "D", "MH": "Fur Seals", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Seals, Eared|T015|NON|EQV|NLM (2005)|040202|abcdef", "ENTRY": "Seals, Fur", "MN": "B01.050.150.900.649.313.750.250.288", "MH_TH": "NLM (1991)", "ST": "T015", "RR": "txid34883", "AN": "SEALS, EARLESS and SEA LIONS are also available", "MS": "A group comprised of several species of eared seals found in two genera, in the family Otariidae. In comparison to SEA LIONS, they have an especially dense wooly undercoat.", "PM": "2005; see SEALS 1990-2004", "HN": "2005; use SEALS, EARLESS 1990-2004", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046069"}, {"RECTYPE": "D", "MH": "Sea Lions", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Zalophus|T015|NON|NRW|NLM (2005)|030811|abcdef", "ENTRY": "Sealion", "MN": "B01.050.150.900.649.313.750.250.670", "MH_TH": "UNK (19XX)", "ST": "T015", "RR": "txid9704", "MS": "A group comprised of several species of aquatic carnivores in different genera, in the family Otariidae. In comparison to FUR SEALS, they have shorter, less dense hair.", "PM": "2005; see SEALS 1978-2004, see PINNIPEDIA 1968-1979", "HN": "2005; use SEALS, EARLESS 1980-2004, use PINNIPEDIA 1968-1979", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046070"}, {"RECTYPE": "D", "MH": "Hearing Loss, Unilateral", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Unilateral Hearing Loss|T047|NON|EQV|NLM (2005)|031106|abcdef", "ENTRY": "Unilateral, Deafness", "MN": "C23.888.592.763.393.341.950", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Hearing Disorders (1967-2004)", "MS": "Partial or complete hearing loss in one ear.", "PM": "2005", "HN": "2005", "MR": "20190617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046088"}, {"RECTYPE": "D", "MH": "Hearing Loss, Mixed Conductive-Sensorineural", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Losses, Mixed Hearing", "MN": "C23.888.592.763.393.341.849", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Hearing Disorders (1985-2004)", "MS": "Hearing loss due to damage or impairment of both the conductive elements (HEARING LOSS, CONDUCTIVE) and the sensorineural elements (HEARING LOSS, SENSORINEURAL) of the ear.", "PM": "2005; see HEARING DISORDERS 2000-2004", "HN": "2005; use HEARING DISORDERS 2000-2004", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046089"}, {"RECTYPE": "D", "MH": "Anseriformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.248.050", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid8826", "PI": "Birds (1973-2004)", "MS": "An order of BIRDS comprising the waterfowl, particularly DUCKS; GEESE; swans; and screamers.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046090"}, {"RECTYPE": "D", "MH": "Charadriiformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Laridae|T012|NON|NRW|NLM (2005)|030812|abcdef", "ENTRY": "Tern", "MN": "B01.050.150.900.248.150", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid8906", "PI": "Birds (1967-2004)", "MS": "An order of BIRDS including over 300 species that primarily inhabit coastal waters, beaches, and marshes. They are comprised of shorebirds, gulls, and terns.", "PM": "2006; see Charadriformes 2005", "HN": "2006 (2005)", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046091"}, {"RECTYPE": "D", "MH": "Columbiformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Raphidae|T012|NON|NRW|NLM (2005)|030812|abcdef", "MN": "B01.050.150.900.248.165", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid8929", "RR": "txid187131", "PI": "Birds (1966-2004)", "MS": "An order of BIRDS comprised of PIGEONS; DOVES; and an extinct family that includes dodos.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046092"}, {"RECTYPE": "D", "MH": "Falconiformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.248.815.350", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid8948", "PI": "Birds (1965-2004)", "MS": "An order of diurnal BIRDS of prey, including EAGLES; HAWKS; buzzards; vultures; and falcons.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046093"}, {"RECTYPE": "D", "MH": "Galliformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Galliforme", "MN": "B01.050.150.900.248.350", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid8976", "PI": "Birds (1968-2004)", "MS": "An order of heavy-bodied, largely terrestrial BIRDS including pheasants, TURKEYS, grouse, QUAIL, and CHICKENS.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046094"}, {"RECTYPE": "D", "MH": "Palaeognathae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Ratites|T012|NON|NRW|NLM (1999)|990101|abcdef", "ENTRY": "Ratite", "MN": "B01.050.150.900.248.600", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid8783", "RR": "txid8821", "MS": "A superorder of large, mostly flightless birds, named for their distinctive PALATE morphology. It includes the orders Apterygiformes, Casuriiformes, Dinornithiformes, RHEIFORMES; STRUTHIONIFORMES and Tinamiformes.", "PM": "2005; for KIWI BIRD see RATITES 2002-2004; for RATITES see RATITES 1999-2004", "HN": "2005", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046108"}, {"RECTYPE": "D", "MH": "Passeriformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Perching Birds|T012|NON|EQV|NLM (2024)|230414|abcdef", "ENTRY": "Perching Bird", "MN": "B01.050.150.900.248.620", "MH_TH": "NLM (1999)", "ST": "T012", "RN": "txid9126", "PI": "Songbirds (1998-2004)", "MS": "A widely distributed order of perching BIRDS, including more than half of all bird species.", "PM": "2005; see SONGBIRDS 1999-2004", "HN": "2005; use SONGBIRDS 1999-2004", "MR": "20230414", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046109"}, {"RECTYPE": "D", "MH": "Hypertension, Pregnancy-Induced", "DE": "HYPERTENSION PREGN IND", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pregnancy-Induced Hypertension", "MN": "C14.907.489.480", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "check tags FEMALE & PREGNANCY", "PI": "Pregnancy Complications, Cardiovascular (1970-2004)", "MS": "A condition in pregnant women with elevated systolic (>140 mm Hg) and diastolic (>90 mm Hg) blood pressure on at least two occasions 6 h apart. HYPERTENSION complicates 8-10% of all pregnancies, generally after 20 weeks of gestation. Gestational hypertension can be divided into several broad categories according to the complexity and associated symptoms, such as EDEMA; PROTEINURIA; SEIZURES; abnormalities in BLOOD COAGULATION and liver functions.", "PM": "2005", "HN": "2005", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046110"}, {"RECTYPE": "D", "MH": "Fetal Therapies", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Fetal Therapy|T061|NON|EQV|BIOETHICS (1984)|920414|FETAL THER|abcdefv", "ENTRY": "Therapies, Fetal", "MN": "E02.467", "MH_TH": "NLM (2005)", "ST": "T061", "AN": "General only; prefer specifics", "PI": "Fetal Diseases (1982-2004)", "MS": "Prenatal interventions to correct fetal anomalies or treat FETAL DISEASES in utero. Fetal therapies include several major areas, such as open surgery; FETOSCOPY; pharmacological therapy; INTRAUTERINE TRANSFUSION; STEM CELL TRANSPLANTATION; and GENETIC THERAPY.", "PM": "2005; see FETAL DISEASES 1993-2004, see FETUS 1986-1992", "HN": "2005; use FETAL DISEASES 1993-2004, use FETUS 1986-1992", "MR": "20120703", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046128"}, {"RECTYPE": "D", "MH": "Ebola Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ebola Virus Vaccines|T121|T129|NON|EQV|NLM (2005)|030814|abbcdef", "ENTRY": "Virus Vaccines, Ebola", "MN": "D20.215.894.899.205", "MH_TH": "NLM (2005)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1980-2004)", "MS": "Vaccines or candidate vaccines used to prevent EBOLA HEMORRHAGIC FEVER.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046129"}, {"RECTYPE": "D", "MH": "Donor Selection", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Donor Screening|T058|NON|EQV|NLM (2005)|031205|abcdef", "ENTRY": "Selection, Donor", "MN": "N02.421.911.600", "MH_TH": "NLM (2005)", "ST": "T058", "PI": "Tissue Donors (1966-2004)", "MS": "The procedure established to evaluate the health status and risk factors of the potential DONORS of biological materials. Donors are selected based on the principles that their health will not be compromised in the process, and the donated materials, such as TISSUES or organs, are safe for reuse in the recipients.", "PM": "2005", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046148"}, {"RECTYPE": "D", "MH": "Embryo Culture Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Embryo Culture Technique", "MN": "E05.481.500.468", "MH_TH": "NLM (2005)", "ST": "T062", "AN": "restrict to whole mammalian embryos; for cultures of embryonic tissue or cells, use TISSUE CULTURE TECHNIQUES or CELL CULTURE", "PI": "Tissue Culture (1966-2004)", "MS": "The technique of maintaining or growing mammalian EMBRYOS in vitro. This method offers an opportunity to observe EMBRYONIC DEVELOPMENT; METABOLISM; and susceptibility to TERATOGENS.", "PM": "2005", "HN": "2005", "MR": "20190429", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046149"}, {"RECTYPE": "D", "MH": "Laron Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Growth Hormone Insensitivity Syndrome|T019|NON|EQV|NLM (2005)|OMIM (2013)|030819|abcdeef", "ENTRY": "Syndrome, Laron", "MN": "C19.297.656", "MH_TH": "OMIM (2013)", "ST": "T019", "PI": "Receptors, Somatotropin (1991-2004)", "MS": "An autosomal recessive disorder characterized by short stature, defective GROWTH HORMONE RECEPTOR, and failure to generate INSULIN-LIKE GROWTH FACTOR I by GROWTH HORMONE. Laron syndrome is not a form of primary pituitary dwarfism (GROWTH HORMONE DEFICIENCY DWARFISM) but the result of mutation of the human GHR gene on chromosome 5.", "PM": "2005", "HN": "2005", "MR": "20120703", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046150"}, {"RECTYPE": "D", "MH": "Lingual Thyroid", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thyroids, Lingual", "MN": "C19.874.689.500", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Tongue (1965-2004)", "MS": "A condition characterized by the presence of rudimentary THYROID tissue at the base of the TONGUE. It is due to failed embryonic development and migration of thyroid tissue to its normal location. The lingual thyroid usually cannot maintain adequate hormone production thereby resulting in HYPOTHYROIDISM.", "PM": "2005", "HN": "2005", "MR": "20090706", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046151"}, {"RECTYPE": "D", "MH": "Gastrointestinal Stromal Tumors", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Gastrointestinal Stromal", "MN": "C06.405.249.308", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with GASTROINTESTINAL NEOPLASMS (IM)", "PI": "Gastrointestinal Neoplasms (1987-2004)", "MS": "All tumors in the GASTROINTESTINAL TRACT arising from mesenchymal cells (MESODERM) except those of smooth muscle cells (LEIOMYOMA) or Schwann cells (SCHWANNOMA).", "PM": "2005", "HN": "2005", "MR": "20130708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046152"}, {"RECTYPE": "D", "MH": "Dermoscopy", "AQ": "AE CL EC ED ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Surface Microscopy, Skin", "MN": "E05.595.185.250", "MH_TH": "NLM (2005)", "ST": "T062", "PI": "Skin Pigmentation (1993-2004)", "MS": "A noninvasive technique that enables direct microscopic examination of the surface and architecture of the SKIN.", "PM": "2005", "HN": "2005", "MR": "20150625", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046169"}, {"RECTYPE": "D", "MH": "Protein Modification, Translational", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Protein Processing, Translational|T044|NON|EQV|NLM (2005)|030905|abcdef", "ENTRY": "Translational Protein Modifications", "MN": "G05.308.670", "MH_TH": "NLM (2005)", "ST": "T044", "AN": "coordinate with specific protein /metab and with specific modification, for example, ACYLATION; AMINATION; DEAMINATION; PROTEIN ISOPRENYLATION; etc.; do not confuse with PROTEIN PROCESSING, POST-TRANSLATIONAL", "MS": "Any of the enzymatically catalyzed modifications of the individual AMINO ACIDS of PROTEINS, and enzymatic cleavage or crosslinking of peptide chains that occur pre-translationally (on the amino acid component of AMINO ACYL TRNA), co-translationally (during the process of GENETIC TRANSLATION), or after translation is completed (POST-TRANSLATIONAL PROTEIN PROCESSING).", "PM": "2005", "HN": "2005", "MR": "20160623", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046188"}, {"RECTYPE": "D", "MH": "Microchip Analytical Procedures", "DE": "MICROCHIP ANAL PROCEDURES", "AQ": "CL EC ES HI MT SN ST TD VE", "ENTRY": "Procedures, Microchip Analytical", "MN": "E05.588", "FX": "Nanotechnology", "EC": "instrumentation:Lab-On-A-Chip Devices", "MH_TH": "NLM (2005)", "ST": "T062", "AN": "MICROCHIP ANALYTICAL DEVICES see LAB-ON-A-CHIP DEVICES is also available", "MS": "The preparation and analysis of samples on miniaturized devices.", "PM": "2005", "HN": "2005", "MR": "20150626", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046208"}, {"RECTYPE": "D", "MH": "Electrophoresis, Microchip", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Microchip Electrophoresis|T059|T062|NON|EQV|NLM (2005)|030905|abbcdef", "ENTRY": "Microchip Electrophoreses", "MN": "E05.588.465.340", "MH_TH": "NLM (2005)", "ST": "T062", "AN": "coord with MICROARRAY ANALYSIS if pertinent", "MS": "A highly miniaturized version of ELECTROPHORESIS performed in a microfluidic device.", "PM": "2005", "HN": "2005", "MR": "20150626", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046209"}, {"RECTYPE": "D", "MH": "Microfluidic Analytical Techniques", "DE": "MICROFLUIDIC ANAL TECHNIQUES", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Microfluidic Analysis|T059|T062|NON|EQV|NLM (2005)|030905|MICROFLUIDIC ANAL|abbcdefv", "ENTRY": "Techniques, Microfluidic Analytical", "MN": "E05.588.465", "FX": "Microfluidics", "MH_TH": "NLM (2005)", "ST": "T062", "MS": "Methods utilizing the principles of MICROFLUIDICS for sample handling, reagent mixing, and separation and detection of specific components in fluids.", "PM": "2005", "HN": "2005", "MR": "20150626", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046210"}, {"RECTYPE": "D", "MH": "Microarray Analysis", "DE": "MICROARRAY ANAL", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Nanoarray Analytical Device", "MN": "E05.588.570", "MH_TH": "NLM (2005)", "ST": "T062", "AN": "general; prefer specifics", "MS": "The simultaneous analysis, on a microchip, of multiple samples or targets arranged in an array format.", "PM": "2005", "HN": "2005", "MR": "20150626", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046228"}, {"RECTYPE": "D", "MH": "Pyloric Stenosis, Hypertrophic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stenosis, Infantile Pyloric", "MN": "C06.405.748.340.690.500", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Pyloric Stenosis (1965-2004)", "MS": "Narrowing of the pyloric canal due to HYPERTROPHY of the surrounding circular muscle. It is usually seen in infants or young children.", "PM": "2005", "HN": "2005", "MR": "20220413", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046248"}, {"RECTYPE": "D", "MH": "Transfer RNA Aminoacylation", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "tRNA Charging|T045|ACX|EQV|NLM (2005)|030911|abcdef", "ENTRY": "tRNA Chargings", "MN": "G03.734.871.850", "FX": "Amino Acyl-tRNA Synthetases", "MH_TH": "NLM (2005)", "ST": "T045", "MS": "The conversion of uncharged TRANSFER RNA to AMINO ACYL TRNA.", "PM": "2005", "HN": "2005", "MR": "20160701", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046249"}, {"RECTYPE": "D", "MH": "Reproductive Rights", "AQ": "CL EC ED ES HI IN LJ PX SN ST TD", "ENTRY": "Rights, Reproductive", "MN": "N03.706.437.675", "MH_TH": "NLM (2005)", "ST": "T078", "PI": "Women's Rights (1970-2004)", "MS": "Reproductive rights rest on the recognition of the basic right of all couples and individuals to decide freely and responsibly the number, spacing and timing of their children and to have the information and means to do so, and the right to attain the highest standard of sexual and reproductive health. They also include the right of all to make decisions concerning reproduction free of discrimination, coercion and violence.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046269"}, {"RECTYPE": "D", "MH": "Body Piercing", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tongue Piercing|T055|NON|NRW|NLM (2005)|030916|abcdef", "ENTRY": "Tongue Piercings", "MN": "E04.085.090", "MH_TH": "NLM (2005)", "ST": "T055", "MS": "The perforation of an anatomical region for the wearing of jewelry.", "PM": "2005", "HN": "2005", "MR": "20150622", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046288"}, {"RECTYPE": "D", "MH": "Body Modification, Non-Therapeutic", "DE": "BODY MODIFICATION NON THER", "AQ": "AE CL EC ES HI IS LJ MO NU PX SN ST TD VE", "PRINT ENTRY": "Cultural Body Modification|T057|NON|NRW|NLM (2005)|030916|abcdef", "ENTRY": "Non-Therapeutic Body Modifications", "MN": "E04.085", "FX": "Self-Injurious Behavior", "MH_TH": "NLM (2005)", "ST": "T057", "MS": "The wounding of the body or body parts by branding, cutting, piercing (BODY PIERCING), or TATTOOING as a cultural practice or expression of creativity or identity.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046289"}, {"RECTYPE": "D", "MH": "Liver Abscess, Pyogenic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pyogenic Liver Abscesses", "MN": "C06.552.597.758", "MH_TH": "NLM (2005)", "ST": "T047", "AN": "coordinate IM with specific organism infection term (IM)", "PI": "Liver Abscess (1966-2004)", "MS": "Single or multiple areas of PUS due to bacterial infection within the hepatic parenchyma. It can be caused by a variety of BACTERIA, local or disseminated from infections elsewhere such as in APPENDICITIS; CHOLECYSTITIS; PERITONITIS; and after LIVER TRANSPLANTATION.", "PM": "2005", "HN": "2005", "MR": "20190617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046290"}, {"RECTYPE": "D", "MH": "Spalax", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "MN": "B01.050.150.900.649.313.992.600.700", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid10062", "PI": "Rodentia (1966-1997)", "MS": "A genus of blind, subterranean MOLE RATS, in the subfamily Spalacinae, family Spalacidae, used as an animal model in neurophysiology. There are at least five different species described, all found in the Ukraine.", "PM": "2005; see MOLE RATS 1998-2004", "HN": "2005; use MOLE RATS 1998-2004", "MR": "20220708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046308"}, {"RECTYPE": "D", "MH": "Porcupines", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Hystrix|T015|NON|NRW|UNK (19XX)|810514|abcdef", "ENTRY": "Porcupine", "MN": "B01.050.150.900.649.313.992.692", "MH_TH": "UNK (19XX)", "ST": "T015", "RR": "txid43319", "PI": "Rodentia (1966-2004)", "MS": "Common name for large, quilled rodents (RODENTIA) comprised of two families: Old World porcupines (Hystricidae) and New World porcupines (Erethizontidae).", "PM": "2005; see RODENTIA 1982-2004; for COENDOU & HYSTRIX see RODENTIA 1982-2004", "HN": "2005; use RODENTIA 1982-2004; for COENDOU & HYSTRIX use RODENTIA 1982-2004", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046328"}, {"RECTYPE": "D", "MH": "Octodon", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Octodon degus|T015|NON|NRW|NLM (2005)|030923|abcdef", "MN": "B01.050.150.900.649.313.992.663", "MH_TH": "UNK (19XX)", "ST": "T015", "RN": "txid10159", "RR": "txid10160", "PI": "Rodentia (1968-2004)", "MS": "A genus of diurnal rats in the family Octodonidae, found in South America. The species Octodon degus is frequently used for research.", "PM": "2005; see RODENTIA 1982-2004", "HN": "2005; use RODENTIA 1982-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046329"}, {"RECTYPE": "D", "MH": "Myoxidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Dormice|T015|NON|EQV|UNK (19XX)|810514|abcdef", "ENTRY": "Dormouse|T015|NON|EQV|NLM (2005)|030923|abcdef", "MN": "B01.050.150.900.649.313.992.640", "MH_TH": "UNK (19XX)", "ST": "T015", "RN": "txid30650", "PI": "Rodentia (1966-2004)", "MS": "A family of nocturnal rodents, similar in appearance to SQUIRRELS, but smaller. There are 28 species, half of which are found in Africa.", "PM": "2005; see RODENTIA 1982-2004", "HN": "2005; use RODENTIA 1982-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046330"}, {"RECTYPE": "D", "MH": "Gophers", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Geomyidae|T015|NON|EQV|NLM (2005)|030924|abcdef", "ENTRY": "Pocket Gopher", "MN": "B01.050.150.900.649.313.992.545", "MH_TH": "NLM (1998)", "ST": "T015", "PI": "Rodentia (1965-2004)", "MS": "The family Geomyidae of burrowing rodents, commonly called pocket gophers. There are six genera, all found in North America.", "PM": "2005; see RODENTIA 1998-2004", "HN": "2005; use RODENTIA 1998-2004", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046348"}, {"RECTYPE": "D", "MH": "Coproporphyria, Hereditary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Deficiency, Coproporphyrinogen Oxidase", "MN": "C18.452.811.400.074", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Porphyria, Hepatic (1993-2004)", "MS": "An autosomal dominant porphyria that is due to a deficiency of COPROPORPHYRINOGEN OXIDASE in the LIVER, the sixth enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include both neurological symptoms and cutaneous lesions. Patients excrete increased levels of porphyrin precursors, 5-AMINOLEVULINATE and COPROPORPHYRINS.", "PM": "2005; see PORPHYRIA, HEPATIC 1993-2004", "HN": "2005; use PORPHYRIA, HEPATIC 1993-2004", "MR": "20150608", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046349"}, {"RECTYPE": "D", "MH": "Porphyria, Variegate", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Porphyria, South African Type|T047|NON|EQV|OMIM (2013)|ORD (2010)|191205|abcdeef", "ENTRY": "Ppox Deficiencies", "MN": "C18.452.811.400.625", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Porphyria, Hepatic (1993-2004)", "MS": "An autosomal dominant porphyria that is due to a deficiency of protoporphyrinogen oxidase (EC 1.3.3.4) in the LIVER, the seventh enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include both neurological symptoms and cutaneous lesions. Patients excrete increased levels of porphyrin precursors, COPROPORPHYRINS and protoporphyrinogen.", "PM": "2005; see PORPHYRIA, HEPATIC 1993-2004", "HN": "2005; use PORPHYRIA, HEPATIC 1993-2004", "MR": "20200228", "DA": "20040715", "DC": "1", "DX": "20050101", "UI": "D046350"}, {"RECTYPE": "D", "MH": "Protoporphyria, Erythropoietic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Erythropoietic Protoporphyria|T047|NON|EQV|NLM (1993)|ORD (2010)|911015|abcdeef", "ENTRY": "Synthetase Deficiency, Heme", "MN": "C18.452.811.400.812", "FX": "Ferrochelatase", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with PORPHYRIA, ERYTHROPOIETIC", "PI": "Porphyria, Erythrohepatic (1993-2004)", "MS": "An autosomal dominant porphyria that is due to a deficiency of FERROCHELATASE (heme synthetase) in both the LIVER and the BONE MARROW, the last enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include mainly neurological symptoms, rarely cutaneous lesions, and elevated levels of protoporphyrin and COPROPORPHYRINS in the feces.", "PM": "2005; see PORPHYRIA, ERYTHROHEPATIC 1993-2004", "HN": "2005; use PORPHYRIA, ERYTHROHEPATIC 1993-2004", "MR": "20150608", "DA": "20040715", "DC": "1", "DX": "20050101", "UI": "D046351"}, {"RECTYPE": "D", "MH": "Freezing Reaction, Cataleptic", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Immobilization Reaction, Cataleptic|T055|NON|EQV|NLM (2005)|030925|abcdef", "ENTRY": "Reactions, Cataleptic Immobilization", "MN": "G11.427.410.698.555", "FX": "Immobilization", "MH_TH": "NLM (2005)", "ST": "T055", "AN": "do not confuse with IMMOBILIZATION: method for restraining body movement, or IMMOBILITY RESPONSE, TONIC: loss of postural tone", "MS": "An induced response to threatening stimuli characterized by the cessation of body movements, except for those that are involved with BREATHING, and the maintenance of an immobile POSTURE.", "PM": "2005", "HN": "2005", "MR": "20160630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046352"}, {"RECTYPE": "D", "MH": "Immobility Response, Tonic", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Tonic Immobilization|T055|NON|EQV|NLM (2005)|030925|abcdef", "ENTRY": "Tonic Immobility Responses", "MN": "G11.427.410.698.680", "FX": "Syncope", "MH_TH": "NLM (2005)", "ST": "T055", "AN": "do not confuse with IMMOBILIZATION: restraining body movement or FREEZING REACTION, CATALEPTIC: cessation of body movement while maintaining an immobile posture via muscle rigidity", "MS": "An induced response to threatening stimuli characterized by complete loss of muscle strength.", "PM": "2005", "HN": "2005", "MR": "20160630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046353"}, {"RECTYPE": "D", "MH": "Crows", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Ravens|T012|NON|REL|NLM (2005)|030925|abcdef", "ENTRY": "Raven", "MN": "B01.050.150.900.248.620.750.150", "MH_TH": "NLM (1999)", "ST": "T012", "RR": "txid30423", "PI": "Songbirds (1998-2004)", "MS": "Common name for the largest birds in the order PASSERIFORMES, family Corvidae. These omnivorous black birds comprise most of the species in the genus Corvus, along with ravens and jackdaws (which are often also referred to as crows).", "PM": "2005; see SONGBIRDS 1999-2004", "HN": "2005; use SONGBIRDS 1999-2004", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046368"}, {"RECTYPE": "D", "MH": "Finches", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Finch|T012|NON|EQV|NLM (1999)|980309|abcdef", "MN": "B01.050.150.900.248.620.750.250", "MH_TH": "NLM (1999)", "ST": "T012", "RN": "txid9133", "PI": "Songbirds (1999-2004)", "MS": "Common name for small PASSERIFORMES in the family Fringillidae. They have a short stout bill (BEAK) adapted for crushing SEEDS. Some species of Old World finches are called CANARIES.", "PM": "2005; see SONGBIRDS 1999-2004", "HN": "2005; use SONGBIRDS 1999-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046369"}, {"RECTYPE": "D", "MH": "Sparrows", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Passeridae|T012|NON|EQV|NLM (2005)|030926|abcdef", "ENTRY": "Sparrow", "MN": "B01.050.150.900.248.620.750.700", "MH_TH": "NLM (1999)", "ST": "T012", "RN": "txid9158", "PI": "Songbirds (1999-2004)", "MS": "The family Passeridae comprised of small, mainly brown and grey seed-eating birds with conical bills.", "PM": "2005; see SONGBIRDS 1999-2004", "HN": "2005; use SONGBIRDS 1999-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046370"}, {"RECTYPE": "D", "MH": "Swallows", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Hirundinidae|T012|NON|EQV|NLM (2005)|030926|abcdef", "ENTRY": "Swallows, Barn", "MN": "B01.050.150.900.248.620.750.725", "MH_TH": "NLM (1999)", "ST": "T012", "RN": "txid43148", "RR": "txid43150", "PI": "Songbirds (1999-2004)", "MS": "The family Hirundinidae, comprised of small BIRDS that hunt flying INSECTS while in sustained flight.", "PM": "2005; see SONGBIRDS 1999-2004", "HN": "2005; use SONGBIRDS 1999-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046388"}, {"RECTYPE": "D", "MH": "Melopsittacus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Budgerigars|T012|NON|EQV|NLM (1995)|940317|abcdef", "ENTRY": "Budgerigar", "MN": "B01.050.150.900.248.710.672.650.500", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid13145", "PI": "Psittaciformes (1975-2004)", "MS": "A genus, commonly called budgerigars, in the family PSITTACIDAE. In the United States they are considered one of the five species of PARAKEETS.", "PM": "2005; see PARROTS 1995-2004", "HN": "2005; use PARROTS 1995-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046408"}, {"RECTYPE": "D", "MH": "Psittacula", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Rose-ringed Parakeets", "MN": "B01.050.150.900.248.710.672.650.650", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid9227", "RR": "txid9228", "PI": "Parakeets (1975-2004)", "MS": "A genus in the family PSITTACIDAE containing three species of PARAKEETS: the Derbyan, the Alexandrine, and the rose-ringed.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046409"}, {"RECTYPE": "D", "MH": "Cockatoos", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Nymphicus hollandicus|T012|NON|NRW|NLM (2005)|030926|abcdef", "ENTRY": "Cockatoo", "MN": "B01.050.150.900.248.710.251", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid35549", "RR": "txid13180", "PI": "Psittaciformes (1974-2004)", "MS": "Large crested BIRDS in the family Cacatuidae, found in Australia, New Guinea, and islands adjacent to the Philippines. The cockatiel (species Nymphicus hollandicus) is much smaller.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046410"}, {"RECTYPE": "D", "MH": "Hawks", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Hawk", "MN": "B01.050.150.900.248.815.350.400", "MH_TH": "NLM (1999)", "ST": "T012", "RN": "txid30396", "PI": "Raptors (1999-2004)", "MS": "Common name for many members of the FALCONIFORMES order, family Accipitridae, generally smaller than EAGLES, and containing short, rounded wings and a long tail.", "PM": "2005; see RAPTORS 1999-2004", "HN": "2005; use RAPTORS 1999-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046428"}, {"RECTYPE": "D", "MH": "Spheniscidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Sphenisciformes|T012|NON|BRD|NLM (2005)|030929|abcdef", "ENTRY": "Penguin", "MN": "B01.050.150.900.248.860", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid9231", "RR": "txid9230", "PI": "Birds (1963-2004)", "MS": "The sole family in the order Sphenisciformes, comprised of 17 species of penguins in six genera. They are flightless seabirds of the Southern Hemisphere, highly adapted for marine life.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046429"}, {"RECTYPE": "D", "MH": "Ice Cover", "AQ": "CH MI PS VI", "PRINT ENTRY": "Sea Ice Cover|T070|NON|NRW|NLM (2005)|030930|abcdef", "ENTRY": "Shelfs, Polar Ice", "MN": "N06.230.291.500", "MH_TH": "NLM (2005)", "ST": "T070", "PI": "Ice (1969-2004)", "MS": "A thick mass of ICE formed over large regions of land; RIVERS; LAKES; ponds; or SEAWATER.", "PM": "2005", "HN": "2005", "MR": "20120703", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046448"}, {"RECTYPE": "D", "MH": "Hernia, Abdominal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hernias, Abdominal Wall|T047|T190|NON|EQV|NLM (2021)|191016|abbcdef", "ENTRY": "Hernias, Abdominal", "MN": "C23.300.707.374", "MH_TH": "UNK (19XX)", "ST": "T190", "PI": "Hernia, Ventral (1965-2004)", "MS": "A protrusion of abdominal structures through the retaining ABDOMINAL WALL. It involves two parts: an opening in the abdominal wall, and a hernia sac consisting of PERITONEUM and abdominal contents. Abdominal hernias include groin hernia (HERNIA, FEMORAL; HERNIA, INGUINAL) and VENTRAL HERNIA.", "PM": "2005; see HERNIA, VENTRAL 1989-2004", "HN": "2005; use HERNIA, VENTRAL 1989-2004", "MR": "20200206", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046449"}, {"RECTYPE": "D", "MH": "Sexual Development", "AQ": "DE GE IM PH RE", "ENTRY": "Development, Sexual", "MN": "G08.686.841", "MH_TH": "NLM (2005)", "ST": "T040", "AN": "human and animal", "MS": "The processes of anatomical and physiological changes related to sexual or reproductive functions during the life span of a human or an animal, from FERTILIZATION to DEATH. These include SEX DETERMINATION PROCESSES; SEX DIFFERENTIATION; SEXUAL MATURATION; and changes during AGING.", "PM": "2005", "HN": "2005", "MR": "20160617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046468"}, {"RECTYPE": "D", "MH": "Culture Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Techniques, Culture", "MN": "E05.481.500", "FX": "Virus Cultivation", "MH_TH": "NLM (2005)", "ST": "T062", "AN": "general or unspecified; prefer specifics; NIM; Manual 18.7.2-.3, 22.26.1, 26.23+", "PI": "Tissue Culture (1966-2004)", "MS": "Methods of maintaining or growing biological materials in controlled laboratory conditions. These include the cultures of CELLS; TISSUES; organs; or embryo in vitro. Both animal and plant tissues may be cultured by a variety of methods. Cultures may derive from normal or abnormal tissues, and consist of a single cell type or mixed cell types.", "PM": "2005", "HN": "2005", "MR": "20150623", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046508"}, {"RECTYPE": "D", "MH": "Tissue Culture Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Tissue Culture Technique", "MN": "E05.481.500.617", "MH_TH": "NLM (2005)", "ST": "T062", "PI": "Tissue Culture (1966-2004)", "MS": "A technique for maintaining or growing TISSUE in vitro, usually by DIFFUSION, perifusion, or PERFUSION. The tissue is cultured directly after removal from the host without being dispersed for cell culture.", "PM": "2005; see TISSUE CULTURE 1966-2004", "HN": "2005; use TISSUE CULTURE 1966-2004", "MR": "20150623", "DA": "20040715", "DC": "1", "DX": "20050101", "UI": "D046509"}, {"RECTYPE": "D", "MH": "Chimerism", "AQ": "CI CL DE EM RE SN VE", "ENTRY": "Microchimerism|T032|NON|REL|NLM (2005)|031008|abcdef", "MN": "G05.365.590.175.125", "FX": "Mosaicism", "MH_TH": "NLM (2005)", "ST": "T032", "PI": "Transplantation Chimera (1966-2004)", "MS": "The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with MOSAICISM in which the different cell populations are derived from a single individual.", "PM": "2005", "HN": "2005", "MR": "20080708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046528"}, {"RECTYPE": "D", "MH": "Microscopy, Electron, Transmission", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Transmission Electron Microscopy|T059|NON|EQV|NLM (1991)|900504|abcdef", "ENTRY": "Microscopy, Transmission Electron", "MN": "E05.595.402.580", "MH_TH": "NLM (1991)", "ST": "T059", "AN": "note specifics", "PI": "Microscopy, Electron (1967-2004)", "MS": "Electron microscopy in which the ELECTRONS or their reaction products that pass down through the specimen are imaged below the plane of the specimen.", "PM": "2005; see MICROSCOPY, ELECTRON 1991-2004; for ELECTRON DIFFRACTION MICROSCOPY see MICROSCOPY, ELECTRON 2003-2004", "HN": "2005; use MICROSCOPY, ELECTRON 1991-2004; for ELECTRON DIFFRACTION MICROSCOPY use MICROSCOPY, ELECTRON 2003-2004", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046529"}, {"RECTYPE": "D", "MH": "Pubic Symphysis Diastasis", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Symphysis Pubis Diastasis|T037|NON|EQV|NLM (2005)|031009|abcdef", "ENTRY": "Symphysis Pubis, Diastasis", "MN": "C26.289.192.500", "MH_TH": "NLM (2005)", "ST": "T037", "PI": "Pubic Symphysis (1966-2003)", "MS": "Separation of the PUBIC SYMPHYSIS. It is an uncommon complication of CHILDBIRTH causing postpartum PAIN, but it can also arise from other causes.", "PM": "2005", "HN": "2005", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046548"}, {"RECTYPE": "D", "MH": "Plantibodies", "AQ": "AD AE AN BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Plant Antibodies, Recombinant|T129|NON|EQV|NLM (2005)|040130|abcdef", "ENTRY": "Recombinant Plant Antibodies", "MN": "D12.776.377.715.548.114.820", "PA": "Immunologic Factors", "FX": "Plants, Genetically Modified", "MH_TH": "NLM (2005)", "ST": "T129", "RN": "0", "PI": "Recombinant Proteins (1997-2004)", "MS": "Recombinant antibodies produced in TRANSGENIC PLANTS. The plants serve as BIOREACTORS to produce the antibodies for medical use or industrial processes.", "PM": "2005", "HN": "2005", "MR": "20050630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046549"}, {"RECTYPE": "D", "MH": "Neuroepithelial Bodies", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Neuroepithelial Body", "MN": "A11.671.650.915.500.530.550", "MH_TH": "NLM (2005)", "ST": "T025", "PI": "Neurosecretory Systems (1982-2004)", "MS": "Innervated clusters of NEUROEPITHELIAL CELLS found in the LUNGS. They act as airway OXYGEN sensors, releasing regulatory PEPTIDES and SEROTONIN in response to HYPOXIA.", "PM": "2005", "HN": "2005", "MR": "20080708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046568"}, {"RECTYPE": "D", "MH": "Neuroepithelial Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Neuroepithelial Cell", "MN": "A11.671.650.915.750.600", "FX": "Taste Buds", "MH_TH": "NLM (2005)", "ST": "T025", "PI": "Neurons (1972-2004)", "MS": "Cells of epithelial origin possessing specialized sensory functions. They include cells that are found in the TASTE BUDS; OLFACTORY MUCOSA; COCHLEA; and NEUROEPITHELIAL BODIES.", "PM": "2005", "HN": "2005", "MR": "20090715", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046569"}, {"RECTYPE": "D", "MH": "Nanoarchaeota", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Nanoarchaeum|T194|NON|NRW|NLM (2005)|031014|abcdef", "MN": "B02.600", "MH_TH": "NLM (2005)", "ST": "T194", "RN": "txid192989", "RR": "txid193568", "PI": "Archaea (2002-2004)", "MS": "A kingdom of hyperthermophilic ARCHAEA found in diverse environments.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046588"}, {"RECTYPE": "D", "MH": "CADASIL", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dementia, Hereditary Multi Infarct Type", "MN": "C23.550.717.489.250.200.100", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Dementia, Multi-Infarct (1994-2004)", "MS": "A familial, cerebral arteriopathy mapped to chromosome 19q12, and characterized by the presence of granular deposits in small CEREBRAL ARTERIES producing ischemic STROKE; PSEUDOBULBAR PALSY; and multiple subcortical infarcts (CEREBRAL INFARCTION). CADASIL is an acronym for Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. CADASIL differs from BINSWANGER DISEASE by the presence of MIGRAINE WITH AURA and usually by the lack of history of arterial HYPERTENSION. (From Bradley et al, Neurology in Clinical Practice, 2000, p1146)", "PM": "2005; see DEMENTIA, MULTI-INFARCT 2000-2004", "HN": "2005; use DEMENTIA, MULTI-INFARCT 2000-2004", "MR": "20190701", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046589"}, {"RECTYPE": "D", "MH": "Spectroscopy, Electron Energy-Loss", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Electron Energy-Loss Spectroscopy|T059|NON|EQV|NLM (2005)|031016|abcdef", "ENTRY": "Spectroscopy, Electron Energy Loss", "MN": "E05.196.867.838", "MH_TH": "NLM (2005)", "ST": "T059", "MS": "A technique for analysis of the chemical composition of molecules. A substance is bombarded with monochromatic ELECTRONS. Some of the electrons passing through the specimen will lose energy when they ionize inner shell electrons of the atoms in the specimen. The energy loss is element dependent. Analysis of the energy loss spectrum reveals the elemental composition of a specimen. ENERGY-FILTERED TRANSMISSION ELECTRON MICROSCOPY is a type of electron energy loss spectroscopy carried out in electron microscopes specially outfitted to analyze the spectrum of electron energy loss.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046590"}, {"RECTYPE": "D", "MH": "Synkinesis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Synkineses", "MN": "C23.888.592.350.675", "MH_TH": "NLM (2005)", "ST": "T184", "PI": "Neurologic Manifestations (1966-2004)", "MS": "An involuntary movement accompanying a volitional movement. It often refers to facial movements that accompany FACIAL PARALYSIS.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046608"}, {"RECTYPE": "D", "MH": "Libraries, Digital", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Virtual Library", "MN": "L01.462.625.596.719.750", "MH_TH": "NLM (2005)", "ST": "T073", "MS": "Libraries in which a major proportion of the resources are available in machine-readable format, rather than on paper or MICROFORM.", "PM": "2005", "HN": "2005", "MR": "20220712", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046609"}, {"RECTYPE": "D", "MH": "Sphincter of Oddi Dysfunction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sphincter of Oddi Dyskinesia|T047|NON|REL|NLM (2005)|031020|abcdef", "ENTRY": "Sphincter of Oddi Stenosis|T047|NON|NRW|NLM (2005)|031020|abcdef", "MN": "C06.130.120.250.098.800", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Sphincter of Oddi/pathophysiology (1974-2004)", "MS": "Organic or functional motility disorder involving the SPHINCTER OF ODDI and associated with biliary COLIC. Pathological changes are most often seen in the COMMON BILE DUCT sphincter, and less commonly the PANCREATIC DUCT sphincter.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046628"}, {"RECTYPE": "D", "MH": "Hematoma, Subdural, Intracranial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intracranial Subdural Hematoma|T020|T037|NON|EQV|NLM (2000)|991103|abbcdef", "ENTRY": "Subdural Hematomas, Intracranial", "MN": "C26.915.300.490.450.400", "MH_TH": "NLM (2005)", "ST": "T037", "PI": "Hematoma, Subdural (1965-2004)", "MS": "Accumulation of blood in the SUBDURAL SPACE over the CEREBRAL HEMISPHERE.", "PM": "2005; see HEMATOMA, SUBDURAL 2000-2004", "HN": "2005; use HEMATOMA, SUBDURAL 2000-2004", "MR": "20150622", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046648"}, {"RECTYPE": "D", "MH": "Hematoma, Subdural, Spinal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spinal Subdural Hematoma|T020|T037|NON|EQV|NLM (2000)|991103|abbcdef", "ENTRY": "Subdural Hematomas, Spinal", "MN": "C23.550.414.838.700.700", "MH_TH": "NLM (2005)", "ST": "T037", "PI": "Hematoma, Subdural (1969-2004)", "MS": "Subdural hematoma of the SPINAL CANAL.", "PM": "2005; see HEMATOMA, SUBDURAL (2000-2004)", "HN": "2005; use HEMATOMA, SUBDURAL (2000-2004)", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046649"}, {"RECTYPE": "D", "MH": "Medical Subject Headings", "AQ": "HI SN", "ENTRY": "Subject Headings, Medical", "MN": "L01.462.750.245.945.700.500", "FX": "MEDLINE", "MH_TH": "NLM (2005)", "ST": "T170", "AN": "CATALOGER: Use NAF entry", "PI": "Subject Headings (1969-2004)", "MS": "Controlled vocabulary thesaurus produced by the NATIONAL LIBRARY OF MEDICINE. It consists of sets of terms naming descriptors in a hierarchical structure that permits searching at various levels of specificity.", "PM": "2005", "HN": "2005", "MR": "20220712", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046650"}, {"RECTYPE": "D", "MH": "Child Mortality", "DE": "CHILD MORTAL", "AQ": "EH HI TD", "ENTRY": "Mortalities, Child", "MN": "N06.850.520.308.985.550.287", "MH_TH": "NLM (1980)", "ST": "T081", "AN": "a statistical concept; check the tag CHILD, PRESCHOOL or CHILD", "PI": "Mortality (1966-2004)", "MS": "Number of deaths of children between one year of age to 12 years of age in a given population.", "PM": "2005; see INFANT MORTALITY 1980-2004", "HN": "2005; use INFANT MORTALITY 1980-2004", "MR": "20170630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046688"}, {"RECTYPE": "D", "MH": "Fetal Mortality", "AQ": "EH HI TD", "ENTRY": "Mortality, Late Fetal", "MN": "N06.850.520.308.985.550.362", "MH_TH": "NLM (2005)", "ST": "T081", "AN": "a statistical concept & not a substitute for / mortal with FETAL DISEASES or with specific diseases in the fetus; do not confuse with FETAL DEATH; add geographic term if pertinent; PERINATAL MORTALITY is also available", "PI": "Fetal Death (1966-2004)", "MS": "Number of fetal deaths with stated or presumed gestation of 20 weeks or more in a given population. Late fetal mortality is death after of 28 weeks or more.", "PM": "2005", "HN": "2005", "MR": "20170630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046689"}, {"RECTYPE": "D", "MH": "Deep Brain Stimulation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Brain Stimulation, Deep|T061|NON|EQV|NLM (2005)|031023|abcdef", "ENTRY": "Stimulations, Deep Brain", "MN": "E04.190", "FX": "Electric Stimulation", "MH_TH": "NLM (2005)", "ST": "T061", "AN": "coord with disease /ther", "PI": "Electric Stimulation Therapy (1973-2004)", "MS": "Therapy for MOVEMENT DISORDERS, especially PARKINSON DISEASE, that applies electricity via stereotactic implantation of ELECTRODES in specific areas of the BRAIN such as the THALAMUS. The electrodes are attached to a neurostimulator placed subcutaneously.", "PM": "2005; for ELECTRICAL STIMULATION OF THE BRAIN see ELECTRIC STIMULATION 1997-2003", "HN": "2005; for ELECTRICAL STIMULATION OF THE BRAIN use ELECTRIC STIMULATION 1997-2003", "MR": "20150706", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046690"}, {"RECTYPE": "D", "MH": "Amazona", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Amazon Parrots|T012|NON|EQV|NLM (2005)|031023|abcdef", "ENTRY": "Parrots, Amazon", "MN": "B01.050.150.900.248.710.672.050", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid12929", "PI": "Parrots (1989-2004)", "MS": "One of the largest genera of PARROTS, ranging from South American to Northern Mexico. Many species are commonly kept as house pets.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046708"}, {"RECTYPE": "D", "MH": "Pattern Recognition, Physiological", "AQ": "CL DE ES PH RE", "ENTRY": "Tactile Pattern Recognition", "MN": "F02.463.593.524", "MH_TH": "NLM (2005)", "ST": "T041", "MS": "The analysis of a critical number of sensory stimuli or facts (the pattern) by physiological processes such as vision (PATTERN RECOGNITION, VISUAL), touch, or hearing.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046709"}, {"RECTYPE": "D", "MH": "Agapornis", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Lovebirds|T012|NON|EQV|NLM (2005)|031023|abcdef", "ENTRY": "Lovebird", "MN": "B01.050.150.900.248.710.672.040", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid60461", "PI": "Parrots (1977-2004)", "MS": "A genus comprised of nine species of small PARROTS from Africa. They are noted for showing affection for their mates.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046710"}, {"RECTYPE": "D", "MH": "Colitis, Microscopic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Microscopic Colitis|T047|NON|EQV|NLM (2005)|031027|abcdef", "MN": "C06.405.469.158.188.173", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Colitis, Ulcerative (1965-2004)", "MS": "A condition characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. This syndrome was first described in 1980 by Read and associates. Subtypes include COLLAGENOUS COLITIS and LYMPHOCYTIC COLITIS. Both have similar clinical symptoms and are distinguishable only by histology.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046728"}, {"RECTYPE": "D", "MH": "Colitis, Collagenous", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Collagenous Colitis|T047|NON|EQV|NLM (2005)|031027|abcdef", "MN": "C06.405.469.158.188.173.500", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Colitis (1976-2004)", "MS": "A subtype of MICROSCOPIC COLITIS, characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. Microscopic examination of biopsy samples taken from the COLON show larger-than-normal band of subepithelial COLLAGEN.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046729"}, {"RECTYPE": "D", "MH": "Colitis, Lymphocytic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lymphocytic Colitis|T047|NON|EQV|NLM (2005)|031027|abcdef", "MN": "C06.405.469.158.188.173.750", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Colitis, Ulcerative (1980-2004)", "MS": "A subtype of MICROSCOPIC COLITIS, characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. Microscopic examination of biopsy samples taken from the COLON show infiltration of LYMPHOCYTES in the superficial EPITHELIUM and the underlying connective tissue (lamina propria).", "PM": "2005", "HN": "2005", "MR": "20130709", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046730"}, {"RECTYPE": "D", "MH": "Hematoma, Epidural, Spinal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spinal Epidural Hematoma|T020|T037|NON|EQV|NLM (2005)|031028|abbcdef", "ENTRY": "Spinal Epidural Hemorrhages", "MN": "C23.550.414.838.355", "MH_TH": "NLM (2005)", "ST": "T037", "PI": "Hematoma, Epidural, Cranial (1966-2004)", "MS": "A rare epidural hematoma in the spinal epidural space, usually due to a vascular malformation (CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS) or TRAUMA. Spontaneous spinal epidural hematoma is a neurologic emergency due to a rapidly evolving compressive MYELOPATHY.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046748"}, {"RECTYPE": "D", "MH": "Starlings", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Sturnidae|T012|NON|EQV|NLM (2005)|031028|abcdef", "ENTRY": "Starling", "MN": "B01.050.150.900.248.620.750.712", "MH_TH": "NLM (2005)", "ST": "T012", "RN": "txid9170", "PI": "Songbirds (1999-2004)", "MS": "The family Sturnidae, in the order PASSERIFORMES. The starling family also includes mynahs and oxpeckers.", "PM": "2005", "HN": "2005", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046749"}, {"RECTYPE": "D", "MH": "Nesidioblastosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperinsulinism, Familial, with Pancreatic Nesidioblastosis|T047|NON|EQV|NLM (2005)|ORD (2010)|031030|abcdeef", "ENTRY": "Pancreatic Nesidioblastoses", "MN": "C18.452.394.984.200.500", "FX": "KATP Channels", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Islets of Langerhans (1968-2004)", "MS": "An inherited autosomal recessive syndrome characterized by the disorganized formation of new islets in the PANCREAS and CONGENITAL HYPERINSULINISM. It is due to focal hyperplasia of pancreatic ISLET CELLS budding off from the ductal structures and forming new islets of Langerhans. Mutations in the islet cells involve the potassium channel gene KCNJ11 or the ATP-binding cassette transporter gene ABCC8, both on CHROMOSOME 11.", "PM": "2005; see PANCREATIC DISEASES 1983-2004", "HN": "2005; use PANCREATIC DISEASES 1983-2004", "MR": "20120703", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046768"}, {"RECTYPE": "D", "MH": "Patellofemoral Pain Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Patellofemoral Pain|T033|NON|REL|NLM (2021)|191122|abcdef", "ENTRY": "Patellofemoral Pains", "MN": "C05.550.700", "FX": "Chondromalacia Patellae", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Syndrome (1984-2004)", "MS": "A syndrome characterized by retropatellar or peripatellar PAIN resulting from physical and biochemical changes in the patellofemoral joint. The pain is most prominent when ascending or descending stairs, squatting, or sitting with flexed knees. There is a lack of consensus on the etiology and treatment. The syndrome is often confused with (or accompanied by) CHONDROMALACIA PATELLAE, the latter describing a pathological condition of the CARTILAGE and not a syndrome.", "PM": "2005", "HN": "2005", "MR": "20200116", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046788"}, {"RECTYPE": "D", "MH": "Chondromalacia Patellae", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Patella, Chondromalacia Of|T047|NON|EQV|OMIM (2013)|111115|abcdef", "MN": "C17.300.182.100", "FX": "Patellofemoral Pain Syndrome", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Cartilage Diseases (1968-2004)", "MS": "A degeneration of the ARTICULAR CARTILAGE of the PATELLA, caused by a decrease in sulfated MUCOPOLYSACCHARIDES in the ground substance. When accompanied by pain, it is sometimes considered part of or confused with PATELLOFEMORAL PAIN SYNDROME.", "PM": "2005", "HN": "2005", "MR": "20120703", "DA": "20040719", "DC": "1", "DX": "20050101", "UI": "D046789"}, {"RECTYPE": "D", "MH": "Pancreas, Exocrine", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Exocrine Pancreas|T023|NON|EQV|NLM (2005)|031030|abcdef", "MN": "A10.336.645", "MH_TH": "NLM (1998)", "ST": "T023", "PI": "Pancreas (1965-2004)", "MS": "The major component (about 80%) of the PANCREAS composed of acinar functional units of tubular and spherical cells. The acinar cells synthesize and secrete several digestive enzymes such as TRYPSINOGEN; LIPASE; AMYLASE; and RIBONUCLEASE. Secretion from the exocrine pancreas drains into the pancreatic ductal system and empties into the DUODENUM.", "PM": "2005; see PANCREAS 1998-2004", "HN": "2005; use PANCREAS 1998-2004", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046790"}, {"RECTYPE": "D", "MH": "Atadenovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Ovine adenovirus D|T005|NON|NRW|NLM (2005)|031102|abcdef", "ENTRY": "adenoviruses, Deer", "MN": "B04.280.030.080", "MH_TH": "NLM (2005)", "ST": "T005", "RN": "txid100953", "RR": "txid130499", "AN": "infection: coord IM with ADENOVIRIDAE INFECTIONS (IM)", "PI": "Adenoviridae (2002-2004)", "MS": "A genus of ADENOVIRIDAE that comprises viruses of several species of MAMMALS and BIRDS. The type species is Ovine adenovirus D.", "PM": "2005", "HN": "2005", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046808"}, {"RECTYPE": "D", "MH": "Siadenovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Turkey adenovirus A|T005|NON|NRW|NLM (2005)|031102|abcdef", "ENTRY": "Siadenoviruses", "MN": "B04.280.030.750", "MH_TH": "NLM (2005)", "ST": "T005", "RN": "txid129876", "RR": "txid41678", "AN": "infection: coord IM with ADENOVIRIDAE INFECTIONS (IM)", "MS": "A genus of ADENOVIRIDAE comprising species including viruses of frogs (FROGS AND TOADS) and TURKEYS. The type species is Frog adenovirus.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046809"}, {"RECTYPE": "D", "MH": "Gyrovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Gyroviruses", "MN": "B04.280.120.400", "MH_TH": "NLM (2005)", "ST": "T005", "RN": "txid227307", "AN": "infection: coord IM with CIRCOVIRIDAE INFECTIONS (IM)", "MS": "A genus in the family CIRCOVIRIDAE comprising the single species CHICKEN ANEMIA VIRUS.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046810"}, {"RECTYPE": "D", "MH": "Roniviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Yellow-head virus|T005|NON|NRW|NLM (2005)|031103|abcdef", "ENTRY": "Yellow-head viruses", "MN": "B04.820.578.500.770", "MH_TH": "NLM (2005)", "ST": "T005", "RN": "txid199704", "RR": "txid96491", "AN": "infection: coordinate IM with NIDOVIRALES INFECTIONS (IM)", "PI": "Nidovirales (2003-2004)", "MS": "A family of rod-shaped viruses, in the order NIDOVIRALES. It includes one genus: Okavirus.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046828"}, {"RECTYPE": "D", "MH": "Isavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Infectious salmon anemia virus|T005|NON|NRW|NLM (2005)|031103|abcdef", "ENTRY": "Isaviruses", "MN": "B04.820.480.968.450", "MH_TH": "NLM (2005)", "ST": "T005", "RN": "txid324913", "RR": "txid55987", "AN": "infection: coord IM with ORTHOMYXOVIRIDAE INFECTIONS (IM)", "MS": "A genus in the family ORTHOMYXOVIRIDAE containing one species: Infectious salmon anemia virus.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046829"}, {"RECTYPE": "D", "MH": "Tymoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Marafiviruses", "MN": "B04.820.578.984", "MH_TH": "NLM (2005)", "ST": "T005", "RN": "txid249184", "RR": "txid249185", "MS": "A family of icosahedral, non-enveloped, RNA plant viruses comprised of three genera: TYMOVIRUS, Marafivirus and Maculavirus.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046830"}, {"RECTYPE": "D", "MH": "White spot syndrome virus 1", "DS": "WHITE SPOT SYNDROME VIRUS 001", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "White Spot Syndrome Virus|T005|NON|EQV|NLM (2005)|031104|abcdef", "MN": "B04.280.505.900", "MH_TH": "NLM (2005)", "ST": "T005", "RN": "txid342409", "PI": "DNA Viruses (1997-2004)", "MS": "A species of DNA virus, in the genus WHISPOVIRUS, infecting PENAEID SHRIMP.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046848"}, {"RECTYPE": "D", "MH": "Nimaviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Whispoviruses", "MN": "B04.280.505", "MH_TH": "NLM (2005)", "ST": "T005", "RN": "txid196937", "RR": "txid249585", "MS": "A family of DNA invertebrate viruses with one genus: Whispovirus.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046849"}, {"RECTYPE": "D", "MH": "Anabaena cylindrica", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.585.051.150", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1165", "PI": "Anabaena (1992-2004)", "MS": "A species in the genus ANABAENA whose trichomes are composed of cylindrical cells.", "PM": "2005", "HN": "2005", "MR": "20200206", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046868"}, {"RECTYPE": "D", "MH": "Dolichospermum flos-aquae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Dolichospermum flosaquae|T007|NON|EQV|NLM (2022)|210401|abcdef", "MN": "B03.440.475.100.283", "MH_TH": "NLM (2022)", "ST": "T007", "RN": "txid1166", "PI": "Cyanobacteria (1969-1991)", "MS": "A species in the genus Dolichospermum containing gas vacuoles that gives buoyancy to the organism. It was formerly classified under ANABAENA. It can form extensive blooms in FRESH WATER and is responsible for acute poisonings of various animals.", "PM": "2022; see ANABAENA FLOS-AQUAE 2005-2021", "HN": "2022(2005)", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046869"}, {"RECTYPE": "D", "MH": "Anabaena variabilis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.585.051.900", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid264691", "PI": "Cyanobacteria (1969-1992)", "MS": "A species of ANABAENA that can form SPORES called akinetes.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046870"}, {"RECTYPE": "D", "MH": "Tissue Array Analysis", "DE": "TISSUE ARRAY ANAL", "AQ": "CL EC HI IS MT SN ST TD VE", "ENTRY": "Tissue Microarray Analyses", "MN": "E05.588.570.850", "MH_TH": "NLM (2005)", "ST": "T060", "MS": "The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips.", "PM": "2005", "HN": "2005", "MR": "20150626", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046888"}, {"RECTYPE": "D", "MH": "Cyanothece", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.200", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid43988", "PI": "Cyanobacteria (1993-2004)", "MS": "A form-genus of unicellular coccoid to rod-shaped CYANOBACTERIA, in the order Chroococcales. Three different clusters of strains from diverse habitats are included.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046889"}, {"RECTYPE": "D", "MH": "Aphanizomenon", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.110", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1175", "PI": "Cyanobacteria (1973-2004)", "MS": "A form-genus of planktonic CYANOBACTERIA in the order Nostocales.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046890"}, {"RECTYPE": "D", "MH": "Cylindrospermopsis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.210", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid77021", "PI": "Cyanobacteria (1985-2004)", "MS": "A form-genus of CYANOBACTERIA in the order Nostocales, characterized by thin trichomes, cylindrical akinetes, and terminal heterocysts.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046891"}, {"RECTYPE": "D", "MH": "Peptide Biosynthesis, Nucleic Acid-Independent", "DE": "PEPTIDE BIOSYN NUCLEIC ACID INDEPENDENT", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Peptide Biosynthesis, Thiotemplate Mechanism|T044|NON|NRW|NLM (2005)|031110|PEPTIDE BIOSYN THIOTEMPLATE MECHANISM|abcdefv", "ENTRY": "Peptide Biosynthesis, Nucleic Acid Independent", "MN": "G03.734.333", "MH_TH": "NLM (2005)", "ST": "T044", "AN": "coordinate with specific peptide /biosyn if pertinent", "PI": "specific peptide/biosynthesis (1969-2004)", "MS": "The enzymatic synthesis of PEPTIDES without an RNA template by processes that do not use the ribosomal apparatus (RIBOSOMES).", "PM": "2005", "HN": "2005", "MR": "20160701", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046908"}, {"RECTYPE": "D", "MH": "Fertile Period", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "MN": "G08.686.605.154", "FX": "Natural Family Planning Methods", "MH_TH": "NLM (1980)", "ST": "T079", "PI": "Menstruation (1980-2004)", "MS": "The period in the MENSTRUAL CYCLE that is optimal for FERTILIZATION of the OVUM and yielding PREGNANCY. The duration of fertile period depends on the life span of male GAMETES within the female reproductive tract and the time of OVULATION. It usually begins a few days before ovulation and ends on the day of ovulation.", "PM": "2005; see MENSTRUATION 1980-2004", "HN": "2005; use MENSTRUATION 1980-2004", "MR": "20080708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046910"}, {"RECTYPE": "D", "MH": "Macromolecular Substances", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "ENTRY": "Substances, Macromolecular", "MN": "D05", "RH": "D5 - MACROMOLECULAR SUBSTANCES", "MH_TH": "NLM (2005)", "ST": "T104", "RN": "0", "AN": "general only; do not use as a routine coordinate with specific macromolecular substances", "MS": "Compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kDa in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure.", "PM": "2005; see MACROMOLECULAR SYSTEMS 1966-2004", "HN": "2005", "MR": "20100625", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046911"}, {"RECTYPE": "D", "MH": "Multiprotein Complexes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Complexes, Macromolecular", "MN": "D05.500", "MH_TH": "NLM (2000)", "ST": "T116", "RN": "0", "AN": "general only; do not use as a routine coordinate with specific multiprotein complexes; MULTIENZYME COMPLEXES is also available", "PI": "Macromolecular Substances (1966-2004)", "MS": "Macromolecular complexes formed from the association of defined protein subunits.", "PM": "2005; see MACROMOLECULAR SYSTEMS 1966-2004", "HN": "2005; use MACROMOLECULAR SUBSTANCES 1966-2004", "MR": "20050630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046912"}, {"RECTYPE": "D", "MH": "Medicago truncatula", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "truncatula, Medicago", "MN": "B01.875.800.575.912.250.401.590.750", "MH_TH": "NLM (2005)", "ST": "T002", "RN": "txid3880", "PI": "Medicago (1992-2004)", "MS": "A plant species of the family FABACEAE used to study GENETICS because it is DIPLOID, self fertile, has a small genome, and short generation time.", "PM": "2005", "HN": "2005", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046913"}, {"RECTYPE": "D", "MH": "Dipteryx", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tonka Bean|T002|NON|NRW|NLM (2005)|031112|abcdef", "ENTRY": "odoratas, Dipteryx", "MN": "B01.875.800.575.912.250.401.194", "MH_TH": "NLM (2005)", "ST": "T002", "RN": "txid53872", "RR": "txid53873", "PI": "Fabaceae (1995-2004)", "MS": "A plant genus of the family FABACEAE. Members contain COUMARINS.", "PM": "2005", "HN": "2005", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046914"}, {"RECTYPE": "D", "MH": "Penicillin-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, Peptidoglycan", "MN": "D12.776.097.545", "FX": "Peptidyl Transferases", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "0", "RR": "EC 2.4.1.129", "PI": "Peptidyltransferase (1978-2004)", "MS": "Bacterial proteins that share the property of binding irreversibly to PENICILLINS and other ANTIBACTERIAL AGENTS derived from LACTAMS. The penicillin-binding proteins are primarily enzymes involved in CELL WALL biosynthesis including MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; PEPTIDE SYNTHASES; TRANSPEPTIDASES; and HEXOSYLTRANSFERASES.", "PM": "2005; PENICILLIN-BINDING PROTEINS was indexed under HEXOSYLTRANSFERASES 1999-2004, under BACTERIAL PROTEINS, MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; CARRIER PROTEINS, & PEPTIDYLTRANSFERASE 1978-2004", "HN": "2005 (1978);", "MR": "20130709", "DA": "20040708", "DC": "1", "DX": "20050101", "UI": "D046915"}, {"RECTYPE": "D", "MH": "Peptidoglycan Glycosyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transglycosylase, Peptidoglycan", "MN": "D08.811.913.400.450.780", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.4.1.129", "PI": "Hexosyltransferases (1981-2004)", "MS": "A hexosyltransferase involved in the transfer of disaccharide molecules to the peptidoglycan structure of the CELL WALL SKELETON. It plays an important role in the genesis of the bacterial CELL WALL.", "PM": "2005; PEPTIDOGLYCAN GLYCOSYLTRANSFERASE was indexed under HEXOSYLTRANSFERASES 1981-2004", "HN": "2005; use PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (NM) 1981-2004", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046928"}, {"RECTYPE": "D", "MH": "Serine-Type D-Ala-D-Ala Carboxypeptidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "D-D Carboxypeptidase|T116|T126|NON|EQV|UNK (19XX)|741111|CARBOXYPEPTIDASE DD|abbcdefs", "ENTRY": "Transpeptidase, D-Alanyl-D-Alanine-Cleaving", "MN": "D08.811.277.656.959.560", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 3.4.16.4", "PI": "Carboxypeptidases (1993-2004)", "MS": "A carboxypeptidase that is specific for proteins that contain two ALANINE residues on their C-terminal. Enzymes in this class play an important role in bacterial CELL WALL biosynthesis.", "PM": "2005; SERINE-TYPE D-ALA-D-ALA CARBOXYPEPTIDASE was indexed under CARBOXYPEPTIDASES 1993-2003; for D-ALANYL-D-ALANINE-CLEAVING TRANSPEPTIDASE see MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1984-2004; for D-D CARBOXYPEPTIDASE see MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1974-2004", "HN": "2005(1993); for D-ALANYL-D-ALANINE-CLEAVING TRANSPEPTIDASE use MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1984-2004; for D-D CARBOXYPEPTIDASE use MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1974-2004", "MR": "20090706", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046929"}, {"RECTYPE": "D", "MH": "Thymus Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "vulgaris, Thymus", "MN": "B01.875.800.575.912.250.583.520.974", "MH_TH": "NLM (2005)", "ST": "T002", "RN": "txid49990", "RR": "txid49992", "PI": "Thyme (1998-2004)", "MS": "A plant genus of the family LAMIACEAE best known for the thyme spice added to foods.", "PM": "2005; for THYME, see THYME 2002-2004, see LAMIACEAE 1998-2001, see HERBS 1983-1997, see THYME 1963-1982", "HN": "2005", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046930"}, {"RECTYPE": "D", "MH": "Microcystis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Microcystis aeruginosa|T007|NON|NRW|NLM (2005)|040310|abcdef", "MN": "B03.440.475.100.500", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1125", "RR": "txid1126", "PI": "Cyanobacteria (1969-2004)", "MS": "A form-genus of CYANOBACTERIA in the order Chroococcales. Many species are planktonic and possess gas vacuoles.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046931"}, {"RECTYPE": "D", "MH": "Nodularia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.585.625", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid159191", "PI": "Cyanobacteria (1977-2004)", "MS": "A form-genus of filamentous CYANOBACTERIA in the order Nostocales. Its members can be planktonic or benthic and the trichomes are composed of disc-shaped vegetative cells.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046932"}, {"RECTYPE": "D", "MH": "Ginkgolides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ginkgolide|T109|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D02.455.849.291.400", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "MS": "DITERPENES with three LACTONES and a unique tert-butyl group, which are found in GINKGO plants along with BILOBALIDES.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046934"}, {"RECTYPE": "D", "MH": "Bilobalides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.849.291.400.500", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "MS": "A degraded form of GINKGOLIDES that have three LACTONES and a unique tert-butyl group which are found in GINKGO plants.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046935"}, {"RECTYPE": "D", "MH": "Photinia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "melanocarpas, Aronia", "MN": "B01.875.800.575.912.250.859.937.500.522", "MH_TH": "NLM (2005)", "ST": "T002", "RN": "txid23199", "RR": "txid661339", "AN": "entry term BLACK CHOKECHERRY TREE: CHOKECHERRY TREE see PRUNUS is also available", "MS": "A plant genus of the family ROSACEAE. The common names of chokeberry or chokecherry are also used for some species of PRUNUS.", "PM": "2005", "HN": "2005", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046936"}, {"RECTYPE": "D", "MH": "Nostoc", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Nostoc punctiforme|T007|NON|NRW|NLM (2006)|041117|abcdef", "MN": "B03.440.475.100.575", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1177", "RR": "txid45916", "PI": "Cyanobacteria (1971-2004)", "MS": "A form-genus of CYANOBACTERIA in the order Nostocales. Trichomes composed of spherical or ovoid vegetative cells along with heterocysts and akinetes. The species form symbiotic associations with a wide range of eukaryotes.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046937"}, {"RECTYPE": "D", "MH": "Plectonema", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.585.880", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1183", "PI": "Cyanobacteria (1970-2004)", "MS": "A form-genus of CYANOBACTERIA in the order Oscillatoriales. They are non-heterocystous but may carry out NITROGEN FIXATION under microaerobic conditions. Some smaller members have undergone transfer to the form-genus Leptolyngbya.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046938"}, {"RECTYPE": "D", "MH": "Synechocystis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.750", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1142", "PI": "Cyanobacteria (1971-2004)", "MS": "A form-genus of unicellular CYANOBACTERIA in the order Chroococcales. None of the strains fix NITROGEN, there are no gas vacuoles, and sheath layers are never produced.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046939"}, {"RECTYPE": "D", "MH": "Synechococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.745", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1129", "PI": "Cyanobacteria (1971-2004)", "MS": "A form-genus of spherical to rod-shaped CYANOBACTERIA in the order Chroococcales. They contain THYLAKOIDS and are found in a wide range of habitats.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046940"}, {"RECTYPE": "D", "MH": "Secologanin Tryptamine Alkaloids", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Monoterpene Indole Alkaloids|T109|NON|EQV|NLM (2024)|230119|abcdef", "ENTRY": "Tryptamine Alkaloids, Secologanin", "MN": "D03.633.100.496.500.500.681", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Rauwolfia Alkaloids (1975-2004)", "MS": "Compounds formed by condensation of secologanin with tryptamine resulting in a tetrahydro-beta-carboline which is processed further to a number of bioactive compounds. These are especially found in plants of the APOCYNACEAE; LOGANIACEAE; and RUBIACEAE families.", "PM": "2005; for YOHIMBANS see YOHIMBANS 1969-2004; for RAUWOLFIA ALKALOIDS see RAUWOLFIA ALKALOIDS 1975-2004", "HN": "2005; for YOHIMBANS use YOHIMBANS 1969-2004; for RAUWOLFIA ALKALOIDS use RAUWOLFIA ALKALOIDS 1975-2004", "MR": "20230226", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046948"}, {"RECTYPE": "D", "MH": "Thermotoga neapolitana", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.425.410.748.750", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid2337", "PI": "Gram-Negative Anaerobic Straight, Curved, and Helical Rods (1998-2004)", "MS": "A species of extremophilic bacteria in the family Thermotogaceae. Generally anaerobic but in the presence of OXYGEN, it can produce hydrogen gas as a byproduct of metabolism.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046949"}, {"RECTYPE": "D", "MH": "Thermoanaerobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.800", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid28895", "AN": "do not confuse with THERMOANAEROBACTER", "PI": "Bacteria, Anaerobic (1985-2004)", "MS": "A genus of gram-positive, anaerobic bacteria in the family Thermoanaerobacteriaceae. They are thermophilic and saccharolytic.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046950"}, {"RECTYPE": "D", "MH": "Thermoanaerobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.790", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1754", "AN": "do not confuse with THERMOANAEROBACTERIUM", "PI": "Bacteria, Anaerobic (1985-2004)", "MS": "A genus of gram-positive, anaerobic bacteria in the family Thermoanaerobacteriaceae. Cultures consist of rods interspersed with coccoid cells.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046968"}, {"RECTYPE": "D", "MH": "Clostridium acetobutylicum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.025", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1488", "AN": "infection: coordinate IM with CLOSTRIDIUM INFECTIONS (IM)", "PI": "Clostridium (1966-2004)", "MS": "A species of gram-positive bacteria in the family Clostridiaceae, used for the industrial production of SOLVENTS.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046969"}, {"RECTYPE": "D", "MH": "Clostridium beijerinckii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.100", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1520", "AN": "infection: coordinate IM with CLOSTRIDIUM INFECTIONS (IM)", "PI": "Clostridium (1974-2004)", "MS": "A species of gram-positive bacteria in the family Clostridiaceae, capable of solventogenesis, and isolated from SOIL, infected WOUNDS, fermenting OLIVES, and spoiled CANDY.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046970"}, {"RECTYPE": "D", "MH": "Clostridium bifermentans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.130", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1490", "AN": "infection: coordinate IM with CLOSTRIDIUM INFECTIONS (IM)", "PI": "Clostridium (1965-2004)", "MS": "A species of gram-positive bacteria in the family Clostridiaceae that ferments both CARBOHYDRATES and AMINO ACIDS.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046971"}, {"RECTYPE": "D", "MH": "Clostridium butyricum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.180", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1492", "AN": "infection: coordinate IM with CLOSTRIDIUM INFECTIONS (IM)", "PI": "Clostridium (1965-2004)", "MS": "Type species of the genus CLOSTRIDIUM, a gram-positive bacteria in the family Clostridiaceae. It is used as a source of PROBIOTICS.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046972"}, {"RECTYPE": "D", "MH": "Clostridium cellulolyticum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.200", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1521", "PI": "Clostridium (1988-2004)", "MS": "A species of gram-positive bacteria in the family Clostridiaceae. It is a cellulolytic, mesophilic species isolated from decayed GRASS.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046973"}, {"RECTYPE": "D", "MH": "Clostridium cellulovorans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.205", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1493", "PI": "Clostridium (1990-2004)", "MS": "A species of gram-positive, cellulolytic bacteria in the family Clostridiaceae. It produces CELLULOSOMES which are involved in plant CELL WALL degradation.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046974"}, {"RECTYPE": "D", "MH": "Clostridium chauvoei", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.215", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid46867", "AN": "infection: coordinate IM with CLOSTRIDIUM INFECTIONS (IM)", "PI": "Clostridium (1965-2004)", "MS": "A species of gram-positive bacteria in the family Clostridiaceae isolated from infected CATTLE; SHEEP; and other animals. It causes blackleg in cattle and sheep and is transmitted through soil-borne spores.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046975"}, {"RECTYPE": "D", "MH": "Proteasome Endopeptidase Complex", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteinase, Multicatalytic", "MN": "D08.811.600.730", "FX": "Ubiquitin-Protein Ligase Complexes", "EC": "antagonists & inhibitors:Proteasome Inhibitors", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 3.4.25.1", "RR": "EC 3.4.25.1", "PI": "Multienzyme Complexes (1986-2004)", "MS": "A large multisubunit complex that plays an important role in the degradation of most of the cytosolic and nuclear proteins in eukaryotic cells. It contains a 700-kDa catalytic sub-complex and two 700-kDa regulatory sub-complexes. The complex digests ubiquitinated proteins and protein activated via ornithine decarboxylase antizyme.", "PM": "2005; PROTEASOME ENDOPEPTIDASE COMPLEX was indexed under CYSTEINE ENDOPEPTIDASES & MULTIENZYME COMPLEXES 1986-2004", "HN": "2005; use PROTEASOME ENDOPEPTIDASE COMPLEX (NM) 1986-2004", "MR": "20120703", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D046988"}, {"RECTYPE": "D", "MH": "Marchantia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Marchantias", "MN": "B01.875.800.575.462.750", "MH_TH": "NLM (2005)", "ST": "T002", "RN": "txid3196", "MS": "A liverwort plant genus of the family Marchantiaceae, order Marchantiales, subclass MARCHANTIAE. Members contain brassinosteroids and DITERPENES.", "PM": "2005", "HN": "2005", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047008"}, {"RECTYPE": "D", "MH": "Clostridium histolyticum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.412", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1498", "AN": "infection: coordinate IM with CLOSTRIDIUM INFECTIONS (IM) or GAS GANGRENE (IM) if appropriate", "PI": "Clostridium (1965-2004)", "MS": "A species of gram-positive, strongly proteolytic bacteria in the family Clostridiaceae. It contains several forms of COLLAGENASE whose action can lead to GAS GANGRENE in humans and HORSES.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047009"}, {"RECTYPE": "D", "MH": "Clostridium kluyveri", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.493", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1534", "PI": "Clostridium (1965-2004)", "MS": "A species of gram-positive bacteria in the family Clostridiaceae. It is distinctive for its ability to ferment ETHANOL to caproic acid.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047010"}, {"RECTYPE": "D", "MH": "Silk", "AQ": "AD AE AG AI AN BI BL CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "MN": "D12.776.093.750", "FX": "Textiles", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Proteins (1975-1997)", "MS": "A continuous protein fiber consisting primarily of FIBROINS. It is synthesized by a variety of INSECTS and ARACHNIDS.", "PM": "2005; SILK was indexed under INSECT PROTEINS 1998-2004 & PROTEINS 1975-1997", "HN": "2005; use SILK (NM) 1980 -2004", "MR": "20150608", "DA": "20040715", "DC": "1", "DX": "20050101", "UI": "D047011"}, {"RECTYPE": "D", "MH": "Clostridium botulinum type A", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Clostridium botulinum A|T007|NON|EQV|NLM (2005)|031117|abcdef", "MN": "B03.510.415.400.200.160.050", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid36826", "AN": "infection: coordinate IM with BOTULISM (IM)", "PI": "Clostridium botulinum (1966-2004)", "MS": "Subtype of CLOSTRIDIUM BOTULINUM that produces BOTULINUM TOXINS, TYPE A which is neurotoxic to humans and animals.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047013"}, {"RECTYPE": "D", "MH": "Clostridium botulinum type B", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.160.100", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid36827", "AN": "infection: coordinate IM with BOTULISM (IM)", "PI": "Clostridium botulinum (1966-2004)", "MS": "Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type B which is neurotoxic to humans and animals.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047014"}, {"RECTYPE": "D", "MH": "Macrocyclic Compounds", "DE": "MACROCYCLIC CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Macrocyclic", "MN": "D04.345", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "AN": "general or unspecified; prefer specific group or specific compound", "MS": "Cyclic compounds with a ring size of approximately 1-4 dozen atoms.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047028"}, {"RECTYPE": "D", "MH": "Lactams, Macrocyclic", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Macrocyclic Lactams|T109|NON|EQV|NLM (2005)|031208|abcdef", "MN": "D04.345.295", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "MS": "LACTAM-forming compounds with a ring size of approximately 1-3 dozen atoms.", "PM": "2005; ANSAMYCINS was indexed under ANTI-BACTERIAL AGENTS 1974-2004", "HN": "2005; for ANSAMYCINS use LACTAMS, MACROCYCLIC 1974-2004", "MR": "20190404", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047029"}, {"RECTYPE": "D", "MH": "Sericins", "AQ": "AD AE AG AI AN BI BL CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "ENTRY": "Sericin 1", "MN": "D12.776.093.750.750", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Peptides, Cyclic (1980-2004)", "MS": "A serine-rich sticky protein secreted by MOTHS. Generally, the term refers to silkworm silk gum protein secreted in the middle section of silk gland cells of SILKWORMS, Bombyx mori. Sericin acts as a cement and coating for the two fibroin filaments in a silk strand and is readily soluble in mild alkaline solution.", "PM": "2005; SERICINS was indexed under PEPTIDES, CYCLIC 1974-2004", "HN": "2005 (1974)", "MR": "20150608", "DA": "20040715", "DC": "1", "DX": "20050101", "UI": "D047030"}, {"RECTYPE": "D", "MH": "Vitellins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Vitellin|T116|T123|NON|EQV|UNK (19XX)|880606|abbcdef", "MN": "D12.776.290.812", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Vitellogenin (1978-2004)", "MS": "Major egg yolk proteins from egg-laying animals such as non-mammalian VERTEBRATES; ARTHROPODS; and others. They are high-density lipoglycoproteins derived from circulating precursors, VITELLOGENINS. Vitellins serve as nutrients for the growing non-mammalian embryos (EMBRYO, NONMAMMALIAN).", "PM": "2005; see EGG PROTEINS 1989-2004", "HN": "2005; use EGG PROTEINS 1989-2004", "MR": "20050630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047048"}, {"RECTYPE": "D", "MH": "Arylalkylamine N-Acetyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serotonin Acetyltransferase|T116|T126|NON|EQV|UNK (19XX)|790523|abbcdef", "ENTRY": "Serotonin N Acetyltransferase", "MN": "D08.811.913.050.134.127", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.3.1.87", "AN": "do not confuse with ARYLAMINE N-ACETYLTRANSFERASE", "PI": "Arylamine N-Acetyltransferase (1986-2004)", "MS": "An acetyltransferase with specificity towards the amine group of aromatic alkylamines (arylalkylamines) such as SEROTONIN. This enzyme is also referred to as serotonin acetylase despite the fact that serotonin acetylation can also occur through the action of broad specificity acetyltransferases such as ARYLAMINE N-ACETYLTRANSFERASE.", "PM": "2005; ARYLALKYLAMINE-N-ACETYLTRANSFERASE was indexed under ARYLAMINE N-ACETYLTRANSFERASE 1986-2004; for SEROTONIN ACETYLTRANSFERASE see ARYLAMINE N-ACETYLTRANSFERASE 1980-2004, for SEROTONIN N-ACETYLTRANSFERASE see ARYLAMINE N-ACETYLTRANSFERASE 1982-2004", "HN": "2005(1986)", "MR": "20120703", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047068"}, {"RECTYPE": "D", "MH": "Pyrazolones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pyrazolin 5 Ones", "MN": "D03.383.129.539.850", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Pyrazoles (1965-2004)", "MS": "Compounds with a five-membered heterocyclic ring with two nitrogens and a keto OXYGEN. Some are inhibitors of TNF-ALPHA production.", "PM": "2005", "HN": "2005", "MR": "20160531", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047069"}, {"RECTYPE": "D", "MH": "Bandages, Hydrocolloid", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Bandages, Hydrogel|T122|NON|NRW|NLM (2005)|031120|abcdef", "ENTRY": "Hydrogel Bandages", "MN": "E07.101.074", "MH_TH": "NLM (2005)", "ST": "T122", "MS": "Dressings comprised of a self-adhesive matrix to which hydrophilic absorbent particles are embedded. The particles consist of CELLULOSE derivatives; calcium ALGINATES; PECTINS; or GELS. The utility is based on providing a moist environment for WOUND HEALING.", "PM": "2005; HYDROCOLLOID DRESSING was indexed under COLLOIDS 1988-2004", "HN": "2005; use BANDAGES, HYDROCOLLOID (NM) 1988-2004", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047070"}, {"RECTYPE": "D", "MH": "beta-Glucans", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Glucan|T109|NON|EQV|NLM (2021)|191125|abcdef", "ENTRY": "beta Glucans", "MN": "D09.698.365.089", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Glucans (1978-2004)", "MS": "Glucose polymers consisting of a backbone of beta(1->3)-linked beta-D-glucopyranosyl units with beta(1->6) linked side chains of various lengths. They are a major component of the CELL WALL of organisms and of soluble DIETARY FIBER.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047071"}, {"RECTYPE": "D", "MH": "Aromatase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aromatase Inhibitor|T121|NON|EQV|NLM (2021)|191126|abcdef", "ENTRY": "Inhibitors, Aromatase", "MN": "D27.505.696.399.450.855.300", "MH_TH": "NLM (2005)", "ST": "T121", "RN": "0", "PI": "Aromatase/antagonists & inhibitors (1975-2004)", "MS": "Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047072"}, {"RECTYPE": "D", "MH": "Dysidea", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Dysideas", "MN": "B01.050.500.802.200", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid190526", "PI": "Porifera (1980-2004)", "MS": "A genus of SPONGES in the family Dysideidae, in which all skeletal fibers are filled with detritus.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047088"}, {"RECTYPE": "D", "MH": "Axinella", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "polypoides, Axinella", "MN": "B01.050.500.802.080", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid12958", "RR": "txid12959", "PI": "Porifera (1973-2004)", "MS": "A genus of SPONGES in the family Axinellidae, comprised of a choanosomal skeleton differentiated in the axial and extra-axial region. The type species is Axinella polypoides.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040719", "DC": "1", "DX": "20050101", "UI": "D047089"}, {"RECTYPE": "D", "MH": "beta-Lactams", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Lactam|T109|T195|NON|EQV|NLM (2021)|191126|abbcdef", "ENTRY": "beta Lactams", "MN": "D03.633.100.300", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (1996)", "ST": "T195", "RN": "0", "PI": "Lactams (1974-2004)", "MS": "Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.", "PM": "2005; see LACTAMS 1996-2004", "HN": "2005; use LACTAMS 1996-2004", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047090"}, {"RECTYPE": "D", "MH": "Eosinophil Granule Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Granule Proteins, Eosinophil", "MN": "D12.776.124.486.379", "PA": "Immunologic Factors", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Ribonucleases (1979-2004)", "MS": "Proteins found in EOSINOPHIL granules. They are primarily basic proteins that play a role in host defense and the proinflammatory actions of activated eosinophils.", "PM": "2005; EOSINOPHIL GRANULE PROTEINS was indexed under BLOOD PROTEINS & RIBONUCLEASES 1979-2004", "HN": "2005(1979)", "MR": "20050630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047091"}, {"RECTYPE": "D", "MH": "Eosinophil Major Basic Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Major Basic Protein, Eosinophil|T116|T131|NON|EQV|NLM (2005)|031121|abbcdef", "ENTRY": "Eosinophil MBP Protein", "MN": "D12.776.124.486.379.500", "PA": "Immunologic Factors", "MH_TH": "NLM (2005)", "ST": "T131", "RN": "EC 3.1.27.-", "RR": "EC 3.1.27.-", "PI": "Ribonucleases (1981-2004)", "MS": "One of several basic proteins released from EOSINOPHIL cytoplasmic granules. Eosinophil major basic protein is a 14-kDa cytotoxic peptide with a pI of 10.9. In addition to its direct cytotoxic effects, it stimulates the release of variety of INFLAMMATION MEDIATORS.", "PM": "2005; EOSINOPHIL BASIC PROTEIN was indexed under BLOOD PROTEINS & RIBONUCLEASES 1981-2004", "HN": "2005(1981)", "MR": "20050630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047093"}, {"RECTYPE": "D", "MH": "Embryonic Development", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Preimplantation Embryo Development|T039|NON|NRW|NLM (2005)|031126|abcdef", "ENTRY": "Pre implantation Embryo Development", "MN": "G08.686.784.170.104", "MH_TH": "NLM (2005)", "ST": "T039", "PI": "Embryonic and Fetal Development (1973-2004)", "MS": "Morphological and physiological development of EMBRYOS.", "PM": "2005; see EMBRYONIC AND FETAL DEVELOPMENT 1985-2004; for POSTIMPLANTATION EMBRYO DEVELOPMENT see POSTIMPLANTATION PHASE 1985-2004, see POSTNIDATION PHASE 1980-1984, see PREGNANCY TRIMESTER, FIRST 1976-1979, see PREGNANCY, FIRST TRIMESTER 1975; for PREIMPLANTATION EMBRYO DEVELOPMENT see PREIMPLANTATION PHASE 1985-2004, see PRENIDATION PHASE 1980-1984, see PREGNANCY TRIMESTER, FIRST 1976-1979, see PREGNANCY, FIRST TRIMESTER 1975; for POSTNIDATION EMBRYO DEVELOPMENT, ANIMAL & PRENIDATION EMBRYO DEVELOPMENT, ANIMAL see PREGNANCY, ANIMAL 1975-1979", "HN": "2005; use EMBRYONIC AND FETAL DEVELOPMENT 1985-2004; for POSTIMPLANTATION EMBRYO DEVELOPMENT & PREIMPLANTATION EMBRYO DEVELOPMENT use EMBRYONIC AND FETAL DEVELOPMENT 1976-2004", "MR": "20160617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047108"}, {"RECTYPE": "D", "MH": "Fetal Development", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Fetal Programming|T038|NON|NRW|NLM (2007)|050810|abcdef", "ENTRY": "Growth, Fetal", "MN": "G08.686.784.170.157", "MH_TH": "NLM (1985)", "ST": "T039", "AN": "mammalian only", "PI": "Fetus (1965-2004)", "MS": "Morphological and physiological development of FETUSES.", "PM": "2005, 1985-2002; see EMBRYONIC AND FETAL DEVELOPMENT 2003-2004", "HN": "2005, 1985-2002; use EMBRYONIC AND FETAL DEVELOPMENT 2003-2004", "MR": "20160617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047109"}, {"RECTYPE": "D", "MH": "Callyspongia", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Callyspongias", "MN": "B01.050.500.802.160", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid178537", "PI": "Porifera (1980-2004)", "MS": "A genus of SPONGES in the family Callyspongiidae comprised of a regular ectosomal reticulate skeleton.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047128"}, {"RECTYPE": "D", "MH": "Haliclona", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Haliclonas", "MN": "B01.050.500.802.380", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid6057", "PI": "Porifera (1967-2004)", "MS": "A genus of SPONGES in the family Chalinidae characterized by unispicular secondary lines in the choanosomal skeleton.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047129"}, {"RECTYPE": "D", "MH": "Petrosia", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Petrosias", "MN": "B01.050.500.802.650", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid68563", "PI": "Porifera (1980-2004)", "MS": "A genus of SPONGES in the family Petrosiidae, characterized by an ectosomal triangular or polygonal reticulation of spicule tracts or single spicules.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047130"}, {"RECTYPE": "D", "MH": "Xestospongia", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Xestospongias", "MN": "B01.050.500.802.900", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid178550", "PI": "Porifera (1981-2004)", "MS": "A genus of SPONGES in the family Petrosiidae, characterized by an ectosomal skeleton consisting only of an isotropic reticulation of single spicules or spicule tracts.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047131"}, {"RECTYPE": "D", "MH": "Crambe Sponge", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Crambe crambe|T204|NON|NRW|NLM (2005)|031124|abcdef", "ENTRY": "crambe, Crambe", "MN": "B01.050.500.802.175", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid72178", "RR": "txid3722", "PI": "Porifera (1966-2004)", "MS": "A genus of SPONGES in the family Crambeidae characterized by desmoid spicules. The type species is Crambe crambe.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047132"}, {"RECTYPE": "D", "MH": "Eosinophil Cationic Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ribonuclease, Eosinophil-Associated", "MN": "D12.776.124.486.379.249", "PA": "Immunologic Factors", "MH_TH": "NLM (2005)", "ST": "T131", "RN": "EC 3.1.27.-", "PI": "Ribonucleases (1979-2004)", "MS": "One of several basic proteins released from EOSINOPHIL cytoplasmic granules. Eosinophil cationic protein is a 21-kDa cytotoxic peptide with a pI of 10.9. Although eosinophil cationic protein is considered a member of the RNAse A superfamily of proteins, it has only limited RNAse activity.", "PM": "2005; EOSINOPHIL CATIONIC PROTEIN was indexed under BLOOD PROTEINS & RIBONUCLEASES 1979-2004", "HN": "2005(1979)", "MR": "20050630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047150"}, {"RECTYPE": "D", "MH": "Amaryllidaceae Alkaloids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Norbelladine-Type Amaryllidaceae Alkaloids|T109|NON|NRW|NLM (2022)|210318|abcdef", "ENTRY": "Norbelladine Type Amaryllidaceae Alkaloids", "MN": "D03.132.052", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Alkaloids (1965-2004)", "MS": "Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the AMARYLLIDACEAE plant family.", "PM": "2005", "HN": "2005", "MR": "20210510", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047151"}, {"RECTYPE": "D", "MH": "Cystine Knot Motifs", "AQ": "DE GE IM PH RE", "ENTRY": "Motifs, Cystine Knot", "MN": "G02.111.570.820.709.275.500.127", "MH_TH": "NLM (2005)", "ST": "T087", "MS": "Amino acid sequence in which two disulfide bonds (DISULFIDES) and their connecting backbone form a ring that is penetrated by a third disulfide bond. Members include CYCLOTIDES and agouti-related protein.", "PM": "2005", "HN": "2005", "MR": "20160527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047168"}, {"RECTYPE": "D", "MH": "Cyclotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclotide|T116|NON|EQV|NLM (2021)|200309|abcdef", "MN": "D12.644.641.243", "MH_TH": "NLM (2005)", "ST": "T116", "RN": "0", "PI": "Peptides, Cyclic (2000-2004)", "MS": "A continuous circle of peptide bonds, typically of 2-3 dozen AMINO ACIDS, so there is no free N- or C-terminus. They are further characterized by six conserved CYSTEINE residues that form CYSTINE KNOT MOTIFS.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047169"}, {"RECTYPE": "D", "MH": "Chalcones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "1,3 Diphenylpropenones", "MN": "D03.633.100.150.266.450.221", "FX": "Benzoates", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Chalcone/analogs & derivatives (1991-2004)", "MS": "Derivatives of CHALCONE that are important intermediates in the formation of FLAVONOIDS with anti-fungal, anti-bacterial, anti-inflammatory, and anti-tumor properties.", "PM": "2005", "HN": "2005", "MR": "20161101", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047188"}, {"RECTYPE": "D", "MH": "Eosinophil-Derived Neurotoxin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Neurotoxin, RNS2", "MN": "D12.776.124.486.379.275", "PA": "Immunologic Factors", "MH_TH": "NLM (2005)", "ST": "T129", "RN": "EC 3.1.-", "PI": "Ribonucleases (1989-2004)", "MS": "A 19-kDa cationic peptide found in EOSINOPHIL granules. Eosinophil-derived neurotoxin is a RIBONUCLEASE and may play a role as an endogenous antiviral agent.", "PM": "2005; EOSINOPHIL-DERIVED NEUROTOXIN was indexed under RIBONUCLEASES 1989-2004", "HN": "2005(1989)", "MR": "20050708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047208"}, {"RECTYPE": "D", "MH": "Eosinophil Peroxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peroxidase, Eosinophil", "MN": "D12.776.124.486.379.600", "PA": "Immunologic Factors", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 1.11.1.-", "PI": "Peroxides (1997-2004)", "MS": "A 66-kDa peroxidase found in EOSINOPHIL granules. Eosinophil peroxidase is a cationic protein with a pI of 10.8 and is comprised of a heavy chain subunit and a light chain subunit. It possesses cytotoxic activity towards BACTERIA and other organisms, which is attributed to its peroxidase activity.", "PM": "2005; EOSINOPHIL PEROXIDASE was indexed under PEROXIDES 1997-2004", "HN": "2005(1997)", "MR": "20060705", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047209"}, {"RECTYPE": "D", "MH": "Angiotensin II Type 1 Receptor Blockers", "DS": "ANGIOTENSIN II TYPE 01 RECEPTOR BLOCKERS", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Sartan|T121|NON|NRW|NLM (2021)|200417|abcdef", "ENTRY": "Type 1 Angiotensin Receptor Blockers|T121|NON|EQV|NLM (2005)|031203|abcdef", "MN": "D27.505.519.162.500", "FX": "Angiotensin-Converting Enzyme Inhibitors", "MH_TH": "NLM (2005)", "ST": "T121", "RN": "0", "PI": "Angiotensin Receptors/antagonists & inhibitors (1984-2004)", "MS": "Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047228"}, {"RECTYPE": "D", "MH": "Plakortis", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Plakorti", "MN": "B01.050.500.802.670", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid86044", "PI": "Porifera (1990-2004)", "MS": "A genus of SPONGES in the family Plakinidae, with the skeleton formed by small diactine (and some triactine) needle-like terminations.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047229"}, {"RECTYPE": "D", "MH": "Agelas", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Agela", "MN": "B01.050.500.802.039", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid72714", "PI": "Porifera (1989-2004)", "MS": "A genus of large, brightly colored SPONGES in the family Agelasidae, possessing a skeleton of spongin fibers with a core of large spicules (megascleres).", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047230"}, {"RECTYPE": "D", "MH": "Geodia", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Geodias", "MN": "B01.050.500.802.360", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid6046", "PI": "Porifera (1974-2004)", "MS": "A genus of massive or globular SPONGES in the family Geodiidae, with large spicules at or near the surface.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047231"}, {"RECTYPE": "D", "MH": "Theonella", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Theonellas", "MN": "B01.050.500.802.785", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid37504", "PI": "Porifera (1987-2004)", "MS": "A genus of shallow-cupped SPONGES with a broad base in the family Theonellidae. They are characterized by ectosomal spicules dominated by phyllotriaenes.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047232"}, {"RECTYPE": "D", "MH": "Suberites", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Suberite", "MN": "B01.050.500.802.775", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid55566", "PI": "Porifera (1971-2004)", "MS": "A genus of velvety smooth SPONGES in the family Suberitidae, characterized by the ectosomal and choanosomal skeletons dominated by tylostyles (pin-like spicules with a pinched bulbous end).", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047233"}, {"RECTYPE": "D", "MH": "Crown Compounds", "DE": "CROWN CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Crown Compounds, Thia", "MN": "D04.345.051", "MH_TH": "NLM (1993)", "ST": "T109", "RN": "0", "PI": "Crown Ethers (1992-2004)", "MS": "Macrocyclic compounds analogous to CROWN ETHERS but which lack any OXYGEN atoms.", "PM": "2005; see CROWN ETHERS 1993-2004", "HN": "2005; use CROWN ETHERS 1993-2004", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047248"}, {"RECTYPE": "D", "MH": "Calixarenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Calixarene|T109|NON|EQV|NLM (2005)|abcde", "ENTRY": "Calix(n)Arenes|T109|NON|EQV|NLM (2005)|031204|abcdef", "MN": "D04.345.025", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "130036-26-9", "MS": "Phenolic metacyclophanes derived from condensation of PHENOLS and ALDEHYDES. The name derives from the vase-like molecular structures. A bracketed [n] indicates the number of aromatic rings.", "PM": "2005", "HN": "2005", "DA": "20040708", "DC": "1", "DX": "20050101", "UI": "D047250"}, {"RECTYPE": "D", "MH": "Lingual Goiter", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lingual Goiters", "MN": "C19.874.689.500.500", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Tongue Diseases (1965-2004)", "MS": "Pathological enlargement of the LINGUAL THYROID, ectopic thyroid tissue at the base of the TONGUE. It may cause upper AIRWAY OBSTRUCTION; DYSPHAGIA; or HYPOTHYROIDISM symptoms.", "PM": "2005", "HN": "2005", "MR": "20050630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047268"}, {"RECTYPE": "D", "MH": "Strongylocentrotus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.408.578.800", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid7664", "PI": "Sea Urchins (1971-2004)", "MS": "A genus of SEA URCHINS in the family Strongylocentrotidae. They possess more than three pore pairs per ambulacral plate. The species STRONGYLOCENTROTUS PURPURATUS is commonly used for research.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047269"}, {"RECTYPE": "D", "MH": "Strongylocentrotus purpuratus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Urchins, Purple Sea", "MN": "B01.050.500.408.578.800.600", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid7668", "PI": "Sea Urchins (1971-2004)", "MS": "A species of SEA URCHINS in the family Strongylocentrotidae found on the Pacific coastline from Alaska to Mexico. This species serves as a major research model for molecular developmental biology and other fields.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047270"}, {"RECTYPE": "D", "MH": "Asterias", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Asteria", "MN": "B01.050.500.408.765.070", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid7601", "PI": "Starfish (1971-2004)", "MS": "A genus of STARFISH in the family Asteriidae. One species, Asterias rubens, is the most common in the north-east Atlantic region.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047271"}, {"RECTYPE": "D", "MH": "Asterina", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "pectiniferas, Asterina", "MN": "B01.050.500.408.765.075", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid7593", "RR": "txid7594", "PI": "Starfish (1972-2004)", "MS": "A genus of STARFISH in the family Asterinidae. They externally hold developing embryos (EMBRYO, NON-MAMMALIAN) among the spines below the oral surface.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047288"}, {"RECTYPE": "D", "MH": "Arbacia", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "punctulatas, Arbacia", "MN": "B01.050.500.408.578.070", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid7639", "RR": "txid7641", "PI": "Sea Urchins (1971-2004)", "MS": "A genus of SEA URCHINS in the family Arbaciidae. They have only one spheridium (stalked body) per ambulacral area (contains tube feet); most sea urchins have several spheridia per area.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047308"}, {"RECTYPE": "D", "MH": "Flavones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "2-Phenyl-2-Ene-Benzopyran-4-One Compounds|T109|NON|EQV|NLM (2005)|031210|abcdef", "MN": "D03.633.100.150.266.450.260", "MH_TH": "NLM (1966)", "ST": "T109", "RN": "0", "PI": "Flavonoids (2004)", "MS": "A group of 4-keto-FLAVONOIDS.", "PM": "2005, 1963-2003; see FLAVONOIDS 2004", "HN": "2005, 1963-2003; use FLAVONOIDS 2004", "MR": "20160531", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047309"}, {"RECTYPE": "D", "MH": "Apigenin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D03.633.100.150.266.450.260.110", "MH_TH": "NLM (2005)", "ST": "T121", "N1": "5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone", "RN": "7V515PI7F6", "RR": "520-36-5 (Apigenin)", "PI": "Flavonoids (1967-2004)", "MS": "5,7,4'-trihydroxy-flavone, one of the FLAVONES.", "PM": "2005; APIGENIN was indexed under FLAVONOIDS 2000-2004", "HN": "2005 (2000)", "MR": "20160527", "DA": "20040708", "DC": "1", "DX": "20050101", "UI": "D047310"}, {"RECTYPE": "D", "MH": "Luteolin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Luteoline|T109|NON|EQV|NLM (2005)|abcde", "MN": "D03.633.100.150.266.450.260.555", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "KUX1ZNC9J2", "RR": "491-70-3 (Luteolin)", "PI": "Flavonoids (1981-2004)", "MS": "5,7,3',4'-tetrahydroxy-flavone, one of the FLAVONES.", "PM": "2005; LUTEOLIN was indexed under FLAVONOIDS 1981-2004", "HN": "2005 (1981)", "MR": "20160531", "DA": "20040708", "DC": "1", "DX": "20050101", "UI": "D047311"}, {"RECTYPE": "D", "MH": "Paracentrotus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Paracentrotus lividus|T204|NON|NRW|NLM (2005)|031210|abcdef", "MN": "B01.050.500.408.578.600", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid7655", "RR": "txid7656", "PI": "Sea Urchins (1971-2004)", "MS": "A genus of SEA URCHINS in the family Echinidae found primarily on the western coasts of Ireland.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047328"}, {"RECTYPE": "D", "MH": "Anthocidaris", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Heliocidaris|T204|NON|EQV|NLM (2005)|040302|abcdef", "ENTRY": "crassispina, Anthocidaris", "MN": "B01.050.500.408.578.050", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid7633", "RR": "txid1043166", "PI": "Sea Urchins (1974-2004)", "MS": "A genus of SEA URCHINS synonymous with Heliocidaris, belonging to the family Echinometridae.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047329"}, {"RECTYPE": "D", "MH": "Hemicentrotus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Hemicentrotus pulcherrimus|T204|NON|NRW|NLM (2005)|031210|abcdef", "MN": "B01.050.500.408.578.400", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid7649", "RR": "txid7650", "PI": "Sea Urchins (1969-2004)", "MS": "A genus of SEA URCHINS in the family Strongylocentrotidae with a hemicyclic apical disk and short spines.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047330"}, {"RECTYPE": "D", "MH": "Lytechinus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Lytechinus variegatus|T204|NON|NRW|NLM (2005)|031210|abcdef", "MN": "B01.050.500.408.578.500", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid7652", "RR": "txid7654", "PI": "Sea Urchins (1971-2004)", "MS": "A genus of SEA URCHINS in the family Toxopneustidae possessing trigeminate ambulacral plating.", "PM": "2007; see LYTECHNIUS 2005-2006", "HN": "2007 (2005)", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047331"}, {"RECTYPE": "D", "MH": "Holothuria", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Holothurias", "MN": "B01.050.500.408.560.400", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid7684", "PI": "Sea Cucumbers (1989-2004)", "MS": "A genus of large SEA CUCUMBERS in the family Holothuriidae possessing thick body walls, a warty body surface, and microscopic ossicles.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047332"}, {"RECTYPE": "D", "MH": "Hydrolyzable Tannins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Tannins, Pyrogallol", "MN": "D05.750.078.937.214", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Tannins (1963-2004)", "MS": "Polymeric derivatives of GALLIC ACID that are esters of a sugar.", "PM": "2005", "HN": "2005", "MR": "20120703", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047348"}, {"RECTYPE": "D", "MH": "Tumor Burden", "AQ": "DE ES GE IM PH RE", "ENTRY": "Weights, Tumor", "MN": "E05.041.124.892", "MH_TH": "NLM (2005)", "ST": "T081", "AN": "coordinate with neoplasm /pathol", "MS": "The total amount (cell number, weight, size or volume) of tumor cells or tissue in the body.", "PM": "2005", "HN": "2005", "MR": "20090706", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047368"}, {"RECTYPE": "D", "MH": "Chromatin Immunoprecipitation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Immunoprecipitation, Chromatin|T063|NON|EQV|NLM (2005)|040209|abcdef", "MN": "E05.478.605.160", "MH_TH": "NLM (2005)", "ST": "T063", "PI": "Precipitin Tests (2000-2004)", "MS": "A technique for identifying specific DNA sequences that are bound, in vivo, to proteins of interest. It involves formaldehyde fixation of CHROMATIN to crosslink the DNA-BINDING PROTEINS to the DNA. After shearing the DNA into small fragments, specific DNA-protein complexes are isolated by immunoprecipitation with protein-specific ANTIBODIES. Then, the DNA isolated from the complex can be identified by PCR amplification and sequencing.", "PM": "2005", "HN": "2005", "DA": "20040719", "DC": "1", "DX": "20050101", "UI": "D047369"}, {"RECTYPE": "D", "MH": "Casein Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Casein Kinase|T116|T126|NON|EQV|NLM (2005)|abbcde", "ENTRY": "Kinases, Casein", "MN": "D12.776.476.563.140", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.1", "AN": "general or unspecified; prefer specifics", "PI": "Protein Kinases (1974-2004)", "MS": "A group of protein-serine-threonine kinases that was originally identified as being responsible for the PHOSPHORYLATION of CASEINS. They are ubiquitous enzymes that have a preference for acidic proteins. Casein kinases play a role in SIGNAL TRANSDUCTION by phosphorylating a variety of regulatory cytoplasmic and regulatory nuclear proteins.", "PM": "2005; CASEIN KINSES was indexed under PROTEIN KINASES 1974-2004", "HN": "2005(1974)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047388"}, {"RECTYPE": "D", "MH": "Casein Kinase I", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kinase I, Casein", "MN": "D12.776.476.563.140.300", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.1", "RR": "EC 2.7.11.1", "PI": "Protein Kinases (1980-2004)", "MS": "A casein kinase that was originally described as a monomeric enzyme with a molecular weight of 30-40 kDa. Several ISOENZYMES of casein kinase I have been found which are encoded by separate genes. Many of the casein kinase I isoenzymes have been shown to play distinctive roles in intracellular SIGNAL TRANSDUCTION.", "PM": "2005; CASEIN KINASE I was indexed under PROTEIN KINASES 1974-2004", "HN": "2005(1974)", "MR": "20210520", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047389"}, {"RECTYPE": "D", "MH": "Casein Kinase II", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kinase CKII, Protein", "MN": "D12.776.476.563.140.600", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.1", "RR": "EC 2.7.11.1", "PI": "Protein-Serine-Threonine Kinases (1992-2004)", "MS": "A ubiquitous casein kinase that is comprised of two distinct catalytic subunits and dimeric regulatory subunit. Casein kinase II has been shown to phosphorylate a large number of substrates, many of which are proteins involved in the regulation of gene expression.", "PM": "2005; CASEIN KINASE II was indexed under PROTEIN-SERINE-THREONINE KINASES 1992-2004", "HN": "2005(1992)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047390"}, {"RECTYPE": "D", "MH": "alpha-Cyclodextrins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "alpha Cyclodextrins", "MN": "D09.698.365.855.400.375.222", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Oligosaccharides (1975-2004)", "MS": "Cyclic GLUCANS consisting of six (6) glucopyranose units linked by 1,4-glycosidic bonds.", "PM": "2005", "HN": "2005", "MR": "20170410", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047391"}, {"RECTYPE": "D", "MH": "beta-Cyclodextrins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta Cyclodextrins", "MN": "D09.698.365.855.400.375.333", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Oligosaccharides (1974-2004)", "MS": "Cyclic GLUCANS consisting of seven (7) glucopyranose units linked by 1,4-glycosidic bonds.", "PM": "2005", "HN": "2005", "MR": "20170410", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047392"}, {"RECTYPE": "D", "MH": "gamma-Cyclodextrins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "gamma Cyclodextrins", "MN": "D09.698.365.855.400.375.444", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Oligosaccharides (1974-2004)", "MS": "Cyclic GLUCANS consisting of eight (8) glucopyranose units linked by 1,4-glycosidic bonds.", "PM": "2005", "HN": "2005", "MR": "20170410", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047408"}, {"RECTYPE": "D", "MH": "Protein Kinase Inhibitors", "DE": "PROTEIN KINASE INHIB", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Protein Kinase Inhibitor|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Kinase Inhibitors, Protein", "MN": "D27.505.519.389.755", "MH_TH": "NLM (2005)", "ST": "T121", "RN": "0", "PI": "Protein Kinases (1973-2004)", "MS": "Agents that inhibit PROTEIN KINASES.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047428"}, {"RECTYPE": "D", "MH": "Immunoprecipitation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Precipitations, Immune", "MN": "E05.478.605", "FX": "Antigen-Antibody Complex", "MH_TH": "UNK (19XX)", "ST": "T059", "PI": "Precipitin Tests (1970-2004)", "MS": "The aggregation of soluble ANTIGENS with ANTIBODIES, alone or with antibody binding factors such as ANTI-ANTIBODIES or STAPHYLOCOCCAL PROTEIN A, into complexes large enough to fall out of solution.", "PM": "2005; see PRECIPITIN TESTS 1989-2004", "HN": "2005; use PRECIPITIN TESTS 1989-2004", "MR": "20090706", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047468"}, {"RECTYPE": "D", "MH": "Retinoid X Receptors", "DE": "RETINOID X RECEPT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Retinoid X Receptor|T116|T123|NON|EQV|NLM (2005)|abbcde", "ENTRY": "protein, XR78E-F", "MN": "D12.776.930.775.500", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Receptors, Retinoic Acid (1993-2004)", "MS": "A subtype of RETINOIC ACID RECEPTORS that are specific for 9-cis-retinoic acid which function as nuclear TRANSCRIPTION FACTORS that regulate multiple signaling pathways.", "PM": "2005", "HN": "2005", "MR": "20150708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047488"}, {"RECTYPE": "D", "MH": "Preconception Injuries", "DE": "PRECONCEPTION INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Preconception Injury", "MN": "C21.676", "MH_TH": "NLM (1993)", "ST": "T037", "AN": "not limited to traumatic injuries", "PI": "Prenatal Exposure Delayed Effects (1974-2004)", "MS": "Damages to reproductive health prior to conception (FERTILIZATION), a legal term for torts liability concerning environmental safety issues. Preconception injuries may involve either the male or the female, such as chromosomal mutations in the OVA or the SPERMATOZOA.", "PM": "2005; see PRENATAL EXPOSURE DELAYED EFFECTS 1992-2004", "HN": "2005; use PRENATAL EXPOSURE DELAYED EFFECTS 1992-2004", "MR": "20140613", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047489"}, {"RECTYPE": "D", "MH": "Retinoid X Receptor alpha", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor, RXR alpha", "MN": "D12.776.826.701.500.500", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Receptors, Retinoic Acid (1993-2004)", "MS": "A nuclear transcription factor. Heterodimerization with PPAR GAMMA is important in regulation of GLUCOSE metabolism and CELL GROWTH PROCESSES.", "PM": "2005", "HN": "2005", "MR": "20150623", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047490"}, {"RECTYPE": "D", "MH": "Retinoid X Receptor gamma", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor, RXR gamma", "MN": "D12.776.826.701.500.750", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Receptors, Retinoic Acid (1993-2004)", "MS": "A nuclear transcription factor. Heterodimerization with PPAR ALPHA is important to metabolism of LIPIDS.", "PM": "2005", "HN": "2005", "MR": "20150623", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047491"}, {"RECTYPE": "D", "MH": "Peroxisome Proliferator-Activated Receptors", "DE": "PEROXISOME PROLIFERATOR ACTIVATED RECEPT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peroxisome Proliferator-Activated Receptor|T116|T192|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Receptors, Peroxisome Proliferator-Activated", "MN": "D12.776.930.705", "FX": "Peroxisome Proliferators", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "AN": "note specifics", "PI": "Transcription Factors (1993-2004)", "MS": "TRANSCRIPTION FACTORS that are activated by ligands and heterodimerize with RETINOID X RECEPTORS and bind to peroxisome proliferator response elements in the promoter regions of target genes.", "PM": "2005; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR was indexed under TRANSCRIPTION FACTORS & RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993", "HN": "2005(1992)", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047492"}, {"RECTYPE": "D", "MH": "PPAR alpha", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PPARalpha|T116|T192|ACX|EQV|NLM (2005)|abbcde", "ENTRY": "Peroxisome Proliferator Activated Receptor alpha", "MN": "D12.776.826.239.500", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "PI": "Transcription Factors (1993-2004)", "MS": "A nuclear transcription factor. Heterodimerization with RETINOID X RECEPTOR GAMMA is important to metabolism of LIPIDS. It is the target of FIBRATES to control HYPERLIPIDEMIAS.", "PM": "2005; PPAR ALPHA was indexed under TRANSCRIPTION FACTORS & RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993", "HN": "2005(1992)", "MR": "20150623", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047493"}, {"RECTYPE": "D", "MH": "PPAR delta", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PPARdelta|T116|T192|ACX|EQV|NLM (2005)|abbcde", "ENTRY": "Peroxisome Proliferator Activated Receptor delta", "MN": "D12.776.826.239.555", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "PI": "Transcription Factors (1993-2004)", "MS": "A nuclear transcription factor. It is activated by PROSTACYCLIN.", "PM": "2005; PPAR DELTA was indexed under TRANSCRIPTION FACTORS & RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993", "HN": "2005(1992)", "MR": "20150623", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047494"}, {"RECTYPE": "D", "MH": "PPAR gamma", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PPARgamma|T116|T192|ACX|EQV|NLM (2005)|abbcde", "ENTRY": "Receptor, Thiazolidinedione", "MN": "D12.776.826.239.588", "FX": "Lipodystrophy, Familial Partial", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "PI": "Transcription Factors (1993-2004)", "MS": "A nuclear transcription factor. Heterodimerization with RETINOID X RECEPTOR ALPHA is important in regulation of GLUCOSE metabolism and CELL GROWTH PROCESSES. It is a target of THIAZOLIDINEDIONES for control of DIABETES MELLITUS.", "PM": "2005; PPAR GAMMA was indexed under TRANSCRIPTION FACTORS & RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993", "HN": "2005(1992)", "MR": "20150623", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047495"}, {"RECTYPE": "D", "MH": "Massive Hepatic Necrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Submassive Hepatic Necrosis|T046|NON|REL|NLM (2020)|190506|abcdef", "ENTRY": "Yellow Atrophy, Acute", "MN": "C06.552.308.500.750.500", "MH_TH": "NLM (2005)", "ST": "T046", "PI": "Necrosis (1968-2004)", "MS": "Extensive and rapid death of parenchymal cells in the LIVER, often due to exposure to toxic materials or drug-induced injury. It is characterized by a soft, flabby, yellow-brown wrinkled, and shrunken liver. It was called \"acute yellow atrophy\".", "PM": "2005; see LIVER DISEASES 1997-2004", "HN": "2005; use LIVER DISEASES 1997-2004", "MR": "20190701", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047508"}, {"RECTYPE": "D", "MH": "Stichopus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Stichopus japonicus|T204|NON|NRW|NLM (2005)|031222|abcdef", "MN": "B01.050.500.408.560.700", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid7691", "RR": "txid307972", "PI": "Sea Cucumbers (1980-2004)", "MS": "A genus of very large, epibenthic SEA CUCUMBERS in the family Stichopodidae, commercially harvested in Southeast Asia for food.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047528"}, {"RECTYPE": "D", "MH": "Defibrillators", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "External Defibrillators, Automated", "MN": "E07.305.250.159", "FX": "Electric Countershock", "MH_TH": "NLM (2005)", "ST": "T074", "PI": "Electric Countershock (1967-2004)", "MS": "Cardiac electrical stimulators that apply brief high-voltage electroshocks to the HEART. These stimulators are used to restore normal rhythm and contractile function in hearts of patients who are experiencing VENTRICULAR FIBRILLATION or ventricular tachycardia (TACHYCARDIA, VENTRICULAR) that is not accompanied by a palpable PULSE. Some defibrillators may also be used to correct certain noncritical dysrhythmias (called synchronized defibrillation or CARDIOVERSION), using relatively low-level discharges synchronized to the patient's ECG waveform. (UMDNS, 2003)", "PM": "2005", "HN": "2005", "MR": "20080708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047548"}, {"RECTYPE": "D", "MH": "Coronary Artery Bypass, Off-Pump", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Off-Pump Coronary Artery Bypass|T061|NON|EQV|NLM (2005)|031222|abcdef", "ENTRY": "Off Pump Coronary Artery Bypass", "MN": "E04.928.220.520.220.189", "MH_TH": "NLM (2005)", "ST": "T061", "PI": "Coronary Artery Bypass/methods (1996-2004)", "MS": "Coronary artery bypass surgery on a beating HEART without a CARDIOPULMONARY BYPASS (diverting the flow of blood from the heart and lungs through an oxygenator).", "PM": "2005", "HN": "2005", "MR": "20100625", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047549"}, {"RECTYPE": "D", "MH": "Unsafe Sex", "AQ": "CL DE EH ES HI PC PH PX RE SN", "PRINT ENTRY": "Unprotected Intercourse|T054|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Sex, Unsafe", "MN": "F01.145.802.987", "MH_TH": "NLM (2001)", "ST": "T054", "PI": "Sexual Behavior (1988-2004)", "MS": "Sexual behaviors which are high-risk for contracting SEXUALLY TRANSMITTED DISEASES or for producing PREGNANCY.", "PM": "2005; see SAFE SEX 2001-2004", "HN": "2005; use SAFE SEX 2001-2004", "MR": "20210512", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047568"}, {"RECTYPE": "D", "MH": "Laser Scanning Cytometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Cytometry, Laser Scanning|T059|NON|EQV|NLM (2005)|031224|abcdef", "ENTRY": "Scanning Cytometry, Laser", "MN": "E05.595.395.500", "MH_TH": "NLM (2005)", "ST": "T059", "PI": "Lasers (1992-2004)", "MS": "A scanning microscope-based, cytofluorimetry technique for making fluorescence measurements and topographic analysis on individual cells. Lasers are used to excite fluorochromes in labeled cellular specimens. Fluorescence is detected in multiple discrete wavelengths and the locational data is processed to quantitatively assess APOPTOSIS; PLOIDIES; cell proliferation; GENE EXPRESSION; PROTEIN TRANSPORT; and other cellular processes.", "PM": "2005", "HN": "2005", "MR": "20150601", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047569"}, {"RECTYPE": "D", "MH": "Leukocyte Reduction Procedures", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Removal Procedures, Leukocyte", "MN": "E05.242.363.540", "MH_TH": "NLM (2005)", "ST": "T061", "MS": "The removal of LEUKOCYTES from BLOOD to reduce BLOOD TRANSFUSION reactions and lower the chance of transmitting VIRUSES. This may be performed by FILTRATION or by CYTAPHERESIS.", "PM": "2005", "HN": "2005", "MR": "20150623", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047589"}, {"RECTYPE": "D", "MH": "Pyrroloiminoquinones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pyrroloiminoquinone|T109|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Pyrrolo Iminoquinones", "MN": "D03.633.100.810.553", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "MS": "Derivatives of QUINOLINES with fused PYRROLES and a keto group or INDOLEQUINONES with fused PIPERIDINES.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047608"}, {"RECTYPE": "D", "MH": "Estrogen Receptor alpha", "DE": "ESTROGEN RECEPT ALPHA", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "alpha, Estradiol Receptor", "MN": "D12.776.826.750.350.174", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "PI": "Receptors, Estrogen (1997-2004)", "MS": "One of the ESTROGEN RECEPTORS that has marked affinity for ESTRADIOL. Its expression and function differs from, and in some ways opposes, ESTROGEN RECEPTOR BETA.", "PM": "2005; ESTROGEN RECEPTOR ALPHA was indexed under RECEPTORS, ESTROGEN 1997-2004", "HN": "2005(1997)", "MR": "20150622", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047628"}, {"RECTYPE": "D", "MH": "Estrogen Receptor beta", "DE": "ESTROGEN RECEPT BETA", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor beta, Estrogen|T116|T192|NON|EQV|NLM (2005)|RECEPTOR BETA ESTROGEN|abbcdev", "MN": "D12.776.826.750.350.262", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "PI": "Receptors, Estrogen (1997-2004)", "MS": "One of the ESTROGEN RECEPTORS that has greater affinity for ISOFLAVONES than ESTROGEN RECEPTOR ALPHA does. There is great sequence homology with ER alpha in the DNA-binding domain but not in the ligand binding and hinge domains.", "PM": "2005; ESTROGEN RECEPTOR BETA was indexed under RECEPTORS, ESTROGEN 1997-2004", "HN": "2005(1997)", "MR": "20150622", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047629"}, {"RECTYPE": "D", "MH": "Depsipeptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Peptolides|T116|NON|NRW|NLM (2024)|221025|abcdef", "ENTRY": "Depsipeptide, Cyclic", "MN": "D12.644.641.297", "MH_TH": "NLM (2005)", "ST": "T116", "RN": "0", "PI": "Peptides, Cyclic (1971-2004)", "MS": "Compounds consisting of chains of AMINO ACIDS alternating with CARBOXYLIC ACIDS via ester and amide linkages. They are commonly cyclized.", "PM": "2005", "HN": "2005", "MR": "20230226", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047630"}, {"RECTYPE": "D", "MH": "Perimenopause", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "MN": "G08.686.841.249.500.562", "MH_TH": "NLM (1994)", "ST": "T079", "PI": "Menopause (1982-2004)", "MS": "The transitional period before and after MENOPAUSE. Perimenopausal symptoms are associated with irregular MENSTRUAL CYCLE and widely fluctuated hormone levels. They may appear 6 years before menopause and subside 2 to 5 years after menopause.", "PM": "2005; see CLIMACTERIC 2002-2004, see PREMENOPAUSE 1995-2001", "HN": "2005; use CLIMACTERIC 2002-2004, use PREMENOPAUSE 1995-2001", "MR": "20160617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047648"}, {"RECTYPE": "D", "MH": "Andropause", "AQ": "DE GE IM PH RE", "ENTRY": "Change of Life, Male|T040|T079|NON|EQV|NLM (2005)|040106|abbcdef", "MN": "G08.686.841.249.249", "MH_TH": "NLM (2005)", "ST": "T079", "PI": "Climacteric (1965-2004)", "MS": "An endocrine state in men, characterized by a significant decline in the production of TESTOSTERONE; DEHYDROEPIANDROSTERONE; and other hormones such as HUMAN GROWTH HORMONE. Andropause symptoms are related to the lack of androgens including DEPRESSION, sexual dysfunction, and OSTEOPOROSIS. Andropause may also result from hormonal ablation therapy for malignant diseases.", "PM": "2005", "HN": "2005", "MR": "20160602", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047649"}, {"RECTYPE": "D", "MH": "Inteins", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Protein Introns|T116|NON|EQV|NLM (2005)|040107|abcdef", "ENTRY": "Sequences, Intervening Protein", "MN": "G02.111.570.060.440", "FX": "Protein Splicing", "MH_TH": "NLM (2005)", "ST": "T116", "PI": "Protein Splicing (1997-2004)", "MS": "The internal fragments of precursor proteins (INternal proTEINS) that are autocatalytically removed by PROTEIN SPLICING. The flanking fragments (EXTEINS) are ligated forming mature proteins. The nucleic acid sequences coding for inteins are considered to be MOBILE GENETIC ELEMENTS. Inteins are composed of self-splicing domains and an endonuclease domain which plays a role in the spread of the intein's genomic sequence. Mini-inteins are composed of the self-splicing domains only.", "PM": "2005", "HN": "2005", "MR": "20080708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047668"}, {"RECTYPE": "D", "MH": "Exteins", "AQ": "DE ES GE PH RE", "ENTRY": "Extein", "MN": "G02.111.570.060.270", "FX": "Protein Splicing", "MH_TH": "NLM (2005)", "ST": "T116", "MS": "The (EXternal proTEIN) sequences flanking INTEINS, which are internal fragments of precursor proteins removed by PROTEIN SPLICING. Concomitantly, as the inteins are excised, the exteins are ligated to form mature proteins.", "PM": "2005", "HN": "2005", "MR": "20130709", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047669"}, {"RECTYPE": "D", "MH": "Breast Cyst", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Breast Cysts|T190|NON|EQV|NLM (1993)|911106|abcdef", "ENTRY": "Cysts, Breast", "MN": "C17.800.090.249", "FX": "Fibrocystic Breast Disease", "MH_TH": "NLM (2005)", "ST": "T190", "AN": "fluid in breast cyst: coordinate IM with CYST FLUID (NIM); FIBROCYSTIC BREAST DISEASE is also available", "PI": "Fibrocystic Disease of Breast (1980-2004)", "MS": "A fluid-filled closed cavity or sac that is lined by an EPITHELIUM and found in the BREAST. It may appear as a single large cyst in one breast, multifocal, or bilateral in FIBROCYSTIC BREAST DISEASE.", "PM": "2005; see FIBROCYSTIC DISEASE OF BREAST 1993-2004", "HN": "2005; use FIBROCYSTIC BREAST DISEASE 1993-2004", "MR": "20070709", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047688"}, {"RECTYPE": "D", "MH": "Myofibroma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Myofibromas", "MN": "C17.300.680.540", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with organ/neoplasm term (IM)", "PI": "Leiomyoma (1963-2004)", "MS": "A benign tumor that consists chiefly of fibrous CONNECTIVE TISSUE, with variable numbers of MUSCLE CELLS forming portions of the neoplasm (From Stedman's, 27th ed).", "PM": "2005; see LEIOMYOMA 1994-2004", "HN": "2005; use LEIOMYOMA 1994-2004", "MR": "20180614", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047708"}, {"RECTYPE": "D", "MH": "Hirudo medicinalis", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "European Medicinal Leech|T204|EPO|EQV|NLM (2024)|230316|abcdef", "ENTRY": "Medicinal Leech, European", "MN": "B01.050.500.091.426.400", "MH_TH": "NLM (2002)", "ST": "T204", "RN": "txid6421", "PI": "Leeches (1965-2004)", "MS": "A species of European freshwater LEECHES used for BLOODLETTING in ancient times and also for LEECHING in modern times.", "PM": "2005; see LEECHES 2002-2004", "HN": "2005; use LEECHES 2002-2004", "MR": "20230405", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047709"}, {"RECTYPE": "D", "MH": "Myopia, Degenerative", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myopia, Progressive|T047|NON|REL|NLM (2005)|040121|abcdef", "ENTRY": "Progressive Myopias", "MN": "C11.744.636.500", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Myopia (1965-2004)", "MS": "Excessive axial myopia associated with complications (especially posterior staphyloma and CHOROIDAL NEOVASCULARIZATION) that can lead to BLINDNESS.", "PM": "2005", "HN": "2005", "MR": "20040729", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047728"}, {"RECTYPE": "D", "MH": "Pituitary ACTH Hypersecretion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Inappropriate Adrenocorticotropic Hormone Secretion|T047|NON|BRD|NLM (2000)|991103|abcdef", "ENTRY": "Pituitary-Dependant Hypercortisolisms", "MN": "C19.700.355.800", "FX": "Cushing Syndrome", "MH_TH": "NLM (2005)", "ST": "T047", "AN": "do not confuse entry term CUSHING DISEASE with CUSHING SYNDROME", "PI": "Pituitary Neoplasms (1973-2004)", "MS": "A disease of the PITUITARY GLAND characterized by the excess amount of ADRENOCORTICOTROPIC HORMONE secreted. This leads to hypersecretion of cortisol (HYDROCORTISONE) by the ADRENAL GLANDS resulting in CUSHING SYNDROME.", "PM": "2005; for INAPPROPRIATE ACTH SECRETION SYNDROME see HYPERPITUITARISM 2000-2004", "HN": "2005; for INAPPROPRIATE ACTH SECRETION SYNDROME use HYPERPITUITARISM 2000-2004", "MR": "20230605", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047748"}, {"RECTYPE": "D", "MH": "Glycerophosphoinositol Inositolphosphodiesterase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Inositol 1,2-Cyclic Phosphate 2-Phosphohydrolase|T116|T126|NON|EQV|NLM (1993)|920312|INOSITOL PHOSPHATE PHOSPHOHYDROLASE CYCLIC 01 02 02|abbcdefs", "ENTRY": "Phosphodiesterase, 1,2-Cyclic-Inositol-Phosphate", "MN": "D08.811.277.352.640.295", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 3.1.4.43", "PI": "Annexin A3 (1980-2004)", "MS": "A phosphoric diester hydrolase with specificity for the cleavage of GLYCEROL from 1-(sn-glycero-3-phospho)-1D-myo-inositol. It also has specificity for hydrolysis of the cyclic phosphate bond in inositol 1,2-cyclic phosphate", "PM": "2005; for 1,2-CYCLIC INOSITOLPHOSPHATE PHOSPHODIESTERASE; 1,2-CYCLIC-INOSITOL-PHOSPHATE PHOSPHODIESTERASE; & INOSITOL 1,2-CYCLIC PHOSPHATE 2-PHOSPHOHYDROLASE see ANNEXIN A3 1980-2004; 1,2-CYCLIC-INOSITOL-PHOSPHATE PHOSPHODIESTERASE was indexed under PHOSPHODIESTERASES 1973-1992", "HN": "2005(1993); for 1,2-CYCLIC INOSITOLPHOSPHATE PHOSPHODIESTERASE; 1,2-CYCLIC-INOSITOL-PHOSPHATE PHOSPHODIESTERASE; & INOSITOL 1,2-CYCLIC PHOSPHATE 2-PHOSPHOHYDROLASE use ANNEXIN A3 1980-2004", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047768"}, {"RECTYPE": "D", "MH": "American Revolution", "PRINT ENTRY": "Revolutionary War|T078|NON|EQV|NLM (2005)|040128|abcdef", "ENTRY": "War, Revolutionary", "MN": "K01.400.504.875.100", "MH_TH": "NLM (2005)", "ST": "T078", "MS": "Armed conflict that resulted in separation of American colonies from Britain and established the United States of America.", "PM": "2005", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047788"}, {"RECTYPE": "D", "MH": "World War II", "DS": "WORLD WAR 02", "PRINT ENTRY": "World War, 1939-1945|T078|NON|EQV|NLM (2005)|040126|abcdef", "ENTRY": "World Wars, Second", "MN": "K01.400.504.968.901", "MH_TH": "NLM (2005)", "ST": "T078", "MS": "Global conflict involving countries of Europe, Africa, Asia, and North America that occurred between 1939 and 1945.", "PM": "2005", "HN": "2005", "MR": "20190506", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047789"}, {"RECTYPE": "D", "MH": "Adrenogenital Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Adrenogenital", "MN": "C19.391.119.090", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Adrenal Hyperplasia, Congenital (1964-2004)", "MS": "Abnormal SEX DIFFERENTIATION or congenital DISORDERS OF SEX DEVELOPMENT caused by abnormal levels of steroid hormones expressed by the GONADS or the ADRENAL GLANDS, such as in CONGENITAL ADRENAL HYPERPLASIA and ADRENAL CORTEX NEOPLASMS. Due to abnormal steroid biosynthesis, clinical features include VIRILISM in females; FEMINIZATION in males; or precocious sexual development in children.", "PM": "2005; see ADRENAL HYPERPLASIA, CONGENITAL 1980-2004", "HN": "2005; use ADRENAL HYPERPLASIA, CONGENITAL 1980-2004", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047808"}, {"RECTYPE": "D", "MH": "World War I", "DS": "WORLD WAR 01", "ENTRY": "World Wars, First", "MN": "K01.400.504.968.900", "MH_TH": "NLM (2005)", "ST": "T078", "MS": "Global conflict primarily fought on European continent, that occurred between 1914 and 1918.", "PM": "2005", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047828"}, {"RECTYPE": "D", "MH": "Vietnam Conflict", "PRINT ENTRY": "Viet Nam Conflict|T078|NON|EQV|NLM (2005)|040128|abcdef", "ENTRY": "Wars, Viet Nam", "MN": "K01.400.504.968.850", "MH_TH": "NLM (2005)", "ST": "T078", "MS": "A conflict occurring from 1954 through 1975 within the Republic of Vietnam. It involved neighboring nations and the United States and other members of the Southeast Asia Treaty Organization.", "PM": "2005", "HN": "2005", "MR": "20170703", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047829"}, {"RECTYPE": "D", "MH": "Gulf War", "PRINT ENTRY": "Operation Desert Storm|T078|NON|EQV|NLM (2005)|040128|abcdef", "ENTRY": "War, Gulf", "MN": "K01.400.504.968.400", "MH_TH": "NLM (2005)", "ST": "T078", "MS": "United Nations' action to intervene in conflict between the nation of Kuwait and occupying Iraqi forces, occurring from 1990 through 1991.", "PM": "2005", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047830"}, {"RECTYPE": "D", "MH": "American Civil War", "PRINT ENTRY": "War Between the States|T078|NON|EQV|NLM (2005)|040128|abcdef", "ENTRY": "Wars, American Civil", "MN": "K01.400.504.937.100", "MH_TH": "NLM (2005)", "ST": "T078", "MS": "1861-1865 conflict between the Union (Northern states) and the 11 Southern states that seceded and were organized as the Confederate States of America.", "PM": "2005", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047831"}, {"RECTYPE": "D", "MH": "Spanish-American War, 1898", "ENTRY": "Wars, Spanish American", "MN": "K01.400.504.937.750", "MH_TH": "NLM (2005)", "ST": "T078", "MS": "Conflict between Spain and the United States, arising out of Spanish policies in Cuba.", "PM": "2005", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047832"}, {"RECTYPE": "D", "MH": "Russian-Japanese War", "ENTRY": "Russo Japanese War, 1904 1905", "MN": "K01.400.504.968.650", "MH_TH": "NLM (2005)", "ST": "T078", "MS": "Conflict from 1904 through 1905 between Russia and Japan regarding Manchuria and Korea.", "PM": "2005", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047848"}, {"RECTYPE": "D", "MH": "Crimean War", "AQ": "EH EP", "ENTRY": "War, Crimean", "MN": "K01.400.504.937.500", "MH_TH": "NLM (2005)", "ST": "T078", "MS": "Conflict between RUSSIA (Pre-1917); the OTTOMAN EMPIRE; ENGLAND; FRANCE; and Sardinia.", "PM": "2005", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047849"}, {"RECTYPE": "D", "MH": "French Revolution", "ENTRY": "Revolution, French", "MN": "K01.400.504.875.374", "MH_TH": "NLM (2005)", "ST": "T078", "MS": "Conflict during which traditional monarchy was ended and modern government functions were instituted.", "PM": "2005", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047850"}, {"RECTYPE": "D", "MH": "September 11 Terrorist Attacks", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "September 11 Terrorist Attack|T078|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Attacks, 9-11-2001", "MN": "K01.400.504.984.500", "MH_TH": "NLM (2005)", "ST": "T078", "MS": "Terrorism on September 11, 2001 against targets in New York, the Pentagon in Virginia, and an aborted attack that ended in Pennsylvania.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047851"}, {"RECTYPE": "D", "MH": "Chernobyl Nuclear Accident", "PRINT ENTRY": "Chornobyl Nuclear Accident|T078|NON|EQV|NLM (2005)|041119|abcdef", "ENTRY": "Nuclear Disasters, Chornobyl", "MN": "N06.850.135.848.500", "FX": "Nuclear Reactors", "MH_TH": "NLM (2005)", "ST": "T078", "PI": "Nuclear Reactors (1986-2004)", "MS": "April 25th -26th, 1986 nuclear power accident that occurred at Chernobyl in the former USSR (Ukraine) located 80 miles north of Kiev.", "PM": "2005", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047852"}, {"RECTYPE": "D", "MH": "Pulmonary Sclerosing Hemangioma", "DE": "PULM SCLEROSING HEMANGIOMA", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Sclerosing Hemangioma of the Lung|T191|NON|EQV|NLM (2005)|040128|abcdef", "ENTRY": "Sclerosing Hemangiomas, Pulmonary", "MN": "C08.785.520.867", "FX": "Hemangioma", "MH_TH": "NLM (2005)", "ST": "T191", "PI": "Dermatofibroma (1972-2004)", "MS": "A benign neoplasm of pneumocytes, cells of the PULMONARY ALVEOLI. Originally considered to be vascular in origin, it is now classified as an epithelial tumor with several elements, including solid cellular areas, papillary structure, sclerotic regions, and dilated blood-filled spaces resembling HEMANGIOMA.", "PM": "2005", "HN": "2005", "MR": "20080708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047868"}, {"RECTYPE": "D", "MH": "Korean War", "PRINT ENTRY": "Korean War, 1950-1953|T078|NON|EQV|NLM (2005)|040129|abcdef", "ENTRY": "War, Korean", "MN": "K01.400.504.968.500", "MH_TH": "NLM (2005)", "ST": "T078", "MS": "An armed conflict between Communist and non-Communist forces in Korea from June 25, 1950, to July 27, 1953. The parties included United Nations forces from 15 member nations under United States command against military from North Korea and the Peoples Republic of China.", "PM": "2005", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047869"}, {"RECTYPE": "D", "MH": "Receptors, Tumor Necrosis Factor, Type I", "DE": "RECEPT TUMOR NECROSIS FACTOR TYPE I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Type I|T116|T192|NON|EQV|NLM (2005)|TUMOR NECROSIS FACTOR RECEPT TYPE I|abbcdev", "ENTRY": "Receptor, TNFRSF1A", "MN": "D12.776.543.750.705.852.760.597", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "PI": "Tumor Necrosis Factor Receptors (1994-2004)", "MS": "A tumor necrosis factor receptor subtype that has specificity for TUMOR NECROSIS FACTOR ALPHA and LYMPHOTOXIN ALPHA. It is constitutively expressed in most tissues and is a key mediator of tumor necrosis factor signaling in the vast majority of cells. The activated receptor signals via a conserved death domain that associates with specific TNF RECEPTOR-ASSOCIATED FACTORS in the CYTOPLASM.", "PM": "2005; TUMOR NECROSIS FACTOR RECEPTOR TYPE I (now RECEPTORS, TUMOR NECROSIS FACTOR TYPE I) was indexed under ANTIGENS, CD & TUMOR NECROSIS FACTOR RECEPTORS 1994-2004", "HN": "2005(1994)", "MR": "20170524", "DA": "20040715", "DC": "1", "DX": "20050101", "UI": "D047888"}, {"RECTYPE": "D", "MH": "Receptors, Tumor Necrosis Factor, Type II", "DE": "RECEPT TUMOR NECROSIS FACTOR TYPE II", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Type II|T116|T129|T192|NON|EQV|NLM (2005)|040202|TUMOR NECROSIS FACTOR RECEPT TYPE II|abbbcdefv", "ENTRY": "Receptor, TNFRSF1B", "MN": "D12.776.543.750.705.852.760.798", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "PI": "Antigens, CD (1994-2004)", "MS": "A tumor necrosis factor receptor subtype that is expressed primarily in IMMUNE SYSTEM cells. It has specificity for membrane-bound form of TUMOR NECROSIS FACTORS and mediates intracellular-signaling through TNF RECEPTOR ASSOCIATED FACTORS.", "PM": "2005; TUMOR NECROSIS FACTOR RECEPTOR II (now RECEPTORS, TUMOR NECROSIS FACTOR II) was indexed under ANTIGENS, CD 1994-2004", "HN": "2005(1994)", "MR": "20170524", "DA": "20040715", "DC": "1", "DX": "20050101", "UI": "D047889"}, {"RECTYPE": "D", "MH": "Intracellular Signaling Peptides and Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Signaling Proteins, Intracellular", "MN": "D12.776.476", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "AN": "do not confuse with SIGNAL PEPTIDES see PROTEIN SORTING SIGNALS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS is also available", "MS": "Proteins and peptides that are involved in SIGNAL TRANSDUCTION within the cell. Included here are peptides and proteins that regulate the activity of TRANSCRIPTION FACTORS and cellular processes in response to signals from CELL SURFACE RECEPTORS. Intracellular signaling peptide and proteins may be part of an enzymatic signaling cascade or act through binding to and modifying the action of other signaling factors.", "PM": "2005", "HN": "2005", "MR": "20151123", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047908"}, {"RECTYPE": "D", "MH": "Premature Birth", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Preterm Births", "MN": "C12.050.703.420.491.500", "FX": "Obstetric Labor, Premature", "MH_TH": "NLM (1995)", "ST": "T046", "AN": "check tags FEMALE & PREGNANCY; OBSTETRIC LABOR, PREMATURE is also available", "PI": "Labor, Premature (1966-2004)", "MS": "CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).", "PM": "2005; see LABOR, PREMATURE 1995-2004", "HN": "2005; use LABOR, PREMATURE 1995-2004", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047928"}, {"RECTYPE": "D", "MH": "Term Birth", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "ENTRY": "Term Births", "MN": "G08.686.784.769.490.500", "FX": "Gestational Age", "MH_TH": "NLM (2005)", "ST": "T040", "PI": "Pregnancy (1973-2004)", "MS": "CHILDBIRTH at the end of a normal duration of PREGNANCY, between 37 to 40 weeks of gestation or about 280 days from the first day of the mother's last menstrual period.", "PM": "2005", "HN": "2005", "MR": "20160617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047929"}, {"RECTYPE": "D", "MH": "Clostridium botulinum type C", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Clostridium botulinum C|T007|NON|EQV|NLM (2005)|040205|abcdef", "MN": "B03.510.415.400.200.160.150", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid36828", "AN": "infection: coordinate IM with BOTULISM (IM)", "PI": "Clostridium botulinum (1965-2004)", "MS": "Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type C which is neurotoxic to ANIMALS, especially CATTLE, but not humans. It causes dissociation of ACTIN FILAMENTS.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047968"}, {"RECTYPE": "D", "MH": "Clostridium botulinum type D", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Clostridium botulinum D|T007|NON|EQV|NLM (2005)|040205|abcdef", "MN": "B03.510.415.400.200.160.200", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid36829", "AN": "infection: coordinate IM with BOTULISM (IM)", "PI": "Clostridium botulinum (1968-2004)", "MS": "Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type D which is neurotoxic to ANIMALS, especially CATTLE, but not humans.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047969"}, {"RECTYPE": "D", "MH": "Clostridium botulinum type E", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Clostridium botulinum E|T007|NON|EQV|NLM (2005)|040205|abcdef", "MN": "B03.510.415.400.200.160.250", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid36830", "AN": "infection: coordinate IM with BOTULISM (IM)", "PI": "Clostridium botulinum (1965-2004)", "MS": "Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type E which is neurotoxic to humans and animals.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047970"}, {"RECTYPE": "D", "MH": "Clostridium botulinum type F", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Clostridium botulinum F|T007|NON|EQV|NLM (2005)|040205|abcdef", "MN": "B03.510.415.400.200.160.300", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid36831", "AN": "infection: coordinate IM with BOTULISM (IM)", "PI": "Clostridium botulinum (1965-2004)", "MS": "Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type F which is neurotoxic to humans and animals.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047971"}, {"RECTYPE": "D", "MH": "Tumor Necrosis Factor Receptor-Associated Peptides and Proteins", "DE": "TUMOR NECROSIS FACTOR RECEPT ASSOC PEPTIDES AND PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor-Associated Factors|T116|T123|NON|NRW|NLM (2005)|040206|TUMOR NECROSIS FACTOR RECEPTOR ASSOC FACTORS|abbcdefv", "ENTRY": "Tumor Necrosis Factor Receptor Associated Peptides and Proteins", "MN": "D12.776.476.024.500", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "MS": "Intracellular signaling peptides and proteins that bind directly or indirectly to the cytoplasmic portion of TUMOR NECROSIS FACTOR RECEPTORS.", "PM": "2005; TRAF-INTERACTING PROTEIN was indexed under RECEPTORS, TUMOR NECROSIS FACTOR", "HN": "2005(1994)", "MR": "20151124", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047988"}, {"RECTYPE": "D", "MH": "Clostridium sordellii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Clostridium sordelli|T007|NON|EQV|NLM (2005)|040205|abcdef", "MN": "B03.510.415.400.200.700", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1505", "AN": "infection: coordinate IM with CLOSTRIDIUM INFECTIONS (IM)", "PI": "Clostridium (1965-2004)", "MS": "A species of gram-positive bacteria in the family Clostridiaceae, found in INTESTINES and SOIL.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047989"}, {"RECTYPE": "D", "MH": "TNF Receptor-Associated Factor 1", "DE": "TNF RECEPT ASSOC FACTOR 1", "DS": "TNF RECEPTOR ASSOCIATED FACTOR 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TNF Receptor Associated Protein 1", "MN": "D12.776.476.024.500.500", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Proteins (1994-2004)", "MS": "A signal transducing tumor necrosis factor receptor associated factor that is involved in TNF RECEPTOR feedback regulation. It is similar in structure and appears to work in conjunction with TNF RECEPTOR-ASSOCIATED FACTOR 2 to inhibit APOPTOSIS.", "PM": "2005; TNF RECEPTOR-ASSOCIATED FACTOR 1 was indexed under PROTEINS 1994-2004", "HN": "2005(1994)", "MR": "20151124", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047990"}, {"RECTYPE": "D", "MH": "Clostridium sticklandii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.710", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1511", "PI": "Clostridium (1968-2004)", "MS": "A species of gram-positive, anaerobic bacteria in the family Clostridiaceae frequently used for the study of ENZYMES.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047991"}, {"RECTYPE": "D", "MH": "TNF Receptor-Associated Factor 2", "DE": "TNF RECEPT ASSOC FACTOR 2", "DS": "TNF RECEPTOR ASSOCIATED FACTOR 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TNF Receptor Associated Factor 2", "MN": "D12.776.476.024.500.750", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Proteins (1994-2004)", "MS": "A signal transducing tumor necrosis factor receptor associated factor that is involved in TNF RECEPTOR feedback regulation. It is similar in structure and appears to work in conjunction with TNF RECEPTOR-ASSOCIATED FACTOR 1 to inhibit APOPTOSIS.", "PM": "2005; TNF RECEPTOR-ASSOCIATED FACTOR 2 was indexed under PROTEINS 1994-2004", "HN": "2005(1994)", "MR": "20151124", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D047992"}, {"RECTYPE": "D", "MH": "TNF Receptor-Associated Factor 3", "DE": "TNF RECEPT ASSOC FACTOR 3", "DS": "TNF RECEPTOR ASSOCIATED FACTOR 03", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TNF Receptor Associated Factor 3", "MN": "D12.776.476.024.500.875", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "PI": "Proteins (1995-2004)", "MS": "A signal transducing tumor necrosis factor receptor associated factor that is involved in regulation of NF-KAPPA B signaling and activation of MITOGEN-ACTIVATED PROTEIN KINASES.", "PM": "2005; TNF RECEPTOR-ASSOCIATED FACTOR 3 was indexed under PROTEINS 1995-2004", "HN": "2005(1995)", "MR": "20151124", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048008"}, {"RECTYPE": "D", "MH": "Clostridium symbiosum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.713", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1512", "PI": "Clostridium (1985-2004)", "MS": "A species of gram-positive bacteria in the family Clostridiaceae. Its GLUTAMATE DEHYDROGENASE is commonly used in research.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048009"}, {"RECTYPE": "D", "MH": "Clostridium tertium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.722", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1559", "AN": "infection: coordinate IM with CLOSTRIDIUM INFECTIONS (IM)", "PI": "Clostridium (1963-2004)", "MS": "A species of gram-positive bacteria in the family Clostridiaceae, causing BACTEREMIA in humans and ANIMALS.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048010"}, {"RECTYPE": "D", "MH": "Clostridium tetanomorphum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.740", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1553", "PI": "Clostridium (1965-2004)", "MS": "A species of gram-positive bacteria in the family Clostridiaceae. Its glutamate mutase is commonly used in research.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048012"}, {"RECTYPE": "D", "MH": "Clostridium thermocellum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.770", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1515", "PI": "Clostridium (1968-2004)", "MS": "A species of gram-positive, thermophilic, cellulolytic bacteria in the family Clostridaceae. It degrades and ferments CELLOBIOSE and CELLULOSE to ETHANOL in the CELLULOSOME.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048013"}, {"RECTYPE": "D", "MH": "Clostridium tyrobutyricum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.800", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1519", "PI": "Clostridium (1969-2004)", "MS": "A species of gram-positive bacteria in the family Clostridiaceae responsible for spoilage of some CHEESE via FERMENTATION of BUTYRIC ACID.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048014"}, {"RECTYPE": "D", "MH": "TNF Receptor-Associated Factor 5", "DE": "TNF RECEPT ASSOC FACTOR 5", "DS": "TNF RECEPTOR ASSOCIATED FACTOR 05", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TNF Receptor Associated Protein 5", "MN": "D12.776.476.024.500.937", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Proteins (1999-2004)", "MS": "A signal transducing tumor necrosis factor receptor associated factor that mediates signaling from CD27 ANTIGENS; CD40 ANTIGENS; and the LYMPHOTOXIN BETA RECEPTOR. It is involved in regulation of NF-KAPPA B signaling.", "PM": "2005; TNF RECEPTOR-ASSOCIATED FACTOR 5 was indexed under PROTEINS 1999-2004, under CARRIER PROTEINS 1996-1998", "HN": "2005(1996)", "MR": "20151124", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048015"}, {"RECTYPE": "D", "MH": "Cucumaria", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Cucumarias", "MN": "B01.050.500.408.560.150", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid28832", "PI": "Sea Cucumbers (1989-2004)", "MS": "A genus of large SEA CUCUMBERS possessing the primitive radial configuration of podia in all five ambulacral areas.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048016"}, {"RECTYPE": "D", "MH": "DNA, Algal", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Algal DNA|T114|NON|EQV|NLM (2005)|040209|abcdef", "MN": "D13.444.308.148", "MH_TH": "NLM (2005)", "ST": "T114", "RN": "0", "MS": "Deoxyribonucleic acid that makes up the genetic material of algae.", "PM": "2005", "HN": "2005", "MR": "20100625", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048028"}, {"RECTYPE": "D", "MH": "TNF Receptor-Associated Factor 6", "DE": "TNF RECEPT ASSOC FACTOR 6", "DS": "TNF RECEPTOR ASSOCIATED FACTOR 06", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TRAF 6 Protein", "MN": "D12.776.476.024.500.968", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Proteins (1996-2004)", "MS": "A signal transducing tumor necrosis factor receptor associated factor that is involved in regulation of NF-KAPPA B signalling and activation of JNK MITOGEN-ACTIVATED PROTEIN KINASES.", "PM": "2005; TNF RECEPTOR-ASSOCIATED FACTOR 6 was indexed under PROTEINS 1996-2004", "HN": "2005(1996)", "MR": "20151124", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048029"}, {"RECTYPE": "D", "MH": "RNA, Algal", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Algal RNA|T114|NON|EQV|NLM (2005)|040209|abcdef", "MN": "D13.444.735.130", "MH_TH": "NLM (2005)", "ST": "T114", "RN": "0", "PI": "RNA, Ribosomal (1974-2004)", "MS": "Ribonucleic acid in algae having regulatory and catalytic roles as well as involvement in protein synthesis.", "PM": "2005", "HN": "2005", "MR": "20100625", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048030"}, {"RECTYPE": "D", "MH": "JNK Mitogen-Activated Protein Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "jun N-Terminal Kinase|T116|T126|NON|EQV|NLM (2021)|191122|abbcdef", "ENTRY": "jun NH2 Terminal Kinases", "MN": "D12.776.476.563.567.374", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.24", "AN": "note specifics", "PI": "Protein-Serine-Threonine Kinases (1993-1994)", "MS": "A subgroup of mitogen-activated protein kinases that activate TRANSCRIPTION FACTOR AP-1 via the phosphorylation of C-JUN PROTEINS. They are components of intracellular signaling pathways that regulate CELL PROLIFERATION; APOPTOSIS; and CELL DIFFERENTIATION.", "PM": "2005; JNK MITOGEN-ACTIVATED PROTEIN KINASES was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE 1995-1999 & under PROTEIN-SERINE-THREONINE KINASES 1993-1994", "HN": "2005", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048031"}, {"RECTYPE": "D", "MH": "Dental Informatics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Informatics, Dental", "MN": "L01.313.249", "MH_TH": "NLM (2005)", "ST": "T058", "PI": "Information Systems (1980-2004)", "MS": "The application of computer and information sciences to improve dental practice, research, education and management.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048048"}, {"RECTYPE": "D", "MH": "Extracellular Signal-Regulated MAP Kinases", "DE": "EXTRACELLULAR SIGNAL REG MAP KINASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "MAP Kinases, Extracellular Signal-Regulated|T116|T126|NON|EQV|NLM (2005)|040416|abbcdef", "ENTRY": "Signal-Regulated Kinase, Extracellular", "MN": "D12.776.476.563.567.249", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.24", "AN": "note specifics", "PI": "Mitogen-Activated Protein Kinases (1992-2004)", "MS": "A mitogen-activated protein kinase subfamily that is widely expressed and plays a role in regulation of MEIOSIS; MITOSIS; and post mitotic functions in differentiated cells. The extracellular signal regulated MAP kinases are regulated by a broad variety of CELL SURFACE RECEPTORS and can be activated by certain CARCINOGENS.", "PM": "2005; see MITOGEN-ACTIVATED PROTEIN KINASES 1994-2004", "HN": "2005; for EXTRACELLULAR SIGNAL-REGULATED KINASES use MITOGEN-ACTIVATED PROTEIN KINASES 1994-2004", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048049"}, {"RECTYPE": "D", "MH": "p38 Mitogen-Activated Protein Kinases", "DS": "P A 038 MITOGEN ACTIVATED PROTEIN KINASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p38 Mitogen-Activated Protein Kinase|T116|T126|NON|EQV|NLM (2021)|191219|abbcdef", "ENTRY": "p38 Mitogen Activated Protein Kinases", "MN": "D12.776.476.563.567.843", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.24", "PI": "Mitogen-Activated Protein Kinases (2000-2004)", "MS": "A mitogen-activated protein kinase subfamily that regulates a variety of cellular processes including CELL GROWTH PROCESSES; CELL DIFFERENTIATION; APOPTOSIS; and cellular responses to INFLAMMATION. The P38 MAP kinases are regulated by CYTOKINE RECEPTORS and can be activated in response to bacterial pathogens.", "PM": "2005; P38 MITOGEN-ACTIVATED PROTEIN KINASES was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2001-2004 & under CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2000", "HN": "2005(1994)", "MR": "20210521", "DA": "20040708", "DC": "1", "DX": "20050101", "UI": "D048051"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase 3", "DS": "MITOGEN ACTIVATED PROTEIN KINASE 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Extracellular Signal-Regulated Kinase 1|T116|T126|NON|EQV|NLM (2005)|EXTRACELLULAR SIGNAL REGULATED KINASE 01|EXTRACELLULAR SIGNAL REG KINASE 1|abbcdesv", "ENTRY": "p44mpk, PSTkinase", "MN": "D12.776.476.563.567.249.750", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.24", "PI": "Mitogen-Activated Protein Kinases (1990-2004)", "MS": "A 44-kDa extracellular signal-regulated MAP kinase that may play a role the initiation and regulation of MEIOSIS; MITOSIS; and postmitotic functions in differentiated cells. It phosphorylates a number of TRANSCRIPTION FACTORS; and MICROTUBULE-ASSOCIATED PROTEINS.", "PM": "2005; MITOGEN-ACTIVATED PROTEIN KINASE 3 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004 & under CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE 1994-1999", "HN": "2005(2000)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048052"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase 6", "DS": "MITOGEN ACTIVATED PROTEIN KINASE 06", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Extracellular Signal-Regulated Kinase 3|T116|T126|NON|EQV|NLM (2005)|EXTRACELLULAR SIGNAL REGULATED KINASE 03|EXTRACELLULAR SIGNAL REG KINASE 3|abbcdesv", "ENTRY": "Mitogen Activated Protein Kinase 6", "MN": "D12.776.476.563.567.249.875", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.24", "PI": "Mitogen-Activated Protein Kinases (1991-2004)", "MS": "A 97-kDa extracellular signal-regulated MAP kinase. Mitogen-activated protein kinase 6 levels increase during cellular differentiation, while in proliferating cells the enzyme is degraded rapidly via the PROTEASOME ENDOPEPTIDASE COMPLEX.", "PM": "2005; MITOGEN-ACTIVATED PROTEIN KINASE 6 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, under CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2000 & under PROTEIN KINASES 1991-1993", "HN": "2005(1991)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048053"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase 7", "DS": "MITOGEN ACTIVATED PROTEIN KINASE 07", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Extracellular Signal-Regulated Kinase 5|T116|T126|NON|EQV|NLM (2005)|EXTRACELLULAR SIGNAL REGULATED KINASE 05|EXTRACELLULAR SIGNAL REG KINASE 5|abbcdesv", "ENTRY": "Mitogen Activated Protein Kinase 7 Isoform 2", "MN": "D12.776.476.563.567.249.937", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.24", "RR": "EC 2.7.11.24", "PI": "Mitogen-Activated Protein Kinases (1999-2004)", "MS": "A 110-kDa extracellular signal-regulated MAP kinase that is activated in response to cellular stress and by GROWTH FACTOR RECEPTORS-mediated pathways.", "PM": "2005; MITOGEN-ACTIVATED PROTEIN KINASE 7 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 1999-2004", "HN": "2005(1999)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048054"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase 8", "DS": "MITOGEN ACTIVATED PROTEIN KINASE 08", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "c jun N Terminal Kinase 1", "MN": "D12.776.476.563.567.374.500", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.24", "PI": "Mitogen-Activated Protein Kinases (2000-2004)", "MS": "A c-jun amino-terminal kinase that is activated by environmental stress and pro-inflammatory cytokines. Several isoforms of the protein with molecular sizes of 43 and 48 KD exist due to multiple ALTERNATIVE SPLICING.", "PM": "2005; MITOGEN-ACTIVATED PROTEIN KINASE 8 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004", "HN": "2005(2000)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048055"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase 9", "DS": "MITOGEN ACTIVATED PROTEIN KINASE 09", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "c jun N terminal Kinase 2", "MN": "D12.776.476.563.567.374.750", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.1.24", "PI": "Protein Kinases (1994-2000)", "MS": "A c-jun amino-terminal kinase that is activated by environmental stress and pro-inflammatory cytokines. Several isoforms of the protein with molecular sizes of 48 and 54 KD exist due to multiple ALTERNATIVE SPLICING.", "PM": "2005; MITOGEN-ACTIVATED PROTEIN KINASE 9 was indexed under MITOGEN-ACITVATED PROTEIN KINASES 2001-2004; under PROTEIN KINASES 1994-2000", "HN": "2005(1994)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048056"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase 10", "DS": "MITOGEN ACTIVATED PROTEIN KINASE 10", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "c jun N Terminal Kinase 3", "MN": "D12.776.476.563.567.374.800", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.1.-", "PI": "Protein-Serine-Threonine Kinases (1995-1999)", "MS": "A c-jun amino-terminal kinase that is found predominantly within NEURONS of the BRAIN, suggesting a role in stress-induced neuronal APOPTOSIS. Several isoforms of the protein with molecular sizes of 47 kDa and 52 kDa exist due to multiple ALTERNATIVE SPLICING.", "PM": "2005; MITOGEN-ACTIVATED PROTEIN KINASE 10 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, under PROTEIN-SERINE-THREONINE KINASES 1995-1999", "HN": "2005(1995)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048057"}, {"RECTYPE": "D", "MH": "PPAR-beta", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "PPAR beta", "MN": "D12.776.826.239.530", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "PI": "Transcription Factors (1993-2004)", "MS": "One of the PPAR nuclear transcription factors.", "PM": "2005; PPAR BETA was indexed under TRANSCRIPTION FACTORS & RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993", "HN": "2005(1992)", "MR": "20150623", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048068"}, {"RECTYPE": "D", "MH": "Tumor Necrosis Factors", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Receptor Ligands, TNF", "MN": "D23.529.374.750", "EC": "antagonists & inhibitors:Tumor Necrosis Factor Inhibitors", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "MS": "A family of proteins that were originally identified by their ability to cause NECROSIS of NEOPLASMS. Their necrotic effect on cells is mediated through TUMOR NECROSIS FACTOR RECEPTORS which induce APOPTOSIS.", "PM": "2005", "HN": "2005", "MR": "20181010", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048069"}, {"RECTYPE": "D", "MH": "Fetal Nutrition Disorders", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Malnutrition, Fetal|T047|NON|NRW|NLM (1998)|960710|abcdef", "ENTRY": "Nutrition Disorder, Fetal", "MN": "C18.654.521.625", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Placental Insufficiency (1982-2004)", "MS": "Disorders caused by nutritional imbalance, either overnutrition or undernutrition, in the FETUS in utero.", "PM": "2005; see PLACENTA INSUFFICIENCY 1998-2004", "HN": "2005; use PLACENTA INSUFFICIENCY 1998-2004", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048070"}, {"RECTYPE": "D", "MH": "Informatics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "L01.313", "MH_TH": "NLM (2005)", "ST": "T057", "AN": "general; prefer specifics", "PI": "Information Systems (1979-2004)", "MS": "The field of information science concerned with the analysis and dissemination of data through the application of computers.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048088"}, {"RECTYPE": "D", "MH": "Pneumonia of Calves, Enzootic", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Enzootic Pneumonia of Calves|T047|NON|EQV|NLM (2005)|040210|abcdef", "ENTRY": "Pneumonias, Enzootic Calf", "MN": "C22.196.090.675", "MH_TH": "NLM (2005)", "ST": "T047", "AN": "infection: coordinate IM with PASTEURELLA MULTOCIDA (IM), MANNHEIMIA HAEMOLYTICA (IM) or HAEMOPHILUS SOMNUS (IM) only if particularly discussed; check the tag CATTLE", "MS": "Chronic endemic respiratory disease of dairy calves and an important component of bovine respiratory disease complex. It primarily affects calves up to six months of age and the etiology is multifactorial. Stress plus a primary viral infection is followed by a secondary bacterial infection. The latter is most commonly associated with PASTEURELLA MULTOCIDA producing a purulent BRONCHOPNEUMONIA. Sometimes present are MANNHEIMIA HAEMOLYTICA; HAEMOPHILUS SOMNUS and mycoplasma species.", "PM": "2005", "HN": "2005", "MR": "20190617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048089"}, {"RECTYPE": "D", "MH": "Bovine Respiratory Disease Complex", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "MN": "C22.196.090", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Respiratory Tract Infections (1972-2004)", "MS": "A multifactorial disease of CATTLE resulting from complex interactions between environmental factors, host factors, and pathogens. The environmental factors act as stressors adversely affecting the IMMUNE SYSTEM and other host defenses and enhancing transmission of infecting agents.", "PM": "2005", "HN": "2005", "MR": "20190617", "DA": "20040719", "DC": "1", "DX": "20050101", "UI": "D048090"}, {"RECTYPE": "D", "MH": "Guided Tissue Regeneration", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tissue Regeneration, Guided", "MN": "E04.617.300", "FX": "Tissue Therapy, Historical", "MH_TH": "NLM (2005)", "ST": "T061", "PI": "Guided Tissue Regeneration, Periodontal (1992-2004)", "MS": "Procedures for enhancing and directing tissue repair and renewal processes, such as BONE REGENERATION; NERVE REGENERATION; etc. They involve surgically implanting growth conducive tracks or conduits (TISSUE SCAFFOLDING) at the damaged site to stimulate and control the location of cell repopulation. The tracks or conduits are made from synthetic and/or natural materials and may include support cells and induction factors for CELL GROWTH PROCESSES; or CELL MIGRATION.", "PM": "2005", "HN": "2005", "MR": "20220406", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048091"}, {"RECTYPE": "D", "MH": "Nursing Informatics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Informatics, Nursing", "MN": "L01.313.650", "MH_TH": "NLM (2005)", "ST": "T057", "PI": "Information Systems (1980-2004)", "MS": "The field of information science concerned with the analysis and dissemination of data through the application of computers applied to the field of nursing.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048108"}, {"RECTYPE": "D", "MH": "Casein Kinase Ialpha", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Casein Kinase IalphaS|T116|T126|NON|NRW|NLM (2005)|abbcde", "MN": "D12.776.476.563.140.300.100", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.1", "RR": "EC 2.7.11.1", "PI": "Protein Kinases (2000-2004)", "MS": "A casein kinase I isoenzyme that plays a role in intracellular signaling pathways including the WNT SIGNALING PATHWAY, the CELL CYCLE, membrane trafficking, and RNA processing. Multiple isoforms of casein kinase I alpha exist and are due to ALTERNATIVE SPLICING.", "PM": "2005; CASEIN KINASE IALPHA was indexed under PROTEIN KINASES 2000-2004", "HN": "2005(2000)", "MR": "20210520", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048128"}, {"RECTYPE": "D", "MH": "Casein Kinase Idelta", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinase CK1delta|T116|T126|ACX|EQV|NLM (2005)|021029|abbcdef", "MN": "D12.776.476.563.140.300.200", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Protein Kinases (1993-2004)", "MS": "A casein kinase I isoenzyme that plays a regulatory role in a variety of cellular functions including vesicular transport, CHROMOSOME SEGREGATION; CYTOKINESIS, developmental processes, and the CIRCADIAN RHYTHM.", "PM": "2005; CASEIN KINASE IALPHA was indxed under PROTEIN KINASES 1993-2004", "HN": "2005(1993)", "MR": "20210520", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048148"}, {"RECTYPE": "D", "MH": "Casein Kinase 1 epsilon", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Casein Kinase Iepsilon|T116|T126|NON|EQV|NLM (2005)|abbcde", "ENTRY": "Protein, CSNK1E", "MN": "D12.776.476.563.140.300.300", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Protein Kinases (1998-2004)", "MS": "A casein kinase I isoenzyme with specificity for proteins involved the regulation of the CIRCADIAN RHYTHM.", "PM": "2005; CASEIN KINASE IEPSILON was indexed under PROTEIN KINASES 1993-2004", "HN": "2005(1998)", "MR": "20210701", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048149"}, {"RECTYPE": "D", "MH": "Escherichia coli K12", "DS": "ESCHERICHIA COLI K 012", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "E coli K12|T007|ABB|EQV|NLM (2005)|040213|E COLI K 012|abcdefs", "MN": "B03.660.250.150.180.100.360", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid83333", "AN": "infection: coordinate IM with ESCHERICHIA COLI INFECTIONS (IM)", "PI": "Escherichia coli (1965-2004)", "MS": "A species of gram-negative, rod-shaped bacteria belonging to the K serogroup of ESCHERICHIA COLI. It lives as a harmless inhabitant of the human LARGE INTESTINE and is widely used in medical and GENETIC RESEARCH.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048168"}, {"RECTYPE": "D", "MH": "Streptomyces lividans", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.810.768.500", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1916", "PI": "Streptomyces (1975-2004)", "MS": "An actinomycete used for production of commercial ANTIBIOTICS and as a host for gene cloning.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048170"}, {"RECTYPE": "D", "MH": "Locusta migratoria", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "migratorias, Locusta", "MN": "B01.050.500.131.617.678.369.500", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid7004", "PI": "Insects (1965-1971)", "MS": "A species of migratory Old World locusts, in the family ACRIDIDAE, that are important pests in Africa and Asia.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048188"}, {"RECTYPE": "D", "MH": "Hymenolepis nana", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Tapeworms, Dwarf", "MN": "B01.050.500.500.736.215.454.410", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid102285", "AN": "infection: coordinate (IM) with HYMENOLEPIASIS (IM)", "PI": "Hymenolepis (1979-2004)", "MS": "The smallest species of TAPEWORMS. It is the only cestode that parasitizes humans without requiring an intermediate host.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048189"}, {"RECTYPE": "D", "MH": "Hymenolepis diminuta", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Rat Tapeworm|T204|NON|EQV|NLM (2005)|040213|abcdef", "ENTRY": "diminuta, Hymenolepis", "MN": "B01.050.500.500.736.215.454.400", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid6216", "AN": "infection: coordinate (IM) with HYMENOLEPIASIS (IM)", "PI": "Insects (1965-1978)", "MS": "A species of tapeworm (TAPEWORMS) infecting RATS and MICE but rarely causing disease in humans. Its life cycle involves RODENTS as the definitive host and BEETLES as the intermediate host.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048190"}, {"RECTYPE": "D", "MH": "Lactobacillus plantarum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.450.475.612", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1590", "PI": "Lactobacillus (1965-2004)", "MS": "A species of rod-shaped, LACTIC ACID bacteria used in PROBIOTICS and SILAGE production.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048191"}, {"RECTYPE": "D", "MH": "Nuchal Translucency Measurement", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Translucency, Nuchal", "MN": "E01.370.378.630.865.500", "MH_TH": "NLM (2005)", "ST": "T060", "PI": "Ultrasonography, Prenatal (1992-2004)", "MS": "A prenatal ultrasonography measurement of the soft tissue behind the fetal neck. Either the translucent area below the skin in the back of the fetal neck (nuchal translucency) or the distance between occipital bone to the outer skin line (nuchal fold) is measured.", "PM": "2005", "HN": "2005", "MR": "20100625", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048208"}, {"RECTYPE": "D", "MH": "Echinococcus granulosus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.736.215.327.400", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid6210", "AN": "infection: coordinate (IM) with ECHINOCOCCOSIS (IM) or specifics (IM); Taenia echinococcus goes here", "PI": "Echinococcus (1965-2004)", "MS": "A species of hydatid tapeworm (class CESTODA) in the family Taeniidae, whose adult form infects the DIGESTIVE TRACT of DOGS, other canines, and CATS. The larval form infects SHEEP; PIGS; HORSES; and may infect humans, where it migrates to various organs and forms permanent HYDATID CYSTS.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048209"}, {"RECTYPE": "D", "MH": "Echinococcus multilocularis", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "multilocularis, Echinococcus", "MN": "B01.050.500.500.736.215.327.500", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid6211", "PI": "Echinococcus (1965-2004)", "MS": "A north temperate species of tapeworm (CESTODA) whose adult form infects FOXES and wild RODENTS. The larval form can infect humans producing HEPATIC HYDATID CYSTS.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048210"}, {"RECTYPE": "D", "MH": "Intermittent Pneumatic Compression Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Pneumatic Compression Stockings|T074|NON|NRW|NLM (2007)|060405|abcdef", "ENTRY": "Stockings, Pneumatic Compression", "MN": "E07.515", "FX": "Stockings, Compression", "MH_TH": "NLM (2005)", "ST": "T074", "AN": "do not confuse with CONTINUOUS PASSIVE MOTION THERAPY", "PI": "Thrombophlebitis/prevention & control (1972-2004)", "MS": "Instruments that generate intermittent forces, uniformed or graduated, to facilitate the emptying of VEINS. These devices are used to reduce limb EDEMA and prevent venous THROMBOEMBOLISM, such as deep vein thrombosis in the legs.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048228"}, {"RECTYPE": "D", "MH": "Sulfolobus solfataricus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.075.725.725.725.800", "MH_TH": "NLM (2005)", "ST": "T194", "RN": "txid2287", "PI": "Sulfolobus (1992-2004)", "MS": "A species of thermoacidophilic ARCHAEA in the family Sulfolobaceae, found in volcanic areas where the temperature is about 80 degrees C and SULFUR is present.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048229"}, {"RECTYPE": "D", "MH": "Corynebacterium glutamicum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.400.200.300", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1718", "PI": "Corynebacterium (1969-2004)", "MS": "A species of gram-positive, asporogenous, non-pathogenic, soil bacteria that produces GLUTAMIC ACID.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048230"}, {"RECTYPE": "D", "MH": "Acanthamoeba castellanii", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "castellanius, Acanthamoeba", "MN": "B01.046.500.100.075.080.150", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid5755", "AN": "infection: coordinate with AMEBIASIS; for encephalitis caused by this organism, coordinate also with CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS + INFECTIOUS ENCEPHALITIS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent ", "PI": "Sarcodina (1968-1974)", "MS": "A species of free-living soil amoebae in the family Acanthamoebidae. It can cause ENCEPHALITIS and KERATITIS in humans.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048248"}, {"RECTYPE": "D", "MH": "Streptococcus thermophilus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872.800", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1308", "PI": "Streptococcus (1968-2004)", "MS": "A species of thermophilic, gram-positive bacteria found in MILK and milk products.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048249"}, {"RECTYPE": "D", "MH": "Squalus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "MN": "B01.050.150.900.493.370.853.392.800", "MH_TH": "NLM (1994)", "ST": "T013", "RN": "txid7796", "PI": "Sharks (1965-1991)", "MS": "A genus of SHARKS in the family SQUALIDAE, comprised of many different species. They travel in large groups and are bottom dwellers that feed mostly on bony fishes.", "PM": "2005; see DOGFISH 1994-2004", "HN": "2005; use DOGFISH 1994-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048250"}, {"RECTYPE": "D", "MH": "Squalus acanthias", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Dogfish, Spiny|T013|NON|EQV|NLM (2005)|040218|abcdef", "ENTRY": "Spiny Dogfish", "MN": "B01.050.150.900.493.370.853.392.800.500", "MH_TH": "NLM (2005)", "ST": "T013", "RN": "txid7797", "PI": "Sharks (1965-2004)", "MS": "A species of shark in the family SQUALIDAE, used for its oil (SQUALENE) and as fish meal. It also figures heavily in biological research, especially with reference to its RECTAL GLAND in studies of WATER-ELECTROLYTE BALANCE.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048251"}, {"RECTYPE": "D", "MH": "Chitosan", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Poliglusam|T109|T121|NON|EQV|USAN (1991)|abbcde", "MN": "D09.698.211.500", "PA": "Hemostatics", "MH_TH": "NLM (2005)", "ST": "T121", "RN": "9012-76-4", "PI": "Chitin/analogs & derivatives (1975-2004)", "MS": "Deacetylated CHITIN, a linear polysaccharide of deacetylated beta-1,4-D-glucosamine. It is used in HYDROGEL and to treat WOUNDS.", "PM": "2005; CHITOSAN was indexed under CHITIN 2001-2004", "HN": "2005(2004)", "DA": "20040708", "DC": "1", "DX": "20050101", "UI": "D048271"}, {"RECTYPE": "D", "MH": "Imidazolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Imidazoline|T109|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D03.383.129.308.436", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Imidazoles (1963-2004)", "MS": "Compounds based on reduced IMIDAZOLES containing a single double bond.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048288"}, {"RECTYPE": "D", "MH": "Imidazolidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Imidazolidine|T109|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D03.383.129.308.432", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Imidazoles (1963-2004)", "MS": "Compounds based on reduced IMIDAZOLINES which contain no double bonds in the ring.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048289"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase 11", "DS": "MITOGEN ACTIVATED PROTEIN KINASE 11", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Stress Activated Protein Kinase 2b", "MN": "D12.776.476.563.567.843.500", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.24", "PI": "Mitogen-Activated Protein Kinases (2000-2004)", "MS": "A 38-kDa mitogen-activated protein kinase that is expressed in a broad variety of cell types. It may play a role in regulating cell proliferation and TRANSCRIPTION FACTOR AP-1 dependent transcription.", "PM": "2005; MITOGEN-ACTIVATED PROTEIN KINASE 11, STRESS-ACTIVATED PROTEIN KINASE 2, SAPK2 & SAP KINASE-2 were indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004", "HN": "2005(2000)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048290"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase 12", "DS": "MITOGEN ACTIVATED PROTEIN KINASE 12", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Stress Activated Protein Kinase 3", "MN": "D12.776.476.563.567.843.750", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.1.-", "PI": "Protein Kinases (1996-1999)", "MS": "A 38-kDa mitogen-activated protein kinase found primarily in SKELETAL MUSCLE.", "PM": "2005; MITOGEN-ACTIVATED PROTEIN KINASE 12 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004 & under MITOGEN-ACTIVATED PROTEIN KINASES 1996-1999", "HN": "2005(1996)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048291"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase 13", "DS": "MITOGEN ACTIVATED PROTEIN KINASE 13", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Stress Activated Protein Kinase 4", "MN": "D12.776.476.563.567.843.875", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.1.-", "PI": "Protein Kinases (1997-1999)", "MS": "A 38-kDa mitogen-activated protein kinase found expressed at high levels in LUNG; KIDNEY; TESTIS; PANCREAS; and SMALL INTESTINE. It may play a role in regulating functions such as CELL DIFFERENTIATION and APOPTOSIS of EPITHELIAL CELLS.", "PM": "2005; MITOGEN-ACTIVATED PROTEIN KINASE 13 was indexed under MITOGEN-ACTIVATED KINASES 2000-2004; under PROTEIN KINASES 1997-1999", "HN": "2005(1997)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048292"}, {"RECTYPE": "D", "MH": "Didelphis", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Opossum, North American|T015|NON|NRW|NLM (2005)|040220|abcdef", "ENTRY": "Opossums, North American", "MN": "B01.050.150.900.649.573.575.150", "MH_TH": "UNK (19XX)", "ST": "T015", "RN": "txid9266", "RR": "txid9267", "PI": "Opossums (1966-2004)", "MS": "A genus of large OPOSSUMS in the family Didelphidae, found in the Americas. The species Didelphis virginiana is prominent in North America.", "PM": "2005; see OPOSSUMS 1968-2004", "HN": "2005; use OPOSSUMS 1968-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048293"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase 14", "DS": "MITOGEN ACTIVATED PROTEIN KINASE 14", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p38alpha Mitogen Activated Protein Kinase", "MN": "D12.776.476.563.567.843.937", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.24", "PI": "Mitogen-Activated Protein Kinases (2000-2004)", "MS": "A 38-kDa mitogen-activated protein kinase that is abundantly expressed in a broad variety of cell types. It is involved in the regulation of cellular stress responses as well as the control of proliferation and survival of many cell types. The kinase activity of the enzyme is inhibited by the pyridinyl-imidazole compound SB 203580.", "PM": "2005; MITOGEN-ACTIVATED PROTEIN KINASE 14 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2002-2004; CSAID-BINDING PROTEIN & KINASE CSBP were indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004; MXI2 PROTEIN was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, under CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2000", "HN": "2005(1994)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048308"}, {"RECTYPE": "D", "MH": "Monodelphis", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Opossums, Short-Tailed|T015|NON|EQV|NLM (2005)|040316|abcdef", "ENTRY": "Short-Tailed Opossums", "MN": "B01.050.150.900.649.573.575.500", "MH_TH": "NLM (1995)", "ST": "T015", "RN": "txid13615", "RR": "txid13616", "PI": "Opossums (1969-2004)", "MS": "A genus of short-tailed OPOSSUMS in the family Didelphidae found in South American, chiefly Brazil. They are opossums least well-adapted to arboreal life.", "PM": "2005; see OPOSSUMS 1995-2004", "HN": "2005; use OPOSSUMS 1995-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048309"}, {"RECTYPE": "D", "MH": "Potoroidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rat Kangaroo|T015|NON|EQV|NLM (2001)|991217|abcdef", "ENTRY": "Rat Kangaroos, Long-Nosed", "MN": "B01.050.150.900.649.573.600", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid65619", "RR": "txid9310", "AN": "do not confuse rat kangaroo with KANGAROO RATS see DIPODOMYS", "PI": "Marsupialia (1967-1996)", "MS": "A family of rat kangaroos found in and around Australia. Genera include Potorous and Bettongia.", "PM": "2005; see KANGAROOS 2001-2004", "HN": "2005; use MACROPODIDAE 2001-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048328"}, {"RECTYPE": "D", "MH": "Phalangeridae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Phalanger|T015|NON|NRW|NLM (2005)|040220|abcdef", "ENTRY": "Phalangers", "MN": "B01.050.150.900.649.573.587", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid9335", "RR": "txid38622", "AN": "possums unspecified go here; OPOSSUMS is also available", "PI": "Marsupialia (1967-2004)", "MS": "A family of possums and cuscuses found in Australia, Tasmania, New Guinea and other islands.", "PM": "2005", "HN": "2005", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048329"}, {"RECTYPE": "D", "MH": "Trichosurus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Possums, Brush-Tailed|T015|NON|EQV|NLM (2005)|040220|abcdef", "ENTRY": "Possums, Brush Tailed", "MN": "B01.050.150.900.649.573.587.800", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid9336", "RR": "txid9337", "PI": "Marsupialia (1965-2004)", "MS": "A genus of brush-tailed possums found chiefly in Australia and New Zealand. Secretions from their ANAL GLAND function both in defense and demarcating territory.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048330"}, {"RECTYPE": "D", "MH": "Reverse Transcription", "AQ": "DE GE IM PH RE", "ENTRY": "Transcription, Reverse|T045|NON|EQV|UNK (19XX)|880729|abcdef", "MN": "G05.297.700.500", "FX": "Reverse Transcriptase Polymerase Chain Reaction", "MH_TH": "UNK (19XX)", "ST": "T045", "PI": "Transcription, Genetic (1971-2004)", "MS": "The biosynthesis of DNA carried out on a template of RNA.", "PM": "2005; see TRANSCRIPTION, GENETIC 1988-2004", "HN": "2005; use TRANSCRIPTION, GENETIC 1988-2004", "MR": "20160617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048348"}, {"RECTYPE": "D", "MH": "Phascolarctidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Phascolarctos cinereus|T015|NON|NRW|NLM (2005)|040224|abcdef", "ENTRY": "Koalas", "MN": "B01.050.150.900.649.573.590", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid38624", "RR": "txid38626", "PI": "Marsupialia (1967-2004)", "MS": "A family of marsupials in the order Diprotodontia, native to Australia and possessing vestigial tails. There is a single living genus and species: Phascolarctos cinereus, the koala.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048368"}, {"RECTYPE": "D", "MH": "MAP Kinase Kinase 1", "DS": "MAP KINASE KINASE 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mitogen Activated Protein Kinase Kinase 1", "MN": "D12.776.476.568.200.100", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.12.2", "PI": "Protein-Tyrosine Kinase (1992-1999)", "MS": "An abundant 43-kDa mitogen-activated protein kinase kinase subtype with specificity for MITOGEN-ACTIVATED PROTEIN KINASE 1 and MITOGEN-ACTIVATED PROTEIN KINASE 3.", "PM": "2005; MAP KINASE KINASE 1 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASES 2000-2004, under PROTEIN-SERINE-THREONINE KINASES 1992-2004 & under PROTEIN-TYROSINE KINASE 1992-1999", "HN": "2005(1999)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048369"}, {"RECTYPE": "D", "MH": "MAP Kinase Kinase 2", "DS": "MAP KINASE KINASE 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mitogen Activated Protein Kinase Kinase 2", "MN": "D12.776.476.568.200.200", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.12.2", "PI": "Protein-Tyrosine Kinase (2000-2004)", "MS": "A 44 kDa mitogen-activated protein kinase kinase with specificity for MITOGEN-ACTIVATED PROTEIN KINASE 1 and MITOGEN-ACTIVATED PROTEIN KINASE 3.", "PM": "2005; MAP KINASE KINASE 2 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES & PROTEIN-TYROSINE KINASE 2000-2004, & under PROTEIN-SERINE-THREONINE KINASES 1993-1999", "HN": "2005(1993)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048370"}, {"RECTYPE": "D", "MH": "MAP Kinase Kinase 3", "DS": "MAP KINASE KINASE 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinase, MKK3", "MN": "D12.776.476.568.200.300", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.12.2", "PI": "Protein-Tyrosine Kinase (2000-2004)", "MS": "A mitogen-activated protein kinase kinase with specificity for a subset of P38 MITOGEN-ACTIVATED PROTEIN KINASES that includes MITOGEN-ACTIVATED PROTEIN KINASE 12; MITOGEN-ACTIVATED PROTEIN KINASE 13; and MITOGEN-ACTIVATED PROTEIN KINASE 14.", "PM": "2005; MAP KINASE KINASE 3 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASES & PROTEIN-TYROSINE KINASE 2000-2004, & under PROTEIN-SERINE-THREONINE KINASES 1995-1999", "HN": "2005(1995)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048371"}, {"RECTYPE": "D", "MH": "Streptomyces coelicolor", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Streptomyces coelicolor A3(2)|T007|NON|NRW|NLM (2005)|040224|abcdef", "MN": "B03.510.460.410.810.768.200", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1902", "RR": "txid100226", "PI": "Streptomyces (1966-2004)", "MS": "A soil-dwelling actinomycete with a complex lifecycle involving mycelial growth and spore formation. It is involved in the production of a number of medically important ANTIBIOTICS.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048372"}, {"RECTYPE": "D", "MH": "Treponema denticola", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Treponema orthodontum|T007|NON|EQV|NLM (2021)|190918|abcdef", "MN": "B03.851.595.795.200", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid158", "PI": "Treponema (1971-2004)", "MS": "A species of bacteria in the family SPIROCHAETACEAE, frequently isolated from periodontal pockets (PERIODONTAL POCKET).", "PM": "2005", "HN": "2005", "MR": "20200128", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048373"}, {"RECTYPE": "D", "MH": "Gadiformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Hakes|T013|NON|NRW|NLM (2005)|040224|abcdef", "ENTRY": "Hake", "MN": "B01.050.150.900.493.467", "MH_TH": "NLM (2005)", "ST": "T013", "RN": "txid8043", "RR": "txid8045", "PI": "Fishes (1969-2004)", "MS": "An order of fish including the families Gadidae (cods), Macrouridae (grenadiers), and hakes. The large Gadidae family includes cod, haddock, whiting, and pollock.", "PM": "2005", "HN": "2005", "MR": "20200902", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048388"}, {"RECTYPE": "D", "MH": "Gadus morhua", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Atlantic Cod|T013|EPO|EQV|NLM (2005)|040224|abcdef", "ENTRY": "Cod, Atlantic", "MN": "B01.050.150.900.493.467.400", "MH_TH": "NLM (2005)", "ST": "T013", "RN": "txid8049", "PI": "Fishes (1968-2004)", "MS": "A species of fish in the cod family GADIDAE, known as the Atlantic cod. It is one of the most important commercial FISHES.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048389"}, {"RECTYPE": "D", "MH": "Chlorella vulgaris", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "vulgaris, Chlorella", "MN": "B01.875.150.469.400", "MH_TH": "NLM (2005)", "ST": "T002", "RN": "txid3077", "PI": "Chlorella (1971-2004)", "MS": "A species of green microalgae in the family Chlorellaceae. It is used as a model organism for PHOTOSYNTHESIS, and as a food supplement (DIETARY SUPPLEMENTS).", "PM": "2005", "HN": "2005", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048408"}, {"RECTYPE": "D", "MH": "Aeromonas salmonicida", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.450.019.025.690", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid645", "AN": "infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS and FURUNCULOSIS if pertinent ", "PI": "Aeromonas (1966-2004)", "MS": "A species of gram-negative bacteria, in the family Aeromonadaceae. It is strictly parasitic and often pathogenic causing FURUNCULOSIS in SALMONIDS and ulcer disease in GOLDFISH.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048409"}, {"RECTYPE": "D", "MH": "Petromyzon", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Sea Lamprey|T013|NON|NRW|NLM (2005)|040225|abcdef", "ENTRY": "Sea Lampreys", "MN": "B01.050.150.900.493.559.600", "MH_TH": "NLM (2005)", "ST": "T013", "RN": "txid7756", "RR": "txid7757", "PI": "Lampreys (1974-2004)", "MS": "A genus of primitive fish in the family Petromyzontidae. The sole species is Petromyzon marinus, known as the sea lamprey. The adult form feeds parasitically on other fish species.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048428"}, {"RECTYPE": "D", "MH": "Cell Size", "AQ": "DE ES RE", "ENTRY": "Volumes, Cell", "MN": "G04.325", "MH_TH": "NLM (1993)", "ST": "T081", "AN": "not for microorganisms; coordinate with organ /cytol or /pathol or specific cell /cytol or /pathol", "PI": "specific organ/cytology (1966-1992)", "MS": "The quantity of volume or surface area of CELLS.", "PM": "2005(1993)", "HN": "2005(1993)", "MR": "20120703", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048429"}, {"RECTYPE": "D", "MH": "Cell Shape", "AQ": "DE ES GE IM PH RE", "ENTRY": "Shapes, Cell", "MN": "G04.320", "MH_TH": "NLM (1993)", "ST": "T080", "AN": "not for microorganisms; coordinate with organ /cytol or /pathol or specific cell /cytol or /pathol", "PI": "Cell Size (1992-2004)", "MS": "The quality of surface form or outline of CELLS.", "PM": "2005; see CELL SIZE 1993-2004", "HN": "2005; use CELL SIZE 1993-2004", "MR": "20120703", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048430"}, {"RECTYPE": "D", "MH": "Phenylcarbamates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phenyl Carbamates", "MN": "D02.241.081.251.583", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Carbamates (1963-2004)", "MS": "Phenyl esters of carbamic acid or of N-substituted carbamic acids. Structures are similar to PHENYLUREA COMPOUNDS with a carbamate in place of the urea.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048448"}, {"RECTYPE": "D", "MH": "Podospora", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Triangularia anserina|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Podosporas", "MN": "B01.300.107.800.700", "MH_TH": "NLM (2005)", "ST": "T004", "RN": "txid5144", "RR": "txid2587412", "PI": "Sordariales (1999-2004)", "MS": "A genus of ascomycete FUNGI in the order SORDARIALES, which is found on SOIL and herbivore dung (FECES).", "PM": "2005", "HN": "2005", "MR": "20200724", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048468"}, {"RECTYPE": "D", "MH": "Paramecium caudatum", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "caudatum, Paramecium", "MN": "B01.043.185.650.375.550.637.150", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid5885", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Paramecium (1965-2004)", "MS": "The most widely distributed species of PARAMECIUM. It is elongated and possesses a bluntly pointed posterior.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048488"}, {"RECTYPE": "D", "MH": "Paramecium aurelia", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "aurelias, Paramecium", "MN": "B01.043.185.650.375.550.637.074", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid5889", "AN": "infection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Paramecium (1965-2004)", "MS": "A species of ciliated PARAMECIUM possessing two micronuclei.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048489"}, {"RECTYPE": "D", "MH": "raf Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "raf MAP Kinase Kinase Kinases|T116|T126|ACX|EQV|NLM (2005)|040227|abbcdef", "ENTRY": "raf Serine Theonine Protein Kinases", "MN": "D12.776.624.664.700.204", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.1", "RR": "EC 2.7.11.1", "PI": "Proto-Oncogene Proteins c-raf (1986-2004)", "MS": "A family of closely-related serine-threonine kinases that were originally identified as the cellular homologs of the retrovirus-derived V-RAF KINASES. They are MAP kinase kinase kinases that play important roles in SIGNAL TRANSDUCTION.", "PM": "2005; MIL-RAF PROTEIN KINASES & MIL-RAF PROTEINS was indexed under PROTEIN-SERINE-THREONINE KINASES 1993-97 & PROTO-ONCOGENE PROTEINS 1986-97", "HN": "2005", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048490"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins A-raf", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proto Oncogene Proteins A raf", "MN": "D12.776.476.563.554.842.374", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Proto-Oncogene Proteins c-raf (1989-2004)", "MS": "A raf kinase subclass expressed primarily in non-neuronal tissues such as SKELETAL MUSCLE. The A-raf kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1.", "PM": "2005; PROTO-ONCOGENE PROTEIN A-RAF was indexed under PROTO-ONCOGENE PROTEINS C-RAF 2001-2004", "HN": "2005(2001)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048491"}, {"RECTYPE": "D", "MH": "Paragonimus westermani", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "westermanus, Paragonimus", "MN": "B01.050.500.500.736.715.800.610.900", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid34504", "AN": "infection: coordinate IM with PARAGONIMIASIS (IM); coordinate with specific helminth terms (for example, ANTIGENS, HELMINTH) if pertinent", "PI": "Paragonimus (1965-2004)", "MS": "A species of lung fluke infecting humans and other animals, and found chiefly in Asia and the ASIA, EASTERN.", "PM": "2005", "HN": "2005", "MR": "20220715", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048492"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins B-raf", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "BRAF Kinase|T116|T126|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Proto Oncogene Proteins B raf", "MN": "D12.776.624.664.700.204.200", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.1", "PI": "Proto-Oncogene Proteins c-raf (1988-2004)", "MS": "A raf kinase subclass found at high levels in neuronal tissue. The B-raf Kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1 and MAP KINASE KINASE 2.", "PM": "2005; PROTO-ONCOGENE PROTEIN B-RAF was indexed under PROTO-OCOGENES C-RAF 2001-2004", "HN": "2005(2001)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048493"}, {"RECTYPE": "D", "MH": "Rhipicephalus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.166.132.832.400.712", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid34630", "PI": "Ticks (1966-2001)", "MS": "A genus of TICKS, in the family IXODIDAE, widespread in Africa. Members of the genus include many important vectors of animal and human pathogens.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048494"}, {"RECTYPE": "D", "MH": "Rhipicephalus sanguineus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Brown Dog Tick|T204|NON|EQV|NLM (2005)|040301|abcdef", "ENTRY": "Ticks, Brown Dog", "MN": "B01.050.500.131.166.132.832.400.712.700", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid34632", "PI": "Ticks (1966-2001)", "MS": "A species of tick (TICKS) in the family IXODIDAE, distributed throughout the world but abundant in southern Europe. It will feed on a wide variety of MAMMALS, but DOGS are its preferred host. It transmits a large number of diseases including BABESIOSIS; THEILERIASIS; EHRLICHIOSIS; and MEDITERRANEAN SPOTTED FEVER.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048508"}, {"RECTYPE": "D", "MH": "Mandrillus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Mandrill|T015|NON|NRW|UNK (19XX)|800509|abcdef", "ENTRY": "Mandrills", "MN": "B01.050.150.900.649.313.988.400.112.199.120.530", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid9567", "RR": "txid9568", "PI": "Papio (1972-2004)", "MS": "A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, comprising two species: the drill (M. leucophaeus) and the mandrill (M. sphinx). They are usually found in thick rainforest and have a gentle disposition despite their ferocious reputation. Some authors consider Mandrillus a subgenus of PAPIO.", "PM": "2005; see PAPIO 1992-2004; for DRILL and MANDRILL use PAPIO 1981-2004", "HN": "2005; use PAPIO 1992-2004; for DRILL and MANDRILL use PAPIO 1981-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048528"}, {"RECTYPE": "D", "MH": "Papio hamadryas", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Hamadryas Baboon|T015|NON|EQV|NLM (2005)|040301|abcdef", "ENTRY": "Hamadryas Baboons", "MN": "B01.050.150.900.649.313.988.400.112.199.120.610.400", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid9557", "PI": "Papio (1972-2004)", "MS": "A species of baboon in the family CERCOPITHECIDAE, which has a well-studied trilevel social structure consisting of troops, bands, and clans.", "PM": "2005; see PAPIO 1975-2004", "HN": "2005; use PAPIO 1975-2004", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048529"}, {"RECTYPE": "D", "MH": "Papio anubis", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Olive Baboon|T015|NON|EQV|NLM (2005)|040301|abcdef", "ENTRY": "Olive Baboons", "MN": "B01.050.150.900.649.313.988.400.112.199.120.610.050", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid9555", "PI": "Papio (1972-2004)", "MS": "A species of baboon in the family CERCOPITHECIDAE with a somewhat different social structure than PAPIO HAMADRYAS. They inhabit several areas in Africa south of the Sahara.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048530"}, {"RECTYPE": "D", "MH": "Papio papio", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Baboon, Guinea", "MN": "B01.050.150.900.649.313.988.400.112.199.120.610.600", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid100937", "PI": "Papio (1972-2004)", "MS": "A species of baboon in the family CERCOPITHECIDAE, often used as an animal model for cognitive studies.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048531"}, {"RECTYPE": "D", "MH": "Papio cynocephalus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Yellow Baboon|T015|NON|EQV|NLM (2005)|040302|abcdef", "ENTRY": "Yellow Baboons", "MN": "B01.050.150.900.649.313.988.400.112.199.120.610.150", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid9556", "RR": "txid106398", "PI": "Papio (1972-2004)", "MS": "A species of baboon in the family CERCOPITHECIDAE found in southern equatorial and east Africa. They are smaller than PAPIO ANUBIS and have a thinner mane.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048548"}, {"RECTYPE": "D", "MH": "Papio ursinus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Chacma Baboon|T015|NON|EQV|NLM (2005)|040302|abcdef", "ENTRY": "Chacma Baboons", "MN": "B01.050.150.900.649.313.988.400.112.199.120.610.800", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid36229", "PI": "Papio (1972-2004)", "MS": "A species of baboon in the family CERCOPITHECIDAE found in southern Africa. They are dark colored and have a variable social structure.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048549"}, {"RECTYPE": "D", "MH": "Hepatic Insufficiency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Insufficiency, Liver", "MN": "C06.552.308", "MH_TH": "NLM (2005)", "ST": "T046", "PI": "Liver Diseases (1965-2004)", "MS": "Conditions in which the LIVER functions fall below the normal ranges. Severe hepatic insufficiency may cause LIVER FAILURE or DEATH. Treatment may include LIVER TRANSPLANTATION.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048550"}, {"RECTYPE": "D", "MH": "Clostridium botulinum type G", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Clostridium botulinum G|T007|NON|EQV|NLM (2005)|040302|abcdef", "MN": "B03.510.415.400.200.160.350", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid447213", "AN": "infection: coordinate IM with BOTULISM (IM)", "PI": "Clostridium botulinum (1972-2004)", "MS": "Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type G. Though it has been isolated from soil, no outbreaks involving this type have been recognized.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048568"}, {"RECTYPE": "D", "MH": "Benzoxazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Benzoxazinones|T109|NON|NRW|NLM (2008)|061201|abcdef", "ENTRY": "Benzoxazinoids|T109|NON|REL|NLM (2005)|040305|abcdef", "MN": "D03.633.100.209", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "AN": "do not confuse with benzoxazolines (index BENZOXAZOLES)", "PI": "Oxazines (1963-2004)", "MS": "OXAZINES with a fused BENZENE ring.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048588"}, {"RECTYPE": "D", "MH": "Rupicapra", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Chamois, Pyrenean|T015|NON|NRW|NLM (2005)|040308|abcdef", "ENTRY": "Rupicapras", "MN": "B01.050.150.900.649.313.500.380.513.500", "MH_TH": "NLM (2005)", "ST": "T015", "RN": "txid34868", "RR": "txid72545", "PI": "Goats (1973-2004)", "MS": "A genus of ruminants in the family Bovidae. The common name chamois usually refers to the species Rupicapra rupicapra. Rupicapra pyrenaica, found in the Pyrenees, is more properly referred to as the Pyrenean chamois.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048608"}, {"RECTYPE": "D", "MH": "Ketolides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Erythromycins, 3 Keto", "MN": "D02.540.576.500.992.445", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Macrolides (1997-2004)", "MS": "Compounds based on ERYTHROMYCIN with the 3-cladinose replaced by a ketone. They bind the 23S part of 70S bacterial RIBOSOMES.", "PM": "2005", "HN": "2005", "MR": "20150622", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048628"}, {"RECTYPE": "D", "MH": "Micronuclei, Chromosome-Defective", "AQ": "CI CL DE EM RE SN VE", "ENTRY": "Micronucleus, Genotoxicant-Induced", "MN": "G05.365.590.175.570", "FX": "Micronucleus, Germline", "MH_TH": "NLM (2005)", "ST": "T026", "MS": "Defective nuclei produced during the TELOPHASE of MITOSIS or MEIOSIS by lagging CHROMOSOMES or chromosome fragments derived from spontaneous or experimentally induced chromosomal structural changes.", "PM": "2005", "HN": "2005", "MR": "20080708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048629"}, {"RECTYPE": "D", "MH": "Polyketide Synthases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polyketide Synthase|T116|T126|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Type II Polyketide Beta Ketoacyl Synthase", "MN": "D08.811.600.715", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "79956-01-7", "RR": "128172-72-5 (6-deoxyerythronolide B synthase)", "PI": "Multienzyme Complexes (1989-2004)", "MS": "Large enzyme complexes composed of a number of component enzymes that are found in STREPTOMYCES which biosynthesize MACROLIDES and other polyketides.", "PM": "2005; POLYKETIDE SYNTHASE was indexed under MULTIENZYME COMPLEXES 1989-2004", "HN": "2005(1989)", "MR": "20200527", "DA": "20040708", "DC": "1", "DX": "20050101", "UI": "D048630"}, {"RECTYPE": "D", "MH": "Micronucleus, Germline", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Micronuclei, Germline|T026|NON|EQV|NLM (2005)|040401|abcdef", "ENTRY": "Micronucleus, Germinal", "MN": "A11.284.430.214.190.875.117.575", "FX": "Micronuclei, Chromosome-Defective", "MH_TH": "NLM (2005)", "ST": "T026", "MS": "The smaller, reproductive, transcriptionally inert nucleus in the cells of ciliate protozoans, as distinguished from the larger, vegetative, transcriptionally active MACRONUCLEUS. Micronuclei participate in MEIOSIS and autogamy during GENETIC CONJUGATION.", "PM": "2005", "HN": "2005", "MR": "20130709", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048631"}, {"RECTYPE": "D", "MH": "Macronucleus", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Macronuclei|T026|NON|EQV|NLM (2005)|040309|abcdef", "MN": "A11.284.430.214.190.875.117.550", "MH_TH": "NLM (2005)", "ST": "T026", "PI": "Cell Nucleus (1965-2004)", "MS": "The larger of two types of nuclei in ciliate protozoans. It is the transcriptionally active nucleus of the vegetative cells as distinguished from the smaller transcriptionally inert GERMLINE MICRONUCLEUS.", "PM": "2005", "HN": "2005", "MR": "20090715", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048648"}, {"RECTYPE": "D", "MH": "Lactobacillus delbrueckii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Lactobacillus delbrueckii subspecies bulgaricus|T007|NON|NRW|NLM (2017)|150909|abcdef", "MN": "B03.510.550.450.475.250", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1584", "RR": "txid1585", "PI": "Lactobacillus (1970-2004)", "MS": "A species of gram-positive, rod-shaped, facultatively anaerobic bacteria. capable of producing LACTIC ACID. It is important in the manufacture of FERMENTED DAIRY PRODUCTS.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048668"}, {"RECTYPE": "D", "MH": "MAP Kinase Kinase 6", "DS": "MAP KINASE KINASE 06", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Stress Activated Protein Kinase Kinase 3", "MN": "D12.776.476.568.200.600", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.12.2", "PI": "Ca(2+)-Calmodulin Dependent Protein Kinase (1996-2004)", "MS": "A mitogen-activated protein kinase kinase with specificity for P38 MITOGEN-ACTIVATED PROTEIN KINASES.", "PM": "2005; MAP KINASE KINASE 6 was indexed under CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE 1996-2004", "HN": "2005(1996)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048669"}, {"RECTYPE": "D", "MH": "MAP Kinase Kinase 4", "DS": "MAP KINASE KINASE 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Stress Activated Protein Kinase Kinase 1", "MN": "D12.776.476.568.200.400", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.12.2", "PI": "Protein-Tyrosine Kinase (2000-2004)", "MS": "A mitogen-activated protein kinase kinase with specificity for JNK MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES and the RETINOID X RECEPTORS. It takes part in a SIGNAL TRANSDUCTION pathway that is activated in response to cellular stress.", "PM": "2005; MAP KINASE KINASE 4 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES & PROTEIN-TYROSINE KINASE 2000-2004, & under PROTEIN-SERINE-THREONINE KINASES 1995-1999; JNK-ACTIVATING PROTEIN KINASE was indexed under JNK MITOGEN-ACTIVATED PROTEIN KINASES 2004-2005; under MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASES 2000-2005, & under PROTEIN KINASES 1995-1999", "HN": "2005(1995)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048670"}, {"RECTYPE": "D", "MH": "MAP Kinase Kinase 5", "DS": "MAP KINASE KINASE 05", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mitogen Activated Protein Kinase Kinase 5", "MN": "D12.776.476.568.200.500", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.12.2", "PI": "Protein-Tyrosine Kinase (1995-1999)", "MS": "A mitogen-activated protein kinase kinase with specificity for MITOGEN-ACTIVATED PROTEIN KINASE 7.", "PM": "2005; MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, & under PROTEIN-TYROSINE KINASE & PROTEIN-SERINE-THREONINE KINASES 1995-1999", "HN": "2005(1995)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048671"}, {"RECTYPE": "D", "MH": "MAP Kinase Kinase 7", "DS": "MAP KINASE KINASE 07", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinase, SKK4", "MN": "D12.776.476.568.200.700", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.12.2", "PI": "Protein Kinases (1997-1999)", "MS": "A mitogen-activated protein kinase kinase with specificity for JNK MITOGEN-ACTIVATED PROTEIN KINASES. It takes part in a SIGNAL TRANSDUCTION pathway that is activated in response to CYTOKINES.", "PM": "2005; MAP KINASE KINASE KINASE 7 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASES 2000-2004 & under PROTEIN KINASES 1997-1999", "HN": "2005(1997)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048688"}, {"RECTYPE": "D", "MH": "Fruiting Bodies, Fungal", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Fungal Fruiting Body", "MN": "A19.374", "FX": "Agaricales", "MH_TH": "NLM (2005)", "ST": "T004", "MS": "The fruiting 'heads' or 'caps' of FUNGI, which as a food item are familiarly known as MUSHROOMS, that contain the FUNGAL SPORES.", "PM": "2005", "HN": "2005", "MR": "20090706", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048690"}, {"RECTYPE": "D", "MH": "Grifola", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Maitake Mushroom|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Mushroom, Maitake", "MN": "B01.300.179.120.372", "MH_TH": "NLM (2005)", "ST": "T004", "RN": "txid5626", "RR": "txid5627", "MS": "A member of the AGARICALES known for edible MUSHROOMS.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048691"}, {"RECTYPE": "D", "MH": "Cell Growth Processes", "AQ": "DE ES GE IM PH RE", "ENTRY": "Processes, Cell Growth", "MN": "G07.345.249.410", "FX": "Cell Survival", "MH_TH": "NLM (2005)", "ST": "T043", "AN": "general or unspecified; prefer specifics", "MS": "Processes required for CELL ENLARGEMENT and CELL PROLIFERATION.", "PM": "2005", "HN": "2005", "MR": "20160115", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048708"}, {"RECTYPE": "D", "MH": "MAP Kinase Kinase Kinase 1", "DS": "MAP KINASE KINASE KINASE 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mitogen-Activated Protein Kinase Kinase Kinase 1|T116|T126|NON|EQV|NLM (2005)|040209|abbcdef", "ENTRY": "Protein Kinase, MEKK-1", "MN": "D12.776.476.563.554.100", "FX": "Zinc Fingers", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.25", "PI": "Protein-Serine-Threonine Kinases (1994-2004)", "MS": "A 195-kDa zinc finger motif-containing MAP kinase kinase kinase with broad specificity for MAP KINASE KINASES. It localizes to the CYTOSKELETON and can activate a variety of MAP kinase-dependent pathways.", "PM": "2005; MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 1 was indexed under MAP KINASE KINASE KINASES 2004 & under PROTEIN-SERINE-THREONINE KINASES 1994-2004", "HN": "2005(1994)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048728"}, {"RECTYPE": "D", "MH": "Anacardic Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Salicylic Acids, 6 Alkyl", "MN": "D02.455.426.559.389.657.410.595.151", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "0", "PI": "Salicylic Acids (1990-2004)", "MS": "A group of 6-alkyl SALICYLIC ACIDS that are found in ANACARDIUM and known for causing CONTACT DERMATITIS.", "PM": "2005", "HN": "2005", "MR": "20120703", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048729"}, {"RECTYPE": "D", "MH": "MAP Kinase Kinase Kinase 2", "DS": "MAP KINASE KINASE KINASE 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinase, MEKK2", "MN": "D12.776.476.563.554.200", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.25", "PI": "MAP Kinase Kinase Kinases (1999-2004)", "MS": "A 70-kDa MAP kinase kinase kinase with specificity for MAP KINASE KINASE 5. It is activated during the cellular response to GROWTH FACTORS, oxidative stress, and hyperosmotic conditions.", "PM": "2005; MAP KINASE KINASE KINASE 2 was indexed under MAP KINASE KINASE KINASES 1999-2004", "HN": "2005(1999)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048730"}, {"RECTYPE": "D", "MH": "MAP Kinase Kinase Kinase 3", "DS": "MAP KINASE KINASE KINASE 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinase, MEKK3", "MN": "D12.776.476.563.554.300", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.25", "PI": "Mitogen-Activated Protein Kinase Kinase Kinases (1997-2004)", "MS": "A 70-kDa MAPK kinase kinase with specificity for MAP KINASE KINASE 5.", "PM": "2005; MAP KINASE KINASE KINASE 3 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASES 1999-2004", "HN": "2005(1999)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048748"}, {"RECTYPE": "D", "MH": "Cytokinesis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Divisions, Cytoplasmic", "MN": "G04.144.220.250", "MH_TH": "UNK (19XX)", "ST": "T043", "AN": "permitted with microorganisms; do not confuse CYTOKINESIS with CELL MOVEMENT or CYTOPLASMIC STREAMING", "PI": "Cell Division (1965-2004)", "MS": "The process by which the CYTOPLASM of a cell is divided.", "PM": "2005; see CELL DIVISION 1985-2004", "HN": "2005; use CELL DIVISION 1985-2004", "MR": "20160617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048749"}, {"RECTYPE": "D", "MH": "Cell Nucleus Division", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Nuclear Division|T043|NON|EQV|NLM (2005)|040316|abcdef", "ENTRY": "Nucleus Divisions, Cell", "MN": "G05.113.220", "MH_TH": "NLM (2005)", "ST": "T043", "PI": "Mitosis (1965-2004)", "MS": "The process by which the CELL NUCLEUS is divided.", "PM": "2005; for KARYOKINESIS see MITOSIS 1981-2004", "HN": "2005; for KARYOKINESIS use MITOSIS 1981-2004", "MR": "20160115", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048750"}, {"RECTYPE": "D", "MH": "MAP Kinase Kinase Kinase 4", "DS": "MAP KINASE KINASE KINASE 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinase, MAP3K4", "MN": "D12.776.476.563.554.400", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.25", "PI": "Protein-Serine-Threonine Kinases (1997-1999)", "MS": "A 180-kDa MAP kinase kinase kinase with specificity for MAP KINASE KINASE 4 and MAP KINASE KINASE 6.", "PM": "2005; MAP KINASE KINASE KINASE 4 was indexed under MAP KINASE KINASE KINASES 2000-2004, & under PROTEIN-SERINE-THREONINE KINASES & PROTEIN KINASES 1997-1999", "HN": "2005(1997)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048768"}, {"RECTYPE": "D", "MH": "Growth and Development", "AQ": "DE ES GE IM PH RE", "ENTRY": "Development and Growth", "MN": "G07.345", "FX": "Gene Expression Regulation, Developmental", "MH_TH": "NLM (2005)", "ST": "T040", "AN": "general only; prefer specifics or /growth with specific organism, organ or tissue", "MS": "The series of changes to the shape, size, components, and functions of an individual organism that occur over time as the organism progresses from its initial form to full size and maturity.", "PM": "2005", "HN": "2005", "MR": "20160617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048788"}, {"RECTYPE": "D", "MH": "Phytoestrogens", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Plant Extracts, Estrogen-Like", "MN": "D27.505.696.399.472.277.540.500", "MH_TH": "NLM (2005)", "ST": "T121", "RN": "0", "PI": "Isoflavones (2004)", "MS": "Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS.", "PM": "2005; PHYTOESTROGENS was indexed under ISOFLAVONES 2004 and ESTROGENS, NON-STEROIDAL 1978-2003", "HN": "2005(1978)", "MR": "20160622", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048789"}, {"RECTYPE": "D", "MH": "Renilla", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sea Pansy|T204|NON|EQV|NLM (2005)|040317|abcdef", "ENTRY": "Sea Pansies", "MN": "B01.050.500.308.237.700", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid6134", "PI": "Cnidaria (1965-2002)", "MS": "A genus of bioluminescent marine invertebrates in the family Renillidae, order Pennatulacea, class ANTHOZOA. It contains Renilla LUCIFERASE which oxidizes coelenterazine resulting in LUMINESCENCE.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048790"}, {"RECTYPE": "D", "MH": "alpha-N-Acetylgalactosaminidase", "DS": "ALPHA ACETYLGALACTOSAMINIDASE N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-N-Acetyl-D-galactosaminidase|T116|T126|NON|EQV|NLM (2005)|ALPHA ACETYLGALACTOSAMINIDASE N D|abbcdes", "ENTRY": "endo alpha N Acetylgalactosaminidase", "MN": "D08.811.277.450.483.044", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 3.2.1.49", "PI": "Hexosaminidases (1978-2004)", "MS": "A hexosaminidase with specificity for terminal non-reducing N-acetyl-D-galactosamine residues in N-acetyl-alpha-D-galactosaminides.", "PM": "2005; ALPHA-N-ACETYL-D-GALATOSAMINIDASE was indexed under GALATOSAMINIDASE 1982-2004 & ACETYLGALACTOSAMINE 1978-1981", "HN": "2005(1978)", "MR": "20060705", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048809"}, {"RECTYPE": "D", "MH": "beta-N-Acetyl-Galactosaminidase", "DS": "BETA ACETYLGALACTOSAMINIDASE N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta N Acetylgalactosaminidase", "MN": "D08.811.277.450.483.112", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 3.2.1.53", "RR": "9054-43-7 (CRN)", "PI": "Hexosaminidases (1982-2004)", "MS": "A hexosiminidase that specifically hydrolyzes terminal non-reducing N-acetyl-D-galactosamine residues in N-acetyl-beta-D-galactosaminides.", "PM": "2005; BETA-N-ACETYL-GALACTOAMINIDASE was indexed under GALACTOSAMINIDASE 1982-2004, under ACETYLGALACTOSAMINE 1978-1981, & under ACETAMIDES & ACETIC ACIDS 1973-1978", "HN": "2005(1973)", "MR": "20060705", "DA": "20040708", "DC": "1", "DX": "20050101", "UI": "D048828"}, {"RECTYPE": "D", "MH": "MAP Kinase Kinase Kinase 5", "DS": "MAP KINASE KINASE KINASE 05", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinase, MAP3K5", "MN": "D12.776.476.563.554.500", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.25", "PI": "Protein-Serine-Threonine Kinases (1995-1999)", "MS": "A 150-kDa MAP kinase kinase kinase that may play a role in the induction of APOPTOSIS. It has specificity for MAP KINASE KINASE 3; MAP KINASE KINASE 4; and MAP KINASE KINASE 6.", "PM": "2005: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 4 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASES 2000-2004, & under PROTEIN-SERINE-THREONINE KINASES 1996-1999", "HN": "2005(1996)", "MR": "20210521", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048848"}, {"RECTYPE": "D", "MH": "Adaptor Proteins, Signal Transducing", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Signal Transducing Adaptor Proteins|T116|T123|NON|EQV|NLM (2005)|040323|abbcdef", "MN": "D12.776.476.024", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1991-2004)", "MS": "A broad category of carrier proteins that play a role in SIGNAL TRANSDUCTION. They generally contain several modular domains, each of which having its own binding activity, and act by forming complexes with other intracellular-signaling molecules. Signal-transducing adaptor proteins lack enzyme activity, however their activity can be modulated by other signal-transducing enzymes", "PM": "2005", "HN": "2005", "MR": "20151123", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048868"}, {"RECTYPE": "D", "MH": "Fireflies", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Lampyridae|T204|NON|EQV|NLM (2005)|040323|abcdef", "ENTRY": "Luciolas", "MN": "B01.050.500.131.617.720.500.500.375.307", "MH_TH": "NLM (1993)", "ST": "T204", "RN": "txid7049", "RR": "txid7053", "PI": "Beetles (1965-2004)", "MS": "The family Lampyidae, which are bioluminescent BEETLES. They contain FIREFLY LUCIFERIN and LUCIFERASES. Oxidation of firefly luciferin results in luminescence.", "PM": "2005; see BEETLES 1993-2004", "HN": "2005; use BEETLES 1993-2004", "MR": "20200813", "DA": "20040715", "DC": "1", "DX": "20050101", "UI": "D048888"}, {"RECTYPE": "D", "MH": "Weevils", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Curculionidae|T204|NON|EQV|NLM (2005)|040323|abcdef", "ENTRY": "Weevil", "MN": "B01.050.500.131.617.720.500.500.375.900", "MH_TH": "NLM (2005)", "ST": "T204", "RN": "txid7042", "PI": "Coleoptera (1974-2004)", "MS": "BEETLES in the family Curculionidae and the largest family in the order COLEOPTERA. They have a markedly convex shape and many are considered pests.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048889"}, {"RECTYPE": "D", "MH": "Aliivibrio fischeri", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Vibrio noctiluca|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.660.250.830.050.860", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid668", "PI": "Vibrio (1975-2004)", "MS": "A species of gram-negative bacteria in the genus ALIIVIBRIO, which exhibits LUMINESCENCE. A. fischeri is found in a symbiotic relationship with the SQUID Euprymna scolopes.", "PM": "2012; see VIBRIO FISCHERI 2005-2011", "HN": "2012 (2005)", "MR": "20200128", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048908"}, {"RECTYPE": "D", "MH": "Diabetes Complications", "DE": "DIABETES COMPL", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diabetic Complication", "MN": "C19.246.099", "MH_TH": "NLM (2005)", "ST": "T047", "AN": "general only; prefer /compl with specific type of diabetes + specific complication: Manual 23.25.3.1", "PI": "Diabetes Mellitus/complications (1965-2004)", "MS": "Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048909"}, {"RECTYPE": "D", "MH": "Prochlorophytes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.655", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1213", "MS": "An order of GRAM-NEGATIVE OXYGENIC PHOTOSYNTHETIC BACTERIA containing CHLOROPHYLL, a and b, but lacking PHYCOBILISOMES (light-harvesting antennae). There are three genera: PROCHLORON; PROCHLOROCOCCUS; and PROCHLOROTHRIX. This order was thought to be the missing link between CYANOBACTERIA and plant CHLOROPLASTS, hence the name.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048928"}, {"RECTYPE": "D", "MH": "Prochlorococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.655.600", "MH_TH": "NLM (2005)", "ST": "T007", "RN": "txid1218", "PI": "Cyanobacteria (1995-2004)", "MS": "A genus of marine planktonic CYANOBACTERIA in the order PROCHLOROPHYTES. They lack PHYCOBILISOMES and contain divinyl CHLOROPHYLL, a and b.", "PM": "2005", "HN": "2005", "MR": "20200813", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048929"}, {"RECTYPE": "D", "MH": "14-3-3 Proteins", "DS": "PROTEINS 14 03 03", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "eta Protein, 14-3-3", "MN": "D12.776.476.024.050", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Tyrosine 3-Monooxygenase (2000-2004)", "MS": "A large family of signal-transducing adaptor proteins present in wide variety of eukaryotes. They are PHOSPHOSERINE and PHOSPHOTHREONINE binding proteins involved in important cellular processes including SIGNAL TRANSDUCTION; CELL CYCLE control; APOPTOSIS; and cellular stress responses. 14-3-3 proteins function by interacting with other signal-transducing proteins and effecting changes in their enzymatic activity and subcellular localization. The name 14-3-3 derives from numerical designations used in the original fractionation patterns of the proteins.", "PM": "2005; 14-3-3 PROTEINS was indexed under TYROSINE 3-MONOOXYGENASE 2000-2004, under PROTEINS 1995-1999, & under NERVE TISSUE PROTEINS 1981-1994", "HN": "2005(1981)", "MR": "20151123", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048948"}, {"RECTYPE": "D", "MH": "Labor Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pain, Obstetric", "MN": "C23.888.592.612.451", "EC": "prevention & control:Analgesia, Obstetrical", "MH_TH": "NLM (2005)", "ST": "T184", "PI": "Pain (1965-2004)", "MS": "Pain associated with OBSTETRIC LABOR in CHILDBIRTH. It is caused primarily by UTERINE CONTRACTION as well as pressure on the CERVIX; BLADDER; and the GASTROINTESTINAL TRACT. Labor pain mostly occurs in the ABDOMEN; the GROIN; and the BACK.", "PM": "2005", "HN": "2005", "MR": "20170620", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048949"}, {"RECTYPE": "D", "MH": "Morning Sickness", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sickness, Morning", "MN": "C23.888.821.937.049", "MH_TH": "NLM (2005)", "ST": "T184", "AN": "check tags FEMALE & PREGNANCY", "PI": "Vomiting (1968-2004)", "MS": "Symptoms of NAUSEA and VOMITING in pregnant women that usually occur in the morning during the first 2 to 3 months of PREGNANCY. Severe persistent vomiting during pregnancy is called HYPEREMESIS GRAVIDARUM.", "PM": "2005", "HN": "2005", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048968"}, {"RECTYPE": "D", "MH": "Corneal Surgery, Laser", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Photokeratectomy|T061|NON|NRW|NLM (1996)|950105|abcdef", "ENTRY": "Surgery, Laser Corneal", "MN": "E04.540.825.437", "MH_TH": "NLM (2008)", "ST": "T061", "AN": "coordinate with specific LASER when discussed", "PI": "Laser Surgery (1987-2004)", "MS": "Surgical techniques on the CORNEA employing LASERS, especially for reshaping the CORNEA to correct REFRACTIVE ERRORS.", "PM": "2008; see KERATECTOMY, LASER 2005-2008; for PHOTOKERATECTOMY see KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LASER 1996-2004", "HN": "2008 (2005); for PHOTOKERATECTOMY use PHOTOREFRACTIVE KERATECTOMY 1996-2004", "MR": "20170620", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D048988"}, {"RECTYPE": "D", "MH": "Keratectomy, Subepithelial, Laser-Assisted", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Laser-Assisted Subepithelial Keratectomy|T061|NON|EQV|NLM (2005)|040326|abcdef", "ENTRY": "Subepithelial Photorefractive Keratectomies", "MN": "E04.540.825.437.249", "MH_TH": "NLM (2005)", "ST": "T061", "AN": "coordinate with specific LASER when discussed", "PI": "Epithelium, Corneal/surgery (2001-2004)", "MS": "A surgical technique to correct REFRACTIVE ERRORS of the EYE, such as MYOPIA and ASTIGMATISM. In this method, a flap of CORNEAL EPITHELIUM is created by exposure of the area to dilute alcohol. The flap is lifted and then replaced after laser ablation of the subepithelial CORNEA.", "PM": "2005", "HN": "2005", "MR": "20170620", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049008"}, {"RECTYPE": "D", "MH": "Dystrophin-Associated Protein Complex", "DE": "DYSTROPHIN ASSOC PROTEIN COMPLEX", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dystrophin Associated Protein Complex", "MN": "D05.500.149", "FX": "Dystroglycans", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "MS": "A macromolecular complex of proteins that includes DYSTROPHIN and DYSTROPHIN-ASSOCIATED PROTEINS. It plays a structural role in the linking the CYTOSKELETON to the EXTRACELLULAR MATRIX.", "PM": "2005", "HN": "2005", "MR": "20100625", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049028"}, {"RECTYPE": "D", "MH": "Dystrophin-Associated Proteins", "DE": "DYSTROPHIN ASSOC PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dystrophin Associated Proteins", "MN": "D12.776.543.268", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "MS": "A group of proteins that associate with DYSTROPHIN at the CELL MEMBRANE to form the DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX.", "PM": "2005", "HN": "2005", "MR": "20050630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049029"}, {"RECTYPE": "D", "MH": "Dystroglycans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dystroglycan|T116|T123|NON|EQV|NLM (2005)|abbcde", "ENTRY": "beta Dystroglycan", "MN": "D12.776.543.268.500", "FX": "Walker-Warburg Syndrome", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "146888-27-9", "PI": "Membrane Glycoproteins (1992-2004)", "MS": "Dystrophin-associated proteins that play role in the formation of a transmembrane link between laminin-2 and DYSTROPHIN. Both the alpha and the beta subtypes of dystroglycan originate via POST-TRANSLATIONAL PROTEIN PROCESSING of a single precursor protein.", "PM": "2005; DYSTROGLYCANS was indexed under CYTOSKELETAL PROTEINS and MEMBRANE GLYCOPROTEINS 1992-2004", "HN": "2005(1992)", "MR": "20100625", "DA": "20040708", "DC": "1", "DX": "20050101", "UI": "D049030"}, {"RECTYPE": "D", "MH": "Sarcoglycans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Sarcoglycan|T116|T123|NON|NRW|NLM (2005)|abbcde", "ENTRY": "zeta Sarcoglycan", "MN": "D12.776.543.550.712", "FX": "Muscular Dystrophies, Limb-Girdle", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1993-2004)", "MS": "A family of transmembrane dystrophin-associated proteins that play a role in the membrane association of the DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX.", "PM": "2005; ADHALIN was indexed under CYTOSKELETAL PROTEINS & MEMBRANE GLYCOPROTEINS 1993-2004; DELTA-SARCOGLYCAN was indexed under CYTOSKELETAL PROTEINS & MEMBRANE GLYCOPROTEINS 1996-2004; EPSILON-SARCOGLYCAN was indexed under CYTOSKELETAL PROTEINS & MEMBRANE GLYCOPROTEINS 1998-2004; GAMMA-SARCOGLYCAN was indexed under CYTOSKELETAL PROTEINS & MEMBRANE GLYCOPROTEINS 1994-2004", "HN": "2005(1993)", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049031"}, {"RECTYPE": "D", "MH": "Chorioallantoic Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Membranes, Chorioallantoic", "MN": "A16.331.400", "FX": "Chorion", "MH_TH": "NLM (2005)", "ST": "T018", "PI": "Fetal Membranes (1965-2004)", "MS": "A highly vascularized extra-embryonic membrane, formed by the fusion of the CHORION and the ALLANTOIS. It is mostly found in BIRDS and REPTILES. It serves as a model for studying tumor or cell biology, such as angiogenesis and TISSUE TRANSPLANTATION.", "PM": "2005", "HN": "2005", "MR": "20070709", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049033"}, {"RECTYPE": "D", "MH": "Pheromones, Human", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Chemosignals, Human", "MN": "D23.641.399", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Pheromones (1971-2004)", "MS": "Chemical substances excreted by humans that elicit behavior or physiological responses from other humans. Perception of these chemical signals may be olfactory or by contact.", "PM": "2005", "HN": "2005", "MR": "20050630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049049"}, {"RECTYPE": "D", "MH": "Plagiocephaly, Nonsynostotic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Positional Plagiocephaly", "MN": "C16.131.621.207.707.624", "MH_TH": "NLM (2005)", "ST": "T020", "MS": "A deformity of the SKULL that is not due to bone fusion (SYNOSTOSIS), such as craniosynostoses, and is characterized by an asymmetric skull and face. It is observed with an increased frequency in INFANTS after the adoption of supine sleeping recommendations to prevent SUDDEN INFANT DEATH SYNDROME.", "PM": "2005", "HN": "2005", "MR": "20100625", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049068"}, {"RECTYPE": "D", "MH": "ATP-Dependent Proteases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ATP-Dependent Protease|T116|T126|ACX|EQV|NLM (2005)|abbcde", "ENTRY": "Proteases, ATP-Dependent", "MN": "D12.776.157.025.750.032", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 3.4.21.-", "RR": "EC 3.6.4.8", "PI": "Serine Endopeptidases (1989-2004)", "MS": "Proteases that contain proteolytic core domains and ATPase-containing regulatory domains. They are usually comprised of large multi-subunit assemblies. The domains can occur within a single peptide chain or on distinct subunits.", "PM": "2005; ATP-DEPENDENT PROTEASE was indexed under SERINE ENDOPEPTIDASES and HEAT-SHOCK PROTEINS 1989-2004 & under PEPTIDE PEPTIDOHYDROLASES 1981-1988", "HN": "2005(1981)", "MR": "20170301", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049069"}, {"RECTYPE": "D", "MH": "Protease La", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lon Protease|T116|T126|NON|EQV|NLM (2005)|abbcde", "ENTRY": "Endopeptidase La|T116|T126|NON|EQV|NLM (2005)|abbcde", "MN": "D12.776.157.025.750.032.099.750", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 3.4.21.53", "RR": "EC 3.4.21.53", "PI": "Serine Endopeptidases (1989-2004)", "MS": "A prokaryotic ATP-dependent protease that plays a role in the degradation of many abnormal proteins. It is a tetramer of 87-kDa subunits, each of which contains a proteolytic site and a ATP-binding site.", "PM": "2005; PROTEASE LA was indexed under SERINE ENDOPEPTIDASES and HEAT-SHOCK PROTEINS 1989-2004 & under PEPTIDE PEPTIDOHYDROLASES 1981-1988", "HN": "2005(1981)", "MR": "20170524", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049070"}, {"RECTYPE": "D", "MH": "Endopeptidase Clp", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protease Ti|T116|T126|NON|EQV|NLM (2005)|abbcde", "ENTRY": "Peptidase B, Caseinolytic", "MN": "D12.776.765.199.249", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 3.4.21.92", "RR": "EC 3.6.1.3", "PI": "Serine Endopeptidases (1988-2004)", "MS": "An ATP-dependent protease found in prokaryotes, CHLOROPLASTS, and MITOCHONDRIA. It is a soluble multisubunit complex that plays a role in the degradation of many abnormal proteins.", "PM": "2005; ATP-DEPENDENT ENDOPROTEASE TI (now ENDOPEPTIDASE CLP) was indexed under SERINE ENDOPEPTIDASES & ADENOSINETRIPHOSPHATASE 1988-2004", "HN": "2005(1988)", "MR": "20170405", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049071"}, {"RECTYPE": "D", "MH": "Bariatrics", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E02.650.500", "FX": "Obesity", "MH_TH": "NLM (2005)", "ST": "T061", "AN": "for the specialty use BARIATRIC MEDICINE", "PI": "Obesity (1974-2004)", "MS": "Activities related to WEIGHT REDUCTION in patients with OBESITY. Treatment methods include DIET; EXERCISE; BEHAVIOR MODIFICATION; medications; and BARIATRIC SURGERY.", "PM": "2005", "HN": "2005", "MR": "20200221", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049088"}, {"RECTYPE": "D", "MH": "Cell Enlargement", "AQ": "DE ES RE", "PRINT ENTRY": "Cell Growth in Size|T043|NON|EQV|NLM (2005)|040402|abcdef", "ENTRY": "Size Growth, Cell", "MN": "G07.345.249.410.500", "FX": "Hypertrophy", "MH_TH": "NLM (2005)", "ST": "T043", "MS": "Growth processes that result in an increase in CELL SIZE.", "PM": "2005", "HN": "2005", "MR": "20160115", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049108"}, {"RECTYPE": "D", "MH": "Cell Proliferation", "AQ": "DE GE PH RE", "PRINT ENTRY": "Cellular Proliferation|T043|NON|EQV|NLM (2005)|040625|abcdef", "ENTRY": "Proliferation, Cellular", "MN": "G07.345.249.410.750", "FX": "Hyperplasia", "MH_TH": "NLM (2005)", "ST": "T043", "PI": "Cell Division (1966-2004)", "MS": "All of the processes involved in increasing CELL NUMBER including CELL DIVISION.", "PM": "2005", "HN": "2005", "MR": "20160115", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049109"}, {"RECTYPE": "D", "MH": "Sphingolipid Activator Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "G(M1) Activator Protein|T116|T123|NON|NRW|NLM (2005)|040512|GM ACTIVATOR PROTEIN 01|abbcdefs", "ENTRY": "Hexosaminidase Activating Factor|T116|T123|NON|NRW|NLM (2005)|abbcde", "MN": "D08.211.790", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Glycoproteins (1977-2004)", "MS": "A family of glycoprotein cofactors that are required for the efficient catabolization of SPHINGOLIPIDS by specific acid hydrolases such as GLUCOSYLCERAMIDASE; GALACTOCEREBROSIDASE; BETA-N-ACETYLHEXOSAMINIDASE; and CEREBROSIDE-SULFATASE.", "PM": "2005; SPHINGOLIPID ACTIVATOR PROTEINS was indexed under GLYCOPROTEINS 1977-2004", "HN": "2005(1977)", "MR": "20060705", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049128"}, {"RECTYPE": "D", "MH": "Aminoacylation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Aminoacylations", "MN": "G03.734.050", "MH_TH": "NLM (2005)", "ST": "T044", "AN": "not for activation of enzymes, receptors, cells, etc. by amino acids: index ENZYME ACTIVATION or specific term with /metab", "MS": "A reaction that introduces an aminoacyl group to a molecule. TRANSFER RNA AMINOACYLATION is the first step in GENETIC TRANSLATION.", "PM": "2005", "HN": "2005", "MR": "20160502", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049148"}, {"RECTYPE": "D", "MH": "Pregnancy, Unplanned", "DE": "PREGN UNPLANNED", "AQ": "BL CF DE EH ES GE IM ME PH PX RE UR", "ENTRY": "Unplanned Pregnancies", "MN": "G08.686.784.769.570", "FX": "Pregnancy, Unwanted", "MH_TH": "NLM (1980)", "ST": "T040", "AN": "PREGNANCY, UNWANTED is also available", "PI": "Pregnancy (1966-2004)", "MS": "Unintended or accidental pregnancy, including pregnancy resulting from failed contraceptive measures.", "PM": "2005; see PREGNANCY 1980-2004", "HN": "2005; use PREGNANCY 1980-2004", "MR": "20170414", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049168"}, {"RECTYPE": "D", "MH": "Prenatal Injuries", "DE": "PRENATAL INJ", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Prenatal Injury", "MN": "C12.050.703.824", "MH_TH": "BIOETHICS (1991)", "ST": "T037", "PI": "Prenatal Exposure Delayed Effects (1977-2004)", "MS": "Damages to the EMBRYO, MAMMALIAN or the FETUS before BIRTH. Damages can be caused by any factors including biological, chemical, or physical.", "PM": "2005; see PRENATAL EXPOSURE DELAYED EFFECTS 1991-2004", "HN": "2005; use PRENATAL EXPOSURE DELAYED EFFECTS 1991-2004", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049188"}, {"RECTYPE": "D", "MH": "Healthcare Common Procedure Coding System", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "HCPCS|T170|ACR|EQV|NLM (2005)|040407|abcdef", "MN": "N04.452.515.350", "MH_TH": "NLM (2005)", "ST": "T170", "AN": "CATALOGER: Use NAF entry", "MS": "Uniform method for health care providers and medical suppliers to report professional services, procedures, and supplies. It consists of alphanumeric codes and modifiers for the use of all public and private health insurers. It is developed by the Centers for Medicare and Medicaid Services.", "PM": "2005", "HN": "2005", "MR": "20220712", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049228"}, {"RECTYPE": "D", "MH": "Dendritic Spines", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "ENTRY": "Spines, Dendritic", "MN": "A11.671.240.169", "MH_TH": "NLM (2005)", "ST": "T026", "PI": "Dendrites (1973-2004)", "MS": "Spiny processes on DENDRITES, each of which receives excitatory input from one nerve ending (NERVE ENDINGS). They are commonly found on PURKINJE CELLS and PYRAMIDAL CELLS.", "PM": "2005", "HN": "2005", "MR": "20130709", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049229"}, {"RECTYPE": "D", "MH": "Retinoid X Receptor beta", "DE": "RETINOID X RECEPT BETA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor, RXR beta", "MN": "D12.776.826.701.500.625", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Receptors, Retinoic Acid (1993-2004)", "PM": "2005", "HN": "2005", "MR": "20150623", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049230"}, {"RECTYPE": "D", "MH": "Saposins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Saposin|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "beta Glucosidase Stimulating Protein", "MN": "D08.211.790.500", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Glycoproteins (1977-2004)", "MS": "A group of four homologous sphingolipid activator proteins that are formed from proteolytic cleavage of a common protein precursor molecule referred to as prosaposin.", "PM": "2005; SAPOSIN A was indexed under GLYCOPROTEINS 1989-2004; SAPOSIN B was indexed under GLYCOPROTEINS 1993-2004 & PROTEINS 1981-1992; SAPOSIN D was indexed under GLYCOPROTEINS 1988-2004", "HN": "2005(1977)", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049231"}, {"RECTYPE": "D", "MH": "Decapitation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Decapitations", "MN": "C26.986.224", "MH_TH": "NLM (2005)", "ST": "T037", "MS": "Traumatic or experimentally induced separation of the head from the body in an animal or human.", "PM": "2005", "HN": "2005", "MR": "20100625", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049248"}, {"RECTYPE": "D", "MH": "Exhumation", "AQ": "EC EH ES HI IS LJ MT PX SN ST VE", "ENTRY": "Exhumations", "MN": "I01.198.780.937.422", "FX": "Postmortem Changes", "MH_TH": "NLM (2005)", "ST": "T057", "MS": "Removal of a dead body from the earth after burial.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049249"}, {"RECTYPE": "D", "MH": "Speech Recognition Software", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Voice Recognition Software|T073|T170|NON|EQV|NLM (2005)|040407|abbcdef", "ENTRY": "Software, Voice Recognition", "MN": "L01.224.900.889", "FX": "User-Computer Interface", "MH_TH": "NLM (2005)", "ST": "T170", "MS": "Software capable of recognizing dictation and transcribing the spoken words into written text.", "PM": "2005", "HN": "2005", "MR": "20170703", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049250"}, {"RECTYPE": "D", "MH": "Positron-Emission Tomography", "DE": "POSITRON EMISS TOMOGR", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tomography, Positron-Emission|T060|NON|EQV|IOM (19XX)|790529|TOMOGR POSITRON EMISS|abcdefv", "ENTRY": "Tomography, Positron Emission", "MN": "E01.370.384.730.800.399", "MH_TH": "IOM (1990)", "ST": "T060", "PI": "Tomography, Emission-Computed (1969-2004)", "MS": "An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.", "PM": "2005; see TOMOGRAPHY, EMISSION-COMPUTED 1979-2004", "HN": "2005; use TOMOGRAPHY, EMISSION-COMPUTED 1979-2004", "MR": "20200206", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049268"}, {"RECTYPE": "D", "MH": "Videoconferencing", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Video Conference|T054|NON|REL|NLM (2022)|210329|abcdef", "ENTRY": "Videoconferencings", "MN": "L01.462.500.847.900", "MH_TH": "NLM (2005)", "ST": "T054", "PI": "Telecommunications (1983-2004)", "MS": "Communications via an interactive conference between two or more participants at different sites, using computer networks (COMPUTER COMMUNICATION NETWORKS) or other telecommunication links to transmit audio, video, and data.", "PM": "2005", "HN": "2005", "MR": "20220712", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049269"}, {"RECTYPE": "D", "MH": "Muscular Dystrophies, Limb-Girdle", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "ENTRY": "Muscular Dystrophy, Limb Girdle", "MN": "C16.320.577.280", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Muscular Dystrophies (1966-2004)", "MS": "A heterogenous group of inherited muscular dystrophy that can be autosomal dominant or autosomal recessive. There are many forms (called LGMDs) involving genes encoding muscle membrane proteins such as the sarcoglycan (SARCOGLYCANS) complex that interacts with DYSTROPHIN. The disease is characterized by progressing wasting and weakness of the proximal muscles of arms and legs around the HIPS and SHOULDERS (the pelvic and shoulder girdles).", "PM": "2005; see MUSCULAR DYSTROPHIES 2000-2004", "HN": "2005; use MUSCULAR DYSTROPHIES 2000-2004", "MR": "20130708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049288"}, {"RECTYPE": "D", "MH": "G(M2) Activator Protein", "DS": "GM ACTIVATOR PROTEIN 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Activator Protein, GM2", "MN": "D08.211.790.249", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Proteins (1983-2004)", "MS": "An essential cofactor for the degradation of G(M2)GANGLIOSIDE by lysosomal BETA-N-ACETYLHEXOSAMINIDASES. Genetic mutations resulting in loss of G(M2) activator protein are one of the causes of TAY-SACHS DISEASE, AB VARIANT.", "PM": "2005; G(M2) ACTIVATOR PROTEIN was indexed under PROTEINS 1983-2004", "HN": "2005(1983)", "MR": "20070711", "DA": "20040708", "DC": "1", "DX": "20050101", "UI": "D049289"}, {"RECTYPE": "D", "MH": "Tay-Sachs Disease, AB Variant", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Gangliosidosis GM2, Type AB|T047|NON|EQV|NLM (2000)|991012|GANGLIOSIDOSIS GM 02 TYPE AB|abcdefs", "ENTRY": "Variant GM2-Gangliosidosis, AB", "MN": "C18.452.648.595.554.825.300.300.920", "FX": "G(M2) Activator Protein", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Gangliosidoses (2000-2004)", "MS": "A progressive neurodegenerative disorder that begins with muscle weakness, then progresses to startle reaction, retardation and seizures. It is characterized by the accumulation of G(M2) GANGLIOSIDE in neurons that is caused by a lack of G(M2) ACTIVATOR PROTEIN function. The AB variant designation refers to the increase of both HEXOSAMINIDASE A and HEXOSAMINIDASE B in tissues that lack of G(M2) activator protein.", "PM": "2005; see GANGLIOSIDOSES GM2 2000-2004", "HN": "2005(2000); use GANGLIOSIDOSES GM2 2000-2004", "MR": "20210701", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049290"}, {"RECTYPE": "D", "MH": "Seroma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Seromas", "MN": "C23.550.470.640", "FX": "Exudates and Transudates", "MH_TH": "NLM (2005)", "ST": "T046", "AN": "non neoplastic", "MS": "Tumor-like sterile accumulation of serum in a tissue, organ, or cavity. It results from a tissue insult and is the product of tissue inflammation. It most commonly occurs following MASTECTOMY.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049291"}, {"RECTYPE": "D", "MH": "Leukoaraiosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Leukoaraioses", "MN": "C23.550.522", "MH_TH": "NLM (2005)", "ST": "T046", "MS": "Non-specific white matter changes in the BRAIN, often seen after age 65. Changes include loss of AXONS; MYELIN pallor, GLIOSIS, loss of ependymal cells, and enlarged perivascular spaces. Leukoaraiosis is a risk factor for DEMENTIA and CEREBROVASCULAR DISORDERS.", "PM": "2005", "HN": "2005", "MR": "20050712", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049292"}, {"RECTYPE": "D", "MH": "MedlinePlus", "AQ": "CL EC ES HI LJ MT SN ST TD", "MN": "L01.313.500.750.280.730", "MH_TH": "NLM (2005)", "ST": "T170", "AN": "CATALOGER: Use NAF entry", "PI": "MEDLINE (2000-2004)", "MS": "NATIONAL LIBRARY OF MEDICINE service for health professionals and consumers. It links extensive information from the National Institutes of Health and other reviewed sources of information on specific diseases and conditions.", "PM": "2005", "HN": "2005", "MR": "20150623", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049293"}, {"RECTYPE": "D", "MH": "Phospholipid Transfer Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphatidylinositol Transfer Proteins|T116|T123|NON|NRW|NLM (2005)|040409|abbcdef", "ENTRY": "Transporter, Aminophospholipid", "MN": "D12.776.543.693", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1979-2004)", "MS": "A ubiquitous family of proteins that transport PHOSPHOLIPIDS such as PHOSPHATIDYLINOSITOL and PHOSPHATIDYLCHOLINE between membranes. They play an important role in phospholipid metabolism during vesicular transport and SIGNAL TRANSDUCTION.", "PM": "2005; PHOSPHATIDYLINOSITOL TRANSFER PROTEINS was indexed under CARRIER PROTEINS & MEMBRANE PROTEINS 1979-2004; PHOSPHATIDYLCHOLINE EXCHANGE PROTEIN was indexed CARRIER PROTEINS 1978-2004; PHOSPHOLIPID EXCHANGE PROTEINS was indexed under PHOSPHOLIPID TRANSFER PROTEINS 2005, MEMBRANE PROTEINS & CARRIER PROTEINS 1979-2004", "HN": "2005(1978)", "MR": "20130709", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049294"}, {"RECTYPE": "D", "MH": "Dioxygenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Dioxygenase|T116|T126|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D08.811.682.690.416", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 1.13.11.-", "RR": "EC 1.14.12.-", "PI": "Oxygenases (1968-2004)", "MS": "Non-heme iron-containing enzymes that incorporate two atoms of OXYGEN into the substrate. They are important in biosynthesis of FLAVONOIDS; GIBBERELLINS; and HYOSCYAMINE; and for degradation of AROMATIC HYDROCARBONS.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049308"}, {"RECTYPE": "D", "MH": "Acanthoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Acanthoma, Clear Cell|T191|NON|NRW|NLM (2005)|040409|abcdef", "ENTRY": "Pilar Sheath Acanthomas", "MN": "C04.588.805.040", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with SKIN NEOPLASMS (IM); do not confuse entry term ACANTHOMA, DEGOS with the non-neoplastic DEGOS DISEASE see MALIGNANT ATROPHIC PAPULOSIS", "PI": "Skin Neoplasms (1965-2004)", "MS": "A neoplasm composed of squamous or epidermal cells.", "PM": "2005", "HN": "2005", "MR": "20090706", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049309"}, {"RECTYPE": "D", "MH": "Distal Myopathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "PRINT ENTRY": "Muscular Dystrophy, Distal|T047|NON|EQV|NLM (2005)|040409|abcdef", "ENTRY": "Udd Markesbery Muscular Dystrophy", "MN": "C16.320.577.074", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Muscular Dystrophies (1966-2004)", "MS": "A heterogeneous group of genetic disorders characterized by progressive MUSCULAR ATROPHY and MUSCLE WEAKNESS beginning in the hands, the legs, or the feet. Most are adult-onset autosomal dominant forms. Others are autosomal recessive.", "PM": "2005; see MUSCULAR DYSTROPHIES 2000-2004", "HN": "2005; use MUSCULAR DYSTROPHIES 2000-2004", "MR": "20181010", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049310"}, {"RECTYPE": "D", "MH": "Receptors, Lysophospholipid", "DE": "RECEPT LYSOPHOSPHOLIPID", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Lysophospholipid Receptors|T116|T192|NON|EQV|NLM (2005)|040409|LYSOPHOSPHOLIPID RECEPT|abbcdefv", "MN": "D12.776.543.750.695.420", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "PI": "Receptors, G-Protein-Coupled (2004)", "MS": "A family of G-protein-coupled receptors that bind to specific LYSOPHOSPHOLIPIDS such as lysophosphatidic acid and lysosphinglipids such as sphingosine-1-phosphate. They play an important role in the formation and function of the CARDIOVASCULAR SYSTEM.", "PM": "2005; RECEPTORS, LYSOPHOSPHOLIPID was indexed under RECEPTORS, G-PROTEIN-COUPLED 2004 & under RECEPTORS, CELL SURFACE 1996-2003", "HN": "2005(1996)", "MR": "20160617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049312"}, {"RECTYPE": "D", "MH": "Mongolian Spot", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Spot, Mongolian", "MN": "C04.557.665.560.615.530", "FX": "Nevus, Blue", "MH_TH": "NLM (2005)", "ST": "T191", "AN": "coordinate IM with SKIN NEOPLASMS (IM) + site (IM or NIM) if relevant", "PI": "Nevus, Pigmented (1969-2004)", "MS": "A bluish-gray to gray-brown benign, melanocytic nevus found usually in the LUMBOSACRAL REGION of dark-skinned people, especially those of East Asian ancestry. It is usually congenital or appears shortly after birth, and disappears in childhood.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049328"}, {"RECTYPE": "D", "MH": "Nanostructures", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "PRINT ENTRY": "Nanostructured Materials|T073|NON|EQV|NLM (2007)|060320|abcdef", "ENTRY": "Nanostructured Material", "MN": "J01.637.512", "FX": "Nanotechnology", "MH_TH": "NLM (2005)", "ST": "T073", "PI": "Nanotechnology (2002-2004)", "MS": "Materials which have structured components with at least one dimension in the range of 1 to 100 nanometers. These include NANOCOMPOSITES; NANOPARTICLES; NANOTUBES; and NANOWIRES.", "PM": "2005", "HN": "2005", "MR": "20150331", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049329"}, {"RECTYPE": "D", "MH": "Receptors, Lysosphingolipid", "DE": "RECEPT LYSOSPHINGOLIPID", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Lysosphingolipid Receptors|T116|T192|NON|EQV|NLM (2005)|abbcde", "ENTRY": "Receptor, Lysosphingolipid|T116|T192|NON|EQV|NLM (2005)|abbcde", "MN": "D12.776.543.750.695.420.500", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "PI": "Receptors, G-Protein-Coupled (2004)", "MS": "A subfamily of lysophospholipid receptors with specificity for LYSOSPHINGOLIPIDS such as sphingosine-1-phosphate and sphingosine phosphorylcholine.", "PM": "2005; RECEPTORS, LYSOSPHINGOLIPID was indexed under RECEPTORS, CELL SURFACE 1996-2003 & under RECEPTORS, G-PROTEIN-COUPLED 2004", "HN": "2005(1996)", "MR": "20190617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049349"}, {"RECTYPE": "D", "MH": "Receptors, Lysophosphatidic Acid", "DE": "RECEPT LYSOPHOSPHATIDIC ACID", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Lysophosphatidic Acid Receptors|T116|T192|NON|EQV|NLM (2005)|abbcde", "ENTRY": "vzg 1 Receptor", "MN": "D12.776.543.750.695.420.249", "MH_TH": "NLM (2005)", "ST": "T192", "RN": "0", "PI": "Receptors, G-Protein-Coupled (2004)", "MS": "A subfamily of lysophospholipid receptors with specificity for LYSOPHOSPHATIDIC ACIDS.", "PM": "2005; RECEPTORS, LYSOPHOSPHATIDIC ACID was indexed under RECEPTORS, CELL SURFACE 1992-2003 & under RECEPTORS, G-PROTEIN-COUPLED 2004", "HN": "2005(1992)", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049368"}, {"RECTYPE": "D", "MH": "Polyanhydrides", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "MN": "D05.750.725", "MH_TH": "NLM (2005)", "ST": "T104", "RN": "0", "PI": "Polymers (1983-2004)", "MS": "Anhydride polymers with a repeating structure of RC(=O)OC(=O)R. They readily hydrolyze in water making them useful for DELAYED-ACTION PREPARATIONS.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049388"}, {"RECTYPE": "D", "MH": "Luminescent Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Agents, Phosphorescent", "MN": "D27.720.470.410.505", "FX": "Fluorescent Dyes", "MH_TH": "NLM (2005)", "ST": "T130", "RN": "0", "PI": "Luminescent Measurements (1964-2004)", "MS": "Compound such as LUMINESCENT PROTEINS that cause or emit light (PHYSICAL LUMINESCENCE).", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049408"}, {"RECTYPE": "D", "MH": "Luciferases, Firefly", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Firefly Luciferase|T116|T126|T130|NON|EQV|NLM (2021)|200129|abbbcdef", "ENTRY": "Luciferase, Firefly", "MN": "D12.776.532.510.500", "PA": "Luminescent Agents", "MH_TH": "NLM (2005)", "ST": "T130", "RN": "EC 1.13.12.7", "PI": "Luciferases (1965-2004)", "MS": "Luciferases from FIREFLIES, usually Photinus, that oxidizes FIREFLY LUCIFERIN to cause emission of PHOTONS.", "PM": "2005", "HN": "2005", "MR": "20200527", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049409"}, {"RECTYPE": "D", "MH": "Luciferases, Renilla", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Renilla Luciferase|T116|T126|T130|NON|EQV|NLM (2022)|201023|abbbcdef", "ENTRY": "Sea Pansy Luciferases", "MN": "D12.776.532.510.750", "PA": "Luminescent Agents", "MH_TH": "NLM (2005)", "ST": "T130", "RN": "EC 1.13.12.5", "PI": "Luciferases (1966-2004)", "MS": "Luciferases from RENILLA that oxidizes certain LUMINESCENT AGENTS to cause emission of PHOTONS.", "PM": "2005", "HN": "2005", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049410"}, {"RECTYPE": "D", "MH": "Utrophin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dystrophin Related Protein 1", "MN": "D12.776.543.985", "FX": "Dystrophin-Associated Protein Complex", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1991-2004)", "MS": "An autosomally-encoded 376-kDa cytoskeletal protein that is similar in structure and function to DYSTROPHIN. It is a ubiquitously-expressed protein that plays a role in anchoring the CYTOSKELETON to the PLASMA MEMBRANE.", "PM": "2005; UTROPHIN was indexed under CYTOSKELETAL PROTEINS & MEMBRANE PROTEINS 1991-2004", "HN": "2005(1991)", "MR": "20040803", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049411"}, {"RECTYPE": "D", "MH": "Blood-Nerve Barrier", "AQ": "AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE UL VI", "ENTRY": "Blood-Nerve Barriers", "MN": "A08.800.800.090", "FX": "Capillary Permeability", "MH_TH": "NLM (2005)", "ST": "T030", "PI": "Endothelium, Vascular (1970-2004)", "MS": "The barrier between the perineurium of PERIPHERAL NERVES and the endothelium (ENDOTHELIUM, VASCULAR) of endoneurial CAPILLARIES. The perineurium acts as a diffusion barrier, but ion permeability at the blood-nerve barrier is still higher than at the BLOOD-BRAIN BARRIER.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049428"}, {"RECTYPE": "D", "MH": "Forensic Pathology", "DE": "FORENSIC PATHOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Pathology, Forensic|T091|NON|EQV|NLM (2005)|040414|PATHOL FORENSIC|abcdefv", "MN": "I01.198.780.937.460", "MH_TH": "NLM (2005)", "ST": "T091", "AN": "specialty; may also be used for forensic aspects in pathology", "PI": "Forensic Medicine (1966-2004)", "MS": "The application of pathology to questions of law.", "PM": "2005", "HN": "2005", "MR": "20090706", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049429"}, {"RECTYPE": "D", "MH": "Cholangiopancreatography, Magnetic Resonance", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Magnetic Resonance Cholangiopancreatography|T060|NON|EQV|NLM (2005)|040415|abcdef", "ENTRY": "Magnetic Resonance Cholangiopancreatographies", "MN": "E01.370.372.207", "MH_TH": "NLM (2005)", "ST": "T060", "PI": "Magnetic Resonance Imaging (1995-2004)", "MS": "Non-invasive diagnostic technique for visualizing the PANCREATIC DUCTS and BILE DUCTS without the use of injected CONTRAST MEDIA or x-ray. MRI scans provide excellent sensitivity for duct dilatation, biliary stricture, and intraductal abnormalities.", "PM": "2005", "HN": "2005", "MR": "20070709", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049448"}, {"RECTYPE": "D", "MH": "Luminescence", "AQ": "AE", "PRINT ENTRY": "Luminescence, Physical|T070|NON|EQV|NLM (2005)|040415|abcdef", "ENTRY": "Physical Luminescence", "MN": "G01.750.770.578.665", "MH_TH": "NLM (2006)", "ST": "T070", "PI": "Luminescent Measurements (1964-2004)", "MS": "Emission of LIGHT when ELECTRONS return to the electronic ground state from an excited state and lose the energy as PHOTONS. It is sometimes called cool light in contrast to INCANDESCENCE. LUMINESCENT MEASUREMENTS take advantage of this type of light emitted from LUMINESCENT AGENTS.", "PM": "2006; see LUMINESCENCE, PHYSICAL 2005-2006; for CHEMILUMENCENCE see CHEMILUMINESCENCE, PHYSICAL 2005-2006", "HN": "2006", "MR": "20150331", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049449"}, {"RECTYPE": "D", "MH": "Incandescence", "AQ": "AE", "MN": "G01.750.770.578.440", "MH_TH": "NLM (2005)", "ST": "T070", "MS": "Emission of LIGHT by a substance as its temperature is raised. It is sometimes called hot light in contrast to LUMINESCENCE.", "PM": "2005", "HN": "2005", "MR": "20150331", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049450"}, {"RECTYPE": "D", "MH": "Nomograms", "ENTRY": "Tables, Partin", "MN": "N06.850.520.830.500.625", "FX": "Neoplasm Staging", "MH_TH": "NLM (2005)", "ST": "T170", "MS": "Graphical representation of a statistical model containing scales for calculating the prognostic weight of a value for each individual variable. Nomograms are instruments that can be used to predict outcomes using specific clinical parameters. They use ALGORITHMS that incorporate several variables to calculate the predicted probability that a patient will achieve a particular clinical endpoint.", "PM": "2005", "HN": "2005", "MR": "20110624", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049451"}, {"RECTYPE": "D", "MH": "Green Fluorescent Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Green-Fluorescent Protein|T116|T130|NON|EQV|NLM (2021)|191126|abbcdef", "ENTRY": "Proteins, Green-Fluorescent", "MN": "D12.776.532.265", "PA": "Luminescent Agents", "MH_TH": "NLM (2005)", "ST": "T130", "RN": "147336-22-9", "PI": "Luminescent Proteins (1992-2004)", "MS": "Protein analogs and derivatives of the Aequorea victoria green fluorescent protein that emit light (FLUORESCENCE) when excited with ULTRAVIOLET RAYS. They are used in REPORTER GENES in doing GENETIC TECHNIQUES. Numerous mutants have been made to emit other colors or be sensitive to pH.", "PM": "2005; GREEN FLUORESCENT PROTEIN (now GREEN FLUORESCENT PROTEINS) was indexed under LUMINESCENT PROTEINS 1992-2004", "HN": "2005(1992)", "MR": "20200527", "DA": "20040708", "DC": "1", "DX": "20050101", "UI": "D049452"}, {"RECTYPE": "D", "MH": "Luciferases, Bacterial", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Bacterial Luciferase|T116|T126|T130|NON|EQV|NLM (2022)|200817|abbbcdef", "ENTRY": "Vibrio Luciferases", "MN": "D12.776.532.510.249", "PA": "Luminescent Agents", "MH_TH": "NLM (2005)", "ST": "T130", "RN": "EC 1.14.14.3", "RR": "EC 1.14.14.3", "PI": "Luciferases (1967-2004)", "MS": "Luciferases from BACTERIA such as PHOTOBACTERIUM; VIBRIO; and PHOTORHABDUS.", "PM": "2005", "HN": "2005", "MR": "20210630", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049453"}, {"RECTYPE": "D", "MH": "Firefly Luciferin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "(S)-4,5-Dihydro-2-(6-hydroxybenzothiazol-2-yl)thiazole-4-carboxylic acid|T109|NON|EQV|NLM (2022)|210628|abcdef", "MN": "D03.383.129.708.298", "PA": "Luminescent Agents", "MH_TH": "NLM (2005)", "ST": "T109", "RN": "5TBB02N29K", "RR": "2591-17-5 (Firefly Luciferin)", "MS": "A benzothaizole which is oxidized by LUCIFERASES, FIREFLY to cause emission of light (LUMINESCENCE).", "PM": "2005", "HN": "2005", "MR": "20210628", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049454"}, {"RECTYPE": "D", "MH": "Prometaphase", "AQ": "DE GE IM PH RE", "ENTRY": "Prometaphases", "MN": "G05.113.220.781.812", "MH_TH": "NLM (2005)", "ST": "T043", "PI": "Metaphase (1978-2004)", "MS": "The phase of cell nucleus division following PROPHASE, when the breakdown of the NUCLEAR ENVELOPE occurs and the MITOTIC SPINDLE APPARATUS enters the nuclear region and attaches to the KINETOCHORES.", "PM": "2005", "HN": "2005", "MR": "20160617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049468"}, {"RECTYPE": "D", "MH": "Meiotic Prophase I", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Zygotene Stage|T043|NON|NRW|NLM (2005)|040416|abcdef", "ENTRY": "Zygotene Stages", "MN": "G05.113.220.687.500", "MH_TH": "NLM (2005)", "ST": "T043", "PI": "Prophase (1978-2004)", "MS": "The prophase of the first division of MEIOSIS (in which homologous CHROMOSOME SEGREGATION occurs). It is divided into five stages: leptonema, zygonema, PACHYNEMA, diplonema, and diakinesis.", "PM": "2005", "HN": "2005", "MR": "20160617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049469"}, {"RECTYPE": "D", "MH": "Pachytene Stage", "AQ": "DE GE IM PH RE", "ENTRY": "Stages, Pachytene", "MN": "G05.113.220.781.906.750", "FX": "Crossing Over, Genetic", "MH_TH": "NLM (2005)", "ST": "T043", "MS": "The stage in the first meiotic prophase, following ZYGOTENE STAGE, when CROSSING OVER between homologous CHROMOSOMES begins.", "PM": "2005", "HN": "2005", "MR": "20160617", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049471"}, {"RECTYPE": "D", "MH": "Phosphatidylethanolamine Binding Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Raf Kinase Inhibitor Protein|T116|T123|ACX|EQV|NLM (2005)|abbcde", "MN": "D12.776.476.555", "PA": "Protein Kinase Inhibitors", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (2000-2004)", "MS": "A ubiquitously found basic protein that binds to phosphatidylethanolamine and NUCLEOTIDES. It is an endogenous inhibitor of RAF KINASES and may play a role in regulating SIGNAL TRANSDUCTION. Phosphatidylethanolamine-binding protein is the precursor of hippocampal cholinergic neurostimulating peptide, which is cleaved from the N-terminal region of the protein.", "PM": "2005; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN was indexed under CARRIER PROTEINS 2000-2004", "HN": "2005(2000)", "MR": "20151124", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049488"}, {"RECTYPE": "D", "MH": "Stroboscopy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E01.370.350.755", "MH_TH": "NLM (2005)", "ST": "T060", "MS": "The observation of successive phases of MOVEMENT by use of a flashing light.", "PM": "2005", "HN": "2005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049489"}, {"RECTYPE": "D", "MH": "Systems Biology", "DE": "SYSTEMS BIOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Biology, Systems", "MN": "H01.158.273.180.800", "FX": "Systems Theory", "MH_TH": "NLM (2005)", "ST": "T091", "MS": "Comprehensive, methodical analysis of complex biological systems by monitoring responses to perturbations of biological processes. Large scale, computerized collection and analysis of the data are used to develop and test models of biological systems.", "PM": "2005", "HN": "2005", "MR": "20080708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049490"}, {"RECTYPE": "D", "MH": "Insulin, Long-Acting", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Semilente Insulin", "MN": "D12.644.548.586.200.300", "PA": "Hypoglycemic Agents", "EC": "antagonists & inhibitors:Insulin Antagonists", "MH_TH": "NLM (2005)", "ST": "T121", "RN": "0", "PI": "Insulin (1977-2004)", "MS": "Insulin formulations that contain substances that retard absorption thus extending the time period of action.", "PM": "2005", "HN": "2005", "MR": "20110624", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049528"}, {"RECTYPE": "D", "MH": "Postpartum Period", "AQ": "BL CF DE EH ES GE IM ME PH PX RE UR", "PRINT ENTRY": "Puerperium|T079|NON|NRW|NLM (1963)|990101|abcdef", "ENTRY": "Women, Postpartum", "MN": "G08.686.702", "MH_TH": "UNK (19XX)", "ST": "T079", "PI": "Puerperium (1965-2004)", "MS": "In females, the period that is shortly after giving birth (PARTURITION).", "PM": "2005; see PUERPERIUM 1980-2004", "HN": "2005", "MR": "20080708", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049590"}, {"RECTYPE": "D", "MH": "Body Size", "AQ": "DE EH GE IM PH RE", "ENTRY": "Sizes, Body", "MN": "G07.345.249.314", "MH_TH": "UNK (19XX)", "ST": "T081", "MS": "The physical measurements of a body.", "PM": "2005; see BODY CONSTITUTION 1984-2004", "HN": "2005; use BODY CONSTITUTION 1984-2004", "MR": "20160115", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049628"}, {"RECTYPE": "D", "MH": "Waist-Hip Ratio", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Waist-to-Hip Ratios", "MN": "G07.100.100.960", "FX": "Body Fat Distribution", "MH_TH": "NLM (1994)", "ST": "T081", "MS": "The waist circumference measurement divided by the hip circumference measurement. For both men and women, a waist-to-hip ratio (WHR) of 1.0 or higher is considered \"at risk\" for undesirable health consequences, such as heart disease and ailments associated with OVERWEIGHT. A healthy WHR is 0.90 or less for men, and 0.80 or less for women. (National Center for Chronic Disease Prevention and Health Promotion, 2004)", "PM": "2005; see BODY CONSTITUTION 1994-2004", "HN": "2005; use BODY CONSTITUTION 1994-2004", "MR": "20090706", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049629"}, {"RECTYPE": "D", "MH": "Esophageal Sphincter, Lower", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Lower Esophageal Sphincter|T023|NON|EQV|NLM (2005)|040601|abcdef", "ENTRY": "Sphincter, Lower Esophageal", "MN": "A03.556.875.875.330.350", "FX": "Gastroesophageal Reflux", "MH_TH": "NLM (2005)", "ST": "T023", "AN": "diseases: coordinate IM with ESOPHAGEAL DISEASES (IM) or specific esophageal disease (IM); neoplasms: coordinate IM with STOMACH NEOPLASMS (IM) or ESOPHAGEAL NEOPLASMS (IM) depending on text", "PI": "Esophagogastric Junction (1966-2004)", "MS": "The physiologic or functional barrier to GASTROESOPHAGEAL REFLUX at the esophagogastric junction. Sphincteric muscles remain tonically contracted during the resting state and form the high-pressure zone separating the lumen of the ESOPHAGUS from that of the STOMACH. (Haubrich et al, Bockus Gastroenterology, 5th ed., pp399, 415)", "PM": "2005", "HN": "2005", "MR": "20181005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049630"}, {"RECTYPE": "D", "MH": "Esophageal Sphincter, Upper", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Upper Esophageal Sphincter|T023|NON|EQV|NLM (2005)|040601|abcdef", "ENTRY": "Sphincter, Upper Esophageal", "MN": "A14.724.617.360", "FX": "Laryngopharyngeal Reflux", "MH_TH": "NLM (2005)", "ST": "T023", "AN": "diseases: coordinate IM with ESOPHAGEAL DISEASES (IM) or specific esophageal disease (IM); neoplasms: coordinate IM with ESOPHAGEAL NEOPLASMS (IM)", "PI": "Esophagus (1966-2004)", "MS": "The structure at the pharyngoesophageal junction consisting chiefly of the cricopharyngeus muscle. It normally occludes the lumen of the ESOPHAGUS, except during SWALLOWING.", "PM": "2005; for CRICOPHARYNGEUS and INFERIOR CONSTRICTOR OF PHARYX see PHARYNGEAL MUSCLES 2005-2019", "HN": "2005; for CRICOPHARYNGEUS and INFERIOR CONSTRICTOR OF PHARYX use PHARYNGEAL MUSCLES 2005-2019", "MR": "20181005", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049631"}, {"RECTYPE": "D", "MH": "Timor-Leste", "AQ": "EH EP", "PRINT ENTRY": "East Timor|T083|NAM|EQV|NLM (2005)|040616|abcdef", "ENTRY": "Democratic Republic of Timor-Leste|T083|NAM|EQV|NLM (2016)|040616|abcdef", "MN": "Z01.252.145.900", "MH_TH": "NLM (2016)", "ST": "T083", "PI": "Indonesia (1976-2004)", "MS": "A country in Southeastern Asia, at the eastern end of the Indonesian archipelago. It includes the eastern half of the island of Timor, the Oecussi (Ambeno) region on the northwest portion of the island of Timor, and the islands of Pulau Atauro and Pulau Jaco. On May 20, 2002, TIMOR-LESTE was internationally recognized as an independent state, following its declared independence from Portugal on November 20, 1975 and a period of armed conflict with Indonesia.", "HN": "2005", "MR": "20180629", "DA": "20040707", "DC": "4", "DX": "20050101", "UI": "D049648"}, {"RECTYPE": "D", "MH": "History, 15th Century", "PRINT ENTRY": "15th Century History|T078|NON|EQV|NLM (2005)|040624|FIFTEENTH CENTURY HISTORY|abcdefs", "ENTRY": "History, 15th Cent. (Medicine)", "MN": "K01.400.475.500", "MH_TH": "NLM (2005)", "ST": "T078", "AN": "IM general only; NIM as check tag", "MS": "Time period from 1401 through 1500 of the common era.", "PM": "2005; see HISTORY OF MEDICINE, 15TH CENT. 1995-2004; for HISTORY OF MEDICINE 15 CENT. see HISTORY OF MEDICINE 15TH CENT. 1964-2004, see HISTORY OF MEDICINE, XV CENT. 1963", "HN": "2005", "MR": "20060705", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049668"}, {"RECTYPE": "D", "MH": "History, 16th Century", "PRINT ENTRY": "16th Century History|T078|NON|EQV|NLM (2005)|040625|SIXTEENTH CENTURY HISTORY|abcdefs", "ENTRY": "Sixteenth Century History", "MN": "K01.400.475.750", "MH_TH": "NLM (2005)", "ST": "T078", "AN": "IM general only; NIM as check tag", "MS": "Time period from 1501 through 1600 of the common era.", "PM": "2005; see HISTORY OF MEDICINE, 16TH CENT. 1995-2004; for HISTORY OF MEDICINE 16 CENT. see HISTORY OF MEDICINE 16TH CENT. 1964-2004, see HISTORY OF MEDICINE, XVI CENT. 1963", "HN": "2005", "MR": "20130709", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049669"}, {"RECTYPE": "D", "MH": "History, 17th Century", "PRINT ENTRY": "17th Century History|T078|NON|EQV|NLM (2005)|040622|SEVENTEENTH CENTURY HISTORY|abcdefs", "ENTRY": "Seventeenth Century History", "MN": "K01.400.504.750", "MH_TH": "NLM (2005)", "ST": "T078", "AN": "IM general only; NIM as check tag", "MS": "Time period from 1601 through 1700 of the common era.", "PM": "2005; see HISTORY OF MEDICINE, 17TH CENT. 1995-2004; for HISTORY OF MEDICINE 17 CENT. see HISTORY OF MEDICINE 17TH CENT. 1964-2004, see HISTORY OF MEDICINE, XVII CENT. 1963", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049670"}, {"RECTYPE": "D", "MH": "History, 18th Century", "PRINT ENTRY": "18th Century History|T078|NON|EQV|NLM (2005)|040625|EIGHTEENTH CENTURY HISTORY|abcdefs", "ENTRY": "History, 18th Cent. (Medicine)", "MN": "K01.400.504.875", "MH_TH": "NLM (2005)", "ST": "T078", "AN": "IM general only; NIM as check tag", "MS": "Time period from 1701 through 1800 of the common era.", "PM": "2005; see HISTORY OF MEDICINE, 18TH CENT. 1995-2004; for HISTORY OF MEDICINE 18 CENT. see HISTORY OF MEDICINE 18TH CENT. 1964-2004, see HISTORY OF MEDICINE, XVIII CENT. 1963", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049671"}, {"RECTYPE": "D", "MH": "History, 19th Century", "PRINT ENTRY": "19th Century History|T078|NON|EQV|NLM (2005)|040625|NINETEENTH CENTURY HISTORY|abcdefs", "ENTRY": "Nineteenth Century History", "MN": "K01.400.504.937", "MH_TH": "NLM (2005)", "ST": "T078", "AN": "IM general only; NIM as check tag", "MS": "Time period from 1801 through 1900 of the common era.", "PM": "2005; see HISTORY OF MEDICINE, 19TH CENT. 1995-2004; for HISTORY OF MEDICINE 19 CENT. see HISTORY OF MEDICINE 19TH CENT. 1964-2004, see HISTORY OF MEDICINE, XIX CENT. 1963", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049672"}, {"RECTYPE": "D", "MH": "History, 20th Century", "PRINT ENTRY": "20th Century History|T078|NON|EQV|NLM (2005)|040625|TWENTIETH CENTURY HISTORY|abcdefs", "ENTRY": "Twentieth Century History", "MN": "K01.400.504.968", "MH_TH": "NLM (2005)", "ST": "T078", "AN": "IM general only; NIM as check tag", "MS": "Time period from 1901 through 2000 of the common era.", "PM": "2005; see HISTORY OF MEDICINE, 20TH CENT. 1995-2004; for HISTORY OF MEDICINE 20 CENT. see HISTORY OF MEDICINE 20TH CENT. 1964-2004, see HISTORY OF MEDICINE, XX CENT. 1963", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049673"}, {"RECTYPE": "D", "MH": "History, 21st Century", "PRINT ENTRY": "21st Century History|T078|NON|EQV|NLM (2005)|040628|TWENTY FIRST CENTURY HISTORY|abcdefs", "ENTRY": "Twenty-first Century History", "MN": "K01.400.504.984", "MH_TH": "NLM (2005)", "ST": "T078", "AN": "IM general only; NIM as check tag", "MS": "Time period from 2001 through 2100 of the common era.", "PM": "2005; for HISTORY OF MEDICINE, 21ST CENT. see HISTORY OF MEDICINE, 21ST CENT. 2001-2004", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049674"}, {"RECTYPE": "D", "MH": "History, Ancient", "DE": "HIST ANCIENT", "PRINT ENTRY": "Ancient History|T079|NON|EQV|BIOETHICS (1976)|940111|ANCIENT HIST|abcdefv", "ENTRY": "Medicines, Ancient History", "MN": "K01.400.470", "MH_TH": "UNK (19XX)", "ST": "T079", "AN": "before 500 AD; IM general only; NIM as check tag; note ANCIENT LANDS in Category Z", "PI": "History of Medicine, Ancient (1966-2004)", "MS": "The period of history before 500 of the common era.", "PM": "2005; see HISTORY OF MEDICINE, ANCIENT 1966-2004", "HN": "2005", "MR": "20060705", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049690"}, {"RECTYPE": "D", "MH": "History, Medieval", "DE": "HIST MEDIEVAL", "PRINT ENTRY": "Medieval History|T079|NON|EQV|NLM (1995)|940111|MEDIEVAL HIST|abcdefv", "ENTRY": "Medieval History Medicine", "MN": "K01.400.500", "MH_TH": "NLM (1995)", "ST": "T079", "AN": "IM general only; NIM as check tag", "MS": "The period of history from the year 500 through 1450 of the common era.", "PM": "2005; see HISTORY OF MEDICINE, MEDIEVAL 1995-2004; for HISTORY OF MEDICINE, MEDIEVAL see HISTORY OF MEDICINE, MEDIEVAL 1966-2004", "HN": "2005", "MR": "20060705", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049691"}, {"RECTYPE": "D", "MH": "History, Early Modern 1451-1600", "PRINT ENTRY": "Early Modern History|T079|NON|EQV|NLM (1995)|940111|EARLY MODERN|abcdefv", "ENTRY": "Modern Medicine, Early", "MN": "K01.400.475", "MH_TH": "NLM (2005)", "ST": "T079", "AN": "INDEXER: Do not use", "MS": "The period of history from 1451 through 1600 of the common era.", "PM": "2005; for HISTORY OF MEDICINE, EARLY MODERN see HISTORY OF MEDICINE, EARLY MODERN 1995-2004", "HN": "2005", "MR": "20150605", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049692"}, {"RECTYPE": "D", "MH": "History, Modern 1601-", "PRINT ENTRY": "Modern History|T079|NON|EQV|NLM (1995)|940121|MODERN HIST|abcdefv", "ENTRY": "Modern 1601- History", "MN": "K01.400.504", "MH_TH": "NLM (2005)", "ST": "T079", "AN": "INDEXER: Do not use", "MS": "The period of history from 1601 of the common era to the present.", "PM": "2005; see HISTORY OF MEDICINE, MODERN 1966-2004; for MEDICINE, MODERN & MODERN HISTORY see HISTORY OF MEDICINE, MODERN 1995-2004", "HN": "2005", "MR": "20150629", "DA": "20040707", "DC": "1", "DX": "20050101", "UI": "D049711"}, {"RECTYPE": "D", "MH": "Genome, Insect", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Insect Genome|T028|NON|EQV|NLM (2006)|040726|abcdef", "ENTRY": "Insect Genomes", "MN": "G05.360.340.357", "FX": "Genes, Insect", "MH_TH": "NLM (2006)", "ST": "T028", "AN": "coordinate IM with specific insect/genet(IM)", "MS": "The genetic complement of an insect (INSECTS) as represented in its DNA.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049750"}, {"RECTYPE": "D", "MH": "Genome, Helminth", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Helminth Genome|T028|NON|EQV|NLM (2006)|040726|abcdef", "ENTRY": "Helminth Genomes", "MN": "G05.360.340.337", "FX": "Genes, Helminth", "MH_TH": "NLM (2006)", "ST": "T028", "AN": "coordinate IM with specific helminth/genet(IM)", "MS": "The genetic complement of a helminth (HELMINTHS) as represented in its DNA.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049751"}, {"RECTYPE": "D", "MH": "Genes, Mating Type, Fungal", "AQ": "DE ES GE IM PH RE", "ENTRY": "Types, Fungal Mating", "MN": "G05.360.340.358.365.500.089", "MH_TH": "NLM (2006)", "ST": "T028", "PI": "Genes, Fungal (1981-2005)", "MS": "Fungal genes that mostly encode TRANSCRIPTION FACTORS. In some FUNGI they also encode PHEROMONES and PHEROMONE RECEPTORS. The transcription factors control expression of specific proteins that give a cell its mating identity. Opposite mating type identities are required for mating.", "PM": "2006", "HN": "2006", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049770"}, {"RECTYPE": "D", "MH": "Nuclear Export Signals", "AQ": "DE ES GE PH RE", "ENTRY": "Signals, Nuclear Export", "MN": "G02.111.570.060.670.600", "FX": "Active Transport, Cell Nucleus", "MH_TH": "NLM (2006)", "ST": "T087", "RN": "0", "PI": "Protein Sorting Signals (1994-2005)", "MS": "Specific amino acid sequences present in the primary amino acid sequence of proteins which mediate their export from the CELL NUCLEUS. They are rich in hydrophobic residues, such as LEUCINE and ISOLEUCINE.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049790"}, {"RECTYPE": "D", "MH": "Genetic Speciation", "PRINT ENTRY": "Speciation, Genetics|T070|NON|EQV|NLM (2006)|040804|abcdef", "ENTRY": "Speciation, Genetic", "MN": "G16.075.350", "MH_TH": "NLM (2006)", "ST": "T070", "MS": "The splitting of an ancestral species into daughter species that coexist in time (King, Dictionary of Genetics, 6th ed). Causal factors may include geographic isolation, HABITAT geometry, migration, REPRODUCTIVE ISOLATION, random GENETIC DRIFT and MUTATION.", "PM": "2006", "HN": "2006", "MR": "20160623", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049810"}, {"RECTYPE": "D", "MH": "Anelloviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Anellovirus|T005|NON|EQV|NLM (2006)|040804|abcdef", "ENTRY": "Anelloviruses", "MN": "B04.970.270", "MH_TH": "NLM (2016)", "ST": "T005", "RN": "txid687329", "PI": "Anellovirus (2006-2015)", "MS": "A family of non-enveloped, vertebrate, single-stranded DNA Viruses.", "PM": "2006; ANELLOVIRIDAE was indexed as ANELLOVIRUS 2006-2015", "HN": "2006; use ANELLOVIRUS (NM) 2006-2015", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049811"}, {"RECTYPE": "D", "MH": "Cephalopoda", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Cephalopodas", "MN": "B01.050.500.644.116", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6605", "PI": "Mollusca (1965-2005)", "MS": "A class in the phylum MOLLUSCA comprised of SQUID; CUTTLEFISH; OCTOPUS; and NAUTILUS. These marine animals are the most highly organized of all the mollusks.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049830"}, {"RECTYPE": "D", "MH": "Octopodiformes", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Octopus|T204|NON|NRW|NLM (1973)|990101|abcdef", "ENTRY": "Octopuse", "MN": "B01.050.500.644.116.600", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid215451", "RR": "txid6638", "AN": "OCTOPUS as animal and food", "PI": "Octopus (1972-2005)", "MS": "A superorder in the class CEPHALOPODA, consisting of the orders Octopoda (octopus) with over 200 species and Vampyromorpha with a single species. The latter is a phylogenetic relic but holds the key to the origins of Octopoda.", "PM": "2006; for OCTOPODA see OCTOPUS 1973-2005", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049831"}, {"RECTYPE": "D", "MH": "Decapodiformes", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Todarodes|T204|NON|NRW|NLM (2006)|040806|abcdef", "ENTRY": "Todarode", "MN": "B01.050.500.644.116.150", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid215450", "RR": "txid6636", "AN": "SQUID as animal & food; squid giant axon: coordinate NIM with AXONS (IM)", "MS": "A superorder of CEPHALOPODS comprised of squid, cuttlefish, and their relatives. Their distinguishing feature is the modification of their fourth pair of arms into tentacles, resulting in 10 limbs.", "PM": "2006; for CUTTLEFISH see MOLLUSCA 1995-2005; for SQUID see SQUID 1973-2005;", "HN": "2006; for CUTTLEFISH use MOLLUSCA 1995-2005", "MR": "20200902", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049832"}, {"RECTYPE": "D", "MH": "Sepia", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Sepias", "MN": "B01.050.500.644.116.150.700", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6609", "PI": "Mollusca (1965-2005)", "MS": "A genus of cuttlefish in the family Sepiidae. They live in tropical, subtropical and temperate waters in most oceans.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049833"}, {"RECTYPE": "D", "MH": "Loligo", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Loligos", "MN": "B01.050.500.644.116.150.500", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6616", "PI": "Squid (1972-2005)", "MS": "A genus of SQUID in the family Loliginidae, superorder DECAPODIFORMES, with a spindle-shaped body. They are well-studied, common inshore squids of the Atlantic and eastern Pacific Oceans, but their various species are taxonomically unresolved.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049834"}, {"RECTYPE": "D", "MH": "Nautilus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.644.116.550", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid34572", "PI": "Mollusca (1967-2005)", "MS": "The sole genus in the family Nautilidae, order Nautilida, comprised of CEPHALOPODS with spiral external shells that are separated into chambers.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049850"}, {"RECTYPE": "D", "MH": "Gastropoda", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Slugs|T204|NON|NRW|NLM (2006)|040809|abcdef", "ENTRY": "Slug", "MN": "B01.050.500.644.400", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6448", "PI": "Mollusca (1965-2005)", "MS": "A class in the phylum MOLLUSCA comprised of SNAILS and slugs. The former have coiled external shells and the latter usually lack shells.", "PM": "2006", "HN": "2006", "MR": "20200902", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049851"}, {"RECTYPE": "D", "MH": "Clione", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "limacina, Clione", "MN": "B01.050.500.644.400.150", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid71515", "RR": "txid71516", "PI": "Mollusca (1972-2005)", "MS": "A genus of small, shell-less, marine mollusks in the family Clione, superorder GASTROPODA. These pteropod (possessing a foot developed into wing-like organ for swimming) sea slugs feed exclusively on another pteropod mollusk, Limacina.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049852"}, {"RECTYPE": "D", "MH": "Pleurobranchaea", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Pleurobranchaeas", "MN": "B01.050.500.644.400.600", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid252551", "PI": "Mollusca (1972-2005)", "MS": "A genus of side-gilled sea slugs in the family Pleurobranchidae, superorder GASTROPODA. They are opportunistic voracious feeders but prefer the sea anemone.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049853"}, {"RECTYPE": "D", "MH": "Hermissenda", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "crassicorni, Hermissenda", "MN": "B01.050.500.644.400.400", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid205592", "RR": "txid205593", "PI": "Mollusca (1967-2005)", "MS": "A genus of marine sea slugs in the family Glaucidae, superorder GASTROPODA, found on the Pacific coast of North America. They are used in behavioral and neurological laboratory studies.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049870"}, {"RECTYPE": "D", "MH": "Tritonia Sea Slug", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Tritonia Sea Slugs", "MN": "B01.050.500.644.400.800", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid797240", "PI": "Mollusca (1965-2005)", "MS": "A genus of large marine sea slugs in the family Tritoniidae found in the northern Pacific Ocean. They are used in neurological research.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049871"}, {"RECTYPE": "D", "MH": "Bivalvia", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Mussels|T204|NON|NRW|NLM (1972)|990101|abcdef", "ENTRY": "Mussel", "MN": "B01.050.500.644.080", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6544", "AN": "as animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)", "PI": "Mollusca (1968-2005)", "MS": "A class in the phylum MOLLUSCA comprised of mussels; clams; OYSTERS; COCKLES; and SCALLOPS. They are characterized by a bilaterally symmetrical hinged shell and a muscular foot used for burrowing and anchoring.", "PM": "2006; for MUSSELS see MUSSELS 1972-2005; for CLAMS see CLAMS 1972-2005", "HN": "2006", "MR": "20200902", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049872"}, {"RECTYPE": "D", "MH": "Cardiidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Cockles|T204|NON|EQV|NLM (2006)|040811|abcdef", "ENTRY": "Cockle", "MN": "B01.050.500.644.080.150", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid55708", "RR": "txid55709", "MS": "A family of bivalve MOLLUSKS with heart-shaped shells, commonly known as cockles. Unlike most BIVALVES, cockles are hermaphroditic.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049873"}, {"RECTYPE": "D", "MH": "Corbicula", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Corbiculas", "MN": "B01.050.500.644.080.175", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid45948", "PI": "Mollusca (1966-2005)", "MS": "A genus of freshwater clams, in the family Corbiculidae, class BIVALVIA. It originated in Asia but was introduced in North America and is now found throughout the United States.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049874"}, {"RECTYPE": "D", "MH": "Dreissena", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Mussels, Zebra|T204|NON|NRW|NLM (2006)|040812|abcdef", "ENTRY": "polymorphas, Dreissena", "MN": "B01.050.500.644.080.225", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid45951", "RR": "txid45954", "PI": "Mollusca (1966-2005)", "MS": "A genus of mussels in the family Dreissenidae, class BIVALVIA. They are found in both fresh and brackish water and are not native to North America. Accidentally introduced into the Great Lakes in 1986, they now proliferate widely throughout the United States.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049875"}, {"RECTYPE": "D", "MH": "Unionidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Mussels, Native|T204|NON|EQV|NLM (2006)|040812|abcdef", "ENTRY": "Unionid", "MN": "B01.050.500.644.080.850", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid47526", "AN": "as animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)", "PI": "Mollusca (1971-2005)", "MS": "A family of freshwater mussels in the class BIVALVIA. They differ from ZEBRA MUSSELS in that they are larger and posses a larval stage called glochidia, which requires attachment to the GILLS or fins of particular species of FISHES.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049876"}, {"RECTYPE": "D", "MH": "Anodonta", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Anodontas", "MN": "B01.050.500.644.080.850.050", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid47527", "PI": "Mollusca (1965-2005)", "MS": "A genus of thin-shelled freshwater mussels in the family UNIONIDAE, class BIVALVIA.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049877"}, {"RECTYPE": "D", "MH": "Mytilus", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.644.080.537.500", "MH_TH": "UNK (19XX)", "ST": "T204", "RN": "txid6548", "PI": "Mollusca (1966-2005)", "MS": "A genus of marine mussels in the family MYTILIDAE, class BIVALVIA. The species MYTILUS EDULIS is the highly edible common mussel.", "PM": "2006; see MUSSELS 1979-2005", "HN": "2006; use BIVALVIA 1979-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049878"}, {"RECTYPE": "D", "MH": "Mytilidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.644.080.537", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6547", "PI": "Bivalvia (1973-2005)", "MS": "A family of marine MUSSELS in the class BIVALVIA.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049879"}, {"RECTYPE": "D", "MH": "Mytilus edulis", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Mussels, Common|T204|NON|EQV|NLM (2006)|040812|abcdef", "ENTRY": "edulis, Mytilus", "MN": "B01.050.500.644.080.537.500.500", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6550", "AN": "as animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)", "PI": "Mollusca (1964-2005)", "MS": "A species of mussel in the genus MYTILUS, family MYTILIDAE, class BIVALVIA, known as the common mussel. It has a bluish-black shell and is highly edible.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049880"}, {"RECTYPE": "D", "MH": "Unio", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Unios", "MN": "B01.050.500.644.080.850.850", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid55836", "PI": "Mollusca (1966-2005)", "MS": "A genus of freshwater mussels in the family UNIONIDAE, class BIVALVIA.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049881"}, {"RECTYPE": "D", "MH": "Perna", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Pernas", "MN": "B01.050.500.644.080.537.600", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid38948", "PI": "Bivalvia (1979-2005)", "MS": "A genus of freshwater mussel in the family MYTILIDAE, class BIVALVIA. It is found in tropical and warm temperate coastal waters. Most species have green in their shells.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049883"}, {"RECTYPE": "D", "MH": "Spisula", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Spisulas", "MN": "B01.050.500.644.080.750", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6582", "AN": "as animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)", "PI": "Mollusca (1967-1970)", "MS": "A genus of surf clams in the family Mactridae, class BIVALVIA. They are often used in EMBRYOLOGY research.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049890"}, {"RECTYPE": "D", "MH": "Mercenaria", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Quahogs|T204|NON|EQV|NLM (2006)|040813|abcdef", "ENTRY": "Quahog", "MN": "B01.050.500.644.080.500", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6595", "AN": "as animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)", "PI": "Mollusca (1965-1970)", "MS": "A genus of hard-shelled clams in the family Veneridae, class BIVALVIA, commonly called quahogs. They are found just below the surface in the subtidal or lower intertidal coastal waters.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049891"}, {"RECTYPE": "D", "MH": "Mya", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Clams, Softshell|T204|NON|NRW|NLM (2006)|040813|abcdef", "ENTRY": "arenarias, Mya", "MN": "B01.050.500.644.080.535", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6603", "RR": "txid6604", "AN": "as animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)", "PI": "Mollusca (1965-1999)", "MS": "A genus of soft-shell clams in the family Myidae, class BIVALVIA.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049892"}, {"RECTYPE": "D", "MH": "Arcidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Anadara|T204|NON|NRW|NLM (2006)|040813|abcdef", "ENTRY": "Shells, Ark", "MN": "B01.050.500.644.080.050", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6553", "RR": "txid6554", "PI": "Mollusca (1984-2005)", "MS": "A family of ark shell mollusks, in the class BIVALVIA. They have soft bodies with platelike GILLS enclosed within two shells hinged together.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049893"}, {"RECTYPE": "D", "MH": "Scapharca", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Scapharcas", "MN": "B01.050.500.644.080.050.700", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6560", "PI": "Mollusca (1981-2005)", "MS": "A genus of mollusks in the family ARCIDAE, class BIVALVIA. It is used in the study of HEMOGLOBINS.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049894"}, {"RECTYPE": "D", "MH": "Ostrea", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Oysters, True|T204|NON|NRW|NLM (2006)|041116|abcdef", "ENTRY": "eduli, Ostrea", "MN": "B01.050.500.644.080.643.600", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid37858", "RR": "txid37623", "AN": "as animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM); index oysters unspecified at OYSTERS see OSTREIDAE", "PI": "Oysters (1972-2005)", "MS": "A genus of oysters in the family OSTREIDAE, which includes the edible true oyster, Ostrea edulis.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049895"}, {"RECTYPE": "D", "MH": "Crassostrea", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Oysters, Eastern|T204|NON|NRW|NLM (2006)|041116|abcdef", "ENTRY": "virginica, Crassostrea", "MN": "B01.050.500.644.080.643.150", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6564", "RR": "txid6565", "AN": "as animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)", "PI": "Oysters (1971-2005)", "MS": "A genus of oysters in the family OSTREIDAE, class BIVALVIA.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049896"}, {"RECTYPE": "D", "MH": "Pectinidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Scallops|T204|NON|EQV|NLM (2006)|040813|abcdef", "ENTRY": "Scallop", "MN": "B01.050.500.644.080.660", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6566", "RR": "txid6572", "AN": "as animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)", "PI": "Mollusca (1966-2005)", "MS": "A large family of mollusks in the class BIVALVIA, known commonly as scallops. They possess flat, almost circular shells and are found in all seas from shallow water to great depths.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049897"}, {"RECTYPE": "D", "MH": "Pecten", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Pectens", "MN": "B01.050.500.644.080.660.600", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6578", "RR": "txid6579", "AN": "as animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)", "PI": "Mollusca (1965-2005)", "MS": "A genus of scallops in the family PECTINIDAE, class BIVALVIA. The shell is usually radially ribbed.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049910"}, {"RECTYPE": "D", "MH": "Pinctada", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Oysters, Pearl|T204|NON|EQV|NLM (2006)|040816|abcdef", "ENTRY": "Pinctadas", "MN": "B01.050.500.644.080.670", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid50425", "PI": "Ostreidae (1969-2005)", "MS": "A genus of pearl oysters in the family Pteriidae, class BIVALVIA. Both cultured and natural pearls are obtained from species in the genus. They are distinct from the distantly related, edible true oysters of the family OSTREIDAE.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049911"}, {"RECTYPE": "D", "MH": "Growth Hormone-Secreting Pituitary Adenoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Somatotroph Adenoma|T191|NON|EQV|NLM (2006)|040817|abcdef", "ENTRY": "Somatotroph Adenomas", "MN": "C19.700.734.292", "MH_TH": "NLM (2006)", "ST": "T191", "AN": "coordinate IM with ADENOMA (IM)", "PI": "Pituitary Neoplasms (1981-2005)", "MS": "A pituitary tumor that secretes GROWTH HORMONE. In humans, excess HUMAN GROWTH HORMONE leads to ACROMEGALY.", "PM": "2006", "HN": "2006", "MR": "20120703", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049912"}, {"RECTYPE": "D", "MH": "ACTH-Secreting Pituitary Adenoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Pituitary Corticotropin-Secreting Adenoma|T191|NON|EQV|NLM (2006)|041018|abcdef", "ENTRY": "Pituitary Corticotropin-Secreting Adenomas", "MN": "C19.700.734.145", "MH_TH": "NLM (2006)", "ST": "T191", "AN": "coordinate IM with ADENOMA (IM)", "PI": "Pituitary Neoplasms (1981-2005)", "MS": "A pituitary adenoma which secretes ADRENOCORTICOTROPIN, leading to CUSHING DISEASE.", "PM": "2006", "HN": "2006", "MR": "20120703", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049913"}, {"RECTYPE": "D", "MH": "DNA Repair-Deficiency Disorders", "DE": "DNA REPAIR DEFIC DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "DNA Repair-Deficiency|T049|ACX|REL|NLM (2006)|041025|DNA REPAIR DEFIC|abcdefv", "ENTRY": "Syndromes, Chromosome Instability", "MN": "C18.452.284", "FX": "Genes, cdc", "MH_TH": "NLM (2006)", "ST": "T047", "AN": "general; prefer specifics", "PI": "DNA Repair (1977-2005)", "MS": "Disorders resulting from defective DNA REPAIR processes or the associated cellular responses to DNA DAMAGE.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049914"}, {"RECTYPE": "D", "MH": "Ipomoea nil", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "nils, Pharbitis", "MN": "B01.875.800.575.912.250.238.500.750", "MH_TH": "NLM (2006)", "ST": "T002", "RN": "txid35883", "PI": "Ipomoea (2001-2005)", "MS": "A plant species of the genus IPOMOEA, family CONVOLVULACEAE. An abundance of spontaneous mutants makes it useful in study of PLANT DNA and GENETICS.", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049915"}, {"RECTYPE": "D", "MH": "Polyplacophora", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Chitons|T204|NON|EQV|NLM (2006)|040817|abcdef", "ENTRY": "Polyplacophoras", "MN": "B01.050.500.644.600", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6650", "PI": "Mollusca (1967-2005)", "MS": "A class in the phylum MOLLUSCA comprised of flattened, elongated marine mollusks, commonly called chitons. They are unique in that they possess seven or eight separate shell plates.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049916"}, {"RECTYPE": "D", "MH": "Dipsacaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Teasels", "MN": "B01.875.800.575.912.250.328.875", "MH_TH": "NLM (2006)", "ST": "T002", "RN": "txid40572", "RR": "txid87007", "MS": "A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. It is sometimes called the teasel family.", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049917"}, {"RECTYPE": "D", "MH": "Salacia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Salacia reticulata|T002|NON|NRW|NLM (2006)|040817|abcdef", "MN": "B01.875.800.575.912.250.859.500.750.682", "MH_TH": "NLM (2006)", "ST": "T002", "RN": "txid4319", "RR": "txid1565083", "MS": "A plant genus of the family Celastraceae. Members contain friedelane-type TRITERPENES and SESQUITERPENES, EUDESMANE.", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049918"}, {"RECTYPE": "D", "MH": "Erigeron", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Fleabanes", "MN": "B01.875.800.575.912.250.100.342", "MH_TH": "NLM (2006)", "ST": "T002", "RN": "txid41574", "PI": "Asteraceae (2001-2005)", "MS": "A plant genus of the family ASTERACEAE that is similar to CONYZA. Members contain SESQUITERPENES.", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049919"}, {"RECTYPE": "D", "MH": "Ralstonia pickettii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.688.600.600", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid329", "AN": "infection: coordinate IM with GRAM NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Ralstonia (2004-2005)", "MS": "The type species in the genus RALSTONIA. It is often found in the hospital ward as a contaminant of antiseptic and disinfectant solutions.", "PM": "2006; see RALSTONIA 2002-2005", "HN": "2006; use RALSTONIA 2002-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049920"}, {"RECTYPE": "D", "MH": "Cupriavidus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Wautersia|T007|NON|EQV|NLM (2006)|040817|abcdef", "MN": "B03.660.075.090.688.200", "MH_TH": "NLM (2007)", "ST": "T007", "RN": "txid106589", "MS": "A genus of gram-negative, aerobic, rod-shaped bacteria, in the family BURKHOLDERIACEAE, that are mobile by means of peritrichous FLAGELLA. The genus was formerly called Wautersia and species in this genus were formerly in the genus RALSTONIA.", "PM": "2006; see WAUTERSIA 2006", "HN": "2007 (2006)", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049921"}, {"RECTYPE": "D", "MH": "Chrysopogon", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Vetiveria|T002|NON|EQV|NLM (2006)|040818|abcdef", "ENTRY": "zizanioides, Vetiveria", "MN": "B01.875.800.575.912.250.822.180", "MH_TH": "NLM (2018)", "ST": "T002", "RN": "txid79830", "RR": "txid167337", "MS": "A plant genus of the family POACEAE. The RHIZOME contains SESQUITERPENES and is the source of vetiver oil used in PERFUME.", "PM": "2018", "HN": "2018(2005)", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049930"}, {"RECTYPE": "D", "MH": "Sesbania", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Sesbanias", "MN": "B01.875.800.575.912.250.401.726", "MH_TH": "NLM (2006)", "ST": "T002", "RN": "txid3894", "PI": "Fabaceae (1982-2005)", "MS": "A plant genus of the family FABACEAE. Members contain piperidine alkaloids (PIPERIDINES).", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049931"}, {"RECTYPE": "D", "MH": "Nijmegen Breakage Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Variant V1s, Ataxia-Telangiectasia", "MN": "C18.452.284.600", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A chromosome instability syndrome resulting from a defective response to DNA double-strand breaks. In addition to characteristic FACIES and MICROCEPHALY, patients have a range of findings including RADIOSENSITIVITY, immunodeficiency, increased cancer risk, and growth retardation. Causative mutations occur in the NBS1 gene, located on human chromosome 8q21. NBS1 codes for nibrin, the key regulator protein of the R/M/N (RAD50/MRE11/NBS1) protein complex which senses and mediates cellular response to DNA DAMAGE caused by IONIZING RADIATION.", "PM": "2006", "HN": "2006", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049932"}, {"RECTYPE": "D", "MH": "Aminocoumarins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Amino Coumarins", "MN": "D03.633.100.150.446.139", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "PI": "Coumarins (1999-2005)", "MS": "COUMARINS with an amino group, exemplified by NOVOBIOCIN.", "PM": "2006", "HN": "2006", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049933"}, {"RECTYPE": "D", "MH": "Isocoumarins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isocoumarin|T109|NON|EQV|NLM (2020)|190109|abcdef", "ENTRY": "1H-2-Benzopyran-1-ones|T109|NON|EQV|NLM (2006)|040819|abcdef", "MN": "D03.633.100.150.446.800", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "PI": "Coumarins (1971-2005)", "MS": "Compounds that differ from COUMARINS in having the positions of the ring and ketone oxygens reversed so the keto oxygen is at the 1-position of the molecule.", "PM": "2006", "HN": "2006", "MR": "20190222", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049934"}, {"RECTYPE": "D", "MH": "Hernandiaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Hernandias", "MN": "B01.875.800.575.912.250.595.300", "MH_TH": "NLM (2006)", "ST": "T002", "RN": "txid22009", "RR": "txid13560", "MS": "A plant family of the order Laurales, subclass Magnoliidae, class Magnoliopsida. Members contain cytotoxic furofuran LIGNANS and isoquinoline ALKALOIDS.", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049935"}, {"RECTYPE": "D", "MH": "Anthocerotophyta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Hornwort", "MN": "B01.875.800.575.100", "MH_TH": "NLM (2006)", "ST": "T002", "RN": "txid13809", "RR": "txid3233", "MS": "A plant division that includes hornworts, named for the horn-like appearance of the spore-producing plant (sporophyte).", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049936"}, {"RECTYPE": "D", "MH": "Hyperparathyroidism, Primary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Primary Hyperparathyroidisms", "MN": "C19.642.355.239", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Hyperparathyroidism (1964-2005)", "MS": "A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.", "PM": "2006", "HN": "2006", "MR": "20090706", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049950"}, {"RECTYPE": "D", "MH": "X Chromosome Inactivation", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "X Inactivation|T045|NON|EQV|UNK (19XX)|810223|abcdef", "ENTRY": "X Inactivations", "MN": "G05.308.203.249.970", "MH_TH": "NLM (2006)", "ST": "T045", "PI": "X Chromosome (1983-2005)", "MS": "A dosage compensation process occurring at an early embryonic stage in mammalian development whereby, at random, one X CHROMOSOME of the pair is repressed in the somatic cells of females.", "PM": "2006; see DOSAGE COMPENSATION (GENETICS) 1982-2005", "HN": "2006; use DOSAGE COMPENSATION, GENETIC 1982-2005", "MR": "20160617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049951"}, {"RECTYPE": "D", "MH": "Graves Ophthalmopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thyroid-Associated Ophthalmopathy|T047|NON|EQV|NLM (1997)|950719|THYROID ASSOC OPHTHALMOPATHY|abcdefv", "ENTRY": "Thyroid Eye Diseases", "MN": "C20.111.555.500", "MH_TH": "NLM (2006)", "ST": "T047", "PI": "Graves Disease (1987-2005)", "MS": "An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.", "PM": "2006; see GRAVES' DISEASE 1997-2005", "HN": "2006; use GRAVES DISEASE 1997-2005", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049970"}, {"RECTYPE": "D", "MH": "Thiazides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiazide|T109|NON|EQV|NLM (2021)|200207|abcdef", "MN": "D02.886.655", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "PI": "Benzothiadiazines (1963-2005)", "MS": "Heterocyclic compounds with SULFUR and NITROGEN in the ring. This term commonly refers to the BENZOTHIADIAZINES that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS and are used as DIURETICS.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049971"}, {"RECTYPE": "D", "MH": "Membrane Transport Modulators", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Transport Modulators, Membrane", "MN": "D27.505.519.562", "MH_TH": "NLM (2006)", "ST": "T121", "RN": "0", "AN": "general; prefer specifics", "PI": "Membrane Transport Proteins (2002-2005)", "MS": "Agents that affect ION PUMPS; ION CHANNELS; ABC TRANSPORTERS; and other MEMBRANE TRANSPORT PROTEINS.", "PM": "2006", "HN": "2006", "MR": "20140625", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049990"}, {"RECTYPE": "D", "MH": "Sodium Chloride Symporters", "AQ": "AA AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Transporter, Sodium-Chloride", "MN": "D12.776.157.530.450.625.374", "FX": "Gitelman Syndrome", "EC": "antagonists & inhibitors:Sodium Chloride Symporter Inhibitors", "MH_TH": "NLM (2006)", "ST": "T116", "RN": "0", "AN": "coordinate with DIURETICS if pertinent", "MS": "A subclass of symporters found in KIDNEY TUBULES, DISTAL that are the major pathway for salt resorption. Inhibition of these symporters by BENZOTHIADIAZINES is the basis of action of some DIURETICS.", "PM": "2006", "HN": "2006(1984); for SODIUM-CHLORIDE COTRANSPORTER use SYMPORTERS (NM)", "MR": "20090706", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049992"}, {"RECTYPE": "D", "MH": "Sodium Chloride Symporter Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiazide Sensitive NaCl Cotransporter Inhibitor|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Diuretics, Potassium Depleting", "MN": "D27.505.696.560.500.863", "MH_TH": "NLM (2006)", "ST": "T121", "RN": "0", "MS": "Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.", "PM": "2006; for THIAZIDE DIURETICS use THIAZIDE DIURETICS 1976-2005", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049993"}, {"RECTYPE": "D", "MH": "Sodium Potassium Chloride Symporter Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Loop Diuretic|T121|NON|REL|NLM (2021)|200225|abcdef", "ENTRY": "Symporter Inhibitors, Na-K-CL", "MN": "D27.505.696.560.500.931", "MH_TH": "NLM (2006)", "ST": "T121", "RN": "0", "PI": "Sodium-Potassium-Chloride Symporters (2002-2005)", "MS": "Agents that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS which are concentrated in the thick ascending limb at the junction of the LOOP OF HENLE and KIDNEY TUBULES, DISTAL. They act as DIURETICS. Excess use is associated with HYPOKALEMIA and HYPERGLYCEMIA.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D049994"}, {"RECTYPE": "D", "MH": "Hyperthyroxinemia, Familial Dysalbuminemic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dysalbuminemic Hyperthyroxinemia, Familial", "MN": "C19.874.410.249", "MH_TH": "NLM (2006)", "ST": "T047", "PI": "Thyroxine (1982-2005)", "MS": "An inherited autosomal dominant trait characterized by abnormally elevated levels of total serum THYROXINE; (T4) in euthyroid patients with abnormal SERUM ALBUMIN that binds T4 with enhanced affinity. The serum levels of free T4, free T3, and TSH are normal. It is one of several T4 abnormalities produced by non-thyroid disorder. This condition is due to mutations of the ALB gene on CHROMOSOME 4.", "PM": "2006", "HN": "2006", "MR": "20050802", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050010"}, {"RECTYPE": "D", "MH": "Andersen Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Andersen Tawil", "MN": "C23.550.073.547.070", "FX": "Pierre Robin Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with ANDERSEN DISEASE see GLYCOGEN STORAGE DISEASE TYPE IV", "MS": "A form of inherited long QT syndrome (or LQT7) that is characterized by a triad of potassium-sensitive periodic paralysis, VENTRICULAR ECTOPIC BEATS, and abnormal features such as short stature, low-set ears, and SCOLIOSIS. It results from mutations of KCNJ2 gene which encodes a channel protein (INWARD RECTIFIER POTASSIUM CHANNELS) that regulates resting membrane potential.", "PM": "2006", "HN": "2006", "MR": "20170620", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050030"}, {"RECTYPE": "D", "MH": "Hashimoto Disease", "DE": "HASHIMOTO DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hashimoto's Disease|T047|EPO|EQV|ORD (2010)|UNK (19XX)|740330|HASHIMOTOS DIS|abcdeefv", "ENTRY": "Thyroiditis, Hashimoto", "MN": "C20.111.809.500", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Thyroiditis, Autoimmune (1964-2005)", "MS": "Chronic autoimmune thyroiditis, characterized by the presence of high serum thyroid AUTOANTIBODIES; GOITER; and HYPOTHYROIDISM.", "PM": "2006; see THYROIDITIS, AUTOIMMUNE 1975-2005", "HN": "2006; use THYROIDITIS, AUTOIMMUNE 1975-2005", "MR": "20230226", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050031"}, {"RECTYPE": "D", "MH": "Postpartum Thyroiditis", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thyroiditis, Postpartum", "MN": "C20.111.809.750", "MH_TH": "NLM (2006)", "ST": "T047", "AN": "check the tag FEMALE", "PI": "Thyroiditis (1983-2005)", "MS": "Transient autoimmune thyroiditis occurring in the POSTPARTUM PERIOD. It is characterized by the presence of high titers of AUTOANTIBODIES against THYROID PEROXIDASE and THYROGLOBULIN. Clinical signs include the triphasic thyroid hormone pattern: beginning with THYROTOXICOSIS, followed with HYPOTHYROIDISM, then return to euthyroid state by 1 year postpartum.", "PM": "2006", "HN": "2006", "MR": "20230226", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050032"}, {"RECTYPE": "D", "MH": "Thyroid Dysgenesis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thyroid Hypoplasia|T047|NON|NRW|NLM (2010)|OMIM (2013)|ORD (2010)|090608|abcdeeef", "ENTRY": "Thyroids, Ectopic", "MN": "C19.874.689", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Thyroid Gland (1966-2005)", "MS": "Defective development of the THYROID GLAND. This concept includes thyroid agenesis (aplasia), hypoplasia, or an ectopic gland. Clinical signs usually are those of CONGENITAL HYPOTHYROIDISM.", "PM": "2006", "HN": "2006", "MR": "20120703", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050033"}, {"RECTYPE": "D", "MH": "Antidiuretic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Antidiuretic", "MN": "D27.505.696.560.249", "MH_TH": "NLM (2006)", "ST": "T121", "RN": "0", "AN": "note entry term ANTIDIURETIC EFFECT: use only for the antidiuretic effect of a chemical substance", "PI": "Diuretics (1965-2005)", "MS": "Agents that reduce the excretion of URINE, most notably the octapeptide VASOPRESSINS.", "PM": "2006", "HN": "2006", "MR": "20140625", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050034"}, {"RECTYPE": "D", "MH": "Sexual Infantilism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Infantilism, Sexual|T047|NON|EQV|UNK (19XX)|830504|abcdef", "MN": "C19.391.482.814", "MH_TH": "NLM (2006)", "ST": "T047", "PI": "Hypogonadism (1969-2005)", "MS": "The permanent lack of SEXUAL DEVELOPMENT in an individual. This defect is usually observed at an age after expected PUBERTY.", "PM": "2006; see HYPOGONADISM 1984-2005; see INFANTILISM 1963-1983", "HN": "2006; use HYPOGONADISM 1984-2005; use INFANTILISM 1963-1983", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050035"}, {"RECTYPE": "D", "MH": "Protein Carbonylation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Carbonylation, Protein|T044|NON|EQV|NLM (2006)|040909|abcdef", "ENTRY": "Protein Carbonylations", "MN": "G07.775.750.750", "MH_TH": "NLM (2006)", "ST": "T044", "MS": "The appearance of carbonyl groups (such as aldehyde or ketone groups) in PROTEINS as the result of several oxidative modification reactions. It is a standard marker for OXIDATIVE STRESS. Carbonylated proteins tend to be more hydrophobic and resistant to proteolysis.", "PM": "2006", "HN": "2006", "MR": "20180228", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050050"}, {"RECTYPE": "D", "MH": "Transient Receptor Potential Channels", "DE": "TRANSIENT RECEPT POTENTIAL CHANNELS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transient Receptor Potential Channel|T116|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Proteins, TRP Membrane", "MN": "D12.776.543.585.400.901", "MH_TH": "NLM (2006)", "ST": "T116", "RN": "0", "AN": "note entry terms: TRP refers to transient receptor potential not TRYPTOPHAN", "PI": "Ion Channels (1995-2005)", "MS": "A broad group of eukaryotic six-transmembrane cation channels that are classified by sequence homology because their functional involvement with SENSATION is varied. They have only weak voltage sensitivity and ion selectivity. They are named after a DROSOPHILA mutant that displayed transient receptor potentials in response to light. A 25-amino-acid motif containing a TRP box (EWKFAR) just C-terminal to S6 is found in TRPC, TRPV and TRPM subgroups. ANKYRIN REPEATS are found in TRPC, TRPV & TRPN subgroups. Some are functionally associated with TYROSINE KINASE or TYPE C PHOSPHOLIPASES.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050051"}, {"RECTYPE": "D", "MH": "TRPC Cation Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Channels, TRPC Cation", "MN": "D12.776.543.585.400.901.500", "MH_TH": "NLM (2006)", "ST": "T116", "RN": "0", "PI": "Ion Channels (1995-2005)", "MS": "A subgroup of TRP cation channels that contain 3-4 ANKYRIN REPEAT DOMAINS and a conserved C-terminal domain. Members are highly expressed in the CENTRAL NERVOUS SYSTEM. Selectivity for calcium over sodium ranges from 0.5 to 10.", "PM": "2006", "HN": "2006(1996)", "MR": "20170227", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050052"}, {"RECTYPE": "D", "MH": "TRPM Cation Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TRPM Cation Channel|T116|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Channels, TRPM Cation", "MN": "D12.776.543.585.400.901.555", "MH_TH": "NLM (2006)", "ST": "T116", "RN": "0", "PI": "Ion Channels (1995-2005)", "MS": "A subgroup of TRP cation channels named after melastatin protein. They have the TRP domain but lack ANKYRIN repeats. Enzyme domains in the C-terminus leads to them being called chanzymes.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050053"}, {"RECTYPE": "D", "MH": "Bone Density Conservation Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antiresorptive Agent|T121|NON|NRW|NLM (2021)|200304|abcdef", "ENTRY": "Resorption Inhibitors, Bone", "MN": "D27.505.696.242", "FX": "Selective Estrogen Receptor Modulators", "MH_TH": "NLM (2006)", "ST": "T121", "RN": "0", "MS": "Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050071"}, {"RECTYPE": "D", "MH": "White Heifer Disease", "DE": "WHITE HEIFER DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "ENTRY": "Disease, White Heifer", "MN": "C22.196.963", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "check tags CATTLE; FEMALE; and ANIMAL", "MS": "A congenital reproductive abnormality in white female offspring (heifers) in certain breeds of CATTLE, such as Belgian Blue and Shorthorn. The white color is inherited as a recessive trait which is associated with defects in the female reproductive tract (Muellerian system). These heifers are usually sterile.", "PM": "2006; see FREEMARTINISM 1975-2005", "HN": "2006; use FREEMARTINISM 1975-2005", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050072"}, {"RECTYPE": "D", "MH": "Ovotesticular Disorders of Sex Development", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hermaphroditism, True|T019|T047|NON|NRW|NLM (2006)|041119|abbcdef", "ENTRY": "XX Male Syndrome, Sry Positive", "MN": "C19.391.119.343", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "note entry term HERMAPHRODITISM, TRUE: HERMAPHRODITISM see DISORDERS OF SEXUAL DEVELOPMENT is also available", "PI": "Hermaphroditism (1964-2005)", "MS": "Conditions of sexual ambiguity in which the individual possesses gonadal tissues of both sexes, tissues from the OVARY and the TESTIS. There can be a testis on one side and an ovary on the other (lateral), or there may be combined ovarian and testicular tissue (ovotestes) on each side (bilateral). The karyotype may be 46,XX; 46,XY; or a mosaic of 46,XX/46,XY. These disorders have historically been called true hermaphroditism.", "PM": "2011; see HERMAPHRODITISM, TRUE 2006-2010", "HN": "2011 (2006)", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050090"}, {"RECTYPE": "D", "MH": "Dendrimers", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Polymers, Dendritic", "MN": "J01.637.512.600.200", "MH_TH": "NLM (2006)", "ST": "T122", "RN": "0", "AN": "coordinate with compounds comprising the dendrimers", "PI": "Polymers (1990-2005)", "MS": "Tree-like, highly branched, polymeric compounds. They grow three-dimensionally by the addition of shells of branched molecules to a central core. The overall globular shape and presence of cavities gives potential as drug carriers and CONTRAST AGENTS.", "PM": "2006", "HN": "2006", "MR": "20070709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050091"}, {"RECTYPE": "D", "MH": "Bariatric Surgery", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Bariatric", "MN": "E04.062", "FX": "Bariatrics", "MH_TH": "NLM (2006)", "ST": "T061", "PI": "Obesity (1981-2005)", "MS": "Surgical procedures aimed at affecting metabolism and producing major WEIGHT REDUCTION in patients with MORBID OBESITY.", "PM": "2006", "HN": "2006", "MR": "20200221", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050110"}, {"RECTYPE": "D", "MH": "Imino Sugars", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sugars, Imino", "MN": "D09.553", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "MS": "Sugars in which the OXYGEN is replaced by a NITROGEN atom. This substitution prevents normal METABOLISM resulting in inhibition of GLYCOSIDASES and GLYCOSYLTRANSFERASES.", "PM": "2006", "HN": "2006", "MR": "20170410", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050111"}, {"RECTYPE": "D", "MH": "Imino Pyranoses", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sugars, 1-N-Imino", "MN": "D09.553.500", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "MS": "Six-carbon pyranose sugars in which the OXYGEN is replaced by a NITROGEN atom.", "PM": "2006", "HN": "2006", "MR": "20170410", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050112"}, {"RECTYPE": "D", "MH": "Imino Furanoses", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sugars, 1,4-Imino", "MN": "D09.553.249", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "MS": "Five-carbon furanose sugars in which the OXYGEN is replaced by a NITROGEN atom.", "PM": "2006", "HN": "2006", "MR": "20170410", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050113"}, {"RECTYPE": "D", "MH": "Oncolytic Virotherapy", "DE": "ONCOLYTIC VIROTHER", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Virus Therapy, Oncolytic", "MN": "E02.095.601", "FX": "Oncolytic Viruses", "MH_TH": "NLM (2006)", "ST": "T061", "MS": "Use of attenuated VIRUSES as ANTINEOPLASTIC AGENTS to selectively kill CANCER cells.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050130"}, {"RECTYPE": "D", "MH": "Chalones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.644.456.270", "MH_TH": "NLM (1993)", "ST": "T116", "RN": "0", "AN": "do not confuse with CHALCONES", "PI": "Growth Inhibitors (1993-2005)", "MS": "Peptides that inhibit mitosis (ANTIMITOTICS). During the 1960's the term referred to crude extracts that inhibited cell proliferation; the activity was later attributed to PYROGLUTAMATE type oligopeptides.", "PM": "2006, 1969-1992; see GROWTH INHIBITORS 1993-2005", "HN": "2006, 1969-1992; use GROWTH INHIBITORS 1993-2005", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050150"}, {"RECTYPE": "D", "MH": "Subcutaneous Fat", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Adipose Tissue, Subcutaneous|T024|NON|EQV|NLM (2006)|040922|abcdef", "ENTRY": "Subcutaneous Fats", "MN": "A10.165.114.830.750", "MH_TH": "NLM (2006)", "ST": "T024", "PI": "Adipose Tissue (1965-2005)", "MS": "Fatty tissue under the SKIN through out the body.", "PM": "2006", "HN": "2006", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050151"}, {"RECTYPE": "D", "MH": "Intra-Abdominal Fat", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Visceral Fats", "MN": "A10.165.114.830.500.500", "MH_TH": "NLM (2006)", "ST": "T024", "PI": "Adipose Tissue (1975-2005)", "MS": "Fatty tissue inside the ABDOMINAL CAVITY, including visceral fat and retroperitoneal fat. It is the most metabolically active fat in the body and easily accessible for LIPOLYSIS. Increased visceral fat is associated with metabolic complications of OBESITY.", "PM": "2006", "HN": "2006", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050152"}, {"RECTYPE": "D", "MH": "Abdominal Fat", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Adipose Tissue, Abdominal|T024|NON|EQV|NLM (2006)|040922|abcdef", "ENTRY": "Fats, Abdominal", "MN": "A10.165.114.830.500", "FX": "Obesity, Abdominal", "MH_TH": "NLM (2006)", "ST": "T024", "PI": "Adipose Tissue (1966-2005)", "MS": "Fatty tissue in the region of the ABDOMEN. It includes the ABDOMINAL SUBCUTANEOUS FAT and the INTRA-ABDOMINAL FAT.", "PM": "2006", "HN": "2006", "MR": "20090706", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050153"}, {"RECTYPE": "D", "MH": "Adiposity", "AQ": "DE EH GE IM PH RE", "MN": "G07.100.049.134.500", "MH_TH": "NLM (2006)", "ST": "T032", "AN": "index body fat at ADIPOSE TISSUE", "PI": "Obesity (1965-2005)", "MS": "The amount of fat or lipid deposit at a site or an organ in the body, an indicator of body fat status.", "PM": "2006", "HN": "2006", "MR": "20160502", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050154"}, {"RECTYPE": "D", "MH": "Lipogenesis", "AQ": "DE GE IM PH RE", "ENTRY": "Lipogeneses", "MN": "G03.458.249", "MH_TH": "NLM (2006)", "ST": "T040", "AN": "do not confuse with ADIPOGENESIS, the differentiation of ADIPOCYTES", "PI": "Fatty Acids (1965-2005)", "MS": "De novo fat synthesis in the body. This includes the synthetic processes of FATTY ACIDS and subsequent TRIGLYCERIDES in the LIVER and the ADIPOSE TISSUE. Lipogenesis is regulated by numerous factors, including nutritional, hormonal, and genetic elements.", "PM": "2006", "HN": "2006", "MR": "20160623", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050155"}, {"RECTYPE": "D", "MH": "Adipogenesis", "AQ": "DE GE IM PH RE", "ENTRY": "Adipogeneses", "MN": "G04.152.149", "MH_TH": "NLM (2006)", "ST": "T043", "AN": "do not confuse with metabolic process LIPOGENESIS.", "PI": "Adipose Tissue (1968-2005)", "MS": "The differentiation of pre-adipocytes into mature ADIPOCYTES.", "PM": "2006", "HN": "2006", "MR": "20160115", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050156"}, {"RECTYPE": "D", "MH": "Dyslipidemias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dyslipoproteinemias|T047|NON|NRW|NLM (2007)|050714|abcdef", "ENTRY": "Dyslipoproteinemia", "MN": "C18.452.584.500", "MH_TH": "NLM (2006)", "ST": "T047", "AN": "general; prefer specifics", "PI": "Lipids (1968-2005)", "MS": "Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.", "PM": "2006; see HYPERLIPIDEMIA 1995-2005", "HN": "2006; use HYPERLIPIDEMIA 1995-2005", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050171"}, {"RECTYPE": "D", "MH": "Genes, X-Linked", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "X-Linked Traits|T039|NON|REL|NLM (2006)|040922|abcdef", "ENTRY": "X-Linked Trait", "MN": "G05.420.457", "FX": "Genetic Diseases, X-Linked", "MH_TH": "NLM (2006)", "ST": "T028", "MS": "Genes that are located on the X CHROMOSOME.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050172"}, {"RECTYPE": "D", "MH": "Genes, Y-Linked", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Y-Linked Genes|T028|NON|EQV|NLM (2006)|040922|abcdef", "ENTRY": "Y-Linked Trait", "MN": "G05.420.523", "MH_TH": "NLM (2006)", "ST": "T028", "MS": "Genes that are located on the Y CHROMOSOME.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050173"}, {"RECTYPE": "D", "MH": "Genetic Diseases, Y-Linked", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Y-Linked Genetic Diseases|T047|NON|EQV|NLM (2006)|040922|abcdef", "ENTRY": "Y-Linked Genetic Disease", "MN": "C16.320.338", "FX": "Genes, Y-Linked", "MH_TH": "NLM (2006)", "ST": "T047", "PI": "Y Chromosome (1984-2005)", "MS": "Genetic diseases that are linked to mutant ALLELES on the Y CHROMOSOME in humans (Y CHROMOSOME, HUMAN) or the Y chromosome in other species. Included here are animal models of human Y-linked diseases.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050174"}, {"RECTYPE": "D", "MH": "Pansporablastina", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Pansporablastinas", "MN": "B01.300.360.500.500.600", "MH_TH": "NLM (2006)", "ST": "T004", "RN": "txid6036", "AN": "infection: coordinate IM with MICROSPORIDIOSIS (IM); coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc) if pertinent", "MS": "A suborder of FUNGI in the phylum MICROSPORIDIA, possessing a pansporoblastic membrane.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050175"}, {"RECTYPE": "D", "MH": "Overweight", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "G07.100.175.313.699", "MH_TH": "NLM (2006)", "ST": "T184", "PI": "Obesity (1965-2005)", "MS": "A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal \"over fat\".", "PM": "2006", "HN": "2006", "MR": "20220712", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050177"}, {"RECTYPE": "D", "MH": "Monoglycerides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Monoglyceride|T109|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D10.351.676", "MH_TH": "UNK (19XX)", "ST": "T109", "RN": "0", "PI": "Glycerides (1963-2005)", "MS": "GLYCEROL esterified with a single acyl (FATTY ACIDS) chain.", "PM": "2006; see GLYCERIDES (1963-2005)", "HN": "2006; use GLYCERIDES (1963-2005)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050178"}, {"RECTYPE": "D", "MH": "Atherosclerosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Atherogenesis|T046|NON|NRW|NLM (2006)|041028|abcdef", "ENTRY": "Atheroscleroses", "MN": "C14.907.137.126.307", "FX": "Plaque, Atherosclerotic", "MH_TH": "NLM (1963)", "ST": "T046", "PI": "Arteriosclerosis (1965-2005)", "MS": "A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.", "PM": "2006; see ARTERIOSCLEROSIS 1963-2005", "HN": "2006; use ARTERIOSCLEROSIS 1963-2005", "MR": "20211018", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050197"}, {"RECTYPE": "D", "MH": "Phenoxypropanolamines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Phenoxy Propanolamines", "MN": "D02.092.063.624.698", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "PI": "Propanol (1972-2005)", "MS": "Compounds based on a propanolamine attached via an OXYGEN atom to a phenoxy ring. The side chain is one carbon longer than PHENYLETHYLAMINES.", "PM": "2006", "HN": "2006", "MR": "20110624", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050198"}, {"RECTYPE": "D", "MH": "Podocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Visceral Epithelial Cells, Glomerular|T025|NON|EQV|NLM (2006)|040929|abcdef", "ENTRY": "Podocyte", "MN": "A11.436.720", "MH_TH": "NLM (2006)", "ST": "T025", "PI": "Kidney Glomerulus (1965-2005)", "MS": "Highly differentiated epithelial cells of the visceral layer of BOWMAN CAPSULE of the KIDNEY. They are composed of a cell body with major CELL SURFACE EXTENSIONS and secondary fingerlike extensions called pedicels. They enwrap the KIDNEY GLOMERULUS capillaries with their cell surface extensions forming a filtration structure. The pedicels of neighboring podocytes interdigitate with each other leaving between them filtration slits that are bridged by an extracellular structure impermeable to large macromolecules called the slit diaphragm, and provide the last barrier to protein loss in the KIDNEY.", "PM": "2006", "HN": "2006", "MR": "20110624", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050199"}, {"RECTYPE": "D", "MH": "Metabolic Detoxication, Phase I", "DE": "METAB DETOX PHASE I", "AQ": "EH GE IM PH RE", "ENTRY": "Oxidative Metabolic Detoxications", "MN": "G07.690.725.225.450.500", "FX": "Drug Interactions", "MH_TH": "NLM (2006)", "ST": "T040", "MS": "Functionalization of exogenous substances to prepare them for conjugation in PHASE II DETOXIFICATION. Phase I enzymes include CYTOCHROME P450 enzymes and some OXIDOREDUCTASES. Excess induction of phase I over phase II detoxification leads to higher levels of FREE RADICALS that can induce CANCER and other cell damage. Induction or antagonism of phase I detoxication is the basis of a number of DRUG INTERACTIONS.", "PM": "2006", "HN": "2006", "MR": "20160630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050216"}, {"RECTYPE": "D", "MH": "Metabolic Detoxication, Phase II", "DE": "METAB DETOX PHASE II", "AQ": "EH GE IM PH RE", "ENTRY": "Phase II Detoxifications", "MN": "G07.690.725.225.450.750", "FX": "Protein Processing, Post-Translational", "MH_TH": "NLM (2006)", "ST": "T040", "MS": "The conjugation of exogenous substances with various hydrophilic substituents to form water soluble products that are excretable in URINE. Phase II modifications include GLUTATHIONE conjugation; ACYLATION; and AMINATION. Phase II enzymes include GLUTATHIONE TRANSFERASE and GLUCURONOSYLTRANSFERASE. In a sense these reactions detoxify phase I reaction products.", "PM": "2006", "HN": "2006", "MR": "20160630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050217"}, {"RECTYPE": "D", "MH": "Body Fat Distribution", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Patterning, Body Fat", "MN": "G07.100.049.134", "FX": "Waist-Hip Ratio", "MH_TH": "NLM (2006)", "ST": "T081", "PI": "Adipose Tissue (1967-2005)", "MS": "Deposits of ADIPOSE TISSUE throughout the body. The pattern of fat deposits in the body regions is an indicator of health status. Excess ABDOMINAL FAT increases health risks more than excess fat around the hips or thighs, therefore, WAIST-HIP RATIO is often used to determine health risks.", "PM": "2006", "HN": "2006", "MR": "20160502", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050218"}, {"RECTYPE": "D", "MH": "Amblyospora", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Amblyosporas", "MN": "B01.300.360.500.500.600.050", "MH_TH": "NLM (2006)", "ST": "T004", "RN": "txid33687", "AN": "coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc) if pertinent", "PI": "Protozoa (1979-1990)", "MS": "A genus of FUNGI, in the family Amblyosporidae, which is a parasite of MOSQUITOES.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050219"}, {"RECTYPE": "D", "MH": "Glugea", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Glugeas", "MN": "B01.300.360.500.500.600.400", "MH_TH": "NLM (2006)", "ST": "T004", "RN": "txid36736", "AN": "infection: coordinate IM with MICROSPORIDIOSIS (IM); coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc) if pertinent", "PI": "Protozoa (1967-2005)", "MS": "A genus of FUNGI in the family Glugeidae, parasitic on FISHES. The PARASITES cause the formation of large cysts causing hypertrophy.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050220"}, {"RECTYPE": "D", "MH": "Antimitotic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antimitotic Drug|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Drugs, Antimitotic", "MN": "D27.505.954.248.147", "MH_TH": "UNK (19XX)", "ST": "T121", "RN": "0", "PI": "Antineoplastic Agents (1988-2005)", "MS": "Agents that arrest cells in MITOSIS, most notably TUBULIN MODULATORS.", "PM": "2006; see ANTINEOPLASTIC AGENTS 1988-2005", "HN": "2006; use ANTINEOPLASTIC AGENTS 1988-2005", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050256"}, {"RECTYPE": "D", "MH": "Tubulin Modulators", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tubulin Promoter|T121|NON|NRW|NLM (2021)|191119|abcdef", "ENTRY": "Promoters, Tubulin Polymerization", "MN": "D27.505.519.593.249.500", "FX": "Microtubules", "MH_TH": "NLM (2006)", "ST": "T121", "RN": "0", "PI": "Tubulin (1980-2005)", "MS": "Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050257"}, {"RECTYPE": "D", "MH": "Mitosis Modulators", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Modulators, Mitosis", "MN": "D27.505.519.593", "MH_TH": "NLM (2006)", "ST": "T121", "RN": "0", "PI": "Mitosis (1973-2005)", "MS": "Agents that affect MITOSIS of CELLS.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050258"}, {"RECTYPE": "D", "MH": "Genes, Mitochondrial", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Mitochondrial Inheritance|T045|NON|NRW|NLM (2001)|000411|abcdef", "ENTRY": "Mitochondrial Gene", "MN": "G05.420.275.500", "FX": "DNA, Mitochondrial", "MH_TH": "NLM (2006)", "ST": "T028", "MS": "Genes that are located on the MITOCHONDRIAL DNA. Mitochondrial inheritance is often referred to as maternal inheritance but should be differentiated from maternal inheritance that is transmitted chromosomally.", "PM": "2006; for MITOCHONDRIAL INHERITANCE see EXTRACHROMOSOMAL INHERITANCE 2001-2005", "HN": "2006; for MITOCHONDRIAL INHERITANCE use EXTRACHROMOSOMAL INHERITANCE 2001-2005", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050259"}, {"RECTYPE": "D", "MH": "Carbohydrate Metabolism", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Metabolism, Carbohydrate|T044|NON|EQV|NLM (2006)|041005|abcdef", "MN": "G03.191", "MH_TH": "NLM (2006)", "ST": "T044", "AN": "general; prefer specific carbohydrate/metab", "PI": "Carbohydrates/metabolism (1964-2005)", "MS": "Cellular processes in biosynthesis (anabolism) and degradation (catabolism) of CARBOHYDRATES.", "PM": "2006", "HN": "2006", "MR": "20160502", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050260"}, {"RECTYPE": "D", "MH": "Glycogenolysis", "AQ": "DE ES GE IM PH RE", "ENTRY": "Glycogenolyses", "MN": "G03.191.625", "MH_TH": "NLM (2006)", "ST": "T044", "PI": "Glycogen/metabolism (1965-2005)", "MS": "The release of GLUCOSE from GLYCOGEN by GLYCOGEN PHOSPHORYLASE (phosphorolysis). The released glucose-1-phosphate is then converted to GLUCOSE-6-PHOSPHATE by PHOSPHOGLUCOMUTASE before entering GLYCOLYSIS. Glycogenolysis is stimulated by GLUCAGON or EPINEPHRINE via the activation of PHOSPHORYLASE KINASE.", "PM": "2006", "HN": "2006", "MR": "20160630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050261"}, {"RECTYPE": "D", "MH": "Loma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Lomas", "MN": "B01.300.360.500.500.600.500", "MH_TH": "NLM (2006)", "ST": "T004", "RN": "txid54561", "AN": "infection: coordinate IM with MICROSPORIDIOSIS (IM); coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc) if pertinent", "PI": "Microsporidia (2000-2005)", "MS": "A genus of FUNGI, in the family Glugeidae, a parasite of ATLANTIC SALMON and other FISHES.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050262"}, {"RECTYPE": "D", "MH": "Thelohania", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Thelohanias", "MN": "B01.300.360.500.500.600.800", "MH_TH": "NLM (2006)", "ST": "T004", "RN": "txid72221", "AN": "coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc) if pertinent", "PI": "Protozoa (1965-2005)", "MS": "A genus of FUNGI, in the family Thelohaniidae, a parasite of red imported fire ants, MOSQUITOES, and other organisms.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050263"}, {"RECTYPE": "D", "MH": "Hand Bones", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Bones of Hand|T023|NON|EQV|NLM (2006)|041006|abcdef", "ENTRY": "Hands Bones", "MN": "A02.835.232.087.319", "MH_TH": "NLM (2006)", "ST": "T023", "AN": "primates only; Manual 21.58", "PI": "Bones of Upper Extremity (1998-2005)", "MS": "The CARPAL BONES; METACARPAL BONES; and FINGER PHALANGES. In each hand there are eight carpal bones, five metacarpal bones, and 14 phalanges.", "PM": "2006", "HN": "2006", "MR": "20180629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050276"}, {"RECTYPE": "D", "MH": "Toe Phalanges", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Toe Bones|T023|NON|EQV|NLM (2006)|041006|abcdef", "ENTRY": "Toes Bones", "MN": "A02.835.232.043.300.800", "MH_TH": "NLM (2006)", "ST": "T023", "AN": "permitted with all vertebrates; Manual 21.58", "PI": "Toes (1970-2005)", "MS": "Bones that make up the SKELETON of the TOES, consisting of two for the great toe, and three for each of the other toes.", "PM": "2006", "HN": "2006", "MR": "20180629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050277"}, {"RECTYPE": "D", "MH": "Finger Phalanges", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Phalanges of Fingers|T023|NON|EQV|NLM (2006)|041006|abcdef", "ENTRY": "Phalanges, Finger", "MN": "A02.835.232.087.319.350", "MH_TH": "NLM (2006)", "ST": "T023", "AN": "primates only; Manual 21.58", "PI": "Fingers (1966-2005)", "MS": "Bones that make up the SKELETON of the FINGERS, consisting of two for the THUMB, and three for each of the other fingers.", "PM": "2006", "HN": "2006", "MR": "20180629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050278"}, {"RECTYPE": "D", "MH": "Metacarpal Bones", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Metacarpals|T023|NON|EQV|NLM (2006)|041006|abcdef", "ENTRY": "Bones, Metacarpal", "MN": "A02.835.232.087.319.550", "FX": "Metacarpus", "MH_TH": "NLM (2006)", "ST": "T023", "AN": "do not confuse with METACARPUS, the anatomical region", "PI": "Metacarpus (1965-2005)", "MS": "The five cylindrical bones of the METACARPUS, articulating with the CARPAL BONES proximally and the PHALANGES OF FINGERS distally.", "PM": "2006", "HN": "2006", "MR": "20180629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050279"}, {"RECTYPE": "D", "MH": "Arm Bones", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Bones of Arm|T023|NON|EQV|NLM (2006)|041007|abcdef", "ENTRY": "Bones, Arm", "MN": "A02.835.232.087.090", "MH_TH": "NLM (1998)", "ST": "T023", "AN": "general or unspecified; prefer specifics; primates only; Manual 21.58", "PI": "Bones of Upper Extremity (1998-2005)", "MS": "The bones of the free part of the upper extremity including the HUMERUS; RADIUS; and ULNA.", "PM": "2006; see BONES OF UPPER EXTREMITY 1998-2005", "HN": "2006; use BONES OF UPPER EXTREMITY 1998-2005", "MR": "20180629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050280"}, {"RECTYPE": "D", "MH": "Bones of Lower Extremity", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Lower Extremity Bones", "MN": "A02.835.232.043", "MH_TH": "NLM (2006)", "ST": "T023", "AN": "avoid: too general; prefer specifics; permitted with all vertebrates; Manual 21.58", "PI": "specific bones of leg (1966-2005)", "MS": "The bones of the upper and lower LEG. They include the PELVIC BONES.", "PM": "2006", "HN": "2006", "MR": "20180629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050281"}, {"RECTYPE": "D", "MH": "Microbial Viability", "AQ": "DE ES GE IM RE", "PRINT ENTRY": "Virus Viability|T070|NON|NRW|NLM (2006)|041012|abcdef", "ENTRY": "Viability, Virus", "MN": "G06.580", "FX": "Colony Count, Microbial", "MH_TH": "NLM (2006)", "ST": "T070", "PI": "organism/growth & development (1966-2005)", "MS": "Ability of a microbe to survive under given conditions. This can also be related to a colony's ability to replicate.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050296"}, {"RECTYPE": "D", "MH": "Mesomycetozoea", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Ichthyosporea|T204|NON|EQV|NLM (2006)|041013|abcdef", "ENTRY": "Ichthyophonida|T204|NON|NRW|NLM (2006)|041013|abcdef", "MN": "B01.500", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid127916", "RR": "txid198625", "MS": "A class of parasitic and saprophytic microorganisms whose origins can be traced near the animal-fungal divergence. Members of the class are typically pathogens of FISHES, but there are exceptions. There are two recognized orders: Icthyophonida and Dermocystida.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050705", "DC": "1", "DX": "20060101", "UI": "D050298"}, {"RECTYPE": "D", "MH": "Fibrin Modulating Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Fibrin Modulators|T121|NON|EQV|NLM (2006)|041013|abcdef", "MN": "D27.505.519.421", "MH_TH": "NLM (2006)", "ST": "T121", "RN": "0", "MS": "Agents that affect the function of FIBRIN in BLOOD COAGULATION. They used as COAGULANTS for HEMORRHAGE or ANTICOAGULANTS for THROMBOSIS.", "PM": "2006", "HN": "2006", "MR": "20140625", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050299"}, {"RECTYPE": "D", "MH": "Medical Order Entry Systems", "DE": "MED ORDER ENTRY SYSTEMS", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Order Entry Systems, Medical|T170|NON|EQV|NLM (2006)|041014|ORDER ENTRY SYSTEMS MED|abcdefv", "ENTRY": "System, Medication Alert", "MN": "N04.452.859.564.650.500", "FX": "Point-of-Care Systems", "MH_TH": "NLM (2006)", "ST": "T170", "MS": "Information systems, usually computer-assisted, that enable providers to initiate medical procedures, prescribe medications, etc. These systems support medical decision-making and error-reduction during patient care.", "PM": "2006", "HN": "2006", "MR": "20190709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050316"}, {"RECTYPE": "D", "MH": "Mulibrey Nanism", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nanism, Mulibrey|T047|ACX|EQV|NLM (1998)|960716|abcdef", "ENTRY": "Syndrome, Perheentupa", "MN": "C16.320.240.875", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "mulibrey (stands for MUscle, LIver, BRain, EYes): spell in titles & translations with lowercase m", "MS": "Growth failure from birth that is due to mutations in a gene (TRIM37) on chromosome 17q22-q23 which encodes a RING-B-box-coiled-coil protein.", "PM": "2006; see DWARFISM 1998-2005", "HN": "2006; use DWARFISM 1998-2005", "MR": "20120703", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050336"}, {"RECTYPE": "D", "MH": "Trimethyl Ammonium Compounds", "DE": "TRIMETHYL AMMONIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ammonium Compounds, Trimethyl", "MN": "D02.092.877.883", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "PI": "Quaternary Ammonium Compounds (1963-2005)", "MS": "QUATERNARY AMMONIUM COMPOUNDS containing three methyl groups, having the general formula of (CH3)3N+R.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050337"}, {"RECTYPE": "D", "MH": "Phenylammonium Compounds", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.092.877.674", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "PI": "Quaternary Ammonium Compounds (1963-2005)", "MS": "QUATERNARY AMMONIUM COMPOUNDS based on PHENYLAMINES with the general formula phenyl-N+R3.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050338"}, {"RECTYPE": "D", "MH": "Benzylammonium Compounds", "DE": "BENZYLAMMONIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ammonium Compounds, Phenylmethyl", "MN": "D02.092.877.096", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "PI": "Quaternary Ammonium Compounds (1963-2005)", "MS": "QUATERNARY AMMONIUM COMPOUNDS based on BENZYLAMINES with the general formula phenyl-CN+R3.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050339"}, {"RECTYPE": "D", "MH": "Lipid Metabolism", "AQ": "DE ES GE IM PH RE", "ENTRY": "Metabolism, Lipid", "MN": "G03.458", "MH_TH": "NLM (2006)", "ST": "T040", "AN": "general; prefer/metab with specific lipids", "PI": "Lipids/metabolism (1965-2005)", "MS": "Physiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS.", "PM": "2006", "HN": "2006", "MR": "20160630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050356"}, {"RECTYPE": "D", "MH": "Bone-Patellar Tendon-Bone Grafting", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Bone Patellar Tendon Bone Grafting", "MN": "E04.936.580.065", "MH_TH": "NLM (2014)", "ST": "T061", "PI": "Tendons, Para-Articular (1991-2005)", "MS": "Fixation of the ANTERIOR CRUCIATE LIGAMENT, during surgical reconstruction, by the use of a bone-patellar tendon graft.", "PM": "2006", "HN": "2006", "MR": "20220406", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050376"}, {"RECTYPE": "D", "MH": "Cold Ischemia", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Time, Cold Ischemia", "MN": "E05.760.833.445", "FX": "Warm Ischemia", "MH_TH": "NLM (2006)", "ST": "T061", "PI": "Ischemia (1976-2005)", "MS": "The chilling of a tissue or organ during decreased BLOOD perfusion or in the absence of blood supply. Cold ischemia time during ORGAN TRANSPLANTATION begins when the organ is cooled with a cold perfusion solution after ORGAN PROCUREMENT surgery, and ends after the tissue reaches physiological temperature during implantation procedures.", "PM": "2006", "HN": "2006", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050377"}, {"RECTYPE": "D", "MH": "T-Lymphocytes, Regulatory", "DE": "T LYMPHOCYTES REG", "DS": "LYMPHOCYTES J REGULATORY", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Treg Cell|T025|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Th3 Cell", "MN": "A15.382.490.555.567.569.500.700", "MH_TH": "NLM (1995)", "ST": "T025", "MS": "CD4-positive T cells that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-cells include naturally occurring CD4+CD25+ cells, IL-10 secreting Tr1 cells, and Th3 cells.", "PM": "2006, 1985-1994; see T-LYMPHOCYTES 1995-2005", "HN": "2006, 1985-1994; use T-LYMPHOCYTES 1995-2005", "MR": "20200114", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050378"}, {"RECTYPE": "D", "MH": "Arteriolosclerosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Arterioloscleroses", "MN": "C14.907.137.126.056", "MH_TH": "NLM (2001)", "ST": "T046", "AN": "do not confuse with ARTERIOSCLEROSIS", "PI": "Arteriosclerosis (1966-2005)", "MS": "Thickening of the walls of small ARTERIES or ARTERIOLES due to cell proliferation or HYALINE deposition.", "PM": "2006; see ARTERIOSCLEROSIS 2001-2005", "HN": "2006; use ARTERIOSCLEROSIS 2001-2005", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050379"}, {"RECTYPE": "D", "MH": "Monckeberg Medial Calcific Sclerosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sclerosis, M\u00f6nckeberg's", "MN": "C18.452.174.130.780.500", "MH_TH": "NLM (2001)", "ST": "T046", "PI": "Arteriosclerosis (1999-2005)", "MS": "Thickening and loss of elasticity of the walls of muscular ARTERIES due to calcification of the TUNICA MEDIA, the concentric layers of helically arranged SMOOTH MUSCLE CELLS.", "PM": "2006; see ARTERIOSCLEROSIS 2001-2005", "HN": "2006; use ARTERIOSCLEROSIS 2001-2005", "MR": "20110624", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050380"}, {"RECTYPE": "D", "MH": "TRPP Cation Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polycystin|T116|NON|EQV|NLM (2021)|200210|abcdef", "ENTRY": "Channels, TRPP Cation", "MN": "D12.776.543.585.400.901.777", "MH_TH": "NLM (2006)", "ST": "T116", "RN": "0", "PI": "Polycystic Kidney Diseases (1995-2005)", "MS": "A subgroup of TRP cation channels that are widely expressed in various cell types. Defects are associated with POLYCYSTIC KIDNEY DISEASES.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050396"}, {"RECTYPE": "D", "MH": "Radiotherapy, Intensity-Modulated", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Volumetric-Modulated Arc Therapies", "MN": "L01.313.500.750.100.710.600.550.700", "MH_TH": "NLM (2006)", "ST": "T061", "PI": "Radiotherapy, Conformal (1999-2005)", "MS": "CONFORMAL RADIOTHERAPY that combines several intensity-modulated beams to provide improved dose homogeneity and highly conformal dose distributions.", "PM": "2006", "HN": "2006", "MR": "20150623", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050397"}, {"RECTYPE": "D", "MH": "Adamantinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Adamantinoma of Long Bones|T191|NON|EQV|NLM (2013)|210308|abcdef", "ENTRY": "Long Bones Adamantinomas", "MN": "C05.116.231.030", "MH_TH": "UNK (19XX)", "ST": "T191", "PI": "Ameloblastoma (1965-2005)", "MS": "A locally aggressive, osteolytic neoplasm of the long bones, probably of epithelial origin and most often involving the TIBIA.", "PM": "2006, 1963-1964; see AMELOBLASTOMA 1965-2005", "HN": "2006, 1963-1964; use AMELOBLASTOMA 1965-2005", "MR": "20210510", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050398"}, {"RECTYPE": "D", "MH": "Glucagon-Secreting Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "alpha Cells, Pancreatic|T025|NON|EQV|NLM (2006)|041101|abcdef", "ENTRY": "alpha Cell, Pancreatic", "MN": "A11.436.294.064", "MH_TH": "NLM (2006)", "ST": "T025", "AN": "/transpl: do not routinely coordinate with ISLETS OF LANGERHANS TRANSPLANTATION", "PI": "Islets of Langerhans (1970-2005)", "MS": "A type of pancreatic cell representing about 5-20% of the islet cells. Alpha cells secrete GLUCAGON.", "PM": "2006; see ISLETS OF LANGERHANS 1980-2005", "HN": "2006; use ISLETS OF LANGERHANS 1980-2005", "MR": "20180630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050416"}, {"RECTYPE": "D", "MH": "Insulin-Secreting Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "beta Cells, Pancreatic|T025|NON|EQV|NLM (2006)|041101|abcdef", "ENTRY": "beta Cell, Pancreatic", "MN": "A11.436.294.092", "MH_TH": "NLM (2006)", "ST": "T025", "AN": "/transpl: do not routinely coordinate with ISLETS OF LANGERHANS TRANSPLANTATION", "PI": "Islets of Langerhans (1967-2005)", "MS": "A type of pancreatic cell representing about 50-80% of the islet cells. Beta cells secrete INSULIN.", "PM": "2006; see ISLETS OF LANGERHANS 1980-2005", "HN": "2006; use ISLETS OF LANGERHANS 1980-2005", "MR": "20180630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050417"}, {"RECTYPE": "D", "MH": "Pancreatic Polypeptide-Secreting Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "PP Cells, Pancreatic|T025|ABX|EQV|NLM (2006)|041101|abcdef", "ENTRY": "Pancreatic Polypeptide-Secreting Cell", "MN": "A11.436.294.900", "MH_TH": "NLM (2006)", "ST": "T025", "AN": "/transpl: do not routinely coordinate with ISLETS OF LANGERHANS TRANSPLANTATION", "PI": "Peptides (1973-2005)", "MS": "A group of islet cells (10-35%) which secrete PANCREATIC POLYPEPTIDE, a hormone that regulates APPETITE and FOOD INTAKE.", "PM": "2006", "HN": "2006", "MR": "20180701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050418"}, {"RECTYPE": "D", "MH": "Regulatory Elements, Transcriptional", "DE": "REG ELEMENTS TRANSCRIPTIONAL", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Transcriptional Regulatory Elements|T028|NON|EQV|UNK (19XX)|840406|TRANSCRIPTIONAL REG ELEMENTS|abcdefv", "ENTRY": "Transcriptional Regulatory Element|T028|NON|EQV|NLM (1992)|901015|TRANSCRIPTIONAL REG ELEMENT|abcdefv", "MN": "G05.360.340.024.340.137.750", "MH_TH": "NLM (1992)", "ST": "T028", "MS": "Nucleotide sequences of a gene that are involved in the regulation of GENETIC TRANSCRIPTION.", "PM": "2006; see GENES, REGULATOR 1991-2005", "HN": "2006; use GENES, REGULATOR 1991-2005", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050436"}, {"RECTYPE": "D", "MH": "Genes, Developmental", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Developmental Genes|T028|NON|EQV|NLM (2006)|041108|abcdef", "ENTRY": "Gene, Developmental", "MN": "G05.360.340.024.340.230", "FX": "Gene Expression Regulation, Developmental", "MH_TH": "UNK (19XX)", "ST": "T028", "MS": "Genes that determine the fate of a cell or CELLS in a region of the embryo during EMBRYONIC DEVELOPMENT.", "PM": "2006; see GENES, STRUCTURAL 1988-2005", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050437"}, {"RECTYPE": "D", "MH": "Genes, Immunoglobulin Heavy Chain", "DE": "GENES IG HEAVY CHAIN", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Immunoglobulin Heavy Chain Genes|T028|NON|EQV|NLM (1992)|910521|IG HEAVY CHAIN GENES|abcdefv", "ENTRY": "Immunoglobulin VH Germ Line Genes|T028|NRW|NLM (1992)|910521|IG VH GERM LINE GENES|abdefv", "MN": "G05.360.340.024.340.335.300", "FX": "Immunoglobulin Heavy Chains", "MH_TH": "UNK (19XX)", "ST": "T028", "MS": "Genes and gene segments encoding the IMMUNOGLOBULIN HEAVY CHAINS. Gene segments of the heavy chain genes are symbolized V (variable), D (diversity), J (joining), and C (constant).", "PM": "2006; see GENES, IMMUNOGLOBULIN 1987-2005", "HN": "2006; use GENES, IMMUNOGLOBULIN 1987-2005", "MR": "20190429", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050438"}, {"RECTYPE": "D", "MH": "Genes, Immunoglobulin Light Chain", "DE": "GENES IG LIGHT CHAIN", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Ig Light Chain Genes|T028|ABX|EQV|NLM (2020)|190408|abcdef", "ENTRY": "Immunoglobulin Light Chain Genes|T028|NON|EQV|NLM (1992)|910521|IG LIGHT CHAIN GENES|abcdefv", "MN": "G05.360.340.024.340.335.310", "FX": "Immunoglobulin Light Chains", "MH_TH": "UNK (19XX)", "ST": "T028", "MS": "Genes and gene segments encoding the IMMUNOGLOBULIN LIGHT CHAINS. Gene segments of the light chain genes are designated as V (variable), J (joining), and C (constant).", "PM": "2006; see GENES, IMMUNOGLOBULIN 1988-2005", "HN": "2006; use GENES, IMMUNOGLOBULIN 1988-2005", "MR": "20190429", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050439"}, {"RECTYPE": "D", "MH": "Immunoglobulin Subunits", "AQ": "AD AE AN BI BL CF CH CL DE DF EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Subunits, Ig", "MN": "D12.776.377.715.548.705", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "The PROTEIN SUBUNITS of the multimeric IMMUNOGLOBULIN proteins, such as IGA; IGD; IGE; IGG; and IGM. Included are the heavy and light chains which contain the specific ANTIGEN binding domains, as well as the accessory proteins that are part of the the secreted forms of IGM and IGA; (SECRETORY IGA).", "PM": "2006", "HN": "2006", "MR": "20050718", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050440"}, {"RECTYPE": "D", "MH": "VDJ Exons", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "VDJ Exon|T028|ABX|EQV|NLM (2006)|041109|abcdef", "ENTRY": "Exons, VDJ", "MN": "G05.360.340.024.340.335.655", "FX": "VDJ Recombinases", "MH_TH": "NLM (2006)", "ST": "T028", "MS": "Exons that are created in vivo during LYMPHOCYTE maturation from the V, D, and J gene segments of immunoglobulin superfamily genes (e.g., the IMMUNOGLOBULIN HEAVY CHAIN GENES, or the T-CELL RECEPTOR BETA GENES or T-CELL RECEPTOR GAMMA GENES ) by the VDJ RECOMBINASE system.", "PM": "2006", "HN": "2006", "MR": "20110624", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050441"}, {"RECTYPE": "D", "MH": "Fomites", "AQ": "CL MI SN VE VI", "ENTRY": "Fomite", "MN": "N06.850.520.203.250.500", "FX": "Equipment Contamination", "MH_TH": "NLM (2006)", "ST": "T073", "MS": "Inanimate objects that carry pathogenic microorganisms and thus can serve as the source of infection. Microorganisms typically survive on fomites for minutes or hours. Common fomites include CLOTHING, tissue paper, hairbrushes, and COOKING AND EATING UTENSILS.", "PM": "2006", "HN": "2006", "MR": "20200612", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050456"}, {"RECTYPE": "D", "MH": "Bowman Capsule", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Capsule, Bowman's", "MN": "A05.810.453.736.560.254", "MH_TH": "NLM (2006)", "ST": "T023", "PI": "Kidney Tubules (1967-2005)", "MS": "A double-walled epithelial capsule that is the bulbous closed proximal end of the kidney tubular system. It surrounds the cluster of convoluted capillaries of KIDNEY GLOMERULUS and is continuous with the convoluted PROXIMAL KIDNEY TUBULE.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050476"}, {"RECTYPE": "D", "MH": "Urofollitropin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Follicle-Stimulating Hormone, Human Urine|T116|T121|T125|NON|EQV|NLM (2006)|041116|abbbcdef", "ENTRY": "Urinary Human FSH", "MN": "D12.644.548.691.525.343.583.500", "MH_TH": "USAN (1987)", "ST": "T125", "RN": "0", "PI": "Menotropins (1998-2005)", "MS": "A protein extract of human menopausal urine in which LUTEINIZING HORMONE has been partially or completely removed. Urofollitropin represents FOLLICLE STIMULATING HORMONE from the urine.", "PM": "2006; see MENOTROPINS 1998-2005", "HN": "2006; use MENOTROPINS 1998-2005", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050477"}, {"RECTYPE": "D", "MH": "Neurotransmitter Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neurotransmitter Transporters|T116|T123|NON|EQV|NLM (2006)|041203|abbcdef", "ENTRY": "Transporters, Neurotransmitter", "MN": "D12.776.543.585.562", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Membrane transport proteins found predominately in NEURONS and neuroendocrine cells that facilitate neurotransmitter transport. They include two distinct families of proteins that transport NEUROTRANSMITTERS across the PLASMA MEMBRANE and that transport NEUROTRANSMITTERS into SECRETORY VESICLES.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050479"}, {"RECTYPE": "D", "MH": "Plasma Membrane Neurotransmitter Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neurotransmitter Transporters, Plasma Membrane|T116|T123|NON|EQV|NLM (2006)|041203|abbcdef", "ENTRY": "Symporters, Sodium-Neurotransmitter", "MN": "D12.776.543.585.562.374", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "don't confuse sodium chloride-dependent neurotransmitter symporters with SODIUM-POTASSIUM-CHLORIDE SYMPORTERS", "MS": "A family of neurotransmitter transporter proteins that facilitate NEUROTRANSMITTER reuptake into PRESYNAPTIC TERMINALS. They may play a role in regulating the intensity and duration of neurotransmission.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050480"}, {"RECTYPE": "D", "MH": "Vesicular Neurotransmitter Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vesicular Neurotransmitter Transporter Proteins|T116|T123|NON|EQV|NLM (2006)|041116|abbcdef", "ENTRY": "Vesicular Neurotransmitter Transporters", "MN": "D12.776.543.585.562.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "do not confuse with VESICULAR TRANSPORT PROTEINS", "MS": "A family of neurotransmitter transporter proteins that are INTEGRAL MEMBRANE PROTEINS of the LIPID BILAYER of SECRETORY VESICLES. They are ANTIPORTERS that exchange vesicular PROTONS for cytoplasmic NEUROTRANSMITTER and play an essential role in regulating neurotransmission.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050481"}, {"RECTYPE": "D", "MH": "Catecholamine Plasma Membrane Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neurotransmitter Transporters, Catecholamine-Specific|T116|T123|NON|EQV|NLM (2006)|041203|abbcdef", "ENTRY": "Transporters, Catecholamine-Specific Neurotransmitter", "MN": "D12.776.543.585.562.374.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Membrane Transport Proteins (1980-2005)", "MS": "A group of membrane transport proteins that transport biogenic amine derivatives of catechol across the PLASMA MEMBRANE. Catecholamine plasma membrane transporter proteins regulate neural transmission as well as catecholamine metabolism and recycling.", "PM": "2006; CATACHOLAMINE TRANSPORT PROTEIN was indexed under MEMBRANE TRANSPORT PROTEINS 2004 & CARRIER PROTEINS 1980-2004", "HN": "2006(1980)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050482"}, {"RECTYPE": "D", "MH": "Dopamine Plasma Membrane Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neurotransmitter Transporters, Dopamine-Specific|T116|T123|NON|EQV|NLM (2006)|041203|abbcdef", "ENTRY": "Transporters, Dopamine-Specific Neurotransmitter", "MN": "D12.776.543.585.937.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Membrane Transport Proteins (1987-2005)", "MS": "Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of dopaminergic neurons. They remove DOPAMINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS and are the target of DOPAMINE UPTAKE INHIBITORS.", "PM": "2006; DOPAMINE TRANSPORTER PROTEINS was indexed under MEMBRANE TRANSPORT PROTEINS 2005, CARRIER PROTEINS 1993-2004, NERVE TISSUE PROTEINS; MEMBRANE GLYOPROTEINS & MEMBRANE PROTEINS 1987-2004; DOPAMINE UPTAKE COMPLEX was indexed under MEMBRANE PROTEINS & NERVE TISSUE PROTEINS 1993-2004, DOPAMINE/metab 1991-1992", "HN": "2006(1987)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050483"}, {"RECTYPE": "D", "MH": "Norepinephrine Plasma Membrane Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Norepinephrine Plasma Membrane Transporters|T116|T123|NON|EQV|NLM (2006)|041203|abbcdef", "ENTRY": "Transporters, Noradrenaline-Specific Neurotransmitter", "MN": "D12.776.543.585.937.700", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Symporters (2005)", "MS": "Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of noradrenergic neurons. They remove NOREPINEPHRINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. The norepinephrine transporter regulates signal amplitude and duration at noradrenergic synapses and is the target of ADRENERGIC UPTAKE INHIBITORS.", "PM": "2006; NOREPINEPHRINE TRANSPORTER PROTEIN was indexed under SYMPORTERS 2005 & under CARRIER PROTEINS 1991-2004", "HN": "2006(1991)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050484"}, {"RECTYPE": "D", "MH": "GABA Plasma Membrane Transport Proteins", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neurotransmitter Transporters, GABA-Specific|T116|T123|ABX|EQV|NLM (2006)|041207|abbcdef", "ENTRY": "Transporters, GABA-Specific Neurotransmitter", "MN": "D12.776.543.585.562.374.750", "FX": "Receptors, GABA", "EC": "antagonists & inhibitors:GABA Uptake Inhibitors", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Membrane Transport Proteins (1980-2005)", "MS": "A family of plasma membrane neurotransmitter transporter proteins that regulates extracellular levels of the inhibitory neurotransmitter GAMMA-AMINOBUTYRIC ACID. They differ from GABA RECEPTORS, which signal cellular responses to GAMMA-AMINOBUTYRIC ACID. They control GABA reuptake into PRESYNAPTIC TERMINALS in the CENTRAL NERVOUS SYSTEM through high-affinity sodium-dependent transport.", "PM": "2006; GABA TRANSPORTERS was indexed under MEMBRANE TRANSPORT PROTEINS 2002-2005, CARRIER PROTEINS & under MEMBRANE PROTEINS 1979-2001", "HN": "2006(1979)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050485"}, {"RECTYPE": "D", "MH": "Serotonin Plasma Membrane Transport Proteins", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serotonin Plasma Membrane Transporter Proteins|T116|T123|NON|EQV|NLM (2006)|041116|abbcdef", "ENTRY": "Transporter, Sodium-Dependent Serotonin", "MN": "D12.776.543.585.937.747", "FX": "Receptors, Serotonin", "EC": "antagonists & inhibitors:Selective Serotonin Reuptake Inhibitors", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1992-2005)", "MS": "Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of serotonergic neurons. They are different than SEROTONIN RECEPTORS, which signal cellular responses to SEROTONIN. They remove SEROTONIN from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. Regulates signal amplitude and duration at serotonergic synapses and is the site of action of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS.", "PM": "2006; SEROTONIN TRANSPORTER was indexed under MEMBRANE TRANSPORT PROTEINS 2005, MEMBRANE GLYCOPROTEINS, NERVE TISSUE PROTEINS & MEMBRANE TRANSPORT PROTEINS 1992-2005, CARRIER PROTEINS 1992-2004; SEROTONECTIN was indexed under CARRIER PROTEINS 1983-2005", "HN": "2006(1992)", "MR": "20220715", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050486"}, {"RECTYPE": "D", "MH": "Glycine Plasma Membrane Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neurotransmitter Transporters, Glycine-Specific|T116|T123|NON|EQV|NLM (2006)|041206|abbcdef", "ENTRY": "Transporters, Glycine-Specific Neurotransmitter", "MN": "D12.776.543.585.562.374.812", "FX": "Receptors, Glycine", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Amino Acid Transport Systems, Neutral (1987-2005)", "MS": "A family of sodium chloride-dependent neurotransmitter symporters that transport the amino acid GLYCINE. They differ from GLYCINE RECEPTORS, which signal cellular responses to GLYCINE. They are located primarily on the PLASMA MEMBRANE of NEURONS; GLIAL CELLS; EPITHELIAL CELLS; and RED BLOOD CELLS where they remove inhibitory neurotransmitter glycine from the EXTRACELLULAR SPACE.", "PM": "2006; GLYCINE TRANSPORTER was indexed under AMINO ACID TRANSPORT SYSTEMS, NEUTRAL 2002-2005 & under CARRIER PROTEINS 1987-2001", "HN": "2006(1987)", "MR": "20070709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050487"}, {"RECTYPE": "D", "MH": "Hallux Varus", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Metatarsus Primus Varus|T190|NON|NRW|NLM (2006)|041116|abcdef", "MN": "C05.330.612", "MH_TH": "NLM (2006)", "ST": "T190", "MS": "Displacement of the great toe (HALLUX) towards the midline or away from the other TOES. It can be congenital or acquired.", "PM": "2006", "HN": "2006", "MR": "20160226", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050488"}, {"RECTYPE": "D", "MH": "Bunion, Tailor's", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tailor's Bunion|T020|NON|EQV|NLM (2006)|041116|abcdef", "ENTRY": "Tailors Bunion", "MN": "C05.330.488.050.500", "FX": "Hallux Valgus", "MH_TH": "NLM (2006)", "ST": "T020", "PI": "Hallux Valgus (1972-2005)", "MS": "Abnormal swelling of the outer aspect of the fifth metatarsal head affecting the fifth METATARSOPHALANGEAL JOINT.", "PM": "2006", "HN": "2006", "MR": "20160226", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050489"}, {"RECTYPE": "D", "MH": "Oncogene Protein tpr-met", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fusion Proteins, tpr-met|T116|NON|EQV|NLM (2006)|041117|abcdef", "ENTRY": "tpr-met, Oncogene Protein", "MN": "D12.776.624.664.500.660", "MH_TH": "NLM (1990)", "ST": "T116", "RN": "0", "MS": "The GENETIC TRANSLATION product from a GENE FUSION between a sequence from the tpr protein gene on the human CHROMOSOME 1 and the gene for PROTO-ONCOGENE PROTEINS C-MET.", "PM": "2006; see ONCOGENE PROTEINS, FUSION 1990-2005", "HN": "2006; use ONCOGENE PROTEINS, FUSION 1990-2005", "MR": "20050727", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050490"}, {"RECTYPE": "D", "MH": "Glutamate Plasma Membrane Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neurotransmitter Transporters, Glutamate-Specific|T116|T123|NON|EQV|NLM (2006)|041207|abbcdef", "ENTRY": "Transporters, Glutamate-Specific Neurotransmitter", "MN": "D12.776.543.585.937.250.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Symporters (1984-2005)", "MS": "A family of plasma membrane neurotransmitter transporter proteins that couple the uptake of GLUTAMATE with the import of SODIUM ions and PROTONS and the export of POTASSIUM ions. In the CENTRAL NERVOUS SYSTEM they regulate neurotransmission through synaptic reuptake of the excitatory neurotransmitter glutamate. Outside the central nervous system they function as signal mediators and regulators of glutamate metabolism.", "PM": "2006; SODIUM-GLUTAMATE COTRANSPORTER was indexed under AMINO ACID TRANSPORT SYSTEM X-AG & SYMPORTERS 2003-2005, CARRIER PROTEINS 1984-2002", "HN": "2006(1984)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050491"}, {"RECTYPE": "D", "MH": "Vesicular Biogenic Amine Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vesicular Amine Transporter Proteins|T116|T123|NON|EQV|NLM (2006)|041117|abbcdef", "ENTRY": "Amine Transporter, Vesicular", "MN": "D12.776.543.585.562.750.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Integral membrane proteins of the LIPID BILAYER of SECRETORY VESICLES that catalyze transport and storage of biogenic amine NEUROTRANSMITTERS such as ACETYLCHOLINE; SEROTONIN; MELATONIN; HISTAMINE; and CATECHOLAMINES. The transporters exchange vesicular protons for cytoplasmic neurotransmitters.", "PM": "2006; VESICULAR AMINE TRANSPORTER was indexed under MEMBRANE GLYCOPROTEINS 1997-2005, under NEUROPEPTIDES 1997-2005, & under GLYCOPROTEINS 1992-1996", "HN": "2006(1992)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050492"}, {"RECTYPE": "D", "MH": "Vesicular Monoamine Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vesicular Monoamine Transporter Proteins|T116|T123|NON|EQV|NLM (2006)|041117|abbcdef", "ENTRY": "Vesicular Transporter, Monoamine", "MN": "D12.776.543.585.562.750.500.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Neuropeptides (1992-2004)", "MS": "A family of vesicular amine transporter proteins that catalyze the transport and storage of CATECHOLAMINES and indolamines into SECRETORY VESICLES.", "PM": "2006; VESICULAR AMINE TRANSPORTER was indexed under MEMBRANE TRANSPORT PROTEINS 2005; MEMBRANE GLYCORPOTEINS & NEUROPEPTIDES 1997-2005, & under GLYCOPROTEINS 1992-1996", "HN": "2006(1992)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050493"}, {"RECTYPE": "D", "MH": "Vesicular Acetylcholine Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vesicular Acetylcholine Transporter Proteins|T116|T123|NON|EQV|NLM (2006)|041117|abbcdef", "ENTRY": "Vesicular Acetylcholine Transporters", "MN": "D12.776.543.585.562.750.500.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Membrane Transport Proteins (2005)", "MS": "Vesicular amine transporter proteins that transport the neurotransmitter ACETYLCHOLINE into small SECRETORY VESICLES. Proteins of this family contain 12 transmembrane domains and exchange vesicular PROTONS for cytoplasmic acetylcholine.", "PM": "2006; VESICULAR ACETYLCHOLINE TRANSPORTER was indexed under MEMBRANE TRANSPORT PROTEINS 1992-2005", "HN": "2006(1992)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050494"}, {"RECTYPE": "D", "MH": "Vesicular Inhibitory Amino Acid Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vesicular Inhibitory Amino Acid Transporter Proteins|T116|T123|NON|EQV|NLM (2006)|041117|abbcdef", "ENTRY": "Vesicular GABA Glycine Transporter Proteins", "MN": "D12.776.543.585.562.750.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of vesicular neurotransmitter transporter proteins that sequester the inhibitory neurotransmitters GLYCINE; GAMMA-AMINOBUTYRIC ACID; and possibly GAMMA-HYDROXYBUTYRATE into SECRETORY VESICLES.", "PM": "2006", "HN": "2006", "MR": "20050715", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050495"}, {"RECTYPE": "D", "MH": "Vesicular Glutamate Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vesicular Glutamate Transporter Proteins|T116|T123|NON|EQV|NLM (2006)|041117|abbcdef", "ENTRY": "Vesicular Glutamate Transporters", "MN": "D12.776.543.585.562.750.625", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of vesicular neurotransmitter transporter proteins that were originally characterized as sodium dependent inorganic phosphate cotransporters. Vesicular glutamate transport proteins sequester the excitatory neurotransmitter GLUTAMATE from the CYTOPLASM into SECRETORY VESICLES in exchange for lumenal PROTONS.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050496"}, {"RECTYPE": "D", "MH": "Stillbirth", "AQ": "EC EH EP GE PX VE", "ENTRY": "Stillbirths", "MN": "G08.686.784.769.496.500", "MH_TH": "UNK (19XX)", "ST": "T080", "PI": "Pregnancy Outcome (2004-2005)", "MS": "The event that a FETUS is born dead or stillborn.", "PM": "2006; see PREGNANCY OUTCOME 2004-2005, see FETAL DEATH 1963-2003", "HN": "2006; use PREGNANCY OUTCOME 2004-2005, use FETAL DEATH 1963-2003", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050497"}, {"RECTYPE": "D", "MH": "Live Birth", "AQ": "EC EH EP GE PX VE", "ENTRY": "Live Births", "MN": "G08.686.784.769.496.249", "MH_TH": "NLM (2004)", "ST": "T080", "AN": "use only in relation to the outcome of the pregnancy; use BIRTH for the physiologic process of giving birth", "PI": "Pregnancy Outcome (2004-2005)", "MS": "The event that a FETUS is born alive with heartbeats or RESPIRATION regardless of GESTATIONAL AGE. Such liveborn is called a newborn infant (INFANT, NEWBORN).", "PM": "2006; see PREGNANCY OUTCOME 2004-2005", "HN": "2006; use PREGNANCY OUTCOME 2004-2005", "MR": "20180630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050498"}, {"RECTYPE": "D", "MH": "Adrenarche", "AQ": "BL CF DE EH GE IM ME PH PX RE UR", "MN": "G08.686.841.374.204", "MH_TH": "NLM (2006)", "ST": "T040", "PI": "Puberty, Precocious (1966-2005)", "MS": "A stage of development at which the ADRENAL GLANDS undergo maturation leading to the capability of producing increasing amounts of adrenal androgens, DEHYDROEPIANDROSTERONE and ANDROSTENEDIONE. Adrenarche usually begins at about 7 or 8 years of age before the signs of PUBERTY and continues throughout puberty.", "PM": "2006", "HN": "2006", "MR": "20160602", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050499"}, {"RECTYPE": "D", "MH": "Pancreatitis, Chronic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Chronic Pancreatitis|T047|NON|EQV|NLM (2006)|ORD (2010)|041117|abcdeef", "MN": "C23.550.291.500.750", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Pancreatitis (1965-2005)", "MS": "INFLAMMATION of the PANCREAS that is characterized by recurring or persistent ABDOMINAL PAIN with or without STEATORRHEA or DIABETES MELLITUS. It is characterized by the irregular destruction of the pancreatic parenchyma which may be focal, segmental, or diffuse.", "PM": "2006", "HN": "2006", "MR": "20210312", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050500"}, {"RECTYPE": "D", "MH": "Nostoc commune", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.585.750", "MH_TH": "NLM (2006)", "ST": "T007", "RN": "txid1178", "PI": "Nostoc (2005)", "MS": "A form species of spore-producing CYANOBACTERIA, in the family Nostocaceae, order Nostocales. It is an important source of fixed NITROGEN in nutrient-depleted soils. When wet, it appears as a jelly-like mass.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050501"}, {"RECTYPE": "D", "MH": "Nostoc muscorum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.585.760", "MH_TH": "NLM (2006)", "ST": "T007", "RN": "txid1179", "PI": "Nostoc (2005)", "MS": "A form-species of nitrogen-fixing CYANOBACTERIA, in the family Nostocaceae, order Nostocales.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050502"}, {"RECTYPE": "D", "MH": "Indoleamine-Pyrrole 2,3,-Dioxygenase", "DS": "INDOLEAMINE PYRROLE DIOXYGENASE 02 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Indoleamine 2,3 Dioxygenase", "MN": "D08.811.682.690.416.333", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "0", "PI": "Tryptophan Oxygenase (1968-2005)", "MS": "A dioxygenase with specificity for the oxidation of the indoleamine ring of TRYPTOPHAN. It is an extrahepatic enzyme that plays a role in metabolism as the first and rate limiting enzyme in the kynurenine pathway of TRYPTOPHAN catabolism.", "PM": "2006; see TRYPTOPHAN OXYGENASE 1990-2005; INDOLAMINE-2,3-DIOXYGENASE was indexed under DIOXYGENASES 2005 and OXYGENASES 1990-2004", "HN": "2006(1990)", "MR": "20120703", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050503"}, {"RECTYPE": "D", "MH": "Oncolytic Viruses", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Viruses, Oncolytic", "MN": "B04.700", "FX": "Oncolytic Virotherapy", "MH_TH": "NLM (1994)", "ST": "T005", "AN": "ONCOGENIC VIRUSES is available", "PI": "Viruses (1999-2005)", "MS": "Tumor-selective, replication competent VIRUSES that have antineoplastic effects. This is achieved by producing cytotoxicity-enhancing proteins and/or eliciting an antitumor immune response. They are genetically engineered so that they can replicate in CANCER cells but not in normal cells, and are used in ONCOLYTIC VIROTHERAPY.", "PM": "2006, 1966-1993; see VIRUSES 1994-2005", "HN": "2006, 1966-1993; use VIRUSES 1994-2005", "MR": "20200902", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050504"}, {"RECTYPE": "D", "MH": "Mutant Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Mutant", "MN": "D12.776.602", "MH_TH": "NLM (2006)", "ST": "T116", "RN": "0", "AN": "coordinate with specific mutant protein", "PI": "Mutation (1966-2005)", "MS": "Proteins produced from GENES that have acquired MUTATIONS.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050505"}, {"RECTYPE": "D", "MH": "Mutant Chimeric Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Mutant Hybrid", "MN": "D12.776.602.500", "MH_TH": "NLM (2006)", "ST": "T116", "RN": "0", "AN": "do not confuse with CHIMERIC PROTEINS, RECOMBINANT see RECOMBINANT FUSION PROTEINS or CHIMERIC PROTEINS, ONCOGENE see ONCOGENE PROTEINS, FUSION", "MS": "Proteins produced from GENES that have mutated by the fusing of protein coding regions of more than one gene. Such hybrid proteins are responsible for some instances of ANTIBIOTIC RESISTANCE and defective biological processes such as NEOPLASMS.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050506"}, {"RECTYPE": "D", "MH": "Subcutaneous Fat, Abdominal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Subcutaneous Fats, Abdominal", "MN": "A10.165.114.830.750.500", "MH_TH": "NLM (2006)", "ST": "T024", "PI": "Adipose Tissue (1967-2005)", "MS": "Fatty tissue under the SKIN in the region of the ABDOMEN.", "PM": "2006", "HN": "2006", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050507"}, {"RECTYPE": "D", "MH": "Mesangial Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Glomerular Mesangial Cells|T025|NON|NRW|NLM (2006)|041123|abcdef", "ENTRY": "Renal Mesangial Cell", "MN": "A11.329.228.950", "MH_TH": "NLM (2006)", "ST": "T025", "PI": "Kidney Glomerulus (1968-2005)", "MS": "Smooth muscle-like cells adhering to the wall of the small blood vessels of the KIDNEY at the glomerulus and along the vascular pole of the glomerulus in the JUXTAGLOMERULAR APPARATUS. They are myofibroblasts with contractile and phagocytic properties. These cells and their MESANGIAL EXTRACELLULAR MATRIX constitute the GLOMERULAR MESANGIUM.", "PM": "2006", "HN": "2006", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050527"}, {"RECTYPE": "D", "MH": "Diet, Carbohydrate-Restricted", "AQ": "AE CL EC EH HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Low-Carbohydrate Diets", "MN": "G07.203.650.240.245", "MH_TH": "NLM (2006)", "ST": "T061", "PI": "Dietary Carbohydrates (1973-2005)", "MS": "A diet that contains limited amounts of CARBOHYDRATES. This is in distinction to a regular DIET.", "PM": "2006", "HN": "2006", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050528"}, {"RECTYPE": "D", "MH": "Glomerular Basement Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Membranes, Glomerular Basement", "MN": "A11.284.295.310.279", "FX": "Anti-Glomerular Basement Membrane Disease", "MH_TH": "NLM (2006)", "ST": "T024", "PI": "Kidney Glomerulus (1965-2005)", "MS": "The layer of EXTRACELLULAR MATRIX that lies between the ENDOTHELIUM of the glomerular capillaries and the PODOCYTES of the inner or visceral layer of the BOWMAN CAPSULE. It is the product of these two cell types. It acts as a physical barrier and an ion-selective filter.", "PM": "2006", "HN": "2006", "MR": "20110624", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050533"}, {"RECTYPE": "D", "MH": "Glycerol-3-Phosphate Dehydrogenase (NAD+)", "DS": "GLYCEROL PHOSPHATE DEHYDROGENASE NAD 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alphaGPDH|T116|T126|ABX|EQV|NLM (2006)|abbcde", "MN": "D08.811.682.047.820.293", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.1.1.8", "RR": "9075-65-4 (CRN)", "PI": "Glycerolphosphate Dehydrogenase (1982-2005)", "MS": "An NAD-dependent enzyme that catalyzes the oxidation of sn-glycerol 3-phosphate to glycerone phosphate.", "PM": "2006; GLYCEROL-3-PHOSPHATE DEHYDROGENASE (NAD+) was indexed under GLYCEROLPHOSPHATE DEHYDROGENASE 1982-2005", "HN": "2006(1982)", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050536"}, {"RECTYPE": "D", "MH": "Hydroxypyruvate Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase, Hydroxypyruvate", "MN": "D08.811.682.047.820.400", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.1.1.81", "RR": "9059-44-3 (CRN)", "MS": "An enzyme that catalyzes the oxidation of D-glycerate to hydroxypyruvate in the presence of NADP.", "PM": "2006; HYDROXYPYRUVATE DEHYDROGENASE was indexed under ALCOHOL OXIDOREDUCTASES 1980-2005 & under GLYCERIC ACIDS 1974-1980", "HN": "2006(1980); use GLYCERIC ACIDS 1974-1980", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050537"}, {"RECTYPE": "D", "MH": "Malate Dehydrogenase (NADP+)", "DS": "MALATE DEHYDROGENASE NADP", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NADP Malate Dehydrogenase", "MN": "D08.811.682.047.820.498", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.1.1.82", "RR": "37250-19-4 (CRN)", "MS": "A light-activated enzyme that catalyzes the oxidation of (S)-malate to OXALOACETATE. It is involved in PYRUVATE metabolism and CARBON fixation.", "PM": "2006; MALATE DEHYDROGENASE (NADP+) was indexed under MALATE DEHYDROGENASE 1988-2005", "HN": "2006(1998)", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050538"}, {"RECTYPE": "D", "MH": "3-Isopropylmalate Dehydrogenase", "DS": "ISOPROPYLMALATE DEHYDROGENASE 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Isopropylmalate Dehydrogenase", "MN": "D08.811.682.047.820.193", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.1.1.85", "RR": "9030-97-1 (CRN)", "MS": "An NAD+ dependent enzyme that catalyzes the oxidation of 3-carboxy-2-hydroxy-4-methylpentanoate to 3-carboxy-4-methyl-2-oxopentanoate. It is involved in the biosynthesis of VALINE; LEUCINE; and ISOLEUCINE.", "PM": "2006; 3-ISOPROPYLMALATE DEHYDROGENASE was indexed under ALCOHOL OXIDOREDUCTASES 1981-2005, & under DICARBOXYLIC ACIDS 1970-1980", "HN": "2006(1980); use DICARBOXYLIC ACIDS 1970-1979", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050539"}, {"RECTYPE": "D", "MH": "Ketol-Acid Reductoisomerase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductoisomerase, Ketol-Acid", "MN": "D08.811.682.047.820.487", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.1.1.86", "RR": "9075-02-9 (CRN)", "MS": "An enzyme that catalyzes the oxidation of (R)-2,3-dihydroxy-3-methylbutanoate to (S)-2-hydroxy-2-methyl-3-oxobutanoate in the presence of NADP. It is involved in the biosynthesis of VALINE; LEUCINE; ISOLEUCINE; pentothenate and COENZYME A. This enzyme was formerly classified as EC 1.1.1.89.", "PM": "2006; KETOL-ACID REDUCTOISOMERASE was indexed under ALCOHOL OXODOREDUCTASES 1983-2000, & under VALERATES 1970-1982", "HN": "2006(1980); use VALERATES 1970-1979", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050540"}, {"RECTYPE": "D", "MH": "Bowman Membrane", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Membranes, Bowman's", "MN": "A09.371.060.217.113", "MH_TH": "NLM (2006)", "ST": "T023", "PI": "Cornea (1965-2005)", "MS": "A layer of acellular matrix that lies beneath the CORNEAL EPITHELIUM and above the CORNEAL STROMA. It consists of randomly arranged COLLAGEN fibers in a condensed bed of intercellular substance. It provides stability and strength to the cornea.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050541"}, {"RECTYPE": "D", "MH": "D-Xylulose Reductase", "DS": "XYLULOSE REDUCTASE D", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Xylitol Dehydrogenase, NAD-Dependent", "MN": "D08.811.682.047.820.800", "MH_TH": "NLM (2006)", "ST": "T126", "N1": "xylitol NAD 2-oxidoreductase (D-xylulose-forming)", "RN": "EC 1.1.1.9", "MS": "An enzyme that plays a role in the PENTOSES and GLUCURONATES interconversion pathway by catalyzing the oxidation of XYLITOL to D-xylulose. This enzyme has been found to be specific for NAD+.", "PM": "2006; D-XYLULOSE REDUCTASE was indexed under SUGAR ALCOHOL DEHYDROGENASES 1981-2005, ALCOHOL OXIDOREDUCTASES 1975-1980, XYLULOSE 1976-1980, & KETOSES & PENTOSES 1975-1976", "HN": "2006(1980)", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050542"}, {"RECTYPE": "D", "MH": "Phosphoglycerate Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidoreductase, Phosphoglycerate", "MN": "D08.811.682.047.150.650", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.1.1.95", "RR": "9075-29-0 (CRN)", "MS": "An enzyme that catalyzes the oxidation of 3-phosphoglycerate to 3-phosphohydroxypyruvate. It takes part in the L-SERINE biosynthesis pathway.", "PM": "2006; PHOSPHOGLYCERATE DEHYDROGENASE was indexed under CARBOHYDRATE DEHYSDROGENASES 1985-2005", "HN": "2006(1985)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050543"}, {"RECTYPE": "D", "MH": "L-Gulonolactone Oxidase", "DS": "GULONOLACTONE OXIDASE L", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, L-Gulonolactone", "MN": "D08.811.682.047.150.700.437", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.1.3.8", "RR": "9028-78-8 (CRN)", "MS": "An enzyme involved in the metabolism of ASCORBIC ACID and aldarate. It catalyzes the oxidation of L-gulono-1,4-lactone to L-xylo-hex-3-ulonolactone.", "PM": "2006; L-GULONOLACTONE OXIDASE was indexed under SUGAR ALCOHOL DEHYDROGENASES 1980-2005, ALCOHOL OXIDOREDUCTASES & GLUCONATES 1973-1979", "HN": "2006(1980); use ALCOHOL OXIDOREDUCTASES & GLUCONATES 1973-1979", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050544"}, {"RECTYPE": "D", "MH": "Choline Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, Choline", "MN": "D08.811.682.047.180", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.1.99.1", "MS": "An enzyme bound to the inner mitochondrial membrane that catalyzes the oxidation of CHOLINE to BETAINE.", "PM": "2006; CHOLINE DEHYDROGENASE was indexed under ALCOHOL OXIDOREDUCTASES 1982-2005, & under CHOLINE 1979-1981", "HN": "2006(1980); use CHOLINE 1979", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050545"}, {"RECTYPE": "D", "MH": "Plastoquinol-Plastocyanin Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase, Plastoquinol-Plastocyanin", "MN": "D12.776.765.199.750.750.374.875", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 7.1.1.6", "PI": "Oxidoreductases (1981-2005)", "MS": "A component of the CYTOCHROME B6F COMPLEX, this enzyme catalyzes the oxidation of plastoquinol-1 to PLASTOQUINONE.", "PM": "2006; PLASTOQUINOL-PLASTOCYANIN REDUCTASE was indexed under OXIDOREDUCTASES 1981-2005", "HN": "2006(1981)", "MR": "20190705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050547"}, {"RECTYPE": "D", "MH": "Catechol 1,2-Dioxygenase", "DS": "CATECHOL DIOXYGENASE 01 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pyrocatechol 1,2 Dioxygenase", "MN": "D08.811.682.690.416.277", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.13.11.1", "RR": "9027-16-1 (CRN)", "MS": "An enzyme that catalyzes the oxidation of catechol to muconic acid with the use of Fe3+ as a cofactor. This enzyme was formerly characterized as EC 1.13.1.1 and EC 1.99.2.2.", "PM": "2006; CATECHOL 1,2-DIOXYGENASE was indexed under DIOXYGENASES 1975-2005, & under CATECHOL 1973-1974", "HN": "2006(1980); use DIOXYGENASES 1975-1979 & CATECHOL 1973-1974", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050548"}, {"RECTYPE": "D", "MH": "Fatty Acid-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fatty Acid-Binding Protein|T116|T123|NON|EQV|NLM (2021)|191227|abbcdef", "ENTRY": "Protein, Fatty Acid-Binding", "MN": "D12.776.157.170", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Carrier Proteins (1980-2005)", "MS": "Intracellular proteins that reversibly bind hydrophobic ligands including: saturated and unsaturated FATTY ACIDS; EICOSANOIDS; and RETINOIDS. They are considered a highly conserved and ubiquitously expressed family of proteins that may play a role in the metabolism of LIPIDS.", "PM": "2006; FATTY ACID-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-2000", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050556"}, {"RECTYPE": "D", "MH": "Catechol 2,3-Dioxygenase", "DS": "CATECHOL DIOXYGENASE 02 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pyrocatechol 2,3 Oxygenase", "MN": "D08.811.682.690.416.305", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.13.11.2", "RR": "9029-46-3 (CRN)", "MS": "Catalyzes the oxidation of catechol to 2-hydroxymuconate semialdehyde in the carbazole and BENZOATE degradation via HYDROXYLATION pathways. It also catalyzes the conversion of 3-methylcatechol to cis, cis-2-hydroxy-6-oxohept-2,4-dienoate in the TOLUENE and XYLENE degradation pathway. This enzyme was formerly characterized as EC 1.13.1.2.", "PM": "2006; CATECHOL 2,3,-DIOXYGENASE was indexed under DIOXYGENASES 1981-2005, under CATECHOLS 1975-1980, & under CATECHOL 1973-1974", "HN": "2006(1981)", "MR": "20090715", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050557"}, {"RECTYPE": "D", "MH": "Cysteine Dioxygenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Cysteine", "MN": "D08.811.682.690.416.319", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.13.11.20", "RR": "37256-59-0 (CRN)", "MS": "An enzyme that catalyzes the conversion of L-CYSTEINE to 3-sulfinoalanine (3-sulfino-L-alanine) in the CYSTEINE metabolism and TAURINE and hypotaurine metabolic pathways.", "PM": "2006; CYSTEINE DIOXYGENASE was indexed under DIOXYGENASES 1981-2005, & under CYSTEINE 1973-1980", "HN": "2006(1980); use CYSTEINE 1973-1979", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050558"}, {"RECTYPE": "D", "MH": "beta-Carotene 15,15'-Monooxygenase", "DS": "BETA CAROTENE MONOOXYGENASE 15 15", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Carotene Cleaving Enzyme", "MN": "D08.811.682.690.708.392.312", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.99.36", "MS": "A monooxygenase that catalyzes the conversion of BETA-CAROTENE into two molecules of RETINAL. It was formerly characterized as EC 1.13.11.21 and EC 1.18.3.1.", "PM": "2006; BETA-CAROTENE 15,15'-MONOOXYGENASE was indexed under OXYGENASES 1969-2005", "HN": "2006(1980); use OXYGENASES 1969-1979", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050559"}, {"RECTYPE": "D", "MH": "Homogentisate 1,2-Dioxygenase", "DS": "HOMOGENTISATE DIOXYGENASE 01 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxygenase, Homogentisate", "MN": "D08.811.682.690.416.326", "FX": "Alkaptonuria", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.13.11.5", "RR": "9029-49-6 (CRN)", "PI": "Dioxygenases (1969-2005)", "MS": "A mononuclear Fe(II)-dependent oxygenase, this enzyme catalyzes the conversion of homogentisate to 4-maleylacetoacetate, the third step in the pathway for the catabolism of TYROSINE. Deficiency in the enzyme causes ALKAPTONURIA, an autosomal recessive disorder, characterized by homogentisic aciduria, OCHRONOSIS and ARTHRITIS. This enzyme was formerly characterized as EC 1.13.1.5 and EC 1.99.2.5.", "PM": "2006; HOMOGENTISATE 1,2-DIOXYGENASE was indexed under DIOXYGENASES 1969-2005, OXYGENASES 1983-2004, & under HOMOGENTISIC ACID 1973-1982", "HN": "2006(1969)", "MR": "20120703", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050560"}, {"RECTYPE": "D", "MH": "3-Hydroxyanthranilate 3,4-Dioxygenase", "DS": "HYDROXYANTHRANILATE DIOXYGENASE 03 03 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxygenase, 3-Hydroxyanthranilic Acid", "MN": "D08.811.682.690.416.328", "MH_TH": "NLM (2006)", "ST": "T126", "N1": "3-hydroxyanthranilic acid oxygenase", "RN": "EC 1.13.11.6", "RR": "9029-50-9 (CRN)", "MS": "An enzyme that catalyzes the conversion of 3-hydroxyanthranilate to 2-amino-3-carboxymuconate semialdehyde. It was formerly characterized as EC 1.13.1.6.", "PM": "2006; 3-HYDROXYANTHRANILATE 3,4-DIOXYGENASE was indexed under DIOXYGENASES 1981-2005, & under ANTHRANILIC ACID 1974-1980", "HN": "2006(1980); use ANTHRANILIC ACID 1974-1979", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050561"}, {"RECTYPE": "D", "MH": "Inositol Oxygenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxygenase, Myo-Inositol", "MN": "D12.776.556.579.374.281", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.13.99.1", "RR": "9029-59-8 (CRN)", "MS": "A non-heme IRON enzyme that catalyzes the conversion of MYOINOSITOL to D-glucuronic acid. The reaction is the first committed step in MYOINOSITOL catabolic pathway. This enzyme was formerly characterized as EC 1.13.1.11 and 1.99.2.6.", "PM": "2006; INOSITOL OXYGENASE was indexed under OXYGENASES 1983-2005 & under INOSITOL 1979-1982", "HN": "2006(1980); use INOSITOL 1979", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050562"}, {"RECTYPE": "D", "MH": "gamma-Butyrobetaine Dioxygenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "gamma Butyrobetaine,2 Oxoglutarate Dioxygenase", "MN": "D08.811.682.690.708.401", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.11.1", "MS": "An enzyme that catalyzes the HYDROXYLATION of gamma-butyrobetaine to L-CARNITINE. It is the last enzyme in the biosynthetic pathway of L-CARNITINE and is dependent on alpha-ketoglutarate; IRON; ASCORBIC ACID; and OXYGEN.", "PM": "2006; GAMMA-BUTYROBETAINE DIOXYGENASE was indexed under MIXED FUNCTION OXYGENASES 1980-2005, KETOGLUTARIC ACID 1973-1974, BETAINE 1972-1980, BUTYRATES 1974-1979, & AMINOBUTYRIC ACID 1970-1974", "HN": "2006(1980); use KETOGLUTARIC ACID 1973-1974, BETAINE 1972-1979, BUTYRATES 1974-1979, & AMINOBUTYRIC ACID 1970-1974", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050563"}, {"RECTYPE": "D", "MH": "Trans-Cinnamate 4-Monooxygenase", "DS": "TRANS CINNAMATE MONOOXYGENASE 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Trans Cinnamic Acid 4 Hydroxylase", "MN": "D08.811.682.690.708.826", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.14.91", "RR": "9077-75-2 (CRN)", "MS": "A member of the P450 superfamily, this enzyme catalyzes the first oxidative step of the phenylpropanoid pathway in higher PLANTS by transforming trans-cinnamate into p-coumarate.", "PM": "2006; TRANS-CINNAMATE 4-MONOOXYGENASE was indexed under CYTOCHROME P-450 ENZYME SYSTEM & MIXED FUNCTION OXYGENASES 1983-2005, & UNDER CINNAMATES 1974-1982", "HN": "2006(1980); use CINNAMATES 1974-1979", "MR": "20190705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050564"}, {"RECTYPE": "D", "MH": "Benzoate 4-Monooxygenase", "DS": "BENZOATE MONOOXYGENASE 04", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Benzoate Para Hydroxylase", "MN": "D08.811.682.690.708.062", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.14.92", "MS": "An enzyme that catalyzes the oxidation of BENZOATE to 4-hydroxybenzoate. It requires IRON and tetrahydropteridine.", "PM": "2006; BENZOATE 4-MONOOXYGENASE was indexed under MIXED FUNCTION OXYGENASES 1982-2005, & under BENZOATES 1977-1981", "HN": "2006(1980); use BENZOATES 1977-1979", "MR": "20190705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050565"}, {"RECTYPE": "D", "MH": "Membrane Fusion Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Membrane Fusion", "MN": "D12.776.543.512", "MH_TH": "NLM (2006)", "ST": "T116", "RN": "0", "AN": "for chimeric membrane fusion proteins coordinate with RECOMBINANT FUSION PROTEINS, if resulting from ARTIFICIAL GENE FUSION, or MUTANT CHIMERIC PROTEINS", "PI": "Membrane Proteins (1983-2005)", "MS": "Proteins that catalyze MEMBRANE FUSION.", "PM": "2006", "HN": "2006", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050576"}, {"RECTYPE": "D", "MH": "Complement C3-C5 Convertases", "DS": "COMPLEMENT C 03 C 05 CONVERTASES", "AQ": "AD AE AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "C3 Convertase|T116|T126|T129|NON|NRW|UNK (19XX)|770517|abbbcdef", "ENTRY": "Convertases, Complement C5", "MN": "D12.776.124.486.274.045.387", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "EC 3.4.21.-", "PI": "Complement C5 (1976-2005)", "MS": "Serine proteases that cleave COMPLEMENT C3 into COMPLEMENT C3A and COMPLEMENT C3B, or cleave COMPLEMENT C5 into COMPLEMENT C5A and COMPLEMENT C5B. These include the different forms of C3/C5 convertases in the classical and the alternative pathways of COMPLEMENT ACTIVATION. Both cleavages take place at the C-terminal of an ARGININE residue.", "PM": "2006; for COMPLEMENT 3 CONVERTASE see COMPLEMENT 3 CONVERTASE 1991-2005, see COMPLEMENT ACTIVATING ENZYMES 1978-1990", "HN": "2006 (1978)", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050577"}, {"RECTYPE": "D", "MH": "Complement C3-C5 Convertases, Alternative Pathway", "DS": "COMPLEMENT C 03 C 05 CONVERTASES ALTERNATIVE PATHWAY", "AQ": "AD AE AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Complement C3 C5 Convertases, Alternative Pathway", "MN": "D12.776.124.486.274.045.387.500", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "EC 3.4.21.47", "PI": "Esterases (1975-2005)", "MS": "Important enzymes in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY. They cleave COMPLEMENT C3 and COMPLEMENT C5.", "PM": "2006", "HN": "2006", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050578"}, {"RECTYPE": "D", "MH": "Complement C3-C5 Convertases, Classical Pathway", "DS": "COMPLEMENT C 03 C 05 CONVERTASE CLASSICAL PATHWAY", "AQ": "AD AE AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Complement C3 C5 Convertases, Classical Pathway", "MN": "D12.776.124.486.274.045.387.750", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "EC 3.4.21.43", "PI": "Complement C5 (1976-2005)", "MS": "Important enzymes in the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. They cleave COMPLEMENT C3 and COMPLEMENT C5.", "PM": "2006", "HN": "2006", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050579"}, {"RECTYPE": "D", "MH": "Excitatory Amino Acid Transporter 3", "DS": "EXCITATORY AMINO ACID TRANSPORTER 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, SLC1A1", "MN": "D12.776.543.585.937.250.500.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Symporters (1984-2005)", "MS": "A neuronal and epithelial type glutamate plasma membrane transporter protein.", "PM": "2006; EXCITATORY AMINO ACID TRANSPORTER 3 was indexed under AMINO ACID TRANSPORT SYSTEM X-AG & SYMPORTERS 2003-2005 & under CARRIER PROTEINS 1984-2002", "HN": "2006(1984)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050580"}, {"RECTYPE": "D", "MH": "Excitatory Amino Acid Transporter 4", "DS": "EXCITATORY AMINO ACID TRANSPORTER 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, SLC1A6", "MN": "D12.776.543.585.937.250.500.937", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A glutamate plasma membrane transporter protein that is primarily expressed in cerebellar PURKINJE CELLS on postsynaptic DENDRITIC SPINES.", "PM": "2006; EXCITATORY AMINO ACID TRANSPORTER 4 was indexed under SYMPORTERS & AMINO ACID TRANSPORT SYSTEM X-AG (2005)", "HN": "2006(2005)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050581"}, {"RECTYPE": "D", "MH": "Excitatory Amino Acid Transporter 5", "DS": "EXCITATORY AMINO ACID TRANSPORTER 005", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, SLC1A7", "MN": "D12.776.543.585.937.250.500.968", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A glutamate plasma membrane transporter protein that is primarily expressed in the RETINA.", "PM": "2006; EXCITATORY AMINO ACID TRANSPORTER 5 was indexed under SYMPORTERS & AMINO ACID TRANSPORT SYSTEM X-AG (2005)", "HN": "2006(2005)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050582"}, {"RECTYPE": "D", "MH": "Oncogene Fusion", "AQ": "DE ES GE IM PH RE", "ENTRY": "Oncogene Fusions", "MN": "G05.728.385.500", "FX": "Oncogene Proteins, Fusion", "MH_TH": "NLM (2006)", "ST": "T049", "MS": "The GENETIC RECOMBINATION of the parts of two or more GENES, including an ONCOGENE as at least one of the fusion partners. Such gene fusions are often detected in neoplastic cells and are transcribed into ONCOGENE FUSION PROTEINS.", "PM": "2006", "HN": "2006", "MR": "20160617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050596"}, {"RECTYPE": "D", "MH": "Vesicular Glutamate Transport Protein 1", "DS": "VESICULAR GLUTAMATE TRANSPORT PROTEIN 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vesicular Glutamate Transporter 1|T116|T123|NON|EQV|NLM (2006)|010905|VESICULAR GLUTAMATE TRANSPORTER 01|abbcdefs", "ENTRY": "Brain Specific Na Dependent Inorganic Phosphate Cotransporter", "MN": "D12.776.543.585.562.750.625.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Vesicular Transport Proteins (2004)", "MS": "A vesicular glutamate transporter protein that is predominately expressed in TELENCEPHALON of the BRAIN.", "PM": "2006; VESICULAR GLUTAMATE TRANSPORTER 1 was indexed under MEMBRANE TRANSPORT PROTEINS 2005, under VESICULAR TRANSPORT PROTEINS 2004-2005, & under CARRIER PROTEINS 2001-2004", "HN": "2006(2001)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050598"}, {"RECTYPE": "D", "MH": "Vesicular Glutamate Transport Protein 2", "DS": "VESICULAR GLUTAMATE TRANSPORT PROTEIN 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vesicular Glutamate Transporter 2|T116|T123|NON|EQV|NLM (2006)|010905|VESICULAR GLUTAMATE TRANSPORTER 02|abbcdefs", "ENTRY": "Differentiation Associated Na Dependent Inorganic Phosphate Cotransporter", "MN": "D12.776.543.585.562.750.625.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Vesicular Transport Proteins (2004)", "MS": "A vesicular glutamate transporter protein that is predominately expressed in the DIENCEPHALON and lower brainstem regions of the CENTRAL NERVOUS SYSTEM.", "PM": "2006; VESICULAR GLUTAMATE TRANSPORTER 2 was indexed under MEMBRANE TRANSPORT PROTEINS 2005, under VESICULAR TRANSPORT PROTEINS 2004-2005, under CARRIER PROTEINS 2001-2004", "HN": "2006(2001)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050599"}, {"RECTYPE": "D", "MH": "SNARE Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "SNARE Protein|T116|T123|NON|EQV|NLM (2021)|200317|abbcdef", "ENTRY": "v SNAREs", "MN": "D12.776.543.990.775", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Vesicular Transport Proteins (2004-2005)", "MS": "A superfamily of small proteins which are involved in the MEMBRANE FUSION events, intracellular protein trafficking and secretory processes. They share a homologous SNARE motif. The SNARE proteins are divided into subfamilies: QA-SNARES; QB-SNARES; QC-SNARES; and R-SNARES. The formation of a SNARE complex (composed of one each of the four different types SNARE domains (Qa, Qb, Qc, and R)) mediates MEMBRANE FUSION. Following membrane fusion SNARE complexes are dissociated by the NSFs (N-ETHYLMALEIMIDE-SENSITIVE FACTORS), in conjunction with SOLUBLE NSF ATTACHMENT PROTEIN, i.e., SNAPs (no relation to SNAP 25.)", "PM": "2006; SNAP RECEPTOR (now SNARE PROTEINS) was indexed under MEMBRANE PROTEINS 1995-2003 and VESICULAR TRANSPORT PROTEINS 2004-2005", "HN": "2006 (1995)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050600"}, {"RECTYPE": "D", "MH": "Kynurenine 3-Monooxygenase", "DS": "KYNURENINE MONOOXYGENASE 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "L Kynurenine 3 Hydroxylase", "MN": "D08.811.682.690.708.557", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.13.9", "RR": "9029-61-2 (CRN)", "MS": "An NADPH-dependent flavin monooxygenase that plays a key role in the catabolism of TRYPTOPHAN by catalyzing the HYDROXYLATION of KYNURENINE to 3-hydroxykynurenine. It was formerly characterized as EC 1.14.1.2 and EC 1.99.1.5.", "PM": "2006; KYNURENINE 3-MONOOXYGENASE was indexed under MIXED FUNCTION OXYGENASES 1981-2005, & under KYNURENINE 1973-1980", "HN": "2006(1980); KYNURENINE 1973-1979", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050601"}, {"RECTYPE": "D", "MH": "Linoleoyl-CoA Desaturase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Linoleic Acid Delta 6 Desaturase", "MN": "D08.811.682.690.708.392.468", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.19.3", "MS": "An enzyme that catalyzes the syn-dehydrogenation of linoleol-CoA gamma-linolenoyl-CoA. It was formerly characterized as EC 1.14.99.25.", "PM": "2006; LINOLEOYL-COA DESATURASE was indexed under FATTY ACID DESATURASES 1981-2005", "HN": "2006(1981)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050602"}, {"RECTYPE": "D", "MH": "Squalene Monooxygenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Monooxygenase, Squalene", "MN": "D08.811.682.690.708.749", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.14.17", "RR": "9029-62-3 (CRN)", "MS": "The second enzyme in the committed pathway for CHOLESTEROL biosynthesis, this enzyme catalyzes the first oxygenation step in the biosynthesis of STEROLS and is thought to be a rate limiting enzyme in this pathway. Specifically, this enzyme catalyzes the conversion of SQUALENE to (S)-squalene-2,3-epoxide.", "PM": "2006; SQUALENE MONOOXYGENASE was indexed under OXYGENASES 1981-2005 & ETHERS, CYCLIC 1970-1980", "HN": "2006(1980); use ETHERS, CYCLIC 1970-1979", "MR": "20160601", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050603"}, {"RECTYPE": "D", "MH": "Succinate-Semialdehyde Dehydrogenase (NADP+)", "DS": "SUCCINATE SEMIALDEHYDE DEHYDROGENASE NADP", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Succinate Semialadehyde Reductase, NADP", "MN": "D08.811.682.657.163.875", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.1.16", "RR": "37250-88-7 (CRN)", "MS": "An enzyme that catalyzes the oxidation of succinate semialdehyde to SUCCINIC ACID. It plays a role in the metabolism of GLUTAMATE; TYROSINE; and butanoate.", "PM": "2006; SUCCINATE-SEMIALDEHYDE DEHYDROGENASE (NADP+) was indexed under ALDEHYDE OXIDOREDUCTASES 1974-2005", "HN": "2006(1974)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050604"}, {"RECTYPE": "D", "MH": "Malonate-Semialdehyde Dehydrogenase (Acetylating)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Malonic-Semialdehyde Dehydrogenase (Acylating)|T116|T126|NON|EQV|NLM (2006)|abbcde", "MN": "D08.811.682.657.163.812", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.1.18", "MS": "An enzyme that catalyzes the oxidation of 3-oxopropanoate (malonate semialdehyde) to acetyl COENZYME A. It plays a role in the metabolism of BETA-ALANINE.", "PM": "2006; MALONATE-SEMIALDEHYDE DEHYDROGENASE (ACETYLATING) was indexed under ALDEHYDE OXIDOREDUCTASES 1987-2005", "HN": "2006(1987)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050605"}, {"RECTYPE": "D", "MH": "Mannose-Binding Protein-Associated Serine Proteases", "AQ": "AD AE AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "MASP|T116|T126|NON|EQV|NLM (2021)|200601|abbcdef", "ENTRY": "Serine Proteases, MBL-Associated", "MN": "D12.776.124.486.274.045.387.875", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 3.4.21.-", "AN": "see SCR for organism-specific terms", "PI": "Serine Endopeptidases (1992-2005)", "MS": "Serum serine proteases which participate in COMPLEMENT ACTIVATION. They are activated when complexed with the MANNOSE-BINDING LECTIN, therefore also known as Mannose-binding protein-Associated Serine Proteases (MASPs). They cleave COMPLEMENT C4 and COMPLEMENT C2 to form C4b2a, the CLASSICAL PATHWAY C3 CONVERTASE.", "PM": "2006; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES was indexed under SERINE ENDOPEPTIDASES 1994-2005", "HN": "2006 (1994)", "MR": "20200617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050606"}, {"RECTYPE": "D", "MH": "Organogold Compounds", "DE": "ORGANOGOLD CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Organogold", "MN": "D02.691.675", "FX": "Gold Sodium Thiosulfate", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "PI": "Gold (1974-2005)", "MS": "Organic compounds that contain GOLD as an integral part of the molecule. Some are used as ANTIRHEUMATIC AGENTS. The term chrysotherapy derives from an ancient Greek term for gold.", "PM": "2006", "HN": "2006", "MR": "20110624", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050607"}, {"RECTYPE": "D", "MH": "Sodium-Phosphate Cotransporter Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporters, Sodium Phosphate", "MN": "D12.776.543.585.450.625.625", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Symporters (1987-2005)", "MS": "A family of symporters that facilitate sodium-dependent membrane transport of phosphate.", "PM": "2006; SODIUM-PHOSPHATE COTRANSPROTER PROTEINS was indexed under SYMPORTERS 2002-2005 & under CARRIER PROTEINS 1987-2001", "HN": "2006(1987)", "MR": "20050725", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050608"}, {"RECTYPE": "D", "MH": "Sodium-Phosphate Cotransporter Proteins, Type I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Type I Sodium-Phosphate Cotransporter Proteins|T116|T123|NON|EQV|NLM (2006)|041201|abbcdef", "ENTRY": "Type I Sodium Phosphate Cotransporter Proteins", "MN": "D12.776.543.585.450.625.625.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of sodium-phosphate cotransporter proteins that also transport organic ANIONS. They are low affinity phosphate transporters.", "PM": "2006; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE I was indexed under SYMPORTERS 2004-2005", "HN": "2006(2004)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050609"}, {"RECTYPE": "D", "MH": "Sodium-Phosphate Cotransporter Proteins, Type II", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Type II Sodium-Phosphate Cotransporter Proteins|T116|T123|NON|EQV|NLM (2006)|041201|abbcdef", "ENTRY": "Type II Sodium Phosphate Symporter Proteins", "MN": "D12.776.543.585.937.829", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of sodium-phosphate cotransporter proteins with eight transmembrane domains. They are present primarily in the KIDNEY and SMALL INTESTINE and are responsible for renal and small intestinal epithelial transport of phosphates.", "PM": "2006; TYPE II NA-PI COTRANSPORTER PROTEIN was indexed under SYMPORTERS 2002-2005, & under CARRIER PROTEINS 1987-2001", "HN": "2006(1987)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050610"}, {"RECTYPE": "D", "MH": "Sodium-Phosphate Cotransporter Proteins, Type III", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Type III Sodium-Phosphate Cotransporter Proteins|T116|T123|NON|EQV|NLM (2006)|041201|abbcdef", "ENTRY": "Type III Sodium Phosphate Symporter Proteins", "MN": "D12.776.543.585.937.844", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Symporters (1987-2005)", "MS": "A family of highly conserved and widely expressed sodium-phosphate cotransporter proteins. They are electrogenic sodium-dependent transporters of phosphate that were originally identified as retroviral receptors in HUMANS and have been described in yeast and many other organisms.", "PM": "2006; TYPE III NA-DEPENDENT PHOSPHATE COTRANSPORTER; PIT1 SODIUM-DEPENDENT PHOSPHATE SYMPORTER; NPT1 PROTEIN; AMPHOTERIC VIRUS RECEPTOR GLVR-2; AMPHOTROPIC MULV RECEPTOR; AMPHOTROPIC MURINE LEUKEMIA VIRUS RECEPTOR; GLVR-2 RECEPTOR; & RAM-1 RECEPTOR were indexed under SYMPORTERS 2001-2005 & under CARRIER PROTEINS 1987-2001", "HN": "2006(1987)", "MR": "20151124", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050611"}, {"RECTYPE": "D", "MH": "Fatty Acid Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fatty Acid-Transport Protein|T116|T123|NON|EQV|NLM (2006)|abbcde", "ENTRY": "Fatty Acid Transport Protein", "MN": "D12.776.543.585.300", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Membrane Transport Proteins (2005)", "MS": "A broad category of membrane transport proteins that specifically transport FREE FATTY ACIDS across cellular membranes. They play an important role in LIPID METABOLISM in CELLS that utilize free fatty acids as an energy source.", "PM": "2006; FATTY ACID TRANSPORT PROTEINS was indexed under MEMBRANE TRANSPORT PROTEINS 2005, MEMBRANE PROTEINS & CARRIER PROTEINS 1997-2004", "HN": "2006(1997)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050612"}, {"RECTYPE": "D", "MH": "Sodium-Phosphate Cotransporter Proteins, Type IIa", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Type IIa Sodium-Phosphate Cotransporter Proteins|T116|T123|NON|EQV|NLM (2006)|041202|abbcdef", "ENTRY": "Type IIa Sodium Phosphate Symporter Proteins", "MN": "D12.776.543.585.937.829.124", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An electrogenic sodium-dependent phosphate transporter. It is present primarily in BRUSH BORDER membranes of PROXIMAL RENAL TUBULES.", "PM": "2006; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIa was indexed under SYMPORTERS 2004-2005", "HN": "2006(2004)", "MR": "20151124", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050613"}, {"RECTYPE": "D", "MH": "Sodium-Phosphate Cotransporter Proteins, Type IIb", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Type IIb Sodium-Phosphate Cotransporter Proteins|T116|T123|NON|EQV|NLM (2006)|041202|abbcdef", "ENTRY": "Type IIb Sodium Phosphate Symporter Proteins", "MN": "D12.776.543.585.937.829.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A sodium-dependent phosphate transporter present primarily at apical sites of EPITHELIAL CELLS in the SMALL INTESTINE.", "PM": "2006; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIb was indexed under SYMPORTERS 2004-2005", "HN": "2006(2004)", "MR": "20151124", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050614"}, {"RECTYPE": "D", "MH": "Sodium-Phosphate Cotransporter Proteins, Type IIc", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Type IIc Sodium-Phosphate Cotransporter Proteins|T116|T123|NON|EQV|NLM (2006)|041202|abbcdef", "ENTRY": "Type IIc Sodium Phosphate Symporter Proteins", "MN": "D12.776.543.585.937.829.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A non-electrogenic sodium-dependent phosphate transporter. It is found primarily in apical membranes of PROXIMAL RENAL TUBULES.", "PM": "2006; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIc was indexed under SYMPORTERS 2004-2005", "HN": "2006(2004)", "MR": "20151124", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050615"}, {"RECTYPE": "D", "MH": "Balaenoptera", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Sei Whale|T015|NON|NRW|NLM (1998)|961009|abcdef", "ENTRY": "Sei Whales", "MN": "B01.050.150.900.649.313.875.865.100", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9766", "RR": "txid9771", "PI": "Whales (1975-2005)", "MS": "A genus of WHALES in the family Balaenopteridae, consisting of five species: Blue Whale, Bryde's Whale, FIN WHALE, Sei Whale, and MINKE WHALE. They are distinguished by a relatively slender body, a compressed tail stock, and a pointed snout.", "PM": "2006; see WHALES 1998-2005; for Blue Whale, Bryde's Whale, and Sei Whale see WHALES 1998-2005", "HN": "2006; use WHALES 1998-2005; for Blue Whale, Bryde's Whale, and Sei Whale use WHALES 1998-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050616"}, {"RECTYPE": "D", "MH": "Fin Whale", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Whales, Finback", "MN": "B01.050.150.900.649.313.875.865.100.350", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9770", "PI": "Whales (1975-2005)", "MS": "The species Balaenoptera physalus, in the family Balaenopteridae, characterized by a large, strongly curved, dorsal fin. It is the second largest of the WHALES, highly migratory, but rarely seen near the shore.", "PM": "2006; see WHALES 1998-2005", "HN": "2006; use WHALES 1998-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050617"}, {"RECTYPE": "D", "MH": "Glycolaldehyde Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, Glycolaldehyde", "MN": "D08.811.682.657.163.781", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.1.21", "PI": "Aldehyde Oxidoreductases (1978-2005)", "MS": "An enzyme that catalyzes the oxidation of glycolaldehyde to glycolate, using NAD and NADP as COENZYMES.", "PM": "2006; GLYCOLALDEHYDE DEHYDROGENASE was indexd under ALDEHYDE OXIDREDUCTASES 1978-2005", "HN": "2006(1978)", "MR": "20090715", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050618"}, {"RECTYPE": "D", "MH": "Minke Whale", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Minke Whales", "MN": "B01.050.150.900.649.313.875.865.100.500", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9767", "RR": "txid33556", "PI": "Whales (1975-2005)", "MS": "The species Balaenoptera acutorostrata, in the family Balaenopteridae. It is the smallest of the WHALES in the family and though mainly oceanic, is often found in coastal waters including bays and estuaries.", "PM": "2006; see WHALES 1998-2005", "HN": "2006; use WHALES 1998-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050636"}, {"RECTYPE": "D", "MH": "Receptors, Dopamine D3", "DE": "RECEPT DOPAMINE D3", "DS": "RECEPTORS DOPAMINE D 003", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Dopamine D3 Receptors|T116|T192|NON|EQV|NLM (2006)|DOPAMINE RECEPTORS D 03|DOPAMINE D3 RECEPT|abbcdesv", "ENTRY": "Dopamine-D3 Receptor", "MN": "D12.776.543.750.720.330.400.500.249", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "PI": "Receptors, Dopamine D2 (1987-2005)", "MS": "A subtype of dopamine D2 receptors that are highly expressed in the LIMBIC SYSTEM of the brain.", "PM": "2006; RECEPTORS, DOPAMINE D3 was indexed under RECEPTORS, DOPAMINE D2 1997-2005, & under RECEPTORS, DOPAMINE 1987-1996", "HN": "2006(1987)", "MR": "20160418", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050637"}, {"RECTYPE": "D", "MH": "Receptors, Dopamine D4", "DE": "RECEPT DOPAMINE D4", "DS": "RECEPTORS DOPAMINE D 004", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Dopamine D4 Receptors|T116|T192|NON|EQV|NLM (2006)|DOPAMINE RECEPTORS D 04|DOPAMINE D4 RECEPT|abbcdesv", "ENTRY": "D4 Receptors, Dopamine", "MN": "D12.776.543.750.720.330.400.500.500", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "137750-34-6", "AN": "see SCR for organism-specific terms", "PI": "Receptors, Dopamine D2 (1991-2005)", "MS": "A subtype of dopamine D2 receptors that has high affinity for the antipsychotic CLOZAPINE.", "PM": "2006; RECEPTORS, DOPAMINE D4 was indexed under RECEPTORS, DOPAMINE D2 2005, & under RECEPTORS, DOPAMINE 1991-2004", "HN": "2006(1991)", "MR": "20160617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050638"}, {"RECTYPE": "D", "MH": "Humpback Whale", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Whales, Humpback", "MN": "B01.050.150.900.649.313.875.865.400", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9773", "PI": "Whales (1978-2005)", "MS": "The species Megaptera novaeangliae, in the family Balaenopteridae, characterized by its huge flippers and the arching of their back when diving. They are also known for their breaching and singing.", "PM": "2006; see WHALES 1998-2005", "HN": "2006; use WHALES 1998-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050640"}, {"RECTYPE": "D", "MH": "Receptors, Dopamine D5", "DE": "RECEPT DOPAMINE D5", "DS": "RECEPTORS DOPAMINE D 005", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Dopamine D5 Receptors|T116|T192|NON|EQV|NLM (2006)|DOPAMINE RECEPTORS D 05|DOPAMINE D5 RECEPT|abbcdesv", "ENTRY": "Receptor, Dopamine D5", "MN": "D12.776.543.750.720.330.400.400.500", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "137750-35-7", "AN": "see SCR for organism-specific terms", "PI": "Receptors, Dopamine D1 (1991-2005)", "MS": "A subtype of dopamine D1 receptors that has higher affinity for DOPAMINE and differentially couples to GTP-BINDING PROTEINS.", "PM": "2006; RECEPTORS, DOPAMINE D5 was indexed under RECEPTORS DOPAMINE 1997-2005, & under RECEPTORS, DOPAMINE 1991-1996", "HN": "2006(1991)", "MR": "20160617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050641"}, {"RECTYPE": "D", "MH": "Bowhead Whale", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Right Whale, Greenland|T015|NON|EQV|NLM (2006)|041203|abcdef", "ENTRY": "Whales, Greenland Right", "MN": "B01.050.150.900.649.313.875.865.130", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid27602", "PI": "Whales (1982-2005)", "MS": "The species Balaena mysticetus, in the family Balaenidae, found in the colder waters of the Northern Hemisphere. The common name is derived from the extreme arching of the lower jaw.", "PM": "2006; see WHALES 1998-2005", "HN": "2006; use WHALES 1998-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050642"}, {"RECTYPE": "D", "MH": "Beluga Whale", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "White Whale|T015|NON|EQV|NLM (1998)|961009|abcdef", "ENTRY": "White Whales", "MN": "B01.050.150.900.649.313.875.865.110", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9749", "PI": "Whales (1976-2005)", "MS": "The species Delphinapterus leucas, in the family Monodontidae, found primarily in the Arctic Ocean and adjoining seas. They are small WHALES lacking a dorsal fin.", "PM": "2006; see WHALES 1998-2005", "HN": "2006; use WHALES 1998-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050643"}, {"RECTYPE": "D", "MH": "Succinate-Semialdehyde Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Semialdehyde Dehydrogenase, Succinic", "MN": "D08.811.682.657.163.843", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.1.24", "RR": "9028-95-9 (CRN)", "MS": "An enzyme that plays a role in the GLUTAMATE and butanoate metabolism pathways by catalyzing the oxidation of succinate semialdehyde to SUCCINATE using NAD+ as a coenzyme. Deficiency of this enzyme, causes 4-hydroxybutyricaciduria, a rare inborn error in the metabolism of the neurotransmitter 4-aminobutyric acid (GABA).", "PM": "2006; SUCCINATE-SEMIALDEHYDE DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASES 1977-2005", "HN": "2006(1980); use ALDEHYDE OXIDREDUCTASES 1977-1979", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050644"}, {"RECTYPE": "D", "MH": "2-Oxoisovalerate Dehydrogenase (Acylating)", "DS": "OXOISOVALERATE DEHYDROGENASE ACYLATING 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Ketoisovalerate Dehydrogenase", "MN": "D08.811.682.657.350.825", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.1.25", "RR": "37211-61-3 (CRN)", "MS": "An NAD+ dependent enzyme that catalyzes the oxidation 3-methyl-2-oxobutanoate to 2-methylpropanoyl-CoA. It plays a role in the degradation of VALINE; LEUCINE; and ISOLEUCINE.", "PM": "2006; 2-OXOISOVALERATE DEHYDROGENASE (ACYLATING) was indexed under KETONE OXIDOREDUCTASES 1983-2005, under AMINO ACIDS, BRANCHED-CHAIN 1979-1982, under KETO ACIDS 1973-1982, & VALERATES 1973-1979", "HN": "2006(1980); use AMINO ACIDS, BRANCHED-CHAIN 1979, & KETO ACIDS & VALERATES 1973-1979", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050645"}, {"RECTYPE": "D", "MH": "Methylmalonate-Semialdehyde Dehydrogenase (Acylating)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, MMSA", "MN": "D08.811.682.657.163.827", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.1.27", "MS": "An enzyme that plays a role in the VALINE; LEUCINE; and ISOLEUCINE catabolic pathways by catalyzing the oxidation of 2-methyl-3-oxopropanate to propanoyl-CoA using NAD+ as a coenzyme. Methylmalonate semialdehyde dehydrogenase deficiency is characterized by elevated BETA-ALANINE and 3-hydropropionic acid.", "PM": "2006; METHYLMALONATE-SEMIALDEHYDE DEHYDROGENASE (ACYLATING) was indexed under ALDEHYDE OXIDOREDUCTASES 1987-2005", "HN": "2006(1987)", "MR": "20090715", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050646"}, {"RECTYPE": "D", "MH": "L-Aminoadipate-Semialdehyde Dehydrogenase", "DS": "AMINOADIPATE SEMIALDEHYDE DEHYDROGENASE L", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Aminoadipate Reductase System", "MN": "D08.811.682.657.163.796", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.1.31", "RR": "9067-87-2 (CRN)", "MS": "An enzyme that catalyzes the oxidation of L-2-aminoadipate 6-semialdehyde to L-2-aminoadipate (alpha-aminoadipic acid). It is involved in the biosynthetic pathway of LYSINE.", "PM": "2006; L-AMINOADIPATE-SEMIALDEHYDE DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASE 1985-2005", "HN": "2006(1985)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050647"}, {"RECTYPE": "D", "MH": "Aminomuconate-Semialdehyde Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, Aminomuconate-Semialdehyde", "MN": "D08.811.682.657.163.342", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.1.32", "PI": "Aldehyde Oxidoreductases (1998-2005)", "MS": "An NAD+ dependent enzyme that catalyzes the oxidation of 2-aminomuconate 6-semialdehyde to 2-aminomuconate.", "PM": "2006; AMINOMUCONATE-SEMIALDEHYDE DEHYDROGENASE was indexed under ALDEHUDE OXIDREDUCTASES 1998-2005", "HN": "2006(1998)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050648"}, {"RECTYPE": "D", "MH": "Transcription Factor AP-2", "DS": "TRANSCRIPTION FACTOR AP 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "AP-2 Enhancer Binding Protein|T116|T123|NON|EQV|NLM (2006)|050106|AP ENHANCER BINDING PROTEIN 002|abbcdefs", "ENTRY": "Transcription Factor Ap 2delta", "MN": "D12.776.930.907", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (1987-2005)", "MS": "A family of DNA binding proteins that regulate expression of a variety of GENES during CELL DIFFERENTIATION and APOPTOSIS. Family members contain a highly conserved carboxy-terminal basic HELIX-TURN-HELIX MOTIF involved in dimerization and sequence-specific DNA binding.", "PM": "2006; TRANSCRIPTION FACTOR AP-2 was indexed under TRANSCRIPTION FACTORS & DNA-BINDING PROTEINS 1987-2005", "HN": "2006(1987)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050656"}, {"RECTYPE": "D", "MH": "Core Binding Factor alpha Subunits", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Core Binding Factor alpha Proteins|T116|T123|NON|EQV|NLM (2006)|041206|abbcdef", "ENTRY": "Transcription Factors, PEBP2A", "MN": "D12.776.930.155.200", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1987-2005)", "MS": "A family of transcription factors that bind to the cofactor CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. Family members contain a highly conserved DNA-binding domain known as the runt domain. They can act as both activators and repressors of expression of GENES involved in CELL DIFFERENTIATION and CELL CYCLE progression.", "PM": "2006; POLYOMAVIRUS ENHANCER A BINDING PROTEIN 2 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1987-2005, & under NEOPLASM PROTEINS 1997-2005; RUNT DOMAIN FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 2000-2005, & under NEOPLASM PROTEINS 2000-2005", "HN": "2006(1987)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050657"}, {"RECTYPE": "D", "MH": "Core Binding Factor beta Subunit", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Core Binding Factor beta Protein|T116|T123|NON|EQV|NLM (2006)|041206|abbcdef", "ENTRY": "Polyomavirus Enhancer Binding Protein 2, beta Subunit|T116|T123|NON|EQV|NLM (2006)|041206|abbcdef", "MN": "D12.776.930.155.400", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (1987-2005)", "MS": "A non-DNA binding transcription factor that is a subunit of core binding factor. It forms heterodimeric complexes with CORE BINDING FACTOR ALPHA SUBUNITS, and regulates GENETIC TRANSCRIPTION of a variety of GENES involved primarily in CELL DIFFERENTIATION and CELL CYCLE progression.", "PM": "2006; CORE BINDING FACTOR BETA & CBFB PROTEIN were indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1987-2005", "HN": "2006(1987)", "MR": "20050803", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050658"}, {"RECTYPE": "D", "MH": "Core Binding Factor Alpha 1 Subunit", "DS": "CORE BINDING FACTOR ALPHA 01 SUBUNIT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SL3 3 Enhancer Factor 1", "MN": "D12.776.930.155.200.100", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (1997-2005)", "MS": "A transcription factor that dimerizes with CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. It contains a highly conserved DNA-binding domain known as the runt domain and is involved in genetic regulation of skeletal development and CELL DIFFERENTIATION.", "PM": "2006; RUNX2 PROTEIN was indexed under NEOPLASM PROTEINS & TRANSCRIPTION FACTORS 1997-2005", "HN": "2006(1997)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050659"}, {"RECTYPE": "D", "MH": "Core Binding Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, PEBP2", "MN": "D12.776.930.155", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (1997-2005)", "MS": "Heterodimeric transcription factors containing a DNA-binding alpha subunits, (CORE BINDING FACTOR ALPHA SUBUNITS), along with a non-DNA-binding beta subunits, CORE BINDING FACTOR BETA SUBUNIT. Core Binding Factor regulates GENETIC TRANSCRIPTION of a variety of GENES involved primarily in CELL DIFFERENTIATION and CELL CYCLE progression.", "PM": "2006; CORE-BINDING FACTOR was indexed under NEOPLASM PROTEINS & TRANSCRIPTION FACTORS 1997-2005", "HN": "2006(1997)", "MR": "20050803", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050660"}, {"RECTYPE": "D", "MH": "Sperm Whale", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Whale, Sperm", "MN": "B01.050.150.900.649.313.875.865.750", "FX": "Ambergris", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9755", "PI": "Whales (1974-2005)", "MS": "The species Physeter catodon (also called Physeter macrocephalus), in the family Physeteridae. The common name is derived from the milky wax substance in its head (spermaceti). The species also produces an intestinal secretion AMBERGRIS, which was previously used in perfumes. The sperm whale is the largest toothed MAMMAL in the world.", "PM": "2006; see WHALES 1998-2005", "HN": "2006; use WHALES 1998-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050661"}, {"RECTYPE": "D", "MH": "Core Binding Factor Alpha 2 Subunit", "DS": "CORE BINDING FACTOR ALPHA 02 SUBUNIT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Runt Related Transcription Factor 1", "MN": "D12.776.930.155.200.200", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1996-2005)", "MS": "A transcription factor that dimerizes with the cofactor CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. It contains a highly conserved DNA-binding domain known as the runt domain. Runx1 is frequently mutated in human LEUKEMIAS.", "PM": "2006; RUNX1 PROTEIN was indexed under DNA-BINDING PROTEINS 1996-2005, NEOPLASM PROTEINS 1993-1996, PROTO-ONCOGENE PROTEINS 1996-2005, & TRANSCRIPTION FACTORS 1996-2005", "HN": "2006(1993)", "MR": "20170602", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050676"}, {"RECTYPE": "D", "MH": "Core Binding Factor Alpha 3 Subunit", "DS": "CORE BINDING FACTOR ALPHA 03 SUBUNIT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Runt Related Transcription Factor 3 Protein", "MN": "D12.776.930.155.200.300", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (2001-2005)", "MS": "A transcription factor that dimerizes with the cofactor CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. It contains a highly conserved DNA-binding domain known as the runt domain.", "PM": "2006; RUNX3 PROTEIN was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 2001-2005", "HN": "2006(2001)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050677"}, {"RECTYPE": "D", "MH": "Complement C2a", "DS": "COMPLEMENT C 02 A", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Complement, C2a", "MN": "D12.776.124.486.274.150.500", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "EC 3.4.21.43", "MS": "The COOH-terminal fragment of COMPLEMENT 2, released by the action of activated COMPLEMENT C1S. It is a SERINE PROTEASE. C2a combines with COMPLEMENT C4B to form C4b2a (CLASSICAL PATHWAY C3 CONVERTASE) and subsequent C4b2a3b (CLASSICAL PATHWAY C5 CONVERTASE).", "PM": "2006; COMPLEMENT C2A was indexed under COMPLEMENT 2 1986-2005", "HN": "2006 (1986)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050678"}, {"RECTYPE": "D", "MH": "Complement C2b", "DS": "COMPLEMENT C 02 B", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fragment, Complement C2b", "MN": "D12.776.124.486.274.150.750", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "PI": "Complement 2 (1985-2005)", "MS": "The N-terminal fragment of COMPLEMENT 2, released by the action of activated COMPLEMENT C1S.", "PM": "2006; COMPLEMENT C2B was indexed under COMPLEMENT 2 1985-2005", "HN": "2006 (1985)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050679"}, {"RECTYPE": "D", "MH": "Transcription Factor DP1", "DS": "TRANSCRIPTION FACTOR DP 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, DRTF1c", "MN": "D12.776.930.908", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (1993-2005)", "MS": "A transcription factor that possesses DNA-binding and E2F-binding domains but lacks a transcriptional activation domain. It is a binding partner for E2F TRANSCRIPTION FACTORS and enhances the DNA binding and transactivation function of the DP-E2F complex.", "PM": "2006; TRANSCRIPTION FACTOR DP1 was indexed under CELL CYCLE PROTEINS & TRANSCRIPTION FACTORS 1997-2005", "HN": "2006(1997)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050680"}, {"RECTYPE": "D", "MH": "Bottle-Nosed Dolphin", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Dolphins, Bottlenosed", "MN": "B01.050.150.900.649.313.875.267.100", "MH_TH": "NLM (2006)", "ST": "T015", "RN": "txid9739", "PI": "Dolphins (1966-2005)", "MS": "The species Tursiops truncatus, in the family Delphinidae, characterized by a bottle-shaped beak and slightly hooked broad dorsal fin.", "PM": "2006; see DOLPHINS 1998-2005", "HN": "2006; use DOLPHINS 1998-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050681"}, {"RECTYPE": "D", "MH": "Q-SNARE Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Q SNAREs", "MN": "D12.776.543.990.775.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "SNARE proteins in which the central amino acid residue of the SNARE motif is a GLUTAMINE. They are classified separately from the R-SNARE PROTEINS where the central amino acid residue of the SNARE motif is an ARGININE. Subfamilies, the QA-SNARES; QB-SNARES; and QC-SNARES are grouped by the position of their SNARE motif-containing-domains in the SNARE complex and by their sequence similarities.", "PM": "2006", "HN": "2006", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050682"}, {"RECTYPE": "D", "MH": "R-SNARE Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Vesicle Associated Membrane Proteins", "MN": "D12.776.543.990.775.750", "MH_TH": "NLM (2006)", "ST": "T116", "RN": "0", "MS": "SNARE proteins where the central amino acid residue of the SNARE motif is an ARGININE. They are classified separately from the Q-SNARE PROTEINS where the central amino acid residue of the SNARE motif is a GLUTAMINE. This subfamily contains the vesicle associated membrane proteins (VAMPs) based on similarity to the prototype for the R-SNAREs, VAMP2 (synaptobrevin 2).", "PM": "2006; VESICLE-ASSOCIATED MEMBRANE PROTEIN (now R-SNARE PROTEINS) was indexed under MEMBRANE PROTEINS 1996-2005 and NERVE TISSUE PROTEINS 1988-1995", "HN": "2006 (1988)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050683"}, {"RECTYPE": "D", "MH": "E2F Transcription Factors", "DS": "E 02 F 00 TRANSCRIPTION FACTORS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "E2F Transcription Factor|T116|T123|NON|EQV|NLM (2021)|200225|abbcdef", "ENTRY": "Transcription Factors, E2F", "MN": "D12.776.930.211", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1991-2005)", "MS": "A family of basic helix-loop-helix transcription factors that control expression of a variety of GENES involved in CELL CYCLE regulation. E2F transcription factors typically form heterodimeric complexes with TRANSCRIPTION FACTOR DP1 or transcription factor DP2, and they have N-terminal DNA binding and dimerization domains. E2F transcription factors can act as mediators of transcriptional repression or transcriptional activation.", "PM": "2006; E2F TRANSCRIPTION FACTORS was indexed under CELL CYCLE PROTEINS, DNA-BINDING PROTEINS, & TRANSCRIPTION FACTORS 1991-2005", "HN": "2006(1991)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050684"}, {"RECTYPE": "D", "MH": "Whale, Killer", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Killer Whale|T015|NON|EQV|NLM (1998)|960628|abcdef", "ENTRY": "Whales, Killer", "MN": "B01.050.150.900.649.313.875.267.900", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9733", "PI": "Dolphins (1968-2005)", "MS": "The species Orcinus orca, in the family Delphinidae, characterized by its black and white coloration, and huge triangular dorsal fin. It is the largest member of the DOLPHINS and derives its name from the fact that it is a fearsome predator.", "PM": "2006; see DOLPHINS 1998-2005", "HN": "2006; use DOLPHINS 1998-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050685"}, {"RECTYPE": "D", "MH": "Whales, Pilot", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Pilot Whales|T015|NON|EQV|NLM (1998)|961010|abcdef", "ENTRY": "Whale, Pilot", "MN": "B01.050.150.900.649.313.875.267.920", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9729", "RR": "txid9731", "PI": "Dolphins (1990-2005)", "MS": "The genus Globicephala, in the family Delphinidae, consisting of two species of DOLPHINS. They are mostly black with a stocky shape and bulbous foreheads.", "PM": "2006; use DOLPHINS 1998-2005", "HN": "2006; use DOLPHINS 1998-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050686"}, {"RECTYPE": "D", "MH": "E2F1 Transcription Factor", "DS": "E 02 F 01 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, E2F1", "MN": "D12.776.930.211.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (1991-2005)", "MS": "An E2F transcription factor that interacts directly with RETINOBLASTOMA PROTEIN and CYCLIN A and activates GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F1 is involved in DNA REPAIR and APOPTOSIS.", "PM": "2006; E2F TRANSCRIPTION FACTORS was indexed under CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; & TRANSCRIPTION FACTORS 1991-2005", "HN": "2006(1991)", "MR": "20160428", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050687"}, {"RECTYPE": "D", "MH": "Common Dolphins", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Short-Beaked Common Dolphins", "MN": "B01.050.150.900.649.313.875.267.150", "MH_TH": "NLM (2006)", "ST": "T015", "RN": "txid9727", "RR": "txid9728", "PI": "Dolphins (1966-2005)", "MS": "The genus Delphinus, in the family Delphinidae, consisting of two species of DOLPHINS. They are multicolored, with a characteristic yellow-tan criss-cross hourglass pattern behind the eyes.", "PM": "2006; see DOLPHINS 1998-2005", "HN": "2006; use DOLPHINS 1998-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050696"}, {"RECTYPE": "D", "MH": "Retinal Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Retinaldehyde Dehydrogenase|T116|T126|NON|EQV|NLM (2020)|190603|abbcdef", "ENTRY": "Retinal Dehydrogenase, Cytosolic", "MN": "D12.776.556.579.374.687", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.1.36", "MS": "A metalloflavoprotein enzyme involved the metabolism of VITAMIN A, this enzyme catalyzes the oxidation of RETINAL to RETINOIC ACID, using both NAD+ and FAD coenzymes. It also acts on both the 11-trans- and 13-cis-forms of RETINAL.", "PM": "2006; RETINAL DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASES 1977-2005", "HN": "2006(1977)", "MR": "20200609", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050697"}, {"RECTYPE": "D", "MH": "Glutamate-5-Semialdehyde Dehydrogenase", "DS": "GLUTAMATE SEMIALDEHYDE DEHYDROGENASE 05", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase, Gamma-Glutamylphosphate", "MN": "D08.811.682.657.163.562", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.1.41", "PI": "Aldehyde Oxidoreductases (1978-2005)", "MS": "An NADP+ dependent enzyme that catalyzes the oxidation of L-glutamate 5-semialdehyde to L-glutamyl 5-phosphate. It plays a role in the urea cycle and metabolism of amino groups.", "PM": "2006; GLUTAMATE-5-SEMIALDEHYDE DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASES 1978-2005", "HN": "2006(1978)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050698"}, {"RECTYPE": "D", "MH": "E2F3 Transcription Factor", "DS": "E 02 F 03 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, E2F3b", "MN": "D12.776.930.211.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (1991-2005)", "MS": "An E2F transcription factor that interacts directly with RETINOBLASTOMA PROTEIN and CYCLIN A. E2F3 regulates GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis.", "PM": "2006; E2F3 transcription factor, E2F Transcription Factor 3 Protein, & Transcription Factor E2F-3 were indexed under CELL CYCLE PROTEINS, DNA-BINDING PROTEINS, & TRANSCRIPTION FACTORS 2004-2005", "HN": "2006(2004)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050699"}, {"RECTYPE": "D", "MH": "E2F5 Transcription Factor", "DS": "E 02 F 05 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, E2F5", "MN": "D12.776.930.211.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (1991-2005)", "MS": "An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F5 recruits chromatin remodeling factors indirectly to target gene promoters through RETINOBLASTOMA LIKE PROTEIN P130.", "PM": "2006; E2F5 TRANSCRIPTION FACTOR, E2F Transcription Factor 5 Protein, & TRANSCRIPTION FACTOR E2F-5 were indexed under DNA-BINDING PROTEINS & TRANSCRIPTIONS FACTORS 2004-2005", "HN": "2006(2004)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050700"}, {"RECTYPE": "D", "MH": "E2F6 Transcription Factor", "DS": "E 02 F 06 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, E2F6", "MN": "D12.776.930.211.937", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (1991-2005)", "MS": "An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F6 recruits chromatin remodeling factors directly to target gene promoters and lacks the transactivation domain responsible for binding to the retinoblastoma family of tumor suppressors.", "PM": "2006; E2F6 TRANSCRIPTION FACTOR, E2F TRANSCRIPTION FACTOR 6 PROTEIN, & TRANSCRIPTION FACTOR E2F-6 were indexed under DNA-BINDING PROTEINS & TRANSCRIPTIONS FACTORS 2004-2005", "HN": "2006(2004)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050701"}, {"RECTYPE": "D", "MH": "E2F7 Transcription Factor", "DS": "E 02 F 07 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, E2F7", "MN": "D12.776.930.211.968", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (1991-2005)", "MS": "An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F7 has two separate DNA-binding domains and binds to DNA independently of a dimerization partner.", "PM": "2006; E2F7 TRANSCRIPTION FACTOR; E2F TRANSCRIPTION FACTOR 7 PROTEIN; & TRANSCRIPTION FACTOR E2F-7 were indexed under DNA-BINDING PROTEINS & TRANSCRIPTIONS FACTORS 1991-2005", "HN": "2006(1991)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050702"}, {"RECTYPE": "D", "MH": "E2F2 Transcription Factor", "DS": "E 02 F 02 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, E2F2", "MN": "D12.776.930.211.625", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (1993-2005)", "MS": "An E2F transcription factor that interacts directly with RETINOBLASTOMA PROTEIN and CYCLIN A. E2F2 activates GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis.", "PM": "2006; E2F TRANSCRIPTION FACTORS was indexed under CELL CYCLE PROTEINS, DNA-BINDING PROTEINS, & TRANSCRIPTION FACTORS 1993-2005", "HN": "2006(1993)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050703"}, {"RECTYPE": "D", "MH": "E2F4 Transcription Factor", "DS": "E 02 F 04 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, E2F4", "MN": "D12.776.930.211.812", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (1994-2005)", "MS": "An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F4 recruits chromatin remodeling factors indirectly to target gene PROMOTER REGIONS through RETINOBLASTOMA LIKE PROTEIN P130 and RETINOBLASTOMA LIKE PROTEIN P107.", "PM": "2006; E2F4 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1994-2005", "HN": "2006(1994)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050704"}, {"RECTYPE": "D", "MH": "Receptors, Guanylate Cyclase-Coupled", "DE": "RECEPT GUANULATE CYCLASE COUPLED", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Guanylyl Cyclase Receptor|T116|T126|NON|EQV|NLM (2022)|200917|abbcdef", "ENTRY": "Receptors, Guanylyl Cyclase-Linked", "MN": "D12.776.543.750.700", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 4.6.1.2", "PI": "Receptors, Cell Surface (1971-2005)", "MS": "A class of cellular membrane receptors that either have an intrinsic guanylate cyclase activity or are closely coupled to specific guanylate cyclases within the cell.", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050705"}, {"RECTYPE": "D", "MH": "Stenella", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Striped Dolphin|T015|NON|NRW|NLM (1998)|961010|abcdef", "ENTRY": "Striped Dolphins", "MN": "B01.050.150.900.649.313.875.267.750", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9734", "RR": "txid9737", "PI": "Dolphins (1966-2005)", "MS": "A genus comprised of spinner, spotted, and striped DOLPHINS, in the family Delphinidae. Schools of Stenella, that may number in the thousands, often associate with schools of TUNA, and are thus vulnerable to accidental harvesting.", "PM": "2006; see DOLPHINS 1998-2005", "HN": "2006; use DOLPHINS 1998-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050706"}, {"RECTYPE": "D", "MH": "Complement C4b-Binding Protein", "DE": "C4BP", "DS": "COMPLEMENT C 04 B BINDING PROTEIN", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, Complement C4b-Binding", "MN": "D12.776.124.486.274.920.662", "PA": "Complement Inactivating Agents", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "PI": "Complement Inactivator Proteins (1981-2005)", "MS": "A serum protein that regulates the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It binds as a cofactor to COMPLEMENT FACTOR I which then hydrolyzes the COMPLEMENT C4B in the CLASSICAL PATHWAY C3 CONVERTASE (C4bC2a).", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050716"}, {"RECTYPE": "D", "MH": "Retinoblastoma-Like Protein p130", "DS": "RETINOBLASTOMA LIKE PROTEIN P 130", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Retinoblastoma-Like Protein 2|T116|T123|NON|EQV|NLM (2006)|041208|RETINOBLASTOMA LIKE PROTEIN 002|abbcdefs", "ENTRY": "p130, Retinoblastoma-Like Protein", "MN": "D12.776.744.755", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A negative regulator of the CELL CYCLE that undergoes PHOSPHORYLATION by CYCLIN-DEPENDENT KINASES. RBL2 contains a conserved pocket region that binds E2F4 TRANSCRIPTION FACTOR and E2F5 TRANSCRIPTION FACTOR. RBL2 also interacts with viral ONCOPROTEINS such as POLYOMAVIRUS TUMOR ANTIGENS; ADENOVIRUS E1A PROTEINS; and PAPILLOMAVIRUS E7 PROTEINS.", "PM": "2006; RETINOBLASTOMA-LIKE PROTEIN P130 was indexed under PROTEIN 2004-2005, under ADAPTOR PROTEINS 2004, under PHOSPHOPROTEINS 1996-2004, & under PROTEINS 1994-1995", "HN": "2006(1994)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050717"}, {"RECTYPE": "D", "MH": "Complement C1 Inhibitor Protein", "DE": "C 1 INH", "DS": "COMPLEMENT C 01 INHIBITOR PROTEIN", "AQ": "AD AE AG AN BI CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Esterase Inhibitor, C1", "MN": "D12.776.872.140.500", "PA": "Complement Inactivating Agents", "EC": "deficiency:Hereditary Angioedema Types I and II", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "do not confuse with COMPLEMENT C1 INACTIVATOR PROTEINS", "PI": "Complement C1 Inactivator Proteins (1970-2005)", "MS": "An endogenous 105-kDa plasma glycoprotein produced primarily by the LIVER and MONOCYTES. It inhibits a broad spectrum of proteases, including the COMPLEMENT C1R and the COMPLEMENT C1S proteases of the CLASSICAL COMPLEMENT PATHWAY, and the MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES. C1-INH-deficient individuals suffer from HEREDITARY ANGIOEDEMA TYPES I AND II.", "PM": "2006; for C1 ESTERASE INHIBITOR see COMPLEMENT C1 INACTIVATOR PROTEINS 1979-2005", "HN": "2006; for C1 ESTERASE INHIBITOR use COMPLEMENT C1 INACTIVATOR PROTEINS 1970-2005", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050718"}, {"RECTYPE": "D", "MH": "Crk-Associated Substrate Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p130Cas Protein, BCAR1", "MN": "D12.776.744.425", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A highly phosphorylated 130 kDa protein that associates with ONCOGENE PROTEIN CRK and ONCOGENE PROTEIN SRC. It undergoes tyrosine PHOSPHORYLATION in signaling pathways that regulate CELL MIGRATION and CELL PROLIFERATION.", "PM": "2006; CRK-ASSOCIATED SUBSTRATE was indexed under PROTEINS 2004-2005", "HN": "2006(2004)", "MR": "20171213", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050719"}, {"RECTYPE": "D", "MH": "Retinoblastoma-Like Protein p107", "DS": "RETINOBLASTOMA LIKE PROTEIN P 107", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Retinoblastoma-Like Protein 1|T116|T123|NON|EQV|NLM (2006)|041208|RETINOBLASTOMA LIKE PROTEIN 001|abbcdefs", "ENTRY": "p107, Retinoblastoma-Like Protein", "MN": "D12.776.744.747", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A negative regulator of the CELL CYCLE that undergoes PHOSPHORYLATION by CYCLIN-DEPENDENT KINASES. It contains a conserved pocket region that binds E2F4 TRANSCRIPTION FACTOR and interacts with viral ONCOPROTEINS such as POLYOMAVIRUS TUMOR ANTIGENS; ADENOVIRUS E1A PROTEINS; and PAPILLOMAVIRUS E7 PROTEINS.", "PM": "2006; RETINOBLASTOMA-LIKE PROTEIN P107 was indexed under NUCLEAR PROTEINS 1995-2005 & under PROTEINS 1991-1994", "HN": "2006(1991)", "MR": "20090706", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050720"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-cbl", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "cbl Proto-Oncogene Protein|T116|T126|ABX|EQV|NLM (2006)|050421|abbcdef", "ENTRY": "cbl Proto Oncogene Protein", "MN": "D12.776.624.664.700.172", "FX": "RING Finger Domains", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.2.27", "MS": "Proto-oncogene proteins that negatively regulate RECEPTOR PROTEIN-TYROSINE KINASE signaling. It is a UBIQUITIN-PROTEIN LIGASE and the cellular homologue of ONCOGENE PROTEIN V-CBL.", "PM": "2006; PROTO-ONCOGENE PROTEINS C-CBL was indexed under UBIQUITIN-PROTEIN LIGASES 2005, & under LIGASES & PROTO-ONCOGENE PROTEINS 1991-2005", "HN": "2006(1991)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050721"}, {"RECTYPE": "D", "MH": "Oncogene Protein v-cbl", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-cbl Protein|T116|T123|ACX|EQV|NLM (2006)|abbcde", "ENTRY": "v-cbl, Oncogene Protein", "MN": "D12.776.624.664.520.750.817", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An oncoprotein from the Cas NS-1 murine retrovirus that induces pre- B-CELL LYMPHOMA and MYELOID LEUKEMIAS. v-cbl protein is a tyrosine-phosphorylated, truncated form of its cellular homologue, PROTO-ONCOGENE PROTEIN C-CBL.", "PM": "2006; ONCOGENE PROTEIN V-CBL was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-2005, & under RETROVIRIDAE PROTEINS 1989", "HN": "2006(1989)", "MR": "20050712", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050722"}, {"RECTYPE": "D", "MH": "Fractures, Bone", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bone Fractures|T037|NON|EQV|NLM (2006)|041209|abcdef", "ENTRY": "Torsion Fracture", "MN": "C26.404", "MH_TH": "NLM (2006)", "ST": "T037", "AN": "coordinate with specific bone /inj  but note many precoordinated Bone/Fracture terms and specific types of fractures", "MS": "Breaks in bones.", "PM": "2006", "HN": "2006", "MR": "20220413", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050723"}, {"RECTYPE": "D", "MH": "Fractures, Cartilage", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fracture, Cartilage", "MN": "C26.411", "MH_TH": "NLM (2006)", "ST": "T037", "AN": "coordinate IM with specific type of cartilage /inj (IM)", "PI": "Fractures, Bone (1963-2005)", "MS": "Breaks in CARTILAGE.", "PM": "2006", "HN": "2006", "MR": "20100625", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050724"}, {"RECTYPE": "D", "MH": "Papillomavirus E7 Proteins", "DS": "PAPILLOMAVIRUS PROTEINS E 07", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oncogene Proteins, E7", "MN": "D12.776.624.664.520.420", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "ONCOGENE PROTEINS from papillomavirus that deregulate the CELL CYCLE of infected cells and lead to NEOPLASTIC CELL TRANSFORMATION. Papillomavirus E7 proteins have been shown to interact with various regulators of the cell cycle including RETINOBLASTOMA PROTEIN and certain cyclin-dependent kinase inhibitors.", "PM": "2006", "HN": "2006", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050725"}, {"RECTYPE": "D", "MH": "Benzaldehyde Dehydrogenase (NADP+)", "DS": "BENZALDEHYDE DEHYDROGENASE NADP", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NADP Linked Benzaldehyde Dehydrogenase", "MN": "D08.811.682.657.163.468", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.1.7", "RR": "9028-89-1 (CRN)", "MS": "An NADP+ dependent enzyme that catalyzes the oxidation of benzaldehyde to BENZOIC ACID. It also plays a role in the degradation of TOLUENE and XYLENE.", "PM": "2006; BENZALDEHYDE DEHYDROGENASE (NADP+) was indexed under ALDEHYDE OXIDOREDUCTASES 1978-2005", "HN": "2006(1980); use ALDEHYDE OXIDOREDUCTASES 1978-1979", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050727"}, {"RECTYPE": "D", "MH": "Betaine-Aldehyde Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Betaine Aldehyde", "MN": "D08.811.682.657.163.515", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.1.8", "RR": "9028-90-4 (CRN)", "MS": "An NAD+ dependent enzyme that catalyzes the oxidation of betain aldehyde to BETAINE.", "PM": "2006; BETAINE-ALDEHYDE DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASES 1979-2005, & under NAD, OXIDOREDUCTASES & ALDEHYDES 1972-1978", "HN": "2006(1980); use ALDEHYDE OXIDOREDUCTASES 1979, & OXIDOREDUCTASES & ALDEHYDES 1972-1978", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050728"}, {"RECTYPE": "D", "MH": "Oncogene Protein v-crk", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-crk Protein|T116|T123|ACX|EQV|NLM (2006)|abbcde", "ENTRY": "v-crk, Oncogene Protein", "MN": "D12.776.624.664.520.750.846", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A signal transducing adaptor protein that is encoded by the crk ONCOGENE from TYPE C AVIAN RETROVIRUSES. It contains SRC HOMOLOGY DOMAINS and is closely related to its cellular homolog, PROTO-ONCOGENE PROTEIN C-CRK.", "PM": "2006; ONCOGENE PROTEIN V-CRK was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1989-2005", "HN": "2006(1989)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050736"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-crk", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "crk Proto-Oncogene Proteins|T116|T123|ABX|EQV|NLM (2006)|050421|abbcdef", "ENTRY": "crk Proto Oncogene Proteins", "MN": "D12.776.624.664.700.174", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Signal transducing adaptor proteins that contain SRC HOMOLOGY DOMAINS and play a role in CYTOSKELETON reorganization. c-crk protein is closely related to ONCOGENE PROTEIN V-CRK and includes several alternatively spliced isoforms.", "PM": "2006; PROTO-ONCOGENE PROTEIN C-CRK was indexed under PROTO-ONCOGENE PROTEINS 1990-2005", "HN": "2006(1990)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050737"}, {"RECTYPE": "D", "MH": "Mesomycetozoea Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "ENTRY": "Mesomycetozoea Infection", "MN": "C01.610.600", "MH_TH": "NLM (2006)", "ST": "T047", "MS": "Infections by MESOMYCETOZOEA, general or unspecified.", "PM": "2006", "HN": "2006", "MR": "20190617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050738"}, {"RECTYPE": "D", "MH": "Phocoena", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Harbor Porpoise|T015|NON|NRW|NLM (2006)|041210|abcdef", "ENTRY": "Porpoises, Harbour", "MN": "B01.050.150.900.649.313.875.566.600", "MH_TH": "NLM (1998)", "ST": "T015", "RN": "txid9741", "RR": "txid9742", "PI": "Porpoises (1998-2005)", "MS": "A genus of PORPOISES, in the family Phocoenidae, comprised of several species. They frequent coastal waters, bays, estuaries, and the mouths of large rivers.", "PM": "2006; see PORPOISES 1998-2005", "HN": "2006; use PORPOISES 1998-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050741"}, {"RECTYPE": "D", "MH": "Pyruvate Synthase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, Pyruvate", "MN": "D08.811.682.657.350.968", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.7.1", "RR": "9082-51-3 (CRN)", "MS": "A ferredoxin-containing enzyme that catalyzes the COENZYME A-dependent oxidative decarboxylation of PYRUVATE to acetyl-COENZYME A and CARBON DIOXIDE.", "PM": "2006; PYRUVATE SYNTHASE was indexed under KETONE OXIDOREDUCTASES 1975-2005, under FERREDOXINS 1972-1979, under ACETYL COENZYME A 1974-1978, under PYRUVATES 1970-1982, & under COENZYME A & CARBOXY-LYASES 1970-1974", "HN": "2006(1980); use KETONE OXIDOREDUCTASES 1975-1979, FERREDOXINS 1972-1979, ACETYL COENZYME A 1974-1978, PYRUVATES 1970-1979, & COENZYME A & CARBOXY-LYASES 1970-1974", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050743"}, {"RECTYPE": "D", "MH": "Dihydrouracil Dehydrogenase (NAD+)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, Dihydrouracil", "MN": "D08.811.682.660.325", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.3.1.1", "RR": "9026-89-5 (CRN)", "PI": "Oxidoreductases Acting on CH-CH Group Donors (2004-2005)", "MS": "An enzyme that catalyzes the oxidation of 5,6-dihydrouracil to URACIL using NAD as a cofactor. This enzyme also plays a role in the catabolism of the antimetabolite 5-FLUOROURACIL.", "PM": "2006; DIHYDROURACIL DEHYDROGENASE (NAD+) was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, OXIDOREDUCTASES 1983-2003, & URACIL 1970-1982", "HN": "2006(1970)", "MR": "20050711", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050744"}, {"RECTYPE": "D", "MH": "Enoyl-(Acyl-Carrier Protein) Reductase (NADPH, B-Specific)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, Acyl-ACP", "MN": "D08.811.682.660.390", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.3.1.10", "PI": "Oxidoreductases (1980-2005)", "MS": "An enzyme that catalyzes the oxidation of acyl-[acyl-carrier protein] to trans-2,3-dehydroacyl-[acyl-carrier protein] in the fatty acid biosynthesis pathway. It has a preference for acyl derivatives with carbon chain length from 4 to 16.", "PM": "2006; ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADPH) was indexed under OXIDOREDUCTASES 1980-2005", "HN": "2006(1980)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050745"}, {"RECTYPE": "D", "MH": "Dihydrodipicolinate Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase, Dihydrodipicolinic Acid", "MN": "D08.811.682.660.275", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.17.1.8", "PI": "Picolinic Acids (1974-1981)", "MS": "An enzyme that catalyzes the oxidation of 2,3,4,5-tetrahydrodipicolinate to 2,3-dihydrodipicolinate using NAD(P)+ as a cofactor. It is found in BACTERIA and higher plants involved in the biosynthesis of DIAMINOPIMELIC ACID and LYSINE.", "PM": "2006; DIHYDRODIPICOLINATE REDUCTASE was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, under OXIDOREDUCTASES 1982-2003, and under PICOLINIC ACIDS 1974-1981", "HN": "2006(1974)", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050746"}, {"RECTYPE": "D", "MH": "Enoyl-(Acyl-Carrier-Protein) Reductase (NADH)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase, NADH-Enoyl ACP", "MN": "D08.811.682.660.387", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.3.1.9", "PI": "Proteins (1970-1972)", "MS": "An NAD-dependent enzyme that catalyzes the oxidation of acyl-[acyl-carrier protein] to trans-2,3-dehydroacyl-[acyl-carrier protein]. It has a preference for acyl groups with a carbon chain length between 4 to 16.", "PM": "2006; ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE (NADH) was indexed under OXIDOREDUCTASES 1984-2005, under ACYL CARRIER PROTEIN 1978-1983, under CARRIER PROTEINS 1972-1979, and under PROTEINS 1970-1972", "HN": "2006(1970)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050753"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase Inhibitor Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "INK4 Cyclin-Dependent Kinase Inhibitors|T116|T123|ABX|NRW|NLM (2006)|041213|abbcdef", "ENTRY": "Inhibitors of Cyclin Dependent Kinase 4 Proteins", "MN": "D12.776.624.776.355", "PA": "Protein Kinase Inhibitors", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A group of cell cycle proteins that negatively regulate the activity of CYCLIN/CYCLIN-DEPENDENT KINASE complexes. They inhibit CELL CYCLE progression and help control CELL PROLIFERATION following GENOTOXIC STRESS as well as during CELL DIFFERENTIATION.", "PM": "2006", "HN": "2006", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050756"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase Inhibitor p21", "DS": "CYCLIN DEPENDENT KINASE INHIBITOR P 021", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Senescent Cell Derived Inhibitor Protein 1", "MN": "D12.776.660.720.250", "PA": "Protein Kinase Inhibitors", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A cyclin-dependent kinase inhibitor that mediates TUMOR SUPPRESSOR PROTEIN P53-dependent CELL CYCLE arrest. p21 interacts with a range of CYCLIN-DEPENDENT KINASES and associates with PROLIFERATING CELL NUCLEAR ANTIGEN and CASPASE 3.", "PM": "2006; CYCLIN-DEPENDENT KINASE INHIBITOR P21 was indexed under CYCLINS 1993-2005, & under CELL CYCLE PROTEINS 2005", "HN": "2006(1993)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050759"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase Inhibitor p27", "DS": "CYCLIN DEPENDENT KINASE INHIBITOR P 027", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p27, CDK Inhibitor", "MN": "D12.776.624.776.355.600", "PA": "Protein Kinase Inhibitors", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "147604-94-2", "MS": "A cyclin-dependent kinase inhibitor that coordinates the activation of CYCLIN and CYCLIN-DEPENDENT KINASES during the CELL CYCLE. It interacts with active CYCLIN D complexed to CYCLIN-DEPENDENT KINASE 4 in proliferating cells, while in arrested cells it binds and inhibits CYCLIN E complexed to CYCLIN-DEPENDENT KINASE 2.", "PM": "2006; CYCLIN-DEPENDENT KINASE INHIBITOR P27 was indexed under CELL CYCLE PROTEINS & TUMOR SUPPRESSOR PROTEINS 1992-2005", "HN": "2006(1992)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050760"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase Inhibitor p57", "DS": "CYCLIN DEPENDENT KINASE INHIBITOR P 057", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "KIP2 Protein, p57", "MN": "D12.776.624.776.355.700", "PA": "Protein Kinase Inhibitors", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A potent inhibitor of CYCLIN-DEPENDENT KINASES in G1 PHASE and S PHASE. In humans, aberrant expression of p57 is associated with various NEOPLASMS as well as with BECKWITH-WIEDEMANN SYNDROME.", "PM": "2006; CYCLIN-DEPENDENT KINASE INHIBITOR P57 was indexed under NUCLEAR PROTEINS 1995-2005", "HN": "2006(1995)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050761"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase Inhibitor p15", "DS": "CYCLIN DEPENDENT KINASE INHIBITOR P 015", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "INK4b Cyclin Dependent Kinase Inhibitor", "MN": "D12.776.624.776.355.100", "PA": "Protein Kinase Inhibitors", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An INK4 cyclin-dependent kinase inhibitor containing four ANKYRIN-LIKE REPEATS. INK4B is often inactivated by deletions, mutations, or hypermethylation in HEMATOLOGIC NEOPLASMS.", "PM": "2006; CYCLIN-DEPENDENT KINASE INHIBITOR P15 was indexed under TUMOR SUPPRESSOR PROTEINS & CELL CYCLE PROTEINS 2004-2005, under PROTEIN P16 2002-2004, & under CARRIER PROTEINS 1994-2001", "HN": "2006(1994)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050762"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase Inhibitor p18", "DS": "CYCLIN DEPENDENT KINASE INHIBITOR P 018", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p18, CDK6-Associated Protein", "MN": "D12.776.624.776.355.300", "PA": "Protein Kinase Inhibitors", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN-LIKE REPEATS. Aberrant expression of this protein has been associated with deregulated EPITHELIAL CELL growth, organ enlargement, and a variety of NEOPLASMS.", "PM": "2006; CYCLIN-DEPENDENT KINASE INHIBITOR P 18 was indexed under TUMOR SUPPRESSOR PROTEINS & CELL CYCLE PROTEINS 2002-2005, & under CARRIER PROTEINS 1994-2001", "HN": "2006(1994)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050763"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase Inhibitor p19", "DS": "CYCLIN DEPENDENT KINASE INHIBITOR P 019", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cyclin Dependent Kinase Inhibitor p19", "MN": "D12.776.624.776.355.400", "PA": "Protein Kinase Inhibitors", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN REPEATS. Aberrant expression of this protein has been associated with TESTICULAR CANCER.", "PM": "2006; CYCLIN-DEPENDENT KINASE INHIBITOR P19 was indexed under CARRIER PROTEINS 1995-2001, under PROTEIN P16 2002-2004, & under CELL CYCLE PROTEINS 2005", "HN": "2006(1995)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050764"}, {"RECTYPE": "D", "MH": "Qa-SNARE Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Qa SNAREs", "MN": "D12.776.543.990.775.500.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A subfamily of Q-SNARE PROTEINS which occupy the same position as syntaxin 1A in the SNARE complex and which also are most similar to syntaxin 1A in their AMINO ACID SEQUENCE. This subfamily is also known as the syntaxins, although a few so called syntaxins are Qc-SNARES.", "PM": "2006; SYNTAXIN (now QA-SNARE PROTEINS) was indexed under MEMBRANE PROTEINS 1995-2005 and PROTEINS 1994", "HN": "2006 (1994)", "MR": "20160628", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050765"}, {"RECTYPE": "D", "MH": "Qb-SNARE Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Qb SNAREs", "MN": "D12.776.543.990.775.500.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A subfamily of Q-SNARE PROTEINS which occupy the same position in the SNARE complex as the N-terminal SNARE domain of SNAP-25 and which also are most similar to the N-terminal region of SNAP-25 in their AMINO ACID SEQUENCE.", "PM": "2006", "HN": "2006", "MR": "20050727", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050766"}, {"RECTYPE": "D", "MH": "Qc-SNARE Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Qc SNAREs", "MN": "D12.776.543.990.775.500.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A subfamily of Q-SNARE PROTEINS which occupy the same position in the SNARE complex as the C-terminal SNARE domain of SNAP-25 and which also are most similar to the C-terminal region of SNAP-25 in their AMINO ACID SEQUENCE.", "PM": "2006", "HN": "2006", "MR": "20050727", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050767"}, {"RECTYPE": "D", "MH": "Protoporphyrinogen Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Protoporphyrinogen IX", "MN": "D12.776.543.697", "EC": "deficiency:Porphyria, Variegate", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.3.3.4", "PI": "Protoporphyrins (1975-1982)", "MS": "A membrane-bound flavoenzyme that catalyzes the oxygen-dependent aromatization of protoporphyrinogen IX (Protogen) to protoporphyrin IX (Proto IX). It is the last enzyme of the common branch of the HEME and CHLOROPHYLL pathways in plants, and is the molecular target of diphenyl ether-type herbicides. VARIEGATE PORPHYRIA is an autosomal dominant disorder associated with deficiency of protoporphyrinogen oxidase.", "PM": "2006; PROTOPORPHYRINOGEN OXIDASE was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, under OXIDOREDUCTASES 1993-2003, under PORPHYRINS 1975-1976, and under PROTOPORPHYRINS 1975-1982", "HN": "2006(1975)", "MR": "20090715", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050768"}, {"RECTYPE": "D", "MH": "Isovaleryl-CoA Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Isovaleryl Coenzyme A Dehydrogenase", "MN": "D08.811.682.660.462", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.3.8.4", "RR": "37274-61-6 (CRN)", "PI": "Valerates (1973-1982)", "MS": "A mitochondrial flavoprotein, this enzyme catalyzes the oxidation of 3-methylbutanoyl-CoA to 3-methylbut-2-enoyl-CoA using FAD as a cofactor. Defects in the enzyme, is associated with isovaleric acidemia (IVA).", "PM": "2006; ISOVALERYL-COA DEHYDROGENASE was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, under OXIDOREDUCTASES 1983-2003, under ACYL COENZYME A 1980-1982, COENZYME A 1973-1980, and under VALERATES 1973-1982", "HN": "2006(1973)", "MR": "20160628", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050769"}, {"RECTYPE": "D", "MH": "Glutaryl-CoA Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glutaryl Coenzyme A Dehydrogenase", "MN": "D08.811.682.660.425", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.3.8.6", "RR": "37255-38-2 (CRN)", "PI": "Oxidoreductases Acting on CH-CH Group Donors (2004-2005)", "MS": "A flavoprotein enzyme that is responsible for the catabolism of LYSINE; HYDROXYLYSINE; and TRYPTOPHAN. It catalyzes the oxidation of GLUTARYL-CoA to crotonoyl-CoA using FAD as a cofactor. Glutaric aciduria type I is an inborn error of metabolism due to the deficiency of glutaryl-CoA dehydrogenase.", "PM": "2006; GLUTARYL-COA DEHYDROGENASE was indexed under ACYL COENZYME A 1973-1979; under GLUTARATES 1973-1982; and under COENZYME A 1973-1979; under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005", "HN": "2006(1973)", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050770"}, {"RECTYPE": "D", "MH": "Complement C5b", "DS": "COMPLEMENT C 05 B", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Component 5b, Complement", "MN": "D12.776.124.486.274.450.625", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "N1": "Complement C 5b", "RN": "80295-55-2", "MS": "The larger fragment generated from the cleavage of C5 by C5 CONVERTASE that yields COMPLEMENT C5A and C5b (beta chain + alpha' chain, the residual alpha chain, bound by disulfide bond). C5b remains bound to the membrane and initiates the spontaneous assembly of the late complement components to form C5b-8-poly-C9, the MEMBRANE ATTACK COMPLEX.", "PM": "2006; COMPLEMENT C5B was indexed under COMPLEMENT 5 1982-2005", "HN": "2006 (1982)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050776"}, {"RECTYPE": "D", "MH": "Stathmin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p19, Phosphoprotein", "MN": "D12.776.744.772", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A ubiquitous phosphoprotein that serves as an intracellular substrate for a variety of SIGNAL TRANSDUCTION PATHWAYS. PHOSPHORYLATION of stathmin occurs during CELL CYCLE progression, and stathmin functions as a microtubule-destabilizing protein that promotes MICROTUBULE depolymerization during INTERPHASE and late MITOSIS. Stathmin is expressed at very high levels in a variety of human CANCERS.", "PM": "2006; STATHMIN was indexed under MICROTUBULE PROTEINS & PHOSPHOPROTEINS 1987-2005", "HN": "2006(1987)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050777"}, {"RECTYPE": "D", "MH": "NFATC Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nuclear Factors of Activated T-Cells|T116|T123|NON|EQV|NLM (2006)|041214|abbcdef", "ENTRY": "Transcription Factors, NFATC", "MN": "D12.776.930.608", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of transcription factors characterized by the presence of highly conserved calcineurin- and DNA-binding domains. NFAT proteins are activated in the CYTOPLASM by the calcium-dependent phosphatase CALCINEURIN. They transduce calcium signals to the nucleus where they can interact with TRANSCRIPTION FACTOR AP-1 or NF-KAPPA B and initiate GENETIC TRANSCRIPTION of GENES involved in CELL DIFFERENTIATION and development. NFAT proteins stimulate T-CELL activation through the induction of IMMEDIATE-EARLY GENES such as INTERLEUKIN-2.", "PM": "2006; NFATC TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEIN, NUCLEAR PROTEINS, & TRANSCRIPTION FACTORS 1993-2005", "HN": "2006(1993)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050778"}, {"RECTYPE": "D", "MH": "Nuclear Factor 90 Proteins", "DS": "NUCLEAR FACTOR PROTEINS 090", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nuclear Factor 90 Protein|T116|T123|NON|NRW|NLM (2006)|050204|NUCLEAR FACTOR PROTEIN 090|abbcdefs", "ENTRY": "NF90 Double Stranded RNA Binding Proteins", "MN": "D12.776.930.616", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of double-stranded RNA-binding proteins that are related to NFATC TRANSCRIPTION FACTORS. In addition to binding to RNA, nuclear factor 90 proteins form heterodimeric complexes that regulate GENETIC TRANSCRIPTION and may play a role in T-CELL activation.", "PM": "2006; NUCLEAR FACTOR 90 PROTEINS were indexed under DNA-BINDING PROTEINS, NUCLEAR PROTEINS, & TRANSCRIPTION FACTORS 1993-2005", "HN": "2006(1993)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050779"}, {"RECTYPE": "D", "MH": "Transcranial Magnetic Stimulation", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Transcranial Magnetic Stimulations", "MN": "E02.621.820", "FX": "Transcranial Direct Current Stimulation", "MH_TH": "NLM (2006)", "ST": "T058", "PI": "Magnetics (1988-2005)", "MS": "A technique that involves the use of electrical coils on the head to generate a brief magnetic field which reaches the CEREBRAL CORTEX. It is coupled with ELECTROMYOGRAPHY response detection to assess cortical excitability by the threshold required to induce MOTOR EVOKED POTENTIALS. This method is also used for BRAIN MAPPING, to study NEUROPHYSIOLOGY, and as a substitute for ELECTROCONVULSIVE THERAPY for treating DEPRESSION. Induction of SEIZURES limits its clinical usage.", "PM": "2006", "HN": "2006", "MR": "20140613", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050781"}, {"RECTYPE": "D", "MH": "Esophageal pH Monitoring", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Monitoring, Esophageal pH|T060|NON|EQV|NLM (2006)|041215|abcdef", "ENTRY": "pH Recordings, Esophageal", "MN": "E01.370.520.215", "MH_TH": "NLM (2006)", "ST": "T060", "PI": "Hydrogen-Ion Concentration (1975-2005)", "MS": "Analysis of the HYDROGEN ION CONCENTRATION in the lumen of the ESOPHAGUS. It is used to record the pattern, frequency, and duration of GASTROESOPHAGEAL REFLUX.", "PM": "2006", "HN": "2006", "MR": "20150626", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050782"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-ets", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ets Transcription Factor|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "ets Proto Oncogene Proteins", "MN": "D12.776.930.720", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1986-2005)", "MS": "A family of transcription factors that share a unique DNA-binding domain. The name derives from viral oncogene-derived protein oncogene protein v-ets of the AVIAN ERYTHROBLASTOSIS VIRUS.", "PM": "2006; PROTO-ONCOGENE PROTEINS C-ETS was indexed under PROTO-ONCOGENE PROTEINS & TRANSCRIPTION FACTORS 1986-2005", "HN": "2006(1986)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050783"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Protein c-ets-1", "DS": "PROTO ONCOGENE PROTEIN C ETS 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-ets-1 Protein|T116|T123|ABX|EQV|NLM (2006)|C ETS 01 PROTEIN|abbcdes", "ENTRY": "ets-1, Proto-Oncogene Protein", "MN": "D12.776.930.720.100", "FX": "ETS Motif", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1986-2005)", "MS": "An ets proto-oncogene protein expressed primarily in adult LYMPHOID TISSUE; BRAIN; and VASCULAR ENDOTHELIAL CELLS.", "PM": "2006; PROTO-ONCOGENE PROTEINS C-ETS-1 was indexed under PROTO-ONCOGENE PROTEINS & TRANSCRIPTION FACTORS 1986-2005", "HN": "2006(1986)", "MR": "20160418", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050784"}, {"RECTYPE": "D", "MH": "Cryoanesthesia", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Anesthesia, Refrigeration|T061|NON|EQV|UNK (19XX)|830617|abcdef", "ENTRY": "Refrigeration Anesthesia|T061|NON|EQV|NLM (2006)|041215|abcdef", "MN": "E03.155.441", "MH_TH": "UNK (19XX)", "ST": "T061", "PI": "Anesthesia (1968-2005)", "MS": "ANESTHESIA achieved by lowering either BODY TEMPERATURE (core cooling) or SKIN TEMPERATURE (external cooling).", "PM": "2006; see HYPOTHERMIA, INDUCED 1984-2005", "HN": "2006; use HYPOTHERMIA, INDUCED 1984-2005", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050785"}, {"RECTYPE": "D", "MH": "Gastric Hypothermia", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Lavages, Cold Gastric", "MN": "E02.258.750.500", "MH_TH": "UNK (19XX)", "ST": "T061", "MS": "A method of lowering core BODY TEMPERATURE by filling the STOMACH with chilled fluids.", "PM": "2006; see HYPOTHERMIA, INDUCED 1984-2005", "HN": "2006; use HYPOTHERMIA, INDUCED 1984-2005", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050786"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Protein c-ets-2", "DS": "PROTO ONCOGENE PROTEIN C ETS 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-ets-2 Protein|T116|T123|ABX|EQV|NLM (2006)|C ETS 02 PROTEIN|abbcdes", "ENTRY": "ets-2, Proto-Oncogene Proteins", "MN": "D12.776.930.720.200", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "MS": "A ubiquitously expressed ets proto-oncogene protein that may play a role in regulation of CELL PROLIFERATION and CELL DIFFERENTIATION.", "PM": "2006; PROTO-ONCOGENE PROTEINS ETS-2 was indexed under PROTO-ONCOGENE PROTEINS & TRANS-ACTIVATORS 1990-2005", "HN": "2006(1990)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050787"}, {"RECTYPE": "D", "MH": "Alanine Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "L Alanine Dehydrogenase", "MN": "D08.811.682.664.500.062", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.4.1.1", "RR": "9029-06-5 (CRN)", "MS": "An NAD-dependent enzyme that catalyzes the reversible DEAMINATION of L-ALANINE to PYRUVATE and AMMONIA. The enzyme is needed for growth when ALANINE is the sole CARBON or NITROGEN source. It may also play a role in CELL WALL synthesis because L-ALANINE is an important constituent of the PEPTIDOGLYCAN layer.", "PM": "2006; ALANINE DEHYDROGENASE was indexed under AMINO ACID OXIDOREDUCTASES 1972-2005, & under ALANINE 1972-1980", "HN": "2006(1980) use AMINO ACID OXIDOREDUCTASES & ALANINE 1972-1979", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050788"}, {"RECTYPE": "D", "MH": "Glycine Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, Glycine", "MN": "D08.811.682.664.500.526", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.4.1.10", "PI": "Amino Acid Oxidoreductases (1977-2005)", "MS": "An oxidoreductase that catalyzes the oxidative DEAMINATION of GLYCINE to glyoxylate and AMMONIA in the presence of NAD. In BACTERIA lacking transaminating pathways the enzyme can act in the reverse direction to synthesize glycine from glyoxylate and ammonia and NADH.", "PM": "2006; GLYCINE DEHYDROGENASE was indexed under AMINO ACID OXIDOREDUCTASES 1977-2005", "HN": "2006(1977)", "MR": "20090715", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050789"}, {"RECTYPE": "D", "MH": "Glutamate Synthase (NADH)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, L-Glutamate", "MN": "D12.776.331.737", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.4.1.14", "PI": "Amino Acid Oxidoreductases (1998-2005)", "MS": "A FLAVOPROTEIN enzyme for AMMONIA assimilation in BACTERIA, microorganisms and PLANTS. It catalyzes the oxidation of 2 molecules of L-GLUTAMATE to generate L-GLUTAMINE and 2-oxoglutarate in the presence of NAD+.", "PM": "2006; GLUTAMATE SYNTHASE (NADH) was indexed under AMINO ACID OXIDOREDUCTASES 1998-2005", "HN": "2006(1998)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050790"}, {"RECTYPE": "D", "MH": "STAT Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, STAT", "MN": "D12.776.930.840", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "MS": "A family of transcription factors containing SH2 DOMAINS that are involved in CYTOKINE-mediated SIGNAL TRANSDUCTION. STAT transcription factors are recruited to the cytoplasmic region of CELL SURFACE RECEPTORS and are activated via PHOSPHORYLATION. Once activated they dimerize and translocate into the CELL NUCLEUS where they influence GENE expression. They play a role in regulating CELL GROWTH PROCESSES and CELL DIFFERENTIATION. STAT transcription factors are inhibited by SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS and PROTEIN INHIBITORS OF ACTIVATED STAT.", "PM": "2006", "HN": "2006", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050791"}, {"RECTYPE": "D", "MH": "Circulatory Arrest, Deep Hypothermia Induced", "DE": "CIRCULATORY ARREST DEEP HYPOTHERMIA IND", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Deep Hypothermic Circulatory Arrest|T061|NON|EQV|NLM (2006)|041216|abcdef", "MN": "E04.928.220.360.500", "MH_TH": "NLM (2006)", "ST": "T061", "PI": "Hypothermia, Induced (1966-2005)", "MS": "A technique to arrest the flow of blood by lowering BODY TEMPERATURE to about 20 degrees Centigrade, usually achieved by infusing chilled perfusate. The technique provides a bloodless surgical field for complex surgeries.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050792"}, {"RECTYPE": "D", "MH": "Orthodontic Extrusion", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tooth Extrusion|T061|NON|EQV|NLM (1998)|961011|abcdef", "ENTRY": "Tooth Extrusions", "MN": "E06.658.578.225", "FX": "Crown Lengthening", "MH_TH": "NLM (2006)", "ST": "T061", "PI": "Tooth Movement (1974-2005)", "MS": "Orthodontic movement in the coronal direction achieved by outward tension on the PERIODONTAL LIGAMENT. It does not include the operative procedure that CROWN LENGTHENING involves.", "PM": "2006; see TOOTH MOVEMENT 1998-2005", "HN": "2006; use TOOTH MOVEMENT 1998-2005", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050793"}, {"RECTYPE": "D", "MH": "STAT1 Transcription Factor", "DS": "STAT 01 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, STAT91", "MN": "D12.776.930.840.100", "FX": "src Homology Domains", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A signal transducer and activator of transcription that mediates cellular responses to INTERFERONS. Stat1 interacts with P53 TUMOR SUPPRESSOR PROTEIN and regulates expression of GENES involved in growth control and APOPTOSIS.", "PM": "2006; STAT1 PROTEIN was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 1992-2005", "HN": "2006(1993)", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050794"}, {"RECTYPE": "D", "MH": "STAT2 Transcription Factor", "DS": "STAT 02 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, STAT2", "MN": "D12.776.930.840.200", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A signal transducer and activator of transcription that mediates cellular responses to TYPE I INTERFERONS. Stat2 protein is associated constitutively with INTERFERON REGULATORY FACTOR-9. After PHOSPHORYLATION Stat2 forms the IFN-STIMULATED GENE FACTOR 3 COMPLEX to regulate expression of target GENES.", "PM": "2006; STAT2 PROTEIN was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 1995-2005", "HN": "2006(1995)", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050795"}, {"RECTYPE": "D", "MH": "STAT3 Transcription Factor", "DS": "STAT 03 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, Stat3beta", "MN": "D12.776.930.840.300", "FX": "src Homology Domains", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-6 family members. STAT3 is constitutively activated in a variety of TUMORS and is a major downstream transducer for the CYTOKINE RECEPTOR GP130.", "PM": "2006; STAT3 PROTEIN was indexed under DNA-BINDING PROTEINS & TRANSACTIVATORS 1994-2005", "HN": "2006", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050796"}, {"RECTYPE": "D", "MH": "STAT4 Transcription Factor", "DS": "STAT 04 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, STAT4b", "MN": "D12.776.930.840.400", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-12 in T-LYMPHOCYTES. Stat4 is an important signaling molecule for differentiation in TH1 CELLS.", "PM": "2006; STAT4 PROTEIN was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 1994-2005", "HN": "2006(1994)", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050797"}, {"RECTYPE": "D", "MH": "SUNCT Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, SUNCT", "MN": "C10.228.140.546.399.937.875", "MH_TH": "ORD (2010)", "ST": "T184", "PI": "Tears (1991-2005)", "MS": "A primary headache disorder that is characterized by frequent short-lasting, unilateral, neuralgiform pain attacks in the ocular area, with CONJUNCTIVA fluid-filling and tearing. SUNCT syndrome is usually resistant to treatment.", "PM": "2006", "HN": "2006", "MR": "20090706", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050798"}, {"RECTYPE": "D", "MH": "STAT5 Transcription Factor", "DS": "STAT 05 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, STAT5b", "MN": "D12.776.930.840.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A signal transducer and activator of transcription that mediates cellular responses to a variety of CYTOKINES. Stat5 activation is associated with transcription of CELL CYCLE regulators such as CYCLIN KINASE INHIBITOR P21 and anti-apoptotic genes such as BCL-2 GENES. Stat5 is constitutively activated in many patients with acute MYELOID LEUKEMIA.", "PM": "2006; STAT5 PROTEIN was indexed under DNA-BINDING PROTEINS; MILK PROTEINS; & TRANS-ACTIVATORS 1992-2005", "HN": "2006(1992)", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050799"}, {"RECTYPE": "D", "MH": "STAT6 Transcription Factor", "DS": "STAT 06 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, STAT6", "MN": "D12.776.930.840.600", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-4. Stat6 has been shown to partner with NF-KAPPA B and CCAAT-ENHANCER-BINDING PROTEINS to regulate GENETIC TRANSCRIPTION of interleukin-4 responsive GENES.", "PM": "2006; STAT6 PROTEIN was indexed under TRANS-ACTIVATORS 1995-2005", "HN": "2006(1995)", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050800"}, {"RECTYPE": "D", "MH": "Ternary Complex Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Complex Proteins, Ternary", "MN": "D12.776.930.720.600", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A subclass of c-ets proto-oncogene proteins that were first described by their property of binding to DNA when associated with other regulatory proteins such as SERUM RESPONSE FACTOR. They contain an amino-terminal ets domain that binds to DNA along with centrally located SERUM RESPONSE FACTOR interacting domain, and carboxy-terminal map kinase activation domains. They play an important role in transcriptional regulation by INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS.", "PM": "2006", "HN": "2006", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050801"}, {"RECTYPE": "D", "MH": "Valine Dehydrogenase (NADP+)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Valine Dehydrogenase, NADP Dependent", "MN": "D08.811.682.664.500.924", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.4.1.8", "MS": "An amino acid oxidoreductase that catalyzes the oxidative hydroxylation of L-VALINE to 3-methyl-2-oxobutanoate and AMMONIA in the presence of NADP.", "PM": "2006; VALINE DEHYDROGENASE (NADP+) was indexed under AMINO ACID OXIDOREDUCTASES 1989-2004", "HN": "2006(1989)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050802"}, {"RECTYPE": "D", "MH": "Leucine Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "L Leucine Dehydrogenase", "MN": "D08.811.682.664.500.724", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.4.1.9", "RR": "9082-71-7 (CRN)", "PI": "Leucine (1970-1979)", "MS": "An octameric enzyme belonging to the superfamily of amino acid dehydrogenases. Leucine dehydrogenase catalyzes the reversible oxidative deamination of L-LEUCINE, to 4-methyl-2-oxopentanoate (2-ketoisocaproate) and AMMONIA, with the corresponding reduction of the cofactor NAD+.", "PM": "2006; LEUCINE DEHYDROGENASE was indexed under AMINO ACID OXIDOREDUCTASES 1970-2005 & LEUCINE 1970-1982", "HN": "2006(1970)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050803"}, {"RECTYPE": "D", "MH": "D-Aspartate Oxidase", "DS": "ASPARATE OXIDASE D", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, D-aspartic", "MN": "D08.811.682.664.500.261", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.4.3.1", "PI": "Aspartic Acid (1975-1979)", "MS": "An FAD-dependent peroxisomal flavoenzyme, this catalyzes the oxidative deamination of D-ASPARTATE to OXALOACETATE and AMMONIA using oxygen as electron acceptor.", "PM": "2006; D-ASPARTATE OXIDASE was indexed under AMINO ACID OXIDOREDUCTASES 1975-2005 & under ASPARTIC ACID 1975-1981", "HN": "2006(1975)", "MR": "20070709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050804"}, {"RECTYPE": "D", "MH": "Wandering Spleen", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Wandering Spleens", "MN": "C15.604.744.954", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Splenic Diseases (1967-2005)", "MS": "A congenital or acquired condition in which the SPLEEN is not in its normal anatomical position but moves about in the ABDOMEN. This is due to laxity or absence of suspensory ligaments which normally provide peritoneal attachments to keep the SPLEEN in a fixed position. Clinical symptoms include ABDOMINAL PAIN, splenic torsion and ISCHEMIA.", "PM": "2006", "HN": "2006", "MR": "20100625", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050805"}, {"RECTYPE": "D", "MH": "Arthroplasty, Replacement, Finger", "DE": "ARTHROPLASTY REPLACE FINGER", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Finger Replacement Arthroplasty|T061|NON|EQV|NLM (2006)|041217|FINGER REPLACE ARTHROPLASTY|abcdefv", "ENTRY": "Replacement Arthroplasty, Finger", "MN": "E04.650.110.054", "MH_TH": "NLM (2006)", "ST": "T061", "PI": "Replantation (1967-2005)", "MS": "Partial or total replacement of one or more FINGERS, or a FINGER JOINT.", "PM": "2006", "HN": "2006", "MR": "20220406", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050806"}, {"RECTYPE": "D", "MH": "ets-Domain Protein Elk-1", "DS": "ETS DOMAIN PROTEIN ELK 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Elk-1 ets-Domain Protein|T116|T123|ABX|EQV|NLM (2006)|040213|ELK 01 ETS DOMAIN PROTEIN|abbcdefs", "ENTRY": "ets-Domain Protein, Elk1", "MN": "D12.776.930.720.600.100", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Transcription Factors (1989-2005)", "MS": "A member of the ternary complex family of ets-related transcription factors that is regulated by MITOGEN-ACTIVATED PROTEIN KINASES including JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; and P38 MITOGEN-ACTIVATED PROTEIN KINASES.", "PM": "2006; ETS-DOMAIN PROTEIN ELK-1 was indexed under PROTO-ONCOGENE PROTEINS, TRANSCRIPTION FACTORS, DNA-BINDING PROTEINS 1995-2005, under RETROVIRIDAE PROTEINS 1989, & under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1994", "HN": "2006(1989)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050807"}, {"RECTYPE": "D", "MH": "ets-Domain Protein Elk-4", "DS": "ETS DOMAIN PROTEIN ELK 04", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serum Response Factor Accessory Protein 1|T116|T123|NON|EQV|NLM (2006)|040402|SERUM RESPONSE FACTOR ACCESSORY PROTEIN 01|abbcdefs", "ENTRY": "ets-Domain Protein, Elk-4", "MN": "D12.776.930.720.600.300", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "146481-62-1", "AN": "see SCR for organism-specific terms", "PI": "Fungal Proteins (1992-1994)", "MS": "A member of the ternary complex family of ets-related transcription factors that is regulated by MITOGEN-ACTIVATED PROTEIN KINASES such as EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; and P38 MITOGEN-ACTIVATED PROTEIN KINASES.", "PM": "2006; ETS-DOMAIN PROTEIN ELK was indexed under DNA-BINDING PROTEINS 1995-2005 & FUNGAL PROTEINS 1992-1994", "HN": "2006(1992)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050808"}, {"RECTYPE": "D", "MH": "POU Domain Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pit Oct Unc Proteins", "MN": "D12.776.930.710", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of transcription factors characterized by the presence of a bipartite DNA-binding domain known as the POU domain. The POU domain contains two subdomains, a POU-specific domain and a POU-homeodomain. The POU domain was originally identified as a region of approximately 150 amino acids shared between the Pit-1, Oct-1, Oct-2, and Unc-86 transcription factors.", "PM": "2006; TRANSCRIPTION FACTOR POU was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1992-2004", "HN": "2006(1992)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050809"}, {"RECTYPE": "D", "MH": "Octamer Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, Octamer", "MN": "D12.776.930.710.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "MS": "A family of POU domain factors that bind the octamer motif ATTTGCAT in enhancer and PROMOTER REGIONS to regulate GENE EXPRESSION.", "PM": "2006", "HN": "2006", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050810"}, {"RECTYPE": "D", "MH": "Octamer Transcription Factor-1", "DS": "OCTAMER TRANSCRIPTION FACTOR 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transcription Factor Oct-1|T116|T123|ABX|EQV|NLM (2006)|TRANSCRIPTION FACTOR OCT 01|abbcdes", "ENTRY": "Transcription Factor-1, Octamer", "MN": "D12.776.930.710.500.100", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A ubiquitously expressed octamer transcription factor that regulates GENETIC TRANSCRIPTION of SMALL NUCLEAR RNA; IMMUNOGLOBULIN GENES; and HISTONE H2B genes.", "PM": "2006; TRANSCRIPTION FACTOR OCT-1 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1990-2005, NUCLEAR PROTEINS 1986-1989, & NUCLEOPROTEINS 1986-1987", "HN": "2006(1986)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050811"}, {"RECTYPE": "D", "MH": "Split-Brain Procedure", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Split-Brain Procedures", "MN": "E04.525.770", "FX": "Functional Laterality", "MH_TH": "NLM (2006)", "ST": "T062", "PI": "Corpus Callosum (1966-2005)", "MS": "Complete severing of the CORPUS CALLOSUM. In humans it is usually performed to treat medically intractable, multifocal EPILEPSY. EXPERIMENTAL ANIMAL MODELS of split brain preparations are used in research.", "PM": "2006", "HN": "2006", "MR": "20060710", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050812"}, {"RECTYPE": "D", "MH": "Octamer Transcription Factor-2", "DS": "OCTAMER TRANSCRIPTION FACTOR 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transcription Factor Oct-2|T116|T123|ABX|EQV|NLM (2006)|041220|TRANSCRIPTION FACTOR OCT 02|abbcdefs", "ENTRY": "Transcription Factor-2, Octamer", "MN": "D12.776.930.710.500.200", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An octamer transcription factor expressed primarily in B-LYMPHOCYTES and the developing CENTRAL NERVOUS SYSTEM that regulates GENETIC TRANSCRIPTION of IMMUNOGLOBULIN GENES.", "PM": "2006", "HN": "2006", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050813"}, {"RECTYPE": "D", "MH": "Octamer Transcription Factor-3", "DS": "OCTAMER TRANSCRIPTION FACTOR 03", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transcription Factor Oct-3|T116|T123|ABX|EQV|NLM (2006)|041220|TRANSCRIPTION FACTOR OCT 03|abbcdefs", "ENTRY": "Transcription Factor-3, Octamer", "MN": "D12.776.930.710.500.300", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An octamer transcription factor that is expressed primarily in totipotent embryonic STEM CELLS and GERM CELLS and is down-regulated during CELL DIFFERENTIATION.", "PM": "2006; TRANSCRIPTION FACTOR OCT-3 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1990-2005", "HN": "2006(1990)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050814"}, {"RECTYPE": "D", "MH": "Fractures, Compression", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Compression Fracture|T037|NON|EQV|NLM (2023)|210827|abcdef", "ENTRY": "Fracture, Compression", "MN": "C26.404.195", "MH_TH": "NLM (2006)", "ST": "T037", "AN": "CRUSH FRACTURES see CRUSH INJURIES is also available", "PI": "Spinal Fractures (1988-2005)", "MS": "Crumbling or smashing of cancellous BONE by forces acting parallel to the long axis of bone. It is applied particularly to vertebral body fractures (SPINAL FRACTURES). (Blauvelt and Nelson, A Manual of Orthopedic Terminology, 1994, p4)", "PM": "2006", "HN": "2006", "MR": "20211018", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050815"}, {"RECTYPE": "D", "MH": "Octamer Transcription Factor-6", "DS": "OCTAMER TRANSCRIPTION FACTOR 06", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transcription Factor Oct-6|T116|T123|ABX|EQV|NLM (2006)|041220|TRANSCRIPTION FACTOR OCT 06|abbcdefs", "ENTRY": "Tst-1, Transcription Factor", "MN": "D12.776.930.710.500.600", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "132052-52-9", "MS": "An octamer transcription factor that plays an important role in the MYELIN SHEATH development by SCHWANN CELLS.", "PM": "2006; TRANSCRIPTION FACTOR OCT-6 was indexed under TRANSCRIPTION FACTORS 1990-2005", "HN": "2006(1990)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050816"}, {"RECTYPE": "D", "MH": "Transcription Factor Pit-1", "DS": "TRANSCRIPTION FACTOR PIT 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transcription Factor Pit-2|T116|T123|ABX|REL|NLM (2006)|041220|TRANSCRIPTION FACTOR PIT 02|abbcdefs", "ENTRY": "Transcription Factor, Pit-1", "MN": "D12.776.930.710.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A POU domain factor that regulates expression of GROWTH HORMONE; PROLACTIN; and THYROTROPIN-BETA in the ANTERIOR PITUITARY GLAND.", "PM": "2006; TRANSCRIPTION FACTOR PIT-1 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1989-2005", "HN": "2006(1989)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050817"}, {"RECTYPE": "D", "MH": "Transcription Factor Brn-3", "DS": "TRANSCRIPTION FACTOR BRN 03", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Brn-3 Transcription Factor|T116|T123|ABX|EQV|NLM (2006)|050119|BRN TRANSCRIPTION FACTOR 03|abbcdefs", "ENTRY": "Transcription Factor, Brn-3", "MN": "D12.776.930.710.625", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "MS": "A family of mammalian POU domain factors that are expressed predominately in NEURONS.", "PM": "2006; TRANSCRIPTION FACTOR BRN-3 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1992-2004", "HN": "2006(1992)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050818"}, {"RECTYPE": "D", "MH": "Transcription Factor Brn-3A", "DS": "TRANSCRIPTION FACTOR BRN 03 A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pou4f1 Transcription Factor|T116|T123|ABX|EQV|NLM (2006)|050118|POU 04 F 01 TRANSCRIPTION FACTOR|abbcdefs", "ENTRY": "Transcription Factor, Pou4f1", "MN": "D12.776.930.710.625.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A POU domain factor that activates GENETIC TRANSCRIPTION of GENES encoding NEUROFILAMENT PROTEINS; alpha internexin; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; and BCL-2 PROTO-ONCOGENE PROTEINS.", "PM": "2006; TRANSCRIPTION FACTOR BRM-3A was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1992-2005", "HN": "2006(1992)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050819"}, {"RECTYPE": "D", "MH": "Transcription Factor Brn-3B", "DS": "TRANSCRIPTION FACTOR BRN 03 B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pou4f2 Transcription Factor|T116|T123|ABX|EQV|NLM (2006)|050119|POU 04 F 02 TRANSCRIPTION FACTOR|abbcdefs", "ENTRY": "Transcription Factor, Pou4f2", "MN": "D12.776.930.710.625.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A POU domain factor that represses GENETIC TRANSCRIPTION of GENES encoding NEUROFILAMENT PROTEINS, alpha internexin, and SYNAPTOSOMAL-ASSOCIATED PROTEIN 25.", "PM": "2006; TRANSCRIPTION FACTOR BRN-3B was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS (1992-2005)", "HN": "2006(1992)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050820"}, {"RECTYPE": "D", "MH": "Transcription Factor Brn-3C", "DS": "TRANSCRIPTION FACTOR BRN 03 C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pou4f3 Transcription Factor|T116|T123|ABX|EQV|NLM (2006)|050119|POU 04 F 03 TRANSCRIPTION FACTOR|abbcdefs", "ENTRY": "Transcription Factor, Pou4f3", "MN": "D12.776.930.710.625.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A POU domain factor that activates neuronal cell GENETIC TRANSCRIPTION of GENES encoding NEUROFILAMENT PROTEINS, alpha internexin, and SYNAPTOSOMAL-ASSOCIATED PROTEIN 25. Mutations in the Brn-3c gene have been associated with DEAFNESS.", "PM": "2006; TRANSCRIPTION FACTOR BRN-3C was indexed under TRANSCRIPTION FACTORS & DNA-BINDING PROTEINS 1992-2005", "HN": "2006", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050821"}, {"RECTYPE": "D", "MH": "Cytokine Receptor gp130", "DS": "CYTOKINE RECEPTOR GP 130", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD130 Antigens|T116|T129|T192|ABX|EQV|NLM (2006)|041220|CD 130 ANTIGENS|abbbcdefs", "ENTRY": "gp130, Soluble", "MN": "D12.776.543.750.750.400.550.250.500", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "133483-10-0", "MS": "A cytokine receptor that contains extracellular FIBRONECTIN TYPE III DOMAINS which mediate its function through the formation of oligomeric complexes with itself, or with a variety of CYTOKINE RECEPTORS. It does not bind IL-6, but activates JANUS KINASES and STAT3 TRANSCRIPTION FACTOR.", "PM": "2006; CYTOKINE RECEPTOR GP130 was indexed under ANTIGENS, CD & MEMBRANES GLYCOPROTEINS 1990-2005", "HN": "2006(1990)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050822"}, {"RECTYPE": "D", "MH": "Hand Joints", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Joints, Intermetacarpal", "MN": "A02.835.583.405", "MH_TH": "NLM (2006)", "ST": "T030", "AN": "primates only", "PI": "specific hand joints (1968-2005)", "MS": "The articulations extending from the WRIST distally to the FINGERS. These include the WRIST JOINT; CARPAL JOINTS; METACARPOPHALANGEAL JOINT; and FINGER JOINT.", "PM": "2006", "HN": "2006", "MR": "20090706", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050823"}, {"RECTYPE": "D", "MH": "Carpal Joints", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Intercarpal Joints|T030|NON|EQV|NLM (2006)|041220|abcdef", "ENTRY": "Joints, Intercarpal", "MN": "A02.835.583.405.174", "MH_TH": "NLM (2006)", "ST": "T030", "AN": "vertebrates only", "MS": "The articulations between the various CARPAL BONES. This does not include the WRIST JOINT which consists of the articulations between the RADIUS; ULNA; and proximal CARPAL BONES.", "PM": "2006", "HN": "2006", "MR": "20090706", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050824"}, {"RECTYPE": "D", "MH": "Synaptosomal-Associated Protein 25", "DE": "SYNAPTOSOMAL ASSOC PROTEIN 25", "DS": "SYNAPTOSOMAL ASSOCIATED PROTEIN 025", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synaptosomal Associated Protein 25", "MN": "D12.776.543.990.775.500.875.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Nerve Tissue Proteins (1989-2005)", "MS": "A ubiquitous target SNARE protein that interacts with SYNTAXIN and SYNAPTOBREVIN. It is a core component of the machinery for intracellular MEMBRANE FUSION. The sequence contains 2 SNARE domains, one is the prototype for the Qb-SNARES, and the other is the prototype for the Qc-SNARES.", "PM": "2006; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25 was indexed under MEMBRANE PROTEINS and NERVE TISSUE PROTEINS 1990-2005", "HN": "2006 (1990)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050825"}, {"RECTYPE": "D", "MH": "Suppressor of Cytokine Signaling Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Suppressors of Cytokine Signaling Proteins|T116|T123|NON|EQV|NLM (2006)|050127|abbcdef", "MN": "D12.776.476.024.437", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of structurally related proteins that are induced by CYTOKINES and negatively regulate cytokine-mediated SIGNAL TRANSDUCTION PATHWAYS. SOCS proteins contain a central SH2 DOMAIN and a C-terminal region of homology known as the SOCS box.", "PM": "2006", "HN": "2006", "MR": "20151124", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050826"}, {"RECTYPE": "D", "MH": "Syntaxin 1", "DS": "SYNTAXIN 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Syntaxin 2 Protein", "MN": "D12.776.543.990.775.500.500.700", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "RR": "147338-67-8", "AN": "see SCR for organism-specific terms", "PI": "Nerve Tissue Proteins (1995-2005)", "MS": "A neuronal cell membrane protein that combines with SNAP-25 and SYNAPTOBREVIN 2 to form a SNARE complex that leads to EXOCYTOSIS.", "PM": "2006; SYNTAXIN 1 was indexed under ANTIGENS, SURFACE and NERVE TISSUE PROTEINS 1993-2005, and MEMBRANE PROTEINS 1992", "HN": "2006 (1992)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050827"}, {"RECTYPE": "D", "MH": "Protein Inhibitors of Activated STAT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PIAS1 Protein Inhibitor of Activated STAT|T116|T123|ABX|NRW|NLM (2006)|041220|abbcdef", "ENTRY": "PIAS4 Protein Inhibitor of Activated STAT|T116|T123|ABX|NRW|NLM (2006)|050128|abbcdef", "MN": "D12.776.476.024.402", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of structurally related proteins that are constitutively expressed and that negatively regulate cytokine-mediated SIGNAL TRANSDUCTION PATHWAYS. PIAS proteins inhibit the activity of signal transducers and activators of transcription.", "PM": "2006; PROTEIN INHIBITORS OF ACTIVATED STAT was indexed under PROTEINS 1998-2005", "HN": "2006(1998)", "MR": "20160330", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050828"}, {"RECTYPE": "D", "MH": "L-Amino Acid Oxidase", "DS": "AMINO ACID OXIDASE L", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Ophio-Amino-Acid", "MN": "D08.811.682.664.500.677", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.4.3.2", "RR": "9000-89-9 (CRN)", "MS": "An enzyme that catalyzes the oxidative deamination of L-amino acids to KETO ACIDS with the generation of AMMONIA and HYDROGEN PEROXIDE. L-amino acid oxidase is widely distributed in and is thought to contribute to the toxicity of SNAKE VENOMS.", "PM": "2006; L-AMINO ACID OXIDASE was indexed under AMINO ACID OXIDOREDUCTASES 1974-2004", "HN": "2006(1974)", "MR": "20070709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050830"}, {"RECTYPE": "D", "MH": "Interferon-Stimulated Gene Factor 3", "DS": "INTERFERON STIMULATED GENE FACTOR 03", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ISGF3 Transcription Factor|T116|T123|ABX|EQV|NLM (2006)|050222|ISGF 03 TRANSCRIPTION FACTOR|abbcdefs", "ENTRY": "Transcription Factor, ISGF3", "MN": "D12.776.930.354", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A multimeric complex that functions as a ligand-dependent transcription factor. ISGF3 is assembled in the CYTOPLASM and translocated to the CELL NUCLEUS in response to INTERFERON signaling. It consists of ISGF3-GAMMA and ISGF3-ALPHA, and it regulates expression of many interferon-responsive GENES.", "PM": "2006; INTERFERON-STIMULATED GENE FACTOR 3 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1990-2005", "HN": "2006(1990)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050832"}, {"RECTYPE": "D", "MH": "Interferon-Stimulated Gene Factor 3, alpha Subunit", "DS": "INTERFERON STIMULATED GENE FACTOR 03 ALPHA SUBUNIT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Interferon Stimulated Gene Factor 3, alpha Subunit", "MN": "D12.776.930.354.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A heterodimeric complex of STAT1 PROTEIN and STAT2 PROTEIN that interacts with ISGF3GAMMA and is a subunit of the ISGF3 COMPLEX.", "PM": "2006; ISGF ALPHA SUBUNIT & ISGF-ALPHA PROTEIN were indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1990-2005", "HN": "2006(1990)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050833"}, {"RECTYPE": "D", "MH": "Interferon-Stimulated Gene Factor 3, gamma Subunit", "DS": "INTERFERON STIMULATED GENE FACTOR 03 GAMMA SUBUNIT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p48, ISRE-Binding Protein", "MN": "D12.776.930.354.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An interferon regulatory factor that recruits STAT1 PROTEIN and STAT2 PROTEIN heterodimers to interferon-stimulated response elements and functions as an immediate-early protein.", "PM": "2006; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1990-2005", "HN": "2006", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050834"}, {"RECTYPE": "D", "MH": "Interferon Regulatory Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Interferon Regulatory Factor|T116|T123|NON|EQV|NLM (2021)|200106|abbcdef", "ENTRY": "Transcription Factors, IRF", "MN": "D12.776.930.332", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of transcription factors that share an N-terminal HELIX-TURN-HELIX MOTIF and bind INTERFERON-inducible promoters to control GENE expression. IRF proteins bind specific DNA sequences such as interferon-stimulated response elements, interferon regulatory elements, and the interferon consensus sequence.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050835"}, {"RECTYPE": "D", "MH": "Interferon Regulatory Factor-2", "DS": "INTERFERON REGULATORY FACTOR 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "IRF-2 Transcription Factor|T116|T123|ABX|EQV|NLM (2006)|050121|IRF 02 TRANSCRIPTION FACTOR|abbcdefs", "ENTRY": "Transcription Factor, IRF-2", "MN": "D12.776.930.332.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An interferon regulatory factor that represses transcription of TYPE I INTERFERONS and activates transcription of HISTONE H4.", "PM": "2006; INTERFERON REGULATORY FACTOR-2 was indexed under DNA-BINDING PROTEINS; REPRESSOR PROTEINS; & TRANSCRIPTION FACTORS 1989-2005", "HN": "2006(1989)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050836"}, {"RECTYPE": "D", "MH": "Oxidoreductases Acting on Aldehyde or Oxo Group Donors", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.682.657", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.-", "PI": "Oxidoreductases (1963-2005)", "MS": "A broad category of oxidoreductases that either reduce double bonds or oxidize single bonds between OXYGEN and CARBON in organic compounds.", "PM": "2006", "HN": "2006", "MR": "20050722", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050837"}, {"RECTYPE": "D", "MH": "Interferon Regulatory Factor-3", "DS": "INTERFERON REGULATORY FACTOR 03", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "IRF-3 Transcription Factor|T116|T123|ACX|EQV|NLM (2006)|050121|IRF 03 TRANSCRIPTION FACTOR|abbcdefs", "ENTRY": "Transcription Factor, IRF-3", "MN": "D12.776.930.332.374", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An interferon regulatory factor that is expressed constitutively and undergoes POST-TRANSLATIONAL MODIFICATION following viral infection. PHOSPHORYLATION of IRF-3 causes the protein to be translocated from the CYTOPLASM to CELL NUCLEUS where it binds DNA, and activates transcription.", "PM": "2006; INTERFERON REGULATORY FACTOR-3 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1996-2005", "HN": "2006(1996)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050838"}, {"RECTYPE": "D", "MH": "Interferon Regulatory Factor-7", "DS": "INTERFERON REGULATORY FACTOR 07", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "IRF-7 Transcription Factor|T116|T123|ABX|EQV|NLM (2006)|050121|IRF 07 TRANSCRIPTION FACTOR|abbcdefs", "ENTRY": "Transcription Factor, IRF-7C", "MN": "D12.776.930.332.437", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An interferon regulatory factor that is induced by INTERFERONS as well as LMP-1 protein from EPSTEIN-BARR VIRUS. IRF-7 undergoes PHOSPHORYLATION prior to nuclear translocation and it activates GENETIC TRANSCRIPTION of multiple interferon GENES.", "PM": "2006; DNA-BINDING PROTEINS 1997-2005", "HN": "2006(1997)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050839"}, {"RECTYPE": "D", "MH": "Glycine Dehydrogenase (Decarboxylating)", "DS": "GLYCINE DEHYDROGENASE DECARBOXYLATING", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "P protein, Glycine Decarboxylase", "MN": "D08.811.682.664.500.498.500", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.4.4.2", "MS": "A PYRIDOXAL PHOSPHATE dependent enzyme that catalyzes the decarboxylation of GLYCINE with the transfer of an aminomethyl group to the LIPOIC ACID moiety of the GLYCINE DECARBOXYLASE COMPLEX H-PROTEIN. Defects in P-protein are the cause of non-ketotic hyperglycinemia. It is one of four subunits of the glycine decarboxylase complex.", "PM": "2006; GLYCINE DEHYDROGENASE (DECARBOXYLATING) was indexed under AMINO ACID OXIDOREDUCTASES 1990-2005", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050841"}, {"RECTYPE": "D", "MH": "1-Pyrroline-5-Carboxylate Dehydrogenase", "DS": "PYRROLINE CARBOXYLATE DEHYDROGENASE 01 05", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NADP+ Specific 8 Glutamate Semialdehyde Dehydrogenase", "MN": "D08.811.682.662.693", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.2.1.88", "RR": "9054-82-4 (CRN)", "MS": "An enzyme that catalyzes the oxidation of 1-pyrroline-5-carboxylate to L-GLUTAMATE in the presence of NAD. Defects in the enzyme are the cause of hyperprolinemia II.", "PM": "2006; 1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE was indexed under AMINE OXIDOREDUCTASES 1981-2004", "HN": "2006(1981)", "MR": "20160602", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050842"}, {"RECTYPE": "D", "MH": "Interferon Regulatory Factor-1", "DS": "INTERFERON REGULATORY FACTOR 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "IRF-1 Transcription Factor|T116|T123|ABX|EQV|NLM (2006)|050121|IRF 01 TRANSCRIPTION FACTOR|abbcdefs", "ENTRY": "Transcription Factor, ISGF1", "MN": "D12.776.930.332.124", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An interferon regulatory factor that binds upstream TRANSCRIPTIONAL REGULATORY ELEMENTS in the GENES for INTERFERON-ALPHA and INTERFERON-BETA. It functions as a transcriptional activator for the INTERFERON TYPE I genes.", "PM": "2006; INTERFERON REGULATORY FACTOR was indexed under DNA-BINDING PROTEINS 1990-2005; PHOSPHOPROTEINS 1990-2005; & PROTEINS 1989", "HN": "2006(1989)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050856"}, {"RECTYPE": "D", "MH": "Synaptotagmins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Synaptotagmin|T116|T123|NON|EQV|NLM (2006)|abbcde", "ENTRY": "Tagmin|T116|T123|NON|EQV|NLM (2006)|abbcde", "MN": "D12.776.543.990.850", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "134193-27-4", "PI": "Nerve Tissue Proteins (1991-2005)", "MS": "A family of vesicular transport proteins characterized by an N-terminal transmembrane region and two C-terminal calcium-binding domains.", "PM": "2006; SYNAPTOTAGMIN was indexed under CALCIUM-BINDING PROTEINS, MEMBRANE GLYCOPROTEINS & NERVE TISSUE PROTEINS 1991-2005", "HN": "2006(1991)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050857"}, {"RECTYPE": "D", "MH": "Betalains", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Betalain|T109|NON|EQV|NLM (2021)|200203|abcdef", "ENTRY": "Betalain Pigments|T109|NON|NRW|NLM (2006)|abcde", "MN": "D12.125.072.050.875.064", "PA": "Coloring Agents", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "37279-84-8", "PI": "Ammonium Compounds (1972-2005)", "MS": "Compounds derived from TYROSINE via betalamic acid, including BETAXANTHINS and BETACYANINS. They are found in the Caryophyllales order of PLANTS and some BASIDIOMYCETES.", "PM": "2006; BETALAINS was under AMMONIUM COMPOUNDS 1982-2005, BETALAIN PIGMENTS was under PIGMENTS 1982-2004", "HN": "2006 (1972)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050858"}, {"RECTYPE": "D", "MH": "Betacyanins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Betanidin|T109|NON|NRW|NLM (2021)|200129|abcdef", "ENTRY": "Betanins|T109|NON|NRW|NLM (2006)|041222|abcdef", "MN": "D12.125.072.050.875.064.500", "PA": "Coloring Agents", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "MS": "Conjugates of betalamic acid with cyclo-dopa, both of which derive from TYROSINE. They appear similar to INDOLES but are biosynthesized by a different path and contain N+. Members are red or violet COLORING AGENTS found in the Caryophyllales order of PLANTS and some BASIDIOMYCETES.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050859"}, {"RECTYPE": "D", "MH": "Betaxanthins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.383.621.080.750", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "MS": "Conjugates of betalamic acid with AMINO ACIDS. Some of them are yellow COLORING AGENTS in the Caryophyllales order of PLANTS. This should not be confused with xanthin which is a term used for CAROTENES nor with XANTHINES.", "PM": "2006", "HN": "2006", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050860"}, {"RECTYPE": "D", "MH": "Synaptotagmin II", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synaptotagmin 2|T116|T123|NON|EQV|NLM (2006)|041222|abbcdef", "MN": "D12.776.543.990.850.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A vesicular transport protein that was originally characterized as an inositol polyphosphate binding protein. Synaptotagmin II helps regulate EXOCYTOSIS of SYNAPTIC VESICLES and appears to serve as a calcium sensor to trigger NEUROTRANSMITTER release. It also acts as a nerve cell receptor for certain BOTULINUM TOXINS.", "PM": "2006; SYNAPTOTAGMIN II was indexed under NERVE TISSUE PROTEINS 1991-2005", "HN": "2006(1991)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050861"}, {"RECTYPE": "D", "MH": "Oxidoreductases Acting on Sulfur Group Donors", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sulfite Reductase|T116|T126|NON|NRW|NLM (2021)|191119|abbcdef", "ENTRY": "Reductases, Sulfite", "MN": "D08.811.682.667", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.8.-", "RR": "EC 1.8.-", "MS": "Oxidoreductases with specificity for oxidation or reduction of SULFUR COMPOUNDS.", "PM": "2006; for SULFITE REDUCTASES see SULFITE REDUCTASES 1980-2005; for SULFITE OXIDASES see SULFITE OXIDASES 1980-2005; for SULFITE DEHYDROGENASES see SULFITE OXIDASES 1980-2005", "HN": "2006(1980)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050862"}, {"RECTYPE": "D", "MH": "Synaptotagmin I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p65 Protein (Synaptotagmin I)|T116|T123|NON|EQV|NLM (2011)|100120|abbcdef", "MN": "D12.776.543.990.850.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A vesicular transport protein expressed predominately in NEURONS. Synaptotagmin helps regulate EXOCYTOSIS of SYNAPTIC VESICLES and appears to serve as a calcium sensor to trigger NEUROTRANSMITTER release. It also acts as a nerve cell receptor for certain BOTULINUM TOXINS.", "PM": "2006; SYNAPTOTAGMIN I was indexed under CALCIUM-BINDING PROTEINS, MEMRANE GLYCOPROTEINS, & NERVE TISSUE PROTEINS 1991-2005", "HN": "2006(1991)", "MR": "20100625", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050863"}, {"RECTYPE": "D", "MH": "Sulfite Reductase (NADPH)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NADPH-Sulfite Reductase|T116|T126|ACX|EQV|NLM (2006)|040819|abbcdef", "ENTRY": "Reductase, NADPH-Sulfite", "MN": "D08.811.682.667.500", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.8.1.2", "PI": "Oxidoreductases Acting on Sulfur Group Donors (1983-2005)", "MS": "A NADPH-dependent oxidase that reduces hydrogen sulfite to HYDROGEN SULFIDE. It is found in many microoganisms.", "PM": "2006; NADPH-SULFITE REDUCTASE was indexed under SULFITE REDUCTASES 1983-2005", "HN": "2006(1983)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050864"}, {"RECTYPE": "D", "MH": "Liquid Crystals", "AQ": "AE AN CH CL EC HI MI PO PS RE SD SN ST TO UL VI", "ENTRY": "Mesomorphous Phase Material", "MN": "J01.637.506", "FX": "Colloids", "MH_TH": "NLM (2006)", "ST": "T073", "PI": "Crystallization (1966-2005)", "MS": "Materials in intermediate state between solid and liquid.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050866"}, {"RECTYPE": "D", "MH": "Sulfite Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Sulphite", "MN": "D08.811.682.667.249", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.8.3.1", "RR": "EC 1.8.3.1", "PI": "Sulfite Oxidases (1983-2005)", "MS": "A MOLYBDENUM requiring enzyme that catalyzes the terminal reaction in the oxidative degradation of SULFUR AMINO ACIDS with the formation of a sulfate. A deficiency of sulfite oxidase results in sulfocysteinuria.", "PM": "2006; for SULPHITE OXIDASE see SULFITE OXIDASES 1982-2005", "HN": "2006(1982)", "MR": "20050801", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050876"}, {"RECTYPE": "D", "MH": "Sarcosine Oxidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxidase, Sarcosine", "MN": "D12.776.331.943", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.5.3.1", "RR": "9029-22-5 (CRN)", "PI": "Oxidoreductases, N-Demethylating (1998-2005)", "MS": "A FLAVOPROTEIN, this enzyme catalyzes the oxidation of SARCOSINE to GLYCINE; FORMALDEHYDE; and HYDROGEN PEROXIDE (H2O2).", "PM": "2006; SARCOSINE OXIDASE was indexed under OXIDOREDUCTASES, N-DEMETHYLATING 1998-2005", "HN": "2006(1998)", "MR": "20050729", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050879"}, {"RECTYPE": "D", "MH": "p300-CBP Transcription Factors", "DS": "P A 300 CBP TRANSCRIPTION FACTORS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p300 CBP Transcription Factors", "MN": "D12.776.930.680", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.48", "MS": "A family of histone acetyltransferases that is structurally-related to CREB-BINDING PROTEIN and to E1A-ASSOCIATED P300 PROTEIN. They function as transcriptional coactivators by bridging between DNA-binding TRANSCRIPTION FACTORS and the basal transcription machinery. They also modify transcription factors and CHROMATIN through ACETYLATION.", "PM": "2006; P300/CBP PROTEINS was indexed under NUCLEAR PROTEINS & TRANS-ACTIVATORS 1999-2005", "HN": "2006(1994)", "MR": "20151202", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050880"}, {"RECTYPE": "D", "MH": "E1A-Associated p300 Protein", "DS": "E 001 A ASSOCIATED P 300 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p300 Protein, E1A-Associated", "MN": "D12.776.930.680.600", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.48", "MS": "A member of the p300-CBP transcription factors that was originally identified as a binding partner for ADENOVIRUS E1A PROTEINS.", "PM": "2006; E1A-ASSOCIATED P300 PROTEIN was indexed under NUCLEAR PROTEINS & TRANS-ACTIVATORS 1999-2005 & under TRANSCRIPTION FACTORS 1994-1998", "HN": "2006(1994)", "MR": "20151202", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050881"}, {"RECTYPE": "D", "MH": "CREB-Binding Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phospho CREB Binding Protein", "MN": "D12.776.930.680.300", "FX": "Zinc Fingers", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.48", "MS": "A member of the p300-CBP transcription factor family that was initially identified as a binding partner for CAMP RESPONSE ELEMENT-BINDING PROTEIN. Mutations in CREB-binding protein are associated with RUBINSTEIN-TAYBI SYNDROME.", "PM": "2006; CREB-BINDING PROTEIN was indexed under TRANS-ACTIVATORS & NUCLEAR PROTEINS 1999-2005, & under TRANSCRIPTION FACTORS 1994-1998", "HN": "2006(1994)", "MR": "20151202", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050882"}, {"RECTYPE": "D", "MH": "HSC70 Heat-Shock Proteins", "DS": "HSC 070 HEAT SHOCK PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hsc70 Protein|T116|T123|ABX|EQV|NLM (2006)|010321|abbcdef", "ENTRY": "Uncoating Protein, Clathrin", "MN": "D12.776.580.216.375.200", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A constitutively expressed subfamily of the HSP70 heat-shock proteins. They preferentially bind and release hydrophobic peptides by an ATP-dependent process and are involved in post-translational PROTEIN TRANSLOCATION.", "PM": "2006; HSC70 PROTEIN, was indexed under HEAT SHOCK PROTEINS 70 2001-2005", "HN": "2006(2001)", "MR": "20160630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050883"}, {"RECTYPE": "D", "MH": "HSP72 Heat-Shock Proteins", "DS": "HSP 072 HEAT SHOCK PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heat Shock Proteins 72|T116|T123|NON|EQV|NLM (2006)|050113|HEAT SHOCK PROTEINS 072|abbcdefs", "ENTRY": "p72, Heat-Shock Protein", "MN": "D12.776.580.216.375.202", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Stress-inducible members of the heat-shock proteins 70 family. HSP72 heat shock proteins function with other MOLECULAR CHAPERONES to mediate PROTEIN FOLDING and to stabilize pre-existent proteins against aggregation.", "PM": "2006; HSP72 PROTEIN was indexed under HEAT SHOCK PROTEINS 1994-2005", "HN": "2006(1994)", "MR": "20150415", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050884"}, {"RECTYPE": "D", "MH": "Hydrogensulfite Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sulfite Reductase, Sirohaem", "MN": "D08.811.682.667.124", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.8.99.3", "RR": "EC 1.8.99.3", "PI": "Oxidoreductases Acting on Sulfur Group Donors (1978-2005)", "MS": "An enzyme found primarily in SULFUR-REDUCING BACTERIA where it plays an important role in the anaerobic carbon oxidation pathway.", "PM": "2006; HYROGENSULFITE REDUCTASE was indexed under SULFITE REDUCTASES 1995-2005; for DESULFOVIRIDINS and BISULFITE REDUCTASES see SULFITE REDUCTASES 1978-2005; for SIROHAEM SULFITE REDUCTASE see SULFITE REDUCTASES 1997-2005", "HN": "2006(1995)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050885"}, {"RECTYPE": "D", "MH": "HSP20 Heat-Shock Proteins", "DS": "HSP 020 HEAT SHOCK PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heat-Shock Proteins 20|T116|T123|NON|EQV|NLM (2006)|041223|HEAT SHOCK PROTEINS 020|abbcdefs", "ENTRY": "pp3, Heat-Shock Protein", "MN": "D12.776.580.216.270.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A subfamily of small heat-shock proteins that are closely related to ALPHA B-CRYSTALLIN. Hsp20 heat-shock proteins can undergo PHOSPHORYLATION by CYCLIC GMP-DEPENDENT PROTEIN KINASES.", "PM": "2006; HEAT-SHOCK PROTEINS 20 was indexed under HEAT-SHOCK PROTEINS & PHOSPHOPROTEINS 1997-2005", "HN": "2006(1997)", "MR": "20090706", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050886"}, {"RECTYPE": "D", "MH": "Heat-Shock Proteins, Small", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Small Heat-Shock Proteins|T116|T123|NON|EQV|NLM (2006)|041223|abbcdef", "ENTRY": "Small Heat Shock Proteins", "MN": "D12.776.580.216.270", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "index only when used by author", "MS": "A family of low molecular weight heat-shock proteins that can serve as MOLECULAR CHAPERONES.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050888"}, {"RECTYPE": "D", "MH": "Sulfite Reductase (Ferredoxin)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sulfite Reductase, Ferredoxin", "MN": "D08.811.682.667.374", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.8.7.1", "PI": "Oxidoreductases Acting on Sulfur Group Donors (1982-2005)", "MS": "A FERREDOXIN-dependent oxidoreductase that is primarily found in PLANTS where it plays an important role in the assimilation of SULFUR atoms for the production of CYSTEINE and METHIONINE.", "PM": "2006; FERREDOXIN SULFITE REDUCTASE was indexed under SULFITE REDUCTASES 1982-2005", "HN": "2006(1982)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050889"}, {"RECTYPE": "D", "MH": "HSP30 Heat-Shock Proteins", "DS": "HSP 030 HEAT SHOCK PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heat-Shock Proteins 30|T116|T123|NON|EQV|NLM (2006)|041223|HEAT SHOCK PROTEINS 030|abbcdefs", "ENTRY": "Heat-Shock Proteins, HSP30", "MN": "D12.776.580.216.270.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A subfamily of small heat-shock proteins found in a wide variety of organisms.", "PM": "2006; HEAT-SHOCK PROTEINS 30 was indexed under HEAT-SHOCK PROTEINS 1993-2005", "HN": "2006(1993)", "MR": "20090706", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050890"}, {"RECTYPE": "D", "MH": "Oxidoreductases Acting on CH-NH2 Group Donors", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Primary Amine Oxidoreductases|T116|T126|NON|EQV|NLM (2006)|050311|abbcdef", "ENTRY": "Oxidoreductases Acting on CH NH2 Group Donors", "MN": "D08.811.682.664", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.4.-", "AN": "general: prefer specifics; do not confuse with OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS", "PI": "Oxidoreductases Acting on CH-NH Group Donors (1975-2005)", "MS": "Enzymes catalyzing the dehydrogenation of or oxidation of compounds containing primary amines.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050891"}, {"RECTYPE": "D", "MH": "Sarcosine Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sarcosine N Demethylase", "MN": "D08.811.682.662.582.550", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.5.8.3", "RR": "37228-65-2 (CRN)", "MS": "A LIVER mitochondrial matrix flavoenzyme that catalyzes the oxidation of SARCOSINE to GLYCINE and FORMALDEHYDE. Mutation in the enzyme causes sarcosinemia, a rare autosomal metabolic defect characterized by elevated levels of SARCOSINE in BLOOD and URINE.", "PM": "2006; SARCOSINE DEHYDROGENASE was indexed under OXIDOREDUCTASES, N-DEMETHYLATING 1976-2004, & under SARCOSINE 1976-1982", "HN": "2006(1976); use OXIDOREDUCTASES, N-DEMETHYLATING, & SARCOSINE 1976-1979", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050892"}, {"RECTYPE": "D", "MH": "Dimethylglycine Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, Dimethylglycine", "MN": "D08.811.682.662.582.369", "MH_TH": "NLM (2006)", "ST": "T126", "N1": "N,N-dimethylglycine oxidoreductase", "RN": "EC 1.5.8.4", "PI": "Oxidoreductases, N-Demethylating (1979-2005)", "MS": "A FLAVOPROTEIN enzyme that catalyzes the oxidative demethylation of dimethylglycine to SARCOSINE and FORMALDEHYDE.", "PM": "2006; DIMETHYLGLYCINE DEHYDROGENASE was indexed under OXIDOREDUCTASES, N-DEMETHYLATING 1979-2005 & under METHYLGLYCINE 1979-1982", "HN": "2006(1979)", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050893"}, {"RECTYPE": "D", "MH": "Nitrate Reductase (NADH)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase, NADH-Nitrate", "MN": "D12.776.331.899", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.7.1.1", "RR": "9013-03-0 (CRN)", "AN": "do not confuse with NITRATE REDUCTASE (NAD(P)H) or NITRATE REDUCTASE (NADPH)", "MS": "An NAD-dependent enzyme that catalyzes the oxidation of nitrite to nitrate. It is a FLAVOPROTEIN that contains IRON and MOLYBDENUM and is involved in the first step of nitrate assimilation in PLANTS; FUNGI; and BACTERIA. It was formerly classified as EC 1.6.6.1.", "PM": "2006; NITRATE REDUCTASE (NADH) was indexed under NITRATE REDUCTASES 1981-2004", "HN": "2006(1981)", "MR": "20050721", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050895"}, {"RECTYPE": "D", "MH": "Nitrate Reductase (NAD(P)H)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nitrite:NAD(P)+ Oxidoreductase|T116|T126|ABX|EQV|NLM (2006)|020611|abbcdef", "MN": "D12.776.556.579.374.375.977", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.7.1.2", "RR": "9029-27-0 (CRN)", "AN": "do not confuse with NITRATE REDUCTASE (NADPH) or NITRATE REDUCTASE (NADH) or NITRITE REDUCTASE (NAD(P)H)", "MS": "An iron-sulfur and MOLYBDENUM containing FLAVOPROTEIN that catalyzes the oxidation of nitrite to nitrate. This enzyme can use either NAD or NADP as cofactors. It is a key enzyme that is involved in the first step of nitrate assimilation in PLANTS; FUNGI; and BACTERIA. This enzyme was formerly classified as EC 1.6.6.2.", "PM": "2006; NITRATE REDUCTASE (NAD(P)H) was indexed under NITRATE REDUCTASES 1981-2004", "HN": "2006", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050896"}, {"RECTYPE": "D", "MH": "Nitrate Reductase (NADPH)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Triphosphopyridine Nucleotide Nitrate Reductase", "MN": "D12.776.556.579.374.375.988", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.7.1.3", "RR": "9029-28-1", "AN": "do not confuse with NITRATE REDUCTASE (NAD(P)H) or NITRATE REDUCTASE (NADH)", "MS": "An enzyme that catalyzes the oxidation of nitrite to nitrate in the presence of NADP+. It is a FLAVOPROTEIN that contains IRON and MOLYBDENUM. This enzyme was formerly classified as EC 1.6.6.3 and should not be confused with the enzyme NITRATE REDUCTASE (NAD(P)H).", "PM": "2006; NITRATE REDUCTASE (NADPH) was indexed under NITRATE REDUCTASES 1984-2004", "HN": "2006(2004)", "MR": "20050721", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050897"}, {"RECTYPE": "D", "MH": "Nitrite Reductase (NAD(P)H)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nitrite Reductase, NADH-Dependent", "MN": "D08.811.682.655.750.500", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.7.1.4", "RR": "9029-29-2 (CRN)", "AN": "do not confuse with NITRATE REDUCTASE (NAD(P)H)", "MS": "An enzyme found primarily in BACTERIA and FUNGI that catalyzes the oxidation of ammonium hydroxide to nitrite. It is an iron-sulfur HEME; FLAVOPROTEIN containing siroheme and can utilize both NAD and NADP as cofactors. This enzyme was formerly classified as EC 1.6.6.4.", "PM": "2006; NITRITE REDUCTASE (NAD(P)H) was indexed under NITRITE REDUCTASES 1981-2004", "HN": "2006(1981)", "MR": "20090715", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050898"}, {"RECTYPE": "D", "MH": "GMP Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase, Guanylate", "MN": "D08.811.682.655.249", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.7.1.7", "RR": "9029-32-7 (CRN)", "MS": "An enzyme that catalyzes the reversible oxidation of inosine 5'-phosphate (IMP) to guanosine 5'-phosphate (GMP) in the presence of AMMONIA and NADP+. This enzyme was formerly classified as EC 1.6.6.8.", "PM": "2006; GMP REDUCTASE was indexed under as NADH, NADPH OXIDOREDUCTASES 1983-2004, GUANOSINE MONOPHOSPHATE 1976-1982, & GUANINE NUCLEOTIDES 1976-1978", "HN": "2006(1980) use GUANOSINE MONOPHOSPHATE 1976-1979 & GUANINE NUCLEOTIDES 1976-1978", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050899"}, {"RECTYPE": "D", "MH": "Ferredoxin-Nitrite Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase, Ferredoxin-Nitrite", "MN": "D12.776.556.579.374.375.150", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.7.7.1", "MS": "An IRON-containing protein that uses siroheme and 4Fe-4S iron-sulfur centers as prosthetic groups. It catalyzes the six-electron oxidation of AMMONIA to nitrite.", "PM": "2006; FERREDOXIN-NITRITE REDUCTASE was indexed under NITRITE REDUCTASES 1980-2004", "HN": "2006", "MR": "20050721", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050900"}, {"RECTYPE": "D", "MH": "Nitrate Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase, Respiratory Nitrate", "MN": "D08.811.682.655.500.124", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.7.99.4", "RR": "37256-45-4 (CRN)", "AN": "note other specific nitrate reductases are available", "MS": "An enzyme that catalyzes the oxidation of nitrite to nitrate. It is a cytochrome protein that contains IRON and MOLYBDENUM.", "PM": "2006; NITRATE REDUCTASE was indexed under NITRATE REDUCTASES 1985-2004", "HN": "2006(1985)", "MR": "20050721", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050901"}, {"RECTYPE": "D", "MH": "Sulfite Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dehydrogenase, Sulphite", "MN": "D08.811.682.667.217", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.8.2.1", "RR": "37256-47-6 (CRN)", "MS": "An enzyme that catalyzes oxidation of sulfite to sulfate along with the reduction of FERROCYTOCHROME C to FERRICYTOCHROME C.", "PM": "2006; SULFITE DEHYDROGENASE was indexed as CYTOCHROME REDUCTASES 1981-2004", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050902"}, {"RECTYPE": "D", "MH": "Nicotinamide N-Methyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nicotinamide S Adenosylmethionine Methyltransferase", "MN": "D08.811.913.555.500.650", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.1.1.1", "RR": "9029-74-7 (CRN)", "MS": "An enzyme found primarily in the LIVER that catalyzes the N-methylation of NICOTINAMIDE and other structurally related compounds.", "PM": "2006; NICOTINAMIDE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1983-2004", "HN": "2006(1983)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050903"}, {"RECTYPE": "D", "MH": "Homocysteine S-Methyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transmethylase, Homocysteine", "MN": "D08.811.913.555.500.625", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.1.1.10", "MS": "An enzyme that catalyzes the demethylation of L-homocysteine to L-METHIONINE.", "PM": "2006; HOMOCYSTEINE S-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1983-2004 & HOMOCYSTEINE 1974-1982", "HN": "2006(1980); use HOMOCYSTEINE 1974-1980", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050904"}, {"RECTYPE": "D", "MH": "TRPV Cation Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vanilloid Receptor|T116|T192|NON|EQV|NLM (2022)|201023|abbcdef", "ENTRY": "Receptors, Vanilloid", "MN": "D12.776.157.530.400.901.888", "FX": "Ankyrin Repeat", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A subgroup of TRP cation channels named after the vanilloid receptor. They are very sensitive to TEMPERATURE; hot spicy food, and CAPSAICIN. They contain a TRP domain (a five-turn amphipathic helix with an invariant TRYPTOPHAN) and ANKYRIN repeats. Selectivity for CALCIUM over SODIUM ranges from 3 to 100 fold.", "PM": "2006; CAPSAICIN RECEPTORS was indexed under RECEPTORS, DRUG 1991-2005", "HN": "2006(1991)", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050916"}, {"RECTYPE": "D", "MH": "Phosphatidylethanolamine N-Methyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "S Adenosylmethionine Phosphatidylethanolamine N Methyltransferase", "MN": "D08.811.913.555.500.712", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.1.1.17", "RR": "37256-91-0 (CRN)", "MS": "An enzyme that catalyses three sequential METHYLATION reactions for conversion of phosphatidylethanolamine to PHOSPHATIDYLCHOLINE.", "PM": "2006; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1981-2005, & under CEPHALINS 1971-1979", "HN": "2006(1980); use CEPHALINS 1971-1979", "MR": "20090715", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050918"}, {"RECTYPE": "D", "MH": "Basic Reproduction Number", "AQ": "CL EC ES HI LJ PC SN VE", "PRINT ENTRY": "Transmissibility Measures|T081|NON|REL|NLM (2021)|200422|abcdef", "ENTRY": "Transmissibility Measure", "MN": "N06.850.520.308.985.525.080", "MH_TH": "NLM (2006)", "ST": "T081", "AN": "not related to REPRODUCTION: see scope note", "MS": "The expected number of new cases of an infection caused by an infected individual, amongst susceptible contacts only.", "PM": "2006", "HN": "2006", "MR": "20200617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050936"}, {"RECTYPE": "D", "MH": "Guanidinoacetate N-Methyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transmethylase, Methionine-Guanidinoacetic", "MN": "D08.811.913.555.500.425", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.1.1.2", "RR": "9029-75-8 (CRN)", "MS": "This enzyme catalyzes the last step of CREATINE biosynthesis by catalyzing the METHYLATION of guanidinoacetate to CREATINE.", "PM": "2006; GUANIDINOACETATE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1978-2005, S-ADENOSYLMETHIONINE 1973-1977, GUANIDINES 1973-1982, & ACETIC ACIDS 1973-1977", "HN": "2006(1980); use METHYLTRANSFERASES 1980-2005, S-ADENOSYLMETHIONINE 1973-1977, GUANIDINES 1973-1980, & ACETIC ACIDS 1973-1977", "MR": "20090715", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050937"}, {"RECTYPE": "D", "MH": "Glycine N-Methyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sarcosine N-Methyltransferase, Glycine", "MN": "D08.811.913.555.500.387", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.1.1.20", "RR": "37228-72-1 (CRN)", "MS": "An enzyme that catalyzes the METHYLATION of GLYCINE using S-ADENOSYLMETHIONINE to form SARCOSINE with the concomitant production of S-ADENOSYLHOMOCYSTEINE.", "PM": "2006; GLYCINE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1983-2005 & under GLYCINE 1974-1982", "HN": "2006(1980); GLYCINE 1974-1979", "MR": "20050729", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050938"}, {"RECTYPE": "D", "MH": "Gene Fusion", "AQ": "DE ES GE IM PH RE", "ENTRY": "Gene Fusions", "MN": "G05.728.385", "FX": "Mutant Chimeric Proteins", "MH_TH": "NLM (2006)", "ST": "T045", "AN": "ARTIFICIAL GENE FUSION is also available", "PI": "Artificial Gene Fusion (1998-2005)", "MS": "The GENETIC RECOMBINATION of the parts of two or more GENES resulting in a gene with different or additional regulatory regions, or a new chimeric gene product. ONCOGENE FUSION includes an ONCOGENE as at least one of the fusion partners and such gene fusions are often detected in neoplastic cells and are transcribed into ONCOGENE FUSION PROTEINS. ARTIFICIAL GENE FUSION is carried out in vitro by RECOMBINANT DNA technology.", "PM": "2006", "HN": "2006", "MR": "20160617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050939"}, {"RECTYPE": "D", "MH": "Betaine-Homocysteine S-Methyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "S-Methyltransferase, Betaine-Homocysteine", "MN": "D08.811.913.555.500.175", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.1.1.5", "RR": "EC 2.1.1.5", "MS": "A ZINC metalloenzyme that catalyzes the transfer of a methyl group from BETAINE to HOMOCYSTEINE to produce dimethylglycine and METHIONINE, respectively. This enzyme is a member of a family of ZINC-dependent METHYLTRANSFERASES that use THIOLS or selenols as methyl acceptors.", "PM": "2006; BETAINE-HOMOCYSTEINE S-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1980-2005, & under BETAINE & HOMOCYSTEINE 1980-1981", "HN": "2006(1980)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050940"}, {"RECTYPE": "D", "MH": "Phosphatidyl-N-Methylethanolamine N-Methyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphatidyl N Methylethanolamine N Methyltransferase", "MN": "D08.811.913.555.500.710", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.1.1.71", "MS": "An enzyme that catalyzes the METHYLATION of phosphatidyl-N-methylethanolamine to produce phosphatidyl-N-dimethylethanolamine. This enzyme can also methylate phosphatidyl-N-dimethylethanolamine to produce phosphatidyl-N-trimethylethanolamine (PHOSPHATIDYLCHOLINE).", "PM": "2006; PHOSPHATIDYL-N-METHYLETHANOLAMINE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1980-2004", "HN": "2006(1980)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050941"}, {"RECTYPE": "D", "MH": "HSP40 Heat-Shock Proteins", "DS": "HSP 040 HEAT SHOCK PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heat-Shock Proteins 40|T116|T123|NON|EQV|NLM (2006)|041223|HEAT SHOCK PROTEINS 040|abbcdefs", "ENTRY": "Proteins, HSP40 Heat-Shock", "MN": "D12.776.580.216.292", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of heat-shock proteins that contain a 70 amino-acid consensus sequence known as the J domain. The J domain of HSP40 heat shock proteins interacts with HSP70 HEAT-SHOCK PROTEINS. HSP40 heat-shock proteins play a role in regulating the ADENOSINE TRIPHOSPHATASES activity of HSP70 heat-shock proteins.", "PM": "2006; HEAT-SHOCK PROTEINS 40 was indexed under HEAT-SHOCK PROTEINS 1986-2005", "HN": "2006(1986)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050956"}, {"RECTYPE": "D", "MH": "HSP110 Heat-Shock Proteins", "DS": "HSP 110 HEAT SHOCK PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heat-Shock Proteins 110|T116|T123|NON|EQV|NLM (2006)|050103|HEAT SHOCK PROTEINS 110|abbcdefs", "ENTRY": "Proteins, HSP110 Heat-Shock", "MN": "D12.776.580.216.375.800", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A group of eukaryotic high-molecular mass heat-shock proteins that represent a subfamily of HSP70 HEAT-SHOCK PROTEINS. Hsp110 proteins prevent protein aggregation and can maintain denatured proteins in folding-competent states.", "PM": "2006; HEAT-SHOCK PROTEINS 110 was indexed under HEAT-SHOCK PROTEINS 70 1995-2005", "HN": "2006(1995)", "MR": "20150415", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050957"}, {"RECTYPE": "D", "MH": "HSP47 Heat-Shock Proteins", "DS": "HSP 047 HEAT SHOCK PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Heat-Shock Protein 47|T116|T123|NON|NRW|NLM (2006)|HEAT SHOCK PROTEIN 047|abbcdes", "ENTRY": "Heat-Shock Proteins, HSP47", "MN": "D12.776.872.418", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Basic glycoprotein members of the SERPIN SUPERFAMILY that function as COLLAGEN-specific MOLECULAR CHAPERONES in the ENDOPLASMIC RETICULUM.", "PM": "2006; HEAT-SHOCK PROTEIN 47 was indexed under HEAT-SHOCK PROTEINS 1993-2005", "HN": "2006(1993)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050958"}, {"RECTYPE": "D", "MH": "Glycine Decarboxylase Complex", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Decarboxylase Complex, Glycine", "MN": "D08.811.682.664.500.498", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.4.4.2", "MS": "A enzyme complex that catalyzes the oxidative DECARBOXYLATION and DEAMINATION of GLYCINE into CARBON DIOXIDE; AMMONIA; NADH; and N5N10-methylenetetrahydrofolate. It is composed of four different component protein components referred to as H, P, L, and T.", "PM": "2006; GLYCINE DECARBOXYLASE COMPLEX was indexed under AMINO ACID OXIDOREDUCTASES 2004-2005", "HN": "2006(2004)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050959"}, {"RECTYPE": "D", "MH": "Aminomethyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "T Protein, Glycine Cleavage System", "MN": "D08.811.913.555.400.100", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.1.2.10", "RR": "37257-08-2 (CRN)", "PI": "Transferases (1975-1979)", "MS": "A one-carbon group transferase that transfers lipoamide-linked methylamine groups to tetrahydrofolate (TETRAHYDROFOLATES) to form methylenetetrahydrofolate and AMMONIA. It is one of four components of the glycine decarboxylase complex.", "PM": "2006; AMINOMETHYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1983-2005, under TRANSFERASES 1975-1997, CARBOXY-LYASES 1973-1974, under GLYCINE 1975-1982", "HN": "2006(1975)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050960"}, {"RECTYPE": "D", "MH": "Glycine Decarboxylase Complex H-Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "H-Protein, Glycine Cleavage System|T116|T123|NON|EQV|NLM (2006)|abbcde", "ENTRY": "H Protein, Glycine Decarboxylase Complex", "MN": "D08.811.600.391.175", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A LIPOIC ACID-containing protein that plays the pivotal role in the transfer of methylamine groups and reducing equivalents between the three enzymatic components of the glycine decarboxylase complex.", "PM": "2006; H-PROTEIN, GLYCINE DECARBOXYLASE SYSTEM was indexed under AMINO ACID OXIDOREDUCTASES 1990-2005", "HN": "2006(1990)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050961"}, {"RECTYPE": "D", "MH": "Basic-Leucine Zipper Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "bZIP Transcription Factor|T116|T123|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "bZIP G Box Binding Factors", "MN": "D12.776.930.127", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A large superfamily of transcription factors that contain a region rich in BASIC AMINO ACID residues followed by a LEUCINE ZIPPER domain.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050976"}, {"RECTYPE": "D", "MH": "Maf Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Maf Transcription Factor|T116|T123|NON|EQV|NLM (2022)|201021|abbcdef", "ENTRY": "Transcription Factors, Maf", "MN": "D12.776.930.127.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Maf transcription factors are a family of basic-leucine zipper transcription factors that are closely related to V-MAF ONCOGENE PROTEIN. The C-MAF PROTO-ONCOGENE PROTEIN was the first mammalian Maf transcription factor identified, and now the family is known to include a variety of other Maf proteins such as MAFB TRANSCRIPTION FACTOR; MAFF TRANSCRIPTION FACTOR; MAFG TRANSCRIPTION FACTOR; and MAFK TRANSCRIPTION FACTOR.", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050977"}, {"RECTYPE": "D", "MH": "Maf Transcription Factors, Small", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Small Maf Transcription Factors|T116|T123|ABX|EQV|NLM (2006)|050104|abbcdef", "MN": "D12.776.930.216.750.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of Maf Transcription Factors that lack activation domains. Small Maf proteins function as transcriptional repressors or form heterodimeric complexes to serve as transcriptional coactivators. Small Maf proteins include MafF, MafG, and MafK.", "PM": "2006", "HN": "2006", "MR": "20160705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050978"}, {"RECTYPE": "D", "MH": "GATA Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "GATA Transcription Factor|T116|T123|NON|EQV|NLM (2021)|200227|abbcdef", "ENTRY": "Transcription Factors, GATA", "MN": "D12.776.930.314", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of transcription factors that contain two ZINC FINGER MOTIFS and bind to the DNA sequence (A/T)GATA(A/G).", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050980"}, {"RECTYPE": "D", "MH": "Erythroid-Specific DNA-Binding Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nuclear Factors, Erythroid-Specific", "MN": "D12.776.930.216", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A group of transcription factors that were originally described as being specific to ERYTHROID CELLS.", "PM": "2006; ERYTHROID-SPECIFIC DNA-BINDING FACTORS was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1980-2005", "HN": "2006(1980)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050981"}, {"RECTYPE": "D", "MH": "GATA1 Transcription Factor", "DS": "GATA 01 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, GATA1", "MN": "D12.776.930.314.100", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A GATA transcription factor that is specifically expressed in hematopoietic lineages and plays an important role in the CELL DIFFERENTIATION of ERYTHROID CELLS and MEGAKARYOCYTES.", "PM": "2006; GATA1 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1980-2005", "HN": "2006(1980)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050982"}, {"RECTYPE": "D", "MH": "NF-E2 Transcription Factor", "DS": "NF E 02 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, NFE2", "MN": "D12.776.930.216.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A basic-leucine zipper transcription factor that regulates GLOBIN gene expression and is related to TRANSCRIPTION FACTOR AP-1. NF-E2 consists of a small MAF protein subunit and a tissue-restricted 45 kDa subunit.", "PM": "2006; NF-E2 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1980-2005", "HN": "2006(1980)", "MR": "20160705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050983"}, {"RECTYPE": "D", "MH": "NF-E2 Transcription Factor, p45 Subunit", "DS": "NF E 02 TRANSCRIPTION FACTOR P 45 SUBUNIT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p45 NF E2 Protein", "MN": "D12.776.930.216.750.770", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A tissue-specific subunit of NF-E2 transcription factor that interacts with small MAF PROTEINS to regulate gene expression. P45 NF-E2 protein is expressed primarily in MEGAKARYOCYTES; ERYTHROID CELLS; and MAST CELLS.", "PM": "2006; NF-E2 TRANSCRIPTION FACTOR, P45 SUBUNIT was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 2005", "HN": "2006(2005)", "MR": "20160705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050984"}, {"RECTYPE": "D", "MH": "MafK Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p18 NF E2 Protein", "MN": "D12.776.930.216.750.750.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A small Maf protein involved in differentiation of ERYTHROID CELLS. MafK was originally described as the small subunit of the NF-E2 Transcription Factor, but other small MAF PROTEINS also serve as NF-E2 subunits.", "PM": "2006; MAFK PROTEIN was indexed under NUCLEAR PROTEINS 1993-2005", "HN": "2006(1993)", "MR": "20160705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050985"}, {"RECTYPE": "D", "MH": "YY1 Transcription Factor", "DS": "YY TRANSCRIPTION FACTOR 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Yin Yang 1 Protein", "MN": "D12.776.930.216.875", "FX": "CYS2-HIS2 Zinc Fingers", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A ubiquitously expressed zinc finger-containing protein that acts both as a repressor and activator of transcription. It interacts with key regulatory proteins such as TATA-BINDING PROTEIN; TFIIB; and ADENOVIRUS E1A PROTEINS.", "PM": "2006; YY1 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1980-2005", "HN": "2006(1980)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050986"}, {"RECTYPE": "D", "MH": "Vesicle-Associated Membrane Protein 1", "DE": "VESICLE ASSOC MEMBRANE PROTEIN 1", "DS": "VESICLE ASSOCIATED MEMBRANE PROTEIN 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Vesicle Associated Membrane Protein 1", "MN": "D12.776.543.990.775.750.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "MS": "A member of the vesicle-associated membrane protein family involved in the MEMBRANE FUSION of TRANSPORT VESICLES to their target membrane.", "PM": "2006; VESICLE-ASSOCIATED MEMBRANE PROTEIN 1 was indexed under MEMBRANE PROTEINS 1996-2005 and NERVE TISSUE PROTEINS 1988-1995", "HN": "2006 (1988)", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050987"}, {"RECTYPE": "D", "MH": "Vesicle-Associated Membrane Protein 2", "DE": "VESICLE ASSOC MEMBRANE PROTEIN 2", "DS": "VESICLE ASSOCIATED MEMBRANE PROTEIN 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Vesicle Associated Membrane Protein 2", "MN": "D12.776.543.990.775.750.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "PI": "Membrane Proteins (1994-2005)", "MS": "A synaptic membrane protein involved in MEMBRANE FUSION of SYNAPTIC VESICLES with the presynaptic membranes. It is the prototype member of the R-SNARE PROTEINS.", "PM": "2006; VESICLE-ASSOCIATED MEMBRANE PROTEIN 2 was indexed under MEMBRANE PROTEINS 1996-2005 and NERVE TISSUE PROTEINS 1988-1995", "HN": "2006 (1988)", "MR": "20050728", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050988"}, {"RECTYPE": "D", "MH": "GATA2 Transcription Factor", "DS": "GATA 02 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, GATA2", "MN": "D12.776.930.314.200", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An essential GATA transcription factor that is expressed primarily in HEMATOPOIETIC STEM CELLS.", "PM": "2006; GATA2 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1991-2005", "HN": "2006(1991)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050989"}, {"RECTYPE": "D", "MH": "GATA3 Transcription Factor", "DS": "GATA 03 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, GATA3", "MN": "D12.776.930.314.300", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A GATA transcription factor that is found predominately in LYMPHOID CELL precursors and has been implicated in the CELL DIFFERENTIATION of HELPER T-CELLS. Haploinsufficiency of GATA3 is associated with HYPOPARATHYROIDISM; SENSORINEURAL HEARING LOSS; and renal anomalies syndrome.", "PM": "2006; GATA3 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 1991-2005", "HN": "2006(1991)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050990"}, {"RECTYPE": "D", "MH": "GATA4 Transcription Factor", "DS": "GATA 04 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, GATA4", "MN": "D12.776.930.314.400", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A GATA transcription factor that is expressed in the MYOCARDIUM of developing heart and has been implicated in the differentiation of CARDIAC MYOCYTES. GATA4 is activated by PHOSPHORYLATION and regulates transcription of cardiac-specific genes.", "PM": "2006; GATA4 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1993-2005", "HN": "2006(1993)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050991"}, {"RECTYPE": "D", "MH": "GATA5 Transcription Factor", "DS": "GATA 05 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, GATA5", "MN": "D12.776.930.314.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A GATA transcription factor that is expressed predominately in SMOOTH MUSCLE CELLS and is involved in the CELL DIFFERENTIATION of CARDIAC MYOCYTES. In the developing heart, GATA5 becomes restricted to the ENDOCARDIUM and regulates transcription of genes such as cardiac TROPONIN C.", "PM": "2006; GATA5 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1994-2005", "HN": "2006(1994)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050992"}, {"RECTYPE": "D", "MH": "GATA6 Transcription Factor", "DS": "GATA 06 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, GATA6", "MN": "D12.776.930.314.600", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A GATA transcription factor that is expressed predominately in SMOOTH MUSCLE CELLS and regulates vascular smooth muscle CELL DIFFERENTIATION.", "PM": "2006; GATA6 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1994-2005", "HN": "2006(1994)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050993"}, {"RECTYPE": "D", "MH": "Voltage-Dependent Anion Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Voltage-Dependent Anion Channel|T116|T123|NON|EQV|NLM (2021)|200220|abbcdef", "ENTRY": "Voltage Dependent, Anion Selective Channels", "MN": "D12.776.543.585.400.730.520", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "MS": "A family of voltage-gated eukaryotic porins that form aqueous channels. They play an essential role in mitochondrial CELL MEMBRANE PERMEABILITY, are often regulated by BCL-2 PROTO-ONCOGENE PROTEINS, and have been implicated in APOPTOSIS.", "PM": "2006; VOLTAGE-DEPENDENT ANION CHANNELS was indexed under MEMBRANE PROTEINS 1985-1999, & under PORINS 2000-2005", "HN": "2006(1985)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050994"}, {"RECTYPE": "D", "MH": "Voltage-Dependent Anion Channel 1", "DS": "VOLTAGE DEPENDENT ANION CHANNEL 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Voltage Dependent Anion Channel 1", "MN": "D12.776.575.750.750", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.6.-", "MS": "Voltage-dependent anion channel 1 is the major pore-forming protein of the mitochondrial outer membrane. It also functions as a ferricyanide reductase in the PLASMA MEMBRANE.", "PM": "2006; VOLTAGE-DEPENDENT ANION CHANNEL 1 was indexed under MEMBRANE PROTEIN 1985-1999, & under PORINS 2000-2005", "HN": "2006(1985)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050995"}, {"RECTYPE": "D", "MH": "Voltage-Dependent Anion Channel 2", "DS": "VOLTAGE DEPENDENT ANION CHANNEL 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Voltage Dependent Anion Channel 2", "MN": "D12.776.575.750.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Voltage-dependent anion channel 2 is a low abundance mammalian isoform of VDAC that interacts with the inactive form of BAK PROTEIN.", "PM": "2006; VOLTAGE-DEPENDENT ANION CHANNEL 2 was indexed under MEMBRANE PROTEINS 1985-1999, & under PORINS 2000-2005", "HN": "2006(1985)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050996"}, {"RECTYPE": "D", "MH": "Nanomedicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "J01.897.520.600.600", "MH_TH": "NLM (2006)", "ST": "T090", "PI": "Nanotechnology (2002-2005)", "MS": "The branch of medicine concerned with the application of NANOTECHNOLOGY to the prevention and treatment of disease. It involves the monitoring, repair, construction, and control of human biological systems at the molecular level, using engineered nanodevices and NANOSTRUCTURES. (From Freitas Jr., Nanomedicine, vol 1, 1999).", "PM": "2006", "HN": "2006", "MR": "20200609", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050997"}, {"RECTYPE": "D", "MH": "bcl-2 Homologous Antagonist-Killer Protein", "DS": "BCL HOMOLOGOUS ANTAGONIST KILLER PROTEIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Bak Protein|T116|T123|ABX|EQV|NLM (2006)|abbcde", "ENTRY": "bcl2 Homologous Antagonist Killer Protein", "MN": "D12.776.476.075.718.425", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A multi-domain mitochondrial membrane protein and member of the bcl-2 Protein family. Bak protein interacts with TUMOR SUPPRESSOR PROTEIN P53 and promotes APOPTOSIS.", "PM": "2006; BAK PROTEIN was indexed under MEMBRANE PROTEINS 1994-2005, & under PROTO-ONCOGENE PROTEINS 2005", "HN": "2006(1995)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D050998"}, {"RECTYPE": "D", "MH": "Apoptosis Regulatory Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Programmed Cell Death Protein|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Regulatory Proteins, Apoptosis", "MN": "D12.776.476.075", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A large group of proteins that control APOPTOSIS. This family of proteins includes many ONCOGENE PROTEINS as well as a wide variety of classes of INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS such as CASPASES.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051017"}, {"RECTYPE": "D", "MH": "bcl-X Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "bcl-XS Protein|T116|T123|ABX|NRW|NLM (2006)|abbcde", "ENTRY": "bcl2 Like 1 Protein", "MN": "D12.776.476.075.718.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "do not confuse with the closely related BCL2-ASSOCIATED X PROTEIN", "MS": "A member of the bcl-2 protein family that plays a role in the regulation of APOPTOSIS and is a regulatory subunit for PROTEIN PHOSPHATASE 1. Two major isoforms of the protein exist due to ALTERNATIVE SPLICING of the BCL2L1 mRNA and are referred to as Bcl-XS and Bcl-XL.", "PM": "2006; BCL-X PROTEIN was indexed under PROTO-ONCOGENE PROTEINS 1993-2004, & under PROTO-ONCOGENE PROTEINS C-BCL-2 2005", "HN": "2006(1993)", "MR": "20151201", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051020"}, {"RECTYPE": "D", "MH": "BH3 Interacting Domain Death Agonist Protein", "DS": "BH 03 INTERACTING DOMAIN DEATH AGONIST PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "tBid Protein|T116|T123|ABX|NRW|NLM (2006)|021023|abbcdef", "ENTRY": "Truncated Bid Protein|T116|T123|ABX|NRW|NLM (2006)|050106|abbcdef", "MN": "D12.776.476.075.718.937", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A member of the Bcl-2 protein family that reversibly binds MEMBRANES. It is a pro-apoptotic protein that is activated by caspase cleavage.", "PM": "2006; BID PROTEIN was indexed under CARRIER PROTEINS 1996-2005", "HN": "2006(1996)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051023"}, {"RECTYPE": "D", "MH": "bcl-Associated Death Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "bcl2 Antagonist of Cell Death Protein", "MN": "D12.776.744.049", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A pro-apoptotic protein and member of the Bcl-2 protein family that is regulated by PHOSPHORYLATION. Unphosphorylated Bad protein inhibits the activity of BCL-XL PROTEIN.", "PM": "2006; BAD PROTEIN was indexed under CARRIER PROTEINS 1995-2005", "HN": "2006(1995)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051025"}, {"RECTYPE": "D", "MH": "Phosphoribosylglycinamide Formyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transformylase, Glycinamideribotide", "MN": "D08.811.913.555.400.750", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.1.2.2", "RR": "9032-02-4 (CRN)", "MS": "An enzyme that catalyzes the transfer of a formyl group from N10-formyltetrahydrofolate to N1-(5-phospho-D-ribosyl)glycinamide to yield N2-formyl-N1-(5-phospho-D-ribosyl)glycinamide and tetrahydrofolate. It plays a role in the de novo purine biosynthetic pathway.", "PM": "2006; PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1998-2005, ACYLTRANSFERASES 1979-1997, GLYCINE 1974-1980, FORMIC ACIDS 1974-1982, GLYCINE 1980-1982, PENTOSEPHOSPHATES 1974-1975, RIBOSEMONOPHOSPHATES 1975-1980, & under TRANSFERASES 1974-1978", "HN": "2006(1980); use ACYLTRANSFERASES 1979, GLYCINE 1974-1979, FORMIC ACIDS 1974-1979, PENTOSEPHOSPHATES 1974-1975, RIBOSEMONOPHOSPHATES 1975-1979, & TRANSFERASES 1974-1978", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051026"}, {"RECTYPE": "D", "MH": "Phosphoribosylaminoimidazolecarboxamide Formyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transformylase, Aminoimidazolecarboxamide Ribonucleotide", "MN": "D08.811.913.555.400.625", "MH_TH": "NLM (2006)", "ST": "T126", "N1": "5-amino-4-imidazolecarboxamide ribotide transformylase", "RN": "EC 2.1.2.3", "RR": "9032-03-5 (CRN)", "MS": "An enzyme that catalyzes the conversion of aminoimidazole-4-carboxamide ribonucleotide to 5-formyl-aminoimidazole-4-carboxamide ribonucleotide in the purine de novo synthesis pathway. It requires the cofactor N(10)-FORMYLTETRAHYDROFOLATE as the formyl donor.", "PM": "2006; PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1998-2005, ACYLTRANSFERASES 1980-1997, FORMIC ACIDS 1974-1980, AMINOIMIDAZOLE CARBOXAMIDE 1979-1980, IMIDAZOLES 1974-1979, PENTOSEPHOSPHATES 1974-1979, TRANSFERASES 1974-1979", "HN": "2006(1980); use FORMIC ACIDS 1974-1980, AMINOIMIDAZOLE CARBOXAMIDE 1979-1980, IMIDAZOLES 1974-1979, PENTOSEPHOSPHATES 1974-1979, TRANSFERASES 1974-1979", "MR": "20090715", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051027"}, {"RECTYPE": "D", "MH": "bcl-2-Associated X Protein", "DS": "BCL ASSOCIATED X PROTEIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Bax-sigma Protein|T116|T123|ABX|NRW|NLM (2006)|050107|abbcdef", "ENTRY": "bcl2 Associated X Protein Isoform sigma", "MN": "D12.776.476.075.718.400", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "Don't confuse with the closely related BCL-X PROTEIN", "MS": "A member of the Bcl-2 protein family and homologous partner of C-BCL-2 PROTO-ONCOGENE PROTEIN. It regulates the release of CYTOCHROME C and APOPTOSIS INDUCING FACTOR from the MITOCHONDRIA. Several isoforms of BCL2-associated X protein occur due to ALTERNATIVE SPLICING of the mRNA for this protein.", "PM": "2006; BCL2-ASSOCIATED X-PROTEIN was indexed under PROTO-ONCOGENE PROTEINS C-BCL-2 1993-2005", "HN": "2006(1993)", "MR": "20151123", "DA": "20050706", "DC": "1", "DX": "20060101", "UI": "D051028"}, {"RECTYPE": "D", "MH": "Apoptosis Inducing Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mitochondrial Apoptosis Inducing Factor", "MN": "D12.776.660.720.063", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "INHIBITOR OF APOPTOSIS PROTEINS is also available", "MS": "A flavoprotein that functions as a powerful antioxidant in the MITOCHONDRIA and promotes APOPTOSIS when released from the mitochondria. In mammalian cells AIF is released in response to pro-apoptotic protein members of the bcl-2 protein family. It translocates to the CELL NUCLEUS and binds DNA to stimulate CASPASE-independent CHROMATIN condensation.", "PM": "2006; APOPTOSIS INDUCING FACTOR was indexed under FLAVOPROTEINS & MEMBRANE PROTEINS 1999-2005", "HN": "2006(1999)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051033"}, {"RECTYPE": "D", "MH": "Inhibitor of Apoptosis Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Inhibitor Of Apoptosis Protein", "MN": "D12.776.476.075.437", "PA": "Caspase Inhibitors", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "0", "RR": "EC 2.3.2.27", "AN": "APOPTOSIS REGULATORY PROTEINS is also available", "MS": "A conserved class of proteins that control APOPTOSIS in both VERTEBRATES and INVERTEBRATES. IAP proteins interact with and inhibit CASPASES, and they function as ANTI-APOPTOTIC PROTEINS. The protein class is defined by an approximately 80-amino acid motif called the baculoviral inhibitor of apoptosis repeat; some members have ubiquitin-protein ligase activity.", "PM": "2006; INHIBITOR OF APOPTOSIS PROTEINS was indexed under PROTEINS 1997-2005", "HN": "2006(1997)", "MR": "20170629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051034"}, {"RECTYPE": "D", "MH": "Large-Conductance Calcium-Activated Potassium Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "MaxiK Channel|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Maxi K Channels", "MN": "D12.776.543.585.400.750.150.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A major class of calcium activated potassium channels whose members are voltage-dependent. MaxiK channels are activated by either membrane depolarization or an increase in intracellular Ca(2+). They are key regulators of calcium and electrical signaling in a variety of tissues.", "PM": "2006; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS was indexed under MEMBRANE PROTEINS 1993-1995, under POTASSIUM CHANNELS 1995-2002, & under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2002-2005", "HN": "2006(2993)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051036"}, {"RECTYPE": "D", "MH": "Large-Conductance Calcium-Activated Potassium Channel alpha Subunits", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Large Conductance Calcium Activated Potassium Channels, alpha Subunit", "MN": "D12.776.543.585.400.750.150.500.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "The pore-forming subunits of large-conductance calcium-activated potassium channels. They form tetramers in CELL MEMBRANES.", "PM": "2006; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS was indexed under MEMBRANE PROTEINS 1993-1995, under POTASSIUM CHANNELS 1995-2002, & under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2002-2005", "HN": "2006(1993)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051037"}, {"RECTYPE": "D", "MH": "Large-Conductance Calcium-Activated Potassium Channel beta Subunits", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Large Conductance Calcium Activated Potassium Channels, beta Subunits", "MN": "D12.776.543.585.400.750.150.500.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "The regulatory subunits of large-conductance calcium-activated potassium channels.", "PM": "2006; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL BETA SUBUNITS was indexed under MEMBRANE PROTEINS 1993-1995, under POTASSIUM CHANNELS 1995-2002, & under POTASSIUM CHANNELS, CALCIUM ACTIVATED 2002-2005", "HN": "2006(1993)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051038"}, {"RECTYPE": "D", "MH": "Leontopithecus", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Tamarin, Lion|T015|NON|EQV|NLM (2006)|050107|abcdef", "ENTRY": "Tamarin, Black Lion", "MN": "B01.050.150.900.649.313.988.400.600.150.150.450", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid30587", "AN": "index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)", "PI": "Callitrichidae (1977-2005)", "MS": "The genus of lion tamarins in the subfamily CALLITRICHINAE. The common name refers to the mane on the shoulders.", "PM": "2006; see CALLITRICHINAE 1990-2005", "HN": "2006; use CALLITRICHIDAE 1990-2005", "MR": "20200902", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051039"}, {"RECTYPE": "D", "MH": "Vesicle-Associated Membrane Protein 3", "DS": "VESICLE ASSOCIATED MEMBRANE PROTEIN 03", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cellubrevin|T116|T123|NON|EQV|NLM (2006)|abbcde", "ENTRY": "Vesicle Associated Membrane Protein 3", "MN": "D12.776.543.990.775.750.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Vesicular Transport Proteins (1997-2005)", "MS": "A member of the vesicle associated membrane protein family. It has a broad tissue distribution and is involved in MEMBRANE FUSION events of the endocytic pathways.", "PM": "2006; CELLUBREVIN (now VESICLE-ASSOCIATED MEMBRANE PROTEIN 3) was indexed under MEMBRANE PROTEINS 1993-2005", "HN": "2006 (1993)", "MR": "20160628", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051040"}, {"RECTYPE": "D", "MH": "Glutamate Formimidoyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transferase, Formiminotetrahydrofolate", "MN": "D08.811.913.555.400.300", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.1.2.5", "RR": "9032-83-1 (CRN)", "MS": "A PYRIDOXAL PHOSPHATE-containing enzyme that catalyzes the transfer of a formyl group from L-GLUTAMATE to N-formimidoyl-L-glutamate and TETRAHYDROFOLATE. This enzyme may also catalyze formyl transfer from 5-formyltetrahydrofolate to L-GLUTAMATE. This enzyme was formerly categorized as EC 2.1.2.6.", "PM": "2006; GLUTAMATE FORMIMIDOYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1980-2005, FORMIMINOGLUTAMIC ACID 1977-1980, TRANSFERASES 1975-1997, GLUTAMATES 1975-1977, & under FORMIC ACIDS & IMINES 1975-1976", "HN": "2006(1980); use FORMIMINOGLUTAMIC ACID 1977-1980, TRANSFERASES 1975-1997, GLUTAMATES 1975-1977, FORMIC ACIDS & IMINES 1975-1976", "MR": "20050714", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051042"}, {"RECTYPE": "D", "MH": "Amino-Acid N-Acetyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, N-Acetylglutamate", "MN": "D08.811.913.050.134.105", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.1", "RR": "9029-88-3", "AN": "do not confuse with N-TERMINAL ACETYLTRANSFERASES", "MS": "A mitochondrial matrix enzyme that catalyzes the synthesis of L-GLUTAMATE to N-acetyl-L-glutamate in the presence of ACETYL-COA.", "PM": "2006; AMINO-ACID N-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1973-2005, & under ACETYL COENZYME A & GLUTAMATES 1973-1980", "HN": "2006(1980); use ACETYLTRANSFERASES, ACETYL COENZYME A & GLUTAMATES 1973-1979", "MR": "20120703", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051046"}, {"RECTYPE": "D", "MH": "Dihydrolipoyllysine-Residue Acetyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transacetylase, Dihydrolipoyl", "MN": "D08.811.913.050.134.310", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.12", "RR": "9032-29-5 (CRN)", "MS": "An enzyme that catalyzes the acetyltransferase reaction using ACETYL CoA as an acetyl donor and dihydrolipoamide as acceptor to produce COENZYME A (CoA) and S-acetyldihydrolipoamide. It forms the (E2) subunit of the PYRUVATE DEHYDROGENASE COMPLEX.", "PM": "2006; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE was indexed under PYRUVATE DEHYDROGENASE COMPLEX 1968-2005, under ACETYLTRANSFERASES 1968-1973, under LIPOIC ACID 1968-1982; PYRUVATE DEHYDROGENASE COMPLEX E2 was indexed under PYRUVATE DEHYDROGENASE COMPLEX 1994-2005", "HN": "2006(1980); use PYRUVATE DEHYDROGENASE COMPLEX, ACETYLTRANSFERASES & under LIPOIC ACID 1968-1979", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051047"}, {"RECTYPE": "D", "MH": "Diacylglycerol O-Acyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Palmitoyl Coenzyme A sn 1,2 Diacylglycerol Acyltransferase", "MN": "D08.811.913.050.387", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.20", "RR": "9029-98-5 (CRN)", "MS": "An enzyme that catalyses the last step of the TRIACYLGLYCEROL synthesis reaction in which diacylglycerol is covalently joined to LONG-CHAIN ACYL COA to form triglyceride. It was formerly categorized as EC 2.3.1.124.", "PM": "2006; DIACYLGLYCEROL O-ACYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1973-2005, & GLYCERIDES 1973-1975", "HN": "2006(1980); use ACETYLTRANSFERASES 1973-1979, & GLYCERIDES 1973-1975", "MR": "20050713", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051048"}, {"RECTYPE": "D", "MH": "Sphingosine N-Acyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, Ceramide", "MN": "D08.811.913.050.712", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.24", "MS": "An enzyme that catalyzes the acyltransferase of SPHINGOSINE to N-acylsphingosine using acyl-COENZYME A as donor and COENZYME A as acceptor. The enzyme is mainly localized in the MITOCHONDRIA.", "PM": "2006; SPHINGOSINE N-ACYLTRANSFERASE was indexed under ACYLTRANSFERASES 1985-2005", "HN": "2006(1985)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051049"}, {"RECTYPE": "D", "MH": "Serine O-Acetyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transacetylase, Serine", "MN": "D08.811.913.050.134.850", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.30", "RR": "9023-16-9 (CRN)", "MS": "An enzyme that catalyzes the conversion of L-SERINE to COENZYME A and O-acetyl-L-serine, using ACETYL-COA as a donor.", "PM": "2006; SERINE O-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1973-2005, under ACETYL COENZYME A 1973-1980, under SERINE 1970-1980, & under ACYLTRANSFERASES 1970-1973", "HN": "2006(1980); use ACETYLTRANSFERASES & ACETYL COENZYME A 1973-1979, SERINE 1970-1979, & ACYLTRANSFERASES 1970-1973", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051050"}, {"RECTYPE": "D", "MH": "Acyl-Carrier Protein S-Acetyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transacylase, Acetyl-CoA", "MN": "D08.811.913.050.134.029", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.38", "MS": "A enzyme that catalyzes the transfer of acetyl groups from ACETYL CoA to acyl-carrier protein to form COENZYME A and acetyl-acyl-carrier protein.", "PM": "2006; (ACYL-CARRIER-PROTEIN) S-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1970-2005, under CARRIER PROTEINS 1973-1978, ACYL CARRIER PROTEIN 1978-1982, ACYLTRANSFERASES 1970-1973, ACETYL COENZYME A 1978-1982, & under ACYLTRANSFERASES & PROTEINS 1970-1973", "HN": "2006(1980); use ACETYLTRANSFERASES 1970-1979, CARRIER PROTEINS 1973-1978, ACYL CARRIER PROTEIN 1978-1979, ACYLTRANSFERASES 1970-1973, ACETYL COENZYME A 1978-1979, & ACYLTRANSFERASES & PROTEINS 1970-1973", "MR": "20050707", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051051"}, {"RECTYPE": "D", "MH": "Complement Inactivating Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Complement Inhibitor|T121|NON|EQV|NLM (2021)|200319|abcdef", "ENTRY": "Inhibitors, Complement", "MN": "D27.505.696.477.656.500", "MH_TH": "NLM (2006)", "ST": "T121", "RN": "0", "AN": "do not confuse with COMPLEMENT INACTIVATOR PROTEINS", "PI": "Complement System Proteins (1975-2005)", "MS": "Compounds that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051056"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-akt", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-akt Protein|T116|T126|ACX|EQV|NLM (2006)|abbcde", "ENTRY": "c-akt3, Proto-Oncogene Proteins", "MN": "D12.776.624.664.700.168", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.11.1", "RR": "EC 2.7.11.1", "MS": "Protein-serine-threonine kinases that contain PLECKSTRIN HOMOLOGY DOMAINS and are activated by PHOSPHORYLATION in response to GROWTH FACTORS or INSULIN. They play a major role in cell metabolism, growth, and survival as a core component of SIGNAL TRANSDUCTION. Three isoforms have been described in mammalian cells.", "PM": "2006; PROTO-ONCOGENE PROTEINS C-AKT was indexed under PROTEIN-SERINE-THREONINE KINASES & PROTO-ONCOGENE PROTEINS 1987-2005", "HN": "2006(1987)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051057"}, {"RECTYPE": "D", "MH": "Oncogene Protein v-akt", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-akt Protein|T116|T126|ACX|EQV|NLM (2006)|abbcde", "ENTRY": "v-akt, Oncogene Protein", "MN": "D12.776.624.664.520.750.788", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A viral oncoprotein originally isolated from a murine T CELL LYMPHOMA infected with the acutely transforming retrovirus AKT8. v-akt protein is the viral homologue of PROTO-ONCOGENE PROTEINS C-AKT.", "PM": "2006; ONCOGENE PROTEIN V-AKT was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-2005, & under RETROVIRIDAE PROTEINS 1987-1989", "HN": "2006(1987)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051058"}, {"RECTYPE": "D", "MH": "PTEN Phosphohydrolase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Phosphatase, PTEN", "MN": "D12.776.624.776.695", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 3.1.3.67", "MS": "A lipid phosphatase that contains a C2 DOMAIN and acts on phosphatidylinositol-3,4,5-trisphosphate to regulate various SIGNAL TRANSDUCTION PATHWAYS. It modulates CELL GROWTH PROCESSES; CELL MIGRATION; and APOPTOSIS. Mutations in PTEN are associated with COWDEN DISEASE and PROTEUS SYNDROME as well as NEOPLASTIC CELL TRANSFORMATION.", "PM": "2006; PTEN PROTEIN was indexed under PROTEIN-TYROSINE-PHOSPHATASES 1997-1998, under TUMOR SUPPRESSOR PROTEINS 1997-2005, & under PHOSPHORIC MONOESTER HYDROLASES 1999-2005", "HN": "2006(1997)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051059"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-fyn", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "fyn Proto-Oncogene Proteins|T116|T126|ABX|EQV|NLM (2006)|050421|abbcdef", "ENTRY": "p72 c fyn Protein", "MN": "D12.776.624.664.700.180", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.10.2", "RR": "EC 2.7.10.2", "MS": "Src-family kinases that associate with T-CELL ANTIGEN RECEPTOR and phosphorylate a wide variety of intracellular signaling molecules.", "PM": "2006; PROTO-ONCOGENE PROTEIN C-FYN was indexed under SRC-FAMILY KINASES & PROTO-ONCOGENE PROTEINS 1989-2005", "HN": "2006(1989)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051076"}, {"RECTYPE": "D", "MH": "Atelidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "MN": "B01.050.150.900.649.313.988.400.600.075", "MH_TH": "NLM (2006)", "ST": "T015", "RN": "txid378855", "AN": "index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)", "PI": "Cebidae (1992-2005)", "MS": "A family of New World Monkeys in the infraorder PLATYRRHINI, comprising two subfamilies: ALOUATTINAE and ATELINAE.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051077"}, {"RECTYPE": "D", "MH": "Platyrrhini", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Monkeys, New World|T015|NON|EQV|UNK (19XX)|800507|abcdef", "ENTRY": "World Monkeys, New", "MN": "B01.050.150.900.649.313.988.400.600", "MH_TH": "NLM (2006)", "ST": "T015", "RN": "txid9479", "AN": "index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)", "MS": "An infraorder of New World monkeys, comprised of the families AOTIDAE; ATELIDAE; CEBIDAE; and PITHECIIDAE. They are found exclusively in the Americas.", "PM": "2006; for MONKEYS, NEW WORLD see CEBIDAE 1981-2005", "HN": "2006; for MONKEYS, NEW WORLD use CEBIDAE 1981-2005", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051078"}, {"RECTYPE": "D", "MH": "Catarrhini", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "MN": "B01.050.150.900.649.313.988.400.112", "MH_TH": "NLM (2006)", "ST": "T015", "RN": "txid9526", "PI": "Cercopithecidae (1980-2005)", "MS": "An infraorder of PRIMATES comprised of the families CERCOPITHECIDAE (old world monkeys); HYLOBATIDAE (siamangs and GIBBONS); and HOMINIDAE (great apes and HUMANS). With the exception of humans, they all live exclusively in Africa and Asia.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051079"}, {"RECTYPE": "D", "MH": "Acyl-Carrier Protein S-Malonyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transferase, Malonyl CoA", "MN": "D08.811.913.050.170", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.39", "MS": "This enzyme catalyzes the transacylation of malonate from MALONYL CoA to activated holo-ACP, to generate malonyl-(acyl-carrier protein), which is an elongation substrate in FATTY ACIDS biosynthesis. It is an essential enzyme in the biosynthesis of FATTY ACIDS in all BACTERIA.", "PM": "2006; (ACYL-CARRIER PROTEIN) MALONYLTRANSFERASE was indexed under ACYLTRANSFERASES 1973-2005, & under CARRIER PROTEINS 1973-1979", "HN": "2006(1980); use ACYLTRANSFERASES & CARRIER PROTEINS 1973-1979", "MR": "20050713", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051080"}, {"RECTYPE": "D", "MH": "Glucosamine 6-Phosphate N-Acetyltransferase", "DS": "GLUCOSAMINE PHOSPHATE N ACETYLTRANSFERASE 06", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "N-Acetyltransferase, Glucosamine-Phosphate", "MN": "D08.811.913.050.134.375", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.4", "RR": "9031-91-8 (CRN)", "MS": "An enzyme that catalyses the reaction of D-glucosamine 6-phosphate with ACETYL-COA to form N-acetylglucosamine 6-phosphate.", "PM": "2006; GLUCOSAMINE 6-PHOSPHATE N-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1977-2005", "HN": "2006(1980); use ACETYLTRANSFERASES 1977-1979", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051081"}, {"RECTYPE": "D", "MH": "Homoserine O-Succinyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transsuccinylase, Homoserine", "MN": "D08.811.913.050.600", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.46", "RR": "62213-51-8 (CRN)", "MS": "The first enzyme in the METHIONINE biosynthetic pathway, this enzyme catalyzes the succinylation reaction of L-homoserine to O-succinyl-L-homoserine and COENZYME A using succinyl-CoA.", "PM": "2006; HOMOSERINE O-SUCCINYLTRANSFERASE was indexed under ACYLTRANSFERASES 1971-2005", "HN": "2006(1980); use ACYLTRANSFERASES 1971-1979", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051082"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-ret", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "ret Proto-Oncogene Proteins|T116|T126|T192|ABX|EQV|NLM (2006)|050422|abbbcdef", "ENTRY": "ret Proto Oncogene Proteins", "MN": "D12.776.624.664.700.194", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "EC 2.7.10.1", "MS": "Receptor protein-tyrosine kinases involved in the signaling of GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR ligands. They contain an extracellular cadherin domain and form a receptor complexes with GDNF RECEPTORS. Mutations in ret protein are responsible for HIRSCHSPRUNG DISEASE and MULTIPLE ENDOCRINE NEOPLASIA TYPE 2.", "PM": "2006; PROTO-ONCOGENE PROTEIN C-RET was indexed under PROTO-ONCOGENE PROTEINS & RECEPTOR PROTEIN-TYROSINE KINASES 1999-2005", "HN": "2006(1999)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051096"}, {"RECTYPE": "D", "MH": "Glial Cell Line-Derived Neurotrophic Factor Receptors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glial Cell Line Derived Neurotrophic Factor Receptors", "MN": "D12.776.543.750.750.400.550.124", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A family of GLYCOSYLPHOSPHATIDYLINOSITOL-anchored cell surface receptors that are specific for GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTORS. They form a multi-component receptor complex with PROTO-ONCOGENE PROTEIN C-RET and regulate a variety of intracellular SIGNAL TRANSDUCTION PATHWAYS in conjunction with c-ret protein.", "PM": "2006; GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR RECEPTORS was indexed under PROTO-ONCOGENE PROTEINS & RECEPTOR PROTEIN-TYROSINE KINASES 1999-2005", "HN": "2006(1999)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051097"}, {"RECTYPE": "D", "MH": "Glial Cell Line-Derived Neurotrophic Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glial Cell Line Derived Neurotrophic Factors", "MN": "D23.529.850.381", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR is also available", "MS": "A family of closely related nerve growth factors that promote NEURON survival. They bind to GDNF RECEPTORS and stimulate SIGNAL TRANSDUCTION through PROTO-ONCOGENE PROTEIN C-RET.", "PM": "2006", "HN": "2006", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051098"}, {"RECTYPE": "D", "MH": "Tarsii", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Tarsiiformes|T015|NON|EQV|NLM (2006)|050112|abcdef", "MN": "B01.050.150.900.649.313.988.400.800", "MH_TH": "NLM (2006)", "ST": "T015", "RN": "txid376912", "AN": "diseases: coordinate IM with PRIMATE DISEASES (IM)", "PI": "Primates (1968-2005)", "MS": "An infraorder (or suborder) of small PRIMATES comprised of a single family and genus.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051099"}, {"RECTYPE": "D", "MH": "Glial Cell Line-Derived Neurotrophic Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glial-Derived Neurotrophic Factor|T116|T123|NON|EQV|NLM (2021)|191122|abbcdef", "ENTRY": "Neurotrophic Factor, Glial-Derived", "MN": "D23.529.850.381.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTORS is also available", "MS": "The founding member of the glial cell line-derived neurotrophic factor family. It was originally characterized as a NERVE GROWTH FACTOR promoting the survival of MIDBRAIN dopaminergic NEURONS, and it has been studied as a potential treatment for PARKINSON DISEASE.", "PM": "2006; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR was indexed under NERVE GROWTH FACTORS 2003-2005, & under NERVE TISSUE PROTEINS 1993-2002", "HN": "2006(1993)", "MR": "20200116", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051100"}, {"RECTYPE": "D", "MH": "Neurturin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nrtn Protein|T116|T123|ACX|EQV|NLM (2006)|050112|abbcdef", "MN": "D23.529.850.381.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A glial cell line-derived neurotrophic factor ligand that is specific for the GFRA2 RECEPTOR. Neurturin is essential for the development of specific postganglionic parasympathetic NEURONS.", "PM": "2006; NEURTURIN was indexed under NERVE GROWTH FACTORS 1997-2005", "HN": "2006(1997)", "MR": "20151124", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051101"}, {"RECTYPE": "D", "MH": "Serine C-Palmitoyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transferase 2, Serine-Palmitoyl-CoA", "MN": "D08.811.913.050.668", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.50", "RR": "EC 2.3.1.50", "PI": "Acyltransferases (1984-2005)", "MS": "A key enzyme in SPHINGOLIPIDS biosynthesis, this enzyme catalyzes the pyridoxal-5'-phosphate-dependent condensation of L-SERINE and PALMITOYL COENZYME A to 3-dehydro-D-sphinganine. The enzyme consists of two different subunits.", "PM": "2006; SERINE C-PALMITOYLTRANSFERASE was indexed under ACYLTRANSFERASES 1984-2005", "HN": "2006(1984)", "MR": "20050801", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051102"}, {"RECTYPE": "D", "MH": "1-Acylglycerol-3-Phosphate O-Acyltransferase", "DS": "ACYLGLYCEROL PHOSPHATE O ACYLTRANSFERASE 01 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "O-Acyltransferase, Acyl CoA-1-Acyl-Syn-Glycerol-3-Phosphate", "MN": "D08.811.913.050.173", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.51", "RR": "EC 2.3.1.51", "MS": "An enzyme that catalyzes the acyl group transfer of ACYL COA to 1-acyl-sn-glycerol 3-phosphate to generate 1,2-diacyl-sn-glycerol 3-phosphate. This enzyme has alpha, beta, gamma, delta and epsilon subunits.", "PM": "2006; 1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE was indexed under ACYLTRANSFERASES 1973-2005, & under COENZYME A & PHOSPHOLIPIDS 1973-1978", "HN": "2006(1980); use ACYLTRANSFERASES 1973-1979, use COENZYME A & PHOSPHOLIPIDS 1973-1978", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051103"}, {"RECTYPE": "D", "MH": "Receptors, Scavenger", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Scavenger Receptors, Macrophage|T116|NON|NRW|NLM (2006)|050114|abcdef", "ENTRY": "Receptors, Acetyl-LDL", "MN": "D12.776.543.750.710.450.750", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "AN": "general; prefer specifics", "MS": "A large group of structurally diverse cell surface receptors that mediate endocytic uptake of modified LIPOPROTEINS. Scavenger receptors are expressed by MYELOID CELLS and some ENDOTHELIAL CELLS, and were originally characterized based on their ability to bind acetylated LOW-DENSITY LIPOPROTEINS. They can also bind a variety of other polyanionic ligand. Certain scavenger receptors can internalize micro-organisms as well as apoptotic cells.", "PM": "2006; RECEPTORS, SCAVENGER was indexed under RECEPTORS, IMMUNOLOGIC 1985-2005, & under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1984", "HN": "2006(1981)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051116"}, {"RECTYPE": "D", "MH": "Scavenger Receptors, Class A", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Scavenger Receptors, Class A, Type II|T116|NON|NRW|NLM (2006)|050113|abcdef", "MN": "D12.776.543.750.710.450.750.500", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A family of scavenger receptors that mediate the influx of LIPIDS into MACROPHAGES and are involved in FOAM CELL formation.", "PM": "2006; SCAVENGER RECEPTORS, CLASS A was indexed under RECEPTORS, IMMUNOLOGIC 2005; SCAVENGER RECEPTORS, CLASS A, TYPE I-II was indexed under RECEPTORS, IMMUNOLOGIC 2005, & under ANTIGENS, CD36 2001-2005; MACROPHAGE TYPE-II CLASS-A SCAVENGER RECEPTOR & MACROPHAGE TYPE-I CLASS-A SCAVENGER RECEPTOR were indexed under RECEPTORS, IMMUNOLOGIC 1994-2005 & under RECEPTORS, ENDOGENOUS SUBSTANCES 1993", "HN": "2006(2005)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051117"}, {"RECTYPE": "D", "MH": "Scavenger Receptors, Class B", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "SR-B Proteins|T116|T192|ACX|EQV|NLM (2006)|050113|abbcdef", "MN": "D12.776.543.750.710.450.750.625", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A family of scavenger receptors that are predominately localized to CAVEOLAE of the PLASMA MEMBRANE and bind HIGH DENSITY LIPOPROTEINS.", "PM": "2006; SCAVENGER RECEPTORS, CLASS B was indexed under RECEPTORS, IMMUNOLOGIC 2005", "HN": "2006(2005)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051122"}, {"RECTYPE": "D", "MH": "Scavenger Receptors, Class C", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Scavenger Receptors, Class C, Type I|T116|NON|NRW|NLM (2006)|050113|abcdef", "ENTRY": "Scavenger Receptor Class C Type I|T116|NON|NRW|NLM (2006)|010925|abcdef", "MN": "D12.776.543.750.710.450.750.687", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A family of scavenger receptors with broad polyanionic ligand binding properties that are expressed in embryonic insect MACROPHAGES.", "PM": "2006; SCAVENGER RECEPTORS, CLASS C was indexed under RECEPTORS, IMMUNOLOGIC 2005", "HN": "2006(2005)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051124"}, {"RECTYPE": "D", "MH": "Scavenger Receptors, Class D", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "SR-D Proteins|T116|T192|ACX|EQV|NLM (2006)|050113|abbcdef", "MN": "D12.776.543.750.710.450.750.718", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A class of scavenger receptors that are specific for oxidized LOW-DENSITY LIPOPROTEINS and apoptotic cells. They are expressed almost exclusively in INTRACELLULAR MEMBRANES of MACROPHAGES.", "PM": "2006; SCAVENGER RECEPTORS, CLASS D was indexed under RECEPTORS, IMMUNOLOGIC 2005", "HN": "2006(2005)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051126"}, {"RECTYPE": "D", "MH": "Scavenger Receptors, Class E", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Scavenger Receptors, Class E, Type I|T116|NON|NRW|NLM (2006)|050113|abcdef", "ENTRY": "SR EI Proteins", "MN": "D12.776.543.750.710.450.750.734", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A class of oxidized LDL receptors that contain C-type lectin-like extracellular domains.", "PM": "2006; SCAVENGER RECEPTORS, CLASS E was indexed under RECEPTORS, IMMUNOLOGIC 2005; SCAVENGER RECEPTORS, CLASS E, TYPE I & SR-EI PROTEINS were indexed under RECEPTORS, LDL 2005; LECTIN-LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR-1 was indexed under RECEPTORS, LDL 2000-2005;", "HN": "2006(2000)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051127"}, {"RECTYPE": "D", "MH": "Scavenger Receptors, Class F", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "SR-F Proteins|T116|T192|ACX|EQV|NLM (2006)|050113|abbcdef", "MN": "D12.776.543.750.710.450.750.742", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A group of structurally related scavenger receptors expressed predominately by ENDOTHELIAL CELLS. They-contain repeats of EPIDERMAL GROWTH FACTOR-like cysteine-rich motifs in their extracellular domains.", "PM": "2006; SCAVENGER RECEPTORS, CLASS F was indexed under RECEPTORS, IMMUNOLOGIC 2005", "HN": "2006(2005)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051128"}, {"RECTYPE": "D", "MH": "Receptors, Oxidized LDL", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Ox-LDL", "MN": "D12.776.543.750.710.450.625", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A group of cell-surface receptors for oxidatively modified LOW-DENSITY LIPOPROTEINS. The group includes certain SCAVENGER RECEPTORS that contribute to the pathogenesis of ATHEROSCLEROSIS by uptake of oxidized LDL.", "PM": "2006; RECEPTORS, OXIDIZED LDL was indexd under RECEPTORS, LDL 1997-2004", "HN": "2006(1997)", "MR": "20050719", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051131"}, {"RECTYPE": "D", "MH": "Rad51 Recombinase", "DS": "RAD 051 RECOMBINASE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Recombinase, Rad51", "MN": "D12.776.313.968", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.7.-", "MS": "A Rec A recombinase found in eukaryotes. Rad51 is involved in DNA REPAIR of double-strand breaks.", "PM": "2006; RAD51 RECOMBINASE was indexed under DNA-BINDING PROTEINS 1996-2005, & under FUNGAL PROTEINS 1992-1995", "HN": "2006(1992)", "MR": "20151124", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051135"}, {"RECTYPE": "D", "MH": "Selenium-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Selenium-Binding Protein|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Selenium Binding Proteins", "MN": "D12.776.863", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A group of proteins that covalently attach to selenium or SELENIUM-containing compounds.", "PM": "2006; SELENIUM-BINDING PROTEINS was indexed as CARRIER PROTEINS 1983-2005", "HN": "2006(1983)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051137"}, {"RECTYPE": "D", "MH": "Selenoproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Selenoprotein P1|T116|T123|NON|NRW|NLM (2006)|abbcde", "MN": "D12.776.864", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "MS": "Selenoproteins are proteins that specifically incorporate SELENOCYSTEINE into their amino acid chain. Most selenoproteins are enzymes with the selenocysteine residues being responsible for their catalytic functions.", "PM": "2006; SELENOPROTEINS was indexed under PROTEINS 1989-2005, & under SELENIUM 1982-1992, & under CARRIER PROTEINS 1982-1988", "HN": "2006(1982)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051140"}, {"RECTYPE": "D", "MH": "Retinol O-Fatty-Acyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, Retinol-Palmitate", "MN": "D08.811.913.050.646", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.76", "MS": "An enzyme that catalyzes the acyl group transfer of acyl COENZYME A to RETINOL to generate COENZYME A and a retinyl ester.", "PM": "2006; RETINOL O-FATTY-ACYLTRANSFERASE was indexed under ACYLTRANSFERASES 1982-2005, & under PALMITATES & VITAMIN A 1977-1981", "HN": "2006(1977)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051142"}, {"RECTYPE": "D", "MH": "N-Acylsphingosine Galactosyltransferase", "DS": "ACYLSPHINGOSINE GALACTOSYLTRANSFERASE N", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "UDP Galactose N Acylsphingosine Galactosyltransferase", "MN": "D08.811.913.400.450.400.460", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.4.1.47", "MS": "An enzyme that catalyzes the conversion of UDP-galactose and N-acylsphingosine to D-galactosylceramide and UDP.", "PM": "2006; N-ACYLSPHINGOSINE GALACTOSYLTRANSFERASE was indexed under GALACTOSYLTRANSFERASES 1980-2005, & under CERAMIDES 1979-1982", "HN": "2006(1980) use CERAMIDES 1979", "MR": "20120703", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051146"}, {"RECTYPE": "D", "MH": "Ganglioside Galactosyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "UDPGal GM2 Beta1 3 Galactosyltransferase", "MN": "D08.811.913.400.450.400.475", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.4.1.62", "RR": "37217-28-0 (CRN)", "MS": "Catalyzes the final step in the galactocerebroside biosynthesis pathway.", "PM": "2006; GANGLIOSIDE GALACTOSYLTRANSFERASE was indexed under GALACTOSYLTRANSFERASES 1981-2005, CERAMIDES 1975-1980, HEXOSYLTRANSFERASES 1973-1976, & under GALACTOSE 1973-1975 & UDP SUGARS 1973-1975", "HN": "2006(1980)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051147"}, {"RECTYPE": "D", "MH": "Selenoprotein P", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SelP Protein|T116|T123|ABX|EQV|NLM (2006)|050114|abbcdef", "MN": "D12.776.864.124", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An extracellular selenoprotein that contains most of the SELENIUM in PLASMA. Selenoprotein P functions as an antioxidant and appears to transport selenium from the LIVER to peripheral tissues.", "PM": "2006; SELENOPROTEIN P was indexed under PROTEINS 1989-2005, & under SELENIUM 1982-1992, & under CARRIER PROTEINS 1982-1988", "HN": "2006(1982)", "MR": "20050708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051149"}, {"RECTYPE": "D", "MH": "Methionine Sulfoxide Reductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Selenoprotein R|T116|T126|NON|NRW|NLM (2006)|050114|abbcdef", "ENTRY": "Sulfoxide Reductases, Methionine", "MN": "D12.776.864.100", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 1.8.4.-", "RR": "EC 1.8.4.12", "MS": "Reductases that catalyze the reaction of peptide-L-methionine -S-oxide + thioredoxin to produce peptide-L-methionine + thioredoxin disulfide + H(2)O.", "PM": "2010; see SELENOPROTEIN R 2006-2009, SELENOPROTEIN was indexed under PROTEINS 2005", "HN": "2010(2005)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051150"}, {"RECTYPE": "D", "MH": "Selenoprotein W", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SelW Protein|T116|T123|ABX|EQV|NLM (2006)|050114|abbcdef", "MN": "D12.776.864.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A single SELENOCYSTEINE containing protein that binds reduced GLUTATHIONE and can act as an antioxidant.", "PM": "2006; SELENOPROTEIN W was indexed under PROTEINS 2005", "HN": "2006(2005)", "MR": "20050708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051151"}, {"RECTYPE": "D", "MH": "Clusterin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "X Ray Inducible Protein 8", "MN": "D12.776.580.215", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A highly conserved heterodimeric glycoprotein that is differentially expressed during many severe physiological disturbance states such as CANCER; APOPTOSIS; and various NEUROLOGICAL DISORDERS. Clusterin is ubiquitously expressed and appears to function as a secreted MOLECULAR CHAPERONE.", "PM": "2006; CLUSTERIN was indexed under GLYCOPROTEINS & MOLECULAR CHAPERONES 1981-2005, & under SALIVARY PROTEINS 1980", "HN": "2006(1980)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051152"}, {"RECTYPE": "D", "MH": "Wnt Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Wnt Protein|T116|T123|NON|EQV|NLM (2021)|191122|abbcdef", "ENTRY": "Type Protein, Wingless", "MN": "D23.529.984", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Wnt proteins are a large family of secreted glycoproteins that play essential roles in EMBRYONIC AND FETAL DEVELOPMENT, and tissue maintenance. They bind to FRIZZLED RECEPTORS and act as PARACRINE PROTEIN FACTORS to initiate a variety of SIGNAL TRANSDUCTION PATHWAYS. The canonical Wnt signaling pathway stabilizes the transcriptional coactivator BETA CATENIN.", "PM": "2006; WNT PROTEINS was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2005, & under PROTO-ONCOGENE PROTEINS 1987-2005", "HN": "2006(1987)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051153"}, {"RECTYPE": "D", "MH": "Wnt2 Protein", "DS": "WNT 002 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Wnt-2 Proto-oncogene Protein|T116|T123|ABX|EQV|NLM (2006)|050421|WNT 002 PROTO ONCOGENE PROTEIN|abbcdefs", "ENTRY": "Wnt-2, Proto-Oncogene Protein", "MN": "D23.529.984.200", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A proto-oncogene protein and member of the Wnt family of proteins. It is frequently up-regulated in human GASTRIC CANCER and is a tumor marker (BIOMARKERS, TUMOR) of gastric and COLORECTAL CANCER.", "PM": "2006; WNT2 PROTEIN was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2005 & under PROTO-ONCOGENE PROTEINS 2004-2005", "HN": "2006(2004)", "MR": "20150713", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051154"}, {"RECTYPE": "D", "MH": "Wnt1 Protein", "DS": "WNT 001 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Wnt1 Proto-Oncogene Protein|T116|T123|ABX|EQV|NLM (2006)|050421|WNT 001 PROTO ONCOGENE PROTEIN|abbcdefs", "ENTRY": "Wnt1 Proto Oncogene Protein", "MN": "D23.529.984.100", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A proto-oncogene protein and member of the Wnt family of proteins. It is expressed in the caudal MIDBRAIN and is essential for proper development of the entire mid-/hindbrain region.", "PM": "2006; WNT1 PROTEIN was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2005; & under PROTO-ONCOGENE PROTEINS 1987-2005", "HN": "2006(1987)", "MR": "20110624", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051155"}, {"RECTYPE": "D", "MH": "Frizzled Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Frizzled", "MN": "D12.776.543.750.850.500", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A family of seven-pass transmembrane cell-surface proteins that combines with LOW DENSITY LIPROTEIN RECEPTOR-RELATED PROTEIN-5 or LOW DENSITY LIPROTEIN RECEPTOR-RELATED PROTEIN-5 to form receptors for WNT PROTEINS. Frizzled receptors often couple with HETEROTRIMERIC G PROTEINS and regulate the WNT SIGNALING PATHWAY.", "PM": "2006; FRIZZLED RECEPTOR was indexed under PROTEINS 1998-2005", "HN": "2006(1998)", "MR": "20160617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051157"}, {"RECTYPE": "D", "MH": "beta Catenin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Catenin, beta", "MN": "D12.776.930.130", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A multi-functional catenin that participates in CELL ADHESION and nuclear signaling. Beta catenin binds CADHERINS and helps link their cytoplasmic tails to the ACTIN in the CYTOSKELETON via ALPHA CATENIN. It also serves as a transcriptional co-activator and downstream component of WNT PROTEIN-mediated SIGNAL TRANSDUCTION PATHWAYS.", "PM": "2006; BETA CATENIN was indexed under CYTOSKELETAL PROTEINS & TRANS-ACTIVATORS 1993-2005, & under CADHERINS 1992", "HN": "2006(1992)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051176"}, {"RECTYPE": "D", "MH": "Catenins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Catenin Protein|T116|T123|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Protein, Catenin", "MN": "D12.776.220.145", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of cytoskeletal proteins that play essential roles in CELL ADHESION at ADHERENS JUNCTIONS by linking CADHERINS to the ACTIN FILAMENTS of the CYTOSKELETON.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051177"}, {"RECTYPE": "D", "MH": "alpha Catenin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha E Catenin", "MN": "D12.776.220.145.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A catenin that binds F-ACTIN and links the CYTOSKELETON with BETA CATENIN and GAMMA CATENIN.", "PM": "2006; ALPHA CATENIN was indexed under CYTOSKELETAL PROTEINS 1994-2000; & under CADHERINS 1991-1993", "HN": "2006(1991)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051178"}, {"RECTYPE": "D", "MH": "Plakins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Adaptor Proteins, Cytoskeletal", "MN": "D12.776.220.790", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of related proteins that associate with cytoskeletal elements and junctional complexes at INTERCELLULAR JUNCTIONS. Plakins share a common plakin domain or a plakin repeat domain.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051179"}, {"RECTYPE": "D", "MH": "Desmoplakins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Desmoplakin 2|T116|T123|NON|NRW|NLM (2006)|050119|DESMOPLAKIN 02|abbcdefs", "ENTRY": "Desmoplakin II|T116|T123|NON|NRW|NLM (2006)|abbcde", "MN": "D12.776.220.790.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Desmoplakins are cytoskeletal linker proteins that anchor INTERMEDIATE FILAMENTS to the PLASMA MEMBRANE at DESMOSOMES.", "PM": "2006; DESMOPLAKINS was indexed under CYTOSKELETAL PROTEINS 1990-2005, & under MEMBRANE GLYCOPROTEINS 1988-1989, & under MEMBRANE PROTEINS 1983-1987", "HN": "2006(1983)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051180"}, {"RECTYPE": "D", "MH": "Desmosomal Cadherins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cadherins, Desmosomal", "MN": "D23.050.301.350.200.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A single-pass transmembrane glycoproteins that mediate CALCIUM-dependent CELL ADHESION and are core components of DESMOSOMES.", "PM": "2006", "HN": "2006", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051181"}, {"RECTYPE": "D", "MH": "Desmogleins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Desmoglein|T116|T123|NON|EQV|NLM (2006)|abbcde", "MN": "D23.050.301.350.200.500.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A group of desmosomal cadherins with cytoplasmic tails that resemble those of classical CADHERINS.", "PM": "2006; DESMOGLEINS was indexed under CYTOSKELETAL PROTEINS 1990-2005, & under MEMBRANE GLYCOPROTEINS 1988-1989, & under MEMBRANE PROTEINS 1983-1987", "HN": "2006(1983)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051182"}, {"RECTYPE": "D", "MH": "Desmoglein 1", "DS": "DESMOGLEIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pemphigus Foliaceus Antigen|T116|T129|NON|EQV|NLM (2006)|abbcde", "MN": "D23.050.422.124", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A desmosomal cadherin that is an autoantigen in the acquired skin disorder PEMPHIGUS FOLIACEUS.", "PM": "2006; DESMOGLEIN 1 was indexed under CADHERINS 1994-2005", "HN": "2006(1994)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051183"}, {"RECTYPE": "D", "MH": "Desmoglein 3", "DS": "DESMOGLEIN 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Desmosomal Glycoprotein 3|T116|T129|NON|EQV|NLM (2006)|abbcde", "MN": "D23.050.422.249", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A desmosomal cadherin that is an autoantigen in the acquired skin disorder PEMPHIGUS VULGARIS.", "PM": "2006; DESMOGLEIN 3 was indexed under CYTOSKELETAL PROTEINS (2005)", "HN": "2006(2005)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051184"}, {"RECTYPE": "D", "MH": "gamma Catenin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Plakoglobin, Junctional", "MN": "D12.776.220.145.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A multi-functional catenin that is highly homologous to BETA CATENIN. Gamma catenin binds CADHERINS and helps link their cytoplasmic tails to ACTIN in the CYTOSKELETON via ALPHA CATENIN. It is also found in DESMOSOMES where it mediates the link between DESMOSOMAL CADHERINS and DESMOPLAKIN.", "PM": "2006; GAMMA CATENIN was indexed under CYTOSKELETAL PROTEINS 1990-2005, & under MEMBRANE GLYCOPROTEINS 1988-1989, & under MEMBRANE PROTEINS 1983-1987", "HN": "2006(1983)", "MR": "20170405", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051185"}, {"RECTYPE": "D", "MH": "Armadillo Domain Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Armadillo Protein|T116|T123|NON|EQV|NLM (2022)|201007|abbcdef", "ENTRY": "Protein, Armadillo", "MN": "D12.776.091", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "do not confuse with proteins from ARMADILLOS", "MS": "A family of proteins that contain several 42-amino acid repeat domains and are homologous to the Drosophila armadillo protein. They bind to other proteins through their armadillo domains and play a variety of roles in the CELL including SIGNAL TRANSDUCTION, regulation of DESMOSOME assembly, and CELL ADHESION.", "PM": "2006; ARMADILLO PROTEINS was indexed under TRANS-ACTIVATORS & DROSOPHILA PROTEINS 2005", "HN": "2006(2005)", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051186"}, {"RECTYPE": "D", "MH": "Desmocollins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Desmocollin|T116|T123|NON|EQV|NLM (2021)|200319|abbcdef", "MN": "D23.050.301.350.200.500.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A group of desmosomal cadherins with cytoplasmic tails that are divergent from those of classical CADHERINS. Their intracytoplasmic domains bind PLAKOGLOBIN; PLAKOPHILINS; and DESMOPLAKINS.", "PM": "2006; DESMOCOLLINS was indexed under CYTOSKELETAL PROTEINS 1990-2005, & under MEMBRANE GLYCOPROTEINS 1988-1989, & under MEMBRANE PROTEINS 1983-1987", "HN": "2006(1983)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051187"}, {"RECTYPE": "D", "MH": "Knowledge Bases", "PRINT ENTRY": "Knowledge Bases (Computer)|T073|NON|EQV|UNK (19XX)|860618|abcdef", "ENTRY": "Knowledgebase", "MN": "L01.313.500.750.300.550", "MH_TH": "NLM (2006)", "ST": "T073", "MS": "Collections of facts, assumptions, beliefs, and heuristics that are used in combination with databases to achieve desired results, such as a diagnosis, an interpretation, or a solution to a problem (From McGraw Hill Dictionary of Scientific and Technical Terms, 6th ed).", "PM": "2006; see ARTIFICIAL INTELLIGENCE (1987-2005)", "HN": "2006; use ARTIFICIAL INTELLIGENCE (1987-2005)", "MR": "20170703", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051188"}, {"RECTYPE": "D", "MH": "Murinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rats, Bandicoot|T015|NON|NRW|UNK (19XX)|810514|abcdef", "ENTRY": "Rat, Bandicoot", "MN": "B01.050.150.900.649.313.992.635.505", "MH_TH": "NLM (2006)", "ST": "T015", "RN": "txid39107", "RR": "txid69078", "AN": "do not check tags MICE or RATS for MURINAE or its entry terms such as RATS, BANDICOOT; do not confuse BANDICOOT RATS with bandicoot (= MARSUPIALIA)", "PI": "Muridae (1987-2005)", "MS": "A subfamily in the family MURIDAE, comprising the Old World MICE and RATS.", "PM": "2006; for ACOMYS, APODEMUS, BANDICOTA, MASTOMYS, PRAOMYS, and RATS, BANDICOTT see MURIDAE 1982-2005", "HN": "2006; for ACOMYS, APODEMUS, BANDICOTA, MASTOMYS, PRAOMYS, and RATS, BANDICOTT use MURIDAE 1982-2005", "MR": "20200902", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051189"}, {"RECTYPE": "D", "MH": "Plectin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "HD1, Hemidesmosomal Protein", "MN": "D12.776.744.736", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A cytoskeletal linker protein with a molecular weight of greater than 500 kDa. It binds INTERMEDIATE FILAMENTS; MICROTUBULES; and ACTIN CYTOSKELETON and plays a central role in the organization and stability of the CYTOSKELETON. Plectin is phosphorylated by CALMODULIN KINASE; PROTEIN KINASE A; and PROTEIN KINASE C.", "PM": "2006; PLECTIN was indexed under INTERMEDIATE FILAMENT PROTEINS 1992-2005, & under PROTEINS 1982-1991", "HN": "2006(1982)", "MR": "20110701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051190"}, {"RECTYPE": "D", "MH": "Plakophilins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Plakophilin|T116|T123|NON|EQV|NLM (2022)|201005|abbcdef", "ENTRY": "Plakophilin-3|T116|T123|NON|NRW|NLM (2006)|abbcde", "MN": "D12.776.220.885", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Members of the armadillo family of proteins that are found in DESMOSOMES and interact with various proteins including desmocadherins; DESMOPLAKIN; ACTIN FILAMENTS; and KERATINS.", "PM": "2006; PLAKOPHILINS was indexed under PROTEINS 1995-2005", "HN": "2006(1995)", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051191"}, {"RECTYPE": "D", "MH": "Receptors, Pattern Recognition", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Pattern Recognition Receptors|T116|T129|T192|NON|EQV|NLM (2006)|050120|abbbcdef", "ENTRY": "Recognition Receptor, Pattern", "MN": "D12.776.543.750.705.910", "FX": "Immunity, Innate", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "AN": "general; prefer specifics", "MS": "A large family of cell surface receptors that bind conserved molecular structures (PAMPS) present in pathogens. They play important roles in host defense by mediating cellular responses to pathogens.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051192"}, {"RECTYPE": "D", "MH": "Toll-Like Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Toll-Like|T116|T129|T192|NON|EQV|NLM (2006)|050120|abbbcdef", "ENTRY": "Toll Like Receptors", "MN": "D12.776.543.750.705.910.500", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "AN": "general; prefer specifics", "MS": "A family of pattern recognition receptors characterized by an extracellular leucine-rich domain and a cytoplasmic domain that share homology with the INTERLEUKIN 1 RECEPTOR and the DROSOPHILA toll protein. Following pathogen recognition, toll-like receptors recruit and activate a variety of SIGNAL TRANSDUCING ADAPTOR PROTEINS.", "PM": "2006; TOLL-LIKE RECEPTOR was indexed under MEMBRANE GLYCOPROTEINS & RECEPTORS, CELL SURFACE 1998-2005", "HN": "2006(1998)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051193"}, {"RECTYPE": "D", "MH": "Toll-Like Receptor 1", "DS": "TOLL LIKE RECEPTOR 001", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Toll Like Receptor 1", "MN": "D12.776.543.750.705.910.500.100", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A pattern recognition receptor that forms heterodimers with TOLL-LIKE RECEPTOR 2.", "PM": "2006; TOLL-LIKE RECEPTOR 1 was indexed under MEMBRANE GLYCOPROTEINS & RECEPTORS, CELL SURFACE 2003-2005", "HN": "2006(2003)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051194"}, {"RECTYPE": "D", "MH": "Toll-Like Receptor 2", "DS": "TOLL LIKE RECEPTOR 002", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Toll Like Receptor 2", "MN": "D12.776.543.750.705.910.500.200", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A pattern recognition receptor that forms heterodimers with other TOLL-LIKE RECEPTORS. It interacts with multiple ligands including PEPTIDOGLYCAN, bacterial LIPOPROTEINS, lipoarabinomannan, and a variety of PORINS.", "PM": "2006; TOLL-LIKE RECEPTOR 2 was indexed under MEMBRANE GLYCOPROTEINS & RECEPTORS, CELL SURFACE 1998-2005", "HN": "2006(1998)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051195"}, {"RECTYPE": "D", "MH": "Toll-Like Receptor 3", "DS": "TOLL LIKE RECEPTOR 003", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Toll Like Receptor 3", "MN": "D12.776.543.750.705.910.500.300", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A pattern recognition receptor that binds DOUBLE-STRANDED RNA. It mediates cellular responses to certain viral pathogens.", "PM": "2006; TOLL-LIKE RECEPTOR 3 was indexed under MEMBRANE GLYCOPROTEINS & RECEPTORS, CELL SURFACE 2005", "HN": "2006(2005)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051196"}, {"RECTYPE": "D", "MH": "Toll-Like Receptor 4", "DS": "TOLL LIKE RECEPTOR 004", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Toll Like Receptor 4", "MN": "D12.776.543.750.705.910.500.400", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A pattern recognition receptor that interacts with LYMPHOCYTE ANTIGEN 96 and LIPOPOLYSACCHARIDES. It mediates cellular responses to GRAM-NEGATIVE BACTERIA.", "PM": "2006; TOLL-LIKE RECEPTOR 4 was indexed under MEMBRANE GLYCOPROTEINS & RECEPTORS, CELL SURFACE 2001-2005", "HN": "2006(2001)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051197"}, {"RECTYPE": "D", "MH": "Toll-Like Receptor 5", "DS": "TOLL LIKE RECEPTOR 005", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Toll Like Receptor 5", "MN": "D12.776.543.750.705.910.500.500", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A pattern recognition receptor that binds FLAGELLIN. It mediates cellular responses to certain bacterial pathogens.", "PM": "2006; TOLL-LIKE RECEPTOR 5 was indexed under MEMBRANE GLYCOPROTEINS & RECEPTORS, CELL SURFACE 2005", "HN": "2006(2005)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051198"}, {"RECTYPE": "D", "MH": "Toll-Like Receptor 7", "DS": "TOLL LIKE RECEPTOR 007", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Toll Like Receptor 7", "MN": "D12.776.543.750.705.910.500.700", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A pattern recognition receptor that binds several forms of imidazo-quinoline including the antiviral compound Imiquimod.", "PM": "2006; TOLL-LIKE RECEPTOR 7 was indexed under MEMBRANE GLYCOPROTEINS & RECEPTORS, CELL SURFACE 2005", "HN": "2006(2005)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051199"}, {"RECTYPE": "D", "MH": "Toll-Like Receptor 8", "DS": "TOLL LIKE RECEPTOR 008", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Toll Like Receptor 8", "MN": "D12.776.543.750.705.910.500.800", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A pattern recognition receptor that recognizes GUANOSINE and URIDINE-rich single-stranded RNA.", "PM": "2006; TOLL-LIKE RECEPTOR 8 was indexed under MEMBRANE GLYCOPROTEINS & RECEPTORS, CELL SURFACE 2005", "HN": "2006(2005)", "MR": "20050729", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051200"}, {"RECTYPE": "D", "MH": "Toll-Like Receptor 10", "DS": "TOLL LIKE RECEPTOR 010", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Toll Like Receptor 10", "MN": "D12.776.543.750.705.910.500.910", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A pattern recognition receptor that is expressed in LUNG and in B-LYMPHOCYTES.", "PM": "2006; TOLL-LIKE RECEPTOR 10 was indexed under MEMBRANE GLYCOPROTEINS & RECEPTORS, CELL SURFACE 2005", "HN": "2006(2005)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051201"}, {"RECTYPE": "D", "MH": "Toll-Like Receptor 6", "DS": "TOLL LIKE RECEPTOR 006", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Toll Like Receptor 6", "MN": "D12.776.543.750.705.910.500.600", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A pattern recognition receptor that forms heterodimers with TLR2 RECEPTOR. The complex interacts with a variety of ligands including LIPOPROTEINS from MYCOPLASMA.", "PM": "2006; TOLL-LIKE RECEPTOR 6 was indexed under MEMBRANE GLYCOPROTEINS & RECEPTORS, CELL SURFACE 1999-2005", "HN": "2006(1999)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051216"}, {"RECTYPE": "D", "MH": "Toll-Like Receptor 9", "DS": "TOLL LIKE RECEPTOR 009", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Toll Like Receptor 9", "MN": "D12.776.543.750.705.910.500.900", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A pattern recognition receptor that binds unmethylated CPG CLUSTERS. It mediates cellular responses to bacterial pathogens by distinguishing between self and bacterial DNA.", "PM": "2006; TOLL-LIKE RECEPTOR 9 was indexed under RECEPTORS, CELL SURFACE & DNA-BINDING PROTEINS 2001-2005", "HN": "2006(2001)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051217"}, {"RECTYPE": "D", "MH": "Lymphocyte Antigen 96", "DS": "LYMPHOCYTE ANTIGEN 096", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "MD-2 Protein|T116|T129|ABX|EQV|NLM (2006)|050121|MD 002 PROTEIN|abbcdefs", "ENTRY": "LY96 Protein|T116|T129|ABX|EQV|NLM (2006)|050121|abbcdef", "MN": "D23.050.301.593", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A secreted protein that associates with TOLL-LIKE RECEPTOR 4 and is essential for receptor recognition of LIPOPOLYSACCHARIDES.", "PM": "2006; MD-2 PROTEIN was indexed under CARRIER PROTEINS & ANTIGENS, SURFACE 1999-2005", "HN": "2006(1999)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051218"}, {"RECTYPE": "D", "MH": "Pituitary Adenylate Cyclase-Activating Polypeptide", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pituitary Adenylate Cyclase Activating Polypeptide 38|T116|T123|NON|NRW|NLM (2006)|050121|abbcdef", "MN": "D23.529.850.887", "PA": "Vasodilator Agents", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A multi-function neuropeptide that acts throughout the body by elevating intracellular cyclic AMP level via its interaction with PACAP RECEPTORS and VASOACTIVE INTESTINAL PEPTIDE RECEPTOR. Although first isolated from hypothalamic extracts and named for its action on the pituitary, it is widely distributed in the central and peripheral nervous systems. PACAP is important in the control of endocrine and homeostatic processes, such as secretion of pituitary and gut hormones and food intake.", "PM": "2006; PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE was indexed under NERVE GROWTH FACTORS & NEUROPEPTIDES & NEUROTRANSMITTERS 1990-2005", "HN": "2006(1990)", "MR": "20200617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051219"}, {"RECTYPE": "D", "MH": "Pisiform Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Pisiform Bones", "MN": "A02.835.232.087.319.150.600", "MH_TH": "NLM (2006)", "ST": "T023", "PI": "Carpal Bones (1971-2005)", "MS": "A pea-shaped carpal bone that actually sits in the tendon of the flexor carpi ulnaris muscle.", "PM": "2006", "HN": "2006", "MR": "20180629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051220"}, {"RECTYPE": "D", "MH": "Triquetrum Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Triquetrum Bones", "MN": "A02.835.232.087.319.150.831", "MH_TH": "NLM (2006)", "ST": "T023", "PI": "Carpal Bones (1972-2005)", "MS": "A carpal bone which is located between the LUNATE BONE and HAMATE BONE.", "PM": "2006", "HN": "2006", "MR": "20180629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051221"}, {"RECTYPE": "D", "MH": "Trapezium Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Trapezium Bones", "MN": "A02.835.232.087.319.150.800", "MH_TH": "NLM (2006)", "ST": "T023", "PI": "Carpal Bones (1971-2005)", "MS": "A carpal bone adjacent to the TRAPEZOID BONE.", "PM": "2006", "HN": "2006", "MR": "20180629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051222"}, {"RECTYPE": "D", "MH": "Trapezoid Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Trapezoid Bones", "MN": "A02.835.232.087.319.150.805", "MH_TH": "NLM (2006)", "ST": "T023", "PI": "Carpal Bones (1978-2005)", "MS": "A carpal bone which is located between the TRAPEZIUM BONE and the CAPITATE BONE.", "PM": "2006", "HN": "2006", "MR": "20180629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051223"}, {"RECTYPE": "D", "MH": "Capitate Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Capitate Bones", "MN": "A02.835.232.087.319.150.150", "MH_TH": "NLM (2006)", "ST": "T023", "PI": "Carpal Bones (1971-2005)", "MS": "A carpal bone with a rounded head located between the TRAPEZOID BONE and the HAMATE BONE.", "PM": "2006", "HN": "2006", "MR": "20180629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051224"}, {"RECTYPE": "D", "MH": "Hamate Bone", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Hamate Bones", "MN": "A02.835.232.087.319.150.400", "MH_TH": "NLM (2006)", "ST": "T023", "PI": "Carpal Bones (1971-2005)", "MS": "A carpal bone located between the CAPITATE BONE and the TRIQUETRUM BONE. The hamate has a prominent process that projects anteriorly.", "PM": "2006", "HN": "2006", "MR": "20180629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051225"}, {"RECTYPE": "D", "MH": "Geranyltranstransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, Farnesyl Pyrophosphate", "MN": "D08.811.913.225.450", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.5.1.10", "MS": "An enzyme involved in the MEVALONATE pathway, it catalyses the synthesis of farnesyl diphosphate from isopentenyl diphosphate and dimethylallyl diphosphate.", "PM": "2006; GERANYLGERANYLTRANSFERASE was indexed under ALKYL AND ARYL TRANSFERASES 1997-2005, under PYROPHOSPHORIC ACIDS 1970-1979, under ALLYL CPDS 1975-1979, & under TERPENES 1970-1979", "HN": "2006(1980); use PYROPHOSPHORIC ACIDS 1970-1979, ALLYL CPDS 1975-1979, & TERPENES 1970-1979", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051228"}, {"RECTYPE": "D", "MH": "3-Phosphoshikimate 1-Carboxyvinyltransferase", "DS": "PHOSPHOSHIKIMATE CARBOXYVINYLTRANSFERASE 03 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "aroA 3 Phosphoshikimate 1 Carboxyvinyltransferase", "MN": "D08.811.913.225.735", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.5.1.19", "RR": "9068-73-9 (CRN)", "MS": "An enzyme of the shikimate pathway of AROMATIC AMINO ACID biosynthesis, it generates 5-enolpyruvylshikimate 3-phosphate and ORTHOPHOSPHATE from PHOSPHOENOLPYRUVATE and shikimate-3-phosphate. The shikimate pathway is present in BACTERIA and PLANTS but not in MAMMALS.", "PM": "2006; 3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE was indexed under ALKYL AND ARYL TRANSFERASES ALKYL 1973-2005, & under PHOSPHOENOLPYRUVATE & SHIKIMIC ACID 1973-1980", "HN": "2006(1980); use ALKYL AND ARYL TRANSFERASES ALKYL, PHOSPHOENOLPYRUVATE & SHIKIMIC ACID 1973-1979", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051229"}, {"RECTYPE": "D", "MH": "Farnesyltranstransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthase, Geranylgeranyl-Diphosphate", "MN": "D08.811.913.225.437", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.5.1.29", "PI": "Alkyl and Aryl Transferases (1992-2005)", "MS": "An enzyme that catalyzes the synthesis of geranylgeranyl diphosphate from trans, trans-farnesyl diphosphate and isopentenyl diphosphate.", "PM": "2006; FARNESYLTRANSFERASE was indexed under ALKYL AND ARYL TRANSFERASES 1992-2005", "HN": "2006(1992)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051231"}, {"RECTYPE": "D", "MH": "Geranylgeranyl-Diphosphate Geranylgeranyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, Phytoene", "MN": "D08.811.913.225.443", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.5.1.32", "PI": "Alkyl and Aryl Transferases (1991-2005)", "MS": "An enzyme that catalyzes the condensation of two molecules of geranylgeranyl diphosphate to give prephytoene diphosphate. The prephytoene diphosphate molecule is a precursor for CAROTENOIDS and other tetraterpenes.", "PM": "2006; GERANYLGERANYL-DIPHOSPHATE GERANYLGERANYLTRANSFERASE was indexed under ALKYL AND ARYL TRANSFERASES 1991-2005, & under OXIDOREDUCTASES 1991-2002", "HN": "2006(1991)", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051232"}, {"RECTYPE": "D", "MH": "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide", "DE": "RECEPT PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Pituitary Adenylate Cyclase-Activating Peptide Receptors|T116|T192|NON|EQV|NLM (2006)|050121|abbcdef", "ENTRY": "Receptors, Pituitary Adenylate Cyclase Activating Polypeptide", "MN": "D12.776.543.750.695.665", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A family of G-protein-coupled receptors that share significant homology with GLUCAGON RECEPTORS. They bind PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE with high affinity and trigger intracellular changes that influence the behavior of CELLS.", "PM": "2006; PACAP RECEPTORS was indexed under RECEPTORS, CELL SURFACE 2005, RECEPTORS, PITUITARY HORMONE 1990-2005, & under RECEPTORS, ENDOGENOUS SUBSTANCES 1990-1993", "HN": "2006(1990)", "MR": "20160617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051236"}, {"RECTYPE": "D", "MH": "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I", "DE": "RECEPT PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE TYPE I", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Pituitary Adenylate Cyclase-Activating Peptide Receptor Type I|T116|T192|NON|EQV|NLM (2006)|050121|PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE RECEPT TYPE I|abbcdefv", "ENTRY": "Pituitary Adenylate Cyclase Activating Peptide Receptor Type I", "MN": "D12.776.543.750.695.665.500", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A pituitary adenylate cyclase-activating peptide receptor subtype that is found in the HYPOTHALAMUS; BRAIN STEM; PITUITARY GLAND; ADRENAL GLAND; PANCREAS; and TESTES and has a high affinity only for PACAP.", "PM": "2006 PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE RECEPTOR TYPE I was indexed under RECEPTORS, CELL SURFACE 2005, & under RECEPTORS, PITUITARY HORMONE 1999-2005", "HN": "2006(1999)", "MR": "20160617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051237"}, {"RECTYPE": "D", "MH": "Receptors, Vasoactive Intestinal Polypeptide, Type I", "DE": "RECEPT VASOACTIVE INTESTINAL PEPTIDE TYPE I", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Vasoactive Intestinal Peptide Receptors, Type I|T116|T192|NON|EQV|NLM (2006)|050124|VASOACTIVE INTESTINAL PEPTIDE RECEPT TYPE I|abbcdefv", "ENTRY": "Receptors, VIP1", "MN": "D12.776.543.750.695.665.625.520", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A pituitary adenylate cyclase-activating polypeptide receptor subtype that binds both PACAP and VASOACTIVE INTESTINAL PEPTIDE. It is found predominately in the BRAIN.", "PM": "2006; VASOACTIVE INTESTINAL PEPTIDE 1 RECEPTOR was indexed under RECEPTORS, CELL SURFACE 1999-2005", "HN": "2006(1999)", "MR": "20200617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051238"}, {"RECTYPE": "D", "MH": "Receptors, Vasoactive Intestinal Peptide, Type II", "DE": "RECEPT VASOACTIVE INTESTINAL PEPTIDE TYPE II", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Vasoactive Intestinal Peptide Receptors, Type II|T116|T192|NON|EQV|NLM (2006)|050124|VASOACTIVE INTESTINAL PEPTIDE RECEPT TYPE II|abbcdefv", "ENTRY": "Receptors, VIP2", "MN": "D12.776.543.750.695.665.625.500", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A pituitary adenylate cyclase-activating peptide receptor subtype found in LYMPHOCYTES. It binds both PACAP and VASOACTIVE INTESTINAL PEPTIDE and regulates immune responses.", "PM": "2006; VASOACTIVE INTESTINAL PEPTIDE 2 RECEPTOR was indexed under RECEPTORS, CELL SURFACE 1999-2005", "HN": "2006(1999)", "MR": "20200617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051239"}, {"RECTYPE": "D", "MH": "Caveolin 1", "DS": "CAVEOLIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Caveolin", "MN": "D12.776.744.287", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A tyrosine phosphoprotein that plays an essential role in CAVEOLAE formation. It binds CHOLESTEROL and is involved in LIPIDS transport, membrane traffic, and SIGNAL TRANSDUCTION.", "PM": "2006; CAVEOLIN 1 was indexed under CAVEOLINS 2001-2005, & under MEMBRANE PROTEINS 1992-2000", "HN": "2006(1992)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051242"}, {"RECTYPE": "D", "MH": "Caveolin 2", "DS": "CAVEOLIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Caveolin-2|T116|T123|NON|EQV|NLM (2006)|abbcde", "MN": "D12.776.744.356", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Caveolin 2 is a binding partner of CAVEOLIN 1. It undergoes tyrosine phosphorylation by C-SRC PROTEIN PP60 and plays a regulatory role in CAVEOLAE formation.", "PM": "2006; CAVEOLIN 2 was indexed under CAVEOLINS 2001-2005, & under MEMBRANE PROTEINS 1997-2000", "HN": "2006(1997)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051243"}, {"RECTYPE": "D", "MH": "Caveolin 3", "DS": "CAVEOLIN 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Caveolin, Muscle", "MN": "D12.776.543.990.100.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A caveolin that is expressed exclusively in MUSCLE CELLS and is sufficient to form CAVEOLAE in SARCOLEMMA. Mutations in caveolin 3 are associated with multiple muscle diseases including DISTAL MYOPATHY and LIMB-GIRDLE MUSCULAR DYSTROPHY.", "PM": "2006 CAVEOLIN 3 was indexed under CAVEOLINS 2005, & under MEMBRANE PROTEINS 2000", "HN": "2006(1996)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051244"}, {"RECTYPE": "D", "MH": "Retinal Bipolar Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Bipolar Cells, Retinal|T025|NON|EQV|NLM (2006)|050126|abcdef", "ENTRY": "Retinal Bipolar Cell", "MN": "A11.671.650.850.750", "MH_TH": "NLM (2006)", "ST": "T025", "PI": "Neurons (1967-2005)", "MS": "INTERNEURONS of the vertebrate RETINA containing two processes. They receive inputs from the RETINAL PHOTORECEPTOR CELLS and send outputs to the RETINAL GANGLION CELLS. The bipolar cells also make lateral connections in the retina with the RETINAL HORIZONTAL CELLS and with the AMACRINE CELLS.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051245"}, {"RECTYPE": "D", "MH": "Glucose Transport Proteins, Facilitative", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glucose Transport Protein|T116|T123|NON|EQV|UNK (19XX)|850605|abbcdef", "ENTRY": "SLC2A Proteins|T116|T123|ACX|EQV|NLM (2006)|050126|abbcdef", "MN": "D12.776.543.585.937.625", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of monosaccharide transport proteins characterized by 12 membrane spanning helices. They facilitate passive diffusion of GLUCOSE across the CELL MEMBRANE.", "PM": "2006; for GLUCOSE TRANSPORT PROTEINS, FACILITATIVE see MONOSACCHARIDE TRANSPORT PROTEINS 1985-2005", "HN": "2006(1985)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051246"}, {"RECTYPE": "D", "MH": "Sodium-Glucose Transport Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sodium-Glucose Transport Protein|T116|T123|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Transporter, Sodium-Sugar", "MN": "D12.776.543.585.500.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "MS": "Monosaccharide transport proteins that function as active symporters. They utilize SODIUM or HYDROGEN IONS to transport GLUCOSE across CELL MEMBRANES.", "PM": "2006; see MONOSACCHARIDE TRANSPORT PROTEINS 1986-2005", "HN": "2006(1986)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051247"}, {"RECTYPE": "D", "MH": "Retinal Horizontal Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Horizontal Cells, Retinal|T025|NON|EQV|NLM (2006)|050126|abcdef", "ENTRY": "Retinal Horizontal Cell", "MN": "A11.671.650.850.937", "MH_TH": "NLM (2006)", "ST": "T025", "PI": "Retina/cytology (1966-2005)", "MS": "NEURONS in the inner nuclear layer of the RETINA that synapse with both the RETINAL PHOTORECEPTOR CELLS and the RETINAL BIPOLAR CELLS, as well as other horizontal cells. The horizontal cells modulate the sensory signal.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051248"}, {"RECTYPE": "D", "MH": "Oncogene Protein v-maf", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "v-maf Protein|T116|T123|ACX|EQV|NLM (2006)|050104|abbcdef", "ENTRY": "v-maf, Oncogene Protein", "MN": "D12.776.964.775.750.817", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An oncogene protein that was originally isolated from a spontaneous musculo-aponeurotic FIBROSARCOMA in CHICKEN and shown to be the transforming gene of the avian retrovirus AS42. It is a basic leucine zipper TRANSCRIPTION FACTOR and the founding member of the MAF TRANSCRIPTION FACTORS.", "PM": "2006; ONCOGENE PROTEIN V-MAF was indexed under DNA-BINDING PROTEINS & ONCOGENE PROTEINS, VIRAL & VIRAL PROTEINS 1993-2005", "HN": "2006(1993)", "MR": "20050708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051256"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-maf", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "maf Proto-Oncogene Protein|T116|T123|ABX|EQV|NLM (2006)|abbcde", "ENTRY": "maf Proto Oncogene Protein", "MN": "D12.776.930.127.500.061.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Maf proto-oncogene protein is the major cellular homolog of the V-MAF ONCOGENE PROTEIN. It was the first of the mammalian MAF TRANSCRIPTION FACTORS identified, and it is induced in activated T-LYMPHOCYTES and regulates GENETIC TRANSCRIPTION of INTERLEUKIN-4. c-maf is frequently translocated to an immunoglobulin locus in MULTIPLE MYELOMA.", "PM": "2006 PROTO-ONCOGENE PROTEIN C-MAF was indexed under DNA-BINDING PROTEINS & PROTO-ONCOGENE PROTEINS 1994-2005", "HN": "2006(1994)", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051257"}, {"RECTYPE": "D", "MH": "MafB Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "MafB Proteins|T116|T123|ABX|EQV|NLM (2006)|050127|abbcdef", "ENTRY": "Transcription Factors, MafB", "MN": "D12.776.930.127.500.061.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A large maf protein that regulates HINDBRAIN development, contributes to CELL DIFFERENTIATION of MONOCYTES, and interacts with ETS-1 TRANSCRIPTION FACTOR.", "PM": "2006", "HN": "2006", "MR": "20050713", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051258"}, {"RECTYPE": "D", "MH": "MafG Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, MafG", "MN": "D12.776.930.216.750.750.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "MafG is a ubiquitously expressed small maf protein that is involved in CELL DIFFERENTIATION of ERYTHROCYTES. It dimerizes with P45 NF-E2 PROTEIN and activates expression of ALPHA-GLOBIN and BETA-GLOBIN.", "PM": "2006", "HN": "2006", "MR": "20160705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051259"}, {"RECTYPE": "D", "MH": "MafF Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, MafF", "MN": "D12.776.930.216.750.750.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A small maf protein that forms dimers with NRF1 protein; NRF2 PROTEIN; and P45 NF-E2 PROTEIN. MafF complexes bind Maf recognition elements to regulate tissue-specific GENETIC TRANSCRIPTION.", "PM": "2006", "HN": "2006", "MR": "20210628", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051260"}, {"RECTYPE": "D", "MH": "Granulomatosis, Orofacial", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Orofacial Granulomatoses", "MN": "C23.550.384", "MH_TH": "NLM (2006)", "ST": "T184", "MS": "A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. Among experts there is disagreement on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.", "PM": "2006", "HN": "2006", "MR": "20110624", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051261"}, {"RECTYPE": "D", "MH": "D-Alanine Transaminase", "DS": "ALANINE TRANSAMINASE D", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transaminase, D-Glutamate-D-Alanine", "MN": "D08.811.913.477.700.347", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.6.1.21", "RR": "37277-85-3 (CRN)", "MS": "A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the reversible transfer of an amino group between D-Alanine and alpha-ketoglutarate to form PYRUVATE and D-GLUTAMATE, respectively. It plays a role in the synthesis of the bacterial CELL WALL. This enzyme was formerly classified as EC 2.6.1.10.", "PM": "2006; D-ALANINE TRANSAMINASE was indexed under ALANINE TRANSAMINASE 1974-2005, & under TRANSAMINASES 1977-2005", "HN": "2006(1980); use ALANINE TRANSAMINASE 1974-1979, & TRANSAMINASES 1977-1979", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051263"}, {"RECTYPE": "D", "MH": "Nuclear Respiratory Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Respiratory Factors, Nuclear", "MN": "D12.776.930.618", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of transcription factors that control expression of a variety of nuclear GENES encoding proteins that function in the RESPIRATORY CHAIN of the MITOCHONDRIA.", "PM": "2006; NUCLEAR RESPIRATORY FACTORS was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 1994-2005, & under TRANSCRIPTION FACTORS 1993", "HN": "2006(1993)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051264"}, {"RECTYPE": "D", "MH": "NF-E2-Related Factor 1", "DS": "NF E 02 RELATED FACTOR 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NRF 1 Protein", "MN": "D12.776.930.127.710", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A basic-leucine zipper transcription factor that is involved in regulating inflammatory responses, MORPHOGENESIS, and HEME biosynthesis.", "PM": "2006; NF-E2-RELATED FACTOR 1 was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 1994-2005, & under TRANSCRIPTION FACTORS 1993", "HN": "2006(1993)", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051265"}, {"RECTYPE": "D", "MH": "Nuclear Respiratory Factor 1", "DS": "NUCLEAR RESPIRATORY FACTOR 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, NRF1", "MN": "D12.776.930.618.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A transcription factor that controls the expression of variety of proteins including CYTOCHROME C and 5-AMINOLEVULINATE SYNTHETASE. It plays an important role in maintenance of the RESPIRATORY CHAIN of MITOCHONDRIA.", "PM": "2006; NUCLEAR RESPIRATORY FACTOR 1 was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 2005", "HN": "2006(2005)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051266"}, {"RECTYPE": "D", "MH": "NF-E2-Related Factor 2", "DS": "NF E 02 RELATED FACTOR 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nuclear Factor E2 Related Factor 2", "MN": "D12.776.930.127.737", "FX": "Antioxidant Response Elements", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A basic-leucine zipper transcription factor that was originally described as a transcriptional regulator controlling expression of the BETA-GLOBIN gene. It may regulate the expression of a wide variety of genes that play a role in protecting cells from oxidative damage.", "PM": "2006; NF-E2-RELATED FACTOR 2 was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 1994-2005", "HN": "2006(1994)", "MR": "20120703", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051267"}, {"RECTYPE": "D", "MH": "GA-Binding Protein Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nuclear Respiratory Factor 2|T116|T123|NON|EQV|NLM (2006)|NUCLEAR RESPIRATORY FACTOR 002|abbcdes", "ENTRY": "Transcription Factor, GABP", "MN": "D12.776.930.618.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A heterotetrameric transcription factor composed of two distinct proteins. Its name refers to the fact it binds to DNA sequences rich in GUANINE and ADENINE. GA-binding protein integrates a variety of SIGNAL TRANSDUCTION PATHWAYS and regulates expression of GENES involved in CELL CYCLE control, PROTEIN BIOSYNTHESIS, and cellular METABOLISM.", "PM": "2006; GA-BINDING PROTEIN was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1991-2005", "HN": "2006(1991)", "MR": "20050727", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051268"}, {"RECTYPE": "D", "MH": "Sodium-Glucose Transporter 1", "DS": "SODIUM GLUCOSE TRANSPORTER 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sodium Glucose Transporter 1", "MN": "D12.776.543.585.937.821", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "The founding member of the sodium glucose transport proteins. It is predominately expressed in the INTESTINAL MUCOSA of the SMALL INTESTINE.", "PM": "2006; SODIUM-GLUCOSE TRANSPORTER 1 was indexed under MEMBRANE GLYCOPROTEINS 1997-2005, & under MONOSACCHARIDE TRANSPORT PROTEINS 1996-2005, & under MEMBRANE PROTEINS 1993-1996, & under CARRIER PROTEINS 1993-1995", "HN": "2006(1993)", "MR": "20151124", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051269"}, {"RECTYPE": "D", "MH": "Headache Disorders, Primary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Primary Headache Disorder", "MN": "C10.228.140.546.399", "MH_TH": "NLM (2006)", "ST": "T047", "AN": "for Valsalva maneuver headache coordinate with VALSALVA MANEUVER", "PI": "Headache (1979-2005)", "MS": "Conditions in which the primary symptom is HEADACHE and the headache cannot be attributed to any known causes.", "PM": "2006; for COUGH HEADACHE; HEADACHE, THUNDERCLAP; and STABBING HEADACHE see HEADACHE 2000-2005; for BENIGN EXERTIONAL HEADACHE and HYPNIC HEADACHE SYNDROME see HEADACHE DISORDERS 2000-2005", "HN": "2006; for COUGH HEADACHE; HEADACHE, THUNDERCLAP; and STABBING HEADACHE use HEADACHE 2000-2005; for BENIGN EXERTIONAL HEADACHE and HYPNIC HEADACHE SYNDROME use HEADACHE DISORDERS 2000-2005", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051270"}, {"RECTYPE": "D", "MH": "Headache Disorders, Secondary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Analgesic Overuse Headache|T047|NON|NRW|NLM (2000)|991012|abcdef", "ENTRY": "Secondary Headache Disorder", "MN": "C10.228.140.546.699", "MH_TH": "NLM (2006)", "ST": "T047", "PI": "Headache (1993-2005)", "MS": "Conditions with HEADACHE symptom that can be attributed to a variety of causes including BRAIN VASCULAR DISORDERS; WOUNDS AND INJURIES; INFECTION; drug use or its withdrawal.", "PM": "2006; see HEADACHE DISORDERS 2000-2005", "HN": "2006; use HEADACHE DISORDERS 2000-2005", "MR": "20150109", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051271"}, {"RECTYPE": "D", "MH": "Glucose Transporter Type 1", "DS": "GLUCOSE TRANSPORTER TYPE 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glucose Transporter, Erythrocyte", "MN": "D12.776.543.585.937.625.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A ubiquitously expressed glucose transporter that is important for constitutive, basal GLUCOSE transport. It is predominately expressed in ENDOTHELIAL CELLS and ERYTHROCYTES at the BLOOD-BRAIN BARRIER and is responsible for GLUCOSE entry into the BRAIN.", "PM": "2006; GLUCOSE TRANSPORTER TYPE 1 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS 1992-2005", "HN": "2006(1992)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051272"}, {"RECTYPE": "D", "MH": "Glucose Transporter Type 2", "DS": "GLUCOSE TRANSPORTER TYPE 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "GLUT 2 Protein", "MN": "D12.776.543.585.937.625.750", "FX": "Fanconi Syndrome", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A glucose transport facilitator that is expressed primarily in PANCREATIC BETA CELLS; LIVER; and KIDNEYS. It may function as a GLUCOSE sensor to regulate INSULIN release and glucose HOMEOSTASIS.", "PM": "2006; GLUCOSE TRANSPORTER TYPE 2 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS 2003-2005, & under MEMBRANE TRANSPORT PROTEINS 1992-2002", "HN": "2006(1992)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051273"}, {"RECTYPE": "D", "MH": "Glucose Transporter Type 3", "DS": "GLUCOSE TRANSPORTER TYPE 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "GLUT 3 Protein", "MN": "D12.776.631.480", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A major glucose transporter found in NEURONS.", "PM": "2006; GLUCOSE TRANSPORTER TYPE 3 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS & NERVE TISSUE PROTEINS 2005, & under MEMBRANE PROTEINS 1991-2004", "HN": "2006(1991)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051274"}, {"RECTYPE": "D", "MH": "Glucose Transporter Type 4", "DS": "GLUCOSE TRANSPORTER TYPE 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Insulin Responsive Glucose Transporter", "MN": "D12.776.543.585.937.625.937", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A glucose transport protein found in mature MUSCLE CELLS and ADIPOCYTES. It promotes transport of glucose from the BLOOD into target TISSUES. The inactive form of the protein is localized in CYTOPLASMIC VESICLES. In response to INSULIN, it is translocated to the PLASMA MEMBRANE where it facilitates glucose uptake.", "PM": "2006; GLUCOSE TRANSPORTER TYPE 4 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS & MUSCLE PROTEINS 1992-2005", "HN": "2006(1992)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051275"}, {"RECTYPE": "D", "MH": "Leucine Transaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transaminase, Leucine", "MN": "D08.811.913.477.700.535", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.6.1.6", "RR": "9030-37-9 (CRN)", "MS": "A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the reversible transamination of branched-chain AMINO ACIDS to 2-oxoglutarate.", "PM": "2006; LEUCINE TRANSAMINASE was indexed under TRANSAMINASES 1973-2005 & under KETOGLUTARIC ACID 1973-1979", "HN": "2006(1980); use TRANSAMINASES 1973-1979, & KETOGLUTARIC ACID 1973-1979", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051276"}, {"RECTYPE": "D", "MH": "Succinyldiaminopimelate Transaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transaminase, Succinyldiaminopimelate", "MN": "D08.811.913.477.700.800", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.6.1.17", "MS": "A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer amino group from N-succinyl-L-2,6-diaminoheptanedioate to 2-oxoglutarate in order to generate N-succinyl-2-L-amino-6-oxoheptanedioate and L-GLUTAMATE, respectively.", "PM": "2006; SUCCINYLDIAMINOPIMELATE TRANSAMINASE was indexed under TRANSAMINASES 1999-2005", "HN": "2006(1999)", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051277"}, {"RECTYPE": "D", "MH": "beta-Alanine-Pyruvate Transaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Alanine Pyruvate Transaminase", "MN": "D08.811.913.477.700.286", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.6.1.18", "MS": "A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer of an amino group from L-ALANINE to 3-oxopropanoate to generate PYRUVATE and BETA-ALANINE.", "PM": "2006; BETA-ALANINE-PYRUVATE TRANSAMINASE was indexed under TRANSAMINASES 1980-2005", "HN": "2006(1980)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051278"}, {"RECTYPE": "D", "MH": "Tryptophan Transaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transaminase, Tryptophan", "MN": "D08.811.913.477.700.850", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.6.1.27", "RR": "9022-98-4 (CRN)", "MS": "A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer amino group from L-TRYPTOPHAN to 2-oxoglutarate in order to generate indolepyruvate and L-GLUTAMATE.", "PM": "2006; TRYPTOPHAN TRANSAMINASES was indexed under TRANSAMINASES 1975-2005, & under TRYPTOPHAN 1975-1980; TRYPTOPHAN AMINOTRANSFERASE was indexed under TRANSAMINASES 1976-2005", "HN": "2006(1980); use TRANSAMINASES & TRYPTOPHAN 1975-1979", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051279"}, {"RECTYPE": "D", "MH": "Glucose Transporter Type 5", "DS": "GLUCOSE TRANSPORTER TYPE 005", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "GLUT 5 Protein", "MN": "D12.776.543.585.937.625.968", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A hexose transporter that mediates FRUCTOSE transport in SKELETAL MUSCLE and ADIPOCYTES and is responsible for luminal uptake of dietary fructose in the SMALL INTESTINE.", "PM": "2006; GLUCOSE TRANSPORTER TYPE 5 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS 1992-2005", "HN": "2006(1992)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051296"}, {"RECTYPE": "D", "MH": "Sodium-Glucose Transporter 2", "DS": "SODIUM GLUCOSE TRANSPORTER 002", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sodium Glucose Transporter 2", "MN": "D12.776.543.585.937.825", "EC": "antagonists & inhibitors:Sodium-Glucose Transporter 2 Inhibitors", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A sodium-glucose transporter that is expressed in the luminal membrane of the PROXIMAL KIDNEY TUBULES.", "PM": "2006", "HN": "2006", "MR": "20180110", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051297"}, {"RECTYPE": "D", "MH": "Post-Traumatic Headache", "DS": "POSTTRAUMATIC HEADACHE", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Post-Traumatic Headaches", "MN": "C10.228.140.546.699.249", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Headache (1966-2005)", "MS": "Secondary headache attributed to TRAUMA of the HEAD and/or the NECK.", "PM": "2006; see HEADACHE DISORDERS 2000-2005", "HN": "2006; use HEADACHE DISORDERS 2000-2005", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051298"}, {"RECTYPE": "D", "MH": "Post-Dural Puncture Headache", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Postdural Puncture Headaches", "MN": "C10.228.140.546.699.124", "MH_TH": "NLM (2000)", "ST": "T184", "PI": "Spinal Puncture (1984-2005)", "MS": "A secondary headache disorder attributed to low CEREBROSPINAL FLUID pressure caused by SPINAL PUNCTURE, usually after dural or lumbar puncture.", "PM": "2006; see HEADACHE 2000-2005", "HN": "2006; use HEADACHE 2000-2005", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051299"}, {"RECTYPE": "D", "MH": "Wiskott-Aldrich Syndrome Protein Family", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "WAVE Proteins|T116|T123|ACX|NRW|NLM (2006)|050201|abbcdef", "ENTRY": "Wiskott Aldrich Syndrome Protein Family, Member 3", "MN": "D12.776.220.525.912", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "WISKOTT-ALDRICH SYNDROME PROTEIN and WISKOTT-ALDRICH SYNDROME PROTEIN, NEURONAL are also available", "MS": "A family of microfilament proteins whose name derives from the fact that mutations in members of this protein family have been associated with WISKOTT-ALDRICH SYNDROME. They are involved in ACTIN polymerization and contain a polyproline-rich region that binds to PROFILIN, and a verprolin homology domain that binds G-ACTIN.", "PM": "2006; WAVE PROTEINS was indexed under MICROFILAMENT PROTEINS 1999-2005", "HN": "2006(1999)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051300"}, {"RECTYPE": "D", "MH": "Desmoglein 2", "DS": "DESMOGLEIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Desmosomal Glycoprotein 2|T116|T123|NON|EQV|NLM (2006)|abbcde", "MN": "D23.050.301.350.200.500.500.625", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A CALCIUM-dependent adhesion molecule of DESMOSOMES that also plays a role in embryonic STEM CELL proliferation.", "PM": "2006; DESMOGLEIN 2 was indexed under CYTOSKELETAL PROTEINS (2001-2005)", "HN": "2006(2001)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051301"}, {"RECTYPE": "D", "MH": "Paroxysmal Hemicrania", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Paroxysmal Hemicranias, Episodic", "MN": "C10.228.140.546.399.937.750", "MH_TH": "NLM (2006)", "ST": "T047", "MS": "A primary headache disorder that is similar to the CLUSTER HEADACHE with unilateral head pain, but differs by its multiple short severe attacks. It is usually seen in females, and may be responsive to non-steroidal-anti-inflammatory drugs (NSAIDS).", "PM": "2006; see VASCULAR HEADACHES 2000-2005", "HN": "2006; use VASCULAR HEADACHES 2000-2005", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051302"}, {"RECTYPE": "D", "MH": "Trigeminal Autonomic Cephalalgias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Trigeminal Autonomic Cephalalgia", "MN": "C10.228.140.546.399.937", "MH_TH": "NLM (2006)", "ST": "T047", "MS": "Primary headache disorders that show symptoms caused by the activation of the AUTONOMIC NERVOUS SYSTEM of the TRIGEMINAL NERVE. These autonomic features include redness and tearing of the EYE, nasal congestion or discharge, facial SWEATING and other symptoms. Most subgroups show unilateral cranial PAIN.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051303"}, {"RECTYPE": "D", "MH": "Profilins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Profilin-4|T116|T123|NON|NRW|NLM (2006)|050422|abbcdef", "MN": "D12.776.220.525.637", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of low molecular weight proteins that bind ACTIN and control actin polymerization. They are found in eukaryotes and are ubiquitously expressed.", "PM": "2006; PROFILINS was indexed under MICROFILAMENT PROTEINS & CONTRACTILE PROTEINS 2005, & under CYTOSKELETAL PROTEINS 1977-2004, & under PROTEINS 1977-1987", "HN": "2006(1990); CYTOSKELETAL PROTEINS 1977-1979", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051304"}, {"RECTYPE": "D", "MH": "L-Lysine 6-Transaminase", "DS": "L LYSINE TRANSAMINASE 06", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "epsilon-Transaminase, Lysine", "MN": "D08.811.913.477.700.550", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.6.1.36", "RR": "9054-68-6 (CRN)", "MS": "A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer of amino group of L-LYSINE onto 2-oxoglutarate to generate 2-aminoadipate 6-semialdehyde and L-GLUTAMATE.", "PM": "2006; LYSINE 6-AMINOTRANSFERASE was indexed under TRANSAMINASES 1978-2005, & under KETOGLUTARIC ACIDS 1978-1980", "HN": "2006(1980) use TRANSAMINASES 1978-1979, & KETOGLUTARIC ACIDS 1978-1979", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051306"}, {"RECTYPE": "D", "MH": "2-Aminoadipate Transaminase", "DS": "AMINOADIPATE TRANSAMINASE 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Aminoadipate Aminotransferase", "MN": "D08.811.913.477.700.120", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.6.1.39", "PI": "Transaminases (1983-2005)", "MS": "A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer of amino group of L-2-aminoadipate onto 2-oxoglutarate to generate 2-oxoadipate and L-GLUTAMATE.", "PM": "2006; 2-AMINOADIPATE TRANSAMINASE was indexed under TRANSAMINASES 1983-2005", "HN": "2006(1983)", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051307"}, {"RECTYPE": "D", "MH": "Glycine Transaminase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transaminase, Glycine", "MN": "D08.811.913.477.700.525", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.6.1.4", "MS": "A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer of the amino group of GLYCINE onto 2-oxoglutarate to generate GLYOXYLATE and L-GLUTAMATE.", "PM": "2006; GLYCINE TRANSAMINASES was indexed under TRANSAMINASES 1974-2005, & under KETOGLUTARIC ACID 1974-2005", "HN": "2006(1980); use TRANSAMINASES 1974-1979, & KETOGLUTARIC ACID 1974-1979", "MR": "20100625", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051308"}, {"RECTYPE": "D", "MH": "Wiskott-Aldrich Syndrome Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "WASP Protein|T116|T123|ACX|EQV|NLM (2006)|abbcde", "ENTRY": "Wiskott Aldrich Syndrome Protein", "MN": "D12.776.220.525.912.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY and WISKOTT-ALDRICH SYNDROME PROTEIN, NEURONAL are also available", "MS": "WASP protein is mutated in WISKOTT-ALDRICH SYNDROME and is expressed primarily in hematopoietic cells. It is the founding member of the WASP protein family and interacts with CDC42 PROTEIN to help regulate ACTIN polymerization.", "PM": "2006; WISKOTT-ALDRICH SYNDROME PROTEIN was indexed under PROTEINS 1994-2005", "HN": "2006(1994)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051316"}, {"RECTYPE": "D", "MH": "Wiskott-Aldrich Syndrome Protein, Neuronal", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Neuronal Wiskott-Aldrich Syndrome Protein|T116|T123|NON|EQV|NLM (2006)|050131|abbcdef", "ENTRY": "Wiskott Aldrich Syndrome Protein, Neuronal", "MN": "D12.776.220.525.912.550", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY and WISKOTT-ALDRICH SYNDROME PROTEIN are also available", "MS": "A member of the Wiskott-Aldrich syndrome protein family that is found at high levels in NERVE CELLS. It interacts with GRB2 ADAPTOR PROTEIN and with CDC42 PROTEIN.", "PM": "2006; NEURONAL WISKOTT-ALDRICH SYNDROME PROTEIN was indexed under NERVE TISSUE PROTEINS 1998-2005, & under PROTEINS 1996-1997", "HN": "2006(1996)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051317"}, {"RECTYPE": "D", "MH": "Mitochondrial Membranes", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Outer Mitochondrial Membranes", "MN": "A11.284.835.514.349", "MH_TH": "NLM (2006)", "ST": "T026", "PI": "Mitochondria (1965-2005)", "MS": "The two lipoprotein layers in the MITOCHONDRION. The outer membrane encloses the entire mitochondrion and contains channels with TRANSPORT PROTEINS to move molecules and ions in and out of the organelle. The inner membrane folds into cristae and contains many ENZYMES important to cell METABOLISM and energy production (MITOCHONDRIAL ATP SYNTHASE).", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051336"}, {"RECTYPE": "D", "MH": "Chemical Terrorism", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Terrorism, Chemical", "MN": "I01.880.735.950.500.340.150", "MH_TH": "NLM (2006)", "ST": "T052", "PI": "Violence (1996-2000)", "MS": "The use of chemical agents in TERRORISM. This includes the malevolent use of nerve agents, blood agents, blister agents, and choking agents (NOXAE).", "PM": "2006", "HN": "2006", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051337"}, {"RECTYPE": "D", "MH": "Cofilin 1", "DS": "COFILIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Non Muscle Cofilin", "MN": "D12.776.220.525.212.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "see SCR for organism-specific terms", "MS": "Cofilin 1 is a member of the cofilin family of proteins that is expressed in non-muscle CELLS. It has ACTIN depolymerization activity that is dependent on HYDROGEN-ION CONCENTRATION.", "PM": "2006; COFILIN 1 was indexed under MICROFILAMENT PROTEINS 2005", "HN": "2006(2005)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051338"}, {"RECTYPE": "D", "MH": "Actin Depolymerizing Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cofilins|T116|T123|NON|EQV|NLM (2006)|050202|abbcdef", "ENTRY": "Protein, Actin Depolymerizing", "MN": "D12.776.220.525.212", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of low MOLECULAR WEIGHT actin-binding proteins found throughout eukaryotes. They remodel the actin CYTOSKELETON by severing ACTIN FILAMENTS and increasing the rate of monomer dissociation.", "PM": "2006; ACTIN DEPOLYMERIZING FACTORS was indexed under MICROFILAMENT PROTEINS 1988-2005, & under MUSCLE PROTEINS & PROTEINS 1981-1987", "HN": "2006(1981)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051339"}, {"RECTYPE": "D", "MH": "Cofilin 2", "DS": "COFILIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cofilin, Muscle", "MN": "D12.776.220.525.212.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A member of the cofilin family of proteins that is expressed in MUSCLE CELLS. It has ACTIN depolymerization activity that is dependent on HYDROGEN-ION CONCENTRATION.", "PM": "2006; COFILIN 2 was indexed under MICROFILAMENT PROTEINS 2001-2005", "HN": "2006(2001)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051340"}, {"RECTYPE": "D", "MH": "Dependent Ambulation", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Ambulation, Dependent", "MN": "G11.427.410.568.900.500", "FX": "Mobility Limitation", "MH_TH": "NLM (2006)", "ST": "T056", "MS": "To move about or walk on foot with the use of aids.", "PM": "2006", "HN": "2006", "MR": "20160630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051341"}, {"RECTYPE": "D", "MH": "Actin Capping Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Actin-Capping Proteins|T116|T123|NON|EQV|NLM (2006)|abbcde", "ENTRY": "Capping Proteins, Actin", "MN": "D12.776.220.525.032", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Actin capping proteins are cytoskeletal proteins that bind to the ends of ACTIN FILAMENTS to regulate actin polymerization.", "PM": "2006; ACTIN CAPPING PROTEINS was indexed under MICROFILAMENT PROTEINS 1988-2005, & under MUSCLE PROTEINS & PROTEINS 1981-1987", "HN": "2006(1981)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051344"}, {"RECTYPE": "D", "MH": "Destrin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Depolymerizing Factor, Actin", "MN": "D12.776.220.525.212.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A member of the actin depolymerizing factors. Its depolymerizing activity is independent of HYDROGEN-ION CONCENTRATION.", "PM": "2006; DESTRIN was indexed under MICROFILAMENT PROTEINS 1988-2005, & under MUSCLE PROTEINS & PROTEINS 1981-1987", "HN": "2006(1981)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051345"}, {"RECTYPE": "D", "MH": "Mobility Limitation", "PRINT ENTRY": "Ambulation Difficulty|T184|NON|NRW|NLM (2006)|050202|abcdef", "ENTRY": "Walking, Difficulty", "MN": "C23.888.550", "FX": "Dependent Ambulation", "MH_TH": "NLM (2006)", "ST": "T184", "MS": "Difficulty in walking from place to place.", "PM": "2006", "HN": "2006", "MR": "20160622", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051346"}, {"RECTYPE": "D", "MH": "CapZ Actin Capping Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CapZ Protein|T116|T123|ABX|EQV|NLM (2006)|abbcde", "ENTRY": "CapZ beta Protein|T116|T123|ABX|NRW|NLM (2006)|050202|abbcdef", "MN": "D12.776.220.525.032.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An actin capping protein that binds to the barbed-ends of ACTIN filaments. It is a heterodimer consisting of an alpha and a beta subunit. It regulates actin assembly by stabilizing actin oligomers for elongation. In SKELETAL MUSCLE, CapZ is localized to the Z-disk.", "PM": "2006; CAPZ PROTEIN was indexed under MICROFILAMENT PROTEINS & MUSCLE PROTEINS 1991-2005", "HN": "2006(1991)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051347"}, {"RECTYPE": "D", "MH": "Tropomodulin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.220.525.032.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An actin capping protein that binds to the pointed-end of ACTIN. It functions in the presence of TROPOMYOSIN to inhibit microfilament elongation.", "PM": "2006; TROPOMODULIN was indexed under MICROFILAMENT PROTEINS & CARRIER PROTEINS 1992-2005", "HN": "2006(1992)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051348"}, {"RECTYPE": "D", "MH": "Cortactin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.744.390", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A microfilament protein that interacts with F-ACTIN and regulates cortical actin assembly and organization. It is also an SH3 DOMAIN containing phosphoprotein, and it mediates tyrosine PHOSPHORYLATION based SIGNAL TRANSDUCTION by PROTO-ONCOGENE PROTEIN PP60(C-SRC).", "PM": "2006; CORTACTIN was indexed under MICROFILAMENT PROTEINS 1993-2005", "HN": "2006(1983)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051356"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase 2", "DS": "CYCLIN DEPENDENT KINASE 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cdk2 Protein Kinase|T116|T126|ABX|EQV|NLM (2006)|050322|CDK PROTEIN KINASE 002|abbcdefs", "ENTRY": "Cyclin Dependent Kinase 2", "MN": "D12.776.476.563.646.500.750", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.11.22", "MS": "A key regulator of CELL CYCLE progression. It partners with CYCLIN E to regulate entry into S PHASE and also interacts with CYCLIN A to phosphorylate RETINOBLASTOMA PROTEIN. Its activity is inhibited by CYCLIN-DEPENDENT KINASE INHIBITOR P27 and CYCLIN-DEPENDENT KINASE INHIBITOR P21.", "PM": "2006; CYCLIN-DEPENDENT KINASE 2 was indexed under CDC2-CDC28 KINASES 2004-2005, & under CYCLIN-DEPENDENT KINASES 1991-2003, & under PROTEIN KINASES 1991-1994", "HN": "2006(1991)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051357"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase 4", "DS": "CYCLIN DEPENDENT KINASE 004", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cdk4 Protein Kinase|T116|T126|ABX|EQV|NLM (2006)|050322|CDK PROTEIN KINASE 004|abbcdefs", "ENTRY": "p34PSK J3 Kinase", "MN": "D12.776.476.563.646.500.875", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.11.22", "MS": "Cyclin-dependent kinase 4 is a key regulator of G1 PHASE of the CELL CYCLE. It partners with CYCLIN D to phosphorylate RETINOBLASTOMA PROTEIN. CDK4 activity is inhibited by CYCLIN-DEPENDENT KINASE INHIBITOR P16.", "PM": "2006; CYCLIN-DEPENDENT KINASE 4 was indexed under CYCLIN-DEPENDENT KINASES & PROTO-ONCOGENE PROTEINS 2005, CELL CYCLE PROTEINS 1992-2004, PROTEIN SERINE THREONINE KINASES 1995, & under PROTEIN KINASES 1992-1994", "HN": "2006(1992)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051358"}, {"RECTYPE": "D", "MH": "Lymphohistiocytosis, Hemophagocytic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Reactive Hemophagocytic Syndrome|T047|NON|NRW|NLM (2006)|050203|abcdef", "ENTRY": "Reticulosis, Familial Hemophagocytic", "MN": "C15.604.250.410.575", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Histiocytosis, Non-Langerhans-Cell (1989-2005)", "MS": "A group of related disorders characterized by LYMPHOCYTOSIS; HISTIOCYTOSIS; and hemophagocytosis. The two major forms are familial and reactive.", "PM": "2006; see HISTIOCYTOSIS, NON-LANGERHANS CELL 1990-2005", "HN": "2006; use HISTIOCYTOSIS, NON-LANGERHANS CELL 1990-2005", "MR": "20190408", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051359"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase 5", "DS": "CYCLIN DEPENDENT KINASE 005", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cdk5 Protein Kinase|T116|T126|ABX|EQV|NLM (2006)|050322|CDK PROTEIN KINASE 005|abbcdefs", "ENTRY": "Protein Kinase, Cdk5", "MN": "D12.776.476.563.646.500.500.500", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A serine-threonine kinase that plays important roles in CELL DIFFERENTIATION; CELL MIGRATION; and CELL DEATH of NERVE CELLS. It is closely related to other CYCLIN-DEPENDENT KINASES but does not seem to participate in CELL CYCLE regulation.", "PM": "2006; CYCLIN-DEPENDENT KINASE 5 was indexed under CYCLIN-DEPENDENT KINASES 2000-2005, & under PROTEIN-SERINE-THREONINE KINASES 1995-1999, & under PROTEIN KINASES 1993-1994", "HN": "2006(1994)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051360"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase 6", "DS": "CYCLIN DEPENDENT KINASE 006", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cdk6 Protein Kinase|T116|T126|ABX|EQV|NLM (2006)|050322|CDK PROTEIN KINASE 006|abbcdefs", "ENTRY": "Protein Kinase, Cdk6", "MN": "D12.776.476.563.646.500.937", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.11.22", "MS": "Cyclin-dependent kinase 6 associates with CYCLIN D and phosphorylates RETINOBLASTOMA PROTEIN during G1 PHASE of the CELL CYCLE. It helps regulate the transition to S PHASE and its kinase activity is inhibited by CYCLIN-DEPENDENT KINASE INHIBITOR P18.", "PM": "2006; CYCLIN-DEPENDENT KINASE 6 was indexed under CYCLIN-DEPENDENT KINASES 2003-2005, & under PROTEIN-SERINE-THREONINE KINASES 1995-2002, & under PROTEIN KINASES 1994", "HN": "2006(1994)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051361"}, {"RECTYPE": "D", "MH": "Actin-Related Protein 2-3 Complex", "DS": "ACTIN RELATED PROTEIN 002 003 COMPLEX", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Arp2-3 Complex|T116|T123|ABX|EQV|NLM (2006)|050204|ARP COMPLEX 02 03|abbcdefs", "ENTRY": "Arp2 3 Protein Complex", "MN": "D12.776.220.525.246", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A complex of seven proteins including ARP2 PROTEIN and ARP3 PROTEIN that plays an essential role in maintenance and assembly of the CYTOSKELETON. Arp2-3 complex binds WASP PROTEIN and existing ACTIN FILAMENTS, and it nucleates the formation of new branch point filaments.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051376"}, {"RECTYPE": "D", "MH": "Actin-Related Protein 2", "DS": "ACTIN RELATED PROTEIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Actin Related Protein 2", "MN": "D12.776.220.525.246.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A PROFILIN binding domain protein that is part of the Arp2-3 complex. It is related in sequence and structure to ACTIN and binds ATP.", "PM": "2006; ACTIN-RELATED PROTEIN 2 was indexed under CYTOSKELETAL PROTEINS 2005, & under ACTINS 1998-2004", "HN": "2006(1998)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051377"}, {"RECTYPE": "D", "MH": "Actin-Related Protein 3", "DS": "ACTIN RELATED PROTEIN 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Actin Related Protein 3", "MN": "D12.776.220.525.246.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A component of the Arp2-3 complex that is related in sequence and structure to ACTIN and that binds ATP. It is expressed at higher levels than ARP2 PROTEIN and does not contain a PROFILIN binding domain.", "PM": "2006; ACTIN-RELATED PROTEIN 3 was indexed under CYTOSKELETAL PROTEINS 2003-2005, & under ACTINS 1998-2002", "HN": "2006(1998)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051378"}, {"RECTYPE": "D", "MH": "Mice", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Mus musculus|T015|NON|NRW|UNK (19XX)|810514|abcdef", "ENTRY": "domesticus, Mus musculus", "MN": "B01.050.150.900.649.313.992.635.505.500", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid10088", "RR": "txid10092", "AN": "check tag: NIM no qualifiers for MICE, the genus MUS unspecified, or any MUS species", "MS": "The common name for the genus Mus.", "PM": "2006", "HN": "2006", "MR": "20200902", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051379"}, {"RECTYPE": "D", "MH": "GRB2 Adaptor Protein", "DS": "GRB ADAPTOR PROTEIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Growth Factor Receptor-Bound Protein-2|T116|T123|NON|EQV|NLM (2006)|GROWTH FACTOR RECEPTOR BOUND PROTEIN 002|abbcdes", "ENTRY": "Growth Factor Receptor Bound Protein 2", "MN": "D12.776.476.024.377", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A signal transducing adaptor protein that links extracellular signals to the MAP KINASE SIGNALING SYSTEM. Grb2 associates with activated EPIDERMAL GROWTH FACTOR RECEPTOR and PLATELET-DERIVED GROWTH FACTOR RECEPTORS via its SH2 DOMAIN. It also binds to and translocates the SON OF SEVENLESS PROTEINS through its SH3 DOMAINS to activate PROTO-ONCOGENE PROTEIN P21(RAS).", "PM": "2006; GROWTH FACTOR RECEPTOR-BOUND PROTEIN-2 was indexed under ADAPTOR PROTEINS, SIGNAL TRANSDUCING 2005, & under PROTEINS 1992-2004", "HN": "2006(1992)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051380"}, {"RECTYPE": "D", "MH": "Rats", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Rattus|T015|NON|EQV|UNK (19XX)|810514|abcdef", "ENTRY": "norvegicus, Rattus", "MN": "B01.050.150.900.649.313.992.635.505.700", "MH_TH": "NLM (1966)", "ST": "T015", "RN": "txid10114", "RR": "txid10116", "AN": "check tag: NIM no qualifiers for RATS, the genus RATTUS unspecified, or any RATTUS species", "MS": "The common name for the genus Rattus.", "PM": "2006", "HN": "2006", "MR": "20221018", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051381"}, {"RECTYPE": "D", "MH": "GRB7 Adaptor Protein", "DS": "GRB ADAPTOR PROTEIN 007", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Growth Factor Receptor-Bound Protein-7|T116|T123|NON|EQV|NLM (2006)|GROWTH FACTOR RECEPTOR BOUND PROTEIN 007|abbcdes", "ENTRY": "Growth Factor Receptor Bound Protein 7", "MN": "D12.776.476.024.379", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "149058-53-7", "MS": "A SH2 DOMAIN-containing protein that mediates SIGNAL TRANSDUCTION pathways from multiple CELL SURFACE RECEPTORS, including the EPHB1 RECEPTOR. It interacts with FOCAL ADHESION KINASE and is involved in CELL MIGRATION.", "PM": "2006; GROWTH FACTOR RECEPTOR-BOUND PROTEIN-7 was indexed under PROTEINS 1995-2005", "HN": "2006(1992)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051382"}, {"RECTYPE": "D", "MH": "GRB10 Adaptor Protein", "DS": "GRB ADAPTOR PROTEIN 010", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Growth Factor Receptor-Bound Protein 10|T116|T123|NON|EQV|NLM (2006)|GROWTH FACTOR RECEPTOR BOUND PROTEIN 010|abbcdes", "ENTRY": "Growth Factor Receptor Bound Protein 10", "MN": "D12.776.476.024.380", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "151441-47-3", "MS": "A binding partner for several RECEPTOR PROTEIN-TYROSINE KINASES, including INSULIN RECEPTOR and INSULIN-LIKE GROWTH FACTOR RECEPTOR. It contains a C-terminal SH2 DOMAIN and mediates various SIGNAL TRANSDUCTION pathways.", "PM": "2006; GROWTH FACTOR RECEPTOR-BOUND PROTEIN 10 was indexed under PROTEINS 1995-2005", "HN": "2006(1995)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051383"}, {"RECTYPE": "D", "MH": "Aquaglyceroporins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Non-Specific Aquaporin|T116|T123|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Non Specific Aquaporins", "MN": "D12.776.543.585.400.730.040.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A subgroup of aquaporins that transport WATER; GLYCEROL; and other small solutes across CELL MEMBRANES.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051397"}, {"RECTYPE": "D", "MH": "Aquaporin 1", "DS": "AQUAPORIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Channel Forming Integral Membrane Protein Of 28 kDa", "MN": "D12.776.543.585.400.730.040.436", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "146410-94-8", "MS": "Aquaporin 1 forms a water-specific channel that is constitutively expressed at the PLASMA MEMBRANE of ERYTHROCYTES and KIDNEY TUBULES, PROXIMAL. It provides these cells with a high permeability to WATER. In humans polymorphisms of this protein result in the Colton blood group antigen.", "PM": "2006; AQUAPORIN 1 was indexed under AQUAPORINS 1999-2005, & under ION CHANNELS 1994-1998, & under MEMBRANE PROTEINS 1992-1993", "HN": "2006(1992)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051398"}, {"RECTYPE": "D", "MH": "Aquaporin 2", "DS": "AQUAPORIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Aquaporin CD", "MN": "D12.776.543.585.400.730.040.530", "FX": "Diabetes Insipidus, Nephrogenic", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Aquaporin 2 is a water-specific channel protein that is expressed in KIDNEY COLLECTING DUCTS. The translocation of aquaporin 2 to the apical PLASMA MEMBRANE is regulated by VASOPRESSIN, and MUTATIONS in AQP2 have been implicated in a variety of kidney disorders including DIABETES INSIPIDUS.", "PM": "2006; AQUAPORIN 2 was indexed under AQUAPORINS 1999-2005, & under ION CHANNELS 1995-1998, & under MEMBRANE PROTEINS 1993-1994", "HN": "2006(1993)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051399"}, {"RECTYPE": "D", "MH": "Aquaporin 3", "DS": "AQUAPORIN 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Aquaporin 3 Protein|T116|T123|NON|EQV|NLM (2006)|050422|abbcdef", "MN": "D12.776.543.585.400.730.040.249.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "158801-98-0", "MS": "Aquaporin 3 is an aquaglyceroporin that is expressed in the KIDNEY COLLECTING DUCTS and is constitutively localized at the basolateral MEMBRANE.", "PM": "2006; AQUAPORIN 3 was indexed under AQUAPORINS 1999-2005, & under ION CHANNELS 1995-1998, & under MEMBRANE PROTEINS 1994", "HN": "2006(1994)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051400"}, {"RECTYPE": "D", "MH": "Aquaporin 4", "DS": "AQUAPORIN 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Aquaporin 4 Protein|T116|T123|NON|EQV|NLM (2006)|050422|abbcdef", "MN": "D12.776.543.585.400.730.040.577", "FX": "Neuromyelitis Optica", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Aquaporin 4 is the major water-selective channel in the CENTRAL NERVOUS SYSTEM of mammals.", "PM": "2006; AQUAPORIN 4 was indexed under AQUAPORINS 1999-2005, & under ION CHANNELS 1995-1998", "HN": "2006(1995)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051401"}, {"RECTYPE": "D", "MH": "Aquaporin 5", "DS": "AQUAPORIN 005", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Aquaporin-5|T116|T123|NON|EQV|NLM (2006)|abbcde", "MN": "D12.776.543.585.400.730.040.600", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Aquaporin 5 is a water-specific channel protein that is expressed primarily in alveolar, tracheal, and upper bronchial EPITHELIUM. It plays an important role in maintaining water HOMEOSTASIS in the LUNGS and may also regulate release of SALIVA and TEARS in the SALIVARY GLANDS and the LACRIMAL GLAND.", "PM": "2006; AQUAPORIN 5 was indexed under AQUAPORINS & MEMBRANE PROTEINS 1999-2005, & under ION CHANNELS 1996-1998", "HN": "2006(1996)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051402"}, {"RECTYPE": "D", "MH": "Aquaporin 6", "DS": "AQUAPORIN 006", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Aquaporin-6|T116|T123|NON|EQV|NLM (2006)|abbcde", "MN": "D12.776.543.585.400.730.040.249.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Aquaporin 6 is an aquaglyceroporin that is found primarily in KIDNEY COLLECTING DUCTS. AQP6 protein functions as an anion-selective channel.", "PM": "2006; AQUAPORIN 6 was indexed under AQUAPORINS 2004-2005", "HN": "2006(2004)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051403"}, {"RECTYPE": "D", "MH": "Focal Adhesion Protein-Tyrosine Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Focal Adhesion Protein-Tyrosine Kinase Family|T116|T126|NON|EQV|NLM (2006)|050208|abbcdef", "ENTRY": "Focal Adhesion Protein Tyrosine Kinases", "MN": "D12.776.476.568.049", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "A family of non-receptor, PROLINE-rich protein-tyrosine kinases.", "PM": "2006; FOCAL ADHESION KINASE was indexed under under PROTEIN-TYROSINE KINASE 2001-2005, CELL ADHESION MOLECULES 1990-2000, MEMBRANE GLYCOPROTEINS 1987-1992, & MEMBRANE PROTEINS 1986-1987", "HN": "2006(1999)", "MR": "20210603", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051416"}, {"RECTYPE": "D", "MH": "Focal Adhesion Kinase 1", "DS": "FOCAL ADHESION KINASE 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Focal Adhesion Associated Protein Tyrosine Kinase pp125FAK", "MN": "D12.776.744.493", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "A non-receptor protein tyrosine kinase with PROTEIN PHOSPHATASE 1 regulatory activity that is localized to FOCAL ADHESIONS and is a central component of integrin-mediated SIGNAL TRANSDUCTION PATHWAYS. Focal adhesion kinase 1 interacts with PAXILLIN and undergoes PHOSPHORYLATION in response to adhesion of cell surface integrins to the EXTRACELLULAR MATRIX. Phosphorylated p125FAK protein binds to a variety of SH2 DOMAIN and SH3 DOMAIN containing proteins and helps regulate CELL ADHESION and CELL MIGRATION.", "PM": "2006; ENDOGENOUS SUBSTRATE PP120, FOCAL ADHESION-ASSOCIATED, PROTEIN-TYROSINE KINASE PP125FAK, & P125FAK PROTEIN were indexed under PROTEIN-TYROSINE KINASE 2001-2005, & under CELL ADHESION MOLECULES 1990-2000, & MEMBRANE GLYCOPROTEINS 1987-1992, MEMBRANE PROTEINS 1986-1987", "HN": "2006(1986)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051417"}, {"RECTYPE": "D", "MH": "Focal Adhesion Kinase 2", "DS": "FOCAL ADHESION KINASE 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proline Rich Tyrosine Kinase 2", "MN": "D23.050.705.552.600.350", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "A non-receptor protein-tyrosine kinase that is expressed primarily in the BRAIN; OSTEOBLASTS; and LYMPHOID CELLS. In the CENTRAL NERVOUS SYSTEM focal adhesion kinase 2 modulates ION CHANNEL function and MITOGEN-ACTIVATED PROTEIN KINASES activity.", "PM": "2006; FOCAL ADHESION KINASE 2 was indexed under PROTEIN-TYROSINE KINASE 1995-2005", "HN": "2006(1995)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051418"}, {"RECTYPE": "D", "MH": "Paxillin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.744.665", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Paxillin is a signal transducing adaptor protein that localizes to FOCAL ADHESIONS via its four LIM domains. It undergoes PHOSPHORYLATION in response to integrin-mediated CELL ADHESION, and interacts with a variety of proteins including VINCULIN; FOCAL ADHESION KINASE; PROTO-ONCOGENE PROTEIN PP60(C-SRC); and PROTO-ONCOGENE PROTEIN C-CRK.", "PM": "2006; PAXILLIN was indexed under CYTOSKELETAL PROTEINS & PHOSPHOPROTEINS 1991-2005", "HN": "2006(1991)", "MR": "20160330", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051419"}, {"RECTYPE": "D", "MH": "Renal Insufficiency, Chronic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Kidney Insufficiency, Chronic|T047|NON|EQV|NLM (1993)|920109|abcdef", "ENTRY": "Renal Insufficiencies, Chronic", "MN": "C23.550.291.500.906", "MH_TH": "NLM (1993)", "ST": "T047", "PI": "Kidney Failure, Chronic (1966-2005)", "MS": "Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)", "PM": "2006; see KIDNEY FAILURE, CHRONIC 1993-2005", "HN": "2006; use KIDNEY FAILURE, CHRONIC 1993-2005", "MR": "20210607", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051436"}, {"RECTYPE": "D", "MH": "Renal Insufficiency", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Kidney Insufficiency|T047|NON|EQV|NLM (1993)|920109|abcdef", "ENTRY": "Renal Insufficiencies", "MN": "C12.950.419.780", "MH_TH": "NLM (1993)", "ST": "T047", "AN": "RENAL INSUFFICIENCY, ACUTE see ACUTE KIDNEY INJURY; and RENAL INSUFFICIENCY, CHRONIC are available", "PI": "Kidney Failure (1992-2005)", "MS": "Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.", "PM": "2006; see KIDNEY FAILURE 1993-2005; for KIDNEY FAILURE see KIDNEY FAILURE 1993-2010", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051437"}, {"RECTYPE": "D", "MH": "Syntaxin 16", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Syntaxin 16 Protein|T116|T123|NON|EQV|NLM (2006)|050321|abbcdef", "MN": "D12.776.543.990.775.500.500.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "PI": "Vesicular Transport Proteins (1998-2005)", "MS": "A ubiquitously expressed member of the syntaxin subfamily of SNARE proteins that localizes to the GOLGI APPARATUS.", "PM": "2006; SYNTAXIN 16 was indexed under MEMBRANE PROTEINS and VESICULAR TRANSPORT PROTEINS 1998-2005", "HN": "2006 (1998)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051438"}, {"RECTYPE": "D", "MH": "Fibrocartilage", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A10.165.382.350", "MH_TH": "NLM (2000)", "ST": "T024", "PI": "Cartilage, Articular (1965-2005)", "MS": "A type of CARTILAGE whose matrix contains large bundles of COLLAGEN TYPE I. Fibrocartilage is typically found in the INTERVERTEBRAL DISK; PUBIC SYMPHYSIS; TIBIAL MENISCI; and articular disks in synovial JOINTS. (From Ross et. al., Histology, 3rd ed., p132,136)", "PM": "2006; see CARTILAGE 2000-2005", "HN": "2006; use CARTILAGE 2000-2005", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051445"}, {"RECTYPE": "D", "MH": "Gene Flow", "AQ": "DE ES GE IM PH RE", "ENTRY": "Flow, Gene", "MN": "G05.330.159", "MH_TH": "NLM (2006)", "ST": "T045", "PI": "Genetics, Population (1967-2005)", "MS": "The change in gene frequency in a population due to migration of gametes or individuals (ANIMAL MIGRATION) across population barriers. In contrast, in GENETIC DRIFT the cause of gene frequency changes are not a result of population or gamete movement.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051456"}, {"RECTYPE": "D", "MH": "Hyaline Cartilage", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Hyaline Cartilages", "MN": "A10.165.382.400", "MH_TH": "NLM (2006)", "ST": "T024", "PI": "Cartilage, Articular (1966-2005)", "MS": "A type of CARTILAGE characterized by a homogenous amorphous matrix containing predominately TYPE II COLLAGEN and ground substance. Hyaline cartilage is found in ARTICULAR CARTILAGE; COSTAL CARTILAGE; LARYNGEAL CARTILAGES; and the NASAL SEPTUM.", "PM": "2006", "HN": "2006", "MR": "20140613", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051457"}, {"RECTYPE": "D", "MH": "Elastic Cartilage", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Elastic Cartilages", "MN": "A10.165.382.300", "MH_TH": "NLM (2006)", "ST": "T024", "AN": "ELASTIC TISSUE is also available", "PI": "Cartilage, Articular (1986-2005)", "MS": "A type of CARTILAGE whose matrix contains ELASTIC FIBERS and elastic lamellae, in addition to the normal components of HYALINE CARTILAGE matrix. Elastic cartilage is found in the EXTERNAL EAR; EUSTACHIAN TUBE; EPIGLOTTIS; and LARYNX.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051472"}, {"RECTYPE": "D", "MH": "Maf Transcription Factors, Large", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Large Maf Transcription Factors|T116|T123|ABX|EQV|NLM (2006)|050104|abbcdef", "MN": "D12.776.930.127.500.061", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of high molecular weight Maf transcription factors that contain distinct activation domains.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051473"}, {"RECTYPE": "D", "MH": "Neuralgia, Postherpetic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Postherpetic Neuralgia|T184|NON|EQV|NLM (2006)|050214|abcdef", "MN": "C23.888.592.612.664.550", "FX": "Herpes Zoster", "MH_TH": "NLM (2006)", "ST": "T184", "PI": "Neuralgia (1968-2005)", "MS": "Pain in nerves, frequently involving facial SKIN, resulting from the activation the latent varicella-zoster virus (HERPESVIRUS 3, HUMAN). The two forms of the condition preceding the pain are HERPES ZOSTER OTICUS; and HERPES ZOSTER OPHTHALMICUS. Following the healing of the rashes and blisters, the pain sometimes persists.", "PM": "2006", "HN": "2006", "MR": "20170620", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051474"}, {"RECTYPE": "D", "MH": "Triangular Fibrocartilage", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Triangular Fibrocartilages", "MN": "A10.165.382.350.800", "MH_TH": "NLM (2006)", "ST": "T024", "PI": "Cartilage, Articular (1969-2005)", "MS": "Fibrocartilage that makes up the triangular fibrocartilage complex which is found in the WRIST JOINT.", "PM": "2006", "HN": "2006", "MR": "20170224", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051478"}, {"RECTYPE": "D", "MH": "Plant Infertility", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Infertility, Plant|T045|NON|EQV|NLM (2006)|050215|abcdef", "ENTRY": "Sterility, Reproductive, Plants|T045|NON|EQV|NLM (2006)|050421|abcdef", "MN": "G15.649", "MH_TH": "NLM (2006)", "ST": "T045", "MS": "The failure of PLANTS to complete fertilization and obtain seed (SEEDS) as a result of defective POLLEN or ovules, or other aberrations. (Dict. of Plant Genet. and Mol. Biol., 1998)", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051479"}, {"RECTYPE": "D", "MH": "Receptor, Fibroblast Growth Factor, Type 1", "DS": "RECEPTOR FIBROBLAST GROWTH FACTOR TYPE 001", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Fibroblast Growth Factor Receptor 1|T116|T126|T192|NON|EQV|NLM (2006)|FIBROBLAST GROWTH FACTOR RECEPTOR 001|abbbcdes", "ENTRY": "fms Like Tyrosine Kinase 2", "MN": "D12.776.543.750.750.400.370.500", "FX": "Kallmann Syndrome", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "EC 2.7.10.1", "MS": "A fibroblast growth factor receptor with specificity for FIBROBLAST GROWTH FACTORS; HEPARAN SULFATE PROTEOGLYCAN; and NEURONAL CELL ADHESION MOLECULES. Several variants of the receptor exist due to multiple ALTERNATIVE SPLICING of its mRNA. Fibroblast growth factor receptor 1 contains three extracellular IMMUNOGLOBULIN C2-SET DOMAINS and is a tyrosine kinase that transmits signals through the MAP KINASE SIGNALING SYSTEM.", "PM": "2006; FIBROBLAST GROWTH FACTOR RECEPTOR 1 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR & RECEPTOR PROTEIN-TYROSINE KINASES 1994-2005, & under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993", "HN": "2006(1992)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051496"}, {"RECTYPE": "D", "MH": "Receptor, Fibroblast Growth Factor, Type 2", "DS": "RECEPTOR FIBROBLAST GROWTH FACTOR TYPE 002", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Fibroblast Growth Factor Receptor 2|T116|T126|T192|NON|EQV|NLM (2006)|FIBROBLAST GROWTH FACTOR RECEPTOR 002|abbbcdes", "ENTRY": "Bek Related Fibroblast Growth Factor Receptor 1", "MN": "D12.776.543.750.750.400.370.750", "FX": "Craniofacial Dysostosis", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "EC 2.7.10.1", "RR": "EC 2.7.10.1", "MS": "A fibroblast growth factor receptor which contains three extracellular IMMUNOGLOBULIN I-SET DOMAINS and is expressed as two isoforms. One receptor isoform is expressed in the MESENCHYME and is activated by FIBROBLAST GROWTH FACTOR 2. A second isoform is expressed mainly by EPITHELIAL CELLS and is activated by FIBROBLAST GROWTH FACTOR 7 and FIBROBLAST GROWTH FACTOR 10. Mutation of the gene for fibroblast growth factor receptor 2 can result in craniosynostotic syndromes (e.g., APERT SYNDROME; and CROUZON SYNDROME).", "PM": "2006; FIBROBLAST GROWTH FACTOR RECEPTOR 2 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR & RECEPTOR PROTEIN-TYROSINE KINASE 2004-2005, & under PROTEIN-TYROSINE KINASE 1999-2003", "HN": "2006(1999)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051497"}, {"RECTYPE": "D", "MH": "Receptor, Fibroblast Growth Factor, Type 3", "DS": "RECEPTOR FIBROBLAST GROWTH FACTOR TYPE 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fibroblast Growth Factor Receptor 3|T116|T126|T192|NON|EQV|NLM (2006)|FIBROBLAST GROWTH FACTOR RECEPTOR 003|abbbcdes", "ENTRY": "Antigen, CD333", "MN": "D12.776.624.664.700.792", "FX": "Achondroplasia", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "EC 2.7.10.1", "MS": "A fibroblast growth factor receptor that regulates CHONDROCYTE growth and CELL DIFFERENTIATION. Mutations in the gene for fibroblast growth factor receptor 3 have been associated with ACHONDROPLASIA; THANATOPHORIC DYSPLASIA and NEOPLASTIC CELL TRANSFORMATION.", "PM": "2006; FIBROBLAST GROWTH FACTOR RECEPTOR 3 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR & RECEPTOR PROTEIN-TYROSINE KINASES 1993-2005, & under RECEPTORS, ENDOGENOUS SUBSTANCES 1992", "HN": "2006(1992)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051498"}, {"RECTYPE": "D", "MH": "Receptor, Fibroblast Growth Factor, Type 4", "DS": "RECEPTOR FIBROBLAST GROWTH FACTOR TYPE 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fibroblast Growth Factor Receptor 4|T116|T126|T192|NON|EQV|NLM (2006)|FIBROBLAST GROWTH FACTOR RECEPTOR 004|abbbcdes", "ENTRY": "Receptor 4, Fibroblast Growth Factor|T116|T126|T192|NON|EQV|NLM (2006)|abbbcde", "MN": "D12.776.543.750.750.400.370.937", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "EC 2.7.10.1", "MS": "A fibroblast growth factor receptor that is mainly expressed in LUNG; KIDNEY; PANCREAS; and SPLEEN. It also plays an important role in SKELETAL MUSCLE development and can contribute to NEOPLASTIC CELL TRANSFORMATION.", "PM": "2006; FIBROBLAST GROWTH FACTOR RECEPTOR 4 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR 1993-2005, & under RECEPTORS, ENDOGENOUS SUBSTANCES 1992", "HN": "2006(1992)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051499"}, {"RECTYPE": "D", "MH": "Receptor, Fibroblast Growth Factor, Type 5", "DS": "RECEPTOR FIBROBLAST GROWTH FACTOR TYPE 005", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Fibroblast Growth Factor Receptor 5|T116|T192|NON|EQV|NLM (2006)|010620|FIBROBLAST GROWTH FACTOR RECEPTOR 005|abbcdefs", "ENTRY": "Receptor-Like Protein, FGF", "MN": "D12.776.543.750.750.400.370.968", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "The most divergent of the known fibroblast growth factor receptors. It does not contain an intracellular TYROSINE KINASE domain and has been shown to interact with FIBROBLAST GROWTH FACTOR 2. Fibroblast growth factor receptor 5 is found primarily in skeletal tissue.", "PM": "2006; FIBROBLAST GROWTH FACTOR RECEPTOR 5 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR 2001-2005", "HN": "2006(2001)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051500"}, {"RECTYPE": "D", "MH": "Hemospermia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hematospermia|T047|NON|EQV|NLM (2006)|050217|abcdef", "MN": "C12.200.294.293", "MH_TH": "NLM (2006)", "ST": "T047", "PI": "Semen (1966-2005)", "MS": "Blood in the SEMEN, usually due to INFLAMMATION of the PROSTATE, the SEMINAL VESICLES, or both.", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051516"}, {"RECTYPE": "D", "MH": "Digital Rectal Examination", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Rectal Palpations", "MN": "E01.370.600.600.500", "MH_TH": "NLM (2006)", "ST": "T060", "PI": "Rectum (1965-2005)", "MS": "A physical examination in which the qualified health care worker inserts a lubricated, gloved finger of one hand into the RECTUM and may use the other hand to press on the lower ABDOMEN or pelvic area to palpate for abnormalities in the lower rectum, and nearby organs or tissues. The method is commonly used to check the lower rectum, the PROSTATE gland in men, and the UTERUS and OVARIES in women.", "PM": "2006", "HN": "2006", "MR": "20050727", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051517"}, {"RECTYPE": "D", "MH": "Fibroblast Growth Factor 3", "DS": "FIBROBLAST GROWTH FACTOR A 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D23.529.624.130", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A fibroblast growth factor that is expressed primarily during development.", "PM": "2006; FIBROBLAST GROWTH FACTOR 3 was indexed under FIBROBLAST GROWTH FACTORS 2005, & under PROTO-ONCOGENE PROTEINS 1989-2004", "HN": "2006(1989)", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051518"}, {"RECTYPE": "D", "MH": "Fibroblast Growth Factor 4", "DS": "FIBROBLAST GROWTH FACTOR A 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "kfgf, Proto-Oncogene Protein", "MN": "D23.529.624.140", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A HEPARIN binding fibroblast growth factor that may play a role in LIMB BUDS development.", "PM": "2006; FIBROBLAST GROWTH FACTOR 4 was indexed under FIBROBLAST GROWTH FACTORS & PROTO-ONCOGENE PROTEINS 1991-2005, & under GROWTH SUBSTANCES 1990", "HN": "2006(1990)", "MR": "20070711", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051519"}, {"RECTYPE": "D", "MH": "Antiperspirants", "AQ": "AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO TU", "ENTRY": "Antiperspirant", "MN": "D27.720.269.189", "MH_TH": "NLM (2006)", "ST": "T120", "RN": "0", "PI": "Sweating (1965-2005)", "MS": "Agents that are put on the SKIN to reduce SWEATING or prevent excess sweating (HYPERHIDROSIS).", "PM": "2006", "HN": "2006", "MR": "20190501", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051520"}, {"RECTYPE": "D", "MH": "Fibroblast Growth Factor 5", "DS": "FIBROBLAST GROWTH FACTOR A 005", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D23.529.624.150", "MH_TH": "NLM (2006)", "ST": "T123", "N1": "Fibroblast Growth Factor 5", "RN": "129653-64-1", "MS": "A fibroblast growth factor that may play a role in regulation of HAIR FOLLICLE phenotype. Spontaneous mutation of the gene for this protein results in a strain of MICE with abnormally long hair, referred to as angora mice.", "PM": "2006; FIBROBLAST GROWTH FACTOR 5 was indexed under FIBROBLAST GROWTH FACTORS 1991-2005", "HN": "2006(1991)", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051521"}, {"RECTYPE": "D", "MH": "Fibroblast Growth Factor 6", "DS": "FIBROBLAST GROWTH FACTOR A 006", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Heparin Secretory Transforming Protein 2", "MN": "D23.529.624.160", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A fibroblast growth factor that was initially identified based on its sequence similarity to FIBROBLAST GROWTH FACTOR 4. It is found in MYOBLASTS and plays an important role in MUSCLE DEVELOPMENT.", "PM": "2006; FIBROBLAST GROWTH FACTOR 6 was indexed under FIBROBLAST GROWTH FACTORS & PROTO-ONCOGENE PROTEINS 1989-2005", "HN": "2006(1989)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051522"}, {"RECTYPE": "D", "MH": "Fibroblast Growth Factor 7", "DS": "FIBROBLAST GROWTH FACTOR A 007", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Palifermin|T116|T123|NON|NRW|NLM (2006)|041230|abbcdef", "MN": "D23.529.624.170", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "126469-10-1", "MS": "A fibroblast growth factor that is a specific mitogen for EPITHELIAL CELLS. It binds a complex of HEPARAN SULFATE and FIBROBLAST GROWTH FACTOR RECEPTOR 2B.", "PM": "2006; FIBROBLAST GROWTH FACTOR 7 was indexed under FIBROBLAST GROWTH FACTORS 2002-2005, & under GROWTH SUBSTANCES 1989-2001", "HN": "2006(1989)", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051523"}, {"RECTYPE": "D", "MH": "Fibroblast Growth Factor 8", "DS": "FIBROBLAST GROWTH FACTOR A 008", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Growth Factor, Androgen-Induced", "MN": "D23.529.624.180", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "148997-75-5", "MS": "A fibroblast growth factor that preferentially activates FIBROBLAST GROWTH FACTOR RECEPTOR 4. It was initially identified as an androgen-induced growth factor and plays a role in regulating growth of human BREAST NEOPLASMS and PROSTATIC NEOPLASMS.", "PM": "2006; FIBROBLAST GROWTH FACTOR 8 was indexed under FIBROBLAST GROWTH FACTORS 1999-2005, & under GROWTH SUBSTANCES 1992-1998, & under NEOPLASM PROTEINS 1992-1996", "HN": "2006(1992)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051524"}, {"RECTYPE": "D", "MH": "Fibroblast Growth Factor 9", "DS": "FIBROBLAST GROWTH FACTOR A 009", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glial Activating Factor|T116|T123|NON|EQV|NLM (2006)|abbcde", "MN": "D23.529.624.190", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A fibroblast growth factor that was originally identified as a mitogen for GLIAL CELLS. It is expressed primarily in NEURONS.", "PM": "2006; FIBROBLAST GROWTH FACTOR 9 was indexed under FIBROBLAST GROWTH FACTORS 2002-2005, & under GROWTH SUBSTANCES 1996-2001", "HN": "2006(1996)", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051525"}, {"RECTYPE": "D", "MH": "Fibroblast Growth Factor 10", "DS": "FIBROBLAST GROWTH FACTOR A 010", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Repifermin|T116|T123|NON|EQV|NLM (2006)|020813|abbcdef", "MN": "D23.529.624.200", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A fibroblast growth factor that is a mitogen for KERATINOCYTES. It activates FIBROBLAST GROWTH FACTOR RECEPTOR 2B and is involved in LUNG and limb development.", "PM": "2006; FIBROBLAST GROWTH FACTOR 10 was indexed under FIBROBLAST GROWTH FACTORS 1996-2005", "HN": "2006(1996)", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051526"}, {"RECTYPE": "D", "MH": "Odontogenic Tumor, Squamous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Squamous Odontogenic Tumor|T191|NON|EQV|NLM (2006)|050218|abcdef", "ENTRY": "Tumors, Squamous Odontogenic", "MN": "C04.557.695.607", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with probably JAW NEOPLASMS (IM) or specific precoordinated jaw/neoplasm term (IM)", "PI": "Odontogenic Tumors (1975-2005)", "MS": "A well-differentiated, benign, hamartomatous proliferation of odontogenic epithelium, probably arising from the rests of Malassez.", "PM": "2006; see AMELOBLASTOMA 1994-2005", "HN": "2006; use AMELOBLASTOMA 1994-2005", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051527"}, {"RECTYPE": "D", "MH": "Guanylate Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Guanylate Kinase|T116|T126|NON|EQV|NLM (2006)|abbcde", "ENTRY": "protein p55, Erythrocyte", "MN": "D08.811.913.696.650.450", "MH_TH": "NLM (2017)", "ST": "T126", "RN": "EC 2.7.4.8", "RR": "EC 2.7.4.8", "MS": "Catalyzes the ATP-dependent PHOSPHORYLATION of GMP to generate GDP and ADP.", "PM": "2006; NUCLEOSIDE-PHOSPHATE KINASE 1979-2005, & under NUCLEOTIDES & PHOSPHOTRANSFERASES, ATP 1974-1978", "HN": "2006(1980); use NUCLEOSIDE-PHOSPHATE KINASE 1979, & NUCLEOTIDES & PHOSPHOTRANSFERASES, ATP 1974-1978", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051528"}, {"RECTYPE": "D", "MH": "Hepatocyte Nuclear Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hepatocyte Nuclear Factor|T116|T123|NON|EQV|NLM (2021)|200526|abbcdef", "ENTRY": "Nuclear Factor, Hepatocyte", "MN": "D12.776.930.318", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "MS": "Hepatocyte nuclear factors are a family of evolutionarily conserved transcription factors that are preferentially expressed in HEPATOCYTES. They play important roles in liver-specific transcription and are critical for CELL DIFFERENTIATION and METABOLISM.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051536"}, {"RECTYPE": "D", "MH": "Hepatocyte Nuclear Factor 1", "DS": "HEPATOCYTE NUCLEAR FACTOR 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, HNF1", "MN": "D12.776.930.318.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "126548-29-6", "MS": "A transcription factor and homeodomain protein that regulates the expression of a large set of hepatic proteins including SERUM ALBUMIN; beta-fibrinogen; and ALPHA 1-ANTITRYPSIN. It is composed of hetero- or homo-dimers of HEPATOCYTE NUCLEAR FACTOR 1-ALPHA and HEPATOCYTE NUCLEAR FACTOR 1-BETA.", "PM": "2006; HEPATOCYTE NUCLEAR FACTOR 1 was indexed under DNA-BINDING PROTEINS & NUCLEAR PROTEINS & TRANSCRIPTION FACTORS 1989-2005", "HN": "2006(1989)", "MR": "20170630", "DA": "20050706", "DC": "1", "DX": "20060101", "UI": "D051537"}, {"RECTYPE": "D", "MH": "Hepatocyte Nuclear Factor 1-alpha", "DS": "HEPATOCYTE NUCLEAR FACTOR 001 ALPHA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Liver Specific Transcription Factor LF B1", "MN": "D12.776.930.318.500.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Hepatocyte nuclear factor 1-alpha is a transcription factor found in the LIVER; PANCREAS; and KIDNEY that regulates HOMEOSTASIS of GLUCOSE.", "PM": "2006; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA was indexed under DNA-BINDING PROTEINS & NUCLEAR PROTEINS & TRANSCRIPTION FACTORS 1989-2005", "HN": "2006(1989)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051538"}, {"RECTYPE": "D", "MH": "Hepatocyte Nuclear Factor 1-beta", "DS": "HEPATOCYTE NUCLEAR FACTOR 001 BETA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Liver Specific Transcription Factor LF B3", "MN": "D12.776.930.318.500.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "138674-15-4", "MS": "A hepatocyte nuclear factor that is closely related to HEPATOCYTE NUCLEAR FACTOR 1-ALPHA but is only weakly expressed in the LIVER. Mutations in hepatocyte nuclear factor 1-beta are associated with renal CYSTS and MATURITY-ONSET DIABETES MELLITUS type 5.", "PM": "2006; HEPATOCYTE NUCLEAR FACTOR 1-BETA was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1991-2005", "HN": "2006(1991)", "MR": "20170630", "DA": "20050706", "DC": "1", "DX": "20060101", "UI": "D051539"}, {"RECTYPE": "D", "MH": "Winged-Helix Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Winged Helix Transcription Factors", "MN": "D12.776.930.977", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A subfamily of HELIX-TURN-HELIX DNA-binding proteins that contain a variable length loop adjacent to the HTH motif. The loop connects two anti-parallel strands and forms a wing when bound to DNA.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051540"}, {"RECTYPE": "D", "MH": "Hepatocyte Nuclear Factor 3-alpha", "DS": "HEPATOCYTE NUCLEAR FACTOR 003 ALPHA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Forkhead Box A1 Protein|T116|T123|NON|EQV|NLM (2006)|050406|FORKHEAD BOX A 001 PROTEIN|abbcdefs", "ENTRY": "Transcription Factor, HNF-3A", "MN": "D12.776.930.977.249.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A forkhead transcription factor that is an essential activator of GLUCAGON gene expression.", "PM": "2006; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA was indexed under DNA-BINDING PROTEINS & NUCLEAR PROTEINS & TRANSCRIPTION FACTORS 1990-2005", "HN": "2006(1990)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051541"}, {"RECTYPE": "D", "MH": "Hepatocyte Nuclear Factor 3-beta", "DS": "HEPATOCYTE NUCLEAR FACTOR 003 BETA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Forkhead Box A2 Protein|T116|T123|NON|EQV|NLM (2006)|050406|FORKHEAD BOX A 002 PROTEIN|abbcdefs", "ENTRY": "Hepatocyte Nuclear Factor 3 beta", "MN": "D12.776.930.977.249.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "135845-92-0", "MS": "A forkhead transcription factor that regulates expression of metabolic GENES and is involved in EMBRYONIC DEVELOPMENT. Mutations in HNF-3beta have been associated with CONGENITAL HYPERINSULINISM.", "PM": "2006; HEPATOCYTE NUCLEAR FACTOR 3-BETA was indexed under DNA-BINDING PROTEINS & NUCLEAR PROTEINS & TRANSCRIPTION FACTORS 1991-2005", "HN": "2006(1991)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051542"}, {"RECTYPE": "D", "MH": "Hepatocyte Nuclear Factor 3-gamma", "DS": "HEPATOCYTE NUCLEAR FACTOR 003 GAMMA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Forkhead Box A3 Protein|T116|T123|NON|EQV|NLM (2006)|050406|FORKHEAD BOX A 003 PROTEIN|abbcdefs", "ENTRY": "Hepatocyte Nuclear Factor 3 gamma", "MN": "D12.776.930.977.249.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "135845-91-9", "MS": "A winged-helix transcription factor that regulates GENE expression in metabolic tissues. It plays a role in HOMEOSTASIS of GLUCOSE and controls expression of GLUT2 PROTEIN.", "PM": "2006; HEPATOCYTE NUCLEAR FACTOR 3-GAMMA was indexed under DNA-BINDING PROTINS & NUCLEAR PROTEINS & TRANSCRIPTION FACTORS 1991-2005", "HN": "2006(1991)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051543"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP3A", "DS": "CYTOCHROME P 450 CYP 003 A", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CYP3A|T116|T126|ACR|EQV|NLM (2006)|CYP 003 A|abbcdes", "ENTRY": "Taurochenodeoxycholate 6 alpha Monooxygenase", "MN": "D12.776.422.220.453.860.500", "EC": "antagonists & inhibitors:Cytochrome P-450 CYP3A Inhibitors", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.14.1", "RR": "EC 1.14.14.1", "MS": "A cytochrome P-450 suptype that has specificity for a broad variety of lipophilic compounds, including STEROIDS; FATTY ACIDS; and XENOBIOTICS. This enzyme has clinical significance due to its ability to metabolize a diverse array of clinically important drugs such as CYCLOSPORINE; VERAPAMIL; and MIDAZOLAM. This enzyme also catalyzes the N-demethylation of ERYTHROMYCIN.", "PM": "2006; CYTOCHROME P-450 CYP3A was indexed under ARYL HYDROCARBON HYDROXYLASES & OXIDOREDUCTASES, N-DEMETHYLATING 1980-2005", "HN": "2006(1980)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051544"}, {"RECTYPE": "D", "MH": "Cyclooxygenase 1", "DS": "CYCLOOXYGENASE 001", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Prostaglandin H Synthase-1|T116|T126|NON|EQV|NLM (2006)|991222|PROSTAGLANDIN H SYNTHASE 001|abbcdefs", "ENTRY": "Synthase, COX-1 Prostaglandin", "MN": "D08.811.600.720.500", "EC": "antagonists & inhibitors:Cyclooxygenase Inhibitors", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.99.1", "MS": "A constitutively-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes.", "PM": "2006; CYCLOOXYGENASE 1 was indexed under ISOENZYMES, & PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1996-2005", "HN": "2006(1996)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051545"}, {"RECTYPE": "D", "MH": "Cyclooxygenase 2", "DS": "CYCLOOXYGENASE 002", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthase, COX-2 Prostaglandin", "MN": "D08.811.600.720.750", "EC": "antagonists & inhibitors:Cyclooxygenase 2 Inhibitors", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.99.1", "MS": "An inducibly-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes and INFLAMMATION. It is the target of COX2 INHIBITORS.", "PM": "2006; CYCLOOXYGENASE 2 was indexed under ISOENZYMES, under PEROXIDASES & PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1996-2005", "HN": "2006(1996)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051546"}, {"RECTYPE": "D", "MH": "Heme Oxygenase-1", "DS": "HEME OXYGENASE 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oxygenase-1, Heme", "MN": "D08.811.682.690.708.410.500", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.14.18", "PI": "Heme Oxygenase (Decyclizing) (1997-2005)", "MS": "A ubiquitous stress-responsive enzyme that catalyzes the oxidative cleavage of HEME to yield IRON; CARBON MONOXIDE; and BILIVERDIN.", "PM": "2006; HEME OXYGENASE-1 was indexed under HEME OXYGENASE (DECYCLIZING) 1997-200", "HN": "2006(1997)", "MR": "20160601", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051547"}, {"RECTYPE": "D", "MH": "Histone Acetyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Acetyltransferases, Histone", "MN": "D08.811.913.050.134.415.500", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.1.48", "MS": "Enzymes that catalyze acyl group transfer from ACETYL-CoA to HISTONES forming CoA and acetyl-histones.", "PM": "2006; HISTONE ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1981-2005, HISTONES 1973-1980", "HN": "2006(1980) use HISTONES 1973-1979", "MR": "20151202", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051548"}, {"RECTYPE": "D", "MH": "Glutathione S-Transferase pi", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transferase P1-1, Glutathione", "MN": "D08.811.913.225.500.500", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.5.1.18", "RR": "EC 2.5.1.18", "MS": "A glutathione transferase that catalyzes the conjugation of electrophilic substrates to GLUTATHIONE. This enzyme has been shown to provide cellular protection against redox-mediated damage by FREE RADICALS.", "PM": "2006; GLUTATHIONE S-TRANSFERASE PI was indexed under GLUTATHIONE TRANSFERASE & ISOENZYMES 1997-2005", "HN": "2006(1997)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051549"}, {"RECTYPE": "D", "MH": "I-kappa B Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NK kappa B Activating Kinase NAK", "MN": "D12.776.476.563.494", "FX": "I-kappa B Proteins", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.11.10", "RR": "EC 2.7.11.10", "MS": "A protein serine-threonine kinase that catalyzes the PHOSPHORYLATION of I KAPPA B PROTEINS. This enzyme also activates the transcription factor NF-KAPPA B and is composed of alpha and beta catalytic subunits, which are protein kinases and gamma, a regulatory subunit.", "PM": "2006; I-KAPPA B KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES 1997-2005", "HN": "2006(1997)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051550"}, {"RECTYPE": "D", "MH": "beta-Adrenergic Receptor Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Adrenergic Receptor Kinase|T116|T126|NON|EQV|NLM (2006)|abbcde", "ENTRY": "beta Adrenergic Receptor Kinases", "MN": "D12.776.476.563.364.049", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.15", "MS": "G-protein-coupled receptor kinases that mediate agonist-dependent PHOSPHORYLATION and desensitization of BETA-ADRENERGIC RECEPTORS.", "PM": "2006; BETA-ADRENERGIC RECEPTOR KINASE was indexed PROTEIN KINASES 1987-1993, & CYCLIC AMP-DEPENDENT PROTEIN KINASES 1992-2005", "HN": "2006(1987)", "MR": "20210520", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051552"}, {"RECTYPE": "D", "MH": "Hyperbilirubinemia, Neonatal", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neonatal Hyperbilirubinemia|T047|NON|EQV|NLM (2006)|050222|abcdef", "ENTRY": "Neonatal Indirect Hyperbilirubinemia", "MN": "C23.550.429.249", "FX": "Jaundice, Neonatal", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "check the tag, INFANT, NEWBORN", "PI": "Jaundice, Neonatal (1965-2005)", "MS": "Accumulation of BILIRUBIN, a breakdown product of HEME PROTEINS, in the BLOOD during the first weeks of life. This may lead to NEONATAL JAUNDICE. The excess bilirubin may exist in the unconjugated (indirect) or the conjugated (direct) form. The condition may be self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) or pathological with toxic levels of bilirubin.", "PM": "2006; see JAUNDICE, NEONATAL 1976-2005", "HN": "2006; use JAUNDICE, NEONATAL 1976-2005", "MR": "20100625", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051556"}, {"RECTYPE": "D", "MH": "Hepatocyte Nuclear Factor 4", "DS": "HEPATOCYTE NUCLEAR FACTOR 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, HNF4", "MN": "D12.776.930.318.968", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A subfamily of nuclear receptors that regulate GENETIC TRANSCRIPTION of a diverse group of GENES involved in the synthesis of BLOOD COAGULATION FACTORS; and in GLUCOSE; CHOLESTEROL; and FATTY ACIDS metabolism.", "PM": "2006; HEPATOCYTE NUCLEAR FACTOR 4 was indexed under DNA-BINDING PROTEINS, PHOSPHOPROTEINS & TRANSCRIPTION FACTORS 1991-2005", "HN": "2006 (1991)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051557"}, {"RECTYPE": "D", "MH": "Onecut Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, Onecut", "MN": "D12.776.930.640", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of transcription factors that contain a single cut domain and a divergent homeodomain. They regulate gene networks by controlling the expression of other transcription factors and they play an important role in CELL DIFFERENTIATION and METABOLISM.", "PM": "2006", "HN": "2006", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051558"}, {"RECTYPE": "D", "MH": "Hepatocyte Nuclear Factor 6", "DS": "HEPATOCYTE NUCLEAR FACTOR 006", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, HNF6beta", "MN": "D12.776.930.640.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A onecut transcription factor that regulates expression of GENES involved in EMBRYONIC DEVELOPMENT of the PANCREAS and LIVER.", "PM": "2006; HEPATOCYTE NUCLEAR FACTOR 6 was indexed under TRANS-ACTIVATORS & HOMEODOMAIN PROTEINS 1996-2005", "HN": "2006(1996)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051559"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-bcl-6", "DS": "PROTO ONCOGENE PROTEINS C BCL 006", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-bcl-6 Proto-Oncogene Proteins|T116|T123|ABX|EQV|NLM (2006)|050421|C BCL PROTO ONCOGENE PROTEINS 06|abbcdefs", "ENTRY": "c-bcl-6, Proto-Oncogene Proteins", "MN": "D12.776.930.715", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A DNA-binding protein that contains an N-terminal BTB (POZ) DOMAIN and C-terminal CYS2-HIS2 ZINC FINGERS. It represses GENETIC TRANSCRIPTION of target genes by recruiting HISTONE DEACETYLASES. Aberrant Blc-6 expression is associated with certain types of human B-CELL LYMPHOMA.", "PM": "2006; PROTO-ONCOGENE PROTEIN C-BCL-6 was indexed under DNA-BINDING PROTEINS & PROTO-ONCOGENE PROTEINS & TRANSCRIPTION FACTORS 1993-2005", "HN": "2006(1993)", "MR": "20160415", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051560"}, {"RECTYPE": "D", "MH": "Complement C3 Convertase, Alternative Pathway", "DS": "COMPLEMENT C 03 CONVERTASE ALTERNATIVE PATHWAY", "AQ": "AD AE AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Complement 3b Associated Factor B fragment Bb", "MN": "D12.776.124.486.274.045.387.500.374", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "EC 3.4.21.47", "RR": "EC 3.4.21.47", "PI": "Esterases (1976-2005)", "MS": "A serine protease that is the complex of COMPLEMENT C3B and COMPLEMENT FACTOR BB. It cleaves multiple COMPLEMENT C3 into COMPLEMENT C3A (anaphylatoxin) and COMPLEMENT C3B in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY.", "PM": "2006; was indexed under COMPLEMENT 3B 1989-2005; for CVFBB see COMPLEMENT FACTOR B 1985-2005", "HN": "2006 (1989); for CVFBB use COMPLEMENT FACTOR B 1985-2005", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051561"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-bcr", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-bcr Proteins|T116|T126|ABX|EQV|NLM (2006)|050422|abbcdef", "ENTRY": "c-bcr, Proto-Oncogene Proteins", "MN": "D12.776.624.664.700.171", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A serine-threonine kinase that contains a C2 DOMAIN and PLECKSTRIN HOMOLOGY DOMAIN. It also has activity as a GTPASE-ACTIVATING PROTEIN for RAC1 PROTEIN and CDC42 PROTEIN. It functions as a negative regulator of CELL PROLIFERATION and NEOPLASTIC CELL TRANSFORMATION and is commonly fused with cellular abl protein to form BCR-ABL FUSION PROTEINS in PHILADELPHIA CHROMOSOME positive LEUKEMIA patients.", "PM": "2006; PROTO-ONCOGENE PROTEIN C-BCR was indexed under PROTEIN-TYROSINE KINASE & PROTO-ONCOGENE PROTEINS 1988-2005", "HN": "2006(1988)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051562"}, {"RECTYPE": "D", "MH": "Complement C5 Convertase, Alternative Pathway", "DS": "COMPLEMENT C 05 CONVERTASE ALTERNATIVE PATHWAY", "AQ": "AD AE AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "C5 Convertase, Alternative Pathway|T116|T126|T129|NON|EQV|NLM (2006)|050223|abbbcdef", "MN": "D12.776.124.486.274.045.387.500.750", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "EC 3.4.21.47", "PI": "Complement C5 (1976-2005)", "MS": "A serine protease that cleaves multiple COMPLEMENT C5 into COMPLEMENT C5A (anaphylatoxin) and COMPLEMENT C5B in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY. It is the complex of ALTERNATIVE PATHWAY C3 CONVERTASE (C3bBb) with an additional COMPLEMENT C3B, or C3bBb3b.", "PM": "2006", "HN": "2006", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051566"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-vav", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "vav Proto-Oncogene Protein|T116|T123|ABX|EQV|NLM (2006)|040528|abbcdef", "ENTRY": "vav1, Proto-Oncogene Protein", "MN": "D12.776.624.664.700.198", "FX": "src Homology Domains", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Proteins that are guanine nucleotide exchange factors for RHO GTPASES. They contain pleckstrin homology and SH2 domains, through which they function as signal transducing adaptor proteins.", "PM": "2006; PROTO-ONCOGENE PROTEIN C-VAV was indexed under PROTO-ONCOGENE PROTEINS & CELL CYCLE PROTEINS 2004-2005, & under ONCOGENE PROTEINS 1991-2004", "HN": "2006(1991)", "MR": "20230609", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051567"}, {"RECTYPE": "D", "MH": "Protein Kinase C-alpha", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PKC-alpha Serine-Threonine Kinase|T116|T126|ABX|EQV|NLM (2006)|050425|abbcdef", "ENTRY": "Serine-Threonine Kinase, PKC-alpha", "MN": "D12.776.476.563.725.100", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.11.13", "MS": "A cytoplasmic serine threonine kinase involved in regulating CELL DIFFERENTIATION and CELLULAR PROLIFERATION. Overexpression of this enzyme has been shown to promote PHOSPHORYLATION of BCL-2 PROTO-ONCOGENE PROTEINS and chemoresistance in human acute leukemia cells.", "PM": "2006; PROTEIN KINASE C ALPHA was indexed under PROTEIN KINASE C 2004-2006, & under ISOENZYMES 1999-2003", "HN": "2006(1999)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051571"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-hck", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "hck Proto-Oncogene Proteins|T116|T126|ABX|EQV|NLM (2006)|050421|abbcdef", "ENTRY": "hck Proto Oncogene Proteins", "MN": "D12.776.624.664.700.181", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "Members of the src-family tyrosine kinase family that are strongly expressed in MYELOID CELLS and B-LYMPHOCYTES.", "PM": "2006; PROTO-ONCOGENE PROTEIN C-HCK was indexed under PROTEIN-TYROSINE KINASE & PROTO-ONCOGENE PROTEINS 1991-2005", "HN": "2006(1991)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051572"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-pim-1", "DS": "PROTO ONCOGENE PROTEINS C PIM 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "pim-1 Proto-Oncogene Protein|T116|T126|ABX|EQV|NLM (2006)|abbcde", "ENTRY": "pim-1, Proto-Oncogene Protein", "MN": "D12.776.624.664.700.191", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "Serine-threonine protein kinases that relay signals from CYTOKINE RECEPTORS and are involved in control of CELL GROWTH PROCESSES; CELL DIFFERENTIATION; and APOPTOSIS.", "PM": "2006; PROTO-ONCOGENE PROTEIN C-PIM-1 was indexed under PROTO-ONCOGENE PROTEINS 1988-2005, & under PROTEIN-SERINE-THREONINE KINASES 1989-2005, & under PROTEIN-TYROSINE KINASE 1988", "HN": "2006(1988)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051573"}, {"RECTYPE": "D", "MH": "Complement C3 Convertase, Classical Pathway", "DS": "COMPLEMENT C 03 CONVERTASE CLASSICAL PATHWAY", "AQ": "AD AE AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "C3 Convertase, Classical", "MN": "D12.776.124.486.274.045.387.750.500", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "EC 3.4.21.43", "PI": "Complement Pathway, Classical (1980-2005)", "MS": "A serine protease that cleaves multiple COMPLEMENT 3 into COMPLEMENT 3A (anaphylatoxin) and COMPLEMENT 3B in the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It is a complex of COMPLEMENT 4B and COMPLEMENT 2A (C4b2a).", "PM": "2006", "HN": "2006", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051574"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-yes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "yes Proto-Oncogene Protein|T116|T126|NON|EQV|NLM (2006)|050422|abbcdef", "ENTRY": "yes, Proto-Oncogene Protein", "MN": "D12.776.624.664.700.199", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "Members of the src-family tyrosine kinases that are activated during the transition from G2 PHASE to M PHASE of the CELL CYCLE. It is highly homologous to PROTO-ONCOGENE PROTEIN PP60(C-SRC).", "PM": "2006; PROTO-ONCOGENE PROTEIN C-YES was indexed under SCR-FAMILY KINASES 2005, & under PROTO-ONCOGENE PROTEINS 1987-2005, & under PROTEIN-TYROSINE KINASE 1987-2004", "HN": "2006(1987)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051575"}, {"RECTYPE": "D", "MH": "Complement C5 Convertase, Classical Pathway", "DS": "COMPLEMENT C 05 CONVERTASE CLASSICAL PATHWAY", "AQ": "AD AE AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "C5 Convertase, Classical", "MN": "D12.776.124.486.274.045.387.750.750", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "EC 3.4.21.43", "PI": "Complement Pathway, Classical (1983-2005)", "MS": "A serine protease that cleaves multiple COMPLEMENT 5 into COMPLEMENT 5A (anaphylatoxin) and COMPLEMENT 5B in the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It is a complex of CLASSICAL PATHWAY C3 CONVERTASE (C4b2a) with an additional COMPLEMENT C3B, or C4b2a3b.", "PM": "2006", "HN": "2006", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051577"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-fes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "fps Proto-Oncogene Protein|T116|T126|ABX|EQV|NLM (2006)|050223|abbcdef", "ENTRY": "fps Proto Oncogene Protein", "MN": "D12.776.624.664.700.177", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "Proto-oncogene proteins fes are protein-tyrosine kinases with a central SH2 DOMAIN. It has been implicated in SIGNAL TRANSDUCTION PATHWAYS for CELL DIFFERENTIATION of a variety of cell types including MYELOID PROGENITOR CELLS. Fes proto-oncogene proteins also bind TUBULIN and promote MICROTUBULE assembly.", "PM": "2006; PROTO-ONCOGENE PROTEIN C-FES was indexed under PROTEIN-TYROSINE KINASE & PROTO-ONCOGENE PROTEINS 1986-2005", "HN": "2006(1986)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051578"}, {"RECTYPE": "D", "MH": "Neurogranin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "RC3 Protein (Neurogranin)|T116|T123|NON|EQV|NLM (2006)|050223|abbcdef", "MN": "D12.776.631.640", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "132654-77-4", "MS": "A BRAIN-specific substrate for PROTEIN KINASE C that binds CALMODULIN and is involved in regulation of CALCIUM SIGNALING.", "PM": "2006; NEUROGRANIN was indexed under CALMODULIN-BINDING PROTEINS & NERVE TISSUE PROTEINS 1991-2005", "HN": "2006(1991)", "MR": "20151124", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051579"}, {"RECTYPE": "D", "MH": "Neuronal Calcium-Sensor Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Neuronal Calcium Sensor Proteins", "MN": "D12.776.631.645", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of intracellular calcium-sensing proteins found predominately in NEURONS and PHOTORECEPTOR CELLS. They contain EF HAND MOTIFS and undergo conformational changes upon calcium-binding. Neuronal calcium-sensor proteins interact with other regulatory proteins to mediate physiological responses to a change in intracellular calcium concentration.", "PM": "2006", "HN": "2006", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051580"}, {"RECTYPE": "D", "MH": "Neurocalcin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Visinin Like Protein", "MN": "D12.776.631.645.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A neuronal calcium sensor protein that is expressed as several isoforms and can interact with ACTIN; TUBULIN; and CLATHRIN.", "PM": "2006; NEUROCALCIN was indexed under RECEPTORS, CALCIUM-SENSING 2004-2005, under NERVE TISSUE PROTEINS 1992-2005, & under CALCIUM-BINDING PROTEINS 1992-2003", "HN": "2006(1992)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051596"}, {"RECTYPE": "D", "MH": "Hippocalcin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Recoverin-Like Protein, P23k", "MN": "D12.776.631.645.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "149223-81-4", "MS": "A neuronal calcium-sensor protein that was initially found in the NEURONS of the HIPPOCAMPUS. It interacts with NEURONAL APOPTOSIS-INHIBITORY PROTEIN.", "PM": "2006; HIPPOCALCIN was indexed under CALCIUM-BINDING PROTEINS & NERVE TISSUE PROTEINS 1992-2005", "HN": "2006(1992)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051597"}, {"RECTYPE": "D", "MH": "Whole Body Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Whole Body Scanning|T060|NON|EQV|NLM (2006)|050223|abcdef", "ENTRY": "Whole Body Screenings", "MN": "E05.979", "MH_TH": "NLM (2006)", "ST": "T060", "MS": "The creation of a visual display of the inside of the entire body of a human or animal for the purposes of diagnostic evaluation. This is most commonly achieved by using MAGNETIC RESONANCE IMAGING; or POSITRON EMISSION TOMOGRAPHY.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051598"}, {"RECTYPE": "D", "MH": "Glucose-1-Phosphate Adenylyltransferase", "DS": "GLUCOSE PHOSPHATE ADENYLYLTRANSFERASE 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synthetase, ADPG", "MN": "D08.811.913.696.445.400", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.7.27", "RR": "9027-71-8 (CRN)", "MS": "An ATP-dependent enzyme that catalyzes the addition of ADP to alpha-D-glucose 1-phosphate to form ADP-glucose and diphosphate. The reaction is the rate-limiting reaction in prokaryotic GLYCOGEN and plant STARCH biosynthesis.", "PM": "2006; GLUCOSE-1-PHOSPHATE ADENYLYLTRANSFERASE was indexed under NUCLEOTIDYLTRANSFERASES 1976-2005, under GLUCOSEPHOSPHATES 1972-1975, under ADENINE NUCLEOTIDES 1970-1972, & under ATP 1972-1975", "HN": "2006(1980); use NUCLEOTIDYLTRANSFERASES 1976-1979, GLUCOSEPHOSPHATES 1972-1975, ADENINE NUCLEOTIDES 1970-1972, & ATP 1972-1975", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051599"}, {"RECTYPE": "D", "MH": "Recoverin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sensitivity Modulating Protein", "MN": "D12.776.631.645.750", "FX": "Paraneoplastic Syndromes, Ocular", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "135844-11-0", "MS": "A neuronal calcium-sensor protein that is found in ROD PHOTORECEPTORS and CONE PHOTORECEPTORS. It interacts with G-PROTEIN-COUPLED RECEPTOR KINASE 1 in a Ca2+ dependent manner and plays an important role in PHOTOTRANSDUCTION.", "PM": "2006; RECOVERIN was indexed under CALCIUM-BINDING PROTEINS, EYE PROTEINS & LIPOPROTEINS 1987-2005, & under ANTIGENS, NEOPLASM 1987-1993", "HN": "2006(1987)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051603"}, {"RECTYPE": "D", "MH": "Guanylate Cyclase-Activating Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Guanylyl Cyclase Activating Protein 3", "MN": "D12.776.631.645.124", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Neuronal calcium sensor proteins that regulate the activation of membrane-bound GUANYLATE CYCLASE. They are primarily expressed in the RETINA where they play an important role in PHOTOTRANSDUCTION.", "PM": "2006; GUANYLATE CYCLASE-ACTIVATING PROTEINS was indexed under CALCIUM-BINDING PROTEINS 1995-2005", "HN": "2006(1995)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051604"}, {"RECTYPE": "D", "MH": "Kv Channel-Interacting Proteins", "DS": "KV 000 CHANNEL INTERACTING PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Potassium Channel Interacting Proteins|T116|T123|NON|EQV|NLM (2006)|050224|abbcdef", "ENTRY": "Protein, KChIP4", "MN": "D12.776.631.645.374", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of neuronal calcium-sensor proteins that interact with and regulate potassium channels, type A.", "PM": "2006; KV CHANNEL-INTERACTING PROTEIN 1 & KV CHANNEL-INTERACTING PROTEIN 2 were indexed under CALCIUM-BINDING PROTEINS 2000-2005; KV CHANNEL-INTERACTING PROTEIN 3 was indexed under CALCIUM-BINDING PROTEINS & REPRESSOR PROTEINS 1998-2005; KV CHANNEL-INTERACTING PROTEIN 4 was indexed under POTASSIUM-CHANNELS, VOLTAGE-GATED 2005, & under POTASSIUM CHANNELS 2004", "HN": "2006(1998)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051605"}, {"RECTYPE": "D", "MH": "G-Protein-Coupled Receptor Kinase 1", "DS": "G PROTEIN COUPLED RECEPTOR KINASE 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Rhodopsin Kinase|T116|T126|NON|EQV|NLM (2006)|abbcde", "ENTRY": "Kinase, Rhodopsin", "MN": "D12.776.476.563.364.100", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.14", "MS": "A PROTEIN-SERINE-THREONINE KINASE that is found in PHOTORECEPTOR CELLS. It mediates light-dependent PHOSPHORYLATION of RHODOPSIN and plays an important role in PHOTOTRANSDUCTION.", "PM": "2006; see RHODOPSIN KINASE 2006-2007, G PROTEIN-COUPLED RECEPTOR KINASE 1 was indexed under EYE PROTEINS & PROTEIN KINASES 1983-2005, & under RHODOPSIN 1979-1982", "HN": "2008(2006)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051606"}, {"RECTYPE": "D", "MH": "CDP-Diacylglycerol-Inositol 3-Phosphatidyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphatidyltransferase, Inositol", "MN": "D08.811.913.696.900.074", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.8.11", "RR": "9027-01-4 (CRN)", "MS": "An enzyme that catalyzes the formation of PHOSPHATIDYLINOSITOL and CMP from CDP-DIACYLGLYCEROL and MYOINOSITOL.", "PM": "2006; CDP-DIACYLGLYCEROL-INOSITOL 3-PHOSPHATIDYLTRANSFERASE was indexed under TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS) 1970-2005, under PHOSPHOINOSITIDES 1970-1977, & under TRANSFERASES 1970-1972", "HN": "2006(1980); use PHOSPHOINOSITIDES 1970-1977, TRANSFERASES 1970-1972, & TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS) 1970-1979", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051607"}, {"RECTYPE": "D", "MH": "Neuronal Apoptosis-Inhibitory Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Neuronal Apoptosis Inhibitory Protein", "MN": "D12.776.631.642", "PA": "Caspase Inhibitors", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An inhibitor of apoptosis protein that was initially identified during analysis of CHROMOSOME DELETIONS associated with SPINAL MUSCULAR ATROPHY. Naip contains a nucleotide binding oligomerization domain and a carboxy-terminal LEUCINE rich repeat.", "PM": "2006; NEURONAL APOPTOSIS-INHIBITORY PROTEIN was indexed under NERVE TISSUE PROTEINS 1995-2005", "HN": "2006(1995)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051616"}, {"RECTYPE": "D", "MH": "X-Linked Inhibitor of Apoptosis Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "X Linked Inhibitor of Apoptosis Protein", "MN": "D12.776.476.075.437.750", "PA": "Caspase Inhibitors", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An inhibitor of apoptosis protein that is translated by a rare cap-independent mechanism. It blocks caspase-mediated cellular destruction by inhibiting CASPASE 3; CASPASE 7; and CASPASE 9.", "PM": "2006; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN was indexed under PROTEINS 1996-2005", "HN": "2006(1996)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051636"}, {"RECTYPE": "D", "MH": "Shaker Superfamily of Potassium Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Shaker Potassium Channels|T116|T123|NON|NRW|NLM (2006)|050301|abbcdef", "MN": "D12.776.543.585.400.750.900.624", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Voltage-gated potassium channels whose primary subunits contain six transmembrane segments and form tetramers to create a pore with a voltage sensor. They are related to their founding member, shaker protein, Drosophila.", "PM": "2006; SHAKER POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS 1994-2005", "HN": "2006(1994)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051637"}, {"RECTYPE": "D", "MH": "Ether-A-Go-Go Potassium Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Potassium Channels, Ether-A-Go-Go", "MN": "D12.776.543.585.400.750.900.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of voltage-gated potassium channels that are characterized by long N-terminal and C-terminal intracellular tails. They are named from the Drosophila protein whose mutation causes abnormal leg shaking under ether anesthesia. Their activation kinetics are dependent on extracellular MAGNESIUM and PROTON concentration.", "PM": "2006; ETHER-A-GO-GO POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS 1994-2005", "HN": "2006(1994)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051638"}, {"RECTYPE": "D", "MH": "Gardening", "AQ": "CL EC ED ES HI LJ MT OG SD SN ST TD", "MN": "J01.040.498.500", "MH_TH": "NLM (2006)", "ST": "T056", "MS": "Cultivation of PLANTS; (FRUIT; VEGETABLES; MEDICINAL HERBS) on small plots of ground or in containers.", "PM": "2006", "HN": "2006", "MR": "20190404", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051639"}, {"RECTYPE": "D", "MH": "Small-Conductance Calcium-Activated Potassium Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Small Conductance Calcium Activated Potassium Channels", "MN": "D12.776.543.585.400.750.150.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A major class of calcium-activated potassium channels that are found primarily in excitable CELLS. They play important roles in the transmission of ACTION POTENTIALS and generate a long-lasting hyperpolarization known as the slow afterhyperpolarization.", "PM": "2006; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2004, & under POTASSIUM CHANNELS 1996-2004", "HN": "2006(1996)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051640"}, {"RECTYPE": "D", "MH": "Histiocytoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Histiocytomas", "MN": "C04.557.450.565.590.425", "MH_TH": "NLM (1994)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "PI": "Dermatofibroma (1964-2005)", "MS": "A neoplasm containing HISTIOCYTES. Important forms include BENIGN FIBROUS HISTIOCYTOMA; and MALIGNANT FIBROUS HISTIOCYTOMA.", "PM": "2006; see DERMATOFIBROMA 1994-2005, see HISTIOCYTOMA 1968-1993", "HN": "2006, 1968-1993; use HISTIOCYTOMA, BENIGN FIBROUS 1994-2005", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051642"}, {"RECTYPE": "D", "MH": "KCNQ Potassium Channels", "DS": "KCNQ 000 POTASSIUM CHANNELS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Potassium Channels, KvLQT", "MN": "D12.776.543.585.400.750.900.124.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of delayed rectifier voltage-gated potassium channels that share homology with their founding member, KCNQ1 PROTEIN. KCNQ potassium channels have been implicated in a variety of diseases including LONG QT SYNDROME; DEAFNESS; and EPILEPSY.", "PM": "2006; KCNQ POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005 & under POTASSIUM CHANNELS 1996-2004", "HN": "2006(1996)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051656"}, {"RECTYPE": "D", "MH": "KCNQ1 Potassium Channel", "DS": "KCNQ 001 POTASSIUM CHANNEL", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Voltage Gated K+ Channel KCNQ1", "MN": "D12.776.543.585.400.750.900.124.249.500", "FX": "Jervell-Lange Nielsen Syndrome", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A voltage-gated potassium channel that is expressed primarily in the HEART.", "PM": "2006; KCNQ1 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, & under POTASSIUM CHANNELS 1996-2004", "HN": "2006(1996)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051657"}, {"RECTYPE": "D", "MH": "KCNQ2 Potassium Channel", "DS": "KCNQ 002 POTASSIUM CHANNEL", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Voltage Gated K+ Channel KCNQ2", "MN": "D12.776.543.585.400.750.900.124.249.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A very slow opening and closing voltage-gated potassium channel that is expressed in NEURONS and is commonly mutated in BENIGN FAMILIAL NEONATAL CONVULSIONS.", "PM": "2006; KCNQ2 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, & under POTASSIUM CHANNELS 1998-2004", "HN": "2006(1998)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051658"}, {"RECTYPE": "D", "MH": "KCNQ3 Potassium Channel", "DS": "KCNQ 003 POTASSIUM CHANNEL", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Voltage Gated K+ Channel KCNQ3", "MN": "D12.776.543.585.400.750.900.124.249.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A very slow opening and closing voltage-gated potassium channel that is expressed in NEURONS and is closely related to KCNQ2 POTASSIUM CHANNEL. It is commonly mutated in BENIGN FAMILIAL NEONATAL CONVULSIONS.", "PM": "2006; KCNQ3 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, & under POTASSIUM CHANNELS 1998-2004", "HN": "2006(1998)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051659"}, {"RECTYPE": "D", "MH": "Intermediate-Conductance Calcium-Activated Potassium Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Potassium Channels, Intermediate-Conductance Calcium-Activated|T116|T123|NON|EQV|NLM (2006)|050509|abbcdef", "ENTRY": "Potassium Channels, Intermediate Conductance Calcium Activated", "MN": "D12.776.543.585.400.750.150.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A major class of calcium-activated potassium channels that were originally discovered in ERYTHROCYTES. They are found primarily in non-excitable CELLS and set up electrical gradients for PASSIVE ION TRANSPORT.", "PM": "2006; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2005, & under POTASSIUM CHANNELS 1997-2004", "HN": "2006(1997)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051660"}, {"RECTYPE": "D", "MH": "Kv1.1 Potassium Channel", "DS": "KV 001 POTASSIUM CHANNEL 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Potassium Channel, Kv1.1", "MN": "D12.776.543.585.400.750.900.624.124", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "147173-20-4", "MS": "A delayed rectifier subtype of shaker potassium channels that is commonly mutated in human episodic ATAXIA and MYOKYMIA.", "PM": "2006; KV1.1 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, & under POTASSIUM CHANNELS 1995-2004", "HN": "2006(1995)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051662"}, {"RECTYPE": "D", "MH": "Kv1.2 Potassium Channel", "DS": "KV 001 POTASSIUM CHANNEL 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Potassium Channel, Kv1.2", "MN": "D12.776.543.585.400.750.900.624.186", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A delayed rectifier subtype of shaker potassium channels that is selectively inhibited by a variety of SCORPION VENOMS.", "PM": "2006; KV1.2 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, & under POTASSIUM CHANNELS 1995-2004", "HN": "2006(1995)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051663"}, {"RECTYPE": "D", "MH": "Kv1.3 Potassium Channel", "DS": "KV 001 POTASSIUM CHANNEL 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Potassium Channel, Kv1.3", "MN": "D12.776.543.585.400.750.900.624.217", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A delayed rectifier subtype of shaker potassium channels that is the predominant VOLTAGE-GATED POTASSIUM CHANNEL of T-LYMPHOCYTES.", "PM": "2006; KV1.3 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, & under POTASSIUM CHANNELS 1994-2004", "HN": "2006(1994)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051664"}, {"RECTYPE": "D", "MH": "Kv1.4 Potassium Channel", "DS": "KV 001 POTASSIUM CHANNEL 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Potassium Channel, Kv1.4", "MN": "D12.776.543.585.400.750.900.624.233", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A fast inactivating subtype of shaker potassium channels that contains two inactivation domains at its N terminus.", "PM": "2006; KV1.4 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, & under POTASSIUM CHANNELS 1995-2004", "HN": "2006(1995)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051665"}, {"RECTYPE": "D", "MH": "Kv1.5 Potassium Channel", "DS": "KV 001 POTASSIUM CHANNEL 005", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Potassium Channel, Kv1.5", "MN": "D12.776.543.585.400.750.900.624.241", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A delayed rectifier subtype of shaker potassium channels that conducts a delayed rectifier current. It contributes to ACTION POTENTIAL repolarization of MYOCYTES in HEART ATRIA.", "PM": "2006; KV1.5 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, & under POTASSIUM CHANNELS 1995-2004", "HN": "2006(1995)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051666"}, {"RECTYPE": "D", "MH": "Kv1.6 Potassium Channel", "DS": "KV 001 POTASSIUM CHANNEL 006", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Potassium Channel, RCK2", "MN": "D12.776.543.585.400.750.900.624.245", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A delayed rectifier subtype of shaker potassium channels that has been described in NEURONS and ASTROCYTES.", "PM": "2006; KV1.6 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2004-2005", "HN": "2006(2004)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051667"}, {"RECTYPE": "D", "MH": "Delayed Rectifier Potassium Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Delayed Rectifying Potassium Channels|T116|T123|NON|EQV|NLM (2006)|050302|abbcdef", "MN": "D12.776.543.585.400.750.900.124", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A group of slow opening and closing voltage-gated potassium channels. Because of their delayed activation kinetics they play an important role in controlling ACTION POTENTIAL duration.", "PM": "2006; DELAYED RECTIFIER POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, & under POTASSIUM CHANNELS 1994-2004", "HN": "2006(1994)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051668"}, {"RECTYPE": "D", "MH": "Shab Potassium Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Potassium Channels, Shab", "MN": "D12.776.543.585.400.750.900.624.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A subfamily of shaker potassium channels that shares homology with its founding member, Shab protein, Drosophila. They regulate delayed rectifier currents in the NERVOUS SYSTEM of DROSOPHILA and in the SKELETAL MUSCLE and HEART of VERTEBRATES.", "PM": "2006; SHAB POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005", "HN": "2006(2005)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051669"}, {"RECTYPE": "D", "MH": "Shaw Potassium Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Kv3.2 Potassium Channel|T116|T123|ABX|NRW|NLM (2006)|050302|KV 003 POTASSIUM CHANNEL 002|abbcdefs", "ENTRY": "Potassium Channels, Shaw", "MN": "D12.776.543.585.400.750.900.624.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A shaker subfamily that is prominently expressed in NEURONS and are necessary for high-frequency, repetitive firing of ACTION POTENTIALS.", "PM": "2006; SHAW POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, & under POTASSIUM CHANNELS 1994-2004", "HN": "2006(1994)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051670"}, {"RECTYPE": "D", "MH": "Shal Potassium Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Potassium Channels, Shal", "MN": "D12.776.543.585.400.750.900.624.625", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A shaker subfamily of potassium channels that participate in transient outward potassium currents by activating at subthreshold MEMBRANE POTENTIALS, inactivating rapidly, and recovering from inactivation quickly.", "PM": "2006; SHAL POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, & under POTASSIUM CHANNELS 1994-2004, & under INSECT HORMONES 1990-1993", "HN": "2006(1990)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051672"}, {"RECTYPE": "D", "MH": "G Protein-Coupled Inwardly-Rectifying Potassium Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Potassium Channels, Kir3", "MN": "D12.776.543.585.400.750.450.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of inwardly-rectifying potassium channels that are activated by PERTUSSIS TOXIN sensitive G-PROTEIN-COUPLED RECEPTORS. GIRK potassium channels are primarily activated by the complex of GTP-BINDING PROTEIN BETA SUBUNITS and GTP-BINDING PROTEIN GAMMA SUBUNITS.", "PM": "2006; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, INWARDLY RECTIFYING 2005, & under POTASSIUM CHANNELS 1995-2004, & under MEMBRANE PROTEINS 1993-1994; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNEL 1, G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNEL 2, G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNEL 3, & G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNEL 4 were indexed under POTASSIUM CHANNELS, INWARDLY RECTIFYING 2004-2005", "HN": "2006(1993)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051676"}, {"RECTYPE": "D", "MH": "Histiocytoma, Malignant Fibrous", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Malignant Fibrous Histiocytoma|T191|NON|EQV|NLM (2006)|ORD (2010)|050303|abcdeef", "ENTRY": "Tumors, Malignant Fibrohistiocytic", "MN": "C04.557.450.795.400", "MH_TH": "NLM (2006)", "ST": "T191", "AN": "do not confuse with MALIGNANT HISTIOCYTOSIS, a lymphoma; coordinate IM with precoordinated organ/neoplasm term (IM)", "PI": "Histiocytoma, Benign Fibrous (1972-2005)", "MS": "The most commonly diagnosed soft tissue sarcoma. It is a neoplasm with a fibrohistiocytic appearance found chiefly in later adult life, with peak incidence in the 7th decade.", "PM": "2006", "HN": "2006", "MR": "20100625", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051677"}, {"RECTYPE": "D", "MH": "Activating Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, ATF", "MN": "D12.776.930.127.061", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "MS": "Activating transcription factors were originally identified as DNA-BINDING PROTEINS that interact with early promoters from ADENOVIRUSES. They are a family of basic leucine zipper transcription factors that bind to the consensus site TGACGTCA of the cyclic AMP response element, and are closely related to CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN.", "PM": "2006", "HN": "2006", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051696"}, {"RECTYPE": "D", "MH": "Activating Transcription Factor 1", "DS": "ACTIVATING TRANSCRIPTION FACTOR 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, ATF1", "MN": "D12.776.930.127.061.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An activating transcription factor that regulates expression of a variety of genes including C-JUN GENES and TRANSFORMING GROWTH FACTOR BETA2.", "PM": "2006; ACTIVATING TRANSCRIPTION FACTOR 1 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1993-2005", "HN": "2006(1993)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051697"}, {"RECTYPE": "D", "MH": "Activating Transcription Factor 2", "DS": "ACTIVATING TRANSCRIPTION FACTOR 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, ATF2", "MN": "D12.776.930.127.061.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An activating transcription factor that regulates expression of a variety of GENES including C-JUN GENES; CYCLIN A; CYCLIN D1; and ACTIVATING TRANSCRIPTION FACTOR 3.", "PM": "2006; ACTIVATING TRANSCRIPTION FACTOR 2 was indexed under DNA-BINDING PROTEIN, CYCLIC-AMP RESPONSIVE & TRANSCRIPTION FACTORS 1993-2005", "HN": "2006(1993)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051698"}, {"RECTYPE": "D", "MH": "Cyclic AMP Response Element-Binding Protein A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CRE BPa Transcription Factor", "MN": "D12.776.930.127.186", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A basic leucine zipper transcription factor that is highly homologous to ACTIVATING TRANSCRIPTION FACTOR 2. It binds the consensus site TGACGTCA of the cyclic AMP response element in partnership with either PROTO-ONCOGENE PROTEINS C-JUN or activating transcription factor 2.", "PM": "2006; CYCLIC AMP RESPONSE ELEMENT BINDING PROTEIN A was indexed under DNA-BINDING PROTEIN, CYCLIC-AMP RESPONSIVE & TRANSCRIPTION FACTORS 1993-2005", "HN": "2006(1993)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051699"}, {"RECTYPE": "D", "MH": "Activating Transcription Factor 3", "DS": "ACTIVATING TRANSCRIPTION FACTOR 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, ATF3", "MN": "D12.776.930.127.061.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An activating transcription factor that plays a key role in cellular responses to GENOTOXIC STRESS and OXIDATIVE STRESS.", "PM": "2006; ACTIVATING TRANSCRIPTION FACTOR 3 was indexed under TRANSCRIPTION FACTORS 1994-2005", "HN": "2006(1994)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051700"}, {"RECTYPE": "D", "MH": "Activating Transcription Factor 4", "DS": "ACTIVATING TRANSCRIPTION FACTOR 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, ATF4", "MN": "D12.776.930.127.061.937", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "145891-90-3", "MS": "An activating transcription factor that regulates the expression of a variety of GENES involved in amino acid metabolism and transport. It also interacts with HTLV-I transactivator protein.", "PM": "2006; ACTIVATING TRANSCRIPTION FACTOR 4 was indexed under TRANSCRIPTION FACTORS 1991-2005", "HN": "2006(1991)", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051701"}, {"RECTYPE": "D", "MH": "Activating Transcription Factor 6", "DS": "ACTIVATING TRANSCRIPTION FACTOR 006", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, ATF6", "MN": "D12.776.930.127.061.968", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "One of the BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS that is synthesized as a membrane-bound protein in the ENDOPLASMIC RETICULUM. In response to endoplasmic reticulum stress it translocates to the GOLGI APPARATUS. It is activated by PROTEASES and then moves to the CELL NUCLEUS to regulate GENETIC TRANSCRIPTION of GENES involved in the unfolded protein response.", "PM": "2006; ACTIVATING TRANSCRIPTION FACTOR 6 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1997-2005", "HN": "2006(1997)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051702"}, {"RECTYPE": "D", "MH": "Sp Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Specificity Protein Transcription Factors|T116|T123|NON|EQV|NLM (2006)|050304|abbcdef", "ENTRY": "Transcription Factors, Sp", "MN": "D12.776.930.375.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of DNA-binding proteins that contain three ZINC FINGERS at their carboxy termini. They are transcription factors that have specificity for GC boxes.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051703"}, {"RECTYPE": "D", "MH": "Sp2 Transcription Factor", "DS": "SP A 02 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transcription Factor Sp2|T116|T123|ABX|EQV|NLM (2006)|TRANSCRIPTION FACTOR SP 002|abbcdes", "ENTRY": "Transcription Factor, Sp2", "MN": "D12.776.930.375.750.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "148710-93-4", "MS": "A ubiquitously expressed Sp transcription factor that binds to the consensus DNA sequence GGGCGGGAC.", "PM": "2006; SP2 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1992-2005", "HN": "2006(1992)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051704"}, {"RECTYPE": "D", "MH": "Sp3 Transcription Factor", "DS": "SP A 03 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transcription Factor Sp3|T116|T123|ABX|EQV|NLM (2006)|TRANSCRIPTION FACTOR SP 003|abbcdes", "ENTRY": "Specificity Protein 3 Transcription Factor|T116|T123|NON|EQV|NLM (2006)|050510|abbcdef", "MN": "D12.776.930.375.750.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "148710-94-5", "MS": "A specificity protein transcription factor that contains three C-terminal CYS2-HIS2 ZINC FINGERS. It regulates expression of a variety of genes including VASCULAR ENDOTHELIAL GROWTH FACTOR and CYCLIN-DEPENDENT KINASE INHIBITOR P27.", "PM": "2006; SP3 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1992-2005", "HN": "2006(1992)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051705"}, {"RECTYPE": "D", "MH": "Sp4 Transcription Factor", "DS": "SV 004 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transcription Factor Sp4|T116|T123|ABX|EQV|NLM (2006)|TRANSCRIPTION FACTOR SP 004|abbcdes", "ENTRY": "Specificity Protein 4 Transcription Factor|T116|T123|NON|EQV|NLM (2006)|050510|abbcdef", "MN": "D12.776.930.375.750.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A specificity protein transcription factor that is expressed primarily in the CENTRAL NERVOUS SYSTEM.", "PM": "2006; SP4 TRANSCRIPTION FACTOR was indexed under TRANSCRIPTION FACTORS 1996-2005", "HN": "2006(1996)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051706"}, {"RECTYPE": "D", "MH": "Replication Protein A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Replication Factor A Single-Stranded DNA-Binding Protein|T116|T123|ABX|EQV|NLM (2006)|050307|abbcdef", "ENTRY": "Single Strand Binding Protein RP A", "MN": "D12.776.260.700", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A single-stranded DNA-binding protein that is found in EUKARYOTIC CELLS. It is required for DNA REPLICATION; DNA REPAIR; and GENETIC RECOMBINATION.", "PM": "2006; see REPLICATION FACTOR A 2006, REPLICATION PROTEIN A was indexed under DNA-BINDING PROTEINS 1990-2005", "HN": "2006(1990)", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051716"}, {"RECTYPE": "D", "MH": "Fushi Tarazu Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Segmentation Protein Fushi Tarazu|T116|T123|NON|EQV|NLM (2006)|040604|abbcdef", "MN": "D12.776.930.312", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Fushi tarazu transcription factors were originally identified in DROSOPHILA. They are found throughout ARTHROPODS and play important roles in segmentation and CENTRAL NERVOUS SYSTEM development.", "PM": "2006; FUSHI TARAZU TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 2005", "HN": "2006(2005)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051717"}, {"RECTYPE": "D", "MH": "MutS Homolog 2 Protein", "DS": "MUTS HOMOLOG PROTEIN 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "HNPCC1 Protein|T116|T126|ABX|EQV|NLM (2018)|170207|abbcdef", "MN": "D12.776.624.664.700.130", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 3.6.1.3", "MS": "A highly conserved eukaryotic homolog of the MUTS DNA MISMATCH-BINDING PROTEIN. It plays an essential role in meiotic RECOMBINATION and DNA REPAIR of mismatched NUCLEOTIDES.", "PM": "2006; MUTS HOMOLOG 2 PROTEIN was indexed under DNA-BINDING PROTEINS & PROTO-ONCOGENE PROTEINS 1994-2005", "HN": "2006(1994)", "MR": "20170227", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051718"}, {"RECTYPE": "D", "MH": "MutS DNA Mismatch-Binding Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "MutS DNA Mismatch Binding Protein", "MN": "D12.776.260.556.500", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 3.6.1.3", "MS": "A methyl-directed mismatch DNA REPAIR protein that has weak ATPASE activity. MutS was originally described in ESCHERICHIA COLI.", "PM": "2006; MUTS DNA MISMATCH-BINDING PROTEIN was indexed under ADENOSINETRIPHOSPHATASE & DNA-BINDING PROTEINS 1991-2005, & under BACTERIAL PROTEINS 2005, & under ESCHERIA COLI PROTEINS 2002-2004", "HN": "2006(1991)", "MR": "20170227", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051719"}, {"RECTYPE": "D", "MH": "Upstream Stimulatory Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "USF, Helix-Loop-Helix Activator", "MN": "D12.776.930.125.937", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Ubiquitously expressed basic HELIX-LOOP-HELIX MOTIF transcription factors. They bind CANNTG sequences in the promoters of a variety of GENES involved in carbohydrate and lipid metabolism.", "PM": "2006; UPSTREAM STIMULATORY FACTORS was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1988-2005", "HN": "2006(1988)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051720"}, {"RECTYPE": "D", "MH": "Rad52 DNA Repair and Recombination Protein", "DS": "RAD 052 DNA REPAIR AND RECOMBINATION PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Rad52 Protein|T116|T123|ACX|EQV|NLM (2006)|abbcde", "MN": "D12.776.260.696", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A DNA-binding protein that mediates DNA REPAIR of double strand breaks, and HOMOLOGOUS RECOMBINATION.", "PM": "2006; RAD52 PROTEIN was indexed under DNA-BINDING PROTEINS 1993-2005, & under FUNGAL PROTEINS 1993-1998", "HN": "2006(1993)", "MR": "20110624", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051721"}, {"RECTYPE": "D", "MH": "ADAM Proteins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "A Disintegrin and Metalloprotease Protein|T116|T126|NON|EQV|NLM (2022)|200720|abbcdef", "ENTRY": "ADAM (A Disintegrin and Metalloprotease) Proteins|T116|T126|ACX|EQV|NLM (2006)|050307|abbcdef", "MN": "D12.776.395.033", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 3.4.24.-", "MS": "A family of membrane-anchored glycoproteins that contain a disintegrin and metalloprotease domain. They are responsible for the proteolytic cleavage of many transmembrane proteins and the release of their extracellular domain.", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051722"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Proteins c-mdm2", "DS": "PROTO ONCOGENE PROTEINS C MDM 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "c-mdm2 Proto-Oncogene Protein|T116|T126|ABX|EQV|NLM (2006)|050419|C MDM 002 PROTO ONCOGENE PROTEIN|abbcdefs", "ENTRY": "c-mdm2, Proto-Oncogene Proteins", "MN": "D12.776.660.764", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.2.27", "MS": "An E3 UBIQUITIN LIGASE that interacts with and inhibits TUMOR SUPPRESSOR PROTEIN P53. Its ability to ubiquitinate p53 is regulated by TUMOR SUPPRESSOR PROTEIN P14ARF.", "PM": "2006; PROTO-ONCOGENE PROTEINS C-MDM2 was indexed under PROTO-ONCOGENE PROTEINS 2005, & under NUCLEAR PROTEINS 1991-2005, & under NEOPLASM PROTEINS 1991-2004", "HN": "2006(1991)", "MR": "20160602", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051736"}, {"RECTYPE": "D", "MH": "Origin Recognition Complex", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Origin Recognition Complex, Subunit 6|T116|T123|NON|NRW|NLM (2006)|050308|abbcdef", "MN": "D12.776.260.640", "FX": "AAA Domain", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "The origin recognition complex is a multi-subunit DNA-binding protein that initiates DNA REPLICATION in eukaryotes.", "PM": "2006; ORIGIN RECOGNTION COMPLEX was indexed under DNA-BINDING PROTEINS 1997-2005, & under REPRESSOR PROTEINS 1993-1996, & under FUNGAL PROTEINS 1993-1995", "HN": "2006(1993)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051738"}, {"RECTYPE": "D", "MH": "Microphthalmia-Associated Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, Microphthalmia-Associated", "MN": "D12.776.930.127.092.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A basic helix-loop-helix leucine zipper transcription factor that regulates the CELL DIFFERENTIATION and development of a variety of cell types including MELANOCYTES; OSTEOCLASTS; and RETINAL PIGMENT EPITHELIUM. Mutations in MITF protein have been associated with OSTEOPETROSIS and WAARDENBURG SYNDROME.", "PM": "2006; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1993-2005", "HN": "2006(1993)", "MR": "20120703", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051739"}, {"RECTYPE": "D", "MH": "Ikaros Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, Ikaros", "MN": "D12.776.930.375.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "148971-36-2", "MS": "A transcription factor that plays a role as a key regulator of HEMATOPOIESIS. Aberrant Ikaros expression has been associated with LYMPHOBLASTIC LEUKEMIA.", "PM": "2006; IKAROS TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1992-2005", "HN": "2006(1992)", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051740"}, {"RECTYPE": "D", "MH": "Kruppel-Like Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Kruppel-Like Transcription Factor|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Transcription Factors, Kruppel-Like", "MN": "D12.776.930.375", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of zinc finger transcription factors that share homology with Kruppel protein, Drosophila. They contain a highly conserved seven amino acid spacer sequence in between their ZINC FINGER MOTIFS.", "PM": "2006; KRUPPEL-LIKE TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEINS & REPRESSOR PROTEINS & TRANSCRIPTION FACTORS 1993-2005, & under JUVENILE HORMONES 1989-1992", "HN": "2006(1989)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051741"}, {"RECTYPE": "D", "MH": "Transcription Factor CHOP", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Homologous Protein, C-EBP", "MN": "D12.776.930.127.124.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "147336-12-7", "RR": "147883-57-6 (GADD153 protein)", "MS": "A CCAAT-enhancer binding protein that is induced by DNA DAMAGE and growth arrest. It serves as a dominant negative inhibitor of other CCAAT-enhancer binding proteins.", "PM": "2006; TRANSCRIPTION FACTOR CHOP was indexed under TRANSCRIPTION FACTORS 1995-2005, under CCAAT-ENHANCER BINDING PROTEINS 2001-2005, under DNA-BINDING PROTEINS 1993-2000, & under PROTEINS 1992-1994", "HN": "2006(1992)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051742"}, {"RECTYPE": "D", "MH": "CCAAT-Enhancer-Binding Protein-delta", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Interleukin 6beta Nuclear Factor", "MN": "D12.776.930.127.124.812", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "142662-43-9", "MS": "A member of the C-EBP protein family of transcription factors. It plays a key role in G0 PHASE mammary EPITHELIAL CELL growth arrest, and it is involved in transcriptional regulation of INTERLEUKIN 1; INTERLEUKIN 6; and TUMOR NECROSIS FACTOR-ALPHA.", "PM": "2006; CCAAT-ENHANCER-BINDING PROTEIN-DELTA was indexed under TRANSCRIPTION FACTORS 1991-2005, under CCAAT-ENHANCER-BINDING PROTEINS 2001-2005, under DNA-BINDING PROTEINS & NUCLEAR PROTEINS 1991-2000", "HN": "2006(1991)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051743"}, {"RECTYPE": "D", "MH": "Protein Kinase C-epsilon", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "PKC epsilon Serine Threonine Kinase", "MN": "D12.776.476.563.725.750", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.11.13", "MS": "A protein kinase C subtype that was originally characterized as a CALCIUM-independent, serine-threonine kinase that is activated by PHORBOL ESTERS and DIACYLGLYCEROLS. It is targeted to specific cellular compartments in response to extracellular signals that activate G-PROTEIN-COUPLED RECEPTORS; TYROSINE KINASE RECEPTORS; and intracellular protein tyrosine kinase.", "PM": "2006; PROTEIN KINASE C EPSILON was indexed under PROTEIN KINASE C 1994-2005", "HN": "2006(1994)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051744"}, {"RECTYPE": "D", "MH": "Protein Kinase C-delta", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PKC-delta Serine-Threonine Kinase|T116|T126|ABX|EQV|NLM (2006)|050425|abbcdef", "ENTRY": "Serine-Threonine Kinase, PKC-delta", "MN": "D12.776.476.563.725.400", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.11.13", "MS": "A ubiquitously expressed protein kinase that is involved in a variety of cellular SIGNAL PATHWAYS. Its activity is regulated by a variety of signaling protein tyrosine kinase.", "PM": "2006; PROTEIN KINASE C-DELTA was indexed under PROTEIN KINASE C 2004-2006, & under ISOENZYMES 1993-2003", "HN": "2006(1993)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051745"}, {"RECTYPE": "D", "MH": "ZAP-70 Protein-Tyrosine Kinase", "DS": "ZAP 070 PROTEIN TYROSINE KINASE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "ZAP 70 Protein Tyrosine Kinase", "MN": "D12.776.476.568.900", "FX": "src Homology Domains", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "A protein tyrosine kinase that is required for T-CELL development and T-CELL ANTIGEN RECEPTOR function.", "PM": "2006; ZAP-70 KINASE was indexed under PROTEIN-TYROSINE KINASE 1992-2005", "HN": "2006(1992)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051746"}, {"RECTYPE": "D", "MH": "DNA-Activated Protein Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinase, DNA-Dependent", "MN": "D12.776.660.720.438", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A serine-threonine protein kinase that, when activated by DNA, phosphorylates several DNA-binding protein substrates including the TUMOR SUPPRESSOR PROTEIN P53 and a variety of TRANSCRIPTION FACTORS.", "PM": "2006; DNA-ACTIVATED PROTEIN KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES & DNA-BINDING PROTEINS 1993-2005", "HN": "2006(1993)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051747"}, {"RECTYPE": "D", "MH": "Leucine-Responsive Regulatory Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Leucine Responsive Regulatory Protein", "MN": "D12.776.930.386", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "138791-20-5", "MS": "A LEUCINE and DNA-binding protein that is found primarily in BACTERIA and ARCHAEA. It regulates GENETIC TRANSCRIPTION involved in METABOLISM of AMINO ACIDS in response to the increased concentration of LEUCINE.", "PM": "2006; LEUCINE-RESPONSIVE REGULATORY PROTEIN was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1991-2005, & under BACTERIAL PROTEINS 1991-2004", "HN": "2006(1991)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051756"}, {"RECTYPE": "D", "MH": "PAX5 Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "B-Cell-Specific Activator Protein|T116|T129|NON|EQV|NLM (2006)|abbcde", "ENTRY": "Transcription Factor, Pax5A", "MN": "D12.776.930.700.500", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A paired box transcription factor that is essential for CELL DIFFERENTIATION of B-LYMPHOCYTES. It functions both as a transcriptional activator and repressor to mediate B-cell commitment.", "PM": "2006; B-CELL-SPECIFIC ACTIVATOR PROTEIN was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 2002-2005, & under NUCLEAR PROTEINS 1992-2001", "HN": "2006(1992)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051757"}, {"RECTYPE": "D", "MH": "Transcription Factor TFIIH", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TFIIH Transcription Factor|T116|T123|ABX|EQV|NLM (2006)|050510|abbcdef", "ENTRY": "Transcription Factor, TFIIH", "MN": "D12.776.930.930.875.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "148710-81-0", "MS": "A general transcription factor that is involved in basal GENETIC TRANSCRIPTION and NUCLEOTIDE EXCISION REPAIR. It consists of nine subunits including ATP-DEPENDENT DNA HELICASES; CYCLIN H; and XERODERMA PIGMENTOSUM GROUP D PROTEIN.", "PM": "2006; TRANSCRIPTION FACTOR TFIIH was indexed under TRANSCRIPTION FACTORS, TFII 2003-2005, & under TRANSCRIPTION FACTORS 1992-2002", "HN": "2006(1992)", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051758"}, {"RECTYPE": "D", "MH": "Xeroderma Pigmentosum Group D Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Excision Repair Cross Complementing Rodent Repair Deficiency, Group 2 Protein", "MN": "D12.776.930.930.875.875.500", "FX": "Xeroderma Pigmentosum", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 3.6.4.12", "MS": "A DNA helicase that is a component of TRANSCRIPTION FACTOR TFIIH. It plays an essential role in NUCLEOTIDE EXCISION REPAIR, and mutations in this protein are associated with XERODERMA PIGMENTOSUM.", "PM": "2006; XERODERMA PIGMENTOSUM GROUP D PROTEIN was indexed under DNA HELICASES & DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1993-2005, & under PROTEINS 1992", "HN": "2006(1992)", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051759"}, {"RECTYPE": "D", "MH": "Xeroderma Pigmentosum Group A Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Xeroderma Pigmentosum A Protein", "MN": "D12.776.660.720.875", "EC": "deficiency:Xeroderma Pigmentosum", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A ZINC FINGER MOTIF protein that recognizes and interacts with damaged DNA. It is a DNA-binding protein that plays an essential role in NUCLEOTIDE EXCISION REPAIR. Mutations in this protein are associated with the most severe form of XERODERMA PIGMENTOSUM.", "PM": "2006; XERODERMA PIGMENTOSUM GROUP A PROTEIN was indexed under DNA-BINDING PROTEINS 1990-2005", "HN": "2006(1990)", "MR": "20170629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051760"}, {"RECTYPE": "D", "MH": "Paired Box Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pax Transcription Factor|T116|T123|NON|EQV|NLM (2022)|201005|abbcdef", "ENTRY": "Transcription Factors, Pax", "MN": "D12.776.930.700", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of transcription factors that control EMBRYONIC DEVELOPMENT within a variety of cell lineages. They are characterized by a highly conserved paired DNA-binding domain that was first identified in DROSOPHILA segmentation genes.", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051761"}, {"RECTYPE": "D", "MH": "PAX2 Transcription Factor", "DS": "PAX 002 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, PAX2", "MN": "D12.776.930.700.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A paired box transcription factor that is essential for ORGANOGENESIS of the CENTRAL NERVOUS SYSTEM and KIDNEY.", "PM": "2006; PAX2 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1992-2005", "HN": "2006(1992)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051762"}, {"RECTYPE": "D", "MH": "PAX7 Transcription Factor", "DS": "PAX 007 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, PAX7", "MN": "D12.776.930.700.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A paired box transcription factor that is involved in EMBRYONIC DEVELOPMENT of the CENTRAL NERVOUS SYSTEM and SKELETAL MUSCLE.", "PM": "2006; PAX7 TRANSCRIPTION FACTOR was indexed under HOMEODOMAIN PROTEINS 2001-2005, & under MUSCLE PROTEINS & NERVE TISSUE PROTEINS 1993-2000", "HN": "2006(1993)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051763"}, {"RECTYPE": "D", "MH": "PAX9 Transcription Factor", "DS": "PAX 009 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, PAX9", "MN": "D12.776.930.700.937", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A paired box transcription factor that is involved in ODONTOGENESIS.", "PM": "2006; PAX9 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1993-2005", "HN": "2006(1993)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051764"}, {"RECTYPE": "D", "MH": "Early Growth Response Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, EGR", "MN": "D12.776.930.213", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of transcription factors that are induced by GROWTH FACTORS and contain a highly conserved DNA-binding domain composed of three ZINC FINGER MOTIFS.", "PM": "2006", "HN": "2006", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051765"}, {"RECTYPE": "D", "MH": "Early Growth Response Protein 1", "DS": "EARLY GROWTH RESPONSE PROTEIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, EGR1", "MN": "D12.776.930.213.500", "FX": "CYS2-HIS2 Zinc Fingers", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An early growth response transcription factor and zinc finger protein that has been implicated in regulation of CELL PROLIFERATION and APOPTOSIS.", "PM": "2006; EARLY GROWTH RESPONSE PROTEIN 1 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS & IMMEDIATE-EARLY PROTEINS 1988-2005", "HN": "2006(1988)", "MR": "20160428", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051766"}, {"RECTYPE": "D", "MH": "Early Growth Response Protein 2", "DS": "EARLY GROWTH RESPONSE PROTEIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, Krox-20", "MN": "D12.776.930.213.750", "FX": "Charcot-Marie-Tooth Disease", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An early growth response transcription factor that controls the formation of the MYELIN SHEATH around peripheral AXONS by SCHWANN CELLS. Mutations in EGR2 transcription factor have been associated with HEREDITARY MOTOR AND SENSORY NEUROPATHIES such as CHARCOT-MARIE-TOOTH DISEASE.", "PM": "2006; EARLY GROWTH RESPONSE PROTEIN 2 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1988-2005", "HN": "2006(1988)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051767"}, {"RECTYPE": "D", "MH": "Early Growth Response Protein 3", "DS": "EARLY GROWTH RESPONSE PROTEIN 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, EGR3", "MN": "D12.776.930.213.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "144516-98-3", "MS": "An early growth response transcription factor that is essential for the development of MUSCLE SPINDLES.", "PM": "2006; EARLY GROWTH RESPONSE PROTEIN 3 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1991-2005", "HN": "2006(1991)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051776"}, {"RECTYPE": "D", "MH": "AraC Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "AraC Transcriptional Regulator|T116|T123|ABX|EQV|NLM (2006)|050408|abbcdef", "ENTRY": "Transcription Regulator, AraC", "MN": "D12.776.930.780.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A transcription factor found in BACTERIA that positively and negatively regulates the expression of proteins required for the uptake and catabolism of L-ARABINOSE.", "PM": "2006; ARAC TRANSCRIPTION REGULATOR was indexed under DNA-BINDING PROTEINS, REPRESSOR PROTEINS, & TRANSCRIPTION FACTORS 1980-2005", "HN": "2006(1980)", "MR": "20150622", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051777"}, {"RECTYPE": "D", "MH": "Basic Helix-Loop-Helix Leucine Zipper Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, BHLHLZ", "MN": "D12.776.930.127.092", "FX": "Leucine Zippers", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of transcription factors that contain regions rich in basic residues, LEUCINE ZIPPER domains, and HELIX-LOOP-HELIX MOTIFS.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051778"}, {"RECTYPE": "D", "MH": "Sterol Regulatory Element Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sterol Regulatory Element Binding Protein|T116|T123|NON|EQV|NLM (2021)|191122|abbcdef", "ENTRY": "Protein, SREBP", "MN": "D12.776.930.127.092.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Sterol regulatory element binding proteins are basic helix-loop-helix leucine zipper transcription factors that bind the sterol regulatory element TCACNCCAC. They are synthesized as precursors that are threaded into the MEMBRANES of the ENDOPLASMIC RETICULUM.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051779"}, {"RECTYPE": "D", "MH": "Sterol Regulatory Element Binding Protein 1", "DS": "STEROL REGULATORY ELEMENT BINDING PROTEIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SREBP 1c", "MN": "D12.776.930.127.092.750.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A sterol regulatory element binding protein that regulates expression of GENES involved in FATTY ACIDS metabolism and LIPOGENESIS. Two major isoforms of the protein exist due to ALTERNATIVE SPLICING.", "PM": "2006; STEROL REGULATORY ELEMENT BINDING PROTEIN 1 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1993-2005, & under CCAAT-ENHANCER-BINDING PROTEINS 2001-2005, & under NUCLEAR PROTEINS 1999-2000", "HN": "2006(1993)", "MR": "20090717", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051780"}, {"RECTYPE": "D", "MH": "Sterol Regulatory Element Binding Protein 2", "DS": "STEROL REGULATORY ELEMENT BINDING PROTEIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SRE 2 Binding Protein", "MN": "D12.776.930.127.092.750.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A sterol regulatory element binding protein that regulates GENES involved in CHOLESTEROL synthesis and uptake.", "PM": "2006; STEROL REGULATORY ELEMENT BINDING PROTEIN 2 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1994-2005", "HN": "2006(1994)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051782"}, {"RECTYPE": "D", "MH": "Methyl-CpG-Binding Protein 2", "DS": "METHYL CPG BINDING PROTEIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Methyl CpG Binding Protein 2", "MN": "D12.776.664.235.700", "FX": "Rett Syndrome", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A DNA-binding protein that interacts with methylated CPG ISLANDS. It plays a role in repressing GENETIC TRANSCRIPTION and is frequently mutated in RETT SYNDROME.", "PM": "2006; METHYL-CPG-BINDING PROTEIN 2 was indexed under CHROMOSOMAL PROTEINS, NON-HISTONE & DNA-BINDING PROTEINS & REPRESSOR PROTEINS 2005, & under TRANSCRIPTION FACTORS 1992-2004", "HN": "2006(1992)", "MR": "20151124", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051783"}, {"RECTYPE": "D", "MH": "Aryl Hydrocarbon Receptor Nuclear Translocator", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hypoxia-Inducible Factor 1, beta Subunit|T116|T123|NON|EQV|NLM (2006)|050311|HYPOXIA INDUCIBLE FACTOR 001 BETA SUBUNIT|abbcdefs", "ENTRY": "Nuclear Translocator, AhR", "MN": "D12.776.930.125.625.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "138391-32-9", "MS": "Aryl hydrocarbon receptor nuclear translocator is a basic HELIX-LOOP-HELIX MOTIF containing protein that forms a complex with DIOXIN RECEPTOR. The complex binds xenobiotic regulatory elements and activates transcription of a variety of genes including UDP GLUCURONOSYLTRANSFERASE. AhR nuclear translocator is also a subunit of HYPOXIA-INDUCIBLE FACTOR 1.", "PM": "2006; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS & RECEPTORS, ARYL HYDROCARBON 1995-2005, & under PROTEINS 1991-1994", "HN": "2006(1991)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051784"}, {"RECTYPE": "D", "MH": "Smad Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sma- and Mad-Related Proteins|T116|T123|ABX|EQV|NLM (2006)|050411|abbcdef", "MN": "D12.776.930.806", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "MS": "A family of proteins that are involved in the translocation of signals from TGF-BETA RECEPTORS; BONE MORPHOGENETIC PROTEIN RECEPTORS; and other surface receptors to the CELL NUCLEUS. They were originally identified as a class of proteins that are related to the mothers against decapentaplegic protein, Drosophila and sma proteins from CAENORHABDITIS ELEGANS.", "PM": "2006; SMAD PROTEINS was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 1996-2005", "HN": "2006(1996)", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051785"}, {"RECTYPE": "D", "MH": "Cyclic AMP Response Element Modulator", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "cAMP-Responsive Element Modulator|T116|T123|ABX|EQV|NLM (2006)|abbcde", "ENTRY": "cAMP Responsive Element Modulator", "MN": "D12.776.930.127.217", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "135844-64-3", "RR": "135844-66-5 (alpha isoform)", "MS": "Cyclic AMP response element modulator is a basic leucine zipper transcription factor that is regulated by CYCLIC AMP. It plays an important role in SPERMATID development in the mammalian TESTIS.", "PM": "2006; CYCLIC AMP RESPONSE ELEMENT MODULATOR was indexed under DNA-BINDING PROTEINS & REPRESSOR PROTEINS & TRANSCRIPTION FACTORS 1991-2005", "HN": "2006(1991)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051786"}, {"RECTYPE": "D", "MH": "Myogenic Regulatory Factor 5", "DS": "MYOGENIC REGULATORY FACTOR 005", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, Myf5", "MN": "D12.776.930.125.750.595", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A SKELETAL MUSCLE-specific transcription factor that contains a basic HELIX-LOOP-HELIX MOTIF. It plays an essential role in MUSCLE DEVELOPMENT.", "PM": "2006; MYOGENIC REGULATORY FACTOR 5 was indexed under DNA-BINDING PROTEINS & MUSCLE PROTEINS 1989-2005, TRANS-ACTIVATORS 2005, & under TRANSCRIPTION FACTORS 1989-2004", "HN": "2006(1989)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051787"}, {"RECTYPE": "D", "MH": "Myeloid-Lymphoid Leukemia Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proto-Oncogene Protein, MLL", "MN": "D12.776.930.483", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "149025-06-9", "MS": "Myeloid-lymphoid leukemia protein is a transcription factor that maintains high levels of HOMEOTIC GENE expression during development. The GENE for myeloid-lymphoid leukemia protein is commonly disrupted in LEUKEMIA and combines with over 40 partner genes to form FUSION ONCOGENE PROTEINS.", "PM": "2006; MYELOID-LYMPHOID LEUKEMIA PROTEIN was indexed under DNA-BINDING PROTEINS & PROTO-ONCOGENE PROTEINS & TRANSCRIPTION FACTORS 1992-2005", "HN": "2006(1992)", "MR": "20111212", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051788"}, {"RECTYPE": "D", "MH": "Proto-Oncogene Protein c-fli-1", "DS": "PROTO ONCOGENE PROTEIN C FLI 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "fli-1 Transcription Factor|T116|T123|ABX|EQV|NLM (2006)|050311|FLI 001 TRANSCRIPTION FACTOR|abbcdefs", "ENTRY": "fli 1 Transcription Factor", "MN": "D12.776.930.720.400", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A member of the c-ets family of transcription factors that is preferentially expressed in cells of hematopoietic lineages and vascular endothelial cells. It was originally identified as a protein that provides a retroviral integration site for integration of FRIEND MURINE LEUKEMIA VIRUS.", "PM": "2006; PROTO-ONCOGENE PROTEIN C-FLI-1 was indexed under DNA-BINDING PROTEINS & PROTO-ONCOGENE PROTEINS & TRANS-ACTIVATORS 1993-2005", "HN": "2006(1993)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051789"}, {"RECTYPE": "D", "MH": "G-Box Binding Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "GBF Transcription Factor|T116|T123|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Transcription Factors, GBF", "MN": "D12.776.930.313", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of transcription factors found primarily in PLANTS that bind to the G-box DNA sequence CACGTG or to a consensus sequence CANNTG.", "PM": "2006; G-BOX BINDING FACTORS was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1992-2005, & under REPRESSOR PROTEINS 1992-2004, & under PLANT PROTEINS 1992-1993", "HN": "2006(1992)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051790"}, {"RECTYPE": "D", "MH": "Basic Helix-Loop-Helix Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "bHLH Transcription Factor|T116|T123|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Transcription Factors, bHLH", "MN": "D12.776.930.125", "FX": "Helix-Loop-Helix Motifs", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of DNA-binding transcription factors that contain a basic HELIX-LOOP-HELIX MOTIF.", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051792"}, {"RECTYPE": "D", "MH": "Hypoxia-Inducible Factor 1", "DS": "HYPOXIA INDUCIBLE FACTOR 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hypoxia Inducible Factor 1", "MN": "D12.776.930.125.625", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A basic helix-loop-helix transcription factor that plays a role in APOPTOSIS. It is composed of two subunits: ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR and HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT.", "PM": "2006; HYPOXIA-INDUCIBLE FACTOR 1 was indexed under DNA-BINDING PROTEINS & NUCLEAR PROTEINS & TRANSCRIPTION FACTORS 1993-2005", "HN": "2006(1993)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051793"}, {"RECTYPE": "D", "MH": "Von Hippel-Lindau Tumor Suppressor Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Von Hippel Lindau Tumor Suppressor Protein", "MN": "D12.776.624.776.865", "EC": "deficiency:von Hippel-Lindau Disease", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.2.27", "MS": "A ubiquitin-protein ligase that mediates OXYGEN-dependent polyubiquitination of HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT. It is inactivated in VON HIPPEL-LINDAU SYNDROME.", "PM": "2006; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN was indexed under TUMOR SUPPRESSOR PROTEINS 2002-2005, under UBIQUITIN-PROTEIN LIGASES 2004-2005, under LIGASES 2002-3003, under PROTEINS 1995-2001, & under NUCLEAR PROTEINS 1995", "HN": "2006 (1995)", "MR": "20160602", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051794"}, {"RECTYPE": "D", "MH": "Hypoxia-Inducible Factor 1, alpha Subunit", "DS": "HYPOXIA INDUCIBLE FACTOR 001 ALPHA SUBUNIT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hypoxia Inducible Factor 1, alpha Subunit", "MN": "D12.776.930.125.625.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Hypoxia-inducible factor 1, alpha subunit is a basic helix-loop-helix transcription factor that is regulated by OXYGEN availability and is targeted for degradation by VHL TUMOR SUPPRESSOR PROTEIN.", "PM": "2006; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT was indexed under TRANSCRIPTION FACTORS 2001-2005", "HN": "2006(2001)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051795"}, {"RECTYPE": "D", "MH": "Inhibitor of Differentiation Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Inhibitor Of Differentiation Protein|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Differentiation Proteins Inhibitor", "MN": "D12.776.930.329", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Inhibitor of differentiation proteins are negative regulators of BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS. They inhibit CELL DIFFERENTIATION and induce CELL PROLIFERATION by modulating different CELL CYCLE regulators.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051796"}, {"RECTYPE": "D", "MH": "Inhibitor of Differentiation Protein 2", "DS": "INHIBITOR OF DIFFERENTIATION PROTEIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DNA Binding Protein Inhibitor ID 2", "MN": "D12.776.930.329.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A negative regulator of BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS. It plays a role in regulating IMMUNOGLOBULIN E expression.", "PM": "2006; INHIBITOR OF DIFFERENTIATION PROTEIN 2 was indexed under DNA-BINDING PROTEINS & REPRESSOR PROTEINS & TRANSCRIPTION FACTORS 1992-2005", "HN": "2006(1992)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051797"}, {"RECTYPE": "D", "MH": "Inhibitor of Differentiation Protein 1", "DS": "INHIBITOR OF DIFFERENTIATION PROTEIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DNA Binding Protein Inhibitor ID1", "MN": "D12.776.930.329.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A HELIX-LOOP-HELIX MOTIF-containing negative regulator of BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS that blocks activation of CYCLIN-DEPENDENT KINASE INHIBITOR P16 and is de-regulated in a variety of NEOPLASMS.", "PM": "2006; INHIBITOR OF DIFFERENTIATION PROTEIN 1 was indexed under REPRESSOR PROTEINS & TRANSCRIPTION FACTORS 1990-2005, & under DNA-BINDING PROTEINS 1990-1996", "HN": "2006(1990)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051798"}, {"RECTYPE": "D", "MH": "Delayed Graft Function", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Graft Function, Delayed", "MN": "C23.550.277", "FX": "Graft Survival", "MH_TH": "NLM (2006)", "ST": "T046", "PI": "Graft Survival (1984-2005)", "MS": "General dysfunction of an organ occurring immediately following its transplantation. The term most frequently refers to renal dysfunction following KIDNEY TRANSPLANTATION.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051799"}, {"RECTYPE": "D", "MH": "Tristetraprolin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "G0 G1 Switch Regulatory Protein 24", "MN": "D12.776.930.960", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A ZINC FINGER MOTIF containing transcription factor that was originally identified as one of the IMMEDIATE-EARLY PROTEINS. It shuttles between the CYTOPLASM and the CELL NUCLEUS and is involved in destabilization of mRNAs for TUMOR NECROSIS FACTOR-ALPHA.", "PM": "2006; TRISTETRAPROLIN was indexed under DNA-BINDING PROTEINS 2001-2005, & under IMMEDIATE-EARLY PROTEINS 1991-2005, & under PROTEINS 1998-2000", "HN": "2006(1991)", "MR": "20050721", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051816"}, {"RECTYPE": "D", "MH": "Butyrate Response Factor 1", "DS": "BUTYRATE RESPONSE FACTOR 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Early Response Factor Berg36|T116|T123|ABX|EQV|NLM (2006)|050314|abbcdef", "MN": "D12.776.664.962.061", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A ZINC FINGER MOTIF containing immediate early protein that is closely related to TRISTETRAPROLIN. It interacts with and helps destabilize VASCULAR ENDOTHELIAL GROWTH FACTOR mRNA.", "PM": "2006; BUTYRATE RESPONSE FACTOR 1 was indexed under DNA-BINDING PROTEINS 2001-2005, & under IMMEDIATE-EARLY PROTEINS 1991-2005, & under PROTEINS 1998-2000", "HN": "2006(1991)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051817"}, {"RECTYPE": "D", "MH": "Replication Protein C", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Replication Factor C|T116|T126|NON|EQV|NLM (2006)|abbcde", "ENTRY": "Replication Protein C, Subunit 5|T116|T123|NON|NRW|NLM (2007)|060123|abbcdef", "MN": "D12.776.260.702", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.6.4.-", "MS": "A DNA-binding protein and AAA ATPase that consists of 5 polypeptides and plays an essential role in DNA REPLICATION in eukaryotes. It binds DNA PRIMER-template junctions and recruits PROLIFERATING CELL NUCLEAR ANTIGEN and DNA POLYMERASES to the site of DNA synthesis.", "PM": "2006; see REPLICATION FACTOR C 2006, REPLICATION PROTEIN C was indexed under DNA-BINDING PROTEINS 1992-2005", "HN": "2006(1992)", "MR": "20170301", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051818"}, {"RECTYPE": "D", "MH": "Immunoglobulin J Recombination Signal Sequence-Binding Protein", "DE": "IG J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ig J Recombination Signal Sequence Binding Protein|T116|T123|NON|EQV|NLM (2020)|190301|abbcdef", "ENTRY": "RBP Jkappa Protein", "MN": "D12.776.930.327", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A ubiquitously expressed sequence-specific transcriptional repressor that is normally the target of signaling by NOTCH PROTEINS.", "PM": "2006; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN was indexed under DNA-BINDING PROTEINS & NUCLEAR PROTEINS 1992-2005", "HN": "2006(1992)", "MR": "20190705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051819"}, {"RECTYPE": "D", "MH": "TCF Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TCF Transcription Factor|T116|T123|NON|EQV|NLM (2021)|191122|abbcdef", "ENTRY": "Transcription Factors, TCF", "MN": "D12.776.930.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of DNA-binding proteins that are primarily expressed in T-LYMPHOCYTES. They interact with BETA CATENIN and serve as transcriptional activators and repressors in a variety of developmental processes.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051820"}, {"RECTYPE": "D", "MH": "Lymphoid Enhancer-Binding Factor 1", "DS": "LYMPHOID ENHANCER BINDING FACTOR 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, LEF-1", "MN": "D12.776.930.875.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A T-cell factor that plays an essential role in EMBRYONIC DEVELOPMENT.", "PM": "2006; LYMPHOID ENHANCER-BINDING FACTOR 1 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1995-2005, & under NUCLEAR PROTEINS 1991-1994", "HN": "2006(1991)", "MR": "20100625", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051821"}, {"RECTYPE": "D", "MH": "T Cell Transcription Factor 1", "DS": "T CELL TRANSCRIPTION FACTOR 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "T Cell Factor 1|T116|T123|NON|EQV|NLM (2006)|000905|T CELL FACTOR 001|abbcdefs", "ENTRY": "Transcription Factor, TCF-1", "MN": "D12.776.930.875.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A TCF transcription factor that was originally identified as a DNA-binding protein that interacts with the enhancers of T-CELL RECEPTOR ALPHA GENES. It plays a role in T-LYMPHOCYTE development.", "PM": "2006; T CELL FACTOR 1 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1995-2005, & under NUCLEAR PROTEINS 1991-1994", "HN": "2006(1991)", "MR": "20100625", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051822"}, {"RECTYPE": "D", "MH": "COUP Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, COUP", "MN": "D12.776.930.160", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A sub-family of steroid receptor-related orphan nuclear receptors that have specificity for a variety of DNA sequences related to AGGTCA. COUP transcription factors can heterodimerize with a variety of factors including RETINOIC ACID RECEPTORS; THYROID HORMONE RECEPTORS; and VITAMIN D RECEPTORS.", "PM": "2006; CHICKEN OVALBUMIN UPSTREAM PROMOTER-TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEINS & RECEPTORS, STEROID & TRANSCRIPTION FACTORS 1991-2005, & under REPRESSOR PROTEINS 1991-2004", "HN": "2006(1991)", "MR": "20150622", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051836"}, {"RECTYPE": "D", "MH": "COUP Transcription Factor II", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Chicken Ovalbumin Upstream Promoter Transcription Factor II", "MN": "D12.776.930.780.750", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A COUP transcription factor that negatively regulates GENETIC TRANSCRIPTION and competes with other hormone receptors for the common response element AGGTCA. It can also stimulate transcription of genes involved in the metabolism of GLUCOSE and CHOLESTEROL.", "PM": "2006; CHICKEN OVALBUMIN UPSTREAM PROMOTER-TRANSCRIPTION FACTOR II was indexed under DNA-BINDING PROTEINS & RECEPTORS, STEROID & TRANSCRIPTION FACTORS 1991-2005, & under REPRESSOR PROTEINS 1991-2004", "HN": "2006(1991)", "MR": "20150622", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051837"}, {"RECTYPE": "D", "MH": "COUP Transcription Factor I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chicken Ovalbumin Upstream Promoter-Transcription Factor I|T116|T192|NON|EQV|NLM (2006)|050314|abbcdef", "ENTRY": "Receptor NR2F1, Nuclear", "MN": "D12.776.826.209.039.249", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A COUP transcription factor that was originally identified as a homodimer that binds to a direct repeat regulatory element in the chicken albumin promoter. It is a transcription factor that plays an important role in EMBRYONIC DEVELOPMENT of the CENTRAL NERVOUS SYSTEM.", "PM": "2006; CHICKEN OVALBUMIN UPSTREAM PROMOTER-TRANSCRIPTION FACTOR I was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1989-2005", "HN": "2006(1989)", "MR": "20150622", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051838"}, {"RECTYPE": "D", "MH": "NFI Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, NFI", "MN": "D12.776.930.612", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Transcription factors that were originally identified as site-specific DNA-binding proteins essential for DNA REPLICATION by ADENOVIRUSES. They play important roles in MAMMARY GLAND function and development.", "PM": "2006; NFI TRANSCRIPTION FACTORS was indexed under TRANSCRIPTION FACTORS 1984-2005, under CCAAT-ENHANCER-BINDING PROTEINS 2005, & under DNA-BINDING PROTEINS 1986-2004", "HN": "2006(1984)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051839"}, {"RECTYPE": "D", "MH": "Y-Box-Binding Protein 1", "DS": "Y BOX BINDING PROTEIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Y Box Protein 1", "MN": "D12.776.930.127.124.937", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A CCAAT-enhancer-binding protein that was originally identified as interacting with Y-box PROMOTER REGIONS of MHC CLASS II GENES. It is a highly conserved transcription factor that regulates expression of a wide variety of GENES.", "PM": "2006; Y-BOX-BINDING PROTEIN 1 was indexed under TRANSCRIPTION FACTORS 1984-2005, under CCAAT-ENHANCER-BINDING PROTEINS 2005, & under DNA-BINDING PROTEINS 1986-2004", "HN": "2006(1984)", "MR": "20160415", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051840"}, {"RECTYPE": "D", "MH": "Transcription Factor RelB", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "v Rel Reticuloendotheliosis Viral Oncogene Homolog B", "MN": "D12.776.930.600.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "147337-75-5", "MS": "A transcription factor that takes part in the NF-kappa-B complex by interacting with NF-KAPPA B P50 SUBUNIT or NF-KAPPA B P52 SUBUNIT. It regulates GENETIC TRANSCRIPTION that is involved in immune and inflammatory responses.", "PM": "2006; TRANSCRIPTION FACTOR RELB was indexed under PROTO-ONCOGENE PROTEINS & TRANSCRIPTION FACTORS 1992-2005", "HN": "2006(1992)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051841"}, {"RECTYPE": "D", "MH": "Olfactory Marker Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.631.653", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A ubiquitous, cytoplasmic protein found in mature OLFACTORY RECEPTOR NEURONS of all VERTEBRATES. It is a modulator of the olfactory SIGNAL TRANSDUCTION PATHWAY.", "PM": "2006; OLFACTORY MARKER PROTEIN was indexed under NERVE TISSUE PROTEINS 1982-2005", "HN": "2006(1982)", "MR": "20190708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051842"}, {"RECTYPE": "D", "MH": "Synucleins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synuclein|T116|T123|NON|EQV|NLM (2006)|abbcde", "MN": "D12.776.631.860", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of homologous proteins of low MOLECULAR WEIGHT that are predominately expressed in the BRAIN and that have been implicated in a variety of human diseases. They were originally isolated from CHOLINERGIC FIBERS of TORPEDO.", "PM": "2006; SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005", "HN": "2006(1988)", "MR": "20151124", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051843"}, {"RECTYPE": "D", "MH": "alpha-Synuclein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Synuclein", "MN": "D12.776.705.500", "FX": "Synucleinopathies", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A synuclein that is a major component of LEWY BODIES and plays a role in SYNUCLEINOPATHIES, neurodegeneration and neuroprotection.", "PM": "2006; ALPHA-SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005", "HN": "2006(1988)", "MR": "20220712", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051844"}, {"RECTYPE": "D", "MH": "gamma-Synuclein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "gamma Synuclein", "MN": "D12.776.631.860.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A homolog of ALPHA-SYNUCLEIN that plays a role in neurofilament network integrity. It is overexpressed in a variety of human NEOPLASMS and may be involved in modulating AXON architecture during EMBRYONIC DEVELOPMENT and in the adult. Gamma-Synuclein may also activate SIGNAL TRANSDUCTION PATHWAYS associated with ETS-DOMAIN PROTEIN ELK-1.", "PM": "2006; GAMMA-SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005", "HN": "2006(1988)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051845"}, {"RECTYPE": "D", "MH": "beta-Synuclein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Synuclein", "MN": "D12.776.631.860.625", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A synuclein that is closely related to ALPHA-SYNUCLEIN. It may play a neuroprotective role against some of the toxic effects of aggregated ALPHA-SYNUCLEIN.", "PM": "2006; BETA-SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005", "HN": "2006(1988)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051846"}, {"RECTYPE": "D", "MH": "Lithostathine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pancreatic Stone Protein|T116|T123|NON|EQV|NLM (2006)|abbcde", "ENTRY": "Regenerating Islet Derived 1 beta Protein", "MN": "D12.776.503.280.578.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "The proteinaceous component of the pancreatic stone in patients with PANCREATITIS.", "PM": "2006; LITHOSTATHINE was indexed under CALCIUM-BINDING PROTEINS & NERVE TISSUE PROTEINS 1982-2005", "HN": "2006(1982)", "MR": "20170117", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051847"}, {"RECTYPE": "D", "MH": "Fanconi Anemia Complementation Group Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fanconi Anemia Proteins|T116|T123|EPO|EQV|NLM (2006)|050315|abbcdef", "ENTRY": "FANC Proteins|T116|T123|ACX|EQV|NLM (2006)|050426|abbcdef", "MN": "D12.776.313", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "MS": "A diverse group of proteins whose genetic MUTATIONS have been associated with the chromosomal instability syndrome FANCONI ANEMIA. Many of these proteins play important roles in protecting CELLS against OXIDATIVE STRESS.", "PM": "2006; FANCONI ANEMIA PROTEINS was indexed under DNA-BINDING PROTEINS & NUCLEAR PROTEINS & CELL CYCLE PROTEINS 1993-2005", "HN": "2006(1993)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051856"}, {"RECTYPE": "D", "MH": "Otx Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, Otx", "MN": "D12.776.930.650", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of VERTEBRATE homeodomain proteins that share homology with orthodenticle protein, Drosophila. They regulate GENETIC TRANSCRIPTION and play an important role in EMBRYONIC DEVELOPMENT of the BRAIN.", "PM": "2006; OTX TRANSCRIPTION FACTORS was indexed under HOMEODOMAIN PROTEINS 2000-2005", "HN": "2006(2000)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051857"}, {"RECTYPE": "D", "MH": "Forkhead Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Forkhead Transcription Factor|T116|T123|NON|EQV|NLM (2022)|200908|abbcdef", "ENTRY": "Transcription Factors, Fox", "MN": "D12.776.930.977.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A subclass of winged helix DNA-binding proteins that share homology with their founding member fork head protein, Drosophila.", "PM": "2006; FORKHEAD TRANSCRIPTION FACTORS was indexed under NUCLEAR PROTEINS & TRANSCRIPTION FACTORS 1989-2005", "HN": "2006(1989)", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051858"}, {"RECTYPE": "D", "MH": "Neuroendocrine Secretory Protein 7B2", "DS": "NEUROENDOCRINE SECRETORY PROTEIN 007 B 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "7B2, Pituitary Protein", "MN": "D12.776.631.615", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An acidic protein found in the NEUROENDOCRINE SYSTEM that functions as a molecular chaperone for PROPROTEIN CONVERTASE 2.", "PM": "2006; NEUROENDOCRINE SECRETORY PROTEIN 7B2 was indexed under NERVE TISSUE PROTEINS & PITUITARY HORMONES 1985-2005", "HN": "2006(1985)", "MR": "20151124", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051859"}, {"RECTYPE": "D", "MH": "Fragile X Mental Retardation Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fragile X Mental Retardation 1 Protein", "MN": "D12.776.664.962.124", "EC": "deficiency:Fragile X Syndrome", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "139135-51-6", "MS": "A RNA-binding protein that is found predominately in the CYTOPLASM. It helps regulate GENETIC TRANSLATION in NEURONS and is absent or under-expressed in FRAGILE X SYNDROME.", "PM": "2006; FRAGILE X MENTAL RETARDATION PROTEIN was indexed under NERVE TISSUE PROTEINS & RNA-BINDING PROTEINS 1991-2005", "HN": "2006(1991)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051860"}, {"RECTYPE": "D", "MH": "Kangai-1 Protein", "DS": "KANGAI 001 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antigens, CD82|T116|T129|ABX|EQV|NLM (2006)|050324|ANTIGENS CD 082|abbcdefs", "ENTRY": "Kangai 1 Protein", "MN": "D12.776.624.776.523", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A widely expressed transmembrane glycoprotein that functions as a METASTASIS suppressor protein. It is underexpressed in a variety of human NEOPLASMS.", "PM": "2018; see ANTIGENS, CD82 2012-2017 and KANGAI-1 PROTEIN 2006-2011; KANGAI-1 PROTEIN was indexed under MEMBRANE GLYCOPROTEINS and PROTO-ONCOGENE PROTEINS 1993-2005; under ANTIGENS, CD 2005; and under SURFACE ANTIGENS 1993-2004", "HN": "2018 (1993)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051861"}, {"RECTYPE": "D", "MH": "Host Cell Factor C1", "DS": "HOST CELL FACTOR C 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "HCFC1 Protein|T116|T123|ABX|EQV|NLM (2017)|160330|abbcdef", "MN": "D12.776.930.325", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A cellular transcriptional coactivator that contains N-terminal KELCH REPEATS and N- and C-terminal FIBRONECTIN TYPE III DOMAINS. It functions as a transcription factor for a number of genes and in the assembly of IMMEDIATE-EARLY PROTEINS of the HERPES SIMPLEX VIRUS.  Mutations in the HCFC1 gene are associated with cases of X-LINKED MENTAL RETARDATION.", "PM": "2006; HOST CELL FACTOR C1 was indexed under TRANSCRIPTION FACTORS 1995-2005", "HN": "2006(1995)", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051863"}, {"RECTYPE": "D", "MH": "Sex-Determining Region Y Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Testis Determining Factor", "MN": "D12.776.930.823.049", "FX": "Genes, sry", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "do not confuse entry term SRY SEX-DETERMINING REGION PROTEIN with SRY (SEX DETERMINING REGION Y)-BOX PROTEINS see SOX TRANSCRIPTION FACTORS", "MS": "A transcription factor that plays an essential role in the development of the TESTES. It is encoded by a gene on the Y chromosome and contains a specific HMG-BOX DOMAIN that is found within members of the SOX family of transcription factors.", "PM": "2006; SEX-DETERMINING REGION Y PROTEIN was indexed under DNA-BINDING PROTEINS & NUCLEAR PROTEINS & TRANSCRIPTION FACTORS 1990-2005", "HN": "2006(1990)", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051876"}, {"RECTYPE": "D", "MH": "RNA Polymerase Sigma 54", "DS": "RNA POLYMERASE SIGMA 054", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sigma Factor 54|T116|T123|NON|NRW|NLM (2006)|SIGMA FACTOR 054|abbcdes", "ENTRY": "Transcription Factor Sigma 54", "MN": "D12.776.097.698", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.7.6", "MS": "A DNA-directed RNA polymerase found in BACTERIA. It is a holoenzyme that consists of multiple subunits including sigma factor 54.", "PM": "2006; RNA POLYMERASE SIGMA 54 was indexed under DNA-BINDING PROTEINS & DNA-DIRECTED RNA POLYMERASES 1991-2005, & under SIGMA FACTOR 2005, & under BACTERIAL PROTEINS & TRANSCRIPTION FACTORS 1991-2004", "HN": "2006(1991)", "MR": "20160628", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051877"}, {"RECTYPE": "D", "MH": "Twist-Related Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Twist Transcription Factor|T116|T123|NON|EQV|NLM (2006)|050317|abbcdef", "ENTRY": "Twist Related Protein 1", "MN": "D12.776.930.125.906.250", "FX": "Acrocephalosyndactylia", "MH_TH": "NLM (2017)", "ST": "T123", "RN": "0", "MS": "A basic helix-loop-helix transcription factor that was originally identified in DROSOPHILA as essential for proper gastrulation and MESODERM formation. It plays an important role in EMBRYONIC DEVELOPMENT and CELL DIFFERENTIATION of MUSCLE CELLS, and is found in a wide variety of organisms.", "PM": "2017; see TWIST TRANSCRIPTION FACTOR 1990-2016; TWIST-RELATED PROTEIN 1  was indexed under NUCLEAR PROTEINS & TRANSCRIPTION FACTORS 1990-2005 and under BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS 2005-2016", "HN": "2017 (1990)", "MR": "20160415", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051879"}, {"RECTYPE": "D", "MH": "Receptors, Notch", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Notch Receptors|T116|T192|NON|EQV|NLM (2006)|040607|abbcdef", "ENTRY": "Receptor, Notch", "MN": "D12.776.930.770", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A family of conserved cell surface receptors that contain EPIDERMAL GROWTH FACTOR repeats in their extracellular domain and ANKYRIN REPEATS in their cytoplasmic domains. The cytoplasmic domains are released upon ligand binding and translocate to the CELL NUCLEUS, where they act as transcription factors.", "PM": "2006; RECEPTORS, NOTCH was indexed under MEMBRANE PROTEINS 1990-2005, & under INSECT HORMONES 1990-1995", "HN": "2006(1990)", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051880"}, {"RECTYPE": "D", "MH": "Receptor, Notch1", "DS": "RECEPTOR NOTCH 001", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Notch1 Receptor|T116|T192|NON|EQV|NLM (2006)|050316|NOTCH 001 RECEPTOR|abbcdefs", "ENTRY": "Notch1 Protein|T116|T192|NON|EQV|NLM (2006)|abbcde", "MN": "D12.776.930.770.500", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A notch receptor that interacts with a variety of ligands and regulates SIGNAL TRANSDUCTION PATHWAYS for multiple cellular processes. It is widely expressed during EMBRYOGENESIS and is essential for EMBRYONIC DEVELOPMENT.", "PM": "2006; RECEPTOR, NOTCH1 was indexed under TRANSCRIPTION FACTORS 1991-2005, under RECEPTORS, CELL SURFACE 2004-2005, & under MEMBRANE PROTEINS 1991-2003", "HN": "2006(1991)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051881"}, {"RECTYPE": "D", "MH": "Receptor, Notch2", "DS": "RECEPTOR NOTCH 002", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Notch2 Receptor|T116|T192|NON|EQV|NLM (2006)|050316|NOTCH 002 RECEPTOR|abbcdefs", "ENTRY": "Notch2 Protein|T116|T192|NON|EQV|NLM (2006)|abbcde", "MN": "D12.776.930.770.750", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A notch receptor that plays an important role in CELL DIFFERENTIATION in a variety of cell types. It is the preferentially expressed notch receptor in mature B-LYMPHOCYTES.", "PM": "2006; RECEPTOR, NOTCH2 was indexed under RECEPTORS, CELL SURFACE 1995-2005", "HN": "2006(1995)", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051883"}, {"RECTYPE": "D", "MH": "Smad Proteins, Receptor-Regulated", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Receptor-Regulated Smad Proteins|T116|T123|NON|EQV|NLM (2006)|050318|abbcdef", "ENTRY": "Smad Proteins, Receptor Regulated", "MN": "D12.776.930.806.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of smad proteins that undergo PHOSPHORYLATION by CELL SURFACE RECEPTORS in response to TRANSFORMING GROWTH FACTOR BETA; ACTIVIN; or BONE MORPHOGENETIC PROTEIN signaling.", "PM": "2006", "HN": "2006", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051896"}, {"RECTYPE": "D", "MH": "Smad Proteins, Inhibitory", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Inhibitory Smad Proteins|T116|T123|ABX|EQV|NLM (2006)|050318|abbcdef", "ENTRY": "I-Smad Proteins|T116|T123|ABX|EQV|NLM (2006)|050318|abbcdef", "MN": "D12.776.476.024.428.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A sub-family of smad proteins that inhibit cell signaling by RECEPTOR-REGULATED SMAD PROTEINS. They form autoinhibitory feedback loops in the TGF-BETA signaling pathway and mediate signaling cross-talk with other signaling pathways", "PM": "2006", "HN": "2006", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051897"}, {"RECTYPE": "D", "MH": "Smad1 Protein", "DS": "SMAD 001 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.930.806.500.100", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS. It regulates BONE MORPHOGENETIC PROTEIN signaling and plays an essential role in EMBRYONIC DEVELOPMENT.", "PM": "2006", "HN": "2006", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051898"}, {"RECTYPE": "D", "MH": "Smad2 Protein", "DS": "SMAD 002 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "MAD Related 2 Protein", "MN": "D12.776.930.806.500.200", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A receptor-regulated smad protein that undergoes PHOSPHORYLATION by ACTIVIN RECEPTORS, TYPE I. It regulates TRANSFORMING GROWTH FACTOR BETA and ACTIVIN signaling.", "PM": "2006; SMAD2 PROTEIN was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 1996-2005", "HN": "2006(1996)", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051899"}, {"RECTYPE": "D", "MH": "Smad3 Protein", "DS": "SMAD 003 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Madh3 Protein|T116|T123|ABX|EQV|NLM (2006)|050318|abbcdef", "MN": "D12.776.930.806.500.300", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A receptor-regulated smad protein that undergoes PHOSPHORYLATION by ACTIVIN RECEPTORS, TYPE I. Activated Smad3 can bind directly to DNA, and it regulates TRANSFORMING GROWTH FACTOR BETA and ACTIVIN signaling.", "PM": "2006; SMAD3 PROTEIN was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 1996-2005", "HN": "2006(1996)", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051900"}, {"RECTYPE": "D", "MH": "Smad4 Protein", "DS": "SMAD 004 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Smad, Common", "MN": "D12.776.930.806.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A signal transducing adaptor protein and tumor suppressor protein. It forms a complex with activated RECEPTOR-REGULATED SMAD PROTEINS. The complex then translocates to the CELL NUCLEUS and regulates GENETIC TRANSCRIPTION of target GENES.", "PM": "2006; SMAD4 PROTEIN was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 1997-2005, & under PROTEINS 1996", "HN": "2006(1996)", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051901"}, {"RECTYPE": "D", "MH": "Smad5 Protein", "DS": "SMAD 005 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dwarfin C", "MN": "D12.776.930.806.500.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS. It regulates BONE MORPHOGENETIC PROTEIN signaling and is essential for PHYSIOLOGICAL ANGIOGENESIS.", "PM": "2006; SMAD5 PROTEIN was indexed under DNA-BINDING PROTEINS & PHOSPHOPROTEINS & TRANS-ACTIVATORS 1996-2005", "HN": "2006(1996)", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051902"}, {"RECTYPE": "D", "MH": "Nuclear Factor 45 Protein", "DS": "NUCLEAR FACTOR PROTEIN 045", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Interleukin Enhancer Binding Factor 2|T116|T123|NON|EQV|NLM (2006)|INTERLEUKIN ENHANCER BINDING FACTOR 002|abbcdes", "ENTRY": "NF45 Protein|T116|T123|ABX|EQV|NLM (2006)|041214|abbcdef", "MN": "D12.776.930.616.500", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A protein subunit that takes part in forming nuclear factor 90 protein complexes.", "PM": "2006; NUCLEAR FACTOR 45 PROTEIN was indexed under TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; & DNA-BINDING PROTEINS 1993-2005", "HN": "2006(1993)", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051903"}, {"RECTYPE": "D", "MH": "Smad8 Protein", "DS": "SMAD 008 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Smad9 Protein|T116|T123|ABX|EQV|NLM (2006)|050318|abbcdef", "MN": "D12.776.930.806.500.800", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS and regulates BONE MORPHOGENETIC PROTEIN signaling.", "PM": "2006", "HN": "2006", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051904"}, {"RECTYPE": "D", "MH": "Smad6 Protein", "DS": "SMAD 006 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.930.806.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An inhibitory Smad protein that negatively regulates the SIGNAL TRANSDUCTION PATHWAYS from BONE MORPHOGENETIC PROTEIN RECEPTORS. Smad6 inhibits PHOSPHORYLATION of SMAD2 PROTEIN and SMAD3 PROTEIN.", "PM": "2006; SMAD6 PROTEIN was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 1997-2005", "HN": "2006(1997)", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051905"}, {"RECTYPE": "D", "MH": "Smad7 Protein", "DS": "SMAD 007 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Madh7 Protein|T116|T123|ABX|EQV|NLM (2006)|050318|abbcdef", "MN": "D12.776.476.024.428.249.700", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An inhibitory smad protein that associates with TRANSFORMING GROWTH FACTOR BETA RECEPTORS and BONE MORPHOGENETIC PROTEIN RECEPTORS. It negatively regulates SIGNAL TRANSDUCTION PATHWAYS by inhibiting PHOSPHORYLATION of RECEPTOR-REGULATED SMAD PROTEINS.", "PM": "2006; SMAD7 PROTEIN was indexed under DNA-BINDING PROTEINS & TRANS-ACTIVATORS 1997-2005", "HN": "2006(1997)", "MR": "20160218", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051906"}, {"RECTYPE": "D", "MH": "Lysosomal Membrane Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lysosome-Associated Membrane Protein|T116|T123|NON|REL|NLM (2021)|191120|abbcdef", "ENTRY": "Membrane Proteins, Lysosome-Associated", "MN": "D12.776.543.550.527", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Ubiquitously expressed integral membrane glycoproteins found in the LYSOSOME.", "PM": "2006; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS was indexed under ANTIGENS, CD 2003-2005, & under MEMBRANE GLYCOPROTEINS 1986-2002", "HN": "2006(1986)", "MR": "20230417", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051907"}, {"RECTYPE": "D", "MH": "Membrane Cofactor Protein", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD46 Antigens|T116|T129|T192|NON|EQV|NLM (2006)|050412|CD 046 ANTIGENS|abbbcdefs", "ENTRY": "Trophoblast Leukocyte Common Antigen", "MN": "D12.776.543.750.705.833.124", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A ubiquitously expressed complement receptor that binds COMPLEMENT C3B and COMPLEMENT C4B and serves as a co-factor for their inactivation by COMPLEMENT FACTOR I. It also interacts with a wide variety of pathogens and mediates the immune response.", "PM": "2018; see ANTIGENS, CD46 1987-2017; MEMBRANE COFACTOR PROTEIN was indexed under MEMBRANE GLYCOPROTEINS 1988-2005; under ANTIGENS, CD 1992-2005; under ANTIGENS, DIFFERENTIATION 1990-1991; and under MEMBRANE PROTEINS 1987", "HN": "2018 (1987)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051916"}, {"RECTYPE": "D", "MH": "Leukosialin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD43 Antigens|T116|T129|NON|EQV|NLM (2006)|050412|CD 043 ANTIGENS|abbcdefs", "ENTRY": "Sialoglycoprotein, Leukocyte", "MN": "D12.776.395.700.174", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A sialic acid-rich protein and an integral cell membrane mucin. It plays an important role in activation of T-LYMPHOCYTES.", "PM": "2018; see ANTIGENS, CD43 2006-2017; LEUKOSIALIN was indexed under SIALOGLYCOPROTEINS and ANTIGENS, CD 1984-2005", "HN": "2018 (1984)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051917"}, {"RECTYPE": "D", "MH": "Sialic Acid Binding Ig-like Lectin 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD22 Antigens|T116|T129|ABX|EQV|NLM (2006)|050412|CD 022 ANTIGENS|abbcdefs", "ENTRY": "Sialic Acid Binding Ig like Lectin 2", "MN": "D23.050.301.350.720", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2013)", "ST": "T129", "RN": "0", "MS": "A lectin and cell adhesion molecule found in B-LYMPHOCYTES. It interacts with SIALIC ACIDS and mediates signaling from B-CELL ANTIGEN RECEPTORS.", "PM": "2006; ANTIGENS, CD22 was indexed under ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE, under ANTIGENS, CD, under CELL ADHESION MOLECULES & under LECTINS 1988-2005", "HN": "2006(1988)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051918"}, {"RECTYPE": "D", "MH": "NK Cell Lectin-Like Receptor Subfamily D", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD94 Antigens|T116|T129|ABX|NRW|NLM (2006)|050509|CD 094 ANTIGENS|abbcdefs", "ENTRY": "NK Cell Lectin Like Receptor Subfamily D, Member 1", "MN": "D12.776.543.750.705.895.800.820", "MH_TH": "NLM (2009)", "ST": "T192", "RN": "0", "MS": "A subclass of NK cell lectin-like receptors that associates with a variety of members of NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C to form heterodimeric receptors for HLA-E antigen.", "PM": "2009; see ANTIGENS, CD94 2003-2008; ANTIGENS, CD94 was indexed under ANTIGENS, CD & LECTINS, C-TYPE 2003-2005, & under MEMBRANE GLYCOPROTEINS 1995-2002", "HN": "2009(1995)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051920"}, {"RECTYPE": "D", "MH": "Fos-Related Antigen-2", "DS": "FOS RELATED ANTIGEN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, Fra-2", "MN": "D12.776.930.127.311", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A basic-leucine zipper transcription factor that is closely related to C-FOS PROTEINS. It forms heterodimeric complexes with C-JUN PROTEINS to regulate GENE transcription.", "PM": "2006; FOS-RELATED ANTIGEN-2 was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1993-2005", "HN": "2006(1993)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051921"}, {"RECTYPE": "D", "MH": "PII Nitrogen Regulatory Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nitrogen Regulated Response Proteins", "MN": "D12.776.476.024.400", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of signal transducing adaptor proteins that control the METABOLISM of NITROGEN. They are primarily found in prokaryotes.", "PM": "2006; NITROGEN REGULATORY PROTEINS was indexed under BACTERIAL PROTEINS & DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS & TRANS-ACTIVATORS 1988-2005", "HN": "2006(1988)", "MR": "20160330", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051922"}, {"RECTYPE": "D", "MH": "CD79 Antigens", "DS": "CD 079 ANTIGENS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD79b Antigens|T116|T192|NON|NRW|NLM (2006)|050412|CD 079B ANTIGENS|abbcdefs", "ENTRY": "Immunoglobulin Associated Beta Protein", "MN": "D12.776.543.750.705.816.821.500", "PA": "Immunologic Factors", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "RR": "120300-00-7", "MS": "Components of the B-cell antigen receptor that function in B-cell antigen receptor heavy chain transport to the PLASMA MEMBRANE. They are expressed almost exclusively by B-LYMPHOCYTES and are markers for B-cell NEOPLASMS.", "PM": "2018; see ANTIGENS, CD79 2006-2017; CD79 ANTIGENS was indexed under RECEPTORS, ANTIGEN, B-CELL and ANTIGENS, CD 2003-2005; and under MEMBRANE GLYCOPROTEINS 1990-2002", "HN": "2018 (1990)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051925"}, {"RECTYPE": "D", "MH": "Basigin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD147 Antigens|T116|T129|NON|EQV|NLM (2006)|050509|CD 147 ANTIGENS|abbcdefs", "ENTRY": "Antigen, CD147", "MN": "D23.050.285.040", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "136894-56-9", "MS": "A widely distributed cell surface transmembrane glycoprotein characterized by extracellular IMMUNOGLOBULIN DOMAINS. It stimulates the synthesis of MATRIX METALLOPROTEINASES and is found at high levels on the surface of malignant NEOPLASMS where it may play a role as a mediator of malignant cell behavior.", "PM": "2018; see ANTIGENS, CD147 2006-2017; BASIGIN was indexed under ANTIGENS, CD 2005; under ANTIGENS, SURFACE and BLOOD PROTEINS 1990-2004; under MEMBRANE GLYCOPROTEINS 1993-2004; and under GLYCOPROTEINS 1990-1992", "HN": "2018 (1990)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051926"}, {"RECTYPE": "D", "MH": "CD24 Antigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD24 Antigens|T116|T129|NON|EQV|NLM (2006)|050412|CD 024 ANTIGENS|abbcdefs", "ENTRY": "Heat Stable Antigen CD24", "MN": "D23.050.301.350.098", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A GPI-linked cell adhesion protein originally identified as a heat stable antigen in mice. It mediates antigen-dependent activation and proliferation of B-CELLS. It is also involved in METASTASIS and is highly expressed in many NEOPLASMS.", "PM": "2018; see ANTIGENS, CD24 2006-2017; CD24 ANTIGEN was indexed under ANTIGENS, CD and MEMBRANE GLYCOPROTEINS 1992-2005; and under ANTIGENS, DIFFERENTIATION 1990-1991", "HN": "2018 (1990)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051927"}, {"RECTYPE": "D", "MH": "CD47 Antigen", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD47 Antigens|T116|T129|T192|NON|EQV|NLM (2006)|050412|CD 047 ANTIGENS|abbbcdefs", "ENTRY": "Integrin Associated Protein p50", "MN": "D12.776.543.550.147", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A ubiquitously expressed membrane glycoprotein. It interacts with a variety of INTEGRINS and mediates responses to EXTRACELLULAR MATRIX PROTEINS.", "PM": "2018; see ANTIGENS, CD47 2006-2017; CD47 ANTIGEN was indexed under ANTIGENS, CD 2005; and under CARRIER PROTEINS 1993-2004", "HN": "2018 (1993)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051928"}, {"RECTYPE": "D", "MH": "CD146 Antigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD146 Antigens|T116|T129|NON|EQV|NLM (2006)|050412|CD 146 ANTIGENS|abbcdefs", "ENTRY": "MUC18, Glycoprotein", "MN": "D23.050.301.350.150", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A cell adhesion molecule of the immunoglobulin superfamily that is expressed by ENDOTHELIAL CELLS where it functions to stabilize INTERCELLULAR JUNCTIONS. It is also highly expressed by melanoma tumor cells and may facilitate their METASTASIS.", "PM": "2018; see ANTIGENS, CD146 2006-2017; CD146 ANTIGEN was indexed under CD ANTIGENS and NEURAL CELL ADHESION MOLECULES 2005; under MEMBRANE GLYCOPROTEINS 1990-2004; and under NEOPLASM PROTEINS 1993-2002", "HN": "2018 (1990)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051929"}, {"RECTYPE": "D", "MH": "Endolyn", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD164 Antigens|T116|T129|NON|EQV|NLM (2006)|050509|CD 164 ANTIGENS|abbcdefs", "ENTRY": "Antigen, CD164", "MN": "D23.050.301.350.154", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A sialomucin protein that functions as a cell adhesion molecule. It is a negative regulator of certain types of HEMATOPOIETIC STEM CELLS.", "PM": "2018; see ANTIGENS, CD164 2006-2017; ENDOLYN was indexed under CD ANTIGENS and NEURAL CELL ADHESION MOLECULES 2005, under MEMBRANE GLYCOPROTEINS 1990-2004, and under NEOPLASM PROTEINS 1993-2002", "HN": "2018 (1990)", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051930"}, {"RECTYPE": "D", "MH": "Centromere Protein B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CENP B Protein", "MN": "D23.050.422.061", "FX": "Centromere", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A DNA-binding protein that interacts with a 17-base pair sequence known as the CENP-B box motif. The protein is localized constitutively to the CENTROMERE and plays an important role in its maintenance.", "PM": "2006; CENTROMERE PROTEIN B was indexed under AUTOANTIGENS & CHROMOSOMAL PROTEINS, NON-HISTONE & DNA-BINDING PROTEINS 1987-2005", "HN": "2006(1987)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051936"}, {"RECTYPE": "D", "MH": "Dopamine and cAMP-Regulated Phosphoprotein 32", "DS": "DOPAMINE AND CAMP REGULATED PHOSPHOPROTEIN 032", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Dopamine and cAMP Regulated Phosphoprotein 32", "MN": "D12.776.744.459", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A phosphoprotein that was initially identified as a major target of DOPAMINE activated ADENYLYL CYCLASE in the CORPUS STRIATUM. It regulates the activities of PROTEIN PHOSPHATASE-1 and PROTEIN KINASE A, and it is a key mediator of the biochemical, electrophysiological, transcriptional, and behavioral effects of DOPAMINE.", "PM": "2006; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN was indexed under NERVE TISSUE PROTEINS & PHOSPHOPROTEINS 1984-2005", "HN": "2006(1984)", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051937"}, {"RECTYPE": "D", "MH": "Munc18 Proteins", "DS": "MUNC 018 PROTEINS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sec1 Munc18 Protein Family", "MN": "D12.776.543.990.587", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A family of proteins involved in intracellular membrane trafficking. They interact with SYNTAXINS and play important roles in vesicular docking and fusion during EXOCYTOSIS. Their name derives from the fact that they are related to Unc-18 protein, C elegans.", "PM": "2006; MUNC18 PROTEINS was indexed under NERVE TISSUE PROTEINS & VESICULAR TRANSPORT PROTEINS 2005, & under MEMBRANE PROTEINS 1992-2004", "HN": "2006(1992)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051938"}, {"RECTYPE": "D", "MH": "Phytochrome B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phytochrome, PhyB", "MN": "D23.767.712.500", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "136250-22-1", "MS": "A plant photo regulatory protein that exists in two forms that are reversibly interconvertible by LIGHT. In response to light it moves to the CELL NUCLEUS and regulates transcription of target genes. Phytochrome B plays an important role in shade avoidance and mediates plant de-etiolation in red light.", "PM": "2006; PHYTOCHROME B was indexed under PHOTORECEPTORS & PHYTOCHROME & TRANSCRIPTION FACTORS 1991-2005, & under PLANT PROTEINS 1991-2004", "HN": "2006(1991)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051939"}, {"RECTYPE": "D", "MH": "B7-2 Antigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD86 Antigens|T116|T129|ABX|EQV|NLM (2006)|050412|CD 086 ANTIGENS|abbcdefs", "ENTRY": "Costimulatory Molecule, B70", "MN": "D23.529.168.200", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A costimulatory ligand glycoprotein that contains a C2 and V-type IMMUNOGLOBULIN DOMAIN. It is expressed by ANTIGEN-PRESENTING CELLS and binds to CD28 ANTIGEN with high specificity and to CTLA-4 ANTIGEN with low specificity. The interaction of CD86 with CD28 ANTIGEN provides a stimulatory signal to T-LYMPHOCYTES, while its interaction with CTLA-4 ANTIGEN may play a role in inducing PERIPHERAL TOLERANCE.", "PM": "2018; see ANTIGENS, CD86 2006-2017; B7-2 ANTIGEN was indexed under MEMBRANE GLYCOPROTEINS and ANTIGENS, CD 1996-2005; and under B-CELL ACTIVATION ANTIGEN 1993-1995", "HN": "2018 (1993)", "MR": "20200327", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051940"}, {"RECTYPE": "D", "MH": "fms-Like Tyrosine Kinase 3", "DS": "FMS LIKE TYROSINE KINASE 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD135 Antigens|T116|T126|T192|NON|EQV|NLM (2006)|050616|CD 135 ANTIGENS|abbbcdefs", "ENTRY": "fms Like Tyrosine Kinase 3", "MN": "D12.776.624.664.700.114", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "EC 2.7.10.1", "MS": "A receptor tyrosine kinase that is involved in HEMATOPOIESIS. It is closely related to FMS PROTO-ONCOGENE PROTEIN and is commonly mutated in acute MYELOID LEUKEMIA.", "PM": "2006; FMS-LIKE TYROSINE KINASE 3 was indexed under PROTO-ONCOGENE PROTEINS 1999-2005, & under RECEPTOR PROTEIN-TYROSINE KINASES 2005, & under PROTEIN-TYROSINE KINASE & RECEPTORS, CELL SURFACE 1999-2004", "HN": "2006(1999)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051941"}, {"RECTYPE": "D", "MH": "Phytochrome A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phytochrome, PhyA", "MN": "D23.767.712.249", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "The primary plant photoreceptor responsible for perceiving and mediating responses to far-red light. It is a PROTEIN-SERINE-THREONINE KINASE that is translocated to the CELL NUCLEUS in response to light signals.", "PM": "2006; PHYTOCHROME A was indexed under PHYTOCHROME 1994-2005, & under PROTEIN-SERINE-THREONINE KINASES 2005", "HN": "2006(1994)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051942"}, {"RECTYPE": "D", "MH": "Antennapedia Homeodomain Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Antennapedia Protein|T116|T123|NON|EQV|NLM (2006)|050322|abbcdef", "MN": "D12.776.930.120", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Antennapedia homeodomain protein is a homeobox protein involved in limb patterning in ARTHROPODS. Mutations in the gene for the antennapedia homeodomain protein are associated with the conversion of antenna to leg or leg to antenna DROSOPHILA.", "PM": "2006; ANTENNAPEDIA HOMEODOMAIN PROTEIN was indexed under NUCLEAR PROTEINS & TRANSCRIPTION FACTORS 1990-2005, under HOMEODOMAIN PROTEINS 1997-2005, & under DNA-BINDING PROTEINS 1990-1996", "HN": "2006(1990)", "MR": "20050708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051943"}, {"RECTYPE": "D", "MH": "Goosecoid Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, Goosecoid", "MN": "D12.776.930.315", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Goosecoid protein is a homeodomain protein that was first identified in XENOPUS. It is found in the SPEMANN ORGANIZER of VERTEBRATES and plays an important role in neuronal CELL DIFFERENTIATION and ORGANOGENESIS.", "PM": "2006; GOOSECOID PROTEIN was indexed under REPRESSOR PROTEINS & TRANSCRIPTION FACTORS 1992-2005, & under HOMEODOMAIN PROTEINS 2005, & under DNA-BINDING PROTEINS 1992-2004", "HN": "2006(1992)", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051956"}, {"RECTYPE": "D", "MH": "MSX1 Transcription Factor", "DS": "MSX 001 TRANSCRIPTION FACTOR", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, MSX1", "MN": "D12.776.930.440", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A homeodomain protein that interacts with TATA-BOX BINDING PROTEIN. It represses GENETIC TRANSCRIPTION of target GENES and plays a critical role in ODONTOGENESIS.", "PM": "2006; MSX1 TRANSCRIPTION FACTOR was indexed under TRANSCRIPTION FACTORS 1993-2005, & under HOMEODOMAIN PROTEINS 2005, & under REPRESSOR PROTEINS 1993-2004 & DNA-BINDING PROTEINS 1993-1994", "HN": "2006(1993)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051957"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Coactivator 2", "DS": "NUCLEAR RECEPTOR COACTIVATOR 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Steroid Receptor Coactivator 2", "MN": "D12.776.930.617.200", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A transcription factor that partners with ligand bound GLUCOCORTICOID RECEPTORS and ESTROGEN RECEPTORS to stimulate GENETIC TRANSCRIPTION. It plays an important role in FERTILITY as well as in METABOLISM of LIPIDS.", "PM": "2006; NUCLEAR RECEPTOR COACTIVATOR 2 was indexed under TRANSCRIPTION FACTORS 1996-2005", "HN": "2006(1996)", "MR": "20160330", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051958"}, {"RECTYPE": "D", "MH": "ELAV Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hu Paraneoplastic Encephalomyelitis Antigens|T116|T129|NON|EQV|NLM (2006)|050323|abbcdef", "ENTRY": "Proteins, ELAV", "MN": "D12.776.664.962.813.500", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "A family of RRM PROTEINS that are homologues of ELAV protein, Drosophila. They were initially identified in humans as the targets of autoantibodies in patients with PARANEOPLASTIC ENCEPHALOMYELITIS. They regulate GENE EXPRESSION at the post-transcriptional level.", "PM": "2016; ELAV PROTEINS was indexed under NERVE TISSUE PROTEINS & RNA-BINDING PROTEINS 1991-2015; ELAV PROTEIN was indexed under RIBONUCLEOPROTEINS 1991-2005", "HN": "2016; use HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS (NM) 1991-2015", "MR": "20151123", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051959"}, {"RECTYPE": "D", "MH": "GTP-Binding Protein alpha Subunit, Gi2", "DS": "GTP BINDING PROTEIN ALPHA SUBUNIT GI 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Gi2 alpha Protein", "MN": "D12.776.543.325.100.200.500", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 3.6.5.1", "MS": "A PERTUSSIS TOXIN-sensitive GTP-binding protein alpha subunit. It couples with a variety of CELL SURFACE RECEPTORS, has been implicated in INTERLEUKIN-12 production, and may play a role in INFLAMMATORY BOWEL DISEASES.", "PM": "2006; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2 was indexed under PROTO-ONCOGENE PROTEINS 1995-2005, & under GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO 2000-2005, & under GTP-BINDING PROTEINS 1994-1999, & under ONCOGENE PROTEINS 1993-1994", "HN": "2006(1993)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051960"}, {"RECTYPE": "D", "MH": "Receptors, Mating Factor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Mating Factor Receptors|T116|T192|NON|EQV|NLM (2006)|abbcde", "ENTRY": "alpha Factor Receptor", "MN": "D12.776.543.750.695.660.500", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "0", "MS": "A family of pheromone receptors that were initially discovered in SACCHAROMYCES CEREVISIAE as proteins necessary for fungal conjugation. Each mating factor receptor is expressed in HAPLOID CELLS of a single mating type.", "PM": "2006; RECEPTORS, MATING FACTOR was indexed under TRANSCRIPTION FACTORS 1986-2005, & under RECEPTORS, PEPTIDE 1994-2005, & under RECEPTORS, ENDOGENOUS SUBSTANCES 1986-1993", "HN": "2006(1986)", "MR": "20160617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051964"}, {"RECTYPE": "D", "MH": "Phospholipase C gamma", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "PLC gamma 2", "MN": "D12.776.476.557.750", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 3.1.4.3", "RR": "EC 3.1.4.3", "MS": "A phosphoinositide phospholipase C subtype that is primarily regulated by PROTEIN-TYROSINE KINASES. It is structurally related to PHOSPHOLIPASE C DELTA with the addition of SRC HOMOLOGY DOMAINS and pleckstrin homology domains located between two halves of the CATALYTIC DOMAIN.", "PM": "2006; PHOSPHOLIPASE C GAMMA was indexed under PHOSPHOLIPASE C 1994-2005", "HN": "2006(1994)", "MR": "20210521", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051966"}, {"RECTYPE": "D", "MH": "Uracil-DNA Glycosidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Uracil N Glycosylase", "MN": "D08.811.074.249.875", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 3.2.2.-", "MS": "An enzyme that catalyzes the HYDROLYSIS of the N-glycosidic bond between sugar phosphate backbone and URACIL residue during DNA synthesis.", "PM": "2006; URACIL-DNA GLYCOSIDASE was indexd under DNA Glycosylases 1981-2005, under DEOXYURACIL NUCLEOTIDES 1978-1980, & under DNA 1976-1980", "HN": "2006(1980) use DNA 1976-1979 & DEOXYURACIL NUCLEOTIDES 1978-1979", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051981"}, {"RECTYPE": "D", "MH": "Transcription Factor RelA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "NF-kappa B p65 Subunit|T116|T123|ABX|EQV|NLM (2006)|NF KAPPA B P 065 SUBUNIT|abbcdes", "ENTRY": "v Rel Reticuloendotheliosis Viral Oncogene Homolog A", "MN": "D12.776.930.600.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A subunit of NF-kappa B that is primarily responsible for its transactivation function. It contains a C-terminal transactivation domain and an N-terminal domain with homology to PROTO-ONCOGENE PROTEINS C-REL.", "PM": "2006; TRANSCRIPTION FACTOR RELA was indexed under NF-KAPPA B 1993-2005", "HN": "2006(1993)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051996"}, {"RECTYPE": "D", "MH": "ADP-ribosyl Cyclase 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD38 Antigens|T116|T126|T129|NON|EQV|NLM (2006)|050412|CD 038 ANTIGENS|abbbcdefs", "ENTRY": "NIM R5 Antigen", "MN": "D12.776.543.550.045", "MH_TH": "NLM (2018)", "ST": "T129", "RN": "EC 3.2.2.6", "MS": "A bifunctional enzyme that catalyzes the synthesis and HYDROLYSIS of CYCLIC ADP-RIBOSE (cADPR) from NAD+ to ADP-RIBOSE. It is a cell surface molecule which is predominantly expressed on LYMPHOID CELLS and MYELOID CELLS.", "PM": "2018; see ANTIGENS, CD38 2006-2017; ADP-RIBOSYL CYCLASE 1 was indexed under ANTIGENS, CD and ADP-RIBOSYL CYCLASE 2003-2005; under NAD+ NUCLEOSIDASE 1998-2002; under ANTIGENS, DIFFERENTIATION 1988-2002; and under NUCLEOSIDASES 1988-1997", "HN": "2018 (1988)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D051997"}, {"RECTYPE": "D", "MH": "NF-kappa B p50 Subunit", "DS": "NF KAPPA B P 050 SUBUNIT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p50, NF-kappa B", "MN": "D12.776.930.600.124", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A component of NF-kappa B transcription factor. It is proteolytically processed from NF-kappa B p105 precursor protein and is capable of forming dimeric complexes with itself or with TRANSCRIPTION FACTOR RELA. It regulates expression of GENES involved in immune and inflammatory responses.", "PM": "2006; NF-KAPPA B P50 SUBUNIT was indexed under NF-KAPPA B & PROTEIN PRECURSORS 1992-2005", "HN": "2006(1992)", "MR": "20050719", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052002"}, {"RECTYPE": "D", "MH": "NF-kappa B p52 Subunit", "DS": "NF KAPPA B P 052 SUBUNIT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p52, NK-kappa B", "MN": "D12.776.930.600.186", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A component of NF-kappa B transcription factor. It is proteolytically processed from NF-kappa B p100 precursor protein and is important for maturation of B-LYMPHOCYTES and adaptive HUMORAL IMMUNITY.", "PM": "2006; NF-KAPPAB P52 SUBUNIT was indexed under NF-KAPPA B 1994-2005, & under TRANSCRIPTION FACTORS 1993", "HN": "2006(1993)", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052003"}, {"RECTYPE": "D", "MH": "Bone Morphogenetic Protein Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, BMP", "MN": "D12.776.543.750.750.400.049", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "EC 2.7.11.30", "MS": "A family of CELL SURFACE RECEPTORS that bind BONE MORPHOGENETIC PROTEINS. They are PROTEIN SERINE-THREONINE KINASES that mediate SIGNAL TRANSDUCTION PATHWAYS through SMAD PROTEINS.", "PM": "2006; BONE MORPHOGENETIC PROTEIN RECEPTORS was indexed under RECEPTORS, GROWTH FACTOR 2004-2005, & under RECEPTORS, CELL SURFACE 1994-2003", "HN": "2006(1994)", "MR": "20210712", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052004"}, {"RECTYPE": "D", "MH": "Bone Morphogenetic Protein Receptors, Type I", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Serine Threonine Protein Kinase Receptor R6", "MN": "D12.776.543.750.750.400.049.500", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "EC 2.7.11.30", "RR": "EC 2.7.11.30", "MS": "A subtype of bone morphogenetic protein receptors with high affinity for BONE MORPHOGENETIC PROTEINS. They can interact with and undergo PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II. They signal primarily through RECEPTOR-REGULATED SMAD PROTEINS.", "PM": "2006; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I was indexed under PROTEIN-SERINE-THREONINE KINASES & RECEPTORS, GROWTH FACTOR 1994-2005", "HN": "2006(1994)", "MR": "20210520", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052005"}, {"RECTYPE": "D", "MH": "Bone Morphogenetic Protein Receptors, Type II", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, BMPR2", "MN": "D12.776.543.750.750.400.049.750", "MH_TH": "NLM (2006)", "ST": "T192", "RN": "EC 2.7.11.30", "MS": "A subtype of bone morphogenetic protein receptors with low affinity for BONE MORPHOGENETIC PROTEINS. They are constitutively active PROTEIN SERINE-THREONINE KINASES that can interact with and phosphorylate TYPE I BONE MORPHOGENETIC PROTEIN RECEPTORS.", "PM": "2006; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II was indexed under PROTEIN-SERINE-THREONINE KINASES 1995-2005", "HN": "2006(1995)", "MR": "20210712", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052006"}, {"RECTYPE": "D", "MH": "Mucositis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mucositides", "MN": "C07.465.584", "MH_TH": "NLM (2006)", "ST": "T047", "PI": "Stomatitis (1979-2005)", "MS": "An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY).", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052016"}, {"RECTYPE": "D", "MH": "Bulimia Nervosa", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Nervosa, Bulimia", "MN": "F03.400.250", "FX": "Bulimia", "MH_TH": "NLM (1997)", "ST": "T048", "AN": "BULIMIA is also available", "PI": "Hyperphagia (1981-1986)", "MS": "An eating disorder that is characterized by a cycle of binge eating (BULIMIA or bingeing) followed by inappropriate acts (purging) to avert weight gain. Purging methods often include self-induced VOMITING, use of LAXATIVES or DIURETICS, excessive exercise, and FASTING.", "PM": "2006; see BULIMIA 1987-2005, use HYPERPHAGIA 1981-1986", "HN": "2006; use BULIMIA 1987-2005, use HYPERPHAGIA 1981-1986", "MR": "20160602", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052018"}, {"RECTYPE": "D", "MH": "Hinge Exons", "AQ": "DE ES GE IM PH RE", "ENTRY": "Exons, Hinge", "MN": "G05.360.340.024.340.335.300.249", "MH_TH": "NLM (2006)", "ST": "T123", "PI": "Immunoglobulins, Heavy-Chain (1982-2005)", "MS": "Immunoglobulin heavy chain gene exons coding for the hinge region of the heavy chains between the first constant region (on the FAB FRAGMENTS) and the second constant region (on the FC FRAGMENTS).", "PM": "2006; see EXONS 1988-2005", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052058"}, {"RECTYPE": "D", "MH": "Research Support, N.I.H., Intramural", "ENTRY": "United States Gov't Supported, P.H.S., N.I.H., Intramural|T064|NON|EQV|NLM (2005)|050404|abcdef", "MN": "V04.750.500.750", "MH_TH": "NLM (2005)", "ST": "T064", "AN": "for all articles noted as resulting from intramural research at any NIH institute; CATALOGER: do not use", "MS": "A designation for publications of research resulting from intramural research at the National Institutes of Health.", "HN": "2005", "MR": "20150605", "DA": "20050404", "DC": "2", "DX": "20050404", "UI": "D052060"}, {"RECTYPE": "D", "MH": "Research Support, N.I.H., Extramural", "ENTRY": "United States Gov't Supported, P.H.S., N.I.H., Extramural|T064|NON|EQV|NLM (2005)|050404|abcdef", "MN": "V04.750.500.500", "MH_TH": "NLM (2005)", "ST": "T064", "AN": "for all articles noted as resulting from extramural research at any NIH institute; CATALOGER: do not use", "MS": "A designation for publications of research resulting from extramural research funded by the National Institutes of Health.", "HN": "2005", "MR": "20150605", "DA": "20050404", "DC": "2", "DX": "20050404", "UI": "D052061"}, {"RECTYPE": "D", "MH": "Vaginismus", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "F03.835.900", "MH_TH": "NLM (1998)", "ST": "T047", "PI": "Vaginal Diseases (1965-2005)", "MS": "Recurrent or persistent involuntary SPASM of the outer muscles of the VAGINA, occurring during vaginal penetration.", "PM": "2006; see SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL 1998-2005", "HN": "2006; use SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL 1998-2005", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052065"}, {"RECTYPE": "D", "MH": "N-Ethylmaleimide-Sensitive Proteins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NEM Sensitive Fusion Proteins", "MN": "D12.776.157.025.750.375", "FX": "Membrane Fusion Proteins", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 3.6.4.6", "MS": "ATPases that are members of the AAA protein superfamily (ATPase family Associated with Diverse cellular Activities). The NSFs functions, acting in conjunction with SOLUBLE NSF ATTACHMENT PROTEINS (i.e. SNAPs, which have no relation to SNAP 25), are to dissociate SNARE complexes.", "PM": "2006", "HN": "2006", "MR": "20170301", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052066"}, {"RECTYPE": "D", "MH": "Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins", "AQ": "AD AE AG AI BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein|T116|T123|NON|EQV|NLM (2006)|abbcde", "ENTRY": "gamma SNAP", "MN": "D12.776.543.990.812", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "SNARE binding proteins that facilitate the ATP hydrolysis-driven dissociation of the SNARE complex. They are required for the binding of N-ETHYLMALEIMIDE-SENSITIVE PROTEIN (NSF) to the SNARE complex which also stimulates the ATPASE activity of NSF. They are unrelated structurally to SNAP-25 PROTEIN.", "PM": "2006", "HN": "2006", "MR": "20130709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052067"}, {"RECTYPE": "D", "MH": "Conus Snail", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Snail, Conus", "MN": "B01.050.500.644.400.275", "FX": "Conotoxins", "MH_TH": "NLM (2006)", "ST": "T204", "RN": "txid6490", "PI": "Mollusca (1966-2005)", "MS": "A genus of cone-shaped marine snails in the family Conidae, class GASTROPODA. It comprises more than 600 species, many containing unique venoms (CONUS VENOMS) with which they immobilize their prey.", "PM": "2006", "HN": "2006", "MR": "20230405", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052078"}, {"RECTYPE": "D", "MH": "Warm Ischemia", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Ischemia, Warm", "MN": "E04.936.932", "FX": "Ischemia", "MH_TH": "NLM (2006)", "ST": "T061", "PI": "Ischemia (1968-2005)", "MS": "A tissue or organ remaining at physiological temperature during decreased BLOOD perfusion or in the absence of blood supply. During ORGAN TRANSPLANTATION it begins when the organ reaches physiological temperature before the completion of SURGICAL ANASTOMOSIS and ends with reestablishment of the BLOOD CIRCULATION through the tissue.", "PM": "2006", "HN": "2006", "MR": "20150629", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052096"}, {"RECTYPE": "D", "MH": "Quadriceps Muscle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Quadriceps Muscles", "MN": "A02.633.567.850", "MH_TH": "NLM (2006)", "ST": "T023", "PI": "Muscles (1963-1994)", "MS": "The quadriceps femoris. A collective name of the four-headed skeletal muscle of the thigh, comprised of the rectus femoris, vastus intermedius, vastus lateralis, and vastus medialis.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052097"}, {"RECTYPE": "D", "MH": "Sialomucins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sialomucin, Endothelial-Specific", "MN": "D12.776.395.560.631.650", "FX": "Sialic Acids", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A subcategory of mucins that contain SIALIC ACID.", "PM": "2006; SIALOMUCINS was indexed under MUCINS 1982-2005, under SIALIC ACIDS, & under MUCOPROTEINS 1976-1981", "HN": "2006(1980); use SIALIC ACIDS & MUCOPROTEINS 1976-1979", "MR": "20230316", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052116"}, {"RECTYPE": "D", "MH": "Benzodioxoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Methylenedioxybenzenes|T109|NON|EQV|NLM (2006)|050413|abcdef", "ENTRY": "1,3 Dioxindans", "MN": "D03.633.100.115", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "PI": "Dioxoles (1970-2005)", "MS": "Compounds based on benzene fused to oxole. They can be formed from methylated CATECHOLS such as EUGENOL.", "PM": "2006", "HN": "2006", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052117"}, {"RECTYPE": "D", "MH": "Lysosomal-Associated Membrane Protein 1", "DS": "LYSOSOMAL ASSOCIATED MEMBRANE PROTEIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD107a Antigens|T116|T123|NON|EQV|NLM (2006)|050413|CD 107 A ANTIGENS|abbcdefs", "ENTRY": "Lysosomal Associated Membrane Protein 1", "MN": "D12.776.543.750.705.675.554", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. In PLATELETS and T-LYMPHOCYTES it may play a role in the cellular degranulation process.", "PM": "2006; CD107A ANTIGEN was indexed under ANTIGENS, CD 1986-2005", "HN": "2006(1986)", "MR": "20230417", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052118"}, {"RECTYPE": "D", "MH": "Lysosomal-Associated Membrane Protein 2", "DS": "LYSOSOMAL ASSOCIATED MEMBRANE PROTEIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD107b Antigens|T116|T123|NON|EQV|NLM (2006)|050413|CD 107 B ANTIGENS|abbcdefs", "ENTRY": "Lysosomal Associated Membrane Protein 2", "MN": "D12.776.543.550.527.750", "EC": "deficiency:Glycogen Storage Disease Type IIb", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. Loss of expression of lysosomal-associated membrane protein 2 is associated with GLYCOGEN STORAGE DISEASE TYPE IIB.", "PM": "2006; ANTIGENS CD107B was indexed under ANTIGENS, CD 2003-2005, & under MEMBRANE GLYCOPROTEINS 1986-2002", "HN": "2006(1986)", "MR": "20230417", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052119"}, {"RECTYPE": "D", "MH": "Glycogen Storage Disease Type IIb", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "X Linked Vacuolar Cardiomyopathy and Myopathy", "MN": "C18.452.648.202.449.510", "MH_TH": "NLM (2006)", "ST": "T047", "MS": "An X-linked dominant multisystem disorder resulting in cardiomyopathy, myopathy and INTELLECTUAL DISABILITY. It is caused by mutation in the gene encoding LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2.", "PM": "2006", "HN": "2006", "MR": "20180630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052120"}, {"RECTYPE": "D", "MH": "Genes, Neoplasm", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Cancer Genes|T028|NON|NRW|UNK (19XX)|840405|abcdef", "ENTRY": "Neoplasm Gene", "MN": "G05.360.340.024.340.375", "FX": "Neoplasm Proteins", "MH_TH": "NLM (2006)", "ST": "T028", "AN": "general; prefer specifics; coordinate with specific neoplasm terms /genet; do not confuse with ONCOGENES", "MS": "Genes whose abnormal expression, or MUTATION are associated with the development, growth, or progression of NEOPLASMS.", "PM": "2006; for CANCER GENES see ONCOGENES 1985-2005", "HN": "2006; for CANCER GENES use ONCOGENES 1985-2005", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052138"}, {"RECTYPE": "D", "MH": "Intracellular Calcium-Sensing Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peptides, Intracellular Calcium-Sensing", "MN": "D12.776.476.387", "FX": "Receptors, Calcium-Sensing", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "Intracellular signaling peptides and proteins that bind to CALCIUM. They undergo allosteric changes when bound to CALCIUM that affects their interaction with other signal-transducing molecules. They differ from CALCIUM-SENSING RECEPTORS which sense extracellular calcium levels.", "PM": "2006", "HN": "2006", "MR": "20170630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052139"}, {"RECTYPE": "D", "MH": "Human papillomavirus 11", "DS": "HUMAN PAPILLOMAVIRUS 011", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "HPV 11", "MN": "B04.613.204.655.450.125", "MH_TH": "NLM (2006)", "ST": "T005", "RN": "txid10580", "AN": "infection: coordinate IM with GENITAL WARTS (IM) or PAPILLOMAVIRUS INFECTIONS (IM) + PAPILLOMATOSIS (IM) or other neoplasms term (IM) if pertinent", "PI": "Papillomavirus, Human (1994-2005)", "MS": "A type of ALPHAPAPILLOMAVIRUS causing recurrent respiratory PAPILLOMATOSIS; GENITAL WARTS; and other neoplasms.", "PM": "2006", "HN": "2006", "MR": "20220523", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052140"}, {"RECTYPE": "D", "MH": "SELEX Aptamer Technique", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Systematic Evolution of Ligands by Exponential Enrichment|T062|NON|EQV|NLM (2011)|100402|abcdef", "ENTRY": "Techniques, SELEX Aptamer", "MN": "J01.897.836.249.249.500", "MH_TH": "NLM (2006)", "ST": "T062", "MS": "A method of generating a large library of randomized nucleotides and selecting NUCLEOTIDE APTAMERS by iterative rounds of in vitro selection. A modified procedure substitutes AMINO ACIDS in place of NUCLEOTIDES to make PEPTIDE APTAMERS.", "PM": "2006", "HN": "2006", "MR": "20160617", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052156"}, {"RECTYPE": "D", "MH": "Aptamers, Nucleotide", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Rna Aptamer|T114|NON|NRW|NLM (2021)|200129|abcdef", "ENTRY": "RNA Oligonucleotide Ligands", "MN": "D13.695.578.424.224", "MH_TH": "NLM (2006)", "ST": "T114", "RN": "0", "MS": "Nucleotide sequences, generated by iterative rounds of SELEX APTAMER TECHNIQUE, that bind to a target molecule specifically and with high affinity.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052157"}, {"RECTYPE": "D", "MH": "Aptamers, Peptide", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Peptide Aptamers|T116|NON|EQV|NLM (2006)|050418|abcdef", "MN": "D12.644.082", "MH_TH": "NLM (2006)", "ST": "T116", "RN": "0", "MS": "Peptide sequences, generated by iterative rounds of SELEX APTAMER TECHNIQUE, that bind to a target molecule specifically and with high affinity.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052158"}, {"RECTYPE": "D", "MH": "Frasier Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Frasier", "MN": "C23.550.291.500.906.500.500", "FX": "Fraser Syndrome", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "do not confuse with FRASER SYNDROME", "MS": "A syndrome characterized by CHRONIC KIDNEY FAILURE and GONADAL DYSGENESIS in phenotypic females with karyotype of 46,XY or female individual with a normal 46,XX karyotype. It is caused by donor splice-site mutations of Wilms tumor suppressor gene (GENES, WILMS TUMOR) on chromosome 11.", "PM": "2006; see DENYS-DRASH SYNDROME 2002-2005", "HN": "2006; use DENYS-DRASH SYNDROME 2002-2005", "MR": "20210607", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052159"}, {"RECTYPE": "D", "MH": "Benzothiazoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.185", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "PI": "Thiazoles (1965-2005)", "MS": "Compounds with a benzene ring fused to a thiazole ring.", "PM": "2006", "HN": "2006", "MR": "20160527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052160"}, {"RECTYPE": "D", "MH": "Human papillomavirus 18", "DS": "HUMAN PAPILLOMAVIRUS 018", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human papillomavirus - 18|T005|NON|EQV|NLM (2023)|220318|abcdef", "ENTRY": "Human papillomavirus type 18|T005|NON|EQV|NLM (2006)|050418|abcdef", "MN": "B04.613.204.655.450.313", "MH_TH": "NLM (2006)", "ST": "T005", "RN": "txid337042", "PI": "Papillomavirus, Human (1994-2005)", "MS": "A type of human papillomavirus especially associated with malignant tumors of the genital and RESPIRATORY MUCOSA.", "PM": "2006", "HN": "2006", "MR": "20220523", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052161"}, {"RECTYPE": "D", "MH": "Human papillomavirus 16", "DS": "HUMAN PAPILLOMAVIRUS 016", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "human papillomavirus type 16 HPV16|T005|NON|EQV|NLM (2023)|220323|abcdef", "ENTRY": "HPV16s", "MN": "B04.613.204.655.450.250", "MH_TH": "NLM (2006)", "ST": "T005", "RN": "txid333760", "AN": "infection: coordinate with PAPILLOMAVIRUS INFECTIONS + UTERINE CERVICAL NEOPLASMS, RESPIRATORY TRACT NEOPLASMS or other neoplasm term if pertinent", "PI": "Papillomavirus, Human (1994-2005)", "MS": "A type of ALPHAPAPILLOMAVIRUS especially associated with malignant tumors of the CERVIX and the RESPIRATORY MUCOSA.", "PM": "2006", "HN": "2006", "MR": "20220523", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052162"}, {"RECTYPE": "D", "MH": "Human papillomavirus 6", "DS": "HUMAN PAPILLOMAVIRUS 006", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "HPV 6", "MN": "B04.613.204.655.450.500", "MH_TH": "NLM (2006)", "ST": "T005", "RN": "txid333754", "AN": "infection: coordinate IM with probably GENITAL WARTS (IM) or PAPILLOMAVIRUS INFECTIONS (IM); coordinate with LARYNGEAL NEOPLASMS if pertinent", "PI": "Papillomavirus, Human (1994-2005)", "MS": "A type of ALPHAPAPILLOMAVIRUS usually associated with GENITAL WARTS; and LARYNGEAL NEOPLASMS.", "PM": "2006", "HN": "2006", "MR": "20220523", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052163"}, {"RECTYPE": "D", "MH": "Azulenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Cyclopentacycloheptenes|T109|NON|NRW|NLM (2006)|050419|abcdef", "MN": "D04.615.133", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "PI": "Cycloheptanes (1968-2005)", "MS": "Compounds based on a seven-membered ring fused to a five-membered ring. Heat can rearrange them to NAPHTHALENES which have two fused six-membered rings. They are similar to guaiazulenes which are SESQUITERPENES with a six-membered ring fused to a five-membered ring.", "PM": "2006", "HN": "2006", "MR": "20060705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052176"}, {"RECTYPE": "D", "MH": "Kidney Diseases, Cystic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Renal Diseases, Cystic", "MN": "C12.950.419.403", "MH_TH": "NLM (2006)", "ST": "T047", "AN": "note specifics", "PI": "Polycystic Kidney Diseases (1976-2005)", "MS": "A heterogeneous group of hereditary and acquired disorders in which the KIDNEY contains one or more CYSTS unilaterally or bilaterally (KIDNEY, CYSTIC).", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052177"}, {"RECTYPE": "D", "MH": "Cephalopelvic Disproportion", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Disproportion, Cephalopelvic", "MN": "C12.050.703.420.235", "MH_TH": "NLM (1992)", "ST": "T047", "MS": "A condition in which the HEAD of the FETUS is larger than the mother's PELVIS through which the fetal head must pass during a vaginal delivery.", "PM": "2006; see LABOR COOMPLICATIONS 1992-2005", "HN": "2006; use LABOR COOMPLICATIONS 1992-2005", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052178"}, {"RECTYPE": "D", "MH": "Antigens, Plant", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Plant Antigens|T129|NON|EQV|NLM (2006)|050420|abcdef", "ENTRY": "Antigen, Plant", "MN": "D23.050.291", "MH_TH": "NLM (2006)", "ST": "T129", "RN": "0", "MS": "Substances found in PLANTS that have antigenic activity.", "PM": "2006", "HN": "2006", "MR": "20220413", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052179"}, {"RECTYPE": "D", "MH": "Publication Formats", "PRINT ENTRY": "Publication Format|T170|NON|EQV|NLM (2022)|201005|abcdef", "MN": "V02", "RH": "V2 - PUBLICATION FORMATS", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "INDEXER: Do not use; CATALOGER: Do not use", "MS": "Specific genre of publication.", "HN": "2008(2006)", "MR": "20210630", "DA": "20050630", "DC": "2", "DX": "20060101", "UI": "D052180"}, {"RECTYPE": "D", "MH": "Publication Components", "MN": "V01", "RH": "V1 - PUBLICATION COMPONENTS", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "INDEXER: Do not use; CATALOGER: Do not use", "MS": "Specific parts of publications.", "HN": "2008(2006)", "MR": "20150605", "DA": "20050630", "DC": "2", "DX": "20060101", "UI": "D052181"}, {"RECTYPE": "D", "MH": "Study Characteristics", "MN": "V03", "RH": "V3 - STUDY CHARACTERISTICS", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "INDEXER: Do not use; CATALOGER: Do not use", "MS": "Type of empirical method used.", "HN": "2008(2006)", "MR": "20171212", "DA": "20050630", "DC": "2", "DX": "20060101", "UI": "D052182"}, {"RECTYPE": "D", "MH": "Levilactobacillus brevis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Lactobacillus brevis|T007|NON|EQV|NLM (2006)|050421|abcdef", "MN": "B03.510.550.450.672", "MH_TH": "NLM (2023)", "ST": "T007", "RN": "txid1580", "PI": "Lactobacillus (1967-2005)", "MS": "A species of gram-positive, rod-shaped LACTIC ACID bacteria that is frequently used as starter culture in SILAGE fermentation, sourdough, and lactic-acid-fermented types of beer and wine.", "PM": "2023; see LACTOBACILLUS BREVIS 2006-2022", "HN": "2023(2006)", "MR": "20221031", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052196"}, {"RECTYPE": "D", "MH": "Limosilactobacillus fermentum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Lactobacillus fermentum|T007|NON|EQV|NLM (2006)|050421|abcdef", "MN": "B03.510.550.450.705", "MH_TH": "NLM (2023)", "ST": "T007", "RN": "txid1613", "PI": "Lactobacillus (1975-2005)", "MS": "A species of gram-positive, rod-shaped bacteria associated with DENTAL CARIES.", "PM": "2023; see LACTOBACILLUS FERMENTUM 2006-2022", "HN": "2023; use LACTOBACILLUS FERMENTUM 2006-2022", "MR": "20221031", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052197"}, {"RECTYPE": "D", "MH": "Lactobacillus helveticus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.450.475.400", "MH_TH": "NLM (2006)", "ST": "T007", "RN": "txid1587", "PI": "Lactobacillus (1970-2005)", "MS": "A species of gram-positive bacteria isolated from MILK and cheese-starter cultures.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052198"}, {"RECTYPE": "D", "MH": "Lactobacillus leichmannii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.450.475.506", "MH_TH": "NLM (2006)", "ST": "T007", "RN": "txid28039", "PI": "Lactobacillus (1965-2005)", "MS": "A species of gram-negative bacteria isolated from MILK, cheese, and compressed yeast.", "PM": "2006", "HN": "2006", "MR": "20200813", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052199"}, {"RECTYPE": "D", "MH": "Limosilactobacillus reuteri", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Lactobacillus reuteri|T007|NON|EQV|NLM (2006)|050421|abcdef", "MN": "B03.510.550.450.721", "MH_TH": "NLM (2023)", "ST": "T007", "RN": "txid1598", "PI": "Lactobacillus (1982-2005)", "MS": "A species of gram-positive, rod-shaped LACTIC ACID bacteria found naturally in the human intestinal flora and BREAST MILK.", "PM": "2023; see LACTOBACILLUS REUTERI 2006-2022", "HN": "2023(2006)", "MR": "20221031", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052200"}, {"RECTYPE": "D", "MH": "Lacticaseibacillus rhamnosus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Lactobacillus rhamnosus|T007|NON|EQV|NLM (2006)|050421|abcdef", "ENTRY": "Lactobacillus GG|T007|NON|NRW|NLM (2017)|150909|abcdef", "MN": "B03.510.550.450.606.875", "MH_TH": "NLM (2023)", "ST": "T007", "RN": "txid47715", "PI": "Lactobacillus (1963-2005)", "MS": "A species of gram-positive, rod-shaped bacteria used in PROBIOTICS.", "PM": "2023; see LACTOBACILLUS RHAMNOSUS 2006-2022", "HN": "2023(2006)", "MR": "20221031", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052201"}, {"RECTYPE": "D", "MH": "Hydrocolpos", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C12.100.250.894.500", "MH_TH": "NLM (2006)", "ST": "T184", "PI": "Vagina/abnormalities (1966-2005)", "MS": "A fluid-filled VAGINA that is obstructed.", "PM": "2006", "HN": "2006", "MR": "20210630", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052202"}, {"RECTYPE": "D", "MH": "Ferrosoferric Oxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ferumoxytol|T130|T197|NON|REL|USAN (19XX)|110131|abbcdef", "ENTRY": "Oxide, Ferrosoferric", "MN": "D01.578.285", "PA": "Parenteral Nutrition Solutions", "FX": "Magnetosomes", "MH_TH": "NLM (2006)", "ST": "T197", "RN": "XM0M87F357", "RR": "CLH5FT6412", "MS": "Iron (II,III) oxide (Fe3O4). It is a black ore of IRON that forms opaque crystals and exerts strong magnetism.", "PM": "2006; FERROSOFERRIC OXIDE was indexed under OXIDES 1991-2005 and IRON 1981-2005", "HN": "2006 (1981)", "MR": "20160701", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052203"}, {"RECTYPE": "D", "MH": "Glucagon-Like Peptide 1", "DS": "GLUCAGON LIKE PEPTIDE 001", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Glucagon Like Peptide 1", "MN": "D06.472.317.680.500.500", "PA": "Incretins", "MH_TH": "NLM (2006)", "ST": "T125", "RN": "89750-14-1", "MS": "A peptide of 36 or 37 amino acids that is derived from PROGLUCAGON and mainly produced by the INTESTINAL L CELLS. GLP-1(1-37 or 1-36) is further N-terminally truncated resulting in GLP-1(7-37) or GLP-1-(7-36) which can be amidated. These GLP-1 peptides are known to enhance glucose-dependent INSULIN release, suppress GLUCAGON release and gastric emptying, lower BLOOD GLUCOSE, and reduce food intake.", "PM": "2006", "HN": "2006", "MR": "20180705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052216"}, {"RECTYPE": "D", "MH": "Fanconi Anemia Complementation Group A Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fanconi Anemia Group A Protein|T116|T123|EPO|EQV|NLM (2006)|050425|abbcdef", "MN": "D12.776.744.476", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A Fanconi anemia complementation group protein that is the most commonly mutated protein in FANCONI ANEMIA. It undergoes PHOSPHORYLATION by PROTEIN KINASE B and forms a complex with FANCC PROTEIN in the CELL NUCLEUS.", "PM": "2006", "HN": "2006", "MR": "20050721", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052217"}, {"RECTYPE": "D", "MH": "Fanconi Anemia Complementation Group C Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fanconi Anemia Group C Protein|T116|T123|EPO|EQV|NLM (2006)|041029|abbcdef", "MN": "D12.776.313.750", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A Fanconi anemia complementation group protein that regulates the activities of CYTOCHROME P450 REDUCTASE and GLUTATHIONE S-TRANSFERASE. It is found predominately in the CYTOPLASM, but moves to the CELL NUCLEUS in response to FANCE PROTEIN.", "PM": "2006; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN was indexed under DNA-BINDING PROTEINS & NUCLEAR PROTEINS & CELL CYCLE PROTEINS 1993-2005", "HN": "2006(1993)", "MR": "20050721", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052218"}, {"RECTYPE": "D", "MH": "Fanconi Anemia Complementation Group F Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fanconi Anemia Group F Protein|T116|T123|NON|EQV|NLM (2006)|050425|abbcdef", "MN": "D12.776.660.293", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A Fanconi anemia complementation group protein. It is an essential component of a nuclear core complex that protects the GENOME against CHROMOSOMAL INSTABILITY. It interacts directly with FANCG PROTEIN and helps stabilize a complex with FANCA PROTEIN and FANCC PROTEIN.", "PM": "2006; FANCONI ANEMIA COMPLEMENTATION GROUP F PROTEIN was indexed under RNA-BINDING PROTEINS 2000-2005", "HN": "2006(2000)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052219"}, {"RECTYPE": "D", "MH": "Fanconi Anemia Complementation Group D2 Protein", "DS": "FANCONI ANEMIA COMPLEMENTATION GROUP D 02 PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fanconi Anemia Group D2 Protein|T116|T123|EPO|EQV|NLM (2006)|050425|abbcdef", "MN": "D12.776.744.484", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A Fanconi anemia complementation group protein that undergoes mono-ubiquitination by FANCL PROTEIN in response to DNA DAMAGE. Also, in response to IONIZING RADIATION it can undergo PHOSPHORYLATION by ataxia telangiectasia mutated protein. Modified FANCD2 interacts with BRCA2 PROTEIN in a stable complex with CHROMATIN, and it is involved in DNA REPAIR by homologous RECOMBINATION.", "PM": "2006; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN was indexed under NUCLEAR PROTEINS 2001-2005", "HN": "2006(2001)", "MR": "20090720", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052236"}, {"RECTYPE": "D", "MH": "Fanconi Anemia Complementation Group E Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fanconi Anemia Group E Protein|T116|T123|EPO|EQV|NLM (2006)|050426|abbcdef", "MN": "D12.776.660.289", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A Fanconi anemia complementation group protein that interacts with FANCC PROTEIN and FANCD2 PROTEIN. It promotes the accumulation of FANCC protein in the CELL NUCLEUS.", "PM": "2006; FANCONI ANEMIA COMPLEMENTATION GROUP E PROTEIN was indexed under NUCLEAR PROTEINS 2000-2005", "HN": "2006(2000)", "MR": "20050721", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052239"}, {"RECTYPE": "D", "MH": "Fanconi Anemia Complementation Group L Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ubiquitin Ligase Protein PHF9|T116|T126|NON|EQV|NLM (2006)|050426|abbcdef", "MN": "D12.776.313.937", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.3.2.27", "MS": "An E3 UBIQUITIN LIGASE that plays a key role in the DNA damage response pathway of FANCONI ANEMIA PROTEINS. It is associated with mono-ubiquitination of FANCD2 PROTEIN and the redistribution of FANCD2 to nuclear foci containing BRCA1 PROTEIN.", "PM": "2006; FANCONI ANEMIA COMPLEMENTATION GROUP L PROTEIN was indexed under LIGASES 2003-2005", "HN": "2006 (2003)", "MR": "20160602", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052240"}, {"RECTYPE": "D", "MH": "Fanconi Anemia Complementation Group G Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "X Ray Repair Complementing Defective Repair In Chinese Hamster Cells 9 Protein", "MN": "D12.776.744.488", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A Fanconi anemia complementation group protein that undergoes PHOSPHORYLATION by CDC2 PROTEIN KINASE during MITOSIS. It forms a complex with other FANCONI ANEMIA PROTEINS and helps protect CELLS from DNA DAMAGE by genotoxic agents.", "PM": "2006; FANCONI ANEMIA COMPLEMENTATION GROUP G PROTEIN was indexed under DNA-BINDING PROTEINS 1997-2005", "HN": "2006(1997)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052241"}, {"RECTYPE": "D", "MH": "Adiponectin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "apM 1 Protein", "MN": "D23.529.024.249", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "MS": "A 30-kDa COMPLEMENT C1Q-related protein, the most abundant gene product secreted by FAT CELLS of the white ADIPOSE TISSUE. Adiponectin modulates several physiological processes, such as metabolism of GLUCOSE and FATTY ACIDS, and immune responses. Decreased plasma adiponectin levels are associated with INSULIN RESISTANCE; TYPE 2 DIABETES MELLITUS; OBESITY; and ATHEROSCLEROSIS.", "PM": "2006; ADIPONECTIN was indexed under INTRACELULAR SIGNALING PEPTIDES AND PROTEINS 1996-2005", "HN": "2006 (1996)", "MR": "20070709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052242"}, {"RECTYPE": "D", "MH": "Resistin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Adipocyte Cysteine Rich Secreted Protein FIZZ3", "MN": "D23.529.024.750", "MH_TH": "NLM (2006)", "ST": "T125", "RN": "0", "MS": "A 12-kDa cysteine-rich polypeptide hormone secreted by FAT CELLS in the ADIPOSE TISSUE. It is the founding member of the resistin-like molecule (RELM) hormone family. Resistin suppresses the ability of INSULIN to stimulate cellular GLUCOSE uptake.", "PM": "2006; RESISTIN was indexed under HORMONES, ECTOPIC 2001-2005", "HN": "2006 (2001)", "MR": "20070709", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052243"}, {"RECTYPE": "D", "MH": "Endocrine Disruptors", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Endocrine Disruptor|T131|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Effects, Endocrine Disruptor", "MN": "D27.888.141", "FX": "Hormones, Hormone Substitutes, and Hormone Antagonists", "MH_TH": "NLM (2006)", "ST": "T131", "RN": "0", "AN": "note entry term ENDOCRINE DISRUPTOR EFFECT: use only for the endocrine disruptor effect of a chemical substance", "PI": "Endocrine System/drug effects (1997-2005)", "MS": "Exogenous agents, synthetic and naturally occurring, which are capable of disrupting the functions of the ENDOCRINE SYSTEM including the maintenance of HOMEOSTASIS and the regulation of developmental processes. Endocrine disruptors are compounds that can mimic HORMONES, or enhance or block the binding of hormones to their receptors, or otherwise lead to activating or inhibiting the endocrine signaling pathways and hormone metabolism.", "PM": "2006", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052244"}, {"RECTYPE": "D", "MH": "Usher Syndromes", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ushers Syndrome", "MN": "C23.888.592.763.393.341.887.886", "MH_TH": "NLM (2006)", "ST": "T047", "PI": "Syndrome (1972-2005)", "MS": "Autosomal recessive hereditary disorders characterized by congenital SENSORINEURAL HEARING LOSS and RETINITIS PIGMENTOSA. Genetically and symptomatically heterogeneous, clinical classes include type I, type II, and type III. Their severity, age of onset of retinitis pigmentosa and the degree of vestibular dysfunction are variable.", "PM": "2006", "HN": "2006", "MR": "20130708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052245"}, {"RECTYPE": "D", "MH": "Cyclooxygenase 2 Inhibitors", "DS": "CYCLOOXYGENASE 002 INHIBITORS", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclooxygenase-2 Inhibitor|T116|T121|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Inhibitors, Cyclooxygenase-2", "MN": "D27.505.954.329.030.500.500", "MH_TH": "NLM (2006)", "ST": "T121", "RN": "0", "MS": "A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2.", "PM": "2006; see CYCLOOXYGENASE INHIBITORS 2005", "HN": "2006", "MR": "20200527", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052246"}, {"RECTYPE": "D", "MH": "Nitric Oxide Synthase Type II", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NOS II", "MN": "D12.776.660.720.575", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.13.39", "RR": "EC 1.14.13.39", "MS": "A CALCIUM-independent subtype of nitric oxide synthase that may play a role in immune function. It is an inducible enzyme whose expression is transcriptionally regulated by a variety of CYTOKINES.", "PM": "2006; INDUCIBLE NITRIC OXIDE SYNTHASE was indexed under NITRIC-OXIDE SYNTHASE 1998-2005; NITRIC OXIDE SYNTHASE II was indexed under NITRIC-OXIDE SYNTHASE 2001-2005", "HN": "2006", "MR": "20170524", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052247"}, {"RECTYPE": "D", "MH": "Nitric Oxide Synthase Type I", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "nNOS Enzyme|T116|T126|ABX|EQV|NLM (2006)|abbcde", "MN": "D08.811.682.664.500.772.249", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.13.39", "RR": "EC 1.14.13.39", "MS": "A CALCIUM-dependent, constitutively-expressed form of nitric oxide synthase found primarily in NERVE TISSUE.", "PM": "2006; NEURONAL CONSTITUTIVE NITRIC OXIDE SYNTHASE was indexed under NITRIC-OXIDE SYNTHASE 1998-2005", "HN": "2006(1998)", "MR": "20090706", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052248"}, {"RECTYPE": "D", "MH": "Nitric Oxide Synthase Type III", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nitric Oxide Synthase, Type III|T116|T126|NON|EQV|NLM (2006)|abbcde", "MN": "D08.811.682.664.500.772.750", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 1.14.13.39", "MS": "A CALCIUM-dependent, constitutively-expressed form of nitric oxide synthase found primarily in ENDOTHELIAL CELLS.", "PM": "2006; ENDOTHELIAL CONSTITUTIVE NITRIC OXIDE SYNTHASE was indexed UNDER NITRIC-OXIDE SYNTHASE 1998-2005", "HN": "2006(1998)", "MR": "20090706", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052250"}, {"RECTYPE": "D", "MH": "Tendinopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tendinosis|T047|NON|NRW|NLM (2006)|050428|abcdef", "ENTRY": "Tendonoses", "MN": "C26.874.800", "MH_TH": "NLM (2006)", "ST": "T047", "PI": "Tendon Injuries (1976-2005)", "MS": "Clinical syndrome describing overuse tendon injuries characterized by a combination of PAIN, diffuse or localized swelling, and impaired performance.", "PM": "2006; for TENDINITIS see TENDINITIS 1965-2005, see TENDONITIS 1963-1964", "HN": "2006", "MR": "20160120", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052256"}, {"RECTYPE": "D", "MH": "Creatine Kinase, BB Form", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kinase, Brain Creatine", "MN": "D08.811.913.696.640.150.500", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.3.2", "RR": "EC 2.7.3.2", "MS": "A form of creatine kinase found in the BRAIN.", "PM": "2006; CREATINE KINASE, BB FORM was indexed under CREATINE KINASE 2000-2005", "HN": "2006(2000)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052276"}, {"RECTYPE": "D", "MH": "Creatine Kinase, MB Form", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kinase, Myocardial Creatine", "MN": "D08.811.913.696.640.150.625", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.3.2", "MS": "An isoenzyme of creatine kinase found in the CARDIAC MUSCLE.", "PM": "2006; CREATINE KINASE, MB FORM was indexed under CREATINE KINASE 2000-2005", "HN": "2006(2000)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052279"}, {"RECTYPE": "D", "MH": "Orthodontic Anchorage Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Techniques, Orthodontic Anchorage", "MN": "E06.658.337", "MH_TH": "NLM (2006)", "ST": "T061", "AN": "consider also DENTAL IMPLANTS", "PI": "Orthodontics (1965-2005)", "MS": "Attachment of orthodontic devices and materials to the MOUTH area for support and to provide a counterforce to orthodontic forces.", "PM": "2006", "HN": "2006", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052280"}, {"RECTYPE": "D", "MH": "Creatine Kinase, Mitochondrial Form", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Creatine Kinase, Mitochondrial|T116|T126|NON|EQV|NLM (2006)|000605|abbcdef", "ENTRY": "Kinase, Mitochondrial Creatine", "MN": "D12.776.575.186", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.3.2", "MS": "A form of creatine kinase found in the MITOCHONDRIA.", "PM": "2006; CREATINE KINASE, MITOCHONDRIAL FORM was indexed under CREATINE KINASE 2000-2005", "HN": "2006(2000)", "MR": "20110624", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052281"}, {"RECTYPE": "D", "MH": "Creatine Kinase, MM Form", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kinase, Muscle Creatine", "MN": "D08.811.913.696.640.150.875", "MH_TH": "NLM (2006)", "ST": "T126", "RN": "EC 2.7.3.2", "MS": "An isoenzyme of creatine kinase found in the MUSCLE.", "PM": "2006; CRATINE KINASE, MM FORM was indexed under CREATINE KINASE 2000-2005", "HN": "2006(2000)", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052283"}, {"RECTYPE": "D", "MH": "Clutch Size", "AQ": "DE GE IM PH RE", "ENTRY": "Sizes, Clutch", "MN": "G08.686.160", "FX": "Ovoviviparity", "MH_TH": "NLM (2006)", "ST": "T081", "AN": "oviparous or ovoviviparous animals only; for viviparous animals use LITTER SIZE", "MS": "The number of offspring produced at one birth by an oviparous or ovoviviparous animal.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052284"}, {"RECTYPE": "D", "MH": "Ovoviviparity", "AQ": "DE GE IM PH RE", "ENTRY": "Ovoviviparous|T042|NON|EQV|NLM (2006)|050429|abcdef", "MN": "G08.686.655", "FX": "Clutch Size", "MH_TH": "NLM (2006)", "ST": "T042", "MS": "The capability of producing yolk-filled eggs that hatch within the body, so that the young are born alive, but without placental attachment. This applies to certain species of REPTILES and FISHES.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052285"}, {"RECTYPE": "D", "MH": "Viviparity, Nonmammalian", "AQ": "DE GE IM PH RE", "ENTRY": "Nonmammalian Viviparity", "MN": "G08.686.920", "FX": "Litter Size", "MH_TH": "NLM (2006)", "ST": "T042", "MS": "The capability of bearing live young (rather than eggs) in nonmammalian species. Some species of REPTILES and FISHES exhibit this.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052286"}, {"RECTYPE": "D", "MH": "Oviparity", "AQ": "DE GE IM PH RE", "ENTRY": "Oviparous|T042|NON|EQV|NLM (2006)|050429|abcdef", "MN": "G08.686.650", "FX": "Oviposition", "MH_TH": "NLM (2006)", "ST": "T042", "MS": "The capability of producing eggs (OVA) from which young are hatched outside the body. While mostly referring to nonmammalian species, this does include MAMMALS of the order MONOTREMATA.", "PM": "2006", "HN": "2006", "MR": "20080708", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052287"}, {"RECTYPE": "D", "MH": "Support of Research", "MN": "V04", "RH": "V4 - SUPPORT OF RESEARCH", "MH_TH": "NLM (2006)", "ST": "T170", "AN": "INDEXER: Do not use; CATALOGER: Do not use", "MS": "Organizational source for funding of research activity.", "HN": "2006", "MR": "20150605", "DA": "20050630", "DC": "2", "DX": "20060101", "UI": "D052288"}, {"RECTYPE": "D", "MH": "Proglucagon", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pro Glucagon", "MN": "D12.776.811.700", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "55963-74-1", "PI": "Glucagon (1973-2005)", "MS": "The common precursor polypeptide of pancreatic GLUCAGON and intestinal GLUCAGON-LIKE PEPTIDES. Proglucagon is the 158-amino acid segment of preproglucagon without the N-terminal signal sequence. Proglucagon is expressed in the PANCREAS; INTESTINES; and the CENTRAL NERVOUS SYSTEM. Posttranslational processing of proglucagon is tissue-specific yielding numerous bioactive peptides.", "PM": "2007; see GLUCAGON PRECURSORS 2006; GLUCAGON PRECURSOR was indexed under PROGLUCAGON 2006-2007, PROTEIN PRECURSORS & GLUCAGON 1977-2005", "HN": "2007 (2006); for GLUCAGON PRECURSOR use GLUCAGON PRECURSOR (NM) 1977-2007", "MR": "20180705", "DA": "20050630", "DC": "1", "DX": "20060101", "UI": "D052336"}, {"RECTYPE": "D", "MH": "Targeted Gene Repair", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Targeted Mutation Repairs", "MN": "E05.393.420.601.575.500", "FX": "DNA Repair", "MH_TH": "NLM (2007)", "ST": "T063", "MS": "A technique which uses synthetic oligonucleotides to direct the cell's inherent DNA repair system to correct a mutation at a specific site in an episome or chromosome.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052416"}, {"RECTYPE": "D", "MH": "Adipose Tissue, White", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "White Fat|T024|NON|EQV|NLM (2007)|050714|abcdef", "ENTRY": "Tissue, White Adipose", "MN": "A10.165.114.830", "MH_TH": "NLM (2007)", "ST": "T024", "PI": "Adipose Tissue (1963-2006)", "MS": "Fatty tissue composed of WHITE ADIPOCYTES and generally found directly under the skin (SUBCUTANEOUS FAT) and around the internal organs (ABDOMINAL FAT). It has less vascularization and less coloration than the BROWN FAT. White fat provides heat insulation, mechanical cushion, and source of energy.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052436"}, {"RECTYPE": "D", "MH": "Adipocytes, Brown", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Fat Cells, Brown", "MN": "A11.329.114.249", "MH_TH": "NLM (2007)", "ST": "T025", "PI": "Adipose Tissue (1967-1993)", "MS": "Fat cells with dark coloration due to the densely packed MITOCHONDRIA. They contain numerous small lipid droplets or vacuoles. Their stored lipids can be converted directly to energy as heat by the mitochondria.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052437"}, {"RECTYPE": "D", "MH": "Adipocytes, White", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "White Fat Cell", "MN": "A11.329.114.500", "MH_TH": "NLM (2007)", "ST": "T025", "PI": "Adipose Tissue (1968-1993)", "MS": "Fat cells with light coloration and few MITOCHONDRIA. They contain a scant ring of CYTOPLASM surrounding a single large lipid droplet or vacuole.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052438"}, {"RECTYPE": "D", "MH": "Lipid Metabolism Disorders", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Metabolism Disorders, Lipid", "MN": "C18.452.584", "MH_TH": "NLM (2007)", "ST": "T047", "AN": "general; prefer specifics", "MS": "Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052439"}, {"RECTYPE": "D", "MH": "Hypoalphalipoproteinemias", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "alpha-Lipoprotein Deficiency Disease, Familial|T047|NON|NRW|NLM (2000)|991104|ALPHA LIPOPROTEIN DEFIC DIS FAMILIAL|abcdefv", "ENTRY": "alpha Lipoproteinemia, Hypo", "MN": "C18.452.648.398.500.330", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Lipoproteins, HDL (1981-2006)", "MS": "Conditions with abnormally low levels of ALPHA-LIPOPROTEINS (high-density lipoproteins) in the blood. Hypoalphalipoproteinemia can be associated with mutations in genes encoding APOLIPOPROTEIN A-I; LECITHIN CHOLESTEROL ACYLTRANSFERASE; and ATP-BINDING CASSETTE TRANSPORTERS.", "PM": "2007; for HYPOALPHALIPOPROTEINEMIA, FAMILIAL & LIPOPROTEIN DEFICIENCY DISEASE, HDL, FAMILIAL see TANGIER DISEASE 1995-2006", "HN": "2007; for HYPOALPHALIPOPROTEINEMIA, FAMILIAL & LIPOPROTEIN DEFICIENCY DISEASE, HDL, FAMILIAL use TANGIER DISEASE 1995-2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052456"}, {"RECTYPE": "D", "MH": "Hypobetalipoproteinemia, Familial, Apolipoprotein B", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Apolipoprotein B Deficiency|T047|NON|EQV|GHR (2014)|NLM (2007)|OMIM (2013)|050728|APOLIPOPROTEIN B DEFIC|abcdeeefv", "ENTRY": "Apolipoprotein B Deficiencies", "MN": "C18.452.584.563.497", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Apolipoproteins B (1986-2006)", "MS": "An autosomal dominant disorder of lipid metabolism. It is caused by mutations of APOLIPOPROTEINS B, main components of CHYLOMICRONS and BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include abnormally low LDL, normal triglyceride level, and dietary fat malabsorption.", "PM": "2007; for APOLIPOPROTEIN B DEFICIENCY DISEASE see ABETALIPOPROTEINEMIA 2000-2006", "HN": "2007; for APOLIPOPROTEIN B DEFICIENCY DISEASE use ABETALIPOPROTEINEMIA 2000-2006", "MR": "20210701", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052476"}, {"RECTYPE": "D", "MH": "Lipodystrophy, Familial Partial", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Reverse Partial Lipodystrophy", "MN": "C18.452.880.391.700", "FX": "PPAR gamma", "MH_TH": "NLM (2005)", "ST": "T047", "PI": "Lipodystrophy (1975-2006)", "MS": "Inherited conditions characterized by the partial loss of ADIPOSE TISSUE, either confined to the extremities with normal or increased fat deposits on the face, neck and trunk (type 1), or confined to the loss of SUBCUTANEOUS FAT from the limbs and trunk (type 2). Type 3 is associated with mutation in the gene encoding PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA.", "PM": "2007; see DIABETES MELLITUS, LIPOATROPHIC 2005-2006", "HN": "2007; use DIABETES MELLITUS, LIPOATROPHIC 2005-2006", "MR": "20210701", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052496"}, {"RECTYPE": "D", "MH": "Lipodystrophy, Congenital Generalized", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Total Lipodystrophies", "MN": "C18.452.880.391.550", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Lipodystrophy (1968-2006)", "MS": "Congenital disorders, usually autosomal recessive, characterized by severe generalized lack of ADIPOSE TISSUE, extreme INSULIN RESISTANCE, and HYPERTRIGLYCERIDEMIA.", "PM": "2007; see DIABETES MELLITUS, LIPOATROPHIC 2005-2006", "HN": "2007; use DIABETES MELLITUS, LIPOATROPHIC 2005-2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052497"}, {"RECTYPE": "D", "MH": "Sulfatidosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sulfatidoses", "MN": "C18.452.648.595.554.825.850", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "A group of inherited metabolic disorders characterized by the intralysosomal accumulation of sulfur-containing lipids (SULFATIDES), including SULFOGLYCOSPHINGOLIPIDS normally found in the MYELIN SHEATH of the brain. These disorders are caused by defective degradative enzymes leading to substrate accumulation (or storage).", "PM": "2007; see LEUKODYSTROPHY, METACHROMATIC 1974-2006", "HN": "2007; use LEUKODYSTROPHY, METACHROMATIC 1974-2006", "MR": "20210701", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052516"}, {"RECTYPE": "D", "MH": "Multiple Sulfatase Deficiency Disease", "DE": "MULTIPLE SULFATASE DEFIC DIS", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sulfatidosis, Juvenile", "MN": "C18.452.648.595.554.825.850.750", "MH_TH": "NLM (2002)", "ST": "T047", "PI": "Sulfatases (1973-2006)", "MS": "An inherited metabolic disorder characterized by the intralysosomal accumulation of sulfur-containing lipids (sulfatides) and MUCOPOLYSACCHARIDES. Excess levels of both substrates are present in urine. This is a disorder of multiple sulfatase (arylsulfatases A, B, and C) deficiency which is caused by the mutation of sulfatase-modifying factor-1. Neurological deterioration is rapid.", "PM": "2007; see SPHINGOLIPIDOSES 2000-2006", "HN": "2007; use SPHINGOLIPIDOSES 2000-2006", "MR": "20210701", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052517"}, {"RECTYPE": "D", "MH": "Niemann-Pick Disease, Type A", "DE": "NIEMANN PICK DIS TYPE A", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sphingomyelinase Deficiency Disease|T047|NON|EQV|NLM (2000)|991104|SPHINGOMYELINASE DEFIC DIS|abcdefv", "ENTRY": "Vertical Ophthalmoplegias, Supraoptic", "MN": "C18.452.648.595.554.825.700.500", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Niemann-Pick Diseases (1997-2006)", "MS": "The classic infantile form of Niemann-Pick Disease, caused by mutation in SPHINGOMYELIN PHOSPHODIESTERASE. It is characterized by accumulation of SPHINGOMYELINS in the cells of the MONONUCLEAR PHAGOCYTE SYSTEM and other cell throughout the body leading to cell death. Clinical signs include JAUNDICE, hepatosplenomegaly, and severe brain damage.", "PM": "2007; see NIEMANN-PICK DISEASES 2000-2006", "HN": "2007; use NIEMANN-PICK DISEASES 2000-2006", "MR": "20210701", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052536"}, {"RECTYPE": "D", "MH": "Niemann-Pick Disease, Type B", "DE": "NIEMANN PICK DIS TYPE B", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Type B Niemann Pick Disease", "MN": "C18.452.648.595.554.825.700.750", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Niemann-Pick Diseases (1975-2006)", "MS": "An allelic disorder of TYPE A NIEMANN-PICK DISEASE, a late-onset form. It is also caused by mutation in SPHINGOMYELIN PHOSPHODIESTERASE but clinical signs involve only visceral organs (non-neuropathic type).", "PM": "2007; see NIEMANN-PICK DISEASES 2000-2006", "HN": "2007; use NIEMANN-PICK DISEASES 2000-2006", "MR": "20210701", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052537"}, {"RECTYPE": "D", "MH": "Niemann-Pick Disease, Type C", "DE": "NEIMANN PICK DIS TYPE C", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Niemann-Pick Type D Disease|T047|NON|NRW|NLM (2021)|191121|abcdef", "ENTRY": "Nova Scotia Niemann Pick Disease (Type D)", "MN": "C18.452.648.595.554.825.700.875", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Niemann-Pick Diseases (1968-2006)", "MS": "An autosomal recessive lipid storage disorder that is characterized by accumulation of CHOLESTEROL and SPHINGOMYELINS in cells of the VISCERA and the CENTRAL NERVOUS SYSTEM. Type C (or C1) and type D are allelic disorders caused by mutation of the NPC1 gene, which encodes  a protein that mediates intracellular cholesterol transport from LYSOSOMES. Clinical signs include hepatosplenomegaly and chronic neurological symptoms. Type D is a variant in people with a Nova Scotia ancestry.", "PM": "2007; see NIEMANN-PICK DISEASES 2000-2006", "HN": "2007; use NIEMANN-PICK DISEASES 2000-2006", "MR": "20210701", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052556"}, {"RECTYPE": "D", "MH": "Clostridium septicum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.200.690", "MH_TH": "NLM (2007)", "ST": "T007", "RN": "txid1504", "AN": "infection: coordinate IM with CLOSTRIDIUM INFECTIONS (IM) or GAS GANGRENE (IM) if pertinent", "PI": "Clostridium (1965-2006)", "MS": "A species of gram-positive bacteria in the family Clostridiaceae. Infections have a strong association with malignancies and also with GAS GANGRENE.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052557"}, {"RECTYPE": "D", "MH": "Menstrual Hygiene Products", "AQ": "AE CL EC ES HI MI PS SD SN ST VE VI", "PRINT ENTRY": "Tampons, Menstrual|T073|NON|NRW|NLM (2007)|051115|abcdef", "ENTRY": "Vaginal Tampons", "MN": "E07.357.500", "MH_TH": "NLM (2007)", "ST": "T073", "AN": "note entry term VAGINAL TAMPON: TAMPONS, SURGICAL is also available", "PI": "Tampons, Surgical (1983-2006)", "MS": "Personal care items used during MENSTRUATION.", "PM": "2007; for VAGINAL TAMPON see TAMPONS 1978-2006", "HN": "2007; for VAGINAL TAMPON use TAMPONS 1978-2006", "MR": "20210707", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052576"}, {"RECTYPE": "D", "MH": "Infant, Extremely Low Birth Weight", "AQ": "BL CF GD IM ME PH PX UR", "ENTRY": "Extremely Low Birth Weight Infant|T100|T101|NON|EQV|NLM (2007)|050810|abbcdef", "MN": "M01.060.703.520.460.600.500", "FX": "Infant, Extremely Premature", "MH_TH": "NLM (2007)", "ST": "T101", "PI": "Infant, Very Low Birth Weight (1996-2006)", "MS": "An infant whose weight at birth is less than 1000 grams (2.2 lbs), regardless of GESTATIONAL AGE.", "PM": "2007", "HN": "2007", "MR": "20120703", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052577"}, {"RECTYPE": "D", "MH": "Ionic Liquids", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Ionic Solvents|T120|NON|NRW|NLM (2022)|210609|abcdef", "ENTRY": "Solvents, Ionic", "MN": "D27.720.844.500", "MH_TH": "NLM (2007)", "ST": "T120", "RN": "0", "PI": "Solvents (2000-2006)", "MS": "Salts that melt below 100 C. Their low VOLATILIZATION can be an advantage over volatile organic solvents.", "PM": "2007", "HN": "2007", "MR": "20210707", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052578"}, {"RECTYPE": "D", "MH": "Muscle Stretching Exercises", "AQ": "PH PX", "PRINT ENTRY": "Proprioceptive Neuromuscular Facilitation|T061|NON|NRW|NLM (2021)|191210|abcdef", "ENTRY": "Stretching, Static-Passive", "MN": "I03.350.249", "FX": "Yoga", "MH_TH": "NLM (2007)", "ST": "T061", "MS": "Exercises that stretch the muscle fibers with the aim to increase muscle-tendon FLEXIBILITY, improve RANGE OF MOTION or musculoskeletal function, and prevent injuries. There are various types of stretching techniques including active, passive (relaxed), static, dynamic (gentle), ballistic (forced), isometric, and others.", "PM": "2007", "HN": "2007", "MR": "20200221", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052580"}, {"RECTYPE": "D", "MH": "Pinch Strength", "AQ": "PH", "ENTRY": "Strength, Pinch", "MN": "G11.427.560.500.500", "MH_TH": "NLM (2007)", "ST": "T081", "PI": "Hand (1971-2006)", "MS": "Force exerted when using the index finger and the thumb. It is a test for determining maximum voluntary contraction force.", "PM": "2007", "HN": "2007", "MR": "20080708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052581"}, {"RECTYPE": "D", "MH": "Trigger Finger Disorder", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Trigger Thumb|T047|NON|NRW|NLM (2007)|OMIM (2013)|ORD (2010)|060303|abcdeeef", "ENTRY": "Trigger Thumbs", "MN": "C05.651.869.816.800", "MH_TH": "NLM (2007)", "ST": "T047", "MS": "A painful disability in the hand affecting the finger or thumb. It is caused by mechanical impingement of the digital flexor tendons as they pass through a narrowed retinacular pulley at the level of the metacarpal head. Thickening of the sheath and fibrocartilaginous metaplasia can occur, and nodules can form. (From Green's Operative Hand Surgery, 5th ed, p2137-58).", "PM": "2007", "HN": "2007", "MR": "20160120", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052582"}, {"RECTYPE": "D", "MH": "Sarraceniaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sarracenia|T002|NON|NRW|NLM (2007)|050811|abcdef", "ENTRY": "Sarracenias", "MN": "B01.875.800.575.912.250.341.992", "MH_TH": "NLM (2007)", "ST": "T002", "RN": "txid4353", "RR": "txid4358", "AN": "entry term FLYTRAP: VENUS FLYTRAP see DROSERACEAE is also available; coordinate with CARNIVOROUS PLANT if pertinent", "MS": "A plant family of the order Nepenthales.", "PM": "2007", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052583"}, {"RECTYPE": "D", "MH": "Xylem", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Xylems", "MN": "A18.450.500", "MH_TH": "NLM (2007)", "ST": "T002", "MS": "Plant tissue that carries water up the root and stem. Xylem cell walls derive most of their strength from LIGNIN. The vessels are similar to PHLOEM sieve tubes but lack companion cells and do not have perforated sides and pores.", "PM": "2007", "HN": "2007", "MR": "20150623", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052584"}, {"RECTYPE": "D", "MH": "Phloem", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Phloems", "MN": "A18.450.250", "MH_TH": "NLM (2007)", "ST": "T002", "MS": "Plant tissue that carries nutrients, especially sucrose, by turgor pressure. Movement is bidirectional, in contrast to XYLEM where it is only upward. Phloem originates and grows outwards from meristematic cells (MERISTEM) in the vascular cambium. P-proteins, a type of LECTINS, are characteristically found in phloem.", "PM": "2007", "HN": "2007", "MR": "20150623", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052585"}, {"RECTYPE": "D", "MH": "Mating Preference, Animal", "AQ": "CL DE ES PH RE", "ENTRY": "Animal Sexual Selection", "MN": "F01.145.113.252.748.300", "FX": "Sexual Selection", "MH_TH": "NLM (2007)", "ST": "T054", "PI": "Sexual Behavior, Animal (1972-2006)", "MS": "The selection or choice of sexual partner in animals. Often this reproductive preference is based on traits in the potential mate, such as coloration, size, or behavioral boldness. If the chosen ones are genetically different from the rejected ones, then NATURAL SELECTION is occurring.", "PM": "2007", "HN": "2007", "MR": "20200221", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052586"}, {"RECTYPE": "D", "MH": "Pulicaria", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Pulicarias", "MN": "B01.875.800.575.912.250.100.613", "MH_TH": "NLM (2007)", "ST": "T002", "RN": "txid56534", "AN": "do not confuse with Daphnia pulicaria use CRUSTACEA", "MS": "A plant genus of the family ASTERACEAE. Members contain pulicanadienes and other cytotoxic SESQUITERPENES.", "PM": "2007", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052587"}, {"RECTYPE": "D", "MH": "Pongamia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Karanja|T002|NON|EQV|NLM (2003)|011102|abcdef", "ENTRY": "Pongamias", "MN": "B01.875.800.575.912.250.401.698", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid56064", "PI": "Fabaceae (1999-2006)", "MS": "A plant genus of the family FABACEAE. Members contain karanjin. Some species of this genus have been reclassified to other genera of FABACEAE including Callerya, DERRIS and MILLETTIA.", "PM": "2007; see FABACEAE 2003-2006", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052596"}, {"RECTYPE": "D", "MH": "Hymenaea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Hymenaeas", "MN": "B01.875.800.575.912.250.401.327", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid20675", "PI": "Fabaceae (1995-2006)", "MS": "A plant genus of the family FABACEAE. Members contain resins (RESINS, PLANT) and GLUCANS.", "PM": "2007; see FABACEAE 2003-2006", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052597"}, {"RECTYPE": "D", "MH": "Dioclea", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Diocleas", "MN": "B01.875.800.575.912.250.401.192", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid3836", "PI": "Fabaceae (1984-2006)", "MS": "A plant genus of the family FABACEAE. Members contain MANNOSE-BINDING LECTINS and dioclein.", "PM": "2007; see FABACEAE 2003-2006", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052598"}, {"RECTYPE": "D", "MH": "Solid Phase Extraction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Solid Phase Extractions", "MN": "E05.196.155.800", "MH_TH": "NLM (2007)", "ST": "T059", "MS": "An extraction method that separates analytes using a solid phase and a liquid phase. It is used for preparative sample cleanup before analysis by CHROMATOGRAPHY and other analytical methods.", "PM": "2007", "HN": "2007", "MR": "20080708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052616"}, {"RECTYPE": "D", "MH": "Solid Phase Microextraction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Solid Phase Microextractions", "MN": "E05.196.155.800.500", "MH_TH": "NLM (2007)", "ST": "T059", "MS": "A solventless sample preparation method, invented in 1989, that uses a fused silica fiber which is coated with a stationary phase. It is used for sample cleanup before using other analytical methods.", "PM": "2007", "HN": "2007", "MR": "20080708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052617"}, {"RECTYPE": "D", "MH": "Allostasis", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Allostatic Load|T081|NON|REL|NLM (2007)|050831|abcdef", "ENTRY": "Loads, Allostatic", "MN": "G16.012.500.274", "FX": "Adaptation, Psychological", "MH_TH": "NLM (2007)", "ST": "T070", "PI": "Homeostasis (1994-2006)", "MS": "Biological adaptation, such as the rise of EPINEPHRINE in response to exercise, stress or perceived danger, followed by a fall of epinephrine during RELAXATION. Allostasis is the achievement of stability by turning on and turning off the allostatic systems including the IMMUNE SYSTEM; the AUTONOMIC NERVOUS SYSTEM and NEUROENDOCRINE SYSTEMS.", "PM": "2007", "HN": "2007", "MR": "20160602", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052636"}, {"RECTYPE": "D", "MH": "Particulate Matter", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ultrafine Particulate Matter|T167|NON|NRW|NLM (2020)|190418|abcdef", "ENTRY": "Particulate Matter, Ultrafine", "MN": "D20.633", "PA": "Air Pollutants", "MH_TH": "NLM (2007)", "ST": "T167", "RN": "0", "PI": "Particle Size (1972-2006)", "MS": "Particles of any solid substance, generally under 30 microns in size, often noted as PM30. There is special concern with PM1 which can get down to PULMONARY ALVEOLI and induce MACROPHAGE ACTIVATION and PHAGOCYTOSIS leading to FOREIGN BODY REACTION and LUNG DISEASES.", "PM": "2007", "HN": "2007", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052638"}, {"RECTYPE": "D", "MH": "Caulimoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Soymovirus|T005|NON|NRW|NLM (2007)|050825|abcdef", "ENTRY": "Soymoviruses", "MN": "B04.715.102", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid186534", "RR": "txid187214", "PI": "Caulimovirus (2001-2006)", "MS": "A family of DNA plant viruses with isometric or bacilliform virions and no envelope. The host ranges of most species are narrow. There are six genera: CAULIMOVIRUS; BADNAVIRUS; Cavemovirus; Soymovirus; Petuvirus; and TUNGROVIRUS.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052639"}, {"RECTYPE": "D", "MH": "Tungrovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Rice tungro bacilliform virus|T005|NON|NRW|NLM (1997)|950908|abcdef", "MN": "B04.715.102.850", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid187212", "RR": "txid10654", "MS": "A genus of DNA plant viruses of the family CAULIMOVIRIDAE. The sole species, Rice tungro bacilliform virus, shows 25% identity with BADNAVIRUS. It is transmitted by leafhoppers with the assistance of RICE TUNGRO SPHERICAL VIRUS.", "PM": "2007; for RICE TUNGRO BACILLIFORM VIRUS see BADNAVIRUS 1997-2006", "HN": "2007; for RICE TUNGRO BACILLIFORM VIRUS use BADNAVIRUS 1997-2006", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052641"}, {"RECTYPE": "D", "MH": "Ictalurivirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Ictalurid herpesvirus 1|T005|NON|NRW|NLM (2007)|050825|abcdef", "ENTRY": "Viruses, Channel Catfish", "MN": "B04.280.382.530", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid172653", "RR": "txid10401", "AN": "infection: coordinate with HERPESVIRIDAE INFECTIONS", "PI": "Herpesviridae (1971-2006)", "MS": "An unassigned genus in the family HERPESVIRIDAE, comprising one species Ictalurid herpesvirus 1 (Channel Catfish Virus).", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052656"}, {"RECTYPE": "D", "MH": "Nanoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.715.499", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid251095", "MS": "A family of DNA viruses infecting plants and transmitted by APHIDS. Genera include NANOVIRUS and BABUVIRUS.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052657"}, {"RECTYPE": "D", "MH": "Babuvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Banana bunchy top virus|T005|NON|NRW|NLM (2002)|010102|abcdef", "ENTRY": "Babuviruses", "MN": "B04.715.499.100", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid251096", "RR": "txid12585", "MS": "A genus in the family NANOVIRIDAE infecting bananas. The type species is Banana bunchy top virus.", "PM": "2007; for BANANA BUNCHY TOP VIRUS see NANOVIRUS 2002-2006", "HN": "2007; for BANANA BUNCHY TOP VIRUS use NANOVIRUS 2002-2006", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052658"}, {"RECTYPE": "D", "MH": "Amdovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Amdoviruses", "MN": "B04.280.580.650.040", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid310911", "AN": "infection: coordinate with PARVOVIRIDAE INFECTIONS or index ALEUTIAN MINK DISEASE if specified in text ", "MS": "A genus in the subfamily PARVOVIRINAE consisting of a single species ALEUTIAN MINK DISEASE VIRUS.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052659"}, {"RECTYPE": "D", "MH": "Bocavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Canine minute virus|T005|NON|NRW|NLM (2007)|050826|abcdef", "ENTRY": "viruses, Canine minute", "MN": "B04.280.580.650.085", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid1507401", "RR": "txid329639", "AN": "do not confuse CANINE MINUTE VIRUS with CANINE PARVOVIRUS; infection: coordinate IM with PARVOVIRIDAE INFECTIONS (IM)", "PI": "Parvoviridae (1973-2006)", "MS": "A genus in the subfamily PARVOVIRINAE comprising three species: Bovine parvovirus, Canine minute virus, and HUMAN BOCAVIRUS.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052660"}, {"RECTYPE": "D", "MH": "H-1 parvovirus", "DS": "H A 01 PARVOVIRUS", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Parvovirus H-1|T005|NON|EQV|NLM (2007)|050826|PARVOVIRUS H 01|abcdefs", "ENTRY": "parvoviruses, H-1", "MN": "B04.280.580.650.600.437", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid10799", "AN": "infection: coordinate IM with PARVOVIRIDAE INFECTIONS (IM)", "PI": "Parvovirus (1993-2006)", "MS": "A species in the genus PARVOVIRUS that has the ability to replicate and kill tumor cells in culture.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052661"}, {"RECTYPE": "D", "MH": "Avastrovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Turkey astrovirus|T005|NON|NRW|NLM (2007)|050829|abcdef", "ENTRY": "nephritis virus, Avian", "MN": "B04.820.578.250.080", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid249589", "RR": "txid70793", "AN": "infection: coordinate with ASTROVIRIDAE INFECTIONS", "MS": "A genus of ASTROVIRIDAE infecting avian species and often involving extra-intestinal manifestations. The type species is Turkey astrovirus.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052676"}, {"RECTYPE": "D", "MH": "Flexiviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Vitivirus|T005|NON|NRW|NLM (2007)|050829|abcdef", "ENTRY": "Vitiviruses", "MN": "B04.820.578.375", "MH_TH": "NLM (2007)", "ST": "T005", "RR": "txid699166", "MS": "A family of RNA plant viruses that infect a wide range of herbaceous and woody plant species. There are at least eight genera including POTEXVIRUS and CARLAVIRUS, both of which are highly immunogenic.", "PM": "2007", "HN": "2007", "MR": "20200902", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052677"}, {"RECTYPE": "D", "MH": "Hepevirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Hepatitis E Virus, Avian|T005|NON|NRW|NLM (2007)|050829|abcdef", "ENTRY": "Hepeviruses", "MN": "B04.820.578.407", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid186677", "RR": "txid1678144", "AN": "infection: coordinate with RNA VIRUS INFECTIONS + HEPATITIS, VIRAL, ANIMAL", "MS": "An unassigned genus of RNA viruses with a single officially described species, HEPATITIS E VIRUS. A distantly related virus, Avian hepatitis E virus, has been listed as a tentative species. Strains have also been identified in swine.", "PM": "2007", "HN": "2007", "MR": "20220708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052678"}, {"RECTYPE": "D", "MH": "Luteoviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Polerovirus|T005|NON|NRW|NLM (2007)|050829|abcdef", "ENTRY": "Poleroviruses", "MN": "B04.820.578.469", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid119163", "RR": "txid12289", "PI": "Luteovirus (2000-2006)", "MS": "A family of RNA plant viruses infecting disparate plant families. They are transmitted by specific aphid vectors. There are three genera: LUTEOVIRUS; Polerovirus; and Enamovirus.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052679"}, {"RECTYPE": "D", "MH": "Corticotrophs", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Pituitary Adrenocorticotropin-Secreting Cells|T025|NON|EQV|NLM (2007)|050830|abcdef", "ENTRY": "Pituitary Adrenocorticotropin-Secreting Cell", "MN": "A11.436.267", "MH_TH": "NLM (2007)", "ST": "T025", "PI": "Pituitary Gland, Anterior (1977-2006)", "MS": "Anterior pituitary cells that produce ADRENOCORTICOTROPHIC HORMONE.", "PM": "2007", "HN": "2007", "MR": "20180630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052680"}, {"RECTYPE": "D", "MH": "Gonadotrophs", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "LH-Secreting Cell", "MN": "A11.436.319", "MH_TH": "NLM (2007)", "ST": "T025", "PI": "Pituitary Gland, Anterior (1974-2006)", "MS": "Anterior pituitary cells that can produce both FOLLICLE STIMULATING HORMONE and LUTEINIZING HORMONE.", "PM": "2007", "HN": "2007", "MR": "20180630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052681"}, {"RECTYPE": "D", "MH": "Lactotrophs", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Pituitary Prolactin-Secreting Cells|T025|NON|EQV|NLM (2007)|050830|abcdef", "ENTRY": "Prolactin-Secreting Cells, Pituitary", "MN": "A11.436.507", "MH_TH": "NLM (2007)", "ST": "T025", "PI": "Prolactin (1965-2006)", "MS": "Anterior pituitary cells that produce PROLACTIN.", "PM": "2007", "HN": "2007", "MR": "20180630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052682"}, {"RECTYPE": "D", "MH": "Somatotrophs", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Pituitary Growth Hormone-Secreting Cells|T025|NON|EQV|NLM (2007)|050830|abcdef", "ENTRY": "Somatotroph", "MN": "A11.436.896", "MH_TH": "NLM (2007)", "ST": "T025", "PI": "Pituitary Gland, Anterior (1977-2006)", "MS": "Anterior pituitary cells which produce GROWTH HORMONE.", "PM": "2007", "HN": "2007", "MR": "20180701", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052683"}, {"RECTYPE": "D", "MH": "Thyrotrophs", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Pituitary TSH-Secreting Cells|T025|ACX|EQV|NLM (2007)|050830|abcdef", "ENTRY": "Thyrotroph", "MN": "A11.436.925", "MH_TH": "NLM (2007)", "ST": "T025", "PI": "Thyrotropin (1968-2006)", "MS": "Anterior pituitary cells that produce THYROID-STIMULATING HORMONE.", "PM": "2007", "HN": "2007", "MR": "20180630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052684"}, {"RECTYPE": "D", "MH": "Alphapapillomavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Alphapapillomaviruses", "MN": "B04.613.204.655.050", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid333750", "AN": "infection: coordinate with PAPILLOMAVIRUS INFECTIONS; consider also WARTS", "MS": "A genus of DNA viruses in the family PAPILLOMAVIRIDAE. They preferentially infect the anogenital and ORAL MUCOSA in humans and primates, causing both malignant and benign neoplasms. Cutaneous lesions are also seen.", "PM": "2007", "HN": "2007", "MR": "20220413", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052685"}, {"RECTYPE": "D", "MH": "Betapapillomavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Betapapillomaviruses", "MN": "B04.613.204.655.100", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid333922", "AN": "infection: coordinate IM with PAPILLOMAVIRUS INFECTIONS; consider also WARTS", "MS": "A genus of DNA viruses in the family PAPILLOMAVIRIDAE, causing cutaneous lesions in humans. Infections exist in latent form in the general population and are activated under conditions of IMMUNOSUPPRESSION THERAPY.", "PM": "2007", "HN": "2007", "MR": "20210712", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052686"}, {"RECTYPE": "D", "MH": "Deltapapillomavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Deltapapillomaviruses", "MN": "B04.613.204.655.200", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid325454", "AN": "infection: coordinate IM with PAPILLOMAVIRUS INFECTIONS", "MS": "A genus of DNA viruses in the family PAPILLOMAVIRIDAE causing fibropapillomas in their respective ungulate hosts. Species infected include cattle, European elk, deer, and sheep.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052687"}, {"RECTYPE": "D", "MH": "Bovine papillomavirus 1", "DS": "BOVINE PAPILLOMAVIRUS 01", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "BVP-1|T005|ACR|EQV|NLM (2007)|050831|BVP 01|abcdefs", "ENTRY": "Papillomavirus 2, Bovine", "MN": "B04.613.204.655.200.100", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid337052", "RR": "txid2758382", "AN": "infection: coordinate IM with PAPILLOMAVIRUS INFECTIONS", "MS": "A species of DELTAPAPILLOMAVIRUS infecting cattle.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052688"}, {"RECTYPE": "D", "MH": "Gammapapillomavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human papillomavirus - 60|T005|NON|NRW|NLM (2023)|220321|abcdef", "ENTRY": "HPV60s", "MN": "B04.613.204.655.400", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid325455", "RR": "txid333930", "AN": "infection: coordinate with PAPILLOMAVIRUS INFECTIONS", "MS": "A genus of DNA viruses in the family PAPILLOMAVIRIDAE, which cause cutaneous lesions in humans. They are histologically distinguishable by intracytoplasmic INCLUSION BODIES which are species specific.", "PM": "2007", "HN": "2007", "MR": "20220523", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052689"}, {"RECTYPE": "D", "MH": "Kappapapillomavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Kappapapillomaviruses", "MN": "B04.613.204.655.500", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid325457", "AN": "infection: coordinate IM with PAPILLOMAVIRUS INFECTIONS", "MS": "A genus of DNA viruses in the family PAPILLOMAVIRIDAE, causing cutaneous and mucosal lesions in rabbits. COTTONTAIL RABBIT PAPILLOMAVIRUS is the type species.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052690"}, {"RECTYPE": "D", "MH": "Lambdapapillomavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Canine oral papillomavirus|T005|NON|NRW|NLM (2007)|050831|abcdef", "ENTRY": "papillomavirus, Canine oral", "MN": "B04.613.204.655.520", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid325462", "RR": "txid35258", "AN": "infection: coordinate IM with PAPILLOMAVIRUS INFECTIONS", "MS": "A genus of DNA viruses in the family papillomaviridae, causing mucosal and cutaneous lesions in cats and dogs. Canine oral papillomavirus is the type species.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052691"}, {"RECTYPE": "D", "MH": "Mupapillomavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Mupapillomaviruses", "MN": "B04.613.204.655.540", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid334202", "AN": "infection: coordinate IM with PAPILLOMAVIRUS INFECTIONS", "MS": "A genus of DNA viruses in the family PAPILLOMAVIRIDAE, causing cutaneous lesions in humans.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052692"}, {"RECTYPE": "D", "MH": "Xipapillomavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Xipapillomaviruses", "MN": "B04.613.204.655.950", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid333921", "AN": "infection: coordinate IM with PAPILLOMAVIRUS INFECTIONS", "MS": "A genus of DNA viruses in the family PAPILLOMAVIRIDAE, causing cutaneous or mucosal papillomas in cattle.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052696"}, {"RECTYPE": "D", "MH": "Bovine papillomavirus 4", "DS": "BOVINE PAPILLOMAVIRUS 04", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "BVP-4|T005|NON|EQV|NLM (2007)|050901|BVP 04|abcdefs", "ENTRY": "BVP 4", "MN": "B04.613.204.655.950.150", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid10562", "AN": "infection: coordinate IM with PAPILLOMAVIRUS INFECTIONS", "MS": "A type of XIPAPILLOMAVIRUS causing alimentary carcinoma in cattle. It is related to Bovine papillomavirus 3.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052697"}, {"RECTYPE": "D", "MH": "Erbovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Equine rhinitis B virus|T005|NON|NRW|NLM (2007)|050902|abcdef", "ENTRY": "Erboviruses", "MN": "B04.820.578.750.290", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid194961", "RR": "txid312185", "AN": "infection: coordinate IM with PICORNAVIRIDAE INFECTIONS (IM)", "MS": "A genus in the family PICORNAVIRIDAE causing upper respiratory disease in horses.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052698"}, {"RECTYPE": "D", "MH": "Kobuvirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Aichi virus|T005|NON|NRW|NLM (2007)|050902|abcdef", "ENTRY": "Kobuviruses", "MN": "B04.820.578.750.500", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid194960", "RR": "txid1313215", "AN": "infection: coordinate with PICORNAVIRIDAE INFECTIONS", "MS": "A genus in the family PICORNAVIRIDAE whose type species Aichi virus, causes gastroenteritis in humans.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052699"}, {"RECTYPE": "D", "MH": "Teschovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Teschen Disease Virus|T005|EPO|NRW|UNK (19XX)|741211|TESCHEN DIS VIRUS|abcdefv", "ENTRY": "teschovirus, Porcine", "MN": "B04.820.578.750.830", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid118139", "RR": "txid118140", "AN": "infection: coordinate IM with PICORNAVIRIDAE INFECTIONS (IM)", "PI": "Picornaviridae (2002-2006)", "MS": "A genus in the family PICORNAVIRIDAE that can cause polioencephalomyelitis in pigs. The type species Porcine teschovirus is comprised of multiple strains.", "PM": "2007; for TALFAN DISEASE VIRUS & TESCHEN DISEASE VIRUS see ENTEROVIRUSES, PORCINE 1974-2006", "HN": "2007; for TALFAN DISEASE VIRUS & TESCHEN DISEASE VIRUS use ENTEROVIRUSES, PORCINE 1974-2006", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052700"}, {"RECTYPE": "D", "MH": "Pituitary Gland, Intermediate", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Intermediate Lobe of Pituitary|T023|NON|EQV|NLM (2007)|050908|abcdef", "ENTRY": "Pituitary Intermediate Lobe", "MN": "A08.713.357.750.750", "MH_TH": "NLM (2007)", "ST": "T023", "AN": "diseases: coordinate IM with PITUITARY DISEASES (IM) or specifics (IM)", "PI": "Pituitary Gland (1965-2006)", "MS": "The intermediate lobe of the pituitary gland. It shows considerable size variation among the species, small in humans, and large in amphibians and lower vertebrates. This lobe produces mainly MELANOCYTE-STIMULATING HORMONES and other peptides from post-translational processing of pro-opiomelanocortin (POMC).", "PM": "2007", "HN": "2007", "MR": "20180630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052716"}, {"RECTYPE": "D", "MH": "Melanotrophs", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Pituitary Melanotropin-Producing Cells|T025|NON|EQV|NLM (2007)|060306|abcdef", "ENTRY": "Pituitary Melanotropin-Producing Cell", "MN": "A11.436.636", "MH_TH": "NLM (2007)", "ST": "T025", "PI": "Pituitary Gland (1977-2006)", "MS": "Neuroendocrine cells in the INTERMEDIATE LOBE OF PITUITARY. They produce MELANOCYTE STIMULATING HORMONES and other peptides from the post-translational processing of pro-opiomelanocortin (POMC).", "PM": "2007", "HN": "2007", "MR": "20180630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052717"}, {"RECTYPE": "D", "MH": "Rous sarcoma virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "virus, Rous sarcoma", "MN": "B04.820.650.070.120.700", "MH_TH": "UNK (19XX)", "ST": "T005", "RN": "txid11886", "AN": "infection: coordinate IM with SARCOMA, AVIAN (IM) + BIRDS or POULTRY (NIM) or specific bird or fowl (IM)", "PI": "Avian Sarcoma Viruses (1963-2006)", "MS": "A species of replication-competent oncogene-containing virus in the genus ALPHARETROVIRUS. It is the original source of the src oncogene (V-SRC GENES) and causes sarcoma in chickens.", "PM": "2007; see SARCOMA VIRUSES, AVIAN 1994-2006, see AVIAN SARCOMA VIRUSES 1983-1993, see ROUS SARCOMA VIRUS 1963-1982", "HN": "2007, 1963-1982; use AVIAN SARCOMA VIRUSES 1983-2006", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052736"}, {"RECTYPE": "D", "MH": "Carpometacarpal Joints", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Joints, Carpometacarpal", "MN": "A02.835.583.405.200", "MH_TH": "NLM (2007)", "ST": "T030", "MS": "The articulations between the CARPAL BONES and the METACARPAL BONES.", "PM": "2007", "HN": "2007", "MR": "20090706", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052737"}, {"RECTYPE": "D", "MH": "Nutritional Sciences", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sciences, Nutritional", "MN": "H02.533", "FX": "Nutritional Physiological Phenomena", "MH_TH": "NLM (2007)", "ST": "T091", "PI": "Nutrition Physiology (1965-2006)", "MS": "The study of NUTRITION PROCESSES as well as the components of food, their actions, interaction, and balance in relation to health and disease.", "PM": "2007", "HN": "2007", "MR": "20130708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052756"}, {"RECTYPE": "D", "MH": "Female Urogenital Diseases", "DE": "FEMALE UROGENITAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Female Genitourinary Diseases|T047|NON|EQV|NLM (2007)|050915|FEMALE GENITOURINARY DIS|abcdefv", "ENTRY": "Urogenital Diseases, Female", "MN": "C12.050.351", "MH_TH": "NLM (2007)", "ST": "T047", "AN": "general; prefer specifics", "MS": "Pathological processes of the female URINARY TRACT and the reproductive system (GENITALIA, FEMALE).", "PM": "2007", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052776"}, {"RECTYPE": "D", "MH": "Balanitis Xerotica Obliterans", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Kraurosis Penis|T047|NON|EQV|UNK (19XX)|850321|abcdef", "MN": "C12.200.294.494.136.500", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Balanitis (1967-2006)", "MS": "An atrophic and sclerotic condition of the head of the PENIS, glans penis. Sometimes it leads to stenosis and occasionally obliteration of the external meatal orifice.", "PM": "2007; see BALANITIS 1963-2006", "HN": "2007; use BALANITIS 1963-2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052798"}, {"RECTYPE": "D", "MH": "Male Urogenital Diseases", "DE": "MALE UROGENITAL DIS", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Urogenital Diseases, Male", "MN": "C12.200", "RH": "C12 - DISEASES-MALE UROGENITAL", "MH_TH": "NLM (2007)", "ST": "T047", "AN": "general; prefer specifics", "MS": "Pathological processes of the male URINARY TRACT and the reproductive system (GENITALIA, MALE).", "PM": "2007", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052801"}, {"RECTYPE": "D", "MH": "Foreskin", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Foreskins", "MN": "A05.360.444.492.362", "FX": "Circumcision, Male", "MH_TH": "NLM (2007)", "ST": "T023", "PI": "Penis (1968-2006)", "MS": "The double-layered skin fold that covers the GLANS PENIS, the head of the penis.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052816"}, {"RECTYPE": "D", "MH": "Phototrophic Processes", "AQ": "DE GE IM PH RE", "ENTRY": "Processes, Phototrophic", "MN": "G03.800", "FX": "Nutritional Physiological Phenomena", "MH_TH": "NLM (2007)", "ST": "T042", "AN": "distinguish from PHOTOTROPISM", "MS": "Processes by which phototrophic organisms use sunlight as their primary energy source. Contrasts with chemotrophic processes which do not depend on light and function in deriving energy from exogenous chemical sources. Photoautotrophy (or photolithotrophy) is the ability to use sunlight as energy to fix inorganic nutrients to be used for other organic requirements. Photoautotrophs include all GREEN PLANTS; GREEN ALGAE; CYANOBACTERIA; and green and PURPLE SULFUR BACTERIA. Photoheterotrophs or photoorganotrophs require a supply of organic nutrients for their organic requirements but use sunlight as their primary energy source; examples include certain PURPLE NONSULFUR BACTERIA. Depending on environmental conditions some organisms can switch between different nutritional modes (AUTOTROPHY; HETEROTROPHY; chemotrophy; or phototrophy) to utilize different sources to meet their nutrients and energy requirements.", "PM": "2007", "HN": "2007", "MR": "20160623", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052817"}, {"RECTYPE": "D", "MH": "Autotrophic Processes", "AQ": "DE GE IM PH RE", "ENTRY": "Processes, Lithotrophic", "MN": "G03.087", "FX": "Phototrophic Processes", "MH_TH": "NLM (2007)", "ST": "T042", "MS": "The processes by which organisms use simple inorganic substances such as gaseous or dissolved carbon dioxide and inorganic nitrogen as nutrient sources. Contrasts with heterotrophic processes which make use of organic materials as the nutrient supply source. Autotrophs can be either chemoautotrophs (or chemolithotrophs), largely ARCHAEA and BACTERIA, which also use simple inorganic substances for their metabolic energy reguirements; or photoautotrophs (or photolithotrophs), such as PLANTS and CYANOBACTERIA, which derive their energy from light. Depending on environmental conditions some organisms can switch between different nutritional modes (autotrophy; HETEROTROPHY; chemotrophy; or PHOTOTROPHY) to utilize different sources to meet their nutrient and energy requirements.", "PM": "2007", "HN": "2007", "MR": "20160616", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052818"}, {"RECTYPE": "D", "MH": "Heterotrophic Processes", "AQ": "DE GE IM PH RE", "ENTRY": "Processes, Heterotrophic", "MN": "G03.393", "FX": "Phototrophic Processes", "MH_TH": "NLM (2007)", "ST": "T042", "MS": "The processes by which organisms utilize organic substances as their nutrient sources. Contrasts with AUTOTROPHIC PROCESSES which make use of simple inorganic substances as the nutrient supply source. Heterotrophs can be either chemoheterotrophs (or chemoorganotrophs) which also require organic substances such as glucose for their primary metabolic energy requirements, or photoheterotrophs (or photoorganotrophs) which derive their primary energy requirements from light. Depending on environmental conditions some organisms can switch between different nutritional modes (AUTOTROPHY; heterotrophy; chemotrophy; or PHOTOTROPHY) to utilize different sources to meet their nutrients and energy requirements.", "PM": "2007", "HN": "2007", "MR": "20160630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052836"}, {"RECTYPE": "D", "MH": "Chemoautotrophic Growth", "AQ": "DE ES GE IM PH RE", "ENTRY": "Growth, Chemolithotrophic", "MN": "G03.087.314", "FX": "Phototrophic Processes", "MH_TH": "NLM (2007)", "ST": "T040", "MS": "Growth of organisms using AUTOTROPHIC PROCESSES for obtaining nutrients and chemotrophic processes for obtaining a primary energy supply. Chemotrophic processes are involved in deriving a primary energy supply from exogenous chemical sources. Chemotrophic autotrophs (chemoautotrophs) generally use inorganic chemicals as energy sources and as such are called chemolithoautotrophs. Most chemoautotrophs live in hostile environments, such as deep sea vents. They are mostly BACTERIA and ARCHAEA, and are the primary producers for those ecosystems.", "PM": "2007", "HN": "2007", "MR": "20160616", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052837"}, {"RECTYPE": "D", "MH": "Cystocele", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Urinary Bladder Prolapse|T020|T047|NON|EQV|NLM (2007)|050928|abbcdef", "ENTRY": "Prolapse, Urinary Bladder", "MN": "C23.300.842.624.249", "MH_TH": "NLM (1990)", "ST": "T047", "PI": "Bladder Diseases (1965-2006)", "MS": "A HERNIA-like condition in which the weakened pelvic muscles cause the URINARY BLADDER to drop from its normal position. Fallen urinary bladder is more common in females with the bladder dropping into the VAGINA and less common in males with the bladder dropping into the SCROTUM.", "PM": "2007; see BLADDER DISEASE 1990-2006", "HN": "2007; use URINARY BLADDER DISEASE 1990-2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052858"}, {"RECTYPE": "D", "MH": "Houttuynia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Dokudamus", "MN": "B01.875.800.575.912.250.888.500", "MH_TH": "NLM (2007)", "ST": "T002", "RN": "txid16751", "RR": "txid16752", "MS": "A plant genus of the family SAURURACEAE. Members contain aristolactams.", "PM": "2007", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052859"}, {"RECTYPE": "D", "MH": "Urolithiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lithiasis, Urinary", "MN": "C12.950.967", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Urinary Calculi (1964-2006)", "MS": "Formation of stones in any part of the URINARY TRACT, usually in the KIDNEY; URINARY BLADDER; or the URETER.", "PM": "2007; see URINARY CALCULI 1989-2006", "HN": "2007; use URINARY CALCULI 1989-2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052878"}, {"RECTYPE": "D", "MH": "Subacute Combined Degeneration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Subacute Combined Neuropathy Degeneration|T049|NON|EQV|NLM (2007)|051003|abcdef", "MN": "C23.550.737.625", "MH_TH": "NLM (2007)", "ST": "T049", "PI": "Nervous System Diseases (1965-2006)", "MS": "A neuropathy due to VITAMIN B 12 DEFICIENCY or to excessive NITROUS OXIDE inhalation. It is associated with overproduction of the myelinolytic TUMOR NECROSIS FACTOR-ALPHA.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052879"}, {"RECTYPE": "D", "MH": "Pyomyositis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Myositis, Tropical", "MN": "C10.668.491.562.787", "MH_TH": "NLM (2007)", "ST": "T046", "PI": "Staphylococcal Infections (1965-2006)", "MS": "An intramuscular suppuration of the large skeletal muscle groups. It is associated with INFECTION such as STAPHYLOCOCCUS AUREUS and PYODERMA. It was known as a tropical disease but is increasing among the immunocompromised (IMMUNOCOMPROMISED HOST). Symptoms include muscle pain, FEVER, and leucocytosis. It has been diagnosed by MRI SCANS.", "PM": "2007", "HN": "2007", "MR": "20190617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052880"}, {"RECTYPE": "D", "MH": "Optical Tweezers", "AQ": "AE CL HI SD SN ST TU", "ENTRY": "Tweezers, Optical", "MN": "E05.650", "FX": "Lasers", "MH_TH": "NLM (2007)", "ST": "T059", "PI": "Lasers (1987-2006)", "MS": "A technique that uses LASERS to trap, image, and manipulate small objects (biomolecules, supramolecular assembles, DENDRIMERS) in three dimensional space. (From Glossary of Biotechnology and Nanobiotechnology Terms, 4th ed.)", "PM": "2007", "HN": "2007", "MR": "20180629", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052898"}, {"RECTYPE": "D", "MH": "Pore Forming Cytotoxic Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.543.695", "FX": "Porins", "MH_TH": "NLM (2007)", "ST": "T116", "RN": "0", "PI": "Porins (1980-2006)", "MS": "Proteins secreted from an organism which form membrane-spanning pores in target cells to destroy them. This is in contrast to PORINS and MEMBRANE TRANSPORT PROTEINS that function within the synthesizing organism and COMPLEMENT immune proteins. These pore forming cytotoxic proteins are a form of primitive cellular defense which are also found in human LYMPHOCYTES.", "PM": "2007", "HN": "2007", "MR": "20210510", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052899"}, {"RECTYPE": "D", "MH": "Environmental Restoration and Remediation", "AQ": "EC ES HI IS LJ MT SN ST TD", "PRINT ENTRY": "Site Remediation|T069|NON|NRW|NLM (2007)|051006|abcdef", "ENTRY": "Site Remediations", "MN": "N06.850.460.375", "FX": "Waste Management", "MH_TH": "NLM (2015)", "ST": "T069", "MS": "Restoration of an environment, ecosystem, or habitat that was physically damaged during land development or by natural disaster, or contaminated by ENVIRONMENTAL POLLUTANTS. This is accomplished by various chemical, biological, and bulk movement methods, in conjunction with ENVIRONMENTAL MONITORING.", "PM": "2015; see ENVIRONMENTAL REMEDIATION 2007-2014", "HN": "2015 (2007)", "MR": "20200708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052918"}, {"RECTYPE": "D", "MH": "Refsum Disease, Infantile", "DE": "REFSUM DIS INFANTILE", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Infantile Refsum Disease|T047|EPO|EQV|NLM (1996)|ORD (2010)|940816|INFANTILE REFSUM DIS|abcdeefv", "ENTRY": "Refsums Disease, Infantile", "MN": "C18.452.648.663.865", "MH_TH": "NLM (1996)", "ST": "T047", "AN": "do not confuse with REFSUM DISEASE", "PI": "Refsum Disease (1986-2006)", "MS": "An early onset form of phytanic acid storage disease with clinical and biochemical signs different from those of REFSUM DISEASE. Features include MENTAL RETARDATION; SENSORINEURAL HEARING LOSS; OSTEOPOROSIS; and severe liver damage. It can be caused by mutation in a number of genes encoding proteins involving in the biogenesis or assembly of PEROXISOMES.", "PM": "2007; see PEROXISOMAL DISORDERS 1996-2006", "HN": "2007; use PEROXISOMAL DISORDERS 1996-2006", "MR": "20150608", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052919"}, {"RECTYPE": "D", "MH": "Bariatric Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Bariatric", "MN": "H02.403.074", "FX": "Bariatrics", "MH_TH": "NLM (2007)", "ST": "T091", "AN": "specialty only; BARIATRICS is available for bariatric procedures", "PI": "Bariatrics (2005-2006)", "MS": "The discipline concerned with WEIGHT REDUCTION in patients with OBESITY.", "PM": "2007", "HN": "2007", "MR": "20130709", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052938"}, {"RECTYPE": "D", "MH": "Schizonts", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Schizont", "MN": "G07.345.500.550.500.800", "MH_TH": "NLM (2007)", "ST": "T025", "MS": "Multinucleate cells or a stage in the development of sporozoan protozoa. It is exemplified by the life cycle of PLASMODIUM FALCIPARUM in the MALARIA infection cycle.", "PM": "2007", "HN": "2007", "MR": "20170224", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052939"}, {"RECTYPE": "D", "MH": "Merozoites", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Merozoite", "MN": "G07.345.500.550.500.800.500", "MH_TH": "NLM (2007)", "ST": "T025", "MS": "Uninuclear cells or a stage in the life cycle of sporozoan protozoa. Merozoites, released from ruptured multinucleate SCHIZONTS, enter the blood stream and infect the ERYTHROCYTES.", "PM": "2007", "HN": "2007", "MR": "20170224", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052940"}, {"RECTYPE": "D", "MH": "Tarlov Cysts", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Tarlov Cyst|T020|NON|EQV|NLM (2021)|191231|abcdef", "ENTRY": "Cysts, Tarlov", "MN": "C10.668.829.900", "MH_TH": "ORD (2010)", "ST": "T020", "AN": "non-neoplastic", "MS": "Perineurial cysts commonly found in the SACRAL REGION. They arise from the PERINEURIUM membrane within the SPINAL NERVE ROOTS. The distinctive feature of the cysts is the presence of spinal nerve root fibers within the cyst wall, or the cyst cavity itself.", "PM": "2007; see ARACHNOID CYSTS 2000-2006", "HN": "2007; use ARACHNOID CYSTS 2000-2006", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052958"}, {"RECTYPE": "D", "MH": "Disk Diffusion Antimicrobial Tests", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Tests, Epsilometer", "MN": "E05.200.875.595.399", "MH_TH": "NLM (2007)", "ST": "T059", "PI": "Microbial Sensitivity Tests (1970-2006)", "MS": "A method where a culturing surface inoculated with microbe is exposed to small disks containing known amounts of a chemical agent resulting in a zone of inhibition (usually in millimeters) of growth of the microbe corresponding to the susceptibility of the strain to the agent.", "PM": "2007", "HN": "2007", "MR": "20140606", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052978"}, {"RECTYPE": "D", "MH": "Phycobiliproteins", "AQ": "AD AE AG AI AN BI CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "PRINT ENTRY": "Phycobiliprotein|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Light Harvesting Bacteriochlorophyll Protein Complexes", "MN": "D08.811.600.710.490.500.500", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Light-Harvesting Protein Complexes (2004-2006)", "MS": "Light harvesting proteins found in phycobilisomes.", "PM": "2007; see LIGHT-HARVESTING PROTEIN COMPLEXES 2004-2006, see PROTEINS 1978-2003; for LIGHT-HARVESTING BACTERIOCHLOROPHYLL PROTEIN COMPLEXES see LIGHT-HARVESTING PROTEIN COMPLEXES 1991-2011", "HN": "2007; use LIGHT-HARVESTING PROTEIN COMPLEXES 2004-2006, use LIGHT-HARVESTING PROTEIN COMPLEXES (NM) 1980-2003 & PROTEINS 1978-1979; for LIGHT-HARVESTING BACTERIOCHLOROPHYLL PROTEIN COMPLEXES use LIGHT-HARVESTING PROTEIN COMPLEXES 1991-2011", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052979"}, {"RECTYPE": "D", "MH": "Phycobilins", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D04.345.783.468", "MH_TH": "NLM (2007)", "ST": "T109", "RN": "0", "MS": "Open chain tetrapyrroles that function as light harvesting chromophores in PHYCOBILIPROTEINS.", "PM": "2007", "HN": "2007", "MR": "20160531", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052980"}, {"RECTYPE": "D", "MH": "Metarhizium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Penicillium anisopliae|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Metarhiziums", "MN": "B01.300.381.541", "MH_TH": "NLM (2007)", "ST": "T004", "RN": "txid5529", "RR": "txid5530", "PI": "Mitosporic Fungi (1982-2006)", "MS": "A mitosporic fungal genus in the family Clavicipitaceae. It has teleomorphs in the family Nectriaceae. Metarhizium anisopliae is used in PESTICIDES.", "PM": "2007", "HN": "2007", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052981"}, {"RECTYPE": "D", "MH": "Beauveria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Tritirachium shiotae|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Beauverias", "MN": "B01.300.381.103", "MH_TH": "NLM (2007)", "ST": "T004", "RN": "txid5581", "RR": "txid176275", "MS": "A mitosporic fungal genus. Teleomorphs are found in the family Clavicipitaceae and include Cordyceps bassiana. The species Beauveria bassiana is a common pathogen of ARTHROPODS and is used in PEST CONTROL.", "PM": "2007", "HN": "2007", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052982"}, {"RECTYPE": "D", "MH": "Microcystins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyanoginosins|T116|NON|EQV|NLM (2021)|200706|abcdef", "MN": "D23.946.123.257.500", "PA": "Carcinogens", "MH_TH": "NLM (2007)", "ST": "T116", "RN": "0", "PI": "Peptides, Cyclic (1988-2006)", "MS": "Cyclic heptapeptides found in MICROCYSTIS and other CYANOBACTERIA. Hepatotoxic and carcinogenic effects have been noted. They are sometimes called cyanotoxins, which should not be confused with chemicals containing a cyano group (CN) which are toxic.", "PM": "2007", "HN": "2007", "MR": "20210510", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052998"}, {"RECTYPE": "D", "MH": "Quinazolinones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Quinazolinone|T109|NON|EQV|NLM (2021)|191227|abcdef", "ENTRY": "Quinazolinediones|T109|NON|NRW|NLM (2007)|051017|abcdef", "MN": "D03.633.100.786.830", "MH_TH": "NLM (2007)", "ST": "T109", "RN": "0", "PI": "Quinazolines (1966-2006)", "MS": "Chemicals with two conjoined aromatic rings incorporating two nitrogen atoms and one of the carbons oxidized with a keto oxygen.", "PM": "2007", "HN": "2007", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D052999"}, {"RECTYPE": "D", "MH": "Analytic Sample Preparation Methods", "AQ": "CL EC ES HI IS MT SN ST TD VE", "MN": "E05.196.059", "FX": "Histocytological Preparation Techniques", "MH_TH": "NLM (2007)", "ST": "T059", "MS": "Use of various chemical separation and extraction methods, such as SOLID PHASE EXTRACTION; CHROMATOGRAPHY; and SUPERCRITICAL FLUID EXTRACTION; to prepare samples for analytical measurement of components.", "PM": "2007", "HN": "2007", "MR": "20110624", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053000"}, {"RECTYPE": "D", "MH": "Tool Use Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Tool Use Behaviors", "MN": "F01.145.113.840", "MH_TH": "NLM (2007)", "ST": "T053", "PI": "Behavior, Animal (1973-2006)", "MS": "Modifying, carrying, or manipulating an item external to itself by an animal, before using it to effect a change on the environment or itself (from Beck, Animal Tool Behavior, 1980).", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053001"}, {"RECTYPE": "D", "MH": "Pyonephrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Infected Hydronephrosis", "MN": "C12.950.419.307.500", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "Distention of KIDNEY with the presence of PUS and suppurative destruction of the renal parenchyma. It is often associated with renal obstruction and can lead to total or nearly total loss of renal function.", "PM": "2007; see PYELONEPHRITIS 1984-2006", "HN": "2007; use PYELONEPHRITIS 1984-2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053018"}, {"RECTYPE": "D", "MH": "Quorum Sensing", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Quorum Quenching|T043|NON|REL|NLM (2007)|060313|abcdef", "ENTRY": "Sensing, Quorum", "MN": "G06.550.700", "MH_TH": "NLM (2007)", "ST": "T043", "PI": "Cell Communication (1994-2006)", "MS": "A phenomenon where microorganisms communicate and coordinate their behavior by the accumulation of signaling molecules. A reaction occurs when a substance accumulates to a sufficient concentration. This is most commonly seen in bacteria.", "PM": "2007", "HN": "2007", "MR": "20160623", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053038"}, {"RECTYPE": "D", "MH": "Ureterolithiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ureterolithiases", "MN": "C12.950.967.374", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Ureteral Calculi (1965-2006)", "MS": "Formation of stones in the URETER.", "PM": "2007; see URETERAL CALCULI 1989-2006", "HN": "2007; use URETERAL CALCULI 1989-2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053039"}, {"RECTYPE": "D", "MH": "Nephrolithiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C12.950.967.249", "MH_TH": "NLM (2006)", "ST": "T047", "PI": "Kidney Calculi (1965-2006)", "MS": "Formation of stones in the KIDNEY.", "PM": "2007; see KIDNEY CALCULI 2006", "HN": "2007; use KIDNEY CALCULI 2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053040"}, {"RECTYPE": "D", "MH": "Trophozoites", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Trophozoite", "MN": "G07.345.500.550.500.950", "FX": "Parasite Encystment", "MH_TH": "NLM (2007)", "ST": "T025", "MS": "Cells or feeding stage in the life cycle of sporozoan protozoa. In the malarial parasite, the trophozoite develops from the MEROZOITE and then splits into the SCHIZONT. Trophozoites that are left over from cell division can go on to form gametocytes.", "PM": "2007", "HN": "2007", "MR": "20170224", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053058"}, {"RECTYPE": "D", "MH": "Dengue Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tetravalent Dengue Vaccine|T121|NON|NRW|NLM (2024)|230103|abcdef", "ENTRY": "Vaccines, Dengue", "MN": "D20.215.894.899.162", "MH_TH": "NLM (2007)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1966-2006)", "MS": "Vaccines or candidate vaccines used to prevent infection with DENGUE VIRUS. These include live-attenuated, subunit, DNA, and inactivated vaccines.", "PM": "2007", "HN": "2007", "MR": "20230522", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053059"}, {"RECTYPE": "D", "MH": "West Nile Virus Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D20.215.894.899.962", "MH_TH": "NLM (2007)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (2000-2006)", "MS": "Vaccines or candidate vaccines used to prevent infection with WEST NILE VIRUS.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053060"}, {"RECTYPE": "D", "MH": "Herpes Zoster Vaccine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Shingles Vaccine|T121|T129|NON|EQV|NLM (2007)|051028|abbcdef", "ENTRY": "Vaccine, Zoster", "MN": "D20.215.894.899.290.130.400", "MH_TH": "NLM (2007)", "ST": "T129", "RN": "0", "PI": "Chickenpox Vaccine (1989-2006)", "MS": "An attenuated vaccine used to prevent and/or treat HERPES ZOSTER, a disease caused by HUMAN HERPESVIRUS 3.", "PM": "2007", "HN": "2007", "MR": "20070709", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053061"}, {"RECTYPE": "D", "MH": "Membrane Potential, Mitochondrial", "AQ": "DE GE IM PH RE", "ENTRY": "Transmembrane Potentials, Mitochondrial", "MN": "G07.265.675.550", "MH_TH": "NLM (2007)", "ST": "T043", "PI": "Mitochondria (1974-2006)", "MS": "The voltage difference, normally maintained at approximately -180mV, across the INNER MITOCHONDRIAL MEMBRANE, by a net movement of positive charge across the membrane. It is a major component of the PROTON MOTIVE FORCE in MITOCHONDRIA used to drive the synthesis of ATP.", "PM": "2007", "HN": "2007", "MR": "20190530", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053078"}, {"RECTYPE": "D", "MH": "Trager duck spleen necrosis virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Spleen Necrosis Virus|T005|NON|EQV|NLM (2007)|051031|abcdef", "ENTRY": "Viruses, Spleen Necrosis", "MN": "B04.820.650.375.700.850", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid11836", "AN": "infection: coordinate IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)", "MS": "A species in the group RETICULOENDOTHELIOSIS VIRUSES, AVIAN of the genus GAMMARETROVIRUS originally isolated from ducks.", "PM": "2007; see use RETICULOENDOTHELIOSIS VIRUSES, AVIAN 2001-2006", "HN": "2007; use RETICULOENDOTHELIOSIS VIRUSES, AVIAN 2001-2006", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053079"}, {"RECTYPE": "D", "MH": "Familial Hypophosphatemic Rickets", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rickets, X-Linked Hypophosphatemic|T047|NON|NRW|NLM (1994)|930212|abcdef", "ENTRY": "X-Linked Hypophosphatemic Rickets", "MN": "C18.654.521.500.133.770.734.875.500", "MH_TH": "NLM (2014)", "ST": "T047", "AN": "coordinate with GENETIC DISEASES, X-LINKED if X-linked variant is discussed", "PI": "Vitamin D (1965-2006)", "MS": "A hereditary disorder characterized by HYPOPHOSPHATEMIA; RICKETS; OSTEOMALACIA; renal defects in phosphate reabsorption and vitamin D metabolism; and growth retardation. Autosomal and X-linked dominant and recessive variants have been reported.", "PM": "2014; see HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT 2006-2013; see HYPOPHOSPHATEMIA, FAMILIAL 1994-2006, see RICKETS, VITAMIN D-RESISTANT 1972-1993", "HN": "2014 (2007); use HYPOPHOSPHATEMIA, FAMILIAL 1994-2006, use RICKETS, VITAMIN D-RESISTANT 1972-1993", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053098"}, {"RECTYPE": "D", "MH": "Azotemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Azotaemia|T033|NON|EQV|NLM (2020)|190507|abcdef", "MN": "C23.550.145", "MH_TH": "UNK (19XX)", "ST": "T033", "PI": "Uremia (1965-2006)", "MS": "A biochemical abnormality referring to an elevation of BLOOD UREA NITROGEN and CREATININE. Azotemia can be produced by KIDNEY DISEASES or other extrarenal disorders. When azotemia becomes associated with a constellation of clinical signs, it is termed UREMIA.", "PM": "2007; see UREMIA 1975-2006", "HN": "2007; use UREMIA 1975-2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053099"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H1N1 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Swine-Origin Influenza A H1N1 Virus|T005|ABX|NRW|NLM (2009)|090501|abcdef", "ENTRY": "subtype, H1N1", "MN": "B04.820.480.968.405.400.214", "FX": "Influenza Pandemic, 1918-1919", "MH_TH": "NLM (2006)", "ST": "T005", "RN": "txid114727", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals", "PI": "Influenza A Virus (1978-2005)", "MS": "A subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918 and 2009 H1N1 pandemic.", "PM": "2006", "HN": "2006", "MR": "20230405", "DA": "20051110", "DC": "1", "DX": "20060101", "UI": "D053118"}, {"RECTYPE": "D", "MH": "Benzophenanthridines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.400.131", "MH_TH": "NLM (2007)", "ST": "T109", "RN": "0", "PI": "Alkaloids (1972-2006)", "MS": "Compounds of four rings containing a nitrogen. They are biosynthesized from reticuline via rearrangement of scoulerine. They are similar to BENZYLISOQUINOLINES. Members include chelerythrine and sanguinarine.", "PM": "2007", "HN": "2007", "MR": "20160527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053119"}, {"RECTYPE": "D", "MH": "Respiratory Aspiration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Foreign Body Aspiration|T042|NON|NRW|NLM (2024)|220901|abcdef", "ENTRY": "Foreign Body Aspirations", "MN": "C23.550.773", "FX": "Pneumonia, Aspiration", "MH_TH": "NLM (2007)", "ST": "T042", "AN": "ASPIRATION, MECHANICAL is also available", "PI": "Pneumonia, Aspiration (1965-2006)", "MS": "Inhaling liquid or solids, such as stomach contents, or other FOREIGN OBJECTS, into the RESPIRATORY TRACT. When this causes severe lung damage, it is called ASPIRATION PNEUMONIA.", "PM": "2007; see INHALATION 2004-2006 and PNEUMONIA, ASPIRATION 1984-2006", "HN": "2007; use INHALATION 2004-2006; for ASPIRATION OF GASTRIC CONTENTS use PNEUMONIA, ASPIRATION 1984-2006", "MR": "20221215", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053120"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H2N2 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H2N2 subtype|T005|NON|EQV|NLM (2024)|230223|abcdef", "ENTRY": "Virus, H2N2", "MN": "B04.820.480.968.405.400.250", "MH_TH": "NLM (2006)", "ST": "T005", "RN": "txid114729", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals", "PI": "Influenza A Virus (1975-2005)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 2 and neuraminidase 2. The H2N2 subtype was responsible for the Asian flu pandemic of 1957.", "PM": "2006", "HN": "2006", "MR": "20230531", "DA": "20051110", "DC": "1", "DX": "20060101", "UI": "D053121"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H3N2 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Influenza A H3N2, Variant Virus|T005|NON|NRW|NLM (2024)|230110|abcdef", "ENTRY": "Viruses, H3N2v", "MN": "B04.820.480.968.405.400.300", "MH_TH": "NLM (2006)", "ST": "T005", "RN": "txid119210", "PI": "Influenza A Virus (1975-2005)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 3 and neuraminidase 2. The H3N2 subtype was responsible for the Hong Kong flu pandemic of 1968.", "PM": "2006", "HN": "2006", "MR": "20230522", "DA": "20051110", "DC": "1", "DX": "20060101", "UI": "D053122"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H3N8 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H3N8 subtype|T005|ABX|EQV|NLM (2024)|230223|abcdef", "ENTRY": "subtype, H3N8", "MN": "B04.820.480.968.405.400.350", "MH_TH": "NLM (2006)", "ST": "T005", "RN": "txid119211", "PI": "Influenza A Virus (1983-2005)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 3 and neuraminidase 8. The H3N8 subtype has frequently been found in horses.", "PM": "2006; for INFLUENZA VIRUS, EQUINE see INFLUENZA A VIRUS 1980-2005, see INFECTIOUS ARTERITIS VIRUS OF HORSES 1975-1979", "HN": "2006; for INFLUENZA VIRUS, EQUINE use INFLUENZA A VIRUS 1980-2005, use INFECTIOUS ARTERITIS VIRUS OF HORSES 1975-1979", "MR": "20230405", "DA": "20051110", "DC": "1", "DX": "20060101", "UI": "D053123"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H5N1 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H5N1 subtype|T005|NON|EQV|NLM (2024)|230223|abcdef", "ENTRY": "Virus, H5N1", "MN": "B04.820.480.968.405.400.500", "MH_TH": "NLM (2006)", "ST": "T005", "RN": "txid102793", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals", "PI": "Influenza A Virus (1988-2005)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 5 and neuraminidase 1. The H5N1 subtype, frequently referred to as the bird flu virus, is endemic in wild birds and very contagious among both domestic (POULTRY) and wild birds. It does not usually infect humans, but some cases have been reported.", "PM": "2006", "HN": "2006", "MR": "20230405", "DA": "20051110", "DC": "1", "DX": "20060101", "UI": "D053124"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H5N2 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H5N2 subtype|T005|ABX|EQV|NLM (2024)|230223|abcdef", "ENTRY": "subtype, H5N2", "MN": "B04.820.480.968.405.400.505", "MH_TH": "NLM (2006)", "ST": "T005", "RN": "txid119220", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals", "PI": "Influenza A Virus (1984-2005)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 5 and neuraminidase 2. The H5N2 subtype has been found to be highly pathogenic in chickens.", "PM": "2006", "HN": "2006", "MR": "20230405", "DA": "20051110", "DC": "1", "DX": "20060101", "UI": "D053125"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H7N7 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H7N7 subtype|T005|ABX|EQV|NLM (2024)|230223|abcdef", "ENTRY": "subtype, H7N7", "MN": "B04.820.480.968.405.400.700", "MH_TH": "NLM (2006)", "ST": "T005", "RN": "txid119218", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals", "PI": "Influenza A Virus (1982-2005)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 7 and neuraminidase 7. The H7N7 subtype produced an epidemic in 2003 which was highly pathogenic among domestic birds (POULTRY). Some infections in humans were reported.", "PM": "2006", "HN": "2006", "MR": "20230405", "DA": "20051110", "DC": "1", "DX": "20060101", "UI": "D053126"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H9N2 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H9N2 subtype|T005|NON|EQV|NLM (2024)|230223|abcdef", "ENTRY": "subtype, H9N2", "MN": "B04.820.480.968.405.400.900", "MH_TH": "NLM (2006)", "ST": "T005", "RN": "txid102796", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals", "PI": "Influenza A Virus (1999-2005)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 9 and neuraminidase 2. The H9N2 subtype usually infects domestic birds (POULTRY) but there have been some human infections reported.", "PM": "2006", "HN": "2006", "MR": "20230405", "DA": "20051110", "DC": "1", "DX": "20060101", "UI": "D053127"}, {"RECTYPE": "D", "MH": "Cyclohexenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclohexadienes|T109|NON|REL|NLM (2007)|051116|abcdef", "MN": "D02.455.426.392.368.367.379", "FX": "Benzoquinones", "MH_TH": "NLM (2007)", "ST": "T109", "RN": "0", "PI": "Cyclohexanes (1965-2006)", "MS": "Six-carbon alicyclic hydrocarbons which contain one or more double bonds in the ring. The cyclohexadienes are not aromatic, in contrast to BENZOQUINONES which are sometimes called 2,5-cyclohexadiene-1,4-diones.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053138"}, {"RECTYPE": "D", "MH": "Oseltamivir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "GS 4071|T109|T121|LAB|NRW|NLM (2007)|abbcde", "ENTRY": "Tamiflu|T109|T121|TRD|REL|NLM (2007)|000203|abbcdef", "MN": "D02.455.426.392.368.367.379.500", "PA": "Enzyme Inhibitors", "MH_TH": "NLM (2007)", "ST": "T121", "N1": "ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxy-cyclohexene-1-carboxylate", "RN": "20O93L6F9H", "MS": "An acetamido cyclohexene that is a structural homolog of SIALIC ACID and inhibits NEURAMINIDASE.", "PM": "2007; GS-4071 was indexed under ACETAMIDES 1997-2006", "HN": "2007(1997)", "MR": "20160628", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053139"}, {"RECTYPE": "D", "MH": "Organelle Shape", "AQ": "DE ES GE IM PH RE", "ENTRY": "Shapes, Organelle", "MN": "G04.655", "MH_TH": "NLM (2007)", "ST": "T080", "AN": "coordinate with specific organelle", "MS": "The quality of surface form or outline of ORGANELLES.", "PM": "2007", "HN": "2007", "MR": "20080708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053140"}, {"RECTYPE": "D", "MH": "Organelle Size", "AQ": "DE ES GE IM PH RE", "ENTRY": "Volumes, Organelle", "MN": "G04.670", "MH_TH": "NLM (2007)", "ST": "T081", "AN": "coordinate with specific organelle; MITOCHONDRIAL SIZE is also available", "MS": "The quantity of volume or surface area of ORGANELLES.", "PM": "2007", "HN": "2007", "MR": "20130709", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053141"}, {"RECTYPE": "D", "MH": "Mitochondrial Size", "AQ": "DE ES GE IM PH RE", "ENTRY": "Volumes, Mitochondrial", "MN": "G04.670.560", "FX": "Mitochondrial Swelling", "MH_TH": "NLM (2007)", "ST": "T081", "AN": "coordinate with specific mitochondria term if pertinent", "PI": "Mitochondria or specifics (1965-2006)", "MS": "The quantity of volume or surface area of MITOCHONDRIA.", "PM": "2007", "HN": "2007", "MR": "20080708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053142"}, {"RECTYPE": "D", "MH": "Caspase 2", "DS": "CASPASE 002", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Procaspase 2", "MN": "D12.776.476.075.405.550.200", "EC": "antagonists & inhibitors:Caspase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.22.-", "MS": "A long pro-domain caspase that contains a caspase recruitment domain in its pro-domain region. Activation of this enzyme can occur via the interaction of its caspase recruitment domain with CARD SIGNALING ADAPTOR PROTEINS. Caspase 2 plays a role in APOPTOSIS by cleaving and activating effector pro-caspases. Several isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA.", "PM": "2007; CASPASE 2 was indexed under CASPASES 1994-2006", "HN": "2007(1994)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053143"}, {"RECTYPE": "D", "MH": "Cell Nucleus Shape", "AQ": "DE ES GE IM PH RE", "ENTRY": "Shapes, Cell Nucleus", "MN": "G04.655.270", "MH_TH": "NLM (2007)", "ST": "T080", "PI": "Cell Nucleus (1968-2006)", "MS": "The quality of surface form or outline of the CELL NUCLEUS.", "PM": "2007", "HN": "2007", "MR": "20080708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053144"}, {"RECTYPE": "D", "MH": "Cell Nucleus Size", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Nuclear Size, Cell|T032|T081|NON|EQV|NLM (2007)|051116|abbcdef", "ENTRY": "Volumes, Cell Nucleus", "MN": "G04.670.160", "MH_TH": "NLM (2007)", "ST": "T081", "PI": "Cell Nucleus (1970-2006)", "MS": "The quantity of volume or surface area of a CELL NUCLEUS.", "PM": "2007", "HN": "2007", "MR": "20080708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053145"}, {"RECTYPE": "D", "MH": "Myeloblastin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Wegener Autoantigen|T116|T126|T129|EPO|EQV|NLM (2007)|abbbcde", "ENTRY": "Proteinase 4, Neutrophil", "MN": "D08.811.277.656.959.350.530", "FX": "Granulomatosis with Polyangiitis", "MH_TH": "NLM (2007)", "ST": "T129", "RN": "EC 3.4.21.76", "PI": "Wegener Granulomatosis (1990-2006)", "MS": "A polymorphonuclear leukocyte-derived serine protease that degrades proteins such as ELASTIN; FIBRONECTIN; LAMININ; VITRONECTIN; and COLLAGEN. It is named for its ability to control myeloid cell growth and differentiation.", "PM": "2007", "HN": "2007", "MR": "20090706", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053146"}, {"RECTYPE": "D", "MH": "Plant Exudates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Plant Exudate|T167|NON|EQV|NLM (2022)|201022|abcdef", "ENTRY": "Exudate, Plant", "MN": "D20.215.721", "FX": "Exudates and Transudates", "MH_TH": "NLM (2007)", "ST": "T167", "RN": "0", "PI": "Plants (1966-2006)", "MS": "Substances released by PLANTS such as PLANT GUMS and PLANT RESINS.", "PM": "2007", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053147"}, {"RECTYPE": "D", "MH": "Caspase 3", "DS": "CASPASE 003", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CASP3|T116|T126|ABB|EQV|NLM (2007)|060223|CASP 03|abbcdefs", "ENTRY": "Procaspase 3", "MN": "D12.776.476.075.405.350.300", "EC": "antagonists & inhibitors:Caspase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.22.-", "MS": "A short pro-domain caspase that plays an effector role in APOPTOSIS. It is activated by INITIATOR CASPASES such as CASPASE 9. Isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA.", "PM": "2007; CASPASE 3 was indexed under CASPASES 1999-2005 & under CYSTEINE PROTEINASES 1995-1998", "HN": "2007(1995)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053148"}, {"RECTYPE": "D", "MH": "Plant Gums", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Gums, Plant", "MN": "D20.215.721.249", "MH_TH": "NLM (2007)", "ST": "T167", "RN": "0", "MS": "Polysaccharide gums from PLANTS.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053149"}, {"RECTYPE": "D", "MH": "Simian foamy virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Human foamy virus|T005|NON|EQV|NLM (1991)|891206|abcdef", "ENTRY": "viruses, Simian foamy", "MN": "B04.820.650.850.750", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid11642", "AN": "infection: coordinate IM with RETROVIRIDAE INFECTIONS (IM); note: MACAQUE SIMIAN FOAMY VIRUS; SIMIAN FOAMY VIRUS 1; AFRICAN GREEN MONKEY SIMIAN FOAMY VIRUS; and SIMIAN FOAMY VIRUS 3 are entry terms to SPUMAVIRUS", "PI": "Spumavirus (1975-2006)", "MS": "A species of SPUMAVIRUS causing non-pathogenic infections in chimpanzees and humans.", "PM": "2007; see SPUMAVIRUS 1991-2006", "HN": "2007; use SPUMAVIRUS 1991-2006", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053150"}, {"RECTYPE": "D", "MH": "Nocturia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nycturia|T184|NON|EQV|NLM (1994)|930225|abcdef", "MN": "C23.888.942.343.550", "MH_TH": "NLM (1994)", "ST": "T184", "PI": "Urination Disorders (1969-2006)", "MS": "Frequent URINATION at night that interrupts sleep. It is often associated with outflow obstruction, DIABETES MELLITUS, or bladder inflammation (CYSTITIS).", "PM": "2007; see URINATION DISORDERS 1994-2006", "HN": "2007; use URINATION DISORDERS 1994-2006", "MR": "20110624", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053158"}, {"RECTYPE": "D", "MH": "Dysuria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.942.343.274", "MH_TH": "NLM (2007)", "ST": "T184", "PI": "Urination Disorders (1965-2006)", "MS": "Painful URINATION. It is often associated with infections of the lower URINARY TRACT.", "PM": "2007", "HN": "2007", "MR": "20110624", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053159"}, {"RECTYPE": "D", "MH": "Caspase 6", "DS": "CASPASE 006", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Caspase-6|T116|T126|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.476.075.405.350.600", "EC": "antagonists & inhibitors:Caspase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.22.-", "MS": "A short pro-domain caspase that plays an effector role in APOPTOSIS. It is activated by INITIATOR CASPASES such as CASPASE 7; CASPASE 8; and CASPASE 10. Isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA.", "PM": "2007; CASPASE 6 was indexed under CASPASES 1999-2005 & under CYSTEINE PROTEINASES 1997-1998", "HN": "2007(1997)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053178"}, {"RECTYPE": "D", "MH": "Caspase 7", "DS": "CASPASE 007", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protease, Mch-3", "MN": "D12.776.476.075.405.350.700", "EC": "antagonists & inhibitors:Caspase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.22.-", "MS": "A short pro-domain caspase that plays an effector role in APOPTOSIS. It is activated by INITIATOR CASPASES such as CASPASE 3 and CASPASE 10. Several isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA.", "PM": "2007; CASPASE 7 was indexed under CASPASES 1997-2006", "HN": "2007(1997)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053179"}, {"RECTYPE": "D", "MH": "Animal Nutrition Sciences", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Veterinary Nutrition Sciences|T091|NON|NRW|NLM (2007)|051122|abcdef", "ENTRY": "Veterinary Nutritional Science", "MN": "H02.533.124", "MH_TH": "NLM (2007)", "ST": "T091", "AN": "discipline only; ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA is available for physiologic aspects of animal nutrition", "PI": "Animal Nutrition Physiology (1973-2006)", "MS": "The study of NUTRITION PROCESSES, as well as the components of food, their actions, interaction, and balance in relation to health and disease in animals.", "PM": "2007", "HN": "2007", "MR": "20130708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053180"}, {"RECTYPE": "D", "MH": "Caspase 8", "DS": "CASPASE 008", "AQ": "AD AE AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Procaspase 8", "MN": "D12.776.476.075.421.037", "FX": "Autoimmune Lymphoproliferative Syndrome", "EC": "deficiency:Alstrom Syndrome", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.22.-", "MS": "A long pro-domain caspase that contains a death effector domain in its pro-domain region. Caspase 8 plays a role in APOPTOSIS by cleaving and activating EFFECTOR CASPASES. Activation of this enzyme can occur via the interaction of its N-terminal death effector domain with DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS.", "PM": "2007; CASPASE 8 was indexed under CASPASES 1999-2006 & under CYSTEINE PROTEINASES 1997-1998", "HN": "2007(2000)", "MR": "20210628", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053181"}, {"RECTYPE": "D", "MH": "Child Nutrition Sciences", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sciences, Infant Nutritional", "MN": "H02.533.252", "MH_TH": "NLM (2007)", "ST": "T091", "PI": "Infant Nutrition Physiology (1965-2006)", "MS": "The study of NUTRITION PROCESSES as well as the components of food, their actions, interaction, and balance in relation to health and disease of children, infants or adolescents.", "PM": "2007", "HN": "2007", "MR": "20130708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053198"}, {"RECTYPE": "D", "MH": "TNF Receptor-Associated Death Domain Protein", "DE": "TNF RECEPT ASSOC DEATH DOMAIN PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TNF Receptor Associated Death Domain Protein", "MN": "D12.776.476.075.421.600", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "MS": "A 34 kDa signal transducing adaptor protein that associates with TUMOR NECROSIS FACTOR RECEPTOR TYPE 1. It facilitates the recruitment of signaling proteins such as TNF RECEPTOR-ASSOCIATED FACTOR 2 and FAS ASSOCIATED DEATH DOMAIN PROTEIN to the receptor complex.", "PM": "2007; see TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS 2006, TRADD PROTEIN was indexed under PROTEINS 1994-2004", "HN": "2007(1994)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053199"}, {"RECTYPE": "D", "MH": "Fas-Associated Death Domain Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fas-Associating FADD Protein", "MN": "D12.776.476.075.421.200", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A signal-transducing adaptor protein that associates with TNF RECEPTOR complexes. It contains a death effector domain that can interact with death effector domains found on INITIATOR CASPASES such as CASPASE 8 and CASPASE 10. Activation of CASPASES via interaction with this protein plays a role in the signaling cascade that leads to APOPTOSIS.", "PM": "2007; FAS-ASSOCIATED DEATH DOMAIN PROTEIN was indexed under ADAPTOR PROTEINS, SIGNAL TRANSDUCING 2005 & under CARRIER PROTEINS 1995-2004", "HN": "2007(1995)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053200"}, {"RECTYPE": "D", "MH": "Urinary Bladder, Overactive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Overactive Detrusor|T047|NON|REL|NLM (2007)|051123|abcdef", "ENTRY": "Detrusor, Overactive", "MN": "C23.888.942.343.780", "MH_TH": "NLM (2007)", "ST": "T184", "PI": "Urinary Incontinence (2004-2006)", "MS": "Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.", "PM": "2007; for OVERACTIVE BLADDER see URINARY INCONTINENCE 2005-2006", "HN": "2007; for OVERACTIVE BLADDER use URINARY INCONTINENCE 2005-2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053201"}, {"RECTYPE": "D", "MH": "Urinary Incontinence, Urge", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Incontinence, Urinary Reflex", "MN": "C23.888.942.343.800.750", "MH_TH": "NLM (2007)", "ST": "T184", "PI": "Urinary Incontinence (1965-2006)", "MS": "Involuntary discharge of URINE that is associated with an abrupt and strong desire to void. It is usually related to the involuntary contractions of the detrusor muscle of the bladder (detrusor hyperreflexia or detrusor instability).", "PM": "2007; see URINARY INCONTINENCE 2005-2006", "HN": "2007; use URINARY INCONTINENCE 2005-2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053202"}, {"RECTYPE": "D", "MH": "Root Nodules, Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Root Nodule, Plant", "MN": "A18.400.875", "FX": "Plant Root Nodulation", "MH_TH": "NLM (2007)", "ST": "T002", "PI": "Plant Roots (1994-2006)", "MS": "Knobbed structures formed from and attached to plant roots, especially of LEGUMES, which result from symbiotic infection by nitrogen fixing bacteria such as RHIZOBIUM or FRANKIA. Root nodules are structures related to MYCORRHIZAE formed by symbiotic associations with fungi.", "PM": "2007", "HN": "2007", "MR": "20090706", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053204"}, {"RECTYPE": "D", "MH": "Pollen Tube", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Tubes, Pollen", "MN": "A18.024.249.500.249.500.500", "MH_TH": "NLM (2003)", "ST": "T002", "PI": "Pollen (1966-2006)", "MS": "A growth from a pollen grain down into the flower style which allows two sperm to pass, one to the ovum within the ovule, and the other to the central cell of the ovule to produce endosperm of SEEDS.", "PM": "2007; see FLOWERS 2002-2006", "HN": "2007; use FLOWERS 2002-2006", "MR": "20130708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053205"}, {"RECTYPE": "D", "MH": "Nocturnal Enuresis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bedwetting|T047|NON|EQV|NLM (1998)|970618|abcdef", "ENTRY": "Urinary Incontinence, Nighttime", "MN": "F03.388.400.500", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Enuresis (1965-2006)", "MS": "Involuntary discharge of URINE during sleep at night after expected age of completed development of urinary control.", "PM": "2007; see ENURESIS 1998-2006", "HN": "2007; use ENURESIS 1998-2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053206"}, {"RECTYPE": "D", "MH": "Diurnal Enuresis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Wetting, Daytime", "MN": "F03.388.400.249", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Enuresis (1975-2006)", "MS": "Involuntary discharge of URINE during the daytime while one is awake.", "PM": "2007", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053207"}, {"RECTYPE": "D", "MH": "Kaplan-Meier Estimate", "PRINT ENTRY": "Kaplan-Meier Survival Curve|T081|NON|REL|NLM (2022)|201020|abcdef", "ENTRY": "Test, Kaplan-Meier", "MN": "N06.850.520.830.998.650", "MH_TH": "NLM (2011)", "ST": "T081", "PI": "Survival Analysis (1990-2006)", "MS": "A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)", "PM": "2011; see KAPLAN-MEIERS ESTIMATE 2007-2010", "HN": "2011(2007)", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053208"}, {"RECTYPE": "D", "MH": "Herbicide Resistance", "AQ": "EH GE IM PH RE", "ENTRY": "Resistance, Herbicide", "MN": "G07.690.773.984.443", "MH_TH": "NLM (2007)", "ST": "T032", "AN": "IM when general; NIM when with specific herbicide (IM) & specific plant (IM)", "PI": "Herbicides (1978-2006)", "MS": "Diminished or failed response of PLANTS to HERBICIDES.", "PM": "2007", "HN": "2007", "MR": "20150629", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053209"}, {"RECTYPE": "D", "MH": "Pharmaceutical Preparations, Dental", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Drugs, Dental|T121|NON|EQV|NLM (2009)|080129|abcdef", "ENTRY": "Preparations, Dental Pharmaceutical", "MN": "D26.655", "MH_TH": "NLM (2007)", "ST": "T121", "RN": "0", "AN": "general or unspecified only; do not add routinely as a coordinate with specific drugs", "PI": "Pharmaceutical Preparations (1965-2006)", "MS": "Drugs intended for DENTISTRY.", "PM": "2007", "HN": "2007", "MR": "20180614", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053210"}, {"RECTYPE": "D", "MH": "Receptors, Death Domain", "DE": "RECEPT DEATH DOMAIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Death Receptor|T116|T192|NON|EQV|NLM (2021)|191227|abbcdef", "ENTRY": "Receptor, Death", "MN": "D12.776.543.750.690", "FX": "Receptors, Tumor Necrosis Factor", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A family of cell surface receptors that signal via a conserved domain that extends into the cell CYTOPLASM. The conserved domain is referred to as a DEATH DOMAIN due to the fact that many of these receptors are involved in APOPTOSIS signaling pathways. Several DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS can bind to the death domains of the activated receptors and through a complex series of interactions activate apoptotic mediators such as CASPASES.", "PM": "2007", "HN": "2007", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053218"}, {"RECTYPE": "D", "MH": "Receptors, Tumor Necrosis Factor, Member 25", "DS": "RECEPTORS TUMOR NECROSIS FACTOR MEMBER 25", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 25|T116|T192|NON|EQV|NLM (2007)|051125|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 25|abbcdefs", "ENTRY": "WSL 1 Protein", "MN": "D12.776.543.750.705.852.760.505", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A tumor necrosis factor receptor subtype with specificity for TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15. It is found in tissues containing LYMPHOCYTES and may play a role in regulating lymphocyte homeostasis and APOPTOSIS. The activated receptor signals via a conserved death domain that associates with specific TNF RECEPTOR-ASSOCIATED FACTORS in the CYTOPLASM.", "PM": "2007; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25 was indexed under RECEPTORS, TUMOR NECROSIS FACTOR 1997-2006", "HN": "2007(1997)", "MR": "20160617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053219"}, {"RECTYPE": "D", "MH": "Receptors, TNF-Related Apoptosis-Inducing Ligand", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 10|T116|T192|NON|EQV|NLM (2007)|051205|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10|abbcdefs", "ENTRY": "TRAIL-4 Receptor", "MN": "D12.776.543.750.705.852.760.396", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "Tumor necrosis factor receptor family members that are widely expressed and play a role in regulation of peripheral immune responses and APOPTOSIS. The receptors are specific for TNF-RELATED APOPTOSIS-INDUCING LIGAND and signal via conserved DEATH DOMAINS that associate with specific TNF RECEPTOR-ASSOCIATED FACTORS in the CYTOPLASM.", "PM": "2007; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 10B was indexed under RECEPTOR, TUMOR NECROSIS FACTOR 1997-2006", "HN": "2007(1997)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053220"}, {"RECTYPE": "D", "MH": "TNF-Related Apoptosis-Inducing Ligand", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Ligand Superfamily Member 10|T116|T121|NON|EQV|NLM (2007)|051207|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 010|abbcdefs", "ENTRY": "TNF Related Apoptosis Inducing Ligand", "MN": "D23.529.374.750.625", "MH_TH": "NLM (2007)", "ST": "T121", "RN": "0", "MS": "A transmembrane-protein belonging to the TNF family of intercellular signaling proteins. It is a widely expressed ligand that activates APOPTOSIS by binding to TNF-RELATED APOPTOSIS-INDUCING LIGAND RECEPTORS. The membrane-bound form of the protein can be cleaved by specific CYSTEINE ENDOPEPTIDASES to form a soluble ligand form.", "PM": "2007; TNF-RELATED APOPTOSIS-INDUCING LIGAND was indexed under APOPTOSIS REGULATORY PROTEINS, TUMOR NECROSIS FACTOR-ALPHA and MEMBRANE GLYCOPROTEINS 1996-2006", "HN": "2007(2005)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053221"}, {"RECTYPE": "D", "MH": "Fas Ligand Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Ligand Superfamily Member 6|T116|T123|NON|EQV|NLM (2007)|051207|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 006|abbcdefs", "ENTRY": "Antigen, CD178", "MN": "D23.529.374.750.249", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A transmembrane protein belonging to the tumor necrosis factor superfamily that was originally discovered on cells of the lymphoid-myeloid lineage, including activated T-LYMPHOCYTES and NATURAL KILLER CELLS. It plays an important role in immune homeostasis and cell-mediated toxicity by binding to the FAS RECEPTOR and triggering APOPTOSIS.", "PM": "2007; FAS LIGAND PROTEIN was indexed under TUMOR NECROSIS FACTORS and MEMBRANE GLYCOPROTEINS 1994-2006", "HN": "2007(1994)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053222"}, {"RECTYPE": "D", "MH": "Receptors, Tumor Necrosis Factor, Member 14", "DS": "RECEPTORS TUMOR NECROSIS FACTOR MEMBER 14", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 14|T116|T192|NON|EQV|NLM (2007)|051205|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 14|abbcdefs", "ENTRY": "Entry Mediator, Herpesvirus", "MN": "D12.776.543.750.830.850", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A novel member of the tumor-necrosis factor receptor family that can also mediate HERPES SIMPLEX VIRUS TYPE 1 entry into cells. It has specificity for TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14 and the homotrimeric form of LYMPHOTOXIN-ALPHA. The receptor is abundantly expressed on T-LYMPHOCYTES and may play a role in regulating lymphocyte activation. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.", "PM": "2007; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14 was indexed under RECEPTORS, VIRUS & RECEPTORS, TUMOR NECROSIS FACTOR 1997-2006", "HN": "2007(1997)", "MR": "20160617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053240"}, {"RECTYPE": "D", "MH": "Apoprotein(a)", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Apolipoprotein Lp(a)|T116|T126|ABX|EQV|NLM (2007)|051129|APOLIPOPROTEIN LP A|abbcdefs", "ENTRY": "Protein, Antiangiogenic AK38", "MN": "D12.776.521.400.500", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.21.-", "AN": "do not confuse with APOLIPOPROTEINS A, normal structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS)", "PI": "Apoproteins (1978-2004)", "MS": "A large and highly glycosylated protein constituent of LIPOPROTEIN (A). It has very little affinity for lipids but forms disulfide-linkage to APOLIPOPROTEIN B-100. Apoprotein(a) has SERINE PROTEINASE activity and can be of varying sizes from 400- to 800-kDa. It is homologous to PLASMINOGEN and is known to modulate THROMBOSIS and FIBRINOLYSIS.", "PM": "2007; see APOLIPOPROTEINS A 1988-2006; APOLIPOPROTEIN LP(A+) was indexed under APOLIPOPROTEINS & LIPOPROTEIN(A) 1986-2006", "HN": "2007 (1986); use APOLIPOPROTEINS A 1988-2006", "MR": "20090720", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053241"}, {"RECTYPE": "D", "MH": "Zanamivir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic", "MN": "D09.811.589.668.775", "PA": "Enzyme Inhibitors", "MH_TH": "USAN (19XX)", "ST": "T121", "N1": "5-acetylamino-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid", "RN": "L6O3XI777I", "RR": "139110-80-8 (Zanamivir)", "MS": "A guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.", "PM": "2007; ZANAMIVIR was indexed under SIALIC ACIDS (1998-2006)", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053243"}, {"RECTYPE": "D", "MH": "Osteoprotegerin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 11b|T116|T192|NON|EQV|NLM (2007)|051208|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 11 B|abbcdefs", "ENTRY": "Follicular Dendritic Cell Derived Receptor 1", "MN": "D12.776.543.750.705.852.760.949.249", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A secreted member of the TNF receptor superfamily that negatively regulates osteoclastogenesis. It is a soluble decoy receptor of RANK LIGAND that inhibits both CELL DIFFERENTIATION and function of OSTEOCLASTS by inhibiting the interaction between RANK LIGAND and RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B.", "PM": "2007; OSTEOPROTEGERIN was indexed under RECEPTORS, TUMOR NECROSIS FACTOR, RECEPTORS, CYTOPLASMIC AND NUCLEAR & GLYCOPROTEINS 1997-2006", "HN": "2007(1997)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053244"}, {"RECTYPE": "D", "MH": "RANK Ligand", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Ligand Superfamily Member 11|T116|T123|NON|EQV|NLM (2007)|051129|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 011|abbcdefs", "ENTRY": "Tumor Necrosis Factor Related Activation Induced Cytokine", "MN": "D23.529.374.750.562", "FX": "Denosumab", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A transmembrane protein belonging to the tumor necrosis factor superfamily that specifically binds RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B and OSTEOPROTEGERIN. It plays an important role in regulating OSTEOCLAST differentiation and activation.", "PM": "2007; RANK LIGAND was indexed under CARRIER PROTEINS & MEMBRANE GLYCOPROTEINS 1997-2006", "HN": "2007(1997)", "MR": "20170531", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053245"}, {"RECTYPE": "D", "MH": "Receptor Activator of Nuclear Factor-kappa B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 11a|T116|T192|NON|EQV|NLM (2007)|051208|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 11 A|abbcdefs", "ENTRY": "TRANCE R", "MN": "D12.776.543.750.705.852.760.345", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A tumor necrosis factor receptor family member that is specific for RANK LIGAND and plays a role in bone homeostasis by regulating osteoclastogenesis. It is also expressed on DENDRITIC CELLS where it plays a role in regulating dendritic cell survival. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.", "PM": "2007; for RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 11A see GLYCOPROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; & RECEPTORS, CYTOPLASMIC AND NUCLEAR 1997-2005", "HN": "2007(1997)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053246"}, {"RECTYPE": "D", "MH": "Lymphotoxin beta Receptor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 3|T116|T192|NON|EQV|NLM (2007)|051130|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 03|abbcdefs", "ENTRY": "beta Receptors, Lymphotoxin", "MN": "D12.776.543.750.705.852.760.245", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A member of the tumor necrosis factor receptor superfamily. It has specificity for LYMPHOTOXIN ALPHA1, BETA2 HETEROTRIMER and TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14. The receptor plays a role in regulating lymphoid ORGANOGENESIS and the differentiation of certain subsets of NATURAL KILLER T-CELLS. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.", "PM": "2007; LYMPHOTOXIN BETA RECEPTOR was indexed under RECEPTORS, TUMOR NECROSIS FACTOR 1994-2006", "HN": "2007(1994)", "MR": "20090720", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053259"}, {"RECTYPE": "D", "MH": "Soot", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Carbon Black|T167|NON|NRW|UNK (19XX)|801203|abcdef", "ENTRY": "Black, Carbon", "MN": "D20.633.937.339", "MH_TH": "UNK (19XX)", "ST": "T167", "RN": "0", "PI": "Carbon (1966-2006)", "MS": "A dark powdery deposit of unburned fuel residues, composed mainly of amorphous CARBON and some HYDROCARBONS, that accumulates in chimneys, automobile mufflers and other surfaces exposed to smoke. It is the product of incomplete combustion of carbon-rich organic fuels in low oxygen conditions. It is sometimes called lampblack or carbon black and is used in INK, in rubber tires, and to prepare CARBON NANOTUBES.", "PM": "2007; see CARBON 1966-2006", "HN": "2007", "MR": "20130708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053260"}, {"RECTYPE": "D", "MH": "Tumor Necrosis Factor Receptor Superfamily, Member 9", "DS": "TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 09", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD137 Antigens|T116|T129|T192|ABX|EQV|NLM (2007)|051208|CD 137 ANTIGENS|abbbcdefs", "ENTRY": "Receptors, 4-1BB", "MN": "D12.776.543.750.705.852.760.220", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A member of the tumor necrosis factor receptor superfamily that is specific for 4-1BB LIGAND. It is found in a variety of immune cell types including activated T-LYMPHOCYTES; NATURAL KILLER CELLS; and DENDRITIC CELLS. Activation of the receptor on T-LYMPHOCYTES plays a role in their expansion, production of cytokines and survival. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.", "PM": "2007; see ANTIGENS, CD137 2007-2017; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 9 was indexed under RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, NERVE GROWTH FACTOR and ANTIGENS, CD 1993-2006", "HN": "2018 (1993)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053261"}, {"RECTYPE": "D", "MH": "Receptors, OX40", "DS": "RECEPTORS OX 40", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 4|T116|T192|NON|EQV|NLM (2007)|040210|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 04|abbcdefs", "ENTRY": "Receptor, OX40", "MN": "D12.776.543.750.705.852.760.350", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A tumor necrosis family receptor with specificity for OX40 LIGAND. It is found on the surface of activated T-LYMPHOCYTES where it plays a role in enhancing cytokine production and proliferation of CD4-POSITIVE T-LYMPHOCYTES. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.", "PM": "2007; ANTIGENS, CD134 was indexed under RECEPTORS, TUMOR NECROSIS FACTOR 1993-2005", "HN": "2007(1993)", "MR": "20200327", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053262"}, {"RECTYPE": "D", "MH": "Gene Regulatory Networks", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Transcriptional Networks|T044|NON|EQV|NLM (2007)|051130|abcdef", "ENTRY": "Transcriptional Network", "MN": "G05.360.080.689.360", "FX": "Protein Interaction Maps", "MH_TH": "NLM (2007)", "ST": "T044", "PI": "Gene Expression Regulation or specifics (1986-2006)", "MS": "Interacting DNA-encoded regulatory subsystems in the GENOME that coordinate input from activator and repressor TRANSCRIPTION FACTORS during development, cell differentiation, or in response to environmental cues. The networks function to ultimately specify expression of particular sets of GENES for specific conditions, times, or locations.", "PM": "2007", "HN": "2007", "MR": "20110624", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053263"}, {"RECTYPE": "D", "MH": "B-Cell Activating Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Ligand Superfamily Member 13b|T116|T129|NON|EQV|NLM (2007)|051207|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 013 B|abbcdefs", "ENTRY": "TNF and APOL Related Leukocyte Expressed Ligand 1", "MN": "D23.529.374.750.061", "MH_TH": "NLM (2007)", "ST": "T129", "RN": "0", "MS": "A tumor necrosis factor superfamily member that plays a role in the regulation of B-LYMPHOCYTE survival. It occurs as a membrane-bound protein that is cleaved to release an biologically active soluble form with specificity to TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; B-CELL ACTIVATION FACTOR RECEPTOR; and B-CELL MATURATION ANTIGEN.", "PM": "2007; B-CELL ACTIVATING FACTOR was indexed under TUMOR NECROSIS FACTOR ALPHA & MEMBRANE PROTEINS 1999-2006", "HN": "2007(1999)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053264"}, {"RECTYPE": "D", "MH": "B-Cell Activation Factor Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 13C|T116|T192|NON|EQV|NLM (2007)|051130|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 13 C|abbcdefs", "ENTRY": "Receptor, BAFF", "MN": "D12.776.543.750.705.852.760.222", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Tumor Necrosis Factor (2004-2006)", "MS": "A member of the tumor necrosis factor receptor superfamily that specifically binds B-CELL ACTIVATING FACTOR. It is found on B-LYMPHOCYTES and plays a role in maturation and survival of B-cells. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.", "PM": "2007; for B CELL-ACTIVATING FACTOR RECEPTOR and RECEPTOR, B CELL-ACTIVATING FACTOR see RECEPTORS, INTERLEUKIN-4 1998-2006", "HN": "2007; for B CELL-ACTIVATING FACTOR RECEPTOR and RECEPTOR, B CELL-ACTIVATING FACTOR use RECEPTORS, INTERLEUKIN-4 1998-2006", "MR": "20170522", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053265"}, {"RECTYPE": "D", "MH": "OX40 Ligand", "DS": "OX LIGAND 40", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Ligand Superfamily Member 4|T116|T123|NON|EQV|NLM (2007)|051207|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 004|abbcdefs", "ENTRY": "gp34 Tumor Necrosis Factor|T116|T123|ABX|EQV|NLM (2007)|051201|abbcdef", "MN": "D23.529.374.750.531", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Tumor Necrosis Factors (2006)", "MS": "A membrane-bound tumor necrosis family member that is expressed on activated antigen-presenting cells such as B-LYMPHOCYTES and MACROPHAGES. It signals T-LYMPHOCYTES by binding the OX40 RECEPTOR.", "PM": "2007", "HN": "2007", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053278"}, {"RECTYPE": "D", "MH": "Polyynes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyyne|T109|T121|NON|EQV|NLM (2024)|230308|abbcdef", "ENTRY": "Polyacetylenes, Natural", "MN": "D02.455.326.397.680", "MH_TH": "NLM (2007)", "ST": "T121", "RN": "25067-58-7", "PI": "Acetylene (1980-2006)", "MS": "Hydrocarbons that contain multiple ACETYLENE groups, i.e., more than one triple bond; or an oxidized form of POLYENES.", "PM": "2019; see POLYACETYLENES 2007-2018; POLYACETYLENES was indexed under ACETYLENE 1980-2006", "HN": "2019 (2007); was POLYACETYLENES 2007-2018", "MR": "20230526", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053279"}, {"RECTYPE": "D", "MH": "Diynes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Oxylipins, Bisacetylenic", "MN": "D02.455.326.397.680.500", "MH_TH": "NLM (2007)", "ST": "T109", "RN": "0", "MS": "Compounds with two triple bonds. Some of them are CYTOTOXINS.", "PM": "2007", "HN": "2007", "MR": "20180703", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053280"}, {"RECTYPE": "D", "MH": "Enediynes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Enediyne Group|T109|NON|EQV|NLM (2007)|051221|abcdef", "MN": "D02.455.326.397.680.500.500", "MH_TH": "NLM (2007)", "ST": "T109", "RN": "0", "MS": "Compounds with triple bonds to each side of a double bond. Many of these are CYTOTOXINS and are researched for use as CYTOTOXIC ANTIBIOTICS.", "PM": "2007", "HN": "2007", "MR": "20180705", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053281"}, {"RECTYPE": "D", "MH": "CD27 Ligand", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Ligand Superfamily Member 7|T116|T129|NON|EQV|NLM (2007)|051201|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 007|abbcdefs", "ENTRY": "Ligand, CD27", "MN": "D23.529.374.750.030", "MH_TH": "NLM (2007)", "ST": "T129", "RN": "0", "MS": "A transmembrane protein belonging to the tumor necrosis factor superfamily that specifically binds to CD27 ANTIGEN. It is found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; and DENDRITIC CELLS where it plays a role in stimulating the proliferation of CD4-POSITIVE T-LYMPHOCYTES and CD8-POSITIVE T-LYMPHOCYTES.", "PM": "2018; see ANTIGENS, CD70 2007-2017; CD27 LIGAND was indexed under ANTIGENS, CD; MEMBRANE PROTEINS; and TUMOR NECROSIS FACTORS 1993-2006", "HN": "2018 (1993)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053282"}, {"RECTYPE": "D", "MH": "Apolipoprotein B-48", "DS": "APOLIPOPROTEIN B 048", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apoprotein B 48", "MN": "D12.776.521.120.300.240", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins B (1983-2006)", "MS": "A 241-kDa protein synthesized only in the INTESTINES. It serves as a structural protein of CHYLOMICRONS. Its exclusive association with chylomicron particles provides an indicator of intestinally derived lipoproteins in circulation. Apo B-48 is a shortened form of apo B-100 and lacks the LDL-receptor region.", "PM": "2007; APOLIPOPROTEIN B-48 was indexed under APOLIPOPROTEINS B 1985-2006 & under APOLIPOPROTEINS 1983-1984; CHYLOMICRON APOLIPOPROTEIN B was indexed under APOLIPOPROTEINS B & CHYLOMICRONS 1985-2006", "HN": "2007 (1983)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053283"}, {"RECTYPE": "D", "MH": "Polyunsaturated Alkamides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyunsaturated Isobutylamides|T109|NON|NRW|NLM (2007)|051201|abcdef", "ENTRY": "Isobutylamides, Polyunsaturated|T109|NON|NRW|NLM (2007)|060421|abcdef", "MN": "D02.455.326.397.675", "MH_TH": "NLM (2007)", "ST": "T109", "RN": "0", "MS": "Amides composed of unsaturated aliphatic FATTY ACIDS linked with AMINES by an amide bond. They are most prominent in ASTERACEAE; PIPERACEAE; and RUTACEAE; and also found in ARISTOLOCHIACEAE; BRASSICACEAE; CONVOLVULACEAE; EUPHORBIACEAE; MENISPERMACEAE; POACEAE; and SOLANACEAE. They are recognized by their pungent taste and for causing numbing and salivation.", "PM": "2007", "HN": "2007", "MR": "20180702", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053284"}, {"RECTYPE": "D", "MH": "CD30 Ligand", "DS": "CD 030 LIGAND", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Ligand Superfamily Member 8|T116|T123|NON|EQV|NLM (2007)|051130|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 008|abbcdefs", "ENTRY": "Antigen, CD153", "MN": "D23.529.374.750.092", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A membrane-bound tumor necrosis family member found primarily on activated T-LYMPHOCYTES that binds specifically to CD30 ANTIGEN. It may play a role in INFLAMMATION and immune regulation.", "PM": "2007; CD30 LIGAND was indexed under TUMOR NECROSIS FACTORS & ANTIGENS, CD 2006, & under MEMBRANE GLYCOPROTEINS 1993-2005", "HN": "2007(1993)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053285"}, {"RECTYPE": "D", "MH": "Chylomicron Remnants", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Remnants, Chylomicron", "MN": "D12.776.521.242.500", "FX": "Atherosclerosis", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Chylomicrons (1976-2006)", "MS": "Metabolic products of chylomicron particles in which TRIGLYCERIDES have been selectively removed by the LIPOPROTEIN LIPASE. These remnants carry dietary lipids in the blood and are cholesterol-rich. Their interactions with MACROPHAGES; ENDOTHELIAL CELLS; and SMOOTH MUSCLE CELLS in the artery wall can lead to ATHEROSCLEROSIS.", "PM": "2007; for CHYLOMICRON REMNANT use CHYLOMICRONS 2000-2006", "HN": "2007 (2000)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053298"}, {"RECTYPE": "D", "MH": "Apolipoprotein B-100", "DS": "APOLIPOPROTEIN B 100", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apolipoprotein B 100", "MN": "D12.776.521.120.300.249", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins B (1983-2006)", "MS": "A 513-kDa protein synthesized in the LIVER. It serves as the major structural protein of low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). It is the ligand for the LDL receptor (RECEPTORS, LDL) that promotes cellular binding and internalization of LDL particles.", "PM": "2007; APOLIPOPROTEIN B-100 was indexed under APOLIPOPROTEINS B (1983-2006)", "HN": "2007 (1983)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053299"}, {"RECTYPE": "D", "MH": "Tumor Necrosis Factor Ligand Superfamily Member 13", "DS": "TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 013", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TNF and APOL Related Leukocyte Expressed Ligand 2 Protein", "MN": "D23.529.374.750.656", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Tumor Necrosis Factor-alpha (1998-2006)", "MS": "A member of tumor necrosis factor superfamily found on MACROPHAGES; DENDRITIC CELLS and T-LYMPHOCYTES. It occurs as transmembrane protein that can be cleaved to release a secreted form that specifically binds to TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; and B CELL MATURATION ANTIGEN.", "PM": "2007", "HN": "2007", "MR": "20150623", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053300"}, {"RECTYPE": "D", "MH": "B-Cell Maturation Antigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Receptors, Tumor Necrosis Factor, Member 17|T116|T192|NON|EQV|NLM (2007)|060622|RECEPTORS TUMOR NECROSIS FACTOR MEMBER 17|abbcdefs", "ENTRY": "Maturation Antigen, B-Cell", "MN": "D12.776.543.750.705.852.760.226", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Tumor Necrosis Factor (2001-2006)", "MS": "A member of the tumor necrosis factor receptor superfamily found on mature B-LYMPHOCYTES. It has specificity for B CELL ACTIVATING FACTOR and TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053301"}, {"RECTYPE": "D", "MH": "Apolipoprotein C-I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pre Apo C I", "MN": "D12.776.521.120.400.500", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins C (1977-2006)", "MS": "A 6.6-kDa protein component of VERY-LOW-DENSITY LIPOPROTEINS; INTERMEDIATE-DENSITY LIPOPROTEINS; and HIGH-DENSITY LIPOPROTEINS. Apo C-I displaces APO E from lipoproteins, modulate their binding to receptors (RECEPTORS, LDL), and thereby decrease their clearance from plasma. Elevated Apo C-I levels are associated with HYPERLIPOPROTEINEMIA and ATHEROSCLEROSIS.", "PM": "2007; APOLIPOPROTEIN C-I was indexed under APOLIPOPROTEINS C 1985-2006 & under APOLIPOPROTEINS 1979-1984", "HN": "2007; use APOLIPOPROTEIN C-I (NM) 1979-2006", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053302"}, {"RECTYPE": "D", "MH": "Transmembrane Activator and CAML Interactor Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 13b|T116|T192|NON|EQV|NLM (2007)|051202|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 13 B|abbcdefs", "ENTRY": "Antigen, CD267", "MN": "D12.776.543.750.705.852.760.899", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Tumor Necrosis Factor (2004-2006)", "MS": "A tumor necrosis factor receptor superfamily member found expressed on peripheral B-LYMPHOCYTES. It has specificity for B-CELL MATURATION ANTIGEN and TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13.", "PM": "2007", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053303"}, {"RECTYPE": "D", "MH": "Apolipoprotein C-II", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apoprotein C II", "MN": "D12.776.521.120.400.750", "FX": "Hyperlipoproteinemia Type I", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins C (1977-2006)", "MS": "A 9-kDa protein component of VERY-LOW-DENSITY LIPOPROTEINS. It contains a cofactor for LIPOPROTEIN LIPASE and activates several triacylglycerol lipases. The association of Apo C-II with plasma CHYLOMICRONS; VLDL, and HIGH-DENSITY LIPOPROTEINS is reversible and changes rapidly as a function of triglyceride metabolism. Clinically, Apo C-II deficiency is similar to lipoprotein lipase deficiency (HYPERLIPOPROTEINEMIA TYPE I) and is therefore called hyperlipoproteinemia type IB.", "PM": "2007; APOLIPOPROTEIN C-II was indexed under APOLIPOPROTEINS C 1984-2006 & under APOLIPOPROTEINS 1978-1984", "HN": "2007; use APOLIPOPROTEIN C-II (NM) 1978-2006", "MR": "20090706", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053304"}, {"RECTYPE": "D", "MH": "Apolipoprotein C-III", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sialyl Apolipoprotein C III", "MN": "D12.776.521.120.400.875", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins C (1977-2006)", "MS": "A 9-kDa protein component of VERY-LOW-DENSITY LIPOPROTEINS and CHYLOMICRON REMNANTS. Apo C-III, synthesized in the liver, is an inhibitor of LIPOPROTEIN LIPASE. Apo C-III modulates the binding of chylomicron remnants and VLDL to receptors (RECEPTORS, LDL) thus decreases the uptake of triglyceride-rich particles by the liver cells and subsequent degradation. The normal Apo C-III is glycosylated. There are several polymorphic forms with varying amounts of SIALIC ACID (Apo C-III-0, Apo C-III-1, and Apo C-III-2).", "PM": "2007; APOLIPOPROTEIN C-III was indexed under APOLIPOPROTEINS C 1985-2006 & under APOLIPOPROTEINS 1979-1984", "HN": "2007; use APOLIPOPROTEIN C-III (NM) 1979-2006", "MR": "20130709", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053305"}, {"RECTYPE": "D", "MH": "Hyper-IgM Immunodeficiency Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyper-IgM Immunodeficiency Syndrome, Type 5|T047|ABX|NRW|NLM (2007)|051205|HYPER IGM IMMUNODEFICIENCY SYNDROME TYPE 05|abcdefs", "ENTRY": "Syndromes, Hyper-IgM Immunodeficiency", "MN": "C20.673.795.625", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Immunologic Deficiency Syndromes (1995-2006)", "MS": "A rare inherited immunodeficiency syndrome characterized by normal or elevated serum IMMUNOGLOBULIN M levels with absence of IMMUNOGLOBULIN G; IMMUNOGLOBULIN A; and IMMUNOGLOBULIN E. It results in a profound susceptibility to BACTERIAL INFECTIONS and an increased susceptibility to OPPORTUNISTIC INFECTIONS. Several subtypes of hyper-IgM immunodeficiency syndrome exist depending upon the location of genetic mutation.", "PM": "2007", "HN": "2007", "MR": "20190617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053306"}, {"RECTYPE": "D", "MH": "Hyper-IgM Immunodeficiency Syndrome, Type 1", "DS": "HYPER IGM IMMUNODEFICIENCY SYNDROME TYPE 01", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "X-Linked Hyper-IgM Immunodeficiency", "MN": "C20.673.795.625.500", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Immunologic Deficiency Syndromes (1995-2006)", "MS": "An X-linked hyper-IgM immunodeficiency subtype resulting from mutation in the gene encoding CD40 LIGAND.", "PM": "2007", "HN": "2007", "MR": "20190617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053307"}, {"RECTYPE": "D", "MH": "Lymphotoxin-beta", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Ligand Superfamily Member 3|T116|T123|NON|EQV|NLM (2007)|051205|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 003|abbcdefs", "ENTRY": "beta, Lymphotoxin", "MN": "D23.529.374.750.515", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A membrane-bound tumor necrosis family member found primarily on LYMPHOCYTES. It can form a heterotrimer (LYMPHOTOXIN ALPHA1, BETA2 HETEROTRIMER) with the soluble ligand LYMPHOTOXIN-ALPHA and anchor it to the cell surface. The membrane-bound complex is specific for the LYMPHOTOXIN BETA receptor.", "PM": "2007; LYMPHOTOXIN-BETA was indexed under LYMPHOTOXIN-ALPHA and MEMBRANE PROTEINS 1995-2006", "HN": "2007(1995)", "MR": "20150623", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053308"}, {"RECTYPE": "D", "MH": "Apolipoprotein E3", "DS": "APOLIPOPROTEIN E 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apolipoprotein E epsilon3", "MN": "D12.776.521.120.500.500", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins E (1983-2006)", "MS": "A 34-kDa glycosylated protein. A major and most common isoform of apolipoprotein E. Therefore, it is also known as apolipoprotein E (ApoE). In human, Apo E3 is a 299-amino acid protein with a cysteine at the 112 and an arginine at the 158 position. It is involved with the transport of TRIGLYCERIDES; PHOSPHOLIPIDS; CHOLESTEROL; and CHOLESTERYL ESTERS in and out of the cells.", "PM": "2007; APOLIPOPROTEIN E-3 was indexed under APOLIPOPROTEINS E 1985-2006 & under APOLIPOPROTEINS 1981-1984", "HN": "2007 (1981)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053318"}, {"RECTYPE": "D", "MH": "Tumor Necrosis Factor Decoy Receptors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Decoy TRAIL Receptors|T116|T123|ABX|NRW|NLM (2007)|051206|abbcdef", "ENTRY": "TRAIL Receptors, Decoy", "MN": "D12.776.543.750.705.852.760.949", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Tumor Necrosis Factor Receptors (1996-2006)", "MS": "A subclass of tumor necrosis family receptors that lack cell signaling domains. They bind to specific TNF RECEPTOR LIGANDS and are believed to play a modulating role in the TNF signaling pathway. Some of the decoy receptors are products of distinct genes, while others are products of ALTERNATIVE SPLICING of the MRNA for the active receptor.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053319"}, {"RECTYPE": "D", "MH": "Receptors, Tumor Necrosis Factor, Member 10c", "DS": "RECEPTORS TUMOR NECROSIS FACTOR MEMBER 10 C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 10c|T116|T192|NON|EQV|NLM (2007)|051206|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10 C|abbcdefs", "ENTRY": "TRAIL-3 Receptor", "MN": "D12.776.543.750.705.852.760.949.500", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Tumor Necrosis Factor (1997-2006)", "MS": "A secreted tumor necrosis factor receptor family member that has specificity for TNF-RELATED APOPTOSIS-INDUCING LIGAND. It plays a modulating role in activation of APOPTOSIS signaling.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053320"}, {"RECTYPE": "D", "MH": "Receptors, Tumor Necrosis Factor, Member 6b", "DS": "RECEPTORS TUMOR NECROSIS FACTOR MEMBER 06 B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 6b|T116|T192|NON|EQV|NLM (2007)|051125|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 06 B|abbcdefs", "ENTRY": "Receptor, DcR3", "MN": "D12.776.543.750.705.852.760.949.400", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A secreted tumor necrosis factor receptor family member that has specificity FAS LIGAND and TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14. It plays a modulating role in tumor necrosis factor signaling pathway.", "PM": "2007; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B was indexed under MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; and RECEPTORS, TUMOR NECROSIS FACTOR 1999-2006", "HN": "2007(1999)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053323"}, {"RECTYPE": "D", "MH": "Tumor Necrosis Factor Ligand Superfamily Member 14", "DS": "TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 014", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "LIGHT Protein|T116|T129|ABX|EQV|NLM (2007)|abbcde", "ENTRY": "Herpesvirus Entry Mediator Ligand Protein", "MN": "D23.529.374.750.690", "MH_TH": "NLM (2007)", "ST": "T129", "RN": "0", "MS": "A member of tumor necrosis factor superfamily found on activated LYMPHOCYTES and MONOCYTES. It occurs as transmembrane protein that can be cleaved to release a secreted form that specifically binds to LYMPHOTOXIN BETA RECEPTOR and TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14.", "PM": "2007; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14 was indexed under MEMBRANE PROTEINS and TUMOR NECROSIS FACTOR ALPHA 1998-2006", "HN": "2007(1998)", "MR": "20150623", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053326"}, {"RECTYPE": "D", "MH": "Apolipoprotein E4", "DS": "APOLIPOPROTEIN E 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apolipoprotein E 4", "MN": "D12.776.521.120.500.750", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins E (1982-2006)", "MS": "A major and the second most common isoform of apolipoprotein E. In humans, Apo E4 differs from APOLIPOPROTEIN E3 at only one residue 112 (cysteine is replaced by arginine), and exhibits a lower resistance to denaturation and greater propensity to form folded intermediates. Apo E4 is a risk factor for ALZHEIMER DISEASE and CARDIOVASCULAR DISEASES.", "PM": "2007; APOLIPOPROTEIN E-4 was indexed under APOLIPOPROTEINS E 1985-2006 & under APOLIPPROTEINS 1982-1984", "HN": "2007 (1982)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053327"}, {"RECTYPE": "D", "MH": "Apolipoprotein E2", "DS": "APOLIPOPROTEIN E 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apolipoprotein E epsilon2", "MN": "D12.776.521.120.500.249", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Apolipoproteins E (1984-2006)", "MS": "One of three major isoforms of apolipoprotein E. In humans, Apo E2 differs from APOLIPOPROTEIN E3 at one residue 158 where arginine is replaced by cysteine (R158--C). In contrast to Apo E3, Apo E2 displays extremely low binding affinity for LDL receptors (RECEPTORS, LDL) which mediate the internalization and catabolism of lipoprotein particles in liver cells. ApoE2 allelic homozygosity is associated with HYPERLIPOPROTEINEMIA TYPE III.", "PM": "2007; APOLIPOPROTEIN E-2 was indexed under APOLIPOPROTEINS E 1985-2006 & under APOLIPOPROTEINS 1984", "HN": "2007 (1984)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053329"}, {"RECTYPE": "D", "MH": "4-1BB Ligand", "DS": "BB LIGAND 4 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Ligand Superfamily Member 9|T116|T123|NON|EQV|NLM (2007)|051207|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 009|abbcdefs", "ENTRY": "4 1BBL Protein", "MN": "D23.529.374.750.065", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A membrane bound member of the TNF superfamily that is expressed on activated B-LYMPHOCYTES; MACROPHAGES; and DENDRITIC CELLS. The ligand is specific for the 4-1BB RECEPTOR and may play a role in inducing the proliferation of activated peripheral blood T-LYMPHOCYTES.", "PM": "2007; 4-1BB LIGAND was indexed under TUMOR NECROSIS FACTORS 2006 & under TUMOR NECROSIS FACTOR-ALPHA 1998-2005", "HN": "2007(1998)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053330"}, {"RECTYPE": "D", "MH": "Ectodysplasins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ectodysplasin A", "MN": "D23.529.374.750.186", "FX": "Ectodermal Dysplasia 1, Anhidrotic", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "Transmembrane proteins belonging to the tumor necrosis factor superfamily that play an essential role in the normal development of several ectodermally derived organs. Several isoforms of the ectodysplasins exist due to multiple ALTERNATIVE SPLICING of the MRNA for the protein. The isoforms ectodysplasin A1 and ectodysplasin A2 are considered biologically active and each bind distinct ECTODYSPLASIN RECEPTORS. Genetic mutations that result in loss of function of ectodysplasin result in ECTODERMAL DYSPLASIA 1, ANHIDROTIC.", "PM": "2007; ECTODYSPLASINS was indexed under MEMBRANE PROTEINS & TUMOR NECROSIS FACTORS 1998-2006", "HN": "2007(1999)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053331"}, {"RECTYPE": "D", "MH": "Receptors, Ectodysplasin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ectodysplasin Receptors|T116|T192|NON|EQV|NLM (2007)|051208|abbcdef", "ENTRY": "Receptor, Ectodysplasin A", "MN": "D12.776.543.750.705.852.760.347", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "Members of the TNF receptor family that are specific for ECTODYSPLASIN. At least two subtypes of the ectodysplasin receptor exist, each being specific for a ectodysplasin isoform. Signaling through ectodysplasin receptors plays an essential role in the normal ectodermal development. Genetic defects that result in loss of ectodysplasin receptor function results ECTODERMAL DYSPLASIA.", "PM": "2007; RECEPTORS, ECTODYSPLASIN was indexed under RECEPTORS, TUMOR NECROSIS FACTOR 1999-2006 & under MEMBRANE PROTEINS 1999-2005", "HN": "2007(1999)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053338"}, {"RECTYPE": "D", "MH": "Edar Receptor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member EDAR|T116|T192|ABX|EQV|NLM (2007)|051207|abbcdef", "ENTRY": "Receptor, Edar", "MN": "D12.776.543.750.705.852.760.347.500", "FX": "Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Tumor Necrosis Factor (2002-2006)", "MS": "A ectodysplasin receptor subtype that is specific for ECTODYSPLASIN A1. It signals via the specific signaling adaptor EDAR-ASSOCIATED DEATH DOMAIN PROTEIN. Loss of function of the edar receptor is associated with AUTOSOMAL RECESSIVE ANHIDROTIC ECTODERMAL DYSPLASIA and ECTODERMAL DYSPLASIA 3, ANHIDROTIC.", "PM": "2007; EDAR RECEPTOR was indexed under RECEPTORS, TUMOR NECROSIS FACTOR 2006", "HN": "2007(2006)", "MR": "20160617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053339"}, {"RECTYPE": "D", "MH": "Xedar Receptor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 27|T116|T192|NON|EQV|NLM (2007)|051208|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 27|abbcdefs", "ENTRY": "X Linked Edar Receptor", "MN": "D12.776.543.750.705.852.760.347.750", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "An ectodysplasin receptor subtype that is specific for ECTODYSPLASIN A2. Unlike the EDAR RECEPTOR the Xedar receptor signals through direct association with TNF RECEPTOR-ASSOCIATED FACTORS. The protein name derives from the fact that gene that encodes it resides on the X CHROMOSOME.", "PM": "2007; XEDAR RECEPTOR was indexed under RECEPTORS, TUMOR NECROSIS FACTOR 2005-2006", "HN": "2007(2005)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053340"}, {"RECTYPE": "D", "MH": "Ectodermal Dysplasia 1, Anhidrotic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Christ-Siemens-Touraine Syndrome|T019|T047|EPO|EQV|GHR (2014)|NLM (1993)|OMIM (2013)|ORD (2010)|920407|abbcdeeeef", "ENTRY": "X Linked Hypohydridic Ectodermal Dysplasia", "MN": "C17.800.827.250.198", "FX": "Ectodysplasins", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An X-linked form of ectodermal dysplasia which results from mutations of the gene encoding ECTODYSPLASIN.", "PM": "2007; see ECTODERMAL DYSPLASIA 1993-2006", "HN": "2007(1993)", "MR": "20150618", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053358"}, {"RECTYPE": "D", "MH": "Ectodermal Dysplasia 3, Anhidrotic", "DS": "ECTODERMAL DYSPLASIA ANHIDROTIC 03", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ectodermal Dysplasia, Hypohidrotic, Autosomal Dominant|T019|T047|NON|EQV|NLM (2007)|OMIM (2013)|051209|abbcdeef", "MN": "C17.800.827.250.298", "FX": "Edar Receptor", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Ectodermal Dysplasia (1987-2006)", "MS": "An autosomal dominant form of ectodermal dysplasia which is due to mutations in the gene for the EDAR RECEPTOR.", "PM": "2007", "HN": "2007", "MR": "20150618", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053359"}, {"RECTYPE": "D", "MH": "Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ectodermal Dysplasia, Hypohydrotic, Autosomal Recessive|T019|T047|NON|EQV|NLM (2007)|060127|abbcdef", "MN": "C17.800.827.250.348", "FX": "Edar-Associated Death Domain Protein", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Ectodermal Dysplasia (1971-2006)", "MS": "An autosomal recessive form of ectodermal dysplasia which is due to mutations in the gene for the EDAR RECEPTOR or EDAR-ASSOCIATED DEATH DOMAIN PROTEIN.", "PM": "2007", "HN": "2007", "MR": "20150618", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053360"}, {"RECTYPE": "D", "MH": "Lymphotoxin alpha1, beta2 Heterotrimer", "DS": "LYMPHOTOXIN ALPHA BETA HETEROTRIMER 01 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alphabeta Heterotrimer, Lymphotoxin", "MN": "D23.529.374.750.505", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Tumor Necrosis Factors (1974-2006)", "MS": "A heterotrimer complex consisting of one molecule of LYMPHOTOXIN-ALPHA and two molecules of the LYMPHOTOXIN-BETA. It is anchored to the cell surface via the transmembrane domains of the lymphotoxin-beta component and has specificity for the LYMPHOTOXIN BETA RECEPTOR. The lymphotoxin alpha1, beta2 heterotrimer plays a role in regulating lymphoid ORGANOGENESIS and the differentiation of certain subsets of NATURAL KILLER CELLS.", "PM": "2007", "HN": "2007", "MR": "20150623", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053361"}, {"RECTYPE": "D", "MH": "Edar-Associated Death Domain Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Edar Associated Death Domain Protein", "MN": "D12.776.476.075.421.100", "EC": "deficiency:Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A tumor necrosis factor receptor-associated factor that acts as a specific signaling adaptor protein for the EDAR RECEPTOR and plays an important role in ectodermal development. It binds to edar receptor via its C-terminal death domain region and to other specific TNF receptor-associated factors via its N-terminal domain. Loss of function of edar-associated death domain protein is associated with AUTOSOMAL RECESSIVE ANHIDROTIC ECTODERMAL DYSPLASIA.", "PM": "2007; EDAR-ASSOCIATED DEATH DOMAIN PROTEIN was indexed under TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS 2002-2006", "HN": "2007(2002)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053362"}, {"RECTYPE": "D", "MH": "Chromogranin B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Secretogranin I|T116|T123|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.631.199.500", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Chromogranins (1985-2006)", "MS": "A type of chromogranin which was initially characterized in a rat PHEOCHROMOCYTOMA CELL LINE. It is found in many species including human, rat, mouse, and others. It is an acidic protein with 626 to 657 amino acid residues. In some species, it inhibits secretion of PARATHYROID HORMONE or INSULIN and exerts bacteriolytic effects in others.", "PM": "2007; CHROMOGRANIN B was indexed under CHROMOGRANINS 1985-2006 & PROTEINS 1985-2006", "HN": "2007 (1985)", "MR": "20151123", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053378"}, {"RECTYPE": "D", "MH": "Chromogranin A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Secretory Protein, Parathyroid", "MN": "D12.776.631.199.249", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Chromogranins (1973-2006)", "MS": "A type of chromogranin which was first isolated from CHROMAFFIN CELLS of the ADRENAL MEDULLA but is also found in other tissues and in many species including human, bovine, rat, mouse, and others. It is an acidic protein with 431 to 445 amino acid residues. It contains fragments that inhibit vasoconstriction or release of hormones and neurotransmitter, while other fragments exert antimicrobial actions.", "PM": "2007; CHROMOGRANIN A was indexed under CHROMOGRANINS 1981-2006", "HN": "2007 (1981)", "MR": "20160527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053379"}, {"RECTYPE": "D", "MH": "Tumor Necrosis Factor Ligand Superfamily Member 15", "DS": "TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 015", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ligand, TL1A", "MN": "D23.529.374.750.710", "PA": "Angiogenesis Inhibitors", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Tumor Necrosis Factors (1999-2006)", "MS": "A member of tumor necrosis factor superfamily found on ENDOTHELIAL CELLS that plays a role in the inhibition of endothelial cell growth and PHYSIOLOGIC ANGIOGENESIS.", "PM": "2007", "HN": "2007", "MR": "20150623", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053380"}, {"RECTYPE": "D", "MH": "Secretogranin II", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chromogranin C|T116|T123|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.631.199.750", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Chromogranins (1986-2006)", "MS": "A type of chromogranin which was initially characterized in the ANTERIOR PITUITARY GLAND. It is found in several species including human, rat, mouse, and others. Secretogranin II is an acidic protein of 559 to 586 amino acid residues that can stimulate DOPAMINE release from neurons and release of pituitary GONADOTROPINS.", "PM": "2007; SECRETOGRANIN II was indexed under CHROMOGRANINS 1986-2006 & under PROTEINS 1986-2006", "HN": "2007 (1986)", "MR": "20151124", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053381"}, {"RECTYPE": "D", "MH": "Apolipoproteins D", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apolipoprotein D|T116|T123|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.521.120.450", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Apoproteins (1973-1976)", "MS": "A glycoprotein component of HIGH-DENSITY LIPOPROTEINS that transports small hydrophobic ligands including CHOLESTEROL and STEROLS. It occurs in the macromolecular complex with LECITHIN CHOLESTEROL ACYLTRANSFERASE. Apo D is expressed in and secreted from a variety of tissues such as liver, placenta, brain tissue and others.", "PM": "2007; APOLIPOPROTEIN D was indexed under APOLIPOPROTEINS 1980-2006", "HN": "2007", "MR": "20090720", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053399"}, {"RECTYPE": "D", "MH": "High Vocal Center", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vocal Center, High", "MN": "A13.468", "FX": "Songbirds", "MH_TH": "NLM (2007)", "ST": "T023", "AN": "found in birds only", "MS": "Nucleus in the NEOSTRIATUM of bird brains that sends signals for song production and receives auditory input. In some adult SONGBIRDS, research has shown that the size of this nucleus changes seasonally and that it exhibits neurogenesis.", "PM": "2007", "HN": "2007", "MR": "20180630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053400"}, {"RECTYPE": "D", "MH": "Palmar Plate", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Volar Plates, Thumb", "MN": "A10.165.382.350.200", "MH_TH": "NLM (2007)", "ST": "T023", "MS": "A thick, fibrocartilaginous ligament at the METACARPOPHALANGEAL JOINT of the hand.", "PM": "2016; see VOLAR PLATE 2007-2015", "HN": "2016; use VOLAR PLATE 2007-2015", "MR": "20210304", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053401"}, {"RECTYPE": "D", "MH": "PHEX Phosphate Regulating Neutral Endopeptidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "X Linked Phosphate Regulating Endopeptidase Homolog", "MN": "D12.776.543.550.607", "EC": "deficiency:Familial Hypophosphatemic Rickets", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.-", "MS": "A membrane-bound metalloendopeptidase that may play a role in the degradation or activation of a variety of PEPTIDE HORMONES and INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS. Genetic mutations that result in loss of function of this protein are a cause of HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT.", "PM": "2007; PHEX PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE was indexed under MEMBRANE GLYCOPROTEINS & METALLOENDOPEPTIDASES 2006, & PROTEINS 1995-2006", "HN": "2007(1995)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053402"}, {"RECTYPE": "D", "MH": "Lateral Line System", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Systems, Lateral Line", "MN": "A13.564", "MH_TH": "NLM (2007)", "ST": "T022", "MS": "Aquatic vertebrate sensory system in fish and amphibians. It is composed of sense organs (canal organs and pit organs) containing neuromasts (MECHANORECEPTORS) that detect water displacement caused by moving objects.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053403"}, {"RECTYPE": "D", "MH": "Death Domain Receptor Signaling Adaptor Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "fas Death Inducing Signaling Complex Components", "MN": "D12.776.476.075.421", "FX": "Death Effector Domain", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "Intracellular signaling adaptor proteins that contain DEATH EFFECTOR DOMAINS and bind to the cytoplasmic DEATH DOMAIN region found on DEATH DOMAIN RECEPTORS. Many of the proteins in this class take part in intracellular signaling involving TUMOR NECROSIS FACTOR RECEPTORS.", "PM": "2007; DISC (DEATH INDUCING SIGNALING COMPLEX) was indexed under TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS 2006 & and under RECEPTORS, TUMOR NECROSIS FACTORS 2002-2006", "HN": "2007(2002)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053418"}, {"RECTYPE": "D", "MH": "Lipoproteins, IDL", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Very-Low-Density Lipoproteins|T109|T116|T123|NON|NRW|UNK (19XX)|810318|abbbcdef", "ENTRY": "beta-Lipoproteins, Floating", "MN": "D12.776.521.514", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Lipoproteins, VLDL (1984-2006)", "MS": "A mixture of very-low-density lipoproteins (VLDL), particularly the triglyceride-poor VLDL, with slow diffuse electrophoretic mobilities in the beta and alpha2 regions which are similar to that of beta-lipoproteins (LDL) or alpha-lipoproteins (HDL). They can be intermediate (remnant) lipoproteins in the de-lipidation process, or remnants of mutant CHYLOMICRONS and VERY-LOW-DENSITY LIPOPROTEINS which cannot be metabolized completely as seen in FAMILIAL DYSBETALIPOPROTEINEMIA.", "PM": "2007; LIPOPROTEINS, IDL was indexed under LIPOPROTEINS 1978-2006; for BETA-VERY-LOW-DENSITY LIPOPROTEINS see LIPOPROTEINS, VLDL 1982-2006; for ALPHA2-VERY-LOW-DENSITY LIPOPROTEINS see LIPOPROTEINS, VLDL 1986-2006", "HN": "2007, use LIPOPROTEINS, IDL (NM) 1978-2006; for BETA-VERY-LOW-DENSITY LIPOPROTEINS use LIPOPROTEINS, VLDL 1982-2006; for ALPHA2-VERY-LOW-DENSITY LIPOPROTEINS use LIPOPROTEINS, VLDL 1986-2006", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053419"}, {"RECTYPE": "D", "MH": "CRADD Signaling Adaptor Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RAIDD Signaling Adaptor Protein|T116|T123|ABX|EQV|NLM (2007)|051216|abbcdef", "ENTRY": "RIP Associated Protein With a Death Domain", "MN": "D12.776.476.075.421.050", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Proteins (1997-2004)", "MS": "A death domain receptor signaling adaptor protein that plays a role in signaling the activation of INITIATOR CASPASES such as CASPASE 2. It contains a death domain that is specific for RIP SERINE-THEONINE KINASES and a caspase-binding domain that binds to and activates CASPASES such as CASPASE 2.", "PM": "2007", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053420"}, {"RECTYPE": "D", "MH": "Hand-Arm Vibration Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vibration Syndromes, Hand-Arm", "MN": "C24.400", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Occupational Diseases (1984-2006)", "MS": "An occupational disorder resulting from prolonged exposure to vibration, affecting the fingers, hands, and forearms. It occurs in workers who regularly use vibrating tools such as jackhammers, power chain saws, riveters, etc. Symptoms include episodic finger blanching, NUMBNESS, tingling, and loss of nerve sensitivity.", "PM": "2007", "HN": "2007", "MR": "20130709", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053421"}, {"RECTYPE": "D", "MH": "Receptor-Interacting Protein Serine-Threonine Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RIP Serine-Threonine Kinases|T116|T126|ABX|EQV|NLM (2007)|051216|abbcdef", "ENTRY": "Serine-Threonine Kinases, RIP", "MN": "D12.776.476.563.801", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 2.7.11.1", "RR": "EC 2.7.11.1", "MS": "A family of serine-threonine kinases that plays a role in intracellular signal transduction by interacting with a variety of signaling adaptor proteins such as CRADD SIGNALING ADAPTOR PROTEIN; TNF RECEPTOR-ASSOCIATED FACTOR 2; and TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN. Although they were initially described as death domain-binding adaptor proteins, members of this family may contain other protein-binding domains such as those involving caspase activation and recruitment.", "PM": "2007; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES was indexed under PROTEIN-SERINE THREONINE KINASES & TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PROTEINS 2006, & under PROTEINS 1995-2006", "HN": "2007(1995)", "MR": "20210628", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053422"}, {"RECTYPE": "D", "MH": "Lipoproteins, HDL2", "DS": "LIPOPROTEINS HDL 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "High Density Lipoprotein-2|T109|T116|T123|NON|EQV|NLM (2007)|HIGH DENSITY LIPOPROTEIN 002|abbbcdes", "ENTRY": "Lipoprotein, HDL2", "MN": "D12.776.521.479.735", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Lipoproteins (1965-2006)", "MS": "Low-density subclass of the high-density lipoproteins, with particle sizes between 8 to 13 nm.", "PM": "2007; HIGH DENSITY LIPOPROTEIN-2 was indexed under LIPOPROTEIN, HDL 1980-2006", "HN": "2007 (1980)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053439"}, {"RECTYPE": "D", "MH": "Lipoproteins, HDL3", "DS": "LIPOPROTEINS HDL 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "High Density Lipoprotein-3|T109|T116|T123|NON|EQV|NLM (2007)|HIGH DENSITY LIPOPROTEIN 003|abbbcdes", "ENTRY": "Lipoprotein, HDL3", "MN": "D12.776.521.479.867", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Lipoproteins (1965-2006)", "MS": "Intermediate-density subclass of the high-density lipoproteins, with particle sizes between 7 to 8 nm. As the larger lighter HDL2 lipoprotein, HDL3 lipoprotein is lipid-rich.", "PM": "2007, see LIPOPROTEINS HDL 1982-2006; HIGH-DENSITY LIPOPROTEIN-3 was indexed under LIPOPROTEINS, HDL 1980-2006", "HN": "2007 (1980)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053440"}, {"RECTYPE": "D", "MH": "Suture Anchors", "AQ": "AE CL EC ES HI MI PS SD SN ST VE VI", "PRINT ENTRY": "Bone Anchors|T074|NON|REL|NLM (2007)|051219|abcdef", "ENTRY": "Suture Anchor", "MN": "E07.858.690.725.460.734", "FX": "Tenodesis", "MH_TH": "NLM (2007)", "ST": "T074", "PI": "Suture Techniques (1993-2006)", "MS": "Implants used in arthroscopic surgery and other orthopedic procedures to attach soft tissue to bone. One end of a suture is tied to soft tissue and the other end to the implant. The anchors are made of a variety of materials including titanium, stainless steel, or absorbable polymers.", "PM": "2007", "HN": "2007", "MR": "20180629", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053441"}, {"RECTYPE": "D", "MH": "High-Density Lipoproteins, Pre-beta", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "PreBeta HDL", "MN": "D12.776.521.479.602", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Lipoproteins, HDL (1990-2006)", "MS": "A highly dense subclass of the high-density lipoproteins, with particle sizes below 7 nm. They are also known as nascent HDL, composed of a few APOLIPOPROTEIN A-I molecules which are complexed with PHOSPHOLIPIDS. The lipid-poor pre-beta-HDL particles serve as progenitors of HDL3 and then HDL2 after absorption of free cholesterol from cell membranes, cholesterol esterification, and acquisition of apolipoproteins A-II, Cs, and E. Pre-beta-HDL initiate the reverse cholesterol transport process from cells to liver.", "PM": "2007; PRE-BETA HIGH-DENSITY LIPOPROTEIN was indexed under LIPOPROTEINS, HDL 1992-2006", "HN": "2007 (1992)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053442"}, {"RECTYPE": "D", "MH": "Visible Human Projects", "AQ": "ES HI SN", "PRINT ENTRY": "Visible Korean Human Project|T170|NON|NRW|NLM (2007)|051219|abcdef", "ENTRY": "Visible Chinese Human Project|T170|NON|NRW|NLM (2007)|051219|abcdef", "MN": "L01.470.750.750.905", "FX": "Imaging, Three-Dimensional", "MH_TH": "NLM (2007)", "ST": "T170", "AN": "coordinate with specific country including CHINA; KOREA; UNITED STATES if pertinent; CATALOGER: Coordinate with specific NAF entry if applicable", "PI": "Anatomy, Cross-Sectional (1991-2004)", "MS": "Digital image data sets, consisting of complete, anatomically detailed, three-dimensional representations of the normal male and female human bodies.", "PM": "2007; for UNITED STATES VISIBLE HUMAN PROJECT see VISIBLE HUMAN PROJECT 2005-2006", "HN": "2007", "MR": "20150623", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053443"}, {"RECTYPE": "D", "MH": "Inhibitory Postsynaptic Potentials", "AQ": "DE GE IM PH RE", "ENTRY": "Potentials, Inhibitory Postsynaptic", "MN": "G11.561.830.750.400", "MH_TH": "NLM (2007)", "ST": "T042", "AN": "for miniature inhibitory postsynaptic potentials coordinate with MINIATURE POSTSYNAPTIC POTENTIALS", "PI": "Synaptic Transmission (1968-2006)", "MS": "Hyperpolarization of membrane potentials at the SYNAPTIC MEMBRANES of target neurons during NEUROTRANSMISSION. They are local changes which diminish responsiveness to excitatory signals.", "PM": "2007", "HN": "2007", "MR": "20160623", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053444"}, {"RECTYPE": "D", "MH": "CASP8 and FADD-Like Apoptosis Regulating Protein", "DS": "CASP 08 AND FADD LIKE APOPTOSIS REGULATING PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "FLIP S Protein", "MN": "D12.776.476.075.421.024", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "An APOPTOSIS-regulating protein that is structurally related to CASPASE 8 and competes with CASPASE 8 for binding to FAS ASSOCIATED DEATH DOMAIN PROTEIN. Two forms of CASP8 and FADD-like apoptosis regulating protein exist, a long form containing a caspase-like enzymatically inactive domain and a short form which lacks the caspase-like domain.", "PM": "2007; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN was indexed under INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 2005-2006 & under CARRIER PROTEINS 2005-2006", "HN": "2007(1997)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053446"}, {"RECTYPE": "D", "MH": "Channelopathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Channelopathy", "MN": "C23.550.177", "FX": "Neuromuscular Junction Diseases", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Ion Channels (1993-2006)", "MS": "A variety of neuromuscular conditions resulting from MUTATIONS in ION CHANNELS manifesting as episodes of EPILEPSY; HEADACHE DISORDERS; and DYSKINESIAS.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053447"}, {"RECTYPE": "D", "MH": "Prostatism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.942.343.600", "FX": "Prostatic Hyperplasia", "MH_TH": "NLM (1998)", "ST": "T184", "AN": "do not confuse with PROSTATITIS", "PI": "Prostatic Hyperplasia (1951-2006)", "MS": "Lower urinary tract symptom, such as slow urinary stream, associated with PROSTATIC HYPERPLASIA in older men.", "PM": "2007; see PROSTATIC HYPERPLASIA 1998-2006", "HN": "2007; use PROSTATIC HYPERPLASIA 1998-2006", "MR": "20110624", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053448"}, {"RECTYPE": "D", "MH": "TNF Receptor-Associated Factor 4", "DS": "TNF RECEPTOR ASSOCIATED FACTOR 04", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TNF Receptor Associated Protein 4", "MN": "D12.776.476.024.500.906", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A widely expressed member of the TNF receptor-associated family that may play a role in neuronal development and EMBRYOGENESIS. Although TNF receptor-associated factor 4 does not strongly associate with TUMOR NECROSIS FACTOR RECEPTORS it may be a signaling partner with the GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN that plays a role in the activation of JNK MITOGEN-ACTIVATED PROTEIN KINASES and NF-KAPPA B.", "PM": "2007: TNF RECEPTOR-ASSOCIATED FACTOR 4 was indexed under TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS 1995-2006", "HN": "2007(1995)", "MR": "20151124", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053449"}, {"RECTYPE": "D", "MH": "Glucocorticoid-Induced TNFR-Related Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tumor Necrosis Factor Receptor Superfamily, Member 18|T116|T192|NON|EQV|NLM (2007)|051221|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 18|abbcdefs", "ENTRY": "TNFR-Related Protein, Glucocorticoid-Induced", "MN": "D12.776.543.750.705.852.760.238", "FX": "Autoimmune Lymphoproliferative Syndrome", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Tumor Necrosis Factor (2004-2006)", "MS": "A member of the TNF receptor family that was initially identified as a DEXAMETHASONE-induced protein from a T-CELL line. It may play a role in regulating APOPTOSIS and modulating immune response by T-lymphocytes. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.", "PM": "2007", "HN": "2007", "MR": "20170629", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053450"}, {"RECTYPE": "D", "MH": "Caspase 9", "DS": "CASPASE 009", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Procaspase 9", "MN": "D12.776.476.075.405.550.900", "EC": "antagonists & inhibitors:Caspase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.22.-", "AN": "Do not confuse with CAS9 ENZYME see CRISPR-ASSOCIATED PROTEIN 9", "MS": "A long pro-domain caspase that contains a CASPASE RECRUITMENT DOMAIN in its pro-domain region. Caspase 9 is activated during cell stress by mitochondria-derived proapoptotic factors and by CARD SIGNALING ADAPTOR PROTEINS such as APOPTOTIC PROTEASE-ACTIVATING FACTOR 1. It activates APOPTOSIS by cleaving and activating EFFECTOR CASPASES.", "PM": "2007; CASPASE 9 was indexed under CASPASES 1999-2005, & under CYSTEINE PROTEINASES 1996-1998", "HN": "2007(2005)", "MR": "20210603", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053453"}, {"RECTYPE": "D", "MH": "Caspase 12", "DS": "CASPASE 012", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Caspase-12|T116|T126|NON|EQV|NLM (2007)|000124|abbcdef", "MN": "D12.776.476.075.405.550.920", "EC": "antagonists & inhibitors:Caspase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.22.-", "MS": "A long pro-domain caspase that contains a caspase recruitment domain in its pro-domain region. Caspase 12 is activated by pro-apoptotic factors that are released during cell stress and by CARD SIGNALING ADAPTOR PROTEINS. It activates APOPTOSIS by cleaving and activating EFFECTOR CASPASES.", "PM": "2007; CASPASE 12 was indexed under CASPASES 2000-2005", "HN": "2007(2000)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053454"}, {"RECTYPE": "D", "MH": "Caspase 10", "DS": "CASPASE 010", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protease, Mch4", "MN": "D12.776.476.075.405.550.910", "FX": "Autoimmune Lymphoproliferative Syndrome", "EC": "antagonists & inhibitors:Caspase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.22.-", "MS": "A long pro-domain caspase that contains a death effector domain in its pro-domain region. Activation of this enzyme can occur via the interaction of its N-terminal death effector domain with DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS. Caspase 10 plays a role in APOPTOSIS by cleaving and activating EFFECTOR CASPASES. Several isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA.", "PM": "2007; CASPASE 10 was indexed under CASPASES 1998-2005", "HN": "2007(1998)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053455"}, {"RECTYPE": "D", "MH": "Caspase 14", "DS": "CASPASE 014", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CASP 14", "MN": "D12.776.476.075.405.350.900", "EC": "antagonists & inhibitors:Caspase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.22.-", "MS": "A short pro-domain caspase that is almost exclusively expressed in the EPIDERMIS and may play a role in the differentiation of epidermal KERATINOCYTES.", "PM": "2007; CASPASE 14 was indexed under CASPASES 1998-2006", "HN": "2007(1998)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053456"}, {"RECTYPE": "D", "MH": "CARD Signaling Adaptor Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Caspase Activation and Recruitment Domain Signaling Proteins|T116|T123|NON|EQV|NLM (2007)|051223|abbcdef", "MN": "D12.776.476.075.358", "FX": "Caspase Activation and Recruitment Domain", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A family of intracellular signaling adaptor proteins that contain CASPASE ACTIVATION AND RECRUITMENT DOMAINS (CARD). They play a role in APOPTOSIS-related signal transduction by associating with other CARD domain-containing members and activating INITIATOR CASPASES that contain CARD domains within their N-terminal pro-domain region.", "PM": "2007", "HN": "2007", "MR": "20160705", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053468"}, {"RECTYPE": "D", "MH": "Caspases, Effector", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Effector Caspases|T116|T126|NON|EQV|NLM (2007)|051116|abbcdef", "MN": "D12.776.476.075.405.350", "EC": "antagonists & inhibitors:Caspase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.22.-", "PI": "Cysteine Proteinases (1997-1998)", "MS": "A subclass of caspases that contain short pro-domain regions. They are activated by the proteolytic action of INITIATOR CASPASES. Once activated they cleave a variety of substrates that cause APOPTOSIS.", "PM": "2007", "HN": "2007", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053470"}, {"RECTYPE": "D", "MH": "Caspases, Initiator", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Initiator Caspases|T116|T126|NON|EQV|NLM (2007)|051116|abbcdef", "MN": "D12.776.476.075.405.550", "EC": "antagonists & inhibitors:Caspase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.22.-", "PI": "Cysteine Proteinases (1997-1998)", "MS": "A subtype of caspases that contain long pro-domain regions that regulate the activation of the enzyme. The pro-domain regions contain protein-protein interaction motifs that can interact with specific signaling adaptor proteins such as DEATH DOMAIN RECEPTORS; DED SIGNALING ADAPTOR PROTEINS; and CARD SIGNALING ADAPTOR PROTEINS. Once activated, the initiator caspases can activate other caspases such as the EFFECTOR CASPASES.", "PM": "2007", "HN": "2007", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053471"}, {"RECTYPE": "D", "MH": "Nod Signaling Adaptor Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nuclear-Binding Oligomerization Domain Proteins|T116|T123|NON|EQV|NLM (2007)|051228|abbcdef", "ENTRY": "Nuclear Binding Oligomerization Domain Proteins", "MN": "D12.776.476.024.391", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "Cytosolic signaling adaptor proteins that were initially discovered by their role in the innate immunity (IMMUNITY, INNATE) response of organisms that lack an adaptive immune system. This class of proteins contains three domains, a C-terminal ligand recognition domain, an N-terminal effector-binding domain, and a centrally located nuclear-binding oligomerization domain. Many members of this class contain a C-terminal leucine rich domain which binds to PEPTIDOGLYCAN on the surface of BACTERIA and plays a role in pathogen resistance.", "PM": "2007", "HN": "2007", "MR": "20160330", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053472"}, {"RECTYPE": "D", "MH": "Nod2 Signaling Adaptor Protein", "DS": "NOD SIGNALING ADAPTOR PROTEIN 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleotide Oligomerization Domain 2 Protein|T116|T123|NON|EQV|NLM (2007)|051228|NUCLEOTIDE OLIGOMERIZATION DOMAIN PROTEIN 02|abbcdefs", "ENTRY": "Caspase Recruitment Domain Protein 15|T116|T123|NON|EQV|NLM (2007)|051228|abbcdef", "MN": "D12.776.476.075.358.500", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Intracellular Signaling Peptides and Proteins (2005-2006)", "MS": "A NOD signaling adaptor protein that contains two C-terminal leucine-rich domains which recognize bacterial PEPTIDOGLYCAN. It signals via an N-terminal capase recruitment domain that interacts with other CARD SIGNALING ADAPTOR PROTEINS such as RIP SERINE-THEONINE KINASES. The protein plays a role in the host defense response by signaling the activation of CASPASES and the MAP KINASE SIGNALING SYSTEM. Mutations of the gene encoding the nucleotide oligomerization domain 2 protein have been associated with increased susceptibility to CROHN DISEASE.", "PM": "2007", "HN": "2007", "MR": "20160330", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053473"}, {"RECTYPE": "D", "MH": "Nod1 Signaling Adaptor Protein", "DS": "NOD SIGNALING ADAPTOR PROTEIN 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleotide Oligomerization Domain 1 Protein|T116|T123|NON|EQV|NLM (2007)|051228|NUCLEOTIDE OLIGOMERIZATION DOMAIN PROTEIN 01|abbcdefs", "ENTRY": "Caspase Recruitment Domain Protein 4|T116|T123|NON|EQV|NLM (2007)|051228|abbcdef", "MN": "D12.776.476.075.358.249", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Carrier Proteins (1999-2004)", "MS": "A NOD-signaling adaptor protein that contains a C-terminal leucine-rich domain which recognizes bacterial PEPTIDOGLYCAN. It signals via an N-terminal caspase recruitment domain that interacts with other CARD SIGNALING ADAPTOR PROTEINS such as RIP SERINE-THEONINE KINASES. It plays a role in the host defense response by signaling the activation of CASPASES and the MAP KINASE SIGNALING SYSTEM.", "PM": "2007", "HN": "2007", "MR": "20160330", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053474"}, {"RECTYPE": "D", "MH": "Receptor-Interacting Protein Serine-Threonine Kinase 2", "DS": "RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor Interacting Serine Threonine Kinase 2", "MN": "D12.776.476.563.801.500", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A RIP serine-theonine kinase that contains a C-terminal caspase activation and recruitment domain. It can signal by associating with other CARD-signaling adaptor proteins and INITIATOR CASPASES that contain CARD domains within their N-terminal pro-domain region.", "PM": "2007; RECEPTOR-INTERACTING PROTEIN SERINE-THEONINE KINASE 2 was indexed under PROTEIN-SERINE-THREONINE KINASES & TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS 2006, & under PROTEIN KINASES 1998-2006", "HN": "2007(1998)", "MR": "20210610", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053475"}, {"RECTYPE": "D", "MH": "Extinction, Biological", "PRINT ENTRY": "Species Extinction|T070|NON|NRW|NLM (2007)|051229|abcdef", "ENTRY": "Species Extinctions", "MN": "G16.510", "MH_TH": "NLM (2007)", "ST": "T070", "AN": "EXTINCTION, PSYCHOLOGICAL is also available", "MS": "The ceasing of existence of a species or taxonomic groups of organisms.", "PM": "2007", "HN": "2007", "MR": "20160623", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053476"}, {"RECTYPE": "D", "MH": "Apoptotic Protease-Activating Factor 1", "DS": "APOPTOTIC PROTEASE ACTIVATING FACTOR 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protease-Activating Factor, Apaf-1", "MN": "D12.776.476.075.358.124", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A CARD signaling adaptor protein characterized by an N-terminal CARD DOMAIN and C-terminal WD40 REPEATS. It plays a role in the mitochondria-stimulated apoptosis (APOPTOSIS, INTRINSIC PATHWAY) and binds to CYTOCHROME C in the CYTOSOL to form an APOPTOSOMAL PROTEIN COMPLEX which activates INITIATOR CASPASES such as CASPASE 9.", "PM": "2007; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1 was indexed under INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 1997-2006 & under PROTEINS 1997-2005", "HN": "2007(1997)", "MR": "20160415", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053477"}, {"RECTYPE": "D", "MH": "Apoptosomes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Complex, Apoptosomal", "MN": "D05.500.099", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Apoptosis (1999-2006)", "MS": "Multimeric protein complexes formed in the CYTOSOL that play a role in the activation of APOPTOSIS. They can occur when MITOCHONDRIA become damaged due to cell stress and release CYTOCHROME C. Cytosolic cytochrome C associates with APOPTOTIC PROTEASE-ACTIVATING FACTOR 1 to form the apoptosomal protein complex. The apoptosome signals apoptosis by binding to and activating specific INITIATOR CASPASES such as CASPASE 9.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053478"}, {"RECTYPE": "D", "MH": "Cholesterol Ester Transfer Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cholesterol Ester Transfer Protein|T116|T123|NON|EQV|NLM (2022)|200824|abbcdef", "ENTRY": "Cholesteryl Ester Transfer Protein|T116|T123|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.395.199", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "Proteins that bind to and transfer CHOLESTEROL ESTERS between LIPOPROTEINS such as LOW-DENSITY LIPOPROTEINS and HIGH-DENSITY LIPOPROTEINS.", "PM": "2007; CHOLESTEROL ESTER TRANSFER PROTEINS was indexed under CARRIER PROTEINS & GLYCOPROTEINS 1978-2006", "HN": "2007(1980)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053480"}, {"RECTYPE": "D", "MH": "Secretory Leukocyte Peptidase Inhibitor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Secretory Leukocyte Protease Inhibitor", "MN": "D12.776.815.500", "PA": "Serine Proteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A proteinase inhibitor found in various BODILY SECRETIONS that coat mucosal surfaces such as SEMINAL PLASMA; CERVICAL MUCUS; and bronchial secretions. It plays a role in protecting epithelial tissues from LEUKOCYTE-derived serine proteases such as NEUTROPHIL ELASTASE.", "PM": "2007; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR was indexed under PROTEINS 2000-2006", "HN": "2007(2000)", "MR": "20220712", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053481"}, {"RECTYPE": "D", "MH": "beta 2-Glycoprotein I", "DS": "BETA GLYCOPROTEIN 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Apolipoprotein H|T116|T123|NON|EQV|NLM (2007)|abbcde", "ENTRY": "beta2 Glycoprotein I", "MN": "D12.776.395.195", "PA": "Anticoagulants", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Glycoproteins (1967-2006)", "MS": "A 44-kDa highly glycosylated plasma protein that binds phospholipids including CARDIOLIPIN; APOLIPOPROTEIN E RECEPTOR; membrane phospholipids, and other anionic phospholipid-containing moieties. It plays a role in coagulation and apoptotic processes. Formerly known as apolipoprotein H, it is an autoantigen in patients with ANTIPHOSPHOLIPID ANTIBODIES.", "PM": "2007; was indexed under GLYCOPROTEINS 1979-2006", "HN": "2007; BETA 2-GLYCOPROTEIN I (NM) 1979-2006", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053482"}, {"RECTYPE": "D", "MH": "Eye Movement Measurements", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Measurements, Eye Movement", "MN": "E01.370.405.312", "FX": "Eye Movements", "MH_TH": "NLM (2007)", "ST": "T060", "AN": "nystagmography may go here but consider also ELECTRONYSTAGMOGRAPHY; EYE MOVEMENTS is also available", "PI": "Eye Movements (1966-2006)", "MS": "Methods and procedures for recording EYE MOVEMENTS.", "PM": "2007", "HN": "2007", "MR": "20220523", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053483"}, {"RECTYPE": "D", "MH": "RecQ Helicases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RecQ Helicase|T116|T126|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Helicases, RecQ", "MN": "D08.811.399.340.249", "FX": "Werner Syndrome", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.6.4.12", "RR": "EC 3.6.4.12", "MS": "A family of structurally-related DNA helicases that play an essential role in the maintenance of genome integrity. RecQ helicases were originally discovered in E COLI and are highly conserved across both prokaryotic and eukaryotic organisms. Genetic mutations that result in loss of RecQ helicase activity gives rise to disorders that are associated with CANCER predisposition and premature aging.", "PM": "2007: RECQ HELICASES was indexed under ADENOSINE TRIPHOSPHATASES & DNA HELICASES 1990-2006; RECQ4 HELICASE was indexed under DNA HELICASES 2002-2006; DNA HELICASE RECQL was indexed under DNA HELICASES & ADENOSINE TRIPHOSPHATASES 1994-2006; RECQ5 HELICASE was indexed under DNA HELICASES 1999-2006", "HN": "2007(1990)", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053484"}, {"RECTYPE": "D", "MH": "Porcine epidemic diarrhea virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.578.500.540.150.075.937", "MH_TH": "NLM (2007)", "ST": "T005", "RN": "txid28295", "AN": "infection: coordinate IM with CORONAVIRUS INFECTIONS (IM)", "PI": "Coronavirus (1988-2006)", "MS": "A species of CORONAVIRUS causing acute enteritis in swine. Infections have been seen mostly in Europe, where it is endemic, and in China.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053485"}, {"RECTYPE": "D", "MH": "Melanocortins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Melanocortin|T116|T125|NON|EQV|NLM (2021)|191231|abbcdef", "MN": "D12.776.631.650.405.935.531", "MH_TH": "NLM (2007)", "ST": "T125", "RN": "0", "PI": "Melanocyte-Stimulating Hormones (1986-2006)", "MS": "Peptides derived from pro-opiomelanocortin (POMC) which can stimulate MELANOCYTES or CORTICOTROPHS. Melanocortins include ACTH; ALPHA-MSH; and other peptides such as BETA-MSH and GAMMA-MSH, derived from other fragments of POMC. These peptides act through a variety of MELANOCORTIN RECEPTORS to control different functions including steroidogenesis, energy homeostasis, feeding, and skin pigmentation.", "PM": "2007", "HN": "2007", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053486"}, {"RECTYPE": "D", "MH": "DEAD-box RNA Helicases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DEAD-box RNA Helicase|T116|T126|NON|EQV|NLM (2021)|200506|abbcdef", "ENTRY": "RNA Helicases, DEAD-box", "MN": "D08.811.913.696.445.735.720.249", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.6.4.13", "RR": "EC 3.6.4.13", "MS": "A large family of RNA helicases that share a common protein motif with the single letter amino acid sequence D-E-A-D (Asp-Glu-Ala-Asp). In addition to RNA helicase activity, members of the DEAD-box family participate in other aspects of RNA metabolism and regulation of RNA function.", "PM": "2007; DEAD-BOX RNA HELICASES was indexed under PROTEIN KINASES & RNA HELICASES 1999-2006, & under NUCLEAR PROTEINS & RNA NUCLEOTIDYLTRANSFERASES 1997-1998", "HN": "2007(1988)", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053487"}, {"RECTYPE": "D", "MH": "DnaB Helicases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "DnaB Helicase|T116|T126|ABX|EQV|NLM (2007)|abbcde", "ENTRY": "Helicases, DnaB", "MN": "D08.811.399.340.124", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.6.4.12", "MS": "A family of DNA helicases that participate in DNA REPLICATION. They assemble into hexameric rings with a central channel and unwind DNA processively in the 5' to 3' direction. DnaB helicases are considered the primary replicative helicases for most prokaryotic organisms.", "PM": "2007; DNAB HELICASES was indexed under BACTERIAL PROTEINS & DNA HELICASES 1991-2006", "HN": "2007(1991)", "MR": "20130708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053488"}, {"RECTYPE": "D", "MH": "Mink Viral Enteritis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Enteritis, Infectious, of Mink|T047|NON|EQV|UNK (19XX)|740330|ENTERITIS INFECT OF MINK|abcdefv", "ENTRY": "Viral Enteritis, Mink", "MN": "C22.557", "MH_TH": "NLM (2007)", "ST": "T047", "AN": "add MINK (IM)", "PI": "Feline Panleukopenia (1970-2006)", "MS": "A highly contagious parvovirus infection in mink, caused by MINK ENTERITIS VIRUS or the closely related FELINE PANLEUKOPENIA VIRUS or CANINE PARVOVIRUS. Transmission usually occurs by the fecal/oral route.", "PM": "2007; see FELINE PANLEUKOPENIA 1997-2006, see FELINE INFECTIOUS ENTERITIS 1970-1996", "HN": "2007; use FELINE PANLEUKOPENIA 1970-1996", "MR": "20190617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053489"}, {"RECTYPE": "D", "MH": "Mink enteritis virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Infectious Enteritis Virus of Mink|T005|NON|EQV|UNK (19XX)|741211|INFECT ENTERITIS VIRUS OF MINK|abcdefv", "ENTRY": "enteritis viruses, Mink", "MN": "B04.280.580.650.600.325.330", "MH_TH": "NLM (1994)", "ST": "T005", "RN": "txid10792", "PI": "Parvoviridae (1977-2006)", "MS": "A species of the genus PARVOVIRUS and a host range variant of FELINE PANLEUKOPENIA VIRUS. It causes a highly contagious inflammatory gastroenteritis (MINK VIRAL ENTERITIS). In addition to mink, this virus can also infect cats and dogs.", "PM": "2007; see PARVOVIRUS 2002-2006, see PARVOVIRUS, FELINE 1994-2001, see FELINE INFECTIOUS ENTERITIS VIRUS 1991-1993, see PARVOVIRIDAE 1981-1990, see PARVOVIRUSES 1975-1980", "HN": "2007; use PARVOVIRUS 2002-2006, use FELINE PANLEUKOPENIA VIRUS 1991-2001, use PARVOVIRIDAE 1975 -1990", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053490"}, {"RECTYPE": "D", "MH": "Proteinase Inhibitory Proteins, Secretory", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proteinase Inhibitory Peptides, Secretory|T116|T123|NON|REL|NLM (2007)|060109|abbcdef", "ENTRY": "Inhibitors, Neutrophil Elastase", "MN": "D12.776.815", "PA": "Protease Inhibitors", "FX": "Protease Inhibitors", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "Peptides and proteins found in BODILY SECRETIONS and BODY FLUIDS that are PROTEASE INHIBITORS. They play a role in INFLAMMATION, tissue repair and innate immunity (IMMUNITY, INNATE) by inhibiting endogenous proteinases such as those produced by LEUKOCYTES and exogenous proteases such as those produced by invading microorganisms.", "PM": "2007; NEUTROPHIL ELASTASE INHIBITORS was indexed under PROTEINS 1996-2006, under SERINE PROTEINASE INHIBITORS 1990-1995, under PROTEASE INHIBITORS 1980-1989, under ENZYME INHIBITORS 1978-1979, & under PEPTIDE PEPTIDOHYDROLASES 1978-1979", "HN": "2007(1980)", "MR": "20220712", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053491"}, {"RECTYPE": "D", "MH": "Elafin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Skin Derived Antileukoproteinase", "MN": "D12.776.815.437", "PA": "Protease Inhibitors", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Protease Inhibitors (1990-2006)", "MS": "A secretory proteinase inhibitory protein that was initially purified from human SKIN. It is found in a variety mucosal secretions and is present at high levels in SPUTUM. Elafin may play a role in the innate immunity (IMMUNITY, INNATE) response of the LUNG.", "PM": "2007; ELAFIN was indexed under PROTEINS 2005-2006", "HN": "2007(2005)", "MR": "20220712", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053492"}, {"RECTYPE": "D", "MH": "Cholestanetriol 26-Monooxygenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Vitamin D3 25 Hydroxylase", "MN": "D12.776.422.220.453.915.150", "FX": "Xanthomatosis, Cerebrotendinous", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 1.14.15.15", "PI": "Cholecalciferols (1978-1979)", "MS": "An NAPH-dependent cytochrome P450 enzyme that catalyzes the oxidation of the side chain of sterol intermediates such as the 27-hydroxylation of 5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol.", "PM": "2013; see CYTOCHROME P-450 CYP27A1 1981-2013 CYTOCHROME P-450 CYP27A1 was indexed under STEROID HYDROXYLASE 1981-2006, & CHOLECALCIFEROLS 1978-1980", "HN": "2013 (1981)", "MR": "20160601", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053493"}, {"RECTYPE": "D", "MH": "Osteopontin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sialoprotein I, Bone", "MN": "D23.529.374.625", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "106441-73-0", "MS": "A negatively-charged extracellular matrix protein that plays a role in the regulation of BONE metabolism and a variety of other biological functions. Cell signaling by osteopontin may occur through a cell adhesion sequence that recognizes INTEGRIN ALPHA-V BETA-3.", "PM": "2007; OSTEOPONTIN was indexed under SIALOGLYCOPROTEINS 1987-2006", "HN": "2007(1987)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053495"}, {"RECTYPE": "D", "MH": "Inositol 1,4,5-Trisphosphate Receptors", "DS": "INOSITOL TRISPHOSPHATE 01 04 05 RECEPTORS", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Inositol 1,4,5-Trisphosphate Receptor|T116|T192|NON|EQV|NLM (2021)|200312|abbcdef", "ENTRY": "Triphosphate Receptor, Inositol", "MN": "D12.776.826.179", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "Intracellular receptors that bind to INOSITOL 1,4,5-TRISPHOSPHATE and play an important role in its intracellular signaling. Inositol 1,4,5-trisphosphate receptors are calcium channels that release CALCIUM in response to increased levels of inositol 1,4,5-trisphosphate in the CYTOPLASM.", "PM": "2007; INOSITOL-1,4,5-TRIPHOSPHATE RECEPTORS was indexed under CALCIUM CHANNELS & RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2006, & under RECEPTORS ENDOGENOUS SUBSTANCES 1986-1993", "HN": "2007(1986)", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053496"}, {"RECTYPE": "D", "MH": "Corticotropin-Like Intermediate Lobe Peptide", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Corticotropin Like Intermediate Lobe Peptide", "MN": "D12.776.631.650.405.935.498", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "53917-42-3", "PI": "Corticotropin (1975-2006)", "MS": "A peptide derived from the cleavage of ADRENOCORTICOTROPIC HORMONE, found primarily in the INTERMEDIATE LOBE OF PITUITARY but also in the ARCUATE NUCLEUS of basal HYPOTHALAMUS. Its sequence is identical to the C-terminal 22-amino acids of ACTH or ACTH 18-39.", "PM": "2007; was indexed under CORTICOTROPIN & PEPTIDE FRAGMENTS 1978-2006", "HN": "2007 (1978)", "MR": "20151123", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053497"}, {"RECTYPE": "D", "MH": "Sarcoplasmic Reticulum Calcium-Transporting ATPases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sarcoplasmic Reticulum Calcium ATPase|T116|T126|ABX|EQV|NLM (2007)|000807|abbcdef", "ENTRY": "Sarcoplasmic endoplasmic Reticulum Calcium ATPase 1", "MN": "D12.776.543.585.813.250.500", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.6.3.8", "RR": "EC 3.6.3.8", "MS": "Calcium-transporting ATPases that catalyze the active transport of CALCIUM into the SARCOPLASMIC RETICULUM vesicles from the CYTOPLASM. They are primarily found in MUSCLE CELLS and play a role in the relaxation of MUSCLES.", "PM": "2007; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES was indexed under CA(2+)-TRANSPORTING ATPASE 2000-2006", "HN": "2007(2000)", "MR": "20170117", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053498"}, {"RECTYPE": "D", "MH": "Plasma Membrane Calcium-Transporting ATPases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Plasma Membrane Calcium Transporting ATPases", "MN": "D12.776.543.585.813.250.249", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.6.3.8", "RR": "EC 3.6.3.8", "MS": "Calcium-transporting ATPases found on the PLASMA MEMBRANE that catalyze the active transport of CALCIUM from the CYTOPLASM into the extracellular space. They play a role in maintaining a CALCIUM gradient across plasma membrane.", "PM": "2007; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES was indexed under CALCIUM-TRANSPORTING ATPASES & CATION TRNASPORT PROTEINS 1995-2006", "HN": "2007(1995)", "MR": "20170117", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053499"}, {"RECTYPE": "D", "MH": "gamma-Lipotropin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "gamma Lipotropin", "MN": "D12.776.631.650.405.935.518", "MH_TH": "UNK (19XX)", "ST": "T125", "RN": "0", "PI": "Lipotropin (1969-2006)", "MS": "A lipotropic peptide that is the N-terminal fragment of beta-lipotropin. It is a peptide of 56 amino acids in humans and 58 amino acids in pigs.", "PM": "2007; see LIPOTROPIN 1988-2006", "HN": "2007 (1988)", "MR": "20151123", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053500"}, {"RECTYPE": "D", "MH": "Arsenite Transporting ATPases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Arsenite-Transporting ATPase|T116|T126|ABX|EQV|NLM (2007)|040301|abbcdef", "ENTRY": "Transporting ATPases, Arsenite", "MN": "D12.776.543.585.450.250.249", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.6.3.16", "MS": "Efflux pumps that use the energy of ATP hydrolysis to pump arsenite across a membrane. They are primarily found in prokaryotic organisms, where they play a role in protection against excess intracellular levels of arsenite ions.", "PM": "2007; ARSENITE-TRANSPORTING ATPASE was indexed under MULTIENZYME COMPLEXES & ION PUMPS 1990-2006", "HN": "2007(1990)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053501"}, {"RECTYPE": "D", "MH": "Arsenate Reductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Arsenate Reductase|T116|T126|NON|EQV|NLM (2007)|abbcde", "ENTRY": "Reductases, Arsenate", "MN": "D08.811.682.113", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 1.20.-", "RR": "EC 1.20.99.1", "MS": "Oxidoreductases that specifically reduce arsenate ion to arsenite ion. Reduction of arsenate is a critical step for its biotransformation into a form that can be transported by ARSENITE TRANSPORTING ATPASES or complexed by specific sulfhydryl-containing proteins for the purpose of detoxification (METABOLIC DETOXIFICATION, DRUG). Arsenate reductases require reducing equivalents such as GLUTAREDOXIN or AZURIN.", "PM": "2007; ARSENATE REDUCTASES was indexed under MULTIENZYME COMPLEXES & ION PUMPS 1990-2006; for ARSENATE REDUCTASE (GLUTAREDOXIN) see OXIDOREDUCTASES 2002-2006", "HN": "2007(1990)", "MR": "20130708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053502"}, {"RECTYPE": "D", "MH": "Epithelial Sodium Channels", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Epithelial Sodium Ion Channels|T116|T123|NON|EQV|NLM (2013)|111212|abbcdef", "ENTRY": "alpha Subunit, SCNN1", "MN": "D12.776.543.585.400.875.200", "EC": "antagonists & inhibitors:Epithelial Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "Sodium channels found on salt-reabsorbing EPITHELIAL CELLS that line the distal NEPHRON; the distal COLON; SALIVARY DUCTS; SWEAT GLANDS; and the LUNG. They are AMILORIDE-sensitive and play a critical role in the control of sodium balance, BLOOD VOLUME, and BLOOD PRESSURE.", "PM": "2013; see EPITHELIAL SODIUM CHANNEL 2007-2012; EPITHELIAL SODIUM CHANNEL was indexed under SODIUM CHANNELS 1995-2006", "HN": "2013(1995)", "MR": "20160701", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053503"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinases, Membrane-Associated", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Membrane-Type Matrix Metalloproteinase|T116|T126|NON|EQV|NLM (2007)|abbcde", "ENTRY": "Metalloproteinases, Membrane-Type Matrix", "MN": "D12.776.543.493", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.-", "AN": "general or unspecified; prefer specifics", "MS": "Matrix metalloproteinases that are associated with the CELL MEMBRANE, either through transmembrane domains or GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORS. Membrane-type matrix metalloproteinases may act within the pericellular environment to influence the process of CELL MIGRATION.", "PM": "2007; MATRIX METALLOPROTEINASES, MEMBRANE ASSOCIATED was indexed under MATRIX METALLOPROTEINASES 2006, & under METALLOENDOPEPTIDASES 1994-2005", "HN": "2007(1994)", "MR": "20120703", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053504"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinases, Secreted", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Metalloproteinases, Secreted Matrix", "MN": "D12.776.467.836", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.-", "AN": "general; prefer specifics", "PI": "Matrix Metalloproteinases (1990-2006)", "MS": "A subclass of matrix metalloproteinases that are secreted into the pericellular space.", "PM": "2007", "HN": "2007", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053505"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 10", "DS": "MATRIX METALLOPROTEINASE 010", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stromelysin 2|T116|T126|NON|EQV|NLM (2007)|STROMELYSIN 02|abbcdes", "ENTRY": "Metalloproteinase, MMP10", "MN": "D12.776.467.836.400", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.22", "RR": "108317-22-2", "MS": "A secreted matrix metalloproteinase that may play a role in matrix degradation during WOUND HEALING. It is expressed at high levels by KERATINOCYTES, suggesting its role in keratinocyte migration.", "PM": "2007; MATRIX METALLOPROTEINASE 10 was indexed under METALLOENDOPEPTIDASES 1995-2006, & under GLYCOPROTEINS 1992-1994", "HN": "2007(1992)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053506"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 11", "DS": "MATRIX METALLOPROTEINASE 011", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stromelysin 3|T116|T126|NON|EQV|NLM (2007)|STROMELYSIN 03|abbcdes", "ENTRY": "Metalloproteinase, MMP11", "MN": "D12.776.467.836.450", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.-", "MS": "A secreted matrix metalloproteinase that is believed to play a role in EXTRACELLULAR MATRIX remodeling and cell fate determination during normal and pathological processes. Matrix metalloproteinase 11 was originally isolated in primary BREAST NEOPLASMS and may be involved in the process of tumorigenesis.", "PM": "2007; MATRIX METALLOPROTEINASE 11 was indexed under METALLOENDOPEPTIDASES 1992-2006", "HN": "2007(1992)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053507"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 12", "DS": "MATRIX METALLOPROTEINASE 012", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Metalloproteinase, MMP12", "MN": "D12.776.467.836.500", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.65", "MS": "A secreted matrix metalloproteinase which is highly expressed by MACROPHAGES where it may play a role in INFLAMMATION and WOUND HEALING.", "PM": "2007; MATRIX METALLOPROTEINASE 12 was indexed under METALLOENDOPETIDASES 1987-2006", "HN": "2007(1987)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053508"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 13", "DS": "MATRIX METALLOPROTEINASE 013", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Collagenase 3|T116|T126|NON|EQV|NLM (2007)|COLLAGENASE 03|abbcdes", "ENTRY": "Metalloproteinase-13, Matrix", "MN": "D12.776.467.836.550", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.-", "MS": "A secreted matrix metalloproteinase that plays a physiological role in the degradation of extracellular matrix found in skeletal tissues. It is synthesized as an inactive precursor that is activated by the proteolytic cleavage of its N-terminal propeptide.", "PM": "2007; MATRIX METALLOPROTEINASE 13 was indexed under COLLAGENASES 1994-2006", "HN": "2007(1994)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053509"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 14", "DS": "MATRIX METALLOPROTEINASE 014", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Metalloproteinase, MT1-Matrix", "MN": "D08.811.277.656.675.374.525.300.500", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.80", "MS": "A transmembrane domain-containing matrix metalloproteinase. It is synthesized as an inactive zymogen that is activated by the action of PROPROTEIN CONVERTASES such as FURIN. Matrix metalloproteinase 14 plays a direct role in the cleavage of proteins in the pericellular environment. In addition, it can function indirectly by enzymatically activating the proprotein form of MATRIX METALLOPROTEINASE 15.", "PM": "2007; MATRIX METALLOPROTEINASE 14 was indexed under MATRIX METALLOPROTEINASES 2006 & under METALLOENDOPEPTIDASES 1994-2005", "HN": "2007(1994)", "MR": "20120703", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053511"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 16", "DS": "MATRIX METALLOPROTEINASE 016", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Metalloproteinase, Membrane-Type-3 Matrix", "MN": "D08.811.277.656.675.374.525.300.750", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.-", "MS": "A transmembrane domain-containing matrix metalloproteinase. It is synthesized as an inactive zymogen that is activated by the proteolytic action of PROPROTEIN CONVERTASES. Matrix metalloproteinase 16 plays a direct role in the cleavage of proteins in the pericellular environment. In addition, it can function indirectly by enzymatically activating the proprotein form of other MATRIX METALLOPROTEINASES such as the zymogen of MATRIX METALLOPROTEINASE 2.", "PM": "2007; MATRIX METALLOPROTEINASE 16 was indexed under MATRIX METALLOPROTEINASES 2006 & under METALLOENDOPEPTIDASES 2005", "HN": "2007(2005)", "MR": "20120703", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053513"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 17", "DS": "MATRIX METALLOPROTEINASE 017", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Metalloproteinase, MMP17", "MN": "D12.776.543.550.418.700", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.-", "MS": "A membrane-type metalloproteinase that is associated with the CELL MEMBRANE via a GLYCOSYL-PHOSPHATIDYLINOSITOL linkage. It is synthesized as an inactive zymogen that is activated by the action of PROPROTEIN CONVERTASES such as FURIN.", "PM": "2007; MATRIX METALLOPROTEINASE 17 was indexed under MATRIX METALLOPROTEINASES 2006 & under METALLOENDOPEPTIDASES 1994-2005", "HN": "2007(2005)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053515"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 15", "DS": "MATRIX METALLOPROTEINASE 015", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Metalloproteinase, MT2-Matrix", "MN": "D08.811.277.656.675.374.525.300.625", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.-", "MS": "A transmembrane domain-containing matrix metalloproteinase that plays a role in the cleavage of proteins in the pericellular environment. It is synthesized as an inactive zymogen that is activated by the action of ENDOPEPTIDASES such as MATRIX METALLOPROTEINASE 14.", "PM": "2007; MATRIX METALLOPROTEINASE 15 was indexed under MATRIX METALLOPROTEINASES 2006 & under METALLOENDOPEPTIDASES 2005", "HN": "2007(2005)", "MR": "20120703", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053517"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase 20", "DS": "MATRIX METALLOPROTEINASE 020", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Enamelysin|T116|T126|NON|EQV|NLM (2007)|abbcde", "ENTRY": "Metalloproteinase, MMP20", "MN": "D12.776.467.836.800", "EC": "antagonists & inhibitors:Matrix Metalloproteinase Inhibitors", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.24.-", "MS": "A secreted matrix metalloproteinase that is the predominant proteolytic activity in the enamel matrix. The enzyme has a high specificity for dental enamel matrix protein AMELOGENIN.", "PM": "2007; MATRIX METALLOPROTEINASE 20 was indexed under MATRIX METALLOPROTEINASES 2000-2006, & under METALLOENDOPEPTIDASES 1997-1999", "HN": "2007(1997)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053519"}, {"RECTYPE": "D", "MH": "Marinobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.021.480", "MH_TH": "NLM (2007)", "ST": "T007", "RN": "txid2742", "PI": "Alteromonadaceae (2003-2006)", "MS": "A genus of gram-negative, rod-shaped bacteria in the family ALTEROMONADACEAE. The inability to utilize carbohydrates is a distinguishing feature from other genera in the family.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053520"}, {"RECTYPE": "D", "MH": "Alcanivoraceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Fundibacter|T007|NON|NRW|NLM (2007)|060119|abcdef", "MN": "B03.660.250.019", "MH_TH": "NLM (2007)", "ST": "T007", "RN": "txid224372", "RR": "txid59753", "MS": "A family of halophilic bacteria in the order Oceanospirillales. Its principal carbon and energy sources are linear-chain ALKANES and their derivatives.", "PM": "2007; for ALCANIVORAX see HALOMONADACEAE 2004-2007", "HN": "2007; for ALCANIVORAX use HALOMONADACEAE 2004-2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053521"}, {"RECTYPE": "D", "MH": "Piscirickettsia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.565.600", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid1237", "PI": "Rickettsiaceae (2000-1992)", "MS": "A genus of bacteria in the family PISCIRICKETTSIACEAE that is an intracellular rickettsial-like pathogen of FISHES, especially species in the family SALMONIDAE.", "PM": "2007; see PISCIRICKETTSIACEAE 2004-2006", "HN": "2007; use PISCIRICKETTSIACEAE 2004-2006", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053522"}, {"RECTYPE": "D", "MH": "Amelogenin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Amelogenins|T116|T123|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.231.500", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Dental Enamel (1973-1979)", "MS": "A major dental enamel-forming protein found in mammals. In humans the protein is encoded by GENES found on both the X CHROMOSOME and the Y CHROMOSOME.", "PM": "2007; AMELOGENIN was indexed under DENTAL ENAMEL PROTEINS 1973-2006", "HN": "2007(1980)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053523"}, {"RECTYPE": "D", "MH": "Beggiatoa", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.770.100", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid1021", "PI": "Thiotrichaceae (1976-2006)", "MS": "A genus of colorless, filamentous bacteria in the family THIOTRICHACEAE whose cells contain inclusions of sulfur granules. When found in decaying seaweed beds and polluted water, its presence signals environmental degradation.", "PM": "2007; see THIOTRICHACEAE 2004-2006", "HN": "2007; use THIOTRICHACEAE 2004-2006", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053524"}, {"RECTYPE": "D", "MH": "Thiothrix", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.770.800", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid1030", "PI": "Thiotrichaceae (1983-2006)", "MS": "A genus of colorless, filamentous, rod-shaped bacteria in the family THIOTRICHACEAE, containing sulfur globules. Thiothrix species are found as components of BIOFILMS in irrigation systems and wastewater treatment plants, and in marine environments as endosymbionts.", "PM": "2007; see THIOTRICHACEAE 2004-2006", "HN": "2007; use THIOTRICHACEAE 2004-2006", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053525"}, {"RECTYPE": "D", "MH": "Listonella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.830.500", "MH_TH": "NLM (2004)", "ST": "T007", "AN": "infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)", "PI": "Vibrionaceae (2003-2006)", "MS": "A genus of gram-negative bacteria with curved rods, in the family VIBRIONACEAE. The organisms are chemoorganotrophic and are found in marine environments.", "PM": "2007; see VIBRIONACEAE 2004-2006", "HN": "2007; use VIBRIONACEAE 2004-2006", "MR": "20200902", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053526"}, {"RECTYPE": "D", "MH": "Keratin-4", "DS": "KERATIN 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 4", "MN": "D12.776.860.607.650.400", "EC": "deficiency:Leukokeratosis, Hereditary Mucosal", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratins (1989-2006)", "MS": "A type II keratin that is found associated with the KERATIN-13 in the internal stratified EPITHELIUM. Defects in gene for keratin-4 are a cause of HEREDITARY MUCOSAL LEUKOKERATOSIS.", "PM": "2007; for CYTOKERATIN-4 see KERATIN 1989-2006", "HN": "2007(1989)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053527"}, {"RECTYPE": "D", "MH": "Lysobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.915.500", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid68", "PI": "Xanthomonadaceae (2004-2006)", "MS": "A genus of gram-negative, rod-shaped, gliding bacteria in the family XANTHOMONADACEAE. Strongly proteolytic, it is involved in lysing a variety of microorganisms.", "PM": "2007; see XANTHOMONADACEAE (2004-2006)", "HN": "2007; use XANTHOMONADACEAE (2004-2006)", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053528"}, {"RECTYPE": "D", "MH": "Leukokeratosis, Hereditary Mucosal", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "White Sponge Nevus of Cannon|T047|EPO|EQV|NLM (2007)|OMIM (2013)|ORD (2010)|060126|abcdeeef", "ENTRY": "Mucosal Leukokeratosis, Hereditary", "MN": "C17.800.827.595", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Leukoplakia (1966-2006)", "MS": "An autosomal dominant disorder that is manifested by thickened spongiform ORAL MUCOSA with a white opalescent tint. Other MUCOSAL TISSUE may also be involved mucosa found in the VAGINA; RECTUM, and NASAL CAVITY may be similarly involved. This form of LEUKOKERATOSIS can be caused by a mutation in the gene for KERATIN 4 and is not considered a PRENEOPLASTIC CONDITION.", "PM": "2007", "HN": "2007", "MR": "20150622", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053529"}, {"RECTYPE": "D", "MH": "Keratins, Type I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Type I Keratins", "MN": "D12.776.860.607.300", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratins (1966-2006)", "MS": "A keratin subtype that includes keratins that are generally smaller and more acidic that TYPE II KERATINS. Type I keratins combine with type II keratins to form keratin filaments.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053530"}, {"RECTYPE": "D", "MH": "Keratins, Type II", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Type II Keratins", "MN": "D12.776.860.607.650", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratins (1966-2006)", "MS": "A keratin subtype that includes keratins that are generally larger and less acidic that TYPE I KERATINS. Type II keratins combine with type I keratins to form keratin filaments.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053531"}, {"RECTYPE": "D", "MH": "Xanthomonas axonopodis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.915.930.049", "MH_TH": "NLM (2007)", "ST": "T007", "RN": "txid53413", "PI": "Xanthomonas (1997-2006)", "MS": "A species of gram-negative bacteria in the genus XANTHOMONAS, which causes citrus cankers and black rot in plants.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053532"}, {"RECTYPE": "D", "MH": "Keratin-8", "DS": "KERATIN 008", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 8", "MN": "D12.776.860.607.650.800", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratin (1984-2006)", "MS": "A type II keratin found associated with KERATIN-18 in simple, or predominately single layered, internal epithelia.", "PM": "2007; for CYTOKERATIN 8 see KERATIN 1989-2006", "HN": "2007(1989)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053533"}, {"RECTYPE": "D", "MH": "Keratin-9", "DS": "KERATIN 009", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 9", "MN": "D12.776.860.607.650.900", "EC": "deficiency:Keratoderma, Palmoplantar, Epidermolytic", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "PI": "Keratins (1990-2006)", "MS": "A type II keratin found predominantly expressed in the terminally differentiated EPIDERMIS of palms and soles. Mutations in the gene for keratin 9 are associated with KERATODERMA, PALMOPLANTAR, EPIDERMOLYTIC.", "PM": "2007; see KERATINS 1992-2006", "HN": "2007(1991)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053534"}, {"RECTYPE": "D", "MH": "Keratin-13", "DS": "KERATIN 013", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 13", "MN": "D12.776.860.607.300.300", "EC": "deficiency:Leukokeratosis, Hereditary Mucosal", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratins (1989-2006)", "MS": "A type I keratin that is found associated with the KERATIN-4 in the internal stratified EPITHELIUM. Defects in gene for keratin 13 cause HEREDITARY MUCOSAL LEUKOKERATOSIS.", "PM": "2007; for CYTOKERATIN 13 see KERATIN 1989-2006", "HN": "2007(1989)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053535"}, {"RECTYPE": "D", "MH": "Keratin-16", "DS": "KERATIN 016", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 16", "MN": "D12.776.860.607.300.600", "EC": "deficiency:Pachyonychia Congenita", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratins (1998-2006)", "MS": "A type I keratin expressed in a variety of EPITHELIUM, including the ESOPHAGUS, the TONGUE, the HAIR FOLLICLE and NAILS. Keratin-16 is normally found associated with KERATIN-6. Mutations in the gene for keratin-6 have been associated with PACHYONYCHIA CONGENITA, TYPE 1.", "PM": "2007; for CYTOKERATIN 16 see KERATIN 1998-2006", "HN": "2007(1998)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053536"}, {"RECTYPE": "D", "MH": "Keratin-17", "DS": "KERATIN 017", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 17", "MN": "D12.776.860.607.300.700", "FX": "Steatocystoma Multiplex", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratins (1988-2006)", "MS": "A type I keratin found associated with KERATIN-6 in rapidly proliferating squamous epithelial tissue. Mutations in the gene for keratin-17 have been associated with PACHYONYCHIA CONGENITA, TYPE 2.", "PM": "2007; for CYTOKERATIN 17 see KERATIN 1998-2006", "HN": "2007(1998)", "MR": "20121010", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053537"}, {"RECTYPE": "D", "MH": "Keratin-18", "DS": "KERATIN 018", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 18", "MN": "D12.776.860.607.300.800", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratin (1982-2006)", "MS": "A type I keratin found associated with KERATIN-8 in simple, or predominately single layered, internal epithelia.", "PM": "2007; for CYTOKERATIN 18 see KERATIN 1989-2006", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053538"}, {"RECTYPE": "D", "MH": "Keratin-19", "DS": "KERATIN 019", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 19", "MN": "D12.776.860.607.300.900", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Keratin (1984-2006)", "MS": "A type I keratin found associated with KERATIN-7 in ductal epithelia and gastrointestinal epithelia.", "PM": "2007; for KERATIN-19 see KERATIN 1990-2006", "HN": "2007(1990)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053539"}, {"RECTYPE": "D", "MH": "Marinomonas", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.540.500", "MH_TH": "NLM (2007)", "ST": "T007", "RN": "txid28253", "PI": "Oceanospirillaceae (2004-2006)", "MS": "A genus of gram-negative, aerobic bacteria in the family OCEANOSPIRILLACEAE. Members of this genus have the ability to synthesize MELANIN pigments.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053544"}, {"RECTYPE": "D", "MH": "Spirulina", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Spirulina maxima|T007|NON|NRW|NLM (2015)|140205|abcdef", "MN": "B03.280.697", "MH_TH": "NLM (2007)", "ST": "T007", "RN": "txid1154", "RR": "txid35823", "AN": "do not confuse with the cephalopod suborder Spirulina", "MS": "A genus of filamentous CYANOBACTERIA found in most lakes and ponds. It has been used as a nutritional supplement particularly due to its high protein content.", "PM": "2007; SPIRULINA was indexed under PROTEINS 1982-1992 & under BACTERIAL PROTEINS 1993-2006", "HN": "2007 (1982)", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053545"}, {"RECTYPE": "D", "MH": "Keratoderma, Palmoplantar, Epidermolytic", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Unna Thost Disease, Epidermolytic", "MN": "C17.800.827.475.440.500", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Keratoderma, Palmoplantar, Diffuse (1989-2006)", "MS": "An autosomal dominant hereditary skin disease characterized by epidermolytic hyperkeratosis that is strictly confined to the palms and soles. It has been associated with mutations in the gene that codes for KERATIN-9.", "PM": "2007", "HN": "2007", "MR": "20150618", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053546"}, {"RECTYPE": "D", "MH": "Keratin-14", "DS": "KERATIN 014", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 14|T116|T123|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.860.607.300.400", "EC": "deficiency:Epidermolysis Bullosa Simplex", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A type I keratin that is found associated with the KERATIN-5 in the internal stratified EPITHELIUM. Mutations in the gene for keratin-14 are associated with EPIDERMOLYSIS BULLOSA SIMPLEX.", "PM": "2007; KERATIN-14 was indexed under KERATINS 1998-2006", "HN": "2007(1998)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053547"}, {"RECTYPE": "D", "MH": "Pachyonychia Congenita", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pachyonychia Congenita, Type 2|T019|T047|NON|NRW|NLM (2007)|OMIM (2013)|ORD (2010)|060131|PACHYONYCHIA CONGENITA TYPE 02|abbcdeeefs", "ENTRY": "Syndrome, Jadassohn-Lewandowski (Pc-1)", "MN": "C17.800.827.250.856", "FX": "Nails, Malformed", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Nails, Malformed (1964-2006)", "MS": "A group of inherited ectodermal dysplasias whose most prominent clinical feature is hypertrophic nail dystrophy resulting in PACHYONYCHIA. Several specific subtypes of pachyonychia congenita have been associated with mutations in genes that encode KERATINS.", "PM": "2007", "HN": "2007", "MR": "20180614", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053549"}, {"RECTYPE": "D", "MH": "Keratin-10", "DS": "KERATIN 010", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 10|T116|T123|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.860.607.300.100", "EC": "deficiency:Hyperkeratosis, Epidermolytic", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "147785-83-9", "PI": "Keratins (1988-2006)", "MS": "A type I keratin that is found associated with the KERATIN-1 in terminally differentiated epidermal cells such as those that form the stratum corneum. Mutations in the genes that encode keratin-10 have been associated with HYPERKERATOSIS, EPIDERMOLYTIC.", "PM": "2007; KERATIN 10 was indexed under KERATINS 1992-2006", "HN": "2007(1992)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053550"}, {"RECTYPE": "D", "MH": "Keratin-12", "DS": "KERATIN 012", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cytokeratin 12", "MN": "D12.776.860.607.300.200", "EC": "deficiency:Corneal Dystrophy, Juvenile Epithelial of Meesmann", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratin (1992-2006)", "MS": "A type I keratin that is found associated with the KERATIN-3 in the CORNEA and is regarded as a marker for corneal-type epithelial differentiation. Mutations in the gene for keratin-12 have been associated with MEESMANN CORNEAL EPITHELIAL DYSTROPHY.", "PM": "2007; KERATIN-12 was indexed under KERATINS 2003-2006", "HN": "2007(2003)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053551"}, {"RECTYPE": "D", "MH": "Keratin-7", "DS": "KERATIN 007", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin CK7|T116|T123|ABX|EQV|NLM (2007)|abbcde", "MN": "D12.776.860.607.650.700", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A type II keratin found associated with KERATIN-19 in ductal epithelia and gastrointestinal epithelia.", "PM": "2007; KERATIN-7 was indexed under KERATIN 1998-2006", "HN": "2007(1998)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053552"}, {"RECTYPE": "D", "MH": "Keratin-6", "DS": "KERATIN 006", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cytokeratin 6F", "MN": "D12.776.860.607.650.600", "FX": "Pachyonychia Congenita", "EC": "deficiency:Pachyonychia Congenita", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratin (1986-2006)", "MS": "A type II keratin found associated with KERATIN-16 or KERATIN-17 in rapidly proliferating squamous epithelial tissue. Mutations in gene for keratin-6A and keratin-6B have been associated with PACHYONYCHIA CONGENITA, TYPE 1 and PACHYONYCHIA CONGENITA, TYPE 2 respectively.", "PM": "2007; KERATIN-6 was indexed under KERATIN 2006", "HN": "2007(2006)", "MR": "20120703", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053553"}, {"RECTYPE": "D", "MH": "Keratin-20", "DS": "KERATIN 020", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 20|T116|T123|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.860.607.300.950", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A type I keratin expressed predominately in gastrointestinal epithelia, MERKEL CELLS, and the TASTE BUDS of the oral mucosa.", "PM": "2007; KERATIN-20 was indexed under KERATINS 1993-2006", "HN": "2007(1993)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053554"}, {"RECTYPE": "D", "MH": "Keratin-5", "DS": "KERATIN 005", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cytokeratin 5", "MN": "D12.776.860.607.650.500", "EC": "deficiency:Epidermolysis Bullosa Simplex", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratins (1983-2006)", "MS": "A type II keratin that is found associated with the KERATIN-14 in the internal stratified EPITHELIUM. Mutations in the gene for keratin-5 are associated with EPIDERMOLYSIS BULLOSA SIMPLEX.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053555"}, {"RECTYPE": "D", "MH": "Keratin-1", "DS": "KERATIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 1|T116|T123|NON|EQV|NLM (2007)|060201|abbcdef", "MN": "D12.776.860.607.650.100", "EC": "deficiency:Hyperkeratosis, Epidermolytic", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratin (1964-2006)", "MS": "A type II keratin that is found associated with the KERATIN-10 in terminally differentiated epidermal cells such as those that form the stratum corneum. Mutations in the genes that encode keratin-1 have been associated with HYPERKERATOSIS, EPIDERMOLYTIC.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053556"}, {"RECTYPE": "D", "MH": "Keratin-2", "DS": "KERATIN 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 2B", "MN": "D12.776.860.607.650.200", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratins (1994-2006)", "MS": "A type II keratin found expressed in the upper spinous layer of epidermal KERATINOCYTES. Mutations in genes that encode keratin-2A have been associated with ICHTHYOSIS BULLOSA OF SIEMENS.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053557"}, {"RECTYPE": "D", "MH": "Keratin-3", "DS": "KERATIN 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cytokeratin 3", "MN": "D12.776.860.607.650.300", "EC": "deficiency:Corneal Dystrophy, Juvenile Epithelial of Meesmann", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratins (1989-2006)", "MS": "A type II keratin that is found associated with the KERATIN-12 in the CORNEA and is regarded as a marker for corneal-type epithelial differentiation. Mutations in the gene for keratin-3 have been associated with MEESMANN CORNEAL EPITHELIAL DYSTROPHY.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053558"}, {"RECTYPE": "D", "MH": "Corneal Dystrophy, Juvenile Epithelial of Meesmann", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Meesmann Corneal Dystrophies", "MN": "C16.320.290.162.204", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Corneal Dystrophies, Hereditary (1965-2006)", "MS": "An autosomal dominant form of hereditary corneal dystrophy due to a defect in cornea-specific KERATIN formation. Mutations in the genes that encode KERATIN-3 and KERATIN-12 have been linked to this disorder.", "PM": "2007", "HN": "2007", "MR": "20130708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053559"}, {"RECTYPE": "D", "MH": "Ichthyosis Bullosa of Siemens", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Siemens Ichthyosis Bullosa", "MN": "C17.800.827.403", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Ichthyosis (1970-2006)", "MS": "An autosomal dominant form of ichthyosis characterized by generalized reddening of the skin (ERYTHEMA) and widespread blistering. The disease shows similar, but somewhat milder, clinical and histopathological findings to those in HYPERKERATOSIS, EPIDERMOLYTIC and is associated with the gene that encodes KERATIN-2A.", "PM": "2007", "HN": "2007", "MR": "20150618", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053560"}, {"RECTYPE": "D", "MH": "Somatostatin-28", "DS": "SOMATOSTATIN 028", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Somatostatin 28|T116|T125|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.631.650.405.700.875.500", "MH_TH": "NLM (2007)", "ST": "T125", "RN": "75037-27-3", "PI": "Somatostatin (1980-2006)", "MS": "A 28-amino acid peptide with the same biological activities of somatostatin-14 but with a 14-amino acid extension at the N-terminal. SRIF-28 is the major form of somatostatin in the GASTROINTESTINAL TRACT.", "PM": "2007; SOMATOSTATIN-28 was indexed under SOMATOSTATIN 1980-2006", "HN": "2007(1980)", "MR": "20151124", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053561"}, {"RECTYPE": "D", "MH": "Keratins, Hair-Specific", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hair-Specific Cytokeratins|T116|T123|NON|EQV|NLM (2007)|060203|abbcdef", "ENTRY": "Trichocyte Type Cytokeratins", "MN": "D12.776.860.607.149", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratins (1988-2006)", "MS": "Keratins that are specific for hard tissues such as HAIR; NAILS; and the filiform papillae of the TONGUE.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053564"}, {"RECTYPE": "D", "MH": "Hypercalciuria", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.942.337", "MH_TH": "NLM (2007)", "ST": "T184", "PI": "Calcium/urine (1953-2006)", "MS": "Excretion of abnormally high level of CALCIUM in the URINE, greater than 4 mg/kg/day.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053565"}, {"RECTYPE": "D", "MH": "Feminine Hygiene Products", "AQ": "AE CL EC ES HI MI PS SD SN ST VE VI", "ENTRY": "Hygiene Products, Feminine", "MN": "E07.357", "FX": "Vaginal Douching", "MH_TH": "NLM (2007)", "ST": "T073", "MS": "Personal care items for women.", "PM": "2007", "HN": "2007", "MR": "20180629", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053566"}, {"RECTYPE": "D", "MH": "Keratin-15", "DS": "KERATIN 015", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Keratin 15", "MN": "D12.776.220.475.450.300.500", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Keratin (1993-2006)", "MS": "A type I keratin found in the basal layer of the adult epidermis and in other stratified epithelia.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053569"}, {"RECTYPE": "D", "MH": "Porcine Postweaning Multisystemic Wasting Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Postweaning Multisystemic Wasting Syndrome, Porcine|T047|NON|EQV|NLM (2007)|060206|abcdef", "MN": "C22.905.690", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Wasting Syndrome (1997-2006)", "MS": "A worldwide emerging disease of weaned piglets first recognized in swine herds in western Canada in 1997. This syndrome is characterized by progressive weight loss, rapid (tachypnea) and difficult (dyspnea) breathing, and yellowing of skin. PMWS is caused by PORCINE CIRCOVIRUS infection, specifically type 2 or PCV-2.", "PM": "2007", "HN": "2007", "MR": "20190617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053570"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-1 Type I", "DS": "RECEPTORS INTERLEUKIN 001 TYPE I", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-1 Receptors Type I|T116|T123|NON|EQV|NLM (2007)|INTERLEUKIN 001 RECEPTORS TYPE I|abbcdes", "ENTRY": "Receptors, Interleukin 1 Type I", "MN": "D12.776.543.750.705.852.420.300.500", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "AN": "RECEPTORS, INTERLEUKIN-1 TYPE I and RECEPTORS, INTERLEUKIN-1 TYPE II are also available", "MS": "An interleukin-1 receptor subtype that is involved in signaling cellular responses to INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The binding of this receptor to its ligand causes its favorable interaction with INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN and the formation of an activated receptor complex.", "PM": "2007; see RECEPTORS, INTERLEUKIN-1 1996-2006; for CD121WA ANTIGENS see RECEPTORS, INTERLEUKIN-1 1996-1999", "HN": "2007(1996)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053573"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-1 Type II", "DS": "RECEPTORS INTERLEUKIN 001 TYPE II", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-1 Receptor Type II|T116|T192|NON|EQV|NLM (2007)|INTERLEUKIN 001 RECEPTOR TYPE II|abbcdes", "ENTRY": "Receptors, Interleukin 1 Type II", "MN": "D12.776.543.750.705.852.420.300.750", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "An interleukin-1 receptor subtype that competes with the INTERLEUKIN-1 RECEPTOR TYPE I for binding to INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The interleukin-1 type II receptor appears to lack signal transduction capability. Therefore it may act as a \"decoy\" receptor that modulates the activity of its ligands. Both membrane-bound and soluble forms of the receptor have been identified.", "PM": "2007; see RECEPTORS, INTERLEUKIN-1 1996-2006", "HN": "2007(1996)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053574"}, {"RECTYPE": "D", "MH": "Interleukin-1 Receptor Accessory Protein", "DS": "INTERLEUKIN 001 RECEPTOR ACCESSORY PROTEIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Interleukin 1 Receptor Accessory Protein", "MN": "D12.776.543.750.705.852.420.300.249", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "AN": "Do not confuse with INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN", "MS": "A protein that takes part in the formation of active interleukin-1 receptor complex. It binds specifically to INTERLEUKIN-1 and the INTERLEUKIN-1 RECEPTOR TYPE I at the cell surface to form a heterotrimeric complex that brings its cytoplasmic domain into contact with the cytoplasm domain of the TYPE-I INTERLEUKIN-1 RECEPTOR. Activation of intracellular signal transduction pathways from the receptor is believed to be driven by this form of cytoplasmic interaction.", "PM": "2007; Interleukin-1 Receptor Accessory Protein was indexed under RECEPTORS, INTERLEUKIN-1 2006 & under PROTEINS 1996-2006", "HN": "2007(1996)", "MR": "20090720", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053577"}, {"RECTYPE": "D", "MH": "Opsoclonus-Myoclonus Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Paraneoplastic Opsoclonus-Myoclonus Ataxia|T047|NON|NRW|NLM (2007)|060208|abcdef", "ENTRY": "Paraneoplastic Opsoclonus Myoclonus Ataxia", "MN": "C11.590.725", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Paraneoplastic Syndromes, Nervous System (2000-2006)", "MS": "A neurological condition that is characterized by uncontrolled rapid irregular movements of the eye (OPSOCLONUS) and the muscle (MYOCLONUS) causing unsteady, trembling gait. It is also known as dancing eyes-dancing feet syndrome and is often associated with neoplasms, viral infections, or autoimmune disorders involving the nervous system.", "PM": "2007; see PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM 2000-2006", "HN": "2007; use PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM 2000-2006", "MR": "20110624", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053578"}, {"RECTYPE": "D", "MH": "Gitelman Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tubular Hypomagnesemia Hypokalemia with Hypocalcuria", "MN": "C16.320.831.491", "FX": "Solute Carrier Family 12, Member 3", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Magnesium (1987-2006)", "MS": "An inherited renal disorder characterized by defective NaCl reabsorption in the convoluted DISTAL KIDNEY TUBULE leading to HYPOKALEMIA. In contrast with BARTTER SYNDROME, Gitelman syndrome includes hypomagnesemia and normocalcemic hypocalciuria, and is caused by mutations in the thiazide-sensitive SODIUM-POTASSIUM-CHLORIDE SYMPORTERS.", "PM": "2007", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053579"}, {"RECTYPE": "D", "MH": "Muscle Strength", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Arthrogenic Muscle Inhibition|T081|NON|REL|NLM (2020)|190108|abcdef", "ENTRY": "Strength, Muscle", "MN": "G11.427.560", "FX": "Muscle Hypotonia", "MH_TH": "NLM (2007)", "ST": "T081", "PI": "Muscles (1950-2006)", "MS": "The amount of force generated by MUSCLE CONTRACTION. Muscle strength can be measured during isometric, isotonic, or isokinetic contraction, either manually or using a device such as a MUSCLE STRENGTH DYNAMOMETER.", "PM": "2007", "HN": "2007", "MR": "20190222", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053580"}, {"RECTYPE": "D", "MH": "Muscle Strength Dynamometer", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Muscle Strength Dynamometers", "MN": "E07.230.460", "MH_TH": "NLM (2007)", "ST": "T074", "MS": "A device that measures MUSCLE STRENGTH during muscle contraction, such as gripping, pushing, and pulling. It is used to evaluate the health status of muscle in sports medicine or physical therapy.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053581"}, {"RECTYPE": "D", "MH": "Interleukin-1alpha", "DE": "IL 1ALPHA", "DS": "INTERLEUKIN 001 ALPHA", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "IL-1 alpha|T116|T129|NON|EQV|NLM (1999)|971030|IL 001 ALPHA|abbcdefs", "ENTRY": "Interleukin 1alpha", "MN": "D23.529.374.500.400.300", "MH_TH": "UNK (19XX)", "ST": "T129", "RN": "0", "PI": "Interleukin-1 (1988-2006)", "MS": "An interleukin-1 subtype that occurs as a membrane-bound pro-protein form that is cleaved by proteases to form a secreted mature form. Unlike INTERLEUKIN-1BETA both membrane-bound and secreted forms of interleukin-1alpha are biologically active.", "PM": "2007; see INTERLEUKIN-1 1988-2006; for HEMATOPOIETIN-1 see HEMATOPOIETIC CELL GROWTH FACTORS 1990-2006", "HN": "2007(1988)", "MR": "20150415", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053582"}, {"RECTYPE": "D", "MH": "Interleukin-1beta", "DS": "INTERLEUKIN 001 BETA", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "IL-1 beta|T116|T129|ABX|EQV|NLM (1999)|971030|IL 001 BETA|abbcdefs", "ENTRY": "Interleukin 1beta", "MN": "D23.529.374.500.400.600", "MH_TH": "NLM (1999)", "ST": "T129", "RN": "0", "MS": "An interleukin-1 subtype that is synthesized as an inactive membrane-bound pro-protein. Proteolytic processing of the precursor form by CASPASE 1 results in release of the active form of interleukin-1beta from the membrane.", "PM": "2007; see INTERLEUKIN-1 1992-2006; CATABOLIN was indexed under INTERLEUKIN-1 1981-2006", "HN": "2007(1981)", "MR": "20150415", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053583"}, {"RECTYPE": "D", "MH": "Urinoma", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Urinomas", "MN": "C23.888.942.900", "MH_TH": "NLM (2007)", "ST": "T184", "MS": "An encapsulated accumulation of URINE in the retroperitoneal area. It has the appearance of a cyst (CYSTS). Urinoma is usually caused by URETERAL OBSTRUCTION, renal trauma or perforation of the renal collecting system.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053584"}, {"RECTYPE": "D", "MH": "Virus Attachment", "AQ": "DE ES RE", "PRINT ENTRY": "Virus Binding|T070|NON|EQV|NLM (2007)|060209|abcdef", "ENTRY": "Binding, Virus", "MN": "G06.920.868", "MH_TH": "NLM (2007)", "ST": "T070", "AN": "do not confuse with ATTACHMENT SITES, MICROBIOLOGICAL", "MS": "The binding of VIRUS PARTICLES to VIRUS RECEPTORS on the host cell surface, facilitating VIRUS ENTRY into the cell.", "PM": "2007", "HN": "2007", "MR": "20200622", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053585"}, {"RECTYPE": "D", "MH": "Virus Internalization", "AQ": "DE RE", "PRINT ENTRY": "Viral Membrane Fusion|T070|NON|NRW|NLM (2007)|060209|abcdef", "ENTRY": "Membrane Fusion, Viral", "MN": "G06.920.881", "FX": "Endocytosis", "MH_TH": "NLM (2007)", "ST": "T070", "MS": "The entering of cells by viruses following VIRUS ATTACHMENT. This is achieved by ENDOCYTOSIS, by translocation of the whole virus across the cell membrane, by direct MEMBRANE FUSION of the viral membrane with the CELL MEMBRANE, or by fusion of the membrane of infected cells with the membrane of non-infected cells causing SYNCYTIA to be formed.", "PM": "2007", "HN": "2007", "MR": "20200622", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053586"}, {"RECTYPE": "D", "MH": "Arthrometry, Articular", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Goniometry, Articular|T081|NON|EQV|NLM (2007)|060210|abcdef", "ENTRY": "Articular Goniometry|T081|NON|EQV|NLM (2007)|060210|abcdef", "MN": "G11.427.760.500", "MH_TH": "NLM (2007)", "ST": "T081", "PI": "Range of Motion, Articular (1991-2006)", "MS": "Measurements of joint flexibility (RANGE OF MOTION, ARTICULAR), usually by employing an angle-measuring device (arthrometer). Arthrometry is used to measure ligamentous laxity and stability. It is often used to evaluate the outcome of ANTERIOR CRUCIATE LIGAMENT replacement surgery.", "PM": "2007", "HN": "2007", "MR": "20080708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053587"}, {"RECTYPE": "D", "MH": "Nuchal Cord", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fetal Cord Entanglement|T047|NON|EQV|NLM (2007)|060427|abcdef", "ENTRY": "Nuchal Cord, Triple", "MN": "C16.300.790", "MH_TH": "NLM (2007)", "ST": "T047", "MS": "A complication of pregnancy in which the UMBILICAL CORD wraps around the fetal neck once or multiple times. In some cases, cord entanglement around fetal neck may not affect pregnancy outcome significantly. In others, the nuchal cord may lead to restricted fetal blood flow, oxygen transport, fetal development, fetal movement, and complicated delivery at birth.", "PM": "2007", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053589"}, {"RECTYPE": "D", "MH": "Interleukin 1 Receptor Antagonist Protein", "DS": "INTERLEUKIN 001 RECEPTOR ANTAGONIST PROTEIN", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Urine IL-1 Inhibitor", "MN": "D23.529.374.460", "PA": "Antirheumatic Agents", "MH_TH": "NLM (2007)", "ST": "T121", "RN": "0", "RR": "9013DUQ28K", "MS": "A ligand that binds to but fails to activate the INTERLEUKIN 1 RECEPTOR. It plays an inhibitory role in the regulation of INFLAMMATION and FEVER. Several isoforms of the protein exist due to multiple ALTERNATIVE SPLICING of its mRNA.", "PM": "2007; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN was indexed under SIALOGLYOPROTEINS 1990-2006, and under PROTEINS 1987-1989", "HN": "2007", "MR": "20160701", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053590"}, {"RECTYPE": "D", "MH": "Pain, Referred", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Referred Pain|T184|NON|EQV|NLM (2007)|060210|abcdef", "ENTRY": "Referred Facial Pain|T184|NON|NRW|NLM (2000)|991103|abcdef", "MN": "C23.888.592.612.888", "MH_TH": "NLM (2007)", "ST": "T184", "AN": "coordinate with specific pain term if pertinent", "PI": "Pain (1963-1999)", "MS": "A type of pain that is perceived in an area away from the site where the pain arises, such as facial pain caused by lesion of the VAGUS NERVE, or throat problem generating referred pain in the ear.", "PM": "2007; for REFERRED FACIAL PAIN see FACIAL PAIN 2000-2006", "HN": "2007; for REFERRED FACIAL PAIN use FACIAL PAIN 2000-2006", "MR": "20170620", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053591"}, {"RECTYPE": "D", "MH": "Interleukin-1 Receptor-Associated Kinases", "DS": "INTERLEUKIN 001 RECEPTOR ASSOCIATED KINASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor-Associated Kinases, Interleukin-1", "MN": "D12.776.476.563.526", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 2.7.11.1", "RR": "EC 2.7.11.1", "MS": "A family of intracellular signaling kinases that were identified by their ability to signal from the activated INTERLEUKIN-1 RECEPTORS. Signaling from these kinases involves their interaction with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88 and TNF RECEPTOR-ASSOCIATED FACTOR 6.", "PM": "2007; INTERLEUKIN-1 RECEPTOR-ASSCIATED KINASES was indexed under PROTEIN-SERINE-THREONINE KINASES & INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 2006, & under PROTEIN KINASES 1996-2006", "HN": "2007(1996)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053592"}, {"RECTYPE": "D", "MH": "Forensic Toxicology", "DE": "FORENSIC TOXICOL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Toxicology, Forensic", "MN": "I01.198.780.968", "MH_TH": "NLM (2007)", "ST": "T090", "PI": "Toxicology (1964-2006)", "MS": "The application of TOXICOLOGY knowledge to questions of law.", "PM": "2007", "HN": "2007", "MR": "20150210", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053593"}, {"RECTYPE": "D", "MH": "Myeloid Differentiation Factor 88", "DS": "MYELOID DIFFERENTIATION FACTOR 088", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Toll Like Receptor Signal Adaptor Protein MyD88", "MN": "D12.776.476.024.390", "MH_TH": "NLM (2007)", "ST": "T129", "RN": "0", "MS": "An intracellular signaling adaptor protein that plays a role in TOLL-LIKE RECEPTOR and INTERLEUKIN 1 RECEPTORS signal transduction. It forms a signaling complex with the activated cell surface receptors and members of the IRAK KINASES.", "PM": "2007; MYELOID DIFFERENTIATION FACTOR 88 was indexed under ADAPTOR PROTEINS, SIGNAL TRANSDUCING 2006, under ANTIGENS, DIFFERENTIATION & RECEPTORS, IMMUNOLOGIC 2000-2006, & under PROTEINS 1990-1999", "HN": "2007(1990)", "MR": "20160330", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053594"}, {"RECTYPE": "D", "MH": "Embryonic Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Stem Cells, Embryonic|T025|NON|EQV|NLM (2007)|060210|abcdef", "ENTRY": "Stem Cell, Embryonic", "MN": "A11.872.700.250", "FX": "Blastocyst Inner Cell Mass", "MH_TH": "NLM (2007)", "ST": "T025", "PI": "Stem Cells (1985-2006)", "MS": "Cells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor cells that can differentiate into specialized cells.", "PM": "2007", "HN": "2007", "MR": "20150706", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053595"}, {"RECTYPE": "D", "MH": "Forensic Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Nursing, Forensic|T091|NON|EQV|NLM (2007)|060213|abcdef", "ENTRY": "Forensic Nursings", "MN": "I01.198.780.952", "MH_TH": "NLM (2007)", "ST": "T091", "PI": "Specialties, Nursing (1993-2006)", "MS": "The application of NURSING knowledge to questions of law. It is a specialty of nursing practice involving victims of crime which includes not only attending to the physical and emotional distress of victims, but also the identifying, collecting, and preserving evidence for law enforcement and the criminal justice system.", "PM": "2007", "HN": "2007", "MR": "20140616", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053604"}, {"RECTYPE": "D", "MH": "Leukemia Inhibitory Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Myeloid Differentiation Stimulating Factor", "MN": "D23.529.374.470", "MH_TH": "NLM (2007)", "ST": "T129", "RN": "0", "MS": "An INTERLEUKIN-6 related cytokine that exhibits pleiotrophic effects on many physiological systems that involve cell proliferation, differentiation, and survival. Leukemia inhibitory factor binds to and acts through the lif receptor.", "PM": "2007; LEUKEMIA INHIBITORY FACTOR was indexed under INTERLEUKIN-6 2004-2006 and under GROWTH INHIBITORS & LYMPHOKINES 1988-2003, & under GLYCOPROTEINS 1980-1986", "HN": "2007(1980)", "MR": "20160701", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053605"}, {"RECTYPE": "D", "MH": "Receptors, OSM-LIF", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Leukemia Inhibitory Factor|T116|T129|T192|NON|EQV|NLM (2007)|060214|abbbcdef", "ENTRY": "Receptors, OSM LIF", "MN": "D12.776.543.750.705.852.583", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "Cell surface receptors formed from the dimerization of LIF RECEPTOR ALPHA SUBUNIT with CYTOKINE RECEPTOR GP130. Although originally described as receptors for LEUKEMIA INHIBITORY FACTOR these receptors also bind the closely-related protein ONCOSTATIN M and are referred to as both LIF receptors and type I oncostatin M receptors.", "PM": "2007; RECEPTORS, LEUKEMIA INIHIBITORY FACTOR was indexed under RECEPTORS, CYTOKINE 1994-2006 & under RECEPTORS, IMMUNOLOGIC 1991-1993", "HN": "2007(1991)", "MR": "20150602", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053606"}, {"RECTYPE": "D", "MH": "Adrenomedullin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Proadrenomedullin N Terminal 20 Peptide", "MN": "D12.644.548.017", "PA": "Vasodilator Agents", "MH_TH": "NLM (2007)", "ST": "T121", "RN": "148498-78-6", "PI": "Peptides (1993-2006)", "MS": "A 52-amino acid peptide with multi-functions. It was originally isolated from PHEOCHROMOCYTOMA and ADRENAL MEDULLA but is widely distributed throughout the body including lung and kidney tissues. Besides controlling fluid-electrolyte homeostasis, adrenomedullin is a potent vasodilator and can inhibit pituitary ACTH secretion.", "PM": "2007; ADRENOMEDULLIN was indexed under PEPTIDES 1993-2006", "HN": "2007 (1993)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053607"}, {"RECTYPE": "D", "MH": "Stupor", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Narcosis|T047|NON|REL|NLM (2007)|060215|abcdef", "MN": "C23.888.592.604.359.800.500", "FX": "Sleep Stages", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Coma (2000-2006)", "MS": "A state of reduced sensibility and response to stimuli which is distinguished from COMA in that the person can be aroused by vigorous and repeated stimulation. The person is still conscious and can make voluntary movements. It can be induced by CENTRAL NERVOUS SYSTEM AGENTS. The word derives from Latin stupere and is related to stunned, stupid, dazed or LETHARGY.", "PM": "2007; see COMA 2000-2006", "HN": "2007; use COMA 2000-2006", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053608"}, {"RECTYPE": "D", "MH": "Lethargy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "F01.700.470", "MH_TH": "UNK (19XX)", "ST": "T048", "PI": "Sleep Stages (1977-2006)", "MS": "A general state of sluggishness, listless, or uninterested, with being tired, and having difficulty concentrating and doing simple tasks. It may be related to DEPRESSION or DRUG ADDICTION.", "PM": "2007; see SLEEP STAGES 1977-2006", "HN": "2007; use SLEEP STAGES 1977-2006", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053609"}, {"RECTYPE": "D", "MH": "Opiate Alkaloids", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Opiate|T109|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Alkaloids, Opiate", "MN": "D03.132.577", "PA": "Analgesics, Opioid", "FX": "Opium", "MH_TH": "NLM (2007)", "ST": "T109", "RN": "0", "PI": "Opium (1963-2006)", "MS": "Alkaloids found in OPIUM from PAPAVER and their derivatives that induce analgesic and narcotic effects by action upon OPIOID RECEPTORS.", "PM": "2007", "HN": "2007", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053610"}, {"RECTYPE": "D", "MH": "Janus Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Janus Kinase|T123|T126|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Kinases, Janus", "MN": "D12.776.476.568.124", "FX": "src Homology Domains", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "A family of intracellular tyrosine kinases that participate in the signaling cascade of cytokines by associating with specific CYTOKINE RECEPTORS. They act upon STAT TRANSCRIPTION FACTORS in signaling pathway referred to as the JAK/STAT pathway. The name Janus kinase refers to the fact the proteins have two phosphate-transferring domains.", "PM": "2007", "HN": "2007", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053612"}, {"RECTYPE": "D", "MH": "Janus Kinase 1", "DS": "JANUS KINASE 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "JAK 1 Protein Tyrosine Kinase", "MN": "D12.776.476.568.124.100", "FX": "src Homology Domains", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "A Janus kinase subtype that is involved in signaling from a broad variety of CYTOKINE RECEPTORS.", "PM": "2007; JANUS KINASE 1 was indexed under PROTEIN-TYROSINE KINASE 1992-2006", "HN": "2007(1992)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053613"}, {"RECTYPE": "D", "MH": "Janus Kinase 2", "DS": "JANUS KINASE 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "JAK 2 Protein Tyrosine Kinase", "MN": "D12.776.624.664.700.117", "FX": "src Homology Domains", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "A Janus kinase subtype that is involved in signaling from GROWTH HORMONE RECEPTORS; PROLACTIN RECEPTORS; and a variety of CYTOKINE RECEPTORS such as ERYTHROPOIETIN RECEPTORS and INTERLEUKIN RECEPTORS. Dysregulation of Janus kinase 2 due to GENETIC TRANSLOCATIONS have been associated with a variety of MYELOPROLIFERATIVE DISORDERS.", "PM": "2007; JANUS KINASE 2 was indexed under PROTEIN-TYROSINE KINASE & PROTO-ONCOGENE PROTEINS 1992-2006", "HN": "2007(1992)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053614"}, {"RECTYPE": "D", "MH": "Janus Kinase 3", "DS": "JANUS KINASE 03", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Kinase 3, Janus", "MN": "D12.776.476.568.124.300", "FX": "src Homology Domains", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 2.7.10.2", "MS": "A Janus kinase subtype that is predominantly expressed in hematopoietic cells. It is involved in signaling from a broad variety of CYTOKINE RECEPTORS including ones that utilize the INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT.", "PM": "2007; JANUS KINASE 3 was indexed under PROTEIN-TYROSINE KINASES 1994-2006", "HN": "2007(1994)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053616"}, {"RECTYPE": "D", "MH": "Blastocyst Inner Cell Mass", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Inner Cell Mass, Blastocyst|T025|NON|EQV|NLM (2007)|060307|abcdef", "ENTRY": "Inner Cell Mass of Blastocyst|T025|NON|EQV|NLM (2007)|060216|abcdef", "MN": "A16.254.500.533", "FX": "Embryonic Stem Cells", "MH_TH": "NLM (2007)", "ST": "T025", "AN": "do not confuse with BLASTOCYTES which are undifferentiated embryonic cells, a term mostly used in foreign literature", "PI": "Cell Differentiation (1966-1972)", "MS": "The cluster of cells inside a blastocyst. These cells give rise to the embryonic disc and eventual embryo proper. They are pluripotent EMBRYONIC STEM CELLS capable of yielding many but not all cell types in a developing organism.", "PM": "2007", "HN": "2007", "MR": "20070709", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053624"}, {"RECTYPE": "D", "MH": "Sperm Retrieval", "AQ": "AE CL EC ES HI IS LJ MO NU PX SN ST TD VE", "ENTRY": "Sperm Retrievals", "MN": "E05.820.800.988", "FX": "Fertility Preservation", "MH_TH": "NLM (2007)", "ST": "T062", "PI": "Tissue and Organ Harvesting (2004-2006)", "MS": "Procedures to obtain viable sperm from the male reproductive tract, including the TESTES, the EPIDIDYMIS, or the VAS DEFERENS.", "PM": "2007", "HN": "2007", "MR": "20110624", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053625"}, {"RECTYPE": "D", "MH": "Atovaquone", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "hydroxynaphthoquinone, 566C80", "MN": "D04.615.638.721.186", "PA": "Enzyme Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "N1": "3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxy-naphthalene-1,2-dione", "RN": "Y883P1Z2LT", "RR": "94015-53-9 (Atovaquone)", "PI": "Naphthoquinones (1990-2006)", "MS": "A hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols.", "PM": "2007; ATOVAQUONE was indexed under NAPHTHOQUINONES 1990-2006", "HN": "2007(1990)", "MR": "20170117", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053626"}, {"RECTYPE": "D", "MH": "Asthenozoospermia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Teratozoospermias, Astheno", "MN": "C12.200.294.430.253", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Sperm Motility (1975-2006)", "MS": "A condition in which the percentage of motile sperm is abnormally low.", "PM": "2007", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053627"}, {"RECTYPE": "D", "MH": "Receptors, Thrombopoietin", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD110 Antigens|T116|T192|ABX|EQV|NLM (2007)|060216|CD 110 ANTIGENS|abbcdefs", "ENTRY": "Thrombopoietin Receptors|T116|T192|NON|EQV|NLM (2007)|060216|abbcdef", "MN": "D12.776.543.750.705.852.610", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1993-2002)", "MS": "Cell surface receptors that are specific for THROMBOPOIETIN. They contain two central FIBRONECTIN TYPE III DOMAINS and signal through interaction with JANUS KINASES such as JANUS KINASE 2.", "PM": "2007", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053628"}, {"RECTYPE": "D", "MH": "Thapsia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Thapsias", "MN": "B01.875.800.575.912.250.075.937", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid79021", "PI": "Apiaceae (2003-2006)", "MS": "A plant genus of the family APIACEAE. Members contain THAPSIGARGIN and other guaianolides (SESQUITERPENES, GUAIANOLIDE).", "PM": "2007; see APIACEAE 2003-2006", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053629"}, {"RECTYPE": "D", "MH": "Depsides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Depside|T109|NON|EQV|NLM (2021)|191120|abcdef", "MN": "D02.455.426.559.389.657.410.100", "MH_TH": "NLM (2007)", "ST": "T109", "RN": "0", "PI": "Hydroxybenzoic Acids (1978-2006)", "MS": "Phenolic benzoic acid esters.", "PM": "2007; DEPSIDES was indexed under HYDROXYBENZOIC ACIDS 1978-2006", "HN": "2007(1978)", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053630"}, {"RECTYPE": "D", "MH": "Interleukin Receptor Common gamma Subunit", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Interleukin Common gamma Chain|T116|T192|NON|EQV|NLM (2007)|060217|abbcdef", "ENTRY": "gamma-Chain Protein, Common", "MN": "D12.776.543.750.705.852.420.900.500", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "An interleukin receptor subunit that was originally discovered as a component of the INTERLEUKIN 2 RECEPTOR. It was subsequently found to be a component of several other receptors including the INTERLEUKIN 4 RECEPTOR, the INTERLEUKIN 7 RECEPTOR, the INTERLEUKIN-9 RECEPTOR, the INTERLEUKIN-15 RECEPTOR, and the INTERLEUKIN-21 RECEPTOR. Mutations in the gene for the interleukin receptor common gamma chain have been associated with X-LINKED COMBINED IMMUNODEFICIENCY DISEASES.", "PM": "2007; INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN was indexed under RECEPTORS, INTERLEUKIN 2006 & under RECEPTORS, INTERLEUKIN-1 2000-2006", "HN": "2007(2000)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053631"}, {"RECTYPE": "D", "MH": "X-Linked Combined Immunodeficiency Diseases", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "X-Linked Severe Combined Immunodeficiency|T047|NON|EQV|GHR (2014)|NLM (2007)|060217|abcdeef", "ENTRY": "X-Linked SCIDs", "MN": "C20.673.795.750.500", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Severe Combined Immunodeficiency (1991-2006)", "MS": "Forms of combined immunodeficiency caused by mutations in the gene for INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT. Both severe and non-severe subtypes of the disease have been identified.", "PM": "2007", "HN": "2007", "MR": "20190617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053632"}, {"RECTYPE": "D", "MH": "Receptor, Interferon alpha-beta", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interferon alpha-beta Receptor|T116|T192|NON|EQV|NLM (2007)|abbcde", "ENTRY": "alpha-beta Receptor-2, Interferon", "MN": "D12.776.543.750.705.852.400.500", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "156986-95-7", "MS": "A ubiquitously expressed heterodimeric receptor that is specific for both INTERFERON-ALPHA and INTERFERON-BETA. It is composed of two subunits referred to as IFNAR1 and IFNAR2. The IFNAR2 subunit is believed to serve as the ligand-binding chain; however both chains are required for signal transduction. The interferon alpha-beta receptor signals through the action of JANUS KINASES such as the TYK2 KINASE.", "PM": "2007; INTERFERON ALPHA-BETA RECEPTOR was indexed under MEMBRANE PROTEINS and RECEPTORS, INTERFERON 1994-2006; INTERFERON ALPHA RECEPTOR was indexed under RECEPTORS, INTERFERON 1993-2006", "HN": "2007(1993)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053633"}, {"RECTYPE": "D", "MH": "TYK2 Kinase", "DS": "TYK KINASE 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Non Receptor Tyrosine Protein Kinase TYK2", "MN": "D12.776.476.568.124.650", "FX": "src Homology Domains", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 2.7.10.2", "PI": "Protein-Tyrosine Kinase (1991-2006)", "MS": "A Janus kinase subtype that is involved in signaling from a broad variety of CYTOKINE RECEPTORS. The TYK2 kinase is considered the founding member of the janus kinase family and was initially discovered as a signaling partner for the INTERFERON ALPHA-BETA RECEPTOR. The kinase has since been shown to signal from several INTERLEUKIN RECEPTORS.", "PM": "2007", "HN": "2007", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053634"}, {"RECTYPE": "D", "MH": "Naphthalimides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Naphthalimide|T109|NON|EQV|NLM (2021)|200106|abcdef", "MN": "D04.615.638.596", "MH_TH": "NLM (2007)", "ST": "T109", "RN": "0", "MS": "Compounds with three fused rings that appear like a naphthalene fused to piperidone or like a benz(de)isoquinoline-1,3-dione (not to be confused with BENZYLISOQUINOLINES which have a methyl separating the naphthyl from the benzyl rings). Members are CYTOTOXINS.", "PM": "2007", "HN": "2007", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053644"}, {"RECTYPE": "D", "MH": "Interleukin-2 Receptor alpha Subunit", "DS": "INTERLEUKIN 002 RECEPTOR ALPHA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Tac P55 Peptide|T116|T192|ABX|EQV|UNK (19XX)|880603|TAC PEPTIDE P 055|abbcdefs", "ENTRY": "Receptors alpha, Interleukin-2", "MN": "D12.776.543.750.705.852.420.320.500", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A low affinity interleukin-2 receptor subunit that combines with the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN to form a high affinity receptor for INTERLEUKIN-2.", "PM": "2007; INTERLEUKIN-2 RECEPTOR ALPHA was indexed under RECEPTORS, INTERLEUKIN-2 2001-2006; for ANTIGENS, CD25 see RECEPTORS, INTERLEUKIN-2 1989-2006", "HN": "2007(2001)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053645"}, {"RECTYPE": "D", "MH": "Interleukin-2 Receptor beta Subunit", "DS": "INTERLEUKIN 002 RECEPTOR BETA SUBUNIT", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Interleukin-2, 15 Receptor beta Subunit|T116|T192|NON|EQV|NLM (2007)|060221|INTERLEUKIN 002 015 RECEPTOR BETA SUBUNIT|abbcdefs", "ENTRY": "Receptor-beta, IL-2-15", "MN": "D12.776.543.750.705.852.420.800.500", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A receptor subunit that is a shared component of the INTERLEUKIN 2 RECEPTOR and the INTERLEUKIN-15 RECEPTOR. High affinity receptor complexes are formed with each of these receptors when their respective alpha subunits are combined with this beta subunit and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN.", "PM": "2007; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT was indexed under RECEPTORS, INTERLEUKIN-2 2001-2006; for CD122 ANTIGENS see RECEPTORS, INTERLEUKIN-2 1996-2006", "HN": "2007(2001)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053646"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-15", "DS": "RECEPTORS INTERLEUKIN 015", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-15 Receptors|T116|T192|NON|EQV|NLM (2007)|INTERLEUKIN 015 RECEPTORS|abbcdes", "ENTRY": "Receptors, Interleukin 15", "MN": "D12.776.543.750.705.852.420.800", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "Cell surface receptors for INTERLEUKIN-15. They are widely-distributed heterotrimeric proteins consisting of the INTERLEUKIN-15 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2, 15 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN.", "PM": "2007; INTERLEUKIN-15 RECEPTOR was indexed under RECEPTORS, INTERLEUKIN-2 1995-2006", "HN": "2007(1995)", "MR": "20090720", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053647"}, {"RECTYPE": "D", "MH": "Cytokine Receptor Common beta Subunit", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-5 Receptor beta Subunit|T116|T192|NON|EQV|NLM (2007)|060301|INTERLEUKIN 005 RECEPTOR BETA SUBUNIT|abbcdefs", "ENTRY": "Receptor, CSF2RB", "MN": "D12.776.543.750.750.400.200.420.500", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (1998-2006)", "MS": "A receptor subunit that is a shared component of the INTERLEUKIN-3 RECEPTOR; the INTERLEUKIN-5 RECEPTOR; and the GM-CSF RECEPTOR. High affinity receptor complexes are formed with each of these receptors when their respective alpha subunits are combined with this shared beta subunit.", "PM": "2007", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053648"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-5", "DS": "RECEPTORS INTERLEUKIN 005", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-5 Receptors|T116|T192|NON|EQV|NLM (2007)|INTERLEUKIN 005 RECEPTORS|abbcdes", "ENTRY": "Receptors, Interleukin 5", "MN": "D12.776.543.750.705.852.420.380", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "Cell surface receptors that are specific for INTERLEUKIN-5. They are heterodimeric proteins consisting of the INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR COMMON BETA SUBUNIT. Signaling from interleukin-5 receptors can occur through interaction of their cytoplasmic domains with SYNTENINS.", "PM": "2007; INTERLEUKIN 5 RECEPTOR was indexed under RECEPTORS, INTERLEUKIN 1994-2006 & under RECEPTORS, IMMUNOLOGIC 1988-1993", "HN": "2007(1988)", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053649"}, {"RECTYPE": "D", "MH": "Interleukin-3 Receptor alpha Subunit", "DS": "INTERLEUKIN 003 RECEPTOR ALPHA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD123 Antigens|T116|T192|ABX|EQV|NLM (2007)|060224|CD 123 ANTIGENS|abbcdefs", "ENTRY": "Interleukin 3 Receptor alpha Subunit", "MN": "D12.776.543.750.705.852.420.340.500", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin-3 (1998-2006)", "MS": "A low affinity interleukin-3 receptor subunit that combines with the CYTOKINE RECEPTOR COMMON BETA SUBUNIT to form a high affinity receptor for INTERLEUKIN-3.", "PM": "2007", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053650"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-9", "DS": "RECEPTORS INTERLEUKIN 009", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, IL-9|T116|T192|ABX|EQV|NLM (2007)|060222|RECEPTORS IL 009|abbcdefs", "ENTRY": "Receptors, Interleukin 9", "MN": "D12.776.543.750.705.852.420.500", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A cell surface receptor that specifically mediates the biological effects of INTERLEUKIN-9. The functional IL9 receptor signals through interaction of its cytoplasm domain with JANUS KINASES and requires the INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT for activity.", "PM": "2007", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053651"}, {"RECTYPE": "D", "MH": "Nuclear Transfer Techniques", "AQ": "AE CL EC ES HI IS LJ MO NU PX SN ST TD VE", "ENTRY": "Transplantation, Nuclear", "MN": "E05.820.540", "FX": "Cloning, Organism", "MH_TH": "NLM (2007)", "ST": "T062", "PI": "Cell Nucleus (1963-2006)", "MS": "Methods of implanting a CELL NUCLEUS from a donor cell into an enucleated acceptor cell.", "PM": "2007", "HN": "2007", "MR": "20150609", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053652"}, {"RECTYPE": "D", "MH": "Pyelocystitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cystopyelitis|T047|NON|EQV|NLM (1997)|960416|abcdef", "MN": "C12.950.829.495.750", "MH_TH": "NLM (1997)", "ST": "T047", "PI": "Pyelitis (1965-2006)", "MS": "Inflammation of the KIDNEY PELVIS and the URINARY BLADDER.", "PM": "2007, 1963-1996; see PYELITIS 1997-2006; for CYSTOPYELITIS see PYELITIS 1997-2006", "HN": "2007, 1963-1996; use PYELITIS 1997-2006; for CYSTOPYELITIS use PYELITIS 1997-2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053653"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-21", "DS": "RECEPTORS INTERLEUKIN 021", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-21 Receptors|T116|T192|NON|EQV|NLM (2007)|060224|INTERLEUKIN 021 RECEPTORS|abbcdefs", "ENTRY": "Receptors, Interleukin 21", "MN": "D12.776.543.750.705.852.420.900", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "Cell surface receptors for interleukin 21. They are heterodimeric proteins found on DENDRITIC CELLS and LYMPHOCYTES that consist of the INTERLEUKIN-21 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR COMMON BETA SUBUNIT.", "PM": "2007; RECEPTORS, INTERLEUKIN-21 was indexed under RECEPTORS, INTERLEUKIN 2000-2006", "HN": "2007(2000)", "MR": "20090720", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053655"}, {"RECTYPE": "D", "MH": "Tenodesis", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Tenodeses", "MN": "E04.987.775.900", "FX": "Suture Anchors", "MH_TH": "NLM (2007)", "ST": "T061", "PI": "Orthopedic Procedures (1973-2006)", "MS": "Fixation of the end of a tendon to a bone, often by suturing.", "PM": "2007", "HN": "2007", "MR": "20100625", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053656"}, {"RECTYPE": "D", "MH": "Platelet-Rich Plasma", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Platelet Rich Plasma", "MN": "A15.145.693.600", "MH_TH": "NLM (2007)", "ST": "T031", "PI": "Plasma (1968-1987)", "MS": "A preparation consisting of PLATELETS concentrated in a limited volume of PLASMA. This is used in various surgical tissue regeneration procedures where the GROWTH FACTORS in the platelets enhance wound healing and regeneration.", "PM": "2007", "HN": "2007", "MR": "20180629", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053657"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-4, Type I", "DS": "RECEPTORS INTERLEUKIN 004 TYPE I", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-4 Receptors, Type I|T116|T192|NON|EQV|NLM (2007)|060227|INTERLEUKIN 004 RECEPTORS TYPE I|abbcdefs", "ENTRY": "Type I Interleukin 4 Receptors", "MN": "D12.776.543.750.705.852.420.360.300", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin-4 (1998-2006)", "MS": "An interleukin-4 receptor subtype that is found predominantly on hematopoietic cells. It is a heterodimer of the INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053658"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-4, Type II", "DS": "RECEPTORS INTERLEUKIN 004 TYPE II", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Interleukin-4, 13|T116|T192|NON|EQV|NLM (2007)|060228|RECEPTORS INTERLEUKIN 004 013|abbcdefs", "ENTRY": "Type II Interleukin 4 Receptors", "MN": "D12.776.543.750.705.852.420.600.800", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin-4 (1998-2006)", "MS": "An interleukin receptor subtype found on both hematopoietic and non-hematopoietic cells. It is a membrane-bound heterodimer that contains the INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT and the INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT. Although commonly referred to as the interleukin-4 type-II receptor this receptor has specificity for both INTERLEUKIN-4 and INTERLEUKIN-13", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053659"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-13", "DS": "RECEPTORS INTERLEUKIN 013", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-13 Receptors|T116|T192|NON|EQV|NLM (2007)|INTERLEUKIN 013 RECEPTORS|abbcdes", "ENTRY": "Receptors, Interleukin 13", "MN": "D12.776.543.750.705.852.420.600", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "Cell surface receptors for INTERLEUKIN-13. Included under this heading are the INTERLEUKIN-13 RECEPTOR ALPHA2 which is a monomeric receptor and the INTERLEUKIN-4 RECEPTOR TYPE II which has specificity for both INTERLEUKIN-4 and INTERLEUKIN-13.", "PM": "2007; RECEPTORS, INTERLEUKIN-13 was indexed under RECEPTORS, INTERLEUKIN 1993-2006 & RECEPTORS, IMMNUNOLOGIC 1993", "HN": "2007(1993)", "MR": "20090720", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053660"}, {"RECTYPE": "D", "MH": "Interleukin-13 Receptor alpha1 Subunit", "DS": "INTERLEUKIN 013 RECEPTOR ALPHA 1 SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-4, 13 Receptor Shared Subunit|T116|T192|NON|EQV|NLM (2007)|060227|INTERLEUKIN 004 Z 013 RECEPTOR SHARED SUBUNIT|abbcdefs", "ENTRY": "Interleukin 4, 13 Receptor Shared Subunit", "MN": "D12.776.543.750.705.852.420.600.800.500", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "An interleukin receptor subunit with specificity for INTERLEUKIN-13. It dimerizes with the INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT to form the TYPE II INTERLEUKIN-4 RECEPTOR which has specificity for both INTERLEUKIN-4 and INTERLEUKIN-13. Signaling of this receptor subunit occurs through the interaction of its cytoplasmic domain with JANUS KINASES such as the TYK2 KINASE.", "PM": "2007; IL-13RALPHA1 was indexed under RECEPTORS, INTERLEUKIN 1993-2006", "HN": "2007(1993)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053661"}, {"RECTYPE": "D", "MH": "Interleukin-4 Receptor alpha Subunit", "DS": "INTERLEUKIN 004 RECEPTOR ALPHA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD124 Antigens|T116|T192|NON|EQV|NLM (1998)|970228|CD 124 ANTIGENS|abbcdefs", "ENTRY": "Receptors alpha, Interleukin-4", "MN": "D12.776.543.750.705.852.420.600.800.200", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A receptor subunit that is a component of the TYPE I INTERLEUKIN-4 RECEPTOR and the TYPE II INTERLEUKIN-4 RECEPTOR. It signals through interaction of its cytoplasmic domain with JANUS KINASES such as JANUS KINASE 1.", "PM": "2007; CD124 ANTIGENS was indexed under RECEPTORS, INTERLEUKIN-4 1998-2005", "HN": "2007(1998)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053662"}, {"RECTYPE": "D", "MH": "Interleukin-13 Receptor alpha2 Subunit", "DS": "INTERLEUKIN 013 RECEPTOR ALPHA 2 SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptor, Interleukin-13 alpha2|T116|T192|NON|EQV|NLM (2007)|060228|RECEPTOR INTERLEUKIN 013 ALPHA 2|abbcdefs", "ENTRY": "alpha2 Receptor, Interleukin-13", "MN": "D12.776.543.750.705.852.420.600.300", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "An interleukin-13 receptor subunit that is closely-related to the INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT. The receptor is found as a monomeric protein and has been considered to be a decoy receptor for interleukin-13 due the fact that it lacks cytoplasmic signaling domains.", "PM": "2007; INTERLEUKIN-13 RECEPTOR ALPHA2 CHAIN was indexed under RECEPTORS, INTERLEUKIN 1993-2006", "HN": "2007(1993)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053663"}, {"RECTYPE": "D", "MH": "Interleukin-5 Receptor alpha Subunit", "DS": "INTERLEUKIN 005 RECEPTOR ALPHA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD125 Antigens|T116|T192|NON|EQV|NLM (2007)|060301|CD 125 ANTIGENS|abbcdefs", "ENTRY": "Interleukin 5 Receptor alpha Subunit", "MN": "D12.776.543.750.705.852.420.380.750", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (1988-2006)", "MS": "A low affinity interleukin-5 receptor subunit that combines with the CYTOKINE RECEPTOR COMMON BETA SUBUNIT to form a high affinity receptor for INTERLEUKIN-5. Several isoforms of the interleukin-5 receptor alpha subunit exist due to multiple ALTERNATIVE SPLICING.", "PM": "2007", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053666"}, {"RECTYPE": "D", "MH": "Syndecans", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Syndecan|T116|T123|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.543.550.847", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A family of transmembrane glycoproteins that contain a short cytoplasmic domain, a single-span transmembrane domain, and an extracellular domain with heparin sulfate and CHONDROITIN SULFATE chains. Syndecans interact with a variety of heparin-binding INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS and may play a role in modulating cellular signaling during EMBRYONIC DEVELOPMENT, tumorigenesis, and angiogenesis.", "PM": "2007; SYNDECANS was indexed under MEMBRANE GLYCOPROTEINS and PROTEOGLYCANS 1989-2005", "HN": "2007(1989)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053667"}, {"RECTYPE": "D", "MH": "Syndecan-1", "DS": "SYNDECAN 01", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "CD138 Antigens|T116|T123|ABX|EQV|NLM (2007)|060301|CD 138 ANTIGENS|abbcdefs", "ENTRY": "Antigen, CD138", "MN": "D12.776.543.550.847.100", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A syndecan that interacts with EXTRACELLULAR MATRIX PROTEINS and plays a role CELL PROLIFERATION and CELL MIGRATION.", "PM": "2007; SYNDECAN 1 was indexed under MEMBRANE GLYCOPROTEINS & PROTEOGLYCANS 2005-2006", "HN": "2007(2005)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053668"}, {"RECTYPE": "D", "MH": "Syndecan-2", "DS": "SYNDECAN 02", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Syndecan 2|T116|T123|NON|EQV|NLM (2007)|051005|abbcdef", "MN": "D12.776.543.550.847.200", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "149769-25-5", "MS": "A syndecan that is predominantly expressed during EMBRYONIC DEVELOPMENT. It may play a role in mediating cellular interactions with the EXTRACELLULAR MATRIX and may modulate the signaling activity of certain INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS.", "PM": "2007; SYNDECAN 2 was indexed under MEMBRANE GLYCPROTEINS & PROTEOGLYCOPROTEINS 1992-2006", "HN": "2007(1992)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053669"}, {"RECTYPE": "D", "MH": "Syndecan-3", "DS": "SYNDECAN 03", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Receptor, HB-GAM", "MN": "D12.776.543.550.847.300", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A syndecan found at high levels in the developing LIMB BUDS. It may play a role in the regulation of MUSCULOSKELETAL DEVELOPMENT by modulating the effects of INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS.", "PM": "2007; SYNDECAN 3 was indexed under MEMBRANE GLYCOPROTEINS & PROTEOGLYCANS 1992-2005", "HN": "2007(1992)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053670"}, {"RECTYPE": "D", "MH": "Syndecan-4", "DS": "SYNDECAN 04", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Syndecan4|T116|T123|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.543.550.847.400", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A ubiquitously expressed syndecan that is found in all stages of embryonic development and in most adult tissues. Syndecan-4 is found localized to focal adhesion sites in fibronectin-adherent cells and may play a role the process of CELL MIGRATION and CELL PROLIFERATION.", "PM": "2007; SYNDECAN 4 was indexed under MEMBRANE GLYCOPROTEINS & PROTEOGLYCANS 1994-2006", "HN": "2007(1994)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053671"}, {"RECTYPE": "D", "MH": "Electrochemotherapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Electrochemotherapies", "MN": "E05.301.500.750.500", "MH_TH": "NLM (2007)", "ST": "T061", "AN": "coordinate with disease/drug ther", "PI": "Electroporation (2001-2006)", "MS": "A cancer treatment modality that uses pulsed electrical currents to permeabilize cell membranes (ELECTROPORATION) and thereby enhance the uptake of chemotherapeutic agents into the body's cells.", "PM": "2007", "HN": "2007", "MR": "20220408", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053672"}, {"RECTYPE": "D", "MH": "Glypicans", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glypican|T116|T123|NON|EQV|NLM (1998)|961231|abbcdef", "ENTRY": "Glypican 5", "MN": "D12.776.543.550.418.500", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A family of GLYCOSYLPHOSPHATIDYLINOSITOL-anchored, cell-surface heparan sulfate proteoglycans that may play a role in CELL GROWTH PROCESSES and CELL DIFFERENTIATION by modulating ligand-receptor interactions.", "PM": "2007; see HEPARAN SULFATE PROTEOGLYCAN 1998-2006; GLYPICAN 3 was indexed under HEPARAN SULFATE PROTEOGLYCANS 2000-2006 & under HEPARITIN SULFATE & PROTEOGLYCANS 1996-1999", "HN": "2007(1998)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053673"}, {"RECTYPE": "D", "MH": "Aggrecans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cartilage Specific Proteoglycan Core Proteins", "MN": "D12.776.860.300.140", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "Large HYALURONAN-containing proteoglycans found in articular cartilage (CARTILAGE, ARTICULAR). They form into aggregates that provide tissues with the capacity to resist high compressive and tensile forces.", "PM": "2007; AGGRECANS was indexed under PROTEOCHONDROITIN SULFATES 2006, & under EXTRACELLULAR MATRIX PROTEINS, LECTINS, C-TYPE & PROTEOGLYCANS 1990-2006", "HN": "2007(1990)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053674"}, {"RECTYPE": "D", "MH": "Versicans", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Versican|T116|T123|NON|EQV|NLM (2007)|abbcde", "ENTRY": "Chondroitin Sulfate Proteoglycan Core Protein 2|T116|T123|NON|EQV|NLM (2007)|040803|abbcdef", "MN": "D12.776.860.300.885", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "126968-45-4", "MS": "HYALURONAN-containing proteoglycans found in the EXTRACELLULAR MATRIX of a variety of tissues and organs. Several versican isoforms exist due to multiple ALTERNATIVE SPLICING of the versican MESSENGER RNA.", "PM": "2007; VERSICAN was indexed under PROTEOCHONDRIOTIN SULFATES & LECTINS, C-TYPE 1989-2006", "HN": "2007(1989)", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053675"}, {"RECTYPE": "D", "MH": "Syntenins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Syntenin 2", "MN": "D12.776.476.024.468", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "Intracellular signaling adaptor proteins that play a role in the coupling of SYNDECANS to CYTOSKELETAL PROTEINS.", "PM": "2007", "HN": "2007", "MR": "20151124", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053676"}, {"RECTYPE": "D", "MH": "Receptors, Oncostatin M", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Oncostatin M|T116|T192|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.543.750.705.852.555", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "AN": "specific types and subunits are also available", "MS": "Cell surface receptors with specificity for ONCOSTATIN M. Two subtypes of receptors have been identified and are defined by their subunit composition.", "PM": "2007; ONCOSTATIN M RECEPTORS was indexed under RECEPTORS, CYTOKINE 1994-2006, & under RECEPTORS, ENDOGENOUS SUBSTANCES 1990-1993", "HN": "2007(1990)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053677"}, {"RECTYPE": "D", "MH": "Receptors, Oncostatin M, Type II", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Oncostatin M Type II Receptor|T116|T192|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.543.750.705.852.555.600", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A subtype of oncostatin receptors that are formed by dimerization of ONCOSTATIN M RECEPTOR BETA SUBUNIT and CYTOKINE RECEPTOR GP130. They are activated specifically by ONCOSTATIN M and signal through interaction of their cytoplasmic domains with JANUS KINASES.", "PM": "2007; ONCOSTATIN M TYPE II RECEPTOR was indexed under RECEPTORS, CYTOKINE 1994-2006 & under RECEPTORS, ENDOGENOUS SUBSTANCES 1990-1993", "HN": "2007(1990)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053679"}, {"RECTYPE": "D", "MH": "Leukemia Inhibitory Factor Receptor alpha Subunit", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CD118 Antigens|T116|T192|ABX|EQV|NLM (2007)|060214|CD 118 ANTIGENS|abbcdefs", "ENTRY": "Antigen, CD118", "MN": "D12.776.543.750.750.400.550.250.750", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A receptor subunit that combines with CYTOKINE RECEPTOR GP130 to form the dual specificity receptor for LEUKEMIA INHIBITORY FACTOR and ONCOSTATIN M. The subunit is also a component of the CILIARY NEUROTROPHIC FACTOR RECEPTOR. Both membrane-bound and secreted isoforms of the receptor subunit exist due to ALTERNATIVE SPLICING of its mRNA. The secreted isoform is believed to act as an inhibitory receptor, while the membrane-bound form is a signaling receptor.", "PM": "2007", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053680"}, {"RECTYPE": "D", "MH": "Oncostatin M Receptor beta Subunit", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Oncostatin M, beta Subunit|T116|T192|NON|EQV|NLM (2007)|060314|abbcdef", "MN": "D12.776.543.750.705.852.555.600.750", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "An ONCOSTATIN M-specific receptor subunit that combines with CYTOKINE RECEPTOR GP130 to form the ONCOSTATIN M TYPE II RECEPTOR.", "PM": "2007; ONCOSTATIN M RECEPTOR BETA was indexed under RECEPTORS, CYTOKINE 2003-2006", "HN": "2007(2003)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053681"}, {"RECTYPE": "D", "MH": "Tendon Entrapment", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tenosynovitis, Stenosing|T047|NON|EQV|NLM (2007)|060303|abcdef", "ENTRY": "Tenovaginitides, Stenosing", "MN": "C05.651.869.816", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Tenosynovitis (1964-2006)", "MS": "Narrowing or stenosis of a tendon's retinacular sheath. It occurs most often in the hand or wrist but can also be found in the foot or ankle. The most common types are DE QUERVAIN DISEASE and TRIGGER FINGER DISORDER.", "PM": "2007", "HN": "2007", "MR": "20160120", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053682"}, {"RECTYPE": "D", "MH": "Oncostatin M", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D23.529.374.562", "PA": "Growth Inhibitors", "MH_TH": "NLM (2007)", "ST": "T123", "N1": "Oncostatin M", "RN": "106956-32-5", "MS": "A cytokine with both pro- and anti-inflammatory actions that depend upon the cellular microenvironment. Oncostatin M is a 28 kDa monomeric glycoprotein that is similar in structure to LEUKEMIA INHIBITORY FACTOR. Its name derives from the the observation that it inhibited the growth of tumor cells and augmented the growth of normal fibroblasts.", "PM": "2007; ONCOSTATIN M was indexed under CYTOKINES 1987-2006", "HN": "2007(1987)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053683"}, {"RECTYPE": "D", "MH": "De Quervain Disease", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Stenosing Tenosynovitis, De Quervain|T047|EPO|EQV|NLM (2007)|060303|abcdef", "ENTRY": "Disease, De Quervain", "MN": "C05.651.869.816.200", "MH_TH": "NLM (1998)", "ST": "T047", "PI": "Tenosynovitis (1963-2006)", "MS": "Stenosing tenosynovitis of the abductor pollicis longus and extensor pollicis brevis tendons in the first dorsal wrist compartment. The presenting symptoms are usually pain and tenderness at the radial styloid. The cause is almost always related to OVERUSE INJURY or is associated with RHEUMATOID ARTHRITIS.", "PM": "2007; see TENOSYNOVITIS 1998-2006", "HN": "2007; use TENOSYNOVITIS 1998-2006", "MR": "20160120", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053684"}, {"RECTYPE": "D", "MH": "Laser Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Vaporization, Laser|T061|NON|NRW|UNK (19XX)|860620|abcdef", "ENTRY": "Tissue Ablation, Laser", "MN": "E04.014.520", "FX": "Lasers", "MH_TH": "NLM (2007)", "ST": "T061", "MS": "The use of photothermal effects of LASERS to coagulate, incise, vaporize, resect, dissect, or resurface tissue.", "PM": "2008; for LASER SURGERY, LASER SCALPEL , LASER KNIFE, and VAPORIZATION, LASER see LASER SURGERY 1987-2007", "HN": "2008", "MR": "20150713", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D053685"}, {"RECTYPE": "D", "MH": "Fetal Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Stem Cells, Fetal", "MN": "A11.872.220", "MH_TH": "NLM (2007)", "ST": "T025", "PI": "Stem Cells (1983-2006)", "MS": "Cells derived from a FETUS that retain the ability to divide, proliferate and provide progenitor cells that can differentiate into specialized cells.", "PM": "2007", "HN": "2007", "MR": "20130709", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053686"}, {"RECTYPE": "D", "MH": "Adult Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Stem Cells, Somatic", "MN": "A11.872.040", "MH_TH": "NLM (2007)", "ST": "T025", "PI": "Stem Cells (1999-2006)", "MS": "Tissue-specific stem cells (also known as Somatic Stem Cells) that appear during fetal development and remain in the body throughout life. The key functions of adult stem cells are to maintain and repair the specific tissues where they reside (e.g. skin or blood).", "PM": "2007", "HN": "2007", "MR": "20160701", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053687"}, {"RECTYPE": "D", "MH": "Interleukin-6 Receptor alpha Subunit", "DS": "INTERLEUKIN 006 RECEPTOR ALPHA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD126 Antigens|T116|T192|ABX|EQV|NLM (1998)|970228|CD 126 ANTIGENS|abbcdefs", "ENTRY": "Receptor, CD126", "MN": "D12.776.543.750.705.852.420.400.750", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A low affinity interleukin-6 receptor subunit that combines with the CYTOKINE RECEPTOR GP130 to form a high affinity receptor for INTERLEUKIN-6.", "PM": "2007; for ANTIGENS, CD126 see RECEPTORS, INTERLEUKIN-6 1997-2006", "HN": "2007(1997); for ANTIGENS, CD126 see RECEPTORS, INTERLEUKIN-6 1997-2006", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053698"}, {"RECTYPE": "D", "MH": "Interleukin-7 Receptor alpha Subunit", "DS": "INTERLEUKIN 007 RECEPTOR ALPHA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD127 Antigens|T116|T192|NON|EQV|NLM (1999)|980309|CD 127 ANTIGENS|abbcdefs", "ENTRY": "Interleukin 7 Receptor alpha Subunit", "MN": "D12.776.543.750.705.852.420.420.450", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "A low affinity interleukin-7 receptor subunit that combines with the INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT to form a high affinity receptor for INTERLEUKIN-7.", "PM": "2007; for ANTIGENS, CD127 see RECEPTORS, INTERELUKIN-7 1998-2006", "HN": "2007(1998)", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053699"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-8", "DS": "RECEPTORS INTERLEUKIN 008", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-8 Receptors|T116|T192|NON|EQV|NLM (2007)|060306|INTERLEUKIN 008 RECEPTORS|abbcdefs", "ENTRY": "Receptors, Interleukin 8", "MN": "D12.776.543.750.705.852.420.421", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "AN": "RECEPTORS, INTERLEUKIN-8A and RECEPTORS, INTERLEUKIN-8B are also available", "PI": "Receptors, Interleukin-8B (2000-2006)", "MS": "Cell surface receptors that are specific for INTERLEUKIN-8. Two specific receptor subtypes (type A and B) have been found and bind IL-8 with high affinity.", "PM": "2007", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053700"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-10", "DS": "RECEPTORS INTERLEUKIN 010", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, IL-10|T116|T192|ABX|EQV|NLM (2007)|060306|RECEPTORS IL 010|abbcdefs", "ENTRY": "Receptors, Interleukin 10", "MN": "D12.776.543.750.705.852.420.550", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "Cell surface receptors for INTERLEUKIN-10. They exist as a tetramer of two alpha chains (INTERLEUKIN-10 RECEPTOR ALPHA CHAIN) and two beta chains (INTERLEUKIN-10 RECEPTOR, BETA CHAIN). Signaling from interleukin-10 receptors occurs through their interaction with JANUS KINASES.", "PM": "2007; RECEPTORS, INTERLEUKIN-10 was indexed under RECEPTORS, INTERLEUKIN 1993-2006", "HN": "2007(1993)", "MR": "20090720", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053701"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-11", "DS": "RECEPTORS INTERLEUKIN 011", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-11 Receptors|T116|T192|NON|EQV|NLM (2007)|INTERLEUKIN 011 RECEPTORS|abbcdes", "ENTRY": "Receptors, Interleukin 11", "MN": "D12.776.543.750.705.852.420.560", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "Cell surface receptors that are specific for INTERLEUKIN-11. They consist of heterodimers of the INTERLEUKIN-11 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR GP130.", "PM": "2007; RECEPTORS, INTERLEUKIN-11 was indexed under RECEPTORS, INTERLEUKIN 2005-2006 & under RECEPTORS, IMMUNOLOGIC 1992-2004", "HN": "2007(1992)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053702"}, {"RECTYPE": "D", "MH": "Interleukin-11 Receptor alpha Subunit", "DS": "INTERLEUKIN 011 RECEPTOR ALPHA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Interleukin 11 Receptor alpha Subunit", "MN": "D12.776.543.750.705.852.420.560.500", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (2005-2006)", "MS": "A low affinity interleukin-11 receptor subunit that combines with the CYTOKINE RECEPTOR GP130 to form a high affinity receptor for INTERLEUKIN-11. Multiple isoforms of this protein exist due to ALTERNATIVE SPLICING of its MRNA.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053703"}, {"RECTYPE": "D", "MH": "Capsule Endoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Wireless Capsule Endoscopies", "MN": "E01.370.388.250.250.250.140", "FX": "Capsule Endoscopes", "MH_TH": "NLM (2007)", "ST": "T060", "PI": "Endoscopy, Gastrointestinal (2002-2006)", "MS": "Non-invasive, endoscopic imaging by use of VIDEO CAPSULE ENDOSCOPES to perform examination of the gastrointestinal tract, especially the small bowel.", "PM": "2007", "HN": "2007", "MR": "20100625", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053704"}, {"RECTYPE": "D", "MH": "Capsule Endoscopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Video Capsule Endoscope", "MN": "E07.230.220.260.140", "FX": "Capsule Endoscopy", "MH_TH": "NLM (2007)", "ST": "T074", "PI": "Endoscopes, Gastrointestinal (2002-2006)", "MS": "A pill sized videocamera encased in a capsule. It is designed to be swallowed and subsequently traverse the gastrointestinal tract while transmitting diagnostic images along the way.", "PM": "2007", "HN": "2007", "MR": "20100625", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053705"}, {"RECTYPE": "D", "MH": "Typhlitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Typhlitis, Neutropenic", "MN": "C06.405.469.110.708", "FX": "Enterocolitis, Neutropenic", "MH_TH": "NLM (2004)", "ST": "T047", "MS": "Necrotizing inflammation of the CECUM (\"typhlon\" in Greek), sometimes spreading to the APPENDIX and/or the ILEUM. Symptoms include ABDOMINAL PAIN and DIARRHEA. Its pathogenesis is multifactorial. Typhlitis is often associated with NEUTROPENIA and chemotherapy in immunocompromised individuals (IMMUNOCOMPROMISED HOST).", "PM": "2007; see ENTEROCOLITIS, NECROTIZING 2004-2006", "HN": "2007 (2004)", "MR": "20190617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053706"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-12", "DS": "RECEPTORS INTERLEUKIN 012", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-12 Receptors|T116|T192|NON|EQV|NLM (2007)|INTERLEUKIN 012 RECEPTORS|abbcdes", "ENTRY": "Receptors, Interleukin 12", "MN": "D12.776.543.750.705.852.420.580", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "Cell surface receptors for INTERLEUKIN-12. They exist as dimers of beta 1 and beta 2 subunits. Signaling from interleukin-12 receptors occurs through their interaction with JANUS KINASES.", "PM": "2007 RECEPTORS, INTERLEUKIN-12 was indexed under RECEPTORS, INTERLEUKIN 1994-2006", "HN": "2007(1994)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053707"}, {"RECTYPE": "D", "MH": "Interleukin-10 Receptor alpha Subunit", "DS": "INTERLEUKIN 010 RECEPTOR ALPHA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-10 Receptor alpha Chain|T116|T192|NON|EQV|NLM (2007)|060306|INTERLEUKIN 010 RECEPTOR ALPHA CHAIN|abbcdefs", "ENTRY": "Receptor, IL-10R1", "MN": "D12.776.543.750.705.852.420.550.500", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (1993-2006)", "MS": "A subunit of the interleukin-10 receptor. It plays a role in receptor signaling by associating with JANUS KINASE 1.", "PM": "2007", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053709"}, {"RECTYPE": "D", "MH": "Interleukin-10 Receptor beta Subunit", "DS": "INTERLEUKIN 010 RECEPTOR BETA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CDW210B Antigens|T116|T192|ABX|EQV|NLM (2007)|060306|CD 210 W B ANTIGENS|abbcdefs", "ENTRY": "Interleukin 10 Receptor, beta Chain", "MN": "D12.776.543.750.705.852.420.550.750", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (1993-2006)", "MS": "A subunit of the interleukin-10 receptor. It plays a role in receptor signaling by associating with TYK2 KINASE.", "PM": "2007", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053710"}, {"RECTYPE": "D", "MH": "Interleukin-12 Receptor beta 1 Subunit", "DS": "INTERLEUKIN 012 RECEPTOR BETA 1 SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Interleukin 12 Receptor p40 Subunit", "MN": "D12.776.543.750.705.852.420.580.500", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (1994-2006)", "MS": "A subunit of the interleukin-12 receptor. It plays a role in receptor signaling by associating with TYK2 KINASE 1.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053711"}, {"RECTYPE": "D", "MH": "Interleukin-12 Receptor beta 2 Subunit", "DS": "INTERLEUKIN 012 RECEPTOR BETA 2 SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Interleukin 12 Receptor p35 Subunit", "MN": "D12.776.543.750.705.852.420.580.750", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (1994-2006)", "MS": "A subunit of the interleukin-12 receptor. It plays a role in receptor signaling by associating with JANUS KINASE 2.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053712"}, {"RECTYPE": "D", "MH": "Azoospermia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C12.200.294.430.380", "FX": "Aspermia", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Oligospermia (1977-2006)", "MS": "A condition of having no sperm present in the ejaculate (SEMEN).", "PM": "2007; see OLIGOSPERMIA 1977-2006", "HN": "2007 (1977)", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053713"}, {"RECTYPE": "D", "MH": "Aspermia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C12.200.294.430.126", "FX": "Azoospermia", "MH_TH": "NLM (2007)", "ST": "T047", "MS": "A condition characterized by the complete absence of SEMEN. This disorder should be differentiated from AZOOSPERMIA, absence of sperm in the semen.", "PM": "2007", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053714"}, {"RECTYPE": "D", "MH": "Cystotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Vesicotomies", "MN": "E04.950.774.162", "FX": "Cystostomy", "MH_TH": "NLM (2007)", "ST": "T061", "AN": "unintentional cystotomy during surgical procedures use URINARY BLADDER/inj; for accidental injury to the urinary bladder coordinate with URINARY BLADDER/inj; do not confuse with CYSTOSTOMY", "PI": "Bladder (1963-2006)", "MS": "Surgical incision or puncture into a URINARY BLADDER. Cystotomy may be used to remove URINARY CALCULI, or to perform tissue repair and reconstruction.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053715"}, {"RECTYPE": "D", "MH": "Female Athlete Triad Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Female Athlete Triad|T047|NON|EQV|NLM (2007)|060309|abcdef", "MN": "F03.400.937.500", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Osteoporosis (1993-2006)", "MS": "A condition of competitive female athletes in which there are interrelated problems of feeding and eating disorders; AMENORRHEA; and OSTEOPOROSIS.", "PM": "2007", "HN": "2007", "MR": "20190708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053716"}, {"RECTYPE": "D", "MH": "Pneumonia, Ventilator-Associated", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ventilator-Associated Pneumonia|T047|NON|EQV|NLM (2007)|060309|abcdef", "MN": "C23.550.291.875.500.500.500", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Pneumonia (1990-2006)", "MS": "Serious INFLAMMATION of the LUNG in patients who required the use of PULMONARY VENTILATOR. It is usually caused by bacterial CROSS INFECTION in hospitals.", "PM": "2007", "HN": "2007", "MR": "20190617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053717"}, {"RECTYPE": "D", "MH": "Scleromyxedema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Papular Mucinosis|T047|NON|EQV|NLM (2007)|ORD (2010)|060309|abcdeef", "ENTRY": "Myxedematosus, Lichen", "MN": "C17.300.550.875", "FX": "Myxedema", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Myxedema (1963-2006)", "MS": "A connective tissue disorder characterized by widespread thickening of SKIN with a cobblestone-like appearance. It is caused by proliferation of FIBROBLASTS and deposition of MUCIN in the DERMIS in the absence of thyroid disease. Most scleromyxedema cases are associated with a MONOCLONAL GAMMOPATHY, immunoglobulin IgG-lambda.", "PM": "2007", "HN": "2007", "MR": "20090706", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053718"}, {"RECTYPE": "D", "MH": "Tandem Mass Spectrometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Mass Spectrometry, Tandem", "MN": "E05.196.566.880", "MH_TH": "NLM (2007)", "ST": "T062", "PI": "Spectrum Analysis, Mass or specifics (1981-2006)", "MS": "A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection.", "PM": "2007", "HN": "2007", "MR": "20150616", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053719"}, {"RECTYPE": "D", "MH": "Interleukin-15 Receptor alpha Subunit", "DS": "INTERLEUKIN 015 RECEPTOR ALPHA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "alpha, Interleukin-15 Receptor", "MN": "D12.776.543.750.705.852.420.800.550", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin-2 (1995-2006)", "MS": "A low affinity interleukin-15 receptor subunit that combines with the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN to form a high affinity receptor for INTERLEUKIN-15.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053720"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-16", "DS": "RECEPTORS INTERLEUKIN 016", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-16 Receptors|T116|T129|NON|EQV|NLM (2007)|060309|INTERLEUKIN 016 RECEPTORS|abbcdefs", "ENTRY": "Receptors, Interleukin 16", "MN": "D12.776.543.750.705.852.420.810", "MH_TH": "NLM (2007)", "ST": "T129", "RN": "0", "PI": "Antigens, CD4 (1990-2006)", "MS": "Cell surface receptors for INTERLEUKIN-16. Although initial studies have identified CD4 ANTIGENS as receptors for interleukin-16, the fact that cells from KNOCKOUT MICE which lack CD4 antigen are responsive to IL-16 indicate that are at least 2 distinct receptors subtypes.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053721"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-17", "DS": "RECEPTORS INTERLEUKIN 017", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin-17 Receptors|T116|T192|NON|EQV|NLM (2007)|060310|INTERLEUKIN 017 RECEPTORS|abbcdefs", "ENTRY": "Receptors, Interleukin 17", "MN": "D12.776.543.750.705.852.420.820", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (1998-2006)", "MS": "Cell surface receptors for INTERLEUKIN-17. Several subtypes of receptors have been found, each with its own in specificity for interleukin-17 subtype.", "PM": "2007", "HN": "2007", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053722"}, {"RECTYPE": "D", "MH": "Panax notoginseng", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "notoginsengs, Panax", "MN": "B01.875.800.575.912.250.087.500.500", "MH_TH": "NLM (2007)", "ST": "T002", "RN": "txid44586", "PI": "Panax (1980-2006)", "MS": "A plant species of the genus PANAX. It contains damarane-type tetracyclic TRITERPENES. The common names of Sanchi or Tienchi are also used for Panax pseudoginseng which is distinguished in containing oleanane-type pentacyclic triterpenoids.", "PM": "2007", "HN": "2007", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053723"}, {"RECTYPE": "D", "MH": "Receptors, Interleukin-18", "DS": "RECEPTORS INTERLEUKIN 018", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Interleukin 18 Receptors|T116|T192|NON|EQV|NLM (2007)|060310|INTERLEUKIN 018 RECEPTORS|abbcdefs", "ENTRY": "Receptors, Interleukin 18", "MN": "D12.776.543.750.705.852.420.830", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "MS": "Cell surface receptors for INTERLEUKIN-18 found on a variety of cell types including MACROPHAGES; NEUTROPHILS; NK CELLS; ENDOTHELIAL CELLS; and SMOOTH MUSCLE CELLS. They are formed as a heterodimer of alpha and beta subunits.", "PM": "2007; RECEPTORS, INTERLEUKIN-18 was indexed under RECEPTORS, INTERLEUKIN 1997-2006", "HN": "2007(1997)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053724"}, {"RECTYPE": "D", "MH": "Interleukin-18 Receptor alpha Subunit", "DS": "INTERLEUKIN 018 RECEPTOR ALPHA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CDw218a Antigens|T116|T192|ABX|EQV|NLM (2007)|060310|CD 218A ANTIGENS W|abbcdefs", "ENTRY": "Interleukin 18 Receptor alpha Subunit", "MN": "D12.776.543.750.705.852.420.830.500", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (1997-2006)", "MS": "A subunit of the interleukin-18 receptor that is responsible of extracellular binding of IL-18.", "PM": "2007", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053727"}, {"RECTYPE": "D", "MH": "Interleukin-18 Receptor beta Subunit", "DS": "INTERLEUKIN 018 RECEPTOR BETA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CDw218b Antigens|T116|T192|ABX|EQV|NLM (2007)|060310|CD 218B ANTIGENS W|abbcdefs", "ENTRY": "Interleukin 18 Receptor beta Subunit", "MN": "D12.776.543.750.705.852.420.830.750", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (1998-2006)", "MS": "A subunit of the interleukin-18 receptor that plays a role in receptor signaling by association of its cytoplasmic domain with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88.", "PM": "2007", "HN": "2007", "MR": "20170524", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053728"}, {"RECTYPE": "D", "MH": "Interleukin-21 Receptor alpha Subunit", "DS": "INTERLEUKIN 021 RECEPTOR ALPHA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Interleukin 21 Receptor alpha Subunit", "MN": "D12.776.543.750.705.852.420.900.450", "MH_TH": "NLM (2007)", "ST": "T192", "RN": "0", "PI": "Receptors, Interleukin (2000-2006)", "MS": "An interleukin-21 receptor subunit that combines with the INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT to form a high affinity receptor for interleukin-21. It signals via interaction of its cytoplasmic domain with JANUS KINASES such as JANUS KINASE 1 and JANUS KINASE 3.", "PM": "2007", "HN": "2007", "MR": "20090720", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053738"}, {"RECTYPE": "D", "MH": "Ciliary Neurotrophic Factor Receptor alpha Subunit", "DE": "CILIARY NEUROTROPHIC FACTOR RECEPT ALPHA SUBUNIT", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Ciliary Neurotrophic Factor Receptor alpha Chain|T116|T192|NON|EQV|NLM (2007)|060314|abbcdef", "MN": "D12.776.543.750.750.400.550.250.249", "MH_TH": "NLM (2000)", "ST": "T192", "RN": "0", "MS": "A ciliary neurotrophic factor receptor subunit. It is anchored to the cell surface via GLYCOSYLPHOSPHATIDYLINOSITOL LINKAGE and has specificity for binding to CILIARY NEUROTROPHIC FACTOR. It lacks signal transducing domains which are found on the other two subunits of the receptor.", "PM": "2007; for CILIARY NEUROTROPHIC FACTOR RECEPTOR ALPHA SUBUNIT see RECEPTOR, CILIARY NEUROTROPHIC FACTOR 2000-2006", "HN": "2007", "MR": "20230316", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053739"}, {"RECTYPE": "D", "MH": "Nanoparticles", "AQ": "AD AE AN CH CL EC HI ME MI PO PS RE SD SN ST TO TU UL VI", "PRINT ENTRY": "Nanocrystals|T073|NON|REL|NLM (2007)|060323|abcdef", "ENTRY": "Nanoparticle", "MN": "J01.637.512.600", "MH_TH": "NLM (2005)", "ST": "T073", "MS": "Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging.", "PM": "2007; see NANOSTRUCTURES 2005-2006", "HN": "2007; use NANOSTRUCTURES 2005-2006", "MR": "20150331", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053758"}, {"RECTYPE": "D", "MH": "Interleukin-23", "DS": "INTERLEUKIN 023", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "IL-23|T116|T123|ABB|EQV|NLM (2007)|010110|IL 023|abbcdefs", "ENTRY": "Interleukin 23", "MN": "D23.529.374.465.550", "FX": "Ustekinumab", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A heterodimeric cytokine that plays a role in innate and adaptive immune responses. Interleukin-23 is comprised of a unique 19 kDa subunit and 40 kDa subunit that is shared with INTERLEUKIN-12. It is produced by DENDRITIC CELLS; MACROPHAGES and a variety of other immune cells", "PM": "2007; INTERLEUKIN-23 was indexed under INTERLEUKINS 2001-2006", "HN": "2007(2001)", "MR": "20170414", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053759"}, {"RECTYPE": "D", "MH": "Interleukin-23 Subunit p19", "DS": "INTERLEUKIN 023 SUBUNIT P19", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha Subunit, Interleukin-23", "MN": "D23.529.374.465.550.500", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A subunit of interleukin-23. It combines with INTERLEUKIN-12 SUBUNIT P40, which is shared between the two cytokines, to form in the active interleukin-23 cytokine.", "PM": "2007; INTERLEUKIN-23 SUBUNIT P19 was indexed under INTERLEUKINS 2003-2006", "HN": "2007(2003)", "MR": "20130708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053760"}, {"RECTYPE": "D", "MH": "Nanocomposites", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "ENTRY": "Nanocomposite", "MN": "J01.637.512.150", "MH_TH": "NLM (2007)", "ST": "T073", "MS": "Nanometer-scale composite structures composed of organic molecules intimately incorporated with inorganic molecules. (Glossary of Biotechnology and Nanobiotechology Terms, 4th ed)", "PM": "2007", "HN": "2007", "MR": "20150331", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053761"}, {"RECTYPE": "D", "MH": "Interleukin-12 Subunit p40", "DS": "INTERLEUKIN 012 SUBUNIT P 040", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p40, Interleukin-23 Subunit", "MN": "D23.529.374.465.550.249", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A cytokine subunit that is a component of both interleukin-12 and interleukin-23. It binds to the INTERLEUKIN-12 SUBUNIT P35 via a disulfide bond to form interleukin-12 and to INTERLEUKIN-23 SUBUNIT P19 to form interleukin-23.", "PM": "2007; INTERLEUKIN-12 SUBUNIT P40 was indexed under INTERLEUKIN-12 & PROTEIN SUBUNITS 2002-2006", "HN": "2007(2002)", "MR": "20130708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053762"}, {"RECTYPE": "D", "MH": "Presenilins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Presenilin|T116|T123|NON|EQV|NLM (2007)|060321|abbcdef", "MN": "D12.776.543.696", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1995-2006)", "MS": "Integral membrane proteins and essential components of the gamma-secretase complex that catalyzes the cleavage of membrane proteins such as NOTCH RECEPTORS and AMYLOID BETA-PEPTIDES precursors. Mutations of presenilins lead to presenile ALZHEIMER DISEASE with onset before age 65 years.", "PM": "2007", "HN": "2007", "MR": "20100625", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053763"}, {"RECTYPE": "D", "MH": "Presenilin-1", "DS": "PRESENILIN 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "S182 Protein|T116|T123|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.543.696.500", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1995-2006)", "MS": "Integral membrane protein of Golgi and endoplasmic reticulum. Its homodimer is an essential component of the gamma-secretase complex that catalyzes the cleavage of membrane proteins such as NOTCH RECEPTORS and AMYLOID BETA-PEPTIDES precursors. PSEN1 mutations cause early-onset ALZHEIMER DISEASE type 3 that may occur as early as 30 years of age in humans.", "PM": "2007; was indexed under MEMBRANE PROTEINS 1995-2006", "HN": "2007", "MR": "20100625", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053764"}, {"RECTYPE": "D", "MH": "Interleukin-12 Subunit p35", "DS": "INTERLEUKIN 012 SUBUNIT P 035", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Subunit p35, Interleukin-12", "MN": "D23.529.374.465.512.249", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A subunit of interleukin-12. It binds to the INTERLEUKIN-12 SUBUNIT P40 via a disulfide bond that results in the active cytokine.", "PM": "2007; INTERLEUKIN-12 SUBUNIT P35 was indexed under INTERLEUKIN-12 & PROTEIN SUBUNITS 2002-2006", "HN": "2007(2002)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053765"}, {"RECTYPE": "D", "MH": "Presenilin-2", "DS": "PRESENILIN 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Presenilin 2|T116|T123|NON|EQV|NLM (2007)|abbcde", "MN": "D12.776.543.696.750", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1996-2006)", "MS": "Integral membrane protein of Golgi and endoplasmic reticulum. Its homodimer is an essential component of the gamma-secretase complex that catalyzes the cleavage of membrane proteins such as NOTCH RECEPTORS and AMYLOID BETA-PEPTIDES precursors. PSEN2 mutations cause ALZHEIMER DISEASE type 4.", "PM": "2007; was indexed under MEMBRANE PROTEINS 1996-2006", "HN": "2007", "MR": "20100625", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053766"}, {"RECTYPE": "D", "MH": "Glucagon-Like Peptide 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Glucagon Like Peptide 2", "MN": "D06.472.317.680.500.750", "MH_TH": "NLM (2007)", "ST": "T125", "RN": "0", "PI": "Glucagon-Like Peptides (2000-2006)", "MS": "A 33-amino acid peptide derived from the C-terminal of PROGLUCAGON and mainly produced by the INTESTINAL L CELLS. It stimulates intestinal mucosal growth and decreased apoptosis of ENTEROCYTES. GLP-2 enhances gastrointestinal function and plays an important role in nutrient homeostasis.", "PM": "2007; GLUCAGON-LIKE PEPTIDE 2 was indexed under GLUCAGON-LIKE PEPTIDES 2000-2006", "HN": "2007(2000)", "MR": "20180705", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053767"}, {"RECTYPE": "D", "MH": "Metal Nanoparticles", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "PRINT ENTRY": "Metal Nanocrystals|T073|NON|REL|NLM (2007)|060323|abcdef", "ENTRY": "Nanoparticles, Metallic", "MN": "J01.637.512.600.500", "FX": "Ferrosoferric Oxide", "MH_TH": "NLM (2007)", "ST": "T073", "PI": "Nanostructures (2003-2006)", "MS": "Nanoparticles produced from metals whose uses include biosensors, optics, and catalysts. In biomedical applications the particles frequently involve the noble metals, especially gold and silver.", "PM": "2007", "HN": "2007", "MR": "20150331", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053768"}, {"RECTYPE": "D", "MH": "Nanocapsules", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "ENTRY": "Nanocapsule", "MN": "J01.637.512.600.575", "MH_TH": "NLM (2007)", "ST": "T073", "RN": "0", "MS": "Nanometer-sized, hollow, spherically-shaped objects that can be utilized to encapsulate small amounts of pharmaceuticals, enzymes, or other catalysts (Glossary of Biotechnology and Nanobiotechnology, 4th ed).", "PM": "2007", "HN": "2007", "MR": "20150402", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053769"}, {"RECTYPE": "D", "MH": "Nanowires", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "ENTRY": "Nanowire", "MN": "J01.637.512.925", "MH_TH": "NLM (2007)", "ST": "T073", "PI": "Nanotechnology (2001-2006)", "MS": "Nanometer-scale wires made of materials that conduct electricity. They can be coated with molecules such as antibodies that will bind to proteins and other substances.", "PM": "2007", "HN": "2007", "MR": "20150331", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053770"}, {"RECTYPE": "D", "MH": "Glicentin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proglucagon (1-69)|T116|T125|NON|EQV|NLM (2007)|abbcde", "MN": "D06.472.317.680.249", "MH_TH": "NLM (2007)", "ST": "T125", "RN": "71567-77-6", "PI": "Glucagon (1979-2006)", "MS": "A 69-amino acid peptide derived from the N-terminal of PROGLUCAGON. It is mainly produced by the INTESTINAL L CELLS. Further processing of glicentin yield a 30-amino acid N-terminal peptide (glicentin-related polypeptide) and a 37-amino acid peptide OXYNTOMODULIN. Both glicentin and oxyntomodulin can reduce digestive secretions and delay gastric emptying.", "PM": "2007; GLICENTIN was indexed under ENTEROGLUCAGONS & PROTEIN PRECURSORS 1988-2006", "HN": "2007 (1988)", "MR": "20180705", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053771"}, {"RECTYPE": "D", "MH": "Oxyntomodulin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proglucagon (33-69)|T116|T123|NON|EQV|NLM (2007)|050425|abbcdef", "MN": "D06.472.317.680.750", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Enteroglucagons (1981-2006)", "MS": "A 37-amino acid peptide derived from the C-terminal of GLICENTIN. It is mainly produced by the INTESTINAL L CELLS. Oxyntomodulin can reduce digestive secretions, delay gastric emptying, and reduced food intake.", "PM": "2007; OXYNTOMODULIN was indexed under ENTEROGLUCAGONS 2005-2006", "HN": "2007 (2005)", "MR": "20180705", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053772"}, {"RECTYPE": "D", "MH": "Transforming Growth Factor beta1", "DS": "TRANSFORMING GROWTH FACTOR BETA 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transforming Growth Factor-beta1|T116|T123|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "TGF beta1LAP", "MN": "D23.529.942.775.100", "EC": "deficiency:Camurati-Engelmann Syndrome", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A subtype of transforming growth factor beta that is synthesized by a wide variety of cells. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta 1 and TGF-beta1 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor. Defects in the gene that encodes TGF-beta1 are the cause of CAMURATI-ENGELMANN SYNDROME.", "PM": "2007; TRANSFORMING GROWTH FACTOR BETA1 was indexed under TRANSFORMING GROWTH FACTOR 2000-2006; TRANSFORMING GROWTH FACTOR BETA 1 LATENCY ASSOCIATED PEPTIDE was indexed under TRANSFORMING GROWTH FACTOR 1992-2006; TRANSFORMING GROWTH FACTOR BETA I was indexed under PROTEINS 2005-2006", "HN": "2007(1992)", "MR": "20200221", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053773"}, {"RECTYPE": "D", "MH": "Thiazolidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thiazolidine|T109|NON|EQV|NLM (2021)|191115|abcdef", "MN": "D02.886.675.966", "MH_TH": "NLM (2007)", "ST": "T109", "RN": "0", "PI": "Thiazoles (1963-2006)", "MS": "Reduced (protonated) form of THIAZOLES. They can be oxidized to THIAZOLIDINEDIONES.", "PM": "2007", "HN": "2007", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053778"}, {"RECTYPE": "D", "MH": "Latent TGF-beta Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Latent TGF-beta Binding Protein|T116|T123|ACX|EQV|NLM (2007)|abbcde", "ENTRY": "Latent TGF beta Binding Proteins", "MN": "D12.776.860.300.688", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A family of secreted multidomain proteins that were originally identified by their association with the latent form of TRANSFORMING GROWTH FACTORS. They interact with a variety of EXTRACELLULAR MATRIX PROTEINS and may play a role in the regulation of TGB-beta bioavailability.", "PM": "2007; LATENT TGF-BETA BINDING PROTEINS was indexed under INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 2005-2006 & under CARRIER PROTEINS 1990-2004", "HN": "2007(1990)", "MR": "20160415", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053779"}, {"RECTYPE": "D", "MH": "Transforming Growth Factor beta2", "DS": "TRANSFORMING GROWTH FACTOR BETA 02", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TGF-beta2|T116|T123|ABB|EQV|NLM (2007)|900227|TGF BETA 02|abbcdefs", "ENTRY": "TGF beta2LAP", "MN": "D23.529.942.775.200", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A TGF-beta subtype that was originally identified as a GLIOBLASTOMA-derived factor which inhibits the antigen-dependent growth of both helper and CYTOTOXIC T LYMPHOCYTES. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta2 and TGF-beta2 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor.", "PM": "2007; TRANSFORMING GROWTH FACTOR BETA2 was indexed under TRANSFROMING GROWTH FACTOR BETA 2000-2006", "HN": "2007(2000)", "MR": "20150602", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053781"}, {"RECTYPE": "D", "MH": "Transforming Growth Factor beta3", "DS": "TRANSFORMING GROWTH FACTOR BETA 03", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "TGF-beta3|T116|T123|ABX|EQV|NLM (2007)|000301|TGF BETA 03|abbcdefs", "ENTRY": "TGF beta3 Latency Associated Protein", "MN": "D23.529.942.775.300", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A TGF-beta subtype that plays role in regulating epithelial-mesenchymal interaction during embryonic development. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta3 and TGF-beta3 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor.", "PM": "2007; TRANSFORMING GROWTH FACTOR BETA3 was indexed under TRANSFORMING GROWTH FACTORS 2000-2003", "HN": "2007(2000)", "MR": "20150602", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053782"}, {"RECTYPE": "D", "MH": "Magnetic Resonance Imaging, Interventional", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "MRI, Interventional|T060|ACX|EQV|NLM (2007)|060329|abcdef", "ENTRY": "Interventional MRI", "MN": "E04.502.515", "MH_TH": "NLM (2007)", "ST": "T060", "AN": "coordinate with specific minimally invasive procedure if pertinent", "PI": "Magnetic Resonance Imaging (1990-2006)", "MS": "Minimally invasive procedures guided with the aid of magnetic resonance imaging to visualize tissue structures.", "PM": "2007", "HN": "2007", "MR": "20100625", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053783"}, {"RECTYPE": "D", "MH": "Magnetocardiography", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E05.540.249", "MH_TH": "NLM (2007)", "ST": "T060", "PI": "Magnetics (1967-2006)", "MS": "The measurement of magnetic fields generated by electric currents from the heart. The measurement of these fields provides information which is complementary to that provided by ELECTROCARDIOGRAPHY.", "PM": "2007", "HN": "2007", "MR": "20110624", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053798"}, {"RECTYPE": "D", "MH": "2-Pyridinylmethylsulfinylbenzimidazoles", "DS": "PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES 02", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sulfoxides, Benzimidazole Methylpyridine", "MN": "D03.633.100.103.034", "MH_TH": "NLM (2007)", "ST": "T121", "RN": "0", "MS": "Compounds that contain benzimidazole joined to a 2-methylpyridine via a sulfoxide linkage. Several of the compounds in this class are ANTI-ULCER AGENTS that act by inhibiting the POTASSIUM HYDROGEN ATPASE found in the PROTON PUMP of GASTRIC PARIETAL CELLS.", "PM": "2007", "HN": "2007", "MR": "20160527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053799"}, {"RECTYPE": "D", "MH": "beta-Keratins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Keratins", "MN": "D12.776.860.607.074", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "Keratins that form into a beta-pleated sheet structure. They are principle constituents of the corneous material of the carapace and plastron of turtles, the epidermis of snakes and the feathers of birds.", "PM": "2007; see KERATINS 1987-2006", "HN": "2007(1987)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053800"}, {"RECTYPE": "D", "MH": "Capillary Electrochromatography", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Electrochromatography, Capillary|T063|NON|EQV|NLM (2007)|060331|abcdef", "ENTRY": "Electrochromatography, Chip", "MN": "E05.301.300.190.500", "MH_TH": "NLM (2007)", "ST": "T063", "MS": "A separation technique which combines LIQUID CHROMATOGRAPHY and CAPILLARY ELECTROPHORESIS.", "PM": "2007", "HN": "2007", "MR": "20080708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053801"}, {"RECTYPE": "D", "MH": "Tryptases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Tryptases|T116|T126|NON|NRW|NLM (2007)|060403|abbcdef", "ENTRY": "gamma Tryptases", "MN": "D08.811.277.656.959.350.902", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.21.59", "RR": "EC 3.4.21.59", "MS": "A family of neutral serine proteases with TRYPSIN-like activity. Tryptases are primarily found in the SECRETORY GRANULES of MAST CELLS and are released during mast cell degranulation.", "PM": "2007; TRYPTASE was indexed under SERINE ENDOPEPTIDASES 1993-2006", "HN": "2007(1993)", "MR": "20090706", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053802"}, {"RECTYPE": "D", "MH": "Forensic Genetics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Genetics, Forensic", "MN": "I01.198.780.937.441", "MH_TH": "NLM (2007)", "ST": "T091", "PI": "Forensic Medicine (1972-2006)", "MS": "The application of genetic analyses and MOLECULAR DIAGNOSTIC TECHNIQUES to legal matters and crime analysis.", "PM": "2007", "HN": "2007", "MR": "20080708", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053803"}, {"RECTYPE": "D", "MH": "Granzymes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Natural Killer Cell Granule Tryptase 2", "MN": "D08.811.277.656.959.350.397", "PA": "Cytotoxins", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.21.-", "RR": "EC 3.4.21.78", "MS": "A family of serine endopeptidases found in the SECRETORY GRANULES of LEUKOCYTES such as CYTOTOXIC T-LYMPHOCYTES and NATURAL KILLER CELLS. When secreted into the intercellular space granzymes act to eliminate transformed and virus-infected host cells.", "PM": "2007; GRANZYME A was indexed under SERINE ENDOPEPTIDASES 1986-2006; GRANZYME B was indexed under SERINE ENDOPEPTIDASES 1989-2006; GRANZYME C was indexed under SERINE ENDOPEPTIDASES 1988-2006; GRANZYME M was indexed under SERINE ENDOPEPTIDASES 1999-2006; GRANZYME-LIKE PROTEIN III was indexed under SERINE ENDOPEPTIDASES 1994-2006; GRANZYME K was indexed under SERINE ENDOPEPTIDASES 2003-2006", "HN": "2007(1986)", "MR": "20090706", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053804"}, {"RECTYPE": "D", "MH": "Fractional Flow Reserve, Myocardial", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Myocardial Fractional Flow Reserve|T042|T081|NON|EQV|NLM (2007)|060404|abbcdef", "MN": "G09.330.100.324.500", "MH_TH": "NLM (2007)", "ST": "T081", "PI": "Coronary Circulation (1995-2006)", "MS": "The ratio of maximum blood flow to the MYOCARDIUM with CORONARY STENOSIS present, to the maximum equivalent blood flow without stenosis. The measurement is commonly used to verify borderline stenosis of CORONARY ARTERIES.", "PM": "2007", "HN": "2007", "MR": "20160617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053805"}, {"RECTYPE": "D", "MH": "Chymases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Chymotrypsin Like Proteases", "MN": "D08.811.277.656.959.350.103", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.21.39", "MS": "A family of neutral serine proteases with CHYMOTRYPSIN-like activity. Chymases are primarily found in the SECRETORY GRANULES of MAST CELLS and are released during mast cell degranulation.", "PM": "2007; CHYMASE was indexed under SERINE ENDOPEPTIDASES 1988-2006, & under PEPTIDE PEPTIDOHYDROLASES 1984-1987", "HN": "2007(1984)", "MR": "20090706", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053818"}, {"RECTYPE": "D", "MH": "Atelinae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Woolly Monkey|T015|NON|NRW|NLM (1992)|901128|abcdef", "ENTRY": "Woolly Spider Monkeys", "MN": "B01.050.150.900.649.313.988.400.600.075.075", "MH_TH": "NLM (1992)", "ST": "T015", "RN": "txid38068", "RR": "txid9518", "AN": "NIM when experimental animal; diseases: coordinate with MONKEY DISEASES", "PI": "Cebidae (1992-2006)", "MS": "A subfamily in the family ATELIDAE, comprising three genera: woolly monkeys (Lagothrix), spider monkeys (Ateles), and woolly spider monkeys (Brachyteles).", "PM": "2007; see CEBIDAE 1992-2006; see CEBIDAE 1992-2006; for BRACYTELES see CEBIDAE 1992-2006; for ATELES & LAGOTHRIX see CEBIDAE 1981-2006", "HN": "2007; use CEBIDAE 1992-2006; for BRACYTELES use CEBIDAE 1992-2006; for ATELES & LAGOTHRIX use CEBIDAE 1981-2006", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053819"}, {"RECTYPE": "D", "MH": "Pitheciidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Plecturocebus|T015|NON|NRW|NLM (2020)|190320|abcdef", "ENTRY": "Saki, Bearded", "MN": "B01.050.150.900.649.313.988.400.600.575", "MH_TH": "NLM (2007)", "ST": "T015", "RN": "txid376919", "RR": "txid9524", "AN": "index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)", "MS": "A family of New World monkeys in the infraorder PLATYRRHINI consisting of two subfamilies: Callicebinae and Pitheciinae.", "PM": "2007; for Cacajao, Callicebinae, Chiropotes, & Pithecinae see CEBIDAE 1992-2006", "HN": "2007; for Cacajao, Callicebinae, Chiropotes, & Pithecinae use CEBIDAE 1992-2006", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053820"}, {"RECTYPE": "D", "MH": "Cardiovascular Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Infections, Cardiovascular|T047|NON|EQV|NLM (2007)|060405|abcdef", "ENTRY": "Infection, Cardiovascular", "MN": "C14.260", "MH_TH": "NLM (2007)", "ST": "T047", "PI": "Cardiovascular Diseases (1966-2006)", "MS": "Pathological conditions of the CARDIOVASCULAR SYSTEM caused by infections.", "PM": "2007", "HN": "2007", "MR": "20190617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053821"}, {"RECTYPE": "D", "MH": "Ailuridae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Pandas, Lesser|T015|NON|NRW|NLM (1997)|960327|abcdef", "ENTRY": "Panda, Lesser", "MN": "B01.050.150.900.649.313.750.250.108", "MH_TH": "NLM (2007)", "ST": "T015", "RN": "txid379582", "RR": "txid9648", "AN": "note entry term PANDAS, LESSER: PANDAS, GIANT and PANDAS, GREATER see URSIDAE is also available", "MS": "A family in the suborder Caniformia, Order CARNIVORA, comprised of one genus Ailurus, the lesser pandas.", "PM": "2007; for AILURUS see PROCYONIDAE 1998-2006; for PANDAS, LESSER see CARNIVORA 1997-2004", "HN": "2007; for AILURUS use PROCYONIDAE 1998-2006; for PANDAS, LESSER use CARNIVORA 1997-2004", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053822"}, {"RECTYPE": "D", "MH": "Hedgehog Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hedgehog Protein, Vertebrate|T116|T123|NON|NRW|NLM (2007)|abbcde", "ENTRY": "Protein, Hedgehog", "MN": "D23.529.671", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A family of intercellular signaling proteins that play an important role in regulating the development of many TISSUES and organs. Their name derives from the observation of a hedgehog-like appearance in DROSOPHILA embryos with genetic mutations that block their action.", "PM": "2007; HEDGEHOG PROTEIN, VERTEBRATE was indexed under PROTEINS 1994-2001, & under TRANS-ACTIVATORS 2002-2006", "HN": "2007(1994)", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053823"}, {"RECTYPE": "D", "MH": "Protein Tyrosine Phosphatase, Non-Receptor Type 6", "DS": "PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR TYPE 006", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tyrosine Phosphatase, SHP-1", "MN": "D12.776.476.564.700.200", "FX": "src Homology Domains", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "MS": "A Src-homology domain-containing protein tyrosine phosphatase found in the CYTOSOL of hematopoietic cells. It plays a role in signal transduction by dephosphorylating signaling proteins that are activated or inactivated by PROTEIN-TYROSINE KINASES.", "PM": "2008; see SHP1 PROTEIN TYROSINE PHOSPHATASE 2007; SHP1 PROTEIN TYROSINE PHOSPHATASE was indexed under PROTEIN-TYROSINE PHOSPHATASE 1993-2006, & under INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 2005-2006", "HN": "2008(1993)", "MR": "20210521", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053824"}, {"RECTYPE": "D", "MH": "Suburethral Slings", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Vaginal Tapes, Tensionless", "MN": "E07.695.752", "MH_TH": "NLM (2007)", "ST": "T074", "MS": "Support structures, made from natural or synthetic materials, that are implanted below the URETHRA to treat URINARY STRESS INCONTINENCE.", "PM": "2007", "HN": "2007", "MR": "20110624", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053825"}, {"RECTYPE": "D", "MH": "Eupleridae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Mongoose, Ring-Tailed|T015|NON|NRW|NLM (2007)|060405|abcdef", "ENTRY": "Ring-Tailed Mongooses", "MN": "B01.050.150.900.649.313.750.377.500", "MH_TH": "NLM (2007)", "ST": "T015", "RN": "txid379589", "RR": "txid61400", "AN": "note entry terms: MONGOOSES see HERPESTIDAE; CIVETS see VIVERRIDAE; and AFRICAN PALM CIVET see NANDINIIDAE are also available", "PI": "Viverridae (2006)", "MS": "A family in the suborder Feliformia, order CARNIVORA, comprised of viverrid-like mammals.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053826"}, {"RECTYPE": "D", "MH": "Nandiniidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Nandinia binotata|T015|NON|NRW|NLM (2007)|060405|abcdef", "ENTRY": "Palm Civet, African", "MN": "B01.050.150.900.649.313.750.377.968", "MH_TH": "NLM (2007)", "ST": "T015", "RN": "txid379588", "RR": "txid71115", "AN": "note entry terms: CIVETS see VIVERRIDAE and CIVET, MALAGASY see EUPLERIDAE are also available", "PI": "Carnivora (1976-2006)", "MS": "A family in the suborder Feliformia, order CARNIVORA, comprising one genus Nandinia binotata.", "PM": "2007", "HN": "2007", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053827"}, {"RECTYPE": "D", "MH": "Stockings, Compression", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Stockings, Elastic|T074|NON|REL|NLM (1990)|890201|abcdef", "ENTRY": "Stocking, Elastic", "MN": "E07.101.400.500", "FX": "Intermittent Pneumatic Compression Devices", "MH_TH": "NLM (1990)", "ST": "T074", "PI": "Bandages (1970-2006)", "MS": "Tight coverings for the foot and leg that are worn to aid circulation in the legs, and prevent the formation of EDEMA and DEEP VEIN THROMBOSIS. PNEUMATIC COMPRESSION STOCKINGS serve a similar purpose especially for bedridden patients, and following surgery.", "PM": "2007; see BANDAGES 1990-2006; for STOCKINGS ELASTIC see BANDAGES 1990-2006", "HN": "2007; use BANDAGES 1990-2006; for STOCKINGS ELASTIC use BANDAGES 1990-2006", "MR": "20100625", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053828"}, {"RECTYPE": "D", "MH": "Amyloid Precursor Protein Secretases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "gamma Secretase", "MN": "D08.811.277.656.300.032", "MH_TH": "NLM (2007)", "ST": "T126", "RN": "EC 3.4.-", "RR": "EC 3.4.-", "MS": "Endopeptidases that are specific for AMYLOID PROTEIN PRECURSOR. Three secretase subtypes referred to as alpha, beta, and gamma have been identified based upon the region of amyloid protein precursor they cleave.", "PM": "2007; SECRETASE was indexed under ENDOPEPTIDASES 1992-2006", "HN": "2007(1992)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053829"}, {"RECTYPE": "D", "MH": "Plant Viral Movement Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Viral Movement Proteins, Plant|T116|T123|NON|EQV|NLM (2007)|060405|abbcdef", "ENTRY": "Virus Movement Proteins, Plant|T116|T123|NON|EQV|NLM (2007)|060405|abbcdef", "MN": "D12.776.964.970.700", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "AN": "coordinate with specific virus", "MS": "Viral proteins that facilitate the movement of viruses between plant cells by means of PLASMODESMATA, channels that traverse the plant cell walls.", "PM": "2007; MOVEMENT PROTEINS, PLANT VIRUS was indexed under VIRAL PROTEINS 1991-2006", "HN": "2007 (1991)", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053830"}, {"RECTYPE": "D", "MH": "Surgical Fixation Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Surgical Fixation Device", "MN": "E07.858.690", "MH_TH": "NLM (2007)", "ST": "T074", "AN": "general; prefer specifics", "MS": "Devices used to hold tissue structures together for repair, reconstruction or to close wounds. They may consist of adsorbable or non-adsorbable, natural or synthetic materials. They include tissue adhesives, skin tape, sutures, buttons, staples, clips, screws, etc., each designed to conform to various tissue geometries.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053831"}, {"RECTYPE": "D", "MH": "Surgical Tape", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Skin Tape|T074|NON|NRW|NLM (2007)|060405|abcdef", "ENTRY": "Tapes, Surgical Adhesive", "MN": "E07.858.690.800", "MH_TH": "NLM (2007)", "ST": "T074", "MS": "A flat, flexible strip of material used to cover or fasten together damaged tissue.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053832"}, {"RECTYPE": "D", "MH": "Wetlands", "ENTRY": "Wetland", "MN": "N06.230.124.625", "FX": "Avicennia", "MH_TH": "NLM (2007)", "ST": "T070", "AN": "note entry term MANGROVE SWAMPS: MANGROVE, GREY and MANGROVE, BLACK see AVICENNIA and MANGROVE, AMERICAN and MANGROVE, RED see RHIZOPHORACEAE are also available", "PI": "Water (1978-2006)", "MS": "Environments or habitats at the interface between truly terrestrial ecosystems and truly aquatic systems making them different from each yet highly dependent on both. Adaptations to low soil oxygen characterize many wetland species.", "PM": "2007", "HN": "2007", "MR": "20150615", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053833"}, {"RECTYPE": "D", "MH": "Explosive Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Explosive|T073|NON|EQV|NLM (2021)|200106|abcdef", "ENTRY": "Agents, Explosive", "MN": "D27.720.317", "FX": "Bombs", "MH_TH": "NLM (2007)", "ST": "T073", "RN": "0", "MS": "Substances that are energetically unstable and can produce a sudden expansion of the material, called an explosion, which is accompanied by heat, pressure and noise. Other things which have been described as explosive that are not included here are explosive action of laser heating, human performance, sudden epidemiological outbreaks, or fast cell growth.", "PM": "2007", "HN": "2007", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053834"}, {"RECTYPE": "D", "MH": "Unilamellar Liposomes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Vesicles, Unilamellar", "MN": "J01.637.087.500.517.500", "MH_TH": "NLM (2007)", "ST": "T109", "RN": "0", "PI": "Liposomes (1975-2006)", "MS": "Single membrane vesicles, generally made of PHOSPHOLIPIDS.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053835"}, {"RECTYPE": "D", "MH": "DNA Degradation, Necrotic", "AQ": "DE RE", "ENTRY": "Necrotic DNA Degradation|T049|ACX|EQV|NLM (2007)|060406|abcdef", "MN": "G05.200.220", "FX": "DNA Fragmentation", "MH_TH": "NLM (2007)", "ST": "T049", "AN": "postmortem DNA degradation in forensic literature: coordinate with POSTMORTEM CHANGES", "MS": "The random catabolism of DNA accompanying the irreversible damage to tissue which leads to the pathological death of one or more cells.", "PM": "2007", "HN": "2007", "MR": "20190618", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053836"}, {"RECTYPE": "D", "MH": "DNA Cleavage", "AQ": "DE RE", "MN": "G05.193", "MH_TH": "NLM (2007)", "ST": "T044", "MS": "A reaction that severs one of the covalent sugar-phosphate linkages between NUCLEOTIDES that compose the sugar phosphate backbone of DNA. It is catalyzed enzymatically, chemically or by radiation. Cleavage may be exonucleolytic - removing the end nucleotide, or endonucleolytic - splitting the strand in two.", "PM": "2007", "HN": "2007", "MR": "20160617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053837"}, {"RECTYPE": "D", "MH": "Scattering, Small Angle", "PRINT ENTRY": "Small Angle Scattering|T070|NON|EQV|NLM (2007)|060407|abcdef", "ENTRY": "Scatterings, Low Angle", "MN": "G01.867.755", "MH_TH": "NLM (2007)", "ST": "T070", "AN": "for SAXS coordinate with X-RAY DIFFRACTION; for SANS coordinate with NEUTRON DIFFRACTION; for SALS coordinate with LIGHT", "PI": "Scattering, Radiation (1996-2006)", "MS": "Scattering of a beam of electromagnetic or acoustic RADIATION, or particles, at small angles by particles or cavities whose dimensions are many times as large as the wavelength of the radiation or the de Broglie wavelength of the scattered particles. Also know as low angle scattering. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Small angle scattering (SAS) techniques, small angle neutron (SANS), X-ray (SAXS), and light (SALS, or just LS) scattering, are used to characterize objects on a nanoscale.", "PM": "2007", "HN": "2007", "MR": "20160617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053838"}, {"RECTYPE": "D", "MH": "Begomovirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Begomoviruses", "MN": "B04.715.270.100", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid10814", "RR": "txid10829", "PI": "Geminiviridae (2000-2006)", "MS": "A genus of plant viruses in the family GEMINIVIRIDAE that are transmitted in nature by whitefly Bemisia tabaci.", "PM": "2007; see GEMINIVIRIDAE 2002-2006", "HN": "2007; use GEMINIVIRIDAE 2002-2006", "MR": "20200813", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053839"}, {"RECTYPE": "D", "MH": "Brugada Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "ECG Pattern, Brugada", "MN": "C16.320.100", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Arrhythmia (1996-2006)", "MS": "An autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible sudden death. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit.", "PM": "2007", "HN": "2007", "MR": "20190517", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053840"}, {"RECTYPE": "D", "MH": "Electroosmosis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Electroosmotic Flow|T070|NON|REL|NLM (2007)|060410|abcdef", "MN": "G02.723.495.250", "MH_TH": "NLM (2007)", "ST": "T070", "PI": "Osmosis (1966-2006)", "MS": "The motion of a liquid through a membrane (or plug or capillary) consequent upon the application of an electric field across the membrane. (Oxford Dictionary of Biochemistry and Molecular Biology, 2001)", "PM": "2007", "HN": "2007", "MR": "20160617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053841"}, {"RECTYPE": "D", "MH": "Microsatellite Instability", "AQ": "DE RE", "ENTRY": "Replication Error Phenotypes", "MN": "G05.370.590", "FX": "Microsatellite Repeats", "MH_TH": "NLM (2007)", "ST": "T049", "PI": "Microsatellite Repeats (1994-2006)", "MS": "The occurrence of highly polymorphic mono- and dinucleotide MICROSATELLITE REPEATS in somatic cells. It is a form of genome instability associated with defects in DNA MISMATCH REPAIR.", "PM": "2007", "HN": "2007", "MR": "20110624", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053842"}, {"RECTYPE": "D", "MH": "DNA Mismatch Repair", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Mismatch Repair|T045|NON|EQV|NLM (2007)|060410|abcdef", "ENTRY": "Repair, Mismatch", "MN": "G05.219.220", "MH_TH": "NLM (2007)", "ST": "T045", "PI": "DNA Repair (1984-2006)", "MS": "A DNA repair pathway involved in correction of errors introduced during DNA replication when an incorrect base, which cannot form hydrogen bonds with the corresponding base in the parent strand, is incorporated into the daughter strand. Excinucleases recognize the BASE PAIR MISMATCH and cause a segment of polynucleotide chain to be excised from the daughter strand, thereby removing the mismatched base. (from Oxford Dictionary of Biochemistry and Molecular Biology, 2001)", "PM": "2007", "HN": "2007", "MR": "20160617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053843"}, {"RECTYPE": "D", "MH": "Lasers, Solid-State", "AQ": "AE CL HI SD SN ST TU", "PRINT ENTRY": "Yttrium-Scandium-Gallium Garnet Lasers|T073|NON|NRW|NLM (2008)|060725|abcdef", "ENTRY": "Yttrium Scandium Gallium Garnet Lasers", "MN": "E07.710.520.490", "MH_TH": "NLM (2008)", "ST": "T073", "AN": "/ther use: coordinate IM with disease /surg (IM), but for low-level laser therapy coordinate / ther use IM with disease /radiother (IM) + LOW-LEVEL LIGHT THERAPY (IM)", "PI": "Lasers (1990-2007)", "MS": "Lasers which use a solid, as opposed to a liquid or gas, as the lasing medium. Common materials used are crystals, such as YAG (YTTRIUM aluminum garnet); alexandrite; and CORUNDUM, doped with a rare earth element such as a NEODYMIUM; ERBIUM; or HOLMIUM. The output is sometimes additionally modified by addition of non-linear optical materials such as potassium titanyl phosphate crystal, which for example is used with neodymium YAG lasers to convert the output light to the visible range.", "PM": "2008", "HN": "2008", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D053844"}, {"RECTYPE": "D", "MH": "Metabolic Networks and Pathways", "AQ": "DE ES GE IM PH RE", "ENTRY": "Pathways, Metabolic", "MN": "G03.493", "MH_TH": "NLM (2007)", "ST": "T044", "AN": "general; prefer specifics", "MS": "Complex sets of enzymatic reactions connected to each other via their product and substrate metabolites.", "PM": "2007", "HN": "2007", "MR": "20160630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053858"}, {"RECTYPE": "D", "MH": "Pallidotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Pallidotomies", "MN": "E04.525.575", "MH_TH": "NLM (2007)", "ST": "T061", "PI": "Globus Pallidus/surgery (1966-2006)", "MS": "Producing a lesion in the posteroventral portion of the medial GLOBUS PALLIDUS to treat PARKINSON DISEASE and other extrapyramidal disorders. The placement of the lesion is aided by STEREOTACTIC TECHNIQUES and imaging procedures.", "PM": "2007", "HN": "2007", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053860"}, {"RECTYPE": "D", "MH": "Hemolytic Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Hemotoxins|T131|NON|REL|UNK (19XX)|770422|abcdef", "ENTRY": "Hematoxins|T131|NON|REL|UNK (19XX)|770422|abcdef", "MN": "D27.888.569.213.444", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "PI": "Hemolysin Proteins (1963-2006)", "MS": "Substances that are toxic to blood in general, including the clotting mechanism; hematotoxins may refer to the hematopoietic system.", "PM": "2007; for HEMOTOXINS see HEMOLYSINS 1978-2006", "HN": "2007; for HEMOTOXINS use HEMOLYSIN PROTEINS 1978-2006", "MR": "20210630", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053878"}, {"RECTYPE": "D", "MH": "Biosynthetic Pathways", "AQ": "DE GE IM PH RE", "ENTRY": "Pathways, Biosynthetic", "MN": "G03.493.100", "MH_TH": "NLM (2006)", "ST": "T044", "AN": "general only", "MS": "Sets of enzymatic reactions occurring in organisms and that form biochemicals by making new covalent bonds.", "PM": "2007", "HN": "2007", "MR": "20160502", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053898"}, {"RECTYPE": "D", "MH": "DNA Breaks, Double-Stranded", "AQ": "DE RE", "PRINT ENTRY": "Double-Stranded DNA Breaks|T049|NON|EQV|NLM (2007)|060412|abcdef", "ENTRY": "Double-Strand DNA Break", "MN": "G05.200.210.220", "MH_TH": "NLM (2007)", "ST": "T049", "MS": "Interruptions in the sugar-phosphate backbone of DNA, across both strands adjacently.", "PM": "2007", "HN": "2007", "MR": "20160617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053903"}, {"RECTYPE": "D", "MH": "DNA Breaks, Single-Stranded", "AQ": "DE RE", "PRINT ENTRY": "Single-Stranded DNA Breaks|T049|NON|EQV|NLM (2007)|060412|abcdef", "ENTRY": "Single-Strand DNA Break", "MN": "G05.200.210.230", "MH_TH": "NLM (2007)", "ST": "T049", "MS": "Interruptions in one of the strands of the sugar-phosphate backbone of double-stranded DNA.", "PM": "2007", "HN": "2007", "MR": "20160617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053904"}, {"RECTYPE": "D", "MH": "Papillomavirus Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Papillomavirus Vaccine|T121|T129|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Vaccines, Papillomavirus", "MN": "D20.215.894.899.498", "FX": "Cancer Vaccines", "MH_TH": "NLM (2007)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1989-2006)", "MS": "Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.", "PM": "2007", "HN": "2007", "MR": "20200527", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053918"}, {"RECTYPE": "D", "MH": "DNA Fragmentation", "AQ": "DE RE", "PRINT ENTRY": "DNA Degradation, Apoptotic|T044|NON|NRW|NLM (2007)|060620|abcdef", "ENTRY": "Fragmentation, DNA", "MN": "G05.200.230", "FX": "DNA Degradation, Necrotic", "MH_TH": "NLM (2007)", "ST": "T044", "AN": "if apoptotic, coordinate with APOPTOSIS", "MS": "Splitting the DNA into shorter pieces by endonucleolytic DNA CLEAVAGE at multiple sites. It includes the internucleosomal DNA fragmentation, which along with chromatin condensation, are considered to be the hallmarks of APOPTOSIS.", "PM": "2007", "HN": "2007", "MR": "20160617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053938"}, {"RECTYPE": "D", "MH": "Dipterocarpaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Vateria|T002|NON|NRW|NLM (2008)|060620|abcdef", "ENTRY": "Vaterias", "MN": "B01.875.800.575.912.250.859.688", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid40588", "RR": "txid65012", "PI": "Theales (2002-2007)", "MS": "A plant family of the order ERICALES.", "PM": "2008; see THEALES 2002-2007", "HN": "2008; use THEALES 2002-2007", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D053958"}, {"RECTYPE": "D", "MH": "Alpha-Amanitin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Alpha Amanitine", "MN": "D23.946.587.175.111", "PA": "Poisons", "FX": "Mushroom Poisoning", "MH_TH": "UNK (19XX)", "ST": "T131", "RN": "0", "PI": "Amanitins (1980-2007)", "MS": "A cyclic octapeptide with a thioether bridge between the cystine and tryptophan. It inhibits RNA POLYMERASE II. Poisoning may require LIVER TRANSPLANTATION.", "PM": "2008; see AMANITINS 1980-2007", "HN": "2008; use AMANITINS 1980-2007", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D053959"}, {"RECTYPE": "D", "MH": "DNA Breaks", "AQ": "DE RE", "ENTRY": "Breaks, DNA", "MN": "G05.200.210", "MH_TH": "NLM (2007)", "ST": "T049", "MS": "Interruptions in the sugar-phosphate backbone of DNA.", "PM": "2007", "HN": "2007", "MR": "20160617", "DA": "20060705", "DC": "1", "DX": "20070101", "UI": "D053960"}, {"RECTYPE": "D", "MH": "Azabicyclo Compounds", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Azabicyclo(5.2.2)Undecanes|T109|NON|NRW|NLM (2008)|060623|abcdef", "MN": "D03.605.084.500", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "MS": "Bicyclic bridged compounds that contain a nitrogen which has three bonds. The nomenclature indicates the number of atoms in each path around the rings, such as [2.2.2] for three equal length paths. Some members are TROPANES and BETA LACTAMS.", "PM": "2007", "HN": "2007", "MR": "20160527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D053961"}, {"RECTYPE": "D", "MH": "Pentacyclic Triterpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pentacyclic Triterpenoids|T109|NON|EQV|NLM (2023)|220316|abcdef", "ENTRY": "Triterpenes, Baccharane", "MN": "D02.455.849.919.530", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "PI": "Triterpenes (1974-2007)", "MS": "Five-ring derivatives of dammarane having a chair-chair-chair-boat configuration. They include the lupanes, oleananes, amyrins, GLYCYRRHIZIC ACID, and soyasaponins.", "PM": "2007", "HN": "2007", "MR": "20220413", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D053978"}, {"RECTYPE": "D", "MH": "Cyclopia Plant", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Cyclopia", "MN": "B01.875.800.575.912.250.401.184", "MH_TH": "NLM (2008)", "ST": "T002", "RN": "txid70072", "PI": "Fabaceae (2003-2007)", "MS": "A plant genus of the family Fabaceae. Members contain cyclopamine, a teratogen producing cyclopia (one eye in the middle of the face) and XANTHONES.", "PM": "2007", "HN": "2007", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D053998"}, {"RECTYPE": "D", "MH": "Nevus, Sebaceous of Jadassohn", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Sebaceous Nevus of Jadassohn|T191|EPO|EQV|NLM (2008)|060711|abcdef", "ENTRY": "Syndrome, Schimmelpenning-Feuerstein-Mims", "MN": "C16.131.077.633", "MH_TH": "NLM (2010)", "ST": "T191", "PI": "Nevus or specifics (1967-2007)", "MS": "A syndrome characterized by lesions occurring on the face, scalp, or neck which consist of congenital hypoplastic malformations of cutaneous structures and which over time undergo verrucous hyperplasia. Additionally it is associated with neurological symptoms and skeletal, ophthalmological, urogenital, and cardiovascular abnormalities.", "PM": "2010; see NEVUS SEBACEOUS OF JADASSOHN 2008-2009", "HN": "2010 (2008)", "MR": "20120703", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054000"}, {"RECTYPE": "D", "MH": "Lasers, Excimer", "AQ": "AE CL HI SD SN ST TU", "PRINT ENTRY": "Xenon Chloride Excimer Lasers|T073|NON|NRW|NLM (2008)|060719|abcdef", "ENTRY": "Xenon Chloride Laser", "MN": "E07.710.520.244", "FX": "Photorefractive Keratectomy", "MH_TH": "NLM (2008)", "ST": "T073", "AN": "/ther use: coordinate IM with disease /surg (IM), but for low-level laser therapy coordinate / ther use IM with disease /radiother (IM) + LOW-LEVEL LIGHT THERAPY (IM)", "MS": "Gas lasers with excited dimers (i.e., excimers) as the active medium. The most commonly used are rare gas monohalides (e.g., argon fluoride, xenon chloride). Their principal emission wavelengths are in the ultraviolet range and depend on the monohalide used (e.g., 193 nm for ArF, 308 nm for Xe Cl). These lasers are operated in pulsed and Q-switched modes and used in photoablative decomposition involving actual removal of tissue. (UMDNS, 2005)", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054018"}, {"RECTYPE": "D", "MH": "Immune Reconstitution Inflammatory Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Immune Restoration Syndrome|T047|NON|EQV|NLM (2008)|060720|abcdef", "ENTRY": "Restoration Syndrome, Immune", "MN": "C20.608", "FX": "Immune Reconstitution", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "Exuberant inflammatory response towards a previously acquired or undiagnosed opportunistic infection. It is frequently seen in AIDS patients following antiretroviral treatment.", "PM": "2008", "HN": "2008", "MR": "20170224", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054019"}, {"RECTYPE": "D", "MH": "Lasers, Gas", "AQ": "AE CL HI SD SN ST TU", "PRINT ENTRY": "Xenon Ion Lasers|T073|NON|NRW|NLM (2008)|060720|abcdef", "ENTRY": "Xenon Ion Laser", "MN": "E07.710.520.367", "MH_TH": "NLM (2008)", "ST": "T073", "AN": "/ther use: coordinate IM with disease /surg (IM), but for low-level laser therapy coordinate / ther use IM with disease /radiother (IM) + LOW-LEVEL LIGHT THERAPY (IM)", "PI": "Lasers (1966-2007)", "MS": "Lasers in which a gas lasing medium is stimulated to emit light by an electric current or high-frequency oscillator.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054020"}, {"RECTYPE": "D", "MH": "Cerebrum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cerebra|T023|NON|EQV|NLM (2022)|220211|abcdef", "ENTRY": "Cerebral Hemisphere, Right", "MN": "A08.186.211.200.885.287", "MH_TH": "UNK (19XX)", "ST": "T023", "PI": "Telencephalon (1966-2007)", "MS": "Derived from TELENCEPHALON, cerebrum is composed of a right and a left hemisphere. Each contains an outer cerebral cortex and a subcortical basal ganglia. The cerebrum includes all parts within the skull except the MEDULLA OBLONGATA, the PONS, and the CEREBELLUM. Cerebral functions include sensorimotor, emotional, and intellectual activities.", "PM": "2008; see TELENCEPHALON 2001-2007, see BRAIN 1975-2000", "HN": "2008; use TELENCEPHALON 2001-2007; use BRAIN 1975-2000", "MR": "20220211", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054022"}, {"RECTYPE": "D", "MH": "Lasers, Semiconductor", "AQ": "AE CL HI SD SN ST TU", "PRINT ENTRY": "Gallium Arsenide Lasers|T073|NON|NRW|NLM (2008)|060724|abcdef", "ENTRY": "Semiconductor Lasers", "MN": "E07.710.520.480", "MH_TH": "NLM (2008)", "ST": "T073", "AN": "/ther use: coordinate IM with disease /surg (IM), but for low-level laser therapy coordinate / ther use IM with disease /radiother (IM) + LOW-LEVEL LIGHT THERAPY (IM)", "PI": "Lasers (1986-2007)", "MS": "Lasers with a semiconductor diode as the active medium. Diode lasers transform electric energy to light using the same principle as a light-emitting diode (LED), but with internal reflection capability, thus forming a resonator where a stimulated light can reflect back and forth, allowing only a certain wavelength to be emitted. The emission of a given device is determined by the active compound used (e.g., gallium arsenide crystals doped with aluminum or indium). Typical wavelengths are 810, 1,060 and 1,300 nm. (From UMDNS, 2005)", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054023"}, {"RECTYPE": "D", "MH": "Myelencephalon", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Myelencephalons", "MN": "A08.186.211.132.810.591", "MH_TH": "UNK (19XX)", "ST": "T023", "PI": "Medulla Oblongata (1974-2007)", "MS": "The most posterior portion of the hindbrain from which MEDULLA OBLONGATA is derived.", "PM": "2008; see MEDULLA OBLONGATA 1986-2007", "HN": "2008; use MEDULLA OBLONGATA 1986-2007", "MR": "20150623", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054024"}, {"RECTYPE": "D", "MH": "Lasers, Dye", "AQ": "AE CL HI SD SN ST TU", "PRINT ENTRY": "Pulsed Dye Lasers|T073|NON|NRW|NLM (2008)|060725|abcdef", "ENTRY": "Tunable Dye Laser", "MN": "E07.710.520.230", "FX": "Intense Pulsed Light Therapy", "MH_TH": "NLM (2008)", "ST": "T073", "AN": "/ther use: coordinate IM with disease /surg (IM), but for low-level laser therapy coordinate / ther use IM with disease /radiother (IM) + LOW-LEVEL LIGHT THERAPY (IM)", "PI": "Lasers (1970-2007)", "MS": "Tunable liquid lasers with organic compounds (i.e., dye) which have a strong absorption band, used as the active medium. During emission, the dye has to be optically excited by another light source (e.g., another laser or flash lamp). The range of the emission wavelength may be anywhere from the ultraviolet to the near infrared (i.e., from 180 to 1100nm). These lasers are operated in continuous wave and pulsed modes. (UMDNS, 2005)", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054025"}, {"RECTYPE": "D", "MH": "Posterior Leukoencephalopathy Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Leukoencephalopathy Syndrome, Posterior|T047|NON|EQV|NLM (2008)|070126|abcdef", "ENTRY": "Syndromes, Posterior Leukoencephalopathy", "MN": "C10.228.140.695.875", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Leukoencephalopathy, Progressive Multifocal (1997-2002)", "MS": "A condition that is characterized by HEADACHE; SEIZURES; and visual loss with edema in the posterior aspects of the CEREBRAL HEMISPHERES, such as the BRAIN STEM. Generally, lesions involve the white matter (nerve fibers) but occasionally the grey matter (nerve cell bodies).", "PM": "2008", "HN": "2008", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054038"}, {"RECTYPE": "D", "MH": "Onycholysis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Photo-onycholyses", "MN": "C17.800.529.478", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "Separation of nail plate from the underlying nail bed. It can be a sign of skin disease, infection (such as ONYCHOMYCOSIS) or tissue injury.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054039"}, {"RECTYPE": "D", "MH": "Weapons", "AQ": "CL EC ES HI LJ SN ST", "ENTRY": "Weapon", "MN": "J01.637.870", "MH_TH": "NLM (2008)", "ST": "T073", "MS": "Devices or tools used in combat or fighting in order to kill or incapacitate.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054041"}, {"RECTYPE": "D", "MH": "Bombs", "AQ": "CL EC ES HI LJ SN ST", "ENTRY": "Bomb", "MN": "J01.637.870.175", "FX": "Explosive Agents", "MH_TH": "NLM (2007)", "ST": "T073", "PI": "Explosive Agents (2007)", "MS": "A weapon designed to explode when deployed. It frequently refers to a hollow case filled with EXPLOSIVE AGENTS.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054042"}, {"RECTYPE": "D", "MH": "Nuclear Weapons", "AQ": "CL EC ES HI LJ SN ST", "PRINT ENTRY": "Nuclear Weapons Testing|T052|NON|REL|NLM (1998)|960723|abcdef", "ENTRY": "Weapons, Nuclear", "MN": "J01.637.870.900.575", "MH_TH": "NLM (2004)", "ST": "T073", "PI": "Nuclear Warfare (2004-2007)", "MS": "A weapon that derives its destructive force from nuclear fission and/or fusion.", "PM": "2008; for NUCLEAR WEAPONS TESTING see NUCLEAR WARFARE 1998-2007", "HN": "2008; for NUCLEAR WEAPONS TESTING use NUCLEAR WARFARE 1998-2007", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054043"}, {"RECTYPE": "D", "MH": "Weapons of Mass Destruction", "AQ": "CL EC ES HI LJ SN ST", "ENTRY": "Mass Destruction Weapons", "MN": "J01.637.870.900", "MH_TH": "NLM (2008)", "ST": "T073", "MS": "Weapons that are capable of a high order of destruction and/or of being used to destroy large numbers of people. It includes NUCLEAR WEAPONS, and biological, chemical, and radiation weapons.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054044"}, {"RECTYPE": "D", "MH": "Biological Warfare Agents", "AQ": "CL EC ES HI LJ SN ST", "ENTRY": "Weapons, Biological", "MN": "J01.637.870.900.100", "MH_TH": "NLM (2008)", "ST": "T072", "RN": "0", "MS": "Living organisms or their toxic products that are used to cause disease or death of humans during WARFARE.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054045"}, {"RECTYPE": "D", "MH": "Plant Stomata", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Stomata, Plant|T002|NON|EQV|NLM (2008)|060802|abcdef", "ENTRY": "Stomatas, Plant", "MN": "A18.024.812.650", "MH_TH": "NLM (2008)", "ST": "T002", "MS": "Closable openings in the epidermis of plants on the underside of leaves. They allow the exchange of gases between the internal tissues of the plant and the outside atmosphere.", "PM": "2008", "HN": "2008", "MR": "20090706", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054046"}, {"RECTYPE": "D", "MH": "Surgical Stomas", "AQ": "AE BS CL EC ES HI IM IR MI PA PH PS SD SN ST TD VE VI", "PRINT ENTRY": "Surgical Stomata|T030|NON|EQV|NLM (2008)|060802|abcdef", "ENTRY": "Surgical Stoma", "MN": "A10.850.720", "FX": "Peritoneal Stomata", "MH_TH": "NLM (2008)", "ST": "T030", "AN": "do not confuse with PERITONEAL STOMATA", "MS": "Artificial openings created by a surgeon for therapeutic reasons. Most often this refers to openings from the GASTROINTESTINAL TRACT through the ABDOMINAL WALL to the outside of the body. It can also refer to the two ends of a surgical anastomosis.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054047"}, {"RECTYPE": "D", "MH": "Peritoneal Stomata", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Stomata, Peritoneal|T030|NON|EQV|NLM (2008)|060802|abcdef", "ENTRY": "Stomatas, Diaphragmatic", "MN": "A10.810", "FX": "Surgical Stomas", "MH_TH": "NLM (2008)", "ST": "T030", "AN": "do not confuse with SURGICAL STOMATA", "MS": "Natural openings in the subdiaphragmatic lymphatic plexus in the PERITONEUM, delimited by adjacent mesothelial cells. Peritoneal stomata constitute the principal pathways for the drainage of intraperitoneal contents from the PERITONEAL CAVITY to the LYMPHATIC SYSTEM.", "PM": "2008", "HN": "2008", "MR": "20110624", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054048"}, {"RECTYPE": "D", "MH": "Acute Coronary Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Acute Coronary", "MN": "C14.907.585.124", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.", "PM": "2008", "HN": "2008", "MR": "20150601", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054058"}, {"RECTYPE": "D", "MH": "Coronary Occlusion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Occlusions, Coronary", "MN": "C14.907.585.250.272", "FX": "Coronary Thrombosis", "MH_TH": "NLM (1995)", "ST": "T047", "PI": "Coronary Disease (1965-2007)", "MS": "Complete blockage of blood flow through one of the CORONARY ARTERIES, usually from CORONARY ATHEROSCLEROSIS.", "PM": "2008; see CORONARY DISEASE 1995-2007", "HN": "2008; use CORONARY DISEASE 1995-2007", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054059"}, {"RECTYPE": "D", "MH": "Pulmonary Infarction", "DE": "PULM INFARCT", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pulmonary Infarct|T047|NON|EQV|NLM (2020)|190301|abcdef", "ENTRY": "Pulmonary Infarcts", "MN": "C23.550.717.489.875", "MH_TH": "NLM (1998)", "ST": "T047", "PI": "Pulmonary Embolism (1963-2007)", "MS": "NECROSIS of lung tissue that is cause by the lack of OXYGEN or blood supply. The most common cause of pulmonary infarction is a blood clot in the lung.", "PM": "2008; see PULMONARY EMBOLISM 1998-2007", "HN": "2008 (1998)", "MR": "20190702", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054060"}, {"RECTYPE": "D", "MH": "Ischemic Contracture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Volkmann Contracture|T047|EPO|EQV|UNK (19XX)|800514|abcdef", "ENTRY": "Volkmanns Ischemic Contracture", "MN": "C14.907.303.531", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "A type of permanent damage to muscles and nerves that results from prolonged lack blood flow to those tissues. It is characterized by shortening and stiffening of the muscles.", "PM": "2008; for VOLKMANN CONTRACTURE see COMPARTMENT SYNDROMES 1981-2007; for VOLKMANN CONTRACTURE see VOLKMANN'S CONTRACTURE 1963-1980", "HN": "2008; for VOLKMANN CONTRACTURE use COMPARTMENT SYNDROMES 1963-2007", "MR": "20130709", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054061"}, {"RECTYPE": "D", "MH": "Deaf-Blind Disorders", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Blind-Deaf Disorders|T047|NON|EQV|NLM (2008)|060811|abcdef", "ENTRY": "Syndromes, Deaf-Blind", "MN": "C23.888.592.763.941.162.625", "FX": "Visually Impaired Persons", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "The absence of both hearing and vision.", "PM": "2008", "HN": "2008", "MR": "20130710", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054062"}, {"RECTYPE": "D", "MH": "Superior Sagittal Sinus", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Sinus, Superior Sagittal", "MN": "A07.015.908.224.667", "MH_TH": "NLM (2008)", "ST": "T023", "PI": "Cranial Sinuses (1967-2007)", "MS": "The long large endothelium-lined venous channel on the top outer surface of the brain. It receives blood from a vein in the nasal cavity, runs backwards, and gradually increases in size as blood drains from veins of the brain and the DURA MATER. Near the lower back of the CRANIUM, the superior sagittal sinus deviates to one side (usually the right) and continues on as one of the TRANSVERSE SINUSES.", "PM": "2008", "HN": "2008", "MR": "20180630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054063"}, {"RECTYPE": "D", "MH": "Transverse Sinuses", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Lateral Sinus|T023|NON|EQV|NLM (2008)|060814|abcdef", "ENTRY": "Transversus, Sinus", "MN": "A07.015.908.224.833", "MH_TH": "NLM (2008)", "ST": "T023", "PI": "Cranial Sinuses (1966-2007)", "MS": "The two large endothelium-lined venous channels that begin at the internal occipital protuberance at the back and lower part of the CRANIUM and travels laterally and forward ending in the internal jugular vein (JUGULAR VEINS). One of the transverse sinuses, usually the right one, is the continuation of the SUPERIOR SAGITTAL SINUS. The other transverse sinus is the continuation of the straight sinus.", "PM": "2008", "HN": "2008", "MR": "20180630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054064"}, {"RECTYPE": "D", "MH": "Leukemia, Large Granular Lymphocytic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "T-Cell Large Granular Lymphocytic Leukemia|T191|NON|NRW|NLM (2008)|060815|abcdef", "ENTRY": "T-LGL Leukemias", "MN": "C20.683.515.528.582.049", "FX": "Lymphocytosis", "MH_TH": "NLM (1997)", "ST": "T191", "PI": "Leukemia, Lymphocytic (1987-2007)", "MS": "A spectrum of disorders characterized by clonal expansions of the peripheral blood LYMPHOCYTE populations known as large granular lymphocytes which contain abundant cytoplasm and azurophilic granules. Subtypes develop from either CD3-negative NATURAL KILLER CELLS or CD3-positive T-CELLS. The clinical course of both subtypes can vary from spontaneous regression to progressive, malignant disease.", "PM": "2008; see LEUKEMIA, LYMPHOCYTIC 1997-2007", "HN": "2008; use LEUKEMIA, LYMPHOCYTIC 1997-2007", "MR": "20230531", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054066"}, {"RECTYPE": "D", "MH": "Dihydropyrimidine Dehydrogenase Deficiency", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thymine-Uracilurias, Hereditary", "MN": "C18.452.648.798.183", "MH_TH": "ORD (2010)", "ST": "T049", "PI": "Dihydrouracil Dehydrogenase (NADP) (1984-2007)", "MS": "An autosomal recessive disorder affecting DIHYDROPYRIMIDINE DEHYDROGENASE and causing familial pyrimidinemia. It is characterized by thymine-uraciluria in homozygous deficient patients. Even a partial deficiency in the enzyme leaves individuals at risk for developing severe 5-FLUOROURACIL-associated toxicity.", "PM": "2008", "HN": "2008", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054067"}, {"RECTYPE": "D", "MH": "Livedo Reticularis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Livedo Racemosa|T184|NON|NRW|NLM (2022)|210316|abcdef", "ENTRY": "Racemosa, Livedo", "MN": "C23.888.885.437", "MH_TH": "NLM (1996)", "ST": "T184", "PI": "Vascular Diseases (1966-1992)", "MS": "A condition characterized by a reticular or fishnet pattern on the skin of lower extremities and other parts of the body. This red and blue pattern is due to deoxygenated blood in unstable dermal blood vessels. The condition is intensified by cold exposure and relieved by rewarming.", "PM": "2008; see SKIN DISEASES, VASCULAR 1996-2007", "HN": "2008; use SKIN DISEASES, VASCULAR 1996-2007", "MR": "20211018", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054068"}, {"RECTYPE": "D", "MH": "Multiple Acyl Coenzyme A Dehydrogenase Deficiency", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Multiple Acyl CoA Dehydrogenase Deficiency", "MN": "C18.452.660.612", "MH_TH": "NLM (2008)", "ST": "T049", "MS": "An autosomal recessive disorder of fatty acid oxidation, and branched chain amino acids (AMINO ACIDS, BRANCHED-CHAIN); LYSINE; and CHOLINE catabolism, that is due to defects in either subunit of ELECTRON TRANSFER FLAVOPROTEIN or its dehydrogenase, electron transfer flavoprotein-ubiquinone oxidoreductase (EC 1.5.5.1).", "PM": "2008", "HN": "2008", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054069"}, {"RECTYPE": "D", "MH": "Postthrombotic Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Venous Stasis", "MN": "C14.907.952.880", "FX": "Varicose Ulcer", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Venous Thrombosis (1999-2007)", "MS": "A condition caused by one or more episodes of DEEP VEIN THROMBOSIS, usually the blood clots are lodged in the legs. Clinical features include EDEMA; PAIN; aching; heaviness; and MUSCLE CRAMP in the leg. When severe leg swelling leads to skin breakdown, it is called venous STASIS ULCER.", "PM": "2008", "HN": "2008", "MR": "20150622", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054070"}, {"RECTYPE": "D", "MH": "Mevalonate Kinase Deficiency", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mevalonicaciduria|T047|NON|NRW|GHR (2014)|NLM (2010)|ORD (2010)|090220|abcdeeef", "ENTRY": "Syndrome, Hyper-IgD", "MN": "C20.683.460.319", "MH_TH": "ORD (2010)", "ST": "T049", "MS": "Autosomal recessive disorder caused by mutations in the mevalonate kinase gene. Because of the mutations cholesterol biosynthesis is disrupted and MEVALONIC ACID accumulates. It is characterized by a range of symptoms, including dysmorphic FACIES, psychomotor retardation, CATARACT, hepatosplenomegaly, CEREBELLAR ATAXIA, elevated IMMUNOGLOBULIN D, and recurrent febrile crises with FEVER; LYMPHADENOPATHY; ARTHRALGIA; EDEMA; and rash.", "PM": "2008", "HN": "2008", "MR": "20150608", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054078"}, {"RECTYPE": "D", "MH": "Vascular Malformations", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vascular Malformation", "MN": "C16.131.240.850", "MH_TH": "NLM (2008)", "ST": "T190", "MS": "A spectrum of congenital, inherited, or acquired abnormalities in BLOOD VESSELS that can adversely affect the normal blood flow in ARTERIES or VEINS. Most are congenital defects such as abnormal communications between blood vessels (fistula), shunting of arterial blood directly into veins bypassing the CAPILLARIES (arteriovenous malformations), formation of large dilated blood blood-filled vessels (cavernous angioma), and swollen capillaries (capillary telangiectases). In rare cases, vascular malformations can result from trauma or diseases.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054079"}, {"RECTYPE": "D", "MH": "Vein of Galen Malformations", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vein Of Galen Malformation|T019|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Malformations Veins, Galen", "MN": "C16.131.666.190.500.500", "MH_TH": "NLM (2008)", "ST": "T019", "MS": "Congenital arteriovenous malformation involving the VEIN OF GALEN, a large deep vein at the base of the brain. The rush of arterial blood directly into the vein of Galen, without passing through the CAPILLARIES, can overwhelm the heart and lead to CONGESTIVE HEART FAILURE.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054080"}, {"RECTYPE": "D", "MH": "Malformations of Cortical Development, Group II", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuronal Migration Disorders|T019|T047|NON|EQV|NLM (2008)|060831|abbcdef", "ENTRY": "Neuronal Migration Disorder", "MN": "C16.131.666.507.450", "MH_TH": "NLM (2015)", "ST": "T047", "MS": "Cortical malformations secondary to abnormal neuronal CELL MIGRATION in NEUROGENESIS. This group includes COBBLESTONE LISSENCEPHALY and PERIVENTRICULAR NODULAR HETEROTOPIA.", "PM": "2008; was Neuronal Migration Disorders (2008-2014)", "HN": "2015(2008)", "MR": "20140613", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054081"}, {"RECTYPE": "D", "MH": "Lissencephaly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pachygyria|T184|NON|REL|NLM (2008)|ORD (2010)|060901|abcdeef", "ENTRY": "Pachygyrias", "MN": "C16.131.666.507.450.499", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "note specifics; MICROLISSENCEPHALY see MICROCEPHALY is also available", "MS": "A smooth brain malformation of the CEREBRAL CORTEX resulting from the abnormal location of developing neurons during corticogenesis. It is characterized by an absence of normal convoluted indentations on the surface of the brain (agyria), or fewer and shallower indentations (pachygryia). There is a reduced number of cortical layers, typically 4 instead of 6, resulting in a thickened cortex, and reduced cerebral white matter that is a reversal of the normal ratio of cerebral white matter to cortex.", "PM": "2008", "HN": "2008", "MR": "20160226", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054082"}, {"RECTYPE": "D", "MH": "Ectopia Cordis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Cordis, Ectopia", "MN": "C16.131.240.400.422", "MH_TH": "UNK (19XX)", "ST": "T019", "PI": "Heart Defects, Congenital (1963-2007)", "MS": "A rare developmental defect in which the heart is abnormally located partially or totally outside the THORAX. It is the result of defective fusion of the anterior chest wall. Depending on the location of the heart, ectopia cordis can be thoracic, thoracoabdominal, abdominal, and cervical.", "PM": "2008; see HEART DEFECTS, CONGENITAL 1963-2007", "HN": "2008; use HEART DEFECTS, CONGENITAL 1963-2007", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054083"}, {"RECTYPE": "D", "MH": "Myocardial Bridging", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Myocardial Bridgings", "MN": "C16.131.240.400.210.500", "MH_TH": "NLM (2008)", "ST": "T019", "PI": "Coronary Vessel Anomalies (1976-2007)", "MS": "A malformation that is characterized by a muscle bridge over a segment of the CORONARY ARTERIES. Systolic contractions of the muscle bridge can lead to narrowing of coronary artery; coronary compression; MYOCARDIAL ISCHEMIA; MYOCARDIAL INFARCTION; and SUDDEN CARDIAC DEATH.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054084"}, {"RECTYPE": "D", "MH": "Foramen Ovale", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Foramen, Oval", "MN": "A07.541.459.500", "MH_TH": "UNK (19XX)", "ST": "T018", "MS": "An opening in the wall between the right and the left upper chambers (HEART ATRIA) of a fetal heart. Oval foramen normally closes soon after birth; when it fails to close the condition is called PATENT OVAL FORAMEN.", "PM": "2008; see HEART SEPTUM 1991-2007", "HN": "2008; use HEART SEPTUM 1991-2007", "MR": "20090720", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054085"}, {"RECTYPE": "D", "MH": "KATP Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "KATP Channel|T116|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Potassium Channels, ATP-Sensitive", "MN": "D12.776.543.585.400.750.450.550", "FX": "Potassium Channel Blockers", "MH_TH": "NLM (2008)", "ST": "T116", "RN": "0", "PI": "Potassium Channels, Inwardly Rectifying (1991-2007)", "MS": "Heteromultimers of Kir6 channels (the pore portion) and sulfonylurea receptor (the regulatory portion) which affect function of the HEART; PANCREATIC BETA CELLS; and KIDNEY COLLECTING DUCTS. KATP channel blockers include GLIBENCLAMIDE and mitiglinide whereas openers include CROMAKALIM and minoxidil sulfate.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054086"}, {"RECTYPE": "D", "MH": "Atrial Septum", "AQ": "AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Septum, Atrial", "MN": "A07.541.459.249", "EC": "abnormalities:Heart Septal Defects, Atrial", "MH_TH": "NLM (2008)", "ST": "T023", "PI": "Heart Septum (1964-2007)", "MS": "The thin membrane-like muscular structure separating the right and the left upper chambers (HEART ATRIA) of a heart.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054087"}, {"RECTYPE": "D", "MH": "Ventricular Septum", "AQ": "AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Septum, Ventricular", "MN": "A07.541.459.750", "EC": "abnormalities:Heart Septal Defects, Ventricular", "MH_TH": "NLM (2008)", "ST": "T023", "PI": "Heart Septum (1963-2007)", "MS": "The muscular structure separating the right and the left lower chambers (HEART VENTRICLES) of the heart. The ventricular septum consists of a very small membranous portion just beneath the AORTIC VALVE, and a large thick muscular portion consisting of three sections including the inlet septum, the trabecular septum, and the outlet septum.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054088"}, {"RECTYPE": "D", "MH": "Endocardial Cushions", "AQ": "AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Endocardial Cushion|T018|NON|EQV|NLM (2024)|230419|abcdef", "ENTRY": "Canal, Atrioventricular", "MN": "A16.378.303.662", "EC": "abnormalities:Endocardial Cushion Defects", "MH_TH": "NLM (2008)", "ST": "T018", "MS": "A fetal heart structure that is the bulging areas in the cardiac septum between the HEART ATRIA and the HEART VENTRICLES. During development, growth and fusion of endocardial cushions at midline forms the two atrioventricular canals, the sites for future TRICUSPID VALVE and BICUSPID VALVE.", "PM": "2008", "HN": "2008", "MR": "20230531", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054089"}, {"RECTYPE": "D", "MH": "Periventricular Nodular Heterotopia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "X-Linked Periventricular Heterotopias", "MN": "C16.131.666.507.450.750", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "A disorder resulting from a defect in the pattern of neuronal migration in which ectopic collections of neurons lie along the lateral ventricles of the brain or just beneath, contiguously or in isolated patches.", "PM": "2008", "HN": "2008", "MR": "20190517", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054091"}, {"RECTYPE": "D", "MH": "Foramen Ovale, Patent", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Patent Foramen Ovale|T019|T047|NON|EQV|NLM (2008)|060908|abbcdef", "ENTRY": "Oval Foramen, Patent", "MN": "C16.131.240.400.560.375.258", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Heart Septal Defects, Atrial (1965-2007)", "MS": "A condition in which the FORAMEN OVALE in the ATRIAL SEPTUM fails to close shortly after birth. This results in abnormal communications between the two upper chambers of the heart. An isolated patent ovale foramen without other structural heart defects is usually of no hemodynamic significance.", "PM": "2008; see HEART SEPTAL DEFECTS, ATRIAL 1980-2007", "HN": "2008; use HEART SEPTAL DEFECTS, ATRIAL 1980-2007", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054092"}, {"RECTYPE": "D", "MH": "Thrombocytopenia, Neonatal Alloimmune", "AQ": "BL CF CI CL DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neonatal Thrombocytopenia|T047|NON|EQV|NLM (2008)|060908|abcdef", "ENTRY": "Thrombocytopenias, Neonatal Alloimmune", "MN": "C16.614.899", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Thrombocytopenia (1980-2007)", "MS": "A condition in newborns caused by immunity of the mother to PLATELET ALLOANTIGENS on the fetal platelets. The PLATELETS, coated with maternal ANTIBODIES, are destroyed and removed by the fetal MONONUCLEAR PHAGOCYTE SYSTEM. Affected infants may have INTRACRANIAL HEMORRHAGES.", "PM": "2008", "HN": "2008", "MR": "20230226", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054098"}, {"RECTYPE": "D", "MH": "Nanospheres", "AQ": "AD AE AN CH CL EC HI ME MI PO PS RE SD SN ST TO TU UL VI", "ENTRY": "Nanosphere|T073|NON|EQV|NLM (2008)|060915|abcdef", "MN": "J01.637.512.600.612", "MH_TH": "NLM (2004)", "ST": "T073", "PI": "Nanostructures (2005-2007)", "MS": "Spherical particles of nanometer dimensions.", "PM": "2008; see NANOTUBES 2007", "HN": "2008; use NANOTUBES 2007", "MR": "20150331", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054118"}, {"RECTYPE": "D", "MH": "Arachnodactyly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Arachnodactylies", "MN": "C16.131.621.585.174", "MH_TH": "UNK (19XX)", "ST": "T019", "PI": "Marfan Syndrome (1963-2007)", "MS": "An abnormal bone development that is characterized by extra long and slender hands and fingers, such that the clenched thumb extends beyond the ulnar side of the hand. Arachnodactyly can include feet and toes. Arachnodactyly has been associated with several gene mutations and syndromes.", "PM": "2008, 1963-1984; see MARFAN SYNDROME 1985-2007", "HN": "2008, 1963-1984; use MARFAN SYNDROME 1985-2007", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054119"}, {"RECTYPE": "D", "MH": "Phakic Intraocular Lenses", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Lens, Intraocular, Phakic|T074|NON|EQV|NLM (2008)|061109|abcdef", "ENTRY": "Lenses, Phakic Intraocular", "MN": "E07.632.500.460.500", "MH_TH": "NLM (2008)", "ST": "T074", "PI": "Lenses, Intraocular (1988-2007)", "MS": "Lenses, generally made of plastic or silicone, that are implanted into the eye in front of the natural EYE LENS, by the IRIS, to improve VISION, OCULAR. These intraocular lenses are used to supplement the natural lens instead of replacing it.", "PM": "2008", "HN": "2008", "MR": "20080710", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054120"}, {"RECTYPE": "D", "MH": "Sinus Arrest, Cardiac", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cardiac Sinus Arrest|T033|T046|NON|EQV|NLM (2008)|060921|abbcdef", "ENTRY": "Sinus Pauses, Cardiac", "MN": "C23.550.073.093.500", "MH_TH": "NLM (2008)", "ST": "T046", "PI": "Arrhythmia, Sinus (1967-2007)", "MS": "The omission of atrial activation that is caused by transient cessation of impulse generation at the SINOATRIAL NODE. It is characterized by a prolonged pause without P wave in an ELECTROCARDIOGRAM. Sinus arrest has been associated with sleep apnea (REM SLEEP-RELATED SINUS ARREST).", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054138"}, {"RECTYPE": "D", "MH": "Tachycardia, Reciprocating", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Reciprocating Tachycardia|T047|NON|EQV|NLM (2008)|060922|abcdef", "ENTRY": "Tachycardias, Reciprocating", "MN": "C23.550.073.845.787", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "Abnormally rapid heartbeats caused by reentrant conduction over the accessory pathways between the HEART ATRIA and the HEART VENTRICLES. The impulse can also travel in the reverse direction, as in some cases, atrial impulses travel to the ventricles over the accessory pathways and back to the atria over the BUNDLE OF HIS and the ATRIOVENTRICULAR NODE.", "PM": "2008; see TACHYCARDIA, PAROXYSMAL 1995-2007", "HN": "2008; use TACHYCARDIA, PAROXYSMAL 1995-2007", "MR": "20170620", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054139"}, {"RECTYPE": "D", "MH": "Refractive Surgical Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Keratorefractive Surgical Procedures|T061|NON|NRW|NLM (2008)|060928|abcdef", "ENTRY": "Surgical Procedures, Refractive", "MN": "E04.540.825", "FX": "Orthokeratologic Procedures", "MH_TH": "NLM (2008)", "ST": "T061", "AN": "general; prefer specific procedures", "PI": "Refractive Errors/surgery or specifics (1981-2007)", "MS": "Surgical procedures employed to correct REFRACTIVE ERRORS such as MYOPIA; HYPEROPIA; or ASTIGMATISM. These may involve altering the curvature of the CORNEA; removal or replacement of the CRYSTALLINE LENS; or modification of the SCLERA to change the axial length of the eye.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054140"}, {"RECTYPE": "D", "MH": "Ventricular Flutter", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ventricular Flutters", "MN": "C23.550.073.961", "MH_TH": "NLM (2008)", "ST": "T046", "AN": "do not confuse with VENTRICULAR FIBRILLATION", "MS": "A potentially lethal cardiac arrhythmia characterized by an extremely rapid, hemodynamically unstable ventricular tachycardia (150-300 beats/min) with a large oscillating sine-wave appearance. If untreated, ventricular flutter typically progresses to VENTRICULAR FIBRILLATION.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054141"}, {"RECTYPE": "D", "MH": "Heart Failure, Systolic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Heart Failure, Reduced Ejection Fraction|T047|NON|EQV|NLM (2022)|210316|abcdef", "ENTRY": "Systolic Heart Failures", "MN": "C14.280.434.676", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "Heart failure caused by abnormal myocardial contraction during SYSTOLE leading to defective cardiac emptying.", "PM": "2008", "HN": "2008", "MR": "20210510", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054143"}, {"RECTYPE": "D", "MH": "Heart Failure, Diastolic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Heart Failure, Preserved Ejection Fraction|T047|NON|EQV|NLM (2022)|210316|abcdef", "ENTRY": "Diastolic Heart Failures", "MN": "C14.280.434.611", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Heart Failure, Congestive (1989-2007)", "MS": "Heart failure caused by abnormal myocardial relaxation during DIASTOLE leading to defective cardiac filling.", "PM": "2008", "HN": "2008", "MR": "20210510", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054144"}, {"RECTYPE": "D", "MH": "Orthokeratologic Procedures", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Procedures, Orthokeratologic", "MN": "E02.706", "FX": "Refractive Surgical Procedures", "MH_TH": "NLM (2008)", "ST": "T061", "PI": "Refractive Errors/therapy or specifics (1968-2007)", "MS": "An alternative to REFRACTIVE SURGICAL PROCEDURES. A therapeutic procedure for correcting REFRACTIVE ERRORS. It involves wearing CONTACT LENSES designed to force corrective changes to the curvature of the CORNEA that remain after the lenses are removed. The effect is temporary but is maintained by wearing the therapeutic lenses daily, usually during sleep.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054158"}, {"RECTYPE": "D", "MH": "Torsion, Mechanical", "ENTRY": "Torsional Forces", "MN": "G01.374.860", "MH_TH": "NLM (2008)", "ST": "T067", "AN": "TORSION ABNORMALITY is also available", "PI": "Stress, Mechanical (1972-2007)", "MS": "A twisting deformation of a solid body about an axis. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "2008", "HN": "2008", "MR": "20160617", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054159"}, {"RECTYPE": "D", "MH": "Systolic Murmurs", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Systolic Regurgitant Murmur", "MN": "C23.888.447.500", "MH_TH": "NLM (2008)", "ST": "T184", "AN": "do not confuse with HEART SOUNDS, a physiologic concept", "MS": "Heart murmurs which are systolic in timing. They occur between the first and the second HEART SOUNDS, between the closure of MITRAL VALVE and TRICUSPID VALVE and the closure of semilunar aortic and pulmonary valves. Systolic murmurs include ejection murmurs and regurgitant murmurs.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054160"}, {"RECTYPE": "D", "MH": "Angioedemas, Hereditary", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Angioedema, Hereditary|T047|NON|EQV|NLM (2008)|OMIM (2013)|061006|abcdeef", "ENTRY": "Hereditary Angioneurotic Edemas", "MN": "C20.673.795.500.500", "MH_TH": "NLM (2010)", "ST": "T047", "AN": "note specific types are available", "PI": "Angioedema (1964-2007)", "MS": "Inherited disorders that are characterized by subcutaneous and submucosal EDEMA in the upper RESPIRATORY TRACT and GASTROINTESTINAL TRACT.", "PM": "2010; see ANGIOEDEMA, HEREDITARY 2008-2009", "HN": "2010(2008)", "MR": "20190617", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054179"}, {"RECTYPE": "D", "MH": "Precursor Cell Lymphoblastic Leukemia-Lymphoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lymphoma, Lymphoblastic|T191|NON|EQV|NLM (1991)|990101|abcdef", "ENTRY": "Precursor Cell Lymphoblastic Leukemia Lymphoma", "MN": "C20.683.515.528.600", "MH_TH": "NLM (2008)", "ST": "T191", "MS": "A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.", "PM": "2008; for LYMPHOBLASTIC LEUKEMIA see LEUKEMIA, LYMPHOCYTIC 1989-2007; for LEUKEMIA, LYMPHOCYTIC, ACUTE see LEUKEMIA, LYMPHOCYTIC ACUTE 1989-2007", "HN": "2008; for LYMPHOBLASTIC LEUKEMIA use LEUKEMIA, LYMPHOID 1989-2007", "MR": "20230531", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054198"}, {"RECTYPE": "D", "MH": "Pseudoephedrine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isoephedrine|T109|T121|NON|REL|UNK (19XX)|770421|abbcdef", "ENTRY": "Ephedrine Threo Isomer", "MN": "D02.092.471.683.847", "PA": "Nasal Decongestants", "MH_TH": "NLM (1978)", "ST": "T121", "N1": "(1S,2S)-2-methylamino-1-phenyl-propan-1-ol", "RN": "7CUC9DDI9F", "RR": "90-82-4 (Pseudoephedrine)", "PI": "Ephedrine (1978-2007)", "MS": "A phenethylamine that is an isomer of EPHEDRINE which has less central nervous system effects and usage is mainly for respiratory tract decongestion.", "PM": "2008; see EPHEDRINE 1978-2007", "HN": "2008(1978)", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054199"}, {"RECTYPE": "D", "MH": "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "T-Lymphocytic Leukemia, Acute|T191|NON|EQV|UNK (19XX)|880609|LYMPHOCYTIC LEUKEMIA ACUTE BT|abcdefs", "ENTRY": "T-Lymphocytic Leukemias, Acute", "MN": "C20.683.515.528.600.620", "MH_TH": "NLM (2008)", "ST": "T191", "MS": "A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.", "PM": "2008; for LEUKEMIA, T-CELL, ACUTE (and other terms with ACUTE) see LEUKEMIA-LYMPHOMA, ADULT T-CELL 2008, see LEUKEMIA, T-CELL ACUTE 1989-2007", "HN": "2008; for LEUKEMIA, T-CELL, ACUTE (and other terms with ACUTE) use LEUKEMIA-LYMPHOMA, ADULT T-CELL 2008", "MR": "20230531", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054218"}, {"RECTYPE": "D", "MH": "Neoplasms, Plasma Cell", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Plasma Cell Neoplasms|T191|NON|EQV|NLM (2008)|061016|abcdef", "ENTRY": "Plasma Cell Neoplasm", "MN": "C04.557.595", "MH_TH": "NLM (2008)", "ST": "T191", "MS": "Neoplasms associated with a proliferation of a single clone of PLASMA CELLS and characterized by the secretion of PARAPROTEINS.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054219"}, {"RECTYPE": "D", "MH": "Malformations of Cortical Development", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Generalized Cortical Dysplasia|T019|NON|NRW|NLM (2023)|210831|abcdef", "ENTRY": "Generalized Cortical Dysplasias", "MN": "C16.131.666.507", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Cerebral Cortex/abnormalities (1995-2007)", "MS": "Abnormalities in the development of the CEREBRAL CORTEX. These include malformations arising from abnormal neuronal and glial CELL PROLIFERATION or APOPTOSIS (Group I); abnormal neuronal migration (Group II); and abnormal establishment of cortical organization (Group III). Many INBORN METABOLIC BRAIN DISORDERS affecting CNS formation are often associated with cortical malformations. They are common causes of EPILEPSY and developmental delay.", "PM": "2008", "HN": "2008", "MR": "20211018", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054220"}, {"RECTYPE": "D", "MH": "Classical Lissencephalies and Subcortical Band Heterotopias", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Subcortical Band Heterotopia|T047|NON|NRW|NLM (2008)|OMIM (2013)|ORD (2010)|060901|abcdeeef", "ENTRY": "X-Linked Lissencephalies", "MN": "C16.320.322.500.186", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Cerebral Cortex/abnormalities (1993-2007)", "MS": "Disorders comprising a spectrum of brain malformations representing the paradigm of a diffuse neuronal migration disorder. They result in cognitive impairment; SEIZURES; and HYPOTONIA or spasticity. Mutations of two genes, LIS1, the gene for the non-catalytic subunit of PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB; and DCX or XLIS, the gene for doublecortin, have been identified as the most common causes of disorders in this spectrum. Additional variants of classical (Type I) lissencephaly have been linked to RELN, the gene for reelin, and ARX, the gene for aristaless related homeobox protein. (From Leventer, R.J., et al, Mol Med Today. 2000 Jul;6(7):277-84 and Barkovich, A.J., et al, Neurology. 2005 Dec 27;65(12):1873-87.)", "PM": "2008", "HN": "2008", "MR": "20181010", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054221"}, {"RECTYPE": "D", "MH": "Cobblestone Lissencephaly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lissencephaly Type 2|T047|NON|EQV|NLM (2008)|061018|LISSENCEPHALY TYPE 002|abcdefs", "ENTRY": "Lissencephaly, Cobblestone", "MN": "C16.131.666.507.450.499.249", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Cerebral Cortex/abnormalities (1996-2007)", "MS": "The smooth pebbled appearance of the CEREBRAL CORTEX with a thickened cortex and reduced and abnormal white matter, which results from migration of heterotopic neurons beyond the marginal zone into the leptomeninges through gaps in the external BASEMENT MEMBRANE. There is also enlarged ventricles, underdeveloped BRAINSTEM and cerebellum, and absence of the CORPUS CALLOSUM. These abnormalities occur as a syndrome without other birth defects (cobblestone complex) or in other syndromes associated with congenital MUSCULAR DYSTROPHY, often involving the eye, such as the Walker-Warburg Syndrome, Fukuyama congenital muscular dystrophy, and muscle-eye-brain disease.", "PM": "2008", "HN": "2008", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054222"}, {"RECTYPE": "D", "MH": "Perinatal Mortality", "DE": "PERINATAL MORTAL", "AQ": "EH HI TD", "ENTRY": "Perinatal Mortalities", "MN": "N06.850.520.308.985.550.475.500", "FX": "Perinatal Death", "MH_TH": "NLM (1990)", "ST": "T081", "AN": "a statistical concept & not a substitute for / mortal with FETAL DISEASES; INFANT, NEWBORN, DISEASES or specific diseases; do not confuse with PERINATAL DEATH; add geographic term if pertinent", "PI": "Infant Mortality (1965-2007)", "MS": "Deaths occurring from the 28th week of GESTATION to the 28th day after birth in a given population.", "PM": "2008; see INFANT MORTALITY 1990-2007", "HN": "2008; use INFANT MORTALITY 1990-2007", "MR": "20170703", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054238"}, {"RECTYPE": "D", "MH": "Blastodisc", "AQ": "AB AH BS CH CY DE DG EM EN IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Germinal Disc|T018|NON|EQV|NLM (2008)|061023|abcdef", "ENTRY": "Germinal Discs", "MN": "A16.331.042", "MH_TH": "NLM (2008)", "ST": "T018", "PI": "Chick Embryo (1964-2007)", "MS": "A small whitish spot on the surface of the EGG YOLK where cleavage begins. Upon fertilization the cytoplasm streams from the vegetal pole away from the yolk to the animal pole where cleavage will occur. This germinal area eventually flattens into a layer of cells (BLASTODERM) that covers the yolk completely.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054239"}, {"RECTYPE": "D", "MH": "Primitive Streak", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Streaks, Primitive", "MN": "A16.830", "MH_TH": "UNK (19XX)", "ST": "T018", "PI": "Gastrula (1979-2007)", "MS": "A linear band of rapidly proliferating cells that begins near the posterior end of an embryo and grows cranially. Primitive streak is formed during GASTRULATION by the convergent migration of primary ectodermal cells (EPIBLAST). The knot at the tip of the streak is called HENSEN NODE.", "PM": "2008; see GASTRULA 1979-2007", "HN": "2008; use GASTRULA 1979-2007", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054240"}, {"RECTYPE": "D", "MH": "Emigrants and Immigrants", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Immigrants|T098|NON|NRW|NLM (1996)|950323|abcdef", "ENTRY": "Immigrants and Emigrants", "MN": "M01.189", "FX": "Emigration and Immigration", "MH_TH": "NLM (2008)", "ST": "T098", "AN": "EMIGRATION AND IMMIGRATION is also available", "PI": "Emigration and Immigration (1963-2007)", "MS": "People who leave their place of residence in one country and settle in a different country.", "PM": "2008; for EMIGRANTS see EMIGRATION AND IMMIGRATION 1995-2007; for IMMIGRATION see EMIGRATION AND IMMIGRATION 1996-2005; for ALIENS see EMIGRATION AND IMMIGRATION 1989-2007; for FOREIGNERS see EMIGRATION AND IMMIGRATION 1992-2007", "HN": "2008; for EMIGRANTS use EMIGRATION AND IMMIGRATION 1995-2007; for IMMIGRATION use EMIGRATION AND IMMIGRATION 1996-2005; for ALIENS use EMIGRATION AND IMMIGRATION 1989-2007; for FOREIGNERS use EMIGRATION AND IMMIGRATION 1992-2007", "MR": "20150630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054242"}, {"RECTYPE": "D", "MH": "Vesicular Stomatitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Stomatitis, Vesicular|T047|NON|EQV|NLM (2008)|061026|abcdef", "ENTRY": "Vesicular Stomatitides", "MN": "C22.952", "MH_TH": "NLM (2008)", "ST": "T047", "AN": "coordinate IM with specifici virus species (IM) if pertinent", "PI": "Stomatitis (1963-1994)", "MS": "A viral disease caused by at least two distinct species (serotypes) in the VESICULOVIRUS genus: VESICULAR STOMATITIS INDIANA VIRUS and VESICULAR STOMATITIS NEW JERSEY VIRUS. It is characterized by vesicular eruptions on the ORAL MUCOSA in cattle, horses, pigs, and other animals. In humans, vesicular stomatitis causes an acute influenza-like illness.", "PM": "2008", "HN": "2008", "MR": "20190617", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054243"}, {"RECTYPE": "D", "MH": "Neural Plate", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Plates, Neural", "MN": "A16.629", "MH_TH": "NLM (2008)", "ST": "T018", "PI": "Embryo (1963-2007)", "MS": "The region in the dorsal ECTODERM of a chordate embryo that gives rise to the future CENTRAL NERVOUS SYSTEM. Tissue in the neural plate is called the neuroectoderm, often used as a synonym of neural plate.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054258"}, {"RECTYPE": "D", "MH": "Neural Tube", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tubes, Neural", "MN": "A16.630", "MH_TH": "NLM (2008)", "ST": "T018", "PI": "Embryology (1964-2007)", "MS": "A tube of ectodermal tissue in an embryo that will give rise to the CENTRAL NERVOUS SYSTEM, including the SPINAL CORD and the BRAIN. Lumen within the neural tube is called neural canal which gives rise to the central canal of the spinal cord and the ventricles of the brain. For malformation of the neural tube, see NEURAL TUBE DEFECTS.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054259"}, {"RECTYPE": "D", "MH": "Vesicular stomatitis New Jersey virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.480.937.750.900.910", "MH_TH": "NLM (2008)", "ST": "T005", "RN": "txid11280", "AN": "infection: coordinate IM with probably VESICULAR STOMATITIS (IM); otherwise coordinate with RHABDOVIRIDAE INFECTIONS (IM)", "PI": "Vesicular stomatitis Indiana virus (1990-2007)", "MS": "A species of VESICULOVIRUS causing VESICULAR STOMATITIS primarily in cattle, horses, and pigs. It can be transmitted to humans where it causes influenza-like symptoms.", "PM": "2008", "HN": "2008", "MR": "20200813", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054260"}, {"RECTYPE": "D", "MH": "Neurulation", "AQ": "DE GE IM PH RE", "MN": "G07.345.500.325.180.875", "MH_TH": "NLM (2008)", "ST": "T039", "PI": "Embryo (1965-2007)", "MS": "An early embryonic developmental process of CHORDATES that is characterized by morphogenic movements of ECTODERM resulting in the formation of the NEURAL PLATE; the NEURAL CREST; and the NEURAL TUBE. Improper closure of the NEURAL GROOVE results in congenital NEURAL TUBE DEFECTS.", "PM": "2008", "HN": "2008", "MR": "20160617", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054261"}, {"RECTYPE": "D", "MH": "Gastrulation", "AQ": "DE GE IM PH RE", "MN": "G07.345.500.325.180.812", "MH_TH": "NLM (2008)", "ST": "T039", "PI": "Gastrula (1979-2007)", "MS": "A process of complicated morphogenetic cell movements that reorganizes a bilayer embryo into one with three GERM LAYERS and specific orientation (dorsal/ventral; anterior/posterior). Gastrulation describes the germ layer development of a non-mammalian BLASTULA or that of a mammalian BLASTOCYST.", "PM": "2008", "HN": "2008", "MR": "20160617", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054262"}, {"RECTYPE": "D", "MH": "Embryonal Carcinoma Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Embryonal Carcinoma Cells|T025|NON|EQV|UNK (19XX)|850611|abcdef", "ENTRY": "Teratocarcinoma Stem Cell", "MN": "A11.872.700.250.500", "MH_TH": "NLM (2008)", "ST": "T025", "MS": "The malignant stem cells of TERATOCARCINOMAS, which resemble pluripotent stem cells of the BLASTOCYST INNER CELL MASS. The EC cells can be grown in vitro, and experimentally induced to differentiate. They are used as a model system for studying early embryonic cell differentiation.", "PM": "2008; see TUMOR STEM CELLS 1986-2007", "HN": "2008; use TUMOR STEM CELLS 1986-2007", "MR": "20160610", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054278"}, {"RECTYPE": "D", "MH": "Human Immunodeficiency Virus Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HIV Proteins|T116|T123|ABX|EQV|NLM (2008)|061114|abbcdef", "ENTRY": "Human Immunodeficiency Virus Gene Products|T116|T123|NON|EQV|NLM (2008)|061114|abbcdef", "MN": "D12.776.964.775.562", "FX": "HIV", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "MS": "Proteins synthesized by HUMAN IMMUNODEFICIENCY VIRUSES such as the HIV-1 and HIV-2.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054298"}, {"RECTYPE": "D", "MH": "env Gene Products, Human Immunodeficiency Virus", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "envelope Proteins, Human Immunodeficiency Virus|T116|T123|NON|EQV|NLM (2008)|061114|abbcdef", "MN": "D12.776.964.970.880.325.164", "FX": "Genes, env", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Gene Products, env (1990-2007)", "MS": "Proteins encoded by the ENV GENE of the HUMAN IMMUNODEFICIENCY VIRUS.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054299"}, {"RECTYPE": "D", "MH": "Oscillatoria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.475.100.612", "MH_TH": "NLM (2008)", "ST": "T007", "RN": "txid1158", "PI": "Cyanobacteria (1969-2007)", "MS": "A genus of filamentous CYANOBACTERIA in the order Oscillatoriales. It is commonly found in freshwater environments, especially hot springs.", "PM": "2008", "HN": "2008", "MR": "20200813", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054300"}, {"RECTYPE": "D", "MH": "gag Gene Products, Human Immunodeficiency Virus", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "gag Proteins, Human Immunodeficiency Virus|T116|T123|ABX|EQV|NLM (2008)|061114|abbcdef", "MN": "D12.776.964.970.600.850.350.362", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "gag Gene Products (1990-2007)", "MS": "Proteins encoded by the GAG GENE of the HUMAN IMMUNODEFICIENCY VIRUS.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054301"}, {"RECTYPE": "D", "MH": "pol Gene Products, Human Immunodeficiency Virus", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "pol Proteins, Human Immunodeficiency Virus|T116|T123|ABX|EQV|NLM (2008)|061114|abbcdef", "MN": "D12.776.964.970.600.850.375.545", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Gene Products, pol (1990-2007)", "MS": "Proteins encoded by the POL GENE of the HUMAN IMMUNODEFICIENCY VIRUS.", "PM": "2008", "HN": "2008", "MR": "20200622", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054302"}, {"RECTYPE": "D", "MH": "HIV Reverse Transcriptase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcriptase, HIV Reverse", "MN": "D12.776.964.970.600.850.375.750.187", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.7.49", "PI": "RNA-Directed DNA Polymerase (1983-2007)", "MS": "A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process.", "PM": "2008", "HN": "2008", "MR": "20200622", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054303"}, {"RECTYPE": "D", "MH": "Anti-Mullerian Hormone", "DS": "ANTIMULLERIAN HORMONE", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Mullerian-Inhibiting Hormone|T116|T125|EPO|EQV|NLM (2008)|abbcde", "ENTRY": "Mullerian Inhibitory Substance", "MN": "D12.776.395.089", "MH_TH": "NLM (2008)", "ST": "T125", "N1": "Muellerian Inhibiting Hormone", "RN": "80497-65-0", "PI": "Testicular Hormones (1977-2007)", "MS": "A glycoprotein that causes regression of MULLERIAN DUCTS. It is produced by SERTOLI CELLS of the TESTES. In the absence of this hormone, the Mullerian ducts develop into structures of the female reproductive tract. In males, defects of this hormone result in persistent Mullerian duct, a form of MALE PSEUDOHERMAPHRODITISM.", "PM": "2008; MULLERIAN-INHIBITING HORMONE was indexed under GLYCOPROTEINS & TESTICULAR HORMONES 1975-2007", "HN": "2008 (1975); for MULLERIAN-INHIBITING HORMONE use ANTI-MULLERIAN HORMONE (NM) 1975-2007", "MR": "20180228", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054304"}, {"RECTYPE": "D", "MH": "Dideoxynucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Triphosphates, Dideoxynucleotide", "MN": "D13.695.225", "MH_TH": "NLM (2008)", "ST": "T114", "RN": "0", "MS": "The phosphate esters of DIDEOXYNUCLEOSIDES.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054306"}, {"RECTYPE": "D", "MH": "Enterotoxigenic Escherichia coli", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Escherichia coli, Enterotoxigenic|T007|NON|EQV|NLM (2008)|070226|abcdef", "ENTRY": "Enterotoxigenic E. coli|T007|ABX|EQV|NLM (2008)|061115|abcdef", "MN": "B03.660.250.150.180.100.340", "MH_TH": "NLM (2008)", "ST": "T007", "AN": "infection: coordinate IM with ESCHERICHIA COLI INFECTION (IM)", "PI": "Escherichia coli (1971-2007)", "MS": "Strains of ESCHERICHIA COLI that produce or contain at least one member of either heat-labile or heat-stable ENTEROTOXINS. The organisms colonize the mucosal surface of the small intestine and elaborate their enterotoxins causing DIARRHEA. They are mainly associated with tropical and developing countries and affect susceptible travelers to those places.", "PM": "2008", "HN": "2008", "MR": "20200902", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054307"}, {"RECTYPE": "D", "MH": "Enteropathogenic Escherichia coli", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Escherichia coli, Enteropathogenic|T007|NON|EQV|NLM (2008)|070226|abcdef", "ENTRY": "Enteropathogenic E. coli|T007|ABX|EQV|NLM (2008)|061115|abcdef", "MN": "B03.660.250.150.180.100.330", "MH_TH": "NLM (2008)", "ST": "T007", "AN": "infection: coordinate IM with ESCHERICHIA COLI INFECTIONS (IM)", "PI": "Escherichia coli (1964-2007)", "MS": "Strains of ESCHERICHIA COLI characterized by attaching-and-effacing histopathology. These strains of bacteria intimately adhere to the epithelial cell membrane and show effacement of microvilli. In developed countries they are associated with INFANTILE DIARRHEA and infantile GASTROENTERITIS and, in contrast to ETEC strains, do not produce ENDOTOXINS.", "PM": "2008", "HN": "2008", "MR": "20200902", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054308"}, {"RECTYPE": "D", "MH": "Ribonuclease H, Human Immunodeficiency Virus", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "HIV Ribonuclease H", "MN": "D12.776.964.970.600.850.375.750.187.500", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.26.4", "PI": "Ribonuclease H (1987-2007)", "MS": "A ribonuclease activity that is a component of the HIV REVERSE TRANSCRIPTASE. It removes the RNA strand of the RNA-DNA heteroduplex produced by reverse transcription. Once the RNA moiety is removed a double stranded DNA copy of the HIV RNA can be synthesized.", "PM": "2008", "HN": "2008", "MR": "20200622", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054309"}, {"RECTYPE": "D", "MH": "nef Gene Products, Human Immunodeficiency Virus", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "nef Protein, Human Immunodeficiency Virus|T116|T123|ABX|EQV|NLM (2008)|061116|abbcdef", "ENTRY": "HIV nef Protein", "MN": "D12.776.964.925.500.500", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Gene Products, nef (1990-2007)", "MS": "Proteins encoded by the NEF GENES of the HUMAN IMMUNODEFICIENCY VIRUS.", "PM": "2008; NEF PROTEIN, HUMAN IMUNNODEFICIENCY VIRUS was indexed under GENE PRODUCTS, NEF 2007, for HIV-3'-ORF PROTEIN see GENE PRODUCTS, NEF 1990-2007", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054311"}, {"RECTYPE": "D", "MH": "Buruli Ulcer", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Mycobacterium ulcerans Infection|T047|NON|EQV|NLM (2008)|061116|abcdef", "ENTRY": "Ulcer, Buruli", "MN": "C17.800.893.295", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "PI": "Skin Ulcer (1965-2007)", "MS": "A lesion in the skin and subcutaneous tissues due to infections by MYCOBACTERIUM ULCERANS. It was first reported in Uganda, Africa.", "PM": "2008", "HN": "2008", "MR": "20190617", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054312"}, {"RECTYPE": "D", "MH": "Drug Agonism", "ENTRY": "Agonism, Drug", "MN": "G07.690.773.968.154", "MH_TH": "NLM (2008)", "ST": "T044", "AN": "general only; prefer specific drug with / agon; DRUG PARTIAL AGONISM and DRUG INVERSE AGONISM are also available", "MS": "Phenomena and pharmaceutics of compounds that selectively bind to a specific receptor and trigger a response. They mimic the action of endogenous biochemical molecules. Their effect can be countered by antagonists (DRUG ANTAGONISM).", "PM": "2008", "HN": "2008", "MR": "20150629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054313"}, {"RECTYPE": "D", "MH": "Drug Inverse Agonism", "AQ": "EH GE IM PH RE", "PRINT ENTRY": "Inverse Agonists|T044|NON|NRW|NLM (2024)|230405|abcdef", "ENTRY": "Inverse Agonisms", "MN": "G07.690.773.968.393", "FX": "Drug Agonism", "MH_TH": "NLM (2008)", "ST": "T044", "AN": "coordinate with specific drug /agon or /antag", "MS": "Phenomena and pharmaceutics of compounds that bind to the same receptor binding-site as an agonist (DRUG AGONISM) for that receptor but exerts the opposite pharmacological effect.", "PM": "2008", "HN": "2008", "MR": "20230530", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054314"}, {"RECTYPE": "D", "MH": "Oocyte Retrieval", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Retrieval, Oocyte", "MN": "E05.820.800.976", "FX": "Fertility Preservation", "MH_TH": "NLM (2008)", "ST": "T061", "PI": "Oocytes (1981-2007)", "MS": "Procedures to obtain viable OOCYTES from the host. Oocytes most often are collected by needle aspiration from OVARIAN FOLLICLES before OVULATION.", "PM": "2008", "HN": "2008", "MR": "20110624", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054315"}, {"RECTYPE": "D", "MH": "Biomarkers, Pharmacological", "AQ": "AN BL CF CH ME UR", "PRINT ENTRY": "Drug Dosing Biomarker|T080|NON|NRW|NLM (2022)|200831|abcdef", "ENTRY": "Safety Biomarkers, Drug", "MN": "D23.101.137", "MH_TH": "NLM (2008)", "ST": "T080", "RN": "0", "AN": "use only in the context of drug development, safety or dosage determination", "PI": "Biological Markers (1990-2007)", "MS": "Measurable biological parameters that serve for drug development, safety and dosing (DRUG MONITORING).", "PM": "2008", "HN": "2008", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054316"}, {"RECTYPE": "D", "MH": "No-Reflow Phenomenon", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Slow Flow Phenomenon", "MN": "C23.550.513.677", "FX": "Coronary Restenosis", "MH_TH": "NLM (2008)", "ST": "T046", "PI": "Microcirculation (1974-2007)", "MS": "Markedly reduced or absent REPERFUSION in an infarct zone following the removal of an obstruction or constriction of an artery.", "PM": "2008", "HN": "2008", "MR": "20190701", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054318"}, {"RECTYPE": "D", "MH": "Marchiafava-Bignami Disease", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Marchiafava Bignami Syndrome", "MN": "C10.314.475", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Demyelinating Diseases (1965-2007)", "MS": "A neurodegenerative condition that is characterized by demyelination or necrosis of the CORPUS CALLOSUM. Symptoms include DEPRESSION; PARANOIA; DEMENTIA; SEIZURES; and ATAXIA which can progress to COMA and death in a few months. Marchiafava-Bignami syndrome is seen often in alcoholics but has been found in non-alcoholics as well.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054319"}, {"RECTYPE": "D", "MH": "vif Gene Products, Human Immunodeficiency Virus", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HIV vif Gene Product|T116|T123|ABX|EQV|NLM (1991)|900420|abbcdef", "ENTRY": "vif Proteins, Human Immunodeficiency Virus|T116|T123|ABX|EQV|NLM (2008)|061117|abbcdef", "MN": "D12.776.964.925.875.500", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Gene Products, vif (1991-2007)", "MS": "Proteins encoded by the VIF GENES of the HUMAN IMMUNODEFICIENCY VIRUS.", "PM": "2008; for HIV VIF GENE PRODUCT see GENE PRODUCTS, VIF 1991-2007", "HN": "2008 for HIV VIF GENE PRODUCT use GENE PRODUCTS, VIF 1991-2007", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054320"}, {"RECTYPE": "D", "MH": "rev Gene Products, Human Immunodeficiency Virus", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "trs-art Gene Protein, HIV|T116|T123|ABX|EQV|NLM (1990)|890213|abbcdef", "ENTRY": "trs art Gene Protein, HIV", "MN": "D12.776.964.925.984.385.500", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Gene Products, rev (1990-2007)", "MS": "Proteins encoded by the REV GENES of the HUMAN IMMUNODEFICIENCY VIRUS.", "PM": "2008; see GENE PRODUCTS, REV 1990-2007", "HN": "2008; use GENE PRODUCTS, REV 1990-2007", "MR": "20200622", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054321"}, {"RECTYPE": "D", "MH": "tat Gene Products, Human Immunodeficiency Virus", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Trans-Acting Transcription Factor, HIV|T116|T123|ABX|EQV|NLM (1990)|890214|TRANS ACTING TRANSCRIPTION FACTOR HIV|abbcdefv", "ENTRY": "tat Protein, HIV", "MN": "D12.776.964.925.984.400.500", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Gene Products, tat (1990-2007)", "MS": "Proteins encoded by the TAT GENES of the HUMAN IMMUNODEFICIENCY VIRUS.", "PM": "2008; use GENE PRODUCTS, TAT 1990-2007", "HN": "2008; see GENE PRODUCTS, TAT 1990-2007", "MR": "20200622", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054322"}, {"RECTYPE": "D", "MH": "Shiga-Toxigenic Escherichia coli", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Verotoxigenic Escherichia coli|T007|NON|EQV|NLM (2008)|061117|abcdef", "ENTRY": "Verotoxin-Producing Escherichia coli|T007|NON|EQV|NLM (2008)|061117|abcdef", "MN": "B03.660.250.150.180.100.800", "MH_TH": "NLM (2008)", "ST": "T007", "AN": "infection: coordinate IM with ESCHERICHIA COLI INFECTION (IM); consider also HEMOLYTIC UREMIC SYNDROME", "PI": "Escherichia coli (1979-2007)", "MS": "Strains of ESCHERICHIA COLI with the ability to produce at least one or more of at least two antigenically distinct, usually bacteriophage-mediated cytotoxins: SHIGA TOXIN 1 and SHIGA TOXIN 2. These bacteria can cause severe disease in humans including bloody DIARRHEA and HEMOLYTIC UREMIC SYNDROME.", "PM": "2008", "HN": "2008", "MR": "20200902", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054323"}, {"RECTYPE": "D", "MH": "Enterohemorrhagic Escherichia coli", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Escherichia coli, Enterohemorrhagic|T007|NON|EQV|NLM (2008)|070226|abcdef", "ENTRY": "Enterohemorrhagic E. coli|T007|ABX|EQV|NLM (2008)|061117|abcdef", "MN": "B03.660.250.150.180.100.800.250", "MH_TH": "NLM (2008)", "ST": "T007", "AN": "infection: coordinate IM with ESCHERICHIA COLI INFECTIONS (IM); consider also HEMOLYTIC UREMIC SYNDROME", "PI": "Escherichia coli O157 (1996-2007)", "MS": "Strains of ESCHERICHIA COLI that are a subgroup of SHIGA-TOXIGENIC ESCHERICHIA COLI. They cause non-bloody and bloody DIARRHEA; HEMOLYTIC UREMIC SYNDROME; and hemorrhagic COLITIS. An important member of this subgroup is ESCHERICHIA COLI O157-H7.", "PM": "2008; see ESCHERICHIA COLI O157 1999-2007", "HN": "2008; use ESCHERICHIA COLI O157 1999-2007", "MR": "20200902", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054324"}, {"RECTYPE": "D", "MH": "vpr Gene Products, Human Immunodeficiency Virus", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "HIV vpr Gene Product|T116|T123|ABX|EQV|NLM (1993)|910926|abbcdef", "ENTRY": "vpr Protein, Human Immunodeficiency Virus|T116|T123|ABX|EQV|NLM (2008)|061120|abbcdef", "MN": "D12.776.964.925.984.430.500", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Gene Products, vpr (1991-2007)", "MS": "Proteins encoded by the VPR GENES of the HUMAN IMMUNODEFICIENCY VIRUS.", "PM": "2008; see GENE PRODUCTS, VPR 1991-2007", "HN": "2008; use GENE PRODUCTS, VPR 1991-2007", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054325"}, {"RECTYPE": "D", "MH": "Coronary Sinus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sinus, Coronary", "MN": "A07.015.908.194.500", "MH_TH": "NLM (2008)", "ST": "T023", "PI": "Coronary Vessels (1963-2007)", "MS": "A short vein that collects about two thirds of the venous blood from the MYOCARDIUM and drains into the RIGHT ATRIUM. Coronary sinus, normally located between the LEFT ATRIUM and LEFT VENTRICLE on the posterior surface of the heart, can serve as an anatomical reference for cardiac procedures.", "PM": "2008", "HN": "2008", "MR": "20180630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054326"}, {"RECTYPE": "D", "MH": "Lubricants", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lubricant|T120|NON|EQV|NLM (2021)|200123|abcdef", "ENTRY": "Agents, Lubrication", "MN": "D27.720.556", "FX": "Surface-Active Agents", "MH_TH": "NLM (1994)", "ST": "T120", "RN": "0", "PI": "Lubrication (1963-2007)", "MS": "Compounds that provide LUBRICATION between surfaces in order to reduce FRICTION.", "PM": "2008; see LUBRICATION 1963-2007", "HN": "2008; use LUBRICATION 1963-2007", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054327"}, {"RECTYPE": "D", "MH": "Proton Pump Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Proton Pump Inhibitor|T121|NON|EQV|NLM (2021)|191125|abcdef", "ENTRY": "Pump Inhibitor, Proton", "MN": "D27.505.519.389.848", "MH_TH": "NLM (2008)", "ST": "T121", "RN": "0", "PI": "Proton Pumps/antagonists & inhibitors (1993-2007)", "MS": "Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054328"}, {"RECTYPE": "D", "MH": "Carbasugars", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pseudosugar|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Carba Sugars", "MN": "D09.161", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "MS": "Sugar analogs in which the ring oxygen is replaced by a methylene (CH2) carbon.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054329"}, {"RECTYPE": "D", "MH": "Thiosugars", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Thio Sugars", "MN": "D09.973", "FX": "Thioglucosides", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "MS": "Sugar analogs in which the ring oxygen is replaced by a sulfur.", "PM": "2008", "HN": "2008", "MR": "20170410", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054330"}, {"RECTYPE": "D", "MH": "Sertoli Cell-Only Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Germinal Cell Aplasia|T047|NON|EQV|NLM (2008)|OMIM (2013)|061121|abcdeef", "ENTRY": "Sertoli Cell Only Syndrome", "MN": "C12.200.294.430.754", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Sertoli Cells (1973-2007)", "MS": "A type of male infertility in which no germ cells are visible in any of the biopsied SEMINIFEROUS TUBULES (type I) or in which germ cells are present in a minority of tubules (type II). Clinical features include AZOOSPERMIA, normal VIRILIZATION, and normal chromosomal complement.", "PM": "2008", "HN": "2008", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054331"}, {"RECTYPE": "D", "MH": "Leishmaniasis Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Leishmaniasis Vaccine|T121|T129|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Vaccines, Leishmaniasis", "MN": "D20.215.894.582.480", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "AN": "coordinate IM with Leishmania species /immunol (IM)", "PI": "Vaccines (1973-1991)", "MS": "Vaccines or candidate vaccines used to prevent infection with LEISHMANIA.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054332"}, {"RECTYPE": "D", "MH": "Drug Partial Agonism", "PRINT ENTRY": "Drug Agonism, Partial|T044|NON|EQV|NLM (2008)|061122|abcdef", "ENTRY": "Partial Drug Agonism", "MN": "G07.690.773.968.154.500", "MH_TH": "NLM (2008)", "ST": "T044", "AN": "coordinate with specific drug /agon or /antag", "MS": "Drug agonism involving selective binding but reduced effect. This can result in some degree of DRUG ANTAGONISM.", "PM": "2008", "HN": "2008", "MR": "20150629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054333"}, {"RECTYPE": "D", "MH": "Viral Regulatory and Accessory Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Viral Regulatory Proteins|T116|T123|NON|NRW|NLM (1990)|990101|VIRAL REG PROTEINS|abbcdefv", "ENTRY": "Proteins, Viral Regulatory", "MN": "D12.776.964.925", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "MS": "A broad category of viral proteins that play indirect roles in the biological processes and activities of viruses. Included here are proteins that either regulate the expression of viral genes or are involved in modifying host cell functions. Many of the proteins in this category serve multiple functions.", "PM": "2008; for VIRAL REGULATORY PROTEINS see VIRAL REGULATORY PROTEINS 1990-2007", "HN": "2008 (1990)", "MR": "20071009", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054334"}, {"RECTYPE": "D", "MH": "Goniothalamus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.065.812", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid261082", "PI": "Annonaceae (2003-2007)", "MS": "A plant genus of the family ANNONACEAE. Members contain cyclopeptides and styrylpyrones.", "PM": "2008; see ANNONACEAE 2003-2007", "HN": "2008; use ANNONACEAE 2003-2007", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054335"}, {"RECTYPE": "D", "MH": "Xylopia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Xylopias", "MN": "B01.875.800.575.912.250.065.992", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid225838", "PI": "Annonaceae (2003-2007)", "MS": "A plant genus of the family ANNONACEAE. Members contain DITERPENES.", "PM": "2008; see ANNONACEAE 2003-2007", "HN": "2008; use ANNONACEAE 2003-2007", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054336"}, {"RECTYPE": "D", "MH": "Cell Dedifferentiation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Dedifferentiation, Cell|T043|NON|EQV|NLM (2008)|061127|abcdef", "ENTRY": "Dedifferentiations, Cell", "MN": "G04.148", "FX": "Cell Transdifferentiation", "MH_TH": "NLM (2008)", "ST": "T043", "MS": "A reverse developmental process in which terminally differentiated cells with specialized functions revert back to a less differentiated stage within their own CELL LINEAGE.", "PM": "2008", "HN": "2008", "MR": "20160115", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054337"}, {"RECTYPE": "D", "MH": "Cell Transdifferentiation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Transdifferentiation, Cell|T043|NON|EQV|NLM (2008)|061127|abcdef", "ENTRY": "Transdifferentiations, Cell", "MN": "G04.356", "FX": "Cellular Reprogramming Techniques", "MH_TH": "NLM (2008)", "ST": "T043", "AN": "CELLULAR REPROGRAMMING is also available", "PI": "Cell Differentiation (1968-2007)", "MS": "A naturally occurring phenomenon where terminally differentiated cells dedifferentiate to the point where they can switch CELL LINEAGES. The cells then differentiate into other cell types.", "PM": "2008", "HN": "2008", "MR": "20160115", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054338"}, {"RECTYPE": "D", "MH": "Steroidogenic Factor 1", "DS": "STEROIDOGENIC FACTOR 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, SF-1", "MN": "D12.776.826.925", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1993-2007)", "MS": "A transcription factor and member of the nuclear receptor family NR5 that is expressed throughout the adrenal and reproductive axes during development. It plays an important role in sexual differentiation, formation of primary steroidogenic tissues, and their functions in post-natal and adult life. It regulates the expression of key steroidogenic enzymes.", "PM": "2008; STEROIDOGENIC FACTOR 1 was indexed under TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEINS; & RECEPTORS, CYTOPLASMIC AND NUCLEAR 2004-2007", "HN": "2008", "MR": "20150623", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054339"}, {"RECTYPE": "D", "MH": "Receptors, KIR", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Killer Inhibitory Receptors|T116|T192|NON|EQV|NLM (2008)|061130|abbcdef", "ENTRY": "Receptors, Killer Inhibitory", "MN": "D12.776.543.750.705.895.500", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "AN": "general; prefer specifics", "MS": "A family of receptors found on NK CELLS that have specificity for a variety of HLA ANTIGENS. KIR receptors contain up to three different extracellular immunoglobulin-like domains referred to as D0, D1, and D2 and play an important role in blocking NK cell activation against cells expressing the appropriate HLA antigens thus preventing cell lysis. Although they are often referred to as being inhibitory receptors, a subset of KIR receptors may also play an activating role in NK cells.", "PM": "2008; KIR RECEPTORS (now RECEPTORS, KIR) was indexed under RECEPTORS, IMMUNOLOGIC 1997-2007", "HN": "2008(1997)", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054340"}, {"RECTYPE": "D", "MH": "Receptors, KIR3DL1", "DS": "RECEPTORS KIR 03 DL 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD158e Antigens|T116|T192|ABX|EQV|NLM (2008)|061129|CD 158 E ANTIGENS|abbcdefs", "ENTRY": "Receptors, NKB1", "MN": "D12.776.543.750.705.895.500.500", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "A KIR receptor that has specificity for HLA-B ANTIGENS. It is an inhibitory receptor that contains D0, D1, and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail.", "PM": "2008; NK CELL RECEPTOR NKB1 (now RECEPTORS, KIR3DL1) was indexed under RECEPTORS, IMMUNOLOGIC 1997-2007", "HN": "2008(1994)", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054341"}, {"RECTYPE": "D", "MH": "Receptors, KIR2DL1", "DS": "RECEPTORS KIR 02 DL 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD158a Antigens|T116|T192|ABX|EQV|NLM (2008)|061128|CD 158 A ANTIGENS|abbcdefs", "ENTRY": "Natural Killer Associated Transcript 1", "MN": "D12.776.543.750.705.895.500.249", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "A KIR receptor that has specificity for HLA-C ANTIGENS. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL2 RECEPTOR and the KIR2DL3 RECEPTORS.", "PM": "2008; RECEPTORS, KIR2DL1 was indexed under RECEPTORS, IMMUNOLOGIC 2006-2007", "HN": "2008(2006)", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054342"}, {"RECTYPE": "D", "MH": "Receptors, KIR2DL2", "DS": "RECEPTORS KIR 02 DL 02", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD158b1 Antigens|T116|T192|ABX|EQV|NLM (2008)|061128|CD 158 B 01 ANTIGENS|abbcdefs", "ENTRY": "Receptor, KIR2DL2", "MN": "D12.776.543.750.705.895.500.374", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "A KIR receptor that has specificity for HLA-C ANTIGENS. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL1 RECEPTORS and the KIR2DL3 RECEPTORS.", "PM": "2008; RECEPTORS, KIR2DL2 was indexed under RECEPTORS, IMMUNOLOGIC 2006-2007", "HN": "2008(2006)", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054343"}, {"RECTYPE": "D", "MH": "Receptors, KIR2DL3", "DS": "RECEPTORS KIR 02 DL 03", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD158b Antigens|T116|T192|ABX|EQV|NLM (2008)|061128|CD 158 B ANTIGENS|abbcdefs", "ENTRY": "Natural Killer Associated Transcript 2", "MN": "D12.776.543.750.705.895.500.437", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "A KIR receptor that has specificity for HLA-C ANTIGEN. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL2 RECEPTORS and the KIR2DL3 RECEPTORS.", "PM": "2008; RECEPTORS, KIR2DL3 was indexed under RECEPTORS, IMMUNOLOGIC 2006-2007", "HN": "2008(2006)", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054344"}, {"RECTYPE": "D", "MH": "Receptors, KIR2DL4", "DS": "RECEPTORS KIR 02 DL 04", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD158d Antigens|T116|T192|ABX|EQV|NLM (2008)|061128|CD 158 D ANTIGENS|abbcdefs", "ENTRY": "Receptor, KIR2DL4", "MN": "D12.776.543.750.705.895.500.468", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "A KIR receptor that has specificity for HLA-G antigen. It contains D0 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail.", "PM": "2008; RECEPTORS, KIR2DL3 was indexed under RECEPTORS, IMMUNOLOGIC 2006-2007", "HN": "2008(2006)", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054345"}, {"RECTYPE": "D", "MH": "Receptors, KIR2DL5", "DS": "RECEPTORS KIR 02 DL 05", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, KIR2DL5", "MN": "D12.776.543.750.705.895.500.484", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "An inhibitory KIR receptor that contains D0 and D1 extracellular immunoglobulin-like domains and a long cytoplasmic tail.", "PM": "2008; KIR2DL5 RECEPTOR (now RECEPTORS, KIR2DL5) was indexed under RECEPTORS, IMMUNOLOGIC 2000-2007", "HN": "2008(2000)", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054346"}, {"RECTYPE": "D", "MH": "Receptors, KIR3DL2", "DS": "RECEPTORS KIR 03 DL 02", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD158k Antigens|T116|T192|ABX|EQV|NLM (2008)|061129|CD 158 K ANTIGENS|abbcdefs", "ENTRY": "p140 KIR3DL2 Inhibitory Receptor", "MN": "D12.776.543.750.705.895.500.750", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "A KIR receptor that has specificity for HLA-A3 ANTIGEN. It is an inhibitory receptor that contains D0, D1, and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail.", "PM": "2008; P140-KIRDL2 INHIBITORY RECEPTOR (now RECEPTORS, KIR3DL2) was indexed under RECEPTORS, IMMUNOLOGIC 1999-2007", "HN": "2008(1999)", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054347"}, {"RECTYPE": "D", "MH": "Receptors, KIR3DS1", "DS": "RECEPTORS KIR 03 DS 01", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Natural Killer Associated Transcript 10 Protein", "MN": "D12.776.543.750.705.895.500.890", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "An activating KIR receptor that contains D0, D1, and D2 extracellular immunoglobulin-like domains and a short cytoplasmic tail.", "PM": "2008; RECEPTORS, KIR3DS1 was indexed under RECEPTORS, IMMUNOLOGIC 2006-2007", "HN": "2008(2006)", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054349"}, {"RECTYPE": "D", "MH": "Electrical Synapses", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Synapses, Electrotonic|T026|NON|NRW|NLM (2008)|061127|abcdef", "ENTRY": "Synapse, Electrotonic", "MN": "A11.284.149.165.420.780.180", "MH_TH": "NLM (2008)", "ST": "T026", "PI": "Synapses (1972-2007)", "MS": "Specialized junctions between NEURONS which connect the cytoplasm of one neuron to another allowing direct passage of an ion current.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054351"}, {"RECTYPE": "D", "MH": "Perforin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lymphocyte Pore-Forming Protein|T116|NON|EQV|NLM (2008)|040810|abcdef", "ENTRY": "Pore-Forming Protein, Lymphocyte", "MN": "D12.776.543.695.875", "PA": "Cytotoxins", "MH_TH": "NLM (2008)", "ST": "T116", "RN": "126465-35-8", "PI": "Pore Forming Cytotoxic Proteins (1985-2007)", "MS": "A calcium-dependent pore-forming protein synthesized in cytolytic LYMPHOCYTES and sequestered in secretory granules. Upon immunological reaction between a cytolytic lymphocyte and a target cell, perforin is released at the plasma membrane and polymerizes into transmembrane tubules (forming pores) which lead to death of a target cell.", "PM": "2008; PERFORIN was indexed under MEMBRANE GLYCOPROTEINS & PORE FORMING CYTOTOXIC PROTEINS 1985-2007", "HN": "2008", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054353"}, {"RECTYPE": "D", "MH": "Iron Carbonyl Compounds", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Carbonyl Compounds, Iron", "MN": "D01.490.500", "FX": "Iron Chelating Agents", "MH_TH": "NLM (2008)", "ST": "T197", "RN": "13463-40-6", "PI": "Iron Compounds (1974-2007)", "MS": "Complexes of iron atoms chelated with carbonyl ions.", "PM": "2008; IRON CARBONYL COMPOUNDS (NM) was indexed under ORGANOMETALLIC COMPOUNDS 1974-2007", "HN": "2008(1974);", "MR": "20190701", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054354"}, {"RECTYPE": "D", "MH": "Chemokine CXCL10", "DS": "CHEMOKINE CXCL 010", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CXCL10 Chemokine|T116|T123|ABX|EQV|NLM (2008)|061129|CXCL 010 CHEMOKINE|abbcdefs", "ENTRY": "gammaIP 10 Protein", "MN": "D23.529.374.200.120.500", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "MS": "A CXC chemokine that is induced by GAMMA-INTERFERON and is chemotactic for MONOCYTES and T-LYMPHOCYTES. It has specificity for the CXCR3 RECEPTOR.", "PM": "2008; CXCL CHEMOKINE (now CHEMOKINE CXCL10) was indexed under CHEMOKINES, CXC 1998-2007, under CHEMOKINES 1997, under CYTOKINES 1991-1997, & under PROTEINS 1987-1990", "HN": "2008(1987)", "MR": "20151123", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054357"}, {"RECTYPE": "D", "MH": "Withanolides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D23.704.500.904", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "PI": "Ergosterol/analogs & derivatives (1980-2007)", "MS": "Ergostane derivatives of 28 carbons with oxygens at C1, C22, and C26 positions and the side chain cyclized. They are found in WITHANIA plant genus and have cytotoxic and other effects.", "PM": "2008", "HN": "2008", "MR": "20160630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054358"}, {"RECTYPE": "D", "MH": "Chemokine CXCL1", "DS": "CHEMOKINE CXCL 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CXCL1 Chemokine|T116|T123|ABX|EQV|NLM (2008)|061205|CXCL 001 CHEMOKINE|abbcdefs", "ENTRY": "Neutrophil Activating Protein 3", "MN": "D23.529.374.200.120.050", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Chemokines, CXC (1987-2007)", "MS": "A CXC chemokine with specificity for CXCR2 RECEPTORS. It has growth factor activities and is implicated as a oncogenic factor in several tumor types.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054360"}, {"RECTYPE": "D", "MH": "Fenamates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "N Phenyl 2 Aminobenzoates", "MN": "D02.455.426.559.389.127.020.906.750", "MH_TH": "NLM (2008)", "ST": "T121", "RN": "0", "PI": "Anthranilic Acids (1966-2007)", "MS": "Derivatives of orthoaminobenzoic acid that have a phenyl group bound to the orthoamino nitrogen. Members modulate ION CHANNELS and are used as ANTI-INFLAMMATORY AGENTS.", "PM": "2008", "HN": "2008", "MR": "20120703", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054361"}, {"RECTYPE": "D", "MH": "Cananga", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Ylang-Ylang|T002|NON|EQV|NLM (2003)|020326|abcdef", "ENTRY": "Ylang-Ylangs", "MN": "B01.875.800.575.912.250.065.781", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid13392", "PI": "Annonaceae (2003-2007)", "MS": "A plant genus of the family ANNONACEAE known for its aromatic oil (OILS, VOLATILE).", "PM": "2008; see ANNONACEAE 2003-2007", "HN": "2008; use ANNONACEAE 2003-2007", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054362"}, {"RECTYPE": "D", "MH": "Solitary Fibrous Tumor, Pleural", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Solitary Fibrous Mesothelioma|T191|NON|EQV|NLM (2008)|061130|abcdef", "ENTRY": "Submesothelial Fibromas", "MN": "C04.588.894.797.640.800", "MH_TH": "NLM (2008)", "ST": "T191", "AN": "note entry terms: MESOTHELIOMA is also available", "MS": "A rare neoplasm, usually benign, derived from mesenchymal fibroblasts located in the submesothelial lining of the PLEURA. It spite of its various synonyms, it has no features of mesothelial cells and is not related to malignant MESOTHELIOMA or asbestos exposure.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054363"}, {"RECTYPE": "D", "MH": "Solitary Fibrous Tumors", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Solitary Fibrous", "MN": "C04.557.450.565.590.797", "MH_TH": "NLM (2008)", "ST": "T191", "MS": "Rare neoplasms of mesenchymal origin, usually benign, and most commonly involving the PLEURA (see SOLITARY FIBROUS TUMOR, PLEURAL). They also are found in extrapleural sites.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054364"}, {"RECTYPE": "D", "MH": "Chemokine CXCL5", "DS": "CHEMOKINE CXCL 005", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CXCL5 Chemokine|T116|T123|ABX|EQV|NLM (2008)|061205|CXCL 005 CHEMOKINE|abbcdefs", "ENTRY": "Neutrophil Attractant-78, Epithelial-Cell-Derived", "MN": "D23.529.374.200.120.250", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Chemokines, CXC (2001-2007)", "MS": "A CXC chemokine that is predominantly expressed in EPITHELIAL CELLS. It has specificity for the CXCR2 RECEPTORS and is involved in the recruitment and activation of NEUTROPHILS.", "PM": "2008", "HN": "2008", "MR": "20090720", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054365"}, {"RECTYPE": "D", "MH": "Agouti Signaling Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Agouti Switch Protein|T116|T123|NON|EQV|NLM (2008)|061201|abbcdef", "MN": "D23.529.049", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Intercellular Signaling Peptides and Proteins (1994-2007)", "MS": "A secreted protein of approximately 131 amino acids (depending on species) that regulates the synthesis of eumelanin (brown/black) pigments in MELANOCYTES. Agouti protein antagonizes the signaling of MELANOCORTIN RECEPTORS and has wide distribution including ADIPOSE TISSUE; GONADS; and HEART. Its overexpression in agouti mice results in uniform yellow coat color, OBESITY, and metabolic defects similar to type II diabetes in humans.", "PM": "2008; AGOUTI PROTEIN was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 1993-2007", "HN": "2008 (1993)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054366"}, {"RECTYPE": "D", "MH": "Receptors, CXCR3", "DS": "RECEPTORS CXCR 003", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CXCR3 Receptors|T116|T192|ABX|EQV|NLM (2008)|061201|CXCR 003 RECEPTORS|abbcdefs", "ENTRY": "Receptors, CMKBR3 Chemokine", "MN": "D12.776.543.750.705.852.125.500.300", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "CXCR receptors that are expressed on the surface of a number of cell types, including T-LYMPHOCYTES; NK CELLS; DENDRITIC CELLS; and a subset of B-LYMPHOCYTES. The receptors are activated by CHEMOKINE CXCL9; CHEMOKINE CXCL10; and CHEMOKINE CXCL11.", "PM": "2008; CXC CHEMOINE RECEPTOR 3 (now RECEPTORS, CXCR3) was indexed under RECEPTORS, CHEMOKINE 1998-2007", "HN": "2008(1998)", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054367"}, {"RECTYPE": "D", "MH": "Laxatives", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Laxative|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Laxatives, Bulk", "MN": "D27.505.954.483.620", "FX": "Dietary Fiber", "MH_TH": "UNK (19XX)", "ST": "T121", "RN": "0", "PI": "Cathartics (1974-2007)", "MS": "Agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve CONSTIPATION.", "PM": "2008; see CATHARTICS 1963-2007", "HN": "2008; use CATHARTICS 1963-2007", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054368"}, {"RECTYPE": "D", "MH": "Agouti-Related Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Agouti Related Protein", "MN": "D23.529.074", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Receptors, Melanocortin (1997-2007)", "MS": "A secreted protein of approximately 131 amino acids that is related to AGOUTI SIGNALING PROTEIN and is also an antagonist of MELANOCORTIN RECEPTOR activity. It is expressed primarily in the HYPOTHALAMUS and the ADRENAL GLAND. As a paracrine signaling molecule, AGRP is known to regulate food intake and body weight. Elevated AGRP has been associated with OBESITY.", "PM": "2008; AGOUTI-RELATED PROTEIN was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 1997-2007", "HN": "2008 (1997)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054369"}, {"RECTYPE": "D", "MH": "Chemokine CXCL9", "DS": "CHEMOKINE CXCL 009", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mig Chemokine|T116|T123|ABX|EQV|NLM (2008)|061204|abbcdef", "ENTRY": "Chemokine, SCYB9", "MN": "D23.529.374.200.120.450", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Chemokines, CXC (1993-2007)", "MS": "An INTEFERON-inducible CXC chemokine that is specific for the CXCR3 RECEPTOR.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054370"}, {"RECTYPE": "D", "MH": "Chemokine CXCL11", "DS": "CHEMOKINE CXCL 011", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CXCL11 Chemokine|T116|T129|ABX|EQV|NLM (2008)|060404|CXCL 011 CHEMOKINE|abbcdefs", "ENTRY": "H174 CXC Chemokine", "MN": "D23.529.374.200.120.550", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "MS": "A CXC chemokine that is induced by GAMMA-INTERFERON. It is a chemotactic factor for activated T-LYMPHOCYTES and has specificity for the CXCR3 RECEPTOR.", "PM": "2008; CXCL11 CHEMOKINE (now CHEMOKINE CXCL11) was indexed under CHEMOKINES, CXC 1999-2007", "HN": "2008(1999)", "MR": "20090720", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054371"}, {"RECTYPE": "D", "MH": "Chemokine CXCL12", "DS": "CHEMOKINE CXCL 012", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Stromal Cell-Derived Factor-1beta|T116|T129|NON|NRW|NLM (2008)|abbcde", "ENTRY": "Stromal Cell Derived Factor 1beta", "MN": "D23.529.374.200.120.600", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "MS": "A CXC chemokine that is chemotactic for T-LYMPHOCYTES and MONOCYTES. It has specificity for CXCR4 RECEPTORS. Two isoforms of CXCL12 are produced by alternative mRNA splicing.", "PM": "2008; CXCL12 CHEMOKINE (now CHEMOKINE CXCL12) was indexed under CHEMOKINES, CXC 1993-2007; STROMAL CELL-DERIVED FACTOR-1BETA was indexed under CYTOKINES 2001-2007", "HN": "2008(1993)", "MR": "20151123", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054377"}, {"RECTYPE": "D", "MH": "Acetogenins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acetogenin Compounds|T109|NON|EQV|NLM (2008)|040318|abcdef", "ENTRY": "Acetogenins, Annonaceous", "MN": "D10.289.054", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "PI": "Lactones (1988-2007)", "MS": "Polyketides of up to a few dozen carbons in length, formed by chain extension of multiple PROPIONATES and oxygenated to form tetrahydrofuran and lactone rings along the length of the chain. They are found in ANNONACEAE and other PLANTS. Related compounds cyclize to MACROLIDES.", "PM": "2008; ACETOGENIN (now ACETOGENINS) was indexed under LACTONES 2004-2007 and FATTY ALCOHOLS 2004-2007", "HN": "2008(2004)", "MR": "20190222", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054378"}, {"RECTYPE": "D", "MH": "Receptors, CXCR5", "DS": "RECEPTORS CXCR 005", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CXCR5 Receptors|T116|T192|ABX|EQV|NLM (2008)|061205|CXCR 005 RECEPTORS|abbcdefs", "ENTRY": "Burkitt Lymphoma Receptor 1|T116|T192|EPO|EQV|NLM (2008)|061205|abbcdef", "MN": "D12.776.543.750.705.852.125.500.500", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "PI": "Receptors, Chemokine (1993-2007)", "MS": "CXCR receptors isolated initially from BURKITT LYMPHOMA cells. CXCR5 receptors are expressed on mature, recirculating B-LYMPHOCYTES and are specific for CHEMOKINE CXCL13.", "PM": "2008", "HN": "2008", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054380"}, {"RECTYPE": "D", "MH": "Chemokine CXCL13", "DS": "CHEMOKINE CXCL 013", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CXCL13 Chemokine|T116|T123|ABX|EQV|NLM (2008)|061206|CXCL 013 CHEMOKINE|abbcdefs", "ENTRY": "Chemokine, SCYB13", "MN": "D23.529.374.200.120.650", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Chemokines, CXC (1998-2007)", "MS": "A CXC chemokine that is chemotactic for B-LYMPHOCYTES. It has specificity for CXCR5 RECEPTORS.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054382"}, {"RECTYPE": "D", "MH": "Receptors, CXCR", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CXCR Receptors|T116|T192|ABX|EQV|NLM (2008)|061206|abbcdef", "ENTRY": "Receptors, CXC Chemokine", "MN": "D12.776.543.750.705.852.125.500", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "PI": "Receptors, Chemokine (1998-2007)", "MS": "Chemokine receptors that are specific for CXC CHEMOKINES.", "PM": "2008", "HN": "2008", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054387"}, {"RECTYPE": "D", "MH": "Receptors, CCR", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CCR Receptors|T116|T192|ABX|EQV|NLM (2008)|061206|CCR 000 RECEPTORS|abbcdefs", "ENTRY": "Chemokine Receptors, CC", "MN": "D12.776.543.750.705.852.125.150", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "PI": "Receptors, Chemokine (1998-2007)", "MS": "Chemokine receptors that are specific for CC CHEMOKINES.", "PM": "2008", "HN": "2008", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054388"}, {"RECTYPE": "D", "MH": "Receptors, CCR1", "DS": "RECEPTORS CCR 001", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD191 Antigens|T116|T192|ABX|EQV|NLM (2008)|061205|CD 191 ANTIGENS|abbcdefs", "ENTRY": "Receptor, CCR1", "MN": "D12.776.543.750.705.852.125.150.100", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "CCR receptors with specificity for a broad variety of CC CHEMOKINES. They are expressed at high levels in MONOCYTES; tissue MACROPHAGES; NEUTROPHILS; and EOSINOPHILS.", "PM": "2008; CC CHEMOKINE RECEPTOR 1 (now RECEPTORS, CCR1) was indexed under RECEPTORS, CHEMOKINE 1997-2007", "HN": "2008(1997)", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054389"}, {"RECTYPE": "D", "MH": "Receptors, CCR2", "DS": "RECEPTORS CCR 002", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD192 Antigens|T116|T192|ABX|EQV|NLM (2008)|061206|CD 192 ANTIGENS|abbcdefs", "ENTRY": "Receptors, MCP-1", "MN": "D12.776.543.750.705.852.125.150.200", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "CCR receptors with specificity for CHEMOKINE CCL2 and several other CCL2-related chemokines. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; MACROPHAGES; BASOPHILS; and NK CELLS.", "PM": "2008; CCR2 RECEPTOR (now RECEPTORS, CCR2) was indexed under RECEPTORS, CHEMOKINE 1998-2006 & under RECEPTORS, CYTOKINE 1994-1997", "HN": "2008(1994)", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054390"}, {"RECTYPE": "D", "MH": "Lymphoma, Extranodal NK-T-Cell", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Extranodal NK-T-Cell Lymphoma|T191|NON|EQV|NLM (2008)|061206|abcdef", "ENTRY": "NK-T-Cell Lymphomas, Extranodal", "MN": "C04.557.386.480.750.199", "MH_TH": "NLM (2008)", "ST": "T191", "PI": "Lymphoma, T-Cell (1998-2007)", "MS": "An extranodal neoplasm, usually possessing an NK-cell phenotype and associated with EPSTEIN-BARR VIRUS. These lymphomas exhibit a broad morphologic spectrum, frequent necrosis, angioinvasion, and most commonly present in the midfacial region, but also in other extranodal sites.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054391"}, {"RECTYPE": "D", "MH": "Adipokines", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Adipocytokine|T116|T123|NON|EQV|NLM (2021)|200210|abbcdef", "ENTRY": "Adipokine|T116|T123|NON|EQV|NLM (2008)|061207|abbcdef", "MN": "D23.529.024", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Intercellular Signaling Peptides and Proteins (2003-2007)", "MS": "Polypeptides produced by the ADIPOCYTES. They include LEPTIN; ADIPONECTIN; RESISTIN; and many cytokines of the immune system, such as TUMOR NECROSIS FACTOR-ALPHA; INTERLEUKIN-6; and COMPLEMENT FACTOR D (also known as ADIPSIN). They have potent autocrine, paracrine, and endocrine functions.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054392"}, {"RECTYPE": "D", "MH": "Receptors, CCR3", "DS": "RECEPTORS CCR 003", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD193 Antigens|T116|T192|ABX|EQV|NLM (2008)|061207|CD 193 ANTIGENS|abbcdefs", "ENTRY": "Receptor, CCR3", "MN": "D12.776.543.750.705.852.125.150.300", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "CCR receptors with specificity for CHEMOKINE CCL11 and a variety of other CC CHEMOKINES. They are expressed at high levels in T-LYMPHOCYTES; EOSINOPHILS; BASOPHILS; and MAST CELLS.", "PM": "2008; CC CHEMOKINE RECEPTOR 3 (now RECEPTORS, CCR3) was indexed under RECEPTORS, CHEMOKINE 1996-2007", "HN": "2008(1996)", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054397"}, {"RECTYPE": "D", "MH": "Receptors, CCR4", "DS": "RECEPTORS CCR 004", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD194 Antigens|T116|T192|ABX|EQV|NLM (2008)|061207|CD 194 ANTIGENS|abbcdefs", "ENTRY": "Receptor, CCR4", "MN": "D12.776.543.750.705.852.125.150.400", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "CCR receptors with specificity for CHEMOKINE CCL17 and CHEMOKINE CCL22. They are expressed at high levels in T-LYMPHOCYTES; MAST CELLS; DENDRITIC CELLS; and NK CELLS.", "PM": "2008; CC CHEMOKINE RECEPTOR 4 (RECEPTORS, CCR4) was indexed under RECEPTORS, CHEMOKINE 1998-2007 & under RECEPTORS, CYTOKINE 1997-2007", "HN": "2008(1997)", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054398"}, {"RECTYPE": "D", "MH": "Receptors, CCR6", "DS": "RECEPTORS CCR 006", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD196 Antigens|T116|T192|ABX|EQV|NLM (2008)|061207|CD 196 ANTIGENS|abbcdefs", "ENTRY": "CC Chemokine Receptors 6|T116|T192|ABX|EQV|NLM (2008)|061207|abbcdef", "MN": "D12.776.543.750.705.852.125.150.600", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "PI": "Receptors, Chemokine (1996-2007)", "MS": "CCR receptors with specificity for CHEMOKINE CCL20. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; and DENDRITIC CELLS.", "PM": "2008", "HN": "2008", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054399"}, {"RECTYPE": "D", "MH": "Receptors, CCR7", "DS": "RECEPTORS CCR 007", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CD197 Antigens|T116|T192|ABX|EQV|NLM (2008)|061207|CD 197 ANTIGENS|abbcdefs", "ENTRY": "Antigen, CD197", "MN": "D12.776.543.750.705.852.125.150.700", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "CCR receptors with specificity for CHEMOKINE CCL19 and CHEMOKINE CCL21. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; and DENDRITIC CELLS.", "PM": "2008; CC CHEMOKINE RECEPTOR 7 (now RECEPTORS, CCR7) was indexed under RECEPTORS, CHEMOKINE 1998-2007", "HN": "2008(1998)", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054400"}, {"RECTYPE": "D", "MH": "Receptors, CCR8", "DS": "RECEPTORS CCR 008", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CDw198 Antigens|T116|T192|ABX|EQV|NLM (2008)|061208|CD 198 ANTIGENS W|abbcdefs", "MN": "D12.776.543.750.705.852.125.150.800", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "PI": "Chemokine Receptors (1990-2007)", "MS": "CCR receptors with specificity for CHEMOKINE CCL1. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; and MACROPHAGES.", "PM": "2008", "HN": "2008", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054401"}, {"RECTYPE": "D", "MH": "Chemokine CCL1", "DS": "CHEMOKINE CCL 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Chemokine, CCL1", "MN": "D23.529.374.200.110.050", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Chemokines, CC (1990-2007)", "MS": "A CC-type chemokine secreted by activated MONOCYTES and T-LYMPHOCYTES. It has specificity for CCR8 RECEPTORS.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054402"}, {"RECTYPE": "D", "MH": "Leukemia, Prolymphocytic, B-Cell", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "B-Cell Prolymphocytic Leukemia|T191|NON|EQV|NLM (2008)|061208|abcdef", "ENTRY": "Prolymphocytic Leukemias, B-Cell", "MN": "C20.683.515.528.565.745", "MH_TH": "NLM (2008)", "ST": "T191", "PI": "Leukemia, Prolymphocytic (1987-2007)", "MS": "A neoplasm of prolymphocytes affecting the blood, bone marrow, and spleen. It is characterized by prolymphocytes exceeding 55% of the lymphoid cells in the blood and profound splenomegaly.", "PM": "2008", "HN": "2008", "MR": "20230531", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054403"}, {"RECTYPE": "D", "MH": "Chemokine CCL3", "DS": "CHEMOKINE CCL 003", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chemokine CCL3L3|T116|T123|ABX|NRW|NLM (2008)|061211|CHEMOKINE CCL 003 L 03|abbcdefs", "ENTRY": "Macrophage Inflammatory Protein 1 alpha", "MN": "D23.529.374.200.600.150", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Chemokines, CC (1997-2007)", "MS": "A CC chemokine with specificity for CCR1 RECEPTORS and CCR5 RECEPTORS. It is a chemoattractant for NK CELLS; MONOCYTES; and a variety of other immune cells. This chemokine is encoded by multiple genes.", "PM": "2008; for MIP-1ALPHA see MACROPHAGE INFLAMMATORY PROTEIN-1 1997-2007, for BB-10010 see MACROPHAGE INFLAMMATORY PROTEIN-1 1998-2007", "HN": "2008; for MIP-1ALPHA use MACROPHAGE INFLAMMATORY PROTEIN-1 1997-2007, for BB-10010 use MACROPHAGE INFLAMMATORY PROTEIN-1 1998-2007", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054405"}, {"RECTYPE": "D", "MH": "Pseudomonas Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME MI PD PK PO RE SD ST TO TU UR VI", "ENTRY": "Vaccines, Pseudomonas", "MN": "D20.215.894.135.620", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "AN": "coordinate IM with Pseudomonas species /immunol (IM)", "PI": "Bacterial Vaccines (1967-2007)", "MS": "Vaccines or candidate vaccines used to prevent or treat PSEUDOMONAS INFECTIONS.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054406"}, {"RECTYPE": "D", "MH": "Chemokine CCL4", "DS": "CHEMOKINE CCL 004", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chemokine CCL4L2|T116|T123|ABX|NRW|NLM (2008)|061211|CHEMOKINE CCL 004 L 02|abbcdefs", "ENTRY": "Macrophage Inflammatory Protein 1beta2", "MN": "D23.529.374.200.600.200", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "PI": "Chemokines, CC (1996-2007)", "MS": "A CC chemokine with specificity for CCR5 RECEPTORS. It is a chemoattractant for NK CELLS; MONOCYTES and a variety of other immune cells. This chemokine is encoded by multiple genes.", "PM": "2008; for MIP-1BETA see MACROPHAGE INFLAMMATORY PROTEIN-1 1996-2007", "HN": "2008; for MIP-1BETA use MACROPHAGE INFLAMMATORY PROTEIN-1 1996-2007", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054407"}, {"RECTYPE": "D", "MH": "Nicotinamide Phosphoribosyltransferase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Visfatin|T116|T126|NON|EQV|NLM (2008)|061212|abbcdef", "ENTRY": "Pre B Cell Colony Enhancing Factor", "MN": "D08.811.913.400.725.575", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.4.2.12", "RR": "9030-27-7 (CRN)", "PI": "Pentosyltransferases (1972-2007)", "MS": "An enzyme that catalyzes the formation of nicotinamide mononucleotide (NMN) from nicotinamide and 5-phosphoribosyl-1-pyrophosphate, the rate-limiting step in the biosynthesis of the NAD coenzyme. It is also known as a growth factor for early B-LYMPHOCYTES, or an ADIPOKINE with insulin-mimetic effects (visfatin).", "PM": "2008; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE was indexed under PENTOSYLTRANSFERASES 1982-2007", "HN": "2008 (1982)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054409"}, {"RECTYPE": "D", "MH": "Chemokine CCL7", "DS": "CHEMOKINE CCL 007", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CCL7 Chemokine|T116|T129|ABX|EQV|NLM (2008)|060404|CCL 007 CHEMOKINE|abbcdefs", "ENTRY": "Monocyte Chemotactic Protein 3", "MN": "D23.529.374.200.110.990.750", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "MS": "A monocyte chemoattractant protein that has activity towards a broad variety of immune cell types. Chemokine CCL7 has specificity for CCR1 RECEPTORS; CCR2 RECEPTORS; and CCR5 RECEPTORS.", "PM": "2008; CCL7 CHEMOKINE was indexed under MONOCYTE CHEMOATTRACTANT PROTEINS 2007, under CYTOKINES 2005-2006 & under CHEMOKINES 1993-2004", "HN": "2008(1993)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054410"}, {"RECTYPE": "D", "MH": "Receptors, Leptin", "DE": "RECEPT LEPTIN", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "OB Receptor|T116|T192|ACX|EQV|NLM (2008)|061212|OB RECEPT|abbcdefv", "ENTRY": "Receptor, OBRb", "MN": "D12.776.543.750.650.500", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (1995-2007)", "MS": "Cell surface receptors for obesity factor (LEPTIN), a hormone secreted by the WHITE ADIPOCYTES. Upon leptin-receptor interaction, the signal is mediated through the JAK2/STAT3 pathway to regulate food intake, energy balance and fat storage.", "PM": "2008; LEPTIN RECEPTOR was indexed under RECEPTORS, CELL SURFACE 1996-2007", "HN": "2008 (1996)", "MR": "20160617", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054411"}, {"RECTYPE": "D", "MH": "Chemokine CCL8", "DS": "CHEMOKINE CCL 008", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CCL8 Chemokine|T116|T129|ABX|EQV|NLM (2008)|060404|CCL 008 CHEMOKINE|abbcdefs", "ENTRY": "Protein-2, Monocyte Chemotactic", "MN": "D23.529.374.200.110.990.875", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "MS": "A monocyte chemoattractant protein that attracts MONOCYTES; LYMPHOCYTES; BASOPHILS; and EOSINOPHILS. Chemokine CCL8 has specificity for CCR3 RECEPTORS and CCR5 RECEPTORS.", "PM": "2008; CHEMOKINE CCL8 (now CCL8 CHEMOKINE) was indexed under MONOCYTE CHEMOATTRACTANT PROTEINS 1993-2007", "HN": "2008(1993)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054412"}, {"RECTYPE": "D", "MH": "Chemokine CCL11", "DS": "CHEMOKINE CCL 011", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CCL11 Chemokine|T116|T123|ABX|EQV|NLM (2008)|060404|CCL 011 CHEMOKINE|abbcdefs", "ENTRY": "Eotaxin 1", "MN": "D23.529.374.200.110.550", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "MS": "A CC-type chemokine that is specific for CCR3 RECEPTORS. It is a potent chemoattractant for EOSINOPHILS.", "PM": "2008; CCL11 CHEMOKINE (now CHEMOKINE CCL11) was indexed under CHEMOKINES, CC 1994-2007", "HN": "2008(1994)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054413"}, {"RECTYPE": "D", "MH": "Chemokine CCL17", "DS": "CHEMOKINE CCL 017", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CCL17 Chemokine|T116|T123|ABX|EQV|NLM (2008)|061212|CCL 017 CHEMOKINE|abbcdefs", "ENTRY": "Thymus and Activation Regulated Chemokine", "MN": "D23.529.374.200.110.850", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Chemokines, CC (1998-2007)", "MS": "A CC-type chemokine that is found at high levels in the THYMUS and has specificity for CCR4 RECEPTORS. It is synthesized by DENDRITIC CELLS; ENDOTHELIAL CELLS; KERATINOCYTES; and FIBROBLASTS.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054414"}, {"RECTYPE": "D", "MH": "Chemokine CCL19", "DS": "CHEMOKINE CCL 019", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CCL19 Chemokine|T116|T129|ABX|EQV|NLM (2008)|060404|CCL 019 CHEMOKINE|abbcdefs", "ENTRY": "Macrophage Inflammatory Protein 3 beta", "MN": "D23.529.374.200.600.870", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "MS": "A CC-type chemokine with specificity for CCR7 RECEPTORS. It has activity towards T LYMPHOCYTES and B LYMPHOCYTES.", "PM": "2008; CCL19 CHEMOKINE (now CHEMOKINE CCL19) was indexed under CHEMOKINES CC 1998-2007 & under CHEMOKINES 1997", "HN": "2008(1998)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054415"}, {"RECTYPE": "D", "MH": "Receptors, Adipokine", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Adipokine Receptors|T116|T192|NON|EQV|NLM (2008)|061213|abbcdef", "MN": "D12.776.543.750.650", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (1995-2007)", "MS": "Cell surface receptors for ADIPOKINES, cytokines secreted by the ADIPOCYTES.", "PM": "2008", "HN": "2008", "MR": "20160617", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054417"}, {"RECTYPE": "D", "MH": "Chemokine CCL20", "DS": "CHEMOKINE CCL 020", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CCL20 Chemokine|T116|T123|ABX|EQV|NLM (2008)|061213|CCL 020 CHEMOKINE|abbcdefs", "ENTRY": "Exodus 1 Chemokine", "MN": "D23.529.374.200.600.880", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Chemokines, CC (1997-2007)", "MS": "A CC-type chemokine with specificity for CCR6 RECEPTORS. It has activity towards DENDRITIC CELLS; T-LYMPHOCYTES; and B-LYMPHOCYTES.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054418"}, {"RECTYPE": "D", "MH": "Receptors, Adiponectin", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Adiponectin Receptor|T116|T192|NON|EQV|NLM (2008)|061213|abbcdef", "ENTRY": "Receptor, Adiponectin", "MN": "D12.776.543.750.650.249", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (2003-2007)", "MS": "Cell surface receptors for ADIPONECTIN, an antidiabetic hormone secreted by ADIPOCYTES. Adiponectin receptors are membrane proteins with multiple cytoplasmic and extracellular regions. They are about 43 kDa and encoded by at least two genes with different affinities for globular and full-length adiponectin.", "PM": "2008", "HN": "2008", "MR": "20160617", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054419"}, {"RECTYPE": "D", "MH": "Pre-B Cell Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, Pre-B Cell", "MN": "D12.776.543.750.705.816.821.750", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "PI": "Receptors, Antigen, B-Cell (1995-2007)", "MS": "Membrane proteins in precursor B-LYMPHOCYTES (pre-B Cells). They are composed of membrane-bound MU IMMUNOGLOBULIN HEAVY CHAINS in complex with SURROGATE LIGHT CHAINS instead of conventional IMMUNOGLOBULIN LIGHT CHAINS. Only successful rearrangement of the VDJ segments, at the Ig heavy chain gene locus (IMMUNOGLOBULIN HEAVY CHAIN GENES), will generate mu heavy chains that can pair with surrogate light chains. Thus formation of the pre-B cell receptors is an important checkpoint in the development of mature B cells.", "PM": "2008", "HN": "2008", "MR": "20170630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054420"}, {"RECTYPE": "D", "MH": "Chemokine CCL21", "DS": "CHEMOKINE CCL 021", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CCL21 Chemokine|T116|T129|ABX|EQV|NLM (2008)|060404|CCL 021 CHEMOKINE|abbcdefs", "ENTRY": "Thymus Derived Chemotactic Agent 4", "MN": "D23.529.374.200.110.890", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "MS": "A CC-type chemokine with specificity for CCR7 RECEPTORS. It has activity towards DENDRITIC CELLS and T-LYMPHOCYTES.", "PM": "2008; CCL21 CHEMOKINE (now CHEMOKINE CCL21) was indexed under CHEMOKINES, CC 1998-2007", "HN": "2008(1998)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054421"}, {"RECTYPE": "D", "MH": "Chemokine CCL22", "DS": "CHEMOKINE CCL 022", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CCL22 Chemokine|T116|T129|ABX|EQV|NLM (2008)|011019|CCL 022 CHEMOKINE|abbcdefs", "ENTRY": "STCP-1, CC Chemokine", "MN": "D23.529.374.200.110.900", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "MS": "A CC-type chemokine with specificity for CCR4 RECEPTORS. It has activity towards TH2 CELLS and TC2 CELLS.", "PM": "2008; CCL22 CHEMOKINE (now CHEMOKINE CCL22) was indexed under CHEMOKINES, CC 1998-2007", "HN": "2008(1998)", "MR": "20130709", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054422"}, {"RECTYPE": "D", "MH": "Chemokine CCL24", "DS": "CHEMOKINE CCL 024", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CCL24 Chemokine|T116|T123|ABX|EQV|NLM (2008)|060404|CCL 024 CHEMOKINE|abbcdefs", "ENTRY": "Eotaxin 2", "MN": "D23.529.374.200.110.910", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "MS": "A CC-type chemokine with specificity for CCR3 RECEPTORS. It is a chemoattractant for EOSINOPHILS.", "PM": "2008; CCL24 CHEMOKINE (now CHEMOKINE CCL24) was indexed under CHEMOKINES, CC 1998-2007 & under CHEMOKINES 1997", "HN": "2008(1997)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054423"}, {"RECTYPE": "D", "MH": "Chemokine CCL27", "DS": "CHEMOKINE CCL 027", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CCL27 Chemokine|T116|T123|ABX|EQV|NLM (2008)|061214|CCL 027 CHEMOKINE|abbcdefs", "ENTRY": "T-Cell-Attracting Chemokine, Cutaneous", "MN": "D23.529.374.200.110.930", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Chemokines, CC (1999-2007)", "MS": "A CC-type chemokine with specificity for CCR10 RECEPTORS. It is constitutively expressed in the skin and may play a role in T-CELL trafficking during cutaneous INFLAMMATION.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054425"}, {"RECTYPE": "D", "MH": "Chemokine CXCL2", "DS": "CHEMOKINE CXCL 002", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CXCL2 Chemokine|T116|T123|ABX|EQV|NLM (2008)|061214|CXCL 002 CHEMOKINE|abbcdefs", "ENTRY": "Macrophage Inflammatory Protein 2alpha", "MN": "D23.529.374.200.600.940", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "MS": "A CXC chemokine that is synthesized by activated MONOCYTES and NEUTROPHILS. It has specificity for CXCR2 RECEPTORS.", "PM": "2008; MACROPHAGE INFLAMMATORY PROTEIN 2 (now CHEMOKINE CXCL2) was indexed under MONOKINES 1997-2007, under CYTOKINES 1991-1996 & under PROTEINS 1990", "HN": "2008(1990)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054426"}, {"RECTYPE": "D", "MH": "Chemokine CXCL6", "DS": "CHEMOKINE CXCL 006", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "CXCL6 Chemokine|T116|T123|ABX|EQV|NLM (2008)|061214|CXCL 006 CHEMOKINE|abbcdefs", "ENTRY": "Granulocyte Chemotactic Protein 2", "MN": "D23.529.374.200.120.300", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "MS": "A CXC chemokine that has stimulatory and chemotactic activities towards NEUTROPHILS. It has specificity for CXCR1 RECEPTORS and CXCR2 RECEPTORS.", "PM": "2008; CXCL6 CHEMOKINE was indexed under CHEMOKINES, CXC 1998-2007; under CHEMOKINES 1996-1997 & under CYTOKINES 1993-1995", "HN": "2008(1993)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054427"}, {"RECTYPE": "D", "MH": "Chemokine CX3CL1", "DS": "CHEMOKINE CXXXC L 01", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Chemokine (C-X3-C Motif) Ligand 1|T116|T123|NON|EQV|NLM (2008)|061011|CHEMOKINE CXXXC MOTIF LIGAND 01|abbcdefs", "ENTRY": "Chemokine, CX3CL1", "MN": "D23.529.374.200.130.500", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "MS": "A CX3C chemokine that is a transmembrane protein found on the surface of cells. The soluble form of chemokine CX3CL1 can be released from cell surface by proteolysis and act as a chemoattractant that may be involved in the extravasation of leukocytes into inflamed tissues. The membrane form of the protein may also play a role in cell adhesion.", "PM": "2008; CHEMOKINE (C-X3-C MOTIF) LIGNAND 1 (now CHEMOKINE CX2CL1) was indexed under CHEMOKINES, CX3C 2002-2007, under CHEMOKINES, CXC 1997-2001 & under CHEMOKINES 1997", "HN": "2008(1997)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054428"}, {"RECTYPE": "D", "MH": "Leukemia, Myelomonocytic, Juvenile", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Juvenile Myelomonocytic Leukemia|T191|NON|EQV|NLM (2008)|OMIM (2013)|ORD (2010)|061215|abcdeeef", "ENTRY": "Myelomonocytic Leukemias, Juvenile", "MN": "C15.378.508.539.525", "MH_TH": "NLM (2008)", "ST": "T191", "MS": "A leukemia affecting young children characterized by SPLENOMEGALY, enlarged lymph nodes, rashes, and hemorrhages. Traditionally classed as a myeloproliferative disease, it is now considered a mixed myeloproliferative-mylelodysplastic disorder.", "PM": "2008", "HN": "2008", "MR": "20230531", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054429"}, {"RECTYPE": "D", "MH": "Myelodysplastic-Myeloproliferative Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myeloproliferative-Myelodisplastic Diseases|T191|NON|EQV|NLM (2008)|061218|abcdef", "ENTRY": "Myeloproliferative-Myelodisplastic Disease", "MN": "C15.378.190.615", "MH_TH": "NLM (2008)", "ST": "T191", "PI": "Myeloproliferative Disorders (1984-2007)", "MS": "Clonal myeloid disorders that possess both dysplastic and proliferative features but are not properly classified as either MYELODYSPLASTIC SYNDROMES or MYELOPROLIFERATIVE DISORDERS.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054437"}, {"RECTYPE": "D", "MH": "Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myeloid Leukemia, Philadelphia-Negative|T191|NON|EQV|UNK (19XX)|880609|abcdef", "ENTRY": "Philadelphia-Negative Myeloid Leukemias", "MN": "C23.550.291.500.493", "MH_TH": "NLM (2008)", "ST": "T191", "PI": "Leukemia, Myeloid, Chronic (1987-2007)", "MS": "A myelodysplastic/myeloproliferative disorder characterized by myelodysplasia associated with bone marrow and peripheral blood patterns similar to CHRONIC MYELOID LEUKEMIA, but cytogenetically lacking a PHILADELPHIA CHROMOSOME or bcr/abl fusion gene (GENES, ABL).", "PM": "2008", "HN": "2008", "MR": "20230531", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054438"}, {"RECTYPE": "D", "MH": "Ghrelin", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Precursor, Motilin-Related Peptide", "MN": "D12.644.548.322", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Peptide Hormones (1999-2007)", "MS": "A 28-amino acid, acylated, orexigenic peptide that is a ligand for GROWTH HORMONE SECRETAGOGUE RECEPTORS. Ghrelin is widely expressed but primarily in the stomach in the adults. Ghrelin acts centrally to stimulate growth hormone secretion and food intake, and peripherally to regulate energy homeostasis. Its large precursor protein, known as appetite-regulating hormone or motilin-related peptide, contains ghrelin and obestatin.", "PM": "2008; GHRELIN was indexed under PEPTIDE HORMONES 2000-2007", "HN": "2008 (2000)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054439"}, {"RECTYPE": "D", "MH": "Receptors, Ghrelin", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Growth Hormone Secretagogue Receptors|T116|T192|NON|EQV|NLM (2008)|061219|abbcdef", "ENTRY": "Receptor, Ghrelin", "MN": "D12.776.543.750.695.322", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "PI": "Receptors, G-Protein-Coupled (1996-2007)", "MS": "Transmembrane proteins that recognize and bind GHRELIN, a potent stimulator of GROWTH HORMONE secretion and food intake in mammals. Ghrelin receptors are found in the pituitary and HYPOTHALAMUS. They belong to the family of G-PROTEIN-COUPLED RECEPTORS.", "PM": "2008; GROWTH HORMONE SECRETAGOGUE RECEPTOR was indexed under RECEPTORS, G-PROTEIN-COUPLED 1999-2007", "HN": "2008 (1999)", "MR": "20160617", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054440"}, {"RECTYPE": "D", "MH": "Cell Migration Assays, Leukocyte", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Migration Inhibitory Tests, Leukocyte|T059|NON|NRW|NLM (1990)|890417|MIGRATION INHIB TESTS LEUKOCYTE|abcdefv", "ENTRY": "Test, Leukocyte Migration", "MN": "E05.478.594.122.500", "MH_TH": "NLM (2008)", "ST": "T059", "PI": "Cell Migration Inhibition (1989-2007)", "MS": "Assays that measure the rate of migration of LEUKOCYTES. They may involve a variety of techniques such as measuring the movement of leukocytes through substrates such as AGAROSE gels or the rate of exit of cells from a glass capillary.", "PM": "2008; for LEUKOCYTE MIGRATION TEST see CELL MIGRATION INHIBITION 1989-2007", "HN": "2008; for LEUKOCYTE MIGRATION TEST use CELL MIGRATION INHIBITION 1989-2007", "MR": "20150601", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054441"}, {"RECTYPE": "D", "MH": "Cell Migration Assays, Macrophage", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Macrophage Migration Test|T059|NON|EQV|UNK (19XX)|880414|abcdef", "ENTRY": "Tests, Macrophage Migration", "MN": "E05.478.594.122.750", "MH_TH": "NLM (2008)", "ST": "T059", "PI": "Cell Migration Inhibition (1988-2007)", "MS": "Assays that measure the rate of migration of MACROPHAGES. They may involve the use hollow plastic chamber, sealed at one end with a porous membrane and suspended over a larger well which may contain CHEMOTACTIC FACTORS. The migration of cell through the pores to the other side of the membrane is measured.", "PM": "2008; for MACROPHAGE MIGRATION TEST see CELL MIGRATION INHIBITION 1988-2007", "HN": "2008; for MACROPHAGE MIGRATION TEST use CELL MIGRATION INHIBITION 1988-2007", "MR": "20150601", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054442"}, {"RECTYPE": "D", "MH": "Cell Migration Assays", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Motility Assays, Cell", "MN": "E05.478.594.122", "MH_TH": "NLM (2008)", "ST": "T059", "AN": "not for microorganisms", "MS": "Specific assays that measure the migration of cells. They are commonly used to measure the migration of immune cells in response to stimuli and the inhibition of immune cell migration by immunosuppressive factors.", "PM": "2008", "HN": "2008", "MR": "20150601", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054443"}, {"RECTYPE": "D", "MH": "Immunoglobulin Light Chains, Surrogate", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Surrogate Light Chains|T116|T129|NON|EQV|NLM (2008)|060802|abbcdef", "ENTRY": "lambda5 Peptide, Immunoglobulin Light Chain Like", "MN": "D12.776.543.750.705.816.821.750.500", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "PI": "Immunoglobulin Light Chains (1991-2007)", "MS": "An immunolglobulin light chain-like protein composed of an IMMUNOGLOBULIN VARIABLE REGION-like peptide (such as light chain like lambda5 peptide) and an IMMUNOGLOBULIN CONSTANT REGION-like peptide (such as Vpreb1 peptide). Surrogate light chains associate with MU IMMUNOGLOBULIN HEAVY CHAINS in place of a conventional immunoglobulin light chains to form pre-B cell receptors.", "PM": "2008", "HN": "2008", "MR": "20170630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054444"}, {"RECTYPE": "D", "MH": "Facial Transplantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Transplants, Facial", "MN": "E04.936.864.850.249", "MH_TH": "NLM (2008)", "ST": "T061", "AN": "for facial skin flaps coordinate FACE or specifics with SKIN TRANSPLANTATION", "MS": "The transference between individuals of the entire face or major facial structures. In addition to the skin and cartilaginous tissue (CARTILAGE), it may include muscle and bone as well.", "PM": "2008", "HN": "2008", "MR": "20220408", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054445"}, {"RECTYPE": "D", "MH": "Lymphoma, Primary Cutaneous Anaplastic Large Cell", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Primary Cutaneous CD30 positive Large T Cell Lymphoma", "MN": "C20.683.515.761.480.750.800.507", "MH_TH": "NLM (2008)", "ST": "T191", "AN": "coordinate IM with SKIN NEOPLASMS (IM)", "MS": "Anaplastic lymphoma of the skin which develops as a primary neoplasm expressing the CD30 ANTIGEN. It is characterized by solitary nodules or ulcerated tumors.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054446"}, {"RECTYPE": "D", "MH": "Receptors, CCR10", "DS": "RECEPTORS CCR 010", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "CCR10 Receptors|T116|T123|ABX|EQV|NLM (2008)|061226|CCR 010 RECEPTORS|abbcdefs", "ENTRY": "Receptor, CCR10", "MN": "D12.776.543.750.705.852.125.150.950", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "MS": "CCR receptors with specificity for CHEMOKINE CCL27. They may play a specialized role in the cutaneous homing of LYMPHOCYTES.", "PM": "2008; CHEMOKINE RECEPTOR 10 (now RECEPTORS, CCR10) was indexed under RECEPTORS, CHEMOKINE 1997-2007", "HN": "2008(1997)", "MR": "20170524", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054447"}, {"RECTYPE": "D", "MH": "Precursor Cells, B-Lymphoid", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Transitional B-Lymphocytes|T025|NON|EQV|NLM (2008)|061226|abcdef", "ENTRY": "Transitional B Lymphocytes", "MN": "A11.872.378.294.500", "MH_TH": "NLM (2008)", "ST": "T025", "PI": "B-Lymphocytes (1979-2007)", "MS": "Lymphocyte progenitor cells that are restricted in their differentiation potential to the B lymphocyte lineage. The pro-B cell stage of B lymphocyte development precedes the pre-B cell stage.", "PM": "2008", "HN": "2008", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054448"}, {"RECTYPE": "D", "MH": "Tissue Scaffolds", "AQ": "AE CH CL EC HI MI PS SD SN ST TD VE VI", "ENTRY": "Tissue Scaffoldings", "MN": "E07.695.825", "FX": "Absorbable Implants", "MH_TH": "NLM (2008)", "ST": "T074", "MS": "Cell growth support structures composed of BIOCOMPATIBLE MATERIALS. They are specially designed solid support matrices for cell attachment in TISSUE ENGINEERING and GUIDED TISSUE REGENERATION uses.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054457"}, {"RECTYPE": "D", "MH": "Amplified Fragment Length Polymorphism Analysis", "AQ": "CL DE EC HI IS MT RE SN ST TD VE", "PRINT ENTRY": "AFLP Analysis|T063|ACX|EQV|NLM (2008)|061228|abcdef", "ENTRY": "Analysis, AFLP", "MN": "E05.393.620.500.324", "FX": "Polymorphism, Restriction Fragment Length", "MH_TH": "NLM (2008)", "ST": "T063", "MS": "The detection of RESTRICTION FRAGMENT LENGTH POLYMORPHISMS by selective PCR amplification of restriction fragments derived from genomic DNA followed by electrophoretic analysis of the amplified restriction fragments.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054458"}, {"RECTYPE": "D", "MH": "Elasticity Imaging Techniques", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Vibro-Acoustographies", "MN": "E01.370.350.850.270", "MH_TH": "NLM (2008)", "ST": "T060", "AN": "coordinate with specific technique for elasticity imaging techniques other than ultrasonography", "PI": "Elasticity (1993-2007)", "MS": "Non-invasive imaging methods based on the mechanical response of an object to a vibrational or impulsive force. It is used for determining the viscoelastic properties of tissue, and thereby differentiating soft from hard inclusions in tissue such as microcalcifications, and some cancer lesions. Most techniques use ultrasound to create the images - eliciting the response with an ultrasonic radiation force and/or recording displacements of the tissue by Doppler ultrasonography.", "PM": "2008", "HN": "2008", "MR": "20110624", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054459"}, {"RECTYPE": "D", "MH": "rho-Associated Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rho-Associated Kinase|T116|T126|NON|EQV|NLM (2008)|abbcde", "ENTRY": "rho Kinase", "MN": "D12.776.476.563.814", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.1", "RR": "EC 2.7.11.1", "MS": "A group of intracellular-signaling serine threonine kinases that bind to RHO GTP-BINDING PROTEINS. They were originally found to mediate the effects of rhoA GTP-BINDING PROTEIN on the formation of STRESS FIBERS and FOCAL ADHESIONS. Rho-associated kinases have specificity for a variety of substrates including MYOSIN-LIGHT-CHAIN PHOSPHATASE and LIM KINASES.", "PM": "2008; RHO-ASSOCIATED KINASES was indexed under PROTEIN-SERINE-THREONINE KINASES & INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 1996-2007", "HN": "2008", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054460"}, {"RECTYPE": "D", "MH": "Lim Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "LIM Motif Containing Protein Kinases", "MN": "D12.776.512.124", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "Serine protein kinases involved in the regulation of ACTIN polymerization and MICROTUBULE disassembly. Their activity is regulated by phosphorylation of a threonine residue within the activation loop by intracellular signaling kinases such as P21-ACTIVATED KINASES and by RHO KINASE.", "PM": "2008; LIM KINASES was indexed under PROTEIN KINASES 1995-2007", "HN": "2008", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054461"}, {"RECTYPE": "D", "MH": "p21-Activated Kinases", "DS": "P A 021 ACTIVATED KINASES", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "p21-Activated Kinase|T116|T126|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "p21-Activated Kinase, beta", "MN": "D12.776.476.563.596", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.1", "RR": "EC 2.7.11.1", "PI": "Protein-Serine-Threonine Kinases (1995-2007)", "MS": "A family of serine-threonine kinases that bind to and are activated by MONOMERIC GTP-BINDING PROTEINS such as RAC GTP-BINDING PROTEINS and CDC42 GTP-BINDING PROTEIN. They are intracellular signaling kinases that play a role the regulation of cytoskeletal organization.", "PM": "2008; P21-ACTIVATED KINASE 1, P21-ACTIVATED KINASE 2 & P21-ACTIVATED KINASE 3 were indexed under PROTEIN-SERINE-THREONINE KINASES 1995-2007", "HN": "2008", "MR": "20210628", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054462"}, {"RECTYPE": "D", "MH": "Trichothiodystrophy Syndromes", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Trichothiodystrophy Syndrome", "MN": "C17.800.827.895", "FX": "Xeroderma Pigmentosum Group D Protein", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Hair Diseases (1980-2007)", "MS": "Autosomal recessive neuroectodermal disorders characterized by brittle sulfur-deficient hair associated with impaired intellect, decreased fertility, and short stature. It may include nail dystrophy, ICHTHYOSIS, and photosensitivity correlated with a NUCLEOTIDE EXCISION REPAIR defect. All individuals with this disorder have a deficiency of cysteine-rich KERATIN-ASSOCIATED PROTEINS found in the interfilamentous matrix. Photosensitive trichothiodystrophy can be caused by mutation in at least 2 separate genes: ERCC2 PROTEIN gene and the related ERCC3. Nonphotosensitive trichothiodystrophy can be caused by mutation in the TTDN1 gene.", "PM": "2008", "HN": "2008", "MR": "20160610", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054463"}, {"RECTYPE": "D", "MH": "Peroxiredoxins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peroxiredoxin|T116|T126|NON|EQV|NLM (2008)|991203|abbcdef", "ENTRY": "Thioredoxin Dependent Peroxide Reductase 2", "MN": "D08.811.682.732.850", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 1.11.1.15", "RR": "EC 1.11.1.15", "MS": "A family of ubiquitously-expressed peroxidases that play a role in the reduction of a broad spectrum of PEROXIDES like HYDROGEN PEROXIDE; LIPID PEROXIDES and peroxinitrite. They are found in a wide range of organisms, such as BACTERIA; PLANTS; and MAMMALS. The enzyme requires the presence of a thiol-containing intermediate such as THIOREDOXIN as a reducing cofactor.", "PM": "2008; PEROXIDOXIN (now PEROXIDOXINS) was indexed under PEROXIDASES 2000-2007 & under OXIDOREDUCTASES 1988-1999; PEROXIREDOXIN IV was indexed under PEROXIDASES 2000-2007", "HN": "2008(1988)", "MR": "20110624", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054464"}, {"RECTYPE": "D", "MH": "Peroxiredoxin VI", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peroxiredoxin 6|T116|T126|NON|EQV|NLM (2008)|070105|abbcdef", "MN": "D08.811.682.732.850.500", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 1.11.1.15", "RR": "EC 3.1.1.4", "PI": "Peroxiredoxins (1999-2007)", "MS": "A peroxiredoxin that is a cytosolic bifunctional enzyme. It functions as a peroxiredoxin via a single redox-active cysteine and also contains a Ca2+-independent acidic phospholipase A2 activity.", "PM": "2008; PEROXIREDOXIN 6 (now PEROXIREDOXIN VI) was indexed under PEROXIDASES 2007", "HN": "2008", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054465"}, {"RECTYPE": "D", "MH": "Phospholipases A1", "DS": "PHOSPHOLIPASES A 01", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lecithinase A1|T116|T126|NON|EQV|UNK (19XX)|790222|LECITHINASE A 01|abbcdefs", "ENTRY": "Phosphatidate 1 Acylhydrolase", "MN": "D08.811.277.352.100.680.750.875", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.32", "PI": "Phospholipases A (1980-2007)", "MS": "A phospholipase that hydrolyzes the acyl group attached to the 1-position of PHOSPHOGLYCERIDES.", "PM": "2008; see PHOSPHOLIPASES A 1980-2007", "HN": "2008; use PHOSPHOLIPASES A 1980-2007", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054466"}, {"RECTYPE": "D", "MH": "Phospholipases A2", "DS": "PHOSPHOLIPASES A 02", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lecithinase A2|T116|T126|NON|EQV|UNK (19XX)|790222|LECITHINASE A 02|abbcdefs", "ENTRY": "Phospholipase A2|T116|T126|NON|EQV|UNK (19XX)|790222|abbcdef", "MN": "D08.811.277.352.100.680.750.937", "EC": "antagonists & inhibitors:Phospholipase A2 Inhibitors", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.4", "AN": "general; prefer specifics", "PI": "Phospholipases (1980-2007)", "MS": "Phospholipases that hydrolyze the acyl group attached to the 2-position of PHOSPHOGLYCERIDES.", "PM": "2008; see PHOSPHOLIPASES A 1980-2007", "HN": "2008; use PHOSPHOLIPASES A 1980-2007", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054467"}, {"RECTYPE": "D", "MH": "Axoneme", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Axonemes|T026|NON|EQV|NLM (2008)|070108|abcdef", "MN": "A11.284.430.214.190.750.602.309", "MH_TH": "NLM (2008)", "ST": "T026", "PI": "Flagella (1972-2007)", "MS": "A bundle of MICROTUBULES and MICROTUBULE-ASSOCIATED PROTEINS forming the core of each CILIUM or FLAGELLUM. In most eukaryotic cilia or flagella, an axoneme shaft has 20 microtubules arranged in nine doublets and two singlets.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054468"}, {"RECTYPE": "D", "MH": "Glutaredoxins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Glutaredoxin|T116|T126|NON|EQV|NLM (2008)|abbcde", "ENTRY": "Thioltransferase 1", "MN": "D08.811.682.667.084", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "0", "MS": "A family of thioltransferases that contain two active site CYSTEINE residues, which either form a disulfide (oxidized form) or a dithiol (reduced form). They function as an electron carrier in the GLUTHIONE-dependent synthesis of deoxyribonucleotides by RIBONUCLEOTIDE REDUCTASES and may play a role in the deglutathionylation of protein thiols. The oxidized forms of glutaredoxins are directly reduced by the GLUTATHIONE.", "PM": "2008; GLUTAREDOXINS were indexed under OXIDOREDUCTASES 2005-2007 & under PROTEINS 1979-2004; THIOLTRANSFERASE was indexed under SULFHYDRYL COMPOUNDS 1978-1981; under OXIDOREDUCTASES 1982-2004 & under PROTEIN DISULFIDE REDUCTASE (GLUTATHIONE) 2005-2007", "HN": "2008(1980); use PROTEINS 1979", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054477"}, {"RECTYPE": "D", "MH": "Chloroplast Thioredoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Thioredoxins, Chloroplast", "MN": "D12.776.915.249", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Thioredoxins (1985-2007)", "MS": "A subtype of thioredoxins found primarily in CHLOROPLASTS.", "PM": "2008; for THIOREDOXIN M see THIOREDOXINS 1986-2007; THIOREDOXIN F was indexed under THIOREDOXINS 1996-2007 & under PLANT PROTEINS 1982-1995", "HN": "2008; for THIOREDOXIN M use THIOREDOXINS 1986-2007", "MR": "20150622", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054479"}, {"RECTYPE": "D", "MH": "Thioredoxin h", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Thioredoxin h3|T116|T123|NON|NRW|NLM (2008)|070111|abbcdef", "MN": "D12.776.915.624", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "MS": "A thioredoxin subtype that is ubiquitously found in the plant kingdom. It reduces a variety of seed storage proteins and may play a role in the germination process of seeds.", "PM": "2008; THIOREDOXIN H was indexed under THIOREDOXINS and PLANT PROTEINS 1991-2007", "HN": "2008(1991)", "MR": "20130709", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054480"}, {"RECTYPE": "D", "MH": "Thioredoxin Reductase 1", "DS": "THIOREDOXIN REDUCTASE 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase 1, Thioredoxin", "MN": "D08.811.682.667.750.500", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 1.8.1.9", "MS": "A subtype of thioredoxin reductase found primarily in the CYTOSOL.", "PM": "2008; THIOREDOXIN REDUCTASE 1 was indexed under THIOREDOXIN REDUCTASE (NADPH) 2000-2007", "HN": "2008(2000)", "MR": "20160628", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054481"}, {"RECTYPE": "D", "MH": "Thioredoxin Reductase 2", "DS": "THIOREDOXIN REDUCTASE 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Reductase 2, Thioredoxin", "MN": "D08.811.682.667.750.750", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 1.8.1.9", "MS": "A subtype of thioredoxin reductase found primarily in MITOCHONDRIA.", "PM": "2008; THIOREDOXIN 2 was indexed under THIOREDOXIN REDUCTASE (NADPH) 2003-2007", "HN": "2008(2003)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054482"}, {"RECTYPE": "D", "MH": "Phospholipases A2, Secretory", "DS": "PHOSPHOLIPASES A 02 SECRETORY", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "sPLA2|T116|T126|NON|EQV|NLM (2021)|200623|abbcdef", "ENTRY": "Secretory Phospholipases A2", "MN": "D08.811.277.352.100.680.750.937.750", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.4", "AN": "/antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS", "PI": "Phospholipases A (1980-2007)", "MS": "A subcategory of phospholipases A2 that are secreted from cells. They are 14 kDa proteins containing multiple disulfide-bonds and access their substrate via an interfacial binding site that interacts with phospholipid membranes. In addition specific PHOSPHOLIPASE A2 RECEPTORS can bind to and internalize the enzymes.", "PM": "2008; SECRETORY PHOSPHOLIPASE A2 was indexed under PHOSPHOLIPASES A 1998-2007", "HN": "2008", "MR": "20200625", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054497"}, {"RECTYPE": "D", "MH": "Group I Phospholipases A2", "DS": "GROUP I PHOSPHOLIPASES A 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phospholipases A2, Group I|T116|T126|NON|EQV|NLM (2008)|070117|PHOSPHOLIPASES A 02 GROUP I|abbcdefs", "MN": "D08.811.277.352.100.680.750.937.750.100", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.4", "AN": "/antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS", "PI": "Phospholipases A (1980-2007)", "MS": "A subcategory of secreted phospholipases A2 that includes enzymes isolated from ELAPID VENOMS and pancreatic sources. The creation of this group is based upon similarities in the structural determinants of the enzymes.", "PM": "2008", "HN": "2008", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054498"}, {"RECTYPE": "D", "MH": "Group IA Phospholipases A2", "DS": "GROUP IA PHOSPHOLIPASES A 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phospholipases A2, Group IA|T116|T126|NON|EQV|NLM (2008)|070117|PHOSPHOLIPASES A 02 GROUP IA|abbcdefs", "MN": "D08.811.277.352.100.680.750.937.750.100.500", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.4", "AN": "/antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS", "PI": "Phospholipases A (1980-2007)", "MS": "A subclass of group I phospholipases A2 that includes enzymes isolated from ELAPID VENOMS.", "PM": "2008", "HN": "2008", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054499"}, {"RECTYPE": "D", "MH": "Group IB Phospholipases A2", "DS": "GROUP IB PHOSPHOLIPASES A 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phospholipases A2, Group IB|T116|T126|NON|EQV|NLM (2008)|070117|PHOSPHOLIPASES A 02 GROUP IB|abbcdefs", "ENTRY": "sPLA2-IB|T116|T126|ABB|EQV|NLM (2008)|020703|abbcdef", "MN": "D08.811.277.352.100.680.750.937.750.100.750", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.4", "AN": "/antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS", "MS": "A subclass of group I phospholipases A2 that includes enzymes isolated from PANCREATIC JUICE. Members of this group have specificity for PHOSPHOLIPASE A2 RECEPTORS.", "PM": "2008; GROUP IB SECRETORY PHOSPHOLIPASE A2 (now GROUP IB PHOSPHOLIPASES A2) was indexed under PHOSPHOLIPASES A 2002-2007", "HN": "2008(2002)", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054500"}, {"RECTYPE": "D", "MH": "Group II Phospholipases A2", "DS": "GROUP II PHOSPHOLIPASES A 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phospholipases A2, Group II|T116|T126|NON|EQV|NLM (2008)|070117|PHOSPHOLIPASES A 02 GROUP II|abbcdefs", "ENTRY": "Phospholipase A2 II", "MN": "D08.811.277.352.100.680.750.937.750.550", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.4", "RR": "EC 3.1.1.4", "AN": "/antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS", "MS": "A subcategory of secreted phospholipases A2 that includes enzymes isolated from a variety of sources. The creation of this group is based upon similarities in the structural determinants of the enzymes including a negatively charged carboxy-terminal segment.", "PM": "2008; GROUP II SECRETORY PHOSPHOLIPASE A2 (now GROUP II PHOSPHOLIPASES A2) was indexed under PHOSPHOLIPASES A 1998-2007; PHOSPHOLIPASE A2-II was indexed under PHOSPHOLIPASES A 1994-2006", "HN": "2008(1994)", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054501"}, {"RECTYPE": "D", "MH": "Histocompatibility, Maternal-Fetal", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Maternal-Fetal Histocompatibility|T080|NON|EQV|NLM (2008)|070118|abcdef", "ENTRY": "Maternal Fetal Immunocompatibility", "MN": "G12.875.519.500", "MH_TH": "NLM (2008)", "ST": "T080", "PI": "Maternal-Fetal Exchange (1966-2007)", "MS": "The degree of antigenic similarity between tissues of the mother and those of the FETUS. Maternal-fetal histocompatibility can determine the acceptance and health of the fetus.", "PM": "2008", "HN": "2008", "MR": "20160623", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054502"}, {"RECTYPE": "D", "MH": "Lymphoid Progenitor Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Stem Cell, Lymphoid", "MN": "A15.378.316.378.550", "MH_TH": "NLM (2008)", "ST": "T025", "PI": "Hematopoietic Stem Cells (1982-2007)", "MS": "Stem cells from which B-LYMPHOCYTES; T-LYMPHOCYTES; NATURAL KILLER CELLS; and some DENDRITIC CELLS derive.", "PM": "2008", "HN": "2008", "MR": "20160610", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054503"}, {"RECTYPE": "D", "MH": "Precursor Cells, T-Lymphoid", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "T-Lymphoid Precursor Cells", "MN": "A11.872.378.294.750", "MH_TH": "NLM (2008)", "ST": "T025", "PI": "T-Lymphocytes (1973-2007)", "MS": "Lymphocyte progenitor cells that are restricted in their differentiation potential to the T lymphocyte lineage.", "PM": "2008", "HN": "2008", "MR": "20160610", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054504"}, {"RECTYPE": "D", "MH": "Group V Phospholipases A2", "DS": "GROUP V PHOSPHOLIPASES A 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phospholipases A2, Group V|T116|T126|NON|EQV|NLM (2008)|070129|PHOSPHOLIPASES A 02 GROUP V|abbcdefs", "ENTRY": "Group V sPLA2|T116|T126|ABX|EQV|NLM (2008)|010105|abbcdef", "MN": "D08.811.277.352.100.680.750.937.750.775", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.4", "AN": "/antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS", "MS": "A subcategory of secreted phospholipases A2 that contains both a negatively charged carboxy-terminal segment and interfacial-binding region specific for PHOSPHATIDYL CHOLINE-containing membranes. This enzyme group may play a role in the release of ARACHIDONIC ACID from phospholipid membranes.", "PM": "2008; GROUP V SECRETORY PHOSPHOLIPASE A2 was indexed under PHOSPHOLIPASES A 2001-2007", "HN": "2008(2001)", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054505"}, {"RECTYPE": "D", "MH": "Chloracne", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Chlorine Acnes", "MN": "C17.800.030.575", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Dermatitis, Occupational (1964-2007)", "MS": "ACNE-like skin eruptions caused by exposure to CHLORINE-containing compounds. Exposure can be by inhalation, ingestion, or through the skin. Chloracne is often seen in people who have occupational contact with chlorinated pesticides, wood preservatives, and sealants.", "PM": "2008", "HN": "2008", "MR": "20150622", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054506"}, {"RECTYPE": "D", "MH": "Receptors, Phospholipase A2", "DS": "RECEPTORS PHOSPHOLIPASE A 02", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Phospholipase A2 Receptor|T116|T192|NON|EQV|NLM (2008)|PHOSPHOLIPASE A 02 RECEPTOR|abbcdes", "ENTRY": "Receptor, Phospholipase A2|T116|T192|NON|EQV|NLM (2008)|abbcde", "MN": "D12.776.543.750.783", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "MS": "Cell surface receptors that bind to and internalize SECRETED PHOSPHOLIPASES A2. Although primarily acting as scavenger receptors, these proteins may also play a role in intracellular signaling. Soluble forms of phospholipase A2 receptors occur through the action of proteases and may a play a role in the inhibition of extracellular phospholipase activity.", "PM": "2008; PHOSPHOLIPASE A2 RECEPTOR (now RECEPTORS, PHOSPHOLIPASE A2) was indexed under RECEPTORS, CELL SURFACE 1994-2007", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054507"}, {"RECTYPE": "D", "MH": "Acute Radiation Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Radiation Syndromes, Acute", "MN": "N06.850.810.300.360.158", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Radiation Injuries (1963-2007)", "MS": "A condition caused by a brief whole body exposure to more than one sievert dose equivalent of radiation. Acute radiation syndrome is initially characterized by ANOREXIA; NAUSEA; VOMITING; but can progress to hematological, gastrointestinal, neurological, pulmonary, and other major organ dysfunction.", "PM": "2008", "HN": "2008", "MR": "20150622", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054508"}, {"RECTYPE": "D", "MH": "Group X Phospholipases A2", "DS": "GROUP X PHOSPHOLIPASES A 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phospholipases A2, Group X|T116|T126|NON|EQV|NLM (2008)|070129|PHOSPHOLIPASES A 02 GROUP X|abbcdefs", "ENTRY": "sPLA2-X|T116|T126|ABB|EQV|NLM (2008)|020115|abbcdef", "MN": "D08.811.277.352.100.680.750.937.750.887", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.4", "AN": "/antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS", "MS": "A secreted phospholipase A2 subtype that contains a interfacial-binding region with specificity for PHOSPHATIDYLCHOLINE. This enzyme group may play a role in eliciting ARACHIDONIC ACID release from intact cellular membranes and from LOW DENSITY LIPOPROTEINS. Members of this group bind specifically to PHOSPHOLIPASE A2 RECEPTORS.", "PM": "2008; GROUP X PHOSPHOLIPASES A2 was indexed under PHOSPHOLIPASES A 2002-2007", "HN": "2008(2002)", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054509"}, {"RECTYPE": "D", "MH": "Phospholipases A2, Cytosolic", "DS": "PHOSPHOLIPASES A 02 CYTOSOLIC", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phospholipases, cPLA2", "MN": "D08.811.277.352.100.680.750.937.625", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.4", "AN": "/antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS", "PI": "Phospholipases A (1979-2007)", "MS": "A subcategory of phospholipases A2 that occur in the CYTOSOL.", "PM": "2008", "HN": "2008", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054510"}, {"RECTYPE": "D", "MH": "Phospholipases A2, Calcium-Independent", "DS": "PHOSPHOLIPASES A 02 CALCIUM INDEPENDENT", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phospholipases A2, Calcium Independent", "MN": "D08.811.277.352.100.680.750.937.300", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.4", "AN": "/antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS", "PI": "Phospholipases (1979-2007)", "MS": "A subcategory of structurally-related phospholipases A2 that do not require calcium for activity.", "PM": "2008", "HN": "2008", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054512"}, {"RECTYPE": "D", "MH": "Group IV Phospholipases A2", "DS": "GROUP IV PHOSPHOLIPASES A 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phospholipases A2, Group IV|T116|T126|NON|EQV|NLM (2008)|070129|PHOSPHOLIPASES A 02 GROUP IV|abbcdefs", "ENTRY": "cPLA2 gamma", "MN": "D08.811.277.352.100.680.750.937.625.249", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.4", "RR": "EC 3.1.1.4", "AN": "/antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS", "MS": "A cytosolic phospholipase A2 group that plays an important role in the release of free ARACHIDONIC ACID, which in turn is metabolized to PROSTAGLANDINS by the CYCLOOXYGENASE pathway and to LEUKOTRIENES by the 5-LIPOXYGENASE pathway.", "PM": "2008; GROUP IV PHOSPHOLIPASE A2 was indexed under to PHOSPHOLIPASES A 1997-2007; PHOSPHOLIPASE A2-ALPHA was indexed under PHOSPHOLIPASES A 2000-2007; PHOSPHOLIPASE A2-BETA was indexed under PHOSPHOLIPASES A 1999-2007; PHOSPHOLIPASE A2-GAMMA was indexed under PHOSPHOLIPASES A 1998-2007", "HN": "2008(1997)", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054513"}, {"RECTYPE": "D", "MH": "Persistent Hyperplastic Primary Vitreous", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Persistent Hyaloid Artery|T047|NON|EQV|NLM (2008)|070124|abcdef", "ENTRY": "Persistent Hyaloid Vasculatures", "MN": "C16.131.384.725", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Vitreous Body (1966-2007)", "MS": "A developmental ocular anomaly in which the primary VITREOUS BODY and its surrounding hyaloid vasculature failed to regress. It is usually unilateral and characterized by CATARACT; MICROPHTHALMOS (small eyeballs), and retrolenticular fibrovascular tissue. (from Yanoff: Ophthalmology, 2nd ed.)", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054514"}, {"RECTYPE": "D", "MH": "Vulvar Vestibulitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vulvar Vestibulitides", "MN": "C12.100.250.944.902.368", "FX": "Vulvodynia", "MH_TH": "NLM (2008)", "ST": "T047", "AN": "do not confuse with VULVODYNIA", "PI": "Vulvitis (1987-2007)", "MS": "Inflammation of the vulvar vestibular region at the entrance of the VAGINA, generally involving surface mucosa and submucosal vestibular glands. It is characterized by ERYTHEMA and chronic recurrent pain in this area.", "PM": "2008", "HN": "2008", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054515"}, {"RECTYPE": "D", "MH": "Orbital Cellulitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Periorbital Cellulitis|T047|NON|REL|NLM (2024)|230209|abcdef", "ENTRY": "Periorbital Cellulitides", "MN": "C17.300.185.500", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Orbit (1967-2007)", "MS": "Inflammation of the loose connective tissues around the ORBIT, bony structure around the eyeball. It is characterized by PAIN; EDEMA of the CONJUNCTIVA; swelling of the EYELIDS; EXOPHTHALMOS; limited eye movement; and loss of vision.", "PM": "2008", "HN": "2008", "MR": "20230405", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054517"}, {"RECTYPE": "D", "MH": "Attentional Blink", "AQ": "CL DE ES GE PH RE", "ENTRY": "Blinks, Attentional", "MN": "F02.463.593.932.145", "MH_TH": "NLM (2008)", "ST": "T041", "PI": "Pattern Recognition, Visual (1992-2007)", "MS": "Temporary visual deficit or impaired visual processing occurring in a rapid serial visual presentation task. After a person identifies the first of two visual targets, the ability to detect the second target is impaired for the next few hundred milliseconds. This phenomenon is called attentional blink.", "PM": "2008", "HN": "2008", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054518"}, {"RECTYPE": "D", "MH": "Aphorisms and Proverbs", "PRINT ENTRY": "Proverbs|T078|NON|NRW|NLM (2008)|070124|abcdef", "MN": "V02.135", "MH_TH": "NLM (2008)", "ST": "T078", "AN": "This heading is used as a Publication Type. Aphorisms & proverbs as a subject are indexed under the main heading APHORISMS AND PROVERBS AS TOPIC. INDEXER: Do not use", "MS": "Short memorable sayings in common use. They express in simple language an obvious truth, familiar experience, or advice.", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "2", "DX": "20080101", "UI": "D054519"}, {"RECTYPE": "D", "MH": "Group III Phospholipases A2", "DS": "GROUP III PHOSPHOLIPASES A 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phospholipases A2, Group III|T116|T126|NON|EQV|NLM (2008)|070124|PHOSPHOLIPASES A 02 GROUP III|abbcdefs", "ENTRY": "Phospholipase A2 III", "MN": "D08.811.277.352.100.680.750.937.750.662", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.4", "AN": "/antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS", "PI": "Phospholipases A (1980-2007)", "MS": "A subcategory of secreted phospholipases A2 with specificity for PHOSPHATIDYLETHANOLAMINES and PHOSPHATIDYLCHOLINE. It occurs as a component of VENOMS and as a mammalian secretory phospholipase A2. The creation of this group is based upon similarities in the structural determinants of the enzymes including a long amino-terminal domain, a conserved group III-specific domain, and a long carboxyl-terminal domain.", "PM": "2008", "HN": "2008", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054520"}, {"RECTYPE": "D", "MH": "Cultural Competency", "AQ": "ED ES LJ OG PX", "PRINT ENTRY": "Cultural Sensitivity|T078|NON|REL|OBSSR (2022)|210518|abcdef", "ENTRY": "Sensitivity, Cultural", "MN": "I01.880.853.100.364", "FX": "Transcultural Nursing", "MH_TH": "NLM (2008)", "ST": "T078", "AN": "consider also TRANSCULTURAL NURSING; for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "PI": "Culture (1966-2007)", "MS": "Cultural and linguistic competence is a set of congruent behaviors, attitudes, and policies that come together in a system, agency, or among professionals that enables effective work in cross-cultural situations. Competence implies the capacity to function effectively as an individual and an organization within the context of the cultural beliefs, behaviors, and needs presented by consumers and their communities.", "PM": "2008", "HN": "2008", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054521"}, {"RECTYPE": "D", "MH": "Group VI Phospholipases A2", "DS": "GROUP VI PHOSPHOLIPASES A 02", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phospholipases A2, Group VI|T116|T126|NON|EQV|NLM (2008)|070129|PHOSPHOLIPASES A 02 GROUP VI|abbcdefs", "ENTRY": "iPLA(2)-2|T116|T126|ABB|EQV|NLM (2008)|000707|abbcdef", "MN": "D08.811.277.352.100.680.750.937.300.249", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.1.4", "AN": "/antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS", "MS": "A calcium-independent phospholipase A2 group that may play a role in membrane phospholipid remodeling and homeostasis by controling the levels of PHOSPHATIDYLCHOLINE in mammalian cell membranes.", "PM": "2008; GROUP VI PHOSPHOLIPASE A2 was indexed under PHOSPHOLIPASES 1997-2007", "HN": "2008(1997)", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054522"}, {"RECTYPE": "D", "MH": "Adult Survivors of Child Abuse", "AQ": "CL HI LJ PX SN", "PRINT ENTRY": "Child Abuse, Adult Survivors|T101|NON|EQV|NLM (2008)|070126|abcdef", "ENTRY": "Adult Survivors, Child Abuse|T101|NON|EQV|NLM (2008)|070223|abcdef", "MN": "M01.860.300.500", "FX": "Battered Child Syndrome", "MH_TH": "NLM (2008)", "ST": "T101", "PI": "Survivors (1994-2007)", "MS": "Persons who were child victims of violence and abuse including physical, sexual, or emotional maltreatment.", "PM": "2008", "HN": "2008", "MR": "20150630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054523"}, {"RECTYPE": "D", "MH": "Medicare Part D", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Part D, Medicare", "MN": "N03.706.615.752", "MH_TH": "NLM (2008)", "ST": "T089", "PI": "Medicare (2000-2007)", "MS": "A stand-alone drug plan offered by insurers and other private companies to beneficiaries that receive their Medicare Part A and/or B benefits through the Original Medicare Plan. It includes Medicare Private Fee-for-Service Plans that do not offer prescription drug coverage and Medicare Cost Plans offering Medicare prescription drug coverage. The plan was enacted as the Medicare Prescription Drug, Improvement and Modernization Act of 2003 with coverage beginning January 1, 2006.", "PM": "2008", "HN": "2008", "MR": "20130709", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054524"}, {"RECTYPE": "D", "MH": "Minority Health", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "ENTRY": "Health, Minority", "MN": "N01.400.512", "FX": "Minority Groups", "MH_TH": "NLM (2008)", "ST": "T078", "PI": "Minority Groups (1989-2007)", "MS": "The concept covering the physical and mental conditions of members of minority groups.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054525"}, {"RECTYPE": "D", "MH": "Men's Health", "AQ": "CL EC EH ES HI LJ SN ST TD", "ENTRY": "Mens Health", "MN": "N01.400.425", "MH_TH": "NLM (2008)", "ST": "T078", "PI": "Men (1986-2007)", "MS": "The concept covering the physical and mental conditions of men.", "PM": "2008", "HN": "2008", "MR": "20150305", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054526"}, {"RECTYPE": "D", "MH": "Mass Casualty Incidents", "AQ": "CL EC ES HI LJ MO PC PX SN", "ENTRY": "Mass Casualty Incident", "MN": "N06.230.100.160", "MH_TH": "NLM (2008)", "ST": "T078", "MS": "Events that overwhelm the resources of local HOSPITALS and health care providers. They are likely to impose a sustained demand for HEALTH SERVICES rather than the short, intense peak customary with smaller scale disasters.", "PM": "2008", "HN": "2008", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054527"}, {"RECTYPE": "D", "MH": "Atrioventricular Block", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Conduction Blocks, Atrioventricular", "MN": "C23.550.073.425.062", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Heart Block (1963-2007)", "MS": "Impaired impulse conduction from HEART ATRIA to HEART VENTRICLES. AV block can mean delayed or completely blocked impulse conduction.", "PM": "2008; see HEART BLOCK 1975-2007", "HN": "2008 (1975)", "MR": "20170620", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054537"}, {"RECTYPE": "D", "MH": "Occupational Health Physicians", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Physicians, Occupational Health|T097|NON|EQV|NLM (2008)|070126|abcdef", "ENTRY": "Physicians, Company", "MN": "N02.360.810.675", "MH_TH": "NLM (2008)", "ST": "T097", "PI": "Occupational Health (1990-2007)", "MS": "Physicians employed in a company or corporate setting that is generally not in the health care industry.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054538"}, {"RECTYPE": "D", "MH": "Medication Therapy Management", "AQ": "CL EC ED ES HI LJ OG SN ST TD", "PRINT ENTRY": "Drug Therapy Management|T058|NON|EQV|NLM (2008)|070127|abcdef", "ENTRY": "Therapy Management, Medication", "MN": "N04.590.661", "MH_TH": "NLM (2008)", "ST": "T058", "MS": "Assistance in managing and monitoring drug therapy for patients receiving treatment for cancer or chronic conditions such as asthma and diabetes, consulting with patients and their families on the proper use of medication; conducting wellness and disease prevention programs to improve public health; overseeing medication use in a variety of settings.", "PM": "2008", "HN": "2008", "MR": "20150629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054539"}, {"RECTYPE": "D", "MH": "Child, Orphaned", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Orphans|T098|NON|EQV|NLM (2008)|070128|abcdef", "ENTRY": "Orphaned Children", "MN": "M01.108", "MH_TH": "NLM (1994)", "ST": "T098", "PI": "Child (1966-2007)", "MS": "Child who has lost both parents through death or desertion.", "PM": "2008; see Foster Home Care 1995-2007", "HN": "2008; use Foster Home Care 1995-2007", "MR": "20070820", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054540"}, {"RECTYPE": "D", "MH": "Family Conflict", "AQ": "EC EH ES HI LJ PX", "PRINT ENTRY": "Marital Conflict|T054|NON|NRW|NLM (2008)|070128|abcdef", "ENTRY": "Married, Currently", "MN": "F01.829.401.142", "MH_TH": "NLM (2008)", "ST": "T054", "MS": "Struggle or disagreement between parents, parent and child or other members of a family.", "PM": "2008", "HN": "2008", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054541"}, {"RECTYPE": "D", "MH": "Iraq War, 2003-2011", "ENTRY": "Operation New Dawns", "MN": "K01.400.504.984.249", "MH_TH": "NLM (2014)", "ST": "T078", "MS": "An armed intervention involving multi-national forces in the country of IRAQ.", "PM": "2008", "HN": "2008", "MR": "20150930", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054542"}, {"RECTYPE": "D", "MH": "United States Department of Homeland Security", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "United States. Dept. of Homeland Security|T092|NAM|EQV|NLM (2008)|070129|abcdef", "MN": "N03.540.348.500.500.650", "FX": "Civil Defense", "MH_TH": "NLM (2008)", "ST": "T092", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "PI": "Terrorism (2001-2007)", "MS": "A cabinet department in the Executive Branch of the United States Government concerned with administering those agencies and offices having programs pertaining to domestic national security.", "PM": "2008", "HN": "2008", "MR": "20150629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054543"}, {"RECTYPE": "D", "MH": "Arthroplasty, Subchondral", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Subchondral Microfractures, Arthroscopic", "MN": "E04.617.101.115", "MH_TH": "NLM (2008)", "ST": "T061", "PI": "Cartilage, Articular (1978-2007)", "MS": "Surgical techniques used to correct or augment healing of chondral defects in the joints (CARTILAGE, ARTICULAR). These include abrasion, drilling, and microfracture of the subchondral bone to enhance chondral resurfacing via autografts, allografts, or cell transplantation.", "PM": "2008", "HN": "2008", "MR": "20220406", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054544"}, {"RECTYPE": "D", "MH": "United States Office of National Drug Control Policy", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "United States. Office of National Drug Control Policy|T092|NAM|EQV|NLM (2008)|070129|abcdef", "MN": "N03.540.348.500.500.997", "MH_TH": "NLM (2008)", "ST": "T092", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "PI": "Drug and Narcotic Control (1988-2007)", "MS": "A component of the Executive Office of the President established by the Anti-Drug Abuse Act of 1988. The Office establishes policies, priorities, and objectives for national DRUG AND NARCOTIC CONTROL. The goals of the program are to reduce illicit drug use, manufacturing, and trafficking, drug-related crime and violence, and drug-related health consequences.", "PM": "2008", "HN": "2008", "MR": "20150629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054545"}, {"RECTYPE": "D", "MH": "Neuroacanthocytosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Choreoacanthocytosis|T047|NON|EQV|NLM (2008)|OMIM (2013)|ORD (2010)|070129|abcdeeef", "ENTRY": "Levine Critchley Syndrome", "MN": "C16.320.400.550", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Movement Disorders (1982-2007)", "MS": "An inherited autosomal disorder that is characterized by neurodegeneration; orofacial and buccal DYSKINESIAS; CHOREA; and thorny-looking red cells (ACANTHOCYTES). This disorder is due to mutations of chorein which is important in protein trafficking and is encoded by Vps13a on chromosome 9q21.", "PM": "2008; see CHOREATIC DISORDERS 2000-2007", "HN": "2008 (2000)", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054546"}, {"RECTYPE": "D", "MH": "National Cancer Institute (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "National Cancer Institute|T093|NAM|EQV|NLM (2008)|070129|abcdef", "MN": "N03.540.348.500.500.600.650.496.150", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1966-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. Through basic and clinical biomedical research and training, it conducts and supports research with the objective of cancer prevention, early stage identification and elimination. This Institute was established in 1937.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054547"}, {"RECTYPE": "D", "MH": "Montenegro", "AQ": "EH EP", "MN": "Z01.542.248.609", "MH_TH": "NLM (1994)", "ST": "T083", "MS": "Country in Europe, between the Adriatic Sea and Serbia. The capital is Podgorica.", "HN": "2008", "MR": "20160707", "DA": "20070709", "DC": "4", "DX": "20080101", "UI": "D054548"}, {"RECTYPE": "D", "MH": "Takotsubo Cardiomyopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Tako-Tsubo Syndrome|T046|NON|EQV|NLM (2008)|ORD (2010)|220207|abcdeef", "ENTRY": "Tako-Tsubo Syndromes", "MN": "C14.280.945.900.500", "MH_TH": "NLM (2008)", "ST": "T046", "PI": "Ventricular Dysfunction, Left (2000-2007)", "MS": "A transient left ventricular apical dysfunction or ballooning accompanied by electrocardiographic (ECG) T wave inversions. This abnormality is associated with high levels of CATECHOLAMINES, either administered or endogenously secreted from a tumor or during extreme stress.", "PM": "2008", "HN": "2008", "MR": "20220413", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054549"}, {"RECTYPE": "D", "MH": "National Eye Institute (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NEI (US)|T093|NON|EQV|NLM (2008)|070707|abcdef", "ENTRY": "National Eye Institute|T093|NAM|EQV|NLM (2008)|070130|abcdef", "MN": "N03.540.348.500.500.600.650.496.200", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1968-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It conducts and supports research on the causes, diagnosis, and treatment of diseases of the eye and visual system. It was originally part of the National Institute of Neurological Diseases and Blindness. The National Eye Institute was established in 1968.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054554"}, {"RECTYPE": "D", "MH": "National Heart, Lung, and Blood Institute (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NHLBI|T093|ACR|EQV|NLM (2008)|070130|abcdef", "ENTRY": "National Heart, Lung, and Blood Institute|T093|NAM|EQV|NLM (2008)|070130|abcdef", "MN": "N03.540.348.500.500.600.650.496.300", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1966-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It conducts and supports research program related to diseases of the heart, blood vessels, lung, and blood; blood resources; and SLEEP WAKE DISORDERS. From 1948 until October 10, 1969, it was known as the National Heart Institute. From June 25, 1976, it was the National Heart and Lung Institute. Since October 1997, the NHLBI has also had administrative responsibility for the NIH Woman's Health Initiative.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054555"}, {"RECTYPE": "D", "MH": "Venous Thromboembolism", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thromboembolism, Venous|T046|NON|EQV|NLM (2008)|070130|abcdef", "MN": "C14.907.355.590.700", "MH_TH": "OMIM (2013)", "ST": "T046", "PI": "Thromboembolism (1967-2007)", "MS": "Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.", "PM": "2008", "HN": "2008", "MR": "20150608", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054556"}, {"RECTYPE": "D", "MH": "Receptor-Like Protein Tyrosine Phosphatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor Like Protein Tyrosine Phosphatases", "MN": "D12.776.543.733", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "PI": "Protein Tyrosine Phosphatases (1991-2007)", "MS": "A subcategory of protein tyrosine phosphatases that are bound to the cell membrane. They contain cytoplasmic tyrosine phosphatase domains and extracellular protein domains that may play a role in cell-cell interactions by interacting with EXTRACELLULAR MATRIX components. They are considered receptor-like proteins in that they appear to lack specific ligands.", "PM": "2008", "HN": "2008", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054557"}, {"RECTYPE": "D", "MH": "Protein Tyrosine Phosphatases, Non-Receptor", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Tyrosine Phosphatases, Non Receptor", "MN": "D12.776.476.564.300", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "PI": "Protein Tyrosine Phosphatases (1991-2007)", "MS": "A subcategory of protein tyrosine phosphatases that occur in the CYTOPLASM. Many of the proteins in this category play a role in intracellular signal transduction.", "PM": "2008", "HN": "2008", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054558"}, {"RECTYPE": "D", "MH": "Hyperphosphatemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperphosphatemias", "MN": "C18.452.750.199", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Phosphates (1963-2007)", "MS": "A condition of abnormally high level of PHOSPHATES in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054559"}, {"RECTYPE": "D", "MH": "National Human Genome Research Institute (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NHGRI|T093|ACR|EQV|NLM (2008)|070201|abcdef", "ENTRY": "National Human Genome Research Institute|T093|NAM|EQV|NLM (2008)|070130|abcdef", "MN": "N03.540.348.500.500.600.650.496.325", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1989-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It conducts and supports research into the mapping of the human genome and other organism genomes. The National Center for Human Genome Research was established in 1989 and re-named the National Human Genome Research Institute in 1997.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054560"}, {"RECTYPE": "D", "MH": "National Institute on Aging (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NIA (US)|T093|ACR|EQV|NLM (2008)|070707|abcdef", "ENTRY": "National Institute on Aging|T093|NAM|EQV|NLM (2008)|070130|abcdef", "MN": "N03.540.348.500.500.600.650.496.465", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1974-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. Through basic and clinical biomedical research and training, it conducts and supports research into the nature of the aging process and diseases associated with the later stages of life. The Institute was established in 1974.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054561"}, {"RECTYPE": "D", "MH": "Protein Tyrosine Phosphatase, Non-Receptor Type 1", "DS": "PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR TYPE 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Tyrosine Phosphatase, Non Receptor Type 1", "MN": "D12.776.476.564.300.100", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "PI": "Protein Tyrosine Phosphatases (1991-2007)", "MS": "A subtype of non-receptor protein tyrosine phosphatases that includes two distinctive targeting motifs; an N-terminal motif specific for the INSULIN RECEPTOR, and a C-terminal motif specific for the SH3 domain containing proteins. This subtype includes a hydrophobic domain which localizes it to the ENDOPLASMIC RETICULUM.", "PM": "2008; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1 was indexed under PROTEIN TYROSINE PHOSPHATASES 2000-2007, and under MEMBRANE PROTEINS & PROTEIN TYROSINE PHOSPHATASES 1999-2000; for PTPase 1B see PROTEIN-TYROSINE-PHOSPHATASE 1991-2007", "HN": "2008", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054562"}, {"RECTYPE": "D", "MH": "National Institute on Alcohol Abuse and Alcoholism (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NIAAA|T093|ACR|EQV|NLM (2008)|070130|abcdef", "ENTRY": "National Institute on Alcohol Abuse and Alcoholism|T093|NAM|EQV|NLM (2008)|070130|abcdef", "MN": "N03.540.348.500.500.600.650.496.467", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1974-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It conducts research focused on improving the treatment and prevention of alcoholism and alcohol-related problems to reduce the health, social, and economic consequences of this disease. NIAAA, NIMH, and NIDA were created as coequal institutes within the Alcohol, Drug Abuse and Mental Health Administration in 1974. It was established within the NATIONAL INSTITUTES OF HEALTH in 1992.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054563"}, {"RECTYPE": "D", "MH": "National Institute on Drug Abuse (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NIDA (US)|T093|ACR|EQV|NLM (2008)|070707|abcdef", "ENTRY": "National Institute on Drug Abuse|T093|NAM|EQV|NLM (2008)|070130|abcdef", "MN": "N03.540.348.500.500.600.650.496.485", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1992-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It supports a comprehensive research portfolio that focuses on the biological, social, behavioral and neuroscientific bases of drug abuse on the body and brain as well as its causes, prevention, and treatment. NIDA, NIAAA, and NIMH were created as coequal institutes within the Alcohol, Drug Abuse and Mental Health Administration in 1974. It was established within the NATIONAL INSTITUTES OF HEALTH in 1992.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054577"}, {"RECTYPE": "D", "MH": "Protein Tyrosine Phosphatase, Non-Receptor Type 2", "DS": "PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR TYPE 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "T Cell Protein Tyrosine Phosphatase", "MN": "D12.776.476.564.300.200", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.48", "MS": "A subtype of non-receptor protein tyrosine phosphatase that is closely-related to PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1. Alternative splicing of the mRNA for this phosphatase results in the production at two gene products, one of which includes a C-terminal nuclear localization domain that may be involved in the transport of the protein to the CELL NUCLEUS. Although initially referred to as T-cell protein tyrosine phosphatase the expression of this subtype occurs widely.", "PM": "2008; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2 was indexed under PROTEIN TYROSINE PHOSPHATASE 1994-2007", "HN": "2008(1994)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054578"}, {"RECTYPE": "D", "MH": "National Institute of Allergy and Infectious Diseases (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NIAID|T093|ACR|EQV|NLM (2008)|070131|abcdef", "ENTRY": "National Institute of Allergy and Infectious Diseases|T093|NAM|EQV|NLM (2008)|070131|abcdef", "MN": "N03.540.348.500.500.600.650.496.400", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1966-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. It was established in 1948.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054579"}, {"RECTYPE": "D", "MH": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NIAMS|T093|ACR|EQV|NLM (2008)|070131|abcdef", "ENTRY": "National Institute of Arthritis and Musculoskeletal and Skin Diseases|T093|NAM|EQV|NLM (2008)|070131|abcdef", "MN": "N03.540.348.500.500.600.650.496.425", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1986-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It supports research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress. It was established in 1986.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054580"}, {"RECTYPE": "D", "MH": "National Institute of Biomedical Imaging and Bioengineering (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NIBIB|T093|ACR|EQV|NLM (2008)|070131|abcdef", "ENTRY": "National Institute of Biomedical Imaging and Bioengineering|T093|NAM|EQV|NLM (2008)|070131|abcdef", "MN": "N03.540.348.500.500.600.650.496.435", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (2000-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. Its mission is to improve health by leading the development and accelerating the application of biomedical technologies, and integrating the physical and engineering sciences with the life sciences to advance basic research and medical care. It was established in 2000.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054581"}, {"RECTYPE": "D", "MH": "National Institute of Child Health and Human Development (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NICHD|T093|ACR|EQV|NLM (2008)|070131|abcdef", "ENTRY": "National Institute of Child Health and Human Development|T093|NAM|EQV|NLM (2008)|070131|abcdef", "MN": "N03.540.348.500.500.600.650.496.440", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It was initially established to investigate the broad aspects of human development as a means of understanding developmental disabilities, including mental retardation, and the events that occur during pregnancy. It now conducts and supports research on all stages of human development. It was established in 1962.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054582"}, {"RECTYPE": "D", "MH": "National Institute on Deafness and Other Communication Disorders (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NIDCD|T093|ACR|EQV|NLM (2008)|070131|abcdef", "ENTRY": "National Institute on Deafness and Other Communication Disorders|T093|NAM|EQV|NLM (2008)|070131|abcdef", "MN": "N03.540.348.500.500.600.650.496.470", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1988-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It conducts and supports biomedical research and research training on normal mechanisms as well as diseases and disorders of hearing, balance, smell, taste, voice, speech, and language. It was established in 1988.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054583"}, {"RECTYPE": "D", "MH": "National Institute of Dental and Craniofacial Research (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NIDR|T093|ACR|EQV|NLM (2008)|070131|abcdef", "ENTRY": "National Institute of Dental and Craniofacial Research|T093|NAM|EQV|NLM (2008)|070131|abcdef", "MN": "N03.540.348.500.500.600.650.496.445", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1966-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It seeks to improve oral, dental and craniofacial health through research, research training, and the dissemination of health information by conducting and supporting basic and clinical research. It was established in 1948 as the National Institute of Dental Research and re-named in 1998 as the National Institute of Dental and Craniofacial Research.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054584"}, {"RECTYPE": "D", "MH": "National Institute of Environmental Health Sciences (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NIEHS|T093|ACR|EQV|NLM (2008)|070131|abcdef", "ENTRY": "National Institute of Environmental Health Sciences|T093|NAM|EQV|NLM (2008)|070131|abcdef", "MN": "N03.540.348.500.500.600.650.496.455", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1969-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It conducts and supports basic and applied research to reduce the burden of human illness and dysfunction from environmental causes by, defining how environmental exposures, genetic susceptibility, and age interact to affect an individual's health. It was established in 1969.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054585"}, {"RECTYPE": "D", "MH": "National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NIDDK|T093|ACR|EQV|NLM (2008)|070131|abcdef", "ENTRY": "National Institute of Diabetes and Digestive and Kidney Diseases|T093|NAM|EQV|NLM (2008)|070131|abcdef", "MN": "N03.540.348.500.500.600.650.496.450", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1966-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It conducts and supports basic and applied research for a national program in diabetes, endocrinology, and metabolic diseases; digestive diseases and nutrition; and kidney, urologic, and hematologic diseases. It was established in 1948.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054586"}, {"RECTYPE": "D", "MH": "National Institute of General Medical Sciences (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NIGMS|T093|ACR|EQV|NLM (2008)|070131|abcdef", "ENTRY": "National Institute of General Medical Sciences|T093|NAM|EQV|NLM (2008)|070131|abcdef", "MN": "N03.540.348.500.500.600.650.496.457", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1966-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It conducts and supports basic biomedical research that is not targeted to specific diseases and funds studies on genes, proteins, and cells, as well as on fundamental processes like communication within and between cells and metabolism. It was established in 1962.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054587"}, {"RECTYPE": "D", "MH": "National Institute of Nursing Research (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "NINR|T093|ACR|EQV|NLM (2008)|070131|abcdef", "ENTRY": "National Institute of Nursing Research|T093|NAM|EQV|NLM (2008)|070131|abcdef", "MN": "N03.540.348.500.500.600.650.496.462", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "PI": "National Institutes of Health (1986-2007)", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It conducts and supports clinical and basic research to establish a scientific basis for the care of individuals across the life span, from the management of patients during illness and recovery to the reduction of risks for disease and disability; the promotion of healthy lifestyles; the promotion of quality of life in those with chronic illness; and the care for individuals at the end of life. It was established in 1986.", "PM": "2008", "HN": "2008", "MR": "20161216", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054588"}, {"RECTYPE": "D", "MH": "Protein Tyrosine Phosphatase, Non-Receptor Type 3", "DS": "PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR TYPE 003", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Tyrosine Phosphatase, Non Receptor Type 3", "MN": "D12.776.476.564.300.300", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "MS": "A subtype of non-receptor protein tyrosine phosphatases that is characterized by the presence of an amino-terminal FERM domain, an intervening region containing one or more PDZ domains, and a carboxyl-terminal phosphatase domain. Expression of this phosphatase subtype has been observed in BONE MARROW; fetal LIVER; LYMPH NODES; and T LYMPHOCYTES.", "PM": "2008; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 3 was indexed under PROTEIN TYROSINE PHOSPHATASES 2000-2007", "HN": "2008(2000)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054589"}, {"RECTYPE": "D", "MH": "Protein Tyrosine Phosphatase, Non-Receptor Type 4", "DS": "PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR TYPE 004", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Tyrosine Phosphatase, Non Receptor Type 4", "MN": "D12.776.476.564.300.400", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "MS": "A subtype of non-receptor protein tyrosine phosphatases that is characterized by the presence of an amino-terminal FERM domain, an intervening region containing one or more PDZ domains, and a carboxyl-terminal phosphatase domain. The subtype was originally identified in a cell line derived from MEGAKARYOCYTES.", "PM": "2008; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 4 was indexed under PROTEIN TYROSINE PHOSPHATASES 1997-2007", "HN": "2008(1997)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054590"}, {"RECTYPE": "D", "MH": "Protein Tyrosine Phosphatase, Non-Receptor Type 11", "DS": "PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR TYPE 011", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tyrosine Phosphatase, Shp-2", "MN": "D12.776.476.564.700.800", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "MS": "A subtype of non-receptor protein tyrosine phosphatases that contain two SRC HOMOLOGY DOMAINS. Mutations in the gene for protein tyrosine phosphatase, non-receptor type 11 are associated with NOONAN SYNDROME.", "PM": "2008; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11 was indexed under PROTEIN TYROSINE PHOSPHATASES 2001-2007", "HN": "2008(2001)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054592"}, {"RECTYPE": "D", "MH": "SH2 Domain-Containing Protein Tyrosine Phosphatases", "DS": "SH Z 002 DOMAIN CONTAINING", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SH2 Domain Containing Protein Tyrosine Phosphatases", "MN": "D12.776.476.564.700", "FX": "src Homology Domains", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "MS": "A subcategory of protein tyrosine phosphatases that contain SH2 type SRC HOMOLOGY DOMAINS. Many of the proteins in this class are recruited to specific cellular targets such as a cell surface receptor complexes via their SH2 domain.", "PM": "2008 SH2 DOMAIN-CONTAINING PROTEIN TYROSINE PHOSPHATASES was indexed under PROTEIN TYROSINE PHOSPHATASES & INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 2001-2007", "HN": "2008(2001)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054593"}, {"RECTYPE": "D", "MH": "Protein Tyrosine Phosphatase, Non-Receptor Type 12", "DS": "PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR TYPE 012", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Tyrosine Phosphatase, Non Receptor Type 12", "MN": "D12.776.476.564.300.850", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "MS": "A subtype of non-receptor protein tyrosine phosphatases that is characterized by the presence of a N-terminal catalytic domain and a large C-terminal domain that is enriched in PROLINE, GLUTAMIC ACID, SERINE, and THREONINE residues (PEST sequences). The phosphatase subtype is ubiquitously expressed and implicated in the regulation of a variety of biological processes such as CELL MOVEMENT; CYTOKINESIS; focal adhesion disassembly; and LYMPHOCYTE ACTIVATION.", "PM": "2008; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 12 was indexed under PROTEIN TYROSINE PHOSPHATASE 1994-2007", "HN": "2008(1994)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054594"}, {"RECTYPE": "D", "MH": "Protein Tyrosine Phosphatase, Non-Receptor Type 13", "DS": "PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR TYPE 013", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Tyrosine Phosphatase, Non Receptor Type 13", "MN": "D12.776.476.564.300.860", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "MS": "A subtype of non-receptor protein tyrosine phosphatases that is characterized by the presence of an amino-terminal FERM domain, an intervening region containing five different PDZ domains, and a carboxyl-terminal phosphatase domain. In addition to playing a role as a regulator of the FAS RECEPTOR activity this subtype interacts via its PDZ and FERM domains with a variety of INTRACELLULAR SIGNALING PROTEINS and CYTOSKELETAL PROTEINS.", "PM": "2008; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 13 was indexed under PROTEIN TYROSINE PHOSPHATASES 2001-2007", "HN": "2008(2001)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054595"}, {"RECTYPE": "D", "MH": "Protein Tyrosine Phosphatase, Non-Receptor Type 22", "DS": "PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR TYPE 022", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tyrosine Protein Phosphatase, Non Receptor Type 22", "MN": "D12.776.476.564.300.930", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.48", "MS": "A subtype of non-receptor protein tyrosine phosphatases that is characterized by the presence of an N-terminal catalytic domain and a C-terminal PROLINE-rich domain. The phosphatase subtype is predominantly expressed in LYMPHOCYTES and plays a key role in the inhibition of downstream T-LYMPHOCYTE activation. Polymorphisms in the gene that encodes this phosphatase subtype are associated with a variety of AUTOIMMUNE DISEASES.", "PM": "2008; TYROSINE PROTEIN PROSPHATASE, NON-RECEPTOR TYPE 22 was indexed under PROTEIN TYROSINE PHOSPHATASES 1999-2007", "HN": "2008(1999)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054596"}, {"RECTYPE": "D", "MH": "Disaster Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Disaster", "MN": "H02.403.230", "MH_TH": "NLM (2008)", "ST": "T091", "AN": "specialty; differentiate from DISASTERS", "MS": "Branch of medicine involved with management and organization of public health response to disasters and major events including the special health and medical needs of a community in a disaster.", "PM": "2008", "HN": "2008", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054597"}, {"RECTYPE": "D", "MH": "Blue Cross Blue Shield Insurance Plans", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Blue Shield|T093|NON|NRW|NLM (1975)|990101|abcdef", "ENTRY": "Shields, Blue", "MN": "N03.219.521.710.305.090.125", "MH_TH": "NLM (2008)", "ST": "T093", "AN": "specify geographic term if possible; CATALOGER: Coordinate with specific NAF entry if applicable", "MS": "Prepaid health and hospital insurance plan.", "PM": "2008; see BLUE CROSS (1975-2006); see BLUE SHIELD (1975-2007)", "HN": "2008(1975)", "MR": "20150605", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054598"}, {"RECTYPE": "D", "MH": "Receptor-Like Protein Tyrosine Phosphatases, Class 1", "DS": "RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASES CLASS 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Receptor-Like Protein Tyrosine Phosphatases, Class 6|T116|T126|NON|EQV|NLM (2008)|070205|RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASES CLASS 006|abbcdefs", "ENTRY": "Receptor Like Protein Tyrosine Phosphatases, Class I", "MN": "D12.776.543.733.937", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "PI": "Protein-Tyrosine-Phosphatase (1992-2007)", "MS": "A subclass of receptor-like protein tryosine phosphatases that contain heavily glycosylated and cysteine-rich extracellular regions that include fibronectin type III-like domains.", "PM": "2008", "HN": "2008", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054622"}, {"RECTYPE": "D", "MH": "Receptor-Like Protein Tyrosine Phosphatases, Class 2", "DS": "RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASES CLASS 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Receptor-Like Protein Tyrosine Phosphatases, Class 2B|T116|T126|NON|NRW|NLM (2008)|070206|RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASES CLASS 002B|abbcdefs", "ENTRY": "Receptor, LAR-PTP", "MN": "D12.776.476.564.400.200", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.48", "MS": "A subclass of receptor-like protein tryosine phosphatases that contain multiple extracellular immunoglobulin G-like domains and fibronectin type III-like domains. An additional memprin-A5-mu domain is found on some members of this subclass.", "PM": "2008; PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE M was indexed under PROTEIN TYROSINE PHOSPHATASES 2000-2007; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASE U was indexed under AUTOANTIGENS; MEMBRANE PROTEINS; & PROTEIN TYROSINE PHOSPHATASES 1994-2007; PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE T was indexed under PROTEIN-TYROSINE KINASES 1999-2007; PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE F was indexed under NERVE TISSUE PROTEINS; RECEPTORS, CELL SURFACE; & PROTEIN TYROSINE PHOSPHATASES 1995-2007; PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE S was indexed under PROTEIN TYROSINE PHOSPHATASE 1994-2007", "HN": "2008(2000)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054623"}, {"RECTYPE": "D", "MH": "Health Status Disparities", "ENTRY": "Disparity, Health Status", "MN": "N06.850.505.400.425.675", "MH_TH": "NLM (2008)", "ST": "T080", "MS": "Variation in rates of disease occurrence and disabilities between population groups defined by various factors including socioeconomic characteristics (see SOCIOECONOMIC DISPARITIES IN HEALTH), age, ethnicity, economic resources, or gender and populations identified geographically or similar measures.", "PM": "2008", "HN": "2008", "MR": "20220523", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054624"}, {"RECTYPE": "D", "MH": "Healthcare Disparities", "AQ": "CL EC EH ES HI LJ OG SN ST TD", "PRINT ENTRY": "Disparities, Healthcare|T080|NON|EQV|NLM (2008)|070206|abcdef", "ENTRY": "Inequality, Healthcare", "MN": "N05.300.493", "MH_TH": "NLM (2008)", "ST": "T080", "MS": "Differences in access to or availability of medical facilities and services.", "PM": "2008", "HN": "2008", "MR": "20230226", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054625"}, {"RECTYPE": "D", "MH": "Consumer Health Information", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Health Information, Consumer|T065|NON|EQV|NLM (2008)|070206|abcdef", "ENTRY": "Information, Consumer Health", "MN": "N02.421.726.407.229", "MH_TH": "NLM (2008)", "ST": "T065", "MS": "Information intended for potential users of medical and healthcare services. There is an emphasis on self-care and preventive approaches as well as information for community-wide dissemination and use.", "PM": "2008", "HN": "2008", "MR": "20150630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054626"}, {"RECTYPE": "D", "MH": "Genome, Plastid", "AQ": "DE GE IM PH RE", "ENTRY": "Genomes, Plastid", "MN": "G05.360.340.370", "MH_TH": "NLM (2008)", "ST": "T026", "MS": "The genetic complement of PLASTIDS as represented in their DNA.", "PM": "2008", "HN": "2008", "MR": "20100625", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054627"}, {"RECTYPE": "D", "MH": "Genome, Chloroplast", "AQ": "DE GE IM PH RE", "ENTRY": "Genomes, Chloroplast", "MN": "G05.360.340.370.200", "MH_TH": "NLM (2008)", "ST": "T028", "MS": "The genetic complement of CHLOROPLASTS as represented in their DNA.", "PM": "2008", "HN": "2008", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054628"}, {"RECTYPE": "D", "MH": "Genome, Mitochondrial", "AQ": "DE GE IM PH RE", "ENTRY": "Mitochondrial Genomes", "MN": "G05.360.340.360", "MH_TH": "NLM (2008)", "ST": "T026", "PI": "DNA, Mitochondrial (1972-2007)", "MS": "The genetic complement of MITOCHONDRIA as represented in their DNA.", "PM": "2008", "HN": "2008", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054629"}, {"RECTYPE": "D", "MH": "Receptor-Like Protein Tyrosine Phosphatases, Class 4", "DS": "RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASES CLASS 004", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Tyrosine Phosphatase, Receptor Type E|T116|T126|NON|NRW|NLM (2008)|070206|abbcdef", "ENTRY": "Receptor Like Protein Tyrosine Phosphatases, Class IV", "MN": "D12.776.476.564.400.400", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.48", "MS": "A subclass of receptor-like protein tryosine phosphatases that contain short highly glycosylated extracellular domains and two active cytosolic protein tyrosine phosphatase domains.", "PM": "2008; PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE A was indexed under RECEPTORS, CELL SURFACE & PROTEIN TYROSINE PHOSPHATASES 1991-2007", "HN": "2008(1991)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054630"}, {"RECTYPE": "D", "MH": "Receptor-Like Protein Tyrosine Phosphatases, Class 3", "DS": "RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASES CLASS 003", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Tyrosine Phosphatase, Receptor Type V|T116|T126|NON|NRW|NLM (2008)|070206|abbcdef", "ENTRY": "VE PTP Phosphatase", "MN": "D12.776.476.564.400.300", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.48", "MS": "A subclass of receptor-like protein tryosine phosphatases that contain a single cytosolic protein tyrosine phosphate domain and multiple extracellular fibronectin III-like domains.", "PM": "2008; PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE B was indexed under PROTEIN TYROSINE PHOSPHATASES 2002-2007; PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE O was indexed under MEMBRANE PROTEINS & PROTEIN TYROSINE PHOSPHATASES 2004-2007", "HN": "2008(2002)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054631"}, {"RECTYPE": "D", "MH": "Receptor-Like Protein Tyrosine Phosphatases, Class 5", "DS": "RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASES CLASS 005", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Tyrosine Phosphatase, Receptor Type Z|T116|T126|NON|NRW|NLM (2008)|070126|abbcdef", "ENTRY": "Receptor Type Protein Tyrosine Phosphatase beta", "MN": "D12.776.476.564.400.500", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.48", "MS": "A subclass of receptor-like protein tryosine phosphatases that contain an extracellular fibronectin III-like domain along with a carbonic anhydrase-like domain.", "PM": "2008; PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE G was indexed under NERVE TISSUE PROTEINS & PROTEIN TYROSINE PHOSPHATASES 1993-2007; PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE Z was indexed under PROTEIN TYROSINE PHOSPHATASES 1994-2007", "HN": "2008(1993)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054633"}, {"RECTYPE": "D", "MH": "Receptor-Like Protein Tyrosine Phosphatases, Class 7", "DS": "RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASES CLASS 007", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Tyrosine Phosphatase, Receptor Type R|T116|T126|NON|NRW|NLM (2008)|070206|abbcdef", "ENTRY": "Receptor Like Protein Tyrosine Phosphatases, Class VII", "MN": "D12.776.476.564.400.700", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.48", "PI": "Protein-Tyrosine-Phosphatase (1992-2007)", "MS": "A subclass of receptor-like protein tryosine phosphatases that contain a short extracellular domain, a cytosolic kinase-interaction domain, and single protein tyrosine kinase domain.", "PM": "2008", "HN": "2008", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054634"}, {"RECTYPE": "D", "MH": "Receptor-Like Protein Tyrosine Phosphatases, Class 8", "DS": "RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASES CLASS 008", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Tyrosine Phosphatase, Receptor Type N|T116|T126|NON|NRW|NLM (2008)|070126|abbcdef", "ENTRY": "Receptor Like Protein Tyrosine Phosphatases, Class VIII", "MN": "D12.776.476.564.400.800", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.48", "MS": "A subclass of receptor-like protein tryosine phosphatases that contain an extracellular RDGS-adhesion recognition motif and a single cytosolic protein tyrosine phosphate domain.", "PM": "2008; PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE N was indexed under AUTOANTIGENS, MEMBRANE PROTEINS, & PROTEIN TYROSINE PHOSPHATASES 1994-2007", "HN": "2008(1994)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054635"}, {"RECTYPE": "D", "MH": "Dual-Specificity Phosphatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphatases, Dual-Specificity", "MN": "D12.776.476.564.250", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.18", "PI": "Protein Tyrosine Phosphatases (1992-2007)", "MS": "A sub-class of protein tyrosine phosphatases that contain an additional phosphatase activity which cleaves phosphate ester bonds on SERINE or THREONINE residues that are located on the same protein.", "PM": "2008", "HN": "2008", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054637"}, {"RECTYPE": "D", "MH": "Dual Specificity Phosphatase 1", "DS": "DUAL SPECIFICITY PHOSPHATASE 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Phosphatase-1, Mitogen-Activated", "MN": "D12.776.476.564.250.200", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.18", "MS": "A dual specificity phosphatase subtype that plays a role in intracellular signal transduction by inactivating MITOGEN-ACTIVATED PROTEIN KINASES. It has specificity for P38 MITOGEN-ACTIVATED PROTEIN KINASES and JNK MITOGEN-ACTIVATED PROTEIN KINASES.", "PM": "2008; DUAL SPECIFICITY PHOSPHATASE 1 was indexed under CELL CYCLE PROTEINS, IMMEDIATE-EARLY PROTEINS & PHOSPHOPROTEIN PHOSPHATASE 1994-2007, & under PROTEINS 1992-1993", "HN": "2008(1992)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054638"}, {"RECTYPE": "D", "MH": "Mitogen-Activated Protein Kinase Phosphatases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mitogen-Activated Protein Kinase Phosphatase|T116|T126|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Phosphatases, MAPK", "MN": "D12.776.476.445", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.16", "RR": "EC 3.1.3.48", "MS": "A subcategory of phosphohydrolases that are specific for MITOGEN-ACTIVATED PROTEIN KINASES. They play a role in the inactivation of the MAP KINASE SIGNALING SYSTEM.", "PM": "2008", "HN": "2008", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054639"}, {"RECTYPE": "D", "MH": "Dual Specificity Phosphatase 3", "DS": "DUAL SPECIFICITY PHOSPHATASE 003", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Vaccinia Virus H1 Related Protein Tyrosine Phosphatase", "MN": "D12.776.476.564.250.300", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.16", "MS": "A dual specificity phosphatase subtype that plays a role in intracellular signal transduction by inactivating MITOGEN-ACTIVATED PROTEIN KINASES. It has specificity for EXTRACELLULAR SIGNAL-REGULATED MAP KINASES.", "PM": "2008; DUAL SPCIFICITY PHOSPHATASE 3 was indexed under PROTEIN TYROSINE PHOSPHATASE & PHOSPHOPROTEIN PHOSPHATASE 1994-2007", "HN": "2008(1994)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054640"}, {"RECTYPE": "D", "MH": "Dual Specificity Phosphatase 2", "DS": "DUAL SPECIFICITY PHOSPHATASE 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphatase, PAC1", "MN": "D12.776.476.564.250.250", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.18", "MS": "A dual specificity phosphatase subtype that plays a role in intracellular signal transduction by inactivating MITOGEN-ACTIVATED PROTEIN KINASES. It has specificity for EXTRACELLULAR SIGNAL-REGULATED MAP KINASES and is primarily localized to the CELL NUCLEUS.", "PM": "2008; DUAL SPECIFICITY PHOSPHATASE 2 was indexed under PROTEIN TYROSINE PHOSPHATASES 1994-2007", "HN": "2008(1994)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054641"}, {"RECTYPE": "D", "MH": "Dual Specificity Phosphatase 6", "DS": "DUAL SPECIFICITY PHOSPHATASE 006", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphatase, MKP3", "MN": "D12.776.476.564.250.600", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.48", "RR": "EC 3.1.3.16", "MS": "A dual specificity phosphatase subtype that plays a role in intracellular signal transduction by inactivating MITOGEN-ACTIVATED PROTEIN KINASES. It has specificity for EXTRACELLULAR SIGNAL-REGULATED MAP KINASES and is primarily localized to the CYTOSOL.", "PM": "2008; DUAL SPECIFICITY PHOSPHATASE 6 was indexed under PROTEIN TYROSINE PHOSPHATASES 1996-2007", "HN": "2008(1996)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054642"}, {"RECTYPE": "D", "MH": "INDEL Mutation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Insertions-Deletions Mutation|T045|NON|EQV|NLM (2023)|211129|abcdef", "ENTRY": "Mutation, Insertions-Deletions", "MN": "G05.558.370", "MH_TH": "NLM (2008)", "ST": "T045", "MS": "A mutation named with the blend of insertion and deletion. It refers to a length difference between two ALLELES where it is unknowable if the difference was originally caused by a SEQUENCE INSERTION or by a SEQUENCE DELETION. If the number of nucleotides in the insertion/deletion is not divisible by three, and it occurs in a protein coding region, it is also a FRAMESHIFT MUTATION.", "PM": "2008", "HN": "2008", "MR": "20220413", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054643"}, {"RECTYPE": "D", "MH": "Ear Auricle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Pinna, Ear|T023|NON|EQV|NLM (2008)|070212|abcdef", "ENTRY": "Pinnas, Ear", "MN": "A09.246.272.197", "MH_TH": "NLM (2008)", "ST": "T023", "PI": "Ear, External (1963-2007)", "MS": "The shell-like structure projects like a little wing (pinna) from the side of the head. Ear auricles collect sound from the environment.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054644"}, {"RECTYPE": "D", "MH": "Protein Phosphatase 1", "DS": "PROTEIN PHOSPHATASE 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Serine Threonine Phosphatase 1 beta", "MN": "D12.776.476.559.687", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.16", "RR": "EC 3.1.3.16", "PI": "Phosphoprotein Phosphatases (1984-2007)", "MS": "A eukayrotic protein serine-threonine phosphatase subtype that dephosphorylates a wide variety of cellular proteins. The enzyme is comprised of a catalytic subunit and regulatory subunit. Several isoforms of the protein phosphatase catalytic subunit exist due to the presence of multiple genes and the alternative splicing of their mRNAs. A large number of proteins have been shown to act as regulatory subunits for this enzyme. Many of the regulatory subunits have additional cellular functions.", "PM": "2008; for PROTEIN PHOSPHATASE-1 see PHOSPHOPROTEIN PHOSPHATASE 1984-2007; PROTEIN PHOSPHATASE 1C GAMMA was indexed under PHOSPHOPROTEIN PHOSPHATASES 1997-2007 & under PROTEIN-SERINE-THREONINE KINASES 1997-2006; PROTEIN-SERINE-THREONINE PHOSPHATASE 1 BETA was indexed under PHOSPHOPROTEIN PHOSPHATASE 1994-2007; TYPE 1 SERINE THREONINE PROTEIN PHOSPHATASE was indexed under PHOSPHOPROTEIN PHOSPHATASES 2002-2007", "HN": "2008(1983); for PROTEIN PHOSPHATASE-1 use PHOSPHOPROTEIN PHOSPHATASES 1984-2007", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054645"}, {"RECTYPE": "D", "MH": "Nutrigenomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Nutrigenomic", "MN": "H02.533.468", "FX": "Metabolomics", "MH_TH": "NLM (2008)", "ST": "T091", "PI": "Nutritional Physiology (1999-2007)", "MS": "The study of the relationship between NUTRITIONAL PHYSIOLOGY and genetic makeup. It includes the effect of different food components on GENE EXPRESSION and how variations in GENES effect responses to food components.", "PM": "2008", "HN": "2008", "MR": "20150617", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054647"}, {"RECTYPE": "D", "MH": "Protein Phosphatase 2", "DS": "PROTEIN PHOSPHATASE 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Serine Threonine Protein Phosphatase 2A Catalytic Subunit alpha Isoform", "MN": "D12.776.476.559.706", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.3.16", "RR": "EC 3.1.3.16", "PI": "Phosphoprotein Phosphatases (1985-2007)", "MS": "A phosphoprotein phosphatase subtype that is comprised of a catalytic subunit and two different regulatory subunits. At least two genes encode isoforms of the protein phosphatase catalytic subunit, while several isoforms of regulatory subunits exist due to the presence of multiple genes and the alternative splicing of their mRNAs. Protein phosphatase 2 acts on a broad variety of cellular proteins and may play a role as a regulator of intracellular signaling processes.", "PM": "2008; for PROTEIN PHOSPHATASE-2A see PHOSPHOPROTEIN PHOSPHATASE 1 1985-2007", "HN": "2008(1985); for PROTEIN PHOSPHATASE-2A use PHOSPHOPROTEIN PHOSPHATASE 1 1985-2007", "MR": "20210610", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054648"}, {"RECTYPE": "D", "MH": "Ribosome Subunits", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Subunits, Ribosome", "MN": "A11.284.430.214.190.875.811.870", "MH_TH": "NLM (2008)", "ST": "T026", "AN": "general; prefer specifics", "PI": "Ribosomes (1966-2007)", "MS": "The two dissimilar sized ribonucleoprotein complexes that comprise a RIBOSOME - the large ribosomal subunit and the small ribosomal subunit. The eukaryotic 80S ribosome is composed of a 60S large subunit and a 40S small subunit. The bacterial 70S ribosome is composed of a 50S large subunit and a 30S small subunit.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054657"}, {"RECTYPE": "D", "MH": "Ribosome Subunits, Large", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Large Ribosome Subunits|T026|NON|EQV|NLM (2008)|070213|abcdef", "ENTRY": "Subunits, Large Ribosome", "MN": "A11.284.430.214.190.875.811.870.700", "MH_TH": "NLM (2008)", "ST": "T026", "PI": "Ribosomes (1969-2007)", "MS": "The largest ribonucleoprotein component of RIBOSOMES. It contains the domains which catalyze formation of the peptide bond and translocation of the ribosome along the MESSENGER RNA during GENETIC TRANSLATION.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054658"}, {"RECTYPE": "D", "MH": "Diketopiperazines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diketopiperazine Compounds|T109|NON|EQV|NLM (2008)|070215|abcdef", "ENTRY": "Pyrrolopiperazinediones|T109|NON|NRW|NLM (2008)|070215|abcdef", "MN": "D03.383.606.385", "PA": "Anti-Bacterial Agents", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "RR": "35054-35-4", "MS": "Piperazines with two keto oxygens.", "PM": "2008; DIKETOPIPERAZINE was indexed under PIPERAZINES 1981-2007", "HN": "2008(1981)", "MR": "20160531", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054659"}, {"RECTYPE": "D", "MH": "Cyclic Nucleotide Phosphodiesterases, Type 1", "DS": "CYCLIC NUCLEOTIDE PHOSPHODIESTERASES TYPE 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cyclic Nucleotide Phosphodiesterases, Type I|T116|T126|NON|EQV|NLM (2008)|070220|abbcdef", "ENTRY": "cGMP Phosphodiesterase, Calmodulin-Dependent", "MN": "D12.776.476.009.100", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.4.17", "RR": "EC 3.1.4.35", "PI": "3',5'-Cyclic-GMP Phosphodiesterases (1981-2007)", "MS": "A CALCIUM and CALMODULIN-dependent cyclic nucleotide phosphodiesterase subfamily. The three members of this family are referred to as type 1A, type 1B, and type 1C and are each product of a distinct gene. In addition, multiple enzyme variants of each subtype can be produced due to multiple alternative mRNA splicing. Although the type 1 enzymes are classified as 3',5'-cyclic-AMP phosphodiesterases (EC 3.1.4.17), some members of this class have additional specificity for CYCLIC GMP.", "PM": "2008; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE I was indexed under PHOSPHORIC DIESTER HYDROLASES 1990-2007, for CA++ CALMODULIN DEPENDENT CYCLIC AMP PHOSPHODIESTERASE see 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE 1986-2007, for CALMODULIN PHOSPHODIESTERASE see 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE 1981-2007, for CALMODULIN-DEPENDENT PHOSPHODIESTERASE see 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE 1984-2007", "HN": "2008(1981) for CA++ CALMODULIN DEPENDENT CYCLIC AMP PHOSPHODIESTERASE use 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE 1986-2007, for CALMODULIN PHOSPHODIESTERASE use 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE 1981-2007, for CALMODULIN-DEPENDENT PHOSPHODIESTERASE use 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE 1984-2007", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054677"}, {"RECTYPE": "D", "MH": "Cyclic Nucleotide Phosphodiesterases, Type 2", "DS": "CYCLIC NUCLEOTIDE PHOSPHODIESTERASES TYPE 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "cGMP Dependent 3',5' Cyclic Phosphodiesterase", "MN": "D12.776.476.009.200", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.4.17", "RR": "EC 3.1.4.17", "MS": "A cyclic nucleotide phosphodiesterase subfamily that is activated by the binding of CYCLIC GMP to an allosteric domain found on the enzyme. Multiple enzyme variants of this subtype can be produced due to multiple alternative mRNA splicing. The subfamily is expressed in a broad variety of tissues and may play a role in mediating cross-talk between CYCLIC GMP and CYCLIC CMP pathways. Although the type 2 enzymes are classified as 3',5'-cyclic-AMP phosphodiesterases (EC 3.1.4.17), members of this class have additional specificity for CYCLIC GMP.", "PM": "2008; PDE2 PHOSPHODIESTERASE now CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 2 was indexed under PHOSPHORIC DIESTER HYDROLASES 2000-2007", "HN": "2008(2000)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054678"}, {"RECTYPE": "D", "MH": "Ribosome Subunits, Small", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Subunits, Small Ribosome", "MN": "A11.284.430.214.190.875.811.870.750", "MH_TH": "NLM (2008)", "ST": "T026", "PI": "Ribosomes (1972-2007)", "MS": "The small ribonucleoprotein component of RIBOSOMES. It contains the MESSENGER RNA binding site and two TRANSFER RNA binding sites - one for the incoming AMINO ACYL TRNA (A site) and the other (P site) for the peptidyl tRNA carrying the elongating peptide chain.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054679"}, {"RECTYPE": "D", "MH": "Ribosome Subunits, Small, Bacterial", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Small Ribosome Subunits, Bacterial|T026|NON|EQV|NLM (2008)|070221|abcdef", "MN": "A20.874", "MH_TH": "NLM (2008)", "ST": "T026", "PI": "Ribosomes (1966-2007)", "MS": "The small subunit of eubacterial RIBOSOMES. It is composed of the 16S RIBOSOMAL RNA and about 23 different RIBOSOMAL PROTEINS.", "PM": "2008", "HN": "2008", "MR": "20090706", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054680"}, {"RECTYPE": "D", "MH": "Ribosome Subunits, Large, Bacterial", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Ribosome Subunits, 50S, Bacterial|T026|NON|EQV|NLM (2008)|070221|abcdef", "MN": "A20.873", "MH_TH": "NLM (2008)", "ST": "T026", "PI": "Ribosomes (1966-2007)", "MS": "The large subunit of the eubacterial 70s ribosome. It is composed of the 23S RIBOSOMAL RNA, the 5S RIBOSOMAL RNA, and about 37 different RIBOSOMAL PROTEINS.", "PM": "2008", "HN": "2008", "MR": "20090720", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054681"}, {"RECTYPE": "D", "MH": "Ribosome Subunits, Small, Eukaryotic", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Subunits, 40S Ribosome", "MN": "A11.284.430.214.190.875.811.870.750.750", "MH_TH": "NLM (2008)", "ST": "T026", "PI": "Ribosomes (1966-2007)", "MS": "The small subunit of the 80s ribosome of eukaryotes. It is composed of the 18S RIBOSOMAL RNA and 32 different RIBOSOMAL PROTEINS.", "PM": "2008", "HN": "2008", "MR": "20090720", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054682"}, {"RECTYPE": "D", "MH": "Ribosome Subunits, Large, Eukaryotic", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Subunits, 60S Ribosome", "MN": "A11.284.430.214.190.875.811.870.700.750", "MH_TH": "NLM (2008)", "ST": "T026", "PI": "Ribosomes (1967-2007)", "MS": "The large subunit of the 80s ribosome of eukaryotes. It is composed of the 28S RIBOSOMAL RNA, the 5.8S RIBOSOMAL RNA, the 5S RIBOSOMAL RNA, and about 50 different RIBOSOMAL PROTEINS.", "PM": "2008", "HN": "2008", "MR": "20090720", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054683"}, {"RECTYPE": "D", "MH": "Cyclic Nucleotide Phosphodiesterases, Type 3", "DS": "CYCLIC NUCLEOTIDE PHOSPHODIESTERASES TYPE 003", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "cGMP Inhibited Phosphodiesterase", "MN": "D12.776.476.008.300", "EC": "antagonists & inhibitors:Phosphodiesterase 3 Inhibitors", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.4.17", "RR": "EC 3.1.4.17", "MS": "A cyclic nucleotide phosphodiesterase subfamily that is inhibited by the binding of CYCLIC GMP to an allosteric domain found on the enzyme and through phosphorylation by regulatory kinases such as PROTEIN KINASE A and PROTEIN KINASE B. The two members of this family are referred to as type 3A, and type 3B, and are each product of a distinct gene. In addition multiple enzyme variants of each subtype can be produced due to multiple alternative mRNA splicing.", "PM": "2008; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3 was indexed under 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE 1995-2007", "HN": "2008(1995)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054684"}, {"RECTYPE": "D", "MH": "Lymphoma, Primary Effusion", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Primary Effusion Lymphoma|T191|NON|EQV|NLM (2008)|ORD (2010)|070221|abcdeef", "ENTRY": "Primary Effusion Lymphomas", "MN": "C20.683.515.761.480.150.592", "MH_TH": "NLM (2008)", "ST": "T191", "AN": "do not confuse with MALIGNANT PLEURAL EFFUSIONS", "MS": "A rare neoplasm of large B-cells usually presenting as serious effusions without detectable tumor masses. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. It is associated with HUMAN HERPESVIRUS 8, most often occurring in the setting of immunodeficiency.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054685"}, {"RECTYPE": "D", "MH": "Cytostatic Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cytostatic Drug|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Drug, Cytostatic", "MN": "D27.888.569.199", "FX": "Cytotoxins", "MH_TH": "UNK (19XX)", "ST": "T121", "RN": "0", "PI": "Antineoplastic Agents (1988-2007)", "MS": "Compounds that inhibit or prevent the proliferation of CELLS.", "PM": "2008; see ANTINEOPLASTIC AGENTS 1988-2007", "HN": "2008; use ANTINEOPLASTIC AGENTS 1988-2007", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054697"}, {"RECTYPE": "D", "MH": "Clausena", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Claussenas", "MN": "B01.875.800.575.912.250.875.216", "MH_TH": "NLM (2003)", "ST": "T002", "RN": "txid76958", "PI": "Rutaceae (2003-2007)", "MS": "A plant genus of the family RUTACEAE. Members contain anethole and CARBAZOLES.", "PM": "2008; see RUTACEAE 2003-2007", "HN": "2008; use RUTACEAE 2003-2007", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054700"}, {"RECTYPE": "D", "MH": "United States Agency for International Development", "PRINT ENTRY": "USAID|T092|NAM|EQV|NLM (1978)|781226|abcdef", "ENTRY": "United States. Agency for International Development|T092|NAM|EQV|NLM (2008)|070223|abcdef", "MN": "N03.540.348.500.500.199", "MH_TH": "NLM (2008)", "ST": "T092", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "MS": "An independent Federal agency established in 1961 as the focal point for economic matters affecting U.S. relations with developing countries.", "PM": "2008", "HN": "2008", "MR": "20150629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054702"}, {"RECTYPE": "D", "MH": "Cyclic Nucleotide Phosphodiesterases, Type 4", "DS": "CYCLIC NUCLEOTIDE PHOSPHODIESTERASES TYPE 004", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "cAMP Specific Phosphodiesterase 4A5", "MN": "D12.776.476.008.400", "EC": "antagonists & inhibitors:Phosphodiesterase 4 Inhibitors", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.4.17", "RR": "EC 3.1.4.17", "MS": "A cyclic nucleotide phosphodiesterase subfamily that is found predominantly in inflammatory cells and may play a role in the regulation of CELL-MEDIATED IMMUNITY. The enzyme family includes over twenty different variants that occur due to multiple ALTERNATIVE SPLICING of the mRNA of at least four different genes.", "PM": "2008; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4 was indexed under 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE 1981-2007; CAMP-SPECIFIC PHOSPHODIESTERASE 4A5 was indexed under 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE 2000-2007; PDE4D3 PHOSPHODIESTERASE was indexed under 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE 1996-2007", "HN": "2008(1981)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054703"}, {"RECTYPE": "D", "MH": "Peace Corps", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Peace Corps (U.S.)|T092|NAM|EQV|NLM (2008)|070223|abcdef", "MN": "N03.540.348.500.500.099", "MH_TH": "UNK (19XX)", "ST": "T092", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "PI": "Government Agencies (1979-2007)", "MS": "It was established in 1961 and made an independent agency in 1981. Its mission is to help the people of interested countries in meeting their need for trained men and women, and to help promote better mutual understanding between Americans and citizens of other countries. (United States Government Manual, 2006-2007, pg497)", "PM": "2008", "HN": "2008", "MR": "20150629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054704"}, {"RECTYPE": "D", "MH": "Mastocytoma, Skin", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Skin Mastocytoma|T191|NON|EQV|NLM (2003)|011219|abcdef", "ENTRY": "Solitary Mastocytoma of Skin|T191|NON|EQV|NLM (2008)|070223|abcdef", "MN": "C20.762.750.563.500", "MH_TH": "NLM (2003)", "ST": "T191", "MS": "A variant of cutaneous mastocytosis which occurs as a single lesion usually in infants. It is found mostly in the wrist and trunk and there is no atypical cytomorphology.", "PM": "2008; see MASTOCYTOMA 2003-2007", "HN": "2008; use MASTOCYTOMA 2003-2007", "MR": "20210707", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054705"}, {"RECTYPE": "D", "MH": "Cyclic Nucleotide Phosphodiesterases, Type 5", "DS": "CYCLIC NUCLEOTIDE PHOSPHODIESTERASES TYPE 005", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "cGMP-Specific Phosphodiesterase 5A", "MN": "D12.776.476.009.500", "EC": "antagonists & inhibitors:Phosphodiesterase 5 Inhibitors", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.4.35", "RR": "EC 3.1.4.17", "MS": "A cyclic nucleotide phosphodiesterase subfamily that is highly specific for CYCLIC GMP. It is found predominantly in vascular tissue and plays an important role in regulating VASCULAR SMOOTH MUSCLE contraction.", "PM": "2008; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5 was indexed under 3',5'-CYCLIC-GMP PHOSPHODIESTERASE 1998-2007", "HN": "2008(1998)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054706"}, {"RECTYPE": "D", "MH": "Cyclic Nucleotide Phosphodiesterases, Type 6", "DS": "CYCLIC NUCLEOTIDE PHOSPHODIESTERASES TYPE 006", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "gamma Subunit, cGMP-PDE", "MN": "D12.776.476.009.750", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.4.35", "RR": "EC 3.1.4.35", "MS": "A cyclic nucleotide phosphodiesterase subfamily that is highly specific for CYCLIC GMP. It is found predominantly in the outer segment PHOTORECEPTOR CELLS of the RETINA. It is comprised of two catalytic subunits, referred to as alpha and beta, that form a dimer. In addition two regulatory subunits, referred to as gamma and delta, modulate the activity and localization of the enzyme.", "PM": "2008; PHOSPHODIESTERASE 6 (now CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 6) was indexed under PHOSPHORIC ACID DIESTERASES 2001-2007; CGMP PHOSPHODIESTERASE DELTA SUBUNIT was indexed under 3,5,'-CYCLIC-GMP PHOSPHODIESTERASE 2004-2007", "HN": "2008(2001)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054707"}, {"RECTYPE": "D", "MH": "Cyclic Nucleotide Phosphodiesterases, Type 7", "DS": "CYCLIC NUCLEOTIDE PHOSPHODIESTERASES TYPE 007", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "cAMP Phosphodiesterase 7", "MN": "D12.776.476.008.700", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.4.17", "RR": "EC 3.1.4.17", "MS": "A cyclic nucleotide phosphodiesterase subfamily that is highly specific for CYCLIC AMP. Several isoforms of the enzyme type exist, each with its own tissue localization. The isoforms are encoded by at least two genes and are a product of multiple alternative splicing of their mRNAs.", "PM": "2008; PHOSPHODIESTERASE-7 (now CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE-7) 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE 1998-2007", "HN": "2008(1998)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054708"}, {"RECTYPE": "D", "MH": "Lecithins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Lecithin|T109|NON|EQV|UNK (19XX)|871112|abcdef", "MN": "D20.215.784.500.492", "PA": "Surface-Active Agents", "MH_TH": "UNK (19XX)", "ST": "T109", "RN": "0", "PI": "Phosphatidylcholines (1977-2007)", "MS": "A complex mixture of PHOSPHOLIPIDS; GLYCOLIPIDS; and TRIGLYCERIDES; with substantial amounts of PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; and PHOSPHATIDYLINOSITOLS, which are sometimes loosely termed as 1,2-diacyl-3-phosphocholines. Lecithin is a component of the CELL MEMBRANE and commercially extracted from SOYBEANS and EGG YOLK. The emulsifying and surfactant properties are useful in FOOD ADDITIVES and for forming organogels (GELS).", "PM": "2008, 1963-1976; see PHOSPHATIDYLCHOLINES 1977-2007", "HN": "2008, 1963-1976; use PHOSPHATIDYLCHOLINES 1977-2007", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054709"}, {"RECTYPE": "D", "MH": "Interactive Tutorial", "ENTRY": "Interactive Media|T170|NON|EQV|NLM (2011)|100426|abcdef", "MN": "V01.255.500.625", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. CATALOGER: do not use", "MS": "Video recordings or other files in which the progress of the instruction or content is determined by user response.", "HN": "2011(2008)", "MR": "20150605", "DA": "20070709", "DC": "2", "DX": "20080101", "UI": "D054710"}, {"RECTYPE": "D", "MH": "Introductory Journal Article", "ENTRY": "Prefatory Journal Article|T170|NON|EQV|NLM (2008)|070228|abcdef", "MN": "V02.600.249", "MH_TH": "NLM (2008)", "ST": "T170", "AN": "This heading is used as a Publication Type. CATALOGER: do not use", "MS": "Prefatory summary to a special issue or section of a journal devoted to a specific topic. This introductory text can be of varying length and substance.", "HN": "2008", "MR": "20191121", "DA": "20070709", "DC": "2", "DX": "20080101", "UI": "D054711"}, {"RECTYPE": "D", "MH": "Salinity", "MN": "G02.640.500", "MH_TH": "NLM (2008)", "ST": "T034", "PI": "Sodium Chloride (1963-2007)", "MS": "Degree of saltiness, which is largely the OSMOLAR CONCENTRATION of SODIUM CHLORIDE plus any other SALTS present. It is an ecological factor of considerable importance, influencing the types of organisms that live in an ENVIRONMENT.", "PM": "2008", "HN": "2008", "MR": "20150625", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054712"}, {"RECTYPE": "D", "MH": "Bryostatins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bryostatin|T109|NON|EQV|NLM (2021)|191121|abcdef", "MN": "D23.946.580.800.250", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "PI": "Macrolides (1985-2007)", "MS": "A group of 20-member macrolactones in which there are three remotely substituted pyran rings that are linked by a methylene bridge and an E-disubstituted alkene and have geminal dimethyls at C8 and C18 carbons. Some interact with PROTEIN KINASE C.", "PM": "2008", "HN": "2008", "MR": "20230607", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054713"}, {"RECTYPE": "D", "MH": "Echinocandins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Pneumocandin|T116|NON|NRW|NLM (2021)|191219|abcdef", "ENTRY": "Pneumocandins|T116|NON|NRW|NLM (2008)|070301|abcdef", "MN": "D12.644.641.311", "PA": "Antifungal Agents", "MH_TH": "NLM (2008)", "ST": "T116", "RN": "0", "PI": "Peptides, Cyclic (1981-2007)", "MS": "Cyclic hexapeptides of proline-ornithine-threonine-proline-threonine-serine. The cyclization with a single non-peptide bond can lead them to be incorrectly called DEPSIPEPTIDES, but the echinocandins lack ester links. Antifungal activity is via inhibition of 1,3-beta-glucan synthase production of BETA-GLUCANS.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054714"}, {"RECTYPE": "D", "MH": "Cardiotoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cardiotoxin|T123|T131|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Agents, Cardiotoxic", "MN": "D27.888.569.142", "MH_TH": "NLM (2008)", "ST": "T131", "RN": "0", "AN": "do not confuse with CARDIOTONIC AGENTS", "MS": "Agents that have a damaging effect on the HEART. Such damage can occur from ALKYLATING AGENTS; FREE RADICALS; or metabolites from OXIDATIVE STRESS and in some cases is countered by CARDIOTONIC AGENTS. Induction of LONG QT SYNDROME or TORSADES DE POINTES has been the reason for viewing some drugs as cardiotoxins.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054715"}, {"RECTYPE": "D", "MH": "Cucurbitacins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cucurbitacin|T109|NON|EQV|NLM (2021)|191118|abcdef", "MN": "D02.455.849.919.138", "MH_TH": "NLM (2008)", "ST": "T109", "N1": "19-Norlanosta-1,5-diene-3,11,22-trione, 16,24-epoxy-2,25-dihydroxy-9-methyl-, (9beta,10alpha,16alpha,24S)-", "RN": "60137-06-6", "MS": "Triterpenes that derive from LANOSTEROL by a shift of the C19 methyl to the C9 position. They are found in seeds and roots of CUCURBITACEAE and other plants and are noted for intense bitterness.", "PM": "2008; CUCURBITACINS was indexed under Triterpenes 1975-2007", "HN": "2008 (1975); use CUCURBITACINS (NM) 1975-1980", "MR": "20200527", "DA": "20070711", "DC": "1", "DX": "20080101", "UI": "D054728"}, {"RECTYPE": "D", "MH": "Calcium-Calmodulin-Dependent Protein Kinase Type 1", "DS": "CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE TYPE 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinase, CamKI-Like", "MN": "D12.776.476.563.125.100", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.17", "RR": "EC 2.7.11.17", "MS": "A monomeric calcium-calmodulin-dependent protein kinase subtype that is expressed in a broad variety of mammalian cell types. Its expression is regulated by the action of CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE. Several isoforms of this enzyme subtype are encoded by distinct genes.", "PM": "2008; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1 was indexed under CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES 1997-2007", "HN": "2008(1994)", "MR": "20210520", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054729"}, {"RECTYPE": "D", "MH": "Protein Interaction Domains and Motifs", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Protein Interaction Motifs|T116|T123|NON|REL|NLM (2008)|070305|abbcdef", "ENTRY": "Protein-Protein Interaction Domain", "MN": "G02.111.570.820.709.275.750.500", "FX": "Protein Interaction Maps", "MH_TH": "NLM (2008)", "ST": "T082", "MS": "Protein modules with conserved ligand-binding surfaces which mediate specific interaction functions in SIGNAL TRANSDUCTION PATHWAYS and the specific BINDING SITES of their cognate protein LIGANDS.", "PM": "2008", "HN": "2008", "MR": "20160531", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054730"}, {"RECTYPE": "D", "MH": "PDZ Domains", "AQ": "DE GE IM PH RE", "ENTRY": "Repeats Domains, GLGF", "MN": "G02.111.570.820.709.275.750.500.500", "MH_TH": "NLM (2008)", "ST": "T082", "MS": "Protein interaction domains of about 70-90 amino acid residues, named after a common structure found in PSD-95, Discs Large, and Zona Occludens 1 proteins. PDZ domains are involved in the recruitment and interaction of proteins, and aid the formation of protein scaffolds and signaling networks. This is achieved by sequence-specific binding between a PDZ domain in one protein and a PDZ motif in another protein.", "PM": "2008", "HN": "2008", "MR": "20160531", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054731"}, {"RECTYPE": "D", "MH": "Calcium-Calmodulin-Dependent Protein Kinase Type 2", "DS": "CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE TYPE 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Calmodulin Dependent Protein Kinase II", "MN": "D12.776.476.563.125.200", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.17", "RR": "EC 2.7.11.17", "MS": "A multifunctional calcium-calmodulin-dependent protein kinase subtype that occurs as an oligomeric protein comprised of twelve subunits. It differs from other enzyme subtypes in that it lacks a phosphorylatable activation domain that can respond to CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE.", "PM": "2008; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2 was indexed under CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES 1993-2006", "HN": "2008(1993)", "MR": "20210520", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054732"}, {"RECTYPE": "D", "MH": "Calcium-Calmodulin-Dependent Protein Kinase Type 4", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Calmodulin-Dependent Protein Kinase IV|T116|T126|NON|EQV|NLM (2008)|abbcde", "ENTRY": "Calmodulin Dependent Protein Kinase IV", "MN": "D12.776.476.563.125.350", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.17", "MS": "A monomeric calcium-calmodulin-dependent protein kinase subtype that is primarily expressed in neuronal tissues; T-LYMPHOCYTES and TESTIS. The activity of this enzyme is regulated by its phosphorylation by CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE.", "PM": "2008; CALMODULIN-DEPENDENT PROTEIN KINASE IV (now CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 4) was indexed under CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES 1991-2007", "HN": "2008(1991)", "MR": "20210520", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054734"}, {"RECTYPE": "D", "MH": "Phosphorothioate Oligonucleotides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oligonucleotides, Phosphorothioate", "MN": "D13.695.578.424.575", "MH_TH": "NLM (2008)", "ST": "T114", "RN": "0", "PI": "Thionucleotides (1990-2007)", "MS": "Modified oligonucleotides in which one of the oxygens of the phosphate group is replaced with a sulfur atom.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054735"}, {"RECTYPE": "D", "MH": "Elongation Factor 2 Kinase", "DS": "ELONGATION FACTOR A 002 KINASE", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Calmodulin-Dependent Protein Kinase III|T116|T126|NON|EQV|NLM (2008)|abbcde", "ENTRY": "eEF 2 Specific Ca and Calmodulin Dependent Protein Kinase III", "MN": "D12.776.476.563.125.425", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.20", "MS": "A monomeric calcium-calmodulin-dependent protein kinase subtype that specifically phosphorylates PEPTIDE ELONGATION FACTOR 2. The enzyme lacks a phosphorylatable activation domain that can respond to CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE, however it is regulated by phosphorylation by PROTEIN KINASE A and through intramolecular autophosphorylation.", "PM": "2008; CALMODULIN-DEPENDENT PROTEIN KINASE III (now ELONGATION FACTOR 2 KINASE) was indexed under CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES 1987-2007", "HN": "2008(1987)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054736"}, {"RECTYPE": "D", "MH": "Calcium-Calmodulin-Dependent Protein Kinase Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Calcium-Calmodulin-Dependent Kinase Kinase|T116|T126|NON|EQV|NLM (2008)|011013|abbcdef", "ENTRY": "CamKK alpha", "MN": "D12.776.476.563.125.049", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.17", "RR": "EC 2.7.11.17", "MS": "A regulatory calcium-calmodulin-dependent protein kinase that specifically phosphorylates CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 4; and PROTEIN KINASE B. It is a monomeric enzyme that is encoded by at least two different genes.", "PM": "2008; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES 1995-2007", "HN": "2008(1995)", "MR": "20210520", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054737"}, {"RECTYPE": "D", "MH": "Scala Vestibuli", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vestibulus, Scala", "MN": "A09.246.300.246.874", "MH_TH": "NLM (2008)", "ST": "T023", "AN": "SCALA TYMPANI is also available", "PI": "Cochlea (1969-2007)", "MS": "The upper chamber of the COCHLEA that is filled with PERILYMPH. It is connected to SCALA TYMPANI via helicotrema at the apex of the cochlea.", "PM": "2008", "HN": "2008", "MR": "20180702", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054738"}, {"RECTYPE": "D", "MH": "Dendritic Cell Sarcoma, Interdigitating", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Interdigitating Dendritic Cell Sarcoma|T191|NON|EQV|NLM (2008)|070306|abcdef", "ENTRY": "Sarcomas, Interdigitating Cell", "MN": "C15.604.250.390.199", "MH_TH": "NLM (2008)", "ST": "T191", "PI": "Sarcoma (2001-2007)", "MS": "A rare sarcoma of INTERDIGITATING CELLS found in the lymph nodes and non-lymphoid organs. They exhibit a variable immunophenotype and lack Birbeck granules.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054739"}, {"RECTYPE": "D", "MH": "Dendritic Cell Sarcoma, Follicular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Follicular Dendritic Cell Sarcoma|T191|NON|EQV|NLM (2008)|070306|abcdef", "MN": "C15.604.250.390.190", "MH_TH": "NLM (2008)", "ST": "T191", "PI": "Sarcoma (1987-2007)", "MS": "Sarcoma of FOLLICULAR DENDRITIC CELLS most often found in the lymph nodes. This rare neoplasm occurs predominately in adults.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054740"}, {"RECTYPE": "D", "MH": "Acyl-Butyrolactones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Butyrylhomoserine Lactone|T109|NON|NRW|NLM (2021)|191118|abcdef", "ENTRY": "Lactones, Butyrylhomoserine", "MN": "D02.540.232", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "PI": "Homoserine (1994-2007)", "MS": "Cyclic esters of acylated BUTYRIC ACID containing four carbons in the ring.", "PM": "2008; ACYLATED HOMOSERINE LACTONE was indexed under 4-BUTYROLACTONE 2003-2007", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054742"}, {"RECTYPE": "D", "MH": "Cyclic AMP-Dependent Protein Kinase Type I", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Kinase Type I, Cyclic AMP-Dependent|T116|T126|ABX|EQV|NLM (2008)|070306|abbcdef", "ENTRY": "Protein Kinase Type I, Cyclic AMP Dependent", "MN": "D12.776.476.563.150.125.750", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.11", "PI": "Cyclic AMP-Dependent Protein Kinases (1994-2007)", "MS": "A cyclic AMP-dependent protein kinase subtype primarily found in the CYTOPLASM. They are tetrameric proteins that contain two catalytic subunits and two type I-specific regulatory subunits.", "PM": "2008", "HN": "2008", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054743"}, {"RECTYPE": "D", "MH": "Cyclic AMP-Dependent Protein Kinase Type II", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Kinase Type II, Cyclic AMP-Dependent|T116|T126|ABX|EQV|NLM (1994)|921019|abbcdef", "ENTRY": "Protein Kinase Type II, Cyclic AMP Dependent", "MN": "D12.776.476.563.150.125.875", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.11", "PI": "Cyclic AMP-Dependent Protein Kinases (1992-2007)", "MS": "A cyclic AMP-dependent protein kinase subtype primarily found in particulate subcellular fractions. They are tetrameric proteins that contain two catalytic subunits and two type II-specific regulatory subunits.", "PM": "2008; for PROTEIN KINASE TYPE II, CYCLIC AMP-DEPENDENT see CYCLIC AMP-DEPENDENT PROTEIN KINASES 1992-2007", "HN": "2008(2007)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054746"}, {"RECTYPE": "D", "MH": "Histiocytic Sarcoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Malignant Histiocytosis|T191|NON|NRW|UNK (19XX)|860418|abcdef", "ENTRY": "True Malignant Histiocytoses", "MN": "C15.604.250.390.380", "MH_TH": "NLM (2008)", "ST": "T191", "MS": "Malignant neoplasms composed of MACROPHAGES or DENDRITIC CELLS. Most histiocytic sarcomas present as localized tumor masses without a leukemic phase. Though the biological behavior of these neoplasms resemble lymphomas, their cell lineage is histiocytic not lymphoid.", "PM": "2008; for HISTIOCYTOSIS, MALIGNANT see HISTIOCYTOSIS, MALIGNANT 1987-2007", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054747"}, {"RECTYPE": "D", "MH": "Ribosome Subunits, Large, Archaeal", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Ribosome Subunits, 50S, Archaeal|T026|NON|EQV|NLM (2008)|070307|abcdef", "MN": "A11.284.430.214.190.875.811.870.700.349", "MH_TH": "NLM (2008)", "ST": "T026", "PI": "Ribosomes (1993-2007)", "MS": "The large subunit of the archaeal 70s ribosome. It is composed of the 23S RIBOSOMAL RNA, the 5S RIBOSOMAL RNA, and about 40 different RIBOSOMAL PROTEINS.", "PM": "2008", "HN": "2008", "MR": "20130709", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054748"}, {"RECTYPE": "D", "MH": "Ribosome Subunits, Small, Archaeal", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Small Ribosome Subunits, Archaeal|T026|NON|EQV|NLM (2008)|070307|abcdef", "MN": "A11.284.430.214.190.875.811.870.750.349", "MH_TH": "NLM (2008)", "ST": "T026", "PI": "Ribosomes (1998-2007)", "MS": "The small subunit of archaeal RIBOSOMES. It is composed of the 16S RIBOSOMAL RNA and about 28 different RIBOSOMAL PROTEINS.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054749"}, {"RECTYPE": "D", "MH": "Ecotoxicology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Toxicology, Environmental", "MN": "H02.884.211", "MH_TH": "NLM (2008)", "ST": "T090", "PI": "Toxicology (1976-2007)", "MS": "The study of ENVIRONMENTAL POLLUTION and the toxic effects of ENVIRONMENTAL POLLUTANTS on the ECOSYSTEM. The term was coined by Truhaut in 1969.", "PM": "2008", "HN": "2008", "MR": "20150210", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054750"}, {"RECTYPE": "D", "MH": "Cyclic AMP-Dependent Protein Kinase Catalytic Subunits", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Kinase A, Catalytic Subunits|T116|T126|NON|EQV|NLM (2008)|070423|abbcdef", "ENTRY": "cAMP Dependent Protein Kinase, gamma Catalytic Subunit", "MN": "D12.776.476.563.150.125.875.500", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.11", "RR": "EC 2.7.11.11", "PI": "Cyclic AMP-Dependent Protein Kinases (1994-2007)", "MS": "Specific enzyme subunits that form the active sites of the type I and type II cyclic-AMP protein kinases. Each molecule of enzyme contains two catalytic subunits.", "PM": "2008", "HN": "2008", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054751"}, {"RECTYPE": "D", "MH": "Langerhans Cell Sarcoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sarcomas, Langerhans Cell", "MN": "C15.604.250.390.500", "MH_TH": "NLM (2008)", "ST": "T191", "MS": "Rare malignant neoplasm of dendritic LANGERHANS CELLS exhibiting atypical cytology, frequent mitoses, and aggressive clinical behavior. They can be distinguished from other histiocytic and dendritic proliferations by immunohistochemical and ultrastructure studies. Cytologically benign proliferations of Langerhans cells are called LANGERHANS CELL HISTIOCYTOSIS.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054752"}, {"RECTYPE": "D", "MH": "Cyclic AMP-Dependent Protein Kinase RIbeta Subunit", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Kinase A, RIbeta Subunit|T116|T126|NON|EQV|NLM (2008)|070423|abbcdef", "ENTRY": "cAMP Dependent Protein Kinase, Type 1beta Regulatory Subunit", "MN": "D12.776.476.563.150.125.750.750", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "0", "MS": "A type I cAMP-dependent protein kinase regulatory subunit that plays a role in confering CYCLIC AMP activation of protein kinase activity. It is found abundantly expressed in the neuronal tissue and may be associated with hippocampal function.", "PM": "2008; CAMP-DEPENDENT PROTEIN KINASE, TYPE1BETA-REGULATORY SUBUNIT (now CYCLIC-AMP-DEPENEDNT PROTEIN KINASE RIBETA SUBUNIT) was indexed under CYCLIC AMP-DEPENDENT KINASES 1998-2007", "HN": "2008(1998)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054753"}, {"RECTYPE": "D", "MH": "Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Kinase A, RII alpha Subunit|T116|T126|NON|EQV|NLM (2008)|070423|abbcdef", "ENTRY": "cAMP Dependent Protein Kinase, Type 2alpha Regulatory Subunit", "MN": "D12.776.476.563.150.125.875.750", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "0", "MS": "A type II cAMP-dependent protein kinase regulatory subunit that plays a role in confering CYCLIC AMP activation of protein kinase activity. It has a higher affinity for cAMP than that of the CYCLIC-AMP-DEPENDENT PROTEIN KINASE RIIBETA SUBUNIT. Binding of this subunit by A KINASE ANCHOR PROTEINS may play a role in the cellular localization of type II protein kinase A.", "PM": "2008; CAMP-DEPENDENT PROTEIN KINASE, TYPE 2ALPHA-REGULATORY SUBUNIT (now CYCLIC-AMP-DEPENDENT PROTEIN KINASE RIIALPHA SUBUNIT) was indexed under 1998-2007", "HN": "2008(1998)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054754"}, {"RECTYPE": "D", "MH": "Imidazoline Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptors, Imidazoline-Guanidinium|T116|T192|NON|EQV|NLM (2008)|abbcde", "ENTRY": "Receptors, Imidazoline Guanidinium", "MN": "D12.776.827.137", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "0", "PI": "Drug Receptors (1988-2007)", "MS": "Receptors of CLONIDINE and other IMIDAZOLINES. Activity of the ligands was earlier attributed to ADRENERGIC ALPHA-2 RECEPTORS. Endogenous ligands include AGMATINE, imidazoleacetic acid ribotide, and harman.", "PM": "2008; for IMIDAZOLINE RECEPTORS use DRUG RECEPTORS 1988-2007", "HN": "2008(1988)", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054755"}, {"RECTYPE": "D", "MH": "Cyclic AMP-Dependent Protein Kinase RIalpha Subunit", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Kinase A, RIalpha Subunit|T116|T126|NON|EQV|NLM (2008)|070423|abbcdef", "ENTRY": "Regulatory Subunit RIalpha, Cyclic AMP Dependent Protein Kinase", "MN": "D12.776.476.563.150.125.750.625", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "0", "MS": "A type I cAMP-dependent protein kinase regulatory subunit that plays a role in confering CYCLIC AMP activation of protein kinase activity. It has a lower affinity for cAMP than the CYCLIC-AMP-DEPENDENT PROTEIN KINASE RIBETA SUBUNIT.", "PM": "2008; CYCLIC-AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT was indexed under CYCLIC AMP-DEPENDENT PROTEIN KINASES 1998-2007", "HN": "2008(1998)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054756"}, {"RECTYPE": "D", "MH": "Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Protein Kinase A, RII beta Subunit|T116|T126|NON|EQV|NLM (2008)|070423|abbcdef", "ENTRY": "cAMP Dependent Protein Kinase, Type 2beta Regulatory Subunit", "MN": "D12.776.476.563.150.125.875.875", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "0", "MS": "A type II cAMP-dependent protein kinase regulatory subunit that plays a role in confering CYCLIC AMP activation of protein kinase activity. It has a lower affinity for cAMP than the CYCLIC-AMP-DEPENDENT PROTEIN KINASE RIIALPHA SUBUNIT. Binding of this subunit by A KINASE ANCHOR PROTEINS may play a role in the cellular localization of type II protein kinase A.", "PM": "2008; CYCLIC-AMP-DEPENDENT PROTEIN KINASE RIIBETA SUBUNIT was indexed under CYCLIC AMP-DEPENDENT PROTEIN KINASES 1998-2006", "HN": "2008(1998)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054757"}, {"RECTYPE": "D", "MH": "A Kinase Anchor Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "A-Kinase Anchoring Proteins|T116|T123|NON|EQV|NLM (2021)|191122|abbcdef", "ENTRY": "Protein, A-Kinase Anchoring", "MN": "D12.776.476.024.069", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "MS": "A structurally-diverse family of intracellular-signaling adaptor proteins that selectively tether specific protein kinase A subtypes to distinct subcellular sites. They play a role in focusing the PROTEIN KINASE A activity toward relevant substrates. Over fifty members of this family exist, most of which bind specifically to regulatory subunits of CYCLIC AMP-DEPENDENT PROTEIN KINASE TYPE II such as CAMP PROTEIN KINASE RIIALPHA or CAMP PROTEIN KINASE RIIBETA.", "PM": "2008", "HN": "2008", "MR": "20200116", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054758"}, {"RECTYPE": "D", "MH": "G-Protein-Coupled Receptor Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "G-Protein-Coupled Receptor Kinase|T116|T126|NON|EQV|NLM (2022)|201016|abbcdef", "ENTRY": "Receptor Kinases, G-Protein-Coupled", "MN": "D12.776.476.563.364", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.16", "MS": "A family of serine-threonine kinases that are specific for G-PROTEIN-COUPLED RECEPTORS. They are regulatory proteins that play a role in G-protein-coupled receptor densensitization.", "PM": "2008", "HN": "2008", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054768"}, {"RECTYPE": "D", "MH": "G-Protein-Coupled Receptor Kinase 2", "DS": "G PROTEIN COUPLED RECEPTOR KINASE 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Adrenergic Receptor Kinase 1|T116|T126|NON|EQV|NLM (2008)|070309|BETA ADRENERGIC RECEPTOR KINASE 001|abbcdefs", "ENTRY": "beta Adrenergic Receptor Kinase 1", "MN": "D12.776.476.563.364.049.200", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.16", "PI": "beta-Adrenergic Receptor Kinases (1987-2007)", "MS": "A ubiquitously expressed G-protein-coupled receptor kinase subtype that has specificity for the agonist-occupied form of BETA-ADRENERGIC RECEPTORS. It may play an essential role in regulating myocardial contractile response.", "PM": "2008", "HN": "2008", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054769"}, {"RECTYPE": "D", "MH": "G-Protein-Coupled Receptor Kinase 3", "DS": "G PROTEIN COUPLED RECEPTOR KINASE 003", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Adrenergic Receptor Kinase 2|T116|T126|NON|EQV|NLM (2008)|070309|BETA ADRENERGIC RECEPTOR KINASE 02|abbcdefs", "ENTRY": "beta Adrenergic Receptor Kinase 2", "MN": "D12.776.476.563.364.049.300", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.15", "RR": "EC 2.7.11.16", "MS": "A ubiquitously expressed G-protein-coupled receptor kinase subtype that has specificity for the agonist-occupied form of BETA-ADRENERGIC RECEPTORS and a variety of other G-PROTEIN-COUPLED RECEPTORS. Although it is highly homologous to G-PROTEIN-COUPLED RECEPTOR KINASE 2, it is not considered to play an essential role in regulating myocardial contractile response.", "PM": "2008; G-PROTEIN-COUPLED RECEPTOR KINASE 3 was indexed under BETA-ADRENERGIC RECEPTOR KINASES 2008, PROTEIN-SERINE-THREONINE KINASES 2000-2007 & under RECEPTOR PROTEIN-TYROSINE KINASES 1995-1999", "HN": "2008(1995)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054770"}, {"RECTYPE": "D", "MH": "G-Protein-Coupled Receptor Kinase 4", "DS": "G PROTEIN COUPLED RECEPTOR KINASE 004", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "GRK4 beta Kinase", "MN": "D12.776.476.563.364.550", "MH_TH": "NLM (2008)", "ST": "T192", "RN": "EC 2.7.11.16", "RR": "EC 2.7.11.16", "MS": "A G-protein-coupled receptor kinase subtype that is primarily expressed in the TESTES and BRAIN. Variants of this subtype exist due to multiple alternative splicing of its mRNA.", "PM": "2008; G-PROTEIN-COUPLED RECEPTOR KINASE 4 was indexed under PROTEIN-SERINE-THREONINE KINASES 2000-2007, & under RECEPTOR PROTEIN-TYROSINE KINASES 1994-1999", "HN": "2008(1994)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054771"}, {"RECTYPE": "D", "MH": "Rats, Hairless", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Rat, Hairless", "MN": "B01.050.150.900.649.313.992.635.505.700.550.408", "MH_TH": "NLM (2008)", "ST": "T015", "MS": "Mutant strains of rats that produce little or no hair. Several different homozygous recessive mutations can cause hairlessness in rats including rnu/rnu (Rowett nude), fz/fz (fuzzy), shn/shn (shorn), and nznu/nznu (New Zealand nude). Note that while NUDE RATS are often hairless, they are most characteristically athymic.", "PM": "2008", "HN": "2008", "MR": "20200902", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054772"}, {"RECTYPE": "D", "MH": "Streptococcus gordonii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.737.872.260", "MH_TH": "NLM (2008)", "ST": "T007", "RN": "txid1302", "AN": "infection: coordinate IM with STREPTOCOCCAL INFECTIONS (IM) and ENDOCARDITIS, BACTERIAL (IM) or DENTAL PLAQUE (IM) if pertinent", "PI": "Streptococcus (1990-2007)", "MS": "A species of gram-positive, facultatively anaerobic bacteria in the family STREPTOCOCCACEAE. It is a normal inhabitant of the human oral cavity, and causes DENTAL PLAQUE and ENDOCARDITIS. It is being investigated as a vehicle for vaccine delivery.", "PM": "2008", "HN": "2008", "MR": "20200813", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054773"}, {"RECTYPE": "D", "MH": "G-Protein-Coupled Receptor Kinase 5", "DS": "G PROTEIN COUPLED RECEPTOR KINASE 005", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "G Protein Coupled Receptor Kinase 5", "MN": "D12.776.476.563.364.775", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.11.16", "MS": "A G-protein-coupled receptor kinase subtype that is primarily expressed in the MYOCARDIUM and may play a role in the regulation of cardiac functions.", "PM": "2008; G-PROTEIN-COUPLED RECEPTOR KINASE 5 was indexed under PROTEIN-SERINE-THREONINE KINASES 2000-2007, under RECEPTOR PROTEIN-TYROSINE KINASES 1994-1999, & under PROTEIN KINASE 1993", "HN": "2008(1993)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054774"}, {"RECTYPE": "D", "MH": "Semicircular Ducts", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Semicircular Duct", "MN": "A09.923.125", "MH_TH": "NLM (2008)", "ST": "T023", "PI": "Vestibular Labyrinth (1971-2007)", "MS": "The three membranous semicircular ducts within the bony semicircular canals. They open into the UTRICLE through five openings. Each duct has at one end a sensory area called the ampullary crest. AMPULLARY HAIR CELLS of the crests sense the movement of ENDOLYMPH resulting from rotation of the head.", "PM": "2008", "HN": "2008", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054776"}, {"RECTYPE": "D", "MH": "Hair Cells, Ampulla", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Hair Cells, Ampullary", "MN": "A09.923.125.500", "FX": "Stereocilia", "MH_TH": "NLM (2008)", "ST": "T025", "PI": "Vestibular Labyrinth (1978-2007)", "MS": "Sensory cells in the ampullary crest of each of the semicircular ducts, with their apical STEREOCILIA embedded in a wedge-shaped gelatinous cupula. These hair cells sense the movement of ENDOLYMPH resulting from angular acceleration of the head, and send signals via the VESTIBULAR NERVE to the brain to maintain balance.", "PM": "2008", "HN": "2008", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054777"}, {"RECTYPE": "D", "MH": "NM23 Nucleoside Diphosphate Kinases", "DS": "NM NUCLEOSIDE DIPHOSPHATE KINASES 23", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nucleoside Diphosphate Kinase A|T116|T123|NON|NRW|NLM (2008)|040914|abbcdef", "ENTRY": "Tumor Metastatic Process Associated Protein", "MN": "D08.811.913.696.650.550.200", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "0", "RR": "EC 2.7.4.6", "MS": "A family of nucleotide diphosphate kinases that play a role in a variety of cellular signaling pathways that effect CELL DIFFERENTIATION; CELL PROLIFERATION; and APOPTOSIS. They are considered multifunctional proteins that interact with a variety of cellular proteins and have functions that are unrelated to their enzyme activity.", "PM": "2008; NUCLEOSIDE DIPHOSPHATE KINASE A (now NM23 NUCLEOSIDE DIPHOSPHATE KINASES) was indexed under NUCLEOSIDE-DIPHOSPHATE KINASE 2005-2007, under GENES, TUMOR SUPPRESSOR 2005, under MONOMERIC GTP-BINDING PROTEINS 1994-2004, under TRANSCRIPTION FACTORS 1994-2004, & under PROTEINS 1989-1993", "HN": "2008(1989)", "MR": "20110624", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054778"}, {"RECTYPE": "D", "MH": "Ribosome Inactivating Proteins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RNA N-Glycosidase|T116|T126|NON|EQV|NLM (2008)|abbcde", "ENTRY": "rRNA N Glycosylases", "MN": "D12.776.765.710", "PA": "Protein Synthesis Inhibitors", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.2.2.22", "PI": "N-Glycosyl Hydrolases (1988-2007)", "MS": "N-Glycosidases that remove adenines from RIBOSOMAL RNA, depurinating the conserved alpha-sarcin loop of 28S RIBOSOMAL RNA. They often consist of a toxic A subunit and a binding lectin B subunit. They may be considered as PROTEIN SYNTHESIS INHIBITORS. They are found in many PLANTS and have cytotoxic and antiviral activity.", "PM": "2008; RNA N-GLYCOSIDASE was indexed under N-GLYCOSYL HYDROLASES 1988-2007", "HN": "2008(1988)", "MR": "20210630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054788"}, {"RECTYPE": "D", "MH": "Ribosome Inactivating Proteins, Type 1", "DS": "RIBOSOME INACTIVATING PROTEINS TYPE 001", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.765.710.500", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "0", "MS": "Ribosome inactivating proteins consisting of only the toxic A subunit, which is a polypeptide of around 30 kDa.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054789"}, {"RECTYPE": "D", "MH": "Ribosome Inactivating Proteins, Type 2", "DS": "RIBOSOME INACTIVATING PROTEINS TYPE 002", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.765.710.750", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "0", "MS": "Ribosome inactivating proteins consisting of two polypeptide chains, the toxic A subunit and a lectin B subunit, linked by disulfide bridges. The lectin portion binds to cell surfaces and facilitates transport into the ENDOPLASMIC RETICULUM.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054790"}, {"RECTYPE": "D", "MH": "Cervical Length Measurement", "AQ": "AE CL DE EC ES HI IS MO MT NU PX RE SN ST TD VE", "ENTRY": "Cervical Length Measurements", "MN": "E01.370.378.630.865.249", "MH_TH": "NLM (2008)", "ST": "T081", "PI": "Ultrasonography (1988-2007)", "MS": "A parameter usually used in PRENATAL ULTRASONOGRAPHY to measure the length of the uterine neck (CERVIX UTERI). Cervical length or its shortening is used to identify and prevent early cervical opening and PRETERM BIRTH.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054791"}, {"RECTYPE": "D", "MH": "Muscle, Striated", "DE": "MUSCLE STRIATED", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Striated Muscle|T024|NON|EQV|NLM (2008)|070314|abcdef", "ENTRY": "Striated Muscles", "MN": "A10.690.552", "MH_TH": "NLM (1995)", "ST": "T024", "PI": "Muscles, Skeletal (1994-2008)", "MS": "One of two types of muscle in the body, characterized by the array of bands observed under microscope. Striated muscles can be divided into two subtypes: the CARDIAC MUSCLE and the SKELETAL MUSCLE.", "PM": "2008; see MUSCLE, SKELETAL 1995-2007", "HN": "2008; use MUSCLE, SKELETAL 1995-2007", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054792"}, {"RECTYPE": "D", "MH": "Truncated Hemoglobins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hemoglobins, Truncated|T116|T123|NON|EQV|NLM (2008)|070328|abbcdef", "ENTRY": "Hemoglobins, TrHb", "MN": "D12.776.422.316.762.932", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Hemoglobins (2000-2007)", "MS": "A family of hemoglobin-like proteins found in BACTERIA; PLANTS; and unicellular eukaryotes. Truncated hemoglobins are distantly related to vertebrate hemoglobins and are typically shorter than vertebrate hemoglobins by 20-40 residues.", "PM": "2008", "HN": "2008", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054793"}, {"RECTYPE": "D", "MH": "Glycomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Sugar Code|T091|NON|REL|NLM (2023)|220121|abcdef", "ENTRY": "Glycobiology|T091|NON|EQV|NLM (2008)|070315|abcdef", "MN": "H01.181.122.508", "FX": "Carbohydrates", "MH_TH": "NLM (2008)", "ST": "T091", "MS": "The systematic study of the structure and function of the complete set of glycans (the glycome) produced in a single organism and identification of all the genes that encode glycoproteins.", "PM": "2008", "HN": "2008", "MR": "20220712", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054794"}, {"RECTYPE": "D", "MH": "Incretins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Glucose-Dependent Insulin-Releasing Hormone|T121|T125|NON|EQV|NLM (2008)|070315|abbcdef", "ENTRY": "Insulin-Releasing Hormone, Glucose-Dependent", "MN": "D27.505.696.399.472.580", "MH_TH": "NLM (2008)", "ST": "T125", "RN": "0", "AN": "note entry term INCRETIN EFFECT: use only for the incretin effect of a chemical substance", "PI": "Peptides (1974-2007)", "MS": "Peptides which stimulate INSULIN release from the PANCREATIC BETA CELLS following oral nutrient ingestion, or postprandially.", "PM": "2008", "HN": "2008", "MR": "20110624", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054795"}, {"RECTYPE": "D", "MH": "Drug Dosage Calculations", "AQ": "HI", "ENTRY": "Pharmaceutical Calculation", "MN": "E02.319.305", "FX": "Pharmaceutical Preparations", "MH_TH": "NLM (2008)", "ST": "T081", "MS": "Math calculations done for preparing appropriate doses of medicines, taking into account conversions of WEIGHTS AND MEASURES. Mistakes are one of the sources of MEDICATION ERRORS.", "PM": "2008", "HN": "2008", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054796"}, {"RECTYPE": "D", "MH": "Volleyball", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Volleyballs", "MN": "I03.450.642.845.932", "MH_TH": "NLM (2008)", "ST": "T056", "AN": "/inj: coordinate IM with specific injury (IM); Manual 30.15.1", "PI": "Sports (1965-2007)", "MS": "A team sport in which two teams hit an inflated ball back and forth over a high net using their hands.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054798"}, {"RECTYPE": "D", "MH": "Phospholipase C beta", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phospholipase C-beta4|T116|T126|NON|NRW|NLM (2008)|050422|abbcdef", "MN": "D12.776.476.557.500", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.4.11", "RR": "EC 3.1.4.11", "MS": "A phosphoinositide phospholipase C subtype that is primarily regulated by its association with HETEROTRIMERIC G-PROTEINS. It is structurally related to PHOSPHOLIPASE C DELTA with the addition of C-terminal extension of 400 residues.", "PM": "2008; PHOSPHOLIPASE C BETA was indexed under TYPE C PHOSPHOLIPASES & ISOENZYMES 1994-2007", "HN": "2008(1994)", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054799"}, {"RECTYPE": "D", "MH": "Glycosylphosphatidylinositol Diacylglycerol-Lyase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "PtdIns Glycan Phospholipase C", "MN": "D08.811.277.352.640.700.700.249", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 4.6.1.14", "RR": "EC 4.6.1.14", "PI": "Phosphatidylinositol Diacylglycerol-Lyase (2004-2007)", "MS": "A type C phospholipase specific for GLYCOSYLPHOSPHATIDYLINOSITOLS. It plays a role in the breaking of GPI MEMBRANE ANCHORS.", "PM": "2008; for GLYCOSYLPHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C see PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE 2005-2007", "HN": "2008(2005); for GLYCOSYLPHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C use PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE 2005-2007", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054800"}, {"RECTYPE": "D", "MH": "Phosphoinositide Phospholipase C", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tri phosphoinositide Phosphodiesterase", "MN": "D12.776.476.557", "MH_TH": "NLM (2004)", "ST": "T126", "RN": "EC 3.1.4.11", "PI": "Phosphatidylinositol Diacylglycerol-Lyase (2005-2007)", "MS": "A type C phospholipase with specificity towards PHOSPHATIDYLINOSITOLS that contain INOSITOL 1,4,5-TRISPHOSPHATE. Many of the enzymes listed under this classification are involved in intracellular signaling.", "PM": "2008; for PHOSPHOINOSITIDE PHOSPHOLIPASE C see PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE 2005-2007", "HN": "2008(2005); for PHOSPHOINOSITIDE PHOSPHOLIPASE C use PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE 2005-2007", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054801"}, {"RECTYPE": "D", "MH": "Molecular Imprinting", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Molecular Imprinting Technique|T070|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Techniques, Molecular Imprinting", "MN": "J01.897.836.249.437", "FX": "Nanostructures", "MH_TH": "NLM (2008)", "ST": "T070", "AN": "note category, a technique", "MS": "A methodology for chemically synthesizing polymer molds of specific molecules or recognition sites of specific molecules. Applications for MOLECULARLY IMPRINTED POLYMERS (MIPs) include separations, assays and biosensors, and catalysis.", "PM": "2008", "HN": "2008", "MR": "20200221", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054802"}, {"RECTYPE": "D", "MH": "Phospholipase C delta", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphoinositide Specific Phospholipase C delta", "MN": "D12.776.476.557.625", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.1.4.11", "RR": "EC 3.1.4.11", "MS": "A phosphoinositide phospholipase C subtype that is structurally defined by the presence of an N-terminal pleckstrin-homology and EF-hand domains, a central catalytic domain, and a C-terminal calcium-dependent membrane-binding domain.", "PM": "2008; PHOSPHOLIPASE C DELTA was indexed under TYPE C PHOSPHOLIPASES & ISOENZYMES 1994-2007; PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C DELTA was indexed under PHOSPHORIC DIESTER HYDROLASES 1983-2007 & under PHOSPHOINOSITIDES 1978-1982", "HN": "2008(1978); use PHOSPHOINOSITIDES 1978-1979", "MR": "20210521", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054803"}, {"RECTYPE": "D", "MH": "Cathelicidins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "hCAP-18|T116|NON|NRW|NLM (2023)|210823|abcdef", "ENTRY": "hCAP 18", "MN": "D12.776.543.695.054.099", "MH_TH": "NLM (2008)", "ST": "T116", "RN": "0", "RR": "143108-26-3", "MS": "Antimicrobial cationic peptides with a highly conserved amino terminal cathelin-like domain and a more variable carboxy terminal domain. They are initially synthesized as preproproteins and then cleaved. They are expressed in many tissues of humans and localized to EPITHELIAL CELLS. They kill nonviral pathogens by forming pores in membranes.", "PM": "2023; ROPOCAMPTIDE was indexed under ANTIMICROBIAL CATIONIC PEPTIDES 2008-2022", "HN": "2023 (2008)", "MR": "20220714", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054804"}, {"RECTYPE": "D", "MH": "Dermcidins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.776.543.695.054.400", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "MS": "47-amino acid peptides secreted by ECCRINE GLANDS and having a role in innate cutaneous defense, being antimicrobial to some pathogenic BACTERIA. They are overexpressed by some primary BREAST CANCER cells. They are derived from 110 residue PROTEIN PRECURSORS.", "PM": "2008", "HN": "2008", "MR": "20210510", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054805"}, {"RECTYPE": "D", "MH": "Magainins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Magainin|T116|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D12.776.543.695.054.500", "MH_TH": "NLM (2008)", "ST": "T116", "RN": "0", "MS": "A class of antimicrobial peptides discovered in the skin of XENOPUS LAEVIS. They kill bacteria by permeabilizing cell membranes without exhibiting significant toxicity against mammalian cells.", "PM": "2008", "HN": "2008", "MR": "20210510", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054806"}, {"RECTYPE": "D", "MH": "Cecropins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cecropin|T116|T129|NON|EQV|NLM (2022)|201014|abbcdef", "MN": "D12.776.543.695.054.149", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "MS": "Antimicrobial peptides that form channels in membranes that are more permeable to anions than cations. They resemble MAGAININS, with their N-terminal region forming a positively charged amphipathic alpha helix, but containing an additional C-terminal segment.", "PM": "2008", "HN": "2008", "MR": "20210510", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054807"}, {"RECTYPE": "D", "MH": "Histatins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Histatin|T116|T129|NON|EQV|NLM (2022)|201016|abbcdef", "MN": "D12.776.850.550", "MH_TH": "NLM (2008)", "ST": "T129", "RN": "0", "MS": "A group of small, histidine-rich, cationic peptides in human SALIVA which are antibacterial and antifungal.", "PM": "2008", "HN": "2008", "MR": "20210510", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054808"}, {"RECTYPE": "D", "MH": "Thionins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Thionin Peptides|T116|NON|EQV|NLM (2021)|210209|abcdef", "ENTRY": "Peptides, Thionin", "MN": "D12.776.543.695.054.800", "MH_TH": "NLM (2008)", "ST": "T116", "RN": "0", "MS": "Antimicrobial peptides of 45-47 amino acids and typically with four disulfide bridges. They are found in PLANTS. Type-V thionins lack the C-terminal nonapeptide. This should not be confused with thionine.", "PM": "2008", "HN": "2008", "MR": "20210510", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054809"}, {"RECTYPE": "D", "MH": "Deep Sedation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Sedation, Deep|T061|NON|EQV|NLM (2008)|070316|abcdef", "ENTRY": "Sedations, Deep", "MN": "E03.295", "MH_TH": "NLM (2008)", "ST": "T061", "AN": "coordinate IM with specific procedure (IM) or specific sedative, analgesic or anesthetic (IM with no qualifiers)", "PI": "Conscious Sedation (1991-2007)", "MS": "Drug-induced depression of consciousness during which patients cannot be easily aroused but respond purposely following repeated painful stimulation. The ability to independently maintain ventilatory function may be impaired. (From: American Society of Anesthesiologists Practice Guidelines)", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054810"}, {"RECTYPE": "D", "MH": "Phytochelatins", "AQ": "AA AD AE AG AI BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Phytochelatin|T116|NON|EQV|NLM (2008)|abcde", "MN": "D12.644.456.448.625", "PA": "Chelating Agents", "MH_TH": "NLM (2008)", "ST": "T116", "RN": "98726-08-0", "PI": "Glutathione (1991-2007)", "MS": "Poly-glutathione peptides composed of (Glu-Cys)n-Gly where n is two to seven. They are biosynthesized by glutathione gamma-glutamylcysteinyltransferase and are found in many PLANTS; YEASTS; and algae. They sequester HEAVY METALS.", "PM": "2008; PHYTOCHELATINS was indexed under GLUTATHIONE 1992-2007", "HN": "2008(1992)", "MR": "20100625", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054811"}, {"RECTYPE": "D", "MH": "Cyclitols", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cyclitol|T109|NON|EQV|NLM (2021)|191121|abcdef", "MN": "D02.455.426.392.368.138", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "MS": "Cycloalkanes containing three or more hydroxyl groups on the ring atoms. Some polyhydroxypiperidines (PIPERIDINES) are called iminocyclitols or aza-sugars.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054812"}, {"RECTYPE": "D", "MH": "Polyhydroxyalkanoates", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyhydroxyalkanoate|T109|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D10.751", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "PI": "Polyesters (1990-2007)", "MS": "Biodegradable microbial polyesters which contain hydroxyacyl monomers. Polyhydroxyalkanoates are carbon and energy reserve materials produced and sequestered in cytoplasmic granules called polyhydroxyalkanoate or PHA granules by various archaea and bacteria and may additionally provide protective mechanism to the microbes. They are biosynthesized by microbial polyhydroxyalkanoate synthase enzymes using fatty acids or citramalate synthase enzymes using glucose.", "PM": "2008", "HN": "2008", "MR": "20220413", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054813"}, {"RECTYPE": "D", "MH": "Anatomists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Anatomist", "MN": "N02.360.133", "MH_TH": "NLM (2008)", "ST": "T097", "PI": "Anatomy (1963-2007)", "MS": "Those persons skilled in anatomy or dissection.", "PM": "2008", "HN": "2008", "MR": "20180629", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054814"}, {"RECTYPE": "D", "MH": "Cyclic Nucleotide-Gated Cation Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cyclic-Nucleotide Gated Ion Channels|T116|T123|NON|EQV|NLM (2008)|040525|abbcdef", "ENTRY": "Gated Channel, Cyclic-Nucleotide", "MN": "D12.776.543.585.400.452", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Ion Channels (1987-2007)", "MS": "A subgroup of cyclic nucleotide-regulated ION CHANNELS within the superfamily of pore-loop cation channels. They are expressed in OLFACTORY NERVE cilia and in PHOTORECEPTOR CELLS and some PLANTS.", "PM": "2008; CYCLIC-NUCLEOTIDE GATED ION CHANNELS was indexed under ION CHANNELS 1987-2008", "HN": "2008(1987)", "MR": "20190701", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054815"}, {"RECTYPE": "D", "MH": "Levopropoxyphene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Napsylate, Levopropoxyphene", "MN": "D02.241.081.751.324", "MH_TH": "NLM (2008)", "ST": "T121", "RN": "U75VZ9PK1J", "RR": "KK9590R73S", "PI": "Dextropropoxyphene (1965-2007)", "MS": "A propionate derivative that is used  to suppress coughing.", "PM": "2008; see DEXTROPROPOXYPHENE 1965-2007", "HN": "2008; use DEXTROPROPOXYPHENE 1965-2007", "MR": "20151123", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054816"}, {"RECTYPE": "D", "MH": "Pollination", "AQ": "DE GE IM PH RE", "MN": "G15.776", "MH_TH": "NLM (2008)", "ST": "T040", "PI": "Pollen (1963-2007)", "MS": "The transfer of POLLEN grains (male gametes) to the plant ovule (female gamete).", "PM": "2008", "HN": "2008", "MR": "20160623", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054817"}, {"RECTYPE": "D", "MH": "Hexosaminidase A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hex A|T116|T126|ABB|EQV|UNK (19XX)|860602|abbcdef", "ENTRY": "beta N Acetylhexosaminidase A", "MN": "D08.811.277.450.483.180.750", "FX": "Tay-Sachs Disease", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 3.2.1.52", "AN": "for deficiency consider: SANDHOFF DISEASE or TAY-SACHS DISEASE", "PI": "beta-N-Acetylhexosaminidases (1999-2007)", "MS": "A mammalian beta-hexosaminidase isoform that is a heteromeric protein comprized of both hexosaminidase alpha and hexosaminidase beta subunits. Deficiency of hexosaminidase A due to mutations in the gene encoding the hexosaminidase alpha subunit is a case of TAY-SACHS DISEASE. Deficiency of hexosaminidase A and HEXOSAMINIDASE B due to mutations in the gene encoding the hexosaminidase beta subunit is a case of SANDHOFF DISEASE.", "PM": "2008; for HEXOSAMINIDASE A see BETA-N-ACETYLHEXOSAMINIDASE 1987-2007", "HN": "2008(1987); for HEXOSAMINIDASE A use BETA-N-ACETYLHEXOSAMINIDASE 1987-2007", "MR": "20090721", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054818"}, {"RECTYPE": "D", "MH": "Hexosaminidase B", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hex B|T116|T126|ABB|EQV|UNK (19XX)|860602|abbcdef", "MN": "D08.811.277.450.483.180.875", "EC": "deficiency:Sandhoff Disease", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 3.2.1.52", "PI": "beta-N-Acetylhexosaminidases (1987-2007)", "MS": "A mammalian beta-hexosaminidase isoform that is comprized of hexosaminidase beta subunits. Deficiency of hexosaminidase B due to mutations in the gene encoding the hexosaminidase beta subunit is a case of SANDHOFF DISEASE.", "PM": "2008; see BETA-N-ACETYLHEXOSAMINIDASE 1987-2007", "HN": "2008; use BETA-N-ACETYLHEXOSAMINIDASES 1987-2007", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054819"}, {"RECTYPE": "D", "MH": "beta-Hexosaminidase alpha Chain", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta N Acetylhexosaminidase alpha Chain", "MN": "D08.811.277.450.483.180.750.500", "EC": "deficiency:Tay-Sachs Disease", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.2.1.52", "PI": "beta-N-Acetylhexosaminidases (1987-2007)", "MS": "The alpha subunit of hexosaminidase A. Mutations in the gene that encodes this protein can result in loss of hexosaminidase A activity and are linked to TAY-SACHS DISEASE.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054820"}, {"RECTYPE": "D", "MH": "beta-Hexosaminidase beta Chain", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta N Acetylhexosaminidase beta Chain", "MN": "D08.811.277.450.483.180.875.500", "EC": "deficiency:Sandhoff Disease", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 3.2.1.52", "PI": "beta-N-Acetylhexosaminidases (1987-2007)", "MS": "The beta subunit of hexosaminidase A and hexosamininidase B. Mutations in the gene that encodes this protein are linked to SANDHOFF DISEASE and can result in loss of both hexosaminidase A activity and hexosaminidase B activity.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054821"}, {"RECTYPE": "D", "MH": "Histamine H3 Antagonists", "DS": "HISTAMINE ANTAGONISTS H 003", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Histamine H3 Receptor Antagonists|T121|NON|EQV|NLM (2008)|070326|HISTAMINE RECEPTOR ANTAGONISTS H3|abcdefs", "ENTRY": "H3 Blockers, Histamine", "MN": "D27.505.696.577.375.425.712", "MH_TH": "NLM (2008)", "ST": "T121", "RN": "0", "PI": "Histamine Antagonists (1983-2007)", "MS": "Drugs that selectively bind to but do not activate HISTAMINE H3 RECEPTORS. They have been used to correct SLEEP WAKE DISORDERS and MEMORY DISORDERS.", "PM": "2008", "HN": "2008", "MR": "20150713", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054828"}, {"RECTYPE": "D", "MH": "RING Finger Domains", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "RING Finger Motifs|T082|ACX|EQV|NLM (2008)|070326|abcdef", "ENTRY": "RING Finger Motif", "MN": "G02.111.570.820.709.275.750.500.625", "MH_TH": "NLM (2008)", "ST": "T082", "MS": "A zinc-binding domain defined by the sequence Cysteine-X2-Cysteine-X(9-39)-Cysteine-X(l-3)-His-X(2-3)-Cysteine-X2-Cysteine -X(4-48)-Cysteine-X2-Cysteine, where X is any amino acid. The RING finger motif binds two atoms of zinc, with each zinc atom ligated tetrahedrally by either four cysteines or three cysteines and a histidine. The motif also forms into a unitary structure with a central cross-brace region and is found in many proteins that are involved in protein-protein interactions. The acronym RING stands for Really Interesting New Gene.", "PM": "2008", "HN": "2008", "MR": "20160531", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054829"}, {"RECTYPE": "D", "MH": "Sesterterpenes", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.455.849.842", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "PI": "Terpenes (1969-2007)", "MS": "Terpenes of five units of HEMITERPENES, formed from geranylfarnesyl pyrophosphate.", "PM": "2008; SESTERTERPENES was indexed under TERPENES 1974-2008", "HN": "2008(1974)", "MR": "20190705", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054830"}, {"RECTYPE": "D", "MH": "Acridones", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.300.046.109", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "PI": "Acridines (1971-2007)", "MS": "Compounds based on acridone, which have three linear rings, with the center ring containing a ring nitrogen and a keto oxygen opposite to each other. Many of them are naturally occurring alkaloids.", "PM": "2008", "HN": "2008", "MR": "20160527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054831"}, {"RECTYPE": "D", "MH": "Urocortins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Urocortin|T116|T123|NON|NRW|NLM (2008)|abbcde", "ENTRY": "Urocortin III|T116|NON|NRW|NLM (2008)|010724|abcdef", "MN": "D12.644.548.887", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "PI": "Corticotropin-Releasing Hormone (1995-2007)", "MS": "Neuropeptides of about 40 amino acids which are structurally similar to CORTICOTROPIN-RELEASING FACTOR. Unlike CRF acting primarily through type 1 CRF RECEPTORS, urocortins signal preferentially through type 2 CRF receptors. Urocortins have wide tissue distribution from fish to mammals, and diverse functions. In mammals, urocortins can suppress food intake, delays gastric emptying, and decreases heat-induced edema.", "PM": "2008; UROCORTIN was indexed under CORTICOTROPIN-RELEASING HORMONE 1995-2007", "HN": "2008 (1995)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054832"}, {"RECTYPE": "D", "MH": "Isoindoles", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isoindole|T109|NON|EQV|NLM (2021)|191119|abcdef", "MN": "D03.633.100.513", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "PI": "Indoles (1968-2007)", "MS": "Benzopyrroles with the nitrogen at the number two carbon, in contrast to INDOLES which have the nitrogen adjacent to the six-membered ring.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054833"}, {"RECTYPE": "D", "MH": "Lipocalins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lipocalin|T116|T123|NON|EQV|NLM (2008)|070328|abbcdef", "MN": "D12.776.157.469", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "MS": "A diverse family of extracellular proteins that bind to small hydrophobic molecules. They were originally characterized as transport proteins, however they may have additional roles such as taking part in the formation of macromolecular complexes with other proteins and binding to CELL SURFACE RECEPTORS.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054834"}, {"RECTYPE": "D", "MH": "Lipocalin 1", "DS": "LIPOCALIN 001", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lipocalin, Tear", "MN": "D12.776.850.700", "MH_TH": "NLM (2008)", "ST": "T121", "RN": "0", "MS": "A lipocalin that was orignally characterized from human TEARS. It is expressed primarily in the LACRIMAL GLAND and the VON EBNER GLANDS. Lipocalin 1 may play a role in olfactory transduction by concentrating and delivering odorants to the ODORANT RECEPTORS.", "PM": "2008; LIPOCALIN 1 was indexed under CARRIER PROTEINS 1990-2007", "HN": "2008(1990)", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054835"}, {"RECTYPE": "D", "MH": "Indolizidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D03.633.100.496.500", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "PI": "Indolizines (1968-2007)", "MS": "Saturated indolizines that are fused six and five-membered rings with a nitrogen atom at the ring fusion. They are biosynthesized in PLANTS by cyclization of a LYSINE coupled to ACETYL COENZYME A. Many of them are naturally occurring ALKALOIDS.", "PM": "2008", "HN": "2008", "MR": "20160531", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054836"}, {"RECTYPE": "D", "MH": "Quinolizidines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Quinolizidine|T109|NON|EQV|NLM (2023)|220121|abcdef", "MN": "D03.633.100.834.737", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "PI": "Quinolizines (1963-2007)", "MS": "Saturated quinolizines that are two fused six-membered rings with a nitrogen atom at the ring fusion. They are biosynthesized in PLANTS by cyclization of a LYSINE coupled to CADAVERINE. Many of them are naturally occurring ALKALOIDS.", "PM": "2008", "HN": "2008", "MR": "20220413", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054837"}, {"RECTYPE": "D", "MH": "von Ebner Glands", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "von Ebner's Glands|T023|EPO|EQV|NLM (2009)|070823|abcdef", "ENTRY": "von Ebners Glands", "MN": "A14.549.760.906", "MH_TH": "NLM (2009)", "ST": "T023", "PI": "Tongue (1963-2007)", "MS": "Small tubulo-alveolar salivary glands located beneath the circumvallate and foliate papillae.", "PM": "2009; see Von Ebner's Gland 2008", "HN": "2009 (2008)", "MR": "20160809", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054838"}, {"RECTYPE": "D", "MH": "Retinol-Binding Proteins, Plasma", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Retinol Binding Proteins, Plasma", "MN": "D12.776.377.715.085.745", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "AN": "RETINOL-BINDING PROTEINS and RETINOL-BINDING PROTEINS, CELLULAR are also available; do not interpret the presence of retinol binding proteins in the blood as RETINOL-BINDING PROTEINS, PLASMA; check text for appropriate term", "PI": "Retinol Binding Proteins (1977-2007)", "MS": "Retinol binding proteins that circulate in the PLASMA. They are members of the lipocalin family of proteins and play a role in the transport of RETINOL from the LIVER to the peripheral tissues. The proteins are usually found in association with TRANSTHYRETIN.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054839"}, {"RECTYPE": "D", "MH": "Retinol-Binding Proteins, Cellular", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Retinol Binding Proteins, Cellular", "MN": "D12.776.157.700.249", "MH_TH": "NLM (2008)", "ST": "T123", "RN": "0", "AN": "RETINOL-BINDING PROTEINS and RETINOL-BINDING PROTEINS, PLASMA are available; do not interpret the presence of retinol binding proteins in the blood as RETINOL-BINDING PROTEINS, PLASMA; check for appropriate term", "PI": "Retinol-Binding Proteins (1982-2007)", "MS": "A subclass of retinol-binding proteins that take part in the intracellular storage and transport of RETINOL. They are both functionally and structurally distinct from PLASMA RETINOL-BINDING PROTEINS.", "PM": "2008; for CELLULAR RETINOL BINDING PROTEIN see RETINOL-BINDING PROTEINS 1982-2007; for RETINOL-BINDING PROTEIN 1 see RETINOL-BINDING PROTEINS 1990-2007, RETINOL BINDING PROTEIN 1, CELLULAR was indexed under RETINOL-BINDING PROTEINS 1995-2007; RETINOL BINDING PROTEIN 2 was indexed under RETINOL-BINDING PROTEINS 1985-2007", "HN": "2008(1982); for CELLULAR RETINOL BINDING PROTEIN use RETINOL-BINDING PROTEINS 1982-2007; for RETINOL-BINDING PROTEIN 1 use RETINOL-BINDING PROTEINS 1990-2007", "MR": "20130709", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054840"}, {"RECTYPE": "D", "MH": "Negative-Pressure Wound Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Wound Therapy, Negative-Pressure", "MN": "E04.987.550", "MH_TH": "NLM (2008)", "ST": "T061", "MS": "The application of a vacuum across the surface of a wound through a foam dressing cut to fit the wound. This removes wound exudates, reduces build-up of inflammatory mediators, and increases the flow of nutrients to the wound thus promoting healing.", "PM": "2008", "HN": "2008", "MR": "20100625", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054843"}, {"RECTYPE": "D", "MH": "Peptaibols", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Zervamicins|T116|NON|NRW|NLM (2008)|070330|abcdef", "ENTRY": "Trichorzianines|T116|NON|NRW|NLM (2008)|070330|abcdef", "MN": "D12.644.504", "MH_TH": "NLM (2008)", "ST": "T116", "RN": "0", "RR": "71812-28-7", "PI": "Peptides (1977-2007)", "MS": "A group of peptides characterized by length of 1-2 dozen residues with a high proportion of them being non-proteinogenic, notably alpha-aminoisobutyric acid (Aib) and isovaline, and have a C-terminal amino alcohol and N terminal alkyl group. They are found in FUNGI and some are ANTI-INFECTIVE AGENTS. They form channels or pores in target organisms. The term is a contraction of peptide-Aib-alcohol.", "PM": "2008; EMERIMICINS was indexed under PEPTIDES 1977-2007", "HN": "2008; for EMERIMICINS use PEPTIDES 1977-2007", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054848"}, {"RECTYPE": "D", "MH": "Cardiac Electrophysiology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Electrophysiology, Cardiac", "MN": "H02.403.429.163.300", "FX": "Electrophysiologic Techniques, Cardiac", "MH_TH": "NLM (2008)", "ST": "T091", "AN": "specialty only; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC is also available", "MS": "The study of the electrical activity and characteristics of the HEART; MYOCARDIUM; and CARDIOMYOCYTES.", "PM": "2008", "HN": "2008", "MR": "20090706", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054849"}, {"RECTYPE": "D", "MH": "Osteophyte", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bone Spur|T047|NON|EQV|NLM (2008)|070330|abcdef", "ENTRY": "Spurs, Bone", "MN": "C05.116.540.310.800", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "Bony outgrowth usually found around joints and often seen in conditions such as ARTHRITIS.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054850"}, {"RECTYPE": "D", "MH": "Tropheryma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Tropheryma whipplei|T007|NON|NRW|NLM (2008)|070330|abcdef", "MN": "B03.510.024.998", "MH_TH": "NLM (2008)", "ST": "T007", "RN": "txid2038", "RR": "txid2039", "PI": "Actinomycetales (2003-2007)", "MS": "A genus of gram-positive bacteria in the family Cellulomonadaceae.", "PM": "2008", "HN": "2008", "MR": "20200813", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054851"}, {"RECTYPE": "D", "MH": "Small Molecule Libraries", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Small Molecular Libraries", "MN": "D27.720.470.765", "MH_TH": "NLM (2008)", "ST": "T104", "RN": "0", "MS": "Large collections of small molecules (molecular weight about 600 or less), of similar or diverse nature which are used for high-throughput screening analysis of the gene function, protein interaction, cellular processing, biochemical pathways, or other chemical interactions. It includes virtual libraries.", "PM": "2008", "HN": "2008", "MR": "20190708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054852"}, {"RECTYPE": "D", "MH": "Malignant Atrophic Papulosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Kohlmeier-Degos Disease|T047|EPO|EQV|NLM (2008)|070402|abcdef", "ENTRY": "Syndrome, Degos", "MN": "C17.800.862.457", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "malignant does not refer to neoplasm; do not confuse with the neoplasm ACANTHOMA, DEGOS see ACANTHOMA", "MS": "Variously described as a vasculopathy, endovasculitis, or occlusive arteriopathy, this condition occurs in a benign cutaneous form and a lethal multiorgan systemic variant. It is characterized by a narrowing and occlusion of the lumen of small to medium-sized blood vessels, leading to ischemia and infarction in the involved organ systems. The etiology and pathophysiology are unknown.", "PM": "2008", "HN": "2008", "MR": "20120703", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054853"}, {"RECTYPE": "D", "MH": "Vertebroplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "MN": "E04.555.165.500", "MH_TH": "NLM (2008)", "ST": "T061", "MS": "Procedures to repair or stabilize vertebral fractures, especially compression fractures accomplished by injecting BONE CEMENTS into the fractured VERTEBRAE.", "PM": "2008", "HN": "2008", "MR": "20110624", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054854"}, {"RECTYPE": "D", "MH": "Drug-Eluting Stents", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Stents, Drug-Eluting|T074|NON|EQV|NLM (2008)|070411|abcdef", "ENTRY": "Stents, Drug Eluting", "MN": "E07.695.750.500", "MH_TH": "NLM (2008)", "ST": "T074", "PI": "Stents (1998-2007)", "MS": "Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054855"}, {"RECTYPE": "D", "MH": "G-Quadruplexes", "AQ": "DE RE", "ENTRY": "RNAs, G-Quadruplexes", "MN": "G05.360.580.550", "FX": "DNA, Cruciform", "MH_TH": "NLM (2008)", "ST": "T082", "MS": "Higher-order DNA and RNA structures formed from guanine-rich sequences. They are formed around a core of at least 2 stacked tetrads of hydrogen-bonded GUANINE bases. They can be formed from one two or four separate strands of DNA (or RNA) and can display a wide variety of topologies, which are a consequence of various combinations of strand direction, length, and sequence. (From Nucleic Acids Res. 2006;34(19):5402-15)", "PM": "2008; QUADRAPLEX DNA was indexed under DNA 1994-2007", "HN": "2008 (1994)", "MR": "20150622", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054856"}, {"RECTYPE": "D", "MH": "Jacobsen Distal 11q Deletion Syndrome", "DS": "JACOBSEN DISTAL DELETION SYNDROME 011Q", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Jacobsen Syndrome|T047|EPO|EQV|GHR (2014)|NLM (2008)|OMIM (2013)|ORD (2010)|070404|abcdeeeef", "ENTRY": "Type Thrombocytopenia, Paris-Trousseau", "MN": "C16.320.180.440", "MH_TH": "NLM (2008)", "ST": "T047", "PI": "Chromosomes, Human, Pair 11 (1986-2007)", "MS": "A clinically recognized congenital malformation condition caused by a distal 11q deletion. The features of the syndrome are growth retardation, psychomotor retardation, trigonocephaly, divergent intermittent strabismus, epicanthus, telecanthus, broad nasal bridge, short nose with anteverted nostrils, carp-shaped upper lip, retrognathia, low-set dysmorphic ears, bilateral camptodactyly, and hammertoes. Platelet dysfunction is a feature in Paris-Trousseau type thrombocytopenia.", "PM": "2008", "HN": "2008", "MR": "20230226", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054868"}, {"RECTYPE": "D", "MH": "Clinical Audit", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Clinical Audits", "MN": "N05.700.175", "FX": "Clinical Governance", "MH_TH": "NLM (2008)", "ST": "T058", "AN": "general; prefer specifics", "MS": "A detailed review and evaluation of selected clinical records by qualified professional personnel to improve the quality of patient care and outcomes. The clinical audit was formally introduced in 1993 into the United Kingdom's National Health Service.", "PM": "2008", "HN": "2008", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054869"}, {"RECTYPE": "D", "MH": "Fatty Acid Synthesis Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D27.505.519.186.071.401", "MH_TH": "NLM (2008)", "ST": "T121", "RN": "0", "PI": "Fatty Acid Synthetase Complex (1971-2007)", "MS": "Compounds that interfere with FATTY ACID SYNTHASE resulting in a reduction of FATTY ACIDS. This is a target mechanism in humans of some ANTINEOPLASTIC AGENTS and ANTI-OBESITY AGENTS and of some ANTI-INFECTIVE AGENTS which interfere with CELL WALL and CELL MEMBRANE formation.", "PM": "2008", "HN": "2008", "MR": "20140625", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054872"}, {"RECTYPE": "D", "MH": "Dipeptidyl-Peptidase IV Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gliptins|T121|NON|EQV|NLM (2008)|070406|abcdef", "ENTRY": "Inhibitor, Dipeptidyl-Peptidase IV", "MN": "D27.505.696.422.500", "MH_TH": "NLM (2008)", "ST": "T121", "RN": "0", "MS": "Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054873"}, {"RECTYPE": "D", "MH": "Athletic Performance", "AQ": "CL EC ED ES HI LJ PH PX SN ST TD", "PRINT ENTRY": "Sports Performance|T056|NON|EQV|NLM (2008)|070406|abcdef", "ENTRY": "Sports Performances", "MN": "I03.450.642.845.054", "FX": "Psychomotor Performance", "MH_TH": "NLM (2008)", "ST": "T056", "PI": "Sports (1964-2007)", "MS": "Carrying out of specific physical routines or procedures by one who is trained or skilled in physical activity. Performance is influenced by a combination of physiological, psychological, and socio-cultural factors.", "PM": "2008", "HN": "2008", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054874"}, {"RECTYPE": "D", "MH": "Ubiquitination", "AQ": "DE GE IM PH RE", "ENTRY": "Ubiquitylation|T070|NON|EQV|NLM (2008)|070409|abcdef", "MN": "G05.308.670.600.831", "FX": "Ubiquitinated Proteins", "MH_TH": "NLM (2008)", "ST": "T070", "AN": "UBIQUITINATED PROTEINS is also available", "PI": "Ubiquitins (1984-2007)", "MS": "The act of ligating UBIQUITINS to PROTEINS to form ubiquitin-protein ligase complexes to label proteins for transport to the PROTEASOME ENDOPEPTIDASE COMPLEX where proteolysis occurs.", "PM": "2008", "HN": "2008", "MR": "20160701", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054875"}, {"RECTYPE": "D", "MH": "Prenylation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Isoprenylation|T070|NON|NRW|NLM (1993)|920305|abcdef", "MN": "G03.804", "MH_TH": "NLM (1993)", "ST": "T070", "AN": "PROTEIN PRENYLATION is also available", "PI": "Protein Isoprenylation (1993-2007)", "MS": "Attachment of isoprenoids (TERPENES) to other compounds, especially PROTEINS and FLAVONOIDS.", "PM": "2008; see PROTEIN ISOPRENYLATION 1993-2008", "HN": "2008; use PROTEIN ISOPRENYLATION 1993-2008", "MR": "20160623", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054876"}, {"RECTYPE": "D", "MH": "Wolf-Hirschhorn Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Wolf Hirschhorn Syndrome", "MN": "C16.320.180.985", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Chromosome Deletion (1978-2007)", "MS": "A syndrome caused by large deletions of the telomereic end of the short arm of CHROMOSOME 4 (4p) in Wolf-Hirchhorn syndrome critial regions (WHSCRs). Several candidate genes have been identified including WHSC1 and WHSCH2 which appear to be responsible for the core phenotype and in combination with other linked and unlinked genes determine the severity and inclusion of rarer phenotypes. Most cases have a characteristic cranio-facial defect often referred to as \"Greek helmet face\" - a combined result of MICROCEPHALY, broad forehead, prominent glabella, HYPERTELORISM, high arched eyebrows, short philtrum and micrognathia. In addition there is mental retardation, growth delays, EPILEPSY, and frequently a wide range of midline and skeletal defects, including HYPOSPADIAS; CONGENITAL HEART DEFECTS; CLEFT LIP; CLEFT PALATE; colobomata; CLUBFOOT; clinodactyly; SCOLIOSIS; and KYPHOSIS.", "PM": "2008", "HN": "2008", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054877"}, {"RECTYPE": "D", "MH": "Lipoylation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Palmitoylation|T070|NON|NRW|NLM (2008)|070409|abcdef", "MN": "G03.458.875", "MH_TH": "NLM (2008)", "ST": "T070", "MS": "Covalent attachment of LIPIDS and FATTY ACIDS to other compounds and PROTEINS.", "PM": "2008", "HN": "2008", "MR": "20160623", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054878"}, {"RECTYPE": "D", "MH": "Halogenation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Iodination|T070|NON|NRW|NLM (2008)|070409|abcdef", "ENTRY": "Iodation|T070|NON|NRW|NLM (2008)|070409|abcdef", "MN": "G03.360", "MH_TH": "NLM (2008)", "ST": "T070", "MS": "Covalent attachment of HALOGENS to other compounds.", "PM": "2008", "HN": "2008", "MR": "20160630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054879"}, {"RECTYPE": "D", "MH": "Aspartylglucosaminuria", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Glycoasparaginase Deficiencies", "MN": "C18.452.648.595.100", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Aspartylglucosylaminase (1975-2008)", "MS": "A recessively inherited, progressive lysosomal storage disease caused by a deficiency of GLYCOSYLASPARAGINASE activity. The lack of this enzyme activity results in the accumulation of N-acetylglucosaminylasparagine (the linkage unit of asparagine-linked glycoproteins) in LYSOSOMES.", "PM": "2009", "HN": "2009", "MR": "20180614", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054880"}, {"RECTYPE": "D", "MH": "Sex Determination by Skeleton", "AQ": "CL EC ES HI IS MT SN ST TD VE", "MN": "E05.393.285.830.500", "MH_TH": "NLM (2008)", "ST": "T060", "AN": "SEX DETERMINATION ANALYSIS is also available", "PI": "Sex Determination (Analysis) (1970-2007)", "MS": "Validation of the sex of an individual by means of the bones of the SKELETON. It is most commonly based on the appearance of the PELVIS; SKULL; STERNUM; and/or long bones.", "PM": "2008", "HN": "2008", "MR": "20170601", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054881"}, {"RECTYPE": "D", "MH": "Antley-Bixler Syndrome Phenotype", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Antley-Bixler Syndrome, Autosomal Recessive|T047|EPO|NRW|NLM (2022)|210324|abcdef", "ENTRY": "Trapezoidocephaly-Synostosis Syndromes", "MN": "C18.452.648.925.324", "FX": "Receptor, Fibroblast Growth Factor, Type 2", "MH_TH": "NLM (2009)", "ST": "T047", "PI": "Synostosis (1982-2008)", "MS": "An inherited condition characterized by multiple malformations of CARTILAGE and bone including CRANIOSYNOSTOSIS; midface hypoplasia; radiohumeral SYNOSTOSIS; CHOANAL ATRESIA; femoral bowing; neonatal fractures; and multiple joint CONTRACTURES and, occasionally, urogenital, gastrointestinal or cardiac defects. In utero exposure to FLUCONAZOLE, as well as mutations in at least two separate genes are associated with this condition - POR (encoding P450 (cytochrome) oxidoreductase (NADPH-FERRIHEMOPROTEIN REDUCTASE)) and FGFR2 (encoding FIBROBLAST GROWTH FACTOR RECEPTOR 2).", "PM": "2009", "HN": "2009", "MR": "20210510", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054882"}, {"RECTYPE": "D", "MH": "Oxylipins", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Oxylipin|T109|NON|EQV|NLM (2021)|191230|abcdef", "MN": "D10.251.355.645", "MH_TH": "NLM (2008)", "ST": "T109", "RN": "0", "PI": "Fatty Acids (1991-2007)", "MS": "Eighteen-carbon cyclopentyl polyunsaturated fatty acids derived from ALPHA-LINOLENIC ACID via an oxidative pathway analogous to the EICOSANOIDS in animals. Biosynthesis is inhibited by SALICYLATES. A key member, jasmonic acid of PLANTS, plays a similar role to ARACHIDONIC ACID in animals.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054883"}, {"RECTYPE": "D", "MH": "Host-Pathogen Interactions", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Pathogen-Host Interaction|T070|NON|EQV|NLM (2021)|200325|abcdef", "ENTRY": "Relations, Host-Pathogen", "MN": "G16.527.200", "MH_TH": "NLM (2008)", "ST": "T070", "AN": "coordinate with host /microbiol or /virol + pathogen /physiol or other more specific qualifier; HOST-PARASITE INTERACTIONS is also available", "MS": "The interactions between a host and a pathogen, usually resulting in disease.", "PM": "2008", "HN": "2008", "MR": "20200527", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054884"}, {"RECTYPE": "D", "MH": "Cumulus Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Granulosa Cells, Cumulus|T025|NON|EQV|NLM (2008)|070410|abcdef", "ENTRY": "Granulosa Cell, Cumulus", "MN": "A11.436.329.500", "MH_TH": "NLM (2008)", "ST": "T025", "MS": "The granulosa cells of the cumulus oophorus which surround the OVUM in the GRAAFIAN FOLLICLE. At OVULATION they are extruded with OVUM.", "PM": "2008", "HN": "2008", "MR": "20180630", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054885"}, {"RECTYPE": "D", "MH": "Fatty Acid Synthase, Type II", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fatty Acid Synthetase Complex, Type II|T116|T126|NON|EQV|NLM (2008)|070411|abbcdef", "ENTRY": "Synthase, FAS-II", "MN": "D08.811.913.050.170.500.200", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 6.-", "PI": "Fatty Acid Synthetase Complex (1971-2007)", "MS": "The form of fatty acid synthase complex found in BACTERIA; FUNGI; and PLANTS. Catalytic steps are like the animal form but the protein structure is different with dissociated enzymes encoded by separate genes. It is a target of some ANTI-INFECTIVE AGENTS which result in disruption of the CELL MEMBRANE and CELL WALL.", "PM": "2008", "HN": "2008", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054889"}, {"RECTYPE": "D", "MH": "Fatty Acid Synthase, Type I", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fatty Acid Synthase, Mammalian|T116|T126|NON|NRW|NLM (2008)|070411|abbcdef", "MN": "D08.811.913.050.170.500.100", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 2.3.1.85", "RR": "EC 4.2.1.59", "PI": "Fatty Acid Synthetase Complex (1971-2007)", "MS": "Animal form of fatty acid synthase which is encoded by a single gene and consists of seven catalytic domains and is functional as a homodimer. It is overexpressed in some NEOPLASMS and is a target in humans of some ANTINEOPLASTIC AGENTS and some ANTI-OBESITY AGENTS.", "PM": "2014; see FATTY ACID SYNTHASE COMPLEX, TYPE I 2008-2013", "HN": "2014(2008)", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054890"}, {"RECTYPE": "D", "MH": "Metagenome", "AQ": "DE GE IM PH RE", "ENTRY": "Metagenomes", "MN": "G05.360.340.550", "FX": "Microbiota", "MH_TH": "NLM (2010)", "ST": "T028", "AN": "coordinate with specific organism, organ or other site / microbiol if pertinent", "MS": "A collective genome representative of the many organisms, primarily microorganisms, existing in a community.", "PM": "2010; see MICROBIOME 2008-2009", "HN": "2010 (2008)", "MR": "20130708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054892"}, {"RECTYPE": "D", "MH": "Cone-Beam Computed Tomography", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tomography, Volume Computed|T060|NON|EQV|NLM (2008)|070507|abcdef", "ENTRY": "Tomography, Volumetric Computed", "MN": "E01.370.350.825.810.810.399", "MH_TH": "NLM (2008)", "ST": "T060", "AN": "do not confuse with SPIRAL CONE-BEAM COMPUTED TOMOGRAPHY", "PI": "Tomography, X-Ray Computed (1997-2007)", "MS": "Computed tomography modalities which use a cone or pyramid-shaped beam of radiation.", "PM": "2008", "HN": "2008", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054893"}, {"RECTYPE": "D", "MH": "Spiral Cone-Beam Computed Tomography", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tomography, Spiral Volumetric Computed|T060|NON|EQV|NLM (2003)|020110|abcdef", "ENTRY": "Volumetric CT, Spiral", "MN": "E01.370.350.825.810.810.800.500", "MH_TH": "NLM (2008)", "ST": "T060", "AN": "do not confuse with TOMOGRAPHY, SPIRAL COMPUTED or with CONE-BEAM COMPUTED TOMOGRAPHY", "MS": "Modality of computed tomography in which the patient is irradiated in a spiral path around the body with a cone or pyramid-shaped beam.", "PM": "2008", "HN": "2008", "MR": "20080708", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054894"}, {"RECTYPE": "D", "MH": "Extensively Drug-Resistant Tuberculosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Tuberculosis, Extensively Drug-Resistant|T047|NON|EQV|NLM (2008)|070507|abcdef", "ENTRY": "Tuberculosis, Extremely Drug Resistant", "MN": "C01.150.252.410.040.552.846.775.500", "MH_TH": "NLM (2008)", "ST": "T047", "AN": "coordinate with specific type of tuberculosis + specific antitubercular agents if pertinent", "PI": "Tuberculosis, Multidrug-Resistant (2006-2007)", "MS": "Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.", "PM": "2008", "HN": "2008", "MR": "20190617", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054908"}, {"RECTYPE": "D", "MH": "Placozoa", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Trichoplax|T204|NON|NRW|NLM (2009)|070510|abcdef", "ENTRY": "Trichoplaxs", "MN": "B01.050.500.740", "MH_TH": "NLM (2009)", "ST": "T204", "RN": "txid10226", "RR": "txid10227", "MS": "A phylum of primitive invertebrate animals that exemplify a simple body organization. Trichoplax adhaerens is considered a key species for early metazoan evolution.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054909"}, {"RECTYPE": "D", "MH": "Compound Eye, Arthropod", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Compound Eyes, Arthropod", "MN": "A13.246", "FX": "Photoreceptor Cells, Invertebrate", "MH_TH": "NLM (2008)", "ST": "T023", "PI": "Eye (1963-2007)", "MS": "Light sensory organ in ARTHROPODS consisting of a large number of ommatidia, each functioning as an independent photoreceptor unit.", "PM": "2008", "HN": "2008", "MR": "20080710", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054910"}, {"RECTYPE": "D", "MH": "Validation Studies as Topic", "MN": "N05.715.360.335.500", "MH_TH": "NLM (2008)", "ST": "T062", "AN": "for general design, methodology, economics, etc. of validation studies; a different heading VALIDATION STUDY is used for reports of a specific validation study", "MS": "Works on research using processes by which the reliability and relevance of a procedure for a specific purpose are established.", "PM": "2008", "HN": "2008", "MR": "20190710", "DA": "20070709", "DC": "1", "DX": "20080101", "UI": "D054928"}, {"RECTYPE": "D", "MH": "Primary Dysautonomias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Primary Dysautonomia", "MN": "C10.177.575", "MH_TH": "NLM (2009)", "ST": "T047", "PI": "Autonomic Nervous System Diseases (1963-2008)", "MS": "Disorders of the AUTONOMIC NERVOUS SYSTEM occurring as a primary condition. Manifestations can involve any or all body systems but commonly affect the BLOOD PRESSURE and HEART RATE.", "PM": "2009", "HN": "2009; for DYSAUTONOMIA use AUTONOMIC NERVOUS SYSTEM DISEASES 1989-2008", "MR": "20230226", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054969"}, {"RECTYPE": "D", "MH": "Pure Autonomic Failure", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bradbury-Eggleston Syndrome|T047|EPO|EQV|NLM (2009)|070713|abcdef", "ENTRY": "Syndrome, Bradbury-Eggleston", "MN": "C10.177.575.650", "MH_TH": "NLM (2000)", "ST": "T047", "PI": "Autonomic Nervous System Diseases (1990-2008)", "MS": "A degenerative disease of the AUTONOMIC NERVOUS SYSTEM that is characterized by idiopathic ORTHOSTATIC HYPOTENSION and a greatly reduced level of CATECHOLAMINES. No other neurological deficits are present.", "PM": "2009; see AUTONOMIC NERVOUS SYSTEM DISEASES 1999-2008", "HN": "2009; use AUTONOMIC NERVOUS SYSTEM DISEASES 1999-2008", "MR": "20120703", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054970"}, {"RECTYPE": "D", "MH": "Orthostatic Intolerance", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Intolerance, Orthostatic", "MN": "C23.888.592.610", "MH_TH": "ORD (2010)", "ST": "T184", "MS": "Symptoms of cerebral hypoperfusion or autonomic overaction which develop while the subject is standing, but are relieved on recumbency. Types of this include NEUROCARDIOGENIC SYNCOPE; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; and neurogenic ORTHOSTATIC HYPOTENSION. (From Noseworthy, JH., Neurological Therapeutics Principles and Practice, 2007, p2575-2576)", "PM": "2009", "HN": "2009", "MR": "20120703", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054971"}, {"RECTYPE": "D", "MH": "Postural Orthostatic Tachycardia Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Postural Tachycardia Syndrome|T047|NON|EQV|NLM (2009)|070713|abcdef", "ENTRY": "Tachycardia Syndrome, Postural", "MN": "C10.177.575.600.625", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Tachycardia (1982-2008)", "MS": "A syndrome of ORTHOSTATIC INTOLERANCE combined with excessive upright TACHYCARDIA, and usually without associated ORTHOSTATIC HYPOTENSION. All variants have in common an excessively reduced venous return to the heart (central HYPOVOLEMIA) while upright.", "PM": "2009", "HN": "2009", "MR": "20090706", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054972"}, {"RECTYPE": "D", "MH": "Perivascular Epithelioid Cell Neoplasms", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Perivascular Epithelioid Cell Tumor|T191|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Tumors, Clear-Cell Sugar", "MN": "C04.557.450.692", "MH_TH": "NLM (2009)", "ST": "T191", "PI": "Epithelioid Cells/pathology (1999-2008)", "MS": "A family of mesenchymal tumors composed of histologically and immunohistochemically distinctive perivascular epithelioid cells. These cells do not have a normal anatomic homolog. (From Fletcher CDM, et. al., World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone, 2002).", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080709", "DC": "1", "DX": "20090101", "UI": "D054973"}, {"RECTYPE": "D", "MH": "Costameres", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Costamere|T026|NON|EQV|NLM (2009)|070726|abcdef", "MN": "A11.284.149.165.165.142", "MH_TH": "NLM (2009)", "ST": "T026", "MS": "STRIATED MUSCLE cell components which anchor the MYOFIBRILS from the Z-bands to the SARCOLEMMA and EXTRACELLULAR MATRIX. Costameric proteins include the proteins of FOCAL ADHESIONS.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054974"}, {"RECTYPE": "D", "MH": "Pallister-Hall Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Hypothalamic Hamartoblastoma", "MN": "C16.131.621.585.600.374", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A pleiotropic disorder of human development that comprises hypothalamic HAMARTOMA; central and postaxial POLYDACTYLY; bifid EPIGLOTTIS; ANAL ATRESIA; and renal and other abnormalities. This disorder is associated with FRAMESHIFT MUTATIONS in the GLI3 gene which encodes the GLI3 protein, a KRUPPEL-LIKE TRANSCRIPTION FACTORS family member.", "PM": "2009", "HN": "2009", "MR": "20130708", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054975"}, {"RECTYPE": "D", "MH": "Clinical Governance", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Governance, Clinical", "MN": "N04.452.115", "FX": "Clinical Audit", "MH_TH": "NLM (2009)", "ST": "T058", "MS": "A framework through which the United Kingdom's National Health Service organizations are accountable for continually improving the quality of their services and safeguarding high standards of care by creating an environment in which excellence in clinical care will flourish. (Scally and Donaldson, BMJ (4 July 1998): 61-65)", "PM": "2009", "HN": "2009", "MR": "20130709", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054976"}, {"RECTYPE": "D", "MH": "Idiopathic Interstitial Pneumonias", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pneumonias, Idiopathic Interstitial", "MN": "C08.381.483.652.500.750", "MH_TH": "NLM (2009)", "ST": "T047", "PI": "Pulmonary Fibrosis (1972-1992)", "MS": "A group of interstitial lung diseases with no known etiology. There are several entities with varying patterns of inflammation and fibrosis. They are classified by their distinct clinical-radiological-pathological features and prognosis. They include IDIOPATHIC PULMONARY FIBROSIS; CRYPTOGENIC ORGANIZING PNEUMONIA; and others.", "PM": "2009", "HN": "2009", "MR": "20210601", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054988"}, {"RECTYPE": "D", "MH": "Nephrogenic Fibrosing Dermopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nephrogenic Systemic Fibrosis|T047|NON|EQV|NLM (2009)|ORD (2010)|070727|abcdeef", "ENTRY": "Systemic Fibrosis, Nephrogenic", "MN": "C23.550.355.550", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A chronic, acquired, idiopathic, progressive eruption of the skin that occurs in the context of RENAL FAILURE. It is sometimes accompanied by systemic fibrosis. The pathogenesis seems to be multifactorial, with postulated involvement of circulating fibrocytes. There is a strong association between this disorder and the use of gadolinium-based contrast agents.", "PM": "2009", "HN": "2009", "MR": "20090706", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054989"}, {"RECTYPE": "D", "MH": "Idiopathic Pulmonary Fibrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cryptogenic Fibrosing Alveolitis|T047|NON|EQV|GHR (2014)|NLM (2009)|ORD (2010)|070730|abcdeeef", "ENTRY": "Usual Interstitial Pneumonitis", "MN": "C08.381.483.652.500", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "PULMONARY FIBROSIS is also available", "PI": "Pulmonary Fibrosis (1964-2008)", "MS": "A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.", "PM": "2009", "HN": "2009", "MR": "20220428", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054990"}, {"RECTYPE": "D", "MH": "Autovaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME MI PD PK PO RE SD ST TO TU UR VI", "PRINT ENTRY": "Autovaccine|T121|T129|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Vaccines, Autogenous", "MN": "D20.215.894.135.098", "MH_TH": "NLM (2009)", "ST": "T129", "RN": "0", "PI": "Vaccines (1963-2008)", "MS": "Bacterial vaccines prepared from non-pathogenic, autologous bacteria of human origin. In Eastern Europe they are used in humans to treat chronic inflammatory disorders that are resistant to standard treatments. Worldwide they have veterinary use in all types of infectious disease.", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054991"}, {"RECTYPE": "D", "MH": "Immunological Synapses", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Synapses, Immunological|T030|NON|EQV|NLM (2009)|070731|abcdef", "ENTRY": "Synapse, Immunological", "MN": "A15.382.370", "FX": "Antigen Presentation", "MH_TH": "NLM (2009)", "ST": "T030", "MS": "The interfaces between T-CELLS and ANTIGEN-PRESENTING CELLS. Supramolecular organization of proteins takes place at these synapses involving various types of immune cells. Immunological synapses can have several functions including LYMPHOCYTE ACTIVATION; enhancing, balancing, or terminating signaling; or directing cytokine secretion.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D054992"}, {"RECTYPE": "D", "MH": "Anthracosis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Coal Worker's Pneumoconiosis|T037|T047|NON|EQV|NLM (2008)|ORD (2010)|070314|abbcdeef", "ENTRY": "Pneumoconiosis, Coalworker's", "MN": "C08.381.520.702.062", "MH_TH": "NLM (2009)", "ST": "T047", "PI": "Pneumoconiosis (1963-2008)", "MS": "A diffuse parenchymal lung disease caused by accumulation of inhaled CARBON or coal dust. The disease can progress from asymptomatic anthracosis to massive lung fibrosis. This lung lesion usually occurs in coal MINERS, but can be seen in urban dwellers and tobacco smokers.", "PM": "2009; see PNEUMOCONIOSIS 2008", "HN": "2009; use PNEUMOCONIOSIS 2008", "MR": "20150112", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055008"}, {"RECTYPE": "D", "MH": "Spondylosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thoracic Spondylosis|T047|NON|NRW|NLM (2009)|070810|abcdef", "ENTRY": "Spondylosis, Thoracic", "MN": "C05.116.900.938", "FX": "Spondylolysis", "MH_TH": "UNK (19XX)", "ST": "T047", "AN": "coordinate with specific vertebra; do not confuse with SPONDYLOLYSIS or SPONDYLITIS", "PI": "Spinal Osteophytosis (1965-2008)", "MS": "A degenerative spinal disease that can involve any part of the VERTEBRA, the INTERVERTEBRAL DISK, and the surrounding soft tissue.", "PM": "2009; see SPINAL OSTEOPHYTOSIS 1988-2008; for SPONDYLOSIS DEFORMANS see SPINAL OSTEOPHYTOSIS 1965-2008", "HN": "2009; use SPINAL OSTEOPHYTOSIS 1988-2008; for SPONDYLOSIS DEFORMANS use SPINAL OSTEOPHYTOSIS 1965-2008", "MR": "20120703", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055009"}, {"RECTYPE": "D", "MH": "Posterior Cervical Sympathetic Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Barre-Lieou Syndrome|T047|EPO|EQV|NLM (1997)|ORD (2010)|960411|abcdeef", "ENTRY": "Syndrome, Barre-Lieou", "MN": "C05.116.900.596", "MH_TH": "NLM (1997)", "ST": "T047", "PI": "Spinal Osteophytosis (1964-2008)", "MS": "A pathological condition that is characterized by a host of cranial symptoms, such as headaches, abnormal functions of the eyes and the ears, and psychological and mental disorders. This syndrome usually appears after neck injuries, inflammation, or neoplasm.", "PM": "2009; see SPINAL OSTEOPHYTOSIS 1997-2008; see BARRE-LIEOU SYNDROME 1975-1996", "HN": "2009; use SPINAL OSTEOPHYTOSIS 1997-2008", "MR": "20110624", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055010"}, {"RECTYPE": "D", "MH": "Ablation Techniques", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Techniques, Ablation", "MN": "E04.014", "MH_TH": "NLM (2009)", "ST": "T061", "AN": "coordinate with organ or disease /surg", "MS": "Removal of tissue by vaporization, abrasion, or destruction. Methods used include heating tissue by hot liquids or microwave thermal heating, freezing (CRYOABLATION), chemical ablation, and photoablation with LASERS.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055011"}, {"RECTYPE": "D", "MH": "Chromosomal Position Effects", "AQ": "DE GE IM PH RE", "ENTRY": "Position Effects, Chromosomal", "MN": "G05.308.203.124", "MH_TH": "NLM (2009)", "ST": "T045", "MS": "The effects on gene expression that depend on the location of a gene with respect to its neighboring genes and region of chromosome. Stable position effects are sequence dependent. Variegated position effects depend on whether the gene is located in or adjacent to HETEROCHROMATIN or EUCHROMATIN.", "PM": "2009", "HN": "2009", "MR": "20160115", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055012"}, {"RECTYPE": "D", "MH": "Osteoarthritis, Spine", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spinal Osteoarthritis|T047|NON|EQV|NLM (2009)|070816|abcdef", "ENTRY": "Osteoarthritis, Spinal", "MN": "C05.799.613.750", "MH_TH": "NLM (2009)", "ST": "T047", "AN": "coordinate with specific vertebra", "PI": "Osteoarthritis (1963-2008)", "MS": "A degenerative joint disease involving the SPINE. It is characterized by progressive deterioration of the spinal articular cartilage (CARTILAGE, ARTICULAR), usually with hardening of the subchondral bone and outgrowth of bone spurs (OSTEOPHYTE).", "PM": "2009", "HN": "2009", "MR": "20190222", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055013"}, {"RECTYPE": "D", "MH": "Granulocyte-Macrophage Progenitor Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Granulocyte-Macrophage Progenitors|T025|NON|EQV|NLM (2009)|070817|abcdef", "ENTRY": "Progenitors, Granulocyte-Macrophage", "MN": "A15.378.316.378.590.675", "MH_TH": "NLM (2009)", "ST": "T025", "PI": "Macrophages (1973-2008)", "MS": "The parent cells that give rise to both cells of the GRANULOCYTE lineage and cells of the monocyte/macrophage lineage.", "PM": "2009", "HN": "2009", "MR": "20160610", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055014"}, {"RECTYPE": "D", "MH": "Megakaryocyte-Erythroid Progenitor Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Progenitors, Megakaryocyte-Erythroid", "MN": "A15.378.316.378.590.837", "MH_TH": "NLM (2009)", "ST": "T025", "MS": "The parent cells that give rise to both cells of the MEGAKARYOCYTE and the ERYTHROCYTE lineages.", "PM": "2009", "HN": "2009", "MR": "20160610", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055015"}, {"RECTYPE": "D", "MH": "Megakaryocyte Progenitor Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Promegakaryocyte", "MN": "A15.378.316.378.590.837.625", "MH_TH": "NLM (2009)", "ST": "T025", "PI": "Megakaryocytes (1981-2008)", "MS": "The parent cells that give rise to cells in the MEGAKARYOCYTE lineage, and ultimately BLOOD PLATELETS.", "PM": "2009", "HN": "2009", "MR": "20160610", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055016"}, {"RECTYPE": "D", "MH": "Monocyte-Macrophage Precursor Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Promonocytes|T025|NON|NRW|NLM (2009)|070821|abcdef", "ENTRY": "Progenitor Cells, Monocyte-Macrophage", "MN": "A15.378.316.378.590.675.750", "MH_TH": "NLM (2009)", "ST": "T025", "PI": "Monocytes (1976-2008)", "MS": "Parent cells in the lineage that gives rise to MONOCYTES and MACROPHAGES.", "PM": "2009", "HN": "2009", "MR": "20160610", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055017"}, {"RECTYPE": "D", "MH": "Hemangioblasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Hemogenic Endotheliums", "MN": "A11.872.378.270", "MH_TH": "NLM (2009)", "ST": "T025", "AN": "do not confuse with HEMANGIOBLASTOMA", "MS": "Bipotential angio-hematopoietic stem cells that give rise to both HEMATOPOIETIC STEM CELLS and ENDOTHELIAL CELLS.", "PM": "2009", "HN": "2009", "MR": "20160610", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055018"}, {"RECTYPE": "D", "MH": "Comparative Genomic Hybridization", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Hybridizations, Comparative Genomic", "MN": "E05.393.661.187", "MH_TH": "NLM (2009)", "ST": "T063", "PI": "Nucleic Acid Hybridization (1992-2008)", "MS": "A method for comparing two sets of chromosomal DNA by analyzing differences in the copy number and location of specific sequences. It is used to look for large sequence changes such as deletions, duplications, amplifications, or translocations.", "PM": "2009", "HN": "2009", "MR": "20100625", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055028"}, {"RECTYPE": "D", "MH": "Inverted Repeat Sequences", "AQ": "DE GE IM PH RE", "ENTRY": "Tandem Repeats, Inverted", "MN": "G05.360.080.708.800.325", "MH_TH": "NLM (2009)", "ST": "T123", "MS": "Copies of nucleic acid sequence that are arranged in opposing orientation. They may lie adjacent to each other (tandem) or be separated by some sequence that is not part of the repeat (hyphenated). They may be true palindromic repeats, i.e. read the same backwards as forward, or complementary which reads as the base complement in the opposite orientation. Complementary inverted repeats have the potential to form hairpin loop or stem-loop structures which results in cruciform structures (such as CRUCIFORM DNA) when the complementary inverted repeats occur in double stranded regions.", "PM": "2009; for INVERTED REPEAT SEQUENCE see REPETITIVE SEQUENCES, NUCLEIC ACID 1990-2008", "HN": "2009; for INVERTED REPEAT SEQUENCE use REPETITIVE SEQUENCES, NUCLEIC ACID 1990-2008", "MR": "20130709", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055029"}, {"RECTYPE": "D", "MH": "Drug Users", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "People Who Inject Drugs|T098|NON|NRW|NLM (2022)|210122|abcdef", "ENTRY": "Users, Intravenous Drug", "MN": "M01.169", "MH_TH": "NLM (2009)", "ST": "T098", "AN": "for drug users as persons only; for the disorder, use SUBSTANCE-RELATED DISORDERS", "MS": "People who take drugs for a non-therapeutic or non-medical effect. The drugs may be legal or illegal, but their use often results in adverse medical, legal, or social consequences for the users.", "PM": "2009", "HN": "2009", "MR": "20210326", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055030"}, {"RECTYPE": "D", "MH": "Primary Graft Dysfunction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Graft Dysfunction, Primary", "MN": "C23.550.767.877.750", "MH_TH": "NLM (2009)", "ST": "T046", "MS": "A form of ischemia-reperfusion injury occurring in the early period following transplantation. Significant pathophysiological changes in MITOCHONDRIA are the main cause of the dysfunction. It is most often seen in the transplanted lung, liver, or kidney and can lead to GRAFT REJECTION.", "PM": "2009", "HN": "2009", "MR": "20081016", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055031"}, {"RECTYPE": "D", "MH": "Electron Microscope Tomography", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tomography, Electron Microscope|T059|NON|EQV|NLM (2009)|070829|abcdef", "ENTRY": "Tomography, TEM", "MN": "E05.595.402.580.239", "MH_TH": "NLM (2009)", "ST": "T059", "AN": "do not confuse entry term ELECTRON TOMOGRAPHY with ELECTRON BEAM TOMOGRAPHY see TOMOGRAPHY, X-RAY COMPUTED", "MS": "A tomographic technique for obtaining 3-dimensional images with transmission electron microscopy.", "PM": "2009", "HN": "2009", "MR": "20090721", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055032"}, {"RECTYPE": "D", "MH": "Osteochondrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Osgood-Schlatter Disease|T047|EPO|NRW|UNK (19XX)|780522|OSGOOD SCHLATTER DIS|abcdefv", "ENTRY": "Osteochondrosis, Navicular", "MN": "C05.116.821", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Osteochondritis (1963-2008)", "MS": "Any of a group of bone disorders involving one or more ossification centers (EPIPHYSES). It is characterized by degeneration or NECROSIS followed by revascularization and reossification. Osteochondrosis often occurs in children causing varying degrees of discomfort or pain. There are many eponymic types for specific affected areas, such as tarsal navicular (Kohler disease) and tibial tuberosity (Osgood-Schlatter disease).", "PM": "2009; see OSTEOCHONDRITIS 1963-2008", "HN": "2009; use OSTEOCHONDRITIS 1963-2008", "MR": "20110624", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055034"}, {"RECTYPE": "D", "MH": "Spinal Osteochondrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spine Osteochondrosis", "MN": "C05.116.900.808", "MH_TH": "OMIM (2013)", "ST": "T047", "AN": "coordinate with specific vertebra", "PI": "Osteochondritis (1967-2008)", "MS": "A bone disorder involving ossification centers (EPIPHYSES) of the VERTEBRAL COLUMN.", "PM": "2009", "HN": "2009", "MR": "20120703", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055035"}, {"RECTYPE": "D", "MH": "Campomelic Dysplasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Campomelic", "MN": "C16.131.621.142", "FX": "Pierre Robin Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A congenital disorder of CHONDROGENESIS and OSTEOGENESIS characterized by hypoplasia of endochondral bones. In most cases there is a curvature of the long bones especially the TIBIA with dimpling of the skin over the bowed areas, malformation of the pelvis and spine, 11 pairs of ribs, hypoplastic scapulae, club feet, micrognathia, CLEFT PALATE, tracheobronchomalacia, and in some patients male-to-female sex reversal (SEX REVERSAL, GONADAL). Most patients die in the neonatal period of respiratory distress. Campomelic dysplasia is associated with haploinsufficiency of the SOX9 TRANSCRIPTION FACTOR gene.", "PM": "2009", "HN": "2009", "MR": "20151020", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055036"}, {"RECTYPE": "D", "MH": "Integrative Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Integrative", "MN": "H02.403.400", "FX": "Holistic Health", "MH_TH": "NLM (2009)", "ST": "T091", "MS": "The discipline concerned with using the combination of conventional allopathic medicine and ALTERNATIVE MEDICINE to address the biological, psychological, social, and spiritual aspects of health and illness.", "PM": "2009", "HN": "2009", "MR": "20160705", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055048"}, {"RECTYPE": "D", "MH": "Salt Tolerance", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Salt-Tolerance|T040|NON|EQV|NLM (2009)|070906|abcdef", "ENTRY": "Tolerance, Salt", "MN": "G16.012.500.133.250", "FX": "Halobacteriaceae", "MH_TH": "NLM (2019)", "ST": "T040", "MS": "The ability of organisms to sense and adapt to high concentrations of salt in their growth environment.", "PM": "2019; see Saline-Tolerance 2009-2018", "HN": "2019(2009); use Saline-Tolerance 2009-2018", "MR": "20190702", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055049"}, {"RECTYPE": "D", "MH": "Diet, Gluten-Free", "AQ": "AE CL EC EH ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Gluten-Free Diet|T061|NON|EQV|NLM (2009)|070907|abcdef", "ENTRY": "Gluten-Free Diets", "MN": "G07.203.650.240.265", "MH_TH": "NLM (2009)", "ST": "T061", "PI": "Gluten (1963-2008)", "MS": "A diet which is devoid of GLUTENS from WHEAT; BARLEY; RYE; and other wheat-related varieties. The diet is designed to reduce exposure to those proteins in gluten that trigger INFLAMMATION of the small intestinal mucosa in patients with CELIAC DISEASE.", "PM": "2009", "HN": "2009", "MR": "20150629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055050"}, {"RECTYPE": "D", "MH": "Salt-Tolerant Plants", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Plants, Salt-Tolerant|T002|NON|EQV|NLM (2009)|070910|abcdef", "ENTRY": "Salt-Tolerant Plant", "MN": "B01.650.723", "FX": "Plants, Genetically Modified", "MH_TH": "NLM (2009)", "ST": "T002", "MS": "Plants that can grow well in soils that have a high SALINITY.", "PM": "2009", "HN": "2009", "MR": "20210630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055051"}, {"RECTYPE": "D", "MH": "Athletic Tape", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Tapes, Kinesio", "MN": "E07.858.442.743.159", "MH_TH": "NLM (2009)", "ST": "T074", "PI": "Bandages (1974-2008)", "MS": "Adhesive tape with the mechanical strength to resist stretching. It is applied to the skin to support, stabilize, and restrict movement to aid healing and/or prevent injuries of the MUSCULOSKELETAL SYSTEM.", "PM": "2009", "HN": "2009", "MR": "20170414", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055052"}, {"RECTYPE": "D", "MH": "Terahertz Radiation", "AQ": "AE", "PRINT ENTRY": "T-Ray|T070|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "THz Radiations", "MN": "G01.750.770.832", "MH_TH": "NLM (2009)", "ST": "T070", "MS": "Non-ionizing electromagnetic energy in the frequency range of 100 gigahertz to 10 terahertz which spans from the mid-INFRARED RAYS frequency to the high-frequency edge of the MICROWAVES band.", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055053"}, {"RECTYPE": "D", "MH": "Terahertz Spectroscopy", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Spectroscopy, Terahertz", "MN": "E05.196.867.945", "MH_TH": "NLM (2009)", "ST": "T059", "PI": "Spectrum Analysis (2004-2008)", "MS": "Spectrum analysis of absorbed or emitted TERAHERTZ RADIATION.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055068"}, {"RECTYPE": "D", "MH": "Terahertz Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Imaging, Terahertz", "MN": "E01.370.350.780", "MH_TH": "NLM (2009)", "ST": "T060", "MS": "The visualization of internal structure using TERAHERTZ RADIATION technologies.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055069"}, {"RECTYPE": "D", "MH": "Resistance Training", "AQ": "AE CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Weight-Lifting Strengthening Program|T061|NON|NRW|NLM (2009)|070918|abcdef", "ENTRY": "Weight-Lifting Strengthening Programs", "MN": "I03.350.311.750", "MH_TH": "NLM (2009)", "ST": "T061", "MS": "A type of strength-building exercise program that requires the body muscle to exert a force against some form of resistance, such as weight, stretch bands, water, or immovable objects. Resistance exercise is a combination of static and dynamic contractions involving shortening and lengthening of skeletal muscles.", "PM": "2009", "HN": "2009", "MR": "20170601", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055070"}, {"RECTYPE": "D", "MH": "Early Detection of Cancer", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Cancer Screening", "MN": "E01.390.500", "MH_TH": "NLM (2009)", "ST": "T060", "MS": "Methods to identify and characterize cancer in the early stages of disease and predict tumor behavior.", "PM": "2009", "HN": "2009", "MR": "20090706", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055088"}, {"RECTYPE": "D", "MH": "Tracheobronchomalacia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chondromalacia of Trachea and Bronchi|T047|NON|EQV|NLM (2009)|070919|abcdef", "ENTRY": "Williams Campbell Syndrome", "MN": "C17.300.182.895", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Trachea (1963-2008)", "MS": "A congenital or acquired condition of underdeveloped or degeneration of CARTILAGE in the TRACHEA and the BRONCHI. This results in a floppy non-rigid airway making patency difficult to maintain.", "PM": "2009", "HN": "2009", "MR": "20120703", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055089"}, {"RECTYPE": "D", "MH": "Tracheomalacia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chondromalacia of Trachea|T047|NON|EQV|NLM (2009)|070919|abcdef", "ENTRY": "Tracheomalacias", "MN": "C17.300.182.895.500", "MH_TH": "NLM (2009)", "ST": "T047", "PI": "Tracheal Diseases (1968-2008)", "MS": "A congenital or acquired condition of underdeveloped or degeneration of CARTILAGE in the TRACHEA. This results in a floppy tracheal wall making patency difficult to maintain. It is characterized by wheezing and difficult breathing.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055090"}, {"RECTYPE": "D", "MH": "Bronchomalacia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chondromalacia of Bronchi|T047|NON|EQV|NLM (2009)|070919|abcdef", "ENTRY": "Bronchomalacias", "MN": "C17.300.182.895.249", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Bronchial Diseases (1966-2008)", "MS": "A congenital or acquired condition of underdeveloped or degeneration of CARTILAGE in the BRONCHI. This results in a floppy bronchial wall making patency difficult to maintain. It is characterized by wheezing and difficult breathing.", "PM": "2009", "HN": "2009", "MR": "20120703", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055091"}, {"RECTYPE": "D", "MH": "Laryngomalacia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chondromalacia of Larynx|T047|NON|EQV|NLM (2009)|070919|abcdef", "ENTRY": "Larynx Chondromalacias", "MN": "C17.300.182.310", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Laryngeal Diseases (1970-2008)", "MS": "A congenital or acquired condition of underdeveloped or degeneration of CARTILAGE in the LARYNX. This results in a floppy laryngeal wall making patency difficult to maintain.", "PM": "2009", "HN": "2009", "MR": "20120703", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055092"}, {"RECTYPE": "D", "MH": "Periodontal Atrophy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Periodontium Atrophy", "MN": "C07.465.714.354", "MH_TH": "NLM (2009)", "ST": "T047", "MS": "Degradation or wasting of the PERIODONTIUM tissues that may involve the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, or the PERIODONTAL LIGAMENT.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055093"}, {"RECTYPE": "D", "MH": "Evidence-Based Dentistry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Dentistry, Evidence-Based|T091|NON|EQV|NLM (2009)|070920|abcdef", "ENTRY": "Evidence-Based Dentistries", "MN": "H02.249.500", "FX": "Evidence-Based Nursing", "MH_TH": "NLM (2009)", "ST": "T091", "PI": "Dentistry (1995-2008)", "MS": "An approach or process of practicing oral health care that requires the judicious integration of systematic assessments of clinical relevant scientific evidence, relating to the patient's oral and medical condition and history, with the dentist's clinical expertise and the patient's treatment needs and preferences. (from J Am Dent Assoc 134: 689, 2003)", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055094"}, {"RECTYPE": "D", "MH": "Optics and Photonics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Photonics and Optics", "MN": "J01.293.688", "FX": "Optical Devices", "MH_TH": "NLM (2009)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use OPTICAL PHENOMENA or specifics treed under it for processes and properties of light and materials interacting with light", "MS": "A specialized field of physics and engineering involved in studying the behavior and properties of light and the technology of analyzing, generating, transmitting, and manipulating ELECTROMAGNETIC RADIATION in the visible, infrared, and ultraviolet range.", "PM": "2009; see OPTICS 1993-2008", "HN": "2009", "MR": "20081130", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055095"}, {"RECTYPE": "D", "MH": "Optical Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Systems, Optical", "MN": "E07.632", "FX": "Optics and Photonics", "MH_TH": "NLM (2009)", "ST": "T073", "MS": "Products or parts of products used to detect, manipulate, or analyze light, such as LENSES, refractors, mirrors, filters, prisms, and OPTICAL FIBERS.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055096"}, {"RECTYPE": "D", "MH": "Auriculotherapy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Auriculotherapies", "MN": "E02.190.204", "MH_TH": "NLM (2009)", "ST": "T061", "AN": "AURICULAR ACUPUNCTURE see ACUPUNCTURE, EAR is also available", "PI": "Ear, External (1972-2008)", "MS": "Treatment of pain, drug addictions, or other ailments by stimulating the various points on the external ear (EAR AURICLES). It is based on the ancient Chinese practices of EAR ACUPUNCTURE, but sometimes magnets and other modes of stimulation are used.", "PM": "2009", "HN": "2009", "MR": "20180629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055097"}, {"RECTYPE": "D", "MH": "Endocrine Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Endocrine Cell", "MN": "A11.382", "MH_TH": "NLM (2009)", "ST": "T025", "AN": "general; prefer specific cell types", "MS": "Secretory cells of the ductless glands. They secrete HORMONES directly into the blood circulation (internal secretion) to be carried to the target cells. The secreted chemicals can be PEPTIDES; STEROIDS; NEUROPEPTIDES; or BIOGENIC AMINES.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055098"}, {"RECTYPE": "D", "MH": "Neuroendocrine Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Neurons, Endocrine", "MN": "A11.382.944", "MH_TH": "NLM (2009)", "ST": "T025", "AN": "coordinate with specific organ", "MS": "Specialized NEURONS that produce hormones, such as NEUROPEPTIDES or BIOGENIC AMINES. They generally are in the NERVOUS SYSTEM, such as HYPOTHALAMUS, but can be found in other organs or systems. These neurons contain dense neurosecretory granules and PROPROTEIN CONVERTASES allowing the rapidly release of NEUROHORMONES into the blood circulation upon stimulation.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055099"}, {"RECTYPE": "D", "MH": "Optical Fibers", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Optical Fiber", "MN": "E07.632.750", "FX": "Fiber Optic Technology", "MH_TH": "NLM (2009)", "ST": "T073", "PI": "Fiber Optic Technology (1970-2008)", "MS": "Thin strands of transparent material, usually glass, that are used for transmitting light waves over long distances.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055100"}, {"RECTYPE": "D", "MH": "Semen Analysis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Semen Quality|T043|T059|T201|NON|REL|NLM (2010)|090220|abbbcdef", "ENTRY": "Semen Quality Analyses", "MN": "E05.200.992", "MH_TH": "NLM (2009)", "ST": "T059", "PI": "Sperm Motility (1975-2009)", "MS": "The quality of SEMEN, an indicator of male fertility, can be determined by semen volume, pH, sperm concentration (SPERM COUNT), total sperm number, sperm viability, sperm vigor (SPERM MOTILITY), normal sperm morphology, ACROSOME integrity, and the concentration of WHITE BLOOD CELLS.", "PM": "2009", "HN": "2009", "MR": "20110624", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055101"}, {"RECTYPE": "D", "MH": "Hypodermoclysis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Hydration, Subcutaneous", "MN": "E02.319.360.500", "MH_TH": "NLM (2009)", "ST": "T061", "PI": "Fluid Therapy (1979-2008)", "MS": "Technique for treating DEHYDRATION and WATER-ELECTROLYTE IMBALANCE by subcutaneous infusion of REHYDRATION SOLUTIONS.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055103"}, {"RECTYPE": "D", "MH": "Infusions, Subcutaneous", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Subcutaneous Infusions|T061|NON|EQV|NLM (2009)|070925|abcdef", "ENTRY": "Subcutaneous Infusion", "MN": "E02.319.267.510.795", "FX": "Subcutaneous Absorption", "MH_TH": "NLM (2009)", "ST": "T061", "PI": "Injections, Subcutaneous (1970-2008)", "MS": "The administration of liquid medication or nutrients under the skin, usually over minutes or hours.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055104"}, {"RECTYPE": "D", "MH": "Waist Circumference", "AQ": "DE EH GE IM PH RE", "ENTRY": "Waist Circumferences", "MN": "G07.100.100.160.560", "FX": "Waist-Hip Ratio", "MH_TH": "NLM (2009)", "ST": "T081", "PI": "Body Constitution (1994-2008)", "MS": "The measurement around the body at the level of the ABDOMEN and just above the hip bone. The measurement is usually taken immediately after exhalation.", "PM": "2009", "HN": "2009", "MR": "20130708", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055105"}, {"RECTYPE": "D", "MH": "Genome-Wide Association Study", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Genome Wide Association Study|T063|NON|EQV|NLM (2009)|070926|abcdef", "ENTRY": "Study, Genome-Wide Association", "MN": "N06.850.520.470.500", "FX": "Genotyping Techniques", "MH_TH": "NLM (2009)", "ST": "T063", "MS": "An analysis comparing the allele frequencies of all available (or a whole GENOME representative set of) polymorphic markers to identify gene candidates or quantitative trait loci associated with a specific organism trait or specific disease or condition.", "PM": "2009", "HN": "2009", "MR": "20220712", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055106"}, {"RECTYPE": "D", "MH": "Suntan", "AQ": "DE ES GE IM PH RE", "MN": "G13.750.837.500", "FX": "Sunburn", "MH_TH": "NLM (2009)", "ST": "T032", "MS": "An induced skin pigment (MELANIN) darkening after exposure to SUNLIGHT or ULTRAVIOLET RAYS. The degree of tanning depends on the intensity and duration of UV exposure, and genetic factors.", "PM": "2009", "HN": "2009", "MR": "20160623", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055107"}, {"RECTYPE": "D", "MH": "Sunbathing", "AQ": "CL EC ED ES HI IN LJ PX SN ST TD", "PRINT ENTRY": "Suntanning|T056|NON|NRW|NLM (2009)|070926|abcdef", "MN": "I03.450.642.922", "FX": "Suntan", "MH_TH": "UNK (19XX)", "ST": "T056", "PI": "Ultraviolet Rays (1965-2008)", "MS": "Exposing oneself to SUNLIGHT or ULTRAVIOLET RAYS.", "PM": "2009; see HELIOTHERAPY 1985-2008", "HN": "2009; use HELIOTHERAPY 1985-2008", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055108"}, {"RECTYPE": "D", "MH": "Ankle Brachial Index", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Toe-Brachial Indices", "MN": "E01.370.370.140.049", "MH_TH": "NLM (2009)", "ST": "T039", "MS": "Comparison of the BLOOD PRESSURE between the BRACHIAL ARTERY and the POSTERIOR TIBIAL ARTERY. It is a predictor of PERIPHERAL ARTERIAL DISEASE.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055109"}, {"RECTYPE": "D", "MH": "Radiometric Dating", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Radiometric Datings", "MN": "E05.799.669", "MH_TH": "NLM (2009)", "ST": "T062", "MS": "Techniques used to determine the age of materials, based on the content and half-lives of the RADIOACTIVE ISOTOPES they contain.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055110"}, {"RECTYPE": "D", "MH": "Failed Back Surgery Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.888.592.612.107.200", "MH_TH": "NLM (2009)", "ST": "T184", "PI": "Postoperative Complications (1985-2008)", "MS": "A condition of persistent pain and discomfort in the BACK and the LEG following lumbar surgery, often seen in patients enrolled in pain centers.", "PM": "2009", "HN": "2009", "MR": "20170620", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055111"}, {"RECTYPE": "D", "MH": "Pyometra", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pyometras", "MN": "C12.100.250.852.544", "MH_TH": "NLM (2009)", "ST": "T184", "PI": "Uterine Diseases (1966-2008)", "MS": "An accumulation of PUS in the uterine cavity (UTERUS). Pyometra generally indicates the presence of infections.", "PM": "2009", "HN": "2009", "MR": "20210630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055112"}, {"RECTYPE": "D", "MH": "Chronic Periodontitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Periodontitides, Chronic", "MN": "C23.550.291.500.313", "MH_TH": "NLM (2009)", "ST": "T047", "PI": "Periodontitis (1966-2008)", "MS": "Chronic inflammation and loss of PERIODONTIUM that is associated with the amount of DENTAL PLAQUE or DENTAL CALCULUS present. Chronic periodontitis occurs mostly in adults and was called adult periodontitis, but this disease can appear in young people.", "PM": "2009", "HN": "2009", "MR": "20210312", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055113"}, {"RECTYPE": "D", "MH": "X-Ray Microtomography", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Xray MicroCTs", "MN": "E01.370.350.825.810.810.900", "MH_TH": "NLM (2009)", "ST": "T060", "PI": "Tomography, X-Ray Computed (1982-2008)", "MS": "X-RAY COMPUTERIZED TOMOGRAPHY with resolution in the micrometer range.", "PM": "2009", "HN": "2009", "MR": "20090706", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055114"}, {"RECTYPE": "D", "MH": "Light-Curing of Dental Adhesives", "AQ": "AE CL EC ES HI IS MT NU PX SN ST TD VE", "PRINT ENTRY": "Light-Curing of Dental Cements|T061|NON|EQV|NLM (2009)|071003|abcdef", "ENTRY": "Light-Cured Dental Bondings", "MN": "E06.095.585", "FX": "Photoinitiators, Dental", "MH_TH": "NLM (2009)", "ST": "T061", "PI": "Light (1979-2008)", "MS": "The hardening or polymerization of bonding agents (DENTAL CEMENTS) via exposure to light.", "PM": "2011; see Dental Bonding, Light-Cured 2009-2010", "HN": "2011(2009)", "MR": "20180629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055115"}, {"RECTYPE": "D", "MH": "Self-Curing of Dental Resins", "AQ": "AE CL EC ES HI IS MT NU PX SN ST TD VE", "PRINT ENTRY": "Dual-Curing of Resin Cements|T061|NON|REL|NLM (2009)|071003|abcdef", "ENTRY": "Self-Cured Dental Bonding", "MN": "E06.095.850", "MH_TH": "NLM (2009)", "ST": "T061", "PI": "Composite Resins (1989-2008)", "MS": "The hardening or polymerization of bonding agents (DENTAL CEMENTS) via chemical reactions, usually involving two components. This type of dental bonding uses a self-cure or dual-cure system.", "PM": "2011; see Dental Bonding, Chemically-Cured 2009-2010", "HN": "2011(2009)", "MR": "20180629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055116"}, {"RECTYPE": "D", "MH": "Curing Lights, Dental", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Dental Curing Lights|T074|NON|EQV|NLM (2009)|071004|abcdef", "ENTRY": "Lights, Dental Curing", "MN": "E07.222.104", "FX": "Photoinitiators, Dental", "MH_TH": "NLM (2009)", "ST": "T074", "PI": "Light (1983-2008)", "MS": "Light sources used to activate polymerization of light-cured DENTAL CEMENTS and DENTAL RESINS. Degree of cure and bond strength depends on exposure time, wavelength, and intensity of the curing light.", "PM": "2009", "HN": "2009", "MR": "20100625", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055117"}, {"RECTYPE": "D", "MH": "Medication Adherence", "AQ": "EH PX SN", "PRINT ENTRY": "Medication Nonadherence|T080|NON|REL|NLM (2009)|080625|abcdef", "ENTRY": "Persistence, Medication", "MN": "N05.300.150.800.500.600.500", "FX": "Treatment Refusal", "MH_TH": "NLM (2009)", "ST": "T055", "AN": "do not confuse entry term MEDICATION NONADHERENCE with TREATMENT REFUSAL", "PI": "Patient Compliance (1974-2008)", "MS": "Voluntary cooperation of the patient in taking drugs or medicine as prescribed. This includes timing, dosage, and frequency.", "PM": "2009", "HN": "2009", "MR": "20210512", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055118"}, {"RECTYPE": "D", "MH": "Elastic Modulus", "AQ": "DE PH RE", "PRINT ENTRY": "Young Modulus|T081|EPO|EQV|NLM (2009)|071004|abcdef", "ENTRY": "Youngs Modulus", "MN": "G01.374.590.605", "FX": "Elasticity", "MH_TH": "NLM (2009)", "ST": "T081", "PI": "Elasticity (1965-2008)", "MS": "Numerical expression indicating the measure of stiffness in a material. It is defined by the ratio of stress in a unit area of substance to the resulting deformation (strain). This allows the behavior of a material under load (such as bone) to be calculated.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055119"}, {"RECTYPE": "D", "MH": "Blastocladiomycota", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Blastocladiomycotas", "MN": "B01.300.230", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid451459", "RR": "txid4805", "MS": "A phylum of flagellated fungi, formerly the order Blastocladiales under CHYTRIDIOMYCOTA.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055133"}, {"RECTYPE": "D", "MH": "Allomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Allomyce", "MN": "B01.300.230.074", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid28581", "PI": "Fungi (1963-2008)", "MS": "A genus of aquatic fungi in the phylum BLASTOCLADIOMYCOTA. It is abundant in warmer climates and exhibits true alternation of generations.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055134"}, {"RECTYPE": "D", "MH": "Coelomomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Coelomomyce", "MN": "B01.300.230.200", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid143959", "PI": "Fungi (1964-2008)", "MS": "A genus of fungi in the phylum BLASTOCLADIOMYCOTA. They exhibit complex life cycles and are parasitic on the larvae of MOSQUITOES.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055135"}, {"RECTYPE": "D", "MH": "Neocallimastigomycota", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Neocallimastigomycotas", "MN": "B01.300.665", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid451455", "MS": "A phylum of anaerobic fungi found in the stomachs of RUMINANTS. These fungi lack mitochondria and reproduce through zoospores.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055136"}, {"RECTYPE": "D", "MH": "Glomeromycota", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Glomeromycotas", "MN": "B01.300.320", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid214504", "PI": "Mycorrhizae (2003-2008)", "MS": "A phylum of fungi that are mutualistic symbionts and form ARBUSCULAR MYCORRHIZAE with PLANT ROOTS.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055137"}, {"RECTYPE": "D", "MH": "Sensory Gating", "AQ": "DE GE IM PH RE", "ENTRY": "Gating, Startle", "MN": "G11.561.794", "MH_TH": "NLM (2009)", "ST": "T039", "AN": "do not confuse with ION CHANNEL GATING", "PI": "Schizophrenia (1982-2008)", "MS": "The ability of the BRAIN to suppress neuronal responses to external sensory inputs, such as auditory and visual stimuli. Sensory filtering (or gating) allows humans to block out irrelevant, meaningless, or redundant stimuli.", "PM": "2009", "HN": "2009", "MR": "20160623", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055139"}, {"RECTYPE": "D", "MH": "Stem Cell Niche", "AQ": "DE GE IM PH RE", "ENTRY": "Stem Cell Niches", "MN": "G04.366.249", "MH_TH": "NLM (2009)", "ST": "T022", "PI": "Stem Cells (1992-2008)", "MS": "A particular zone of tissue composed of a specialized microenvironment where stem cells are retained in a undifferentiated, self-renewable state.", "PM": "2009", "HN": "2009", "MR": "20110624", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055153"}, {"RECTYPE": "D", "MH": "Dysphonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spastic Dysphonia|T184|NON|NRW|NLM (2000)|991103|abcdef", "ENTRY": "Phonation Disorder", "MN": "C23.888.592.979.325", "FX": "Vocal Cord Dysfunction", "MH_TH": "UNK (19XX)", "ST": "T184", "PI": "Voice Disorders (1979-2008)", "MS": "Difficulty and/or pain in PHONATION or speaking.", "PM": "2009", "HN": "2009", "MR": "20130708", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055154"}, {"RECTYPE": "D", "MH": "Ophiostomatales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Ophiostomatale", "MN": "B01.300.107.655", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid5151", "PI": "Ascomycota (2006-2008)", "MS": "An order of fungi in the phylum ASCOMYCOTA that are important plant pathogens.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055155"}, {"RECTYPE": "D", "MH": "Ophiostoma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Ophiostomas", "MN": "B01.300.107.655.600", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid5159", "AN": "Ascomycota (1963-2008)", "MS": "A genus of fungi in the family Ophiostomataceae, order OPHIOSTOMATALES. Several species are the source of Dutch elm disease, which is spread by the elm bark beetle.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055156"}, {"RECTYPE": "D", "MH": "Dipodascus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.930.330", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid27314", "PI": "Saccharomycetales (1975-2008)", "MS": "A genus of ascomycetous yeast in the family Dipodascaceae, order SACCHAROMYCETALES. It is characterized by asci which have persistent walls and by smooth-walled ascospores. Anamorphs are in the genus GEOTRICHUM.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055157"}, {"RECTYPE": "D", "MH": "Velopharyngeal Sphincter", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Palatopharyngeal Sphincter|T023|NON|EQV|NLM (2009)|071023|abcdef", "ENTRY": "Sphincter, Velopharyngeal", "MN": "A14.724.617.680", "MH_TH": "NLM (2009)", "ST": "T023", "PI": "Pharynx (1977-2008)", "MS": "A group of muscles attached to the SOFT PALATE (or velum) and the PHARYNX. They include the superior constrictor, the PALATOPHARYNGEUS, the levator veli palatini muscle, and the muscularis uvulae. This sphincter is situated between the oral and nasal cavities. A competent velopharyngeal sphincter is essential for normal speech and swallowing.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055158"}, {"RECTYPE": "D", "MH": "Endomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Endomyce", "MN": "B01.300.930.340", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid44279", "PI": "Ascomycota (1964-2008)", "MS": "A genus of ascomycetous yeast in the family Endomycetaceae, order SACCHAROMYCETALES. They have been described as ascus-bearing parasites of basidiocarps, the fruiting bodies of BASIDIOMYCOTA.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055159"}, {"RECTYPE": "D", "MH": "Lipomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Lipomyce", "MN": "B01.300.930.555", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid29828", "PI": "Saccharomyces (1974-2008)", "MS": "A genus of ascomycetous soil yeast in the family Lipomycetaceae, order SACCHAROMYCETALES.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055160"}, {"RECTYPE": "D", "MH": "Speleotherapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Speleotherapies", "MN": "E02.190.894", "MH_TH": "NLM (2009)", "ST": "T061", "PI": "Physical Therapy Modalities (1976-2008)", "MS": "The use of CAVES, mines, or other subterranean environments in treatment of diseases. Speleotherapy is used in some Central and Eastern European countries to treat CHRONIC OBSTRUCTIVE AIRWAY DISEASE.", "PM": "2009", "HN": "2009", "MR": "20110624", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055161"}, {"RECTYPE": "D", "MH": "Biocatalysis", "AQ": "DE RE", "MN": "G03.105", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "CATALYSIS is also available", "PI": "Catalysis (1963-2008)", "MS": "The facilitation of biochemical reactions with the aid of naturally occurring catalysts such as ENZYMES.", "PM": "2009", "HN": "2009", "MR": "20160502", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055162"}, {"RECTYPE": "D", "MH": "Metschnikowia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Metschnikowias", "MN": "B01.300.930.587", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid27320", "PI": "Yeasts (1969-2008)", "MS": "A genus of ascomycetous yeast in the family Metschnikowiaceae, order SACCHAROMYCETALES. Its antifungal activity is used to inhibit postharvest decay of fruit.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055163"}, {"RECTYPE": "D", "MH": "Nerve Expansion", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Stretchings, Nerve", "MN": "E04.617.800.500", "MH_TH": "NLM (2009)", "ST": "T061", "MS": "Procedures that stimulate nerve elongation over a period of time. They are used in repairing nerve tissue.", "PM": "2009", "HN": "2009", "MR": "20220406", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055164"}, {"RECTYPE": "D", "MH": "Debaryomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Debaryomyces hansenii|T004|NON|NRW|NLM (2022)|210409|abcdef", "MN": "B01.300.930.323", "MH_TH": "NLM (2021)", "ST": "T004", "RN": "txid4958", "RR": "txid4959", "PI": "Saccharomycetales (1976-2008)", "MS": "A genus of ascomycetous yeast in the family Debaryomycetaceae, order SACCHAROMYCETALES and phylum ASCOMYCOTA. Debaryomyces fungi are budding yeasts commonly found in the environment and used in the food industry. Debaryomyces hansenii (formerly Candida famata) is a salt-tolerant marine species sometimes involved in INVASIVE CANDIDIASIS and CANDIDEMIA.", "PM": "2021; see Debaromyces 2009-2020", "HN": "2021(2009)", "MR": "20210510", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055165"}, {"RECTYPE": "D", "MH": "Hepatic Stellate Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Stellate Cells, Hepatic", "MN": "A11.561", "MH_TH": "NLM (2009)", "ST": "T025", "MS": "Perisinusoidal cells of the liver, located in the space of Disse between HEPATOCYTES and sinusoidal endothelial cells.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055166"}, {"RECTYPE": "D", "MH": "Dekkera", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Dekkeras", "MN": "B01.300.930.326", "MH_TH": "NLM (2009)", "ST": "T004", "PI": "Saccharomycetales (1980-2008)", "MS": "A genus of ascomycetous yeast in the family Saccharomycetaceae, order SACCHAROMYCETALES. It has been implicated in wine spoilage. Anamorphic forms are found in the genus BRETTANOMYCES.", "PM": "2009", "HN": "2009", "MR": "20200902", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055167"}, {"RECTYPE": "D", "MH": "Brettanomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Brettanomyce", "MN": "B01.300.930.150", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid13366", "PI": "Yeasts (1969-2008)", "MS": "The anamorphic form of the yeast DEKKERA. It is implicated as a spoilage microorganism in wines.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055168"}, {"RECTYPE": "D", "MH": "Eremothecium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Eremotheciums", "MN": "B01.300.930.350", "MH_TH": "UNK (19XX)", "ST": "T004", "RN": "txid33170", "PI": "Saccharomycetales (1974-2008)", "MS": "A genus of ascomycetous yeast in the family Saccharomycetaceae, order SACCHAROMYCETALES. Species in the genus are plant pathogens.", "PM": "2009: for EREMOTHECIUM see SACCHAROMYCETALES 1986-2008, see ASCOMYCETES 1963-1985", "HN": "2009; for EREMOTHECIUM use SACCHAROMYCETALES 1986-2008, use ASCOMYCOTA 1963-1985", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055169"}, {"RECTYPE": "D", "MH": "Plant Root Nodulation", "AQ": "DE GE IM PH RE", "ENTRY": "Root Nodulation, Plant", "MN": "G15.682", "FX": "Root Nodules, Plant", "MH_TH": "NLM (2009)", "ST": "T040", "PI": "Root Nodules, Plant (2007-2008)", "MS": "The formation of a nitrogen-fixing cell mass on PLANT ROOTS following symbiotic infection by nitrogen-fixing bacteria such as RHIZOBIUM or FRANKIA.", "PM": "2009", "HN": "2009", "MR": "20160623", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055170"}, {"RECTYPE": "D", "MH": "Nasal Cartilages", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Septal Nasal Cartilages", "MN": "A04.531.413", "MH_TH": "NLM (2009)", "ST": "T023", "PI": "Nose (1964-2008)", "MS": "Hyaline cartilages in the nose. There are five major nasal cartilages including two lateral, two alar, and one septal.", "PM": "2009", "HN": "2009", "MR": "20180629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055171"}, {"RECTYPE": "D", "MH": "Vomer", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vomers", "MN": "A04.531.591.469", "MH_TH": "UNK (19XX)", "ST": "T023", "AN": "fractures: coordinate VOMER / inj (IM) + SKULL FRACTURES (IM); neoplasms: coordinate VOMER (IM) + SKULL NEOPLASMS", "PI": "Nasal Septum (1964-2008)", "MS": "An unpaired thin ploughshare-shaped facial bone. It is situated in the median plane of the SKULL. The vomer forms the posterior and inferior border of the NASAL SEPTUM.", "PM": "2009; see NASAL SEPTUM 1975-2008", "HN": "2009; use NASAL SEPTUM 1975-2008", "MR": "20180629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055172"}, {"RECTYPE": "D", "MH": "Delayed Emergence from Anesthesia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Delayed Awakening, Post-Anesthesia|T046|NON|EQV|NLM (2009)|080114|abcdef", "ENTRY": "Weaknesses, Postoperative Residual", "MN": "C23.550.767.137", "FX": "Anesthesia Recovery Period", "MH_TH": "NLM (2009)", "ST": "T046", "PI": "Postoperative Complications (1972-2008)", "MS": "Abnormally slow pace of regaining CONSCIOUSNESS after general anesthesia (ANESTHESIA, GENERAL) usually given during surgical procedures. This condition is characterized by persistent somnolence.", "PM": "2009", "HN": "2009", "MR": "20150706", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055191"}, {"RECTYPE": "D", "MH": "Retinal Photoreceptor Cell Inner Segment", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Rod Cell Inner Segment|T026|NON|NRW|NLM (2009)|080122|abcdef", "ENTRY": "Rod Inner Segments", "MN": "A11.671.650.915.937.670.237", "MH_TH": "NLM (2009)", "ST": "T026", "PI": "Photoreceptor Cells (1977-2008)", "MS": "The inner portion of a retinal rod or a cone photoreceptor cell, situated between the PHOTORECEPTOR CONNECTING CILIUM and the synapse with the adjacent neurons (RETINAL BIPOLAR CELLS; RETINAL HORIZONTAL CELLS). The inner segment contains the cell body, the nucleus, the mitochondria, and apparatus for protein synthesis.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055211"}, {"RECTYPE": "D", "MH": "Photoreceptor Connecting Cilium", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Photoreceptor Connecting Ciliums", "MN": "A11.671.650.915.937.670.049", "MH_TH": "NLM (2009)", "ST": "T026", "PI": "Photoreceptor Cells (1978-2008)", "MS": "The bridge between the inner and the outer segments of a retinal rod or a cone photoreceptor cell. Through it, proteins synthesized in the inner segment are transported to the outer segment.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055212"}, {"RECTYPE": "D", "MH": "Retinal Pigment Epithelium", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Epithelium, Retinal Pigment|T023|NON|EQV|NLM (1991)|900308|abcdef", "ENTRY": "Pigment Epithelium, Retinal", "MN": "A09.371.729.887", "MH_TH": "UNK (19XX)", "ST": "T023", "PI": "Retina (1963-2008)", "MS": "The single layer of pigment-containing epithelial cells in the RETINA, situated closely to the tips (outer segments) of the RETINAL PHOTORECEPTOR CELLS. These epithelial cells are macroglia that perform essential functions for the photoreceptor cells, such as in nutrient transport, phagocytosis of the shed photoreceptor membranes, and ensuring retinal attachment.", "PM": "2009; see PIGMENT EPITHELIUM OF EYE 1976-2008", "HN": "2009; use PIGMENT EPITHELIUM OF EYE 1976-2008", "MR": "20130708", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055213"}, {"RECTYPE": "D", "MH": "Retinal Photoreceptor Cell Outer Segment", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Retinal Outer Segments", "MN": "A11.671.650.915.937.670.375", "MH_TH": "NLM (2009)", "ST": "T026", "PI": "Retina (1964-2008)", "MS": "The light sensitive outer portion of a retinal rod or a cone photoreceptor cell. The outer segment contains a stack of disk membranes laden with photoreceptive pigments (RETINAL PIGMENTS). The outer segment is connected to the inner segment by a PHOTORECEPTOR CONNECTING CILIUM.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055214"}, {"RECTYPE": "D", "MH": "Lincosamides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D09.408.471", "PA": "Protein Synthesis Inhibitors", "MH_TH": "NLM (2009)", "ST": "T195", "RN": "0", "PI": "Lincomycin (1963-2008)", "MS": "A family of LINCOMYCIN-related glycosides that contain a pyrrolidine ring linked via an amide-bond to a pyranose moiety. Individual members of this family are defined by the arrangement of specific constituent groups on the lyncomycin molecule. Many lincosamides are ANTIBIOTICS produced by a variety STREPTOMYCES species.", "PM": "2009", "HN": "2009", "MR": "20160531", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055231"}, {"RECTYPE": "D", "MH": "Proline-Rich Protein Domains", "AQ": "DE GE IM PH RE", "ENTRY": "Protein Domains, Proline-Rich", "MN": "G02.111.570.820.709.275.750.485", "FX": "Salivary Proline-Rich Proteins", "MH_TH": "NLM (2009)", "ST": "T082", "MS": "Protein domains that are enriched in PROLINE. The cyclical nature of proline causes the peptide bonds it forms to have a limited degree of conformational mobility. Therefore the presence of multiple prolines in close proximity to each other can convey a distinct conformational arrangement to a peptide chain.", "PM": "2009; PROLINE-RICH POLYPEPTIDE (now proline-rich peptide domains) was indexed under PEPTIDES 1979-2008", "HN": "2009(1979)", "MR": "20160527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055232"}, {"RECTYPE": "D", "MH": "Cornified Envelope Proline-Rich Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Small Proline Rich Protein IA", "MN": "D12.776.543.200", "FX": "Proline-Rich Protein Domains", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055233"}, {"RECTYPE": "D", "MH": "Cell-Derived Microparticles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Shedding Microvesicle", "MN": "A11.284.295.588.500", "FX": "Exosomes", "MH_TH": "NLM (2009)", "ST": "T026", "MS": "Extracellular vesicles generated by the shedding of CELL MEMBRANE blebs.", "PM": "2009", "HN": "2009", "MR": "20150707", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055252"}, {"RECTYPE": "D", "MH": "Color Vision", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Photopic Vision|T042|NON|EQV|NLM (2009)|071128|abcdef", "ENTRY": "Visions, Color", "MN": "G14.935.124", "FX": "Color Perception", "MH_TH": "UNK (19XX)", "ST": "T042", "AN": "do not confuse with COLOR PERCEPTION", "PI": "Color Perception (1963-2008)", "MS": "Function of the human eye that is used in bright illumination or in daylight (at photopic intensities). Photopic vision is performed by the three types of RETINAL CONE PHOTORECEPTORS with varied peak absorption wavelengths in the color spectrum (from violet to red, 400 - 700 nm).", "PM": "2009; see COLOR PERCEPTION 1986-2008", "HN": "2009 (1986)", "MR": "20160623", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055253"}, {"RECTYPE": "D", "MH": "Night Vision", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Scotopic Vision|T042|NON|EQV|NLM (2009)|071128|abcdef", "ENTRY": "Vision, Scotopic", "MN": "G14.935.249", "MH_TH": "NLM (2009)", "ST": "T042", "MS": "Function of the human eye that is used in dim illumination (scotopic intensities) or at nighttime. Scotopic vision is performed by RETINAL ROD PHOTORECEPTORS with high sensitivity to light and peak absorption wavelength at 507 nm near the blue end of the spectrum.", "PM": "2009", "HN": "2009", "MR": "20160623", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055254"}, {"RECTYPE": "D", "MH": "Mesopic Vision", "AQ": "DE GE IM PH RE", "ENTRY": "Vision, Mesopic", "MN": "G14.935.186", "MH_TH": "NLM (2009)", "ST": "T042", "MS": "The function of the eye that is used in the intermediate level of illumination (mesopic intensities) where both the RETINAL ROD PHOTORECEPTORS and the RETINAL CONE PHOTORECEPTORS are active in processing light input simultaneously.", "PM": "2009", "HN": "2009", "MR": "20160623", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055255"}, {"RECTYPE": "D", "MH": "Infectious Disease Incubation Period", "PRINT ENTRY": "Incubation Period of Infectious Agent|T079|NON|EQV|NLM (2021)|200422|abcdef", "ENTRY": "Incubation Period, Infectious Disease|T079|NON|EQV|NLM (2009)|071128|abcdef", "MN": "N06.850.335.250", "MH_TH": "NLM (2009)", "ST": "T079", "PI": "Time Factors (1991-2008)", "MS": "The amount time between exposure to an infectious agent and becoming symptomatic.", "PM": "2009", "HN": "2009", "MR": "20200617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055256"}, {"RECTYPE": "D", "MH": "Mucin-5B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mucin 5B", "MN": "D12.776.850.850", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A gel-forming mucin that is predominantly expressed by submucosal glands of airway tissues and the SUBLINGUAL GLAND. It is one of the principal components of high molecular weight salivary mucin.", "PM": "2009; MUCIN-5B was indexed under MUCINS 1997-2008", "HN": "2009(1997)", "MR": "20230316", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055257"}, {"RECTYPE": "D", "MH": "Rod-Cone Interaction", "AQ": "DE GE IM PH RE", "ENTRY": "Rod-Cone Interactions", "MN": "G14.935.186.624", "MH_TH": "NLM (2009)", "ST": "T042", "PI": "Photoreceptor Cells (1969-2008)", "MS": "Reciprocal action of two vertebrate photoreceptor cells (RODS AND CONES). Rod-cone interaction occurs during MESOPIC VISION in which both rods and cones are active in light transduction to the VISUAL CORTEX. Such interaction can influence visual sensitivity and luminous efficiency.", "PM": "2009", "HN": "2009", "MR": "20160623", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055258"}, {"RECTYPE": "D", "MH": "Immunogenetic Phenomena", "AQ": "DE GE PH RE", "PRINT ENTRY": "Immunogenetic Processes|T045|NON|NRW|NLM (2009)|071128|abcdef", "ENTRY": "Processes, Immunogenetic", "MN": "G12.500", "MH_TH": "NLM (2009)", "ST": "T045", "AN": "general or unspecified; prefer specifics", "MS": "GENETIC PHENOMENA and processes involved in IMMUNITY and the immune response.", "PM": "2009; for IMMUNOGENETIC PROCESSES see IMMUNOGENETIC PROCESSES 2009-2016", "HN": "2009", "MR": "20160511", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055261"}, {"RECTYPE": "D", "MH": "Mucin-2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mucin-2, Intestinal", "MN": "D12.776.395.560.631.161", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A gel-forming mucin found predominantly in SMALL INTESTINE and variety of mucous membrane-containing organs. It provides a protective, lubricating barrier against particles and infectious agents.", "PM": "2009; MUCIN-2 was indexed under MUCINS 1993-2008", "HN": "2009(1993)", "MR": "20230316", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055262"}, {"RECTYPE": "D", "MH": "Mucin-3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mucin-3B|T116|T123|NON|NRW|NLM (2009)|071130|abbcdef", "MN": "D12.776.543.550.542", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A membrane-bound mucin subtype that is primarily found in INTESTINAL MUCOSA. Two closely-related subtypes of this protein have been identified in humans.", "PM": "2009; MUCIN-3 was indexed under MUCINS 1995-2008", "HN": "2009(1995)", "MR": "20230316", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055263"}, {"RECTYPE": "D", "MH": "Mucin-4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sialoglycoprotein 1, Ascites", "MN": "D12.776.476.534", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A transmembrane mucin that is found in a broad variety of epithelial tissue. Mucin-4 may play a role in regulating cellular adhesion and in cell surface signaling from the ERBB-2 RECEPTOR PROTEIN-TYROSINE KINASE. Mucin-4 is a heterodimer of alpha and beta chains. The alpha and beta chains result from the proteolytic cleavage of a precursor protein.", "PM": "2009; MUCIN-4 was indexed under MUCINS 1997-2008; ASCITES SIALOGLYCOPROTEIN 1 was indexed under SIALOGLYCOPROTEINS 1986-2008; SIALOGLYCOPROTEIN 2 was indexed under SIALOGLYCOPROTEINS 1988-2008", "HN": "2009(1986)", "MR": "20230316", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055264"}, {"RECTYPE": "D", "MH": "Mucin 5AC", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mucin 5C|T116|T123|NON|NRW|NLM (2009)|071203|abbcdef", "MN": "D12.776.395.560.631.100.500", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A gel-forming mucin that is primarily found on the surface of gastric epithelium and in the RESPIRATORY TRACT. Mucin 5AC was originally identified as two distinct proteins, however a single gene encodes the protein which gives rise to the mucin 5A and mucin 5C variants.", "PM": "2009; MUCIN 5AC was indexed under MUCINS 1997-2008", "HN": "2009(1997)", "MR": "20230316", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055271"}, {"RECTYPE": "D", "MH": "Mucin-6", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mucin 6", "MN": "D12.776.395.560.631.100.750", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A gel-forming mucin that is predominantly associated with the gastric epithelium.", "PM": "2009; MUCIN 6 was indexed under MUCINS 1997-2008", "HN": "2009(1997)", "MR": "20230316", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055272"}, {"RECTYPE": "D", "MH": "Salivary Proline-Rich Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Salivary Proline Rich Proteins", "MN": "D12.776.850.925", "FX": "Proline-Rich Protein Domains", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A family of proline-rich proteins that constitute the majority of the protein component of SALIVA. Salivary proline-rich proteins occur as acidic, basic and glycosylated basic proteins. They perform a variety of functions such as adhering to the acquired ENAMEL PELLICLE, acting as lubricants and precipitating TANNINS.", "PM": "2009; SALIVARY PROLINE-RICH PROTEINS was indexed under PEPTIDES 1980-2008", "HN": "2009(1979); use PROLINE-RICH PROTEIN DOMAINS 1980-2008", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055273"}, {"RECTYPE": "D", "MH": "Salivary alpha-Amylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Salivary alpha-Amylase|T116|T126|NON|EQV|NLM (2021)|191227|abbcdef", "ENTRY": "alpha-Amylases, Salivary", "MN": "D12.776.850.887", "MH_TH": "NLM (2009)", "ST": "T126", "RN": "EC 3.2.1.1", "PI": "alpha-Amylases (1978-2008)", "MS": "A subclass of alpha-amylase ISOENZYMES that are secreted into SALIVA.", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055291"}, {"RECTYPE": "D", "MH": "Pancreatic alpha-Amylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Pancreatic alpha-Amylase|T116|T126|NON|EQV|NLM (2021)|200317|abbcdef", "ENTRY": "alpha-Amylases, Pancreatic", "MN": "D08.811.277.450.066.050.249", "MH_TH": "NLM (2009)", "ST": "T126", "RN": "EC 3.2.1.1", "PI": "alpha-Amylases (1978-2008)", "MS": "A subclass of alpha-amylase ISOENZYMES that are secreted into PANCREATIC JUICE.", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055292"}, {"RECTYPE": "D", "MH": "Receptors, Urokinase Plasminogen Activator", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Urokinase-Type Plasminogen Activator Receptor|T116|T192|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Urokinase Type Plasminogen Activator Receptors", "MN": "D12.776.543.750.815", "MH_TH": "NLM (2009)", "ST": "T192", "RN": "0", "MS": "An extracellular receptor specific for UROKINASE-TYPE PLASMINOGEN ACTIVATOR. It is attached to the cell membrane via a GLYCOSYLPHOSPHATIDYLINOSITOL LINKAGE and plays a role in the co-localization of urokinase-type plasminogen activator with PLASMINOGEN.", "PM": "2009; UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTORS (now RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR) was indexed under RECEPTORS, CELL SURFACE 1985-2008", "HN": "2009(1985)", "MR": "20230316", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055293"}, {"RECTYPE": "D", "MH": "Cystatin A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Epidermal SH Protease Inhibitor", "MN": "D12.776.215.100", "MH_TH": "NLM (1990)", "ST": "T123", "RN": "0", "PI": "Cystatins (1990-2008)", "MS": "A cytastin subtype found at high levels in the SKIN and in BLOOD CELLS. Cystatin A incorporates into the cornified cell envelope of stratified squamous epithelial cells and may play a role in bacteriostatic properties of skin.", "PM": "2009; see CYSTATINS 1990-2008; STEFIN A (now CYSTATIN A) was indexed under CYSTATINS 1990-2008", "HN": "2009(1990); use CYSTATINS 1990-2008", "MR": "20130709", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055312"}, {"RECTYPE": "D", "MH": "Cystatin B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Stefin B|T116|T121|NON|EQV|NLM (2009)|071214|abbcdef", "MN": "D12.776.215.200", "PA": "Cysteine Proteinase Inhibitors", "FX": "Unverricht-Lundborg Syndrome", "MH_TH": "NLM (2009)", "ST": "T121", "RN": "88844-95-5", "MS": "An intracellular cystatin subtype that is found in a broad variety of cell types. It is a cytosolic enzyme inhibitor that protects the cell against the proteolytic action of lysosomal enzymes such as CATHEPSINS.", "PM": "2009; CYSTATIN B was indexed under CYSTATINS 1990-2008 & under PROTEINS 1984-1989", "HN": "2009(1984)", "MR": "20110624", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055313"}, {"RECTYPE": "D", "MH": "Seed Storage Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Seed Storage Protein|T116|T123|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Storage Proteins, Seed", "MN": "D12.776.765.725", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Plant proteins or specifics (1977-2008)", "MS": "One or more types of plant seed proteins providing the large amounts of AMINO ACIDS utilized in GERMINATION and SEEDLING growth. As seeds are the major food source from AGRICULTURAL CROPS, seed storage proteins are a major source of DIETARY PROTEINS.", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055314"}, {"RECTYPE": "D", "MH": "Prolamins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Prolamin|T116|T123|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Prolamin Protein, Plant|T116|T123|NON|EQV|NLM (2009)|071214|abbcdef", "MN": "D12.776.765.725.500", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "AN": "may appear in the literature as \"prolamines\"; do not confuse with the drug prolamine", "PI": "Plant Proteins (1962-2008)", "MS": "A group of seed storage proteins restricted to the POACEAE family. They are rich in GLUTAMINE and PROLINE.", "PM": "2009; PROLAMIN PROTEIN, PLANT (now PROLAMINS) was indexed with PLANT PROTEINS 1978-2008", "HN": "2009 (1978)", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055315"}, {"RECTYPE": "D", "MH": "Cystatin C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "gamma Trace", "MN": "D12.776.215.300", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "An extracellular cystatin subtype that is abundantly expressed in bodily fluids. It may play a role in the inhibition of interstitial CYSTEINE PROTEASES.", "PM": "2009; CYSTATIN C was indexed under CYSTATINS 1990-2008, GLOBULINS 1977-1984, & under PROTEINS 1985-1989", "HN": "2009(1980)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055316"}, {"RECTYPE": "D", "MH": "Evidence-Based Practice", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Evidence-Based Health Care|T091|NON|NRW|NLM (2009)|080229|abcdef", "ENTRY": "Healthcares, Evidence-Based", "MN": "H02.249", "FX": "Evidence Gaps", "MH_TH": "NLM (2009)", "ST": "T091", "AN": "general or unspecified; prefer specifics", "MS": "A way of providing health care that is guided by a thoughtful integration of the best available scientific knowledge with clinical expertise. This approach allows the practitioner to critically assess research data, clinical guidelines, and other information resources in order to correctly identify the clinical problem, apply the most high-quality intervention, and re-evaluate the outcome for future improvement.", "PM": "2009", "HN": "2009", "MR": "20220711", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055317"}, {"RECTYPE": "D", "MH": "Evidence-Based Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Nursing, Evidence-Based|T091|NON|EQV|NLM (2009)|071218|abcdef", "ENTRY": "Nursing, Evidence Based", "MN": "H02.478.197", "FX": "Evidence-Based Medicine", "MH_TH": "NLM (2009)", "ST": "T091", "PI": "Nursing Care (1996-2008)", "MS": "A way of providing nursing care that is guided by the integration of the best available scientific knowledge with nursing expertise. This approach requires nurses to critically assess relevant scientific data or research evidence, and to implement high-quality interventions for their nursing practice.", "PM": "2009", "HN": "2009", "MR": "20140616", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055318"}, {"RECTYPE": "D", "MH": "Torulaspora", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Saccharomyces rosei|T004|NON|NRW|NLM (2021)|200319|abcdef", "ENTRY": "Torulasporas", "MN": "B01.300.930.910", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid4948", "RR": "txid4950", "PI": "Saccharomycetales (1990-2008)", "MS": "A genus of ascomycetous yeast in the family Saccharomycetaceae, order SACCHAROMYCETALES. It is used commercially in the production of wines and beer.", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055319"}, {"RECTYPE": "D", "MH": "Williopsis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Williopses", "MN": "B01.300.930.945", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid4962", "PI": "Saccharomycetales (1986-2008)", "MS": "A genus of ascomycetous yeast in the family Saccharomycetaceae, order SACCHAROMYCETALES. Many species show mycocinogenic activity against other yeasts.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055320"}, {"RECTYPE": "D", "MH": "Hanseniaspora", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Hanseniasporas", "MN": "B01.300.930.443", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid29832", "PI": "Saccharomycetales (1978-2008)", "MS": "A genus of the ascomycetous yeast in the family Saccharomycodaceae, order SACCHAROMYCETALES, that contributes to the spontaneous fermentation of cider. Anamorphic forms are in the genus KLOECKERA.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055321"}, {"RECTYPE": "D", "MH": "Kloeckera", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Kloeckeras", "MN": "B01.300.930.530", "MH_TH": "NLM (2009)", "ST": "T004", "PI": "Mitosporic Fungi (1966-2008)", "MS": "A mitosporic fungal genus used in the fermentation of wine. Teleomorphs are in the genus HANSENIASPORA.", "PM": "2009", "HN": "2009", "MR": "20200902", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055322"}, {"RECTYPE": "D", "MH": "Byssochlamys", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Byssochlamy", "MN": "B01.300.107.320.125", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid5092", "PI": "Eurotiales (2003-2008)", "MS": "A genus of ascomycetous mold in the family Trichocomaceae, order EUROTIALES. Byssochlamys species are responsible for spoilage and degradation of fruit and fruit juices. Anamorphs are found in the genus PAECILOMYCES.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055323"}, {"RECTYPE": "D", "MH": "Eupenicillium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Eupenicilliums", "MN": "B01.300.107.320.215", "MH_TH": "NLM (2009)", "ST": "T004", "PI": "Penicillium (1967-1995)", "MS": "A genus of endophytic, ascomycetous mold in the family Trichocomaceae, order EUROTIALES. Anamorphic forms are in the genus PENICILLIUM.", "PM": "2009", "HN": "2009", "MR": "20200902", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055324"}, {"RECTYPE": "D", "MH": "Eurotium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Eurotiums", "MN": "B01.300.107.320.218", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid28569", "PI": "Ascomycota (1976-2008)", "MS": "A genus of ascomycetous fungi in the family Trichocomaceae, order EUROTIALES. Health effects, allergenicity, and toxicity of Eurotium are closely related to its anamorph ASPERGILLUS.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080709", "DC": "1", "DX": "20090101", "UI": "D055325"}, {"RECTYPE": "D", "MH": "Neosartorya", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Neosartoryas", "MN": "B01.300.107.320.550", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid36629", "AN": "infection: coordinate IM with MYCOSES (IM) or specific mycosis (IM)", "PI": "Eurotiales (2004-2008)", "MS": "A genus of ascomycetous fungi in the family Trichocomaceae, order EUROTIALES. Some species can cause opportunistic infections in humans, similar to its anamorph ASPERGILLUS.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055326"}, {"RECTYPE": "D", "MH": "Thermoascus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Thermoascus aurantiacus|T004|NON|NRW|NLM (2009)|071219|abcdef", "MN": "B01.300.107.320.820", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid5086", "RR": "txid5087", "PI": "Ascomycota (1967-2008)", "MS": "A genus of thermophilic, ascomycetous fungi in the family Trichocomaceae, order EUROTIALES. Anamorphic forms are in the genus PAECILOMYCES.", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055327"}, {"RECTYPE": "D", "MH": "Neotyphodium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Neotyphodiums", "MN": "B01.300.381.570", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid45284", "MS": "The anamorphic form of the fungus EPICHLOE. Many Neotyphodium species produce ERGOT ALKALOIDS.", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055328"}, {"RECTYPE": "D", "MH": "Epichloe", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Epichloes", "MN": "B01.300.107.501.310", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid5112", "MS": "A genus of ascomycetous fungi in the family Clavicipitaceae, order HYPOCREALES, which are fungal symbionts of grasses. Anamorphic forms are in the genus NEOTYPHODIUM.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055329"}, {"RECTYPE": "D", "MH": "Nectria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Nectrias", "MN": "B01.300.107.501.550", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid5133", "PI": "Hypocreales (1975-2008)", "MS": "A genus of ascomycetous fungi in the family Nectriaceae, order HYPOCREALES. They are found as saprophytes on decaying wood or parasites of trees. Anamorphs include FUSARIUM and Cylindrocarpon.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055330"}, {"RECTYPE": "D", "MH": "Adenomyoepithelioma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Adenomyoepitheliomas", "MN": "C04.557.435.108", "MH_TH": "NLM (2009)", "ST": "T191", "PI": "Myoepithelioma (1963-2008)", "MS": "A mixed epithelial and myoepithelial neoplasm usually encountered within the breast. It is a multinodular lesion presenting with a bicellular pattern of proliferating epithelial and myoepithelial cells, which are regularly distributed in the glandular structures.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055331"}, {"RECTYPE": "D", "MH": "Cystatin M", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cystatin E|T116|T121|NON|EQV|NLM (2009)|071220|abbcdef", "ENTRY": "Cystatin 6", "MN": "D12.776.624.776.418", "MH_TH": "NLM (2009)", "ST": "T121", "RN": "0", "MS": "A cystatin subtype that has a diverse tissue distribution, target specificity, and functions as an endogenous inhibitor of lysosomal cysteine proteases.", "PM": "2009; CYSTATIN E (now CYSTATIN M) was indexed under CYSTATINS 1997-2008", "HN": "2009(1997)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055332"}, {"RECTYPE": "D", "MH": "Salivary Cystatins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cystatin S|T116|T123|NON|NRW|NLM (2009)|071221|abbcdef", "ENTRY": "SD Type Cystatins", "MN": "D12.776.850.906", "PA": "Cysteine Proteinase Inhibitors", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A group of closely-related cystatins found in SALIVA.", "PM": "2009; CYSTATIN S (now SALIVARY CYSTATINS) was indexed under CYSTATINS 1990-2007, under SALIVARY PROTEINS 1980-1089 & under GLYCOPROTEINS 1980-1982", "HN": "2009(1980)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055333"}, {"RECTYPE": "D", "MH": "Retinal Neurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Retinal Neuron", "MN": "A11.671.650.850", "MH_TH": "NLM (2009)", "ST": "T025", "PI": "Retina (1964-2008)", "MS": "Nerve cells of the RETINA in the pathway of transmitting light signals to the CENTRAL NERVOUS SYSTEM. They include the outer layer of PHOTORECEPTOR CELLS, the intermediate layer of RETINAL BIPOLAR CELLS and AMACRINE CELLS, and the internal layer of RETINAL GANGLION CELLS.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055351"}, {"RECTYPE": "D", "MH": "Halorubrum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B02.200.400.400.445", "MH_TH": "NLM (2009)", "ST": "T194", "RN": "txid56688", "PI": "Halobacteriaceae (1997-2008)", "MS": "A genus of HALOBACTERIACEAE which are chemoorganotrophic and strictly aerobic. They have been isolated from multiple hypersaline environments that vary widely in chemical and physical properties.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055352"}, {"RECTYPE": "D", "MH": "Chromohalobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.350.249", "MH_TH": "NLM (2004)", "ST": "T007", "RN": "txid42054", "PI": "Halomonadaceae (2004-2008)", "MS": "A genus of gram-negative, moderately halophilic bacteria in the family HALOMONADACEAE. They are chemoorganotrophic and grow optimally in media containing 8-10% salt.", "PM": "2009; see HALOMONADACEAE 2004-2008", "HN": "2009; use HALOMONADACEAE 2004-2008", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055353"}, {"RECTYPE": "D", "MH": "Exosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "MN": "A11.284.430.214.190.875.190.880.495", "FX": "Secretory Vesicles", "MH_TH": "NLM (2009)", "ST": "T026", "AN": "do not confuse with EXOSOME MULTIENZYME RIBONUCLEASE COMPLEX", "MS": "A type of extracellular vesicle, containing RNA and proteins, that is secreted into the extracellular space by EXOCYTOSIS when MULTIVESICULAR BODIES fuse with the PLASMA MEMBRANE.", "PM": "2009", "HN": "2009", "MR": "20150706", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055354"}, {"RECTYPE": "D", "MH": "Opsins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Opsin|T116|T123|NON|EQV|NLM (1993)|990101|abbcdef", "MN": "D23.767.930.750", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Retinal Pigments (1977-1992)", "MS": "Photosensitive proteins in the membranes of PHOTORECEPTOR CELLS such as the rods and the cones. Opsins have varied light absorption properties and are members of the G-PROTEIN-COUPLED RECEPTORS family. Their ligands are VITAMIN A-based chromophores.", "PM": "2009; for OPSIN see OPSIN 1993-2008", "HN": "2009; for OPSIN use OPSIN 1993-2008", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055355"}, {"RECTYPE": "D", "MH": "Endometrial Ablation Techniques", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Techniques, Endometrial Ablation", "MN": "E04.950.300.320", "MH_TH": "NLM (2009)", "ST": "T061", "PI": "Endometrium/surgery (1986-2008)", "MS": "Procedures used for the targeted destruction of the mucous membrane lining of the uterine cavity.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055356"}, {"RECTYPE": "D", "MH": "Uterine Artery Embolization", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Uterine Artery Embolizations", "MN": "E04.950.300.883", "FX": "Uterine Artery", "MH_TH": "NLM (2009)", "ST": "T061", "PI": "Embolization, Therapeutic (1990-2008)", "MS": "The use of embolizing agents to block the arterial blood supply to parts or all of the UTERUS. The procedures are done to control bleeding or to cause destruction of uterine tissues.", "PM": "2009", "HN": "2009", "MR": "20110624", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055357"}, {"RECTYPE": "D", "MH": "Cone Opsins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Red-Sensitive Cone Opsins|T116|T123|NON|NRW|NLM (2009)|080104|abbcdef", "ENTRY": "Short Wavelength Sensitive Cone Opsins", "MN": "D23.767.930.750.249", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Opsin (1990-2008)", "MS": "Photosensitive proteins expressed in the CONE PHOTORECEPTOR CELLS. They are the protein components of cone photopigments. Cone opsins are classified by their peak absorption wavelengths.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055358"}, {"RECTYPE": "D", "MH": "Antistatic Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Materials, Antistatic", "MN": "D27.720.066", "MH_TH": "NLM (2009)", "ST": "T120", "RN": "0", "MS": "Chemical compounds applied to materials to reduce their retention of an electrostatic charge.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055359"}, {"RECTYPE": "D", "MH": "Osteopathic Physicians", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Osteopaths|T097|NON|EQV|NLM (2009)|080229|abcdef", "ENTRY": "Physicians, Osteopathic", "MN": "N02.360.810.722", "FX": "Osteopathic Medicine", "MH_TH": "NLM (2009)", "ST": "T097", "PI": "Osteopathic Medicine (1966-2008)", "MS": "Licensed physicians trained in OSTEOPATHIC MEDICINE. An osteopathic physician, also known as D.O. (Doctor of Osteopathy), is able to perform surgery and prescribe medications.", "PM": "2009", "HN": "2009", "MR": "20180629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055360"}, {"RECTYPE": "D", "MH": "Multilevel Analysis", "AQ": "CL EC ED ES HI IS LJ MT OG ST TD", "ENTRY": "Multilevel Analyses", "MN": "N06.850.520.830.562", "MH_TH": "NLM (2009)", "ST": "T081", "MS": "The statistical manipulation of hierarchically and non-hierarchically nested data. It includes clustered data, such as a sample of subjects within a group of schools. Prevalent in the social, behavioral sciences, and biomedical sciences, both linear and nonlinear regression models are applied.", "PM": "2009", "HN": "2009", "MR": "20130709", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055361"}, {"RECTYPE": "D", "MH": "Agrocybe", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Agrocybes", "MN": "B01.300.179.100.107", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid5399", "PI": "Basidiomycota (1976-2004)", "MS": "A genus of saprobic mushrooms in the family Bolbitiaceae that grow in grass, dung, garden mulch, or in woods.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080709", "DC": "1", "DX": "20090101", "UI": "D055362"}, {"RECTYPE": "D", "MH": "Cortinarius", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.179.100.205", "MH_TH": "NLM (1997)", "ST": "T004", "RN": "txid34451", "AN": "poisoning: coordinate with MUSHROOM POISONING", "PI": "Agaricales (1985-2008)", "MS": "A genus of mushrooms in the family Cortinariaceae. When ingested, species of Cortinarius cause delayed acute RENAL FAILURE.", "PM": "2009, 1991-1996; see AGARICALES 1997-2008 and 1986-1990", "HN": "2009, 1991-1996; use AGARICALES 1997-2008 and 1986-1990", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055363"}, {"RECTYPE": "D", "MH": "Hebeloma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Hebelomas", "MN": "B01.300.179.100.360", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid34453", "AN": "poisoning: coordinate with MUSHROOM POISONING", "PI": "Basidiomycota (1986-2008)", "MS": "A genus of ectomycorrhizae basidiomycetous fungi in the family Cortinariaceae. Some species are poisonous.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055364"}, {"RECTYPE": "D", "MH": "Cyathus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.179.100.215", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid68776", "PI": "Basidiomycota (1971-2008)", "MS": "A genus of saprophytic fungi in the family Nidulariaceae. They look like small bird's nests complete with eggs. The eggs are small capsules known as peridioles, which contain the spores.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055365"}, {"RECTYPE": "D", "MH": "Synaptic Potentials", "AQ": "DE GE IM PH RE", "ENTRY": "Potentials, Postsynaptic", "MN": "G11.561.830.750", "MH_TH": "NLM (1994)", "ST": "T042", "PI": "Synaptic Transmission (1967-2008)", "MS": "The voltages across pre- or post-SYNAPTIC MEMBRANES.", "PM": "2009; see SYNAPTIC TRANSMISSION 1994-2008", "HN": "2009; use SYNAPTIC TRANSMISSION 1994-2008", "MR": "20160623", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055366"}, {"RECTYPE": "D", "MH": "Volvariella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Volvariellas", "MN": "B01.300.179.100.875", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid36658", "PI": "Basidiomycota (1971-2008)", "MS": "A genus of edible mushrooms in the family Pluteaceae. They have pink gills and a volva at the stem base, and species can be confused with those of the poisonous genus AMANITA.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055367"}, {"RECTYPE": "D", "MH": "Pholiota", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Pholiotas", "MN": "B01.300.179.100.645", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid13205", "PI": "Basidiomycota (1965-2008)", "MS": "A genus of basidiomycetous mushroom in the family Strophariaceae, exhibiting a bipolar mating system.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055368"}, {"RECTYPE": "D", "MH": "Miniature Postsynaptic Potentials", "AQ": "DE GE IM PH RE", "ENTRY": "Spontaneous Postsynaptic Potential", "MN": "G11.561.830.750.560", "MH_TH": "NLM (2009)", "ST": "T042", "AN": "for miniature end plate potentials or miniature excitatory postsynaptic potentials coordinate with EXCITATORY POSTSYNAPTIC POTENTIALS; for miniature inhibitory postsynaptic potentials coordinate with INHIBITORY POSTSYNAPTIC POTENTIALS", "PI": "Synaptic Transmission (1978-2008)", "MS": "Postsynaptic potentials generated from a release of neurotransmitters from a presynaptic nerve terminal in the absence of an ACTION POTENTIAL. They may be m.e.p.p.s (miniature EXCITATORY POSTSYNAPTIC POTENTIALS) or m.i.p.p.s (miniature INHIBITORY POSTSYNAPTIC POTENTIALS).", "PM": "2009", "HN": "2009", "MR": "20160623", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055369"}, {"RECTYPE": "D", "MH": "Lung Injury", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vaping Product Use-Associated Lung Injury|T037|NON|NRW|NLM (2023)|220208|abcdef", "ENTRY": "Vaping Product Use Associated Lung Injury", "MN": "C26.891.554", "MH_TH": "NLM (2009)", "ST": "T037", "AN": "ACUTE LUNG INJURY and VENTILATOR-INDUCED LUNG INJURY are also available", "PI": "Lung Diseases (1969-2008)", "MS": "Damage to any compartment of the lung caused by physical, chemical, or biological agents which characteristically elicit inflammatory reaction. These inflammatory reactions can either be acute and dominated by NEUTROPHILS, or chronic and dominated by LYMPHOCYTES and MACROPHAGES.", "PM": "2009", "HN": "2009", "MR": "20220714", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055370"}, {"RECTYPE": "D", "MH": "Acute Lung Injury", "DE": "ACUTE LUNG INJ", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lung Injury, Acute|T037|T047|NON|EQV|NLM (1994)|930219|LUNG INJ ACUTE|abbcdefv", "ENTRY": "Lung Injuries, Acute", "MN": "C08.381.520.500", "MH_TH": "NLM (1994)", "ST": "T047", "MS": "A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).", "PM": "2009; see RESPIRATORY DISTRESS SYNDROME, ADULT 1994-2008", "HN": "2009; use RESPIRATORY DISTRESS SYNDROME, ADULT 1994-2008", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055371"}, {"RECTYPE": "D", "MH": "AMP-Activated Protein Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "AMP Activated Protein Kinases", "MN": "D12.776.476.563.085", "MH_TH": "NLM (2009)", "ST": "T126", "RN": "EC 2.7.11.31", "RR": "EC 2.7.11.31", "MS": "Intracellular signaling protein kinases that play a signaling role in the regulation of cellular energy metabolism. Their activity largely depends upon the concentration of cellular AMP which is increased under conditions of low energy or metabolic stress. AMP-activated protein kinases modify enzymes involved in LIPID METABOLISM, which in turn provide substrates needed to convert AMP into ATP.", "PM": "2009; AMP-ACTIVATED PROTEIN KINASES was indexed under MULTIENZYME COMPLEXES & PROTEIN-SERINE-THREONIN KINASES 2000-2008, & under HMG COA REDUCTASES & PROTEIN KINASES 1980-2000", "HN": "2009(1980)", "MR": "20210521", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055372"}, {"RECTYPE": "D", "MH": "Psilocybe", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Teonanacatl Mushrooms|T004|NON|NRW|NLM (2024)|230526|abcdef", "ENTRY": "Teonanacatl Mushroom", "MN": "B01.300.179.100.660", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid71950", "PI": "Basidiomycota (1966-2008)", "MS": "A genus of small mushrooms in the family Strophariaceae. Some species are known for their hallucinogenic properties.", "PM": "2009", "HN": "2009", "MR": "20230531", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055391"}, {"RECTYPE": "D", "MH": "Armillaria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Armillarias", "MN": "B01.300.179.100.125", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid47424", "PI": "Basidiomycota (1965-2008)", "MS": "A genus of root and butt rot fungi in the family Tricholomataceae that produce rhizomorphs and are facultatively parasitic. Many species are pathogenic to trees causing Armillaria root disease.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055392"}, {"RECTYPE": "D", "MH": "Flammulina", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Collybia velutipes|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Flammulinas", "MN": "B01.300.179.100.320", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid38944", "RR": "txid38945", "PI": "Basidiomycota (1963-2008)", "MS": "A genus of mushrooms in the family Tricholomataceae, whose species are characterized by a slimy cap (FRUITING BODIES, FUNGAL).", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055393"}, {"RECTYPE": "D", "MH": "Tolloid-Like Metalloproteinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tolloid Like Metalloproteinases", "MN": "D23.529.948", "MH_TH": "NLM (2009)", "ST": "T126", "RN": "EC 3.4.-", "MS": "A family of metalloproteases that are related to the DROSOPHILA protein tolloid, which is a gene product necessary for dorsal-ventral patterning in early Drosophila embryogenesis. Many members of the group may play a significant role in intercellular signaling.", "PM": "2009: TOLLOID METALLOPROTEINASE (now TOLLOID-LIKE METALLOPROTEINASES) was indexed under METALLOPROTEASES & BONE MORPHOGENETIC PROTEINS 1999-2008", "HN": "2009(1999)", "MR": "20210521", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055394"}, {"RECTYPE": "D", "MH": "Bone Morphogenetic Protein 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Procollagen C Endopeptidase", "MN": "D23.529.948.500", "MH_TH": "NLM (2009)", "ST": "T126", "RN": "EC 3.4.24.19", "MS": "A bone morphogenetic protein family member that includes an active tolloid-like metalloproteinase domain. The metalloproteinase activity of bone morphogenetic protein 1 is specific for the removal of the C-propeptide of PROCOLLAGEN and may act as a regulator of EXTRACELLULAR MATRIX deposition. Alternative splicing of MRNA for bone morphogenetic protein 1 results in the production of several PROTEIN ISOFORMS.", "PM": "2009; BONE MORPHOGENETIC PROTEIN 1 was inedxed under METALLOENDPEPTIDASES & BONE MORPHOGENETIC PROTEINS 1996-2008, under PEPTIDE PEPTIDOHYDROLASES 1978-1995, & under PROCOLLAGEN 1978-1982", "HN": "2009(1978)", "MR": "20210520", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055395"}, {"RECTYPE": "D", "MH": "Bone Morphogenetic Protein 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D23.529.942.200.200", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A potent osteoinductive protein that plays a critical role in the differentiation of osteoprogenitor cells into OSTEOBLASTS.", "PM": "2009; BONE MORPHOGENETIC PROTEIN 2 was indexed under BONE MORPHOGENETIC PROTEINS and TRANSFORMING GROWTH FACTOR BETA 1993-2008", "HN": "2009(1993)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055396"}, {"RECTYPE": "D", "MH": "Ventilator-Induced Lung Injury", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ventilator-Induced Lung Injuries", "MN": "C08.381.520.750", "FX": "Ventilators, Mechanical", "MH_TH": "NLM (2009)", "ST": "T047", "AN": "BRONCHOPULMONARY DYSPLASIA is available for lung injury caused by oxygen inhalation therapy or mechanical ventilation in newborn infants", "MS": "Lung damage that is caused by the adverse effects of PULMONARY VENTILATOR usage. The high frequency and tidal volumes produced by a mechanical ventilator can cause alveolar disruption and PULMONARY EDEMA.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055397"}, {"RECTYPE": "D", "MH": "Bone Morphogenetic Protein 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Osteogenin|T116|T123|NON|EQV|NLM (2009)|080122|abbcdef", "MN": "D23.529.942.200.300", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A bone morphogenetic protein that is found at high concentrations in a purified osteoinductive protein fraction from BONE. Bone morphogenetic protein 3 is referred to as osteogenin, however it may play a role in variety of developmental processes.", "PM": "2009; BONE MORPHOGENETIC PROTEIN 3 was indexed under BONE MORPHOGENETIC PROTEINS 1989-2008", "HN": "2009(1989)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055398"}, {"RECTYPE": "D", "MH": "Laccaria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Laccarias", "MN": "B01.300.179.100.502", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid29882", "PI": "Agaricales (2001-2008)", "MS": "A genus of white-spored mushrooms in the family Tricholomataceae. They form symbiotic partnerships (MYCORRHIZAE) with trees.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080709", "DC": "1", "DX": "20090101", "UI": "D055399"}, {"RECTYPE": "D", "MH": "TGF-beta Superfamily Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TGF beta Superfamily Proteins", "MN": "D23.529.942", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "PI": "Transforming Growth Factors (1988-2008)", "MS": "A large family of cell regulatory proteins which are structurally related to TRANSFORMING GROWTH FACTOR BETA. The superfamily is subdivided into at least three related protein families: BONE MORPHOGENETIC PROTEINS; GROWTH DIFFERENTIATION FACTORS; and TRANSFORMING GROWTH FACTORS.", "PM": "2009", "HN": "2009", "MR": "20090721", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055411"}, {"RECTYPE": "D", "MH": "Growth Differentiation Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Factors, Growth Differentiation", "MN": "D23.529.942.300", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "AN": "general; prefer specifics", "PI": "Transforming Growth Factors (1988-2008)", "MS": "A family of BONE MORPHOGENETIC PROTEIN-related proteins that are primarily involved in regulation of CELL DIFFERENTIATION.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055412"}, {"RECTYPE": "D", "MH": "Growth Differentiation Factor 10", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "GDF-10|T116|T123|ABB|EQV|NLM (2009)|abbcde", "MN": "D23.529.942.300.900", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Bone Morphogenetic Protein 3 (1989-2008)", "MS": "A growth differentiation factor that is closely-related in structure to BONE MORPHOGENETIC PROTEIN 3. Growth differentiation factor 10 is found at high levels in BONE, however it plays an additional roles in regulating EMBRYONIC DEVELOPMENT.", "PM": "2009; GROWTH DIFFERENTIATION FACTOR 10 was indexed under BONE MORPHOGENETIC PROTEINS 1997-2008 & under PROTEINS 1989-1996", "HN": "2009; use BONE MORPHOGENETIC PROTEIN 3 1989-2008", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055413"}, {"RECTYPE": "D", "MH": "Myocardial Perfusion Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Perfusion Imaging, Myocardial", "MN": "E01.370.384.730.354.500", "MH_TH": "NLM (2009)", "ST": "T060", "MS": "The creation and display of functional images showing where the blood is flowing into the MYOCARDIUM by following over time the distribution of tracers injected into the blood stream.", "PM": "2009", "HN": "2009", "MR": "20100625", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055414"}, {"RECTYPE": "D", "MH": "Bone Morphogenetic Protein 4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Bone Morphogenetic Protein 2B|T116|T123|NON|EQV|NLM (2009)|080122|abbcdef", "MN": "D23.529.942.200.400", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A bone morphogenetic protein that is a potent inducer of bone formation. It also functions as a regulator of MESODERM formation during EMBRYONIC DEVELOPMENT.", "PM": "2009; BONE MORPHOGENETIC PROTEIN 4 was indexed under BONE MORPHOGENETIC PROTEINS 1996-2008", "HN": "2009(1996)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055415"}, {"RECTYPE": "D", "MH": "Evidence-Based Emergency Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Emergency Medicine, Evidence-Based|T091|NON|EQV|NLM (2009)|080325|abcdef", "ENTRY": "Medicines, Evidence-Based Emergency", "MN": "H02.403.200.400.500", "MH_TH": "NLM (2009)", "ST": "T091", "PI": "Evidence-Based Medicine (1997-2008)", "MS": "A way of providing emergency medical care that is guided by a thoughtful integration of the best available scientific knowledge with clinical expertise in EMERGENCY MEDICINE. This approach allows the practitioner to critically assess research data, clinical guidelines, and other information resources in order to correctly identify the clinical problem, apply the most high-quality intervention, and re-evaluate the outcome for future improvement.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055416"}, {"RECTYPE": "D", "MH": "Bone Morphogenetic Protein 5", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "BMP-5|T116|T123|ABB|EQV|NLM (2009)|abbcde", "MN": "D23.529.942.200.500", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A bone morphogenetic protein that may play a role in CARTILAGE formation. It is a potent regulator of the growth of CHONDROCYTES and the synthesis of cartilage matrix proteins. Evidence for its role in cartilage formation can be seen in MICE, where genetic mutations that cause loss of bone morphogenetic protein 5 function result in the formation of small malformed ears.", "PM": "2009; BONE MORPHOGENETIC PROTEIN 5 was indexed under BONE MORPHOGENETIC PROTEINS 1997-2008", "HN": "2009(1997)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055417"}, {"RECTYPE": "D", "MH": "Bone Morphogenetic Protein 6", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "BMP-6|T116|T123|ABB|EQV|NLM (2009)|080123|abbcdef", "MN": "D23.529.942.200.600", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A bone morphogenetic protein that is a potent inducer of BONE formation. It plays additional roles in regulating CELL DIFFERENTIATION of non-osteoblastic cell types and epithelial-mesenchymal interactions.", "PM": "2009; BONE MORPHOGENETIC PROTEIN 6 was indexed under BONE MORPHOGENETIC PROTEINS 1997-2008", "HN": "2009(2007)", "MR": "20090721", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055418"}, {"RECTYPE": "D", "MH": "Bone Morphogenetic Protein 7", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Osteogenic Protein 1", "MN": "D23.529.942.200.700", "MH_TH": "NLM (2009)", "ST": "T121", "RN": "0", "MS": "A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis.", "PM": "2009; BONE MORPHOGENETIC PROTEIN 7 was indexed under BONE MORPHOGENETIC PROTEINS & TRANSFORMING GROWTH FACTOR BETA 1996-2008, & under PROTEINS 1990-1996", "HN": "2009(1990)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055419"}, {"RECTYPE": "D", "MH": "Perfusion Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Scintigraphy, Perfusion", "MN": "E01.370.384.730.354", "MH_TH": "NLM (2009)", "ST": "T060", "MS": "The creation and display of functional images showing where the blood flow reaches by following the distribution of tracers injected into the blood stream.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055420"}, {"RECTYPE": "D", "MH": "Venous Valves", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Venous Valve", "MN": "A07.015.908.950", "MH_TH": "NLM (2009)", "ST": "T023", "AN": "coordinate with specific vein term if pertinent", "MS": "Flaps within the VEINS that allow the blood to flow only in one direction. They are usually in the medium size veins that carry blood to the heart against gravity.", "PM": "2009", "HN": "2009", "MR": "20180630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055422"}, {"RECTYPE": "D", "MH": "Diet, Ketogenic", "AQ": "AE CL EC EH HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Ketogenic Diet|T061|NON|EQV|NLM (2009)|080117|abcdef", "ENTRY": "Ketogenic Diets", "MN": "G07.203.650.240.245.500", "MH_TH": "NLM (2018)", "ST": "T061", "PI": "Diet Therapy (1964-2008)", "MS": "A course of food intake that is high in FATS and low in CARBOHYDRATES. This diet provides sufficient PROTEINS for growth but insufficient amount of carbohydrates for the energy needs of the body. A ketogenic diet generates 80-90% of caloric requirements from fats and the remainder from proteins.", "PM": "2018; see KETOGENIC DIET 2009-2017", "HN": "2018 (2009)", "MR": "20170630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055423"}, {"RECTYPE": "D", "MH": "Cardiac-Gated Imaging Techniques", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Techniques, EKG-Triggered Imaging", "MN": "E01.370.350.130.500", "MH_TH": "NLM (2009)", "ST": "T060", "AN": "coordinate with specific type of imaging", "MS": "Timing the acquisition of imaging data to specific points in the cardiac cycle to minimize image blurring and other motion artifacts.", "PM": "2009", "HN": "2009", "MR": "20100625", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055424"}, {"RECTYPE": "D", "MH": "Respiratory-Gated Imaging Techniques", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Techniques, Respiratory-Gated Imaging", "MN": "E01.370.386.730", "MH_TH": "NLM (2009)", "ST": "T060", "MS": "Timing the acquisition of imaging data to specific points in the breathing cycle to minimize image blurring and other motion artifacts. The images are used diagnostically and also interventionally to coordinate radiation treatment beam on/off cycles to protect healthy tissues when they move into the beam field during different times in the breathing cycle.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055425"}, {"RECTYPE": "D", "MH": "Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "SPECT, Cardiac-Gated", "MN": "E01.370.384.730.800.800.500", "MH_TH": "NLM (2009)", "ST": "T060", "AN": "for gated blood-pool SPECT imaging, coordinate with GATED BLOOD-POOL IMAGING; for gated myocardial perfusion SPECT imaging, coordinate with MYOCARDIAL PERFUSION IMAGING", "PI": "Tomography, Emission-Computed, Single-Photon (1990-2008)", "MS": "Tomography using single-photon emitting RADIONUCLIDES to create images that are captured in times corresponding to various points in the cardiac cycle.", "PM": "2009", "HN": "2009", "MR": "20100625", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055426"}, {"RECTYPE": "D", "MH": "Growth Differentiation Factor 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Bone Morphogenetic Protein 9|T116|T123|NON|EQV|NLM (2009)|080118|abbcdef", "MN": "D23.529.942.300.200", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A growth differentiation factor that plays a regulatory role as a paracrine factor for a diverse array of cell types during EMBRYONIC DEVELOPMENT and in the adult tissues. Growth differentiation factor 2 is also a potent regulator of CHONDROGENESIS and was previously referred to as bone morphogenetic protein 9.", "PM": "2009; GROWTH DIFFERENTIATION FACTOR 2 was indexed under BONE MORPHOGENETIC PROTEINS 2000-2008", "HN": "2009(2000)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055427"}, {"RECTYPE": "D", "MH": "Growth Differentiation Factor 5", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cartilage Derived Morphogenetic Protein 1", "MN": "D23.529.942.300.500", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A growth differentiation factor that plays a role in early CHONDROGENESIS and joint formation.", "PM": "2009; GROWTH DIFFERENTIATION FACTOR 5 was indexed under BONE MORPHOGENETIC PROTEINS 2003-2008, & under GROWTH SUBSTANCES 1994-2002; CARTILAGE-DERIVED MORPHOGENETIC PROTEIN-1 was indexed under BONE MORPHOGENETIC PROTEINS 2003-2008, & under GROWTH SUBSTANCES 1994-2002", "HN": "2009(1994)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055428"}, {"RECTYPE": "D", "MH": "Growth Differentiation Factor 9", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "GDF-9|T116|T123|ABB|EQV|NLM (2009)|abbcde", "MN": "D23.529.942.300.800", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A bone morphogenetic protein that plays an essential role in the regulation of ovarian folliculogenesis.", "PM": "2009; GROWTH DIFFERENTIATION FACTOR 9 was indexxed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 1994-2005, & under GROWTH SUBSTANCES 1993-2002", "HN": "2009(1993)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055429"}, {"RECTYPE": "D", "MH": "Bone Morphogenetic Protein 15", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "GDF 9 Related Protein", "MN": "D23.529.942.300.049", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A protein that plays a role in GRANULOSA CELLS where it regulates folliculogenesis. Mutations in the gene for bone morphogenetic protein 15 are linked to reproductive abnormalities such as PREMATURE OVARIAN FAILURE.", "PM": "2009; BONE MORPHOGENETIC PROTEIN 15 was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2003-2008, & under GROWTH SUBSTANCES 1993-2002", "HN": "2009(1993) for BONE MORPHOGENETIC PROTEIN 15 use GROWTH DIFFERENTIATION FACTOR 9 1993-2008", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055430"}, {"RECTYPE": "D", "MH": "Growth Differentiation Factor 6", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "GDF-6|T116|T123|ABB|EQV|NLM (2009)|080129|abbcdef", "MN": "D23.529.942.300.600", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A growth differentiation factor that plays a role in the neural differentiation, specifically in the retinal development of the EYE.", "PM": "2009; GROWTH DIFFERENTIATION FACTOR 6 was indexed under BONE MORPHOGENETIC PROTEINS 2003-2008, & under GROWTH SUBSTANCES 1994-2002", "HN": "2009(1994)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055431"}, {"RECTYPE": "D", "MH": "Metabolomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Metabonomic", "MN": "H01.181.122.638", "FX": "Nutrigenomics", "MH_TH": "NLM (2008)", "ST": "T040", "MS": "The systematic identification and quantitation of all the metabolic products of a cell, tissue, organ, or organism under varying conditions. The METABOLOME of a cell or organism is a dynamic collection of metabolites which represent its net response to current conditions.", "PM": "2009; see METABOLISM 2008", "HN": "2009; use METABOLISM 2008", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055432"}, {"RECTYPE": "D", "MH": "Marasmius", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.179.100.550", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid34448", "PI": "Agaricales (1980-2008)", "MS": "A genus of tiny mushrooms in the family Tricholomataceae. They help break down the decaying organic matter of the forest floor.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055433"}, {"RECTYPE": "D", "MH": "Termitomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Termitomyce", "MN": "B01.300.179.100.780", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid71927", "PI": "Basidiomycota (1980-1995)", "MS": "A paleotropical genus of fungi in the family Tricholomataceae. They are obligate symbionts of termites.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080709", "DC": "1", "DX": "20090101", "UI": "D055434"}, {"RECTYPE": "D", "MH": "Myostatin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Growth Differentiation Factor 8|T116|T123|NON|EQV|NLM (2009)|080118|abbcdef", "ENTRY": "GDF-8|T116|T123|ABB|EQV|NLM (2009)|abbcde", "MN": "D23.529.942.300.925", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A growth differentiation factor that is a potent inhibitor of SKELETAL MUSCLE growth. It may play a role in the regulation of MYOGENESIS and in muscle maintenance during adulthood.", "PM": "2009; GROWTH DIFFERENTIATION FACTOR 8 (now MYOSTATIN) was indexed under TRANSFORMING GROWTH FACTOR BETA 1997-2008", "HN": "2009(1997)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055435"}, {"RECTYPE": "D", "MH": "Growth Differentiation Factor 15", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Differentiation Factor, Prostate", "MN": "D23.529.942.300.915", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A growth differentiation factor that is secreted in response to cell stress and in response to MACROPHAGE ACTIVATION. In addition growth differentiation factor 15 demonstrates a diverse array of biological properties including the induction of cartilage formation, the inhibition of hematopoietic progenitor proliferation, and the induction of neuronal migration.", "PM": "2009; GROWTH DIFFERENTIATION FACTOR 15 was indexed under CYTOKINES 1997-2008", "HN": "2009(1997)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055436"}, {"RECTYPE": "D", "MH": "Tricholoma", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Tricholomas", "MN": "B01.300.179.100.790", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid40144", "PI": "Basidiomycota (1967-2008)", "MS": "A large genus of gilled mushrooms in the family Tricholomataceae. They are most often found in mountain and northern forests.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055439"}, {"RECTYPE": "D", "MH": "Poria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Porias", "MN": "B01.300.179.120.174.600", "MH_TH": "NLM (2003)", "ST": "T004", "RN": "txid81051", "PI": "Polyporaceae (1972-2008)", "MS": "A genus of basiodiomycetous fungi in the family Coriolaceae. Members are known for infesting wood.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055441"}, {"RECTYPE": "D", "MH": "Metabolome", "AQ": "DE GE IM PH RE", "ENTRY": "Profiles, Metabolic", "MN": "G03.500", "FX": "Metabolomics", "MH_TH": "NLM (2009)", "ST": "T070", "MS": "The dynamic collection of metabolites which represent a cell's or organism's net metabolic response to current conditions.", "PM": "2009", "HN": "2009", "MR": "20160630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055442"}, {"RECTYPE": "D", "MH": "Growth Differentiation Factor 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "GDF-3|T116|T123|ABB|EQV|NLM (2009)|abbcde", "MN": "D23.529.942.550.300", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A growth differentiation factor that may play a role in maintaining the undifferentiated state of PLURIPOTENT STEM CELLS by inhibiting the actions of BONE MORPHOGENETIC PROTEINS. Differentiation factor 3 is also considered a nodal signaling ligand that influences the genesis of left-right asymmetry.", "PM": "2009; GROWTH DIFFERENTIATION FACTOR 3 was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2003-2008, & under GROWTH SUBSTANCES 1993-2002", "HN": "2009(1993)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055451"}, {"RECTYPE": "D", "MH": "Growth Differentiation Factor 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "GDF-1|T116|T123|ABB|EQV|NLM (2009)|080124|abbcdef", "MN": "D23.529.942.550.100", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A growth differentiation factor that plays a role in the genesis of left-right asymmetry during vertebrate development. Evidence for this role is seen in MICE where loss of growth differentiation factor 1 function results in right-left isomerism of visceral organs. In HUMANS heterozygous loss of growth differentiation factor 1 function has been associated with CONGENITAL HEART DEFECTS and TRANSPOSITION OF GREAT VESSELS.", "PM": "2009; GROWTH DIFFERENTIATION FACTOR 1 was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2005-2008", "HN": "2009(2005)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055452"}, {"RECTYPE": "D", "MH": "Coriolaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Fomitopsis|T004|NON|NRW|NLM (2009)|080122|abcdef", "ENTRY": "Bjerkanderas", "MN": "B01.300.179.120.174", "MH_TH": "NLM (2009)", "ST": "T004", "RR": "txid5330", "MS": "A family of fungi, order POLYPORALES, found on decaying wood.", "PM": "2009", "HN": "2009", "MR": "20200902", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055453"}, {"RECTYPE": "D", "MH": "Trametes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Tramete", "MN": "B01.300.179.120.174.850", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid5324", "PI": "Polyporales (2000-2008)", "MS": "A genus of fungi in the family Coriolaceae.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055454"}, {"RECTYPE": "D", "MH": "Nodal Signaling Ligands", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Signaling Proteins, Nodal", "MN": "D23.529.942.550", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "Members of the transforming growth factor superfamily that play a role in pattern formation and differentiation during the pregastrulation and GASTRULATION stages of chordate development. Several nodal signaling ligands are specifically involved in the genesis of left-right asymmetry during development. The protein group is named after a critical region of the vertebrate embryo PRIMITIVE STREAK referred to as HENSEN'S NODE.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055456"}, {"RECTYPE": "D", "MH": "Nodal Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D23.529.942.550.650", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "The founding member of the nodal signaling ligand family of proteins. Nodal protein was originally discovered in the region of the mouse embryo primitive streak referred to as HENSEN'S NODE. It is expressed asymmetrically on the left side in chordates and plays a critical role in the genesis of left-right asymmetry during vertebrate development.", "PM": "2009; NODAL PROTEIN was indexed under TRANSFORMING GROWTH FACTOR BETA 1999-2008, & under PROTEINS 1996-1998", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055457"}, {"RECTYPE": "D", "MH": "Left-Right Determination Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lefty Proteins|T116|T123|NON|EQV|NLM (2009)|080124|abbcdef", "ENTRY": "Left Right Determination, Factor B", "MN": "D23.529.942.550.475", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "Signaling ligands that act in opposition to NODAL PROTEIN. During vertebrate development they regulate the degree of left-right asymmetry by controlling the spatiotemporal influence of NODAL PROTEIN.", "PM": "2009; LEFT-RIGHT DETEMINATION FACTOR PROTEINS was indexed under TRANSFORMING GROWTH FACTOR BETA 1996-2008", "HN": "2009(1996)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055458"}, {"RECTYPE": "D", "MH": "Facilitated Diffusion", "AQ": "DE GE IM PH RE", "ENTRY": "Diffusion, Facilitated", "MN": "G03.143.427", "MH_TH": "NLM (2009)", "ST": "T043", "PI": "Diffusion (1969-2008)", "MS": "The passive movement of molecules exceeding the rate expected by simple diffusion. No energy is expended in the process. It is achieved by the introduction of passively diffusing molecules to an enviroment or path that is more favorable to the movement of those molecules. Examples of facilitated diffusion are passive transport of hydrophilic substances across a lipid membrane through hydrophilic pores that traverse the membrane, and the sliding of a DNA BINDING PROTEIN along a strand of DNA.", "PM": "2009", "HN": "2009", "MR": "20160623", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055459"}, {"RECTYPE": "D", "MH": "Thermal Diffusion", "AQ": "DE GE IM PH RE", "ENTRY": "Diffusion, Thermal", "MN": "G02.196.750", "MH_TH": "NLM (2009)", "ST": "T070", "MS": "The movement of molecules from one location to another as effected by temperature changes.", "PM": "2009", "HN": "2009", "MR": "20160617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055471"}, {"RECTYPE": "D", "MH": "Antrodia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Antrodias", "MN": "B01.300.179.120.174.070", "MH_TH": "NLM (2006)", "ST": "T004", "RN": "txid40415", "PI": "Polyporales (2002-2008)", "MS": "A genus of brown-rot fungi in the family Coriolaceae. The biologically active ingredients of its species have potential pharmaceutical value.", "PM": "2009; see POLYPORALES 2006-2008", "HN": "2009; use POLYPORALES 2006-2008", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055491"}, {"RECTYPE": "D", "MH": "Polyporus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.179.120.760.675", "MH_TH": "NLM (2009)", "ST": "T072", "RN": "txid5637", "PI": "Polyporales (1974-2008)", "MS": "A genus of basidiomyceteous fungi in the family POLYPORACEAE found mostly on living trees or dead wood.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055492"}, {"RECTYPE": "D", "MH": "Spiral Ligament of Cochlea", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Spiral Ligaments", "MN": "A09.246.300.246.965", "MH_TH": "NLM (2009)", "ST": "T023", "PI": "Cochlea (1963-2008)", "MS": "A spiral thickening of the fibrous lining of the cochlear wall. Spiral ligament secures the membranous COCHLEAR DUCT to the bony spiral canal of the COCHLEA. Its spiral ligament fibrocytes function in conjunction with the STRIA VASCULARIS to mediate cochlear ion homeostasis.", "PM": "2009", "HN": "2009", "MR": "20180702", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055493"}, {"RECTYPE": "D", "MH": "Pycnoporus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.179.120.760.690", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid5642", "PI": "Polyporaceae (1978-2008)", "MS": "A genus of basidiomyceteous fungi in the family POLYPORACEAE. The species all contain bright orange, bracket-like fruiting bodies.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055494"}, {"RECTYPE": "D", "MH": "Neurogenesis", "AQ": "DE GE IM PH RE", "ENTRY": "Neurogeneses", "MN": "G11.561.620", "MH_TH": "NLM (2009)", "ST": "T038", "PI": "Neurons (1966-2008)", "MS": "Formation of NEURONS which involves the differentiation and division of STEM CELLS in which one or both of the daughter cells become neurons.", "PM": "2009", "HN": "2009", "MR": "20160623", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055495"}, {"RECTYPE": "D", "MH": "Neurogenic Bowel", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neurogenic Bowels", "MN": "C06.405.469.158.272.804", "MH_TH": "NLM (2009)", "ST": "T047", "PI": "Fecal Incontinence (1973-2008)", "MS": "Loss or absence of normal intestinal function due to nerve damage or birth defects. It is characterized by the inability to control the elimination of stool from the body.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055496"}, {"RECTYPE": "D", "MH": "Jewelry", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Jewelries", "MN": "J01.637.502", "MH_TH": "NLM (2009)", "ST": "T073", "MS": "Objects of precious metal usually containing gems and worn to enhance personal appearance. Health concerns include possible contamination from lead content or bacteria.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055498"}, {"RECTYPE": "D", "MH": "Catheter-Related Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Catheter Related Infection|T046|NON|EQV|NLM (2022)|201014|abcdef", "ENTRY": "Related Infections, Catheter", "MN": "C01.195", "FX": "Cross Infection", "MH_TH": "NLM (2009)", "ST": "T046", "AN": "coordinate with CROSS INFECTION if pertinent", "PI": "specific catheterization/adverse effects (1977-2008)", "MS": "Infections resulting from the use of catheters. Proper aseptic technique, site of catheter placement, material composition, and virulence of the organism are all factors that can influence possible infection.", "PM": "2009", "HN": "2009", "MR": "20210630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055499"}, {"RECTYPE": "D", "MH": "Resilience, Psychological", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Stress Immunity|T041|NON|NRW|NLM (2024)|230421|abcdef", "ENTRY": "Stress Immunities", "MN": "F02.940", "FX": "Adaptation, Psychological", "MH_TH": "NLM (2009)", "ST": "T041", "MS": "The human ability to adapt in the face of tragedy, trauma, adversity, hardship, and ongoing significant life stressors.", "PM": "2009", "HN": "2009", "MR": "20230616", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055500"}, {"RECTYPE": "D", "MH": "Macrophage Activation Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Macrophage Activation", "MN": "C20.683.515.800", "MH_TH": "NLM (2009)", "ST": "T047", "PI": "Syndrome (1989-2001)", "MS": "A serious complication of childhood systemic inflammatory disorders that is thought to be caused by excessive activation and proliferation of T-LYMPHOCYTES and MACROPHAGES. It is seen predominantly in children with systemic onset JUVENILE IDIOPATHIC ARTHRITIS.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055501"}, {"RECTYPE": "D", "MH": "Secondary Prevention", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapy, Early", "MN": "N06.850.780.750", "FX": "Chemoprevention", "MH_TH": "NLM (2009)", "ST": "T061", "MS": "The prevention of recurrences or exacerbations of a disease or complications of its therapy.", "PM": "2009", "HN": "2009", "MR": "20170224", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055502"}, {"RECTYPE": "D", "MH": "Protein Multimerization", "AQ": "DE GE IM PH RE", "ENTRY": "Trimerization, Protein", "MN": "G02.111.694", "FX": "Protein Folding", "MH_TH": "NLM (2009)", "ST": "T067", "MS": "The assembly of the QUATERNARY PROTEIN STRUCTURE of multimeric proteins (MULTIPROTEIN COMPLEXES) from their composite PROTEIN SUBUNITS.", "PM": "2009", "HN": "2009", "MR": "20160617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055503"}, {"RECTYPE": "D", "MH": "Insulin Receptor Substrate Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Insulin Receptor Substrate 4 Protein", "MN": "D12.776.476.024.382", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Phosphoproteins (1992-2008)", "MS": "A structurally-related group of signaling proteins that are phosphorylated by the INSULIN RECEPTOR PROTEIN-TYROSINE KINASE. The proteins share an N-terminal PLECKSTRIN HOMOLOGY DOMAIN, a phosphotyrosine-binding domain that interacts with the phosphorylated INSULIN RECEPTOR, and a C-terminal TYROSINE-rich domain. Upon tyrosine phosphorylation, insulin receptor substrate proteins interact with specific SH2 DOMAIN containing proteins that are involved in insulin receptor signaling.", "PM": "2009; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN was indexed under PHOSPHOPROTEINS 1992-2008, & under ADAPTOR PROTEINS, SIGNAL TRANSDUCING 2008; INSULIN RECEPTOR SUBSTRATE-2 PROTEIN was indexed under PHOSPHOPROTEINS 1995-2008, & under ADAPTOR PROTEINS, SIGNAL TRANSDUCING 2008", "HN": "2009(1992)", "MR": "20170524", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055504"}, {"RECTYPE": "D", "MH": "CCN Intercellular Signaling Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Matricellular CCN Proteins|T116|T123|ABX|EQV|NLM (2009)|080205|abbcdef", "MN": "D23.529.237", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A family of secreted proteins found associated with the EXTRACELLULAR MATRIX and cell surface receptors. They are believed to play a role in modulating the effects of a variety of GROWTH FACTORS and PROTEASES at the cell membrane extracellular matrix. The CCN protein family is named after three protypical members; CYSTEINE-RICH PROTEIN 61; CONNECTIVE TISSUE GROWTH FACTOR; and NEPHROBLASTOMA OVEREXPRESSED PROTEIN.", "PM": "2009", "HN": "2009", "MR": "20151123", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055511"}, {"RECTYPE": "D", "MH": "Tertiary Prevention", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Tertiary Preventions", "MN": "N06.850.780.800", "MH_TH": "NLM (2009)", "ST": "T061", "MS": "Measures aimed at providing appropriate supportive and rehabilitative services to minimize morbidity and maximize quality of life after a long-term disease or injury is present.", "PM": "2009", "HN": "2009", "MR": "20150626", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055512"}, {"RECTYPE": "D", "MH": "Connective Tissue Growth Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Insulin Like Growth Factor Binding Protein 8", "MN": "D23.529.237.100", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "139568-91-5", "MS": "A CCN protein family member that regulates a variety of extracellular functions including CELL ADHESION; CELL MIGRATION; and EXTRACELLULAR MATRIX synthesis. It is found in hypertrophic CHONDROCYTES where it may play a role in CHONDROGENESIS and endochondral ossification.", "PM": "2009; CONNECTIVE TISSUE GROWTH FACTOR was indexed under IMMEDIATE EARLY PROTEINS, & INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2003-2008, & under GROWTH SUBSTANCES 1991-2002", "HN": "2009(1991)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055513"}, {"RECTYPE": "D", "MH": "Nephroblastoma Overexpressed Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nephroblastoma Overexpressed Gene Product|T116|T123|NON|EQV|NLM (2009)|080205|abbcdef", "MN": "D23.529.237.600", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A CCN protein family member found at high levels in NEPHROBLASTOMA cells. It is found both intracellularly and in the EXTRACELLULAR MATRIX and may play a role in the regulation of CELL PROLIFERATION and EXTRACELLULAR MATRIX synthesis.", "PM": "2009", "HN": "2009", "MR": "20150622", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055514"}, {"RECTYPE": "D", "MH": "Cysteine-Rich Protein 61", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cysteine Rich Protein 61", "MN": "D23.529.237.200", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Intercellular Signaling Peptides and Proteins (2005-2008)", "MS": "A CCN protein family member that regulates a variety of extracellular functions including CELL ADHESION; CELL MIGRATION; and EXTRACELLULAR MATRIX synthesis. It may play an important role in the development of branched CAPILLARIES during EMBRYOGENESIS.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055515"}, {"RECTYPE": "D", "MH": "2S Albumins, Plant", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Plant 2S Albumins", "MN": "D12.776.765.725.249", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A major class of water-soluble seed storage proteins. Many proteins from this class are major PLANT ALLERGENS.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055516"}, {"RECTYPE": "D", "MH": "snRNP Core Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sm Nuclear Antigens|T116|T129|ABX|EQV|NLM (2009)|080208|abbcdef", "ENTRY": "Small Nuclear Ribonucleoprotein Associated Protein N", "MN": "D23.050.422.750", "FX": "RNA Splicing Factors", "MH_TH": "NLM (2009)", "ST": "T129", "RN": "0", "MS": "The protein components that constitute the common core of small nuclear ribonucleoprotein particles. These proteins are commonly referred as Sm nuclear antigens due to their antigenic nature.", "PM": "2009; SM NUCLEAR ANTIGENS (now SNRNP CORE PROTEINS) was indexed under AUTOANTIGENS & RIBONUCLEOPROTEINS, SMALL NUCLEAR 1981-2008", "HN": "2009(1981)", "MR": "20160701", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055517"}, {"RECTYPE": "D", "MH": "Photoreceptors, Plant", "DE": "PHOTORECEPT PLANT", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "ENTRY": "Plant Photoreceptors|T116|NON|EQV|NLM (1999)|980331|PLANT PHOTORECEPT|abcdefv", "MN": "D12.776.765.593", "FX": "Light Signal Transduction", "MH_TH": "NLM (1999)", "ST": "T116", "RN": "0", "AN": "not for plant photosynthetic apparatus, use PHOTOSYNTHETIC REACTION CENTER, PLANT see PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS", "MS": "Plant proteins that mediate LIGHT SIGNAL TRANSDUCTION. They are involved in PHOTOTROPISM and other light adaption responses during plant growth and development . They include the phototropins, phytochromes (PHYTOCHROME), and members of the ubiquitous cryptochrome family.", "PM": "2009; see PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1999-2008", "HN": "2009; use PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1999-2008", "MR": "20090721", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055519"}, {"RECTYPE": "D", "MH": "Gemini of Coiled Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Gemini of Cajal Bodies|T026|EPO|EQV|NLM (2022)|201124|abcdef", "ENTRY": "Coiled Bodies Gemini", "MN": "A11.284.430.106.279.345.574.750", "FX": "SMN Complex Proteins", "MH_TH": "NLM (2009)", "ST": "T026", "MS": "Small, punctate nuclear structures found in close proximity to COILED BODIES. They are enriched with SMN COMPLEX PROTEINS and may play a role in the processing of SMALL NUCLEAR RIBONUCLEOPROTEINS.", "PM": "2009", "HN": "2009", "MR": "20210701", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055531"}, {"RECTYPE": "D", "MH": "SMN Complex Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Survival of Motor Neuron Protein Interacting Protein 1", "MN": "D12.776.664.962.875", "FX": "Gemini of Coiled Bodies", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A complex of proteins that assemble the SNRNP CORE PROTEINS into a core structure that surrounds a highly conserved RNA sequence found in SMALL NUCLEAR RNA. They are found localized in the GEMINI OF COILED BODIES and in the CYTOPLASM. The SMN complex is named after the Survival of Motor Neuron Complex Protein 1, which is a critical component of the complex.", "PM": "2009; SMN PROTEIN (SPINAL MUSCULAR ATROPHY) now SMN COMPLEX PROTEINS was indexed under NERVE TISSUE PROTEINS, RNA-BINDING PROTEINS, & CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN 1995-2008", "HN": "2009(1995)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055532"}, {"RECTYPE": "D", "MH": "Survival of Motor Neuron 1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Survival of Motor Neuron 1, Telomeric Protein|T116|T123|NON|EQV|NLM (2009)|080211|abbcdef", "MN": "D12.776.664.962.875.500", "EC": "deficiency:Spinal Muscular Atrophies of Childhood", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "SMN Complex Proteins (2005-2008)", "MS": "An SMN complex protein that contains a TUDOR DOMAIN and is essential for the function of the SMN protein complex. In humans, the protein is encoded by a single gene found near the inversion TELOMERE of a large inverted region of CHROMOSOME 5. Mutations in the gene coding for survival of motor neuron 1 protein may result in SPINAL MUSCULAR ATROPHIES OF CHILDHOOD.", "PM": "2009; SURVIVAL OF MOTOR NEURON 1 PROTEIN was indexed under NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS; & CYCLIC-AMP RESPONSE ELEMENT-BINDING PROTEIN 2005-2008", "HN": "2009(2005); use SMN COMPLEX PROTEINS 2005-2008", "MR": "20160527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055533"}, {"RECTYPE": "D", "MH": "Bulbo-Spinal Atrophy, X-Linked", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Spinobulbar Muscular Atrophy|T047|NON|EQV|NLM (2000)|991012|abcdef", "ENTRY": "X-Linked Bulbo-Spinal Atrophies", "MN": "C16.320.400.100", "MH_TH": "NLM (2000)", "ST": "T047", "MS": "An X-linked recessive form of spinal muscular atrophy. It is due to a mutation of the gene encoding the ANDROGEN RECEPTOR.", "PM": "2009; see MUSCULAR ATROPHY, SPINAL 2000-2008", "HN": "2009(2000); use MUSCULAR ATROPHY, SPINAL 2000-2008", "MR": "20180629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055534"}, {"RECTYPE": "D", "MH": "Morgellons Disease", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Syndrome, Morgellons", "MN": "F03.700.412", "FX": "Delusional Parasitosis", "MH_TH": "NLM (2009)", "ST": "T048", "PI": "Skin Diseases, Parasitic (2006-2008)", "MS": "An unexplained illness which is characterized by skin manifestations including non-healing lesions, itching, and the appearance of fibers.", "PM": "2009", "HN": "2009", "MR": "20130708", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055535"}, {"RECTYPE": "D", "MH": "Vagus Nerve Stimulation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Vagus Nerve Stimulations", "MN": "E02.331.900", "MH_TH": "NLM (2009)", "ST": "T061", "PI": "Electric Stimulation Therapy (1990-2008)", "MS": "An adjunctive treatment for PARTIAL EPILEPSY and refractory DEPRESSION that delivers electrical impulses to the brain via the VAGUS NERVE. A battery implanted under the skin supplies the energy.", "PM": "2009", "HN": "2009", "MR": "20150706", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055536"}, {"RECTYPE": "D", "MH": "Light Signal Transduction", "AQ": "DE GE IM PH RE", "ENTRY": "Transduction, Light Signal", "MN": "G04.835.480", "FX": "Photoreceptors, Plant", "MH_TH": "NLM (2009)", "ST": "T043", "AN": "phototransduction in plants or microorganisms or non-image forming/non-visual phototransduction goes here; PHOTOTRANSDUCTION, VISUAL see VISION, OCULAR is also available", "MS": "The conversion of absorbed light energy into molecular signals.", "PM": "2009", "HN": "2009", "MR": "20160617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055537"}, {"RECTYPE": "D", "MH": "delta-Thalassemia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "delta-Thalassemias", "MN": "C16.320.365.826.575", "MH_TH": "NLM (2009)", "ST": "T047", "MS": "A hereditary disorder characterized by reduced or absent DELTA-GLOBIN thus effecting the level of HEMOGLOBIN A2, a minor component of adult hemoglobin monitored in the diagnosis of BETA-THALASSEMIA.", "PM": "2009", "HN": "2009", "MR": "20230226", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055538"}, {"RECTYPE": "D", "MH": "MP3-Player", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "iPODs", "MN": "L01.462.500.820.090.615", "MH_TH": "NLM (2009)", "ST": "T073", "PI": "Computers, Handheld (2006-2008)", "MS": "Portable electronics device for storing and playing audio and or media files. MP3 for MPEG-1 audio layer 3, is a digital coding format.", "PM": "2009", "HN": "2009", "MR": "20220712", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055539"}, {"RECTYPE": "D", "MH": "Survival of Motor Neuron 2 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Survival of Motor Neuron 3, Centromeric Protein|T116|T123|NON|EQV|NLM (2009)|080212|abbcdef", "MN": "D12.776.664.962.875.750", "FX": "Tudor Domain", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "An SMN complex protein that is closely-related to SURVIVAL OF MOTOR NEURON 1 PROTEIN. In humans, the protein is encoded by an often duplicated gene found near the inversion CENTEROMERE of a large inverted region of CHROMOSOME 5.", "PM": "2009; SURVIVAL OF MOTOR NEURON 1 PROTEIN was indexed under NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS; & CYCLIC-AMP RESPONSE ELEMENT-BINDING PROTEIN 2005-2008", "HN": "2009(2005); use SMN COMPLEX PROTEINS 2005-2008", "MR": "20160527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055540"}, {"RECTYPE": "D", "MH": "DEAD Box Protein 20", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Gemin 3 Protein", "MN": "D12.776.664.962.875.249", "MH_TH": "NLM (2009)", "ST": "T126", "RN": "EC 3.6.1.-", "PI": "RNA Helicases (1999-2006)", "MS": "A multifunctional protein that is both a DEAD-box RNA helicase and a component of the SMN protein complex.", "PM": "2009", "HN": "2009", "MR": "20130709", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055541"}, {"RECTYPE": "D", "MH": "alpha-Globins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha-Globin|T116|T123|NON|EQV|UNK (19XX)|870504|abbcdef", "ENTRY": "alpha Globins", "MN": "D12.776.422.316.762.403.320", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Globins (1968-2008)", "MS": "Members of the alpha-globin family. In humans, they are encoded in a gene cluster on CHROMOSOME 16. They include zeta-globin and alpha-globin. There are also pseudogenes of zeta (theta-zeta) and alpha (theta-alpha) in the cluster. Adult HEMOGLOBIN is comprised of 2 alpha-globin chains and 2 beta-globin chains.", "PM": "2009; for ALPHA-GLOBIN see GLOBINS 1988-2008", "HN": "2009", "MR": "20090721", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055542"}, {"RECTYPE": "D", "MH": "zeta-Globins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "zeta-Globin|T116|T123|NON|EQV|UNK (19XX)|830217|abbcdef", "ENTRY": "zeta Globins", "MN": "D12.776.422.316.762.403.320.500", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Globins (1982-2008)", "MS": "A member of the alpha-globin family. In humans, zeta-globin is encoded in the alpha-globin gene cluster located on CHROMOSOME 16. Two zeta-globin chains combine with two EPSILON GLOBIN chains to form the embryonic HEMOGLOBIN Gower 1.", "PM": "2009; for ZETA-GLOBIN see GLOBINS 1984-2008", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055543"}, {"RECTYPE": "D", "MH": "beta-Globins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "beta-Globin|T116|T123|NON|EQV|UNK (19XX)|870504|abbcdef", "ENTRY": "beta Globins", "MN": "D12.776.422.316.762.403.325", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Globins (1968-2008)", "MS": "Members of the beta-globin family. In humans, they are encoded in a gene cluster on CHROMOSOME 11. They include epsilon-globin, gamma-globin, delta-globin and beta-globin. There is also a pseudogene of beta (theta-beta) in the gene cluster. Adult HEMOGLOBIN is comprised of two ALPHA-GLOBIN chains and two beta-globin chains.", "PM": "2009; for BETA-GLOBIN see GLOBINS 1988-2008", "HN": "2009", "MR": "20090721", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055544"}, {"RECTYPE": "D", "MH": "gamma-Globins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "gamma-Globin|T116|T123|NON|EQV|UNK (19XX)|870504|abbcdef", "ENTRY": "gamma Globins", "MN": "D12.776.422.316.762.403.325.500", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Globins (1968-2008)", "MS": "Members of the beta-globin family. In humans, two non-allelic types of gamma-globin - A gamma and G gamma are encoded in the beta-globin gene cluster on CHROMOSOME 11. Two gamma-globin chains combine with two ZETA-GLOBIN chains to form the embryonic hemoglobin Portland. Fetal HEMOGLOBIN F is formed from two gamma-globin chains combined with two ALPHA-GLOBIN chains.", "PM": "2009; for GAMMA-GLOBIN see GLOBINS (1988-2008)", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055545"}, {"RECTYPE": "D", "MH": "delta-Globins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "delta-Globin|T116|T123|NON|EQV|UNK (19XX)|821206|abbcdef", "ENTRY": "delta Globins", "MN": "D12.776.422.316.762.403.325.249", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Globins (1979-2008)", "MS": "A member of the beta-globin family. In humans, delta-globin is encoded in the beta-globin gene cluster located on CHROMOSOME 11. Two delta-globin chains along with two alpha-globin chains form HEMOGLOBIN A2 which makes up about 3% of the HEMOGLOBIN in adults.", "PM": "2009; for DELTA-GLOBIN see GLOBINS 1984-2008", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055546"}, {"RECTYPE": "D", "MH": "epsilon-Globins", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "epsilon Globins", "MN": "D12.776.422.316.762.403.325.374", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Globins (1979-2008)", "MS": "A member of the beta-globin family. In humans, epsilon-globin is encoded in the beta-globin gene cluster located on CHROMOSOME 11. Two epsilon-globin chains combine with two ZETA-GLOBIN chains to form the embryonic hemoglobin Gower I or two epsilon-globin chains combine with two ALPHA-2 GLOBIN chains to form the embryonic hemoglobin Gower II.", "PM": "2009; for EPSILON-GLOBIN see GLOBINS 1984-2008", "HN": "2009", "MR": "20090721", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055547"}, {"RECTYPE": "D", "MH": "Vapor Pressure", "ENTRY": "Vapor Pressures", "MN": "G01.374.715.951", "MH_TH": "NLM (2009)", "ST": "T070", "MS": "The contribution to barometric PRESSURE of gaseous substance in equilibrium with its solid or liquid phase.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055548"}, {"RECTYPE": "D", "MH": "Volatile Organic Compounds", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Volatile Organic Compound|T109|NON|EQV|NLM (2021)|191219|abcdef", "ENTRY": "Organic Compounds, Volatile", "MN": "D02.974", "MH_TH": "NLM (2009)", "ST": "T109", "RN": "0", "AN": "general or unspecified; do not add routinely as a coordinate with specific organic compounds; index only when volatility is specifically discussed", "MS": "Organic compounds that have a relatively high VAPOR PRESSURE at room temperature.", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055549"}, {"RECTYPE": "D", "MH": "Protein Stability", "AQ": "DE ES RE", "ENTRY": "Stability, Protein", "MN": "G02.111.700", "FX": "Protein Unfolding", "MH_TH": "NLM (2009)", "ST": "T080", "AN": "IM general only; coordinate NIM with specific protein (IM)", "MS": "The ability of a protein to retain its structural conformation or its activity when subjected to physical or chemical manipulations.", "PM": "2009", "HN": "2009", "MR": "20100625", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055550"}, {"RECTYPE": "D", "MH": "HSP27 Heat-Shock Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein 27, Heat-Shock", "MN": "D12.776.580.216.270.625", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Neoplasm Proteins (1988-2008)", "MS": "A subfamily of small heat-shock proteins that function as molecular chaperones that aid in refolding of non-native proteins. They play a protective role that increases cellular survival during times of stress.", "PM": "2009; see HEAT SHOCK PROTEINS 1989-2008", "HN": "2009(1989); use HEAT SHOCK PROTEINS 1989-2008", "MR": "20090706", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055551"}, {"RECTYPE": "D", "MH": "Infectious Disease Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Infectious Diseases Specialty|T091|NON|EQV|NLM (2009)|080219|abcdef", "ENTRY": "Specialty, Infectious Diseases", "MN": "H02.403.429.480", "FX": "Virology", "MH_TH": "NLM (2009)", "ST": "T091", "AN": "use for the discipline (education, history, etc) only; corresponding disease term is INFECTIOUS DISEASES", "MS": "A branch of internal medicine concerned with the diagnosis and treatment of INFECTIOUS DISEASES.", "PM": "2009", "HN": "2009", "MR": "20090706", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055552"}, {"RECTYPE": "D", "MH": "Prescription Drugs", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Prescription Drug|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Drug, Prescription", "MN": "D26.670", "MH_TH": "NLM (2009)", "ST": "T121", "RN": "0", "AN": "note category: do not confuse with DRUG PRESCRIPTIONS; DRUG PRESCRIPTIONS are the written directions for obtaining drugs; PRESCRIPTION DRUGS are the drugs that are prescribed", "PI": "Pharmaceutical Preparations (1963-2008)", "MS": "Drugs that cannot be sold legally without a prescription.", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055553"}, {"RECTYPE": "D", "MH": "Hemoglobin Subunits", "AQ": "AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Subunits, Hemoglobin", "MN": "D12.776.422.316.762.403", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Hemoglobins (1964-2008)", "MS": "The PROTEIN SUBUNITS that comprise multimeric HEMOGLOBINS.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055554"}, {"RECTYPE": "D", "MH": "Nasal Lavage", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Nasal Lavages", "MN": "E05.927.573", "MH_TH": "NLM (2009)", "ST": "T061", "AN": "do not confuse with NASAL LAVAGE FLUID, the washings obtained by lavage", "PI": "Nasal Mucosa (1987-1993)", "MS": "Irrigation of the nose with saline or irrigation solutions for diagnostic or therapeutic purposes. It is used to remove irritants, allergens, or microorganisms from the nose.", "PM": "2009", "HN": "2009", "MR": "20100625", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055556"}, {"RECTYPE": "D", "MH": "Secretory Pathway", "AQ": "DE GE IM PH RE", "ENTRY": "Secretory Processes", "MN": "G04.468.580", "MH_TH": "NLM (2009)", "ST": "T043", "MS": "A series of sequential intracellular steps involved in the transport of proteins (such as hormones and enzymes) from the site of synthesis to outside the cell. The pathway involves membrane-bound compartments through which the newly synthesized proteins undergo POST-TRANSLATIONAL MODIFICATIONS, packaging, storage, or transportation to the PLASMA MEMBRANE for secretion.", "PM": "2009", "HN": "2009", "MR": "20160701", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055571"}, {"RECTYPE": "D", "MH": "Ceramidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "N Acylsphingosine Amidohydrolase", "MN": "D08.811.277.087.250", "MH_TH": "NLM (2009)", "ST": "T126", "RN": "EC 3.5.1.23", "PI": "Galactosylgalactosylglucosylceramidase (1982-2008)", "MS": "Amidohydrolases that are specific for the cleavage of the N-acyl linkage of CERAMIDES. Ceramidases are classified as acidic, neutral or basic according to the optimal pH with which they function.", "PM": "2009; CERAMIDASE was indexed under AMIDOHYDROLASES 1982-2008, under CERAMIDES 1975-1981, under SPHINGOSINE 1973-1975, under SPHINGOSINE 1973-1975, & under GLYCOLS 1970-1973", "HN": "2009(1980)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055572"}, {"RECTYPE": "D", "MH": "Acid Ceramidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.087.250.100", "EC": "deficiency:Farber Lipogranulomatosis", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 3.5.1.23", "PI": "Galactosylgalactosylglucosylceramidase (1974-2008)", "MS": "A ceramidase subtype that is active at acid pH. It plays an important role in sphingolipid degradation by catalyzing the lysosomal hydrolysis of ceramide to sphingosine and free fatty acid. Inherited deficiency of acid ceramidase activity results in FARBER LIPOGRANULOMATOSIS.", "PM": "2009; see CERAMIDE TRIHEXOSIDASE 1983-2008", "HN": "2009(1982); use GALACTOSYLGALACTOSYLGLUCOSYLCERAMIDASE 1983-2008", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055573"}, {"RECTYPE": "D", "MH": "Alkaline Ceramidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Ceramidase, Alkaline", "MN": "D08.811.277.087.250.300", "MH_TH": "NLM (2009)", "ST": "T126", "RN": "EC 3.5.1.23", "PI": "Ceramidases (1980-2008)", "MS": "A ceramidase subtype that is active at alkaline pH. It is found at high levels within the SMALL INTESTINE.", "PM": "2009; ALKALINE CERAMIDASE was indexed under AMIDOHYDROLASES 2007-2008", "HN": "2009(2007); for ALKALINE CERAMIDASE use CERAMIDASES 2007-2008", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055574"}, {"RECTYPE": "D", "MH": "Neutral Ceramidase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.087.250.650", "MH_TH": "NLM (2009)", "ST": "T126", "RN": "EC 3.5.1.23", "PI": "Ceramidases (1980-2008)", "MS": "A ceramidase subtype that is active at neutral pH. It is found at high levels within the SMALL INTESTINE and in the BRAIN.", "PM": "2009; NEUTRAL CERAMIDASE was indexed under AMIDOHYDROLASES 2007-2008", "HN": "2009(2007); for NEUTRAL CERAMIDASE use CERAMIDASES 2007-2008", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055576"}, {"RECTYPE": "D", "MH": "Farber Lipogranulomatosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "N-Laurylsphingosine Deacylase Deficiencies", "MN": "C18.452.648.595.554.825.250", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Sphingolipidoses (1992-2008)", "MS": "A sphingolipidosis subtype that is characterized by the histological appearance of granulomatous deposits in tissues. It results from the accumulation of CERAMIDES in various tissues due to an inherited deficiency of ACID CERAMIDASE.", "PM": "2009", "HN": "2009", "MR": "20210701", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055577"}, {"RECTYPE": "D", "MH": "Astronomical Phenomena", "PRINT ENTRY": "Astronomical Processes|T070|NON|NRW|NLM (2009)|080225|abcdef", "ENTRY": "Processes, Astrophysical", "MN": "G01.060", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "Aggregates of matter in outer space, such as stars, planets, and comets; their properties; and the processes they undergo.", "PM": "2009; for ASTRONOMICAL PROCESSES see ASTRONOMICAL PROCESSES 2009-2016", "HN": "2009", "MR": "20160115", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055580"}, {"RECTYPE": "D", "MH": "Physical Phenomena", "PRINT ENTRY": "Physical Processes|T070|NON|NRW|NLM (2007)|080225|abcdef", "ENTRY": "Processes, Physical", "MN": "G01", "RH": "G1 - PHYSICAL PHENOMENA", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "The entities of matter and energy, and the processes, principles, properties, and relationships describing their nature and interactions.", "PM": "2009; for PHYSICAL PROCESSES see PHYSICAL PROCESSES 2009-2016", "HN": "2009", "MR": "20160617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055585"}, {"RECTYPE": "D", "MH": "Astronomical Objects", "ENTRY": "Objects, Astronomical", "MN": "G01.060.075", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "Aggregates of matter in outer space.", "PM": "2009", "HN": "2009", "MR": "20160115", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055587"}, {"RECTYPE": "D", "MH": "Pancreatitis, Graft", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Graft Pancreatitis|T047|NON|EQV|NLM (2009)|080225|abcdef", "MN": "C06.689.750.860", "MH_TH": "NLM (2009)", "ST": "T047", "PI": "Pancreatitis (1988-2008)", "MS": "An inflammatory disease and serious complication of PANCREAS TRANSPLANTATION. It is caused by a premature activation of pancreatic proenzymes leading to autodigestion of the gland and can be attributed to immunological or nonimmunological causes.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055589"}, {"RECTYPE": "D", "MH": "Electromagnetic Phenomena", "PRINT ENTRY": "Electromagnetic Concepts|T070|NON|EQV|NLM (2009)|080603|abcdef", "ENTRY": "Phenomenon, Electromagnetic", "MN": "G01.358.500", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "Characteristics of ELECTRICITY and magnetism such as charged particles and the properties and behavior of charged particles, and other phenomena related to or associated with electromagnetism.", "PM": "2009; for ELECTROMAGNETICS see ELECTROMAGNETICS 1974-2008", "HN": "2009", "MR": "20110624", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055590"}, {"RECTYPE": "D", "MH": "Biophysical Phenomena", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Biophysical Processes|T070|NON|NRW|NLM (2009)|080226|abcdef", "ENTRY": "Processes, Biophysical", "MN": "G01.154", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "The physical characteristics and processes of biological systems.", "PM": "2009; for BIOPHYSICAL PROCESSES see BIOPHYSICAL PROCESSES 2009-2016", "HN": "2009", "MR": "20160928", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055592"}, {"RECTYPE": "D", "MH": "Geological Phenomena", "PRINT ENTRY": "Geological Processes|T070|NON|NRW|NLM (2009)|080226|abcdef", "ENTRY": "Processes, Geophysical", "MN": "G01.311", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "Structures, properties, and processes involving the inanimate matter of Earth.", "PM": "2009; for GEOLOGICAL PROCESSES see GEOLOGICAL PROCESSES 2009-2016", "HN": "2009", "MR": "20160617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055593"}, {"RECTYPE": "D", "MH": "Mechanical Phenomena", "AQ": "DE RE", "PRINT ENTRY": "Mechanical Processes|T070|NON|NRW|NLM (2009)|080226|abcdef", "ENTRY": "Processes, Mechanical", "MN": "G01.374", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "The properties and processes of materials that affect their behavior under force.", "PM": "2009; for MECHANICAL PROCESSES see MECHANICAL PROCESSES 2009-2016", "HN": "2009", "MR": "20160617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055595"}, {"RECTYPE": "D", "MH": "Chemical Phenomena", "AQ": "DE RE", "PRINT ENTRY": "Physicochemical Processes|T070|NON|NRW|NLM (2009)|080516|abcdef", "ENTRY": "Processes, Physicochemical", "MN": "G02", "RH": "G2 - CHEMICAL PHENOMENA", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes.", "PM": "2009; for CHEMICAL PROCESSES see CHEMICAL PROCESSES 2009-2016; for PHYSICOCHEMICAL PHENOMENA see PHYSICOCHEMICAL PHENOMENA 2009-2016; for PHYSICOCHEMICAL PROCESSES see PHYSICOCHEMICAL PROCESSES 2009-2016.", "HN": "2009", "MR": "20160115", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055598"}, {"RECTYPE": "D", "MH": "Organic Chemistry Phenomena", "AQ": "DE RE", "PRINT ENTRY": "Organic Chemistry Processes|T070|NON|NRW|NLM (2009)|080226|abcdef", "ENTRY": "Processes, Organic Chemistry", "MN": "G02.607", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "The conformation, properties, reaction processes, and the properties of the reactions of organic carbon compounds.", "PM": "2009; for ORGANIC CHEMISTRY PROCESSES see ORGANIC CHEMISTRY PROCESSES 2009-2016", "HN": "2009", "MR": "20160617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055601"}, {"RECTYPE": "D", "MH": "Receptors, Natural Killer Cell", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Natural Killer Cell Receptor|T116|T192|NON|EQV|NLM (2021)|200603|abbcdef", "ENTRY": "Receptors, NK Cell", "MN": "D12.776.543.750.705.895", "MH_TH": "NLM (2009)", "ST": "T192", "RN": "0", "AN": "not for receptors on NATURAL KILLER T-CELLS", "MS": "Receptors that are specifically found on the surface of NATURAL KILLER CELLS. They play an important role in regulating the cellular component of INNATE IMMUNITY.", "PM": "2009; NATURAL KILLER CELL ACTIVATING RECEPTORS (now RECEPTORS, NATURAL KILLER CELL) was indexed under RECEPTORS, IMMUNOLOGICAL 2005-2008, under RECEPTORS, MITOGEN 1993-2004, & under MEMBRANE GLYCOPROTEINS 1993-1998", "HN": "2009(1993)", "MR": "20200617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055607"}, {"RECTYPE": "D", "MH": "Galaxies", "AQ": "CH", "ENTRY": "Galaxy|T083|NON|EQV|NLM (2009)|080226|abcdef", "MN": "G01.060.075.320", "MH_TH": "NLM (1996)", "ST": "T083", "PI": "Astronomy (1994-2008)", "MS": "Large aggregates of CELESTIAL STARS; COSMIC DUST; and gas. (From McGraw Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "2009; see ASTRONOMY 1995-2008", "HN": "2009; use ASTRONOMY 1995-2008", "MR": "20160617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055608"}, {"RECTYPE": "D", "MH": "Stars, Celestial", "AQ": "CH", "ENTRY": "Star, Celestial", "MN": "G01.060.075.750", "MH_TH": "NLM (2009)", "ST": "T072", "PI": "Astronomy (1987-2008)", "MS": "Large bodies consisting of self-luminous gas held together by their own gravity. (From McGraw Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "2009; see ASTRONOMY 1996-2008", "HN": "2009; use ASTRONOMY 1996-2008", "MR": "20160617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055609"}, {"RECTYPE": "D", "MH": "Antigens, CD1d", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "CD1d Antigens", "MN": "D23.101.100.894.080.500", "FX": "Histocompatibility Antigens Class I", "MH_TH": "NLM (2009)", "ST": "T129", "RN": "0", "MS": "A major histocompatibility complex class I-like protein that contains an IMMUNOGLOBULIN C1-SET DOMAIN. It plays a unique role in the presentation of lipid ANTIGENS to NATURAL KILLER T-CELLS.", "PM": "2009; CD1D ANTIGEN (now ANTIGENS, CD1D) was indexed under ANTIGENS CD1 1999-2008", "HN": "2009(1999)", "MR": "20160527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055610"}, {"RECTYPE": "D", "MH": "Natural Killer T-Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "iNKT Cell|T025|NON|NRW|NLM (2021)|191118|abcdef", "ENTRY": "T-Cells, Natural Killer", "MN": "A15.382.490.555.567.569.470", "MH_TH": "NLM (2009)", "ST": "T025", "AN": "do not confuse with KILLER CELLS, NATURAL", "PI": "T-Lymphocytes (1986-2008)", "MS": "A specialized subset of T-LYMPHOCYTES that exhibit features of INNATE IMMUNITY similar to that of NATURAL KILLER CELLS. They are reactive to glycolipids presented in the context of the major histocompatibility complex (MHC) class I-like molecule, CD1D ANTIGEN.", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055611"}, {"RECTYPE": "D", "MH": "Cytokine-Induced Killer Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Lymphocyte Activated Killer Cells", "MN": "A15.382.490.555.283", "MH_TH": "NLM (2009)", "ST": "T025", "MS": "Mononuclear leukocytes that have been expanded in CELL CULTURE and activated with CYTOKINES such as INTERLEUKIN-2 to produce large numbers of highly cytotoxic cells.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055612"}, {"RECTYPE": "D", "MH": "Multiple Pulmonary Nodules", "DE": "MULTIPLE PULM NODULE", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Pulmonary Nodules, Multiple", "MN": "C08.785.520.148", "MH_TH": "NLM (2009)", "ST": "T190", "AN": "if neoplastic, coordinate with LUNG NEOPLASMS; if non-neoplastic, do not coordinate with LUNG DISEASES", "MS": "A number of small lung lesions characterized by small round masses of 2- to 3-mm in diameter. They are usually detected by chest CT scans (COMPUTED TOMOGRAPHY, X-RAY). Such nodules can be associated with metastases of malignancies inside or outside the lung, benign granulomas, or other lesions.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055613"}, {"RECTYPE": "D", "MH": "Genetic Phenomena", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Genetic Processes|T070|NON|NRW|NLM (2003)|020328|abcdef", "ENTRY": "Processes, Genetic", "MN": "G05", "RH": "G5 - GENETIC PHENOMENA", "FX": "Molecular Biology", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "The biological processes, properties, and objects that are involved in maintaining, expressing, and transmitting from one organism to another, genetically encoded traits.", "PM": "2009; for GENETIC PROCESSES see GENETIC PROCESSES  2003-2016", "HN": "2009", "MR": "20160617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055614"}, {"RECTYPE": "D", "MH": "Electrical Equipment and Supplies", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Electronic Equipment and Supplies|T073|NON|NRW|NLM (2009)|080228|abcdef", "MN": "E07.305", "FX": "Electronics", "MH_TH": "NLM (2009)", "ST": "T073", "MS": "Apparatus and instruments that generate and operate with ELECTRICITY, and their electrical components.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055615"}, {"RECTYPE": "D", "MH": "Microtechnology", "AQ": "IS MT SN ST", "ENTRY": "Microtechnologies", "MN": "J01.897.520.500", "MH_TH": "NLM (2009)", "ST": "T068", "MS": "Manufacturing technology for making microscopic devices in the micrometer range (typically 1-100 micrometers), such as integrated circuits or MEMS. The process usually involves replication and parallel fabrication of hundreds or millions of identical structures using various thin film deposition techniques and carried out in environmentally-controlled clean rooms.", "PM": "2009", "HN": "2009", "MR": "20081016", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055616"}, {"RECTYPE": "D", "MH": "Micro-Electrical-Mechanical Systems", "AQ": "IS MT SN ST", "ENTRY": "Systems, Micro-Electro-Mechanical", "MN": "J01.637.509", "MH_TH": "NLM (2009)", "ST": "T073", "MS": "A class of devices combining electrical and mechanical components that have at least one of the dimensions in the micrometer range (between 1 micron and 1 millimeter). They include sensors, actuators, microducts, and micropumps.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055617"}, {"RECTYPE": "D", "MH": "Radiation Equipment and Supplies", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "MN": "E07.710", "MH_TH": "NLM (2009)", "ST": "T073", "MS": "Instruments and apparatus for radiation applications and their components and associated expendables.", "PM": "2009", "HN": "2009", "MR": "20081016", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055618"}, {"RECTYPE": "D", "MH": "Optical Phenomena", "PRINT ENTRY": "Optical Processes|T070|NON|NRW|NLM (2009)|080229|abcdef", "ENTRY": "Processes, Optical", "MN": "G01.590", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "LIGHT, its processes and properties, and the characteristics of materials interacting with it.", "PM": "2009; for OPTICAL PROCESSES see OPTICAL PROCESSES 2009-2016", "HN": "2009", "MR": "20160617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055620"}, {"RECTYPE": "D", "MH": "Orbital Myositis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myositis, Orbital|T047|NON|EQV|NLM (1992)|901231|abcdef", "ENTRY": "Orbital Myositides", "MN": "C11.675.426", "MH_TH": "NLM (1992)", "ST": "T047", "PI": "Orbital Pseudotumor (1992-2008)", "MS": "Inflammation of the extraocular muscle of the eye. It is characterized by swelling which can lead to ischemia, fibrosis, or ORBITAL PSEUDOTUMOR.", "PM": "2009; see GRANULOMA, PLASMA CELL, ORBITAL 1992-2008", "HN": "2009; use GRANULOMA, PLASMA CELL, ORBITAL 1992-2008", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055622"}, {"RECTYPE": "D", "MH": "Keratosis, Actinic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Actinic Keratosis|T047|NON|EQV|NLM (2009)|080303|abcdef", "ENTRY": "Keratoses, Actinic", "MN": "C17.800.428.570", "MH_TH": "NLM (2009)", "ST": "T047", "MS": "White or pink lesions on the arms, hands, face, or scalp that arise from sun-induced DNA DAMAGE to KERATINOCYTES in exposed areas. They are considered precursor lesions to superficial SQUAMOUS CELL CARCINOMA.", "PM": "2009", "HN": "2009", "MR": "20170707", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055623"}, {"RECTYPE": "D", "MH": "Methicillin-Resistant Staphylococcus aureus", "DE": "METHICILLIN RESISTANT STAPH AUREUS", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "MRSA|T007|NON|EQV|NLM (2009)|080303|abcdef", "ENTRY": "Methicillin Resistant Staphylococcus aureus|T007|NON|EQV|NLM (2018)|160930|abcdef", "MN": "B03.510.400.790.750.100.500", "FX": "Methicillin Resistance", "MH_TH": "NLM (2009)", "ST": "T007", "AN": "infection: coordinate with STAPHYLOCOCCAL INFECTIONS or specifics", "PI": "Staphylococcus aureus (1982-2008)", "MS": "A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN. The mechanism of resistance usually involves modification of normal or the presence of acquired PENICILLIN BINDING PROTEINS.", "PM": "2009", "HN": "2009", "MR": "20200902", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055624"}, {"RECTYPE": "D", "MH": "Natural Cytotoxicity Triggering Receptor 1", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, NKp46", "MN": "D12.776.543.750.705.895.750.100", "MH_TH": "NLM (2009)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1998-2008)", "MS": "A 46-kD stimulatory receptor found on resting and activated NATURAL KILLER CELLS. It has specificity for VIRAL HEMAGGLUTININS that are expressed on infected cells.", "PM": "2009", "HN": "2009", "MR": "20170524", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055627"}, {"RECTYPE": "D", "MH": "Natural Cytotoxicity Triggering Receptor 3", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, NKp30", "MN": "D12.776.543.750.705.895.750.300", "MH_TH": "NLM (2009)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (2001-2008)", "MS": "A 30 kDa stimulatory receptor found on resting and activated NATURAL KILLER CELLS.", "PM": "2009", "HN": "2009", "MR": "20170524", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055628"}, {"RECTYPE": "D", "MH": "Natural Cytotoxicity Triggering Receptor 2", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, NKp44", "MN": "D12.776.543.750.705.895.750.200", "MH_TH": "NLM (2009)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1998-2008)", "MS": "A 44-kD stimulatory receptor found on activated NATURAL KILLER CELLS. It has specificity for VIRAL HEMAGGLUTININS that are expressed on infected cells.", "PM": "2009", "HN": "2009", "MR": "20170524", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055629"}, {"RECTYPE": "D", "MH": "Receptors, NK Cell Lectin-Like", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "NK Cell Lectin-Like Receptors|T116|T192|ABX|EQV|NLM (2009)|080305|abbcdef", "ENTRY": "Receptors, NK Cell Lectin Like", "MN": "D12.776.543.750.705.895.800", "MH_TH": "NLM (2009)", "ST": "T192", "RN": "0", "PI": "Receptors, Immunologic (1980-2008)", "MS": "Structurally-related receptors that are typically found on NATURAL KILLER CELLS. They are considered lectin-like proteins in that they share sequence homology with the carbohydrate binding domains of C-TYPE LECTINS. They differ from classical C-type lectins, however, in that they appear to lack CALCIUM-binding domains.", "PM": "2009", "HN": "2009", "MR": "20100625", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055630"}, {"RECTYPE": "D", "MH": "Immune System Phenomena", "AQ": "DE GE PH RE", "PRINT ENTRY": "Immune System Processes|T040|NON|NRW|NLM (2009)|080307|abcdef", "ENTRY": "Processes, Immune System", "MN": "G12", "RH": "G12 - IMMUNE SYSTEM PHENOMENA", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "The characteristic properties and processes involved in IMMUNITY and an organism's immune response.", "PM": "2009; for IMMUNE SYSTEM PROCESSES see  IMMUNE SYSTEM PROCESSES 2009-2016", "HN": "2009", "MR": "20160928", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055633"}, {"RECTYPE": "D", "MH": "Receptors, Natural Cytotoxicity Triggering", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Natural Cytotoxicity Triggering Receptors|T116|T192|NON|EQV|NLM (2009)|080307|abbcdef", "MN": "D12.776.543.750.705.895.750", "MH_TH": "NLM (2009)", "ST": "T192", "RN": "0", "MS": "A subclass of natural killer cell receptors that perform an important role in the recognition of tumor cells by NK CELLS.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055636"}, {"RECTYPE": "D", "MH": "Mathematical Concepts", "ENTRY": "Mathematical Concept", "MN": "G17", "RH": "G17 - MATHEMATICAL CONCEPTS", "MH_TH": "NLM (2009)", "ST": "T081", "AN": "general or unspecified; prefer specifics", "MS": "Numeric or quantitative entities, descriptions, properties, relationships, operations, and events.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055641"}, {"RECTYPE": "D", "MH": "Killer Factors, Yeast", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Yeast Killer Toxin", "MN": "D23.946.587.531", "PA": "Cytotoxins", "MH_TH": "NLM (2009)", "ST": "T129", "RN": "0", "PI": "Proteins (1974-2008)", "MS": "Protein factors released from one species of YEAST that are selectively toxic to another species of yeast.", "PM": "2009; KILLER FACTOR (now KILLER FACTORS, YEAST) was indexed under PROTEINS 1974-2008, KILLER FACTOR, YEAST was indexed under MYCOTOXINS 1985-2008", "HN": "2009(1980)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055646"}, {"RECTYPE": "D", "MH": "Rats, Transgenic", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Transgenic Rats|T015|NON|EQV|NLM (2009)|080310|abcdef", "ENTRY": "Transgenic Rat", "MN": "B01.050.150.900.649.313.992.635.505.700.825", "MH_TH": "NLM (2009)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal; check the tag RATS", "PI": "Rats (1990-2008)", "MS": "Laboratory rats that have been produced from a genetically manipulated rat EGG or rat EMBRYO, MAMMALIAN. They contain genes from another species.", "PM": "2009", "HN": "2009", "MR": "20200902", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055647"}, {"RECTYPE": "D", "MH": "NK Cell Lectin-Like Receptor Subfamily A", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Natural Killer Cell Lectin Like Receptor Subfamily A", "MN": "D23.101.100.920.500", "MH_TH": "NLM (2009)", "ST": "T192", "RN": "0", "MS": "An inhibitory subclass of NK cell lectin-like receptors that interacts with CLASS I MAJOR HISTOCOMPATIBILITY ANTIGENS and prevents the activation of NK CELLS.", "PM": "2009; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A was indexed under LECTINS, C-TYPE & ANTIGENS, LY 1995-2008, and under MEMBRANE GLYCOPROTEINS 1994-2002", "HN": "2009(1994)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055650"}, {"RECTYPE": "D", "MH": "NK Cell Lectin-Like Receptor Subfamily B", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, NKR P1", "MN": "D12.776.543.750.705.895.800.200", "MH_TH": "NLM (2009)", "ST": "T192", "RN": "0", "MS": "A subclass of NK cell lectin-like receptors that includes both inhibitory and stimulatory members.", "PM": "2009; KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY B was indexed under LECTINS, C-TYPE & ANTIGENS, SURFACE 1991-2008", "HN": "2009(1991)", "MR": "20170524", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055651"}, {"RECTYPE": "D", "MH": "Gray Platelet Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "alpha-Granule Deficiency, Platelet", "MN": "C16.320.099.417", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Blood Platelet Disorders (1971-2008)", "MS": "A rare, inherited platelet disorder characterized by a selective deficiency in the number and contents of platelet alpha-granules. It is associated with THROMBOCYTOPENIA, enlarged platelets, and prolonged bleeding time.", "PM": "2009", "HN": "2009", "MR": "20120703", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055652"}, {"RECTYPE": "D", "MH": "Muir-Torre Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Muir-Torre", "MN": "C17.800.882.712.500", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Sebaceous Gland Neoplasms (1985-2008)", "MS": "A form of LYNCH SYNDROME II associated with cutaneous SEBACEOUS GLAND NEOPLASMS. Muir-Torre syndrome is also associated with other visceral malignant diseases include colorectal, endometrial, urological, and upper gastrointestinal neoplasms.", "PM": "2009", "HN": "2009", "MR": "20150618", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055653"}, {"RECTYPE": "D", "MH": "NK Cell Lectin-Like Receptor Subfamily C", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, NKG2E", "MN": "D12.776.543.750.705.895.800.810", "MH_TH": "NLM (2009)", "ST": "T192", "RN": "0", "MS": "A subclass of NK cell lectin-like receptors that associates with members of NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D to form heterodimeric receptors for HLA-E antigen.", "PM": "2009; KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY C was indexed under RECEPTORS, IMMUNOLOGIC 2005-2008, under RECEPTORS MITOGEN 1993-2004, and under UNDER MEMBRANE GLYCOPROTEINS 1993-1998", "HN": "2009; for KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY C use RECEPTORS, NATURAL KILLER CELL 1993-2008", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055654"}, {"RECTYPE": "D", "MH": "NK Cell Lectin-Like Receptor Subfamily K", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, NKG2D", "MN": "D12.776.543.750.705.895.800.910", "MH_TH": "NLM (2009)", "ST": "T192", "RN": "0", "MS": "An activating NK cell lectin-like receptor subfamily that regulates immune responses to INFECTION and NEOPLASMS. Members of this subfamily generally occur as homodimers.", "PM": "2009; NKG2D RECEPTOR (now KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY K) was indexed under RECEPTORS, IMMUNOLOGIC 2005-2008, under RECEPTORS MITOGEN 1993-2004, and under UNDER MEMBRANE GLYCOPROTEINS 1993-1998", "HN": "2009; for KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY K use RECEPTORS, NATURAL KILLER CELL 1993-2008", "MR": "20170524", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055655"}, {"RECTYPE": "D", "MH": "Prescriptions", "AQ": "CL EC HI NU SN ST VE", "ENTRY": "Prescriptions, Non Drug", "MN": "N02.421.668.778", "MH_TH": "NLM (1963)", "ST": "T170", "PI": "Drug Prescriptions (1963-2008)", "MS": "Directions written for the obtaining and use of PHARMACEUTICAL PREPARATIONS; MEDICAL DEVICES; corrective LENSES; and a variety of other medical remedies.", "PM": "2009; see PRESCRIPTIONS, DRUG 1978-2008, see PRESCRIPTONS 1963-1977; for PRESCRIPTIONS, NON-DRUG see PRESCRIPTIONS, NON-DRUG 1977-2008", "HN": "2009, 1963-1977", "MR": "20150626", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055656"}, {"RECTYPE": "D", "MH": "Electrochemical Techniques", "AQ": "CL EC HI IS MT SN ST TD VE", "ENTRY": "Techniques, Electrochemical", "MN": "E05.301", "MH_TH": "NLM (2009)", "ST": "T059", "PI": "Electrochemistry (1968-2008)", "MS": "The utilization of an electrical current to measure, analyze, or alter chemicals or chemical reactions in solution, cells, or tissues.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055664"}, {"RECTYPE": "D", "MH": "Purpura Fulminans", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Fulminans, Purpura", "MN": "C23.888.885.687.230", "FX": "Disseminated Intravascular Coagulation", "MH_TH": "NLM (1997)", "ST": "T047", "PI": "Purpura, Schoenlein-Henoch (1995-2008)", "MS": "A severe, rapidly fatal reaction occurring most commonly in children following an infectious illness. It is characterized by large, rapidly spreading skin hemorrhages, fever, or shock. Purpura fulminans often accompanies or is triggered by DISSEMINATED INTRAVASCULAR COAGULATION.", "PM": "2009; see PURPURA, SCHOENLEIN-HENOCH (1997-2008)", "HN": "2009; use PURPURA, SCHOENLEIN-HENOCH (1997-2008)", "MR": "20100625", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055665"}, {"RECTYPE": "D", "MH": "Lipopeptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Lipopeptide|T109|T116|NON|EQV|NLM (2021)|191219|abbcdef", "ENTRY": "Lipopeptides, Cationic", "MN": "D12.644.365", "MH_TH": "NLM (2009)", "ST": "T116", "RN": "0", "MS": "Compounds consisting of a short peptide chain conjugated with an acyl chain.", "PM": "2009", "HN": "2009", "MR": "20210630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055666"}, {"RECTYPE": "D", "MH": "Arcanobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Archanobacterium|T007|NON|EQV|NLM (2009)|080313|abcdef", "MN": "B03.510.460.400.400.049.049.200", "MH_TH": "NLM (2009)", "ST": "T007", "RN": "txid28263", "AN": "infection: coordinate IM with ACTINOMYCETALES INFECTIONS (IM)", "PI": "Corynebacterium (1982-2005)", "MS": "A genus of facultatively anaerobic, gram-positive bacteria in the family ACTINOMYCETACEAE, order ACTINOMYCETALES. They are obligate parasites of the PHARYNX in humans and farm animals.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055667"}, {"RECTYPE": "D", "MH": "Photochemical Processes", "AQ": "DE RE", "ENTRY": "Processes, Photochemical", "MN": "G02.740", "MH_TH": "NLM (2009)", "ST": "T070", "MS": "Chemical reactions effected by light.", "PM": "2009", "HN": "2009", "MR": "20160617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055668"}, {"RECTYPE": "D", "MH": "Ecological and Environmental Phenomena", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Ecological and Environmental Processes|T070|NON|NRW|NLM (2009)|080318|abcdef", "MN": "G16.500", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "Ecological and environmental entities, characteristics, properties, relationships and processes.", "PM": "2009; for ECOLOGICAL AND ENVIRONMENTAL PROCESSES see ECOLOGICAL AND ENVIRONMENTAL PROCESSES 2009-2016", "HN": "2009", "MR": "20160623", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055669"}, {"RECTYPE": "D", "MH": "Medicine, Korean Traditional", "AQ": "AE EC HI IS MT PX SN ST TD", "PRINT ENTRY": "Traditional Medicine, Korea|T058|NON|EQV|NLM (2009)|080314|abcdef", "ENTRY": "Traditional Medicine, Korean", "MN": "I01.076.201.450.654.558.700", "MH_TH": "NLM (2009)", "ST": "T058", "AN": "for hand acupuncture (Koryo Sooji Chim) in Korean traditional medicine index ACUPUNCTURE THERAPY + HAND + MEDICINE, KOREAN TRADITIONAL", "PI": "Medicine, Oriental Traditional (1981-2008)", "MS": "Medical practice or discipline that is based on the knowledge, cultures, and beliefs of the people of KOREA.", "PM": "2009", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055670"}, {"RECTYPE": "D", "MH": "Static Electricity", "AQ": "AE", "PRINT ENTRY": "Electrostatic|T070|NON|NRW|NLM (2021)|200225|abcdef", "ENTRY": "Static Charges", "MN": "G01.358.500.249.820", "MH_TH": "NLM (1997)", "ST": "T070", "MS": "The accumulation of an electric charge on a object", "PM": "2009; see ELECTROSTATICS (1997-2008)", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055672"}, {"RECTYPE": "D", "MH": "Acrocallosal Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Acrocallosal", "MN": "C16.131.666.034.500", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Corpus Callosum (1963-2008)", "MS": "Autosomal recessive syndrome characterized by hypogenesis or agenesis of CORPUS CALLOSUM. Clinical features include MENTAL RETARDATION; CRANIOFACIAL ABNORMALITIES; digital malformations, and growth retardation.", "PM": "2009", "HN": "2009", "MR": "20120703", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055673"}, {"RECTYPE": "D", "MH": "Viscosupplements", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Supplements, Visco", "MN": "D27.720.944.500", "FX": "Viscosupplementation", "MH_TH": "NLM (2009)", "ST": "T121", "RN": "0", "PI": "Injections, Intra-Articular (1993-2008)", "MS": "Viscoelastic solutions that are injected into JOINTS in order to alleviate symptoms of joint-related disorders such as OSTEOARTHRITIS.", "PM": "2009", "HN": "2009", "MR": "20160120", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055675"}, {"RECTYPE": "D", "MH": "Viscosupplementation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Viscosupplementations", "MN": "E02.718.875", "FX": "Viscosupplements", "MH_TH": "NLM (2009)", "ST": "T061", "PI": "Injections, Intra-Articular (1993-2008)", "MS": "A therapeutic treatment typically involving INTRA-ARTICULAR INJECTIONS of HYALURONIC ACID and related compounds. The procedure is commonly used in the treatment of OSTEOARTHRITIS with the therapeutic goal to restore the viscoelasticity of SYNOVIAL FLUID, decrease pain, improve mobility and restore the natural protective functions of hyaluronan in the joint.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055676"}, {"RECTYPE": "D", "MH": "Refeeding Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Refeeding", "MN": "C18.654.521.687", "MH_TH": "NLM (2009)", "ST": "T047", "MS": "A condition of metabolic imbalance that is caused by complications of initially feeding a severely malnourished patient too aggressively. Usually occurring within the first 5 days of refeeding, this syndrome is characterized by WATER-ELECTROLYTE IMBALANCE; GLUCOSE INTOLERANCE; CARDIAC ARRHYTHMIAS; and DIARRHEA.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055677"}, {"RECTYPE": "D", "MH": "Viscoelastic Substances", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Substances, Viscoelastic", "MN": "D27.720.944", "MH_TH": "NLM (2009)", "ST": "T120", "RN": "0", "MS": "Substances that display the physical properties of ELASTICITY and VISCOSITY. The dual-nature of these substances causes them to resist applied forces in a time-dependent manner.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055682"}, {"RECTYPE": "D", "MH": "Pyricularia grisea", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Magnaporthe grisea|T004|NON|EQV|NLM (2009)|080317|abcdef", "MN": "B01.300.381.723", "MH_TH": "NLM (2009)", "ST": "T004", "RN": "txid148305", "PI": "Magnaporthe (1999-2008)", "MS": "A fungal pathogen of rice worldwide. It causes rice blast which prevents maturation of the rice grains.", "PM": "2009; for MAGNAPORTHE GRISEA see MAGNAPORTHE", "HN": "2009; for MAGNAPORTHE GRISEA was MAGNAPORTHE", "MR": "20200527", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055685"}, {"RECTYPE": "D", "MH": "Metabolic Equivalent", "AQ": "DE GE IM PH RE", "ENTRY": "Metabolic Equivalents", "MN": "G03.680.365", "MH_TH": "NLM (2009)", "ST": "T081", "PI": "Oxygen Consumption (2004-2008)", "MS": "A measurement of OXYGEN uptake in a sitting, resting person (resting oxygen consumption), varying with age, sex, race, and other factors. In normal adult men, one MET is approximately 3.5 ml O2/kg/min of body weight. Oxygen uptake during activities or work can be measured in METs which can be use to determine health status and exercise prescription.", "PM": "2009", "HN": "2009", "MR": "20160630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055686"}, {"RECTYPE": "D", "MH": "Musculoskeletal and Neural Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Musculoskeletal and Neural Physiology|T040|NON|EQV|NLM (2009)|080318|abcdef", "ENTRY": "Musculoskeletal and Neural Physiological Phenomenon|T040|NON|EQV|NLM (2009)|080701|abcdef", "MN": "G11", "RH": "G11 - PHYSIOLOGICAL PHENOMENA-MUSCULOSKELETAL AND NEURAL", "MH_TH": "NLM (2009)", "ST": "T040", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Properties, and processes of the MUSCULOSKELETAL SYSTEM and the NERVOUS SYSTEM or their parts.", "PM": "2009", "HN": "2009", "MR": "20150605", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055687"}, {"RECTYPE": "D", "MH": "Digestive System and Oral Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Digestive System and Oral Physiology|T040|NON|EQV|NLM (2009)|080318|abcdef", "ENTRY": "Digestive System and Oral Physiological Phenomenon|T040|NON|EQV|NLM (2009)|080702|abcdef", "MN": "G10", "RH": "G10 - PHYSIOLOGICAL PHENOMENA-DIGESTIVE AND ORAL", "MH_TH": "NLM (2009)", "ST": "T040", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Properties and processes of the DIGESTIVE SYSTEM and DENTITION as a whole or of any of its parts.", "PM": "2009", "HN": "2009", "MR": "20150605", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055688"}, {"RECTYPE": "D", "MH": "Electronic Prescribing", "AQ": "CL EC HI NU SN ST VE", "ENTRY": "Prescriptions, Electronic", "MN": "N02.421.668.778.750", "FX": "Medical Order Entry Systems", "MH_TH": "NLM (2009)", "ST": "T058", "PI": "Drug Prescriptions (1993-2008)", "MS": "The use of COMPUTER COMMUNICATION NETWORKS to store and transmit medical PRESCRIPTIONS.", "PM": "2009", "HN": "2009", "MR": "20150629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055695"}, {"RECTYPE": "D", "MH": "Olfactory Perception", "AQ": "DE GE IM PH RE", "ENTRY": "Perceptions, Olfactory", "MN": "F02.463.593.485", "MH_TH": "NLM (2009)", "ST": "T041", "AN": "differentiate from SMELL: OLFACTORY PERCEPTION takes place in the brain, SMELL takes place in the nose", "PI": "Smell (1964-2008)", "MS": "The process by which the nature and meaning of olfactory stimuli, such as odors, are recognized and interpreted by the brain.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055696"}, {"RECTYPE": "D", "MH": "Taste Perception", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Gustatory Response|T041|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Taste Perceptions", "MN": "F02.463.593.817", "MH_TH": "NLM (2009)", "ST": "T041", "AN": "differentiate from TASTE: TASTE PERCEPTION takes place in the brain, TASTE takes place in the mouth", "PI": "Taste (1964-2008)", "MS": "The process by which the nature and meaning of gustatory stimuli are recognized and interpreted by the brain. The five basic classes of taste perception are salty, sweet, bitter, sour and umami.", "PM": "2009", "HN": "2009", "MR": "20210512", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055697"}, {"RECTYPE": "D", "MH": "Touch Perception", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Tactile Perception|T041|NON|EQV|NLM (2009)|080320|abcdef", "ENTRY": "Touch Perceptions", "MN": "F02.463.593.894", "MH_TH": "NLM (2009)", "ST": "T041", "AN": "differentiate from TOUCH: TOUCH PERCEPTION takes place in the brain, TOUCH takes place in the skin and mucous membranes", "PI": "Touch (1965-2008)", "MS": "The process by which the nature and meaning of tactile stimuli are recognized and interpreted by the brain, such as realizing the characteristics or name of an object being touched.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055698"}, {"RECTYPE": "D", "MH": "Cemeteries", "AQ": "EC HI LJ SN ST", "ENTRY": "Graveyard", "MN": "J03.150", "MH_TH": "UNK (19XX)", "ST": "T083", "PI": "Mortuary Practice (1965-2008)", "MS": "Areas set apart as burial grounds.", "PM": "2009; see MORTUARY PRACTICE 1966-2008", "HN": "2009; use MORTUARY PRACTICE 1963-2008", "MR": "20160616", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055699"}, {"RECTYPE": "D", "MH": "Cremation", "AQ": "EC ES HI LJ MT SN ST", "PRINT ENTRY": "Cremains|T167|NON|REL|NLM (2009)|080321|abcdef", "ENTRY": "Cremations", "MN": "I01.076.201.450.550.175", "MH_TH": "UNK (19XX)", "ST": "T052", "PI": "Mortuary Practice (1964-2008)", "MS": "Reducing a dead body to ashes by burning, incineration, or chemicals.", "PM": "2009; see MORTUARY PRACTICE 1979-2008", "HN": "2009; use MORTUARY PRACTICE 1979-2008", "MR": "20220711", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055700"}, {"RECTYPE": "D", "MH": "Reproductive Physiological Phenomena", "AQ": "DE GE IM RE", "PRINT ENTRY": "Reproductive Physiological Processes|T042|NON|NRW|NLM (2009)|080327|abcdef", "ENTRY": "Reproductive Physiological Concept", "MN": "G08.686", "MH_TH": "NLM (2009)", "ST": "T042", "AN": "general or unspecified; prefer specifics", "MS": "Physiological processes, factors, properties and characteristics pertaining to REPRODUCTION.", "PM": "2009; for REPRODUCTIVE PHYSIOLOGICAL PROCESSES see REPRODUCTIVE PHYSIOLOGICAL PROCESSES 2009-2016", "HN": "2009", "MR": "20160701", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055703"}, {"RECTYPE": "D", "MH": "Electrophysiological Phenomena", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Electrophysiological Processes|T040|NON|NRW|NLM (2009)|080325|abcdef", "ENTRY": "Processes, Electrophysiological", "MN": "G07.265", "MH_TH": "NLM (2009)", "ST": "T042", "AN": "general or unspecified; prefer specifics", "MS": "The electrical properties, characteristics of living organisms, and the processes of organisms or their parts that are involved in generating and responding to electricity.", "PM": "2009; for ELECTROPHYSIOLOGICAL PROCESSES see ELECTROPHYSIOLOGICAL PROCESSES 2009-2016", "HN": "2009", "MR": "20160928", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055724"}, {"RECTYPE": "D", "MH": "Cabo Verde", "AQ": "EH EP", "PRINT ENTRY": "Cape Verde|T083|NAM|EQV|NLM (1983)|920908|abcdef", "ENTRY": "Republic of Cape Verde|T083|NAM|EQV|NLM (2009)|080325|abcdef", "MN": "Z01.639.040.543", "MH_TH": "NLM (2018)", "ST": "T083", "MS": "A country in western Africa composed of a group of islands in the North Atlantic Ocean, west of Senegal. The capital is Praia.", "HN": "2018; see Cape Verde 2017-2009; see Africa, Western 1983-2008", "MR": "20161216", "DA": "20080708", "DC": "4", "DX": "20090101", "UI": "D055726"}, {"RECTYPE": "D", "MH": "Primary Myelofibrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Primary Myelofibroses", "MN": "C15.378.190.636.765", "MH_TH": "NLM (2009)", "ST": "T047", "PI": "Myelofibrosis (1963-2008)", "MS": "A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.", "PM": "2009; see MYELOID METAPLASIA or MYELOFIBROSIS 1975-2008", "HN": "2009", "MR": "20130708", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055728"}, {"RECTYPE": "D", "MH": "Carbohydrate Biochemistry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Biochemistry, Carbohydrate", "MN": "H01.158.201.085", "MH_TH": "NLM (2008)", "ST": "T091", "MS": "The study of the structure, biosynthesis, and function of CARBOHYDRATES and GLYCOSYLATION.", "PM": "2009; see GLYCOMICS 2008", "HN": "2009; use GLYCOMICS 2008", "MR": "20130709", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055731"}, {"RECTYPE": "D", "MH": "Pulmonary Aspergillosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Bronchopulmonary Aspergillosis|T047|NON|NRW|UNK (19XX)|780519|BRONCHOPULM ASPERG|abcdefv", "ENTRY": "Pulmonary Aspergilloses", "MN": "C08.381.472.850", "MH_TH": "NLM (2009)", "ST": "T047", "PI": "Lung Diseases, Fungal (1963-2008)", "MS": "Infections of the respiratory tract with fungi of the genus ASPERGILLUS.", "PM": "2009; for BRONCHOPULMONARY ASPERGILLOSIS see ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY 1992-2008", "HN": "2009; for BRONCHOPULMONARY ASPERGILLOSIS use ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY 1992-2008", "MR": "20190617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055732"}, {"RECTYPE": "D", "MH": "Invasive Pulmonary Aspergillosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Chronic Necrotizing Pulmonary Aspergillosis|T047|NON|NRW|NLM (2009)|080402|abcdef", "ENTRY": "Pulmonary Aspergillosis, Invasive", "MN": "C08.381.472.850.750", "MH_TH": "NLM (2009)", "ST": "T047", "PI": "Lung Diseases, Fungal (1977-2008)", "MS": "Lung infections with the invasive forms of ASPERGILLUS, usually after surgery, transplantation, prolonged NEUTROPENIA or treatment with high-doses of CORTICOSTEROIDS. Invasive pulmonary aspergillosis can progress to CHRONIC NECROTIZING PULMONARY ASPERGILLOSIS or hematogenous spread to other organs.", "PM": "2009", "HN": "2009", "MR": "20190617", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055744"}, {"RECTYPE": "D", "MH": "Bronchioles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Terminal Bronchiole", "MN": "A04.411.125.500", "MH_TH": "UNK (19XX)", "ST": "T023", "PI": "Bronchi (1963-2008)", "MS": "The small airways branching off the TERTIARY BRONCHI. Terminal bronchioles lead into several orders of respiratory bronchioles which in turn lead into alveolar ducts and then into PULMONARY ALVEOLI.", "PM": "2009; see BRONCHI 1984-2008", "HN": "2009; use BRONCHI 1984-2008", "MR": "20160601", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055745"}, {"RECTYPE": "D", "MH": "Stage-Specific Embryonic Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Stage Specific Embryonic Antigens", "MN": "D23.101.100.965", "MH_TH": "NLM (2009)", "ST": "T129", "RN": "0", "MS": "Cell-surface molecules that exhibit lineage-restricted patterns of expression during EMBRYONIC DEVELOPMENT. The antigens are useful markers in the identification of EMBRYONIC STEM CELLS.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055746"}, {"RECTYPE": "D", "MH": "SOX Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, SOX", "MN": "D12.776.930.823", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "AN": "do not confuse entry term SRY (SEX DETERMINING REGION Y)-BOX PROTEINS with SRY SEX-DETERMINING REGION PROTEIN see SEX-DETERMINING REGION Y PROTEIN", "PI": "Transcription Factors (1992-2008)", "MS": "A large family of structurally-related transcription factors that were originally discovered based upon their close sequence homology to an HMG-box domain found in SEX-DETERMINING REGION Y PROTEIN. Many SOX transcription factors play important roles in regulating CELL DIFFERENTIATION. The numerous members of this family are organized in several subgroups according to structural identities found within the proteins.", "PM": "2009", "HN": "2009", "MR": "20090721", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055747"}, {"RECTYPE": "D", "MH": "SOXB1 Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, SOXB1", "MN": "D12.776.930.823.100", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "High Mobility Group Proteins (1993-2008)", "MS": "A subclass of SOX transcription factors that are expressed in neuronal tissue where they may play a role in the regulation of CELL DIFFERENTIATION. Members of this subclass are generally considered to be transcriptional activators.", "PM": "2009; SOX-2 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS, TRANSCRIPTION FACTORS, & HMGB PROTEINS 2006-2008, and under NUCLEAR PROTEIN 1995-2005; SOX3 PROTEIN (now SOX3 TRANSCRIPTION FACTOR) was indexed under DNA-DINDING PROTEINS, HIGH MOBILITY GROUP PROTEINS, & TRANSCRIPTION FACTORS 1994-2008", "HN": "2009(1994)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055748"}, {"RECTYPE": "D", "MH": "SOXB2 Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, SOXB2", "MN": "D12.776.930.823.200", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (2004-2008)", "MS": "A subclass of SOX transcription factors that are expressed in neuronal tissue where they may play a role in the regulation of CELL DIFFERENTIATION. Members of this subclass are generally considered to be transcriptional repressors.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055749"}, {"RECTYPE": "D", "MH": "Phytophthora infestans", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "infestans, Phytophthora", "MN": "B01.750.580.715.600", "MH_TH": "NLM (2009)", "ST": "T204", "RN": "txid4787", "PI": "Phytophthora (1978-2008)", "MS": "A species of parasitic OOMYCETES in the family Peronosporaceae that is the causative agent of late blight of potato.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055750"}, {"RECTYPE": "D", "MH": "SOXC Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, SOXC", "MN": "D12.776.930.823.300", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "High Mobility Group Proteins (1996-2008)", "MS": "A subclass of closely-related SOX transcription factors. Members of the group have been found expressed in developing neuronal tissue, LYMPHOCYTES, and during EMBRYONIC DEVELOPMENT.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055751"}, {"RECTYPE": "D", "MH": "Small Cell Lung Carcinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Oat Cell Carcinoma of Lung|T191|NON|EQV|NLM (2009)|080407|abcdef", "ENTRY": "Small Cell Lung Cancer|T191|NON|EQV|NLM (1994)|930330|abcdef", "MN": "C08.785.520.100.220.750", "MH_TH": "NLM (2009)", "ST": "T191", "AN": "coordinate IM with LUNG NEOPLASMS (IM); CARCINOMA, NON-SMALL-CELL LUNG and CARCINOMA, SMALL CELL are also available", "PI": "Carcinoma, Small Cell (1975-2008)", "MS": "A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA).", "PM": "2009; see CARCINOMA, SMALL CELL 1994-2008", "HN": "2009; use CARCINOMA, SMALL CELL 1994-2008", "MR": "20120703", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055752"}, {"RECTYPE": "D", "MH": "SOXD Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, SOXD", "MN": "D12.776.930.823.400", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "High Mobility Group Proteins (2004-2008)", "MS": "A subclass of closely-related SOX transcription factors. In addition to a conserved HMG-BOX DOMAIN, members of this group contain a leucine zipper motif which mediates protein DIMERIZATION.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055755"}, {"RECTYPE": "D", "MH": "Meningeal Carcinomatosis", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Carcinomatous Meningitis|T047|NON|EQV|NLM (2009)|080408|abcdef", "ENTRY": "Meningitis, Carcinomatous", "MN": "C10.551.240.500.150", "FX": "Meningitis", "MH_TH": "NLM (2009)", "ST": "T047", "PI": "Meningitis (1966-2008)", "MS": "Primary or secondary neoplasm in the ARACHNOID or SUBARACHNOID SPACE. It appears as a diffuse fibrotic thickening of the MENINGES associated with variable degrees of inflammation.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055756"}, {"RECTYPE": "D", "MH": "SOXE Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, SOXE", "MN": "D12.776.930.823.500", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1995-2008)", "MS": "A subclass of closely-related SOX transcription factors. Members of this subfamily have been implicated in regulating the differentiation of OLIGODENDROCYTES during neural crest formation and in CHONDROGENESIS.", "PM": "2009; SOX10 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS, HIGH MOBILITY GROUP PROTEINS, & TRANSCRIPTION FACTORS 1998-2008", "HN": "2009(1998)", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055757"}, {"RECTYPE": "D", "MH": "SOX9 Transcription Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, SOX9", "MN": "D12.776.930.823.500.500", "FX": "Pierre Robin Syndrome", "EC": "deficiency:Campomelic Dysplasia", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A SOXE transcription factor that plays a critical role in regulating CHONDROGENESIS; OSTEOGENESIS; and male sex determination. Loss of function of the SOX9 transcription factor due to genetic mutations is a cause of CAMPOMELIC DYSPLASIA.", "PM": "2009; SOX9 TRANSCRIPTION FACTOR was indexed under HIGH MOBILITY GROUP PROTEINS & TRANSCRIPTION FACTORS 1995-2008", "HN": "2009(1995)", "MR": "20140613", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055758"}, {"RECTYPE": "D", "MH": "SOXF Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, SOXF", "MN": "D12.776.930.823.600", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1997-2008)", "MS": "A subclass of closely-related SOX transcription factors. Members of this subclass are expressed in VASCULAR ENDOTHELIAL CELLS and may play a role in vasculogenesis.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055760"}, {"RECTYPE": "D", "MH": "Reticuloendotheliosis, Avian", "AQ": "BL CF CI CL CN DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Avian Reticuloendotheliosis|T047|NON|EQV|NLM (2009)|080409|abcdef", "ENTRY": "Reticuloendothelioses, Avian", "MN": "C22.131.780", "MH_TH": "NLM (2009)", "ST": "T047", "AN": "RETICULOENDOTHELIOSIS, LEUKEMIC see LEUKEMIA, HAIRY CELL is also available", "PI": "Lymphatic Diseases (1966-2008)", "MS": "A group of pathologic syndromes found in avian species caused by RETICULOENDOTHELIOSIS VIRUS. The distinct syndromes include non-neoplastic runting, acute neoplastic disease, and chronic neoplastic disease. Humans and mammals appear resistant.", "PM": "2009", "HN": "2009", "MR": "20190617", "DA": "20080709", "DC": "1", "DX": "20090101", "UI": "D055761"}, {"RECTYPE": "D", "MH": "Cranial Fontanelles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sphenoidal Fontanels", "MN": "A02.835.232.781.175", "MH_TH": "NLM (2009)", "ST": "T030", "PI": "Skull (1963-2008)", "MS": "Any of six membrane-covered openings between the CRANIAL SUTURES in the incompletely ossified skull of the fetus or newborn infant. The fontanelles normally close sometime after birth.", "PM": "2009", "HN": "2009", "MR": "20180629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055762"}, {"RECTYPE": "D", "MH": "Myxozoa", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Myxozoas", "MN": "B01.050.500.308.550", "MH_TH": "NLM (2009)", "ST": "T204", "RN": "txid35581", "RR": "txid519426", "AN": "infection: coordinate IM with PARASITIC DISEASES, ANIMAL (IM) or PARASITIC DISEASES if in humans", "PI": "Protozoa (1982-2008)", "MS": "Single-celled, aquatic endoparasitic worms that are currently considered belonging to the phylum CNIDARIA. They have a complex life cycle and parasitize a wide range of hosts including FISHES; ANNELIDA; and BRYOZOA.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055764"}, {"RECTYPE": "D", "MH": "Shc Signaling Adaptor Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Adaptor Proteins, Shc", "MN": "D12.776.476.024.424", "MH_TH": "NLM (2009)", "ST": "T123", "RN": "0", "MS": "A family of signaling adaptor proteins that contain SRC HOMOLOGY DOMAINS. Many members of this family are involved in transmitting signals from CELL SURFACE RECEPTORS to MITOGEN-ACTIVATED PROTEIN KINASES.", "HN": "2009(1993)", "MR": "20160415", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055765"}, {"RECTYPE": "D", "MH": "Myxobolus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Myxobolus Cerebrali", "MN": "B01.050.500.308.550.500", "MH_TH": "NLM (2009)", "ST": "T204", "RN": "txid35588", "RR": "txid59783", "AN": "infection: coordinate IM with PARASITIC DISEASES, ANIMAL (IM) or PARASITIC DISEASES if in humans", "PI": "Protozoa (1970-2008)", "MS": "The largest genus in the family Myxobolidae, class MYXOSPOREA, containing over 400 species.", "PM": "2009", "HN": "2009", "MR": "20200813", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055766"}, {"RECTYPE": "D", "MH": "Immobilized Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Immobilized", "MN": "D12.776.463", "MH_TH": "NLM (2009)", "ST": "T120", "RN": "0", "MS": "Proteins that are chemically bound to a substrate material which renders their location fixed. The immobilization of proteins allows their use in chemical reactions without being diluted by solvent.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055767"}, {"RECTYPE": "D", "MH": "Halogenated Diphenyl Ethers", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ethers, Polybrominated Diphenyl", "MN": "D02.455.426.559.389.657.654.601", "MH_TH": "NLM (2009)", "ST": "T109", "RN": "0", "PI": "Phenyl Ethers (1974-2008)", "MS": "Compounds that contain two halogenated benzene rings linked via an OXYGEN atom. Many polybrominated diphenyl ethers are used as FLAME RETARDANTS.", "PM": "2009", "HN": "2009", "MR": "20120703", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055768"}, {"RECTYPE": "D", "MH": "Interpleural Analgesia", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Intrapleural Analgesia|T061|NON|EQV|NLM (2009)|080415|abcdef", "ENTRY": "Interpleural Analgesias", "MN": "E03.091.430", "MH_TH": "NLM (2009)", "ST": "T061", "PI": "Analgesia (1988-2008)", "MS": "Injection of ANALGESICS; LOCAL ANESTHETICS; or NARCOTICS into the PLEURAL CAVITY between the two pleural membranes.", "PM": "2009", "HN": "2009", "MR": "20090721", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055770"}, {"RECTYPE": "D", "MH": "Serbia", "AQ": "EH EP", "MN": "Z01.542.248.786", "MH_TH": "NLM (1994)", "ST": "T083", "MS": "A republic located south of HUNGARY, west of ROMANIA and BULGARIA, and part of the former YUGOSLAVIA. The capital is Belgrade.", "MR": "20130709", "DA": "20080708", "DC": "4", "DX": "20090101", "UI": "D055771"}, {"RECTYPE": "D", "MH": "Green Chemistry Technology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Technology, Sustainable Chemistry", "MN": "J01.897.360", "MH_TH": "NLM (2009)", "ST": "T057", "MS": "Pollution prevention through the design of effective chemical products that have low or no toxicity and use of chemical processes that reduce or eliminate the use and generation of hazardous substances.", "PM": "2009", "HN": "2009", "MR": "20200708", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055772"}, {"RECTYPE": "D", "MH": "Gene Knockdown Techniques", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Gene Knock Down Techniques|T063|NON|EQV|NLM (2009)|080417|abcdef", "ENTRY": "Techniques, Gene Knockdown", "MN": "E05.393.335.500", "MH_TH": "NLM (2009)", "ST": "T063", "AN": "GENE KNOCK-IN TECHNIQUES and GENE KNOCKOUT TECHNIQUES are also available", "MS": "The artificial induction of GENE SILENCING by the use of RNA INTERFERENCE to reduce the expression of a specific gene. It includes the use of DOUBLE-STRANDED RNA, such as SMALL INTERFERING RNA and RNA containing HAIRPIN LOOP SEQUENCE, and ANTI-SENSE OLIGONUCLEOTIDES.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055785"}, {"RECTYPE": "D", "MH": "Gene Knockout Techniques", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Gene Knock-Out Techniques|T063|NON|EQV|NLM (2009)|080417|abcdef", "ENTRY": "Techniques, Gene Knockout", "MN": "E05.393.335.750", "FX": "Mice, Knockout", "MH_TH": "NLM (2009)", "ST": "T063", "AN": "GENE KNOCKDOWN TECHNIQUES and GENE KNOCK-IN TECHNIQUES are also available", "MS": "Techniques to alter a gene sequence that result in an inactivated gene, or one in which the expression can be inactivated at a chosen time during development to study the loss of function of a gene.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055786"}, {"RECTYPE": "D", "MH": "Prussia", "AQ": "EH EP", "MN": "Z01.586.772", "MH_TH": "NLM (2009)", "ST": "T083", "MS": "Former state in north central Germany. Formally abolished March 1, 1947. Kingdom established 1701.", "HN": "2009", "MR": "20161221", "DA": "20080708", "DC": "4", "DX": "20090101", "UI": "D055787"}, {"RECTYPE": "D", "MH": "Moving and Lifting Patients", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Patient Moving and Lifting|T057|NON|EQV|NLM (2009)|080423|abcdef", "ENTRY": "Repositionings, Patient", "MN": "N02.421.585.525", "FX": "Transportation of Patients", "MH_TH": "NLM (2009)", "ST": "T057", "AN": "do not confuse with PATIENT TRANSFER (interfacility or intrahospital transfer for administrative reasons with regard to special care or economics) or with TRANSPORTATION OF PATIENTS or with PATIENT POSITIONING", "MS": "Moving or repositioning patients within their beds, from bed to bed, bed to chair, or otherwise from one posture or surface to another.", "PM": "2009", "HN": "2009", "MR": "20150629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055805"}, {"RECTYPE": "D", "MH": "Microvessels", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Microvasculature|T023|NON|REL|NLM (2009)|071128|abcdef", "ENTRY": "Networks, Microvascular", "MN": "A07.015.461", "MH_TH": "NLM (2009)", "ST": "T023", "PI": "Microcirculation (1969-2008)", "MS": "The finer blood vessels of the vasculature that are generally less than 100 microns in internal diameter.", "PM": "2009", "HN": "2009", "MR": "20180701", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055806"}, {"RECTYPE": "D", "MH": "Stalking", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Stalkings", "MN": "I01.880.735.223.500", "MH_TH": "NLM (2009)", "ST": "T055", "MS": "Course of conduct directed at a specific person that involves repeated (two or more occasions) visual or physical proximity, nonconsensual communication, or verbal, written, or implied threats, or a combination thereof, that would cause a reasonable person fear.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055807"}, {"RECTYPE": "D", "MH": "Drug Discovery", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Prospecting, Drug", "MN": "E05.290.563", "MH_TH": "NLM (2009)", "ST": "T062", "AN": "do not confuse with DRUG DEVELOPMENT which is the process of bringing a new drug to the market", "PI": "Drug Evaluation, Preclinical (1979-2008)", "MS": "The process of finding chemicals for potential therapeutic use.", "PM": "2009; for DRUG PROSPECTING see DRUG EVALUATION, PRECLINICAL 2000-2009", "HN": "2009; for DRUG PROSPECTING use DRUG EVALUATION, PRECLINICAL 2000-2009", "MR": "20220523", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055808"}, {"RECTYPE": "D", "MH": "Illness Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Sickness Behaviors", "MN": "F01.145.499", "FX": "Sick Role", "MH_TH": "UNK (19XX)", "ST": "T053", "PI": "Sick Role (1975-2008)", "MS": "Coordinate set of non-specific behavioral responses to non-psychiatric illness. These may include loss of APPETITE or LIBIDO; disinterest in ACTIVITIES OF DAILY LIVING; or withdrawal from social interaction.", "PM": "2009; see Sick Role 1975-2008", "HN": "2009; use Sick Role 1975-2008", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055809"}, {"RECTYPE": "D", "MH": "Lot Quality Assurance Sampling", "AQ": "CL EC ES HI LJ MT SD SN ST TD", "ENTRY": "LQAS|T062|ACR|EQV|NLM (2009)|080427|abcdef", "MN": "N06.850.520.308.461", "MH_TH": "NLM (2009)", "ST": "T062", "MS": "A sampling methodology using small sample sizes when conducting surveys in small geographical or population-based areas or lots.", "PM": "2009", "HN": "2009", "MR": "20180630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055810"}, {"RECTYPE": "D", "MH": "Journal Impact Factor", "AQ": "HI", "ENTRY": "Journal Impact Factors", "MN": "L01.462.750.183.291.500", "MH_TH": "NLM (2009)", "ST": "T062", "PI": "Bibliometrics (1989-2008)", "MS": "A quantitative measure of the frequency on average with which articles in a journal have been cited in a given period of time.", "PM": "2009", "HN": "2009", "MR": "20220712", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055811"}, {"RECTYPE": "D", "MH": "Community-Based Participatory Research", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Researchs, Consumer-Driven Community-Based", "MN": "N05.425.104", "MH_TH": "NLM (2009)", "ST": "T062", "PI": "Cooperative Behavior (1997-2008)", "MS": "Collaborative process of research involving researchers and community representatives.", "PM": "2009", "HN": "2009", "MR": "20180629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055812"}, {"RECTYPE": "D", "MH": "Wilderness Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Wilderness", "MN": "H02.403.959", "MH_TH": "NLM (2009)", "ST": "T091", "MS": "Skills and knowledge required for assessment and treatment of traumatic, environmental, and medical emergencies in remote geographic or wilderness environments.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055813"}, {"RECTYPE": "D", "MH": "Wilderness", "MN": "G16.500.275.965", "MH_TH": "NLM (2009)", "ST": "T082", "MS": "Environment un-modified by human activity. Areas in which natural processes operate without human interference.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055814"}, {"RECTYPE": "D", "MH": "Young Adult", "AQ": "PH PX SN", "ENTRY": "Young Adults", "MN": "M01.060.116.815", "MH_TH": "NLM (2009)", "ST": "T100", "AN": "age 19-24; IM only as social, political, psychological entity; NIM as check tag", "MS": "A person between 19 and 24 years of age.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055815"}, {"RECTYPE": "D", "MH": "Wandering Behavior", "AQ": "CL EC ED ES HI IN LJ PH PX SN ST TD", "ENTRY": "Behavior, Wandering", "MN": "F01.145.126.995", "MH_TH": "NLM (2009)", "ST": "T048", "MS": "Moving oneself through space while confused or otherwise cognitively impaired. Patterns include akathisia, exhibiting neuroleptic-induced pacing and restlessness; exit seekers who are often newly admitted institution residents who try to open locked exit doors; self-stimulators who perform other activities such as turning doorknobs, in addition to continuous pacing; and modelers who shadow other pacers.", "PM": "2009", "HN": "2009", "MR": "20230405", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055816"}, {"RECTYPE": "D", "MH": "Telenursing", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "N04.590.374.800.575", "MH_TH": "NLM (2009)", "ST": "T058", "MS": "Delivery of nursing services via remote telecommunications.", "PM": "2009", "HN": "2009", "MR": "20211202", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055817"}, {"RECTYPE": "D", "MH": "Public-Private Sector Partnerships", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Public-Private Sector Partnership|T064|T092|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Public-Private Sector Cooperations", "MN": "N03.540.706", "MH_TH": "NLM (2009)", "ST": "T092", "MS": "An organizational enterprise between a public sector agency (federal, state or local) and a private sector entity. Skills and assets of each sector are shared to deliver a service or facility for the benefit or use of the general public.", "PM": "2009", "HN": "2009", "MR": "20210630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055818"}, {"RECTYPE": "D", "MH": "Hospitals, Isolation", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Station, Quarantine", "MN": "N02.278.421.556.330", "MH_TH": "NLM (2009)", "ST": "T093", "AN": "coordinate with hospital ownership term (e.g., HOSPITALS, COUNTY); specify geographic location if pertinent", "PI": "Hospitals, Special (1966-2008)", "MS": "Hospitals designed or used to isolate or quarantine persons with communicable diseases.", "PM": "2009", "HN": "2009", "MR": "20130709", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055819"}, {"RECTYPE": "D", "MH": "New Orleans", "AQ": "EH EP", "MN": "Z01.433.697", "MH_TH": "NLM (2009)", "ST": "T083", "MS": "City in Orleans Parish (county), largest city in state of LOUISIANA. It is located between the Mississippi River and Lake Pontchartrain.", "HN": "2009", "DA": "20080708", "DC": "4", "DX": "20090101", "UI": "D055820"}, {"RECTYPE": "D", "MH": "Poetry", "MN": "V02.712", "MH_TH": "NLM (2009)", "ST": "T170", "AN": "This heading is used as a Publication Type. Poetry as a subject is indexed under the main heading POETRY AS TOPIC. INDEXER: Do not use", "MS": "Works that consist of literary and oral genre expressing meaning via symbolism and following formal or informal patterns.", "HN": "2009", "MR": "20150605", "DA": "20080708", "DC": "2", "DX": "20090101", "UI": "D055821"}, {"RECTYPE": "D", "MH": "Cookbook", "PRINT ENTRY": "Recipe|T170|NON|REL|NLM (2021)|200317|abcdef", "ENTRY": "Recipes|T170|NON|REL|NLM (2009)|080630|abcdef", "MN": "V02.272", "MH_TH": "NLM (2009)", "ST": "T170", "AN": "This heading is used as a Publication Type. Cookbooks as a subject are indexed under the main heading COOKBOOKS AS TOPIC. INDEXER: Do not use", "MS": "Collection of recipes or instructions for preparation of food and organization of meals.", "HN": "2009", "MR": "20200527", "DA": "20080708", "DC": "2", "DX": "20090101", "UI": "D055823"}, {"RECTYPE": "D", "MH": "Formulary", "PRINT ENTRY": "Formularies|T170|NON|EQV|NLM (2009)|080429|abcdef", "ENTRY": "Preferred Drug List|T170|NON|NRW|NLM (2015)|140515|abcdef", "MN": "V02.480", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Formularies as a subject are indexed under the main heading FORMULARIES AS TOPIC. INDEXER: Do not use", "MS": "Work that consists of lists of drugs or collections of recipes, formulas, and prescriptions for the compounding of medicinal preparations.", "HN": "2009", "MR": "20180702", "DA": "20080708", "DC": "2", "DX": "20090101", "UI": "D055824"}, {"RECTYPE": "D", "MH": "National Institute of Neurological Disorders and Stroke (U.S.)", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "National Institute of Neurological Disorders and Stroke|T093|NON|EQV|NLM (2009)|080429|abcdef", "ENTRY": "NINDS|T093|ACR|EQV|NLM (2009)|080429|abcdef", "MN": "N03.540.348.500.500.600.650.496.461", "MH_TH": "NLM (2009)", "ST": "T093", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, N.I.H., EXTRAMURAL or RESEARCH SUPPORT, N.I.H., INTRAMURAL; CATALOGER: Use NAF entry", "MS": "Component of the NATIONAL INSTITUTES OF HEALTH. It supports and conducts research, both basic and clinical, on the normal and diseases nervous system. It was established in 1950.", "PM": "2018; see NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE 2009-2018", "HN": "2018(2009)", "MR": "20180612", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055825"}, {"RECTYPE": "D", "MH": "Afghan Campaign 2001-", "ENTRY": "Wars, 2001- Afghan", "MN": "K01.400.504.984.124", "MH_TH": "NLM (2009)", "ST": "T078", "MS": "Multinational coalition military operation initiated in October 2001 to counter terrorism and bring security to AFGHANISTAN in collaboration with Afghan forces.", "PM": "2009", "HN": "2009", "MR": "20150629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055826"}, {"RECTYPE": "D", "MH": "Integumentary System Physiological Phenomena", "AQ": "DE GE IM PH RE", "ENTRY": "Physiology, Integumentary System", "MN": "G13", "RH": "G13 - INTEGUMENTARY SYSTEM PHYSIOLOGICAL PHENOMENA", "MH_TH": "NLM (2009)", "ST": "T040", "AN": "general or unspecified; prefer specifics", "MS": "The properties and relationships and biological processes that characterize the nature and function of the SKIN and its appendages.", "PM": "2009", "HN": "2009", "MR": "20160928", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055827"}, {"RECTYPE": "D", "MH": "Lynch Syndrome II", "AQ": "BL BS CF CH CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Lynch cancer family syndrome 2|T191|NON|EQV|GHR (2014)|ORD (2010)|090224|abcdeef", "MN": "C16.320.700.250.500", "MH_TH": "OMIM (2013)", "ST": "T191", "PI": "Colorectal Neoplasms, Hereditary Nonpolyposis (1986-2008)", "MS": "Hereditary nonpolyposis colorectal neoplasms associated with other malignancies, more commonly of ovarian or uterine origin. When also associated with SEBACEOUS GLAND NEOPLASMS, it is called MUIR-TORRE SYNDROME.", "PM": "2009; see COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS 1992-2008", "HN": "2009; use COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS 1992-2008", "MR": "20130708", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055847"}, {"RECTYPE": "D", "MH": "Nuclear Power Plants", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Power Plants, Nuclear", "MN": "J03.540.680.600", "MH_TH": "NLM (1995)", "ST": "T073", "PI": "Power Plants (1978-2008)", "MS": "Facilities that convert NUCLEAR ENERGY into electrical energy.", "PM": "2009; see POWER PLANTS 1995-2008", "HN": "2009; use POWER PLANTS 1995-2008", "MR": "20160608", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055848"}, {"RECTYPE": "D", "MH": "Droughts", "AQ": "CL EC HI MO PC SN", "PRINT ENTRY": "Drought|T070|NON|EQV|NLM (1988)|890227|abcdef", "MN": "N06.230.100.230.150", "FX": "Drought Resistance", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "coordinate with DISASTERS if pertinent; specify geographic location", "PI": "Disasters (1974-2008)", "MS": "Prolonged dry periods in natural climate cycle. They are slow-onset phenomena caused by rainfall deficit combined with other predisposing factors.", "PM": "2009; see NATURAL DISASTERS 1990-2008", "HN": "2009; use DISASTERS 1990-2008", "MR": "20211128", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055864"}, {"RECTYPE": "D", "MH": "Sleep Phase Chronotherapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sleep Phase Chronotherapies", "MN": "F04.754.137.875", "MH_TH": "NLM (2009)", "ST": "T061", "MS": "A progressive advance or delay of bedtime until the desired bedtime is achieved.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055865"}, {"RECTYPE": "D", "MH": "Earthquakes", "AQ": "CL EC HI MO PC SN", "ENTRY": "Earthquake", "MN": "N06.230.100.230.200", "MH_TH": "UNK (19XX)", "ST": "T070", "AN": "coordinate with DISASTERS if pertinent; specify geographic location", "PI": "Disasters (1972-2008)", "MS": "Sudden slips on a geological fault, and the resulting ground shaking and radiated seismic energy caused by the slips, or by volcanic or magmatic activity, or other sudden stress changes in the earth. Faults are fractures along which the blocks of EARTH crust on either side have moved relative to one another parallel to the fracture.", "PM": "2009; see NATURAL DISASTERS 1976-2008", "HN": "2009; use DISASTERS 1976-2008", "MR": "20180630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055866"}, {"RECTYPE": "D", "MH": "Cyclonic Storms", "AQ": "CL EC HI MO PC SN", "PRINT ENTRY": "Cyclones|T070|NON|EQV|NLM (2009)|080526|abcdef", "ENTRY": "Tropical Storms", "MN": "N06.230.100.230.100", "MH_TH": "NLM (2010)", "ST": "T070", "AN": "coordinate with DISASTERS if pertinent; specify geographic location", "MS": "Non-frontal low-pressure systems over tropical or sub-tropical waters with organized convection and definite pattern of surface wind circulation.", "PM": "2010; see CYCLONES 2009", "HN": "2010 (2009)", "MR": "20180630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055867"}, {"RECTYPE": "D", "MH": "Floods", "AQ": "CL EC HI MO PC SN", "PRINT ENTRY": "Flooding, Catastrophic|T070|NON|NRW|NLM (2010)|080811|abcdef", "ENTRY": "Floodings, Catastrophic", "MN": "N06.230.100.230.250", "MH_TH": "UNK (19XX)", "ST": "T070", "AN": "coordinate with DISASTERS if pertinent; specify geographic location", "PI": "Disasters (1972-2008)", "MS": "Sudden onset water phenomena with different speed of occurrence. These include flash floods, seasonal river floods, and coastal floods, associated with CYCLONIC STORMS; TIDALWAVES; and storm surges.", "PM": "2009; see NATURAL DISASTERS 1982-2008", "HN": "2009; use DISASTERS 1982-2008", "MR": "20180630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055868"}, {"RECTYPE": "D", "MH": "Tornadoes", "AQ": "CL EC HI MO PC SN", "ENTRY": "Tornados", "MN": "N06.230.100.230.850", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "coordinate with DISASTERS if pertinent; specify geographic location", "PI": "Disasters (1972-2008)", "MS": "Rotating column of air extending from a thunderstorm to the ground. Tornadoes generally produce damage paths of 100 yards wide or less, with path lengths of a couple miles.", "PM": "2009; see NATURAL DISASTERS 1990-2008", "HN": "2009; use DISASTERS 1990-2008", "MR": "20180630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055869"}, {"RECTYPE": "D", "MH": "Drug Chronotherapy", "AQ": "VE", "ENTRY": "Drug Chronotherapies", "MN": "E02.319.283.400", "FX": "Administration, Metronomic", "MH_TH": "NLM (2009)", "ST": "T061", "AN": "coordinate with specific drug with probably / admin (IM) but do not coordinate with DRUG ADMINISTRATION SCHEDULE or CIRCADIAN RHYTHM", "PI": "Chronotherapy (1996-2008)", "MS": "The adaptation of drug administration to the known variations in biological RHYTHMICITY, such as CIRCADIAN RHYTHMS. The treatment is aimed at supporting normal rhythms, or modifying the timing of therapy to achieve maximal efficacy and minimal adverse effect.", "PM": "2009", "HN": "2009", "MR": "20110624", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055870"}, {"RECTYPE": "D", "MH": "Tidal Waves", "AQ": "CL EC HI MO PC SN", "ENTRY": "Waves, Tidal", "MN": "N06.230.132.644.750.500", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "coordinate with DISASTERS if pertinent; specify geographic location", "MS": "Water waves caused by the gravitational interactions between the EARTH; MOON; and SUN.", "PM": "2009", "HN": "2009", "MR": "20180630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055871"}, {"RECTYPE": "D", "MH": "Surge Capacity", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Surge Capacities", "MN": "N05.300.450.760", "MH_TH": "NLM (2009)", "ST": "T078", "AN": "note category: restrict to health care", "MS": "A health care system's ability to rapidly mobilize to meet an increased demand, to rapidly expand beyond normal services levels to meet the increased demand in the event of large-scale DISASTERS or public health emergencies.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055872"}, {"RECTYPE": "D", "MH": "Extreme Cold", "AQ": "AE", "PRINT ENTRY": "Extreme Cold Weather|T070|NON|EQV|NLM (2020)|190507|abcdef", "ENTRY": "Weather, Extreme Cold", "MN": "N06.230.300.100.725.710.300.500", "MH_TH": "NLM (2009)", "ST": "T070", "PI": "Cold (1966-2008)", "MS": "Below normal weather temperatures that may lead to serious health problems. Extreme cold is a dangerous situation that can bring on health emergencies in susceptible people.", "PM": "2009", "HN": "2009", "MR": "20230526", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055873"}, {"RECTYPE": "D", "MH": "Extreme Heat", "AQ": "AE", "PRINT ENTRY": "Extreme Hot Weather|T070|NON|EQV|NLM (2024)|230516|abcdef", "ENTRY": "Hot Weather, Extreme", "MN": "N06.230.300.100.725.710.380.500", "MH_TH": "NLM (2009)", "ST": "T070", "PI": "Heat (1966-2008)", "MS": "High temperature weather exceeding the average and of several days' duration. Extreme heat is a dangerous situation that can bring on health emergencies in susceptible people.", "PM": "2009; for EXTREME HOT WEATHER see EXTREME HOT WEATHER 2020-2023", "HN": "2009", "MR": "20230526", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055874"}, {"RECTYPE": "D", "MH": "Avalanches", "AQ": "CL EC HI MO PC SN", "PRINT ENTRY": "Avalanche|T070|NON|EQV|NLM (2009)|080514|abcdef", "MN": "N06.230.100.230.050", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "coordinate with DISASTERS if pertinent; specify geographic location", "PI": "Snow (1966-2008)", "MS": "Mass of snow and/or ice falling down a mountain or incline.", "PM": "2009", "HN": "2009", "MR": "20180630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055875"}, {"RECTYPE": "D", "MH": "Landslides", "AQ": "CL EC HI MO PC SN", "ENTRY": "Rockslide", "MN": "N06.230.100.230.625", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "coordinate with DISASTERS if pertinent; specify geographic location", "PI": "Disasters (1972-2008)", "MS": "Downslope movements of soil and and/or rock resulting from natural phenomena or man made actions. These can be secondary effects of severe storms, VOLCANIC ERUPTIONS and EARTHQUAKES.", "PM": "2009", "HN": "2009", "MR": "20180630", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055876"}, {"RECTYPE": "D", "MH": "Biosurveillance", "AQ": "LJ MT", "ENTRY": "Biosurveillances", "MN": "N06.850.780.675.324", "MH_TH": "NLM (2009)", "ST": "T058", "PI": "Population Surveillance (2002-2008)", "MS": "Monitoring of information sources of potential value in detecting an emerging epidemic, whether naturally occurring or the result of bioterrorism.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055877"}, {"RECTYPE": "D", "MH": "Gene Knock-In Techniques", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Techniques, Gene Knock-In", "MN": "E05.393.335.249", "MH_TH": "NLM (2009)", "ST": "T063", "AN": "GENE KNOCKDOWN TECHNIQUES and GENE KNOCKOUT TECHNIQUES are also available", "MS": "Techniques used to add in exogenous gene sequence such as mutated genes; REPORTER GENES, to study mechanisms of gene expression; or regulatory control sequences, to study effects of temporal changes to GENE EXPRESSION.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055879"}, {"RECTYPE": "D", "MH": "Chronobiology Discipline", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Disciplines, Chronobiology", "MN": "H01.158.580", "FX": "Sleep Phase Chronotherapy", "MH_TH": "NLM (2009)", "ST": "T091", "AN": "the discipline (education, history, etc) only; use CHRONOBIOLOGY PHENOMENA or specifics treed under it for characteristics and processes of biological systems as affected by time", "PI": "Chronobiology Phenomena (1985-2008)", "MS": "A multidisciplinary field of research and practice studying the periodicity of biological systems and the application of principles of chronobiology to various therapeutic strategies. Aging, biological rhythms, and cyclic phenomena are included. Statistical, computer-aided mathematical procedures are used to describe, in mathematical terminology, various biological functions over time.", "PM": "2009", "HN": "2009", "MR": "20081130", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055881"}, {"RECTYPE": "D", "MH": "Nevus, Halo", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Halo Nevus", "MN": "C04.557.665.560.580", "MH_TH": "NLM (1994)", "ST": "T191", "MS": "A benign skin lesion characterized by a zone of depigmentation surrounding the nevus.", "PM": "2009; see NEVUS, PIGMENTED 1994-2008", "HN": "2009; use NEVUS, PIGMENTED 1994-2008", "MR": "20120703", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055882"}, {"RECTYPE": "D", "MH": "Structure Collapse", "AQ": "CL EC HI PC SN", "ENTRY": "Structure Failures", "MN": "N06.230.750", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "coordinate with DISASTERS if pertinent", "MS": "Failure in built environment with loss of functional integrity.", "PM": "2009", "HN": "2009", "MR": "20130709", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055883"}, {"RECTYPE": "D", "MH": "Chemical Hazard Release", "AQ": "CL EC HI LJ MO PC PX SN TD", "PRINT ENTRY": "Accidents, Chemical|T068|T070|NON|NRW|NLM (2009)|080523|abbcdef", "ENTRY": "Releases, Chemical Accidental", "MN": "N06.850.135.195", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "for release resulting in disaster, coordinate with DISASTERS; for deliberate release of chemicals, coordinate CHEMICAL HAZARD RELEASE with TERRORISM; specify geographic location", "PI": "Accidents (1986-2008)", "MS": "Uncontrolled release of a chemical from its containment that either threatens to or causes exposure to a chemical hazard. Such an incident may occur accidentally or deliberately.", "PM": "2009", "HN": "2009", "MR": "20190429", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055884"}, {"RECTYPE": "D", "MH": "Biohazard Release", "AQ": "CL EC HI LJ MO PC PX SN TD", "PRINT ENTRY": "Accidents, Biological|T068|T070|NON|NRW|NLM (2009)|080523|abbcdef", "ENTRY": "Releases, Biohazard", "MN": "N06.850.135.190", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "for release resulting in disaster, coordinate with DISASTERS; for deliberate release of biological material, coordinate BIOHAZARD RELEASE with BIOTERRORISM; specify geographic location", "PI": "Accidents (1970-2008)", "MS": "Uncontrolled release of biological material from its containment. This either threatens to, or does, cause exposure to a biological hazard. Such an incident may occur accidentally or deliberately.", "PM": "2009", "HN": "2009", "MR": "20090728", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055885"}, {"RECTYPE": "D", "MH": "Meteorology", "DE": "METEOROL", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Climatology|T090|NON|NRW|NLM (2009)|080602|abcdef", "MN": "H01.671.547", "MH_TH": "UNK (19XX)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use METEOROLOGICAL CONCEPTS or specifics treed under it for atmospheric and climatic characteristics and phenomena", "MS": "The science of studying the characteristics of the atmosphere such as its temperature, density, winds, clouds, precipitation, and other atmospheric phenomena and aiming to account for the weather in terms of external influences and the basic laws of physics. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "2009; see METEROLOGY FACTORS 1977-2008 & WEATHER 1963-1976", "HN": "2009; use METEROLOGY CONCEPTS 1977-2008 & WEATHER 1963-1976", "MR": "20130709", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055904"}, {"RECTYPE": "D", "MH": "Sverdlovsk Accidental Release", "AQ": "CL EC LJ MO PX SN TD", "ENTRY": "Release, Sverdlovsk Accidental", "MN": "N06.850.135.190.500", "MH_TH": "NLM (2009)", "ST": "T068", "AN": "coordinate with DISASTERS if pertinent", "PI": "Anthrax (1979-2008)", "MS": "ANTHRAX outbreak that occurred in 1979 and was associated with a research facility in Sverdlovsk, in the Ural mountain region of central RUSSIA. Most victims worked or lived in a narrow zone extending from the facility. The zone of anthrax-caused livestock mortality paralleled the northerly wind that prevailed shortly before the outbreak. It was concluded that an escape of ANTHRAX caused outbreak.", "PM": "2009", "HN": "2009", "MR": "20150629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055905"}, {"RECTYPE": "D", "MH": "Seveso Accidental Release", "AQ": "CL EC LJ MO PX SN TD", "ENTRY": "Release, Seveso Accidental", "MN": "N06.850.135.195.500", "MH_TH": "NLM (2009)", "ST": "T068", "AN": "coordinate with DISASTERS if pertinent", "PI": "Accidents (1977-2008)", "MS": "1976 accidental release of DIOXINS from a manufacturing facility in Seveso, ITALY following an equipment failure.", "PM": "2009", "HN": "2009", "MR": "20150629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055906"}, {"RECTYPE": "D", "MH": "Climatic Processes", "ENTRY": "Processes, Climatic", "MN": "G16.500.175", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "MS": "Characteristic events occurring in the ATMOSPHERE during the interactions and transformation of various atmospheric components and conditions.", "PM": "2009", "HN": "2009", "MR": "20160616", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055907"}, {"RECTYPE": "D", "MH": "Bhopal Accidental Release", "AQ": "CL EC LJ MO PC PX SN TD", "ENTRY": "Release, Bhopal Accidental", "MN": "N06.850.135.195.249", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "coordinate with DISASTERS if pertinent", "PI": "Disasters (1984-2008)", "MS": "1984 accident in Bhopal, INDIA at a PESTICIDES facility, resulting when WATER entered a storage tank containing ISOCYANATES. The following accidental chemical release and uncontrolled reaction resulted in several thousand deaths.", "PM": "2009", "HN": "2009", "MR": "20150629", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055908"}, {"RECTYPE": "D", "MH": "Magnetic Field Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Static Magnetic Field Therapy|T061|NON|EQV|NLM (2021)|200721|abcdef", "ENTRY": "Therapy, Magnetic Stimulation", "MN": "E02.621", "FX": "Magnets", "MH_TH": "NLM (2009)", "ST": "T061", "MS": "The magnetic stimulation of specific target tissues or areas of the body for therapeutic purposes via the application of magnetic fields generated by MAGNETS or ELECTROMAGNETS.", "PM": "2009", "HN": "2009", "MR": "20200721", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055909"}, {"RECTYPE": "D", "MH": "Antibodies, Immobilized", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Immobilized Antibodies|T116|T129|NON|EQV|NLM (2009)|080606|abbcdef", "MN": "D12.776.463.250", "MH_TH": "NLM (2009)", "ST": "T129", "RN": "0", "MS": "Antibodies that are chemically bound to a substrate material which renders their location fixed.", "PM": "2009", "HN": "2009", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055910"}, {"RECTYPE": "D", "MH": "Cookbooks as Topic", "AQ": "CL EC ES HI IS LJ MT SN ST", "ENTRY": "Recipes as Topics", "MN": "L01.462.500.682.192.402", "MH_TH": "NLM (2009)", "ST": "T170", "AN": "do not confuse with the Publication Type COOKBOOK", "MS": "Works about a set of instructions about how to prepare food for eating using specific directions.", "PM": "2009", "HN": "2009", "MR": "20220712", "DA": "20080708", "DC": "1", "DX": "20090101", "UI": "D055927"}, {"RECTYPE": "D", "MH": "Magnetosomes", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Magnetosome", "MN": "A20.859", "FX": "Magnetospirillum", "MH_TH": "NLM (2010)", "ST": "T026", "MS": "Membrane-bound prokaryotic organelles of magnetotactic bacteria that contain chains of MAGNETITE crystals which orient the bacteria to geomagnetic fields.", "PM": "2010", "HN": "2010", "MR": "20130710", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055944"}, {"RECTYPE": "D", "MH": "Loeys-Dietz Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Loeys-Dietz Aortic Aneurysm Syndrome|T047|EPO|REL|GHR (2014)|NLM (2010)|OMIM (2013)|081003|abcdeeef", "ENTRY": "Syndrome, Loeys-Dietz", "MN": "C16.320.510", "FX": "Marfan Syndrome", "MH_TH": "NLM (2010)", "ST": "T190", "PI": "Marfan Syndrome (2005-2009)", "MS": "An autosomal dominant aneurysm with multisystem abnormalities caused by increased TGF-BETA signaling due to mutations in type I or II of TGF-BETA RECEPTOR. Additional craniofacial features include CLEFT PALATE; CRANIOSYNOSTOSIS; HYPERTELORISM; or bifid uvula. Phenotypes closely resemble MARFAN SYNDROME; Marfanoid craniosynostosis syndrome (Shprintzen-Goldberg syndrome); and EHLERS-DANLOS SYNDROME.", "PM": "2010", "HN": "2010", "MR": "20220712", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055947"}, {"RECTYPE": "D", "MH": "Sarcopenia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sarcopenias", "MN": "C23.888.592.608.612.500", "MH_TH": "NLM (2010)", "ST": "T184", "PI": "Muscular Atrophy (1995-2009)", "MS": "Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055948"}, {"RECTYPE": "D", "MH": "Vasa Previa", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vasa Previas", "MN": "C12.050.703.420.952", "MH_TH": "NLM (2010)", "ST": "T047", "AN": "check the tags FEMALE and PREGNANCY", "PI": "Umbilical Cord (1951-2009)", "MS": "Pregnancy complication where fetal blood vessels, normally inside the umbilical cord, are left unprotected and cross FETAL MEMBRANES. It is associated with antepartum bleeding and FETAL DEATH and STILLBIRTH due to exsanguination.", "PM": "2010", "HN": "2010", "MR": "20210630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055949"}, {"RECTYPE": "D", "MH": "Functional Food", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Functional Foods", "MN": "J02.500.572", "FX": "Dietary Supplements", "MH_TH": "NLM (2010)", "ST": "T168", "AN": "do not confuse with FOOD, FORTIFIED; FOOD, FORMULATED; FOOD ADDITIVES; or DIETARY SUPPLEMENTS; coordinate IM with specific nutrient if relevant (IM)", "PI": "Food, Fortified (1998-2009)", "MS": "Components of the usual diet that may provide health benefits beyond basic nutrients. Examples of functional foods include soy, nuts, chocolate, and cranberries (From NCCAM Backgrounder, March 2004, p3).", "PM": "2010", "HN": "2010", "MR": "20150612", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055951"}, {"RECTYPE": "D", "MH": "Cogan Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Cogans", "MN": "C14.907.940.320", "MH_TH": "NLM (2010)", "ST": "T047", "MS": "A condition consisting of inflammatory eye disease usually presenting as interstitial KERATITIS, vestibuloauditory dysfunction, and large- to medium-vessel vasculitis.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055952"}, {"RECTYPE": "D", "MH": "Microscopic Polyangiitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Polyangiitis, Microscopic", "MN": "C20.111.193.750", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Vasculitis (1994-2009)", "MS": "A primary systemic vasculitis of small- and some medium-sized vessels. It is characterized by a tropism for kidneys and lungs, positive association with anti-neutrophil cytoplasmic antibodies (ANCA), and a paucity of immunoglobulin deposits in vessel walls.", "PM": "2010", "HN": "2010", "MR": "20211018", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055953"}, {"RECTYPE": "D", "MH": "Corneal Endothelial Cell Loss", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Endothelial Cell Loss, Corneal|T046|T184|NON|EQV|NLM (2010)|081027|abbcdef", "MN": "C23.888.307.250", "MH_TH": "NLM (2010)", "ST": "T184", "PI": "Endothelium, Corneal (1987-2009)", "MS": "Loss of CORNEAL ENDOTHELIUM usually following intraocular surgery (e.g., cataract surgery) or due to FUCHS' ENDOTHELIAL DYSTROPHY; ANGLE-CLOSURE GLAUCOMA; IRITIS; or aging.", "PM": "2010", "HN": "2010", "MR": "20200228", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055954"}, {"RECTYPE": "D", "MH": "Susac Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Susac's Syndrome|T047|EPO|EQV|NLM (2010)|080731|abcdef", "ENTRY": "Vasculopathy, Retinocochleocerebral", "MN": "C23.888.592.848", "MH_TH": "NLM (2010)", "ST": "T047", "MS": "A rare disorder consisting of microangiopathy of brain, retina, and inner ear ARTERIOLES. It is characterized by the clinical triad of encephalopathy, BRANCH RETINAL ARTERY OCCLUSION and VERTIGO/hearing loss.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055955"}, {"RECTYPE": "D", "MH": "Diffuse Neurofibrillary Tangles with Calcification", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Kosaka Shibayama Disease", "MN": "F03.615.400.370", "FX": "Neurofibrillary Tangles", "MH_TH": "NLM (2010)", "ST": "T048", "PI": "Neurofibrillary Tangles/pathology (1994-2009)", "MS": "A form of presenile DEMENTIA characterized by cortical dementia, NEUROFIBRILLARY TANGLES without SENILE PLAQUES, Fahr's type CALCINOSIS, and ATROPHY in frontotemporal or TEMPORAL LOBE.", "PM": "2010", "HN": "2010", "MR": "20150630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055956"}, {"RECTYPE": "D", "MH": "Piriformis Muscle Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "syndromes, Piriformis", "MN": "C23.888.592.612.944.750", "MH_TH": "NLM (2010)", "ST": "T184", "PI": "Nerve Compression Syndromes (1979-2009)", "MS": "A chronic PELVIC PAIN characterized by pain deep in the buttock that may radiate to posterior aspects of the leg. It is caused by the piriformis muscle compressing or irritating the SCIATIC NERVE due to trauma, hypertrophy, inflammation or anatomic variations.", "PM": "2010", "HN": "2010", "MR": "20170620", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055958"}, {"RECTYPE": "D", "MH": "Intervertebral Disc Degeneration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Intervertebral Disk Degeneration|T047|NON|EQV|NLM (2010)|080801|abcdef", "ENTRY": "Intervertebral Disk, Degenerative", "MN": "C05.116.900.153", "FX": "Sciatica", "MH_TH": "NLM (2012)", "ST": "T047", "AN": "coordinate IM with specific vertebrae (IM); INTERVERTEBRAL DISC DISPLACEMENT is also available", "PI": "Intervertebral Disk Displacement (1952-2009)", "MS": "Degenerative changes in the INTERVERTEBRAL DISC due to aging or structural damage, especially to the vertebral end-plates.", "PM": "2012; see INTERVERTEBRAL DISK DISPLACEMENT 2010-2011", "HN": "2012 (2010)", "MR": "20200116", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055959"}, {"RECTYPE": "D", "MH": "Asthma, Aspirin-Induced", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "NSAID-Exacerbated Respiratory Disease|T184|NON|NRW|NLM (2024)|230323|abcdef", "ENTRY": "Syndromes, Aspirin-Induced Asthma", "MN": "C25.100.468.189", "MH_TH": "NLM (2010)", "ST": "T184", "PI": "Asthma/chemically induced (1973-2009)", "MS": "Asthmatic adverse reaction (e.g., BRONCHOCONSTRICTION) to conventional NSAIDS including aspirin use.", "PM": "2010", "HN": "2010", "MR": "20230522", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055963"}, {"RECTYPE": "D", "MH": "Alien Limb Phenomenon", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Syndrome, Anarchic Hand|T048|NON|NRW|NLM (2023)|220419|abcdef", "ENTRY": "Leg Syndrome, Alien", "MN": "F01.700.875.350.099", "MH_TH": "NLM (2023)", "ST": "T048", "PI": "Ataxia (1986-2009)", "MS": "An apraxia characterized by the affected limb having involuntary, autonomous, and seemingly purposeful behaviors that are perceived as being controlled by an external force. Often the affected limb interferes with the actions of the normal limb. Symptoms develop from lesions in the CORPUS CALLOSUM or medial frontal cortex caused by stroke, infarction, and neurodegenerative diseases (e.g., CREUTZFELDT-JAKOB SYNDROME, corticobasal degeneration).", "PM": "2023; see ALIEN HAND SYNDROME 2010-2022", "HN": "2023(2010)", "MR": "20230601", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055964"}, {"RECTYPE": "D", "MH": "Nipple Aspirate Fluid", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "ENTRY": "Nipple Aspirate Fluids", "MN": "A12.207.824.500", "FX": "Nipples", "MH_TH": "NLM (2010)", "ST": "T031", "PI": "Nipples (2006-2009)", "MS": "Fluid collected from nipple by gentle aspiration. The fluid contains cells and extracellular fluid from the breast ductal epithelium.", "PM": "2010", "HN": "2010", "MR": "20160630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055966"}, {"RECTYPE": "D", "MH": "Cathode Ray Tube", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Cathode Rays|T070|NON|REL|UNK (19XX)|840224|abcdef", "ENTRY": "Tubes, Cathode Ray", "MN": "E07.305.092", "MH_TH": "NLM (2010)", "ST": "T073", "PI": "Data Display (1967-2009)", "MS": "A vacuum tube equipped with an electron emitting CATHODE and a fluorescent screen which emits visible light when excited by the cathode ray. Cathode ray tubes are used as imaging devises for TELEVISIONS; COMPUTER TERMINALS; TEXT TELECOMMUNICATION DEVICES; oscilloscopes; and other DATA DISPLAY devices.", "PM": "2010; for CATHODE RAYS see BETA RAYS 1985-2009, RADIATION, IONIZING 1976-1984, see RADIATION 1963-1975; for CATHODE RAY TUBE DISPLAY see DATA DISPLAY 1991-2009", "HN": "2010; for CATHODE RAYS use BETA RAYS 1985-2009, RADIATION, IONIZING 1976-1984, use RADIATION 1963-1975; for CATHODE RAY TUBE DISPLAY see DATA DISPLAY 1991-2009", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055984"}, {"RECTYPE": "D", "MH": "Latent Tuberculosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Latent Tuberculosis Infection|T047|NON|EQV|NLM (2010)|080909|abcdef", "ENTRY": "Tuberculosis, Latent", "MN": "C01.550.500", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Tuberculosis (1950-2009)", "MS": "The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.", "PM": "2010", "HN": "2010", "MR": "20200527", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055985"}, {"RECTYPE": "D", "MH": "Vital Signs", "AQ": "DE GE IM PH RE", "ENTRY": "Vital Sign", "MN": "E01.370.600.875", "MH_TH": "NLM (2010)", "ST": "T040", "PI": "Respiration (1964-2009)", "MS": "The signs of life that may be monitored or measured, namely pulse rate, respiratory rate, body temperature, and blood pressure.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055986"}, {"RECTYPE": "D", "MH": "Uterine Artery", "AQ": "AB AH CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Uterine Arteries", "MN": "A07.015.114.940", "FX": "Uterine Artery Embolization", "MH_TH": "NLM (2010)", "ST": "T023", "MS": "A branch arising from the internal iliac artery in females, that supplies blood to the uterus.", "PM": "2010", "HN": "2010", "MR": "20180630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055988"}, {"RECTYPE": "D", "MH": "Septal Occluder Device", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD UL VE VI", "ENTRY": "Septal Occluders, Helex", "MN": "E07.695.715", "MH_TH": "NLM (2010)", "ST": "T074", "PI": "Prostheses and Implants (1997-2009)", "MS": "A CATHETER-delivered implant used for closing abnormal holes in the cardiovascular system, especially HEART SEPTAL DEFECTS; or passageways intentionally made during cardiovascular surgical procedures.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055989"}, {"RECTYPE": "D", "MH": "Therapeutic Misconception", "AQ": "ES HI PX", "ENTRY": "Therapeutic Misestimations", "MN": "N05.350.670.875", "FX": "Informed Consent", "MH_TH": "NLM (2010)", "ST": "T041", "PI": "Informed Consent/ethics (1982-2009)", "MS": "Misunderstanding among individuals, frequently research subjects, of scientific methods such as randomization and placebo controls.", "PM": "2010", "HN": "2010", "MR": "20150623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055990"}, {"RECTYPE": "D", "MH": "Health Records, Personal", "AQ": "EC ES HI PX", "ENTRY": "Records, Personal Medical", "MN": "E05.318.308.940.968.249", "MH_TH": "UNK (19XX)", "ST": "T170", "PI": "Medical Records (2000-2009)", "MS": "Longitudinal patient-maintained records of individual health history and tools that allow individual control of access.", "PM": "2010", "HN": "2010", "MR": "20150109", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055991"}, {"RECTYPE": "D", "MH": "Germ Cells, Plant", "AQ": "CH CL CY DE EN GD IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Gametes, Plant|T002|T025|NON|NRW|NLM (2010)|080926|abbcdef", "ENTRY": "Plant Germ Cell", "MN": "A18.024.249.500.249", "MH_TH": "NLM (2010)", "ST": "T025", "MS": "The reproductive cells of plants.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055993"}, {"RECTYPE": "D", "MH": "Limnology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.277.625", "FX": "Oceanography", "MH_TH": "NLM (2010)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "MS": "The study of the physical, chemical, hydrological, and biological aspects of fresh water bodies. (EPA Terms of Environment: Glossary, Abbreviations and Acronyms [Internet] US Environmental Protection Agency [cited 2008 Sep 25] available from http://www.epa.gov/OCEPAterms/aterms.html)", "PM": "2010", "HN": "2010", "MR": "20120703", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D055994"}, {"RECTYPE": "D", "MH": "Molecular Dynamics Simulation", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Molecular Dynamics Simulations|T066|NON|EQV|NLM (2010)|081029|abcdef", "ENTRY": "Simulations, Molecular Dynamics", "MN": "L01.224.160.500", "MH_TH": "NLM (2010)", "ST": "T066", "PI": "Models, Molecular (1985-2009)", "MS": "A computer simulation developed to study the motion of molecules over a period of time.", "PM": "2010", "HN": "2010", "MR": "20170703", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056004"}, {"RECTYPE": "D", "MH": "Leprosy, Paucibacillary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Paucibacillary Leprosy|T047|NON|EQV|NLM (2010)|080916|abcdef", "ENTRY": "Tuberculoids, Indeterminate", "MN": "C01.150.252.410.040.552.475.371.850", "MH_TH": "NLM (2010)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "PI": "Leprosy (1979-2009)", "MS": "A form of LEPROSY classified by the World Health Organization for the purpose of treatment, based on clinical manifestations and skin smear results. Patients with paucibacillary leprosy have fewer than six skin lesions with no causative agent MYCOBACTERIUM LEPRAE on any slit-skin smear testing. Paucibacillary leprosy encompasses indeterminate, borderline tuberculoid, and tuberculoid leprosy.", "PM": "2010", "HN": "2010", "MR": "20190617", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056005"}, {"RECTYPE": "D", "MH": "Leprosy, Multibacillary", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Multibacillary Leprosy|T047|NON|EQV|NLM (2010)|080916|abcdef", "ENTRY": "Multibacillary Leprosies", "MN": "C01.150.252.410.040.552.475.371.775", "MH_TH": "NLM (2010)", "ST": "T047", "AN": "coordinate with NEGLECTED DISEASES if pertinent", "PI": "Leprosy (1983-2009)", "MS": "A form of LEPROSY classified by the World Health Organization for the purpose of treatment, based on clinical manifestations and skin smear results. Patients with multibacillary leprosy have six or more lesions with or without positive skin smear results for the causative agent MYCOBACTERIUM LEPRAE. Multibacillary leprosy encompasses borderline lepromatous, midborderline, and lepromatous leprosy.", "PM": "2010", "HN": "2010", "MR": "20190617", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056006"}, {"RECTYPE": "D", "MH": "Actigraphy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E05.003.500", "FX": "Polysomnography", "MH_TH": "NLM (2010)", "ST": "T060", "MS": "The measurement and recording of MOTOR ACTIVITY to assess rest/activity cycles.", "PM": "2010", "HN": "2010", "MR": "20150622", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056044"}, {"RECTYPE": "D", "MH": "Genetic Fitness", "AQ": "DE GE IM PH RE", "ENTRY": "Fitness, Reproductive", "MN": "G05.347", "FX": "Selection, Genetic", "MH_TH": "NLM (2010)", "ST": "T045", "MS": "The capability of an organism to survive and reproduce. The phenotypic expression of the genotype in a particular environment determines how genetically fit an organism will be.", "PM": "2010", "HN": "2010", "MR": "20090717", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056084"}, {"RECTYPE": "D", "MH": "Commotio Cordis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cardiac Concussion|T033|T046|NON|EQV|NLM (2010)|081008|abbcdef", "ENTRY": "Concussions, Cardiac", "MN": "C26.974.250.875.500", "FX": "Death, Sudden, Cardiac", "MH_TH": "NLM (2010)", "ST": "T046", "MS": "A sudden CARDIAC ARRHYTHMIA (e.g., VENTRICULAR FIBRILLATION) caused by a blunt, non-penetrating impact to the precordial region of chest wall. Commotio cordis often results in sudden death without prompt cardiopulmonary defibrillation.", "PM": "2010", "HN": "2010", "MR": "20160531", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056104"}, {"RECTYPE": "D", "MH": "Slit Ventricle Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Slit Ventricle", "MN": "C23.888.592.612.441.500", "MH_TH": "NLM (2010)", "ST": "T184", "PI": "Ventriculostomy (2001-2009)", "MS": "An intermittent and self-limiting headache disorder in individuals with CEREBROSPINAL FLUID SHUNTS emplaced for the treatment of HYDROCEPHALUS. The symptoms of headache, vomiting, and cranial neuropathies are associated with intermittent obstruction of the shunt.", "PM": "2010", "HN": "2010", "MR": "20170620", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056124"}, {"RECTYPE": "D", "MH": "Orchiopexy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Orchidopexy|T061|NON|EQV|NLM (2010)|081010|abcdef", "ENTRY": "Orchiopexy, Laparoscopic", "MN": "E04.950.774.860.619", "FX": "Orchiectomy", "MH_TH": "NLM (2010)", "ST": "T061", "AN": "check tags MALE & ANIMALS or HUMAN.", "PI": "Urologic Surgical Procedures, Male (1998-2009)", "MS": "A surgical procedure in which an undescended testicle is sutured inside the SCROTUM in male infants or children to correct CRYPTORCHIDISM. Orchiopexy is also performed to treat TESTICULAR TORSION in adults and adolescents.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056126"}, {"RECTYPE": "D", "MH": "Hydrobiology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Ecology, Aquatic", "MN": "H01.277.249.750", "FX": "Limnology", "MH_TH": "NLM (2010)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "MS": "The study of aquatic life inhabiting bodies of water, including growth, morphology, physiology, genetics, distribution, and interactions with other organisms and the environment. It includes MARINE HYDROBIOLOGY.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056127"}, {"RECTYPE": "D", "MH": "Obesity, Abdominal", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Central Obesity|T184|NON|EQV|NLM (2010)|081010|abcdef", "ENTRY": "Visceral Obesities", "MN": "C23.888.144.699.500.063", "FX": "Abdominal Fat", "MH_TH": "NLM (2010)", "ST": "T184", "PI": "Obesity (1966-2009)", "MS": "A condition of having excess fat in the abdomen. Abdominal obesity is typically defined as waist circumferences of 40 inches or more in men and 35 inches or more in women. Abdominal obesity raises the risk of developing disorders, such as DIABETES; HYPERTENSION; and METABOLIC SYNDROME.", "PM": "2010", "HN": "2010", "MR": "20210707", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056128"}, {"RECTYPE": "D", "MH": "Gametogenesis, Plant", "AQ": "DE GE IM PH RE", "ENTRY": "Spermatogenesis, Plant|T042|NON|NRW|NLM (2010)|081010|abcdef", "MN": "G15.300", "FX": "Germ Cells, Plant", "MH_TH": "NLM (2010)", "ST": "T042", "PI": "Gametogenesis (1991-2009)", "MS": "The process of germ cell development in plants, from the primordial PLANT GERM CELLS to the mature haploid PLANT GAMETES.", "PM": "2010", "HN": "2010", "MR": "20160623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056130"}, {"RECTYPE": "D", "MH": "Pyriform Sinus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Sinus, Pyriform", "MN": "A04.623.490.600", "MH_TH": "NLM (2010)", "ST": "T030", "MS": "A recess on each side in the wall of the HYPOPHARYNX.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056144"}, {"RECTYPE": "D", "MH": "Freshwater Biology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Biology, Freshwater", "MN": "H01.277.625.500", "MH_TH": "NLM (2010)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "MS": "The study of life and ECOLOGIC SYSTEMS in bodies of FRESHWATER.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056145"}, {"RECTYPE": "D", "MH": "Corpse Dismemberment", "AQ": "ES HI LJ", "ENTRY": "Dismemberments, Corpse", "MN": "I01.198.240.194", "MH_TH": "NLM (2010)", "ST": "T068", "MS": "Disjoining the limbs or other parts of a corpse, often in association with criminal acts.", "PM": "2010", "HN": "2010", "MR": "20100625", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056146"}, {"RECTYPE": "D", "MH": "Equine-Assisted Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Recreational Horseback Riding Therapy|T061|NON|NRW|NLM (2010)|081103|abcdef", "ENTRY": "Therapy, Horseback Riding", "MN": "F04.754.017.500", "MH_TH": "NLM (2010)", "ST": "T061", "PI": "Recreation (1993-2009)", "MS": "Therapy assisted by the use of a horse and/or its movement, including equine-assisted psychotherapy, horseback riding, and hippotherapy.", "PM": "2010", "HN": "2010", "MR": "20160531", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056147"}, {"RECTYPE": "D", "MH": "Chromatography, Reverse-Phase", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Reversed-Phase Liquid Chromatography|T059|NON|NRW|NLM (2010)|081022|abcdef", "ENTRY": "Reversed Phase Chromatography", "MN": "E05.196.181.400.495", "MH_TH": "NLM (2010)", "ST": "T059", "AN": "coordinate with specific type of chromatography", "PI": "Chromatography, Liquid (1976-2009)", "MS": "A chromatography technique in which the stationary phase is composed of a non-polar substance with a polar mobile phase, in contrast to normal-phase chromatography in which the stationary phase is a polar substance with a non-polar mobile phase.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056148"}, {"RECTYPE": "D", "MH": "Epicardial Mapping", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Epicardial Mapping, Percutaneous", "MN": "E01.370.370.380.245.500", "MH_TH": "NLM (2010)", "ST": "T060", "PI": "Electrocardiography (1972-2009)", "MS": "Recording the locations and measurements of electrical activity in the EPICARDIUM by placing electrodes on the surface of the heart to analyze the patterns of activation and to locate arrhythmogenic sites.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056149"}, {"RECTYPE": "D", "MH": "Acute Generalized Exanthematous Pustulosis", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Acute Generalised Exanthematous Pustulosis|T047|NON|EQV|NLM (2020)|190507|abcdef", "ENTRY": "Pustulosis, Exanthematous, Acute Localized|T047|NON|REL|NLM (2010)|090115|abcdef", "MN": "C25.100.468.380.174", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Skin Diseases, Vesiculobullous (1991-2009)", "MS": "Rare skin eruption characterized by acute formation of pustules filled with NEUTROPHILS, fever, and peripheral blood LEUKOCYTOSIS. Most cases are associated with the use of antibiotics (e.g., BETA-LACTAMS).", "PM": "2010", "HN": "2010", "MR": "20220413", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056150"}, {"RECTYPE": "D", "MH": "Airway Remodeling", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Small Airway Remodelling|T020|T033|NON|NRW|NLM (2010)|081104|abbcdef", "ENTRY": "Wall Remodellings, Airway", "MN": "G09.772.029", "MH_TH": "NLM (2010)", "ST": "T033", "PI": "Respiratory System (1988-2009)", "MS": "The structural changes in the number, mass, size and/or composition of the airway tissues.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056151"}, {"RECTYPE": "D", "MH": "Respiratory Rate", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Respiration Rate|T032|T033|NON|EQV|NLM (2010)|081023|abbcdef", "ENTRY": "Respiratory Rates", "MN": "G09.772.705.730", "MH_TH": "NLM (2010)", "ST": "T033", "PI": "Respiration (1964-2009)", "MS": "The number of times an organism breathes with the lungs (RESPIRATION) per unit time, usually per minute.", "PM": "2010", "HN": "2010", "MR": "20160617", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056152"}, {"RECTYPE": "D", "MH": "Teaching Rounds", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Morning Report|T065|NON|NRW|NLM (2010)|081027|abcdef", "ENTRY": "Rounds, Teaching", "MN": "I02.358.399.822", "MH_TH": "NLM (2010)", "ST": "T065", "PI": "Internship and Residency (1966-2009)", "MS": "Systematic discussions and TEACHING conducted in HOSPITALS and HEALTHCARE facilities related to patient care.", "PM": "2010", "HN": "2010", "MR": "20161101", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056164"}, {"RECTYPE": "D", "MH": "Simian T-lymphotropic virus 3", "DS": "SIMIAN LYMPHOTROPIC VIRUS T 003", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Simian T-lymphotropic virus-L|T005|NON|EQV|NLM (2007)|051031|abcdef", "ENTRY": "T-lymphotropic virus-L, Simian", "MN": "B04.820.650.200.735.750", "MH_TH": "NLM (2002)", "ST": "T005", "RN": "txid39101", "AN": "infection: coordinate IM with DELTARETROVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) if pertinent", "PI": "Primate T-lymphotropic virus 3 (1987-2009)", "MS": "Strains of PRIMATE T-LYMPHOTROPIC VIRUS 3 isolated from diverse primate species.", "PM": "2010; see PRIMATE T-LYMPHOTROPIC VIRUS 3 2002-2009", "HN": "2010; use PRIMATE T-LYMPHOTROPIC VIRUS 3 2002-2009", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056185"}, {"RECTYPE": "D", "MH": "Metagenomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Genomics, Population", "MN": "H01.158.273.343.350.261", "FX": "DNA, Environmental", "MH_TH": "NLM (2010)", "ST": "T090", "PI": "Genomics (2003-2009)", "MS": "The systematic study of the GENOMES of assemblages of organisms.", "PM": "2010", "HN": "2010", "MR": "20210713", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056186"}, {"RECTYPE": "D", "MH": "Human T-lymphotropic virus 3", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "Human T lymphotropic virus 3", "MN": "B04.820.650.200.735.374", "MH_TH": "NLM (2010)", "ST": "T005", "RN": "txid28332", "AN": "do not confuse with HTLV-III, an old name for the lentivirus HIV; infection: coordinate IM with DELTARETROVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) if pertinent", "PI": "Deltaretrovirus (2005-2009)", "MS": "A strain of PRIMATE T-LYMPHOTROPIC VIRUS 3 that is genetically similar to STLV-3.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056187"}, {"RECTYPE": "D", "MH": "Viral Tropism", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Virus Tropism|T039|NON|EQV|NLM (2024)|230119|abcdef", "ENTRY": "Tropism, Virus", "MN": "G07.443.500", "FX": "Tropism", "MH_TH": "NLM (2010)", "ST": "T039", "AN": "coordinate with specific virus /physiol", "MS": "The specificity of a virus for infecting a particular type of cell or tissue.", "PM": "2010", "HN": "2010", "MR": "20230522", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056189"}, {"RECTYPE": "D", "MH": "Viral Structures", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Virus Structures|T017|NON|EQV|NLM (2010)|081110|abcdef", "ENTRY": "Virus Structure", "MN": "A21", "RH": "A21 - ANATOMY - VIRAL STRUCTURES", "MH_TH": "NLM (2010)", "ST": "T017", "AN": "general or unspecified; prefer specifics", "MS": "The structural parts of the VIRION.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056224"}, {"RECTYPE": "D", "MH": "Bacterial Structures", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Structures, Bacterial", "MN": "A20", "RH": "A20 - ANATOMY - BACTERIAL STRUCTURES", "MH_TH": "NLM (2010)", "ST": "T017", "AN": "general or unspecified; prefer specifics", "MS": "The parts of bacteria.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056226"}, {"RECTYPE": "D", "MH": "Feedback, Sensory", "AQ": "DE PH RE", "PRINT ENTRY": "Visual Feedback|T067|NON|NRW|NLM (2010)|090115|abcdef", "ENTRY": "Visual Feedbacks", "MN": "G07.410.732.500", "MH_TH": "NLM (2010)", "ST": "T067", "MS": "A mechanism of communicating one's own sensory system information about a task, movement or skill.", "PM": "2010", "HN": "2010", "MR": "20170630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056228"}, {"RECTYPE": "D", "MH": "Fungal Structures", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Structures, Fungal", "MN": "A19", "RH": "A19 - ANATOMY - FUNGAL STRUCTURES", "MH_TH": "NLM (2010)", "ST": "T017", "AN": "general or unspecified; prefer specifics", "MS": "The parts of fungi.", "PM": "2010; for FUNGAL COMPONENTS see FUNGAL COMPONENTS 2002-2009", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056229"}, {"RECTYPE": "D", "MH": "Mi-2 Nucleosome Remodeling and Deacetylase Complex", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Histone Deacetylase Complex NuRD|T116|T126|ABX|EQV|NLM (2010)|081118|abbcdef", "ENTRY": "Mi 2 Nucleosome Remodeling and Deacetylase Complex", "MN": "D08.811.600.620", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.5.1.98", "RR": "EC 3.6.1.-", "MS": "A enzyme complex involved in the remodeling of NUCLEOSOMES. The complex is comprised of at least seven subunits and includes both histone deacetylase and ATPase activities.", "PM": "2010; NURD HISTONE DEACETYLASE COMPLEX (now MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX) was indexed under HISTONE DEACETYLASES 2000-2009", "HN": "2010(2000)", "MR": "20130709", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056245"}, {"RECTYPE": "D", "MH": "Chemistry, Analytic", "AQ": "CL EC ED ES HI LJ OG SN ST TD", "ENTRY": "Analytic Chemistry|T090|NON|EQV|NLM (2010)|090129|abcdef", "MN": "H01.181.309", "FX": "Chemistry, Clinical", "MH_TH": "UNK (19XX)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use CHEMISTRY TECHNIQUES, ANALYTICAL or specifics treed under it for techniques in analytical chemistry", "PI": "Analytical Chemistry Techniques (1966-2009)", "MS": "The branch of chemistry dealing with detection (qualitative) and determination (quantitative) of substances. (Grant & Hackh's Chemical Dictionary, 5th ed)", "PM": "2010", "HN": "2010", "MR": "20091009", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056246"}, {"RECTYPE": "D", "MH": "Sin3 Histone Deacetylase and Corepressor Complex", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "SIN 3 Histone Deacetylase Complex", "MN": "D12.776.930.780.625.750", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.5.1.98", "MS": "A multisubunit enzyme complex that regulates GENETIC TRANSCRIPTION by deacetylating the HISTONE residues of NUCLEOSOMES.", "PM": "2010; SIN3 COMPLEX (now SIN3 HISTONE DEACETYLASE AND COREPRESSOR COMPLEX) was indexed under HISTONE DEACETYLASES 2001-2009", "HN": "2010(2001)", "MR": "20150629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056264"}, {"RECTYPE": "D", "MH": "Microbial Interactions", "AQ": "DE GE IM PH RE", "ENTRY": "Microbial Interaction", "MN": "G06.550", "FX": "Microbial Consortia", "MH_TH": "NLM (2010)", "ST": "T070", "MS": "The inter- and intra-relationships between various microorganisms. This can include both positive (like SYMBIOSIS) and negative (like ANTIBIOSIS) interactions. Examples include virus - bacteria and bacteria - bacteria.", "PM": "2010", "HN": "2010", "MR": "20160623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056265"}, {"RECTYPE": "D", "MH": "Erythrokeratodermia Variabilis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mendes De Costa Syndrome|T019|T047|EPO|EQV|NLM (2010)|081120|abbcdef", "ENTRY": "Progressive Symmetric Erythrokeratodermia", "MN": "C17.800.827.337", "FX": "Keratoderma, Palmoplantar", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Skin Diseases, Genetic (2002-2009)", "MS": "An autosomal dominant skin disease characterized by transient and variable noninflammatory ERYTHEMA and hyperkeratosis. It has been associated with mutations in the genes that code for CONNEXINS. Erythrokeratodermia variabilis inherited in an autosomal recessive fashion has also been reported. Affected individuals often develop PALMOPLANTAR KERATODERMA.", "PM": "2010; ERYTHROKERATODERMIA FIGURATA, CONGENITAL FAMILIAL, IN PLAQUES and ERYTHROKERATODERMIA VARIABILIS WITH ERYTHEMA GYRATUM REPENS were indexed under PAPILLON-LEFEVRE DISEASE 2010-2016.", "HN": "2010", "MR": "20170620", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056266"}, {"RECTYPE": "D", "MH": "Pagetoid Reticulosis", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Woringer-Kolopp Disease|T191|EPO|EQV|NLM (2010)|081120|abcdef", "ENTRY": "Reticulosis, Pagetoid", "MN": "C20.683.515.761.480.750.800.550.600", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with SKIN NEOPLASMS (IM)", "PI": "Mycosis Fungoides (1977-2009)", "MS": "A distinct variant of mycosis fungoides characterized by the presence of localized patches or plaques with an intraepidermal proliferation of neoplastic cells.", "PM": "2010; see MYCOSIS FUNGOIDES 2008-2009", "HN": "2010; use MYCOSIS FUNGOIDES 2008-2009", "MR": "20180629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056267"}, {"RECTYPE": "D", "MH": "Histone Deacetylase 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Histone Deacetylase, RPD3L1", "MN": "D08.811.600.795.100", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.5.1.98", "PI": "Histone Deacetylases (2003-2009)", "MS": "A histone deacetylase subtype that is found along with HISTONE DEACETYLASE 2; RETINOBLASTOMA-BINDING PROTEIN 4; and RETINOBLASTOMA-BINDING PROTEIN 7 as core components of histone deacetylase complexes.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056284"}, {"RECTYPE": "D", "MH": "Cryptococcus gattii", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Cryptococcus neoformans var. gattii|T004|NON|EQV|NLM (2010)|081120|abcdef", "MN": "B01.300.930.316.300", "MH_TH": "NLM (2010)", "ST": "T004", "RN": "txid37769", "AN": "infection: coordinate with CRYPTOCOCCOSIS ", "PI": "Cryptococcus (2004-2009)", "MS": "A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella bacillispora.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056285"}, {"RECTYPE": "D", "MH": "Retinoblastoma Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Retinoblastoma Protein Binding Proteins|T116|T123|NON|EQV|NLM (2010)|081124|abbcdef", "ENTRY": "RBBP Proteins|T116|T123|ABX|EQV|NLM (2010)|081124|abbcdef", "MN": "D12.776.660.769", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "A family of endogenous regulatory proteins that associate with RETINOBLASTOMA PROTEIN via a specific high-affinity binding domain. Members of this family of proteins are often found associated with histone-modifying enzymes and protein complexes that regulate gene expression.", "PM": "2010", "HN": "2010", "MR": "20160218", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056286"}, {"RECTYPE": "D", "MH": "Genu Valgum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Knock Knee|T039|T047|NON|EQV|NLM (2010)|081121|abbcdef", "ENTRY": "Valgas, Genu", "MN": "C05.116.482", "FX": "Rickets", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Knee Joint (1966-2009)", "MS": "An inward slant of the thigh in which the knees are close together and the ankles far apart. Genu valgum can develop due to skeletal and joint dysplasias (e.g., OSTEOARTHRITIS; HURLER SYNDROME); and malnutrition (e.g., RICKETS; FLUORIDE POISONING).", "PM": "2010", "HN": "2010", "MR": "20110624", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056304"}, {"RECTYPE": "D", "MH": "Genu Varum", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Legs, Bow", "MN": "C05.116.511", "FX": "Rickets", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Knee Joint (1966-2009)", "MS": "An outward slant of the thigh in which the knees are wide apart and the ankles close together. Genu varum can develop due to skeletal and joint dysplasia (e.g., OSTEOARTHRITIS; Blount's disease); and malnutrition (e.g., RICKETS; FLUORIDE POISONING).", "PM": "2010", "HN": "2010", "MR": "20130708", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056305"}, {"RECTYPE": "D", "MH": "Diffusion Tensor Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Diffusion Tractography|T060|T062|NON|NRW|NLM (2010)|081121|abbcdef", "ENTRY": "Tractography, Diffusion", "MN": "E05.629.750", "MH_TH": "NLM (2010)", "ST": "T062", "PI": "Diffusion Magnetic Resonance Imaging (2002-2009)", "MS": "The use of diffusion ANISOTROPY data from diffusion magnetic resonance imaging results to construct images based on the direction of the faster diffusing molecules.", "PM": "2010", "HN": "2010", "MR": "20171214", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056324"}, {"RECTYPE": "D", "MH": "Neuronal Tract-Tracers", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Tract-Tracing Markers, Neuroanatomical", "MN": "D27.720.470.410.577", "FX": "Neuroanatomical Tract-Tracing Techniques", "MH_TH": "NLM (2010)", "ST": "T120", "RN": "0", "MS": "Substances used to identify the location and to characterize the types of NEURAL PATHWAYS.", "PM": "2010", "HN": "2010", "MR": "20130708", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056325"}, {"RECTYPE": "D", "MH": "Executive Function", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Executive Control|T041|NON|EQV|NLM (2010)|081124|abcdef", "ENTRY": "Functions, Executive", "MN": "F02.463.217", "FX": "Problem Solving", "MH_TH": "NLM (2010)", "ST": "T041", "PI": "Problem Solving (1990-2009)", "MS": "A set of cognitive functions that controls complex, goal-directed thought and behavior. Executive function involves multiple domains, such as CONCEPT FORMATION, goal management, cognitive flexibility, INHIBITION control, and WORKING MEMORY. Impaired executive function is seen in a range of disorders, e.g., SCHIZOPHRENIA; and ADHD.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056344"}, {"RECTYPE": "D", "MH": "Theory of Mind", "AQ": "CL DE ES PH RE", "MN": "F02.739.897", "MH_TH": "NLM (2010)", "ST": "T041", "PI": "Schizophrenic Psychology (1992-2009)", "MS": "The ability to attribute mental states (e.g., beliefs, desires, feelings, intentions, thoughts, etc.) to self and to others, allowing an individual to understand and infer behavior on the basis of the mental states. Difference or deficit in theory of mind is associated with ASPERGER SYNDROME; AUTISTIC DISORDER; and SCHIZOPHRENIA, etc.", "PM": "2010", "HN": "2010", "MR": "20190507", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056345"}, {"RECTYPE": "D", "MH": "Sternotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Sternotomy, Median", "MN": "E04.928.710", "MH_TH": "NLM (2010)", "ST": "T061", "PI": "Sternum/surgery (1964-2009)", "MS": "Making an incision in the STERNUM.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056346"}, {"RECTYPE": "D", "MH": "Neuroanatomical Tract-Tracing Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Neuron Pathway Tracing|T062|NON|EQV|NLM (2010)|081124|abcdef", "ENTRY": "Tract-Tracings, Neuroanatomical", "MN": "E05.200.750.600.670.570", "FX": "Neuronal Tract-Tracers", "MH_TH": "NLM (2010)", "ST": "T062", "PI": "Neural Pathways or specifics (1984-2009)", "MS": "Methods used to label and follow the course of NEURAL PATHWAYS by AXONAL TRANSPORT of injected NEURONAL TRACT-TRACERS.", "PM": "2010", "HN": "2010", "MR": "20110624", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056347"}, {"RECTYPE": "D", "MH": "Emotional Intelligence", "AQ": "CL DE ES GE PH RE", "PRINT ENTRY": "Social Intelligence|T041|NON|REL|NLM (2010)|081216|abcdef", "ENTRY": "Social Intelligences", "MN": "F01.752.543.500", "FX": "Interpersonal Relations", "MH_TH": "NLM (2010)", "ST": "T041", "PI": "Intelligence (1966-2009)", "MS": "The ability to understand and manage emotions and to use emotional knowledge to enhance thought and deal effectively with tasks. Components of emotional intelligence include empathy, self-motivation, self-awareness, self-regulation, and social skill. Emotional intelligence is a measurement of one's ability to socialize or relate to others.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056348"}, {"RECTYPE": "D", "MH": "Athletes", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Professional Athletes|T098|NON|NRW|NLM (2021)|200323|abcdef", "ENTRY": "Professional Athlete", "MN": "M01.072", "MH_TH": "NLM (2010)", "ST": "T098", "PI": "Sports (1966-2009)", "MS": "Individuals who have developed skills, physical stamina and strength or participants in SPORTS or other physical activities.", "PM": "2010", "HN": "2010", "MR": "20210115", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056352"}, {"RECTYPE": "D", "MH": "Colloid Cysts", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Cysts, Colloid", "MN": "C16.131.666.142.200", "MH_TH": "NLM (2010)", "ST": "T190", "PI": "Cysts (1963-2009)", "MS": "Benign, congenital, neuroepithelial cysts that are typically filled with a viscous mucus. They usually arise in the anterior portion of the THIRD VENTRICLE between the fornices.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056364"}, {"RECTYPE": "D", "MH": "Group I Chaperonins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Chaperonins, Type I", "MN": "D12.776.580.216.210.590", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.6.1.-", "MS": "A subcategory of chaperonins found in MITOCHONDRIA; CHLOROPLASTS; and BACTERIA. Group I chaperonins form into a barrel-shaped macromolecular structure that is enclosed by a separate lid-like protein component.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056384"}, {"RECTYPE": "D", "MH": "Group II Chaperonins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Group II Chaparonins|T116|T126|NON|EQV|NLM (2010)|081201|abbcdef", "ENTRY": "Chaperonins, Type II", "MN": "D12.776.580.216.210.795", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.6.1.-", "MS": "A subcategory of chaperonins found in ARCHAEA and the CYTOSOL of eukaryotic cells. Group II chaperonins form a barrel-shaped macromolecular structure that is distinct from GROUP I CHAPERONINS in that it does not utilize a separate lid like structure to enclose proteins.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056385"}, {"RECTYPE": "D", "MH": "Chaperonin Containing TCP-1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "t Complex Protein 1", "MN": "D12.776.580.216.210.795.500", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.6.1.-", "MS": "A group II chaperonin found in eukaryotic CYTOSOL. It is comprised of eight subunits with each subunit encoded by a separate gene. This chaperonin is named after one of its subunits which is a T-COMPLEX REGION-encoded polypeptide.", "PM": "2010; CHAPERONIN CCT was indexed under CHAPERONINS 1992-2009", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056404"}, {"RECTYPE": "D", "MH": "Thermosomes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Thermosome|T116|T126|NON|EQV|NLM (2010)|081202|abbcdef", "ENTRY": "Thermosome Proteins|T116|T126|NON|EQV|NLM (2010)|081202|abbcdef", "MN": "D12.776.580.216.210.795.750", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.6.1.-", "MS": "Group II chaperonins found in species of ARCHAEA.", "PM": "2010; THERMOSOME PROTEIN, ARCHAEAL was indexed under CHAPERONINS and ARCHAEAL PROTEINS 1998-2009", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056405"}, {"RECTYPE": "D", "MH": "Decompressive Craniectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Decompressive Craniotomies", "MN": "E04.525.190.200", "MH_TH": "NLM (2010)", "ST": "T061", "PI": "Decompression, Surgical (1996-2009)", "MS": "Excision of part of the skull. This procedure is used to treat elevated intracranial pressure that is unresponsive to conventional treatment.", "PM": "2010", "HN": "2010", "MR": "20170620", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056424"}, {"RECTYPE": "D", "MH": "Genetic Loci", "AQ": "DE GE IM PH RE", "ENTRY": "Locus, Genetic", "MN": "G05.360.340.024.380", "MH_TH": "NLM (2010)", "ST": "T028", "MS": "Specific regions that are mapped within a GENOME. Genetic loci are usually identified with a shorthand notation that indicates the chromosome number and the position of a specific band along the P or Q arm of the chromosome where they are found. For example the locus 6p21 is found within band 21 of the P-arm of CHROMOSOME 6. Many well known genetic loci are also known by common names that are associated with a genetic function or HEREDITARY DISEASE.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056426"}, {"RECTYPE": "D", "MH": "t-Complex Genome Region", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "t-Complex Region|T028|NON|EQV|NLM (2010)|081203|abcdef", "ENTRY": "t-Haplotypes, Mouse", "MN": "G05.360.340.024.380.968", "MH_TH": "NLM (2010)", "ST": "T028", "AN": "check the tag MICE", "MS": "A 20 cM region of mouse chromosome 17 that is represented by a least two HAPLOTYPES. One of the haplotypes is referred to as the t-haplotype and contains an unusual array of mutations that affect embryonic development and male fertility. The t-haplotype is maintained in the gene pool by the presence of unusual features that prevent its recombination.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056427"}, {"RECTYPE": "D", "MH": "Axonemal Dyneins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Axonemal Dynein|T116|T126|NON|EQV|NLM (2022)|201007|abbcdef", "ENTRY": "Dyneins, Axonemal", "MN": "D12.776.220.600.200.500", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.6.4.2", "PI": "Dyneins (1976-2009)", "MS": "Dyneins that are responsible for ciliary and flagellar beating.", "PM": "2010", "HN": "2010", "MR": "20230316", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056444"}, {"RECTYPE": "D", "MH": "Cytoplasmic Dyneins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytoplasmic Dynein|T116|T126|NON|EQV|NLM (2021)|200430|abbcdef", "ENTRY": "Dyneins, Cytoplasmic", "MN": "D12.776.220.600.200.750", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.6.4.2", "RR": "EC 3.6.4.2", "MS": "Dyneins that are responsible for intracellular transport, MITOSIS, cell polarization, and movement within the cell.", "PM": "2010", "HN": "2010", "MR": "20230316", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056445"}, {"RECTYPE": "D", "MH": "Knee-Chest Position", "AQ": "AE PH", "ENTRY": "Positions, Knee-Chest", "MN": "G11.427.695.380", "MH_TH": "NLM (2010)", "ST": "T082", "PI": "Posture (1964-2009)", "MS": "The posture of an individual supported by the knees and chest resting on a table.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056446"}, {"RECTYPE": "D", "MH": "Animal Assisted Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Pet-Assisted Therapy|T061|NON|NRW|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Therapy, Pet-Assisted", "MN": "N02.421.784.177", "FX": "Human Activities", "MH_TH": "OBSSR (2021)", "ST": "T061", "MS": "The use of live animals as a means of therapy.", "PM": "2010", "HN": "2010", "MR": "20220712", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056447"}, {"RECTYPE": "D", "MH": "Earth Sciences", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sciences, Earth", "MN": "H01.277", "MH_TH": "NLM (2010)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "MS": "Fields of science encompassing studies and research from the disciplines of PHYSICS; CHEMISTRY; BIOLOGICAL SCIENCES; and MATHEMATICS; that are related to the planet EARTH. Subfields include atmospheric chemistry; CLIMATOLOGY; ENVIRONMENTAL SCIENCES; GEOGRAPHY; GEOLOGY; geophysics; METEOROLOGY; OCEANOGRAPHY; PALEONTOLOGY; mineralogy; and seismology.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056448"}, {"RECTYPE": "D", "MH": "Bacillales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.100", "MH_TH": "NLM (2010)", "ST": "T007", "RN": "txid1385", "MS": "An order of gram-positive bacteria in the class Bacilli, phylum Firmicutes.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056449"}, {"RECTYPE": "D", "MH": "Alicyclobacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.400.078", "MH_TH": "NLM (2010)", "ST": "T007", "RN": "txid29330", "PI": "Gram-Positive Endospore-Forming Rods (1992-2009)", "MS": "A genus of GRAM-POSITIVE ENDOSPORE-FORMING RODS, in the family Alicyclobacillaceae, containing a unique lipid in their membranes.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056450"}, {"RECTYPE": "D", "MH": "Histone Deacetylase 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "HDAC2 Histone Deacetylase|T116|T123|ABX|EQV|NLM (2010)|081219|abbcdef", "MN": "D08.811.600.795.200", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "EC 3.5.1.98", "MS": "A histone deacetylase subtype that is found along with HISTONE DEACETYLASE 1; RETINOBLASTOMA-BINDING PROTEIN 4; and RETINOBLASTOMA-BINDING PROTEIN 7 as core components of histone deacetylase complexes.", "PM": "2010; HISTONE DEACETYLASE 2 was indexed under HISTONE DEACETYLASES and REPRESSOR PROTEINS 1999-2009", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056464"}, {"RECTYPE": "D", "MH": "Retinoblastoma-Binding Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Retinoblastoma Binding Protein 1", "MN": "D12.776.660.769.100", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A ubiquitously expressed regulatory protein that contains a retinoblastoma protein binding domain and an AT-rich interactive domain. The protein may play a role in recruiting HISTONE DEACETYLASES to the site of RETINOBLASTOMA PROTEIN-containing transcriptional repressor complexes.", "PM": "2010; RETINOBLASTOMA-BINDING PROTEIN 1 was indexed under CARRIER PROTEINS 2001-2009", "HN": "2010", "MR": "20160218", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056465"}, {"RECTYPE": "D", "MH": "Histone Demethylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Histone Lysine Demethylase|T116|T126|NON|NRW|NLM (2021)|191129|abbcdef", "ENTRY": "Lysine Demethylases, Histone", "MN": "D08.811.682.662.582.475", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 1.14.11.-", "MS": "Enzymes that catalyse the removal of methyl groups from LYSINE or ARGININE residues found on HISTONES. Many histone demethylases generally function through an oxidoreductive mechanism.", "PM": "2010", "HN": "2010", "MR": "20200527", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056466"}, {"RECTYPE": "D", "MH": "Jumonji Domain-Containing Histone Demethylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Jumonji Domain Containing Histone Demethylases", "MN": "D08.811.682.690.416.388", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 1.14.11.-", "MS": "A family of histone demethylases that share a conserved Jumonji C domain. The enzymes function via an iron-dependent dioxygenase mechanism that couples the conversion of 2-oxoglutarate to succinate to the hydroxylation of N-methyl groups.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056484"}, {"RECTYPE": "D", "MH": "Retinoblastoma-Binding Protein 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Retinoblastoma Binding Protein 2", "MN": "D12.776.660.769.200", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 1.14.11.27", "PI": "Tumor Suppressor Proteins (2005-2009)", "MS": "A retinoblastoma binding protein that is also a member of the Jumonji-domain histone demethylases. It has demethylation activity towards specific LYSINE residues found on HISTONE H3.", "PM": "2010", "HN": "2010", "MR": "20160628", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056485"}, {"RECTYPE": "D", "MH": "Chemical and Drug Induced Liver Injury", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Liver Injury, Drug-Induced|T047|NON|NRW|NLM (2010)|081210|abcdef", "ENTRY": "Toxicity, Chemically-Induced Liver", "MN": "C25.723.260", "MH_TH": "NLM (2017)", "ST": "T047", "AN": "coordinate with specific substance /adv eff /pois or /tox; CHEMICAL AND DRUG INDUCED LIVER INJURY, CHRONIC is also available", "PI": "Liver Diseases/chemically induced (1973-2009)", "MS": "A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.", "PM": "2017; for HEPATITIS, DRUG-INDUCED see HEPATITIS, TOXIC 1996-2009; for HEPATITIS, TOXIC see HEPATITIS, TOXIC 1966-2009; was DRUG-INDUCED LIVER INJURY 2010-2017", "HN": "2017(2010)", "MR": "20180630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056486"}, {"RECTYPE": "D", "MH": "Chemical and Drug Induced Liver Injury, Chronic", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Liver Injury, Drug-Induced, Chronic|T047|NON|NRW|NLM (2010)|081209|abcdef", "ENTRY": "Drug Induced Liver Injury, Chronic", "MN": "C25.723.260.200", "MH_TH": "NLM (2018)", "ST": "T047", "AN": "coordinate with specific drug /adv eff /pois or/ tox", "PI": "Liver Diseases/chemically induced (1985-2009)", "MS": "Liver disease lasting six months or more, caused by an adverse effect of a drug or chemical. The adverse effect may be caused by drugs, drug metabolites, chemicals from the environment, or an idiosyncratic response.", "PM": "2018; see DRUG-INDUCED LIVER INJURY, CHRONIC 2010-2017; for HEPATITIS, CHRONIC, DRUG-INDUCED see HEPATITIS, CHRONIC, DRUG-INDUCED 1998-2009", "HN": "2018; was DRUG-INDUCED LIVER INJURY, CHRONIC 2010-2017; for HEPATITIS, CHRONIC, DRUG-INDUCED use HEPATITIS, CHRONIC, DRUG-INDUCED 1998-2009", "MR": "20210312", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056487"}, {"RECTYPE": "D", "MH": "Histone Chaperones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Histone Chaperone|T116|T123|NON|EQV|NLM (2021)|191230|abbcdef", "ENTRY": "Chaperones, Histone", "MN": "D12.776.580.219", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "Proteins involved in the assembly and disassembly of HISTONES into NUCLEOSOMES.", "PM": "2010", "HN": "2010", "MR": "20200527", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056488"}, {"RECTYPE": "D", "MH": "Nucleoplasmins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nucleoplasmin|T116|T123|NON|EQV|NLM (2010)|081210|abbcdef", "MN": "D12.776.580.219.500", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A family of histone molecular chaperones that play roles in sperm CHROMATIN decondensation and CHROMATIN ASSEMBLY in fertilized eggs. They were originally discovered in XENOPUS egg extracts as histone-binding factors that mediate nucleosome formation in vitro.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056489"}, {"RECTYPE": "D", "MH": "Nucleosome Assembly Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.580.219.550", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A histone chaperone that facilitates nucleosome assembly by mediating the formation of the histone octamer and its transfer to DNA.", "PM": "2010; NUCLEOSOME ASSEMBLY PROTEIN 1 was indexed under NUCLEAR PROTEINS and CELL CYCLE PROTEINS 2005-2009, and under PROTEINS 1986-2005", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056490"}, {"RECTYPE": "D", "MH": "Chromatin Assembly Factor-1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Chromatin Assembly Factor 1", "MN": "D12.776.580.219.200", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A histone chaperone protein that plays a role in the deposition of NUCLEOSOMES on newly synthesized DNA. It is comprised of three different subunits of 48, 60, and 150 kDa molecular size. The 48 kDa subunit, RETINOBLASTOMA-BINDING PROTEIN 4, is also a component of several other protein complexes involved in chromatin remodeling.", "PM": "2010; CHROMATIN ASSEMBLY FACTOR-1 was indexed under CHROMOSOMAL PROTEINS, NON-HISTONE and DNA-BINDING PROTEINS 1995-2009", "HN": "2010(1995)", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056504"}, {"RECTYPE": "D", "MH": "Retinoblastoma-Binding Protein 4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "p48-Binding Protein, Retinoblastoma", "MN": "D12.776.930.780.890.200.500", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A retinoblastoma-binding protein that is involved in CHROMATIN REMODELING, histone deacetylation, and repression of GENETIC TRANSCRIPTION. Although initially discovered as a retinoblastoma binding protein it has an affinity for core HISTONES and is a subunit of chromatin assembly factor-1 and polycomb repressive complex 2.", "PM": "2010", "HN": "2010", "MR": "20160218", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056505"}, {"RECTYPE": "D", "MH": "Geobacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.158.400", "MH_TH": "NLM (2010)", "ST": "T007", "RN": "txid129337", "PI": "Bacillaceae (2002-2009)", "MS": "A genus of gram-positive, endospore-forming, thermophilic bacteria in the family BACILLACEAE.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056506"}, {"RECTYPE": "D", "MH": "Paenibacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.645", "MH_TH": "NLM (2010)", "ST": "T007", "RN": "txid44249", "AN": "infection: coordinate IM with GRAM POSITIVE BACTERIAL INFECTIONS (IM)", "PI": "Bacillus (1993-2009)", "MS": "A genus of GRAM-POSITIVE ENDOSPORE-FORMING RODS in the family Paenibacillaceae.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056507"}, {"RECTYPE": "D", "MH": "Sleep Medicine Specialty", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Specialty, Sleep Medicine", "MN": "H02.403.429.865", "MH_TH": "NLM (2010)", "ST": "T091", "AN": "use for the discipline (education, history, etc) only; do not use for sleep medications", "MS": "A medical specialty concerned with the diagnosis and treatment of SLEEP WAKE DISORDERS and their causes.", "PM": "2010", "HN": "2010", "MR": "20150713", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056508"}, {"RECTYPE": "D", "MH": "Thermoactinomyces", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.100.800", "MH_TH": "NLM (1993)", "ST": "T007", "RN": "txid2023", "PI": "Micromonosporaceae (1972-2009)", "MS": "A genus of gram-positive bacteria in the family Thermoactinomycetaceae, that can cause FARMER'S LUNG.", "PM": "2010; see MICROMONOSPORACEAE 1993-2009", "HN": "2010; use MICROMONOSPORACEAE 1993-2009", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056509"}, {"RECTYPE": "D", "MH": "Position-Specific Scoring Matrices", "PRINT ENTRY": "Position-Specific Weight Matrices|T081|NON|EQV|NLM (2010)|081212|abcdef", "ENTRY": "Weight Matrix, Position-Specific", "MN": "G02.111.570.580.175.500", "MH_TH": "NLM (2010)", "ST": "T081", "MS": "Tabular numerical representations of sequence motifs displaying their variability as likelihood values for each possible residue at each position in a sequence. Position-specific scoring matrices (PSSMs) are calculated from position frequency matrices.", "PM": "2010", "HN": "2010", "MR": "20090717", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056510"}, {"RECTYPE": "D", "MH": "Metallochaperones", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Metallochaperone|T116|T123|NON|EQV|NLM (2010)|081212|abbcdef", "MN": "D12.776.580.612", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Molecular Chaperones (1999-2009)", "MS": "A family of soluble metal binding proteins that are involved in the intracellular transport of specific metal ions and their transfer to the appropriate metalloprotein precursor.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056511"}, {"RECTYPE": "D", "MH": "Retinoblastoma-Binding Protein 7", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Retinoblastoma Binding Protein 7", "MN": "D12.776.930.780.890.200.750", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Nuclear Proteins (2004-2009)", "MS": "A retinoblastoma-binding protein that has an affinity for core HISTONES. It is found as a subunit of protein complexes that are in involved in the enzymatic modification of histones including the Mi2 and Sin3 histone deacetylase complexes and the polycomb repressive complex 2.", "PM": "2010", "HN": "2010", "MR": "20160218", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056524"}, {"RECTYPE": "D", "MH": "Group III Histone Deacetylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sirtuin Histone Deacetylases|T116|T126|NON|NRW|NLM (2010)|081216|abbcdef", "ENTRY": "Sir2 like Deacetylases", "MN": "D08.811.277.087.520.200", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.5.1.-", "MS": "A subclass of histone deacetylases that are NAD-dependent. Several members of the SIRTUINS family are included in this subclass.", "PM": "2010; for SIR2-LIKE DEACETYLASES see SIRTUINS 2003-2009", "HN": "2010; for SIR2-LIKE DEACETYLASES use SIRTUINS 2003-2009", "MR": "20090721", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056545"}, {"RECTYPE": "D", "MH": "Lactobacillales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Lactic Acid Bacteria|T007|NON|EQV|NLM (2018)|170112|abcdef", "MN": "B03.510.550", "MH_TH": "NLM (2010)", "ST": "T007", "RN": "txid186826", "MS": "An order of gram-positive bacteria in the class Bacilli, that have the ability to ferment sugars to lactic acid. They are widespread in nature and commonly used to produce FERMENTED FOODS.", "PM": "2010", "HN": "2010", "MR": "20210712", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056546"}, {"RECTYPE": "D", "MH": "CA1 Region, Hippocampal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Stratum Radiatums, CA1", "MN": "A08.186.211.200.885.287.500.345.099", "FX": "Pyramidal Cells", "MH_TH": "NLM (2010)", "ST": "T023", "AN": "note entry term CA1 PYRAMIDAL CELL AREA: coordinate with PYRAMIDAL CELLS if pertinent", "PI": "Hippocampus (1976-2009)", "MS": "One of four subsections of the hippocampus described by Lorente de No, located furthest from the DENTATE GYRUS.", "PM": "2010", "HN": "2010", "MR": "20180630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056547"}, {"RECTYPE": "D", "MH": "Sirtuin 1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sirt1|T116|T126|ABB|EQV|NLM (2019)|180326|abbcdef", "MN": "D12.776.476.900.100", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.5.1.-", "PI": "Sirtuins (2007-2009)", "MS": "A sirtuin family member found primarily in the CELL NUCLEUS. It is an NAD-dependent deacetylase with specificity towards HISTONES and a variety of proteins involved in gene regulation.", "PM": "2010", "HN": "2010", "MR": "20180614", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056564"}, {"RECTYPE": "D", "MH": "Sirtuin 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sirt2|T116|T126|ABB|EQV|NLM (2019)|180326|abbcdef", "MN": "D12.776.476.900.200", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.5.1.-", "RR": "EC 2.4.2.-", "PI": "Sirtuins (2007-2009)", "MS": "A sirtuin family member found primarily in the CYTOPLASM. It is a multifunctional enzyme that contains a NAD-dependent deacetylase activity that is specific for HISTONES and a mono-ADP-ribosyltransferase activity.", "PM": "2010", "HN": "2010", "MR": "20180614", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056565"}, {"RECTYPE": "D", "MH": "Sirtuin 3", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sirt3|T116|T126|NON|EQV|NLM (2019)|180326|abbcdef", "MN": "D12.776.575.875", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.5.1.-", "RR": "EC 2.4.2.-", "PI": "Sirtuins (2006-2009)", "MS": "A sirtuin family member found primarily in MITOCHONDRIA. It is a multifunctional enzyme that contains a NAD-dependent deacetylase activity that is specific for HISTONES and a mono-ADP-ribosyltransferase activity.", "PM": "2010", "HN": "2010", "MR": "20180614", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056566"}, {"RECTYPE": "D", "MH": "Aerococcaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.030", "MH_TH": "NLM (2010)", "ST": "T007", "RN": "txid186827", "MS": "A family of gram-positive lactic acid-producing bacteria in the order Lactobacillales.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056567"}, {"RECTYPE": "D", "MH": "Carnobacteriaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.130", "MH_TH": "NLM (2010)", "ST": "T007", "RN": "txid186828", "MS": "A family of gram-positive, lactic acid-producing bacteria in the order Lactobacillales. It includes both high-pressure-loving species (piezophiles) found in the deep ocean, and Antarctic species.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056568"}, {"RECTYPE": "D", "MH": "Enterococcaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Tetragenococcus|T007|NON|NRW|NLM (2010)|081218|abcdef", "MN": "B03.510.550.250", "MH_TH": "NLM (2010)", "ST": "T007", "RN": "txid81852", "RR": "txid51668", "MS": "A family of gram-positive bacteria in the order Lactobacillales, phylum Firmicutes.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056569"}, {"RECTYPE": "D", "MH": "Aerococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.030.030", "MH_TH": "UNK (19XX)", "ST": "T007", "RN": "txid1375", "AN": "infection: coordinate IM with GRAM POSITIVE BACTERIAL INFECTIONS", "PI": "Streptococcaceae (1970-2009)", "MS": "A genus of gram-positive cocci in the family AEROCOCCACEAE, occurring as airborne saprophytes.", "PM": "2010; see STREPTOCOCCACEAE 1979-2009", "HN": "2010; use STREPTOCOCCACEAE 1979-2009", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056570"}, {"RECTYPE": "D", "MH": "Postcard", "PRINT ENTRY": "Postcards|T170|NON|EQV|NLM (2010)|081219|abcdef", "MN": "V02.731", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Postcards as a subject are indexed under the main heading POSTCARDS AS TOPIC. INDEXER: Do not use", "MS": "Card on which a message may be written or printed for mailing without an envelope. Art & Architectural Thesaurus Online www.getty.edu/research/conducting_research/vocabularies/aat/ accessed 12/18/2008", "HN": "2010", "MR": "20180702", "DA": "20090706", "DC": "2", "DX": "20100101", "UI": "D056571"}, {"RECTYPE": "D", "MH": "Histone Deacetylase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "HDAC Inhibitor|T121|NON|EQV|NLM (2021)|191129|abcdef", "ENTRY": "Inhibitors, Histone Deacetylase", "MN": "D27.505.519.389.360", "MH_TH": "NLM (2010)", "ST": "T121", "RN": "0", "PI": "Histone Deacetylases/antagonists & inhibitors (1978-2009)", "MS": "Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains.", "PM": "2010", "HN": "2010", "MR": "20200527", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056572"}, {"RECTYPE": "D", "MH": "Carnobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.130.150", "MH_TH": "NLM (2010)", "ST": "T007", "RN": "txid2747", "PI": "Lactobacillaceae (1989-2005)", "MS": "A genus of gram-positive bacteria in the family CARNOBACTERIACEAE. They are tolerant to freezing/thawing and high pressure and able to grow at low temperatures.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056573"}, {"RECTYPE": "D", "MH": "Leuconostocaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Weisella|T007|NON|NRW|NLM (2010)|081222|abcdef", "MN": "B03.510.550.475", "MH_TH": "NLM (2010)", "ST": "T007", "RN": "txid81850", "MS": "A family of gram-positive bacteria in the order Lactobacillales. Lactic acid is the main product of their carbohydrate metabolism.", "PM": "2010", "HN": "2010", "MR": "20200902", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056584"}, {"RECTYPE": "D", "MH": "Oenococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.475.600", "MH_TH": "NLM (2010)", "ST": "T007", "RN": "txid46254", "PI": "Gram-Positive Cocci (1995-2009)", "MS": "A genus of GRAM-POSITIVE COCCI in the family LEUCONOSTOCACEAE. It is the primary bacteria involved in carrying out malolactic conversion in winemaking.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056585"}, {"RECTYPE": "D", "MH": "Acute Chest Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Acute Chest", "MN": "C16.320.365.155.219", "FX": "Respiratory Distress Syndrome", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Respiratory Distress Syndrome, Adult (1989-2009)", "MS": "Respiratory syndrome characterized by the appearance of a new pulmonary infiltrate on chest x-ray, accompanied by symptoms of fever, cough, chest pain, tachypnea, or DYSPNEA, often seen in patients with SICKLE CELL ANEMIA. Multiple factors (e.g., infection, and pulmonary FAT EMBOLISM) may contribute to the development of the syndrome.", "PM": "2010", "HN": "2010", "MR": "20230226", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056586"}, {"RECTYPE": "D", "MH": "Cryopyrin-Associated Periodic Syndromes", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neonatal Onset Multisystem Inflammatory Disease|T047|NON|NRW|GHR (2014)|NLM (2010)|ORD (2010)|081224|abcdeeef", "ENTRY": "Urticaria-Deafness-Amyloidosis Syndromes", "MN": "C23.550.291.500.360.500.500", "FX": "NLR Family, Pyrin Domain-Containing 3 Protein", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Urticaria (1972-2009)", "MS": "A group of rare autosomal dominant diseases, commonly characterized by atypical URTICARIA (hives) with systemic symptoms that develop into end-organ damage. The atypical hives do not involve T-cell or autoantibody. Cryopyrin-associated periodic syndrome includes three previously distinct disorders: Familial cold autoinflammatory syndrome; Muckle-Wells Syndrome; and CINCA Syndrome, that are now considered to represent a disease continuum, all caused by NLRP3 PROTEIN mutations.", "PM": "2010; see Cryopyrin-associated Periodic Syndromes, 2010", "HN": "2010; use Cryopyrin-associated Periodic Syndromes, 2010", "MR": "20230405", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056587"}, {"RECTYPE": "D", "MH": "Grape Seed Extract", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Seed Extract, Grape", "MN": "D26.667.500", "PA": "Antioxidants", "FX": "Proanthocyanidins", "MH_TH": "NLM (2010)", "ST": "T167", "RN": "0", "PI": "Plant Extracts (1998-2009)", "MS": "Exudate from seeds of the grape plant Vitis vinifera, composed of oils and secondary plant metabolites (BIOFLAVONOIDS and polyphenols) credited with important medicinal properties.", "PM": "2010; IH636 GRAPE SEED PROANTHOCYANIDIN EXTRACTS was indexed under PLANT EXTRACTS and PROANTHOCYANIDINS 2001-2009", "HN": "2010 (2001)", "MR": "20090721", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056604"}, {"RECTYPE": "D", "MH": "Apexification", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Apexogenesis|T061|NON|REL|NLM (2010)|081230|abcdef", "ENTRY": "Apexogeneses", "MN": "E06.397.778.188", "MH_TH": "NLM (2010)", "ST": "T061", "PI": "Root Canal Therapy (1974-2009)", "MS": "Endodontic procedure performed to induce TOOTH APEX barrier development. ROOT CANAL FILLING MATERIALS are used to repair open apex or DENTAL PULP NECROSIS in an immature tooth. CALCIUM HYDROXIDE and mineral trioxide aggregate are commonly used as the filling materials.", "PM": "2010; see ROOT CANAL APEXIFICATION 2008-2009", "HN": "2010; use ROOT CANAL APEXIFICATION 2008-2009", "MR": "20090721", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056624"}, {"RECTYPE": "D", "MH": "Endosperm", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Endosperms", "MN": "A18.024.500.750.666", "FX": "Starch", "MH_TH": "NLM (2010)", "ST": "T002", "PI": "Seeds (2003-2009)", "MS": "Nutritive tissue of the seeds of flowering plants that surrounds the EMBRYOS. It is produced by a parallel process of fertilization in which a second male gamete from the pollen grain fuses with two female nuclei within the embryo sac. The endosperm varies in ploidy and contains reserves of starch, oils, and proteins, making it an important source of human nutrition.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056625"}, {"RECTYPE": "D", "MH": "Inflorescence", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Types, Inflorescence", "MN": "A18.024.249.500.624", "MH_TH": "NLM (2010)", "ST": "T002", "PI": "Flowers (2002-2009)", "MS": "A cluster of FLOWERS (as opposed to a solitary flower) arranged on a main stem of a plant.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056626"}, {"RECTYPE": "D", "MH": "Peritoneal Fibrosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Peritoneal Sclerosis|T033|T046|NON|NRW|NLM (2010)|081230|abbcdef", "ENTRY": "Syndromes, Peritoneal Fibrosing", "MN": "C23.550.355.625", "FX": "Retroperitoneal Fibrosis", "MH_TH": "NLM (2010)", "ST": "T046", "PI": "Peritoneal Diseases (1964-2009)", "MS": "Disorder characterized by a wide range of structural changes in PERITONEUM, resulting from fibrogenic or inflammatory processes. Peritoneal fibrosis is a common complication in patients receiving PERITONEAL DIALYSIS and contributes to its gradual decrease in efficiency.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056627"}, {"RECTYPE": "D", "MH": "Dicistroviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Israeli acute paralysis virus of bees|T005|NON|NRW|NLM (2010)|081230|abcdef", "ENTRY": "Cripaviruses", "MN": "B04.820.578.329", "MH_TH": "NLM (2010)", "ST": "T005", "RN": "txid232795", "RR": "txid294365", "MS": "A family of invertebrate RNA viruses in the order Picornavirales.", "PM": "2010", "HN": "2010", "MR": "20211018", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056629"}, {"RECTYPE": "D", "MH": "Beekeeping", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Apiculture|T090|NON|EQV|NLM (2010)|090123|abcdef", "MN": "J01.040.207", "MH_TH": "NLM (2010)", "ST": "T090", "MS": "The management and maintenance of colonies of honeybees.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056630"}, {"RECTYPE": "D", "MH": "Colony Collapse", "AQ": "CI CL EC EP GE HI LJ MI PC PS SN VI", "PRINT ENTRY": "Colony Collapse Disorder|T046|NON|REL|NLM (2010)|081231|abcdef", "ENTRY": "Disorders, Colony Collapse", "MN": "G16.150", "MH_TH": "NLM (2010)", "ST": "T067", "AN": "coordinate with BEES or other organism", "MS": "The sudden collapse and disappearance or diminution of a colony of organisms.", "PM": "2010", "HN": "2010", "MR": "20160623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056631"}, {"RECTYPE": "D", "MH": "Cathepsin F", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.656.300.200.146", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.4.22.41", "MS": "A lysosomal papain-related cysteine proteinase that is expressed in a broad variety of cell types.", "PM": "2010; CATHEPSIN F was indexed under CATHEPSINS 1998-2009", "HN": "2010(1998)", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056646"}, {"RECTYPE": "D", "MH": "Systemic Vasculitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vasculitis, Systemic", "MN": "C14.907.940.897", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Vasculitis (1966-2009)", "MS": "A heterogeneous group of diseases characterized by inflammation and necrosis of the blood vessel walls.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056647"}, {"RECTYPE": "D", "MH": "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pauci-Immune Vasculitis|T047|NON|EQV|NLM (2010)|090108|abcdef", "ENTRY": "Vasculitis, Pauci-Immune", "MN": "C20.111.193", "MH_TH": "NLM (2010)", "ST": "T047", "MS": "Group of systemic vasculitis with a strong association with ANCA. The disorders are characterized by necrotizing inflammation of small and medium size vessels, with little or no immune-complex deposits in vessel walls.", "PM": "2010", "HN": "2010", "MR": "20211018", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056648"}, {"RECTYPE": "D", "MH": "Cathepsin G", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.656.959.350.066", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.4.21.20", "MS": "A serine protease found in the azurophil granules of NEUTROPHILS. It has an enzyme specificity similar to that of chymotrypsin C.", "PM": "2010; Cathepsin G was indexed under CATHEPSINS and SERINE ENDOPEPTIDASES 1980-2009", "HN": "2010(1980)", "MR": "20151123", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056649"}, {"RECTYPE": "D", "MH": "Vulvodynia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vulva Pain|T047|NON|REL|NLM (2023)|210830|abcdef", "ENTRY": "Vulvodynia, Generalized", "MN": "C12.100.250.944.951", "FX": "Vulvar Vestibulitis", "MH_TH": "NLM (2010)", "ST": "T047", "AN": "do not confuse with VULVAR VESTIBULITIS", "PI": "Vulvitis (1987-2007)", "MS": "Complex pain syndrome with unknown etiology, characterized by constant or intermittent generalized vulva pain (Generalized vulvodynia) or localized burning sensations in the VESTIBULE area when pressure is applied (Vestibulodynia, or Vulvar Vestibulitis Syndrome). Typically, vulvar tissue with vulvodynia appears normal without infection or skin disease. Vulvodynia impacts negatively on a woman's quality of life as it interferes with sexual and daily activities.", "PM": "2010; for Vestibulodynia, see VULVAR VESTIBULITIS SYNDROME 2008-2009", "HN": "2010; for Vestibulodynia, use VULVAR VESTIBULITIS SYNDROME 2008-2009", "MR": "20211018", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056650"}, {"RECTYPE": "D", "MH": "CA2 Region, Hippocampal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Stratum Radiatums, CA2", "MN": "A08.186.211.200.885.287.500.345.149", "FX": "Pyramidal Cells", "MH_TH": "NLM (2010)", "ST": "T023", "AN": "note entry term CA2 PYRAMIDAL CELL AREA: coordinate with PYRAMIDAL CELLS if pertinent", "PI": "Hippocampus (1983-2009)", "MS": "A subsection of the hippocampus, described by Lorente de No, that is located between the HIPPOCAMPUS CA1 FIELD and the HIPPOCAMPUS CA3 FIELD.", "PM": "2010", "HN": "2010", "MR": "20180630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056651"}, {"RECTYPE": "D", "MH": "Rheumatoid Vasculitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vasculitis, Rheumatoid", "MN": "C20.111.199.581", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Vasculitis (1977-2009)", "MS": "Necrotizing VASCULITIS of small and medium size vessels, developing as a complication in RHEUMATOID ARTHRITIS patients. It is characterized by peripheral vascular lesions, cutaneous ULCERS, peripheral GANGRENE, and MONONEURITIS MULTIPLEX.", "PM": "2010", "HN": "2010", "MR": "20200527", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056653"}, {"RECTYPE": "D", "MH": "CA3 Region, Hippocampal", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Stratum Radiatums, CA3", "MN": "A08.186.211.200.885.287.500.345.174", "FX": "Pyramidal Cells", "MH_TH": "NLM (2010)", "ST": "T023", "AN": "note entry term CA3 PYRAMIDAL CELL AREA: coordinate with PYRAMIDAL CELLS if pertinent", "PI": "Hippocampus (1963-2009)", "MS": "A subsection of the hippocampus, described by Lorente de No, that is located between the HIPPOCAMPUS CA2 FIELD and the DENTATE GYRUS.", "PM": "2010", "HN": "2010", "MR": "20180630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056654"}, {"RECTYPE": "D", "MH": "Cathepsin H", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D23.050.705.552.600.300", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.4.22.16", "MS": "An ubiquitously-expressed lysosomal cysteine protease that is involved in protein processing. The enzyme has both endopeptidase and aminopeptidase activities.", "PM": "2010; CATHEPSIN H was indexed under CATHEPSINS and CYSTEINE ENDOPEPTIDASES 1975-2009, under BENZOYLARGININE-2-NAPHTHYLAMIDE 1976-1981, & under AMIDES, AMIDOHYDROLASES, and NAPHTHALENES 1973-1974", "HN": "2010(1980)", "MR": "20160226", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056655"}, {"RECTYPE": "D", "MH": "Lab-On-A-Chip Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Nanochip Analytical Device", "MN": "E07.305.343.500", "FX": "Microchip Analytical Procedures", "MH_TH": "NLM (2010)", "ST": "T075", "AN": "note entry term MICROCHIP ANALYTICAL DEVICES: MICROCHIP ANALYTICAL PROCEDURES is also available", "PI": "Microchip Analytical Devices (2001-2009)", "MS": "Microdevices that combine microfluidics technology with electrical and/or mechanical functions for analyzing very small fluid volumes. They consist of microchannels etched into substrates made of silicon, glass, or polymer using processes similar to photolithography. The test fluids in the channels can then interact with different elements such as electrodes, photodetectors, chemical sensors, pumps, and valves.", "PM": "2010; see MICROCHIP ANALYTICAL PROCEDURES 2005-2009; ; for MICROCHIP ANALYTICAL DEVICES & NANOCHIP ANALYTICAL DEVICES use MICROCHIP ANALYTICAL PROCEDURES 2005-2009", "HN": "2010; use MICROCHIP ANALYTICAL PROCEDURES 2005-2009; for MICROCHIP ANALYTICAL DEVICES & NANOCHIP ANALYTICAL DEVICES use MICROCHIP ANALYTICAL PROCEDURES 2005-2009", "MR": "20150626", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056656"}, {"RECTYPE": "D", "MH": "Cathepsin K", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.656.300.200.156", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.4.22.38", "AN": "Cathepsin X, an obsolete multi-meaning term appearing in older literature goes here or at CATHEPSIN Z: check text; Cathepsin O and Cathepsin O2 in older literature go here.", "MS": "A cysteine protease that is highly expressed in OSTEOCLASTS and plays an essential role in BONE RESORPTION as a potent EXTRACELLULAR MATRIX-degrading enzyme.", "PM": "2010; CATHEPSIN K was indexed under CATHEPSINS 1984-2009", "HN": "2010(1984)", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056657"}, {"RECTYPE": "D", "MH": "Hereditary Autoinflammatory Diseases", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hereditary Recurrent Fevers|T047|NON|EQV|NLM (2010)|090108|abcdef", "ENTRY": "Siegal Cattan Mamou Disease", "MN": "C17.800.827.368", "MH_TH": "NLM (2010)", "ST": "T047", "MS": "Hereditary inflammation conditions, characterized by recurrent episodes of systemic inflammation. Common symptoms include recurrent fever, rash, arthritis, fatigue, and secondary AMYLOIDOSIS. Hereditary autoinflammatory diseases are associated with mutations in genes involved in regulation of normal inflammatory process and are not caused by AUTOANTIBODIES, or antigen specific T-LYMPHOCYTES.", "PM": "2010; for Hereditary Periodic Fever Syndromes see Familial Mediterranean Fever 2000-2009", "HN": "2010 (2000); for Hereditary Periodic Fever Syndromes use Familial Mediterranean Fever 2000-2009", "MR": "20150618", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056660"}, {"RECTYPE": "D", "MH": "Human bocavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "bocavirus, Human", "MN": "B04.280.580.650.085.500", "MH_TH": "NLM (2010)", "ST": "T005", "RN": "txid329641", "AN": "infection: coordinate IM with PARVOVIRIDAE INFECTIONS (IM)", "PI": "Bocavirus (2007-2009)", "MS": "A member of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, originally isolated from human nasopharyngeal aspirates in patients with respiratory disease.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056661"}, {"RECTYPE": "D", "MH": "Proboscidea Mammal", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Proboscidea Mammals", "MN": "B01.050.150.900.649.313.250.500", "MH_TH": "NLM (2003)", "ST": "T015", "RN": "txid9779", "AN": "do not confuse the order Proboscidea with the Proboscidea plant genus (PEDALIACEAE).", "MS": "An order of MAMMALS that feeds using their trunks. It contains one family, the Elephantidae, comprised of two living genera of ELEPHANTS plus the extinct MAMMOTHS and MASTODONS.", "PM": "2010; see ELEPHANTS 2003-2009", "HN": "2010; use ELEPHANTS 2003-2009", "MR": "20210630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056662"}, {"RECTYPE": "D", "MH": "Cathepsin Z", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cathepsin P|T116|T126|NON|EQV|NLM (2010)|090108|abbcdef", "MN": "D08.811.277.656.350.245.270", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.4.18.1", "AN": "Cathepsin X, an obsolete multi-meaning term appearing in older literature goes here or at CATHEPSIN K: check text", "MS": "A ubiquitously-expressed cysteine peptidase that exhibits carboxypeptidase activity. It is highly expressed in a variety of immune cell types and may play a role in inflammatory processes and immune responses.", "PM": "2010; CATHEPSIN Z was indexed under CATHEPSINS 1984-2009", "HN": "2010(1984); use CATHEPSIN K 1984-2009", "MR": "20130709", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056663"}, {"RECTYPE": "D", "MH": "Cathepsin W", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lymphopain|T116|T126|NON|EQV|NLM (2010)|090108|abbcdef", "MN": "D08.811.277.656.300.200.158", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.4.22.-", "MS": "A cysteine endopeptidase found in NATURAL KILLER CELLS and CYTOTOXIC T-LYMPHOCYTES. It may have a specific function in the mechanism or regulation of cytolytic activity of immune cells.", "PM": "2010; CATHEPSIN W was indexed under CATHEPSINS and CYSTEINE ENDOPEPTIDASES 1997-2009", "HN": "2010(1997)", "MR": "20130709", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056664"}, {"RECTYPE": "D", "MH": "Mammoths", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Woolly Mammoth|T015|NON|NRW|NLM (2010)|090108|abcdef", "ENTRY": "Woolly Mammoths", "MN": "B01.050.150.900.649.313.250.500.500", "MH_TH": "NLM (2010)", "ST": "T015", "RN": "txid37348", "RR": "txid37349", "PI": "Elephants (1985-2009)", "MS": "An extinct genus of large mammals in the family Elephantidae that fed by grazing on low vegetation. Most died out at the end of the last ice age.", "PM": "2010", "HN": "2010", "MR": "20210630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056665"}, {"RECTYPE": "D", "MH": "Mastodons", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Mastodons, American", "MN": "B01.050.150.900.649.313.250.500.525", "MH_TH": "NLM (2010)", "ST": "T015", "RN": "txid39051", "RR": "txid39053", "PI": "Elephants (1983-2009)", "MS": "An extinct genus of large mammals in the family Mammutidae, that fed by browsing on tall plants. Eurasian species died out three million years ago, but some specimens of the American Mastodon survived the last Ice Age.", "PM": "2010", "HN": "2010", "MR": "20210630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056666"}, {"RECTYPE": "D", "MH": "Biometric Identification", "AQ": "EC ES HI IS MT SN ST TD", "PRINT ENTRY": "Automated Identity Recognition|T066|NON|EQV|NLM (2021)|200528|abcdef", "ENTRY": "Identity Recognition, Automated", "MN": "N04.452.910.099", "FX": "Speech Recognition Software", "MH_TH": "NLM (2010)", "ST": "T066", "PI": "Security Measures (2007-2009)", "MS": "A method of differentiating individuals based on the analysis of qualitative or quantitative biological traits or patterns. Biometric identification, which has applications in forensics and identity theft prevention, includes DNA profiles or DNA FINGERPRINTS; FINGERPRINTS; AUTOMATED FACIAL RECOGNITION; IRIS scan; RETINA scan; hand geometry; vascular patterns; automated VOICE pattern recognition; ultrasound of fingers; and X-RAYS.", "PM": "2010", "HN": "2010", "MR": "20200623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056667"}, {"RECTYPE": "D", "MH": "Cathepsin L", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D08.811.277.656.300.200.157", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.4.22.15", "MS": "A ubiquitously-expressed cysteine protease that plays an enzymatic role in POST-TRANSLATIONAL PROTEIN PROCESSING of proteins within SECRETORY GRANULES.", "PM": "2010; CATHEPSIN L was indexed under CATHEPSINS and CYSTEINE ENDOPEPTIDASES 1980-2009", "HN": "2010(1980)", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056668"}, {"RECTYPE": "D", "MH": "Galactogogues", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Galactagogues|T121|NON|EQV|NLM (2010)|090109|abcdef", "MN": "D27.505.696.365", "FX": "Lactation", "MH_TH": "NLM (2010)", "ST": "T121", "RN": "0", "PI": "Lactation (1963-2009)", "MS": "Substances that induce LACTATION.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056669"}, {"RECTYPE": "D", "MH": "Yellow Nail Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Yellow Nail Syndromes", "MN": "C23.300.820.500", "FX": "Pleural Effusion", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Nails, Malformed (1965-2009)", "MS": "A rare condition characterized by the presence of yellow nails, LYMPHEDEMA, and/or PLEURAL EFFUSION with respiratory tract involvement. Abnormal lymphatic network may play a role in its etiology. Occasionally inherited, yellow nail syndrome mostly is sporadic without apparent family history.", "PM": "2010", "HN": "2010", "MR": "20160701", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056684"}, {"RECTYPE": "D", "MH": "Costello Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Faciocutaneoskeletal Syndrome|T019|T047|NON|EQV|GHR (2014)|NLM (2010)|OMIM (2013)|ORD (2010)|090113|abbcdeeeef", "ENTRY": "Syndromes, Faciocutaneoskeletal", "MN": "C16.320.188", "FX": "Proto-Oncogene Proteins p21(ras)", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Rare congenital disorder with multiple anomalies including: characteristic dysmorphic craniofacial features, musculoskeletal abnormalities, neurocognitive delay, and high prevalence of cancer. Germline mutations in H-Ras protein can cause Costello syndrome. Costello syndrome shows early phenotypic overlap with other disorders that involve MAP KINASE SIGNALING SYSTEM (e.g., NOONAN SYNDROME and cardiofaciocutaneous syndrome).", "PM": "2010", "HN": "2010", "MR": "20190701", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056685"}, {"RECTYPE": "D", "MH": "Mimiviridae", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Mimivirus|T005|NON|NRW|NLM (2010)|090113|abcdef", "ENTRY": "Mimiviruses", "MN": "B04.280.475", "MH_TH": "NLM (2010)", "ST": "T005", "RN": "txid549779", "RR": "txid315393", "PI": "DNA Viruses (2004-2009)", "MS": "A family of nucleocytoplasmic, large, double-stranded DNA viruses with extremely complex genomes.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056686"}, {"RECTYPE": "D", "MH": "Off-Label Use", "AQ": "CL EC ES HI LJ NU SN ST VE", "ENTRY": "Unlabeled Indications", "MN": "E02.319.307.500", "FX": "Drug Utilization", "MH_TH": "NLM (2010)", "ST": "T061", "AN": "do not confuse with DRUG REPOSITIONING", "PI": "Drug Prescriptions (2008-2009)", "MS": "The practice of prescribing or using a drug or a vaccine outside the scope of the drug's official approved label as designated by a regulatory agency concerning the treatment of a particular disease or condition.", "PM": "2010", "HN": "2010", "MR": "20180206", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056687"}, {"RECTYPE": "D", "MH": "Uropathogenic Escherichia coli", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Uropathogenic E. coli|T007|ABX|EQV|NLM (2017)|160509|abcdef", "MN": "B03.660.250.150.180.100.580.500", "MH_TH": "NLM (2010)", "ST": "T007", "AN": "infection: coordinate IM with ESCHERICHIA COLI INFECTIONS (IM) + URINARY TRACT INFECTIONS (IM)", "PI": "Escherichia coli (1980-2009)", "MS": "Strains of Escherichia coli that preferentially grow and persist within the urinary tract. They exhibit certain virulence factors and infection pathways that cause URINARY TRACT INFECTIONS.", "PM": "2010", "HN": "2010", "MR": "20200902", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056689"}, {"RECTYPE": "D", "MH": "Prolactin-Releasing Hormone", "DE": "PRL RH", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Prolactin Releasing Peptide PrRP31", "MN": "D12.776.631.650.405.967", "MH_TH": "NLM (1975)", "ST": "T121", "RN": "0", "MS": "A hypothalamic hormone that is synthesized as a precursor protein which is cleaved into two peptides. In addition to stimulating PROLACTIN release the peptides bind to specific G-PROTEIN-COUPLED RECEPTORS found at locations within the BRAIN.", "PM": "2010; see THYROTROPIN-RELEASING HORMONE 2007-2009 and PROLACTIN-RELEASING HORMONE 1975-2006; PROLACTIN-RELEASING PEPTIDE was indexed under HYPOTHALAMIC HORMONES 2009 and under NEUROPEPTIDES 1998-2008", "HN": "2010, 1975-2006; use THYROTROPIN-RELEASING HORMONE 2007-2009", "MR": "20151124", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056690"}, {"RECTYPE": "D", "MH": "Prebiotics", "AQ": "AD AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Prebiotic", "MN": "J02.500.456.249", "FX": "Probiotics", "MH_TH": "NLM (2010)", "ST": "T109", "RN": "0", "AN": "Do not confuse with PROBIOTICS; Do not confuse with PREBIOTIC CHEMICAL EVOLUTION see ORIGIN OF LIFE", "PI": "Dietary Fiber (1998-2009)", "MS": "Non-digestible food ingredients mostly of a carbohydrate base that improve human health by selectively stimulating the growth and/or activity of existing BACTERIA in the COLON.", "PM": "2010", "HN": "2010", "MR": "20220708", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056692"}, {"RECTYPE": "D", "MH": "Propionic Acidemia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Propionyl-CoA Carboxylase Deficiency|T047|ABX|EQV|GHR (2014)|NLM (2010)|OMIM (2013)|ORD (2010)|090116|abcdeeeef", "ENTRY": "Propionyl-CoA Carboxylase Deficiencies", "MN": "C18.452.648.100.823", "FX": "Methylmalonyl-CoA Decarboxylase", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Methylmalonyl-CoA Decarboxylase (1981-2009)", "MS": "Autosomal recessive metabolic disorder caused by mutations in PROPIONYL-COA CARBOXYLASE genes that result in dysfunction of branch chain amino acids and of the metabolism of certain fatty acids. Neonatal clinical onset is characterized by severe metabolic acidemia accompanied by hyperammonemia, HYPERGLYCEMIA, lethargy, vomiting, HYPOTONIA; and HEPATOMEGALY. Survivors of the neonatal onset propionic acidemia often show developmental retardation, and intolerance to dietary proteins. Late-onset form of the disease shows mild mental and/or developmental retardation, sometimes without metabolic acidemia.", "PM": "2010", "HN": "2010", "MR": "20230226", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056693"}, {"RECTYPE": "D", "MH": "Adaptive Immunity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Hybrid Immunity|T040|NON|REL|NLM (2023)|211212|abcdef", "ENTRY": "Response, Adaptive Immune", "MN": "G12.450.050", "FX": "Immunity, Innate", "MH_TH": "NLM (2010)", "ST": "T040", "AN": "coordinate with specific disease / immunol", "MS": "Protection from an infectious disease agent that is mediated by B- and T- LYMPHOCYTES following exposure to specific antigen, and characterized by IMMUNOLOGIC MEMORY. It can result from either previous infection with that agent or vaccination (IMMUNITY, ACTIVE), or transfer of antibody or lymphocytes from an immune donor (IMMUNIZATION, PASSIVE).", "PM": "2010", "HN": "2010", "MR": "20220413", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056704"}, {"RECTYPE": "D", "MH": "Apitherapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Apitherapies", "MN": "E02.046", "FX": "Honey", "MH_TH": "NLM (2010)", "ST": "T061", "PI": "Biological Factors/therapeutic use (1986-2006)", "MS": "The medical use of honey bee products such as BEE VENOM; HONEY; bee pollen; PROPOLIS; and royal jelly.", "PM": "2010", "HN": "2010", "MR": "20090721", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056705"}, {"RECTYPE": "D", "MH": "Immunity, Humoral", "AQ": "DE GE IM PH RE", "ENTRY": "Response, Humoral Immune", "MN": "G12.450.050.420", "MH_TH": "UNK (19XX)", "ST": "T040", "AN": "coordinate with specific disease / immunol", "PI": "Antibody Formation (1963-2009)", "MS": "Antibody-mediated immune response. Humoral immunity is brought about by ANTIBODY FORMATION, resulting from TH2 CELLS activating B-LYMPHOCYTES, followed by COMPLEMENT ACTIVATION.", "PM": "2010; see ANTIBODY FORMATION 1980-2009", "HN": "2010; use ANTIBODY FORMATION 1980-2009", "MR": "20100625", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056724"}, {"RECTYPE": "D", "MH": "von Willebrand Disease, Type 1", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "von Willebrand Disease, Type I|T047|EPO|EQV|NLM (2010)|090126|abcdef", "MN": "C16.320.099.920.100", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "von Willebrand Disease (1968-2009)", "MS": "A subtype of von Willebrand disease that results from a partial deficiency of VON WILLEBRAND FACTOR.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056725"}, {"RECTYPE": "D", "MH": "Genetic Association Studies", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Candidate Gene Identification|T063|NON|NRW|NLM (2010)|090126|abcdef", "ENTRY": "Study, Genetic Association", "MN": "E05.393.385", "FX": "Genetic Predisposition to Disease", "MH_TH": "NLM (2010)", "ST": "T063", "MS": "The analysis of a sequence such as a region of a chromosome, a haplotype, a gene, or an allele for its involvement in controlling the phenotype of a specific trait, metabolic pathway, or disease.", "PM": "2010", "HN": "2010", "MR": "20090717", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056726"}, {"RECTYPE": "D", "MH": "Endangered Species", "AQ": "EC HI LJ SN TD", "PRINT ENTRY": "Threatened Species|T098|NON|REL|NLM (2010)|090126|abcdef", "ENTRY": "Species, Threatened", "MN": "N06.230.124.049.250", "FX": "Extinction, Biological", "MH_TH": "NLM (2010)", "ST": "T098", "MS": "An animal or plant species in danger of extinction. Causes can include human activity, changing climate, or change in predator/prey ratios.", "PM": "2010", "HN": "2010", "MR": "20200708", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056727"}, {"RECTYPE": "D", "MH": "von Willebrand Disease, Type 2", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "von Willebrand Disease, Type IIN|T047|EPO|NRW|NLM (2010)|090126|abcdef", "MN": "C16.320.099.920.200", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "von Willebrand Disease (1968-2009)", "MS": "A subtype of von Willebrand disease that results from qualitative deficiencies of VON WILLEBRAND FACTOR. The subtype is divided into several variants with each variant having a distinctive pattern of PLATELET-interaction.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056728"}, {"RECTYPE": "D", "MH": "von Willebrand Disease, Type 3", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Von Willebrand Disease, Severe Form|T047|EPO|EQV|ORD (2010)|090227|abcdef", "MN": "C16.320.099.920.300", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "von Willebrand Disease (1968-2009)", "MS": "A subtype of von Willebrand disease that results from a total or near total deficiency of VON WILLEBRAND FACTOR.", "PM": "2010", "HN": "2010", "MR": "20160628", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056729"}, {"RECTYPE": "D", "MH": "Silver-Russell Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Silver-Russell Dwarfism|T019|T047|EPO|EQV|GHR (2014)|NLM (2010)|OMIM (2013)|ORD (2010)|090127|abbcdeeeef", "ENTRY": "Syndromes, Russell-Silver", "MN": "C16.320.447.750", "FX": "Beckwith-Wiedemann Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Growth Disorders (1970-2009)", "MS": "Genetically and clinically heterogeneous disorder characterized by low birth weight, postnatal growth retardation, facial dysmorphism, bilateral body asymmetry, and clinodactyly of the fifth fingers. Alterations in GENETIC IMPRINTING are involved. Hypomethylation of IGF2/H19 locus near an imprinting center region of chromosome 11p15 plays a role in a subset of Silver-Russell syndrome. Hypermethylation of the same chromosomal region, on the other hand, can cause BECKWITH-WIEDEMANN SYNDROME. Maternal UNIPARENTAL DISOMY for chromosome 7 is known to play a role in its etiology.", "PM": "2010", "HN": "2010", "MR": "20230414", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056730"}, {"RECTYPE": "D", "MH": "Donohue Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rabson-Mendenhall Syndrome|T019|T047|EPO|REL|NLM (2010)|OMIM (2013)|ORD (2010)|090127|abbcdeeef", "ENTRY": "Syndrome, Rabson-Mendenhall", "MN": "C19.246.537", "FX": "Receptor, Insulin", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Diabetes Mellitus (2000-2009)", "MS": "Rare autosomal recessive syndrome of extreme insulin resistance due to mutations in the binding domain of INSULIN RECEPTOR. Clinical features include severe intrauterine and postnatal growth restriction, characteristic dysmorphic FACIES; HIRSUTISM; VIRILIZATION; multiple endocrine abnormalities, and early death.", "PM": "2010", "HN": "2010", "MR": "20120703", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056731"}, {"RECTYPE": "D", "MH": "Prolidase Deficiency", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Prolidase Deficiencies", "MN": "C16.320.850.746", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Dipeptidases (1972-2009)", "MS": "Rare autosomal recessive disorder of metabolism due to mutations in the prolidase gene. It is characterized by recurrent lower extremity skin ulcers, recurrent infections, and FACIES, often with INTELLECTUAL DISABILITY.", "PM": "2010", "HN": "2010", "MR": "20130708", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056732"}, {"RECTYPE": "D", "MH": "Carney Complex", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "NAME Syndrome|T047|ACX|EQV|OMIM (2013)|ORD (2010)|090127|abcdeef", "ENTRY": "Syndromes, LAMB", "MN": "C16.131.831.108", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Autosomal dominant syndrome characterized by cardiac and cutaneous MYXOMAS; LENTIGINOSIS (spotty pigmentation of the skin), and endocrinopathy and its associated endocrine tumors. The cardiac myxomas may lead to SUDDEN CARDIAC DEATH and other complications in Carney complex patients. The gene coding for the PRKAR1A protein is one of the causative genetic loci (type 1). A second locus is at chromosome 2p16 (type 2).", "PM": "2010", "HN": "2010", "MR": "20130708", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056733"}, {"RECTYPE": "D", "MH": "Monilethrix", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Nodose Hair|T047|NON|EQV|NLM (2010)|ORD (2010)|090127|abcdeef", "ENTRY": "Nodose Hairs", "MN": "C17.800.827.602", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Hair Diseases (1963-2009)", "MS": "Rare autosomal dominant disorder of the hair shaft. The clinical features of the disease include HYPOTRICHOSIS, dry, and/or brittle hair, with varying degrees of ALOPECIA. Mutations in the hair-specific keratin genes KRTHB1, KRTHB3, or KRTHB6 are associated with monilethrix. Autosomal recessive monilethrix with limited HYPOTRICHOSIS are also known. Mutations in Dsg4, Liph, and P2ry5 protein genes are associated with the recessive form of monilethrix.", "PM": "2010", "HN": "2010", "MR": "20150618", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056734"}, {"RECTYPE": "D", "MH": "Autoimmune Lymphoproliferative Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Caspase-8 Deficiency|T047|NON|NRW|NLM (2010)|ORD (2010)|090127|abcdeef", "ENTRY": "Syndromes, Canale-Smith", "MN": "C20.683.515.124", "FX": "fas Receptor", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Lymphoproliferative Disorders (1983-2009)", "MS": "Rare congenital lymphoid disorder due to mutations in certain Fas-Fas ligand pathway genes. Known causes include mutations in FAS, TNFSF6, NRAS, CASP8, and CASP10 proteins. Clinical features include LYMPHADENOPATHY; SPLENOMEGALY; and AUTOIMMUNITY.", "PM": "2010", "HN": "2010", "MR": "20170717", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056735"}, {"RECTYPE": "D", "MH": "Drug Recalls", "AQ": "EC ES HI LJ MT OG SN TD", "PRINT ENTRY": "Drug Recall|T089|NON|EQV|NLM (1993)|920312|abcdef", "ENTRY": "Recalls, Drug", "MN": "N06.850.210.637.200", "FX": "Safety-Based Drug Withdrawals", "MH_TH": "NLM (2010)", "ST": "T089", "AN": "SAFETY-BASED DRUG WITHDRAWALS is also available", "PI": "Drug and Narcotic Control (1965-2009)", "MS": "Removal of a drug from the market due to a problem occurring in the manufacture or distribution of the product.", "PM": "2010; for DRUG RECALL see DRUG AND NARCOTIC CONTROL 1992-2009", "HN": "2010; for DRUG RECALL use DRUG AND NARCOTIC CONTROL 1992-2009", "MR": "20180629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056736"}, {"RECTYPE": "D", "MH": "Safety-Based Drug Withdrawals", "AQ": "EC ES HI LJ MT OG SN TD", "ENTRY": "Safety Based Drug Withdrawals", "MN": "N06.850.210.637.700", "FX": "Drug Recalls", "MH_TH": "NLM (2010)", "ST": "T089", "AN": "DRUG RECALLS is also available", "MS": "Removal of a drug from the market due to the identification of an intrinsic property of the drug that results in a serious risk to public health.", "PM": "2010", "HN": "2010", "MR": "20180629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056737"}, {"RECTYPE": "D", "MH": "Cross Protection", "AQ": "DE GE IM PH RE", "ENTRY": "Protection, Cross", "MN": "G12.450.275", "FX": "Immunity, Heterologous", "MH_TH": "NLM (2010)", "ST": "T044", "AN": "do not confuse with CROSS REACTIONS", "MS": "Protection conferred on a host by inoculation with one strain or component of a microorganism that prevents infection when later challenged with a similar strain. Most commonly the microorganism is a virus.", "PM": "2010", "HN": "2010", "MR": "20130708", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056738"}, {"RECTYPE": "D", "MH": "Pterygopalatine Fossa", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Fossa, Pterygopalatine", "MN": "A02.835.232.781.670", "MH_TH": "NLM (2010)", "ST": "T030", "MS": "A small space in the skull between the MAXILLA and the SPHENOID BONE, medial to the pterygomaxillary fissure, and connecting to the NASAL CAVITY via the sphenopalatine foramen.", "PM": "2010", "HN": "2010", "MR": "20180629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056739"}, {"RECTYPE": "D", "MH": "Olecranon Process", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Process, Olecranon", "MN": "A02.835.232.087.090.850.600", "FX": "Elbow Joint", "MH_TH": "NLM (2010)", "ST": "T023", "MS": "A prominent projection of the ulna that articulates with the HUMERUS and forms the outer protuberance of the ELBOW JOINT.", "PM": "2010", "HN": "2010", "MR": "20180629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056740"}, {"RECTYPE": "D", "MH": "Cyclin D", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "D Cyclins, Type", "MN": "D12.776.476.262.150", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A cyclin subtype that is specific for CYCLIN-DEPENDENT KINASE 4 and CYCLIN-DEPENDENT KINASE 6. Unlike most cyclins, cyclin D expression is not cyclical, but rather it is expressed in response to proliferative signals. Cyclin D may therefore play a role in cellular responses to mitogenic signals.", "PM": "2010; CYCLIN D was indexed under CYCLINS 1996-2009", "HN": "2010(1996)", "MR": "20151123", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056741"}, {"RECTYPE": "D", "MH": "Cyclin D2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.262.150.200", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Cyclins (1993-2009)", "MS": "A cyclin D subtype which is regulated by GATA4 TRANSCRIPTION FACTOR. Experiments using KNOCKOUT MICE suggest a role for cyclin D2 in granulosa cell proliferation and gonadal development.", "PM": "2010", "HN": "2010", "MR": "20151123", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056742"}, {"RECTYPE": "D", "MH": "Cyclin D3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.262.150.300", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A broadly expressed type D cyclin. Experiments using KNOCKOUT MICE suggest a role for cyclin D3 in LYMPHOCYTE development.", "PM": "2010; CYCLIN D3 was indexed under CYCLINS 1992-2009", "HN": "2010", "MR": "20151123", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056743"}, {"RECTYPE": "D", "MH": "Cyclin B1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.262.120.100", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A cyclin B subtype that colocalizes with MICROTUBULES during INTERPHASE and is transported into the CELL NUCLEUS at the end of the G2 PHASE.", "PM": "2010; CYCLIN B1 was indexed under CYCLIN B 1998-2009 and under CYCLINS 1996-1997", "HN": "2010(1996)", "MR": "20151123", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056744"}, {"RECTYPE": "D", "MH": "Cyclin C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cyclins, Type C", "MN": "D12.776.660.551.249", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Cyclins (1991-2009)", "MS": "A cyclin subtype that binds to the CYCLIN-DEPENDENT KINASE 3 and CYCLIN-DEPENDENT KINASE 8. Cyclin C plays a dual role as a transcriptional regulator and a G1 phase CELL CYCLE regulator.", "PM": "2010", "HN": "2010", "MR": "20160330", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056745"}, {"RECTYPE": "D", "MH": "Cyclin G", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.262.200", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A cyclin subtype that is found associated with CYCLIN-DEPENDENT KINASE 5; cyclin G associated kinase, and PROTEIN PHOSPHATASE 2.", "PM": "2010; CYCLIN G was indexed under CYCLINS 1993-2009", "HN": "2010(1993)", "MR": "20151123", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056746"}, {"RECTYPE": "D", "MH": "Immunomodulation", "AQ": "DE GE IM PH RE", "ENTRY": "Therapy, Immunomodulatory", "MN": "G12.535", "MH_TH": "NLM (2010)", "ST": "T070", "MS": "Alteration of the immune system or of an immune response by agents that activate or suppress its function. This can include IMMUNIZATION or administration of immunomodulatory drugs. Immunomodulation can also encompass non-therapeutic alteration of the immune system effected by endogenous or exogenous substances.", "PM": "2010", "HN": "2010", "MR": "20160623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056747"}, {"RECTYPE": "D", "MH": "Cyclin H", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.262.300", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A cyclin subtype that is found as a component of a heterotrimeric complex containing cyclin-dependent kinase 7 and CDK-activating kinase assembly factor. The complex plays a role in cellular proliferation by phosphorylating several CYCLIN DEPENDENT KINASES at specific regulatory threonine sites.", "PM": "2010; CYCLIN H was indexed under CYCLINS 1994-2009", "HN": "2010(1994)", "MR": "20151123", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056748"}, {"RECTYPE": "D", "MH": "Cyclin I", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.262.400", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A cyclin subtype that is found abundantly in post-mitotic tissues. In contrast to the classical cyclins, its level does not fluctuate during the cell cycle.", "PM": "2010; CYCLIN I was indexed under CYCLINS 1996-2009", "HN": "2010(1996)", "MR": "20160705", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056749"}, {"RECTYPE": "D", "MH": "Cyclin A1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.262.100.100", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Cyclins (1991-1997)", "MS": "A cyclin A subtype primarily found in male GERM CELLS. It may play a role in the passage of SPERMATOCYTES into meiosis I.", "PM": "2010", "HN": "2010", "MR": "20151123", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056750"}, {"RECTYPE": "D", "MH": "Cyclin A2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.262.100.200", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Cyclins (1991-1997)", "MS": "A widely-expressed cyclin A subtype that functions during the G1/S and G2/M transitions of the CELL CYCLE.", "PM": "2010", "HN": "2010", "MR": "20151123", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056751"}, {"RECTYPE": "D", "MH": "Cyclin B2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.262.120.200", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Cyclins (1993-1997)", "MS": "A cyclin B subtype that colocalizes with GOLGI APPARATUS during INTERPHASE and is transported into the CELL NUCLEUS at the end of the G2 PHASE.", "PM": "2010", "HN": "2010", "MR": "20151123", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056765"}, {"RECTYPE": "D", "MH": "Cyclin G1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.262.200.100", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "AN": "a specific cyclin; not for cyclins present during G1 PHASE of the cell cycle", "PI": "Cyclins (1993-2009)", "MS": "A cyclin G subtype that is constitutively expressed throughout the cell cycle. Cyclin G1 is considered a major transcriptional target of TUMOR SUPPRESSOR PROTEIN P53 and is highly induced in response to DNA damage.", "PM": "2010; CYCLIN G1 was indexed under CYCLINS 1993-2009", "HN": "2010(1993); for CYCLIN G1 use CYCLIN G 1993-2009", "MR": "20151123", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056766"}, {"RECTYPE": "D", "MH": "Cyclin G2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.476.262.200.200", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "AN": "a specific cyclin; not for cyclins present during G2 PHASE of the cell cycle", "PI": "Cyclins (1986-2009)", "MS": "An unusual cyclin subtype that is found highly expressed in terminally differentiated cells. Unlike conventional cyclins increased expression of cyclin G2 is believed to cause a withdrawal of cells from the CELL CYCLE.", "PM": "2010", "HN": "2010", "MR": "20151123", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056767"}, {"RECTYPE": "D", "MH": "Giant Axonal Neuropathy", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuropathy, Giant Axonal|T047|NON|EQV|GHR (2014)|NLM (2010)|ORD (2010)|090203|abcdeeef", "ENTRY": "Neuropathy, Giant Axonal (GAN)", "MN": "C16.320.400.375.490", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Peripheral Nervous System Diseases (1972-2009)", "MS": "Rare autosomal recessive disorder of INTERMEDIATE FILAMENT PROTEINS. The disease is caused by mutations in the gene that codes gigaxonin protein. The mutations result in disorganization of axonal NEUROFILAMENT PROTEINS, formation of the characteristic giant axons, and progressive neuropathy. The clinical features of the disease include early-onset progressive peripheral motor and sensory neuropathies often associated with central nervous system involvement (INTELLECTUAL DISABILITY, seizures, DYSMETRIA, and CONGENITAL NYSTAGMUS).", "PM": "2010", "HN": "2010", "MR": "20200527", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056768"}, {"RECTYPE": "D", "MH": "Alstrom Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Alstrom's Syndrome|T047|EPO|EQV|NLM (2010)|ORD (2010)|090202|abcdeef", "ENTRY": "Syndrome, Alstr\u00f6m", "MN": "C16.320.400.375.099", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Rare autosomal recessive disease characterized by multiple organ dysfunction. The key clinical features include retinal degeneration (NYSTAGMUS, PATHOLOGIC; RETINITIS PIGMENTOSA; and eventual blindness), childhood obesity, sensorineural hearing loss, and normal mental development. Endocrinologic complications include TYPE 2 DIABETES MELLITUS; HYPERINSULINEMIA; ACANTHOSIS NIGRICANS; HYPOTHYROIDISM; and progressive renal and hepatic failures. The disease is caused by mutations in the ALMS1 gene.", "PM": "2010", "HN": "2010", "MR": "20160531", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056769"}, {"RECTYPE": "D", "MH": "Netherton Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Netherton Disease|T047|EPO|EQV|NLM (2010)|OMIM (2013)|ORD (2010)|090202|abcdeeef", "MN": "C17.800.827.655", "FX": "Serine Peptidase Inhibitor Kazal-Type 5", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Ichthyosiform Erythroderma, Congenital (1992-2009)", "MS": "Rare autosomal recessive disease with variable expressions. Clinical features of the disease include variable ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL; bamboo hair (trichorrhexis invaginata); and ATOPIC DERMATITIS. The disease is caused by mutations in the SPINK5 gene.", "PM": "2010", "HN": "2010", "MR": "20170227", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056770"}, {"RECTYPE": "D", "MH": "Ovule", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plant Megaspores", "MN": "A18.024.249.500.249.249", "MH_TH": "NLM (2010)", "ST": "T002", "MS": "The element in plants that contains the female GAMETOPHYTES.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056771"}, {"RECTYPE": "D", "MH": "Leukoencephalopathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vanishing White Matter Disease|T047|NON|REL|NLM (2021)|191120|abcdef", "ENTRY": "White Matter Disease", "MN": "C10.228.140.695", "FX": "Eukaryotic Initiation Factor-2B", "MH_TH": "NLM (2010)", "ST": "T047", "MS": "Any of various diseases affecting the white matter of the central nervous system.", "PM": "2010", "HN": "2010", "MR": "20200116", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056784"}, {"RECTYPE": "D", "MH": "Medicine, Mongolian Traditional", "AQ": "AE EC HI IS MT PX SN ST TD", "ENTRY": "Traditional Medicines, Mongolian", "MN": "I01.076.201.450.654.558.750", "FX": "Phytotherapy", "MH_TH": "NLM (2010)", "ST": "T058", "PI": "Traditional Medicine (1993-2009)", "MS": "Medical practice indigenous to the peoples of Mongolia, developed over many years according to their culture, beliefs, and traditions.", "PM": "2010", "HN": "2010", "MR": "20180629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056785"}, {"RECTYPE": "D", "MH": "Biofuels", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Oils, Biofuel", "MN": "N06.230.132.644.124", "MH_TH": "NLM (2010)", "ST": "T109", "RN": "0", "AN": "do not confuse with BIOFUEL CELLS see BIOELECTRIC ENERGY SOURCES", "PI": "Bioelectric Energy Sources (2004-2009)", "MS": "Hydrocarbon-rich byproducts from the non-fossilized BIOMASS that are combusted to generate energy as opposed to fossilized hydrocarbon deposits (FOSSIL FUELS).", "PM": "2010", "HN": "2010", "MR": "20110624", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056804"}, {"RECTYPE": "D", "MH": "Consciousness Monitors", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Monitors, Consciousness", "MN": "E07.858.195", "FX": "Monitoring, Intraoperative", "MH_TH": "NLM (2010)", "ST": "T074", "PI": "Monitoring, Physiologic (1997-2009)", "MS": "Devices used to assess the level of consciousness especially during anesthesia. They measure brain activity level based on the EEG.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056805"}, {"RECTYPE": "D", "MH": "Urea Cycle Disorders, Inborn", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Urea Cycle Disorders|T047|NON|EQV|NLM (2010)|ORD (2010)|090204|abcdeef", "ENTRY": "Urea Cycle Disorder", "MN": "C18.452.648.189.937", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Urea/metabolism (1977-2009)", "MS": "Rare congenital metabolism disorders of the urea cycle. The disorders are due to mutations that result in complete (neonatal onset) or partial (childhood or adult onset) inactivity of an enzyme, involved in the urea cycle. Neonatal onset results in clinical features that include irritability, vomiting, lethargy, seizures, NEONATAL HYPOTONIA; RESPIRATORY ALKALOSIS; HYPERAMMONEMIA; coma, and death. Survivors of the neonatal onset and childhood/adult onset disorders share common risks for ENCEPHALOPATHIES, METABOLIC, INBORN; and RESPIRATORY ALKALOSIS due to HYPERAMMONEMIA.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056806"}, {"RECTYPE": "D", "MH": "Argininosuccinic Aciduria", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Arginino Succinase Deficiency|T047|NON|EQV|NLM (2010)|ORD (2010)|090204|abcdeef", "ENTRY": "Deficiency, Argininosuccinate Lyase", "MN": "C18.452.648.189.937.124", "FX": "Argininosuccinate Lyase", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Amino Acid Metabolism, Inborn Errors (1664-2009)", "MS": "Rare autosomal recessive disorder of the urea cycle which leads to the accumulation of argininosuccinic acid in body fluids and severe HYPERAMMONEMIA. Clinical features of the neonatal onset of the disorder include poor feeding, vomiting, lethargy, seizures, tachypnea, coma, and death. Later onset results in milder set of clinical features including vomiting, failure to thrive, irritability, behavioral problems, or psychomotor retardation. Mutations in the ARGININOSUCCINATE LYASE gene cause the disorder.", "PM": "2010", "HN": "2010", "MR": "20130708", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056807"}, {"RECTYPE": "D", "MH": "Biostatistics", "DE": "BIOSTATIST", "AQ": "HI IS MT", "ENTRY": "Statistics, Biological", "MN": "E05.318.740.237", "MH_TH": "UNK (19XX)", "ST": "T090", "PI": "Biometry (1974-2009)", "MS": "The application of STATISTICS to biological systems and organisms involving the retrieval or collection, analysis, reduction, and interpretation of qualitative and quantitative data.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056808"}, {"RECTYPE": "D", "MH": "Alveolar Epithelial Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Pneumocytes|T025|NON|EQV|NLM (2010)|090205|abcdef", "ENTRY": "Type-II Pneumocyte", "MN": "A11.436.081", "MH_TH": "NLM (2017)", "ST": "T025", "PI": "Lung/cytology (1967-2009)", "MS": "Epithelial cells that line the PULMONARY ALVEOLI.", "PM": "2010", "HN": "2010", "MR": "20180701", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056809"}, {"RECTYPE": "D", "MH": "Acaricides", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Acaricide|T131|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Control Agent, Mite", "MN": "D27.888.723.071", "FX": "Mites", "MH_TH": "NLM (2010)", "ST": "T131", "RN": "0", "AN": "For use to kill or control mites and ticks, use no qualifiers on the acaricide or the mite or tick; appropriate qualifiers may be used when other aspects of the acaricide are discussed, such as the effect on a physiologic process or behavioral aspect of the mite or tick.", "PI": "Insecticides (1981-2009)", "MS": "A pesticide or chemical agent that kills mites and ticks. This is a large class that includes carbamates, formamides, organochlorines, organophosphates, etc, that act as antibiotics or growth regulators.", "PM": "2010", "HN": "2010", "MR": "20200527", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056810"}, {"RECTYPE": "D", "MH": "Unfolded Protein Response", "AQ": "DE GE IM PH RE", "ENTRY": "Unfolded Protein Responses", "MN": "G05.308.670.600.850", "FX": "Endoplasmic Reticulum-Associated Degradation", "MH_TH": "NLM (2010)", "ST": "T070", "PI": "Protein Folding (1995-2009)", "MS": "A cellular response to environmental insults that cause disruptions in PROTEIN FOLDING and/or accumulation of defectively folded protein in the ENDOPLASMIC RETICULUM. It consists of a group of regulatory cascades that are triggered as a response to altered levels of calcium and/or the redox state of the endoplasmic reticulum. Persistent activation of the unfolded protein response leads to the induction of APOPTOSIS.", "PM": "2010", "HN": "2010", "MR": "20220712", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056811"}, {"RECTYPE": "D", "MH": "Upper Extremity Deep Vein Thrombosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Upper Extremity Deep Vein Thrombosis, Primary|T046|T047|NON|NRW|NLM (2010)|090209|abbcdef", "ENTRY": "Syndrome, Paget-Schroetter", "MN": "C14.907.355.830.925.885", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Venous Thrombosis (1999-2009)", "MS": "DEEP VEIN THROMBOSIS of an upper extremity vein (e.g., AXILLARY VEIN; SUBCLAVIAN VEIN; and JUGULAR VEINS). It is associated with mechanical factors (Upper Extremity Deep Vein Thrombosis, Primary) secondary to other anatomic factors (Upper Extremity Deep Vein Thrombosis, Secondary). Symptoms may include sudden onset of pain, warmth, redness, blueness, and swelling in the arm.", "PM": "2010", "HN": "2010", "MR": "20150618", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056824"}, {"RECTYPE": "D", "MH": "Thyroxine-Binding Globulin", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Thyroxine Binding Globulin", "MN": "D12.776.872.847", "MH_TH": "NLM (1992)", "ST": "T123", "RN": "0", "MS": "A thyroid hormone transport protein found in serum. It binds about 75% of circulating THYROXINE and 70% of circulating TRIIODOTHYRONINE.", "PM": "2010; see THYROXINE-BINDING PROTEINS 1992-2009", "HN": "2010(1992); use THYROXINE-BINDING PROTEINS 1992-2009", "MR": "20230316", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056825"}, {"RECTYPE": "D", "MH": "Single Embryo Transfer", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Transfers, Single Embryo", "MN": "E05.820.800.500.500", "MH_TH": "NLM (2010)", "ST": "T062", "PI": "Embryo Transfer (1998-2009)", "MS": "The techniques used to select and/or place only one embryo from FERTILIZATION IN VITRO into the uterine cavity to establish a singleton pregnancy.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056826"}, {"RECTYPE": "D", "MH": "Endosomal Sorting Complexes Required for Transport", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Machinery, ESCRT", "MN": "D12.776.543.990.493", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Vesicular Transport Proteins (2001-2009)", "MS": "A set of protein subcomplexes involved in PROTEIN SORTING of UBIQUITINATED PROTEINS into intraluminal vesicles of MULTIVESICULAR BODIES and in membrane scission during formation of intraluminal vesicles, during the final step of CYTOKINESIS, and during the budding of enveloped viruses. The ESCRT machinery is comprised of the protein products of Class E vacuolar protein sorting genes.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056827"}, {"RECTYPE": "D", "MH": "Hereditary Angioedema Type III", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hereditary Angioedemas, Estrogen-Sensitive", "MN": "C20.543.480.904.066.500.500", "FX": "Factor XII", "MH_TH": "NLM (2010)", "ST": "T046", "PI": "Angioedemas, Hereditary (2007-2009)", "MS": "A form of hereditary angioedema that occurs in women and is precipitated or worsened by high ESTROGEN levels. It is associated with mutations in the gene for FACTOR XII that result in its increased activity.", "PM": "2010", "HN": "2010", "MR": "20120703", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056828"}, {"RECTYPE": "D", "MH": "Hereditary Angioedema Types I and II", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hereditary Angioedema Type II|T019|T047|NON|NRW|NLM (2010)|090209|abbcdef", "MN": "C20.543.480.904.066.500.750", "FX": "Complement C1 Inhibitor Protein", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Angioedemas, Hereditary (2007-2009)", "MS": "Forms of hereditary angioedema that occur due to mutations in the gene for COMPLEMENT C1 INHIBITOR PROTEIN. Type I hereditary angioedema is associated with reduced serum levels of complement C1 inhibitor protein. Type II hereditary angioedema is associated with the production of a non-functional complement C1 inhibitor protein.", "PM": "2010", "HN": "2010", "MR": "20120703", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056829"}, {"RECTYPE": "D", "MH": "Isolated Noncompaction of the Ventricular Myocardium", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Noncompaction of the Left Ventricular Myocardium, Autosomal Dominant|T047|NON|NRW|NLM (2010)|090210|abcdef", "MN": "C16.320.322.370", "MH_TH": "NLM (2010)", "ST": "T047", "MS": "Rare congenital cardiomyopathies characterized by the lack of left ventricular myocardium compaction. The noncompaction results in numerous prominent trabeculations and a loose myocardial meshwork (spongy myocardium) in the LEFT VENTRICLE. Heterogeneous clinical features include diminished systolic function sometimes associated with left ventricular dilation, that presents either neonatally or progressively. Often, the RIGHT VENTRICLE is also affected. CONGESTIVE HEART FAILURE; PULMONARY EMBOLISM; and ventricular ARRHYTHMIA are commonly seen.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056830"}, {"RECTYPE": "D", "MH": "Coordination Complexes", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Complexes, Metal", "MN": "D02.257", "FX": "Chelating Agents", "MH_TH": "NLM (2010)", "ST": "T104", "RN": "0", "PI": "Organometallic Compounds (2003-2009)", "MS": "Neutral or negatively charged ligands bonded to metal cations or neutral atoms. The number of ligand atoms to which the metal center is directly bonded is the metal cation's coordination number, and this number is always greater than the regular valence or oxidation number of the metal. A coordination complex can be negative, neutral, or positively charged.", "PM": "2010", "HN": "2010", "MR": "20190701", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056831"}, {"RECTYPE": "D", "MH": "Central Serous Chorioretinopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Serous Retinopathy, Central", "MN": "C11.768.175", "MH_TH": "NLM (2010)", "ST": "T190", "PI": "Retinal Diseases (1973-2009)", "MS": "A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056833"}, {"RECTYPE": "D", "MH": "Renal Colic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ureteral Colic|T184|NON|EQV|NLM (2010)|090211|abcdef", "ENTRY": "Ureteral Colics", "MN": "G11.561.790.444.850", "MH_TH": "NLM (2010)", "ST": "T184", "PI": "Urinary Calculi (1961-2009)", "MS": "A severe intermittent and spasmodic pain in the lower back radiating to the groin, scrotum, and labia which is most commonly caused by a kidney stone (RENAL CALCULUS) passing through the URETER or by other urinary track blockage. It is often associated with nausea, vomiting, fever, restlessness, dull pain, frequent urination, and HEMATURIA.", "PM": "2010", "HN": "2010", "MR": "20170620", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056844"}, {"RECTYPE": "D", "MH": "Weill-Marchesani Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Weill-Marchesani Syndrome, Autosomal Recessive|T047|EPO|NRW|NLM (2010)|OMIM (2013)|090212|abcdeef", "ENTRY": "Weill Marchesani Syndrome, Autosomal Recessive", "MN": "C17.300.899", "FX": "Marfan Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Rare congenital disorder of connective tissue characterized by brachydactyly, joint stiffness, childhood onset of ocular abnormalities (e.g., microspherophakia, ECTOPIA LENTIS; GLAUCOMA), and proportionate short stature. Cardiovascular anomalies are occasionally seen.", "PM": "2010", "HN": "2010", "MR": "20150623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056846"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase 3", "DS": "CYCLIN DEPENDENT KINASE 003", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cyclin Dependent Kinase 3", "MN": "D12.776.476.563.646.500.812", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 2.7.11.22", "PI": "Cyclin-Dependent Kinases (1993-2009)", "MS": "A cyclin-dependent kinase that forms a complex with CYCLIN C and is active during the G1 PHASE of the CELL CYCLE. It plays a role in the transition from G1 to S PHASE and in transcriptional regulation.", "PM": "2010", "HN": "2010", "MR": "20210521", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056849"}, {"RECTYPE": "D", "MH": "Cyclin-Dependent Kinase 8", "DS": "CYCLIN DEPENDENT KINASE 008", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinase, Cdk8", "MN": "D12.776.660.551.500", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 2.7.11.22", "RR": "EC 2.7.11.23", "PI": "Cyclin-Dependent Kinases (1995-2009)", "MS": "A CYCLIN C dependent kinase that is an important component of the mediator complex. The enzyme is activated by its interaction with CYCLIN C and plays a role in transcriptional regulation by phosphorylating RNA POLYMERASE II.", "PM": "2010", "HN": "2010", "MR": "20210521", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056850"}, {"RECTYPE": "D", "MH": "Behind-the-Counter Drugs", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Drugs, Behind-the-Counter", "MN": "D26.530.500", "FX": "Prescription Drugs", "MH_TH": "NLM (2010)", "ST": "T121", "RN": "0", "AN": "OVER-THE-COUNTER DRUGS see NONPRESCRIPTION DRUGS is also available.", "PI": "Nonprescription Drugs (1982-2009)", "MS": "Medicines that are stocked behind the counter of a pharmacy which require the attention or counsel of a pharmacist before being dispensed or handed over to a consumer or patient.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056864"}, {"RECTYPE": "D", "MH": "Ideal Body Weight", "AQ": "DE EH GE IM PH RE", "ENTRY": "Weights, Normal Body", "MN": "G07.345.249.314.120.650", "MH_TH": "NLM (2010)", "ST": "T081", "PI": "Body Weight (1992-2009)", "MS": "Expected weight of a healthy normal individual based on age, sex, and height. Thus, a malnourished person would weigh less than their ideal body weight.", "PM": "2010", "HN": "2010", "MR": "20220712", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056865"}, {"RECTYPE": "D", "MH": "Interstitial Cells of Cajal", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cajal Interstitial Cells", "MN": "A11.620.124", "FX": "Telocytes", "MH_TH": "NLM (2010)", "ST": "T025", "PI": "Gastrointestinal Tract/cytology or specifics (1972-2009)", "MS": "c-Kit positive cells related to SMOOTH MUSCLE CELLS that are intercalated between the autonomic nerves and the effector smooth muscle cells of the GASTROINTESTINAL TRACT. Different phenotypic classes play roles as pacemakers, mediators of neural inputs, and mechanosensors.", "PM": "2010", "HN": "2010", "MR": "20150112", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056885"}, {"RECTYPE": "D", "MH": "Contrecoup Injury", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Contre-coup Injury|T037|NON|EQV|NLM (2010)|090224|abcdef", "ENTRY": "Injury, Contrecoup", "MN": "C26.974.382.200.250", "MH_TH": "NLM (2010)", "ST": "T037", "MS": "An injury in which the damage is located on the opposite side of the primary impact site. A blow to the back of head which results in contrecoup injury to the frontal lobes of the brain is the most common type.", "PM": "2010", "HN": "2010", "MR": "20160225", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056886"}, {"RECTYPE": "D", "MH": "Pelvic Organ Prolapse", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vault Prolapses, Vaginal", "MN": "C23.300.842.624", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Uterine Prolapse (1966-2009)", "MS": "Abnormal descent of a pelvic organ resulting in the protrusion of the organ beyond its normal anatomical confines. Symptoms often include vaginal discomfort, DYSPAREUNIA; URINARY STRESS INCONTINENCE; and FECAL INCONTINENCE.", "PM": "2010", "HN": "2010", "MR": "20110624", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056887"}, {"RECTYPE": "D", "MH": "Patient Positioning", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Positionings, Patient", "MN": "N02.421.585.700", "FX": "Posture", "MH_TH": "NLM (2010)", "ST": "T057", "AN": "do not confuse with MOVING AND LIFTING PATIENTS", "MS": "Moving a patient into a specific position or POSTURE to facilitate examination, surgery, or for therapeutic purposes.", "PM": "2010", "HN": "2010", "MR": "20150629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056888"}, {"RECTYPE": "D", "MH": "Barth Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Type IIs, MGA", "MN": "C18.452.648.398.224", "FX": "Isolated Noncompaction of the Ventricular Myocardium", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Rare congenital X-linked disorder of lipid metabolism. Barth syndrome is transmitted in an X-linked recessive pattern. The syndrome is characterized by muscular weakness, growth retardation, DILATED CARDIOMYOPATHY, variable NEUTROPENIA, 3-methylglutaconic aciduria (type II) and decreases in mitochondrial CARDIOLIPIN level. Other biochemical and morphological mitochondrial abnormalities also exist.", "PM": "2010", "HN": "2010", "MR": "20210630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056889"}, {"RECTYPE": "D", "MH": "Eukaryota", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Eukaryotes|T204|NON|EQV|NLM (2010)|090224|abcdef", "ENTRY": "Eukaryote", "MN": "B01", "RH": "B1 - ORGANISMS-EUKARYOTA", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid2759", "AN": "do not confuse with EUKARYOTIC CELLS; specific algae and protozoa are located under various groups treed under Eukaryota", "PI": "Eukaryotic Cells (1986-2009)", "MS": "One of the three domains of life (the others being BACTERIA and ARCHAEA), also called Eukarya. These are organisms whose cells are enclosed in membranes and possess a nucleus. They comprise almost all multicellular and many unicellular organisms, and are traditionally divided into groups (sometimes called kingdoms) including ANIMALS; PLANTS; FUNGI; and various algae and other taxa that were previously part of the old kingdom Protista.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056890"}, {"RECTYPE": "D", "MH": "Organism Forms", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B05", "RH": "B5 - ORGANISMS-ORGANISM FORMS", "MH_TH": "NLM (2010)", "ST": "T001", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "MS": "Specific states or life cycle stages of organisms. These include post-embryonic stages of insects, symbiotic relationships between organisms, and reproductive elements such as spores.", "PM": "2010", "HN": "2010", "MR": "20150605", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056891"}, {"RECTYPE": "D", "MH": "Mediator Complex", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Thyroid Hormone Associated Protein Complex", "MN": "D12.776.660.551", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1994-2009)", "MS": "A large protein complex which acts as a signaling adaptor protein that allows communication between the various regulatory and functional components of GENETIC TRANSCRIPTION including DNA POLYMERASE II; GENERAL TRANSCRIPTION FACTORS; and TRANSCRIPTION FACTORS that are bound to upstream ENHANCER ELEMENTS. The mediator complex was originally studied in YEAST where at least 21 subunits were identified. Many of the yeast subunits are homologs to proteins in higher organisms that are found associated with specific nuclear receptors such as THYROID HORMONE RECEPTORS and VITAMIN D RECEPTORS.", "PM": "2010; TRAP (THYROID HORMONE ASSOCIATED PROTEIN) COMPLEX, TR-ASSOCIATED PROTEIN (TRAP) COMPLEX and THYROID HORMONE-ASSOCIATED PROTEIN COMPLEX were indexed under TRANSCRIPTION FACTORS 2003-2009", "HN": "2010; for TRAP (THYROID HORMONE ASSOCIATED PROTEIN) COMPLEX, TR-ASSOCIATED PROTEIN (TRAP) COMPLEX and THYROID HORMONE-ASSOCIATED PROTEIN COMPLEX use MEDIATOR COMPLEX SUBUNIT 1 2003-2009", "MR": "20160330", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056892"}, {"RECTYPE": "D", "MH": "Alveolata", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.043", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid33630", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent", "MS": "A group of three related eukaryotic phyla whose members possess an alveolar membrane system, consisting of flattened membrane-bound sacs lying beneath the outer cell membrane.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056893"}, {"RECTYPE": "D", "MH": "Amoebozoa", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.046", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid554915", "AN": "general; prefer specifics; infection: coordinate with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A supergroup (some say phylum) of ameboid EUKARYOTES, comprising ARCHAMOEBAE; LOBOSEA; and MYCETOZOA.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056894"}, {"RECTYPE": "D", "MH": "Mycetozoa", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Mycetozoas", "MN": "B01.046.550", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid142796", "AN": "general; prefer specifics; infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent", "MS": "A group of AMOEBOZOA comprising two distinct groups with the ability to form fruiting bodies: DICTYOSTELIIDA (dictyostelid cellular slime molds) and MYXOMYCETES (plasmodial slime molds).", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056895"}, {"RECTYPE": "D", "MH": "Archamoebae", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.046.060", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid555406", "AN": "infection: coordinate IM with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent", "PI": "Eukaryota (1991-2009)", "MS": "A group (some say infraphylum) of AMOEBOZOA that lack mitochondria.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056896"}, {"RECTYPE": "D", "MH": "Choanoflagellata", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Choanozoas", "MN": "B01.175", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid28009", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent", "MS": "An order of stalked, sessile, single-celled EUKARYOTES. They are considered the transitional link between the flagellated protozoa and the SPONGES, the most primitive metazoans.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056897"}, {"RECTYPE": "D", "MH": "Euglenozoa", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Diplonemida|T204|NON|NRW|NLM (2010)|090226|abcdef", "MN": "B01.268", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid33682", "RR": "txid191814", "MS": "A large group of flagellated EUKARYOTES found in both free-living and parasitic forms. The flagella are present in pairs and contain unique paraxonemal rods.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056898"}, {"RECTYPE": "D", "MH": "Oxymonadida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Oxymonad", "MN": "B01.625", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid66288", "AN": "infection; coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "An order of EUKARYOTES found in the gut of termites and other insects that live on LIGNIN. MITOCHONDRIA and GOLGI APPARATUS are absent from oxymonads.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056899"}, {"RECTYPE": "D", "MH": "Parabasalidea", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Parabasalid", "MN": "B01.630", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid5719", "AN": "infection; coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A group (or phylum) of flagellated, anaerobic EUKARYOTES that are endosymbionts of animals. They lack mitochondria but contain small energy-producing hydrogenosomes. The group is comprised of two major classes: HYPERMASTIGIA and TRICHOMONADIDA.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056900"}, {"RECTYPE": "D", "MH": "Rhizaria", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.680", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid543769", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A large supergroup of mostly amoeboid EUKARYOTES whose three main subgroups are CERCOZOA; FORAMINIFERA; and HAPLOSPORIDA. Nearly all of the species possess MITOCHONDRIA and historically many were considered ANIMALS.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056901"}, {"RECTYPE": "D", "MH": "Clinical Alarms", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Physiologic Monitor Alarm", "MN": "E07.230.200", "MH_TH": "NLM (2010)", "ST": "T074", "PI": "Equipment Failure (2003-2009)", "MS": "Components of medical instrumentation used for physiological evaluation of patients, that signal when a threshold value is reached.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056902"}, {"RECTYPE": "D", "MH": "Chromosome Breakpoints", "AQ": "DE RE", "PRINT ENTRY": "Chromosome Breakpoint|T114|NON|EQV|NLM (2010)|090302|abcdef", "ENTRY": "Sequences, Chromosome Breakpoint", "MN": "G05.360.080.210", "FX": "Chromosome Breakage", "MH_TH": "NLM (2010)", "ST": "T114", "MS": "The locations in specific DNA sequences where CHROMOSOME BREAKS have occurred.", "PM": "2010", "HN": "2010", "MR": "20230526", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056905"}, {"RECTYPE": "D", "MH": "Cyclin T", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cyclins, Type T", "MN": "D12.776.930.955.500.249", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Cyclins (2001-2009)", "MS": "A cyclin subtype that is found associated with CYCLIN-DEPENDENT KINASE 9. Unlike traditional cyclins, which regulate the CELL CYCLE, type T cyclins appear to regulate transcription and are components of positive transcriptional elongation factor B.", "PM": "2010", "HN": "2010", "MR": "20151123", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056906"}, {"RECTYPE": "D", "MH": "Cercozoa", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.680.150", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid136419", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A group of amoeboid and flagellate EUKARYOTES in the supergroup RHIZARIA. They feed by means of threadlike pseudopods.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056907"}, {"RECTYPE": "D", "MH": "Foraminifera", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Foram", "MN": "B01.680.275", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid29178", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "An order of amoeboid EUKARYOTES characterized by reticulating pseudopods and a complex life cycle with an alternation of generations. Most are less than 1mm in size and found in marine or brackish water.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056908"}, {"RECTYPE": "D", "MH": "Plasmodiophorida", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Polymyxa|T204|NON|NRW|NLM (2010)|090309|abcdef", "ENTRY": "Plasmodiophorid", "MN": "B01.680.150.600", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid37357", "RR": "txid41455", "AN": "infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A group of EUKARYOTES that are parasites of plants. Life cycle stages include zoospores and plasmodia.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056909"}, {"RECTYPE": "D", "MH": "Republic of Korea", "AQ": "EH EP", "PRINT ENTRY": "South Korea|T083|NAM|EQV|POPLINE (1986)|750101|abcdef", "MN": "Z01.252.474.557.750", "MH_TH": "NLM (2010)", "ST": "T083", "PI": "Korea (1965-2009)", "MS": "The capital is Seoul. The country, established September 9, 1948, is located on the southern part of the Korean Peninsula. Its northern border is shared with the Democratic People's Republic of Korea.", "HN": "2010", "MR": "20130709", "DA": "20090706", "DC": "4", "DX": "20100101", "UI": "D056910"}, {"RECTYPE": "D", "MH": "Democratic People's Republic of Korea", "AQ": "EH EP", "PRINT ENTRY": "North Korea|T083|NAM|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Korea, Democratic People's Republic of|T083|NAM|EQV|POPLINE (1983)|861231|abcdef", "MN": "Z01.252.474.557.500", "MH_TH": "NLM (2010)", "ST": "T083", "PI": "Korea (1965-2009)", "MS": "A country located on the Korean Peninsula whose capital is Pyongyang. The country was established September 9, 1948.", "HN": "2010", "DA": "20090706", "DC": "4", "DX": "20100101", "UI": "D056911"}, {"RECTYPE": "D", "MH": "Binge-Eating Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Disorders, Binge-Eating", "MN": "F03.400.188", "MH_TH": "NLM (2001)", "ST": "T048", "PI": "Bulimia Nervosa (2000-2009)", "MS": "A disorder associated with three or more of the following: eating until feeling uncomfortably full; eating large amounts of food when not physically hungry; eating much more rapidly than normal; eating alone due to embarrassment; feeling of disgust, DEPRESSION, or guilt after overeating. Criteria includes occurrence on average, at least 2 days a week for 6 months. The binge eating is not associated with the regular use of inappropriate compensatory behavior (i.e. purging, excessive exercise, etc.) and does not co-occur exclusively with BULIMIA NERVOSA or ANOREXIA NERVOSA. (From DSM-IV, 1994)", "PM": "2010; see BULIMIA NERVOSA 2000-2009", "HN": "2010; use BULIMIA NERVOSA 2000-2009", "MR": "20160602", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056912"}, {"RECTYPE": "D", "MH": "Mediator Complex Subunit 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Vitamin D Receptor Interacting Protein Complex Component DRIP205", "MN": "D12.776.930.617.049", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A mediator complex subunit that is believed to play a key role in the coactivation of nuclear receptor-activated transcription by the mediator complex. It interacts with a variety of nuclear receptors including RETINOIC ACID RECEPTORS; THYROID HORMONE RECEPTORS; VITAMIN D RECEPTORS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; ESTROGEN RECEPTORS; and GLUCOCORTICOID RECEPTORS.", "PM": "2010; MEDIATOR OF RNA POLYMERASE II TRANSCRIPTIION SUBUNIT 1 (now MEDIATOR COMPLEX SUBUNIT 1) was indexed under TRANSCRIPTION FACTORS 1998-2009", "HN": "2010(1998)", "MR": "20160330", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056913"}, {"RECTYPE": "D", "MH": "Genomic Structural Variation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Genome Structural Variation|T045|NON|EQV|NLM (2010)|090303|abcdef", "ENTRY": "Variations, Genomic Structural", "MN": "G05.365.795.297", "MH_TH": "NLM (2010)", "ST": "T045", "MS": "Contiguous large-scale (1000-400,000 basepairs) differences in the genomic DNA between individuals, due to SEQUENCE DELETION; SEQUENCE INSERTION; or SEQUENCE INVERSION.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056914"}, {"RECTYPE": "D", "MH": "DNA Copy Number Variations", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "DNA Copy Number Variant|T045|NON|EQV|NLM (2022)|201015|abcdef", "ENTRY": "Polymorphisms, Copy Number", "MN": "G05.365.795.297.500", "FX": "Gene Dosage", "MH_TH": "NLM (2010)", "ST": "T045", "PI": "Gene Dosage (1998-2009)", "MS": "Stretches of genomic DNA that exist in different multiples between individuals. Many copy number variations have been associated with susceptibility or resistance to disease.", "PM": "2010", "HN": "2010", "MR": "20210630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056915"}, {"RECTYPE": "D", "MH": "Segmental Duplications, Genomic", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Segmental Duplications|T114|NON|EQV|NLM (2010)|090303|abcdef", "ENTRY": "Sequences, Low-Copy Repeat", "MN": "G05.360.080.708.565", "FX": "Gene Duplication", "MH_TH": "NLM (2010)", "ST": "T114", "PI": "Gene Duplication (1997-2009)", "MS": "Low-copy (2-50) repetitive DNA elements that are highly homologous and range in size from 1000 to 400,000 base pairs.", "PM": "2010", "HN": "2010", "MR": "20100625", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056916"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Coactivators", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.930.617", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Transcription Factors (1991-2009)", "MS": "Proteins that enhance gene expression when associated with ligand bound activated NUCLEAR RECEPTORS. The coactivators may act through an enzymatic process that affects the rate of transcription or the structure of chromatin. Alternatively nuclear receptor coactivators can function as adaptor proteins that bring nuclear receptors into close proximity with transcriptional complexes.", "PM": "2010", "HN": "2010", "MR": "20160330", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056918"}, {"RECTYPE": "D", "MH": "Retortamonadidae", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Retortamonadidas", "MN": "B01.675", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid193075", "RR": "txid450634", "AN": "infection; coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "PI": "Invertebrates (2001-2009)", "MS": "A family of flagellated EUKARYOTES that live in the intestines of several invertebrate and vertebrate species.", "PM": "2010; for CHILOMASTIX see ZOOMASTIGOPHORA 1992-2009", "HN": "2010; for CHILOMASTIX use INVERTEBRATES 1992-2009", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056919"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Coactivator 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NCoA 1 Protein", "MN": "D12.776.930.617.100", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "EC 2.3.1.48", "MS": "A nuclear receptor coactivator with specificity for ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and THYROID HORMONE RECEPTORS. It contains a HISTONE ACETYLTRANSFRASE activity that may play a role in the transcriptional activation of CHROMATIN regions.", "PM": "2010; NUCLEAR RECEPTOR COACTIVATOR 1 was indexed under TRANSCRIPTION FACTORS and HISTONE ACETYLTRANSFERASES 1995-2009", "HN": "2010(1995)", "MR": "20160415", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056920"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Coactivator 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nuclear Receptor Coactivator-3|T116|T126|NON|EQV|NLM (2010)|090304|abbcdef", "ENTRY": "Receptor Associated Coactivator 3", "MN": "D12.776.930.617.300", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 2.3.1.48", "MS": "A nuclear receptor coactivator with specificity for ESTROGEN RECEPTORS and PROGESTERONE RECEPTORS. It contains a histone acetyltransferase activity that may play a role in CHROMATIN REMODELING during the process of nuclear receptor-induced transcription. The coactivator has been found at elevated levels in certain HORMONE-DEPENDENT NEOPLASMS such as those found in BREAST CANCER.", "PM": "2010; NUCLEAR RECEPTOR COACTIVATOR 3 was indexed under TRANSACTIVATORS and HISTONE ACETYLTRANSFERASES 1997-2009; THYROID HORMONE RECEPTOR ACTIVATOR MOLECULE 1 was indexed under TRANSCRIPTION FACTORS 2000-2009", "HN": "2010(1997)", "MR": "20160330", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056921"}, {"RECTYPE": "D", "MH": "Circadian Rhythm Signaling Peptides and Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Circadian Clock Proteins and Peptides|T116|T123|NON|EQV|NLM (2010)|090305|abbcdef", "ENTRY": "Circadian Rhythm Signaling Proteins|T116|T123|NON|NRW|NLM (2010)|090305|abbcdef", "MN": "D12.776.476.156", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A broad category of proteins that regulate the CIRCADIAN RHYTHM of an organism. Included here are proteins that transmit intracellular and intercellular signals in a chronological manner along with proteins that sense light and time-dependent changes in the environment such as the PHOTOPERIOD.", "PM": "2010", "HN": "2010", "MR": "20180630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056925"}, {"RECTYPE": "D", "MH": "CLOCK Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Circadian Locomotor Output Cycles Kaput Proteins|T116|T123|NON|EQV|NLM (2010)|090727|abbcdef", "MN": "D12.776.930.125.562", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "EC 2.3.1.48", "MS": "Basic helix-loop-helix (bHLH) domain-containing proteins that contain intrinsic HISTONE ACETYLTRANSFERASE activity and play important roles in CIRCADIAN RHYTHM regulation. Clock proteins combine with Arntl proteins to form heterodimeric transcription factors that are specific for E-BOX ELEMENTS and stimulate the transcription of several E-box genes that are involved in cyclical regulation. This transcriptional activation also sets into motion a time-dependent feedback loop which in turn down-regulates the expression of clock proteins.", "PM": "2010; CLOCK PROTEIN (now CLOCK PROTEINS) was indexed under TRANSACTIVATORS 1997-2009", "HN": "2010(1997)", "MR": "20180630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056926"}, {"RECTYPE": "D", "MH": "X-Ray Absorption Spectroscopy", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Near Edge X-Ray Absorption Fine Structure Spectroscopy|T059|NON|NRW|NLM (2010)|090305|abcdef", "ENTRY": "X Ray Absorption Spectroscopy", "MN": "E05.196.867.972", "FX": "Absorption, Radiation", "MH_TH": "NLM (2010)", "ST": "T059", "PI": "X-Rays (1975-2009)", "MS": "Analysis of the energy absorbed across a spectrum of x-ray energies/wavelengths to determine the chemical structure and electronic states of the absorbing medium.", "PM": "2010", "HN": "2010", "MR": "20140606", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056928"}, {"RECTYPE": "D", "MH": "Liddle Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pseudoaldosteronism|T047|NON|EQV|NLM (2010)|OMIM (2013)|ORD (2010)|090306|abcdeeef", "ENTRY": "Syndrome, Liddle", "MN": "C16.320.831.698", "FX": "Epithelial Sodium Channels", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Familial pseudoaldosteronism characterized by autosomal dominant inheritance of hypertension with HYPOKALEMIA; ALKALOSIS; RENIN and ALDOSTERONE level decreases. It is caused by mutations in EPITHELIAL SODIUM CHANNELS beta and gamma subunits. Different mutations in the same EPITHELIAL SODIUM CHANNELS subunits can cause PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT.", "PM": "2010", "HN": "2010", "MR": "20210630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056929"}, {"RECTYPE": "D", "MH": "ARNTL Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, ARNTL", "MN": "D12.776.930.125.249", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "Basic helix-loop-helix (bHLH) domain-containing proteins that play important roles in CIRCADIAN RHYTHM regulation. They combine with CLOCK PROTEINS to form heterodimeric transcription factors that are specific for E-BOX ELEMENTS and stimulate the transcription of several E-box genes that are involved in cyclical regulation.", "PM": "2010; BMAL1 PROTEIN (now ARNTL TRANSCRIPTION FACTORS) was indexed under BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS 2006-2009 and under TRANSCRIPTION FACTORS 1997-2009", "HN": "2010(1997)", "MR": "20180702", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056930"}, {"RECTYPE": "D", "MH": "Cryptochromes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cryptochrome Proteins|T116|T123|NON|EQV|NLM (2010)|090306|abbcdef", "ENTRY": "Cryptochrome|T116|T123|NON|EQV|NLM (2010)|090310|abbcdef", "MN": "D12.776.765.593.500", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "Flavoproteins that function as circadian rhythm signaling proteins in ANIMALS and as blue-light photoreceptors in PLANTS. They are structurally-related to DNA PHOTOLYASES and it is believed that both classes of proteins may have originated from an earlier protein that played a role in protecting primitive organisms from the cyclical exposure to UV LIGHT.", "PM": "2010; CHRYPTOCHROME (now CHRYPTOCHROMES) was indexed under FLAVOPROTEINS 1999-2009 and under PLANT PROTEINS 1990-2004", "HN": "2010(1990)", "MR": "20180630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056931"}, {"RECTYPE": "D", "MH": "Hep G2 Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "HepG2 Cell", "MN": "A11.436.348.500", "MH_TH": "NLM (2010)", "ST": "T025", "AN": "almost always NIM with no subheadings; check HUMAN; do not routinely add LIVER NEOPLASMS or HEPATOBLASTOMA", "PI": "Tumor Cells, Cultured (1988-2009)", "MS": "A human liver tumor cell line used to study a variety of liver-specific metabolic functions.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056945"}, {"RECTYPE": "D", "MH": "Enzyme Replacement Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Enzyme Replacement", "MN": "E02.319.353.500", "MH_TH": "NLM (2010)", "ST": "T061", "AN": "coordinate with specific enzyme / ther use", "MS": "Therapeutic replacement or supplementation of defective or missing enzymes to alleviate the effects of enzyme deficiency (e.g., GLUCOSYLCERAMIDASE replacement for GAUCHER DISEASE).", "PM": "2010", "HN": "2010", "MR": "20100625", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056947"}, {"RECTYPE": "D", "MH": "Orthognathic Surgical Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Orthognathic", "MN": "E06.645.562", "MH_TH": "NLM (2010)", "ST": "T061", "AN": "do not confuse with the surgical specialty  ORTHOGNATHIC SURGERY", "PI": "Osteotomy (1975-2009)", "MS": "Surgery performed to repair or correct the skeletal anomalies of the jaw and its associated dental and facial structures (e.g. CLEFT PALATE).", "PM": "2010", "HN": "2010", "MR": "20180406", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056948"}, {"RECTYPE": "D", "MH": "Phototropins", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "ENTRY": "Phototropin|T116|T123|NON|EQV|NLM (2010)|090310|abbcdef", "MN": "D12.776.765.593.750", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "Blue-light receptors that regulate a range of physiological responses in PLANTS. Examples include: PHOTOTROPISM, light-induced stomatal opening, and CHLOROPLAST movements in response to changes in light intensity.", "PM": "2010; PHOTOTROPIN (now PHOTOTROPINS) was indexed under FLAVOPROTEINS 1999-2009 and under PLANT PROTEINS 1990-1998", "HN": "2010(1990); for PHOTROPIN use CHRYPTOCHROME PROTEINS 1990-2009", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056949"}, {"RECTYPE": "D", "MH": "Period Circadian Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Period Proteins|T116|T123|NON|EQV|NLM (2010)|090313|abbcdef", "MN": "D12.776.543.585.750.687", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "Circadian rhythm signaling proteins that influence circadian clock by interacting with other circadian regulatory proteins and transporting them into the CELL NUCLEUS.", "PM": "2010; PERIOD CIRCADIAN PROTEIN (now PERIOD CIRCADIAN PROTEINS) was indexed under INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 2009 and under EYE PROTEINS 2001-2009", "HN": "2010(2001)", "MR": "20180702", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056950"}, {"RECTYPE": "D", "MH": "Photoelectron Spectroscopy", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Photoelectron Spectrometry|T059|NON|REL|NLM (2010)|090310|abcdef", "ENTRY": "X Ray Photoelectron Spectroscopy", "MN": "E05.196.867.618", "MH_TH": "NLM (2010)", "ST": "T090", "MS": "The study of the energy of electrons ejected from matter by the photoelectric effect, i.e., as a direct result of absorption of energy from electromagnetic radiation. As the energies of the electrons are characteristic of a specific element, the measurement of the energy of these electrons is a technique used to determine the chemical composition of surfaces.", "PM": "2010", "HN": "2010", "MR": "20090717", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056951"}, {"RECTYPE": "D", "MH": "Hypermastigia", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Trichonymphas", "MN": "B01.630.399", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid285691", "RR": "txid63627", "AN": "infection; coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent", "MS": "A class of endosymbiont EUKARYOTES, in the group PARABASALIDEA, that are obligate mutualists in the digestive tracts of wood-eating insects. Hypermastigotes produce CELLULASE that breaks down the cellulose in wood so that insects can metabolize it.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056952"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Subfamily 1, Group D, Member 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Rev-erb-alpha Nuclear Receptors|T116|T123|ABX|EQV|NLM (2010)|090311|abbcdef", "ENTRY": "V erbA Related Protein EAR 1", "MN": "D12.776.826.209.080", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Receptors, Cytoplasmic and Nuclear (1990-2009)", "MS": "A DNA-binding orphan nuclear receptor that negatively regulates expression of ARNTL TRANSCRIPTION FACTORS and plays a role as a regulatory component of the circadian clock system. The Nr1d1 nuclear receptor expression is cyclically-regulated by a feedback loop involving its positive regulation by CLOCK PROTEIN; BMAL1 PROTEIN heterodimers and its negative regulation by CRYPTOCHROME and PERIOD PROTEINS.", "PM": "2010", "HN": "2010", "MR": "20180702", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056953"}, {"RECTYPE": "D", "MH": "Injections, Intraocular", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Periocular Injections", "MN": "E02.319.267.530.475", "MH_TH": "NLM (2010)", "ST": "T061", "PI": "Injections (1972-2009)", "MS": "The administration of substances into the eye with a hypodermic syringe.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056965"}, {"RECTYPE": "D", "MH": "Excitation Contraction Coupling", "AQ": "DE GE IM PH RE", "ENTRY": "Excitation Contraction Couplings", "MN": "G11.427.494.235", "MH_TH": "NLM (2010)", "ST": "T043", "PI": "Myocardial Contraction (1975-2009)", "MS": "A process fundamental to muscle physiology whereby an electrical stimulus or action potential triggers a myocyte to depolarize and contract. This mechanical muscle contraction response is regulated by entry of calcium ions into the cell.", "PM": "2010", "HN": "2010", "MR": "20160623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056966"}, {"RECTYPE": "D", "MH": "Lac Repressors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Repressors, Lac", "MN": "D12.776.930.780.781", "MH_TH": "UNK (19XX)", "ST": "T123", "RN": "0", "MS": "Bacterial repressor proteins that bind to the LAC OPERON and thereby prevent the synthesis of proteins involved in catabolism of LACTOSE. When lactose levels are high lac repressors undergo an allosteric change that causes their release from the DNA and the resumption of lac operon transcription.", "PM": "2010; see REPRESSOR PROTEINS 1979-2009", "HN": "2010; use REPRESSOR PROTEINS 1979-2009", "MR": "20150629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056968"}, {"RECTYPE": "D", "MH": "Voltage-Sensitive Dye Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Voltage Sensitive Dye Imaging", "MN": "E01.370.350.887", "MH_TH": "NLM (2010)", "ST": "T062", "MS": "Optical imaging techniques used for recording patterns of electrical activity in tissues by monitoring transmembrane potentials via FLUORESCENCE imaging with voltage-sensitive fluorescent dyes.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056969"}, {"RECTYPE": "D", "MH": "Co-Repressor Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Nuclear Receptor Corepressor|T116|T123|NON|NRW|NLM (2021)|191118|abbcdef", "ENTRY": "Receptor Corepressor, Nuclear", "MN": "D12.776.930.780.625", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Repressor Proteins (1978-2009)", "MS": "A subclass of repressor proteins that do not directly bind DNA. Instead, co-repressors generally act via their interaction with DNA-BINDING PROTEINS such as a TRANSCRIPTIONAL SILENCING FACTORS or NUCLEAR RECEPTORS.", "PM": "2010", "HN": "2010", "MR": "20200527", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056970"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Co-Repressor 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Retinoid X Receptor Interacting Protein 13", "MN": "D12.776.930.780.625.374", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A nuclear protein that regulates the expression of genes involved in a diverse array of processes related to metabolism and reproduction. The protein contains three nuclear receptor interaction domains and three repressor domains and is closely-related in structure to NUCLEAR RECEPTOR CO-REPRESSOR 2.", "PM": "2010; NUCLEAR RECEPTOR CO-REPRSSOR 1 was indexed under NUCLEAR PROTEINS and REPRESSOR PROTEINS 1995-2009", "HN": "2010(1995)", "MR": "20150629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056971"}, {"RECTYPE": "D", "MH": "Optical Restriction Mapping", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Restriction Mapping, Optical", "MN": "E05.393.712.500", "MH_TH": "NLM (2010)", "ST": "T059", "PI": "Restriction Mapping (1993-2009)", "MS": "A technique to generate restriction maps from single large DNA molecules by spreading the DNA onto a glass surface, digesting with DNA RESTRICTION ENZYMES, staining with FLUORESCENT DYES, and visualizing the DNA cleavage sites by FLUORESCENCE MICROSCOPY.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056972"}, {"RECTYPE": "D", "MH": "Four-Dimensional Computed Tomography", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tomography, Four-Dimensional Computed", "MN": "E01.370.350.825.810.810.599", "MH_TH": "NLM (2010)", "ST": "T060", "PI": "Tomography, X-Ray Computed (2003-2009)", "MS": "Three-dimensional computed tomographic imaging with the added dimension of time, to follow motion during imaging.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056973"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Co-Repressor 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TRAC Co repressor", "MN": "D12.776.930.780.625.400", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "MS": "A nuclear co-repressor protein that shows specificity for RETINOIC ACID RECEPTORS and THYROID HORMONE RECEPTORS. The dissociation of this co-repressor from nuclear receptors is generally ligand-dependent, but can also occur by way of its phosphorylation by members of the MAP KINASE SIGNALING SYSTEM. The protein contains two nuclear receptor interaction domains and four repressor domains and is closely-related in structure to NUCLEAR RECEPTOR CO-REPRESSOR 1.", "PM": "2010; NUCLEAR RECEPTOR CO-REPRESSOR 2 was indexed under DNA-BINDING PROTEINS and REPRESSOR PROTEINS 1995-2009", "HN": "2010(1995)", "MR": "20150629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056985"}, {"RECTYPE": "D", "MH": "Euglenozoa Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Euglenozoa", "MN": "C01.610.752.300", "MH_TH": "NLM (2010)", "ST": "T047", "MS": "Infections with the protozoa of the phylum EUGLENOZOA.", "PM": "2010", "HN": "2010", "MR": "20190617", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056986"}, {"RECTYPE": "D", "MH": "Vasoplegia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vasoplegic Syndrome|T046|T184|NON|NRW|NLM (2010)|090317|abbcdef", "ENTRY": "Vasoplegic Syndromes, Post-operative", "MN": "C23.550.767.962", "MH_TH": "NLM (2010)", "ST": "T184", "PI": "Vascular Diseases (1978-2009)", "MS": "Condition of low SYSTEMIC VASCULAR RESISTANCE that develops secondary to other conditions such as ANAPHYLAXIS; SEPSIS; SURGICAL SHOCK; and SEPTIC SHOCK. Vasoplegia that develops during or post surgery (e.g., CARDIOPULMONARY BYPASS) is called postoperative vasoplegic syndrome or vasoplegic syndrome.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056987"}, {"RECTYPE": "D", "MH": "Anterior Wall Myocardial Infarction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myocardial Infarction, Anterior Wall|T047|NON|EQV|NLM (2010)|090430|abcdef", "ENTRY": "Myocardial Infarctions, Anteroseptal", "MN": "C23.550.717.489.750.093", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Myocardial Infarction (1963-2009)", "MS": "MYOCARDIAL INFARCTION in which the anterior wall of the heart is involved. Anterior wall myocardial infarction is often caused by occlusion of the left anterior descending coronary artery. It can be categorized as anteroseptal or anterolateral wall myocardial infarction.", "PM": "2010", "HN": "2010", "MR": "20190701", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056988"}, {"RECTYPE": "D", "MH": "Inferior Wall Myocardial Infarction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Myocardial Infarction, Inferior Wall|T047|NON|EQV|NLM (2010)|090430|abcdef", "ENTRY": "Myocardial Infarctions, Inferior", "MN": "C23.550.717.489.750.187", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Myocardial Infarction (1969-2009)", "MS": "MYOCARDIAL INFARCTION in which the inferior wall of the heart is involved. It is often caused by occlusion of the right coronary artery.", "PM": "2010", "HN": "2010", "MR": "20190701", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056989"}, {"RECTYPE": "D", "MH": "Post-Exposure Prophylaxis", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Prophylaxis, Post-Exposure", "MN": "N02.421.726.755", "MH_TH": "NLM (2010)", "ST": "T061", "PI": "specific disease/prevention and control (1972-2009)", "MS": "The prevention of infection or disease following exposure to a pathogen.", "PM": "2010", "HN": "2010", "MR": "20150626", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D056990"}, {"RECTYPE": "D", "MH": "Bioengineering", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Bio-Engineering|T090|NON|EQV|NLM (2010)|090414|abcdef", "ENTRY": "engineerings, Bio", "MN": "J01.293.069", "MH_TH": "NLM (2010)", "ST": "T090", "PI": "Biomedical Engineering (1978-2009)", "MS": "The application of engineering principles and methods to living organisms or biological systems.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057005"}, {"RECTYPE": "D", "MH": "Induced Pluripotent Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Induced Pluripotent Stem Cell|T025|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "IPS Cells, Fibroblast-Derived", "MN": "A11.872.700.500", "MH_TH": "NLM (2010)", "ST": "T025", "PI": "Pluripotent Stem Cells (2007-2009)", "MS": "Cells from adult organisms that have been reprogrammed into a pluripotential state similar to that of EMBRYONIC STEM CELLS.", "PM": "2010", "HN": "2010", "MR": "20200527", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057026"}, {"RECTYPE": "D", "MH": "Laryngopharyngeal Reflux", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Regurgitation, Gastric|T046|NON|REL|UNK (19XX)|771125|abcdef", "ENTRY": "Reflux, Supraesophageal Gastric (SEGR)", "MN": "C08.360.577", "FX": "Esophageal Sphincter, Upper", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Pharyngeal Diseases (1997-2009)", "MS": "Back flow of gastric contents to the LARYNGOPHARYNX where it comes in contact with tissues of the upper aerodigestive tract. Laryngopharyngeal reflux is an extraesophageal manifestation of GASTROESOPHAGEAL REFLUX.", "PM": "2012; see REGURGITATION, GASTRIC 2011; for REGURGITATION, GASTRIC see GASTROESOPHAGEAL REFLUX 1984-2009, see REGURGITATION, GASTRIC 1967-1978", "HN": "2012; for REGURGITATION, GASTRIC use GASTROESOPHAGEAL REFLUX 1984-2009, use REGURGITATION, GASTRIC 1967-1978", "MR": "20150522", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057045"}, {"RECTYPE": "D", "MH": "Plant Nectar", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Nectar|T167|NON|EQV|NLM (2010)|090325|abcdef", "ENTRY": "Nectar, Plant", "MN": "D20.215.780", "FX": "Pollination", "MH_TH": "NLM (2011)", "ST": "T167", "RN": "0", "PI": "Plant Proteins (1999-2009)", "MS": "Sugar-rich liquid produced in plant glands called nectaries. It is either produced in flowers or other plant structures (extrafloral nectaries), providing a source of attraction for pollinating insects and animals, as well as being a nutrient source to animal mutualists which provide protection of plants against herbivores.", "PM": "2010", "HN": "2010", "MR": "20230531", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057048"}, {"RECTYPE": "D", "MH": "Thrombotic Microangiopathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Thrombotic Microangiopathy", "MN": "C15.378.243.937.925", "FX": "Thrombosis", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Purpura, Thrombotic Thrombocytopenic (1965-2009)", "MS": "Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.", "PM": "2010", "HN": "2010", "MR": "20230226", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057049"}, {"RECTYPE": "D", "MH": "Receptor Tyrosine Kinase-like Orphan Receptors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Receptor Tyrosine Kinase-like Orphan Receptor|T116|T192|NON|EQV|NLM (2022)|201006|abbcdef", "ENTRY": "Tyrosine Kinase, ROR1", "MN": "D12.776.543.750.630.233", "MH_TH": "NLM (2010)", "ST": "T192", "RN": "EC 2.7.10.1", "RR": "EC 2.7.10.1", "AN": "do not confuse with ORPHAN NUCLEAR RECEPTORS", "PI": "Receptor Protein-Tyrosine Kinases (1994-2009)", "MS": "A family of cell surface receptors that were originally identified by their structural homology to neurotropic TYROSINE KINASES and referred to as orphan receptors because the associated ligand and signaling pathways were unknown. Evidence for the functionality of these proteins has been established by experiments showing that disruption of the orphan receptor genes results in developmental defects.", "PM": "2010", "HN": "2010", "MR": "20210630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057050"}, {"RECTYPE": "D", "MH": "Product Recalls and Withdrawals", "AQ": "ES LJ ST", "ENTRY": "Withdrawals, Product", "MN": "N06.850.210.637", "MH_TH": "NLM (2010)", "ST": "T064", "AN": "general; prefer specifics", "PI": "Consumer Product Safety (1987-2009)", "MS": "The removal of a consumer product from the market place. The reason for the removal can be due a variety of causes, including the discovery of a manufacturing defect, a safety issue with the product's use, or marketing decisions.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057051"}, {"RECTYPE": "D", "MH": "Medical Device Recalls", "AQ": "ES LJ ST", "PRINT ENTRY": "Biomedical Device Recalls|T089|NON|REL|NLM (2010)|090326|abcdef", "ENTRY": "Recalls, Medical Device", "MN": "N06.850.210.637.500", "FX": "Prosthesis Failure", "MH_TH": "NLM (2010)", "ST": "T089", "AN": "SAFETY-BASED MEDICAL DEVICE WITHDRAWALS is also available", "PI": "Specific Device /adverse effects (1978-2009)", "MS": "Removal of a MEDICAL DEVICE from the market due to a problem occurring in the manufacture or distribution of the product.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057052"}, {"RECTYPE": "D", "MH": "Safety-Based Medical Device Withdrawals", "AQ": "ES LJ ST", "PRINT ENTRY": "Biomedical Device Safety Withdrawals|T064|NON|NRW|NLM (2010)|090326|abcdef", "ENTRY": "Safety Based Medical Device Withdrawals", "MN": "N06.850.210.637.750", "MH_TH": "NLM (2010)", "ST": "T064", "AN": "MEDICAL DEVICE RECALLS is also available", "MS": "Removal of a MEDICAL DEVICE from the market due to the identification of an intrinsic property of the device that results in a serious risk to public health.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057053"}, {"RECTYPE": "D", "MH": "Molecular Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Imaging, Molecular", "MN": "E05.601.555", "MH_TH": "NLM (2010)", "ST": "T060", "MS": "The use of molecularly targeted imaging probes to localize and/or monitor biochemical and cellular processes via various imaging modalities that include RADIONUCLIDE IMAGING; ULTRASONOGRAPHY; MAGNETIC RESONANCE IMAGING; FLUORESCENCE IMAGING; and MICROSCOPY.", "PM": "2010", "HN": "2010", "MR": "20150623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057054"}, {"RECTYPE": "D", "MH": "Aspartic Acid Proteases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aspartyl Proteinases|T116|T126|NON|EQV|NLM (1991)|900404|abbcdef", "ENTRY": "Proteinases, Aspartyl", "MN": "D08.811.277.656.074", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "EC 3.4.-", "PI": "Peptide Hydrolases (1966-1990)", "MS": "A subclass of peptide hydrolases that depend on an ASPARTIC ACID residue for their activity.", "PM": "2010; see ASPARTIC ENDOPEPTIDASES 2000-2009, see ASPARTIC PROTEINASES 1991-1999", "HN": "2010; use ASPARTIC ACID ENDOPEPTIDASES 1991-2009", "MR": "20200527", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057055"}, {"RECTYPE": "D", "MH": "Cysteine Proteases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cysteine Proteinases|T116|T126|NON|EQV|NLM (1988)|990101|abbcdef", "ENTRY": "Proteinases, Cysteine", "MN": "D08.811.277.656.262", "EC": "antagonists & inhibitors:Cysteine Proteinase Inhibitors", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 3.4.-", "RR": "EC 3.4.-", "AN": "do not confuse with CYSTEINE ENDOPEPTIDASES", "PI": "Cysteine Endopeptidases (1988-2009)", "MS": "A subclass of peptide hydrolases that depend on a CYSTEINE residue for their activity.", "PM": "2010; see CYSTEINE ENDOPEPTIDASES 2000-2009, see CYSTEINE PROTEINASES 1988-1999", "HN": "2010, 1988-1999; use CYSTEINE ENDOPEPTIDASES 2000-2009", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057056"}, {"RECTYPE": "D", "MH": "Serine Proteases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Serine Proteinases|T116|T126|NON|EQV|NLM (1988)|990101|abbcdef", "ENTRY": "Proteinases, Serine", "MN": "D08.811.277.656.959", "EC": "antagonists & inhibitors:Serine Proteinase Inhibitors", "MH_TH": "UNK (19XX)", "ST": "T126", "RN": "EC 3.4.-", "RR": "EC 3.4.-", "AN": "do not confuse with SERINE ENDOPEPTIDASES", "MS": "Peptide hydrolases that contain at the active site a SERINE residue involved in catalysis.", "PM": "2010; see SERINE ENDOPEPTIDASES 2000-2009, see SERINE PROTEINASES 1988-1999", "HN": "2010, 1988-1999; use SERINE ENDOPEPTIDASES 2000-2009", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057057"}, {"RECTYPE": "D", "MH": "ATP-Dependent Endopeptidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Endoproteases, ATP-Dependent", "MN": "D12.776.157.025.750.032.099", "MH_TH": "NLM (2010)", "ST": "T126", "RN": "0", "PI": "ATP-Dependent Proteases (1981-2009)", "MS": "Endoproteases that contain proteolytic core domains and ATPase-containing regulatory domains.", "PM": "2010; see ATP-DEPENDENT PROTEASES 2005-2009", "HN": "2010; use ATP-DEPENDENT PROTEASES 2005-2009", "MR": "20170524", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057065"}, {"RECTYPE": "D", "MH": "Low Tension Glaucoma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Normal Tension Glaucomas", "MN": "C11.640.225", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "scattered (1976-2009)", "MS": "A form of glaucoma in which chronic optic nerve damage and loss of vision normally attributable to buildup of intraocular pressure occurs despite prevailing conditions of normal intraocular pressure.", "PM": "2010", "HN": "2010", "MR": "20170620", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057066"}, {"RECTYPE": "D", "MH": "Periprosthetic Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Periprosthetic Fracture", "MN": "C26.404.550", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "specific Fractures/etiology (1996-2009)", "MS": "Fractures around joint replacement prosthetics or implants. They can occur intraoperatively or postoperatively.", "PM": "2010", "HN": "2010", "MR": "20100625", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057068"}, {"RECTYPE": "D", "MH": "Diagnostic Test Approval", "AQ": "EC HI LJ ST TD", "ENTRY": "Diagnostic Test Approvals", "MN": "N06.850.210.275.500", "MH_TH": "NLM (2010)", "ST": "T064", "MS": "The process of gaining approval by a government regulatory agency for DIAGNOSTIC REAGENTS AND TEST KITS. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057069"}, {"RECTYPE": "D", "MH": "Cervical Rib", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ribs, Cervical", "MN": "A02.835.232.570.500.150", "FX": "Thoracic Outlet Syndrome", "MH_TH": "OMIM (2013)", "ST": "T023", "MS": "A supernumerary rib developing from an abnormal enlargement of the costal element of the C7 vertebra. This anomaly is found in 1-2% of the population and can put pressure on adjacent structures causing CERVICAL RIB SYNDROME; THORACIC OUTLET SYNDROME; or other conditions.", "PM": "2010", "HN": "2010", "MR": "20180629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057070"}, {"RECTYPE": "D", "MH": "Patellofemoral Joint", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Patellofemoral Contact|T030|NON|EQV|NLM (2024)|230405|abcdef", "ENTRY": "Patellofemoral Joints", "MN": "A02.835.583.475.650", "MH_TH": "NLM (2010)", "ST": "T030", "PI": "Knee Joint (1989-2009)", "MS": "The articulation between the articular surface of the PATELLA and the patellar surface of the FEMUR.", "PM": "2010", "HN": "2010", "MR": "20230531", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057071"}, {"RECTYPE": "D", "MH": "Intra-Articular Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Intraarticular Fracture", "MN": "C26.404.505", "MH_TH": "NLM (2010)", "ST": "T037", "PI": "specific bone/injuries (1971-2009)", "MS": "Fractures of the articular surface of a bone.", "PM": "2010", "HN": "2010", "MR": "20100625", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057072"}, {"RECTYPE": "D", "MH": "Thyrotropin Alfa", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TSH, Recombinant Human", "MN": "D06.472.699.631.525.883.374", "MH_TH": "NLM (2010)", "ST": "T125", "RN": "0", "PI": "Glycoprotein Hormones, alpha Subunit (1991-2009)", "MS": "A highly purified recombinant glycoprotein form of human THYROID-STIMULATING HORMONE, produced by recombinant DNA technology comprising two non-covalently linked subunits, an alpha subunit of 92 amino acid residues containing two N-linked glycosylation sites, and a beta subunit of 118 residues containing one N-linked glycosylation site. The amino acid sequence of thyrotropin alfa is identical to that of human pituitary thyroid stimulating hormone.", "PM": "2010", "HN": "2010", "MR": "20160701", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057073"}, {"RECTYPE": "D", "MH": "Virus Release", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Virus Egress|T070|NON|EQV|NLM (2010)|090401|abcdef", "ENTRY": "Release, Virus", "MN": "G06.920.913", "FX": "Virus Shedding", "MH_TH": "NLM (2010)", "ST": "T070", "AN": "do not confuse with VIRUS SHEDDING", "MS": "Release of a virus from the host cell following VIRUS ASSEMBLY and maturation. Egress can occur by host cell lysis, EXOCYTOSIS, or budding through the plasma membrane.", "PM": "2010", "HN": "2010", "MR": "20160617", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057074"}, {"RECTYPE": "D", "MH": "Enzyme Assays", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Indirect Enzyme Assay", "MN": "E05.196.427", "MH_TH": "NLM (2010)", "ST": "T059", "MS": "Methods used to measure the relative activity of a specific enzyme or its concentration in solution. Typically an enzyme substrate is added to a buffer solution containing enzyme and the rate of conversion of substrate to product is measured under controlled conditions. Many classical enzymatic assay methods involve the use of synthetic colorimetric substrates and measuring the reaction rates using a spectrophotometer.", "PM": "2010", "HN": "2010", "MR": "20090717", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057075"}, {"RECTYPE": "D", "MH": "Varroidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Varroa|T204|NON|NRW|NLM (2010)|090403|abcdef", "ENTRY": "Mites, Honeybee", "MN": "B01.050.500.131.166.132.419.900", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid109261", "RR": "txid62624", "PI": "Mites (1975-2009)", "MS": "A family of MITES in the subclass ACARI. It includes the single genus Varroa.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057077"}, {"RECTYPE": "D", "MH": "Pentastomida", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Tongue Worms|T204|NON|EQV|NLM (2010)|090403|abcdef", "ENTRY": "Worms, Tongue", "MN": "B01.050.500.131.365.640", "MH_TH": "NLM (2010)", "ST": "T204", "RN": "txid7561", "RR": "txid646052", "AN": "infection: coordinate (IM) with PARASITIC DISEASES (IM) or PARASITIC DISEASES, ANIMAL (IM)", "PI": "Arthropods (1966-2009)", "MS": "A subclass of CRUSTACEA comprising the tongue worms which are obligatory parasites of reptiles, birds, and mammals including humans.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057078"}, {"RECTYPE": "D", "MH": "Pongo", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Orangutans|T015|NON|EQV|NLM (2010)|090605|abcdef", "MN": "B01.050.150.900.649.313.988.400.112.400.635", "MH_TH": "NLM (2010)", "ST": "T015", "RN": "txid9599", "AN": "diseases: coordinate with APE DISEASES + specific disease /vet ", "MS": "A genus of orangutans in the family HOMINIDAE, comprising two species. Among the PRIMATES, the orangutan is second in size only to the gorilla (GORILLA GORILLA).", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057079"}, {"RECTYPE": "D", "MH": "Pongo abelii", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Orangutan, Sumatran|T015|EPO|EQV|NLM (2010)|090605|abcdef", "ENTRY": "Pongo abelius", "MN": "B01.050.150.900.649.313.988.400.112.400.635.050", "MH_TH": "NLM (2010)", "ST": "T015", "RN": "txid9601", "AN": "diseases: coordinate with APE DISEASES + specific disease /vet", "PI": "Pongo pygmaeus (2003-2009)", "MS": "A species of orangutan, family HOMINIDAE, found in the forests on the island of Sumatra.", "PM": "2010", "HN": "2010", "MR": "20200813", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057080"}, {"RECTYPE": "D", "MH": "Tooth Wear", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dental Wear|T037|T047|NON|EQV|NLM (2010)|090406|abbcdef", "ENTRY": "Wears, Tooth", "MN": "C07.793.818", "MH_TH": "NLM (2010)", "ST": "T047", "AN": "note specifics TOOTH ABRASION; TOOTH ATTRITION; & TOOTH EROSION are also available", "PI": "Tooth Attrition (1995-2009)", "MS": "Loss of the tooth substance by chemical or mechanical processes", "PM": "2010", "HN": "2010; Tooth Erosion (1999-2009)", "MR": "20090820", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057085"}, {"RECTYPE": "D", "MH": "High-Intensity Focused Ultrasound Ablation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "High Intensity Focused Ultrasound Ablation", "MN": "E04.014.380", "MH_TH": "NLM (2010)", "ST": "T061", "PI": "Ultrasonic Therapy (1993-2009)", "MS": "The use of focused, high-frequency sound waves to destroy tissue. It is sometimes used in conjunction with but is distinct from INTERVENTIONAL ULTRASONOGRAPHY.", "PM": "2010", "HN": "2010", "MR": "20150626", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057086"}, {"RECTYPE": "D", "MH": "Dental Atraumatic Restorative Treatment", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Atraumatic Restorative Treatment, Dental|T061|NON|EQV|NLM (2010)|090604|abcdef", "MN": "E06.070", "MH_TH": "NLM (2010)", "ST": "T061", "PI": "Dental Restoration, Permanent (1994-2009)", "MS": "Treatment modality for DENTAL CARIES that uses manual excavation method and GLASS IONOMER CEMENTS. Because of its noninvasiveness and no need for expensive equipment and anesthesia it is promoted as an approach in places where dental care is not readily available.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057087"}, {"RECTYPE": "D", "MH": "Anetoderma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anetoderma, Primary|T047|NON|NRW|NLM (2010)|090407|abcdef", "ENTRY": "Secondary Anetodermas", "MN": "C17.800.804.108", "FX": "Cutis Laxa", "MH_TH": "NLM (2010)", "ST": "T047", "AN": "do not confuse with CUTIS LAXA, mostly a genetic disease: both are described as \"loose skin\"", "PI": "Skin Diseases (1963-2009)", "MS": "Benign DERMATOSIS caused by a loss of dermal ELASTIC TISSUE resulting in localized sac-like areas of flaccid skin. It can be either primary (idiopathic) or secondary to other skin conditions, PENICILLAMINE use, or premature birth.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057088"}, {"RECTYPE": "D", "MH": "Pathology, Molecular", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Molecular Diagnostics|T057|T091|NON|NRW|NLM (2010)|090407|abbcdef", "ENTRY": "Pathology, Diagnostic Molecular", "MN": "H02.403.650.505", "MH_TH": "NLM (2010)", "ST": "T091", "AN": "use for the discipline (education, history, etc) only", "PI": "Pathology (1963-2009)", "MS": "A subspecialty of pathology concerned with the molecular basis (e.g., mutations) of various diseases.", "PM": "2010", "HN": "2010", "MR": "20120703", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057089"}, {"RECTYPE": "D", "MH": "Eccrine Porocarcinoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Malignant Eccrine Poroma|T191|NON|EQV|NLM (2010)|090407|abcdef", "ENTRY": "Poromas, Malignant Eccrine", "MN": "C04.557.470.200.025.500", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with SWEAT GLAND NEOPLASMS (IM)", "PI": "Sweat Gland Neoplasms (1970-2009)", "MS": "A rare malignant neoplasm of the sweat glands. It most often develops as a form of degenerative progression from a benign ECCRINE POROMA.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057090"}, {"RECTYPE": "D", "MH": "Poroma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Hidracanthoma Simplex|T191|NON|NRW|NLM (2010)|090407|abcdef", "ENTRY": "Tumor, Dermal Duct", "MN": "C04.557.470.550.175.588", "FX": "Eccrine Porocarcinoma", "MH_TH": "NLM (2010)", "ST": "T191", "AN": "coordinate IM with SWEAT GLAND NEOPLASMS (IM)", "PI": "Sweat Gland Neoplasms (1967-2009)", "MS": "A benign adnexal neoplasm derived from cells of the terminal duct of eccrine or apocrine SWEAT GLAND lineage. They typically manifest as solitary papules and occur only in the skin but unlike in ACROSPIROMA involves the epidermis.", "PM": "2010", "HN": "2010", "MR": "20170707", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057091"}, {"RECTYPE": "D", "MH": "Geographic Atrophy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Macular Degenerations, Dry", "MN": "C11.768.585.439.122", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Retinal Degeneration (1970-2009)", "MS": "A form of MACULAR DEGENERATION also known as dry macular degeneration marked by occurrence of a well-defined progressive lesion or atrophy in the central part of the RETINA called the MACULA LUTEA. It is distinguishable from WET MACULAR DEGENERATION in that the latter involves neovascular exudates.", "PM": "2010", "HN": "2010", "MR": "20090721", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057092"}, {"RECTYPE": "D", "MH": "Orphan Nuclear Receptors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Orphan Nuclear Receptor|T116|T192|NON|EQV|NLM (2021)|200317|abbcdef", "ENTRY": "Receptors, Orphan Nuclear", "MN": "D12.776.930.645", "MH_TH": "NLM (2010)", "ST": "T192", "RN": "0", "AN": "do not confuse with RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS", "MS": "A broad category of receptor-like proteins that may play a role in transcriptional-regulation in the CELL NUCLEUS. Many of these proteins are similar in structure to known NUCLEAR RECEPTORS but appear to lack a functional ligand-binding domain, while in other cases the specific ligands have yet to be identified.", "PM": "2010", "HN": "2010", "MR": "20200527", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057093"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Subfamily 1, Group F, Member 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Retinoid Related Orphan Receptor alpha4", "MN": "D12.776.826.209.100", "MH_TH": "NLM (2010)", "ST": "T192", "RN": "0", "MS": "A DNA-binding orphan nuclear receptor that positively regulates expression of ARNTL TRANSCRIPTION FACTORS and is a regulatory component of the circadian clock system. The protein also has a role in neuron cell survival and differentiation in that loss of function mutations of its gene result in the mouse phenotype referred to as the STAGGERER MOUSE.", "PM": "2010; RAR-RELATED ORPHAN RECEPTOR A (now NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1) was indexed under TRANS-ACTIVATORS and RECEPTORS, CYTOPLASMIC AND NUCLEAR 1996-2009", "HN": "2010(1996)", "MR": "20180702", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057094"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Subfamily 1, Group F, Member 2", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "RAR-related Orphan Receptor B|T116|T192|ABX|EQV|NLM (2010)|090409|abbcdef", "ENTRY": "Retinoid related Orphan Receptor beta", "MN": "D12.776.826.209.110", "MH_TH": "NLM (2010)", "ST": "T192", "RN": "0", "MS": "An orphan nuclear receptor that is expressed at high levels in neuronal tissues, the RETINA; EPIDIDYMIS; and VAS DEFERENS. The receptor is believed to play a role in regulating a variety of functions including the processing of sensory information, the differentiation of PHOTORECEPTOR CELLS and the CIRCADIAN RHYTHM.", "PM": "2010; RAR-RELATED ORPHAN RECEPTOR B (now NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 2) was indexed under RECEPTORS, CYTOPLASMIC AND NUCLEAR 1999-2003, and under RECEPTORS, CELL SURFACE 1998-2003", "HN": "2010(1998)", "MR": "20180702", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057095"}, {"RECTYPE": "D", "MH": "Shellfish Poisoning", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Shellfish Poisonings, Paralytic", "MN": "C25.723.415.792", "FX": "Shellfish Hypersensitivity", "MH_TH": "NLM (2010)", "ST": "T037", "AN": "coordinate with specific shellfish if pertinent", "PI": "Shellfish/poisoning (1965-2009)", "MS": "Poisoning from toxins present in bivalve mollusks that have been ingested. Four distinct types of shellfish poisoning are recognized based on the toxin involved.", "PM": "2010", "HN": "2010", "MR": "20141121", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057096"}, {"RECTYPE": "D", "MH": "Harmful Algal Bloom", "AQ": "DE PH RE", "PRINT ENTRY": "Red Tide|T070|NON|REL|UNK (19XX)|850520|abcdef", "ENTRY": "Tides, Red", "MN": "G16.500.285.400", "FX": "Shellfish Poisoning", "MH_TH": "NLM (2010)", "ST": "T067", "AN": "ALGAL BLOOM is also available", "PI": "Eutrophication (2003-2009)", "MS": "An algal bloom where the algae produce powerful toxins that can kill fish, birds, and mammals, and ultimately cause illness in humans. The harmful bloom can also cause oxygen depletion in the water due to the death and decomposition of non-toxic algae species.", "PM": "2010; for RED TIDE see DINOFLAGELLIDA 1986-2009, see RED TIDE 1979-1985, see MASTIGOPHORA 1974-1978", "HN": "2010; for RED TIDE use DINOFLAGELLIDA 1979-2009, use INVERTEBRATES 1974-1978", "MR": "20160623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057097"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Subfamily 4, Group A, Member 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Orphan Nuclear Receptor NGFI B", "MN": "D12.776.826.209.400", "MH_TH": "NLM (2010)", "ST": "T192", "RN": "0", "MS": "An orphan nuclear receptor that is closely related to members of the thyroid-steroid receptor gene family. It was originally identified in NERVE CELLS and may play a role in mediation of NERVE GROWTH FACTOR-induced CELL DIFFERENTIATION. However, several other functions have been attributed to this protein including the positive and negative regulation of APOPTOSIS.", "PM": "2010; ORPHAN NUCLEAR RECEPTOR NGFI-B (now NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1) was indexed under DNA-BINDING PROTEINS and RECEPTORS, STEROID 2009, and under RECEPTORS, CYTOPLASMIC AND NUCLEAR and TRANSCRIPTION FACTORS 1991-2008", "HN": "2010(1991)", "MR": "20150708", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057105"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Subfamily 4, Group A, Member 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nuclear Hormone Receptor NOR 1", "MN": "D12.776.826.209.430", "MH_TH": "NLM (2010)", "ST": "T192", "RN": "0", "PI": "Transcription Factors (2005)", "MS": "An orphan nuclear receptor that is closely related to members of the thyroid-steroid receptor family. It was originally identified in NERVE CELLS, however it may play regulatory roles in a variety of other tissues.", "PM": "2010", "HN": "2010", "MR": "20150623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057106"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Subfamily 2, Group C, Member 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TR2 11 Receptor", "MN": "D12.776.826.209.255", "MH_TH": "NLM (2010)", "ST": "T192", "RN": "0", "MS": "A DNA-binding orphan nuclear receptor that has specificity for directly repeated (DR) AGGTCA sequences. It binds DNA as either as a homodimer or as a heterodimer with the closely-related orphan nuclear receptor NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 2. The protein was originally identified as a PROSTATE-specific protein and is involved in the regulation of variety of cellular processes, including CELL DIFFERENTIATION; CELL PROLIFERATION; and APOPTOSIS.", "PM": "2010; NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 1 was indexed under RECEPTORS, THYROID HORMONE 1995-2009", "HN": "2010(1995)", "MR": "20150623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057107"}, {"RECTYPE": "D", "MH": "Corneal Wavefront Aberration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Wavefront Aberrations, Corneal", "MN": "C11.744.345", "FX": "Aberrometry", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Corneal Topography (2000-2009)", "MS": "Asymmetries in the topography and refractive index of the corneal surface that affect visual acuity.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057108"}, {"RECTYPE": "D", "MH": "Scanning Laser Polarimetry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Scanning Laser Polarimetries", "MN": "E01.370.380.655", "MH_TH": "NLM (2010)", "ST": "T060", "PI": "Lasers (1998-2009)", "MS": "A technique of diagnostic imaging of RETINA or CORNEA of the human eye involving the measurement and interpretation of polarizing ELECTROMAGNETIC WAVES such as radio or light waves. It is helpful in the diagnosis of GLAUCOMA; MACULAR DEGENERATION; and other retinal disorders.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057109"}, {"RECTYPE": "D", "MH": "Descemet Stripping Endothelial Keratoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "MN": "E04.936.580.262", "MH_TH": "NLM (2010)", "ST": "T061", "PI": "Keratoplasty (2006-2009)", "MS": "A surgical procedure or KERATOPLASTY involving selective stripping and replacement of diseased host DESCEMET MEMBRANE and CORNEAL ENDOTHELIUM with a suitable and healthy donor posterior lamella. The advantage to this procedure is that the normal corneal surface of the recipient is retained, thereby avoiding corneal surface incisions and sutures.", "PM": "2010", "HN": "2010", "MR": "20170224", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057111"}, {"RECTYPE": "D", "MH": "Corneal Perforation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Perforations, Corneal", "MN": "C26.915.300.425.250.124.500", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Eye Diseases (1975-2009)", "MS": "A puncture or hole through the CORNEAL STROMA resulting from various diseases or trauma.", "PM": "2010", "HN": "2010", "MR": "20160602", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057112"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Subfamily 2, Group C, Member 2", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, TAK1", "MN": "D12.776.826.209.327", "MH_TH": "NLM (2010)", "ST": "T192", "RN": "0", "PI": "Receptors, Thyroid Hormone (2004-2009)", "MS": "An orphan nuclear receptor that has specificity for hormone response elements found in the promoters of target genes. It binds DNA either as a homodimer or as heterodimer with the closely-related orphan nuclear receptor NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 1. The protein was originally identified as a TESTES-specific protein and is involved in the regulation of variety of cellular processes, including CELL DIFFERENTIATION; CELL PROLIFERATION; and APOPTOSIS.", "PM": "2010", "HN": "2010", "MR": "20150623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057125"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Subfamily 4, Group A, Member 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor NR4A2, Nuclear", "MN": "D12.776.826.209.415", "MH_TH": "NLM (2010)", "ST": "T192", "RN": "0", "MS": "An orphan nuclear receptor that is found at high levels in BRAIN tissue. The protein is believed to play a role in development and maintenance of NEURONS, particularly dopaminergic neurons.", "PM": "2010; NURR1 NUCLEAR RECEPTOR (now NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2) was indexed under DNA-BINDING PROTEINS and TRANSCRIPTION FACTORS 1995-2009", "HN": "2010(1995)", "MR": "20160628", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057126"}, {"RECTYPE": "D", "MH": "Single-Chain Antibodies", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Variable Fragments, Single-Chain", "MN": "D12.776.377.715.548.680.650.500.795", "FX": "Single-Domain Antibodies", "MH_TH": "NLM (2010)", "ST": "T129", "RN": "0", "PI": "Immunoglobulin Variable Region (1993-2009)", "MS": "A form of antibodies consisting only of the variable regions of the heavy and light chains (FV FRAGMENTS), connected by a small linker peptide. They are less immunogenic than complete immunoglobulin and thus have potential therapeutic use.", "PM": "2010", "HN": "2010", "MR": "20120703", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057127"}, {"RECTYPE": "D", "MH": "Aberrometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Aberrometries", "MN": "E01.370.380.074", "FX": "Corneal Wavefront Aberration", "MH_TH": "NLM (2010)", "ST": "T060", "PI": "Diagnostic Techniques, Ophthalmological (2000-2009)", "MS": "The use of an aberrometer to measure eye tissue imperfections or abnormalities based on the way light passes through the eye which affects the ability of the eye to focus properly.", "PM": "2010", "HN": "2010", "MR": "20130709", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057128"}, {"RECTYPE": "D", "MH": "Iridocorneal Endothelial Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "ICE Syndrome|T047|ACX|EQV|NLM (2020)|191219|abcdef", "ENTRY": "Iridocorneal Endothelial Syndromes", "MN": "C11.941.375.322", "FX": "Glaucoma", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Iris Diseases (1979-2009)", "MS": "A grouping of three closely linked conditions: iris nevus (or Cogan-Reese) syndrome, Chandler Syndrome, and essential (progressive) iris atrophy. The most common features of this syndrome are the movement of endothelial cells off the cornea onto the iris leading to corneal swelling, distortion of the iris, and variable degrees of distortion of the pupil. The abnormal cell movement plugs fluid outflow channels of the eye causing GLAUCOMA.", "PM": "2010", "HN": "2010", "MR": "20200228", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057129"}, {"RECTYPE": "D", "MH": "Leber Congenital Amaurosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Retinal Blindnesses, Congenital", "MN": "C11.768.364", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Retinal Diseases (1963-2009)", "MS": "A rare degenerative inherited eye disease that appears at birth or in the first few months of life that results in a loss of vision. Not to be confused with LEBER HEREDITARY OPTIC NEUROPATHY, the disease is thought to be caused by abnormal development of PHOTORECEPTOR CELLS in the RETINA, or by the extremely premature degeneration of retinal cells.", "PM": "2010", "HN": "2010", "MR": "20130708", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057130"}, {"RECTYPE": "D", "MH": "Immune Evasion", "AQ": "DE GE IM PH RE", "ENTRY": "Immune Evasions", "MN": "G16.527.200.700", "MH_TH": "NLM (2010)", "ST": "T046", "AN": "IMMUNE EVASION, TUMOR is also available", "MS": "Methods used by pathogenic organisms to evade a host's immune system.", "PM": "2010", "HN": "2010", "MR": "20171214", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057131"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Subfamily 1, Group F, Member 3", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor RZR-gamma, Nuclear", "MN": "D12.776.826.209.182", "MH_TH": "NLM (2010)", "ST": "T192", "RN": "0", "MS": "An orphan nuclear receptor found in the THYMUS where it plays a role in regulating the development and maturation of thymocytes. An isoform of this protein, referred to as RORgammaT, is produced by an alternatively transcribed mRNA.", "PM": "2010; ORPHAN NUCLEAR RECEPTOR ROR-GAMMA (now NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3) was indexed under RECEPTORS, THYROID HORMONE and RECEPTORS, RETINOIC ACID 1996-2009", "HN": "2010(1996)", "MR": "20150623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057132"}, {"RECTYPE": "D", "MH": "Dentin Desensitizing Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Desensitizing Agents, Dentin", "MN": "D27.505.954.427.040.437", "MH_TH": "NLM (2010)", "ST": "T121", "RN": "0", "PI": "Dentin Sensitivity (1973-2009)", "MS": "Substances which reduce or eliminate dentinal sensitivity or the pain associated with a source of stimulus (such as touch, heat, or cold) at the orifice of exposed dentinal tubules causing the movement of tubular fluid that in turn stimulates tooth nerve receptors.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057133"}, {"RECTYPE": "D", "MH": "Antibodies, Neutralizing", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Neutralizing Antibodies|T116|T129|NON|EQV|NLM (2010)|090416|abbcdef", "ENTRY": "Neutralizing Antibody|T116|T129|NON|EQV|NLM (2010)|090605|abbcdef", "MN": "D12.776.377.715.548.114.244", "FX": "Neutralization Tests", "MH_TH": "NLM (2010)", "ST": "T129", "RN": "0", "AN": "do not coordinate with ANTIBODY FORMATION for /biosyn", "MS": "Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057134"}, {"RECTYPE": "D", "MH": "Wet Macular Degeneration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Wet Macular Degenerations", "MN": "C11.768.585.439.622", "MH_TH": "NLM (2010)", "ST": "T047", "PI": "Retinal Degeneration (1973-2009)", "MS": "A form of RETINAL DEGENERATION in which abnormal CHOROIDAL NEOVASCULARIZATION occurs under the RETINA and MACULA LUTEA, causing bleeding and leaking of fluid. This leads to bulging and or lifting of the macula and the distortion or destruction of central vision.", "PM": "2010", "HN": "2010", "MR": "20090820", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057135"}, {"RECTYPE": "D", "MH": "Nuclear Receptor Subfamily 6, Group A, Member 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Retinoid Receptor Related Testis Associated Receptor", "MN": "D12.776.826.209.572", "MH_TH": "NLM (2010)", "ST": "T192", "RN": "0", "MS": "An orphan nuclear receptor expressed mainly in the GERM CELLS of GONADS. It functions as a transcription factor that binds to a direct repeat of the sequence AGGTCA and may play a role in the regulation of EMBRYOGENESIS and germ cell differentiation.", "PM": "2010; GERM CELL NUCLEAR FACTOR (now NUCLEAR RECEPTOR SUBFAMILY 6, GROUP A, MEMBER 1) was indexed under DNA-BINDING PROTEINS and RECEPTORS, CYTOPLASMIC AND NUCLEAR 2006-2009; and under RECEPTORS, RETINOIC ACID 2004-2005", "HN": "2010(2004)", "MR": "20150623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057136"}, {"RECTYPE": "D", "MH": "DAX-1 Orphan Nuclear Receptor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nuclear Receptor DAX 1", "MN": "D12.776.930.780.625.186", "MH_TH": "NLM (2010)", "ST": "T192", "RN": "0", "MS": "An orphan nuclear receptor that is implicated in regulation of steroidogenic pathways. It is unlike most orphan nuclear receptors in that it appears to lack an essential DNA-binding domain and instead acts as a transcriptional co-repressor. Mutations in the gene Dax-1 cause congenital adrenal hypoplasia.", "PM": "2010; DAX-1 ORPHAN NUCLEAR RECEPTOR was indexed under DNA-BINDING PROTEINS, REPRESSOR PROTEINS, and RECEPTORS, RETINOIC ACID 2003-2009, and under TRANSCRIPTION FACTORS 1994-2003", "HN": "2010(1995)", "MR": "20160701", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057137"}, {"RECTYPE": "D", "MH": "Bacterial Shedding", "AQ": "DE GE IM PH RE", "ENTRY": "Sheddings, Bacterial", "MN": "G07.075", "MH_TH": "NLM (2010)", "ST": "T039", "MS": "The expelling of bacteria from the body. Important routes include the respiratory tract, genital tract, and intestinal tract.", "PM": "2010", "HN": "2010", "MR": "20160115", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057138"}, {"RECTYPE": "D", "MH": "Nanofibers", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "ENTRY": "Nanofiber", "MN": "J01.637.512.300", "MH_TH": "NLM (2010)", "ST": "T073", "PI": "Nanostructures (2004-2009)", "MS": "Submicron-sized fibers with diameters typically between 50 and 500 nanometers. The very small dimension of these fibers can generate a high surface area to volume ratio, which makes them potential candidates for various biomedical and other applications.", "PM": "2010", "HN": "2010", "MR": "20150331", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057139"}, {"RECTYPE": "D", "MH": "Fast Foods", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Ready-To-Eat Meal", "MN": "J02.500.477", "MH_TH": "NLM (2010)", "ST": "T168", "MS": "Prepared food that is ready to eat or partially prepared food that has a final preparation time of a few minutes or less.", "PM": "2010", "HN": "2010", "MR": "20141014", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057140"}, {"RECTYPE": "D", "MH": "Food, Preserved", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Food, Dried|T168|NON|NRW|UNK (19XX)|810519|abcdef", "ENTRY": "Preserved Foods", "MN": "J02.500.521", "FX": "Food Preservation", "MH_TH": "UNK (19XX)", "ST": "T168", "AN": "FOOD PRESERVATION and FOOD PRESERVATIVES is also available", "PI": "Food Preservation (1963-2009)", "MS": "Food that has been prepared and stored in a way to prevent spoilage.", "PM": "2010; see FOOD PRESERVATION 1981-2009; for FOOD, CANNED & FOOD, DRIED see FOOD PRESERVATION 1981-2009", "HN": "2010; use FOOD PRESERVATION 1981-2009; for FOOD, CANNED & FOOD, DRIED use FOOD PRESERVATION 1981-2009", "MR": "20141014", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057141"}, {"RECTYPE": "D", "MH": "Nanoshells", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "PRINT ENTRY": "Metal Nanoshells|T073|NON|EQV|NLM (2010)|090603|abcdef", "ENTRY": "Nanoshells, Metal", "MN": "J01.637.512.600.500.575", "MH_TH": "NLM (2010)", "ST": "T073", "MS": "Nanometer range spherical cores of particular semiconductor compounds surrounded by an ultrathin metal shell that is commonly made of gold or silver. This configuration gives the nanoshells highly tunable optical properties. They have potential in biomedicine for diagnosis and therapy.", "PM": "2010", "HN": "2010", "MR": "20150331", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057145"}, {"RECTYPE": "D", "MH": "Multivesicular Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Multivesicular Body", "MN": "A11.284.430.214.190.875.190.880.337.500", "MH_TH": "NLM (2009)", "ST": "T026", "MS": "Endosomes containing intraluminal vesicles which are formed by the inward budding of the endosome membrane. Multivesicular bodies (MVBs) may fuse with other organelles such as LYSOSOMES or fuse back with the PLASMA MEMBRANE releasing their contents by EXOCYTOSIS. The MVB intraluminal vesicles released into the extracellular environment are known as EXOSOMES.", "PM": "2010; see ENDOSOMES 2009", "HN": "2010; use ENDOSOMES 2009", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057146"}, {"RECTYPE": "D", "MH": "Mosquito Nets", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Portable Mosquito Nets", "MN": "J01.494.221.750", "MH_TH": "NLM (2010)", "ST": "T074", "PI": "Mosquito Control (1986-2009)", "MS": "Free-standing or supported lightweight meshwork fabric made of cotton, silk, polyester or other material, having openings too small to allow entry of mosquitoes or other insects, thereby protecting against INSECT BITES; INSECT STINGS, and insect-borne diseases.", "PM": "2010", "HN": "2010", "MR": "20130708", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057147"}, {"RECTYPE": "D", "MH": "Insecticide-Treated Bednets", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Treated Mosquito Nets", "MN": "E07.700.510.500", "MH_TH": "NLM (2010)", "ST": "T074", "PI": "Mosquito Control (1990-2009)", "MS": "Lightweight meshwork fabric made of cotton, silk, polyester, nylon (polyamides), or other material impregnated with insecticide, having openings too small to allow entry of mosquitoes or other insects, thereby offering protection against insect bite and insect-borne diseases.", "PM": "2010", "HN": "2010", "MR": "20130708", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057148"}, {"RECTYPE": "D", "MH": "Ubiquitinated Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Ubiquitinated", "MN": "D12.776.938", "FX": "Ubiquitination", "MH_TH": "NLM (2008)", "ST": "T116", "RN": "0", "AN": "UBIQUITINATION is also available", "MS": "Proteins covalently modified with UBIQUITINS or UBIQUITIN-LIKE PROTEINS.", "PM": "2010; see Ubiquitination 2008-2009", "HN": "2010; use Ubiquitination 2008-2009", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057149"}, {"RECTYPE": "D", "MH": "Proteostasis Deficiencies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Proteinopathy|T049|NON|EQV|NLM (2023)|220325|abcdef", "ENTRY": "Proteostasis Dysfunction", "MN": "C18.452.845", "FX": "Proteostasis", "MH_TH": "NLM (2010)", "ST": "T049", "MS": "Disorders caused by imbalances in the PROTEIN HOMEOSTASIS network - synthesis, folding, and transport of proteins; post-translational modifications; and degradation or clearance of misfolded proteins.", "PM": "2010", "HN": "2010", "MR": "20220523", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057165"}, {"RECTYPE": "D", "MH": "High-Throughput Screening Assays", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "High-Throughput Screening|T059|NON|REL|NLM (2021)|191122|abcdef", "ENTRY": "Screening, High-Throughput", "MN": "E05.916.680", "FX": "Small Molecule Libraries", "MH_TH": "NLM (2010)", "ST": "T059", "MS": "Rapid methods of measuring the effects of an agent in a biological or chemical assay. The assay usually involves some form of automation or a way to conduct multiple assays at the same time using sample arrays.", "PM": "2010", "HN": "2010", "MR": "20200116", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057166"}, {"RECTYPE": "D", "MH": "Claudins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Claudin|T116|T123|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Claudin Proteins|T116|T123|NON|EQV|NLM (2010)|090421|abbcdef", "MN": "D12.776.543.940.200", "MH_TH": "NLM (2010)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1998-2009)", "MS": "A large family of transmembrane proteins found in TIGHT JUNCTIONS. They take part in the formation of paracellular barriers and pores that regulate paracellular permeability.", "PM": "2010", "HN": "2010", "MR": "20200527", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057167"}, {"RECTYPE": "D", "MH": "Distillation", "AQ": "IS MT", "ENTRY": "Distillations", "MN": "E05.196.155.249", "MH_TH": "NLM (2010)", "ST": "T059", "MS": "A chemical process for separating the components of a liquid mixture by boiling and collecting condensed vapors.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057168"}, {"RECTYPE": "D", "MH": "Eye Movement Desensitization Reprocessing", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Eye Movement Desensitization and Processing|T061|NON|EQV|NLM (2010)|090422|abcdef", "MN": "F04.754.137.506.162", "MH_TH": "NLM (2010)", "ST": "T061", "PI": "Desensitization, Psychologic (1995-2009)", "MS": "A technique that induces the processing of disturbing memories and experiences, by stimulating neural mechanisms that are similar to those activated during REM sleep. The technique consists of eye movements following side-to-side movements of the index and middle fingers, or the alternate tapping of the hands on the knees. This procedure triggers the processing of information, thus facilitating the connection of neural networks.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057169"}, {"RECTYPE": "D", "MH": "Translational Research, Biomedical", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Translational Research|T062|NON|EQV|NLM (2010)|090422|abcdef", "ENTRY": "Research, Translational Medical", "MN": "H01.770.644.145.675", "FX": "National Center for Advancing Translational Sciences (U.S.)", "MH_TH": "NLM (2022)", "ST": "T062", "AN": "TRANSLATIONAL SCIENCE, BIOMEDICAL is available for translational research as a field or the progress or status of translational research in a particular field; do not add routinely for specific studies involving \"translational research\"", "PI": "Research (1996-2002)", "MS": "The endeavour to traverse a specific step of the translation process of turning an observation in the laboratory, clinic, or community into an intervention that will improve the health of individuals and the public. (from Nat Rev Drug Discov. 2018 July ; 17(7): 455\u2013456.)", "PM": "2022; see TRANSLATIONAL MEDICAL RESEARCH 2012-2021; see TRANSLATIONAL RESEARCH 2010-2011", "HN": "2022 (2010)", "MR": "20210707", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057170"}, {"RECTYPE": "D", "MH": "American Recovery and Reinvestment Act", "AQ": "CL EC ES HI OG SN ST TD", "ENTRY": "Public Law 111-5s", "MN": "N03.706.615.049", "FX": "Medical Informatics", "MH_TH": "NLM (2010)", "ST": "T089", "AN": "add UNITED STATES; coordinate with specific topic covered by the act /legis + FINANCING, GOVERNMENT /legis if pertinent; CATALOGER: use NAF entry", "MS": "Public Law No: 111-5, enacted February 2009, makes supplemental appropriations for job preservation and creation, infrastructure investment, energy efficiency and science, assistance to the unemployed, and State and local fiscal stabilization, for fiscal year ending September 30, 2009.", "PM": "2010", "HN": "2010", "MR": "20150605", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057171"}, {"RECTYPE": "D", "MH": "Economic Recession", "DE": "ECON RECESSION", "AQ": "HI LJ SN TD", "PRINT ENTRY": "Recession, Economic|T081|NON|EQV|NLM (1994)|921209|RECESSION ECON|abcdefv", "ENTRY": "Recessions, Economic", "MN": "I01.261.425", "MH_TH": "NLM (1990)", "ST": "T081", "PI": "Economics (1990-2009)", "MS": "Significant decline in economic activity spread across the economy, lasting more than a few months, normally visible in real gross domestic product, real income, employment, industrial production, and wholesale-retail sales. (National Bureau of Economic Research, Inc, www.nber.org/cycles.html, accessed 4/23/2009)", "PM": "2010; see ECONOMICS 1990-2009", "HN": "2010; use ECONOMICS 1990-2009", "MR": "20091026", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057172"}, {"RECTYPE": "D", "MH": "Recreation Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG PX SN ST TD", "ENTRY": "Therapy, Recreational", "MN": "E02.831.580", "MH_TH": "NLM (2010)", "ST": "T058", "PI": "Recreation (1963-2009)", "MS": "The enhancement of physical, cognitive, emotional and social skills so an individual may participate in chosen activities. Recreational modalities are used in designed intervention strategies, incorporating individual's interests to make the therapy process meaningful and relevant.", "PM": "2010", "HN": "2010", "MR": "20160531", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057173"}, {"RECTYPE": "D", "MH": "Frontotemporal Lobar Degeneration", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Lobar Degenerations, Frontotemporal", "MN": "F03.615.400.380", "MH_TH": "OMIM (2013)", "ST": "T048", "PI": "Dementia (2002-2009)", "MS": "Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU PROTEIN inclusions. FTLD includes three clinical syndromes: FRONTOTEMPORAL DEMENTIA, semantic dementia, and PRIMARY PROGRESSIVE NONFLUENT APHASIA.", "PM": "2010; see DEMENTIA 2000-2009; for SEMANTIC DEMENTIA see DEMENTIA 2000-2009", "HN": "2010; use DEMENTIA 2000-2009; for SEMANTIC DEMENTIA use DEMENTIA 2000-2009", "MR": "20150623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057174"}, {"RECTYPE": "D", "MH": "Posters as Topic", "ENTRY": "Posters as Topics", "MN": "L01.462.500.820.090.703", "MH_TH": "NLM (2010)", "ST": "T170", "AN": "do not confuse with the Publication Type POSTER", "PI": "Audiovisual Aids (1996-2009)", "MS": "Works about single or multi-sheet notices made to attract attention to events, activities, causes, goods, or services. They are for display, usually in a public place and are chiefly pictorial.", "PM": "2010", "HN": "2010", "MR": "20220712", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057175"}, {"RECTYPE": "D", "MH": "Compassionate Use Trials", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Use, Compassionate", "MN": "E05.337.300.199", "MH_TH": "NLM (2010)", "ST": "T061", "MS": "Providing an investigational therapy to a patient who is not eligible to receive that therapy in a clinical trial, but who has a serious or life-threatening illness for which other treatments are not available. Compassionate use trials allow patients to receive promising but not yet fully studied or approved therapies when no other treatment option exists. Also called expanded access trial.", "PM": "2010", "HN": "2010", "MR": "20171208", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057176"}, {"RECTYPE": "D", "MH": "TDP-43 Proteinopathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "TDP-43 Proteinopathy", "MN": "C18.452.845.800", "MH_TH": "NLM (2010)", "ST": "T047", "MS": "Diseases characterized by the presence of abnormally phosphorylated, ubiquitinated, and cleaved DNA-binding protein TDP-43 in affected brain and spinal cord. Inclusions of the pathologic protein in neurons and glia, without the presence of AMYLOID, is the major feature of these conditions, thus making these proteinopathies distinct from most other neurogenerative disorders in which protein misfolding leads to brain amyloidosis. Both frontotemporal lobar degeneration and AMYOTROPHIC LATERAL SCLEROSIS exhibit this common method of pathogenesis and thus they may represent two extremes of a continuous clinicopathological spectrum of one disease.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057177"}, {"RECTYPE": "D", "MH": "Primary Progressive Nonfluent Aphasia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Progressive Nonfluent Aphasia|T048|NON|EQV|NLM (2000)|ORD (2010)|991103|abcdeef", "ENTRY": "Syndromes, PPA", "MN": "F03.615.400.380.600", "MH_TH": "NLM (2010)", "ST": "T048", "PI": "Aphasia, Primary Progressive (2003-2009)", "MS": "A form of frontotemporal lobar degeneration and a progressive form of dementia characterized by motor speech impairment and AGRAMMATISM, with relative sparing of single word comprehension and semantic memory.", "PM": "2010; see APHASIA, PRIMARY PROGRESSIVE 2001-2009", "HN": "2010; use APHASIA, PRIMARY PROGRESSIVE 2001-2009", "MR": "20150630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057178"}, {"RECTYPE": "D", "MH": "Advanced Practice Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Practice Nursing, Advanced", "MN": "H02.478.676.074", "MH_TH": "NLM (2010)", "ST": "T091", "PI": "Nurse's Role (2002-2009)", "MS": "Evidence-based nursing, midwifery and healthcare grounded in research and scholarship. Practitioners include nurse practitioners, clinical nurse specialists, nurse anesthetists, and nurse midwives.", "PM": "2010", "HN": "2010", "MR": "20140616", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057179"}, {"RECTYPE": "D", "MH": "Frontotemporal Dementia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Wilhelmsen-Lynch Diseases", "MN": "F03.615.400.380.299", "MH_TH": "ORD (2010)", "ST": "T048", "PI": "Dementia (1994-2009)", "MS": "The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.", "PM": "2010", "HN": "2010", "MR": "20150623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057180"}, {"RECTYPE": "D", "MH": "Pleasure", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Gratification|T041|NON|REL|NLM (2021)|OBSSR (2021)|200515|abcdeef", "MN": "F02.830.816.492", "MH_TH": "NLM (2010)", "ST": "T042", "PI": "Emotions (1963-2009)", "MS": "Sensation of enjoyment or gratification.", "PM": "2010", "HN": "2010", "MR": "20210512", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057181"}, {"RECTYPE": "D", "MH": "Mendelian Randomization Analysis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Analysis, Mendelian Randomization", "MN": "E05.318.416.500", "MH_TH": "NLM (2010)", "ST": "T062", "MS": "The use of the GENETIC VARIATION of known functions or phenotypes to correlate the causal effects of those functions or phenotypes with a disease outcome.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057182"}, {"RECTYPE": "D", "MH": "Practice Patterns, Nurses'", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Nurse's Practice Patterns|T057|NON|EQV|NLM (2010)|090424|abcdef", "ENTRY": "Practice Patterns, Nurse's", "MN": "N05.300.581", "MH_TH": "NLM (2016)", "ST": "T057", "MS": "Patterns of practice in nursing related to provision of services including diagnosis and treatment.", "PM": "2016; see Nurse's Practice Patterns 2010-2015", "HN": "2016 (2010)", "MR": "20150630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057184"}, {"RECTYPE": "D", "MH": "Sedentary Behavior", "AQ": "EH HI", "PRINT ENTRY": "Sedentary Time|T081|NON|REL|NLM (2021)|OBSSR (2021)|191119|abcdeef", "ENTRY": "Time, Sedentary", "MN": "F01.829.458.705", "MH_TH": "NLM (2019)", "ST": "T053", "MS": "Behaviors during waking hours that have low energy expenditure and are often performed in a sitting or reclining POSTURE.", "PM": "2019(2010)", "HN": "2019(2010)", "MR": "20210511", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057185"}, {"RECTYPE": "D", "MH": "Comparative Effectiveness Research", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Research, Comparative Effectiveness", "MN": "N05.425.157", "FX": "Pragmatic Clinical Trials as Topic", "MH_TH": "NLM (2010)", "ST": "T057", "MS": "Conduct and synthesis of systematic research comparing interventions and strategies to prevent, diagnose, treat, and monitor health conditions. The purpose of this research is to inform patients, providers, and decision-makers, responding to their expressed needs, about which interventions are most effective for which patients under specific circumstances. (hhs.gov/recovery/programs/cer/draftdefinition.html accessed 6/12/2009)", "PM": "2010", "HN": "2010", "MR": "20180629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057186"}, {"RECTYPE": "D", "MH": "Independent Living", "AQ": "CL EC ED ES HI IN LJ PX SN ST TD", "ENTRY": "Living, Independent", "MN": "N06.850.505.400.800.550", "FX": "Assisted Living Facilities", "MH_TH": "UNK (19XX)", "ST": "T056", "PI": "Activities of Daily Living (1984-2009)", "MS": "A housing and community arrangement that maximizes independence and self-determination.", "PM": "2010; see ACTIVITIES OF DAILY LIVING (1984-2009)", "HN": "2010; use ACTIVITIES OF DAILY LIVING (1984-2009)", "MR": "20150629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057187"}, {"RECTYPE": "D", "MH": "Workflow", "ENTRY": "Workflows", "MN": "L01.906.893", "MH_TH": "NLM (2010)", "ST": "T052", "MS": "Description of pattern of recurrent functions or procedures frequently found in organizational processes, such as notification, decision, and action.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057188"}, {"RECTYPE": "D", "MH": "Checklist", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Checklists", "MN": "N05.715.360.300.179", "MH_TH": "NLM (2010)", "ST": "T170", "MS": "Aid for consistent recording of data such as tasks completed and observations noted.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057189"}, {"RECTYPE": "D", "MH": "Stroop Test", "AQ": "HI SN ST", "ENTRY": "Stroop Task|T170|NAM|EQV|NLM (2018)|160830|abcdef", "MN": "F04.711.513.703", "MH_TH": "NLM (2010)", "ST": "T170", "MS": "Timed test in which the subject must read a list of words or identify colors presented with varying instructions and different degrees of distraction. (Campbell's Psychiatric Dictionary. 8th ed.)", "PM": "2010", "HN": "2010", "MR": "20170224", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057190"}, {"RECTYPE": "D", "MH": "Capacity Building", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Building, Capacity", "MN": "N06.850.780.200.625.250", "MH_TH": "NLM (2010)", "ST": "T058", "MS": "Organizational development including enhancement of management structures, processes and procedures, within organizations and among different organizations and sectors to meet present and future needs.", "PM": "2010", "HN": "2010", "MR": "20230414", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057191"}, {"RECTYPE": "D", "MH": "Tsunamis", "AQ": "CL EC HI SN", "PRINT ENTRY": "Tsunami|T070|NON|EQV|NLM (2009)|080513|abcdef", "MN": "G01.311.933", "MH_TH": "NLM (2009)", "ST": "T070", "AN": "coordinate with DISASTERS if pertinent; specify geographic location", "MS": "Series of ocean waves produced by geologic events or underwater LANDSLIDES. These waves can travel at speeds averaging 450 (and up to 600) miles per hour in the open ocean.", "PM": "2010; see TIDAL WAVES (2009)", "HN": "2010; use TIDAL WAVES (2009)", "MR": "20160617", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057192"}, {"RECTYPE": "D", "MH": "Medical Tourism", "AQ": "CL EC ES HI LJ OG PX SN ST TD", "ENTRY": "Tourists, Medical", "MN": "N05.300.515", "MH_TH": "NLM (2010)", "ST": "T058", "MS": "Travel to another country for the purpose of medical treatment or care.", "PM": "2010", "HN": "2010", "MR": "20190115", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057193"}, {"RECTYPE": "D", "MH": "Intention to Treat Analysis", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "MN": "N06.850.520.450.250.250.365.500.500", "MH_TH": "NLM (2010)", "ST": "T062", "MS": "Strategy for the analysis of RANDOMIZED CONTROLLED TRIALS AS TOPIC that compares patients in the groups to which they were originally randomly assigned.", "PM": "2010", "HN": "2010", "MR": "20180630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057194"}, {"RECTYPE": "D", "MH": "Automation, Laboratory", "AQ": "CL EC ES HI IS LJ MT SN ST", "ENTRY": "Laboratory Automation", "MN": "J01.897.104.416", "MH_TH": "NLM (2010)", "ST": "T066", "PI": "Clinical Laboratory Techniques (1997-2009)", "MS": "Controlled operations of analytic or diagnostic processes, or systems by mechanical or electronic devices.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057205"}, {"RECTYPE": "D", "MH": "Child Restraint Systems", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Systems, Child Restraint", "MN": "J01.637.708.175", "FX": "Seat Belts", "MH_TH": "NLM (2010)", "ST": "T073", "PI": "Protective Devices (1984-2009)", "MS": "Devices used to protect and restrain infant and child automotive passengers.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057207"}, {"RECTYPE": "D", "MH": "Health Level Seven", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Level 7, Health", "MN": "N03.540.630.480", "MH_TH": "NLM (2010)", "ST": "T093", "AN": "CATALOGER: Use NAF entry", "PI": "Hospital Information Systems (1990-2009)", "MS": "An American National Standards Institute-accredited organization working on specifications to support development and advancement of clinical and administrative standards for healthcare.", "PM": "2010", "HN": "2010", "MR": "20150605", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057208"}, {"RECTYPE": "D", "MH": "Hospital Rapid Response Team", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Teams, Rapid Response", "MN": "N04.590.715.550", "MH_TH": "NLM (2010)", "ST": "T058", "PI": "Patient Care Team (2005-2009)", "MS": "Multidisciplinary team most frequently consisting of INTENSIVE CARE UNIT trained personnel who are available 24 hours per day, 7 days per week for evaluation of patients who develop signs or symptoms of severe CLINICAL DETERIORATION.", "PM": "2010", "HN": "2010", "MR": "20181012", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057209"}, {"RECTYPE": "D", "MH": "Delayed Diagnosis", "AQ": "AE CL EC ES HI LJ MO NU PC PX SN TD VE", "PRINT ENTRY": "Late Diagnosis|T060|NON|REL|NLM (2010)|090427|abcdef", "ENTRY": "Late Diagnoses", "MN": "N02.421.585.263", "FX": "Undiagnosed Diseases", "MH_TH": "NLM (2010)", "ST": "T060", "AN": "DIAGNOSTIC ERRORS is also available", "PI": "Diagnostic Errors (1972-2009)", "MS": "Non-optimal interval of time between onset of symptoms, identification, and initiation of treatment.", "PM": "2010", "HN": "2010", "MR": "20230526", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057210"}, {"RECTYPE": "D", "MH": "Webcasts as Topic", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Webcasts as Topics", "MN": "L01.462.500.847.900.500", "MH_TH": "NLM (2010)", "ST": "T170", "AN": "do not confuse with the Publication Type WEBCAST", "PI": "Internet (1999-2009)", "MS": "Works about transmission of live or pre-recorded audio or video content via connection or download from the INTERNET.", "PM": "2010", "HN": "2010", "MR": "20220712", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057211"}, {"RECTYPE": "D", "MH": "Therapeutic Equipoise", "AQ": "ED HI", "ENTRY": "Equipoise, Therapeutic", "MN": "N05.350.670.750", "MH_TH": "NLM (2010)", "ST": "T041", "MS": "Expectation of real uncertainty on the part of the investigator regarding the comparative therapeutic merits of each arm in a trial.", "PM": "2010", "HN": "2010", "MR": "20150623", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057212"}, {"RECTYPE": "D", "MH": "Incunabula", "MN": "V02.545", "MH_TH": "NLM (2010)", "ST": "T170", "AN": "This heading is used as a Publication Type. Incunabula as a subject are indexed under the main heading INCUNABULA AS TOPIC. INDEXER: Do not use", "MS": "Books printed before 1501.", "HN": "2010", "MR": "20150605", "DA": "20090706", "DC": "2", "DX": "20100101", "UI": "D057213"}, {"RECTYPE": "D", "MH": "Ottoman Empire", "AQ": "EH EP", "MN": "Z01.586.687", "MH_TH": "NLM (2010)", "ST": "T083", "MS": "A sultanate comprised at various times of parts of EUROPE, ASIA, and AFRICA. Its period extends generally from 1301 to 1922.", "HN": "2010", "DA": "20090706", "DC": "4", "DX": "20100101", "UI": "D057214"}, {"RECTYPE": "D", "MH": "Body Dysmorphic Disorders", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Image Disorders, Body", "MN": "F03.875.149", "FX": "Anorexia Nervosa", "MH_TH": "NLM (2010)", "ST": "T048", "PI": "Somatoform Disorders (1989-2009)", "MS": "Preoccupations with appearance or self-image causing significant distress or impairment in important areas of functioning.", "PM": "2010", "HN": "2010", "MR": "20100625", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057215"}, {"RECTYPE": "D", "MH": "Propensity Score", "ENTRY": "Scores, Propensity", "MN": "N06.850.520.830.600.650", "MH_TH": "NLM (2010)", "ST": "T170", "MS": "Conditional probability of exposure to a treatment given observed covariates.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057216"}, {"RECTYPE": "D", "MH": "Economic Development", "DE": "ECON DEVELOPMENT", "AQ": "HI LJ SN TD", "ENTRY": "Growth, Economic", "MN": "N03.219.206", "MH_TH": "NLM (1978)", "ST": "T081", "PI": "Economics (1963-2009)", "MS": "Mobilization of human, financial, capital, physical and or natural resources to generate goods and services.", "PM": "2010; see ECONOMICS 1978-2009", "HN": "2010; use ECONOMICS 1978-2009", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057217"}, {"RECTYPE": "D", "MH": "Blogging", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Blogs as Topics", "MN": "L01.559.423.906.296", "MH_TH": "NLM (2010)", "ST": "T052", "AN": "Do not confuse with the Publication Type BLOG.", "PI": "Internet (2003-2009)", "MS": "Creating an INTERNET-based personal journal which may consist of reflections, comments, and often hyperlinks.", "PM": "2010", "HN": "2010", "MR": "20220712", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057218"}, {"RECTYPE": "D", "MH": "Biofouling", "AQ": "EC LJ PC SN", "MN": "N06.850.540.500", "FX": "Biofilms", "MH_TH": "NLM (2010)", "ST": "T070", "MS": "Process by which unwanted microbial, plant or animal materials or organisms accumulate on man-made surfaces.", "PM": "2010", "HN": "2010", "MR": "20160602", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057219"}, {"RECTYPE": "D", "MH": "Health Literacy", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Literacy, Health", "MN": "N02.421.726.407.229.500", "FX": "Patient Education as Topic", "MH_TH": "NLM (2010)", "ST": "T058", "MS": "Degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions.", "PM": "2010", "HN": "2010", "MR": "20150630", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057220"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H1N2 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Influenza A H1N2, Variant Virus|T005|NON|REL|NLM (2024)|230227|abcdef", "ENTRY": "subtype, H1N2", "MN": "B04.820.480.968.405.400.216", "MH_TH": "NLM (2010)", "ST": "T005", "RN": "txid114728", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals", "PI": "Influenza A virus (1983-2009)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 1 and neuraminidase 2. It is endemic in both human and pig populations.", "PM": "2010", "HN": "2010", "MR": "20230405", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057221"}, {"RECTYPE": "D", "MH": "Data Mining", "AQ": "CL EC ES HI LJ MT SN ST TD", "ENTRY": "Mining, Text", "MN": "L01.470.625", "MH_TH": "NLM (2010)", "ST": "T052", "PI": "Information Storage and Retrieval (1997-2009)", "MS": "Use of sophisticated analysis tools to sort through, organize, examine, and combine large sets of information.", "PM": "2010", "HN": "2010", "MR": "20150622", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057225"}, {"RECTYPE": "D", "MH": "Information Seeking Behavior", "AQ": "CL DE ES PH RE", "ENTRY": "Seeking Behavior, Information", "MN": "L01.143.458", "MH_TH": "NLM (2010)", "ST": "T052", "MS": "How information is gathered in personal, academic or work environments and the resources used.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057226"}, {"RECTYPE": "D", "MH": "Femininity", "AQ": "HI", "MN": "F01.752.747.385.200.500", "MH_TH": "NLM (2010)", "ST": "T055", "AN": "human only", "MS": "Female-associated sex-specific social roles and behaviors unrelated to biologic function.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057227"}, {"RECTYPE": "D", "MH": "Masculinity", "AQ": "HI", "MN": "F01.752.747.385.200.750", "MH_TH": "NLM (2010)", "ST": "T055", "AN": "human only", "MS": "Male-associated sex-specific social roles and behaviors unrelated to biologic function.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057228"}, {"RECTYPE": "D", "MH": "Alcoholics", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Skid Row Alcoholics|T098|NON|NRW|NLM (1996)|941025|abcdef", "ENTRY": "Skid Row Alcoholic", "MN": "M01.066", "MH_TH": "NLM (2010)", "ST": "T098", "PI": "Alcoholism (1999-2009)", "MS": "Persons who have a history of physical or psychological dependence on ETHANOL.", "PM": "2010; SKID ROW ALCOHOLICS was heading 1975-1995; see under ALCOHOLISM 1975; see HOMELESS PERSONS for SKID ROW ALCOHOLICS 1996-2009", "HN": "2010; SKID ROW ALCOHOLICS was heading 1975-1995; use ALCOHOLISM 1975; use HOMELESS PERSONS for SKID ROW ALCOHOLICS 1996-2009", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057229"}, {"RECTYPE": "D", "MH": "Limit of Detection", "ENTRY": "Detection Limits", "MN": "N06.850.520.830.872.500", "MH_TH": "NLM (2010)", "ST": "T081", "MS": "Concentration or quantity that is derived from the smallest measure that can be detected with reasonable certainty for a given analytical procedure.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057230"}, {"RECTYPE": "D", "MH": "Climate Change", "AQ": "CL EC HI MO SN", "ENTRY": "Climate Changes", "MN": "G16.500.175.374", "MH_TH": "NLM (2010)", "ST": "T070", "PI": "Climate (1993-2009)", "MS": "Any significant change in measures of climate (such as temperature, precipitation, or wind) lasting for an extended period (decades or longer). It may result from natural factors such as changes in the sun's intensity, natural processes within the climate system such as changes in ocean circulation, or human activities.", "PM": "2010", "HN": "2010", "MR": "20160616", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057231"}, {"RECTYPE": "D", "MH": "Global Warming", "AQ": "EC HI LJ MO PC SN", "ENTRY": "Warming, Global", "MN": "G16.500.175.374.500", "FX": "Greenhouse Gases", "MH_TH": "NLM (2010)", "ST": "T070", "PI": "Greenhouse Effect (1994-2009)", "MS": "Increase in the temperature of the atmosphere near the Earth's surface and in the troposphere, which can contribute to changes in global climate patterns.", "PM": "2010; see GREENHOUSE EFFECT 1994-2009", "HN": "2010; use GREENHOUSE EFFECT 1994-2009", "MR": "20170224", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057232"}, {"RECTYPE": "D", "MH": "Radio Frequency Identification Device", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Radio Frequency Identification|T057|NON|REL|NLM (2010)|090428|abcdef", "ENTRY": "RFID|T073|ACR|EQV|NLM (2010)|090622|abcdef", "MN": "N04.452.653.500", "FX": "Remote Sensing Technology", "MH_TH": "NLM (2010)", "ST": "T073", "MS": "Machine readable patient or equipment identification device using radio frequency from 125 kHz to 5.8 Ghz.", "PM": "2010", "HN": "2010", "MR": "20100625", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057233"}, {"RECTYPE": "D", "MH": "Preoperative Period", "ENTRY": "Period, Preoperative", "MN": "N02.421.585.753.937", "MH_TH": "NLM (2010)", "ST": "T079", "MS": "The period before a surgical operation.", "PM": "2010", "HN": "2010", "MR": "20150629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057234"}, {"RECTYPE": "D", "MH": "Austria-Hungary", "AQ": "EH EP", "ENTRY": "Habsburg Empire|T083|NON|EQV|NLM (2010)|090428|abcdef", "MN": "Z01.586.117", "MH_TH": "NLM (2010)", "ST": "T083", "MS": "A dual monarchy formed in 1867. It included AUSTRIA; HUNGARY; CZECHOSLOVAKIA; Moravia, Bukovina, Transylvania, Carniola, Kustenland, Dalmatia, CROATIA; Fiume, and Galicia.", "HN": "2010", "MR": "20090820", "DA": "20090706", "DC": "4", "DX": "20100101", "UI": "D057235"}, {"RECTYPE": "D", "MH": "Travel Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Medicine, Emporiatric|T091|NON|EQV|NLM (1993)|911108|abcdef", "ENTRY": "Medicine, Travel", "MN": "H02.403.850", "MH_TH": "NLM (2010)", "ST": "T091", "AN": "the specialty; TRAVEL-RELATED ILLNESS is also available; do not confuse with TRAVEL NURSING - nursing practice in which nurses travel to work in temporary positions", "PI": "Travel (1999-2009)", "MS": "Multidisciplinary field focusing on prevention of infectious diseases and patient safety during international TRAVEL. Key element of patient's pre-travel visit to the physician is a health risk assessment.", "PM": "2010; for MEDICINE, EMPORIATRIC & EMPORIATRICS see TRAVEL 1993-2009", "HN": "2010; for MEDICINE, EMPORIATRIC & EMPORIATRICS use TRAVEL 1993-2009", "MR": "20170711", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057236"}, {"RECTYPE": "D", "MH": "Criminals", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Offender", "MN": "M01.142", "MH_TH": "NLM (2010)", "ST": "T098", "PI": "Criminology (1966-1967)", "MS": "Persons who have committed a crime or have been convicted of a crime.", "PM": "2010", "HN": "2010", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057237"}, {"RECTYPE": "D", "MH": "Growth Charts", "ENTRY": "Reference Growth Curve", "MN": "E05.978.808.500", "MH_TH": "NLM (2010)", "ST": "T170", "PI": "Reference Values (1980-2009)", "MS": "Graphic displays of height and weight showing development over time.", "PM": "2010", "HN": "2010", "MR": "20180629", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057238"}, {"RECTYPE": "D", "MH": "Early Termination of Clinical Trials", "AQ": "AE EC ES HI LJ MO MT NU PX SN ST TD VE", "MN": "N05.715.360.575.575.800.379", "MH_TH": "NLM (2010)", "ST": "T062", "PI": "Research Design (1994-2009)", "MS": "Earlier than planned termination of clinical trials.", "PM": "2010", "HN": "2010", "MR": "20190530", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057239"}, {"RECTYPE": "D", "MH": "Patient Preference", "AQ": "EC EH LJ PX SN", "ENTRY": "Preferences, Patient", "MN": "N05.300.150.800.625.500", "MH_TH": "NLM (1997)", "ST": "T080", "AN": "PATIENT SATISFACTION is also available", "PI": "Patient Satisfaction (1997-2009)", "MS": "Individual's expression of desirability or value of one course of action, outcome, or selection in contrast to others.", "PM": "2010; see PATIENT SATISFACTION 1997-2009", "HN": "2010; use PATIENT SATISFACTION 1997-2009", "MR": "20170620", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057240"}, {"RECTYPE": "D", "MH": "Site-Specific DNA-Methyltransferase (Cytosine-N4-Specific)", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Site-Specific DNA-Methyltransferase (Cytosine-N(4)-Specific)|T116|T126|ABX|EQV|NLM (2010)|090511|abbcdef", "ENTRY": "N(4)-Cytosine-Specific DNA Methylase|T116|T126|ABX|EQV|NLM (2010)|090511|abbcdef", "MN": "D08.811.913.555.500.350.100.750", "MH_TH": "NLM (2021)", "ST": "T126", "RN": "EC 2.1.1.113", "PI": "DNA-Cytosine Methylases (1988-2009)", "MS": "A DNA-methyltransferase that catalyzes the transfer of a methyl group from S-ADENOSYLMETHIONINE to the exocyclic NH2 group at the 4 position of CYTOSINE.", "PM": "2020; was SITE-SPECIFIC DNA-METHYLTRANSFERASE (CYTOSINE-N(4)-SPECIFIC) 2010-2019", "HN": "2020 (2010)", "MR": "20200609", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057265"}, {"RECTYPE": "D", "MH": "Precision Medicine", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Predictive Medicine|T061|NON|NRW|NLM (2021)|200401|abcdef", "ENTRY": "Theranostic", "MN": "H02.403.200.700", "FX": "Pharmacogenomic Variants", "MH_TH": "NLM (2016)", "ST": "T061", "MS": "Clinical, therapeutic and diagnostic approaches to optimal disease management based on individual variations in a patient's genetic profile.", "PM": "2010; for Theranostics see Theranostic Nanomedicine 2016-2020", "HN": "2010; for Theranostics use Theranostic Nanomedicine 2016-2020", "MR": "20210706", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057285"}, {"RECTYPE": "D", "MH": "Electronic Health Records", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Electronic Medical Records|T170|NON|EQV|NLM (2010)|090513|abcdef", "ENTRY": "Medical Records, Electronic", "MN": "N06.850.520.308.940.968.625.250", "FX": "Medical Record Linkage", "MH_TH": "NLM (2010)", "ST": "T170", "MS": "Media that facilitate transportability of pertinent information concerning patient's illness across varied providers and geographic locations. Some versions include direct linkages to online CONSUMER HEALTH INFORMATION that is relevant to the health conditions and treatments related to a specific patient.", "PM": "2010", "HN": "2010", "MR": "20220711", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057286"}, {"RECTYPE": "D", "MH": "Sequence Inversion", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Inversion, Sequence|T049|NON|EQV|NLM (2005)|040226|abcdef", "ENTRY": "Sequences, Inverted", "MN": "G05.558.805", "MH_TH": "NLM (2010)", "ST": "T049", "PI": "Inversion, Chromosome (1972-2009)", "MS": "The deletion and reinsertion of a segment of a nucleic acid sequence in the same place, but flipped in an opposite orientation.", "PM": "2010; see INVERSION, CHROMOSOME 2005-2009", "HN": "2010; use CHROMOSOME INVERSION 2005-2009", "MR": "20160617", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057345"}, {"RECTYPE": "D", "MH": "Search Engine", "AQ": "CL EC ES HI LJ MT SN ST TD", "ENTRY": "Search Engines", "MN": "L01.470.875", "FX": "Software", "MH_TH": "NLM (2010)", "ST": "T066", "MS": "Software used to locate data or information stored in machine-readable form locally or at a distance such as an INTERNET site.", "PM": "2010", "HN": "2010", "MR": "20130709", "DA": "20090706", "DC": "1", "DX": "20100101", "UI": "D057386"}, {"RECTYPE": "D", "MH": "Webcast", "PRINT ENTRY": "Webcasts|T170|NON|EQV|NLM (2010)|090622|abcdef", "ENTRY": "Streaming Video|T170|NON|NRW|NLM (2010)|090622|abcdef", "MN": "V02.990", "MH_TH": "NLM (2020)", "ST": "T170", "AN": "this heading is used as a Publication Type; webcasts as a subject are indexed under the main heading WEBCASTS AS TOPIC", "MS": "Content from transmission of live or pre-recorded audio or video via connection or download from the INTERNET.", "HN": "2010", "MR": "20190705", "DA": "20090706", "DC": "2", "DX": "20100101", "UI": "D057405"}, {"RECTYPE": "D", "MH": "Plant Dormancy", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Seed Dormancy|T038|T039|NON|NRW|NLM (2011)|090713|abbcdef", "ENTRY": "Seed Dormancies", "MN": "G15.589.250.500", "MH_TH": "NLM (2014)", "ST": "T038", "PI": "Seeds (1967-2010)", "MS": "The state of failure to initiate and complete the process of growth, reproduction, or gemination of otherwise normal plants or vegetative structures thereof.", "PM": "2011", "HN": "2011", "MR": "20210707", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057445"}, {"RECTYPE": "D", "MH": "Hydrodynamics", "ENTRY": "Hydrodynamic", "MN": "G01.342", "MH_TH": "NLM (2011)", "ST": "T070", "PI": "Biomechanics (1978-2010)", "MS": "The motion of fluids, especially noncompressible liquids, under the influence of internal and external forces.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057446"}, {"RECTYPE": "D", "MH": "Catabolite Repression", "AQ": "DE GE IM PH RE", "ENTRY": "Repressions, Catabolite", "MN": "G06.173", "MH_TH": "NLM (2011)", "ST": "T067", "PI": "Glucose (1978-2010)", "MS": "Process by which micro-organisms adapt quickly to a preferred rapidly-metabolizable intermediate through the inhibition or repression of genes related to CATABOLISM of less preferred source(s).", "PM": "2011", "HN": "2011", "MR": "20160502", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057465"}, {"RECTYPE": "D", "MH": "Nonsteroidal Anti-Androgens", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Nonsteroidal Anti Androgens", "MN": "D27.505.696.399.450.065.500", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Androgen Antagonists (1981-2010)", "MS": "Nonsteroidal agents which block the action or downregulate the synthesis of ANDROGENS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057466"}, {"RECTYPE": "D", "MH": "Carbon Cycle", "AQ": "DE GE IM PH RE", "ENTRY": "Fluxs, Carbon", "MN": "G16.500.150", "MH_TH": "NLM (2011)", "ST": "T070", "PI": "Carbon (1970-2010)", "MS": "The cycle by which the element carbon is exchanged between organic matter and the earth's physical environment.", "PM": "2011", "HN": "2011", "MR": "20160219", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057486"}, {"RECTYPE": "D", "MH": "Enzyme Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Systemic Enzyme", "MN": "E02.319.353", "MH_TH": "NLM (2011)", "ST": "T061", "AN": "coordinate with specific enzyme/ther use; ENZYME REPLACEMENT THERAPY is also available.", "PI": "Enzymes/therapeutic use (1963-2010)", "MS": "The use of enzymes to correct metabolic and physiological processes.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057487"}, {"RECTYPE": "D", "MH": "Visual Prosthesis", "AQ": "AE CH CL EC ES HI MI PS PX SD SN ST TD UL VE VI", "ENTRY": "Visual Prostheses", "MN": "E07.695.950", "MH_TH": "NLM (2011)", "ST": "T074", "PI": "Vision, Ocular (1970-2010)", "MS": "Artificial device such as an externally-worn camera attached to a stimulator on the RETINA, OPTIC NERVE, or VISUAL CORTEX, intended to restore or amplify vision.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057488"}, {"RECTYPE": "D", "MH": "Embolic Protection Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Protection Filters, Embolic", "MN": "E07.695.207", "MH_TH": "NLM (2011)", "ST": "T074", "PI": "Embolism/prevention & control (2002-2010)", "MS": "Vascular filters or occlusive devices that provide mechanical protection of the distal end organ from blood clots or EMBOLISM-causing debri dislodged during ENDOVASCULAR PROCEDURES.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057505"}, {"RECTYPE": "D", "MH": "Arthropod Antennae", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Insect Antennas", "MN": "A13.093", "MH_TH": "NLM (2011)", "ST": "T023", "MS": "Paired sense organs connected to the anterior segments of ARTHROPODS that help them navigate through the environment.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057506"}, {"RECTYPE": "D", "MH": "Mice, 129 Strain", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Strain Mice, 129", "MN": "B01.050.150.900.649.313.992.635.505.500.800.500.025", "MH_TH": "NLM (2011)", "ST": "T015", "AN": "NIM with no qualifiers when experimental animal; check the tag MICE", "MS": "Strains of mice arising from a parental inbred stock that was subsequently used to produce substrains of knockout and other mutant mice with targeted mutations.", "PM": "2011", "HN": "2011", "MR": "20200902", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057507"}, {"RECTYPE": "D", "MH": "Burkholderia cenocepacia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.075.090.688.100.110.490", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid95486", "AN": "infection: coordinate IM with BURKHOLDERIA INFECTIONS (IM)", "PI": "Burkholderia cepacia complex (2004-2010)", "MS": "A species of gram-negative bacteria that causes disease in plants. It is found commonly in the environment and is an opportunistic pathogen in humans.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057508"}, {"RECTYPE": "D", "MH": "Trypanosoma rangeli", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.268.475.868.887.680", "MH_TH": "NLM (2011)", "ST": "T204", "RN": "txid5698", "AN": "infection: coordinate IM with TRYPANOSOMIASIS (IM)", "PI": "Trypanosoma (1965-2010)", "MS": "A hemoflagellate parasite affecting domestic and wild animals, as well as humans and invertebrates. Though it induces an immune response, it is non-pathogenic in humans and other vertebrates. It is cross-reactive with TRYPANOSOMA CRUZI and can thus cause false positives for CHAGAS DISEASE.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057509"}, {"RECTYPE": "D", "MH": "Endovascular Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Techniques, Intravascular", "MN": "E04.502.382", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "Minimally invasive procedures, diagnostic or therapeutic, performed within the BLOOD VESSELS. They may be perfomed via ANGIOSCOPY; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; INTERVENTIONAL RADIOGRAPHY; or INTERVENTIONAL ULTRASONOGRAPHY.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057510"}, {"RECTYPE": "D", "MH": "Social Stigma", "ENTRY": "Stigmas, Social", "MN": "F01.145.813.840", "FX": "Shame", "MH_TH": "NLM (2011)", "ST": "T054", "PI": "Shame (1975-2010)", "MS": "A perceived attribute that is deeply discrediting and is considered to be a violation of social norms.", "PM": "2011", "HN": "2011", "MR": "20120703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057545"}, {"RECTYPE": "D", "MH": "Apathy", "AQ": "CL DE ES PH RE", "MN": "F01.470.137", "MH_TH": "NLM (2011)", "ST": "T055", "PI": "Motivation (1966-2010)", "MS": "Lack of emotion or emotional expression; a disorder of motivation that persists over time.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057565"}, {"RECTYPE": "D", "MH": "Self Report", "AQ": "CL EC SN ST", "ENTRY": "Self Reports", "MN": "N06.850.520.308.980.500", "MH_TH": "NLM (2011)", "ST": "T170", "PI": "Questionnaires (1966-2010)", "MS": "Method for obtaining information through verbal responses, written or oral, from subjects.", "PM": "2011", "HN": "2011", "MR": "20180629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057566"}, {"RECTYPE": "D", "MH": "Memory, Long-Term", "AQ": "CL DE PH RE", "ENTRY": "Remote Memories", "MN": "F02.463.425.540.305", "MH_TH": "NLM (2011)", "ST": "T041", "PI": "Memory (1966-2010)", "MS": "Remembrance of information from 3 or more years previously.", "PM": "2011", "HN": "2011", "MR": "20110701", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057567"}, {"RECTYPE": "D", "MH": "Aeromonas caviae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Bacillus punctatus|T007|NON|EQV|NLM (2021)|190919|abcdef", "MN": "B03.440.450.019.025.150", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid648", "AN": "infection: coordinate with GRAM-NEGATIVE BACTERIAL INFECTIONS and GASTROENTERITIS if pertinent ", "PI": "Aeromonas (1984-2010)", "MS": "A species of gram-negative, facultatively anaerobic bacteria that is found in domestic and wild animals including birds, and fish. In humans it causes GASTROENTERITIS in young children and some adults.", "PM": "2011", "HN": "2011", "MR": "20200128", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057585"}, {"RECTYPE": "D", "MH": "Vitreoretinal Surgery", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Vitreoretinal Surgeries", "MN": "E04.540.980", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Retina (1967-2010)", "MS": "Specialized ophthalmic technique used in the surgical repair and or treatment of disorders that include retinal tears or detachment; MACULAR HOLES; hereditary retinal disease; AIDS-related retinal infections; ocular tumors; MACULAR DEGENERATION; DIABETIC RETINOPATHY; and UVEITIS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057586"}, {"RECTYPE": "D", "MH": "Natural Orifice Endoscopic Surgery", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Natural Orifice Transluminal Endoscopy|T060|T061|NON|NRW|NLM (2011)|090810|abbcdef", "MN": "E04.502.250.630", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "Surgical procedures performed through a natural opening in the body such as the mouth, nose, urethra, or anus, and along the natural body cavities with which they are continuous.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057605"}, {"RECTYPE": "D", "MH": "Isotachophoresis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Electrophoresis, Displacement", "MN": "E05.301.300.831", "MH_TH": "UNK (19XX)", "ST": "T059", "PI": "Electrophoresis or specifics (1970-2010)", "MS": "A nonlinear electrophoretic technique used to separate a variety of ionic compounds, ranging from small metal ions to large molecules like proteins. Unlike \"linear\" zone electrophoresis in which separating solute bands continually spread by diffusion or dispersion, isotachophoresis forms self-sharpening, adjacent zones of substantially pure solute whose concentrations often exceed several mgs/ml. In isotachophoresis a multianalyte sample is introduced between the leading electrolyte and the terminating electrolyte where the sample ions have lower electrophoretic mobilities than the leading ion but larger than the terminating ion. (From \"Isotachophoresis\" on the AES Web Site [Internet]. Madison, WI: The American Electrophoresis Society; c2000-2008 [cited 2009 Aug 20]. Available from http://www.aesociety.org/areas/isotachophoresis.php)", "PM": "2011; see Electrophoresis 1985-2010", "HN": "2011; use Electrophoresis 1985-2010", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057625"}, {"RECTYPE": "D", "MH": "Deltoid Muscle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Muscles, Deltoid", "MN": "A02.633.567.300", "MH_TH": "NLM (2011)", "ST": "T023", "AN": "/ growth: coordinate with MUSCLE DEVELOPMENT; / embryol: coordinate with MUSCLE DEVELOPMENT if pertinent", "PI": "Muscles (1963-1985)", "MS": "Thick triangular muscle in the SHOULDER whose function is to abduct, flex, and extend the arm. It is a common site of INTRAMUSCULAR INJECTIONS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057645"}, {"RECTYPE": "D", "MH": "Virus Uncoating", "AQ": "DE GE IM PH RE", "ENTRY": "Viral Uncoatings", "MN": "G06.920.950", "MH_TH": "NLM (2011)", "ST": "T070", "MS": "Intracellular step that follows VIRUS INTERNALIZATION during which the viral nucleic acid and CAPSID are separated.", "PM": "2011", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057646"}, {"RECTYPE": "D", "MH": "Melinis repens", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "roseum, Rhynchelytrum", "MN": "B01.875.800.575.912.250.822.558", "MH_TH": "NLM (2011)", "ST": "T002", "RN": "txid29709", "PI": "Plant Extracts (2004-2010)", "MS": "Formerly known as Rhynchelytrum repens, a member of the perennial grass family native to South Africa, widely distributed and known by different common names. It is used as a diabetes cure in folk medicine and actively studied for its hypoglycemic properties.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057665"}, {"RECTYPE": "D", "MH": "Research Support, American Recovery and Reinvestment Act", "MN": "V04.750.124", "MH_TH": "NLM (2010)", "ST": "T064", "AN": "for all articles as supported under the ARRA Act including both PHS and Non-PHS; CATALOGER: do not use", "MS": "Acknowledgement that funding support is from the American Recovery and Reinvestment Act.", "HN": "2010", "MR": "20171211", "DA": "20090828", "DC": "2", "DX": "20100101", "UI": "D057666"}, {"RECTYPE": "D", "MH": "Conducted Energy Weapon Injuries", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "TASER Injury", "MN": "C26.324.436", "MH_TH": "NLM (2011)", "ST": "T037", "PI": "Electric Injuries (1992-2010)", "MS": "The injuries caused by conducted energy weapons such as stun guns, shock batons, and cattle prods.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057667"}, {"RECTYPE": "D", "MH": "Bloodless Medical and Surgical Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Bloodless Medicine and Surgery Programs|T058|NON|REL|NLM (2011)|090828|abcdef", "ENTRY": "Transfusion-Free Surgeries", "MN": "N02.421.585.148", "FX": "Operative Blood Salvage", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "The treatment of patients without the use of allogeneic BLOOD TRANSFUSIONS or blood products.", "PM": "2011", "HN": "2011", "MR": "20150629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057668"}, {"RECTYPE": "D", "MH": "Plant Weeds", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Weeds, Plant", "MN": "B01.650.449", "FX": "Weed Control", "MH_TH": "NLM (2011)", "ST": "T002", "AN": "coordinate with specific plant if pertinent", "PI": "Plants (1968-2010)", "MS": "A plant growing in a location where it is not wanted, often competing with cultivated plants.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057685"}, {"RECTYPE": "D", "MH": "Cell-in-Cell Formation", "DS": "CELL IN CELL FORMATION", "AQ": "DE GE IM PH RE", "ENTRY": "Cell in Cell Formation", "MN": "G04.165", "MH_TH": "NLM (2011)", "ST": "T043", "MS": "The mechanisms by which a cell becomes internalized in another. The host cell may engulf another as do PHAGOCYTIC CELLS, or the host cell may be invaded by another cell (ENTOSIS), or internalization processes may involve the cooperation of both the host cell and the cell being internalized. Viable cells may remain in non-phagocytic cells (EMPERIPOLESIS), undergo cell division, pass through and then out of the host cell (TRANSCELLULAR CELL MIGRATION), or trigger APOPTOSIS of the invaded cell.", "PM": "2011", "HN": "2011", "MR": "20160115", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057686"}, {"RECTYPE": "D", "MH": "Emperipolesis", "AQ": "DE GE IM PH RE", "MN": "G04.165.500", "MH_TH": "NLM (2011)", "ST": "T043", "MS": "The movement of one cell within another cell (non-phagocytic).", "PM": "2011", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057687"}, {"RECTYPE": "D", "MH": "Transcellular Cell Migration", "AQ": "DE GE IM PH RE", "ENTRY": "Transcellular Cell Migrations", "MN": "G04.468.790.500", "FX": "Transendothelial and Transepithelial Migration", "MH_TH": "NLM (2011)", "ST": "T043", "PI": "Cell Movement (1981-2010)", "MS": "The movement of one cell into, through, and out of another cell.", "PM": "2011", "HN": "2011", "MR": "20160701", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057688"}, {"RECTYPE": "D", "MH": "Research Support, U.S. Government", "MN": "V04.750", "MH_TH": "NLM (2011)", "ST": "T064", "AN": "INDEXER: Do not use; CATALOGER: Do not use", "MS": "For publications noted as supported by US Government.", "HN": "2011", "MR": "20150605", "DA": "20100625", "DC": "2", "DX": "20110101", "UI": "D057689"}, {"RECTYPE": "D", "MH": "Entosis", "AQ": "DE GE IM PH RE", "ENTRY": "Entoses", "MN": "G04.165.750", "MH_TH": "NLM (2011)", "ST": "T043", "MS": "The processes by which one cell actively invades and becomes internalized within another cell.", "PM": "2011", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057691"}, {"RECTYPE": "D", "MH": "Transendothelial and Transepithelial Migration", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Transendothelial Migration|T042|NON|NRW|NLM (2011)|090902|abcdef", "ENTRY": "Transmigration, Endothelial", "MN": "G07.568.500.180.500", "FX": "Transcellular Cell Migration", "MH_TH": "NLM (2011)", "ST": "T042", "PI": "Endothelium or specifics (1984-2010)", "MS": "The passage of cells across the layer of ENDOTHELIAL CELLS, i.e., the ENDOTHELIUM; or across the layer of EPITHELIAL CELLS, i.e. the EPITHELIUM.", "PM": "2011", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057705"}, {"RECTYPE": "D", "MH": "Operative Blood Salvage", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Cell Saver Technique|T061|NON|NRW|NLM (2024)|220913|abcdef", "ENTRY": "Technique, Cell Saver", "MN": "E04.936.537.687", "FX": "Bloodless Medical and Surgical Procedures", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "Recovery of blood lost from surgical procedures for reuse by the same patient in AUTOLOGOUS BLOOD TRANSFUSIONS. It is collected during (intraoperatively) or after completion of (postoperatively) the surgical procedures.", "PM": "2011", "HN": "2011", "MR": "20230226", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057725"}, {"RECTYPE": "D", "MH": "Periodontal Debridement", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Nonsurgical Periodontal Debridement|T061|NON|EQV|NLM (2011)|090909|abcdef", "ENTRY": "Periodontal Pocket Debridements", "MN": "E06.721.189.675", "FX": "Subgingival Curettage", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Subgingival Curettage (1978-2010)", "MS": "Removal or disruption of DENTAL DEPOSITS and plaque-retentive DENTAL CALCULUS from tooth surfaces and within the periodontal pocket space without deliberate removal of CEMENTUM as done in ROOT PLANING and often in DENTAL SCALING. The goal is to conserve dental cementum to help maintain or re-establish healthy periodontal environment and eliminate PERIODONTITIS by using light instrumentation strokes and nonsurgical techniques (e.g., ultrasonic, laser instruments).", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057747"}, {"RECTYPE": "D", "MH": "Mesotherapy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "MN": "E02.319.267.530.620.785", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Injections or specifics (1976-2010)", "MS": "The application of medicine, vitamins, extracts, or other bioactive substances for a localized effect via multiple subcutaneous injections or perfusion of substances into the various layers of the skin below the EPIDERMIS.", "PM": "2011", "HN": "2011", "MR": "20180629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057748"}, {"RECTYPE": "D", "MH": "Eosinophilic Esophagitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Esophagitis, Eosinophilic Chronic", "MN": "C20.543.480.356", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Esophagitis (1978-2010)", "MS": "Chronic ESOPHAGITIS characterized by esophageal mucosal EOSINOPHILIA. It is diagnosed when an increase in EOSINOPHILS are present over the entire esophagus. The reflux symptoms fail to respond to PROTON PUMP INHIBITORS treatment, unlike in GASTROESOPHAGEAL REFLUX DISEASE. The symptoms are associated with IgE-mediated hypersensitivity to food or inhalant allergens.", "PM": "2011", "HN": "2011", "MR": "20120703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057765"}, {"RECTYPE": "D", "MH": "Policy", "ENTRY": "Policies", "MN": "N03.623", "MH_TH": "NLM (1984)", "ST": "T170", "MS": "A course or method of action selected to guide and determine present and future decisions.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057766"}, {"RECTYPE": "D", "MH": "Kashin-Beck Disease", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Kashin Beck Disease", "MN": "C05.116.099.708.534", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Osteoarthritis (1968-2010)", "MS": "Disabling osteochondrodysplasia with OSTEOSCLEROSIS, cone-shaped METAPHYSIS, and shortening of the DIAPHYSIS. It is endemic in parts of Siberia and northern China. Mineral deficiencies (e.g., selenium, iodine), fungal cereal contamination, and water contamination may be contributing factors in its etiology.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057767"}, {"RECTYPE": "D", "MH": "Brief, Resolved, Unexplained Event", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Infantile Apparent Life-Threatening Event|T033|NON|REL|NLM (2011)|090910|abcdef", "ENTRY": "Life-Threatening Events, Apparent", "MN": "C23.888.852.700", "MH_TH": "NLM (2021)", "ST": "T033", "PI": "Cyanosis (1996-2010)", "MS": "An event experienced by an infant or a child that is characterized by some combination of apnea, color change, change in muscle tone, choking, and gagging.", "PM": "2021; see Infantile Apparent Life-Threatening Event 2011-2020", "HN": "2021(2011)", "MR": "20201207", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057768"}, {"RECTYPE": "D", "MH": "Transmyocardial Laser Revascularization", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Transmyocardial Revascularization, Laser", "MN": "E04.928.220.520.610", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Myocardial Revascularization (1993-2010)", "MS": "A procedure to increase the flow of blood to the MYOCARDIUM by creating transmural channels in the heart wall via the application of laser pulses to epicardial or endocardial surfaces.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057769"}, {"RECTYPE": "D", "MH": "Hyaline Fibromatosis Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyalinosis, Systemic|T047|NON|EQV|NLM (2011)|090911|abcdef", "ENTRY": "Systemic Juvenile Hyalinosis", "MN": "C17.800.827.384", "FX": "Lipoid Proteinosis of Urbach and Wiethe", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "do not confuse entry term INFANTILE SYSTEMIC HYALINOSIS with HYALINE MEMBRANE DISEASE", "PI": "Hyalin (1975-2010)", "MS": "Autosomal recessive disorder characterized by HYALINE deposition in the skin, bone, gastrointestinal tract, muscles and glands; multiple subcutaneous skin nodules; GINGIVAL HYPERTROPHY; and joint CONTRACTURES. Mutations in the capillary morphogenesis protein-2 are associated with the disorder.", "PM": "2011", "HN": "2011", "MR": "20230825", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057770"}, {"RECTYPE": "D", "MH": "Cystine-Knot Miniproteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cystine Knot Miniproteins", "MN": "D12.776.217", "MH_TH": "NLM (2011)", "ST": "T116", "RN": "0", "MS": "A structurally-related family of small proteins that form a stable tertiary fold pattern which is supported by a series of disulfide bonds. The arrangement of disulfide bonds between the CYSTEINE moieties results in a knotted structure which is unique to this family of proteins.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057771"}, {"RECTYPE": "D", "MH": "Vascular System Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Vascular Injuries|T037|NON|EQV|NLM (2011)|090911|abcdef", "ENTRY": "Vascular System Injury", "MN": "C26.940", "MH_TH": "NLM (2011)", "ST": "T037", "AN": "coordinate with ARTERIES / inj or VEINS /inj or specific artery or vein / inj", "PI": "Vasculitis (1963-2010)", "MS": "Injuries to blood vessels caused by laceration, contusion, puncture, or crush and other types of injuries. Symptoms vary by site and mode of injuries and may include bleeding, bruising, swelling, pain, and numbness. It does not include injuries secondary to pathologic function or diseases such as ATHEROSCLEROSIS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057772"}, {"RECTYPE": "D", "MH": "Cold Shock Proteins and Peptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cold Stress Protein|T116|T123|NON|NRW|NLM (2021)|191118|abbcdef", "ENTRY": "Stress Proteins, Cold", "MN": "D12.776.476.175", "FX": "Heat-Shock Proteins", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "Cellular proteins and peptides that are induced in response to cold stress. They are found in a broad variety of prokaryotic and eukaryotic organisms.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057773"}, {"RECTYPE": "D", "MH": "Post-Exercise Hypotension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Postexercise Hypotensions", "MN": "C14.907.514.611", "MH_TH": "NLM (2011)", "ST": "T033", "PI": "Hypotension (1991-2010)", "MS": "Transient reduction in blood pressure levels immediately after exercises that lasts 2-12 hours. The reduction varies but is typically 5-20 mm Hg when compared to pre-exercise levels. It exists both in normotensive and hypertensive individuals and may play a role in excercise related PHYSIOLOGIC ADAPTATION.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057774"}, {"RECTYPE": "D", "MH": "Ischemic Postconditioning", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Postconditioning, Ischemic", "MN": "E02.587", "FX": "Ischemic Preconditioning", "MH_TH": "NLM (2011)", "ST": "T061", "AN": "coordinate IM with tissue / blood supply (IM)", "MS": "The application of repeated, brief periods of vascular occlusion at the onset of REPERFUSION to reduce REPERFUSION INJURY that follows a prolonged ischemic event. The techniques are similar to ISCHEMIC PRECONDITIONING but the time of application is after the ischemic event instead of before.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057775"}, {"RECTYPE": "D", "MH": "Catheters", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Catheter|T074|NON|EQV|NLM (1978)|931129|abcdef", "MN": "E07.132", "MH_TH": "NLM (2011)", "ST": "T074", "PI": "Catheterization or specifics (1960-2010)", "MS": "A flexible, tubular device that is used to carry fluids into or from a blood vessel, hollow organ, or body cavity.", "PM": "2011", "HN": "2011", "MR": "20160531", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057785"}, {"RECTYPE": "D", "MH": "Peptidomimetics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Peptidomimetic|T121|NON|EQV|NLM (2021)|191114|abcdef", "MN": "D27.505.519.828", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "MS": "Compounds that are designed to mimic the 3D structure of a natural peptide or protein.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057786"}, {"RECTYPE": "D", "MH": "Staphylococcus lugdunensis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.790.750.500", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid28035", "AN": "infection: coordinate IM with STAPHYLOCOCCAL INFECTIONS (IM)", "PI": "Staphylococcus (1989-2010)", "MS": "A species of gram-positive bacteria in the family STAPHYLOCOCCACEAE. It is responsible for skin and soft-tissue infections among others, and is part of the normal human skin flora.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057787"}, {"RECTYPE": "D", "MH": "Staphylococcus hyicus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.790.750.435", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid1284", "AN": "infection: coordinate IM with STAPHYLOCOCCAL INFECTIONS (IM)", "PI": "Staphylococcus (1969-2010)", "MS": "A species of gram-positive bacteria in the family STAPHYLOCOCCACEAE. It is an important opportunistic pathogen in swine.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057788"}, {"RECTYPE": "D", "MH": "Staphylococcus intermedius", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.790.750.445", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid1285", "AN": "infection: coordinate IM with STAPHYLOCOCCAL INFECTIONS (IM)", "PI": "Staphylococcus (1981-2010)", "MS": "A species of gram-positive bacteria in the family STAPHYLOCOCCACEAE. It is a zoonotic organism and common commensal in dogs, but can cause disease in dogs and other animals. It also can be associated with human disease.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057789"}, {"RECTYPE": "D", "MH": "Staphylococcus saprophyticus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.790.750.750", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid29385", "AN": "infection: coordinate IM with STAPHYLOCOCCAL INFECTIONS (IM)", "PI": "Staphylococcus (1976-2010)", "MS": "A species of gram-positive bacteria in the family STAPHYLOCOCCACEAE. It commonly causes urinary tract infections in humans.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057790"}, {"RECTYPE": "D", "MH": "Cardiac Imaging Techniques", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Techniques, Intracardiac Imaging", "MN": "E01.370.350.130", "MH_TH": "NLM (2011)", "ST": "T060", "AN": "cardioscopy: coordinate CARDIAC IMAGING TECHNIQUES with ENDOSCOPY", "MS": "Visualization of the heart structure and cardiac blood flow for diagnostic evaluation or to guide cardiac procedures via techniques including ENDOSCOPY (cardiac endoscopy, sometimes refered to as cardioscopy), RADIONUCLIDE IMAGING; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY; or ULTRASONOGRAPHY.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057791"}, {"RECTYPE": "D", "MH": "Mirizzi Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Mirizzi's", "MN": "C06.130.120.135.812", "FX": "Jaundice, Obstructive", "MH_TH": "ORD (2011)", "ST": "T047", "MS": "Complication of CHOLELITHIASIS characterized by OBSTRUCTIVE JAUNDICE; abdominal pain, and fever.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057792"}, {"RECTYPE": "D", "MH": "Pets", "AQ": "AB AH BL CF CL EC EM GD GE HI IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Companion Dogs|T008|NON|NRW|NLM (2021)|200407|abcdef", "ENTRY": "Pet", "MN": "B01.050.050.116.600", "FX": "Human-Animal Bond", "MH_TH": "UNK (19XX)", "ST": "T008", "AN": "coordinate with specific animal if pertinent", "PI": "Animals, Domestic (1963-2010)", "MS": "Animals kept by humans for companionship and enjoyment, as opposed to DOMESTIC ANIMALS such as livestock or farm animals, which are kept for economic reasons.", "PM": "2011; see ANIMALS, DOMESTIC 1983-2010", "HN": "2011; use ANIMALS, DOMESTIC 1983-2010", "MR": "20200902", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057805"}, {"RECTYPE": "D", "MH": "Molineoidae", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Molineidae|T204|NON|NRW|NLM (2011)|090917|abcdef", "MN": "B01.050.500.500.294.400.968.600", "MH_TH": "NLM (2011)", "ST": "T204", "RR": "txid33266", "AN": "infection: coordinate IM with STRONGYLIDA INFECTIONS (IM)", "PI": "Strongylida (2006-2010)", "MS": "A superfamily of roundworms in the order STRONGYLIDA. It comprises the single family Molineidae and subfamily Nematodirinae.", "PM": "2011", "HN": "2011", "MR": "20200902", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057807"}, {"RECTYPE": "D", "MH": "Nematodirus", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.294.400.968.600.550", "MH_TH": "NLM (2011)", "ST": "T204", "RN": "txid28838", "AN": "infection: coordinate IM with STRONGYLIDA INFECTIONS (IM)", "PI": "Strongylida (1965-2010)", "MS": "A genus of roundworms in the family MOLINIEIDAE, whose species are important gastrointestinal parasites of RUMINANTS, especially CATTLE; SHEEP; and GOATS.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057808"}, {"RECTYPE": "D", "MH": "HEK293 Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "HEK293 Cell", "MN": "A11.436.334", "MH_TH": "NLM (2011)", "ST": "T025", "AN": "almost always NIM with no qualifiers; check the tag HUMAN; do not routinely add KIDNEY or EMBRYO, MAMMALIAN", "PI": "Cell Line or specifics (1994-2010)", "MS": "A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5.", "PM": "2011", "HN": "2011", "MR": "20150108", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057809"}, {"RECTYPE": "D", "MH": "Two-Dimensional Difference Gel Electrophoresis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Two Dimensional Difference Gel Electrophoresis", "MN": "E05.301.300.230.500", "MH_TH": "NLM (2011)", "ST": "T059", "PI": "Electrophoresis, Gel, Two-Dimensional (2002-2010)", "MS": "Methods of comparing two or more samples on the same two-dimensional gel electrophoresis gel.", "PM": "2011", "HN": "2011", "MR": "20150626", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057825"}, {"RECTYPE": "D", "MH": "Vitelliform Macular Dystrophy", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vitelliform Macular Dystrophy, Juvenile Onset", "MN": "C16.320.290.763", "FX": "Macular Degeneration", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Retinal Degeneration (1973-2010)", "MS": "Autosomal dominant hereditary maculopathy with childhood-onset accumulation of LIPOFUSION in RETINAL PIGMENT EPITHELIUM. Affected individuals develop progressive central acuity loss, and distorted vision (METAMORPHOPSIA). It is associated with mutations in bestrophin, a chloride channel.", "PM": "2011", "HN": "2011", "MR": "20130708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057826"}, {"RECTYPE": "D", "MH": "Informed Consent By Minors", "AQ": "ES HI LJ PX SN ST", "MN": "N03.706.535.489.384", "FX": "Coercion", "MH_TH": "NLM (2011)", "ST": "T078", "PI": "Informed Consent (1978-2010)", "MS": "Voluntary authorization by a person not of usual legal age for diagnostic or investigative procedures, or for medical and surgical treatment. (from English A, Shaw FE, McCauley MM, Fishbein DB Pediatrics 121:Suppl Jan 2008 pp S85-7).", "PM": "2011", "HN": "2011", "MR": "20130709", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057828"}, {"RECTYPE": "D", "MH": "Sex Reassignment Procedures", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD", "ENTRY": "Sex Reassignment Procedure", "MN": "N05.300.361.500", "FX": "Transsexualism", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Transsexualism (1989-2010)", "MS": "Clinical treatments used to change the physiological sexual characteristics of an individual.", "PM": "2011", "HN": "2011", "MR": "20230531", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057829"}, {"RECTYPE": "D", "MH": "Sex Reassignment Surgery", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD", "PRINT ENTRY": "Gender-Affirming Surgery|T061|NON|EQV|NLM (2023)|220104|abcdef", "ENTRY": "Surgery, Gender-Affirming", "MN": "N05.300.361.500.500", "FX": "Transsexualism", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Transsexualism/surgery (1968-2010)", "MS": "Surgical procedure(s) by which a person's physical appearance and functional abilities are changed to align with their identified gender.", "PM": "2011", "HN": "2011", "MR": "20230531", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057830"}, {"RECTYPE": "D", "MH": "Lemierre Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Syndrome, Lemierre's", "MN": "C14.907.940.740.910.500", "MH_TH": "ORD (2011)", "ST": "T047", "PI": "Thrombophlebitis (1989-2010)", "MS": "A superinfection of the damaged oropharyngeal mucosa by FUSOBACTERIUM NECROPHORUM leading to the secondary septic THROMBOPHLEBITIS of the internal jugular vein.", "PM": "2011", "HN": "2011", "MR": "20190617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057831"}, {"RECTYPE": "D", "MH": "Watchful Waiting", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Expectant Management|T078|NON|EQV|NLM (2020)|181226|abcdef", "ENTRY": "Waiting, Watchful", "MN": "N04.761.559.590.900", "MH_TH": "NLM (2011)", "ST": "T078", "AN": "active surveillance in the context of clinical management of patients goes here", "PI": "Follow-Up Studies (1975-2010)", "MS": "Clinical management approach wherein immediate therapy is not provided but there is a period of observation during which periodic tests monitor patient and the progression of the illness. (Driffield T, Smith PC Med Decis Making. 2007 Mar-Apr;27(2):178-88)", "PM": "2011", "HN": "2011", "MR": "20190114", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057832"}, {"RECTYPE": "D", "MH": "Pyrimidine Phosphorylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphorylases, Pyrimidine", "MN": "D08.811.913.400.725.850", "MH_TH": "NLM (2011)", "ST": "T126", "RN": "EC 2.4.2.-", "PI": "Pentosyltransferases (1982-2010)", "MS": "Pentosyltransferases that catalyze the reaction between a pyrimidine nucleoside and orthophosphate to form a free pyrimidine and ribose-5-phosphate.", "PM": "2011; PYRIMIDINE-NUCLEOSIDE PHOSPHORYLASE was indexed under PENTOSYLTRANSFERASES 1983-2010, and under PYRIMIDINE NUCLEOSIDES 1974-1982", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057845"}, {"RECTYPE": "D", "MH": "Cell-Penetrating Peptides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cell-Penetrating Peptide|T116|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Peptides, Cell Penetrating", "MN": "D12.644.098", "MH_TH": "NLM (2011)", "ST": "T116", "RN": "0", "PI": "Peptides (2000-2010)", "MS": "Peptides that have the ability to enter cells by crossing the plasma membrane directly, or through uptake by the endocytotic pathway.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057846"}, {"RECTYPE": "D", "MH": "Lipid Regulating Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lipid Regulating Drugs|T121|NON|EQV|NLM (2011)|090923|abcdef", "ENTRY": "Regulating Drugs, Lipid", "MN": "D27.505.954.557", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Hypolipidemic Agents (1966-2010)", "MS": "Substances that alter the metabolism of LIPIDS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057847"}, {"RECTYPE": "D", "MH": "Optic Flow", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Optical Flow|T070|T082|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abbcdeef", "ENTRY": "Optical Flows", "MN": "G14.700", "MH_TH": "NLM (2011)", "ST": "T082", "PI": "Motion Perception (1980-2010)", "MS": "The continuous visual field seen by a subject through space and time.", "PM": "2011", "HN": "2011", "MR": "20210512", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057849"}, {"RECTYPE": "D", "MH": "Hermaphroditic Organisms", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Protogynous Organisms|T204|NON|NRW|NLM (2011)|090923|abcdef", "MN": "B05.275", "MH_TH": "NLM (2011)", "ST": "T204", "AN": "natural sex reversal processes are indexed SEX DETERMINATION PROCESSES", "PI": "Disorders of Sex Development (1964-2010)", "MS": "Animals and plants which have, as their normal mode of reproduction, both male and female sex organs in the same individual.", "PM": "2011", "HN": "2011", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057850"}, {"RECTYPE": "D", "MH": "Posterior Capsular Rupture, Ocular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C11.297.500", "MH_TH": "NLM (2011)", "ST": "T037", "PI": "Eye Injuries (1986-2010)", "MS": "A breach in the continuity of the posterior chamber of the eyeball.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057851"}, {"RECTYPE": "D", "MH": "Posterior Capsule of the Lens", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Posterior Capsule, Lens|T023|NON|EQV|NLM (2011)|090924|abcdef", "ENTRY": "Posterior Capsules, Lens", "MN": "A09.371.060.500.155.500", "MH_TH": "NLM (2011)", "ST": "T023", "MS": "The posterior aspect of the casing that surrounds the natural CRYSTALLINE LENS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057852"}, {"RECTYPE": "D", "MH": "Plant Immunity", "AQ": "DE GE IM PH RE", "ENTRY": "Systems, Plant Immune", "MN": "G15.630", "MH_TH": "NLM (2011)", "ST": "T039", "PI": "Plants (1996-2010)", "MS": "The inherent or induced capacity of plants to withstand or ward off biological attack by pathogens.", "PM": "2011", "HN": "2011", "MR": "20160623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057865"}, {"RECTYPE": "D", "MH": "Anterior Capsule of the Lens", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "MN": "A09.371.061", "MH_TH": "NLM (2011)", "ST": "T023", "MS": "The anterior aspect of the casing that surrounds the natural CRYSTALLINE LENS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057866"}, {"RECTYPE": "D", "MH": "Endoleak", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Perigraft Leaks", "MN": "C23.550.767.850.500", "FX": "Capillary Leak Syndrome", "MH_TH": "NLM (2011)", "ST": "T046", "PI": "Prosthesis Failure (1996-2010)", "MS": "Postoperative hemorrhage from an endovascular AORTIC ANEURYSM repaired with endoluminal placement of stent grafts (ENDOVASCULAR ANEURYSM REPAIR). It is associated with pressurization, expansion, and eventual rupture of the aneurysm.", "PM": "2011", "HN": "2011", "MR": "20220523", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057867"}, {"RECTYPE": "D", "MH": "Anastomotic Leak", "AQ": "BL CF CI CL DG DH DI DT EC EN EP ET HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Leaks, Anastomotic", "MN": "C23.550.767.071", "FX": "Anastomosis, Surgical", "MH_TH": "NLM (2011)", "ST": "T046", "PI": "Postoperative Complications (1966-2010)", "MS": "Breakdown of the connection and subsequent leakage of effluent (fluids, secretions, air) from a SURGICAL ANASTOMOSIS of the digestive, respiratory, genitourinary, and cardiovascular systems. Most common leakages are from the breakdown of suture lines in gastrointestinal or bowel anastomosis.", "PM": "2011", "HN": "2011", "MR": "20130708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057868"}, {"RECTYPE": "D", "MH": "Pulp Capping and Pulpectomy Agents", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Pulpectomy Agent", "MN": "J01.637.051.339.788", "MH_TH": "NLM (2011)", "ST": "T122", "RN": "0", "AN": "coordinate with specific material if pertinent", "PI": "Pulpectomy (2000-2010)", "MS": "Materials used in DENTAL PULP CAPPING or PULPECTOMY.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057872"}, {"RECTYPE": "D", "MH": "Peri-Implantitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Periimplantitides", "MN": "C07.465.714.282", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "Peri-implant mucositis (a reversible inflammation localized to the soft tissues): index DENTAL IMPLANTS + STOMATITIS", "PI": "Periodontitis (1991-2010)", "MS": "An inflammatory process with loss of supporting bone in the tissues surrounding functioning DENTAL IMPLANTS.", "PM": "2011", "HN": "2011", "MR": "20150623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057873"}, {"RECTYPE": "D", "MH": "Triploidy", "ENTRY": "Triploids", "MN": "G05.700.740.500", "FX": "Trisomy", "MH_TH": "NLM (2011)", "ST": "T049", "PI": "Trisomy (1968-2010)", "MS": "Polyploidy with three sets of chromosomes. Triploidy in humans are 69XXX, 69XXY, and 69XYY. It is associated with HOLOPROSENCEPHALY; ABNORMALITIES, MULTIPLE; PARTIAL HYDATIDIFORM MOLE; and MISCARRAGES.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057885"}, {"RECTYPE": "D", "MH": "Bleaching Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Whitening Agent|T120|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Agents, Whitening", "MN": "D27.720.642.315", "MH_TH": "NLM (2011)", "ST": "T120", "RN": "0", "PI": "Oxidation-Reduction (1966-1991)", "MS": "Chemicals that are used to oxidize pigments and thus effect whitening.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057886"}, {"RECTYPE": "D", "MH": "Overbite", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Protrusion, Incisor", "MN": "C07.793.494.630.500", "MH_TH": "NLM (2011)", "ST": "T190", "PI": "Malocclusion, Angle Class II (1979-2010)", "MS": "A malocclusion in which maxillary incisor and canine teeth project over the mandibular teeth excessively. The overlap is measured perpendicular to the occlusal plane and is also called vertical overlap. When the overlap is measured parallel to the occlusal plane it is referred to as overjet.", "PM": "2011", "HN": "2011", "MR": "20170224", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057887"}, {"RECTYPE": "D", "MH": "Iridoid Glucosides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Secoiridoid Glucoside|T109|NON|NRW|NLM (2021)|191119|abcdef", "ENTRY": "Glucosides, Secoiridoid", "MN": "D09.408.423.500", "MH_TH": "NLM (2003)", "ST": "T109", "RN": "0", "PI": "Iridoids (1979-2010)", "MS": "A subclass of iridoid compounds that include a glucoside moiety, usually found at the C-1 position.", "PM": "2011; see IRIDOIDS 2003-2010; for SECOIRIDOID GLUCOSIDES see IRIDOIDS 2003-2010", "HN": "2011; use IRIDOIDS 2003-2010; for SECOIRIDOID GLUCOSIDES use IRIDOIDS 2003-2010", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057888"}, {"RECTYPE": "D", "MH": "Iridoid Glycosides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Glycosides, Secoiridoid", "MN": "D09.408.423", "MH_TH": "NLM (2011)", "ST": "T109", "RN": "0", "PI": "Iridoids (1979-2010)", "MS": "A subclass of iridoid compounds that include a glycoside moiety, usually found at the C-1 position.", "PM": "2011", "HN": "2011", "MR": "20190705", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057889"}, {"RECTYPE": "D", "MH": "Epigenomics", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Epigenomic", "MN": "H01.158.273.343.350.042", "MH_TH": "NLM (2011)", "ST": "T091", "PI": "Epigenesis, Genetic (2002-2010)", "MS": "The systematic study of the global gene expression changes due to EPIGENETIC PROCESSES and not due to DNA base sequence changes.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057890"}, {"RECTYPE": "D", "MH": "Tetraploidy", "ENTRY": "Tetraploids", "MN": "G05.700.740.249", "MH_TH": "NLM (2011)", "ST": "T049", "PI": "Polyploidy (1967-2010)", "MS": "The presence of four sets of chromosomes. It is associated with ABNORMALITIES, MULTIPLE; and MISCARRAGES.", "PM": "2011", "HN": "2011", "MR": "20170630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057891"}, {"RECTYPE": "D", "MH": "Lesser Pelvis", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "PRINT ENTRY": "True Pelvis|T029|NON|EQV|NLM (2011)|090929|abcdef", "ENTRY": "Pelvis, True", "MN": "A01.923.600.500", "MH_TH": "NLM (2011)", "ST": "T029", "PI": "Pelvis (1963-2010)", "MS": "The part of the pelvis, inferior to the pelvic brim, that comprises both the pelvic cavity and the part of the PERINEUM lying inferior to the PELVIC DIAPHRAGM.", "PM": "2011", "HN": "2011", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057892"}, {"RECTYPE": "D", "MH": "Immediate Dental Implant Loading", "AQ": "AE CL EC ED ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Socket-Shield Technique|T061|NON|NRW|NLM (2021)|191210|abcdef", "ENTRY": "Technique, Socket-Shield", "MN": "E06.780.314.310.450", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Dental Implantation, Endosseous (2007-2010)", "MS": "Endosseous dental implantation where implants are fitted with an abutment or where an implant with a transmucosal coronal portion is used immediately (within 1 week) after the initial extraction. Conventionally, the implantation is performed in two stages with more than two months in between the stages.", "PM": "2011", "HN": "2011", "MR": "20200221", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057893"}, {"RECTYPE": "D", "MH": "Coral Reefs", "ENTRY": "Reefs, Coral", "MN": "N06.230.124.130", "FX": "Anthozoa", "MH_TH": "NLM (2011)", "ST": "T070", "MS": "Marine ridges composed of living CORALS, coral skeletons, calcareous algae, and other organisms, mixed with minerals and organic matter. They are found most commonly in tropical waters and support other animal and plant life.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057894"}, {"RECTYPE": "D", "MH": "Haploinsufficiency", "AQ": "DE GE IM PH RE", "ENTRY": "Haploinsufficiencies", "MN": "G05.380.350.500", "MH_TH": "NLM (2011)", "ST": "T081", "PI": "Mutation (1994-2010)", "MS": "A copy number variation that results in reduced GENE DOSAGE due to any loss-of-function mutation. The loss of heterozygosity is associated with abnormal phenotypes or diseased states because the remaining gene is insufficient.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057895"}, {"RECTYPE": "D", "MH": "Striae Distensae", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Stretch Mark", "MN": "C23.888.885.800", "MH_TH": "NLM (2011)", "ST": "T046", "PI": "Skin/pathology (1966-2010)", "MS": "Linear dermal scars accompanied by epidermal atrophy that affects skin that is subjected to continuous stretching. They usually do not cause any significant medical problems, only cosmetic problems.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057896"}, {"RECTYPE": "D", "MH": "Reflex, Righting", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Vestibular Reflex|T042|NON|EQV|NLM (2021)|200130|abcdef", "ENTRY": "Righting Responses", "MN": "G11.561.731.745", "MH_TH": "NLM (2011)", "ST": "T042", "PI": "Reflex (1964-2010)", "MS": "The instinctive tendency (or ability) to assume a normal position of the body in space when it has been displaced.", "PM": "2011", "HN": "2011", "MR": "20200609", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057897"}, {"RECTYPE": "D", "MH": "Hemizygote", "ENTRY": "Hemizygotes", "MN": "G05.380.371", "FX": "Loss of Heterozygosity", "MH_TH": "NLM (2011)", "ST": "T001", "PI": "Heterozygote (1971-2010)", "MS": "An individual having only one allele at a given locus because of the loss of the other allele through a mutation (e.g., CHROMOSOME DELETION).", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057898"}, {"RECTYPE": "D", "MH": "Cytophagocytosis", "AQ": "DE GE IM PH RE", "ENTRY": "Phagocytosis, Cell", "MN": "G12.688.500", "MH_TH": "NLM (2011)", "ST": "T043", "PI": "Phagocytosis (1962-2010)", "MS": "The engulfment and degradation of cells by other cells.", "PM": "2011", "HN": "2011", "MR": "20160623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057899"}, {"RECTYPE": "D", "MH": "Transcytosis", "AQ": "DE GE IM PH RE", "ENTRY": "Transport, Transcellular", "MN": "G04.468.790", "MH_TH": "NLM (2011)", "ST": "T043", "MS": "The transport of materials through a cell. It includes the uptake of materials by the cell (ENDOCYTOSIS), the movement of those materials through the cell, and the subsequent secretion of those materials (EXOCYTOSIS).", "PM": "2011", "HN": "2011", "MR": "20160701", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057900"}, {"RECTYPE": "D", "MH": "Stem Cell Research", "AQ": "EC ES HI LJ", "ENTRY": "Stem Cell Researchs", "MN": "H01.770.644.145.512", "FX": "Stem Cells", "MH_TH": "NLM (2011)", "ST": "T062", "AN": "IM for ethical, legal, moral, social, or religious aspects of research on embryos; do not routinely add for research involving stem cells; coordinate with specific type of stem cell if pertinent; note entry term EMBRYONIC STEM CELL RESEARCH: coordinate with EMBRYONIC STEM CELLS but not also with EMBRYO RESEARCH", "PI": "Stem Cells (1999-2010)", "MS": "Experimentation on STEM CELLS and on the use of stem cells.", "PM": "2011", "HN": "2011", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057905"}, {"RECTYPE": "D", "MH": "Circadian Clocks", "AQ": "DE GE IM PH RE", "ENTRY": "Timing Systems, Circadian", "MN": "G07.180.562.094.500", "FX": "Circadian Rhythm", "MH_TH": "NLM (2011)", "ST": "T040", "PI": "Circadian Rhythm (1967-2010)", "MS": "Biological mechanism that controls CIRCADIAN RHYTHM. Circadian clocks exist in the simplest form in cyanobacteria and as more complex systems in fungi, plants, and animals. In humans the system includes photoresponsive RETINAL GANGLION CELLS and the SUPRACHIASMATIC NUCLEUS that acts as the central oscillator.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057906"}, {"RECTYPE": "D", "MH": "Post-Synaptic Density", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Postsynaptic Densities|T026|NON|EQV|NLM (2022)|210523|abcdef", "ENTRY": "Regions, Postsynaptic Density", "MN": "A11.284.149.165.420.780.800.500", "MH_TH": "NLM (2011)", "ST": "T026", "PI": "Synapses (1983-2010)", "MS": "Cytoskeleton specialization at the cytoplasmic side of postsynaptic membrane in SYNAPSES. It is involved in neuronal signaling and NEURONAL PLASTICITY and comprised of GLUTAMATE RECEPTORS; scaffolding molecules (e.g., PSD95, PSD93), and other proteins (e.g., CaCMKII).", "PM": "2011", "HN": "2011", "MR": "20210707", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057907"}, {"RECTYPE": "D", "MH": "Argon Plasma Coagulation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Plasma Coagulation, Argon", "MN": "E04.350.500", "FX": "Laser Coagulation", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Laser Coagulation (1997-2010)", "MS": "A method of tissue ablation and bleeding control that uses ARGON plasma (ionized argon gas) to deliver a current of thermocoagulating energy to the area of tissue to be coagulated.", "PM": "2011", "HN": "2011", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057908"}, {"RECTYPE": "D", "MH": "Orthognathic Surgery", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Surgery, Orthognathic", "MN": "H02.403.810.481", "MH_TH": "NLM (2011)", "ST": "T091", "AN": "do not confuse with ORTHOGNATHIC SURGICAL PROCEDURES", "PI": "Orthodontics, Corrective (1974-2010)", "MS": "A surgical specialty concerned with correcting conditions related to malposition of the jawbones and other related MAXILLOFACIAL ABNORMALITIES (e.g., CLEFT PALATE; RETROGNATHISM).", "PM": "2011", "HN": "2011", "MR": "20180301", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057909"}, {"RECTYPE": "D", "MH": "Implant Capsular Contracture", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Contracture, Implant Capsular", "MN": "C23.550.767.865.500", "FX": "Contracture", "MH_TH": "NLM (2011)", "ST": "T046", "MS": "The shrinkage of the foreign body encapsulation scar tissue that forms around artificial implants imbedded in body tissues.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057910"}, {"RECTYPE": "D", "MH": "Angiotensin Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Angiotensin Receptor Blocker|T121|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Receptor Blockers, Angiotensin", "MN": "D27.505.519.162", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Angiotensin II Type 1 Receptor Blockers (2004-2010)", "MS": "Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057911"}, {"RECTYPE": "D", "MH": "Angiotensin II Type 2 Receptor Blockers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Type 2 Angiotensin Receptor Blockers|T121|NON|EQV|NLM (2011)|091006|abcdef", "MN": "D27.505.519.162.750", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptor, Angiotensin, Type 2/antagonists & inhibitors (2001-2010)", "MS": "Agents that antagonize the ANGIOTENSIN II TYPE 2 RECEPTOR.", "PM": "2011", "HN": "2011", "MR": "20140610", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057912"}, {"RECTYPE": "D", "MH": "Joint Capsule Release", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Capsular Release|T061|NON|EQV|NLM (2011)|091006|abcdef", "ENTRY": "Release, Joint Capsule", "MN": "E04.555.113.500", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "Surgical procedure to relax the JOINT CAPSULE tissues in a joint that has a reduced range of motion due to CONTRACTURE or TISSUE ADHESIONS or joint deformities.", "PM": "2011", "HN": "2011", "MR": "20150622", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057913"}, {"RECTYPE": "D", "MH": "Agricultural Irrigation", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Irrigations, Agricultural", "MN": "J01.040.044", "MH_TH": "NLM (2011)", "ST": "T068", "PI": "Agriculture (1965-2010)", "MS": "The routing of water to open or closed areas where it is used for agricultural purposes.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057914"}, {"RECTYPE": "D", "MH": "Drug Substitution", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapeutic Substitutions", "MN": "N02.421.668.778.500.312", "MH_TH": "NLM (2011)", "ST": "T170", "PI": "Therapeutic Equivalency (1979-2010)", "MS": "The practice of replacing one prescribed drug with another that is expected to have the same clinical or psychological effect.", "PM": "2011", "HN": "2011", "MR": "20150629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057915"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H7N1 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H7N1 subtype|T005|ABX|EQV|NLM (2024)|230223|abcdef", "ENTRY": "subtype, H7N1", "MN": "B04.820.480.968.405.400.690", "MH_TH": "NLM (2011)", "ST": "T005", "RN": "txid119216", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals", "PI": "Influenza A virus (1984-2010)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 7 and neuraminidase 1. This subtype has demonstrated the ability to mutate from a low pathogenic form to a highly pathogenic form in birds. It was responsible for a 1999 outbreak in turkeys in Italy.", "PM": "2011", "HN": "2011", "MR": "20230405", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057916"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H7N2 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H7N2 subtype|T005|NON|EQV|NLM (2024)|230223|abcdef", "ENTRY": "subtype, H7N2", "MN": "B04.820.480.968.405.400.692", "MH_TH": "NLM (2011)", "ST": "T005", "RN": "txid119214", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals", "PI": "Influenza A virus (1986-2010)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 7 and neuraminidase 2. It has been involved in a number of outbreaks in the 21st century on poultry farms and has been isolated a few times in humans.", "PM": "2011", "HN": "2011", "MR": "20230405", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057917"}, {"RECTYPE": "D", "MH": "Fiducial Markers", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Targets, Fiducial", "MN": "E07.710.259", "MH_TH": "NLM (2011)", "ST": "T073", "MS": "Materials used as reference points for imaging studies.", "PM": "2011", "HN": "2011", "MR": "20120703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057918"}, {"RECTYPE": "D", "MH": "Biological Oxygen Demand Analysis", "AQ": "EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Biological Oxygen Demand Analyses|T059|NON|EQV|NLM (2011)|091009|abcdef", "ENTRY": "Oxygen Demand, Chemical", "MN": "N06.850.780.375.349", "MH_TH": "NLM (2011)", "ST": "T059", "MS": "Testing for the amount of biodegradable organic material in a water sample by measuring the quantity of oxygen consumed by biodegradation of those materials over a specific time period.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057919"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H7N3 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H7N3 subtype|T005|NON|EQV|NLM (2024)|230223|abcdef", "ENTRY": "Virus, H7N3", "MN": "B04.820.480.968.405.400.694", "MH_TH": "NLM (2011)", "ST": "T005", "RN": "txid119215", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals", "PI": "Influenza A virus (1997-2010)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 7 and neuraminidase 3. It was first detected in turkeys in Britain in 1963 and there have been several outbreaks on poultry farms since that time.", "PM": "2011", "HN": "2011", "MR": "20230405", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057920"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H10N7 Subtype", "DS": "INFLUENZA A VIRUS, H910N7 SUBTYPE", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H10N7 subtype|T005|NON|EQV|NLM (2024)|230223|abcdef", "ENTRY": "subtype, H10N7", "MN": "B04.820.480.968.405.400.105", "MH_TH": "NLM (2011)", "ST": "T005", "RN": "txid102801", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals", "PI": "Influenza A virus (1983-2010)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 10 and neuraminidase 7. It has been isolated from a variety of wild and domestic animals including ducks, emu, and mink. It was found for the first time in humans in 2004.", "PM": "2011", "HN": "2011", "MR": "20230405", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057921"}, {"RECTYPE": "D", "MH": "Femoracetabular Impingement", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Femoroacetabular Impingement", "MN": "C23.550.347", "MH_TH": "NLM (2011)", "ST": "T046", "PI": "Hip Joint (2001-2010)", "MS": "A pathological mechanical process that can lead to hip failure. It is caused by abnormalities of the ACETABULUM and/or FEMUR combined with rigorous hip motion, leading to repetitive collisions that damage the soft tissue structures.", "PM": "2011", "HN": "2011", "MR": "20130708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057925"}, {"RECTYPE": "D", "MH": "Hydrophobic and Hydrophilic Interactions", "AQ": "DE RE", "ENTRY": "Interactions, Hydrophobic", "MN": "G02.409", "MH_TH": "NLM (2011)", "ST": "T070", "AN": "do not confuse entry term HYDROPHOBICITY with HYDROPHOBIA see RABIES", "MS": "The thermodynamic interaction between a substance and WATER.", "PM": "2011; for HYDROPHOBICITY use HYDROPHOBICITY 2001-2010", "HN": "2011", "MR": "20160518", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057927"}, {"RECTYPE": "D", "MH": "Intermittent Urethral Catheterization", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Urethral Self-Catheterizations", "MN": "E05.157.500.500", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Urinary Catheterization (1975-2010)", "MS": "Insertion of a catheter into the urethra to drain the urine from the bladder at intervals as needed.", "PM": "2011", "HN": "2011", "MR": "20150622", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057928"}, {"RECTYPE": "D", "MH": "Arthroplasty, Replacement, Elbow", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Total Elbow Replacements", "MN": "E04.650.110.045", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Elbow Joint (1975-2010)", "MS": "Replacement of the ELBOW JOINT.", "PM": "2011", "HN": "2011", "MR": "20220406", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057929"}, {"RECTYPE": "D", "MH": "Click Chemistry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Techniques, Click Chemical", "MN": "J01.897.836.249.124", "FX": "Green Chemistry Technology", "MH_TH": "NLM (2011)", "ST": "T062", "MS": "Organic chemistry methodology that mimics the modular nature of various biosynthetic processes. It uses highly reliable and selective reactions designed to \"click\" i.e., rapidly join small modular units together in high yield, without offensive byproducts. In combination with COMBINATORIAL CHEMISTRY TECHNIQUES, it is used for the synthesis of new compounds and combinatorial libraries.", "PM": "2011", "HN": "2011", "MR": "20160616", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057930"}, {"RECTYPE": "D", "MH": "Self-Fertilization", "AQ": "DE GE IM PH RE", "ENTRY": "Self-Fertilizations", "MN": "G15.830", "MH_TH": "NLM (1998)", "ST": "T040", "AN": "self pollination: index POLLINATION + SELF-FERTILIZATION", "MS": "The fusion of a male gamete with a female gamete from the same individual animal or plant.", "PM": "2011; see INBREEDING 1998-2010", "HN": "2011; use INBREEDING 1998-2010", "MR": "20160623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057945"}, {"RECTYPE": "D", "MH": "Charophyceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Charophytes|T002|NON|EQV|NLM (2004)|030131|abcdef", "ENTRY": "Charophyte", "MN": "B01.875.800.150", "MH_TH": "NLM (2011)", "ST": "T002", "RN": "txid304574", "RR": "txid204509", "PI": "Chlorophyta (1971-2003)", "MS": "A group (or class) of aquatic plants, including the streptophyte algae, that are the closest relatives to land plants (EMBRYOPHYTA).", "PM": "2011; for CHAROPHYTES and STONEWORTS see CHARACEAE 2004-2010", "HN": "2011; for CHAROPHYTES and STONEWORTS use CHARACEAE 2004-2010", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057946"}, {"RECTYPE": "D", "MH": "Parenteral Nutrition Solutions", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Solutions, Intravenous Feeding", "MN": "D27.720.752.733", "FX": "Parenteral Nutrition", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Parenteral Nutrition (1996-2010)", "MS": "Specialized solutions for PARENTERAL NUTRITION. They may contain a variety of MICRONUTRIENTS; VITAMINS; AMINO ACIDS; CARBOHYDRATES; LIPIDS; and SALTS.", "PM": "2011", "HN": "2011", "MR": "20130708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057947"}, {"RECTYPE": "D", "MH": "Viridiplantae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Plants, Green", "MN": "B01.875", "MH_TH": "NLM (2011)", "ST": "T002", "RN": "txid33090", "AN": "general or unspecified; prefer specifics", "MS": "A monophyletic group of green plants that includes all land plants (EMBRYOPHYTA) and all green algae (CHLOROPHYTA and STREPTOPHYTA).", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057948"}, {"RECTYPE": "D", "MH": "Streptophyta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800", "MH_TH": "NLM (2011)", "ST": "T002", "RN": "txid35493", "PI": "Plants (2006-2010)", "MS": "A phylum of green plants comprising CHAROPHYCEAE (streptophyte green algae) and EMBRYOPHYTA (land plants).", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057949"}, {"RECTYPE": "D", "MH": "Carbon Sequestration", "AQ": "DE GE IM PH RE", "ENTRY": "Techniques, Carbon Sequestration", "MN": "G16.500.150.500", "MH_TH": "NLM (2011)", "ST": "T067", "PI": "Carbon (2004-2010)", "MS": "Any of several processes for the permanent or long-term artificial or natural capture or removal and storage of carbon dioxide and other forms of carbon, through biological, chemical or physical processes, in a manner that prevents it from being released into the atmosphere.", "PM": "2011", "HN": "2011", "MR": "20160219", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057965"}, {"RECTYPE": "D", "MH": "Calcimimetic Agents", "AQ": "AD AE AG AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Agents, Calcimimetic", "MN": "D27.505.696.399.450.230", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Hyperparathyroidism (1998-2010)", "MS": "Small organic molecules that act as allosteric activators of the calcium sensing receptor (CaSR) in the PARATHYROID GLANDS and other tissues. They lower the threshold for CaSR activation by extracellular calcium ions and diminish PARATHYROID HORMONE (PTH) release from parathyroid cells.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057966"}, {"RECTYPE": "D", "MH": "Infusions, Intraventricular", "ENTRY": "Intraventricular Infusions", "MN": "E02.319.267.510.692", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Injections, Intraventricular (1976-2010)", "MS": "The delivery of a drug into a fluid-filled cavity of the brain.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057967"}, {"RECTYPE": "D", "MH": "Transdermal Patch", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Transdermal Patchs", "MN": "E07.935", "MH_TH": "NLM (2011)", "ST": "T203", "PI": "Administration, Cutaneous (1982-2010)", "MS": "A medicated adhesive patch placed on the skin to deliver a specific dose of medication into the bloodstream.", "PM": "2011", "HN": "2011", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057968"}, {"RECTYPE": "D", "MH": "Inappropriate Prescribing", "AQ": "AE CL EC ES HI LJ MO NU PC PX SN TD VE", "PRINT ENTRY": "Inappropriate Prescriptions|T061|NON|NRW|NLM (2011)|091110|abcdef", "ENTRY": "Prescriptions, Inappropriate", "MN": "N02.421.450.500.249", "FX": "Medical Overuse", "MH_TH": "NLM (2011)", "ST": "T080", "PI": "Drug Prescriptions (1975-2010)", "MS": "The practice of administering medications in a manner that poses more risk than benefit, particularly where safer alternatives exist.", "PM": "2011", "HN": "2011", "MR": "20180629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057970"}, {"RECTYPE": "D", "MH": "Anterior Capsular Rupture, Ocular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C11.297.249", "MH_TH": "NLM (2011)", "ST": "T037", "PI": "Eye Injuries (1986-2010)", "MS": "A breach in the continuity of the ANTERIOR CHAMBER of the eyeball.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057971"}, {"RECTYPE": "D", "MH": "Posterior Eye Segment", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Segments, Posterior Eye", "MN": "A09.371.714", "MH_TH": "NLM (2011)", "ST": "T023", "MS": "The back two-thirds of the eye that includes the anterior hyaloid membrane and all of the optical structures behind it: the VITREOUS HUMOR; RETINA; CHOROID; and OPTIC NERVE.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057972"}, {"RECTYPE": "D", "MH": "Dent Disease", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Dent's Disease|T047|EPO|EQV|GHR (2014)|NLM (2011)|091023|abcdeef", "ENTRY": "Disease, Dents", "MN": "C16.320.831.271", "FX": "Oculocerebrorenal Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "X-linked recessive NEPHROLITHIASIS characterized by HYPERCALCIURIA; HYPOPHOSPHATEMIA; NEPHROCALCINOSIS; and PROTEINURIA. It is associated with mutations in the voltage-gated chloride channel, CLC-5 (Dent Disease I). Another group of mutations associated with this disease is in phosphatidylinositol 4,5-bisphosphate-5-phosphatase gene.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057973"}, {"RECTYPE": "D", "MH": "Multi-Ingredient Cold, Flu, and Allergy Medications", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Multi-Ingredient Cold Medications|T121|ABX|NRW|NLM (2011)|091026|abcdef", "ENTRY": "Remedies, Multi-Ingredient Cold", "MN": "D26.310.500", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "AN": "IM general only; coordinate NIM with specific ingredients", "MS": "A broad category of multi-ingredient preparations that are marketed for the relief of upper respiratory symptoms resulting from the COMMON COLD; ALLERGIES; or HUMAN INFLUENZA. While the majority of these medications are available as OVER-THE-COUNTER DRUGS some of them contain ingredients that require them to be sold as PRESCRIPTION DRUGS or as BEHIND-THE COUNTER DRUGS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D057985"}, {"RECTYPE": "D", "MH": "General Practitioners", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Practitioners, General", "MN": "N02.360.810.485", "MH_TH": "UNK (19XX)", "ST": "T097", "PI": "Physicians, Family (1966-2010)", "MS": "Physicians whose practice is not restricted to a specific field of MEDICINE.", "PM": "2011", "HN": "2011", "MR": "20180629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058005"}, {"RECTYPE": "D", "MH": "General Practice", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Practice, General", "MN": "H02.403.340", "FX": "General Practitioners", "MH_TH": "UNK (19XX)", "ST": "T091", "PI": "Family Practice (1978-2010)", "MS": "Patient-based medical care provided across age and gender or specialty boundaries.", "PM": "2011; 1963-1977; see FAMILY PRACTICE 1978-2010", "HN": "2011; 1963-1977; use FAMILY PRACTICE 1978-2010", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058006"}, {"RECTYPE": "D", "MH": "Physicians, Primary Care", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Primary Care Physicians|T097|NON|EQV|UNK (19XX)|770509|abcdef", "ENTRY": "Primary Care Physician", "MN": "N02.360.810.795", "MH_TH": "NLM (2011)", "ST": "T097", "PI": "Physicians, Family (1980-2010)", "MS": "Providers of initial care for patients. These PHYSICIANS refer patients when appropriate for secondary or specialist care.", "PM": "2011", "HN": "2011", "MR": "20180629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058007"}, {"RECTYPE": "D", "MH": "Xenotropic murine leukemia virus-related virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Xenotropic MuLV-related virus|T005|NON|EQV|NLM (2011)|091028|abcdef", "ENTRY": "Xenotropic murine leukemia virus related virus", "MN": "B04.820.650.375.930", "MH_TH": "NLM (2011)", "ST": "T005", "RN": "txid438045", "AN": "infection: coordinate IM with RETROVIRIDAE INFECTIONS (IM)", "PI": "Gammaretrovirus (2008-2010)", "MS": "An endogenous GAMMARETROVIRUS from the germ line of mice but isolated from humans. It has close similarity to xenotropic MURINE LEUKEMIA VIRUS.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058008"}, {"RECTYPE": "D", "MH": "Stramenopiles", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Heterokonts|T204|NON|EQV|NLM (2011)|091028|abcdef", "ENTRY": "Stramenopile", "MN": "B01.750", "MH_TH": "NLM (2011)", "ST": "T204", "RN": "txid33634", "AN": "general or unspecified; prefer specifics", "MS": "A common name (but used formally) for a group of organisms that are mostly kinds of algae including BACILLARIOPHYTA; OOMYCETES; PHAEOPHYCEAE; and CHRYSOPHYCEAE. They all contain CHLOROPLASTS that are thought to have been derived from the endosymbiosis of ancient RED ALGAE.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058009"}, {"RECTYPE": "D", "MH": "Millon Clinical Multiaxial Inventory", "AQ": "HI SN ST", "MN": "F04.711.647.513.535", "MH_TH": "NLM (2011)", "ST": "T060", "PI": "Personality Inventory (1978-2010)", "MS": "A psychological test consisting of true/false items. It is used as a diagnostic screening or clinical assessment of adults who evidence problematic emotional and interpersonal symptoms or who are undergoing PSYCHOTHERAPY or a psychodiagnostic evaluation.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058010"}, {"RECTYPE": "D", "MH": "Multifactor Dimensionality Reduction", "AQ": "CL EC ES HI LJ MT SN ST TD", "ENTRY": "Multifactor Dimensionality Reductions", "MN": "L01.470.625.500", "MH_TH": "NLM (2011)", "ST": "T170", "PI": "Statistics as Topic (2003-2010)", "MS": "A statistical tool for detecting and modeling gene-gene interactions. It is a non-parametric and model-free approach.", "PM": "2011", "HN": "2011", "MR": "20150623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058011"}, {"RECTYPE": "D", "MH": "Small Business", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Small Businesses", "MN": "J01.219.921", "MH_TH": "NLM (2011)", "ST": "T081", "PI": "Business (1966-2010)", "MS": "For-profit enterprise with relatively few to moderate number of employees and low to moderate volume of sales.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058012"}, {"RECTYPE": "D", "MH": "Test Taking Skills", "AQ": "DE EC HI MT PX SN ST", "PRINT ENTRY": "Test-Taking|T065|NON|EQV|NLM (2011)|091029|abcdef", "ENTRY": "Wiseness, Test", "MN": "I02.399.890", "MH_TH": "NLM (2011)", "ST": "T065", "PI": "Educational Measurement (1976-2010)", "MS": "Skills and strategies, unrelated to the traits a test is intended to measure, that may increase test takers' scores -- may include the effects of coaching or experience in taking tests. (ERIC Thesaurus)", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058013"}, {"RECTYPE": "D", "MH": "Veterans Health", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "ENTRY": "Health, Veterans", "MN": "N01.400.850", "FX": "Veterans Health Services", "MH_TH": "NLM (2011)", "ST": "T078", "PI": "Veterans (1963-2010)", "MS": "The concept covering the physical and mental conditions of VETERANS.", "PM": "2011", "HN": "2011", "MR": "20190707", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058014"}, {"RECTYPE": "D", "MH": "Health Communication", "AQ": "CL EC ES HI MT ST TD", "ENTRY": "Health Communications", "MN": "N02.208", "MH_TH": "NLM (2011)", "ST": "T058", "MS": "The transfer of information from experts in the medical and public health fields to patients and the public. The study and use of communication strategies to inform and influence individual and community decisions that enhance health.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058015"}, {"RECTYPE": "D", "MH": "Health Facility Administration", "AQ": "CL EC ED ES HI IS LJ MT SN ST TD", "ENTRY": "Facility Administration, Health", "MN": "N04.452.442", "MH_TH": "NLM (2011)", "ST": "T058", "PI": "Health Facilities (1968-2010)", "MS": "Management of the organization of HEALTH FACILITIES.", "PM": "2011", "HN": "2011", "MR": "20190709", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058016"}, {"RECTYPE": "D", "MH": "Vascular Grafting", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Vessel Grafting, Blood", "MN": "E04.100.814.868", "MH_TH": "NLM (2011)", "ST": "T061", "AN": "coordinate with specific blood vessel/transpl if pertinent", "MS": "Surgical insertion of BLOOD VESSEL PROSTHESES, or transplanted BLOOD VESSELS, or other biological material to repair injured or diseased blood vessels.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058017"}, {"RECTYPE": "D", "MH": "Interdisciplinary Studies", "AQ": "SN ST TD", "ENTRY": "Study, Interdisciplinary", "MN": "I02.158.405", "MH_TH": "NLM (1995)", "ST": "T057", "PI": "Curriculum (1990-2010)", "MS": "Programs of study which span the traditional boundaries of academic scholarship.", "PM": "2011", "HN": "2011", "MR": "20170703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058025"}, {"RECTYPE": "D", "MH": "Neuropsychiatry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H02.403.690.754", "FX": "Neuropsychology", "MH_TH": "NLM (2011)", "ST": "T091", "AN": "specialty only", "MS": "A subfield of psychiatry that emphasizes the somatic substructure on which mental operations and emotions are based, and the functional or organic disturbances of the central nervous system that give rise to, contribute to, or are associated with mental and emotional disorders. (From Campbell's Psychiatric Dictionary, 8th ed.)", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058027"}, {"RECTYPE": "D", "MH": "Research Report", "AQ": "HI LJ ST TD", "PRINT ENTRY": "Report|T170|NON|REL|NLM (2011)|091103|abcdef", "ENTRY": "Summary Reports", "MN": "L01.559.423.906.769", "MH_TH": "NLM (2011)", "ST": "T170", "PI": "Research (1991-2010)", "MS": "Detailed account or statement or formal record of data resulting from empirical inquiry.", "PM": "2011", "HN": "2011", "MR": "20170703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058028"}, {"RECTYPE": "D", "MH": "Artificial Cells", "AQ": "CH CL CY DE EN IM ME MI PS RE TR UL VI", "ENTRY": "Synthetic Organelle", "MN": "J01.637.087.500.254", "FX": "Blood Substitutes", "MH_TH": "NLM (2011)", "ST": "T073", "MS": "Chemically synthesized structures which functionally resemble natural cells.", "PM": "2011", "HN": "2011", "MR": "20180629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058045"}, {"RECTYPE": "D", "MH": "Diabetic Cardiomyopathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Diabetic Cardiomyopathy", "MN": "C19.246.099.625", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "coordinate IM with specific heart disease (IM) + specific type of diabetes mellitus (IM) if pertinent", "PI": "Diabetes Complications (1974-2010)", "MS": "Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058065"}, {"RECTYPE": "D", "MH": "Digital Dermatitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RT SU TH TM UR VI", "PRINT ENTRY": "Bovine Digital Dermatitis|T047|NON|NRW|NLM (2011)|091109|abcdef", "ENTRY": "Warts, Bovine Foot", "MN": "C22.214", "FX": "Treponema", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "animal only; coordinate IM with appropriate infection term (IM) + precoordinated animal/disease term (IM) if pertinent", "PI": "Dermatitis (1987-2010)", "MS": "Highly contagious infectious dermatitis with lesions near the interdigital spaces usually in cattle. It causes discomfort and often severe lameness (LAMENESS, ANIMAL). Lesions can be either erosive or proliferative and wart-like with papillary growths and hypertrophied hairs. DICHELOBACTER NODOSUS and TREPONEMA are the most commonly associated causative agents for this mixed bacterial infection disease.", "PM": "2011", "HN": "2011", "MR": "20190617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058066"}, {"RECTYPE": "D", "MH": "Wavelet Analysis", "ENTRY": "Wavelet Transforms", "MN": "L01.224.800.750", "FX": "Fourier Analysis", "MH_TH": "NLM (2011)", "ST": "T081", "MS": "Signal and data processing method that uses decomposition of wavelets to approximate, estimate, or compress signals with finite time and frequency domains. It represents a signal or data in terms of a fast decaying wavelet series from the original prototype wavelet, called the mother wavelet. This mathematical algorithm has been adopted widely in biomedical disciplines for data and signal processing in noise removal and audio/image compression (e.g., EEG and MRI).", "PM": "2011", "HN": "2011", "MR": "20170703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058067"}, {"RECTYPE": "D", "MH": "Endophenotypes", "AQ": "AN BL CF CH ME UR", "ENTRY": "Endophenotype", "MN": "G05.695.224", "FX": "Biomarkers", "MH_TH": "NLM (2011)", "ST": "T184", "PI": "Phenotype (2001-2010)", "MS": "Measurable biological (physiological, biochemical, and anatomical features), behavioral (psychometric pattern) or cognitive markers that are found more often in individuals with a disease than in the general population. Because many endophenotypes are present before the disease onset and in individuals with heritable risk for disease such as unaffected family members, they can be used to help diagnose and search for causative genes.", "PM": "2011", "HN": "2011", "MR": "20150714", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058068"}, {"RECTYPE": "D", "MH": "Neglected Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neglected Tropical Diseases|T047|NON|NRW|NLM (2024)|230504|abcdef", "ENTRY": "Tropical Disease, Neglected", "MN": "C23.550.291.890", "FX": "Rare Diseases", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Tropical Medicine (2002-2010)", "MS": "Diseases that are underfunded and have low name recognition but are major burdens in less developed countries. Neglected diseases include many tropical infectious diseases, e.g., HELMINTHIASIS; LEPROSY; LYMPHATIC FILARIASIS; ONCHOCERCIASIS; SCHISTOSOMIASIS; and TRACHOMA.", "PM": "2011", "HN": "2011", "MR": "20230531", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058069"}, {"RECTYPE": "D", "MH": "Asymptomatic Diseases", "AQ": "CL EC EP MO NU PX RH TH", "ENTRY": "Presymptomatic Disease", "MN": "C23.550.291.187", "FX": "Elite Controllers", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "ASYMPTOMATIC INFECTIONS is also available", "MS": "Diseases that do not exhibit symptoms.", "PM": "2011", "HN": "2011", "MR": "20210701", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058070"}, {"RECTYPE": "D", "MH": "Iron Compounds", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Compounds, Iron", "MN": "D01.490", "MH_TH": "NLM (2011)", "ST": "T104", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Organic and inorganic compounds that contain iron as an integral part of the molecule.", "PM": "2011", "HN": "2011", "MR": "20190617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058085"}, {"RECTYPE": "D", "MH": "Microalgae", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Microphytes|T007|T204|NON|EQV|NLM (2011)|091113|abbcdef", "MN": "B05.080.500.600.500", "MH_TH": "NLM (2011)", "ST": "T204", "AN": "coordinate with specific organism if pertinent", "MS": "A non-taxonomic term for unicellular microscopic algae which are found in both freshwater and marine environments. Some authors consider DIATOMS; CYANOBACTERIA; HAPTOPHYTA; and DINOFLAGELLATES as part of microalgae, even though they are not algae.", "PM": "2011", "HN": "2011", "MR": "20120703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058086"}, {"RECTYPE": "D", "MH": "Haptophyta", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Prymnesiophyte", "MN": "B01.400", "MH_TH": "NLM (2011)", "ST": "T204", "RN": "txid2830", "RR": "txid37098", "MS": "A group (or phylum) of unicellular EUKARYOTA (or algae) possessing CHLOROPLASTS and FLAGELLA.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058087"}, {"RECTYPE": "D", "MH": "Sarcoglycanopathies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Primary Adhalinopathy", "MN": "C16.320.577.280.500", "MH_TH": "NLM (2011)", "ST": "T047", "MS": "Deficiencies or mutations in the genes for the SARCOGLYCAN COMPLEX subunits. A variety of phenotypes are associated with these mutations including a subgroup of autosomal recessive limb girdle muscular dystrophies, cardiomyopathies, and respiratory deficiency.", "PM": "2011", "HN": "2011", "MR": "20130708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058088"}, {"RECTYPE": "D", "MH": "Polymerization", "AQ": "DE RE", "ENTRY": "Polymerizations", "MN": "G02.750", "MH_TH": "NLM (2011)", "ST": "T067", "PI": "Polymers (1963-2010)", "MS": "Chemical reaction in which monomeric components are combined to form POLYMERS (e.g., POLYMETHYLMETHACRYLATE).", "PM": "2011", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058105"}, {"RECTYPE": "D", "MH": "Wound Closure Techniques", "AQ": "AE CL EC ED ES HI IS LJ MO NU PX RH SN ST TD VE", "ENTRY": "Wound Closure Technique", "MN": "E04.987", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "Methods to repair breaks in tissue caused by trauma or to close surgical incisions.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058106"}, {"RECTYPE": "D", "MH": "Abdominal Wound Closure Techniques", "AQ": "AE CL EC ED ES HI IS LJ MO NU PX RH SN ST TD VE", "PRINT ENTRY": "Abdominal Wound Closure Technique|T061|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Wound Closures, Abdominal", "MN": "E04.987.100", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "Methods to repair breaks in abdominal tissues caused by trauma or to close surgical incisions during abdominal surgery.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058107"}, {"RECTYPE": "D", "MH": "Glaucophyta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Glaucophyceae|T002|NON|EQV|NLM (2011)|091117|abcdef", "MN": "B01.350", "MH_TH": "NLM (2011)", "ST": "T002", "RN": "txid38254", "MS": "A phylum or class of freshwater microscopic EUKARYOTA sometimes considered to be plants or MICROALGAE. Their CHLOROPLASTS (called cyanelles) are believed to be derived from the direct endosymbiosis of CYANOBACTERIA.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058108"}, {"RECTYPE": "D", "MH": "Airway Management", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Management, Airway", "MN": "E02.041", "FX": "Respiratory Therapy", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "Evaluation, planning, and use of a range of procedures and airway devices for the maintenance or restoration of a patient's ventilation.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058109"}, {"RECTYPE": "D", "MH": "Counterfeit Drugs", "AQ": "AD AE AN BL CF CH CL CS EC HI IP ME PD PK PO RE SD TO TU UR", "PRINT ENTRY": "Falsified Medicine|T121|T131|NON|NRW|NLM (2021)|191119|abbcdef", "ENTRY": "Medicines, Falsified", "MN": "D26.894.500", "MH_TH": "NLM (2011)", "ST": "T131", "RN": "0", "AN": "DRUG COUNTERFEITING see FRAUD is available", "PI": "Pharmaceutical Preparations (1998-2010)", "MS": "Fake medicine that may be contaminated or contain the wrong or no active ingredient, or the correct active ingredient at the wrong dose. Counterfeit drugs are illegal and may be harmful to health.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058110"}, {"RECTYPE": "D", "MH": "Septins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Septin|T116|T126|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D12.776.476.338.700", "MH_TH": "NLM (2011)", "ST": "T126", "RN": "EC 3.6.1.-", "MS": "A family of GTP-binding proteins that were initially identified in YEASTS where they were shown to initiate the process of septation and bud formation. Septins form into hetero-oligomeric complexes that are comprised of several distinct septin subunits. These complexes can act as cytoskeletal elements that play important roles in CYTOKINESIS, cytoskeletal reorganization, BIOLOGICAL TRANSPORT, and membrane dynamics.", "PM": "2011", "HN": "2011", "MR": "20210521", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058112"}, {"RECTYPE": "D", "MH": "Cerumenolytic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Solvent, Wax", "MN": "D27.720.877.383.500", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Surface Active Agents (1963-2010)", "MS": "Compounds that disintegrate natural waxy exudates such as EAR WAX.", "PM": "2011", "HN": "2011", "MR": "20140625", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058113"}, {"RECTYPE": "D", "MH": "Desmidiales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Desmid", "MN": "B01.875.800.150.200", "MH_TH": "NLM (2011)", "ST": "T002", "RN": "txid131210", "PI": "Eukaryota (1966-2010)", "MS": "An order of mostly unicellular, microscopic, freshwater algae that have highly symmetrical and varied shapes.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058114"}, {"RECTYPE": "D", "MH": "Lewis Bases", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lewis Base|T120|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Bases, Lewis", "MN": "D02.572", "MH_TH": "NLM (2011)", "ST": "T120", "RN": "0", "PI": "Oxidation-Reduction (2009-2010)", "MS": "Any chemical species which acts as an electron-pair donor in a chemical bonding reaction with a LEWIS ACID.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058115"}, {"RECTYPE": "D", "MH": "Lewis Acids", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lewis Acid|T120|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Acids, Lewis", "MN": "D02.561", "MH_TH": "NLM (2011)", "ST": "T120", "RN": "0", "PI": "Acids (1969-2010)", "MS": "Any chemical species which accepts an electron-pair from a LEWIS BASE in a chemical bonding reaction.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058116"}, {"RECTYPE": "D", "MH": "Neural Prostheses", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Prosthesis, Neural", "MN": "E07.695.202.381.500", "MH_TH": "NLM (2011)", "ST": "T074", "PI": "Prostheses and Implants (1977-2010)", "MS": "Medical devices which substitute for a nervous system function by electrically stimulating the nerves directly and monitoring the response to the electrical stimulation.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058117"}, {"RECTYPE": "D", "MH": "Transcription Factor 7-Like 2 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, TCF7L2", "MN": "D12.776.930.875.875", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A transcription factor that takes part in WNT signaling pathway. The activity of the protein is regulated via its interaction with BETA CATENIN. Transcription factor 7-like 2 protein plays an important role in the embryogenesis of the PANCREAS and ISLET CELLS.", "PM": "2011; TCF7L2 TRANSCRIPTION FACTOR (now TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN) was indexed under TCF TRANSCRIPTION FACTORS 2005-2010 and under TRANSCRIPTION FACTORS 1997-2005", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058118"}, {"RECTYPE": "D", "MH": "Closterium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.150.200.150", "MH_TH": "NLM (2011)", "ST": "T002", "RN": "txid34145", "AN": "do not confuse the genus Closterium with the species name closterium (e.g. Cylindrotheca closterium or Nitzschia closterium), which are DIATOMS", "MS": "A genus of crescent-shaped algae in the family Closteriaceae, order DESMIDIALES.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058119"}, {"RECTYPE": "D", "MH": "Micrasterias", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Micrasteria", "MN": "B01.875.800.150.200.500", "MH_TH": "NLM (2011)", "ST": "T002", "RN": "txid130980", "PI": "Chlorophyta (1970-2010)", "MS": "A genus of unicellular streptophyte algae in the family Desmidiaceae, order DESMIDIALES.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058120"}, {"RECTYPE": "D", "MH": "Transcription Factor 7-Like 1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factor, TCF7L1", "MN": "D12.776.930.875.812", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A transcription factor that takes part in WNT signaling pathway where it may play a role in the differentiation of KERATINOCYTES. The transcriptional activity of this protein is regulated via its interaction with BETA CATENIN.", "PM": "2011; TRANSCRIPTION FACTOR 7-LIKE 1 PROTEIN was indexed under TCF TRANSCRIPTION FACTORS 2006-2010, and under TCF TRANSCRIPTION FACTORS & HMGB PROTEINS 1996-2005", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058125"}, {"RECTYPE": "D", "MH": "Balanced Anesthesia", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Anoci Association", "MN": "E03.155.197.682", "FX": "Adjuvants, Anesthesia", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Anesthesia or specifics (1963-2010)", "MS": "The use of several ANESTHETICS together in small amounts, as opposed to a larger amount of one drug, to induce loss of sensation and loss of consciousness.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058126"}, {"RECTYPE": "D", "MH": "Transcription Factor 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Transcription Factor E2-alpha|T116|T123|NON|EQV|NLM (2011)|091120|abbcdef", "ENTRY": "kappa E2 Binding Factor", "MN": "D12.776.930.127.092.875", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A basic helix-loop-helix transcription factor that plays a role in determining cell fate during embryogenesis. It forms a heterodimer with TWIST-RELATED PROTEIN 1 and ACHAETE-SCUTE GENE COMPLEX-related TRANSCRIPTION FACTORS.", "PM": "2011; TRANSCRIPTION FACTOR 3 was indexed under TCF TRANSCRIPTION FACTORS 2006-2010, and under TCF TRANSCRIPTION FACTORS & HMGB PROTEINS 1996-2005", "HN": "2011; use TRANSCRIPTION FACTOR 7 LIKE 1 PROTEIN 1996-2009", "MR": "20160712", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058127"}, {"RECTYPE": "D", "MH": "Compression Bandages", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Wraps, Elastic Compression", "MN": "E07.101.400", "FX": "Stockings, Compression", "MH_TH": "NLM (2011)", "ST": "T074", "PI": "Bandages (1964-2010)", "MS": "Strips of elastic material used to apply pressure to body parts to control EDEMA and aid circulation.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058128"}, {"RECTYPE": "D", "MH": "Zygnematales", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.150.990", "MH_TH": "NLM (2011)", "ST": "T002", "RN": "txid3176", "PI": "Chlorophyta (1994-2010)", "MS": "An order of freshwater algae possessing unbranched filaments. Sexual reproduction takes place via conjugation.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058129"}, {"RECTYPE": "D", "MH": "Mougeotia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.150.990.550", "MH_TH": "NLM (2011)", "ST": "T002", "RN": "txid13157", "PI": "Chlorophyta (1978-2010)", "MS": "A genus of filamentous algae in the order ZYGNEMATALES, family Zygnemataceae, that possess CHLOROPLASTS that can orient to the direction of light.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058130"}, {"RECTYPE": "D", "MH": "Spirogyra", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.150.990.800", "MH_TH": "NLM (1998)", "ST": "T002", "RN": "txid3179", "PI": "Chlorophyta (1983-2010)", "MS": "A genus of filamentous algae in the order ZYGNEMATALES, family Zygnemataceae, named for the helical arrangement of its CHLOROPLASTS. It is commonly found in freshwater habitats.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058131"}, {"RECTYPE": "D", "MH": "Achaete-Scute Complex Genome Region", "AQ": "DE GE IM PH RE", "ENTRY": "Gene Complices, Achaete-Scute", "MN": "G05.360.340.024.380.124", "MH_TH": "NLM (2011)", "ST": "T028", "MS": "A genomic region found in DROSOPHILA. The region contains genes encoding BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS that play a critical role in the regulation of pattern formation during EMBRYONIC DEVELOPMENT.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058145"}, {"RECTYPE": "D", "MH": "22q11 Deletion Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, 22q11 Deletion", "MN": "C19.642.482.500", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Chromosomes, Human, Pair 22 (1997-2010)", "MS": "Condition with a variable constellation of phenotypes due to deletion polymorphisms at chromosome location 22q11. It encompasses several syndromes with overlapping abnormalities including the DIGEORGE SYNDROME, VELOCARDIOFACIAL SYNDROME, and CONOTRUNCAL AMOMALY FACE SYNDROME. In addition, variable developmental problems and schizoid features are also associated with this syndrome. (From BMC Med Genet. 2009 Feb 25;10:16) Not all deletions at 22q11 result in the 22q11deletion syndrome.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058165"}, {"RECTYPE": "D", "MH": "Magnetite Nanoparticles", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "PRINT ENTRY": "Superparamagnetic Magnetite Nanoparticles|T130|NON|NRW|NLM (2021)|200306|abcdef", "ENTRY": "Superparamagnetic Magnetite Nanoparticle", "MN": "J01.637.512.600.500.144.500", "PA": "Contrast Media", "MH_TH": "NLM (2010)", "ST": "T197", "RN": "0", "MS": "Synthesized magnetic particles under 100 nanometers used in many biomedical applications including DRUG DELIVERY SYSTEMS and CONTRAST AGENTS. The particles are usually coated with a variety of polymeric compounds.", "PM": "2011; see FERROSOFERRIC OXIDE 2010", "HN": "2011; use FERROSOFERRIC OXIDE 2010", "MR": "20200612", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058185"}, {"RECTYPE": "D", "MH": "Acute Kidney Injury", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Renal Insufficiencies, Acute", "MN": "C12.950.419.780.050", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "traumatic kidney injury: index KIDNEY/ inj", "MS": "Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.", "PM": "2011; for KIDNEY FAILURE, ACUTE see KIDNEY FAILURE, ACUTE 1967-2010; for RENAL INSUFFICIENCY, ACUTE see RENAL INSUFFICIENCY, ACUTE 1993-2010", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058186"}, {"RECTYPE": "D", "MH": "Tooth Bleaching Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Whitening Agents, Tooth", "MN": "D27.720.642.315.500", "FX": "Tooth Bleaching", "MH_TH": "NLM (2011)", "ST": "T120", "RN": "0", "PI": "Tooth Bleaching (1973-2010)", "MS": "Chemicals that are used to oxidize pigments in TEETH and thus effect whitening.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058205"}, {"RECTYPE": "D", "MH": "Hair Bleaching Agents", "AQ": "AD AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO TU", "ENTRY": "Lightening Agents, Hair", "MN": "D27.720.642.315.249", "MH_TH": "NLM (2011)", "ST": "T120", "RN": "0", "PI": "Hair Preparations (1980-2010)", "MS": "Chemicals that are used to oxidize pigments in HAIR.", "PM": "2011", "HN": "2011", "MR": "20190501", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058206"}, {"RECTYPE": "D", "MH": "Sumoylation", "AQ": "DE ES GE IM PH RE", "ENTRY": "Sumoylations", "MN": "G05.308.670.600.831.500", "MH_TH": "NLM (2011)", "ST": "T070", "PI": "Small Ubiquitin-Related Modifier Proteins (2001-2010)", "MS": "A type of POST-TRANSLATIONAL PROTEIN MODIFICATION by SMALL UBIQUITIN-RELATED MODIFIER PROTEINS (also known as SUMO proteins).", "PM": "2011", "HN": "2011", "MR": "20160701", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058207"}, {"RECTYPE": "D", "MH": "Plaque, Amyloid", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Plaques, Amyloid|T020|T046|NON|EQV|NLM (2011)|091231|abbcdef", "ENTRY": "Senile Plaque", "MN": "C23.300.821", "FX": "Amyloidosis", "MH_TH": "NLM (2011)", "ST": "T046", "AN": "coordinate with anatomical heading/ pathol for location of plaque deposit", "MS": "Accumulations of extracellularly deposited AMYLOID FIBRILS within tissues.", "PM": "2011; see SENILE PLAQUES 1997-2010", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058225"}, {"RECTYPE": "D", "MH": "Plaque, Atherosclerotic", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "PRINT ENTRY": "Atheromatous Plaque|T031|T046|NON|NRW|NLM (2021)|200304|abbcdef", "ENTRY": "Streak, Arterial Fatty", "MN": "C23.300.823", "FX": "Coronary Artery Disease", "MH_TH": "NLM (2011)", "ST": "T046", "PI": "Atherosclerosis/pathology (1963-2010)", "MS": "Lesions formed within the walls of ARTERIES associated with deposits of fat and other substances that accumulate in the lining of the artery wall.", "PM": "2011; for FATTY STREAK, ARTERIAL see ATHEROSCLEROSIS 1963-2010; for ATHEROMA see ATHEROSCLEROSIS 1984-2010", "HN": "2011; for FATTY STREAK, ARTERIAL use ATHEROSCLEROSIS 1963-2010; for ATHEROMA use ATHEROSCLEROSIS 1984-2010", "MR": "20220708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058226"}, {"RECTYPE": "D", "MH": "Amyloidogenic Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Amyloidogenic Protein|T116|T123|NON|EQV|NLM (2022)|200720|abbcdef", "ENTRY": "Proteins, Amyloidogenic", "MN": "D12.776.049.407", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "PI": "Amyloid (2004-2010)", "MS": "Proteins that form the core of amyloid fibrils. For example, the core of amyloid A is formed from amyloid A protein, also known as serum amyloid A protein or SAA protein.", "PM": "2011; see AMYLOID 2004-2010", "HN": "2011; use AMYLOID 2004-2010", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058227"}, {"RECTYPE": "D", "MH": "Islet Amyloid Polypeptide", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Polypeptide, Islet Amyloid", "MN": "D12.776.049.407.500", "PA": "Appetite Depressants", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A pancreatic beta-cell hormone that is co-secreted with INSULIN. It displays an anorectic effect on nutrient metabolism by inhibiting gastric acid secretion, gastric emptying and postprandial GLUCAGON secretion. Islet amyloid polypeptide can fold into AMYLOID FIBRILS that have been found as a major constituent of pancreatic AMYLOID DEPOSITS.", "PM": "2011; AMYLIN now ISLET AMYLOID POLYPEPTIDE was indexed under AMYLOID 1987-2010", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058228"}, {"RECTYPE": "D", "MH": "Cognitive Reserve", "AQ": "CL DE ES PH RE", "ENTRY": "Reserves, Cognitive", "MN": "F02.463.188.331", "MH_TH": "NLM (2011)", "ST": "T041", "PI": "Cognition (1992-2010)", "MS": "Capacity that enables an individual to cope with and/or recover from the impact of a neural injury or a psychotic episode.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058245"}, {"RECTYPE": "D", "MH": "Prehypertension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pre-Hypertension|T033|T046|NON|EQV|NLM (2011)|091209|abbcdef", "ENTRY": "Prehypertensions", "MN": "C14.907.653", "MH_TH": "NLM (2011)", "ST": "T046", "PI": "Hypertension (1963-2010)", "MS": "Blood pressure levels that are between normotension and hypertension. Individuals with prehypertension are at a higher risk for developing cardiovascular diseases. Generally, prehypertension is defined as SYSTOLIC PRESSURE of 131-139 mm Hg and/or DIASTOLIC PRESSURE of 81-89 when the optimal is 120/80 mm Hg. For diabetics and other metabolism diseases the prehypertension is around 110-129/70-79 mm Hg.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058246"}, {"RECTYPE": "D", "MH": "Loose Anagen Hair Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Loose Anagen", "MN": "C23.300.035.500", "MH_TH": "ORD (2010)", "ST": "T184", "PI": "Hair Diseases (1990-2010)", "MS": "Benign childhood alopecia that improves spontaneously with aging. It is characterized by anagen hairs (misshapen hair bulbs and absent inner and outer root sheaths), thin, and sparse hairs that pulls out easily.", "PM": "2011", "HN": "2011", "MR": "20120703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058247"}, {"RECTYPE": "D", "MH": "Serum Bactericidal Antibody Assay", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Bactericidal Antibody Assays", "MN": "E05.478.594.760.845", "FX": "Blood Bactericidal Activity", "MH_TH": "NLM (2011)", "ST": "T059", "AN": "do not confuse with SERUM BACTERICIDAL TEST (bactericidal activity in serum after antimicrobial therapy) or BLOOD BACTERICIDAL ACTIVITY (natural bactericidal property of blood)", "MS": "Procedures for identification and measurement of IMMUNOGLOBULINS in the blood that initiate lysis of bacteria.", "PM": "2011", "HN": "2011", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058248"}, {"RECTYPE": "D", "MH": "Birt-Hogg-Dube Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fibrofolliculomas with Trichodiscomas and Acrochordons|T047|NON|EQV|GHR (2014)|NLM (2011)|OMIM (2013)|ORD (2010)|091209|abcdeeeef", "ENTRY": "Birt Hogg Dube Syndrome", "MN": "C16.320.700.212", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Autosomal dominant neoplastic syndrome characterised by genodermatosis, lung cysts, spontaneous and recurrent PNEUMOTHORAX; and RENAL CANCER. It is associated with mutations in the folliculin protein gene (FLCN protein).", "PM": "2011", "HN": "2011", "MR": "20180629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058249"}, {"RECTYPE": "D", "MH": "Dental Restoration Repair", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Restoration Repairs, Dental", "MN": "E07.695.190.190.250", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "The process of repairing broken or worn parts of a PERMANENT DENTAL RESTORATION.", "PM": "2011", "HN": "2011", "MR": "20230705", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058250"}, {"RECTYPE": "D", "MH": "Ctenocephalides", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Fleas, Cat", "MN": "B01.050.500.131.617.720.500.500.968.200", "MH_TH": "NLM (2011)", "ST": "T204", "RN": "txid7514", "RR": "txid7515", "AN": "infestation: coordinate IM with FLEA INFESTATIONS (IM); for killing Ctenocephalides with insecticides, see note at INSECTICIDES", "PI": "Siphonaptera (1963-2010)", "MS": "A genus of FLEAS in the family Pulicidae. It includes the cat flea (Ctenocephalides felis), one of the most common species on earth.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058251"}, {"RECTYPE": "D", "MH": "Necrobiotic Xanthogranuloma", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Xanthogranulomas, Necrobiotic", "MN": "C23.550.382.984", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Xanthomatosis (1980-2010)", "MS": "A cutaneous necrobiotic disorder characterized by firm, yellow plaques or nodules, often in a periorbital distribution. It is often accompanied by an elevated ERYTHROCYTE SEDIMENTATION RATE; LEUKOPENIA; and MONOCLONAL GAMMOPATHY (IgG-kappa type) and systemic involvement.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058252"}, {"RECTYPE": "D", "MH": "Tunga", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Tunga penetrans|T204|NON|NRW|NLM (2011)|091210|abcdef", "ENTRY": "Jigger Fleas", "MN": "B01.050.500.131.617.720.500.500.968.800", "MH_TH": "NLM (2011)", "ST": "T204", "RN": "txid140713", "RR": "txid214035", "PI": "Siphonaptera (1963-2010)", "MS": "A genus of parasitic fleas in the family Pulicidae. They are found mainly in Africa, South America, and Central America.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058253"}, {"RECTYPE": "D", "MH": "Stretchers", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Patient Holding Stretchers|T073|NON|EQV|NLM (2011)|091210|abcdef", "ENTRY": "Wheeled Stretcher", "MN": "N02.421.297.879.550", "FX": "Transportation of Patients", "MH_TH": "NLM (2011)", "ST": "T073", "PI": "Transportation of Patients (1963-2010)", "MS": "Bed-like structures for transporting or temporarily holding patients.", "PM": "2011", "HN": "2011", "MR": "20150629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058254"}, {"RECTYPE": "D", "MH": "Protease Nexins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protease-Associated Nexin", "MN": "D12.776.815.468", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "Extracellular protease inhibitors that are secreted from FIBROBLASTS. They form a covalent complex with SERINE PROTEASES and can mediate their cellular internalization and degradation.", "PM": "2011; PROTEASE NEXINS was indexed under RECEPTORS, CELL SURFACE and AMYLOID BETA-PROTEIN PRECURSOR 2006-2010, and under CARRIER PROTEINS 2004-2005", "HN": "2011", "MR": "20220712", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058255"}, {"RECTYPE": "D", "MH": "Brain Waves", "AQ": "DE GE IM PH RE", "ENTRY": "Brainwave", "MN": "G11.561.127", "MH_TH": "NLM (2011)", "ST": "T042", "PI": "Electroencephalography (1966-2010)", "MS": "Wave-like oscillations of electric potential between parts of the brain recorded by EEG.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058256"}, {"RECTYPE": "D", "MH": "Surgical Attire", "AQ": "AE CL EC ES HI LJ MI PS SD SN ST TD VE VI", "ENTRY": "Surgical Shoe Cover", "MN": "E07.858.594", "MH_TH": "NLM (2011)", "ST": "T073", "MS": "Sterile clothing worn during surgical procedures to protect the surgical site from sources of contamination.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058257"}, {"RECTYPE": "D", "MH": "Serpin E2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Nexin I, Protease", "MN": "D12.776.872.695.850", "PA": "Serine Proteinase Inhibitors", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A protease nexin and serpin subtype that is specific for several SERINE PROTEASES including UROKINASE; THROMBIN; TRYPSIN; and PLASMINOGEN ACTIVATORS.", "PM": "2011; SERPIN E2 was indexed under RECEPTORS, CELL SURFACE and AMYLOID BETA-PROTEINS PRECURSOR 2006-2010, and under CARRIER PROTEINS 2004-2005", "HN": "2011; use PROTEASE NEXINS 2004-2010", "MR": "20220712", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058258"}, {"RECTYPE": "D", "MH": "Xenopsylla", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Rat Fleas, Oriental", "MN": "B01.050.500.131.617.720.500.500.968.950", "MH_TH": "NLM (2011)", "ST": "T204", "RN": "txid163158", "RR": "txid163159", "AN": "infestation: coordinate IM with FLEA INFESTATIONS (IM); for killing Xenopsylla with insecticides, see note at INSECTICIDES", "PI": "Siphonaptera (1964-2010)", "MS": "A genus of fleas in the family Pulicidae which includes the species that serves as the primary vector of BUBONIC PLAGUE, Xenopsylla cheopis.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058260"}, {"RECTYPE": "D", "MH": "Receptor Activity-Modifying Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor Activity Modifying Proteins", "MN": "D12.776.543.725", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A family of proteins that bind to CELL SURFACE RECEPTORS and alter their specificity, signaling mechanism, or mode of intracellular transport.", "PM": "2011; RECEPTOR ACTIVITY-MODIFYING PROTEINS was indexed under MEMBRANE PROTEINS and INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 1998-2010", "HN": "2011", "MR": "20170630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058261"}, {"RECTYPE": "D", "MH": "Receptor Activity-Modifying Protein 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor Activity Modifying Protein 1", "MN": "D12.776.543.725.100", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1998-2010)", "MS": "A receptor activity-modifying protein that is a subunit of specific G-PROTEIN COUPLED RECEPTORS. The CALCITONIN GENE-RELATED PEPTIDE RECEPTOR is formed from a dimer of this protein and CALCITONIN RECEPTOR-LIKE PROTEIN, while an isoform of the ISLET AMYLOID POLYPEPTIDE RECEPTOR is formed from this protein dimerizing with the CALCITONIN RECEPTOR.", "PM": "2011", "HN": "2011", "MR": "20170630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058262"}, {"RECTYPE": "D", "MH": "Receptor Activity-Modifying Protein 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor Activity Modifying Protein 2", "MN": "D12.776.543.725.200", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1998-2010)", "MS": "A receptor activity-modifying protein that heterodimerizes with CALCITONIN RECEPTOR-LIKE PROTEIN to form the ADRENOMEDULLIN RECEPTOR. In addition, an isoform of the ISLET AMYLOID POLYPEPTIDE RECEPTOR is formed from this protein dimerizing with the CALCITONIN RECEPTOR.", "PM": "2011", "HN": "2011", "MR": "20170630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058263"}, {"RECTYPE": "D", "MH": "Receptor Activity-Modifying Protein 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor Activity Modifying Protein 3", "MN": "D12.776.543.725.300", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1998-2010)", "MS": "A receptor activity-modifying protein that heterodimerizes with CALCITONIN RECEPTOR-LIKE PROTEIN to form the ADRENOMEDULLIN RECEPTOR. In addition, an isoform of the ISLET AMYLOID POLYPEPTIDE RECEPTOR is formed from this protein dimerizing with the CALCITONIN RECEPTOR.", "PM": "2011", "HN": "2011", "MR": "20170630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058264"}, {"RECTYPE": "D", "MH": "Receptors, Adrenomedullin", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, Adrenomedullin", "MN": "D12.776.543.750.750.049", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "G-protein-coupled cell surface receptors for ADRENOMEDULLIN. They are formed by the heterodimerization of CALCITONIN RECEPTOR-LIKE PROTEIN and either RECEPTOR ACTIVITY-MODIFYING PROTEIN 2 or RECEPTOR ACTIVITY-MODIFYING PROTEIN 3.", "PM": "2011; RECEPTORS, ADRENOMEDULLIN was indexed under RECEPTORS, PEPTIDE 2001-2010, under MEMBRANE PROTEINS 1999-2000, and under RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE 1995", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058265"}, {"RECTYPE": "D", "MH": "Dielectric Spectroscopy", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Spectroscopy, Impedance", "MN": "E05.196.867.335", "MH_TH": "NLM (2011)", "ST": "T059", "PI": "Electrical Impedance (1993-2010)", "MS": "A technique of measuring the dielectric properties of materials, which vary over a range of frequencies depending on the physical properties of the material. The technique involves measuring, over a range of frequencies, ELECTRICAL IMPEDANCE and phase shift of an electric field as it passes through the material.", "PM": "2011", "HN": "2011", "MR": "20130709", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058266"}, {"RECTYPE": "D", "MH": "Flea Infestations", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infestations, Flea", "MN": "C01.610.858.211.250", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "coordinate IM with specific flea (IM)", "PI": "Ectoparasitic Infestations (1969-2010)", "MS": "Parasitic attack by members of the order SIPHONAPTERA.", "PM": "2011", "HN": "2011", "MR": "20190617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058267"}, {"RECTYPE": "D", "MH": "Tungiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C01.610.858.211.250.800", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Skin Diseases, Parasitic (1972-2010)", "MS": "An infestation with the flea TUNGA PENETRANS causing inflammation, pruritus, and pain, in both humans and other mammals. There is a high incidence of secondary infections such as BACTEREMIA and TETANUS.", "PM": "2011", "HN": "2011", "MR": "20190617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058285"}, {"RECTYPE": "D", "MH": "Calcitonin Receptor-Like Protein", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Calcitonin Receptor-Like Receptor|T116|T192|NON|EQV|NLM (2011)|091214|abbcdef", "ENTRY": "Receptor-Like Receptor, Calcitonin", "MN": "D12.776.543.750.695.011", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A receptor protein that is associated with RECEPTOR ACTIVITY-MODIFYING PROTEINS. When bound to RECEPTOR ACTIVITY-MODIFYING PROTEIN 1 it forms the CALCITONIN GENE-RELATED RECEPTOR. When bound to RECEPTOR ACTIVITY-MODIFYING PROTEIN 2 or RECEPTOR ACTIVITY-MODIFYING PROTEIN 3 it forms the ADRENOMEDULLIN RECEPTOR.", "PM": "2011; CALCITONIN RECEPTOR-LIKE PROTEIN was indexed under RECEPTORS, CALCITONIN 1998-2010", "HN": "2011", "MR": "20160115", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058286"}, {"RECTYPE": "D", "MH": "Receptors, Islet Amyloid Polypeptide", "AQ": "AD AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, Amylin", "MN": "D12.776.543.750.695.360", "EC": "agonists:Amylin Receptor Agonists", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "G-protein coupled receptors that are formed through the dimerization of the CALCITONIN RECEPTOR with a RECEPTOR ACTIVITY-MODIFYING PROTEIN. Their affinity for ISLET AMYLOID POLYPEPTIDE is dependent upon which of several receptor activity-modifying protein subtypes they are bound to.", "PM": "2011; AMYLIN RECEPTOR (now RECEPTORS, ISLET AMYLOID POLYPEPTIDE) was indexed under RECEPTORS, PEPTIDE 1994-2010, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058287"}, {"RECTYPE": "D", "MH": "Sister Mary Joseph's Nodule", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Sister Josephs Nodule", "MN": "C04.588.033.740", "MH_TH": "NLM (2011)", "ST": "T191", "PI": "Umbilicus/pathology (1969-2010)", "MS": "Metastatic lesion of the UMBILICUS associated with intra-abdominal neoplasms especially of the GASTROINTESTINAL TRACT or OVARY.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058288"}, {"RECTYPE": "D", "MH": "Sorting Nexins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sorting Nexin", "MN": "D12.776.543.990.150.875", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A large family of phosphatidylinositol phosphate-binding proteins that are involved in mediating intracellular transport and sorting of proteins via a variety of endocytic pathways.", "PM": "2011; SORTING NEXINS was indexed under VESICULAR TRANSPORT PROTEINS and CARRIER PROTEINS 2006-2010", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058305"}, {"RECTYPE": "D", "MH": "Receptors, Prostaglandin E, EP1 Subtype", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "EP1, Prostanoid Receptor", "MN": "D12.776.543.750.695.200.700.600.100", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A subtype of prostaglandin E receptors that specifically couples to GTP-BINDING PROTEIN ALPHA SUBUNIT, GQ and the subsequently activates TYPE C PHOSPHOLIPASES. Additional evidence has shown that the receptor can act through a calcium-dependent signaling pathway.", "PM": "2011; PROSTANOID RECEPTOR EP1 (now RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE) was indexed under RECEPTORS, PROSTAGLANDIN E 1995-2010", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058306"}, {"RECTYPE": "D", "MH": "Receptors, Prostaglandin E, EP2 Subtype", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor EP2, Prostanoid", "MN": "D12.776.543.750.695.200.700.600.200", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A subtype of prostaglandin E receptors that specifically couples to GS ALPHA GTP-BINDING PROTEIN SUBUNITS and subsequently activates ADENYLYL CYCLASES.", "PM": "2011; PROSTAGLANDIN EP2 RECEPTOR (now RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE) was indexed under RECEPTORS, PROSTAGLANSDIN E 1998-2010", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058307"}, {"RECTYPE": "D", "MH": "Receptors, Prostaglandin E, EP3 Subtype", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor EP3, Prostanoid", "MN": "D12.776.543.750.695.200.700.600.300", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A subtype of prostaglandin E receptors that specifically couples to GTP-BINDING PROTEIN ALPHA SUBUNIT, GI and subsequently inhibits ADENYLYL CYCLASES.", "PM": "2011; PROSTAGLANDIN EP3 RECEPTOR (now RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE) was indexed under RECEPTORS, PROSTAGLANDIN E 1997-2010", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058308"}, {"RECTYPE": "D", "MH": "Receptors, Prostaglandin E, EP4 Subtype", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, Prostaglandin EP4", "MN": "D12.776.543.750.695.200.700.600.400", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A subtype of prostaglandin E receptors that specifically couples to GS ALPHA GTP-BINDING PROTEIN SUBUNITS and subsequently activates ADENYLYL CYCLASES. The receptor may also signal through the activation of PHOSPHATIDYLINOSITOL 3-KINASE.", "PM": "2011; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE was indexed under RECEPTORS, PROSTAGLANDIN E 1996-2010", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058309"}, {"RECTYPE": "D", "MH": "Amblycera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "MN": "B01.050.500.131.617.690.050", "MH_TH": "NLM (1999)", "ST": "T204", "RN": "txid50629", "AN": "infestation: coordinate IM with LICE INFESTATIONS (IM); for killing Amblycera with insecticides, see note at INSECTICIDES", "PI": "Phthiraptera (1983-2010)", "MS": "A suborder of chewing lice, in the order PHTHIRAPTERA, that are ectoparasites of poultry and some mammals.", "PM": "2011; see MALLOPHAGA 1999-2010", "HN": "2011; use PHTHIRAPTERA 1999-2010", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058325"}, {"RECTYPE": "D", "MH": "Ischnocera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Damalinia|T204|NON|NRW|NLM (1999)|971103|abcdef", "MN": "B01.050.500.131.617.690.450", "MH_TH": "NLM (1999)", "ST": "T204", "RN": "txid35634", "RR": "txid160096", "AN": "infestation: coordinate IM with LICE INFESTATIONS (IM); for killing Ischnocera with insecticides, see note at INSECTICIDES", "PI": "Phthiraptera (1970-2010)", "MS": "A suborder of chewing lice, in the order PHTHIRAPTERA, that are parasites of birds and mammals.", "PM": "2011; see MALLOPHAGA 1999-2010", "HN": "2011; use PHTHIRAPTERA 1999-2010", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058326"}, {"RECTYPE": "D", "MH": "Norwood Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Norwood Procedure|T061|NON|EQV|NLM (2011)|091218|abcdef", "ENTRY": "Procedures, Norwood", "MN": "E04.928.220.560", "MH_TH": "NLM (2011)", "ST": "T061", "AN": "NORWOOD PROCEDURE, STAGE 2 and NORWOOD PROCEDURE, STAGE 3 see FONTAN PROCEDURE are also available", "PI": "Hypoplastic Left Heart Syndrome/surgery (1995-2010)", "MS": "A set of surgical procedures performed to establish sufficient outflow to the systemic circulation in individuals with univentricular congenital heart malformations, such as HYPOPLASTIC LEFT HEART SYNDROME, and MITRAL VALVE atresia, associated with systemic outflow obstruction. Follow-on surgeries may be performed and consist of a HEMI-FONTAN PROCEDURE as the stage 2 Norwood procedure and a FONTAN PROCEDURE as the stage 3 Norwood procedure.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058327"}, {"RECTYPE": "D", "MH": "Asymptomatic Infections", "AQ": "CL EC EP MO NU PX RH TH", "PRINT ENTRY": "Subclinical Infections|T047|NON|EQV|NLM (2011)|091110|abcdef", "ENTRY": "Subclinical Infection", "MN": "C23.550.291.187.500", "MH_TH": "NLM (2011)", "ST": "T047", "MS": "Infections that do not exhibit symptoms.", "PM": "2011", "HN": "2011", "MR": "20200617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058345"}, {"RECTYPE": "D", "MH": "Candidiasis, Invasive", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Invasive Candidiasis", "MN": "C01.150.703.492.500", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Candidiasis (1978-2010)", "MS": "An important nosocomial fungal infection with species of the genus CANDIDA, most frequently CANDIDA ALBICANS. Invasive candidiasis occurs when candidiasis goes beyond a superficial infection and manifests as CANDIDEMIA, deep tissue infection, or disseminated disease with deep organ involvement.", "PM": "2011", "HN": "2011", "MR": "20190617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058365"}, {"RECTYPE": "D", "MH": "Blalock-Taussig Procedure", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Taussig Shunt, Blalock", "MN": "E04.100.814.868.374", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "A cardiovascular procedure performed to create a blood supply to the PULMONARY CIRCULATION. It involves making a connection between the subclavian, or carotid branch of the AORTA, or the AORTIC ARCH to the PULMONARY ARTERY.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058366"}, {"RECTYPE": "D", "MH": "Cardiac Valve Annuloplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Valvular Annuloplasties", "MN": "E04.928.220.109", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Heart Valves/surgery (1972-2010)", "MS": "A type of heart valve surgery that involves the repair, replacement, or reconstruction of the annuli of HEART VALVES. It includes shortening the circumference of the annulus to improve valve closing capacity and reinforcing the annulus as a step in more complex valve repairs.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058385"}, {"RECTYPE": "D", "MH": "Mitral Valve Annuloplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Valve Annuloplasty, Mitral", "MN": "E04.928.220.109.500", "MH_TH": "NLM (2011)", "ST": "T061", "AN": "mitral ring annuloplasty (where \"ring\" refers to a prosthesis): coordinate MITRAL VALVE ANNULOPLASTY with HEART VALVE PROSTHESIS IMPLANTATION", "PI": "Mitral Valve/surgery (1965-2010)", "MS": "A type of heart valve surgery that involves the repair, replacement, or reconstruction of the annulus of the MITRAL VALVE. It includes shortening the circumference of the annulus to improve valve closing capacity and reinforcing the annulus as a step in more complex valve repairs.", "PM": "2011", "HN": "2011", "MR": "20130709", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058386"}, {"RECTYPE": "D", "MH": "Candidemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "MN": "C23.550.470.790.500.360.150", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Fungemia (1991-2010)", "MS": "A form of invasive candidiasis where species of CANDIDA are present in the blood.", "PM": "2011", "HN": "2011", "MR": "20190617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058387"}, {"RECTYPE": "D", "MH": "Desmoplastic Small Round Cell Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Tumors, Desmoplastic Small-Cell", "MN": "C04.557.450.795.315", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "MS": "A rare, aggressive soft tissue sarcoma that primarily affects adolescents and young adults. It is most commonly found in the abdomen.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058405"}, {"RECTYPE": "D", "MH": "Cardiac Resynchronization Therapy", "AQ": "AE CL EC ES HI MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Cardiac Resynchronization", "MN": "E02.331.200.500", "FX": "Cardiac Resynchronization Therapy Devices", "EC": "instrumentation:Cardiac Resynchronization Therapy Devices", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Cardiac Pacing, Artificial (1987-2010)", "MS": "The restoration of the sequential order of contraction and relaxation of the HEART ATRIA and HEART VENTRICLES by atrio-biventricular pacing.", "PM": "2011", "HN": "2011", "MR": "20150706", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058406"}, {"RECTYPE": "D", "MH": "Electroencephalography Phase Synchronization", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Phase Synchronization, EEG|T042|T060|ABX|EQV|NLM (2011)|100105|abbcdef", "ENTRY": "Synchrony, Electroencephalography Phase", "MN": "G07.265.256", "FX": "Evoked Potentials", "MH_TH": "NLM (2011)", "ST": "T060", "PI": "Electroencephalography (1999-2010)", "MS": "Adjustment of BRAIN WAVES from two or more neuronal groups within or across a brain structure (e.g., cortical and limbic brain structures) to become uniform in EEG oscillation patterns in response to a stimulus. It is interpreted as a brain integration sign during many processes such as learning, memory, and perception and involves reciprocal neural connections.", "PM": "2011", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058407"}, {"RECTYPE": "D", "MH": "Th1-Th2 Balance", "AQ": "DE GE PH RE", "ENTRY": "Th1-Th2 Cytokine Balances", "MN": "G12.838", "FX": "CD4 Lymphocyte Count", "MH_TH": "NLM (2011)", "ST": "T040", "PI": "Th2 Cells (1995-2010)", "MS": "Homeostatic control of the IMMUNE SYSTEM by different CYTOKINES that induce the differentiation of HELPER T-CELLS into TH1 and TH2 CELLS and result in a balance or imbalance (leading to disease) of Th1 and Th2 cells' immune responses.", "PM": "2011", "HN": "2011", "MR": "20170414", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058408"}, {"RECTYPE": "D", "MH": "Cardiac Resynchronization Therapy Devices", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Cardiac Resynchronization Therapy Device|T074|NON|EQV|NLM (2022)|200824|abcdef", "ENTRY": "Pacemakers, Artificial Biventricular", "MN": "E07.305.250.750.500", "FX": "Cardiac Resynchronization Therapy", "MH_TH": "NLM (2011)", "ST": "T074", "PI": "Pacemaker, Artificial (2000-2010)", "MS": "Types of artificial pacemakers with implantable leads to be placed at multiple intracardial sites. They are used to treat various cardiac conduction disturbances which interfere with the timing of contraction of the ventricles. They may or may not include defibrillating electrodes (IMPLANTABLE DEFIBRILLATORS) as well.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058409"}, {"RECTYPE": "D", "MH": "Vaccines, Virus-Like Particle", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME MI PD PO RE SD ST TO TU UL UR VI", "PRINT ENTRY": "Virus-Like Particle Vaccines|T121|T129|NON|EQV|NLM (2011)|100107|abbcdef", "ENTRY": "Virus Like Particle Vaccines", "MN": "D23.050.865.955", "MH_TH": "NLM (2011)", "ST": "T129", "RN": "0", "PI": "Viral Vaccines (1997-2010)", "MS": "Vaccines using supra-molecular structures composed of multiple copies of recombinantly expressed viral structural proteins. They are often antigentically indistinguishable from the virus from which they were derived.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058425"}, {"RECTYPE": "D", "MH": "Neointima", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neointimas", "MN": "C23.550.722", "FX": "Tunica Intima", "MH_TH": "NLM (2011)", "ST": "T047", "MS": "The new and thickened layer of scar tissue that forms on a PROSTHESIS, or as a result of vessel injury especially following ANGIOPLASTY or stent placement.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058426"}, {"RECTYPE": "D", "MH": "Hygroscopic Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Hygroscopic Agent|T130|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Agents, Hygroscopic", "MN": "D27.720.375", "FX": "Desiccation", "MH_TH": "NLM (2011)", "ST": "T130", "RN": "0", "PI": "Desiccation (1977-2010)", "MS": "Materials that readily absorb moisture from their surroundings.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058427"}, {"RECTYPE": "D", "MH": "Silica Gel", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Gel, Silica", "MN": "D26.255.165.320.687", "PA": "Hygroscopic Agents", "MH_TH": "NLM (2011)", "ST": "T197", "RN": "60650-90-0", "MS": "A non-crystalline form of silicon oxide that has absorptive properties. It is commonly used as a desiccating agent and as a stationary phase for CHROMATOGRAPHY. The fully hydrated form of silica gel has distinct properties and is referred to as SILICIC ACID.", "PM": "2011; SILOCHROME now SILICA GEL was indexed under SILICON DIOXIDE 1978-2010", "HN": "2011", "MR": "20140617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058428"}, {"RECTYPE": "D", "MH": "Gnathostomiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Gnathostoma Infection|T047|NON|EQV|NLM (2011)|100104|abcdef", "ENTRY": "Infections, Gnathostoma", "MN": "C01.610.335.508.700.750.380", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Spirurida Infections (1992-2010)", "MS": "Infections with nematodes of the genus GNATHOSTOMA, superfamily THELAZIOIDEA. Gnathostomiasis is a food-borne zoonosis caused by eating undercooked or raw fish or meat.", "PM": "2011", "HN": "2011", "MR": "20190617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058429"}, {"RECTYPE": "D", "MH": "Humeral Head", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Humerus Heads", "MN": "A02.835.232.087.090.400.400", "MH_TH": "NLM (2011)", "ST": "T023", "PI": "Humerus (1964-2010)", "MS": "The upper rounded extremity of the humerus fitting into the GLENOID CAVITY of the SCAPULA.", "PM": "2011", "HN": "2011", "MR": "20180629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058430"}, {"RECTYPE": "D", "MH": "Brachypodium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Brachypodium distachyon|T002|NON|NRW|NLM (2011)|100105|abcdef", "MN": "B01.875.800.575.912.250.822.072", "MH_TH": "NLM (2011)", "ST": "T002", "RN": "txid15367", "RR": "txid15368", "PI": "Poaceae (1982-2010)", "MS": "A plant genus in the family POACEAE. Brachypodium distachyon is a model species for functional genomics studies.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058431"}, {"RECTYPE": "D", "MH": "Sporangia", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Sporangium|T002|T004|T204|NON|EQV|NLM (2011)|100105|abbbcdef", "MN": "A19.800", "MH_TH": "NLM (2011)", "ST": "T204", "MS": "A structure found in plants, fungi, and algae, that produces and contains spores.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058432"}, {"RECTYPE": "D", "MH": "Photobioreactors", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Photobioreactor", "MN": "J01.897.120.115.600", "MH_TH": "NLM (2011)", "ST": "T072", "PI": "Bioreactors (2003-2010)", "MS": "Devices for generating biological products that use light as the energy source. They are used for controlled BIOMASS production such as growing cyanobacteria, mosses, or algae.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058433"}, {"RECTYPE": "D", "MH": "Knowledge Management", "AQ": "EC SN ST", "ENTRY": "Management, Knowledge", "MN": "N04.452.480", "MH_TH": "NLM (2011)", "ST": "T057", "MS": "The leveraging of collective wisdom within an organization as a catalyst to increase responsiveness and innovation.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058436"}, {"RECTYPE": "D", "MH": "Hypertensive Retinopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Retinopathy, Hypertensive", "MN": "C14.907.489.815", "FX": "Ocular Hypertension", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Retinal Diseases (1971-2010)", "MS": "Degenerative changes to the RETINA due to HYPERTENSION.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058437"}, {"RECTYPE": "D", "MH": "Water Cycle", "AQ": "DE GE IM PH RE", "ENTRY": "Water Cycles", "MN": "G16.500.943", "FX": "Water Movements", "MH_TH": "NLM (2011)", "ST": "T067", "PI": "Water Supply (1980-2010)", "MS": "Circulation of water among various ecological systems, in various states, on, above, and below the surface of the earth.", "PM": "2011", "HN": "2011", "MR": "20160623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058438"}, {"RECTYPE": "D", "MH": "Plant Somatic Embryogenesis Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Somatic Embryogenesis, Plant", "MN": "G15.698", "MH_TH": "NLM (2011)", "ST": "T059", "PI": "Tissue Culture/methods (1986-2010)", "MS": "The process of embryo initiation in culture from vegetative, non-gametic, sporophytic, or somatic plant cells.", "PM": "2011", "HN": "2011", "MR": "20160623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058439"}, {"RECTYPE": "D", "MH": "Denitrification", "AQ": "DE GE IM PH RE", "ENTRY": "Denitrifications", "MN": "G16.500.768.249", "FX": "Nitrogen Cycle", "MH_TH": "NLM (2011)", "ST": "T067", "PI": "Nitrates (1963-2010)", "MS": "Nitrate reduction process generally mediated by anaerobic bacteria by which nitrogen available to plants is converted to a gaseous form and lost from the soil or water column. It is a part of the nitrogen cycle.", "PM": "2011", "HN": "2011", "MR": "20160623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058440"}, {"RECTYPE": "D", "MH": "Rhizosphere", "ENTRY": "Rhizospheres", "MN": "N06.230.124.437", "MH_TH": "NLM (2011)", "ST": "T070", "PI": "Soil Microbiology (1963-2010)", "MS": "The immediate physical zone surrounding plant roots that include the plant roots. It is an area of intense and complex biological activity involving plants, microorganisms, other soil organisms, and the soil.", "PM": "2011", "HN": "2011", "MR": "20160623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058441"}, {"RECTYPE": "D", "MH": "Capsule Opacification", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Secondary Cataracts", "MN": "C11.510.245.500", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Lens, Crystalline/pathology (1985-2010)", "MS": "Clouding or loss of transparency of the posterior lens capsule, usually following CATARACT extraction.", "PM": "2011", "HN": "2011", "MR": "20130708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058442"}, {"RECTYPE": "D", "MH": "Catastrophization", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Scattershot Catastrophization|T041|NON|NRW|NLM (2023)|210927|abcdef", "ENTRY": "Thinking, Catastrophic", "MN": "F01.470.132.225", "MH_TH": "NLM (2011)", "ST": "T041", "PI": "Anxiety (1984-2010)", "MS": "Cognitive and emotional processes encompassing magnification of pain-related stimuli, feelings of helplessness, and a generally pessimistic orientation.", "PM": "2011", "HN": "2011", "MR": "20220711", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058443"}, {"RECTYPE": "D", "MH": "Bullying", "AQ": "CL DE ES PC PX SN", "MN": "I01.880.735.070", "MH_TH": "NLM (2011)", "ST": "T054", "PI": "Aggression (1991-2010)", "MS": "Aggressive behavior by a more powerful party that results in physical harm to or emotional distress of the victim.", "PM": "2011", "HN": "2011", "MR": "20230405", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058445"}, {"RECTYPE": "D", "MH": "Ligand-Gated Ion Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ligand-Gated Ion Channel|T116|T192|NON|EQV|NLM (2021)|191115|abbcdef", "ENTRY": "Ligand Gated Ion Channels", "MN": "D12.776.543.585.400.500", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "PI": "Ion Channels (1979-2010)", "MS": "A subclass of ion channels that open or close in response to the binding of specific LIGANDS.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058446"}, {"RECTYPE": "D", "MH": "Eye Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pains, Eye", "MN": "C23.888.592.612.316", "MH_TH": "NLM (2011)", "ST": "T184", "MS": "A dull or sharp painful sensation associated with the outer or inner structures of the eyeball, having different causes.", "PM": "2011", "HN": "2011", "MR": "20170620", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058447"}, {"RECTYPE": "D", "MH": "Biota", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Community Structure, Ecological|T080|NON|REL|NLM (2011)|100421|abcdef", "ENTRY": "Structure, Ecological Community", "MN": "N06.230.124.049.100", "FX": "Microbial Interactions", "MH_TH": "NLM (2004)", "ST": "T080", "MS": "The spectrum of different living organisms inhabiting a particular region, habitat, or biotope.", "PM": "2011; see BIODIVERSITY 2004-2010", "HN": "2011; use BIODIVERSITY 2004-2010", "MR": "20130708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058448"}, {"RECTYPE": "D", "MH": "Intravitreal Injections", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Intravitreal Injection", "MN": "E02.319.267.530.475.500", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Injections (1977-2010)", "MS": "The administration of substances into the VITREOUS BODY of the eye with a hypodermic syringe.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058449"}, {"RECTYPE": "D", "MH": "Endotamponade", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Endotamponades", "MN": "E02.520.392", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Vitrectomy (1991-2010)", "MS": "A method of stopping internal bleeding or blood flow, or the closure of a wound or body cavity, achieved by applying pressure or introducing an absorbent liquid, gel, or tampon.", "PM": "2011", "HN": "2011", "MR": "20150623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058450"}, {"RECTYPE": "D", "MH": "Oxidative Coupling", "AQ": "DE RE", "ENTRY": "Oxidative Couplings", "MN": "G02.700.500", "MH_TH": "NLM (2011)", "ST": "T070", "PI": "Oxidation-Reduction (1967-2010)", "MS": "The reaction of two molecular entities via oxidation usually catalyzed by a transition metal compound and involving dioxygen as the oxidant.", "PM": "2011", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058451"}, {"RECTYPE": "D", "MH": "Axial Length, Eye", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Lengths, Eye Axial", "MN": "E01.370.600.115.100.660.500", "MH_TH": "NLM (2011)", "ST": "T081", "PI": "Biometry (1964-2010)", "MS": "The distance between the anterior and posterior poles of the eye, measured either by ULTRASONOGRAPHY or by partial coherence interferometry.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058452"}, {"RECTYPE": "D", "MH": "Emmetropia", "AQ": "DE GE IM PH RE", "ENTRY": "Emmetropias", "MN": "G14.940.750", "MH_TH": "NLM (2011)", "ST": "T169", "PI": "Refraction, Ocular (1963-2010)", "MS": "The condition of where images are correctly brought to a focus on the retina.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058453"}, {"RECTYPE": "D", "MH": "Retinal Telangiectasis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Coats' Disease|T019|EPO|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Telangiectasis, Retinal", "MN": "C14.907.823.502", "MH_TH": "OMIM (2013)", "ST": "T019", "PI": "Retinal Vessels (1967-2010)", "MS": "A group of rare, idiopathic, congenital retinal vascular anomalies affecting the retinal capillaries. It is characterized by dilation and tortuosity of retinal vessels and formation of multiple aneurysms, with different degrees of leakage and exudates emanating from the blood vessels.", "PM": "2011", "HN": "2011", "MR": "20200116", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058456"}, {"RECTYPE": "D", "MH": "Trichiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Trichiases", "MN": "C11.338.912", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Eyelashes/abnormalities (1970-2010)", "MS": "A disease of the eye in which the eyelashes abnormally turn inwards toward the eyeball producing constant irritation caused by motion of the lids.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058457"}, {"RECTYPE": "D", "MH": "Nitrogen Cycle", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Ammonification|T067|NON|NRW|NLM (2022)|210414|abcdef", "ENTRY": "Nitrogen Cycles", "MN": "G16.500.768", "MH_TH": "NLM (2011)", "ST": "T067", "PI": "Nitrogen (1963-2010)", "MS": "The circulation of nitrogen in nature, consisting of a cycle of biochemical reactions in which atmospheric nitrogen is compounded, dissolved in rain, and deposited in the soil, where it is assimilated and metabolized by animals, plants, bacteria, and fungi, eventually returning to the atmosphere by bacterial decomposition of organic matter.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058458"}, {"RECTYPE": "D", "MH": "Nitrification", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Nitrite Oxidation|T067|NON|NRW|NLM (2022)|210414|abcdef", "ENTRY": "Oxidation, Nitrite", "MN": "G16.500.768.500", "MH_TH": "NLM (2011)", "ST": "T067", "PI": "Oxidation-Reduction (1963-2010)", "MS": "A process facilitated by specialized bacteria involving the oxidations of ammonium to nitrite and nitrite to nitrate.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058465"}, {"RECTYPE": "D", "MH": "Cysteine Loop Ligand-Gated Ion Channel Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Cysteine Loop Ligand-Gated Ion Channel Receptor|T116|T192|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Superfamily, Cys-Loop Receptor", "MN": "D12.776.543.750.130", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A subfamily of ligand-gated ion channel receptors that share a characteristic loop which is formed by a disulfide bond between two CYSTEINE residues. These receptors typically contain five subunits with the cysteine-loop occurring near an N-terminal extracellular domain.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058466"}, {"RECTYPE": "D", "MH": "Tardigrada", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Water Bear", "MN": "B01.050.500.901", "MH_TH": "NLM (2011)", "ST": "T204", "RN": "txid42241", "RR": "txid58670", "PI": "Invertebrates (1973-2010)", "MS": "A phylum of microscopic ecdysozoan invertebrates, closely related to ARTHROPODS. Members exhibit anabiosis and cryptobiosis, dormant states where metabolic activity is reduced or absent, thus making them tolerant to extreme environmental conditions. They are distributed worldwide and most are semi-aquatic.", "PM": "2011", "HN": "2011", "MR": "20200902", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058467"}, {"RECTYPE": "D", "MH": "Receptors, Ionotropic Glutamate", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Ionotropic Glutamate Receptor|T116|T192|NON|EQV|NLM (2021)|200227|abbcdef", "ENTRY": "Receptor, Ionotropic Glutamate", "MN": "D12.776.543.750.720.200.450.400", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A class of ligand-gated ion channel receptors that have specificity for GLUTAMATE. They are distinct from METABOTROPIC GLUTAMATE RECEPTORS which act through a G-protein-coupled mechanism.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058468"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic P2X", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Purinoceptors, P2X", "MN": "D12.776.543.750.720.700.720.500", "EC": "antagonists & inhibitors:Purinergic P2X Receptor Antagonists", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "PI": "Receptors, Purinergic P2 (1994-2010)", "MS": "A subclass of purinergic P2 receptors that signal by means of a ligand-gated ion channel. They are comprised of three P2X subunits which can be identical (homotrimeric form) or dissimilar (heterotrimeric form).", "PM": "2011; PURINERGIC P2X RECEPTOR (now RECEPTORS, PURINERGIC P2X) was indexed under RECEPTORS, PURINERGIC P2 1996-2010", "HN": "2011", "MR": "20160701", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058469"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic P2Y", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Purinoceptors, P2Y", "MN": "D12.776.543.750.720.700.720.750", "EC": "antagonists & inhibitors:Purinergic P2Y Receptor Antagonists", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "PI": "Receptors, Purinergic P2 (1993-2010)", "MS": "A subclass of purinergic P2 receptors whose signaling is coupled through a G-PROTEIN signaling mechanism.", "PM": "2011", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058470"}, {"RECTYPE": "D", "MH": "Subretinal Fluid", "AQ": "CH CY DE DG EN IM ME MI PH PS RE VI", "PRINT ENTRY": "Sub-Retinal Fluid|T031|NON|EQV|NLM (2023)|210830|abcdef", "ENTRY": "Sub Retinal Fluid", "MN": "A12.383.800", "MH_TH": "NLM (2011)", "ST": "T031", "MS": "An exudate between the RETINA and CHOROID from various sources including the vitreous cavity, SUBARACHNOID SPACE, or abnormal vessels.", "PM": "2011", "HN": "2011", "MR": "20220413", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058471"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic P2Y1", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptors, P2Y1", "MN": "D12.776.543.750.720.700.720.750.100", "EC": "antagonists & inhibitors:Purinergic P2Y Receptor Antagonists", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A subclass of purinergic P2Y receptors that have a preference for ATP and ADP. The activated P2Y1 receptor signals through the G-PROTEIN-coupled activation of PHOSPHOLIPASE C and mobilization of intracellular CALCIUM.", "PM": "2011; PURINOCEPTOR P2Y1 (now RECEPTORS, PURINERGIC P2Y1) was indexed under RECEPTORS, PURINERGIC P2 1996-2010", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058472"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic P2Y2", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "P2Y2 Receptor|T116|T192|NON|EQV|NLM (2021)|200317|abbcdef", "ENTRY": "Receptors, P2Y2", "MN": "D12.776.543.750.720.700.720.750.200", "EC": "antagonists & inhibitors:Purinergic P2Y Receptor Antagonists", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A subclass of purinergic P2Y receptors that have a preference for ATP and UTP. The activated P2Y2 receptor acts through a G-PROTEIN-coupled PHOSPHATIDYLINOSITOL and intracellular CALCIUM SIGNALING pathway.", "PM": "2011; PURINERGIC RECEPTOR P2Y2 (now RECEPTORS, PURINERGIC P2Y2) was indexed under RECEPTORS, PURINERGIC P2 1994-2010", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058473"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic P2X1", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, P2X1", "MN": "D12.776.543.750.720.700.720.500.100", "EC": "antagonists & inhibitors:Purinergic P2X Receptor Antagonists", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "PI": "Receptors, Purinergic P2 (1996-2010)", "MS": "A purinergic P2X neurotransmitter receptor found at sympathetically innervated SMOOTH MUSCLE. It may play a functional role regulating the juxtoglomerular apparatus of the KIDNEY.", "PM": "2011; for P2X1 PURINOCEPTOR see RECEPTORS, PURINERGIC P2X 1996-2010", "HN": "2011; for P2X1 PURINOCEPTOR use RECEPTORS, PURINERGIC P2X 1996-2010", "MR": "20160701", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058474"}, {"RECTYPE": "D", "MH": "Tenon Capsule", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tenons Capsule", "MN": "A10.165.425.750", "MH_TH": "NLM (2011)", "ST": "T023", "MS": "Sheath of the eyeball consisting of fascia extending from the OPTIC NERVE to the corneal limbus.", "PM": "2011", "HN": "2011", "MR": "20170620", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058475"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic P2X2", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, P2X2", "MN": "D12.776.543.750.720.700.720.500.200", "EC": "antagonists & inhibitors:Purinergic P2X Receptor Antagonists", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A purinergic P2X neurotransmitter receptor involved in sensory signaling of TASTE PERCEPTION, chemoreception, visceral distension and NEUROPATHIC PAIN. The receptor comprises three P2X2 subunits. The P2X2 subunits also have been found associated with P2X3 RECEPTOR subunits in a heterotrimeric receptor variant.", "PM": "2011; PURINERGIC P2X2 RECEPTOR (now RECEPTORS, PURINERGIC P2X2) was indexed under RECEPTORS, PURINERGIC P2 1995-2010", "HN": "2011", "MR": "20160701", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058476"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic P2X3", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, P2X3", "MN": "D12.776.543.750.720.700.720.500.300", "EC": "antagonists & inhibitors:Purinergic P2X Receptor Antagonists", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A purinergic P2X neurotransmitter receptor involved in sensory signaling of TASTE PERCEPTION, chemoreception, visceral distension, and NEUROPATHIC PAIN. The receptor comprises three P2X3 subunits. The P2X3 subunits are also associated with P2X2 RECEPTOR subunits in a heterotrimeric receptor variant.", "PM": "2011; PURINERGIC P2X3 RECEPTOR (now RECEPTORS, PURINERGIC P2X3) was indexed under RECEPTORS, PURINERGIC 1995-2010", "HN": "2011", "MR": "20160701", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058477"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic P2X5", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Purinoceptors, P2X5", "MN": "D23.050.705.552.600.625", "EC": "antagonists & inhibitors:Purinergic P2X Receptor Antagonists", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A purinergic P2X neurotransmitter receptor found at high levels in the BRAIN and IMMUNE SYSTEM.", "PM": "2011; PURINOCEPTOR P2X5 (now RECEPTORS, PURINERGIC P2X5) was indexed under RECEPTORS, PURINERGIC P2 1996-2010", "HN": "2011", "MR": "20160701", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058485"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic P2X7", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Purinergic P2X7 Receptor|T116|T192|NON|EQV|NLM (2022)|201022|abbcdef", "ENTRY": "Receptor, Purinergic P2X7", "MN": "D12.776.543.750.720.700.720.500.700", "EC": "antagonists & inhibitors:Purinergic P2X Receptor Antagonists", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A purinergic P2X neurotransmitter receptor that plays a role in pain sensation signaling and regulation of inflammatory processes.", "PM": "2011; PURINERGIC P2X7 RECEPTOR (now RECEPTORS, PURINERGIC P2X7) was indexed under RECEPTORS, PURINERGIC P2 1996-2010", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058486"}, {"RECTYPE": "D", "MH": "Cercaria", "AQ": "AH CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "G07.345.500.550.500.500.150", "MH_TH": "NLM (2011)", "ST": "T204", "AN": "do not use / embryol with reference to cercaria", "MS": "The free-swimming larval forms of parasites found in an intermediate host.", "PM": "2011", "HN": "2011", "MR": "20160115", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058487"}, {"RECTYPE": "D", "MH": "Metacercariae", "AQ": "AH CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "G07.345.500.550.500.500.150.500", "MH_TH": "NLM (2011)", "ST": "T204", "AN": "do not use / embryol with reference to metacercariae", "MS": "Encysted cercaria which house the intermediate stages of trematode parasites in tissues of an intermediate host.", "PM": "2011", "HN": "2011", "MR": "20160617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058488"}, {"RECTYPE": "D", "MH": "46, XX Disorders of Sex Development", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pseudohermaphroditisms, Female", "MN": "C19.391.119.064", "MH_TH": "NLM (2011)", "ST": "T047", "MS": "Congenital conditions in individuals with a female karyotype, in which the development of the gonadal or anatomical sex is atypical.", "PM": "2011; for FEMALE PSEUDOHERMAPHRODITISM see PSEUDOHERMAPHRODITISM 2006-2010", "HN": "2011; for FEMALE PSEUDOHERMAPHRODITISM use DISORDERS OF SEX DEVELOPMENT 2006-2010", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058489"}, {"RECTYPE": "D", "MH": "Disorder of Sex Development, 46,XY", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "46, XY Disorders of Sex Development|T019|T047|NON|EQV|NLM (2011)|100119|abbcdef", "ENTRY": "Pseudohermaphroditisms, Male", "MN": "C19.391.119.096", "MH_TH": "OMIM (2013)", "ST": "T047", "MS": "Congenital conditions in individuals with a male karyotype, in which the development of the gonadal or anatomical sex is atypical.", "PM": "2019; for MALE PSEUDOHERMAPHRODITISM see PSEUDOHERMAPHRODITISM 2006-2010", "HN": "2019(2011); for MALE PSEUDOHERMAPHRODITISM use DISORDERS OF SEX DEVELOPMENT 2006-2010", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058490"}, {"RECTYPE": "D", "MH": "Bacterial Load", "AQ": "CL DE EC ES GE HI IM IS MT PH RE SN ST TD VE", "PRINT ENTRY": "Bacterial Count|T034|T081|NON|REL|UNK (19XX)|880408|BACT COUNT|abbcdefv", "ENTRY": "Loads, Bacterial", "MN": "G06.099.100", "MH_TH": "NLM (2011)", "ST": "T081", "MS": "Measurable quantity of bacteria in an object, organism, or organism compartment.", "PM": "2011; for BACTERIAL COUNT see COLONY COUNT, MICROBIAL 1992-2010", "HN": "2011; for BACTERIAL COUNT use COLONY COUNT, MICROBIAL 1992-2010", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058491"}, {"RECTYPE": "D", "MH": "Drug Repositioning", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Rescue, Drug", "MN": "E05.290.875", "FX": "Off-Label Use", "MH_TH": "NLM (2011)", "ST": "T062", "AN": "do not confuse with OFF-LABEL USE", "MS": "The deliberate and methodical practice of finding new applications for existing drugs.", "PM": "2011", "HN": "2011", "MR": "20171208", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058492"}, {"RECTYPE": "D", "MH": "Sarcophagidae", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "PRINT ENTRY": "Sarcophaga|T204|NON|NRW|NLM (2011)|100120|abcdef", "ENTRY": "Fly, Flesh", "MN": "B01.050.500.131.617.720.500.500.750.797", "MH_TH": "NLM (2011)", "ST": "T204", "RN": "txid7381", "RR": "txid7384", "AN": "for killing Sarcophagidae with insecticides, see note at INSECTICIDES", "PI": "Diptera (1964-2010)", "MS": "Family of flies in the order DIPTERA, commonly known as flesh flies. They lay their eggs in dead or decaying matter or open wounds.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058493"}, {"RECTYPE": "D", "MH": "Walker-Warburg Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "alpha-Dystroglycanopathies|T047|NON|BRD|NLM (2011)|100121|abcdef", "ENTRY": "alpha Dystroglycanopathies", "MN": "C16.320.577.750", "FX": "Dystroglycans", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Muscular Dystrophies/congenital (1979-2010)", "MS": "Rare autosomal recessive lissencephaly type 2 associated with congenital MUSCULAR DYSTROPHY and eye anomalies (e.g., RETINAL DETACHMENT; CATARACT; MICROPHTHALMOS). It is often associated with additional brain malformations such as HYDROCEPHALY and cerebellar hypoplasia and is the most severe form of the group of related syndromes (alpha-dystroglycanopathies) with common congenital abnormalities in the brain, eye and muscle development.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058494"}, {"RECTYPE": "D", "MH": "Sotos Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Sotos'", "MN": "C16.320.180.905", "FX": "Gigantism", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Gigantism (1977-2010)", "MS": "Congenital or postnatal overgrowth syndrome most often in height and occipitofrontal circumference with variable delayed motor and cognitive development. Other associated features include advanced bone age, seizures, NEONATAL JAUNDICE; HYPOTONIA; and SCOLIOSIS. It is also associated with increased risk of developing neoplasms in adulthood. Mutations in the NSD1 protein and its HAPLOINSUFFICIENCY are associated with the syndrome.", "PM": "2011", "HN": "2011", "MR": "20130708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058495"}, {"RECTYPE": "D", "MH": "Smith-Magenis Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Smith-Magenis", "MN": "C16.320.180.887", "FX": "Chronobiology Disorders", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Complex neurobehavioral disorder characterized by distinctive facial features (FACIES), developmental delay and INTELLECTUAL DISABILITY. Behavioral phenotypes include sleep disturbance, maladaptive, self-injurious and attention-seeking behaviors. The sleep disturbance is linked to an abnormal circadian secretion pattern of MELATONIN. The syndrome is associated with de novo deletion or mutation and HAPLOINSUFFICIENCY of the retinoic acid-induced 1 protein on chromosome 17p11.2.", "PM": "2011", "HN": "2011", "MR": "20130708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058496"}, {"RECTYPE": "D", "MH": "Fraser Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Fraser", "MN": "C16.131.939.410", "FX": "Frasier Syndrome", "MH_TH": "ORD (2010)", "ST": "T047", "AN": "do not confuse with FRASIER SYNDROME", "MS": "Rare autosomal recessive congenital malformation syndrome characterized by cryptophthalmos, SYNDACTYLY and UROGENITAL ABNORMALITIES. Other anomalies of bone, ear, lung, and nose are common. Mutations on FRAS1 and FREM2 are associated with the syndrome.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058497"}, {"RECTYPE": "D", "MH": "Kyphoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Vertebroplasty, Balloon", "MN": "E04.555.165.500.500", "MH_TH": "NLM (2008)", "ST": "T061", "PI": "Vertebroplasty (2006-2010)", "MS": "Procedures to restore vertebrae to their original shape following vertebral compression fractures by inflating a balloon inserted into the vertebrae, followed by removal of the balloon and injection of BONE CEMENTS to fill the cavity.", "PM": "2011", "HN": "2011", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058498"}, {"RECTYPE": "D", "MH": "Retinal Dystrophies", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Retinal Dystrophy", "MN": "C11.768.585.658", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "CONE-ROD DYSTROPHY see RETINITIS PIGMENTOSA is also available", "PI": "Retinal Degeneration (2001-2010)", "MS": "A group of disorders involving predominantly the posterior portion of the ocular fundus, due to degeneration in the sensory layer of the RETINA; RETINAL PIGMENT EPITHELIUM; BRUCH MEMBRANE; CHOROID; or a combination of these tissues.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058499"}, {"RECTYPE": "D", "MH": "Animal Fins", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Fins, Animal", "MN": "A13.075", "MH_TH": "NLM (2011)", "ST": "T023", "MS": "Membranous appendage of fish and other aquatic organisms used for locomotion or balance.", "PM": "2011", "HN": "2011", "MR": "20170711", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058500"}, {"RECTYPE": "D", "MH": "Enzyme-Linked Immunospot Assay", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Immunospot Assays, Enzyme-Linked", "MN": "E05.601.470.380.360.500", "MH_TH": "NLM (2011)", "ST": "T059", "PI": "Enzyme-Linked Immunosorbent Assay (1983-2010)", "MS": "A method of detection of the number of cells in a sample secreting a specific molecule. With this method, a population of cells are plated over top of the immunosorbent substrate that captures the secreted molecules.", "PM": "2011", "HN": "2011", "MR": "20150708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058501"}, {"RECTYPE": "D", "MH": "Pentalogy of Cantrell", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Thoracoabdominal Syndrome|T047|NON|EQV|NLM (2011)|OMIM (2013)|ORD (2010)|100122|abcdeeef", "ENTRY": "Thoracoabdominal Syndromes", "MN": "C16.131.666.680.705", "FX": "Tetralogy of Fallot", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Abnormalities, Multiple (1984-2010)", "MS": "Rare congenital deformity syndrome characterized by a combination of five anomalies as a result of neural tube defect. The five anomalies are a midline supraumbilical abdominal wall defect (e.g., OMPHALOCELE), a lower STERNUM defect, a congenital intracardiac defect, an anterior DIAPHRAGM defect, and a diaphragmatic PERICARDIUM defect (e.g., PERICARDIAL EFFUSION). Variants with incomplete and variable combinations of the defects are known. ECTOPIA CORDIS; CLEFT LIP; and CLEFT PALATE are often associated with the syndrome.", "PM": "2011", "HN": "2011", "MR": "20120703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058502"}, {"RECTYPE": "D", "MH": "Mesophyll Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Spongy Mesophyll Cell", "MN": "A18.024.812.324", "MH_TH": "NLM (2011)", "ST": "T025", "MS": "Large and highly vacuolated cells possessing many chloroplasts occuring in the interior cross-section of leaves, juxtaposed between the epidermal layers.", "PM": "2011", "HN": "2011", "MR": "20120703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058503"}, {"RECTYPE": "D", "MH": "Th17 Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Type 17 Helper T Cell|T025|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "TH 17 Cells", "MN": "A15.382.490.555.567.569.500.400.915", "MH_TH": "NLM (2011)", "ST": "T025", "PI": "T-Lymphocytes, Helper-Inducer (2007-2010)", "MS": "A subset of helper-effector T-lymphocytes which synthesize and secrete INTERLEUKINS IL-17; IL-17F; and IL-22. These cytokines are involved in host defenses and tissue inflammation in autoimmune diseases.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058504"}, {"RECTYPE": "D", "MH": "Cambium", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Cambiums", "MN": "A18.400.500.299", "MH_TH": "NLM (2011)", "ST": "T002", "MS": "A layer of living cells between the bark and hardwood that each year produces additional wood and bark cells, forming concentric growth rings.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058506"}, {"RECTYPE": "D", "MH": "Host Specificity", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Host Specialization|T070|NON|EQV|NLM (2024)|230201|abcdef", "ENTRY": "Specificity, Host Species", "MN": "G16.527.200.380", "MH_TH": "NLM (2011)", "ST": "T070", "PI": "Host-Parasite Interactions (1970-2010)", "MS": "The properties of a pathogen that makes it capable of infecting one or more specific hosts. The pathogen can include PARASITES as well as VIRUSES; BACTERIA; FUNGI; or PLANTS.", "PM": "2011", "HN": "2011", "MR": "20230522", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058507"}, {"RECTYPE": "D", "MH": "Quartz Crystal Microbalance Techniques", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Quartz Crystal Microbalances", "MN": "E05.978.673", "MH_TH": "NLM (2011)", "ST": "T062", "MS": "The use of a quartz crystal microbalance for measuring weights and forces in the micro- to nanogram range. It is used to study the chemical and mechanical properties of thin layers, such as polymer coatings and lipid membranes; and interactions between molecues.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058525"}, {"RECTYPE": "D", "MH": "Plant Vascular Bundle", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Vascular Bundles, Plant", "MN": "A18.450", "MH_TH": "NLM (2011)", "ST": "T002", "MS": "A strand of primary conductive plant tissue consisting essentially of XYLEM, PHLOEM, and CAMBIUM.", "PM": "2011", "HN": "2011", "MR": "20150623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058526"}, {"RECTYPE": "D", "MH": "Enteropathy-Associated T-Cell Lymphoma", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "T-Cell Lymphomas, Enteropathy-Associated", "MN": "C20.683.515.761.480.750.199", "FX": "Celiac Disease", "MH_TH": "NLM (2011)", "ST": "T191", "PI": "Lymphoma, Non-Hodgkin (1992-2010)", "MS": "A primary peripheral T-cell lymphoma in the gastrointestinal tract, most often in the jejunum, associated with a history of CELIAC DISEASE or other gastrointestinal diseases.", "PM": "2011", "HN": "2011", "MR": "20180629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058527"}, {"RECTYPE": "D", "MH": "Single Umbilical Artery", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Umbilical Artery, Single", "MN": "C16.131.240.850.952", "MH_TH": "NLM (2011)", "ST": "T019", "PI": "Umbilical Arteries (1965-2010)", "MS": "Congenital abnormality where one, instead of the usual two, UMBILICAL ARTERY connects the fetus to the placenta.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058529"}, {"RECTYPE": "D", "MH": "Datura metel", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "MN": "B01.875.800.575.912.250.908.500.188.550", "MH_TH": "NLM (2011)", "ST": "T002", "RN": "txid35625", "PI": "Datura (1965-2010)", "MS": "A plant species and perennial herb of the genus DATURA, family SOLANACEAE, containing poisonous tropane ALKALOIDS.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058530"}, {"RECTYPE": "D", "MH": "46, XX Testicular Disorders of Sex Development", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "XX Sex Reversals", "MN": "C19.391.119.064.124", "MH_TH": "NLM (2011)", "ST": "T047", "MS": "Congenital conditions in individuals in which male GONADS develop in a genetic female (female to male sex reversal).", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058531"}, {"RECTYPE": "D", "MH": "Sex Chromosome Disorders of Sex Development", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sex Chromosome DSDs", "MN": "C19.391.119.795", "FX": "Sex Chromosome Aberrations", "MH_TH": "NLM (2011)", "ST": "T019", "MS": "Congenital conditions of atypical sexual development associated with abnormal sex chromosome constitutions including MONOSOMY; TRISOMY; and MOSAICISM.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058533"}, {"RECTYPE": "D", "MH": "Class I Phosphatidylinositol 3-Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphatidylinositol 3-Kinase, Class I|T116|T126|NON|EQV|NLM (2011)|100127|abbcdef", "ENTRY": "Phosphatidylinositol 3 Kinase, Class I", "MN": "D12.776.476.556.200.100", "MH_TH": "NLM (2011)", "ST": "T126", "RN": "EC 2.7.1.137", "RR": "EC 2.7.1.154", "PI": "Phosphatidylinositol 3-Kinases (1998-2010)", "MS": "A phosphatidylinositol 3-kinase subclass that includes enzymes with a specificity for 1-phosphatidylinositol, 1-phosphatidylinositol 4-phosphate, and 1-phosphatidylinositol 4,5-bisphosphate. Members of this enzyme subclass are activated by cell surface receptors and occur as heterodimers of enzymatic and regulatory subunits.", "PM": "2011", "HN": "2011", "MR": "20210521", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058534"}, {"RECTYPE": "D", "MH": "Echogenic Bowel", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Hyperechogenic Bowel|T019|T033|NON|EQV|NLM (2011)|100126|abbcdef", "ENTRY": "Hyperechogenic Bowels", "MN": "C16.300.050", "MH_TH": "NLM (2011)", "ST": "T033", "PI": "Fetal Diseases (1992-2010)", "MS": "A PRENATAL ULTRASONOGRAPHY finding of excessively dense fetal bowel due to MECONIUM buildup.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058535"}, {"RECTYPE": "D", "MH": "Pyelectasis", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pyelectasis, Fetal", "MN": "C16.300.895", "MH_TH": "NLM (2011)", "ST": "T019", "PI": "Kidney Pelvis (1962-2010)", "MS": "Dilation of fetal KIDNEY PELVIS. It is a common PRENATAL ULTRASONOGRAPHY finding with no significant long-term sequelae.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058536"}, {"RECTYPE": "D", "MH": "Electronic Supplementary Materials", "PRINT ENTRY": "Supplementary Material|T170|NON|EQV|NLM (2011)|100127|abcdef", "ENTRY": "Supporting Information|T170|NON|EQV|NLM (2011)|100127|abcdef", "MN": "V01.255", "MH_TH": "NLM (2011)", "ST": "T170", "AN": "INDEXER: Do not use; CATALOGER: Do not use", "MS": "Supporting content or information, such as animation, datasets, multimedia files, video, movies, audio files, text files, or software, which is submitted for publication in an online journal or an online edition of a journal. This information may be referenced in the text of the article with a link to the supplementary data provided. CATALOG: do not use", "HN": "2011", "MR": "20191103", "DA": "20100625", "DC": "2", "DX": "20110101", "UI": "D058537"}, {"RECTYPE": "D", "MH": "Phosphatidylinositol-4-Phosphate 3-Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Phosphatidylinositol 4 Phosphate 3 Kinase", "MN": "D12.776.476.556.200", "MH_TH": "NLM (2011)", "ST": "T126", "RN": "EC 2.7.1.154", "RR": "EC 2.7.1.154", "PI": "Phosphatidylinositol 3-Kinases (1997-2010)", "MS": "A phosphatidylinositol 3-kinase that catalyzes the conversion of 1-phosphatidylinositol 4-phosphate into phosphatidylinositol 3,4-bisphosphate.", "PM": "2011", "HN": "2011", "MR": "20210521", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058538"}, {"RECTYPE": "D", "MH": "Phosphatidylinositol 3-Kinase", "DS": "PHOSPHATIDYLINOSITOL KINASE 03", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "1-Phosphatidylinositol 3-Kinase|T116|T126|NON|EQV|NLM (1998)|990101|PHOSPHATIDYLINOSITOL KINASE 01 03|abbcdefs", "ENTRY": "Phosphatidylinositol 3 Kinase", "MN": "D12.776.476.556.100", "EC": "antagonists & inhibitors:Phosphoinositide-3 Kinase Inhibitors", "MH_TH": "NLM (1998)", "ST": "T126", "RN": "EC 2.7.1.137", "RR": "EC 2.7.1.137", "AN": "PHOSPHATIDYLINOSITOL 3-KINASES is also available", "MS": "A phosphatidylinositol 3-kinase that catalyzes the conversion of 1-phosphatidylinositol into 1-phosphatidylinositol 3-phosphate.", "PM": "2011; see PHOSPHATIDYLINOSITOL 3-KINASES 1998-2010", "HN": "2011; use PHOSPHATIDYLINOSITOL 3-KINASES 1998-2010", "MR": "20210521", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058539"}, {"RECTYPE": "D", "MH": "Aicardi Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Aicardi's", "MN": "C16.320.322.030", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Syndrome (1972-2010)", "MS": "A rare genetic disorder characterized by partial or complete absence of the CORPUS CALLOSUM, resulting in infantile spasms, MENTAL RETARDATION, and lesions of the RETINA or OPTIC NERVE.", "PM": "2011", "HN": "2011", "MR": "20130708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058540"}, {"RECTYPE": "D", "MH": "Class II Phosphatidylinositol 3-Kinases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "PtdIns 3 Kinase C2 gamma", "MN": "D12.776.476.556.200.200", "MH_TH": "NLM (2011)", "ST": "T126", "RN": "EC 2.7.1.137", "RR": "EC 2.7.1.154", "PI": "Phosphatidylinositol 3-Kinases (1998-2010)", "MS": "A subclass of phosphatidylinositol 3-kinases that have specificity for 1-phosphatidylinositol and 1-phosphatidylinositol 4-phosphate. Members of this subclass consist of a single subunit structure and are regulated by RECEPTOR TYROSINE KINASES; CYTOKINE RECEPTORS; and INTEGRINS.", "PM": "2011; PHOSPHOINOSITIDE 3-KINASE C2ALPHA was indexed under PHOSPHATIDYLINOSITOL 3-KINASES 2003-2010", "HN": "2011", "MR": "20210521", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058541"}, {"RECTYPE": "D", "MH": "Implantable Neurostimulators", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Neurostimulators, Implanted", "MN": "E07.695.202.381", "MH_TH": "NLM (2011)", "ST": "T074", "PI": "Electric Stimulation Therapy/instrumentation (1990-2010)", "MS": "Surgically placed electric conductors through which ELECTRIC STIMULATION of nerve tissue is delivered.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058542"}, {"RECTYPE": "D", "MH": "Class Ia Phosphatidylinositol 3-Kinase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Class Ia Phosphatidylinositol 3-Kinases|T116|T126|NON|EQV|NLM (2011)|100128|abbcdef", "ENTRY": "p85beta Subunit, Class Ia Phosphatidylinositol 3 Kinase", "MN": "D12.776.476.556.200.100.100", "MH_TH": "NLM (2011)", "ST": "T126", "RN": "EC 2.7.1.137", "RR": "EC 2.7.1.154", "PI": "Phosphatidylinositol 3-Kinases (1998-2010)", "MS": "A phosphatidylinositol 3-kinase subclass that includes enzymes formed through the heterodimerization of a p110 catalytic and a p85, p55, or p50 regulatory subunit. This subclass of enzymes is a downstream target of TYROSINE KINASE RECEPTORS and G PROTEIN-COUPLED RECEPTORS.", "PM": "2011; for ALPHA-P85 SUBUNIT, PI-3K see PHOSPHATIDYLINOSITOL 3-KINASE 1998-2010", "HN": "2011; for ALPHA-P85 SUBUNIT, PI-3K use PHOSPHATIDYLINOSITOL 3-KINASES 1998-2010", "MR": "20210521", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058543"}, {"RECTYPE": "D", "MH": "Class Ib Phosphatidylinositol 3-Kinase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Class Ib Phosphatidylinositol 3-Kinases|T116|T126|NON|EQV|NLM (2011)|100128|abbcdef", "ENTRY": "p87 Subunit, Class Ib Phosphatidylinositol 3 Kinase", "MN": "D12.776.476.556.200.100.200", "MH_TH": "NLM (2011)", "ST": "T126", "RN": "EC 2.7.1.137", "RR": "EC 2.7.1.154", "PI": "Phosphatidylinositol 3-Kinases (1998-2010)", "MS": "A phosphatidylinositol 3-kinase subclass that includes enzymes formed through the association of a p110gamma catalytic subunit and one of the three regulatory subunits of 84, 87, and 101 kDa in size. This subclass of enzymes is a downstream target of G PROTEIN-COUPLED RECEPTORS.", "PM": "2011", "HN": "2011", "MR": "20210521", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058544"}, {"RECTYPE": "D", "MH": "Inhalant Abuse", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Glue Sniffing|T048|NON|NRW|NLM (1981)|970611|abcdef", "ENTRY": "Inhalant Abuses", "MN": "F03.900.467", "MH_TH": "NLM (2011)", "ST": "T048", "MS": "Illicit use of chemicals and products whose vapors can be inhaled to produce a rapid mind-altering effect. Inhalants include aerosols, gases, and volatile solvents that are often inhaled repeatedly to achieve the short-lived intoxicating effect.", "PM": "2011; for Glue Sniffing, see Substance-Related Disorders 1981-2010; Glue Sniffing was a heading 1969-1980", "HN": "2011; for Glue Sniffing, use Substance-Related Disorders 1981-2010; Glue Sniffing was a heading 1969-1980", "MR": "20130708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058545"}, {"RECTYPE": "D", "MH": "Class III Phosphatidylinositol 3-Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphatidylinositol 3-Kinase, Class III|T116|T126|NON|EQV|NLM (2011)|100129|abbcdef", "ENTRY": "Vps34 Phosphatidylinositol 3 Kinase", "MN": "D12.776.543.990.175", "MH_TH": "NLM (2011)", "ST": "T126", "RN": "EC 2.7.1.137", "RR": "EC 2.7.1.137", "PI": "Phosphatidylinositol 3-Kinases (1998-2010)", "MS": "A phosphatidylinositol 3-kinase subclass that includes enzymes whose specificity is limited to 1-phosphatidylinositol. Members of this class play a role in vesicular transport and in the regulation of TOR KINASES.", "PM": "2011; for VPS34 PHOSPHATIDYLINOSITOL 3-KINASE see PHOSPHATIDYLINOSITOL 3-KINASES 1998-2010", "HN": "2011; for VPS34 PHOSPHATIDYLINOSITOL 3-KINASE use PHOSPHATIDYLINOSITOL 3-KINASES 1998-2010", "MR": "20210521", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058546"}, {"RECTYPE": "D", "MH": "Cerebral Ventriculitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ventriculitis, Infectious", "MN": "C10.586.250.249", "FX": "Meningitis, Bacterial", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Encephalitis (1967-2010)", "MS": "Inflammation of CEREBRAL VENTRICLES.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058565"}, {"RECTYPE": "D", "MH": "Sacroiliitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Septic Sacroiliitides", "MN": "C05.550.114.854", "FX": "Sacroiliac Joint", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Sacroiliac Joint (1963-2010)", "MS": "Inflammation of the SACROILIAC JOINT. It is characterized by lower back pain, especially upon walking, fever, UVEITIS; PSORIASIS; and decreased range of motion. Many factors are associated with and cause sacroiliitis including infection; injury to spine, lower back, and pelvis; DEGENERATIVE ARTHRITIS; and pregnancy.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058566"}, {"RECTYPE": "D", "MH": "Photoinitiators, Dental", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO", "PRINT ENTRY": "Resin Photoinitiators, Dental|T122|NON|EQV|NLM (2011)|100325|abcdef", "ENTRY": "Resin Photoinitiator, Dental", "MN": "J01.637.051.339.574", "FX": "Light-Curing of Dental Adhesives", "MH_TH": "NLM (2011)", "ST": "T122", "RN": "0", "PI": "Photosensitizing Agents (1994-2010)", "MS": "Chemical compound used to initiate polymerization of dental resins by the use of DENTAL CURING LIGHTS. It absorbs UV light and undergoes decomposition into free radicals that initiate polymerization process of the resins in the mix. Each photoinitiator has optimum emission spectrum and intensity for proper curing of dental materials.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058567"}, {"RECTYPE": "D", "MH": "Necrolytic Migratory Erythema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pseudoglucagonoma Syndrome|T047|NON|REL|NLM (2011)|100201|abcdef", "ENTRY": "Syndromes, Pseudoglucagonoma", "MN": "C23.888.885.468", "FX": "Glucagonoma", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "for glucagonoma syndrome, coordinate with GLUCAGONOMA and PANCREATIC NEOPLASMS", "PI": "Glucagonoma (1981-2010)", "MS": "Recurrent cutaneous manifestation of GLUCAGONOMA characterized by necrolytic polycyclic migratory lesions with scaling borders. It is associated with elevated secretion of GLUCAGON by the tumor. Other conditions with elevated serum glucagon levels such as HEPATIC CIRRHOSIS may also result in similar skin lesions, which are referred to as pseudoglucagonoma syndrome.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058568"}, {"RECTYPE": "D", "MH": "Elbow Prosthesis", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Prosthesis, Elbow", "MN": "E07.695.400.300", "MH_TH": "NLM (2011)", "ST": "T074", "PI": "Joint Prosthesis (1972-2010)", "MS": "Replacement for an elbow joint.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058569"}, {"RECTYPE": "D", "MH": "TOR Serine-Threonine Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "mTOR Serine-Threonine Kinases|T116|T126|ABX|EQV|NLM (2011)|100202|abbcdef", "ENTRY": "mTOR Serine Threonine Kinases", "MN": "D12.776.476.563.931", "MH_TH": "NLM (2011)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A serine threonine kinase that controls a wide range of growth-related cellular processes. The protein is referred to as the target of RAPAMYCIN due to the discovery that SIROLIMUS (commonly known as rapamycin) forms an inhibitory complex with TACROLIMUS BINDING PROTEIN 1A that blocks the action of its enzymatic activity.", "PM": "2011; MTOR PROTEIN (now TOR SERINE-THREONINE KINASES) was indexed under PROTEIN KINASES 1995-2010 and under PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR) 1995-2001", "HN": "2011", "MR": "20210521", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058570"}, {"RECTYPE": "D", "MH": "Vacuolar Sorting Protein VPS15", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinase, Vps15", "MN": "D12.776.543.990.175.500", "MH_TH": "NLM (2011)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A 150 kDa protein serine-threonine kinase that is found as a regulatory subunit of the class III phosphatidylinositol 3-kinases. The protein is believed to play an important role in the regulation of vesicular trafficking with the cell.", "PM": "2011; VPS15 PROTEIN KINASE (now VACUOLAR SORTING PROTEIN VPS15) was indexed under PROTEIN-SERINE-THREONINE KINASES and ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT 2006-2010, and under FUNGAL PROTEINS 1995-2005", "HN": "2011", "MR": "20210628", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058571"}, {"RECTYPE": "D", "MH": "Carbon Footprint", "AQ": "EC LJ SN ST", "ENTRY": "Footprints, Carbon", "MN": "N06.230.063", "FX": "Greenhouse Effect", "MH_TH": "NLM (2011)", "ST": "T081", "PI": "Greenhouse Effect (2007-2010)", "MS": "A measure of the total greenhouse gas emissions produced by an individual, organization, event, or product. It is measured in units of equivalent kilograms of CARBON DIOXIDE generated in a given time frame.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058572"}, {"RECTYPE": "D", "MH": "Performance-Enhancing Substances", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Performance-Enhancing Substance|T121|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Substances, Performance-Enhancing", "MN": "D27.505.696.620", "FX": "Doping in Sports", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "AN": "note entry term PERFORMANCE-ENHANCING EFFECT: use only for the performance enhancing effect of a chemical substance", "MS": "Agents that improve the ability to carry out activities such as athletics, mental endurance, work, and resistance to stress. The substances can include PRESCRIPTION DRUGS; DIETARY SUPPLEMENTS; phytochemicals; and ILLICIT DRUGS.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058573"}, {"RECTYPE": "D", "MH": "Integrin-Binding Sialoprotein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sialoprotein, Integrin-Binding", "MN": "D12.776.860.300.562", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A highly glycosylated and sulfated phosphoprotein that is found almost exclusively in mineralized connective tissues. It is an extracellular matrix protein that binds to hydroxyapatite through polyglutamic acid sequences and mediates cell attachment through an RGD sequence.", "PM": "2011; INTEGRIN-BINDING SIALOPROTEIN was indexed under SIALOGLYCOPROTEINS 2005-2010, and under GLYCOPROTEINS 1989-2004", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058574"}, {"RECTYPE": "D", "MH": "Decorin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteoglycan II, Bone", "MN": "D12.776.860.300.806.750", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A small leucine-rich proteoglycan that interacts with FIBRILLAR COLLAGENS and modifies the EXTRACELLULAR MATRIX structure of CONNECTIVE TISSUE. Decorin has also been shown to play additional roles in the regulation of cellular responses to GROWTH FACTORS. The protein contains a single glycosaminoglycan chain and is similar in structure to BIGLYCAN.", "PM": "2011; DECORIN was indexed under PROTEOGLYCANS and EXTRACELLULAR MATRIX PROTEINS 1988-2010", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058575"}, {"RECTYPE": "D", "MH": "Biglycan", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteoglycan S1|T116|T123|NON|EQV|NLM (2011)|100204|abbcdef", "MN": "D12.776.860.300.806.500", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A small leucine-rich proteoglycan found in a variety of tissues including CAPILLARY ENDOTHELIUM; SKELETAL MUSCLE; CARTILAGE; BONE; and TENDONS. The protein contains two glycosaminoglycan chains and is similar in structure to DECORIN.", "PM": "2011; BIGLYCAN was indexed under PROTEOGLYCANS and EXTRACELLULAR MATRIX PROTEINS 1989-2010", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058578"}, {"RECTYPE": "D", "MH": "Hyalectins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.503.280.437", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "PI": "Chondroitin Sulfate Proteoglycans (1976-2010)", "MS": "A group of high molecular weight chondroitin sulfate proteoglycans that form aggregates with HYALURONIC ACID.", "PM": "2011", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058579"}, {"RECTYPE": "D", "MH": "Neurocan", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Chondroitin Sulfate Proteoglycan 3|T116|T123|NON|EQV|NLM (2011)|100205|abbcdef", "MN": "D23.050.301.350.250.520.789", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (1992-2010)", "MS": "A hyalectin family member that is expressed in neuronal tissue and plays a role in neuronal CELL ADHESION.", "PM": "2011", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058580"}, {"RECTYPE": "D", "MH": "Brevican", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Hyaluronan-Binding Protein, Brain-Enriched", "MN": "D12.776.503.280.437.275", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A BRAIN-specific hyalectin that may play a role in terminally differentiating NEURONS. It is found highly overexpressed in primary BRAIN TUMORS and in experimental models of GLIOMA.", "PM": "2011; BREVICAN was indexed under NERVE TISSUE PROTEINS and CHONDROITIN SULFATE PROTEOGLYCANS 1994-2010", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058581"}, {"RECTYPE": "D", "MH": "Double-Balloon Enteroscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Push-and-Pull Enteroscopies", "MN": "E04.502.250.250.250.080.250", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Endoscopy, Gastrointestinal (2003-2010)", "MS": "Endoscopy of the small intestines accomplished while advancing the endoscope into the intestines from the stomach by alternating the inflation of two balloons, one on an innertube of the endoscope and the other on an overtube.", "PM": "2011", "HN": "2011", "MR": "20160610", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058582"}, {"RECTYPE": "D", "MH": "Vestibular Evoked Myogenic Potentials", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Vestibular Evoked Neurogenic Potential|T042|T060|NON|REL|NLM (2021)|191119|abbcdef", "ENTRY": "Vestibular Evoked Neurogenic Potentials|T042|T060|NON|REL|NLM (2011)|100212|abbcdef", "MN": "G07.265.216.500.385.500", "FX": "Vestibular Function Tests", "MH_TH": "NLM (2011)", "ST": "T060", "PI": "Evoked Potentials or specifics (1995-2010)", "MS": "Recorded electrical responses from muscles, especially the neck muscles or muscles around the eyes, following stimulation of the EAR VESTIBULE.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058585"}, {"RECTYPE": "D", "MH": "Host-Derived Cellular Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Host Derived Cellular Factors", "MN": "D23.297", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "AN": "coordinate with specific factor; do not confuse with INTEGRATION HOST FACTORS", "PI": "Integration Host Factor (2002-2010)", "MS": "A broad category of endogenous cellular factors that are used by VIRUSES for essential functions such as VIRUS REPLICATION. Many host-derived factors play normal cellular roles in non-infected cells.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058605"}, {"RECTYPE": "D", "MH": "Accessory Atrioventricular Bundle", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mahaim Fiber|T190|NON|NRW|NLM (2021)|200601|abcdef", "ENTRY": "Tracts, Atriohisian", "MN": "C23.300.190", "MH_TH": "NLM (2011)", "ST": "T190", "PI": "Heart Conduction System (1972-2010)", "MS": "Extra impulse-conducting tissue in the heart that creates abnormal impulse-conducting connections between HEART ATRIA and HEART VENTRICLES.", "PM": "2011; for BUNDLE OF KENT see HEART CONDUCTION SYSTEM 1986-2010", "HN": "2011; for BUNDLE OF KENT use HEART CONDUCTION SYSTEM 1986-2010", "MR": "20200617", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058606"}, {"RECTYPE": "D", "MH": "Fibric Acids", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Fibrates|T109|NON|NRW|NLM (2005)|031218|abcdef", "ENTRY": "Methyl 2 Phenoxypropanoic Acid Derivatives", "MN": "D02.455.426.559.389.657.654.305", "MH_TH": "NLM (2011)", "ST": "T109", "RN": "0", "MS": "Compounds that either share the structure of fibric acid in their molecular arrangement or are considered variants of the fibric acid structure.", "PM": "2011; for FIBRATES see CLOFIBRIC ACID 1991-2010", "HN": "2011; for FIBRATES use CLOFIBRIC ACID 1991-2010", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058607"}, {"RECTYPE": "D", "MH": "Nanopores", "AQ": "UL", "ENTRY": "Nanopore", "MN": "J01.637.512.650", "FX": "Nuclear Pore", "MH_TH": "NLM (2011)", "ST": "T073", "PI": "Porosity (2002-2010)", "MS": "Small holes of nanometer dimensions in a membrane, that can be used as single molecule detectors. The pores can be biological or synthetic.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058608"}, {"RECTYPE": "D", "MH": "Visual Field Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Visual Field Test", "MN": "E01.370.380.850.962", "MH_TH": "NLM (2011)", "ST": "T059", "AN": "VISUAL FIELDS is also available", "PI": "Vision Tests (1963-2010)", "MS": "Method of measuring and mapping the scope of vision, from central to peripheral of each eye.", "PM": "2011; for PERIMETRY see PERIMETRY 1963-2010", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058609"}, {"RECTYPE": "D", "MH": "Isobutyrates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Isobutyric Acids|T109|NON|REL|NLM (2011)|100217|abcdef", "ENTRY": "2 Methylpropionic Acids", "MN": "D10.251.400.143.875", "MH_TH": "NLM (2011)", "ST": "T109", "RN": "0", "PI": "Butyric Acids (1979-2010)", "MS": "Aliphatic acids that contain four carbons in a branched-chain configuration. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the 2-carboxypropane structure.", "PM": "2011; see ISOBUTYRIC ACIDS 2011-2012", "HN": "2011", "MR": "20120703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058610"}, {"RECTYPE": "D", "MH": "Horticultural Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Therapeutic Horticulture|T061|NON|EQV|NLM (2021)|200612|abcdef", "ENTRY": "Therapy, Horticulture", "MN": "F04.754.392", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "A therapeutic approach in which the engagement of a person in gardening and plant-based activities are utilized in improving an individual's social, emotional, educational, psychological, and physical well-being.", "PM": "2011", "HN": "2011", "MR": "20220413", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058611"}, {"RECTYPE": "D", "MH": "Nanodiamonds", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "ENTRY": "Nanodiamond", "MN": "J01.637.512.600.580", "MH_TH": "NLM (2011)", "ST": "T073", "RN": "0", "MS": "Diamond nanoparticles that exhibit unique biological, thermal, mechanical, and optoelectronic properties. They have important NANOMEDICINE applications including DRUG DELIVERY SYSTEMS; DIAGNOSTIC IMAGING; protein separation; and BIOSENSING TECHNIQUES.", "PM": "2011", "HN": "2011", "MR": "20150331", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058612"}, {"RECTYPE": "D", "MH": "Seed Dispersal", "AQ": "DE GE IM PH RE", "ENTRY": "Seed Dispersals", "MN": "G15.808", "MH_TH": "NLM (2011)", "ST": "T082", "PI": "Seeds (1965-2010)", "MS": "The various physical methods which include wind, insects, animals, tension, and water, by which a plant scatters its seeds away from the parent plant.", "PM": "2011", "HN": "2011", "MR": "20160623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058614"}, {"RECTYPE": "D", "MH": "Synthetic Biology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Synthetic Biologies", "MN": "J01.293.069.500", "MH_TH": "NLM (2011)", "ST": "T090", "AN": "IM for the discipline (education, history, etc); NIM as a coordinate for studies involving specific synthetic biology concepts and applications", "MS": "A field of biological research combining engineering in the formulation, design, and building (synthesis) of novel biological structures, functions, and systems.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058615"}, {"RECTYPE": "D", "MH": "Synbiotics", "AQ": "AD AE AN CL EC HI PO RE SN ST TO VI", "ENTRY": "Synbiotic", "MN": "J02.500.456.500.500", "MH_TH": "NLM (2011)", "ST": "T168", "PI": "Probiotics (1998-2010)", "MS": "Nutritional supplements combining PROBIOTICS (bacteria) and PREBIOTICS (sugars).", "PM": "2011", "HN": "2011", "MR": "20210707", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058616"}, {"RECTYPE": "D", "MH": "Composite Lymphoma", "AQ": "BL CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Lymphomas, Composite", "MN": "C20.683.515.761.150", "MH_TH": "NLM (2011)", "ST": "T191", "AN": "coordinate with specific types of lymphoma if pertinent", "MS": "Two or more distinct types of malignant lymphoid tumors occurring within a single organ or tissue at the same time. It may contain different types of non-Hodgkin lymphoma cells or both Hodgkin and non-Hodgkin lymphoma cells.", "PM": "2011", "HN": "2011", "MR": "20180629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058617"}, {"RECTYPE": "D", "MH": "Sensilla", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sensillums, Antennal", "MN": "A13.093.500", "FX": "Mechanoreceptors", "MH_TH": "NLM (2011)", "ST": "T023", "PI": "Sensory Receptor Cells (1964-2010)", "MS": "Collective name for a group of external MECHANORECEPTORS and CHEMORECEPTORS manifesting as sensory structures in ARTHROPODS. They include cuticular projections (setae, hairs, bristles), pores, and slits.", "PM": "2011", "HN": "2011", "MR": "20160531", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058618"}, {"RECTYPE": "D", "MH": "Maltose-Binding Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Maltose Binding Proteins", "MN": "D12.776.097.577.500.500", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "Periplasmic proteins that bind MALTOSE and maltodextrin. They take part in the maltose transport system of BACTERIA.", "PM": "2011; MALTOSE-BINDING PROTEIN (now MALTOSE-BINDING PROTEINS) was indexed under PRIPLASMIC BINDING PROTEINS 2010 and under CARRIER PROTEINS 1978-2010", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058619"}, {"RECTYPE": "D", "MH": "Elder Nutritional Physiological Phenomena", "AQ": "DE EH GE IM PH RE", "ENTRY": "Physiology, Elder Nutritional", "MN": "G07.203.650.315", "MH_TH": "NLM (2011)", "ST": "T040", "MS": "Nutritional physiology of adults aged 65 years of age and older.", "PM": "2011", "HN": "2011", "MR": "20160928", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058620"}, {"RECTYPE": "D", "MH": "Blood Buffy Coat", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Buffy Coats, Blood", "MN": "A15.145.229.093", "MH_TH": "NLM (2011)", "ST": "T025", "MS": "The fraction of a blood sample, following CENTRIFUGATION, that is distinguished as a thin light-colored layer between the RED BLOOD CELLS, underneath it, and the PLASMA, above it. It is composed mostly of WHITE BLOOD CELLS and PLATELETS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058621"}, {"RECTYPE": "D", "MH": "End Stage Liver Disease", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Liver Failures, Chronic", "MN": "C06.552.308.500.177", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "For \"Model for End Stage Liver Disease (MELD)\" and related \"Pediatric End Stage Liver Disease Model (PELD)\" coordinate with SEVERITY OF ILLNESS INDEX and probably LIVER TRANSPLANTATION", "PI": "Liver Failure (1992-2010)", "MS": "Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058625"}, {"RECTYPE": "D", "MH": "Plasma Gases", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Plasma, Thermal", "MN": "D01.362.740", "MH_TH": "NLM (2011)", "ST": "T104", "RN": "0", "AN": "do not use for blood gases or blood plasma", "MS": "Ionized gases, consisting of free electrons and ionized atoms or molecules which collectively behave differently than gas, solid, or liquid. Plasma gases are used in biomedical fields in surface modification; biological decontamination; dentistry (e.g., PLASMA ARC DENTAL CURING LIGHTS); and in other treatments (e.g., ARGON PLASMA COAGULATION).", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058626"}, {"RECTYPE": "D", "MH": "Megalencephaly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Macrocephaly|T019|T047|NON|EQV|NLM (2011)|OMIM (2013)|100222|abbcdeef", "ENTRY": "Megalocephalies", "MN": "C16.131.666.507.400.249", "FX": "Hydrocephalus", "MH_TH": "OMIM (2013)", "ST": "T047", "PI": "Head/abnormalities (1970-2010)", "MS": "A congenital abnormality in which the occipitofrontal circumference is greater than two standard deviations above the mean for a given age. It is associated with HYDROCEPHALUS; SUBDURAL EFFUSION; ARACHNOID CYSTS; or is part of a genetic condition (e.g., ALEXANDER DISEASE; SOTOS SYNDROME).", "PM": "2011; use Macrocephaly 2011-2014, Megalencephaly was under Macrocephaly 2011-2014", "HN": "2011; use Macrocephaly 2011-2014, Megalencephaly was under Macrocephaly 2011-2014", "MR": "20140613", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058627"}, {"RECTYPE": "D", "MH": "Myofibroblasts", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Myofibroblast", "MN": "A11.620.520.500", "MH_TH": "NLM (2011)", "ST": "T025", "PI": "Fibroblasts (1972-2010)", "MS": "Spindle-shaped cells with characteristic CONTRACTILE PROTEINS and structures that contribute to the WOUND HEALING process. They occur in GRANULATION TISSUE and also in pathological processes such as FIBROSIS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058628"}, {"RECTYPE": "D", "MH": "Plasma Skin Regeneration", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Plasma Skin Resurfacing|T061|NON|EQV|NLM (2011)|100223|abcdef", "ENTRY": "Skin Resurfacings, Plasma", "MN": "E02.218.707", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "A cosmetic technique that uses PLASMA GASES in therapeutic treatment to help achieve skin REJUVENATION or REGENERATION and delay SKIN AGING.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058629"}, {"RECTYPE": "D", "MH": "Spinal Cord Regeneration", "AQ": "DE ES GE IM PH RE", "ENTRY": "Spinal Cord Repairs", "MN": "G16.762.611.500", "FX": "Spinal Cord Injuries", "MH_TH": "NLM (2011)", "ST": "T043", "PI": "Nerve Regeneration (1966-2010)", "MS": "Repair of the damaged neuron function after SPINAL CORD INJURY or SPINAL CORD DISEASES.", "PM": "2011", "HN": "2011", "MR": "20160623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058630"}, {"RECTYPE": "D", "MH": "Pycnodysostosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Pyknodysostosis|T047|NON|EQV|NLM (2011)|OMIM (2013)|ORD (2010)|090224|abcdeeef", "ENTRY": "Pyknodysostoses", "MN": "C18.452.648.595.800", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Dysostoses (1966-2010)", "MS": "Rare autosomal recessive syndrome characterized by delayed closing of CRANIAL SUTURES, short stature, ACRO-OSTEOLYSIS of distal phalanges, dental and MAXILLOFACIAL ABNORMALITIES and an increase in bone density that results in frequent BONE FRACTURES. It is associated with BONE RESORPTION defect due to mutations in the lysosomal cysteine protease CATHEPSIN K.", "PM": "2011", "HN": "2011", "MR": "20120703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058631"}, {"RECTYPE": "D", "MH": "Neuroprostanes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D10.251.355.411.750", "MH_TH": "NLM (2006)", "ST": "T109", "RN": "0", "MS": "Prostaglandin-like compounds produced by free radical-induced peroxidation of DOCOSAHEXAENOIC ACIDS, which are highly enriched in the brain. Formation is analogous to ISOPROSTANES formation from ARACHIDONIC ACID.", "PM": "2011; see DOCOSAHEXAENOIC ACIDS 2006-2010", "HN": "2011; use DOCOSAHEXAENOIC ACIDS 2006-2010", "MR": "20150623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058632"}, {"RECTYPE": "D", "MH": "Antipyretics", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Antipyretic Agent|T121|NON|EQV|NLM (2021)|200210|abcdef", "ENTRY": "Effects, Antipyretic", "MN": "D27.505.696.068", "MH_TH": "NLM (1995)", "ST": "T121", "RN": "0", "PI": "Analgesics, Non-Narcotic (1995-2010)", "MS": "Drugs that are used to reduce body temperature in fever.", "PM": "2011; see ANALGESICS, NON-NARCOTIC 1995-2010", "HN": "2011; use ANALGESICS, NON-NARCOTIC 1995-2010", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058633"}, {"RECTYPE": "D", "MH": "Molecular Farming", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Pharming, Molecular", "MN": "J01.897.836.750", "FX": "Protein Engineering", "MH_TH": "NLM (2011)", "ST": "T090", "MS": "The large scale production of pharmaceutically important and commercially valuable RECOMBINANT PROTEINS.", "PM": "2011", "HN": "2011", "MR": "20171213", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058634"}, {"RECTYPE": "D", "MH": "Lipid-Linked Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Membrane Lipid-Linked", "MN": "D12.776.543.484", "FX": "Proteolipids", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "AN": "do not confuse with PROTEOLIPIDS or LIPOPROTEINS", "MS": "Proteins that are covalently-linked to lipid molecules or hydrophobic molecules such as those that contain prenyl groups. The lipid moieties aid in the association of the proteins with CELL MEMBRANES.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058635"}, {"RECTYPE": "D", "MH": "Surgical Drapes", "AQ": "AE CL EC ES HI LJ MI PS SD SN ST TD VE VI", "ENTRY": "Surgical Drape", "MN": "E07.858.642", "MH_TH": "NLM (2011)", "ST": "T073", "PI": "Surgical Equipment (1963-2010)", "MS": "Sterile fabric or fabric-like material used to isolate the surgical site from the rest of the body and other possible sources of contamination.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058636"}, {"RECTYPE": "D", "MH": "Examination Tables", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Tables, Examination", "MN": "E07.325.409", "MH_TH": "NLM (2011)", "ST": "T073", "MS": "A raised flat surface on which a patient is placed during a PHYSICAL EXAMINATION.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058637"}, {"RECTYPE": "D", "MH": "Operating Tables", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Operating Room Tables|T073|NON|EQV|NLM (2011)|091210|abcdef", "ENTRY": "Tables, Operation", "MN": "E07.858.421", "MH_TH": "NLM (2011)", "ST": "T073", "PI": "Surgical Equipment (1968-2010)", "MS": "A raised flat surface on which a patient is placed during surgical procedures.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058638"}, {"RECTYPE": "D", "MH": "Cold-Shock Response", "AQ": "DE GE IM PH RE", "ENTRY": "Stresses, Cold Shock", "MN": "G07.775.249", "FX": "Hypothermia", "MH_TH": "NLM (2011)", "ST": "T040", "PI": "Stress, Physiological (1993-2010)", "MS": "A sequence of responses that occur when an organism is exposed to excessive cold. In humans, a fall in skin temperature triggers gasping, hypertension, and hyperventilation.", "PM": "2011", "HN": "2011", "MR": "20180228", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058639"}, {"RECTYPE": "D", "MH": "Brochothrix", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.400.410.120", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid2755", "MS": "A genus of gram-positive bacteria in the family Listeriaceae. It has 93% homology to LISTERIA and shares with it many phenotypic properties.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058640"}, {"RECTYPE": "D", "MH": "Planococcaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Caryophanon|T007|NON|NRW|NLM (2011)|100226|abcdef", "MN": "B03.510.400.630", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid186818", "RR": "txid33976", "MS": "A family of gram-positive bacteria in the order BACILLALES. Most are strict aerobic heterotrophs.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058641"}, {"RECTYPE": "D", "MH": "Planococcus Bacteria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.400.630.600", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid1372", "AN": "do not confuse with the insect genus Planococcus: see PLANOCOCCUS INSECT", "MS": "A genus of coccoid bacteria in the family PLANOCOCCACEAE. They are widely distributed in various habitats including sea water, freshwater ponds, cyanobacterial mats, and in marine animals.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058642"}, {"RECTYPE": "D", "MH": "Planococcus Insect", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Planococcus Insects", "MN": "B01.050.500.131.617.412.600", "MH_TH": "NLM (2011)", "ST": "T204", "RN": "txid40929", "AN": "do not confuse with the bacteria genus Planococcus: see PLANOCOCCUS BACTERIA", "PI": "Insects (1965-1974)", "MS": "A genus of insect in the mealybug family Pseudococcidae.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058643"}, {"RECTYPE": "D", "MH": "Sporosarcina", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.700", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid1569", "MS": "A genus of endospore-forming bacteria in the family Planococcaceae. The species are strict or facultative anerobes.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058644"}, {"RECTYPE": "D", "MH": "Denaturing Gradient Gel Electrophoresis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Temperature Gradient Gel Electrophoresis|T059|NON|REL|NLM (2011)|100226|abcdef", "MN": "E05.301.300.319.201", "MH_TH": "NLM (2011)", "ST": "T059", "PI": "Electrophoresis, Polyacrylamide Gel (1988-2010)", "MS": "Electrophoresis in which various denaturant gradients are used to induce nucleic acids to melt at various stages resulting in separation of molecules based on small sequence differences including SNPs. The denaturants used include heat, formamide, and urea.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058645"}, {"RECTYPE": "D", "MH": "Adrenergic alpha-1 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "alpha1-Agonists, Adrenergic", "MN": "D27.505.696.577.050.100.100.100", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Sympathomimetics (1966-1968)", "MS": "Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058646"}, {"RECTYPE": "D", "MH": "Adrenergic alpha-2 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "alpha2-Agonists, Adrenergic", "MN": "D27.505.696.577.050.100.100.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Sympathomimetics (1966-1968)", "MS": "Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058647"}, {"RECTYPE": "D", "MH": "Adrenergic beta-1 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta1-Agonists, Adrenergic", "MN": "D27.505.696.577.050.100.200.100", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Sympathomimetics (1966-1968)", "MS": "Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058665"}, {"RECTYPE": "D", "MH": "Adrenergic beta-2 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta2-Agonists, Adrenergic", "MN": "D27.505.696.577.050.100.200.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Sympathomimetics (1966-1968)", "MS": "Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058666"}, {"RECTYPE": "D", "MH": "Adrenergic beta-3 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta3-Agonists, Adrenergic", "MN": "D27.505.696.577.050.100.200.300", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Sympathomimetics (1966-1968)", "MS": "Compounds that bind to and activate ADRENERGIC BETA-3 RECEPTORS.", "PM": "2011", "HN": "2011", "MR": "20140610", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058667"}, {"RECTYPE": "D", "MH": "Adrenergic alpha-1 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "alpha1-Antagonists, Adrenergic", "MN": "D27.505.696.577.050.200.100.100", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Sympatholytics (1966-1968)", "MS": "Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS.", "PM": "2011", "HN": "2011", "MR": "20180614", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058668"}, {"RECTYPE": "D", "MH": "Adrenergic alpha-2 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "alpha2-Antagonists, Adrenergic", "MN": "D27.505.696.577.050.200.100.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Sympatholytics (1966-1968)", "MS": "Drugs that bind to and block the activation of ADRENERGIC ALPHA-2 RECEPTORS.", "PM": "2011", "HN": "2011", "MR": "20180614", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058669"}, {"RECTYPE": "D", "MH": "Tetrasomy", "AQ": "DI GE IM PA PP", "PRINT ENTRY": "Partial Tetrasomy|T019|NON|NRW|NLM (2011)|100301|abcdef", "ENTRY": "Tetrasomy, Partial", "MN": "G05.700.131.625", "MH_TH": "NLM (2011)", "ST": "T019", "AN": "coordinate IM with specific chromosome number (IM)", "MS": "The possession of four chromosomes of any one type in an otherwise diploid cell.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058670"}, {"RECTYPE": "D", "MH": "Adrenergic beta-1 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta1-Antagonists, Adrenergic", "MN": "D27.505.696.577.050.200.200.100", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Sympatholytics (1966-1968)", "MS": "Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS.", "PM": "2011", "HN": "2011", "MR": "20180614", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058671"}, {"RECTYPE": "D", "MH": "Adrenergic beta-2 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta2-Antagonists, Adrenergic", "MN": "D27.505.696.577.050.200.200.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Sympatholytics (1966-1968)", "MS": "Drugs that bind to and block the activation of ADRENERGIC BETA-2 RECEPTORS.", "PM": "2011", "HN": "2011", "MR": "20180614", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058672"}, {"RECTYPE": "D", "MH": "Adrenergic beta-3 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "beta3 Adrenergic Antagonists", "MN": "D27.505.696.577.050.200.200.300", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Sympatholytics (1966-1968)", "MS": "Drugs that bind to and block the activation of ADRENERGIC BETA-3 RECEPTORS.", "PM": "2011", "HN": "2011", "MR": "20180614", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058673"}, {"RECTYPE": "D", "MH": "Chromosome Duplication", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Duplication, Chromosome|T049|NON|EQV|NLM (2011)|100301|abcdef", "ENTRY": "Duplications, Chromosome", "MN": "G05.558.164", "FX": "Segmental Duplications, Genomic", "MH_TH": "NLM (2011)", "ST": "T049", "MS": "An aberration in which an extra chromosome or a chromosomal segment is made.", "PM": "2011", "HN": "2011", "MR": "20160115", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058674"}, {"RECTYPE": "D", "MH": "Brevibacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.165", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid55080", "MS": "A genus of GRAM-POSITIVE ENDOSPORE-FORMING RODS in the family Paenibacillaceae. Most strains have been isolated from the natural environment, particularly soils.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058675"}, {"RECTYPE": "D", "MH": "Pasteuria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.415.650", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid86004", "PI": "Gram-Positive Endospore-Forming Bacteria (1991-2010)", "MS": "A genus of GRAM-POSITIVE ENDOSPORE-FORMING BACTERIA in the family Pasteuriaceae. It is transmitted via soil or waterborne SPORES.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058676"}, {"RECTYPE": "D", "MH": "Anoxybacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.158.108", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid150247", "PI": "Bacillaceae (2003-2010)", "MS": "A genus of GRAM-POSITIVE ENDOSPORE-FORMING BACTERIA in the family Bacillaceae. Most species have been isolated from HOT SPRINGS.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058677"}, {"RECTYPE": "D", "MH": "Halobacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.158.425", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid45667", "PI": "Bacillaceae (2002-2010)", "MS": "A genus of GRAM-POSITIVE ENDOSPORE-FORMING BACTERIA in the family BACILLACEAE. Species are widely distributed in a variety of hypersaline environments.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058678"}, {"RECTYPE": "D", "MH": "Virgibacillus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.158.900", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid84406", "PI": "Bacillaceae (1999-2010)", "MS": "A genus of GRAM-POSITIVE ENDOSPORE-FORMING RODS in the family BACILLACEAE. They have been isolated from salty environments, food, water, and clinical specimens.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058679"}, {"RECTYPE": "D", "MH": "Genetic Pleiotropy", "AQ": "DE GE IM PH RE", "ENTRY": "Pleiotropy, Genetic", "MN": "G05.695.550", "MH_TH": "NLM (2011)", "ST": "T045", "AN": "may appear in the literature spelled pleiotrophic, pleiotrophy or pleiotrophism", "MS": "A phenomenon in which multiple and diverse phenotypic outcomes are influenced by a single gene (or single gene product.)", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058685"}, {"RECTYPE": "D", "MH": "Coronary-Subclavian Steal Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Coronary-Subclavian Steal", "MN": "C23.550.767.115", "FX": "Subclavian Steal Syndrome", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "do not confuse with SUBCLAVIAN STEAL SYNDROME", "PI": "Subclavian Steal Syndrome (1986-2010)", "MS": "A complication of INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS whereby an occlusion or stenosis of the proximal SUBCLAVIAN ARTERY causes a reversal of the blood flow away from the CORONARY CIRCULATION, through the grafted INTERNAL MAMMARY ARTERY (internal thoracic artery), and back to the distal subclavian distribution.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058686"}, {"RECTYPE": "D", "MH": "Out-of-Hospital Cardiac Arrest", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Out-of-Hospital Heart Arrests", "MN": "C14.280.383.610", "MH_TH": "NLM (2011)", "ST": "T046", "PI": "Heart Arrest (1976-2010)", "MS": "Occurrence of heart arrest in an individual when there is no immediate access to medical personnel or equipment.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058687"}, {"RECTYPE": "D", "MH": "Peripartum Period", "AQ": "BL CF DE EH ES GE IM ME PH PX RE UR", "ENTRY": "Womens, Peripartum", "MN": "G08.686.701", "MH_TH": "NLM (2011)", "ST": "T079", "PI": "Pregnancy (1975-2010)", "MS": "The period shortly before, during, and immediately after giving birth.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058725"}, {"RECTYPE": "D", "MH": "Nanoconjugates", "AQ": "AD AE AN CH CL EC HI MI PO PS RE SD SN ST TO TU UL VI", "ENTRY": "Nanoconjugate", "MN": "J01.637.512.600.577", "MH_TH": "NLM (2011)", "ST": "T073", "RN": "0", "MS": "Tailored macromolecules harboring covalently-bound biologically active modules that target specific tissues and cells. The active modules or functional groups can include drugs, prodrugs, antibodies, and oligonucleotides, which can act synergistically and be multitargeting.", "PM": "2011", "HN": "2011", "MR": "20150331", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058726"}, {"RECTYPE": "D", "MH": "RNA, Small Untranslated", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Untranslated RNA, Small", "MN": "D13.444.735.790.552", "MH_TH": "NLM (2011)", "ST": "T114", "RN": "0", "PI": "RNA, Untranslated (2005-2010)", "MS": "Short RNA, about 200 base pairs in length or shorter, that does not code for protein.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058727"}, {"RECTYPE": "D", "MH": "Weed Control", "AQ": "EC ES HI IS LJ MT OG SN ST TD", "ENTRY": "Control, Weed", "MN": "N06.850.780.200.650.925", "FX": "Plant Weeds", "MH_TH": "NLM (2011)", "ST": "T068", "PI": "Herbicides (1968-2010)", "MS": "The prevention of growth and or spread of unwanted plants.", "PM": "2011", "HN": "2011", "MR": "20150210", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058728"}, {"RECTYPE": "D", "MH": "Peripheral Arterial Disease", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Peripheral Artery Diseases", "MN": "C14.907.617.671", "MH_TH": "NLM (2011)", "ST": "T047", "AN": "coordinate IM with specific peripheral artery IM if pertinent", "PI": "Peripheral Vascular Diseases (1991-2010)", "MS": "Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.", "PM": "2011; for PERIPHERAL ARTERIAL DISEASES see PERIPHERAL VASCULAR DISEASES 2007-2010", "HN": "2011; for PERIPHERAL ARTERIAL DISEASES use PERIPHERAL VASCULAR DISEASES 2007-2010", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058729"}, {"RECTYPE": "D", "MH": "Blood Safety", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Hemovigilance|T061|NON|REL|NLM (2011)|100311|abcdef", "ENTRY": "Safety, Blood Supply", "MN": "N06.850.780.200.450.325", "FX": "Transfusion Reaction", "MH_TH": "NLM (2011)", "ST": "T080", "PI": "Blood Transfusion/standards (1998-2010)", "MS": "The degree to which the blood supply for BLOOD TRANSFUSIONS is free of harmful substances or infectious agents, and properly typed and crossmatched (BLOOD GROUPING AND CROSSMATCHING) to insure serological compatibility between BLOOD DONORS and recipients.", "PM": "2011", "HN": "2011", "MR": "20220711", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058731"}, {"RECTYPE": "D", "MH": "Embryoid Bodies", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Embryoid Body", "MN": "A11.872.700.250.260", "MH_TH": "NLM (2011)", "ST": "T025", "PI": "Embryonic Stem Cells (1986-2010)", "MS": "Spontaneous aggregations of human embryonic stem cells that occur in vitro after culturing in a medium that lacks LEUKEMIC INHIBITORY FACTOR. The embryoid bodies can further differentiate into cells that represent different lineages.", "PM": "2011", "HN": "2011", "MR": "20150706", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058732"}, {"RECTYPE": "D", "MH": "Hand-Assisted Laparoscopy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgery, Hand-Assisted Laparoscopic", "MN": "E04.502.250.520.580", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Laparoscopy/methods (1995-2010)", "MS": "Placement of one of the surgeon's gloved hands into the ABDOMINAL CAVITY to perform manual manipulations that facilitate the laparoscopic procedures.", "PM": "2011", "HN": "2011", "MR": "20150629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058733"}, {"RECTYPE": "D", "MH": "Exsanguination", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hemorrhages, Exsanguinating", "MN": "C23.550.414.734", "MH_TH": "NLM (2011)", "ST": "T033", "MS": "Rapid and extreme blood loss leading to HEMORRHAGIC SHOCK.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058734"}, {"RECTYPE": "D", "MH": "Environmental Policy", "DE": "ENVIR POLICY", "AQ": "EC HI LJ TD", "ENTRY": "Policy, Environmental|T064|NON|EQV|NLM (1996)|950323|POLICY ENVIR|abcdefv", "MN": "N06.230.204", "MH_TH": "NLM (1996)", "ST": "T064", "PI": "Public Policy (1987-2010)", "MS": "A course of action or principle adopted or proposed by a government, party, business, or individual that concerns human interactions with nature and natural resources.", "PM": "2011; see ENVIRONMENT 1996-2010", "HN": "2011; use ENVIRONMENT 1996-2010", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058735"}, {"RECTYPE": "D", "MH": "Intrauterine Device Migration", "AQ": "AE DE ET RE TD", "ENTRY": "Migrations, Intrauterine Device", "MN": "E05.325.578", "MH_TH": "NLM (1996)", "ST": "T067", "PI": "Intrauterine Devices (1977-2010)", "MS": "The shifting in position or location of an INTRAUTERINE DEVICE from its original placement.", "PM": "2011; see INTRAUTERINE DEVICE 1996-2010; for IUD MIGRATION see INTRAUTERINE DEVICE 1994-2010", "HN": "2011; use INTRAUTERINE DEVICE 1996-2010; for IUD MIGRATION use INTRAUTERINE DEVICE 1994-2010", "MR": "20130709", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058736"}, {"RECTYPE": "D", "MH": "Arthroplasty, Replacement, Ankle", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Total Ankle Replacements", "MN": "E04.650.110.010", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Arthroplasty, Replacement (2000-2010)", "MS": "Replacement of the ANKLE JOINT.", "PM": "2011", "HN": "2011", "MR": "20220406", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058737"}, {"RECTYPE": "D", "MH": "Uterine Balloon Tamponade", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Uterine Balloon Tamponades", "MN": "E05.157.063.500", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "Inflation of a balloon CATHETER within the uterine cavity to control UTERINE HEMORRHAGE.", "PM": "2011", "HN": "2011", "MR": "20150622", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058738"}, {"RECTYPE": "D", "MH": "Aberrant Crypt Foci", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Foci, Aberrant Crypt", "MN": "C04.834.020", "MH_TH": "NLM (2011)", "ST": "T191", "AN": "coordinate IM with COLORECTAL NEOPLASMS or specifics (IM)", "PI": "Precancerous Conditions (1991-2010)", "MS": "Clusters of colonic crypts that appear different from the surrounding mucosa when visualized after staining. They are of interest as putative precursors to colorectal adenomas and potential biomarkers for colorectal carcinoma.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058739"}, {"RECTYPE": "D", "MH": "Iliotibial Band Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "IT Band Syndrome|T047|ABX|EQV|NLM (2020)|190118|abcdef", "MN": "C26.844.150.425", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Knee Injuries (1993-2010)", "MS": "An overuse injury causing lateral knee pain that results from repetitive friction of the iliotibial band over the lateral femoral epicondyle.", "PM": "2011", "HN": "2011", "MR": "20190222", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058745"}, {"RECTYPE": "D", "MH": "Gestational Sac", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sacs, Gestational", "MN": "A16.535", "MH_TH": "NLM (2011)", "ST": "T018", "MS": "Round-shaped structure usually located in the upper fundus of the UTERUS in early pregnancy. It comprises EMBRYO; AMNIOTIC FLUID; and YOLK SAC. It is visible in PRENATAL ULTRASONOGRAPHY by the fifth week of pregnancy. Its size is often used to determine and monitor GESTATIONAL AGE; FETAL GROWTH; and PREGNANCY COMPLICATIONS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058746"}, {"RECTYPE": "D", "MH": "CHARGE Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Familial CHARGE Syndrome|T047|ACX|NRW|NLM (2011)|ORD (2010)|100315|abcdeef", "ENTRY": "Hall Hittner Syndrome", "MN": "C23.888.592.763.941.162.625.500", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Rare disease characterized by COLOBOMA; CHOANAL ATRESIA; and abnormal SEMICIRCULAR CANALS. Mutations in CHD7 protein resulting in disturbed neural crest development are associated with CHARGE Syndrome.", "PM": "2011", "HN": "2011", "MR": "20220413", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058747"}, {"RECTYPE": "D", "MH": "Pain Perception", "AQ": "CL DE ES PH RE", "ENTRY": "Perceptions, Pain", "MN": "F02.463.593.504", "MH_TH": "NLM (2011)", "ST": "T041", "AN": "differentiate from PAIN; PAIN PERCEPTION takes place in the brain", "PI": "Pain (1963-2010)", "MS": "The process by which PAIN is recognized and interpreted by the brain.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058748"}, {"RECTYPE": "D", "MH": "Military Facilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Military Fort", "MN": "J03.560", "MH_TH": "NLM (2011)", "ST": "T073", "MS": "Areas designated for use by the armed forces personnel.", "PM": "2011", "HN": "2011", "MR": "20160608", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058749"}, {"RECTYPE": "D", "MH": "Epithelial-Mesenchymal Transition", "AQ": "DE GE IM PH RE", "ENTRY": "Transition, Epithelial-Mesenchymal", "MN": "G04.356.500", "MH_TH": "NLM (2011)", "ST": "T043", "AN": "epithelial-mesenchymal transition may occur in the progression of both neoplastic and non-neoplastic diseases", "MS": "Phenotypic changes of EPITHELIAL CELLS to MESENCHYME type, which increase cell mobility critical in many developmental processes such as NEURAL TUBE development. NEOPLASM METASTASIS and DISEASE PROGRESSION may also induce this transition.", "PM": "2011", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058750"}, {"RECTYPE": "D", "MH": "Livestock", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Livestocks", "MN": "B01.050.050.116.500", "MH_TH": "NLM (1993)", "ST": "T008", "AN": "prefer specific domestic animals like CATTLE; SHEEP; HORSES; etc.; excludes POULTRY", "PI": "Animals, Domestic (1963-2010)", "MS": "Domesticated farm animals raised for home use or profit but excluding POULTRY. Typically livestock includes CATTLE; SHEEP; HORSES; SWINE; GOATS; and others.", "PM": "2011; see ANIMALS, DOMESTIC 1993-2010", "HN": "2011; use ANIMALS, DOMESTIC 1993-2010", "MR": "20200902", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058751"}, {"RECTYPE": "D", "MH": "Free Tissue Flaps", "AQ": "AE BS CL EC ES HI IM IR MI PA PH PS SD SN ST SU TD TR VE VI", "PRINT ENTRY": "Free Flaps|T023|NON|EQV|NLM (2011)|100316|abcdef", "ENTRY": "Tissue Flaps, Free", "MN": "E07.862.710.500", "MH_TH": "NLM (2011)", "ST": "T023", "PI": "Surgical Flaps (1979-2010)", "MS": "A mass of tissue that has been cut away from its surrounding areas to be used in TISSUE TRANSPLANTATION.", "PM": "2011", "HN": "2011", "MR": "20120703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058752"}, {"RECTYPE": "D", "MH": "Laryngoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Medialization Laryngoplasties", "MN": "E04.580.371", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Larynx or specifics /surgery (1969-2010)", "MS": "Restoration, reconstruction, or improvement of a defective or damaged LARYNX.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058753"}, {"RECTYPE": "D", "MH": "Neurofeedback", "AQ": "CL DE ES IS MT PH RE", "PRINT ENTRY": "Brainwave Feedback|T041|T061|NON|NRW|NLM (2010)|081021|abbcdef", "ENTRY": "Neurofeedbacks", "MN": "F04.754.308.500.750", "MH_TH": "NLM (2010)", "ST": "T061", "PI": "Biofeedback, Psychology (1995-2010)", "MS": "A technique to self-regulate brain activities provided as a feedback in order to better control or enhance one's own performance, control or function. This is done by trying to bring brain activities into a range associated with a desired brain function or status.", "PM": "2011", "HN": "2011", "MR": "20170703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058765"}, {"RECTYPE": "D", "MH": "Levoleucovorin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "levo leucovorin", "MN": "D03.633.100.733.631.400.800.350.450.500", "PA": "Antidotes", "MH_TH": "NLM (1998)", "ST": "T127", "RN": "990S25980Y", "RR": "80433-71-2", "MS": "A folate analog consisting of the pharmacologically active isomer of LEUCOVORIN.", "PM": "2011; See LEUCOVORIN 1998-2010: See LEUCOVORIN, (S)-Isomer 1998-2010: See LEUCOVORIN, Calcium (1:1) Salt, (S)-Isomer 1998-2010: See LEUCOVORIN, Monopotassium Salt, (S)-Isomer 1998-2010: See LEUCOVORIN, Monosodium Salt, (S)-Isomer 1998-2010", "HN": "2011; Use LEUCOVORIN 1998-2010: Use LEUCOVORIN, (S)-Isomer 1998-2010: Use LEUCOVORIN, Calcium (1:1) Salt, (S)-Isomer 1998-2010: Use LEUCOVORIN, Monopotassium Salt, (S)-Isomer 1998-2010: Use LEUCOVORIN, Monosodium Salt, (S)-Isomer 1998-2010", "MR": "20160531", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058766"}, {"RECTYPE": "D", "MH": "Protein Unfolding", "AQ": "DE RE", "ENTRY": "Unfolding, Protein", "MN": "G02.111.688.750", "FX": "Unfolded Protein Response", "MH_TH": "NLM (2011)", "ST": "T044", "PI": "Protein Folding (1992-2010)", "MS": "Conformational transitions of the shape of a protein to various unfolded states.", "PM": "2011", "HN": "2011", "MR": "20180702", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058767"}, {"RECTYPE": "D", "MH": "GABA-A Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Receptor Agonists, GABA-A", "MN": "D27.505.696.577.240.200.500", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "GABA Agonists (1994-2010)", "MS": "Endogenous compounds and drugs that bind to and activate GABA-A RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058785"}, {"RECTYPE": "D", "MH": "GABA-B Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Receptor Agonists, GABA-B", "MN": "D27.505.696.577.240.200.750", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "GABA Agonists (1994-2010)", "MS": "Endogenous compounds and drugs that bind to and activate GABA-B RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058786"}, {"RECTYPE": "D", "MH": "GABA-A Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Receptor Antagonists, GABA-A", "MN": "D27.505.696.577.240.300.500", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "GABA Antagonists (1994-2010)", "MS": "Drugs that bind to but do not activate GABA-A RECEPTORS thereby blocking the actions of endogenous or exogenous GABA-A RECEPTOR AGONISTS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058787"}, {"RECTYPE": "D", "MH": "GABA-B Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Receptor Antagonists, GABA-B", "MN": "D27.505.696.577.240.300.750", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "GABA Antagonists (1994-2010)", "MS": "Drugs that bind to but do not activate GABA-B RECEPTORS thereby blocking the actions of endogenous or exogenous GABA-B RECEPTOR AGONISTS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058788"}, {"RECTYPE": "D", "MH": "GABA Uptake Inhibitors", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gamma-Aminobutyric Acid Plasma Membrane Transport Inhibitor|T121|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Uptake Inhibitors, Gamma Aminobutyric Acid", "MN": "D27.505.696.577.600.535", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "GABA Plasma Membrane Transport Proteins/antagonists & inhibitors (2006-2010)", "MS": "Compounds that suppress or block the plasma membrane transport of GAMMA-AMINOBUTYRIC ACID by GABA PLASMA MEMBRANE TRANSPORT PROTEINS.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058805"}, {"RECTYPE": "D", "MH": "Serotonin 5-HT1 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "5-HT1 Agonists|T121|ABX|EQV|NLM (1993)|920303|5 HT1 AG|abcdefv", "ENTRY": "Serotonin 5 HT1D Receptor Agonists", "MN": "D27.505.696.577.850.800.100", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "MS": "Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes.", "PM": "2011; see SEROTONIN AGONISTS 1992-2010", "HN": "2011; use SEROTONIN AGONISTS 1992-2010", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058825"}, {"RECTYPE": "D", "MH": "Serotonin 5-HT2 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Serotonin 5 HT2C Receptor Agonists", "MN": "D27.505.696.577.850.800.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Serotonin Agonists (1993-2010)", "MS": "Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT2 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT2 receptor subtypes.", "PM": "2011; see SEROTONIN AGONISTS 1993-2010", "HN": "2011; use SEROTONIN AGONISTS 1993-2010", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058826"}, {"RECTYPE": "D", "MH": "Serotonin 5-HT3 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Serotonin 5 HT3 Receptor Agonists", "MN": "D27.505.696.577.850.800.300", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Serotonin Agonists (1993-2010)", "MS": "Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT3 RECEPTORS.", "PM": "2011; see SEROTONIN AGONISTS 1993-2010", "HN": "2011; use SEROTONIN AGONISTS 1993-2010", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058827"}, {"RECTYPE": "D", "MH": "Serotonin 5-HT4 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Serotonin 5 HT4 Receptor Agonists", "MN": "D27.505.696.577.850.800.400", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Serotonin/physiology (1966-1992)", "MS": "Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT4 RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058828"}, {"RECTYPE": "D", "MH": "Serotonin 5-HT1 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Serotonin 5 HT1D Receptor Antagonists", "MN": "D27.505.696.577.850.850.100", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Serotonin Antagonists (1978-2010)", "MS": "Drugs that bind to but do not activate SEROTONIN 5-HT1 RECEPTORS, thereby blocking the actions of SEROTONIN 5-HT1 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more of the specific 5-HT1 receptor subtypes.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058829"}, {"RECTYPE": "D", "MH": "Serotonin 5-HT2 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Serotonin 5 HT2C Receptor Antagonists", "MN": "D27.505.696.577.850.850.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Serotonin Antagonists (1978-2010)", "MS": "Drugs that bind to but do not activate SEROTONIN 5-HT2 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT2 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more specific 5-HT2 receptor subtypes.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058830"}, {"RECTYPE": "D", "MH": "Serotonin 5-HT3 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Serotonin 5 HT3 Receptor Antagonists", "MN": "D27.505.696.577.850.850.300", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Serotonin Antagonists (1978-2010)", "MS": "Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058831"}, {"RECTYPE": "D", "MH": "Serotonin 5-HT4 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Serotonin 5 HT4 Receptor Antagonists", "MN": "D27.505.696.577.850.850.400", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Serotonin Antagonists (1978-2010)", "MS": "Drugs that bind to but do not activate SEROTONIN 5-HT4 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN RECEPTOR AGONISTS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058832"}, {"RECTYPE": "D", "MH": "Antithrombin Proteins", "AQ": "AD AE AG AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.872.060", "PA": "Antithrombins", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "AN": "ANTITHROMBINS is also available", "PI": "Antithrombins (1976-2010)", "MS": "An endogenous family of proteins belonging to the serpin superfamily that neutralizes the action of thrombin. Six naturally occurring antithrombins have been identified and are designated by Roman numerals I to VI. Of these, Antithrombin I (see FIBRIN) and ANTITHROMBIN III appear to be of major importance.", "PM": "2011", "HN": "2011", "MR": "20150622", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058833"}, {"RECTYPE": "D", "MH": "Gemella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.100.310", "MH_TH": "NLM (2003)", "ST": "T007", "RN": "txid1378", "AN": "infection: coordinate IM with GRAM POSITIVE BACTERIAL INFECTIONS (IM)", "PI": "Staphylococcaceae (2002-2010)", "MS": "A genus that has been reclassified into BACILLALES incertae sedis because of its ambiguous taxonomy. Previously it was considered part of the Staphylococcaceae family.", "PM": "2011; see STAPHYLOCOCCACEAE 2003-2010", "HN": "2011; use STAPHYLOCOCCACEAE 2003-2010", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058834"}, {"RECTYPE": "D", "MH": "Abiotrophia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.030.014", "MH_TH": "NLM (2010)", "ST": "T007", "RN": "txid46123", "AN": "infection: coordinate IM with GRAM POSITIVE BACTERIAL INFECTIONS (IM)", "PI": "Streptococcus (1995-2008)", "MS": "A genus of gram-positive, facultatively anaerobic bacteria in the family Aerococcaceae.", "PM": "2011; see AEROCOCCACEAE 2010-2011", "HN": "2011; use AEROCOCCACEAE 2010-2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058835"}, {"RECTYPE": "D", "MH": "Weissella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.550.475.900", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid46255", "AN": "infection: coordinate IM with GRAM POSITIVE BACTERIAL INFECTIONS (IM)", "PI": "Leuconostocaceae (1993-2010)", "MS": "A genus of gram-positive, asporogenous, lactic acid bacteria, in the family LEUCONOSTOCACEAE.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058836"}, {"RECTYPE": "D", "MH": "Moorella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.525", "MH_TH": "NLM (2011)", "ST": "T007", "RN": "txid44260", "MS": "A genus of gram positive, acetogenic, thermophilic bacteria in the family Thermoanaerobacteraceae. Known habitats include HOT SPRINGS, horse manure, emu droppings, and sewage SLUDGE.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058845"}, {"RECTYPE": "D", "MH": "Antibodies, Monoclonal, Murine-Derived", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Murine Derived Monoclonal Antibodies", "MN": "D12.776.377.715.548.114.224.284", "MH_TH": "NLM (2011)", "ST": "T129", "RN": "0", "AN": "use when indicated in text; follow author's terminology", "PI": "Antibodies, Monoclonal (1996-2010)", "MS": "Antibodies obtained from a single clone of cells grown in mice or rats.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058846"}, {"RECTYPE": "D", "MH": "Inflammasomes", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pyroptosomes|T116|T123|NON|EQV|NLM (2016)|150520|abbcdef", "MN": "D05.500.224", "FX": "NLR Family, Pyrin Domain-Containing 3 Protein", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "Multiprotein complexes that mediate the activation of CASPASE-1. Dysregulation of inflammasomes has also been linked to a number of autoinflammatory and autoimmune disorders.", "PM": "2011", "HN": "2011", "MR": "20170224", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058847"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic P2X4", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Receptor, P2X4", "MN": "D12.776.543.750.720.700.720.500.400", "EC": "antagonists & inhibitors:Purinergic P2X Receptor Antagonists", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A widely distributed purinergic P2X receptor subtype that plays a role in pain sensation. P2X4 receptors found on MICROGLIA cells may also play a role in the mediation of allodynia-related NEUROPATHIC PAIN.", "PM": "2011; PURINERGIC P2X4 RECEPTOR now RECEPTORS, PURINERGIC P2X4 was indexed under RECEPTORS, PURINERGIC P2X4 1996-2010", "HN": "2011", "MR": "20160701", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058848"}, {"RECTYPE": "D", "MH": "Protein Refolding", "AQ": "DE RE", "ENTRY": "Refolding, Protein", "MN": "G02.111.688.501", "MH_TH": "NLM (2011)", "ST": "T044", "PI": "Protein Folding (1992-2010)", "MS": "Conformational transitions of a protein from unfolded states (after PROTEIN UNFOLDING)  to a more folded state.", "PM": "2011", "HN": "2011", "MR": "20180702", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058849"}, {"RECTYPE": "D", "MH": "Opiate Substitution Treatment", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Opioid Maintenance Treatment|T061|NON|EQV|NLM (2021)|191129|abcdef", "ENTRY": "Treatment, Opioid Maintenance", "MN": "E02.319.620", "FX": "Methadone", "MH_TH": "NLM (2011)", "ST": "T061", "AN": "coordinate with specific opioid dependence /rehabil or /drug ther and specific substituted opioid /ther use", "PI": "Opioid-Related Disorders/rehabilitation (1981-2010)", "MS": "Medication-assisted treatment of opioid dependence using a substitute opiate such as METHADONE or BUPRENORPHINE.", "PM": "2011", "HN": "2011", "MR": "20200116", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058850"}, {"RECTYPE": "D", "MH": "GPI-Linked Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "GPI-Anchored Proteins|T116|T123|ABX|EQV|NLM (2021)|200312|abbcdef", "ENTRY": "Proteins, Glycosylphosphatidylinositol Linked", "MN": "D12.776.543.550.418", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A subclass of lipid-linked proteins that contain a GLYCOSYLPHOSPHATIDYLINOSITOL LINKAGE which holds them to the CELL MEMBRANE.", "PM": "2011", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058851"}, {"RECTYPE": "D", "MH": "Introduced Species", "AQ": "EC HI LJ SN TD", "PRINT ENTRY": "Invasive Species|T098|NON|NRW|NLM (2011)|100402|abcdef", "ENTRY": "Alien Specy", "MN": "N06.230.124.049.400", "MH_TH": "NLM (2011)", "ST": "T098", "MS": "Non-native organisms brought into a region, habitat, or ECOSYSTEM by human activity.", "PM": "2011", "HN": "2011", "MR": "20200116", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058865"}, {"RECTYPE": "D", "MH": "Osteoporotic Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Osteoporotic Fracture", "MN": "C26.404.545", "MH_TH": "NLM (2011)", "ST": "T037", "PI": "Osteoporosis/complications (1982-2010)", "MS": "Breaks in bones resulting from low bone mass and microarchitectural deterioration characteristic of OSTEOPOROSIS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058866"}, {"RECTYPE": "D", "MH": "Lipoprotein Lipase Activators", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lipoprotein Lipase Activating Agents|T121|NON|EQV|NLM (2011)|100401|abcdef", "ENTRY": "Lipase Activators, Lipoprotein", "MN": "D27.505.954.557.500.601.500", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "MS": "Compounds that increase the enzymatic activity of LIPOPROTEIN LIPASE. Lipoprotein lipase activators have a potential role in the treatment of OBESITY by increasing LIPID METABOLISM. Note that substances that increase the synthesis of lipoprotein lipase are not included here.", "PM": "2011; LIPOPROTEIN LIPASE ACTIVATORS was indexed under PEPTIDES 1980-2010", "HN": "2011", "MR": "20140625", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058867"}, {"RECTYPE": "D", "MH": "Compressed Air", "AQ": "AE CL EC ES HI MI PS SD SN ST TD TU VE VI", "ENTRY": "Air, Pressurized", "MN": "N06.230.300.100.150.592", "MH_TH": "NLM (2011)", "ST": "T167", "MS": "Air that is reduced in volume by pressure.", "PM": "2011", "HN": "2011", "MR": "20150331", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058868"}, {"RECTYPE": "D", "MH": "Gynecological Examination", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Vaginal Exams", "MN": "E01.370.600.293", "MH_TH": "NLM (2011)", "ST": "T060", "MS": "Inspection and PALPATATION of female breasts, abdomen, and GENITALIA, as well as obtaining a gynecological history. (from Dictionary of Obstetrics and Gynecology)", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058869"}, {"RECTYPE": "D", "MH": "Food, Organic", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Organic Food|T168|NON|EQV|NLM (1996)|950403|abcdef", "ENTRY": "Produce, Organic", "MN": "J02.500.519", "FX": "Organic Agriculture", "MH_TH": "NLM (1996)", "ST": "T168", "PI": "Health Food (1997-2010)", "MS": "Food that is grown or manufactured in accordance with nationally regulated production standards that include restrictions on the use of pesticides, non-organic fertilizers, genetic engineering, growth hormones, irradiation, antibiotics, and non-organic ingredients.", "PM": "2011; see HEALTH FOOD 1996-2010", "HN": "2011(1996)", "MR": "20230526", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058870"}, {"RECTYPE": "D", "MH": "Organic Agriculture", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Organic Garden", "MN": "J01.040.895", "FX": "Food, Organic", "MH_TH": "NLM (2011)", "ST": "T057", "PI": "Agriculture or specifics (1993-2010)", "MS": "Systems of agriculture which adhere to nationally regulated standards that restrict the use of pesticides, non-organic fertilizers, genetic engineering, growth hormones, irradiation, antibiotics, and non-organic ANIMAL FEED.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058871"}, {"RECTYPE": "D", "MH": "Epidemics", "AQ": "CL EC ES HI LJ PC PX SN VE", "MN": "N06.850.290.200", "MH_TH": "NLM (1983)", "ST": "T067", "AN": "coordinate IM with specific disease / epidemiol (IM) & specify geographic location if pertinent; differentiate from DISEASE OUTBREAKS, follow terminology in text", "PI": "Disease Outbreaks (1966-2010)", "MS": "Sudden outbreaks of a disease in a country or region not previously recognized in that area, or a rapid increase in the number of new cases of a previous existing endemic disease. Epidemics can also refer to outbreaks of disease in animal or plant populations.", "PM": "2011; see DISEASE OUTBREAKS 1968-2010", "HN": "2011; use DISEASE OUTBREAKS 1968-2010", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058872"}, {"RECTYPE": "D", "MH": "Pandemics", "AQ": "CL EC ES HI LJ PC SN VE", "ENTRY": "Pandemic", "MN": "N06.850.290.200.600", "MH_TH": "NLM (2006)", "ST": "T067", "AN": "coordinate with specific disease / epidemiol and specify geographic location if pertinent", "PI": "Disease Outbreaks (1967-2010)", "MS": "Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people.", "PM": "2011; see DISEASE OUTBREAKS 2006-2010", "HN": "2011; use DISEASE OUTBREAKS 2006-2010", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058873"}, {"RECTYPE": "D", "MH": "Electrowetting", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Electrowettings", "MN": "E05.830.666.500", "FX": "Wettability", "MH_TH": "NLM (2011)", "ST": "T062", "AN": "for electrowetting agents coordinate with WETTING AGENTS", "PI": "Wettability (2003-2010)", "MS": "Reducing the SURFACE TENSION at a liquid/solid interface by the application of an electric current across the interface thereby enhancing the WETTABILITY of the surface.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058874"}, {"RECTYPE": "D", "MH": "Multilocus Sequence Typing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Typing, Multilocus Sequence", "MN": "E05.393.760.700.650", "MH_TH": "NLM (2011)", "ST": "T062", "AN": "coordinate with BACTERIAL TYPING TECHNIQUES or MYCOLOGICAL TYPING TECHNIQUES if pertinent", "MS": "Direct nucleotide sequencing of gene fragments from multiple housekeeping genes for the purpose of phylogenetic analysis, organism identification, and typing of species, strain, serovar, or other distinguishable phylogenetic level.", "PM": "2011", "HN": "2011", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058885"}, {"RECTYPE": "D", "MH": "Sterol 14-Demethylase", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Sterol 14-Demethylases|T116|T126|NON|EQV|NLM (2011)|100405|abbcdef", "ENTRY": "Sterol 14 alpha Demethylase", "MN": "D12.776.422.220.453.915.880", "EC": "antagonists & inhibitors:14-alpha Demethylase Inhibitors", "MH_TH": "NLM (2011)", "ST": "T126", "RN": "EC 1.14.14.154", "MS": "An NADPH-dependent P450 enzyme that plays an essential role in the sterol biosynthetic pathway by catalyzing the demethylation of 14-methyl sterols such as lanosterol. The enzyme acts via the repeated hydroxylation of the 14-methyl group, resulting in its stepwise conversion into an alcohol, an aldehyde and then a carboxylate, which is removed as formic acid. Sterol 14-demethylase is an unusual cytochrome P450 enzyme in that it is found in a broad variety of organisms including ANIMALS; PLANTS; FUNGI; and protozoa.", "PM": "2011; STEROL 14-DEMETHYLASE was indexed under CYTOCHROME P-450 ENZYME SYSTEM 2009-2010, under OXIDOREDUCTASES 1978-2008, & under LANOSTEROL 1976-1982", "HN": "2011", "MR": "20190705", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058886"}, {"RECTYPE": "D", "MH": "14-alpha Demethylase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Lanosterol 14 alpha Demethylase Inhibitors", "MN": "D27.505.696.399.450.855.100", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "MS": "Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL AGENTS act through this mechanism.", "PM": "2011", "HN": "2011", "MR": "20140625", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058888"}, {"RECTYPE": "D", "MH": "Molecular Typing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Typing, Molecular", "MN": "E05.393.542", "FX": "Molecular Epidemiology", "MH_TH": "NLM (2011)", "ST": "T062", "AN": "for molecular typing of fungi, coordinate with MYCOLOGICAL TYPING TECHNIQUES", "MS": "Using MOLECULAR BIOLOGY techniques, such as DNA SEQUENCE ANALYSIS; PULSED-FIELD GEL ELECTROPHORESIS; and DNA FINGERPRINTING, to identify, classify, and compare organisms and their subtypes.", "PM": "2011", "HN": "2011", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058889"}, {"RECTYPE": "D", "MH": "Granulomatous Mastitis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Mastitis, Granulomatous", "MN": "C17.800.090.968.400", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Mastitis (1971-2010)", "MS": "A rare, benign, inflammatory breast disease occurring in premenopausal women shortly after a recent pregnancy. The origin is unknown but it is commonly mistaken for malignancy and sometimes associated with BREAST FEEDING and the use of ORAL CONTRACEPTIVES.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058890"}, {"RECTYPE": "D", "MH": "5-alpha Reductase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Testosterone 5-alpha-Reductase Inhibitor|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Testosterone 5 alpha Reductase Inhibitors", "MN": "D27.505.696.399.450.855.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "3-Oxo-5-alpha-Steroid 4-Dehydrogenase/antagonists & inhibitors (1976-2010)", "MS": "Drugs that inhibit 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. They are commonly used to reduce the production of DIHYDROTESTOSTERONE.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058891"}, {"RECTYPE": "D", "MH": "Adenosine Deaminase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inhibitors, Adenosine Deaminase", "MN": "D27.505.519.389.092", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Adenosine Deaminase (1975-2010)", "MS": "Drugs that inhibit ADENOSINE DEAMINASE activity.", "PM": "2011", "HN": "2011", "MR": "20140625", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058892"}, {"RECTYPE": "D", "MH": "DNA Barcoding, Taxonomic", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Taxonomic DNA Barcodings", "MN": "E05.393.760.700.149", "MH_TH": "NLM (2011)", "ST": "T062", "MS": "Techniques for standardizing and expediting taxonomic identification or classification of organisms that are based on deciphering the sequence of one or a few regions of DNA known as the \"DNA barcode\".", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058893"}, {"RECTYPE": "D", "MH": "Nematocyst", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nematocysts", "MN": "A13.655", "FX": "Cnidarian Venoms", "MH_TH": "NLM (2011)", "ST": "T023", "MS": "A double-walled capsule found in jellyfish and other CNIDARIA whose functions include prey capture, defense, locomotion, and attachment. Nematocysts contain toxic CNIDARIAN VENOMS which are injected into the victim via a barbed tubule.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058894"}, {"RECTYPE": "D", "MH": "Purinergic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Effects, Purinergic", "MN": "D27.505.696.577.725", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics; note entry term PURINERGIC EFFECT: use only for the purinergic effect of a chemical substance", "MS": "Compounds that act on PURINERGIC RECEPTORS or influence the synthesis, storage, uptake, metabolism, or release of purinergic transmitters.", "PM": "2011", "HN": "2011", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058905"}, {"RECTYPE": "D", "MH": "Purinergic P1 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Receptor Agonists, Adenosine", "MN": "D27.505.696.577.725.200.100", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptors, Purinergic P1/agonists (1994-2010)", "MS": "Compounds that bind to and stimulate PURINERGIC P1 RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058906"}, {"RECTYPE": "D", "MH": "Adenosine A1 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D27.505.696.577.725.200.100.100", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptor, Adenosine A1/agonists (2004-2010)", "MS": "Compounds that bind to and stimulate ADENOSINE A1 RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058907"}, {"RECTYPE": "D", "MH": "Adenosine A2 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Adenosine A2B Receptor Agonists|T121|NON|NRW|NLM (2011)|100408|abcdef", "MN": "D27.505.696.577.725.200.100.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptors, Adenosine A2/agonists (2004-2010)", "MS": "Compounds that selectively bind to and activate ADENOSINE A2 RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058908"}, {"RECTYPE": "D", "MH": "Adenosine A3 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D27.505.696.577.725.200.100.300", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptor, Adenosine A3/agonists (2004-2010)", "MS": "Drugs that selectively bind to and activate ADENOSINE A3 RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058909"}, {"RECTYPE": "D", "MH": "Purinergic P2 Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Purinoceptor Agonists, P2", "MN": "D27.505.696.577.725.200.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptors, Purinergic P2/agonists (1994-2010)", "MS": "Compounds that bind to and stimulate PURINERGIC P2 RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058910"}, {"RECTYPE": "D", "MH": "Purinergic P2X Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Purinoceptor Agonists, P2X7", "MN": "D27.505.696.577.725.200.200.100", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptors, Purinergic P2/agonists (1994-2010)", "MS": "Compounds that bind to and stimulate PURINERGIC P2X RECEPTORS. Included under this heading are agonists for specific P2X receptor subtypes.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058911"}, {"RECTYPE": "D", "MH": "Purinergic P2Y Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Purinoceptor Agonists, P2Y2", "MN": "D27.505.696.577.725.200.200.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptors, Purinergic P2/agonists (1993-2010)", "MS": "Compounds that bind to and stimulate PURINERGIC P2Y RECEPTORS. Included under this heading are agonists for specific P2Y receptor subtypes.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058912"}, {"RECTYPE": "D", "MH": "Purinergic Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Purinoceptor Agonist|T121|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Receptor Agonists, Purinergic", "MN": "D27.505.696.577.725.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptors, Purinergic/agonists (1986-2010)", "MS": "Compounds that bind to and activate PURINERGIC RECEPTORS.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058913"}, {"RECTYPE": "D", "MH": "Purinergic Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Receptor Antagonists, Purinergic", "MN": "D27.505.696.577.725.400", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Drugs that bind to and block the activation of PURINERGIC RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058914"}, {"RECTYPE": "D", "MH": "Purinergic P1 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Purinergic P1 Receptor Antagonist|T121|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Receptor Antagonists, Adenosine", "MN": "D27.505.696.577.725.400.100", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptors, Purinergic P1/antagonists & inhibitors (1994-2010)", "MS": "Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058915"}, {"RECTYPE": "D", "MH": "Adenosine A1 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D27.505.696.577.725.400.100.100", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptor, Adenosine A1/antagonists & inhibitors (2004-2010)", "MS": "Compounds that bind to and block the stimulation of ADENOSINE A1 RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058916"}, {"RECTYPE": "D", "MH": "Adenosine A2 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Adenosine A2B Receptor Antagonists|T121|ABX|NRW|NLM (2011)|100408|abcdef", "MN": "D27.505.696.577.725.400.100.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptors, Adenosine A2/antagonists & inhibitors (2004-2010)", "MS": "Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058917"}, {"RECTYPE": "D", "MH": "Adenosine A3 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D27.505.696.577.725.400.100.300", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptor, Adenosine A3/antagonists & inhibitors (2004-2010)", "MS": "Compounds that selectively bind to and block the activation of ADENOSINE A3 RECEPTORS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058918"}, {"RECTYPE": "D", "MH": "Purinergic P2 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Purinoceptor Blockers, P2", "MN": "D27.505.696.577.725.400.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptors, Purinergic P2/antagonists & inhibitors (1994-2010)", "MS": "Compounds that bind to and block the stimulation of PURINERGIC P2 RECEPTORS.", "PM": "2011", "HN": "2011", "MR": "20140612", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058919"}, {"RECTYPE": "D", "MH": "Purinergic P2X Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Purinoceptor Antagonists, P2X7", "MN": "D27.505.696.577.725.400.200.100", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptors, Purinergic P2/antagonists & inhibitors (1994-2010)", "MS": "Compounds that bind to and block the stimulation of PURINERGIC P2X RECEPTORS. Included under this heading are antagonists for specific P2X receptor subtypes.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058920"}, {"RECTYPE": "D", "MH": "Purinergic P2Y Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Purinergic P2Y2 Receptor Antagonist|T121|NON|NRW|NLM (2021)|191120|abcdef", "ENTRY": "Receptor Blockers, ADP", "MN": "D27.505.696.577.725.400.200.200", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Receptors, Purinergic P2/antagonists & inhibitors (1993-2010)", "MS": "Compounds that bind to and block the stimulation of PURINERGIC P2Y RECEPTORS. Included under this heading are antagonists for specific P2Y receptor subtypes.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058921"}, {"RECTYPE": "D", "MH": "Inflammatory Breast Neoplasms", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Inflammatory Breast Cancer|T191|NON|EQV|NLM (2011)|100413|abcdef", "ENTRY": "Neoplasms, Inflammatory Breast", "MN": "C17.800.090.500.576", "MH_TH": "NLM (2011)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM)", "PI": "Breast Neoplasms (1973-2010)", "MS": "Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058922"}, {"RECTYPE": "D", "MH": "Medial Tibial Stress Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Medial Tibial Stress Syndromes|T047|NON|EQV|NLM (2021)|200123|abcdef", "ENTRY": "Shin Splint", "MN": "C26.558.705", "MH_TH": "NLM (2011)", "ST": "T047", "PI": "Tibia (1967-2010)", "MS": "SKELETAL MUSCLE pain and tenderness along the posteromedial TIBIA resulting from exercise such as running and other physical activity.", "PM": "2011", "HN": "2011", "MR": "20200228", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058923"}, {"RECTYPE": "D", "MH": "Thienopyridines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Derivatives, Thienopyridine", "MN": "D03.633.100.928", "MH_TH": "NLM (2011)", "ST": "T109", "RN": "0", "MS": "Heterocyclic compounds that contain 4H,5H,6H,7H-thieno[2,3-c]pyridine as part of their structure.", "PM": "2011", "HN": "2011", "MR": "20160601", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058924"}, {"RECTYPE": "D", "MH": "Receptors, Purinergic P2Y12", "AQ": "AD AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Purinoceptors, P2Y12", "MN": "D12.776.543.750.720.700.720.750.300", "EC": "antagonists & inhibitors:Purinergic P2Y Receptor Antagonists", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "A subclass of purinergic P2Y receptors that have a preference for ADP binding and are coupled to GTP-BINDING PROTEIN ALPHA SUBUNIT, GI. The P2Y12 purinergic receptors are found in PLATELETS where they play an important role regulating PLATELET ACTIVATION.", "PM": "2011; PURINOCEPTOR (now RECEPTORS, PURINERGIC P2Y12) was indexed under RECEPTORS, PURINERGIC P2 2009-2010, and under MEMBRANE PROTEINS 2001-2008", "HN": "2011", "MR": "20160415", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058925"}, {"RECTYPE": "D", "MH": "Intraoperative Awareness", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Anesthesia Awareness|T046|NON|EQV|NLM (2011)|100412|abcdef", "ENTRY": "During Anesthesia, Awareness", "MN": "C23.550.505.400", "MH_TH": "NLM (2011)", "ST": "T046", "PI": "Awareness (1976-2010)", "MS": "Occurence of a patient becoming conscious during a procedure performed under GENERAL ANESTHESIA and subsequently having recall of these events. (From Anesthesiology 2006, 104(4): 847-64.)", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058926"}, {"RECTYPE": "D", "MH": "5-Lipoxygenase-Activating Proteins", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Arachidonate 5 Lipoxygenase Activating Proteins", "MN": "D12.776.543.019", "EC": "antagonists & inhibitors:5-Lipoxygenase-Activating Protein Inhibitors", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "Scaffolding proteins that play an important role in the localization and activation of 5-LIPOXYGENASE.", "PM": "2011; 5-LIPOOXYGENASE-ACTIVATING PROTEINS was indexed under CARRIER PROTEINS and MEMBRANE PROTEINS 1990-2010", "HN": "2011(1990)", "MR": "20111031", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058927"}, {"RECTYPE": "D", "MH": "Riboswitch", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Riboswitches|T114|T123|NON|EQV|NLM (2011)|100412|abbcdef", "ENTRY": "Ribosensors|T114|T123|NON|NRW|NLM (2011)|100412|abbcdef", "MN": "G05.360.080.689.687.124", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "Part of a MESSENGER RNA molecule that undergoes a conformation change upon binding a specific metabolite or other small molecule thereby regulating the messenger RNA's transcription, post-transcriptional processing, transport, translation, or stability in response to varying levels of the metabolite or other small molecule.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058928"}, {"RECTYPE": "D", "MH": "Lipoxygenases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.556.579.374.568", "EC": "antagonists & inhibitors:Lipoxygenase Inhibitors", "MH_TH": "NLM (1992)", "ST": "T126", "RN": "EC 1.13.11.-", "AN": "LIPOXYGENASE is also available", "PI": "Lipoxygenase (1992-2010)", "MS": "Dioxygenases that catalyze the peroxidation of methylene-interrupted UNSATURATED FATTY ACIDS.", "PM": "2011; see LIPOXYGENASE 1992-2010", "HN": "2011; use LIPOXYGENASE 1992-2010", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058945"}, {"RECTYPE": "D", "MH": "5-Lipoxygenase-Activating Protein Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Protein Inhibitors, 5-Lipoxygenase-Activating", "MN": "D27.505.519.389.086", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "MS": "Compounds that bind to and inhibit the action of 5-LIPOXYGENASE-ACTIVATING PROTEINS.", "PM": "2011", "HN": "2011", "MR": "20140625", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058946"}, {"RECTYPE": "D", "MH": "Bacterial Secretion Systems", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Systems, Bacterial Secretion", "MN": "D05.500.890.500", "FX": "Membrane Transport Proteins", "MH_TH": "NLM (2011)", "ST": "T116", "RN": "0", "MS": "In GRAM NEGATIVE BACTERIA, multiprotein complexes that function to translocate pathogen protein effector molecules across the bacterial cell envelope, often directly into the host. These effectors are involved in producing surface structures for adhesion, bacterial motility, manipulation of host functions, modulation of host defense responses, and other functions involved in facilitating survival of the pathogen. Several of the systems have homologous components functioning similarly in GRAM POSITIVE BACTERIA.", "PM": "2011", "HN": "2011", "MR": "20150625", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058947"}, {"RECTYPE": "D", "MH": "Cell Tracking", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Trackings, Cell", "MN": "E05.242.373", "FX": "Cell Movement", "MH_TH": "NLM (2011)", "ST": "T062", "MS": "Non-invasive imaging of cells that have been labeled non-destructively, such as with nanoemulsions or reporter genes that can be detected by molecular imaging, to monitor their location, viability, cell lineage expansion, response to drugs, movement, or other behaviors in vivo.", "PM": "2011", "HN": "2011", "MR": "20150601", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058948"}, {"RECTYPE": "D", "MH": "Uromodulin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tamm Horsfall Protein", "MN": "D12.776.543.550.418.850", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A glycosyl-phosphatidyl-inositol (GPI) - anchored membrane protein found on the thick ascending limb of the LOOP OF HENLE. The cleaved form of the protein is found abundantly in URINE.", "PM": "2011; TAMM-HORSFALL PROTEIN (now UROMODULIN) was indexed under MUCOPROTEINS 1974-2010", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058949"}, {"RECTYPE": "D", "MH": "Melanoma-Specific Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Melanoma Antigens|T116|T129|NON|EQV|NLM (2011)|100413|abbcdef", "ENTRY": "Melanoma Specific Antigens", "MN": "D23.050.285.439", "MH_TH": "NLM (2011)", "ST": "T129", "RN": "0", "MS": "Cellular antigens that are specific for MELANOMA cells.", "PM": "2011; MELANOMA-SPECIFIC ANTIGENS was indexed under ANTIGENS, NEOPLASM, and NEOPLASM PROTEINS 1980-2010", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058950"}, {"RECTYPE": "D", "MH": "gp100 Melanoma Antigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "gp100 Melanoma Associated Antigen", "MN": "D23.050.285.439.500", "MH_TH": "NLM (2011)", "ST": "T129", "RN": "0", "MS": "A melanosome-associated protein that plays a role in the maturation of the MELANOSOME.", "PM": "2011; MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100 (now GP100 MELANOMA ANTIGEN) was indexed under MEMBRANE GLYCOPROTEINS 2007-2010, and under NEOPLASM PROTEINS 1994-2006", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058951"}, {"RECTYPE": "D", "MH": "Human papillomavirus 31", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "HPV-31s", "MN": "B04.613.204.655.450.375", "MH_TH": "NLM (2011)", "ST": "T005", "AN": "infection: coordinate IM with PAPILLOMAVIRUS INFECTIONS (IM)", "PI": "Papillomaviridae (1989-2010)", "MS": "A type of ALPHAPAPILLOMAVIRUS associated with high risk for anogenital neoplasms.", "PM": "2011", "HN": "2011", "MR": "20220523", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058952"}, {"RECTYPE": "D", "MH": "Neural Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Stem Cells, Neural", "MN": "A11.872.653", "MH_TH": "NLM (2011)", "ST": "T025", "PI": "Stem Cells (1994-2010)", "MS": "Self-renewing cells that generate the main phenotypes of the nervous system in both the embryo and adult. Neural stem cells are precursors to both NEURONS and NEUROGLIA.", "PM": "2011", "HN": "2011", "MR": "20160701", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058953"}, {"RECTYPE": "D", "MH": "Pancreatic Stellate Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Stellate Cells, Pancreatic", "MN": "A11.700", "MH_TH": "NLM (2011)", "ST": "T025", "PI": "Pancreas/cytology (1998-2010)", "MS": "Star-shaped, myofibroblast-like cells located in the periacinar, perivascular, and periductal regions of the EXOCRINE PANCREAS. They play a key role in the pathobiology of FIBROSIS; PANCREATITIS; and PANCREATIC CANCER.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058954"}, {"RECTYPE": "D", "MH": "Metalloids", "AQ": "AD AE AG AN BL CF CH CL DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Semi-Metal|T196|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Semi Metals", "MN": "D01.268.513", "MH_TH": "NLM (2011)", "ST": "T196", "RN": "0", "PI": "Metals (1962-2010)", "MS": "A class of nonmetals such as arsenic that have some of the chemical properties of a metal.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058955"}, {"RECTYPE": "D", "MH": "Administration, Mucosal", "PRINT ENTRY": "Mucosal Administration|T061|NON|EQV|NLM (2011)|100414|abcdef", "ENTRY": "Transmucosal Routings", "MN": "E02.319.267.120.655", "FX": "Mucous Membrane", "MH_TH": "NLM (2011)", "ST": "T061", "AN": "NIM but only if discussed: do not index here routinely for every mucosal administration of a drug", "MS": "Delivery of a drug or other substance into the body through the epithelium lining of MUCOUS MEMBRANE involved with absorption and secretion.", "PM": "2011", "HN": "2011", "MR": "20150623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058956"}, {"RECTYPE": "D", "MH": "Coronavirus NL63, Human", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "NL63, Human Coronavirus", "MN": "B04.820.578.500.540.150.075.875", "MH_TH": "NLM (2011)", "ST": "T005", "RN": "txid277944", "AN": "infection: coordinate with CORONAVIRUS INFECTIONS and RESPIRATORY TRACT INFECTIONS", "PI": "Coronavirus (2004-2010)", "MS": "A species in the genus CORONAVIRUS causing upper and lower RESPIRATORY TRACT INFECTIONS. It shares the receptor used by the SARS VIRUS.", "PM": "2011", "HN": "2011", "MR": "20200813", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058957"}, {"RECTYPE": "D", "MH": "Organs at Risk", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "at Risks, Organs", "MN": "A01.635", "FX": "Risk Factors", "MH_TH": "NLM (2011)", "ST": "T023", "PI": "specific organ/radiation effects (1979-2010)", "MS": "Organs which might be damaged during exposure to a toxin or to some form of therapy. It most frequently refers to healthy organs located in the radiation field during radiation therapy.", "PM": "2011", "HN": "2011", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058958"}, {"RECTYPE": "D", "MH": "MART-1 Antigen", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Melanoma Antigen Recognized by T-Cells 1|T116|T129|NON|EQV|NLM (2011)|100415|abbcdef", "ENTRY": "Melanoma Antigen Recognized by T Cells 1", "MN": "D23.050.285.439.750", "MH_TH": "NLM (2011)", "ST": "T129", "RN": "0", "MS": "A melanosome-specific protein that plays a role in the expression, stability, trafficking, and processing of GP100 MELANOMA ANTIGEN, which is critical to the formation of Stage II MELANOSOMES. The protein is used as an antigen marker for MELANOMA cells.", "PM": "2011; MART1 ANTIGEN was indexed under ANTIGENS, NEOPLASM and NEOPLASM PROTEINS 1996-2010", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058965"}, {"RECTYPE": "D", "MH": "Contactins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D23.050.301.350.250.325", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A family of immunoglobulin-related cell adhesion molecules that are involved in NERVOUS SYSTEM patterning.", "PM": "2011; CONTACTINS was indexed under CELL ADHESION MOLECULES, NEURONAL 1993-2010, and under MEMBRANE PROTEINS & NERVE TISSUE PROTEINS 1989-1992", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058966"}, {"RECTYPE": "D", "MH": "Contactin 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "gp135, Glycoprotein", "MN": "D23.050.301.350.250.325.100", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A contactin subtype that is predominantly expressed in the CEREBELLUM; HIPPOCAMPUS; NEOCORTEX; and HYPOTHALAMUS.", "PM": "2011; GLYCOPROTEIN GP135 was indexed under MEMBRANE GLYCOPROTEINS and NERVE TISSUE PROTEINS 1991-2010", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058967"}, {"RECTYPE": "D", "MH": "Pythiosis", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VI", "PRINT ENTRY": "Pythium insidiosum Infection|T047|NON|EQV|NLM (2021)|200206|abcdef", "ENTRY": "Pythium insidiosum Infections", "MN": "C22.761", "MH_TH": "NLM (2011)", "ST": "T047", "MS": "A granulomatous disease caused by the aquatic organism PYTHIUM insidiosum and occurring primarily in horses, cattle, dogs, cats, fishes, and rarely in humans. It is classified into three forms: ocular, cutaneous, and arterial.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058968"}, {"RECTYPE": "D", "MH": "Contactin 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "TAX 1 Axonal Glycoprotein", "MN": "D23.050.301.350.250.325.200", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A contactin subtype that plays a role in axon outgrowth, axon fasciculation, and neuronal migration.", "PM": "2011; CONTACTIN 2 was indexed under CELL ADHESION MOLECULES, NEURONAL 2002-2010, and under MEMBRANE GLYCOPROTEINS 1990-2001", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058969"}, {"RECTYPE": "D", "MH": "Tenotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Tenotomies", "MN": "E04.555.712", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "specific muscles/surgery (1968-2010)", "MS": "Surgical division of a tendon for relief of a deformity that is caused by congenital or acquired shortening of a muscle (Stedman, 27th ed). Tenotomy is performed in order to lengthen a muscle that has developed improperly, or become shortened and is resistant to stretching.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058971"}, {"RECTYPE": "D", "MH": "Folic Acid Transporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporters, Folic Acid", "MN": "D12.776.543.585.450.074.500.224", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Membrane Transport Proteins (1978-2010)", "MS": "Proteins involved in the transport of FOLIC ACID and folate derivatives across the CELLULAR MEMBRANE.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058972"}, {"RECTYPE": "D", "MH": "Folate Receptors, GPI-Anchored", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptors, GPI-Anchored Folate", "MN": "D12.776.543.750.301", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "MS": "Cell surface receptors that bind to and transport FOLIC ACID, 5-methyltetrahydrofolate, and a variety of folic acid derivatives. The receptors are essential for normal NEURAL TUBE development and transport folic acid via receptor-mediated endocytosis.", "PM": "2011; FOLATE-BINDING PROTEIN (now FOLATE-RECEPTORS, GPI-ANCHORED) was indexed under CARRIER PROTEINS & RECEPTORS, CELL SURFACE 1979-2010", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058973"}, {"RECTYPE": "D", "MH": "Phylogeography", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Biogeography, Phylogenetic", "MN": "H01.277.500.589", "FX": "Phylogeny", "MH_TH": "NLM (2011)", "ST": "T090", "AN": "IM for the discipline (education, history, etc); NIM as a coordinate for phylogeographic studies of populations", "PI": "Phylogeny (1993-2010)", "MS": "A field of study concerned with the principles and processes governing the geographic distributions of genealogical lineages, especially those within and among closely related species. (Avise, J.C., Phylogeography: The History and Formation of Species. Harvard University Press, 2000)", "PM": "2011", "HN": "2011", "MR": "20100702", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058974"}, {"RECTYPE": "D", "MH": "Folate Receptor 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor alpha, Folate", "MN": "D23.050.285.384", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (1987-2010)", "MS": "A subtype of GPI-anchored folate receptors that is expressed in tissues of epithelial origin. This protein is also identified as an ovarian-tumor-specific antigen.", "PM": "2011", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058975"}, {"RECTYPE": "D", "MH": "Folate Receptor 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta, Folate Receptor", "MN": "D12.776.543.750.301.750", "MH_TH": "NLM (2011)", "ST": "T192", "RN": "0", "PI": "Folate Receptors, GPI-Anchored (1980-2010)", "MS": "A subtype of GPI-anchored folate receptors that is expressed in PLACENTA and hematopoietic cells.", "PM": "2011; FOLIC ACID RECEPTOR BETA was indexed under CARRIER PROTEINS & RECEPTORS, CELL SURFACE 1979-2010", "HN": "2011", "MR": "20230316", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058976"}, {"RECTYPE": "D", "MH": "Molecular Sequence Annotation", "AQ": "CL EC ES HI MT SN ST TD", "PRINT ENTRY": "Gene Annotation|T063|NON|NRW|NLM (2011)|100416|abcdef", "ENTRY": "Sequence Annotations, Molecular", "MN": "L01.462.750.245.667.580", "FX": "Sequence Analysis, RNA", "MH_TH": "NLM (2011)", "ST": "T063", "MS": "The addition of descriptive information about the function or structure of a molecular sequence to its MOLECULAR SEQUENCE DATA record.", "PM": "2011", "HN": "2011", "MR": "20220712", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058977"}, {"RECTYPE": "D", "MH": "Reduced Folate Carrier Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, SLC19a1", "MN": "D23.050.705.552.600.663", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "MS": "A ubiquitously expressed folic acid transporter that functions via an antiporter mechanism which is coupled to the transport of organic phosphates.", "PM": "2001; REDUCED FOLATE CARRIER was indexed under MEMBRANE TRANSPORT PROTEIN 2005-2010, and under CARRIER PROTEINS 1994-2004", "HN": "2011", "MR": "20160226", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058978"}, {"RECTYPE": "D", "MH": "Proton-Coupled Folate Transporter", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, Proton-Coupled Folate", "MN": "D12.776.543.585.937.735", "MH_TH": "NLM (2011)", "ST": "T123", "RN": "0", "PI": "Membrane Transport Proteins (2005-2010)", "MS": "A symporter protein that couples the transport of FOLIC ACID with HYDROGEN IONS. The transporter functions most effectively under acidic conditions.", "PM": "2011", "HN": "2011", "MR": "20151124", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058979"}, {"RECTYPE": "D", "MH": "Information Literacy", "AQ": "HI", "ENTRY": "Literacy, Information", "MN": "L01.143.450", "FX": "Information Seeking Behavior", "MH_TH": "NLM (2011)", "ST": "T041", "PI": "Information Storage and Retrieval (1996-2010)", "MS": "The ability to recognize when information is needed and to locate, evaluate, and use the needed information effectively.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058980"}, {"RECTYPE": "D", "MH": "Side-Population Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Side-Population Cell", "MN": "A11.872.785", "MH_TH": "NLM (2011)", "ST": "T025", "AN": "coordinate with specific progenitor cell type if pertinent", "PI": "Stem Cells or specifics (2000-2010)", "MS": "A group of cells identified on FLOW CYTOMETRY profiles as distinct from the main group of cells by their ability to extrude the fluorescent dye Hoechst 33342, often a characteristic property of less differentiated progenitor and STEM CELLS.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058985"}, {"RECTYPE": "D", "MH": "Phosphodiesterase 5 Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphodiesterase Type 5 Inhibitor|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "PDE 5 Inhibitors", "MN": "D27.505.519.389.735.500", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Phosphodiesterase Inhibitors (1977-2010)", "MS": "Compounds that specifically inhibit PHOSPHODIESTERASE 5.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058986"}, {"RECTYPE": "D", "MH": "Phosphodiesterase 3 Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphodiesterase Type 3 Inhibitor|T121|NON|EQV|NLM (2022)|201005|abcdef", "ENTRY": "PDE 3 Inhibitors", "MN": "D27.505.519.389.735.249", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Phosphodiesterase Inhibitors (1977-2010)", "MS": "Compounds that specifically inhibit PHOSPHODIESTERASE 3.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058987"}, {"RECTYPE": "D", "MH": "Phosphodiesterase 4 Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Phosphodiesterase Type 4 Inhibitor|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "PDE 4 Inhibitors", "MN": "D27.505.519.389.735.374", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Phosphodiesterase Inhibitors (1977-2010)", "MS": "Compounds that specifically inhibit PHOSPHODIESTERASE 4.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058988"}, {"RECTYPE": "D", "MH": "Vitrification", "AQ": "DE RE", "ENTRY": "Transition, Liquid-Glass", "MN": "G01.645.625", "FX": "Cryopreservation", "MH_TH": "NLM (2011)", "ST": "T070", "PI": "Cryopreservation (1984-2010)", "MS": "The transformation of a liquid to a glassy solid i.e., without the formation of crystals during the cooling process.", "PM": "2011", "HN": "2011", "MR": "20180206", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058989"}, {"RECTYPE": "D", "MH": "Molecular Targeted Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Targeted Molecular", "MN": "E02.319.574", "FX": "Immunoconjugates", "MH_TH": "NLM (2011)", "ST": "T061", "AN": "do not confuse with DRUG TARGETING see DRUG DELIVERY SYSTEMS", "MS": "Treatments with drugs which interact with or block synthesis of specific cellular components characteristic of the individual's disease in order to stop or interrupt the specific biochemical dysfunction involved in progression of the disease.", "PM": "2011", "HN": "2011", "MR": "20180614", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058990"}, {"RECTYPE": "D", "MH": "Patient Protection and Affordable Care Act", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Public Law 111 148", "MN": "N03.706.615.806", "MH_TH": "NLM (2011)", "ST": "T089", "AN": "add UNITED STATES; CATALOGER: Use NAF entry", "MS": "An Act prohibiting a health plan from establishing lifetime limits or annual limits on the dollar value of benefits for any participant or beneficiary after January 1, 2014. It permits a restricted annual limit for plan years beginning prior to January 1, 2014. It provides that a health plan shall not be prevented from placing annual or lifetime per-beneficiary limits on covered benefits. The Act sets up a competitive health insurance market.", "PM": "2011", "HN": "2011", "MR": "20150605", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058991"}, {"RECTYPE": "D", "MH": "Social Participation", "AQ": "HI PX", "PRINT ENTRY": "Social Engagement|T054|NON|NRW|NLM (2021)|200118|abcdef", "ENTRY": "Participation, Social", "MN": "I03.050.750", "MH_TH": "NLM (2011)", "ST": "T054", "PI": "Activities of Daily Living (1990-2010)", "MS": "Involvement in community activities or programs.", "PM": "2011", "HN": "2011", "MR": "20200429", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058992"}, {"RECTYPE": "D", "MH": "Oral Sprays", "PRINT ENTRY": "Oral Spray|T121|NON|EQV|NLM (2022)|201021|abcdef", "ENTRY": "Sprays, Oral", "MN": "D26.255.165.055.527", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "MS": "Pharmacologic agents in the form of a mist or spray delivered into the body through the mouth.", "PM": "2011", "HN": "2011", "MR": "20210630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058993"}, {"RECTYPE": "D", "MH": "Salpingectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Tubectomies", "MN": "E04.950.300.715", "MH_TH": "NLM (2011)", "ST": "T061", "PI": "Fallopian Tubes/surgery (1963-2010)", "MS": "Excision of one or both of the FALLOPIAN TUBES.", "PM": "2011", "HN": "2011", "MR": "20130708", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058994"}, {"RECTYPE": "D", "MH": "Dry Powder Inhalers", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Powder Inhalers, Dry", "MN": "E07.605.500", "MH_TH": "NLM (2011)", "ST": "T074", "PI": "Powders (1991-2010)", "MS": "A device that delivers medication to the lungs in the form of a dry powder.", "PM": "2011", "HN": "2011", "MR": "20150623", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058995"}, {"RECTYPE": "D", "MH": "Quality Improvement", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Quality Improvements", "MN": "N04.761.744", "MH_TH": "NLM (2011)", "ST": "T057", "MS": "The attainment or process of attaining a new level of performance or quality.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058996"}, {"RECTYPE": "D", "MH": "Remote Sensing Technology", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Technology, Remote Sensing", "MN": "L01.462.500.847.675.500", "FX": "Radio Frequency Identification Device", "MH_TH": "NLM (2011)", "ST": "T066", "MS": "Observation and acquisition of physical data from a distance by viewing and making measurements from a distance or receiving transmitted data from observations made at distant location.", "PM": "2011", "HN": "2011", "MR": "20220712", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058998"}, {"RECTYPE": "D", "MH": "Drug-Seeking Behavior", "AQ": "CL DE ES HI PH RE TD", "ENTRY": "Drug-Seeking Behaviors", "MN": "F01.145.342", "MH_TH": "NLM (2011)", "ST": "T055", "PI": "Behavior (1970-2010)", "MS": "Activities performed to obtain licit or illicit substances.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D058999"}, {"RECTYPE": "D", "MH": "El Nino-Southern Oscillation", "AQ": "AE HI", "PRINT ENTRY": "La Nina|T070|NON|NRW|NLM (2011)|100421|abcdef", "ENTRY": "Oscillations, El Nino-Southern", "MN": "G16.500.275.071.387", "MH_TH": "NLM (2011)", "ST": "T070", "PI": "Climate (1995-2010)", "MS": "El Nino-Southern Oscillation or ENSO is a cycle of extreme alternating warm El Ni\u00f1o and cold La Nina events which is the dominant year-to-year climate pattern on Earth. Both terms refer to large-scale changes in sea-surface temperature across the eastern tropical Pacific. ENSO is associated with a heightened risk of certain vector-borne diseases. (From http://www.elnino.noaa.gov/lanina_new_faq.html, accessed 5/12/2020)", "PM": "2011", "HN": "2011", "MR": "20130709", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059000"}, {"RECTYPE": "D", "MH": "Aquatic Organisms", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Organisms, Marine", "MN": "G16.500.275.725.500.650.075", "FX": "Plankton", "MH_TH": "NLM (2011)", "ST": "T001", "AN": "general or unspecified; prefer specific organisms", "MS": "Organisms that live in water.", "PM": "2011", "HN": "2011", "MR": "20150616", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059001"}, {"RECTYPE": "D", "MH": "Androgen Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Androgen Receptor Antagonist|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Receptor Antagonists, Androgen", "MN": "D27.505.696.399.450.065.249", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "Androgen Antagonists (1978-2010)", "MS": "Compounds that bind to and inhibit the activation of ANDROGEN RECEPTORS.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059002"}, {"RECTYPE": "D", "MH": "Topoisomerase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Topoisomerase Inhibitor|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Topoisomerase Inhibitors, DNA", "MN": "D27.505.954.248.794", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "DNA Topoisomerases (2002-2010)", "MS": "Compounds that inhibit the activity of DNA TOPOISOMERASES.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059003"}, {"RECTYPE": "D", "MH": "Topoisomerase I Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Topoisomerase III Inhibitors|T121|NON|BRD|NLM (2020)|190518|abcdef", "ENTRY": "Inhibitors, Topoisomerase III", "MN": "D27.505.954.248.794.500", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "DNA Topoisomerases/antagonists & inhibitors (1994-2002)", "MS": "Compounds that inhibit the activity of DNA TOPOISOMERASE I.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059004"}, {"RECTYPE": "D", "MH": "Topoisomerase II Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Topoisomerase II Inhibitor|T121|NON|EQV|NLM (2021)|200629|abcdef", "ENTRY": "Inhibitors, Topoisomerase II", "MN": "D27.505.954.248.794.750", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "PI": "DNA Topoisomerases, Type II/antagonists & inhibitors (1994-2010)", "MS": "Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.", "PM": "2011", "HN": "2011", "MR": "20200629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059005"}, {"RECTYPE": "D", "MH": "Chromosomes, Insect", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "ENTRY": "Insect Chromosomes", "MN": "G05.360.162.440", "MH_TH": "NLM (2011)", "ST": "T026", "PI": "Chromosomes (1963-2010)", "MS": "Structures within the CELL NUCLEUS of insect cells containing DNA.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059006"}, {"RECTYPE": "D", "MH": "Polytene Chromosomes", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "PRINT ENTRY": "Polytene Chromosome|T026|NON|EQV|NLM (2011)|100421|abcdef", "ENTRY": "Chromosomes, Polytene", "MN": "G05.360.162.440.500", "FX": "Polyploidy", "MH_TH": "NLM (2011)", "ST": "T026", "PI": "Chromosomes (1963-2010)", "MS": "Extra large CHROMOSOMES, each consisting of many identical copies of a chromosome lying next to each other in parallel.", "PM": "2013; see CHROMOSOME, POLYTENE 2011-2012", "HN": "2013 (2011)", "MR": "20120703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059007"}, {"RECTYPE": "D", "MH": "Time-Lapse Imaging", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Time Lapsed Imaging", "MN": "L01.280.960.399", "MH_TH": "NLM (2011)", "ST": "T068", "AN": "coordinate with specific imaging technique (MICROSCOPY, MOLECULAR IMAGING, etc) if pertinent", "MS": "Recording serial images of a process at regular intervals spaced out over a longer period of time than the time in which the recordings will be played back.", "PM": "2011", "HN": "2011", "MR": "20170707", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059008"}, {"RECTYPE": "D", "MH": "Confederate States of America", "AQ": "EH EP", "MN": "Z01.586.225", "MH_TH": "NLM (2011)", "ST": "T083", "MS": "The area of those states which seceded in 1861 from the union of the United States of America. They include South Carolina, Mississippi, Florida, Alabama, Georgia, Louisiana, Texas, Virginia, Arkansas, North Carolina, and Tennessee.", "HN": "2011", "DA": "20100625", "DC": "4", "DX": "20110101", "UI": "D059009"}, {"RECTYPE": "D", "MH": "Single-Cell Analysis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Single-Cell Analyses", "MN": "E05.242.900", "MH_TH": "NLM (2011)", "ST": "T062", "AN": "permitted with microorganisms", "MS": "Assaying the products of or monitoring various biochemical processes and reactions in an individual cell.", "PM": "2011", "HN": "2011", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059010"}, {"RECTYPE": "D", "MH": "Lost to Follow-Up", "ENTRY": "Lost to Follow-Ups", "MN": "E05.318.370.438", "MH_TH": "NLM (2011)", "ST": "T078", "MS": "Study subjects in COHORT STUDIES whose outcomes are unknown e.g., because they could not or did not wish to attend follow-up visits.(from Dictionary of Epidemiology, 5th ed.)", "PM": "2011", "HN": "2011", "MR": "20180630", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059012"}, {"RECTYPE": "D", "MH": "Microbial Consortia", "AQ": "DE GE IM PH RE", "ENTRY": "Consortium, Microbial", "MN": "N06.230.124.049.100.500.500", "FX": "Microbial Interactions", "MH_TH": "NLM (2011)", "ST": "T001", "MS": "Groups of microorganisms that share metabolic interdependence.", "PM": "2011", "HN": "2011", "MR": "20180228", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059013"}, {"RECTYPE": "D", "MH": "High-Throughput Nucleotide Sequencing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Next-Generation Sequencing|T063|NON|EQV|NLM (2020)|190506|abcdef", "ENTRY": "Sequencing, Next-Generation", "MN": "E05.393.760.319", "MH_TH": "NLM (2011)", "ST": "T063", "AN": "coordinate with SEQUENCE ANALYSIS, DNA or SEQUENCE ANALYSIS, RNA", "PI": "Sequence Analysis or specifics (1998-2010)", "MS": "Techniques of nucleotide sequence analysis that increase the range, complexity, sensitivity, and accuracy of results by greatly increasing the scale of operations and thus the number of nucleotides, and the number of copies of each nucleotide sequenced. The sequencing may be done by analysis of the synthesis or ligation products, hybridization to preexisting sequences, etc.", "PM": "2011", "HN": "2011", "MR": "20200116", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059014"}, {"RECTYPE": "D", "MH": "Wireless Technology", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Wireless Technologies", "MN": "L01.462.500.847.950", "MH_TH": "NLM (2011)", "ST": "T073", "PI": "Telemetry (2004-2010)", "MS": "Techniques using energy such as radio frequency, infrared light, laser light, visible light, or acoustic energy to transfer information without the use of wires, over both short and long distances.", "PM": "2011", "HN": "2011", "MR": "20220712", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059015"}, {"RECTYPE": "D", "MH": "Tumor Microenvironment", "AQ": "DE GE IM PH RE", "ENTRY": "Tumor Microenvironments", "MN": "G04.366.500", "MH_TH": "NLM (2011)", "ST": "T070", "MS": "The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth.", "PM": "2011", "HN": "2011", "MR": "20120703", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059016"}, {"RECTYPE": "D", "MH": "Primary Care Nursing", "AQ": "AE CL EC ES HI IS MO MT PX SN ST TD VE", "ENTRY": "Nursing, Primary Care", "MN": "E02.760.611.735", "MH_TH": "NLM (2011)", "ST": "T058", "AN": "do not confuse with PRIMARY NURSING which refers to the responsibility of one nurse in the planning evaluation and care of a patient throughout the course of an illness.", "PI": "Nursing Care (2000-2010)", "MS": "Techniques or methods of patient care used by nurses as primary careproviders.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059017"}, {"RECTYPE": "D", "MH": "DNA Contamination", "ENTRY": "DNA Contaminations", "MN": "I01.198.780.937.375.500", "FX": "Forensic Medicine", "MH_TH": "NLM (2011)", "ST": "T068", "MS": "The presence of DNA from a source foreign to the sample being analysed.", "PM": "2011", "HN": "2011", "MR": "20110624", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059018"}, {"RECTYPE": "D", "MH": "Clinical Coding", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Coding, Medical", "MN": "N06.850.520.308.940.968.249", "MH_TH": "NLM (2011)", "ST": "T058", "PI": "Forms and Records Control (1978-2010)", "MS": "Process of substituting a symbol or code for a term such as a diagnosis or procedure. (from Slee's Health Care Terms, 3d ed.)", "PM": "2011; for CODING see FORMS AND RECORDS CONTROL 1978-2010", "HN": "2011; for CODING use FORMS AND RECORDS CONTROL 1978-2010", "MR": "20130709", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059019"}, {"RECTYPE": "D", "MH": "Suicidal Ideation", "ENTRY": "Suicidal Ideations", "MN": "I01.880.735.856.149", "MH_TH": "NLM (2011)", "ST": "T041", "PI": "Suicide (1966-2010)", "MS": "A risk factor for suicide attempts and completions, it is the most common of all suicidal behavior, but only a minority of ideators engage in overt self-harm.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059020"}, {"RECTYPE": "D", "MH": "Laboratory Proficiency Testing", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Testing, Laboratory Proficiency", "MN": "N04.761.700.512", "MH_TH": "NLM (2011)", "ST": "T057", "PI": "Laboratories (1968-2010)", "MS": "Assessments aimed at determining agreement in diagnostic test results among laboratories. Identical survey samples are distributed to participating laboratories, with results stratified according to testing methodologies.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059021"}, {"RECTYPE": "D", "MH": "Food Safety", "AQ": "MT", "ENTRY": "Safety, Food", "MN": "N06.850.601.500", "FX": "Dietary Exposure", "MH_TH": "NLM (2011)", "ST": "T061", "MS": "Activities involved in ensuring the safety of FOOD including avoidance of bacterial and other contamination.", "PM": "2011", "HN": "2011", "MR": "20170224", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059022"}, {"RECTYPE": "D", "MH": "Diagnostic Self Evaluation", "PRINT ENTRY": "Self-Evaluation|T041|NON|REL|NLM (2011)|100424|abcdef", "ENTRY": "Subjective Healths", "MN": "F01.752.747.792.220", "MH_TH": "NLM (2011)", "ST": "T041", "AN": "do not confuse with SELF-ASSESSMENT, a psychological concept", "MS": "A self-evaluation of health status.", "PM": "2011", "HN": "2011", "MR": "20141016", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059026"}, {"RECTYPE": "D", "MH": "Recycling", "AQ": "EC ES HI LJ MT SN ST TD", "MN": "N06.850.860.510.900.300", "MH_TH": "NLM (1996)", "ST": "T052", "PI": "Conservation of Natural Resources (1996-2010)", "MS": "The extraction and recovery of usable or valuable material from scrap or other discarded materials. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed.)", "PM": "2011; see CONSERVATION OF NATURAL RESOURCES 1996-2010", "HN": "2011; use CONSERVATION OF NATURAL RESOURCES 1996-2010", "MR": "20230524", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059027"}, {"RECTYPE": "D", "MH": "Airports", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Airport|T073|NON|EQV|NLM (2011)|100425|abcdef", "MN": "J03.970.100", "MH_TH": "NLM (2011)", "ST": "T073", "MS": "Terminal facilities used for aircraft takeoff and landing and including facilities for handling passengers. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed.)", "PM": "2011", "HN": "2011", "MR": "20160602", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059028"}, {"RECTYPE": "D", "MH": "Electronic Waste", "AQ": "AE AN CL EC SN", "ENTRY": "Wastes, Electronic", "MN": "N06.850.460.710.189", "MH_TH": "NLM (2011)", "ST": "T068", "PI": "Waste Management (2006-2010)", "MS": "Discarded electronic devices containing valuable and sometimes hazardous materials such as LEAD, NICKEL, CADMIUM, and MERCURY. (from http://www.epa.gov/osw/conserve/materials/ecycling/faq.htm#impact accessed 4/25/2010)", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059029"}, {"RECTYPE": "D", "MH": "United States Department of Defense", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "United States Dept. of Defense|T092|NON|EQV|NLM (2011)|100425|abcdef", "MN": "N03.540.348.500.500.500", "MH_TH": "NLM (2011)", "ST": "T092", "AN": "add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.; CATALOGER: Use NAF entry", "PI": "Government Agencies (1966-2010)", "MS": "A cabinet department in the Executive Branch of the United States Government whose mission is to provide the military forces needed to deter WARFARE and to protect the security of our country.", "PM": "2011", "HN": "2011", "MR": "20150713", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059030"}, {"RECTYPE": "D", "MH": "Anticipation, Psychological", "AQ": "CL DE ES PH RE", "ENTRY": "Psychological Anticipation", "MN": "F02.463.093", "MH_TH": "NLM (2011)", "ST": "T041", "MS": "The ability to foresee what is likely to happen on the basis of past experience. It is largely a frontal lobe function.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059031"}, {"RECTYPE": "D", "MH": "Learning Curve", "ENTRY": "Learning Curves", "MN": "F02.784.629.529.274", "MH_TH": "NLM (2011)", "ST": "T041", "PI": "Learning (1985-2010)", "MS": "The course of learning of an individual or a group. It is a measure of performance plotted over time.", "PM": "2011", "HN": "2011", "MR": "20150616", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059032"}, {"RECTYPE": "D", "MH": "For-Profit Insurance Plans", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Plans, For-Profit Insurance", "MN": "N03.219.521.576.343.144", "MH_TH": "NLM (2011)", "ST": "T093", "AN": "specify geographic term if possible", "MS": "Health insurance plans that are intended to be for profit.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059033"}, {"RECTYPE": "D", "MH": "Not-For-Profit Insurance Plans", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Plans, Not-For-Profit Insurance", "MN": "N03.219.521.576.343.912", "MH_TH": "NLM (2011)", "ST": "T093", "AN": "specify geographic term if possible", "MS": "Health insurance plans that are not intended to generate profit.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059034"}, {"RECTYPE": "D", "MH": "Perioperative Period", "AQ": "AE CL EC ED ES LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Perioperative Periods", "MN": "N02.421.585.753", "MH_TH": "NLM (2011)", "ST": "T079", "PI": "Patient Care (2000-2010)", "MS": "The time periods immediately before, during and following a surgical operation.", "PM": "2011", "HN": "2011", "MR": "20150629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059035"}, {"RECTYPE": "D", "MH": "Photograph", "PRINT ENTRY": "Photographs|T170|NON|EQV|NLM (2011)|100425|abcdef", "MN": "V02.697", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Photographs as a subject are indexed under the main heading PHOTOGRAPHY. INDEXER: Do not use", "MS": "Still image produced from radiation-sensitive materials (sensitive to light, electron beams, or nuclear radiation), generally by means of the chemical action of light on a sensitive film, paper, glass, or metal. Photographs may be positive or negative, opaque or transparent.", "HN": "2011", "MR": "20180702", "DA": "20100625", "DC": "2", "DX": "20110101", "UI": "D059036"}, {"RECTYPE": "D", "MH": "Doulas", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Doula", "MN": "N02.360.338", "MH_TH": "NLM (2011)", "ST": "T097", "MS": "Trained lay women who provide emotional and/or physical support during obstetric labor and the postpartum period for mothers and their partners.", "PM": "2011", "HN": "2011", "MR": "20180629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059037"}, {"RECTYPE": "D", "MH": "Black Sea", "AQ": "EH EP", "MN": "Z01.756.217", "MH_TH": "NLM (2011)", "ST": "T083", "MS": "An inland sea between Europe and Asia. It is connected with the Aegean Sea by the Bosporus, the Sea of Marmara, and the Dardanelles.", "HN": "2011", "DA": "20100625", "DC": "4", "DX": "20110101", "UI": "D059038"}, {"RECTYPE": "D", "MH": "Standard of Care", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Care Standards", "MN": "N05.715.840", "MH_TH": "NLM (2011)", "ST": "T080", "MS": "The minimum acceptable patient care, based on statutes, court decisions, policies, or professional guidelines.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059039"}, {"RECTYPE": "D", "MH": "Video-Audio Media", "ENTRY": "Audiovisual Media|T170|NON|EQV|NLM (2011)|100621|abcdef", "MN": "V02.970", "MH_TH": "NLM (2011)", "ST": "T170", "AN": "This heading is used as a Publication Type. CATALOGER: Do not use", "MS": "Used with articles which include video files or clips, or for articles which are entirely video.", "HN": "2011", "MR": "20150605", "DA": "20100625", "DC": "2", "DX": "20110101", "UI": "D059040"}, {"RECTYPE": "D", "MH": "Plagiocephaly", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Plagiocephalies", "MN": "C16.131.621.207.707", "MH_TH": "NLM (2011)", "ST": "T047", "MS": "The condition characterized by uneven or irregular shape of the head often in parallelogram shape with a flat spot on the back or one side of the head. It can either result from the premature CRANIAL SUTURE closure (CRANIOSYNOSTOSIS) or from external forces (NONSYNOSTOTIC PLAGIOCEPHALY).", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059041"}, {"RECTYPE": "D", "MH": "Chromosomal Puffs", "AQ": "CH CL DE EN GE IM ME MI PH PS RE UL VI", "ENTRY": "Rings, Balbiani", "MN": "A11.284.430.106.279.345.190.580.500", "MH_TH": "NLM (2011)", "ST": "T026", "PI": "Chromosomes (1964-2010)", "MS": "Regions along polytene chromosomes that are uncondensed and active in DNA REPLICATION or RNA transcription (GENETIC TRANSCRIPTION).", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059045"}, {"RECTYPE": "D", "MH": "Medication Reconciliation", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Reconciliations, Medication", "MN": "N04.590.656", "MH_TH": "NLM (2011)", "ST": "T058", "PI": "Medication Errors/prevention & control (2003-2010)", "MS": "The formal process of obtaining a complete and accurate list of each patient's current home medications including name, dosage, frequency, and route of administration, and comparing admission, transfer, and/or discharge medication orders to that list. The reconciliation is done to avoid medication errors.", "PM": "2011", "HN": "2011", "MR": "20150629", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059065"}, {"RECTYPE": "D", "MH": "Gross Domestic Product", "AQ": "HI LJ SN TD", "ENTRY": "Gross Domestic Products", "MN": "I01.261.587", "MH_TH": "NLM (2011)", "ST": "T081", "PI": "Economics (1982-2010)", "MS": "Value of all final goods and services produced in a country in one year.", "PM": "2011", "HN": "2011", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059066"}, {"RECTYPE": "D", "MH": "Nasal Sprays", "PRINT ENTRY": "Nasal Spray|T121|NON|EQV|NLM (2021)|200113|abcdef", "ENTRY": "Sprays, Nasal", "MN": "D26.255.165.055.291", "MH_TH": "NLM (2011)", "ST": "T121", "RN": "0", "MS": "Pharmacologic agents delivered into the nostrils in the form of a mist or spray.", "PM": "2011", "HN": "2011", "MR": "20200527", "DA": "20100625", "DC": "1", "DX": "20110101", "UI": "D059085"}, {"RECTYPE": "D", "MH": "Neanderthals", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "PRINT ENTRY": "Neanderthal Man|T015|NON|EQV|NLM (2020)|190517|abcdef", "ENTRY": "Neanderthal", "MN": "B01.050.150.900.649.313.988.400.112.400.550", "MH_TH": "NLM (2012)", "ST": "T015", "RN": "txid63221", "AN": "check the tag ANIMAL", "PI": "Humans (1965-2011)", "MS": "Common name for an extinct species of the Homo genus. Fossils have been found in Europe and Asia. Genetic evidence suggests that limited interbreeding with modern HUMANS (Homo sapiens) took place.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059125"}, {"RECTYPE": "D", "MH": "Cronobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.150.110", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid413496", "PI": "Enterobacteriaceae (2009-2011)", "MS": "A genus of gram-negative opportunistic foodborne pathogens.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059126"}, {"RECTYPE": "D", "MH": "Phyllobacteriaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.600", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid69277", "MS": "Family of gram-negative bacteria that occur in leaf nodules and the rhizosphere of higher plants.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059127"}, {"RECTYPE": "D", "MH": "Mesorhizobium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.600.500", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid68287", "PI": "Alphaproteobacteria (1997-2011)", "MS": "A genus of gram-negative, rod-shaped bacteria in the family PHYLLOBACTERIACEAE. They are able to invade root-hairs of a wide range of plants, inciting the production of PLANT ROOT NODULES.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059128"}, {"RECTYPE": "D", "MH": "Total Disc Replacement", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Total Disk Replacements", "MN": "E04.650.110.850", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Arthroplasty, Replacement (2003-2011)", "MS": "The replacement of intervertebral discs in the spinal column with artificial devices. The procedure is done in the lumbar or cervical spine to relieve severe pain resulting from INTERVERTEBRAL DISC DEGENERATION.", "PM": "2012", "HN": "2012", "MR": "20220406", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059145"}, {"RECTYPE": "D", "MH": "Metastasectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Metastasectomies", "MN": "E04.480", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "specific neoplasms/secondary/surgery (1980-2011)", "MS": "Surgery to remove one or more NEOPLASM METASTASES.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059146"}, {"RECTYPE": "D", "MH": "HIV Serosorting", "AQ": "CL DE EH ES HI PH PX RE SN", "ENTRY": "Serosorting, HIV", "MN": "F01.145.802.400", "MH_TH": "NLM (2012)", "ST": "T054", "PI": "Sexual Behavior (2004-2011)", "MS": "The practice of making choices about SEXUAL PARTNERS based on their HIV status.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059147"}, {"RECTYPE": "D", "MH": "Hormesis", "AQ": "DE GE IM PH RE", "ENTRY": "Hormetic Dose-Responses", "MN": "G07.690.936.500.500", "MH_TH": "NLM (2012)", "ST": "T040", "MS": "Biphasic dose responses of cells or organisms (including microorganisms) to an exogenous or intrinsic factor, in which the factor induces stimulatory or beneficial effects at low doses and inhibitory or adverse effects at high doses.", "PM": "2012", "HN": "2012", "MR": "20150629", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059165"}, {"RECTYPE": "D", "MH": "Osteology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "H01.158.100.720", "FX": "Orthopedics", "MH_TH": "NLM (2012)", "ST": "T091", "AN": "use for the discipline (education, history, etc) only", "MS": "The branch of anatomy that concerns the structure and function of bones.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059166"}, {"RECTYPE": "D", "MH": "Mirror Neurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Neurons, Mirror", "MN": "A11.671.487", "MH_TH": "NLM (2012)", "ST": "T025", "PI": "Neurons (1999-2011)", "MS": "Neurons that fire when an animal acts or observes the same action of another thus coding the motor response. They were originally discovered in the premotor and parietal cortex of the monkey and studies have shown that neurons that have a similar mechanism are present in humans. Mirror neurons are theorized to be related to social cognition.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059167"}, {"RECTYPE": "D", "MH": "Carotid Intima-Media Thickness", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Intima-Media Thickness, Carotid", "MN": "G09.330.210", "FX": "Tunica Media", "MH_TH": "NLM (2012)", "ST": "T081", "PI": "Tunica Media/ultrasonography (1994-2011)", "MS": "A measurement of the thickness of the carotid artery walls. It is measured by B-mode ULTRASONOGRAPHY and is used as a surrogate marker for ATHEROSCLEROSIS.", "PM": "2012", "HN": "2012", "MR": "20220408", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059168"}, {"RECTYPE": "D", "MH": "Chemoradiotherapy, Adjuvant", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Adjuvant Chemoradiotherapy|T061|NON|EQV|NLM (2012)|100730|abcdef", "ENTRY": "Radiochemotherapies, Adjuvant", "MN": "E02.815.160.500", "FX": "Radiotherapy, Adjuvant", "MH_TH": "NLM (2012)", "ST": "T061", "AN": "coordinate with disease/ ther", "PI": "Radiotherapy, Adjuvant (1997-2011)", "MS": "Combined chemotherapy and radiotherapy given to augment some other form of treatment such as surgery. It is commonly used in the therapy of cancer.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059186"}, {"RECTYPE": "D", "MH": "Renewable Energy", "AQ": "AE CL EC ES HI LJ SN ST", "ENTRY": "Sustainable Energies", "MN": "N06.230.132.644", "MH_TH": "NLM (2012)", "ST": "T169", "MS": "Forms of energy that are constantly and rapidly renewed by natural processes such as solar, ocean wave, and wind energy. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "2012", "HN": "2012", "MR": "20141121", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059205"}, {"RECTYPE": "D", "MH": "Natural Gas", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Gas, Natural|T109|NON|EQV|UNK (19XX)|770421|abcdef", "ENTRY": "Gas, Shale", "MN": "N06.230.132.258.369", "FX": "Oil and Gas Fields", "MH_TH": "NLM (2015)", "ST": "T109", "RN": "0", "PI": "Fossil Fuels (1966-2011)", "MS": "A combustible, gaseous mixture of low-molecular weight PARAFFIN hydrocarbons, generated below the surface of the earth. It contains mostly METHANE and ETHANE with small amounts of PROPANE; BUTANES; and higher hydrocarbons, and sometimes NITROGEN; CARBON DIOXIDE; HYDROGEN SULFIDE; and HELIUM. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "2012", "HN": "2012", "MR": "20160705", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059206"}, {"RECTYPE": "D", "MH": "Geothermal Energy", "AQ": "AE CL EC ES HI LJ SN ST", "ENTRY": "Energy, Geothermal", "MN": "N06.230.132.644.186", "MH_TH": "NLM (2012)", "ST": "T070", "MS": "Thermal energy contained in the earth. It can be used directly to supply heat or converted to mechanical or electrical energy. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "2012", "HN": "2012", "MR": "20130709", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059207"}, {"RECTYPE": "D", "MH": "Parasite Load", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Parasitic Loads", "MN": "E05.200.932", "FX": "Parasites", "MH_TH": "NLM (2012)", "ST": "T081", "MS": "Measure of the number of the PARASITES present in a host organism.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059208"}, {"RECTYPE": "D", "MH": "Nociception", "AQ": "CL DE ES PH RE", "ENTRY": "Nociperceptions", "MN": "F02.463.593.504.500", "MH_TH": "NLM (2012)", "ST": "T042", "AN": "NOCICEPTIVE PAIN is also available", "PI": "Pain (1966-2011)", "MS": "Sensing of noxious mechanical, thermal or chemical stimuli by NOCICEPTORS. It is the sensory component of visceral and tissue pain (NOCICEPTIVE PAIN).", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059225"}, {"RECTYPE": "D", "MH": "Nociceptive Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tissue Pains", "MN": "C23.888.592.612.720", "MH_TH": "NLM (2012)", "ST": "T184", "AN": "NOCICEPTION is also available", "PI": "Pain (1963-2011)", "MS": "Dull or sharp aching pain caused by stimulated NOCICEPTORS due to tissue injury, inflammation or diseases. It can be divided into somatic or tissue pain and VISCERAL PAIN.", "PM": "2012", "HN": "2012", "MR": "20170620", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059226"}, {"RECTYPE": "D", "MH": "Postsynaptic Potential Summation", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Neurophysiology Summation|T042|NON|EQV|NLM (2012)|100809|abcdef", "ENTRY": "Temporal Summations, Neurophysiology", "MN": "G11.561.830.750.780", "MH_TH": "NLM (2012)", "ST": "T042", "PI": "Synaptic Transmission (1969-2011)", "MS": "Physiological integration of multiple SYNAPTIC POTENTIAL signals to reach the threshold and initiate postsynaptic ACTION POTENTIALS. In spatial summation stimulations from additional synaptic junctions are recruited to generate s response. In temporal summation succeeding stimuli signals are summed up to reach the threshold. The postsynaptic potentials can be either excitatory or inhibitory (EPSP or IPSP).", "PM": "2012", "HN": "2012", "MR": "20160623", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059227"}, {"RECTYPE": "D", "MH": "Renal Nutcracker Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Renal Nutcracker Syndromes", "MN": "C12.950.419.787", "FX": "Superior Mesenteric Artery Syndrome", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Vascular Diseases (1982-2011)", "MS": "Left RENAL VEIN compression between the AORTA, ABDOMINAL and the SUPERIOR MESENTERIC ARTERY. Variable symptoms include HYPERTENSION, RENOVASCULAR; HEMATURIA; and VARICOSE VEINS.", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059228"}, {"RECTYPE": "D", "MH": "Osteotomy, Sagittal Split Ramus", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Sagittal Split Ramus Osteotomy|T061|NON|EQV|NLM (2012)|100809|abcdef", "MN": "E06.645.637", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Osteotomy (1969-2011)", "MS": "Sagittal sectioning and repositioning of the ramus of the MANDIBLE to correct a mandibular retrusion, MALOCCLUSION, ANGLE CLASS III; and PROGNATHISM. The oblique sectioning line consists of multiple cuts horizontal and vertical to the mandibular ramus.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059229"}, {"RECTYPE": "D", "MH": "Reflex, Trigeminocardiac", "AQ": "DE GE IM PH RE", "ENTRY": "Trigeminocardiac Reflex", "MN": "G11.561.731.781", "MH_TH": "NLM (2012)", "ST": "T040", "PI": "Reflex (1991-2011)", "MS": "Sudden occurrence of BRADYCARDIA or HEART ARREST induced by manipulations of the MAXILLARY NERVE AND MANDIBULAR NERVE during a craniomaxillofacial or oral surgery. It is the maxillary and mandibular variants of OCULOCARDIAC REFLEX.", "PM": "2012", "HN": "2012", "MR": "20160622", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059230"}, {"RECTYPE": "D", "MH": "Laboratory Personnel", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Laboratory Technicians|T097|NON|NRW|NLM (1992)|910503|abcdef", "ENTRY": "Technicians, Laboratory", "MN": "M01.526.502", "MH_TH": "NLM (1992)", "ST": "T097", "AN": "coordinate IM with type of lab or occup (IM)", "MS": "Professionals, technicians, and assistants staffing LABORATORIES.", "PM": "2012; see MEDICAL LABORATORY PERSONNEL 1992-2011", "HN": "2012; use MEDICAL LABORATORY PERSONNEL 1992-2011", "MR": "20180629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059232"}, {"RECTYPE": "D", "MH": "Transient Tachypnea of the Newborn", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Newborn Transient Tachypneas", "MN": "C23.888.852.944.500", "MH_TH": "NLM (2012)", "ST": "T184", "AN": "check the tag INFANT, NEWBORN", "PI": "Respiratory Distress Syndrome, Newborn (1966-2011)", "MS": "Abnormal increase in RESPIRATORY RATE in the newborn. It is self-limiting and attributed to the delayed fetal lung fluid clearance often in CAESAREAN SECTION delivery.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059245"}, {"RECTYPE": "D", "MH": "Tachypnea", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tachypneas", "MN": "C23.888.852.944", "MH_TH": "NLM (2012)", "ST": "T184", "PI": "Respiration Disorders (1966-2011)", "MS": "Increased RESPIRATORY RATE.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059246"}, {"RECTYPE": "D", "MH": "Fertility Preservation", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Sperm Freezing|T061|NON|NRW|NLM (2022)|210122|abcdef", "ENTRY": "Preservation, Fertility", "MN": "E05.820.800.625", "FX": "Sperm Retrieval", "MH_TH": "NLM (2012)", "ST": "T062", "PI": "Fertility (1992-2011)", "MS": "A method of providing future reproductive opportunities. Typically CRYOPRESERVATION of reproductive organs or tissues (e.g., sperm, egg, embryos and ovarian or testicular tissues) are carried out before known risk of loss of fertility (e.g., chemotherapy, radiation or military deployment) begins for future use.", "PM": "2012", "HN": "2012", "MR": "20210312", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059247"}, {"RECTYPE": "D", "MH": "Chemoradiotherapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Concurrent Chemoradiotherapy|T061|NON|NRW|NLM (2012)|101028|abcdef", "ENTRY": "Synchronous Chemoradiotherapies", "MN": "E02.815.160", "MH_TH": "NLM (2012)", "ST": "T061", "AN": "coordinate with disease/ ther", "PI": "Radiotherapy, Adjuvant (1994-2011)", "MS": "Treatment that combines chemotherapy with radiotherapy.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059248"}, {"RECTYPE": "D", "MH": "Otomycosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Otomycoses", "MN": "C09.218.736", "FX": "Otitis Externa", "MH_TH": "NLM (2012)", "ST": "T047", "AN": "coordinate IM with specific fungal disease (IM) if pertinent", "PI": "Mycoses (1966-2011)", "MS": "Fungus infection of the external ear, usually by ASPERGILLUS species", "PM": "2012", "HN": "2012", "MR": "20190617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059249"}, {"RECTYPE": "D", "MH": "Administration, Metronomic", "AQ": "VE", "ENTRY": "Metronomic Drug Therapies", "MN": "E02.319.283.199", "FX": "Maintenance Chemotherapy", "MH_TH": "NLM (2012)", "ST": "T079", "AN": "coordinate with specific drug / admin", "PI": "Drug Administration Schedule (2003-2011)", "MS": "Administration of low doses of a drug or a drug combination over prolonged periods of time usually at a regular interval.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059250"}, {"RECTYPE": "D", "MH": "Visceral Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Visceral Pains", "MN": "C23.888.592.612.720.500", "MH_TH": "NLM (2012)", "ST": "T184", "PI": "Pain (1963-2011)", "MS": "Pain originating from internal organs (VISCERA) associated with autonomic phenomena (PALLOR; SWEATING; NAUSEA; and VOMITING). It often becomes a REFERRED PAIN.", "PM": "2012", "HN": "2012", "MR": "20170620", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059265"}, {"RECTYPE": "D", "MH": "Bisphosphonate-Associated Osteonecrosis of the Jaw", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Bisphosphonate-Associated Osteonecrosis|T047|NON|BRD|NLM (2012)|100817|abcdef", "ENTRY": "Osteonecrosis, Bisphosphonate-Associated", "MN": "C23.550.717.732.183", "MH_TH": "NLM (2012)", "ST": "T046", "PI": "Osteonecrosis (2005-2011)", "MS": "Necrotic jaws or other maxillofacial skeleton necrosis associated with bisphosphonate use (see BISPHOSPHONATES). Injury, dental procedures, and trauma can trigger the necrotic process.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059266"}, {"RECTYPE": "D", "MH": "Cardiomegaly, Exercise-Induced", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Athletic Bradycardia|T042|NON|REL|NLM (2021)|200211|abcdef", "ENTRY": "Physiological Heart Enlargements", "MN": "G09.330.170", "MH_TH": "NLM (2012)", "ST": "T042", "AN": "CARDIOMEGALY is also available", "PI": "Cardiomegaly (1964-2011)", "MS": "Non-pathological heart enlargement and other remodeling in cardiac morphology and electrical circuitry found in individuals who participate in intense repeated exercises.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059267"}, {"RECTYPE": "D", "MH": "Atrophic Vaginitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vaginitis, Atrophic", "MN": "C12.100.250.894.906.316", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Vaginitis (1965-2011)", "MS": "Inflammation of the vagina due to thinning of the vaginal wall and decreased lubrication associated with reduced estrogen levels at MENOPAUSE.", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059268"}, {"RECTYPE": "D", "MH": "Chilaiditi Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chilaiditi's Syndrome|T047|EPO|EQV|NLM (2012)|100817|abcdef", "ENTRY": "Syndrome, Chilaiditi's", "MN": "C06.405.469.158.093", "MH_TH": "ORD (2011)", "ST": "T047", "MS": "Interposition of a portion of the colon (e.g., SIGMOID COLON) between the liver and the diaphragm. It is associated with abdominal pain, vomiting, constipation, anorexia and volvulus. Chilaiditi anomaly refers to asymptomatic interposition.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059269"}, {"RECTYPE": "D", "MH": "Petrositis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Gradenigo-Lannois", "MN": "C09.218.705.663.841", "MH_TH": "NLM (2012)", "ST": "T047", "MS": "Inflammation of PETROUS BONE.", "PM": "2012; for GRADENIGO'S SYNDROME see under OTITIS MEDIA 1963-81, see OTITIS MEDIA 1982-92", "HN": "2012; for GRADENIGO'S SYNDROME see under OTITIS MEDIA 1963-81, use OTITIS MEDIA 1982-92", "MR": "20190617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059270"}, {"RECTYPE": "D", "MH": "Pregnancy, Twin", "AQ": "BL CF DE EH GE IM ME PH PX RE SN UR", "ENTRY": "Twin Pregnancy", "MN": "G08.686.784.769.545.253", "MH_TH": "NLM (2012)", "ST": "T040", "AN": "human only; for animals, use PREGNANCY, MULTIPLE, but see note there; TWINS is also available for the offspring; check tags FEMALE & PREGNANCY", "PI": "Twins (1963-2011)", "MS": "The condition of carrying TWINS simultaneously.", "PM": "2012", "HN": "2012", "MR": "20190530", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059285"}, {"RECTYPE": "D", "MH": "Pregnancy, Triplet", "AQ": "BL CF DE EH GE IM ME PH PX RE SN UR", "ENTRY": "Triplet Pregnancy", "MN": "G08.686.784.769.545.126", "MH_TH": "NLM (2012)", "ST": "T040", "AN": "human only; for animals, use PREGNANCY, MULTIPLE, but see note there; TRIPLETS is also available for the offspring; check tags FEMALE & PREGNANCY", "PI": "Triplets (1968-2011)", "MS": "The condition of carrying TRIPLETS simultaneously.", "PM": "2012", "HN": "2012", "MR": "20190530", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059286"}, {"RECTYPE": "D", "MH": "Pregnancy, Quadruplet", "AQ": "BL CF DE EH GE IM ME PH PX RE SN UR", "ENTRY": "Quadruplet Pregnancy", "MN": "G08.686.784.769.545.030", "MH_TH": "NLM (2012)", "ST": "T040", "AN": "human only; for animals, use PREGNANCY, MULTIPLE, but see note there; QUADRUPLETS is also available for the offspring; check tags FEMALE & PREGNANCY", "PI": "Quadruplets (1965-2011)", "MS": "The condition of carrying QUADRUPLETS simultaneously.", "PM": "2012", "HN": "2012", "MR": "20190530", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059287"}, {"RECTYPE": "D", "MH": "Pregnancy, Quintuplet", "AQ": "BL CF DE EH GE IM ME PH PX RE SN UR", "ENTRY": "Quintuplet Pregnancy", "MN": "G08.686.784.769.545.062", "MH_TH": "NLM (2012)", "ST": "T040", "AN": "human only; for animals, use PREGNANCY, MULTIPLE, but see note there; QUINTUPLETS is also available for the offspring; check tags FEMALE & PREGNANCY", "PI": "Quintuplets (1966-2011)", "MS": "The condition of carrying QUINTUPLETS simultaneously.", "PM": "2012", "HN": "2012", "MR": "20190530", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059288"}, {"RECTYPE": "D", "MH": "Vascular Stiffness", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Arterial Stiffness|T046|NON|NRW|NLM (2012)|100823|abcdef", "ENTRY": "Vascular Stiffnesses", "MN": "G09.330.940", "FX": "Vascular Calcification", "MH_TH": "NLM (2012)", "ST": "T046", "PI": "Elasticity (1990-2011)", "MS": "Loss of vascular ELASTICITY due to factors such as AGING; and ARTERIOSCLEROSIS. Increased arterial stiffness is one of the RISK FACTORS for many CARDIOVASCULAR DISEASES.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059289"}, {"RECTYPE": "D", "MH": "Dopaminergic Neurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Neurons, Dopaminergic", "MN": "A11.671.270", "MH_TH": "NLM (2012)", "ST": "T025", "PI": "Dopamine (1964-2011)", "MS": "Neurons whose primary neurotransmitter is DOPAMINE.", "PM": "2012", "HN": "2012", "MR": "20150706", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059290"}, {"RECTYPE": "D", "MH": "Diet, High-Fat", "AQ": "AE CL EC EH HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Diet, High Fat|T061|NON|EQV|NLM (2012)|100907|abcdef", "ENTRY": "High-Fat Diets", "MN": "G07.203.650.240.267", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Dietary Fats (1964-2011)", "MS": "Consumption of excessive DIETARY FATS.", "PM": "2012", "HN": "2012", "MR": "20150629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059305"}, {"RECTYPE": "D", "MH": "Intra-Abdominal Hypertension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Abdominal Compartment Syndrome|T047|NON|REL|NLM (2012)|100830|abcdef", "ENTRY": "Syndromes, Abdominal Compartment", "MN": "C14.907.303.297", "MH_TH": "NLM (2012)", "ST": "T047", "MS": "Pathological elevation of intra-abdominal pressure (>12 mm Hg). It may develop as a result of SEPSIS; PANCREATITIS; capillary leaks, burns, or surgery. When the pressure is higher than 20 mm Hg, often with end-organ dysfunction, it is referred to as abdominal compartment syndrome.", "PM": "2012", "HN": "2012", "DA": "20110627", "DC": "1", "DX": "20120101", "UI": "D059325"}, {"RECTYPE": "D", "MH": "Serotonergic Neurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Serotoninergic Neuron", "MN": "A11.671.895", "MH_TH": "NLM (2012)", "ST": "T025", "PI": "Serotonin (1965-2011)", "MS": "Neurons whose primary neurotransmitter is SEROTONIN.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059326"}, {"RECTYPE": "D", "MH": "Brachydactyly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Brachydactylisms", "MN": "C16.131.621.585.262", "MH_TH": "NLM (2012)", "ST": "T019", "AN": "coordinate IM with FINGERS / abnorm (IM) or TOES / abnorm (IM)", "PI": "Hand Deformities, Congenital (1963-2011)", "MS": "Congenital anomaly of abnormally short fingers or toes.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059327"}, {"RECTYPE": "D", "MH": "Diffuse Noxious Inhibitory Control", "AQ": "DE GE IM PH RE", "MN": "E03.091.322", "MH_TH": "NLM (2012)", "ST": "T067", "PI": "Pain (1994-2011)", "MS": "A physiological process by which the perception of pain at a local area of the body is inhibited by a second painful stimulus administered at a distal body site", "PM": "2012", "HN": "2012", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059328"}, {"RECTYPE": "D", "MH": "Cholinergic Neurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Neurons, Cholinergic", "MN": "A11.671.188", "FX": "Non-Neuronal Cholinergic System", "MH_TH": "NLM (2012)", "ST": "T025", "PI": "Cholinergic Fibers (1976-2011)", "MS": "Neurons whose primary neurotransmitter is ACETYLCHOLINE.", "PM": "2012", "HN": "2012", "MR": "20160415", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059329"}, {"RECTYPE": "D", "MH": "GABAergic Neurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Neurons, GABAergic", "MN": "A11.671.285", "MH_TH": "NLM (2012)", "ST": "T025", "PI": "gamma-Aminobutyric Acid (1981-2011)", "MS": "Neurons whose primary neurotransmitter is GAMMA-AMINOBUTYRIC ACID.", "PM": "2012", "HN": "2012", "MR": "20141121", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059330"}, {"RECTYPE": "D", "MH": "Adrenergic Neurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Noradrenergic Neurons|T025|NON|NRW|NLM (2012)|100830|abcdef", "ENTRY": "Noradrenergic Neuron", "MN": "A11.671.050", "FX": "Adrenergic Fibers", "MH_TH": "NLM (2012)", "ST": "T025", "AN": "ADRENERGIC FIBERS is also available", "PI": "Receptors, Adrenergic (1972-2011)", "MS": "Neurons whose primary neurotransmitter is EPINEPHRINE.", "PM": "2012", "HN": "2012", "MR": "20220714", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059331"}, {"RECTYPE": "D", "MH": "Central Nervous System Sensitization", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Central Sensitization|T042|T067|NON|EQV|NLM (2012)|100830|abbcdef", "ENTRY": "Sensitizations, Central", "MN": "G11.561.148", "MH_TH": "NLM (2012)", "ST": "T067", "PI": "Pain (1998-2011)", "MS": "An increased response to stimulation that is mediated by amplification of signaling in the CENTRAL NERVOUS SYSTEM (CNS).", "PM": "2012", "HN": "2012", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059333"}, {"RECTYPE": "D", "MH": "Cerebral Small Vessel Diseases", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Microangiopathy, Cerebral", "MN": "C14.907.253.329", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Cerebrovascular Disorders (1988-2011)", "MS": "Pathological processes or diseases where cerebral MICROVESSELS show abnormalities. They are often associated with aging, hypertension and risk factors for lacunar infarcts (see LACUNAR INFARCTION); LEUKOARAIOSIS; and CEREBRAL HEMORRHAGE.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059345"}, {"RECTYPE": "D", "MH": "Magnets", "AQ": "AE AN CH CL EC HI MI PO PS RE SD SN ST TO UL VI", "ENTRY": "Magnet", "MN": "J01.637.507", "FX": "Magnetics", "MH_TH": "NLM (2012)", "ST": "T073", "PI": "Magnetics (1964-2011)", "MS": "Objects that produce a magnetic field.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059346"}, {"RECTYPE": "D", "MH": "Cardio-Renal Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Cardiorenal Syndrome|T047|NON|EQV|NLM (2012)|100902|abcdef", "ENTRY": "Syndromes, Renocardiac", "MN": "C14.280.434.156", "MH_TH": "NLM (2012)", "ST": "T047", "MS": "Condition where a primary dysfunction of either heart or kidney results in failure of the other organ (e.g., HEART FAILURE with worsening RENAL INSUFFICIENCY).", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059347"}, {"RECTYPE": "D", "MH": "Peripheral Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Peripheral Nerve Injury|T037|NON|EQV|NLM (2012)|100902|abcdef", "ENTRY": "Nerve Injury, Peripheral", "MN": "C26.915.650", "MH_TH": "NLM (2012)", "ST": "T037", "AN": "coordinate IM with specific peripheral nerve/ inj (IM) but note CRANIAL NERVE INJURIES and specifics are available", "PI": "Peripheral Nerves/injuries (1965-2011)", "MS": "Injuries to the PERIPHERAL NERVES.", "PM": "2012", "HN": "2012", "MR": "20160120", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059348"}, {"RECTYPE": "D", "MH": "Urine Specimen Collection", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Urine Specimen Collections", "MN": "E05.200.998.762", "MH_TH": "NLM (2012)", "ST": "T060", "PI": "Specimen Handling (1964-2011)", "MS": "Methods or procedures used to obtain samples of URINE.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059349"}, {"RECTYPE": "D", "MH": "Chronic Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chronic Secondary Pain|T184|NON|NRW|NLM (2024)|230203|abcdef", "ENTRY": "Secondary Pain, Chronic", "MN": "C23.888.592.612.274", "FX": "Acute Pain", "MH_TH": "NLM (2012)", "ST": "T184", "AN": "differentiate from PAIN, INTRACTABLE", "PI": "Pain (1993-2011)", "MS": "Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.", "PM": "2012", "HN": "2012", "MR": "20230405", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059350"}, {"RECTYPE": "D", "MH": "Organ Sparing Treatments", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Treatments, Organ Sparing", "MN": "E02.674", "FX": "Organs at Risk", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "Techniques, procedures, and therapies carried out on diseased organs in such a way to avoid complete removal of the organ and preserve the remaining organ function.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059351"}, {"RECTYPE": "D", "MH": "Musculoskeletal Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pains, Musculoskeletal", "MN": "G11.561.790.353", "MH_TH": "NLM (2012)", "ST": "T184", "PI": "Pain (1963-2011)", "MS": "Discomfort stemming from muscles, LIGAMENTS, tendons, and bones.", "PM": "2012", "HN": "2012", "MR": "20170620", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059352"}, {"RECTYPE": "D", "MH": "Nonsense Mediated mRNA Decay", "AQ": "DE GE IM PH RE", "ENTRY": "mRNA Decay, Nonsense-Mediated", "MN": "G05.308.700.112", "FX": "RNA Cleavage", "MH_TH": "NLM (2012)", "ST": "T044", "PI": "RNA, Messenger/metabolism (1994-2011)", "MS": "An mRNA metabolic process that distinguishes a normal STOP CODON from a premature stop codon (NONSENSE CODON) and facilitates rapid degradation of aberrant mRNAs containing premature stop codons.", "PM": "2012", "HN": "2012", "MR": "20160630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059365"}, {"RECTYPE": "D", "MH": "Asthma, Occupational", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Occupational Asthmas", "MN": "C24.102", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Asthma (1964-2011)", "MS": "Asthma attacks caused, triggered, or exacerbated by OCCUPATIONAL EXPOSURE.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059366"}, {"RECTYPE": "D", "MH": "RNA Cleavage", "AQ": "DE GE IM PH RE", "ENTRY": "RNA Cleavages", "MN": "G05.755", "FX": "RNA Stability", "MH_TH": "NLM (2012)", "ST": "T044", "PI": "RNA or specifics/metabolism (1981-2011)", "MS": "A reaction that severs one of the sugar-phosphate linkages of the phosphodiester backbone of RNA. It is catalyzed enzymatically, chemically, or by radiation. Cleavage may be exonucleolytic, or endonucleolytic.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059367"}, {"RECTYPE": "D", "MH": "RNA Isoforms", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "mRNA Isoform|T114|T123|NON|NRW|NLM (2021)|200601|abbcdef", "ENTRY": "RNA Isoforms, Messenger", "MN": "D13.444.735.064", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "PI": "RNA or specifics (1988-2011)", "MS": "The different gene transcripts generated from a single gene by RNA EDITING or ALTERNATIVE SPLICING of RNA PRECURSORS.", "PM": "2012", "HN": "2012", "MR": "20200617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059368"}, {"RECTYPE": "D", "MH": "Pott Puffy Tumor", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tumor, Pott's Puffy", "MN": "C11.675.689", "FX": "Tuberculosis, Spinal", "MH_TH": "NLM (2012)", "ST": "T047", "AN": "do not confuse with POTT DISEASE see TUBERCULOSIS, SPINAL", "PI": "Sinusitis (1978-2011)", "MS": "Infection of the FRONTAL BONE often as a complication of FRONTAL SINUSITIS or trauma to the frontal bone and skull. It is characterized by subperiosteal abscess with OSTEOMYELITIS.", "PM": "2012", "HN": "2012", "MR": "20190617", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059369"}, {"RECTYPE": "D", "MH": "RNA Folding", "AQ": "DE GE IM PH RE", "ENTRY": "Unfoldings, RNA", "MN": "G05.360.580.718", "FX": "Nucleic Acid Conformation", "MH_TH": "NLM (2012)", "ST": "T044", "PI": "Nucleic Acid Conformation (1973-2011)", "MS": "The processes of RNA tertiary structure formation.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059370"}, {"RECTYPE": "D", "MH": "DNA, B-Form", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DNA, B Form", "MN": "G05.360.580.121", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Nucleic Acid Conformation (1972-2011)", "MS": "The most common form of DNA found in nature. It is a right-handed helix with 10 base pairs per turn, a pitch of 0.338 nm per base pair and a helical diameter of 1.9 nm.", "PM": "2012; for DNA, B-FORM see DNA 2004-2011", "HN": "2012; for DNA, B-FORM use DNA 2004-2011", "MR": "20150622", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059371"}, {"RECTYPE": "D", "MH": "Nucleotide Motifs", "AQ": "DE GE PH RE", "ENTRY": "Motifs, RNA", "MN": "G05.360.580.662", "FX": "Regulatory Sequences, Nucleic Acid", "MH_TH": "NLM (2012)", "ST": "T114", "MS": "Commonly observed BASE SEQUENCE or nucleotide structural components which can be represented by a CONSENSUS SEQUENCE or a SEQUENCE LOGO.", "PM": "2012", "HN": "2012", "MR": "20150623", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059372"}, {"RECTYPE": "D", "MH": "Mastodynia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Mastalgia|T184|NON|EQV|NLM (2012)|100908|abcdef", "ENTRY": "Pains, Breast", "MN": "G11.561.790.308", "MH_TH": "NLM (2012)", "ST": "T184", "PI": "Pain (1975-2011)", "MS": "Pain in the breast generally classified as cyclical (associated with menstrual periods), or noncyclical, i.e. originating from the breast or nearby muscles or joints, ranging from minor discomfort to severely incapacitating.", "PM": "2012", "HN": "2012", "MR": "20170620", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059373"}, {"RECTYPE": "D", "MH": "Plyometric Exercise", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Trainings, Plyometric", "MN": "I03.350.311.500", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Muscle Stretching Exercises (2006-2011)", "MS": "Exercises in which muscles are repeatedly and rapidly stretched, followed by shortening, concentric MUSCLE CONTRACTION (e.g. jumping and rebounding). They are designed to exert maximal force in minimal time by increasing STRETCH REFLEX.", "PM": "2012", "HN": "2012", "MR": "20170630", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059385"}, {"RECTYPE": "D", "MH": "Reverse Genetics", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Genetics, Reverse", "MN": "E05.393.731", "MH_TH": "NLM (2012)", "ST": "T063", "MS": "The use of techniques that produce a functional MUTATION or an effect on GENE EXPRESSION of a specific gene of interest in order to identify the role or activity of the gene product of that gene.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059386"}, {"RECTYPE": "D", "MH": "Sphenopalatine Ganglion Block", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Sphenopalatine Ganglion Blocks", "MN": "E04.525.210.550.500.500", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "Method of treating pain associated with the sphenopalatine ganglion located in the PTERYGOPALATINE FOSSA, posterior to the middle nasal turbinate. The transnasal approach involves application of suitable local anesthetic to the mucous membrane overlying the ganglion.", "PM": "2012", "HN": "2012", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059387"}, {"RECTYPE": "D", "MH": "Pelvic Girdle Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Symphysis Pubis Dysfunctions", "MN": "C23.888.592.612.944.625", "MH_TH": "NLM (2012)", "ST": "T184", "PI": "Pelvic Pain (2004-2011)", "MS": "Discomfort associated with the bones that make up the pelvic girdle. It occurs frequently during pregnancy.", "PM": "2012", "HN": "2012", "MR": "20170620", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059388"}, {"RECTYPE": "D", "MH": "Breakthrough Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pains, Breakthrough", "MN": "G11.561.790.444.393", "MH_TH": "NLM (2012)", "ST": "T184", "PI": "Pain (1989-2011)", "MS": "Acute pain that comes on rapidly despite the use of pain medication.", "PM": "2012", "HN": "2012", "MR": "20170620", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059390"}, {"RECTYPE": "D", "MH": "Petroleum Pollution", "AQ": "AE AN EC ES HI LJ PC SN", "PRINT ENTRY": "Oil Spills|T068|NON|EQV|NLM (2012)|100910|abcdef", "ENTRY": "Spills, Oil", "MN": "N06.850.460.660", "MH_TH": "NLM (2012)", "ST": "T068", "MS": "Release of oil into the environment usually due to human activity.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059392"}, {"RECTYPE": "D", "MH": "Sun Protection Factor", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Sun Protection Factors", "MN": "E05.799.890", "FX": "Sunscreening Agents", "MH_TH": "NLM (2012)", "ST": "T034", "PI": "Sunscreening Agents (1982-2011)", "MS": "A measure of relative protection provided by SUNSCREENING AGENTS against burns due to ultraviolet (UV) radiation from a light source.", "PM": "2012", "HN": "2012", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059405"}, {"RECTYPE": "D", "MH": "Pinguecula", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pingueculas", "MN": "C11.187.631", "MH_TH": "NLM (2012)", "ST": "T047", "MS": "A yellowish thickened lesion on the conjunctiva near the CORNEA representing a benign degenerative change in the CONJUNCTIVA caused by the leakage and deposition of certain blood proteins through the permeable capillaries near the LIMBUS.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059407"}, {"RECTYPE": "D", "MH": "Pain Management", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Pain Managements", "MN": "N04.590.607.500", "FX": "Chronic Disease", "MH_TH": "NLM (2012)", "ST": "T061", "AN": "consider also PALLIATIVE CARE", "PI": "Pain (1966-2011)", "MS": "A form of therapy that employs a coordinated and interdisciplinary approach for easing the suffering and improving the quality of life of those experiencing pain.", "PM": "2012", "HN": "2012", "MR": "20130708", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059408"}, {"RECTYPE": "D", "MH": "Stroke, Lacunar", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Infarction, Lacunar|T047|NON|REL|NLM (2000)|991012|INFARCT LACUNAR|abcdefv", "ENTRY": "Syndromes, Lacunar", "MN": "C23.550.717.489.250.600", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Cerebral Infarction (1982-2011)", "MS": "Stroke caused by lacunar infarction or other small vessel diseases of the brain. It features hemiparesis (see PARESIS), hemisensory, or hemisensory motor loss.", "PM": "2012; for Infarction, Lacunar see BRAIN INFARCTION 2000-2011", "HN": "2012; for Infarction, Lacunar use BRAIN INFARCTION 2000-2011", "MR": "20200228", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059409"}, {"RECTYPE": "D", "MH": "Lower Urinary Tract Symptoms", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lower Urinary Tract Symptom|T184|NON|EQV|NLM (2021)|200211|abcdef", "MN": "C23.888.942.343", "MH_TH": "NLM (2012)", "ST": "T184", "MS": "Symptoms of disorders of the lower urinary tract including frequency, NOCTURIA; urgency, incomplete voiding, and URINARY INCONTINENCE. They are often associated with OVERACTIVE BLADDER; URINARY INCOMPETENCE; and INTERSTITIAL CYSTITIS. Lower urinary tract symptoms in males were traditionally called PROSTATISM.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059411"}, {"RECTYPE": "D", "MH": "Intraabdominal Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Intraabdominal Infection", "MN": "C01.463", "MH_TH": "NLM (2012)", "ST": "T047", "MS": "Infection within the PERITONEAL CAVITY. A frequent cause is an ANASTOMOTIC LEAK following surgery.", "PM": "2012", "HN": "2012", "MR": "20190617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059413"}, {"RECTYPE": "D", "MH": "Interferon-gamma Release Tests", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Interferon-gamma Release Assay|T059|T060|NON|EQV|NLM (2021)|200129|abbcdef", "ENTRY": "Tests, Interferon-gamma Release", "MN": "E05.478.594.475", "FX": "Tuberculosis", "MH_TH": "NLM (2012)", "ST": "T060", "PI": "Interferon-gamma (1999-2011)", "MS": "The assay of INTERFERON-GAMMA released from lymphocytes after their exposure to a specific test antigen, to check for IMMUNOLOGIC MEMORY resulting from a previous exposure to the antigen. The amount of interferon-gamma released is usually assayed by an ENZYME-LINKED IMMUNOSORBENT ASSAY.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059425"}, {"RECTYPE": "D", "MH": "Anhedonia", "AQ": "CL DE ES PH RE", "ENTRY": "Social Anhedonias", "MN": "F01.700.039", "MH_TH": "NLM (2012)", "ST": "T048", "MS": "Inability to experience pleasure due to impairment or dysfunction of normal psychological and neurobiological mechanisms. It is a symptom of many PSYCHOTIC DISORDERS (e.g., DEPRESSIVE DISORDER, MAJOR; and SCHIZOPHRENIA).", "PM": "2012", "HN": "2012", "DA": "20110627", "DC": "1", "DX": "20120101", "UI": "D059445"}, {"RECTYPE": "D", "MH": "Heterotaxy Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Viscerums, Situs Ambiguus", "MN": "C16.131.240.400.592", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Viscera/abnormalities (1994-2011)", "MS": "Abnormal thoracoabdominal VISCERA arrangement (visceral heterotaxy) or malformation that involves additional CONGENITAL HEART DEFECTS (e.g., heart isomerism; DEXTROCARDIA) and/or abnormal SPLEEN (e.g., asplenia and polysplenia). Irregularities with the central nervous system, the skeleton and urinary tract are often associated with the syndrome.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059446"}, {"RECTYPE": "D", "MH": "Cell Cycle Checkpoints", "AQ": "DE GE IM PH RE", "ENTRY": "Point, Cell Cycle-Transition", "MN": "G04.144.109", "FX": "Genes, cdc", "MH_TH": "NLM (2012)", "ST": "T043", "AN": "general; prefer specifics", "PI": "Cell Cycle or specifics(1989-2011)", "MS": "Regulatory signaling systems that control the progression through the CELL CYCLE. They ensure that the cell has completed, in the correct order and without mistakes, all the processes required to replicate the GENOME and CYTOPLASM, and divide them equally between two daughter cells. If cells sense they have not completed these processes or that the environment does not have the nutrients and growth hormones in place to proceed, then the cells are restrained (or \"arrested\") until the processes are completed and growth conditions are suitable.", "PM": "2012", "HN": "2012", "MR": "20160115", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059447"}, {"RECTYPE": "D", "MH": "Biosimilar Pharmaceuticals", "AQ": "AD AE AN BL CF CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Biosimilar|T121|NON|BRD|NLM (2021)|191113|abcdef", "ENTRY": "Pharmaceuticals, Biosimilar", "MN": "D20.215.261", "MH_TH": "NLM (2012)", "ST": "T121", "RN": "0", "PI": "Biological Agents (2004-2011)", "MS": "Biological products that are imitations but not exact replicas of innovator biological products.", "PM": "2012", "HN": "2012", "MR": "20200114", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059451"}, {"RECTYPE": "D", "MH": "White Coat Hypertension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "White Coat Syndrome|T033|NON|EQV|NLM (2012)|100929|abcdef", "ENTRY": "Syndrome, White Coat", "MN": "C14.907.489.907", "MH_TH": "NLM (2012)", "ST": "T033", "PI": "Hypertension (1988-2011)", "MS": "Phenomenon where BLOOD PRESSURE readings are elevated only when taken in clinical settings.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059466"}, {"RECTYPE": "D", "MH": "Transcriptome", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Transcriptomes|T086|NON|EQV|NLM (2008)|061120|abcdef", "ENTRY": "Transcriptome Profile", "MN": "G05.360.920", "FX": "Gene Expression Profiling", "MH_TH": "NLM (2012)", "ST": "T086", "PI": "Gene Expression Profiling (1999-2011)", "MS": "The pattern of GENE EXPRESSION at the level of genetic transcription in a specific organism or under specific circumstances in specific cells.", "PM": "2012; for GENE EXPRESSION PROFILES see GENE EXPRESSION PROFILING 2006-2011", "HN": "2012; for GENE EXPRESSION PROFILES use GENE EXPRESSION PROFILING 2006-2011", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059467"}, {"RECTYPE": "D", "MH": "Masked Hypertension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Masked Hypertensions", "MN": "C14.907.489.861", "MH_TH": "NLM (2012)", "ST": "T033", "PI": "Hypertension (1978-2011)", "MS": "Phenomenon where increased BLOOD PRESSURE readings taken in non-clinical settings (e.g., HOME BLOOD PRESSURE MONITORING) do not replicate in clinical settings.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059468"}, {"RECTYPE": "D", "MH": "Tetraspanins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tetraspanin|T116|T123|NON|EQV|NLM (2021)|191227|abbcdef", "MN": "D12.776.543.900", "FX": "MARVEL Domain-Containing Proteins", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Membrane Proteins (1997-2011)", "MS": "A large superfamily of cell surface membrane proteins characterized by their four transmembrane domains. They play a role in a variety of processes such as cellular adhesion and motility. They may be involved in the organization of cell surface MEMBRANE MICRODOMAINS that regulate the activation of LEUKOCYTES.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059470"}, {"RECTYPE": "D", "MH": "In Vitro Oocyte Maturation Techniques", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "PRINT ENTRY": "In Vitro Oocyte Maturation|T061|NON|EQV|NLM (2012)|100929|abcdef", "ENTRY": "Oocyte In Vitro Maturation|T061|NON|EQV|NLM (2012)|100929|abcdef", "MN": "E05.820.800.906", "FX": "Oogenesis", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "Methods used to induce premature oocytes, that are maintained in tissue culture, to progress through developmental stages including to a stage that is competent to undergo FERTILIZATION.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059471"}, {"RECTYPE": "D", "MH": "Exome", "AQ": "DE GE IM PH RE", "ENTRY": "Exomes|T028|NON|EQV|NLM (2012)|100930|abcdef", "MN": "G05.360.340.011", "FX": "Transcriptome", "MH_TH": "NLM (2012)", "ST": "T028", "PI": "Genome (2008-2011)", "MS": "That part of the genome that corresponds to the complete complement of EXONS of an organism or cell.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059472"}, {"RECTYPE": "D", "MH": "Gastropexy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Gastropexis|T061|NON|EQV|NLM (2012)|101004|abcdef", "MN": "E04.210.471", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Stomach/surgery (1968-2011)", "MS": "Surgical fixation of the stomach to the abdominal wall.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059485"}, {"RECTYPE": "D", "MH": "Telomere Homeostasis", "AQ": "DE GE IM PH RE", "ENTRY": "Maintenance, Telomere Length", "MN": "G07.345.249.410.750.500.750", "FX": "Telomere-Binding Proteins", "MH_TH": "NLM (2012)", "ST": "T043", "PI": "Telomere (1997-2011)", "MS": "Maintenance of TELOMERE length. During DNA REPLICATION, chromosome ends loose some of their telomere sequence (TELOMERE SHORTENING.) Various cellular mechanism are involved in repairing, extending, and recapping the telomere ends.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059505"}, {"RECTYPE": "D", "MH": "Telomere Shortening", "AQ": "DE GE IM PH RE", "ENTRY": "Telomere Shortenings", "MN": "G07.345.124.130.630", "FX": "Telomere Homeostasis", "MH_TH": "NLM (2012)", "ST": "T043", "PI": "Telomere (1992-2011)", "MS": "The loss of some TELOMERE sequence during DNA REPLICATION of the first several base pairs of a linear DNA molecule; or from DNA DAMAGE. Cells have various mechanisms to restore length (TELOMERE HOMEOSTASIS.) Telomere shortening is involved in the progression of CELL AGING.", "PM": "2012", "HN": "2012", "MR": "20210707", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059506"}, {"RECTYPE": "D", "MH": "Supraglottitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Supraglottitides", "MN": "C09.400.840", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Glottis (1970-2011)", "MS": "Inflammation of the EPIGLOTTIS and supraglottic structures including the PHARYNX; UVULA; base of tongue; and aryepiglottic folds. It is usually caused by HAEMOPHILUS INFLUENZAE in children but often by different organisms in adults.", "PM": "2012", "HN": "2012", "MR": "20190617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059525"}, {"RECTYPE": "D", "MH": "Foraminotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Foraminotomies", "MN": "E04.525.305", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "Surgical enlargement of the intervertebral foramina to relieve NERVE ROOT COMPRESSION.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059526"}, {"RECTYPE": "D", "MH": "Paraneoplastic Syndromes, Ocular", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Ocular Paraneoplastic", "MN": "C11.319.466", "FX": "Recoverin", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Paraneoplastic Syndromes (1986-2011)", "MS": "Ocular manifestations secondary to various NEOPLASMS in which antibodies to antigens of the primary tumor cross-react with ocular antigens. This autoimmune response often leads to visual loss and other ocular dysfunctions.", "PM": "2012", "HN": "2012", "MR": "20180629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059545"}, {"RECTYPE": "D", "MH": "Sinus Floor Augmentation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Sinus Augmentation", "MN": "E06.645.668", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Bone Transplantation (1993-2011)", "MS": "Guided BONE TRANSPLANTATION of the MAXILLARY SINUS surface with a BONE SUBSTITUTE grafting. It increases the bone volume at the site of the DENTAL IMPLANT and helps stabilize it.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059546"}, {"RECTYPE": "D", "MH": "Stereocilia", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Stereovillus", "MN": "A11.284.180.800", "FX": "Hair Cells, Vestibular", "MH_TH": "NLM (2012)", "ST": "T026", "PI": "Cell Surface Extensions (1964-2011)", "MS": "Mechanosensing organelles of hair cells which respond to fluid motion or fluid pressure changes. They have various functions in many different animals, but are primarily used in hearing.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059547"}, {"RECTYPE": "D", "MH": "Anterior Cruciate Ligament Reconstruction", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "MN": "E04.617.101.026", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Anterior Cruciate Ligament/surgery (1990-2011)", "MS": "Rebuilding of the ANTERIOR CRUCIATE LIGAMENT to restore functional stability of the knee. AUTOGRAFTING or ALLOGRAFTING of tissues is often used.", "PM": "2012", "HN": "2012", "MR": "20220406", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059549"}, {"RECTYPE": "D", "MH": "Toxicity Tests, Subchronic", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Toxicity Test, Subchronic", "MN": "E05.940.900", "MH_TH": "NLM (2012)", "ST": "T060", "AN": "TOXICITY TESTS, CHRONIC is also available", "MS": "Experiments designed to determine the potential toxic effects of mid-term (a few months) exposure to a chemical or chemicals.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059550"}, {"RECTYPE": "D", "MH": "Toxicity Tests, Subacute", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Toxicity Test, Subacute", "MN": "E05.940.850", "MH_TH": "NLM (2012)", "ST": "T060", "AN": "ACUTE TOXICITY TESTS is also available", "MS": "Experiments designed to determine the potential toxic effects of a short-term (a few weeks) exposure to a chemical or chemicals.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059551"}, {"RECTYPE": "D", "MH": "Caves", "AQ": "CH MI PS VI", "PRINT ENTRY": "Cavern|T070|NON|EQV|NLM (2021)|191227|abcdef", "ENTRY": "Caverns|T070|NON|EQV|NLM (2012)|101007|abcdef", "MN": "N06.230.066", "MH_TH": "NLM (2012)", "ST": "T070", "MS": "Geological formations consisting of underground enclosures with access from the surface.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059552"}, {"RECTYPE": "D", "MH": "G2 Phase Cell Cycle Checkpoints", "AQ": "DE GE IM PH RE", "ENTRY": "Restriction Points, G2", "MN": "G04.144.500.340.500", "MH_TH": "NLM (2012)", "ST": "T043", "PI": "G2 Phase (1992-2011)", "MS": "CELL CYCLE regulatory signaling systems that are triggered by DNA DAMAGE or lack of nutrients during G2 PHASE. When triggered they restrain cells transitioning from G2 phase to M PHASE.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059565"}, {"RECTYPE": "D", "MH": "M Phase Cell Cycle Checkpoints", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "M Phase Cell Cycle Checkpoint|T043|NON|EQV|NLM (2012)|101008|abcdef", "ENTRY": "Spindle Checkpoints, Mitotic", "MN": "G05.113.220.781.338", "MH_TH": "NLM (2012)", "ST": "T043", "PI": "Mitosis (1991-2011)", "MS": "The cellular signaling system that halts the progression of cells through MITOSIS or MEIOSIS if a defect that will affect CHROMOSOME SEGREGATION is detected.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059566"}, {"RECTYPE": "D", "MH": "G1 Phase Cell Cycle Checkpoints", "AQ": "DE GE IM PH RE", "ENTRY": "Restriction Points, G1", "MN": "G04.144.500.320.500", "MH_TH": "NLM (2012)", "ST": "T043", "PI": "G1 Phase (1992-2011)", "MS": "Regulatory signaling systems that control the progression of the CELL CYCLE through the G1 PHASE and allow transition to S PHASE when the cells are ready to undergo DNA REPLICATION. DNA DAMAGE, or the deficiencies in specific cellular components or nutrients may cause the cells to halt before progressing through G1 phase.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059585"}, {"RECTYPE": "D", "MH": "Duddingtonia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B01.300.381.299", "MH_TH": "NLM (2012)", "ST": "T004", "RN": "txid13348", "PI": "Mitosporic Fungi (1994-2011)", "MS": "A genus of ascomycetous mitosporic fungi in the family Orbiliaceae. It is used for the biological control of nematodes in livestock.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059586"}, {"RECTYPE": "D", "MH": "Calcifying Nanoparticles", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Nanoparticles, Calcifying", "MN": "J01.637.512.600.150", "MH_TH": "NLM (2012)", "ST": "T120", "RN": "0", "PI": "Nanoparticles (2006-2011)", "MS": "Protein-mineral complexes that comprise substrates needed for the normal calcium-carbonate-phosphate homeostasis. Nanobacteria was the prior name for the particles which were originally thought to be microorganisms.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059587"}, {"RECTYPE": "D", "MH": "Dental Implant-Abutment Design", "AQ": "AE CL EC ES HI IS MT NU PX SN ST TD VE", "PRINT ENTRY": "Morse Taper Dental Implant-Abutment Interface|T170|EPO|NRW|NLM (2012)|101018|abcdef", "ENTRY": "Morse Taper Dental Implant Abutment Interface", "MN": "E06.912.145.750", "MH_TH": "NLM (2012)", "ST": "T170", "PI": "Dental Implants (1992-2011)", "MS": "The plan and delineation of DENTAL IMPLANT fitting with DENTAL ABUTMENT.", "PM": "2012", "HN": "2012", "MR": "20180629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059605"}, {"RECTYPE": "D", "MH": "Polydipsia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Polydipsias", "MN": "C23.888.663", "FX": "Thirst", "MH_TH": "NLM (2012)", "ST": "T184", "AN": "Do not confuse with POLYDIPSIA, PSYCHOGENIC", "PI": "Thirst (1963-2011)", "MS": "Excessive thirst manifested by excessive fluid intake. It is characteristic of many diseases such as DIABETES MELLITUS; DIABETES INSIPIDUS; and NEPHROGENIC DIABETES INSIPIDUS. The condition may be psychogenic in origin.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059606"}, {"RECTYPE": "D", "MH": "Polydipsia, Psychogenic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Psychogenic Polydipsias", "MN": "F01.700.812", "MH_TH": "NLM (2012)", "ST": "T184", "AN": "Do not confuse with POLYDIPSIA", "PI": "Thirst (1963-2011)", "MS": "A clinical disorder characterized by excessive fluid intake (polydipsia); HYPONATREMIA; and POLYURIA in SCHIZOPHRENIA and other psychiatric disorders. Impaired water metabolism in psychogenic polydipsia can result in WATER INTOXICATION.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059607"}, {"RECTYPE": "D", "MH": "Laryngocele", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Laryngoceles", "MN": "C16.131.740.650", "MH_TH": "NLM (2012)", "ST": "T019", "PI": "Laryngeal Diseases (1963-2011)", "MS": "Congenital anomalous dilitation of the laryngeal saccule that may extend internally into the airway or externally through the thyrohyoid membrane.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059608"}, {"RECTYPE": "D", "MH": "Mallory Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Bodies, Mallory", "MN": "A11.284.420.500", "MH_TH": "NLM (2012)", "ST": "T026", "PI": "Inclusion Bodies (1971-2011)", "MS": "Cytoplasmic hyaline inclusions in HEPATOCYTES. They are associated with ALCOHOLIC STEATOHEPATITIS and non-alcoholic STEATOHEPATITIS, but are also present in benign and malignant hepatocellular neoplasms, and metabolic, toxic, and chronic cholestatic LIVER DISEASES.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059609"}, {"RECTYPE": "D", "MH": "Balamuthia mandrillaris", "AQ": "CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.046.090", "MH_TH": "NLM (2012)", "ST": "T204", "RN": "txid66527", "AN": "infection: coordinate with AMEBIASIS; for encephalitis caused by this organism, coordinate also with CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS + INFECTIOUS ENCEPHALITIS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent ", "PI": "Amoebozoa (1994-2011)", "MS": "A species of free-living soil amoeba in the family Balamuthiidae, causing AMEBIASIS and a deadly form of ENCEPHALITIS in humans.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059611"}, {"RECTYPE": "D", "MH": "Liquid-Liquid Extraction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Phase Extractions, Liquid", "MN": "E05.196.155.650", "MH_TH": "NLM (2012)", "ST": "T059", "MS": "The removal of a soluble component from a liquid mixture by contact with a second liquid, immiscible with the carrier liquid, in which the component is preferentially soluble. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059625"}, {"RECTYPE": "D", "MH": "Liquid Phase Microextraction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Phase Microextractions, Liquid", "MN": "E05.196.155.650.500", "MH_TH": "NLM (2012)", "ST": "T059", "MS": "Miniaturized methods of liquid-liquid extraction.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059627"}, {"RECTYPE": "D", "MH": "Signal-To-Noise Ratio", "ENTRY": "Signal-To-Noise Ratios", "MN": "N06.850.520.830.872.750", "MH_TH": "NLM (2012)", "ST": "T081", "MS": "The comparison of the quantity of meaningful data to the irrelevant or incorrect data.", "PM": "2012", "HN": "2012", "MR": "20180629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059629"}, {"RECTYPE": "D", "MH": "Mesenchymal Stem Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE UL VI", "PRINT ENTRY": "Multipotent Mesenchymal Stromal Cell|T025|NON|NRW|NLM (2021)|200220|abcdef", "ENTRY": "Whartons Jelly Cells", "MN": "A11.872.590.500", "EC": "transplantation:Mesenchymal Stem Cell Transplantation", "MH_TH": "NLM (2004)", "ST": "T025", "AN": "note entry term WHARTON JELLY CELLS: consider also WHARTON JELLY /cytol", "PI": "Stromal Cells (2002-2011)", "MS": "Mesenchymal stem cells, also referred to as multipotent stromal cells or mesenchymal stromal cells are multipotent, non-hematopoietic adult stem cells that are present in multiple tissues, including BONE MARROW; ADIPOSE TISSUE; and WHARTON JELLY. Mesenchymal stem cells can differentiate into mesodermal lineages, such as adipocytic, osteocytic and chondrocytic.", "PM": "2019; see Mesenchymal Stromal Cells 2012-2018; for MESENCHYMAL STEM CELLS and MESENCHYMAL PROGENITOR CELLS see MESENCHYMAL STEM CELLS 2004-2012", "HN": "2019(2004); was Mesenchymal Stromal Cells 2012-2018", "MR": "20210510", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059630"}, {"RECTYPE": "D", "MH": "Wharton Jelly", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Whartons Jelly", "MN": "A10.165.970", "MH_TH": "NLM (2012)", "ST": "T024", "AN": "/cytol: consider also WHARTON JELLY CELLS see MESENCHYMAL STEM CELLS", "MS": "Jelly-like connective tissue of the UMBILICAL CORD that contains MESENCHYMAL STEM CELLS.", "PM": "2012", "HN": "2012", "MR": "20180713", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059631"}, {"RECTYPE": "D", "MH": "Mutation Rate", "ENTRY": "Rates, Mutation", "MN": "G16.075.250.750", "MH_TH": "NLM (2012)", "ST": "T080", "PI": "Mutation (1963-2011)", "MS": "The number of mutations that occur in a specific sequence, GENE, or GENOME over a specified period of time such as years, CELL DIVISIONS, or generations.", "PM": "2012", "HN": "2012", "MR": "20160623", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059645"}, {"RECTYPE": "D", "MH": "Genome Size", "AQ": "DE GE IM PH RE", "ENTRY": "Sizes, Genome", "MN": "G05.360.340.037", "MH_TH": "NLM (2012)", "ST": "T081", "PI": "Genome or specifics (1974-2011)", "MS": "The amount of DNA (or RNA) in one copy of a genome.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059646"}, {"RECTYPE": "D", "MH": "Gene-Environment Interaction", "ENTRY": "Interactions, Gene-Environment", "MN": "G05.695.337", "FX": "Genetic Predisposition to Disease", "MH_TH": "NLM (2012)", "ST": "T045", "MS": "The combined effects of genotypes and environmental factors together on phenotypic characteristics.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059647"}, {"RECTYPE": "D", "MH": "Kisspeptins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Metastin|T116|T123|NON|EQV|NLM (2021)|191125|abbcdef", "ENTRY": "Metastasis Suppressor, KiSS-1", "MN": "D12.776.624.776.546", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "PI": "Tumor Suppressor Proteins (1997-2011)", "MS": "Intercellular signaling peptides that were originally characterized by their ability to suppress NEOPLASM METASTASIS. Kisspeptins have since been found to play an important role in the neuroendocrine regulation of REPRODUCTION.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059648"}, {"RECTYPE": "D", "MH": "Lysosomal-Associated Membrane Protein 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Lysosomal Associated Membrane Protein 3", "MN": "D12.776.543.550.527.875", "MH_TH": "NLM (2006)", "ST": "T123", "RN": "0", "AN": "note that LAMP-3 and Lysosomal-Associated Membrane Protein 3 appear in the literature as synonyms for CD63 antigen, however they are separate and distinct proteins", "PI": "Lysosome-Associated Membrane Glycoproteins (2006-2011)", "MS": "A lysosomal-associated membrane glycoprotein that is expressed at high levels in mature DENDRITIC CELLS.", "PM": "2012; see LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS 2006-2011", "HN": "2012; use LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS 2006-2011", "MR": "20230417", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059666"}, {"RECTYPE": "D", "MH": "Herniorrhaphy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Repairs, Hernia", "MN": "E04.617.325", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Hernia/surgery (1965-2011)", "MS": "Surgical procedures undertaken to repair abnormal openings through which tissue or parts of organs can protrude or are already protruding.", "PM": "2012", "HN": "2012", "MR": "20220406", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059685"}, {"RECTYPE": "D", "MH": "Polar Bodies", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Polar Cell", "MN": "A11.497.497.600.500", "MH_TH": "NLM (2012)", "ST": "T025", "PI": "Oocytes (1976-2011)", "MS": "Minute cells produced during development of an OOCYTE as it undergoes MEIOSIS. A polar body contains one of the nuclei derived from the first or second meiotic CELL DIVISION. Polar bodies have practically no CYTOPLASM. They are eventually discarded by the oocyte. (from King & Stansfield, A Dictionary of Genetics, 4th ed)", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059705"}, {"RECTYPE": "D", "MH": "Aliivibrio", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.830.050", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid511678", "MS": "A genus of gram-negative, rod-shaped bacteria in the family VIBRIONACEAE. They are found in the marine environment often associated with animals.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059706"}, {"RECTYPE": "D", "MH": "Aliivibrio Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infections, Aliivibrio", "MN": "C01.150.252.400.050", "MH_TH": "NLM (2012)", "ST": "T047", "MS": "Infections with bacteria of the genus ALIIVIBRIO.", "PM": "2012", "HN": "2012", "MR": "20190617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059707"}, {"RECTYPE": "D", "MH": "Ultrasonic Surgical Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Ultrasound Surgical Procedures|T061|NON|EQV|NLM (2023)|210902|abcdef", "ENTRY": "Ultrasound Surgical Procedure", "MN": "E04.943", "FX": "Ultrasonic Therapy", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "The use of HIGH-ENERGY SHOCK WAVES, in the frequency range of 20-60 kHz, to cut through or remove tissue. The tissue fragmentation by ultrasonic surgical instruments is caused by mechanical effects not heat as with HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION.", "PM": "2012", "HN": "2012", "MR": "20220408", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059708"}, {"RECTYPE": "D", "MH": "Interactive Ventilatory Support", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Ventilatory Support, Interactive", "MN": "E02.880.820.516", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "Mechanical ventilation delivered to match the patient's efforts in breathing as detected by the interactive ventilation device.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059725"}, {"RECTYPE": "D", "MH": "Piezosurgery", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgery, Piezo-Electric Bone", "MN": "E04.943.937", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Ultrasonic Therapy (2004-2011)", "MS": "The use of HIGH-ENERGY SHOCK WAVES, in the frequency range of 20-30 kHz, to cut through mineralized tissue.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059745"}, {"RECTYPE": "D", "MH": "Heimlich Maneuver", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Maneuver, Heimlich", "MN": "E02.365.476", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Resuscitation (1979-2011)", "MS": "An emergency treatment commonly used to clear food and other foreign objects causing AIRWAY OBSTRUCTION.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059746"}, {"RECTYPE": "D", "MH": "Nasal Surgical Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Nasal", "MN": "E04.580.392", "FX": "Otolaryngology", "MH_TH": "NLM (2012)", "ST": "T061", "AN": "for transnasal or endonasal surgery performed on areas of the body reached through the nose use NATURAL ORIFICE ENDOSCOPIC SURGERY", "PI": "Nose/surgery or specifics (1963-2011)", "MS": "Surgical operations on the nose and nasal cavity.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059747"}, {"RECTYPE": "D", "MH": "Proteolysis", "AQ": "DE RE", "ENTRY": "Proteolyses", "MN": "G03.812", "MH_TH": "NLM (2012)", "ST": "T044", "MS": "Cleavage of proteins into smaller peptides or amino acids either by PROTEASES or non-enzymatically (e.g., Hydrolysis). It does not include Protein Processing, Post-Translational.", "PM": "2012", "HN": "2012", "MR": "20160623", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059748"}, {"RECTYPE": "D", "MH": "Homologous Recombination", "AQ": "DE GE IM PH RE", "ENTRY": "Recombinations, Homologous", "MN": "G05.728.615", "MH_TH": "NLM (2012)", "ST": "T045", "PI": "Recombination, Genetic (1982-2011)", "MS": "An exchange of DNA between matching or similar sequences.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059765"}, {"RECTYPE": "D", "MH": "DNA End-Joining Repair", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Non-Homologous DNA End-Joining|T045|ACX|NRW|NLM (2012)|101101|abcdef", "ENTRY": "Repair, NHEJ DNA", "MN": "G05.219.200", "MH_TH": "NLM (2012)", "ST": "T045", "PI": "DNA Repair (1996-2011)", "MS": "The repair of DOUBLE-STRAND DNA BREAKS by rejoining the broken ends of DNA to each other directly.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059766"}, {"RECTYPE": "D", "MH": "Recombinational DNA Repair", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Homology-Directed dsDNA Break Repair|T045|ACX|NRW|NLM (2012)|101101|abcdef", "ENTRY": "Repair, Recombinational DNA", "MN": "G05.728.615.612", "MH_TH": "NLM (2012)", "ST": "T045", "PI": "Recombination, Genetic (1972-2011)", "MS": "Repair of DNA DAMAGE by exchange of DNA between matching sequences, usually between the allelic DNA (ALLELES) of sister chromatids.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059767"}, {"RECTYPE": "D", "MH": "Karyotype", "ENTRY": "Karyotypes", "MN": "G05.360.162.679", "FX": "Karyotyping", "MH_TH": "NLM (2012)", "ST": "T032", "PI": "Karyotyping (1965-2011)", "MS": "The full set of CHROMOSOMES presented as a systematized array of METAPHASE chromosomes from a photomicrograph of a single CELL NUCLEUS arranged in pairs in descending order of size and according to the position of the CENTROMERE. (From Stedman, 25th ed)", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059785"}, {"RECTYPE": "D", "MH": "Abnormal Karyotype", "AQ": "CI CL DE EM RE SN VE", "PRINT ENTRY": "Karyotype, Abnormal|T049|NON|EQV|NLM (2002)|010102|abcdef", "ENTRY": "Karyotypes, Abnormal", "MN": "G05.365.590.175.024", "MH_TH": "NLM (2002)", "ST": "T049", "PI": "Karyotyping (1964-2011)", "MS": "A variation from the normal set of chromosomes characteristic of a species.", "PM": "2012; see CHROMOSOME ABERRATIONS 2002-2011", "HN": "2012; use CHROMOSOME ABERRATIONS 2002-2011", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059786"}, {"RECTYPE": "D", "MH": "Acute Pain", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pains, Acute", "MN": "C23.888.592.612.081", "FX": "Chronic Pain", "MH_TH": "NLM (2012)", "ST": "T184", "PI": "Pain (1963-2011)", "MS": "Intensely discomforting, distressful, or agonizing sensation associated with trauma or disease, with well-defined location, character, and timing.", "PM": "2012", "HN": "2012", "MR": "20170620", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059787"}, {"RECTYPE": "D", "MH": "Dried Blood Spot Testing", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Dried Blood Spot Method|T059|NON|EQV|NLM (2012)|101109|abcdef", "MN": "E05.200.124.100.232", "MH_TH": "NLM (2012)", "ST": "T059", "MS": "Techniques for using whole blood samples collected on filter paper for a variety of clinical laboratory tests.", "PM": "2012", "HN": "2012", "MR": "20150622", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059788"}, {"RECTYPE": "D", "MH": "HLA-DR alpha-Chains", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "HLA-DR alpha-Chain|T116|T129|ABX|EQV|NLM (2012)|101116|abbcdef", "ENTRY": "alpha-Chains, HLA-DR", "MN": "D23.050.705.552.450.400.440.222", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "HLA-DR Antigens (1987-2011)", "MS": "Transmembrane proteins that form the alpha subunits of the HLA-DR antigens. They are also referred to as the HLA-DR heavy chains.", "PM": "2012; for HLA-D ALPHA see HLA-DR ANTIGENS 1987-2011; HLA-DRA was indexed under HLA-DR ANTIGENS 1992-2011", "HN": "2012; for HLA-D ALPHA use HLA-DR ANTIGENS 1987-2011", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059805"}, {"RECTYPE": "D", "MH": "HLA-DR beta-Chains", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "HLA-DR beta|T116|T129|EQV|UNK (19XX)|870810|abbdef", "ENTRY": "beta-Chain, HLA-DR", "MN": "D23.050.705.552.450.400.440.333", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "HLA-DR Antigens (1987-2011)", "MS": "Transmembrane proteins that form the beta subunits of the HLA-DR antigens. They are also referred to as the HLA-DR light chains.", "PM": "2012; for HLA-D BETA see HLA-DR ANTIGENS 1987-2011", "HN": "2012; for HLA-D BETA use HLA-DR ANTIGENS 1987-2011", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059806"}, {"RECTYPE": "D", "MH": "S Phase Cell Cycle Checkpoints", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "S Phase Checkpoint|T043|NON|EQV|NLM (2012)|101116|abcdef", "ENTRY": "S Phase Checkpoints", "MN": "G04.144.500.800.500", "MH_TH": "NLM (2012)", "ST": "T043", "PI": "S Phase (1995-2011)", "MS": "Cell regulatory signaling system that controls progression through S PHASE and stabilizes the replication forks during conditions that could affect the fidelity of DNA REPLICATION, such as DNA DAMAGE or depletion of nucleotide pools.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059807"}, {"RECTYPE": "D", "MH": "Polyphenols", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyphenol|T109|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Provinols|T109|NON|NRW|NLM (2012)|101129|abcdef", "MN": "D02.455.426.559.389.657.715", "MH_TH": "NLM (2012)", "ST": "T109", "RN": "0", "PI": "Phenols (1963-2011)", "MS": "A large class of organic compounds having more than one PHENOL group.", "PM": "2012; POLYPHENOLS was indexed under PHENOLS 1963-2011.", "HN": "2012 (2010)", "MR": "20220413", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059808"}, {"RECTYPE": "D", "MH": "HLA-DR Serological Subtypes", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Subtypes, HLA-DR Serological", "MN": "D23.050.705.552.450.400.440.389", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "AN": "general; prefer specifics", "PI": "HLA-DR Antigens (1986-2011)", "MS": "HLA-DR antigen subtypes that have been classified according to their affinity to specific ANTIBODIES. The DNA sequence analyses of HLA-DR ALPHA-CHAINS and HLA-DR BETA-CHAINS has for the most part revealed the specific alleles that are responsible for each serological subtype.", "PM": "2012", "HN": "2012", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059810"}, {"RECTYPE": "D", "MH": "HLA-DRB1 Chains", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA DRB1 Chains", "MN": "D23.050.705.552.450.400.440.333.500", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A subtype of HLA-DRB beta chains that includes over one hundred allele variants. The HLA-DRB1 subtype is associated with several of the HLA-DR SEROLOGICAL SUBTYPES.", "PM": "2012; HLA-DRB1 ANTIGEN was indexed under HLA-DR ANTIGENS 1991-2011", "HN": "2012(1991)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059811"}, {"RECTYPE": "D", "MH": "Physical Therapists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Therapists, Physical", "MN": "N02.360.790", "MH_TH": "NLM (2012)", "ST": "T097", "PI": "Physical Therapy Modalities (1966-2011)", "MS": "Persons trained in PHYSICAL THERAPY SPECIALTY to make use of PHYSICAL THERAPY MODALITIES to prevent, correct, and alleviate movement dysfunction.", "PM": "2012", "HN": "2012", "MR": "20180629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059825"}, {"RECTYPE": "D", "MH": "HLA-DRB3 Chains", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA DRB3 Chains", "MN": "D23.050.705.552.450.400.440.333.750", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A subtype of HLA-DRB beta chains that includes over 50 allelic variants. The HLA-DRB3 beta-chain subtype is associated with HLA-DR52 serological subtype.", "PM": "2012; HLA-DRB3 was indexed under HLA-DR ANTIGENS 1993-2011", "HN": "2012(1993)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059826"}, {"RECTYPE": "D", "MH": "Agricultural Inoculants", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Microbial Inoculants|T007|NON|EQV|NLM (2012)|101117|abcdef", "ENTRY": "Microbial Inoculant", "MN": "B03.054", "FX": "Growth Substances", "MH_TH": "NLM (2012)", "ST": "T007", "PI": "Bacteria (1993-2011)", "MS": "Beneficial microorganisms (bacteria or fungi) encapsulated in carrier material and applied to the environment for remediation and enhancement of agricultural productivity.", "PM": "2012", "HN": "2012", "MR": "20200902", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059827"}, {"RECTYPE": "D", "MH": "Plant Cells", "AQ": "CH CL DE EN IM ME MI PA PH PS RE UL VI", "ENTRY": "Plant Cell", "MN": "A11.750", "MH_TH": "NLM (2012)", "ST": "T025", "AN": "General or unspecified. prefer specific plant with /cytol.", "PI": "Plants (1963-2011)", "MS": "Basic functional unit of plants.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059828"}, {"RECTYPE": "D", "MH": "HLA-DRB4 Chains", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA DRB4 Chains", "MN": "D23.050.705.552.450.400.440.333.875", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "HLA-DR Antigens (1987-2011)", "MS": "A subtype of HLA-DRB beta chains that is associated with the HLA-DR53 serological subtype.", "PM": "2012; HLA-DRB4 was indexed under HLA-DR ANTIGENS 1992-2011", "HN": "2012(1992)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059845"}, {"RECTYPE": "D", "MH": "Analgesics, Short-Acting", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Short-Acting Analgesics", "MN": "D27.505.954.427.040.381", "MH_TH": "NLM (2012)", "ST": "T121", "RN": "0", "PI": "Analgesics (1963-2011)", "MS": "Pain-alleviating drugs characterized by rapid action time.", "PM": "2012", "HN": "2012", "MR": "20140625", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059846"}, {"RECTYPE": "D", "MH": "HLA-DRB5 Chains", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA DRB5 Chains", "MN": "D23.050.705.552.450.400.440.333.937", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A subtype of HLA-DRB beta chains that is associated with the HLA-DR51 serological subtype.", "PM": "2012; HLA-DRB5 was indexed under 1992-2011", "HN": "2012(1992)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059847"}, {"RECTYPE": "D", "MH": "HLA-DQ alpha-Chains", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "alpha-Chains, HLA-DQ", "MN": "D23.050.705.552.450.400.430.500", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "HLA-DQ Antigens (1987-2011)", "MS": "Transmembrane proteins that form the alpha subunits of the HLA-DQ antigens.", "PM": "2012", "HN": "2012", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059848"}, {"RECTYPE": "D", "MH": "Endoplasmic Reticulum Stress", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Stress, Endoplasmic Reticulum|T049|NON|EQV|NLM (2012)|101119|abcdef", "ENTRY": "Stresses, Endoplasmic Reticulum", "MN": "G04.434", "FX": "Unfolded Protein Response", "MH_TH": "NLM (2012)", "ST": "T049", "PI": "Stress, Physiological (1997-2011)", "MS": "Various physiological or molecular disturbances that impair ENDOPLASMIC RETICULUM function. It triggers many responses, including UNFOLDED PROTEIN RESPONSE, which may lead to APOPTOSIS; and AUTOPHAGY.", "PM": "2012", "HN": "2012", "MR": "20150622", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059865"}, {"RECTYPE": "D", "MH": "HLA-DQ beta-Chains", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "beta-Chains, HLA-DQ", "MN": "D23.050.705.552.450.400.430.750", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "HLA-DQ Antigens (1987-2011)", "MS": "Transmembrane proteins that form the beta subunits of the HLA-DQ antigens.", "PM": "2012", "HN": "2012", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059866"}, {"RECTYPE": "D", "MH": "HLA-DP alpha-Chains", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "alpha-Chains, HLA-DP", "MN": "D23.050.705.552.450.400.420.500", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "HLA-DP Antigens (1986-2011)", "MS": "Transmembrane proteins that form the alpha subunits of the HLA-DP antigens.", "PM": "2012", "HN": "2012", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059867"}, {"RECTYPE": "D", "MH": "HLA-DP beta-Chains", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "beta-Chains, HLA-DP", "MN": "D23.050.705.552.450.400.420.750", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "HLA-DP Antigens (1987-2011)", "MS": "Transmembrane proteins that form the beta subunits of the HLA-DP antigens.", "PM": "2012", "HN": "2012", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059868"}, {"RECTYPE": "D", "MH": "Radiostereometric Analysis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Stereophotogrammetry, Roentgen", "MN": "E01.370.350.700.750", "MH_TH": "NLM (2012)", "ST": "T060", "MS": "Methods for performing three-dimensional measurement and motion analysis using stereoscopic radiographs.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059869"}, {"RECTYPE": "D", "MH": "HLA-A11 Antigen", "DS": "HLA A 011 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, A 11 alpha Chain", "MN": "D23.050.705.552.450.370.500", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A specific HLA-A surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-A*11 allele family.", "PM": "2012; HLA-A11 was indexed under HLA-A ANTIGENS 1989-2011 and under HLA ANTIGENS 1982-1988", "HN": "2012(1989)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059870"}, {"RECTYPE": "D", "MH": "HLA-A24 Antigen", "DS": "HLA A 024 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, A 24 alpha Chain", "MN": "D23.050.705.552.450.370.600", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A specific HLA-A surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-A*24 allele family.", "PM": "2012; HLA-A24 was indexed under HLA-A ANTIGENS 1989-2011 and under HLA ANTIGENS 1986-1988", "HN": "2012(1986)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059871"}, {"RECTYPE": "D", "MH": "Kasabach-Merritt Syndrome", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Thrombocytopenia-Hemangioma Syndrome|T047|NON|EQV|NLM (2012)|ORD (2010)|101122|abcdeef", "ENTRY": "Thrombocytopenia-Hemangioma Syndromes", "MN": "C15.378.243.937.645", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Hemangioma (1964-2011)", "MS": "Rapidly growing vascular lesion along the midline axis of the neck, upper trunk, and extremities that is characterized by CONSUMPTION COAGULOPATHY; THROMBOCYTOPENIA; and HEMOLYTIC ANEMIA. It is often associated with infantile Kaposiform HEMANGIOENDOTHELIOMA and other vascular tumors such as tufted ANGIOMA.", "PM": "2012", "HN": "2012", "MR": "20230226", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059885"}, {"RECTYPE": "D", "MH": "Endocarditis, Non-Infective", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Non-Bacterial Thrombotic Endocarditis|T047|NON|NRW|NLM (2012)|101123|abcdef", "ENTRY": "Non-Infective Endocarditides", "MN": "C14.280.282.703", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Endocarditis (1971-2011)", "MS": "Formation of a non-infectious THROMBUS, referred to as vegetation, on previously undamaged ENDOCARDIUM. It usually occurs as a complication of connective-tissue diseases and cancers because of the associated hypercoagulable state (see THROMBOPHILIA).", "PM": "2012", "HN": "2012", "DA": "20110627", "DC": "1", "DX": "20120101", "UI": "D059905"}, {"RECTYPE": "D", "MH": "Neuroimaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Imaging, Brain", "MN": "E05.629", "MH_TH": "NLM (2012)", "ST": "T062", "AN": "coordinate with specific imaging modality if appropriate", "MS": "Non-invasive methods of visualizing the CENTRAL NERVOUS SYSTEM, especially the brain, by various imaging modalities.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059906"}, {"RECTYPE": "D", "MH": "Functional Neuroimaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Neuroimaging, Functional", "MN": "E05.629.875", "MH_TH": "NLM (2012)", "ST": "T062", "AN": "coordinate with specific imaging modality if appropriate", "MS": "Methods for visualizing REGIONAL BLOOD FLOW, metabolic, electrical, or other physiological activities in the CENTRAL NERVOUS SYSTEM using various imaging modalities.", "PM": "2012", "HN": "2012", "MR": "20140624", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059907"}, {"RECTYPE": "D", "MH": "HLA-B13 Antigen", "DS": "HLA B 013 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, B 13 alpha Chain", "MN": "D23.050.705.552.450.380.130", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*13 allele family.", "PM": "2012; HLA-B13 was indexed under HLA-B ANTIGENS 1983-2011", "HN": "2012(1983)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059908"}, {"RECTYPE": "D", "MH": "HLA-B14 Antigen", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, B 14 alpha Chain", "MN": "D23.050.705.552.450.380.140", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*14 allele family.", "PM": "2012; HLA-B14 was indexed under HLA-B ANTIGENS 1982-1988, and under HLA ANTIGENS 1989-2011", "HN": "2012(1982)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059909"}, {"RECTYPE": "D", "MH": "HLA-B15 Antigen", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "HLA B15 Antigen|T116|T129|ABX|EQV|NLM (2012)|101123|HLA B 015 ANTIGEN|abbcdefs", "ENTRY": "HLA Class I Histocompatibility Antigen, B 15 alpha Chain", "MN": "D23.050.705.552.450.380.150", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*15 allele family.", "PM": "2012; HLA-B15 was indexed under HLA-B ANTIGENS 1989-2011 and under HLA ANTIGENS 1981-1988", "HN": "2012(1981)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059910"}, {"RECTYPE": "D", "MH": "HLA-B18 Antigen", "DS": "HLA B 018 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, B 18 alpha Chain", "MN": "D23.050.705.552.450.380.180", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*18 allele family.", "PM": "2012; HLA-B18 was indexed under HLA-B ANTIGENS 1989-2011 and under HLA ANTIGENS 1981-1988", "HN": "2012(1981)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059911"}, {"RECTYPE": "D", "MH": "HLA-B37 Antigen", "DS": "HLA B 037 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, B 37 alpha Chain", "MN": "D23.050.705.552.450.380.370", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*37 allele family.", "PM": "2012 HLA-B37 was indexed under HLA-B ANTIGENS 1989-2011 and under HLA-ANTIGENS 1986-1988", "HN": "2012(1986)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059912"}, {"RECTYPE": "D", "MH": "Anatomic Landmarks", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Landmarks, Anatomic", "MN": "A01.111", "FX": "Fiducial Markers", "MH_TH": "NLM (2012)", "ST": "T029", "MS": "Reference points located by visual inspection, palpation, or computer assistance, that are useful in localizing structures on or within the human body.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059925"}, {"RECTYPE": "D", "MH": "HLA-B38 Antigen", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "HLA B38 Antigen|T116|T129|ABX|EQV|NLM (2012)|101126|abbcdef", "ENTRY": "HLA Class I Histocompatibility Antigen, B 38 alpha Chain", "MN": "D23.050.705.552.450.380.380", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*38 allele family.", "PM": "2012; HLB-B38 was indexed under HLA-B ANTIGENS 1987-2011", "HN": "2012(1987)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059945"}, {"RECTYPE": "D", "MH": "HLA-B39 Antigen", "DS": "HLA B 039 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, B 39 alpha Chain", "MN": "D23.050.705.552.450.380.390", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*39 allele family.", "PM": "2012; HLA-B39 was indexed under HLA-B ANTIGENS 1989-2011 and under HLA ANTIGENS 1987-1988", "HN": "2012(1987)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059946"}, {"RECTYPE": "D", "MH": "HLA-B40 Antigen", "DS": "HLA B 040 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, B 40 alpha Chain", "MN": "D23.050.705.552.450.380.400", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*40 allele family.", "PM": "2012; HLA-B40 was indexed under HLA-B ANTIGENS 1989-2011 and under HLA ANTIGENS 1981-1988", "HN": "2012(1989)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059947"}, {"RECTYPE": "D", "MH": "HLA-B44 Antigen", "DS": "HLA B 044 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, B 44 alpha Chain", "MN": "D23.050.705.552.450.380.440", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*44 allele family.", "PM": "2012; 2012; HLA-B44 was indexed under HLA-B ANTIGENS 1985-2011", "HN": "2012(1985)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059948"}, {"RECTYPE": "D", "MH": "HLA-B51 Antigen", "DS": "HLA B 051 ANTIGEN", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "HLA Class I Histocompatibility Antigen, B 51 alpha Chain", "MN": "D23.050.705.552.450.380.510", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*51 allele family.", "PM": "2012; HLA-B51 was indexed under *HLA-B ANTIGENS 1989-2011 and under HLA ANTIGENS 1982-1988", "HN": "2012(1982)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059949"}, {"RECTYPE": "D", "MH": "HLA-B52 Antigen", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "HLA B52 Antigen|T116|T129|ABX|EQV|NLM (2012)|101126|HLA B 052 ANTIGEN|abbcdefs", "ENTRY": "HLA Class I Histocompatibility Antigen, B 52 alpha Chain", "MN": "D23.050.705.552.450.380.520", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*52 allele family.", "PM": "2012; HLA-B52 was indexed under HLA-B ANTIGENS 1989-2011 and under HLA-ANTIGENS 1985-1988", "HN": "2012(1985)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059950"}, {"RECTYPE": "D", "MH": "HLA-G Antigens", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "ENTRY": "Isoform, HLA-G7", "MN": "D23.050.705.552.450.700", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "Class I human histocompatibility (HLA) surface antigens encoded by alleles on locus B of the HLA complex. The HLA-G antigens are considered non-classical class I antigens due to their distinct tissue distribution which differs from HLA-A; HLA-B; and HLA-C antigens. Note that several isoforms of HLA-G antigens result from alternative splicing of messenger RNAs produced from the HLA-G*01 allele.", "PM": "2012; HLA-G ANTIGEN was indexed under HLA-ANTIGENS and HISTOCOMPATIBILITY ANTIGENS 1990-2011; HLA-G7 ANTIGEN was indexed under HLA-ANTIGENS 2001-2011", "HN": "2012(1990)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059951"}, {"RECTYPE": "D", "MH": "Pelvic Floor Disorders", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pelvic Floor Disorder", "MN": "C12.400", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Pelvic Floor (1993-2011)", "MS": "Injury, weakening, or PROLAPSE of the pelvic muscles, surrounding connective tissues or ligaments (PELVIC FLOOR).", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059952"}, {"RECTYPE": "D", "MH": "Merkel cell polyomavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "ENTRY": "polyomavirus, Merkel cell", "MN": "B04.613.204.670.615.550", "MH_TH": "NLM (2012)", "ST": "T005", "RN": "txid493803", "AN": "infection: coordinate IM with POLYOMAVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS + CARCINOMA, MERKEL CELL if pertinent", "PI": "Polyomavirus (2008-2011)", "MS": "A species of POLYOMAVIRUS suspected to be the cause of most cases of MERKEL CELL CARCINOMA, a rare but highly lethal form of skin cancer.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D059965"}, {"RECTYPE": "D", "MH": "Cryogels", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Cryogel|T109|T130|NON|EQV|NLM (2012)|101208|abbcdef", "MN": "D26.255.165.320.375.187", "MH_TH": "NLM (2012)", "ST": "T130", "RN": "0", "MS": "Macroporous hydrogels that are produced at subzero temperatures. Cryogels have pores that are produced by growing ice crystals and have been developed with a tissue-like elasticity that is suitable for cell immunization experiments.", "PM": "2012; CRYOGEL was indexed under HYDROGELS 2010-2011, and under BLOOD PROTEINS and FIBRONECTINS 2003-2009", "HN": "2012(2003)", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D059985"}, {"RECTYPE": "D", "MH": "Genotyping Techniques", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Techniques, Genotyping", "MN": "E05.393.442", "FX": "Genotype", "MH_TH": "NLM (2012)", "ST": "T063", "PI": "Genotype (1969-2011)", "MS": "Methods used to determine individuals' specific ALLELES or SNPS (single nucleotide polymorphisms).", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060005"}, {"RECTYPE": "D", "MH": "Endophytes", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Endophyte|T001|NON|EQV|NLM (2021)|191125|abcdef", "ENTRY": "Endophytic Organism|T001|NON|EQV|NLM (2020)|180917|abcdef", "MN": "B05.237", "FX": "Symbiosis", "MH_TH": "NLM (2012)", "ST": "T001", "MS": "An endosymbiont that is either a bacterium or fungus living part of its life in a plant. Endophytes can benefit host plants by preventing pathogenic organisms from colonizing them.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060026"}, {"RECTYPE": "D", "MH": "Genes, Modifier", "AQ": "DE GE IM PH RE", "ENTRY": "Gene, Modifier", "MN": "G05.360.340.024.340.370", "FX": "Quantitative Trait, Heritable", "MH_TH": "NLM (2012)", "ST": "T028", "MS": "GENES with ALLELES that affect the PHENOTYPE associated with a nonallelic gene.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060045"}, {"RECTYPE": "D", "MH": "Maintenance Chemotherapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Maintenance Chemotherapies", "MN": "E02.319.509", "FX": "Administration, Metronomic", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "Treatment designed to help prevent a relapse of a disease following the successful primary treatments (INDUCTION CHEMOTHERAPY and CONSOLIDATION CHEMOTHERAPY) with a long-term low-dose drug therapy.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060046"}, {"RECTYPE": "D", "MH": "Reproductive Isolation", "PRINT ENTRY": "Hybridization Barrier|T070|NON|REL|NLM (2021)|191120|abcdef", "ENTRY": "Reproductive Isolations", "MN": "G16.075.802", "MH_TH": "NLM (2012)", "ST": "T070", "AN": "permitted with animals, plants and microorganisms", "PI": "Reproduction (1964-2011)", "MS": "Mechanisms that prevent different populations from exchanging genes (GENE FLOW), resulting in or maintaining GENETIC SPECIATION. It can either prevent mating to take place or ensure that any offspring produced is either inviable or sterile, thereby preventing further REPRODUCTION.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060047"}, {"RECTYPE": "D", "MH": "Slipped Capital Femoral Epiphyses", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Slipped Capital Femoral Epiphysis|T033|T047|NON|EQV|NLM (2012)|101217|abbcdef", "ENTRY": "Coxa Vara, Adolescent", "MN": "C05.116.425.500", "FX": "Coxa Vara", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Epiphyses, Slipped (1966-2011)", "MS": "A developmental deformity in which the metaphysis of the FEMUR moves proximally and anteriorly away from FEMUR HEAD (epiphysis) at the upper GROWTH PLATE. It is most common in male adolescents and is associated with a greater risk of early OSTEOARTHRITIS of the hip.", "PM": "2012", "HN": "2012", "MR": "20160120", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060048"}, {"RECTYPE": "D", "MH": "Asymmetric Cell Division", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Asymmetric Stem Cell Division|T043|NON|NRW|NLM (2012)|101217|abcdef", "ENTRY": "Divisions, Asymmetric Cell", "MN": "G07.345.249.410.750.500.500", "MH_TH": "NLM (2012)", "ST": "T043", "PI": "Stem Cells (1971-2011)", "MS": "Unequal cell division that results in daughter cells of different sizes.", "PM": "2012", "HN": "2012", "MR": "20160115", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060049"}, {"RECTYPE": "D", "MH": "Angina, Stable", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Chronic Stable Angina|T047|T184|NON|EQV|NLM (2012)|101217|abbcdef", "ENTRY": "Stable Anginas, Chronic", "MN": "C23.888.592.612.233.500.575", "MH_TH": "NLM (2012)", "ST": "T184", "PI": "Angina Pectoris (1977-2011)", "MS": "Persistent and reproducible chest discomfort usually precipitated by a physical exertion that dissipates upon cessation of such an activity. The symptoms are manifestations of MYOCARDIAL ISCHEMIA.", "PM": "2012", "HN": "2012", "MR": "20170620", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060050"}, {"RECTYPE": "D", "MH": "Occupational Injuries", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SN SU TH UR VE VI", "ENTRY": "Occupational Injury", "MN": "C26.716", "FX": "Accidents, Occupational", "MH_TH": "NLM (2012)", "ST": "T037", "AN": "coordinate with specific occupation and specific injury if pertinent ", "PI": "Occupational Diseases (1965-2011)", "MS": "Injuries sustained from incidents in the course of work-related activities.", "PM": "2012", "HN": "2012", "MR": "20190501", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060051"}, {"RECTYPE": "D", "MH": "Nasolabial Fold", "AQ": "AB AH BS DG EM IR MI PA PH PP PS RE SU VI", "ENTRY": "Nasolabial Folds", "MN": "A01.456.505.682", "MH_TH": "NLM (2012)", "ST": "T023", "MS": "A skin crease on each side of the face that runs from the outer corners of the nose to the corner of the mouth. It is a common site of PLASTIC SURGERY.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060052"}, {"RECTYPE": "D", "MH": "Transplant Donor Site", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Transplant Donor Sites", "MN": "A01.935", "FX": "Tissue Donors", "MH_TH": "NLM (2012)", "ST": "T029", "MS": "The body location or part from which tissue is taken for TRANSPLANTATION.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060053"}, {"RECTYPE": "D", "MH": "Agrobacterium", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.050.662.024", "MH_TH": "NLM (1966)", "ST": "T007", "RN": "txid357", "PI": "Rhizobium (1963-2011)", "MS": "A genus of gram negative, aerobic, rod-shaped bacteria found in soil, plants, and marine mud.", "PM": "2012; see AGROBACTERIUM 1963-2003, see RHIZOBIUM 2004-2011", "HN": "2012, 1963-2003; use RHIZOBIUM 1963-2011", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060054"}, {"RECTYPE": "D", "MH": "Protein Interaction Maps", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Protein-Protein Interaction Network|T169|NON|REL|NLM (2021)|191119|abcdef", "ENTRY": "Protein-Protein Interaction Networks", "MN": "G03.493.750", "FX": "Protein Interaction Mapping", "MH_TH": "NLM (2002)", "ST": "T169", "PI": "Protein Interaction Mapping (2001-2011)", "MS": "Graphs representing sets of measurable, non-covalent physical contacts with specific PROTEINS in living organisms or in cells.", "PM": "2012; for PROTEIN INTERACTION MAPS see PROTEIN INTERACTION MAPPING 2002-2011", "HN": "2012; for PROTEIN INTERACTION MAPS use PROTEIN INTERACTION MAPPING 2002-2011", "MR": "20200206", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060066"}, {"RECTYPE": "D", "MH": "Coinfection", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Mixed Infection|T047|NON|EQV|NLM (2012)|101222|abcdef", "ENTRY": "Polymicrobial Infections", "MN": "C01.218", "MH_TH": "NLM (2012)", "ST": "T047", "AN": "coordinate with specific infections if pertinent", "MS": "Simultaneous infection of a host organism by two or more pathogens. In virology, coinfection commonly refers to simultaneous infection of a single cell by two or more different viruses.", "PM": "2012", "HN": "2012", "MR": "20190617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060085"}, {"RECTYPE": "D", "MH": "Hydrothermal Vents", "AQ": "AN CH MI PS ST VI", "ENTRY": "Vents, Hydrothermal", "MN": "G16.500.275.260.750", "MH_TH": "NLM (2012)", "ST": "T070", "MS": "Hot springs on the ocean floor. They are commonly found near volcanically active places such as mid-oceanic ridges.", "PM": "2012", "HN": "2012", "MR": "20160705", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060086"}, {"RECTYPE": "D", "MH": "Animal Shells", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Shells, Animal", "MN": "A13.080", "FX": "Shellfish", "MH_TH": "NLM (2012)", "ST": "T023", "AN": "EGG SHELL is also available", "PI": "Animals (1963-2011)", "MS": "The hard rigid covering of animals including MOLLUSCS; TURTLES; INSECTS; and crustaceans.", "PM": "2012", "HN": "2012", "MR": "20170711", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060105"}, {"RECTYPE": "D", "MH": "Lakes", "AQ": "AN CH MI PS VI", "ENTRY": "Lakes, Soda", "MN": "N06.230.232.500", "MH_TH": "NLM (2012)", "ST": "T070", "PI": "Fresh Water (1972-2011)", "MS": "Inland bodies of still or slowly moving FRESH WATER or salt water, larger than a pond, and supplied by RIVERS and streams.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060106"}, {"RECTYPE": "D", "MH": "Characiformes", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Piranha", "MN": "B01.050.150.900.493.130", "MH_TH": "NLM (2012)", "ST": "T013", "RN": "txid7991", "PI": "Fishes (1991-2011)", "MS": "An order of fresh water fish with 18 families and over 1600 species. The order includes CHARACINS, hatchetfish, piranhas, and TETRAS.", "PM": "2012", "HN": "2012", "MR": "20200902", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060125"}, {"RECTYPE": "D", "MH": "Characidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "ENTRY": "Tetra", "MN": "B01.050.150.900.493.130.150", "MH_TH": "NLM (2012)", "ST": "T013", "RN": "txid7992", "RR": "txid42598", "PI": "Fishes (1966-2011)", "MS": "A family of fresh water fish in the order CHARACIFORMES, which includes the Tetras.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060126"}, {"RECTYPE": "D", "MH": "Kangaroo-Mother Care Method", "AQ": "CL EC ES HI IS LJ MT OG PX SD SN ST TD", "ENTRY": "Methods, Kangaroo-Mother Care", "MN": "N02.421.585.700.500", "MH_TH": "NLM (2004)", "ST": "T061", "AN": "humans only; check the tags HUMAN and INFANT or INFANT, NEWBORN", "MS": "A method of continuously holding a partially wrapped baby to the chest, involving skin-to-skin contact. Originally it was a method of caring for LOW-BIRTH-WEIGHT INFANT in developing countries and is now more widespread in developed nations. Aside from encouraging breast feeding, the extra sleep that the infant gets assists in regulating body temperature, helps the baby conserve energy, and redirects calorie expenditures toward growth and weight gain.", "PM": "2012; see INFANT CARE 2004-2011", "HN": "2012; use INFANT CARE 2004-2011", "MR": "20150629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060127"}, {"RECTYPE": "D", "MH": "Text Messaging", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "ENTRY": "Textings", "MN": "L01.559.423.906.377.666", "MH_TH": "NLM (2012)", "ST": "T052", "MS": "Communication between CELL PHONE users via the Short Message Service protocol which allows the interchange of short written messages.", "PM": "2012", "HN": "2012", "MR": "20220712", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D060145"}, {"RECTYPE": "D", "MH": "Ecotype", "ENTRY": "Ecotypes", "MN": "N06.230.124.049.230", "FX": "Gene-Environment Interaction", "MH_TH": "NLM (2012)", "ST": "T032", "MS": "Geographic variety, population, or race, within a species, that is genetically adapted to a particular habitat. An ecotype typically exhibits phenotypic differences but is capable of interbreeding with other ecotypes.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060146"}, {"RECTYPE": "D", "MH": "HapMap Project", "AQ": "EC ES HI LJ OG", "ENTRY": "Projects, International HapMap", "MN": "H01.770.644.145.350.249", "FX": "Haplotypes", "MH_TH": "NLM (2012)", "ST": "T062", "AN": "CATALOGER: Use NAF entry", "PI": "Haplotypes (2002-2011)", "MS": "A coordinated international effort to identify and catalog patterns of linked variations (HAPLOTYPES) found in the human genome across the entire human population.", "PM": "2012", "HN": "2012", "MR": "20170405", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060148"}, {"RECTYPE": "D", "MH": "Tetraspanin 30", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antigens, CD63|T116|T123|NON|EQV|NLM (2012)|101230|abbcdef", "ENTRY": "CD63 Antigens", "MN": "D12.776.543.990.024", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "AN": "note CD63 antigen may be referred to in the literature as \"lysosomal-associated membrane protein 3\" however they are separate and distinct proteins", "MS": "Ubiquitously-expressed tetraspanin protein that is found in late ENDOSOMES and LYSOSOMES. It functions in intracellular protein transport and signaling.", "PM": "2018; see ANTIGENS, CD63 2012-2017; TETRASPANIN 30 was indexed under PLATELET MEMBRANE GLYCOPROTEINS and ANTIGENS, CD 2003-2011 and under MEMBRANE PROTEINS 1990-2002", "HN": "2018 (1990)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060149"}, {"RECTYPE": "D", "MH": "B-Lymphocytes, Regulatory", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Regulatory B Cell|T025|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Regulatory B-Lymphocytes", "MN": "A15.382.490.555.567.562.450.300", "MH_TH": "NLM (2012)", "ST": "T025", "PI": "B-Lymphocytes (1992-2011)", "MS": "B-cells that have a role in regulating the immune response including the production of CYTOKINES. This function is in addition to their traditional role in making antibodies.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060151"}, {"RECTYPE": "D", "MH": "V(D)J Recombination", "AQ": "DE GE IM PH RE", "ENTRY": "VDJ Recombinations", "MN": "G05.728.932", "FX": "VDJ Recombinases", "MH_TH": "NLM (2012)", "ST": "T045", "PI": "Recombination, Genetic (1987-2011)", "MS": "The process by which the V (variable), D (diversity), and J (joining) segments of IMMUNOGLOBULIN GENES or T-CELL RECEPTOR GENES are assembled during the development of LYMPHOID CELLS using NONHOMOLOGOUS DNA END-JOINING.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060152"}, {"RECTYPE": "D", "MH": "Uroplakins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Uroplakin|T116|T123|NON|EQV|NLM (2012)|110103|abbcdef", "MN": "D12.776.543.550.942", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Membrane Glycoproteins (1994-2011)", "MS": "Specialized membrane glycoproteins that are found on UROTHELIUM cells. They associate into a hexagonal array of 16-nm cell surface particles which form the asymmetric unit membrane of urothelial plaques.", "PM": "2012", "HN": "2012", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060165"}, {"RECTYPE": "D", "MH": "Capillary Tubing", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Tubings, Capillary", "MN": "E07.123", "MH_TH": "NLM (2012)", "ST": "T073", "MS": "Hollow cylindrical objects with an internal diameter that is small enough to fill by and hold liquids inside by CAPILLARY ACTION.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060166"}, {"RECTYPE": "D", "MH": "Uroplakin Ia", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Uroplakin 1a|T116|T123|NON|EQV|NLM (2012)|110103|abbcdef", "MN": "D12.776.543.900.750", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "PI": "Membrane Glycoproteins (1994-2011)", "MS": "A tetraspanin domain-containing uroplakin subtype. It heterodimerizes with UROPLAKIN II to form a component of the asymmetric unit membrane found in urothelial cells.", "PM": "2012", "HN": "2012", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060167"}, {"RECTYPE": "D", "MH": "Thymocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Thymocyte", "MN": "A11.900", "MH_TH": "NLM (2012)", "ST": "T025", "PI": "T-Lymphocytes (1963-2011)", "MS": "HEMATOPOIETIC PROGENITOR CELLS that have migrated to the THYMUS where they differentiate into T-LYMPHOCYTES. Thymocytes are classified into maturational stages based on the expression of CELL SURFACE ANTIGENS.", "PM": "2012", "HN": "2012", "MR": "20160610", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060168"}, {"RECTYPE": "D", "MH": "Uroplakin Ib", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Uroplakin 1b|T116|T123|NON|EQV|NLM (2012)|110103|abbcdef", "MN": "D12.776.543.900.875", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "PI": "Membrane Glycoproteins (1994-2011)", "MS": "A tetraspanin domain-containing uroplakin subtype. It heterodimerizes with UROPLAKIN III to form a component of the asymmetric unit membrane found in urothelial cells.", "PM": "2012", "HN": "2012", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060169"}, {"RECTYPE": "D", "MH": "Uroplakin II", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Uroplakin 2|T116|T123|NON|EQV|NLM (2012)|110103|abbcdef", "MN": "D12.776.543.550.942.200", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "A uroplakin subtype that heterodimerizes with UROPLAKIN IA to form a component of the asymmetric unit membrane found in urothelial cells.", "PM": "2012; UROPLAKIN II was indexed under MEMBRANE PROTEINS 1994-2011", "HN": "2012(1994)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060170"}, {"RECTYPE": "D", "MH": "Uroplakin III", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Uroplakin IIIb|T116|T123|NON|NRW|NLM (2012)|110103|abbcdef", "MN": "D12.776.543.550.942.300", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "A uroplakin subtype that heterodimerizes with UROPLAKIN IB to form a component of the asymmetric unit membrane found in urothelial cells.", "PM": "2012; UROPLAKIN III was indexed under MEMBRANE GLYCOPROTEINS 1994-2011", "HN": "2012(1994)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060171"}, {"RECTYPE": "D", "MH": "Morpholinos", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Phosphorodiamidate Morpholino Oligomer|T114|NON|EQV|NLM (2021)|200220|abcdef", "ENTRY": "Oligos, Morpholino", "MN": "D13.695.578.424.337", "FX": "Oligonucleotides, Antisense", "MH_TH": "NLM (2012)", "ST": "T114", "RN": "0", "MS": "Synthetic analogs of NUCLEIC ACIDS composed of morpholine ring derivatives (MORPHOLINES) linked by phosphorodimidates. One standard DNA nucleic acid base (ADENINE; GUANINE; CYTOSINE; OR THYMINE) is bound to each morpholine ring.", "PM": "2012; see MORPHOLINES 2003-2011", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060172"}, {"RECTYPE": "D", "MH": "Tetraspanin 24", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antigens, CD151|T116|T129|ABX|EQV|NLM (2012)|110104|abbcdef", "ENTRY": "CD151, Antigen", "MN": "D12.776.543.900.028", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A tetraspanin protein that associates with LAMININ-binding INTEGRINS. It is essential for proper assembly of BASEMENT MEMBRANE in the KIDNEY GLOMERULUS and KIDNEY TUBULES and may play a role in the regulation of CELL MOTILITY.", "PM": "2018; see ANTIGENS, CD151 2012-2017; TETRASPANIN 24 was indexed under ANTIGENS, CD 1998-2011, and under MEMBRANE GLYCOPROTEINS 1996-1997", "HN": "2018 (1996)", "MR": "20180620", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060185"}, {"RECTYPE": "D", "MH": "Infusions, Spinal", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Spinal Infusions", "MN": "E02.319.267.510.794", "MH_TH": "NLM (2012)", "ST": "T061", "AN": "do not confuse with INJECTIONS, SPINAL", "PI": "Injections (1979-2011)", "MS": "The administration of medication by insertion of a tiny needle or catheter into the spinal sac or epidural cavity.", "PM": "2012", "HN": "2012", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D060186"}, {"RECTYPE": "D", "MH": "Therapeutic Occlusion", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapeutic Occlusions", "MN": "E02.926", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "Methods used to temporarily or permanently block the flow of BODY FLUIDS through various ducts and tubules throughout the body, including BLOOD VESSELS and LYMPHATIC VESSELS such as by THERAPEUTIC EMBOLIZATION or LIGATION.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060205"}, {"RECTYPE": "D", "MH": "Tetraspanin 28", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antigens, CD81|T116|T129|ABX|EQV|NLM (2012)|110107|abbcdef", "ENTRY": "TAPA 1 Antigen", "MN": "D12.776.543.900.070", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A tetraspanin protein that is involved in a variety of cellular functions including BASEMENT MEMBRANE assembly, and in the formation of a molecular complexes on the surface of LYMPHOCYTES.", "PM": "2018; see ANTIGENS, CD81 2012-2017; TETRASPANIN-28 was indexed under ANTIGENS, CD 2004-2011; and under ANTIGENS, SURFACE and MEMBRANE PROTEINS 1990-2004", "HN": "2018 (1990)", "MR": "20180620", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060225"}, {"RECTYPE": "D", "MH": "Head Kidney", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Kidneys, Head", "MN": "A16.835.400", "FX": "Hematopoiesis, Extramedullary", "MH_TH": "NLM (2012)", "ST": "T023", "PI": "Kidney (1969-2011)", "MS": "A primitive form of vertebrate kidney that is found in adults of some primitive FISHES and in the embryos of more advanced fishes. In some species of fishes it contains phagocytic cells and is also a major site of HEMATOPOIESIS, analogous to the mammalian BONE MARROW.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060226"}, {"RECTYPE": "D", "MH": "Imaginal Discs", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Imaginal Disk", "MN": "A13.518", "FX": "Larva", "MH_TH": "NLM (2012)", "ST": "T023", "MS": "Hollow sacs of cells in LARVA that form adult structures in insects during BIOLOGICAL METAMORPHOSIS.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060227"}, {"RECTYPE": "D", "MH": "Tetraspanin 29", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antigens, CD9|T116|T129|ABX|EQV|NLM (2012)|110110|abbcdef", "ENTRY": "p24 CD9 Antigen", "MN": "D12.776.543.900.109", "MH_TH": "NLM (2019)", "ST": "T129", "RN": "0", "MS": "A subtype of tetraspanin protein that plays a role in cell adhesion, cell motility, and tumor metastasis. It functions in platelet activation and aggregation, the formation of paranodal junctions in neuronal tissue, and the fusion of sperm with egg.", "PM": "2019; see TETRASPANIN-29 2018; see ANTIGENS, CD9 2012-2017; TETRASPANIN-29 was indexed under ANTIGENS, CD and MEMBRANE GLYCOPROTEINS 1992-2011; and under ANTIGENS, DIFFERENTIATION 1988-1991", "HN": "2019 (1988)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060245"}, {"RECTYPE": "D", "MH": "Tetraspanin 25", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Antigens, CD53|T116|T129|ABX|EQV|NLM (2012)|110111|abbcdef", "ENTRY": "CD53 Antigens", "MN": "D12.776.543.900.055", "MH_TH": "NLM (2019)", "ST": "T129", "RN": "0", "MS": "A tetraspanin protein found at high levels in cells of the lymphoid-myeloid lineage. It may function in regulating the differentiation of T-LYMPHOCYTES and the activation of B-LYMPHOCYTES.", "PM": "2019; see TETRASPANIN-25 2018; see ANTIGENS, CD53 2012-2017; TETRASPANIN 25 was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE and ANTIGENS, CD 1987-2010", "HN": "2019 (1987)", "MR": "20180620", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060265"}, {"RECTYPE": "D", "MH": "Receptors, Autocrine Motility Factor", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor, AMF", "MN": "D12.776.543.750.660", "MH_TH": "NLM (2012)", "ST": "T192", "RN": "EC 2.3.2.27", "MS": "Cell surface receptors for AUTOCRINE MOTILITY FACTOR, which is the secreted form of GLUCOSE-6-PHOSPHATE ISOMERASE. The receptor has an unusual composition in that it shares some structural similarities with G-PROTEIN-COUPLED RECEPTORS and functions as an ubiquitin protein ligase when internalized.", "PM": "2012; AUTOCRINE MOTILITY RECEPTOR was indexed under RECEPTORS, CYTOKINE and UBIQUITIN PROTEIN LIGASE 1994-2011, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1991-1993", "HN": "2012 (1991)", "MR": "20160602", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060285"}, {"RECTYPE": "D", "MH": "Transition to Adult Care", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Transferring to Adult Care|T058|NON|EQV|NLM (2016)|150109|abcdef", "MN": "N04.590.233.727.210.718", "MH_TH": "NLM (2012)", "ST": "T058", "PI": "Continuity of Patient Care (1975-2011)", "MS": "Transfer from pediatric to adult care.", "PM": "2012", "HN": "2012", "MR": "20160325", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060305"}, {"RECTYPE": "D", "MH": "Magnetometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "MN": "E05.540", "MH_TH": "UNK (19XX)", "ST": "T057", "PI": "Magnetics (1984-2011)", "MS": "The measurement of various aspects of MAGNETIC FIELDS.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060306"}, {"RECTYPE": "D", "MH": "Chemistry Techniques, Synthetic", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Techniques, Synthetic Chemistry", "MN": "J01.897.836.249", "MH_TH": "NLM (2012)", "ST": "T059", "PI": "Chemistry, Organic (1966-2011)", "MS": "Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs.", "PM": "2012", "HN": "2012", "MR": "20160115", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060326"}, {"RECTYPE": "D", "MH": "Solid-Phase Synthesis Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Solid-Phase Synthesis|T052|NON|REL|NLM (2012)|110119|abcdef", "ENTRY": "Techniques, Solid-Phase Synthesis", "MN": "J01.897.836.249.500", "MH_TH": "NLM (2012)", "ST": "T059", "MS": "Techniques used to synthesize chemicals using molecular substrates that are bound to a solid surface. Typically a series of reactions are conducted on the bound substrate that results in either the covalent attachment of specific moieties or the modification of existing function groups. These techniques offer an advantage to those involving solution reactions in that the substrate compound does not have to be isolated and purified between the reaction steps.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060327"}, {"RECTYPE": "D", "MH": "Magnetic Phenomena", "ENTRY": "Phenomenon, Magnetic", "MN": "G01.358", "FX": "Magnets", "MH_TH": "NLM (2012)", "ST": "T070", "AN": "general or unspecified; prefer specifics", "PI": "Magnetics (1982-2011)", "MS": "Characteristics, properties, and effects of magnetic substances and magnetic fields.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060328"}, {"RECTYPE": "D", "MH": "Education of Visually Disabled", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Visually Disabled Education", "MN": "I02.233.213.500", "MH_TH": "NLM (2012)", "ST": "T065", "MS": "The teaching or training of those individuals with visual disability.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060329"}, {"RECTYPE": "D", "MH": "Education of Hearing Disabled", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Disabled Education, Hearing", "MN": "I02.233.213.199", "MH_TH": "NLM (2012)", "ST": "T065", "MS": "The teaching or training of those individuals with hearing disability or impairment.", "PM": "2012", "HN": "2012", "MR": "20130708", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060345"}, {"RECTYPE": "D", "MH": "Sodium-Coupled Vitamin C Transporters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, SLC23A2", "MN": "D12.776.543.585.937.813", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "Membrane transport proteins that actively co-transport ASCORBIC ACID and sodium ions across the CELL MEMBRANE. Dietary absorption of VITAMIN C is highly dependent upon this class of transporters and a subset of SODIUM GLUCOSE TRANSPORTERS which transport the oxidized form of vitamin C, DEHYDROASCORBIC ACID.", "PM": "2012; SODIUM-DEPENDENT VITAMIN C TRANSPORTER was indexed under ORGANIC ANION TRANSPORTERS, SODIUM -DEPENDENT 2003-2011, and under PROTEINS 1999-2002", "HN": "2012(1999)", "MR": "20151124", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060347"}, {"RECTYPE": "D", "MH": "Dirofilaria repens", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "MN": "B01.050.500.500.294.400.937.463.230.650", "MH_TH": "NLM (2012)", "ST": "T204", "RN": "txid31241", "PI": "Dirofilaria (1963-2011)", "MS": "A filarial parasite primarily affecting dogs and cats, but causing an emerging zoonosis in humans involving subcutaneous lesions. It is transmitted by MOSQUITOES.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060348"}, {"RECTYPE": "D", "MH": "Chloroplast Proteins", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "ENTRY": "Proteins, Plastid", "MN": "D12.776.765.199", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "PI": "Chloroplasts (1966-2011)", "MS": "Proteins encoded by the CHLOROPLAST GENOME or proteins encoded by the nuclear genome that are imported to and resident in the CHOROPLASTS.", "PM": "2012", "HN": "2012", "MR": "20150622", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060365"}, {"RECTYPE": "D", "MH": "Entomoplasmatales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.860.300", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid186328", "MS": "An order of nonhelical (ENTOMOPLASMATACEAE) and helical (SPIROPLASMATACEAE) gram-negative bacteria in the class MOLLICUTES, that are regularly associated with arthropod or plant hosts.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060366"}, {"RECTYPE": "D", "MH": "Lacazia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Paracoccidioides loboi nom. inval.|T004|NON|NRW|NLM (2021)|200318|abcdef", "MN": "B01.300.381.502", "MH_TH": "NLM (2012)", "ST": "T004", "RN": "txid121739", "RR": "txid121752", "AN": "infection: coordinate with LOBOMYCOSIS ", "PI": "Paracoccidioides (1999-2011)", "MS": "A mitosporic ONYGENALES fungal genus. The species Lacazia loboi is the etiological agent of LOBOMYCOSIS in humans, dolphins, and other wild animals.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060367"}, {"RECTYPE": "D", "MH": "Lobomycosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Lobomycosis-like Disease|T047|NON|REL|NLM (2021)|200206|abcdef", "ENTRY": "Lobomycosis-like Diseases", "MN": "C17.800.838.208.475", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Dermatomycoses (1969-2011)", "MS": "A chronic, fungal, subcutaneous infection endemic in rural regions in South America and Central America. The causal organism is Lacazia labol.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060368"}, {"RECTYPE": "D", "MH": "Sex Workers", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Worker Clients, Sex", "MN": "M01.776", "MH_TH": "NLM (2012)", "ST": "T098", "MS": "People who engage in occupational sexual behavior in exchange for economic rewards or other extrinsic considerations.", "PM": "2012", "HN": "2012", "MR": "20160707", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060386"}, {"RECTYPE": "D", "MH": "Ascorbate Peroxidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peroxidases, Ascorbate", "MN": "D08.811.682.732.165", "MH_TH": "NLM (2012)", "ST": "T126", "RN": "EC 1.11.1.11", "MS": "Peroxidases that utilize ASCORBIC ACID as an electron donor to reduce HYDROGEN PEROXIDE to WATER. The reaction results in the production of monodehydroascorbic acid and DEHYDROASCORBIC ACID.", "PM": "2012; ASCORBATE PEROXIDASE was indexed under PEROXIDASES 1980-2011", "HN": "2012(1980)", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060387"}, {"RECTYPE": "D", "MH": "Support Vector Machine", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Vector Networks, Support", "MN": "L01.224.050.375.530.500.500", "MH_TH": "NLM (2016)", "ST": "T066", "PI": "Pattern Recognition, Automated (1998-2011)", "MS": "SUPERVISED MACHINE LEARNING algorithm which learns to assign labels to objects from a set of training examples. Examples are learning to recognize fraudulent credit card activity by examining hundreds or thousands of fraudulent and non-fraudulent credit card activity, or learning to make disease diagnosis or prognosis based on automatic classification of microarray gene expression profiles drawn from hundreds or thousands of samples.", "PM": "2012", "HN": "2012", "MR": "20170703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060388"}, {"RECTYPE": "D", "MH": "Construction Industry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Trades, Construction", "MN": "J01.576.655.125", "FX": "Facility Design and Construction", "MH_TH": "NLM (2012)", "ST": "T092", "MS": "The aggregate business enterprise of building.", "PM": "2012", "HN": "2012", "MR": "20140612", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060389"}, {"RECTYPE": "D", "MH": "Florigen", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hormone, Flowering", "MN": "D12.776.765.342", "PA": "Plant Growth Regulators", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "PI": "Plant Growth Regulators (1998-2011)", "MS": "Molecule produced in plant leaves that acts like a hormone by inducing flowering in the shoot apical meristem of buds and growing tips.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060405"}, {"RECTYPE": "D", "MH": "Brassinosteroids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Brassinosteroid|T109|T123|NON|EQV|NLM (2021)|191114|abbcdef", "MN": "D23.704.500.071", "PA": "Plant Growth Regulators", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "Plant steroids ubiquitously distributed throughout the plant kingdom. They play essential roles in modulating growth and differentiation of cells at nanomolar to micromolar concentrations.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D060406"}, {"RECTYPE": "D", "MH": "Cerebral Phaeohyphomycosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Primary Central Nervous System Phaeohyphomycosis|T047|NON|NRW|NLM (2012)|110125|abcdef", "MN": "C17.800.838.208.416.375", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Mycoses (1974-2011)", "MS": "CNS infections caused by neurotropic dematiaceous fungi that contain melanin in their cell walls. The infections often result in BRAIN ABSCESS; ENCEPHALITIS; and MENINGITIS in patients who are often immunocompetent. The common causative fungi include members Cladophialophora bantiana, Exophiala dermatitidis, Rhinocladiella mackenziei, and Ochroconis gallopavum. R. mackenziei infection is seen almost exclusively in patients from the MIDDLE EAST.", "PM": "2012", "HN": "2012", "MR": "20190617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060425"}, {"RECTYPE": "D", "MH": "Anti-N-Methyl-D-Aspartate Receptor Encephalitis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Receptor Encephalitis, Anti-NMDA", "MN": "C20.111.258.124", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Receptors, N-Methyl-D-Aspartate/immunology (2007-2011)", "MS": "Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060426"}, {"RECTYPE": "D", "MH": "Thylakoid Membrane Proteins", "AQ": "AD AE AG AI AN BI CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "ENTRY": "Proteins, Thylakoid Membrane", "MN": "D12.776.765.199.750", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "PI": "Thylakoids (2000-2011)", "MS": "Proteins found within the THYLAKOID MEMBRANES of photosynthetic organisms such as PLANTS and PHYTOPLANKTON. Many of the proteins in this class are involved in the process of PHOTOSYNTHESIS and the generation of ADENOSINE TRIPHOSPHATE.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060431"}, {"RECTYPE": "D", "MH": "Anthropology, Medical", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Medical Anthropology|T090|NON|EQV|NLM (2012)|110125|abcdef", "MN": "I01.076.284", "MH_TH": "NLM (2012)", "ST": "T090", "AN": "IM as the discipline (education, history, etc) only; NIM with no qualifiers as a coordinate", "PI": "Anthropology (1966-2011)", "MS": "Field of social science that is concerned with differences between human groups as related to health status and beliefs.", "PM": "2012", "HN": "2012", "MR": "20110908", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060432"}, {"RECTYPE": "D", "MH": "Administration, Ophthalmic", "AQ": "VE", "PRINT ENTRY": "Ocular Administration|T061|NON|EQV|NLM (2012)|110125|abcdef", "ENTRY": "Ophthalmic Administrations", "MN": "E02.319.267.120.805", "FX": "Ocular Absorption", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Administration, Topical (1971-2011)", "MS": "Application of pharmaceutically active agents on the tissues of the EYE.", "PM": "2012", "HN": "2012", "MR": "20140606", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060433"}, {"RECTYPE": "D", "MH": "Herbivory", "AQ": "CL DE EH GE IM PH RE", "ENTRY": "Herbivories", "MN": "G07.203.650.353.758", "FX": "Diet, Plant-Based", "MH_TH": "NLM (2012)", "ST": "T040", "PI": "Feeding Behavior (1980-2011)", "MS": "The act of feeding on plants by animals.", "PM": "2012", "HN": "2012", "MR": "20221215", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060434"}, {"RECTYPE": "D", "MH": "Carnivory", "AQ": "CL DE EH ES PH PX RE", "ENTRY": "Carnivories", "MN": "G07.203.650.353.299", "MH_TH": "NLM (2012)", "ST": "T038", "PI": "Feeding Behavior (1980-2011)", "MS": "The consumption of animal flesh.", "PM": "2012", "HN": "2012", "MR": "20150708", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060435"}, {"RECTYPE": "D", "MH": "Self-Incompatibility in Flowering Plants", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Nuclear-Cytoplasmic Incompatibility in Plants|T039|NON|REL|NLM (2023)|220324|abcdef", "ENTRY": "Self-Incompatibilty, Gametophytic", "MN": "G15.840", "MH_TH": "NLM (2012)", "ST": "T039", "PI": "Fertilization (1970-2011)", "MS": "A naturally occurring reproductive phenomenon of FLOWERING PLANTS where self-incompatibility arises due to differences between NUCLEUS, CYTOPLASM, MITOCHONDRIA, or CHLOROPLASTS that occur in gamete cells from separate sources when they are brought together by cross-hybridization or in vitro manipulation.", "PM": "2012", "HN": "2012", "MR": "20220712", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060436"}, {"RECTYPE": "D", "MH": "Artificial Lens Implant Migration", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Artificial Intra ocular Implant Dislocation", "MN": "C26.392.500.249", "MH_TH": "NLM (2012)", "ST": "T046", "PI": "Foreign-Body Migration (1993-2011)", "MS": "The shifting and or tilting of implanted artificial lens resulting in impaired vision.", "PM": "2012", "HN": "2012", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D060437"}, {"RECTYPE": "D", "MH": "Phaeohyphomycosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Subcutaneous Phaeohyphomycosis|T047|NON|NRW|NLM (2012)|110126|abcdef", "ENTRY": "Subcutaneous Phaeohyphomycoses", "MN": "C01.150.703.726", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Mycoses (1974-2011)", "MS": "OPPORTUNISTIC INFECTIONS caused by the dematiaceous (darkly pigmented) MITOSPORIC FUNGI of ALTERNARIA, Bipolaris, CLADOSPORIUM, Curvularia, and EXOPHIALA. These fungi have pigmented HYPHAE due to MELANIN in the cell wall. The initial subcutaneous cyst from the infection can become systemic and spread rapidly to renal, pulmonary and cerebral systems (see CEREBRAL PHAEOHYPHOMYCOSIS) in an IMMUNOCOMPROMISED HOST.", "PM": "2012", "HN": "2012", "MR": "20190617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060446"}, {"RECTYPE": "D", "MH": "Emergency Shelter", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Shelters, Evacuation", "MN": "N06.230.100.121", "MH_TH": "NLM (2012)", "ST": "T073", "MS": "Temporary shelter provided in response to a major disaster or emergency.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060447"}, {"RECTYPE": "D", "MH": "Wnt Signaling Pathway", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Wnt Signaling|T044|ABX|REL|NLM (2021)|191129|abcdef", "ENTRY": "Wnt beta Catenin Signaling Pathway", "MN": "G04.835.925", "MH_TH": "NLM (2012)", "ST": "T044", "PI": "Wnt Proteins (2005-2011)", "MS": "A complex signaling pathway whose name is derived from the DROSOPHILA Wg gene, and the vertebrate INT gene. The signaling pathway is initiated by the binding of WNT PROTEINS to cell surface WNT RECEPTORS which interact with the AXIN SIGNALING COMPLEX and an array of second messengers that influence the actions of BETA CATENIN.", "PM": "2012", "HN": "2012", "MR": "20200116", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060449"}, {"RECTYPE": "D", "MH": "Axin Signaling Complex", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Axin Signaling Complex Proteins|T116|T123|NON|EQV|NLM (2012)|110131|abbcdef", "ENTRY": "beta Catenin Destruction Complex", "MN": "D12.776.476.081", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "A specific complex of WNT SIGNALING PATHWAY proteins that mediates the phosphorylation-dependent destruction of cytosolic BETA-CATENIN. The complex is disrupted by cell surface binding of WNT PROTEINS, which allows beta-catenin levels to rise to the point where they migrate to the CELL NUCLEUS and activate transcription.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060465"}, {"RECTYPE": "D", "MH": "Axin Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Axin Proteins|T116|T123|NON|EQV|NLM (2012)|110131|abbcdef", "ENTRY": "Proteins, Axin", "MN": "D12.776.476.081.500", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "A scaffolding protein that is a critical component of the axin signaling complex which binds to ADENOMATOUS POLYPOSIS COLI PROTEIN; GLYCOGEN SYNTHASE KINASE 3; and CASEIN KINASE I.", "PM": "2012; AXIN PROTEIN was indexed under REPRESSOR PROTEINS 1997-2011 and under ADAPTOR PROTEINS, SIGNAL TRANSDUCING 2011", "HN": "2012(1997)", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060466"}, {"RECTYPE": "D", "MH": "Disease Resistance", "DE": "DIS RESISTANCE", "AQ": "DE GE IM PH RE", "ENTRY": "Resistances, Disease", "MN": "G15.630.250", "MH_TH": "UNK (19XX)", "ST": "T032", "PI": "Immunity, Innate (1978-2011)", "MS": "The capacity of an organism to defend itself against pathological processes or the agents of those processes. This most often involves innate immunity whereby the organism responds to pathogens in a generic way. The term disease resistance is used most frequently when referring to plants.", "PM": "2012; see IMMUNITY, INNATE 1979-2011", "HN": "2012; use IMMUNITY, INNATE 1978-2011", "MR": "20160622", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060467"}, {"RECTYPE": "D", "MH": "Pedobacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.400.425.611", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid84567", "PI": "Bacteroidetes (2003-2011)", "MS": "A genus of gram-negative, aerobic, rod-shaped bacteria in the family Sphingobacteriaceae. They exhibit gliding motility.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060485"}, {"RECTYPE": "D", "MH": "Ophthalmoplegic Migraine", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Ophthalmoplegic Migraine", "MN": "C23.888.592.636.447.600", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Ophthalmoplegia (1964-2011)", "MS": "Childhood-onset of recurrent headaches with an oculomotor cranial nerve palsy. Typically, ABDUCENS NERVE; OCULOMOTOR NERVE; and TROCHLEAR NERVE are involved with DIPLOPIA and BLEPHAROPTOSIS.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060486"}, {"RECTYPE": "D", "MH": "Alternariosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Cutaneous Alternariosis|T047|NON|NRW|NLM (2012)|110201|abcdef", "ENTRY": "Subcutaneous Alternarioses", "MN": "C17.800.838.208.416.125", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Dermatomycoses (1972-2011)", "MS": "Opportunistic fungal infection by a member of ALTERNARIA genus.", "PM": "2012", "HN": "2012", "MR": "20190617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060487"}, {"RECTYPE": "D", "MH": "Low Density Lipoprotein Receptor-Related Protein-6", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Low Density Lipoprotein Receptor Related Protein 6", "MN": "D12.776.543.750.850.781", "MH_TH": "NLM (2012)", "ST": "T192", "RN": "0", "MS": "An LDL-receptor related protein that combines with cell surface FRIZZLED RECEPTORS to form WNT PROTEIN-binding receptors. The protein plays an important role in the WNT SIGNALING PATHWAY during EMBRYONIC DEVELOPMENT and in regulation of vascular cell proliferation.", "PM": "2012; LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6 was indexed under LDL-RECEPTOR RELATED PROTEINS 2011 and under RECEPTORS, LDL 1999-2011", "HN": "2012(1999)", "MR": "20160617", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D060488"}, {"RECTYPE": "D", "MH": "Prosthesis Retention", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Retention, Prosthesis", "MN": "E02.794.500", "FX": "Prosthesis Failure", "MH_TH": "NLM (2012)", "ST": "T061", "AN": "coordinate with specific prosthesis with no qualifiers; DENTAL PROSTHESIS RETENTION is also available", "MS": "Holding a PROSTHESIS in place.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060489"}, {"RECTYPE": "D", "MH": "Receptors, Wnt", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Wnt Receptors|T116|T192|ABX|EQV|NLM (2012)|110201|abbcdef", "MN": "D12.776.543.750.850", "MH_TH": "NLM (2012)", "ST": "T192", "RN": "0", "PI": "Wnt Proteins (2005-2011)", "MS": "Cell-surface receptors that specifically bind to WNT PROTEINS and activate the WNT SIGNALING PATHWAY.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060490"}, {"RECTYPE": "D", "MH": "Low Density Lipoprotein Receptor-Related Protein-5", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "Low Density Lipoprotein Receptor Related Protein 5", "MN": "D12.776.543.750.850.687", "MH_TH": "NLM (2012)", "ST": "T192", "RN": "0", "MS": "LDL-receptor related protein that combines with FRIZZLED RECEPTORS at the cell surface to form receptors that bind WNT PROTEINS. The protein plays an important role in the WNT SIGNALING PATHWAY in OSTEOBLASTS and during EMBRYONIC DEVELOPMENT.", "PM": "2012; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 5 was indexed under LDL-RECEPTOR RELATED PROTEINS 2006-2011, and under RECEPTORS, LDL 1998-2005", "HN": "2012(1998)", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060492"}, {"RECTYPE": "D", "MH": "Tenacibaculum", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.400.425.310.800", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid104267", "AN": "infection: coordinate IM with FLAVOBACTERIACEAE INFECTIONS (IM)", "PI": "Flavobacteriaceae (2004-2011)", "MS": "A genus of gram-negative, rod-shaped bacteria in the family FLAVOBACTERIACEAE. Tenacibaculum adheres to surfaces of marine organisms and is pathogenic to fish.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060493"}, {"RECTYPE": "D", "MH": "Riemerella", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.400.425.310.700", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid34084", "AN": "infection: coordinate IM with FLAVOBACTERIACEAE INFECTIONS (IM)", "PI": "Gram-Negative Bacteria (1999-2011)", "MS": "A genus of gram-negative, rod-shaped bacteria in the family FLAVOBACTERIACEAE that causes exudative SEPTICEMIA in ducks, pigeons, and other domestic and wild birds.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060494"}, {"RECTYPE": "D", "MH": "Wnt3 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Wnt3 Proteins|T116|T123|ABX|EQV|NLM (2012)|110202|abbcdef", "ENTRY": "Wnt 3 Protein", "MN": "D23.529.984.300", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "A Wnt protein subtype that plays a role in cell-cell signaling during EMBRYONIC DEVELOPMENT and the morphogenesis of the developing NEURAL TUBE. Defects in Wnt3 protein are associated with autosomal recessive tetra-AMELIA in humans.", "PM": "2012; WNT-3 PROTEIN was indexed under WNT PROTEINS 2006-2011 and under PROTEINS 1990-2005", "HN": "2012(1990)", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060508"}, {"RECTYPE": "D", "MH": "Wnt3A Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Wnt 3A Protein", "MN": "D23.529.984.350", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "A Wnt protein subtype that plays a role in cell-cell signaling during EMBRYONIC DEVELOPMENT and the morphogenesis of the developing NEURAL TUBE.", "PM": "2012; WNT3A PROTEIN was indexed under WNT PROTEINS 2006-2011, and under PROTEINS 1990-2005", "HN": "2012; use WNT3 PROTEIN 1990-2011", "MR": "20210628", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060509"}, {"RECTYPE": "D", "MH": "Pudendal Nerve", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Pudendal Nerves", "MN": "A08.800.800.720.450.680", "FX": "Peroneal Nerve", "MH_TH": "NLM (2012)", "ST": "T023", "AN": "do not confuse with PERONEAL NERVE", "PI": "Urinary Bladder (1967-2011)", "MS": "A nerve which originates in the sacral spinal cord (S2 to S4) and innervates the PERINEUM, the external GENITALIA, the external ANAL SPHINCTER and the external urethral sphincter. It has three major branches: the perineal nerve, inferior anal nerves, and the dorsal nerve of penis or clitoris.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060525"}, {"RECTYPE": "D", "MH": "Magnetic Fields", "AQ": "AE", "ENTRY": "Fields, Magnetic", "MN": "G01.358.750", "MH_TH": "NLM (2012)", "ST": "T070", "MS": "Areas of attractive or repulsive force surrounding MAGNETS.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060526"}, {"RECTYPE": "D", "MH": "Corneal Keratocytes", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Keratocytes, Corneal", "MN": "A11.329.228.109", "MH_TH": "NLM (2012)", "ST": "T025", "PI": "Fibroblasts (1969-2011)", "MS": "Fibroblasts which occur in the CORNEAL STROMA.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060527"}, {"RECTYPE": "D", "MH": "Wnt4 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Wnt-4 Proteins|T116|T123|ABX|EQV|NLM (2012)|110203|abbcdef", "ENTRY": "Wnt 4 Proteins", "MN": "D23.529.984.400", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "A Wnt protein that is involved in regulating multiple developmental processes such as the formation of the KIDNEY; ADRENAL GLANDS; MAMMARY GLANDS; the PITUITARY GLAND; and the female reproductive system. Defects in WNT4 are a cause of ROKITANSKY KUSTER HAUSER SYNDROME.", "PM": "2012; WNT-4 PROTEIN was indexed under WNT PROTEINS 2008-2011 and under PROTEIN-ONCOGENE PROTEINS 1994-2007", "HN": "2012(1994)", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060528"}, {"RECTYPE": "D", "MH": "Pudendal Neuralgia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Neuralgia, Pudendal|T047|T184|NON|EQV|NLM (2012)|110207|abbcdef", "ENTRY": "Pudendal Neuropathies", "MN": "C23.888.592.612.664.737", "MH_TH": "ORD (2011)", "ST": "T184", "PI": "Perineum (1982-2011)", "MS": "Pain associated with a damaged PUDENDAL NERVE. Clinical features may include positional pain with sitting in the perineal and genital areas, sexual dysfunction and FECAL INCONTINENCE and URINARY INCONTINENCE.", "PM": "2012", "HN": "2012", "MR": "20170620", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060545"}, {"RECTYPE": "D", "MH": "Argonaute Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "PIWI Subfamily of Argonaute Protein|T116|T123|NON|NRW|NLM (2021)|191119|abbcdef", "ENTRY": "Proteins, Argonaute", "MN": "D12.776.664.962.500.906.500", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "A family of RNA-binding proteins that has specificity for MICRORNAS and SMALL INTERFERING RNA molecules. The proteins take part in RNA processing events as core components of RNA-induced silencing complex.", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D060565"}, {"RECTYPE": "D", "MH": "Fusariosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Pulmonary Fusarioses", "MN": "C17.800.838.208.416.500", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Fusarium (1970-2011)", "MS": "OPPORTUNISTIC INFECTIONS with the soil fungus FUSARIUM. Typically the infection is limited to the nail plate (ONYCHOMYCOSIS). The infection can however become systemic especially in an IMMUNOCOMPROMISED HOST (e.g., NEUTROPENIA) and results in cutaneous and subcutaneous lesions, fever, KERATITIS, and pulmonary infections.", "PM": "2012", "HN": "2012", "MR": "20190617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060585"}, {"RECTYPE": "D", "MH": "Trichosporonosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "PRINT ENTRY": "Trichosporon Infection|T047|NON|EQV|NLM (2021)|200206|abcdef", "ENTRY": "Trichosporonosis, Invasive", "MN": "C20.543.480.680.075.682", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Trichosporon (1986-2011)", "MS": "Fungal infections caused by TRICHOSPORON that may become systemic especially in an IMMUNOCOMPROMISED HOST. Clinical manifestations range from superficial cutaneous infections to systemic lesions in multiple organs.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060586"}, {"RECTYPE": "D", "MH": "Groundwater", "AQ": "AN CH MI PS ST VI", "ENTRY": "Waters, Underground", "MN": "G01.311.355", "FX": "Water Supply", "MH_TH": "NLM (2012)", "ST": "T070", "PI": "Water Supply (1964-2011)", "MS": "Liquid water present beneath the surface of the earth.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060587"}, {"RECTYPE": "D", "MH": "LIM Domain Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.512", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "A large class of structurally-related proteins that contain one or more LIM zinc finger domains. Many of the proteins in this class are involved in intracellular signaling processes and mediate their effects via LIM domain protein-protein interactions. The name LIM is derived from the first three proteins in which the motif was found: LIN-11, Isl1 and Mec-3.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060588"}, {"RECTYPE": "D", "MH": "Zyxin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Zyxin Protein|T116|T123|NON|EQV|NLM (2012)|110412|abbcdef", "MN": "D12.776.744.962", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "PI": "Glycoproteins (1995-2011)", "MS": "A zinc-binding phosphoprotein that concentrates at focal adhesions and along the actin cytoskeleton. Zyxin has an N-terminal proline-rich domain and three LIM domains in its C-terminal half.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060589"}, {"RECTYPE": "D", "MH": "Hyalohyphomycosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Subcutaneous Hyalohyphomycoses", "MN": "C17.800.838.208.416", "MH_TH": "NLM (2012)", "ST": "T047", "AN": "coordinate IM with specific fungus (IM) but note specifics", "PI": "Mycoses (1986-2011)", "MS": "OPPORTUNISTIC INFECTIONS caused by a heterogeneous group of MITOSPORIC FUNGI with clear (hyalo-) HYPHAE in the host. Common causative agents include ACREMONIUM; ASPERGILLUS; CHRYSOSPORIUM; FUSARIUM; PAECILOMYCES; PENICILLIUM; PSEUDALLESCHERIA; SCEDOSPORIUM; and SCOPULARIOPSIS. Normally a dermatomycoses, it can become invasive in the IMMUNOCOMPROMISED HOST.", "PM": "2012", "HN": "2012", "MR": "20190617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060605"}, {"RECTYPE": "D", "MH": "Scopulariopsis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Microascus brevicaulis|T004|NON|NRW|NLM (2021)|200318|abcdef", "ENTRY": "Scopulariopsis brevicaulis|T004|NON|NRW|NLM (2012)|110215|abcdef", "MN": "B01.300.381.802", "MH_TH": "NLM (2012)", "ST": "T004", "RN": "txid40374", "RR": "txid561152", "AN": "infection: coordiante with MYCOSES or specific mycosis ", "MS": "A mitosporic fungal genus commonly found in soil. It includes both saprophytes and animal pathogens. Scopulariopsis brevicaulis and related species may convert ARSENIC to volatile and toxic arsine. ONYCHOMYCOSIS; and rarely BRAIN ABSCESS; MYCETOMA and disseminated infections, mainly in the IMMUNOCOMPROMISED HOSTS, are associated with Scopulariopsis.", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060645"}, {"RECTYPE": "D", "MH": "Airway Extubation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tracheal Extubations", "MN": "E05.008", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "Removal of an endotracheal tube from the patient.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060666"}, {"RECTYPE": "D", "MH": "Sense of Coherence", "AQ": "CL DE ES PH RE", "ENTRY": "Salutogeneses", "MN": "F01.752.747.792.925", "MH_TH": "NLM (2012)", "ST": "T041", "MS": "A view of the world and the individual's environment as comprehensible, manageable, and meaningful, claiming that the way people view their life has a positive influence on their health.", "PM": "2012", "HN": "2012", "MR": "20170620", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060685"}, {"RECTYPE": "D", "MH": "Dyscalculia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Secondary Acalculias", "MN": "F03.625.562.700.250", "FX": "Gerstmann Syndrome", "MH_TH": "NLM (2012)", "ST": "T184", "PI": "Learning Disorders (1968-2011)", "MS": "Impaired ability in numerical concepts. These inabilities arise as a result of primary neurological lesion, are syndromic (e.g., GERSTMANN SYNDROME ) or acquired due to brain damage.", "PM": "2012", "HN": "2012", "MR": "20230531", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060705"}, {"RECTYPE": "D", "MH": "Uterine Retroversion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Uterus, Tipped", "MN": "C23.300.970.750", "MH_TH": "NLM (2012)", "ST": "T033", "AN": "coordinate with OBSTETRIC LABOR COMPLICATIONS if pertinent", "PI": "Uterus/abnormalities (1992-2011)", "MS": "A condition in which the UTERUS is found tilted backward toward the spine. The uterus is more commonly found in a straight vertical or anteverted (tipped forward) position. Although retroverted uterus is a normal variant position without symptoms, it is sometimes associated with pain, discomfort and other pregnancy complications.", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060725"}, {"RECTYPE": "D", "MH": "Torso", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Torsos", "MN": "A01.923", "MH_TH": "NLM (2012)", "ST": "T029", "AN": "do not confuse with torso protein often referred to as \"torso\"; \"trunk\" in reference to the main part of the body goes here", "MS": "The central part of the body to which the neck and limbs are attached.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060726"}, {"RECTYPE": "D", "MH": "Reproductive Health", "AQ": "CL EC ED EH ES HI LJ SN ST TD", "ENTRY": "Health, Reproductive", "MN": "N01.400.625", "FX": "Reproductive Medicine", "MH_TH": "NLM (2012)", "ST": "T078", "PI": "Reproductive Medicine (1988-2011)", "MS": "The state of the REPRODUCTIVE SYSTEM when functioning optimally without evidence of disease, disorders, or deficiencies.", "PM": "2012; see Reproductive Medicine 1995-2011", "HN": "2012; use Reproductive Medicine 1995-2011", "MR": "20170414", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060728"}, {"RECTYPE": "D", "MH": "Coal Ash", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Pollutant, ROFA", "MN": "D20.633.110", "PA": "Environmental Pollutants", "MH_TH": "NLM (2012)", "ST": "T131", "RN": "0", "RR": "68131-74-8", "PI": "Coal (1966-2011)", "MS": "Residue generated from combustion of coal or petroleum.", "PM": "2012", "HN": "2012", "MR": "20130708", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D060729"}, {"RECTYPE": "D", "MH": "Glomerular Filtration Barrier", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Glomerular Filtration Barriers", "MN": "A07.500", "MH_TH": "NLM (2012)", "ST": "T042", "PI": "Kidney Glomerulus (1975-2011)", "MS": "A specialized barrier in the kidney, consisting of the fenestrated CAPILLARY ENDOTHELIUM; GLOMERULAR BASEMENT MEMBRANE; and glomerular epithelium (PODOCYTES). The barrier prevents the filtration of PLASMA PROTEINS.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060730"}, {"RECTYPE": "D", "MH": "Emergency Responders", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Responders, First", "MN": "M01.526.373", "MH_TH": "NLM (2012)", "ST": "T097", "PI": "Emergency Medical Technicians (1986-2011)", "MS": "Personnel trained to provide the initial services, care, and support in EMERGENCIES or DISASTERS.", "PM": "2012", "HN": "2012", "MR": "20171213", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060731"}, {"RECTYPE": "D", "MH": "Electromagnetic Radiation", "DE": "ELECTROMAGNETIC RAD", "AQ": "CL", "PRINT ENTRY": "Electromagnetic Waves|T070|NON|EQV|UNK (19XX)|880412|abcdef", "ENTRY": "Waves, Electromagnetic", "MN": "G01.750.250", "MH_TH": "UNK (19XX)", "ST": "T070", "MS": "Waves of oscillating electric and MAGNETIC FIELDS which move at right angles to each other and outward from the source.", "PM": "2012; for ELECTROMAGNETIC ENERGY and ELECTROMAGNETIC WAVES see RADIATION 1988-2011", "HN": "2012; for ELECTROMAGNETIC ENERGY and ELECTROMAGNETIC WAVES use RADIATION 1988-2011", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060733"}, {"RECTYPE": "D", "MH": "Nacre", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Mother of Pearl|T104|NON|EQV|NLM (2012)|110228|abcdef", "MN": "D01.578.200.500", "MH_TH": "NLM (2012)", "ST": "T104", "RN": "0", "AN": "NACRE PROTEIN, ZEBRAFISH is also available", "MS": "A biomineral consisting of layers of crystalized ARAGONITE, separated by interlamellar layers of organic matrix containing beta-CHITIN, and surrounded by an intercrystalline organic membrane of silk fibroin. Nacre is the iridescent substance better known as mother-of-pearl that is secreted by MOLLUSCS.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060734"}, {"RECTYPE": "D", "MH": "Pharmacovigilance", "ENTRY": "Pharmacovigilances", "MN": "N06.850.505.636", "FX": "Drug Monitoring", "MH_TH": "NLM (2012)", "ST": "T062", "MS": "The detection of long and short term side effects of conventional and traditional medicines through research, data mining, monitoring, and evaluation of healthcare information obtained from healthcare providers and patients.", "PM": "2012", "HN": "2012", "MR": "20170703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060735"}, {"RECTYPE": "D", "MH": "Reproductive Tract Infections", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Reproductive Tract Infection", "MN": "C12.200.294.604", "FX": "Sexually Transmitted Diseases", "MH_TH": "NLM (2012)", "ST": "T047", "MS": "Infections of the genital tract in females or males. They can be caused by endogenous, iatrogenic, or sexually transmitted organisms.", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060737"}, {"RECTYPE": "D", "MH": "Phonons", "AQ": "AE CL HI TU", "ENTRY": "Phonons, Optical", "MN": "G01.750.770.776.783", "MH_TH": "NLM (2012)", "ST": "T167", "MS": "Quanta of acoustic energy which move at the speed of sound.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060739"}, {"RECTYPE": "D", "MH": "Disease Eradication", "AQ": "EC HI IS LJ MT OG SN ST TD", "ENTRY": "Eradications, Disease", "MN": "N06.850.275", "FX": "Communicable Disease Control", "MH_TH": "NLM (2012)", "ST": "T058", "AN": "coordinate with specific disease / prev", "PI": "specific disease/prevention and control (1968-2011)", "MS": "Termination of all transmission of infection by global extermination of the infectious agent through surveillance and containment (From Porta, A Dictionary of Epidemiology, 5th ed).", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060740"}, {"RECTYPE": "D", "MH": "Gingival Retraction Techniques", "AQ": "AE CL EC ES HI IS MO NU PX SN ST TD VE", "ENTRY": "Techniques, Gingival Retraction", "MN": "E06.912.480", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Dental Impression Technique (1965-2011)", "MS": "Techniques used to expose dental surface below the gingival margin in order to obtain better dental impression during periodental and peri-implant applications. The retraction of the gingival tissue can be achieved surgically (e.g., laser gingivectomy and rotary curettage) or chemically with a retraction cord.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060745"}, {"RECTYPE": "D", "MH": "Endoplasmic Reticulum-Associated Degradation", "AQ": "DE GE IM PH RE", "ENTRY": "Reticulum-Associated Degradation, Endoplasmic", "MN": "G05.308.670.600.850.500", "FX": "Ubiquitination", "MH_TH": "NLM (2012)", "ST": "T044", "PI": "Protein Folding (1995-2011)", "MS": "A degradation process whereby incorrectly folded proteins are selectively transported out of the ENDOPLASMIC RETICULUM and into the CYTOSOL. The misfolded proteins are subsequently ubiquitinated and degraded by the PROTEASOME.", "PM": "2012", "HN": "2012", "MR": "20220712", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060746"}, {"RECTYPE": "D", "MH": "Fetal Globulins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Globulins, Fetal", "MN": "D12.776.377.228", "MH_TH": "UNK (19XX)", "ST": "T123", "RN": "0", "PI": "Fetal Proteins (1984-2011)", "MS": "Specialized proteins that are preferentially expressed during FETAL DEVELOPMENT.", "PM": "2012; see FETAL PROTEINS 1984-2011", "HN": "2012; use FETAL PROTEINS 1984-2011", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060747"}, {"RECTYPE": "D", "MH": "Fetuins", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Fetuin|T116|T123|NON|EQV|UNK (19XX)|790221|abbcdef", "MN": "D12.776.377.715.085.304", "MH_TH": "UNK (19XX)", "ST": "T123", "RN": "0", "PI": "alpha-Fetoproteins (1975-2011)", "MS": "A family of calcium-binding alpha-globulins that are synthesized in the LIVER and play an essential role in maintaining the solubility of CALCIUM in the BLOOD. In addition the fetuins contain aminoterminal cystatin domains and are classified as type 3 cystatins.", "PM": "2012; see ALPHA-FETOPROTEINS 1975-2011", "HN": "2012; use ALPHA-FETOPROTEINS 1975-2011", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060748"}, {"RECTYPE": "D", "MH": "alpha-2-HS-Glycoprotein", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "alpha2 Heremans-Schmid Glycoprotein|T116|T123|EPO|EQV|NLM (2012)|110307|abbcdef", "ENTRY": "alpha 2HS Glycoprotein", "MN": "D12.776.395.086", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "A fetuin subtype that is synthesized by HEPATOCYTES and secreted into the circulation. It plays a major role in preventing CALCIUM precipitation in the BLOOD.", "PM": "2012; ALPHA2HS GLYCOPROTEIN was indexed under BLOOD PROTEINS 1981-2011", "HN": "2012(1981)", "MR": "20230316", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060749"}, {"RECTYPE": "D", "MH": "Bone Anteversion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Bone Anteversions", "MN": "C23.300.970.249", "MH_TH": "NLM (2012)", "ST": "T046", "MS": "Malalignment of a bone in which its head and neck is rotated excessively forward or inward.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060750"}, {"RECTYPE": "D", "MH": "Bone Retroversion", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Retroversions, Bone", "MN": "C23.300.970.374", "MH_TH": "NLM (2012)", "ST": "T046", "MS": "Attachment of a bone in which its head and neck is rotated excessively backward.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060751"}, {"RECTYPE": "D", "MH": "Fetuin-B", "AQ": "AA AD AE AG AI AN BI CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein IRL685, Fetuin-Like", "MN": "D12.776.377.715.085.304.750", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "PI": "alpha-Fetoproteins (1975-2011)", "MS": "A fetuin subtype that is closely-related to ALPHA-2-HS-GLYCOPROTEIN. Although fetuin-B binds calcium, it is a minor component of SERUM and therefore it may not play a primary role in preventing serum calcium phosphate precipitation.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060752"}, {"RECTYPE": "D", "MH": "Water Quality", "AQ": "ST", "ENTRY": "Quality, Water", "MN": "N06.850.460.790.730", "MH_TH": "NLM (2012)", "ST": "T080", "MS": "A rating of a body of water based on measurable physical, chemical, and biological characteristics.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060753"}, {"RECTYPE": "D", "MH": "Equol", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Equol, 4'-O-Methyl", "MN": "D03.633.100.150.266.450.400.281", "PA": "Phytoestrogens", "MH_TH": "NLM (2012)", "ST": "T121", "RN": "531-95-3", "RR": "66036-38-2 ((+-)-isomer)", "PI": "Isoflavones (1963-2011)", "MS": "A non-steroidal ESTROGEN generated when soybean products are metabolized by certain bacteria in the intestines.", "PM": "2012", "HN": "2012", "MR": "20160531", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D060754"}, {"RECTYPE": "D", "MH": "Germ Theory of Disease", "AQ": "HI", "ENTRY": "Disease Germ Theory", "MN": "K01.752.667.555", "MH_TH": "NLM (2012)", "ST": "T078", "MS": "The fundamental tenet of modern medicine that certain diseases are caused by microorganisms. It was confirmed by the work of Pasteur, Lister, and Koch.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060755"}, {"RECTYPE": "D", "MH": "Social Networking", "AQ": "HI", "ENTRY": "Social Network", "MN": "L01.143.910", "MH_TH": "NLM (2012)", "ST": "T054", "MS": "Individuals connected by family, work or other interests. It also includes connectivity facilitated by computer-based communications.", "PM": "2012", "HN": "2012", "MR": "20200429", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060756"}, {"RECTYPE": "D", "MH": "Secretoglobins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Secretoglobin|T116|T123|NON|EQV|NLM (2021)|200317|abbcdef", "MN": "D12.776.861", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "A structurally related family of small, multimeric proteins that are secreted in the mucosa of mammalian epithelial tissues. A variety of proteins are classed under this heading including some secretoglobin subtypes that appear unique to a particular mammalian species, and others whose functions differ between species.", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060765"}, {"RECTYPE": "D", "MH": "Drinking Water", "AQ": "AD AE AN CH LJ ME MI PS ST VI", "ENTRY": "Water, Potable", "MN": "J02.200.418", "FX": "Fresh Water", "MH_TH": "NLM (2012)", "ST": "T197", "RN": "0", "PI": "Water Supply (1963-2011)", "MS": "Water that is intended to be ingested.", "PM": "2012", "HN": "2012", "MR": "20190708", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060766"}, {"RECTYPE": "D", "MH": "Mammaglobin A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Mammaglobin-A|T116|T123|NON|EQV|NLM (2012)|110310|abbcdef", "ENTRY": "Secretoglobin Family 2A Member 2|T116|T123|NON|EQV|NLM (2012)|110310|abbcdef", "MN": "D23.101.140.425", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "A secretoglobin that is produced by the MAMMARY GLAND of HUMANS and may be involved in the binding of ANDROGENS and other STEROIDS. The expression of this protein in normal breast epithelium and in human breast cancer has made it an important histological marker.", "PM": "2012; MAMMAGLOBIN A was indexed under NEOPLASM PROTEINS and UTEROGLOBIN 1996-2011", "HN": "2012(1996)", "MR": "20150622", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060785"}, {"RECTYPE": "D", "MH": "Holy Roman Empire", "AQ": "EH EP", "MN": "Z01.586.361", "MH_TH": "NLM (2012)", "ST": "T083", "AN": "do not confuse with ROMAN EMPIRE see ROMAN WORLD or with ROME which is used for the ancient & modern city", "MS": "Realm in central Europe consisting of a confederation of German and Italian territories under the suzerainty of an emperor and existing from the 9th or 10th century to 1806.", "HN": "2012", "DA": "20110624", "DC": "4", "DX": "20120101", "UI": "D060786"}, {"RECTYPE": "D", "MH": "Neoplasm Grading", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Score, Gleason", "MN": "E01.789.612", "FX": "Nomograms", "MH_TH": "NLM (2012)", "ST": "T080", "AN": "IM general only; coordinate NIM with no qualifiers with neoplasm terms /diag, /diag image and or /pathol; do not confuse with NEOPLASM STAGING; grading is given in Arabic numerals, staging in Roman numerals", "PI": "Neoplasms or specifics /pathology (1974-2011)", "MS": "Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.", "PM": "2012", "HN": "2012", "MR": "20170711", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060787"}, {"RECTYPE": "D", "MH": "Mammaglobin B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Secretoglobin family 2A member 1|T116|T123|NON|EQV|NLM (2012)|090916|abbcdef", "ENTRY": "Mammaglobin 2", "MN": "D12.776.861.260", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "PI": "Secretoglobins (2001-2011)", "MS": "A MAMMAGLOBIN A-related secretoglobin that is expressed in several HUMAN tissues including the UTERUS; BREAST; SALIVARY GLAND; and LACRIMAL GLAND.", "PM": "2012; LIPOPHILIN-C was indexed under MYELIN PROTEINS, PROTEOLIPIDS, and UTEROGLOBIN 2001-2011, LACRYGLOBIN, MAMMAGLOBIN-B, and MAMMAGLOBIN-1 were indexed under MYELIN PROTEINS, PROTEOLIPIDS, and UTEROGLOBIN 2009-2011", "HN": "2012; for LIPOPHILIN-C use SECRETOGLOBINS 2001-2011, for LACRYGLOBIN, MAMMAGLOBIN-B, and MAMMAGLOBIN-1 use SECRETOGLOBINS 2009-2011", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060788"}, {"RECTYPE": "D", "MH": "Prostatein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Steroid-Binding Protein, Prostatic", "MN": "D12.776.861.311", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "PI": "Uteroglobin (2005-2011)", "MS": "A secreted prostate-specific protein which can bind non-polar steroids, cholesterol and a group of small, proline-rich peptides. The protein is specifically found in RATS and comprises three distinct secretoglobin-related subunits referred to as prostatic steroid-binding protein C1, C2 and C3.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060789"}, {"RECTYPE": "D", "MH": "Performance Anxiety", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Performance Anxieties", "MN": "F01.470.132.650", "MH_TH": "NLM (2012)", "ST": "T041", "PI": "Anxiety (1982-2011)", "MS": "Anxiety related to the execution of a task. (Campbell's Psychiatric Dictionary, 9th ed.)", "PM": "2012", "HN": "2012", "MR": "20130709", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060805"}, {"RECTYPE": "D", "MH": "Bioluminescence Resonance Energy Transfer Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "MN": "E05.196.712.516.099", "MH_TH": "NLM (2012)", "ST": "T059", "PI": "Luminescent Measurements (1999-2011)", "MS": "Techniques for determining the proximity of molecules based on ENERGY TRANSFER between bioluminescent chromophores and acceptor fluorophores that have overlapping emission and absorption spectra.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060807"}, {"RECTYPE": "D", "MH": "Cognitive Dysfunction", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Mild Cognitive Impairment|T048|NON|NRW|NLM (2012)|110314|abcdef", "ENTRY": "Mild Cognitive Impairments", "MN": "F03.615.250.700", "MH_TH": "NLM (2017)", "ST": "T048", "PI": "Cognition Disorders (1998-2016)", "MS": "Diminished or impaired mental and/or intellectual function.", "PM": "2017(2012)", "HN": "2017(2012)", "MR": "20220712", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060825"}, {"RECTYPE": "D", "MH": "Cementoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Percutaneous Osteoplasties", "MN": "E04.555.165", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Bone Cements (1999-2011)", "MS": "Injection of BONE CEMENTS into bone to treat bone lesions.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060826"}, {"RECTYPE": "D", "MH": "Induction Chemotherapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Induction Chemotherapies", "MN": "E02.860.500", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Remission Induction (1986-2011)", "MS": "Initial drug treatment designed to bring about REMISSION INDUCTION. It is typically a short-term and high-dose drug treatment that is followed by CONSOLIDATION CHEMOTHERAPY and then MAINTENANCE CHEMOTHERAPY.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060828"}, {"RECTYPE": "D", "MH": "Arthropod Proteins", "AQ": "AD AE AG AI AN BI BL CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "ENTRY": "Tick Proteins|T116|NON|NRW|NLM (2012)|110314|abcdef", "MN": "D12.776.093", "MH_TH": "NLM (2012)", "ST": "T116", "RN": "0", "MS": "Proteins synthesized by organisms belonging to the phylum ARTHROPODA. Included in this heading are proteins from the subdivisions ARACHNIDA; CRUSTACEA; and HORSESHOE CRABS. Note that a separate heading for INSECT PROTEINS is listed under this heading.", "PM": "2012", "HN": "2012", "MR": "20150618", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060829"}, {"RECTYPE": "D", "MH": "Consolidation Chemotherapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Consolidation Chemotherapies", "MN": "E02.319.218", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "Drug treatment designed to further diminish the disease toward complete remission following INDUCTION CHEMOTHERAPY. It helps to consolidate the gains during induction chemotherapy and may be followed by MAINTENANCE CHEMOTHERAPY.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060830"}, {"RECTYPE": "D", "MH": "Hand-Foot Syndrome", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Hand-Foot", "MN": "C25.100.468.380.587", "FX": "Hand, Foot and Mouth Disease", "MH_TH": "NLM (2012)", "ST": "T047", "AN": "do not confuse with HAND, FOOT AND MOUTH DISEASE", "PI": "Hand Dermatoses/chemically induced (1997-2011)", "MS": "Chemotherapy-induced dermal side effects that are associated with the use of various CYTOSTATIC AGENTS. Symptoms range from mild ERYTHEMA and/or PARESTHESIA to severe ulcerative dermatitis with debilitating pain involving typically palmoplantar and intertriginous areas. These cutaneous manifestations are sometimes accompanied by nail anomalies.", "PM": "2012", "HN": "2012", "MR": "20130708", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060831"}, {"RECTYPE": "D", "MH": "Apomixis", "AQ": "DE GE IM PH RE", "ENTRY": "Apomixis, Male", "MN": "G15.547.500", "MH_TH": "NLM (2012)", "ST": "T039", "PI": "Reproduction, Asexual (1963-2011)", "MS": "Asexual reproduction resulting in the formation of viable seeds from FLOWERS without fertlization (i.e. use of POLLEN). Progeny plants produced from apomictic seeds are perfect clones of the parent.", "PM": "2012", "HN": "2012", "MR": "20160602", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D060832"}, {"RECTYPE": "D", "MH": "Cellular Microenvironment", "AQ": "DE GE IM PH RE", "ENTRY": "Microenvironments, Cellular", "MN": "G04.366", "MH_TH": "NLM (2012)", "ST": "T070", "MS": "Local surroundings with which cells interact by processing various chemical and physical signals, and by contributing their own effects to this environment.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060833"}, {"RECTYPE": "D", "MH": "Hoarding", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "MN": "F01.145.493", "MH_TH": "NLM (2012)", "ST": "T048", "AN": "differentiate from HOARDING DISORDER", "PI": "Obsessive-Compulsive Disorder (1990-2011)", "MS": "A persistent difficulty discarding or parting with possessions.", "PM": "2017; see Obsessive Hoarding 2012-2016", "MR": "20190709", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060845"}, {"RECTYPE": "D", "MH": "Cell Engineering", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "ENTRY": "Engineering, Cellular", "MN": "J01.293.069.249", "FX": "Tissue Therapy, Historical", "MH_TH": "NLM (2012)", "ST": "T063", "MS": "Methods and techniques used to modify or select cells and develop conditions for growing cells for biosynthetic production of molecules (METABOLIC ENGINEERING), for generation of tissue structures and organs in vitro (TISSUE ENGINEERING), or for other BIOENGINEERING research objectives.", "PM": "2012", "HN": "2012", "MR": "20150623", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060846"}, {"RECTYPE": "D", "MH": "Metabolic Engineering", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "ENTRY": "Engineering, Metabolic", "MN": "J01.293.069.249.249", "FX": "Metabolic Flux Analysis", "MH_TH": "NLM (2012)", "ST": "T063", "PI": "Genetic Engineering (1990-2011)", "MS": "Methods and techniques used to genetically modify cells' biosynthetic product output and develop conditions for growing the cells as BIOREACTORS.", "PM": "2012", "HN": "2012", "MR": "20150623", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060847"}, {"RECTYPE": "D", "MH": "Agatoxins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC EN GE HI IM IP ME PD PK PO RE TO TU UR", "ENTRY": "omega Agatoxins", "MN": "D23.946.833.065.870.324", "PA": "Neurotoxins", "MH_TH": "NLM (2012)", "ST": "T131", "RN": "0", "PI": "Spider Venoms (1989-2011)", "MS": "A class of polyamine and peptide toxins which are isolated from the venom of spiders such as Agelenopsis aperta.", "PM": "2012", "HN": "2012", "MR": "20150618", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060848"}, {"RECTYPE": "D", "MH": "LIM-Homeodomain Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "LIM-Homeodomain Protein|T116|T123|NON|EQV|NLM (2022)|201020|abbcdef", "ENTRY": "Protein, LIM-Homeodomain", "MN": "D12.776.512.249", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "MS": "A subclass of LIM domain proteins that include an additional centrally-located homeodomain region that binds AT-rich sites on DNA. Many LIM-homeodomain proteins play a role as transcriptional regulators that direct cell fate.", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060850"}, {"RECTYPE": "D", "MH": "Gulf of Mexico", "AQ": "EH EP", "MN": "Z01.756.092.325", "MH_TH": "NLM (2012)", "ST": "T083", "MS": "A body of water located at the southeastern corner of North America. It is bordered by the states to the north of Florida, Alabama, Mississippi, Louisiana, Texas; by five Mexican states to the west: Tamaulipas, Veracruz, Tabasco, Campeche, Yucatan; and by Cuba to the southeast.", "HN": "2012", "MR": "20170630", "DA": "20110624", "DC": "4", "DX": "20120101", "UI": "D060851"}, {"RECTYPE": "D", "MH": "Repetition Priming", "AQ": "CL DE ES PH RE", "ENTRY": "Priming, Repetition", "MN": "F02.463.425.540.739", "MH_TH": "NLM (2012)", "ST": "T041", "PI": "Mental Recall (2003-2011)", "MS": "A type of procedural memory manifested as a change in the ability to identify an item as a result of a previous encounter with the item or stimuli.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060865"}, {"RECTYPE": "D", "MH": "Accountable Care Organizations", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Accountable Care Organization|T093|NON|EQV|NLM (2012)|110316|abcdef", "ENTRY": "Organizations, Accountable Care", "MN": "N05.300.380.500", "MH_TH": "NLM (2012)", "ST": "T093", "MS": "Organizations of health care providers that agree to be accountable for the quality, cost, and overall care of Medicare beneficiaries who are enrolled in the traditional fee-for-service program who are assigned to it. Assigned means those beneficiaries for whom the professionals in the organization provide the bulk of primary care services. (www.cms.gov/OfficeofLegislation/Downloads/Accountable CareOrganization.pdf accessed 03/16/2011)", "PM": "2012", "HN": "2012", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D060866"}, {"RECTYPE": "D", "MH": "Facilitated Tucking", "AQ": "CL EC ES HI IS LJ MT PX SN ST TD", "ENTRY": "Tucking, Facilitated", "MN": "N02.421.088.120.059", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Intensive Care, Neonatal (2004-2011)", "MS": "A method of soothing PREMATURE INFANTS during POSTNATAL CARE. It involves holding the infant's arms and legs in flexed positions close to the midline of the TORSO.", "PM": "2012", "HN": "2012", "MR": "20150629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060867"}, {"RECTYPE": "D", "MH": "Multiplex Polymerase Chain Reaction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "PCR, Triplex", "MN": "E05.393.620.500.487", "MH_TH": "NLM (2012)", "ST": "T063", "PI": "Polymerase Chain Reaction (1989-2011)", "MS": "Methods for using more than one primer set in a polymerase chain reaction to amplify more than one segment of the target DNA sequence in a single reaction.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060885"}, {"RECTYPE": "D", "MH": "B7 Antigens", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Molecules, B7", "MN": "D23.529.168", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "Antigens, CD80 (1994-2011)", "MS": "A family of cell-surface proteins found on ANTIGEN-PRESENTING CELLS. B7 antigens are ligands for specific cell surface receptor subtypes found on T-CELLS. They play an immunomodulatory role by stimulating or inhibiting the T-CELL activation process.", "PM": "2012; for B7 ANTIGEN and ANTIGEN B7 see ANTIGENS, CD80 1994-2011", "HN": "2012; for B7 ANTIGEN and ANTIGEN B7 use ANTIGENS, CD80 1994-2011", "MR": "20170524", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060887"}, {"RECTYPE": "D", "MH": "Real-Time Polymerase Chain Reaction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Real-Time PCRs, Quantitative", "MN": "E05.393.620.500.706", "MH_TH": "NLM (2012)", "ST": "T063", "AN": "RT-PCR in the literature is probably REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION not this term; check text", "PI": "Polymerase Chain Reaction (1999-2011)", "MS": "Methods used for detecting the amplified DNA products from the polymerase chain reaction as they accumulate instead of at the end of the reaction.", "PM": "2012", "HN": "2012", "MR": "20140606", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D060888"}, {"RECTYPE": "D", "MH": "Inducible T-Cell Co-Stimulator Protein", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "T-Cell Co-Stimulator, Inducible", "MN": "D23.101.100.894.580", "MH_TH": "NLM (2012)", "ST": "T192", "RN": "0", "MS": "A costimulatory receptor that is specific for INDUCIBLE T-CELL CO-STIMULATOR LIGAND. The receptor is associated with a diverse array of immunologically-related effects including the increased synthesis of INTERLEUKIN 10 in REGULATORY T-LYMPHOCYTES and the induction of PERIPHERAL TOLERANCE.", "PM": "2012; INDUCIBLE T-CELL CO-STIMULATOR was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1999-2011", "HN": "2012(1999)", "MR": "20170524", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060889"}, {"RECTYPE": "D", "MH": "B7-H1 Antigen", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Programmed Death Ligand 1|T116|T129|NON|EQV|NLM (2021)|191127|abbcdef", "ENTRY": "PD L1 Protein", "MN": "D23.529.168.300", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "Blood Proteins (2001-2005)", "MS": "An inhibitory B7 antigen that contains V-type and C2 type immunoglobulin domains. It has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 PROTEIN and provides negative signals that control and inhibit T-cell responses. It is found at higher than normal levels on tumor cells, suggesting its potential role in TUMOR IMMUNE EVASION.", "PM": "2018; see ANTIGENS, CD274 2012-2017", "HN": "2018 (2007)", "MR": "20200327", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060890"}, {"RECTYPE": "D", "MH": "Root Cause Analysis", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Root Cause Analyses", "MN": "N05.715.360.700", "MH_TH": "NLM (2012)", "ST": "T080", "MS": "Multi-step systematic review process used for improving safety by investigation of incidents to find what happened, why it happened, and to determine what can be done to prevent it from happening again.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060891"}, {"RECTYPE": "D", "MH": "Coxa Vara", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Congenital Coxa Vara|T033|T047|NON|NRW|NLM (2012)|110321|abbcdef", "ENTRY": "Varus, Coxa", "MN": "C23.300.970.249.500", "FX": "Slipped Capital Femoral Epiphyses", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Joint Diseases (1964-2011)", "MS": "Hip deformity in which the femoral neck leans forward resulting in a decrease in the angle between femoral neck and its shaft. It may be congenital often syndromic, acquired, or developmental.", "PM": "2012", "HN": "2012", "MR": "20130708", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060905"}, {"RECTYPE": "D", "MH": "Coxa Valga", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Valgus, Coxa", "MN": "C23.300.970.374.500", "MH_TH": "NLM (2012)", "ST": "T047", "PI": "Joint Diseases (1965-2011)", "MS": "Hip deformity in which the angle between the femoral neck and its shaft is increased. It may be congenital, acquired, or developmental.", "PM": "2012", "HN": "2012", "MR": "20130708", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060906"}, {"RECTYPE": "D", "MH": "V-Set Domain-Containing T-Cell Activation Inhibitor 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "V Set Domain Containing T Cell Activation Inhibitor 1", "MN": "D23.529.168.900", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "Antigens, CD80 (2003-2011)", "MS": "A B7 antigen subtype that inhibits the costimulation of T-cell activation, proliferation, cytokine production and development of cytotoxicity. The over expression of this protein in a variety of tumor cell types suggests its role in TUMOR IMMUNE EVASION.", "PM": "2012", "HN": "2012", "MR": "20170524", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D060907"}, {"RECTYPE": "D", "MH": "CTLA-4 Antigen", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Cytotoxic T-Lymphocyte Antigen 4|T116|T129|T192|NON|EQV|NLM (2012)|110321|abbbcdef", "ENTRY": "Cytotoxic T Lymphocyte Associated Antigen 4", "MN": "D23.101.100.894.158", "FX": "Ipilimumab", "MH_TH": "NLM (2012)", "ST": "T192", "RN": "0", "MS": "An inhibitory T CELL receptor that is closely related to CD28 ANTIGEN. It has specificity for CD80 ANTIGEN and CD86 ANTIGEN and acts as a negative regulator of peripheral T cell function. CTLA-4 antigen is believed to play role in inducing PERIPHERAL TOLERANCE.", "PM": "2012; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4 was indexed under ANTIGENS, CD 2008-2011, and under ANTIGENS, DIFFERENTIATION 1992-2007", "HN": "2012(1991)", "MR": "20200327", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060908"}, {"RECTYPE": "D", "MH": "Economics, Behavioral", "AQ": "HI LJ SN TD", "ENTRY": "Behavioral Economics|T090|NON|EQV|NLM (2012)|110511|abcdef", "MN": "N03.219.215", "MH_TH": "NLM (2012)", "ST": "T090", "AN": "use for the discipline (education, history, etc) only", "MS": "The combined discipline of psychology and economics that investigates what happens in markets in which some of the agents display human limitations and complications.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060909"}, {"RECTYPE": "D", "MH": "Pronephros", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Pronephroi|T023|NON|EQV|NLM (2012)|110321|abcdef", "MN": "A16.835", "MH_TH": "NLM (2012)", "ST": "T023", "PI": "Kidney (1969-2011)", "MS": "The primordial kidney that develops from the INTERMEDIATE MESODERM in the embryos of vertebrates, and is succeeded by the MESONEPHROS. In higher vertebrates and humans, the pronephros is a vestigial and transient structure.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060910"}, {"RECTYPE": "D", "MH": "Remuneration", "ENTRY": "Remunerations", "MN": "N01.824.417.605", "MH_TH": "BIOETHICS (1974)", "ST": "T081", "PI": "Fees and Charges (1978-2011)", "MS": "Payment for a service or for a commodity such as a body part.", "PM": "2012; see FEES AND CHARGES 1978-2011", "HN": "2012; use FEES AND CHARGES 1993-2011", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060926"}, {"RECTYPE": "D", "MH": "Inducible T-Cell Co-Stimulator Ligand", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Gl50, B7-Like", "MN": "D23.529.168.500", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A B7 antigen that binds specifically to INDUCIBLE T-CELL CO-STIMULATOR PROTEIN on T-CELLS. It provides a costimulatory signal for T-cell proliferation and cytokine secretion.", "PM": "2012; B7-RELATED PROTEIN-1 was indexed under ANTIGENS, CD80 2000-2011", "HN": "2012(2000)", "MR": "20170524", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060945"}, {"RECTYPE": "D", "MH": "Pharmaceutical Services, Online", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Services, Online Pharmacy", "MN": "N02.421.668.475", "FX": "Pharmacies", "MH_TH": "NLM (2012)", "ST": "T058", "PI": "Pharmaceutical Services (2000-2011)", "MS": "Pharmacy services accessed via electronic means.", "PM": "2012", "HN": "2012", "MR": "20150629", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D060946"}, {"RECTYPE": "D", "MH": "Clonal Evolution", "AQ": "DE GE IM PH RE", "ENTRY": "Evolution, Somatic", "MN": "G05.158", "FX": "Clonal Selection, Antigen-Mediated", "MH_TH": "NLM (2012)", "ST": "T043", "MS": "The process of accumulation of genetic and epigenetic changes over time in individual cells and the effect of the changes on CELL PROLIFERATION.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060965"}, {"RECTYPE": "D", "MH": "Clonal Selection, Antigen-Mediated", "AQ": "DE GE IM PH RE", "ENTRY": "Theory, Clonal Selection", "MN": "G12.450.050.184", "FX": "Clonal Evolution", "MH_TH": "NLM (2012)", "ST": "T070", "MS": "LYMPHOCYTE ACTIVATION by a specific ANTIGEN thus triggering clonal expansion of LYMPHOCYTES already capable of mounting an immune response to the antigen.", "PM": "2012", "HN": "2012", "MR": "20160623", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060966"}, {"RECTYPE": "D", "MH": "Natural Springs", "AQ": "AN CH MI PS ST VI", "ENTRY": "Springs, Natural", "MN": "G01.311.355.750", "FX": "Mineral Waters", "MH_TH": "NLM (2012)", "ST": "T070", "MS": "Water that emerges to the surface of the earth from underground.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060985"}, {"RECTYPE": "D", "MH": "Water Wells", "ENTRY": "Wells, Water", "MN": "J01.293.821.500.500", "MH_TH": "NLM (2012)", "ST": "T073", "PI": "Water Supply (1989-2011)", "MS": "Constructions built to access underground water.", "PM": "2012", "HN": "2012", "MR": "20150629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D060986"}, {"RECTYPE": "D", "MH": "Ponds", "AQ": "AN CH MI PS VI", "PRINT ENTRY": "Ponds, Freshwater|T070|NON|EQV|NLM (2022)|201229|abcdef", "ENTRY": "Pond, Freshwater", "MN": "N06.230.232.625", "MH_TH": "NLM (2012)", "ST": "T070", "AN": "do not use for salt ponds", "MS": "Inland bodies of standing FRESHWATER usually smaller than LAKES. They can be man-made or natural but there is no universal agreement as to their exact size. Some consider a pond to be a small body of water that is shallow enough for sunlight to reach the bottom.", "PM": "2012", "HN": "2012", "MR": "20210706", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061005"}, {"RECTYPE": "D", "MH": "Bays", "AQ": "AN CH MI PS VI", "PRINT ENTRY": "Inlets|T083|NON|REL|NLM (2012)|110328|abcdef", "ENTRY": "Inlet", "MN": "G01.311.625.080", "MH_TH": "NLM (2012)", "ST": "T070", "MS": "An area of water mostly surrounded by land, usually smaller than a gulf, and affording access to the sea.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061006"}, {"RECTYPE": "D", "MH": "Costimulatory and Inhibitory T-Cell Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "T-Lymphocyte Receptors, Inhibitory", "MN": "D12.776.543.750.705.222", "MH_TH": "NLM (2012)", "ST": "T192", "RN": "0", "MS": "A family of receptors that modulate the activation of T-LYMPHOCYTES by the T-CELL ANTIGEN RECEPTOR. The receptors are responsive to one or more B7 ANTIGENS found on ANTIGEN-PRESENTING CELLS and, depending upon the specific ligand-receptor combination, modulate a variety of T-cell functions such as the rate of clonal expansion, CELL SURVIVAL and cytokine production. Although commonly referred to as costimulatory receptors, some of the receptors have inhibitory effects such as inducing PERIPHERAL TOLERANCE.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061025"}, {"RECTYPE": "D", "MH": "Programmed Cell Death 1 Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Programmed Cell Death Protein 1|T116|T129|T192|NON|EQV|NLM (2021)|191127|abbbcdef", "ENTRY": "Receptor, PD1", "MN": "D23.101.100.894.790", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2012)", "ST": "T192", "RN": "0", "PI": "Apoptosis Regulatory Proteins (1977-2011)", "MS": "An inhibitory T-lymphocyte receptor that has specificity for CD274 ANTIGEN and PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN. Signaling by the receptor limits T cell proliferation and INTERFERON GAMMA synthesis. The receptor also may play an essential role in the regulatory pathway that induces PERIPHERAL TOLERANCE.", "PM": "2012", "HN": "2012", "MR": "20200327", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061026"}, {"RECTYPE": "D", "MH": "Programmed Cell Death 1 Ligand 2 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "PD L2 Ligand", "MN": "D23.529.168.800", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "MS": "A costimulatory B7 antigen that has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 RECEPTOR. It is closely-related to CD274 antigen; however, its expression is restricted to DENDRITIC CELLS and activated MACROPHAGES.", "PM": "2012; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN was indexed under ANTIGENS, CD80 2001-2011", "HN": "2012(2001)", "MR": "20200327", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061027"}, {"RECTYPE": "D", "MH": "Trigger Points", "AQ": "AB AH BS DG EM GD IN IR MI PA PH PP PS RE SU VI", "ENTRY": "Trigger Areas", "MN": "A01.947", "FX": "Acupuncture Points", "MH_TH": "NLM (2012)", "ST": "T029", "AN": "for trigger point injections, coordinate with INJECTIONS or specifics", "PI": "Myofascial Pain Syndromes (1984-2011)", "MS": "Discrete spots in taut bands of muscle that produce local and referred pain when muscle bands are compressed.", "PM": "2012", "HN": "2012", "MR": "20130708", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061028"}, {"RECTYPE": "D", "MH": "Biological Control Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Biopesticide|T001|T123|NON|NRW|NLM (2021)|191129|abbcdef", "ENTRY": "Pesticides, Biological", "MN": "D20.215.113", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "AN": "Coordinate with specific organism(s)", "PI": "Pest Control, Biological (1973-2011)", "MS": "Organisms, biological agents, or biologically derived agents used strategically for their positive or adverse effect on the physiology and/or reproductive health of other organisms.", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061046"}, {"RECTYPE": "D", "MH": "Polyketides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Polyketide|T109|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Ketides|T109|NON|NRW|NLM (2012)|110401|abcdef", "MN": "D04.345.674", "MH_TH": "NLM (2012)", "ST": "T109", "RN": "0", "MS": "Natural compounds containing alternating carbonyl and methylene groups (beta-polyketones), bioenergenetically derived from repeated condensation of acetyl coenzyme A via malonyl coenzyme A, in a process similar to fatty acid synthesis.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D061065"}, {"RECTYPE": "D", "MH": "Plant Pathology", "AQ": "CL EC ED ES HI IS LJ OG SN ST TD", "ENTRY": "Virology, Plant", "MN": "H01.158.273.540.706", "MH_TH": "NLM (2012)", "ST": "T090", "AN": "the discipline (education, history, etc) only; use PLANT DISEASES for diseases in plants; use PLANTS /microbiol or /virol for microbiologic or virologic studies of plants and do not index here", "PI": "Plant Diseases (1963-2011)", "MS": "The study of infectious diseases associated with plants.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D061066"}, {"RECTYPE": "D", "MH": "Antibodies, Monoclonal, Humanized", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "PRINT ENTRY": "Antibodies, Humanized|T116|T121|T129|NON|EQV|NLM (2012)|110401|abbbcdef", "ENTRY": "Humanized Antibodies", "MN": "D12.776.377.715.548.114.224.200", "MH_TH": "NLM (2012)", "ST": "T129", "RN": "0", "PI": "Antibodies, Monoclonal (1991-2011)", "MS": "Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061067"}, {"RECTYPE": "D", "MH": "Agenesis of Corpus Callosum", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Corpus Callosum Agenesis|T019|T033|NON|EQV|NLM (2009)|ORD (2010)|080314|abbcdeef", "ENTRY": "Hypogenesis, Corpus Callosum", "MN": "C23.300.008", "MH_TH": "NLM (2011)", "ST": "T033", "PI": "Corpus Callosum/abnormalities (1971-2011)", "MS": "Birth defect that results in a partial or complete absence of the CORPUS CALLOSUM. It may be isolated or a part of a syndrome (e.g., AICARDI'S SYNDROME; ACROCALLOSAL SYNDROME; ANDERMANN SYNDROME; and HOLOPROSENCEPHALY). Clinical manifestations include neuromotor skill impairment and INTELLECTUAL DISABILITY of variable severity.", "PM": "2012; for Absence of Corpus Callosum see Acrocallosal Syndrome 2009-2011; for Agenesis of Corpus Callosum see Aicardi Syndrome 2011", "HN": "2012; for Absence of Corpus Callosum use Acrocallosal Syndrome 2009-2011; for Agenesis of Corpus Callosum use Aicardi Syndrome 2011", "MR": "20120703", "DA": "20110627", "DC": "1", "DX": "20120101", "UI": "D061085"}, {"RECTYPE": "D", "MH": "NADP Transhydrogenase, B-Specific", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pyridine Nucleotide Transhydrogenase, B Specific", "MN": "D12.776.097.541", "MH_TH": "NLM (2012)", "ST": "T126", "RN": "EC 1.6.1.1", "PI": "NADP Transhydrogenases (1978-2011)", "MS": "A NADP transhydrogenase subtype found in certain types of BACTERIA. This transhydrogenase uses a mechanism that transfers hydrogen to the B side of the NAD(+) or NADP(+) ring structure.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061086"}, {"RECTYPE": "D", "MH": "NADP Transhydrogenase, AB-Specific", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pyridine nucleotide transhydrogenase, AB Specific", "MN": "D08.811.682.608.540.500", "MH_TH": "NLM (2012)", "ST": "T126", "RN": "EC 1.6.1.2", "PI": "NADP Transhydrogenases (1978-2011)", "MS": "A NADP transhydrogenase subtype found in certain types of BACTERIA and mammalian MITOCHONDRIA. This transhydrogenase uses a mechanism that can transfer hydrogen to either side, A or B, of the NAD(+) or NADP(+) ring structure. In heart mitochondria, the enzyme is A-specific with respect to NAD(+) and B-specific with respect to NADP(+).", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061087"}, {"RECTYPE": "D", "MH": "Photoacoustic Techniques", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Technology, Photoacoustic", "MN": "E05.696", "MH_TH": "NLM (2012)", "ST": "T060", "AN": "coordinate with specific investigative or diagnostic technique (DIAGNOSTIC IMAGING; MICROSCOPY; TOMOGRAPHY; etc.) if pertinent", "MS": "Investigative and diagnostic methods and procedures based on the photoacoustic effect, which is the generation of SOUND WAVES from the absorption of ELECTROMAGNETIC RADIATION.", "PM": "2012", "HN": "2012", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D061088"}, {"RECTYPE": "D", "MH": "Radiotherapy, Image-Guided", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Image-Guided Radiation", "MN": "E02.815.768", "FX": "Patient Positioning", "MH_TH": "NLM (2012)", "ST": "T061", "PI": "Radiotherapy or specifics (2002-2011)", "MS": "The use of pre-treatment imaging modalities to position the patient, delineate the target, and align the beam of radiation to achieve optimal accuracy and reduce radiation damage to surrounding non-target tissues.", "PM": "2012", "HN": "2012", "MR": "20120703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061089"}, {"RECTYPE": "D", "MH": "Peroxiredoxin III", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Thioredoxin Dependent Peroxide Reductase, Mitochondrial", "MN": "D12.776.575.812", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 1.11.1.15", "PI": "Peroxiredoxins (2003-2011)", "MS": "A THIOREDOXIN-dependent hydroperoxidase that is localized in the mitochondrial matrix. The enzyme plays a crucial role in protecting mitochondrial components from elevated levels of HYDROGEN PEROXIDE.", "PM": "2012; see PEROXIREDOXINS 2003-2011; PEROXIREDOXIN III was indexed under PEROXIDASES 2002-2007", "HN": "2012; use PEROXIREDOXINS 2003-2011", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061105"}, {"RECTYPE": "D", "MH": "Radiotherapy Setup Errors", "AQ": "AE CL EC ES HI LJ MO NU PC PX SN TD VE", "ENTRY": "Setup Errors, Radiotherapy", "MN": "N02.421.450.800", "FX": "Organs at Risk", "MH_TH": "NLM (2012)", "ST": "T080", "MS": "Mistakes committed in the preparations for radiotherapy, including errors in positioning of patients, alignment radiation beams, or calculation of radiation doses.", "PM": "2012", "HN": "2012", "MR": "20180629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061106"}, {"RECTYPE": "D", "MH": "Nucleoside Diphosphate Kinase D", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NM23 M4 Nucleoside Diphosphate Kinase", "MN": "D12.776.575.781", "MH_TH": "NLM (2008)", "ST": "T126", "RN": "EC 2.7.4.6", "PI": "NM23 Nucleoside Diphosphate Kinases (2004-2011)", "MS": "A nucleoside diphosphate kinase subtype that is localized to the intermembrane space of MITOCHONDRIA. It is believed to play a role in the synthesis of triphosphonucleotides using ATP formed through OXIDATIVE PHOSPHORYLATION.", "PM": "2012; see NM23 NUCLEOSIDE DIPHOSPHATE KINASES 2004-2011", "HN": "2012; use NM23 NUCLEOSIDE DIPHOSPHATE KINASES 2004-2011", "MR": "20130709", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061107"}, {"RECTYPE": "D", "MH": "Social Media", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "PRINT ENTRY": "Social Tagging|T052|NON|REL|NLM (2024)|221019|abcdef", "ENTRY": "Web 2.0s", "MN": "L01.462.500.751", "MH_TH": "NLM (2012)", "ST": "T052", "MS": "Platforms that provide the ability and tools to create and publish information accessed via the INTERNET. Generally these platforms have three characteristics with content user generated, high degree of interaction between creator and viewer, and easily integrated with other sites.", "PM": "2012", "HN": "2012; use INTERNET for TWITTER MESSAGING 1999-2015", "MR": "20230531", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061108"}, {"RECTYPE": "D", "MH": "Genes, Chloroplast", "AQ": "DE GE IM PH RE", "ENTRY": "Gene, Chloroplast", "MN": "G05.420.275.249", "FX": "DNA, Chloroplast", "MH_TH": "NLM (2012)", "ST": "T028", "PI": "Chloroplasts (1974-2011)", "MS": "Those nucleic acid sequences that function as units of heredity which are located within the CHLOROPLAST DNA.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061125"}, {"RECTYPE": "D", "MH": "Microvascular Decompression Surgery", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgery, Microvascular Decompression", "MN": "E04.525.500", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "Surgery performed to relieve pressure from MICROVESSELS that are located around nerves and are causing NERVE COMPRESSION SYNDROMES.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061145"}, {"RECTYPE": "D", "MH": "Chlorophyll Binding Proteins", "AQ": "AD AE AG AI AN BI CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL", "ENTRY": "Proteins, Fucoxanthin Chlorophyll", "MN": "D12.776.765.199.750.750.490.500", "MH_TH": "NLM (2004)", "ST": "T123", "RN": "0", "PI": "Light-Harvesting Protein Complexes (2004-2011)", "MS": "A large family of proteins that have been traditionally classified as the light-harvesting proteins of the photosynthetic reaction complex. Chlorophyll binding proteins are also found in non-photosynthetic settings where they may play a photoprotective role in response to light stress.", "PM": "2012; see LIGHT-HARVESTING PROTEIN COMPLEXES 2004-2011; for CHLOROPHYLL AB-PROTEINS, CHLOROPHYL A-PROTEINS, CHLOROPHYLL AC-PROTEINS and LIGHT-HARVESTING CHLOROPHYLL PROTEIN see LIGHT-HARVESTING PROTEIN COMPLEXES 2004-2011 and PHOTOSYNTHETIC REACTION CENTER, PLANT 1991-2003", "HN": "2012; use LIGHT-HARVESTING PROTEIN COMPLEXES 2004-2011; for CHLOROPHYLL AB-PROTEINS, CHLOROPHYL A-PROTEINS, and CHLOROPHYLL AC-PROTEINS, use LIGHT-HARVESTING PROTEIN COMPLEXES 2004-2011 and PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1991-2003", "MR": "20160115", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061146"}, {"RECTYPE": "D", "MH": "Therapy with Helminths", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Helminthic Therapy|T061|NON|EQV|NLM (2012)|110407|abcdef", "ENTRY": "Therapy, Helminthic", "MN": "E02.960", "FX": "Hygiene Hypothesis", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "The treatment of immune system diseases by deliberate infestation with helminths. This therapy is partly based on the HYGIENE HYPOTHESIS which states that the absence of parasites increases immune dysregulation because of the lack of stimulation of REGULATORY T-CELLS.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061147"}, {"RECTYPE": "D", "MH": "Hygiene Hypothesis", "AQ": "HI", "ENTRY": "Hypothesis, Hygiene", "MN": "K01.752.667.875", "FX": "Therapy with Helminths", "MH_TH": "NLM (2012)", "ST": "T170", "MS": "The theory that infectious agents, symbiotic microorganisms, and parasites are normal stimulants for the maturation of the immune system toward a balanced immune response. The theory predicts that lack of such stimulation leads to allergies and AUTOIMMUNE DISEASES.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061148"}, {"RECTYPE": "D", "MH": "Thysanoptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Thrips|T204|NON|EQV|NLM (2012)|110407|abcdef", "MN": "B01.050.500.131.617.800", "MH_TH": "NLM (2012)", "ST": "T204", "RN": "txid30262", "AN": "for killing THYSANOPTERA with insecticides, see note at INSECTICIDES", "PI": "Insects (1966-2011)", "MS": "An order of very small, fringed-wing INSECTS including many agricultural pests.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061149"}, {"RECTYPE": "D", "MH": "Glenoid Cavity", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Fossas, Glenoid", "MN": "A02.835.232.087.783.450", "MH_TH": "NLM (2012)", "ST": "T023", "PI": "Scapula (1963-2011)", "MS": "A depression in the lateral angle of the scapula that articulates with the HUMERAL HEAD.", "PM": "2012", "HN": "2012", "MR": "20180629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061165"}, {"RECTYPE": "D", "MH": "Peripheral Tolerance", "AQ": "DE GE IM PH RE", "ENTRY": "Tolerance, Peripheral", "MN": "G12.535.425.800.600", "MH_TH": "NLM (2012)", "ST": "T042", "PI": "Immune Tolerance (1989-2011)", "MS": "The mechanism, in peripheral lymphoid organs (LYMPH NODES; SPLEEN; TONSILS; and mucosal-associated lymphoid tissue), that prevents mature lymphocytes from reacting to SELF-ANTIGENS. This is accomplished through a variety of means including CLONAL ANERGY and CLONAL DELETION.", "PM": "2012", "HN": "2012", "MR": "20160623", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061166"}, {"RECTYPE": "D", "MH": "Central Tolerance", "AQ": "DE GE IM PH RE", "ENTRY": "Tolerance, Central", "MN": "G12.535.425.800.200", "MH_TH": "NLM (2012)", "ST": "T042", "PI": "Self Tolerance (1998-2011)", "MS": "The mechanism, in central lymphoid organs (THYMUS; BONE MARROW), that prevents immature lymphocytes from reacting to SELF-ANTIGENS. This is accomplished by CLONAL ANERGY and CLONAL DELETION.", "PM": "2012", "HN": "2012", "MR": "20160616", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061167"}, {"RECTYPE": "D", "MH": "Mechanical Thrombolysis", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Thrombolysis, Mechanical", "MN": "E04.100.814.842.500", "FX": "Thrombolytic Therapy", "MH_TH": "NLM (2012)", "ST": "T061", "AN": "coordinate with disease/ ther", "MS": "Procedures to cause the disintegration of THROMBI by physical interventions.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061185"}, {"RECTYPE": "D", "MH": "Breast Milk Expression", "AQ": "AE EC EH ES HI IS MT PX SN TD", "ENTRY": "Pumpings, Breast", "MN": "G07.203.650.353.199.500", "FX": "Milk Ejection", "MH_TH": "NLM (2012)", "ST": "T055", "AN": "coordinate with BOTTLE FEEDING if pertinent", "MS": "The act of evacuating BREAST MILK by hand or with a pump.", "PM": "2012", "HN": "2012", "MR": "20180629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061186"}, {"RECTYPE": "D", "MH": "Vascular Calcification", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vascular Calcinoses", "MN": "C18.452.174.130.780", "MH_TH": "NLM (2012)", "ST": "T046", "PI": "Calcinosis (1964-2011)", "MS": "Deposition of calcium into the blood vessel structures. Excessive calcification of the vessels is associated with ATHEROSCLEROTIC PLAQUES formation particularly after MYOCARDIAL INFARCTION (see MONCKEBERG MEDIAL CALCIFIC SCLEROSIS) and chronic kidney diseases which in turn increase VASCULAR STIFFNESS.", "PM": "2012", "HN": "2012", "MR": "20211018", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061205"}, {"RECTYPE": "D", "MH": "Neoplasm Micrometastasis", "AQ": "DG DI DT GE IM PA PC PP RT TH UL", "ENTRY": "Neoplasm Micrometastase", "MN": "C23.550.727.650.695", "MH_TH": "NLM (2012)", "ST": "T191", "PI": "Neoplasm Metastasis (1976-2011)", "MS": "Newly arising secondary tumors so small they are difficult to detect by physical examination or routine imaging techniques.", "PM": "2012", "HN": "2012", "MR": "20160601", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061206"}, {"RECTYPE": "D", "MH": "Calcium Ionophores", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Calcium Ionophore|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Ionophores, Calcium", "MN": "D27.720.395.100", "MH_TH": "NLM (2012)", "ST": "T121", "RN": "0", "PI": "Ionophores (1976-2011)", "MS": "Chemical agents that increase the permeability of CELL MEMBRANES to CALCIUM ions.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061207"}, {"RECTYPE": "D", "MH": "Pulsed Radiofrequency Treatment", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Treatments, Pulsed Radiofrequency", "MN": "E02.831.535.468.599", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "The application, often via IMPLANTED ELECTRODES, of short bursts of electrical energy in the radiofrequency range, interspersed with pauses in delivery of the current long enough to dissipate the generated heat and avoid heat-induced tissue necrosis.", "PM": "2012", "HN": "2012", "MR": "20180702", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061208"}, {"RECTYPE": "D", "MH": "Proton Ionophores", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ionophores, Proton", "MN": "D27.720.395.500", "MH_TH": "NLM (2012)", "ST": "T121", "RN": "0", "PI": "Ionophores (1976-2011)", "MS": "Chemical agents that increase the permeability of CELL MEMBRANES to PROTONS.", "PM": "2012", "HN": "2012", "MR": "20140625", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061209"}, {"RECTYPE": "D", "MH": "Sodium Ionophores", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ionophores, Sodium", "MN": "D27.720.395.750", "MH_TH": "NLM (2012)", "ST": "T121", "RN": "0", "PI": "Ionophores (1976-2011)", "MS": "Chemical agents that increase the permeability of CELL MEMBRANES to SODIUM ions.", "PM": "2012", "HN": "2012", "MR": "20140625", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061210"}, {"RECTYPE": "D", "MH": "Memory, Episodic", "PRINT ENTRY": "Episodic Memory|T041|NON|EQV|NLM (2010)|090429|abcdef", "ENTRY": "Prospective Memories", "MN": "F02.463.425.540.254", "MH_TH": "NLM (2012)", "ST": "T041", "PI": "Mental Recall (2010-2011)", "MS": "Type of declarative memory, consisting of personal memory in contrast to general knowledge.", "PM": "2012; see MENTAL RECALL 2010-2011", "HN": "2012; use MENTAL RECALL 2010-2011", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061212"}, {"RECTYPE": "D", "MH": "Mortality, Premature", "DE": "MORTAL PREMATURE", "AQ": "EH HI TD", "PRINT ENTRY": "Premature Mortality|T081|NON|EQV|NLM (1995)|940315|PREMATURE MORTAL|abcdefv", "ENTRY": "Premature Mortalities", "MN": "N06.850.520.308.985.550.550", "FX": "Life Expectancy", "MH_TH": "NLM (1995)", "ST": "T081", "PI": "Mortality (1963-2011)", "MS": "Deaths that occur before LIFE EXPECTANCY is reached within a given population.", "PM": "2012; see Mortality 1995-2011", "HN": "2012; use Mortality 1995-2011", "MR": "20170703", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061213"}, {"RECTYPE": "D", "MH": "Patient Safety", "AQ": "EC HI LJ SN ST", "ENTRY": "Safety, Patient", "MN": "N06.850.135.060.075.399", "MH_TH": "NLM (2012)", "ST": "T068", "MS": "Efforts to reduce risk, to address and reduce incidents and accidents that may negatively impact healthcare consumers.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061214"}, {"RECTYPE": "D", "MH": "Energy Drinks", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "ENTRY": "Energy Drink", "MN": "J02.200.512", "MH_TH": "NLM (2012)", "ST": "T168", "PI": "Beverages (1996-2011)", "MS": "Beverages that contain stimulants such as a combination of CAFFEINE with other substances such as VITAMINS; AMINO ACIDS; and sugar or sugar derivatives.", "PM": "2012", "HN": "2012", "MR": "20190708", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061215"}, {"RECTYPE": "D", "MH": "Potassium Ionophores", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Potassium Ionophore|T121|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Ionophores, Potassium", "MN": "D27.720.395.400", "MH_TH": "NLM (2012)", "ST": "T121", "RN": "0", "PI": "Ionophores (1976-2011)", "MS": "Chemical agents that increase the permeability of CELL MEMBRANES to POTASSIUM ions.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061216"}, {"RECTYPE": "D", "MH": "Weight Reduction Programs", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Weight Reduction Program", "MN": "N02.421.726.407.579.650", "FX": "Diet, Reducing", "MH_TH": "NLM (2012)", "ST": "T058", "PI": "Weight Loss (1989-2011)", "MS": "Services providing counseling and activities that help overweight individuals to attain a more healthy body weight.", "PM": "2012", "HN": "2012", "MR": "20170713", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061217"}, {"RECTYPE": "D", "MH": "Depressive Disorder, Treatment-Resistant", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Treatment-Resistant Depressive Disorders", "MN": "F03.600.300.388", "MH_TH": "NLM (2012)", "ST": "T048", "PI": "Depressive Disorder (1981-2011)", "MS": "Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)", "PM": "2012", "HN": "2012", "MR": "20150708", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061218"}, {"RECTYPE": "D", "MH": "Olfactory Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Olfactory Nerve Injury|T037|NON|EQV|NLM (2012)|110414|abcdef", "ENTRY": "Traumatic Olfactory Neuropathy", "MN": "C26.915.300.400.562", "MH_TH": "NLM (2012)", "ST": "T037", "PI": "Olfactory Nerve/injuries (1989-2011)", "MS": "Traumatic injuries to the OLFACTORY NERVE. It may result in various olfactory dysfunction including a complete loss of smell.", "PM": "2012", "HN": "2012", "MR": "20180630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061219"}, {"RECTYPE": "D", "MH": "Oculomotor Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Oculomotor Nerve Injury|T037|NON|EQV|NLM (2012)|110414|abcdef", "ENTRY": "Traumatic Third-Nerve Palsies", "MN": "C26.915.300.400.518", "MH_TH": "NLM (2012)", "ST": "T037", "MS": "Traumatic injuries to the OCULOMOTOR NERVE. This may result in various eye movement dysfunction.", "PM": "2012", "HN": "2012", "MR": "20220419", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061220"}, {"RECTYPE": "D", "MH": "Trigeminal Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Trigeminal Neuropathies, Traumatic", "MN": "C26.915.300.400.825", "MH_TH": "NLM (2012)", "ST": "T037", "PI": "Trigeminal Nerve (1992-2011)", "MS": "Traumatic injuries to the TRIGEMINAL NERVE. It may result in extreme pain, abnormal sensation in the areas the nerve innervates on face, jaw, gums and tongue and can cause difficulties with speech and chewing. It is sometimes associated with various dental treatments.", "PM": "2012", "HN": "2012", "MR": "20180630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061221"}, {"RECTYPE": "D", "MH": "Lingual Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Transections, Lingual Nerve", "MN": "C26.915.300.400.825.500", "MH_TH": "NLM (2012)", "ST": "T037", "PI": "Lingual Nerve (1971-2011)", "MS": "Traumatic injuries to the LINGUAL NERVE. It may be a complication following dental treatments.", "PM": "2012", "HN": "2012", "MR": "20180630", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D061222"}, {"RECTYPE": "D", "MH": "Vagus Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vagus Neuropathies, Traumatic", "MN": "C26.915.300.400.912", "MH_TH": "NLM (2012)", "ST": "T037", "MS": "Traumatic injuries to the VAGUS NERVE. Because the vagus nerve innervates multiple organs, injuries in the nerve fibers may result in any gastrointestinal organ dysfunction downstream of the injury site.", "PM": "2012", "HN": "2012", "MR": "20180630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061223"}, {"RECTYPE": "D", "MH": "Laryngeal Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Traumatic Laryngeal Neuropathy", "MN": "C26.915.300.400.912.750", "MH_TH": "NLM (2012)", "ST": "T037", "MS": "Traumatic injuries to the LARYNGEAL NERVE.", "PM": "2012", "HN": "2012", "MR": "20180630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061224"}, {"RECTYPE": "D", "MH": "Recurrent Laryngeal Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Recurrent Laryngeal Neuropathy, Traumatic|T037|NON|EQV|NLM (2012)|110415|abcdef", "MN": "C26.915.300.400.912.750.500", "MH_TH": "NLM (2012)", "ST": "T037", "MS": "Traumatic injuries to the RECURRENT LARYNGEAL NERVE that may result in vocal cord dysfunction.", "PM": "2012", "HN": "2012", "MR": "20180630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061226"}, {"RECTYPE": "D", "MH": "Accessory Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Traumatic Eleventh-Nerve Palsies", "MN": "C26.915.300.400.200", "MH_TH": "NLM (2012)", "ST": "T037", "MS": "Traumatic injuries to the ACCESSORY NERVE. Damage to the nerve may produce weakness in head rotation and shoulder elevation.", "PM": "2012", "HN": "2012", "MR": "20180630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061227"}, {"RECTYPE": "D", "MH": "Hypoglossal Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Twelfth-Nerve Traumas", "MN": "C26.915.300.400.387", "MH_TH": "NLM (2012)", "ST": "T037", "MS": "Traumatic injuries to the HYPOGLOSSAL NERVE.", "PM": "2012", "HN": "2012", "MR": "20180630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061228"}, {"RECTYPE": "D", "MH": "Axenic Culture", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Cultures, Axenic", "MN": "E05.481.500.124", "FX": "Germ-Free Life", "MH_TH": "NLM (2012)", "ST": "T062", "MS": "Culture of an isolated organism free from any other associating or contaminating organisms.", "PM": "2012", "HN": "2012", "MR": "20150623", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061245"}, {"RECTYPE": "D", "MH": "Trochlear Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Trochlear Neuropathies, Traumatic", "MN": "C26.915.300.400.868", "MH_TH": "NLM (2012)", "ST": "T037", "MS": "Traumatic injuries to the TROCHLEAR NERVE.", "PM": "2012", "HN": "2012", "MR": "20180630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061247"}, {"RECTYPE": "D", "MH": "Batch Cell Culture Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Batch Culture Techniques|T059|T062|NON|EQV|NLM (2012)|110415|abbcdef", "ENTRY": "Techniques, Fed-Batch Culture", "MN": "E05.481.500.249.124", "FX": "Bioreactors", "MH_TH": "NLM (2012)", "ST": "T062", "MS": "Methods for cultivation of cells, usually on a large-scale, in a closed system for the purpose of producing cells or cellular products to harvest.", "PM": "2012", "HN": "2012", "MR": "20160701", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061249"}, {"RECTYPE": "D", "MH": "Transferrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.556.579.750", "MH_TH": "NLM (2012)", "ST": "T123", "RN": "0", "AN": "TRANSFERRIN is also available", "MS": "A group of iron-binding proteins that tightly bind two ferrate ions along with two carbonate ions. They are found in the bodily fluids of vertebrates where they act as transport and storage molecules for iron.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061250"}, {"RECTYPE": "D", "MH": "Primary Cell Culture", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Primary Cell Cultures", "MN": "E05.481.500.249.500", "MH_TH": "NLM (2005)", "ST": "T062", "PI": "Cells, Cultured (1972-2011)", "MS": "The initial culturing of cells derived directly from fresh TISSUES.", "PM": "2012; see CELL CULTURE TECHNIQUES 2005-2011", "HN": "2012; use CELL CULTURE TECHNIQUES 2005-2011", "MR": "20150706", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061251"}, {"RECTYPE": "D", "MH": "Feeder Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Layers, Feeder Cell", "MN": "A11.251.538", "MH_TH": "NLM (2012)", "ST": "T025", "PI": "Cells, Cultured or specifics (1972-2011)", "MS": "Cells used in COCULTURE TECHNIQUES which support the growth of the other cells in the culture. Feeder cells provide auxillary substances including attachment substrates, nutrients, or other factors that are needed for growth in culture.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061252"}, {"RECTYPE": "D", "MH": "Biphasic Insulins", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Biphasic Insulin|T116|T121|NON|EQV|NLM (2012)|110418|abbcdef", "ENTRY": "Insulins, Mixed", "MN": "D26.310.249", "PA": "Hypoglycemic Agents", "EC": "antagonists & inhibitors:Insulin Antagonists", "MH_TH": "NLM (2012)", "ST": "T121", "RN": "0", "PI": "Insulin, Long-Acting (1982-2011)", "MS": "An insulin preparation that is designed to provide immediate and long term glycemic control in a single dosage. Biphasic insulin typically contains a mixture of REGULAR INSULIN or SHORT-ACTING INSULIN combined with a LONG-ACTING INSULIN.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061265"}, {"RECTYPE": "D", "MH": "Insulin, Short-Acting", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Short-Acting Insulin", "MN": "D12.644.548.586.200.400", "PA": "Hypoglycemic Agents", "EC": "antagonists & inhibitors:Insulin Antagonists", "MH_TH": "NLM (2012)", "ST": "T121", "RN": "0", "PI": "Insulin (1965-2011)", "MS": "Insulin derivatives and preparations that are designed to induce a rapid HYPOGLYCEMIC EFFECT.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061266"}, {"RECTYPE": "D", "MH": "Insulin Aspart", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Insulin-Aspart|T116|T121|NON|EQV|NLM (2012)|110418|abbcdef", "ENTRY": "B28asp, Insulin", "MN": "D12.644.548.586.200.400.100", "PA": "Hypoglycemic Agents", "EC": "antagonists & inhibitors:Insulin Antagonists", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "D933668QVX", "MS": "Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.", "PM": "2012; INSULIN ASPART was indexed under INSULIN 1991-2011", "HN": "2012(1991)", "MR": "20160701", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061267"}, {"RECTYPE": "D", "MH": "Insulin Lispro", "AQ": "AA AD AE BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Lispro, Insulin", "MN": "D12.644.548.586.200.400.500", "PA": "Hypoglycemic Agents", "EC": "antagonists & inhibitors:Insulin Antagonists", "MH_TH": "NLM (2012)", "ST": "T121", "RN": "0", "MS": "Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.", "PM": "2012; INSULIN LISPRO was indexed under INSULIN 1995-2011", "HN": "2012(1995)", "MR": "20150526", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061268"}, {"RECTYPE": "D", "MH": "DNA Transformation Competence", "AQ": "DE GE IM PH RE", "ENTRY": "Transformation Competence, DNA", "MN": "G06.099.850.500", "MH_TH": "NLM (2012)", "ST": "T080", "PI": "Transformation, Genetic or specifics(1976-2011)", "MS": "The ability of bacterial cells to take up exogenous DNA and be genetically transformed by it.", "PM": "2012", "HN": "2012", "MR": "20160617", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061269"}, {"RECTYPE": "D", "MH": "Nasal Septal Perforation", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Septum Perforations, Nasal", "MN": "C26.670", "MH_TH": "NLM (2012)", "ST": "T033", "PI": "Nose Diseases (1967-2011)", "MS": "An opening or hole in the NASAL SEPTUM that is caused by TRAUMA, injury, drug use, or pathological process.", "PM": "2012", "HN": "2012", "MR": "20160602", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061270"}, {"RECTYPE": "D", "MH": "Acidobacteria", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.400.050", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid57723", "PI": "Bacteria (2000-2011)", "MS": "A physiologically diverse phylum of acidophilic, gram-negative bacteria found in a wide variety of habitats, but particularly abundant in soils and sediments.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061271"}, {"RECTYPE": "D", "MH": "Vestibulocochlear Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vestibulocochlear Neuropathies, Traumatic", "MN": "C26.915.300.400.956", "MH_TH": "NLM (2012)", "ST": "T037", "MS": "Traumatic injuries to the VESTIBULOCOCHLEAR NERVE.", "PM": "2012", "HN": "2012", "MR": "20180630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061285"}, {"RECTYPE": "D", "MH": "Osmometry", "AQ": "CL EC ES HI IS MT SN ST TD VE", "MN": "E05.196.690", "MH_TH": "NLM (2012)", "ST": "T059", "PI": "Osmolar Concentration (1968-2011)", "MS": "Measurement of the OSMOLARITY of solutions or BODY FLUIDS.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061286"}, {"RECTYPE": "D", "MH": "Glossopharyngeal Nerve Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Traumatic Ninth-Nerve Palsies", "MN": "C26.915.300.400.343", "MH_TH": "NLM (2012)", "ST": "T037", "MS": "Traumatic injuries to the GLOSSOPHARYNGEAL NERVE.", "PM": "2012", "HN": "2012", "MR": "20180630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061287"}, {"RECTYPE": "D", "MH": "Lymphoscintigraphy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Lymphoscintigraphies", "MN": "E01.370.384.730.176", "MH_TH": "NLM (2012)", "ST": "T060", "PI": "Lymphatic System/radionuclide imaging or specifics (1978-2011)", "MS": "Radionuclide imaging of the LYMPHATIC SYSTEM.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061305"}, {"RECTYPE": "D", "MH": "Fibrobacteres", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.305", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid65842", "MS": "A phylum of gram-negative bacteria closely related to the BACTEROIDETES. Species have been found in the gastrointestinal tracts of animals, especially termites, though indications are that species are more broadly distributed in other environments.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061306"}, {"RECTYPE": "D", "MH": "Human Umbilical Vein Endothelial Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Human Umbilical Vein Endothelial Cell|T025|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "HUVEC Cell", "MN": "A11.436.275.682", "FX": "Cells, Cultured", "MH_TH": "NLM (2012)", "ST": "T025", "MS": "Endothelial cells that line venous vessels of the UMBILICAL CORD.", "PM": "2012", "HN": "2012", "MR": "20200527", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061307"}, {"RECTYPE": "D", "MH": "Hereditary Breast and Ovarian Cancer Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, HBOC", "MN": "C19.391.630.705.431", "FX": "BRCA2 Protein", "MH_TH": "NLM (2012)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM) if pertinent", "PI": "Ovarian Neoplasms (1989-2011)", "MS": "Autosomal dominant HEREDITARY CANCER SYNDROME in which a mutation most often in either BRCA1 or BRCA2 is associated with a significantly increased risk for breast and ovarian cancers.", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061325"}, {"RECTYPE": "D", "MH": "Index of Orthodontic Treatment Need", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Index of Orthodontic Treatment Needs|T062|NON|EQV|NLM (2012)|110420|abcdef", "MN": "N06.890.160.134", "MH_TH": "NLM (2012)", "ST": "T062", "PI": "Malocclusion (1975-2011)", "MS": "A dental health survey developed to evaluate a patient's orthodontic treatment need and priority for orthodontic care. The index is based on an assessment of degree of MALOCCLUSION and the potential aesthetic and dental health benefit of the treatment under consideration.", "PM": "2012", "HN": "2012", "MR": "20170630", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D061326"}, {"RECTYPE": "D", "MH": "Verrucomicrobia", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.930", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid74201", "MS": "A phylum of gram-negative bacteria containing seven class-level groups from a wide variety of environments. Most members are chemoheterotrophs.", "PM": "2012", "HN": "2012", "MR": "20200813", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061327"}, {"RECTYPE": "D", "MH": "Planctomycetales", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.440.619.500", "MH_TH": "NLM (2012)", "ST": "T007", "RN": "txid112", "PI": "Bacteria (1995-2011)", "MS": "A order of gram-negative bacteria whose members are found in a variety of aquatic habitats as well as animal hosts.", "PM": "2012", "HN": "2012", "MR": "20210630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061328"}, {"RECTYPE": "D", "MH": "Oil and Gas Fields", "AQ": "CH MI PS VI", "ENTRY": "Wells, Oil", "MN": "G01.311.687", "FX": "Petroleum", "MH_TH": "NLM (2012)", "ST": "T070", "PI": "Petroleum (1971-2011)", "MS": "Areas of the earth where hydrocarbon deposits of PETROLEUM and/or NATURAL GAS are located.", "PM": "2012", "HN": "2012", "MR": "20140630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061329"}, {"RECTYPE": "D", "MH": "Multidetector Computed Tomography", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tomography, Multislice Computed", "MN": "E01.370.350.825.810.810.800.249", "MH_TH": "NLM (2012)", "ST": "T060", "MS": "Types of spiral computed tomography technology in which multiple slices of data are acquired simultaneously improving the resolution over single slice acquisition technology.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061330"}, {"RECTYPE": "D", "MH": "Early Medical Intervention", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Medical Interventions, Early", "MN": "N02.421.726.363", "MH_TH": "NLM (2012)", "ST": "T061", "AN": "EARLY INTERVENTION (EDUCATION) is also available", "MS": "Action taken to reduce susceptibility or exposure to health problems and to detect and treat disease in early stages.", "PM": "2012", "HN": "2012", "MR": "20150629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061345"}, {"RECTYPE": "D", "MH": "Laser Capture Microdissection", "AQ": "AE CL EC ED ES HI IS LJ MO MT SN ST TD VE", "ENTRY": "Microdissections, Laser Capture", "MN": "E05.591.560.500", "MH_TH": "NLM (2012)", "ST": "T062", "PI": "Microdissection (2003-2011)", "MS": "Techniques using a laser to cut away and harvest a specific cell or cluster of cells from a tissue section while viewing it under the microscope.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061346"}, {"RECTYPE": "D", "MH": "Forgiveness", "AQ": "CL DE ES GE PH RE", "ENTRY": "Forgivenesses", "MN": "F01.829.401.166", "MH_TH": "NLM (2012)", "ST": "T053", "MS": "Excusing or pardoning for an offense or release of anger or resentment.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061347"}, {"RECTYPE": "D", "MH": "Medical Chaperones", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Patient Chaperone", "MN": "N02.360.500", "MH_TH": "NLM (2012)", "ST": "T097", "MS": "Individuals who are present as a third party during medical encounters such as physical examination by a healthcare professional of an individual of the opposite sex.", "PM": "2012", "HN": "2012", "MR": "20180629", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061348"}, {"RECTYPE": "D", "MH": "Unrelated Donors", "AQ": "CL ED ES HI LJ PX SD SN", "ENTRY": "Unrelated Donor", "MN": "M01.898.828", "MH_TH": "NLM (2012)", "ST": "T098", "PI": "Tissue Donors (1990-2011)", "MS": "Providers of tissues for transplant to non-related individuals.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061349"}, {"RECTYPE": "D", "MH": "Sympatry", "AQ": "DE GE IM PH RE", "ENTRY": "Sympatries", "MN": "G05.910", "MH_TH": "NLM (2012)", "ST": "T070", "AN": "for sympatric speciation, coordinate with GENETIC SPECIATION", "MS": "In evolutionary theory, overlapping geographic distribution of diverging species. In sympatric GENETIC SPECIATION, genetic diversion occurs without geographic separation.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061350"}, {"RECTYPE": "D", "MH": "Telescopes", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Telescope", "MN": "E07.632.875", "MH_TH": "NLM (2012)", "ST": "T073", "MS": "Instruments used to observe distant objects.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061351"}, {"RECTYPE": "D", "MH": "Pasteurization", "AQ": "CL EC ES HI IS LJ MT SN ST", "ENTRY": "Ultrapasteurizations", "MN": "J01.576.423.850.700.700", "FX": "Sterilization", "MH_TH": "NLM (2012)", "ST": "T061", "MS": "Treatment of food with physical methods such as heat, high pressure, radiation, or electric current to destroy organisms that cause disease or food spoilage.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061352"}, {"RECTYPE": "D", "MH": "Food Storage", "AQ": "CL EC ES HI IS LJ MT SN ST", "ENTRY": "Storage, Food", "MN": "J01.576.423.200.387", "FX": "Food Supply", "MH_TH": "NLM (2012)", "ST": "T070", "MS": "Keeping food for later consumption.", "PM": "2012", "HN": "2012", "MR": "20160630", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061353"}, {"RECTYPE": "D", "MH": "Acinar Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Cells, Acinus", "MN": "A11.031", "MH_TH": "NLM (2012)", "ST": "T025", "MS": "Cells lining the saclike dilatations known as acini of various glands or the lungs.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061354"}, {"RECTYPE": "D", "MH": "Amish", "AQ": "CL ED GE HI LJ PX SN", "MN": "M01.270.750", "MH_TH": "NLM (2012)", "ST": "T098", "PI": "Ethnic Groups (1968-2011)", "MS": "An ethnic group with shared religious beliefs in PROTESTANTISM. Originating in Switzerland in the late 1600s, and first migrating to the mid-Atlantic, they now live throughout Eastern and Mid-Western United States and elsewhere. Communities are usually close-knit and marriage is within the community.", "PM": "2012", "HN": "2012", "MR": "20211119", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061365"}, {"RECTYPE": "D", "MH": "Numbers Needed To Treat", "AQ": "LJ SN ST TD", "ENTRY": "Risk Reductions, Absolute", "MN": "E05.581.500.902.500", "MH_TH": "NLM (2012)", "ST": "T081", "MS": "Number of patients who need to be treated in order to prevent one additional bad outcome. It is the inverse of Absolute Risk Reduction.", "PM": "2012", "HN": "2012", "MR": "20150623", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061366"}, {"RECTYPE": "D", "MH": "Insulins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D12.644.548.586.200", "MH_TH": "NLM (2012)", "ST": "T125", "RN": "0", "AN": "general or unspecified; prefer specifics", "MS": "Peptide hormones that cause an increase in the absorption of GLUCOSE by cells within organs such as LIVER; MUSCLE and ADIPOSE TISSUE. During normal metabolism insulins are produced by the PANCREATIC BETA CELLS in response to increased GLUCOSE. Natural and chemically-modified forms of insulin are also used in the treatment of GLUCOSE METABOLISM DISORDERS such as DIABETES MELLITUS.", "PM": "2012", "HN": "2012", "MR": "20200205", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061385"}, {"RECTYPE": "D", "MH": "Insulin, Regular, Human", "AQ": "AA AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Humulin S|T116|T121|T125|TRD|NRW|IE|NLM (1990)|NLM (2012)|UK|890609|abbbcdeeeef", "MN": "D12.644.548.586.200.500.625.500", "MH_TH": "NLM (2003)", "ST": "T125", "RN": "0", "PI": "Insulin (2003-2011)", "MS": "Regular insulin preparations that contain the HUMAN insulin peptide sequence.", "PM": "2012; see INSULIN 2003-2011", "HN": "2012; use INSULIN 2003-2011", "MR": "20160701", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061386"}, {"RECTYPE": "D", "MH": "Chlamydial Pneumonia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Pneumonias, Chlamydophila", "MN": "C08.730.610.540.249", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Pneumonia (1976-2011)", "MS": "Pneumonia caused by infections with the genus CHLAMYDIA; and CHLAMYDOPHILA, usually with CHLAMYDOPHILA PNEUMONIAE.", "PM": "2012; see PSITTACOSIS 2006-2011; see ORNITHOSIS 1963-2005", "HN": "2012; use PSITTACOSIS 2006-2011; use ORNITHOSIS 1963-2005", "MR": "20190617", "DA": "20110701", "DC": "1", "DX": "20120101", "UI": "D061387"}, {"RECTYPE": "D", "MH": "Firefighters", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Firefighter", "MN": "M01.526.373.400", "MH_TH": "NLM (2012)", "ST": "T097", "PI": "Fires (1974-2011)", "MS": "Professional or volunteer members of a fire department who are trained to suppress fire and respond to related emergency.", "PM": "2012", "HN": "2012", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061388"}, {"RECTYPE": "D", "MH": "Insulin, Regular, Pork", "AQ": "AA AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Insulin, Porcine", "MN": "D12.644.548.586.200.500.625.700", "PA": "Hypoglycemic Agents", "EC": "antagonists & inhibitors:Insulin Antagonists", "MH_TH": "NLM (2003)", "ST": "T125", "RN": "0", "PI": "Insulin (2003-2011)", "MS": "Regular insulin preparations that contain the SUS SCROFA insulin peptide sequence.", "PM": "2012; see INSULIN 2003-2011", "HN": "2012; use INSULIN 2003-2011", "MR": "20160701", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061389"}, {"RECTYPE": "D", "MH": "Insulin, Lente", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Novo Monotard, Insulin", "MN": "D12.644.548.586.200.300.300", "PA": "Hypoglycemic Agents", "EC": "antagonists & inhibitors:Insulin Antagonists", "MH_TH": "NLM (1966)", "ST": "T125", "RN": "8049-62-5", "PI": "Insulin, Long-Acting (1966-2011)", "MS": "An insulin, zinc chloride preparation in the form of a suspension of crystals and amorphous material in a ratio of approximately 7:3. Typically, lente insulin has a duration of activity that lasts between 13-20 hours after dosage.", "PM": "2012; see INSULIN, LONG-ACTING 1966-2011; for INSULIN, LENTE, MONOCOMPONENT see INSULIN, LONG-ACTING 1983-2011; for INSULIN, MONTARD and INSULIN NOVO MONOTARD see INSULIN, LONG-ACTING 1984-2011", "HN": "2012; use INSULIN, LONG-ACTING 1966-2011; for INSULIN, LENTE, MONOCOMPONENT use INSULIN, LONG-ACTING 1983-2011; for INSULIN, MONTARD and INSULIN NOVO MONOTARD use INSULIN, LONG-ACTING 1984-2011", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061405"}, {"RECTYPE": "D", "MH": "Insulin, Ultralente", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Ultralente Insulin|T116|T121|T125|NON|EQV|UNK (19XX)|800801|abbbcdef", "MN": "D12.644.548.586.200.300.800", "PA": "Hypoglycemic Agents", "EC": "antagonists & inhibitors:Insulin Antagonists", "MH_TH": "NLM (2012)", "ST": "T125", "RN": "0", "PI": "Insulin, Long-Acting (1966-2011)", "MS": "A preparation of insulin and zinc chloride in the form of a crystalline suspension. Typically the duration of ultralente insulin activity lasts between 18-30 hours after dosage.", "PM": "2012; see INSULIN, LONG-ACTING 1966-2011", "HN": "2012; use INSULIN, LONG-ACTING 1966-2011", "DA": "20110624", "DC": "1", "DX": "20120101", "UI": "D061406"}, {"RECTYPE": "D", "MH": "Lopinavir", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ABT378", "MN": "D03.383.742.698.553", "PA": "HIV Protease Inhibitors", "MH_TH": "NLM (2012)", "ST": "T121", "RN": "2494G1JF75", "MS": "An HIV protease inhibitor used in a fixed-dose combination with RITONAVIR. It is also an inhibitor of CYTOCHROME P-450 CYP3A.", "PM": "2012; LOPNAVIR was indexed under PYRIMIDINONES 2000-2011", "HN": "2012", "MR": "20160701", "DA": "20110627", "DC": "1", "DX": "20120101", "UI": "D061466"}, {"RECTYPE": "D", "MH": "Tobacco Use Cessation Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Tobacco Use Cessation Products|T074|NON|REL|NLM (2012)|110705|abcdef", "ENTRY": "Transdermal Patch, Nicotine", "MN": "E02.980", "FX": "Tobacco Use Cessation", "MH_TH": "NLM (2019)", "ST": "T074", "MS": "Devices or delivery systems used to aid in ending a TOBACCO habit.", "PM": "2019; see TOBACCO USE CESSATION PRODUCTS 2012-2018; NICOTINE POLACRILEX was indexed under NICOTINE, POLYVINYLS, and POLYMETHACRYLIC ACIDS 1987-2011", "HN": "2019(1968)", "MR": "20230609", "DA": "20110705", "DC": "1", "DX": "20120101", "UI": "D061485"}, {"RECTYPE": "D", "MH": "Cell Surface Display Techniques", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "ENTRY": "Techniques, Phage Display", "MN": "E05.393.420.601.292", "FX": "Peptide Library", "MH_TH": "NLM (2013)", "ST": "T063", "MS": "Techniques utilizing cells that express RECOMBINANT FUSION PROTEINS engineered to translocate through the CELL MEMBRANE and remain attached to the outside of the cell.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061505"}, {"RECTYPE": "D", "MH": "Perforator Flap", "AQ": "AE BS CL EC ES HI IM IR MI PA PH PS SD SN ST SU TD TR VE VI", "ENTRY": "Flaps, Perforator", "MN": "E07.862.710.750", "MH_TH": "NLM (2013)", "ST": "T023", "PI": "Surgical Flaps (1994-2012)", "MS": "A mass of tissue for transplantation that includes the skin and/or the SUBCUTANEOUS FAT, and the perforating blood vessel that traverses the underlying tissue to supply blood to the skin. Perforator flaps are named after the anatomical region or muscle from where they are transplanted and/or the perforating blood vessel.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061525"}, {"RECTYPE": "D", "MH": "Carbonated Water", "AQ": "AD AE AN CL EC HI LJ MI PO PS RE SD SN ST TO TU VI", "ENTRY": "Waters, Sparkling", "MN": "J02.200.418.500", "MH_TH": "NLM (2013)", "ST": "T197", "RN": "0", "MS": "Water naturally or artificially infused with CARBON DIOXIDE.", "PM": "2013", "HN": "2013", "MR": "20190708", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061545"}, {"RECTYPE": "D", "MH": "Cycloaddition Reaction", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Cycloaddition|T059|NON|EQV|NLM (2013)|110720|abcdef", "ENTRY": "Techniques, Cycloaddition Reaction", "MN": "J01.897.836.249.374", "MH_TH": "NLM (2013)", "ST": "T059", "MS": "Synthetic organic reactions that use reactions between unsaturated molecules to form cyclical products.", "PM": "2013", "HN": "2013", "MR": "20160617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061565"}, {"RECTYPE": "D", "MH": "Voltage-Gated Sodium Channels", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Voltage-Gated Sodium Channel|T116|T123|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Voltage Gated Sodium Channels", "MN": "D12.776.631.960", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specifics", "PI": "Sodium Channels (1989-2012)", "MS": "A family of membrane proteins that selectively conduct SODIUM ions due to changes in the TRANSMEMBRANE POTENTIAL DIFFERENCE. They typically have a multimeric structure with a core alpha subunit that defines the sodium channel subtype and several beta subunits that modulate sodium channel activity.", "PM": "2013", "HN": "2013", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061566"}, {"RECTYPE": "D", "MH": "Voltage-Gated Sodium Channel Blockers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Voltage Gated Sodium Channel Inhibitors", "MN": "D27.505.954.411.720.500", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "PI": "Sodium Channels/antagonists & inhibitors (1988-2001)", "MS": "A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061567"}, {"RECTYPE": "D", "MH": "Voltage-Gated Sodium Channel Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Voltage-Gated Sodium Channel Activators|T121|NON|EQV|NLM (2013)|110721|abcdef", "ENTRY": "Voltage Gated Sodium Channel Stimulators", "MN": "D27.505.519.562.625.500", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "PI": "Sodium Channels/agonists (1988-2012)", "MS": "Compounds that either stimulate the opening or prevent closure of VOLTAGE-GATED SODIUM CHANNELS.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061585"}, {"RECTYPE": "D", "MH": "Administration, Intravenous", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Intravenous Administrations", "MN": "E02.319.267.082", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "Delivery of substances through VENIPUNCTURE into the VEINS.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061605"}, {"RECTYPE": "D", "MH": "Immunoreceptor Tyrosine-Based Activation Motif", "AQ": "DE GE IM PH RE", "ENTRY": "Immunoreceptor Tyrosine Based Activation Motif", "MN": "G02.111.570.820.709.275.500.440", "MH_TH": "NLM (2013)", "ST": "T087", "MS": "A conserved AMINO ACID SEQUENCE located in the intracellular domains of a family of transmembrane proteins involved in various IMMUNE RESPONSES. The CONSENSUS SEQUENCE of this motif is YXXL(or I)X(6-8)YXXL(or I) (where X denotes any amino acid). When phosphorylated ITAM motifs provide docking sites for PROTEIN TYROSINE KINASES of the Syk family thus forming signaling complexes which lead to activation of immune responses.", "PM": "2013", "HN": "2013", "MR": "20160705", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061625"}, {"RECTYPE": "D", "MH": "Immunoreceptor Tyrosine-Based Inhibition Motif", "AQ": "DE GE IM PH RE", "ENTRY": "Immunoreceptor Tyrosine Based Inhibition Motif", "MN": "G02.111.570.820.709.275.500.480", "MH_TH": "NLM (2013)", "ST": "T087", "MS": "A conserved AMINO ACID SEQUENCE located in the intracellular domains of a family of transmembrane proteins that negatively regulate the signal transduction processes emanating from transmembrane proteins containing IMMUNORECEPTOR TYROSINE-BASED ACTIVATION MOTIFS. The CONSENSUS SEQUENCE of this motif is I(or V)LXYXXL(or V) (where X denotes any amino acid). Also known as ITIM motifs.", "PM": "2013", "HN": "2013", "MR": "20160705", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061626"}, {"RECTYPE": "D", "MH": "Abdominoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Panniculectomies", "MN": "E04.617.025", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "Surgical removal of excess abdominal skin and fat and tightening of the ABDOMINAL WALL. Abdominoplasty may include LIPECTOMY of INTRA-ABDOMINAL FAT, tightening of the ABDOMINAL MUSCLES, and re-creation of the UMBILICUS.", "PM": "2013", "HN": "2013", "MR": "20220406", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061645"}, {"RECTYPE": "D", "MH": "Operative Time", "ENTRY": "Times, Surgical", "MN": "N02.421.585.753.374.500", "MH_TH": "NLM (2013)", "ST": "T079", "PI": "Time Factors (1981-2012)", "MS": "The duration of a surgical procedure in hours and minutes.", "PM": "2013", "HN": "2013", "MR": "20150629", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061646"}, {"RECTYPE": "D", "MH": "Time-to-Treatment", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Time to Treatment|T079|NON|EQV|NLM (2013)|110804|abcdef", "ENTRY": "Time-to-Treatments", "MN": "N02.421.585.928", "FX": "Treatment Delay", "MH_TH": "NLM (2013)", "ST": "T079", "PI": "Time Factors (1981-2012)", "MS": "The interval of time between onset of symptoms, or suspicion of disease and initiation of therapy; being a combination of wait times for consultative, diagnostic, and treatment services.", "PM": "2013", "HN": "2013", "MR": "20230602", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061665"}, {"RECTYPE": "D", "MH": "Time-to-Pregnancy", "AQ": "DE GE IM PH RE", "ENTRY": "Time-to-Pregnancies", "MN": "G08.686.210.500", "FX": "Reproductive History", "MH_TH": "NLM (2013)", "ST": "T079", "PI": "Time Factors (1986-2012)", "MS": "Time interval, or number of non-contraceptive menstrual cycles that it takes for a couple to conceive.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061685"}, {"RECTYPE": "D", "MH": "Premature Ejaculation", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Premature Ejaculations", "MN": "F03.835.700", "FX": "Ejaculation", "MH_TH": "NLM (2013)", "ST": "T047", "PI": "Ejaculation (1963-2012)", "MS": "The emission of SEMEN and seminal fluid during the act of preparation for sexual intercourse, i.e. before there is penetration, or shortly after penetration.", "PM": "2013", "HN": "2013", "MR": "20230526", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061686"}, {"RECTYPE": "D", "MH": "Image-Guided Biopsy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Imaging Guided Biopsies", "MN": "E05.242.384.100.370", "FX": "Surgery, Computer-Assisted", "MH_TH": "NLM (2013)", "ST": "T061", "AN": "usually NIM with specific organ /pathol + disease /diag and/or /pathol", "PI": "Diagnostic Imaging or specifics (1977-2012)", "MS": "Conducting a biopsy procedure with the aid of a MEDICAL IMAGING modality.", "PM": "2013", "HN": "2013", "MR": "20170321", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061705"}, {"RECTYPE": "D", "MH": "Accelerometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E05.003", "MH_TH": "NLM (2013)", "ST": "T057", "MS": "Qualitative and quantitative measurement of MOVEMENT patterns.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061725"}, {"RECTYPE": "D", "MH": "Antioxidant Response Elements", "AQ": "DE GE IM PH RE", "ENTRY": "Response Elements, Electrophile", "MN": "G05.360.340.024.340.137.750.680.765.040", "FX": "NF-E2-Related Factor 2", "MH_TH": "NLM (2013)", "ST": "T123", "PI": "Response Elements (1999-2012)", "MS": "Nucleotide sequences that are found in the PROMOTER REGIONS of the genes of stress-responsive and cytoprotective proteins, such as those encoding antioxidant and PHASE II DETOXIFICATION enzymes. NF-E2-RELATED FACTOR 2 containing transcription factors bind to these elements during induction of these genes.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061745"}, {"RECTYPE": "D", "MH": "Endoscopic Ultrasound-Guided Fine Needle Aspiration", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Endoscopic Ultrasound Guided Fine Needle Aspiration", "MN": "E05.242.384.100.370.500", "FX": "Rapid On-site Evaluation", "MH_TH": "NLM (2013)", "ST": "T060", "PI": "Biopsy, Fine-Needle (1993-2012)", "MS": "Conducting a fine needle biopsy with the aid of ENDOSCOPIC ULTRASONOGRAPHY.", "PM": "2013", "HN": "2013", "MR": "20210510", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061765"}, {"RECTYPE": "D", "MH": "Proton Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Proton Beam", "MN": "E02.815.250.500", "MH_TH": "NLM (2013)", "ST": "T061", "AN": "coordinate with disease /radiother", "PI": "Protons (1980-2012)", "MS": "The use of an external beam of PROTONS as radiotherapy.", "PM": "2013", "HN": "2013", "MR": "20171208", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061766"}, {"RECTYPE": "D", "MH": "Transcription Initiation, Genetic", "AQ": "DE IM PH RE", "ENTRY": "Initiation, Genetic Transcription", "MN": "G05.297.700.625", "MH_TH": "NLM (2013)", "ST": "T045", "PI": "Transcription, Genetic (1976-2012)", "MS": "The process that starts the transcription of an RNA molecule. It includes the assembly of the initiation complex and establishment of the start site.", "PM": "2013", "HN": "2013", "MR": "20160617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061785"}, {"RECTYPE": "D", "MH": "Transcription Elongation, Genetic", "AQ": "DE IM PH RE", "ENTRY": "Genetic Transcription Elongation", "MN": "G05.297.700.562", "MH_TH": "NLM (2013)", "ST": "T045", "PI": "Transcription, Genetic (1987-2012)", "MS": "The lengthening of a nascent RNA molecule by RNA POLYMERASE during transcription.", "PM": "2013", "HN": "2013", "MR": "20160617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061805"}, {"RECTYPE": "D", "MH": "Transcription Termination, Genetic", "AQ": "DE IM PH RE", "ENTRY": "Termination, Genetic Transcription", "MN": "G05.297.700.687", "MH_TH": "NLM (2013)", "ST": "T045", "PI": "Transcription, Genetic (1974-2012)", "MS": "The discontinuation of transcription at the end of a transcription unit, including the recognition of termination sites and release of the newly synthesized RNA molecule.", "PM": "2013", "HN": "2013", "MR": "20160617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061806"}, {"RECTYPE": "D", "MH": "Catheter Obstruction", "AQ": "AE EC ET SN VE", "ENTRY": "Obstructions, Catheter", "MN": "E07.132.249", "FX": "Catheter-Related Infections", "MH_TH": "NLM (2013)", "ST": "T067", "AN": "coordinate with specific type of catheterization", "MS": "A hindrance to the passage of fluids through a CATHETER.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061807"}, {"RECTYPE": "D", "MH": "Air Filters", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Air Filter|T073|NON|EQV|NLM (2013)|110818|abcdef", "ENTRY": "Purifiers, Air", "MN": "E07.039", "MH_TH": "NLM (2013)", "ST": "T073", "PI": "Filtration (1963-2012)", "MS": "Barriers used to separate and remove PARTICULATE MATTER from air.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061808"}, {"RECTYPE": "D", "MH": "Human Papillomavirus DNA Tests", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Human Papillomavirus DNA Test|T059|T060|NON|EQV|NLM (2022)|200928|abbcdef", "ENTRY": "Tests, HPV DNA", "MN": "E05.393.520.750", "FX": "DNA Probes, HPV", "MH_TH": "NLM (2013)", "ST": "T060", "MS": "Methods for detecting or typing the DNA of an ALPHAPAPILLOMAVIRUS in biological tissues and fluids.", "PM": "2013", "HN": "2013", "MR": "20210630", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061809"}, {"RECTYPE": "D", "MH": "One-Lung Ventilation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Ventilations, Single-Lung", "MN": "E02.041.625.657", "MH_TH": "NLM (2013)", "ST": "T061", "AN": "/instrum: consider also VENTILATORS, MECHANICAL", "PI": "Respiration, Artificial (1975-2012)", "MS": "Techniques for supplying artificial respiration to a single lung.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061810"}, {"RECTYPE": "D", "MH": "Metal-on-Metal Joint Prostheses", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Prostheses, Metal-on-Metal Joint", "MN": "E07.695.400.705", "MH_TH": "NLM (2013)", "ST": "T074", "PI": "Joint Prosthesis (1973-2012)", "MS": "Types of prosthetic joints in which both wear surfaces of the joint coupling are metallic.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061825"}, {"RECTYPE": "D", "MH": "Foot Orthoses", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Supports, Foot Arch", "MN": "E07.858.442.743.659", "MH_TH": "NLM (2013)", "ST": "T074", "PI": "Orthotic Devices (1973-2012)", "MS": "Devices used to support or align the foot structure, or to prevent or correct foot deformities.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061826"}, {"RECTYPE": "D", "MH": "Dimensional Measurement Accuracy", "ENTRY": "Measurement Accuracy, Dimensional", "MN": "N06.850.520.445.725.500", "MH_TH": "NLM (2013)", "ST": "T081", "MS": "The closeness of a determined value of a physical dimension to the actual value.", "PM": "2013", "HN": "2013", "MR": "20180629", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061827"}, {"RECTYPE": "D", "MH": "Smoke-Free Policy", "AQ": "EC HI LJ TD", "ENTRY": "Smoking Prohibitions", "MN": "N03.623.500.608.428.825.500", "FX": "Smoking Cessation", "MH_TH": "NLM (2013)", "ST": "T170", "MS": "Prohibition against tobacco smoking in specific areas to control TOBACCO SMOKE POLLUTION.", "PM": "2013", "HN": "2013", "MR": "20220708", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061845"}, {"RECTYPE": "D", "MH": "Hospitals, Low-Volume", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "PRINT ENTRY": "Low-Volume Hospitals|T073|T093|NON|EQV|NLM (2013)|110824|abbcdef", "ENTRY": "Low-Volume Hospital", "MN": "N02.278.421.434", "MH_TH": "NLM (2013)", "ST": "T093", "PI": "Hospitals (1995-2012)", "MS": "Hospitals with a much lower than average utilization by physicians and smaller number of procedures.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061846"}, {"RECTYPE": "D", "MH": "Hospitals, High-Volume", "AQ": "CL ES HI SD SN ST TD", "ENTRY": "Hospitals, High Volume", "MN": "N02.278.421.414", "MH_TH": "NLM (2013)", "ST": "T093", "PI": "Hospitals (1995-2012)", "MS": "Hospitals with a much higher than average utilization by physicians and a large number of procedures.", "PM": "2013", "HN": "2013", "MR": "20120814", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061847"}, {"RECTYPE": "D", "MH": "Optical Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Fundus Autofluorescence Imaging|T060|NON|NRW|NLM (2020)|190215|abcdef", "ENTRY": "Imaging, Optical", "MN": "E05.642", "MH_TH": "NLM (2013)", "ST": "T062", "MS": "The use of light interaction (scattering, absorption, and fluorescence) with biological tissue to obtain morphologically based information. It includes measuring inherent tissue optical properties such as scattering, absorption, and autofluorescence; or optical properties of exogenous targeted fluorescent molecular probes such as those used in optical MOLECULAR IMAGING, or nontargeted optical CONTRAST AGENTS.", "PM": "2013", "HN": "2013", "MR": "20190429", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061848"}, {"RECTYPE": "D", "MH": "Hemorrhoidectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Hemorrhoidectomies", "MN": "E04.210.526", "MH_TH": "NLM (2013)", "ST": "T061", "PI": "Hemorrhoids/surgery (1965-2012)", "MS": "The surgical removal of HEMORRHOIDS.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061865"}, {"RECTYPE": "D", "MH": "Chromophore-Assisted Light Inactivation", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Light Inactivations, Fluorophore-Assisted", "MN": "E05.198", "MH_TH": "NLM (2013)", "ST": "T063", "MS": "A technique for causing a targeted loss of molecular function from REACTIVE OXYGEN SPECIES that are formed by the illumination of dyes placed in the immediate vicinity of the target molecule.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061885"}, {"RECTYPE": "D", "MH": "Neuromuscular Monitoring", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Train of Four Monitoring", "MN": "E01.370.520.567", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "The use of peripheral nerve stimulation to assess transmission at the NEUROMUSCULAR JUNCTION, especially in the response to anesthetics, such as the intensity of NEUROMUSCULAR BLOCKADE by NEUROMUSCULAR BLOCKING AGENTS.", "PM": "2013", "HN": "2013", "MR": "20150623", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061886"}, {"RECTYPE": "D", "MH": "Conversion to Open Surgery", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Conversion to an Open Surgical Procedure|T061|NON|EQV|NLM (2013)|110919|abcdef", "MN": "E04.502.250.155", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "Changing an operative procedure from an endoscopic surgical procedure to an open approach during the INTRAOPERATIVE PERIOD.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061887"}, {"RECTYPE": "D", "MH": "Craniospinal Irradiation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Irradiation, Spinocranial", "MN": "E02.815.230", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "A comprehensive radiation treatment of the entire CENTRAL NERVOUS SYSTEM.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061888"}, {"RECTYPE": "D", "MH": "Healthcare Financing", "AQ": "ES", "PRINT ENTRY": "Health Financing|T078|NON|NRW|NLM (2013)|110830|abcdef", "ENTRY": "Healthcare Financings", "MN": "N03.219.483.500", "MH_TH": "NLM (2013)", "ST": "T078", "MS": "Methods of generating, allocating, and using financial resources in healthcare systems.", "PM": "2013", "HN": "2013", "MR": "20130708", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061889"}, {"RECTYPE": "D", "MH": "Controlled Substances", "AQ": "AD AE AN BL CF CH CL CS EC HI IP ME RE SD ST UR", "PRINT ENTRY": "Controlled Substance|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Substances, Controlled", "MN": "D26.049", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "PI": "Narcotics (1963-2012)", "MS": "Drugs or chemical agents whose manufacture, possession, or use are regulated by government. This may include narcotics and prescription medications.", "PM": "2013", "HN": "2013", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061891"}, {"RECTYPE": "D", "MH": "External Debt", "AQ": "HI LJ SN TD", "ENTRY": "Foreign Debts", "MN": "N03.219.416", "MH_TH": "NLM (2013)", "ST": "T081", "MS": "Money owed to creditors outside of a country.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061895"}, {"RECTYPE": "D", "MH": "Single-Domain Antibodies", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "VHH Antibody|T116|T129|ABX|NRW|NLM (2021)|200510|abbcdef", "ENTRY": "Single Domain Antibody", "MN": "D12.776.377.715.548.680.650.500.897", "FX": "Single-Chain Antibodies", "MH_TH": "NLM (2013)", "ST": "T129", "RN": "0", "MS": "An immunoglobulin fragment composed of one variable domain from an IMMUNOGLOBULIN HEAVY CHAIN or IMMUNOGLOBULIN LIGHT CHAIN.", "PM": "2013", "HN": "2013", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061905"}, {"RECTYPE": "D", "MH": "Advanced Trauma Life Support Care", "AQ": "CL EC ES HI IS LJ MT OG PX SN ST TD", "PRINT ENTRY": "Advanced Trauma Life Support|T058|NON|REL|NLM (2013)|110831|abcdef", "MN": "N02.421.585.440.040", "FX": "Traumatology", "MH_TH": "NLM (2013)", "ST": "T058", "PI": "Life Support Care (1979-2012)", "MS": "The initial life support care of the severely injured patient.", "PM": "2013", "HN": "2013", "MR": "20150706", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061906"}, {"RECTYPE": "D", "MH": "Immobilized Nucleic Acids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "RNA, Immobilized", "MN": "D13.444.404", "MH_TH": "NLM (2013)", "ST": "T130", "RN": "0", "MS": "DNA or RNA bound to a substrate thereby having fixed positions.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061925"}, {"RECTYPE": "D", "MH": "Caspase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inhibitors, Caspase Activation", "MN": "D27.505.519.389.745.325.500", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "MS": "Endogenous and exogenous compounds and that either inhibit CASPASES or prevent their activation.", "PM": "2013", "HN": "2013", "MR": "20140625", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061945"}, {"RECTYPE": "D", "MH": "Matrix Metalloproteinase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Matrix Metalloproteinase Inhibitor|T121|NON|EQV|NLM (2021)|200312|abcdef", "ENTRY": "Metalloproteinase Inhibitors, Matrix", "MN": "D27.505.519.389.745.610", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "PI": "Protease Inhibitors (1978-2012)", "MS": "Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES.", "PM": "2013", "HN": "2013", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061965"}, {"RECTYPE": "D", "MH": "Madin Darby Canine Kidney Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "MDCK Cell", "MN": "A11.436.589", "MH_TH": "NLM (2013)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMALS & DOGS; do not routinely check FEMALE", "MS": "An epithelial cell line derived from a kidney of a normal adult female dog.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061985"}, {"RECTYPE": "D", "MH": "MCF-7 Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "MCF7 Cell", "MN": "A11.251.210.190.630", "MH_TH": "NLM (2013)", "ST": "T025", "AN": "almost always NIM with no subheadings; check HUMANS", "PI": "Cell Line, Tumor (1987-2012)", "MS": "An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.)", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061986"}, {"RECTYPE": "D", "MH": "Sf9 Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Spodoptera frugiperda 9 Cell|T025|NON|EQV|NLM (2021)|210209|abcdef", "ENTRY": "Cells, Sf9", "MN": "A11.251.210.891", "MH_TH": "NLM (2013)", "ST": "T025", "AN": "almost always NIM with no subheadings; check ANIMALS and add SPODOPTERA (NIM)", "PI": "Spodoptera (1994-2012)", "MS": "Cell line derived from SF21 CELLS which are a cell line isolated from primary explants of SPODOPTERA FRUGIPERDA pupal tissue.", "PM": "2013", "HN": "2013", "MR": "20210209", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061987"}, {"RECTYPE": "D", "MH": "Proteasome Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inhibitors, Proteasome", "MN": "D27.505.519.389.745.705", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "PI": "Proteasome Endopeptidase Complex (1992-2012)", "MS": "Compounds that inhibit the function or proteolytic action of the PROTEASOME.", "PM": "2013", "HN": "2013", "MR": "20140625", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D061988"}, {"RECTYPE": "D", "MH": "Biopsy, Large-Core Needle", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Needle Biopsy, Large-Core", "MN": "E05.242.384.100.119.750", "MH_TH": "NLM (2013)", "ST": "T060", "AN": "usually NIM with specific organ/pathol (IM) + disease /pathol (IM)", "PI": "Biopsy, Needle (1993-2012)", "MS": "The use of needles usually larger than 14-gauge to remove tissue samples large enough to retain cellular architecture for pathology examination.", "PM": "2013", "HN": "2013", "MR": "20150601", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062005"}, {"RECTYPE": "D", "MH": "Organophosphate Poisoning", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Poisonings, Organothiophosphonate", "MN": "C25.723.717", "MH_TH": "NLM (2013)", "ST": "T037", "AN": "coordinate with specific organophosphate if pertinent", "PI": "Phosphates/poisoning (1959-1969)", "MS": "Poisoning due to exposure to ORGANOPHOSPHORUS COMPOUNDS, such as ORGANOPHOSPHATES; ORGANOTHIOPHOSPHATES; and ORGANOTHIOPHOSPHONATES.", "PM": "2013", "HN": "2013", "MR": "20130708", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062025"}, {"RECTYPE": "D", "MH": "Alice in Wonderland Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "MN": "F01.700.750.150", "MH_TH": "NLM (2013)", "ST": "T047", "PI": "Neurologic Manifestations (1973-2012)", "MS": "Neurological condition characterized by disturbances in VISUAL PERCEPTION, most often of BODY SCHEMA, TIME PERCEPTION and HALLUCINATIONS. It is associated with MIGRAINE, infections (e.g., INFECTIOUS MONONUCLEOSIS), FEVER, EPILEPSY, and other neurological and psychiatric disorders.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062026"}, {"RECTYPE": "D", "MH": "Linear IgA Bullous Dermatosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Linear IgA Dermatoses", "MN": "C20.111.585", "MH_TH": "NLM (2013)", "ST": "T047", "PI": "Skin Diseases (1980-2012)", "MS": "Autoimmune disease characterized by subepidermal blisters and linear deposition of autoantibodies at the dermoepidermal junction. The accumulated autoantibodies are of IMMUNOGLOBULIN A and occasionally IMMUNOGLOBULIN G classes against epidermal BASEMENT MEMBRANE proteins. The dermatosis is sometimes associated with malignancies and use of certain drugs (e.g., VANCOMYCIN).", "PM": "2013", "HN": "2013", "MR": "20151020", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062027"}, {"RECTYPE": "D", "MH": "Bioprinting", "AQ": "CL EC ES HI IS LJ MT SN ST TD VE", "PRINT ENTRY": "Three-Dimensional Bioprinting|T063|NON|NRW|NLM (2024)|221019|abcdef", "ENTRY": "Three-Dimensional Bioprintings", "MN": "J01.293.069.124", "FX": "Guided Tissue Regeneration", "MH_TH": "NLM (2013)", "ST": "T063", "PI": "Tissue Engineering (2005-2012)", "MS": "A material transfer technique used for assembling biological material or cells into a prescribed organization to create functional structures such as MICROCHIP ANALYTICAL DEVICES, cell microarrays, or three dimensional anatomical structures.", "PM": "2013", "HN": "2013", "MR": "20230226", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062028"}, {"RECTYPE": "D", "MH": "Silorane Resins", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "System Adhesives, Silorane", "MN": "J01.637.051.339.291.300.500", "MH_TH": "NLM (2013)", "ST": "T122", "RN": "0", "MS": "Polymeric resins containing a combination of SILOXANES and OXIRANES.", "PM": "2013; SILORANE SYSTEM ADHESIVE was indexed under DENTIN-BINDING AGENTS 2008-2012", "HN": "2013", "MR": "20190627", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062047"}, {"RECTYPE": "D", "MH": "Narrow Band Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Narrowband Imagings", "MN": "E05.642.124", "MH_TH": "NLM (2013)", "ST": "T062", "MS": "Imaging techniques that use illumination created with several optical interference filters by which the frequency ranges are spectrally narrowed and light scatter is greatly reduced. Thus the reflected photons reconstituting the images are from distinct depths (the surface and deeper layers) of the object being imaged.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062048"}, {"RECTYPE": "D", "MH": "Wastewater", "AQ": "AN CH EC LJ MI PS SN TO VI", "PRINT ENTRY": "Waste Water|T069|NON|EQV|NLM (2013)|110928|abcdef", "ENTRY": "Waters, Waste", "MN": "N06.850.460.710.865", "FX": "Waste Disposal, Fluid", "MH_TH": "NLM (2013)", "ST": "T069", "RN": "0", "MS": "Contaminated water generated as a waste product of human activity.", "PM": "2013; see WASTE WATER (2013-2022)", "HN": "2013", "MR": "20220708", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062065"}, {"RECTYPE": "D", "MH": "Water Resources", "AQ": "SD", "ENTRY": "Water Resource", "MN": "N06.230.350.500", "FX": "Groundwater", "MH_TH": "NLM (2013)", "ST": "T070", "MS": "Environmental reservoirs of water related to natural WATER CYCLE by which water is obtained for various purposes. This includes but is not limited to watersheds, aquifers and springs.", "PM": "2013", "HN": "2013", "MR": "20170711", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062066"}, {"RECTYPE": "D", "MH": "Chemical Safety", "AQ": "EC HI IS LJ MT SN ST TD", "ENTRY": "Safety, Chemical", "MN": "N06.850.135.060.075.199", "MH_TH": "NLM (2013)", "ST": "T080", "MS": "Risk or hazard associated with the handling and use of chemicals.", "PM": "2013", "HN": "2013", "MR": "20130708", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062067"}, {"RECTYPE": "D", "MH": "Inventors", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Co-Inventor", "MN": "M01.526.493", "MH_TH": "NLM (2013)", "ST": "T097", "MS": "Persons or entities that introduce a novel composition, device, or process, as well as improvements thereof.", "PM": "2013", "HN": "2013", "MR": "20180629", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062068"}, {"RECTYPE": "D", "MH": "Inventions", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Technological Innovation", "MN": "J01.897.400", "FX": "Patent", "MH_TH": "NLM (2013)", "ST": "T170", "PI": "Patents as Topic (1963-2012)", "MS": "A novel composition, device, or process, independently conceived de novo or derived from a pre-existing model.", "PM": "2013", "HN": "2013", "MR": "20180716", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062069"}, {"RECTYPE": "D", "MH": "Hydrology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Hydrologies", "MN": "J01.293.622", "FX": "Limnology", "MH_TH": "NLM (2013)", "ST": "T090", "AN": "IM as the discipline (education, history, etc) only; NIM with no qualifiers as a coordinate", "PI": "Water Movements (1963-2012)", "MS": "Science dealing with the properties, distribution, and circulation of water on and below the earth's surface, and atmosphere.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062070"}, {"RECTYPE": "D", "MH": "Infant, Extremely Premature", "AQ": "BL CF GD IM ME PH PX UR", "ENTRY": "Preterm Infants, Extremely", "MN": "M01.060.703.520.520.500", "FX": "Premature Birth", "MH_TH": "NLM (2013)", "ST": "T100", "AN": "check the tag INFANT, NEWBORN", "PI": "Infant, Premature (1984-2012)", "MS": "A human infant born before 28 weeks of GESTATION.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062071"}, {"RECTYPE": "D", "MH": "Patient Acuity", "PRINT ENTRY": "Severity of Illness|T080|NON|BRD|NLM (2022)|210223|abcdef", "ENTRY": "Severity, Disease", "MN": "N06.850.520.308.980.438.475.364", "MH_TH": "NLM (2013)", "ST": "T080", "MS": "An assessment of a patient's illness, its chronicity, severity, and other qualitative aspects.", "PM": "2013", "HN": "2013", "MR": "20211202", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062072"}, {"RECTYPE": "D", "MH": "RNA, Long Noncoding", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "RNA, Long Untranslated|T114|T123|ABX|EQV|NLM (2013)|111003|abbcdef", "ENTRY": "ncRNAs, Long", "MN": "D13.444.735.790.375", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "RNA, Untranslated (2000-2012)", "MS": "A class of untranslated RNA molecules that are typically greater than 200 nucleotides in length and do not code for proteins. Members of this class have been found to play roles in transcriptional regulation, post-transcriptional processing, CHROMATIN REMODELING, and in the epigenetic control of chromatin.", "PM": "2014; see RNA, LONG UNTRANSLATED 2013", "HN": "2014 (2013)", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062085"}, {"RECTYPE": "D", "MH": "Transtympanic Micropressure Treatment", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Treatments, Transtympanic Micropressure", "MN": "E04.580.450.802", "FX": "Meniere Disease", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "The intermittent delivery of pulses of air pressure (5 -20 cmH2O) to the middle ear space through a TYMPANOSTOMY tube.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062086"}, {"RECTYPE": "D", "MH": "Plant Mucilage", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Plant Mucilages", "MN": "D25.720.099.718", "FX": "Adhesives", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "AN": "do not confuse with MUCILAGES, ADHESIVE see ADHESIVES", "MS": "A type of viscous polysaccharide that is secreted from PLANTS. It has natural properties that are useful in the formulation of ADHESIVES.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062087"}, {"RECTYPE": "D", "MH": "Acellular Dermis", "AQ": "AE CL DE EC ES HI ME MI PS PX RE SD SN ST TD VE VI", "ENTRY": "Tissues, Acellular Dermal", "MN": "A17.815.180.040", "MH_TH": "NLM (2013)", "ST": "T024", "AN": "coordinate with SKIN TRANSPLANTATION if appropriate", "MS": "Remaining tissue from normal DERMIS tissue after the cells are removed.", "PM": "2013", "HN": "2013", "MR": "20130708", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062088"}, {"RECTYPE": "D", "MH": "Molecular Docking Simulation", "AQ": "CL EC HI IS LJ MT SD SN ST TD", "PRINT ENTRY": "Molecular Docking Simulations|T063|NON|EQV|NLM (2013)|111005|abcdef", "ENTRY": "Simulation, Molecular Docking", "MN": "L01.224.160.249", "FX": "Protein Interaction Maps", "MH_TH": "NLM (2013)", "ST": "T063", "MS": "A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein.", "PM": "2013", "HN": "2013", "MR": "20200116", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062105"}, {"RECTYPE": "D", "MH": "Protein Degradation End Products", "AQ": "AD AE AG AI AN BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "End Products of Protein Degradation|T116|NON|EQV|NLM (2013)|111006|abcdef", "MN": "D12.776.794", "FX": "Glycation End Products, Advanced", "MH_TH": "NLM (2013)", "ST": "T116", "RN": "0", "MS": "Degraded protein components that are found within TISSUES, bodily fluids, and cells under certain pathological conditions. They are largely formed through chemical reactions which occur during non-physiological conditions such as ISCHEMIA; HYPERGLYCEMIA; and PHYSIOLOGICAL STRESS.", "PM": "2013", "HN": "2013", "MR": "20220407", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062106"}, {"RECTYPE": "D", "MH": "Advanced Oxidation Protein Products", "AQ": "AD AE AG AI AN BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Advanced Oxidation Protein Product|T116|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "AOPPs|T116|ABB|EQV|NLM (2013)|111005|abcdef", "MN": "D12.776.794.249", "MH_TH": "NLM (2013)", "ST": "T116", "RN": "0", "MS": "A class of dityrosine-containing protein-derived molecules formed by OXIDATIVE STRESS. Their accumulation in plasma is associated with certain pathological conditions.", "PM": "2013", "HN": "2013", "MR": "20220407", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062107"}, {"RECTYPE": "D", "MH": "May-Thurner Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Iliocaval Compression Syndrome|T046|T047|NON|EQV|NLM (2013)|111006|abbcdef", "ENTRY": "Syndromes, Iliocaval Compression", "MN": "C16.131.240.850.890", "FX": "Constriction, Pathologic", "MH_TH": "NLM (2013)", "ST": "T047", "PI": "Peripheral Vascular Diseases (1995-2012)", "MS": "A compression of ILIAC VEIN that results in a decreased flow in the vein and in the left LOWER EXTREMITY due to a vascular malformation. It may result in left leg EDEMA, pain, iliofemoral DEEP VENOUS THROMBOSIS and POSTTHROMBOTIC SYNDROME. Compression of the left common ILIAC VEIN by the right common ILIAC ARTERY against the underlying fifth LUMBAR VERTEBRA is the typical underlying malformation.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062108"}, {"RECTYPE": "D", "MH": "Dermatologic Surgical Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Dermatologic", "MN": "E04.617.275", "FX": "Surgery, Plastic", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "Operative procedures performed on the SKIN.", "PM": "2013", "HN": "2013", "MR": "20220406", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062109"}, {"RECTYPE": "D", "MH": "Thermometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E05.933", "MH_TH": "NLM (2013)", "ST": "T057", "AN": "coordinate with specific measuring method or property measured", "MS": "Measurement of the temperature of a material, or of the body or an organ by various temperature sensing devices which measure changes in properties of the material that vary with temperature, such as ELASTICITY; MAGNETIC FIELDS; or LUMINESCENCE.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062125"}, {"RECTYPE": "D", "MH": "Databases, Chemical", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Databases, Molecular|T170|NON|REL|NLM (2013)|111007|abcdef", "ENTRY": "Molecular Databases", "MN": "L01.470.750.750.300", "MH_TH": "NLM (2013)", "ST": "T170", "MS": "Databases devoted to knowledge about specific chemicals.", "PM": "2013", "HN": "2013", "MR": "20150622", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062126"}, {"RECTYPE": "D", "MH": "Maternal Serum Screening Tests", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Maternal Serum Triple Test|T060|NON|NRW|NLM (2013)|111222|abcdef", "MN": "E01.370.378.630.582", "MH_TH": "NLM (2013)", "ST": "T060", "MS": "Analysis of the level of specific BIOMARKERS in a pregnant woman's sera to identify those at risk for PREGNANCY COMPLICATIONS or BIRTH DEFECTS.", "PM": "2013", "HN": "2013", "MR": "20150713", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062145"}, {"RECTYPE": "D", "MH": "Receptors, Artificial", "AQ": "AD AG AI AN BL CH CL CS DE GE HI IM IP ME RE TU UL", "ENTRY": "Synthetic Receptors, Biocompatible", "MN": "J01.637.087.750", "MH_TH": "NLM (2013)", "ST": "T192", "RN": "0", "MS": "Receptors that are created by SYNTHETIC CHEMISTRY TECHNIQUES. They are usually designed to mimic endogenous CELL SURFACE RECEPTORS.", "PM": "2013", "HN": "2013", "MR": "20160617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062165"}, {"RECTYPE": "D", "MH": "Atrial Pressure", "AQ": "DE GE IM PH RE", "ENTRY": "Pressures, Intraatrial", "MN": "G09.330.380.037", "MH_TH": "NLM (2013)", "ST": "T042", "PI": "Heart Atria (1966-2012)", "MS": "The pressure within the CARDIAC ATRIUM. It can be measured directly by using a pressure catheter (see HEART CATHETERIZATION). It can be also estimated using various imaging techniques or other pressure readings such as PULMONARY CAPILLARY WEDGE PRESSURE (an estimate of left atrial pressure) and CENTRAL VENOUS PRESSURE (an estimate of right atrial pressure).", "PM": "2013", "HN": "2013", "MR": "20160602", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062185"}, {"RECTYPE": "D", "MH": "Arterial Pressure", "AQ": "DE GE IM PH RE", "ENTRY": "Tensions, Arterial", "MN": "G09.330.380.076.347", "MH_TH": "NLM (2013)", "ST": "T040", "PI": "Blood Pressure (1963-2012)", "MS": "The blood pressure in the ARTERIES. It is commonly measured with a SPHYGMOMANOMETER on the upper arm which represents the arterial pressure in the BRACHIAL ARTERY.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062186"}, {"RECTYPE": "D", "MH": "Spinal Cord Stimulation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Stimulation, Spinal Cord", "MN": "E02.831.535.468.699", "MH_TH": "NLM (2013)", "ST": "T061", "PI": "Electric Stimulation Therapy (1971-2012)", "MS": "Application of electric current to the spine for treatment of a variety of conditions involving innervation from the spinal cord.", "PM": "2013", "HN": "2013", "MR": "20160531", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062187"}, {"RECTYPE": "D", "MH": "Strategic Stockpile", "AQ": "EC HI LJ MT OG SN ST TD", "ENTRY": "Strategic Stockpiles", "MN": "N06.230.100.035.500", "MH_TH": "NLM (2013)", "ST": "T064", "PI": "Disaster Planning (1978-2012)", "MS": "Planned and coordinated pre-event accumulation of ESSENTIAL DRUGS and medical supplies.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062205"}, {"RECTYPE": "D", "MH": "Spatial Analysis", "ENTRY": "Spatial Interpolations", "MN": "N06.850.520.830.933", "FX": "Geographic Information Systems", "MH_TH": "NLM (2013)", "ST": "T062", "MS": "Investigative techniques which measure the topological, geometric, and or geographic properties of the entities studied.", "PM": "2013", "HN": "2013", "MR": "20160705", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062206"}, {"RECTYPE": "D", "MH": "Brain-Computer Interfaces", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "PRINT ENTRY": "Brain Machine Interface|T074|NON|REL|NLM (2021)|191115|abcdef", "ENTRY": "Machine Interfaces, Brain", "MN": "E07.305.076", "FX": "User-Computer Interface", "MH_TH": "NLM (2013)", "ST": "T074", "MS": "Instrumentation consisting of hardware and software that communicates with the BRAIN. The hardware component of the interface records brain signals, while the software component analyzes the signals and converts them into a command that controls a device or sends a feedback signal to the brain.", "PM": "2013", "HN": "2013", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062207"}, {"RECTYPE": "D", "MH": "Patient Handoff", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Signovers, Patient", "MN": "N05.715.840.500", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "The transferring of patient care responsibility from one health-care professional to another.", "PM": "2013", "HN": "2013", "MR": "20160531", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062209"}, {"RECTYPE": "D", "MH": "Personal Narrative", "PRINT ENTRY": "Personal Narratives|T170|NON|EQV|NLM (2008)|070625|abcdef", "MN": "V02.530.150.750", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. used for accounts of personal experiences; Personal narratives as a subject is indexed under the main heading PERSONAL NARRATIVES AS TOPIC. CATALOGER: Use for single as well as for collections of self-described accounts on specific topics and for personal reminiscences on specific topics. Use AUTOBIOGRAPHY for self-described narratives of a person's life.", "MS": "Work consisting of accounts of individual experience in relation to a particular field or of participation in related activities.", "HN": "2019(2013)", "MR": "20190705", "DA": "20120703", "DC": "2", "DX": "20130101", "UI": "D062210"}, {"RECTYPE": "D", "MH": "Spatio-Temporal Analysis", "ENTRY": "Temporal Analysis, Spatial", "MN": "N06.850.520.830.933.500", "MH_TH": "NLM (2013)", "ST": "T062", "MS": "Techniques which study entities using their topological, geometric, or geographic properties and include the dimension of time in the analysis.", "PM": "2013", "HN": "2013", "MR": "20190705", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062211"}, {"RECTYPE": "D", "MH": "RxNorm", "AQ": "HI", "MN": "L01.462.750.245.945.550", "MH_TH": "NLM (2013)", "ST": "T170", "AN": "CATALOGER: Use NAF entry", "MS": "A standardized nomenclature for clinical drugs and drug delivery devices. It links its names to many of the drug vocabularies commonly used in pharmacy management.", "PM": "2013", "HN": "2013", "MR": "20220712", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062245"}, {"RECTYPE": "D", "MH": "Health Insurance Exchanges", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Marketplaces, Health Insurance", "MN": "N03.219.521.576.343.918.500", "MH_TH": "NLM (2013)", "ST": "T058", "PI": "Insurance, Health (2011-2012)", "MS": "State-provided health insurance marketplaces established under the PATIENT PROTECTION AND AFFORDABLE CARE ACT.", "PM": "2013", "HN": "2013", "MR": "20130708", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062265"}, {"RECTYPE": "D", "MH": "Geographic Mapping", "ENTRY": "Mapping, Geographic", "MN": "N06.850.520.830.933.249", "FX": "Topography, Medical", "MH_TH": "NLM (2013)", "ST": "T062", "MS": "Creating a representation of areas of the earth or other celestial bodies, for the purpose of visualizing spatial distributions of various information.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062305"}, {"RECTYPE": "D", "MH": "Geography, Medical", "DE": "GEOGR MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Medical Geography|T090|NON|EQV|NLM (1997)|960517|MED GEOGR|abcdefv", "ENTRY": "Nosogeography|T090|NON|EQV|NLM (2013)|111102|abcdef", "MN": "H02.403.352", "MH_TH": "NLM (1997)", "ST": "T090", "AN": "IM as the discipline (education, history, etc); NIM with no qualifiers as a coordinate", "PI": "Geography (1964-2012)", "MS": "The area of medicine concerned with the effects on health and disease due to geographic factors such as CLIMATE, environmental conditions, and geographic location.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062306"}, {"RECTYPE": "D", "MH": "Medical Device Legislation", "AQ": "CL EC ES HI OG SN ST TD", "ENTRY": "Regulations, Medical Device", "MN": "N03.706.615.473.500", "MH_TH": "NLM (2013)", "ST": "T089", "MS": "Laws, statutes, and regulations pertaining to devices used in medicine.", "PM": "2013", "HN": "2013", "MR": "20151124", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062307"}, {"RECTYPE": "D", "MH": "Optogenetics", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Techniques, Optogenetic", "MN": "E05.393.667", "MH_TH": "NLM (2013)", "ST": "T063", "MS": "The combination of genetic and optical methods in controlling specific events with temporal precision in targeted cells of a functioning intact biological system.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062308"}, {"RECTYPE": "D", "MH": "Community Integration", "AQ": "CL EC EH ES HI LJ PX SN TD", "ENTRY": "Integrations, Community", "MN": "I01.880.787.354", "MH_TH": "NLM (2013)", "ST": "T054", "MS": "Policies and programs which ensure that DISABLED PERSONS and those with CHRONIC ILLNESS receive the support and SOCIAL SERVICES needed to live in their communities.", "PM": "2013", "HN": "2013", "MR": "20200618", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062309"}, {"RECTYPE": "D", "MH": "Islands", "AQ": "EH EP", "MN": "Z01.639", "MH_TH": "NLM (1986)", "ST": "T083", "AN": "general or unspecified; prefer specifics", "MS": "Tracts of land completely surrounded by water.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062312"}, {"RECTYPE": "D", "MH": "Databases, Pharmaceutical", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Databases, Drug|T170|NON|EQV|NLM (2013)|111103|abcdef", "ENTRY": "Pharmaceutical Databases", "MN": "L01.470.750.750.400", "FX": "Dictionaries, Pharmaceutic as Topic", "MH_TH": "NLM (2013)", "ST": "T170", "PI": "Databases, Factual (1996-2012)", "MS": "Databases devoted to knowledge about PHARMACEUTICAL PRODUCTS.", "PM": "2013", "HN": "2013", "MR": "20170717", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062313"}, {"RECTYPE": "D", "MH": "Intense Pulsed Light Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E02.774.465", "FX": "Lasers, Dye", "MH_TH": "NLM (2013)", "ST": "T061", "AN": "coordinate with specific skin disease /ther and/or cosmetic technique; use PHOTOCHEMOTHERAPY for intense pulsed light used with PHOTOSENSITIZING AGENTS and do not index here", "MS": "Treatment of the skin with flashlamps of prescribed wavelengths, fluence, and pulse durations which target specific chromophores to induce photothermolysis at specific locations in the skin such as at the HAIR FOLLICLE or SPIDER VEINS.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062325"}, {"RECTYPE": "D", "MH": "Re-Epithelialization", "AQ": "DE GE IM PH RE", "ENTRY": "Re Epithelialization", "MN": "G16.762.891.750", "MH_TH": "NLM (2013)", "ST": "T043", "MS": "Reconstitution of eroded or injured EPITHELIUM by proliferation and migration of EPITHELIAL CELLS from below or adjacent to the damaged site.", "PM": "2013", "HN": "2013", "MR": "20160623", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062326"}, {"RECTYPE": "D", "MH": "Skin Lightening Preparations", "AQ": "AD AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO TU", "ENTRY": "Whitening Agents, Skin", "MN": "J01.516.213.500", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "MS": "Substances used to obtain a lighter skin complexion or to treat HYPERPIGMENTATION disorders.", "PM": "2013", "HN": "2013", "MR": "20190501", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062327"}, {"RECTYPE": "D", "MH": "Nuclear Microscopy", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Nuclear Microscope Analyses", "MN": "E05.595.744", "FX": "Electron Probe Microanalysis", "MH_TH": "NLM (2013)", "ST": "T059", "MS": "A method of simultaneously imaging and measuring elements at the submicron level. Nuclear microscopy uses a focused high-energy ion beam of PROTONS and ALPHA PARTICLES (a nuclear microprobe) to interact with the sample. The resulting emitted radiations are analyzed by a group of techniques simultaneously: PARTICLE INDUCED X RAY EMISSION SPECTROMETRY for minor and trace element identification; Rutherford Backscattering Spectroscopy to assess sample thickness and bulk elements such as carbon, hydrogen, oxygen, and nitrogen; and Scanning Transmission Ion Microscopy to assess sample structure and density.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062345"}, {"RECTYPE": "D", "MH": "Molecular Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Molecular Medicines", "MN": "H02.403.530", "FX": "Genetics, Medical", "MH_TH": "NLM (2013)", "ST": "T091", "AN": "use for the discipline only (education, history, etc)", "MS": "The field of medicine concerned with understanding the biochemical basis of health and disease and involved in developing diagnostic and therapeutic methods that utilize MOLECULAR BIOLOGY techniques.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062346"}, {"RECTYPE": "D", "MH": "Aminobenzoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Aminobenzoic", "MN": "D02.455.426.559.389.127.020", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "MS": "Derivatives of BENZOIC ACID that contain one or more amino groups attached to the benzene ring structure. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the aminobenzoate structure.", "PM": "2013; see Aminobenzoic Acids 1965-2012", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062365"}, {"RECTYPE": "D", "MH": "para-Aminobenzoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "para-Aminobenzoate|T109|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "para Aminobenzoates", "MN": "D02.455.426.559.389.127.020.937", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "PI": "4-Aminobenzoic Acid (1976-2012)", "MS": "Benzoic acids, salts, or esters that contain an amino group attached to carbon number 4 of the benzene ring structure.", "PM": "2013", "HN": "2013", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062366"}, {"RECTYPE": "D", "MH": "ortho-Aminobenzoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "ortho Aminobenzoic Acids", "MN": "D02.455.426.559.389.127.020.906", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "MS": "Benzoic acids, salts, or esters that contain an amino group attached to carbon number 2 or 6 of the benzene ring structure.", "PM": "2013; see ANTHRANILIC ACIDS 1966-2012", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062367"}, {"RECTYPE": "D", "MH": "meta-Aminobenzoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "meta Aminobenzoic Acids", "MN": "D02.455.426.559.389.127.020.452", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "PI": "Aminobenzoates (1965-2012)", "MS": "Aminobenzoate derivatives that contain an amino group attached to carbon number 3 or 5 of the benzene ring structure.", "PM": "2013", "HN": "2013", "MR": "20130708", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062368"}, {"RECTYPE": "D", "MH": "Hydroxybenzoates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Hydroxybenzoic", "MN": "D02.455.426.559.389.657.410", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "MS": "Benzoate derivatives substituted by one or more hydroxy groups in any position on the benzene ring.", "PM": "2013; see HYDROXYBENZOIC ACIDS 1976-2012", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062385"}, {"RECTYPE": "D", "MH": "Motivational Interviewing", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Interviewing, Motivational", "MN": "N02.421.461.363.349.500", "MH_TH": "NLM (2013)", "ST": "T061", "PI": "Nondirective Therapy (1996-2012)", "MS": "It is a client-centered, directive method for eliciting intrinsic motivation to change using open-ended questions, reflective listening, and decisional balancing. This nonjudgmental, nonconfrontational interviewing style is designed to minimize a patient's resistance to change by creating an interaction that supports open discussion of risky or problem behavior.", "PM": "2013", "HN": "2013", "MR": "20150629", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062405"}, {"RECTYPE": "D", "MH": "Fukushima Nuclear Accident", "ENTRY": "Nuclear Disasters, Fukushima", "MN": "N06.850.135.848.750", "MH_TH": "NLM (2013)", "ST": "T078", "MS": "Nuclear power accident that occurred following the Tohoku-Kanto earthquake of March 11, 2011 in the northern region of Japan.", "PM": "2013", "HN": "2013", "MR": "20150629", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062406"}, {"RECTYPE": "D", "MH": "Meals", "AQ": "CL DE EH ES PH PX RE", "PRINT ENTRY": "Mealtimes|T079|NON|REL|NLM (2013)|111118|abcdef", "ENTRY": "Times, Meal", "MN": "J02.500.590", "MH_TH": "NLM (2013)", "ST": "T168", "MS": "A portion of the food eaten for the day, usually at regular occasions during the day.", "PM": "2013", "HN": "2013", "MR": "20160518", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062407"}, {"RECTYPE": "D", "MH": "Breakfast", "AQ": "CL DE EH ES PH PX RE", "ENTRY": "Times, Breakfast", "MN": "J02.500.590.120", "MH_TH": "NLM (2013)", "ST": "T168", "MS": "The first meal of the day.", "PM": "2013", "HN": "2013", "MR": "20160518", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062408"}, {"RECTYPE": "D", "MH": "Lunch", "AQ": "CL DE EH ES PH PX RE", "PRINT ENTRY": "Lunchtime|T079|NON|REL|NLM (2013)|111118|abcdef", "ENTRY": "Times, Lunch", "MN": "J02.500.590.560", "MH_TH": "NLM (2013)", "ST": "T168", "MS": "The meal taken at midday.", "PM": "2013", "HN": "2013", "MR": "20160630", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062409"}, {"RECTYPE": "D", "MH": "Snacks", "AQ": "CL DE EH ES PH PX RE", "PRINT ENTRY": "Snacktime|T079|NON|REL|NLM (2013)|111118|abcdef", "ENTRY": "Snacktimes", "MN": "J02.500.590.780", "MH_TH": "NLM (2013)", "ST": "T168", "MS": "Foods eaten between MEALTIMES.", "PM": "2013", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062410"}, {"RECTYPE": "D", "MH": "Hydroxybenzoate Ethers", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ethers, Hydroxybenzoate", "MN": "D02.455.426.559.389.657.654.638", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "MS": "Benzoate derivatives that contain one or more alkyl or aryl groups linked to the benzene ring structure by OXYGEN.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062425"}, {"RECTYPE": "D", "MH": "Claudin-1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Claudin 1|T116|T123|NON|EQV|NLM (2013)|111122|abbcdef", "MN": "D12.776.543.940.200.100", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "An integral membrane protein that is localized to TIGHT JUNCTIONS, where it plays a role in controlling the paracellular permeability of polarized cells. Mutations in the gene for claudin-1 are associated with Neonatal Ichthyosis-Sclerosing Cholangitis (NISCH) Syndrome.", "PM": "2013; CLAUDIN-1 was indexed under MEMBRANE PROTEINS 1998-2012", "HN": "2013", "MR": "20160115", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062445"}, {"RECTYPE": "D", "MH": "Claudin-2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Claudin 2", "MN": "D12.776.543.940.200.200", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Claudins (2004-2012)", "MS": "A claudin subtype that is associated with the formation of cation-selective channels and increased epithelial permeability. It is localized to the TIGHT JUNCTIONS of the PROXIMAL KIDNEY TUBULE and INTESTINAL EPITHELIUM.", "PM": "2013", "HN": "2013", "MR": "20160115", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062446"}, {"RECTYPE": "D", "MH": "Claudin-3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Claudin 3|T116|T123|NON|EQV|NLM (2013)|111123|abbcdef", "MN": "D12.776.543.940.200.300", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "A ubiquitously-expressed claudin subtype that acts as a general barrier-forming protein in TIGHT JUNCTIONS. Elevated expression of claudin-3 is found in a variety of tumor cell types, suggesting its role as a therapeutic target for specific ANTINEOPLASTIC AGENTS.", "PM": "2013; CLAUDIN-3 was indexed under CLAUDINS 1999-2012", "HN": "2013", "MR": "20160115", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062465"}, {"RECTYPE": "D", "MH": "Breath Holding", "AQ": "DE ES GE IM RE", "ENTRY": "Holdings, Breath", "MN": "G09.772.705.349", "MH_TH": "NLM (2013)", "ST": "T039", "PI": "Respiration (1967-2012)", "MS": "An involuntary or voluntary pause in breathing, sometimes accompanied by loss of consciousness.", "PM": "2013", "HN": "2013", "MR": "20160602", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062485"}, {"RECTYPE": "D", "MH": "Public Health Surveillance", "AQ": "MT", "ENTRY": "Surveillance, Public Health", "MN": "N06.850.780.675.487", "MH_TH": "NLM (1990)", "ST": "T062", "MS": "The ongoing, systematic collection, analysis, and interpretation of health-related data with the purpose of preventing or controlling disease or injury, or of identifying unusual events of public health importance, followed by the dissemination and use of information for public health action. (From Am J Prev Med 2011;41(6):636)", "PM": "2013; see Population Surveillance 1990-2012", "HN": "2013, use Population Surveillance 1990-2012", "MR": "20170703", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062486"}, {"RECTYPE": "D", "MH": "Social Marginalization", "AQ": "HI PX", "ENTRY": "Social Marginalizations", "MN": "I01.880.853.872", "MH_TH": "NLM (2013)", "ST": "T054", "PI": "Social Isolation (1992-2012)", "MS": "Individuals or groups, excluded from participation in the economic, social, and political activities of membership in a community.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062487"}, {"RECTYPE": "D", "MH": "Health Impact Assessment", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Impact Assessments, Health", "MN": "N03.349.380.210.500", "MH_TH": "NLM (2013)", "ST": "T058", "MS": "Combination of procedures, methods, and tools by which a policy, program, or project may be judged as to its potential effects on the health of a population, and the distribution of those effects within the population.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062489"}, {"RECTYPE": "D", "MH": "Value-Based Purchasing", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Value-Based Purchasings", "MN": "N03.219.521.576.343.981", "MH_TH": "NLM (2013)", "ST": "T058", "MS": "Purchasers are provided information on the quality of health care, including patient outcomes and health status, with data on the dollar outlays going towards health. The focus is on managing the use of the health care system to reduce inappropriate care and to identify and reward the best-performing providers. (from http://www.ahrq.gov/qual/meyerrpt.htm accessed 11/25/2011)", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062505"}, {"RECTYPE": "D", "MH": "Claudin-4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Claudin4|T116|T123|NON|EQV|NLM (2013)|111125|abbcdef", "ENTRY": "Claudin 4|T116|T123|NON|EQV|NLM (2013)|111125|abbcdef", "MN": "D12.776.543.940.200.400", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "A claudin subtype that takes part in maintaining the barrier-forming property of TIGHT JUNCTIONS. Claudin-4 is found associated with CLAUDIN-8 in the KIDNEY COLLECTING DUCT where it may play a role in paracellular chloride ion reabsorption.", "PM": "2013: CLAUDIN-4 was indexed under CLAUDINS (199-2012)", "HN": "2013", "MR": "20160115", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062506"}, {"RECTYPE": "D", "MH": "Claudin-5", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transmembrane Protein Deleted in Velocardiofacial Syndrome|T116|T123|NON|EQV|NLM (2013)|111125|abbcdef", "MN": "D12.776.543.940.200.500", "FX": "DiGeorge Syndrome", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (1997-2010)", "MS": "A claudin subtype that is found localized to TIGHT JUNCTIONS in VASCULAR ENDOTHELIAL CELLS. The protein was initially identified as one of several proteins which are deleted in VELOCARDIOFACIAL SYNDROME and may play an important role in maintaining the integrity of the BLOOD-BRAIN BARRIER.", "PM": "2013", "HN": "2013", "MR": "20160115", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062507"}, {"RECTYPE": "D", "MH": "Narrative Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Therapy, Narrative", "MN": "F04.754.570", "FX": "Narration", "MH_TH": "NLM (2013)", "ST": "T061", "PI": "Psychotherapy (1994-2012)", "MS": "A form of PSYCHOTHERAPY that centers on the individuals as the experts in their own lives and views problems as separate from people. It is assumed that people have many skills, competencies, beliefs, values, commitments, and abilities that will assist them to reduce the influence of problems in their lives.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062525"}, {"RECTYPE": "D", "MH": "Patient Navigation", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Patient Navigator", "MN": "N04.590.233.727.407.500", "MH_TH": "NLM (2013)", "ST": "T058", "PI": "Patient-Centered Care (2002-2012)", "MS": "The process of helping patients to effectively and efficiently use the health care system when faced with one or more of these challenges: (1) choosing, understanding, and using health coverage or applying for assistance when uninsured; (2) choosing, using, and understanding different types of health providers and services; (3) making treatment decisions; and (4) managing care received by multiple providers.", "PM": "2013", "HN": "2013", "MR": "20180629", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062526"}, {"RECTYPE": "D", "MH": "Meaningful Use", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Uses, Meaningful", "MN": "N04.761.744.500", "MH_TH": "NLM (2013)", "ST": "T058", "MS": "Using certified ELECTRONIC HEALTH RECORDS technology to improve quality, safety, efficiency, and reduce HEALTHCARE DISPARITIES; engage patients and families in their health care; improve care coordination; improve population and public health; while maintaining privacy and security.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062527"}, {"RECTYPE": "D", "MH": "Medicalization", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Pathologization|T054|NON|REL|NLM (2024)|220831|abcdef", "MN": "I01.880.853.250", "FX": "Overdiagnosis", "MH_TH": "NLM (2013)", "ST": "T054", "MS": "The process by which human conditions and problems come to be defined as medical conditions, and so become the subject of medical study, diagnosis, prevention, or treatment. This may result in health, medical, economic, sociological, and ethical issues.", "PM": "2013", "HN": "2013", "MR": "20221215", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062528"}, {"RECTYPE": "D", "MH": "Voltage-Gated Sodium Channel beta Subunits", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Voltage Gated Sodium Channel beta Subunits", "MN": "D12.776.631.960.970", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (1988-2012)", "MS": "Voltage-gated sodium channel subunits that play a role in the assembly, expression, and functional modulation of the sodium channel. They form a heterotrimeric complex with the pore-forming sodium channel alpha subunits.", "PM": "2013", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062546"}, {"RECTYPE": "D", "MH": "Voltage-Gated Sodium Channel beta-1 Subunit", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Voltage Gated Sodium Channel beta 1 Subunit", "MN": "D12.776.631.960.970.100", "FX": "Brugada Syndrome", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (2002-2012)", "MS": "A voltage-gated sodium channel beta subunit abundantly expressed in SKELETAL MUSCLE; HEART; and BRAIN. It non-covalently associates with voltage-gated alpha subunits. Defects in the SCN1B gene, which codes for this beta subunit, are associated with generalized epilepsy with febrile seizures plus, type 1, and Brugada syndrome 5.", "PM": "2013", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062547"}, {"RECTYPE": "D", "MH": "Voltage-Gated Sodium Channel beta-2 Subunit", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Voltage Gated Sodium Channel beta 2 Subunit", "MN": "D12.776.631.960.970.200", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (2002-2012)", "MS": "A voltage-gated sodium channel beta subunit that binds covalently to voltage-gated alpha subunits.", "PM": "2013", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062548"}, {"RECTYPE": "D", "MH": "Voltage-Gated Sodium Channel beta-3 Subunit", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Voltage Gated Sodium Channel beta 3 Subunit", "MN": "D12.776.631.960.970.300", "FX": "Brugada Syndrome", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (1989-2012)", "MS": "A voltage-gated sodium channel beta subunit subtype that non-covalently associates with voltage-gated alpha subunits. Defects in the SCN3B gene which codes for this beta subunit are associated with Brugada syndrome 7.", "PM": "2013", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062549"}, {"RECTYPE": "D", "MH": "NAV1.1 Voltage-Gated Sodium Channel", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Voltage-Gated Sodium Channel Type 1 Subunit alpha|T116|T123|NON|NRW|NLM (2013)|111129|abbcdef", "ENTRY": "alpha Subunit, NAV1.1", "MN": "D12.776.631.960.100", "FX": "Epilepsies, Myoclonic", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (1989-2012)", "MS": "A voltage-gated sodium channel subtype that is predominantly expressed in the CENTRAL NERVOUS SYSTEM. Defects in the SCN1A gene which codes for the alpha subunit of this sodium channel are associated with DRAVET SYNDROME, generalized epilepsy with febrile seizures plus, type 2 (GEFS+2), and familial hemiplegic migraine type 3.", "PM": "2013; SODIUM CHANNEL, VOLTAGE-GATED, TYPE I, ALPHA PROTEIN was indexed under SODIUM CHANNELS 2000-2012", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062550"}, {"RECTYPE": "D", "MH": "NAV1.2 Voltage-Gated Sodium Channel", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Voltage-Gated Sodium Channel Type 2 Subunit alpha|T116|T123|NON|NRW|NLM (2013)|111129|abbcdef", "ENTRY": "Voltage Gated Sodium Channel Type 2 alpha Subunit", "MN": "D12.776.631.960.200", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (1989-2012)", "MS": "A voltage-gated sodium channel subtype that mediates the sodium ion permeability of excitable membranes. Defects in the SCN2A gene which codes for the alpha subunit of this sodium channel are associated with benign familial infantile seizures type 3, and early infantile epileptic encephalopathy type 11.", "PM": "2013", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062551"}, {"RECTYPE": "D", "MH": "NAV1.3 Voltage-Gated Sodium Channel", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Voltage-Gated Sodium Channel Type 3 Subunit alpha|T116|T123|NON|NRW|NLM (2013)|111129|abbcdef", "ENTRY": "alpha Subunit, NAV1.3", "MN": "D12.776.631.960.300", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (1989-2012)", "MS": "A voltage-gated sodium channel subtype found in neuronal tissue that mediates the sodium ion PERMEABILITY of excitable membranes.", "PM": "2013", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062552"}, {"RECTYPE": "D", "MH": "NAV1.4 Voltage-Gated Sodium Channel", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Voltage-Gated Sodium Channel Type 4 Subunit alpha|T116|T123|NON|NRW|NLM (2013)|111129|abbcdef", "ENTRY": "alpha Subunit, NAV1.4", "MN": "D12.776.543.585.400.875.750.400", "FX": "Paralysis, Hyperkalemic Periodic", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (1989-2012)", "MS": "A voltage-gated sodium channel subtype that mediates the sodium ion PERMEABILITY of SKELETAL MYOCYTES. Defects in the SCN4A gene, which codes for the alpha subunit of this sodium channel, are associated with several MYOTONIC DISORDERS.", "PM": "2013", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062553"}, {"RECTYPE": "D", "MH": "NAV1.5 Voltage-Gated Sodium Channel", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Voltage-Gated Sodium Channel Type 5 Subunit alpha|T116|T123|NON|NRW|NLM (2013)|111129|abbcdef", "ENTRY": "Voltage Gated Sodium Channel Type 5 Subunit alpha", "MN": "D12.776.631.960.500", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (2002-2012)", "MS": "A voltage-gated sodium channel subtype that mediates the sodium ion PERMEABILITY of CARDIOMYOCYTES. Defects in the SCN5A gene, which codes for the alpha subunit of this sodium channel, are associated with a variety of CARDIAC DISEASES that result from loss of sodium channel function.", "PM": "2013; SODIUM CHANNEL PROTEIN TYPE 5 SUBUNIT ALPHA (now NAV1.5 VOLTAGE-GATED SODIUM CHANNEL) was indexed under SODIUM CHANNELS 2002-2012", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062554"}, {"RECTYPE": "D", "MH": "NAV1.7 Voltage-Gated Sodium Channel", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Voltage Gated Sodium Channel Type 9 Subunit alpha", "MN": "D12.776.631.960.700", "FX": "Erythromelalgia", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (1989-2012)", "MS": "A voltage-gated sodium channel subtype found widely expressed in nociceptive primary sensory neurons. Defects in the SCN9A gene, which codes for the alpha subunit of this sodium channel, are associated with several pain sensation-related disorders.", "PM": "2013", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062556"}, {"RECTYPE": "D", "MH": "NAV1.6 Voltage-Gated Sodium Channel", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Voltage-Gated Sodium Channel Type 8 Subunit alpha|T116|T123|NON|NRW|NLM (2013)|111129|abbcdef", "ENTRY": "Voltage Gated Sodium Channel Type 8 Subunit alpha", "MN": "D12.776.631.960.600", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (1989-2012)", "MS": "A voltage-gated sodium channel subtype found widely expressed in neurons of the central and peripheral nervous systems. Defects in the SCN8A gene which codes for the alpha subunit of this sodium channel are associated with ATAXIA and cognitive deficits.", "PM": "2013", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062557"}, {"RECTYPE": "D", "MH": "NAV1.9 Voltage-Gated Sodium Channel", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Voltage-Gated Sodium Channel Type 11 Subunit alpha|T116|T123|NON|NRW|NLM (2013)|111129|abbcdef", "ENTRY": "Voltage Gated Sodium Channel Type 11 Subunit alpha", "MN": "D12.776.631.960.900", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (1996-2012)", "MS": "A voltage-gated sodium channel subtype found in the neurons of the NERVOUS SYSTEM and DORSAL ROOT GANGLIA. It may play a role in the generation of heat and mechanical pain hypersensitivity.", "PM": "2013", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062558"}, {"RECTYPE": "D", "MH": "NAV1.8 Voltage-Gated Sodium Channel", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Voltage-Gated Sodium Channel Type 10 Subunit alpha|T116|T123|NON|NRW|NLM (2013)|111129|abbcdef", "ENTRY": "Voltage Gated Sodium Channel Type 10 Subunit alpha", "MN": "D12.776.631.960.800", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (1996-2012)", "MS": "A voltage-gated sodium channel subtype that is expressed in nociceptors, including spinal and trigeminal sensory neurons. It plays a role in the transmission of pain signals induced by cold, heat, and mechanical stimuli.", "PM": "2013; SENSORY NEURON SPECIFIC (SNS) SODIUM CHANNEL (now NAV1.8 VOLTAGE-GATED SODIUM CHANNEL) was indexed under SODIUM CHANNELS 1996-2012", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062559"}, {"RECTYPE": "D", "MH": "Acid Sensing Ion Channels", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proton-Gated Sodium Channels|T116|T123|NON|EQV|NLM (2013)|111213|abbcdef", "ENTRY": "Sodium Channels, Proton-Gated", "MN": "D12.776.631.024", "EC": "antagonists & inhibitors:Acid Sensing Ion Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (1988-2012)", "MS": "A family of proton-gated sodium channels that are primarily expressed in neuronal tissue. They are AMILORIDE-sensitive and are implicated in the signaling of a variety of neurological stimuli, most notably that of pain in response to acidic conditions.", "PM": "2013; ASIC CHANNEL (now ACID SENSING ION CHANNELS) was indexed under NERVE TISSUE PROTEINS and SODIUM CHANNELS 2009-2012, and under MEMBRANE PROTEINS 1997-2008", "HN": "2013", "MR": "20210630", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062565"}, {"RECTYPE": "D", "MH": "Voltage-Gated Sodium Channel beta-4 Subunit", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Voltage Gated Sodium Channel beta 4 Subunit", "MN": "D12.776.631.960.970.650", "FX": "Long QT Syndrome", "EC": "antagonists & inhibitors:Voltage-Gated Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Sodium Channels (1988-2012)", "MS": "A voltage-gated sodium channel beta subunit subtype that covalently associates with voltage-gated alpha subunits. Defects in the SCN4B gene, which codes for this beta subunit, are associated with long QT syndrome-10.", "PM": "2013", "HN": "2013", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062585"}, {"RECTYPE": "D", "MH": "Quillaja Saponins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Quillaja Saponin|T109|NON|EQV|NLM (2021)|200227|abcdef", "ENTRY": "Saponins, Quillaja", "MN": "D09.408.782.512", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "MS": "Natural detergents made up of a heterogeneous mixture of molecules having a triterpenoid core structure. They vary in aglycone (sapogenin) and sugar moieties, including glucose.", "PM": "2013; see Quillaja 2003-2012", "HN": "2013; use Quillaja 2003-2012", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062605"}, {"RECTYPE": "D", "MH": "Tertiary Care Centers", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Tertiary Referral Hospitals", "MN": "N02.278.421.830", "FX": "Referral and Consultation", "MH_TH": "NLM (2013)", "ST": "T093", "AN": "TERTIARY CARE is also available", "MS": "A medical facility which provides a high degree of subspecialty expertise for patients from centers where they received SECONDARY CARE.", "PM": "2013", "HN": "2013", "MR": "20130708", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062606"}, {"RECTYPE": "D", "MH": "Fungal Capsules", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Fungal Capsule", "MN": "A19.530", "MH_TH": "NLM (2013)", "ST": "T026", "MS": "An extracellular layer outside the cell wall of a fungus composed of polysaccharides. It may serve a protective role amongst others.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062607"}, {"RECTYPE": "D", "MH": "Electronic Nose", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "e Nose", "MN": "E07.305.296", "MH_TH": "NLM (2013)", "ST": "T073", "PI": "Odors (1998-2012)", "MS": "A device used to detect airborne odors, gases, flavors, volatile substances or vapors.", "PM": "2013", "HN": "2013", "MR": "20160705", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062609"}, {"RECTYPE": "D", "MH": "Fungal Polysaccharides", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fungal Polysaccharide|T109|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Polysaccharide, Fungal", "MN": "D23.050.202.283", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "MS": "Cell wall components constituting a polysaccharide core found in fungi. They may act as antigens or structural substrates.", "PM": "2013", "HN": "2013", "MR": "20220413", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062610"}, {"RECTYPE": "D", "MH": "Solid Waste", "AQ": "AN CL EC SN", "ENTRY": "Wastes, Solid", "MN": "N06.850.460.710.730", "FX": "Refuse Disposal", "MH_TH": "NLM (2013)", "ST": "T167", "RN": "0", "MS": "Garbage, refuse, or sludge, or other discarded materials from a wastewater treatment plant, water supply treatment plant, and air pollution control facility that include solid, semi-solid, or contained material. It does not include materials dissolved in domestic sewage, irrigation return flows, or industrial discharges.", "PM": "2013", "HN": "2013", "MR": "20190530", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062611"}, {"RECTYPE": "D", "MH": "Cystadenofibroma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Cystadenofibromas, Borderline", "MN": "C04.557.470.625.050.500", "FX": "Adenocarcinoma, Clear Cell", "MH_TH": "NLM (2013)", "ST": "T191", "AN": "coordinate IM with probably OVARIAN NEOPLASMS (IM)", "PI": "Ovarian Neoplasms (1966-2012)", "MS": "Benign or borderline malignant neoplasm of the ovary and surrounding tissues. It is characterized by tumor(s) with cystic glands which are lined by cuboidal EPITHELIAL CELLS with clear cytoplasm, resembling ENDOMETRIUM cells. The glands are separated by fibroblastic STROMAL CELLS.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062625"}, {"RECTYPE": "D", "MH": "Degenerin Sodium Channels", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Degenerin Ion Channels|T116|T123|NON|EQV|NLM (2013)|111206|abbcdef", "ENTRY": "Sodium Channels, Degenerin", "MN": "D12.776.543.585.400.875.100", "EC": "antagonists & inhibitors:Sodium Channel Blockers", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Nerve Tissue Proteins (2007-2012)", "MS": "A family of mechanosensitive sodium channels found primarily in NEMATODES where they play a role in CELLULAR MECHANOTRANSDUCTION. Degenerin sodium channels are structurally-related to EPITHELIAL SODIUM CHANNELS and are named after the fact that loss of their activity results in cellular degeneration.", "PM": "2013; DEGENERIN EPITHELIAL SODIUM CHANNELS (now DEGENERIN ION CHANNELS) was indexed under NERVE TISSUE PROTEINS and EPITHELIAL SODIUM CHANNEL 2007-2012, and under ION CHANNELS 1996-2006", "HN": "2013", "MR": "20210630", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062626"}, {"RECTYPE": "D", "MH": "Percutaneous Coronary Intervention", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Revascularizations, Percutaneous Coronary", "MN": "E04.502.382.968", "MH_TH": "NLM (2013)", "ST": "T061", "PI": "Angioplasty, Balloon, Coronary (1992-2012)", "MS": "A family of percutaneous techniques that are used to manage CORONARY OCCLUSION, including standard balloon angioplasty (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY), the placement of intracoronary STENTS, and atheroablative technologies (e.g., ATHERECTOMY; ENDARTERECTOMY; THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY). PTCA was the dominant form of PCI, before the widespread use of stenting.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062645"}, {"RECTYPE": "D", "MH": "Acid Sensing Ion Channel Blockers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Proton-Gated Sodium Channel Blockers|T121|NON|EQV|NLM (2013)|111213|abcdef", "ENTRY": "Proton Gated Sodium Channel Blockers", "MN": "D27.505.519.562.750.100", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "PI": "Sodium Channels/antagonists & inhibitors (1988-2001)", "MS": "A subclass of sodium channel blockers that are specific for ACID-SENSING SODIUM CHANNELS.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062646"}, {"RECTYPE": "D", "MH": "Epidemiological Monitoring", "DE": "EPIDEMIOL MONITORING", "AQ": "VE", "ENTRY": "Surveillances, Epidemiologic", "MN": "N06.850.520.460", "MH_TH": "UNK (19XX)", "ST": "T057", "AN": "do not confuse with ENVIRONMENTAL MONITORING", "MS": "Collection, analysis, and interpretation of data about the frequency, distribution, and consequences of disease or health conditions, for use in the planning, implementing, and evaluating public health programs.", "PM": "2013; see ENVIRONMENTAL MONITORING 1986-2012", "HN": "2013 (1986)", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062665"}, {"RECTYPE": "D", "MH": "Vascular Access Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "PRINT ENTRY": "Venous Reservoirs|T074|NON|NRW|NLM (1998)|970128|abcdef", "ENTRY": "Venous Reservoir", "MN": "E07.132.750", "MH_TH": "NLM (2013)", "ST": "T074", "MS": "Devices to be inserted into veins or arteries for the purpose of carrying fluids into or from a peripheral or central vascular location. They may include component parts such as catheters, ports, reservoirs, and valves. They may be left in place temporarily for therapeutic or diagnostic purposes.", "PM": "2013; for VASCULAR ACCESS PORTS see CATHETERS, INDWELLING 1990-2012; for INTRA-ARTERIAL LINES see CATHETERS, INDWELLING 1987-2012; for VENOUS RESERVOIRS see CATHETERS, INDWELLING 1998-2012", "HN": "2013; for VASCULAR ACCESS PORTS use CATHETERS, INDWELLING 1990-2012; for INTRA-ARTERIAL LINES use CATHETERS, INDWELLING 1987-2012; for VENOUS RESERVOIRS use CATHETERS, INDWELLING 1998-2012", "MR": "20160701", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062666"}, {"RECTYPE": "D", "MH": "Steatocystoma Multiplex", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Steatocystomas, Multiplex", "MN": "C17.800.827.250.856.500", "FX": "Keratin-17", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A disorder characterized by multiple, wide spread cutaneous cysts that often become inflamed and rupture. It is caused by the same mutations in the gene coding for KRT-17 that are causative mutations for Pachyonychia congenita, Type 2. Natal teeth involvement is sometimes associated with steatocystoma multiplex.", "PM": "2013", "HN": "2013", "MR": "20150618", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062685"}, {"RECTYPE": "D", "MH": "Epithelial Sodium Channel Blockers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Epithelial Sodium Ion Channel Blockers|T121|NON|EQV|NLM (2013)|111212|abcdef", "ENTRY": "Channel Blockers, ENaC", "MN": "D27.505.696.560.500.726.100", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "PI": "Sodium Channels/antagonists & inhibitors (1988-2001)", "MS": "A subclass of sodium channel blockers that are specific for EPITHELIAL SODIUM CHANNELS.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062686"}, {"RECTYPE": "D", "MH": "Sodium Channel Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Stimulators, Sodium Channel", "MN": "D27.505.519.562.625", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "PI": "Sodium Channels/agonists (1988-2012)", "MS": "A class of drugs that stimulate sodium influx through cell membrane channels.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062687"}, {"RECTYPE": "D", "MH": "Buschke-Lowenstein Tumor", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "PRINT ENTRY": "Buschke-L\u00f6wenstein Tumor|T191|EPO|EQV|NLM (2013)|111212|abcdef", "ENTRY": "Tumor, Buschke-L\u00f6wenstein", "MN": "C17.800.838.790.810.110.500", "MH_TH": "NLM (2013)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "PI": "Penile Neoplasms (1960-2012)", "MS": "Exophytic tumor of the anogenital region associated with HPV infections. It becomes a large cauliflower-like, hyperkeratotic, verrucous mass that is locally destructive with little atypical cells. Histologically, tumor cells are broad rete peg structures that tend to invade deeper than CONDYLOMATA ACUMINATA.", "PM": "2013", "HN": "2013", "MR": "20210630", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062688"}, {"RECTYPE": "D", "MH": "Lipoblastoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "Lipoblastomatoses", "MN": "C04.557.450.550.400.500", "MH_TH": "NLM (2013)", "ST": "T191", "AN": "coordinate IM with precoordinated organ/neoplasm term (IM)", "PI": "Lipoma (1963-2012)", "MS": "Benign tumors of fatty tissues found in infancy and childhood. It is associated chromosomal aberrations that result in activation of an oncogene on chromosome band 8q12.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062689"}, {"RECTYPE": "D", "MH": "Vaccines, Live, Unattenuated", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaccines, Unattenuated|T121|T129|NON|EQV|NLM (2013)|111212|abbcdef", "ENTRY": "Vaccines, Live Unattenuated", "MN": "D20.215.894.882", "MH_TH": "NLM (2013)", "ST": "T129", "RN": "0", "AN": "coordinate NIM with specific vaccine (IM)", "MS": "Live vaccines prepared from microorganisms without their virulence altered. Examples include smallpox (vaccinia) and adenovirus vaccines.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062690"}, {"RECTYPE": "D", "MH": "Adenovirus Vaccines", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vaccines, Adenovirus|T121|T129|NON|EQV|NLM (2013)|120104|abbcdef", "ENTRY": "Vaccine, Adenovirus", "MN": "D20.215.894.899.024", "MH_TH": "NLM (2013)", "ST": "T129", "RN": "0", "AN": "use only for vaccines to prevent infection by ADENOVIRIDAE; not for adenovirus vector-based synthetic vaccines to prevent other infections (for example: adenovirus 5, rabies glycoprotein recombinant vaccine)", "MS": "Vaccines used to prevent infection by any virus from the family ADENOVIRIDAE.", "PM": "2014; was VACCINES, ADENOVIRUS 2013", "HN": "2014(2013)", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062705"}, {"RECTYPE": "D", "MH": "Prodromal Symptoms", "ENTRY": "Syndromes, Prodromal", "MN": "E01.599", "MH_TH": "NLM (2013)", "ST": "T184", "PI": "Early Diagnosis (1963-2012)", "MS": "Clinical or physiological indicators that precede the onset of disease.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062706"}, {"RECTYPE": "D", "MH": "Return to Work", "AQ": "EC ES HI LJ PX SN TD", "ENTRY": "Work, Return to", "MN": "N01.824.245.725", "FX": "Work Engagement", "MH_TH": "NLM (2013)", "ST": "T080", "MS": "Resumption of normal work routine following a hiatus or period of absence due to injury, disability, or other reasons.", "PM": "2013", "HN": "2013", "MR": "20170620", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062707"}, {"RECTYPE": "D", "MH": "Epithelial Sodium Channel Agonists", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Epithelial Sodium Channel Stimulators|T121|NON|EQV|NLM (2013)|111213|abcdef", "MN": "D27.505.519.562.625.249", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "PI": "Sodium Channels/agonists (1988-2012)", "MS": "Compounds that either stimulate the opening or prevent closure of EPITHELIAL SODIUM ION CHANNELS.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062708"}, {"RECTYPE": "D", "MH": "Tight Junction Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Tight Junction Protein|T116|T123|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Proteins, Tight Junction", "MN": "D12.776.543.940", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "Proteins that take part in the formation or structure of TIGHT JUNCTIONS.", "PM": "2013", "HN": "2013", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062725"}, {"RECTYPE": "D", "MH": "Junctional Adhesion Molecules", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Adhesion Molecules, Junctional", "MN": "D23.050.301.350.537", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "A family of membrane glycoproteins localized to TIGHT JUNCTIONS that contain two extracellular Ig-like domains, a single transmembrane segment, and a cytoplasmic tail of variable length.", "PM": "2013; JUNCTIONAL ADHESION MOLECULE (now JUNCTIONAL ADHESION MOLECULES) was indexed under CELL ADHESION MOLECULES 1998-2012", "HN": "2013", "MR": "20230316", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062726"}, {"RECTYPE": "D", "MH": "Coxsackie and Adenovirus Receptor-Like Membrane Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor, Coxsackie-Adenovirus", "MN": "D23.050.301.350.537.500", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2013)", "ST": "T192", "RN": "0", "MS": "An Ig superfamily transmembrane protein that localizes to junctional complexes that occur between ENDOTHELIAL CELLS and EPTHELIAL CELLS. The protein may play a role in cell-cell adhesion and is the primary site for the attachment of ADENOVIRUSES during infection.", "PM": "2013; CXADR-LIKE MEMBRANE PROTEIN (now COXSACKIE AND ADENOVIRUS RECEPTOR-LIKE MEMBRANE PROTEIN) was indexed under RECEPTORS, VIRUS 1997-2012", "HN": "2013", "MR": "20230316", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062727"}, {"RECTYPE": "D", "MH": "Junctional Adhesion Molecule A", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Receptor, F11", "MN": "D23.050.301.350.537.750", "MH_TH": "NLM (2013)", "ST": "T192", "RN": "0", "PI": "Receptors, Cell Surface (2000-2012)", "MS": "A cell adhesion protein that is found within TIGHT JUNCTIONS of ENDOTHELIAL CELLS and on the CELL MEMBRANE surface of circulating PLATELETS.", "PM": "2013", "HN": "2013", "MR": "20230316", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062745"}, {"RECTYPE": "D", "MH": "Junctional Adhesion Molecule B", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "CD322, Antigens", "MN": "D23.050.301.350.537.875", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Cell Adhesion Molecules (2005-2012)", "MS": "A junctional adhesion molecule subtype that is localized to high endothelial VENULES, heart ENDOTHELIUM, TROPHOBLASTS of the PLANCENTA, and in the ENDOTHELIUM of ARTERIOLES.", "PM": "2013", "HN": "2013", "MR": "20230316", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062765"}, {"RECTYPE": "D", "MH": "Hemiarthroplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Hemiarthroplasties", "MN": "E04.650.110.482", "MH_TH": "NLM (2013)", "ST": "T061", "PI": "Arthroplasty or specifics (1966-2012)", "MS": "A partial joint replacement in which only one surface of the joint is replaced with a PROSTHESIS.", "PM": "2013", "HN": "2013", "MR": "20220406", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062785"}, {"RECTYPE": "D", "MH": "Junctional Adhesion Molecule C", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Junctional Adhesion Molecule 3|T116|T123|NON|EQV|NLM (2013)|120103|abbcdef", "MN": "D23.050.301.350.537.937", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (2002-2006)", "MS": "A junctional adhesion molecule subtype that is expressed at high levels in PLACENTA; BRAIN; KIDNEY; and PLATELETS. It serves a variety of functions such as mediating leukocyte-platelet interactions, regulating trans-epithelial migration of POLYMORPHONUCLEAR LEUKOCYTES, and acting as a counter receptor for ALPHAM INTEGRIN.", "PM": "2013", "HN": "2013", "MR": "20230316", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062786"}, {"RECTYPE": "D", "MH": "Drug Overdose", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Overdoses, Drug", "MN": "F03.900.384.500.500", "MH_TH": "NLM (2013)", "ST": "T037", "MS": "Accidental or deliberate use of a medication or street drug in excess of normal dosage.", "PM": "2013", "HN": "2013", "MR": "20230405", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062787"}, {"RECTYPE": "D", "MH": "Adenomyosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Adenomyoses", "MN": "C12.100.250.852.113", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "The extension of endometrial tissue (ENDOMETRIUM) into the MYOMETRIUM. It usually occurs in women in their reproductive years and may result in a diffusely enlarged uterus with ectopic and benign endometrial glands and stroma.", "PM": "2013; see ENDOMETRITIS 1975-2012", "HN": "2013; use ENDOMETRITIS 1975-2012", "MR": "20210630", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062788"}, {"RECTYPE": "D", "MH": "Tobacco Products", "AQ": "AE AN CL EC HI LJ MI PO PS RE SD SN ST TO VI", "PRINT ENTRY": "Cigars|T073|NON|NRW|NLM (2013)|120127|abcdef", "ENTRY": "Tobaccos, Pipe", "MN": "J01.637.767.844", "FX": "Cigarette Smoking", "MH_TH": "NLM (2013)", "ST": "T073", "PI": "Tobacco (1974-2012)", "MS": "Substances and products derived from NICOTIANA TABACUM.", "PM": "2013", "HN": "2013", "MR": "20170619", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062789"}, {"RECTYPE": "D", "MH": "Optically Stimulated Luminescence Dosimetry", "AQ": "EC ES HI IS LJ MT SN ST", "PRINT ENTRY": "Optically Stimulated Luminescent Dosimetry|T057|NON|EQV|NLM (2013)|120103|abcdef", "MN": "N06.850.810.370.365", "MH_TH": "NLM (2013)", "ST": "T057", "MS": "The use of a radiation monitoring device composed of material which emits light after being illuminated. The amount of light emitted is proportional to the amount of IONIZING RADIATION to which the material has been previously exposed.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062791"}, {"RECTYPE": "D", "MH": "MARVEL Domain-Containing Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "MARVEL Domain Proteins|T116|T123|ABX|EQV|NLM (2013)|120103|abbcdef", "ENTRY": "Proteins, MARVEL Domain-Containing", "MN": "D12.776.543.488", "FX": "Tetraspanins", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "A family of proteins that share a domain with a four transmembrane-helix architecture referred to as the MARVEL domain. The MARVEL domain proteins play important role in vesicular trafficking and in the formation of TIGHT JUNCTIONS.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062792"}, {"RECTYPE": "D", "MH": "Occludin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Occludins|T116|T123|NON|EQV|NLM (2013)|120103|abbcdef", "MN": "D12.776.543.940.750", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "A MARVEL domain protein that binds to and regulates PROTEIN PHOSPHATASE 1. Occludin plays an important role in the formation and regulation of the TIGHT JUNCTION paracellular permeability barrier.", "PM": "2013; OCCLUDIN was indexed under MEMBRANE PROTEINS 1994-2012", "HN": "2013", "MR": "20160616", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062793"}, {"RECTYPE": "D", "MH": "MARVEL Domain Containing 2 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Tricellulin|T116|T123|NON|EQV|NLM (2013)|120103|abbcdef", "MN": "D12.776.543.940.675", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Membrane Proteins (2007-2012)", "MS": "A tight junction-associated MARVEL protein that may play a role in separating the endolymphatic and perilymphatic spaces of the ORGAN OF CORTI. Defects in the gene that codes for MARVELD2 protein are a cause of deafness autosomal recessive type 49.", "PM": "2013", "HN": "2013", "MR": "20160617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062794"}, {"RECTYPE": "D", "MH": "Synaptogyrins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Synaptogyrin|T116|T123|NON|EQV|NLM (2013)|120104|abbcdef", "MN": "D12.776.631.775", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "A subfamily of MARVEL domain-containing proteins that are found in SYNAPTIC VESICLES, where they may play a role in modulating neuronal signaling.", "PM": "2013; SYNAPTOGYRIN was indexed under MEMBRANE PROTEINS and NERVE TISSUE PROTEINS 1996-2012", "HN": "2013", "MR": "20151124", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062805"}, {"RECTYPE": "D", "MH": "Myelin and Lymphocyte-Associated Proteolipid Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Myelin and Lymphocyte-Associated Protein|T116|T123|NON|NRW|NLM (2013)|120104|abbcdef", "ENTRY": "T-cell MAL Protein", "MN": "D12.776.816.249", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "A family of MARVEL domain-containing proteolipid proteins involved in vesicular trafficking cycling between the GOLGI COMPLEX and the apical PLASMA MEMBRANE.", "PM": "2013; MAL PROTEIN, T-CELL was indexed under MYELIN PROTEINS, PROTEOLIPIDS, and MEMBRANE TRANSPORT PROTEINS 1996-2012; and under PROTEINS 1987-1996", "HN": "2013", "MR": "20151124", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062806"}, {"RECTYPE": "D", "MH": "Zonula Occludens Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Zona Occludens Proteins|T116|T123|NON|EQV|NLM (2013)|120105|abbcdef", "ENTRY": "Occludens Proteins, Zonula", "MN": "D12.776.543.940.900", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "A family of proteins that play a role in TIGHT JUNCTION formation by binding to and anchoring proteins to the ACTIN CYTOSKELETON.", "PM": "2013", "HN": "2013", "MR": "20160617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062825"}, {"RECTYPE": "D", "MH": "Zonula Occludens-1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Zona Occludens 1 Protein|T116|T123|NON|EQV|NLM (2013)|120105|abbcdef", "ENTRY": "Zonula Occludens 1 Protein", "MN": "D12.776.543.940.900.500", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "A 195-kDa zonula occludens protein with similarity to MEMBRANE-ASSOCIATED GUANYLATE KINASES. It is distinguished by the presence of a ZU5 domain at the C-terminal of the molecule.", "PM": "2013; ZONULA OCCLUDINS-1 PROTEIN was indexed under MEMBRANE PROTEINS and PHOSPHOPROTEINS 1988-2012", "HN": "2013", "MR": "20151224", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062826"}, {"RECTYPE": "D", "MH": "Zonula Occludens-2 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Zona Occludens 2 Protein|T116|T123|NON|EQV|NLM (2013)|120105|abbcdef", "ENTRY": "Zonula Occludens 2 Protein Isoform C1", "MN": "D12.776.543.940.900.750", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "A zonula occludens protein subtype found in epithelial cell junctions. Several isoforms of zonula occludens-2 protein exist due to use of alternative promoter regions and alternative mRNA splicings.", "PM": "2013; ZONULA OCCLUDENS-2 PROTEIN was indexed under MEMBRANE PROTEINS and PHOSPHOLIPIDS 1988-2012", "HN": "2013", "MR": "20160617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062827"}, {"RECTYPE": "D", "MH": "Chloroacetates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acids, Chloroacetic", "MN": "D02.455.526.439.196", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "PI": "Acetates (1978-2012)", "MS": "ACETIC ACID or acetic acid esters substituted with one or more CHLORINE atoms.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062845"}, {"RECTYPE": "D", "MH": "Non-Filarial Lymphedema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Non-Filarial Lymphedemas", "MN": "C15.604.496.660", "MH_TH": "NLM (2013)", "ST": "T047", "MS": "A form of elephantiasis caused by soil particles which penetrate the skin of the foot. It is limited to tropical regions with soils of high volcanic content.", "PM": "2013", "HN": "2013", "MR": "20140613", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062846"}, {"RECTYPE": "D", "MH": "Diuretics, Potassium Sparing", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Potassium Sparing Diuretics|T121|NON|EQV|NLM (2006)|040901|abcdef", "MN": "D27.505.696.560.500.726", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "MS": "A subclass of diuretics that limits the secretion of POTASSIUM into the URINE.", "PM": "2013; see SODIUM CHANNEL BLOCKERS 2002-2012", "HN": "2013; use SODIUM CHANNEL BLOCKERS 2002-2012", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062865"}, {"RECTYPE": "D", "MH": "Urinary Catheters", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Urinary Catheter", "MN": "E07.132.625", "FX": "Urinary Catheterization", "MH_TH": "NLM (2013)", "ST": "T074", "PI": "Urinary Catheterization (1964-2012)", "MS": "Catheters inserted into the URINARY BLADDER or kidney for therapeutic or diagnostic purposes.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062885"}, {"RECTYPE": "D", "MH": "Central Venous Catheters", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Venous Catheters, Central", "MN": "E07.132.750.500", "FX": "Catheterization, Central Venous", "MH_TH": "NLM (2013)", "ST": "T074", "PI": "Catheterization, Central Venous (1969-2012)", "MS": "Catheters that are inserted into a large central vein such as a SUBCLAVIAN VEIN or FEMORAL VEIN.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062905"}, {"RECTYPE": "D", "MH": "Cardiac Catheters", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Intracardiac Catheter", "MN": "E07.132.750.249", "FX": "Cardiac Catheterization", "MH_TH": "NLM (2013)", "ST": "T074", "PI": "Cardiac Catheterization (1963-2012)", "MS": "Catheters inserted into various locations within the heart for diagnostic or therapeutic purposes.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062906"}, {"RECTYPE": "D", "MH": "Oxaloacetic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Acid, Oxaloacetic", "MN": "D02.241.755.648.750", "EC": "analogs & derivatives:Oxaloacetates", "MH_TH": "NLM (1999)", "ST": "T123", "N1": "Butanedioic acid, 2-oxo-", "RN": "2F399MM81J", "RR": "328-42-7 (Oxaloacetic Acid)", "MS": "A dicarboxylic acid ketone that is an important metabolic intermediate of the CITRIC ACID CYCLE. It can be converted to ASPARTIC ACID by ASPARTATE TRANSAMINASE.", "PM": "2013; for OXALOACETATE see OXALOACETATE 1999-2012", "HN": "2013", "MR": "20130708", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062907"}, {"RECTYPE": "D", "MH": "rho-Specific Guanine Nucleotide Dissociation Inhibitors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "rho Guanine Nucleotide Dissociation Inhibitor|T116|T123|NON|EQV|NLM (2022)|201023|abbcdef", "ENTRY": "rho Specific Guanine Nucleotide Dissociation Inhibitors", "MN": "D12.776.476.325.225.500", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "A subcategory of guanine nucleotide dissociation inhibitors that are specific for RHO GTP-BINDING PROTEINS.", "PM": "2013; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS now RHO-SPECIFIC GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS was indexed under GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS 2000-2012", "HN": "2013", "MR": "20210630", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062947"}, {"RECTYPE": "D", "MH": "rho Guanine Nucleotide Dissociation Inhibitor alpha", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "rho GDP Dissociation Inhibitor 1", "MN": "D12.776.476.325.225.500.100", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "An abundantly-expressed rho GDP-dissociation inhibitor subtype that regulates a broad variety of RHO GTPASES.", "PM": "2013; RHO-GDIALPHA was indexed under GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS 2011-2012, RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 1 was indexed under GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS 2012", "HN": "2013", "MR": "20151124", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062948"}, {"RECTYPE": "D", "MH": "rho Guanine Nucleotide Dissociation Inhibitor beta", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "rho GDP Dissociation Inhibitor beta", "MN": "D23.050.705.552.600.700", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "PI": "Guanine Nucleotide Dissociation Inhibitors (2000-2012)", "MS": "A rho GDP-dissociation inhibitor subtype that is highly expressed in hematopoietic cells and in LYMPHOCYTES. The expression of this subtype is associated with the regulation of CELL PROLIFERATION; TUMORIGENESIS; and APOPTOSIS.", "PM": "2013", "HN": "2013", "MR": "20151221", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062949"}, {"RECTYPE": "D", "MH": "rho Guanine Nucleotide Dissociation Inhibitor gamma", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "rhoGDIgamma|T116|T123|ABB|EQV|NLM (1998)|abbcde", "MN": "D12.776.476.325.225.500.300", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "A rho GDP-dissociation inhibitor subtype that has a unique C-terminal alpha helical membrane-binding domain. It is found bound to CYTOPLASMIC VESICLES such as those associated with the GOLGI APPARATUS.", "PM": "2013; RHOGDI GAMMA (now RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR GAMMA) was indexed under GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS 1999-2012", "HN": "2013", "MR": "20151124", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062950"}, {"RECTYPE": "D", "MH": "Endoreduplication", "AQ": "DE GE IM PH RE", "ENTRY": "Polytenizations", "MN": "G05.226.820", "FX": "Polytene Chromosomes", "MH_TH": "NLM (2013)", "ST": "T045", "MS": "A type of nuclear polyploidization in which multiple cycles of DNA REPLICATION occur in the absence of CELL DIVISION and result in a POLYPLOID CELL.", "PM": "2013", "HN": "2013", "MR": "20160617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062951"}, {"RECTYPE": "D", "MH": "Stratospheric Ozone", "AQ": "AN CH", "PRINT ENTRY": "Ozone Layer|T082|NON|NRW|NLM (2013)|120201|abcdef", "ENTRY": "Ozone, Stratospheric", "MN": "N06.230.300.100.700", "MH_TH": "NLM (2013)", "ST": "T103", "RN": "0", "PI": "Ozone (1975-2012)", "MS": "Ozone in the Earth's stratosphere. It is produced continuously by the action of solar ULTRAVIOLET RAYS on oxygen in the stratosphere. The stratospheric ozone (especially at the ozone layer) blocks much of the solar UV radiation of wavelengths of 320 nanometers or less from being transmitted to lower ATMOSPHERE of the Earth.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062952"}, {"RECTYPE": "D", "MH": "Cyclic GMP-Dependent Protein Kinase Type I", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "cGMP Dependent Protein Kinase Ibeta", "MN": "D12.776.476.563.150.150.500", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 2.7.11.12", "RR": "EC 2.7.11.12", "MS": "A cyclic GMP-dependent protein kinase subtype that is expressed in SMOOTH MUSCLE tissues and plays a role in regulation of smooth muscle contraction. Two isoforms, PKGIalpha and PKGIbeta, of the type I protein kinase exist due to alternative splicing of its mRNA.", "PM": "2013; CGMP-DEPENDENT PROTEIN KINASE I (now CYCLIC GMP-DEPENDENT PROTEIN KINASE TYPE I) was indexed under CYCLIC GMP DEPENDENT PROTEIN KINASE TYPE I 1994-2012", "HN": "2013", "MR": "20210521", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062965"}, {"RECTYPE": "D", "MH": "Ozone Depletion", "AQ": "EC HI LJ PC SN TD", "ENTRY": "Ozone Holes", "MN": "N06.230.300.100.700.500", "MH_TH": "NLM (2013)", "ST": "T067", "PI": "Ozone (1978-2012)", "MS": "A shift in the balance between production and destruction of STRATOSPHERIC OZONE that results in a decline of the amount of OZONE in the lower stratosphere.", "PM": "2013", "HN": "2013", "MR": "20160623", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062966"}, {"RECTYPE": "D", "MH": "Cyclic GMP-Dependent Protein Kinase Type II", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "cGMP Dependent Protein Kinase II", "MN": "D12.776.476.563.150.150.750", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 2.7.11.12", "MS": "A cyclic GMP-dependent protein kinase subtype that is expressed predominantly in INTESTINES, BRAIN, and KIDNEY. The protein is myristoylated on its N-terminus which may play a role its membrane localization.", "PM": "2013; CGMP-DEPENDENT PROTEIN KINASE II (now CYCLIC GMP-DEPENDENT PROTEIN KINASE TYPE II) was indexed under CYCLIC GMP-DEPENDENT PROTEIN KINASES 1998-2012", "HN": "2013", "MR": "20210521", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062967"}, {"RECTYPE": "D", "MH": "Health Services for Transgender Persons", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "PRINT ENTRY": "Health Services for Transgendered Persons|T058|NON|EQV|NLM (2013)|120209|abcdef", "MN": "N02.421.325", "FX": "Transgender Persons", "MH_TH": "NLM (2016)", "ST": "T058", "MS": "Access to specialized care for transgender populations. Health systems organized to take account of the special healthcare needs of marginalized groups who may face barriers in accessing health services. (http://www.who.int/reproductivehealth/topics/linkages/guidance_package.pdf)", "PM": "2016; SEE HEALTH SERVICES FOR TRANSGENDERED PERSONS 2013-2015", "HN": "2016 (2013)", "MR": "20150626", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D062985"}, {"RECTYPE": "D", "MH": "Health Information Systems", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Systems, Health Information", "MN": "L01.313.500.750.300.361", "MH_TH": "NLM (2013)", "ST": "T170", "MS": "A system for the collection and/or processing of data from various sources, and using the information for policy making and management of health services. It could be paper-based or electronic. (From http://web.worldbank.org/WBSITE/EXTERNAL/TOPICS/EXTHEALTHNUTRITIONANDPOPULATION/EXTHSD/0,,contentMDK:22239824~menuPK:376799~pagePK:148956~piPK:216618~theSitePK:376793,00.html. http://www.who.int/healthinfo/systems/en/)", "PM": "2013", "HN": "2013", "MR": "20150622", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063005"}, {"RECTYPE": "D", "MH": "Health Information Management", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Managements, Health Information", "MN": "L01.399.500", "MH_TH": "NLM (2013)", "ST": "T057", "MS": "Management of the acquisition, organization, retrieval, and dissemination of health information.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063025"}, {"RECTYPE": "D", "MH": "Dual MEDICAID MEDICARE Eligibility", "MN": "N03.109", "MH_TH": "NLM (2013)", "ST": "T064", "MS": "Coordination of coverage eligibility of those individuals who are entitled to MEDICAID and MEDICARE.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063026"}, {"RECTYPE": "D", "MH": "Crowdsourcing", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "PRINT ENTRY": "Cyber Crowdsourcing|T062|NON|EQV|NLM (2022)|210205|abcdef", "ENTRY": "Sourcing, Crowd", "MN": "L01.399.250.179", "MH_TH": "NLM (2013)", "ST": "T062", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "Social media model for enabling public involvement and recruitment in participation. Use of social media to collect feedback and recruit volunteer subjects.", "PM": "2013", "HN": "2013", "MR": "20210326", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063045"}, {"RECTYPE": "D", "MH": "Patient Medication Knowledge", "AQ": "CL EC ES HI LJ MT NU OG SN ST TD", "ENTRY": "Medication Knowledge, Patient", "MN": "N02.421.726.407.229.500.500", "MH_TH": "NLM (2013)", "ST": "T058", "MS": "Patient health knowledge related to medications including what is being used and why as well as instructions and precautions.", "PM": "2013", "HN": "2013", "MR": "20180629", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063046"}, {"RECTYPE": "D", "MH": "Organophosphonates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "PRINT ENTRY": "Phosphonate|T109|NON|REL|NLM (2021)|191115|abcdef", "ENTRY": "Esters, Phosphonic Acid", "MN": "D02.705.429", "EC": "poisoning:Organophosphate Poisoning", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "MS": "Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P=O)O2 structure.", "PM": "2013; for PHOSPHONATES and PHOSPHONIC ACID ESTERS see PHOSPHONIC ACIDS 2005-2012", "HN": "2013", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063065"}, {"RECTYPE": "D", "MH": "Organofluorophosphonates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "MN": "D02.705.429.750", "EC": "poisoning:Organophosphate Poisoning", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "MS": "A subclass of organophosphates that have a FLUORINE atom substituted for one of the OXYGEN atoms.", "PM": "2013", "HN": "2013", "MR": "20121016", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063066"}, {"RECTYPE": "D", "MH": "Organothiophosphonates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Organodithiophosphonates|T109|NON|REL|NLM (2013)|120217|abcdef", "MN": "D02.886.300.846", "EC": "poisoning:Organophosphate Poisoning", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "PI": "Organothiophosphorus Compounds (1972-2012)", "MS": "Carbon-containing thiophosphonic acid compounds. Included under this heading are compounds that have carbon bound to either SULFUR atom, PHOSPHOROUS atom, or the OXYGEN atom of the SPO2 core structure.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063085"}, {"RECTYPE": "D", "MH": "Organothiophosphates", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK RE SD ST TO TU UR", "ENTRY": "Esters, Thiophosphoric Acid", "MN": "D02.886.300.692", "EC": "poisoning:Organophosphate Poisoning", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "PI": "Organothiophosphorus Compounds (1972-2012)", "MS": "Carbon-containing thiophosphoric acid derivatives. Included under this heading are compounds that have carbon bound to either SULFUR atom, or the OXYGEN atom of the SPO3 core structure.", "PM": "2013; for THIOPHOSPHORIC ACID ESTERS use THIOPHOSPHORIC ACID ESTERS 1975-2012", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063086"}, {"RECTYPE": "D", "MH": "Noninvasive Ventilation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Ventilations, Noninvasive", "MN": "E02.880.820.657", "MH_TH": "NLM (2013)", "ST": "T061", "PI": "Respiration, Artificial or specifics (1993-2012)", "MS": "Techniques for administering artificial respiration without the need for INTRATRACHEAL INTUBATION.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063087"}, {"RECTYPE": "D", "MH": "Phosphoramides", "AQ": "AA AD AE AG AI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D02.705.672", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "PI": "Organophosphorus Compounds (1971-2012)", "MS": "Amide derivatives of phosphoric acid such as compounds that include the phosphoric triamide (P(=O)(N)(N)(N)) structure.", "PM": "2013", "HN": "2013", "MR": "20130708", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063088"}, {"RECTYPE": "D", "MH": "Food Assistance", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "WIC Programs", "MN": "N03.219.521.346.506.281", "MH_TH": "NLM (2013)", "ST": "T057", "AN": "do not confuse with FOOD SERVICES", "MS": "Food or financial assistance for food given to those in need.", "PM": "2013", "HN": "2013", "MR": "20160630", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063105"}, {"RECTYPE": "D", "MH": "Transgender Persons", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Transmasculine Persons|T098|NON|NRW|NLM (2024)|230419|abcdef", "ENTRY": "Two-Spirit Person", "MN": "M01.909", "FX": "Transsexualism", "MH_TH": "NLM (2013)", "ST": "T098", "AN": "index both MALE and FEMALE check tags", "PI": "Transsexualism (2001-2012)", "MS": "Persons having a sense of persistent identification with, and expression of, gender-coded behaviors not typically associated with one's anatomical sex at birth, with or without a desire to undergo SEX REASSIGNMENT PROCEDURES.", "PM": "2016; see TRANSGENDERED PERSONS 2013-2015", "HN": "2016 (2013)", "MR": "20230531", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063106"}, {"RECTYPE": "D", "MH": "Balloon Embolectomy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Fogarty Balloon Catheterization|T061|EPO|NRW|UNK (19XX)|870508|FOGARTY BALLOON CATH|abcdefv", "ENTRY": "Embolectomy, Balloon", "MN": "E05.157.032", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "The use of balloon CATHETERS to remove emboli by retraction of the balloon that is inflated behind the EMBOLUS.", "PM": "2013; for FOGARTY BALLOON CATHETHERIZATION see BALLOON DILATION 1988-2012", "HN": "2013", "MR": "20150622", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063125"}, {"RECTYPE": "D", "MH": "Balloon Valvuloplasty", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Balloon Valvotomy|T061|NON|EQV|UNK (19XX)|880506|abcdef", "ENTRY": "Valvuloplasty, Balloon", "MN": "E05.157.125", "MH_TH": "UNK (19XX)", "ST": "T061", "PI": "Catheterization (1982-2012)", "MS": "Widening of a stenosed HEART VALVE by the insertion of a balloon CATHETER into the valve and inflation of the balloon.", "PM": "2013", "HN": "2013", "MR": "20150622", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063126"}, {"RECTYPE": "D", "MH": "Secondary Care", "AQ": "CL EC EH ES HI LJ MT OG SN ST TD", "ENTRY": "Secondary Cares", "MN": "N05.300.745", "MH_TH": "NLM (2013)", "ST": "T058", "MS": "Specialized healthcare delivered as a follow-up or referral from a PRIMARY CARE provider.", "PM": "2013", "HN": "2013", "MR": "20180629", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063127"}, {"RECTYPE": "D", "MH": "Tertiary Healthcare", "AQ": "CL EC EH ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Tertiary Care|T058|NON|EQV|NLM (2013)|120229|abcdef", "ENTRY": "Healthcare, Tertiary", "MN": "N05.300.787", "MH_TH": "NLM (2013)", "ST": "T058", "AN": "TERTIARY CARE CENTERS is also available", "MS": "Care of a highly technical and specialized nature, provided in a medical center, usually one affiliated with a university, for patients with unusually severe, complex, or uncommon health problems.", "PM": "2013", "HN": "2013", "MR": "20180629", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063128"}, {"RECTYPE": "D", "MH": "Parental Death", "AQ": "CL EC EH ES ET HI LJ PC PX SN TD", "ENTRY": "Paternal Deaths", "MN": "I01.880.735.607", "MH_TH": "NLM (2013)", "ST": "T040", "MS": "The death of the father or mother or another person in this role.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063129"}, {"RECTYPE": "D", "MH": "Maternal Death", "AQ": "CL EC EH ES ET HI LJ PC PX SN TD", "ENTRY": "Maternal Deaths", "MN": "I01.880.735.607.500", "MH_TH": "NLM (2013)", "ST": "T040", "AN": "do not confuse with MATERNAL MORTALITY, a statistical concept", "PI": "Maternal Mortality (1963-2012)", "MS": "The death of the female parent.", "PM": "2013", "HN": "2013", "MR": "20210630", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063130"}, {"RECTYPE": "D", "MH": "Connectome", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Connectomics|T091|NON|NRW|NLM (2013)|120301|abcdef", "ENTRY": "Mappings, Connectome", "MN": "E05.629.875.500.500", "MH_TH": "NLM (2013)", "ST": "T017", "MS": "A comprehensive map of the physical interconnections of an organism's neural networks. This modular organization of neuronal architecture is believed to underlie disease mechanisms and the biological development of the CENTRAL NERVOUS SYSTEM.", "PM": "2013", "HN": "2013", "MR": "20160531", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063132"}, {"RECTYPE": "D", "MH": "Polycomb-Group Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Polycomb-Group Protein Complex|T116|T123|NON|REL|NLM (2021)|191120|abbcdef", "ENTRY": "Protein, Polycomb-Group", "MN": "D12.776.930.780.890", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "MS": "A family of proteins that play a role in CHROMATIN REMODELING. They are best known for silencing HOX GENES and the regulation of EPIGENETIC PROCESSES.", "PM": "2013; POLYCOMB GROUP PROTEINS was indexed under REPRESSOR PROTEINS 1998-2012, and TRANSCRIPTION FACTORS 1997", "HN": "2013", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063146"}, {"RECTYPE": "D", "MH": "Animal Distribution", "AQ": "CL DE ES PH RE", "PRINT ENTRY": "Animal Dispersal|T054|T055|NON|EQV|NLM (2013)|120302|abbcdef", "ENTRY": "Distributions, Animal", "MN": "G16.049", "MH_TH": "NLM (2013)", "ST": "T055", "MS": "A process by which animals in various forms and stages of development are physically distributed through time and space.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063147"}, {"RECTYPE": "D", "MH": "Plant Dispersal", "AQ": "DE ES GE IM PH RE", "ENTRY": "Plant Distributions", "MN": "G15.620", "MH_TH": "NLM (2013)", "ST": "T067", "MS": "The physical distribution of plants in various forms and stages of development through time and space.", "PM": "2013", "HN": "2013", "MR": "20160623", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063148"}, {"RECTYPE": "D", "MH": "Polycomb Repressive Complex 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.930.780.890.100", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 2.3.2.27", "PI": "Transcription Factors (1997)", "MS": "A multisubunit polycomb protein complex with affinity for CHROMATIN that contains methylated HISTONE H3. It contains an E3 ubiquitin ligase activity that is specific for HISTONE H2A and works in conjunction with POLYCOMB REPRESSIVE COMPLEX 2 to effect EPIGENETIC REPRESSION.", "PM": "2013", "HN": "2013", "MR": "20160602", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063150"}, {"RECTYPE": "D", "MH": "Polycomb Repressive Complex 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.930.780.890.200", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 2.1.1.43", "PI": "Transcription Factors (1997)", "MS": "A multisubunit polycomb protein complex that catalyzes the METHYLATION of chromosomal HISTONE H3. It works in conjunction with POLYCOMB REPRESSIVE COMPLEX 1 to effect EPIGENETIC REPRESSION.", "PM": "2013", "HN": "2013", "MR": "20180116", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063151"}, {"RECTYPE": "D", "MH": "Mitochondrial Dynamics", "AQ": "DE GE IM PH RE", "ENTRY": "Mitochondrial Fusions", "MN": "G04.599.750", "MH_TH": "NLM (2013)", "ST": "T043", "PI": "Mitochondria (1992-2012)", "MS": "The continuous remodeling of MITOCHONDRIA shape by fission and fusion in response to physiological conditions.", "PM": "2013", "HN": "2013", "MR": "20160617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063154"}, {"RECTYPE": "D", "MH": "Neurotology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Neuro Otology", "MN": "H02.403.810.526.500", "MH_TH": "NLM (2013)", "ST": "T091", "AN": "use for the specialty only", "MS": "A subspecialty of otolaryngology dealing with the parts of the nervous system related to the ear.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063165"}, {"RECTYPE": "D", "MH": "Maxillary Osteotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Osteotomy, Maxillary", "MN": "E06.645.562.750", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "Surgery of the upper jaw bone usually performed to correct upper and lower jaw misalignment.", "PM": "2013", "HN": "2013", "MR": "20170620", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063166"}, {"RECTYPE": "D", "MH": "Mandibular Osteotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Segmental Mandibulectomy|T061|NON|REL|NLM (2013)|120306|abcdef", "ENTRY": "Segmental Mandibulectomies", "MN": "E06.645.562.374", "FX": "Mandibular Reconstruction", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "Intraoral OSTEOTOMY of the lower jaw usually performed in order to correct MALOCCLUSION.", "PM": "2013", "HN": "2013", "MR": "20170620", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063168"}, {"RECTYPE": "D", "MH": "Dentofacial Deformities", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dyplasias, Dentofacial", "MN": "C16.131.850.500.229", "MH_TH": "NLM (2013)", "ST": "T020", "MS": "An abnormality of the jaws or teeth affecting the contour of the face. Such abnormality could be acquired or congenital.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063169"}, {"RECTYPE": "D", "MH": "Corneal Pachymetry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Thickness Measurements, Corneal", "MN": "E01.370.380.112", "MH_TH": "NLM (2013)", "ST": "T060", "PI": "Diagnostic Techniques, Ophthalmological (1990-2012)", "MS": "Measurement of the thickness of the CORNEA.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063171"}, {"RECTYPE": "D", "MH": "Genioplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Repositionings, Chin", "MN": "E06.645.562.249", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "A surgical procedure done largely for cosmetic reasons to correct receding chins, chin misalignment, or chin excess.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063172"}, {"RECTYPE": "D", "MH": "Retrognathia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Retrusions, Maxillary", "MN": "C16.131.850.500.460.827", "FX": "Mandibular Advancement", "MH_TH": "NLM (2013)", "ST": "T190", "MS": "A physical misalignment of the upper (maxilla) and lower (mandibular) jaw bones in which either or both recede relative to the frontal plane of the forehead.", "PM": "2013; see Retrognathism 2000-2012", "HN": "2013; use Retrognathism 2000-2012", "MR": "20140613", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063173"}, {"RECTYPE": "D", "MH": "Mandibular Reconstruction", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgery, Mandibular Reconstructive", "MN": "E06.645.562.500", "FX": "Mandibular Osteotomy", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "The physical restoration of oromandibular defects.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063175"}, {"RECTYPE": "D", "MH": "Pulse Wave Analysis", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Wave Velocity, Pulse", "MN": "E01.370.370.680", "MH_TH": "NLM (2013)", "ST": "T060", "AN": "note entry term PULSE WAVE VELOCITY: do not confuse with BLOOD FLOW VELOCITY", "MS": "Evaluation of the contour of the PULSE waves which vary in different parts of the circulation and depend on physiological as well as pathophysiological conditions of the individual.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063177"}, {"RECTYPE": "D", "MH": "Epigenetic Repression", "AQ": "DE GE IM PH RE", "ENTRY": "Repression, Epigenetic", "MN": "G05.308.203.311", "MH_TH": "NLM (2013)", "ST": "T045", "PI": "Epigenesis, Genetic (2004-2012)", "MS": "The turning off of GENETIC TRANSCRIPTION in certain regions of CHROMATIN without changes in the DNA sequence. Typically epigenetic repression is a way that developmental changes are programmed at the cellular level.", "PM": "2013", "HN": "2013", "MR": "20160617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063185"}, {"RECTYPE": "D", "MH": "Uterine Myomectomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Uterine Myomectomies", "MN": "E04.950.300.941", "MH_TH": "NLM (2013)", "ST": "T061", "PI": "Uterine Neoplasms/surgery (1965-2012)", "MS": "Surgical removal of a LEIOMYOMA of the UTERUS.", "PM": "2013", "HN": "2013", "MR": "20160226", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063186"}, {"RECTYPE": "D", "MH": "Nursing Stations", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Stations, Nursing", "MN": "N02.278.388.620", "MH_TH": "NLM (2013)", "ST": "T093", "MS": "An area in a clinic, unit, or ward in a health care facility that serves as the administrative center for nursing care. (from Mosby's Medical Dictionary, 8th ed)", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063187"}, {"RECTYPE": "D", "MH": "Rana clamitans", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI", "PRINT ENTRY": "Green Frog|T011|NON|EQV|UNK (19XX)|750101|abcdef", "ENTRY": "Northern Green Frogs", "MN": "B01.050.150.900.090.180.708.210", "MH_TH": "NLM (2013)", "ST": "T011", "RN": "txid145282", "RR": "txid1574420", "AN": "NIM with no qualifiers when experimental animal", "PI": "Ranidae (1974-2012)", "MS": "A species of the family Ranidae which occurs primarily in the eastern half of the United States and Canada. Two subspecies exist, commonly referred to as green frog (R. c. melanota) and bronze frog (R. c. clamitans).", "PM": "2013; for Green Frog see Rana esculenta (1976-2012)", "HN": "2013", "MR": "20200902", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063188"}, {"RECTYPE": "D", "MH": "Symptom Assessment", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Symptom Evaluations", "MN": "E01.370.872", "MH_TH": "NLM (2013)", "ST": "T058", "MS": "Evaluation of manifestations of disease.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063189"}, {"RECTYPE": "D", "MH": "Odonata", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Zygopteras", "MN": "B01.050.500.131.617.720.750.750", "MH_TH": "NLM (2013)", "ST": "T204", "RN": "txid6961", "RR": "txid6962", "AN": "for killing Odonata with insecticides, see note at INSECTICIDES", "PI": "Insects (1964-2012)", "MS": "An order of insects comprising three suborders: Anisoptera, Zygoptera, and Anisozygoptera. They consist of dragonflies and damselflies.", "PM": "2013", "HN": "2013", "MR": "20200813", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063191"}, {"RECTYPE": "D", "MH": "Pregnancy, Heterotopic", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pregnancies, Heterotopic", "MN": "C12.050.703.733.650", "MH_TH": "NLM (2013)", "ST": "T047", "AN": "check the tags FEMALE & PREGNANCY; coordinate with specific type of ectopic pregnancy if pertinent", "PI": "Pregnancy, Tubal (1964-2012)", "MS": "MULTIPLE PREGNANCY with EMBRYO IMPLANTATION occuring at different locations, involving both an intrauterine site and an extrauterine (ECTOPIC PREGNANCY) site.", "PM": "2013", "HN": "2013", "MR": "20210630", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063192"}, {"RECTYPE": "D", "MH": "Heavy Ion Radiotherapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Therapy, Heavy Ion", "MN": "E02.815.250", "MH_TH": "NLM (2013)", "ST": "T061", "PI": "Radiotherapy (2002-2012)", "MS": "The use of a heavy ion particle beam for radiotherapy, such as the HEAVY IONS of CARBON.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063193"}, {"RECTYPE": "D", "MH": "Adventitia", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tissues, Adventitious", "MN": "A10.165.189", "MH_TH": "NLM (2005)", "ST": "T024", "MS": "The outermost covering of organs, blood vessels, and other such structures in the body.", "PM": "2013; see CONNECTIVE TISSUE 2005-2012", "HN": "2013; use CONNECTIVE TISSUE 2005-2012", "MR": "20180630", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063194"}, {"RECTYPE": "D", "MH": "Pneumorrhachis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Subarachnoid Pneumorrhachis", "MN": "C10.228.854.583", "MH_TH": "NLM (2013)", "ST": "T047", "PI": "Emphysema (1994-2012)", "MS": "Presence of air or gas within the spinal canal cavity (EPIDURAL SPACE; or SUBARACHNOID SPACE). It may result from traumatic injuries, emphysema, infection and other conditions. It can also develop as a complication of various SURGICAL PROCEDURES (e.g., MYELOGRAPHY).", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063205"}, {"RECTYPE": "D", "MH": "N-Terminal Acetyltransferases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "N-alpha-Acetyltransferase|T116|T126|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Peptide N alpha Acetyltransferases", "MN": "D08.811.913.050.134.423", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 2.3.1.88", "AN": "do not confuse with AMINO-ACID N-ACETYLTRANSFERASE", "PI": "Acetyltransferases (1974-2012)", "MS": "Enzymes that catalyze the transfer of an acetyl group, usually from ACETYL COENZYME A, to the N-terminus of a peptide chain.", "PM": "2013; PEPTIDE N-ALPHA ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1984-2012", "HN": "2013", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063206"}, {"RECTYPE": "D", "MH": "Methionyl Aminopeptidases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "N Terminal Methionine Specific Peptidase", "MN": "D08.811.277.656.350.100.633", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 3.4.11.18", "MS": "Aminopeptidases that remove METHIONINE from the amino-terminus of a peptide chain, such as the initiator METHIONINE found on nascent peptide chains.", "PM": "2013; METHIONYL AMINOPEPTIDASE was indexed under AMINOPEPTIDASES 1981-2012", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063208"}, {"RECTYPE": "D", "MH": "N-Terminal Acetyltransferase A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NatA N Terminal Acetyltransferase", "MN": "D08.811.913.050.134.423.100", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 2.3.1.254", "PI": "Acetyltransferases (1974-2012)", "MS": "An N-terminal acetyltransferase subtype that consists of the Naa10p catalytic subunit and the Naa15p auxiliary subunit. The structure of this enzyme is conserved between lower and higher eukaryotes. It has specificity for N-terminal SERINE; ALANINE; THREONINE; GLYCINE; VALINE; and CYSTINE residues and acts on nascent peptide chains after the removal of the initiator METHIONINE by METHIONYL AMINOPEPTIDASES.", "PM": "2013", "HN": "2013", "MR": "20190705", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063209"}, {"RECTYPE": "D", "MH": "N-Terminal Acetyltransferase B", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NatB N Terminal Acetyltransferase", "MN": "D08.811.913.050.134.423.200", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 2.3.1.255", "PI": "Acetyltransferases (1974-2012)", "MS": "An N-terminal acetyltransferase subtype that consists of the Naa20p catalytic subunit and the Naa25p auxiliary subunit. The structure of this enzyme is conserved between YEASTS and HUMAN. It has specificity for the N-terminal METHIONINE of peptides where the next amino acid in the chain is either ASPARTATE; GLUTAMATE; ASPARAGINE; or GLUTAMINE.", "PM": "2013", "HN": "2013", "MR": "20200205", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063210"}, {"RECTYPE": "D", "MH": "N-Terminal Acetyltransferase C", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NatC N Terminal Acetyltransferase", "MN": "D08.811.913.050.134.423.300", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 2.3.1.256", "PI": "Acetyltransferases (1974-2012)", "MS": "An N-terminal acetyltransferase subtype that consists of the Naa30p catalytic subunit, and the Naa35p and Naa38p auxiliary subunits. It has specificity for the N-terminal METHIONINE of peptides where the next amino acid in the chain is either LEUCINE; PHENYALANINE; ISOLEUCINE; or TRYPTOPHANE.", "PM": "2013", "HN": "2013", "MR": "20190705", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063211"}, {"RECTYPE": "D", "MH": "N-Terminal Acetyltransferase D", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NatD N Terminal Acetyltransferase", "MN": "D08.811.913.050.134.423.400", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 2.3.1.257", "PI": "Acetyltransferases (1974-2012)", "MS": "An N-terminal acetyltransferase subtype that consists of the Naa40p catalytic subunit. It has specificity for N-termini of HISTONE H2A and HISTONE H4.", "PM": "2013", "HN": "2013", "MR": "20190705", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063212"}, {"RECTYPE": "D", "MH": "N-Terminal Acetyltransferase E", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NatE N Terminal Acetyltransferase", "MN": "D08.811.913.050.134.423.500", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 2.3.1.258", "PI": "Acetyltransferases (1974-2012)", "MS": "An N-terminal acetyltransferase subtype that consists of the Naa50p catalytic subunit, and the Naa10p and Naa15p auxiliary subunits. It has specificity for the N-terminal METHIONINE of peptides where the next amino acid in the chain is hydrophobic.", "PM": "2013", "HN": "2013", "MR": "20190705", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063213"}, {"RECTYPE": "D", "MH": "N-Terminal Acetyltransferase F", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "NatF N Terminal Acetyltransferase", "MN": "D08.811.913.050.134.423.600", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 2.3.1.259", "PI": "Acetyltransferases (1974-2012)", "MS": "An N-terminal acetyltransferase subtype that consists of the Naa60p catalytic subunit. It is found in higher eukayotes and displays a substrate specificity for the N-terminal METHIONINE of peptides where the next amino acid in the chain is either LEUCINE; LYSINE; PHENYALANINE; ISOLEUCINE; or TRYPTOPHANE.", "PM": "2013", "HN": "2013", "MR": "20190705", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063214"}, {"RECTYPE": "D", "MH": "Organically Modified Ceramics", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Ormocers", "MN": "J01.637.153.688", "MH_TH": "NLM (2013)", "ST": "T122", "RN": "0", "MS": "Organic-inorganic hybrid polymers developed primarily for DENTAL RESTORATION. They typically contain a defined mixture of ORGANOSILICON COMPOUNDS; CERAMICS; and organic POLYMERS.", "PM": "2013; ORMOCER was indexed under CERAMICS and SILANES 2003-2012", "HN": "2013", "MR": "20190627", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063225"}, {"RECTYPE": "D", "MH": "Central Pattern Generators", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "PRINT ENTRY": "Pacemaker Neurons|T025|NON|REL|NLM (2023)|220317|abcdef", "ENTRY": "Pacemaker Neuron", "MN": "A08.511.500", "FX": "Commissural Interneurons", "MH_TH": "NLM (2013)", "ST": "T023", "MS": "Networks of nerve cells that control the firing patterns of MOTOR NEURONS to produce rhythmic movements such as MASTICATION; WALKING; SWIMMING; RESPIRATION; and PERISTALSIS.", "PM": "2013", "HN": "2013", "MR": "20220413", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063226"}, {"RECTYPE": "D", "MH": "Plant Development", "AQ": "DE GE IM PH RE", "ENTRY": "Plant Morphogeneses", "MN": "G15.589", "MH_TH": "NLM (2013)", "ST": "T038", "AN": "general or unspecified; prefer /growth with specific plant", "MS": "Processes orchestrated or driven by a plethora of genes, plant hormones, and inherent biological timing mechanisms facilitated by secondary molecules, which result in the systematic transformation of plants and plant parts, from one stage of maturity to another.", "PM": "2013", "HN": "2013", "MR": "20160623", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063245"}, {"RECTYPE": "D", "MH": "Organogenesis, Plant", "AQ": "DE GE IM PH RE", "ENTRY": "Plant Organogenesis", "MN": "G15.525", "MH_TH": "NLM (2013)", "ST": "T038", "MS": "Transformative processes which occur in cells and tissues to produce differentiated plant organs.", "PM": "2013", "HN": "2013", "MR": "20160623", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063246"}, {"RECTYPE": "D", "MH": "Sialic Acid Binding Immunoglobulin-like Lectins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sialic Acid binding Hemagglutinin", "MN": "D12.776.503.921", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2013)", "ST": "T192", "RN": "0", "MS": "A family of SIALIC ACID binding proteins found in vertebrate species. They are transmembrane proteins which act as cell surface receptors for a variety of sialylated GLYCOCONJUGATES. While a subset of siglec protein subtypes are evolutionarily conserved between mammalian species, there are many others that are species specific.", "PM": "2013; SIALIC ACID BINDING IG-LIKE LECTIN was indexed under LECTINS 1982-2012 and under SIALIC ACIDS 1980-1982", "HN": "2013", "MR": "20170524", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063265"}, {"RECTYPE": "D", "MH": "Sialic Acid Binding Ig-like Lectin 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Sialic Acid Binding Ig like Lectin 1", "MN": "D12.776.503.921.100", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2013)", "ST": "T129", "RN": "0", "MS": "A sialic acid binding lectin that was originally identified as an adhesion molecule for inflammatory MACROPHAGES and activated MONOCYTES. This protein is the largest known siglec subtype and contains 16 immunoglobulin C2-set domains. It plays a role in cell to cell interactions and interactions with bacteria.", "PM": "2013; ERYTHROCYTE RECEPTOR (now SIALIC ACID BINDING IG-LIKE LECTIN 1) was indexed under MEMBRANE GLYCOPROTEINS and RECEPTORS, IMMUNOLOGIC 1991-2012", "HN": "2013", "MR": "20170524", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063267"}, {"RECTYPE": "D", "MH": "Sialic Acid Binding Ig-like Lectin 3", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "gp67, Glycoprotein", "MN": "D23.101.100.900.565", "FX": "Immunoglobulin Domains", "MH_TH": "NLM (2013)", "ST": "T129", "RN": "0", "MS": "A 67-kDa sialic acid binding lectin that is specific for MYELOID CELLS and MONOCYTE-MACROPHAGE PRECURSOR CELLS. This protein is the smallest siglec subtype and contains a single immunoglobulin C2-set domain. It may play a role in intracellular signaling via its interaction with SHP-1 PROTEIN-TYROSINE PHOSPHATASE and SHP-2 PROTEIN-TYROSINE PHOSPHATASE.", "PM": "2013; CD33 ANTIGEN (now SIALIC ACID BINDING IG-LIKE LECTIN 3) was indexed under ANTINGENS, DIFFERENTIATION, MYELOMONOCYTIC and ANTIGENS, CD 2003-2012, and under NEOPLASM ANTIGENS 1988-2002", "HN": "2013", "MR": "20170524", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063268"}, {"RECTYPE": "D", "MH": "Mitochondrial Turnover", "AQ": "DE GE IM PH RE", "ENTRY": "Turnover, Mitochondrial", "MN": "G04.599", "MH_TH": "NLM (2013)", "ST": "T043", "PI": "Mitochondria/metabolism (1981-2012)", "MS": "The cellular processes involved in adjustments to the MITOCHONDRIAL VOLUME, content, and activity, that depend on the energy demands of the cell.", "PM": "2013", "HN": "2013", "MR": "20160617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063269"}, {"RECTYPE": "D", "MH": "Fibrin Clot Lysis Time", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Times, Euglobulin Lysis", "MN": "G09.188.315", "FX": "Fibrinolysis", "MH_TH": "NLM (2013)", "ST": "T034", "PI": "Fibrinolysis (1965-2012)", "MS": "A measurement of the time needed for FIBRINOLYSIS to occur.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063285"}, {"RECTYPE": "D", "MH": "Brown Recluse Spider", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Violin Spiders, Brown", "MN": "B01.050.500.131.166.803.600", "MH_TH": "NLM (2013)", "ST": "T204", "RN": "txid6921", "AN": "bite: coordinate IM with ARACHNIDISM (IM)", "PI": "Spiders (1963-2012)", "MS": "A spider of the genus Loxosceles, found in the midwestern and other parts of the United States, which carries a hemolytic venom that produces local necrosis or ulceration.", "PM": "2013", "HN": "2013", "MR": "20200813", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063287"}, {"RECTYPE": "D", "MH": "Organ Dysfunction Scores", "PRINT ENTRY": "Sequential Organ Failure Assessment Score|T081|NON|NRW|NLM (2021)|200207|abcdef", "ENTRY": "Scores, SOFAS", "MN": "N06.850.520.308.980.438.475.364.500.625", "FX": "Multiple Organ Failure", "MH_TH": "NLM (2013)", "ST": "T081", "MS": "Ratings that express in numerical values the degree of impairment or abnormality in the function of specific organs.", "PM": "2013", "HN": "2013", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063305"}, {"RECTYPE": "D", "MH": "Mitophagy", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Mitochondrial Degradation|T043|NON|EQV|NLM (2013)|120412|abcdef", "MN": "G04.599.500", "MH_TH": "NLM (2013)", "ST": "T043", "MS": "Proteolytic breakdown of the MITOCHONDRIA via autophagy.", "PM": "2020; see MITOCHONDRIAL DEGRADATION 2013-2019", "HN": "2020 (2013)", "MR": "20190705", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063306"}, {"RECTYPE": "D", "MH": "AU Rich Elements", "AQ": "DE GE PH RE", "ENTRY": "Rich Elements, AU", "MN": "G05.360.340.024.340.137.910.880.500", "MH_TH": "NLM (2013)", "ST": "T123", "PI": "Base Sequence (1988-2012)", "MS": "RNA sequences composed of ADENINE NUCLEOTIDES and URACIL NUCLEOTIDES, that are located in the 3'UNTRANSLATED REGIONS of MESSENGER RNA molecules that are rapidly degraded. They are also known as AREs.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063307"}, {"RECTYPE": "D", "MH": "Myelin-Oligodendrocyte Glycoprotein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Myelin Oligodendrocyte Glycoprotein", "MN": "D23.050.422.625", "FX": "Multiple Sclerosis", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "AN": "do not confuse with MYELIN-ASSOCIATED GLYCOPROTEIN or OLIGODENDROCYTE-MYELIN GLYCOPROTEIN", "MS": "A transmembrane protein present in the MYELIN SHEATH of the CENTRAL NERVOUS SYSTEM. It is one of the main autoantigens implicated in the pathogenesis of MULTIPLE SCLEROSIS.", "PM": "2013; MYELIN OLIGODENDROCYTE GLYCOPROTEIN was indexed under MYELIN PROTEINS 2012, under MYELIN-ASSOCIATED GLYCOPROTEIN 1996-2011; under MYELIN PROTEINS 1990-1996, 2012, and under MEMBRANE GLYCOPROTEINS 1990-1995", "HN": "2013", "MR": "20230316", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063308"}, {"RECTYPE": "D", "MH": "2',3'-Cyclic Nucleotide 3'-Phosphodiesterase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "2',3'-Cyclic Nucleotide 3'-Phosphodiesterases|T116|T126|NON|EQV|NLM (2013)|120413|abbcdef", "ENTRY": "3'-Phosphodiesterase, 2',3'-Cyclic Nucleotide", "MN": "D12.776.631.580.124", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 3.1.4.37", "MS": "A phosphodiesterase that specifically cleaves the 3'-phosphate linkage of 2',3'-cyclic nucleotides. It is found at high level in the cytoplasm of cells that form the MYELIN SHEATH.", "PM": "2013; 2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE was indexed under PHOSPHORIC DIESTER HYDROLASES 1983-2012, under CYTIDINE CYCLIC MONOPHOSPHATE 1980-1982, and under CMP/ANALOGS 1978-1980", "HN": "2013", "MR": "20151123", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063309"}, {"RECTYPE": "D", "MH": "Tiapride Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tiapride Monohydrochloride|T109|T121|EQV|NLM (1999)|990913|abbdef", "ENTRY": "Monohydrochloride, Tiapride", "MN": "D02.455.426.559.389.127.085.933", "PA": "Dopamine Antagonists", "MH_TH": "NLM (2013)", "ST": "T121", "N1": "N,N-Diethyl-2-((2-methoxy-5-(methylsulfonyl)benzoyl)amino)ethanaminium chloride", "RN": "51012-32-9", "RR": "LAH70H9JPH", "MS": "A benzamide derivative that is used as a dopamine antagonist.", "PM": "2013; see BENZAMIDES 1980-2012", "HN": "2013; use BENZAMIDES 1980-2012", "MR": "20141014", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063325"}, {"RECTYPE": "D", "MH": "Exosome Multienzyme Ribonuclease Complex", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Exosome, RNA", "MN": "D08.811.600.283", "FX": "Exosomes", "MH_TH": "NLM (2013)", "ST": "T126", "RN": "EC 3.1.-", "AN": "do not confuse with EXOSOMES", "PI": "Exoribonucleases (1997-2012)", "MS": "An intracellular ribonucleolytic protein complex that participates in POSTRANSCRIPTIONAL RNA PROCESSING and RNA DEGRADATION.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063326"}, {"RECTYPE": "D", "MH": "Oligodendrocyte-Myelin Glycoprotein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Oligodendrocyte Myelin Glycoprotein", "MN": "D12.776.631.580.895", "MH_TH": "NLM (2013)", "ST": "T123", "RN": "0", "AN": "do not confuse with MYELIN-OLIGODENDROCYTE GLYCOPROTEIN", "PI": "Myelin-Associated Glycoprotein (1996-2012)", "MS": "A glycosylated extracellular myelin protein found on the MYELIN SHEATH of the CENTRAL NERVOUS SYSTEM. It is linked to the cell surface via a GLYCOSYLPHOSPHATIDYLINOSITOL LINKAGE.", "PM": "2013", "HN": "2013", "MR": "20230316", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063345"}, {"RECTYPE": "D", "MH": "Singing", "AQ": "DE ES GE IM PH RE", "ENTRY": "Whistlings", "MN": "G09.772.585.500", "FX": "Music", "MH_TH": "NLM (2013)", "ST": "T054", "AN": "SINGING, ANIMAL see VOCALIZATION, ANIMAL is also available", "MS": "Modulation of human voice to produce sounds augmented by musical tonality and rhythm.", "PM": "2013", "HN": "2013", "MR": "20160617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063346"}, {"RECTYPE": "D", "MH": "Native Polyacrylamide Gel Electrophoresis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "PAGE, Non-Denaturing", "MN": "E05.301.300.319.725", "MH_TH": "NLM (2013)", "ST": "T059", "AN": "for \"blue native polyacrylamide gel electrophoresis\" or BN-PAGE coordinate with the specific blue dye being used in the procedure", "PI": "Electrophoresis, Polyacrylamide Gel (1989-2012)", "MS": "Polyacrylamide gel electrophoresis under conditions in which the components, such as PROTEINS, being separated can remain in their naturally folded state.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063347"}, {"RECTYPE": "D", "MH": "Genocide", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "MN": "I01.880.735.950.500.903.149", "MH_TH": "NLM (1978)", "ST": "T054", "PI": "War Crimes (1979-2012)", "MS": "The deliberate annihilation of a national, ethnic, or religious group, in part or in whole.", "PM": "2013; see Homicide 2000-2012", "HN": "2013; use Homicide 2000-2012", "MR": "20150629", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063365"}, {"RECTYPE": "D", "MH": "Estuaries", "AQ": "CL EC HI SN", "ENTRY": "Fjords", "MN": "G01.311.625.540", "MH_TH": "NLM (2013)", "ST": "T070", "MS": "A partially enclosed body of water, and its surrounding coastal habitats, where saltwater from the ocean mixes with fresh water from rivers or streams. The resulting mixture of seawater and fresh water is called brackish water and its salinity can range from 0.5 to 35 ppt. (accessed http://oceanservice.noaa.gov/education/kits/estuaries/estuaries01_whatis.html)", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063366"}, {"RECTYPE": "D", "MH": "Virtual Reality Exposure Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Virtual Reality Therapies", "MN": "F04.754.137.506.662", "MH_TH": "NLM (2013)", "ST": "T061", "MS": "Treatment technique in a virtual environment which allows the participant to experience a sense of presence in an immersive, computer-generated, three-dimensional, interactive environment that minimizes avoidance behavior and facilitates emotional involvement. (from Curr Psychiatry Rep (2010) 12:298)", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063367"}, {"RECTYPE": "D", "MH": "Balkan Peninsula", "AQ": "EH EP", "ENTRY": "Balkans|T083|NON|EQV|NLM (2013)|120424|abcdef", "MN": "Z01.542.101", "MH_TH": "NLM (2013)", "ST": "T083", "MS": "A peninsula in Southeast EUROPE between the Adriatic and Ionian seas on the West and Aegean and Black Seas on the East. (from www.merriam-webster.com/dictionary/balkan%20peninsula)", "HN": "2013", "DA": "20120703", "DC": "4", "DX": "20130101", "UI": "D063368"}, {"RECTYPE": "D", "MH": "Knowledge Discovery", "AQ": "HI LJ MT", "PRINT ENTRY": "Literature Based Discovery|T062|NON|NRW|NLM (2013)|120424|abcdef", "ENTRY": "Literature Based Discoveries", "MN": "L01.462.500.682.099.325.750", "MH_TH": "NLM (2020)", "ST": "T062", "MS": "A process that searches for hidden and important connections among information or results.", "PM": "2013", "HN": "2013", "MR": "20220712", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063369"}, {"RECTYPE": "D", "MH": "Myringosclerosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Myringoscleroses", "MN": "C09.218.951.500", "MH_TH": "NLM (2013)", "ST": "T047", "PI": "Tympanic Membrane (1975-2012)", "MS": "The formation of dense connective tissue and calcification in the TYMPANIC MEMBRANE that does not necessarily cause or lead to loss of hearing.", "PM": "2013", "HN": "2013", "MR": "20211018", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063371"}, {"RECTYPE": "D", "MH": "Physical Therapist Assistants", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Physical Therapy Assistant", "MN": "N02.360.067.732", "FX": "Physical Therapy Specialty", "MH_TH": "NLM (2013)", "ST": "T097", "PI": "Allied Health Personnel (1971-2012)", "MS": "Persons who, under the supervision of licensed PHYSICAL THERAPISTS, provide patient treatment using various PHYSICAL THERAPY TECHNIQUES.", "PM": "2013", "HN": "2013", "MR": "20180629", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063372"}, {"RECTYPE": "D", "MH": "Hand Hygiene", "AQ": "EC HI IS LJ MT OG SN ST TD", "ENTRY": "Hygiene, Hand", "MN": "N06.850.670.150", "MH_TH": "NLM (2013)", "ST": "T055", "PI": "Hand Disinfection (1981-2012)", "MS": "Practices involved in preventing the transmission of diseases by hand.", "PM": "2013", "HN": "2013", "MR": "20151124", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063373"}, {"RECTYPE": "D", "MH": "Cannabinoid Receptor Modulators", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Receptor Modulators, Cannabinoid", "MN": "D27.505.696.399.472.188", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "MS": "Compounds that interact with and modulate the activity of CANNABINOID RECEPTORS.", "PM": "2013; for CANNABINOID RECEPTOR MODULATORS see ENDOCANNABINOIDS 2003-2012", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063385"}, {"RECTYPE": "D", "MH": "Cannabinoid Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cannabinoid Receptor Agonist|T121|NON|EQV|NLM (2021)|200430|abcdef", "ENTRY": "Receptor Agonists, Cannabinoid", "MN": "D27.505.696.399.472.188.500", "FX": "Receptors, Cannabinoid", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "PI": "Cannabinoid Receptor Modulators (2004-2012)", "MS": "Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS.", "PM": "2013", "HN": "2013", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063386"}, {"RECTYPE": "D", "MH": "Cannabinoid Receptor Antagonists", "AQ": "AD AE AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Cannabinoid Receptor Blocker|T121|NON|EQV|NLM (2021)|191121|abcdef", "ENTRY": "Receptor Blockers, Cannabinoid", "MN": "D27.505.696.399.472.188.750", "MH_TH": "NLM (2013)", "ST": "T121", "RN": "0", "MS": "Compounds that inhibit or block the activity of CANNABINOID RECEPTORS.", "PM": "2013", "HN": "2013", "MR": "20200527", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063387"}, {"RECTYPE": "D", "MH": "Endocannabinoids", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Endocannabinoid|T109|NON|EQV|NLM (2013)|120426|abcdef", "MN": "D10.251.265", "MH_TH": "NLM (2013)", "ST": "T109", "RN": "0", "PI": "Cannabinoids (1992-2003)", "MS": "Fatty acid derivatives that have specificity for CANNABINOID RECEPTORS. They are structurally distinct from CANNABINOIDS and were originally discovered as a group of endogenous CANNABINOID RECEPTOR AGONISTS.", "PM": "2013", "HN": "2013(2004)", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063388"}, {"RECTYPE": "D", "MH": "Anatomic Variation", "AQ": "DE GE IM PH RE", "MN": "G16.117.500", "MH_TH": "NLM (2013)", "ST": "T070", "MS": "Peculiarities associated with the internal structure, form, topology, or architecture of organisms that distinguishes them from others of the same species or group.", "PM": "2013", "HN": "2013", "MR": "20170630", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063405"}, {"RECTYPE": "D", "MH": "Binge Drinking", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM LJ ME MI MO NU PA PC PP PS PX RH SU TD TH UR VI", "PRINT ENTRY": "Binge Alcohol Consumption|T048|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Drinking, Binge", "MN": "F03.900.100.550", "MH_TH": "NLM (2013)", "ST": "T048", "PI": "Ethanol (1982-2012)", "MS": "Drinking an excessive amount of ALCOHOLIC BEVERAGES in a short period of time.", "PM": "2013", "HN": "2013", "MR": "20210512", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063425"}, {"RECTYPE": "D", "MH": "Human Migration", "AQ": "CL HI LJ SN TD", "PRINT ENTRY": "Diaspora|T052|NON|NRW|NLM (2020)|181218|abcdef", "ENTRY": "Migrations, Human", "MN": "N06.850.505.400.700.525", "MH_TH": "NLM (2013)", "ST": "T052", "AN": "migration of ancient populations goes here; ANIMAL MIGRATION is available for animals", "PI": "Emigration and Immigration (1972-2012)", "MS": "Dispersion or dislocation of people from their country of origin, either voluntarily or involuntarily.", "PM": "2013", "HN": "2013", "MR": "20190114", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063426"}, {"RECTYPE": "D", "MH": "Food Quality", "ENTRY": "Quality, Food", "MN": "N06.850.601", "FX": "Food Labeling", "MH_TH": "NLM (2013)", "ST": "T080", "MS": "Ratings of the characteristics of food including flavor, appearance, nutritional content, and the amount of microbial and chemical contamination.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063427"}, {"RECTYPE": "D", "MH": "Skin Cream", "AQ": "AD AE AN CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO TU", "ENTRY": "Skin Lotions", "MN": "J01.516.213.249", "MH_TH": "NLM (2013)", "ST": "T122", "MS": "A water-soluble medicinal preparation applied to the skin.", "PM": "2013", "HN": "2013", "MR": "20190425", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063465"}, {"RECTYPE": "D", "MH": "Respiratory Aspiration of Gastric Contents", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.550.773.500", "FX": "Pneumonia, Aspiration", "MH_TH": "NLM (2007)", "ST": "T047", "MS": "Inhaling refluxed gastric or duodenal contents.", "PM": "2013; see RESPIRATORY ASPIRATION 2007-2012", "HN": "2013; use RESPIRATORY ASPIRATION 2007-2012", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063466"}, {"RECTYPE": "D", "MH": "Acanthocheilonemiasis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Acanthocheilonemiases", "MN": "C01.610.335.508.700.750.361.137", "MH_TH": "UNK (19XX)", "ST": "T047", "MS": "A tropical infectious disease found mainly in Africa that is caused by the filarial parasite ACANTHOCHEILONEMA. Symptoms include skin rashes, abdominal, chest, muscle, and joint pains, neurologic disorders, skin lumps, and elevated levels of white blood cells. The parasite is transmitted through the bite of small flies.", "PM": "2013", "HN": "2013", "MR": "20190617", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063485"}, {"RECTYPE": "D", "MH": "Acanthocheilonema", "AQ": "AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI", "ENTRY": "Acanthocheilonemas", "MN": "B01.050.500.500.294.400.937.463.043", "MH_TH": "UNK (19XX)", "ST": "T204", "RN": "txid6276", "PI": "Dipetalonema (1963-2012)", "MS": "A common genus of tropical filarial worms parasitic in humans and monkeys.", "PM": "2013; was MH 1963-1985, see Dipetalonema 1986-2012", "HN": "2013; use Dipetalonema 1986-2012", "MR": "20200813", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063486"}, {"RECTYPE": "D", "MH": "Prescription Drug Misuse", "AQ": "AE CL EC ES HI LJ MO NU PC PX SN TD", "ENTRY": "Prescription Medicine Misuses", "MN": "F03.900.384.500", "FX": "Substance-Related Disorders", "MH_TH": "NLM (2013)", "ST": "T080", "MS": "Improper use of prescription drugs or medications outside the intended purpose, scope, or guidelines for use.", "PM": "2013", "HN": "2013", "MR": "20230531", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063487"}, {"RECTYPE": "D", "MH": "Racism", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Everyday Racism|T054|T055|NON|EQV|OBSSR (2022)|210518|abbcdef", "ENTRY": "Racism, Everyday", "MN": "I01.880.735.820.500.500", "FX": "Antiracism", "MH_TH": "NLM (1994)", "ST": "T055", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "PI": "Prejudice (1994-2012)", "MS": "Differential treatment or unequal access to opportunities, based on group membership such as origin or ethnicity.", "PM": "2013; see PREJUDICE 1994-2012", "HN": "2013; use PREJUDICE 1994-2012", "MR": "20220713", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063505"}, {"RECTYPE": "D", "MH": "Ageism", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Discriminations, Age", "MN": "F01.829.595.249", "MH_TH": "NLM (1995)", "ST": "T055", "PI": "Prejudice (1995-2012)", "MS": "Biased behaviors or attitudes, differential treatment, unequal access to social participation or opportunities based on age.", "PM": "2013; see PREJUDICE 1995-2012", "HN": "2013; use PREJUDICE 1995-2012", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063506"}, {"RECTYPE": "D", "MH": "Sexism", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Sexual Discrimination|T054|T055|NON|NRW|NLM (2021)|OBSSR (2021)|200515|abbcdeef", "ENTRY": "Discrimination, Sexual", "MN": "F01.829.595.750", "MH_TH": "NLM (1994)", "ST": "T055", "MS": "Prejudice or discrimination based on gender or behavior or attitudes that foster stereotyped social roles based on gender.", "PM": "2013; see PREJUDICE 1994-2012; for GENDER ISSUES see INTERPERSONAL RELATIONS 1996-2022", "HN": "2013; use PREJUDICE 1994-2012; for GENDER ISSUES use INTERPERSONAL RELATIONS 1996-2022", "MR": "20220523", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063507"}, {"RECTYPE": "D", "MH": "Social Discrimination", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Housing Discrimination|T054|NON|NRW|NLM (2023)|220419|abcdef", "ENTRY": "Practice, Discriminatory", "MN": "F01.145.813.629", "MH_TH": "NLM (1982)", "ST": "T054", "AN": "do not confuse with DISCRIMINATION, PSYCHOLOGICAL", "PI": "Prejudice (1982-2012)", "MS": "Differential or prejudicial group behavior toward others by virtue of their group membership.", "PM": "2013; see PREJUDICE 1982-2012", "HN": "2013; use PREJUDICE 1982-2012", "MR": "20230616", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063508"}, {"RECTYPE": "D", "MH": "Homophobia", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Homophobias", "MN": "F01.829.595.374", "MH_TH": "NLM (2013)", "ST": "T055", "PI": "Stereotyping (1966-2012)", "MS": "Differential treatment or unequal access to opportunities or services based on perceived homosexual preference or orientation.", "PM": "2013", "HN": "2013", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063509"}, {"RECTYPE": "D", "MH": "Personal Narratives as Topic", "MN": "K01.517.211.753", "MH_TH": "NLM (2013)", "ST": "T170", "AN": "use only for personal narratives as a subject; for accounts of individual experiences use the Publication Type PERSONAL NARRATIVES.", "MS": "Works about accounts of individual experience in relation to a particular field or of participation in related activities.", "PM": "2013", "HN": "2013", "MR": "20121010", "DA": "20120703", "DC": "1", "DX": "20130101", "UI": "D063545"}, {"RECTYPE": "D", "MH": "Apicoplasts", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Plastids, Apicomplexan", "MN": "A11.284.430.214.190.875.700.069", "MH_TH": "NLM (2014)", "ST": "T026", "PI": "Plastids (1999-2013)", "MS": "Non-photosynthetic plastids derived from RED ALGAE endosymbionts. They are found in species of the phylum APICOMPLEXA including PLASMODIUM MALARAIAE.", "PM": "2014", "HN": "2014", "MR": "20130706", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063546"}, {"RECTYPE": "D", "MH": "Biodegradable Plastics", "AQ": "AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Plastics, Compostable", "MN": "J01.637.051.720.716.195", "MH_TH": "NLM (2014)", "ST": "T073", "RN": "0", "MS": "Organic polymeric materials which can be broken down by naturally occurring processes. This includes plastics created from bio-based or petrochemical-based materials.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063566"}, {"RECTYPE": "D", "MH": "Social Validity, Research", "AQ": "MT SN ST TD", "ENTRY": "Validity, Research Social", "MN": "H01.770.644.932", "FX": "Program Evaluation", "MH_TH": "NLM (2014)", "ST": "T062", "MS": "Evaluation of the degree of acceptance for the immediate variables associated with a procedure or program designed to change behavior. This includes the social significance of the goals of treatment, the social appropriateness of the treatment procedures, and the social importance of the effects of treatments.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063586"}, {"RECTYPE": "D", "MH": "National Longitudinal Study of Adolescent Health", "AQ": "CL EC ES HI LJ MT SD SN ST TD", "ENTRY": "Add Health Study|T062|T081|ABB|EQV|NLM (2014)|130618|abbcdef", "MN": "N06.850.520.450.500.750.500.500", "MH_TH": "NLM (2014)", "ST": "T081", "AN": "CATALOGER: Use NAF entry", "PI": "Longitudinal Studies (1995-2013)", "MS": "Longitudinal study of a nationally representative sample of adolescents in grades 7-12 in the United States during the 1994-95 school year. The Add Health cohort has been followed into young adulthood. (from http://www.cpc.unc.edu/projects/addhealth accessed 08/2012)", "PM": "2014", "HN": "2014", "MR": "20180629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063588"}, {"RECTYPE": "D", "MH": "Dander", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR", "ENTRY": "Danders", "MN": "A12.200.250", "MH_TH": "NLM (2014)", "ST": "T031", "PI": "Allergens (1966-2013)", "MS": "Microscopic particles comprising dead skin, dried salivary proteins, hair, SEBUM and microorganisms, shed by animals which causes allergic reactions in atopic persons.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063607"}, {"RECTYPE": "D", "MH": "Carcinogenesis", "AQ": "CH CI CL DE GE IM ME PA RE UL", "PRINT ENTRY": "Tumorigenesis|T191|NON|EQV|NLM (2012)|101103|abcdef", "ENTRY": "Tumorigeneses", "MN": "C23.550.727.098", "MH_TH": "NLM (2014)", "ST": "T191", "PI": "Cell Transformation, Neoplastic (1963-2013)", "MS": "The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.", "PM": "2014; for TUMORIGENESIS and ONCOGENESIS see CELL TRANSFORMATION, NEOPLASTIC 2012-2013", "HN": "2014; for TUMORIGENESIS and ONCOGENESIS see CELL TRANSFORMATION, NEOPLASTIC 2012-2013", "MR": "20180629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063646"}, {"RECTYPE": "D", "MH": "Fetal Alcohol Spectrum Disorders", "AQ": "BL CF CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Fetal Alcohol Spectrum Disorder|T047|NON|EQV|NLM (2021)|191114|abcdef", "ENTRY": "Syndrome, Fetal Alcohol", "MN": "C25.775.100.087.323", "FX": "Alcoholism", "MH_TH": "NLM (2014)", "ST": "T047", "PI": "Fetal Alcohol Syndrome (1979-2013)", "MS": "An umbrella term used to describe a pattern of disabilities and abnormalities that result from fetal exposure to ETHANOL during pregnancy. It encompasses a phenotypic range that can vary greatly between individuals, but reliably includes one or more of the following: characteristic facial dysmorphism, FETAL GROWTH RETARDATION, central nervous system abnormalities, cognitive and/or behavioral dysfunction, BIRTH DEFECTS. The level of maternal alcohol consumption does not necessarily correlate directly with disease severity.", "PM": "2014; Fetal Alcohol Syndrome was a descriptor 1979-2013", "HN": "2014", "MR": "20210630", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063647"}, {"RECTYPE": "D", "MH": "Delusional Parasitosis", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Psychogenic Parasitosis, Ekbom", "MN": "F03.700.356", "FX": "Morgellons Disease", "MH_TH": "NLM (2014)", "ST": "T048", "AN": "note entry terms containing \"Ekbom\": do not confuse with entry terms for RESTLESS LEGS SYNDROME which also contain \"Ekbom\"", "MS": "A delusional disorder of belief in infestation by insects or other parasites. This FORMICATION is typically accompanied by dermatological manifestation such as PRURITUS that may lead to self-mutilation in order to remove the perceived parasites. It can be either primary or secondary to a somatic or psychiatric condition.", "PM": "2014; see Restless Legs Syndrome 2000-2013", "HN": "2014; use Restless Legs Syndrome 2000-2013", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063726"}, {"RECTYPE": "D", "MH": "Secondary Care Centers", "AQ": "CL ES HI SD SN ST TD", "ENTRY": "Secondary Referral Hospitals", "MN": "N02.278.421.745", "MH_TH": "NLM (2014)", "ST": "T093", "MS": "A healthcare facility equipped to provide all but the most specialized forms of care, surgery, and diagnostic techniques.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063728"}, {"RECTYPE": "D", "MH": "Sublingual Immunotherapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Sublingual Immunotherapies", "MN": "E05.478.610.310.500", "MH_TH": "NLM (2014)", "ST": "T061", "PI": "Hypersensitivity or specifics/therapy (1990-2013)", "MS": "A method of treating an ALLERGY by administering ALLERGENS, in liquid formulation or tablets, to the ORAL MUCOSA under the tongue.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063729"}, {"RECTYPE": "D", "MH": "Rickets, Hypophosphatemic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Rickets, Vitamin D-Resistant|T047|NON|NRW|NLM (1994)|930212|abcdef", "ENTRY": "Vitamin D-Resistant Rickets", "MN": "C18.654.521.500.133.770.734.875", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "A disorder characterized by HYPOPHOSPHATEMIA; RICKETS; OSTEOMALACIA; resulting from lack of phosphate reabsorption by the kidneys and possible defects in vitamin D metabolism.", "PM": "2014; see HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT 2006-2013; see HYPOPHOSPHATEMIA, FAMILIAL 1994-2006", "HN": "2014; use HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT 2006-2013; use HYPOPHOSPHATEMIA, FAMILIAL 1994-2006", "MR": "20151124", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063730"}, {"RECTYPE": "D", "MH": "Mobile Applications", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Smartphone Apps|T170|NON|REL|NLM (2022)|210125|abcdef", "ENTRY": "Software Application, Portable", "MN": "L01.224.900.685", "FX": "Smartphone", "MH_TH": "NLM (2014)", "ST": "T170", "MS": "Computer programs or software installed on mobile electronic devices which support a wide range of functions and uses which include television, telephone, video, music, word processing, and Internet service.", "PM": "2014", "HN": "2014", "MR": "20210312", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063731"}, {"RECTYPE": "D", "MH": "Methanocaldococcaceae", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Methanotorris|T194|NON|NRW|NLM (2014)|120914|abcdef", "MN": "B02.200.538.262", "MH_TH": "NLM (2014)", "ST": "T194", "RN": "txid196117", "RR": "txid196119", "MS": "A family of anaerobic METHANOCOCCALES whose organisms are thermophilic methanogens that produce methane from hydrogen and simple carbon sources such as carbon dioxide.", "PM": "2014", "HN": "2014", "MR": "20200813", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063746"}, {"RECTYPE": "D", "MH": "Methanocaldococcus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Methanococcus jannaschii|T194|NON|NRW|NLM (2014)|120917|abcdef", "MN": "B02.200.538.262.500", "MH_TH": "NLM (2014)", "ST": "T194", "RN": "txid196118", "RR": "txid83171", "PI": "Methanococcales (2001-2013)", "MS": "A genus of obligate anaerobic METHANOCALDOCOCCACEAE whose organisms are non-motile despite possessing long thin flagella. These methanogens are found in deep-sea vent and other hydrothermal environments.", "PM": "2014", "HN": "2014", "MR": "20200813", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063747"}, {"RECTYPE": "D", "MH": "Bland White Garland Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Bland-White-Garland", "MN": "C23.300.575.950.150.500", "MH_TH": "NLM (2014)", "ST": "T019", "PI": "Coronary Vessel Anomalies (1969-2013)", "MS": "A congenital coronary vessel anomaly in which the left main CORONARY ARTERY originates from the PULMONARY ARTERY instead of from AORTA. The congenital heart defect typically results in coronary artery FISTULA; LEFT-SIDED HEART FAILURE and MITRAL VALVE INSUFFICIENCY during the first months of life.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063748"}, {"RECTYPE": "D", "MH": "Pediatric Obesity", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Childhood Obesity|T047|NON|EQV|NLM (2014)|120921|abcdef", "ENTRY": "Overweight, Infant", "MN": "C23.888.144.699.500.750", "MH_TH": "NLM (2014)", "ST": "T047", "PI": "Obesity (1963-2013)", "MS": "BODY MASS INDEX in children (ages 2-12) and in adolescents (ages 13-18) that is grossly above the recommended cut-off for a specific age and sex. For infants less than 2 years of age, obesity is determined based on standard weight-for-length percentile measures.", "PM": "2014", "HN": "2014", "MR": "20210707", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063766"}, {"RECTYPE": "D", "MH": "Myalgia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Muscle Soreness|T184|NON|EQV|NLM (2014)|121010|abcdef", "ENTRY": "Tenderness, Muscle", "MN": "G11.561.790.353.500", "MH_TH": "NLM (2014)", "ST": "T184", "MS": "Painful sensation in the muscles.", "PM": "2014", "HN": "2014", "MR": "20170620", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063806"}, {"RECTYPE": "D", "MH": "Dandruff", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Scurf|T047|NON|EQV|NLM (2014)|121010|abcdef", "MN": "C17.800.738.353", "FX": "Dermatitis, Seborrheic", "MH_TH": "NLM (2014)", "ST": "T047", "MS": "Excessive shedding of dry scaly material from the scalp in humans.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063807"}, {"RECTYPE": "D", "MH": "Satellite Imagery", "AQ": "CL EC ES HI IS MT SN ST TD", "ENTRY": "Satellite Imageries", "MN": "L01.462.500.847.675.500.500", "FX": "Geographic Information Systems", "MH_TH": "NLM (2014)", "ST": "T068", "MS": "Composition of images of EARTH or other planets from data collected during SPACE FLIGHT by remote sensing instruments onboard SPACECRAFT. The satellite sensor systems measure and record absorbed, emitted, or reflected energy across the spectra, as well as global position and time.", "PM": "2014", "HN": "2014", "MR": "20220712", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063809"}, {"RECTYPE": "D", "MH": "Kosovo", "AQ": "EH EP", "ENTRY": "Republic of Kosovo|T083|NON|EQV|NLM (2014)|121012|abcdef", "MN": "Z01.542.248.506", "MH_TH": "NLM (1994)", "ST": "T083", "MS": "Independence from SERBIA was declared on February 17, 2008.", "HN": "2014; use Yugoslavia 1994-2013", "DA": "20130708", "DC": "4", "DX": "20140101", "UI": "D063826"}, {"RECTYPE": "D", "MH": "Mean Platelet Volume", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Volumes, Mean Platelet", "MN": "G04.325.500", "MH_TH": "NLM (2014)", "ST": "T081", "MS": "A measure of the size of PLATELETS.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063847"}, {"RECTYPE": "D", "MH": "Medical Identity Theft", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Theft, Medical Identity", "MN": "I01.198.240.300.249.500", "MH_TH": "NLM (2014)", "ST": "T054", "PI": "Fraud (2000-2013)", "MS": "Unauthorized access to personal information to obtain medical care or drugs, or to submit fraudulent billing for services. (from https://oig.hhs.gov/fraud/medical-id-theft/index.asp)", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063866"}, {"RECTYPE": "D", "MH": "Identity Theft", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Thefts, Identity", "MN": "I01.198.240.300.249", "MH_TH": "NLM (2014)", "ST": "T054", "PI": "Fraud (2000-2013)", "MS": "All types of crime in which personal data is obtained wrongfully, typically for economic gain. (from www.justice.gov/criminal/fraud/websites/idtheft.html)", "PM": "2014", "HN": "2014", "MR": "20180206", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063867"}, {"RECTYPE": "D", "MH": "Patient Outcome Assessment", "DE": "PATIENT OUTCOME ASSESS", "ENTRY": "Research, Patient-Centered Outcomes", "MN": "N05.715.360.575.575.399", "MH_TH": "NLM (1992)", "ST": "T058", "MS": "Patient-generated evaluation data of treatment outcome or interaction in healthcare environment.", "PM": "2014", "HN": "2014", "MR": "20171208", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063868"}, {"RECTYPE": "D", "MH": "Patient Discharge Summaries", "AQ": "CL EC LJ SN ST", "ENTRY": "Summary, Patient Discharge", "MN": "N06.850.520.308.940.968.750", "FX": "Patient Discharge", "MH_TH": "NLM (2014)", "ST": "T170", "MS": "Summaries that serve as the primary documents communicating a patient's care plan to the post-hospital care team.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063886"}, {"RECTYPE": "D", "MH": "Prisoners of War", "AQ": "CL ED HI LJ PX SN", "ENTRY": "War Prisoners", "MN": "M01.729.500", "MH_TH": "NLM (2014)", "ST": "T098", "PI": "Prisoners (1966-2013)", "MS": "Members held prisoner of the armed forces, members of militias of such armed forces, members of other militias, members of other volunteer corps, and organized resistance movements. (Geneva Convention of 1929 and 1949)", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063906"}, {"RECTYPE": "D", "MH": "Drug Hypersensitivity Syndrome", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Drug Reaction With Eosinophilia And Systemic Symptom|T047|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Syndromes, Drug Hypersensitivity", "MN": "C25.100.468.380.262", "FX": "Drug Hypersensitivity", "MH_TH": "NLM (2014)", "ST": "T047", "MS": "Severe drug eruption characterized by high fever, erythematous rash and inflammation of internal organ(s).", "PM": "2014", "HN": "2014", "MR": "20220711", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063926"}, {"RECTYPE": "D", "MH": "Lujo virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "MN": "B04.820.480.500.070.100.525", "MH_TH": "NLM (2014)", "ST": "T005", "RN": "txid649188", "AN": "infection: coordinate IM with ARENAVIRIDAE INFECTIONS (IM) + HEMORRHAGIC FEVERS, VIRAL (IM) if pertinent", "MS": "A species of ARENAVIRUS, OLD WORLD that is the etiologic agent of acute febrile illness with hemorrhagic manifestations in Africa.", "PM": "2014", "HN": "2014", "MR": "20200813", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063927"}, {"RECTYPE": "D", "MH": "Ependymoglial Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Tanycyte|T025|NON|REL|NLM (2021)|191120|abcdef", "ENTRY": "Radial Glias", "MN": "A11.650.300", "FX": "Ependymoma", "MH_TH": "NLM (2014)", "ST": "T025", "PI": "Neuroglia (1987-2013)", "MS": "The macroglial cells of EPENDYMA. They are characterized by bipolar cell body shape and processes that contact BASAL LAMINA around blood vessels and/or the PIA MATER and the CEREBRAL VENTRICLES. Muller cells of the RETINA are included based on similar microenvironmental contacts and morphology.", "PM": "2014", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063928"}, {"RECTYPE": "D", "MH": "Enslavement", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Slavery|T054|NON|EQV|NLM (2014)|121018|abcdef", "ENTRY": "Enslavements", "MN": "I01.880.735.384.350", "FX": "Enslaved Persons", "MH_TH": "NLM (2014)", "ST": "T054", "MS": "The status or condition of a person over whom any or all of the powers attaching to the right of ownership are exercised. The slave trade is all acts involved in the capture, acquisition or disposal of persons with intent to reduce them to enslavement; all acts involved in the acquisition of enslaved persons with a view to selling or exchanging them; all acts of disposal by sale or exchange of persons acquired with a view to being sold or exchanged, and, in general, every act of trade or transport of slaves. (from http://www.ohchr.org/Documents/Publications/slaveryen.pdf accessed 10/18/2012)", "PM": "2019; see SLAVERY 2013-2018", "HN": "2019(2014)", "MR": "20190705", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063947"}, {"RECTYPE": "D", "MH": "Enslaved Persons", "AQ": "CL ED HI LJ PX SN", "PRINT ENTRY": "Slaves|T098|NON|EQV|NLM (1982)|861231|abcdef", "ENTRY": "Slave", "MN": "M01.210", "FX": "Enslavement", "MH_TH": "NLM (2014)", "ST": "T098", "MS": "Persons involuntarily controlled by another and exploited for forced or compulsory work or service.", "PM": "2019; was SLAVES 1986-2018", "HN": "2019(1986)", "MR": "20180227", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063948"}, {"RECTYPE": "D", "MH": "Material Safety Data Sheets", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Material Safety Data Sheet|T170|NON|EQV|NLM (2014)|121210|abcdef", "MN": "N06.850.135.060.075.800.500", "MH_TH": "NLM (2014)", "ST": "T170", "MS": "Information or data used to ensure the safe handling and disposal of substances in the workplace. Such information includes physical properties (i.e. melting, boiling, flashing points), as well as data on toxicity, health effects, reactivity, storage, disposal, first-aid, protective equipment, and spill-handling procedures.", "PM": "2014", "HN": "2014", "MR": "20150113", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063967"}, {"RECTYPE": "D", "MH": "Vascularized Composite Allotransplantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Composite Tissue Allogeneic Transplantation|T061|NON|EQV|NLM (2023)|220111|abcdef", "ENTRY": "Allotransplantation, Vascularized Composite", "MN": "E04.936.864.850", "MH_TH": "NLM (2014)", "ST": "T061", "AN": "use for the surgical procedure; use VASCULARIZED COMPOSITE ALLOGRAFTS see COMPOSITE TISSUE ALLOGRAFTS for the graft itself", "MS": "Transference of multiple tissues, such as muscle, bone, nerve, and skin, as a functional unit for reconstructive purposes. Blood supply to the transplanted tissues is maintained throughout the transplantation procedure with minimal ischemia. Maintenance of vascularity in the graft promotes its viability, function, and survival in the recipient.", "PM": "2014", "HN": "2014", "MR": "20220408", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063986"}, {"RECTYPE": "D", "MH": "Hand Transplantation", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Transplantation, Hand", "MN": "E04.936.864.850.500", "MH_TH": "NLM (2014)", "ST": "T061", "PI": "Hand (1987-2013)", "MS": "The transference of a complete HAND, as a composite of many tissue types, from one individual to another.", "PM": "2014", "HN": "2014", "MR": "20220408", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063987"}, {"RECTYPE": "D", "MH": "3-Hydroxyacyl-CoA Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Keto Reductase", "MN": "D08.811.682.047.820.150.207", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 1.1.1.35", "MS": "An NAD-dependent 3-hydroxyacyl CoA dehydrogenase that has broad specificity with regards to the acyl chain length of the substrate.", "PM": "2014; see 3-HYDROXYACYL COA DEHYDROGENASES 1981-2013", "HN": "2014; use 3-HYDROXYACYL COA DEHYDROGENASES 1981-2013", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063988"}, {"RECTYPE": "D", "MH": "Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Long Chain 3 Hydroxyacyl CoA Dehydrogenase", "MN": "D08.811.682.047.820.150.707", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 1.1.1.211", "MS": "An NAD-dependent 3-hydroxyacyl CoA dehydrogenase that has specificity for acyl chains containing 8 and 10 carbons.", "PM": "2014; LONG-CHAIN 3-HYDROXY COA DEHYDROGENASE was indexed under 3-HYDROXYACL COA DEHYDROGENASE 1992-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063989"}, {"RECTYPE": "D", "MH": "Gene Ontology", "AQ": "HI OG SN TD", "ENTRY": "Projects, Gene Ontology", "MN": "L01.462.750.245.945.079.500", "MH_TH": "NLM (2014)", "ST": "T170", "MS": "Sets of structured vocabularies used for describing and categorizing genes, and gene products by their molecular function, involvement in biological processes, and cellular location. These vocabularies and their associations to genes and gene products (Gene Ontology annotations) are generated and curated by the Gene Ontology Consortium.", "PM": "2014", "HN": "2014", "MR": "20220712", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063990"}, {"RECTYPE": "D", "MH": "Mitochondrial Trifunctional Protein", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Trifunctional Protein, Mitochondrial", "MN": "D12.776.575.765", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 2.3.1.16", "RR": "EC 4.2.1.17", "MS": "A mitochondrial protein consisting of four alpha-subunits and four beta-subunits. It contains enoyl-CoA hydratase, long-chain-3-hydroxyacyl-CoA dehydrogenase, and acetyl-CoA C-acyltransferase activities and plays an important role in the metabolism of long chain FATTY ACIDS.", "PM": "2014; MITOCHONDRIAL FATTY ACID BETA-OXIDATION TRIFUNCTIONAL PROTEIN (now MITOCHONDRIAL TRIFUNCTIONAL PROTEIN) was indexed under MULTIENZYME COMPLEXES 1994-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063991"}, {"RECTYPE": "D", "MH": "Mitochondrial Trifunctional Protein, alpha Subunit", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.575.765.200", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 1.1.1.211", "RR": "EC 4.2.1.17", "PI": "Multienzyme Complexes (1994-2013)", "MS": "The alpha subunit of mitochondrial trifunctional protein. It contains both enoyl-CoA hydratase activity (EC 4.2.1.17) and long-chain-3-hydroxyacyl-CoA dehydrogenase activity (EC 1.1.1.211). There are four of these alpha subunits in each mitochondrial trifunctional protein molecule.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063992"}, {"RECTYPE": "D", "MH": "Mitochondrial Trifunctional Protein, beta Subunit", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.575.765.500", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 2.3.1.16", "PI": "Multienzyme Complexes (1994-2013)", "MS": "The beta subunit of mitochondrial trifunctional protein that contains acetyl-CoA C-acyltransferase activity. There are four of these beta subunits in each trifunctional protein complex.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063993"}, {"RECTYPE": "D", "MH": "Peroxisomal Bifunctional Enzyme", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peroxisomal-Bifunctional Enzymes|T116|T126|NON|EQV|NLM (2014)|121116|abbcdef", "ENTRY": "Peroxisomal Multifunctional beta Oxidation Protein", "MN": "D08.811.682.047.820.150.207.500", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 4.2.1.17", "RR": "EC 5.3.3.8", "MS": "A monomeric protein found in liver peroxisomes that contains two enzymatically active domains; an enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase domain, and an (S)-3-hydroxyacyl-CoA dehydrogenase domain. The enzyme is stereospecific with regards to how cis and trans double bonds are metabolized. It is complemented by PEROXISOMAL MULTIFUNCTIONAL PROTEIN-2, which has the opposite stereospecificity.", "PM": "2014; PEROXIISOMAL-BIFUNCTIONAL ENZYME was indexed under ENOYL-COA-HYDRATASE, ISOMERASES, 3-HYDROXYACYL COA DEHYDROGENASES, and MULTIENZYME COMPLEXES 1986-2013", "HN": "2014", "MR": "20160418", "DA": "20130709", "DC": "1", "DX": "20140101", "UI": "D063994"}, {"RECTYPE": "D", "MH": "Warm-Up Exercise", "AQ": "PH PX", "ENTRY": "Warmup Exercises", "MN": "I03.350.968", "FX": "Cool-Down Exercise", "MH_TH": "NLM (2009)", "ST": "T040", "PI": "Exercise (1977-2013)", "MS": "Physical activities done to prepare the body for more intense physical activities.", "PM": "2014; see EXERCISE 2009-2013", "HN": "2014; use EXERCISE 2009-2013", "MR": "20160701", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D063996"}, {"RECTYPE": "D", "MH": "Dodecenoyl-CoA Isomerase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "delta-Isomerase, Dodecenoyl-Coenzyme A", "MN": "D08.811.399.475.400.349", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 5.3.3.8", "MS": "A carbon-carbon double bond isomerase that catalyzes the movement double bond from C3 to C2 of an unsaturated acyl-CoA. The enzyme plays a key role in allowing acyl-CoA substrates to re-enter the beta-oxidation pathway.", "PM": "2014; DOCDECENOYL-COA ISOMERASE was indexed under CARBON-CARBON DOUBLE BOND ISOMERASES 1979-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064006"}, {"RECTYPE": "D", "MH": "Ataxia Telangiectasia Mutated Proteins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, AT Mutated", "MN": "D12.776.660.720.125", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A group of PROTEIN SERINE-THREONINE KINASES which activate critical signaling cascades in double strand breaks, APOPTOSIS, and GENOTOXIC STRESS such as ionizing ultraviolet A light, thereby acting as a DNA damage sensor. These proteins play a role in a wide range of signaling mechanisms in cell cycle control.", "PM": "2014; was indexed under PROTEIN KINASES 1983-1992; PROTEIN-SERINE-THREONINE KINASES 1993-2013", "HN": "2014", "MR": "20210712", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064007"}, {"RECTYPE": "D", "MH": "Enoyl-CoA Hydratase 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Enoyl CoA Hydratase 2", "MN": "D08.811.520.241.300.275", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 4.2.1.119", "PI": "Hydro-Lyases (1997-2013)", "MS": "A PEROXISOME-specific enzyme that catalyzes the hydration step of the beta-oxidation pathway.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064008"}, {"RECTYPE": "D", "MH": "Calbindins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Calbindin|T116|T123|NON|EQV|NLM (2014)|121214|abbcdef", "MN": "D12.776.157.125.090", "FX": "EF Hand Motifs", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "Calcium-Binding Protein, Vitamin D-Dependent (1985-2013)", "MS": "Calcium-binding proteins that are found in DISTAL KIDNEY TUBULES, INTESTINES, BRAIN, and other tissues where they bind, buffer and transport cytoplasmic calcium. Calbindins possess a variable number of EF-HAND MOTIFS which contain calcium-binding sites. Some isoforms are regulated by VITAMIN D.", "PM": "2014; was indexed under CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT 1986-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064026"}, {"RECTYPE": "D", "MH": "Tracheophyta", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Tracheobionta|T002|NON|EQV|NLM (2014)|121126|abcdef", "ENTRY": "Conifer", "MN": "B01.875.800.575.912", "MH_TH": "NLM (2002)", "ST": "T002", "RN": "txid58023", "MS": "A subset of plants bearing a vascular system. Examples are ferns and seed-bearing species.", "PM": "2018; see TRACHEOBIONTA 2014-2017; see FERNS 2001-2013", "HN": "2018 (2001); use FERNS 2001-2013", "MR": "20210630", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064028"}, {"RECTYPE": "D", "MH": "Peroxisomal Multifunctional Protein-2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Peroxisomal Multifunctional Protein 2", "MN": "D08.811.682.047.820.150.926", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 4.2.1.107", "RR": "EC 4.2.1.119", "PI": "Enoyl-CoA Hydratase (1997-2013)", "MS": "A dimeric protein found in liver peroxisomes that plays an important role in FATTY ACID metabolism and steroid metabolism. The dimer is formed by cleavage of a single protein precursor and contains an enoyl-CoA hydratase-2 domain and a second domain that displays (S)-3-hydroxyacyl-CoA dehydrogenase and 17-beta-estradiol dehydrogenase activities. The enzyme is stereospecific with regards to arrangement of the substrate double bonds and position of the 3-hydroxy group of the reaction intermediate. It is complemented by PEROXISOMAL BIFUNCTIONAL ENZYME, which has the opposite reaction stereospecificity.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064029"}, {"RECTYPE": "D", "MH": "S100 Calcium Binding Protein G", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Vitamin D Dependent Calcium Binding Protein", "MN": "D12.776.157.125.750.750", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "A calbindin protein found in many mammalian tissues, including the UTERUS, PLACENTA, BONE, PITUITARY GLAND, and KIDNEYS. In intestinal ENTEROCYTES it mediates intracellular calcium transport from apical to basolateral membranes via calcium binding at two EF-HAND MOTIFS. Expression is regulated in some tissues by VITAMIN D.", "PM": "2014; was indexed under CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT 1987-2013; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT was a descriptor 1978-2013; for INTESTINAL MEMBRANE CALCIUM-BINDING PROTEIN see under CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT 1978-2013.", "HN": "2014(1979)", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064030"}, {"RECTYPE": "D", "MH": "Calbindin 2", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Calretinin|T116|T123|NON|EQV|NLM (1987)|121213|abbcdef", "MN": "D12.776.157.125.090.249", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "0", "MS": "A calbindin protein that is differentially expressed in distinct populations of NEURONS throughout the vertebrate and invertebrate NERVOUS SYSTEM, and modulates intrinsic neuronal excitability and influences LONG-TERM POTENTIATION. It is also found in LUNG, TESTIS, OVARY, KIDNEY, and BREAST, and is expressed in many tumor types found in these tissues. It is often used as an immunohistochemical marker for MESOTHELIOMA.", "PM": "2014; was indexed under CALCIUM-BINDING PROTEINS, VITAMIN D-DEPENDENT 1987-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064032"}, {"RECTYPE": "D", "MH": "Secretagogins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Secretagogin|T116|T123|NON|EQV|NLM (2021)|200220|abbcdef", "MN": "D12.776.157.125.787", "FX": "EF Hand Motifs", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "Secretagogins are EF HAND MOTIF-containing calcium-binding proteins that are involved in early neuronal migration and neurogenesis. They are also present in many adult organs and in brain and endocrine neoplasms.", "PM": "2014; was indexed under CALCIUM-BINDING PROTEINS 2004-2013", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064046"}, {"RECTYPE": "D", "MH": "Spindle Poles", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Spindle Pole", "MN": "A11.284.430.214.190.750.820.500", "MH_TH": "NLM (2014)", "ST": "T026", "PI": "Mitotic Spindle Apparatus (1983-2013)", "MS": "The sites in a dividing cell where the minus ends of the spindle MICROTUBULES assemble and where the separated sister CHROMATIDS converge.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064047"}, {"RECTYPE": "D", "MH": "Spindle Pole Bodies", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Spindle Pole Body", "MN": "A11.284.430.214.190.750.820.500.750", "MH_TH": "NLM (2014)", "ST": "T026", "PI": "Mitotic Spindle Apparatus (1986-2013)", "MS": "Microtubule organizing centers of FUNGI and DIATOMS. They are embedded in the NUCLEAR ENVELOPE and evolve into the spindle apparatus during CELL DIVISION.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064048"}, {"RECTYPE": "D", "MH": "Rho Guanine Nucleotide Exchange Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "RhoGEF, p115", "MN": "D12.776.476.325.300.099", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "Signaling proteins which function as master molecular switches by activating Rho GTPases through conversion of guanine nucleotides. Rho GTPases in turn control many aspects of cell behavior through the regulation of multiple downstream signal transduction pathways.", "PM": "2014; was indexed under GUANINE NUCLEOTIDE EXCHANGE FACTORS", "HN": "2014", "MR": "20151124", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064067"}, {"RECTYPE": "D", "MH": "Collagenous Sprue", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sprues, Collagenous", "MN": "C18.452.603.314", "MH_TH": "NLM (2014)", "ST": "T047", "MS": "A malabsorption syndrome characterized by collagenous mucosal lesions of the SMALL INTESTINE, atrophy of MICROVILLI, severe malabsorption, diarrhea, and MALNUTRITION often refractory to a gluten-free diet.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064068"}, {"RECTYPE": "D", "MH": "Medical Marijuana", "AQ": "AD AE AN BL CF CH CL CS EC HI IP LJ ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Treatment, Marijuana", "MN": "D26.528", "FX": "Phytotherapy", "MH_TH": "NLM (2014)", "ST": "T121", "RN": "0", "MS": "Product of the CANNABIS plant, CANNABINOIDS, or synthetic derivatives thereof, used in the treatment of a wide range of clinical symptoms.", "PM": "2014", "HN": "2014", "MR": "20230622", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064086"}, {"RECTYPE": "D", "MH": "Head Impulse Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Tests, Head Thrust", "MN": "E01.370.382.900.640", "MH_TH": "NLM (2014)", "ST": "T060", "MS": "Identification of SACCADES during a rapid head rotation to assess VESTIBULOOCULAR REFLEX.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064087"}, {"RECTYPE": "D", "MH": "Hazard Analysis and Critical Control Points", "AQ": "MT", "PRINT ENTRY": "Hazard Analysis Critical Control Point|T058|T080|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Systems, Food Safety", "MN": "N06.850.601.500.750", "FX": "Food Safety", "MH_TH": "NLM (2014)", "ST": "T080", "MS": "A system of safety management (abbreviated HACCP) applied mainly to the food industry. It involves the analysis and control of biological, chemical, and physical hazards, from raw material production, procurement and handling, to manufacturing, distribution and consumption of finished products.", "PM": "2014", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064088"}, {"RECTYPE": "D", "MH": "Allelopathy", "AQ": "DE GE IM PH RE", "ENTRY": "Allelopathies", "MN": "G16.024", "MH_TH": "NLM (2014)", "ST": "T070", "MS": "The process by which organisms release chemical compounds known as ALLELOCHEMICALS which influence the physiology, growth, survival, colonization, and reproductive activities of other species usually located nearby.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064089"}, {"RECTYPE": "D", "MH": "Intraocular Lymphoma", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Lymphomas, Intraocular", "MN": "C20.683.515.761.417", "MH_TH": "NLM (2014)", "ST": "T191", "MS": "A form of malignant cancer which occurs within the eyeball.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064090"}, {"RECTYPE": "D", "MH": "Waste Disposal Facilities", "AQ": "CL EC ES HI IS LJ SN ST", "ENTRY": "Waste Dumping Site", "MN": "N06.850.860.510.900.700", "MH_TH": "NLM (2014)", "ST": "T073", "AN": "specify geographic location if pertinent", "MS": "Sites that receive and store WASTE PRODUCTS. Some facilities also sort, process, and recycle specific waste products.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064091"}, {"RECTYPE": "D", "MH": "Calbindin 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Calbindin-D28K|T116|T123|NON|EQV|NLM (1986)|121212|abbcdef", "MN": "D12.776.631.087", "MH_TH": "NLM (2005)", "ST": "T123", "RN": "0", "MS": "A calcium-binding protein that mediates calcium HOMEOSTASIS in KIDNEYS, BRAIN, and other tissues. It is found in well-defined populations of NEURONS and is involved in CALCIUM SIGNALING and NEURONAL PLASTICITY. It is regulated in some tissues by VITAMIN D.", "PM": "2014; was indexed under CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT 1986-2013", "HN": "2014", "MR": "20160418", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064092"}, {"RECTYPE": "D", "MH": "Interleukin-27", "DS": "INTERLEUKIN 027", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Interleukin 27", "MN": "D23.529.374.465.600", "MH_TH": "NLM (2007)", "ST": "T123", "RN": "0", "MS": "A heterodimeric cytokine composed of the IL-27p28 and EBI3 subunits. It is produced primarily by antigen-presenting cells after stimulation by microbial products or inflammatory mediators.", "PM": "2014; see INTERLEUKIN-17 2007-2013", "HN": "2014; use INTERLEUKIN-17 2007-2013", "MR": "20150415", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064094"}, {"RECTYPE": "D", "MH": "Aurora Kinase A", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aurora Kinases A|T116|T126|NON|EQV|NLM (2014)|121214|abbcdef", "ENTRY": "Serine Threonine Protein Kinase 15", "MN": "D12.776.476.563.103.500", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "An aurora kinase that localizes to the CENTROSOME during MITOSIS and is involved in centrosome regulation and formation of the MITOTIC SPINDLE. Aurora A overexpression in many malignant tumor types suggests that it may be directly involved in NEOPLASTIC CELL TRANSFORMATION.", "PM": "2014; was indexed under PROTEIN SERINE-THREONINE KINASES 1995-2013", "HN": "2014", "MR": "20210520", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064096"}, {"RECTYPE": "D", "MH": "Esomeprazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Strontium, Esomeprazole", "MN": "D03.633.100.103.034.500.500", "PA": "Proton Pump Inhibitors", "MH_TH": "NLM (2003)", "ST": "T121", "N1": "5-methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole", "RN": "N3PA6559FT", "RR": "SCC2RK476A", "PI": "Omeprazole (2003-2012)", "MS": "The S-isomer of omeprazole.", "PM": "2014; see OMEPRAZOLE SODIUM 2013, see OMEPRAZOLE 2003-2012", "HN": "2014(2013); use OMEPRAZOLE 2003-2012", "MR": "20170524", "DA": "20121214", "DC": "1", "DX": "20130101", "UI": "D064098"}, {"RECTYPE": "D", "MH": "Human Coprophagia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Human Coprophagy|T048|NON|EQV|NLM (2013)|120629|abcdef", "ENTRY": "Coprophagy, Human", "MN": "F01.145.126.900", "MH_TH": "NLM (2013)", "ST": "T048", "AN": "COPROPHAGIA is available for animals", "PI": "Feces (1966-1969)", "MS": "A rare aberrant human behavior involving consumption of excrement.", "PM": "2014(2013)", "HN": "2014(2013)", "MR": "20210512", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064106"}, {"RECTYPE": "D", "MH": "Aurora Kinase B", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aurora Kinases B|T116|T126|NON|EQV|NLM (2014)|121217|abbcdef", "ENTRY": "Serine Threonine Protein Kinase 12", "MN": "D12.776.476.563.103.750", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "An aurora kinase that is a component of the chromosomal passenger protein complex and is involved in the regulation of MITOSIS. It mediates proper CHROMOSOME SEGREGATION and contractile ring function during CYTOKINESIS.", "PM": "2014; was indexed under PROTEIN-SERINE-THREONINE KINASES 1995-2013", "HN": "2014", "MR": "20210520", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064107"}, {"RECTYPE": "D", "MH": "Aurora Kinase C", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aurora Kinases C|T116|T126|NON|EQV|NLM (2014)|121217|abbcdef", "ENTRY": "Serine Threonine Protein Kinase 13", "MN": "D12.776.476.563.103.875", "MH_TH": "NLM (2005)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "Aurora kinase C is a chromosomal passenger protein that interacts with aurora kinase B in the regulation of MITOSIS. It is found primarily in GERM CELLS in the TESTIS, and may mediate CHROMOSOME SEGREGATION during SPERMATOGENESIS.", "PM": "2014; was indexed under PROTEIN SERINE-THREONINE KINASES 1995-2013", "HN": "2014", "MR": "20210520", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064108"}, {"RECTYPE": "D", "MH": "Minichromosome Maintenance Proteins", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Maintenance Proteins, Minichromosome", "MN": "D12.776.664.235.750", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 3.6.4.12", "RR": "EC 3.6.4.12", "AN": "general or unspecified; prefer specifics", "MS": "A family of proteins that were originally identified in SACCHAROMYCES CEREVISIAE as being essential for maintaining the structure of minichromosomes00. They form into a protein complex that has helicase activity and is involved in a variety of DNA-related functions including replication elongation, RNA transcription, chromatin remodeling, and genome stability.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064110"}, {"RECTYPE": "D", "MH": "Minichromosome Maintenance Complex Component 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein BM28, Nuclear", "MN": "D12.776.664.235.750.200", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 3.6.4.12", "PI": "Nuclear Proteins (1994-2013)", "MS": "A minichromosome maintenance protein that is a key component of the six member MCM protein complex. It contains a NUCLEAR LOCALIZATION SIGNAL which may provide targeting of the protein complex and an extended N-terminus which is rich in SERINE residues.", "PM": "2014; MCM2 PROTEIN, MAMMALIAN (now MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 2) was indexed under NUCLEAR PROTEINS 1995-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064111"}, {"RECTYPE": "D", "MH": "Clustered Regularly Interspaced Short Palindromic Repeats", "AQ": "DE GE IM PH RE", "ENTRY": "Spacers, CRISPR", "MN": "G05.360.340.024.850.069", "FX": "CRISPR-Associated Proteins", "MH_TH": "NLM (2014)", "ST": "T114", "MS": "Repetitive nucleic acid sequences that are principal components of the archaeal and bacterial CRISPR-CAS SYSTEMS, which function as adaptive antiviral defense systems.", "PM": "2014", "HN": "2014", "MR": "20130705", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064112"}, {"RECTYPE": "D", "MH": "CRISPR-Cas Systems", "AQ": "DE GE IM PH RE", "ENTRY": "Systems, CRISPR-Cas", "MN": "G05.308.203.374.394", "FX": "Gene Editing", "MH_TH": "NLM (2014)", "ST": "T044", "MS": "Adaptive antiviral defense mechanisms, in archaea and bacteria, based on DNA repeat arrays called CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR elements) that function in conjunction with CRISPR-ASSOCIATED PROTEINS (Cas proteins). Several types have been distinguished, including Type I, Type II, and Type III, based on signature motifs of CRISPR-ASSOCIATED PROTEINS.", "PM": "2014", "HN": "2014", "MR": "20180116", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064113"}, {"RECTYPE": "D", "MH": "Minichromosome Maintenance Complex Component 3", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta, RLF Subunit", "MN": "D12.776.664.235.750.300", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "EC 3.6.4.12", "PI": "Nuclear Proteins (1990-2013)", "MS": "A minichromosome maintenance protein that is a key component of the six member MCM protein complex. It contains a NUCLEAR LOCALIZATION SIGNAL, which provide targeting of the protein complex. In addition, acetylation of this protein may play a role in regulating of DNA replication and cell cycle progression.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064126"}, {"RECTYPE": "D", "MH": "Aurora Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Aurora Kinase|T116|T126|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Kinase, Aurora", "MN": "D12.776.476.563.103", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "A family of highly conserved serine-threonine kinases that are involved in the regulation of MITOSIS. They are involved in many aspects of cell division, including centrosome duplication, SPINDLE APPARATUS formation, chromosome alignment, attachment to the spindle, checkpoint activation, and CYTOKINESIS.", "PM": "2014; was indexed under PROTEIN-SERINE-THREONINE KINASES 1995-2013", "HN": "2014", "MR": "20210520", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064127"}, {"RECTYPE": "D", "MH": "Nodding Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Nodding", "MN": "C10.228.140.490.375.525", "MH_TH": "NLM (2014)", "ST": "T047", "PI": "Seizures (2009-2013)", "MS": "Unexplained neurologic condition characterized by episodes of atonic seizures, convulsions or staring spells with further cognitive decline.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064128"}, {"RECTYPE": "D", "MH": "Prostatic Neoplasms, Castration-Resistant", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Prostatic Neoplasms, Castration Resistant", "MN": "C12.900.619.750.500", "FX": "Androgen Receptor Antagonists", "MH_TH": "NLM (2014)", "ST": "T191", "PI": "Prostatic Neoplasms (1981-2013)", "MS": "Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.", "PM": "2014", "HN": "2014", "MR": "20210630", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064129"}, {"RECTYPE": "D", "MH": "CRISPR-Associated Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Repeat Associated Mysterious Proteins", "MN": "D12.776.212", "FX": "Clustered Regularly Interspaced Short Palindromic Repeats", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "Protein components of the CRISPR-CAS SYSTEMS for anti-viral defense in ARCHAEA and BACTERIA. These are proteins that carry out a variety of functions during the creation and expansion of the CRISPR ARRAYS, the capture of new CRISPR SPACERS, biogenesis of SMALL INTERFERING RNA (CRISPR or crRNAs), and the targeting and silencing of invading viruses and plasmids. They include DNA HELICASES; RNA-BINDING PROTEINS; ENDONUCLEASES; and RNA and DNA POLYMERASES.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064130"}, {"RECTYPE": "D", "MH": "Back Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Muscles, Back", "MN": "A02.633.567.175", "MH_TH": "NLM (2014)", "ST": "T023", "AN": "general or unspecified; prefer specifics", "PI": "Muscle, Skeletal (1972-2013)", "MS": "Musculature of the BACK.", "PM": "2014", "HN": "2014", "MR": "20150302", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064131"}, {"RECTYPE": "D", "MH": "Sports Nutritional Sciences", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Sports Nutritional Science", "MN": "H02.533.645", "FX": "Sports Nutritional Physiological Phenomena", "MH_TH": "NLM (2014)", "ST": "T091", "MS": "The study of NUTRITION PROCESSES during EXERCISE and ATHLETIC PERFORMANCE as well as specific NUTRITIONAL REQUIREMENTS of ATHLETES and the relationship between NUTRITIONAL STATUS and NUTRITION DISORDERS in athletes.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064132"}, {"RECTYPE": "D", "MH": "Sports Nutritional Physiological Phenomena", "AQ": "DE EH GE IM PH RE", "ENTRY": "Physiology, Sports Nutritional", "MN": "G07.203.650.830", "FX": "Sports Nutritional Sciences", "MH_TH": "NLM (2014)", "ST": "T040", "MS": "Nutritional physiology related to EXERCISE or ATHLETIC PERFORMANCE.", "PM": "2014", "HN": "2014", "MR": "20160928", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064133"}, {"RECTYPE": "D", "MH": "Chemotherapy-Induced Febrile Neutropenia", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neutropenias, Drug-Induced Febrile", "MN": "C15.378.553.546.184.564.750.500", "MH_TH": "NLM (2014)", "ST": "T047", "PI": "Neutropenia (1987-2013)", "MS": "FEVER accompanied by a significant reduction in NEUTROPHIL count associated with CHEMOTHERAPY.", "PM": "2014", "HN": "2014", "MR": "20230226", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064146"}, {"RECTYPE": "D", "MH": "Febrile Neutropenia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Neutropenias, Febrile", "MN": "C15.378.553.546.184.564.750", "MH_TH": "NLM (2014)", "ST": "T047", "PI": "Neutropenia (1980-2013)", "MS": "Fever accompanied by a significant reduction in the number of NEUTROPHILS.", "PM": "2014", "HN": "2014", "MR": "20230226", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064147"}, {"RECTYPE": "D", "MH": "Minichromosome Maintenance Complex Component 4", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "P1 CDC21 Protein", "MN": "D12.776.664.235.750.400", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 3.6.4.12", "PI": "Nuclear Proteins (1996-2013)", "MS": "A minichromosome maintenance protein that is a key component of the six member MCM protein complex. It is also found in tightly-bound trimeric complex with MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 6 and MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 7.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064148"}, {"RECTYPE": "D", "MH": "Influenza Pandemic, 1918-1919", "AQ": "EC HI LJ MO PC SN", "ENTRY": "Spanish Flu Pandemic, 1918 1919", "MN": "K01.400.504.968.450", "FX": "Influenza, Human", "MH_TH": "NLM (2014)", "ST": "T067", "PI": "Pandemics (1998-2013)", "MS": "The influenza outbreaks of 1918 to 1919 also known as Spanish flu pandemic. First reported in Haskell County in Kansas in March of 1918 the disease spread throughout the world and may have killed as many as 25 million people.", "PM": "2014", "HN": "2014", "MR": "20150629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064149"}, {"RECTYPE": "D", "MH": "Minichromosome Maintenance Complex Component 5", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DNA Replication Licensing Factor MCM5|T116|T126|ABX|EQV|NLM (2014)|130104|abbcdef", "MN": "D12.776.664.235.750.500", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 3.6.4.12", "PI": "Cell Cycle Proteins (2004-2013)", "MS": "A minichromosome maintenance protein that is a key component of the six member MCM protein complex. In addition, interaction of this protein with cyclin A results in its recruitment to CENTROSOMES where it may play a role in controlling centrosome reduplication.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064150"}, {"RECTYPE": "D", "MH": "Minichromosome Maintenance Complex Component 6", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Homolog Protein, MIS5", "MN": "D12.776.664.235.750.600", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 3.6.4.12", "PI": "Cell Cycle Proteins (1997-2013)", "MS": "A minichromosome maintenance protein that is a key component of the six member MCM protein complex. It is also found in tightly-bound trimeric complex with MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 4 and MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 7.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064151"}, {"RECTYPE": "D", "MH": "Vaccine Potency", "ENTRY": "Vaccine Stabilities", "MN": "G12.300.500", "MH_TH": "NLM (2014)", "ST": "T081", "MS": "The relationship between an elicited ADAPTIVE IMMUNE RESPONSE and the dose of the vaccine administered. It is typically measured in an assay to ensure proper dosing and storage of vaccines whereas VACCINE EFFICACY determines disease risk reduction attributable to vaccination under ideal conditions such as a clinical trial and vaccine immunogenicity measures vaccine's ability to induce an immune response in a vaccinated individual in observational studies setting.", "PM": "2014", "HN": "2014", "MR": "20220712", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064166"}, {"RECTYPE": "D", "MH": "Recommended Dietary Allowances", "AQ": "EC HI LJ TD", "PRINT ENTRY": "Recommended Daily Allowances|T170|NON|REL|NLM (1998)|961029|abcdef", "ENTRY": "Reference Intakes, Dietary", "MN": "N03.623.500.608.428.650.500", "MH_TH": "NLM (1998)", "ST": "T170", "PI": "Nutritional Requirements (1968-2013)", "MS": "The amounts of various substances in the diet recommended by governmental guidelines as needed to sustain healthy life.", "PM": "2014; see NUTRITION POLICY 1998-2013", "HN": "2014; use NUTRITION POLICY 1998-2013", "MR": "20150629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064167"}, {"RECTYPE": "D", "MH": "Minichromosome Maintenance Complex Component 7", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DNA Replication Licensing Factor MCM7|T116|T126|ABX|EQV|NLM (2014)|121231|abbcdef", "MN": "D12.776.664.235.750.700", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 3.6.4.12", "PI": "Nuclear Proteins (1996-2013)", "MS": "A minichromosome maintenance protein that is a key component of the six member MCM protein complex. It is also found in tightly-bound trimeric complex with MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 4 and MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 6.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064168"}, {"RECTYPE": "D", "MH": "Intermediate Back Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Serratus Posterior Superiors", "MN": "A02.633.567.175.500", "MH_TH": "NLM (2014)", "ST": "T023", "PI": "Muscle, Skeletal (1972-2013)", "MS": "Two muscles, the serratus posterior superior and serratus posterior inferior, located in between the deep and the superficial back muscle layers. Their function is to control THORAX movement.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064169"}, {"RECTYPE": "D", "MH": "Paraspinal Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Spinalis, Sacrospinalis", "MN": "A02.633.567.175.750", "MH_TH": "NLM (2014)", "ST": "T023", "PI": "Muscle, Skeletal (1972-2013)", "MS": "Deep muscles in the BACK whose function is to extend and rotate the SPINE and maintain POSTURE. It consists splenius, semispinalis, multifidus, rotatores, interspinales, intertransversarii and sacrospinalis.", "PM": "2014", "HN": "2014", "MR": "20130705", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064170"}, {"RECTYPE": "D", "MH": "Superficial Back Muscles", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Trapezius Muscles", "MN": "A02.633.567.175.875", "MH_TH": "NLM (2014)", "ST": "T023", "PI": "Muscle, Skeletal (1972-2013)", "MS": "The top layer of the back muscles whose function is to move the SCAPULA. This group of muscles consists of the trapezius, latissimus dorsi, rhomboid major, rhomboid minor and levator scapulae.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064171"}, {"RECTYPE": "D", "MH": "Pharmacy Residencies", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Residency, Pharmacy", "MN": "I02.358.750.500", "MH_TH": "NLM (2014)", "ST": "T065", "PI": "Internship, Nonmedical (1975-2013)", "MS": "Advanced programs of training to meet certain professional requirements in the practice of compounding and dispensing medicinal preparations.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064172"}, {"RECTYPE": "D", "MH": "Anaphase-Promoting Complex-Cyclosome", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Anaphase Promoting Complex|T116|T126|NON|EQV|NLM (2014)|130116|abbcdef", "MN": "D12.776.167.024", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 2.3.2.27", "PI": "Ubiquitin-Protein Ligase Complexes (2004-2013)", "MS": "An E3 ubiquitin ligase primarily involved in regulation of the metaphase-to-anaphase transition during MITOSIS through ubiquitination of specific CELL CYCLE PROTEINS. Enzyme activity is tightly regulated through subunits and cofactors, which modulate activation, inhibition, and substrate specificity. The anaphase-promoting complex, or APC-C, is also involved in tissue differentiation in the PLACENTA, CRYSTALLINE LENS, and SKELETAL MUSCLE, and in regulation of postmitotic NEURONAL PLASTICITY and excitability.", "PM": "2014; was indexed under UBIQUITIN-PROTEIN LIGASE COMPLEXES 2004-2013", "HN": "2014", "MR": "20160602", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064173"}, {"RECTYPE": "D", "MH": "Cephalochordata", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Cephalochordatas", "MN": "B01.050.500.272.199", "MH_TH": "NLM (2014)", "ST": "T008", "RN": "txid7735", "PI": "Chordata (1963-2013)", "MS": "A subphylum of chordates intermediate between the invertebrates and the true vertebrates. It includes the LANCELETS. Its members are characterized by a NOTOCHORD which extends into the adult stage head.", "PM": "2014", "HN": "2014", "MR": "20200813", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064174"}, {"RECTYPE": "D", "MH": "Lancelets", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "nigerienses, Branchiostoma", "MN": "B01.050.500.272.199.500", "MH_TH": "NLM (2014)", "ST": "T008", "RN": "txid7737", "RR": "txid7741", "PI": "Chordata (1963-2013)", "MS": "Small fish-like marine creatures often used in phylogenetic comparative studies of CHORDATES.", "PM": "2014", "HN": "2014", "MR": "20200902", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064175"}, {"RECTYPE": "D", "MH": "Prenatal Education", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Antenatal Education|T058|T065|NON|EQV|NLM (2014)|130107|abbcdef", "ENTRY": "Parenthood Educations, Antenatal", "MN": "N02.421.726.407.680.500", "MH_TH": "NLM (2014)", "ST": "T065", "MS": "Training for pregnant women and parents-to-be to prepare for CHILDBIRTH; CHILD CARE; and parenthood.", "PM": "2014", "HN": "2014", "MR": "20150626", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064186"}, {"RECTYPE": "D", "MH": "Minichromosome Maintenance Complex Component 8", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DNA Replication Licensing Factor MCM8|T116|T126|ABX|EQV|NLM (2014)|130107|abbcdef", "MN": "D12.776.664.235.750.800", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 3.6.4.12", "PI": "DNA-Binding Proteins (2005-2013)", "MS": "A minichromosome maintenance protein that forms a hexameric complex with MINICHROMSOME MAINTENANCE COMPLEX COMPONENT 9. The MCM8-MCM9 helicase complex is involved in HOMOLOGOUS RECOMBINATION REPAIR following the formation of DNA interstrand cross-links.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064187"}, {"RECTYPE": "D", "MH": "Minichromosome Maintenance Complex Component 9", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "DNA Replication Licensing Factor MCM9|T116|T126|ABX|EQV|NLM (2014)|130108|abbcdef", "MN": "D12.776.664.235.750.900", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 3.6.4.12", "PI": "DNA-Binding Proteins (2005-2013)", "MS": "A minichromosome maintenance protein that forms a hexameric complex with MINICHROMSOME MAINTENANCE COMPLEX COMPONENT 8. The MCM8-MCM9 helicase complex is involved in HOMOLOGOUS RECOMBINATION REPAIR following the formation of DNA interstrand cross-links.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064188"}, {"RECTYPE": "D", "MH": "Apc1 Subunit, Anaphase-Promoting Complex-Cyclosome", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apc1 Subunit, Anaphase Promoting Complex Cyclosome", "MN": "D12.776.167.024.500", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "Ubiquitin-Protein Ligase Complexes (2004-2013)", "MS": "The largest subunit of the anaphase-promoting complex. It acts primarily as a scaffold for the proper organization and arrangement of subunits. The C-terminal region of Apc1 contains a series of tandem amino acid repeats that are also seen in the 26S proteasome regulatory particle, and may assist with forming and stabilizing protein-protein interactions.", "PM": "2014; was indexed under UBIQUITIN-PROTEIN LIGASE COMPLEXES 2004-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064189"}, {"RECTYPE": "D", "MH": "Apc2 Subunit, Anaphase-Promoting Complex-Cyclosome", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apc2 Subunit, Anaphase Promoting Complex Cyclosome", "MN": "D12.776.167.024.750", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 2.3.2.27", "PI": "Ubiquitin-Protein Ligase Complexes (2003-2013)", "MS": "Together with the Apc11 subunit, forms the catalytic core of the E3 ubiquitin ligase anaphase-promoting complex (APC-C). Its N-terminus has cullin domains which associate with the RING FINGER DOMAINS of Apc11. Apc2 also interacts with the E2 ubiquitin ligases involved in APC-C ubiquitination reactions.", "PM": "2014; was indexed under UBIQUITIN-PROTEIN LIGASE COMPLEXES 2004-2013", "HN": "2014", "MR": "20160602", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064190"}, {"RECTYPE": "D", "MH": "Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apc3 Subunit, Anaphase Promoting Complex Cyclosome", "MN": "D12.776.167.024.875", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "Ubiquitin-Protein Ligase Complexes (2004-2013)", "MS": "A highly evolutionarily conserved subunit of the anaphase-promoting complex (APC-C) containing multiple 34-amino-acid tetratricopeptide repeats. These domains, also found in Apc subunits 6, 7, and 8, have been shown to mediate protein-protein interactions, suggesting that Apc3 may assist in coordinating the juxtaposition of the catalytic and substrate recognition module subunits relative to co-activators and APC-C inhibitors.", "PM": "2014; was indexed under UBIQUITIN-PROTEIN LIGASE COMPLEXES 2004-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064191"}, {"RECTYPE": "D", "MH": "Apc4 Subunit, Anaphase-Promoting Complex-Cyclosome", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apc4 Subunit, Anaphase Promoting Complex Cyclosome", "MN": "D12.776.167.024.937", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "Ubiquitin-Protein Ligase Complexes (2004-2013)", "MS": "A subunit of the anaphase-promoting complex whose primary function is to provide structural support for the catalytic and substrate-recognition modules of the complex. Apc4, along with Apc5, tethers the tetratricopeptide-coactivator binding subcomplex to the main structural subunit, Apc1.", "PM": "2014; was indexed under UBIQUITIN-PROTEIN LIGASE COMPLEXES 2004-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064192"}, {"RECTYPE": "D", "MH": "Apc5 Subunit, Anaphase-Promoting Complex-Cyclosome", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apc5 Subunit, Anaphase Promoting Complex Cyclosome", "MN": "D12.776.167.024.968", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "Ubiquitin-Protein Ligase Complexes (2004-2013)", "MS": "A subunit of the anaphase-promoting complex whose primary function is to provide structural support for the catalytic and substrate-recognition modules of the complex. Apc5, along with Apc4, tethers the tetratricopeptide-coactivator binding subcomplex to the main structural subunit, Apc1.", "PM": "2014; was indexed under UBIQUITIN-PROTEIN LIGASE COMPLEXES 2004-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064193"}, {"RECTYPE": "D", "MH": "Apc6 Subunit, Anaphase-Promoting Complex-Cyclosome", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apc6 Subunit, Anaphase Promoting Complex Cyclosome", "MN": "D12.776.167.024.984", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "Ubiquitin-Protein Ligase Complexes (2004-2013)", "MS": "A highly conserved subunit of the anaphase-promoting complex (APC-C) containing multiple 34 amino acid tetratricopeptide repeats. These domains, also found in Apc3, Apc7, and Apc8, have been shown to mediate protein-protein interactions, suggesting that Apc6 may assist in coordinating the juxtaposition of the catalytic and substrate recognition module subunits relative to coactivators and APC-C inhibitors.", "PM": "2014; was indexed under UBIQUITIN-PROTEIN LIGASE COMPLEXES 2004-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064194"}, {"RECTYPE": "D", "MH": "Apc7 Subunit, Anaphase-Promoting Complex-Cyclosome", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apc7 Subunit, Anaphase Promoting Complex Cyclosome", "MN": "D12.776.167.024.992", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "Ubiquitin-Protein Ligase Complexes (2004-2013)", "MS": "A highly conserved subunit of the anaphase-promoting complex (APC-C) containing multiple 34 amino acid tetratricopeptide repeats. These domains, also found in Apc3, Apc6, and Apc8, have been shown to mediate protein-protein interactions, suggesting that Apc7 may assist in coordinating the juxtaposition of the catalytic and substrate recognition module subunits relative to coactivators and APC-C inhibitors.", "PM": "2014; was indexed under UBIQUITIN-PROTEIN LIGASE COMPLEXES 2004-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064195"}, {"RECTYPE": "D", "MH": "Apc8 Subunit, Anaphase-Promoting Complex-Cyclosome", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apc8 Subunit, Anaphase Promoting Complex Cyclosome", "MN": "D12.776.167.024.996", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "Ubiquitin-Protein Ligase Complexes (2004-2013)", "MS": "A highly conserved subunit of the anaphase-promoting complex (APC-C) containing multiple 34-amino-acid tetratricopeptide repeats. These domains, also found in Apc3, Apc6, and Apc7, have been shown to mediate protein-protein interactions, suggesting that Apc8 may assist in coordinating the juxtaposition of the catalytic and substrate recognition module subunits relative to coactivators and APC-C inhibitors.", "PM": "2014; was indexed under UBIQUITIN-PROTEIN LIGASE COMPLEXES 2004-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064196"}, {"RECTYPE": "D", "MH": "Apc10 Subunit, Anaphase-Promoting Complex-Cyclosome", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apc10 Subunit, Anaphase Promoting Complex", "MN": "D12.776.167.024.625", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "Ubiquitin-Protein Ligase Complexes (2004-2013)", "MS": "Apc10 is necessary for coactivator-dependent substrate recognition by the anaphase-promoting complex-cyclosome. It binds the Apc2 subunit, which is a part of the catalytic core, and interacts with coactivators Cdh1 or Cdc20 to recruit substrates to the complex.", "PM": "2014; was indexed under UBIQUITIN-PROTEIN LIGASE COMPLEXES 2004-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064197"}, {"RECTYPE": "D", "MH": "Apc11 Subunit, Anaphase-Promoting Complex-Cyclosome", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Apc11 Subunit, Anaphase Promoting Complex Cyclosome", "MN": "D12.776.167.024.687", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 2.3.2.27", "PI": "Ubiquitin-Protein Ligase Complexes (2004-2013)", "MS": "Together with the Apc2 subunit, forms the catalytic core of the E3 ubiquitin ligase, anaphase-promoting complex-cyclosome. It has a RING H2 domain which interacts with the cullin domain of Apc2. Apc11 also interacts with the E2 ubiquitin ligases involved in APC-C ubiquitination reactions.", "PM": "2014; was indexed under UBIQUITIN-PROTEIN LIGASE COMPLEXES 2004-2013", "HN": "2014", "MR": "20160602", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064198"}, {"RECTYPE": "D", "MH": "Cdc20 Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.167.024.998", "MH_TH": "NLM (2014)", "ST": "T116", "RN": "0", "PI": "Cell Cycle Proteins (1987-2013)", "MS": "Highly conserved proteins that specifically bind to and activate the anaphase-promoting complex-cyclosome, promoting ubiquitination and proteolysis of cell-cycle-regulatory proteins. Cdc20 is essential for anaphase-promoting complex activity, initiation of anaphase, and cyclin proteolysis during mitosis.", "PM": "2014; was indexed under CELL CYCLE PROTEINS 1987-2013", "HN": "2014", "MR": "20150622", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064199"}, {"RECTYPE": "D", "MH": "Cdh1 Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cdh1 Protein|T116|T123|NON|EQV|NLM (2021)|191121|abbcdef", "ENTRY": "Protein, Cdh1", "MN": "D12.776.167.024.999", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "Ubiquitin-Protein Ligase Complexes (2004-2013)", "MS": "Cdh1 is an activator of the anaphase-promoting complex-cyclosome and is involved in substrate recognition. It associates with the complex in late MITOSIS from anaphase through G1 to regulate activity of CYCLIN-DEPENDENT KINASES and to prevent premature DNA replication.", "PM": "2014; was indexed under UBIQUITIN-PROTEIN LIGASE COMPLEXES 2003-2013; was indexed under LIGASES 1999-2002", "HN": "2014", "MR": "20210630", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064200"}, {"RECTYPE": "D", "MH": "Trichomes", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Trichome", "MN": "A18.024.750.825", "MH_TH": "NLM (2014)", "ST": "T023", "MS": "Hair-like extensions on specialized epidermal surfaces of plants which protect against damage from insects, animals, light degradation and fungal infection. Trichomes may also occur on certain unicellular EUKARYOTES.", "PM": "2014", "HN": "2014", "MR": "20130705", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064201"}, {"RECTYPE": "D", "MH": "O'nyong-nyong Virus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "O'nyong'nyong Virus|T005|NON|EQV|NLM (2014)|130109|abcdef", "ENTRY": "nyong Viruses, Onyong", "MN": "B04.820.578.875.054.586", "MH_TH": "NLM (2014)", "ST": "T005", "RN": "txid2169701", "RR": "txid79899", "AN": "infection: coordinate IM with ALPHAVIRUS INFECTIONS (IM)", "MS": "A species of ALPHAVIRUS causing a measles-like acute febrile rash illness. It is closely related to the Chikungunya virus and Igbo Ora viruses.", "PM": "2014", "HN": "2014", "MR": "20200813", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064202"}, {"RECTYPE": "D", "MH": "Aggregatibacter", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.660.250.550.170", "MH_TH": "NLM (2014)", "ST": "T007", "RN": "txid416916", "MS": "A genus of PASTEURELLACEAE. Members are nonmotile, Gram-negative, facultatively anaerobic rods or coccobacilli. Its members are X factor (HEMIN) independent and variably dependent on V factor (NAD).", "PM": "2014", "HN": "2014", "MR": "20200813", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064206"}, {"RECTYPE": "D", "MH": "Aggregatibacter aphrophilus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Haemophilus aphrophilus|T007|NON|EQV|NLM (2014)|130110|abcdef", "MN": "B03.660.250.550.170.750", "MH_TH": "NLM (2014)", "ST": "T007", "RN": "txid732", "AN": "infection: coordinate IM with PASTEURELLACEAE INFECTIONS (IM)", "MS": "A species of Gram-negative, facultatively anaerobic spherical or rod-shaped bacteria indigenous to oral cavity and pharynx. It is associated with BACTERIAL ENDOCARDITIS; and MENINGITIS.", "PM": "2014", "HN": "2014", "MR": "20200128", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064207"}, {"RECTYPE": "D", "MH": "Aggregatibacter segnis", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "ENTRY": "Haemophilus segnis|T007|NON|EQV|NLM (2014)|130110|abcdef", "MN": "B03.660.250.550.170.875", "MH_TH": "NLM (2014)", "ST": "T007", "RN": "txid739", "AN": "infection: coordinate IM with PASTEURELLACEAE INFECTIONS (IM)", "PI": "Haemophilus (1986-2013)", "MS": "A species of Gram-negative, facultatively anaerobic pleomorphic rod-shaped often filamentous bacteria in the genus of AGGREGATIBACTER found in the oral cavity. It is associated with DENTAL PLAQUE; and BACTERIAL ENDOCARDITIS.", "PM": "2014", "HN": "2014", "MR": "20200128", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064208"}, {"RECTYPE": "D", "MH": "Phytochemicals", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Plant-Derived Compound|T123|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Plant Derived Compounds", "MN": "D23.704", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "AN": "general or unspecified; prefer specific chemical; note PLANT ALKALOIDS see ALKALOIDS is available", "MS": "A broad range of biologically active compounds which occur naturally in plants having important medicinal and nutritional properties.", "PM": "2014", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064209"}, {"RECTYPE": "D", "MH": "Secondary Metabolism", "AQ": "DE GE IM PH RE", "ENTRY": "Secondary Metabolisms", "MN": "G03.493.875", "FX": "Phytochemicals", "MH_TH": "NLM (2014)", "ST": "T040", "MS": "A physiochemical process which occurs in a wide range of organisms which unlike BASAL METABOLISM is not required for or essential to short-term survivability but to long-term general well-being of the organism.", "PM": "2014", "HN": "2014", "MR": "20220708", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064210"}, {"RECTYPE": "D", "MH": "Connectin", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Connectin", "MN": "D12.776.210.500.246", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "A giant elastic protein of molecular mass ranging from 2,993 kDa (cardiac), 3,300 kDa (psoas), to 3,700 kDa (soleus) having a kinase domain. The amino- terminal is involved in a Z line binding, and the carboxy-terminal region is bound to the myosin filament with an overlap between the counter-connectin filaments at the M line.", "PM": "2014; was indexed under MUSCLE PROTEINS 1978-2013 and PROTEIN KINASES 198-2013", "HN": "2014", "MR": "20160628", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064211"}, {"RECTYPE": "D", "MH": "Prescription Drug Diversion", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Substance Diversions, Controlled", "MN": "I01.880.735.191.204", "FX": "Prescription Drug Misuse", "MH_TH": "NLM (2014)", "ST": "T068", "MS": "The transfer of prescription drugs from legal to illegal distribution and marketing networks.", "PM": "2014", "HN": "2014", "MR": "20190711", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064226"}, {"RECTYPE": "D", "MH": "Chlorofluorocarbons, Ethane", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ethane Chlorofluorocarbons", "MN": "D02.455.526.510.140.224", "MH_TH": "NLM (2014)", "ST": "T109", "RN": "0", "PI": "Chlorofluorocarbons (1994-2013)", "MS": "A group of ethane-based halogenated hydrocarbons containing one or more fluorine and chlorine atoms.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064227"}, {"RECTYPE": "D", "MH": "Bromochlorofluorocarbons", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Halons|T109|NON|NRW|NLM (2014)|130115|abcdef", "MN": "D02.455.526.510.140.149", "MH_TH": "NLM (2014)", "ST": "T109", "RN": "0", "MS": "A series of hydrocarbons containing BROMINE; CHLORINE and FLOURINE.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064228"}, {"RECTYPE": "D", "MH": "Biological Ontologies", "AQ": "HI OG SN TD", "ENTRY": "Ontology, Biomedical", "MN": "L01.462.750.245.945.079", "MH_TH": "NLM (2014)", "ST": "T170", "MS": "Structured vocabularies describing concepts from the fields of biology and relationships between concepts.", "PM": "2014", "HN": "2014", "MR": "20220712", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064229"}, {"RECTYPE": "D", "MH": "Nestin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, Nestin", "MN": "D12.776.631.607", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "A type VI intermediate filament protein expressed mostly in nerve cells where it is associated with the survival, renewal and mitogen-stimulated proliferation of neural progenitor cells.", "PM": "2014; was indexed under INTERMEDIATE FILAMENT PROTEINS and NERVE TISSUE PROTEINS 1990-2013", "HN": "2014", "MR": "20151124", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064231"}, {"RECTYPE": "D", "MH": "Visual Analog Scale", "ENTRY": "Visual Analog Scales", "MN": "E01.370.928", "MH_TH": "NLM (2014)", "ST": "T060", "PI": "Pain Measurement (1986-2013)", "MS": "A subjective psychometric response scale used to measure distinct behavioral or physiological phenomena based on linear numerical gradient or yes/no alternatives.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064232"}, {"RECTYPE": "D", "MH": "Sulfonylurea Receptors", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Sulfonylurea Receptor|T116|T192|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "Receptors, Sulfonylurea", "MN": "D12.776.827.775", "MH_TH": "NLM (2014)", "ST": "T192", "RN": "0", "MS": "ATP-BINDING CASSETTE PROTEINS that are highly conserved and widely expressed in nature. They form an integral part of the ATP-sensitive potassium channel complex which has two intracellular nucleotide folds that bind to sulfonylureas and their analogs.", "PM": "2014", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064233"}, {"RECTYPE": "D", "MH": "Matrilin Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, Matrilin", "MN": "D12.776.860.300.700", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "PROTEOGLYCANS-associated proteins that are major components of EXTRACELLULAR MATRIX of various tissues including CARTILAGE; and INTERVERTEBRAL DISC structures. They bind COLLAGEN fibers and contain protein domains that enable oligomer formation and interaction with other extracellular matrix proteins such as CARTILAGE OLIGOMERIC MATRIX PROTEIN.", "PM": "2014; was under GLYCOPROTEIN 1982-2013; and EXTRACELLULAR MATRIX PROTEINS 1982-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064235"}, {"RECTYPE": "D", "MH": "Cartilage Oligomeric Matrix Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, Thrombospondin-5", "MN": "D12.776.860.300.155", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "Major component of chondrocyte EXTRACELLULAR MATRIX of various tissues including bone, tendon, ligament, SYNOVIUM and blood vessels. It binds MATRILIN PROTEINS and is associated with development of cartilage and bone.", "PM": "2014; was under GLYCOPROTEIN 1982-2013; and EXTRACELLULAR MATRIX PROTEINS 1982-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064236"}, {"RECTYPE": "D", "MH": "Lipid Accumulation Product", "AQ": "DE EH GE IM PH RE", "ENTRY": "Products, Lipid Accumulation", "MN": "E05.041.124.160.875.500", "FX": "Hypertriglyceridemic Waist", "MH_TH": "NLM (2014)", "ST": "T081", "MS": "An index for monitoring the accumulation of lipids based on the WAIST CIRCUMFERENCE measurement and the level of TRIGLYCERIDES circulating in the blood.", "PM": "2014", "HN": "2014", "MR": "20130801", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064237"}, {"RECTYPE": "D", "MH": "Mad2 Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Mad2 Mitotic Arrest Deficient-like 1 Proteins|T116|T123|ACX|EQV|NLM (2014)|130204|abbcdef", "MN": "D12.776.660.526", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "Mad2 is a component of the spindle-assembly checkpoint apparatus. It binds to and inhibits the Cdc20 activator subunit of the anaphase-promoting complex, preventing the onset of anaphase until all chromosomes are properly aligned at the metaphase plate. Mad2 is required for proper microtubule capture at KINETOCHORES.", "PM": "2014; was indexed under CELL CYCLE PROTEINS 2000-2013 and NUCLEAR PROTEINS 2005-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064246"}, {"RECTYPE": "D", "MH": "Separase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.167.552", "MH_TH": "NLM (2001)", "ST": "T126", "RN": "EC 3.4.22.49", "PI": "Endopeptidases (1999-2013)", "MS": "Separase is a caspase-like cysteine protease, which plays a central role in triggering ANAPHASE by cleaving the SCC1/RAD21 subunit of the cohesin complex. Cohesin holds the sister CHROMATIDS together during METAPHASE and its cleavage results in chromosome segregation.", "PM": "2014; was indexed under ENDOPEPTIDASES and CELL CYCLE PROTEINS 1999-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064247"}, {"RECTYPE": "D", "MH": "Geminin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "MN": "D12.776.167.265", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "Cell Cycle Proteins (1998-2013)", "MS": "Geminin inhibits DNA replication by preventing the incorporation of MCM complex into pre-replication complex. It is absent during G1 phase of the CELL CYCLE and accumulates through S, G2,and M phases. It is degraded at the metaphase-anaphase transition by the ANAPHASE-PROMOTING COMPLEX-CYCLOSOME.", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064248"}, {"RECTYPE": "D", "MH": "Securin", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Pituitary Tumor Transforming Proteins", "MN": "D12.776.167.504", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "Neoplasm Proteins (1997-2013)", "MS": "Securin is involved in the control of the metaphase-anaphase transition during MITOSIS. It promotes the onset of anaphase by blocking SEPARASE function and preventing proteolysis of cohesin and separation of sister CHROMATIDS. Overexpression of securin is associated with NEOPLASTIC CELL TRANSFORMATION and tumor formation.", "PM": "2014; was indexed under NEOPLASM PROTEINS 1997-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064249"}, {"RECTYPE": "D", "MH": "Hypertriglyceridemic Waist", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Waist, Hypertriglyceridemic", "MN": "C23.888.521", "FX": "Lipid Accumulation Product", "MH_TH": "NLM (2014)", "ST": "T184", "PI": "Hypertriglyceridemia (2000-2013)", "MS": "A screening phenotype consisting of both elevated WAIST CIRCUMFERENCE and elevated fasting TRIGLYCERIDES level.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064250"}, {"RECTYPE": "D", "MH": "Multifunctional Enzymes", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Multifunctional Enzyme|T126|NON|EQV|NLM (2021)|200210|abcdef", "ENTRY": "Enzymes, Multifunctional", "MN": "D08.811.641", "FX": "Multienzyme Complexes", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "0", "AN": "MULTIENZYME COMPLEXES is also available", "PI": "Multienzyme Complexes (1974-2013)", "MS": "Molecules that contain multiple active sites which are used to catalyze more than one enzymatic reaction. Proteins in this class generally contain multiple active sites within a single peptide chain and may also contain more than one enzymatically active subunit. They are distinguished from MULTIENZYME COMPLEXES in that their subunits are not found as distinct enzymes.", "PM": "2014", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064251"}, {"RECTYPE": "D", "MH": "Preexisting Condition Coverage", "AQ": "CL EC ES HI LJ OG SN ST TD", "PRINT ENTRY": "Preexisting Condition|T080|NON|EQV|NLM (2014)|130125|abcdef", "ENTRY": "Preexisting Illnesses", "MN": "N03.219.521.576.585.500", "MH_TH": "NLM (2014)", "ST": "T080", "AN": "do not use for discussions of preexisting coverage associated with WORKERS' COMPENSATION", "MS": "Insurance coverage of a physical or mental health condition, disability, or illness existing before health insurance is applied for or enrolled in.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064266"}, {"RECTYPE": "D", "MH": "Intrinsically Disordered Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Unstructured Protein|T116|T123|NON|EQV|NLM (2021)|200629|abbcdef", "ENTRY": "Unfolded Protein, Natively", "MN": "D12.776.481", "FX": "Protein Unfolding", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "Functional proteins that do not have unique, stable, folded, three-dimensional native structures or that possess non-ordered regions under physiological conditions. They are characterized by extraordinary structural flexibility and plasticity, which enable them to adopt different conformations in response to different stimuli or different interactions.", "PM": "2014", "HN": "2014", "MR": "20200629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064267"}, {"RECTYPE": "D", "MH": "ATP Binding Cassette Transporter 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Cholesterol Efflux Regulatory Protein", "MN": "D12.776.543.585.100.190.500", "FX": "Tangier Disease", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "A superfamily of integral ATP-binding cassette membrane proteins whose expression pattern is consistent with a role in lipid (cholesterol) efflux. It is implicated in TANGIER DISEASE, characterized by accumulation of cholesteryl ester in various tissues.", "PM": "2014; was indexed under ATP-BINDING CASSETTE TRANSPORTERS 2003-2013.", "HN": "2014 (2003)", "MR": "20230316", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064286"}, {"RECTYPE": "D", "MH": "Non-Nutritive Sweeteners", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Sweeteners, Non-Nutritive", "MN": "J02.500.514.500.400.700.500", "MH_TH": "NLM (2014)", "ST": "T120", "RN": "0", "PI": "Sweetening Agents (1969-2013)", "MS": "Chemical additives, such as aspartame, saccharin, and sucralose, that give a sweet taste to foods without contributing significant calories or promoting tooth decay. They are generally much sweeter than sucrose.", "PM": "2014", "HN": "2014", "MR": "20170628", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064306"}, {"RECTYPE": "D", "MH": "Microbiota", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Microbiome, Human|T001|NON|NRW|NLM (2008)|070413|abcdef", "ENTRY": "Microbiotas", "MN": "N06.230.124.049.100.500", "FX": "Metagenome", "MH_TH": "NLM (2010)", "ST": "T001", "AN": "coordinate with specific organism, organ or other site with / microbiol if pertinent", "MS": "The full collection of microbes (bacteria, fungi, virus, etc.) that naturally exist within a particular biological niche such as an organism, soil, a body of water, etc.", "PM": "2014; see METAGENOME 2009-2013; see MICROBIOME 2008-2009", "HN": "2014; use METAGENOME 2008-2013", "MR": "20180228", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064307"}, {"RECTYPE": "D", "MH": "Ecological Parameter Monitoring", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Parameter Monitoring, Ecological", "MN": "E05.298", "FX": "Environmental Monitoring", "MH_TH": "NLM (2014)", "ST": "T057", "MS": "Ongoing collection, analysis, and interpretation of ecological data that is used to assess changes in the components, processes, and overall condition and functioning of an ECOSYSTEM.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064308"}, {"RECTYPE": "D", "MH": "MEF2 Transcription Factors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transcription Factors, MEF2", "MN": "D12.776.930.397.700", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "Activating transcription factors of the MADS family which bind a specific sequence element (MEF2 element) in many muscle-specific genes and are involved in skeletal and cardiac myogenesis, neuronal differentiation and survival/apoptosis.", "PM": "2014; was indexed under MYOGENIC REGULATORY FACTORS 2004-2013; TRANSCRIPTION FACTORS 1992-2005; MADS DOMAIN PROTEINS 2005-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064326"}, {"RECTYPE": "D", "MH": "Sagittal Abdominal Diameter", "AQ": "DE EH GE IM PH RE", "ENTRY": "Sagittal Abdominal Diameters", "MN": "G07.100.100.160.340", "FX": "Waist Circumference", "MH_TH": "NLM (2014)", "ST": "T081", "MS": "The height of the ABDOMEN as measured in the SUPINE POSITION.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064346"}, {"RECTYPE": "D", "MH": "Microscopy, Electrochemical, Scanning", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Scanning Microscopy, Electrochemical", "MN": "E05.595.666.450", "MH_TH": "NLM (2014)", "ST": "T059", "MS": "A scanning probe microscopy technique that uses an ultramicroelectrode as the scanning probe that simultaneously records changes in electrochemical potential as it scans thereby creating topographical images with localized electrochemical information.", "PM": "2014", "HN": "2014", "MR": "20130705", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064347"}, {"RECTYPE": "D", "MH": "Torpor", "AQ": "DE GE IM PH RE", "MN": "G16.012.500.535.889", "FX": "Diapause", "MH_TH": "NLM (2014)", "ST": "T040", "MS": "A state of decreased activity in animals characterized by depressed metabolism, reduced body temperature, and low sensitivity to external stimuli.", "PM": "2014", "HN": "2014", "MR": "20170414", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064348"}, {"RECTYPE": "D", "MH": "Genome, Microbial", "AQ": "DE GE IM PH RE", "ENTRY": "Microbial Genomes", "MN": "G05.360.340.358", "FX": "Genetics, Microbial", "MH_TH": "NLM (2014)", "ST": "T028", "AN": "general or unspecified; prefer specifics", "PI": "Genome or specifics (1997-2013)", "MS": "The genetic complement of a microorganism as represented in its DNA or in some microorganisms its RNA.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064349"}, {"RECTYPE": "D", "MH": "Genes, Microbial", "AQ": "DE GE IM PH RE", "ENTRY": "Microbial Genes", "MN": "G05.360.340.358.024", "MH_TH": "NLM (2014)", "ST": "T028", "AN": "general or unspecified; prefer specifics", "PI": "Genes or specifics (1996-2013)", "MS": "The functional hereditary units of a microorganism.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064351"}, {"RECTYPE": "D", "MH": "Olfactometry", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "MN": "E05.638", "FX": "Smell", "MH_TH": "NLM (2014)", "ST": "T060", "PI": "Smell (1963-2013)", "MS": "Procedures for measuring a response to odorants.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064367"}, {"RECTYPE": "D", "MH": "Healthy Volunteers", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Volunteers, Normal", "MN": "M01.955.236", "MH_TH": "NLM (2014)", "ST": "T098", "AN": "IM when ethical, legal, psychological, social or economic aspects of the volunteers are discussed", "MS": "Persons with no known significant health problems who are recruited to participate in research to test a new drug, device, or intervention as controls for a patient group. (from http://clinicalcenter.nih.gov/recruit/volunteers.html, accessed 2/14/2013)", "PM": "2014", "HN": "2014", "MR": "20140616", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064368"}, {"RECTYPE": "D", "MH": "Spike Glycoprotein, Coronavirus", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Spike Glycoproteins, Coronavirus|T116|T123|NON|EQV|NLM (2014)|130215|abbcdef", "ENTRY": "Coronavirus Spike Protein", "MN": "D12.776.964.970.880.910.665", "MH_TH": "NLM (1991)", "ST": "T123", "RN": "0", "PI": "Viral Proteins (1979-1982)", "MS": "A class I viral fusion protein that forms the characteristic spikes, or peplomers, found on the viral surface that mediate virus attachment, fusion, and entry into the host cell. During virus maturation, it is cleaved into two subunits: S1, which binds to receptors in the host cell, and S2, which mediates membrane fusion.", "PM": "2014; was indexed under MEMBRANE GLYCOPROTEINS 1991-2013 and VIRAL ENVELOPE PROTEINS 1991-2013", "HN": "2014", "MR": "20200622", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064370"}, {"RECTYPE": "D", "MH": "Hazardous Waste Sites", "AQ": "CL EC ES HI IS LJ SN ST", "ENTRY": "Waste Sites, Hazardous", "MN": "N06.850.860.510.900.700.500", "MH_TH": "NLM (2014)", "ST": "T073", "AN": "specify geographic location if pertinent", "PI": "Hazardous Waste (1988-2013)", "MS": "Sites where HAZARDOUS SUBSTANCES are deposited. Some have facilities for safely storing, processing, and recycling these waste products.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064371"}, {"RECTYPE": "D", "MH": "Ankle Fractures", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Trimalleolar Fracture", "MN": "C26.558.100.500", "MH_TH": "NLM (2014)", "ST": "T037", "MS": "Fractures of any of the bones of the ANKLE.", "PM": "2014", "HN": "2014", "MR": "20220413", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064386"}, {"RECTYPE": "D", "MH": "Patient Harm", "AQ": "AE CL EC ES HI LJ MO NU PC PX SN TD VE", "ENTRY": "Harms, Patient", "MN": "N06.850.725", "MH_TH": "NLM (2014)", "ST": "T080", "MS": "A measure of PATIENT SAFETY considering errors or mistakes which result in harm to the patient. They include errors in the administration of drugs and other medications (MEDICATION ERRORS), errors in the performance of procedures or the use of other types of therapy, in the use of equipment, and in the interpretation of laboratory findings and preventable accidents involving patients.", "PM": "2014", "HN": "2014", "MR": "20180629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064406"}, {"RECTYPE": "D", "MH": "Senior Centers", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Senior Center", "MN": "N02.421.143.913", "FX": "Adult Day Care Centers", "MH_TH": "NLM (2014)", "ST": "T092", "MS": "Community centers for older adults and providers of resources for the community. In addition to providing services and activities for older adults that reflect the community's diversity, they link participants with resources offered by other agencies.", "PM": "2014", "HN": "2014", "MR": "20160608", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064407"}, {"RECTYPE": "D", "MH": "Human Trafficking", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Traffickings, Human", "MN": "I01.880.735.384.399", "FX": "Organ Trafficking", "MH_TH": "NLM (2014)", "ST": "T068", "MS": "Recruitment, transportation, transfer, harboring or receipt of persons, by means of the threat or use of force or other forms of coercion, of abduction, of fraud, of deception, of the abuse of power or of a position of vulnerability or of the giving or receiving of payments or benefits to achieve the consent of a person having control over another person, for the purpose of exploitation. (UN. Protocol to prevent, suppress and punish trafficking in persons, especially women and children, supplementing the United Nations convention against transnational organized crime. General Assembly resolution 55/25. United Nations General Assembly, 2000)", "PM": "2014", "HN": "2014", "MR": "20130801", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064410"}, {"RECTYPE": "D", "MH": "Streptomyces rimosus", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "MN": "B03.510.460.410.810.768.750", "MH_TH": "NLM (2014)", "ST": "T007", "RN": "txid1927", "PI": "Streptomyces (1955-2013)", "MS": "An actinomycete best known as the producer of the commercially important antibiotic OXYTETRACYCLINE.", "PM": "2014", "HN": "2014", "MR": "20200813", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064411"}, {"RECTYPE": "D", "MH": "Levalbuterol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Levosalbutamol", "MN": "D02.092.471.683.061.500", "MH_TH": "NLM (2001)", "ST": "T121", "RN": "EDN2NBH5SS", "RR": "WDQ1526QJM", "PI": "Albuterol (2001-2013)", "MS": "The R-isomer of albuterol.", "PM": "2014; see ALBUTEROL 2001-2013", "HN": "2014; use ALBUTEROL 2001-2013", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064412"}, {"RECTYPE": "D", "MH": "3-Phosphoinositide-Dependent Protein Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinases, 3-Phosphoinositide-Dependent", "MN": "D12.776.476.563.745", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 2.7.11.1", "RR": "EC 2.7.11.1", "PI": "Protein-Serine-Threonine Kinases (1997-2013)", "MS": "Highly conserved protein-serine threonine kinases that phosphorylate and activate a group of AGC protein kinases, especially in response to the production of the SECOND MESSENGERS, phosphatidylinositol 3,4,-biphosphate (PtdIns(3,4)P2) and phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P3).", "PM": "2014; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES 1997-2013", "HN": "2014", "MR": "20210520", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064413"}, {"RECTYPE": "D", "MH": "Type B Personality", "ENTRY": "Type B, Personality", "MN": "F01.752.747.905", "MH_TH": "NLM (2014)", "ST": "T041", "PI": "Personality (1966-2013)", "MS": "Behavior pattern characterized by a generally calm and even-tempered demeanor. Emotionally, such personality types show less frequent irritation, anger, hostility, and aggression than Type A individuals. (from International Encyclopedia of the Social Sciences, 2008, p. 223)", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064414"}, {"RECTYPE": "D", "MH": "Type D Personality", "ENTRY": "Type D, Personality", "MN": "F01.752.747.917", "MH_TH": "NLM (2014)", "ST": "T041", "PI": "Personality (1966-2013)", "MS": "Behavior pattern characterized by negative emotionality, an inability to express emotions, and social isolation, which has been linked to greater cardiovascular disease and increased mortality. (from International Encyclopedia of the Social Sciences, 2008, p. 217)", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064415"}, {"RECTYPE": "D", "MH": "Hospital Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Hospital", "MN": "H02.403.377", "FX": "Hospitalists", "MH_TH": "NLM (2014)", "ST": "T091", "AN": "use for the specialty only", "MS": "The branch of medicine concerned with the delivery of comprehensive medical care to hospitalized patients. Practitioners include physicians and non-physician providers who engage in clinical care, teaching, research, or leadership in the field of general hospital medicine.(from http://www.hospitalmedicine.org/AM/Template.cfm?Section=Hospitalist_Definition)", "PM": "2014", "HN": "2014", "MR": "20130705", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064416"}, {"RECTYPE": "D", "MH": "Vitamin K Epoxide Reductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Vitamin K Epoxidase|T116|T126|NON|EQV|NLM (2014)|130228|abbcdef", "ENTRY": "Vitamin K 2,3 Epoxide Reductase", "MN": "D08.811.682.690.708.961", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 1.17.4.4", "RR": "EC 1.17.4.5", "MS": "OXIDOREDUCTASES which mediate vitamin K metabolism by converting inactive vitamin K 2,3-epoxide to active vitamin K.", "PM": "2014; was indexed under MIXED FUNCTION OXYGENASES 1978-2013.", "HN": "2014 (1978)", "MR": "20160601", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064417"}, {"RECTYPE": "D", "MH": "Chemically-Induced Disorders", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Chemically-Induced Disorder", "MN": "C25", "RH": "C25 - CHEMICALLY-INDUCED DISORDERS", "FX": "Bioaccumulation", "MH_TH": "NLM (2014)", "ST": "T047", "AN": "general or unspecified; prefer specifics", "PI": "Substance-Related Disorders (1999-2013)", "MS": "Disorders caused by the intentional or unintentional ingestion or exposure to chemical substances such as PHARMACEUTICAL PREPARATIONS; NOXAE; and PESTICIDES.", "PM": "2014", "HN": "2014", "MR": "20190701", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064419"}, {"RECTYPE": "D", "MH": "Drug-Related Side Effects and Adverse Reactions", "AQ": "BL CF CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Drug-Related Side Effects and Adverse Reaction|T037|T047|NON|EQV|NLM (2022)|201015|abbcdef", "ENTRY": "Toxicities, Drug", "MN": "C25.100", "FX": "Drug Interactions", "MH_TH": "NLM (2014)", "ST": "T047", "AN": "general or unspecified only; prefer specific drug-related disorder + specific drug with /adv eff /pois or /tox; for disorders relating to the abuse of drugs use SUBSTANCE-RELATED DISORDERS or specifics", "PI": "Substance-Related Disorders (1998-2013)", "MS": "Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.", "PM": "2014; see DRUG-TOXICITY 1998-2013", "HN": "2014; DRUG-TOXICITY was heading 1998-2013", "MR": "20210630", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064420"}, {"RECTYPE": "D", "MH": "Ambulance Diversion", "AQ": "EC ES HI LJ OG SN ST TD", "ENTRY": "Diversions, Ambulance", "MN": "N02.421.297.879.049", "MH_TH": "NLM (2014)", "ST": "T058", "MS": "The practice of redirecting ambulances and patients seeking urgent care from one emergency department to others for various reasons such as overcrowding and shortage of skilled staff.", "PM": "2014", "HN": "2014", "MR": "20150629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064422"}, {"RECTYPE": "D", "MH": "Drug Trafficking", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Traffickings, Drug", "MN": "I01.880.735.191.101", "MH_TH": "NLM (2014)", "ST": "T055", "MS": "The illegal acquisition, sale, production, transport, movement, and distribution of controlled substances such as narcotics.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064423"}, {"RECTYPE": "D", "MH": "Tobacco Use", "AQ": "AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PC PP PX TD TH UR", "PRINT ENTRY": "Tobacco Consumption|T078|NON|EQV|NLM (2014)|130228|abcdef", "ENTRY": "Tobacco Uses", "MN": "F01.145.958", "MH_TH": "NLM (2014)", "ST": "T078", "MS": "Use of TOBACCO (Nicotiana tabacum L) and TOBACCO PRODUCTS.", "PM": "2014", "HN": "2014", "MR": "20210628", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064424"}, {"RECTYPE": "D", "MH": "Herbals as Topic", "AQ": "CL HI ST", "ENTRY": "as Topics, Herbals", "MN": "L01.462.500.682.192.836.642", "MH_TH": "NLM (2014)", "ST": "T170", "AN": "do not confuse with the Publication Type HERBAL", "MS": "Works about books, articles or other publications on herbs or plants describing their medicinal value.", "PM": "2014", "HN": "2014", "MR": "20220712", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064425"}, {"RECTYPE": "D", "MH": "Gasotransmitters", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Gasotransmitter|T123|T197|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Transducers, Gaseous Signal", "MN": "D27.505.519.625.270", "FX": "Signal Transduction", "MH_TH": "NLM (2014)", "ST": "T197", "RN": "0", "MS": "Endogenously produced lipid-soluble gaseous molecules which function as neurotransmitters and signal mediators targeting ION CHANNELS and transporters.", "PM": "2014", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064426"}, {"RECTYPE": "D", "MH": "Nutritive Sweeteners", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "Sweeteners, Nutritive", "MN": "J02.500.514.500.400.700.750", "MH_TH": "NLM (2014)", "ST": "T120", "RN": "0", "PI": "Sweetening Agents (1966-2013)", "MS": "Any agent that adds not only sweet taste but some energy value to food. They include natural sugars such as SUCROSE; FRUCTOSE; and GALACTOSE; and certain SUGAR ALCOHOLS.", "PM": "2014", "HN": "2014", "MR": "20170628", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064427"}, {"RECTYPE": "D", "MH": "Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Hyperpolarization Cyclic-Nucleotide Gated Ion Channels|T116|NON|EQV|NLM (2008)|070322|abcdef", "ENTRY": "Potassium Sodium Hyperpolarization Activated Cyclic Nucleotide Gated Channel 2", "MN": "D12.776.543.585.400.476", "MH_TH": "NLM (2014)", "ST": "T116", "RN": "0", "PI": "Cyclic Nucleotide-Gated Cation Channels (2001-2013)", "MS": "A subgroup of cyclic nucleotide-regulated ION CHANNELS of the superfamily of pore-loop cation channels that are opened by hyperpolarization rather than depolarization. The ion conducting pore passes SODIUM, CALCIUM, and POTASSIUM cations with a preference for potassium.", "PM": "2014; see CYCLIC NUCLEOTIDE-GATED CATION CHANNELS 2009-2013; for HCN2 POTASSIUM CHANNEL see ION CHANNELS 2005-2013 and MUSCLE PROTEINS 1999-2005", "HN": "2014", "MR": "20160701", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064428"}, {"RECTYPE": "D", "MH": "Fatty Acid Synthases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Fatty Acid Synthase|T116|T126|NON|EQV|NLM (2021)|191114|abbcdef", "ENTRY": "Synthetases, Fatty Acid", "MN": "D08.811.913.050.170.500", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 2.3.1.85", "RR": "EC 4.2.1.59", "MS": "Enzymes that catalyze the synthesis of FATTY ACIDS from acetyl-CoA and malonyl-CoA derivatives.", "PM": "2014; see FATTY ACID SYNTHETASE COMPLEX 1972-2013", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064429"}, {"RECTYPE": "D", "MH": "NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Alchohol Oxidoreductases, NAD (+) and NADP (+) Dependent|T116|T126|NON|EQV|NLM (2014)|130328|abbcdef", "MN": "D08.811.682.047.820", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 1.1.1.-", "PI": "Alcohol Oxidoreductases (1964-2013)", "MS": "Oxidoreductases that act on the CH-OH group of donors with NAD (+) or NADPH (+) as acceptors.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064430"}, {"RECTYPE": "D", "MH": "3-Oxoacyl-(Acyl-Carrier-Protein) Reductase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta Ketoacyl ACP Reductase", "MN": "D08.811.682.047.820.196", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 1.1.1.100", "PI": "Alcohol Oxidoreductases (1964-2013)", "MS": "A 3-oxoacyl reductase that has specificity for ACYL CARRIER PROTEIN-derived FATTY ACIDS.", "PM": "2014; 3-OXOACYL-(ACYL-CARRIER-PROTEIN) REDUCTASE was indexed under ACHOHOL OXIDOREDUCTASES 1970-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064431"}, {"RECTYPE": "D", "MH": "Orexin Receptors", "AQ": "AD AG AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Orexin Receptor|T116|T192|NON|EQV|NLM (2021)|191118|abbcdef", "ENTRY": "Receptors, Orexin-B", "MN": "D12.776.543.750.750.555.074", "EC": "antagonists & inhibitors:Orexin Receptor Antagonists", "MH_TH": "NLM (2014)", "ST": "T192", "RN": "0", "MS": "G-protein-coupled NEUROPEPTIDE RECEPTORS that have specificity for OREXINS and play a role in appetite control, and sleep-wake cycles. Two principle receptor types exist, each having a specificity for OREXIN A and OREXIN B peptide subtypes.", "PM": "2014; was indexed under NEUROPEPTIDE RECEPTORS and G PROTEIN- COUPLED RECEPTORS 1998-2013.", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064446"}, {"RECTYPE": "D", "MH": "Checkpoint Kinase 2", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Kinase, PP1425", "MN": "D12.776.476.563.145", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 2.7.1.11", "MS": "Enzyme activated in response to DNA DAMAGE involved in cell cycle arrest. The gene is located on the long (q) arm of chromosome 22 at position 12.1. In humans it is encoded by the CHEK2 gene.", "PM": "2014; was indexed under PROTEIN-SERINE-THREONINE-KINASES 1995-2013.", "HN": "2014", "MR": "20210521", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064447"}, {"RECTYPE": "D", "MH": "Filamins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta-Filamins", "MN": "D12.776.220.525.315", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "A family of crosslinking filament proteins encoded by distinct FLN genes. Filamins are involved in cell adhesion, spreading, and migration, acting as scaffolds for over 90 binding partners including channels, receptors, intracellular signaling molecules and transcription factors. Due to the range of molecular interactions, mutations in FLN genes result in anomalies with moderate to lethal consequences.", "PM": "2014; was indexed under CONTRACTILE PROTEINS and MICROFILAMENT PROTEINS 1977-2013.", "HN": "2014", "MR": "20160628", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064448"}, {"RECTYPE": "D", "MH": "Sequestering Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Sequestering Agent|T120|NON|EQV|NLM (2014)|130306|abcdef", "ENTRY": "Agents, Sequestering", "MN": "D27.720.832", "MH_TH": "NLM (2014)", "ST": "T120", "RN": "0", "MS": "Compounds that bind to and reduce the biological availability of a chemical or pharmaceutical agent.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064449"}, {"RECTYPE": "D", "MH": "Workplace Violence", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Workplace Violences", "MN": "I01.880.735.900.912", "MH_TH": "NLM (2014)", "ST": "T054", "PI": "Violence (1970-2013)", "MS": "Threatened or actual attempt to harm others at place of employment.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064450"}, {"RECTYPE": "D", "MH": "Hepcidins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Pro Hepcidin", "MN": "D12.776.543.695.054.425", "PA": "Anti-Infective Agents", "FX": "Hemochromatosis", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "PI": "Antimicrobial Cationic Peptides (2013)", "MS": "Forms of hepcidin, a cationic amphipathic peptide synthesized in the liver as a prepropeptide which is first processed into prohepcidin and then into the biologically active hepcidin forms, including in human the 20-, 22-, and 25-amino acid residue peptide forms. Hepcidin acts as a homeostatic regulators of iron metabolism and also possesses antimicrobial activity.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064451"}, {"RECTYPE": "D", "MH": "Solute Carrier Family 12, Member 1", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transport Protein, BSC1", "MN": "D12.776.543.585.937.875.500", "FX": "Bartter Syndrome", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "Na-K-Cl transporter in the ASCENDING LIMB OF LOOP OF HENLE. It mediates active reabsorption of sodium chloride and is inhibited by LOOP DIURETICS such as FUROSEMIDE; and BUMETANIDE. Mutations in the gene encoding SLC12A1 are associated with a BARTTER SYNDROME.", "PM": "2014; was indexed under SYMPORTER 2001-2013", "HN": "2014", "MR": "20230405", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064466"}, {"RECTYPE": "D", "MH": "Solute Carrier Family 12, Member 3", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Thiazide-Sensitive Cotransporter, Na-Cl", "MN": "D12.776.543.585.937.875.750", "FX": "Gitelman Syndrome", "EC": "antagonists & inhibitors:Sodium Chloride Symporter Inhibitors", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "Na-Cl cotransporter in the convoluted segments of the DISTAL KIDNEY TUBULE. It mediates active reabsorption of sodium and chloride and is inhibited by THIAZIDE DIURETICS.", "PM": "2014; was indexed under CARRIER PROTEINS 1984-2001 and SODIUM CHLORIDE SYMPORTERS 2002-2013", "HN": "2014", "MR": "20151124", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064486"}, {"RECTYPE": "D", "MH": "Solute Carrier Family 12, Member 2", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Transporter, SLC12A2", "MN": "D12.776.543.585.937.875.625", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "Na-K-Cl transporter ubiquitously expressed. It plays a key role in salt secretion in epithelial cells and cell volume regulation in nonepithelial cells.", "PM": "2014", "HN": "2014", "MR": "20230405", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064506"}, {"RECTYPE": "D", "MH": "Solute Carrier Family 12, Member 4", "AQ": "AD AE AG AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Solute Carrier Family 12 Member 4|T116|T123|NON|EQV|NLM (2024)|230330|abbcdef", "ENTRY": "Protein, SLC12A4", "MN": "D12.776.543.585.937.875.875", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "K-Cl cotransporter ubiquitously expressed with higher expression levels in ERYTHROCYTES of ANEMIA, SICKLE CELL. It mediates active potassium and chloride cotransport across the plasma membrane and contributes to cell volume homeostasis", "PM": "2014", "HN": "2014", "MR": "20230531", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064507"}, {"RECTYPE": "D", "MH": "Etiolation", "AQ": "DE GE IM PH RE", "ENTRY": "Etiolations", "MN": "G15.589.125", "MH_TH": "NLM (2014)", "ST": "T039", "MS": "Physical changes in the growth patterns of a plant brought on by sustained absence of light. These changes are characterized by lengthened internodes which produce long weak stems, fewer leaves, and pale yellow color (chlorosis). The physiological basis for etiolation is induction of the phytohormone, AUXIN.", "PM": "2014", "HN": "2014", "MR": "20210707", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064527"}, {"RECTYPE": "D", "MH": "Receptor, Metabotropic Glutamate 5", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "PRINT ENTRY": "Receptor 5, Metabotropic Glutamate|T116|T192|NON|EQV|NLM (2014)|130327|abbcdef", "ENTRY": "Protein, mGluR5b", "MN": "D12.776.543.750.720.200.450.500.500", "MH_TH": "NLM (2014)", "ST": "T192", "RN": "0", "MS": "A type I G protein-coupled receptor mostly expressed post-synaptic pyramidal cells of the cortex and CENTRAL NERVOUS SYSTEM.", "PM": "2014; was indexed under RECEPTORS, METABOTROPIC GLUTAMATE 1996-2013.", "HN": "2014", "MR": "20160617", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064529"}, {"RECTYPE": "D", "MH": "Peripherins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Peripherin|T116|T123|NON|EQV|NLM (2022)|201005|abbcdef", "MN": "D05.750.078.593.765", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "Type III intermediate filament proteins expressed mainly in neurons of the peripheral and CENTRAL NERVOUS SYSTEMS. Peripherins are implicated in neurite elongation during development and axonal regeneration after injury.", "PM": "2014; was indexed under Intermediate Filament Proteins, Membrane Glycoproteins, and Nerve Tissue Proteins 1985-2005; 2005-2013.", "HN": "2014", "MR": "20210630", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064531"}, {"RECTYPE": "D", "MH": "Histocompatibility Antigen H-2D", "AQ": "AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR", "PRINT ENTRY": "Histocompatibility Antigen H-2D(b)|T116|T129|NON|NRW|NLM (2014)|130320|abbcdef", "ENTRY": "Histocompatibility Antigen H 2D", "MN": "D23.050.301.500.100.375", "MH_TH": "NLM (2014)", "ST": "T129", "RN": "0", "MS": "A component of the murine major histocompatibility complex class I family. It contains one Ig-like C1-type domain and functions in processing and presentation of exogenous peptide antigens to the immune system.", "PM": "2014; was indexed under GLYCOPROTEINS 1981-1982 and H-2 ANTIGENS 1983-2013.", "HN": "2014", "MR": "20130801", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064532"}, {"RECTYPE": "D", "MH": "Protein Kinase C beta", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "beta 2, PKC", "MN": "D12.776.476.563.725.049", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 2.7.11.13", "MS": "PKC beta encodes two proteins (PKCB1 and PKCBII) generated by alternative splicing of C-terminal exons. It is widely distributed with wide-ranging roles in processes such as B-cell receptor regulation, oxidative stress-induced apoptosis, androgen receptor-dependent transcriptional regulation, insulin signaling, and endothelial cell proliferation.", "PM": "2014; was indexed under Isoenzymes 1999-2003 and Protein Kinase C 2003-2013", "HN": "2014", "MR": "20210521", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064546"}, {"RECTYPE": "D", "MH": "Myxovirus Resistance Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein Mx, Interferon Induced", "MN": "D12.776.476.338.550", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "0", "MS": "Interferon-induced DYNAMIN-like GTP-binding proteins localized in the cytoplasm, nuclear pore complex and nucleus. They play a role in antiviral defense and immunity.", "PM": "2014; was previously indexed under PROTEINS 1990-2000 and GTP-BINDING PROTEINS 1999-2013", "HN": "2014", "MR": "20210510", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064547"}, {"RECTYPE": "D", "MH": "Hand Sanitizers", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hand Sanitizer|T121|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Sanitizer, Hand", "MN": "D27.720.274.650", "FX": "Hand Disinfection", "MH_TH": "NLM (2014)", "ST": "T121", "RN": "0", "MS": "Preparations used as alternatives or supplements to hand washing with soap and water to destroy microorganisms and prevent transmission of pathogens. The active ingredient may be ETHANOL; 1-PROPANOL; or POVIDONE-IODINE in a gel, foam, or liquid solution.", "PM": "2014", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064548"}, {"RECTYPE": "D", "MH": "Myeloid Cell Leukemia Sequence 1 Protein", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Myeloid Cell Factor 1", "MN": "D12.776.624.664.700.169.500", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "A member of the myeloid leukemia factor (MLF) protein family with multiple alternatively spliced transcript variants encoding different protein isoforms. In hematopoietic cells, it is located mainly in the nucleus, and in non-hematopoietic cells, primarily in the cytoplasm with a punctate nuclear localization. MLF1 plays a role in cell cycle differentiation.", "PM": "2014; was indexed under NEOPLASM PROTEINS 1993-2008, and PROTO-ONCOGENE PROTEINS C-BCL-2 2009-2013", "HN": "2014", "MR": "20151124", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064549"}, {"RECTYPE": "D", "MH": "Death-Associated Protein Kinases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Death Associated Protein Kinase|T116|T126|NON|EQV|NLM (2021)|191120|abbcdef", "ENTRY": "ZIP Like Kinase", "MN": "D12.776.476.563.125.387", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 2.7.11.1", "RR": "EC 2.7.11.1", "MS": "A family of calcium/calmodulin-dependent PROETIN-SERINE-THREONINE KINASES. They are ubiquitously expressed in adult and embryonic mammalian tissues, and their functions are tightly related to the early stages of eukaryotic programmed cell death.", "PM": "2014; was indexed under CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES 1995-2013", "HN": "2014", "MR": "20210521", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064550"}, {"RECTYPE": "D", "MH": "S100 Calcium Binding Protein beta Subunit", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "S100beta, Neurotrophic Protein", "MN": "D12.776.631.658.875", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "A calcium-binding protein that is 92 AA long, contains 2 EF-hand domains, and is concentrated mainly in GLIAL CELLS. Elevation of S100B levels in brain tissue correlates with a role in neurological disorders.", "PM": "2014; was indexed under CALCIUM-BINDING PROTEINS 1991-2002, NERVE GROWTH PROTEINS and S100 PROTEINS 2003-2013.", "HN": "2014", "MR": "20230609", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064568"}, {"RECTYPE": "D", "MH": "alpha7 Nicotinic Acetylcholine Receptor", "AQ": "AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL", "ENTRY": "alpha7 Subunit, nAChR", "MN": "D12.776.543.750.720.360.550.500", "MH_TH": "NLM (2014)", "ST": "T192", "RN": "0", "MS": "A member of the NICOTINIC ACETYLCHOLINE RECEPTOR subfamily of the LIGAND-GATED ION CHANNEL family. It consists entirely of pentameric \u03b17 subunits expressed in the CNS, autonomic nervous system, vascular system, lymphocytes and spleen.", "PM": "2014; was indexed under RECEPTORS, CHOLINERGIC 1980-2004 and RECEPTORS, NICOTINIC 2005-2013.", "HN": "2014", "MR": "20160701", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064569"}, {"RECTYPE": "D", "MH": "Ubiquitin-Specific Proteases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Ubiquitin-Specific Protease|T116|T123|NON|EQV|NLM (2021)|200317|abbcdef", "ENTRY": "Ubiquitin Specific Proteases", "MN": "D08.811.277.656.300.887", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "EC 3.4.19.12", "MS": "Members of the peptidase C19 family which regulate signal transduction by removing UBIQUITIN from specific protein substrates via a process known as deubiquitination or deubiquitylation.", "PM": "2014; UBIQUITIN-SPECIFIC PROTEASES was indexed under ENDOPEPTIDASES 1998-2013", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064570"}, {"RECTYPE": "D", "MH": "Selenic Acid", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Selenate, Sodium", "MN": "D01.810.449", "PA": "Trace Elements", "MH_TH": "NLM (2014)", "ST": "T197", "RN": "HV0Y51NC4J", "RR": "99798PU7MI", "MS": "A strong dibasic acid with the molecular formula H2SeO4. Included under this heading is the acid form, and inorganic salts of dihydrogen selenium tetraoxide.", "PM": "2014; SELENIC ACID was indexed under SELENIUM COMPOUNDS 1988-2013; SODIUM SELENATE was indexed under SELENIUM COMPOUNDS 1978-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064586"}, {"RECTYPE": "D", "MH": "Osmoregulation", "AQ": "DE GE IM PH RE", "ENTRY": "Stress Responses, Osmotic", "MN": "G07.775.625", "FX": "Osmotic Pressure", "MH_TH": "UNK (19XX)", "ST": "T040", "PI": "Water-Electrolyte Balance (1964-2013)", "MS": "The response of cells in sensing a difference in OSMOTIC PRESSURE between the inside and outside of the cell. This response includes signaling from osmotic sensors to activate transcription factors, which in turn regulate the expression of osmocompensatory genes, all functioning to maintain CELL VOLUME and the water concentration inside the cells.", "PM": "2014; see WATER-ELECTROLYTE BALANCE 1975-2013", "HN": "2014; use WATER-ELECTROLYTE BALANCE 1975-2013", "MR": "20180206", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064587"}, {"RECTYPE": "D", "MH": "Selenium Oxides", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Trioxide, Selenium", "MN": "D01.810.950", "MH_TH": "NLM (2014)", "ST": "T197", "RN": "0", "RR": "7446-08-4 (dioxide)", "MS": "Inorganic compounds formed through the oxidation of selenium.", "PM": "2014; SELENIUM OXIDE was indexed under SELENIUM COMPOUNDS 1981-2013", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064588"}, {"RECTYPE": "D", "MH": "Cool-Down Exercise", "AQ": "PH PX", "ENTRY": "Warming-Down Exercises", "MN": "I03.350.124", "FX": "Warm-Up Exercise", "MH_TH": "NLM (2014)", "ST": "T040", "MS": "Tapering-off physical activity from vigorous to light, to gradually return the body to pre-exercise condition and metabolic state.", "PM": "2014", "HN": "2014", "MR": "20230316", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064590"}, {"RECTYPE": "D", "MH": "Allografts", "AQ": "AB AH BS CH CL CY DE DG EC EM EN GD HI IM IN IR ME MI PA PH PP PS RE SD SN ST SU TR UL VI", "ENTRY": "Transplants, Homologous", "MN": "A01.941.500", "FX": "Transplantation, Homologous", "MH_TH": "UNK (19XX)", "ST": "T024", "PI": "Transplantation, Homologous (1966-2013)", "MS": "Tissues, cells, or organs transplanted between genetically different individuals of the same species.", "PM": "2014", "HN": "2014", "MR": "20180702", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064591"}, {"RECTYPE": "D", "MH": "Autografts", "AQ": "AB AH BS CH CL CY DE DG EC EM EN GD HI IM IN IR ME MI PA PH PP PS RE SD SN ST SU TR UL VI", "ENTRY": "Transplants, Autologous", "MN": "A01.941.750", "FX": "Transplantation, Autologous", "MH_TH": "NLM (2014)", "ST": "T024", "AN": "use for the autograft itself; use AUTOGRAFTING see TRANSPLANTATION, AUTOLOGOUS for the surgical procedure", "PI": "Transplantation, Autologous (1966-2013)", "MS": "Transplant comprised of an individual's own tissue, transferred from one part of the body to another.", "PM": "2014", "HN": "2014", "MR": "20130705", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064592"}, {"RECTYPE": "D", "MH": "Heterografts", "AQ": "AB AH BS CH CL CY DE DG EC EM EN GD HI IM IN IR ME MI PA PH PP PS RE SD SN ST SU TR UL VI", "ENTRY": "Xenograft", "MN": "A01.941.875", "FX": "Transplantation, Heterologous", "MH_TH": "NLM (2014)", "ST": "T024", "AN": "use for the heterograft itself; use HETEROGRAFTING see TRANSPLANTATION, HETEROLOGOUS for the surgical procedure", "PI": "Transplantation, Homologous (1966-2013)", "MS": "Tissues, cells or organs transplanted between animals of different species.", "PM": "2014", "HN": "2014", "MR": "20130705", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064593"}, {"RECTYPE": "D", "MH": "Bone-Patellar Tendon-Bone Grafts", "AQ": "AB AH BS CH CL CY DE DG EC EM EN GD HI IM IN IR ME MI PA PH PP PS RE SD SN ST SU TR UL VI", "ENTRY": "Bone-Patellar Tendon-Bone Graft", "MN": "A01.941.812", "MH_TH": "NLM (2014)", "ST": "T024", "AN": "use for the graft itself; use BONE-PATELLAR TENDON-BONE GRAFTING for the surgical procedure", "PI": "Bone-Patellar Tendon-Bone Graft (2007-2013)", "MS": "A bone-patellar tendon graft used for fixation of the ANTERIOR CRUCIATE LIGAMENT during surgical reconstruction of the knee.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064594"}, {"RECTYPE": "D", "MH": "Composite Tissue Allografts", "AQ": "AB AH BS CH CL CY DE DG EC EM EN GD HI IM IN IR ME MI PA PH PP PS RE SD SN ST SU TR UL VI", "ENTRY": "Vascularized Composite Allograft", "MN": "A01.941.843", "MH_TH": "NLM (2014)", "ST": "T024", "AN": "use for the graft itself; for COMPOSITE TISSUE ALLOGRAFTING see VASCULARIZED COMPOSITE ALLOTRANSPLANTATION for the surgical procedure", "MS": "A graft consisting of multiple tissues, such as muscle, bone, nerve, vasculature, and skin, comprising a functional unit for reconstructive purposes.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064595"}, {"RECTYPE": "D", "MH": "Isografts", "AQ": "AB AH BS CH CL CY DE DG EC EM EN GD HI IM IN IR ME MI PA PH PP PS RE SD SN ST SU TR UL VI", "ENTRY": "Syngeneic Homografts", "MN": "A01.941.937", "FX": "Transplantation, Isogeneic", "MH_TH": "NLM (2014)", "ST": "T024", "AN": "use for the isograft itself; use ISOGRAFTING see TRANSPLANTATION, ISOGENEIC for the surgical procedure", "PI": "Transplantation, Isogeneic (1976-2013)", "MS": "Tissues, cells or organs transplanted between genetically identical individuals, i.e. members of the same species with identical histocompatibility antigens, such as monozygotic twins, members of the same inbred strain, or members of a hybrid population produced by crossing certain inbred strains.", "PM": "2014", "HN": "2014", "MR": "20130705", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064596"}, {"RECTYPE": "D", "MH": "SLC4A Proteins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Proteins, SLC4A", "MN": "D12.776.543.585.937.776", "MH_TH": "NLM (2014)", "ST": "T123", "RN": "0", "MS": "Bicarbonate transporters that move BICARBONATE IONS in exchange of CHLORIDE IONS or SODIUM IONS across membranes. They regulate acid-base HOMEOSTASIS, cell volume and intracellular pH. Members include CHLORIDE-BICARBONATE ANTIPORTERS (SLC4A1, 2, 3, and 9); SODIUM-COUPLED BICARBONATE TRANSPORTERS (SLC4A4 and 5, 7, 8 and 10); and a sodium borate cotransporter (SLC4A11 protein).", "PM": "2014", "HN": "2014", "MR": "20190524", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064606"}, {"RECTYPE": "D", "MH": "Cardiovascular Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Vascular", "MN": "N02.421.533.099", "MH_TH": "NLM (2014)", "ST": "T091", "PI": "Specialties, Nursing (1973-2013)", "MS": "A specialty concerned with the nursing care of patients suffering from disorders of the CARDIOVASCULAR SYSTEM as well as those identified as at risk for adverse cardiac or vascular events.", "PM": "2014", "HN": "2014", "MR": "20150629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064646"}, {"RECTYPE": "D", "MH": "Nephrology Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Urology", "MN": "N02.421.533.490", "MH_TH": "NLM (2014)", "ST": "T091", "PI": "Specialties, Nursing (1973-2013)", "MS": "A nursing specialty involving the care of patients with or at risk for KIDNEY DISEASES.", "PM": "2014", "HN": "2014", "MR": "20150629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064647"}, {"RECTYPE": "D", "MH": "Critical Care Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Intensive Care", "MN": "N02.421.533.149", "MH_TH": "NLM (2014)", "ST": "T091", "PI": "Specialties, Nursing (1974-2013)", "MS": "A nursing specialty that deals specifically with the care of patients who are critically ill.", "PM": "2014", "HN": "2014", "MR": "20150629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064648"}, {"RECTYPE": "D", "MH": "Home Health Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Home Health", "MN": "N02.421.539.089.500", "MH_TH": "NLM (2014)", "ST": "T091", "PI": "Home Care Services (1984-2013)", "MS": "A nursing specialty in which skilled nursing care is provided to patients in their homes by registered or licensed practical NURSES. Home health nursing differs from HOME NURSING in that home health nurses are licensed professionals, while home nursing involves non-professional caregivers.", "PM": "2014", "HN": "2014", "MR": "20150629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064650"}, {"RECTYPE": "D", "MH": "Basal Bodies", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Body, Basal", "MN": "A11.284.430.214.190.750.585.079", "MH_TH": "NLM (2014)", "ST": "T026", "MS": "Structures which form the base of FLAGELLA and CILIA. They contain nine triplets of MICROTUBULES that are arranged around the periphery and that serve as the nucleation center for AXONEME assembly.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064652"}, {"RECTYPE": "D", "MH": "Diapause, Insect", "AQ": "DE GE IM PH RE", "ENTRY": "Insect Diapause", "MN": "G07.345.500.550.500.250.500", "MH_TH": "NLM (2014)", "ST": "T040", "PI": "Metamorphosis, Biological (1965-2013)", "MS": "Seasonal suspension of insect growth development. It can be either induced by environmental cues (e.g., PHOTOPERIOD) or as a facultative part of the life cycle in order to time development with seasonal changes.", "PM": "2014", "HN": "2014", "MR": "20170414", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064666"}, {"RECTYPE": "D", "MH": "Nutritionists", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Dieticians|T097|NON|NRW|NLM (2014)|130409|abcdef", "ENTRY": "Nutritionist", "MN": "N02.360.695", "MH_TH": "NLM (2014)", "ST": "T097", "PI": "Dietetics (1963-2013)", "MS": "Persons specially trained in NUTRITION SCIENCES.", "PM": "2014", "HN": "2014", "MR": "20180629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064686"}, {"RECTYPE": "D", "MH": "Diarylquinolines", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Diarylquinoline Derivative|T109|T121|NON|EQV|NLM (2021)|191119|abbcdef", "ENTRY": "Quinoline Derivatives, Diaryl", "MN": "D03.633.100.810.087", "PA": "Antitubercular Agents", "MH_TH": "NLM (2014)", "ST": "T121", "RN": "0", "PI": "Quinolines (1966-2013)", "MS": "A class of quinoline compounds defined by the presence of two aromatic ring structures which are attached via a side chain to carbon 3 of the qunolinyl structure. The two aromatic moieties are typically NAPTHALENE and BENZENE. Several compounds in this class are used as ANTITUBERCULAR AGENTS.", "PM": "2014", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064687"}, {"RECTYPE": "D", "MH": "Metabolic Flux Analysis", "AQ": "CL EC ES HI IS MT SN ST TD VE", "ENTRY": "Metabolic Flux Analyses", "MN": "E05.242.654", "FX": "Metabolic Engineering", "MH_TH": "NLM (2014)", "ST": "T059", "MS": "Measurement of cells' substrate utilization and biosynthetic output for modeling of METABOLIC NETWORKS.", "PM": "2014", "HN": "2014", "MR": "20150602", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064688"}, {"RECTYPE": "D", "MH": "Nurses, Public Health", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Public Health Nurses|T097|NON|EQV|UNK (19XX)|781226|abcdef", "ENTRY": "Public Health Nurse", "MN": "N02.360.650.835", "MH_TH": "NLM (2014)", "ST": "T097", "PI": "Public Health Nursing (1952-2013)", "MS": "Nurses whose goal is to improve health and quality of life in a population or community through the prevention and treatment of disease and other physical and mental health conditions, the surveillance of cases and health indicators, and the promotion of healthy behaviors through public education and awareness.", "PM": "2014", "HN": "2014", "MR": "20180629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064689"}, {"RECTYPE": "D", "MH": "Wakefulness-Promoting Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Wake-Promoting Drug|T121|NON|EQV|NLM (2022)|201007|abcdef", "ENTRY": "Wakefulness Promoting Agents", "MN": "D27.505.954.427.220.612", "MH_TH": "NLM (2014)", "ST": "T121", "RN": "0", "PI": "Sleep Disorders/drug therapy (2006-2013)", "MS": "A specific category of drugs that prevent sleepiness by specifically targeting sleep-mechanisms in the brain. They are used to treat DISORDERS OF EXCESSIVE SOMNOLENCE such as NARCOLEPSY. Note that this drug category does not include broadly-acting central nervous system stimulants such as AMPHETAMINES.", "PM": "2014", "HN": "2014", "MR": "20210630", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064690"}, {"RECTYPE": "D", "MH": "Nurses, Community Health", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "PRINT ENTRY": "Visiting Nurses|T097|NON|REL|UNK (19XX)|770421|abcdef", "ENTRY": "Visiting Nurse", "MN": "N02.360.650.655", "MH_TH": "NLM (2014)", "ST": "T097", "PI": "Community Health Nursing (1975-2013)", "MS": "Nurses whose work combines elements of both primary care nursing and public health practice and takes place primarily outside the therapeutic institution. Primary nursing care is directed to individuals, families, or groups in their natural settings within communities.", "PM": "2014", "HN": "2014", "MR": "20180629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064691"}, {"RECTYPE": "D", "MH": "Hyoscyamine", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Hyoscyamine Sulfate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2014)|USP (19XX)|861103|abbcdeeef", "ENTRY": "Hyoscyamine Sulfate Anhydrous|T109|T121|NON|NRW|NLM (2014)|130410|abbcdef", "MN": "D03.605.869.229.199.500", "PA": "Parasympatholytics", "EC": "analogs & derivatives:Atropine Derivatives", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "PX44XO846X", "RR": "OB570Z127K", "MS": "The 3(S)-endo isomer of atropine.", "PM": "2014; see ATROPINE 1976-2013; see BELLADONNA 1963-1974", "HN": "2014; use ATROPINE 1976-2013; use BELLADONNA 1963-1974", "MR": "20160531", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064692"}, {"RECTYPE": "D", "MH": "Rural Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Rural Nursing, Remote", "MN": "N02.421.816.500", "MH_TH": "NLM (2014)", "ST": "T091", "MS": "A branch of nursing requiring generalist training with specialty knowledge in crisis assessment and management in all subdisciplines of nursing. Rural nursing practices often include geographical and social distance concepts in delivery of health care.", "PM": "2014", "HN": "2014", "MR": "20150629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064694"}, {"RECTYPE": "D", "MH": "Enclomiphene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "trans Clomiphene Citrate", "MN": "D02.455.426.559.389.150.700.125.500", "PA": "Selective Estrogen Receptor Modulators", "MH_TH": "USAN (1974)", "ST": "T121", "RN": "R6D2UI4FLS", "RR": "J303A6U9Y6", "MS": "The trans or (E)-isomer of clomiphene.", "PM": "2014; see CLOMIPHENE 1992-2013", "HN": "2014; use CLOMIPHENE 1992-2013", "MR": "20160701", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064695"}, {"RECTYPE": "D", "MH": "Zuclomiphene", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Citrate, Zuclomifene", "MN": "D02.455.426.559.389.150.700.125.750", "PA": "Selective Estrogen Receptor Modulators", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "3JU1DU3652", "RR": "UY5X264QZV", "MS": "The cis or (Z)-isomer of clomiphene.", "PM": "2014; see CLOMIPHENE 1992-2013", "HN": "2014; use CLOMIPHENE 1992-2013", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064696"}, {"RECTYPE": "D", "MH": "Racemethionine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Methionine, DL Isomer", "MN": "D12.125.166.676.089", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "73JWT2K6T3", "MS": "A preparation of METHIONINE that includes a mixture of D-methionine and L-methionine isomers.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064697"}, {"RECTYPE": "D", "MH": "Parish Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Parish", "MN": "N02.421.143.150.750", "FX": "Religion and Medicine", "MH_TH": "NLM (2014)", "ST": "T091", "PI": "Religion and Medicine (1972-2013)", "MS": "A nursing specialty involving programs designed to bring wholeness and healing to a particular faith community through addressing the health needs of body, mind, and spirit. They are coordinated by registered NURSES and may involve HEALTH EDUCATION and counseling, facilitation, referral, PATIENT ADVOCACY, and health care plan interpretation, as influenced and defined by the unique needs of the congregation.", "PM": "2014", "HN": "2014", "MR": "20150629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064698"}, {"RECTYPE": "D", "MH": "Dexmethylphenidate Hydrochloride", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dexmethylphenidate|T109|T121|NON|BRD|FDA SRS (2014)|INN (19XX)|NLM (2009)|071019|abbcdeeef", "ENTRY": "XR, Focalin", "MN": "D03.383.621.460.500", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "1678OK0E08", "RR": "M32RH9MFGP", "MS": "A methylphenidate derivative, DOPAMINE UPTAKE INHIBITOR and CENTRAL NERVOUS SYSTEM STIMULANT that is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.", "PM": "2014; see METHYLPHENIDATE 2008-2013", "HN": "2014; use METHYLPHENIDATE 2008-2013", "MR": "20160426", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064699"}, {"RECTYPE": "D", "MH": "Nurses, International", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Nurse, International", "MN": "N02.360.650.662", "MH_TH": "NLM (2014)", "ST": "T097", "MS": "Nurses who provide nursing care in countries other than the ones in which they received their training.", "PM": "2014", "HN": "2014", "MR": "20180629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064700"}, {"RECTYPE": "D", "MH": "Pediatric Nurse Practitioners", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Pediatric Nurse Practitioner", "MN": "N02.360.650.640.500", "FX": "Pediatric Assistants", "MH_TH": "NLM (2014)", "ST": "T097", "PI": "Pediatric Nursing (1967-2013)", "MS": "Registered nurses with graduate degrees in nursing who provide care to pediatric patients who are acutely or critically ill.", "PM": "2014", "HN": "2014", "MR": "20180629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064701"}, {"RECTYPE": "D", "MH": "International Classification of Functioning, Disability and Health", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "MN": "L01.462.750.245.945.450", "FX": "Disability Evaluation", "MH_TH": "NLM (2014)", "ST": "T170", "AN": "CATALOGER: Use NAF entry", "PI": "Disability Evaluation (2002-2013)", "MS": "The World Health Organization's classification categories of health and health-related domains. The International Classification of Functioning, Disability and Health (ICF) consists of two lists: a list of body functions and structure, and a list of domains of activity and participation. The ICF also includes a list of environmental factors.", "PM": "2014", "HN": "2014", "MR": "20220712", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064702"}, {"RECTYPE": "D", "MH": "Family Nurse Practitioners", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Nurse Practitioners, Family", "MN": "N02.360.650.640.249", "MH_TH": "NLM (2014)", "ST": "T097", "PI": "Public Health Nursing (1965-1973)", "MS": "Registered nurses with graduate degrees in nursing who provide care to patients of all age levels, and who focus their efforts on the health care needs of the entire family.", "PM": "2014", "HN": "2014", "MR": "20180629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064703"}, {"RECTYPE": "D", "MH": "Levofloxacin", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Anhydrous, Levofloxacin", "MN": "D03.633.100.810.835.322.500.500", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "6GNT3Y5LMF", "RR": "RIX4E89Y14", "PI": "Ofloxacin (2000-2013)", "MS": "The L-isomer of Ofloxacin.", "PM": "2014; see OFLOXACIN 2000-2013", "HN": "2014; use OFLOXACIN 2000-2013", "MR": "20160531", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064704"}, {"RECTYPE": "D", "MH": "Racepinephrine", "AQ": "AA AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Racemic Mixture Epinephrine", "MN": "D02.455.426.559.389.657.166.175.461.825", "PA": "Vasoconstrictor Agents", "FX": "Receptors, Adrenergic", "MH_TH": "USP (19XX)", "ST": "T123", "RN": "GR0L9S3J0F", "RR": "336096P2WE", "PI": "Epinephrine (1986-2013)", "MS": "A racemic mixture of d-epinephrine and l-epinephrine.", "PM": "2014; see EPINEPHRINE 1986-2013", "HN": "2014; use EPINEPHRINE 1986-2013", "MR": "20180529", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064705"}, {"RECTYPE": "D", "MH": "Vocal Cord Dysfunction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Vocal Cord Dysfunctions", "MN": "C09.400.895", "FX": "Dysphonia", "MH_TH": "NLM (2014)", "ST": "T184", "PI": "Respiration Disorders (1979-2013)", "MS": "A disorder characterized by an intermittent abnormal VOCAL CORDS movement toward the midline during inspiration or expiration resulting in upper AIRWAY OBSTRUCTION.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064706"}, {"RECTYPE": "D", "MH": "Triple Negative Breast Neoplasms", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Triple-Negative Breast Neoplasms", "MN": "C17.800.090.500.788", "MH_TH": "NLM (2014)", "ST": "T191", "AN": "coordinate IM with histological type of neoplasm (IM)", "PI": "Breast Neoplasms (2006-2013)", "MS": "Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.", "PM": "2014", "HN": "2014", "MR": "20130705", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064726"}, {"RECTYPE": "D", "MH": "Posterior Capsulotomy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Posterior Capsulotomies, Laser", "MN": "E04.540.825.784", "MH_TH": "NLM (2014)", "ST": "T061", "MS": "Procedures performed to remove CAPSULE OPACIFICATION that develops on the POSTERIOR CAPSULE OF THE LENS following removal of a primary CATARACT.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064727"}, {"RECTYPE": "D", "MH": "Alveolar Bone Grafting", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Alveolar Cleft Grafting|T061|NON|EQV|NLM (2014)|130412|abcdef", "MN": "E06.645.562.124", "MH_TH": "NLM (2014)", "ST": "T061", "PI": "Cleft Palate/SU (1962-2013)", "MS": "Surgical procedure to add bone to the ALVEOLAR RIDGE in children born with a CLEFT LIP and a CLEFT PALATE.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064728"}, {"RECTYPE": "D", "MH": "Neurokinin-1 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Tachykinin Receptor 1 Blocker|T121|NON|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Receptor Blockers, Neuroleukin-1", "MN": "D27.505.696.577.487", "MH_TH": "NLM (2014)", "ST": "T121", "RN": "0", "PI": "Receptors, Neurokinin-1/antagonists & inhibitors (1995-2013)", "MS": "Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS.", "PM": "2014", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064729"}, {"RECTYPE": "D", "MH": "Dexrazoxane", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "NSC169780", "MN": "D03.383.606.385.500.500", "PA": "Topoisomerase II Inhibitors", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "048L81261F", "RR": "5346058Q7S", "MS": "The (+)-enantiomorph of razoxane.", "PM": "2014", "HN": "2014", "MR": "20160529", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064730"}, {"RECTYPE": "D", "MH": "Therapy, Soft Tissue", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "PRINT ENTRY": "Soft Tissue Therapy|T061|NON|EQV|NLM (2014)|130415|abcdef", "MN": "E02.831.535.867.880", "MH_TH": "NLM (2014)", "ST": "T061", "MS": "The assessment, treatment, and management of soft tissue injury or dysfunction. Therapy is designed to reduce tension and irritation in affected tissues and may include MASSAGE; muscle stretching, or direct pressure on muscles, connective tissue, and TRIGGER POINTS.", "PM": "2014", "HN": "2014", "MR": "20180629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064746"}, {"RECTYPE": "D", "MH": "Lansoprazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Lansoprazoles|T109|T121|NON|EQV|NLM (2014)|130415|abbcdef", "ENTRY": "Sodium, Lansoprazole", "MN": "D03.633.100.103.034.249", "PA": "Proton Pump Inhibitors", "MH_TH": "USP (19XX)", "ST": "T121", "RN": "0K5C5T2QPG", "RR": "GV9NY1U369", "MS": "A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.", "PM": "2014; LANSOPRAZOLE was indexed under 2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES 2007-2013 and under OMEPRAZOLE 1989-2006", "HN": "2014", "MR": "20170117", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064747"}, {"RECTYPE": "D", "MH": "Dexlansoprazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "TAK390", "MN": "D03.633.100.103.034.249.500", "PA": "Proton Pump Inhibitors", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "UYE4T5I70X", "RR": "HS2S9VK3NH", "PI": "Lansoprazole (2008-2013)", "MS": "The R-isomer of lansoprazole that is used to treat severe GASTROESOPHAGEAL REFLUX DISEASE.", "PM": "2014; DEXLANSOPRAZOLE was indexed under 2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES 2008-2013", "HN": "2014; use LANSOPRAZOLE 2008-2013", "MR": "20160528", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064748"}, {"RECTYPE": "D", "MH": "Retrocaval Ureter", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Ureter, Retrocaval", "MN": "C16.131.939.915", "FX": "Ureter", "MH_TH": "NLM (2014)", "ST": "T190", "PI": "Ureter/abnormalities (1947-2013)", "MS": "A rare congenital abnormality resulting in the URETER passing dorsal to and being obstructed by the INFERIOR VENA CAVA.", "PM": "2014", "HN": "2014", "MR": "20210630", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064749"}, {"RECTYPE": "D", "MH": "Rabeprazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Sodium, Rabeprazole", "MN": "D03.633.100.103.034.750", "PA": "Proton Pump Inhibitors", "MH_TH": "NLM (2014)", "ST": "T121", "RN": "32828355LL", "RR": "3L36P16U4R", "MS": "A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.", "PM": "2014; RABEPRAZOLE was indexed under 2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES 1990-2013", "HN": "2014", "MR": "20160701", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064750"}, {"RECTYPE": "D", "MH": "Ammonium Compounds", "DE": "AMMONIUM CPDS", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Ammonium|T197|NON|NRW|NLM (1994)|930520|abcdef", "MN": "D01.625.062", "MH_TH": "NLM (1966)", "ST": "T197", "RN": "0", "MS": "Inorganic compounds that include a positively charged tetrahedral nitrogen (ammonium ion) as part of their structure. This class of compounds includes a broad variety of simple ammonium salts and derivatives.", "PM": "2014; see QUATERNARY AMMONIUM COMPOUNDS 2006-2013", "HN": "2014; use QUATERNARY AMMONIUM COMPOUNDS 2006-2013", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064751"}, {"RECTYPE": "D", "MH": "Atrial Remodeling", "AQ": "DE GE IM PH RE", "ENTRY": "Remodeling, Electrical", "MN": "G09.330.040.800", "MH_TH": "NLM (2014)", "ST": "T046", "PI": "Heart Atria (1998-2013)", "MS": "Long-term changes in the electrophysiological parameters and/or anatomical structures of the HEART ATRIA that result from prolonged changes in atrial rate, often associated with ATRIAL FIBRILLATION or long periods of intense EXERCISE.", "PM": "2014", "HN": "2014", "MR": "20160602", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064752"}, {"RECTYPE": "D", "MH": "Ammonium Hydroxide", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydroxide, Ammonium", "MN": "D01.625.062.311", "FX": "Ammonia", "MH_TH": "NLM (2014)", "ST": "T197", "RN": "5138Q19F1X", "RR": "1336-21-6 (ammonium hydroxide)", "MS": "The hydroxy salt of ammonium ion. It is formed when AMMONIA reacts with water molecules in solution.", "PM": "2014; AMMONIUM HYDROXIDE was listed under HYDROXIDES 1977-2013", "HN": "2014", "MR": "20150622", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064753"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H7N9 Subtype", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H7N9 subtype|T005|ABX|EQV|NLM (2024)|230223|abcdef", "ENTRY": "subtype, H7N9", "MN": "B04.820.480.968.405.400.800", "MH_TH": "NLM (2014)", "ST": "T005", "RN": "txid333278", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals", "MS": "A subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 7 and neuraminidase 9. This avian origin virus was first identified in humans in 2013.", "PM": "2014", "HN": "2014", "MR": "20230405", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064766"}, {"RECTYPE": "D", "MH": "Nocebo Effect", "ENTRY": "Nocebo Effects", "MN": "N06.850.490.734.875.500", "MH_TH": "NLM (2014)", "ST": "T078", "AN": "not restricted to drugs; IM general only", "MS": "An adverse effect occurring with a medical treatment that is not attributable to the actions of the treatment.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064786"}, {"RECTYPE": "D", "MH": "Portion Size", "AQ": "AE EC EH HI PX SN ST TD", "ENTRY": "Portion Sizes", "MN": "G07.203.650.240.835", "MH_TH": "NLM (2014)", "ST": "T081", "AN": "SERVING SIZE is also available", "MS": "The amount of a particular food one chooses to eat at a single meal. It is different from SERVING SIZE, which is a reference amount of food as defined by an authoritative source, such as the Food Guide Pyramid devised by the UNITED STATES DEPARTMENT OF AGRICULTURE.", "PM": "2014", "HN": "2014", "MR": "20150629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064787"}, {"RECTYPE": "D", "MH": "Serving Size", "AQ": "AE EC EH HI PX SN ST TD", "ENTRY": "Serving Sizes", "MN": "G07.203.650.240.917", "MH_TH": "NLM (2014)", "ST": "T081", "AN": "PORTION SIZE is also available", "MS": "A reference measure of food used to identify the calorie and nutrient content in a particular amount of that food. It is defined by an authoritative source, such as the Food Guide Pyramid devised by the UNITED STATES DEPARTMENT OF AGRICULTURE. It is different from PORTION SIZE, which is the amount of food one chooses to eat at a single meal.", "PM": "2014", "HN": "2014", "MR": "20150629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064788"}, {"RECTYPE": "D", "MH": "Immunity, Heterologous", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Heterologous Immunity|T039|NON|EQV|NLM (2014)|130422|abcdef", "ENTRY": "Vaccines Non-Specific Effects", "MN": "G12.450.418", "FX": "Cross Reactions", "MH_TH": "NLM (2014)", "ST": "T039", "MS": "The immunological phenomenon by which exposure to some organisms or vaccines can profoundly alter the host's response to subsequent exposure to unrelated (heterologous) organisms or vaccines.", "PM": "2014", "HN": "2014", "MR": "20150622", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064789"}, {"RECTYPE": "D", "MH": "Clinical Laboratory Services", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Services, Clinical Laboratory", "MN": "N02.421.726.233.110", "FX": "Laboratories, Clinical", "MH_TH": "NLM (2014)", "ST": "T058", "MS": "Organized services provided by MEDICAL LABORATORY PERSONNEL for the purpose of carrying out CLINICAL LABORATORY TECHNIQUES used for the diagnosis, treatment, and prevention of disease.", "PM": "2014", "HN": "2014", "MR": "20210707", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064790"}, {"RECTYPE": "D", "MH": "Desoxycorticosterone Acetate", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "DOCA|T109|T121|T125|ABB|EQV|FDA SRS (2014)|UNK (19XX)|760520|abbbcdeef", "ENTRY": "Desoxycorticosterone 21 acetate", "MN": "D06.472.040.585.611.700", "PA": "Mineralocorticoids", "MH_TH": "USP (19XX)", "ST": "T125", "RN": "6E0A168OB8", "PI": "Desoxycorticosterone (2006-2013)", "MS": "The 21-acetate derivative of desoxycorticosterone.", "PM": "2014; for DESOXYCORTICOSTERONE ACETATE see DESOXYCORTICOSTERONE 2006-2013, DESOXYCORTONE ACETATE was indexed under DESOXYCORTICOSTERONE 1989-2013", "HN": "2014; for DESOXYCORTICOSTERONE ACETATE use DESOXYCORTICOSTERONE 2006-2013,", "MR": "20160528", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064791"}, {"RECTYPE": "D", "MH": "Pragmatic Clinical Trials as Topic", "AQ": "CL EC ES HI IS LJ MT PX SN ST VE", "PRINT ENTRY": "Pragmatic Clinical Trials|T062|T170|NON|EQV|NLM (2014)|130424|abbcdef", "ENTRY": "Trials, Pragmatic Clinical", "MN": "N06.850.520.450.250.250.365.500.750", "FX": "Comparative Effectiveness Research", "MH_TH": "NLM (2014)", "ST": "T170", "AN": "for general design, methodology, economics, etc. of pragmatic clinical trials; a different heading PRAGMATIC CLINICAL TRIAL is used for reports of a specific pragmatic clinical trial; use only when specified by author", "PI": "Clinical Trials as Topic or specifics (1994-2013)", "MS": "Works about randomized clinical trials that compare interventions in clinical settings and which look at a range of effectiveness outcomes and impacts.", "PM": "2014", "HN": "2014", "MR": "20180629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064792"}, {"RECTYPE": "D", "MH": "Teratogenesis", "AQ": "DE ES GE IM PH RE", "MN": "C23.550.863", "FX": "Teratology", "MH_TH": "NLM (2014)", "ST": "T049", "MS": "The formation of CONGENITAL ABNORMALITIES.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064793"}, {"RECTYPE": "D", "MH": "Lorajmine", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Hydrochloride, Lorajmine", "MN": "D03.633.100.496.500.500.681.077.324", "PA": "Anti-Arrhythmia Agents", "MH_TH": "INN (19XX)", "ST": "T121", "RN": "F96VX65849", "RR": "F8RIT10785", "PI": "Ajmaline (1973-2013)", "MS": "A monochloroacetyl derivative of ajmaline. It is a class Ia antiarrhythmic agent that is rapidly hydrolyzed to ajmaline by plasma and tissue esterases.", "PM": "2014; see AJMALINE 1973-2013", "HN": "2014; use AJMALINE 1973-2013", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064794"}, {"RECTYPE": "D", "MH": "Intraoperative Neurophysiological Monitoring", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Neurophysiological Monitoring, Intraoperative", "MN": "E04.510.500", "MH_TH": "NLM (2014)", "ST": "T060", "PI": "Monitoring, Intraoperative (1992-2013)", "MS": "The systematic checking of the condition and function of a patient's CENTRAL NERVOUS SYSTEM during the course of a surgical operation.", "PM": "2014", "HN": "2014", "MR": "20150622", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064795"}, {"RECTYPE": "D", "MH": "Veterinary Sports Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Veterinary Medicine, Sports", "MN": "H02.956.929", "FX": "Physical Conditioning, Animal", "MH_TH": "NLM (2014)", "ST": "T091", "MS": "The field of veterinary medicine concerned with PHYSICAL FITNESS of animals in sports (horse racing, dog racing, etc.) and the diagnosis and treatment of sports injuries in animals.", "PM": "2014", "HN": "2014", "MR": "20130705", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064796"}, {"RECTYPE": "D", "MH": "Physical Conditioning, Human", "AQ": "AE CL EC ES HI IS MO MT NU PH PX SN ST TD", "ENTRY": "Training, Human Physical", "MN": "I03.350.311", "FX": "Sports Medicine", "MH_TH": "NLM (1997)", "ST": "T061", "MS": "Diet modification and physical exercise to improve the ability to carry out daily tasks and perform physical activities.", "PM": "2014; see PHYSICAL FITNESS (1997-2013); see EXERCISE THERAPY 1986-96", "HN": "2014; use PHYSICAL FITNESS (1997-2013); use EXERCISE THERAPY 1986-96", "MR": "20170630", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064797"}, {"RECTYPE": "D", "MH": "Polypharmacology", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "E05.290.563.250.500", "FX": "Network Pharmacology", "MH_TH": "NLM (2014)", "ST": "T090", "AN": "do not confuse with POLYPHARMACY, the use of multiple drugs administered to a single patient or with PHARMACOLOGY, the discipline", "MS": "The design or use of pharmaceutical agents that act on multiple targets or disease pathways.", "PM": "2014", "HN": "2014", "MR": "20220523", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064798"}, {"RECTYPE": "D", "MH": "Hypoxia-Inducible Factor-Proline Dioxygenases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Prolyl-4-Hydroxylases, HIF", "MN": "D08.811.682.690.708.694.500", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 1.14.11.29", "RR": "EC 1.14.11.29", "PI": "Procollagen-Proline Dioxygenase (2004-2013)", "MS": "Dioxygenase enzymes that specifically hydroxylate a PROLINE residue on the HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT. They are OXYGEN-dependent enzymes that play an important role in mediating cellular adaptive responses to HYPOXIA.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064799"}, {"RECTYPE": "D", "MH": "Prolyl-Hydroxylase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Prolyl-Hydroxylase Inhibitor|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Prolyl Hydroxylase Inhibitors", "MN": "D27.505.519.389.740", "MH_TH": "NLM (2014)", "ST": "T121", "RN": "0", "PI": "Enzyme Inhibitors (1968-2013)", "MS": "Compounds that inhibit the action of HYDROXYLASES that act on PROLINE to form HYDROXYPROLINE.", "PM": "2014", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064800"}, {"RECTYPE": "D", "MH": "Phospholipase A2 Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inhibitors, Phospholipase A2", "MN": "D27.505.519.389.737", "MH_TH": "NLM (2014)", "ST": "T121", "RN": "0", "MS": "Compounds that inhibit or block the activity of a PHOSPHOLIPASE A2 enzyme.", "PM": "2014", "HN": "2014", "MR": "20140625", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064801"}, {"RECTYPE": "D", "MH": "Urological Agents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Agents, Urological", "MN": "D27.505.954.493.500", "MH_TH": "NLM (2014)", "ST": "T121", "RN": "0", "MS": "Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS.", "PM": "2014", "HN": "2014", "MR": "20210708", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064804"}, {"RECTYPE": "D", "MH": "Bunolol", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "W6412A", "MN": "D04.615.638.960.446", "PA": "Sympatholytics", "MH_TH": "NLM (1991)", "ST": "T121", "RN": "71QSY2UT3G", "RR": "W0Q9J8634Z", "PI": "Levobunolol (1991-2013)", "MS": "A nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma.", "PM": "2014; see LEVOBUNOLOL 1991-2013", "HN": "2014; use LEVOBUNOLOL 1991-2013", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064805"}, {"RECTYPE": "D", "MH": "Dysbiosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Dysbioses", "MN": "C23.550.308", "FX": "Microbiological Phenomena", "MH_TH": "NLM (2014)", "ST": "T070", "MS": "Changes in quantitative and qualitative composition of MICROBIOTA. The changes may lead to altered host microbial interaction or homeostatic imbalance that can contribute to a disease state often with inflammation.", "PM": "2014", "HN": "2014", "MR": "20130705", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064806"}, {"RECTYPE": "D", "MH": "Anticholinergic Syndrome", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndromes, Peripheral Anticholinergic", "MN": "C25.100.311", "FX": "Cholinergic Antagonists", "MH_TH": "NLM (2014)", "ST": "T037", "PI": "Cholinergic Antagonists (1995-2013)", "MS": "Adverse drug effects associated with CHOLINERGIC ANTAGONISTS. Clinical features include TACHYCARDIA; HYPERTHERMIA; MYDRIASIS, dry skin and dry mucous membranes, decreased bowel sounds and urinary retention in peripheral anticholinergic syndrome; and HALLUCINATIONS; PSYCHOSES; SEIZURES; and COMA in central anticholinergic syndrome.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064807"}, {"RECTYPE": "D", "MH": "Transfusion Medicine", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Transfusion", "MN": "H02.403.429.445.500", "FX": "Blood Safety", "MH_TH": "NLM (2014)", "ST": "T091", "PI": "Blood Transfusion (1979-2013)", "MS": "The area of hematology that is concerned with the transfusion of blood and blood components, and in prevention and treatment of adverse effects from BLOOD TRANSFUSION errors.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064826"}, {"RECTYPE": "D", "MH": "Myocutaneous Flap", "AQ": "AE BS CL EC ES HI IM IR MI PA PH PS SD SN ST SU TD TR VE VI", "ENTRY": "Myocutaneous Flaps", "MN": "E07.862.710.625", "MH_TH": "NLM (2014)", "ST": "T023", "PI": "Surgical Flaps (1979-2013)", "MS": "A mass of tissue, including skin and muscle, that has been cut away from surrounding areas for transplantation.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064827"}, {"RECTYPE": "D", "MH": "Prolyl Hydroxylases", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Proline,2-Oxoglutarate 4-Dioxygenase|T116|T126|NON|EQV|UNK (19XX)|760520|PROLINE OXOGLUTARATE DIOXYGENASE 02|abbcdefs", "ENTRY": "Hydroxylases, Prolyl", "MN": "D08.811.682.690.708.694", "EC": "antagonists & inhibitors:Prolyl-Hydroxylase Inhibitors", "MH_TH": "NLM (2014)", "ST": "T126", "RN": "EC 1.14.11.-", "MS": "Enzymes that specifically hydroxylate PROLINE residues on proteins.", "PM": "2014; for PROLYL 4-HYDROXYLASE see PROCOLLAGEN-PROLINE DIOXYGENASE 1983-2013; for PEPTIDYL PROLYL HYDROXYLASE see PROCOLLAGEN-PROLINE DIOXYGENASE 1985-2013; for PROLINE,2-OXOGLUTARATE 4-DIOXYGENASE see PROCOLLAGEN-PROLINE DIOXYGENASE 1977-2013; for PROLINE HYDROXYLASE see PROCOLLAGEN-PROLINE DIOXYGENASE 1993-2013; for PROLYL HYDROXYLASE see PROCOLLAGEN-PROLINE DIOXYGENASE 1982-2013", "HN": "2014; for PROLYL 4-HYDROXYLASE use PROCOLLAGEN-PROLINE DIOXYGENASE 1983-2013; for PEPTIDYL PROLYL HYDROXYLASE use PROCOLLAGEN-PROLINE DIOXYGENASE 1985-2013; for PROLINE,2-OXOGLUTARATE 4-DIOXYGENASE use PROCOLLAGEN-PROLINE DIOXYGENASE 1977-2013; for PROLINE HYDROXYLASE use PROCOLLAGEN-PROLINE DIOXYGENASE 1993-2013; for PROLYL HYDROXYLASE use PROCOLLAGEN-PROLINE DIOXYGENASE 1982-2013", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064828"}, {"RECTYPE": "D", "MH": "Alcohol Abstinence", "AQ": "CL EC ES HI LJ PX SN TD", "PRINT ENTRY": "Ethanol Abstinence|T055|NON|EQV|NLM (2021)|OBSSR (2021)|200515|abcdeef", "ENTRY": "Abstinence, Ethanol", "MN": "F01.145.317.134", "MH_TH": "NLM (2014)", "ST": "T055", "AN": "TEMPERANCE is also available", "MS": "Non-consumption of ALCOHOLIC BEVERAGES.", "PM": "2014", "HN": "2014", "MR": "20210512", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064829"}, {"RECTYPE": "D", "MH": "Temperance Movement", "AQ": "CL EC ED ES HI LJ PX SN ST TD", "ENTRY": "Temperance Movements", "MN": "I03.833", "MH_TH": "NLM (2014)", "ST": "T095", "PI": "Temperance (1966-2013)", "MS": "Social effort most active in the 19th and early 20th centuries dedicated to promoting moderation or complete abstinence in the use of ALCOHOLIC BEVERAGES.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064830"}, {"RECTYPE": "D", "MH": "Sports for Persons with Disabilities", "AQ": "CL EC ED ES HI LJ PH PX SN ST TD", "PRINT ENTRY": "Wheelchair Sports|T056|NON|NRW|NLM (2021)|200315|abcdef", "ENTRY": "Wheelchair Sport", "MN": "I03.450.642.845.834", "FX": "Rehabilitation", "EC": "injuries:Athletic Injuries", "MH_TH": "NLM (2014)", "ST": "T056", "MS": "Activities or games played by PERSONS WITH DISABILITIES, usually requiring physical effort or skill. The activities or games may be specifically created or based on existing sports, with or without modifications, to meet the needs of persons with physical or intellectual disabilities.", "PM": "2014", "HN": "2014", "MR": "20200618", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064846"}, {"RECTYPE": "D", "MH": "Multimodal Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Imaging, Multimodal|T060|NON|EQV|NLM (2014)|130502|abcdef", "MN": "E01.370.350.567", "FX": "Image Processing, Computer-Assisted", "MH_TH": "NLM (2014)", "ST": "T060", "AN": "prefer specific precoordinated multimodal imaging techniques, otherwise coordinate with specific imaging techniques used in combination", "MS": "The use of combination of imaging techniques or platforms (e.g., MRI SCAN and PET SCAN) encompassing aspects of anatomical, functional, or molecular imaging methods.", "PM": "2014", "HN": "2014", "MR": "20171213", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064847"}, {"RECTYPE": "D", "MH": "Mindfulness", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "F04.754.137.350.500", "MH_TH": "NLM (2014)", "ST": "T061", "PI": "Cognitive Therapy (2000-2013)", "MS": "A psychological state of awareness, the practices that promote this awareness, a mode of processing information and a character trait. As a therapy mindfulness is defined as a moment-to-moment awareness of one's experience without judgment and as a state and not a trait.", "PM": "2014", "HN": "2014", "MR": "20180630", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064866"}, {"RECTYPE": "D", "MH": "Mesopotamia", "AQ": "EH EP", "MN": "Z01.586.035.587", "MH_TH": "NLM (2014)", "ST": "T083", "PI": "Middle East (1982-2013)", "MS": "Ancient land between the Tigris and Euphrates rivers, corresponding to modern-day Iraq and partly NE Syria, SE Turkey and smaller parts of SW Iran. It is considered to be the cradle of civilization in the West. Bronze Age Mesopotamia included Sumer and the Akkadian, Babylonian and Assyrian empires (from http://www.merriam-webster.com/dictionary/mesopotamia )", "HN": "2014", "MR": "20130705", "DA": "20130708", "DC": "4", "DX": "20140101", "UI": "D064867"}, {"RECTYPE": "D", "MH": "Ethnic Violence", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Ethnic Conflict|T054|NON|REL|NLM (2014)|130504|abcdef", "ENTRY": "Wars, Ethnic", "MN": "I01.880.735.900.575", "MH_TH": "NLM (2014)", "ST": "T054", "MS": "Violence or other hostile behavior arising when an ethnic group either feels itself under threat, or where it seeks to assert its superiority or dominance over other groups.", "PM": "2014; see ETHNIC CONFLICT 2014-2015", "HN": "2014(2016)", "MR": "20150708", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064868"}, {"RECTYPE": "D", "MH": "Acceptance and Commitment Therapy", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "MN": "F04.754.137.350.249", "MH_TH": "NLM (2014)", "ST": "T061", "PI": "Cognitive Therapy (1990-2013)", "MS": "Contextually focused form of cognitive behavioral psychotherapy that uses MINDFULNESS and behavioral activation to increase patients' psychological flexibility in areas such as ability to engage in values-based, positive behaviors while experiencing difficult thoughts, emotions, or sensations.", "PM": "2014", "HN": "2014", "MR": "20180629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064869"}, {"RECTYPE": "D", "MH": "Air Travel", "AQ": "CL EC ES HI LJ PX SN TD", "ENTRY": "by Air, Travel", "MN": "I03.883.209", "FX": "Jet Lag Syndrome", "MH_TH": "NLM (2013)", "ST": "T056", "MS": "Travel by means of an airplane, helicopter, or balloon.", "PM": "2014; see TRAVEL 2013", "HN": "2014; use TRAVEL 2013", "MR": "20170710", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064870"}, {"RECTYPE": "D", "MH": "Teach-Back Communication", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Teach-Back Communications", "MN": "I02.233.332.874", "FX": "Professional-Patient Relations", "MH_TH": "NLM (2014)", "ST": "T065", "MS": "Providing the patient, family or others information, and then allowing them to take an action or restate the information in their own words. The clinician prefaces communications with a statement framed to show the clinician has the burden of effective communication rather than the patient.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064871"}, {"RECTYPE": "D", "MH": "Patient Care Bundles", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Care Bundles|T061|NON|EQV|NLM (2014)|130505|abcdef", "ENTRY": "Patient Care Bundle", "MN": "E02.765", "MH_TH": "NLM (2014)", "ST": "T061", "MS": "Small sets of evidence-based interventions for a defined patient population and care setting.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064872"}, {"RECTYPE": "D", "MH": "Asia, Northern", "AQ": "EH EP", "ENTRY": "Northern Asia|T083|NON|EQV|NLM (2014)|130505|abcdef", "MN": "Z01.252.122", "MH_TH": "NLM (2014)", "ST": "T083", "MS": "A subregion of Asia, consisting of Asian portion of Russia.", "HN": "2014", "MR": "20220708", "DA": "20130708", "DC": "4", "DX": "20140101", "UI": "D064873"}, {"RECTYPE": "D", "MH": "Tatarstan", "AQ": "EH EP", "ENTRY": "Tatariya|T083|NON|EQV|NLM (2014)|130505|abcdef", "MN": "Z01.542.248.775.900", "MH_TH": "NLM (2014)", "ST": "T083", "MS": "Political subdivision of eastern RUSSIA located within Europe. It lies between the Volga River and the Kama River, and extends east to the Ural mountains.", "HN": "2014", "MR": "20130705", "DA": "20130708", "DC": "4", "DX": "20140101", "UI": "D064874"}, {"RECTYPE": "D", "MH": "Safety-net Providers", "AQ": "CL EC EH ES HI LJ MT OG SN ST TD", "ENTRY": "Safety-net Provider", "MN": "N04.590.374.700", "MH_TH": "NLM (2014)", "ST": "T058", "AN": "use only for the facility and not for the personnel providing the health service", "MS": "Providers that by mandate or mission organize and deliver a significant level of health care and other health-related services to the uninsured, Medicaid recipients, and other vulnerable patients.", "PM": "2014", "HN": "2014", "MR": "20180629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064876"}, {"RECTYPE": "D", "MH": "Organ Trafficking", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Traffickings, Organ", "MN": "I01.880.735.384.599", "FX": "Human Trafficking", "MH_TH": "NLM (2014)", "ST": "T068", "MS": "Criminal activity that occurs in three broad categories. Firstly, cases where traffickers force or deceive the victims into giving up an organ. Secondly, there are cases where victims formally or informally agree to sell an organ and are cheated because they are not paid for the organ or are paid less than the promised price. Thirdly, vulnerable persons are treated for an ailment, which may or may not exist and thereupon organs are removed without the victim's knowledge.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064877"}, {"RECTYPE": "D", "MH": "Web Browser", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Web Browsers", "MN": "L01.470.937", "MH_TH": "NLM (2014)", "ST": "T170", "PI": "Software (1994-2013)", "MS": "Software application for retrieving, presenting and traversing information resources on the World Wide Web.", "PM": "2014", "HN": "2014", "MR": "20170703", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064878"}, {"RECTYPE": "D", "MH": "Dataset", "ENTRY": "Data Set|T170|NON|EQV|NLM (2014)|130509|abcdef", "MN": "V02.302", "MH_TH": "NLM (2014)", "ST": "T170", "AN": "this heading is used as a Publication Type; use DATASETS AS TOPIC for articles on the subject of datasets", "MS": "Works consisting of organized collections of data, which have been stored permanently in a formalized manner suitable for communication, interpretation, or processing.", "HN": "2014", "MR": "20140625", "DA": "20130708", "DC": "2", "DX": "20140101", "UI": "D064886"}, {"RECTYPE": "D", "MH": "Observational Studies as Topic", "AQ": "CL EC ES HI IS LJ MT PX SN ST", "PRINT ENTRY": "Observational Study as Topic|T170|NON|EQV|NLM (2014)|130509|abcdef", "MN": "N06.850.520.450.250.500", "MH_TH": "NLM (2016)", "ST": "T170", "AN": "for general design, methodology, economics, etc. of observational studies; a different heading OBSERVATIONAL STUDY is used for reports of a specific observational study", "MS": "Works about clinical studies in which participants may receive diagnostic, therapeutic, or other types of interventions, but the investigator does not assign participants to specific interventions (as in an interventional study).", "PM": "2014", "HN": "2014", "MR": "20230531", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064887"}, {"RECTYPE": "D", "MH": "Observational Study", "PRINT ENTRY": "Naturalistic Observation Study|T170|NON|REL|NLM (2024)|230419|abcdef", "MN": "V03.175.500", "MH_TH": "NLM (2014)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific observational study; a different heading OBSERVATIONAL STUDIES AS TOPIC is used for general design, methodology, economics, etc. of observational studies", "MS": "A work that reports on the results of a clinical study in which participants may receive diagnostic, therapeutic, or other types of interventions, but the investigator does not assign participants to specific interventions (as in an interventional study).", "HN": "2014", "MR": "20230531", "DA": "20130708", "DC": "2", "DX": "20140101", "UI": "D064888"}, {"RECTYPE": "D", "MH": "Psychotherapy, Psychodynamic", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Psychotherapies, Psychodynamic", "MN": "F04.754.775", "MH_TH": "NLM (2014)", "ST": "T061", "MS": "Forms of PSYCHOTHERAPY falling within or deriving from the psychoanalytic tradition, that view individuals as reacting to unconscious forces (e.g., motivation, drive), that focus on processes of change and development, and that place a premium on self understanding and making meaning of what is unconscious.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064889"}, {"RECTYPE": "D", "MH": "Social Determinants of Health", "AQ": "CL EC EH ES HI LJ SN ST TD", "PRINT ENTRY": "Structural Determinants of Health|T067|NON|REL|NLM (2021)|191109|abcdef", "ENTRY": "Socio Economic Determinants of Health", "MN": "N01.400.675", "MH_TH": "NLM (2014)", "ST": "T058", "MS": "The circumstances in which people are born, grow up, live, work, and age, as well as the systems put in place to deal with illness. These circumstances are in turn shaped by a wider set of forces: economics, social policies, and politics (http://www.cdc.gov/socialdeterminants/).", "PM": "2014", "HN": "2014", "MR": "20230531", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064890"}, {"RECTYPE": "D", "MH": "Disaster Victims", "AQ": "CL ED HI LJ PX RH SN", "ENTRY": "Victims, Disaster", "MN": "M01.159", "MH_TH": "NLM (2014)", "ST": "T098", "MS": "Persons adversely effected by DISASTERS, occurrences that result in property damage, deaths, and/or injuries to a community.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064891"}, {"RECTYPE": "D", "MH": "Qigong", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Qi Gong|T061|NON|EQV|NLM (2002)|010409|abcdef", "MN": "E02.779.474.124.500", "MH_TH": "NLM (1996)", "ST": "T061", "PI": "Breathing Exercises (1981-2013)", "MS": "An ancient Chinese system of postures, exercises, breathing techniques, and meditations designed to improve and enhance the body's QI.", "PM": "2014; see BREATHING EXERCISES 1981-2013", "HN": "2014", "MR": "20160531", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064906"}, {"RECTYPE": "D", "MH": "Diagnostic Uses of Chemicals", "MN": "D27.505.259", "MH_TH": "NLM (2014)", "ST": "T169", "RN": "0", "AN": "general only; do not use as a coordinate with specific chemicals", "MS": "Chemicals administered to patients in order to diagnose or study the pathology of medical conditions, diseases, or syndromes.", "PM": "2014", "HN": "2014", "MR": "20150605", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064907"}, {"RECTYPE": "D", "MH": "Neurophysiological Monitoring", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Monitoring, Neurophysiological", "MN": "E01.370.520.596", "MH_TH": "NLM (2014)", "ST": "T060", "PI": "Monitoring, Physiologic (1987-2013)", "MS": "The systematic checking of the condition and function of a patient's CENTRAL NERVOUS SYSTEM during disease periods or following injuries, using various NEUROLOGICAL DIAGNOSTIC TECHNIQUES.", "PM": "2014", "HN": "2014", "MR": "20150623", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064926"}, {"RECTYPE": "D", "MH": "Tick Bites", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Tick Bite", "MN": "C26.176.793", "MH_TH": "NLM (2014)", "ST": "T037", "PI": "Arachnidism (1963-2013)", "MS": "The effects, both local and systemic, caused by the bites of TICKS.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064927"}, {"RECTYPE": "D", "MH": "Hospice and Palliative Care Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Palliative Care Nursing|T058|NON|NRW|NLM (2014)|130405|abcdef", "ENTRY": "Nursings, Hospice", "MN": "N02.421.533.390", "FX": "Palliative Medicine", "MH_TH": "NLM (2014)", "ST": "T058", "PI": "Palliative Care (1987-2013)", "MS": "A nursing specialty concerned with care of patients facing serious or life-threatening illnesses. The goal of palliative nursing is to prevent and relieve suffering, and to support the best possible quality of life for patients and their families. Hospice nursing is palliative care for people in their final stages of life.", "PM": "2014; for HOSPICE NURSING see HOSPICES 1980-1991, see HOSPICE CARE 1992-2013 ; for PALLIATIVE CARE NURSING see PALLIATIVE CARE 1987-2013; for PALLIATIVE NURSING see PALLIATIVE CARE 1980-2013.", "HN": "2014", "MR": "20150629", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064946"}, {"RECTYPE": "D", "MH": "British Virgin Islands", "PRINT ENTRY": "Virgin Islands, British|T083|NAM|EQV|UNK (19XX)|810515|abcdef", "MN": "Z01.107.084.900.182", "MH_TH": "NLM (1979)", "ST": "T083", "PI": "West Indies (1979-2013)", "MS": "A British overseas territory, part of the British West Indies, lying about 60 miles east of Puerto Rico. Tortola is the main island, other islands include Virgin Gorda, Jost Van Dyke and Anegada.", "HN": "2014; use WEST INDIES 1979-2013", "DA": "20130708", "DC": "4", "DX": "20140101", "UI": "D064966"}, {"RECTYPE": "D", "MH": "Cell- and Tissue-Based Therapy", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Tissue Therapy|T061|NON|REL|NLM (1966)|990101|TISSUE THER|abcdefv", "ENTRY": "Cell and Tissue Based Therapy", "MN": "E02.095.147", "FX": "Tissue Therapy, Historical", "MH_TH": "NLM (2014)", "ST": "T061", "MS": "Therapies that involve the TRANSPLANTATION of CELLS or TISSUES developed for the purpose of restoring the function of diseased or dysfunctional cells or tissues.", "PM": "2014; for CELL THERAPY see TISSUE THERAPY 1997-2013; TISSUE THERAPY was heading 1966-2013 now TISSUE THERAPY, HISTORICAL", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D064987"}, {"RECTYPE": "D", "MH": "Papanicolaou Test", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "PRINT ENTRY": "Papanicolaou Smear|T060|EPO|EQV|NLM (1991)|900202|abcdef", "ENTRY": "Test, Papanicolaou", "MN": "E05.242.384.100.422", "MH_TH": "NLM (1991)", "ST": "T060", "AN": "coordinate with VAGINAL SMEARS if pertinent", "PI": "Vaginal Smears (1966-2013)", "MS": "Cytological preparation of cells collected from a mucosal surface and stained with Papanicolaou stain.", "PM": "2014; see VAGINAL SMEARS 1991-2013", "HN": "2014; use VAGINAL SMEARS 1991-2013", "MR": "20150601", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D065006"}, {"RECTYPE": "D", "MH": "Pragmatic Clinical Trial", "MN": "V03.175.250.500.500.500", "MH_TH": "NLM (2014)", "ST": "T170", "AN": "this heading is used as a Publication Type; for original report of the conduct or results of a specific pragmatic clinical trial; a different heading PRAGMATIC CLINICAL TRIALS AS TOPIC is used for general design, methodology, economics, etc. of pragmatic clinical trials; use only when specified by author", "MS": "Randomized clinical trials that compare interventions in clinical settings and which look at a range of effectiveness outcomes and impacts.", "HN": "2014", "MR": "20190508", "DA": "20130708", "DC": "2", "DX": "20140101", "UI": "D065007"}, {"RECTYPE": "D", "MH": "Scorpion Stings", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Scorpion Envenoming|T037|NON|EQV|NLM (2021)|200131|abcdef", "ENTRY": "Stings, Scorpion", "MN": "C26.176.443", "MH_TH": "NLM (2014)", "ST": "T037", "MS": "The effects, both local and systemic, caused by the bite of SCORPIONS.", "PM": "2014", "HN": "2014", "MR": "20200527", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D065008"}, {"RECTYPE": "D", "MH": "Hope", "AQ": "CL DE ES PH RE", "ENTRY": "Hopes", "MN": "F01.470.572", "MH_TH": "NLM (2014)", "ST": "T041", "AN": "use only in the context of a mental process (for example, hope as a motivation for recovery, but not hope for increased research funding)", "MS": "Belief in a positive outcome.", "PM": "2014", "HN": "2014", "DA": "20130708", "DC": "1", "DX": "20140101", "UI": "D065026"}, {"RECTYPE": "D", "MH": "Antihyperkalemic Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Drugs, Antihyperkalemic", "MN": "D27.505.696.560.374", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Hyperkalemia/ drug therapy (1965-2014)", "MS": "Compounds used to lower excessive POTASSIUM levels in the body.", "PM": "2015", "HN": "2015", "MR": "20140610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065067"}, {"RECTYPE": "D", "MH": "Acetaldehyde Dehydrogenase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Dehydrogenase Inhibitors, Acetaldehyde", "MN": "D27.505.519.389.089", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "MS": "Compounds that bind to and inhibit the enzymatic activity of acetaldehyde dehydrogenases.", "PM": "2015", "HN": "2015", "MR": "20140610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065086"}, {"RECTYPE": "D", "MH": "Acetylcholine Release Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Release Blockers, Acetylcholine", "MN": "D27.505.696.577.120.069", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "MS": "Compounds that block release of the neurotransmitter ACETYLCHOLINE.", "PM": "2015", "HN": "2015", "MR": "20140610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065087"}, {"RECTYPE": "D", "MH": "Steroid Synthesis Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Synthesis Inhibitors, Steroid", "MN": "D27.505.696.399.450.855", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "MS": "Compounds that bind to and inhibit enzymes involved in the synthesis of STEROIDS.", "PM": "2015", "HN": "2015", "MR": "20140624", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065088"}, {"RECTYPE": "D", "MH": "Glycoside Hydrolase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "alpha-Glucosidase Inhibitors|T121|NON|NRW|NLM (2015)|130827|abcdef", "ENTRY": "alpha-Amylase Inhibitors, Intestinal", "MN": "D27.505.696.422.249", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "alpha-Glucosidases/Antagonists and Inhibitors (1978-2014)", "MS": "Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES.", "PM": "2015", "HN": "2015", "MR": "20200527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065089"}, {"RECTYPE": "D", "MH": "Amylin Receptor Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Receptor Agonists, Amylin", "MN": "D27.505.696.422.374", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "MS": "Compounds that stimulate the activity of AMYMIN RECEPTORS. Included under this heading is the endogenous form of ISLET AMYLOID POLYPEPTIDE and synthetic compounds that mimic its effect.", "PM": "2015", "HN": "2015", "MR": "20140610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065091"}, {"RECTYPE": "D", "MH": "Antidiuretic Hormone Receptor Antagonists", "AQ": "AD AE BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Vasopressin Receptor Antagonist|T121|NON|EQV|NLM (2021)|191122|abcdef", "ENTRY": "Receptor Antagonists, Vasopressin", "MN": "D27.505.696.560.311", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Vasopressins/ Antagonists & Inhibitors (1966-2014)", "MS": "Endogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS.", "PM": "2015", "HN": "2015", "MR": "20200527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065092"}, {"RECTYPE": "D", "MH": "beta-Lactamase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "beta-Lactamase Inhibitor|T121|NON|EQV|NLM (2021)|191219|abcdef", "ENTRY": "Lactamase Inhibitors, beta", "MN": "D27.505.954.122.085.516", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "beta-Lactamases / Antagonists & Inhibitors (1966-2013)", "MS": "Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES.", "PM": "2015", "HN": "2015", "MR": "20200527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065093"}, {"RECTYPE": "D", "MH": "Bradykinin B2 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "B2 Antagonists, Bradykinin", "MN": "D27.505.696.477.656.500.500", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Receptor, Bradykinin B2/ Antagonists & Inhibitors (2004-2014)", "MS": "Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ B2 RECEPTORS.", "PM": "2015", "HN": "2015", "MR": "20140610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065094"}, {"RECTYPE": "D", "MH": "Calcineurin Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Calcineurin Inhibitor|T121|NON|EQV|NLM (2021)|191129|abcdef", "ENTRY": "Protein Phosphatase 2B Inhibitors", "MN": "D27.505.519.389.174", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Calcineurin/ Antagonists and Inhibitors (1998-2014)", "MS": "Compounds that inhibit or block the PHOSPHATASE activity of CALCINEURIN.", "PM": "2015", "HN": "2015", "MR": "20200527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065095"}, {"RECTYPE": "D", "MH": "Calcium Chelating Agents", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Calcium Chelator|T121|T130|NON|EQV|NLM (2022)|200824|abbcdef", "ENTRY": "Chelators, Calcium", "MN": "D27.720.832.500.204", "MH_TH": "NLM (2015)", "ST": "T130", "RN": "0", "PI": "Chelating Agents (1966-2014)", "MS": "Substances that bind to and sequester CALCIUM ions.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065096"}, {"RECTYPE": "D", "MH": "Carbamoyl Phosphate Synthetase I Activators", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Carbamoyl-Phosphate Synthase (Ammonia) Activators|T121|NON|EQV|NLM (2015)|130828|abcdef", "MN": "D27.505.519.374.099", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Carbamoyl-Phosphate Synthase (Ammonia) (1998-2013)", "MS": "Substances and drugs that stimulate the synthesis or increase the activity of CARBAMOYL PHOSPHATE SYNTHETASE I. Drugs in this class of compounds have been used to treat the genetic disorder, CARBAMOYL-PHOSPHATE SYNTHASE I DEFICIENCY DISEASE.", "PM": "2015", "HN": "2015", "MR": "20140624", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065097"}, {"RECTYPE": "D", "MH": "Catechol O-Methyltransferase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "O-Methyltransferase Inhibitors, Catechol", "MN": "D27.505.954.427.090.050.500", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Catechol O-Methyltransferase/ Antagonists & Inhibitors (1996-2014)", "MS": "Compounds and drugs that inhibit or block the activity of CATECHOL O-METHYLTRANSFERASE enzymes. Drugs in this class are used in management of central nervous system disorders such as PARKINSON DISEASE.", "PM": "2015", "HN": "2015", "MR": "20140624", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065098"}, {"RECTYPE": "D", "MH": "Travel Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Travel", "MN": "N04.452.758.377.968", "MH_TH": "NLM (2015)", "ST": "T091", "AN": "do not confuse with TRAVEL MEDICINE - a field focusing on disease prevention and safety of patients during international travel", "PI": "Nursing Staff (1991-2014)", "MS": "A type of nursing practice involving licensed professional nurses who travel to work in temporary nursing positions.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065099"}, {"RECTYPE": "D", "MH": "CCR5 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Receptor Blockers, CCR5", "MN": "D27.505.954.122.388.077.088.104", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Receptors, CCR5/ Antagonists & Inhibitors (1998-2014)", "MS": "Compounds and drugs that inhibit or block the activity of CCR5 RECEPTORS.", "PM": "2015", "HN": "2015", "MR": "20140610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065100"}, {"RECTYPE": "D", "MH": "Chloride Channel Agonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Stimulators, Chloride Channel", "MN": "D27.505.519.562.311", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Chloride Channels/ Agonists (1995-2014)", "MS": "A class of drugs that stimulate chloride ion influx through cell membrane channels.", "PM": "2015", "HN": "2015", "MR": "20140610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065101"}, {"RECTYPE": "D", "MH": "Licensed Practical Nurses", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "ENTRY": "Nurses, Licensed Vocational", "MN": "N02.360.067.450", "MH_TH": "NLM (2015)", "ST": "T097", "PI": "Nursing, Practical (1963-2014)", "MS": "Health personnel who do not hold professional degrees or credentials, but have completed training and are licensed to provide routine patient care under the direction of registered nurses and physicians.", "PM": "2015", "HN": "2015", "MR": "20180629", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065102"}, {"RECTYPE": "D", "MH": "Cystine Depleting Agents", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Reducers, Cystine Disulfide", "MN": "D27.505.519.334", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "MS": "Compounds and drugs that react with CYSTINE and convert it into a compound that can be more easily metabolized or intracellularly transported. Drugs in this class have been used to treat CYSTINOSIS.", "PM": "2015", "HN": "2015", "MR": "20140610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065104"}, {"RECTYPE": "D", "MH": "Aromatic Amino Acid Decarboxylase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Aromatic-L-Amino-Acid Decarboxylase Inhibitors|T121|NON|EQV|NLM (2021)|200518|abcdef", "ENTRY": "Inhibitors, Dihydroxyphenylalanine Decarboxylase", "MN": "D27.505.954.427.090.050.249", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Aromatic-L-Amino-Acid Decarboxylases/ Antagonists & Inhibitors (1998-2014)", "MS": "Compounds and drugs that block or inhibit the enzymatic action of AROMATIC AMINO ACID DECARBOXYLASES. Pharmaceutical agents in this category are used in conjunction with LEVODOPA in order to slow its metabolism.", "PM": "2015", "HN": "2015", "MR": "20200518", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065105"}, {"RECTYPE": "D", "MH": "Demulcents", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Agents, Mucoprotective", "MN": "D27.720.877.156", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "MS": "Compounds that form soothing films on the surface of MUCOUS MEMBRANES. They are generally used as agents to protect the integrity of internal EPITHELIUM.", "PM": "2015", "HN": "2015", "MR": "20140610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065106"}, {"RECTYPE": "D", "MH": "Ornithine Decarboxylase Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inhibitors, Ornithine Decarboxylase", "MN": "D27.505.519.389.705", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Ornithine Decarboxylase/ Antagonists & Inihibitors (1975-2014)", "MS": "Substances and drugs that inhibit or block the activity of ORNITHINE DECARBOXYLASE.", "PM": "2015", "HN": "2015", "MR": "20140610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065108"}, {"RECTYPE": "D", "MH": "Palliative Medicine", "DE": "PALLIATIVE MED", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Medicine, Palliative Care", "MN": "H02.403.645", "FX": "Palliative Care", "MH_TH": "NLM (1996)", "ST": "T091", "AN": "specialty only; use PALLIATIVE CARE for care of patients", "PI": "Palliative Care (1996-2014)", "MS": "A branch of medicine concerned with preventing and relieving the suffering of patients in any stage of disease. Its focus is on comprehensive care and improving the quality of all areas of the patient's life.", "PM": "2015; see PALLIATIVE CARE 1996-2014", "HN": "2015; use PALLIATIVE CARE 1996-2014", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065126"}, {"RECTYPE": "D", "MH": "Dopamine D2 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Dopamine D2 Receptor Antagonist|T121|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "D2 Antagonists, Dopamine", "MN": "D27.505.696.577.150.175.500", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Dopamine Antagonists (1995-2014)", "MS": "Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS.", "PM": "2015", "HN": "2015", "MR": "20200527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065127"}, {"RECTYPE": "D", "MH": "Endothelin Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Endothelin Receptor Antagonist|T121|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "Receptor Antagonist, Endothelin", "MN": "D27.505.519.364", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Receptors, Endothelin/ Antagonists & Inhibitors (1994-2014)", "MS": "Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS.", "PM": "2015", "HN": "2015", "MR": "20200527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065128"}, {"RECTYPE": "D", "MH": "Pre-Exposure Prophylaxis", "AQ": "CL EC ES HI LJ MT OG SN ST TD", "ENTRY": "Prophylaxis, Pre-Exposure (PrEP)", "MN": "N06.850.780.680.655", "MH_TH": "NLM (2015)", "ST": "T061", "PI": "specific disease/prevention and control (1972-2014)", "MS": "A method of disease prevention (abbreviated PrEP) which involves the administration of drugs to at-risk persons who have not been exposed to the disease-causing agent.", "PM": "2015", "HN": "2015", "MR": "20150626", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065129"}, {"RECTYPE": "D", "MH": "Endothelin A Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Endothelin Type A Receptor Antagonists|T121|NON|EQV|NLM (2015)|130904|abcdef", "MN": "D27.505.519.364.500", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Receptor, Endothelin A/ Antagonist & Inhibitors (2004-2014)", "MS": "Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN A RECECPTORS.", "PM": "2015", "HN": "2015", "MR": "20140610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065130"}, {"RECTYPE": "D", "MH": "Endothelin B Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Endothelin B Receptor Blockers|T121|NON|EQV|NLM (2015)|130904|abcdef", "MN": "D27.505.519.364.750", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Receptor, Endothelin B/ Antagonist & Inhibitors (2004-2014)", "MS": "Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN B RECEPTORS.", "PM": "2015", "HN": "2015", "MR": "20140610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065131"}, {"RECTYPE": "D", "MH": "Bioprospecting", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Biopanning|T062|NON|EQV|NLM (2020)|190124|abcdef", "MN": "E05.114", "FX": "Drug Discovery", "MH_TH": "NLM (2015)", "ST": "T062", "MS": "The systematic search and discovery of natural substances which may have potential commercial applications.", "PM": "2015", "HN": "2015", "MR": "20190530", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065132"}, {"RECTYPE": "D", "MH": "Ephemeroptera", "AQ": "AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI", "ENTRY": "Mayfly|T204|NON|EQV|NLM (2015)|131216|abcdef", "MN": "B01.050.500.131.617.720.750.500", "MH_TH": "NLM (2015)", "ST": "T204", "RN": "txid30073", "AN": "for killing Ephemeroptera with insecticides, see note at INSECTICIDES", "PI": "Insects (1963-2014)", "MS": "An Order of aquatic INSECTS comprising about 2,500 species worldwide. It is the only insect group with two flying stages, each with relatively large forewings. The immature stage called \"naiad\" or \"nymph\" lasts one year in fresh water, and the adult stage is shortlived, lasting from a few minutes to a few days, depending on the species. The Ephemeroptera includes mayflies (also called shadflies)", "PM": "2015", "HN": "2015", "MR": "20200813", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065133"}, {"RECTYPE": "D", "MH": "Lipedema", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Lipolymphedemas", "MN": "C17.300.451", "FX": "Lymphedema", "MH_TH": "NLM (2015)", "ST": "T047", "PI": "Edema (1974-2014)", "MS": "Disorder of adipose tissue characterized by symmetric and bilateral enlargement of the lower extremities due to abnormal deposition of SUBCUTANEOUS FAT often in obese women. It is associated with HEMATOMA, pain and may progress to secondary LYMPHEDEMA which is known as lipolymphedema.", "PM": "2015", "HN": "2015", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065134"}, {"RECTYPE": "D", "MH": "Animal Culling", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Culling, Animal", "MN": "N06.850.780.200.112", "FX": "Euthanasia, Animal", "MH_TH": "NLM (2015)", "ST": "T068", "MS": "Selection and removal of individuals from a population or group. Culling is a common strategy with livestock and wildlife, used to control and eradicate diseases or pests, control population size, select for desired genetic characteristics, and maximize economic profit.", "PM": "2015", "HN": "2015", "MR": "20140625", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065136"}, {"RECTYPE": "D", "MH": "Zeaxanthins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Beta Carotene 3,3' Diol", "MN": "D23.767.261.887.750", "MH_TH": "NLM (2015)", "ST": "T123", "RN": "0", "RR": "144-68-3", "PI": "Xanthophylls (1967-2014)", "MS": "Carotenoids found in fruits and vegetables. Zeaxanthin accumulates in the MACULA LUTEA.", "PM": "2015; ZEAXANTHIN  was indexed under XANTHOPHYLLS 1973-2014", "HN": "2015", "MR": "20140606", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065146"}, {"RECTYPE": "D", "MH": "Viral Fusion Protein Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "MN": "D27.505.954.122.388.538", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "MS": "Drugs that are designed to block the action of VIRAL FUSION PROTEINS and prevent VIRUSES from entering the cell.", "PM": "2015", "HN": "2015", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065147"}, {"RECTYPE": "D", "MH": "Nicolau Syndrome", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Nicolau's Livedoid", "MN": "C25.100.468.380.693", "MH_TH": "NLM (2015)", "ST": "T047", "MS": "An uncommon complication of INTRAMUSCULAR INJECTION leading to variable degrees of necrosis of skin and underlying tissue.", "PM": "2015", "HN": "2015", "MR": "20220711", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065148"}, {"RECTYPE": "D", "MH": "Cellular Reprogramming", "AQ": "DE GE IM PH RE", "ENTRY": "Reprogramming, Nuclear", "MN": "G05.135", "FX": "Induced Pluripotent Stem Cells", "MH_TH": "NLM (2015)", "ST": "T043", "AN": "CELL TRANSDIFFERENTIATION is also available", "MS": "A process where fully differentiated or specialized cells revert to pluripotency or a less differentiated cell type.", "PM": "2015(2007)", "HN": "2015", "MR": "20160115", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065150"}, {"RECTYPE": "D", "MH": "Sepsis-Associated Encephalopathy", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Sepsis-Associated Encephalopathies", "MN": "C10.228.140.807", "FX": "Systemic Inflammatory Response Syndrome", "MH_TH": "NLM (2015)", "ST": "T048", "AN": "coordinate with SEPSIS or specifics", "PI": "Sepsis (2007-2014)", "MS": "Acute neurological dysfunction during severe SEPSIS in the absence of direct brain infection characterized by systemic inflammation and BLOOD BRAIN BARRIER perturbation.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065166"}, {"RECTYPE": "D", "MH": "Pregnancy, Interstitial", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Interstitial Pregnancy|T047|NON|EQV|NLM (2015)|130911|abcdef", "ENTRY": "Pregnancies, Interstitial", "MN": "C12.050.703.733.703.500", "MH_TH": "NLM (2015)", "ST": "T047", "PI": "Pregnancy, Ectopic or specifics (1963-2014)", "MS": "A type of ectopic pregnancy in which the extrauterine EMBRYO IMPLANTATION occurs in the portion of the FALLOPIAN TUBE that traverses the muscular wall of the uterus.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065167"}, {"RECTYPE": "D", "MH": "Bradykinin Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bradykinin Receptor Inhibitor|T121|NON|EQV|NLM (2021)|191120|abcdef", "ENTRY": "Receptor Inhibitors, Bradykinin", "MN": "D27.505.519.265", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Bradykinin Receptor/ Antoagonists & Inhibitors (1994-2014)", "MS": "Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ RECEPTORS.", "PM": "2015", "HN": "2015", "MR": "20200527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065168"}, {"RECTYPE": "D", "MH": "Bradykinin B1 Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Antagonists, Bradykinin B1", "MN": "D27.505.519.265.249", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Receptor, Bradykinin B1/ Antagonistis & Inhibitors (2004-2014)", "MS": "Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ B1 RECEPTORS.", "PM": "2015", "HN": "2015", "MR": "20160628", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065169"}, {"RECTYPE": "D", "MH": "Pregnancy, Angular", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pregnancies, Angular", "MN": "C12.050.703.733.619", "MH_TH": "NLM (2015)", "ST": "T047", "PI": "Pregnancy, Ectopic (1967-2014)", "MS": "A rare type of abnormal pregnancy in which EMBRYO IMPLANTATION occurs at a lateral angle of the UTERUS, medial to the uterotubal junction and the ROUND LIGAMENT OF UTERUS.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065170"}, {"RECTYPE": "D", "MH": "Estrogen Receptor Antagonists", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Estrogen Receptor Antagonist|T121|NON|EQV|NLM (2022)|200908|abcdef", "ENTRY": "Receptor Antagonists, Estrogen", "MN": "D27.505.696.399.450.327.650", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "AN": "do not confuse with ESTROGEN RECEPTOR MODULATORS", "PI": "Estrogen Antagonists (1978-2014)", "MS": "Compounds and drugs that bind to and block or inhibit the activation of ESTROGEN RECEPTORS.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065171"}, {"RECTYPE": "D", "MH": "Pregnancy, Ovarian", "DE": "PREGN OVARIAN", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Ovarian Pregnancy|T047|NON|EQV|NLM (1992)|910618|OVARIAN PREGN|abcdefv", "ENTRY": "Pregnancies, Ovarian", "MN": "C12.050.703.733.661", "MH_TH": "UNK (19XX)", "ST": "T047", "PI": "Pregnancy, Ectopic (1963-2014)", "MS": "A type of pregnancy in which EMBRYO IMPLANTATION occurs in an OVARY instead of in the uterine cavity.", "PM": "2015; see PREGNANCY, ECTOPIC 1980-2014", "HN": "2015; use PREGNANCY, ECTOPIC 1980-2014", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065172"}, {"RECTYPE": "D", "MH": "Pregnancy, Cornual", "AQ": "BL CF CI CL DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pregnancies, Cornual", "MN": "C12.050.703.733.640", "MH_TH": "NLM (2015)", "ST": "T047", "PI": "Pregnancy, Ectopic (1966-2014)", "MS": "A type of pregnancy in which the EMBRYO IMPLANTATION occurs in the horn of the UTERUS instead of in the uterine cavity, i.e. at the junction of the uterus and one of the FALLOPIAN TUBES.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065173"}, {"RECTYPE": "D", "MH": "Interrupted Time Series Analysis", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "PRINT ENTRY": "Interrupted Time Series|T062|T081|NON|EQV|NLM (2015)|130930|abbcdef", "ENTRY": "Time Series, Interrupted", "MN": "N06.850.520.450.500.912", "MH_TH": "NLM (2015)", "ST": "T081", "MS": "A study that uses observations at multiple time points before and after an intervention (the \"interruption\"), in an attempt to detect whether the intervention has had an effect significantly greater than any underlying trend over time.", "PM": "2015", "HN": "2015", "MR": "20180629", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065186"}, {"RECTYPE": "D", "MH": "Controlled Before-After Studies", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Controlled Before-After Study", "MN": "N06.850.520.450.500.812", "MH_TH": "NLM (2015)", "ST": "T081", "MS": "A study in which observations are made before and after an intervention, both in a group that receives the intervention and in a control group that does not.", "PM": "2015", "HN": "2015", "MR": "20180629", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065187"}, {"RECTYPE": "D", "MH": "Extracellular Traps", "AQ": "CH DE DG EN GE IM ME MI PH PS RE VI", "PRINT ENTRY": "Neutrophil Extracellular Traps|T026|NON|NRW|NLM (2015)|131022|abcdef", "ENTRY": "Traps, Neutrophil Extracellular", "MN": "A11.284.295.495", "FX": "Neutrophils", "MH_TH": "NLM (2015)", "ST": "T026", "PI": "Neutrophils (2006-2014)", "MS": "Extracellular structure primarily composed of CHROMATIN and associated PROTEASES.", "PM": "2015", "HN": "2015", "MR": "20180629", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065206"}, {"RECTYPE": "D", "MH": "Middle East Respiratory Syndrome Coronavirus", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "Merbecovirus|T005|NON|BRD|NLM (2023)|220404|abcdef", "ENTRY": "Virus, MERS", "MN": "B04.820.578.500.540.150.113.750", "MH_TH": "NLM (2015)", "ST": "T005", "RN": "txid1335626", "RR": "txid2509494", "AN": "infection: coordinate with MIDDLE EAST RESPIRATORY SYNDROME see CORONAVIRUS INFECTIONS", "PI": "Coronavirus (2013-2014)", "MS": "A coronavirus first reported in the summer of 2012 in a pneumonia patient in SAUDI ARABIA. It is related to SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS. MERS-CoV has an estimated incubation period of 12 days and symptoms include renal failure and severe acute pneumonia with often fatal outcome.", "PM": "2015", "HN": "2015", "MR": "20220715", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065207"}, {"RECTYPE": "D", "MH": "Transfusion Reaction", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Delayed Hemolytic Transfusion Reaction|T033|T046|NON|NRW|NLM (2015)|131024|abbcdef", "ENTRY": "Transfusion-Transmitted Infections", "MN": "C20.920", "FX": "Blood Safety", "MH_TH": "NLM (2012)", "ST": "T046", "PI": "Hemolysis (1964-2014)", "MS": "Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.", "PM": "2015; see BLOOD GROUP INCOMPATIBILITY 2012-2014", "HN": "2015; use BLOOD GROUP INCOMPATIBILITY 2012-2014", "MR": "20180521", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065227"}, {"RECTYPE": "D", "MH": "Non-Randomized Controlled Trials as Topic", "AQ": "AE CL EC ES HI IS LJ MO MT NU PX SN ST TD VE", "ENTRY": "Trials, Nonrandomized Clinical", "MN": "N06.850.520.450.250.250.365.250", "FX": "Randomized Controlled Trials as Topic", "MH_TH": "NLM (2015)", "ST": "T081", "PI": "Clinical Trials as Topic (1987-2014)", "MS": "Works about a study where participants are assigned to a treatment, procedure, or intervention by methods that are not random. Non-randomized clinical trials are sometimes referred to as quasi-experimental clinical trials or non-equivalent control group designs.", "PM": "2015", "HN": "2015", "MR": "20180629", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065228"}, {"RECTYPE": "D", "MH": "Culturally Competent Care", "AQ": "CL EC EH ES HI LJ MT OG SN ST TD", "PRINT ENTRY": "Culturally Sensitive Care|T058|NON|NRW|OBSSR (2022)|210608|abcdef", "ENTRY": "Culturally Sensitive Cares", "MN": "N05.300.206", "FX": "Cultural Competency", "MH_TH": "NLM (2015)", "ST": "T080", "AN": "coordinate with SOCIAL DETERMINANTS OF HEALTH", "PI": "Clinical Competence (1994-2014)", "MS": "Health care services that are respectful of and responsive to the health beliefs, practices and cultural and linguistic needs of diverse patients. The provider and the patient each bring their individual learned patterns of language and culture to the health care experience which must be transcended to achieve equal access and quality health care.", "PM": "2015", "HN": "2015", "MR": "20220713", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065246"}, {"RECTYPE": "D", "MH": "Frankincense", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Olibanum|T109|T123|NON|EQV|NLM (2002)|010425|abbcdef", "ENTRY": "Resin, Olibanum", "MN": "D20.215.721.500.354", "MH_TH": "NLM (2002)", "ST": "T123", "RN": "R9XLF1R1WM", "PI": "Boswellia (2002-2014)", "MS": "Resin exudate from certain trees of the genus BOSWELLIA in the BURSERACEAE family.", "PM": "2015; see BOSWELLIA 2002-2014", "HN": "2015; use BOSWELLIA 2002-2014", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065260"}, {"RECTYPE": "D", "MH": "Prophylactic Surgical Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Prophylactic|T061|NON|EQV|NLM (2015)|131030|abcdef", "ENTRY": "Surgical Procedure, Prophylactic", "MN": "E04.625", "FX": "Primary Prevention", "MH_TH": "NLM (2015)", "ST": "T061", "AN": "coordinate with specific surgical procedure and specific disease /prev", "MS": "Surgical procedures done to prevent or reduce the risk of developing cancer or other disease conditions in persons who may be predisposed to such conditions.", "PM": "2015", "HN": "2015", "MR": "20140624", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065286"}, {"RECTYPE": "D", "MH": "Robotic Surgical Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "PRINT ENTRY": "Surgical Procedures, Robotic|T061|NON|EQV|NLM (2015)|131030|abcdef", "ENTRY": "Surgical Procedure, Robotic", "MN": "J01.897.104.834.500", "MH_TH": "NLM (2015)", "ST": "T061", "PI": "Robotics (1998-2014)", "MS": "Surgical procedures performed remotely using a computer that controls surgical instruments attached to mechanical arms designed to perform the tasks of the surgeon.", "PM": "2015", "HN": "2015", "MR": "20200722", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065287"}, {"RECTYPE": "D", "MH": "Serogroup", "ENTRY": "Serovars", "MN": "G05.695.825", "FX": "Serotyping", "MH_TH": "NLM (2015)", "ST": "T032", "AN": "SEROTYPING is also available", "MS": "A set of variants within a species of microorganisms that are antigenically, closely related. With bacteria, a serogroup refers to a group that shares a common antigen.", "PM": "2015", "HN": "2015", "MR": "20140606", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065288"}, {"RECTYPE": "D", "MH": "Pedicle Screws", "AQ": "AE CL EC ES HI MI PS PX SD SN ST TD VE VI", "ENTRY": "Screws, Pedicle", "MN": "E07.858.690.725.460.437.500", "MH_TH": "NLM (2015)", "ST": "T074", "PI": "Bone Screws (1986-2014)", "MS": "BONE SCREWS to be used in the pedicle of the vertebral arch.", "PM": "2015", "HN": "2015", "MR": "20140606", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065289"}, {"RECTYPE": "D", "MH": "Acute-On-Chronic Liver Failure", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Liver Failure, Acute-On-Chronic|T047|NON|EQV|NLM (2015)|131031|abcdef", "ENTRY": "Liver Failures, Acute-On-Chronic (ACLF)", "MN": "C06.552.308.500.750.249", "MH_TH": "NLM (2015)", "ST": "T047", "PI": "Liver Failure, Acute (1995-2014)", "MS": "Sudden liver failure in the presence of underlying compensated chronic LIVER DISEASE (e.g., LIVER CIRRHOSIS; HEPATITIS; and liver injury and failure) due to a precipitating acute hepatic insult.", "PM": "2015", "HN": "2015", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065290"}, {"RECTYPE": "D", "MH": "Corneal Injuries", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Corneal Abrasions|T037|NON|NRW|NLM (2020)|190215|abcdef", "ENTRY": "Trauma, Corneal", "MN": "C26.915.300.425.250.124", "FX": "Cicatrix", "MH_TH": "NLM (2015)", "ST": "T037", "MS": "Damage or trauma inflicted to the CORNEA by external means.", "PM": "2015", "HN": "2015", "MR": "20190429", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065306"}, {"RECTYPE": "D", "MH": "Morphological and Microscopic Findings", "MN": "C23.149", "MH_TH": "NLM (2015)", "ST": "T033", "AN": "INDEXER: Do not use", "MS": "Morphological findings useful in differentiation and classification of results in CYTODIAGNOSIS and related techniques.", "PM": "2015", "HN": "2015", "MR": "20150605", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065308"}, {"RECTYPE": "D", "MH": "Atypical Squamous Cells of the Cervix", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "PRINT ENTRY": "Atypical Squamous Cells|T033|NON|REL|NLM (2015)|131122|abcdef", "ENTRY": "Squamous Cells, Atypical", "MN": "C23.149.500", "MH_TH": "NLM (2015)", "ST": "T033", "PI": "Epithelial Cells (1997-2014)", "MS": "Morphological abnormalities of the cervical EPITHELIUM, usually revealed in PAP SMEAR, which do not meet the criteria for squamous CERVICAL INTRAEPITHELIAL NEOPLASIA or SQUAMOUS CELL CARCINOMAS of the CERVIX . It may be a sign of infection with certain types of human papillomavirus (HPV).or sign of a benign (not cancer) growth, such as a cyst or polyp or, in menopausal women, of low hormone levels. More testing, such as HPV test, may be needed.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065309"}, {"RECTYPE": "D", "MH": "Squamous Intraepithelial Lesions of the Cervix", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "MN": "C23.149.688.500", "MH_TH": "NLM (2015)", "ST": "T033", "PI": "Epithelial Cells (1996-2014)", "MS": "A cytological test finding often from PAP SMEARS that shows abnormal lesions of SQUAMOUS EPITHELIAL CELLS of the CERVIX. It is a diagnostic criterion used in the Bethesda System for UTERINE CERVICAL NEOPLASMS and represents the PAP TEST result that is abnormal. Although squamous intraepithelial lesions test result does not mean UTERINE CERVICAL NEOPLASMS it requires follow-ups (e.g., HPV DNA TESTS; and COLPOSCOPY).", "PM": "2015", "HN": "2015", "MR": "20211018", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065310"}, {"RECTYPE": "D", "MH": "Adenocarcinoma in Situ", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UL UR VE VI", "ENTRY": "in Situ, Adenocarcinoma", "MN": "C23.149.249", "MH_TH": "NLM (2015)", "ST": "T191", "PI": "Carcinoma in Situ (1972-2014)", "MS": "A lesion with cytological characteristics associated with invasive adenocarcinoma but the tumor cells are confined to the GLANDULAR EPITHELIAL CELLS of origin. Adenocarcinoma in situ of the CERVIX and the LUNG are the most common.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065311"}, {"RECTYPE": "D", "MH": "Children's Health Insurance Program", "AQ": "CL EC ES HI LJ OG SN ST TD", "MN": "N03.349.650.480.500", "MH_TH": "NLM (2016)", "ST": "T058", "AN": "CATALOGER: Use NAF entry", "MS": "Federal program, enacted in 1997, for the funding of children's health insurance coverage at the state level for low-income families, affording them effective protection against erosions in employer sponsored coverage.", "PM": "2016", "HN": "2016", "MR": "20150707", "DA": "20150709", "DC": "1", "DX": "20160101", "UI": "D065326"}, {"RECTYPE": "D", "MH": "Circuit-Based Exercise", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Training, Circuit", "MN": "I03.350.311.125", "FX": "Exercise Therapy", "MH_TH": "NLM (2015)", "ST": "T061", "MS": "Alternating sets of exercise that work out different muscle groups and that also alternate between aerobic and anaerobic exercises, which, when combined together, offer an overall program to improve strength, stamina, balance, or functioning.", "PM": "2015", "HN": "2015", "MR": "20180629", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065327"}, {"RECTYPE": "D", "MH": "Lubricant Eye Drops", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "PRINT ENTRY": "Tears, Artificial|T121|NON|EQV|NLM (1993)|911023|abcdef", "ENTRY": "Tear, Artificial", "MN": "D27.720.752.608.500", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Ophthalmic Solutions (1967-2014)", "MS": "Ophthalmic solutions that include LUBRICANTS and WETTING AGENTS such as POLYETHYLENE GLYCOL; HYPROMELLOSE; GLYCEROL; PROPYLENE GLYCOL. They are used to treat conditions caused by deficient tear production such as DRY EYE SYNDROME.", "PM": "2015; for TEARS, ARTIFICIAL see OPHTHALMIC SOLUTIONS 1992-2014", "HN": "2015; for TEARS, ARTIFICIAL use OPHTHALMIC SOLUTIONS 1992-2014", "MR": "20200527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065346"}, {"RECTYPE": "D", "MH": "Hypromellose Derivatives", "AQ": "AD AE AN CH CL CS EC HI IP ME PD PK PO RE SD ST TO TU", "ENTRY": "K 8515", "MN": "J01.637.051.720.099.500.719", "MH_TH": "NLM (2015)", "ST": "T130", "RN": "3NXW29V3WO", "RR": "9004-65-3", "MS": "Polymeric compounds that contain repeating units of hydroxypropyl methylcellulose. The properties of hypromellose polymers can vary greatly and are defined by their molecular weight, the percentage of hydroxyl groups, the percentage of hydroxypropyl groups, and viscosity measurements. They are found a broad variety of commercial products such as FOOD ADDITIVES; EXCIPIENTS; and LUBRICANTS.", "PM": "2015; HYPROMELLOSE DERIVATIVES was indexed under METHYLCELLULOSE/AA 1977-2014; ALCOHOL, PROPYL/AA 1975-1976; METHYLCELLULOSE 1973-1975; and ALCOHOL, PROPYL 1973-1975", "HN": "2015", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065347"}, {"RECTYPE": "D", "MH": "Macular Pigment", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Pigment, Macular", "MN": "D23.767.261.887.625", "MH_TH": "NLM (2015)", "ST": "T123", "RN": "0", "PI": "Retinal Pigments (1971-2014)", "MS": "A yellow pigment that accumulates in the MACULA LUTEA. It is composed of LUTEIN, meso-zeaxanthin, and ZEAXANTHIN.", "PM": "2015", "HN": "2015", "MR": "20140606", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065348"}, {"RECTYPE": "D", "MH": "Cryptoxanthins", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Beta Caroten 3 ol", "MN": "D23.767.261.887.374", "MH_TH": "NLM (2015)", "ST": "T127", "RN": "0", "RR": "472-70-8 (cryptoxanthin)", "PI": "Xanthophylls (1984-2014)", "MS": "Mono-hydroxylated xanthophylls formed from the hydroxylation of BETA-CAROTENE. Isomers include: beta-cryptoxanthin, alpha-cryptoxanthin, and zeinoxanthin. The alpha- and beta-cryptoxanthin are provitamin A precursors.", "PM": "2015; CRYPTOXANTHIN was indexed under XANTHOPHYLLS 1975-2014", "HN": "2015", "MR": "20160630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065366"}, {"RECTYPE": "D", "MH": "Historically Controlled Study", "AQ": "CL EC ES HI IS LJ MT SD SN ST TD", "ENTRY": "Study, Historically Controlled", "MN": "E05.318.372.500.912", "MH_TH": "NLM (2015)", "ST": "T081", "MS": "A study that compares a group of participants receiving an intervention with a similar group from the past who did not.", "PM": "2015", "HN": "2015", "MR": "20180629", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065386"}, {"RECTYPE": "D", "MH": "Laminoplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Laminoplasties", "MN": "E04.525.475", "MH_TH": "NLM (2015)", "ST": "T061", "PI": "Laminectomy (1983-2014)", "MS": "A surgical procedure performed on selected pairs of vertebral lamina to relieve pressure on the SPINAL CORD and which also allows for osteoplastic enlargement of the SPINAL CANAL.", "PM": "2015", "HN": "2015", "MR": "20170711", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065406"}, {"RECTYPE": "D", "MH": "Cytoreduction Surgical Procedures", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Surgical Procedures, Cytoreductive", "MN": "E04.166", "MH_TH": "NLM (2015)", "ST": "T061", "MS": "Operative procedures carried out to reduce a mass of tissue, for example, to reduce the total amount of tissue composing a tumor.", "PM": "2015", "HN": "2015", "MR": "20170620", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065426"}, {"RECTYPE": "D", "MH": "Factor Xa Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Factor Xa Inhibitor|T121|NON|EQV|NLM (2021)|191115|abcdef", "ENTRY": "Xa Inhibitor, Factor", "MN": "D27.505.954.502.119.500.500", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Factor Xa/antagonists & inhibitors (1990-2014)", "MS": "Endogenous factors and drugs that inhibit or block the activity of FACTOR XA.", "PM": "2015", "HN": "2015", "MR": "20200527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065427"}, {"RECTYPE": "D", "MH": "Premenstrual Dysphoric Disorder", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VI", "ENTRY": "Syndrome, Premenstrual Dysphoric", "MN": "F03.600.300.550", "MH_TH": "NLM (2015)", "ST": "T047", "PI": "Premenstrual Syndrome (1987-2014)", "MS": "A condition in which a woman suffers from severe depression, irritability, and tension before MENSTRUATION. Premenstrual dysphoric disorder (PMDD) may involve a wide range of physical or emotional symptoms, which are more severe and debilitating than those seen with premenstrual syndrome (PMS), and which include at least one mood-related symptom. Symptoms usually stop when, or shortly after, menstruation begins.", "PM": "2015", "HN": "2015", "MR": "20150708", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065446"}, {"RECTYPE": "D", "MH": "Practice Management, Veterinary", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Veterinary Practice Management", "MN": "N04.452.758.708.525", "FX": "Hospitals, Animal", "MH_TH": "NLM (2015)", "ST": "T058", "PI": "Veterinary Medicine (1964-2014)", "MS": "The organization and operation of the business aspects of a veterinary practice.", "PM": "2015", "HN": "2015", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065447"}, {"RECTYPE": "D", "MH": "Lysholm Knee Score", "AQ": "CL EC SN ST", "ENTRY": "Activity Score, Tegner", "MN": "N05.715.360.575.575.399.500", "FX": "Treatment Outcome", "MH_TH": "NLM (2015)", "ST": "T170", "MS": "An instrument used to assess the results of rehabilitation from knee injuries, especially those requiring ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION. It measures recovery of knee joint function based on ACTIVITIES OF DAILY LIVING.", "PM": "2015", "HN": "2015", "MR": "20180629", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065466"}, {"RECTYPE": "D", "MH": "Transcatheter Aortic Valve Replacement", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Transcatheter Aortic Valve Implantation|T061|NON|EQV|NLM (2015)|131217|abcdef", "MN": "E04.928.220.410.500", "MH_TH": "NLM (2015)", "ST": "T061", "PI": "Heart Valve Prosthesis Implantation (2008-2014)", "MS": "Surgical treatment for severe AORTIC VALVE STENOSIS. Transcatheter aortic valve replacement (TAVR) is used as an alternative option in patients who are deemed at high risk or inoperable for traditional open-heart surgery.", "PM": "2015", "HN": "2015", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065467"}, {"RECTYPE": "D", "MH": "Dasyproctidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Brazilian Agouti", "MN": "B01.050.150.900.649.313.992.419", "MH_TH": "NLM (2015)", "ST": "T015", "RN": "txid30646", "RR": "txid43318", "AN": "do not confuse entry term Agoutis with AGOUTIDAE see CUNICULIDAE", "PI": "Rodentia (1967-2014)", "MS": "A family of Central and South American plant-eating rodents comprising the agoutis (Dasyprocta) and acouchis (Myoprocta). They look similar to guinea pigs (CAVIA) but are larger and have longer legs. Their fur is reddish or dark brown.", "PM": "2015", "HN": "2015", "MR": "20200813", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065468"}, {"RECTYPE": "D", "MH": "Cuniculidae", "AQ": "AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI", "ENTRY": "Pacas, Lowland", "MN": "B01.050.150.900.649.313.992.373", "MH_TH": "NLM (2015)", "ST": "T015", "RN": "txid723806", "RR": "txid723807", "AN": "do not confuse entry term AGOUTIDAE with AGOUTIS see DASYPROCTIDAE", "PI": "Rodentia (1970-2014)", "MS": "A family of large (20 to 30 inches long) plant eating rodents found in Central and South America. They are nearly tailless and have chunky bodies, dark brown fur with spotted lines along their sides and back, with stout legs and hind limbs that are longer than the forelimbs, and a large, square head with short ears.", "PM": "2015", "HN": "2015", "MR": "20200813", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065469"}, {"RECTYPE": "D", "MH": "Vascular Closure Devices", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Vascular Closure Device", "MN": "E07.858.690.930", "FX": "Hemostatics", "MH_TH": "NLM (2015)", "ST": "T074", "MS": "Products used to seal the openings in BLOOD VESSELS from incisions or punctures made during ENDOVASCULAR PROCEDURES.", "PM": "2015", "HN": "2015", "MR": "20140606", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065506"}, {"RECTYPE": "D", "MH": "Vancomycin-Resistant Enterococci", "AQ": "CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI", "PRINT ENTRY": "Vancomycin Resistant Enterococci|T007|NON|EQV|NLM (2015)|131220|abcdef", "MN": "B03.510.550.250.250.650", "FX": "Vancomycin Resistance", "MH_TH": "NLM (2015)", "ST": "T007", "AN": "coordinate with species of Enterococcus if relevant", "PI": "Vancomycin Resistance (1999-2014)", "MS": "Strains of the genus Enterococcus that are resistant to the antibiotic VANCOMYCIN. The enterococci become resistant by acquiring plasmids carrying genes for VANCOMYCIN RESISTANCE.", "PM": "2015", "HN": "2015", "MR": "20200902", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065507"}, {"RECTYPE": "D", "MH": "Diving Reflex", "AQ": "DE ES GE IM PH RE", "ENTRY": "Reflex, Mammalian Diving", "MN": "G11.561.731.189", "MH_TH": "NLM (2015)", "ST": "T040", "PI": "Reflex (1967-2014)", "MS": "BREATH HOLDING; VASOCONSTRICTION; and a drop in HEART RATE in response to submersion of the face in cold water.", "PM": "2015", "HN": "2015", "MR": "20160622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065508"}, {"RECTYPE": "D", "MH": "Acetabuloplasty", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Acetabuloplasties", "MN": "E04.617.038", "FX": "Arthroplasty", "MH_TH": "NLM (2015)", "ST": "T061", "PI": "Acetabulum/surgery (2014)", "MS": "Surgical reconstruction of the ACETABULUM.", "PM": "2015", "HN": "2015", "MR": "20220406", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065526"}, {"RECTYPE": "D", "MH": "Brachial Plexus Block", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Plexus Blockades, Brachial", "MN": "E03.155.086.711.649", "FX": "Brachial Plexus", "MH_TH": "NLM (2015)", "ST": "T061", "PI": "Brachial Plexus (1963-2014)", "MS": "A blocking of NEURAL CONDUCTION in the network of nerve fibers innervating the UPPER EXTREMITY.", "PM": "2015", "HN": "2015", "MR": "20140606", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065527"}, {"RECTYPE": "D", "MH": "Drug Liberation", "AQ": "DE GE IM PH RE", "ENTRY": "Release, Drug", "MN": "G07.690.725.321", "FX": "Solubility", "MH_TH": "NLM (2015)", "ST": "T070", "MS": "Release of drugs from DOSAGE FORMS into solution.", "PM": "2015", "HN": "2015", "MR": "20160623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065546"}, {"RECTYPE": "D", "MH": "Subcutaneous Absorption", "AQ": "DE GE IM PH RE", "ENTRY": "Absorption, Subcutaneous", "MN": "G07.690.725.015.500.875", "FX": "Injections, Subcutaneous", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Absorption or specifics (1964-2014)", "MS": "The uptake of substances via the SUBCUTANEOUS TISSUE.", "PM": "2015", "HN": "2015", "MR": "20160701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065566"}, {"RECTYPE": "D", "MH": "Absorption, Physiological", "AQ": "DE GE IM PH RE", "ENTRY": "Systemic Absorption|T042|NON|NRW|NLM (2015)|131230|abcdef", "MN": "G07.690.725.015.500", "FX": "Absorption, Physicochemical", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Absorption (1963-2014)", "MS": "Uptake of substances by the body, tissues, or cells. The uptake may occur by various forms of BIOLOGICAL TRANSPORT or by simple DIFFUSION.", "PM": "2015", "HN": "2015", "MR": "20160502", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065567"}, {"RECTYPE": "D", "MH": "Oral Mucosal Absorption", "AQ": "DE GE IM PH RE", "ENTRY": "Mucosal Absorption, Oral", "MN": "G10.261.353.650", "FX": "Administration, Sublingual", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Absorption (1980-2014)", "MS": "Uptake of substances into the body via the mucosal surfaces (MUCOUS MEMBRANE) of the oral cavity.", "PM": "2015", "HN": "2015", "MR": "20160701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065568"}, {"RECTYPE": "D", "MH": "Gastrointestinal Absorption", "AQ": "DE GE IM PH RE", "ENTRY": "Absorption, Gut", "MN": "G10.261.353", "FX": "Administration, Oral", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Intestinal Absorption (1964-2014)", "MS": "Uptake of substances via the GASTROINTESTINAL TRACT.", "PM": "2015", "HN": "2015", "MR": "20160623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065569"}, {"RECTYPE": "D", "MH": "Gastric Absorption", "AQ": "DE GE IM PH RE", "ENTRY": "Stomach Absorptions", "MN": "G10.261.353.249", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Absorption (1963-2014)", "MS": "Uptake of substances via the stomach.", "PM": "2015", "HN": "2015", "MR": "20160623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065570"}, {"RECTYPE": "D", "MH": "Intramuscular Absorption", "AQ": "DE GE IM PH RE", "ENTRY": "Absorption, Intramuscular", "MN": "G11.427.325", "FX": "Injections, Intramuscular", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Absorption (1972-2014)", "MS": "Uptake of substances via muscle tissue.", "PM": "2015", "HN": "2015", "MR": "20160630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065586"}, {"RECTYPE": "D", "MH": "Ocular Absorption", "AQ": "DE GE IM PH RE", "ENTRY": "Absorption, Ophthalmic", "MN": "G14.590", "FX": "Injections, Intraocular", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Absorption (1966-2014)", "MS": "Uptake of substances by tissues of the eye.", "PM": "2015", "HN": "2015", "MR": "20160630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065587"}, {"RECTYPE": "D", "MH": "Nasal Absorption", "AQ": "DE GE IM PH RE", "ENTRY": "Absorption, Nasal", "MN": "G09.772.813.500", "FX": "Administration, Intranasal", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Absorption (1969-2014)", "MS": "Uptake of substances through the nasal mucosa.", "PM": "2015", "HN": "2015", "MR": "20160630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065588"}, {"RECTYPE": "D", "MH": "Respiratory Tract Absorption", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Respiratory System Absorption|T042|NON|EQV|NLM (2023)|220712|abcdef", "ENTRY": "Respiratory System Absorptions", "MN": "G09.772.813", "FX": "Administration, Inhalation", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Absorption (1985-2014)", "MS": "Uptake of substances via the RESPIRATORY SYSTEM.", "PM": "2015", "HN": "2015", "MR": "20220712", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065589"}, {"RECTYPE": "D", "MH": "Rectal Absorption", "AQ": "DE GE IM PH RE", "ENTRY": "Absorption, Rectal", "MN": "G10.261.353.825", "FX": "Suppositories", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Intestinal Absorption (1965-2014)", "MS": "Uptake of substances from the RECTUM.", "PM": "2015", "HN": "2015", "MR": "20160701", "DA": "20140704", "DC": "1", "DX": "20150101", "UI": "D065590"}, {"RECTYPE": "D", "MH": "Metabolic Side Effects of Drugs and Substances", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Substance Effects on Metabolism|T121|NON|NRW|NLM (2015)|140103|abcdef", "MN": "D27.505.389", "FX": "Herb-Drug Interactions", "MH_TH": "NLM (2015)", "ST": "T169", "RN": "0", "AN": "used for searching; INDEXER: Do not use; CATALOGER: Do not use", "PI": "Drug-Related Side Effects and Adverse Reactions (2013-2014)", "MS": "Specific effects of drugs and substances on metabolic pathways such as those occurring through the CYTOCHROME P-450 ENZYME SYSTEM. These include effects that often result in DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; and HERB-DRUG INTERACTIONS.", "PM": "2015", "HN": "2015", "MR": "20150605", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065606"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 Enzyme Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "P-450 Inhibitors, Cytochrome", "MN": "D27.505.519.389.335", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "AN": "general or unspecified; note specifics treed here", "PI": "Cytochrome P-450 Enzyme System/antagonists & inhibitors (1973-2014)", "MS": "Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065607"}, {"RECTYPE": "D", "MH": "Renal Reabsorption", "AQ": "DE GE IM PH RE", "ENTRY": "Reabsorption, Tubule", "MN": "G08.852.536.500", "MH_TH": "NLM (2015)", "ST": "T039", "MS": "The reuptake of water, ELECTROLYTES, and other substances by the KIDNEY to the blood supply.", "PM": "2015", "HN": "2015", "MR": "20160701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065608"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP1A2 Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inhibitors, P450 CYP1A2", "MN": "D27.505.519.389.335.120", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 CYP1A2/antagonists & inhibitors (1997-2014)", "MS": "Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP1A2.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065609"}, {"RECTYPE": "D", "MH": "Non-alcoholic Fatty Liver Disease", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Steatohepatitis, Nonalcoholic", "MN": "C06.552.241.519", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Fatty Liver (2001-2014)", "MS": "Fatty liver finding without excessive ALCOHOL CONSUMPTION.", "PM": "2015; see Fatty Liver 2010-2014", "HN": "2015; use Fatty Liver 2010-2014", "MR": "20140611", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065626"}, {"RECTYPE": "D", "MH": "Familial Primary Pulmonary Hypertension", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pulmonary Hypertension, Primary", "MN": "C08.381.423.300", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Hypertension, Pulmonary (1966-2014)", "MS": "Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.", "PM": "2015; see HYPERTENSION, PULMONARY 2010-2014", "HN": "2015; use HYPERTENSION, PULMONARY 2010-2014", "MR": "20181010", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065627"}, {"RECTYPE": "D", "MH": "Intestinal Reabsorption", "AQ": "DE EH GE IM PH RE", "PRINT ENTRY": "Enterohepatic Reabsorption|T042|NON|EQV|NLM (2015)|140228|abcdef", "ENTRY": "Reabsorptions, Enterohepatic", "MN": "G10.261.353.500.500", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Intestinal Absorption (1968-2014)", "MS": "The re-uptake of substances in the intestines after their prior absorption from the intestines into the PORTAL SYSTEM and reintroduction into the intestines as substances accumulated in the BILE.", "PM": "2015", "HN": "2015", "MR": "20160630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065628"}, {"RECTYPE": "D", "MH": "Peritoneal Absorption", "AQ": "DE GE IM PH RE", "ENTRY": "Peritoneal Absorptions", "MN": "G07.690.725.015.500.667", "FX": "Injections, Intraperitoneal", "MH_TH": "NLM (2015)", "ST": "T042", "MS": "Uptake of substances from the PERITONEAL CAVITY.", "PM": "2015", "HN": "2015", "MR": "20160701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065629"}, {"RECTYPE": "D", "MH": "Hernias, Diaphragmatic, Congenital", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Morgagni's Hernia|T047|T190|NON|NRW|NLM (2021)|200312|abbcdef", "ENTRY": "Morgagnis Hernias", "MN": "C23.300.707.960.500.116", "MH_TH": "NLM (2015)", "ST": "T019", "MS": "Protrusion of abdominal structures into the THORAX as a result of embryologic defects in the DIAPHRAGM often present in the neonatal period. It can be isolated, syndromic, non-syndromic or be a part of chromosome abnormality. Associated pulmonary hypoplasia and PULMONARY HYPERTENSION can further complicate stabilization and surgical intervention.", "PM": "2015; see HERNIA, DIAPHRAGMATIC 2010-2014", "HN": "2015; use HERNIA, DIAPHRAGMATIC 2010-2014", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065630"}, {"RECTYPE": "D", "MH": "Rhinitis, Allergic", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Allergic Rhinitis|T047|NON|EQV|OMIM (2013)|111115|abcdef", "ENTRY": "Rhinitides, Allergic", "MN": "C20.543.480.680.443", "MH_TH": "NLM (2015)", "ST": "T047", "MS": "An inflammation of the NASAL MUCOSA triggered by ALLERGENS.", "PM": "2015", "HN": "2015", "MR": "20140624", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065631"}, {"RECTYPE": "D", "MH": "Chikungunya Fever", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI", "ENTRY": "Infection, Chikungunya Virus", "MN": "C01.925.782.930.100.184", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Arbovirus Infections (1965-2014)", "MS": "An acute infection caused by a mosquito-borne alphavirus CHIKUNGUNYA VIRUS characterized by RASH; FEVER; JOINT PAINS; CONJUNCTIVITIS; MENINGOENCEPHALITIS; LYMPHOPENIA; and THROMBOCYTOPENIA.", "PM": "2015; see under CHIKUNGUNYA FEVER 2010-2014", "HN": "2015; use under CHIKUNGUNYA FEVER 2010-2014", "MR": "20230601", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065632"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP1B1", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "P450 CYP1B1, Cytochrome", "MN": "D12.776.422.220.453.100.875", "MH_TH": "NLM (2015)", "ST": "T126", "RN": "EC 1.14.14.1", "RR": "156320-24-0", "AN": "/antag: coordinate with CYTOCHROME P-450 ENZYME INHIBITORS", "MS": "A cytochrome P450 aryl hydrocarbon hydroxylase that has specificity for ESTROGENS which it converts into 4-hydroxy estrogens. CYP1B1 has been shown to be physiologically important for FETAL DEVELOPMENT with mutations in the CYP1B1 gene resulting in congenital forms of GLAUCOMA and Peter's anomaly.", "PM": "2015; CYTOCHROME P-450 CYPB1 was indexed under ARYL HYDROCARBON HYDROXYLASES 1995-2014", "HN": "2015", "MR": "20160527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065633"}, {"RECTYPE": "D", "MH": "Cerebrospinal Fluid Leak", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Spinal Cerebrospinal Fluid Leak, Post Traumatic", "MN": "C26.915.300.225", "MH_TH": "ORD (2010)", "ST": "T047", "PI": "Cerebrospinal Fluid Rhinorrhea (1972-2014)", "MS": "Discharge of cerebrospinal fluid through a hole through the skull bone most commonly draining from the nose (CEREBROSPINAL FLUID RHINORRHEA) or the ear (CEREBROSPINAL FLUID OTORRHEA).", "PM": "2015; see CEREBROSPINAL FLUID RHINORRHEA 2010-2014", "HN": "2015; use CEREBROSPINAL FLUID RHINORRHEA 2010-2014", "MR": "20150622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065634"}, {"RECTYPE": "D", "MH": "Benign Paroxysmal Positional Vertigo", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Benign Recurrent Vertigo|T047|NON|EQV|NLM (2015)|140108|abcdef", "ENTRY": "Vestibulopathies, Familial", "MN": "C23.888.592.958.500", "FX": "Vestibular Neuronitis", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Idiopathic recurrent VERTIGO associated with POSITIONAL NYSTAGMUS. It is associated with a vestibular loss without other neurological or auditory signs. Unlike in LABYRINTHITIS and VESTIBULAR NEURONITIS, inflammation in the ear is not observed.", "PM": "2015; see Vertigo 2010-2014", "HN": "2015; use Vertigo 2010-2014", "MR": "20160610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065635"}, {"RECTYPE": "D", "MH": "Myotonin-Protein Kinase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Protein, MDPK", "MN": "D12.776.476.563.576", "FX": "Myotonic Dystrophy", "MH_TH": "NLM (2015)", "ST": "T126", "RN": "EC 2.7.11.1", "MS": "Serine/threonine protein kinase responsible for various SKELETAL MUSCLE functions; HEART CONDUCTION SYSTEM activity; calcium HOMEOSTASIS; calcium uptake by SARCOPLASMIC RETICULUM and SYNAPTIC PLASTICITY. It is encoded by the DMPK gene and its abnormal EXPANDED TRINUCLEOTIDE REPEAT of CTG in the 3'-UTR is associated with MYOTONIC DYSTROPHY 1.", "PM": "2015", "HN": "2015", "MR": "20210521", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065636"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2A6", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "Cytochrome P-450 CYP-2A3|T116|T126|NON|EQV|NLM (2015)|140108|abbcdef", "ENTRY": "P450 CYP2A6, Cytochrome", "MN": "D12.776.422.220.453.491.250", "MH_TH": "NLM (2015)", "ST": "T126", "RN": "EC 1.14.14.1", "MS": "A cytochrome P450 enzyme that has specificity for the 7-hydroxylation of coumarin.", "PM": "2015; CYTOCHROME P-450 CYP2A6 was indexed under ARYL HYDROCARBON HYDROXYLASES 1970-2014", "HN": "2015", "MR": "20160628", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065637"}, {"RECTYPE": "D", "MH": "Absorption, Radiation", "AQ": "DE GE IM PH RE", "ENTRY": "Radiation Absorption|T070|NON|EQV|NLM (2015)|140108|abcdef", "MN": "G02.010.500.500", "FX": "X-Ray Absorption Spectroscopy", "MH_TH": "NLM (2015)", "ST": "T070", "AN": "coordinate with specific type of radiation if pertinent", "MS": "The uptake or transfer of energy from RADIATION.", "PM": "2015", "HN": "2015", "MR": "20160115", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065638"}, {"RECTYPE": "D", "MH": "Thyroid Carcinoma, Anaplastic", "AQ": "BL BS CF CH CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SC SU TH UL UR VE VI", "ENTRY": "Thyroid Carcinomas, Anaplastic", "MN": "C04.557.470.200.725", "MH_TH": "ORD (2010)", "ST": "T191", "AN": "coordinate IM with THYROID NEOPLASMS (IM)", "PI": "Thyroid Neoplasms (2010-2014)", "MS": "An aggressive THYROID GLAND malignancy which generally occurs in IODINE-deficient areas in people with previous thyroid pathology such as GOITER. It is associated with CELL DEDIFFERENTIATION of THYROID CARCINOMA (e.g., FOLLICULAR THYROID CARCINOMA; PAPILLARY THYROID CANCER). Typical initial presentation is a rapidly growing neck mass which upon metastasis is associated with DYSPHAGIA; NECK PAIN; bone pain; DYSPNEA; and NEUROLOGIC DEFICITS.", "PM": "2015; see THYROID NEOPLASMS 2010-2014", "HN": "2015 (2010); use Thyroid Neoplasms 2010-2014", "MR": "20190701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065646"}, {"RECTYPE": "D", "MH": "Mesenteric Ischemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Venous Thrombosis, Mesenteric", "MN": "C14.907.549", "FX": "Superior Mesenteric Artery Syndrome", "MH_TH": "NLM (2015)", "ST": "T047", "PI": "Mesenteric Vascular Occlusion (1964-2014)", "MS": "Ischemic tissue injury produced by insufficient perfusion of intestinal tissue by the MESENTERIC CIRCULATION (i.e., CELIAC ARTERY; SUPERIOR MESENTERIC ARTERY; INFERERIOR MESENTERIC ARTERY; and MESENTERIC VEINS). It can progress from ISCHEMIA; EDEMA; and GANGRENE of the bowel wall to PERITONITIS and cardiovascular collapse.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065666"}, {"RECTYPE": "D", "MH": "Renal Elimination", "AQ": "DE GE IM PH RE", "ENTRY": "Excretion, Renal", "MN": "G08.852.761", "FX": "Metabolic Clearance Rate", "MH_TH": "NLM (2015)", "ST": "T042", "MS": "The discharge of substances from the blood supply via the URINARY TRACT.", "PM": "2015", "HN": "2015", "MR": "20200609", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065667"}, {"RECTYPE": "D", "MH": "Vitamin D3 24-Hydroxylase", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "alpha,25-Dihydroxycholecalciferol-24-Hydroxylase, 1", "MN": "D12.776.422.220.453.496.500", "MH_TH": "NLM (2015)", "ST": "T126", "RN": "EC 1.14.15.16", "MS": "A cytochrome P-450 enzyme that has specificity for CHOLECALCIFEROL (Vitamin D3). It hydroxylates the molecule at carbon position 24.", "PM": "2015; VITAMIN D3 24-HYDROXYLASE was indexed under STEROID HYDROXYLASES 1978-2014", "HN": "2015 (1978)", "MR": "20160601", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065668"}, {"RECTYPE": "D", "MH": "Hepatobiliary Elimination", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Biliary Elimination|T042|NON|NRW|NLM (2015)|140110|abcdef", "ENTRY": "Excretion, Hepatobiliary", "MN": "G10.261.375", "FX": "Metabolic Clearance Rate", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Bile (1963-2014)", "MS": "The removal of substances from the blood supply via the LIVER and BILIARY TRACT.", "PM": "2015", "HN": "2015", "MR": "20200609", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065669"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2B6 Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inhibitors, P450 CYP2B6", "MN": "D27.505.519.389.335.260", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 Enzyme System/antagonists & inhibitors (1973-2014)", "MS": "Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2B6.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065686"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2C8 Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inhibitors, P450 CYP2C8", "MN": "D27.505.519.389.335.308", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 Enzyme System/antagonists & inhibitors (1973-2014)", "MS": "Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C8.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065687"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2C9 Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inhibitors, P450 CYP2C9", "MN": "D27.505.519.389.335.329", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 Enzyme System/antagonists & inhibitors (1973-2014)", "MS": "Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C9.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065688"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2C19 Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inhibitors, P450 CYP2C19", "MN": "D27.505.519.389.335.319", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 Enzyme System/antagonists & inhibitors (1973-2014)", "MS": "Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C19.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065689"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2D6 Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "CYP2D6 Inhibitor|T121|NON|EQV|NLM (2022)|201015|abcdef", "ENTRY": "Inhibitors, P450 CYP2D6", "MN": "D27.505.519.389.335.368", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 Enzyme System/antagonists & inhibitors (1973-2014)", "MS": "Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2D6.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065690"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2E1 Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inhibitors, P450 CYP2E1", "MN": "D27.505.519.389.335.421", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 CYP2E1/antagonists & inhibitors (1997-2014)", "MS": "Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2E1.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065691"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP3A Inhibitors", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "P450 CYP3A7 Inhibitor|T121|NON|NRW|NLM (2021)|191121|abcdef", "ENTRY": "Inhibitors, P450 CYP3A7", "MN": "D27.505.519.389.335.503", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 CYP3A/antagonsits & inhibitors (2006-2014)", "MS": "Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A.", "PM": "2015", "HN": "2015", "MR": "20200527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065692"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 Enzyme Inducers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "P 450 Enzyme Inducers", "MN": "D27.505.519.349", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "AN": "general or unspecified;  note specifics  treed here", "PI": "Cytochrome P-450 Enzyme System (1978-2014)", "MS": "Drugs and compounds that induce the synthesis of CYTOCHROME P-450 ENZYMES.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065693"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP1A2 Inducers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inducers, P450 CYP1A2", "MN": "D27.505.519.349.120", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 CYP1A2 (1998-2014)", "MS": "Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP1A2.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065694"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2B6 Inducers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inducers, P450 CYP2B6", "MN": "D27.505.519.349.260", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 Enyzme System (1973-2014)", "MS": "Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP2B6.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065695"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2C8 Inducers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inducers, P450 CYP2C8", "MN": "D27.505.519.349.308", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 Enzyme System (1978-2014)", "MS": "Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP2C8.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065696"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2C19 Inducers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inducers, P450 CYP2C19", "MN": "D27.505.519.349.350", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 Enzyme System (1978-2014)", "MS": "Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP2C19.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065697"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2C9 Inducers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inducers, P450 CYP2C9", "MN": "D27.505.519.349.320", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 Enzyme System (1978-2014)", "MS": "Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP2C9.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065698"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2D6 Inducers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inducers, CYP2D6", "MN": "D27.505.519.349.500", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 Enzyme System (1978-2014)", "MS": "Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP2D6.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065699"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2E1 Inducers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Inducers, P450 CYP2E1", "MN": "D27.505.519.349.600", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 CYP2E1 (1997-2014)", "MS": "Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP2E1.", "PM": "2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065700"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP3A Inducers", "AQ": "AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "CYP3A4 Inducer|T121|NON|NRW|NLM (2022)|200824|abcdef", "ENTRY": "Inducers, P450 CYP3A7", "MN": "D27.505.519.349.700", "MH_TH": "NLM (2015)", "ST": "T121", "RN": "0", "PI": "Cytochrome P-450 CYP3A (2006-2014)", "MS": "Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP3A.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065701"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2B6", "DS": "CYTOCHROME P 450 CYP 002 B 006", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "P450 2B6, Cytochrome", "MN": "D12.776.422.220.453.491.344", "EC": "antagonists & inhibitors:Cytochrome P-450 CYP2B6 Inhibitors", "MH_TH": "NLM (2015)", "ST": "T126", "RN": "EC 1.14.14.1", "MS": "A cytochrome P450 enzyme subtype that oxidizes a diverse array of XENOBIOTICS. The expression of CYP2B6 varies widely between individuals which is due to the high rate of GENETIC POLYMORPHISMS.  Examples of drugs metabolized by CYP2B6 include BUPROPION; efavirenz; CYCLOPHOSPHAMIDE; and MEPERIDINE.", "PM": "2015; CYTOCHROME P-450 CYP2B6 was indexed under ARYL HYDROCARBON HYDROXYLASES 1997-2014", "HN": "2015", "MR": "20160527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065702"}, {"RECTYPE": "D", "MH": "Malformations of Cortical Development, Group I", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Malformations Secondary to Abnormal Neuronal and Glial Proliferation or Apoptosis|T019|T047|NON|EQV|NLM (2015)|140114|abbcdef", "MN": "C16.131.666.507.400", "MH_TH": "NLM (2015)", "ST": "T047", "PI": "Malformations of Cortical Development (2008-2014)", "MS": "Cortical malformations secondary to abnormal neuronal and glial CELL PROLIFERATION or APOPTOSIS in NEUROGENESIS. This group includes congenital MICROCEPHALIES; MICROLISSENCEPHALIES, megalencephalies, HEMIMEGALENCEPHALIES and cortical dysplasias with balloon cells.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065703"}, {"RECTYPE": "D", "MH": "Malformations of Cortical Development, Group III", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Malformations Secondary to Abnormal Postmigrational Development|T019|T047|NON|EQV|NLM (2015)|140114|abbcdef", "MN": "C16.131.666.507.500", "MH_TH": "NLM (2015)", "ST": "T047", "PI": "Malformations of Cortical Development (2008-2014)", "MS": "Cortical malformations secondary to abnormal cortical maturation after CELL MIGRATION in NEUROGENESIS. This group includes injury to the cortex during later stages of cortical development such as POLYMICROGYRIA and focal cortical dysplasias.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065704"}, {"RECTYPE": "D", "MH": "Hemimegalencephaly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Unilateral Megalencephalies", "MN": "C16.131.666.507.400.249.500", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "Rare MALFORMATIONS OF CORTICAL DEVELOPMENT, GROUP I characterized by the enlargement of one side of the brain. It is associated with seizures, partial paralysis, and mental retardation.", "PM": "2015; see MALFORMATIONS OF CORTICAL DEVELOPMENT 2008-2014", "HN": "2015 (2008); use MALFORMATIONS OF CORTICAL DEVELOPMENT 2008-2014", "MR": "20190701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065705"}, {"RECTYPE": "D", "MH": "Polymicrogyria", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Polymicrogyrias, Cerebral", "MN": "C16.131.666.507.500.500", "MH_TH": "NLM (2008)", "ST": "T047", "MS": "Heterogeneous disorders of cortical malformation characterized by excessive and small fused gyri and shallow sulci of the CORTEX with abnormal cortical lamination. It is considered a malformation secondary to abnormal post-migrational development of the neurons during cerebral cortical development and is associated with EPILEPSY and learning difficulties.", "PM": "2015; see Malformations of Cortical Development 2008-2014", "HN": "2015 (2008); use Malformations of Cortical Development 2008-2014", "MR": "20190701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065706"}, {"RECTYPE": "D", "MH": "Schizencephaly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Schizencephalies", "MN": "C16.131.666.507.500.750", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "Cortical malformations characterized by grey matter-lined cleft or cyst that extends from the EPENDYMA often to the PIA MATER outer surface. The grey matter that lines the cleft is often POLYMICROGYRIA. It is associated with developmental delay, motor disturbance and seizures.", "PM": "2015; see Malformations of Cortical Development 2008-2014", "HN": "2015 (2008); use Malformations of Cortical Development 2008-2014", "MR": "20190701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065707"}, {"RECTYPE": "D", "MH": "Porencephaly", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Posttraumatic Porencephaly|T047|NON|NRW|NLM (2021)|200110|abcdef", "ENTRY": "Type 1 Porencephaly", "MN": "C16.131.666.507.500.625", "FX": "Collagen Type IV", "MH_TH": "NLM (2015)", "ST": "T047", "PI": "Brain Diseases (1963-2014)", "MS": "Cortical malformations characterized by white matter-lined cleft or cyst associated with ISCHEMIA and hemorrhagic insults. Symptoms include delayed growth and development, HYPOTONIA; SEIZURES; SPASTIC HEMIPLEGIA and MACROCEPHALY; MICROCEPHALY; or HYDROCEPHALUS. Mutations in the genes encoding COLLAGEN TYPE IV are associated with familial types.", "PM": "2015", "HN": "2015", "MR": "20210510", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065708"}, {"RECTYPE": "D", "MH": "Common Data Elements", "AQ": "HI ST", "ENTRY": "Elements, Common Data", "MN": "L01.399.250.090", "MH_TH": "NLM (2015)", "ST": "T170", "PI": "Vocabulary, Controlled (2009-2014)", "MS": "Data elements that are common to multiple data sets across different studies.", "PM": "2015", "HN": "2015", "MR": "20170630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065709"}, {"RECTYPE": "D", "MH": "Glossoptosis", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Glossoptoses", "MN": "C07.465.910.411", "MH_TH": "NLM (2015)", "ST": "T184", "PI": "Tongue/abnormalities (1963-2014)", "MS": "Posterior displacement of the TONGUE toward the PHARYNX. It is often a feature in syndromes such as in PIERRE ROBIN SYNDROME and DOWN SYNDROME and associated with AIRWAY OBSTRUCTION during sleep (OBSTRUCTIVE SLEEP APNEAS).", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065710"}, {"RECTYPE": "D", "MH": "Broca Area", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Brodmann's Area 45|T023|EPO|NRW|NLM (2022)|201009|abcdef", "ENTRY": "Triangularis, Pars", "MN": "A08.186.211.200.885.287.500.270.700.500", "FX": "Wernicke Area", "MH_TH": "UNK (19XX)", "ST": "T023", "MS": "Functional neuroanatomical region of the inferior frontal gyrus consisting of pars opercularis and pars triangularis. It is important in SPEECH and LANGUAGE production. Injuries to Broca area are associated with BROCA APHASIA and APRAXIA.", "PM": "2015; see FRONTAL LOBE 1982-2014", "HN": "2015 (1982); use FRONTAL LOBE 1982-2014", "MR": "20210305", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065711"}, {"RECTYPE": "D", "MH": "Limbic Lobe", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Lobes, Limbic", "MN": "A08.186.211.200.885.287.500.382", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Limbic System (1965-2014)", "MS": "The medial surface of the cerebral hemisphere around the brain stem.", "PM": "2015", "HN": "2015", "MR": "20180630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065726"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2C8", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "S Mephenytoin 4 Hydroxylase", "MN": "D12.776.422.220.453.491.360", "EC": "antagonists & inhibitors:Cytochrome P-450 CYP2C8 Inhibitors", "MH_TH": "NLM (2015)", "ST": "T126", "RN": "EC 1.14.14.1", "PI": "Aryl Hydrocarbon Hydroxylases (2002-2014)", "MS": "A liver microsomal cytochrome P450 hydroxylase that oxidizes a broad spectrum of substrates including STEROIDS, FATTY ACIDS, and XENOBIOTICS. Examples of pharmaceutical substrates for CYP2C8 include; PACLITAXOL; torsemide; and; AMODIAQUINE", "PM": "2015", "HN": "2015", "MR": "20160527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065727"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2C9", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "PB-1, Cytochrome P450", "MN": "D12.776.422.220.453.491.500.500", "EC": "antagonists & inhibitors:Cytochrome P-450 CYP2C9 Inhibitors", "MH_TH": "NLM (2015)", "ST": "T126", "RN": "EC 1.14.13.-", "PI": "*Aryl Hydrocarbon Hydroxylases (2003-2014)", "MS": "A cytochrome P-450 subtype that has specificity for acidic XENOBIOTICS. It oxidizes a broad range of important clinical drugs that fall under the categories of NONSTEROIDAL ANTI-INFLAMMATORY AGENTS; HYPOGLYCEMIC AGENTS; ANTCOAGULANTS; and DIURETICS.", "PM": "2015", "HN": "2015", "MR": "20160527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065729"}, {"RECTYPE": "D", "MH": "Limonene Hydroxylases", "AQ": "AD AE AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "Monooxygenases, Limonene", "MN": "D12.776.422.220.453.491.500", "MH_TH": "NLM (2015)", "ST": "T126", "RN": "EC 1.14.13.-", "RR": "EC 1.14.13.80", "PI": "Cytochrome P-450 Enzyme System (1972-2014)", "MS": "Members of the P-450 enzyme family that take part in the hydroxylation of limonene.", "PM": "2015", "HN": "2015", "MR": "20160527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065730"}, {"RECTYPE": "D", "MH": "Cytochrome P-450 CYP2C19", "AQ": "AD AE AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "S Mephenytoin 4' Hydroxylase", "MN": "D12.776.422.220.453.491.500.700", "EC": "antagonists & inhibitors:Cytochrome P-450 CYP2C19 Inhibitors", "MH_TH": "NLM (2015)", "ST": "T126", "RN": "EC 1.14.14.1", "MS": "A cytochrome P-450 enzyme subtype that oxidizes several important groups of drugs including many PROTON PUMP INHIBITORS and ANTICONVULSANTS.", "PM": "2015", "HN": "2015", "MR": "20160628", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065731"}, {"RECTYPE": "D", "MH": "Euterpe", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Acai Berries|T002|T168|NON|NRW|NLM (2015)|140121|abbcdef", "ENTRY": "oleracea Mart.s, Euterpe", "MN": "B01.875.800.575.912.250.093.480", "MH_TH": "NLM (2004)", "ST": "T002", "RN": "txid115465", "RR": "txid157786", "PI": "Arecaceae (2003-2014)", "MS": "A genus in the family Arecaceae. They are a source of ACAI BERRIES.", "PM": "2015; see ARECACEAE 2004-2014", "HN": "2015; use ARECACEAE 2004-2014", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065748"}, {"RECTYPE": "D", "MH": "Phoeniceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Phoenix dactylifera|T002|NON|NRW|NLM (2015)|140121|abcdef", "ENTRY": "Trees, Date Palm", "MN": "B01.875.800.575.912.250.093.615", "MH_TH": "NLM (2015)", "ST": "T002", "RN": "txid169748", "RR": "txid42345", "PI": "Arecaceae (2002-2014)", "MS": "Tribe of palms in the subfamily Coryphoideae, family Arecaceae.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065749"}, {"RECTYPE": "D", "MH": "Atypical Hemolytic Uremic Syndrome", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Toxin-Associated HUSs, Non-Shiga-Like", "MN": "C15.378.243.937.925.500.500", "MH_TH": "ORD (2010)", "ST": "T047", "MS": "An hereditary hemolytic uremic syndrome associated with variations in the gene that encodes COMPLEMENT FACTOR H, or the related proteins CFHR1 and CFHR3. Disease often progresses to CHRONIC KIDNEY FAILURE without the prodromal symptoms of ENTEROCOLITIS and DIARRHEA that characterize typical hemolytic uremic syndrome.", "PM": "2015; see HEMOLYTIC-UREMIC SYNDROME 2010-2014;", "HN": "2015; use Hemolytic-Uremic Syndrome 2010-2014", "MR": "20230226", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065766"}, {"RECTYPE": "D", "MH": "Activation, Metabolic", "DE": "ACTIVATION METAB", "AQ": "DE GE IM PH RE", "PRINT ENTRY": "Metabolic Activation|T040|NON|EQV|UNK (19XX)|790530|METAB ACTIVATION|abcdefv", "ENTRY": "Activation, Drug", "MN": "G07.690.725.225.224", "MH_TH": "NLM (1992)", "ST": "T040", "AN": "restrict to chemical changes of exogenous substances; IM general only; coordinate NIM with specific drug /pharmacokin (IM) or /metab (IM)", "PI": "Biotransformation (1976-2014)", "MS": "The conversion of an exogenous substance by a biological system resulting in the production on an active metabolite.", "PM": "2015; see Biotransformation 1980-2014", "HN": "2015; use Biotransformation 1980-2014", "MR": "20160502", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065767"}, {"RECTYPE": "D", "MH": "Lennox Gastaut Syndrome", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "PRINT ENTRY": "Lennox-Gastaut Syndrome|T047|EPO|EQV|NLM (2021)|191119|abcdef", "ENTRY": "Lennox Gastaut Syndromes", "MN": "C16.320.495", "MH_TH": "NLM (2015)", "ST": "T047", "PI": "Spasms, Infantile (1988-2014)", "MS": "A childhood-onset epilepsy syndrome.", "PM": "2015", "HN": "2015", "MR": "20200206", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065768"}, {"RECTYPE": "D", "MH": "Delay Discounting", "AQ": "CL DE ES PH RE", "ENTRY": "Preferences, Intertemporal", "MN": "F02.463.785.373.346.700", "FX": "Reward", "MH_TH": "NLM (2015)", "ST": "T184", "MS": "The tendency to devalue an outcome as a function of its temporal delay or probability of achievement. It can be evaluated in a psychological paradigm that involves the choice between receiving a smaller immediate reward or a larger delayed reward, and may be used to provide a measure of impulsive behavior.", "PM": "2015", "HN": "2015", "MR": "20160226", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065786"}, {"RECTYPE": "D", "MH": "Salivary Elimination", "AQ": "DE GE IM PH RE", "ENTRY": "Excretion, Salivary", "MN": "G07.690.725.297.937", "MH_TH": "NLM (2015)", "ST": "T042", "AN": "distinguish from SALIVATION, the discharge of saliva from the salivary glands", "MS": "The discharge of substances from the blood supply via diffusion into the SALIVA from the ORAL MUCOSA or from the SALIVARY GLANDS.", "PM": "2015", "HN": "2015", "MR": "20200609", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065787"}, {"RECTYPE": "D", "MH": "Xenophobia", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "PRINT ENTRY": "Phobia, Strangers|T055|NON|EQV|NLM (2023)|210921|abcdef", "ENTRY": "Strangers Phobia", "MN": "F01.829.595.875", "MH_TH": "NLM (2015)", "ST": "T055", "MS": "Intense or irrational dislike or fear of anything that is strange or foreign, particularly of people who are strangers or foreigners. It is an attitudinal orientation of hostility against non-natives in a given population that includes attitudes, prejudices and behavior that reject, exclude or vilify persons, based on the perception that they are outsiders or foreigners to the community, society or national identity.", "PM": "2015", "HN": "2015", "MR": "20220413", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065806"}, {"RECTYPE": "D", "MH": "Prepulse Inhibition", "AQ": "DE GE IM PH RE", "ENTRY": "Inhibition, Prepulse", "MN": "G11.561.794.500", "FX": "Reflex, Startle", "MH_TH": "NLM (2015)", "ST": "T039", "PI": "Reflex, Startle (1974-2014)", "MS": "A neurophysiological phenomenon in which the response to a startling stimulus (pulse) is decreased when a weaker prestimulus (prepulse) precedes it closely in time. It is used as an operational measure of sensorimotor gating.", "PM": "2015", "HN": "2015", "MR": "20160623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065808"}, {"RECTYPE": "D", "MH": "Respiratory Sinus Arrhythmia", "AQ": "DE GE IM PH RE", "ENTRY": "Sinus Arrhythmia, Respiratory", "MN": "G09.330.380.500.715", "MH_TH": "NLM (2015)", "ST": "T039", "MS": "A naturally occurring variation in heart rate that occurs during a BREATHING cycle, where the time between heartbeats is shortened during inspiration and prolonged during expiration. It is not the same as SINUS ARRHYTHMIA, the disorder.", "PM": "2015", "HN": "2015", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065809"}, {"RECTYPE": "D", "MH": "Ethnic Cleansing", "AQ": "CL EC EH ES HI LJ PC PX SN TD", "ENTRY": "Ethnic Cleansings", "MN": "I01.880.735.950.500.903.074", "MH_TH": "NLM (2013)", "ST": "T054", "MS": "Expulsion of a population from a given territory due to religious or ethnic discrimination, political, strategic or ideological considerations, or a combination of these.", "PM": "2015; see under GENOCIDE 2014", "HN": "2015; use under GENOCIDE 2014", "MR": "20150629", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065811"}, {"RECTYPE": "D", "MH": "Interoception", "AQ": "CL DE ES PH RE", "ENTRY": "Alliesthesias", "MN": "F02.463.593.465", "MH_TH": "NLM (2015)", "ST": "T041", "AN": "do not confuse with enteroception; note entry term ALLIESTHESIA: do not confuse with ALLESTHESIA", "MS": "The perception of and sensitivity to stimuli originating inside of the body. It is a sense of the physiological condition of the entire body.", "PM": "2015", "HN": "2015", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065812"}, {"RECTYPE": "D", "MH": "Wernicke Area", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Wernickes Area", "MN": "A08.186.211.200.885.287.500.863.850", "FX": "Broca Area", "MH_TH": "UNK (19XX)", "ST": "T023", "MS": "Functional region comprising posterior part of the SUPERIOR TEMPORAL GYRUS in the dominant cerebral hemisphere (see CEREBRAL DOMINANCE) and often portions of the PARIETAL LOBE. Along with BROCA AREA it is important in SPEECH and LANGUAGE processes. A lesion in the area is associated with WERNICKE APHASIA and CONDUCTION APHASIA.", "PM": "2015; see TEMPORAL LOBE 1982-2014", "HN": "2015 (1982); use TEMPORAL LOBE 1982-2014", "MR": "20190701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065813"}, {"RECTYPE": "D", "MH": "Cerebellar Vermis", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Vermis, Cerebellar", "MN": "A08.186.211.132.810.428.200.212.299", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Cerebellum (1965-2014)", "MS": "A subregion of the CEREBELLAR CORTEX, located along the midsagittal plane of the CEREBELLUM.", "PM": "2015", "HN": "2015", "MR": "20150622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065814"}, {"RECTYPE": "D", "MH": "Acalypha", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "wilkesianas, Acalypha", "MN": "B01.875.800.575.912.250.859.797.438.038", "MH_TH": "NLM (2015)", "ST": "T002", "RN": "txid20025", "RR": "txid478095", "PI": "Euphorbiaceae (1999-2014)", "MS": "Nettle-like plants in the subfamily Acalyphoideae. Acalypha is the largest genus in the Euphorbiaceae family.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065815"}, {"RECTYPE": "D", "MH": "Neuroscience Nursing", "AQ": "CL EC ED ES HI LJ MT OG SN ST TD", "ENTRY": "Nursing, Neuroscience", "MN": "N02.421.533.505", "MH_TH": "NLM (2015)", "ST": "T091", "PI": "Specialties, Nursing (1984-2014)", "MS": "The nursing specialty focusing on the needs of patients with dysfunction of the NERVOUS SYSTEM.", "PM": "2015", "HN": "2015", "MR": "20150626", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065816"}, {"RECTYPE": "D", "MH": "Congenital Microtia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Microtias, Congenital", "MN": "C16.131.287", "MH_TH": "NLM (2015)", "ST": "T047", "MS": "Malformation of external portion of EAR AURICLE.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065817"}, {"RECTYPE": "D", "MH": "Gamma Rhythm", "AQ": "DE GE IM PH RE", "ENTRY": "Rhythms, Gamma", "MN": "G11.561.127.906", "MH_TH": "NLM (2015)", "ST": "T042", "MS": "Brain waves characterized by a relatively high voltage or amplitude and a frequency of approximately 30-100 Hz. They are primarily observed during network engagement and sensory processing activities, during both waking and sleeping states.", "PM": "2015", "HN": "2015", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065818"}, {"RECTYPE": "D", "MH": "Voriconazole", "AQ": "AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "UK109496", "MN": "D03.383.129.799.950", "PA": "Cytochrome P-450 CYP3A Inhibitors", "MH_TH": "USAN (19XX)", "ST": "T121", "RN": "JFU09I87TR", "MS": "A triazole antifungal agent that specifically inhibits STEROL 14-ALPHA-DEMETHYLASE and CYTOCHROME P-450 CYP3A.", "PM": "2015; VORICONAZOLE was indexed under PYRIMIDINES and TRIAZOLES 1997-2014", "HN": "2015", "MR": "20160601", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065819"}, {"RECTYPE": "D", "MH": "Zona Incerta", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Zona Inserta, Medial", "MN": "A08.186.211.200.317.800.900", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Thalamus (1963-2000)", "MS": "A region of the subthalamus located ventral to the THALAMUS and dorsal to the SUBTHALAMIC NUCLEUS.", "PM": "2015; see SUBTHALAMUS 2000-2014", "HN": "2015; use SUBTHALAMUS 2000-2014", "MR": "20180630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065820"}, {"RECTYPE": "D", "MH": "Pontine Tegmentum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tracts, Central Tegmental", "MN": "A08.186.211.132.810.428.600.650", "FX": "Trigeminal Nerve", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Pons (1967-2014)", "MS": "The dorsal region of pons bounded by the middle CEREBELLAR PEDUNCLES and the ventral part of the pons. It is continuous with the TEGMENTUM MESENCEPHALI and contains CEREBELLAR NUCLEI, lemnisci and RETICULAR FORMATION.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065821"}, {"RECTYPE": "D", "MH": "College Fraternities and Sororities", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Sorority, Collegiate", "MN": "N03.540.162", "FX": "Students", "MH_TH": "NLM (2015)", "ST": "T092", "MS": "Local or national organizations of college students, primarily for social purposes, usually with secret initiations and rites and a name composed of two or three Greek letters.", "PM": "2015", "HN": "2015", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065822"}, {"RECTYPE": "D", "MH": "Parabrachial Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Parabrachialis Medialis, Nucleus", "MN": "A08.186.211.132.810.428.600.650.500", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Pons (1976-2014)", "MS": "A cell group in the pontine tegmentum surrounding the surfaces of the superior CEREBRAL PEDUNCLE of the PONS.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065823"}, {"RECTYPE": "D", "MH": "Oxalidaceae", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Woodsorrels", "MN": "B01.875.800.575.912.250.789", "MH_TH": "NLM (2015)", "ST": "T002", "RN": "txid4033", "RR": "txid4034", "MS": "Wood-sorrel family in the order Oxalidales. Some species of RUMEX (of the family POLYGONACEAE) also known by the common name of sorrels.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065825"}, {"RECTYPE": "D", "MH": "Averrhoa", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Trees, Starfruit", "MN": "B01.875.800.575.912.250.789.500", "MH_TH": "NLM (2015)", "ST": "T002", "RN": "txid21563", "RR": "txid28974", "MS": "Tropical trees in the family Oxalidaceae", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065826"}, {"RECTYPE": "D", "MH": "Abducens Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nucleus, Abducens Nerve", "MN": "A08.186.211.132.810.428.600.650.249", "FX": "Abducens Nerve", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Pons (1963-2014)", "MS": "A region in the PONTINE TEGMENTUM that is the nucleus of the ABDUCENS NERVE.", "PM": "2015", "HN": "2015", "MR": "20150622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065827"}, {"RECTYPE": "D", "MH": "Facial Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nucleus, Facial Motor", "MN": "A08.186.211.132.810.428.600.650.374", "FX": "Facial Nerve", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Pons (1965-2014)", "MS": "A region in the pontine tegmentum that is the nucleus of the FACIAL NERVE.", "PM": "2015", "HN": "2015", "MR": "20150622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065828"}, {"RECTYPE": "D", "MH": "Flower Essences", "AQ": "AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Bach Flower Remedies|T123|EPO|NRW|NLM (2015)|140206|abcdef", "ENTRY": "Rescue Remedy, Bach", "MN": "D26.667.249", "FX": "Phytotherapy", "MH_TH": "NLM (2015)", "ST": "T123", "RN": "0", "MS": "Aqueous extracts of flowers that are used in healing systems.", "PM": "2015", "HN": "2015", "MR": "20140818", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065829"}, {"RECTYPE": "D", "MH": "Monks", "AQ": "CL ED ES HI LJ PX SN", "ENTRY": "Religious Brother", "MN": "M01.526.799.750", "FX": "Religious Missions", "MH_TH": "NLM (2015)", "ST": "T097", "AN": "specify religion if pertinent", "PI": "Religion or specifics (1963-2014)", "MS": "Members of a religious community of men typically living under vows of poverty, chastity, and obedience.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065830"}, {"RECTYPE": "D", "MH": "Nuns", "AQ": "CL ED ES HI LJ PX SN", "ENTRY": "Sisters, Religious", "MN": "M01.526.799.875", "FX": "Religious Missions", "MH_TH": "NLM (2015)", "ST": "T097", "PI": "Religion or specifics (1963-2014)", "MS": "Members of a religious community of women typically living under vows of poverty, chastity, and obedience.", "PM": "2015", "HN": "2015", "MR": "20140625", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065831"}, {"RECTYPE": "D", "MH": "Superior Olivary Complex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Superior Olivary Body|T023|NON|EQV|NLM (2024)|220928|abcdef", "ENTRY": "Superior Olives", "MN": "A08.186.211.132.810.591.750.500", "FX": "Olivary Nucleus", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Olivary Nucleus (1964-2014)", "MS": "An auditory brainstem structure in the pontine tegmentum and a part of the olivary nucleus complex.  It contains several nuclei associated with auditory localization and is a component of ascending and descending auditory pathways.", "PM": "2015", "HN": "2015", "MR": "20230601", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065832"}, {"RECTYPE": "D", "MH": "Trapezoid Body", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Trapezoideums, Corpus", "MN": "A08.186.211.132.810.428.600.650.687", "FX": "Auditory Pathways", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Pons (1967-2014)", "MS": "A region in the pontine tegmentum containing nuclei and fibers associated with AUDITORY PATHWAYS.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065833"}, {"RECTYPE": "D", "MH": "Religious Personnel", "AQ": "CL ED ES HI LJ PX SN", "ENTRY": "Personnel, Religious", "MN": "M01.526.799", "MH_TH": "NLM (2015)", "ST": "T097", "MS": "Persons that live and work according to a religious vocation, or calling, to a consecrated or ordained life.", "PM": "2015", "HN": "2015", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065834"}, {"RECTYPE": "D", "MH": "Barrington's Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nucleus, Barrington's", "MN": "A08.186.211.132.810.428.600.067", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Pons (1994-2014)", "MS": "A nucleus in the pons with exon projections to the sacral parasympathetic nucleus associated with bladder control.", "PM": "2015", "HN": "2015", "MR": "20150622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065835"}, {"RECTYPE": "D", "MH": "Kolliker-Fuse Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nucleus, K\u00f6lliker-Fuse", "MN": "A08.186.211.132.810.428.600.392", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Pons (1982-2014)", "MS": "A nucleus in the pons associated with RESPIRATION RATE control.", "PM": "2015", "HN": "2015", "MR": "20150622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065836"}, {"RECTYPE": "D", "MH": "Middle Cerebellar Peduncle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Pontis, Brachium", "MN": "A08.186.211.132.810.428.600.521", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Pons (1985-2014)", "MS": "WHITE MATTER consisting of a large bundle of paired fibers originating in the pontine nuclei in the pre pontis and the nucleus reticularis tegmenti pontis projecting to the contralateral cerebral cortex.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065837"}, {"RECTYPE": "D", "MH": "Oculomotor Nuclear Complex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Perlia Nucleus", "MN": "A08.186.211.132.659.413.875.381", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Mesencephalon (1981-2014)", "MS": "A collection of nuclei in the midbrain tegmentum for the OCULOMOTOR NERVE fibers.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065838"}, {"RECTYPE": "D", "MH": "Edinger-Westphal Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Parvocellular Oculomotor Nucleus|T023|NON|EQV|NLM (2015)|140207|abcdef", "ENTRY": "Westphals, Nucleus Edinger", "MN": "A08.186.211.132.659.413.875.381.500", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Mesencephalon (1963-2014)", "MS": "Nucleus in the oculomotor nuclear complex associated with oculomotor activities and stress adaptation.", "PM": "2015", "HN": "2015", "MR": "20150622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065839"}, {"RECTYPE": "D", "MH": "Protective Factors", "ENTRY": "Protective Factor", "MN": "N06.850.520.830.600.800.582", "MH_TH": "NLM (2015)", "ST": "T081", "AN": "coordinate NIM with specific disease or other concept (IM)", "MS": "An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with prevention or mitigation of a health-related condition considered important to prevent.", "PM": "2015", "HN": "2015", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065840"}, {"RECTYPE": "D", "MH": "Pars Reticulata", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Substantia Nigra Reticulatas", "MN": "A08.186.211.132.659.413.656.500", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Substantia Nigra (2009-2014)", "MS": "A region in the substantia nigra located ventral and lateral to the PARS COMPACTA.", "PM": "2015", "HN": "2015", "MR": "20150622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065841"}, {"RECTYPE": "D", "MH": "Pars Compacta", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Substantia Nigra Compactas", "MN": "A08.186.211.132.659.413.656.249", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Substantia Nigra (1978-2014)", "MS": "A region in the substantia nigra located dorsal to the PARS RETICULATA.", "PM": "2015", "HN": "2015", "MR": "20150622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065842"}, {"RECTYPE": "D", "MH": "Cerebral Crus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Crus, Cerebral", "MN": "A08.186.211.132.659.413.437", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Mesencephalon (1980-2014)", "MS": "Anterior portion of the cerebral peduncle which contains the motor tracts.", "PM": "2015", "HN": "2015", "MR": "20150622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065843"}, {"RECTYPE": "D", "MH": "Tectospinal Fibers", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tectospinal Fiber", "MN": "A08.186.211.132.810.753", "MH_TH": "NLM (2015)", "ST": "T023", "MS": "A neural tract which connects the TECTUM MESENCEPHALI and the SPINAL CORD and is involved in head and eye movement coordination.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065844"}, {"RECTYPE": "D", "MH": "Nucleus Raphe Magnus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Raphes Magnus, Nucleus", "MN": "A08.186.211.132.810.428.600.650.562.500", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Raphe Nuclei (1978-2014)", "MS": "A nucleus located directly rostral to the NUCLEUS RAPHE OBSCURUS in the pontine part of the Raphe nuclei. Another pontine nucleus located directly rostral to the magnus nucleus is the nucleus raphe pontis.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065846"}, {"RECTYPE": "D", "MH": "Dorsal Raphe Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Raphe, Dorsal Nucleus", "MN": "A08.186.211.132.659.413.875.618.249", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Raphe Nuclei (1977-2014)", "MS": "The dorsal region of the raphe nucleus which is a source of the SEROTONERGIC NEURONS innervating the TELENCEPHALON; DIENCEPHALON; MESENCEPHALON; and RHOMBENCEPHALON.", "PM": "2015", "HN": "2015", "MR": "20210305", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065847"}, {"RECTYPE": "D", "MH": "Nucleus Raphe Pallidus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Raphe Pallidus, Nucleus", "MN": "A08.186.211.132.810.591.500.662.624", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Raphe Nuclei (1982-2014)", "MS": "A nucleus in the medullary Raphe nuclei located rostral to the NUCLEUS RAPHE OBSCURUS and caudal to the NUCLEUS RAPHE MAGNUS.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065848"}, {"RECTYPE": "D", "MH": "Nucleus Raphe Obscurus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Raphes, Nucleus Obscurus", "MN": "A08.186.211.132.810.591.500.662.436", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Raphe Nuclei (1986-2014)", "MS": "A nucleus in the medullary Raphe nuclei located caudal to the NUCLEUS RAPHE PALLIDUS.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065849"}, {"RECTYPE": "D", "MH": "Cerebral Peduncle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cerebral Peduncles|T023|NON|EQV|NLM (2008)|060720|abcdef", "ENTRY": "Pedunculus, Basis", "MN": "A08.186.211.132.659.413", "MH_TH": "UNK (19XX)", "ST": "T023", "MS": "Ventral portion of the mesencephalon including the MIDBRAIN TEGMENTUM; CRUS CEREBRI; and the PRETECTUM. It does not include tectum mesencephali and TROCHLEAR NERVE.", "PM": "2015; see Tegmentum Mesencephali 2008-2014", "HN": "2015; use Tegmentum Mesencephali 2008-2014", "MR": "20150622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065850"}, {"RECTYPE": "D", "MH": "Ovarian Reserve", "AQ": "DE ES GE IM PH RE", "ENTRY": "Reserves, Ovarian", "MN": "G08.686.628", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Ovary (1993-2014)", "MS": "Capacity of the ovary to provide viable eggs.", "PM": "2015", "HN": "2015", "MR": "20160617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065851"}, {"RECTYPE": "D", "MH": "Spatial Memory", "AQ": "CL DE PH RE", "ENTRY": "Spatial Memories", "MN": "F02.463.425.540.886", "FX": "Spatial Learning", "MH_TH": "NLM (2015)", "ST": "T041", "PI": "Space Perception (1973-2014)", "MS": "Memory related to spatial information.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065852"}, {"RECTYPE": "D", "MH": "Spatial Learning", "AQ": "DE PH RE", "ENTRY": "Spatial Learnings", "MN": "F02.784.629.529.775", "FX": "Spatial Memory", "MH_TH": "NLM (2015)", "ST": "T055", "PI": "Space Perception (1968-2014)", "MS": "A process through which individuals encode information about their environmental CUES to facilitate SPATIAL NAVIGATION.", "PM": "2015", "HN": "2015", "MR": "20140623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065853"}, {"RECTYPE": "D", "MH": "Spatial Navigation", "AQ": "DE PH RE", "ENTRY": "Visualizations, Spatial", "MN": "F02.463.641", "MH_TH": "NLM (2015)", "ST": "T055", "PI": "Spatial Behavior (1985-2014)", "MS": "Process by which organisms use various cues to develop a route to a destination and their ability to travel such a planned route.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065854"}, {"RECTYPE": "D", "MH": "Spatial Processing", "AQ": "DE PH RE", "ENTRY": "Visual-Auditory Spatial Processings", "MN": "F01.145.875.830", "FX": "Spatial Memory", "MH_TH": "NLM (2015)", "ST": "T041", "PI": "Spatial Behavior (1988-2014)", "MS": "Integration of spatial information perceived by visual and/or auditory CUES.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065855"}, {"RECTYPE": "D", "MH": "Rubus", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Raspberry Plant|T002|NON|NRW|NLM (2023)|211115|abcdef", "ENTRY": "Raspberry Plants", "MN": "B01.875.800.575.912.250.859.937.500.764", "MH_TH": "NLM (2015)", "ST": "T002", "RN": "txid23216", "RR": "txid32247", "MS": "A plant genus of the family Rosaceae whose members include blackberries and raspberries.", "PM": "2015", "HN": "2015", "MR": "20220413", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065856"}, {"RECTYPE": "D", "MH": "Optic Tract", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Tracts, Optic", "MN": "A08.186.211.200.317.689", "MH_TH": "NLM (2000)", "ST": "T023", "PI": "Visual Pathways (1971-2014)", "MS": "Nerve fiber originating from the OPTIC CHIASM that connects predominantly to the LATERAL GENICULATE BODIES. It is the continuation of the VISUAL PATHWAY that conveys the visual information originally from the RETINA to the optic chiasm via the OPTIC NERVES.", "PM": "2015; see VISUAL PATHWAYS 1971-2014", "HN": "2015; use VISUAL PATHWAYS 1971-2014", "MR": "20180630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065866"}, {"RECTYPE": "D", "MH": "Neurodevelopmental Disorders", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Neurodevelopmental Disorders Usually Diagnosed in Infancy, Childhood or Adolescence|T048|NON|EQV|NLM (2022)|210316|abcdef", "ENTRY": "Neurodevelopmental Disorder", "MN": "F03.625", "MH_TH": "NLM (2015)", "ST": "T048", "MS": "These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning.  (From DSM-5).", "PM": "2015; see MENTAL DISORDERS DIAGNOSED IN CHILDHOOD 1999-2014 and CHILD MENTAL DISORDERS 1998-1999", "HN": "2015 (1998)", "MR": "20210510", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D065886"}, {"RECTYPE": "D", "MH": "Hyperlactatemia", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Hyperlactatemias", "MN": "C23.888.516", "FX": "Acidosis, Lactic", "MH_TH": "NLM (2015)", "ST": "T046", "PI": "Lactates/blood (1967-2014)", "MS": "Increase in blood LACTATE concentration often associated with SEPTIC SHOCK; LUNG INJURY; SEPSIS; and DRUG TOXICITY. When hyperlactatemia is associated with low body pH (acidosis) it is LACTIC ACIDOSIS.", "PM": "2015", "HN": "2015", "MR": "20140610", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065906"}, {"RECTYPE": "D", "MH": "Karoshi Death", "AQ": "EH EP ET PA PC VE", "PRINT ENTRY": "Karoshi-Death|T033|T046|NON|EQV|NLM (2015)|140225|abbcdef", "ENTRY": "Karoshi-Deaths", "MN": "C23.550.260.322.250.500", "FX": "Occupational Diseases", "MH_TH": "NLM (2015)", "ST": "T046", "PI": "Death, Sudden, Cardiac (1992-2014)", "MS": "Sudden death from overwork, most often as a result of acute CARDIOVASCULAR STROKE.", "PM": "2015", "HN": "2015", "MR": "20180702", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065907"}, {"RECTYPE": "D", "MH": "Transcranial Direct Current Stimulation", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "tDCSs, Cathodal Stimulation", "MN": "F04.669.224.650", "FX": "Transcutaneous Electric Nerve Stimulation", "MH_TH": "NLM (2015)", "ST": "T061", "PI": "Transcutaneous Electric Nerve Stimulation (2002-2014)", "MS": "A technique of brain electric stimulation therapy which uses constant, low current delivered via ELECTRODES placed on various locations on the scalp.", "PM": "2015", "HN": "2015", "MR": "20150706", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065908"}, {"RECTYPE": "D", "MH": "Influenza A Virus, H10N8 Subtype", "DS": "INFLUENZA A VIRUS, H910N8 SUBTYPE", "AQ": "CH CL DE EN GD GE IM IP ME PH PY RE UL", "PRINT ENTRY": "H10N8 subtype|T005|ABX|EQV|NLM (2024)|230223|abcdef", "ENTRY": "subtype, H10N8", "MN": "B04.820.480.968.405.400.106", "MH_TH": "NLM (2015)", "ST": "T005", "RN": "txid286285", "AN": "infection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals", "PI": "\tInfluenza A virus (2004-2014)", "MS": "A subtype of INFLUENZA A VIRUS comprised of the surface proteins HEMAGGLUTININ 10 and NEURAMINIDASE 8. The H10N8 subtype usually infects domestic birds (POULTRY) but there have been some human infections reported.", "PM": "2015", "HN": "2015", "MR": "20230405", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065926"}, {"RECTYPE": "D", "MH": "Waist-Height Ratio", "ENTRY": "Waist-Height Ratios", "MN": "E05.041.124.160.937", "MH_TH": "NLM (2015)", "ST": "T081", "PI": "Waist Circumference (2008-2014)", "MS": "The ratio of WAIST CIRCUMFERENCE to BODY HEIGHT.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065927"}, {"RECTYPE": "D", "MH": "Forests", "ENTRY": "Woodlands", "MN": "N06.230.124.343", "FX": "Wood", "MH_TH": "NLM (1992)", "ST": "T070", "PI": "Trees (1964-2014)", "MS": "An ecosystem dominated by trees and other woody vegetation.", "PM": "2015; see Trees 1983-2014", "HN": "2015; use Trees 1983-2014", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065928"}, {"RECTYPE": "D", "MH": "Tundra", "ENTRY": "Tundras, Arctic", "MN": "N06.230.124.531", "MH_TH": "NLM (2015)", "ST": "T082", "PI": "Ecosystem (2000-2014)", "MS": "An ecosystem dominated by grasses, lichens, mosses, sedges and shrubs in cold landscapes or at high elevations where a layer of the ground remains perennially frozen (PERMAFROST).", "PM": "2015", "HN": "2015", "MR": "20150618", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065929"}, {"RECTYPE": "D", "MH": "Permafrost", "AQ": "CH CL MI PS ST VI", "ENTRY": "Soils, Permafrost", "MN": "N06.230.600.500", "MH_TH": "NLM (2015)", "ST": "T167", "PI": "Soil (2000-2014)", "MS": "Perennially frozen layer of soil below the surface in tundra.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065946"}, {"RECTYPE": "D", "MH": "Rainforest", "ENTRY": "Tropical Rainforests", "MN": "N06.230.124.343.500", "MH_TH": "NLM (2015)", "ST": "T070", "PI": "Tropical Climate (1987-2014)", "MS": "Forests with high average annual rainfall.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065947"}, {"RECTYPE": "D", "MH": "Grassland", "PRINT ENTRY": "Steppe|T070|NON|EQV|NLM (2015)|140506|abcdef", "ENTRY": "Steppes", "MN": "N06.230.124.390", "MH_TH": "NLM (2015)", "ST": "T070", "PI": "Poaceae (1964-2014)", "MS": "An ecosystem dominated by grasses (POACEAE) with few trees or shrubs.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065948"}, {"RECTYPE": "D", "MH": "Absorption, Physicochemical", "AQ": "DE GE IM PH RE", "ENTRY": "Physicochemical Absorption|T070|NON|EQV|NLM (2015)|140228|abcdef", "MN": "G02.010.500", "FX": "Absorption, Physiological", "MH_TH": "NLM (2015)", "ST": "T070", "PI": "Absorption (2014)", "MS": "The physical process of passing into, or being taken up or taken in by a substance.", "PM": "2015", "HN": "2015", "MR": "20160115", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065966"}, {"RECTYPE": "D", "MH": "Citrullus colocynthis", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "ENTRY": "Colocynths", "MN": "B01.875.800.575.912.250.300.140.500", "MH_TH": "NLM (2015)", "ST": "T002", "RN": "txid252529", "PI": "Citrullus (2002-2014)", "MS": "A plant species of the family CUCURBITACEAE distributed tropically and subtropically mainly in North Africa and Asia. It is a medicinal plant of TRADITIONAL MEDICINE and well known in ancient medicine as the wild gourd.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D065986"}, {"RECTYPE": "D", "MH": "Toxicokinetics", "MN": "G07.690.915", "MH_TH": "NLM (1996)", "ST": "T046", "AN": "IM general only: coordinate NIM with specific drug / tox / pois or / adv eff", "PI": "Chemicals and Drugs or specifics/pharmacokinetics (1987-2014)", "MS": "The quantitation of the body's metabolism of toxic xenobiotic compounds, as measured by the plasma concentration of the toxicant at various time points.", "PM": "2015; see PHARMACOKINETICS 1996-2014", "HN": "2015; use PHARMACOKINETICS 1996-2014", "MR": "20160701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066007"}, {"RECTYPE": "D", "MH": "Cervical Plexus Block", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Plexus Blocks, Cervical", "MN": "E03.155.086.711.824", "FX": "Cervical Plexus", "MH_TH": "NLM (2015)", "ST": "T061", "MS": "A blocking of NEURAL CONDUCTION in the network of nerve fibers innervating the neck and shoulder.", "PM": "2015", "HN": "2015", "MR": "20140606", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066008"}, {"RECTYPE": "D", "MH": "Endothelial Progenitor Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Progenitor Cells, Endothelial", "MN": "A11.436.275.182", "MH_TH": "NLM (2015)", "ST": "T025", "PI": "Stem Cells (1997-2014)", "MS": "Cells derived from BONE MARROW that circulate in the adult bloodstream and possess the potential to proliferate and differentiate into mature ENDOTHELIAL CELLS.", "PM": "2015", "HN": "2015", "MR": "20160701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066026"}, {"RECTYPE": "D", "MH": "Transplant Recipients", "DE": "TRANSPL RECIPIENTS", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Transplant Recipient|T101|NON|EQV|NLM (1996)|960321|TRANSPL RECIPIENT|abcdefv", "MN": "M01.925", "MH_TH": "NLM (1976)", "ST": "T101", "PI": "Transplantation (1976-2014)", "MS": "Individuals receiving tissues or organs transferred from another individual of the same or different species, or from within the same individual.", "PM": "2015; was indexed under TRANSPLANTATION 1976-2014", "HN": "2015(1976); was indexed under TRANSPLANTATION 1976-2014", "MR": "20190701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066027"}, {"RECTYPE": "D", "MH": "Diet, Paleolithic", "AQ": "AE EC EH HI PX SN", "ENTRY": "Stone Age Diets", "MN": "G07.203.650.240.275", "MH_TH": "NLM (2015)", "ST": "T061", "PI": "Diet (1987-2014)", "MS": "A nutritional plan based on the presumed diet of pre-agricultural human ancestors. It consists mainly of MEAT, EGGS, NUTS, roots and fresh VEGETABLES and FRUITS, and excludes GRAIN, LEGUMES, DAIRY PRODUCTS, and refined DIETARY SUGARS.", "PM": "2015", "HN": "2015", "MR": "20150629", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066046"}, {"RECTYPE": "D", "MH": "Vincetoxicum", "AQ": "AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI", "PRINT ENTRY": "Cynanchum atratum|T002|NON|NRW|NLM (2015)|140312|abcdef", "ENTRY": "atratums, Vincetoxicum", "MN": "B01.875.800.575.912.250.456.500.979", "MH_TH": "NLM (2015)", "ST": "T002", "RN": "txid63501", "RR": "txid157443", "MS": "A plant genus of the dogbane family ASCLEPIADACEAE.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066047"}, {"RECTYPE": "D", "MH": "Response Evaluation Criteria in Solid Tumors", "PRINT ENTRY": "RECIST|T185|ACR|EQV|NLM (2015)|140314|abcdef", "MN": "N05.715.360.575.575.800.569", "MH_TH": "NLM (2015)", "ST": "T185", "MS": "An internationally recognized set of published rules used for evaluation of cancer treatment that define when tumors found in cancer patients improve, worsen, or remain stable during treatment. These criteria are based specifically on the response of the tumor(s) to treatment, and not on the overall health status of the patient resulting from treatment.", "PM": "2015", "HN": "2015", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066066"}, {"RECTYPE": "D", "MH": "Military Family", "AQ": "EC EH HI PX SN", "PRINT ENTRY": "Military Families|T099|NON|EQV|NLM (2015)|140314|abcdef", "ENTRY": "Veterans Family", "MN": "I01.880.853.150.482", "FX": "Veterans", "MH_TH": "NLM (2015)", "ST": "T099", "AN": "for families of veterans, coordinate with VETERANS", "PI": "Military Personnel (1979-2014)", "MS": "Men and women serving on active duty in the military, or in a reserve military force, and their immediate family including spouses, children, and parents.", "PM": "2015", "HN": "2015", "MR": "20190821", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066067"}, {"RECTYPE": "D", "MH": "Health Services for Persons with Disabilities", "AQ": "CL EC ES HI LJ OG SD SN ST TD", "ENTRY": "Health Services for the Disabled|T058|NON|EQV|NLM (2015)|140317|abcdef", "MN": "N02.421.314", "FX": "Disabled Persons", "MH_TH": "NLM (2015)", "ST": "T058", "MS": "Health services and access for DISABLED PERSONS. Disabilities include impairments, activity limitations, or participation restrictions, and reflect the interaction between the individual with the disability and personal and environmental factors.", "PM": "2015", "HN": "2015", "MR": "20150629", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066086"}, {"RECTYPE": "D", "MH": "Perinatal Death", "AQ": "ET PC", "ENTRY": "Perinatal Deaths", "MN": "C23.550.260.865", "FX": "Perinatal Mortality", "MH_TH": "NLM (2015)", "ST": "T046", "AN": "Do not confuse with PERINATAL MORTALITY, a statistical concept", "MS": "The death of a FETUS of GESTATIONAL AGE 28 weeks or more, or the death of a live-born INFANT less than 28 days of age.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066087"}, {"RECTYPE": "D", "MH": "Infant Death", "AQ": "ET PC", "ENTRY": "Infant Deaths", "MN": "C23.550.260.657", "FX": "Perinatal Mortality", "MH_TH": "NLM (2015)", "ST": "T046", "AN": "use PERINATAL DEATH for death of an infant less than 28 days of age; do not confuse with INFANT MORTALITY, a statistical concept", "MS": "The death of a live-born INFANT within its first year of life.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066088"}, {"RECTYPE": "D", "MH": "Seoul", "AQ": "EH EP", "MN": "Z01.433.887", "MH_TH": "NLM (2015)", "ST": "T083", "MS": "The capital of SOUTH KOREA.", "HN": "2015", "MR": "20140609", "DA": "20140626", "DC": "4", "DX": "20150101", "UI": "D066106"}, {"RECTYPE": "D", "MH": "Social Skills", "ENTRY": "Social Skill", "MN": "F01.829.401.737", "MH_TH": "NLM (2015)", "ST": "T054", "PI": "Social Behavior (1970-2014)", "MS": "The personal set of abilities required to successfully interact and communicate with others, both verbally and non-verbally through gestures, body language and personal appearance.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066107"}, {"RECTYPE": "D", "MH": "Cardiotoxicity", "AQ": "BL CF CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VE VI", "ENTRY": "Toxicity, Cardiac", "MN": "G01.750.748.500.266", "MH_TH": "NLM (2015)", "ST": "T037", "AN": "coordinate NIM with specific heart disease (IM) if pertinent", "PI": "Radiation Injuries (1975-2014)", "MS": "Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.", "PM": "2015", "HN": "2015", "MR": "20190705", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066126"}, {"RECTYPE": "D", "MH": "White Matter", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Cerebellar White Matter|T023|NON|NRW|NLM (2015)|140324|abcdef", "ENTRY": "White Matters, Cerebellar", "MN": "A08.186.854.880", "FX": "Nerve Fibers, Myelinated", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Nerve Fibers, Myelinated (1963-2014)", "MS": "The region of CENTRAL NERVOUS SYSTEM that appears lighter in color than the other type, GRAY MATTER. It mainly consists of MYELINATED NERVE FIBERS and contains few neuronal cell bodies or DENDRITES.", "PM": "2015", "HN": "2015", "MR": "20140611", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066127"}, {"RECTYPE": "D", "MH": "Gray Matter", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Matters, Grey", "MN": "A08.186.854.348", "FX": "Nerve Fibers, Unmyelinated", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Brain (1963-2014)", "MS": "Region of CENTRAL NERVOUS SYSTEM that appears darker in color than the other type, WHITE MATTER. It is composed of neuronal CELL BODIES; NEUROPIL; GLIAL CELLS and CAPILLARIES but few MYELINATED NERVE FIBERS.", "PM": "2015", "HN": "2015", "MR": "20140625", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066128"}, {"RECTYPE": "D", "MH": "Cell Body", "AQ": "CH CL DE EN GE IM ME MI PA PH PS RE UL VI", "ENTRY": "Body, Cell", "MN": "A11.284.074", "MH_TH": "NLM (2015)", "ST": "T026", "MS": "The portion of a cell that contains the NUCLEUS and CYTOPLASM but not CELL SURFACE EXTENSIONS such as FLAGELLA and NEURITES.", "PM": "2015", "HN": "2015", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066146"}, {"RECTYPE": "D", "MH": "Spinal Cord Dorsal Horn", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Zona Spongiosas", "MN": "A08.186.854.697", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Spinal Cord (1970-2014)", "MS": "One of three central columns of the spinal cord. It is composed of GRAY MATTER spinal laminae I-VI.", "PM": "2015", "HN": "2015", "MR": "20140611", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066148"}, {"RECTYPE": "D", "MH": "International Planned Parenthood Federation", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Planned Parenthood Federation of America|T093|NON|NRW|UNK (19XX)|781226|abcdef", "MN": "N03.540.630.780.305", "MH_TH": "NLM (2015)", "ST": "T093", "AN": "CATALOGER: USE NAF entry", "MS": "A non-profit organization concerned with providing access to sexual and reproductive health information and services.", "PM": "2015; for IPPF see INTERNATIONAL AGENCIES 1978-2014; for PLANNED PARENTHOOD FEDERATION OF AMERICA see VOLUNTARY HEALTH AGENCIES 1978-2015", "HN": "2015; for IPPF use INTERNATIONAL AGENCIES 1978-2014; for PLANNED PARENTHOOD FEDERATION OF AMERICA use VOLUNTARY HEALTH AGENCIES 1978-2015", "MR": "20150615", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066149"}, {"RECTYPE": "D", "MH": "Organisation for Economic Co-Operation and Development", "AQ": "CL EC ES HI LJ OG SN ST TD", "ENTRY": "Organization for Economic Cooperation and Development|T093|NON|EQV|NLM (2015)|140606|abcdef", "MN": "N03.540.514.481", "MH_TH": "NLM (2015)", "ST": "T093", "AN": "CATALOGER: Use NAF entry", "MS": "An international organization whose mission is to stimulate world trade and economic progress by offering a forum where governments can collectively develop and refine social and economic policies.", "PM": "2015", "HN": "2015", "MR": "20150605", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066150"}, {"RECTYPE": "D", "MH": "Spinal Cord Ventral Horn", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Anterius, Cornu", "MN": "A08.186.854.729", "MH_TH": "NLM (2015)", "ST": "T023", "MS": "One of three central columns of the spinal cord. It is composed of GRAY MATTER spinal laminae VIII and IX.", "PM": "2015", "HN": "2015", "MR": "20141202", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066151"}, {"RECTYPE": "D", "MH": "Spinal Cord Lateral Horn", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Lateral Gray Column|T023|NON|EQV|NLM (2015)|140325|abcdef", "ENTRY": "Nucleus, Intermediolateral", "MN": "A08.186.854.443", "MH_TH": "NLM (2015)", "ST": "T023", "MS": "One of three central columns of the spinal cord. It is composed of GRAY MATTER and is located laterally in lamina VII.", "PM": "2015", "HN": "2015", "MR": "20140611", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066152"}, {"RECTYPE": "D", "MH": "Pectus Carinatum", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Syndrome, Currarino-Silverman", "MN": "C17.300.182.525", "MH_TH": "NLM (2015)", "ST": "T019", "PI": "Sternum/abnormalities (1967-2014)", "MS": "A developmental anomaly characterized by abnormal anterior protrusion of the STERNUM and adjacent COSTAL CARTILAGE.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066166"}, {"RECTYPE": "D", "MH": "Slit Lamp", "AQ": "AE CL EC ES HI MI PS SD SN ST TD VE VI", "ENTRY": "Slit Lamps", "MN": "E07.230.540.750", "FX": "Slit Lamp Microscopy", "MH_TH": "NLM (2015)", "ST": "T074", "PI": "Ophthalmoscopy (1964-2014)", "MS": "A microscope with a light source that can be projected into a linear beam. It allows cross-sectional viewing of the AQUEOUS HUMOR; CONJUNCTEIVA; CORNEA; EYELIDS; IRIS; and lens (see LENS, EYE) of the eye.", "PM": "2015", "HN": "2015", "MR": "20160527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066167"}, {"RECTYPE": "D", "MH": "Costal Cartilage", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN IR ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sternal Cartilages", "MN": "A02.165.407.325", "MH_TH": "NLM (2015)", "ST": "T024", "PI": "Ribs (1964-2014)", "MS": "Bars of HYALINE CARTILAGE extending from the anterior ends of the upper RIBS. They attach to the STERNUM directly or indirectly by connecting to upper costal cartilage that attaches to the STERNUM. Costal cartilages extend the ribs anteriorly and contribute to the enhanced elasticity of the THORACIC WALL.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066186"}, {"RECTYPE": "D", "MH": "Basal Forebrain", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Ventral Pallidums", "MN": "A08.186.211.200.885.287.750.374", "MH_TH": "NLM (2015)", "ST": "T023", "MS": "The region of the telencephalon located rostral and ventral to the STRIATUM comprising AMYGDALA; SEPTAL NUCLEI; SUBSTANTIA INNOMINATA and ventral pallidum.", "PM": "2015; for ANTERIOR PERFORATED SUBSTANCE see OLFACTORY PATHWAYS 1972-2014", "HN": "2015; for ANTERIOR PERFORATED SUBSTANCE use OLFACTORY PATHWAYS 1972-2014", "MR": "20210701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066187"}, {"RECTYPE": "D", "MH": "Taiga", "ENTRY": "Taigas", "MN": "N06.230.124.343.750", "MH_TH": "NLM (2015)", "ST": "T082", "PI": "Ecosystem (2000-2014)", "MS": "An ecosystem dominated by coniferous forests including the tree line bordered by TUNDRA to the north and STEPPE to the south.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066188"}, {"RECTYPE": "D", "MH": "Missionaries", "AQ": "CL ED HI LJ PX SN", "ENTRY": "Missionary", "MN": "M01.427", "FX": "Religious Missions", "MH_TH": "NLM (1991)", "ST": "T097", "AN": "RELIGIOUS MISSIONS and MEDICAL MISSIONS are also available", "PI": "Missions and Missionaries (1990-2014)", "MS": "Persons sent into an area to evangelize or to perform acts of service, such as medical care, EDUCATION, or SOCIAL JUSTICE.", "PM": "2015; see MISSIONS AND MISSIONARIES 1990-2014", "HN": "2015(1991); use MISSIONS AND MISSIONARIES 1990-2014", "MR": "20190701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066189"}, {"RECTYPE": "D", "MH": "Allesthesia", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "PRINT ENTRY": "Allochiria|T048|NON|REL|NLM (2015)|140401|abcdef", "ENTRY": "Dyschirias", "MN": "F01.700.750.175", "MH_TH": "NLM (2015)", "ST": "T048", "AN": "do not confuse with ALLIESTHESIA see INTEROCEPTION", "MS": "A neurological disorder in which a sensory stimulus, usually tactile but more rarely other sensory modalities, is misperceived in a location distant from the original stimulus.", "PM": "2015", "HN": "2015", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066190"}, {"RECTYPE": "D", "MH": "Sensorimotor Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Sensory-Motor Cortices", "MN": "A08.186.211.200.885.287.500.814", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Somatosensory Cortex (1970-2014)", "MS": "A composite area of the cerebral cortex concerned with motor control and sensory perception comprising the motor cortex areas, the somatosensory areas, the gustatory cortex, the olfactory areas, the auditory cortex, and the visual cortex.", "PM": "2015", "HN": "2015", "MR": "20180630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066191"}, {"RECTYPE": "D", "MH": "Manufacturing Industry", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "ENTRY": "Manufacturing Industries", "MN": "J01.576.655", "MH_TH": "NLM (2012)", "ST": "T057", "PI": "Industry (1977-2014)", "MS": "An INDUSTRY which specializes in the fabrication or manufacture of products from raw or intermediate materials.", "PM": "2015; see INDUSTRY 2012-2014", "HN": "2015; use INDUSTRY 2012-2014", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066192"}, {"RECTYPE": "D", "MH": "Cervical Cord", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Spinal Cords, Cervical", "MN": "A08.186.854.126", "MH_TH": "NLM (2015)", "ST": "T023", "MS": "The segment of the spinal cord within the CERVICAL VERTEBRAE.", "PM": "2015", "HN": "2015", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066193"}, {"RECTYPE": "D", "MH": "Olfactory Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Rhinencephalon|T023|NON|EQV|UNK (19XX)|740330|abcdef", "ENTRY": "Rhinencephalons", "MN": "A08.186.211.200.885.287.750", "MH_TH": "NLM (1993)", "ST": "T023", "PI": "Olfactory Pathways (1991-2014)", "MS": "Basal forebrain and medial part of temporal lobe areas that receive synaptic inputs from the OLFACTORY BULB.", "PM": "2015; see CENTRAL NERVOUS SYSTEM 1972-1990 and OLFACTORY PATHWAYS 1991-2014; for RHINENCEPHALON see LIMBIC SYSTEM 1963-1999 and OLFACTORY PATHWAYS 2000-2014", "HN": "2015; use CENTRAL NERVOUS SYSTEM 1972-1990 and OLFACTORY PATHWAYS 1991-2014; for RHINENCEPHALON use LIMBIC SYSTEM 1963-1999 and OLFACTORY PATHWAYS 2000-2014", "MR": "20210701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066194"}, {"RECTYPE": "D", "MH": "Piriform Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Region, Prepyriform", "MN": "A08.186.211.200.885.287.750.750", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Olfactory Pathways (1967-2014)", "MS": "An area of the olfactory cortex comprising the rostral half of the uncus of the PARAHIPPOCAMPAL GYRUS and the anterior PARAHIPPOCAMPAL GYRUS. It receives major afferents directly from the OLFACTORY BULB.", "PM": "2015", "HN": "2015", "MR": "20210701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066195"}, {"RECTYPE": "D", "MH": "Olfactory Tubercle", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Anterior Perforated Substance|T023|NON|EQV|NLM (1993)|911220|abcdef", "ENTRY": "Tuberculum Olfactoriums", "MN": "A08.186.211.200.885.287.750.656", "MH_TH": "NLM (1993)", "ST": "T023", "PI": "Olfactory Pathways (1971-2014)", "MS": "Region in the ventral TELENCEPHALON located anterior to the OPTIC CHIASM, posterior to the OLFACTORY PEDUNCLE, rostral to the PIRIFORM AREA and ventral to the NUCLEUS ACCUMBENS.", "PM": "2015; see OLFACTORY PATHWAYS 1972-2014", "HN": "2015; use OLFACTORY PATHWAYS 1972-2014", "MR": "20210701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066208"}, {"RECTYPE": "D", "MH": "Medical Writing", "AQ": "HI ST", "ENTRY": "Writings, Medical", "MN": "L01.559.423.906.654", "FX": "Manuscripts, Medical as Topic", "MH_TH": "NLM (2015)", "ST": "T090", "PI": "Writing (1963-2014)", "MS": "The practice of writing usually by a skilled or specialized writer focused on the reporting or dissemination of medical information for a target audience.", "PM": "2015", "HN": "2015", "MR": "20170703", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066209"}, {"RECTYPE": "D", "MH": "Vaginal Absorption", "AQ": "DE GE IM PH RE", "ENTRY": "Absorption, Vaginal", "MN": "G07.690.725.015.500.937", "FX": "Administration, Intravaginal", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Vagina/metab (1976-2014)", "MS": "The uptake of substances from the VAGINA via the vaginal epithelium/mucosa.", "PM": "2015", "HN": "2015", "MR": "20160701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066228"}, {"RECTYPE": "D", "MH": "Speech Sound Disorder", "AQ": "BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH SU TH UR VI", "ENTRY": "Speech Sound Disorders", "MN": "F03.625.374.500", "MH_TH": "NLM (2016)", "ST": "T048", "MS": "Persistent difficulty with speech sound production such that it interferes with verbal communication.", "PM": "2016; SPEECH SOUND DISORDER was indexed under LANGUAGE DISORDERS 2013-2015", "HN": "2016 (2013)", "MR": "20180619", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D066229"}, {"RECTYPE": "D", "MH": "Patient-Specific Modeling", "AQ": "CL EC ES HI SN ST TD", "ENTRY": "Physiomes", "MN": "L01.224.160.750", "FX": "Precision Medicine", "MH_TH": "NLM (2015)", "ST": "T066", "PI": "Models, Biological (2006-2014)", "MS": "The development and application of computational models of human pathophysiology that are individualized to patient-specific data.", "PM": "2015", "HN": "2015", "MR": "20170703", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066230"}, {"RECTYPE": "D", "MH": "Surgeons", "AQ": "CL EC ED ES HI LJ OG PX SD SN ST TD", "MN": "N02.360.810.910", "MH_TH": "NLM (2015)", "ST": "T097", "MS": "Medical practitioners qualified to practice surgery.", "PM": "2015", "HN": "2015", "MR": "20180629", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066231"}, {"RECTYPE": "D", "MH": "Pulmonary Elimination", "AQ": "DE GE IM PH RE", "ENTRY": "Excretion, Pulmonary", "MN": "G09.772.625", "FX": "Exhalation", "MH_TH": "NLM (2015)", "ST": "T042", "MS": "The discharge of substances from the pulmonary capillary blood into the alveolar space to be exhaled or removed by MUCOCILIARY CLEARANCE.", "PM": "2015", "HN": "2015", "MR": "20200609", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066232"}, {"RECTYPE": "D", "MH": "Psychology, Developmental", "AQ": "CL EC ED ES HI IS LJ MT OG SN ST TD", "PRINT ENTRY": "Developmental Psychology|T091|NON|EQV|NLM (2015)|140407|abcdef", "MN": "F04.096.628.270", "FX": "Psychology, Child", "MH_TH": "NLM (2015)", "ST": "T091", "AN": "use for the specialty only", "MS": "Field of study concerned with age-related changes in BEHAVIOR that occur in human beings over the course of life, from birth to death. It includes all aspects of human growth, including emotional, intellectual, social, perceptual and personality development.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066233"}, {"RECTYPE": "D", "MH": "Lacrimal Elimination", "AQ": "DE GE IM PH RE", "ENTRY": "Excretion, Lacrimal", "MN": "G14.540", "MH_TH": "NLM (2015)", "ST": "T042", "AN": "distinguish from lacrimation, tear formation and secretion: see note at TEARS", "MS": "The discharge of substances into the TEARS.", "PM": "2015", "HN": "2015", "MR": "20200609", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066234"}, {"RECTYPE": "D", "MH": "Fluorine-19 Magnetic Resonance Imaging", "AQ": "AE CL EC ES HI IS MO MT NU PX SN ST TD VE", "ENTRY": "Fluorine 19 Magnetic Resonance Imaging", "MN": "E01.370.350.825.500.350", "MH_TH": "NLM (2015)", "ST": "T060", "MS": "Magnetic resonance imaging diagnostic technique which uses fluorine-19 perfluorocarbon probes and contrast agents for high resolution image detection and quantitation.", "PM": "2015", "HN": "2015", "MR": "20140612", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066235"}, {"RECTYPE": "D", "MH": "Bioresonance Therapy", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU OG PX SN ST TD VE", "ENTRY": "Therapy, MORA", "MN": "E02.190.321.500", "FX": "Magnetic Field Therapy", "MH_TH": "NLM (2015)", "ST": "T061", "PI": "Complementary Therapies (1989-2014)", "MS": "A form of holistic medicine in which ELECTROMAGNETIC WAVES are used to diagnose and treat human and animal illness via manipulation of endogenous electromagnetic oscillations corresponding to the patient's current physiological condition.", "PM": "2016", "HN": "2016", "MR": "20141015", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D066236"}, {"RECTYPE": "D", "MH": "Intestinal Elimination", "AQ": "DE GE IM PH RE", "ENTRY": "Excretion, Intestinal", "MN": "G10.261.433", "MH_TH": "NLM (2015)", "ST": "T042", "AN": "do not confuse with DEFECATION", "MS": "The discharge of substances from the blood supply into the intestinal lumen for excretion by DEFECATION.", "PM": "2015", "HN": "2015", "MR": "20200609", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066237"}, {"RECTYPE": "D", "MH": "Cutaneous Elimination", "AQ": "DE GE IM PH RE", "ENTRY": "Excretions, Cutaneous", "MN": "G13.750.208", "FX": "Sweating", "MH_TH": "NLM (2015)", "ST": "T042", "AN": "do not confuse with SWEATING", "MS": "The discharge of substances from the blood supply to the glands of the skin and excretion in the SWEAT and SEBUM.", "PM": "2015", "HN": "2015", "MR": "20200609", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066238"}, {"RECTYPE": "D", "MH": "Lacteal Elimination", "AQ": "DE GE IM PH RE", "ENTRY": "Lacteal Excretions", "MN": "G08.686.525", "MH_TH": "NLM (2015)", "ST": "T042", "MS": "The discharge of substances from the blood supply into the milk formed in and secreted by the MAMMARY GLAND.", "PM": "2015", "HN": "2015", "MR": "20200609", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066239"}, {"RECTYPE": "D", "MH": "Anterior Commissure, Brain", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Anterior Commissure of Brain|T023|NON|EQV|NLM (2020)|181109|abcdef", "ENTRY": "Commissure, Brain Anterior", "MN": "A08.186.211.200.885.800.500", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Brain (1964-2014)", "MS": "Bundle of MYELINATED NERVE FIBERS that connects the two CEREBRAL HEMISPHERES in the LAMINA TERMINALIS. It is located ventral to the SEPTAL NUCLEI, and caudal to the median PREOPTIC NUCLEUS.", "PM": "2020; see Anterior Cerebellar Commissure 2015-2019", "HN": "2020; was Anterior Cerebellar Commissure 2015-2019", "MR": "20190222", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066240"}, {"RECTYPE": "D", "MH": "Carbon-13 Magnetic Resonance Spectroscopy", "AQ": "AE CL EC HI IS MT SN ST TU", "ENTRY": "Carbon 13 Magnetic Resonance Spectroscopy", "MN": "E05.196.867.519.136", "MH_TH": "NLM (2015)", "ST": "T060", "PI": "Magnetic Resonance Spectroscopy (1973-2014)", "MS": "Magnetic resonance spectroscopy involving detection of changes in the resonance of carbon-13 nuclei in organic molecules.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066241"}, {"RECTYPE": "D", "MH": "Posterior Cerebellar Commissure", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Posterior Commissures, Cerebellar", "MN": "A08.186.211.132.659.800.611", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Diencephalon (1964-2014)", "MS": "A bundle of nerve fibers that crosses the midline in the tectum mesencephali dorsal to the CEREBRAL AQUEDUCT.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066243"}, {"RECTYPE": "D", "MH": "Proton Magnetic Resonance Spectroscopy", "AQ": "AE CL EC HI IS MT SN ST TU", "ENTRY": "1H-NMR|T060|ABB|NRW|NLM (2015)|140609|abcdef", "MN": "E05.196.867.519.775", "MH_TH": "NLM (2015)", "ST": "T060", "PI": "Spectrum Analysis (1966-2014)", "MS": "Spectroscopy technique which measures changes in organic compounds by tracking the spectral energy of absorption of HYDROGEN atoms.", "PM": "2015", "HN": "2015", "MR": "20140625", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066244"}, {"RECTYPE": "D", "MH": "Telencephalic Commissures", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Forebrain Commissures|T023|NON|EQV|NLM (2015)|140409|abcdef", "ENTRY": "Telencephalic Commissure", "MN": "A08.186.211.200.885.800", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Telencephalon (1964-2014)", "MS": "Set of nerve fibers that cross the midline of the TELENCEPHALON. They include the ANTERIOR COMMISSURE; the CORPUS CALLOSUM; and the HIPPOCAMPAL COMMISSURE of the fornix.", "PM": "2015", "HN": "2015", "MR": "20180702", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066245"}, {"RECTYPE": "D", "MH": "ErbB Receptors", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "PRINT ENTRY": "erbB-1 Proto-Oncogene Protein|T116|T126|T192|NON|NRW|NLM (2000)|991104|ERBB PROTO ONCOGENE PROTEIN 001|abbbcdefs", "ENTRY": "erbB 1 Proto Oncogene Protein", "MN": "D12.776.543.750.750.400.074", "FX": "Genes, erbB", "MH_TH": "NLM (2015)", "ST": "T192", "RN": "EC 2.7.10.1", "MS": "A family of structurally related cell-surface receptors that signal through an intrinsic PROTEIN-TYROSINE KINASE. The receptors are activated upon binding of specific ligands which include EPIDERMAL GROWTH FACTORS, and NEUREGULINS.", "PM": "2019; for RECEPTOR, EPIDERMAL GROWTH FACTOR see RECEPTOR, EPIDERMAL GROWTH FACTOR 1999-2018; see RECEPTORS, EPIDERMAL GROWTH FACTOR-UROGASTRONE 1978-1999; for EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE see EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999", "HN": "2019 (2015); for RECEPTOR, EPIDERMAL GROWTH FACTOR use RECEPTOR, EPIDERMAL GROWTH FACTOR 1999-2018; for EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE use RECEPTOR, EPIDERMAL GROWTH FACTOR 1994-1999", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066246"}, {"RECTYPE": "D", "MH": "Receptor, ErbB-4", "AQ": "AD AE AG AI AN BI BL CF CH CL CS DE DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UL UR", "ENTRY": "c ErbB 4 Protein", "MN": "D23.101.140.760", "MH_TH": "NLM (2015)", "ST": "T192", "RN": "EC 2.7.10.1", "MS": "A cell surface protein-tyrosine kinase receptor that has specificity for EPIREGULIN; BETACELLIN; NEUREGULINS; and HEPARIN-BINDING EGF-LIKE GROWTH-FACTOR.", "PM": "2015; RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4 was indexed under RECEPTOR, EPIDERMAL GROWTH FACTOR 1993-2014", "HN": "2015", "MR": "20210521", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066247"}, {"RECTYPE": "D", "MH": "High Fructose Corn Syrup", "AQ": "AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR", "ENTRY": "Syrup, Maize", "MN": "J02.500.514.500.400.700.750.500", "PA": "Sweetening Agents", "MH_TH": "NLM (2015)", "ST": "T168", "RN": "0", "MS": "Syrup made from corn used widely in foods and beverages as a cheaper alternative sweetener to SUCROSE (common table sugar). It is generated by enzymatic processing of natural corn syrup to produce a liquid most widely composed of 42 or 55% FRUCTOSE, GLUCOSE, and various POLYSACCHARIDES.", "PM": "2015", "HN": "2015", "MR": "20170628", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066248"}, {"RECTYPE": "D", "MH": "Craving", "AQ": "CL DE ES PH RE", "ENTRY": "Cravings", "MN": "F01.658.293.195", "FX": "Appetite", "MH_TH": "NLM (2015)", "ST": "T041", "MS": "An intense, urgent, or abnormal desire or longing (for food, drugs, alcohol, etc.)", "PM": "2015", "HN": "2015", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066249"}, {"RECTYPE": "D", "MH": "Pretectal Region", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Regions, Pretectal", "MN": "A08.186.211.132.659.800.662", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Tectum Mesencephali (1964-2014)", "MS": "Region of midbrain tectum located posterior to the THALAMUS and anterior to the SUPERIOR COLLICULUS.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066250"}, {"RECTYPE": "D", "MH": "Subtractive Hybridization Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "Subtractive Genomic Hybridization|T059|NON|REL|NLM (2022)|210315|abcdef", "ENTRY": "Technique, Subtractive Hybridization", "MN": "E05.393.661.820", "FX": "Gene Expression Profiling", "MH_TH": "NLM (2015)", "ST": "T063", "MS": "Methods of studying differential GENE EXPRESSION of especially low-abundance, tissue-specific gene transcripts.", "PM": "2015", "HN": "2015", "MR": "20210510", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066251"}, {"RECTYPE": "D", "MH": "Sociological Factors", "PRINT ENTRY": "Sociological Phenomena|T078|NON|EQV|NLM (2015)|140411|abcdef", "ENTRY": "Traits, Social", "MN": "I01.880.853", "MH_TH": "NLM (2015)", "ST": "T078", "MS": "Attributes and experiences that influence an individual's personality, attitudes, and lifestyle, which are derived from the social values and/or behavior of the groups to which an individual belongs, or aspires to belong.", "PM": "2015; for SOCIAL CHARACTERISTICS see SOCIOLOGY 1981-2014", "HN": "2015; for SOCIAL CHARACTERISTICS use SOCIOLOGY 1981-2014", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066252"}, {"RECTYPE": "D", "MH": "Vascular Remodeling", "AQ": "DE GE IM PH RE", "ENTRY": "Vascular Remodelings", "MN": "G09.330.930", "FX": "Neovascularization, Physiologic", "MH_TH": "NLM (2015)", "ST": "T042", "PI": "Neovascularization, Physiologic (1998-2014)", "MS": "The active alterations of vascular wall structures, often leading to elevated VASCULAR RESISTANCE. It is associated with AGING; ATHEROSCLEROSIS; DIABETES MELLITUS; HYPERTENSION; PREGNANCY; PULMONARY HYPERTENSION; and STROKE, but is also a normal part of EMBRYOGENESIS.", "PM": "2015", "HN": "2015", "MR": "20230706", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066253"}, {"RECTYPE": "D", "MH": "Axillofemoral Bypass Grafting", "AQ": "AE CL EC ED ES HI IS LJ MO MT NU PX RH SN ST TD VE", "ENTRY": "Grafting, Axillofemoral Bypass", "MN": "E04.100.814.334", "MH_TH": "NLM (2015)", "ST": "T061", "MS": "An extra-anatomic method of surgical revascularization in which the AXILLARY ARTERY is anastomosed to FEMORAL ARTERY.", "PM": "2015", "HN": "2015", "MR": "20140606", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066254"}, {"RECTYPE": "D", "MH": "EGF Family of Proteins", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Receptor Ligands, EGF", "MN": "D23.529.382", "MH_TH": "NLM (2015)", "ST": "T123", "RN": "0", "PI": "Epidermal Growth Factor (1981-2014)", "MS": "A family of proteins that are related to epidermal growth factor. They share in common a consensus sequence consisting of six spatially conserved CYSTEINE residues which form three intramolecular bonds. This consensus sequence is commonly referred to EGF motif and is considered essential for binding of the proteins to ERB RECEPTORS.", "PM": "2015; For EPIDERMAL GROWTH FACTORS see EPIDERMAL GROWTH FACTOR 1981-2014", "HN": "2015; for EPIDERMAL GROWTH FACTORS use EPIDERMAL GROWTH FACTOR 1981-2014", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066255"}, {"RECTYPE": "D", "MH": "Raw Foods", "AQ": "AE AN CL EC HI MI PO PS RE SD SN ST TO VI", "ENTRY": "Uncooked Food", "MN": "J02.500.737", "MH_TH": "NLM (2015)", "ST": "T168", "MS": "Food prepared for consumption without exposure to heat.", "PM": "2015", "HN": "2015", "MR": "20141014", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066256"}, {"RECTYPE": "D", "MH": "Heparin-binding EGF-like Growth Factor", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "PRINT ENTRY": "Heparin-binding EGF-like Growth-Factor|T116|T123|ABX|EQV|NLM (2015)|140411|abbcdef", "ENTRY": "Toxin Receptors, Diphtheria", "MN": "D23.529.382.625", "MH_TH": "NLM (2015)", "ST": "T123", "RN": "0", "MS": "An EGF family member that is expressed in a variety of hematopoietic, endothelial, vascular smooth muscle, and epithelial cells. It is synthesized as a transmembrane protein which is cleaved by proteases to produce the secreted form of the protein which has specificity for the EGF RECEPTOR and the ERBB-4 RECEPTOR. The membrane-bound form of the protein has been identified as the receptor which binds to and allows DIPHTHERIA TOXIN to enter cells.", "PM": "2015; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2008-2014, and under EPIDERMAL GROWTH FACTOR 1992-2007", "HN": "2015", "MR": "20140624", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066257"}, {"RECTYPE": "D", "MH": "Amphiregulin", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Schwannoma derived Growth Factor", "MN": "D23.529.382.249", "MH_TH": "NLM (2015)", "ST": "T123", "RN": "0", "MS": "An autocrine growth factor and mitogen for a broad range of target cells including EPITHELIAL CELLS; FIBROBLASTS and immune cells. It occurs as a membrane-bound protein that can be cleaved to release an active secreted form.", "PM": "2015; AMPHIREGULIN was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 1988-2014", "HN": "2015", "MR": "20160418", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066258"}, {"RECTYPE": "D", "MH": "Betacellulin", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.529.382.374", "MH_TH": "NLM (2015)", "ST": "T123", "RN": "0", "MS": "An EGF family member that plays an important role in regulating growth and differentiation of PANCREATIC BETA CELLS. Betacellulin has specificity for the EGF RECEPTOR and the ERBB-4 RECEPTOR.", "PM": "2015; BETACELLULIN was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2003-2014, and under GROWTH SUBSTANCES 1993-2002", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066259"}, {"RECTYPE": "D", "MH": "Epiregulin", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "MN": "D23.529.382.562", "MH_TH": "NLM (2015)", "ST": "T123", "RN": "0", "MS": "A member of the epidermal growth factor (EGF) family of peptide growth factors that is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. Epiregulin has specificity for the EGF RECEPTOR and the ERBB-4 RECEPTOR.", "PM": "2015; EPIREGULIN was indexed under EPIDERMAL GROWTH FACTOR 1995-2015", "HN": "2015", "MR": "20140617", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066260"}, {"RECTYPE": "D", "MH": "Epigen", "AQ": "AD AE AG AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR", "ENTRY": "Mitogen, Epithelial", "MN": "D23.529.382.531", "MH_TH": "NLM (2015)", "ST": "T123", "RN": "0", "MS": "An EGF family member that is synthesized as a membrane-bound protein that can be cleaved to release an active secreted form. It has a mitogenic effect on EPITHELIAL CELLS.", "PM": "2015; EPIGEN was indexed under EPIDERMAL GROWTH FACTOR 2001-2014", "HN": "2015", "MR": "20140624", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066261"}, {"RECTYPE": "D", "MH": "Social Norms", "AQ": "EH HI", "ENTRY": "Societal Norm", "MN": "I01.880.853.903", "FX": "Social Values", "MH_TH": "NLM (2015)", "ST": "T078", "MS": "Customary standards that govern behavior in groups, cultures, or societies. They reflect what a group deems acceptable in a social context in terms of appropriate and inappropriate values, beliefs, attitudes, and behaviors.", "PM": "2015", "HN": "2015", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066262"}, {"RECTYPE": "D", "MH": "Protein Aggregation, Pathological", "AQ": "BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI", "ENTRY": "Pathological Protein Aggregation", "MN": "G02.111.675", "FX": "Protein Aggregates", "MH_TH": "NLM (2015)", "ST": "T044", "MS": "A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS.", "PM": "2015", "HN": "2015", "MR": "20200205", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066263"}, {"RECTYPE": "D", "MH": "Datasets as Topic", "AQ": "CL EC ES HI LJ SD SN ST TD", "PRINT ENTRY": "Dataset as Topic|T170|NON|EQV|NLM (2015)|140415|abcdef", "ENTRY": "Data Sets as Topic|T170|NON|EQV|NLM (2015)|140415|abcdef", "MN": "N06.850.520.308.056", "MH_TH": "NLM (2015)", "ST": "T170", "AN": "use only for datasets as a subject; do not confuse with Publication Type DATASET", "MS": "Subject matter related to the curation of data from research projects, stored permanently in a formalized manner suitable for communication, interpretation, or processing.", "PM": "2015", "HN": "2015", "MR": "20170630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066264"}, {"RECTYPE": "D", "MH": "Midbrain Reticular Formation", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Tegmental Reticular Formations", "MN": "A08.186.211.132.772.322", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Reticular Formation (1963-2014)", "MS": "The midbrain portion of the reticular formation located in the MIDBRAIN TEGMENTUM.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066265"}, {"RECTYPE": "D", "MH": "Trigeminal Motor Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Nucleus, Trigeminal Motor", "MN": "A08.186.211.132.931.459", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Trigeminal Nuclei (1963-2014)", "MS": "Nucleus located in the pontine tegmentum with motor neurons that innervate the muscles of the JAW through the motor portion of the TRIGEMINAL NERVE.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066266"}, {"RECTYPE": "D", "MH": "Midbrain Raphe Nuclei", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU UL VI", "ENTRY": "Rostral Raphe Nucleus", "MN": "A08.186.211.132.659.413.875.618.624", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Raphe Nuclei (1977-2014)", "MS": "Raphe nuclei located in the midbrain including the dorsal and median raphe nuclei. They are the origin of the major serotonergic innervation in the FOREBRAIN.", "PM": "2015", "HN": "2015", "MR": "20150623", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066267"}, {"RECTYPE": "D", "MH": "Interpeduncular Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nucleus, Interpeduncular", "MN": "A08.186.211.132.659.413.875.618.436", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Mesencephalon (1963-2014)", "MS": "A nucleus located at the midline of the ventral MIDBRAIN TEGMENTUM with primarily GABAergic projections to the median and dorsal raphe nuclei and the MIDBRAIN CENTRAL GRAY.", "PM": "2015", "HN": "2015", "MR": "20150622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066268"}, {"RECTYPE": "D", "MH": "Social Theory", "ENTRY": "Theory, Sociological", "MN": "F02.970", "MH_TH": "NLM (2015)", "ST": "T078", "MS": "Frameworks of empirical evidence used to study and interpret social phenomena.", "PM": "2015", "HN": "2015", "MR": "20150616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066269"}, {"RECTYPE": "D", "MH": "Social Capital", "PRINT ENTRY": "Social Infrastructure|T078|NON|REL|OBSSR (2022)|210609|abcdef", "ENTRY": "Social Infrastructures", "MN": "I01.880.853.375", "MH_TH": "NLM (2015)", "ST": "T078", "AN": "for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH", "MS": "Resources of social trust, norms, and networks that people can draw upon to solve common problems. It  includes families, schools, churches, neighborhood associations, clubs, and community organizations. (ERIC Thesaurus accessed 6/8/2021)", "PM": "2015", "HN": "2015", "MR": "20220523", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066270"}, {"RECTYPE": "D", "MH": "External Capsule", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Externas, Capsula", "MN": "A08.186.211.200.885.382", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Putamen (1979-2014)", "MS": "Thin layer of WHITE MATTER mostly of GABAERGIC NEURONS located between the PUTAMEN and the CLAUSTRUM.", "PM": "2015", "HN": "2015", "MR": "20180702", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066271"}, {"RECTYPE": "D", "MH": "Basolateral Nuclear Complex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Basolateral Amygdaloid Nucleus|T023|NON|NRW|NLM (2022)|210426|abcdef", "ENTRY": "Nucleus, Basolateral Amygdaloid", "MN": "A08.186.211.200.885.287.249.152.500", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Amygdala (1968-2014)", "MS": "A set of amygdalar nuclei bordered laterally by the EXTERNAL CAPSULE and medially by the CENTRAL AMYGDALOID NUCLEUS.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066272"}, {"RECTYPE": "D", "MH": "Diet, Western", "AQ": "AE EC EH HI PX SN", "PRINT ENTRY": "Western Diet|T061|NON|EQV|NLM (2015)|140417|abcdef", "ENTRY": "Western Diets", "MN": "G07.203.650.240.310", "MH_TH": "NLM (2015)", "ST": "T061", "PI": "Diet (1970-2014)", "MS": "A pattern of food consumption adopted mainly by the people of North America and Western Europe. It is mainly characterized by high intake of MEAT, processed grains, DIETARY SUGARS, DAIRY PRODUCTS, and DIETARY FATS.", "PM": "2015", "HN": "2015", "MR": "20150629", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066273"}, {"RECTYPE": "D", "MH": "Central Amygdaloid Nucleus", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Central Amygdala Nucleus|T023|NON|EQV|NLM (2015)|140417|abcdef", "ENTRY": "Nucleus, Central Amygdaloid", "MN": "A08.186.211.200.885.287.249.152.750", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Amygdala (1968-2014)", "MS": "A nucleus located in the caudal half of the amygdala. It is a primary region involved in controlling responses and receives many intrinsic GABAergic amygdaloid connections.", "PM": "2015", "HN": "2015", "MR": "20180630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066274"}, {"RECTYPE": "D", "MH": "Health Information Exchange", "AQ": "CL EC ES HI LJ SD SN ST TD", "ENTRY": "Medical Information Exchanges", "MN": "L01.399.500.500", "MH_TH": "NLM (2015)", "ST": "T065", "MS": "Organizational framework for the dissemination of electronic healthcare information or clinical data, across health-related institutions and systems. Its overall purpose is to enhance PATIENT CARE.", "PM": "2015", "HN": "2015", "MR": "20150622", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066275"}, {"RECTYPE": "D", "MH": "Corticomedial Nuclear Complex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Nucleus of Lateral Olfactory Tract|T023|NON|NRW|NLM (2015)|140418|abcdef", "ENTRY": "Superficial Nucleus, Amygdaloid", "MN": "A08.186.211.200.885.287.249.152.875", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Amygdala (1974-2014)", "MS": "The rostral part of the amygdala with cortical-like layered structure. It receives major inputs from the OLFACTORY BULB and PIRIFORM CORTEX.", "PM": "2015", "HN": "2015", "MR": "20180630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066276"}, {"RECTYPE": "D", "MH": "Periamygdaloid Cortex", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Nucleus, Cortical Amygdalar", "MN": "A08.186.211.200.885.287.500.382.750.612", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Cerebral Cortex (1970-2014)", "MS": "The surface of the parahippocampal gyrus overlying the cortical amygdaloid nucleus.", "PM": "2015", "HN": "2015", "MR": "20210701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066277"}, {"RECTYPE": "D", "MH": "Organum Vasculosum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Organum Vasculosum Laminae Terminalis|T023|NON|EQV|NLM (2001)|991216|abcdef", "ENTRY": "Vasculosums, Organum", "MN": "A08.186.211.200.885.287.500.814.695.249.500", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Cerebellar Nuclei (1973-2014)", "MS": "Circumventricular cellular structure in the anterior hypothalamic region. It is located in the optic recess at the anteroventral end of the THIRD VENTRICLE and forms the ventral part of the midline anterior wall.", "PM": "2015; see HYPOTHALAMUS 2000-2014", "HN": "2015; use HYPOTHALAMUS 2000-2014", "MR": "20210701", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066278"}, {"RECTYPE": "D", "MH": "Courage", "AQ": "CL DE ES PH RE", "ENTRY": "Heroism|T041|NON|EQV|NLM (2015)|140418|abcdef", "MN": "F01.470.257", "FX": "Morale", "MH_TH": "NLM (2015)", "ST": "T041", "MS": "State of mind or spirit that enables one to act in the face of perceived danger, difficulty, or pain.", "PM": "2015", "HN": "2015", "MR": "20140606", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066279"}, {"RECTYPE": "D", "MH": "Circumventricular Organs", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "PRINT ENTRY": "Neurohemal Organ|T023|NON|NRW|UNK (19XX)|830504|abcdef", "ENTRY": "Sensory Circumventricular Organ", "MN": "A08.713.049", "MH_TH": "NLM (2015)", "ST": "T023", "PI": "Neurosecretory Systems (1965-2014)", "MS": "Highly vascularized and specialized tissues distributed principally along the midline of the VENTRICULAR SYSTEM from the FOREBRAIN to the HINDBRAIN. They are distinguished by their lack of normal BLOOD-BRAIN BARRIER and fenestrated capillaries and contain either neurosecretory neurons or chemoreceptors.", "PM": "2015; for NEUROHEMAL ORGAN see NEUROSECRETORY SYSTEMS (1984-2014)", "HN": "2015; for NEUROHEMAL ORGAN use NEUROSECRETORY SYSTEMS (1984-2014)", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066280"}, {"RECTYPE": "D", "MH": "Romanticism", "AQ": "HI", "MN": "K01.883", "MH_TH": "NLM (2016)", "ST": "T078", "MS": "The attitude or intellectual orientation that characterized many works of literature, painting, music, architecture, criticism, and historiography in Western civilization over a period from the late 18th to the mid-19th century.", "PM": "2016", "HN": "2016", "MR": "20150210", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D066288"}, {"RECTYPE": "D", "MH": "Data Curation", "AQ": "CL EC ES HI MT SN ST TD", "ENTRY": "Curation, Data", "MN": "L01.462.750.245.332", "MH_TH": "NLM (2015)", "ST": "T066", "MS": "Management activities required to maintain research data to ensure that they are fit for contemporary use and available for discovery and reuse.", "PM": "2015", "HN": "2015", "MR": "20220712", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066289"}, {"RECTYPE": "D", "MH": "Libraries, Special", "AQ": "CL EC ES HI LJ MT OG SD SN ST TD", "ENTRY": "Special Library", "MN": "L01.462.625.596.719", "MH_TH": "NLM (2016)", "ST": "T092", "PI": "Libraries (1966-2014)", "MS": "Collections covering specialized subjects, containing materials in a special format, or serving a specialized clientele.", "PM": "2016", "HN": "2016", "MR": "20220712", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D066290"}, {"RECTYPE": "D", "MH": "Psychiatry in Literature", "ENTRY": "Literature, Psychiatry in", "MN": "K01.517.584.500", "MH_TH": "NLM (2016)", "ST": "T078", "AN": "coordinate with psychiatric aspect + specific literature heading + literary type if pertinent (POETRY; DRAMA, etc.)", "MS": "Written or other literary works whose subject matter is related to mental disorders or psychiatry from the lay or practitioner perspective.", "PM": "2016", "HN": "2016", "MR": "20190429", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D066291"}, {"RECTYPE": "D", "MH": "Lipid Droplets", "AQ": "CH CL DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Storage Body, Lipid", "MN": "A11.284.430.214.190.875.393", "MH_TH": "NLM (2015)", "ST": "T026", "AN": "differentiate from LIPOSOMES which are artificially created vesicles", "PI": "Lipids (1953-2014)", "MS": "Dynamic cytoplasmic organelles found in almost all cells. They consist of a central core of LIPIDS surrounded by a phospholipid monolayer studded with surface proteins, and are involved in LIPID METABOLISM and storage.", "PM": "2015", "HN": "2015", "MR": "20140616", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066292"}, {"RECTYPE": "D", "MH": "Renshaw Cells", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "V1-Derived Interneuron", "MN": "A11.671.358.375", "MH_TH": "NLM (2015)", "ST": "T025", "PI": "Interneurons (1967-2014)", "MS": "Ipsilateral glycinergic inhibitory interneurons of the SPINAL CORD VENTRAL HORN which modulate recurrent firing of MOTOR NEURONS. They develop from embryonic progenitor domain V1.Ia inhibitory interneurons which also originate from V1 are responsible for reciprocal inhibition of MOTONEURONS.", "PM": "2015", "HN": "2015", "MR": "20141121", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066293"}, {"RECTYPE": "D", "MH": "Commissural Interneurons", "AQ": "CH CL CY DE EN IM ME MI PA PH PS RE TR UL VI", "ENTRY": "Interneurons, Commissural", "MN": "A11.671.358.212", "FX": "Central Pattern Generators", "MH_TH": "NLM (2015)", "ST": "T025", "PI": "Interneurons (1978-2014)", "MS": "INTERNEURONS with projections to the contralateral side of the SPINAL CORD. Both excitatory and inhibitory interneurons are involved in coordinating alternative left-right activities during LOCOMOTION.", "PM": "2015", "HN": "2015", "MR": "20140613", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066294"}, {"RECTYPE": "D", "MH": "Open Access Publishing", "AQ": "CL EC ES HI IS LJ OG SD SN ST TD", "ENTRY": "Publishing, Open Access", "MN": "L01.737.569", "MH_TH": "NLM (2016)", "ST": "T057", "PI": "Publishing (2009-2014)", "MS": "Agreement in which author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use. A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving. (from Bethesda Statement on Open Access Publishing)", "PM": "2016", "HN": "2016", "MR": "20150210", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D066295"}, {"RECTYPE": "D", "MH": "Grounded Theory", "ENTRY": "Theory, Grounded", "MN": "H01.770.644.241.424", "MH_TH": "NLM (2015)", "ST": "T062", "MS": "The generation of theories from analysis of empirical data.", "PM": "2015", "HN": "2015", "MR": "20140606", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066296"}, {"RECTYPE": "D", "MH": "Hermeneutics", "ENTRY": "Hermeneutic", "MN": "H01.770.644.241.850.750", "MH_TH": "NLM (2015)", "ST": "T062", "MS": "The art, theory, and philosophy of interpreting the meaning of an object (a text, work of art, social action, utterances of another speaker, etc.) (Dictionary of Qualitative Inquiry, 2nd ed..)", "PM": "2015", "HN": "2015", "MR": "20140606", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066297"}, {"RECTYPE": "D", "MH": "In Vitro Techniques", "AQ": "CL EC ES HI IS MT SN ST TD VE", "PRINT ENTRY": "In Vitro as Topic|T059|T062|NON|EQV|NLM (2015)|140423|abbcdef", "ENTRY": "Vitro Testing, In", "MN": "E05.481", "MH_TH": "NLM (2015)", "ST": "T062", "AN": "general or unspecified; prefer specifics; NIM for studies of isolated (not cultured) organs and tissues; not for microorganisms", "PI": "In Vitro (1966-2014)", "MS": "Methods to study reactions or processes taking place in an artificial environment outside the living organism.", "PM": "2015", "HN": "2015", "MR": "20200609", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066298"}, {"RECTYPE": "D", "MH": "Electronic Nicotine Delivery Systems", "AQ": "CL EC HI MI PS RE SD SN ST VI", "PRINT ENTRY": "Electronic Nicotine Delivery System|T073|NON|EQV|NLM (2021)|191118|abcdef", "ENTRY": "E Cigs", "MN": "J01.637.767.500", "MH_TH": "NLM (2018)", "ST": "T073", "PI": "Tobacco Products (2009-2014)", "MS": "Devices or objects designed to provide NICOTINE in the form of an inhaled aerosol.", "PM": "2018; see ELECTRONIC CIGARETTES 2015-2017", "HN": "2018 (2015)", "MR": "20200527", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066300"}, {"RECTYPE": "D", "MH": "Public Service Announcements as Topic", "AQ": "CL EC ES HI LJ SN ST TD", "ENTRY": "Public Service Advertising as Topic|T170|NON|EQV|AHCPR (1996)|140425|abcdef", "MN": "L01.143.805", "MH_TH": "NLM (2016)", "ST": "T170", "AN": "do not confuse with the Publication Type PUBLIC SERVICE ANNOUNCEMENT", "MS": "Works about announcements for which no charge is made and which promote programs, activities, or services of federal, state, or local governments or those of non-profit organizations and other announcements regarded as serving community interests.", "PM": "2016", "HN": "2016", "MR": "20190705", "DA": "20150701", "DC": "1", "DX": "20160101", "UI": "D066308"}, {"RECTYPE": "D", "MH": "Public Service Announcement", "PRINT ENTRY": "Public Service Announcements|T170|NON|EQV|NLM (2016)|140425|abcdef", "ENTRY": "Public Service Advertising|T170|NON|EQV|AHCPR (1996)|NLM (2016)|140425|abcdeef", "MN": "V02.736", "MH_TH": "NLM (2019)", "ST": "T170", "AN": "This heading is used as a Publication Type. Public Service Announcements as a subject are indexed under the main heading PUBLIC SERVICE ANNOUNCEMENTS AS TOPIC; INDEXER: Do not use ", "MS": "Work consisting of announcements which promote programs, activities, or services of federal, state, or local governments or those of non-profit organizations and other announcements regarded as serving community interests.", "HN": "2016", "MR": "20180702", "DA": "20150701", "DC": "2", "DX": "20160101", "UI": "D066309"}, {"RECTYPE": "D", "MH": "Digital Divide", "AQ": "HI TD", "ENTRY": "Divide, Digital", "MN": "L01.143.230.500", "MH_TH": "NLM (2016)", "ST": "T068", "MS": "Gap between individuals, households, businesses and geographic areas at different socioeconomic levels with regard to both their opportunities to access electronic  information and communication technologies (ICTs). Their use of the Internet for a wide variety of activities, reflects various differences among and within countries.", "PM": "2016", "HN": "2016", "MR": "20150706", "DA": "20150707", "DC": "1", "DX": "20160101", "UI": "D066310"}, {"RECTYPE": "D", "MH": "Ventral Striatum", "AQ": "AB AH BS CH CY DE DG EM EN GD IM IN ME MI PA PH PP PS RE SU TR UL VI", "ENTRY": "Striatum, Ventral", "MN": "A08.186.211.200.885.287.249.487.775", "MH_TH": "NLM (2000)", "ST": "T023", "MS": "A composite structure of the TELENCEPHALON that is defined by connectivity. It includes the NUCLEUS ACCUMBENS; the ISLANDS OF CALLEJA; and parts of the CAUDATE NUCLEUS; the PUTAMEN; and the SUBSTANTIA INNOMINATA.", "PM": "2015; see BASAL FOREBRAIN 2000-2014", "HN": "2015; use BASAL FOREBRAIN 2000-2014", "MR": "20180630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066328"}, {"RECTYPE": "D", "MH": "Protein Aggregates", "AQ": "DE ES GE IM PH RE", "PRINT ENTRY": "Protein Aggregate|T116|NON|EQV|NLM (2022)|201022|abcdef", "ENTRY": "Aggregates, Protein", "MN": "D05.875", "FX": "Protein Aggregation, Pathological", "MH_TH": "NLM (2015)", "ST": "T116", "RN": "0", "MS": "Any mixture of secondary, tertiary, or quaternary protein molecules which appear as clumps in or outside the cell.", "PM": "2015", "HN": "2015", "MR": "20210630", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066329"}, {"RECTYPE": "D", "MH": "Printing, Three-Dimensional", "AQ": "CL EC ES HI IS LJ SD SN ST TD", "ENTRY": "Three-Dimensional Printings", "MN": "L01.296.110.150.500", "MH_TH": "NLM (2015)", "ST": "T073", "MS": "Process for making, building or constructing a physical object from a three-dimensional digital model by laying down many successive thin layers of building material.", "PM": "2015", "HN": "2015", "MR": "20171010", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066330"}, {"RECTYPE": "D", "MH": "Laser-Evoked Potentials", "AQ": "DE GE IM PH RE", "ENTRY": "Potentials, Laser-Evoked", "MN": "G11.561.200.500.400.500", "MH_TH": "NLM (2015)", "ST": "T060", "PI": "Evoked Potentials (1991-2014)", "MS": "Somatosensory evoked potentials generated through the application of HEAT to the SKIN with a LASER. They are often used clinically to assess the function of the central nociceptive system and in diagnosing NOCICEPTIVE PAIN.", "PM": "2015", "HN": "2015", "MR": "20160120", "DA": "20140626", "DC": "1", "DX": "20150101", "UI": "D066331"}]